Psyllid ID: psy11767
Local Sequence Feature Prediction
| Prediction and (Method) | Result |
|---|
|
|
Close Homologs for Annotation Transfer
Close Homologs in SWISS-PROT Database Detected by BLAST 
Original result of BLAST against SWISS-PROT Database
| ID | Alignment graph | Length |
Definition |
RBH(Q2H) |
RBH(H2Q) |
Q cover |
H cover |
Identity |
E-value |
| Query | 966 | 2.2.26 [Sep-21-2011] | |||||||
| Q5F3L1 | 789 | Ribosomal protein S6 kina | yes | N/A | 0.448 | 0.548 | 0.459 | 1e-121 | |
| O75582 | 802 | Ribosomal protein S6 kina | yes | N/A | 0.447 | 0.538 | 0.459 | 1e-118 | |
| Q5R4K3 | 802 | Ribosomal protein S6 kina | yes | N/A | 0.447 | 0.538 | 0.455 | 1e-117 | |
| Q9Z2B9 | 773 | Ribosomal protein S6 kina | yes | N/A | 0.456 | 0.570 | 0.425 | 1e-106 | |
| O75676 | 772 | Ribosomal protein S6 kina | no | N/A | 0.476 | 0.595 | 0.399 | 1e-101 | |
| Q18846 | 772 | Putative ribosomal protei | yes | N/A | 0.474 | 0.593 | 0.373 | 3e-92 | |
| Q9WUT3 | 733 | Ribosomal protein S6 kina | no | N/A | 0.433 | 0.571 | 0.361 | 1e-75 | |
| P51812 | 740 | Ribosomal protein S6 kina | no | N/A | 0.391 | 0.510 | 0.388 | 1e-74 | |
| P18654 | 740 | Ribosomal protein S6 kina | no | N/A | 0.391 | 0.510 | 0.388 | 1e-74 | |
| Q15349 | 733 | Ribosomal protein S6 kina | no | N/A | 0.407 | 0.537 | 0.370 | 2e-74 |
| >sp|Q5F3L1|KS6A5_CHICK Ribosomal protein S6 kinase alpha-5 OS=Gallus gallus GN=RPS6KA5 PE=2 SV=1 | Back alignment and function desciption |
|---|
Score = 437 bits (1124), Expect = e-121, Method: Compositional matrix adjust.
Identities = 252/548 (45%), Positives = 330/548 (60%), Gaps = 115/548 (20%)
Query: 264 RRILKTEPPIPEDLSPDVADFISRLLVKDPRRRLGGGELDAEELKRHPFFNVIDWDDLAT 323
RRILK+EPP P+++S D I RLL+KDP++RLG G DA+E+K+HPFF I+WDDLA
Sbjct: 259 RRILKSEPPYPQEMSALSKDIIQRLLMKDPKKRLGCGPTDADEIKQHPFFQNINWDDLAA 318
Query: 324 KRIPAPFVPKISNELDVSNFSDEFTKMIPADSPAIVPPNFDKIFKG-------------- 369
K++PAPF P I +ELDVSNF++EFT+M P SPA P +KIF+G
Sbjct: 319 KKVPAPFKPVIRDELDVSNFAEEFTEMDPTYSPAATPQTSEKIFQGYSFVAPSILFKRNA 378
Query: 370 ----------------------------SLFFEQYDMDLDKAGILGDGSYSVCRRCVEKS 401
S FF+ Y++DL K LG+GS+S+CR+C+ K
Sbjct: 379 ATVDPVQFYVGDERPGTTTIARSAMMKDSPFFQHYELDL-KEKPLGEGSFSICRKCLHKK 437
Query: 402 TGQEYAVKIISRKIDCS--EEINLLRACQGHPNIVNLHCVFQDEVHTYLVLELLKGGELL 459
T QEYAVKIIS++++ + EI L+ C+GHPN+V LH V+ D++HT+LV+ELLKGGELL
Sbjct: 438 TSQEYAVKIISKRMEANTQREITALKLCEGHPNVVKLHEVYHDQLHTFLVMELLKGGELL 497
Query: 460 DRIRQKGRCGFTENEASRIMRQLVAAVHFMHSRGVVHRDLKPENLLFSDPAGDN-IKVVD 518
+RI++K F+E EAS IMR+LV+AV MH GVVHRDLKPENLLF+D ++ IK++D
Sbjct: 498 ERIQKKQH--FSETEASHIMRRLVSAVSHMHDVGVVHRDLKPENLLFTDETDNSEIKIID 555
Query: 519 FGFACLK---RESLHTPCFTLQYAAPEVLRQDKSGYDENCDLWSLGVILVNVLRQDKSGY 575
FGFA LK + L TPCFTL YAAPE+ + GYDE+CDLWS
Sbjct: 556 FGFARLKPPDNQPLKTPCFTLHYAAPELFNHN--GYDESCDLWS---------------- 597
Query: 576 DENCDLWSLGVILYTMLCGRVPFHARSRD---DSALSIMARIKEGQFNFDAEAWSTVSSE 632
LGVILYTML G+VPF ++ + SAL IM +IK+G+F+F+ EAW VS E
Sbjct: 598 --------LGVILYTMLSGQVPFQSQDKSLTCTSALEIMKKIKKGEFSFEGEAWKNVSEE 649
Query: 633 AKELTKSLLTVNPAQRIRM----------------------------------MRVKLTF 658
AKEL + LLTV+P +RI+M VK TF
Sbjct: 650 AKELIQGLLTVDPNKRIKMSSLRYNEWLQDGSQLSSNPLMTPDNLGSSGAAVHTYVKATF 709
Query: 659 HAFHQAQKEGFRLQDVTSAKLAQRRKNKNVSNDNSRSFSSTSSSLSSSSSGTSSLKTPCS 718
HAF++ ++EGF LQ+V A LA+RRK K S SS+ SS SSSS TP
Sbjct: 710 HAFNKYKREGFCLQNVDKAPLAKRRKMKKTSTSTETRSSSSESSHSSSSHSHGK-TTPTK 768
Query: 719 STQPSVPS 726
+ QP+ P+
Sbjct: 769 TLQPTNPT 776
|
Serine/threonine-protein kinase that is required for the mitogen or stress-induced phosphorylation of the transcription factors CREB1 and ATF1 and that contributes to gene activation by histone phosphorylation. Phosphorylates CREB1 and ATF1 in response to mitogenic or stress stimuli such as UV-C irradiation, epidermal growth factor (EGF) and anisomycin. Directly represses transcription via phosphorylation of 'Ser-1' of histone H2A. Phosphorylates 'Ser-10' of histone H3 in response to mitogenics, stress stimuli and EGF, which results in the transcriptional activation of several immediate early genes, including proto-oncogenes c-fos/FOS and c-jun/JUN. May also phosphorylate 'Ser-28' of histone H3. Mediates the mitogen- and stress-induced phosphorylation of high mobility group protein 1 (HMGN1/HMG14). Gallus gallus (taxid: 9031) EC: 2EC: .EC: 7EC: .EC: 1EC: 1EC: .EC: 1 |
| >sp|O75582|KS6A5_HUMAN Ribosomal protein S6 kinase alpha-5 OS=Homo sapiens GN=RPS6KA5 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 428 bits (1100), Expect = e-118, Method: Compositional matrix adjust.
Identities = 252/549 (45%), Positives = 330/549 (60%), Gaps = 117/549 (21%)
Query: 264 RRILKTEPPIPEDLSPDVADFISRLLVKDPRRRLGGGELDAEELKRHPFFNVIDWDDLAT 323
RRILK+EPP P+++S D I RLL+KDP++RLG G DA+E+K H FF I+WDDLA
Sbjct: 269 RRILKSEPPYPQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEHLFFQKINWDDLAA 328
Query: 324 KRIPAPFVPKISNELDVSNFSDEFTKMIPADSPAIVPPNFDKIFKG-------------- 369
K++PAPF P I +ELDVSNF++EFT+M P SPA +P + +K+F+G
Sbjct: 329 KKVPAPFKPVIRDELDVSNFAEEFTEMDPTYSPAALPQSSEKLFQGYSFVAPSILFKRNA 388
Query: 370 ----------------------------SLFFEQYDMDLDKAGILGDGSYSVCRRCVEKS 401
S F++ YD+DL K LG+GS+S+CR+CV K
Sbjct: 389 AVIDPLQFHMGVERPGVTNVARSAMMKDSPFYQHYDLDL-KDKPLGEGSFSICRKCVHKK 447
Query: 402 TGQEYAVKIISRKIDCS--EEINLLRACQGHPNIVNLHCVFQDEVHTYLVLELLKGGELL 459
+ Q +AVKIIS++++ + +EI L+ C+GHPNIV LH VF D++HT+LV+ELL GGEL
Sbjct: 448 SNQAFAVKIISKRMEANTQKEITALKLCEGHPNIVKLHEVFHDQLHTFLVMELLNGGELF 507
Query: 460 DRIRQKGRCGFTENEASRIMRQLVAAVHFMHSRGVVHRDLKPENLLFSDPAGDN--IKVV 517
+RI++K F+E EAS IMR+LV+AV MH GVVHRDLKPENLLF+D DN IK++
Sbjct: 508 ERIKKKKH--FSETEASYIMRKLVSAVSHMHDVGVVHRDLKPENLLFTD-ENDNLEIKII 564
Query: 518 DFGFACLK---RESLHTPCFTLQYAAPEVLRQDKSGYDENCDLWSLGVILVNVLRQDKSG 574
DFGFA LK + L TPCFTL YAAPE+L Q+ GYDE+CDLWS
Sbjct: 565 DFGFARLKPPDNQPLKTPCFTLHYAAPELLNQN--GYDESCDLWS--------------- 607
Query: 575 YDENCDLWSLGVILYTMLCGRVPFHARSRD---DSALSIMARIKEGQFNFDAEAWSTVSS 631
LGVILYTML G+VPF + R SA+ IM +IK+G F+F+ EAW VS
Sbjct: 608 ---------LGVILYTMLSGQVPFQSHDRSLTCTSAVEIMKKIKKGDFSFEGEAWKNVSQ 658
Query: 632 EAKELTKSLLTVNPAQRIRM--MR--------------------------------VKLT 657
EAK+L + LLTV+P +R++M +R VK T
Sbjct: 659 EAKDLIQGLLTVDPNKRLKMSGLRYNEWLQDGSQLSSNPLMTPDILGSSGAAVHTCVKAT 718
Query: 658 FHAFHQAQKEGFRLQDVTSAKLAQRRKNKNVSNDNSRSFSSTSSSLSSSSSGTSSLKTPC 717
FHAF++ ++EGF LQ+V A LA+RRK K S SS+ SS SSSS TP
Sbjct: 719 FHAFNKYKREGFCLQNVDKAPLAKRRKMKKTSTSTETRSSSSESSHSSSSHSHGK-TTPT 777
Query: 718 SSTQPSVPS 726
+ QPS P+
Sbjct: 778 KTLQPSNPA 786
|
Serine/threonine-protein kinase that is required for the mitogen or stress-induced phosphorylation of the transcription factors CREB1 and ATF1 and for the regulation of the transcription factors RELA, STAT3 and ETV1/ER81, and that contributes to gene activation by histone phosphorylation and functions in the regulation of inflammatory genes. Phosphorylates CREB1 and ATF1 in response to mitogenic or stress stimuli such as UV-C irradiation, epidermal growth factor (EGF) and anisomycin. Plays an essential role in the control of RELA transcriptional activity in response to TNF and upon glucocorticoid, associates in the cytoplasm with the glucocorticoid receptor NR3C1 and contributes to RELA inhibition and repression of inflammatory gene expression. In skeletal myoblasts is required for phosphorylation of RELA at 'Ser-276' during oxidative stress. In erythropoietin-stimulated cells, is necessary for the 'Ser-727' phosphorylation of STAT3 and regulation of its transcriptional potential. Phosphorylates ETV1/ER81 at 'Ser-191' and 'Ser-216', and thereby regulates its ability to stimulate transcription, which may be important during development and breast tumor formation. Directly represses transcription via phosphorylation of 'Ser-1' of histone H2A. Phosphorylates 'Ser-10' of histone H3 in response to mitogenics, stress stimuli and EGF, which results in the transcriptional activation of several immediate early genes, including proto-oncogenes c-fos/FOS and c-jun/JUN. May also phosphorylate 'Ser-28' of histone H3. Mediates the mitogen- and stress-induced phosphorylation of high mobility group protein 1 (HMGN1/HMG14). In lipopolysaccharide-stimulated primary macrophages, acts downstream of the Toll-like receptor TLR4 to limit the production of pro-inflammatory cytokines. Functions probably by inducing transcription of the MAP kinase phosphatase DUSP1 and the anti-inflammatory cytokine interleukin 10 (IL10), via CREB1 and ATF1 transcription factors. Plays a role in neuronal cell death by mediating the downstream effects of excitotoxic injury. Homo sapiens (taxid: 9606) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q5R4K3|KS6A5_PONAB Ribosomal protein S6 kinase alpha-5 OS=Pongo abelii GN=RPS6KA5 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 422 bits (1085), Expect = e-117, Method: Compositional matrix adjust.
Identities = 250/549 (45%), Positives = 328/549 (59%), Gaps = 117/549 (21%)
Query: 264 RRILKTEPPIPEDLSPDVADFISRLLVKDPRRRLGGGELDAEELKRHPFFNVIDWDDLAT 323
RRILK+EPP P+++S D I LL+KDP++RLG G DA+E+K H FF I+WDDLA
Sbjct: 269 RRILKSEPPYPQEMSALAKDLIQHLLMKDPKKRLGCGPRDADEIKEHLFFQKINWDDLAA 328
Query: 324 KRIPAPFVPKISNELDVSNFSDEFTKMIPADSPAIVPPNFDKIFKG-------------- 369
K++PAPF P I +ELDVSNF++EFT+M P SPA +P + +K+F+G
Sbjct: 329 KKVPAPFKPVIRDELDVSNFAEEFTEMDPTYSPAALPQSSEKLFQGYSFVAPSILFKRNA 388
Query: 370 ----------------------------SLFFEQYDMDLDKAGILGDGSYSVCRRCVEKS 401
S F++ YD+DL K LG+GS+S+CR+CV K
Sbjct: 389 AVIDPLQFHMEVERPGVTNVARSAMMKDSPFYQHYDLDL-KDKPLGEGSFSICRKCVHKK 447
Query: 402 TGQEYAVKIISRKIDCS--EEINLLRACQGHPNIVNLHCVFQDEVHTYLVLELLKGGELL 459
+ Q +AVKIIS++++ + +EI L+ C+GHPNIV LH VF D++HT+LV+ELL GGEL
Sbjct: 448 SNQAFAVKIISKRMEANTQKEITALKLCEGHPNIVKLHEVFHDQLHTFLVMELLNGGELF 507
Query: 460 DRIRQKGRCGFTENEASRIMRQLVAAVHFMHSRGVVHRDLKPENLLFSDPAGDN--IKVV 517
+RI++K F+E EAS IMR+LV+AV MH GVVHRDLKPENLLF+D DN IK++
Sbjct: 508 ERIKKKKH--FSETEASYIMRKLVSAVSHMHDVGVVHRDLKPENLLFTD-ENDNLEIKII 564
Query: 518 DFGFACLK---RESLHTPCFTLQYAAPEVLRQDKSGYDENCDLWSLGVILVNVLRQDKSG 574
DFGFA K + L TPCFTL YAAPE+L Q+ GYDE+CDLWS
Sbjct: 565 DFGFARPKPPDNQPLKTPCFTLHYAAPELLNQN--GYDESCDLWS--------------- 607
Query: 575 YDENCDLWSLGVILYTMLCGRVPFHARSRD---DSALSIMARIKEGQFNFDAEAWSTVSS 631
LGVILYTML G+VPF + R SA+ IM +IK+G F+F+ EAW VS
Sbjct: 608 ---------LGVILYTMLSGQVPFQSHDRSLTCTSAVEIMKKIKKGDFSFEGEAWKNVSQ 658
Query: 632 EAKELTKSLLTVNPAQRIRM--MR--------------------------------VKLT 657
EAK+L + LLTV+P +R++M +R VK T
Sbjct: 659 EAKDLIQGLLTVDPNKRLKMSGLRYNEWLQDGSQLSSNPLMTPDILGSSGAAVHTCVKAT 718
Query: 658 FHAFHQAQKEGFRLQDVTSAKLAQRRKNKNVSNDNSRSFSSTSSSLSSSSSGTSSLKTPC 717
FHAF++ ++EGF LQ+V A LA+RRK K S SS+ SS SSSS TP
Sbjct: 719 FHAFNKYKREGFCLQNVDKAPLAKRRKMKKTSTSTETRSSSSESSHSSSSHSHGK-TTPT 777
Query: 718 SSTQPSVPS 726
+ QPS P+
Sbjct: 778 KTLQPSNPA 786
|
Serine/threonine-protein kinase that is required for the mitogen or stress-induced phosphorylation of the transcription factors CREB1 and ATF1 and for the regulation of the transcription factors RELA, STAT3 and ETV1/ER81, and that contributes to gene activation by histone phosphorylation and functions in the regulation of inflammatory genes. Phosphorylates CREB1 and ATF1 in response to mitogenic or stress stimuli such as UV-C irradiation, epidermal growth factor (EGF) and anisomycin. Plays an essential role in the control of RELA transcriptional activity in response to TNF and upon glucocorticoid, associates in the cytoplasm with the glucocorticoid receptor NR3C1 and contributes to RELA inhibition and repression of inflammatory gene expression. In skeletal myoblasts is required for phosphorylation of RELA at 'Ser-276' during oxidative stress. In erythropoietin-stimulated cells, is necessary for the 'Ser-727' phosphorylation of STAT3 and regulation of its transcriptional potential. Phosphorylates ETV1/ER81 at 'Ser-191' and 'Ser-216', and thereby regulates its ability to stimulate transcription, which may be important during development and breast tumor formation. Directly represses transcription via phosphorylation of 'Ser-1' of histone H2A. Phosphorylates 'Ser-10' of histone H3 in response to mitogenics, stress stimuli and EGF, which results in the transcriptional activation of several immediate early genes, including proto-oncogenes c-fos/FOS and c-jun/JUN. May also phosphorylate 'Ser-28' of histone H3. Mediates the mitogen- and stress-induced phosphorylation of high mobility group protein 1 (HMGN1/HMG14). In lipopolysaccharide-stimulated primary macrophages, acts downstream of the Toll-like receptor TLR4 to limit the production of pro-inflammatory cytokines. Functions probably by inducing transcription of the MAP kinase phosphatase DUSP1 and the anti-inflammatory cytokine interleukin 10 (IL10), via CREB1 and ATF1 transcription factors. Plays a role in neuronal cell death by mediating the downstream effects of excitotoxic injury. Pongo abelii (taxid: 9601) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9Z2B9|KS6A4_MOUSE Ribosomal protein S6 kinase alpha-4 OS=Mus musculus GN=Rps6ka4 PE=1 SV=2 | Back alignment and function description |
|---|
Score = 385 bits (990), Expect = e-106, Method: Compositional matrix adjust.
Identities = 241/567 (42%), Positives = 323/567 (56%), Gaps = 126/567 (22%)
Query: 242 IIFFIILS----FTLSFIHDYYHIQYRRILKTEPPIPEDLSPDVADFISRLLVKDPRRRL 297
I+ F +L+ FTL + RRILK PP P + P D + RLL KDP++RL
Sbjct: 226 ILLFELLTGASPFTLEGERNTQAEVSRRILKCSPPFPLRIGPVAQDLLQRLLCKDPKKRL 285
Query: 298 GGGELDAEELKRHPFFNVIDWDDLATKRIPAPFVPKISNELDVSNFSDEFTKMIPADSPA 357
G G A+E+K HPFF +DW LA ++IPAPF P+I +ELDV NF++EFT++ P SPA
Sbjct: 286 GAGPQGAQEVKSHPFFQGLDWVALAARKIPAPFRPQIRSELDVGNFAEEFTRLEPVYSPA 345
Query: 358 IVPPNFD-KIFKG-------------------------------------------SLFF 373
PP D +IF+G S FF
Sbjct: 346 GSPPPGDPRIFQGYSFVAPSILFDHNNAVMADVLQAPGAGYRPGRAAVARSAMMQDSPFF 405
Query: 374 EQYDMDLDKAGILGDGSYSVCRRCVEKSTGQEYAVKIISRKID--CSEEINLLRACQGHP 431
+QY++DL + LG GS+SVCRRC ++ +GQE+AVKI+SR+++ E+ LR CQ HP
Sbjct: 406 QQYELDLREPA-LGQGSFSVCRRCRQRQSGQEFAVKILSRRLEENTQREVAALRLCQSHP 464
Query: 432 NIVNLHCVFQDEVHTYLVLELLKGGELLDRIRQKGRCGFTENEASRIMRQLVAAVHFMHS 491
N+VNLH V D++HTYLVLELL+GGELL+ IR+K F+E+EAS+I+R LV+AV FMH
Sbjct: 465 NVVNLHEVLHDQLHTYLVLELLRGGELLEHIRKKRL--FSESEASQILRSLVSAVSFMHE 522
Query: 492 R-GVVHRDLKPENLLFSDPA-GDNIKVVDFGFACLKRES----LHTPCFTLQYAAPEVLR 545
GVVHRDLKPEN+L++D G +K++DFGFA L+ +S + TPCFTLQYAAPE+L
Sbjct: 523 EAGVVHRDLKPENILYADDTPGAPVKIIDFGFARLRPQSPAEPMQTPCFTLQYAAPELLA 582
Query: 546 QDKSGYDENCDLWSLGVILVNVLRQDKSGYDENCDLWSLGVILYTMLCGRVPFHARSRDD 605
Q GYDE+CDLWS LGVILY ML G+VPF S
Sbjct: 583 QQ--GYDESCDLWS------------------------LGVILYMMLSGQVPFQGASGQG 616
Query: 606 S---ALSIMARIKEGQFNFDAEAWSTVSSEAKELTKSLLTVNPAQRIRMMRVK------- 655
A IM +I+EG+F+ D EAW VS EAKEL + LLTV+PA+R+++ ++
Sbjct: 617 GQSQAAEIMCKIREGRFSLDGEAWQGVSEEAKELVRGLLTVDPAKRLKLEGLRSSSWLQD 676
Query: 656 ---------------------------LTFHAFHQAQKEGFRLQDVTSAKLAQRRKNKNV 688
TF AF++ ++EGF L+ V +A LA+RRK K
Sbjct: 677 GSARSSPPLRTPDVLESSGPAVRSGLNATFMAFNRGKREGFFLKSVENAPLAKRRKQKLR 736
Query: 689 SNDNSRSFSSTSSSL----SSSSSGTS 711
S SR S +S +S++ GT+
Sbjct: 737 SAAASRRGSPVPASSGRLPASAAKGTT 763
|
Serine/threonine-protein kinase that is required for the mitogen or stress-induced phosphorylation of the transcription factors CREB1 and ATF1 and for the regulation of the transcription factor RELA, and that contributes to gene activation by histone phosphorylation and functions in the regulation of inflammatory genes. Phosphorylates CREB1 and ATF1 in response to mitogenic or stress stimuli such as UV-C irradiation, epidermal growth factor (EGF) and anisomycin. Plays an essential role in the control of RELA transcriptional activity in response to TNF. Phosphorylates 'Ser-10' of histone H3 in response to mitogenics, stress stimuli and EGF, which results in the transcriptional activation of several immediate early genes, including proto-oncogenes c-fos/FOS and c-jun/JUN. May also phosphorylate 'Ser-28' of histone H3. Mediates the mitogen- and stress-induced phosphorylation of high mobility group protein 1 (HMGN1/HMG14). In lipopolysaccharide-stimulated primary macrophages, acts downstream of the Toll-like receptor TLR4 to limit the production of pro-inflammatory cytokines. Functions probably by inducing transcription of the MAP kinase phosphatase DUSP1 and the anti-inflammatory cytokine interleukin 10 (IL10), via CREB1 and ATF1 transcription factors. Mus musculus (taxid: 10090) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|O75676|KS6A4_HUMAN Ribosomal protein S6 kinase alpha-4 OS=Homo sapiens GN=RPS6KA4 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 371 bits (953), Expect = e-101, Method: Compositional matrix adjust.
Identities = 233/583 (39%), Positives = 321/583 (55%), Gaps = 123/583 (21%)
Query: 236 FFSSSLIIFFIILS---FTLSFIHDYYHIQYRRILKTEPPIPEDLSPDVADFISRLLVKD 292
++S +++F ++ FTL + RRILK PP P + P D + RLL KD
Sbjct: 221 WWSLGILLFELLTGASPFTLEGERNTQAEVSRRILKCSPPFPPRIGPVAQDLLQRLLCKD 280
Query: 293 PRRRLGGGELDAEELKRHPFFNVIDWDDLATKRIPAPFVPKISNELDVSNFSDEFTKMIP 352
P++RLG G A+E++ HPFF +DW LA ++IPAPF P+I +ELDV NF++EFT++ P
Sbjct: 281 PKKRLGAGPQGAQEVRNHPFFQGLDWVALAARKIPAPFRPQIRSELDVGNFAEEFTRLEP 340
Query: 353 --------------------------------------------ADSPAIVPPNFDKIFK 368
D P + +
Sbjct: 341 VYSPPGSPPPGDPRIFQGYSFVAPSILFDHNNAVMTDGLEAPGAGDRPGRAAVARSAMMQ 400
Query: 369 GSLFFEQYDMDLDKAGILGDGSYSVCRRCVEKSTGQEYAVKIISRKIDCS--EEINLLRA 426
S FF+QY++DL + LG GS+SVCRRC ++ +GQE+AVKI+SR+++ + E+ LR
Sbjct: 401 DSPFFQQYELDLREPA-LGQGSFSVCRRCRQRQSGQEFAVKILSRRLEANTQREVAALRL 459
Query: 427 CQGHPNIVNLHCVFQDEVHTYLVLELLKGGELLDRIRQKGRCGFTENEASRIMRQLVAAV 486
CQ HPN+VNLH V D++HTYLVLELL+GGELL+ IR+K F+E+EAS+I+R LV+AV
Sbjct: 460 CQSHPNVVNLHEVHHDQLHTYLVLELLRGGELLEHIRKKRH--FSESEASQILRSLVSAV 517
Query: 487 HFMHSR-GVVHRDLKPENLLFSDPA-GDNIKVVDFGFACLKRES----LHTPCFTLQYAA 540
FMH GVVHRDLKPEN+L++D G +K++DFGFA L+ +S + TPCFTLQYAA
Sbjct: 518 SFMHEEAGVVHRDLKPENILYADDTPGAPVKIIDFGFARLRPQSPGVPMQTPCFTLQYAA 577
Query: 541 PEVLRQDKSGYDENCDLWSLGVILVNVLRQDKSGYDENCDLWSLGVILYTMLCGRVPFHA 600
PE+L Q GYDE+CDLWS LGVILY ML G+VPF
Sbjct: 578 PELLAQQ--GYDESCDLWS------------------------LGVILYMMLSGQVPFQG 611
Query: 601 RSRDDS---ALSIMARIKEGQFNFDAEAWSTVSSEAKELTKSLLTVNPAQRIRMMRVK-- 655
S A IM +I+EG+F+ D EAW VS EAKEL + LLTV+PA+R+++ ++
Sbjct: 612 ASGQGGQSQAAEIMCKIREGRFSLDGEAWQGVSEEAKELVRGLLTVDPAKRLKLEGLRGS 671
Query: 656 --------------------------------LTFHAFHQAQKEGFRLQDVTSAKLAQRR 683
TF AF++ ++EGF L+ V +A LA+RR
Sbjct: 672 SWLQDGSARSSPPLRTPDVLESSGPAVRSGLNATFMAFNRGKREGFFLKSVENAPLAKRR 731
Query: 684 KNKNVSNDNSRSFSSTSSSLSSSSSGTSSLKTPCSSTQPSVPS 726
K K S SR S + + + +S P + P PS
Sbjct: 732 KQKLRSATASRRGSPAPA--NPGRAPVASKGAPRRANGPLPPS 772
|
Serine/threonine-protein kinase that is required for the mitogen or stress-induced phosphorylation of the transcription factors CREB1 and ATF1 and for the regulation of the transcription factor RELA, and that contributes to gene activation by histone phosphorylation and functions in the regulation of inflammatory genes. Phosphorylates CREB1 and ATF1 in response to mitogenic or stress stimuli such as UV-C irradiation, epidermal growth factor (EGF) and anisomycin. Plays an essential role in the control of RELA transcriptional activity in response to TNF. Phosphorylates 'Ser-10' of histone H3 in response to mitogenics, stress stimuli and EGF, which results in the transcriptional activation of several immediate early genes, including proto-oncogenes c-fos/FOS and c-jun/JUN. May also phosphorylate 'Ser-28' of histone H3. Mediates the mitogen- and stress-induced phosphorylation of high mobility group protein 1 (HMGN1/HMG14). In lipopolysaccharide-stimulated primary macrophages, acts downstream of the Toll-like receptor TLR4 to limit the production of pro-inflammatory cytokines. Functions probably by inducing transcription of the MAP kinase phosphatase DUSP1 and the anti-inflammatory cytokine interleukin 10 (IL10), via CREB1 and ATF1 transcription factors. Homo sapiens (taxid: 9606) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q18846|KS6A2_CAEEL Putative ribosomal protein S6 kinase alpha-2 OS=Caenorhabditis elegans GN=rskn-2 PE=3 SV=2 | Back alignment and function description |
|---|
Score = 340 bits (872), Expect = 3e-92, Method: Compositional matrix adjust.
Identities = 215/576 (37%), Positives = 295/576 (51%), Gaps = 118/576 (20%)
Query: 209 PNIVNLHCVFQDEVIDWDDFSRGIECVFFSSSLIIFFIILS----FTLSFIHDYYHIQYR 264
P ++N +V+DW +S G+ I F +L+ FT+ + +
Sbjct: 190 PEVINRPEGGYSDVVDW--WSLGV----------ISFELLTGCSPFTVDGAQNSSKDIAK 237
Query: 265 RILKTEPPIPEDLSPDVADFISRLLVKDPRRRLGGGELDAEELKRHPFFNVIDWDDLATK 324
RI+ + P P+ + D DFI +LL K +RLG +D E+K H F + IDWD +
Sbjct: 238 RIMTKKVPFPKTMDVDARDFIGQLLEKKLEKRLGYNGVD--EIKNHKFMSSIDWDAAVKR 295
Query: 325 RIPAPFVPKISNELDVSNFSDEFTKMIPADSPAIVPPNFDKIFKG--------------- 369
+ VP+I ++LD FS EFT P SPA P N + +F+G
Sbjct: 296 TLKPVIVPRIGHDLDTQFFSAEFTSQPPLYSPAESPLNANTLFRGYSYVSPSVIFANDNV 355
Query: 370 ----------------SLFFEQYDMDLDKAGILGDGSYSVCRRCVEKSTGQEYAVKIISR 413
S FF +Y +D AG+LG G++SV RRC G ++AVKI+S+
Sbjct: 356 IGEELMAEDVNALLASSSFFAKYKLDKSDAGLLGKGAFSVVRRCERVVDGAQFAVKIVSQ 415
Query: 414 KI--DCSEEINLLRACQGHPNIVNLHCVFQDEVHTYLVLELLKGGELLDRIRQKGRCGFT 471
K E +L QGHPNIV LH V D +H YLV+E+L G ELL+RIR+ R FT
Sbjct: 416 KFASQAQREARILEMVQGHPNIVQLHDVHSDPLHFYLVMEILTGNELLERIRKLER--FT 473
Query: 472 ENEASRIMRQLVAAVHFMHSRGVVHRDLKPENLLF-SDPAGDNIKVVDFGFACLKRESLH 530
E+EA+ IMRQLV+AV ++H + +VHRDLKPEN+LF S + +++VDFGFA L S+
Sbjct: 474 ESEAADIMRQLVSAVKYLHDKRIVHRDLKPENILFESIDSSARLRLVDFGFARLLPNSME 533
Query: 531 ------------TPCFTLQYAAPEVLRQDKSGYDENCDLWSLGVILVNVLRQDKSGYDEN 578
TPCFTLQYAAPEVL S + Y+E
Sbjct: 534 QQLKSVQVLRKMTPCFTLQYAAPEVLDVGDS----------------------QPEYNEQ 571
Query: 579 CDLWSLGVILYTMLCGRVPFHARSRDDSALSIMARIKEGQFNFDAEAWSTVSSEAKELTK 638
CDLWSLGV+L+TML G+VPFHARSR +SA IM RI +F+F +AW+ VS++AK L
Sbjct: 572 CDLWSLGVVLFTMLSGQVPFHARSRQESATEIMQRICRAEFSFTGDAWTNVSADAKNLIT 631
Query: 639 SLLTVNPAQRIRMMRVKL------------------------------TFHAFHQAQKEG 668
LLTV+P +R+ M + T AF A ++G
Sbjct: 632 GLLTVDPKKRLSMQELTAHMWLKSSASMDTPLQTPSILPSSADETFNETLRAFLHANRDG 691
Query: 669 FRLQDVTSAKLAQRRKNKNVSNDNSRSFSSTSSSLS 704
F L DV +A L +RR K S D S +S +S ++
Sbjct: 692 FHLLDVAAAPLMKRRGIKRQSGDKDASGNSKNSRVT 727
|
Serine/threonine kinase that may play a role in mediating the mitogen- and stress-induced effects on transcription. May repress transcription via phosphorylation of 'Ser-1' of histone H2A. May phosphorylate histone H3. Caenorhabditis elegans (taxid: 6239) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9WUT3|KS6A2_MOUSE Ribosomal protein S6 kinase alpha-2 OS=Mus musculus GN=Rps6ka2 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 285 bits (728), Expect = 1e-75, Method: Compositional matrix adjust.
Identities = 186/514 (36%), Positives = 265/514 (51%), Gaps = 95/514 (18%)
Query: 242 IIFFIILSFTLSFIHDYYHIQYRRILKTEPPIPEDLSPDVADFISRLLVKDPRRRLGGGE 301
++ F +L+ +L F ILK + +P+ LS + + L ++P RLG G
Sbjct: 247 VLMFEMLTGSLPFQGKDRKETMALILKAKLGMPQFLSAEAQSLLRALFKRNPCNRLGAGV 306
Query: 302 LDAEELKRHPFFNVIDWDDLATKRIPAPFVPKISNELDVSNFSDEFTKMIPADSPAIVP- 360
EE+KRHPFF IDW+ L K I PF P + D +F EFT P DSP + P
Sbjct: 307 DGVEEIKRHPFFVTIDWNKLYRKEIKPPFKPAVGRPEDTFHFDPEFTARTPTDSPGVPPS 366
Query: 361 PNFDKIFKG------SLFFEQYDMDLDKAGI-----------------------LGDGSY 391
N +F+G SL E D+ KA I +G GSY
Sbjct: 367 ANAHHLFRGFSFVASSLVQEPSQQDVPKAPIHPIVQQLHGNNIHFTDGYEIKEDIGVGSY 426
Query: 392 SVCRRCVEKSTGQEYAVKIISR-KIDCSEEINLLRACQGHPNIVNLHCVFQDEVHTYLVL 450
SVC+RCV K+T EYAVKII + K D SEEI +L HPNI+ L V+ D + YLV+
Sbjct: 427 SVCKRCVHKATDAEYAVKIIDKSKRDPSEEIEILLRYGQHPNIITLKDVYDDGKYVYLVM 486
Query: 451 ELLKGGELLDRIRQKGRCGFTENEASRIMRQLVAAVHFMHSRGVVHRDLKPENLLFSDPA 510
EL++GGELLDRI ++ RC F+E EAS ++ + + ++HS+GVVHRDLKP N+L+ D +
Sbjct: 487 ELMRGGELLDRILRQ-RC-FSEREASDVLYTIARTMDYLHSQGVVHRDLKPSNILYMDES 544
Query: 511 G--DNIKVVDFGFA-CLKRES--LHTPCFTLQYAAPEVLRQDKSGYDENCDLWSLGVILV 565
G ++I++ DFGFA L+ E+ L TPC+T + APEVL+ + GYD CD+W
Sbjct: 545 GNPESIRICDFGFAKQLRAENGLLMTPCYTANFVAPEVLK--RQGYDAACDVW------- 595
Query: 566 NVLRQDKSGYDENCDLWSLGVILYTMLCGRVPFHARSRDDSALSIMARIKEGQFNFDAEA 625
SLG++LYTML G PF A DD+ I+ARI G++
Sbjct: 596 -----------------SLGILLYTMLAGFTPF-ANGPDDTPEEILARIGSGKYALSGGN 637
Query: 626 WSTVSSEAKELTKSLLTVNPAQRIRMMRV-----------------------------KL 656
W ++S AK++ +L V+P QR+ ++V
Sbjct: 638 WDSISDAAKDVVSKMLHVDPQQRLTAVQVLKHPWIVNREYLSQNQLSRQDVHLVKGAMAA 697
Query: 657 TFHAFHQAQKEGFRLQDVTSAKLAQRRKNKNVSN 690
T+ A ++ + RL+ V S+ LAQRR K +++
Sbjct: 698 TYFALNRT-PQAPRLEPVLSSSLAQRRGMKRLTS 730
|
Serine/threonine-protein kinase that acts downstream of ERK (MAPK1/ERK2 and MAPK3/ERK1) signaling and mediates mitogenic and stress-induced activation of transcription factors, regulates translation, and mediates cellular proliferation, survival, and differentiation. May function as tumor suppressor in epithelial ovarian cancer cells. Mus musculus (taxid: 10090) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|P51812|KS6A3_HUMAN Ribosomal protein S6 kinase alpha-3 OS=Homo sapiens GN=RPS6KA3 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 281 bits (720), Expect = 1e-74, Method: Compositional matrix adjust.
Identities = 172/443 (38%), Positives = 239/443 (53%), Gaps = 65/443 (14%)
Query: 242 IIFFIILSFTLSFIHDYYHIQYRRILKTEPPIPEDLSPDVADFISRLLVKDPRRRLGGGE 301
++ F +L+ TL F ILK + +P+ LSP+ + L ++P RLG G
Sbjct: 256 VLMFEMLTGTLPFQGKDRKETMTMILKAKLGMPQFLSPEAQSLLRMLFKRNPANRLGAGP 315
Query: 302 LDAEELKRHPFFNVIDWDDLATKRIPAPFVPKISNELDVSNFSDEFTKMIPADSPAIVP- 360
EE+KRH FF+ IDW+ L + I PF P D F EFT P DSP I P
Sbjct: 316 DGVEEIKRHSFFSTIDWNKLYRREIHPPFKPATGRPEDTFYFDPEFTAKTPKDSPGIPPS 375
Query: 361 PNFDKIFKGSLFFEQYDMDLDKA----GI-----------------------LGDGSYSV 393
N ++F+G F D +A G+ +G GSYSV
Sbjct: 376 ANAHQLFRGFSFVAITSDDESQAMQTVGVHSIVQQLHRNSIQFTDGYEVKEDIGVGSYSV 435
Query: 394 CRRCVEKSTGQEYAVKIISR-KIDCSEEINLLRACQGHPNIVNLHCVFQDEVHTYLVLEL 452
C+RC+ K+T E+AVKII + K D +EEI +L HPNI+ L V+ D + Y+V EL
Sbjct: 436 CKRCIHKATNMEFAVKIIDKSKRDPTEEIEILLRYGQHPNIITLKDVYDDGKYVYVVTEL 495
Query: 453 LKGGELLDRI-RQKGRCGFTENEASRIMRQLVAAVHFMHSRGVVHRDLKPENLLFSDPAG 511
+KGGELLD+I RQK F+E EAS ++ + V ++H++GVVHRDLKP N+L+ D +G
Sbjct: 496 MKGGELLDKILRQK---FFSEREASAVLFTITKTVEYLHAQGVVHRDLKPSNILYVDESG 552
Query: 512 --DNIKVVDFGFA-CLKRES--LHTPCFTLQYAAPEVLRQDKSGYDENCDLWSLGVILVN 566
++I++ DFGFA L+ E+ L TPC+T + APEVL+ + GYD CD+WS
Sbjct: 553 NPESIRICDFGFAKQLRAENGLLMTPCYTANFVAPEVLK--RQGYDAACDIWS------- 603
Query: 567 VLRQDKSGYDENCDLWSLGVILYTMLCGRVPFHARSRDDSALSIMARIKEGQFNFDAEAW 626
LGV+LYTML G PF A DD+ I+ARI G+F+ W
Sbjct: 604 -----------------LGVLLYTMLTGYTPF-ANGPDDTPEEILARIGSGKFSLSGGYW 645
Query: 627 STVSSEAKELTKSLLTVNPAQRI 649
++VS AK+L +L V+P QR+
Sbjct: 646 NSVSDTAKDLVSKMLHVDPHQRL 668
|
Serine/threonine-protein kinase that acts downstream of ERK (MAPK1/ERK2 and MAPK3/ERK1) signaling and mediates mitogenic and stress-induced activation of the transcription factors CREB1, ETV1/ER81 and NR4A1/NUR77, regulates translation through RPS6 and EIF4B phosphorylation, and mediates cellular proliferation, survival, and differentiation by modulating mTOR signaling and repressing pro-apoptotic function of BAD and DAPK1. In fibroblast, is required for EGF-stimulated phosphorylation of CREB1 and histone H3 at 'Ser-10', which results in the subsequent transcriptional activation of several immediate-early genes. In response to mitogenic stimulation (EGF and PMA), phosphorylates and activates NR4A1/NUR77 and ETV1/ER81 transcription factors and the cofactor CREBBP. Upon insulin-derived signal, acts indirectly on the transcription regulation of several genes by phosphorylating GSK3B at 'Ser-9' and inhibiting its activity. Phosphorylates RPS6 in response to serum or EGF via an mTOR-independent mechanism and promotes translation initiation by facilitating assembly of the preinitiation complex. In response to insulin, phosphorylates EIF4B, enhancing EIF4B affinity for the EIF3 complex and stimulating cap-dependent translation. Is involved in the mTOR nutrient-sensing pathway by directly phosphorylating TSC2 at 'Ser-1798', which potently inhibits TSC2 ability to suppress mTOR signaling, and mediates phosphorylation of RPTOR, which regulates mTORC1 activity and may promote rapamycin-sensitive signaling independently of the PI3K/AKT pathway. Mediates cell survival by phosphorylating the pro-apoptotic proteins BAD and DAPK1 and suppressing their pro-apoptotic function. Promotes the survival of hepatic stellate cells by phosphorylating CEBPB in response to the hepatotoxin carbon tetrachloride (CCl4). Is involved in cell cycle regulation by phosphorylating the CDK inhibitor CDKN1B, which promotes CDKN1B association with 14-3-3 proteins and prevents its translocation to the nucleus and inhibition of G1 progression. In LPS-stimulated dendritic cells, is involved in TLR4-induced macropinocytosis, and in myeloma cells, acts as effector of FGFR3-mediated transformation signaling, after direct phosphorylation at Thr-529 by FGFR3. Phosphorylates DAPK1. Homo sapiens (taxid: 9606) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|P18654|KS6A3_MOUSE Ribosomal protein S6 kinase alpha-3 OS=Mus musculus GN=Rps6ka3 PE=1 SV=2 | Back alignment and function description |
|---|
Score = 281 bits (720), Expect = 1e-74, Method: Compositional matrix adjust.
Identities = 172/443 (38%), Positives = 239/443 (53%), Gaps = 65/443 (14%)
Query: 242 IIFFIILSFTLSFIHDYYHIQYRRILKTEPPIPEDLSPDVADFISRLLVKDPRRRLGGGE 301
++ F +L+ TL F ILK + +P+ LSP+ + L ++P RLG G
Sbjct: 256 VLMFEMLTGTLPFQGKDRKETMTMILKAKLGMPQFLSPEAQSLLRMLFKRNPANRLGAGP 315
Query: 302 LDAEELKRHPFFNVIDWDDLATKRIPAPFVPKISNELDVSNFSDEFTKMIPADSPAIVP- 360
EE+KRH FF+ IDW+ L + I PF P D F EFT P DSP I P
Sbjct: 316 DGVEEIKRHSFFSTIDWNKLYRREIHPPFKPATGRPEDTFYFDPEFTAKTPKDSPGIPPS 375
Query: 361 PNFDKIFKGSLFFEQYDMDLDKA----GI-----------------------LGDGSYSV 393
N ++F+G F D +A G+ +G GSYSV
Sbjct: 376 ANAHQLFRGFSFVAITSDDESQAMQTVGVHSIVQQLHRNSIQFTDGYEVKEDIGVGSYSV 435
Query: 394 CRRCVEKSTGQEYAVKIISR-KIDCSEEINLLRACQGHPNIVNLHCVFQDEVHTYLVLEL 452
C+RC+ K+T E+AVKII + K D +EEI +L HPNI+ L V+ D + Y+V EL
Sbjct: 436 CKRCIHKATNMEFAVKIIDKSKRDPTEEIEILLRYGQHPNIITLKDVYDDGKYVYVVTEL 495
Query: 453 LKGGELLDRI-RQKGRCGFTENEASRIMRQLVAAVHFMHSRGVVHRDLKPENLLFSDPAG 511
+KGGELLD+I RQK F+E EAS ++ + V ++H++GVVHRDLKP N+L+ D +G
Sbjct: 496 MKGGELLDKILRQK---FFSEREASAVLFTITKTVEYLHAQGVVHRDLKPSNILYVDESG 552
Query: 512 --DNIKVVDFGFA-CLKRES--LHTPCFTLQYAAPEVLRQDKSGYDENCDLWSLGVILVN 566
++I++ DFGFA L+ E+ L TPC+T + APEVL+ + GYD CD+WS
Sbjct: 553 NPESIRICDFGFAKQLRAENGLLMTPCYTANFVAPEVLK--RQGYDAACDIWS------- 603
Query: 567 VLRQDKSGYDENCDLWSLGVILYTMLCGRVPFHARSRDDSALSIMARIKEGQFNFDAEAW 626
LGV+LYTML G PF A DD+ I+ARI G+F+ W
Sbjct: 604 -----------------LGVLLYTMLTGYTPF-ANGPDDTPEEILARIGSGKFSLSGGYW 645
Query: 627 STVSSEAKELTKSLLTVNPAQRI 649
++VS AK+L +L V+P QR+
Sbjct: 646 NSVSDTAKDLVSKMLHVDPHQRL 668
|
Serine/threonine-protein kinase that acts downstream of ERK (MAPK1/ERK2 and MAPK3/ERK1) signaling and mediates mitogenic and stress-induced activation of the transcription factors CREB1, ETV1/ER81 and NR4A1/NUR77, regulates translation through RPS6 and EIF4B phosphorylation, and mediates cellular proliferation, survival, and differentiation by modulating mTOR signaling and repressing pro-apoptotic function of BAD and DAPK1. In fibroblast, is required for EGF-stimulated phosphorylation of CREB1 and histone H3 at 'Ser-10', which results in the subsequent transcriptional activation of several immediate-early genes. In response to mitogenic stimulation (EGF and PMA), phosphorylates and activates NR4A1/NUR77 and ETV1/ER81 transcription factors and the cofactor CREBBP. Upon insulin-derived signal, acts indirectly on the transcription regulation of several genes by phosphorylating GSK3B at 'Ser-9' and inhibiting its activity. Phosphorylates RPS6 in response to serum or EGF via an mTOR-independent mechanism and promotes translation initiation by facilitating assembly of the preinitiation complex. In response to insulin, phosphorylates EIF4B, enhancing EIF4B affinity for the EIF3 complex and stimulating cap-dependent translation. Is involved in the mTOR nutrient-sensing pathway by directly phosphorylating TSC2 at 'Ser-1798', which potently inhibits TSC2 ability to suppress mTOR signaling, and mediates phosphorylation of RPTOR, which regulates mTORC1 activity and may promote rapamycin-sensitive signaling independently of the PI3K/AKT pathway. Mediates cell survival by phosphorylating the pro-apoptotic proteins BAD and DAPK1 and suppressing their pro-apoptotic function. Promotes the survival of hepatic stellate cells by phosphorylating CEBPB in response to the hepatotoxin carbon tetrachloride (CCl4). Is involved in cell cycle regulation by phosphorylating the CDK inhibitor CDKN1B, which promotes CDKN1B association with 14-3-3 proteins and prevents its translocation to the nucleus and inhibition of G1 progression. In LPS-stimulated dendritic cells, is involved in TLR4-induced macropinocytosis, and in myeloma cells, acts as effector of FGFR3-mediated transformation signaling, after direct phosphorylation at Thr-529 by FGFR3. Phosphorylates DAPK1. Mus musculus (taxid: 10090) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q15349|KS6A2_HUMAN Ribosomal protein S6 kinase alpha-2 OS=Homo sapiens GN=RPS6KA2 PE=1 SV=2 | Back alignment and function description |
|---|
Score = 281 bits (720), Expect = 2e-74, Method: Compositional matrix adjust.
Identities = 182/491 (37%), Positives = 250/491 (50%), Gaps = 97/491 (19%)
Query: 266 ILKTEPPIPEDLSPDVADFISRLLVKDPRRRLGGGELDAEELKRHPFFNVIDWDDLATKR 325
ILK + +P+ LS + + L ++P RLG G EE+KRHPFF IDW+ L K
Sbjct: 271 ILKAKLGMPQFLSGEAQSLLRALFKRNPCNRLGAGIDGVEEIKRHPFFVTIDWNTLYRKE 330
Query: 326 IPAPFVPKISNELDVSNFSDEFTKMIPADSPAIVP-PNFDKIFKG------SLFFEQYDM 378
I PF P + D +F EFT P DSP + P N +F+G SL E
Sbjct: 331 IKPPFKPAVGRPEDTFHFDPEFTARTPTDSPGVPPSANAHHLFRGFSFVASSLIQEPSQQ 390
Query: 379 DLDKAGI-----------------------LGDGSYSVCRRCVEKSTGQEYAVKIISR-K 414
DL K + +G GSYSVC+RCV K+T EYAVKII + K
Sbjct: 391 DLHKVPVHPIVQQLHGNNIHFTDGYEIKEDIGVGSYSVCKRCVHKATDTEYAVKIIDKSK 450
Query: 415 IDCSEEINLLRACQGHPNIVNLHCVFQDEVHTYLVLELLKGGELLDRI-RQKGRCGFTEN 473
D SEEI +L HPNI+ L V+ D YLV+EL++GGELLDRI RQ+ F+E
Sbjct: 451 RDPSEEIEILLRYGQHPNIITLKDVYDDGKFVYLVMELMRGGELLDRILRQR---YFSER 507
Query: 474 EASRIMRQLVAAVHFMHSRGVVHRDLKPENLLFSDPAG--DNIKVVDFGFACLKRES--- 528
EAS ++ + + ++HS+GVVHRDLKP N+L+ D +G ++I+V DFGFA R
Sbjct: 508 EASDVLCTITKTMDYLHSQGVVHRDLKPSNILYRDESGSPESIRVCDFGFAKQLRAGNGL 567
Query: 529 LHTPCFTLQYAAPEVLRQDKSGYDENCDLWSLGVILVNVLRQDKSGYDENCDLWSLGVIL 588
L TPC+T + APEVL+ + GYD CD+W SLG++L
Sbjct: 568 LMTPCYTANFVAPEVLK--RQGYDAACDIW------------------------SLGILL 601
Query: 589 YTMLCGRVPFHARSRDDSALSIMARIKEGQFNFDAEAWSTVSSEAKELTKSLLTVNPAQR 648
YTML G PF A DD+ I+ARI G++ W ++S AK++ +L V+P QR
Sbjct: 602 YTMLAGFTPF-ANGPDDTPEEILARIGSGKYALSGGNWDSISDAAKDVVSKMLHVDPHQR 660
Query: 649 IRMMRV-----------------------------KLTFHAFHQAQKEGFRLQDVTSAKL 679
+ M+V T+ A ++ + RL+ V S+ L
Sbjct: 661 LTAMQVLKHPWVVNREYLSPNQLSRQDVHLVKGAMAATYFALNRT-PQAPRLEPVLSSNL 719
Query: 680 AQRRKNKNVSN 690
AQRR K +++
Sbjct: 720 AQRRGMKRLTS 730
|
Serine/threonine-protein kinase that acts downstream of ERK (MAPK1/ERK2 and MAPK3/ERK1) signaling and mediates mitogenic and stress-induced activation of transcription factors, regulates translation, and mediates cellular proliferation, survival, and differentiation. May function as tumor suppressor in epithelial ovarian cancer cells. Homo sapiens (taxid: 9606) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
Close Homologs in the Non-Redundant Database Detected by BLAST
Original result of BLAST against Nonredundant Database
| GI | Alignment Graph | Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 966 | ||||||
| 91093150 | 928 | PREDICTED: similar to ribosomal protein | 0.486 | 0.506 | 0.540 | 1e-160 | |
| 242021181 | 1026 | Ribosomal protein S6 kinase alpha-5, put | 0.414 | 0.389 | 0.587 | 1e-151 | |
| 321468990 | 954 | hypothetical protein DAPPUDRAFT_318992 [ | 0.482 | 0.488 | 0.504 | 1e-142 | |
| 427784431 | 965 | Putative ribosomal protein s6 kinase alp | 0.597 | 0.597 | 0.412 | 1e-125 | |
| 427784429 | 965 | Putative ribosomal protein s6 kinase alp | 0.597 | 0.597 | 0.410 | 1e-125 | |
| 291045152 | 973 | ribosomal protein S6 kinase [Haemaphysal | 0.414 | 0.411 | 0.496 | 1e-124 | |
| 449502742 | 786 | PREDICTED: ribosomal protein S6 kinase a | 0.461 | 0.567 | 0.452 | 1e-120 | |
| 60302822 | 789 | ribosomal protein S6 kinase alpha-5 [Gal | 0.448 | 0.548 | 0.459 | 1e-119 | |
| 383855894 | 943 | PREDICTED: ribosomal protein S6 kinase a | 0.502 | 0.514 | 0.430 | 1e-119 | |
| 326920944 | 811 | PREDICTED: ribosomal protein S6 kinase a | 0.448 | 0.533 | 0.459 | 1e-119 |
| >gi|91093150|ref|XP_970085.1| PREDICTED: similar to ribosomal protein S6 kinase, 90kDa, polypeptide 5 [Tribolium castaneum] gi|270003008|gb|EEZ99455.1| hypothetical protein TcasGA2_TC000021 [Tribolium castaneum] | Back alignment and taxonomy information |
|---|
Score = 571 bits (1472), Expect = e-160, Method: Compositional matrix adjust.
Identities = 315/583 (54%), Positives = 379/583 (65%), Gaps = 113/583 (19%)
Query: 264 RRILKTEPPIPEDLSPDVADFISRLLVKDPRRRLGGGELDAEELKRHPFFNVIDWDDLAT 323
RRILKT PPIP+ L DVADFIS+LLVKDPR+RLGGGE DA+ELK+H FF +DW+ LA
Sbjct: 295 RRILKTTPPIPDSLGKDVADFISKLLVKDPRKRLGGGEGDAKELKKHSFFKSLDWEKLAR 354
Query: 324 KRIPAPFVPKISNELDVSNFSDEFTKMIPADSPAIVPPNFDKIFKG-------------- 369
K IPAPF P I +ELDVSNFS+EFT+M P DSPA+VPPN+DKIFKG
Sbjct: 355 KEIPAPFKPVIRSELDVSNFSEEFTQMPPTDSPAVVPPNYDKIFKGYSYVAPSVLFTKNA 414
Query: 370 ------------------------SLFFEQYDMDLDKAGILGDGSYSVCRRCVEKSTGQE 405
S FF+ YD+DL++ ILGDG++SVCR+CV TG+E
Sbjct: 415 ISDEILKPAKQHDSTKLISCKINNSQFFQTYDIDLNEP-ILGDGTFSVCRKCVNLQTGKE 473
Query: 406 YAVKIISRKIDCSEEINLLRACQGHPNIVNLHCVFQDEVHTYLVLELLKGGELLDRIRQK 465
YAVKI+SRK DCS+EINLLRACQGHPNIV LH V QDE HTYLVLE LKGGEL +RIR+K
Sbjct: 474 YAVKIVSRKKDCSQEINLLRACQGHPNIVTLHDVIQDEAHTYLVLEYLKGGELFERIRKK 533
Query: 466 GRCGFTENEASRIMRQLVAAVHFMHSRGVVHRDLKPENLLFSDPAGD-NIKVVDFGFACL 524
+ FTE+EAS I+R+LV+AV FMHS GVVHRDLKPENL+F+D IKV+DFGFA L
Sbjct: 534 SK--FTESEASGILRKLVSAVSFMHSCGVVHRDLKPENLVFTDDDDSAEIKVIDFGFARL 591
Query: 525 K--RESLHTPCFTLQYAAPEVLRQDKSGYDENCDLWSLGVILVNVLRQDKSGYDENCDLW 582
K +ESLHTPCFTL YAAPEVL+ D GYDENCDLWS
Sbjct: 592 KQEKESLHTPCFTLHYAAPEVLKGDPEGYDENCDLWS----------------------- 628
Query: 583 SLGVILYTMLCGRVPFHARSRDDSALSIMARIKEGQFNFDAEAWSTVSSEAKELTKSLLT 642
LGVILYTMLCG+ PFHARSRD++ SIM RIKEG FNF++ AW+ VS+EAK + + LLT
Sbjct: 629 -LGVILYTMLCGKAPFHARSRDENVSSIMERIKEGDFNFNSSAWTGVSNEAKSVVRGLLT 687
Query: 643 VNPAQRIRMMR--------------------------------VKLTFHAFHQAQKEGFR 670
VNP QR+RM ++ TF+AFH+AQ+EGFR
Sbjct: 688 VNPGQRLRMSHLETNPWVQGSQHFVSTPLMTPDVLLETAPEKSLQTTFNAFHKAQREGFR 747
Query: 671 LQDVTSAKLAQRRKNKNVSNDNSRSFSSTSSSLSSSSSGTSSLKTPCSSTQPSVPSKPVK 730
LQDV SAKLAQRR+ K S+ ++ + SS+ +S S SG P + S VK
Sbjct: 748 LQDVFSAKLAQRRRMKKSSSGDNSTSSSSFTSEGSLKSG------------PKL-SVDVK 794
Query: 731 RINKDASSGTVFDFAEARVQEYLSSLSSSSSSEHGTSPPSSST 773
+ +K A G VF+F E RV E+L ++SS+ SP ST
Sbjct: 795 KTDKVALGGNVFNFGENRVTEFLETMSSNPLDPETVSPCREST 837
|
Source: Tribolium castaneum Species: Tribolium castaneum Genus: Tribolium Family: Tenebrionidae Order: Coleoptera Class: Insecta Phylum: Arthropoda Superkingdom: Eukaryota |
| >gi|242021181|ref|XP_002431024.1| Ribosomal protein S6 kinase alpha-5, putative [Pediculus humanus corporis] gi|212516253|gb|EEB18286.1| Ribosomal protein S6 kinase alpha-5, putative [Pediculus humanus corporis] | Back alignment and taxonomy information |
|---|
Score = 542 bits (1397), Expect = e-151, Method: Compositional matrix adjust.
Identities = 295/502 (58%), Positives = 342/502 (68%), Gaps = 102/502 (20%)
Query: 264 RRILKTEPPIPEDLSPDVADFISRLLVKDPRRRLGGGELDAEELKRHPFFNVIDWDDLAT 323
RRIL PP+P SP+VADFISRLLVK+PR+RLGGGE DAEELKRH FF DW +LA
Sbjct: 224 RRILNVNPPMPPGFSPEVADFISRLLVKNPRKRLGGGEDDAEELKRHQFFAGTDWTELAR 283
Query: 324 KRIPAPFVPKISNELDVSNFSDEFTKMIPADSPAIVPPNFDKIFKG-------------- 369
K IPAPFVPKISNELDVSNFS+EFTKM P DSPAIVPPN+DKIFKG
Sbjct: 284 KNIPAPFVPKISNELDVSNFSEEFTKMTPTDSPAIVPPNYDKIFKGYSYVAPSVLFSENV 343
Query: 370 -------------------------SLFFEQYDMDLDKAGILGDGSYSVCRRCVEKSTGQ 404
S FF+ YD++L K GILGDGS+SVCR+CV + TGQ
Sbjct: 344 VSEDIFNIADRRPSLANLIAEKFKDSPFFQNYDINL-KEGILGDGSFSVCRKCVHRRTGQ 402
Query: 405 EYAVKIISRKIDCSEEINLLRACQGHPNIVNLHCVFQDEVHTYLVLELLKGGELLDRIRQ 464
EYAVKI++R++DC+ EINLLR CQGHPNIVNLH V+ DE HTY+VLELL+GGELL+RIR+
Sbjct: 403 EYAVKIVTRRLDCTHEINLLRTCQGHPNIVNLHEVYFDEAHTYIVLELLRGGELLERIRR 462
Query: 465 KGRCGFTENEASRIMRQLVAAVHFMHSRGVVHRDLKPENLLFSDPAGD-NIKVVDFGFA- 522
K R FTE+EAS+IMR+LV+AV FMHS GVVHRDLKPENLLF+D + IK+VDFGFA
Sbjct: 463 KDR--FTESEASQIMRKLVSAVSFMHSHGVVHRDLKPENLLFTDDSDTAEIKIVDFGFAR 520
Query: 523 CLKRESLHTPCFTLQYAAPEVLRQDKSGYDENCDLWSLGVILVNVLRQDKSGYDENCDLW 582
+ ES+HTPCFTL YAAPEVL+Q +++ GYDENCDLW
Sbjct: 521 KHEEESMHTPCFTLLYAAPEVLKQ--------------------AFNREEDGYDENCDLW 560
Query: 583 SLGVILYTMLCGRVPFHARSRDDSALSIMARIKEGQFNFDAEAWSTVSSEAKELTKSLLT 642
SLGVILYTML GRVPFHARSRDDSA ++M RIK G+FNF EAW VS++AK LTK LLT
Sbjct: 561 SLGVILYTMLSGRVPFHARSRDDSAAAVMCRIKGGEFNFQDEAWGPVSNQAKSLTKGLLT 620
Query: 643 VNPAQRIRM--------------------------------------MRVKLTFHAFHQA 664
V+P QR++M + VK TF AFHQA
Sbjct: 621 VDPKQRLQMKDLLENEWLQGSNTSVYPTTPLMTPDVLTTGSSARSAEIGVKKTFKAFHQA 680
Query: 665 QKEGFRLQDVTSAKLAQRRKNK 686
KEGFRLQDV +AKLAQRR+ K
Sbjct: 681 HKEGFRLQDVVNAKLAQRRRMK 702
|
Source: Pediculus humanus corporis Species: Pediculus humanus Genus: Pediculus Family: Pediculidae Order: Phthiraptera Class: Insecta Phylum: Arthropoda Superkingdom: Eukaryota |
| >gi|321468990|gb|EFX79972.1| hypothetical protein DAPPUDRAFT_318992 [Daphnia pulex] | Back alignment and taxonomy information |
|---|
Score = 513 bits (1320), Expect = e-142, Method: Compositional matrix adjust.
Identities = 290/575 (50%), Positives = 362/575 (62%), Gaps = 109/575 (18%)
Query: 264 RRILKTEPPIPEDLSPDVADFISRLLVKDPRRRLGGGELDAEELKRHPFFNVIDWDDLAT 323
RRIL PPIPEDLS +V DFI +LL KDP RRLGGG DA ELK+H FF ++W+++
Sbjct: 238 RRILSIHPPIPEDLSIEVKDFIGQLLTKDPSRRLGGGISDAVELKQHSFFRNLNWEEVGK 297
Query: 324 KRIPAPFVPKISNELDVSNFSDEFTKMIPADSPAIVPPNFDKIFKG-------------- 369
K + APF+P+I++ELDVSNF++EFT M P DSPAIVP N DKIFKG
Sbjct: 298 KMVRAPFIPRIADELDVSNFAEEFTGMAPTDSPAIVPTNVDKIFKGYSYIAPSILFTDNI 357
Query: 370 --------------------------SLFFEQYDMDLDKAGILGDGSYSVCRRCVEKSTG 403
S FF Y MDL + LGDGS+S+CRRCV K++G
Sbjct: 358 ISEDLFALSADNKPTLSNIIGARFKNSTFFLHYHMDLREQA-LGDGSFSICRRCVHKASG 416
Query: 404 QEYAVKIISRKIDCSEEINLLRACQGHPNIVNLHCVFQDEVHTYLVLELLKGGELLDRIR 463
QE AVKI+SR++DCS+EINLLRACQGHPNIV LH VF DE HTY+V+ELLKGGELL RIR
Sbjct: 417 QEMAVKIVSRRVDCSQEINLLRACQGHPNIVRLHDVFYDEAHTYIVMELLKGGELLQRIR 476
Query: 464 QKGRCGFTENEASRIMRQLVAAVHFMHSRGVVHRDLKPENLLFSDPAGDN--IKVVDFGF 521
Q+ + FTE+EA+RI ++LVA V +H +G+VHRDLKPENLLF + A +N +K+VDFGF
Sbjct: 477 QQKQ--FTESEAARIWQKLVAGVQHVHCKGIVHRDLKPENLLF-ESADENAELKIVDFGF 533
Query: 522 ACLKRES---LHTPCFTLQYAAPEVLRQDKSGYDENCDLWSLGVILVNVLRQDKSGYDEN 578
A LK E L+TPCFTLQYAAPEVL+ +LV + + GYDE+
Sbjct: 534 ARLKPEPQKLLNTPCFTLQYAAPEVLK----------------TVLVPKDGRYEGGYDES 577
Query: 579 CDLWSLGVILYTMLCGRVPFHARSRDDSALSIMARIKEGQFNFDAEAWSTVSSEAKELTK 638
CDLWSLGVILYTMLCGRVPFH+ SR+ +A ++M RIK G F+FD EAW VSS+AK + +
Sbjct: 578 CDLWSLGVILYTMLCGRVPFHSNSREGNAAAVMQRIKTGDFDFDGEAWKHVSSKAKSVIQ 637
Query: 639 SLLTVNPAQRIRM---------------------------------------MRVKLTFH 659
LLTV+P +R+ + + VK T
Sbjct: 638 GLLTVDPKKRLTIKEVINCSWLMPRNRESSFGFPSLMTPGILSIRSFPKATELAVKQTID 697
Query: 660 AFHQAQKEGFRLQDVTSAKLAQRRKNKNVSNDNSRSFSSTSSSLSSSSSGT--SSLKTPC 717
AFH A +EGFRLQDV +A+LAQRRK K SND +S+S S SSS + + ++ K
Sbjct: 698 AFHMAAREGFRLQDVCNARLAQRRKAKRPSNDARSISTSSSFSSSSSGNSSMRTASKGEG 757
Query: 718 SSTQPSVPSKPVKRINKDASSGTVFDFAEARVQEY 752
S++ SV P K ++D VF F EARVQEY
Sbjct: 758 SASWSSVGFTPRKMTSED---DNVFSFREARVQEY 789
|
Source: Daphnia pulex Species: Daphnia pulex Genus: Daphnia Family: Daphniidae Order: Diplostraca Class: Branchiopoda Phylum: Arthropoda Superkingdom: Eukaryota |
| >gi|427784431|gb|JAA57667.1| Putative ribosomal protein s6 kinase alpha-5 [Rhipicephalus pulchellus] | Back alignment and taxonomy information |
|---|
Score = 455 bits (1170), Expect = e-125, Method: Compositional matrix adjust.
Identities = 291/706 (41%), Positives = 396/706 (56%), Gaps = 129/706 (18%)
Query: 264 RRILKTEPPIPEDLSPDVADFISRLLVKDPRRRLGGGELDAEELKRHPFFNVIDWDDLAT 323
+RILK++PPIP+ ++ DV DFI +LL+KDPR+RLGGG DAEE+KRH FF I+WDDLA
Sbjct: 259 KRILKSQPPIPDRITGDVRDFIQKLLIKDPRKRLGGGIEDAEEIKRHRFFKGINWDDLAA 318
Query: 324 KRIPAPFVPKISNELDVSNFSDEFTKMIPADSPAIVPPNFDKIFKG-------------- 369
K+IPAPFVPKI +ELDVSNF+DEFT M+PA SPA+ P + DK+FKG
Sbjct: 319 KKIPAPFVPKIDDELDVSNFADEFTSMVPAYSPALAPVSDDKVFKGYSYVAPSVLFNENI 378
Query: 370 --------------------------SLFFEQYDMDLDKAGILGDGSYSVCRRCVEKSTG 403
S FF+ YD+ + K G+LGDGS+SVCR+C+ K TG
Sbjct: 379 LTDDLLDCPTENRPNINQLLAAKFKNSAFFQNYDL-VGKEGMLGDGSFSVCRKCINKKTG 437
Query: 404 QEYAVKIISRKIDCSEEINLLRACQGHPNIVNLHCVFQDEVHTYLVLELLKGGELLDRIR 463
AVKI+SR+ID ++E+ LL+ CQGH NIV FQDE HTY+VLELL GGELLDRIR
Sbjct: 438 VARAVKIVSRRIDTTQEVQLLKMCQGHNNIVQFVESFQDEAHTYIVLELLTGGELLDRIR 497
Query: 464 QKGRCGFTENEASRIMRQLVAAVHFMHSRGVVHRDLKPENLLFSDPAGD-NIKVVDFGFA 522
GR FTE+EA RI R+LV+AVH MHSRGVVHRDLKPENLLF+D + + IKVVDFGFA
Sbjct: 498 --GRTHFTESEARRIFRRLVSAVHHMHSRGVVHRDLKPENLLFTDNSDNATIKVVDFGFA 555
Query: 523 CLKRES---LHTPCFTLQYAAPEVLRQDKSGYDENCDLWSLGVILVNVLRQDKSGYDENC 579
LK + + TPCFTL YAAPEVL+Q + G + +GY E+C
Sbjct: 556 GLKPQDNQLMKTPCFTLNYAAPEVLQQARPGNNA------------------ANGYTESC 597
Query: 580 DLWSLGVILYTMLCGRVPFHARSRDDSALSIMARIKEGQFNFDAEAWSTVSSEAKELTKS 639
DLWSLGVILYTML GR PF SR+ ++ ++M RI+EG+F+F+ W VS +AK++ +
Sbjct: 598 DLWSLGVILYTMLSGRAPFQTPSRNANSAALMQRIREGEFSFNGPQWEPVSDQAKDVIRR 657
Query: 640 LLTVNPAQRIRMMR------------------------------------VKLTFHAFHQ 663
LLTV R+ M V+ F AFH
Sbjct: 658 LLTVEIQHRLTMSELRAHQWVHDRSSQRSAALMTPDVLSSSSSPRAAESGVRAAFSAFHL 717
Query: 664 AQKEGFRLQDVTSAKLAQRRKNKNVSND------NSRSFSSTSSSLSSSSSGTSSLKTPC 717
A + GFRL DV++A LAQRR+ K S D + + S +S + +SS+ +SL +
Sbjct: 718 ATRSGFRLLDVSAAPLAQRRRLKRNSADVRSSDSSISTSSGSSLTSTSSAHSAASLNSAT 777
Query: 718 SSTQPSVPSKPVKRINKDASSGTVFDFAEARVQEYLSSLSSSSSSEHGTSPPSSSTIQLQ 777
+++ S+ P R + S +VF + E +V YLS+L + G+ S+ I++
Sbjct: 778 AASTRSMGFVPA-RDDSTRSVDSVFTYPETKVAAYLSTLPDMAECPRGSG--STDDIEII 834
Query: 778 LSPVRKKKKPDLTLPASNKAESEQLHLAEPSTLAGTKRKHKPDTSSQCSKSLPATHSTPA 837
+ L +P + + + L P+ + KP + + + + P
Sbjct: 835 TGDL---AITGLAVPQARPSRPQTPTL--PALVVTADVPEKPQGGKEVRVTAFSLPTIPE 889
Query: 838 RKKKKADRQPAKQEEKQPVPQTTPPTDLVTLFEEQLLGPITRARRR 883
+ D + A +QP+ + GP+TR+RR+
Sbjct: 890 TAEASDDSRTASVSIEQPLLDSE--------------GPVTRSRRK 921
|
Source: Rhipicephalus pulchellus Species: Rhipicephalus pulchellus Genus: Rhipicephalus Family: Ixodidae Order: Ixodida Class: Arachnida Phylum: Arthropoda Superkingdom: Eukaryota |
| >gi|427784429|gb|JAA57666.1| Putative ribosomal protein s6 kinase alpha-5 [Rhipicephalus pulchellus] | Back alignment and taxonomy information |
|---|
Score = 454 bits (1169), Expect = e-125, Method: Compositional matrix adjust.
Identities = 290/706 (41%), Positives = 396/706 (56%), Gaps = 129/706 (18%)
Query: 264 RRILKTEPPIPEDLSPDVADFISRLLVKDPRRRLGGGELDAEELKRHPFFNVIDWDDLAT 323
+RILK++PPIP+ ++ DV DFI +LL+KDPR+RLGGG DAEE+KRH FF I+WDDLA
Sbjct: 259 KRILKSQPPIPDRITGDVRDFIQKLLIKDPRKRLGGGIEDAEEIKRHRFFKGINWDDLAA 318
Query: 324 KRIPAPFVPKISNELDVSNFSDEFTKMIPADSPAIVPPNFDKIFKG-------------- 369
K+IPAPFVPK+ +ELDVSNF+DEFT M+PA SPA+ P + DK+FKG
Sbjct: 319 KKIPAPFVPKVDDELDVSNFADEFTSMVPAYSPALAPVSDDKVFKGYSYVAPSVLFNENI 378
Query: 370 --------------------------SLFFEQYDMDLDKAGILGDGSYSVCRRCVEKSTG 403
S FF+ YD+ + K G+LGDGS+SVCR+C+ K TG
Sbjct: 379 LTDDLLDCPTENRPNINQLLAAKFKNSAFFQNYDL-VGKEGMLGDGSFSVCRKCINKKTG 437
Query: 404 QEYAVKIISRKIDCSEEINLLRACQGHPNIVNLHCVFQDEVHTYLVLELLKGGELLDRIR 463
AVKI+SR+ID ++E+ LL+ CQGH NIV FQDE HTY+VLELL GGELLDRIR
Sbjct: 438 VARAVKIVSRRIDTTQEVQLLKMCQGHNNIVQFVESFQDEAHTYIVLELLTGGELLDRIR 497
Query: 464 QKGRCGFTENEASRIMRQLVAAVHFMHSRGVVHRDLKPENLLFSDPAGD-NIKVVDFGFA 522
GR FTE+EA RI R+LV+AVH MHSRGVVHRDLKPENLLF+D + + IKVVDFGFA
Sbjct: 498 --GRTHFTESEARRIFRRLVSAVHHMHSRGVVHRDLKPENLLFTDNSDNATIKVVDFGFA 555
Query: 523 CLKRES---LHTPCFTLQYAAPEVLRQDKSGYDENCDLWSLGVILVNVLRQDKSGYDENC 579
LK + + TPCFTL YAAPEVL+Q + G + +GY E+C
Sbjct: 556 GLKPQDNQLMKTPCFTLNYAAPEVLQQARPGNNA------------------ANGYTESC 597
Query: 580 DLWSLGVILYTMLCGRVPFHARSRDDSALSIMARIKEGQFNFDAEAWSTVSSEAKELTKS 639
DLWSLGVILYTML GR PF SR+ ++ ++M RI+EG+F+F+ W VS +AK++ +
Sbjct: 598 DLWSLGVILYTMLSGRAPFQTPSRNANSAALMQRIREGEFSFNGPQWEPVSDQAKDVIRR 657
Query: 640 LLTVNPAQRIRMMR------------------------------------VKLTFHAFHQ 663
LLTV R+ M V+ F AFH
Sbjct: 658 LLTVEIQHRLTMSELRAHQWVHDRSSQRSAALMTPDVLSSSSSPRAAESGVRAAFSAFHL 717
Query: 664 AQKEGFRLQDVTSAKLAQRRKNKNVSND------NSRSFSSTSSSLSSSSSGTSSLKTPC 717
A + GFRL DV++A LAQRR+ K S D + + S +S + +SS+ +SL +
Sbjct: 718 ATRSGFRLLDVSAAPLAQRRRLKRNSADVRSSDSSISTSSGSSLTSTSSAHSAASLNSAT 777
Query: 718 SSTQPSVPSKPVKRINKDASSGTVFDFAEARVQEYLSSLSSSSSSEHGTSPPSSSTIQLQ 777
+++ S+ P R + S +VF + E +V YLS+L + G+ S+ I++
Sbjct: 778 AASTRSMGFVPA-RDDSTRSVDSVFTYPETKVAAYLSTLPDMAECPRGSG--STDDIEII 834
Query: 778 LSPVRKKKKPDLTLPASNKAESEQLHLAEPSTLAGTKRKHKPDTSSQCSKSLPATHSTPA 837
+ L +P + + + L P+ + KP + + + + P
Sbjct: 835 TGDL---AITGLAVPQARPSRPQTPTL--PALVVTADVPEKPQGGKEVRVTAFSLPTIPE 889
Query: 838 RKKKKADRQPAKQEEKQPVPQTTPPTDLVTLFEEQLLGPITRARRR 883
+ D + A +QP+ + GP+TR+RR+
Sbjct: 890 TAEASDDSRTASVSIEQPLLDSE--------------GPVTRSRRK 921
|
Source: Rhipicephalus pulchellus Species: Rhipicephalus pulchellus Genus: Rhipicephalus Family: Ixodidae Order: Ixodida Class: Arachnida Phylum: Arthropoda Superkingdom: Eukaryota |
| >gi|291045152|dbj|BAI82363.1| ribosomal protein S6 kinase [Haemaphysalis longicornis] | Back alignment and taxonomy information |
|---|
Score = 454 bits (1168), Expect = e-124, Method: Compositional matrix adjust.
Identities = 255/514 (49%), Positives = 320/514 (62%), Gaps = 114/514 (22%)
Query: 264 RRILKTEPPIPEDLSPDVADFISRLLVKDPRRRLGGGELDAEELKRHPFFNVIDWDDLAT 323
+RILK++PP+P+++S D+ DFI +LLVKDPR+RLGGG DA ELK+H FF +DW+DL+T
Sbjct: 261 KRILKSQPPMPDNISGDIKDFIQKLLVKDPRKRLGGGIDDALELKKHRFFKGLDWEDLST 320
Query: 324 KRIPAPFVPKISNELDVSNFSDEFTKMIPADSPAIVP----------------------- 360
KRI APFVPKI+ ELDVSNF++EFT M+PADSPA+ P
Sbjct: 321 KRIAAPFVPKIAGELDVSNFAEEFTSMVPADSPALAPMSDDKVFKGYSYVAPSVLFSDNI 380
Query: 361 -------------PNFDKI----FKGSLFFEQYDMDLDKAGILGDGSYSVCRRCVEKSTG 403
PN ++ FK S FF+ YD+ + + GILGDGS+SVCR+C+ K TG
Sbjct: 381 LTEELLGCTNDSRPNISQLLAAKFKNSAFFQNYDL-ITREGILGDGSFSVCRKCINKKTG 439
Query: 404 QEYAVKIISRKIDCSEEINLLRACQGHPNIVNLHCVFQDEVHTYLVLELLKGGELLDRIR 463
YAVKI+SR+ID ++E+ LLR CQGHPNIV FQDE HTY+VLELL GGELL+RIR
Sbjct: 440 LAYAVKIVSRRIDTTQEVQLLRLCQGHPNIVQFVEAFQDEAHTYIVLELLTGGELLERIR 499
Query: 464 QKGRCGFTENEASRIMRQLVAAVHFMHSRGVVHRDLKPENLLFSDPAGDN--IKVVDFGF 521
++ R FTE+EA RI R+LV+AVHFMH+RGVVHRDLKPENLLF+D + DN IKVVDFGF
Sbjct: 500 RRAR--FTESEACRIFRRLVSAVHFMHARGVVHRDLKPENLLFTD-SSDNATIKVVDFGF 556
Query: 522 ACLK---RESLHTPCFTLQYAAPEVLRQ-----DKSGYDENCDLWSLGVILVNVLRQDKS 573
A LK + + TPCFTL YAAPEVLRQ +GY E+CDLWS
Sbjct: 557 ARLKPSDNQLMKTPCFTLNYAAPEVLRQASAGNGATGYSESCDLWS-------------- 602
Query: 574 GYDENCDLWSLGVILYTMLCGRVPFHARSRDDSALSIMARIKEGQFNFDAEAWSTVSSEA 633
LGVILYTML GR PF SR+ SA ++M RI+EG+F+F W VS +A
Sbjct: 603 ----------LGVILYTMLSGRAPFQTPSRNASAAALMQRIREGEFSFSGPQWEPVSDQA 652
Query: 634 KELTKSLLTVNPAQRIRMMR------------------------------------VKLT 657
K++ + LLTV +R+ M ++ T
Sbjct: 653 KDVIRGLLTVEAQRRLTMAELRAHPWVHTRSSHWSASLMTPDVLSSSSSPRAAESALRAT 712
Query: 658 FHAFHQAQKEGFRLQDVTSAKLAQRRKNKNVSND 691
F AFH A + GFRL DV++A LAQRR+ K S D
Sbjct: 713 FDAFHLATRGGFRLLDVSAAPLAQRRRLKRNSAD 746
|
Source: Haemaphysalis longicornis Species: Haemaphysalis longicornis Genus: Haemaphysalis Family: Ixodidae Order: Ixodida Class: Arachnida Phylum: Arthropoda Superkingdom: Eukaryota |
| >gi|449502742|ref|XP_002200143.2| PREDICTED: ribosomal protein S6 kinase alpha-5 [Taeniopygia guttata] | Back alignment and taxonomy information |
|---|
Score = 438 bits (1127), Expect = e-120, Method: Compositional matrix adjust.
Identities = 257/568 (45%), Positives = 337/568 (59%), Gaps = 122/568 (21%)
Query: 264 RRILKTEPPIPEDLSPDVADFISRLLVKDPRRRLGGGELDAEELKRHPFFNVIDWDDLAT 323
RRILK+EPP P+++S D I RLL+KDP++RLG G DA+E+K+HPFF ++W+DLA
Sbjct: 256 RRILKSEPPYPQEMSALSKDIIQRLLMKDPKKRLGCGPTDADEIKQHPFFQNMNWEDLAA 315
Query: 324 KRIPAPFVPKISNELDVSNFSDEFTKMIPADSPAIVPPNFDKIFKG-------------- 369
K+IPAPF P I +ELDVSNF++EFT+M P SPA P ++IF+G
Sbjct: 316 KKIPAPFKPVIRDELDVSNFAEEFTEMDPTYSPAATPQTSERIFQGYSFVAPSILFKRNA 375
Query: 370 ----------------------------SLFFEQYDMDLDKAGILGDGSYSVCRRCVEKS 401
S F+ Y++DL K LG+GS+S+CR+C+ K
Sbjct: 376 ATVDPFQFYVGDERPGATTIARSAMMKDSPFYHHYELDL-KEKPLGEGSFSICRKCLHKK 434
Query: 402 TGQEYAVKIISRKIDCS--EEINLLRACQGHPNIVNLHCVFQDEVHTYLVLELLKGGELL 459
T QEYAVKIIS++++ + EI LR C+GHPN+V LH VF D++HT+LV+ELLKGGELL
Sbjct: 435 TSQEYAVKIISKRMEANTQREITALRLCEGHPNVVKLHEVFHDQLHTFLVMELLKGGELL 494
Query: 460 DRIRQKGRCGFTENEASRIMRQLVAAVHFMHSRGVVHRDLKPENLLFSDPAGDN-IKVVD 518
+RI++K F+E EAS IMR+LV+AV MH GVVHRDLKPENLLF+D ++ IK++D
Sbjct: 495 ERIQKKKH--FSETEASHIMRRLVSAVSHMHDVGVVHRDLKPENLLFTDETDNSEIKIID 552
Query: 519 FGFACLK---RESLHTPCFTLQYAAPEVLRQDKSGYDENCDLWSLGVILVNVLRQDKSGY 575
FGFA LK + L TPCFTL YAAPE+L + GYDE+CDLWS
Sbjct: 553 FGFARLKPPDNQPLKTPCFTLHYAAPELLNHN--GYDESCDLWS---------------- 594
Query: 576 DENCDLWSLGVILYTMLCGRVPFHARSRD---DSALSIMARIKEGQFNFDAEAWSTVSSE 632
LGVILYTML G+VPF ++ R SAL IM +IK+G+F+F+ EAW VS E
Sbjct: 595 --------LGVILYTMLSGQVPFQSQDRSLTCTSALEIMKKIKKGEFSFEGEAWKNVSEE 646
Query: 633 AKELTKSLLTVNPAQRIRM----------------------------------MRVKLTF 658
AKEL + LLTV+P +RI+M VK TF
Sbjct: 647 AKELIRGLLTVDPNKRIKMSSLRYNEWLQDGSQLSSNPLMTPDNLGSSGAAVHTYVKATF 706
Query: 659 HAFHQAQKEGFRLQDVTSAKLAQRRKNKNVSNDNSRSFSSTSSSLSSSSSGTSSLKTPCS 718
HAF++ ++EGF LQ+V A LA+RRK K S SS+ SS SSSS TP
Sbjct: 707 HAFNKYKREGFCLQNVDKAPLAKRRKMKKTSTSTETRSSSSESSHSSSSHSHGK-TTPTK 765
Query: 719 STQPSVPSKPVKRINKDASSGTVFDFAE 746
+ QP+ P+ + T+F F+E
Sbjct: 766 TLQPTNPT-------DSNNPETIFQFSE 786
|
Source: Taeniopygia guttata Species: Taeniopygia guttata Genus: Taeniopygia Family: Estrildidae Order: Passeriformes Class: Aves Phylum: Chordata Superkingdom: Eukaryota |
| >gi|60302822|ref|NP_001012605.1| ribosomal protein S6 kinase alpha-5 [Gallus gallus] gi|82231192|sp|Q5F3L1.1|KS6A5_CHICK RecName: Full=Ribosomal protein S6 kinase alpha-5; Short=S6K-alpha-5 gi|60098885|emb|CAH65273.1| hypothetical protein RCJMB04_14g1 [Gallus gallus] | Back alignment and taxonomy information |
|---|
Score = 437 bits (1124), Expect = e-119, Method: Compositional matrix adjust.
Identities = 252/548 (45%), Positives = 330/548 (60%), Gaps = 115/548 (20%)
Query: 264 RRILKTEPPIPEDLSPDVADFISRLLVKDPRRRLGGGELDAEELKRHPFFNVIDWDDLAT 323
RRILK+EPP P+++S D I RLL+KDP++RLG G DA+E+K+HPFF I+WDDLA
Sbjct: 259 RRILKSEPPYPQEMSALSKDIIQRLLMKDPKKRLGCGPTDADEIKQHPFFQNINWDDLAA 318
Query: 324 KRIPAPFVPKISNELDVSNFSDEFTKMIPADSPAIVPPNFDKIFKG-------------- 369
K++PAPF P I +ELDVSNF++EFT+M P SPA P +KIF+G
Sbjct: 319 KKVPAPFKPVIRDELDVSNFAEEFTEMDPTYSPAATPQTSEKIFQGYSFVAPSILFKRNA 378
Query: 370 ----------------------------SLFFEQYDMDLDKAGILGDGSYSVCRRCVEKS 401
S FF+ Y++DL K LG+GS+S+CR+C+ K
Sbjct: 379 ATVDPVQFYVGDERPGTTTIARSAMMKDSPFFQHYELDL-KEKPLGEGSFSICRKCLHKK 437
Query: 402 TGQEYAVKIISRKIDCS--EEINLLRACQGHPNIVNLHCVFQDEVHTYLVLELLKGGELL 459
T QEYAVKIIS++++ + EI L+ C+GHPN+V LH V+ D++HT+LV+ELLKGGELL
Sbjct: 438 TSQEYAVKIISKRMEANTQREITALKLCEGHPNVVKLHEVYHDQLHTFLVMELLKGGELL 497
Query: 460 DRIRQKGRCGFTENEASRIMRQLVAAVHFMHSRGVVHRDLKPENLLFSDPAGDN-IKVVD 518
+RI++K F+E EAS IMR+LV+AV MH GVVHRDLKPENLLF+D ++ IK++D
Sbjct: 498 ERIQKKQH--FSETEASHIMRRLVSAVSHMHDVGVVHRDLKPENLLFTDETDNSEIKIID 555
Query: 519 FGFACLK---RESLHTPCFTLQYAAPEVLRQDKSGYDENCDLWSLGVILVNVLRQDKSGY 575
FGFA LK + L TPCFTL YAAPE+ + GYDE+CDLWS
Sbjct: 556 FGFARLKPPDNQPLKTPCFTLHYAAPELFNHN--GYDESCDLWS---------------- 597
Query: 576 DENCDLWSLGVILYTMLCGRVPFHARSRD---DSALSIMARIKEGQFNFDAEAWSTVSSE 632
LGVILYTML G+VPF ++ + SAL IM +IK+G+F+F+ EAW VS E
Sbjct: 598 --------LGVILYTMLSGQVPFQSQDKSLTCTSALEIMKKIKKGEFSFEGEAWKNVSEE 649
Query: 633 AKELTKSLLTVNPAQRIRM----------------------------------MRVKLTF 658
AKEL + LLTV+P +RI+M VK TF
Sbjct: 650 AKELIQGLLTVDPNKRIKMSSLRYNEWLQDGSQLSSNPLMTPDNLGSSGAAVHTYVKATF 709
Query: 659 HAFHQAQKEGFRLQDVTSAKLAQRRKNKNVSNDNSRSFSSTSSSLSSSSSGTSSLKTPCS 718
HAF++ ++EGF LQ+V A LA+RRK K S SS+ SS SSSS TP
Sbjct: 710 HAFNKYKREGFCLQNVDKAPLAKRRKMKKTSTSTETRSSSSESSHSSSSHSHGK-TTPTK 768
Query: 719 STQPSVPS 726
+ QP+ P+
Sbjct: 769 TLQPTNPT 776
|
Source: Gallus gallus Species: Gallus gallus Genus: Gallus Family: Phasianidae Order: Galliformes Class: Aves Phylum: Chordata Superkingdom: Eukaryota |
| >gi|383855894|ref|XP_003703445.1| PREDICTED: ribosomal protein S6 kinase alpha-5-like [Megachile rotundata] | Back alignment and taxonomy information |
|---|
Score = 437 bits (1124), Expect = e-119, Method: Compositional matrix adjust.
Identities = 269/625 (43%), Positives = 344/625 (55%), Gaps = 140/625 (22%)
Query: 209 PNIVNLHCVFQDEVIDWDDFSRGIECVFFSSSLIIFFIILS---FTLSFIHDYYHIQYRR 265
P +V D +DW +S ++ + ++ FT+ + RR
Sbjct: 267 PEVVRGGSAGHDIAVDW-----------WSVGVLTYELLTGASPFTVEGEKNTQQDISRR 315
Query: 266 ILKTEPPIPEDLSPDVADFISRLLVKDPRRRLGGGELDAEELKRHPFFNV----IDWDDL 321
ILKT+PPIP LSP V DFI RLLVKDPR+RLGGG DA ELK HPFF W L
Sbjct: 316 ILKTDPPIPGHLSPTVRDFILRLLVKDPRQRLGGGPNDARELKEHPFFRKAPPPFGWAAL 375
Query: 322 ATKRIPAPFVPKISNELDVSNFSDEFTKMIPADSPAIVPPNFDKIFKG------------ 369
+ I PFVP+I++ELD SNFSDEFTKMI ADSPA+VPPN+DKIF+G
Sbjct: 376 ERREISPPFVPRITHELDTSNFSDEFTKMIAADSPAVVPPNYDKIFRGYSYVAPSILFGD 435
Query: 370 ---------------------------------SLFFEQYDMDLDKAGILGDGSYSVCRR 396
S FF+ Y++D + LGDGS+SVCR+
Sbjct: 436 NVVSKDIFKEATKASTECQRPSASDVLAARFEESTFFQTYELD-PREEALGDGSFSVCRK 494
Query: 397 CVEKSTGQEYAVKIISRKIDCSEEINLLRACQGHPNIVNLHCVFQDEVHTYLVLELLKGG 456
C + T QE+AVKI+SR+IDC E NLLR CQGHPN+V L V QD HTYLV+ELL GG
Sbjct: 495 CRHRKTQQEFAVKIVSRRIDCGREANLLRTCQGHPNVVKLIEVHQDRAHTYLVMELLSGG 554
Query: 457 ELLDRIRQKGRCGFTENEASRIMRQLVAAVHFMHSRGVVHRDLKPENLLFSDPAGDN-IK 515
ELL R R F E ASRIMRQL +AV FMHSRGVVHRDLKPEN++F+ D+ +K
Sbjct: 555 ELLRRPRP-----FNEQHASRIMRQLASAVRFMHSRGVVHRDLKPENIVFAHQGEDSPVK 609
Query: 516 VVDFGFACLKR--ESLHTPCFTLQYAAPEVLRQDKSGYDENCDLWSLGVILVNVLRQDKS 573
+VDFGFA +KR E LHTPCFTL YAAPEV+ + GYD++CDLW
Sbjct: 610 IVDFGFARIKRGCEPLHTPCFTLPYAAPEVVA--RQGYDQSCDLW--------------- 652
Query: 574 GYDENCDLWSLGVILYTMLCGRVPFHARSRDDSALSIMARIKEGQFNFDAEAWSTVSSEA 633
SLG ILY+ML G+ PF S D + RI+ G+ +FD E+WS VSS A
Sbjct: 653 ---------SLGAILYSMLSGKPPFRTGSPD-----LATRIRAGEIDFDGESWSHVSSHA 698
Query: 634 KELTKSLLTVNPAQRIRMMRV-----------------KLTFHAFHQA---------QKE 667
K++ K LLTV+P++R+ + L +A H + E
Sbjct: 699 KQVAKGLLTVDPSKRLTASGLTNHPWLNETSSFDVTTGSLDANALHDGIHANPNILEKPE 758
Query: 668 GFRLQDVTSAKLAQRRKNKNVSNDNSRSFSSTSSSLSSSSSGTSSLKTPCSSTQPSVPSK 727
GFRL++V A+LAQRRK + ++ S S+S+S +SSS L+ P +T + +
Sbjct: 759 GFRLREVDGARLAQRRK---LHKRSTSSSVSSSASTTSSSPSMQLLRPPSVATNLATSAS 815
Query: 728 PVKRINKDASSGTVFDFAEARVQEY 752
P + + FDF E +V EY
Sbjct: 816 PAQ--------PSAFDFGEDKVNEY 832
|
Source: Megachile rotundata Species: Megachile rotundata Genus: Megachile Family: Megachilidae Order: Hymenoptera Class: Insecta Phylum: Arthropoda Superkingdom: Eukaryota |
| >gi|326920944|ref|XP_003206726.1| PREDICTED: ribosomal protein S6 kinase alpha-5-like [Meleagris gallopavo] | Back alignment and taxonomy information |
|---|
Score = 437 bits (1123), Expect = e-119, Method: Compositional matrix adjust.
Identities = 252/548 (45%), Positives = 330/548 (60%), Gaps = 115/548 (20%)
Query: 264 RRILKTEPPIPEDLSPDVADFISRLLVKDPRRRLGGGELDAEELKRHPFFNVIDWDDLAT 323
RRILK+EPP P+++S D I RLL+KDP++RLG G DA+E+K+HPFF I+WDDLA
Sbjct: 281 RRILKSEPPYPQEMSALSKDIIQRLLMKDPKKRLGCGPADADEIKQHPFFQNINWDDLAA 340
Query: 324 KRIPAPFVPKISNELDVSNFSDEFTKMIPADSPAIVPPNFDKIFKG-------------- 369
K++PAPF P I +ELDVSNF++EFT+M P SPA P +KIF+G
Sbjct: 341 KKVPAPFKPVIRDELDVSNFAEEFTEMDPTYSPAATPQTSEKIFQGYSFVAPSILFKRNA 400
Query: 370 ----------------------------SLFFEQYDMDLDKAGILGDGSYSVCRRCVEKS 401
S FF+ Y++DL K LG+GS+S+CR+C+ K
Sbjct: 401 ATVDPVQFYVGDERPGTTTIARSAMMKDSPFFQHYELDL-KEKPLGEGSFSICRKCLHKK 459
Query: 402 TGQEYAVKIISRKIDCS--EEINLLRACQGHPNIVNLHCVFQDEVHTYLVLELLKGGELL 459
T QEYAVKIIS++++ + EI L+ C+GHPN+V LH V+ D++HT+LV+ELLKGGELL
Sbjct: 460 TSQEYAVKIISKRMEANTQREITALKLCEGHPNVVKLHEVYHDQLHTFLVMELLKGGELL 519
Query: 460 DRIRQKGRCGFTENEASRIMRQLVAAVHFMHSRGVVHRDLKPENLLFSDPAGDN-IKVVD 518
+RI++K F+E EAS IMR+LV+AV MH GVVHRDLKPENLLF+D ++ IK++D
Sbjct: 520 ERIQKKQH--FSETEASHIMRRLVSAVSHMHDVGVVHRDLKPENLLFTDETDNSEIKIID 577
Query: 519 FGFACLK---RESLHTPCFTLQYAAPEVLRQDKSGYDENCDLWSLGVILVNVLRQDKSGY 575
FGFA LK + L TPCFTL YAAPE+ + GYDE+CDLWS
Sbjct: 578 FGFARLKPPDNQPLKTPCFTLHYAAPELFNHN--GYDESCDLWS---------------- 619
Query: 576 DENCDLWSLGVILYTMLCGRVPFHARSRD---DSALSIMARIKEGQFNFDAEAWSTVSSE 632
LGVILYTML G+VPF ++ + SAL IM +IK+G+F+F+ EAW VS E
Sbjct: 620 --------LGVILYTMLSGQVPFQSQDKSLTCTSALEIMKKIKKGEFSFEGEAWKNVSEE 671
Query: 633 AKELTKSLLTVNPAQRIRM----------------------------------MRVKLTF 658
AKEL + LLTV+P +RI+M VK TF
Sbjct: 672 AKELIQGLLTVDPNKRIKMSSLRYNEWLQDGSQLSSNPLMTPDNLGSSGAAVHTYVKATF 731
Query: 659 HAFHQAQKEGFRLQDVTSAKLAQRRKNKNVSNDNSRSFSSTSSSLSSSSSGTSSLKTPCS 718
HAF++ ++EGF LQ+V A LA+RRK K S SS+ SS SSSS TP
Sbjct: 732 HAFNKYKREGFCLQNVDKAPLAKRRKMKKTSTSTETRSSSSESSHSSSSHSHGK-TTPTK 790
Query: 719 STQPSVPS 726
+ QP+ P+
Sbjct: 791 TLQPTNPT 798
|
Source: Meleagris gallopavo Species: Meleagris gallopavo Genus: Meleagris Family: Phasianidae Order: Galliformes Class: Aves Phylum: Chordata Superkingdom: Eukaryota |
Prediction of Gene Ontology (GO) Terms
Close Homologs with Gene Ontology terms Detected by BLAST
Original result of BLAST against Gene Ontology (AMIGO)
| ID |
Alignment graph |
Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 966 | ||||||
| UNIPROTKB|F1MQE1 | 771 | RPS6KA4 "Ribosomal protein S6 | 0.204 | 0.256 | 0.521 | 2.2e-103 | |
| RGD|1307277 | 697 | Rps6ka4 "ribosomal protein S6 | 0.193 | 0.268 | 0.530 | 1.9e-102 | |
| UNIPROTKB|F1PH63 | 772 | RPS6KA4 "Ribosomal protein S6 | 0.204 | 0.256 | 0.521 | 4.1e-101 | |
| MGI|MGI:1930076 | 773 | Rps6ka4 "ribosomal protein S6 | 0.204 | 0.256 | 0.530 | 7.7e-101 | |
| UNIPROTKB|I3LS09 | 771 | RPS6KA4 "Ribosomal protein S6 | 0.204 | 0.256 | 0.521 | 3.3e-99 | |
| UNIPROTKB|E1BN61 | 790 | RPS6KA5 "Ribosomal protein S6 | 0.340 | 0.416 | 0.420 | 6.7e-99 | |
| ZFIN|ZDB-GENE-060526-284 | 745 | rps6ka4 "ribosomal protein S6 | 0.227 | 0.295 | 0.476 | 9.3e-99 | |
| UNIPROTKB|O75582 | 802 | RPS6KA5 "Ribosomal protein S6 | 0.391 | 0.471 | 0.382 | 3.8e-96 | |
| UNIPROTKB|B7Z2Y5 | 723 | RPS6KA5 "Ribosomal protein S6 | 0.391 | 0.522 | 0.382 | 5.5e-95 | |
| UNIPROTKB|Q5R4K3 | 802 | RPS6KA5 "Ribosomal protein S6 | 0.391 | 0.471 | 0.379 | 8.8e-95 |
| UNIPROTKB|F1MQE1 RPS6KA4 "Ribosomal protein S6 kinase" [Bos taurus (taxid:9913)] | Back alignment and assigned GO terms |
|---|
Score = 533 (192.7 bits), Expect = 2.2e-103, Sum P(4) = 2.2e-103
Identities = 110/211 (52%), Positives = 147/211 (69%)
Query: 366 IFKGSLFFEQYDMDLDKAGILGDGSYSVCRRCVEKSTGQEYAVKIISRKID--CSEEINL 423
+ + S FF+QY++DL + LG GS+SVCRRC + +GQE+AVKI+SR+++ E+
Sbjct: 398 MMQDSPFFQQYELDLREPA-LGQGSFSVCRRCRQLQSGQEFAVKILSRRLEENTQREVAA 456
Query: 424 LRACQGHPNIVNLHCVFQDEVHTYXXXXXXXXXXXXDRIRQKGRCGFTENEASRIMRQLV 483
LR CQ HPN+V LH V D++HTY + IR+K F+E+EAS+I+R LV
Sbjct: 457 LRLCQSHPNVVKLHEVHHDQLHTYLVLELLQGGELLEHIRKKRH--FSESEASQILRSLV 514
Query: 484 AAVHFMHSR-GVVHRDLKPENLLFSDPA-GDNIKVVDFGFACLKRES----LHTPCFTLQ 537
+AV FMH GVVHRDLKPEN+L++D G +K++DFGFA L+ +S + TPCFTLQ
Sbjct: 515 SAVSFMHEEAGVVHRDLKPENILYADDTPGAPVKIIDFGFARLRPQSPAGPMQTPCFTLQ 574
Query: 538 YAAPEVLRQDKSGYDENCDLWSLGVILVNVL 568
YAAPE+L Q GYDE+CDLWSLGVIL +L
Sbjct: 575 YAAPELLAQQ--GYDESCDLWSLGVILYMML 603
|
|
| RGD|1307277 Rps6ka4 "ribosomal protein S6 kinase, polypeptide 4" [Rattus norvegicus (taxid:10116)] | Back alignment and assigned GO terms |
|---|
Score = 525 (189.9 bits), Expect = 1.9e-102, Sum P(4) = 1.9e-102
Identities = 112/211 (53%), Positives = 150/211 (71%)
Query: 366 IFKGSLFFEQYDMDLDKAGILGDGSYSVCRRCVEKSTGQEYAVKIISRKID--CSEEINL 423
+ + S FF+QY++DL + LG GS+SVCRRC ++ +GQE+AVKI+SR+++ E+
Sbjct: 333 MMQDSPFFQQYELDLREPA-LGQGSFSVCRRCRQRQSGQEFAVKILSRRLEENTQREVAA 391
Query: 424 LRACQGHPNIVNLHCVFQDEVHTYXXXXXXXXXXXXDRIRQKGRCGFTENEASRIMRQLV 483
LR CQ HPN+VNLH V D++HTY + IR+K R F+E+EAS+I+R LV
Sbjct: 392 LRLCQSHPNVVNLHEVLHDQLHTYL-----------EHIRKK-RL-FSESEASQILRSLV 438
Query: 484 AAVHFMHSR-GVVHRDLKPENLLFSDPA-GDNIKVVDFGFACLKRES----LHTPCFTLQ 537
+AV FMH GVVHRDLKPEN+L++D G +K++DFGFA L+ +S + TPCFTLQ
Sbjct: 439 SAVSFMHEEAGVVHRDLKPENILYADDTPGAPVKIIDFGFARLRPQSPAGPMQTPCFTLQ 498
Query: 538 YAAPEVLRQDKSGYDENCDLWSLGVILVNVL 568
YAAPE+L Q GYDE+CDLWSLGVIL +L
Sbjct: 499 YAAPELLAQQ--GYDESCDLWSLGVILYMML 527
|
|
| UNIPROTKB|F1PH63 RPS6KA4 "Ribosomal protein S6 kinase" [Canis lupus familiaris (taxid:9615)] | Back alignment and assigned GO terms |
|---|
Score = 540 (195.1 bits), Expect = 4.1e-101, Sum P(4) = 4.1e-101
Identities = 110/211 (52%), Positives = 149/211 (70%)
Query: 366 IFKGSLFFEQYDMDLDKAGILGDGSYSVCRRCVEKSTGQEYAVKIISRKIDCS--EEINL 423
+ + S FF+QY++DL + LG GS+SVCRRC ++ +GQE+AVKI+SR+++ + E+
Sbjct: 399 MMQDSPFFQQYELDLREPA-LGQGSFSVCRRCRQRQSGQEFAVKILSRRLEANTQREVAA 457
Query: 424 LRACQGHPNIVNLHCVFQDEVHTYXXXXXXXXXXXXDRIRQKGRCGFTENEASRIMRQLV 483
LR CQ HPN+V LH V D++HTY + IR+K F+E+EAS+I+R LV
Sbjct: 458 LRLCQSHPNVVKLHDVHHDQLHTYLVLELLRGGELLEHIRKKRH--FSESEASQILRSLV 515
Query: 484 AAVHFMHSR-GVVHRDLKPENLLFSDPA-GDNIKVVDFGFACLKRES----LHTPCFTLQ 537
+AV FMH GVVHRDLKPEN+L++D G +K++DFGFA L+ +S + TPCFTLQ
Sbjct: 516 SAVSFMHEEAGVVHRDLKPENILYADDTPGAPVKIIDFGFARLRPQSPAGPMQTPCFTLQ 575
Query: 538 YAAPEVLRQDKSGYDENCDLWSLGVILVNVL 568
YAAPE+L Q GYDE+CDLWSLGVIL +L
Sbjct: 576 YAAPELLAQQ--GYDESCDLWSLGVILYMML 604
|
|
| MGI|MGI:1930076 Rps6ka4 "ribosomal protein S6 kinase, polypeptide 4" [Mus musculus (taxid:10090)] | Back alignment and assigned GO terms |
|---|
Score = 543 (196.2 bits), Expect = 7.7e-101, Sum P(4) = 7.7e-101
Identities = 112/211 (53%), Positives = 150/211 (71%)
Query: 366 IFKGSLFFEQYDMDLDKAGILGDGSYSVCRRCVEKSTGQEYAVKIISRKID--CSEEINL 423
+ + S FF+QY++DL + LG GS+SVCRRC ++ +GQE+AVKI+SR+++ E+
Sbjct: 398 MMQDSPFFQQYELDLREPA-LGQGSFSVCRRCRQRQSGQEFAVKILSRRLEENTQREVAA 456
Query: 424 LRACQGHPNIVNLHCVFQDEVHTYXXXXXXXXXXXXDRIRQKGRCGFTENEASRIMRQLV 483
LR CQ HPN+VNLH V D++HTY + IR+K R F+E+EAS+I+R LV
Sbjct: 457 LRLCQSHPNVVNLHEVLHDQLHTYLVLELLRGGELLEHIRKK-RL-FSESEASQILRSLV 514
Query: 484 AAVHFMHSR-GVVHRDLKPENLLFSDPA-GDNIKVVDFGFACLKRES----LHTPCFTLQ 537
+AV FMH GVVHRDLKPEN+L++D G +K++DFGFA L+ +S + TPCFTLQ
Sbjct: 515 SAVSFMHEEAGVVHRDLKPENILYADDTPGAPVKIIDFGFARLRPQSPAEPMQTPCFTLQ 574
Query: 538 YAAPEVLRQDKSGYDENCDLWSLGVILVNVL 568
YAAPE+L Q GYDE+CDLWSLGVIL +L
Sbjct: 575 YAAPELLAQQ--GYDESCDLWSLGVILYMML 603
|
|
| UNIPROTKB|I3LS09 RPS6KA4 "Ribosomal protein S6 kinase" [Sus scrofa (taxid:9823)] | Back alignment and assigned GO terms |
|---|
Score = 539 (194.8 bits), Expect = 3.3e-99, Sum P(3) = 3.3e-99
Identities = 110/211 (52%), Positives = 149/211 (70%)
Query: 366 IFKGSLFFEQYDMDLDKAGILGDGSYSVCRRCVEKSTGQEYAVKIISRKIDCS--EEINL 423
+ + S FF+QY++DL + LG GS+SVCRRC ++ +GQE+AVKI+SR+++ + E+
Sbjct: 398 MMQDSPFFQQYELDLREPA-LGQGSFSVCRRCRQRQSGQEFAVKILSRRLEANTQREVAA 456
Query: 424 LRACQGHPNIVNLHCVFQDEVHTYXXXXXXXXXXXXDRIRQKGRCGFTENEASRIMRQLV 483
LR CQ HPN+V LH V D++HTY + IR+K F+E+EAS+I+R LV
Sbjct: 457 LRLCQSHPNVVKLHEVHHDQLHTYLVLELLQGGELLEHIRKKRH--FSESEASQILRSLV 514
Query: 484 AAVHFMHSR-GVVHRDLKPENLLFSDPA-GDNIKVVDFGFACLKRES----LHTPCFTLQ 537
+AV FMH GVVHRDLKPEN+L++D G +K++DFGFA L+ +S + TPCFTLQ
Sbjct: 515 SAVSFMHEEAGVVHRDLKPENILYADDTPGAPVKIIDFGFARLRPQSPAGPMQTPCFTLQ 574
Query: 538 YAAPEVLRQDKSGYDENCDLWSLGVILVNVL 568
YAAPE+L Q GYDE+CDLWSLGVIL +L
Sbjct: 575 YAAPELLAQQ--GYDESCDLWSLGVILYMML 603
|
|
| UNIPROTKB|E1BN61 RPS6KA5 "Ribosomal protein S6 kinase" [Bos taurus (taxid:9913)] | Back alignment and assigned GO terms |
|---|
Score = 602 (217.0 bits), Expect = 6.7e-99, Sum P(4) = 6.7e-99
Identities = 150/357 (42%), Positives = 205/357 (57%)
Query: 354 DSPAIVPPNFDKIFKGSLFFEQYDMDLDKAGILGDGSYSVCRRCVEKSTGQEYAVKIISR 413
D P + + K S F++ YD+DL K LG+GS+S+CR+C+ K + Q +AVKIIS+
Sbjct: 392 DRPGVTHVARSAMLKDSPFYQHYDLDL-KDTPLGEGSFSICRKCIHKKSNQAFAVKIISK 450
Query: 414 KIDCS--EEINLLRACQGHPNIVNLHCVFQDEVHTYXXXXXXXXXXXXDRIRQKGRCGFT 471
+++ S +E+ LR C+GHPNIV LH VF D++HT+ +RI++K F+
Sbjct: 451 RMEASTQKEVTALRLCEGHPNIVKLHEVFHDQLHTFLVMELLNGGELFERIKRKKH--FS 508
Query: 472 ENEASRIMRQLVAAVHFMHSRGVVHRDLKPENLLFSDPAGDN--IKVVDFGFACLK---R 526
E EAS IMR+LV+AV MH GVVHRDLKPENLLF+D DN IKV+DFGFA LK
Sbjct: 509 ETEASYIMRKLVSAVSHMHDVGVVHRDLKPENLLFTDE-NDNLEIKVIDFGFARLKPPDN 567
Query: 527 ESLHTPCFTLQYAAPEVLRQDKSGYDENCDLWSLGVILVNVLRQDK--SGYDENCDLWSL 584
+ L TPCFTL YAAPE+L SGYDE+CDLWSLGVIL +L +D++ S
Sbjct: 568 QPLKTPCFTLHYAAPELLNH--SGYDESCDLWSLGVILYTMLSGQVPFQSHDKSLTCTSA 625
Query: 585 GVILYTMLCGRVPFHARSRDDSALSIMARIKEGQFNFDAEAWSTVSS-EAKELTK--SLL 641
I+ + G F + + + I +G D + E + S L
Sbjct: 626 VEIMKKIKKGDFSFEGEAWKNVSQEAKDLI-QGLLTVDPNKRLKMPDLRYNEWLQDGSQL 684
Query: 642 TVNPAQRIRMMR---------VKLTFHAFHQAQKEGFRLQDVTSAKLAQRRKNKNVS 689
+ NP ++ VK TFHAF++ ++EGF LQ+V A LA+RR+ K S
Sbjct: 685 SSNPLMTPDILGSSGAAVHTCVKATFHAFNKYKREGFCLQNVDKAPLAKRRRMKKTS 741
|
|
| ZFIN|ZDB-GENE-060526-284 rps6ka4 "ribosomal protein S6 kinase, polypeptide 4" [Danio rerio (taxid:7955)] | Back alignment and assigned GO terms |
|---|
Score = 520 (188.1 bits), Expect = 9.3e-99, Sum P(4) = 9.3e-99
Identities = 111/233 (47%), Positives = 147/233 (63%)
Query: 344 SDEFTKMIPADSPAIVPPNFDKIFKGSLFFEQYDMDLDKAGILGDGSYSVCRRCVEKSTG 403
+D + D P + K S FF+ Y++ L + LG+GS+SVCR+C K +G
Sbjct: 345 ADVLDAHVNVDRPGSATVQRSAMLKESQFFQHYELCL-QGSPLGEGSFSVCRKCRHKQSG 403
Query: 404 QEYAVKIISRKIDC--SEEINLLRACQGHPNIVNLHCVFQDEVHTYXXXXXXXXXXXXDR 461
QEYAVKI+SR+++ EI LR C+ HPNIV LH V+ D+ HTY +R
Sbjct: 404 QEYAVKIVSRRMEAMTQREIAALRQCESHPNIVTLHEVYTDQYHTYLVMEMLRGGELLER 463
Query: 462 IRQKGRCGFTENEASRIMRQLVAAVHFMHSRGVVHRDLKPENLLFSDPAGDNI-KVVDFG 520
IR++ F E EAS++M+ LV+AV +MH GVVHRDLKPEN+LF+D + +++ KV+DFG
Sbjct: 464 IRKRKM--FAEWEASQLMKSLVSAVSYMHEAGVVHRDLKPENVLFADESDESVLKVIDFG 521
Query: 521 FACL-----KRESLHTPCFTLQYAAPEVLRQDKSGYDENCDLWSLGVILVNVL 568
FA L L TPCFTLQYAAPE+ SGYD+ CDLWSLGVIL +L
Sbjct: 522 FARLFPAGSGSAPLQTPCFTLQYAAPELFHS--SGYDQACDLWSLGVILYTML 572
|
|
| UNIPROTKB|O75582 RPS6KA5 "Ribosomal protein S6 kinase alpha-5" [Homo sapiens (taxid:9606)] | Back alignment and assigned GO terms |
|---|
Score = 606 (218.4 bits), Expect = 3.8e-96, Sum P(3) = 3.8e-96
Identities = 159/416 (38%), Positives = 221/416 (53%)
Query: 354 DSPAIVPPNFDKIFKGSLFFEQYDMDL-DKAGILGDGSYSVCRRCVEKSTGQEYAVKIIS 412
+ P + + K S F++ YD+DL DK LG+GS+S+CR+CV K + Q +AVKIIS
Sbjct: 401 ERPGVTNVARSAMMKDSPFYQHYDLDLKDKP--LGEGSFSICRKCVHKKSNQAFAVKIIS 458
Query: 413 RKIDCS--EEINLLRACQGHPNIVNLHCVFQDEVHTYXXXXXXXXXXXXDRIRQKGRCGF 470
++++ + +EI L+ C+GHPNIV LH VF D++HT+ +RI++K F
Sbjct: 459 KRMEANTQKEITALKLCEGHPNIVKLHEVFHDQLHTFLVMELLNGGELFERIKKKKH--F 516
Query: 471 TENEASRIMRQLVAAVHFMHSRGVVHRDLKPENLLFSDPAGDN--IKVVDFGFACLK--- 525
+E EAS IMR+LV+AV MH GVVHRDLKPENLLF+D DN IK++DFGFA LK
Sbjct: 517 SETEASYIMRKLVSAVSHMHDVGVVHRDLKPENLLFTDE-NDNLEIKIIDFGFARLKPPD 575
Query: 526 RESLHTPCFTLQYAAPEVLRQDKSGYDENCDLWSLGVILVNVLRQDK--SGYDENCDLWS 583
+ L TPCFTL YAAPE+L Q+ GYDE+CDLWSLGVIL +L +D + S
Sbjct: 576 NQPLKTPCFTLHYAAPELLNQN--GYDESCDLWSLGVILYTMLSGQVPFQSHDRSLTCTS 633
Query: 584 LGVILYTMLCGRVPFHARSRDDSALSIMARIKEGQFNFDAEAWSTVSS-EAKELTK--SL 640
I+ + G F + + + I +G D +S E + S
Sbjct: 634 AVEIMKKIKKGDFSFEGEAWKNVSQEAKDLI-QGLLTVDPNKRLKMSGLRYNEWLQDGSQ 692
Query: 641 LTVNPAQRIRMMR---------VKLTFHAFHQAQKEGFRLQDVTSAKLAQRRKNKNVSND 691
L+ NP ++ VK TFHAF++ ++EGF LQ+V A LA+RRK K S
Sbjct: 693 LSSNPLMTPDILGSSGAAVHTCVKATFHAFNKYKREGFCLQNVDKAPLAKRRKMKKTSTS 752
Query: 692 NXXXXXXXXXXXXXXXXXXXXXXXXXXXTQPSVPSKPVKRINKDASSGTVFDFAEA 747
T+ PS P N + T+F F+++
Sbjct: 753 TETRSSSSESSHSSSSHSHGKTTP----TKTLQPSNPADSNNPE----TLFQFSDS 800
|
|
| UNIPROTKB|B7Z2Y5 RPS6KA5 "Ribosomal protein S6 kinase" [Homo sapiens (taxid:9606)] | Back alignment and assigned GO terms |
|---|
Score = 606 (218.4 bits), Expect = 5.5e-95, Sum P(3) = 5.5e-95
Identities = 159/416 (38%), Positives = 221/416 (53%)
Query: 354 DSPAIVPPNFDKIFKGSLFFEQYDMDL-DKAGILGDGSYSVCRRCVEKSTGQEYAVKIIS 412
+ P + + K S F++ YD+DL DK LG+GS+S+CR+CV K + Q +AVKIIS
Sbjct: 322 ERPGVTNVARSAMMKDSPFYQHYDLDLKDKP--LGEGSFSICRKCVHKKSNQAFAVKIIS 379
Query: 413 RKIDCS--EEINLLRACQGHPNIVNLHCVFQDEVHTYXXXXXXXXXXXXDRIRQKGRCGF 470
++++ + +EI L+ C+GHPNIV LH VF D++HT+ +RI++K F
Sbjct: 380 KRMEANTQKEITALKLCEGHPNIVKLHEVFHDQLHTFLVMELLNGGELFERIKKKKH--F 437
Query: 471 TENEASRIMRQLVAAVHFMHSRGVVHRDLKPENLLFSDPAGDN--IKVVDFGFACLK--- 525
+E EAS IMR+LV+AV MH GVVHRDLKPENLLF+D DN IK++DFGFA LK
Sbjct: 438 SETEASYIMRKLVSAVSHMHDVGVVHRDLKPENLLFTDE-NDNLEIKIIDFGFARLKPPD 496
Query: 526 RESLHTPCFTLQYAAPEVLRQDKSGYDENCDLWSLGVILVNVLRQDK--SGYDENCDLWS 583
+ L TPCFTL YAAPE+L Q+ GYDE+CDLWSLGVIL +L +D + S
Sbjct: 497 NQPLKTPCFTLHYAAPELLNQN--GYDESCDLWSLGVILYTMLSGQVPFQSHDRSLTCTS 554
Query: 584 LGVILYTMLCGRVPFHARSRDDSALSIMARIKEGQFNFDAEAWSTVSS-EAKELTK--SL 640
I+ + G F + + + I +G D +S E + S
Sbjct: 555 AVEIMKKIKKGDFSFEGEAWKNVSQEAKDLI-QGLLTVDPNKRLKMSGLRYNEWLQDGSQ 613
Query: 641 LTVNPAQRIRMMR---------VKLTFHAFHQAQKEGFRLQDVTSAKLAQRRKNKNVSND 691
L+ NP ++ VK TFHAF++ ++EGF LQ+V A LA+RRK K S
Sbjct: 614 LSSNPLMTPDILGSSGAAVHTCVKATFHAFNKYKREGFCLQNVDKAPLAKRRKMKKTSTS 673
Query: 692 NXXXXXXXXXXXXXXXXXXXXXXXXXXXTQPSVPSKPVKRINKDASSGTVFDFAEA 747
T+ PS P N + T+F F+++
Sbjct: 674 TETRSSSSESSHSSSSHSHGKTTP----TKTLQPSNPADSNNPE----TLFQFSDS 721
|
|
| UNIPROTKB|Q5R4K3 RPS6KA5 "Ribosomal protein S6 kinase alpha-5" [Pongo abelii (taxid:9601)] | Back alignment and assigned GO terms |
|---|
Score = 599 (215.9 bits), Expect = 8.8e-95, Sum P(3) = 8.8e-95
Identities = 158/416 (37%), Positives = 220/416 (52%)
Query: 354 DSPAIVPPNFDKIFKGSLFFEQYDMDL-DKAGILGDGSYSVCRRCVEKSTGQEYAVKIIS 412
+ P + + K S F++ YD+DL DK LG+GS+S+CR+CV K + Q +AVKIIS
Sbjct: 401 ERPGVTNVARSAMMKDSPFYQHYDLDLKDKP--LGEGSFSICRKCVHKKSNQAFAVKIIS 458
Query: 413 RKIDCS--EEINLLRACQGHPNIVNLHCVFQDEVHTYXXXXXXXXXXXXDRIRQKGRCGF 470
++++ + +EI L+ C+GHPNIV LH VF D++HT+ +RI++K F
Sbjct: 459 KRMEANTQKEITALKLCEGHPNIVKLHEVFHDQLHTFLVMELLNGGELFERIKKKKH--F 516
Query: 471 TENEASRIMRQLVAAVHFMHSRGVVHRDLKPENLLFSDPAGDN--IKVVDFGFACLK--- 525
+E EAS IMR+LV+AV MH GVVHRDLKPENLLF+D DN IK++DFGFA K
Sbjct: 517 SETEASYIMRKLVSAVSHMHDVGVVHRDLKPENLLFTDE-NDNLEIKIIDFGFARPKPPD 575
Query: 526 RESLHTPCFTLQYAAPEVLRQDKSGYDENCDLWSLGVILVNVLRQDK--SGYDENCDLWS 583
+ L TPCFTL YAAPE+L Q+ GYDE+CDLWSLGVIL +L +D + S
Sbjct: 576 NQPLKTPCFTLHYAAPELLNQN--GYDESCDLWSLGVILYTMLSGQVPFQSHDRSLTCTS 633
Query: 584 LGVILYTMLCGRVPFHARSRDDSALSIMARIKEGQFNFDAEAWSTVSS-EAKELTK--SL 640
I+ + G F + + + I +G D +S E + S
Sbjct: 634 AVEIMKKIKKGDFSFEGEAWKNVSQEAKDLI-QGLLTVDPNKRLKMSGLRYNEWLQDGSQ 692
Query: 641 LTVNPAQRIRMMR---------VKLTFHAFHQAQKEGFRLQDVTSAKLAQRRKNKNVSND 691
L+ NP ++ VK TFHAF++ ++EGF LQ+V A LA+RRK K S
Sbjct: 693 LSSNPLMTPDILGSSGAAVHTCVKATFHAFNKYKREGFCLQNVDKAPLAKRRKMKKTSTS 752
Query: 692 NXXXXXXXXXXXXXXXXXXXXXXXXXXXTQPSVPSKPVKRINKDASSGTVFDFAEA 747
T+ PS P N + T+F F+++
Sbjct: 753 TETRSSSSESSHSSSSHSHGKTTP----TKTLQPSNPADSNNPE----TLFQFSDS 800
|
|
Prediction of Enzyme Commission (EC) Number
EC Number Prediction by Annotation Transfer from SWISS-PROT Entries
Original result of BLAST against SWISS-PROT
No confident hit for EC number transfering in SWISSPROT detected by BLAST
EC Number Prediction by EFICAz Software
| Prediction Level | EC number | Confidence of Prediction |
| 3rd Layer | 2.7.1 | LOW CONFIDENCE prediction! |
| 4th Layer | 2.7.11.1 | 0.737 |
| 3rd Layer | 2.7.11 | 0.691 |
Prediction of Functionally Associated Proteins
Conserved Domains and Related Protein Families
Conserved Domains Detected by RPS-BLAST
Original result of RPS-BLAST against CDD database
| ID | Alignment Graph | Length |
Definition |
E-value |
| Query | 966 | |||
| smart00220 | 254 | smart00220, S_TKc, Serine/Threonine protein kinase | 2e-80 | |
| pfam00069 | 260 | pfam00069, Pkinase, Protein kinase domain | 3e-75 | |
| cd05123 | 250 | cd05123, STKc_AGC, Catalytic domain of AGC family | 3e-61 | |
| cd00180 | 215 | cd00180, PKc, Catalytic domain of Protein Kinases | 7e-54 | |
| cd05581 | 280 | cd05581, STKc_PDK1, Catalytic domain of the Protei | 1e-51 | |
| cd05580 | 290 | cd05580, STKc_PKA, Catalytic domain of the Protein | 1e-49 | |
| cd08215 | 258 | cd08215, STKc_Nek, Catalytic domain of the Protein | 2e-45 | |
| cd05572 | 262 | cd05572, STKc_cGK_PKG, Catalytic domain of the Pro | 7e-44 | |
| PTZ00263 | 329 | PTZ00263, PTZ00263, protein kinase A catalytic sub | 9e-43 | |
| cd05578 | 258 | cd05578, STKc_Yank1, Catalytic domain of the Prote | 2e-40 | |
| COG0515 | 384 | COG0515, SPS1, Serine/threonine protein kinase [Ge | 5e-40 | |
| cd05573 | 350 | cd05573, STKc_ROCK_NDR_like, Catalytic domain of R | 3e-39 | |
| cd05122 | 253 | cd05122, PKc_STE, Catalytic domain of STE family P | 3e-38 | |
| cd06606 | 260 | cd06606, STKc_MAPKKK, Catalytic domain of the Prot | 5e-38 | |
| cd05579 | 265 | cd05579, STKc_MAST_like, Catalytic domain of Micro | 5e-38 | |
| cd07829 | 282 | cd07829, STKc_CDK_like, Catalytic domain of Cyclin | 6e-38 | |
| cd05612 | 291 | cd05612, STKc_PRKX_like, Catalytic domain of PRKX- | 1e-36 | |
| cd05614 | 332 | cd05614, STKc_MSK2_N, N-terminal catalytic domain | 1e-35 | |
| cd05601 | 330 | cd05601, STKc_CRIK, Catalytic domain of the Protei | 1e-35 | |
| cd05570 | 318 | cd05570, STKc_PKC, Catalytic domain of the Protein | 8e-35 | |
| cd07830 | 283 | cd07830, STKc_MAK_like, Catalytic domain of Male g | 9e-35 | |
| cd05582 | 318 | cd05582, STKc_RSK_N, N-terminal catalytic domain o | 1e-34 | |
| cd05584 | 323 | cd05584, STKc_p70S6K, Catalytic domain of the Prot | 2e-34 | |
| cd05611 | 260 | cd05611, STKc_Rim15_like, Catalytic domain of fung | 3e-34 | |
| cd05118 | 283 | cd05118, STKc_CMGC, Catalytic domain of CMGC famil | 7e-33 | |
| cd08530 | 256 | cd08530, STKc_CNK2-like, Catalytic domain of the P | 2e-32 | |
| cd08217 | 265 | cd08217, STKc_Nek2, Catalytic domain of the Protei | 7e-32 | |
| cd05583 | 288 | cd05583, STKc_MSK_N, N-terminal catalytic domain o | 2e-31 | |
| cd05586 | 330 | cd05586, STKc_Sck1_like, Catalytic domain of Suppr | 4e-31 | |
| cd05599 | 364 | cd05599, STKc_NDR_like, Catalytic domain of Nuclea | 4e-31 | |
| cd07832 | 286 | cd07832, STKc_CCRK, Catalytic domain of the Serine | 9e-31 | |
| cd05571 | 323 | cd05571, STKc_PKB, Catalytic domain of the Protein | 2e-30 | |
| cd06614 | 286 | cd06614, STKc_PAK, Catalytic domain of the Protein | 2e-30 | |
| cd05590 | 320 | cd05590, STKc_nPKC_eta, Catalytic domain of the Pr | 1e-29 | |
| cd05592 | 316 | cd05592, STKc_nPKC_theta_delta, Catalytic domain o | 1e-29 | |
| cd05591 | 321 | cd05591, STKc_nPKC_epsilon, Catalytic domain of th | 4e-29 | |
| cd05574 | 316 | cd05574, STKc_phototropin_like, Catalytic domain o | 5e-29 | |
| cd06623 | 264 | cd06623, PKc_MAPKK_plant_like, Catalytic domain of | 5e-29 | |
| cd06612 | 256 | cd06612, STKc_MST1_2, Catalytic domain of the Prot | 5e-29 | |
| cd06627 | 254 | cd06627, STKc_Cdc7_like, Catalytic domain of Cell | 2e-28 | |
| cd05613 | 290 | cd05613, STKc_MSK1_N, N-terminal catalytic domain | 3e-28 | |
| cd05587 | 324 | cd05587, STKc_cPKC, Catalytic domain of the Protei | 5e-28 | |
| cd05596 | 370 | cd05596, STKc_ROCK, Catalytic domain of the Protei | 1e-27 | |
| cd05595 | 323 | cd05595, STKc_PKB_beta, Catalytic domain of the Pr | 2e-27 | |
| cd06608 | 275 | cd06608, STKc_myosinIII_like, Catalytic domain of | 2e-27 | |
| cd05589 | 324 | cd05589, STKc_PKN, Catalytic domain of the Protein | 2e-27 | |
| cd07833 | 288 | cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep | 6e-27 | |
| cd06610 | 267 | cd06610, STKc_OSR1_SPAK, Catalytic domain of the P | 7e-27 | |
| cd05621 | 370 | cd05621, STKc_ROCK2, Catalytic domain of the Prote | 7e-27 | |
| cd05597 | 331 | cd05597, STKc_DMPK_like, Catalytic domain of Myoto | 1e-26 | |
| cd06609 | 274 | cd06609, STKc_MST3_like, Catalytic domain of Mamma | 1e-26 | |
| cd05589 | 324 | cd05589, STKc_PKN, Catalytic domain of the Protein | 2e-26 | |
| cd05583 | 288 | cd05583, STKc_MSK_N, N-terminal catalytic domain o | 4e-26 | |
| cd07843 | 293 | cd07843, STKc_CDC2L1, Catalytic domain of the Seri | 4e-26 | |
| cd05620 | 316 | cd05620, STKc_nPKC_delta, Catalytic domain of the | 4e-26 | |
| cd05616 | 323 | cd05616, STKc_cPKC_beta, Catalytic domain of the P | 5e-26 | |
| cd05584 | 323 | cd05584, STKc_p70S6K, Catalytic domain of the Prot | 8e-26 | |
| cd05575 | 323 | cd05575, STKc_SGK, Catalytic domain of the Protein | 9e-26 | |
| cd07840 | 287 | cd07840, STKc_CDK9_like, Catalytic domain of Cycli | 2e-25 | |
| cd05577 | 277 | cd05577, STKc_GRK, Catalytic domain of the Protein | 3e-25 | |
| cd07831 | 282 | cd07831, STKc_MOK, Catalytic domain of the Serine/ | 3e-25 | |
| cd05593 | 328 | cd05593, STKc_PKB_gamma, Catalytic domain of the P | 3e-25 | |
| cd06625 | 263 | cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ | 5e-25 | |
| cd05603 | 321 | cd05603, STKc_SGK2, Catalytic domain of the Protei | 8e-25 | |
| cd07838 | 287 | cd07838, STKc_CDK4_6_like, Catalytic domain of Cyc | 8e-25 | |
| cd05613 | 290 | cd05613, STKc_MSK1_N, N-terminal catalytic domain | 1e-24 | |
| cd05619 | 316 | cd05619, STKc_nPKC_theta, Catalytic domain of the | 1e-24 | |
| cd05594 | 325 | cd05594, STKc_PKB_alpha, Catalytic domain of the P | 1e-24 | |
| cd06611 | 280 | cd06611, STKc_SLK_like, Catalytic domain of Ste20- | 1e-24 | |
| cd07841 | 298 | cd07841, STKc_CDK7, Catalytic domain of the Serine | 1e-24 | |
| cd05588 | 329 | cd05588, STKc_aPKC, Catalytic domain of the Protei | 2e-24 | |
| cd05624 | 331 | cd05624, STKc_MRCK_beta, Catalytic domain of the P | 2e-24 | |
| cd07845 | 309 | cd07845, STKc_CDK10, Catalytic domain of the Serin | 3e-24 | |
| cd05614 | 332 | cd05614, STKc_MSK2_N, N-terminal catalytic domain | 4e-24 | |
| cd06626 | 264 | cd06626, STKc_MEKK4, Catalytic domain of the Prote | 4e-24 | |
| cd05615 | 323 | cd05615, STKc_cPKC_alpha, Catalytic domain of the | 4e-24 | |
| PTZ00426 | 340 | PTZ00426, PTZ00426, cAMP-dependent protein kinase | 4e-24 | |
| cd05604 | 325 | cd05604, STKc_SGK3, Catalytic domain of the Protei | 5e-24 | |
| cd05585 | 312 | cd05585, STKc_YPK1_like, Catalytic domain of Yeast | 5e-24 | |
| PHA03390 | 267 | PHA03390, pk1, serine/threonine-protein kinase 1; | 6e-24 | |
| cd05602 | 325 | cd05602, STKc_SGK1, Catalytic domain of the Protei | 7e-24 | |
| cd08529 | 256 | cd08529, STKc_FA2-like, Catalytic domain of the Pr | 8e-24 | |
| cd06613 | 262 | cd06613, STKc_MAP4K3_like, Catalytic domain of Mit | 1e-23 | |
| smart00220 | 254 | smart00220, S_TKc, Serine/Threonine protein kinase | 3e-23 | |
| PLN00034 | 353 | PLN00034, PLN00034, mitogen-activated protein kina | 3e-23 | |
| cd05622 | 371 | cd05622, STKc_ROCK1, Catalytic domain of the Prote | 5e-23 | |
| cd07834 | 330 | cd07834, STKc_MAPK, Catalytic domain of the Serine | 6e-23 | |
| cd07846 | 286 | cd07846, STKc_CDKL2_3, Catalytic domain of the Ser | 7e-23 | |
| cd05571 | 323 | cd05571, STKc_PKB, Catalytic domain of the Protein | 1e-22 | |
| cd05600 | 333 | cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fun | 1e-22 | |
| cd05580 | 290 | cd05580, STKc_PKA, Catalytic domain of the Protein | 2e-22 | |
| cd05570 | 318 | cd05570, STKc_PKC, Catalytic domain of the Protein | 2e-22 | |
| cd06639 | 291 | cd06639, STKc_myosinIIIB, Catalytic domain of the | 2e-22 | |
| cd07835 | 283 | cd07835, STKc_CDK1_like, Catalytic domain of Cycli | 2e-22 | |
| cd07847 | 286 | cd07847, STKc_CDKL1_4, Catalytic domain of the Ser | 4e-22 | |
| cd05609 | 305 | cd05609, STKc_MAST, Catalytic domain of the Protei | 5e-22 | |
| cd05628 | 363 | cd05628, STKc_NDR1, Catalytic domain of the Protei | 7e-22 | |
| cd08528 | 269 | cd08528, STKc_Nek10, Catalytic domain of the Prote | 1e-21 | |
| cd05606 | 278 | cd05606, STKc_beta_ARK, Catalytic domain of the Pr | 2e-21 | |
| cd06648 | 285 | cd06648, STKc_PAK_II, Catalytic domain of the Prot | 2e-21 | |
| cd08219 | 255 | cd08219, STKc_Nek3, Catalytic domain of the Protei | 2e-21 | |
| smart00221 | 258 | smart00221, STYKc, Protein kinase; unclassified sp | 3e-21 | |
| cd06630 | 268 | cd06630, STKc_MEKK1, Catalytic domain of the Prote | 3e-21 | |
| cd06605 | 265 | cd06605, PKc_MAPKK, Catalytic domain of the dual-s | 3e-21 | |
| cd07852 | 337 | cd07852, STKc_MAPK15, Catalytic domain of the Seri | 3e-21 | |
| cd06638 | 286 | cd06638, STKc_myosinIIIA, Catalytic domain of the | 4e-21 | |
| pfam00069 | 260 | pfam00069, Pkinase, Protein kinase domain | 5e-21 | |
| cd05632 | 285 | cd05632, STKc_GRK5, Catalytic domain of the Protei | 5e-21 | |
| cd05605 | 285 | cd05605, STKc_GRK4_like, Catalytic domain of G pro | 5e-21 | |
| cd05627 | 360 | cd05627, STKc_NDR2, Catalytic domain of the Protei | 5e-21 | |
| cd05598 | 376 | cd05598, STKc_LATS, Catalytic domain of the Protei | 5e-21 | |
| cd05618 | 329 | cd05618, STKc_aPKC_iota, Catalytic domain of the P | 7e-21 | |
| cd07861 | 285 | cd07861, STKc_CDK1_euk, Catalytic domain of the Se | 8e-21 | |
| cd05582 | 318 | cd05582, STKc_RSK_N, N-terminal catalytic domain o | 1e-20 | |
| cd08224 | 267 | cd08224, STKc_Nek6_Nek7, Catalytic domain of the P | 3e-20 | |
| cd05607 | 277 | cd05607, STKc_GRK7, Catalytic domain of the Protei | 3e-20 | |
| cd07860 | 284 | cd07860, STKc_CDK2_3, Catalytic domain of the Seri | 3e-20 | |
| cd08220 | 256 | cd08220, STKc_Nek8, Catalytic domain of the Protei | 4e-20 | |
| cd05617 | 327 | cd05617, STKc_aPKC_zeta, Catalytic domain of the P | 4e-20 | |
| cd07836 | 284 | cd07836, STKc_Pho85, Catalytic domain of the Serin | 4e-20 | |
| cd05630 | 285 | cd05630, STKc_GRK6, Catalytic domain of the Protei | 5e-20 | |
| cd05623 | 332 | cd05623, STKc_MRCK_alpha, Catalytic domain of the | 5e-20 | |
| cd06624 | 268 | cd06624, STKc_ASK, Catalytic domain of the Protein | 5e-20 | |
| cd05633 | 279 | cd05633, STKc_GRK3, Catalytic domain of the Protei | 6e-20 | |
| cd05595 | 323 | cd05595, STKc_PKB_beta, Catalytic domain of the Pr | 7e-20 | |
| cd05585 | 312 | cd05585, STKc_YPK1_like, Catalytic domain of Yeast | 9e-20 | |
| cd06917 | 277 | cd06917, STKc_NAK1_like, Catalytic domain of Funga | 1e-19 | |
| pfam07714 | 258 | pfam07714, Pkinase_Tyr, Protein tyrosine kinase | 1e-19 | |
| cd08222 | 260 | cd08222, STKc_Nek11, Catalytic domain of the Prote | 1e-19 | |
| smart00219 | 257 | smart00219, TyrKc, Tyrosine kinase, catalytic doma | 1e-19 | |
| cd00180 | 215 | cd00180, PKc, Catalytic domain of Protein Kinases | 2e-19 | |
| cd06644 | 292 | cd06644, STKc_STK10_LOK, Catalytic domain of the P | 2e-19 | |
| cd06632 | 258 | cd06632, STKc_MEKK1_plant, Catalytic domain of the | 2e-19 | |
| cd05629 | 377 | cd05629, STKc_NDR_like_fungal, Catalytic domain of | 2e-19 | |
| cd08221 | 256 | cd08221, STKc_Nek9, Catalytic domain of the Protei | 3e-19 | |
| cd05593 | 328 | cd05593, STKc_PKB_gamma, Catalytic domain of the P | 4e-19 | |
| cd08229 | 267 | cd08229, STKc_Nek7, Catalytic domain of the Protei | 4e-19 | |
| cd06652 | 265 | cd06652, STKc_MEKK2, Catalytic domain of the Prote | 4e-19 | |
| cd05594 | 325 | cd05594, STKc_PKB_alpha, Catalytic domain of the P | 7e-19 | |
| cd05631 | 285 | cd05631, STKc_GRK4, Catalytic domain of the Protei | 9e-19 | |
| cd05608 | 280 | cd05608, STKc_GRK1, Catalytic domain of the Protei | 1e-18 | |
| cd07855 | 334 | cd07855, STKc_ERK5, Catalytic domain of the Serine | 1e-18 | |
| cd07837 | 295 | cd07837, STKc_CdkB_plant, Catalytic domain of the | 2e-18 | |
| cd00192 | 262 | cd00192, PTKc, Catalytic domain of Protein Tyrosin | 2e-18 | |
| cd06643 | 282 | cd06643, STKc_SLK, Catalytic domain of the Protein | 3e-18 | |
| cd06653 | 264 | cd06653, STKc_MEKK3_like_1, Catalytic domain of MA | 4e-18 | |
| PTZ00267 | 478 | PTZ00267, PTZ00267, NIMA-related protein kinase; P | 4e-18 | |
| cd07864 | 302 | cd07864, STKc_CDK12, Catalytic domain of the Serin | 5e-18 | |
| cd05575 | 323 | cd05575, STKc_SGK, Catalytic domain of the Protein | 6e-18 | |
| PLN00009 | 294 | PLN00009, PLN00009, cyclin-dependent kinase A; Pro | 1e-17 | |
| cd05573 | 350 | cd05573, STKc_ROCK_NDR_like, Catalytic domain of R | 2e-17 | |
| cd06621 | 287 | cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of | 2e-17 | |
| cd06647 | 293 | cd06647, STKc_PAK_I, Catalytic domain of the Prote | 2e-17 | |
| cd06651 | 266 | cd06651, STKc_MEKK3, Catalytic domain of the Prote | 3e-17 | |
| cd07848 | 287 | cd07848, STKc_CDKL5, Catalytic domain of the Serin | 3e-17 | |
| PTZ00283 | 496 | PTZ00283, PTZ00283, serine/threonine protein kinas | 3e-17 | |
| cd07844 | 291 | cd07844, STKc_PCTAIRE_like, Catalytic domain of PC | 4e-17 | |
| cd05039 | 256 | cd05039, PTKc_Csk_like, Catalytic domain of C-term | 4e-17 | |
| cd06645 | 267 | cd06645, STKc_MAP4K3, Catalytic domain of the Prot | 4e-17 | |
| cd06636 | 282 | cd06636, STKc_MAP4K4_6, Catalytic domain of the Pr | 4e-17 | |
| cd06628 | 267 | cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o | 4e-17 | |
| cd05586 | 330 | cd05586, STKc_Sck1_like, Catalytic domain of Suppr | 7e-17 | |
| cd08228 | 267 | cd08228, STKc_Nek6, Catalytic domain of the Protei | 8e-17 | |
| cd07842 | 316 | cd07842, STKc_CDK8_like, Catalytic domain of Cycli | 8e-17 | |
| cd06629 | 272 | cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o | 1e-16 | |
| cd06640 | 277 | cd06640, STKc_MST4, Catalytic domain of the Protei | 1e-16 | |
| cd05123 | 250 | cd05123, STKc_AGC, Catalytic domain of AGC family | 2e-16 | |
| cd07857 | 332 | cd07857, STKc_MPK1, Catalytic domain of the Serine | 2e-16 | |
| cd06641 | 277 | cd06641, STKc_MST3, Catalytic domain of the Protei | 3e-16 | |
| cd05587 | 324 | cd05587, STKc_cPKC, Catalytic domain of the Protei | 6e-16 | |
| cd07839 | 284 | cd07839, STKc_CDK5, Catalytic domain of the Serine | 6e-16 | |
| cd07851 | 343 | cd07851, STKc_p38, Catalytic domain of the Serine/ | 6e-16 | |
| cd06659 | 297 | cd06659, STKc_PAK6, Catalytic domain of the Protei | 6e-16 | |
| cd08225 | 257 | cd08225, STKc_Nek5, Catalytic domain of the Protei | 7e-16 | |
| cd07850 | 353 | cd07850, STKc_JNK, Catalytic domain of the Serine/ | 8e-16 | |
| cd05625 | 382 | cd05625, STKc_LATS1, Catalytic domain of the Prote | 9e-16 | |
| cd06637 | 272 | cd06637, STKc_TNIK, Catalytic domain of the Protei | 9e-16 | |
| cd05581 | 280 | cd05581, STKc_PDK1, Catalytic domain of the Protei | 1e-15 | |
| cd06646 | 267 | cd06646, STKc_MAP4K5, Catalytic domain of the Prot | 1e-15 | |
| cd07870 | 291 | cd07870, STKc_PFTAIRE2, Catalytic domain of the Se | 1e-15 | |
| cd06642 | 277 | cd06642, STKc_STK25-YSK1, Catalytic domain of the | 1e-15 | |
| cd05592 | 316 | cd05592, STKc_nPKC_theta_delta, Catalytic domain o | 2e-15 | |
| cd07874 | 355 | cd07874, STKc_JNK3, Catalytic domain of the Serine | 2e-15 | |
| cd07863 | 288 | cd07863, STKc_CDK4, Catalytic domain of the Serine | 2e-15 | |
| cd07869 | 303 | cd07869, STKc_PFTAIRE1, Catalytic domain of the Se | 2e-15 | |
| cd08218 | 256 | cd08218, STKc_Nek1, Catalytic domain of the Protei | 2e-15 | |
| cd05083 | 254 | cd05083, PTKc_Chk, Catalytic domain of the Protein | 3e-15 | |
| cd06656 | 297 | cd06656, STKc_PAK3, Catalytic domain of the Protei | 4e-15 | |
| cd06654 | 296 | cd06654, STKc_PAK1, Catalytic domain of the Protei | 4e-15 | |
| cd07871 | 288 | cd07871, STKc_PCTAIRE3, Catalytic domain of the Se | 5e-15 | |
| cd05123 | 250 | cd05123, STKc_AGC, Catalytic domain of AGC family | 6e-15 | |
| cd07859 | 338 | cd07859, STKc_TDY_MAPK_plant, Catalytic domain of | 6e-15 | |
| cd07862 | 290 | cd07862, STKc_CDK6, Catalytic domain of the Serine | 7e-15 | |
| cd05034 | 261 | cd05034, PTKc_Src_like, Catalytic domain of Src ki | 9e-15 | |
| cd07856 | 328 | cd07856, STKc_Sty1_Hog1, Catalytic domain of the S | 9e-15 | |
| cd05590 | 320 | cd05590, STKc_nPKC_eta, Catalytic domain of the Pr | 1e-14 | |
| cd07865 | 310 | cd07865, STKc_CDK9, Catalytic domain of the Serine | 1e-14 | |
| PTZ00024 | 335 | PTZ00024, PTZ00024, cyclin-dependent protein kinas | 1e-14 | |
| cd05626 | 381 | cd05626, STKc_LATS2, Catalytic domain of the Prote | 1e-14 | |
| cd05599 | 364 | cd05599, STKc_NDR_like, Catalytic domain of Nuclea | 2e-14 | |
| cd06658 | 292 | cd06658, STKc_PAK5, Catalytic domain of the Protei | 2e-14 | |
| cd06607 | 307 | cd06607, STKc_TAO, Catalytic domain of the Protein | 2e-14 | |
| cd08215 | 258 | cd08215, STKc_Nek, Catalytic domain of the Protein | 3e-14 | |
| cd07849 | 336 | cd07849, STKc_ERK1_2_like, Catalytic domain of Ext | 3e-14 | |
| cd07880 | 343 | cd07880, STKc_p38gamma_MAPK12, Catalytic domain of | 3e-14 | |
| cd05612 | 291 | cd05612, STKc_PRKX_like, Catalytic domain of PRKX- | 4e-14 | |
| cd07876 | 359 | cd07876, STKc_JNK2, Catalytic domain of the Serine | 4e-14 | |
| cd06655 | 296 | cd06655, STKc_PAK2, Catalytic domain of the Protei | 4e-14 | |
| cd06618 | 296 | cd06618, PKc_MKK7, Catalytic domain of the dual-sp | 6e-14 | |
| cd06631 | 265 | cd06631, STKc_YSK4, Catalytic domain of the Protei | 6e-14 | |
| cd07879 | 342 | cd07879, STKc_p38delta_MAPK13, Catalytic domain of | 6e-14 | |
| smart00133 | 64 | smart00133, S_TK_X, Extension to Ser/Thr-type prot | 7e-14 | |
| cd05041 | 251 | cd05041, PTKc_Fes_like, Catalytic domain of Fes-li | 7e-14 | |
| cd05591 | 321 | cd05591, STKc_nPKC_epsilon, Catalytic domain of th | 8e-14 | |
| cd05040 | 257 | cd05040, PTKc_Ack_like, Catalytic domain of the Pr | 1e-13 | |
| cd07875 | 364 | cd07875, STKc_JNK1, Catalytic domain of the Serine | 1e-13 | |
| cd05052 | 263 | cd05052, PTKc_Abl, Catalytic domain of the Protein | 1e-13 | |
| cd07873 | 301 | cd07873, STKc_PCTAIRE1, Catalytic domain of the Se | 2e-13 | |
| cd05576 | 237 | cd05576, STKc_RPK118_like, Catalytic domain of the | 2e-13 | |
| PHA03211 | 461 | PHA03211, PHA03211, serine/threonine kinase US3; P | 3e-13 | |
| cd08223 | 257 | cd08223, STKc_Nek4, Catalytic domain of the Protei | 4e-13 | |
| cd07877 | 345 | cd07877, STKc_p38alpha_MAPK14, Catalytic domain of | 4e-13 | |
| TIGR03903 | 1266 | TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclas | 5e-13 | |
| cd06606 | 260 | cd06606, STKc_MAPKKK, Catalytic domain of the Prot | 6e-13 | |
| cd07858 | 337 | cd07858, STKc_TEY_MAPK_plant, Catalytic domain of | 6e-13 | |
| cd05068 | 261 | cd05068, PTKc_Frk_like, Catalytic domain of Fyn-re | 7e-13 | |
| cd06622 | 286 | cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of | 7e-13 | |
| cd05580 | 290 | cd05580, STKc_PKA, Catalytic domain of the Protein | 8e-13 | |
| cd07829 | 282 | cd07829, STKc_CDK_like, Catalytic domain of Cyclin | 8e-13 | |
| cd05629 | 377 | cd05629, STKc_NDR_like_fungal, Catalytic domain of | 8e-13 | |
| cd07878 | 343 | cd07878, STKc_p38beta_MAPK11, Catalytic domain of | 8e-13 | |
| cd05577 | 277 | cd05577, STKc_GRK, Catalytic domain of the Protein | 2e-12 | |
| cd08216 | 314 | cd08216, PK_STRAD, Pseudokinase domain of STE20-re | 2e-12 | |
| cd05603 | 321 | cd05603, STKc_SGK2, Catalytic domain of the Protei | 3e-12 | |
| cd05604 | 325 | cd05604, STKc_SGK3, Catalytic domain of the Protei | 3e-12 | |
| cd05581 | 280 | cd05581, STKc_PDK1, Catalytic domain of the Protei | 4e-12 | |
| cd06657 | 292 | cd06657, STKc_PAK4, Catalytic domain of the Protei | 4e-12 | |
| cd07866 | 311 | cd07866, STKc_BUR1, Catalytic domain of the Serine | 4e-12 | |
| cd07830 | 283 | cd07830, STKc_MAK_like, Catalytic domain of Male g | 5e-12 | |
| cd07872 | 309 | cd07872, STKc_PCTAIRE2, Catalytic domain of the Se | 5e-12 | |
| cd05572 | 262 | cd05572, STKc_cGK_PKG, Catalytic domain of the Pro | 8e-12 | |
| cd07832 | 286 | cd07832, STKc_CCRK, Catalytic domain of the Serine | 9e-12 | |
| cd06616 | 288 | cd06616, PKc_MKK4, Catalytic domain of the dual-sp | 1e-11 | |
| cd05082 | 256 | cd05082, PTKc_Csk, Catalytic domain of the Protein | 1e-11 | |
| smart00220 | 254 | smart00220, S_TKc, Serine/Threonine protein kinase | 2e-11 | |
| cd05578 | 258 | cd05578, STKc_Yank1, Catalytic domain of the Prote | 2e-11 | |
| cd05619 | 316 | cd05619, STKc_nPKC_theta, Catalytic domain of the | 2e-11 | |
| cd05609 | 305 | cd05609, STKc_MAST, Catalytic domain of the Protei | 2e-11 | |
| cd06617 | 283 | cd06617, PKc_MKK3_6, Catalytic domain of the dual- | 2e-11 | |
| cd05059 | 256 | cd05059, PTKc_Tec_like, Catalytic domain of Tec-li | 2e-11 | |
| cd05588 | 329 | cd05588, STKc_aPKC, Catalytic domain of the Protei | 3e-11 | |
| cd05598 | 376 | cd05598, STKc_LATS, Catalytic domain of the Protei | 3e-11 | |
| cd05113 | 256 | cd05113, PTKc_Btk_Bmx, Catalytic domain of the Pro | 3e-11 | |
| cd06633 | 313 | cd06633, STKc_TAO3, Catalytic domain of the Protei | 3e-11 | |
| COG0515 | 384 | COG0515, SPS1, Serine/threonine protein kinase [Ge | 4e-11 | |
| cd05084 | 252 | cd05084, PTKc_Fes, Catalytic domain of the Protein | 5e-11 | |
| cd05597 | 331 | cd05597, STKc_DMPK_like, Catalytic domain of Myoto | 6e-11 | |
| cd05618 | 329 | cd05618, STKc_aPKC_iota, Catalytic domain of the P | 6e-11 | |
| cd05112 | 256 | cd05112, PTKc_Itk, Catalytic domain of the Protein | 6e-11 | |
| cd05067 | 260 | cd05067, PTKc_Lck_Blk, Catalytic domain of the Pro | 6e-11 | |
| cd05579 | 265 | cd05579, STKc_MAST_like, Catalytic domain of Micro | 7e-11 | |
| PHA03212 | 391 | PHA03212, PHA03212, serine/threonine kinase US3; P | 7e-11 | |
| PHA03207 | 392 | PHA03207, PHA03207, serine/threonine kinase US3; P | 9e-11 | |
| cd05616 | 323 | cd05616, STKc_cPKC_beta, Catalytic domain of the P | 1e-10 | |
| cd05600 | 333 | cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fun | 1e-10 | |
| cd05605 | 285 | cd05605, STKc_GRK4_like, Catalytic domain of G pro | 1e-10 | |
| cd06635 | 317 | cd06635, STKc_TAO1, Catalytic domain of the Protei | 1e-10 | |
| cd05072 | 261 | cd05072, PTKc_Lyn, Catalytic domain of the Protein | 1e-10 | |
| cd07854 | 342 | cd07854, STKc_MAPK4_6, Catalytic domain of the Ser | 1e-10 | |
| cd05574 | 316 | cd05574, STKc_phototropin_like, Catalytic domain o | 2e-10 | |
| cd05057 | 279 | cd05057, PTKc_EGFR_like, Catalytic domain of Epide | 2e-10 | |
| cd05579 | 265 | cd05579, STKc_MAST_like, Catalytic domain of Micro | 3e-10 | |
| cd05617 | 327 | cd05617, STKc_aPKC_zeta, Catalytic domain of the P | 3e-10 | |
| cd07868 | 317 | cd07868, STKc_CDK8, Catalytic domain of the Serine | 3e-10 | |
| cd05085 | 250 | cd05085, PTKc_Fer, Catalytic domain of the Protein | 3e-10 | |
| cd06614 | 286 | cd06614, STKc_PAK, Catalytic domain of the Protein | 4e-10 | |
| cd07867 | 317 | cd07867, STKc_CDC2L6, Catalytic domain of Serine/T | 4e-10 | |
| cd07840 | 287 | cd07840, STKc_CDK9_like, Catalytic domain of Cycli | 5e-10 | |
| cd05148 | 261 | cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro | 6e-10 | |
| cd05073 | 260 | cd05073, PTKc_Hck, Catalytic domain of the Protein | 8e-10 | |
| cd05615 | 323 | cd05615, STKc_cPKC_alpha, Catalytic domain of the | 9e-10 | |
| PTZ00263 | 329 | PTZ00263, PTZ00263, protein kinase A catalytic sub | 1e-09 | |
| cd05122 | 253 | cd05122, PKc_STE, Catalytic domain of STE family P | 1e-09 | |
| cd05624 | 331 | cd05624, STKc_MRCK_beta, Catalytic domain of the P | 1e-09 | |
| cd05602 | 325 | cd05602, STKc_SGK1, Catalytic domain of the Protei | 1e-09 | |
| cd05114 | 256 | cd05114, PTKc_Tec_Rlk, Catalytic domain of the Pro | 1e-09 | |
| cd05612 | 291 | cd05612, STKc_PRKX_like, Catalytic domain of PRKX- | 2e-09 | |
| cd05601 | 330 | cd05601, STKc_CRIK, Catalytic domain of the Protei | 2e-09 | |
| cd07843 | 293 | cd07843, STKc_CDC2L1, Catalytic domain of the Seri | 2e-09 | |
| cd05620 | 316 | cd05620, STKc_nPKC_delta, Catalytic domain of the | 2e-09 | |
| cd05608 | 280 | cd05608, STKc_GRK1, Catalytic domain of the Protei | 2e-09 | |
| cd05044 | 269 | cd05044, PTKc_c-ros, Catalytic domain of the Prote | 2e-09 | |
| cd06634 | 308 | cd06634, STKc_TAO2, Catalytic domain of the Protei | 2e-09 | |
| smart00220 | 254 | smart00220, S_TKc, Serine/Threonine protein kinase | 3e-09 | |
| pfam00069 | 260 | pfam00069, Pkinase, Protein kinase domain | 3e-09 | |
| PTZ00263 | 329 | PTZ00263, PTZ00263, protein kinase A catalytic sub | 3e-09 | |
| cd05573 | 350 | cd05573, STKc_ROCK_NDR_like, Catalytic domain of R | 3e-09 | |
| cd05610 | 669 | cd05610, STKc_MASTL, Catalytic domain of the Prote | 3e-09 | |
| PTZ00036 | 440 | PTZ00036, PTZ00036, glycogen synthase kinase; Prov | 3e-09 | |
| cd07831 | 282 | cd07831, STKc_MOK, Catalytic domain of the Serine/ | 4e-09 | |
| PHA03390 | 267 | PHA03390, pk1, serine/threonine-protein kinase 1; | 4e-09 | |
| cd05584 | 323 | cd05584, STKc_p70S6K, Catalytic domain of the Prot | 5e-09 | |
| cd05055 | 302 | cd05055, PTKc_PDGFR, Catalytic domain of the Prote | 5e-09 | |
| cd05032 | 277 | cd05032, PTKc_InsR_like, Catalytic domain of Insul | 5e-09 | |
| cd05036 | 277 | cd05036, PTKc_ALK_LTK, Catalytic domain of the Pro | 5e-09 | |
| PHA03209 | 357 | PHA03209, PHA03209, serine/threonine kinase US3; P | 6e-09 | |
| PHA03210 | 501 | PHA03210, PHA03210, serine/threonine kinase US3; P | 7e-09 | |
| cd05080 | 283 | cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) doma | 9e-09 | |
| cd05038 | 284 | cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai | 9e-09 | |
| cd05611 | 260 | cd05611, STKc_Rim15_like, Catalytic domain of fung | 1e-08 | |
| cd06627 | 254 | cd06627, STKc_Cdc7_like, Catalytic domain of Cell | 1e-08 | |
| smart00221 | 258 | smart00221, STYKc, Protein kinase; unclassified sp | 1e-08 | |
| cd05071 | 262 | cd05071, PTKc_Src, Catalytic domain of the Protein | 1e-08 | |
| cd05582 | 318 | cd05582, STKc_RSK_N, N-terminal catalytic domain o | 2e-08 | |
| cd05118 | 283 | cd05118, STKc_CMGC, Catalytic domain of CMGC famil | 2e-08 | |
| cd05574 | 316 | cd05574, STKc_phototropin_like, Catalytic domain o | 2e-08 | |
| cd06623 | 264 | cd06623, PKc_MAPKK_plant_like, Catalytic domain of | 2e-08 | |
| PTZ00426 | 340 | PTZ00426, PTZ00426, cAMP-dependent protein kinase | 2e-08 | |
| cd05623 | 332 | cd05623, STKc_MRCK_alpha, Catalytic domain of the | 2e-08 | |
| cd05626 | 381 | cd05626, STKc_LATS2, Catalytic domain of the Prote | 2e-08 | |
| PTZ00266 | 1021 | PTZ00266, PTZ00266, NIMA-related protein kinase; P | 2e-08 | |
| cd05120 | 155 | cd05120, APH_ChoK_like, Aminoglycoside 3'-phosphot | 2e-08 | |
| cd05606 | 278 | cd05606, STKc_beta_ARK, Catalytic domain of the Pr | 3e-08 | |
| cd07853 | 372 | cd07853, STKc_NLK, Catalytic domain of the Serine/ | 3e-08 | |
| PLN03225 | 566 | PLN03225, PLN03225, Serine/threonine-protein kinas | 3e-08 | |
| cd05601 | 330 | cd05601, STKc_CRIK, Catalytic domain of the Protei | 4e-08 | |
| cd08528 | 269 | cd08528, STKc_Nek10, Catalytic domain of the Prote | 4e-08 | |
| cd07852 | 337 | cd07852, STKc_MAPK15, Catalytic domain of the Seri | 4e-08 | |
| cd05089 | 297 | cd05089, PTKc_Tie1, Catalytic domain of the Protei | 4e-08 | |
| cd05611 | 260 | cd05611, STKc_Rim15_like, Catalytic domain of fung | 5e-08 | |
| cd05583 | 288 | cd05583, STKc_MSK_N, N-terminal catalytic domain o | 5e-08 | |
| cd06609 | 274 | cd06609, STKc_MST3_like, Catalytic domain of Mamma | 5e-08 | |
| cd05581 | 280 | cd05581, STKc_PDK1, Catalytic domain of the Protei | 7e-08 | |
| cd05592 | 316 | cd05592, STKc_nPKC_theta_delta, Catalytic domain o | 7e-08 | |
| cd05577 | 277 | cd05577, STKc_GRK, Catalytic domain of the Protein | 7e-08 | |
| cd06650 | 333 | cd06650, PKc_MEK1, Catalytic domain of the dual-sp | 7e-08 | |
| cd05070 | 260 | cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Pro | 8e-08 | |
| cd05069 | 260 | cd05069, PTKc_Yes, Catalytic domain of the Protein | 8e-08 | |
| cd05599 | 364 | cd05599, STKc_NDR_like, Catalytic domain of Nuclea | 9e-08 | |
| cd05632 | 285 | cd05632, STKc_GRK5, Catalytic domain of the Protei | 9e-08 | |
| cd06615 | 308 | cd06615, PKc_MEK, Catalytic domain of the dual-spe | 9e-08 | |
| cd05065 | 269 | cd05065, PTKc_EphR_B, Catalytic domain of the Prot | 9e-08 | |
| cd05570 | 318 | cd05570, STKc_PKC, Catalytic domain of the Protein | 1e-07 | |
| cd07838 | 287 | cd07838, STKc_CDK4_6_like, Catalytic domain of Cyc | 1e-07 | |
| smart00219 | 257 | smart00219, TyrKc, Tyrosine kinase, catalytic doma | 1e-07 | |
| cd07837 | 295 | cd07837, STKc_CdkB_plant, Catalytic domain of the | 1e-07 | |
| cd05625 | 382 | cd05625, STKc_LATS1, Catalytic domain of the Prote | 1e-07 | |
| cd06620 | 284 | cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of | 1e-07 | |
| cd05572 | 262 | cd05572, STKc_cGK_PKG, Catalytic domain of the Pro | 2e-07 | |
| cd06606 | 260 | cd06606, STKc_MAPKKK, Catalytic domain of the Prot | 2e-07 | |
| cd06610 | 267 | cd06610, STKc_OSR1_SPAK, Catalytic domain of the P | 2e-07 | |
| cd05620 | 316 | cd05620, STKc_nPKC_delta, Catalytic domain of the | 2e-07 | |
| cd06625 | 263 | cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ | 2e-07 | |
| cd05603 | 321 | cd05603, STKc_SGK2, Catalytic domain of the Protei | 2e-07 | |
| cd05585 | 312 | cd05585, STKc_YPK1_like, Catalytic domain of Yeast | 2e-07 | |
| pfam07714 | 258 | pfam07714, Pkinase_Tyr, Protein tyrosine kinase | 2e-07 | |
| cd08222 | 260 | cd08222, STKc_Nek11, Catalytic domain of the Prote | 2e-07 | |
| cd06632 | 258 | cd06632, STKc_MEKK1_plant, Catalytic domain of the | 2e-07 | |
| cd05610 | 669 | cd05610, STKc_MASTL, Catalytic domain of the Prote | 2e-07 | |
| PLN03225 | 566 | PLN03225, PLN03225, Serine/threonine-protein kinas | 2e-07 | |
| cd08226 | 328 | cd08226, PK_STRAD_beta, Pseudokinase domain of STE | 2e-07 | |
| cd05586 | 330 | cd05586, STKc_Sck1_like, Catalytic domain of Suppr | 3e-07 | |
| cd07833 | 288 | cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep | 3e-07 | |
| cd05622 | 371 | cd05622, STKc_ROCK1, Catalytic domain of the Prote | 4e-07 | |
| cd00192 | 262 | cd00192, PTKc, Catalytic domain of Protein Tyrosin | 4e-07 | |
| cd05047 | 270 | cd05047, PTKc_Tie, Catalytic domain of Tie Protein | 4e-07 | |
| cd05613 | 290 | cd05613, STKc_MSK1_N, N-terminal catalytic domain | 5e-07 | |
| cd06619 | 279 | cd06619, PKc_MKK5, Catalytic domain of the dual-sp | 5e-07 | |
| cd08530 | 256 | cd08530, STKc_CNK2-like, Catalytic domain of the P | 6e-07 | |
| PTZ00283 | 496 | PTZ00283, PTZ00283, serine/threonine protein kinas | 6e-07 | |
| cd05033 | 266 | cd05033, PTKc_EphR, Catalytic domain of Ephrin Rec | 6e-07 | |
| cd08227 | 327 | cd08227, PK_STRAD_alpha, Pseudokinase domain of ST | 6e-07 | |
| cd05587 | 324 | cd05587, STKc_cPKC, Catalytic domain of the Protei | 7e-07 | |
| pfam00069 | 260 | pfam00069, Pkinase, Protein kinase domain | 8e-07 | |
| cd06647 | 293 | cd06647, STKc_PAK_I, Catalytic domain of the Prote | 9e-07 | |
| cd06649 | 331 | cd06649, PKc_MEK2, Catalytic domain of the dual-sp | 9e-07 | |
| cd05081 | 284 | cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) | 9e-07 | |
| cd05590 | 320 | cd05590, STKc_nPKC_eta, Catalytic domain of the Pr | 1e-06 | |
| cd05596 | 370 | cd05596, STKc_ROCK, Catalytic domain of the Protei | 1e-06 | |
| cd05621 | 370 | cd05621, STKc_ROCK2, Catalytic domain of the Prote | 1e-06 | |
| cd08220 | 256 | cd08220, STKc_Nek8, Catalytic domain of the Protei | 1e-06 | |
| PRK13184 | 932 | PRK13184, pknD, serine/threonine-protein kinase; R | 1e-06 | |
| cd05056 | 270 | cd05056, PTKc_FAK, Catalytic domain of the Protein | 1e-06 | |
| cd05088 | 303 | cd05088, PTKc_Tie2, Catalytic domain of the Protei | 1e-06 | |
| cd05060 | 257 | cd05060, PTKc_Syk_like, Catalytic domain of Spleen | 1e-06 | |
| cd05616 | 323 | cd05616, STKc_cPKC_beta, Catalytic domain of the P | 2e-06 | |
| cd05575 | 323 | cd05575, STKc_SGK, Catalytic domain of the Protein | 2e-06 | |
| cd06611 | 280 | cd06611, STKc_SLK_like, Catalytic domain of Ste20- | 2e-06 | |
| cd07845 | 309 | cd07845, STKc_CDK10, Catalytic domain of the Serin | 2e-06 | |
| cd05602 | 325 | cd05602, STKc_SGK1, Catalytic domain of the Protei | 2e-06 | |
| cd07834 | 330 | cd07834, STKc_MAPK, Catalytic domain of the Serine | 2e-06 | |
| cd08221 | 256 | cd08221, STKc_Nek9, Catalytic domain of the Protei | 2e-06 | |
| cd05079 | 284 | cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) doma | 2e-06 | |
| cd05066 | 267 | cd05066, PTKc_EphR_A, Catalytic domain of the Prot | 2e-06 | |
| cd05110 | 303 | cd05110, PTKc_HER4, Catalytic domain of the Protei | 2e-06 | |
| cd08217 | 265 | cd08217, STKc_Nek2, Catalytic domain of the Protei | 3e-06 | |
| cd05571 | 323 | cd05571, STKc_PKB, Catalytic domain of the Protein | 3e-06 | |
| cd06627 | 254 | cd06627, STKc_Cdc7_like, Catalytic domain of Cell | 3e-06 | |
| cd07835 | 283 | cd07835, STKc_CDK1_like, Catalytic domain of Cycli | 3e-06 | |
| cd06648 | 285 | cd06648, STKc_PAK_II, Catalytic domain of the Prot | 3e-06 | |
| cd08219 | 255 | cd08219, STKc_Nek3, Catalytic domain of the Protei | 3e-06 | |
| cd07865 | 310 | cd07865, STKc_CDK9, Catalytic domain of the Serine | 3e-06 | |
| cd05045 | 290 | cd05045, PTKc_RET, Catalytic domain of the Protein | 3e-06 | |
| cd05053 | 293 | cd05053, PTKc_FGFR, Catalytic domain of the Protei | 3e-06 | |
| cd05605 | 285 | cd05605, STKc_GRK4_like, Catalytic domain of G pro | 6e-06 | |
| cd05040 | 257 | cd05040, PTKc_Ack_like, Catalytic domain of the Pr | 6e-06 | |
| cd05606 | 278 | cd05606, STKc_beta_ARK, Catalytic domain of the Pr | 7e-06 | |
| cd05631 | 285 | cd05631, STKc_GRK4, Catalytic domain of the Protei | 7e-06 | |
| cd07842 | 316 | cd07842, STKc_CDK8_like, Catalytic domain of Cycli | 8e-06 | |
| cd05604 | 325 | cd05604, STKc_SGK3, Catalytic domain of the Protei | 9e-06 | |
| cd05630 | 285 | cd05630, STKc_GRK6, Catalytic domain of the Protei | 9e-06 | |
| cd06652 | 265 | cd06652, STKc_MEKK2, Catalytic domain of the Prote | 9e-06 | |
| cd08225 | 257 | cd08225, STKc_Nek5, Catalytic domain of the Protei | 9e-06 | |
| cd05610 | 669 | cd05610, STKc_MASTL, Catalytic domain of the Prote | 9e-06 | |
| PLN03224 | 507 | PLN03224, PLN03224, probable serine/threonine prot | 9e-06 | |
| cd06612 | 256 | cd06612, STKc_MST1_2, Catalytic domain of the Prot | 1e-05 | |
| cd05595 | 323 | cd05595, STKc_PKB_beta, Catalytic domain of the Pr | 1e-05 | |
| cd05615 | 323 | cd05615, STKc_cPKC_alpha, Catalytic domain of the | 1e-05 | |
| PLN00034 | 353 | PLN00034, PLN00034, mitogen-activated protein kina | 1e-05 | |
| cd07846 | 286 | cd07846, STKc_CDKL2_3, Catalytic domain of the Ser | 1e-05 | |
| cd05600 | 333 | cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fun | 1e-05 | |
| cd05628 | 363 | cd05628, STKc_NDR1, Catalytic domain of the Protei | 1e-05 | |
| cd06605 | 265 | cd06605, PKc_MAPKK, Catalytic domain of the dual-s | 1e-05 | |
| cd05632 | 285 | cd05632, STKc_GRK5, Catalytic domain of the Protei | 1e-05 | |
| cd05627 | 360 | cd05627, STKc_NDR2, Catalytic domain of the Protei | 1e-05 | |
| cd05630 | 285 | cd05630, STKc_GRK6, Catalytic domain of the Protei | 1e-05 | |
| cd06632 | 258 | cd06632, STKc_MEKK1_plant, Catalytic domain of the | 1e-05 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 1e-05 | |
| PTZ00284 | 467 | PTZ00284, PTZ00284, protein kinase; Provisional | 1e-05 | |
| cd05048 | 283 | cd05048, PTKc_Ror, Catalytic Domain of the Protein | 1e-05 | |
| cd05098 | 307 | cd05098, PTKc_FGFR1, Catalytic domain of the Prote | 1e-05 | |
| cd05064 | 266 | cd05064, PTKc_EphR_A10, Catalytic domain of the Pr | 1e-05 | |
| cd00180 | 215 | cd00180, PKc, Catalytic domain of Protein Kinases | 2e-05 | |
| cd05591 | 321 | cd05591, STKc_nPKC_epsilon, Catalytic domain of th | 2e-05 | |
| cd07841 | 298 | cd07841, STKc_CDK7, Catalytic domain of the Serine | 2e-05 | |
| cd06626 | 264 | cd06626, STKc_MEKK4, Catalytic domain of the Prote | 2e-05 | |
| cd05102 | 338 | cd05102, PTKc_VEGFR3, Catalytic domain of the Prot | 2e-05 | |
| cd05093 | 288 | cd05093, PTKc_TrkB, Catalytic domain of the Protei | 2e-05 | |
| cd05619 | 316 | cd05619, STKc_nPKC_theta, Catalytic domain of the | 3e-05 | |
| cd05588 | 329 | cd05588, STKc_aPKC, Catalytic domain of the Protei | 3e-05 | |
| PTZ00426 | 340 | PTZ00426, PTZ00426, cAMP-dependent protein kinase | 3e-05 | |
| cd05633 | 279 | cd05633, STKc_GRK3, Catalytic domain of the Protei | 3e-05 | |
| TIGR03903 | 1266 | TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclas | 3e-05 | |
| cd05091 | 283 | cd05091, PTKc_Ror2, Catalytic domain of the Protei | 3e-05 | |
| cd05049 | 280 | cd05049, PTKc_Trk, Catalytic domain of the Protein | 3e-05 | |
| cd06608 | 275 | cd06608, STKc_myosinIII_like, Catalytic domain of | 4e-05 | |
| cd06644 | 292 | cd06644, STKc_STK10_LOK, Catalytic domain of the P | 4e-05 | |
| cd06621 | 287 | cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of | 4e-05 | |
| cd06629 | 272 | cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o | 4e-05 | |
| cd06654 | 296 | cd06654, STKc_PAK1, Catalytic domain of the Protei | 4e-05 | |
| cd05103 | 343 | cd05103, PTKc_VEGFR2, Catalytic domain of the Prot | 4e-05 | |
| cd05086 | 268 | cd05086, PTKc_Aatyk2, Catalytic domain of the Prot | 4e-05 | |
| cd05607 | 277 | cd05607, STKc_GRK7, Catalytic domain of the Protei | 5e-05 | |
| cd07836 | 284 | cd07836, STKc_Pho85, Catalytic domain of the Serin | 5e-05 | |
| cd05633 | 279 | cd05633, STKc_GRK3, Catalytic domain of the Protei | 5e-05 | |
| cd06653 | 264 | cd06653, STKc_MEKK3_like_1, Catalytic domain of MA | 5e-05 | |
| PTZ00267 | 478 | PTZ00267, PTZ00267, NIMA-related protein kinase; P | 5e-05 | |
| cd06656 | 297 | cd06656, STKc_PAK3, Catalytic domain of the Protei | 5e-05 | |
| cd08223 | 257 | cd08223, STKc_Nek4, Catalytic domain of the Protei | 5e-05 | |
| cd07847 | 286 | cd07847, STKc_CDKL1_4, Catalytic domain of the Ser | 6e-05 | |
| cd05063 | 268 | cd05063, PTKc_EphR_A2, Catalytic domain of the Pro | 6e-05 | |
| cd00180 | 215 | cd00180, PKc, Catalytic domain of Protein Kinases | 7e-05 | |
| cd06612 | 256 | cd06612, STKc_MST1_2, Catalytic domain of the Prot | 7e-05 | |
| cd05598 | 376 | cd05598, STKc_LATS, Catalytic domain of the Protei | 7e-05 | |
| cd07855 | 334 | cd07855, STKc_ERK5, Catalytic domain of the Serine | 7e-05 | |
| cd05576 | 237 | cd05576, STKc_RPK118_like, Catalytic domain of the | 7e-05 | |
| cd05099 | 314 | cd05099, PTKc_FGFR4, Catalytic domain of the Prote | 7e-05 | |
| cd05105 | 400 | cd05105, PTKc_PDGFR_alpha, Catalytic domain of the | 7e-05 | |
| cd05617 | 327 | cd05617, STKc_aPKC_zeta, Catalytic domain of the P | 8e-05 | |
| cd05100 | 334 | cd05100, PTKc_FGFR3, Catalytic domain of the Prote | 8e-05 | |
| cd05609 | 305 | cd05609, STKc_MAST, Catalytic domain of the Protei | 9e-05 | |
| cd07856 | 328 | cd07856, STKc_Sty1_Hog1, Catalytic domain of the S | 9e-05 | |
| pfam00433 | 47 | pfam00433, Pkinase_C, Protein kinase C terminal do | 9e-05 | |
| cd05596 | 370 | cd05596, STKc_ROCK, Catalytic domain of the Protei | 1e-04 | |
| cd05589 | 324 | cd05589, STKc_PKN, Catalytic domain of the Protein | 1e-04 | |
| cd05621 | 370 | cd05621, STKc_ROCK2, Catalytic domain of the Prote | 1e-04 | |
| cd08529 | 256 | cd08529, STKc_FA2-like, Catalytic domain of the Pr | 1e-04 | |
| cd08224 | 267 | cd08224, STKc_Nek6_Nek7, Catalytic domain of the P | 1e-04 | |
| cd08229 | 267 | cd08229, STKc_Nek7, Catalytic domain of the Protei | 1e-04 | |
| cd05631 | 285 | cd05631, STKc_GRK4, Catalytic domain of the Protei | 1e-04 | |
| cd06655 | 296 | cd06655, STKc_PAK2, Catalytic domain of the Protei | 1e-04 | |
| cd05614 | 332 | cd05614, STKc_MSK2_N, N-terminal catalytic domain | 2e-04 | |
| cd06614 | 286 | cd06614, STKc_PAK, Catalytic domain of the Protein | 2e-04 | |
| cd06608 | 275 | cd06608, STKc_myosinIII_like, Catalytic domain of | 2e-04 | |
| cd05597 | 331 | cd05597, STKc_DMPK_like, Catalytic domain of Myoto | 2e-04 | |
| cd05624 | 331 | cd05624, STKc_MRCK_beta, Catalytic domain of the P | 2e-04 | |
| cd07848 | 287 | cd07848, STKc_CDKL5, Catalytic domain of the Serin | 2e-04 | |
| cd05039 | 256 | cd05039, PTKc_Csk_like, Catalytic domain of C-term | 2e-04 | |
| cd08228 | 267 | cd08228, STKc_Nek6, Catalytic domain of the Protei | 2e-04 | |
| cd06659 | 297 | cd06659, STKc_PAK6, Catalytic domain of the Protei | 2e-04 | |
| cd07863 | 288 | cd07863, STKc_CDK4, Catalytic domain of the Serine | 2e-04 | |
| cd08218 | 256 | cd08218, STKc_Nek1, Catalytic domain of the Protei | 2e-04 | |
| PHA03210 | 501 | PHA03210, PHA03210, serine/threonine kinase US3; P | 2e-04 | |
| PRK13184 | 932 | PRK13184, pknD, serine/threonine-protein kinase; R | 2e-04 | |
| cd05054 | 337 | cd05054, PTKc_VEGFR, Catalytic domain of the Prote | 2e-04 | |
| cd05074 | 273 | cd05074, PTKc_Tyro3, Catalytic domain of the Prote | 2e-04 | |
| cd05108 | 316 | cd05108, PTKc_EGFR, Catalytic domain of the Protei | 2e-04 | |
| cd05101 | 304 | cd05101, PTKc_FGFR2, Catalytic domain of the Prote | 2e-04 | |
| cd05058 | 262 | cd05058, PTKc_Met_Ron, Catalytic domain of the Pro | 2e-04 | |
| PHA03309 | 2033 | PHA03309, PHA03309, transcriptional regulator ICP4 | 2e-04 | |
| cd07829 | 282 | cd07829, STKc_CDK_like, Catalytic domain of Cyclin | 3e-04 | |
| cd05627 | 360 | cd05627, STKc_NDR2, Catalytic domain of the Protei | 3e-04 | |
| cd06917 | 277 | cd06917, STKc_NAK1_like, Catalytic domain of Funga | 3e-04 | |
| cd05629 | 377 | cd05629, STKc_NDR_like_fungal, Catalytic domain of | 3e-04 | |
| cd05608 | 280 | cd05608, STKc_GRK1, Catalytic domain of the Protei | 3e-04 | |
| cd07851 | 343 | cd07851, STKc_p38, Catalytic domain of the Serine/ | 3e-04 | |
| cd05050 | 288 | cd05050, PTKc_Musk, Catalytic domain of the Protei | 3e-04 | |
| cd05094 | 291 | cd05094, PTKc_TrkC, Catalytic domain of the Protei | 3e-04 | |
| cd05123 | 250 | cd05123, STKc_AGC, Catalytic domain of AGC family | 4e-04 | |
| cd06623 | 264 | cd06623, PKc_MAPKK_plant_like, Catalytic domain of | 4e-04 | |
| cd06612 | 256 | cd06612, STKc_MST1_2, Catalytic domain of the Prot | 4e-04 | |
| cd06630 | 268 | cd06630, STKc_MEKK1, Catalytic domain of the Prote | 4e-04 | |
| cd05618 | 329 | cd05618, STKc_aPKC_iota, Catalytic domain of the P | 4e-04 | |
| cd07861 | 285 | cd07861, STKc_CDK1_euk, Catalytic domain of the Se | 4e-04 | |
| cd07854 | 342 | cd07854, STKc_MAPK4_6, Catalytic domain of the Ser | 4e-04 | |
| cd05115 | 257 | cd05115, PTKc_Zap-70, Catalytic domain of the Prot | 4e-04 | |
| cd07830 | 283 | cd07830, STKc_MAK_like, Catalytic domain of Male g | 5e-04 | |
| cd05593 | 328 | cd05593, STKc_PKB_gamma, Catalytic domain of the P | 5e-04 | |
| cd06613 | 262 | cd06613, STKc_MAP4K3_like, Catalytic domain of Mit | 5e-04 | |
| cd06648 | 285 | cd06648, STKc_PAK_II, Catalytic domain of the Prot | 5e-04 | |
| cd05625 | 382 | cd05625, STKc_LATS1, Catalytic domain of the Prote | 5e-04 | |
| cd06617 | 283 | cd06617, PKc_MKK3_6, Catalytic domain of the dual- | 5e-04 | |
| cd08215 | 258 | cd08215, STKc_Nek, Catalytic domain of the Protein | 6e-04 | |
| cd06623 | 264 | cd06623, PKc_MAPKK_plant_like, Catalytic domain of | 6e-04 | |
| cd06626 | 264 | cd06626, STKc_MEKK4, Catalytic domain of the Prote | 6e-04 | |
| cd06628 | 267 | cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o | 6e-04 | |
| cd06640 | 277 | cd06640, STKc_MST4, Catalytic domain of the Protei | 6e-04 | |
| PLN03224 | 507 | PLN03224, PLN03224, probable serine/threonine prot | 7e-04 | |
| cd05043 | 280 | cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Rece | 7e-04 | |
| cd05107 | 401 | cd05107, PTKc_PDGFR_beta, Catalytic domain of the | 7e-04 | |
| cd05594 | 325 | cd05594, STKc_PKB_alpha, Catalytic domain of the P | 8e-04 | |
| cd07862 | 290 | cd07862, STKc_CDK6, Catalytic domain of the Serine | 8e-04 | |
| cd07849 | 336 | cd07849, STKc_ERK1_2_like, Catalytic domain of Ext | 8e-04 | |
| PRK14879 | 211 | PRK14879, PRK14879, serine/threonine protein kinas | 8e-04 | |
| cd07839 | 284 | cd07839, STKc_CDK5, Catalytic domain of the Serine | 9e-04 | |
| cd05578 | 258 | cd05578, STKc_Yank1, Catalytic domain of the Prote | 0.001 | |
| cd06611 | 280 | cd06611, STKc_SLK_like, Catalytic domain of Ste20- | 0.001 | |
| cd07834 | 330 | cd07834, STKc_MAPK, Catalytic domain of the Serine | 0.001 | |
| cd06639 | 291 | cd06639, STKc_myosinIIIB, Catalytic domain of the | 0.001 | |
| cd05607 | 277 | cd05607, STKc_GRK7, Catalytic domain of the Protei | 0.001 | |
| PLN00009 | 294 | PLN00009, PLN00009, cyclin-dependent kinase A; Pro | 0.001 | |
| cd06641 | 277 | cd06641, STKc_MST3, Catalytic domain of the Protei | 0.001 | |
| cd06658 | 292 | cd06658, STKc_PAK5, Catalytic domain of the Protei | 0.001 | |
| PHA03211 | 461 | PHA03211, PHA03211, serine/threonine kinase US3; P | 0.001 | |
| cd05037 | 259 | cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) dom | 0.001 | |
| cd05111 | 279 | cd05111, PTK_HER3, Pseudokinase domain of the Prot | 0.001 | |
| cd05116 | 257 | cd05116, PTKc_Syk, Catalytic domain of the Protein | 0.001 | |
| cd05090 | 283 | cd05090, PTKc_Ror1, Catalytic domain of the Protei | 0.001 | |
| cd05122 | 253 | cd05122, PKc_STE, Catalytic domain of STE family P | 0.002 | |
| cd06606 | 260 | cd06606, STKc_MAPKKK, Catalytic domain of the Prot | 0.002 | |
| cd06625 | 263 | cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ | 0.002 | |
| cd05622 | 371 | cd05622, STKc_ROCK1, Catalytic domain of the Prote | 0.002 | |
| cd06605 | 265 | cd06605, PKc_MAPKK, Catalytic domain of the dual-s | 0.002 | |
| cd06651 | 266 | cd06651, STKc_MEKK3, Catalytic domain of the Prote | 0.002 | |
| cd07844 | 291 | cd07844, STKc_PCTAIRE_like, Catalytic domain of PC | 0.002 | |
| cd06636 | 282 | cd06636, STKc_MAP4K4_6, Catalytic domain of the Pr | 0.002 | |
| cd05041 | 251 | cd05041, PTKc_Fes_like, Catalytic domain of Fes-li | 0.002 | |
| cd06657 | 292 | cd06657, STKc_PAK4, Catalytic domain of the Protei | 0.002 | |
| cd05055 | 302 | cd05055, PTKc_PDGFR, Catalytic domain of the Prote | 0.002 | |
| cd05109 | 279 | cd05109, PTKc_HER2, Catalytic domain of the Protei | 0.002 | |
| cd05061 | 288 | cd05061, PTKc_InsR, Catalytic domain of the Protei | 0.002 | |
| cd07860 | 284 | cd07860, STKc_CDK2_3, Catalytic domain of the Seri | 0.003 | |
| cd07864 | 302 | cd07864, STKc_CDK12, Catalytic domain of the Serin | 0.003 | |
| cd06645 | 267 | cd06645, STKc_MAP4K3, Catalytic domain of the Prot | 0.003 | |
| cd07870 | 291 | cd07870, STKc_PFTAIRE2, Catalytic domain of the Se | 0.003 | |
| cd05042 | 269 | cd05042, PTKc_Aatyk, Catalytic domain of the Prote | 0.003 | |
| pfam01636 | 238 | pfam01636, APH, Phosphotransferase enzyme family | 0.003 | |
| COG0515 | 384 | COG0515, SPS1, Serine/threonine protein kinase [Ge | 0.004 | |
| cd06630 | 268 | cd06630, STKc_MEKK1, Catalytic domain of the Prote | 0.004 | |
| cd06642 | 277 | cd06642, STKc_STK25-YSK1, Catalytic domain of the | 0.004 | |
| cd07859 | 338 | cd07859, STKc_TDY_MAPK_plant, Catalytic domain of | 0.004 | |
| cd05092 | 280 | cd05092, PTKc_TrkA, Catalytic domain of the Protei | 0.004 |
| >gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Score = 260 bits (668), Expect = 2e-80
Identities = 97/273 (35%), Positives = 147/273 (53%), Gaps = 43/273 (15%)
Query: 385 ILGDGSYSVCRRCVEKSTGQEYAVKIISRK------IDCSEEINLLRACQGHPNIVNLHC 438
LG+GS+ +K TG+ A+K+I +K EI +L+ + HPNIV L+
Sbjct: 6 KLGEGSFGKVYLARDKKTGKLVAIKVIKKKKIKKDRERILREIKILKKLK-HPNIVRLYD 64
Query: 439 VFQDEVHTYLVLELLKGGELLDRIRQKGRCGFTENEASRIMRQLVAAVHFMHSRGVVHRD 498
VF+DE YLV+E +GG+L D ++++GR +E+EA +RQ+++A+ ++HS+G+VHRD
Sbjct: 65 VFEDEDKLYLVMEYCEGGDLFDLLKKRGR--LSEDEARFYLRQILSALEYLHSKGIVHRD 122
Query: 499 LKPENLLFSDPAGDNIKVVDFGFACLKRES--LHTPCFTLQYAAPEVLRQDKSGYDENCD 556
LKPEN+L + ++K+ DFG A L T T +Y APEVL
Sbjct: 123 LKPENILLDED--GHVKLADFGLARQLDPGEKLTTFVGTPEYMAPEVLLGK--------- 171
Query: 557 LWSLGVILVNVLRQDKSGYDENCDLWSLGVILYTMLCGRVPFHARSRDDSALSIMARIKE 616
GY + D+WSLGVILY +L G+ PF DD L + +I +
Sbjct: 172 -----------------GYGKAVDIWSLGVILYELLTGKPPFPG---DDQLLELFKKIGK 211
Query: 617 GQFNFDAEAWSTVSSEAKELTKSLLTVNPAQRI 649
+ F W +S EAK+L + LL +P +R+
Sbjct: 212 PKPPFPPPEWD-ISPEAKDLIRKLLVKDPEKRL 243
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254 |
| >gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain | Back alignment and domain information |
|---|
Score = 247 bits (632), Expect = 3e-75
Identities = 98/276 (35%), Positives = 137/276 (49%), Gaps = 41/276 (14%)
Query: 384 GILGDGSYSVCRRCVEKSTGQEYAVKIIS-RKIDCSE------EINLLRACQGHPNIVNL 436
LG GS+ + K TG+ AVKI+ R + EI +LR HPNIV L
Sbjct: 5 RKLGSGSFGTVYKAKHKGTGKIVAVKILKKRSEKSKKDQTARREIRILRRLS-HPNIVRL 63
Query: 437 HCVFQDEVHTYLVLELLKGGELLDRIRQKGRCGFTENEASRIMRQLVAAVHFMHSRGVVH 496
F+D+ H YLV+E +GG+L D + + G +E+EA +I Q++ + ++HS G++H
Sbjct: 64 IDAFEDKDHLYLVMEYCEGGDLFDYLSRGGP--LSEDEAKKIALQILRGLEYLHSNGIIH 121
Query: 497 RDLKPENLLFSDPAGDNIKVVDFGFACLK---RESLHTPCFTLQYAAPEVLRQDKSGYDE 553
RDLKPEN+L + +K+ DFG A SL T T Y APEVL
Sbjct: 122 RDLKPENILLDEN--GVVKIADFGLAKKLLKSSSSLTTFVGTPWYMAPEVLL-------- 171
Query: 554 NCDLWSLGVILVNVLRQDKSGYDENCDLWSLGVILYTMLCGRVPFHARSRDDSALSIMAR 613
+GY D+WSLGVILY +L G+ PF + D L ++ R
Sbjct: 172 -----------------GGNGYGPKVDVWSLGVILYELLTGKPPFSGENILDQ-LQLIRR 213
Query: 614 IKEGQFNFDAEAWSTVSSEAKELTKSLLTVNPAQRI 649
I FD WS+ S EAK+L K L +P++R
Sbjct: 214 ILGPPLEFDEPKWSSGSEEAKDLIKKCLNKDPSKRP 249
|
Length = 260 |
| >gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 208 bits (532), Expect = 3e-61
Identities = 95/275 (34%), Positives = 137/275 (49%), Gaps = 50/275 (18%)
Query: 386 LGDGSYSVCRRCVEKSTGQEYAVKIISRK-------IDCS-EEINLLRACQGHPNIVNLH 437
LG GS+ +K TG+ YA+K++ +K ++ + E N+L HP IV LH
Sbjct: 1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRIN-HPFIVKLH 59
Query: 438 CVFQDEVHTYLVLELLKGGELLDRIRQKGRCGFTENEASRIMRQLVAAVHFMHSRGVVHR 497
FQ E YLVLE GGEL + ++GR F+E A ++V A+ ++HS G+++R
Sbjct: 60 YAFQTEEKLYLVLEYAPGGELFSHLSKEGR--FSEERARFYAAEIVLALEYLHSLGIIYR 117
Query: 498 DLKPENLLFSDPAGDNIKVVDFGFA---CLKRESLHTPCFTLQYAAPEVLRQDKSGYDEN 554
DLKPEN+L D G +IK+ DFG A + +T C T +Y APEVL
Sbjct: 118 DLKPENILL-DADG-HIKLTDFGLAKELSSEGSRTNTFCGTPEYLAPEVLL--------- 166
Query: 555 CDLWSLGVILVNVLRQDKSGYDENCDLWSLGVILYTMLCGRVPFHARSRDDSALSIMARI 614
GY + D WSLGV+LY ML G+ PF+A R + I +I
Sbjct: 167 -----------------GKGYGKAVDWWSLGVLLYEMLTGKPPFYAEDRKE----IYEKI 205
Query: 615 KEGQFNFDAEAWSTVSSEAKELTKSLLTVNPAQRI 649
+ F +S EA++L LL +P +R+
Sbjct: 206 LKDPLRFP----EFLSPEARDLISGLLQKDPTKRL 236
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250 |
| >gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Score = 186 bits (474), Expect = 7e-54
Identities = 74/188 (39%), Positives = 107/188 (56%), Gaps = 13/188 (6%)
Query: 386 LGDGSYSVCRRCVEKSTGQEYAVKIISRK------IDCSEEINLLRACQGHPNIVNLHCV 439
LG+G + +K TG++ A+KII ++ + EI +L+ HPNIV L+ V
Sbjct: 1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLN-HPNIVKLYGV 59
Query: 440 FQDEVHTYLVLELLKGGELLDRIRQKGRCGFTENEASRIMRQLVAAVHFMHSRGVVHRDL 499
F+DE H YLV+E +GG L D +++ +E+E RI+ Q++ + ++HS G++HRDL
Sbjct: 60 FEDENHLYLVMEYCEGGSLKDLLKEN-EGKLSEDEILRILLQILEGLEYLHSNGIIHRDL 118
Query: 500 KPENLLFSDPAGDNIKVVDFGFACLKRES---LHTPCFTLQYAAPEVLRQDKSGYDENCD 556
KPEN+L +K+ DFG + L L T T Y APEVL K Y E D
Sbjct: 119 KPENILLDSD-NGKVKLADFGLSKLLTSDKSLLKTIVGTPAYMAPEVLLG-KGYYSEKSD 176
Query: 557 LWSLGVIL 564
+WSLGVIL
Sbjct: 177 IWSLGVIL 184
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215 |
| >gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Score = 182 bits (464), Expect = 1e-51
Identities = 86/298 (28%), Positives = 132/298 (44%), Gaps = 73/298 (24%)
Query: 385 ILGDGSYSVCRRCVEKSTGQEYAVKIIS-------RKID--CSEEINLLRACQGHPNIVN 435
I+G+GS+S EK T +EYA+KI+ +K+ E+ L R GHP I+
Sbjct: 8 IIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTR-LNGHPGIIK 66
Query: 436 LHCVFQDEVHTYLVLELLKGGELLDRIRQKGRCGFTENEASRIMRQLVAAVHFMHSRGVV 495
L+ FQDE + Y VLE GELL IR+ G E +++ A+ ++HS+G++
Sbjct: 67 LYYTFQDEENLYFVLEYAPNGELLQYIRKYGS--LDEKCTRFYAAEILLALEYLHSKGII 124
Query: 496 HRDLKPENLLFSDPAGDN-IKVVDFGFA----------------CLKRESLHTP------ 532
HRDLKPEN+L D IK+ DFG A +
Sbjct: 125 HRDLKPENILLDK---DMHIKITDFGTAKVLDPNSSPESNKGDATNIDSQIEKNRRRFAS 181
Query: 533 -CFTLQYAAPEVLRQDKSGYDENCDLWSLGVILVNVLRQDKSGYDENCDLWSLGVILYTM 591
T +Y +PE+L + +G + DLW+LG I+Y M
Sbjct: 182 FVGTAEYVSPELLNEKPAGK--------------------------SSDLWALGCIIYQM 215
Query: 592 LCGRVPFHARSRDDSALSIMARIKEGQFNFDAEAWSTVSSEAKELTKSLLTVNPAQRI 649
L G+ PF R + +I + +++F +AK+L + LL ++P R+
Sbjct: 216 LTGKPPF----RGSNEYLTFQKILKLEYSFP----PNFPPDAKDLIEKLLVLDPQDRL 265
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280 |
| >gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 176 bits (450), Expect = 1e-49
Identities = 96/271 (35%), Positives = 140/271 (51%), Gaps = 47/271 (17%)
Query: 386 LGDGSYSVCRRCVEKSTGQEYAVKIIS-RKI-------DCSEEINLLRACQGHPNIVNLH 437
LG GS+ K +G+ YA+KI+S KI E +L++ + HP +VNL+
Sbjct: 9 LGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIR-HPFLVNLY 67
Query: 438 CVFQDEVHTYLVLELLKGGELLDRIRQKGRCGFTENEASRIMRQLVAAVHFMHSRGVVHR 497
FQD+ + YLV+E + GGEL +R+ GR F E A Q+V A+ ++HS +V+R
Sbjct: 68 GSFQDDSNLYLVMEYVPGGELFSHLRKSGR--FPEPVARFYAAQVVLALEYLHSLDIVYR 125
Query: 498 DLKPENLLFSDPAGDNIKVVDFGFACLKRESLHTPCFTLQYAAPEVLRQDKSGYDENCDL 557
DLKPENLL D G IK+ DFGFA + +T C T +Y APE++
Sbjct: 126 DLKPENLLL-DSDG-YIKITDFGFAKRVKGRTYTLCGTPEYLAPEIIL------------ 171
Query: 558 WSLGVILVNVLRQDKSGYDENCDLWSLGVILYTMLCGRVPFHARSRDDSALSIMARIKEG 617
GY + D W+LG+++Y ML G PF DD+ + I +I EG
Sbjct: 172 --------------SKGYGKAVDWWALGILIYEMLAGYPPF----FDDNPIQIYEKILEG 213
Query: 618 QFNFDAEAWSTVSSEAKELTKSLLTVNPAQR 648
+ F S S +AK+L ++LL V+ +R
Sbjct: 214 KVRFP----SFFSPDAKDLIRNLLQVDLTKR 240
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290 |
| >gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Score = 164 bits (417), Expect = 2e-45
Identities = 71/275 (25%), Positives = 124/275 (45%), Gaps = 48/275 (17%)
Query: 386 LGDGSYSVCRRCVEKSTGQEYAVKIIS-------RKIDCSEEINLLRACQGHPNIVNLHC 438
+G GS+ KS G+ Y +K I + D E+ +L+ HPNI+ +
Sbjct: 8 IGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLN-HPNIIKYYE 66
Query: 439 VFQDEVHTYLVLELLKGGELLDRIRQKGRCG--FTENEASRIMRQLVAAVHFMHSRGVVH 496
F+++ +V+E GG+L +I+++ + G F E + QL A+ ++HSR ++H
Sbjct: 67 SFEEKGKLCIVMEYADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLHSRKILH 126
Query: 497 RDLKPENLLFSDPAGDNIKVVDFGFACLKRESL---HTPCFTLQYAAPEVLRQDKSGYDE 553
RD+KP+N+ + +K+ DFG + + ++ T T Y +PE+ +
Sbjct: 127 RDIKPQNIFLTS--NGLVKLGDFGISKVLSSTVDLAKTVVGTPYYLSPELCQNKP----- 179
Query: 554 NCDLWSLGVILVNVLRQDKSGYDENCDLWSLGVILYTMLCGRVPFHARSRDDSALSIMAR 613
Y+ D+WSLG +LY + + PF + L + +
Sbjct: 180 ---------------------YNYKSDIWSLGCVLYELCTLKHPFEGENL----LELALK 214
Query: 614 IKEGQFNFDAEAWSTVSSEAKELTKSLLTVNPAQR 648
I +GQ+ S SSE + L SLL +P +R
Sbjct: 215 ILKGQY---PPIPSQYSSELRNLVSSLLQKDPEER 246
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258 |
| >gnl|CDD|173663 cd05572, STKc_cGK_PKG, Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 159 bits (405), Expect = 7e-44
Identities = 90/278 (32%), Positives = 136/278 (48%), Gaps = 45/278 (16%)
Query: 386 LGDGSYSVCRRCVEKSTGQEYAVKIISRKI----DCSEEI----NLLRACQGHPNIVNLH 437
LG G + KS + +A+K + ++ E I +L C HP IV L+
Sbjct: 1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECN-HPFIVKLY 59
Query: 438 CVFQDEVHTYLVLELLKGGELLDRIRQKGRCGFTENEASRIMRQLVAAVHFMHSRGVVHR 497
F+D+ + Y+++E GGEL +R +G F E A + +V A ++H+RG+++R
Sbjct: 60 RTFKDKKYIYMLMEYCLGGELWTILRDRGL--FDEYTARFYIACVVLAFEYLHNRGIIYR 117
Query: 498 DLKPENLLFSDPAGDNIKVVDFGFA--CLKRESLHTPCFTLQYAAPEVLRQDKSGYDENC 555
DLKPENLL D G +K+VDFGFA + T C T +Y APE++ +K
Sbjct: 118 DLKPENLLL-DSNG-YVKLVDFGFAKKLKSGQKTWTFCGTPEYVAPEII-LNK------- 167
Query: 556 DLWSLGVILVNVLRQDKSGYDENCDLWSLGVILYTMLCGRVPFHARSRDDSALSIMARIK 615
GYD + D WSLG++LY +L GR PF D+ + I I
Sbjct: 168 ------------------GYDFSVDYWSLGILLYELLTGRPPF--GEDDEDPMEIYNDIL 207
Query: 616 EGQFNFDAEAWSTVSSEAKELTKSLLTVNPAQRIRMMR 653
+G N E + + AK+L K LL NP +R+ ++
Sbjct: 208 KG--NGKLEFPNYIDKAAKDLIKQLLRRNPEERLGNLK 243
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowing autophosphorylation and activation of the kinase. cGKI is a soluble protein expressed in all smooth muscles, platelets, cerebellum, and kidney. It is also expressed at lower concentrations in other tissues. cGKII is a membrane-bound protein that is most abundantly expressed in the intestine. It is also present in the brain nuclei, adrenal cortex, kidney, lung, and prostate. cGKI is involved in the regulation of smooth muscle tone, smooth cell proliferation, and platelet activation. cGKII plays a role in the regulation of secretion, such as renin secretion by the kidney and aldosterone secretion by the adrenal. It also regulates bone growth and the circadian rhythm. Length = 262 |
| >gnl|CDD|140289 PTZ00263, PTZ00263, protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 158 bits (402), Expect = 9e-43
Identities = 93/283 (32%), Positives = 134/283 (47%), Gaps = 55/283 (19%)
Query: 379 DLDKAGILGDGSYSVCRRCVEKSTGQEYAVKIISRKIDCSEEINLLRACQ---------- 428
D + LG GS+ R K TG+ YA+K + ++ EI ++ Q
Sbjct: 19 DFEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKR-----EILKMKQVQHVAQEKSILM 73
Query: 429 --GHPNIVNLHCVFQDEVHTYLVLELLKGGELLDRIRQKGRCGFTENEASRIMRQLVAAV 486
HP IVN+ C FQDE Y +LE + GGEL +R+ GR F + A +LV A
Sbjct: 74 ELSHPFIVNMMCSFQDENRVYFLLEFVVGGELFTHLRKAGR--FPNDVAKFYHAELVLAF 131
Query: 487 HFMHSRGVVHRDLKPENLLFSDPAGDNIKVVDFGFACLKRESLHTPCFTLQYAAPEVLRQ 546
++HS+ +++RDLKPENLL D G ++KV DFGFA + T C T +Y APEV+ Q
Sbjct: 132 EYLHSKDIIYRDLKPENLLL-DNKG-HVKVTDFGFAKKVPDRTFTLCGTPEYLAPEVI-Q 188
Query: 547 DKSGYDENCDLWSLGVILVNVLRQDKSGYDENCDLWSLGVILYTMLCGRVPFHARSRDDS 606
K G+ + D W++GV+LY + G PF DD+
Sbjct: 189 SK-------------------------GHGKAVDWWTMGVLLYEFIAGYPPFF----DDT 219
Query: 607 ALSIMARIKEGQFNFDAEAWSTVSSEAKELTKSLLTVNPAQRI 649
I +I G+ F W A++L K LL + +R+
Sbjct: 220 PFRIYEKILAGRLKF--PNW--FDGRARDLVKGLLQTDHTKRL 258
|
Length = 329 |
| >gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Score = 149 bits (379), Expect = 2e-40
Identities = 78/274 (28%), Positives = 127/274 (46%), Gaps = 44/274 (16%)
Query: 385 ILGDGSYSVCRRCVEKSTGQEYAVKIISR-KIDCSEEINL----LRACQG--HPNIVNLH 437
++G G++ ++ T + +A+K +++ K + R Q HP +VNL
Sbjct: 7 VIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPFLVNLW 66
Query: 438 CVFQDEVHTYLVLELLKGGELLDRIRQKGRCGFTENEASRIMRQLVAAVHFMHSRGVVHR 497
FQDE + YLV++LL GG+L + QK + F+E + + ++V A+ ++HS+G++HR
Sbjct: 67 YSFQDEENMYLVVDLLLGGDLRYHLSQKVK--FSEEQVKFWICEIVLALEYLHSKGIIHR 124
Query: 498 DLKPENLLFSDPAGDNIKVVDFGFACL--KRESLHTPCFTLQYAAPEVLRQDKSGYDENC 555
D+KP+N+L D G ++ + DF A + T Y APEVL
Sbjct: 125 DIKPDNILL-DEQG-HVHITDFNIATKVTPDTLTTSTSGTPGYMAPEVLC---------- 172
Query: 556 DLWSLGVILVNVLRQDKSGYDENCDLWSLGVILYTMLCGRVPFHARSRDDSALSIMARIK 615
+ GY D WSLGV Y L G+ P+ SR I A+ +
Sbjct: 173 ----------------RQGYSVAVDWWSLGVTAYECLRGKRPYRGHSRTIRDQ-IRAKQE 215
Query: 616 EGQFNFDAEAWSTVSSEAKELTKSLLTVNPAQRI 649
D +T S+EA + LL +P +R+
Sbjct: 216 TA----DVLYPATWSTEAIDAINKLLERDPQKRL 245
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258 |
| >gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Score = 152 bits (384), Expect = 5e-40
Identities = 105/405 (25%), Positives = 169/405 (41%), Gaps = 51/405 (12%)
Query: 386 LGDGSYSVCRRCVEKSTGQEYAVKIISRKID--------CSEEINLLRACQGHPNIVNLH 437
LG+GS+ ++ + A+K++++K++ EI +L + PNIV L+
Sbjct: 8 LGEGSFGEVYLARDR---KLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKLY 64
Query: 438 CVFQDEVHTYLVLELLKGGELLDRIRQKGRCG-FTENEASRIMRQLVAAVHFMHSRGVVH 496
FQDE YLV+E + GG L D +++ GR G +E+EA I+ Q+++A+ ++HS+G++H
Sbjct: 65 DFFQDEGSLYLVMEYVDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLHSKGIIH 124
Query: 497 RDLKPENLLFSDPAGDNIKVVDFGFACLKRES---------LHTPCFTLQYAAPEVLRQD 547
RD+KPEN+L D G +K++DFG A L + T T Y APEVL
Sbjct: 125 RDIKPENILL-DRDGRVVKLIDFGLAKLLPDPGSTSSIPALPSTSVGTPGYMAPEVLLGL 183
Query: 548 KSGYDENCDLWSLGVILVNVLRQDKSGYDENCDLWSLGVILYTMLCGRVPFHARSRDDSA 607
Y + D+WSLG+ LY +L G PF +
Sbjct: 184 SLAY-----------------------ASSSSDIWSLGITLYELLTGLPPFEGEKNSSAT 220
Query: 608 LSIMARIKEGQFNFDAEAWS-----TVSSEAKELTKSLLTVNPAQRIRMMRVKLTFHAFH 662
+ I E A S +S A +L K LL +P R+ L+
Sbjct: 221 SQTLKIILELPTPSLASPLSPSNPELISKAASDLLKKLLAKDPKNRLSSSS-DLSHDLLA 279
Query: 663 QAQKEGFRLQDVTSAKLAQRRKNKNVSNDNSRSFSSTSSSLSSSSSGTSSLKTPCSSTQP 722
+ + L D+ + + + + S S ++S S
Sbjct: 280 HLKLKESDLSDLLKPDDSAPLRLSLPPSLEALISSLNSLAISGSDLKLDDSNFSKELAPN 339
Query: 723 SVPSKPVKRINKDASSGTVFDFAEARVQEYLSSLSSSSSSEHGTS 767
V S P + S+ + + ++ S S SSSS S
Sbjct: 340 GVSSSPHNSSSLLLSTASSKRSSLPKISARSSPSSLSSSSRQQAS 384
|
Length = 384 |
| >gnl|CDD|173664 cd05573, STKc_ROCK_NDR_like, Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 148 bits (377), Expect = 3e-39
Identities = 94/324 (29%), Positives = 135/324 (41%), Gaps = 79/324 (24%)
Query: 379 DLDKAGILGDGSYSVCRRCVEKSTGQEYAVKIISRKIDC--SEEINLLRA-----CQGH- 430
D + ++G G++ +K TGQ YA+K++ RK D +I +RA
Sbjct: 2 DFEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVL-RKSDMIKRNQIAHVRAERDILADADS 60
Query: 431 PNIVNLHCVFQDEVHTYLVLELLKGGELLDRIRQKGRCGFTENEASRIMRQLVAAVHFMH 490
P IV L+ FQDE H YLV+E + GG+L++ + +K F E A + +LV A+ +H
Sbjct: 61 PWIVKLYYSFQDEEHLYLVMEYMPGGDLMNLLIRKDV--FPEETARFYIAELVLALDSVH 118
Query: 491 SRGVVHRDLKPENLLFSDPAGDNIKVVDFGFA---------CLKRESLHTPCF------- 534
G +HRD+KP+N+L D G +IK+ DFG H F
Sbjct: 119 KLGFIHRDIKPDNILI-DADG-HIKLADFGLCKKMNKAKDREYYLNDSHNLLFRDNVLVR 176
Query: 535 ----------------TLQYAAPEVLRQDKSGYDENCDLWSLGVILVNVLRQDKSGYDEN 578
T Y APEVLR Y
Sbjct: 177 RRDHKQRRVRANSTVGTPDYIAPEVLRGT--------------------------PYGLE 210
Query: 579 CDLWSLGVILYTMLCGRVPFHARSRDDSALSIMARIKEGQFNFDAEAWSTVSSEAKELTK 638
CD WSLGVILY ML G PF++ + ++ I+ + +F D VS EA +L
Sbjct: 211 CDWWSLGVILYEMLYGFPPFYSDTLQETYNKIINWKESLRFPPDPP----VSPEAIDLIC 266
Query: 639 SLLTVNPAQRIRMMRVK-LTFHAF 661
LL R+ + + H F
Sbjct: 267 RLLC---DPEDRLGSFEEIKSHPF 287
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Proteins in this subfamily are involved in regulating many cellular functions including contraction, motility, division, proliferation, apoptosis, morphogenesis, and cytokinesis. Length = 350 |
| >gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Score = 143 bits (362), Expect = 3e-38
Identities = 67/272 (24%), Positives = 122/272 (44%), Gaps = 46/272 (16%)
Query: 386 LGDGSYSVCRRCVEKSTGQEYAVKIISRKIDCS-----EEINLLRACQGHPNIVNLHCVF 440
+G G + + K TG+E A+K+I + EI +L+ C+ HPNIV + +
Sbjct: 8 IGKGGFGEVYKARHKRTGKEVAIKVIKLESKEKKEKIINEIQILKKCK-HPNIVKYYGSY 66
Query: 441 QDEVHTYLVLELLKGGELLDRIRQKGRCGFTENEASRIMRQLVAAVHFMHSRGVVHRDLK 500
+ ++V+E GG L D ++ + TE++ + + ++L+ + ++HS G++HRD+K
Sbjct: 67 LKKDELWIVMEFCSGGSLKDLLKSTNQT-LTESQIAYVCKELLKGLEYLHSNGIIHRDIK 125
Query: 501 PENLLFSDPAGDNIKVVDFGFA--CLKRESLHTPCFTLQYAAPEVLRQDKSGYDENCDLW 558
N+L + +K++DFG + ++ +T T + APEV+
Sbjct: 126 AANILLTSDGE--VKLIDFGLSAQLSDTKARNTMVGTPYWMAPEVINGK----------- 172
Query: 559 SLGVILVNVLRQDKSGYDENCDLWSLGVILYTMLCGRVPFHARSRDDSALSIMARI-KEG 617
YD D+WSLG+ + G+ P+ + + + +I G
Sbjct: 173 ---------------PYDYKADIWSLGITAIELAEGKPPYS----ELPPMKALFKIATNG 213
Query: 618 QFNF-DAEAWSTVSSEAKELTKSLLTVNPAQR 648
+ E WS E K+ K L NP +R
Sbjct: 214 PPGLRNPEKWSD---EFKDFLKKCLQKNPEKR 242
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253 |
| >gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Score = 142 bits (361), Expect = 5e-38
Identities = 74/280 (26%), Positives = 123/280 (43%), Gaps = 54/280 (19%)
Query: 385 ILGDGSYSVCRRCVEKSTGQEYAVKII------SRKIDC-SEEINLLRACQGHPNIVN-L 436
+LG GS+ ++K TG+ AVK + +++ EI +L + Q HPNIV
Sbjct: 7 LLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQ-HPNIVRYY 65
Query: 437 HCVFQDEVHTY-LVLELLKGGELLDRIRQKGRCGFTENEASRIMRQLVAAVHFMHSRGVV 495
+E +T + LE + GG L +++ G+ E + RQ++ + ++HS G+V
Sbjct: 66 GSERDEEKNTLNIFLEYVSGGSLSSLLKKFGK--LPEPVIRKYTRQILEGLAYLHSNGIV 123
Query: 496 HRDLKPENLLFSDPAGDNIKVVDFGFACLKR-------ESLHTPCFTLQYAAPEVLRQDK 548
HRD+K N+L + +K+ DFG C KR E + T + APEV+R +
Sbjct: 124 HRDIKGANILVD--SDGVVKLADFG--CAKRLGDIETGEGTGSVRGTPYWMAPEVIRGE- 178
Query: 549 SGYDENCDLWSLGVILVNVLRQDKSGYDENCDLWSLGVILYTMLCGRVPFHARSRDDSAL 608
Y D+WSLG + M G+ P+ S + +
Sbjct: 179 -------------------------EYGRAADIWSLGCTVIEMATGKPPW---SELGNPM 210
Query: 609 SIMARIKEGQFNFDAEAWSTVSSEAKELTKSLLTVNPAQR 648
+ + +I G E +S EAK+ + L +P +R
Sbjct: 211 AALYKI--GSSGEPPEIPEHLSEEAKDFLRKCLRRDPKKR 248
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260 |
| >gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Score = 142 bits (361), Expect = 5e-38
Identities = 80/268 (29%), Positives = 120/268 (44%), Gaps = 56/268 (20%)
Query: 400 KSTGQEYAVKIISRKIDCSE--------EINLLRACQGHPNIVNLHCVFQDEVHTYLVLE 451
KSTG YA+K+I + + E ++L Q P +V L+ FQ + + YLV+E
Sbjct: 15 KSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQ-SPYVVKLYYSFQGKKNLYLVME 73
Query: 452 LLKGGELLDRIRQKGRCGFTENEASRIMRQLVAAVHFMHSRGVVHRDLKPENLLFSDPAG 511
L GG+L + G E+ A + ++V A+ ++HS G++HRDLKP+N+L D G
Sbjct: 74 YLPGGDLASLLENVG--SLDEDVARIYIAEIVLALEYLHSNGIIHRDLKPDNILI-DSNG 130
Query: 512 DNIKVVDFGF--ACLKRESLHTP---------CFTLQYAAPEVLRQDKSGYDENCDLWSL 560
++K+ DFG L R ++ T Y APEV+
Sbjct: 131 -HLKLTDFGLSKVGLVRRQINLNDDEKEDKRIVGTPDYIAPEVIL--------------- 174
Query: 561 GVILVNVLRQDKSGYDENCDLWSLGVILYTMLCGRVPFHARSRDDSALSIMARIKEGQFN 620
G+ + D WSLG ILY L G PFH ++ I I G+
Sbjct: 175 -----------GQGHSKTVDWWSLGCILYEFLVGIPPFH----GETPEEIFQNILNGKIE 219
Query: 621 FDAEAWSTVSSEAKELTKSLLTVNPAQR 648
+ + VS EA +L LL +P +R
Sbjct: 220 WPEDV--EVSDEAIDLISKLLVPDPEKR 245
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265 |
| >gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 143 bits (362), Expect = 6e-38
Identities = 84/308 (27%), Positives = 125/308 (40%), Gaps = 79/308 (25%)
Query: 382 KAGILGDGSYSVCRRCVEKSTGQEYAVKIISRKIDCSE---------EINLLRACQGHPN 432
K LG+G+Y V + +K TG+ A+K I ++D E EI+LL+ + HPN
Sbjct: 3 KLEKLGEGTYGVVYKARDKKTGEIVALKKI--RLDNEEEGIPSTALREISLLKELK-HPN 59
Query: 433 IVNLHCVFQDEVHTYLVLEL----LKGGELLDRIRQKGRCGFTENEASRIMRQLVAAVHF 488
IV L V E YLV E LK LD+ + N IM QL+ + +
Sbjct: 60 IVKLLDVIHTERKLYLVFEYCDMDLKK--YLDKRPGP----LSPNLIKSIMYQLLRGLAY 113
Query: 489 MHSRGVVHRDLKPENLLFSDPAGDNIKVVDFGFACLKRE-SLHTPCF-----TLQYAAPE 542
HS ++HRDLKP+N+L + +K+ DFG A R + + TL Y APE
Sbjct: 114 CHSHRILHRDLKPQNILINR--DGVLKLADFGLA---RAFGIPLRTYTHEVVTLWYRAPE 168
Query: 543 VLRQDKSGYDENCDLWSLGVILVNVLRQDKSGYDENCDLWSLGVILYTMLCGRVPFHARS 602
+L +S V D+WS+G I M+ G+ F S
Sbjct: 169 ILL--------GSKHYSTAV-----------------DIWSVGCIFAEMITGKPLFPGDS 203
Query: 603 RDDSALSI--------------MARIKEGQFNFD-------AEAWSTVSSEAKELTKSLL 641
D I + ++ + + F + + E +L +L
Sbjct: 204 EIDQLFKIFQILGTPTEESWPGVTKLPDYKPTFPKFPPKDLEKVLPRLDPEGIDLLSKML 263
Query: 642 TVNPAQRI 649
NPA+RI
Sbjct: 264 QYNPAKRI 271
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282 |
| >gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 139 bits (353), Expect = 1e-36
Identities = 83/283 (29%), Positives = 135/283 (47%), Gaps = 47/283 (16%)
Query: 379 DLDKAGILGDGSYSVCRRCVEKSTGQEYAVKI--ISRKIDCSE------EINLLRACQGH 430
DL++ +G G++ ++ + YA+K+ I I + E +L+ H
Sbjct: 2 DLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVS-H 60
Query: 431 PNIVNLHCVFQDEVHTYLVLELLKGGELLDRIRQKGRCGFTENEASRIMRQLVAAVHFMH 490
P I+ L D+ Y+++E + GGEL +R GR F+ + ++V A+ ++H
Sbjct: 61 PFIIRLFWTEHDQRFLYMLMEYVPGGELFSYLRNSGR--FSNSTGLFYASEIVCALEYLH 118
Query: 491 SRGVVHRDLKPENLLFSDPAGDNIKVVDFGFACLKRESLHTPCFTLQYAAPEVLRQDKSG 550
S+ +V+RDLKPEN+L +IK+ DFGFA R+ T C T +Y APEV+ Q K
Sbjct: 119 SKEIVYRDLKPENILLDKEG--HIKLTDFGFAKKLRDRTWTLCGTPEYLAPEVI-QSK-- 173
Query: 551 YDENCDLWSLGVILVNVLRQDKSGYDENCDLWSLGVILYTMLCGRVPFHARSRDDSALSI 610
G+++ D W+LG+++Y ML G PF DD+ I
Sbjct: 174 -----------------------GHNKAVDWWALGILIYEMLVGYPPF----FDDNPFGI 206
Query: 611 MARIKEGQFNFDAEAWSTVSSEAKELTKSLLTVNPAQRIRMMR 653
+I G+ F + AK+L K LL V+ +R+ M+
Sbjct: 207 YEKILAGKLEFP----RHLDLYAKDLIKKLLVVDRTRRLGNMK 245
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291 |
| >gnl|CDD|173705 cd05614, STKc_MSK2_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Score = 138 bits (348), Expect = 1e-35
Identities = 53/109 (48%), Positives = 73/109 (66%)
Query: 264 RRILKTEPPIPEDLSPDVADFISRLLVKDPRRRLGGGELDAEELKRHPFFNVIDWDDLAT 323
RRILK +PP P + P+ D + +LL KDP++RLG G A E+K HPFF +DW+ LA
Sbjct: 221 RRILKCDPPFPSFIGPEAQDLLHKLLRKDPKKRLGAGPQGASEIKEHPFFKGLDWEALAL 280
Query: 324 KRIPAPFVPKISNELDVSNFSDEFTKMIPADSPAIVPPNFDKIFKGSLF 372
+++ PF P I NELDV NF++EFT + P SPA PP+ ++F+G F
Sbjct: 281 RKVNPPFRPSIRNELDVGNFAEEFTNLEPVYSPAGTPPSGARVFQGYSF 329
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK2 and MSK1 play nonredundant roles in activating histone H3 kinases, which play pivotal roles in compaction of the chromatin fiber. MSK2 is the required H3 kinase in response to stress stimuli and activation of the p38 MAPK pathway. MSK2 also plays a role in the pathogenesis of psoriasis. Length = 332 |
| >gnl|CDD|173692 cd05601, STKc_CRIK, Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Score = 138 bits (348), Expect = 1e-35
Identities = 95/296 (32%), Positives = 140/296 (47%), Gaps = 45/296 (15%)
Query: 379 DLDKAGILGDGSYSVCRRCVEKSTGQEYAVKIISRKIDCS--------EEINLLRACQGH 430
D D ++G G + + EK+TG YA+K++ + + + EE ++L +
Sbjct: 2 DFDVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDIL-SISNS 60
Query: 431 PNIVNLHCVFQDEVHTYLVLELLKGGELLDRI-RQKGRCGFTENEASRIMRQLVAAVHFM 489
P I L FQD+ + YLV+E GG+LL + R + + F E+ A + +LV A+H +
Sbjct: 61 PWIPQLQYAFQDKDNLYLVMEYQPGGDLLSLLNRYEDQ--FDEDMAQFYLAELVLAIHSV 118
Query: 490 HSRGVVHRDLKPENLLFSDPAGDNIKVVDFGFACLKRESLHT----PCFTLQYAAPEVLR 545
H G VHRD+KPEN+L D G +IK+ DFG A + P T Y APEVL
Sbjct: 119 HQMGYVHRDIKPENVLI-DRTG-HIKLADFGSAARLTANKMVNSKLPVGTPDYIAPEVL- 175
Query: 546 QDKSGYDENCDLWSLGVILVNVLRQDKSGYDENCDLWSLGVILYTMLCGRVPFHARSRDD 605
+G K Y CD WSLGVI Y M+ GR PFH +
Sbjct: 176 TTMNGDG-------------------KGTYGVECDWWSLGVIAYEMIYGRSPFHEGTSAK 216
Query: 606 SALSIMARIKEGQFNFDAEAWSTVSSEAKELTKSLLTVNPAQRIRMMRVKLTFHAF 661
+ +IM + +F D + VSS+ +L +SLL +R+ + H F
Sbjct: 217 TYNNIMNFQRFLKFPEDPK----VSSDFLDLIQSLLC-GQKERLGYEGLCC--HPF 265
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnormal cytokinesis and massive apoptosis in neuronal precursors. A Down syndrome critical region protein TTC3 interacts with CRIK and inhibits CRIK-dependent neuronal differentiation and neurite extension. Length = 330 |
| >gnl|CDD|173661 cd05570, STKc_PKC, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Score = 135 bits (341), Expect = 8e-35
Identities = 85/277 (30%), Positives = 127/277 (45%), Gaps = 51/277 (18%)
Query: 385 ILGDGSYSVCRRCVEKSTGQEYAVKIISR-------KIDCSE-EINLLRACQGHPNIVNL 436
+LG GS+ K T + YAVK++ + ++C+ E +L HP + L
Sbjct: 2 VLGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQL 61
Query: 437 HCVFQDEVHTYLVLELLKGGELLDRIRQKGRCGFTENEASRIMRQLVAAVHFMHSRGVVH 496
H FQ + + V+E + GG+L+ I++ GR F E A ++V + F+H RG+++
Sbjct: 62 HSCFQTKDRLFFVMEYVNGGDLMFHIQRSGR--FDEPRARFYAAEIVLGLQFLHERGIIY 119
Query: 497 RDLKPENLLFSDPAGDNIKVVDFGFAC----LKRESLHTPCFTLQYAAPEVLRQDKSGYD 552
RDLK +N+L D G +IK+ DFG C L + T C T Y APE+L
Sbjct: 120 RDLKLDNVLL-DSEG-HIKIADFGM-CKEGILGGVTTSTFCGTPDYIAPEILSYQP---- 172
Query: 553 ENCDLWSLGVILVNVLRQDKSGYDENCDLWSLGVILYTMLCGRVPFHARSRDDSALSIMA 612
Y D W+LGV+LY ML G+ PF D+ SI+
Sbjct: 173 ----------------------YGPAVDWWALGVLLYEMLAGQSPFEGDDEDELFQSIL- 209
Query: 613 RIKEGQFNFDAEAWSTVSSEAKELTKSLLTVNPAQRI 649
+ +S EAK + KS LT NP +R+
Sbjct: 210 -------EDEVRYPRWLSKEAKSILKSFLTKNPEKRL 239
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only require PS. PKCs phosphorylate and modify the activities of a wide variety of cellular proteins including receptors, enzymes, cytoskeletal proteins, transcription factors, and other kinases. They play a central role in signal transduction pathways that regulate cell migration and polarity, proliferation, differentiation, and apoptosis. Also included in this subfamily are the PKC-like proteins, called PKNs. Length = 318 |
| >gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 134 bits (339), Expect = 9e-35
Identities = 66/191 (34%), Positives = 97/191 (50%), Gaps = 18/191 (9%)
Query: 386 LGDGSYSVCRRCVEKSTGQEYAVKIISRKI----DCSE--EINLLRACQGHPNIVNLHCV 439
LGDG++ K TG+ A+K + +K +C E+ LR HPNIV L V
Sbjct: 7 LGDGTFGSVYLARNKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNEHPNIVKLKEV 66
Query: 440 FQDEVHTYLVLELLKGGELLDRIRQKGRCGFTENEASRIMRQLVAAVHFMHSRGVVHRDL 499
F++ Y V E ++G L ++ + F+E+ I+ Q++ + +H G HRDL
Sbjct: 67 FRENDELYFVFEYMEG-NLYQLMKDRKGKPFSESVIRSIIYQILQGLAHIHKHGFFHRDL 125
Query: 500 KPENLLFSDPAGDNIKVVDFGFACLKRESLHTPCFTLQ-----YAAPEVLRQDKSGYDEN 554
KPENLL S P + +K+ DFG A RE P +T Y APE+L + S Y
Sbjct: 126 KPENLLVSGP--EVVKIADFGLA---REIRSRPPYTDYVSTRWYRAPEILLRSTS-YSSP 179
Query: 555 CDLWSLGVILV 565
D+W+LG I+
Sbjct: 180 VDIWALGCIMA 190
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283 |
| >gnl|CDD|173673 cd05582, STKc_RSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 134 bits (340), Expect = 1e-34
Identities = 88/282 (31%), Positives = 143/282 (50%), Gaps = 60/282 (21%)
Query: 385 ILGDGSYS---VCRRCVEKSTGQEYAVKIISR-------KIDCSEEINLLRACQGHPNIV 434
+LG GS+ + R+ GQ YA+K++ + ++ E ++L A HP IV
Sbjct: 3 VLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKMERDIL-AEVNHPFIV 61
Query: 435 NLHCVFQDEVHTYLVLELLKGGELLDRIRQKGRCGFTENEASRIMRQLVAAVHFMHSRGV 494
LH FQ E YL+L+ L+GG+L R+ ++ FTE + + +L A+ +HS G+
Sbjct: 62 KLHYAFQTEGKLYLILDFLRGGDLFTRLSKE--VMFTEEDVKFYLAELALALDHLHSLGI 119
Query: 495 VHRDLKPENLLFSDPAGDNIKVVDFGFACLKRESLHTP------CFTLQYAAPEVLRQDK 548
++RDLKPEN+L D G +IK+ DFG L +ES+ C T++Y APEV+
Sbjct: 120 IYRDLKPENILL-DEEG-HIKLTDFG---LSKESIDHEKKAYSFCGTVEYMAPEVV---- 170
Query: 549 SGYDENCDLWSLGVILVNVLRQDKSGYDENCDLWSLGVILYTMLCGRVPFHARSRDDSAL 608
++ G+ ++ D WS GV+++ ML G +PF + R ++
Sbjct: 171 ----------------------NRRGHTQSADWWSFGVLMFEMLTGSLPFQGKDRKETMT 208
Query: 609 SIM-ARIKEGQFNFDAEAWSTVSSEAKELTKSLLTVNPAQRI 649
I+ A++ QF +S EA+ L ++L NPA R+
Sbjct: 209 MILKAKLGMPQF---------LSPEAQSLLRALFKRNPANRL 241
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylates all known RSK substrates. RSKs act as downstream effectors of mitogen-activated protein kinase (MAPK) and play key roles in mitogen-activated cell growth, differentiation, and survival. Mammals possess four RSK isoforms (RSK1-4) from distinct genes. RSK proteins are also referred to as MAP kinase-activated protein kinases (MAPKAPKs), p90-RSKs, or p90S6Ks. Length = 318 |
| >gnl|CDD|173675 cd05584, STKc_p70S6K, Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 134 bits (338), Expect = 2e-34
Identities = 90/283 (31%), Positives = 141/283 (49%), Gaps = 60/283 (21%)
Query: 385 ILGDGSYS---VCRRCVEKSTGQEYAVK------IISRKIDCSE---EINLLRACQGHPN 432
+LG G Y R+ TG+ +A+K I+ + D + E N+L A + HP
Sbjct: 3 VLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVK-HPF 61
Query: 433 IVNLHCVFQDEVHTYLVLELLKGGELLDRIRQKGRCGFTENEASRIMRQLVAAVHFMHSR 492
IV+L FQ YL+LE L GGEL + ++G F E+ A + ++ A+ +H +
Sbjct: 62 IVDLIYAFQTGGKLYLILEYLSGGELFMHLEREGI--FMEDTACFYLSEISLALEHLHQQ 119
Query: 493 GVVHRDLKPENLLFSDPAGDNIKVVDFGFACLKRESL------HTPCFTLQYAAPEVLRQ 546
G+++RDLKPEN+L A ++K+ DFG L +ES+ HT C T++Y APE+L
Sbjct: 120 GIIYRDLKPENILLD--AQGHVKLTDFG---LCKESIHEGTVTHTFCGTIEYMAPEILM- 173
Query: 547 DKSGYDENCDLWSLGVILVNVLRQDKSGYDENCDLWSLGVILYTMLCGRVPFHARSRDDS 606
+SG+ + D WSLG ++Y ML G PF A +R +
Sbjct: 174 -------------------------RSGHGKAVDWWSLGALMYDMLTGAPPFTAENRKKT 208
Query: 607 ALSIMARIKEGQFNFDAEAWSTVSSEAKELTKSLLTVNPAQRI 649
+ +I +G+ N ++ EA++L K LL NP+ R+
Sbjct: 209 ----IDKILKGKLNLPP----YLTPEARDLLKKLLKRNPSSRL 243
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the insulin receptor substrate IRS-1, among others. Mammals contain two isoforms of p70S6K, named S6K1 and S6K2 (or S6K-beta). Length = 323 |
| >gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 131 bits (332), Expect = 3e-34
Identities = 82/261 (31%), Positives = 128/261 (49%), Gaps = 47/261 (18%)
Query: 399 EKSTGQEYAVKIISRK-IDCSEEINLLRA------CQGH-PNIVNLHCVFQDEVHTYLVL 450
++STG +A+K++ + + ++ ++A QG P + L+ FQ + + YLV+
Sbjct: 17 KRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLYYSFQSKDYLYLVM 76
Query: 451 ELLKGGELLDRIRQKGRCGFTENEASRIMRQLVAAVHFMHSRGVVHRDLKPENLLFSDPA 510
E L GG+ I+ G G E+ A + + ++V V +H RG++HRD+KPENLL D
Sbjct: 77 EYLNGGDCASLIKTLG--GLPEDWAKQYIAEVVLGVEDLHQRGIIHRDIKPENLLI-DQT 133
Query: 511 GDNIKVVDFGFACLKRESLHTPCF--TLQYAAPEVLRQDKSGYDENCDLWSLGVILVNVL 568
G ++K+ DFG L R L F T Y APE + LGV
Sbjct: 134 G-HLKLTDFG---LSRNGLENKKFVGTPDYLAPETI---------------LGV------ 168
Query: 569 RQDKSGYDENCDLWSLGVILYTMLCGRVPFHARSRDDSALSIMARIKEGQFNFDAEAWST 628
G D+ D WSLG +++ L G PFHA + D ++ I + N+ E
Sbjct: 169 -----GDDKMSDWWSLGCVIFEFLFGYPPFHAETPD----AVFDNILSRRINWPEEVKEF 219
Query: 629 VSSEAKELTKSLLTVNPAQRI 649
S EA +L LL ++PA+R+
Sbjct: 220 CSPEAVDLINRLLCMDPAKRL 240
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260 |
| >gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 128 bits (324), Expect = 7e-33
Identities = 82/300 (27%), Positives = 124/300 (41%), Gaps = 62/300 (20%)
Query: 382 KAGILGDGSYSVCRRCVEKSTGQEYAVKIISRK----IDCS---EEINLLRACQGHPNIV 434
K G +G+G+Y V + +K TG+ A+K I + EI LL+ HPNI+
Sbjct: 3 KLGKIGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLK-ELNHPNII 61
Query: 435 NLHCVFQDEVHTYLVLELLKGGELLDRIRQKGRCGFTENEASRIMRQLVAAVHFMHSRGV 494
L VF+ + YLV E + L ++ + + G E+ + QL+ + F HS G+
Sbjct: 62 KLLDVFRHKGDLYLVFEFMD--TDLYKLIKDRQRGLPESLIKSYLYQLLQGLAFCHSHGI 119
Query: 495 VHRDLKPENLLFSDPAGDNIKVVDFGFACLKRES--LHTP-CFTLQYAAPEVLRQDKSGY 551
+HRDLKPENLL + +K+ DFG A +T T Y APE+L DK
Sbjct: 120 LHRDLKPENLLINTE--GVLKLADFGLARSFGSPVRPYTHYVVTRWYRAPELLLGDK--- 174
Query: 552 DENCDLWSLGVILVNVLRQDKSGYDENCDLWSLGVILYTMLCGRVPFHARSRDDS----- 606
GY D+WS+G I +L R F +S D
Sbjct: 175 ----------------------GYSTPVDIWSVGCIFAELLSRRPLFPGKSEIDQLFKIF 212
Query: 607 ------ALSIMARIKEGQ----FNFDAEA---WSTV----SSEAKELTKSLLTVNPAQRI 649
+ + F+F +A + S +A +L +L +P +RI
Sbjct: 213 RTLGTPDPEVWPKFTSLARNYKFSFPKKAGMPLPKLFPNASPQALDLLSQMLHYDPHKRI 272
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283 |
| >gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Score = 126 bits (318), Expect = 2e-32
Identities = 79/273 (28%), Positives = 114/273 (41%), Gaps = 46/273 (16%)
Query: 386 LGDGSYSVCRRCVEKSTGQEYAVKII-------SRKIDCSEEINLLRACQGHPNIVNLHC 438
LG GSY + S Q YA+K + + D EI +L + HPNI++
Sbjct: 8 LGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVN-HPNIISYKE 66
Query: 439 VFQDEVHTYLVLELLKGGELLDRI--RQKGRCGFTENEASRIMRQLVAAVHFMHSRGVVH 496
F D +V+E G+L I R+K R E E RI QL+ + +H + ++H
Sbjct: 67 AFLDGNKLCIVMEYAPFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALHEQKILH 126
Query: 497 RDLKPENLLFSDPAGDNIKVVDFGFA-CLKRESLHTPCFTLQYAAPEVLRQDKSGYDENC 555
RDLK N+L A D +K+ D G + LK+ T T Y APEV
Sbjct: 127 RDLKSANILLV--ANDLVKIGDLGISKVLKKNMAKTQIGTPHYMAPEV------------ 172
Query: 556 DLWSLGVILVNVLRQDKSGYDENCDLWSLGVILYTMLCGRVPFHARSRDDSALSIMARIK 615
W Y D+WSLG +LY M PF ARS D + +++
Sbjct: 173 --WK------------GRPYSYKSDIWSLGCLLYEMATFAPPFEARSMQD----LRYKVQ 214
Query: 616 EGQFNFDAEAWSTVSSEAKELTKSLLTVNPAQR 648
G++ S + + +S+L V P R
Sbjct: 215 RGKYP---PIPPIYSQDLQNFIRSMLQVKPKLR 244
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256 |
| >gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Score = 125 bits (315), Expect = 7e-32
Identities = 88/283 (31%), Positives = 131/283 (46%), Gaps = 55/283 (19%)
Query: 385 ILGDGSYSVCRRCVEKSTGQEYAVKIIS-RKIDCSE------EINLLRACQGHPNIVNLH 437
+G GS+ R+ KS G+ K I + E E+N+LR + HPNIV +
Sbjct: 7 TIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELK-HPNIVRYY 65
Query: 438 CVFQDEVHT--YLVLELLKGGELLDRIR--QKGRCGFTENEASRIMRQLVAAVHFMHSRG 493
D + Y+V+E +GG+L I+ +K R E RI+ QL+ A++ H+R
Sbjct: 66 DRIIDRSNQTLYIVMEYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHNRS 125
Query: 494 -----VVHRDLKPENLLFSDPAGDNIKVVDFGFA-CLKRESLHTPCF--TLQYAAPEVLR 545
V+HRDLKP N+ A +N+K+ DFG A L +S + T Y +PE L
Sbjct: 126 DPGNTVLHRDLKPANIFLD--ANNNVKLGDFGLAKILGHDSSFAKTYVGTPYYMSPEQLN 183
Query: 546 QDKSGYDENCDLWSLGVILVNVLRQDKSGYDENCDLWSLGVILYTMLCGRVPFHARSRDD 605
YDE D+WSLG ++Y + PF AR++
Sbjct: 184 HMS--------------------------YDEKSDIWSLGCLIYELCALSPPFTARNQ-- 215
Query: 606 SALSIMARIKEGQFNFDAEAWSTVSSEAKELTKSLLTVNPAQR 648
L + ++IKEG+F SSE E+ KS+L V+P +R
Sbjct: 216 --LQLASKIKEGKFR---RIPYRYSSELNEVIKSMLNVDPDKR 253
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265 |
| >gnl|CDD|173674 cd05583, STKc_MSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Score = 124 bits (314), Expect = 2e-31
Identities = 83/281 (29%), Positives = 138/281 (49%), Gaps = 48/281 (17%)
Query: 385 ILGDGSYS---VCRRCVEKSTGQEYAVKI-----ISRKIDCSE----EINLLRACQGHPN 432
+LG G+Y + R+ G+ YA+K+ I +K +E E +L A + P
Sbjct: 7 VLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVRRCPF 66
Query: 433 IVNLHCVFQDEVHTYLVLELLKGGELLDRIRQKGRCGFTENEASRIMRQLVAAVHFMHSR 492
+V LH FQ + +L+L+ + GGEL + Q+ FTE+E + ++V A+ +H
Sbjct: 67 LVTLHYAFQTDTKLHLILDYVNGGELFTHLYQREH--FTESEVRVYIAEIVLALDHLHQL 124
Query: 493 GVVHRDLKPENLLFSDPAGDNIKVVDFG----FACLKRESLHTPCFTLQYAAPEVLRQDK 548
G+++RD+K EN+L D G ++ + DFG F + E ++ C T++Y APEV+R
Sbjct: 125 GIIYRDIKLENILL-DSEG-HVVLTDFGLSKEFLAEEEERAYSFCGTIEYMAPEVIRGGS 182
Query: 549 SGYDENCDLWSLGVILVNVLRQDKSGYDENCDLWSLGVILYTMLCGRVPFHARSRDDSAL 608
G+D+ D W WSLGV+ + +L G PF +S
Sbjct: 183 GGHDKAVD-W-----------------------WSLGVLTFELLTGASPFTVDGEQNSQS 218
Query: 609 SIMARIKEGQFNFDAEAWSTVSSEAKELTKSLLTVNPAQRI 649
I RI + + F T+S+EA++ + LL +P +R+
Sbjct: 219 EISRRILKSKPPFP----KTMSAEARDFIQKLLEKDPKKRL 255
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines. This triggers phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) in the C-terminal extension of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSKs are predominantly nuclear proteins. They are widely expressed in many tissues including heart, brain, lung, liver, kidney, and pancreas. There are two isoforms of MSK, called MSK1 and MSK2. Length = 288 |
| >gnl|CDD|173677 cd05586, STKc_Sck1_like, Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 125 bits (314), Expect = 4e-31
Identities = 101/362 (27%), Positives = 159/362 (43%), Gaps = 63/362 (17%)
Query: 386 LGDGSYSVCRRCVEKSTGQEYAVKIISRKIDCSE--------EINLLR--ACQGHPNIVN 435
+G G++ + +K T + YA+K++S+K ++ E N+L P IV
Sbjct: 1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVG 60
Query: 436 LHCVFQDEVHTYLVLELLKGGELLDRIRQKGRCGFTENEASRIMRQLVAAVHFMHSRGVV 495
L FQ + YLV + + GGEL ++++GR F+E+ A + +LV A+ +H +V
Sbjct: 61 LKFSFQTDSDLYLVTDYMSGGELFWHLQKEGR--FSEDRAKFYIAELVLALEHLHKYDIV 118
Query: 496 HRDLKPENLLFSDPAGDNIKVVDFGFA---CLKRESLHTPCFTLQYAAPEVLRQDKSGYD 552
+RDLKPEN+L A +I + DFG + ++ +T C T +Y APEVL +K
Sbjct: 119 YRDLKPENILLD--ATGHIALCDFGLSKANLTDNKTTNTFCGTTEYLAPEVLLDEK---- 172
Query: 553 ENCDLWSLGVILVNVLRQDKSGYDENCDLWSLGVILYTMLCGRVPFHARSRDDSALSIMA 612
GY ++ D WSLGV+++ M CG PF+A M
Sbjct: 173 ---------------------GYTKHVDFWSLGVLVFEMCCGWSPFYAEDTQQ-----MY 206
Query: 613 R-IKEGQFNFDAEAWSTVSSEAKELTKSLLTVNPAQRIRMMR--VKLTFHAFHQAQKEGF 669
R I G+ F +S E ++ K LL NP R+ R V+L H F
Sbjct: 207 RNIAFGKVRFPKN---VLSDEGRQFVKGLLNRNPQHRLGAHRDAVELKEHPFFADID--- 260
Query: 670 RLQDVTSAKLAQRRKNKNVSNDNSRS-----FSSTSSSLSSSSSGTSSLKTPCSSTQPSV 724
D+ S K V +D S F+++S + P +++ P
Sbjct: 261 --WDLLSKKQITPPFKPIVDSDEDVSNFDPEFTNSSLLNAGIVPWEDVPGLPGANSTPLS 318
Query: 725 PS 726
S
Sbjct: 319 SS 320
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of yeast to environmental changes. Length = 330 |
| >gnl|CDD|173690 cd05599, STKc_NDR_like, Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 125 bits (317), Expect = 4e-31
Identities = 88/293 (30%), Positives = 140/293 (47%), Gaps = 43/293 (14%)
Query: 385 ILGDGSYSVCRRCVEKSTGQEYAVKIISRKIDCSE---------EINLLRACQGHPNIVN 435
++G G++ R +K TG YA+K + RK + E E ++L A +P +V
Sbjct: 8 VIGRGAFGEVRLVQKKDTGHIYAMKKL-RKSEMLEKEQVAHVRAERDIL-AEADNPWVVK 65
Query: 436 LHCVFQDEVHTYLVLELLKGGELLDRIRQKGRCGFTENEASRIMRQLVAAVHFMHSRGVV 495
L+ FQDE + YL++E L GG+++ + +K FTE E + + + A+ +H G +
Sbjct: 66 LYYSFQDENYLYLIMEYLPGGDMMTLLMKKDT--FTEEETRFYIAETILAIDSIHKLGYI 123
Query: 496 HRDLKPENLLFSDPAGDNIKVVDFGFACLKRESLHTPCF------TLQYAAPEVLRQDKS 549
HRD+KP+NLL D G +IK+ DFG C + H F L + + + S
Sbjct: 124 HRDIKPDNLLL-DAKG-HIKLSDFGL-CTGLKKSHRTEFYRILSHALPSNFLDFISKPMS 180
Query: 550 GYDENCDLW----------SLGV---ILVNVLRQDKSGYDENCDLWSLGVILYTMLCGRV 596
+ W ++G I V Q GY++ CD WSLGVI+Y ML G
Sbjct: 181 S-KRKAETWKRNRRALAYSTVGTPDYIAPEVFLQT--GYNKECDWWSLGVIMYEMLVGYP 237
Query: 597 PFHARSRDDSALSIMARIKEGQFNFDAEAWSTVSSEAKELTKSLLTVNPAQRI 649
PF + + ++ I+ + QF + +S EAK+L K L +R+
Sbjct: 238 PFCSDNPQETYRKIINWKETLQFPDEVP----LSPEAKDLIKRLCC-EAERRL 285
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplication. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. This subfamily also contains fungal NDR-like kinases. Length = 364 |
| >gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Score = 122 bits (308), Expect = 9e-31
Identities = 66/200 (33%), Positives = 102/200 (51%), Gaps = 23/200 (11%)
Query: 384 GILGDGSYSVCRRCVEKSTGQEYAVKIIS--RKIDCSE-----EINLLRACQGHPNIVNL 436
G +G+G++ + + ++ TG+ A+K ++ R EI L+ACQ HP +V L
Sbjct: 6 GRIGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQ-HPYVVKL 64
Query: 437 HCVFQDEVHTYLVLELLKGGELLDRIRQKGRCGFTENEASRIMRQLVAAVHFMHSRGVVH 496
VF LV+E + +L + +R + R E + MR L+ V +MH+ G++H
Sbjct: 65 LDVFPHGSGFVLVMEYM-PSDLSEVLRDEER-PLPEAQVKSYMRMLLKGVAYMHANGIMH 122
Query: 497 RDLKPENLLFSDPAGDNIKVVDFGFACL---KRESLHTP-CFTLQYAAPEVL---RQDKS 549
RDLKP NLL S +K+ DFG A L + L++ T Y APE+L R+
Sbjct: 123 RDLKPANLLISAD--GVLKIADFGLARLFSEEEPRLYSHQVATRWYRAPELLYGARK--- 177
Query: 550 GYDENCDLWSLGVILVNVLR 569
YD DLW++G I +L
Sbjct: 178 -YDPGVDLWAVGCIFAELLN 196
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286 |
| >gnl|CDD|173662 cd05571, STKc_PKB, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Score = 122 bits (309), Expect = 2e-30
Identities = 87/280 (31%), Positives = 136/280 (48%), Gaps = 58/280 (20%)
Query: 385 ILGDGSYSVCRRCVEKSTGQEYAVKIISRKIDCSE--------EINLLRACQGHPNIVNL 436
+LG G++ EK+TG+ YA+KI+ +++ ++ E +L+ + HP + L
Sbjct: 2 LLGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTR-HPFLTAL 60
Query: 437 HCVFQDEVHTYLVLELLKGGELLDRIRQKGRCG-FTENEASRIMRQLVAAVHFMHSRGVV 495
FQ V+E GGEL + R F+E+ A ++V+A+ ++HS VV
Sbjct: 61 KYSFQTHDRLCFVMEYANGGELFFHLS---RERVFSEDRARFYGAEIVSALGYLHSCDVV 117
Query: 496 HRDLKPENLLFSDPAGDNIKVVDFGFACLKRESL------HTPCFTLQYAAPEVLRQDKS 549
+RDLK ENL+ D G +IK+ DFG L +E + T C T +Y APEVL
Sbjct: 118 YRDLKLENLML-DKDG-HIKITDFG---LCKEGISDGATMKTFCGTPEYLAPEVL----- 167
Query: 550 GYDENCDLWSLGVILVNVLRQDKSGYDENCDLWSLGVILYTMLCGRVPFHARSRDDSALS 609
+ + Y D W LGV++Y M+CGR+PF+ ++D L
Sbjct: 168 ---------------------EDNDYGRAVDWWGLGVVMYEMMCGRLPFY--NQDHEKLF 204
Query: 610 IMARIKEGQFNFDAEAWSTVSSEAKELTKSLLTVNPAQRI 649
+ ++E +F T+S EAK L LL +P QR+
Sbjct: 205 ELILMEEIRFP------RTLSPEAKSLLAGLLKKDPKQRL 238
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having been implicated in tumor initiation, progression, and metastasis. Length = 323 |
| >gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Score = 121 bits (306), Expect = 2e-30
Identities = 75/278 (26%), Positives = 127/278 (45%), Gaps = 58/278 (20%)
Query: 386 LGDGSYSVCRRCVEKSTGQEYAVKIISRKIDCSE----EINLLRACQGHPNIVNLHCVFQ 441
+G+G+ + +++TG+E A+K + + E EI +++ C+ HPNIV+ + +
Sbjct: 27 IGEGASGEVYKATDRATGKEVAIKKMRLRKQNKELIINEILIMKDCK-HPNIVDYYDSYL 85
Query: 442 DEVHTYLVLELLKGGELLDRIRQKGRCGFTENEASRIMRQLVAAVHFMHSRGVVHRDLKP 501
++V+E + GG L D I Q E + + + R+++ + ++HS+ V+HRD+K
Sbjct: 86 VGDELWVVMEYMDGGSLTDIITQNFVR-MNEPQIAYVCREVLQGLEYLHSQNVIHRDIKS 144
Query: 502 EN-LLFSDPAGDNIKVVDFGFAC------LKRESL-HTPCFTLQYAAPEVLRQDKSGYDE 553
+N LL D G +K+ DFGFA KR S+ TP + APEV
Sbjct: 145 DNILLSKD--GS-VKLADFGFAAQLTKEKSKRNSVVGTPYWM----APEV---------- 187
Query: 554 NCDLWSLGVILVNVLRQDKSGYDENCDLWSLGVILYTMLCGRVPFHARSRDDSALSIMAR 613
+ R+D Y D+WSLG++ M G P+ + L +
Sbjct: 188 -------------IKRKD---YGPKVDIWSLGIMCIEMAEGEPPYL----REPPLRALFL 227
Query: 614 I-KEG--QFNFDAEAWSTVSSEAKELTKSLLTVNPAQR 648
I +G + E W S E K+ L +P +R
Sbjct: 228 ITTKGIPPLK-NPEKW---SPEFKDFLNKCLVKDPEKR 261
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286 |
| >gnl|CDD|173681 cd05590, STKc_nPKC_eta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Score = 120 bits (302), Expect = 1e-29
Identities = 80/280 (28%), Positives = 133/280 (47%), Gaps = 57/280 (20%)
Query: 385 ILGDGSYSVCRRCVEKSTGQEYAVKIISRKI-------DCS-EEINLLRACQGHPNIVNL 436
+LG GS+ K +G+ YAVK++ + + +C+ E +L + HP + L
Sbjct: 2 VLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQL 61
Query: 437 HCVFQDEVHTYLVLELLKGGELLDRIRQKGRCGFTENEASRIMRQLVAAVHFMHSRGVVH 496
+C FQ + V+E + GG+L+ I++ R F E A ++ +A+ F+H +G+++
Sbjct: 62 YCCFQTPDRLFFVMEFVNGGDLMFHIQKSRR--FDEARARFYAAEITSALMFLHDKGIIY 119
Query: 497 RDLKPENLLFSDPAGDNIKVVDFGFACLKRESLH------TPCFTLQYAAPEVLRQDKSG 550
RDLK +N+L D G + K+ DFG +E + T C T Y APE+L++ G
Sbjct: 120 RDLKLDNVLL-DHEG-HCKLADFGMC---KEGIFNGKTTSTFCGTPDYIAPEILQEMLYG 174
Query: 551 YDENCDLWSLGVILVNVLRQDKSGYDENCDLWSLGVILYTMLCGRVPFHARSRDDSALSI 610
D W++GV+LY MLCG PF A + DD +I
Sbjct: 175 PS--------------------------VDWWAMGVLLYEMLCGHAPFEAENEDDLFEAI 208
Query: 611 MARIKEGQFNFDAEAWST-VSSEAKELTKSLLTVNPAQRI 649
+ D + T +S +A ++ K+ +T NP R+
Sbjct: 209 LN---------DEVVYPTWLSQDAVDILKAFMTKNPTMRL 239
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signaling of cell-type specific differentiation. It is also expressed in pro-B cells and early-stage thymocytes, and acts as a key regulator in early B-cell development. PKC-eta increases glioblastoma multiforme (GBM) proliferation and resistance to radiation, and is being developed as a therapeutic target for the management of GBM. Length = 320 |
| >gnl|CDD|173683 cd05592, STKc_nPKC_theta_delta, Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Score = 119 bits (301), Expect = 1e-29
Identities = 81/278 (29%), Positives = 126/278 (45%), Gaps = 49/278 (17%)
Query: 385 ILGDGSYSVCRRCVEKSTGQEYAVKIISRK-------IDCSE-EINLLRACQGHPNIVNL 436
+LG GS+ K T + +A+K + + ++C+ E +L HP + +L
Sbjct: 2 VLGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTHL 61
Query: 437 HCVFQDEVHTYLVLELLKGGELLDRIRQKGRCGFTENEASRIMRQLVAAVHFMHSRGVVH 496
C FQ + H + V+E L GG+L+ I+ GR F E A +++ + F+H +G+++
Sbjct: 62 FCTFQTKEHLFFVMEYLNGGDLMFHIQSSGR--FDEARARFYAAEIICGLQFLHKKGIIY 119
Query: 497 RDLKPENLLFSDPAGDNIKVVDFGFA---CLKRESLHTPCFTLQYAAPEVLRQDKSGYDE 553
RDLK +N+L D G +IK+ DFG T C T Y APE+L+ K
Sbjct: 120 RDLKLDNVLL-DKDG-HIKIADFGMCKENMNGEGKASTFCGTPDYIAPEILKGQK----- 172
Query: 554 NCDLWSLGVILVNVLRQDKSGYDENCDLWSLGVILYTMLCGRVPFHARSRDDSALSIMAR 613
Y+E+ D WS GV+LY ML G+ PFH D+ SI
Sbjct: 173 ---------------------YNESVDWWSFGVLLYEMLIGQSPFHGEDEDELFDSI--L 209
Query: 614 IKEGQFNFDAEAWSTVSSEAKELTKSLLTVNPAQRIRM 651
F +S EAK+ L +P +R+ +
Sbjct: 210 NDRPHFP------RWISKEAKDCLSKLFERDPTKRLGV 241
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. Length = 316 |
| >gnl|CDD|173682 cd05591, STKc_nPKC_epsilon, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Score = 118 bits (298), Expect = 4e-29
Identities = 80/276 (28%), Positives = 130/276 (47%), Gaps = 49/276 (17%)
Query: 385 ILGDGSYSVCRRCVEKSTGQEYAVKIISRK-------IDCS-EEINLLRACQGHPNIVNL 436
+LG GS+ K T + YA+K++ + +DC+ E +L HP + L
Sbjct: 2 VLGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTAL 61
Query: 437 HCVFQDEVHTYLVLELLKGGELLDRIRQKGRCGFTENEASRIMRQLVAAVHFMHSRGVVH 496
HC FQ + + V+E + GG+L+ +I Q+ R F E + ++ A+ F+H GV++
Sbjct: 62 HCCFQTKDRLFFVMEYVNGGDLMFQI-QRSR-KFDEPRSRFYAAEVTLALMFLHRHGVIY 119
Query: 497 RDLKPENLLFSDPAGDNIKVVDFGF---ACLKRESLHTPCFTLQYAAPEVLRQDKSGYDE 553
RDLK +N+L A + K+ DFG L + T C T Y APE+L++ +
Sbjct: 120 RDLKLDNILLD--AEGHCKLADFGMCKEGILNGVTTTTFCGTPDYIAPEILQELE----- 172
Query: 554 NCDLWSLGVILVNVLRQDKSGYDENCDLWSLGVILYTMLCGRVPFHARSRDDSALSIMAR 613
Y + D W+LGV++Y M+ G+ PF A + DD SI+
Sbjct: 173 ---------------------YGPSVDWWALGVLMYEMMAGQPPFEADNEDDLFESIL-- 209
Query: 614 IKEGQFNFDAEAWSTVSSEAKELTKSLLTVNPAQRI 649
+ D +S EA + K+ +T NP +R+
Sbjct: 210 ------HDDVLYPVWLSKEAVSILKAFMTKNPNKRL 239
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to neoplastic transformation depending on the cell type. It contributes to oncogenesis by inducing disordered cell growth and inhibiting cell death. It also plays a role in tumor invasion and metastasis. PKC-epsilon has also been found to confer cardioprotection against ischemia and reperfusion-mediated damage. Other cellular functions include the regulation of gene expression, cell adhesion, and cell motility. Length = 321 |
| >gnl|CDD|173665 cd05574, STKc_phototropin_like, Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 118 bits (298), Expect = 5e-29
Identities = 75/312 (24%), Positives = 124/312 (39%), Gaps = 75/312 (24%)
Query: 378 MDLDKAGILGDGSYSVCRRCVEKSTGQEYAVKIISRK-IDCSEEINLLRACQG------H 430
K +LG G K TG+ +A+K++ +K + ++ + Q H
Sbjct: 1 KHFKKIKLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDH 60
Query: 431 PNIVNLHCVFQDEVHTYLVLELLKGGELLD-RIRQKGRCGFTENEASRIMRQLVAAVHFM 489
P + L+ FQ E + LV++ GGEL RQ G+C +E A +++ A+ ++
Sbjct: 61 PFLPTLYASFQTETYLCLVMDYCPGGELFRLLQRQPGKC-LSEEVARFYAAEVLLALEYL 119
Query: 490 HSRGVVHRDLKPENLLFSDPAGDNIKVVDFGFACLKRESLHTPCFTL------------- 536
H G+V+RDLKPEN+L +I + DF + L
Sbjct: 120 HLLGIVYRDLKPENILLH--ESGHIMLSDFDLSKQSDVEPPPVSKALRKGSRRSSVNSIP 177
Query: 537 -------------------QYAAPEVLRQDKSGYDENCDLWSLGVILVNVLRQDKSGYDE 577
+Y APEV+ G+
Sbjct: 178 SETFSEEPSFRSNSFVGTEEYIAPEVIS--------------------------GDGHGS 211
Query: 578 NCDLWSLGVILYTMLCGRVPFHARSRDDSALSIMARIKEGQFNFDAEAWSTVSSEAKELT 637
D W+LG++LY ML G PF +RD++ + I + + F VSS A++L
Sbjct: 212 AVDWWTLGILLYEMLYGTTPFKGSNRDET----FSNILKKEVTFPGSP--PVSSSARDLI 265
Query: 638 KSLLTVNPAQRI 649
+ LL +P++R+
Sbjct: 266 RKLLVKDPSKRL 277
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-terminal photosensory domain and a C-terminal catalytic domain. The N-terminal domain contains two LOV (Light, Oxygen or Voltage) domains that binds FMN. Photoexcitation of the LOV domains results in autophosphorylation at multiple sites and activation of the catalytic domain. Neurospora crassa nrc-2 plays a role in growth and development by controlling entry into the conidiation program. Length = 316 |
| >gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Score = 116 bits (294), Expect = 5e-29
Identities = 63/198 (31%), Positives = 101/198 (51%), Gaps = 19/198 (9%)
Query: 379 DLDKAGILGDGSYSVCRRCVEKSTGQEYAVKIISRKIDCSE------EINLLRACQGHPN 432
DL++ +LG GS V + K TG+ YA+K I D E+ LR+C+ P
Sbjct: 2 DLERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRKQLLRELKTLRSCE-SPY 60
Query: 433 IVNLHCVFQDEVHTYLVLELLKGGELLDRIRQKGRCGFTENEASRIMRQLVAAVHFMHS- 491
+V + F E +VLE + GG L D +++ G E + I RQ++ + ++H+
Sbjct: 61 VVKCYGAFYKEGEISIVLEYMDGGSLADLLKKVG--KIPEPVLAYIARQILKGLDYLHTK 118
Query: 492 RGVVHRDLKPENLLFSDPAGDNIKVVDFGFACLKRESLHTPCF----TLQYAAPEVLRQD 547
R ++HRD+KP NLL + G +K+ DFG E+ C T+ Y +PE ++ +
Sbjct: 119 RHIIHRDIKPSNLLINS-KG-EVKIADFG-ISKVLENTLDQCNTFVGTVTYMSPERIQGE 175
Query: 548 KSGYDENCDLWSLGVILV 565
Y D+WSLG+ L+
Sbjct: 176 SYSYA--ADIWSLGLTLL 191
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264 |
| >gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Score = 116 bits (293), Expect = 5e-29
Identities = 60/192 (31%), Positives = 99/192 (51%), Gaps = 26/192 (13%)
Query: 384 GILGDGSY-SVCRRCVEKSTGQEYAVKIISRKIDCSE---EINLLRACQGHPNIVNLHCV 439
LG+GSY SV + + K TGQ A+K++ + D E EI++L+ C P IV +
Sbjct: 9 EKLGEGSYGSVYK-AIHKETGQVVAIKVVPVEEDLQEIIKEISILKQCD-SPYIVKYYGS 66
Query: 440 FQDEVHTYLVLELLKGGELLD--RIRQKGRCGFTENEASRIMRQLVAAVHFMHSRGVVHR 497
+ ++V+E G + D +I K TE E + I+ Q + + ++HS +HR
Sbjct: 67 YFKNTDLWIVMEYCGAGSVSDIMKITNKT---LTEEEIAAILYQTLKGLEYLHSNKKIHR 123
Query: 498 DLKPENLLFSDPAGDNIKVVDFGFAC------LKRESL-HTPCFTLQYAAPEVLRQDKSG 550
D+K N+L ++ K+ DFG + KR ++ TP + APEV++ + G
Sbjct: 124 DIKAGNILLNEEG--QAKLADFGVSGQLTDTMAKRNTVIGTPF----WMAPEVIQ--EIG 175
Query: 551 YDENCDLWSLGV 562
Y+ D+WSLG+
Sbjct: 176 YNNKADIWSLGI 187
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256 |
| >gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 114 bits (288), Expect = 2e-28
Identities = 53/188 (28%), Positives = 92/188 (48%), Gaps = 19/188 (10%)
Query: 385 ILGDGSYSVCRRCVEKSTGQEYAVKIISRKI-------DCSEEINLLRACQGHPNIVNLH 437
++G G++ V + + TG A+K IS + +EI+LL+ + HPNIV
Sbjct: 7 LIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLK-HPNIVKYI 65
Query: 438 CVFQDEVHTYLVLELLKGGELLDRIRQKGRCGFTENEASRIMRQLVAAVHFMHSRGVVHR 497
+ Y++LE + G L I++ G E+ + + Q++ + ++H +GV+HR
Sbjct: 66 GSIETSDSLYIILEYAENGSLRQIIKKFGPFP--ESLVAVYVYQVLQGLAYLHEQGVIHR 123
Query: 498 DLKPENLLFSDPAGDNIKVVDFGFACLKRESLHTPCFTLQ----YAAPEVLRQDKSGYDE 553
D+K N+L + +K+ DFG A K + ++ + APEV+ SG
Sbjct: 124 DIKAANILTT--KDGVVKLADFGVA-TKLNDVSKDDASVVGTPYWMAPEVIEM--SGAST 178
Query: 554 NCDLWSLG 561
D+WSLG
Sbjct: 179 ASDIWSLG 186
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254 |
| >gnl|CDD|173704 cd05613, STKc_MSK1_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Score = 115 bits (289), Expect = 3e-28
Identities = 79/281 (28%), Positives = 137/281 (48%), Gaps = 48/281 (17%)
Query: 385 ILGDGSYS---VCRRCVEKSTGQEYAVKI-----ISRKIDCSE----EINLLRACQGHPN 432
+LG G+Y + R+ +G+ YA+K+ I +K +E E +L + P
Sbjct: 7 VLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPF 66
Query: 433 IVNLHCVFQDEVHTYLVLELLKGGELLDRIRQKGRCGFTENEASRIMRQLVAAVHFMHSR 492
+V LH FQ + +L+L+ + GGEL + Q+ R F E E ++V A+ +H
Sbjct: 67 LVTLHYAFQTDTKLHLILDYINGGELFTHLSQRER--FKEQEVQIYSGEIVLALEHLHKL 124
Query: 493 GVVHRDLKPENLLFSDPAGDNIKVVDFG----FACLKRESLHTPCFTLQYAAPEVLRQDK 548
G+++RD+K EN+L D G ++ + DFG F + E ++ C T++Y AP+++R
Sbjct: 125 GIIYRDIKLENILL-DSNG-HVVLTDFGLSKEFHEDEVERAYSFCGTIEYMAPDIVRGGD 182
Query: 549 SGYDENCDLWSLGVILVNVLRQDKSGYDENCDLWSLGVILYTMLCGRVPFHARSRDDSAL 608
G+D+ D W WS+GV++Y +L G PF +S
Sbjct: 183 GGHDKAVD-W-----------------------WSMGVLMYELLTGASPFTVDGEKNSQA 218
Query: 609 SIMARIKEGQFNFDAEAWSTVSSEAKELTKSLLTVNPAQRI 649
I RI + + + E +S+ AK++ + LL +P +R+
Sbjct: 219 EISRRILKSEPPYPQE----MSALAKDIIQRLLMKDPKKRL 255
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK1 plays a role in the regulation of translational control and transcriptional activation. It phosphorylates the transcription factors, CREB and NFkappaB. It also phosphorylates the nucleosomal proteins H3 and HMG-14. Increased phosphorylation of MEK1 is associated with the development of cerebral ischemic/hypoxic preconditioning. Length = 290 |
| >gnl|CDD|173678 cd05587, STKc_cPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Score = 115 bits (290), Expect = 5e-28
Identities = 83/279 (29%), Positives = 132/279 (47%), Gaps = 55/279 (19%)
Query: 385 ILGDGSYSVCRRCVEKSTGQEYAVKIISRKI-------DCSEEINLLRACQGHPN-IVNL 436
+LG GS+ K T + YA+KI+ + + +C+ + A G P + L
Sbjct: 7 VLGKGSFGKVMLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLTQL 66
Query: 437 HCVFQDEVHTYLVLELLKGGELLDRIRQKGRCGFTENEASRIMRQLVAAVHFMHSRGVVH 496
H FQ Y V+E + GG+L+ I+Q G+ F E A ++ + F+HS+G+++
Sbjct: 67 HSCFQTMDRLYFVMEYVNGGDLMYHIQQVGK--FKEPHAVFYAAEIAIGLFFLHSKGIIY 124
Query: 497 RDLKPENLLFSDPAGDNIKVVDFGFACLKRESL------HTPCFTLQYAAPEVLRQDKSG 550
RDLK +N++ D G +IK+ DFG C +E++ T C T Y APE+
Sbjct: 125 RDLKLDNVML-DAEG-HIKIADFGM-C--KENIFGGKTTRTFCGTPDYIAPEI------- 172
Query: 551 YDENCDLWSLGVILVNVLRQDKSGYDENCDLWSLGVILYTMLCGRVPFHARSRDDSALSI 610
+ Q Y ++ D W+ GV+LY ML G+ PF D+ SI
Sbjct: 173 ----------------IAYQP---YGKSVDWWAFGVLLYEMLAGQPPFDGEDEDELFQSI 213
Query: 611 MARIKEGQFNFDAEAWSTVSSEAKELTKSLLTVNPAQRI 649
M E ++ ++S EA + K LLT +PA+R+
Sbjct: 214 M----EHNVSYP----KSLSKEAVSICKGLLTKHPAKRL 244
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory domain. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. cPKCs are potent kinases for histones, myelin basic protein, and protamine. PKC-gamma is mainly expressed in neuronal tissues. It plays a role in protection from ischemia. Length = 324 |
| >gnl|CDD|173687 cd05596, STKc_ROCK, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Score = 115 bits (290), Expect = 1e-27
Identities = 87/278 (31%), Positives = 135/278 (48%), Gaps = 48/278 (17%)
Query: 379 DLDKAGILGDGSYSVCRRCVEKSTGQEYAVKIISR-----KIDCS---EEINLLRACQGH 430
D D ++G G++ + KS+ Q YA+K++S+ + D + EE +++ A
Sbjct: 44 DFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEERDIM-AHANS 102
Query: 431 PNIVNLHCVFQDEVHTYLVLELLKGGELLDRIRQKGRCGFTENEASRIMRQLVAAVHFMH 490
IV LH FQD+ + Y+V+E + GG+L++ + E A ++V A+ +H
Sbjct: 103 EWIVQLHYAFQDDKYLYMVMEYMPGGDLVNLM---SNYDIPEKWARFYTAEVVLALDAIH 159
Query: 491 SRGVVHRDLKPENLLFSDPAGDNIKVVDFGFACLKRES-----LHTPCFTLQYAAPEVLR 545
S G +HRD+KP+N+L D +G ++K+ DFG C+K ++ T T Y +PEVL+
Sbjct: 160 SMGFIHRDVKPDNMLL-DKSG-HLKLADFG-TCMKMDANGMVRCDTAVGTPDYISPEVLK 216
Query: 546 -QDKSGYDENCDLWSLGVILVNVLRQDKSGYDENCDLWSLGVILYTMLCGRVPFHARSRD 604
Q GY Y CD WS+GV LY ML G PF+A S
Sbjct: 217 SQGGDGY-----------------------YGRECDWWSVGVFLYEMLVGDTPFYADSLV 253
Query: 605 DSALSIMARIKEGQFNFDAEAWSTVSSEAKELTKSLLT 642
+ IM F D E +S +AK+L + LT
Sbjct: 254 GTYSKIMDHKNSLTFPDDIE----ISKQAKDLICAFLT 287
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via interaction with Rho GTPases and is involved in many cellular functions including contraction, adhesion, migration, motility, proliferation, and apoptosis. The ROCK subfamily consists of two isoforms, ROCK1 and ROCK2, which may be functionally redundant in some systems, but exhibit different tissue distributions. Both isoforms are ubiquitously expressed in most tissues, but ROCK2 is more prominent in brain and skeletal muscle while ROCK1 is more pronounced in the liver, testes, and kidney. Studies in knockout mice result in different phenotypes, suggesting that the two isoforms do not compensate for each other during embryonic development. Length = 370 |
| >gnl|CDD|173686 cd05595, STKc_PKB_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Score = 113 bits (285), Expect = 2e-27
Identities = 99/328 (30%), Positives = 148/328 (45%), Gaps = 61/328 (18%)
Query: 385 ILGDGSYSVCRRCVEKSTGQEYAVKIISRKI-----DCSEEINLLRACQG--HPNIVNLH 437
+LG G++ EK+TG+ YA+KI+ +++ + + + R Q HP + L
Sbjct: 2 LLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALK 61
Query: 438 CVFQDEVHTYLVLELLKGGEL---LDRIRQKGRCGFTENEASRIMRQLVAAVHFMHSRGV 494
FQ V+E GGEL L R R FTE A ++V+A+ ++HSR V
Sbjct: 62 YAFQTHDRLCFVMEYANGGELFFHLSRERV-----FTEERARFYGAEIVSALEYLHSRDV 116
Query: 495 VHRDLKPENLLFSDPAGDNIKVVDFGF---ACLKRESLHTPCFTLQYAAPEVLRQDKSGY 551
V+RD+K ENL+ D G +IK+ DFG ++ T C T +Y APEVL +
Sbjct: 117 VYRDIKLENLML-DKDG-HIKITDFGLCKEGISDGATMKTFCGTPEYLAPEVLEDND--- 171
Query: 552 DENCDLWSLGVILVNVLRQDKSGYDENCDLWSLGVILYTMLCGRVPFHARSRDDSALSIM 611
Y D W LGV++Y M+CGR+PF+ ++D L +
Sbjct: 172 -----------------------YGRAVDWWGLGVVMYEMMCGRLPFY--NQDHERLFEL 206
Query: 612 ARIKEGQFNFDAEAWSTVSSEAKELTKSLLTVNPAQRI---RMMRVKLTFHAFHQAQKEG 668
++E +F T+S EAK L LL +P QR+ ++ H F
Sbjct: 207 ILMEEIRFP------RTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEHRFFL----S 256
Query: 669 FRLQDVTSAKLAQRRKNKNVSNDNSRSF 696
QDV KL K + S ++R F
Sbjct: 257 INWQDVVQKKLLPPFKPQVTSEVDTRYF 284
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in PKB-beta display normal growth weights but exhibit severe insulin resistance and diabetes, accompanied by lipoatrophy and B-cell failure. Length = 323 |
| >gnl|CDD|173725 cd06608, STKc_myosinIII_like, Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 112 bits (283), Expect = 2e-27
Identities = 63/201 (31%), Positives = 102/201 (50%), Gaps = 30/201 (14%)
Query: 385 ILGDGSYSVCRRCVEKSTGQEYAVKIIS----RKIDCSEEINLLRACQGHPNIVNLHCVF 440
++G+G+Y + K TGQ A+KI+ + + EE N+LR HPNI + F
Sbjct: 13 VIGEGTYGKVYKARHKKTGQLVAIKIMDIIEDEEEEIKEEYNILRKYSNHPNIATFYGAF 72
Query: 441 QDEVHT------YLVLELLKGG---ELLDRIRQKGRCGFTENEASRIMRQLVAAVHFMHS 491
+ +LV+EL GG +L+ +R+KG+ E + I+R+ + + ++H
Sbjct: 73 IKKNPPGNDDQLWLVMELCGGGSVTDLVKGLRKKGK-RLKEEWIAYILRETLRGLAYLHE 131
Query: 492 RGVVHRDLKPENLLFSDPAGDNIKVVDFGF-ACLKRE------SLHTPCFTLQYAAPEVL 544
V+HRD+K +N+L + A +K+VDFG A L + TP + APEV+
Sbjct: 132 NKVIHRDIKGQNILLTKNAE--VKLVDFGVSAQLDSTLGRRNTFIGTPY----WMAPEVI 185
Query: 545 ---RQDKSGYDENCDLWSLGV 562
Q + YD D+WSLG+
Sbjct: 186 ACDEQPDASYDARSDVWSLGI 206
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin III may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. It may also function as a cargo carrier during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. The Drosophila class III myosin, called NinaC (Neither inactivation nor afterpotential protein C), is critical in normal adaptation and termination of photoresponse. Vertebrates contain two isoforms of class III myosin, IIIA and IIIB. This subfamily also includes mammalian NIK-like embryo-specific kinase (NESK), Traf2- and Nck-interacting kinase (TNIK), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6). MAP4Ks are involved in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Length = 275 |
| >gnl|CDD|173680 cd05589, STKc_PKN, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Score = 113 bits (285), Expect = 2e-27
Identities = 43/92 (46%), Positives = 56/92 (60%)
Query: 266 ILKTEPPIPEDLSPDVADFISRLLVKDPRRRLGGGELDAEELKRHPFFNVIDWDDLATKR 325
I+ E P LS + + RLL ++P RRLG GE DAE++K+ PFF I+WDDL ++
Sbjct: 213 IVNDEVRYPRFLSREAISIMRRLLRRNPERRLGSGEKDAEDVKKQPFFRDINWDDLLARK 272
Query: 326 IPAPFVPKISNELDVSNFSDEFTKMIPADSPA 357
I PFVP I DVSNF +EFT P +P
Sbjct: 273 IKPPFVPTIKGPEDVSNFDEEFTSEAPVLTPP 304
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved in many biological processes including cytokeletal regulation, cell adhesion, vesicle transport, glucose transport, regulation of meiotic maturation and embryonic cell cycles, signaling to the nucleus, and tumorigenesis. Length = 324 |
| >gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 111 bits (280), Expect = 6e-27
Identities = 65/199 (32%), Positives = 101/199 (50%), Gaps = 31/199 (15%)
Query: 384 GILGDGSYSVCRRCVEKSTGQEYAVK---------IISRKIDCSEEINLLRACQGHPNIV 434
G++G+G+Y V +C K+TG+ A+K + + E+ +LR + H NIV
Sbjct: 7 GVVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTA--LREVKVLRQLR-HENIV 63
Query: 435 NLHCVFQDEVHTYLVLE-----LLKGGELLDRIRQKGRCGFTENEASRIMRQLVAAVHFM 489
NL F+ + YLV E LL ELL+ G + + QL+ A+ +
Sbjct: 64 NLKEAFRRKGRLYLVFEYVERTLL---ELLEASPG----GLPPDAVRSYIWQLLQAIAYC 116
Query: 490 HSRGVVHRDLKPENLLFSDPAGDNIKVVDFGFACLKRESLHTPC----FTLQYAAPEVLR 545
HS ++HRD+KPEN+L S+ +K+ DFGFA R +P T Y APE+L
Sbjct: 117 HSHNIIHRDIKPENILVSE--SGVLKLCDFGFARALRARPASPLTDYVATRWYRAPELLV 174
Query: 546 QDKSGYDENCDLWSLGVIL 564
D + Y + D+W++G I+
Sbjct: 175 GDTN-YGKPVDVWAIGCIM 192
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288 |
| >gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Score = 110 bits (278), Expect = 7e-27
Identities = 58/233 (24%), Positives = 100/233 (42%), Gaps = 47/233 (20%)
Query: 386 LGDGSYSVCRRCVEKSTGQEYAVKIISRKIDCSEEINLLR-------ACQGHPNIVNLHC 438
+G G+ +V + ++ A+K I + C ++ LR C HPN+V +
Sbjct: 9 IGVGATAVVYAAICLPNNEKVAIKRIDLE-KCQTSVDELRKEVQAMSQCN-HPNVVKYYT 66
Query: 439 VFQDEVHTYLVLELLKGGELLDRIRQKGRCG-FTENEASRIMRQLVAAVHFMHSRGVVHR 497
F +LV+ L GG LLD ++ G E + ++++++ + ++HS G +HR
Sbjct: 67 SFVVGDELWLVMPYLSGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYLHSNGQIHR 126
Query: 498 DLKPENLLFSDPAGDNIKVVDFGFA-------CLKRESLH----TPCFTLQYAAPEVLRQ 546
D+K N+L + +K+ DFG + R+ TPC + APEV+ Q
Sbjct: 127 DIKAGNILLGEDGS--VKIADFGVSASLADGGDRTRKVRKTFVGTPC----WMAPEVMEQ 180
Query: 547 DKSGYDENCDLWSLGV-------------------ILVNVLRQDKSGYDENCD 580
GYD D+WS G+ +L+ L+ D + D
Sbjct: 181 VH-GYDFKADIWSFGITAIELATGAAPYSKYPPMKVLMLTLQNDPPSLETGAD 232
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267 |
| >gnl|CDD|173711 cd05621, STKc_ROCK2, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Score = 113 bits (283), Expect = 7e-27
Identities = 87/294 (29%), Positives = 139/294 (47%), Gaps = 48/294 (16%)
Query: 363 FDKIFKGSLFFEQYDMDLDKAGILGDGSYSVCRRCVEKSTGQEYAVKIISR-----KIDC 417
++KI + + D D ++G G++ + KS+ + YA+K++S+ + D
Sbjct: 28 YEKIVRKIRKLQMKAEDYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDS 87
Query: 418 S---EEINLLRACQGHPNIVNLHCVFQDEVHTYLVLELLKGGELLDRIRQKGRCGFTENE 474
+ EE +++ A P +V L C FQD+ + Y+V+E + GG+L++ + E
Sbjct: 88 AFFWEERDIM-AFANSPWVVQLFCAFQDDKYLYMVMEYMPGGDLVNLMSNYD---VPEKW 143
Query: 475 ASRIMRQLVAAVHFMHSRGVVHRDLKPENLLFSDPAGDNIKVVDFGFACLKRESL----- 529
A ++V A+ +HS G++HRD+KP+N+L D G ++K+ DFG C+K +
Sbjct: 144 AKFYTAEVVLALDAIHSMGLIHRDVKPDNMLL-DKHG-HLKLADFG-TCMKMDETGMVRC 200
Query: 530 HTPCFTLQYAAPEVLR-QDKSGYDENCDLWSLGVILVNVLRQDKSGYDENCDLWSLGVIL 588
T T Y +PEVL+ Q GY Y CD WS+GV L
Sbjct: 201 DTAVGTPDYISPEVLKSQGGDGY-----------------------YGRECDWWSVGVFL 237
Query: 589 YTMLCGRVPFHARSRDDSALSIMARIKEGQFNFDAEAWSTVSSEAKELTKSLLT 642
+ ML G PF+A S + IM F D E +S AK L + LT
Sbjct: 238 FEMLVGDTPFYADSLVGTYSKIMDHKNSLNFPEDVE----ISKHAKNLICAFLT 287
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found to play a role in stress fiber and focal adhesion formation. It is prominently expressed in the brain, heart, and skeletal muscles. It is implicated in vascular and neurological disorders, such as hypertension and vasospasm of the coronary and cerebral arteries. ROCK2 is also activated by caspase-2 cleavage, resulting in thrombin-induced microparticle generation in response to cell activation. Mice deficient in ROCK2 show intrauterine growth retardation and embryonic lethality because of placental dysfunction. Length = 370 |
| >gnl|CDD|173688 cd05597, STKc_DMPK_like, Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 111 bits (280), Expect = 1e-26
Identities = 90/284 (31%), Positives = 137/284 (48%), Gaps = 58/284 (20%)
Query: 379 DLDKAGILGDGSYSVCRRCVEKSTGQEYAVKIISR-------KIDC-SEEINLLRACQGH 430
D + ++G G++ K+TGQ YA+KI+++ + C EE ++L G
Sbjct: 2 DFEILKVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDVL--VNGD 59
Query: 431 PN-IVNLHCVFQDEVHTYLVLELLKGGELL-------DRIRQKGRCGFTENEASRIMRQL 482
I NLH FQDE + YLV++ GG+LL DR+ E+ A + ++
Sbjct: 60 RRWITNLHYAFQDENNLYLVMDYYVGGDLLTLLSKFEDRL--------PEDMARFYLAEM 111
Query: 483 VAAVHFMHSRGVVHRDLKPENLLFSDPAGDNIKVVDFGFACLKRESLHT-----PCFTLQ 537
V A+ +H G VHRD+KP+N+L D G +I++ DFG +CL+ + T T
Sbjct: 112 VLAIDSVHQLGYVHRDIKPDNVLL-DKNG-HIRLADFG-SCLRLLADGTVQSNVAVGTPD 168
Query: 538 YAAPEVLRQDKSGYDENCDLWSLGVILVNVLRQDKSGYDENCDLWSLGVILYTMLCGRVP 597
Y +PE+L+ + G K Y CD WSLGV +Y ML G P
Sbjct: 169 YISPEILQAMEDG---------------------KGRYGPECDWWSLGVCMYEMLYGETP 207
Query: 598 FHARSRDDSALSIMARIKEGQFNFDAEAWSTVSSEAKELTKSLL 641
F+A S ++ IM + F F + + VS EAK+L + L+
Sbjct: 208 FYAESLVETYGKIMNH--KEHFQFPPDV-TDVSEEAKDLIRRLI 248
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, and cardiac conduction defects. The genetic basis for DM1 is the mutational expansion of a CTG repeat in the 3'-UTR of DMPK. DMPK is expressed in skeletal and cardiac muscles, and in central nervous tissues. The functional role of DMPK is not fully understood. It may play a role in the signal transduction and homeostasis of calcium. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKgamma is expressed in heart and skeletal muscles, unlike MRCKalpha and MRCKbeta, which are expressed ubiquitously. Length = 331 |
| >gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 110 bits (276), Expect = 1e-26
Identities = 59/191 (30%), Positives = 97/191 (50%), Gaps = 27/191 (14%)
Query: 386 LGDGSYSVCRRCVEKSTGQEYAVKIISRKIDCSE--------EINLLRACQGHPNIVNLH 437
+G GS+ + ++K T Q A+K+I ++ +E EI L C+ P I +
Sbjct: 9 IGKGSFGEVYKAIDKRTNQVVAIKVID--LEEAEDEIEDIQQEIQFLSQCRS-PYITKYY 65
Query: 438 CVFQDEVHTYLVLELLKGGELLDRIRQKGRCGFTENEASRIMRQLVAAVHFMHSRGVVHR 497
F ++++E GG LD ++ E + I+R+++ + ++H G +HR
Sbjct: 66 GSFLKGSKLWIIMEYCGGGSCLDLLK---PGKLDETYIAFILREVLLGLEYLHEEGKIHR 122
Query: 498 DLKPENLLFSDPAGDNIKVVDFG------FACLKRESLHTPCFTLQYAAPEVLRQDKSGY 551
D+K N+L S+ GD +K+ DFG KR +T T + APEV++Q SGY
Sbjct: 123 DIKAANILLSE-EGD-VKLADFGVSGQLTSTMSKR---NTFVGTPFWMAPEVIKQ--SGY 175
Query: 552 DENCDLWSLGV 562
DE D+WSLG+
Sbjct: 176 DEKADIWSLGI 186
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274 |
| >gnl|CDD|173680 cd05589, STKc_PKN, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Score = 110 bits (278), Expect = 2e-26
Identities = 81/281 (28%), Positives = 120/281 (42%), Gaps = 58/281 (20%)
Query: 385 ILGDGSYSVCRRCVEKSTGQEYAVK------IISR----KIDCSEEINLLRACQGHPNIV 434
+LG G + K TG+ YA+K II+R + C + I + HP +V
Sbjct: 6 VLGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPFLV 65
Query: 435 NLHCVFQDEVHTYLVLELLKGGELLDRIRQKGRCGFTENEASRIMRQLVAAVHFMHSRGV 494
NL FQ E H V+E GG+L+ I F+E A +V + ++H +
Sbjct: 66 NLFACFQTEDHVCFVMEYAAGGDLMMHIHTD---VFSEPRAVFYAACVVLGLQYLHENKI 122
Query: 495 VHRDLKPENLLFSDPAGDNIKVVDFGFACLKRESL------HTPCFTLQYAAPEVLRQDK 548
V+RDLK +NLL D G +K+ DFG L +E + T C T ++ APEVL +
Sbjct: 123 VYRDLKLDNLLL-DTEG-FVKIADFG---LCKEGMGFGDRTSTFCGTPEFLAPEVLTE-- 175
Query: 549 SGYDENCDLWSLGVILVNVLRQDKSGYDENCDLWSLGVILYTMLCGRVPFHARSRDDSAL 608
+ Y D W LGV++Y ML G PF ++
Sbjct: 176 ------------------------TSYTRAVDWWGLGVLIYEMLVGESPFPGDDEEEVFD 211
Query: 609 SIMARIKEGQFNFDAEAWSTVSSEAKELTKSLLTVNPAQRI 649
SI+ N + +S EA + + LL NP +R+
Sbjct: 212 SIV--------NDEVRYPRFLSREAISIMRRLLRRNPERRL 244
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved in many biological processes including cytokeletal regulation, cell adhesion, vesicle transport, glucose transport, regulation of meiotic maturation and embryonic cell cycles, signaling to the nucleus, and tumorigenesis. Length = 324 |
| >gnl|CDD|173674 cd05583, STKc_MSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Score = 109 bits (273), Expect = 4e-26
Identities = 42/69 (60%), Positives = 52/69 (75%), Gaps = 2/69 (2%)
Query: 264 RRILKTEPPIPEDLSPDVADFISRLLVKDPRRRLGGGELDAEELKRHPFFNVIDWDDLAT 323
RRILK++PP P+ +S + DFI +LL KDP++RLG A+E+K HPFF IDWDDLA
Sbjct: 222 RRILKSKPPFPKTMSAEARDFIQKLLEKDPKKRLGAN--GADEIKNHPFFQGIDWDDLAA 279
Query: 324 KRIPAPFVP 332
KRIPAPF P
Sbjct: 280 KRIPAPFKP 288
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines. This triggers phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) in the C-terminal extension of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSKs are predominantly nuclear proteins. They are widely expressed in many tissues including heart, brain, lung, liver, kidney, and pancreas. There are two isoforms of MSK, called MSK1 and MSK2. Length = 288 |
| >gnl|CDD|173741 cd07843, STKc_CDC2L1, Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Score = 109 bits (274), Expect = 4e-26
Identities = 68/207 (32%), Positives = 102/207 (49%), Gaps = 42/207 (20%)
Query: 389 GSYSVCRRCVEKSTGQEYAVKIISRKIDCSE----------EINLLRACQGHPNIVNLHC 438
G+Y V R +K TG+ A+K + K++ E EIN+L Q HPNIV +
Sbjct: 16 GTYGVVYRARDKKTGEIVALKKL--KME-KEKEGFPITSLREINILLKLQ-HPNIVTVKE 71
Query: 439 VF----QDEVHTYLVLEL----LKGGELLDRIRQKGRCGFTENEASRIMRQLVAAVHFMH 490
V D++ Y+V+E LK L++ ++Q F ++E +M QL++ V +H
Sbjct: 72 VVVGSNLDKI--YMVMEYVEHDLKS--LMETMKQ----PFLQSEVKCLMLQLLSGVAHLH 123
Query: 491 SRGVVHRDLKPENLLFSDPAGDNIKVVDFGFACLKRE------SLHTPCFTLQYAAPEVL 544
++HRDLK NLL ++ G +K+ DFG A RE TL Y APE+L
Sbjct: 124 DNWILHRDLKTSNLLLNN-RGI-LKICDFGLA---REYGSPLKPYTQLVVTLWYRAPELL 178
Query: 545 RQDKSGYDENCDLWSLGVILVNVLRQD 571
K Y D+WS+G I +L +
Sbjct: 179 LGAKE-YSTAIDMWSVGCIFAELLTKK 204
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the major isoform, associates with cyclin L and is expressed throughout the cell cycle. It is involved in RNA processing and the regulation of transcription. CDK11(p58) associates with cyclin D3 and is expressed during the G2/M phase of the cell cycle. It plays roles in spindle morphogenesis, centrosome maturation, sister chromatid cohesion, and the completion of mitosis. CDK11(p46) is formed from the larger isoforms by caspases during TNFalpha- and Fas-induced apoptosis. It functions as a downstream effector kinase in apoptotic signaling pathways and interacts with eukaryotic initiation factor 3f (eIF3f), p21-activated kinase (PAK1), and Ran-binding protein (RanBPM). Length = 293 |
| >gnl|CDD|173710 cd05620, STKc_nPKC_delta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Score = 109 bits (274), Expect = 4e-26
Identities = 93/339 (27%), Positives = 151/339 (44%), Gaps = 56/339 (16%)
Query: 385 ILGDGSYSVCRRCVEKSTGQEYAVK-------IISRKIDCSE-EINLLRACQGHPNIVNL 436
+LG GS+ K G+ +AVK +I ++C+ E +L +P + +L
Sbjct: 2 VLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHL 61
Query: 437 HCVFQDEVHTYLVLELLKGGELLDRIRQKGRCGFTENEASRIMRQLVAAVHFMHSRGVVH 496
+C FQ + H + V+E L GG+L+ I+ KGR F A+ ++V + F+HS+G+++
Sbjct: 62 YCTFQTKEHLFFVMEFLNGGDLMFHIQDKGR--FDLYRATFYAAEIVCGLQFLHSKGIIY 119
Query: 497 RDLKPENLLFSDPAGDNIKVVDFGFA---CLKRESLHTPCFTLQYAAPEVLRQDKSGYDE 553
RDLK +N++ D G +IK+ DFG T C T Y APE+L+ K
Sbjct: 120 RDLKLDNVML-DRDG-HIKIADFGMCKENVFGDNRASTFCGTPDYIAPEILQGLK----- 172
Query: 554 NCDLWSLGVILVNVLRQDKSGYDENCDLWSLGVILYTMLCGRVPFHARSRDDSALSIMAR 613
Y + D WS GV+LY ML G+ PFH D+ SI R
Sbjct: 173 ---------------------YTFSVDWWSFGVLLYEMLIGQSPFHGDDEDELFESI--R 209
Query: 614 IKEGQFNFDAEAWSTVSSEAKELTKSLLTVNPAQRIRM---MRVKLTFHAFHQAQKEGFR 670
+ + W ++ E+K++ + L +P +R+ + +R F + E
Sbjct: 210 VDTPHY----PRW--ITKESKDILEKLFERDPTRRLGVVGNIRGHPFFKTINWTALEKRE 263
Query: 671 LQDVTSAKLAQRRKNKNVSNDNSRSFSSTSSSLSSSSSG 709
L K+ K+ + ++ R F S LS S
Sbjct: 264 LDPPFKPKV----KSPSDYSNFDREFLSEKPRLSYSDKN 298
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. It slows down cell proliferation, inducing cell cycle arrest and enhancing cell differentiation. PKC-delta is also involved in the regulation of transcription as well as immune and inflammatory responses. It plays a central role in the genotoxic stress response that leads to DNA damaged-induced apoptosis. Length = 316 |
| >gnl|CDD|173707 cd05616, STKc_cPKC_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Score = 109 bits (274), Expect = 5e-26
Identities = 80/285 (28%), Positives = 130/285 (45%), Gaps = 55/285 (19%)
Query: 379 DLDKAGILGDGSYSVCRRCVEKSTGQEYAVKIISRKI-------DCSEEINLLRACQGHP 431
D + +LG GS+ K T + YA+KI+ + + +C+ + A G P
Sbjct: 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKP 60
Query: 432 N-IVNLHCVFQDEVHTYLVLELLKGGELLDRIRQKGRCGFTENEASRIMRQLVAAVHFMH 490
+ LH FQ Y V+E + GG+L+ +I+Q GR F E A ++ + F+H
Sbjct: 61 PFLTQLHSCFQTMDRLYFVMEYVNGGDLMYQIQQVGR--FKEPHAVFYAAEIAIGLFFLH 118
Query: 491 SRGVVHRDLKPENLLFSDPAGDNIKVVDFGFACLKRESL------HTPCFTLQYAAPEVL 544
S+G+++RDLK +N++ D G +IK+ DFG +E++ T C T Y APE++
Sbjct: 119 SKGIIYRDLKLDNVML-DSEG-HIKIADFGMC---KENMWDGVTTKTFCGTPDYIAPEII 173
Query: 545 RQDKSGYDENCDLWSLGVILVNVLRQDKSGYDENCDLWSLGVILYTMLCGRVPFHARSRD 604
Y ++ D W+ GV+LY ML G+ PF D
Sbjct: 174 AYQP--------------------------YGKSVDWWAFGVLLYEMLAGQAPFEGEDED 207
Query: 605 DSALSIMARIKEGQFNFDAEAWSTVSSEAKELTKSLLTVNPAQRI 649
+ SIM + ++S EA + K L+T +P +R+
Sbjct: 208 ELFQSIMEH--------NVAYPKSMSKEAVAICKGLMTKHPGKRL 244
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. The PKC beta isoforms (I and II), generated by alternative splicing of a single gene, are preferentially activated by hyperglycemia-induced DAG in retinal tissues. This is implicated in diabetic microangiopathy such as ischemia, neovascularization, and abnormal vasodilator function. PKC-beta also plays an important role in VEGF signaling. In addition, glucose regulates proliferation in retinal endothelial cells via PKC-betaI. PKC-beta is also being explored as a therapeutic target in cancer. It contributes to tumor formation and is involved in the tumor host mechanisms of inflammation and angiogenesis. Length = 323 |
| >gnl|CDD|173675 cd05584, STKc_p70S6K, Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 109 bits (273), Expect = 8e-26
Identities = 42/107 (39%), Positives = 67/107 (62%), Gaps = 2/107 (1%)
Query: 265 RILKTEPPIPEDLSPDVADFISRLLVKDPRRRLGGGELDAEELKRHPFFNVIDWDDLATK 324
+ILK + +P L+P+ D + +LL ++P RLG G DA E++ HPFF ++WDDL +
Sbjct: 211 KILKGKLNLPPYLTPEARDLLKKLLKRNPSSRLGAGPGDAAEVQSHPFFRHVNWDDLLAR 270
Query: 325 RIPAPFVPKISNELDVSNFSDEFTKMIPADSP--AIVPPNFDKIFKG 369
++ PF P + +E DVS F +FT+ P DSP + + + ++IF G
Sbjct: 271 KVEPPFKPLLQSEEDVSQFDSKFTRQTPVDSPDDSTLSESANQIFLG 317
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the insulin receptor substrate IRS-1, among others. Mammals contain two isoforms of p70S6K, named S6K1 and S6K2 (or S6K-beta). Length = 323 |
| >gnl|CDD|173666 cd05575, STKc_SGK, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Score = 108 bits (272), Expect = 9e-26
Identities = 85/284 (29%), Positives = 126/284 (44%), Gaps = 65/284 (22%)
Query: 385 ILGDGSYSVCRRCVEKSTGQEYAVKIISRKI--------DCSEEINLLRACQGHPNIVNL 436
++G GS+ K+ G+ YAVK++ +K E N+L HP +V L
Sbjct: 2 VIGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGL 61
Query: 437 HCVFQDEVHTYLVLELLKGGELLDRIRQKGRCGFTENEASRIMRQLVAAVHFMHSRGVVH 496
H FQ Y VL+ + GGEL + Q+ R F E A ++ +A+ ++HS +++
Sbjct: 62 HYSFQTADKLYFVLDYVNGGELFFHL-QRERS-FPEPRARFYAAEIASALGYLHSLNIIY 119
Query: 497 RDLKPENLLFSDPAGDNIKVVDFGFACLKRESLH------TPCFTLQYAAPEVLRQDKSG 550
RDLKPEN+L ++ + DFG L +E + T C T +Y APEVLR
Sbjct: 120 RDLKPENILLDSQG--HVVLTDFG---LCKEGIEHSKTTSTFCGTPEYLAPEVLR----- 169
Query: 551 YDENCDLWSLGVILVNVLRQDKSGYDENCDLWSLGVILYTMLCGRVPFHARSRD-----D 605
K YD D W LG +LY ML G PF+ SRD D
Sbjct: 170 ---------------------KQPYDRTVDWWCLGAVLYEMLYGLPPFY--SRDTAEMYD 206
Query: 606 SALSIMARIKEGQFNFDAEAWSTVSSEAKELTKSLLTVNPAQRI 649
+ L+ R+K +S A+ L + LL + +R+
Sbjct: 207 NILNKPLRLKPN-----------ISVSARHLLEGLLQKDRTKRL 239
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell proliferation, and apoptosis. Length = 323 |
| >gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 106 bits (268), Expect = 2e-25
Identities = 82/320 (25%), Positives = 125/320 (39%), Gaps = 96/320 (30%)
Query: 381 DKAGILGDGSYSVCRRCVEKSTGQEYAVKIISRK-------IDCSEEINLLRACQGHPNI 433
+K +G+G+Y + K TG+ A+K I + I EI LL+ + HPNI
Sbjct: 2 EKIAQIGEGTYGQVYKARNKKTGELVALKKIRMENEKEGFPITAIREIKLLQKLR-HPNI 60
Query: 434 VNLHCVFQDEVH--TYLVLEL----LKGGELLDRIRQKGRCGFTENEASRIMRQLVAAVH 487
V L + + Y+V E L G LLD K FTE++ M+QL+ +
Sbjct: 61 VRLKEIVTSKGKGSIYMVFEYMDHDLTG--LLDSPEVK----FTESQIKCYMKQLLEGLQ 114
Query: 488 FMHSRGVVHRDLKPENLLFSDPAGDNIKVVDFGFACLKR--ESLHTPCF-----TLQYAA 540
++HS G++HRD+K N+L ++ +K+ DFG A R ++ + TL Y
Sbjct: 115 YLHSNGILHRDIKGSNILINN--DGVLKLADFGLA---RPYTKRNSADYTNRVITLWYRP 169
Query: 541 PEVLRQDKSGYDENCDLWSLGVILVNVLRQDKSGYDENCDLWSLGVILYTMLCGRVPFHA 600
PE+L LG Y D+WS+G IL + G+ F
Sbjct: 170 PELL---------------LGATR----------YGPEVDMWSVGCILAELFLGKPIFQG 204
Query: 601 RSRDDSALSIMARIKEGQFNF----DAEAWSTV--------------------------- 629
+ L + +I F E W V
Sbjct: 205 STE----LEQLEKI----FELCGSPTDENWPGVSKLPWFENLKPKKPYKRRLREFFKHLI 256
Query: 630 SSEAKELTKSLLTVNPAQRI 649
A +L LLT++P +RI
Sbjct: 257 DPSALDLLDKLLTLDPKKRI 276
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287 |
| >gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Score = 106 bits (266), Expect = 3e-25
Identities = 78/276 (28%), Positives = 119/276 (43%), Gaps = 47/276 (17%)
Query: 386 LGDGSYSVCRRCVEKSTGQEYAVKIISRK---------IDCSEEINLLRACQGHPNIVNL 436
LG G + C K+TG+ YA K + +K + +E+ L + IV+L
Sbjct: 1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKV--SSRFIVSL 58
Query: 437 HCVFQDEVHTYLVLELLKGGELLDRIRQKGRCGFTENEASRIMRQLVAAVHFMHSRGVVH 496
F+ + LV+ L+ GG+L I G GF E A Q++ + +H R +V+
Sbjct: 59 AYAFETKDDLCLVMTLMNGGDLKYHIYNVGEPGFPEARAIFYAAQIICGLEHLHQRRIVY 118
Query: 497 RDLKPENLLFSDPAGDNIKVVDFGFAC--LKRESLHTPCFTLQYAAPEVLRQDKSGYDEN 554
RDLKPEN+L D N+++ D G A + + T Y APEVL+ +
Sbjct: 119 RDLKPENVLLDDHG--NVRISDLGLAVELKGGKKIKGRAGTPGYMAPEVLQGEV------ 170
Query: 555 CDLWSLGVILVNVLRQDKSGYDENCDLWSLGVILYTMLCGRVPFHARSRDDSALSIMARI 614
YD + D ++LG LY M+ GR PF R + R
Sbjct: 171 --------------------YDFSVDWFALGCTLYEMIAGRSPFRQRKEKVEKEELKRRT 210
Query: 615 KEGQFNFDAEAWS-TVSSEAKELTKSLLTVNPAQRI 649
E A + S EAK+L ++LL +P +R+
Sbjct: 211 LE-----MAVEYPDKFSPEAKDLCEALLQKDPEKRL 241
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of G protein signaling) homology (RH) domain and several motifs. The C-terminus diverges among different groups of GRKs. There are seven types of GRKs, named GRK1 to GRK7. They are subdivided into three main groups: visual (GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is widespread while GRK1/4/7 show a limited tissue distribution. The substrate spectrum of the widely expressed GRKs partially overlaps. GRKs play important roles in the cardiovascular, immune, respiratory, skeletal, and nervous systems. Length = 277 |
| >gnl|CDD|173735 cd07831, STKc_MOK, Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Score = 106 bits (267), Expect = 3e-25
Identities = 60/197 (30%), Positives = 94/197 (47%), Gaps = 24/197 (12%)
Query: 386 LGDGSYSVCRRCVEKSTGQEYAVKIISRKIDCSEEIN------LLRACQGHPNIVNLHCV 439
+G+G++S + + TG+ YA+K + + E++N LR HPNI+ L V
Sbjct: 7 IGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSLEQVNNLREIQALRRLSPHPNILRLIEV 66
Query: 440 FQDEVH--TYLVLELLKGGELLDRIRQKGRCGFTENEASRIMRQLVAAVHFMHSRGVVHR 497
D LV EL+ L + I+ + R E M QL+ ++ MH G+ HR
Sbjct: 67 LFDRKTGRLALVFELMDM-NLYELIKGRKRP-LPEKRVKSYMYQLLKSLDHMHRNGIFHR 124
Query: 498 DLKPENLLFSDPAGDNIKVVDFGFACLKRESLHT-PCFTLQ-----YAAPEVLRQDKSGY 551
D+KPEN+L D D +K+ DFG +++ P +T Y APE L D Y
Sbjct: 125 DIKPENILIKD---DILKLADFGSCR----GIYSKPPYTEYISTRWYRAPECLLTDGY-Y 176
Query: 552 DENCDLWSLGVILVNVL 568
D+W++G + +L
Sbjct: 177 GPKMDIWAVGCVFFEIL 193
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. Length = 282 |
| >gnl|CDD|173684 cd05593, STKc_PKB_gamma, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Score = 107 bits (268), Expect = 3e-25
Identities = 92/331 (27%), Positives = 156/331 (47%), Gaps = 67/331 (20%)
Query: 385 ILGDGSYSVCRRCVEKSTGQEYAVKIISRKIDCSE--------EINLLRACQGHPNIVNL 436
+LG G++ EK++G+ YA+KI+ +++ ++ E +L+ + HP + +L
Sbjct: 2 LLGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTR-HPFLTSL 60
Query: 437 HCVFQDEVHTYLVLELLKGGELLDRIRQKGRCGFTENEASRIMRQLVAAVHFMHSRGVVH 496
FQ + V+E + GGEL + ++ F+E+ ++V+A+ ++HS +V+
Sbjct: 61 KYSFQTKDRLCFVMEYVNGGELFFHLSRERV--FSEDRTRFYGAEIVSALDYLHSGKIVY 118
Query: 497 RDLKPENLLFSDPAGDNIKVVDFGF---ACLKRESLHTPCFTLQYAAPEVLRQDKSGYDE 553
RDLK ENL+ D G +IK+ DFG ++ T C T +Y APEVL +
Sbjct: 119 RDLKLENLML-DKDG-HIKITDFGLCKEGITDAATMKTFCGTPEYLAPEVLEDND----- 171
Query: 554 NCDLWSLGVILVNVLRQDKSGYDENCDLWSLGVILYTMLCGRVPFHARSRDDSALSIMAR 613
Y D W LGV++Y M+CGR+PF+ ++D L +
Sbjct: 172 ---------------------YGRAVDWWGLGVVMYEMMCGRLPFY--NQDHEKLFELIL 208
Query: 614 IKEGQFNFDAEAWSTVSSEAKELTKSLLTVNPAQRI--------RMMRVKLTFHAFHQAQ 665
+++ +F T+S++AK L LL +P +R+ +MR H+F
Sbjct: 209 MEDIKFP------RTLSADAKSLLSGLLIKDPNKRLGGGPDDAKEIMR-----HSFFT-- 255
Query: 666 KEGFRLQDVTSAKLAQRRKNKNVSNDNSRSF 696
G QDV KL K + S ++R F
Sbjct: 256 --GVNWQDVYDKKLVPPFKPQVTSETDTRYF 284
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulated in estrogen-deficient breast cancer cells, androgen-independent prostate cancer cells, and primary ovarian tumors. It acts as a key mediator in the genesis of ovarian cancer. Length = 328 |
| >gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 105 bits (263), Expect = 5e-25
Identities = 61/200 (30%), Positives = 99/200 (49%), Gaps = 23/200 (11%)
Query: 385 ILGDGSYSVCRRCVEKSTGQEYAVKIISRKIDCSE----------EINLLRACQGHPNIV 434
+LG G++ C + TG+E AVK + D E EI LL+ Q H IV
Sbjct: 9 LLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQ-HERIV 67
Query: 435 NLHCVFQDEVHTYLVLELLKGGELLDRIRQKGRCGFTENEASRIMRQLVAAVHFMHSRGV 494
+ +D+ + +E + GG + D+++ G TE + RQ++ V ++HS +
Sbjct: 68 QYYGCLRDDETLSIFMEYMPGGSVKDQLKAYG--ALTETVTRKYTRQILEGVEYLHSNMI 125
Query: 495 VHRDLKPENLLFSDPAGDNIKVVDFGFA------CLKRESLHTPCFTLQYAAPEVLRQDK 548
VHRD+K N+L D AG N+K+ DFG + C + + T + +PEV+ +
Sbjct: 126 VHRDIKGANIL-RDSAG-NVKLGDFGASKRLQTICSSGTGMKSVTGTPYWMSPEVISGE- 182
Query: 549 SGYDENCDLWSLGVILVNVL 568
GY D+WS+G +V +L
Sbjct: 183 -GYGRKADVWSVGCTVVEML 201
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263 |
| >gnl|CDD|173694 cd05603, STKc_SGK2, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Score = 106 bits (265), Expect = 8e-25
Identities = 76/228 (33%), Positives = 107/228 (46%), Gaps = 41/228 (17%)
Query: 385 ILGDGSYSVCRRCVEKSTGQEYAVKIISRKIDCSE--------EINLLRACQGHPNIVNL 436
++G GS+ KS G YAVK++ +K + E N+L HP +V L
Sbjct: 2 VIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGL 61
Query: 437 HCVFQDEVHTYLVLELLKGGELLDRIRQKGRCGFTENEASRIMRQLVAAVHFMHSRGVVH 496
H FQ Y VL+ + GGEL + Q+ RC F E A ++ +A+ ++HS +++
Sbjct: 62 HYSFQTAEKLYFVLDYVNGGELFFHL-QRERC-FLEPRARFYAAEVASAIGYLHSLNIIY 119
Query: 497 RDLKPENLLFSDPAGDNIKVVDFGF---ACLKRESLHTPCFTLQYAAPEVLRQDKSGYDE 553
RDLKPEN+L D G ++ + DFG E+ T C T +Y APEVLR
Sbjct: 120 RDLKPENILL-DSQG-HVVLTDFGLCKEGVEPEETTSTFCGTPEYLAPEVLR-------- 169
Query: 554 NCDLWSLGVILVNVLRQDKSGYDENCDLWSLGVILYTMLCGRVPFHAR 601
K YD D W LG +LY ML G PF++R
Sbjct: 170 ------------------KEPYDRTVDWWCLGAVLYEMLYGLPPFYSR 199
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. Length = 321 |
| >gnl|CDD|173739 cd07838, STKc_CDK4_6_like, Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 105 bits (264), Expect = 8e-25
Identities = 66/200 (33%), Positives = 95/200 (47%), Gaps = 29/200 (14%)
Query: 385 ILGDGSYSVCRRCVEKSTGQEYAVKIISRKIDCSE---------EINLLRACQ--GHPNI 433
+G+G+Y + + +TG+ A+K + ++ SE EI LL+ + HPNI
Sbjct: 6 EIGEGAYGTVYKARDLNTGRFVALKKV--RVPLSEEGIPLSTLREIALLKQLESFEHPNI 63
Query: 434 VNLHCVFQ-----DEVHTYLVLELLKG--GELLDRIRQKGRCGFTENEASRIMRQLVAAV 486
V L V E+ LV E + L + + G +MRQL+ V
Sbjct: 64 VRLLDVCHGPRTDRELKLTLVFEHVDQDLATYLSKCPKPG---LPPETIKDLMRQLLRGV 120
Query: 487 HFMHSRGVVHRDLKPENLLFSDPAGDNIKVVDFGFA-CLKRESLHTPCF-TLQYAAPEVL 544
F+HS +VHRDLKP+N+L + + +K+ DFG A E T TL Y APEVL
Sbjct: 121 DFLHSHRIVHRDLKPQNILVT--SDGQVKIADFGLARIYSFEMALTSVVVTLWYRAPEVL 178
Query: 545 RQDKSGYDENCDLWSLGVIL 564
Q S Y D+WS+G I
Sbjct: 179 LQ--SSYATPVDMWSVGCIF 196
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both expressed ubiquitously, associate with all three D cyclins (D1, D2 and D3), and phosphorylate the retinoblastoma (pRb) protein. They are also regulated by the INK4 family of inhibitors which associate with either the CDK alone or the CDK/cyclin complex. CDK4 and CDK6 show differences in subcellular localization, sensitivity to some inhibitors, timing in activation, tumor selectivity, and possibly substrate profiles. Although CDK4 and CDK6 seem to show some redundancy, they also have discrete, nonoverlapping functions. CDK6 plays an important role in cell differentiation. Length = 287 |
| >gnl|CDD|173704 cd05613, STKc_MSK1_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Score = 104 bits (261), Expect = 1e-24
Identities = 42/69 (60%), Positives = 55/69 (79%)
Query: 264 RRILKTEPPIPEDLSPDVADFISRLLVKDPRRRLGGGELDAEELKRHPFFNVIDWDDLAT 323
RRILK+EPP P+++S D I RLL+KDP++RLG G DA+E+K+HPFF I+WDDLA
Sbjct: 222 RRILKSEPPYPQEMSALAKDIIQRLLMKDPKKRLGCGPSDADEIKKHPFFQKINWDDLAA 281
Query: 324 KRIPAPFVP 332
K++PAPF P
Sbjct: 282 KKVPAPFKP 290
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK1 plays a role in the regulation of translational control and transcriptional activation. It phosphorylates the transcription factors, CREB and NFkappaB. It also phosphorylates the nucleosomal proteins H3 and HMG-14. Increased phosphorylation of MEK1 is associated with the development of cerebral ischemic/hypoxic preconditioning. Length = 290 |
| >gnl|CDD|173709 cd05619, STKc_nPKC_theta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Score = 105 bits (263), Expect = 1e-24
Identities = 79/276 (28%), Positives = 128/276 (46%), Gaps = 49/276 (17%)
Query: 385 ILGDGSYSVCRRCVEKSTGQEYAVKIISRKI-------DCSE-EINLLRACQGHPNIVNL 436
+LG GS+ K T Q +A+K + + + +C+ E +L HP + +L
Sbjct: 2 MLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHL 61
Query: 437 HCVFQDEVHTYLVLELLKGGELLDRIRQKGRCGFTENEASRIMRQLVAAVHFMHSRGVVH 496
+C FQ + + + V+E L GG+L+ I+ + F A+ +++ + F+HS+G+V+
Sbjct: 62 YCTFQTKENLFFVMEYLNGGDLMFHIQSCHK--FDLPRATFYAAEIICGLQFLHSKGIVY 119
Query: 497 RDLKPENLLFSDPAGDNIKVVDFGF---ACLKRESLHTPCFTLQYAAPEVLRQDKSGYDE 553
RDLK +N+L D G +IK+ DFG L T C T Y APE+L K
Sbjct: 120 RDLKLDNILL-DTDG-HIKIADFGMCKENMLGDAKTCTFCGTPDYIAPEILLGQK----- 172
Query: 554 NCDLWSLGVILVNVLRQDKSGYDENCDLWSLGVILYTMLCGRVPFHARSRDDSALSIMAR 613
Y+ + D WS GV+LY ML G+ PFH ++ SI R
Sbjct: 173 ---------------------YNTSVDWWSFGVLLYEMLIGQSPFHGHDEEELFQSI--R 209
Query: 614 IKEGQFNFDAEAWSTVSSEAKELTKSLLTVNPAQRI 649
+ + W ++ EAK++ L P +R+
Sbjct: 210 MDNPCY----PRW--LTREAKDILVKLFVREPERRL 239
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. Although T-cells also express other PKC isoforms, PKC-theta is unique in that upon antigen stimulation, it is translocated to the plasma membrane at the immunological synapse, where it mediates signals essential for T-cell activation. It is essential for TCR-induced proliferation, cytokine production, T-cell survival, and the differentiation and effector function of T-helper (Th) cells, particularly Th2 and Th17. PKC-theta is being developed as a therapeutic target for Th2-mediated allergic inflammation and Th17-mediated autoimmune diseases. Length = 316 |
| >gnl|CDD|173685 cd05594, STKc_PKB_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Score = 105 bits (264), Expect = 1e-24
Identities = 105/366 (28%), Positives = 164/366 (44%), Gaps = 75/366 (20%)
Query: 385 ILGDGSYSVCRRCVEKSTGQEYAVKIISRKI-----DCSEEINLLRACQG--HPNIVNLH 437
+LG G++ EK+TG+ YA+KI+ +++ + + + R Q HP + L
Sbjct: 2 LLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALK 61
Query: 438 CVFQDEVHTYLVLELLKGGEL---LDRIRQKGRCGFTENEASRIMRQLVAAVHFMHS-RG 493
FQ V+E GGEL L R R F+E+ A ++V+A+ ++HS +
Sbjct: 62 YSFQTHDRLCFVMEYANGGELFFHLSRERV-----FSEDRARFYGAEIVSALDYLHSEKN 116
Query: 494 VVHRDLKPENLLFSDPAGDNIKVVDFGF---ACLKRESLHTPCFTLQYAAPEVLRQDKSG 550
VV+RDLK ENL+ D G +IK+ DFG ++ T C T +Y APEVL +
Sbjct: 117 VVYRDLKLENLML-DKDG-HIKITDFGLCKEGIKDGATMKTFCGTPEYLAPEVLEDND-- 172
Query: 551 YDENCDLWSLGVILVNVLRQDKSGYDENCDLWSLGVILYTMLCGRVPFHARSRDDSALSI 610
Y D W LGV++Y M+CGR+PF+ ++D L
Sbjct: 173 ------------------------YGRAVDWWGLGVVMYEMMCGRLPFY--NQDHEKLFE 206
Query: 611 MARIKEGQFNFDAEAWSTVSSEAKELTKSLLTVNPAQRI--------RMMRVKLTFHAFH 662
+ ++E +F T+S EAK L LL +P QR+ +M+ H F
Sbjct: 207 LILMEEIRFP------RTLSPEAKSLLSGLLKKDPKQRLGGGPDDAKEIMQ-----HKFF 255
Query: 663 QAQKEGFRLQDVTSAKLAQRRKNKNVSNDNSRSFSS--TSSSLSSSSSGT-SSLKTPCSS 719
G QDV KL K + S ++R F T+ ++ + S++T +
Sbjct: 256 A----GIVWQDVYEKKLVPPFKPQVTSETDTRYFDEEFTAQMITITPPDQDDSMETVDNE 311
Query: 720 TQPSVP 725
+P P
Sbjct: 312 RRPHFP 317
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficient in PKB-alpha exhibit perinatal morbidity, growth retardation, reduction in body weight accompanied by reduced sizes of multiple organs, and enhanced apoptosis in some cell types. PKB-alpha activity has been reported to be frequently elevated in breast and prostate cancers. In some cancer cells, PKB-alpha may act as a suppressor of metastasis. Length = 325 |
| >gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 104 bits (261), Expect = 1e-24
Identities = 68/193 (35%), Positives = 100/193 (51%), Gaps = 15/193 (7%)
Query: 384 GILGDGSYSVCRRCVEKSTGQEYAVKIISRKI-----DCSEEINLLRACQGHPNIVNLHC 438
G LGDG++ + K TG A KII + D EI++L C+ HPNIV L+
Sbjct: 11 GELGDGAFGKVYKAQHKETGLFAAAKIIQIESEEELEDFMVEIDILSECK-HPNIVGLYE 69
Query: 439 VFQDEVHTYLVLELLKGGELLDRIRQKGRCGFTENEASRIMRQLVAAVHFMHSRGVVHRD 498
+ E ++++E GG L D I + G TE + + RQ++ A++F+HS V+HRD
Sbjct: 70 AYFYENKLWILIEFCDGGAL-DSIMLELERGLTEPQIRYVCRQMLEALNFLHSHKVIHRD 128
Query: 499 LKPENLLFSDPAGDNIKVVDFGF-ACLKRE--SLHTPCFTLQYAAPEVL--RQDKSG-YD 552
LK N+L + ++K+ DFG A K T T + APEV+ K YD
Sbjct: 129 LKAGNILLT--LDGDVKLADFGVSAKNKSTLQKRDTFIGTPYWMAPEVVACETFKDNPYD 186
Query: 553 ENCDLWSLGVILV 565
D+WSLG+ L+
Sbjct: 187 YKADIWSLGITLI 199
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280 |
| >gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Score = 104 bits (263), Expect = 1e-24
Identities = 82/297 (27%), Positives = 124/297 (41%), Gaps = 53/297 (17%)
Query: 381 DKAGILGDGSYSVCRRCVEKSTGQEYAVKIISRKIDCSE-----------EINLLRACQG 429
+K LG+G+Y+V + +K TG+ A+K I + + E EI LL+ +
Sbjct: 3 EKGKKLGEGTYAVVYKARDKETGRIVAIKKI-KLGERKEAKDGINFTALREIKLLQELK- 60
Query: 430 HPNIVNLHCVFQDEVHTYLVLELLKGGELLDRIRQKGRCGFTENEASRIMRQLVAAVHFM 489
HPNI+ L VF + + LV E + +L I+ K T + M + + ++
Sbjct: 61 HPNIIGLLDVFGHKSNINLVFEFM-ETDLEKVIKDK-SIVLTPADIKSYMLMTLRGLEYL 118
Query: 490 HSRGVVHRDLKPENLLFSDPAGDNIKVVDFGFACL----KRESLHTPCFTLQYAAPEVLR 545
HS ++HRDLKP NLL G +K+ DFG A R+ H T Y APE+L
Sbjct: 119 HSNWILHRDLKPNNLLI-ASDGV-LKLADFGLARSFGSPNRKMTHQ-VVTRWYRAPELLF 175
Query: 546 QDKSGYDENCDLWSLGVILVNVLRQDKSGYDENCDLWSLGVIL-------------YTML 592
+ Y D+WS+G I +L + + D+ LG I T L
Sbjct: 176 GARH-YGVGVDMWSVGCIFAELLLR-VPFLPGDSDIDQLGKIFEALGTPTEENWPGVTSL 233
Query: 593 CGRVPFHARSRDDSALSIMARIKEGQFNFDAEAWSTVSSEAKELTKSLLTVNPAQRI 649
V F + S +A +L + LLT+NP +RI
Sbjct: 234 PDYVEFKPF----PPTPLKQIF------------PAASDDALDLLQRLLTLNPNKRI 274
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298 |
| >gnl|CDD|173679 cd05588, STKc_aPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Score = 105 bits (263), Expect = 2e-24
Identities = 66/228 (28%), Positives = 110/228 (48%), Gaps = 47/228 (20%)
Query: 385 ILGDGSYSVCRRCVEKSTGQEYAVKIISRK-------ID-CSEEINLLRACQGHPNIVNL 436
++G GSY+ K T + YA+K+I ++ ID E ++ HP +V L
Sbjct: 2 VIGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGL 61
Query: 437 HCVFQDEVHTYLVLELLKGGELLDRIRQKGRCGFTENEASRIMRQLVAAVHFMHSRGVVH 496
H FQ E + V+E + GG+L+ ++++ + E A ++ A++F+H RG+++
Sbjct: 62 HSCFQTESRLFFVIEFVSGGDLMFHMQRQRK--LPEEHARFYSAEISLALNFLHERGIIY 119
Query: 497 RDLKPENLLFSDPAGDNIKVVDFGFACLKRESLH------TPCFTLQYAAPEVLRQDKSG 550
RDLK +N+L D G +IK+ D+G +E + T C T Y APE+LR +
Sbjct: 120 RDLKLDNVLL-DAEG-HIKLTDYGMC---KEGIRPGDTTSTFCGTPNYIAPEILRGED-- 172
Query: 551 YDENCDLWSLGVILVNVLRQDKSGYDENCDLWSLGVILYTMLCGRVPF 598
Y + D W+LGV+++ M+ GR PF
Sbjct: 173 ------------------------YGFSVDWWALGVLMFEMMAGRSPF 196
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions including proliferation, migration, apoptosis, polarity maintenance and cytoskeletal regulation. They also play a critical role in the regulation of glucose metabolism and in the pathogenesis of type 2 diabetes. Length = 329 |
| >gnl|CDD|173713 cd05624, STKc_MRCK_beta, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Score = 105 bits (262), Expect = 2e-24
Identities = 89/278 (32%), Positives = 134/278 (48%), Gaps = 46/278 (16%)
Query: 379 DLDKAGILGDGSYSVCRRCVEKSTGQEYAVKIISR-------KIDC-SEEINLLRA--CQ 428
D + ++G G++ K T + YA+KI+++ + C EE N+L CQ
Sbjct: 2 DFEIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVNGDCQ 61
Query: 429 GHPNIVNLHCVFQDEVHTYLVLELLKGGELLDRIRQKGRCGFTENEASRIMRQLVAAVHF 488
I LH FQDE + YLV++ GG+LL + K E+ A + ++V A+H
Sbjct: 62 W---ITTLHYAFQDENYLYLVMDYYVGGDLLTLL-SKFEDRLPEDMARFYIAEMVLAIHS 117
Query: 489 MHSRGVVHRDLKPENLLFSDPAGDNIKVVDFGFACLKRESLHT-----PCFTLQYAAPEV 543
+H VHRD+KP+N+L D G +I++ DFG +CLK T T Y +PE+
Sbjct: 118 IHQLHYVHRDIKPDNVLL-DMNG-HIRLADFG-SCLKMNQDGTVQSSVAVGTPDYISPEI 174
Query: 544 LRQDKSGYDENCDLWSLGVILVNVLRQDKSGYDENCDLWSLGVILYTMLCGRVPFHARSR 603
L+ + G + Y CD WSLGV +Y ML G PF+A S
Sbjct: 175 LQAMEDGMGK---------------------YGPECDWWSLGVCMYEMLYGETPFYAESL 213
Query: 604 DDSALSIMARIKEGQFNFDAEAWSTVSSEAKELTKSLL 641
++ IM E +F F + + VS EAK+L + L+
Sbjct: 214 VETYGKIMNH--EERFQFPSHI-TDVSEEAKDLIQRLI 248
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. Length = 331 |
| >gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Score = 104 bits (261), Expect = 3e-24
Identities = 64/206 (31%), Positives = 101/206 (49%), Gaps = 30/206 (14%)
Query: 381 DKAGILGDGSYSVCRRCVEKSTGQEYAVKIISRK-------IDCSEEINLLRACQGHPNI 433
+K +G+G+Y + R + ++G+ A+K + I EI LL + HPNI
Sbjct: 10 EKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLREITLLLNLR-HPNI 68
Query: 434 VNLHCVFQ----DEVHTYLVLELLKG--GELLDRIRQKGRCGFTENEASRIMRQLVAAVH 487
V L V D + +LV+E + LLD + F+E++ +M QL+ +
Sbjct: 69 VELKEVVVGKHLDSI--FLVMEYCEQDLASLLDNMP----TPFSESQVKCLMLQLLRGLQ 122
Query: 488 FMHSRGVVHRDLKPENLLFSDPAGDNIKVVDFGFACLKRESLH----TPCF-TLQYAAPE 542
++H ++HRDLK NLL +D +K+ DFG A + L TP TL Y APE
Sbjct: 123 YLHENFIIHRDLKVSNLLLTD--KGCLKIADFGLA--RTYGLPAKPMTPKVVTLWYRAPE 178
Query: 543 VLRQDKSGYDENCDLWSLGVILVNVL 568
+L + Y D+W++G IL +L
Sbjct: 179 LLLGCTT-YTTAIDMWAVGCILAELL 203
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309 |
| >gnl|CDD|173705 cd05614, STKc_MSK2_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Score = 104 bits (260), Expect = 4e-24
Identities = 78/281 (27%), Positives = 135/281 (48%), Gaps = 49/281 (17%)
Query: 385 ILGDGSYS---VCRRCVEKSTGQEYAVKIISR-----KIDCSE----EINLLRACQGHPN 432
+LG G+Y + R+ TG+ YA+K++ + K E E N+L + P
Sbjct: 7 VLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVRQSPF 66
Query: 433 IVNLHCVFQDEVHTYLVLELLKGGELLDRIRQKGRCGFTENEASRIMRQLVAAVHFMHSR 492
+V LH FQ E +L+L+ + GGE+ + Q R F+E+E +++ A+ +H
Sbjct: 67 LVTLHYAFQTEAKLHLILDYVSGGEMFTHLYQ--RDNFSEDEVRFYSGEIILALEHLHKL 124
Query: 493 GVVHRDLKPENLLFSDPAGDNIKVVDFG----FACLKRESLHTPCFTLQYAAPEVLRQDK 548
G+V+RD+K EN+L D G ++ + DFG F ++E ++ C T++Y APE++R
Sbjct: 125 GIVYRDIKLENILL-DSEG-HVVLTDFGLSKEFLSEEKERTYSFCGTIEYMAPEIIR--- 179
Query: 549 SGYDENCDLWSLGVILVNVLRQDKSGYDENCDLWSLGVILYTMLCGRVPFHARSRDDSAL 608
K G+ + D WSLG++++ +L G PF ++
Sbjct: 180 ----------------------GKGGHGKAVDWWSLGILIFELLTGASPFTLEGERNTQS 217
Query: 609 SIMARIKEGQFNFDAEAWSTVSSEAKELTKSLLTVNPAQRI 649
+ RI + F S + EA++L LL +P +R+
Sbjct: 218 EVSRRILKCDPPFP----SFIGPEAQDLLHKLLRKDPKKRL 254
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK2 and MSK1 play nonredundant roles in activating histone H3 kinases, which play pivotal roles in compaction of the chromatin fiber. MSK2 is the required H3 kinase in response to stress stimuli and activation of the p38 MAPK pathway. MSK2 also plays a role in the pathogenesis of psoriasis. Length = 332 |
| >gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Score = 102 bits (256), Expect = 4e-24
Identities = 72/287 (25%), Positives = 113/287 (39%), Gaps = 66/287 (22%)
Query: 386 LGDGSYSVCRRCVEKSTGQEYAVKII-----SRKI--DCSEEINLLRACQGHPNIVNLHC 438
+G G++ V TG+ AVK I K + ++E+ +L + HPN+V +
Sbjct: 8 IGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLK-HPNLVKYYG 66
Query: 439 VFQDEVH---TYLVLELLKGGELLDRIRQKGRCGFTENEA--SRIMRQLVAAVHFMHSRG 493
V EVH Y+ +E GG L + + G +E QL+ + ++HS G
Sbjct: 67 V---EVHREKVYIFMEYCSGGTLEELLEH----GRILDEHVIRVYTLQLLEGLAYLHSHG 119
Query: 494 VVHRDLKPENLLFSDPAGDNIKVVDFGFACLKRESLH-TPCF--------TLQYAAPEVL 544
+VHRD+KP N+ IK+ DFG C + + T T Y APEV+
Sbjct: 120 IVHRDIKPANIFLDH--NGVIKLGDFG--CAVKLKNNTTTMGEEVQSLAGTPAYMAPEVI 175
Query: 545 RQDKSGYDENCDLWSLGVILVNVLRQDKSGYDENCDLWSLGVILYTMLCGRVPFHARSRD 604
K G+ D+WSLG ++ M G+ P+
Sbjct: 176 TGGKG-----------------------KGHGRAADIWSLGCVVLEMATGKRPWS---EL 209
Query: 605 DSALSIMARIKEG---QFNFDAEAWSTVSSEAKELTKSLLTVNPAQR 648
D+ IM + G + +S E K+ L +P +R
Sbjct: 210 DNEFQIMFHVGAGHKPPIPDSLQ----LSPEGKDFLDRCLESDPKKR 252
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264 |
| >gnl|CDD|173706 cd05615, STKc_cPKC_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Score = 103 bits (259), Expect = 4e-24
Identities = 79/285 (27%), Positives = 129/285 (45%), Gaps = 55/285 (19%)
Query: 379 DLDKAGILGDGSYSVCRRCVEKSTGQEYAVKIISRKI-------DCSE-EINLLRACQGH 430
D + +LG GS+ K T + YA+KI+ + + +C+ E +L
Sbjct: 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKP 60
Query: 431 PNIVNLHCVFQDEVHTYLVLELLKGGELLDRIRQKGRCGFTENEASRIMRQLVAAVHFMH 490
P + LH FQ Y V+E + GG+L+ I+Q G+ F E +A ++ + F+H
Sbjct: 61 PFLTQLHSCFQTVDRLYFVMEYVNGGDLMYHIQQVGK--FKEPQAVFYAAEISVGLFFLH 118
Query: 491 SRGVVHRDLKPENLLFSDPAGDNIKVVDFGFACLKRESL------HTPCFTLQYAAPEVL 544
RG+++RDLK +N++ D G +IK+ DFG +E + T C T Y APE++
Sbjct: 119 RRGIIYRDLKLDNVML-DSEG-HIKIADFGMC---KEHMVDGVTTRTFCGTPDYIAPEII 173
Query: 545 RQDKSGYDENCDLWSLGVILVNVLRQDKSGYDENCDLWSLGVILYTMLCGRVPFHARSRD 604
Y ++ D W+ GV+LY ML G+ PF D
Sbjct: 174 AYQP--------------------------YGKSVDWWAYGVLLYEMLAGQPPFDGEDED 207
Query: 605 DSALSIMARIKEGQFNFDAEAWSTVSSEAKELTKSLLTVNPAQRI 649
+ SIM + ++S EA + K L+T +P++R+
Sbjct: 208 ELFQSIMEH--------NVSYPKSLSKEAVSICKGLMTKHPSKRL 244
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. PKC-alpha is expressed in many tissues and is associated with cell proliferation, apoptosis, and cell motility. It plays a role in the signaling of the growth factors PDGF, VEGF, EGF, and FGF. Abnormal levels of PKC-alpha have been detected in many transformed cell lines and several human tumors. In addition, PKC-alpha is required for HER2 dependent breast cancer invasion. Length = 323 |
| >gnl|CDD|173616 PTZ00426, PTZ00426, cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 104 bits (260), Expect = 4e-24
Identities = 75/219 (34%), Positives = 106/219 (48%), Gaps = 38/219 (17%)
Query: 430 HPNIVNLHCVFQDEVHTYLVLELLKGGELLDRIRQKGRCGFTENEASRIMRQLVAAVHFM 489
HP VNL+ F+DE + YLVLE + GGE +R+ R F + Q+V ++
Sbjct: 90 HPFCVNLYGSFKDESYLYLVLEFVIGGEFFTFLRRNKR--FPNDVGCFYAAQIVLIFEYL 147
Query: 490 HSRGVVHRDLKPENLLFSDPAGDNIKVVDFGFACLKRESLHTPCFTLQYAAPEVLRQDKS 549
S +V+RDLKPENLL D G IK+ DFGFA + +T C T +Y APE
Sbjct: 148 QSLNIVYRDLKPENLLL-DKDG-FIKMTDFGFAKVVDTRTYTLCGTPEYIAPE------- 198
Query: 550 GYDENCDLWSLGVILVNVLRQDKSGYDENCDLWSLGVILYTMLCGRVPFHARSRDDSALS 609
IL+NV G+ + D W+LG+ +Y +L G PF+A + L
Sbjct: 199 -------------ILLNV------GHGKAADWWTLGIFIYEILVGCPPFYA----NEPLL 235
Query: 610 IMARIKEGQFNFDAEAWSTVSSEAKELTKSLLTVNPAQR 648
I +I EG F + + K L K LL+ + +R
Sbjct: 236 IYQKILEGIIYFP----KFLDNNCKHLMKKLLSHDLTKR 270
|
Length = 340 |
| >gnl|CDD|173695 cd05604, STKc_SGK3, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Score = 103 bits (259), Expect = 5e-24
Identities = 74/228 (32%), Positives = 107/228 (46%), Gaps = 41/228 (17%)
Query: 385 ILGDGSYSVCRRCVEKSTGQEYAVKIISRKIDCSE--------EINLLRACQGHPNIVNL 436
++G GS+ K G+ YAVK++ +KI + E N+L HP +V L
Sbjct: 2 VIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGL 61
Query: 437 HCVFQDEVHTYLVLELLKGGELLDRIRQKGRCGFTENEASRIMRQLVAAVHFMHSRGVVH 496
H FQ Y VL+ + GGEL + Q+ R F E A ++ +A+ ++HS +V+
Sbjct: 62 HYSFQTTEKLYFVLDFVNGGELFFHL-QRERS-FPEPRARFYAAEIASALGYLHSINIVY 119
Query: 497 RDLKPENLLFSDPAGDNIKVVDFGF---ACLKRESLHTPCFTLQYAAPEVLRQDKSGYDE 553
RDLKPEN+L D G ++ + DFG + ++ T C T +Y APEV+R
Sbjct: 120 RDLKPENILL-DSQG-HVVLTDFGLCKEGIAQSDTTTTFCGTPEYLAPEVIR-------- 169
Query: 554 NCDLWSLGVILVNVLRQDKSGYDENCDLWSLGVILYTMLCGRVPFHAR 601
K YD D W LG +LY ML G PF+ R
Sbjct: 170 ------------------KQPYDNTVDWWCLGAVLYEMLYGLPPFYCR 199
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, and receptors. It plays a critical role in hair follicle morphogenesis and hair cycling. Length = 325 |
| >gnl|CDD|173676 cd05585, STKc_YPK1_like, Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 103 bits (258), Expect = 5e-24
Identities = 81/274 (29%), Positives = 128/274 (46%), Gaps = 48/274 (17%)
Query: 386 LGDGSYSVCRRCVEKSTGQEYAVK------IISR-KIDCSEEINLLRACQGHPNIVNLHC 438
+G GS+ + ++ T + YA+K I+SR ++ + + A P IV L
Sbjct: 1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKF 60
Query: 439 VFQDEVHTYLVLELLKGGELLDRIRQKGRCGFTENEASRIMRQLVAAVHFMHSRGVVHRD 498
FQ YLVL + GGEL ++++GR F + A +L+ A+ +H V++RD
Sbjct: 61 SFQSPEKLYLVLAFINGGELFHHLQREGR--FDLSRARFYTAELLCALENLHKFNVIYRD 118
Query: 499 LKPENLLFSDPAGDNIKVVDFGFACL---KRESLHTPCFTLQYAAPEVLRQDKSGYDENC 555
LKPEN+L D G +I + DFG L + +T C T +Y APE+L G+
Sbjct: 119 LKPENILL-DYQG-HIALCDFGLCKLNMKDDDKTNTFCGTPEYLAPELL----LGH---- 168
Query: 556 DLWSLGVILVNVLRQDKSGYDENCDLWSLGVILYTMLCGRVPFHARSRDDSALSIMARIK 615
GY + D W+LGV+LY ML G PF+ D++ + +I
Sbjct: 169 ------------------GYTKAVDWWTLGVLLYEMLTGLPPFY----DENVNEMYRKIL 206
Query: 616 EGQFNFDAEAWSTVSSEAKELTKSLLTVNPAQRI 649
+ F +AK+L LL+ +P +R+
Sbjct: 207 QEPLRFP----DGFDRDAKDLLIGLLSRDPTRRL 236
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It plays a role in cell growth and sexual development. Length = 312 |
| >gnl|CDD|223069 PHA03390, pk1, serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Score = 101 bits (255), Expect = 6e-24
Identities = 68/263 (25%), Positives = 121/263 (46%), Gaps = 46/263 (17%)
Query: 388 DGSY---SVCRRCVEKSTGQEYAVKIISRKIDCSEEINLLRACQGHPNIVNLHCVFQDEV 444
DG + SV + K T + + KII K + E + + + +PN + L+
Sbjct: 26 DGKFGKVSVLKH---KPTQKLFVQKIIKAKNFNAIEPMVHQLMKDNPNFIKLYYSVTTLK 82
Query: 445 HTYLVLELLKGGELLDRIRQKGRCGFTENEASRIMRQLVAAVHFMHSRGVVHRDLKPENL 504
L+++ +K G+L D ++++G+ +E E +I+RQLV A++ +H ++H D+K EN+
Sbjct: 83 GHVLIMDYIKDGDLFDLLKKEGK--LSEAEVKKIIRQLVEALNDLHKHNIIHNDIKLENV 140
Query: 505 LFSDPAGDNIKVVDFGFACLKRESLHTPCF---TLQYAAPEVLRQDKSGYDENCDLWSLG 561
L+ D A D I + D+G K TP TL Y +PE ++
Sbjct: 141 LY-DRAKDRIYLCDYGLC--KII--GTPSCYDGTLDYFSPEKIK---------------- 179
Query: 562 VILVNVLRQDKSGYDENCDLWSLGVILYTMLCGRVPFHARSRDDSALSIMARIKEGQFNF 621
YD + D W++GV+ Y +L G+ PF ++ L + + ++ + F
Sbjct: 180 ----------GHNYDVSFDWWAVGVLTYELLTGKHPFKEDEDEELDLESLLKRQQKKLPF 229
Query: 622 DAEAWSTVSSEAKELTKSLLTVN 644
VS A + +S+L N
Sbjct: 230 I----KNVSKNANDFVQSMLKYN 248
|
Length = 267 |
| >gnl|CDD|173693 cd05602, STKc_SGK1, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Score = 103 bits (258), Expect = 7e-24
Identities = 82/276 (29%), Positives = 125/276 (45%), Gaps = 49/276 (17%)
Query: 385 ILGDGSYSVCRRCVEKSTGQEYAVKIISRKIDCSE--------EINLLRACQGHPNIVNL 436
++G GS+ K+ + YAVK++ +K + E N+L HP +V L
Sbjct: 2 VIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGL 61
Query: 437 HCVFQDEVHTYLVLELLKGGELLDRIRQKGRCGFTENEASRIMRQLVAAVHFMHSRGVVH 496
H FQ Y VL+ + GGEL + Q+ RC F E A ++ +A+ ++HS +V+
Sbjct: 62 HFSFQTADKLYFVLDYINGGELFYHL-QRERC-FLEPRARFYAAEIASALGYLHSLNIVY 119
Query: 497 RDLKPENLLFSDPAGDNIKVVDFGFACLKRE---SLHTPCFTLQYAAPEVLRQDKSGYDE 553
RDLKPEN+L D G +I + DFG E + T C T +Y APEVL
Sbjct: 120 RDLKPENILL-DSQG-HIVLTDFGLCKENIEHNGTTSTFCGTPEYLAPEVLH-------- 169
Query: 554 NCDLWSLGVILVNVLRQDKSGYDENCDLWSLGVILYTMLCGRVPFHARSRDDSALSIMAR 613
K YD D W LG +LY ML G PF++R+ A
Sbjct: 170 ------------------KQPYDRTVDWWCLGAVLYEMLYGLPPFYSRN--------TAE 203
Query: 614 IKEGQFNFDAEAWSTVSSEAKELTKSLLTVNPAQRI 649
+ + N + +++ A+ L + LL + +R+
Sbjct: 204 MYDNILNKPLQLKPNITNSARHLLEGLLQKDRTKRL 239
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt sensitivity, memory consolidation, and cardiac repolarization. A common SGK1 variant is associated with increased blood pressure and body weight. SGK1 may also contribute to tumor growth, neurodegeneration, fibrosing disease, and ischemia. Length = 325 |
| >gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Score = 101 bits (253), Expect = 8e-24
Identities = 68/277 (24%), Positives = 120/277 (43%), Gaps = 54/277 (19%)
Query: 386 LGDGSYSVCRRCVEKSTGQEYAVKIIS-------RKIDCSEEINLLRACQGHPNIVNLHC 438
+G GS+ V + V K+ + YA+K I + + +E +L A I+ +
Sbjct: 8 IGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVL-AKLDSSYIIRYYE 66
Query: 439 VFQDEVHTYLVLELLKGGELLDRIRQKGRCGFTENEASRIMRQLVAAVHFMHSRGVVHRD 498
F D+ +V+E + G+L ++ + E++ R Q++ + +HS+ ++HRD
Sbjct: 67 SFLDKGKLNIVMEYAENGDLHKLLKMQRGRPLPEDQVWRFFIQILLGLAHLHSKKILHRD 126
Query: 499 LKPENLLFSDPAGDNIKVVDFGFA-------CLKRESLHTPCFTLQYAAPEVLRQDKSGY 551
+K NL A DN+K+ D G A + TP Y +PE L +DK
Sbjct: 127 IKSLNLFLD--AYDNVKIGDLGVAKLLSDNTNFANTIVGTP----YYLSPE-LCEDKP-- 177
Query: 552 DENCDLWSLGVILVNVLRQDKSGYDENCDLWSLGVILYTMLCGRVPFHARSRDDSALSIM 611
Y+E D+W+LGV+LY G+ PF A ++ +++
Sbjct: 178 -----------------------YNEKSDVWALGVVLYECCTGKHPFDA----NNQGALI 210
Query: 612 ARIKEGQFNFDAEAWSTVSSEAKELTKSLLTVNPAQR 648
+I G F ++ + S + +L LT + QR
Sbjct: 211 LKIIRGVFPPVSQMY---SQQLAQLIDQCLTKDYRQR 244
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256 |
| >gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 101 bits (253), Expect = 1e-23
Identities = 61/193 (31%), Positives = 103/193 (53%), Gaps = 27/193 (13%)
Query: 386 LGDGSYSVCRRCVEKSTGQEYAVKIISRKIDCSE-------EINLLRACQGHPNIVNLHC 438
+G G+Y + + +TG+ A+K+I K++ + EI++L+ C+ HPNIV
Sbjct: 11 IGSGTYGDVYKARDIATGELVAIKVI--KLEPGDDFEIIQQEISMLKECR-HPNIVAYFG 67
Query: 439 VFQDEVHTYLVLELLKGGELLDRIRQKGRCGFTENEASRIMRQLVAAVHFMHSRGVVHRD 498
+ ++V+E GG L D I Q R +E + + + R+ + + ++H G +HRD
Sbjct: 68 SYLRRDKLWIVMEYCGGGSLQD-IYQVTRGPLSELQIAYVCRETLKGLAYLHETGKIHRD 126
Query: 499 LKPENLLFSDPAGDNIKVVDFGFACL------KRESLHTPCF--TLQYAAPEVLR-QDKS 549
+K N+L ++ GD +K+ DFG + KR+S F T + APEV + K
Sbjct: 127 IKGANILLTE-DGD-VKLADFGVSAQLTATIAKRKS-----FIGTPYWMAPEVAAVERKG 179
Query: 550 GYDENCDLWSLGV 562
GYD CD+W+LG+
Sbjct: 180 GYDGKCDIWALGI 192
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262 |
| >gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Score = 99.5 bits (249), Expect = 3e-23
Identities = 31/74 (41%), Positives = 52/74 (70%), Gaps = 4/74 (5%)
Query: 892 NVHTYLVLELLKGGELLDRIRQKGRCGFTENEASRIMRQLVAAVHFMHSRGVVHRDLKPE 951
YLV+E +GG+L D ++++GR +E+EA +RQ+++A+ ++HS+G+VHRDLKPE
Sbjct: 69 EDKLYLVMEYCEGGDLFDLLKKRGR--LSEDEARFYLRQILSALEYLHSKGIVHRDLKPE 126
Query: 952 NLLLSGISGNLIKI 965
N+LL +K+
Sbjct: 127 NILLD--EDGHVKL 138
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254 |
| >gnl|CDD|215036 PLN00034, PLN00034, mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Score = 101 bits (254), Expect = 3e-23
Identities = 84/294 (28%), Positives = 135/294 (45%), Gaps = 49/294 (16%)
Query: 379 DLDKAGILGDGSYSVCRRCVEKSTGQEYAVKII------SRKIDCSEEINLLRACQGHPN 432
+L++ +G G+ + + + TG+ YA+K+I + + EI +LR HPN
Sbjct: 75 ELERVNRIGSGAGGTVYKVIHRPTGRLYALKVIYGNHEDTVRRQICREIEILRDVN-HPN 133
Query: 433 IVNLHCVFQDEVHTYLVLELLKGGELLDRIRQKGRCGFTENEASRIMRQLVAAVHFMHSR 492
+V H +F ++LE + GG L +G E + + RQ+++ + ++H R
Sbjct: 134 VVKCHDMFDHNGEIQVLLEFMDGGSL------EGTHIADEQFLADVARQILSGIAYLHRR 187
Query: 493 GVVHRDLKPENLLFSDPAGDNIKVVDFGFACLKRESLHTPCF----TLQYAAPEVLRQDK 548
+VHRD+KP NLL + + N+K+ DFG + + +++ PC T+ Y +PE +
Sbjct: 188 HIVHRDIKPSNLLIN--SAKNVKIADFGVSRILAQTM-DPCNSSVGTIAYMSPERI---- 240
Query: 549 SGYDENCDLWSLGVILVNVLRQDKSGYDENC-DLWSLGVILYTMLCGRVPFHARSRDDSA 607
N DL + YD D+WSLGV + GR PF + D A
Sbjct: 241 -----NTDL-------------NHGAYDGYAGDIWSLGVSILEFYLGRFPFGVGRQGDWA 282
Query: 608 LSIMARIKEGQFNFDAEAWSTVSSEAKELTKSLLTVNPAQRIRMMRVKLTFHAF 661
S+M I Q EA +T S E + L PA+R M+ L H F
Sbjct: 283 -SLMCAICMSQ---PPEAPATASREFRHFISCCLQREPAKRWSAMQ--LLQHPF 330
|
Length = 353 |
| >gnl|CDD|173712 cd05622, STKc_ROCK1, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Score = 101 bits (253), Expect = 5e-23
Identities = 86/278 (30%), Positives = 135/278 (48%), Gaps = 48/278 (17%)
Query: 379 DLDKAGILGDGSYSVCRRCVEKSTGQEYAVKIISR-----KIDCS---EEINLLRACQGH 430
D + ++G G++ + KST + YA+K++S+ + D + EE +++ A
Sbjct: 44 DYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIM-AFANS 102
Query: 431 PNIVNLHCVFQDEVHTYLVLELLKGGELLDRIRQKGRCGFTENEASRIMRQLVAAVHFMH 490
P +V L FQD+ + Y+V+E + GG+L++ + E A ++V A+ +H
Sbjct: 103 PWVVQLFYAFQDDRYLYMVMEYMPGGDLVNLMSNYD---VPEKWARFYTAEVVLALDAIH 159
Query: 491 SRGVVHRDLKPENLLFSDPAGDNIKVVDFGFACLK--RESL---HTPCFTLQYAAPEVLR 545
S G +HRD+KP+N+L D +G ++K+ DFG C+K +E + T T Y +PEVL+
Sbjct: 160 SMGFIHRDVKPDNMLL-DKSG-HLKLADFG-TCMKMNKEGMVRCDTAVGTPDYISPEVLK 216
Query: 546 -QDKSGYDENCDLWSLGVILVNVLRQDKSGYDENCDLWSLGVILYTMLCGRVPFHARSRD 604
Q GY Y CD WS+GV LY ML G PF+A S
Sbjct: 217 SQGGDGY-----------------------YGRECDWWSVGVFLYEMLVGDTPFYADSLV 253
Query: 605 DSALSIMARIKEGQFNFDAEAWSTVSSEAKELTKSLLT 642
+ IM F D + +S EAK L + LT
Sbjct: 254 GTYSKIMNHKNSLTFPDD----NDISKEAKNLICAFLT 287
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, and kidney. It mediates signaling from Rho to the actin cytoskeleton. It is implicated in the development of cardiac fibrosis, cardiomyocyte apoptosis, and hyperglycemia. Mice deficient with ROCK1 display eyelids open at birth (EOB) and omphalocele phenotypes due to the disorganization of actin filaments in the eyelids and the umbilical ring. Length = 371 |
| >gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 100 bits (252), Expect = 6e-23
Identities = 61/205 (29%), Positives = 94/205 (45%), Gaps = 39/205 (19%)
Query: 385 ILGDGSY-SVCRRCVEKSTGQEYAVKIISR----KIDCSE---EINLLRACQGHPNIVNL 436
+G G+Y VC V+K TG++ A+K IS ID EI LLR + H NI+ L
Sbjct: 7 PIGSGAYGVVCS-AVDKRTGRKVAIKKISNVFDDLIDAKRILREIKLLRHLR-HENIIGL 64
Query: 437 HCVFQDEV-----HTYLVLELLKGGEL-LDR-IRQKGRCGFTENEASRIMRQLVAAVHFM 489
+ + Y+V EL+ E L + I+ T++ + Q++ + ++
Sbjct: 65 LDILRPPSPEDFNDVYIVTELM---ETDLHKVIKSPQP--LTDDHIQYFLYQILRGLKYL 119
Query: 490 HSRGVVHRDLKPENLLFSDPAGD-NIKVVDFGFACLKRESLHTPCFTLQ---------YA 539
HS V+HRDLKP N+L + + ++K+ DFG A R Y
Sbjct: 120 HSANVIHRDLKPSNILVNS---NCDLKICDFGLA---RGVDPDEDEKGFLTEYVVTRWYR 173
Query: 540 APEVLRQDKSGYDENCDLWSLGVIL 564
APE+L Y + D+WS+G I
Sbjct: 174 APELLLSSS-RYTKAIDIWSVGCIF 197
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330 |
| >gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Score = 99.4 bits (248), Expect = 7e-23
Identities = 68/209 (32%), Positives = 107/209 (51%), Gaps = 28/209 (13%)
Query: 374 EQYDMDLDKAGILGDGSYSVCRRCVEKSTGQEYAVKIISRKIDCSE-------EINLLRA 426
E+Y+ G++G+GSY + +C K TGQ A+K D EI +L+
Sbjct: 1 EKYEN----LGLVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQ 56
Query: 427 CQGHPNIVNLHCVFQDEVHTYLVLELLKGGELLDRIRQKGRCGFTENEASRIMRQLVAAV 486
+ H N+VNL VF+ + YLV E + +LD + +K G E+ + + Q++ +
Sbjct: 57 LR-HENLVNLIEVFRRKKRLYLVFEFVDH-TVLDDL-EKYPNGLDESRVRKYLFQILRGI 113
Query: 487 HFMHSRGVVHRDLKPENLLFSDPAGDNIKVVDFGFACLKRESLHTP-------CFTLQYA 539
F HS ++HRD+KPEN+L S +G +K+ DFGFA +L P T Y
Sbjct: 114 EFCHSHNIIHRDIKPENILVS-QSG-VVKLCDFGFA----RTLAAPGEVYTDYVATRWYR 167
Query: 540 APEVLRQDKSGYDENCDLWSLGVILVNVL 568
APE+L D Y D+W++G ++ +L
Sbjct: 168 APELLVGDTK-YGRAVDIWAVGCLVTEML 195
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286 |
| >gnl|CDD|173662 cd05571, STKc_PKB, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Score = 99.9 bits (249), Expect = 1e-22
Identities = 48/142 (33%), Positives = 78/142 (54%), Gaps = 7/142 (4%)
Query: 221 EVIDWDDFSRGIECVFFSSSLIIFFIILSFTLSFIHDYYHIQYRRILKTEPPIPEDLSPD 280
EV++ +D+ R V + ++ + ++ L F + + + IL E P LSP+
Sbjct: 165 EVLEDNDYGR---AVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEIRFPRTLSPE 221
Query: 281 VADFISRLLVKDPRRRLGGGELDAEELKRHPFFNVIDWDDLATKRIPAPFVPKISNELDV 340
++ LL KDP++RLGGG DA+E+ H FF I+W D+ K++ PF P++++E D
Sbjct: 222 AKSLLAGLLKKDPKQRLGGGPEDAKEIMEHRFFASINWQDVVQKKLEPPFKPQVTSETDT 281
Query: 341 SNFSDEFTKMIPADSPAIVPPN 362
F +EFT A S I PP+
Sbjct: 282 RYFDEEFT----AQSITITPPD 299
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having been implicated in tumor initiation, progression, and metastasis. Length = 323 |
| >gnl|CDD|173691 cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 100 bits (250), Expect = 1e-22
Identities = 70/261 (26%), Positives = 110/261 (42%), Gaps = 47/261 (18%)
Query: 386 LGDGSYSVCRRCVEKSTGQEYAVKIISRKI--------DCSEEINLLRACQGHPNIVNLH 437
+G G Y +K TG+ A+K + + + E ++L + +V L
Sbjct: 9 VGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTK-SEWLVKLL 67
Query: 438 CVFQDEVHTYLVLELLKGGELLDRIRQKGRCGFTENEASRIMRQLVAAVHFMHSRGVVHR 497
FQD+ + YL +E + GG+ + G +E+ A M ++ AV +H G +HR
Sbjct: 68 YAFQDDEYLYLAMEYVPGGDFRTLLNNLG--VLSEDHARFYMAEMFEAVDALHELGYIHR 125
Query: 498 DLKPENLLFSDPAGDNIKVVDFGFACLKRESLHTPCFTLQYAAPEVLRQDKSGYDENCDL 557
DLKPEN L A +IK+ DFG + ++ + Y APEVLR
Sbjct: 126 DLKPENFLID--ASGHIKLTDFGLSKGIVTYANSVVGSPDYMAPEVLR------------ 171
Query: 558 WSLGVILVNVLRQDKSGYDENCDLWSLGVILYTMLCGRVPFHARSRDDSALSIM------ 611
GYD D WSLG +LY LCG PF + +++ ++
Sbjct: 172 --------------GKGYDFTVDYWSLGCMLYEFLCGFPPFSGSTPNETWENLKYWKETL 217
Query: 612 --ARIKEGQFNFDAEAWSTVS 630
+ +FN EAW ++
Sbjct: 218 QRPVYDDPRFNLSDEAWDLIT 238
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. Dbf2p is important in regulating the mitotic exit network (MEN) and in cytokinesis. Length = 333 |
| >gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 98.4 bits (246), Expect = 2e-22
Identities = 34/83 (40%), Positives = 46/83 (55%)
Query: 263 YRRILKTEPPIPEDLSPDVADFISRLLVKDPRRRLGGGELDAEELKRHPFFNVIDWDDLA 322
Y +IL+ + P SPD D I LL D +RLG + ++K HP+F IDW L
Sbjct: 207 YEKILEGKVRFPSFFSPDAKDLIRNLLQVDLTKRLGNLKNGVNDIKNHPWFAGIDWIALL 266
Query: 323 TKRIPAPFVPKISNELDVSNFSD 345
++I APF+PK+ D SNF D
Sbjct: 267 QRKIEAPFIPKVKGPGDTSNFDD 289
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290 |
| >gnl|CDD|173661 cd05570, STKc_PKC, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Score = 99.0 bits (247), Expect = 2e-22
Identities = 41/95 (43%), Positives = 52/95 (54%)
Query: 263 YRRILKTEPPIPEDLSPDVADFISRLLVKDPRRRLGGGELDAEELKRHPFFNVIDWDDLA 322
++ IL+ E P LS + + L K+P +RLG +++K HPFF IDWD L
Sbjct: 205 FQSILEDEVRYPRWLSKEAKSILKSFLTKNPEKRLGCLPTGEQDIKGHPFFREIDWDKLE 264
Query: 323 TKRIPAPFVPKISNELDVSNFSDEFTKMIPADSPA 357
K I PF PKI DVSNF DEFTK P +P
Sbjct: 265 RKEIKPPFKPKIKGRFDVSNFDDEFTKEKPVLTPP 299
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only require PS. PKCs phosphorylate and modify the activities of a wide variety of cellular proteins including receptors, enzymes, cytoskeletal proteins, transcription factors, and other kinases. They play a central role in signal transduction pathways that regulate cell migration and polarity, proliferation, differentiation, and apoptosis. Also included in this subfamily are the PKC-like proteins, called PKNs. Length = 318 |
| >gnl|CDD|132970 cd06639, STKc_myosinIIIB, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Score = 98.5 bits (245), Expect = 2e-22
Identities = 66/212 (31%), Positives = 105/212 (49%), Gaps = 27/212 (12%)
Query: 386 LGDGSYSVCRRCVEKSTGQEYAVKIISRKIDCSEEI----NLLRACQGHPNIVNLHCVFQ 441
+G G+Y + K G AVKI+ D EEI N+L++ HPN+V + +F
Sbjct: 30 IGKGTYGKVYKVTNKKDGSLAAVKILDPISDVDEEIEAEYNILQSLPNHPNVVKFYGMFY 89
Query: 442 DEVH-----TYLVLELLKGGELLDRIRQKGRCGFTENEA--SRIMRQLVAAVHFMHSRGV 494
+LVLEL GG + + ++ CG +EA S I+ + + +H+ +
Sbjct: 90 KADKLVGGQLWLVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGALLGLQHLHNNRI 149
Query: 495 VHRDLKPENLLFSDPAGDNIKVVDFGFAC------LKRE-SLHTPCFTLQYAAPEVL--- 544
+HRD+K N+L + G +K+VDFG + L+R S+ TP + APEV+
Sbjct: 150 IHRDVKGNNILLTTEGG--VKLVDFGVSAQLTSTRLRRNTSVGTPF----WMAPEVIACE 203
Query: 545 RQDKSGYDENCDLWSLGVILVNVLRQDKSGYD 576
+Q YD CD+WSLG+ + + D +D
Sbjct: 204 QQYDYSYDARCDVWSLGITAIELGDGDPPLFD 235
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also present in the brain and testis. The human class IIIB myosin gene maps to a region that overlaps the locus for Bardet-Biedl syndrome, which is characterized by dysmorphic extremities, retinal dystrophy, obesity, male hypogenitalism, and renal abnormalities. Length = 291 |
| >gnl|CDD|173738 cd07835, STKc_CDK1_like, Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 98.2 bits (245), Expect = 2e-22
Identities = 69/193 (35%), Positives = 92/193 (47%), Gaps = 25/193 (12%)
Query: 386 LGDGSYSVCRRCVEKSTGQEYAVKIISRKIDCSE--------EINLLRACQGHPNIVNLH 437
+G+G+Y V + +K TG+ A+K I R E EI+LL+ HPNIV L
Sbjct: 7 IGEGTYGVVYKARDKLTGEIVALKKI-RLETEDEGVPSTAIREISLLKELN-HPNIVRLL 64
Query: 438 CVFQDEVHTYLVLELLKGGELLDRIRQKGRCGFTENEASRI---MRQLVAAVHFMHSRGV 494
V E YLV E L LD + T + I + QL+ + + HS V
Sbjct: 65 DVVHSENKLYLVFEFLD----LDLKKYMDSSPLTGLDPPLIKSYLYQLLQGIAYCHSHRV 120
Query: 495 VHRDLKPENLLFSDPAGDNIKVVDFG----FACLKRESLHTPCFTLQYAAPEVLRQDKSG 550
+HRDLKP+NLL D G +K+ DFG F R H TL Y APE+L +
Sbjct: 121 LHRDLKPQNLLI-DREG-ALKLADFGLARAFGVPVRTYTHE-VVTLWYRAPEILLGSRQ- 176
Query: 551 YDENCDLWSLGVI 563
Y D+WS+G I
Sbjct: 177 YSTPVDIWSIGCI 189
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression while the CDK1/cyclin B complex is critical for G2 to M phase transition. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. Studies in knockout mice revealed that CDK1 can compensate for the loss of the cdk2 gene as it can also bind cyclin E and drive G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 283 |
| >gnl|CDD|173744 cd07847, STKc_CDKL1_4, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Score = 97.4 bits (243), Expect = 4e-22
Identities = 67/204 (32%), Positives = 104/204 (50%), Gaps = 26/204 (12%)
Query: 381 DKAGILGDGSYSVCRRCVEKSTGQEYAVK--------IISRKIDCSEEINLLRACQGHPN 432
+K +G+GSY V +C + TGQ A+K + +KI EI +L+ + HPN
Sbjct: 4 EKLSKIGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKI-ALREIRMLKQLK-HPN 61
Query: 433 IVNLHCVFQDEVHTYLVLELLKGGELLDRIRQKGRCGFTENEASRIMRQLVAAVHFMHSR 492
+VNL VF+ + +LV E +L+ + + R G E+ +I+ Q + AV+F H
Sbjct: 62 LVNLIEVFRRKRKLHLVFEYCDH-TVLNELEKNPR-GVPEHLIKKIIWQTLQAVNFCHKH 119
Query: 493 GVVHRDLKPENLLFSDPAGDNIKVVDFGFACLKRESLHTPCF-------TLQYAAPEVLR 545
+HRD+KPEN+L + IK+ DFGFA + L P T Y APE+L
Sbjct: 120 NCIHRDVKPENILIT--KQGQIKLCDFGFARI----LTGPGDDYTDYVATRWYRAPELLV 173
Query: 546 QDKSGYDENCDLWSLGVILVNVLR 569
D + Y D+W++G + +L
Sbjct: 174 GD-TQYGPPVDVWAIGCVFAELLT 196
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The function of CDKL4 is unknown. Length = 286 |
| >gnl|CDD|173700 cd05609, STKc_MAST, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Score = 97.5 bits (243), Expect = 5e-22
Identities = 82/310 (26%), Positives = 137/310 (44%), Gaps = 88/310 (28%)
Query: 379 DLDKAGILGDGSYSVCRRCVEKSTGQEYAVKIISRKIDCSEEINLLRACQGH-------- 430
D + ++ +G+Y K T Q +A+K I+++ NL+ Q
Sbjct: 2 DFETIKLISNGAYGAVYLVRHKETRQRFAMKKINKQ-------NLILRNQIQQVFVERDI 54
Query: 431 ------PNIVNLHCVFQDEVHTYLVLELLKGGE---LLDRIRQKGRCGFTENEASRI-MR 480
P +V++ C F+ + H +V+E ++GG+ LL I G + +R+
Sbjct: 55 LTFAENPFVVSMFCSFETKRHLCMVMEYVEGGDCATLLKNI------GALPVDMARMYFA 108
Query: 481 QLVAAVHFMHSRGVVHRDLKPENLLFSDPAGDNIKVVDFGFACLKRESLHTP-------- 532
+ V A+ ++H+ G+VHRDLKP+NLL + + +IK+ DFG + + SL T
Sbjct: 109 ETVLALEYLHNYGIVHRDLKPDNLLIT--SMGHIKLTDFGLSKIGLMSLTTNLYEGHIEK 166
Query: 533 ----------CFTLQYAAPEVLRQDKSGYDENCDLWSLGVILVNVLRQDKSGYDENCDLW 582
C T +Y APEV +LRQ GY + D W
Sbjct: 167 DTREFLDKQVCGTPEYIAPEV-----------------------ILRQ---GYGKPVDWW 200
Query: 583 SLGVILYTMLCGRVPFHARSRDD---SALSIMARIKEGQFNFDAEAWSTVSSEAKELTKS 639
++G+ILY L G VPF + ++ +S EG +A + ++A++L
Sbjct: 201 AMGIILYEFLVGCVPFFGDTPEELFGQVISDDIEWPEGD---EA-----LPADAQDLISR 252
Query: 640 LLTVNPAQRI 649
LL NP +R+
Sbjct: 253 LLRQNPLERL 262
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. MAST1, MAST2, and MAST3 bind and phosphorylate the tumor suppressor PTEN, and may contribute to the regulation and stabilization of PTEN. MAST2 is involved in the regulation of the Fc-gamma receptor of the innate immune response in macrophages, and may also be involved in the regulation of the Na+/H+ exchanger NHE3. Length = 305 |
| >gnl|CDD|173717 cd05628, STKc_NDR1, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Score = 98.2 bits (244), Expect = 7e-22
Identities = 76/256 (29%), Positives = 125/256 (48%), Gaps = 31/256 (12%)
Query: 379 DLDKAGILGDGSYSVCRRCVEKSTGQEYAVKIISRKIDC--SEEINLLRACQG------H 430
D + ++G G++ R +K TG YA+KI+ RK D E++ +RA +
Sbjct: 2 DFESLKVIGRGAFGEVRLVQKKDTGHVYAMKIL-RKADMLEKEQVGHIRAERDILVEADS 60
Query: 431 PNIVNLHCVFQDEVHTYLVLELLKGGELLDRIRQKGRCGFTENEASRIMRQLVAAVHFMH 490
+V + FQD+++ YL++E L GG+++ + +K TE E + + V A+ +H
Sbjct: 61 LWVVKMFYSFQDKLNLYLIMEFLPGGDMMTLLMKKDT--LTEEETQFYIAETVLAIDSIH 118
Query: 491 SRGVVHRDLKPENLLFSDPAGDNIKVVDFGFACLKRESLHTPCF--TLQYAAPEVLRQDK 548
G +HRD+KP+NLL D G ++K+ DFG C + H F L ++ P
Sbjct: 119 QLGFIHRDIKPDNLLL-DSKG-HVKLSDFGL-CTGLKKAHRTEFYRNLNHSLPSDFTFQN 175
Query: 549 SGYDENCDLW----------SLGV---ILVNVLRQDKSGYDENCDLWSLGVILYTMLCGR 595
+ W ++G I V Q +GY++ CD WSLGVI+Y ML G
Sbjct: 176 MNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQ--TGYNKLCDWWSLGVIMYEMLIGY 233
Query: 596 VPFHARSRDDSALSIM 611
PF + + ++ +M
Sbjct: 234 PPFCSETPQETYKKVM 249
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, muscle, lung and spleen. It is not an essential protein because mice deficient of NDR1 remain viable and fertile. However, these mice develop T-cell lymphomas and appear to be hypersenstive to carcinogenic treatment. NDR1 appears to act as a tumor suppressor. NDR1 is also called STK38. Length = 363 |
| >gnl|CDD|173770 cd08528, STKc_Nek10, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Score = 95.3 bits (237), Expect = 1e-21
Identities = 74/291 (25%), Positives = 133/291 (45%), Gaps = 57/291 (19%)
Query: 386 LGDGSYSVCRRCVEKSTGQEY-AVKIIS----------RKIDCS-----EEINLLRACQG 429
LG G++ + +K+ GQ A+K I+ R+ D S E+ +++
Sbjct: 8 LGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLR 67
Query: 430 HPNIVNLHCVFQDEVHTYLVLELLKG---GELLDRIRQKGRCGFTENEASRIMRQLVAAV 486
HPNIV + F + Y+V++L++G GE + +++K + FTE I Q+V A+
Sbjct: 68 HPNIVRYYKTFLENDRLYIVMDLIEGAPLGEHFNSLKEKKQ-RFTEERIWNIFVQMVLAL 126
Query: 487 HFMH-SRGVVHRDLKPENLLFSDPAGDNIKVVDFGFACLKRES--LHTPCFTLQYAAPEV 543
++H + +VHRDL P N++ + D + + DFG A K+ L + T+ Y+ PE+
Sbjct: 127 RYLHKEKRIVHRDLTPNNIMLGE--DDKVTITDFGLAKQKQPESKLTSVVGTILYSCPEI 184
Query: 544 LRQDKSGYDENCDLWSLGVILVNVLRQDKSGYDENCDLWSLGVILYTMLCGRVPFHARSR 603
++ + Y E D+W+ G ILY M + PF++
Sbjct: 185 VKNEP--------------------------YGEKADVWAFGCILYQMCTLQPPFYS--- 215
Query: 604 DDSALSIMARIKEGQFNFDAEAWSTVSSEAKELTKSLLTVNPAQRIRMMRV 654
+ LS+ +I E + E S + ++ S LT + R +++V
Sbjct: 216 -TNMLSLATKIVEAVYEPLPE--GMYSEDVTDVITSCLTPDAEARPDIIQV 263
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. Length = 269 |
| >gnl|CDD|173697 cd05606, STKc_beta_ARK, Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Score = 95.0 bits (236), Expect = 2e-21
Identities = 75/276 (27%), Positives = 116/276 (42%), Gaps = 45/276 (16%)
Query: 385 ILGDGSYSVCRRCVEKSTGQEYAVKIISRK---------IDCSEEINL-LRACQGHPNIV 434
I+G G + C + TG+ YA+K + +K + +E I L L + P IV
Sbjct: 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIV 60
Query: 435 NLHCVFQDEVHTYLVLELLKGGELLDRIRQKGRCGFTENEASRIMRQLVAAVHFMHSRGV 494
+ F +L+L+ GG+L + Q G F+E E +++ + MH+R V
Sbjct: 61 CMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGV--FSEAEMRFYAAEIILGLEHMHNRFV 118
Query: 495 VHRDLKPENLLFSDPAGDNIKVVDFGFAC-LKRESLHTPCFTLQYAAPEVLRQDKSGYDE 553
V+RDLKP N+L D G ++++ D G AC ++ H T Y APEVL
Sbjct: 119 VYRDLKPANILL-DEHG-HVRISDLGLACDFSKKKPHASVGTHGYMAPEVL--------- 167
Query: 554 NCDLWSLGVILVNVLRQDKSGYDENCDLWSLGVILYTMLCGRVPFHARSRDDSALSIMAR 613
Q YD + D +SLG +L+ +L G PF D
Sbjct: 168 ----------------QKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDK-----HE 206
Query: 614 IKEGQFNFDAEAWSTVSSEAKELTKSLLTVNPAQRI 649
I E + S E + L + LL + +R+
Sbjct: 207 IDRMTLTMAVELPDSFSPELRSLLEGLLQRDVNRRL 242
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is composed of GRK2, GRK3, and similar proteins. GRK2 and GRK3 are both widely expressed in many tissues, although GRK2 is present at higher levels. They contain an N-terminal RGS homology (RH) domain, a central catalytic domain, and C-terminal pleckstrin homology (PH) domain that mediates PIP2 and G protein betagamma-subunit translocation to the membrane. GRK2 (also called beta-ARK or beta-ARK1) is important in regulating several cardiac receptor responses. It plays a role in cardiac development and in hypertension. Deletion of GRK2 in mice results in embryonic lethality, caused by hypoplasia of the ventricular myocardium. GRK2 also plays important roles in the liver (as a regulator of portal blood pressure), in immune cells, and in the nervous system. Altered GRK2 expression has been reported in several disorders including major depression, schizophrenia, bipolar disorder, and Parkinsonism. Length = 278 |
| >gnl|CDD|132979 cd06648, STKc_PAK_II, Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Score = 95.2 bits (237), Expect = 2e-21
Identities = 79/285 (27%), Positives = 134/285 (47%), Gaps = 59/285 (20%)
Query: 379 DLDKAGILGDGSYSVCRRCVEKSTGQEYAVKIIS-RKIDCSE----EINLLRACQGHPNI 433
LD +G+GS + +KSTG++ AVK + RK E E+ ++R Q HPNI
Sbjct: 20 YLDNFVKIGEGSTGIVCIATDKSTGRQVAVKKMDLRKQQRRELLFNEVVIMRDYQ-HPNI 78
Query: 434 VNLHCVF--QDEVHTYLVLELLKGGELLDRIRQKGRCGFTENEASRIMRQLVAAVHFMHS 491
V ++ + DE+ ++V+E L+GG L D + R E + + + ++ A+ F+H+
Sbjct: 79 VEMYSSYLVGDEL--WVVMEFLEGGALTDIVTH-TR--MNEEQIATVCLAVLKALSFLHA 133
Query: 492 RGVVHRDLKPENLLFSDPAGDNIKVVDFGFACL-------KRESL-HTPCFTLQYAAPEV 543
+GV+HRD+K +++L + + +K+ DFGF C +R+SL TP + APEV
Sbjct: 134 QGVIHRDIKSDSILLT--SDGRVKLSDFGF-CAQVSKEVPRRKSLVGTPYWM----APEV 186
Query: 544 LRQDKSGYDENCDLWSLGVILVNVLRQDKSGYDENCDLWSLGVILYTMLCGRVPFHARSR 603
+ + Y D+WSLG+++ M+ G P+
Sbjct: 187 I--------------------------SRLPYGTEVDIWSLGIMVIEMVDGEPPYF---- 216
Query: 604 DDSALSIMARIKEGQFNFDAEAWSTVSSEAKELTKSLLTVNPAQR 648
++ L M RI++ VS + +L +PAQR
Sbjct: 217 NEPPLQAMKRIRDNLPPKLKNL-HKVSPRLRSFLDRMLVRDPAQR 260
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs found in group I PAKs, such as an AID (autoinhibitory domain) and SH3 binding sites. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. While group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX, no such binding has been demonstrated for group II PAKs. Some known substrates of group II PAKs are also substrates of group I PAKs such as Raf, BAD, LIMK and GEFH1. Unique group II substrates include MARK/Par-1 and PDZ-RhoGEF. Group II PAKs play important roles in filopodia formation, neuron extension, cytoskeletal organization, and cell survival. Length = 285 |
| >gnl|CDD|173759 cd08219, STKc_Nek3, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Score = 94.3 bits (234), Expect = 2e-21
Identities = 73/273 (26%), Positives = 122/273 (44%), Gaps = 45/273 (16%)
Query: 385 ILGDGSYSVCRRCVEKSTGQEYAVKII-----SRKIDCSEEINLLRACQGHPNIVNLHCV 439
++G+GS+ ++ Q+YA+K I S ++ S + +L A HPNIV
Sbjct: 7 VVGEGSFGRALLVQHVNSDQKYAMKEIRLPKSSSAVEDSRKEAVLLAKMKHPNIVAFKES 66
Query: 440 FQDEVHTYLVLELLKGGELLDRIR-QKGRCGFTENEASRIMRQLVAAVHFMHSRGVVHRD 498
F+ + H Y+V+E GG+L+ +I+ Q+G+ F E+ + Q+ V +H + V+HRD
Sbjct: 67 FEADGHLYIVMEYCDGGDLMQKIKLQRGKL-FPEDTILQWFVQMCLGVQHIHEKRVLHRD 125
Query: 499 LKPENLLFSDPAGDNIKVVDFGFACLKRESLHTPCF---TLQYAAPEVLRQDKSGYDENC 555
+K +N+ + +K+ DFG A L C T Y PE+
Sbjct: 126 IKSKNIFLTQNG--KVKLGDFGSARLLTSPGAYACTYVGTPYYVPPEI------------ 171
Query: 556 DLWSLGVILVNVLRQDKSGYDENCDLWSLGVILYTMLCGRVPFHARSRDDSALSIMARIK 615
W + Y+ D+WSLG ILY + + PF A S + ++ ++
Sbjct: 172 --W------------ENMPYNNKSDIWSLGCILYELCTLKHPFQANSWKN----LILKVC 213
Query: 616 EGQFNFDAEAWSTVSSEAKELTKSLLTVNPAQR 648
+G + S S E + L K + NP R
Sbjct: 214 QGSYK---PLPSHYSYELRSLIKQMFKRNPRSR 243
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activation of Vav2 and contributes to prolactin-mediated motility of breast cancer cells. Length = 255 |
| >gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Score = 94.2 bits (235), Expect = 3e-21
Identities = 53/197 (26%), Positives = 92/197 (46%), Gaps = 25/197 (12%)
Query: 385 ILGDGSY-SVCR---RCVEKSTGQEYAVKIISRKIDCSE--------EINLLRACQGHPN 432
LG+G++ V + + E AVK + K D SE E ++R HPN
Sbjct: 6 KLGEGAFGEVYKGTLKGKGDGKEVEVAVKTL--KEDASEQQIEEFLREARIMRKLD-HPN 62
Query: 433 IVNLH-CVFQDEVHTYLVLELLKGGELLDRIRQKGRCGFTENEASRIMRQLVAAVHFMHS 491
IV L ++E +V+E + GG+LLD +R+ + ++ Q+ + ++ S
Sbjct: 63 IVKLLGVCTEEEPL-MIVMEYMPGGDLLDYLRKNRPKELSLSDLLSFALQIARGMEYLES 121
Query: 492 RGVVHRDLKPENLLFSDPAGDNIKVVDFGFAC-LKRESLHTPC---FTLQYAAPEVLRQD 547
+ +HRDL N L + +K+ DFG + L + + +++ APE L++
Sbjct: 122 KNFIHRDLAARNCLVGE--NLVVKISDFGLSRDLYDDDYYKVKGGKLPIRWMAPESLKEG 179
Query: 548 KSGYDENCDLWSLGVIL 564
K + D+WS GV+L
Sbjct: 180 K--FTSKSDVWSFGVLL 194
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258 |
| >gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 94.2 bits (234), Expect = 3e-21
Identities = 61/237 (25%), Positives = 103/237 (43%), Gaps = 48/237 (20%)
Query: 382 KAGILGDGSYSVCRRCVEKSTGQEYAVKIISRKIDCS-----------EEINLLRACQGH 430
K LG G++S C + + TG AVK ++ + S +EI L+ A H
Sbjct: 4 KGQQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLM-ARLNH 62
Query: 431 PNIVNLHCVFQDEVHTYLVLELLKGGELLDRIRQKGRCGFTENEASRIMRQLVAAVHFMH 490
P+I+ + ++ H L +E + GG + + + G F E QL+ + ++H
Sbjct: 63 PHIIRMLGATCEDSHFNLFVEWMAGGSVSHLLSKYG--AFKEAVIINYTEQLLRGLSYLH 120
Query: 491 SRGVVHRDLKPENLLFSDPAGDNIKVVDFGFAC-LKRESLHTPCF------TLQYAAPEV 543
++HRD+K NLL D G +++ DFG A L + F T+ + APEV
Sbjct: 121 ENQIIHRDVKGANLLI-DSTGQRLRIADFGAAARLAAKGTGAGEFQGQLLGTIAFMAPEV 179
Query: 544 LRQDKSGYDENCDLWSLGVILVNVLRQDKSGYDENCDLWSLGVILYTMLCGRVPFHA 600
LR ++ Y +CD+WS+G ++ M + P++A
Sbjct: 180 LRGEQ--------------------------YGRSCDVWSVGCVIIEMATAKPPWNA 210
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268 |
| >gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Score = 93.9 bits (234), Expect = 3e-21
Identities = 58/195 (29%), Positives = 97/195 (49%), Gaps = 14/195 (7%)
Query: 379 DLDKAGILGDGSYSVCRRCVEKSTGQEYAVKIISRKIDCSE------EINLLRACQGHPN 432
DL+ G LG G+ V + + + TG+ AVK I +I+ + E+++L C P
Sbjct: 2 DLEYLGELGAGNSGVVSKVLHRPTGKIMAVKTIRLEINEAIQKQILRELDILHKCN-SPY 60
Query: 433 IVNLHCVFQDEVHTYLVLELLKGGELLDRIRQKGRCGFTENEASRIMRQLVAAVHFMHS- 491
IV + F + + +E + GG LD+I ++ + E +I ++ + ++H
Sbjct: 61 IVGFYGAFYNNGDISICMEYMDGGS-LDKILKEVQGRIPERILGKIAVAVLKGLTYLHEK 119
Query: 492 RGVVHRDLKPENLLFSDPAGDNIKVVDFGFACLKRESL-HTPCFTLQYAAPEVLRQDKSG 550
++HRD+KP N+L + + IK+ DFG + SL T T Y APE R +
Sbjct: 120 HKIIHRDVKPSNILVN--SRGQIKLCDFGVSGQLVNSLAKTFVGTSSYMAPE--RIQGND 175
Query: 551 YDENCDLWSLGVILV 565
Y D+WSLG+ L+
Sbjct: 176 YSVKSDIWSLGLSLI 190
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265 |
| >gnl|CDD|173747 cd07852, STKc_MAPK15, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Score = 95.7 bits (239), Expect = 3e-21
Identities = 83/320 (25%), Positives = 123/320 (38%), Gaps = 103/320 (32%)
Query: 386 LGDGSYSVCRRCVEKSTGQEYAVKIISRKI-----DCSE------EINLLRACQGHPNIV 434
LG G+Y + + +++ T + A+K KI + ++ EI L+ HPNIV
Sbjct: 15 LGKGAYGIVWKAIDRRTKEVVALK----KIFDAFRNATDAQRTFREIMFLQELGDHPNIV 70
Query: 435 NLHCVFQDEVHT--YLVLELL--------KGGELLDRIRQKGRCGFTENEASRIMRQLVA 484
L V + E YLV E + + L D ++ IM QL+
Sbjct: 71 KLLNVIKAENDKDIYLVFEYMETDLHAVIRANILEDVHKR------------YIMYQLLK 118
Query: 485 AVHFMHSRGVVHRDLKPENLLF-SDPAGDNIKVVDFGFA---CLKRESLHTPCF-----T 535
A+ ++HS V+HRDLKP N+L SD +K+ DFG A E+ P T
Sbjct: 119 ALKYIHSGNVIHRDLKPSNILLNSDC---RVKLADFGLARSLSELEENPENPVLTDYVAT 175
Query: 536 LQYAAPEVLRQDKSGYDENCDLWSLGVILVNVLRQDKSGYDENCDLWSLGVILYTMLCGR 595
Y APE+L ++ GV D+WS+G IL ML G+
Sbjct: 176 RWYRAPEILLGSTR--------YTKGV-----------------DMWSVGCILGEMLLGK 210
Query: 596 VPFHARS----------------RDD----------SALSIMARIKEGQFNFDAEAWSTV 629
F S +D + L + + D E
Sbjct: 211 PLFPGTSTLNQLEKIIEVIGPPSAEDIESIKSPFAATMLDSLPSRP--RKPLD-ELLPKA 267
Query: 630 SSEAKELTKSLLTVNPAQRI 649
S +A +L K LL NP +R+
Sbjct: 268 SDDALDLLKKLLVFNPNKRL 287
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimuli whereas ERK8 shows low basal activity and is activated by DNA-damaging agents. ERK7 and ERK8 also have different substrate profiles. Genome analysis shows that they are orthologs with similar gene structures. ERK7 and ERK 8 may be involved in the signaling of some nuclear receptor transcription factors. ERK7 regulates hormone-dependent degradation of estrogen receptor alpha while ERK8 down-regulates the transcriptional co-activation androgen and glucocorticoid receptors. Length = 337 |
| >gnl|CDD|132969 cd06638, STKc_myosinIIIA, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Score = 94.3 bits (234), Expect = 4e-21
Identities = 62/199 (31%), Positives = 101/199 (50%), Gaps = 19/199 (9%)
Query: 386 LGDGSYSVCRRCVEKSTGQEYAVKIISRKIDCSEEI----NLLRACQGHPNIVNLHCVF- 440
+G G+Y + + K G + AVKI+ D EEI N+L+A HPN+V + ++
Sbjct: 26 IGKGTYGKVFKVLNKKNGSKAAVKILDPIHDIDEEIEAEYNILKALSDHPNVVKFYGMYY 85
Query: 441 -QDEV---HTYLVLELLKGGELLDRIRQKGRCGFTENEA--SRIMRQLVAAVHFMHSRGV 494
+D +LVLEL GG + D ++ + G E + I+ + + + +H
Sbjct: 86 KKDVKNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGLQHLHVNKT 145
Query: 495 VHRDLKPENLLFSDPAGDNIKVVDFGFACL---KRESLHTPCFTLQYAAPEVL---RQDK 548
+HRD+K N+L + G +K+VDFG + R +T T + APEV+ +Q
Sbjct: 146 IHRDVKGNNILLTTEGG--VKLVDFGVSAQLTSTRLRRNTSVGTPFWMAPEVIACEQQLD 203
Query: 549 SGYDENCDLWSLGVILVNV 567
S YD CD+WSLG+ + +
Sbjct: 204 STYDARCDVWSLGITAIEL 222
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear hair cells. It is localized to the distal ends of actin-bundled structures. Mutations in human myosin IIIA are responsible for progressive nonsyndromic hearing loss. Human myosin IIIA possesses ATPase and kinase activities, and the ability to move actin filaments in a motility assay. It may function as a cellular transporter capable of moving along actin bundles in sensory cells. Length = 286 |
| >gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain | Back alignment and domain information |
|---|
Score = 93.5 bits (233), Expect = 5e-21
Identities = 28/67 (41%), Positives = 44/67 (65%), Gaps = 2/67 (2%)
Query: 890 RYNVHTYLVLELLKGGELLDRIRQKGRCGFTENEASRIMRQLVAAVHFMHSRGVVHRDLK 949
H YLV+E +GG+L D + + G +E+EA +I Q++ + ++HS G++HRDLK
Sbjct: 68 EDKDHLYLVMEYCEGGDLFDYLSRGGP--LSEDEAKKIALQILRGLEYLHSNGIIHRDLK 125
Query: 950 PENLLLS 956
PEN+LL
Sbjct: 126 PENILLD 132
|
Length = 260 |
| >gnl|CDD|173721 cd05632, STKc_GRK5, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Score = 94.3 bits (234), Expect = 5e-21
Identities = 76/276 (27%), Positives = 115/276 (41%), Gaps = 45/276 (16%)
Query: 385 ILGDGSYSVCRRCVEKSTGQEYAVKIISRK--------IDCSEEINLLRACQGHPNIVNL 436
+LG G + C ++TG+ YA K + +K E +L +VNL
Sbjct: 7 VLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQ-FVVNL 65
Query: 437 HCVFQDEVHTYLVLELLKGGELLDRIRQKGRCGFTENEASRIMRQLVAAVHFMHSRGVVH 496
++ + LVL ++ GG+L I G GF E A +++ + +H V+
Sbjct: 66 AYAYETKDALCLVLTIMNGGDLKFHIYNMGNPGFEEERALFYAAEILCGLEDLHRENTVY 125
Query: 497 RDLKPENLLFSDPAGDNIKVVDFGFACL--KRESLHTPCFTLQYAAPEVLRQDKSGYDEN 554
RDLKPEN+L D +I++ D G A + ES+ T+ Y APEVL +
Sbjct: 126 RDLKPENILLDDYG--HIRISDLGLAVKIPEGESIRGRVGTVGYMAPEVLNNQRYTLSP- 182
Query: 555 CDLWSLGVILVNVLRQDKSGYDENCDLWSLGVILYTMLCGRVPFHARSRDDSALSIMARI 614
D W LG ++Y M+ G+ PF R + R+
Sbjct: 183 -------------------------DYWGLGCLIYEMIEGQSPFRGRKEKVKREEVDRRV 217
Query: 615 KEGQFNFDAEAWST-VSSEAKELTKSLLTVNPAQRI 649
E E +S S EAK + K LLT +P QR+
Sbjct: 218 LE-----TEEVYSAKFSEEAKSICKMLLTKDPKQRL 248
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with the membrane though an N-terminal PIP2 binding domain and also binds phospholipids via its C-terminus. GRK5 deficiency is associated with early Alzheimer's disease in humans and mouse models. GRK5 also plays a crucial role in the pathogenesis of sporadic Parkinson's disease. It participates in the regulation and desensitization of PDGFRbeta, a receptor tyrosine kinase involved in a variety of downstream cellular effects including cell growth, chemotaxis, apoptosis, and angiogenesis. GRK5 also regulates Toll-like receptor 4, which is involved in innate and adaptive immunity. Length = 285 |
| >gnl|CDD|173696 cd05605, STKc_GRK4_like, Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 94.1 bits (234), Expect = 5e-21
Identities = 74/276 (26%), Positives = 118/276 (42%), Gaps = 45/276 (16%)
Query: 385 ILGDGSYSVCRRCVEKSTGQEYAVK------IISRKIDCS--EEINLLRACQGHPNIVNL 436
+LG G + C ++TG+ YA K I RK + E +L +V+L
Sbjct: 7 VLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNS-RFVVSL 65
Query: 437 HCVFQDEVHTYLVLELLKGGELLDRIRQKGRCGFTENEASRIMRQLVAAVHFMHSRGVVH 496
++ + LVL L+ GG+L I G GF E A ++ + +H +V+
Sbjct: 66 AYAYETKDALCLVLTLMNGGDLKFHIYNMGNPGFDEERAVFYAAEITCGLEDLHRERIVY 125
Query: 497 RDLKPENLLFSDPAGDNIKVVDFGFACLKRE--SLHTPCFTLQYAAPEVLRQDKSGYDEN 554
RDLKPEN+L D +I++ D G A E ++ T+ Y APEV++ ++ +
Sbjct: 126 RDLKPENILLDDYG--HIRISDLGLAVEIPEGETIRGRVGTVGYMAPEVVKNERYTFSP- 182
Query: 555 CDLWSLGVILVNVLRQDKSGYDENCDLWSLGVILYTMLCGRVPFHARSRDDSALSIMARI 614
D W LG ++Y M+ G+ PF R + R+
Sbjct: 183 -------------------------DWWGLGCLIYEMIEGKSPFRQRKEKVKREEVERRV 217
Query: 615 KEGQFNFDAEAWST-VSSEAKELTKSLLTVNPAQRI 649
KE D E +S S A+ + + LLT +P R+
Sbjct: 218 KE-----DQEEYSEKFSEAARSICRQLLTKDPGFRL 248
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, GRK6, and similar GRKs. GRKs in this group contain an N-terminal RGS homology (RH) domain and a catalytic domain, but lack a G protein betagamma-subunit binding domain. They are localized to the plasma membrane through post-translational lipid modification or direct binding to PIP2. Length = 285 |
| >gnl|CDD|173716 cd05627, STKc_NDR2, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Score = 95.5 bits (237), Expect = 5e-21
Identities = 74/257 (28%), Positives = 120/257 (46%), Gaps = 33/257 (12%)
Query: 379 DLDKAGILGDGSYSVCRRCVEKSTGQEYAVKIISRKIDCSE---------EINLLRACQG 429
D + ++G G++ R +K TG YA+KI+ RK D E E ++L G
Sbjct: 2 DFESLKVIGRGAFGEVRLVQKKDTGHIYAMKIL-RKADMLEKEQVAHIRAERDILVEADG 60
Query: 430 HPNIVNLHCVFQDEVHTYLVLELLKGGELLDRIRQKGRCGFTENEASRIMRQLVAAVHFM 489
+V + FQD+ + YL++E L GG+++ + +K +E + + V A+ +
Sbjct: 61 -AWVVKMFYSFQDKRNLYLIMEFLPGGDMMTLLMKKDT--LSEEATQFYIAETVLAIDAI 117
Query: 490 HSRGVVHRDLKPENLLFSDPAGDNIKVVDFGFACLKRESLHTPCF--TLQYAAPEVLRQD 547
H G +HRD+KP+NLL A ++K+ DFG C + H F L + P
Sbjct: 118 HQLGFIHRDIKPDNLLLD--AKGHVKLSDFGL-CTGLKKAHRTEFYRNLTHNPPSDFSFQ 174
Query: 548 KSGYDENCDLW----------SLGV---ILVNVLRQDKSGYDENCDLWSLGVILYTMLCG 594
+ W ++G I V Q +GY++ CD WSLGVI+Y ML G
Sbjct: 175 NMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQ--TGYNKLCDWWSLGVIMYEMLIG 232
Query: 595 RVPFHARSRDDSALSIM 611
PF + + ++ +M
Sbjct: 233 YPPFCSETPQETYRKVM 249
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regulating neuronal growth and differentiation, as well as in facilitating neurite outgrowth. It is also implicated in fear conditioning as it contributes to the coupling of neuronal morphological changes with fear-memory consolidation. NDR2 is also referred to as STK38-like. Length = 360 |
| >gnl|CDD|173689 cd05598, STKc_LATS, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Score = 96.0 bits (239), Expect = 5e-21
Identities = 73/287 (25%), Positives = 119/287 (41%), Gaps = 60/287 (20%)
Query: 402 TGQEYAVKIISRKIDCSEEINLLRACQGH-------------PNIVNLHCVFQDEVHTYL 448
T YA+K + RK D L+R H +V L+ FQD+ + Y
Sbjct: 25 TNALYAMKTL-RKADV-----LMRNQAAHVKAERDILAEADNEWVVKLYYSFQDKDNLYF 78
Query: 449 VLELLKGGELLDRIRQKGRCGFTENEASRIMRQLVAAVHFMHSRGVVHRDLKPENLLFSD 508
V++ + GG+++ + + G F E+ A + +L A+ +H G +HRD+KP+N+L D
Sbjct: 79 VMDYIPGGDMMSLLIRLGI--FEEDLARFYIAELTCAIESVHKMGFIHRDIKPDNILI-D 135
Query: 509 PAGDNIKVVDFGFACLKRESLHTPCFTLQYAAPEVLRQDKSGYDENCDLWSLGVILVNVL 568
G +IK+ DFG C H + Y + RQD E + + + L
Sbjct: 136 RDG-HIKLTDFGL-CTGFRWTHDSKY---YQKGDHHRQDSMEPSE--EWSEIDRCRLKPL 188
Query: 569 RQ--------------------------DKSGYDENCDLWSLGVILYTMLCGRVPFHARS 602
+ ++GY + CD WS+GVILY ML G+ PF A
Sbjct: 189 ERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVILYEMLVGQPPFLA-- 246
Query: 603 RDDSALSIMARIKEGQFNFDAEAWSTVSSEAKELTKSLLTVNPAQRI 649
D+ ++ + + + +S EA +L L R+
Sbjct: 247 --DTPAETQLKVINWETTLHIPSQAKLSREASDLILRLCC-GAEDRL 290
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Length = 376 |
| >gnl|CDD|88519 cd05618, STKc_aPKC_iota, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Score = 94.7 bits (235), Expect = 7e-21
Identities = 74/284 (26%), Positives = 132/284 (46%), Gaps = 56/284 (19%)
Query: 385 ILGDGSYSVCRRCVEKSTGQEYAVKIISRK-IDCSEEIN-------LLRACQGHPNIVNL 436
++G GSY+ K T + YA+K++ ++ ++ E+I+ + HP +V L
Sbjct: 2 VIGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGL 61
Query: 437 HCVFQDEVHTYLVLELLKGGELLDRIRQKGRCGFTENEASRIMRQLVAAVHFMHSRGVVH 496
H FQ E + V+E + GG+L+ ++++ + E A ++ A++++H RG+++
Sbjct: 62 HSCFQTESRLFFVIEYVNGGDLMFHMQRQRK--LPEEHARFYSAEISLALNYLHERGIIY 119
Query: 497 RDLKPENLLFSDPAGDNIKVVDFGFACLKRESLHTP------CFTLQYAAPEVLRQDKSG 550
RDLK +N+L D G +IK+ D+G +E L C T Y APE+LR + G
Sbjct: 120 RDLKLDNVLL-DSEG-HIKLTDYGMC---KEGLRPGDTTSTFCGTPNYIAPEILRGEDYG 174
Query: 551 YDENCDLWSLGVILVNVLRQDKSGYDENCDLWSLGVILYTMLCGRVPFHARSRDDSALS- 609
+ + D W+LGV+++ M+ GR PF D+
Sbjct: 175 F--------------------------SVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQN 208
Query: 610 ----IMARIKEGQFNFDAEAWSTVSSEAKELTKSLLTVNPAQRI 649
+ I E Q ++S +A + KS L +P +R+
Sbjct: 209 TEDYLFQVILEKQIRIP----RSLSVKAASVLKSFLNKDPKERL 248
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target of tumor-specific gene amplification in many human cancers, and has been identified as a human oncogene. In addition to its role in transformed growth, PKC-iota also promotes invasion, chemoresistance, and tumor cell survival. Expression profiling of PKC-iota is a prognostic marker of poor clinical outcome in several human cancers. PKC-iota also plays a role in establishing cell polarity, and has critical embryonic functions. Length = 329 |
| >gnl|CDD|173752 cd07861, STKc_CDK1_euk, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Score = 93.6 bits (233), Expect = 8e-21
Identities = 71/211 (33%), Positives = 94/211 (44%), Gaps = 42/211 (19%)
Query: 379 DLDKAGILGDGSYSVCRRCVEKSTGQEYAVKIISRKIDCSE---------EINLLRACQG 429
D K +G+G+Y V + K TGQ A+K I +++ E EI+LL+ Q
Sbjct: 1 DYTKIEKIGEGTYGVVYKGRNKKTGQIVAMKKI--RLESEEEGVPSTAIREISLLKELQ- 57
Query: 430 HPNIVNLHCVFQDEVHTYLVLELL-----------KGGELLDRIRQKGRCGFTENEASRI 478
HPNIV L V E YL+ E L G+ +D K
Sbjct: 58 HPNIVCLQDVLMQESRLYLIFEFLSMDLKKYLDSLPKGQYMDAELVKS-----------Y 106
Query: 479 MRQLVAAVHFMHSRGVVHRDLKPENLLFSDPAGDNIKVVDFG----FACLKRESLHTPCF 534
+ Q++ + F HSR V+HRDLKP+NLL + IK+ DFG F R H
Sbjct: 107 LYQILQGILFCHSRRVLHRDLKPQNLLIDNKG--VIKLADFGLARAFGIPVRVYTHE-VV 163
Query: 535 TLQYAAPEVLRQDKSGYDENCDLWSLGVILV 565
TL Y APEVL Y D+WS+G I
Sbjct: 164 TLWYRAPEVL-LGSPRYSTPVDIWSIGTIFA 193
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression. CDK1/cyclin A2 has also been implicated as an important regulator of S phase events. The CDK1/cyclin B complex is critical for G2 to M phase transition. It induces mitosis by activating nuclear enzymes that regulate chromatin condensation, nuclear membrane degradation, mitosis-specific microtubule and cytoskeletal reorganization. CDK1 also associates with cyclin E and plays a role in the entry into S phase. CDK1 transcription is stable throughout the cell cycle but is modulated in some pathological conditions. It may play a role in regulating apoptosis under these conditions. In breast cancer cells, HER2 can mediate apoptosis by inactivating CDK1. Activation of CDK1 may contribute to HIV-1 induced apoptosis and neuronal apoptosis in neurodegenerative diseases. Length = 285 |
| >gnl|CDD|173673 cd05582, STKc_RSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 93.7 bits (233), Expect = 1e-20
Identities = 44/108 (40%), Positives = 59/108 (54%), Gaps = 1/108 (0%)
Query: 266 ILKTEPPIPEDLSPDVADFISRLLVKDPRRRLGGGELDAEELKRHPFFNVIDWDDLATKR 325
ILK + +P+ LSP+ + L ++P RLG G EE+KRHPFF+ IDW+ L +
Sbjct: 210 ILKAKLGMPQFLSPEAQSLLRALFKRNPANRLGAGPDGVEEIKRHPFFSTIDWNKLYRRE 269
Query: 326 IPAPFVPKISNELDVSNFSDEFTKMIPADSPAIVP-PNFDKIFKGSLF 372
I PF P + D F EFT P DSP I P N ++F+G F
Sbjct: 270 IKPPFKPAVGRPDDTFYFDPEFTSRTPKDSPGIPPSANAHQLFRGFSF 317
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylates all known RSK substrates. RSKs act as downstream effectors of mitogen-activated protein kinase (MAPK) and play key roles in mitogen-activated cell growth, differentiation, and survival. Mammals possess four RSK isoforms (RSK1-4) from distinct genes. RSK proteins are also referred to as MAP kinase-activated protein kinases (MAPKAPKs), p90-RSKs, or p90S6Ks. Length = 318 |
| >gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Score = 91.3 bits (227), Expect = 3e-20
Identities = 71/278 (25%), Positives = 124/278 (44%), Gaps = 50/278 (17%)
Query: 386 LGDGSYSVCRRCVEKSTGQEYAVKIIS--------RKIDCSEEINLLRACQGHPNIVNLH 437
+G G +SV + + G+ A+K + + DC +EI+LL+ HPN++
Sbjct: 10 IGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLD-HPNVIKYL 68
Query: 438 CVFQDEVHTYLVLELLKGGELLDRIR--QKGRCGFTENEASRIMRQLVAAVHFMHSRGVV 495
F + +VLEL G+L I+ +K + E + QL +A+ MHS+ ++
Sbjct: 69 ASFIENNELNIVLELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALEHMHSKRIM 128
Query: 496 HRDLKPENLLFSDPAGDNIKVVDFG---FACLKRESLHTPCFTLQYAAPEVLRQDKSGYD 552
HRD+KP N+ + A +K+ D G F K + H+ T Y +PE + +
Sbjct: 129 HRDIKPANVFIT--ATGVVKLGDLGLGRFFSSKTTAAHSLVGTPYYMSPERIHE------ 180
Query: 553 ENCDLWSLGVILVNVLRQDKSGYDENCDLWSLGVILYTMLCGRVPFHARSRDDSAL-SIM 611
+GY+ D+WSLG +LY M + PF+ D L S+
Sbjct: 181 --------------------NGYNFKSDIWSLGCLLYEMAALQSPFYG---DKMNLYSLC 217
Query: 612 ARIKEGQFN-FDAEAWSTVSSEAKELTKSLLTVNPAQR 648
+I++ + A+ +S E ++L + +P +R
Sbjct: 218 KKIEKCDYPPLPADHYSE---ELRDLVSRCINPDPEKR 252
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|173698 cd05607, STKc_GRK7, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Score = 91.5 bits (227), Expect = 3e-20
Identities = 71/274 (25%), Positives = 117/274 (42%), Gaps = 42/274 (15%)
Query: 386 LGDGSY-SVCRRCVEKSTGQEYAVKIISRK---IDCSEEINLLRA----CQGHPNIVNLH 437
LG G + VC V K+TG+ YA K + +K E++ LL P IVNL
Sbjct: 1 LGKGGFGEVCAVQV-KNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLA 59
Query: 438 CVFQDEVHTYLVLELLKGGELLDRIRQKGRCGFTENEASRIMRQLVAAVHFMHSRGVVHR 497
F+ + H LV+ L+ GG+L I G G Q+ + +HS +V+R
Sbjct: 60 YAFESKTHLCLVMSLMNGGDLKYHIYNVGERGLEMERVIHYSAQITCGILHLHSMDIVYR 119
Query: 498 DLKPENLLFSDPAGDNIKVVDFGFACLKRE--SLHTPCFTLQYAAPEVLRQDKSGYDENC 555
D+KPEN+L D N ++ D G A ++ ++ T Y APE+L+++
Sbjct: 120 DMKPENVLLDDQG--NCRLSDLGLAVELKDGKTITQRAGTNGYMAPEILKEEP------- 170
Query: 556 DLWSLGVILVNVLRQDKSGYDENCDLWSLGVILYTMLCGRVPFHARSRDDSALSIMARIK 615
Y D +++G +Y M+ GR PF + + R
Sbjct: 171 -------------------YSYPVDWFAMGCSIYEMVAGRTPFKDHKEKVAKEELKRRTL 211
Query: 616 EGQFNFDAEAWSTVSSEAKELTKSLLTVNPAQRI 649
E + F+ + + + E+K++ + L P R+
Sbjct: 212 EDEVKFEHQNF---TEESKDICRLFLAKKPEDRL 242
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual group of GRKs. It is primarily found in the retina and plays a role in the regulation of opsin light receptors. GRK7 is located in retinal cone outer segments and plays an important role in regulating photoresponse of the cones. Length = 277 |
| >gnl|CDD|173751 cd07860, STKc_CDK2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Score = 91.8 bits (228), Expect = 3e-20
Identities = 68/194 (35%), Positives = 90/194 (46%), Gaps = 17/194 (8%)
Query: 386 LGDGSYSVCRRCVEKSTGQEYAVKIISRKIDCS-------EEINLLRACQGHPNIVNLHC 438
+G+G+Y V + K TG+ A+K I + EI+LL+ HPNIV L
Sbjct: 8 IGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN-HPNIVKLLD 66
Query: 439 VFQDEVHTYLVLELLKGGELLDRIRQKGRCGFTENEASRIMRQLVAAVHFMHSRGVVHRD 498
V E YLV E L +L + G + QL+ + F HS V+HRD
Sbjct: 67 VIHTENKLYLVFEFLHQ-DLKKFMDASPLSGIPLPLIKSYLFQLLQGLAFCHSHRVLHRD 125
Query: 499 LKPENLLFSDPAGDNIKVVDFG----FACLKRESLHTPCFTLQYAAPEVLRQDKSGYDEN 554
LKP+NLL + G IK+ DFG F R H TL Y APE+L K Y
Sbjct: 126 LKPQNLLI-NTEG-AIKLADFGLARAFGVPVRTYTHE-VVTLWYRAPEILLGCKY-YSTA 181
Query: 555 CDLWSLGVILVNVL 568
D+WSLG I ++
Sbjct: 182 VDIWSLGCIFAEMV 195
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. CDK2, together with CDK4, also regulates embryonic cell proliferation. Despite these important roles, mice deleted for the cdk2 gene are viable and normal except for being sterile. This may be due to compensation provided by CDK1 (also called Cdc2), which can also bind cyclin E and drive the G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 284 |
| >gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Score = 90.7 bits (225), Expect = 4e-20
Identities = 66/281 (23%), Positives = 127/281 (45%), Gaps = 52/281 (18%)
Query: 381 DKAGILGDGSYSVCRRCVEKSTGQEYAVKII-------SRKIDCSEEINLLRACQGHPNI 433
+K ++G G++ + C K+ + +K I ++ E +L+ HPNI
Sbjct: 3 EKIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLS-HPNI 61
Query: 434 VNLHCVFQDEVHTYLVLELLKGGELLDRIRQKGRCGFTENEASRIMRQLVAAVHFMHSRG 493
+ + F ++ +V+E GG L + I+++ E+ Q++ A+H +H++
Sbjct: 62 IEYYENFLEDKALMIVMEYAPGGTLAEYIQKRCNSLLDEDTILHFFVQILLALHHVHTKL 121
Query: 494 VVHRDLKPENLLFSDPAGDNIKVVDFGFA-CLKRES-----LHTPCFTLQYAAPEVLRQD 547
++HRDLK +N+L D +K+ DFG + L +S + TPC Y +PE+
Sbjct: 122 ILHRDLKTQNILL-DKHKMVVKIGDFGISKILSSKSKAYTVVGTPC----YISPEL---- 172
Query: 548 KSGYDENCDLWSLGVILVNVLRQDKSGYDENCDLWSLGVILYTMLCGRVPFHARSRDDSA 607
C + Y++ D+W+LG +LY + + F A +
Sbjct: 173 -------C---------------EGKPYNQKSDIWALGCVLYELASLKRAFEAANLPALV 210
Query: 608 LSIMARIKEGQFNFDAEAWSTVSSEAKELTKSLLTVNPAQR 648
L IM+ G F ++ S + ++L S+L ++P++R
Sbjct: 211 LKIMS----GTFAPISD---RYSPDLRQLILSMLNLDPSKR 244
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256 |
| >gnl|CDD|173708 cd05617, STKc_aPKC_zeta, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Score = 92.0 bits (228), Expect = 4e-20
Identities = 62/225 (27%), Positives = 109/225 (48%), Gaps = 41/225 (18%)
Query: 385 ILGDGSYSVCRRCVEKSTGQEYAVKIISRK-------ID-CSEEINLLRACQGHPNIVNL 436
++G GSY+ K Q YA+K++ ++ ID E ++ +P +V L
Sbjct: 2 VIGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGL 61
Query: 437 HCVFQDEVHTYLVLELLKGGELLDRIRQKGRCGFTENEASRIMRQLVAAVHFMHSRGVVH 496
H FQ +LV+E + GG+L+ ++++ + E A ++ A++F+H RG+++
Sbjct: 62 HSCFQTTSRLFLVIEYVNGGDLMFHMQRQRK--LPEEHARFYAAEICIALNFLHERGIIY 119
Query: 497 RDLKPENLLFSDPAGDNIKVVDFGF---ACLKRESLHTPCFTLQYAAPEVLRQDKSGYDE 553
RDLK +N+L A +IK+ D+G ++ T C T Y APE+LR ++ G+
Sbjct: 120 RDLKLDNVLLD--ADGHIKLTDYGMCKEGLGPGDTTSTFCGTPNYIAPEILRGEEYGF-- 175
Query: 554 NCDLWSLGVILVNVLRQDKSGYDENCDLWSLGVILYTMLCGRVPF 598
+ D W+LGV+++ M+ GR PF
Sbjct: 176 ------------------------SVDWWALGVLMFEMMAGRSPF 196
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways. PKC-zeta also plays a central role in maintaining cell polarity in yeast and mammalian cells. In addition, it affects actin remodeling in muscle cells. Length = 327 |
| >gnl|CDD|143341 cd07836, STKc_Pho85, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Score = 91.4 bits (227), Expect = 4e-20
Identities = 68/238 (28%), Positives = 103/238 (43%), Gaps = 43/238 (18%)
Query: 386 LGDGSYSVCRRCVEKSTGQEYAVKIISRKIDCSE--------EINLLRACQGHPNIVNLH 437
LG+G+Y+ + ++TG+ A+K I +D E EI+L++ + H NIV LH
Sbjct: 8 LGEGTYATVYKGRNRTTGEIVALKEI--HLDAEEGTPSTAIREISLMKELK-HENIVRLH 64
Query: 438 CVFQDEVHTYLVLELLKGGELLDRIRQKG-RCGFTENEASRIMRQLVAAVHFMHSRGVVH 496
V E LV E + +L + G R N QL+ + F H V+H
Sbjct: 65 DVIHTENKLMLVFEYMDK-DLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFCHENRVLH 123
Query: 497 RDLKPENLLFSDPAGDNIKVVDFGFA---CLKRESLHTPCFTLQYAAPEVLRQDKSGYDE 553
RDLKP+NLL + +K+ DFG A + + TL Y AP+VL ++
Sbjct: 124 RDLKPQNLLINKRG--ELKLADFGLARAFGIPVNTFSNEVVTLWYRAPDVLLGSRT---- 177
Query: 554 NCDLWSLGVILVNVLRQDKSGYDENCDLWSLGVILYTMLCGRVPFHARSRDDSALSIM 611
Y + D+WS+G I+ M+ GR F + +D L I
Sbjct: 178 ---------------------YSTSIDIWSVGCIMAEMITGRPLFPGTNNEDQLLKIF 214
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. It is not essential for yeast viability and is the functional homolog of mammalian CDK5, which plays a role in central nervous system development. Length = 284 |
| >gnl|CDD|173719 cd05630, STKc_GRK6, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Score = 91.2 bits (226), Expect = 5e-20
Identities = 72/276 (26%), Positives = 122/276 (44%), Gaps = 45/276 (16%)
Query: 385 ILGDGSYSVCRRCVEKSTGQEYAVKIISRK---------IDCSEEINLLRACQGHPNIVN 435
+LG G + C ++TG+ YA K + +K + +E+ L + +V+
Sbjct: 7 VLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRF--VVS 64
Query: 436 LHCVFQDEVHTYLVLELLKGGELLDRIRQKGRCGFTENEASRIMRQLVAAVHFMHSRGVV 495
L ++ + LVL L+ GG+L I G GF E A ++ + +H +V
Sbjct: 65 LAYAYETKDALCLVLTLMNGGDLKFHIYHMGEAGFEEGRAVFYAAEICCGLEDLHQERIV 124
Query: 496 HRDLKPENLLFSDPAGDNIKVVDFGFACLKRE--SLHTPCFTLQYAAPEVLRQDKSGYDE 553
+RDLKPEN+L D +I++ D G A E ++ T+ Y APEV++ ++
Sbjct: 125 YRDLKPENILLDDHG--HIRISDLGLAVHVPEGQTIKGRVGTVGYMAPEVVKNER----- 177
Query: 554 NCDLWSLGVILVNVLRQDKSGYDENCDLWSLGVILYTMLCGRVPFHARSRDDSALSIMAR 613
Y + D W+LG +LY M+ G+ PF R + +
Sbjct: 178 ---------------------YTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERL 216
Query: 614 IKEGQFNFDAEAWSTVSSEAKELTKSLLTVNPAQRI 649
+KE Q + + S +A+ L K LL +P +R+
Sbjct: 217 VKEVQEEYSEK----FSPDARSLCKMLLCKDPKERL 248
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK6 plays important roles in the regulation of dopamine, M3 muscarinic, opioid, and chemokine receptor signaling. It also plays maladaptive roles in addiction and Parkinson's disease. GRK6-deficient mice exhibit altered dopamine receptor regulation, decreased lymphocyte chemotaxis, and increased acute inflammation and neutrophil chemotaxis. Length = 285 |
| >gnl|CDD|88524 cd05623, STKc_MRCK_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Score = 92.1 bits (228), Expect = 5e-20
Identities = 83/275 (30%), Positives = 131/275 (47%), Gaps = 40/275 (14%)
Query: 379 DLDKAGILGDGSYSVCRRCVEKSTGQEYAVKIISR-------KIDCSEEINLLRACQGHP 431
D + ++G G++ K+ + +A+KI+++ + C E + +
Sbjct: 2 DFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQ 61
Query: 432 NIVNLHCVFQDEVHTYLVLELLKGGELLDRIRQKGRCGFTENEASRIMRQLVAAVHFMHS 491
I LH FQDE + YLV++ GG+LL + K E+ A + ++V A+ +H
Sbjct: 62 WITTLHYAFQDENNLYLVMDYYVGGDLLTLL-SKFEDRLPEDMARFYLAEMVIAIDSVHQ 120
Query: 492 RGVVHRDLKPENLLFSDPAGDNIKVVDFGFACLKRESLHT-----PCFTLQYAAPEVLRQ 546
VHRD+KP+N+L D G +I++ DFG +CLK T T Y +PE+L+
Sbjct: 121 LHYVHRDIKPDNILM-DMNG-HIRLADFG-SCLKLMEDGTVQSSVAVGTPDYISPEILQA 177
Query: 547 DKSGYDENCDLWSLGVILVNVLRQDKSGYDENCDLWSLGVILYTMLCGRVPFHARSRDDS 606
+ G K Y CD WSLGV +Y ML G PF+A S ++
Sbjct: 178 MEDG---------------------KGKYGPECDWWSLGVCMYEMLYGETPFYAESLVET 216
Query: 607 ALSIMARIKEGQFNFDAEAWSTVSSEAKELTKSLL 641
IM KE +F F A+ + VS +AK+L + L+
Sbjct: 217 YGKIMNH-KE-RFQFPAQV-TDVSEDAKDLIRRLI 248
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathway. Length = 332 |
| >gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Score = 90.7 bits (225), Expect = 5e-20
Identities = 77/288 (26%), Positives = 121/288 (42%), Gaps = 47/288 (16%)
Query: 375 QYDMDLDKAG---ILGDGSYSVCRRCVEKSTGQEYAVKIISRKID-----CSEEINLLRA 426
+Y+ + D+ G +LG G+Y + + ST A+K I + EEI L
Sbjct: 2 EYEYEYDENGERVVLGKGTYGIVYAARDLSTQVRIAIKEIPERDSRYVQPLHEEIALHSY 61
Query: 427 CQGHPNIVNLHCVFQDEVHTYLVLELLKGGELLDRIRQK-GRCGFTENEASRIMRQLVAA 485
+ H NIV + + +E + GG L +R K G E +Q++
Sbjct: 62 LK-HRNIVQYLGSDSENGFFKIFMEQVPGGSLSALLRSKWGPLKDNEQTIIFYTKQILEG 120
Query: 486 VHFMHSRGVVHRDLKPENLLFSDPAGDNIKVVDFGFACLKRESLHTPCF-----TLQYAA 540
+ ++H +VHRD+K +N+L + +G +K+ DFG + KR + PC TLQY A
Sbjct: 121 LKYLHDNQIVHRDIKGDNVLVNTYSG-VVKISDFGTS--KRLAGINPCTETFTGTLQYMA 177
Query: 541 PEVLRQDKSGYDENCDLWSLGVILVNVLRQDKSGYDENCDLWSLGVILYTMLCGRVPFHA 600
PEV+ + GY D+WSLG +V M G+ PF
Sbjct: 178 PEVIDKGPRGYGAPADIWSLGCTIVE------------------------MATGKPPFIE 213
Query: 601 RSRDDSALSIMARIKEGQFNFDAEAWSTVSSEAKELTKSLLTVNPAQR 648
+A+ K G F E ++S+EAK +P +R
Sbjct: 214 LGEPQAAM-----FKVGMFKIHPEIPESLSAEAKNFILRCFEPDPDKR 256
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268 |
| >gnl|CDD|173722 cd05633, STKc_GRK3, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Score = 90.8 bits (225), Expect = 6e-20
Identities = 74/276 (26%), Positives = 117/276 (42%), Gaps = 45/276 (16%)
Query: 385 ILGDGSYSVCRRCVEKSTGQEYAVKIISRK---------IDCSEEINLLRACQGH-PNIV 434
I+G G + C + TG+ YA+K + +K + +E I L G P IV
Sbjct: 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIV 60
Query: 435 NLHCVFQDEVHTYLVLELLKGGELLDRIRQKGRCGFTENEASRIMRQLVAAVHFMHSRGV 494
+ F +L+L+ GG+L + Q G F+E E +++ + MH+R V
Sbjct: 61 CMTYAFHTPDKLCFILDLMNGGDLHYHLSQHGV--FSEKEMRFYATEIILGLEHMHNRFV 118
Query: 495 VHRDLKPENLLFSDPAGDNIKVVDFGFAC-LKRESLHTPCFTLQYAAPEVLRQDKSGYDE 553
V+RDLKP N+L + ++++ D G AC ++ H T Y APEVL
Sbjct: 119 VYRDLKPANILLDEHG--HVRISDLGLACDFSKKKPHASVGTHGYMAPEVL--------- 167
Query: 554 NCDLWSLGVILVNVLRQDKSGYDENCDLWSLGVILYTMLCGRVPFHARSRDDSALSIMAR 613
Q + YD + D +SLG +L+ +L G PF D
Sbjct: 168 ----------------QKGTAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDK-----HE 206
Query: 614 IKEGQFNFDAEAWSTVSSEAKELTKSLLTVNPAQRI 649
I + E + S E K L + LL + ++R+
Sbjct: 207 IDRMTLTVNVELPDSFSPELKSLLEGLLQRDVSKRL 242
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is widely expressed in many tissues. GRK3-deficient mice show a lack of olfactory receptor desensitization and altered regulation of the M2 muscarinic airway. GRK3 is involved in modulating the cholinergic response of airway smooth muscles. It also plays a role in dopamine receptor regulation. GRK3 promoter polymorphisms may be associated with bipolar disorder. Length = 279 |
| >gnl|CDD|173686 cd05595, STKc_PKB_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Score = 91.6 bits (227), Expect = 7e-20
Identities = 48/142 (33%), Positives = 79/142 (55%), Gaps = 7/142 (4%)
Query: 221 EVIDWDDFSRGIECVFFSSSLIIFFIILSFTLSFIHDYYHIQYRRILKTEPPIPEDLSPD 280
EV++ +D+ R ++ ++ + ++ L F + + + IL E P LSP+
Sbjct: 165 EVLEDNDYGRAVDWWGLG---VVMYEMMCGRLPFYNQDHERLFELILMEEIRFPRTLSPE 221
Query: 281 VADFISRLLVKDPRRRLGGGELDAEELKRHPFFNVIDWDDLATKRIPAPFVPKISNELDV 340
++ LL KDP++RLGGG DA+E+ H FF I+W D+ K++ PF P++++E+D
Sbjct: 222 AKSLLAGLLKKDPKQRLGGGPSDAKEVMEHRFFLSINWQDVVQKKLLPPFKPQVTSEVDT 281
Query: 341 SNFSDEFTKMIPADSPAIVPPN 362
F DEFT A S I PP+
Sbjct: 282 RYFDDEFT----AQSITITPPD 299
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in PKB-beta display normal growth weights but exhibit severe insulin resistance and diabetes, accompanied by lipoatrophy and B-cell failure. Length = 323 |
| >gnl|CDD|173676 cd05585, STKc_YPK1_like, Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 90.8 bits (225), Expect = 9e-20
Identities = 40/93 (43%), Positives = 54/93 (58%), Gaps = 2/93 (2%)
Query: 263 YRRILKTEPPIPEDLSPDVADFISRLLVKDPRRRLGGGELDAEELKRHPFFNVIDWDDLA 322
YR+IL+ P+ D D + LL +DP RRLG A+E+K HPFF+ + W L
Sbjct: 202 YRKILQEPLRFPDGFDRDAKDLLIGLLSRDPTRRLGYN--GAQEIKNHPFFSQLSWKKLL 259
Query: 323 TKRIPAPFVPKISNELDVSNFSDEFTKMIPADS 355
K I PF P +S+ +D SNF +EFT+ P DS
Sbjct: 260 MKGIQPPFKPAVSSAIDTSNFDEEFTREKPIDS 292
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It plays a role in cell growth and sexual development. Length = 312 |
| >gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 89.8 bits (223), Expect = 1e-19
Identities = 71/281 (25%), Positives = 120/281 (42%), Gaps = 57/281 (20%)
Query: 385 ILGDGSYSVCRRCVEKSTGQEYAVKIISRKIDCSE------EINLLRACQGH--PNIVNL 436
++G G+Y R TG+ A+KII+ + E+ LL + PNI
Sbjct: 8 LIGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQREVALLSQLRQSQPPNITKY 67
Query: 437 HCVFQDEVHTYLVLELLKGGELLDRIRQKGRCG-FTENEASRIMRQLVAAVHFMHSRGVV 495
+ + ++++E +GG +R + G E S I+R+++ A+ ++H GV+
Sbjct: 68 YGSYLKGPRLWIIMEYAEGGS----VRTLMKAGPIAEKYISVIIREVLVALKYIHKVGVI 123
Query: 496 HRDLKPENLLFSDPAGDNIKVVDFGFACL------KRESL-HTPCFTLQYAAPEVLRQDK 548
HRD+K N+L ++ N+K+ DFG A L KR + TP + APEV+ + K
Sbjct: 124 HRDIKAANILVTNTG--NVKLCDFGVAALLNQNSSKRSTFVGTP----YWMAPEVITEGK 177
Query: 549 SGYDENCDLWSLGVILVNVLRQDKSGYDENCDLWSLGVILYTMLCGRVPFHARSRDDSAL 608
YD D+WSLG+ +Y M G P+ S D+
Sbjct: 178 Y-------------------------YDTKADIWSLGITIYEMATGNPPY---SDVDAFR 209
Query: 609 SIMARIKEGQFNFDAEAWSTVSSEAKELTKSLLTVNPAQRI 649
++M K + +S +E + L P +R+
Sbjct: 210 AMMLIPKSKPPRLEDNGYSK---LLREFVAACLDEEPKERL 247
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277 |
| >gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase | Back alignment and domain information |
|---|
Score = 89.5 bits (223), Expect = 1e-19
Identities = 55/197 (27%), Positives = 90/197 (45%), Gaps = 27/197 (13%)
Query: 386 LGDGSYSVCRRCVEKSTGQEY----AVKIISRKIDCS------EEINLLRACQGHPNIVN 435
LG+G++ + K G+ AVK + EE ++++ HPNIV
Sbjct: 7 LGEGAFGEVYKGTLKGDGEGTETKVAVKTLKEGASEEEREEFLEEASIMKKLS-HPNIVR 65
Query: 436 LHCVFQDEVHTYLVLELLKGGELLDRIRQKGRCGFTENEASRIMRQLVAAVHFMHSRGVV 495
L V Y+V E + GG+LLD +R+ G T + ++ Q+ + ++ S+ V
Sbjct: 66 LLGVCTQGEPLYIVTEYMPGGDLLDFLRKHGEK-LTLKDLLQMALQIAKGMEYLESKNFV 124
Query: 496 HRDLKPENLLFSDPAGDNIKVVDFGFA--------CLKRESLHTPCFTLQYAAPEVLRQD 547
HRDL N L ++ +K+ DFG + KR P +++ APE L+
Sbjct: 125 HRDLAARNCLVTE--NLVVKISDFGLSRDIYEDDYYRKRGGGKLP---IKWMAPESLKDG 179
Query: 548 KSGYDENCDLWSLGVIL 564
K + D+WS GV+L
Sbjct: 180 K--FTSKSDVWSFGVLL 194
|
Length = 258 |
| >gnl|CDD|173762 cd08222, STKc_Nek11, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Score = 89.2 bits (221), Expect = 1e-19
Identities = 74/279 (26%), Positives = 117/279 (41%), Gaps = 52/279 (18%)
Query: 386 LGDGSYSVCRRCVEKSTGQEYAVKII----------SRKIDCSEEINLLRACQGHPNIVN 435
LG GS+ +K E +K++ + + ++E LL HP IV
Sbjct: 8 LGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLD-HPAIVK 66
Query: 436 LHCVFQDEVHTYLVLELLKGGELLDRIRQKGRCG--FTENEASRIMRQLVAAVHFMHSRG 493
H F + ++ E +G +L ++ + G +EN+ QL+ VH+MH R
Sbjct: 67 FHASFLERDAFCIITEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMHQRR 126
Query: 494 VVHRDLKPENLLFSDPAGDNIKVVDFGFACLKRESLH---TPCFTLQYAAPEVLRQDKSG 550
++HRDLK +N+ + + +K+ DFG + L S T T Y +PE L+
Sbjct: 127 ILHRDLKAKNIFLKN---NLLKIGDFGVSRLLMGSCDLATTFTGTPYYMSPEALKH---- 179
Query: 551 YDENCDLWSLGVILVNVLRQDKSGYDENCDLWSLGVILYTMLCGRVPFHARSRDDSALSI 610
GYD D+WSLG ILY M C F + + LS+
Sbjct: 180 ----------------------QGYDSKSDIWSLGCILYEMCCLAHAFEGQ----NFLSV 213
Query: 611 MARIKEGQFNFDAEAWSTVSSEAKELTKSLLTVNPAQRI 649
+ RI EG E T S + + +S+L +P+ R
Sbjct: 214 VLRIVEGPTPSLPE---TYSRQLNSIMQSMLNKDPSLRP 249
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M checkpoint. Nek11 may also play a role in the S-phase checkpoint as well as in DNA replication and genotoxic stress responses. Length = 260 |
| >gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Score = 89.1 bits (222), Expect = 1e-19
Identities = 53/197 (26%), Positives = 94/197 (47%), Gaps = 26/197 (13%)
Query: 385 ILGDGSY-SVCR---RCVEKSTGQEYAVKIISRKIDCSE--------EINLLRACQGHPN 432
LG+G++ V + + E AVK + K D SE E ++R HPN
Sbjct: 6 KLGEGAFGEVYKGKLKGKGGKKKVEVAVKTL--KEDASEQQIEEFLREARIMRKLD-HPN 62
Query: 433 IVNLH-CVFQDEVHTYLVLELLKGGELLDRIRQKGRCGFTENEASRIMRQLVAAVHFMHS 491
+V L ++E Y+V+E ++GG+LL +R+ R + ++ Q+ + ++ S
Sbjct: 63 VVKLLGVCTEEEPL-YIVMEYMEGGDLLSYLRKN-RPKLSLSDLLSFALQIARGMEYLES 120
Query: 492 RGVVHRDLKPENLLFSDPAGDNIKVVDFGFAC-LKRESLHTPC---FTLQYAAPEVLRQD 547
+ +HRDL N L + +K+ DFG + L + + +++ APE L++
Sbjct: 121 KNFIHRDLAARNCLVGE--NLVVKISDFGLSRDLYDDDYYRKRGGKLPIRWMAPESLKEG 178
Query: 548 KSGYDENCDLWSLGVIL 564
K + D+WS GV+L
Sbjct: 179 K--FTSKSDVWSFGVLL 193
|
Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257 |
| >gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Score = 87.7 bits (218), Expect = 2e-19
Identities = 29/72 (40%), Positives = 48/72 (66%), Gaps = 2/72 (2%)
Query: 894 HTYLVLELLKGGELLDRIRQKGRCGFTENEASRIMRQLVAAVHFMHSRGVVHRDLKPENL 953
H YLV+E +GG L D +++ +E+E RI+ Q++ + ++HS G++HRDLKPEN+
Sbjct: 65 HLYLVMEYCEGGSLKDLLKEN-EGKLSEDEILRILLQILEGLEYLHSNGIIHRDLKPENI 123
Query: 954 LLSGISGNLIKI 965
LL +G +K+
Sbjct: 124 LLDSDNGK-VKL 134
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215 |
| >gnl|CDD|132975 cd06644, STKc_STK10_LOK, Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Score = 89.7 bits (222), Expect = 2e-19
Identities = 71/216 (32%), Positives = 106/216 (49%), Gaps = 29/216 (13%)
Query: 373 FEQYDMDLDK------AGILGDGSYSVCRRCVEKSTGQEYAVKIISRKI-----DCSEEI 421
+E DLD G LGDG++ + K TG A K+I K D EI
Sbjct: 1 YEHVRRDLDPNEVWEIIGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYMVEI 60
Query: 422 NLLRACQGHPNIVNLHCVFQDEVHTYLVLELLKGGELLDRIRQKGRCGFTENEASRIMRQ 481
+L C HP IV L F + ++++E GG + D I + G TE + I RQ
Sbjct: 61 EILATCN-HPYIVKLLGAFYWDGKLWIMIEFCPGGAV-DAIMLELDRGLTEPQIQVICRQ 118
Query: 482 LVAAVHFMHSRGVVHRDLKPENLLFSDPAGDNIKVVDFGFAC------LKRES-LHTPCF 534
++ A+ ++HS ++HRDLK N+L + GD IK+ DFG + +R+S + TP
Sbjct: 119 MLEALQYLHSMKIIHRDLKAGNVLLTLD-GD-IKLADFGVSAKNVKTLQRRDSFIGTP-- 174
Query: 535 TLQYAAPEVL---RQDKSGYDENCDLWSLGVILVNV 567
+ APEV+ + YD D+WSLG+ L+ +
Sbjct: 175 --YWMAPEVVMCETMKDTPYDYKADIWSLGITLIEM 208
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. Length = 292 |
| >gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 88.6 bits (220), Expect = 2e-19
Identities = 77/279 (27%), Positives = 114/279 (40%), Gaps = 48/279 (17%)
Query: 382 KAGILGDGSYSVCRRCVEKSTGQEYAVKIISRKIDCS----------EEINLLRACQGHP 431
K +LG GS+ + G +AVK +S D +EI LL Q HP
Sbjct: 4 KGELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQ-HP 62
Query: 432 NIVNLHCVFQDEVHTYLVLELLKGGELLDRIRQKGRCGFTENEASRIMRQLVAAVHFMHS 491
NIV ++E + Y+ LEL+ GG L +++ G F E RQ++ + ++H
Sbjct: 63 NIVQYLGTEREEDNLYIFLELVPGGSLAKLLKKYG--SFPEPVIRLYTRQILLGLEYLHD 120
Query: 492 RGVVHRDLKPENLLFSDPAGDNIKVVDFGFACLKRESLHTPCF--TLQYAAPEVLRQDKS 549
R VHRD+K N+L D G +K+ DFG A E F + + APEV+ Q
Sbjct: 121 RNTVHRDIKGANILV-DTNGV-VKLADFGMAKQVVEFSFAKSFKGSPYWMAPEVIAQ--- 175
Query: 550 GYDENCDLWSLGVILVNVLRQDKSGYDENCDLWSLGVILYTMLCGRVPFHARSRDDSALS 609
+ GY D+WSLG + M G+ P+
Sbjct: 176 ----------------------QGGYGLAADIWSLGCTVLEMATGKPPWSQLE------G 207
Query: 610 IMARIKEGQFNFDAEAWSTVSSEAKELTKSLLTVNPAQR 648
+ A K G+ +S EAK+ L +P+ R
Sbjct: 208 VAAVFKIGRSKELPPIPDHLSDEAKDFILKCLQRDPSLR 246
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258 |
| >gnl|CDD|173718 cd05629, STKc_NDR_like_fungal, Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 91.1 bits (226), Expect = 2e-19
Identities = 85/318 (26%), Positives = 140/318 (44%), Gaps = 59/318 (18%)
Query: 385 ILGDGSYSVCRRCVEKSTGQEYAVKIISR----KID----CSEEINLLRACQGHPNIVNL 436
++G G++ R +K TG+ YA+K + + K D E ++L A P +V+L
Sbjct: 8 VIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVL-AESDSPWVVSL 66
Query: 437 HCVFQDEVHTYLVLELLKGGELLDR-IRQKGRCGFTENEASRIMRQLVAAVHFMHSRGVV 495
+ FQD + YL++E L GG+L+ I+ F+E+ M + V A+ +H G +
Sbjct: 67 YYSFQDAQYLYLIMEFLPGGDLMTMLIKYDT---FSEDVTRFYMAECVLAIEAVHKLGFI 123
Query: 496 HRDLKPENLLFSDPAGDNIKVVDFGFACLKRESLHTPCFTLQYAAPEVLRQDKSGYDENC 555
HRD+KP+N+L G +IK+ DFG + H A + L Q KS +
Sbjct: 124 HRDIKPDNILID--RGGHIKLSDFGLST----GFHK---QHDSAYYQKLLQGKSNKNRID 174
Query: 556 DLWSLGVILVNVLRQDKS-------------------------------GYDENCDLWSL 584
+ S+ V +N+ K GY + CD WSL
Sbjct: 175 NRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQGYGQECDWWSL 234
Query: 585 GVILYTMLCGRVPFHARSRDDSALSIMARIKEGQFNFDAEAWSTVSSEAKELTKSLLTVN 644
G I++ L G PF + + ++ I+ + F D +S EA++L + L+T N
Sbjct: 235 GAIMFECLIGWPPFCSENSHETYRKIINWRETLYFPDDI----HLSVEAEDLIRRLIT-N 289
Query: 645 PAQRI-RMMRVKLTFHAF 661
R+ R ++ H F
Sbjct: 290 AENRLGRGGAHEIKSHPF 307
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of Ace2p activity and cellular morphogenesis) network. CBK1 and Orb6 play similar roles in coordinating cell morphology with cell cycle progression. Ukc1 is involved in morphogenesis, pathogenicity, and pigment formation. Cot1 plays a role in polar tip extension. Length = 377 |
| >gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Score = 87.9 bits (218), Expect = 3e-19
Identities = 65/236 (27%), Positives = 105/236 (44%), Gaps = 39/236 (16%)
Query: 416 DCSEEINLLRACQGHPNIVNLHCVFQDEVHTYLVLELLKGGELLDRIRQKGRCGFTENEA 475
D EI +L Q HPNI+ + F D+ + +E GG L D+I ++ F E
Sbjct: 45 DALNEIVILSLLQ-HPNIIAYYNHFMDDNTLLIEMEYANGGTLYDKIVRQKGQLFEEEMV 103
Query: 476 SRIMRQLVAAVHFMHSRGVVHRDLKPENLLFSDPAGDNIKVVDFGFA-CLKRESLH--TP 532
+ Q+V+AV ++H G++HRD+K N+ + IK+ DFG + L E T
Sbjct: 104 LWYLFQIVSAVSYIHKAGILHRDIKTLNIFLT--KAGLIKLGDFGISKILGSEYSMAETV 161
Query: 533 CFTLQYAAPEVLRQDKSGYDENCDLWSLGVILVNVLRQDKSGYDENCDLWSLGVILYTML 592
T Y +PE+ + K Y+ D+W+LG +LY +L
Sbjct: 162 VGTPYYMSPELCQGVK--------------------------YNFKSDIWALGCVLYELL 195
Query: 593 CGRVPFHARSRDDSALSIMARIKEGQFNFDAEAWSTVSSEAKELTKSLLTVNPAQR 648
+ F A + L+++ +I +G + + SSE L SLL +P +R
Sbjct: 196 TLKRTFDA----TNPLNLVVKIVQGNYTPVVSVY---SSELISLVHSLLQQDPEKR 244
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256 |
| >gnl|CDD|173684 cd05593, STKc_PKB_gamma, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Score = 89.4 bits (221), Expect = 4e-19
Identities = 46/141 (32%), Positives = 77/141 (54%), Gaps = 7/141 (4%)
Query: 221 EVIDWDDFSRGIECVFFSSSLIIFFIILSFTLSFIHDYYHIQYRRILKTEPPIPEDLSPD 280
EV++ +D+ R ++ ++ + ++ L F + + + IL + P LS D
Sbjct: 165 EVLEDNDYGRAVDWWGLG---VVMYEMMCGRLPFYNQDHEKLFELILMEDIKFPRTLSAD 221
Query: 281 VADFISRLLVKDPRRRLGGGELDAEELKRHPFFNVIDWDDLATKRIPAPFVPKISNELDV 340
+S LL+KDP +RLGGG DA+E+ RH FF ++W D+ K++ PF P++++E D
Sbjct: 222 AKSLLSGLLIKDPNKRLGGGPDDAKEIMRHSFFTGVNWQDVYDKKLVPPFKPQVTSETDT 281
Query: 341 SNFSDEFTKMIPADSPAIVPP 361
F +EFT A + I PP
Sbjct: 282 RYFDEEFT----AQTITITPP 298
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulated in estrogen-deficient breast cancer cells, androgen-independent prostate cancer cells, and primary ovarian tumors. It acts as a key mediator in the genesis of ovarian cancer. Length = 328 |
| >gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Score = 88.2 bits (218), Expect = 4e-19
Identities = 57/176 (32%), Positives = 92/176 (52%), Gaps = 10/176 (5%)
Query: 414 KIDCSEEINLLRACQGHPNIVNLHCVFQDEVHTYLVLELLKGGELLDRIR--QKGRCGFT 471
+ DC +EI+LL+ HPN++ + F ++ +VLEL G+L I+ +K +
Sbjct: 46 RADCIKEIDLLKQLN-HPNVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIP 104
Query: 472 ENEASRIMRQLVAAVHFMHSRGVVHRDLKPENLLFSDPAGDNIKVVDFG---FACLKRES 528
E + QL +A+ MHSR V+HRD+KP N+ + A +K+ D G F K +
Sbjct: 105 EKTVWKYFVQLCSALEHMHSRRVMHRDIKPANVFIT--ATGVVKLGDLGLGRFFSSKTTA 162
Query: 529 LHTPCFTLQYAAPEVLRQDKSGYDENCDLWSLGVILVNVLRQDKSGYDENCDLWSL 584
H+ T Y +PE R ++GY+ D+WSLG +L + Y + +L+SL
Sbjct: 163 AHSLVGTPYYMSPE--RIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSL 216
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|132983 cd06652, STKc_MEKK2, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Score = 87.8 bits (217), Expect = 4e-19
Identities = 62/204 (30%), Positives = 104/204 (50%), Gaps = 25/204 (12%)
Query: 385 ILGDGSYSVCRRCVEKSTGQEYAVKII---------SRKIDCSE-EINLLRACQGHPNIV 434
+LG G++ C + TG+E AVK + S++++ E EI LL+ H IV
Sbjct: 9 LLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLL-HERIV 67
Query: 435 NLHCVFQD--EVHTYLVLELLKGGELLDRIRQKGRCGFTENEASRIMRQLVAAVHFMHSR 492
+ +D E + +E + GG + D+++ G TEN + RQ++ V ++HS
Sbjct: 68 QYYGCLRDPMERTLSIFMEHMPGGSIKDQLKSYG--ALTENVTRKYTRQILEGVSYLHSN 125
Query: 493 GVVHRDLKPENLLFSDPAGDNIKVVDFGFA------CLKRESLHTPCFTLQYAAPEVLRQ 546
+VHRD+K N+L D G N+K+ DFG + CL + + T + +PEV+
Sbjct: 126 MIVHRDIKGANIL-RDSVG-NVKLGDFGASKRLQTICLSGTGMKSVTGTPYWMSPEVISG 183
Query: 547 DKSGYDENCDLWSLGVILVNVLRQ 570
+ GY D+WS+G +V +L +
Sbjct: 184 E--GYGRKADIWSVGCTVVEMLTE 205
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their respective MAPKKs MEK1/2, JNK-activating kinase 2 (JNKK2), and MKK3/6. MEKK2 plays roles in T cell receptor signaling, immune synapse formation, cytokine gene expression, as well as in EGF and FGF receptor signaling. Length = 265 |
| >gnl|CDD|173685 cd05594, STKc_PKB_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Score = 88.5 bits (219), Expect = 7e-19
Identities = 48/149 (32%), Positives = 79/149 (53%), Gaps = 7/149 (4%)
Query: 221 EVIDWDDFSRGIECVFFSSSLIIFFIILSFTLSFIHDYYHIQYRRILKTEPPIPEDLSPD 280
EV++ +D+ R ++ ++ + ++ L F + + + IL E P LSP+
Sbjct: 166 EVLEDNDYGRAVDWWGLG---VVMYEMMCGRLPFYNQDHEKLFELILMEEIRFPRTLSPE 222
Query: 281 VADFISRLLVKDPRRRLGGGELDAEELKRHPFFNVIDWDDLATKRIPAPFVPKISNELDV 340
+S LL KDP++RLGGG DA+E+ +H FF I W D+ K++ PF P++++E D
Sbjct: 223 AKSLLSGLLKKDPKQRLGGGPDDAKEIMQHKFFAGIVWQDVYEKKLVPPFKPQVTSETDT 282
Query: 341 SNFSDEFTKMIPADSPAIVPPNFDKIFKG 369
F +EFT A I PP+ D +
Sbjct: 283 RYFDEEFT----AQMITITPPDQDDSMET 307
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficient in PKB-alpha exhibit perinatal morbidity, growth retardation, reduction in body weight accompanied by reduced sizes of multiple organs, and enhanced apoptosis in some cell types. PKB-alpha activity has been reported to be frequently elevated in breast and prostate cancers. In some cancer cells, PKB-alpha may act as a suppressor of metastasis. Length = 325 |
| >gnl|CDD|173720 cd05631, STKc_GRK4, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Score = 87.4 bits (216), Expect = 9e-19
Identities = 75/276 (27%), Positives = 119/276 (43%), Gaps = 45/276 (16%)
Query: 385 ILGDGSYSVCRRCVEKSTGQEYAVKIISRK--------IDCSEEINLLRACQGHPNIVNL 436
+LG G + C ++TG+ YA K + +K E +L +V+L
Sbjct: 7 VLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSR-FVVSL 65
Query: 437 HCVFQDEVHTYLVLELLKGGELLDRIRQKGRCGFTENEASRIMRQLVAAVHFMHSRGVVH 496
++ + LVL ++ GG+L I G GF E A +L + + +V+
Sbjct: 66 AYAYETKDALCLVLTIMNGGDLKFHIYNMGNPGFDEQRAIFYAAELCCGLEDLQRERIVY 125
Query: 497 RDLKPENLLFSDPAGDNIKVVDFGFACL--KRESLHTPCFTLQYAAPEVLRQDKSGYDEN 554
RDLKPEN+L D +I++ D G A + E++ T+ Y APEV+ +K
Sbjct: 126 RDLKPENILLDDRG--HIRISDLGLAVQIPEGETVRGRVGTVGYMAPEVINNEK------ 177
Query: 555 CDLWSLGVILVNVLRQDKSGYDENCDLWSLGVILYTMLCGRVPFHARSRDDSALSIMARI 614
Y + D W LG ++Y M+ G+ PF R + R+
Sbjct: 178 --------------------YTFSPDWWGLGCLIYEMIQGQSPFRKRKERVKREEVDRRV 217
Query: 615 KEGQFNFDAEAWS-TVSSEAKELTKSLLTVNPAQRI 649
KE D E +S S +AK + + LLT NP +R+
Sbjct: 218 KE-----DQEEYSEKFSEDAKSICRMLLTKNPKERL 248
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found in the testis, but is also present in the cerebellum and kidney. It is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK4 polymorphisms are associated with hypertension and salt sensitivity, as they cause hyperphosphorylation, desensitization, and internalization of the dopamine 1 (D1) receptor while increasing the expression of the angiotensin II type 1 receptor. GRK4 plays a crucial role in the D1 receptor regulation of sodium excretion and blood pressure. Length = 285 |
| >gnl|CDD|173699 cd05608, STKc_GRK1, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Score = 86.8 bits (215), Expect = 1e-18
Identities = 76/309 (24%), Positives = 127/309 (41%), Gaps = 67/309 (21%)
Query: 386 LGDGSYSVCRRCVEKSTGQEYAVKIISRKIDCSEEINLLRACQGHPN------------- 432
LG G + C ++TG+ YA K +++K L+ +G+
Sbjct: 1 LGKGGFGEVSACQMRATGKLYACKKLNKK--------RLKKRKGYEGAMVEKRILAKVHS 52
Query: 433 --IVNLHCVFQDEVHTYLVLELLKGGELLDRIRQ--KGRCGFTENEASRIMRQLVAAVHF 488
IV+L FQ + LV+ ++ GG+L I + GF E A Q+++ +
Sbjct: 53 RFIVSLAYAFQTKTDLCLVMTIMNGGDLRYHIYNVDEENPGFPEPRACFYTAQIISGLEH 112
Query: 489 MHSRGVVHRDLKPENLLFSDPAGDNIKVVDFGFAC-LKRESLHTPCF--TLQYAAPEVLR 545
+H R +++RDLKPEN+L + N+++ D G A LK T + T + APE+L+
Sbjct: 113 LHQRRIIYRDLKPENVLLDNDG--NVRISDLGLAVELKDGQSKTKGYAGTPGFMAPELLQ 170
Query: 546 QDKSGYDENCDLWSLGVILVNVLRQDKSGYDENCDLWSLGVILYTMLCGRVPFHARSRDD 605
++ YD + D ++LGV LY M+ R PF AR
Sbjct: 171 GEE--------------------------YDFSVDYFALGVTLYEMIAARGPFRARGEKV 204
Query: 606 SALSIMARIKEGQFNFDAEAWSTVSSEAKELTKSLLTVNPAQRI-------RMMRVKLTF 658
+ RI + + S +K ++LL +P +R+ +R F
Sbjct: 205 ENKELKQRILNDSVTYPDK----FSPASKSFCEALLAKDPEKRLGFRDGNCDGLRTHPLF 260
Query: 659 HAFHQAQKE 667
+ Q E
Sbjct: 261 RDLNWRQLE 269
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual group of GRKs and is expressed in retinal cells. It phosphorylates rhodopsin in rod cells, which leads to termination of the phototransduction cascade. Mutations in GRK1 are associated to a recessively inherited form of stationary nightblindness called Oguchi disease. Length = 280 |
| >gnl|CDD|173749 cd07855, STKc_ERK5, Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Score = 87.8 bits (218), Expect = 1e-18
Identities = 75/289 (25%), Positives = 124/289 (42%), Gaps = 38/289 (13%)
Query: 385 ILGDGSYSVCRRCVEKSTGQEYAVKIISRKIDCS-------EEINLLRACQGHPNIVNLH 437
+G G+Y V ++ +G++ A+K I D E+ +LR + H NI+ +
Sbjct: 12 NIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVPTLAKRTLRELKILRHFK-HDNIIAIR 70
Query: 438 CVFQDEV----HTYLVLELLKGGELLDRIRQKGRCGFTENEASRIMRQLVAAVHFMHSRG 493
+ + Y+V++L++ L I TE + QL+ + ++HS
Sbjct: 71 DILRPPGADFKDVYVVMDLMESD--LHHIIH-SDQPLTEEHIRYFLYQLLRGLKYIHSAN 127
Query: 494 VVHRDLKPENLLFSDPAGDNIKVVDFGFA-CLKRESLHTPCF------TLQYAAPEVLRQ 546
V+HRDLKP NLL ++ +++ DFG A L F T Y APE+L
Sbjct: 128 VIHRDLKPSNLLVNEDC--ELRIGDFGMARGLSSSPTEHKYFMTEYVATRWYRAPELLLS 185
Query: 547 DKSGYDENCDLWSLGVILVNVL--RQDKSGYDENCDLWSLGVILYTMLCGRVPFHARSRD 604
Y D+WS+G I +L RQ G + + L +IL ++L G +R
Sbjct: 186 -LPEYTTAIDMWSVGCIFAEMLGRRQLFPGKNY---VHQLKLIL-SVL-GSPSEEVLNRI 239
Query: 605 DSALSIMARIKEGQFNFDAEAWSTV----SSEAKELTKSLLTVNPAQRI 649
S + + + WS + S EA +L +L +P +RI
Sbjct: 240 GSDR--VRKYIQNLPRKQPVPWSKIFPKASPEALDLLSQMLQFDPEERI 286
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the MAP2K MEK5, which in turn is regulated by the MAP3Ks MEKK2 and MEKK3. Activated ERK5 phosphorylates its targets including myocyte enhancer factor 2 (MEF2), Sap1a, c-Myc, and RSK. It plays a role in EGF-induced cell proliferation during the G1/S phase transition. Studies on knockout mice revealed that ERK5 is essential for cardiovascular development and plays an important role in angiogenesis. It is also critical for neural differentiation and survival. The ERK5 pathway has been implicated in the pathogenesis of many diseases including cancer, cardiac hypertrophy, and atherosclerosis. Length = 334 |
| >gnl|CDD|143342 cd07837, STKc_CdkB_plant, Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Score = 86.8 bits (215), Expect = 2e-18
Identities = 62/211 (29%), Positives = 89/211 (42%), Gaps = 29/211 (13%)
Query: 381 DKAGILGDGSYSVCRRCVEKSTGQEYAVKIISRKID-------CSEEINLLRACQGHPNI 433
+K +G+G+Y + +K+TG+ A+K ++D EI+LL+ I
Sbjct: 4 EKLEKIGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALREISLLQMLSESIYI 63
Query: 434 VNLHCVFQDEVHT---------YLVLELLKGG--ELLDRIRQKGRCGFTENEASRIMRQL 482
V L V H YLV E L + +D + M QL
Sbjct: 64 VRLLDV----EHVEEKNGKPSLYLVFEYLDSDLKKFMDSNGRGPGRPLPAKTIKSFMYQL 119
Query: 483 VAAVHFMHSRGVVHRDLKPENLLFSDPAGDNIKVVDFG----FACLKRESLHTPCFTLQY 538
+ V H GV+HRDLKP+NLL D +K+ D G F+ + H TL Y
Sbjct: 120 LKGVAHCHKHGVMHRDLKPQNLLV-DKQKGLLKIADLGLGRAFSIPVKSYTHE-IVTLWY 177
Query: 539 AAPEVLRQDKSGYDENCDLWSLGVILVNVLR 569
APEVL + Y D+WS+G I + R
Sbjct: 178 RAPEVL-LGSTHYSTPVDIWSVGCIFAEMSR 207
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developmental pathways, such as stomata and leaf development. CdkB has been shown to associate with both cyclin B, which controls G2/M transition, and cyclin D, which acts as a mediator in linking extracellular signals to the cell cycle. Length = 295 |
| >gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 85.7 bits (213), Expect = 2e-18
Identities = 52/204 (25%), Positives = 90/204 (44%), Gaps = 32/204 (15%)
Query: 385 ILGDGSYSVCRRCV---EKSTGQEYAVKIISRKIDCSEEINLLRACQ-----GHPNIVNL 436
LG+G++ + + E AVK + E + L+ + GHPN+V L
Sbjct: 2 KLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVRL 61
Query: 437 -HCVFQDEVHTYLVLELLKGGELLDRIRQKGRCGFTENEAS-------RIMRQLVAAVHF 488
++E YLVLE ++GG+LLD +R+ + +++ Q+ + +
Sbjct: 62 LGVCTEEE-PLYLVLEYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEY 120
Query: 489 MHSRGVVHRDLKPENLLFSDPAGDNIKVVDFGFA--------CLKRESLHTPCFTLQYAA 540
+ S+ VHRDL N L + +K+ DFG + K+ P +++ A
Sbjct: 121 LASKKFVHRDLAARNCLVGE--DLVVKISDFGLSRDVYDDDYYRKKTGGKLP---IRWMA 175
Query: 541 PEVLRQDKSGYDENCDLWSLGVIL 564
PE L+ + D+WS GV+L
Sbjct: 176 PESLKDGI--FTSKSDVWSFGVLL 197
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262 |
| >gnl|CDD|132974 cd06643, STKc_SLK, Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Score = 85.8 bits (212), Expect = 3e-18
Identities = 61/195 (31%), Positives = 101/195 (51%), Gaps = 15/195 (7%)
Query: 384 GILGDGSYSVCRRCVEKSTGQEYAVKIISRKI-----DCSEEINLLRACQGHPNIVNLHC 438
G LGDG++ + K TG A K+I K D EI++L +C HPNIV L
Sbjct: 11 GELGDGAFGKVYKAQNKETGVLAAAKVIDTKSEEELEDYMVEIDILASCD-HPNIVKLLD 69
Query: 439 VFQDEVHTYLVLELLKGGELLDRIRQKGRCGFTENEASRIMRQLVAAVHFMHSRGVVHRD 498
F E + ++++E GG + D + + TE + + +Q + A++++H ++HRD
Sbjct: 70 AFYYENNLWILIEFCAGGAV-DAVMLELERPLTEPQIRVVCKQTLEALNYLHENKIIHRD 128
Query: 499 LKPENLLFSDPAGDNIKVVDFGFACLKRESLH---TPCFTLQYAAPEVLRQDKSG---YD 552
LK N+LF+ +IK+ DFG + ++ + T + APEV+ + S YD
Sbjct: 129 LKAGNILFT--LDGDIKLADFGVSAKNTRTIQRRDSFIGTPYWMAPEVVMCETSKDRPYD 186
Query: 553 ENCDLWSLGVILVNV 567
D+WSLG+ L+ +
Sbjct: 187 YKADVWSLGITLIEM 201
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. Length = 282 |
| >gnl|CDD|132984 cd06653, STKc_MEKK3_like_1, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 85.1 bits (210), Expect = 4e-18
Identities = 62/204 (30%), Positives = 100/204 (49%), Gaps = 25/204 (12%)
Query: 385 ILGDGSYSVCRRCVEKSTGQEYAVKIISRKIDCSE----------EINLLRACQGHPNIV 434
+LG G++ C + TG+E AVK + D E EI LL+ + H IV
Sbjct: 9 LLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLR-HDRIV 67
Query: 435 NLHCVFQDEVHTYLVL--ELLKGGELLDRIRQKGRCGFTENEASRIMRQLVAAVHFMHSR 492
+ +D L + E + GG + D+++ G TEN R RQ++ V ++HS
Sbjct: 68 QYYGCLRDPEEKKLSIFVEYMPGGSIKDQLKAYG--ALTENVTRRYTRQILQGVSYLHSN 125
Query: 493 GVVHRDLKPENLLFSDPAGDNIKVVDFGFA------CLKRESLHTPCFTLQYAAPEVLRQ 546
+VHRD+K N+L D AG N+K+ DFG + C+ + + T + +PEV+
Sbjct: 126 MIVHRDIKGANIL-RDSAG-NVKLGDFGASKRIQTICMSGTGIKSVTGTPYWMSPEVISG 183
Query: 547 DKSGYDENCDLWSLGVILVNVLRQ 570
+ GY D+WS+ +V +L +
Sbjct: 184 E--GYGRKADVWSVACTVVEMLTE 205
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 264 |
| >gnl|CDD|140293 PTZ00267, PTZ00267, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 88.2 bits (218), Expect = 4e-18
Identities = 77/236 (32%), Positives = 111/236 (47%), Gaps = 43/236 (18%)
Query: 420 EINLLRACQGHPNIVNLHCVFQDEVHTYLVLELLKGGELLDRIRQ--KGRCGFTENEASR 477
E++ L AC H IV F+ + L++E GG+L +I+Q K F E E
Sbjct: 115 ELHCLAACD-HFGIVKHFDDFKSDDKLLLIMEYGSGGDLNKQIKQRLKEHLPFQEYEVGL 173
Query: 478 IMRQLVAAVHFMHSRGVVHRDLKPENLLFSDPAGDNIKVVDFGFACLKRESL-----HTP 532
+ Q+V A+ +HSR ++HRDLK N +F P G IK+ DFGF+ +S+ +
Sbjct: 174 LFYQIVLALDEVHSRKMMHRDLKSAN-IFLMPTGI-IKLGDFGFSKQYSDSVSLDVASSF 231
Query: 533 CFTLQYAAPEVLRQDKSGYDENCDLWSLGVILVNVLRQDKSGYDENCDLWSLGVILYTML 592
C T Y APE LW ++ Y + D+WSLGVILY +L
Sbjct: 232 CGTPYYLAPE--------------LW------------ERKRYSKKADMWSLGVILYELL 265
Query: 593 CGRVPFHARSRDDSALSIMARIKEGQFNFDAEAWSTVSSEAKELTKSLLTVNPAQR 648
PF S+ + IM ++ G+++ VSS K L LL+ NPA R
Sbjct: 266 TLHRPFKGPSQRE----IMQQVLYGKYD---PFPCPVSSGMKALLDPLLSKNPALR 314
|
Length = 478 |
| >gnl|CDD|173753 cd07864, STKc_CDK12, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Score = 85.6 bits (212), Expect = 5e-18
Identities = 82/289 (28%), Positives = 132/289 (45%), Gaps = 33/289 (11%)
Query: 384 GILGDGSYSVCRRCVEKSTGQEYAVKIISRK-------IDCSEEINLLRACQGHPNIVNL 436
G +G+G+Y + +K TG+ A+K + I EI +LR H NIVNL
Sbjct: 13 GQIGEGTYGQVYKARDKDTGELVALKKVRLDNEKEGFPITAIREIKILRQLN-HRNIVNL 71
Query: 437 HCVFQDEVHT----------YLVLELLKGGELLDRIRQKGRCGFTENEASRIMRQLVAAV 486
+ D+ YLV E + L + + G F+E+ M+QL+ +
Sbjct: 72 KEIVTDKQDALDFKKDKGAFYLVFEYMDHD--LMGLLESGLVHFSEDHIKSFMKQLLEGL 129
Query: 487 HFMHSRGVVHRDLKPENLLFSDPAGDNIKVVDFGFACLKRESLHTP----CFTLQYAAPE 542
++ H + +HRD+K N+L ++ IK+ DFG A L P TL Y PE
Sbjct: 130 NYCHKKNFLHRDIKCSNILLNNKG--QIKLADFGLARLYNSEESRPYTNKVITLWYRPPE 187
Query: 543 VLRQDKSGYDENCDLWSLGVILVNVLRQDKSGYDENCDLWSLGVILYTMLCGRVPFHARS 602
+L ++ Y D+WS G IL + + K + N +L L +I + LCG P A
Sbjct: 188 LLLGEER-YGPAIDVWSCGCILGELFTK-KPIFQANQELAQLELI--SRLCGS-PCPAVW 242
Query: 603 RDDSALSIMARIK-EGQFNFD-AEAWSTVSSEAKELTKSLLTVNPAQRI 649
D L +K + Q+ E +S + + A +L +LT++P++R
Sbjct: 243 PDVIKLPYFNTMKPKKQYRRRLREEFSFIPTPALDLLDHMLTLDPSKRC 291
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely expressed in tissues. It interacts with cyclins L1 and L2, and plays roles in regulating transcription and alternative splicing. Length = 302 |
| >gnl|CDD|173666 cd05575, STKc_SGK, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Score = 86.0 bits (213), Expect = 6e-18
Identities = 35/100 (35%), Positives = 52/100 (52%), Gaps = 2/100 (2%)
Query: 263 YRRILKTEPPIPEDLSPDVADFISRLLVKDPRRRLGGGELDAEELKRHPFFNVIDWDDLA 322
Y IL + ++S + LL KD +RLG + D E+K H FF+ I+WDDL
Sbjct: 205 YDNILNKPLRLKPNISVSARHLLEGLLQKDRTKRLGAKD-DFLEIKNHVFFSSINWDDLV 263
Query: 323 TKRIPAPFVPKISNELDVSNFSDEFTKMIPADSPAIVPPN 362
K+I PF P +S +D+ +F EFT+ P + P+
Sbjct: 264 NKKITPPFNPNVSGPMDLKHFDPEFTE-EPVPNSVGKSPD 302
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell proliferation, and apoptosis. Length = 323 |
| >gnl|CDD|177649 PLN00009, PLN00009, cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Score = 84.5 bits (209), Expect = 1e-17
Identities = 69/214 (32%), Positives = 99/214 (46%), Gaps = 32/214 (14%)
Query: 374 EQYDMDLDKAGILGDGSYSVCRRCVEKSTGQEYAVKII----------SRKIDCSEEINL 423
+QY+ K +G+G+Y V + ++ T + A+K I S I EI+L
Sbjct: 2 DQYE----KVEKIGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAI---REISL 54
Query: 424 LRACQGHPNIVNLHCVFQDEVHTYLVLELLKGGELLDRIRQKGRC-GFTENE--ASRIMR 480
L+ Q H NIV L V E YLV E L LD + F +N +
Sbjct: 55 LKEMQ-HGNIVRLQDVVHSEKRLYLVFEYLD----LDLKKHMDSSPDFAKNPRLIKTYLY 109
Query: 481 QLVAAVHFMHSRGVVHRDLKPENLLFSDPAGDNIKVVDFG----FACLKRESLHTPCFTL 536
Q++ + + HS V+HRDLKP+NLL D + +K+ DFG F R H TL
Sbjct: 110 QILRGIAYCHSHRVLHRDLKPQNLLI-DRRTNALKLADFGLARAFGIPVRTFTHE-VVTL 167
Query: 537 QYAAPEVLRQDKSGYDENCDLWSLGVILVNVLRQ 570
Y APE+L + Y D+WS+G I ++ Q
Sbjct: 168 WYRAPEILLGSRH-YSTPVDIWSVGCIFAEMVNQ 200
|
Length = 294 |
| >gnl|CDD|173664 cd05573, STKc_ROCK_NDR_like, Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 85.0 bits (211), Expect = 2e-17
Identities = 51/151 (33%), Positives = 73/151 (48%), Gaps = 18/151 (11%)
Query: 231 GIECVFFSSSLIIFFIILSFTLSFIHDYYHIQYRRILKTE-----PPIPEDLSPDVADFI 285
G+EC ++S +I++ ++ F F D Y +I+ + PP P +SP+ D I
Sbjct: 208 GLECDWWSLGVILYEMLYGFP-PFYSDTLQETYNKIINWKESLRFPPDP-PVSPEAIDLI 265
Query: 286 SRLLVKDPRRRLGGGELDAEELKRHPFFNVIDWDDLATKRIPAPFVPKISNELDVSNFSD 345
RLL DP RLG EE+K HPFF IDW++L + PFVP++S+ LD SNF D
Sbjct: 266 CRLLC-DPEDRLG----SFEEIKSHPFFKGIDWENL--RETKPPFVPELSSPLDTSNFDD 318
Query: 346 -EFTKMIPADSPAIVPPNFDK---IFKGSLF 372
E K + F G +
Sbjct: 319 FEDDKDLSDYLSQNSKKLNKGKQLAFVGFTY 349
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Proteins in this subfamily are involved in regulating many cellular functions including contraction, motility, division, proliferation, apoptosis, morphogenesis, and cytokinesis. Length = 350 |
| >gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 83.6 bits (207), Expect = 2e-17
Identities = 58/197 (29%), Positives = 98/197 (49%), Gaps = 20/197 (10%)
Query: 384 GILGDGSYSVCRRCVEKSTGQEYAVKIISRKIDCS------EEINLLRACQGHPNIVNLH 437
LG+G+ +C K+TG +A+K I+ + E+ + ++C+ P IV +
Sbjct: 7 SRLGEGAGGSVTKCRLKNTGMIFALKTITTDPNPDLQKQILRELEINKSCK-SPYIVKYY 65
Query: 438 CVFQDEVHT--YLVLELLKGGEL---LDRIRQKG-RCGFTENEASRIMRQLVAAVHFMHS 491
F DE + + +E +GG L +++++G R G E +I ++ + ++HS
Sbjct: 66 GAFLDESSSSIGIAMEYCEGGSLDSIYKKVKKRGGRIG--EKVLGKIAESVLKGLSYLHS 123
Query: 492 RGVVHRDLKPENLLFSDPAGDNIKVVDFGFACLKRESL-HTPCFTLQYAAPEVLRQDKSG 550
R ++HRD+KP N+L + +K+ DFG + SL T T Y APE R
Sbjct: 124 RKIIHRDIKPSNILLTRKG--QVKLCDFGVSGELVNSLAGTFTGTSFYMAPE--RIQGKP 179
Query: 551 YDENCDLWSLGVILVNV 567
Y D+WSLG+ L+ V
Sbjct: 180 YSITSDVWSLGLTLLEV 196
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287 |
| >gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Score = 83.8 bits (207), Expect = 2e-17
Identities = 57/200 (28%), Positives = 101/200 (50%), Gaps = 14/200 (7%)
Query: 386 LGDGSYSVCRRCVEKSTGQEYAVKIISRKIDCSEE--IN--LLRACQGHPNIVNLHCVFQ 441
+G G+ ++ +TGQE A+K ++ + +E IN L+ HPNIVN +
Sbjct: 27 IGQGASGTVYTAIDVATGQEVAIKQMNLQQQPKKELIINEILVMRENKHPNIVNYLDSYL 86
Query: 442 DEVHTYLVLELLKGGELLDRIRQKGRCGFTENEASRIMRQLVAAVHFMHSRGVVHRDLKP 501
++V+E L GG L D + + E + + + R+ + A+ F+HS V+HRD+K
Sbjct: 87 VGDELWVVMEYLAGGSLTDVVTE---TCMDEGQIAAVCRECLQALEFLHSNQVIHRDIKS 143
Query: 502 ENLLFSDPAGDNIKVVDFGFACL---KRESLHTPCFTLQYAAPEVLRQDKSGYDENCDLW 558
+N+L ++K+ DFGF ++ T T + APEV+ + Y D+W
Sbjct: 144 DNILLG--MDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVV--TRKAYGPKVDIW 199
Query: 559 SLGVILVNVLRQDKSGYDEN 578
SLG++ + ++ + +EN
Sbjct: 200 SLGIMAIEMVEGEPPYLNEN 219
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293 |
| >gnl|CDD|132982 cd06651, STKc_MEKK3, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Score = 82.8 bits (204), Expect = 3e-17
Identities = 60/207 (28%), Positives = 101/207 (48%), Gaps = 25/207 (12%)
Query: 382 KAGILGDGSYSVCRRCVEKSTGQEYAVKIISRKIDCSE----------EINLLRACQGHP 431
+ +LG G++ C + TG+E A K + + E EI LL+ Q H
Sbjct: 6 RGKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQ-HE 64
Query: 432 NIVNLHCVFQDEVHTYLV--LELLKGGELLDRIRQKGRCGFTENEASRIMRQLVAAVHFM 489
IV + +D L +E + GG + D+++ G TE+ + RQ++ + ++
Sbjct: 65 RIVQYYGCLRDRAEKTLTIFMEYMPGGSVKDQLKAYG--ALTESVTRKYTRQILEGMSYL 122
Query: 490 HSRGVVHRDLKPENLLFSDPAGDNIKVVDFGFA------CLKRESLHTPCFTLQYAAPEV 543
HS +VHRD+K N+L D AG N+K+ DFG + C+ + + T + +PEV
Sbjct: 123 HSNMIVHRDIKGANIL-RDSAG-NVKLGDFGASKRLQTICMSGTGIRSVTGTPYWMSPEV 180
Query: 544 LRQDKSGYDENCDLWSLGVILVNVLRQ 570
+ + GY D+WSLG +V +L +
Sbjct: 181 ISGE--GYGRKADVWSLGCTVVEMLTE 205
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. In addition, MEKK3 is involved in interleukin-1 receptor and Toll-like receptor 4 signaling. It is also a specific regulator of the proinflammatory cytokines IL-6 and GM-CSF in some immune cells. MEKK3 also regulates calcineurin, which plays a critical role in T cell activation, apoptosis, skeletal myocyte differentiation, and cardiac hypertrophy. Length = 266 |
| >gnl|CDD|173745 cd07848, STKc_CDKL5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Score = 82.7 bits (204), Expect = 3e-17
Identities = 63/194 (32%), Positives = 95/194 (48%), Gaps = 22/194 (11%)
Query: 384 GILGDGSYSVCRRCVEKSTGQEYAVKIISRKIDCSE-------EINLLRACQGHPNIVNL 436
G++G+G+Y V +C K T + A+K + E E+ +LR + NIV L
Sbjct: 7 GVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLK-QENIVEL 65
Query: 437 HCVFQDEVHTYLVLELLKGG--ELLDRIRQKGRCGFTENEASRIMRQLVAAVHFMHSRGV 494
F+ YLV E ++ ELL+ + G + + QL+ A+H+ H +
Sbjct: 66 KEAFRRRGKLYLVFEYVEKNMLELLEEMPN----GVPPEKVRSYIYQLIKAIHWCHKNDI 121
Query: 495 VHRDLKPENLLFSDPAGDNIKVVDFGFACLKRESLHTP----CFTLQYAAPEVLRQDKSG 550
VHRD+KPENLL S D +K+ DFGFA E + T Y +PE+L +
Sbjct: 122 VHRDIKPENLLIS--HNDVLKLCDFGFARNLSEGSNANYTEYVATRWYRSPELLL--GAP 177
Query: 551 YDENCDLWSLGVIL 564
Y + D+WS+G IL
Sbjct: 178 YGKAVDMWSVGCIL 191
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes cause a phenotype similar to Rett syndrome (RTT), a progressive neurodevelopmental disorder. These pathogenic mutations are located in the N-terminal portion of the protein within the kinase domain. Length = 287 |
| >gnl|CDD|240344 PTZ00283, PTZ00283, serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 85.3 bits (211), Expect = 3e-17
Identities = 72/286 (25%), Positives = 128/286 (44%), Gaps = 58/286 (20%)
Query: 385 ILGDGSYSVCRRCVEKSTGQEYAVKII-------SRKIDCSEEINLLRACQGHPNIVNLH 437
+LG G+ S G+ +AVK++ + K E+ L C +IV H
Sbjct: 39 VLGSGATGTVLCAKRVSDGEPFAVKVVDMEGMSEADKNRAQAEVCCLLNCD-FFSIVKCH 97
Query: 438 CVF-----QDEVHTY---LVLELLKGGELLDRIRQKGRCG--FTENEASRIMRQLVAAVH 487
F ++ + LVL+ G+L I+ + + F E+EA + Q++ AVH
Sbjct: 98 EDFAKKDPRNPENVLMIALVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFIQVLLAVH 157
Query: 488 FMHSRGVVHRDLKPENLLFSDPAGDNIKVVDFGF-----ACLKRESLHTPCFTLQYAAPE 542
+HS+ ++HRD+K N+L + +K+ DFGF A + + T C T Y APE
Sbjct: 158 HVHSKHMIHRDIKSANILLC--SNGLVKLGDFGFSKMYAATVSDDVGRTFCGTPYYVAPE 215
Query: 543 VLRQDKSGYDENCDLWSLGVILVNVLRQDKSGYDENCDLWSLGVILYTMLCGRVPFHARS 602
+ R + Y + D++SLGV+LY +L + PF +
Sbjct: 216 IWR--------------------------RKPYSKKADMFSLGVLLYELLTLKRPFDGEN 249
Query: 603 RDDSALSIMARIKEGQFNFDAEAWSTVSSEAKELTKSLLTVNPAQR 648
++ +M + G+++ ++S E +E+ +LL+ +P +R
Sbjct: 250 MEE----VMHKTLAGRYD---PLPPSISPEMQEIVTALLSSDPKRR 288
|
Length = 496 |
| >gnl|CDD|143349 cd07844, STKc_PCTAIRE_like, Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 82.8 bits (205), Expect = 4e-17
Identities = 73/231 (31%), Positives = 103/231 (44%), Gaps = 47/231 (20%)
Query: 381 DKAGILGDGSYSVCRRCVEKSTGQEYAVKIISRKID----CS--EEINLLRACQGHPNIV 434
K LG+GSY+ + K TGQ A+K I + + + E +LL+ + H NIV
Sbjct: 8 KKLDKLGEGSYATVYKGRSKLTGQLVALKEIRLEHEEGAPFTAIREASLLKDLK-HANIV 66
Query: 435 NLHCVFQDEVHT----YLVLELLKGGELLDRIRQKGRCGFTENEASRIMRQLVAAVHFMH 490
LH D +HT LV E L +L + G G + + + QL+ + + H
Sbjct: 67 TLH----DIIHTKKTLTLVFEYLDT-DLKQYMDDCGG-GLSMHNVRLFLFQLLRGLAYCH 120
Query: 491 SRGVVHRDLKPENLLFSDPAGDNIKVVDFGFACLKRESLHT---PCFTLQYAAPEVLRQD 547
R V+HRDLKP+NLL S+ G+ +K+ DFG A K T TL Y P+VL
Sbjct: 121 QRRVLHRDLKPQNLLISE-RGE-LKLADFGLARAKSVPSKTYSNEVVTLWYRPPDVL--- 175
Query: 548 KSGYDENCDLWSLGVILVNVLRQDKSGYDENCDLWSLGVILYTMLCGRVPF 598
LG + Y + D+W +G I Y M GR F
Sbjct: 176 ------------LG----------STEYSTSLDMWGVGCIFYEMATGRPLF 204
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the membrane-associated cyclin Y. PCTAIRE-like proteins show unusual expression patterns with high levels in post-mitotic tissues, suggesting that they may be involved in regulating post-mitotic cellular events. Length = 291 |
| >gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 82.1 bits (203), Expect = 4e-17
Identities = 42/136 (30%), Positives = 67/136 (49%), Gaps = 6/136 (4%)
Query: 430 HPNIVNLHCVFQDEVHTYLVLELLKGGELLDRIRQKGRCGFTENEASRIMRQLVAAVHFM 489
HPN+V L V Y+V E + G L+D +R +GR T + + + ++
Sbjct: 59 HPNLVQLLGVVLQGNPLYIVTEYMAKGSLVDYLRSRGRAVITLAQQLGFALDVCEGMEYL 118
Query: 490 HSRGVVHRDLKPENLLFSDPAGDNI-KVVDFGFACLKRESLHTPCFTLQYAAPEVLRQDK 548
+ VHRDL N+L S+ D + KV DFG A + + +++ APE LR+ K
Sbjct: 119 EEKNFVHRDLAARNVLVSE---DLVAKVSDFGLAKEASQGQDSGKLPVKWTAPEALREKK 175
Query: 549 SGYDENCDLWSLGVIL 564
+ D+WS G++L
Sbjct: 176 --FSTKSDVWSFGILL 189
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256 |
| >gnl|CDD|132976 cd06645, STKc_MAP4K3, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Score = 82.0 bits (202), Expect = 4e-17
Identities = 56/206 (27%), Positives = 106/206 (51%), Gaps = 26/206 (12%)
Query: 386 LGDGSYSVCRRCVEKSTGQEYAVKIISRKIDCSE-------EINLLRACQGHPNIVNLHC 438
+G G+Y + +TG+ A+K+I K++ E EI +++ C+ H NIV
Sbjct: 17 IGSGTYGDVYKARNVNTGELAAIKVI--KLEPGEDFAVVQQEIIMMKDCK-HSNIVAYFG 73
Query: 439 VFQDEVHTYLVLELLKGGELLDRIRQKGRCGFTENEASRIMRQLVAAVHFMHSRGVVHRD 498
+ ++ +E GG L D G +E++ + + R+ + ++++HS+G +HRD
Sbjct: 74 SYLRRDKLWICMEFCGGGSLQDIYHVTGP--LSESQIAYVSRETLQGLYYLHSKGKMHRD 131
Query: 499 LKPENLLFSDPAGDNIKVVDFGFAC------LKRES-LHTPCFTLQYAAPEVLR-QDKSG 550
+K N+L +D ++K+ DFG + KR+S + TP + APEV + K G
Sbjct: 132 IKGANILLTD--NGHVKLADFGVSAQITATIAKRKSFIGTP----YWMAPEVAAVERKGG 185
Query: 551 YDENCDLWSLGVILVNVLRQDKSGYD 576
Y++ CD+W++G+ + + +D
Sbjct: 186 YNQLCDIWAVGITAIELAELQPPMFD 211
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. MAP4K3 is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. mTOR regulates ribosome biogenesis and protein translation, and is frequently deregulated in cancer. Length = 267 |
| >gnl|CDD|132967 cd06636, STKc_MAP4K4_6, Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Score = 82.4 bits (203), Expect = 4e-17
Identities = 67/219 (30%), Positives = 108/219 (49%), Gaps = 32/219 (14%)
Query: 377 DMDL----DKAGI------LGDGSYSVCRRCVEKSTGQEYAVKIISRKIDCSEEI----N 422
D+DL D AGI +G+G+Y + TGQ A+K++ D EEI N
Sbjct: 5 DIDLSALRDPAGIFELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVTEDEEEEIKLEIN 64
Query: 423 LLRACQGHPNIVNLHCVF-------QDEVHTYLVLELLKGGELLDRIRQ-KGRCGFTENE 474
+L+ H NI + F D+ +LV+E G + D ++ KG E+
Sbjct: 65 MLKKYSHHRNIATYYGAFIKKSPPGHDD-QLWLVMEFCGAGSVTDLVKNTKGNA-LKEDW 122
Query: 475 ASRIMRQLVAAVHFMHSRGVVHRDLKPENLLFSDPAGDNIKVVDFGF-ACLKRESLHTPC 533
+ I R+++ + +H+ V+HRD+K +N+L ++ A +K+VDFG A L R
Sbjct: 123 IAYICREILRGLAHLHAHKVIHRDIKGQNVLLTENA--EVKLVDFGVSAQLDRTVGRRNT 180
Query: 534 F--TLQYAAPEVLRQDK---SGYDENCDLWSLGVILVNV 567
F T + APEV+ D+ + YD D+WSLG+ + +
Sbjct: 181 FIGTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEM 219
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K4 is also called Nck Interacting kinase (NIK). It facilitates the activation of the MAPKs, extracellular signal-regulated kinase (ERK) 1, ERK2, and c-Jun N-terminal kinase (JNK), by phosphorylating and activating MEKK1. MAP4K4 plays a role in tumor necrosis factor (TNF) alpha-induced insulin resistance. MAP4K4 silencing in skeletal muscle cells from type II diabetic patients restores insulin-mediated glucose uptake. MAP4K4, through JNK, also plays a broad role in cell motility, which impacts inflammation, homeostasis, as well as the invasion and spread of cancer. MAP4K4 is found to be highly expressed in most tumor cell lines relative to normal tissue. MAP4K6 (also called MINK for Misshapen/NIKs-related kinase) is activated after Ras induction and mediates activation of p38 MAPK. MAP4K6 plays a role in cell cycle arrest, cytoskeleton organization, cell adhesion, and cell motility. Length = 282 |
| >gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 82.2 bits (203), Expect = 4e-17
Identities = 64/210 (30%), Positives = 103/210 (49%), Gaps = 30/210 (14%)
Query: 382 KAGILGDGSYSVCRRCVEKSTGQEYAVKII----------SRK---IDCSE-EINLLRAC 427
K ++G GS+ + S+G+ AVK + RK +D EI LL+
Sbjct: 4 KGALIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKEL 63
Query: 428 QGHPNIVNLHCVFQDEVHTYLVLELLKGGELLDRIRQKGRCGFTENEASRIMRQLVAAVH 487
Q H NIV D H + LE + GG + + G F E +RQ++ ++
Sbjct: 64 Q-HENIVQYLGSSLDADHLNIFLEYVPGGSVAALLNNYG--AFEETLVRNFVRQILKGLN 120
Query: 488 FMHSRGVVHRDLKPENLLFSDPAGDNIKVVDFGFA-CLKRESL------HTPCF--TLQY 538
++H+RG++HRD+K N+L + G IK+ DFG + L+ SL P ++ +
Sbjct: 121 YLHNRGIIHRDIKGANILVDNKGG--IKISDFGISKKLEANSLSTKTNGARPSLQGSVFW 178
Query: 539 AAPEVLRQDKSGYDENCDLWSLGVILVNVL 568
APEV++Q + Y D+WSLG ++V +L
Sbjct: 179 MAPEVVKQ--TSYTRKADIWSLGCLVVEML 206
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267 |
| >gnl|CDD|173677 cd05586, STKc_Sck1_like, Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 82.7 bits (204), Expect = 7e-17
Identities = 43/99 (43%), Positives = 58/99 (58%), Gaps = 3/99 (3%)
Query: 263 YRRILKTEPPIPED-LSPDVADFISRLLVKDPRRRLGGGELDAEELKRHPFFNVIDWDDL 321
YR I + P++ LS + F+ LL ++P+ RLG DA ELK HPFF IDWD L
Sbjct: 206 YRNIAFGKVRFPKNVLSDEGRQFVKGLLNRNPQHRLGAHR-DAVELKEHPFFADIDWDLL 264
Query: 322 ATKRIPAPFVPKISNELDVSNFSDEFTKMIPADSPAIVP 360
+ K+I PF P + ++ DVSNF EFT ++ IVP
Sbjct: 265 SKKQITPPFKPIVDSDEDVSNFDPEFTNSSLLNA-GIVP 302
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of yeast to environmental changes. Length = 330 |
| >gnl|CDD|173768 cd08228, STKc_Nek6, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Score = 81.2 bits (200), Expect = 8e-17
Identities = 58/174 (33%), Positives = 90/174 (51%), Gaps = 10/174 (5%)
Query: 416 DCSEEINLLRACQGHPNIVNLHCVFQDEVHTYLVLELLKGGELLDRIR--QKGRCGFTEN 473
DC +EI+LL+ HPN++ F ++ +VLEL G+L I+ +K + E
Sbjct: 48 DCVKEIDLLKQLN-HPNVIKYLDSFIEDNELNIVLELADAGDLSQMIKYFKKQKRLIPER 106
Query: 474 EASRIMRQLVAAVHFMHSRGVVHRDLKPENLLFSDPAGDNIKVVDFG---FACLKRESLH 530
+ QL +AV MHSR V+HRD+KP N+ + A +K+ D G F K + H
Sbjct: 107 TVWKYFVQLCSAVEHMHSRRVMHRDIKPANVFIT--ATGVVKLGDLGLGRFFSSKTTAAH 164
Query: 531 TPCFTLQYAAPEVLRQDKSGYDENCDLWSLGVILVNVLRQDKSGYDENCDLWSL 584
+ T Y +PE R ++GY+ D+WSLG +L + Y + +L+SL
Sbjct: 165 SLVGTPYYMSPE--RIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLFSL 216
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase and anaphase, and to the midbody during cytokinesis. Length = 267 |
| >gnl|CDD|173740 cd07842, STKc_CDK8_like, Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 82.3 bits (204), Expect = 8e-17
Identities = 59/207 (28%), Positives = 93/207 (44%), Gaps = 30/207 (14%)
Query: 383 AGILGDGSYSVCRRCVEK--STGQEYAVKIISRKIDCSE--------EINLLRACQGHPN 432
G +G G+Y + K G+EYA+K + EI LLR + H N
Sbjct: 5 EGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELK-HEN 63
Query: 433 IVNLHCVFQD--EVHTYLVLE-----LLKGGELLDRIRQKGRCGFTENEASRIMRQLVAA 485
+V+L VF + + YL+ + L +++ RQ R + ++ Q++
Sbjct: 64 VVSLVEVFLEHADKSVYLLFDYAEHDLW---QIIKFHRQAKRVSIPPSMVKSLLWQILNG 120
Query: 486 VHFMHSRGVVHRDLKPENLLFS--DPAGDNIKVVDFGFACLKRESLHTP------CFTLQ 537
VH++HS V+HRDLKP N+L P +K+ D G A L L T+
Sbjct: 121 VHYLHSNWVLHRDLKPANILVMGEGPERGVVKIGDLGLARLFNAPLKPLADLDPVVVTIW 180
Query: 538 YAAPEVLRQDKSGYDENCDLWSLGVIL 564
Y APE+L + Y + D+W++G I
Sbjct: 181 YRAPELLLGARH-YTKAIDIWAIGCIF 206
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDC2L6 also associates with Mediator in complexes lacking CDK8. In VP16-dependent transcriptional activation, CDK8 and CDC2L6 exerts opposing effects by positive and negative regulation, respectively, in similar conditions. Length = 316 |
| >gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 81.0 bits (200), Expect = 1e-16
Identities = 75/300 (25%), Positives = 123/300 (41%), Gaps = 53/300 (17%)
Query: 382 KAGILGDGSYSVCRRCVEKSTGQEYAVKII-----------SRKIDCSE----EINLLRA 426
K ++G G+Y + +TG+ AVK + SR+ D + EI L+
Sbjct: 5 KGELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKD 64
Query: 427 CQGHPNIVNLHCVFQDEVHTYLVLELLKGGELLDRIRQKGRCGFTENEASRIMRQLVAAV 486
H NIV E + + LE + GG + +R GR F E Q++ +
Sbjct: 65 LD-HLNIVQYLGFETTEEYLSIFLEYVPGGSIGSCLRTYGR--FEEQLVRFFTEQVLEGL 121
Query: 487 HFMHSRGVVHRDLKPENLLFSDPAGDNIKVVDFGFACLKRESLHTPCFTLQYAAPEVLRQ 546
++HS+G++HRDLK +NLL D G K+ DFG + ++
Sbjct: 122 AYLHSKGILHRDLKADNLLV-DADG-ICKISDFG----------------------ISKK 157
Query: 547 DKSGYDENCDLWSLGVIL---VNVLRQDKSGYDENCDLWSLGVILYTMLCGRVPFHARSR 603
YD + ++ G + V+ GY D+WSLG ++ M GR P+
Sbjct: 158 SDDIYDNDQNMSMQGSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPW----S 213
Query: 604 DDSALSIMARI--KEGQFNFDAEAWSTVSSEAKELTKSLLTVNPAQRIRMMRVKLTFHAF 661
D+ A++ M ++ K + +S A + + T+NP R +L H F
Sbjct: 214 DEEAIAAMFKLGNKRSAPPIPPDVSMNLSPVALDFLNACFTINP--DNRPTARELLQHPF 271
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272 |
| >gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Score = 81.3 bits (200), Expect = 1e-16
Identities = 58/216 (26%), Positives = 106/216 (49%), Gaps = 27/216 (12%)
Query: 386 LGDGSYSVCRRCVEKSTGQEYAVKIISRKI------DCSEEINLLRACQGHPNIVNLHCV 439
+G GS+ + ++ T Q A+KII + D +EI +L C P + +
Sbjct: 12 IGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDS-PYVTKYYGS 70
Query: 440 FQDEVHTYLVLELLKGGELLDRIRQKGRCGFTENEASRIMRQLVAAVHFMHSRGVVHRDL 499
+ ++++E L GG LD +R F E + + ++++++ + ++HS +HRD+
Sbjct: 71 YLKGTKLWIIMEYLGGGSALDLLRAGP---FDEFQIATMLKEILKGLDYLHSEKKIHRDI 127
Query: 500 KPENLLFSDPAGDNIKVVDFGFAC------LKRESLHTPCFTLQYAAPEVLRQDKSGYDE 553
K N+L S+ ++K+ DFG A +KR + F + APEV++Q S YD
Sbjct: 128 KAANVLLSEQG--DVKLADFGVAGQLTDTQIKRNTFVGTPF---WMAPEVIQQ--SAYDS 180
Query: 554 NCDLWSLGVILVNVLRQDKSGYDENCDLWSLGVILY 589
D+WSLG+ + + + G N D+ + V+
Sbjct: 181 KADIWSLGITAIELAK----GEPPNSDMHPMRVLFL 212
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277 |
| >gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 79.9 bits (198), Expect = 2e-16
Identities = 28/62 (45%), Positives = 41/62 (66%), Gaps = 2/62 (3%)
Query: 894 HTYLVLELLKGGELLDRIRQKGRCGFTENEASRIMRQLVAAVHFMHSRGVVHRDLKPENL 953
YLVLE GGEL + ++GR F+E A ++V A+ ++HS G+++RDLKPEN+
Sbjct: 67 KLYLVLEYAPGGELFSHLSKEGR--FSEERARFYAAEIVLALEYLHSLGIIYRDLKPENI 124
Query: 954 LL 955
LL
Sbjct: 125 LL 126
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250 |
| >gnl|CDD|173750 cd07857, STKc_MPK1, Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Score = 81.3 bits (201), Expect = 2e-16
Identities = 66/203 (32%), Positives = 98/203 (48%), Gaps = 26/203 (12%)
Query: 386 LGDGSYS-VCR-RCVEKSTGQEYAVK----IISRKIDCSE---EINLLRACQGHPNIVNL 436
LG G+Y VC R E S + A+K + S+KI E+ LLR +GH NI L
Sbjct: 8 LGQGAYGIVCSARNAETSEEETVAIKKITNVFSKKILAKRALRELKLLRHFRGHKNITCL 67
Query: 437 H---CVFQDEVH-TYLVLELLKGGELLDRIRQKGRCGFTENEASRIMRQLVAAVHFMHSR 492
+ VF + YL EL++ +L IR T+ + Q++ + ++HS
Sbjct: 68 YDMDIVFPGNFNELYLYEELMEA-DLHQIIRSGQP--LTDAHFQSFIYQILCGLKYIHSA 124
Query: 493 GVVHRDLKPENLLFSDPAGDNIKVVDFGFAC-----LKRESLHTPCF--TLQYAAPEVLR 545
V+HRDLKP NLL + A +K+ DFG A + + T Y APE++
Sbjct: 125 NVLHRDLKPGNLLVN--ADCELKICDFGLARGFSENPGENAGFMTEYVATRWYRAPEIML 182
Query: 546 QDKSGYDENCDLWSLGVILVNVL 568
+S Y + D+WS+G IL +L
Sbjct: 183 SFQS-YTKAIDVWSVGCILAELL 204
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall construction, morphogenesis, and ion homeostasis. MPK1 is activated in response to cell wall stress including heat stimulation, osmotic shock, UV irradiation, and any agents that interfere with cell wall biogenesis such as chitin antagonists, caffeine, or zymolase. MPK1 is regulated by the MAP2Ks Mkk1/2, which are regulated by the MAP3K Bck1. Pmk1 is also activated by multiple stresses including elevated temperatures, hyper- or hypotonic stress, glucose deprivation, exposure to cell-wall damaging compounds, and oxidative stress. It is regulated by the MAP2K Pek1, which is regulated by the MAP3K Mkh1. Length = 332 |
| >gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Score = 79.7 bits (196), Expect = 3e-16
Identities = 53/196 (27%), Positives = 97/196 (49%), Gaps = 23/196 (11%)
Query: 386 LGDGSYSVCRRCVEKSTGQEYAVKIISRKI------DCSEEINLLRACQGHPNIVNLHCV 439
+G GS+ + ++ T + A+KII + D +EI +L C P + +
Sbjct: 12 IGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDS-PYVTKYYGS 70
Query: 440 FQDEVHTYLVLELLKGGELLDRIRQKGRCGFTENEASRIMRQLVAAVHFMHSRGVVHRDL 499
+ + ++++E L GG LD + E + + I+R+++ + ++HS +HRD+
Sbjct: 71 YLKDTKLWIIMEYLGGGSALDLLEPGP---LDETQIATILREILKGLDYLHSEKKIHRDI 127
Query: 500 KPENLLFSDPAGDNIKVVDFGFAC------LKRESLHTPCFTLQYAAPEVLRQDKSGYDE 553
K N+L S+ +K+ DFG A +KR + F + APEV++Q S YD
Sbjct: 128 KAANVLLSEHG--EVKLADFGVAGQLTDTQIKRNTFVGTPF---WMAPEVIKQ--SAYDS 180
Query: 554 NCDLWSLGVILVNVLR 569
D+WSLG+ + + +
Sbjct: 181 KADIWSLGITAIELAK 196
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277 |
| >gnl|CDD|173678 cd05587, STKc_cPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Score = 79.8 bits (197), Expect = 6e-16
Identities = 30/94 (31%), Positives = 45/94 (47%)
Query: 263 YRRILKTEPPIPEDLSPDVADFISRLLVKDPRRRLGGGELDAEELKRHPFFNVIDWDDLA 322
++ I++ P+ LS + LL K P +RLG G +++ H FF IDW+ L
Sbjct: 210 FQSIMEHNVSYPKSLSKEAVSICKGLLTKHPAKRLGCGPTGERDIREHAFFRRIDWEKLE 269
Query: 323 TKRIPAPFVPKISNELDVSNFSDEFTKMIPADSP 356
+ I PF PK+ NF FT+ P +P
Sbjct: 270 RREIQPPFKPKVKGRRSAENFDKFFTREPPVLTP 303
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory domain. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. cPKCs are potent kinases for histones, myelin basic protein, and protamine. PKC-gamma is mainly expressed in neuronal tissues. It plays a role in protection from ischemia. Length = 324 |
| >gnl|CDD|143344 cd07839, STKc_CDK5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Score = 79.0 bits (195), Expect = 6e-16
Identities = 82/295 (27%), Positives = 122/295 (41%), Gaps = 50/295 (16%)
Query: 381 DKAGILGDGSYSVCRRCVEKSTGQEYAVKIISRKID-------CSEEINLLRACQGHPNI 433
+K +G+G+Y + + T + A+K + D EI LL+ + H NI
Sbjct: 3 EKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELK-HKNI 61
Query: 434 VNLHCVFQDEVHTYLVLEL----LKGGELLDRIRQKGRCGFTENEASR-IMRQLVAAVHF 488
V L+ V + LV E LK + D G + E + M QL+ + F
Sbjct: 62 VRLYDVLHSDKKLTLVFEYCDQDLK--KYFDSCN-----GDIDPEIVKSFMFQLLKGLAF 114
Query: 489 MHSRGVVHRDLKPENLLFSDPAGDNIKVVDFGFACLKRESLHTP--CF-----TLQYAAP 541
HS V+HRDLKP+NLL + +K+ DFG A + P C+ TL Y P
Sbjct: 115 CHSHNVLHRDLKPQNLLINKNG--ELKLADFGLA----RAFGIPVRCYSAEVVTLWYRPP 168
Query: 542 EVLRQDKSGYDENCDLWSLGVI---LVNVLRQDKSGYDENCDLWSLGVILYTMLCGRVPF 598
+VL K Y + D+WS G I L N R G D + L + +L T P
Sbjct: 169 DVLFGAK-LYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEESWPG 227
Query: 599 HARSRDDSALSIMARIKEGQFNFDAEAWSTV----SSEAKELTKSLLTVNPAQRI 649
++ D + + V +S ++L ++LL NP QRI
Sbjct: 228 VSKLPDYKPYPMYPATT---------SLVNVVPKLNSTGRDLLQNLLVCNPVQRI 273
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also important in synaptic plasticity and learning. CDK5 also participates in protecting against cell death and promoting angiogenesis. Impaired CDK5 activity is implicated in Alzheimer's disease, amyotrophic lateral sclerosis, Parkinson's disease, Huntington's disease and acute neuronal injury. Length = 284 |
| >gnl|CDD|143356 cd07851, STKc_p38, Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 80.0 bits (198), Expect = 6e-16
Identities = 56/227 (24%), Positives = 103/227 (45%), Gaps = 47/227 (20%)
Query: 386 LGDGSY-SVCRRCVEKSTGQEYAVKIISRKIDCSE-------EINLLRACQGHPNIVNLH 437
+G G+Y VC + TG++ A+K +SR + E+ LL+ H N++ L
Sbjct: 23 VGSGAYGQVCS-AFDTKTGRKVAIKKLSRPFQSAIHAKRTYRELRLLK-HMDHENVIGLL 80
Query: 438 CVFQDEVHT------YLVLELLKGGELLDRIRQKGRCGFTENEASRIMRQLVAAVHFMHS 491
VF YLV L+ G +L + ++ + +++ ++ Q++ + ++HS
Sbjct: 81 DVFTPASSLEDFQDVYLVTHLM-GADLNNIVKCQK---LSDDHIQFLVYQILRGLKYIHS 136
Query: 492 RGVVHRDLKPENLLFSDPAGDNIKVVDFGFACLKRESLHTPCFTLQYAAPEVLRQDKSGY 551
G++HRDLKP N+ ++ +K++DFG A + + T Y APE++
Sbjct: 137 AGIIHRDLKPSNIAVNEDC--ELKILDFGLARHTDDEMTGYVATRWYRAPEIM------- 187
Query: 552 DENCDLWSLGVILVNVLRQDKSGYDENCDLWSLGVILYTMLCGRVPF 598
L Y++ D+WS+G I+ +L G+ F
Sbjct: 188 -----LN-------------WMHYNQTVDIWSVGCIMAELLTGKTLF 216
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. p38 substrates include other protein kinases and factors that regulate transcription, nuclear export, mRNA stability and translation. p38 kinases are drug targets for the inflammatory diseases psoriasis, rheumatoid arthritis, and chronic pulmonary disease. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta, which show varying substrate specificity and expression patterns. p38alpha and p38beta are ubiquitously expressed, p38gamma is predominantly found in skeletal muscle, and p38delta is found in the heart, lung, testis, pancreas, and small intestine. Length = 343 |
| >gnl|CDD|132990 cd06659, STKc_PAK6, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Score = 79.3 bits (195), Expect = 6e-16
Identities = 69/275 (25%), Positives = 130/275 (47%), Gaps = 53/275 (19%)
Query: 386 LGDGSYSVCRRCVEKSTGQEYAVKIIS-RKIDCSE----EINLLRACQGHPNIVNLHCVF 440
+G+GS + EK +G++ AVK++ RK E E+ ++R Q H N+V ++ +
Sbjct: 29 IGEGSTGIVCIAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQ-HQNVVEMYKSY 87
Query: 441 QDEVHTYLVLELLKGGELLDRIRQKGRCGFTENEASRIMRQLVAAVHFMHSRGVVHRDLK 500
++++E L+GG L D + Q E + + + ++ A+ ++HS+GV+HRD+K
Sbjct: 88 LVGEELWVLMEFLQGGALTDIVSQ---TRLNEEQIATVCESVLQALCYLHSQGVIHRDIK 144
Query: 501 PENLLFSDPAGDNIKVVDFGFACL------KRESL-HTPCFTLQYAAPEVLRQDKSGYDE 553
+++L + +K+ DFGF KR+SL TP + APEV+
Sbjct: 145 SDSILLT--LDGRVKLSDFGFCAQISKDVPKRKSLVGTP----YWMAPEVI--------- 189
Query: 554 NCDLWSLGVILVNVLRQDKSGYDENCDLWSLGVILYTMLCGRVPFHARSRDDSALSIMAR 613
++ Y D+WSLG+++ M+ G P+ + DS + M R
Sbjct: 190 -----------------SRTPYGTEVDIWSLGIMVIEMVDGEPPYFS----DSPVQAMKR 228
Query: 614 IKEGQFNFDAEAWSTVSSEAKELTKSLLTVNPAQR 648
+++ + +S ++ + +LT P +R
Sbjct: 229 LRDSP-PPKLKNAHKISPVLRDFLERMLTREPQER 262
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role in stress responses through its activation by the mitogen-activated protein kinase (MAPK) p38 and MAPK kinase 6 (MKK6) pathway. PAK6 is highly expressed in the brain. It is not required for viability, but together with PAK5, it is required for normal levels of locomotion and activity, and for learning and memory. Increased expression of PAK6 is found in primary and metastatic prostate cancer. PAK6 may play a role in the regulation of motility. Length = 297 |
| >gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Score = 78.1 bits (192), Expect = 7e-16
Identities = 55/189 (29%), Positives = 96/189 (50%), Gaps = 12/189 (6%)
Query: 385 ILGDGSYSVCRRCVEKSTGQEYAVKIIS------RKIDCSEEINLLRACQGHPNIVNLHC 438
+G+GS+ KS + +K I ++ + S++ +L A HPNIV
Sbjct: 7 KIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPNIVTFFA 66
Query: 439 VFQDEVHTYLVLELLKGGELLDRIRQKGRCGFTENEASRIMRQLVAAVHFMHSRGVVHRD 498
FQ+ ++V+E GG+L+ RI ++ F+E++ Q+ + +H R ++HRD
Sbjct: 67 SFQENGRLFIVMEYCDGGDLMKRINRQRGVLFSEDQILSWFVQISLGLKHIHDRKILHRD 126
Query: 499 LKPENLLFSDPAGDNIKVVDFGFACLKRESL---HTPCFTLQYAAPEVLRQDKSGYDENC 555
+K +N+ S G K+ DFG A +S+ +T T Y +PE+ Q++ Y+
Sbjct: 127 IKSQNIFLSK-NGMVAKLGDFGIARQLNDSMELAYTCVGTPYYLSPEIC-QNRP-YNNKT 183
Query: 556 DLWSLGVIL 564
D+WSLG +L
Sbjct: 184 DIWSLGCVL 192
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257 |
| >gnl|CDD|173746 cd07850, STKc_JNK, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Score = 79.8 bits (197), Expect = 8e-16
Identities = 65/225 (28%), Positives = 95/225 (42%), Gaps = 61/225 (27%)
Query: 402 TGQEYAVKIISRKID-------CSEEINLLRACQGHPNIVNLHCVF------QDEVHTYL 448
TGQ A+K +SR E+ L++ H NI+ L VF ++ YL
Sbjct: 40 TGQNVAIKKLSRPFQNVTHAKRAYRELVLMKLVN-HKNIIGLLNVFTPQKSLEEFQDVYL 98
Query: 449 VLELLKGG------ELLDRIRQKGRCGFTENEASRIMRQLVAAVHFMHSRGVVHRDLKPE 502
V+EL+ LD R S ++ Q++ + +HS G++HRDLKP
Sbjct: 99 VMELMDANLCQVIQMDLDHER-----------MSYLLYQMLCGIKHLHSAGIIHRDLKPS 147
Query: 503 NLLFSDPAGDNIKVVDFGFACLKRES-LHTP-CFTLQYAAPEVLRQDKSGYDENCDLWSL 560
N++ +K++DFG A S + TP T Y APEV+ L
Sbjct: 148 NIVVKSDC--TLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVI---------------L 190
Query: 561 GVILVNVLRQDKSGYDENCDLWSLGVILYTMLCGRVPFHARSRDD 605
G+ GY EN D+WS+G I+ M+ G V F D
Sbjct: 191 GM-----------GYKENVDIWSVGCIMGEMIRGTVLFPGTDHID 224
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3) that are alternatively spliced to produce at least 10 isoforms. JNKs are specifically activated by the MAPK kinases MKK4 and MKK7, which are in turn activated by upstream MAPK kinase kinases as a result of different stimuli including stresses such as ultraviolet (UV) irradiation, hyperosmolarity, heat shock, or cytokines. JNKs activate a large number of different substrates based on specific stimulus, cell type, and cellular condition, and may be implicated in seemingly contradictory functions. Length = 353 |
| >gnl|CDD|173714 cd05625, STKc_LATS1, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Score = 80.0 bits (197), Expect = 9e-16
Identities = 67/236 (28%), Positives = 108/236 (45%), Gaps = 40/236 (16%)
Query: 433 IVNLHCVFQDEVHTYLVLELLKGGELLDRIRQKGRCGFTENEASRIMRQLVAAVHFMHSR 492
+V L+ FQD+ + Y V++ + GG+++ + + G F E+ A + +L AV +H
Sbjct: 63 VVRLYYSFQDKDNLYFVMDYIPGGDMMSLLIRMGI--FPEDLARFYIAELTCAVESVHKM 120
Query: 493 GVVHRDLKPENLLFSDPAGDNIKVVDFGFACLKRESLHTPCFTLQYAAPEVLRQDKSGYD 552
G +HRD+KP+N+L D G +IK+ DFG C H + Y + + +RQD +
Sbjct: 121 GFIHRDIKPDNILI-DRDG-HIKLTDFGL-CTGFRWTHDSKY---YQSGDHVRQDSMDFS 174
Query: 553 ------ENCDLWS-LGVILVNVLRQD---------------------KSGYDENCDLWSL 584
NC L + RQ ++GY + CD WS+
Sbjct: 175 NEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSV 234
Query: 585 GVILYTMLCGRVPFHARSRDDSALSIMARIKEGQFNFDAEAWSTVSSEAKELTKSL 640
GVILY ML G+ PF A+ + L ++ Q + + +S EA +L L
Sbjct: 235 GVILYEMLVGQPPFLAQ----TPLETQMKVINWQTSLHIPPQAKLSPEASDLIIKL 286
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype and poor prognosis. LATS1 induces G2 arrest and promotes cytokinesis. It may be a component of the mitotic exit network in higher eukaryotes. Length = 382 |
| >gnl|CDD|132968 cd06637, STKc_TNIK, Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Score = 78.2 bits (192), Expect = 9e-16
Identities = 64/211 (30%), Positives = 101/211 (47%), Gaps = 28/211 (13%)
Query: 381 DKAGI------LGDGSYSVCRRCVEKSTGQEYAVKIISRKIDCSEEI----NLLRACQGH 430
D AGI +G+G+Y + TGQ A+K++ D EEI N+L+ H
Sbjct: 3 DPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEEEEIKQEINMLKKYSHH 62
Query: 431 PNIVNLHCVF--------QDEVHTYLVLELLKGGELLDRIRQKGRCGFTENEASRIMRQL 482
NI + F D++ +LV+E G + D I+ E + I R++
Sbjct: 63 RNIATYYGAFIKKNPPGMDDQL--WLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREI 120
Query: 483 VAAVHFMHSRGVVHRDLKPENLLFSDPAGDNIKVVDFGF-ACLKRESLHTPCF--TLQYA 539
+ + +H V+HRD+K +N+L ++ A +K+VDFG A L R F T +
Sbjct: 121 LRGLSHLHQHKVIHRDIKGQNVLLTENA--EVKLVDFGVSAQLDRTVGRRNTFIGTPYWM 178
Query: 540 APEVLRQDK---SGYDENCDLWSLGVILVNV 567
APEV+ D+ + YD DLWSLG+ + +
Sbjct: 179 APEVIACDENPDATYDFKSDLWSLGITAIEM 209
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activates the c-Jun N-terminal kinase (JNK) pathway and plays a role in regulating the actin cytoskeleton. Length = 272 |
| >gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Score = 78.0 bits (193), Expect = 1e-15
Identities = 26/61 (42%), Positives = 37/61 (60%), Gaps = 2/61 (3%)
Query: 896 YLVLELLKGGELLDRIRQKGRCGFTENEASRIMRQLVAAVHFMHSRGVVHRDLKPENLLL 955
Y VLE GELL IR+ G E +++ A+ ++HS+G++HRDLKPEN+LL
Sbjct: 78 YFVLEYAPNGELLQYIRKYGS--LDEKCTRFYAAEILLALEYLHSKGIIHRDLKPENILL 135
Query: 956 S 956
Sbjct: 136 D 136
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280 |
| >gnl|CDD|132977 cd06646, STKc_MAP4K5, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Score = 77.8 bits (191), Expect = 1e-15
Identities = 63/206 (30%), Positives = 109/206 (52%), Gaps = 24/206 (11%)
Query: 375 QYDMDLDKAGILGDGSYSVCRRCVEKSTGQEYAVKIISRKI--DCS---EEINLLRACQG 429
Q+D +L + +G G+Y + TG+ AVKII + D S +EI +++ C+
Sbjct: 8 QHDYELIQR--VGSGTYGDVYKARNLHTGELAAVKIIKLEPGDDFSLIQQEIFMVKECK- 64
Query: 430 HPNIVNLHCVFQDEVHTYLVLELLKGGELLDRIRQKGRCGFTENEASRIMRQLVAAVHFM 489
H NIV + ++ +E GG L D G +E + + + R+ + + ++
Sbjct: 65 HCNIVAYFGSYLSREKLWICMEYCGGGSLQDIYHVTGP--LSELQIAYVCRETLQGLAYL 122
Query: 490 HSRGVVHRDLKPENLLFSDPAGDNIKVVDFGFAC------LKRES-LHTPCFTLQYAAPE 542
HS+G +HRD+K N+L +D GD +K+ DFG A KR+S + TP + APE
Sbjct: 123 HSKGKMHRDIKGANILLTD-NGD-VKLADFGVAAKITATIAKRKSFIGTP----YWMAPE 176
Query: 543 VLRQDKS-GYDENCDLWSLGVILVNV 567
V +K+ GY++ CD+W++G+ + +
Sbjct: 177 VAAVEKNGGYNQLCDIWAVGITAIEL 202
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). MAP4K5 also facilitates Wnt signaling in B cells, and may therefore be implicated in the control of cell fate, proliferation, and polarity. Length = 267 |
| >gnl|CDD|143375 cd07870, STKc_PFTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 78.5 bits (193), Expect = 1e-15
Identities = 58/193 (30%), Positives = 92/193 (47%), Gaps = 15/193 (7%)
Query: 386 LGDGSYSVCRRCVEKSTGQEYAVKIISRKID------CSEEINLLRACQGHPNIVNLHCV 439
LG+GSY+ + + + GQ A+K+IS K + E +LL+ + H NIV LH +
Sbjct: 13 LGEGSYATVYKGISRINGQLVALKVISMKTEEGVPFTAIREASLLKGLK-HANIVLLHDI 71
Query: 440 FQDEVHTYLVLELLKGGELLDRIRQKGRCGFTENEASRIMRQLVAAVHFMHSRGVVHRDL 499
+ V E + I+ G G M QL+ + ++H + ++HRDL
Sbjct: 72 IHTKETLTFVFEYMHTDLAQYMIQHPG--GLHPYNVRLFMFQLLRGLAYIHGQHILHRDL 129
Query: 500 KPENLLFSDPAGDNIKVVDFGFACLKR---ESLHTPCFTLQYAAPEVLRQDKSGYDENCD 556
KP+NLL S +K+ DFG A K ++ + TL Y P+VL + Y D
Sbjct: 130 KPQNLLISYLG--ELKLADFGLARAKSIPSQTYSSEVVTLWYRPPDVL-LGATDYSSALD 186
Query: 557 LWSLGVILVNVLR 569
+W G I + +L+
Sbjct: 187 IWGAGCIFIEMLQ 199
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recessive form of juvenile ALS. The function of PFTAIRE-2 is not yet known. Length = 291 |
| >gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Score = 78.2 bits (192), Expect = 1e-15
Identities = 61/215 (28%), Positives = 105/215 (48%), Gaps = 27/215 (12%)
Query: 386 LGDGSYSVCRRCVEKSTGQEYAVKIISRKI------DCSEEINLLRACQGHPNIVNLHCV 439
+G GS+ + ++ T + A+KII + D +EI +L C P I +
Sbjct: 12 IGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDS-PYITRYYGS 70
Query: 440 FQDEVHTYLVLELLKGGELLDRIRQKGRCGFTENEASRIMRQLVAAVHFMHSRGVVHRDL 499
+ ++++E L GG LD ++ E + I+R+++ + ++HS +HRD+
Sbjct: 71 YLKGTKLWIIMEYLGGGSALDLLKPGP---LEETYIATILREILKGLDYLHSERKIHRDI 127
Query: 500 KPENLLFSDPAGDNIKVVDFGFAC------LKRESLHTPCFTLQYAAPEVLRQDKSGYDE 553
K N+L S+ GD +K+ DFG A +KR + F + APEV++Q S YD
Sbjct: 128 KAANVLLSE-QGD-VKLADFGVAGQLTDTQIKRNTFVGTPF---WMAPEVIKQ--SAYDF 180
Query: 554 NCDLWSLGVILVNVLRQDKSGYDENCDLWSLGVIL 588
D+WSLG+ + + + G N DL + V+
Sbjct: 181 KADIWSLGITAIELAK----GEPPNSDLHPMRVLF 211
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277 |
| >gnl|CDD|173683 cd05592, STKc_nPKC_theta_delta, Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Score = 78.3 bits (193), Expect = 2e-15
Identities = 36/92 (39%), Positives = 50/92 (54%), Gaps = 4/92 (4%)
Query: 266 ILKTEPPIPEDLSPDVADFISRLLVKDPRRRLGGGELDAEELKRHPFFNVIDWDDLATKR 325
IL P P +S + D +S+L +DP +RLG ++++HPFF IDW+ L +
Sbjct: 208 ILNDRPHFPRWISKEAKDCLSKLFERDPTKRLGV----DGDIRQHPFFRGIDWERLEKRE 263
Query: 326 IPAPFVPKISNELDVSNFSDEFTKMIPADSPA 357
IP PF PK+ + D SNF EFT SP
Sbjct: 264 IPPPFKPKVKSPSDASNFDREFTNEKVRLSPV 295
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. Length = 316 |
| >gnl|CDD|143379 cd07874, STKc_JNK3, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Score = 79.0 bits (194), Expect = 2e-15
Identities = 71/246 (28%), Positives = 115/246 (46%), Gaps = 29/246 (11%)
Query: 423 LLRACQGHPNIVNLHCVF------QDEVHTYLVLELLKGGELLDRIRQKGRCGFTENEAS 476
+L C H NI++L VF ++ YLV+EL+ L I+ + S
Sbjct: 68 VLMKCVNHKNIISLLNVFTPQKSLEEFQDVYLVMELMDA-NLCQVIQME----LDHERMS 122
Query: 477 RIMRQLVAAVHFMHSRGVVHRDLKPENLLFSDPAGDNIKVVDFGFACLKRES-LHTP-CF 534
++ Q++ + +HS G++HRDLKP N++ +K++DFG A S + TP
Sbjct: 123 YLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDC--TLKILDFGLARTAGTSFMMTPYVV 180
Query: 535 TLQYAAPEVLRQDKSGYDENCDLWSLGVILVNVLRQDK--SGYDENCDLWSLGVILYTML 592
T Y APEV+ GY EN D+WS+G I+ ++R G D D W+ +
Sbjct: 181 TRYYRAPEVIL--GMGYKENVDIWSVGCIMGEMVRHKILFPGRDY-IDQWNKVIEQLGTP 237
Query: 593 CGR--------VPFHARSRDDSA-LSIMARIKEGQFNFDAEAWSTVSSEAKELTKSLLTV 643
C V + +R A L+ + F D+E +S+A++L +L +
Sbjct: 238 CPEFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVI 297
Query: 644 NPAQRI 649
+PA+RI
Sbjct: 298 DPAKRI 303
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, stroke, sciatic axotomy neural death, and neuronal death due to NGF deprivation, oxidative stress, or exposure to beta-amyloid peptide. This suggests that JNK3 may play roles in the pathogenesis of these diseases. Length = 355 |
| >gnl|CDD|143368 cd07863, STKc_CDK4, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Score = 77.7 bits (191), Expect = 2e-15
Identities = 61/201 (30%), Positives = 95/201 (47%), Gaps = 21/201 (10%)
Query: 386 LGDGSYSVCRRCVEKSTGQEYAVKIISRK-------IDCSEEINLLRACQG--HPNIVNL 436
+G G+Y + + +G A+K + + + E+ LL+ + HPNIV L
Sbjct: 8 IGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVRL 67
Query: 437 HCV-----FQDEVHTYLVLELLKGGELLDRIRQKGRCGFTENEASRIMRQLVAAVHFMHS 491
V E LV E + +L + + G +MRQ + + F+H+
Sbjct: 68 MDVCATSRTDRETKVTLVFEHVDQ-DLRTYLDKVPPPGLPAETIKDLMRQFLRGLDFLHA 126
Query: 492 RGVVHRDLKPENLLFSDPAGDNIKVVDFGFACLK--RESLHTPCFTLQYAAPEVLRQDKS 549
+VHRDLKPEN+L + +G +K+ DFG A + + +L TL Y APEVL Q S
Sbjct: 127 NCIVHRDLKPENILVT--SGGQVKLADFGLARIYSCQMALTPVVVTLWYRAPEVLLQ--S 182
Query: 550 GYDENCDLWSLGVILVNVLRQ 570
Y D+WS+G I + R+
Sbjct: 183 TYATPVDMWSVGCIFAEMFRR 203
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the nucleus. CDK4 also shows kinase activity towards Smad3, a signal transducer of transforming growth factor (TGF)-beta signaling which modulates transcription and plays a role in cell proliferation and apoptosis. CDK4 is inhibited by the p21 inhibitor and is specifically mutated in human melanoma. Length = 288 |
| >gnl|CDD|143374 cd07869, STKc_PFTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 78.2 bits (192), Expect = 2e-15
Identities = 60/193 (31%), Positives = 91/193 (47%), Gaps = 15/193 (7%)
Query: 386 LGDGSYSVCRRCVEKSTGQEYAVKIISRK------IDCSEEINLLRACQGHPNIVNLHCV 439
LG+GSY+ + K G+ A+K+I + E +LL+ + H NIV LH +
Sbjct: 13 LGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTAIREASLLKGLK-HANIVLLHDI 71
Query: 440 FQDEVHTYLVLELLKGGELLDRIRQKGRCGFTENEASRIMRQLVAAVHFMHSRGVVHRDL 499
+ LV E + L + K G + QL+ + ++H R ++HRDL
Sbjct: 72 IHTKETLTLVFEYVHTD--LCQYMDKHPGGLHPENVKLFLFQLLRGLSYIHQRYILHRDL 129
Query: 500 KPENLLFSDPAGDNIKVVDFGFACLKRESLHT---PCFTLQYAAPEVLRQDKSGYDENCD 556
KP+NLL SD +K+ DFG A K HT TL Y P+VL + Y D
Sbjct: 130 KPQNLLISDTG--ELKLADFGLARAKSVPSHTYSNEVVTLWYRPPDVL-LGSTEYSTCLD 186
Query: 557 LWSLGVILVNVLR 569
+W +G I V +++
Sbjct: 187 MWGVGCIFVEMIQ 199
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 and is inhibited by the p21 cell cycle inhibitor. It has also been shown to interact with the membrane-associated cyclin Y, which recruits the protein to the plasma membrane. Length = 303 |
| >gnl|CDD|173758 cd08218, STKc_Nek1, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Score = 76.8 bits (189), Expect = 2e-15
Identities = 68/277 (24%), Positives = 117/277 (42%), Gaps = 54/277 (19%)
Query: 386 LGDGSYSVCRRCVEKSTGQEYAVKIIS-------RKIDCSEEINLLRACQGHPNIVNLHC 438
+G+GS+ K G++Y +K I+ + + +E+ +L + HPNIV
Sbjct: 8 IGEGSFGKAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVL-SNMKHPNIVQYQE 66
Query: 439 VFQDEVHTYLVLELLKGGELLDRIRQKGRCGFTENEASRIMRQLVAAVHFMHSRGVVHRD 498
F++ + Y+V++ +GG+L +I + F E++ Q+ A+ +H R ++HRD
Sbjct: 67 SFEENGNLYIVMDYCEGGDLYKKINAQRGVLFPEDQILDWFVQICLALKHVHDRKILHRD 126
Query: 499 LKPENLLFSDPAGDNIKVVDFGFAC-------LKRESLHTPCFTLQYAAPEVLRQDKSGY 551
+K +N+ + IK+ DFG A L R + TP Y +PE+
Sbjct: 127 IKSQNIFLT--KDGTIKLGDFGIARVLNSTVELARTCIGTP----YYLSPEIC------- 173
Query: 552 DENCDLWSLGVILVNVLRQDKSGYDENCDLWSLGVILYTMLCGRVPFHARSRDDSALSIM 611
EN Y+ D+W+LG +LY M + F A + + L I+
Sbjct: 174 -EN------------------RPYNNKSDIWALGCVLYEMCTLKHAFEAGNMKNLVLKII 214
Query: 612 ARIKEGQFNFDAEAWSTVSSEAKELTKSLLTVNPAQR 648
G + S S + + L L NP R
Sbjct: 215 ----RGSY---PPVSSHYSYDLRNLVSQLFKRNPRDR 244
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycystic kidney disease, which is characterized by benign polycystic tumors formed by abnormal overgrowth of renal epithelial cells. It appears also to be involved in DNA damage response, and may be important for both correct DNA damage checkpoint activation and DNA repair. Length = 256 |
| >gnl|CDD|133214 cd05083, PTKc_Chk, Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Score = 76.5 bits (188), Expect = 3e-15
Identities = 55/182 (30%), Positives = 91/182 (50%), Gaps = 19/182 (10%)
Query: 402 TGQEYAVKIISRKIDCS-----EEINLLRACQGHPNIVNLHCVFQDEVHT--YLVLELLK 454
TGQ+ AVK I K D + EE ++ H N+V L V +H Y+V+EL+
Sbjct: 28 TGQKVAVKNI--KCDVTAQAFLEETAVMTKLH-HKNLVRLLGVI---LHNGLYIVMELMS 81
Query: 455 GGELLDRIRQKGRCGFTENEASRIMRQLVAAVHFMHSRGVVHRDLKPENLLFSDPAGDNI 514
G L++ +R +GR + + + + + ++ S+ +VHRDL N+L S+ D +
Sbjct: 82 KGNLVNFLRTRGRALVSVIQLLQFSLDVAEGMEYLESKKLVHRDLAARNILVSE---DGV 138
Query: 515 -KVVDFGFACLKRESLHTPCFTLQYAAPEVLRQDKSGYDENCDLWSLGVILVNVLRQDKS 573
KV DFG A + + +++ APE L+ K + D+WS GV+L V ++
Sbjct: 139 AKVSDFGLARVGSMGVDNSKLPVKWTAPEALKHKK--FSSKSDVWSYGVLLWEVFSYGRA 196
Query: 574 GY 575
Y
Sbjct: 197 PY 198
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As a negative regulator of Src kinases, Chk may play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Chk is expressed in brain and hematopoietic cells. Studies in mice reveal that Chk is not functionally redundant with Csk and that it plays an important role as a regulator of immune responses. Chk also plays a role in neural differentiation in a manner independent of Src by enhancing Mapk activation via Ras-mediated signaling. Length = 254 |
| >gnl|CDD|132987 cd06656, STKc_PAK3, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Score = 77.1 bits (189), Expect = 4e-15
Identities = 57/201 (28%), Positives = 103/201 (51%), Gaps = 16/201 (7%)
Query: 386 LGDGSYSVCRRCVEKSTGQEYAVKIIS-----RKIDCSEEINLLRACQGHPNIVNLHCVF 440
+G G+ ++ +TGQE A+K ++ +K EI ++R + +PNIVN +
Sbjct: 27 IGQGASGTVYTAIDIATGQEVAIKQMNLQQQPKKELIINEILVMRENK-NPNIVNYLDSY 85
Query: 441 QDEVHTYLVLELLKGGELLDRIRQKGRCGFTENEASRIMRQLVAAVHFMHSRGVVHRDLK 500
++V+E L GG L D + + C E + + + R+ + A+ F+HS V+HRD+K
Sbjct: 86 LVGDELWVVMEYLAGGSLTDVVTET--C-MDEGQIAAVCRECLQALDFLHSNQVIHRDIK 142
Query: 501 PENLLFSDPAGDNIKVVDFGFACL---KRESLHTPCFTLQYAAPEVLRQDKSGYDENCDL 557
+N+L ++K+ DFGF ++ T T + APEV+ + Y D+
Sbjct: 143 SDNILLG--MDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVV--TRKAYGPKVDI 198
Query: 558 WSLGVILVNVLRQDKSGYDEN 578
WSLG++ + ++ + +EN
Sbjct: 199 WSLGIMAIEMVEGEPPYLNEN 219
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK3 is highly expressed in the brain. It is implicated in neuronal plasticity, synapse formation, dendritic spine morphogenesis, cell cycle progression, neuronal migration, and apoptosis. Inactivating mutations in the PAK3 gene cause X-linked non-syndromic mental retardation, the severity of which depends on the site of the mutation. Length = 297 |
| >gnl|CDD|132985 cd06654, STKc_PAK1, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Score = 76.7 bits (188), Expect = 4e-15
Identities = 56/205 (27%), Positives = 103/205 (50%), Gaps = 24/205 (11%)
Query: 386 LGDGSYSVCRRCVEKSTGQEYAVKIIS-----RKIDCSEEINLLRACQGHPNIVNLHCVF 440
+G G+ ++ +TGQE A++ ++ +K EI ++R + +PNIVN +
Sbjct: 28 IGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENK-NPNIVNYLDSY 86
Query: 441 QDEVHTYLVLELLKGGELLDRIRQKGRCGFTENEASRIMRQLVAAVHFMHSRGVVHRDLK 500
++V+E L GG L D + + C E + + + R+ + A+ F+HS V+HRD+K
Sbjct: 87 LVGDELWVVMEYLAGGSLTDVVTET--C-MDEGQIAAVCRECLQALEFLHSNQVIHRDIK 143
Query: 501 PENLLFSDPAGDNIKVVDFGFACL-------KRESLHTPCFTLQYAAPEVLRQDKSGYDE 553
+N+L ++K+ DFGF + + TP + APEV+ + Y
Sbjct: 144 SDNILLG--MDGSVKLTDFGFCAQITPEQSKRSTMVGTP----YWMAPEVV--TRKAYGP 195
Query: 554 NCDLWSLGVILVNVLRQDKSGYDEN 578
D+WSLG++ + ++ + +EN
Sbjct: 196 KVDIWSLGIMAIEMIEGEPPYLNEN 220
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK1 is important in the regulation of many cellular processes including cytoskeletal dynamics, cell motility, growth, and proliferation. Although PAK1 has been regarded mainly as a cytosolic protein, recent reports indicate that PAK1 also exists in significant amounts in the nucleus, where it is involved in transcription modulation and in cell cycle regulatory events. PAK1 is also involved in transformation and tumorigenesis. Its overexpression, hyperactivation and increased nuclear accumulation is correlated to breast cancer invasiveness and progression. Nuclear accumulation is also linked to tamoxifen resistance in breast cancer cells. Length = 296 |
| >gnl|CDD|143376 cd07871, STKc_PCTAIRE3, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Score = 76.6 bits (188), Expect = 5e-15
Identities = 68/230 (29%), Positives = 102/230 (44%), Gaps = 47/230 (20%)
Query: 382 KAGILGDGSYSVCRRCVEKSTGQEYAVKIISRKID----CS--EEINLLRACQGHPNIVN 435
K LG+G+Y+ + K T A+K I + + C+ E++LL+ + H NIV
Sbjct: 9 KLDKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKNLK-HANIVT 67
Query: 436 LHCVFQDEVHTYLVLELLKGGELLDRIRQKGRCG--FTENEASRIMRQLVAAVHFMHSRG 493
LH + E LV E L D + CG + + M QL+ + + H R
Sbjct: 68 LHDIIHTERCLTLVFEYLDS----DLKQYLDNCGNLMSMHNVKIFMFQLLRGLSYCHKRK 123
Query: 494 VVHRDLKPENLLFSDPAGDNIKVVDFGFACLKRESLHTPCF-----TLQYAAPEVLRQDK 548
++HRDLKP+NLL ++ +K+ DFG A + +S+ T + TL Y P+VL
Sbjct: 124 ILHRDLKPQNLLINEKG--ELKLADFGLA--RAKSVPTKTYSNEVVTLWYRPPDVL---- 175
Query: 549 SGYDENCDLWSLGVILVNVLRQDKSGYDENCDLWSLGVILYTMLCGRVPF 598
LG + Y D+W +G ILY M GR F
Sbjct: 176 -----------LG----------STEYSTPIDMWGVGCILYEMATGRPMF 204
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filaments (PHFs) and stimulate Tau phosphorylation. As AD progresses, phosphorylated Tau aggregates and forms PHFs, which leads to the formation of neurofibrillary tangles (NFTs). In human glioma cells, PCTAIRE-3 induces cell cycle arrest and cell death. Length = 288 |
| >gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 75.2 bits (186), Expect = 6e-15
Identities = 31/72 (43%), Positives = 41/72 (56%), Gaps = 2/72 (2%)
Query: 242 IIFFIILSFTLSFIHDYYHIQYRRILKTEPPIPEDLSPDVADFISRLLVKDPRRRLGGGE 301
++ + +L+ F + Y +ILK PE LSP+ D IS LL KDP +RLG G
Sbjct: 181 VLLYEMLTGKPPFYAEDRKEIYEKILKDPLRFPEFLSPEARDLISGLLQKDPTKRLGSGG 240
Query: 302 LDAEELKRHPFF 313
AEE+K HPFF
Sbjct: 241 --AEEIKAHPFF 250
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250 |
| >gnl|CDD|143364 cd07859, STKc_TDY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 76.7 bits (189), Expect = 6e-15
Identities = 65/206 (31%), Positives = 95/206 (46%), Gaps = 30/206 (14%)
Query: 385 ILGDGSYSVCRRCVEKSTGQEYAVKII-------SRKIDCSEEINLLRACQGHPNIVNLH 437
++G GSY V ++ TG++ A+K I S EI LLR + HP+IV +
Sbjct: 7 VIGKGSYGVVCSAIDTHTGEKVAIKKINDVFEHVSDATRILREIKLLRLLR-HPDIVEIK 65
Query: 438 CV--------FQDEVHTYLVLELLKGGELLDRIRQKGRCGFTENEASRIMRQLVAAVHFM 489
+ F+D Y+V EL+ +L I K T + QL+ A+ ++
Sbjct: 66 HIMLPPSRREFKD---IYVVFELM-ESDLHQVI--KANDDLTPEHHQFFLYQLLRALKYI 119
Query: 490 HSRGVVHRDLKPENLLFSDPAGDNIKVVDFGFACLKRESLHTPCF------TLQYAAPEV 543
H+ V HRDLKP+N+L + A +K+ DFG A + T F T Y APE+
Sbjct: 120 HTANVFHRDLKPKNILAN--ADCKLKICDFGLARVAFNDTPTAIFWTDYVATRWYRAPEL 177
Query: 544 LRQDKSGYDENCDLWSLGVILVNVLR 569
S Y D+WS+G I VL
Sbjct: 178 CGSFFSKYTPAIDIWSIGCIFAEVLT 203
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. Arabidopsis thaliana contains more TEY-type MAPKs than TDY-type, whereas the reverse is true for Oryza sativa. This subfamily represents the TDY subtype and is composed of Group D plant MAPKs including Arabidopsis thaliana MPK18 (AtMPK18), Oryza sativa Blast- and Wound-induced MAPK1 (OsBWMK1), OsWJUMK1 (Wound- and JA-Uninducible MAPK1), Zea mays MPK6, and the Medicago sativa TDY1 gene product. OsBWMK1 enhances resistance to pathogenic infections. It mediates stress-activated defense responses by activating a transcription factor that affects the expression of stress-related genes. AtMPK18 is involved in microtubule-related functions. Length = 338 |
| >gnl|CDD|143367 cd07862, STKc_CDK6, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Score = 75.8 bits (186), Expect = 7e-15
Identities = 62/178 (34%), Positives = 89/178 (50%), Gaps = 15/178 (8%)
Query: 420 EINLLRACQG--HPNIVNLHCV-----FQDEVHTYLVLELLKGGELLDRIRQKGRCGFTE 472
E+ +LR + HPN+V L V E LV E + +L + + G
Sbjct: 51 EVAVLRHLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQ-DLTTYLDKVPEPGVPT 109
Query: 473 NEASRIMRQLVAAVHFMHSRGVVHRDLKPENLLFSDPAGDNIKVVDFGFACLK--RESLH 530
+M QL+ + F+HS VVHRDLKP+N+L + + IK+ DFG A + + +L
Sbjct: 110 ETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVT--SSGQIKLADFGLARIYSFQMALT 167
Query: 531 TPCFTLQYAAPEVLRQDKSGYDENCDLWSLGVILVNVLRQDKSGYDENCDLWSLGVIL 588
+ TL Y APEVL Q S Y DLWS+G I + R+ K + + D+ LG IL
Sbjct: 168 SVVVTLWYRAPEVLLQ--SSYATPVDLWSVGCIFAEMFRR-KPLFRGSSDVDQLGKIL 222
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytoplasm. It is also present in the ruffling edge of spreading fibroblasts and may play a role in cell spreading. It binds to the p21 inhibitor without any effect on its own activity and it is overexpressed in squamous cell carcinomas and neuroblastomas. CDK6 has also been shown to inhibit cell differentiation in many cell types. Length = 290 |
| >gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 75.0 bits (185), Expect = 9e-15
Identities = 38/150 (25%), Positives = 70/150 (46%), Gaps = 9/150 (6%)
Query: 419 EEINLLRACQGHPNIVNLHCVFQDEVHTYLVLELLKGGELLDRIRQKGRCGFTENEASRI 478
+E +++ + H +V L+ V +E Y+V E + G LLD ++ + +
Sbjct: 50 QEAQIMKKLR-HDKLVQLYAVCSEEEPIYIVTEYMSKGSLLDFLKSGEGKKLRLPQLVDM 108
Query: 479 MRQLVAAVHFMHSRGVVHRDLKPENLLFSDPAGDNIKVVDFGFACLKRESLHTPC----F 534
Q+ + ++ SR +HRDL N+L + K+ DFG A L + +T F
Sbjct: 109 AAQIAEGMAYLESRNYIHRDLAARNILVGE--NLVCKIADFGLARLIEDDEYTAREGAKF 166
Query: 535 TLQYAAPEVLRQDKSGYDENCDLWSLGVIL 564
+++ APE + + D+WS G++L
Sbjct: 167 PIKWTAPEAANYGR--FTIKSDVWSFGILL 194
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261 |
| >gnl|CDD|143361 cd07856, STKc_Sty1_Hog1, Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Score = 76.4 bits (188), Expect = 9e-15
Identities = 59/193 (30%), Positives = 94/193 (48%), Gaps = 20/193 (10%)
Query: 386 LGDGSYSVCRRCVEKSTGQEYAVKIISRKIDCS-------EEINLLRACQGHPNIVNLHC 438
+G G++ + ++ TGQ A+K I + E+ LL+ + H NI++L
Sbjct: 18 VGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYRELKLLKHLR-HENIISLSD 76
Query: 439 VFQDEVH-TYLVLELLKGGELLDRIRQKGRC--GFTENEASRIMRQLVAAVHFMHSRGVV 495
+F + Y V ELL G L R+ F + +I+R L ++HS GVV
Sbjct: 77 IFISPLEDIYFVTELL--GTDLHRLLTSRPLEKQFIQYFLYQILRGL----KYVHSAGVV 130
Query: 496 HRDLKPENLLFSDPAGDNIKVVDFGFACLKRESLHTPCFTLQYAAPEVLRQDKSGYDENC 555
HRDLKP N+L ++ ++K+ DFG A ++ + T Y APE++ + YD
Sbjct: 131 HRDLKPSNILINENC--DLKICDFGLARIQDPQMTGYVSTRYYRAPEIMLTWQK-YDVEV 187
Query: 556 DLWSLGVILVNVL 568
D+WS G I +L
Sbjct: 188 DIWSAGCIFAEML 200
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and UV radiation. Sty1 is regulated by the MAP2K Wis1, which is activated by the MAP3Ks Wis4 and Win1, which receive signals of the stress condition from membrane-spanning histidine kinases Mak1-3. Activated Sty1 stabilizes the Atf1 transcription factor and induces transcription of Atf1-dependent genes of the core environmetal stress response (CESR). Hog1 is the key element in the high osmolarity glycerol (HOG) pathway and is activated upon hyperosmotic stress. Activated Hog1 accumulates in the nucleus and regulates stress-induced transcription. The HOG pathway is mediated by two transmembrane osmosensors, Sln1 and Sho1. Length = 328 |
| >gnl|CDD|173681 cd05590, STKc_nPKC_eta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Score = 75.7 bits (186), Expect = 1e-14
Identities = 39/103 (37%), Positives = 55/103 (53%), Gaps = 4/103 (3%)
Query: 263 YRRILKTEPPIPEDLSPDVADFISRLLVKDPRRRLGGGELDAEE-LKRHPFFNVIDWDDL 321
+ IL E P LS D D + + K+P RLG L EE + RHPFF +DW+ L
Sbjct: 205 FEAILNDEVVYPTWLSQDAVDILKAFMTKNPTMRLGSLTLGGEEAILRHPFFKELDWEKL 264
Query: 322 ATKRIPAPFVPKISNELDVSNFSDEFTKMIPADSP---AIVPP 361
++I PF P+I + DVSNF +F K P +P +++P
Sbjct: 265 NRRQIEPPFRPRIKSREDVSNFDPDFIKEDPVLTPIEESLLPM 307
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signaling of cell-type specific differentiation. It is also expressed in pro-B cells and early-stage thymocytes, and acts as a key regulator in early B-cell development. PKC-eta increases glioblastoma multiforme (GBM) proliferation and resistance to radiation, and is being developed as a therapeutic target for the management of GBM. Length = 320 |
| >gnl|CDD|173754 cd07865, STKc_CDK9, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Score = 75.5 bits (186), Expect = 1e-14
Identities = 57/211 (27%), Positives = 95/211 (45%), Gaps = 38/211 (18%)
Query: 381 DKAGILGDGSYSVCRRCVEKSTGQEYAVKII---SRK----IDCSEEINLLRACQGHPNI 433
+K +G G++ + K T Q A+K + + K I EI +L+ + H N+
Sbjct: 15 EKLAKIGQGTFGEVFKARHKKTKQIVALKKVLMENEKEGFPITALREIKILQLLK-HENV 73
Query: 434 VNLHCVFQDEVHT--------YLVLEL----LKGGELLDRIRQKGRCGFTENEASRIMRQ 481
VNL + + + YLV E L G LL K FT +E ++M+
Sbjct: 74 VNLIEICRTKATPYNRYKGSFYLVFEFCEHDLAG--LLSNKNVK----FTLSEIKKVMKM 127
Query: 482 LVAAVHFMHSRGVVHRDLKPENLLFSDPAGDNI-KVVDFGFA--CLKRESLHTPCF---- 534
L+ ++++H ++HRD+K N+L + D I K+ DFG A ++ +
Sbjct: 128 LLNGLYYIHRNKILHRDMKAANILITK---DGILKLADFGLARAFSLSKNSKPNRYTNRV 184
Query: 535 -TLQYAAPEVLRQDKSGYDENCDLWSLGVIL 564
TL Y PE+L ++ Y D+W G I+
Sbjct: 185 VTLWYRPPELLLGERD-YGPPIDMWGAGCIM 214
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multiple steps of gene expression including transcription elongation, mRNA synthesis, processing, export, and translation. It also plays a role in mediating cytokine induced transcription networks such as IL6-induced STAT3 signaling. In addition, the CDK9/cyclin T2a complex promotes muscle differentiation and enhances the function of some myogenic regulatory factors. Length = 310 |
| >gnl|CDD|240233 PTZ00024, PTZ00024, cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 76.0 bits (187), Expect = 1e-14
Identities = 59/220 (26%), Positives = 96/220 (43%), Gaps = 41/220 (18%)
Query: 386 LGDGSYSVCRRCVEKSTGQEYA---VKIISRKIDCSEEINLLRACQ-------------- 428
LG+G+Y + + TG+ A VKII D +++ L+ C
Sbjct: 17 LGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNE 76
Query: 429 -GHPNIVNLHCVFQDEVHTYLVLELLKGGELLDRIRQKGRCGFTENEASRIMRQLVAAVH 487
H NI+ L V+ + LV++++ +L + +K R TE++ I+ Q++ ++
Sbjct: 77 IKHENIMGLVDVYVEGDFINLVMDIMAS-DLKKVVDRKIR--LTESQVKCILLQILNGLN 133
Query: 488 FMHSRGVVHRDLKPENLLFSDPAGDNIKVVDFGFA-----------CLK------RESLH 530
+H +HRDL P N +F + G K+ DFG A K RE +
Sbjct: 134 VLHKWYFMHRDLSPAN-IFINSKGI-CKIADFGLARRYGYPPYSDTLSKDETMQRREEMT 191
Query: 531 TPCFTLQYAAPEVLRQDKSGYDENCDLWSLGVILVNVLRQ 570
+ TL Y APE+L Y D+WS+G I +L
Sbjct: 192 SKVVTLWYRAPELL-MGAEKYHFAVDMWSVGCIFAELLTG 230
|
Length = 335 |
| >gnl|CDD|173715 cd05626, STKc_LATS2, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Score = 76.2 bits (187), Expect = 1e-14
Identities = 74/270 (27%), Positives = 119/270 (44%), Gaps = 53/270 (19%)
Query: 382 KAGILGDGSY-SVCRRCVEKSTGQEYAVKIISRK--------IDCSEEINLLRACQGHPN 432
K LG G++ VC C + T YA+K + +K E ++L A +
Sbjct: 5 KIKTLGIGAFGEVCLAC-KVDTHALYAMKTLRKKDVLNRNQVAHVKAERDIL-AEADNEW 62
Query: 433 IVNLHCVFQDEVHTYLVLELLKGGELLDRIRQKGRCGFTENEASRIMRQLVAAVHFMHSR 492
+V L+ FQD+ + Y V++ + GG+++ + + F E A + +L A+ +H
Sbjct: 63 VVKLYYSFQDKDNLYFVMDYIPGGDMMSLLIRMEV--FPEVLARFYIAELTLAIESVHKM 120
Query: 493 GVVHRDLKPENLLFSDPAGDNIKVVDFGFACLKRESLHTPCFTLQYAAPEVLRQDKSGYD 552
G +HRD+KP+N+L D G +IK+ DFG C H + Y +RQD
Sbjct: 121 GFIHRDIKPDNILI-DLDG-HIKLTDFGL-CTGFRWTHNSKY---YQKGSHIRQDSM--- 171
Query: 553 ENCDLWS----------LGVILVNVLRQD---------------------KSGYDENCDL 581
E DLW L + +Q + GY + CD
Sbjct: 172 EPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYTQLCDW 231
Query: 582 WSLGVILYTMLCGRVPFHARSRDDSALSIM 611
WS+GVIL+ ML G+ PF A + ++ L ++
Sbjct: 232 WSVGVILFEMLVGQPPFLAPTPTETQLKVI 261
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with poor prognosis in acute lymphoblastic leukemia and breast cancer. Length = 381 |
| >gnl|CDD|173690 cd05599, STKc_NDR_like, Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 75.5 bits (186), Expect = 2e-14
Identities = 40/121 (33%), Positives = 65/121 (53%), Gaps = 11/121 (9%)
Query: 231 GIECVFFSSSLIIFFIILSFTLSFIHDYYHIQYRRIL--KTEPPIPED--LSPDVADFIS 286
EC ++S +I++ +++ + F D YR+I+ K P++ LSP+ D I
Sbjct: 217 NKECDWWSLGVIMYEMLVGYP-PFCSDNPQETYRKIINWKETLQFPDEVPLSPEAKDLIK 275
Query: 287 RLLVKDPRRRLGGGELDAEELKRHPFFNVIDWDDLATKRIPAPFVPKISNELDVSNFSDE 346
RL + RRLG E+K HPFF +DW+ + + PAP +P++ + D SNF D+
Sbjct: 276 RLCC-EAERRLGNN--GVNEIKSHPFFKGVDWEHI--RERPAPIIPELKSITDTSNF-DD 329
Query: 347 F 347
F
Sbjct: 330 F 330
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplication. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. This subfamily also contains fungal NDR-like kinases. Length = 364 |
| >gnl|CDD|132989 cd06658, STKc_PAK5, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Score = 75.1 bits (184), Expect = 2e-14
Identities = 58/204 (28%), Positives = 109/204 (53%), Gaps = 24/204 (11%)
Query: 386 LGDGSYSVCRRCVEKSTGQEYAVKIIS-RKIDCSE----EINLLRACQGHPNIVNLHCVF 440
+G+GS + EK TG++ AVK + RK E E+ ++R H N+V+++ +
Sbjct: 30 IGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRRELLFNEVVIMRDYH-HENVVDMYNSY 88
Query: 441 QDEVHTYLVLELLKGGELLDRIRQKGRCGFTENEASRIMRQLVAAVHFMHSRGVVHRDLK 500
++V+E L+GG L D + E + + + ++ A+ ++H++GV+HRD+K
Sbjct: 89 LVGDELWVVMEFLEGGALTDIVTHTR---MNEEQIATVCLSVLRALSYLHNQGVIHRDIK 145
Query: 501 PENLLFSDPAGDNIKVVDFGFACL------KRESL-HTPCFTLQYAAPEVLRQDKSGYDE 553
+++L + + IK+ DFGF KR+SL TP + APEV+ + Y
Sbjct: 146 SDSILLT--SDGRIKLSDFGFCAQVSKEVPKRKSLVGTP----YWMAPEVI--SRLPYGT 197
Query: 554 NCDLWSLGVILVNVLRQDKSGYDE 577
D+WSLG++++ ++ + ++E
Sbjct: 198 EVDIWSLGIMVIEMIDGEPPYFNE 221
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly expressed in the brain. It is not required for viability, but together with PAK6, it is required for normal levels of locomotion and activity, and for learning and memory. PAK5 cooperates with Inca (induced in neural crest by AP2) in the regulation of cell adhesion and cytoskeletal organization in the embryo and in neural crest cells during craniofacial development. PAK5 may also play a role in controlling the signaling of Raf-1, an effector of Ras, at the mitochondria. Length = 292 |
| >gnl|CDD|132938 cd06607, STKc_TAO, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Score = 74.8 bits (184), Expect = 2e-14
Identities = 52/191 (27%), Positives = 90/191 (47%), Gaps = 25/191 (13%)
Query: 386 LGDGSYSVCRRCVEKSTGQEYAVKIIS--------RKIDCSEEINLLRACQGHPNIVNLH 437
+G GS+ + T + A+K +S + D +E+ L+ + HPN +
Sbjct: 23 IGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLR-HPNTIEYK 81
Query: 438 CVFQDEVHTYLVLELLKG--GELLDRIRQKGRCGFTENEASRIMRQLVAAVHFMHSRGVV 495
+ E +LV+E G ++L+ ++ E E + I + + ++HS +
Sbjct: 82 GCYLREHTAWLVMEYCLGSASDILEVHKK----PLQEVEIAAICHGALQGLAYLHSHERI 137
Query: 496 HRDLKPENLLFSDPAGDNIKVVDFGFACLKRES---LHTPCFTLQYAAPEV-LRQDKSGY 551
HRD+K N+L ++P +K+ DFG A L + + TP + APEV L D+ Y
Sbjct: 138 HRDIKAGNILLTEPG--TVKLADFGSASLVSPANSFVGTPYWM----APEVILAMDEGQY 191
Query: 552 DENCDLWSLGV 562
D D+WSLG+
Sbjct: 192 DGKVDVWSLGI 202
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily members, named TAO1, TAO2, and TAO3. Length = 307 |
| >gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Score = 73.3 bits (181), Expect = 3e-14
Identities = 25/76 (32%), Positives = 45/76 (59%), Gaps = 4/76 (5%)
Query: 892 NVHTYLVLELLKGGELLDRIRQKGRCG--FTENEASRIMRQLVAAVHFMHSRGVVHRDLK 949
+V+E GG+L +I+++ + G F E + QL A+ ++HSR ++HRD+K
Sbjct: 71 KGKLCIVMEYADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLHSRKILHRDIK 130
Query: 950 PENLLLSGISGNLIKI 965
P+N+ L+ S L+K+
Sbjct: 131 PQNIFLT--SNGLVKL 144
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258 |
| >gnl|CDD|143354 cd07849, STKc_ERK1_2_like, Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 75.0 bits (185), Expect = 3e-14
Identities = 83/310 (26%), Positives = 128/310 (41%), Gaps = 82/310 (26%)
Query: 385 ILGDGSYSVCRRCVEKSTGQEYAVKIIS---RKIDCSE---EINLLRACQGHPNIVNLH- 437
+G+G+Y + K TG + A+K IS + C EI +LR + H NI+ +
Sbjct: 12 YIGEGAYGMVCSATHKPTGVKVAIKKISPFEHQTFCQRTLREIKILRRFK-HENIIGILD 70
Query: 438 -------CVFQDEVHTYLVLELLKGGELLDRIR-QKGRCGFTENEASRIMRQLVAAVHFM 489
F D Y+V EL++ +L I+ Q + + + Q++ + ++
Sbjct: 71 IIRPPSFESFND---VYIVQELMET-DLYKLIKTQH----LSNDHIQYFLYQILRGLKYI 122
Query: 490 HSRGVVHRDLKPENLLFSDPAGDNIKVVDFGFACLK-RESLHTPCF-----TLQYAAPEV 543
HS V+HRDLKP NLL + ++K+ DFG A + E HT T Y APE+
Sbjct: 123 HSANVLHRDLKPSNLLLN--TNCDLKICDFGLARIADPEHDHTGFLTEYVATRWYRAPEI 180
Query: 544 LRQDKSGYDENCDLWSLGVILVNVLRQDKSGYDENCDLWSLGVILYTMLCGRVPFHAR-- 601
+ K GY + D+WS+G IL ML R F +
Sbjct: 181 MLNSK-------------------------GYTKAIDIWSVGCILAEMLSNRPLFPGKDY 215
Query: 602 --------------SRDD--SALSIMAR--IKEGQFNFDAEAWST----VSSEAKELTKS 639
S++D +S+ AR IK F W+ +A +L
Sbjct: 216 LHQLNLILGVLGTPSQEDLNCIISLRARNYIKSLPFK-PKVPWNKLFPNADPKALDLLDK 274
Query: 640 LLTVNPAQRI 649
+LT NP +RI
Sbjct: 275 MLTFNPHKRI 284
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase kinase from the Raf family. ERK1/2 have numerous substrates, many of which are nuclear and participate in transcriptional regulation of many cellular processes. They regulate cell growth, cell proliferation, and cell cycle progression from G1 to S phase. Although the distinct roles of ERK1 and ERK2 have not been fully determined, it is known that ERK2 can maintain most functions in the absence of ERK1, and that the deletion of ERK2 is embryonically lethal. The MAPK, Fus3, regulates yeast mating processes including mating-specific gene expression, G1 arrest, mating projection, and cell fusion. Length = 336 |
| >gnl|CDD|143385 cd07880, STKc_p38gamma_MAPK12, Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 75.0 bits (184), Expect = 3e-14
Identities = 66/268 (24%), Positives = 113/268 (42%), Gaps = 48/268 (17%)
Query: 386 LGDGSYSVCRRCVEKSTGQEYAVKIISRKIDCS-------EEINLLRACQGHPNIVNLHC 438
+G G+Y +++ TG + A+K + R E+ LL+ + H N++ L
Sbjct: 23 VGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMK-HENVIGLLD 81
Query: 439 VFQ-----DEVHT-YLVLELLKGGELLDRIRQKGRCGFTENEASRIMRQLVAAVHFMHSR 492
VF D H YLV+ + G L ++ + + E+ ++ Q++ + ++H+
Sbjct: 82 VFTPDLSLDRFHDFYLVMPFM--GTDLGKLMKHEKLS--EDRIQFLVYQMLKGLKYIHAA 137
Query: 493 GVVHRDLKPENLLFSDPAGDNIKVVDFGFACLKRESLHTPCFTLQYAAPEVLRQDKSGYD 552
G++HRDLKP NL ++ +K++DFG A + T Y APEV
Sbjct: 138 GIIHRDLKPGNLAVNEDC--ELKILDFGLARQTDSEMTGYVVTRWYRAPEV--------- 186
Query: 553 ENCDLWSLGVILVNVLRQDKSGYDENCDLWSLGVILYTMLCGRVPFHARSRDDSALSIMA 612
++N + Y + D+WS+G I+ ML G+ F D + IM
Sbjct: 187 -----------ILNWMH-----YTQTVDIWSVGCIMAEMLTGKPLFKGHDHLDQLMEIMK 230
Query: 613 RIKEGQFNFDAEAWSTVSSEAKELTKSL 640
F + S +AK K L
Sbjct: 231 VTGTPSKEFVQKLQSE---DAKNYVKKL 255
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12, is predominantly expressed in skeletal muscle. Unlike p38alpha and p38beta, p38gamma is insensitive to pyridinylimidazoles. It displays an antagonizing function compared to p38alpha. p38gamma inhibits, while p38alpha stimulates, c-Jun phosphorylation and AP-1 mediated transcription. p38gamma also plays a role in the signaling between Ras and the estrogen receptor and has been implicated to increase cell invasion and breast cancer progression. In Xenopus, p38gamma is critical in the meiotic maturation of oocytes. Length = 343 |
| >gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 73.6 bits (181), Expect = 4e-14
Identities = 33/83 (39%), Positives = 49/83 (59%)
Query: 263 YRRILKTEPPIPEDLSPDVADFISRLLVKDPRRRLGGGELDAEELKRHPFFNVIDWDDLA 322
Y +IL + P L D I +LLV D RRLG + A+++K H +F +DWDD+
Sbjct: 207 YEKILAGKLEFPRHLDLYAKDLIKKLLVVDRTRRLGNMKNGADDVKNHRWFKSVDWDDVP 266
Query: 323 TKRIPAPFVPKISNELDVSNFSD 345
+++ P VPK+S++ D SNF D
Sbjct: 267 QRKLKPPIVPKVSHDGDTSNFDD 289
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291 |
| >gnl|CDD|143381 cd07876, STKc_JNK2, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Score = 74.7 bits (183), Expect = 4e-14
Identities = 75/313 (23%), Positives = 124/313 (39%), Gaps = 83/313 (26%)
Query: 386 LGDGSYSVCRRCVEKSTGQEYAVKIISRKID-------CSEEINLLRACQGHPNIVNLHC 438
+G G+ + + G AVK +SR E+ LL+ C H NI++L
Sbjct: 29 IGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAYRELVLLK-CVNHKNIISLLN 87
Query: 439 VF------QDEVHTYLVLELLKGGELLDRIRQKGRCGFTENEASRIMRQLVAAVHFMHSR 492
VF ++ YLV+EL+ + Q S ++ Q++ + +HS
Sbjct: 88 VFTPQKSLEEFQDVYLVMELMDAN-----LCQVIHMELDHERMSYLLYQMLCGIKHLHSA 142
Query: 493 GVVHRDLKPENLLFSDPAGDNIKVVDFGFA-CLKRESLHTP-CFTLQYAAPEVLRQDKSG 550
G++HRDLKP N++ +K++DFG A + TP T Y APEV+
Sbjct: 143 GIIHRDLKPSNIVVKSDC--TLKILDFGLARTACTNFMMTPYVVTRYYRAPEVI------ 194
Query: 551 YDENCDLWSLGVILVNVLRQDKSGYDENCDLWSLGVILYTMLCGRVPFHARSRDDS---- 606
LG+ GY EN D+WS+G I+ ++ G V F D
Sbjct: 195 ---------LGM-----------GYKENVDIWSVGCIMGELVKGSVIFQGTDHIDQWNKV 234
Query: 607 -------ALSIMARIKEGQFNF-----------------------DAEAWSTVSSEAKEL 636
+ M R++ N+ ++E +S+A++L
Sbjct: 235 IEQLGTPSAEFMNRLQPTVRNYVENRPQYPGISFEELFPDWIFPSESERDKLKTSQARDL 294
Query: 637 TKSLLTVNPAQRI 649
+L ++P +RI
Sbjct: 295 LSKMLVIDPDKRI 307
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK2 is specifically translocated to the mitochondria during dopaminergic cell death. Specific substrates include the microtubule-associated proteins DCX and Tau, as well as TIF-IA which is involved in ribosomal RNA synthesis regulation. Mice deficient in Jnk2 show protection against arthritis, type 1 diabetes, atherosclerosis, abdominal aortic aneurysm, cardiac cell death, TNF-induced liver damage, and tumor growth, indicating that JNK2 may play roles in the pathogenesis of these diseases. Length = 359 |
| >gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Score = 73.6 bits (180), Expect = 4e-14
Identities = 58/200 (29%), Positives = 102/200 (51%), Gaps = 14/200 (7%)
Query: 386 LGDGSYSVCRRCVEKSTGQEYAVKIISRKIDCSEE--IN--LLRACQGHPNIVNLHCVFQ 441
+G G+ ++ +TGQE A+K I+ + +E IN L+ +PNIVN F
Sbjct: 27 IGQGASGTVFTAIDVATGQEVAIKQINLQKQPKKELIINEILVMKELKNPNIVNFLDSFL 86
Query: 442 DEVHTYLVLELLKGGELLDRIRQKGRCGFTENEASRIMRQLVAAVHFMHSRGVVHRDLKP 501
++V+E L GG L D + + C E + + + R+ + A+ F+H+ V+HRD+K
Sbjct: 87 VGDELFVVMEYLAGGSLTDVVTET--C-MDEAQIAAVCRECLQALEFLHANQVIHRDIKS 143
Query: 502 ENLLFSDPAGDNIKVVDFGFACL---KRESLHTPCFTLQYAAPEVLRQDKSGYDENCDLW 558
+N+L ++K+ DFGF ++ T T + APEV+ + Y D+W
Sbjct: 144 DNVLLGMDG--SVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVV--TRKAYGPKVDIW 199
Query: 559 SLGVILVNVLRQDKSGYDEN 578
SLG++ + ++ + +EN
Sbjct: 200 SLGIMAIEMVEGEPPYLNEN 219
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296 |
| >gnl|CDD|132949 cd06618, PKc_MKK7, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Score = 73.2 bits (180), Expect = 6e-14
Identities = 61/209 (29%), Positives = 102/209 (48%), Gaps = 24/209 (11%)
Query: 374 EQYDMDLDK---AGILGDGSYSVCRRCVEKSTGQEYAVKIISRKIDCSEE-----INLLR 425
++Y DL+ G +G G+ + K TG AVK + R+ EE ++L
Sbjct: 8 QKYPADLNDLENLGEIGSGTCGQVYKMRFKKTGHVMAVKQM-RRTGNKEENKRILMDLDV 66
Query: 426 ACQGH--PNIVNLHCVFQDEVHTYLVLELLKGGELLDRIRQKGRCGFTENEASRIMRQLV 483
+ H P IV + F + ++ +EL+ LD++ ++ + E+ ++ +V
Sbjct: 67 VLKSHDCPYIVKCYGYFITDSDVFICMELM--STCLDKLLKRIQGPIPEDILGKMTVAIV 124
Query: 484 AAVHFMHSR-GVVHRDLKPENLLFSDPAGDNIKVVDFGFACLKRESL-HTP---CFTLQY 538
A+H++ + GV+HRD+KP N+L D +G N+K+ DFG + +S T C Y
Sbjct: 125 KALHYLKEKHGVIHRDVKPSNILL-DASG-NVKLCDFGISGRLVDSKAKTRSAGCAA--Y 180
Query: 539 AAPEVLRQD--KSGYDENCDLWSLGVILV 565
APE + YD D+WSLG+ LV
Sbjct: 181 MAPERIDPPDPNPKYDIRADVWSLGISLV 209
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates its downstream target, c-Jun N-terminal kinase (JNK), on specific threonine and tyrosine residues. Although MKK7 is capable of dual phosphorylation, it prefers to phosphorylate the threonine residue of JNK. Thus, optimal activation of JNK requires both MKK4 (not included in this subfamily) and MKK7. MKK7 is primarily activated by cytokines. MKK7 is essential for liver formation during embryogenesis. It plays roles in G2/M cell cycle arrest and cell growth. In addition, it is involved in the control of programmed cell death, which is crucial in oncogenesis, cancer chemoresistance, and antagonism to TNFalpha-induced killing, through its inhibition by Gadd45beta and the subsequent suppression of the JNK cascade. Length = 296 |
| >gnl|CDD|132962 cd06631, STKc_YSK4, Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Score = 72.6 bits (178), Expect = 6e-14
Identities = 60/208 (28%), Positives = 97/208 (46%), Gaps = 44/208 (21%)
Query: 382 KAGILGDGSYSVCRRCVEKSTGQEYAVKIIS-------------RKIDCSEEINLLRACQ 428
K +LG G+Y C + GQ AVK + K+ EE++LL++ +
Sbjct: 4 KGEVLGKGAYGTVY-CGLTNQGQLIAVKQVELDTSNVLAAEKEYEKL--QEEVDLLKSLK 60
Query: 429 GHPNIVNLHCVFQDEVHTYLVLELLKGGELLDRIRQKGRCGFTENEASRIMRQLVAAVHF 488
H NIV D+ + +E + GG + + + G E + +Q++ V +
Sbjct: 61 -HVNIVQYLGTCLDDNTISIFMEFVPGGSISSILNRFG--PLPEPVFCKYTKQILDGVAY 117
Query: 489 MHSRGVVHRDLKPENLLFSDPAGDNIKVVDFGFACLKR--------------ESLH-TPC 533
+H+ VVHRD+K N++ P G IK++DFG C +R +S+H TP
Sbjct: 118 LHNNCVVHRDIKGNNVMLM-PNG-IIKLIDFG--CARRLAWVGLHGTHSNMLKSMHGTP- 172
Query: 534 FTLQYAAPEVLRQDKSGYDENCDLWSLG 561
+ APEV+ + SGY D+WS+G
Sbjct: 173 ---YWMAPEVINE--SGYGRKSDIWSIG 195
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Length = 265 |
| >gnl|CDD|143384 cd07879, STKc_p38delta_MAPK13, Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 73.8 bits (181), Expect = 6e-14
Identities = 62/198 (31%), Positives = 104/198 (52%), Gaps = 26/198 (13%)
Query: 386 LGDGSY-SVCRRCVEKSTGQEYAVKIISRKIDCSE--------EINLLRACQGHPNIVNL 436
+G G+Y SVC ++K TG++ A+K +SR SE E+ LL+ Q H N++ L
Sbjct: 23 VGSGAYGSVCS-AIDKRTGEKVAIKKLSRPFQ-SEIFAKRAYRELTLLKHMQ-HENVIGL 79
Query: 437 HCVFQ-----DEVHT-YLVLELLKGGELLDRIRQKGRCGFTENEASRIMRQLVAAVHFMH 490
VF DE YLV+ ++ L +I +E++ ++ Q++ + ++H
Sbjct: 80 LDVFTSAVSGDEFQDFYLVMPYMQTD--LQKIMGHP---LSEDKVQYLVYQMLCGLKYIH 134
Query: 491 SRGVVHRDLKPENLLFSDPAGDNIKVVDFGFACLKRESLHTPCFTLQYAAPEVLRQDKSG 550
S G++HRDLKP NL ++ +K++DFG A + T Y APEV+ +
Sbjct: 135 SAGIIHRDLKPGNLAVNEDC--ELKILDFGLARHADAEMTGYVVTRWYRAPEVI-LNWMH 191
Query: 551 YDENCDLWSLGVILVNVL 568
Y++ D+WS+G I+ +L
Sbjct: 192 YNQTVDIWSVGCIMAEML 209
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13, is found in skeletal muscle, heart, lung, testis, pancreas, and small intestine. It regulates microtubule function by phosphorylating Tau. It activates the c-jun promoter and plays a role in G2 cell cycle arrest. It also controls the degration of c-Myb, which is associated with myeloid leukemia and poor prognosis in colorectal cancer. p38delta is the main isoform involved in regulating the differentiation and apoptosis of keratinocytes. Length = 342 |
| >gnl|CDD|214529 smart00133, S_TK_X, Extension to Ser/Thr-type protein kinases | Back alignment and domain information |
|---|
Score = 67.0 bits (164), Expect = 7e-14
Identities = 24/57 (42%), Positives = 30/57 (52%), Gaps = 3/57 (5%)
Query: 316 IDWDDLATKRIPAPFVPKISNELDVSNFSDEFTKMIPADSPA---IVPPNFDKIFKG 369
IDWD L K I PFVPKI + D SNF EFT+ P +P + + F+G
Sbjct: 3 IDWDKLENKEIEPPFVPKIKSPTDTSNFDPEFTEETPVLTPVDSPLSGGIQQEPFRG 59
|
Length = 64 |
| >gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 72.1 bits (177), Expect = 7e-14
Identities = 43/144 (29%), Positives = 69/144 (47%), Gaps = 18/144 (12%)
Query: 430 HPNIVNLHCVFQDEVHTYLVLELLKGGELLDRIRQKGRCGFTENEASRIMRQLVAAVHFM 489
HPNIV L V + Y+V+EL+ GG LL +R+K T + ++ A + ++
Sbjct: 51 HPNIVKLIGVCVQKQPIYIVMELVPGGSLLTFLRKKKN-RLTVKKLLQMSLDAAAGMEYL 109
Query: 490 HSRGVVHRDLKPENLLFSDPAGDNIKVVDFGFACLKRESLHTPCFTLQ---------YAA 540
S+ +HRDL N L + + +K+ DFG + RE +T+ + A
Sbjct: 110 ESKNCIHRDLAARNCLVGE--NNVLKISDFG---MSREE-EGGIYTVSDGLKQIPIKWTA 163
Query: 541 PEVLRQDKSGYDENCDLWSLGVIL 564
PE L + Y D+WS G++L
Sbjct: 164 PEALNYGR--YTSESDVWSYGILL 185
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251 |
| >gnl|CDD|173682 cd05591, STKc_nPKC_epsilon, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Score = 73.3 bits (180), Expect = 8e-14
Identities = 40/117 (34%), Positives = 60/117 (51%), Gaps = 7/117 (5%)
Query: 263 YRRILKTEPPIPEDLSPDVADFISRLLVKDPRRRLG--GGELDAEELKRHPFFNVIDWDD 320
+ IL + P LS + + + K+P +RLG + + +K+HPFF IDW
Sbjct: 205 FESILHDDVLYPVWLSKEAVSILKAFMTKNPNKRLGCVASQGGEDAIKQHPFFKEIDWVL 264
Query: 321 LATKRIPAPFVPKISNELDVSNFSDEFTK----MIPADSPAIVPPNFDKIFKGSLFF 373
L ++I PF PKI + DV+NF +FTK + P D I N ++ F+G FF
Sbjct: 265 LEQRKIKPPFKPKIKTKRDVNNFDQDFTKEEPVLTPVDPAVIKQINQEE-FRGFSFF 320
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to neoplastic transformation depending on the cell type. It contributes to oncogenesis by inducing disordered cell growth and inhibiting cell death. It also plays a role in tumor invasion and metastasis. PKC-epsilon has also been found to confer cardioprotection against ischemia and reperfusion-mediated damage. Other cellular functions include the regulation of gene expression, cell adhesion, and cell motility. Length = 321 |
| >gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Score = 72.0 bits (177), Expect = 1e-13
Identities = 57/195 (29%), Positives = 87/195 (44%), Gaps = 23/195 (11%)
Query: 386 LGDGSYSVCRRCVEKSTGQEY---AVKIISRK--IDCSE----EINLLRACQGHPNIVNL 436
LGDGS+ V RR ++G + AVK + D + E ++ + H N++ L
Sbjct: 3 LGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSLD-HENLIRL 61
Query: 437 HCVFQDEVHTYLVLELLKGGELLDRIRQKGRCGFTENEASRIMRQLVAAVHFMHSRGVVH 496
+ V +V EL G LLDR+R+ F + Q+ + ++ S+ +H
Sbjct: 62 YGVVLTH-PLMMVTELAPLGSLLDRLRKDALGHFLISTLCDYAVQIANGMRYLESKRFIH 120
Query: 497 RDLKPEN-LLFSDPAGDNIKVVDFGF--ACLKRESLHTPCFTLQ----YAAPEVLRQDKS 549
RDL N LL SD D +K+ DFG A + E + L+ + APE LR
Sbjct: 121 RDLAARNILLASD---DKVKIGDFGLMRALPQNEDHYVMEEHLKVPFAWCAPESLRTRT- 176
Query: 550 GYDENCDLWSLGVIL 564
+ D+W GV L
Sbjct: 177 -FSHASDVWMFGVTL 190
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257 |
| >gnl|CDD|143380 cd07875, STKc_JNK1, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Score = 73.2 bits (179), Expect = 1e-13
Identities = 56/191 (29%), Positives = 85/191 (44%), Gaps = 41/191 (21%)
Query: 423 LLRACQGHPNIVNLHCVF------QDEVHTYLVLELLKGGELLDRIRQKGRCGFTENEAS 476
+L C H NI+ L VF ++ Y+V+EL+ L I+ + S
Sbjct: 75 VLMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDA-NLCQVIQME----LDHERMS 129
Query: 477 RIMRQLVAAVHFMHSRGVVHRDLKPENLLFSDPAGDNIKVVDFGFACLKRES-LHTP-CF 534
++ Q++ + +HS G++HRDLKP N++ +K++DFG A S + TP
Sbjct: 130 YLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDC--TLKILDFGLARTAGTSFMMTPYVV 187
Query: 535 TLQYAAPEVLRQDKSGYDENCDLWSLGVILVNVLRQDKSGYDENCDLWSLGVILYTMLCG 594
T Y APEV+ LG+ GY EN D+WS+G I+ M+ G
Sbjct: 188 TRYYRAPEVI---------------LGM-----------GYKENVDIWSVGCIMGEMIKG 221
Query: 595 RVPFHARSRDD 605
V F D
Sbjct: 222 GVLFPGTDHID 232
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK1 specifically binds with JAMP (JNK1-associated membrane protein), which regulates the duration of JNK1 activity in response to stimuli. Specific JNK1 substrates include Itch and SG10, which are implicated in Th2 responses and airway inflammation, and microtubule dynamics and axodendritic length, respectively. Mice deficient in Jnk1 are protected against arthritis, obesity, type 2 diabetes, cardiac cell death, and non-alcoholic liver disease, suggesting that JNK1 may play roles in the pathogenesis of these diseases. Length = 364 |
| >gnl|CDD|173633 cd05052, PTKc_Abl, Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Score = 71.4 bits (175), Expect = 1e-13
Identities = 56/190 (29%), Positives = 84/190 (44%), Gaps = 19/190 (10%)
Query: 386 LGDGSYSVCRRCVEKSTGQEYAVKIISRKIDCSEEINLLRACQ-----GHPNIVNLHCVF 440
LG G Y V K AVK + K D E L+ HPN+V L V
Sbjct: 14 LGGGQYGEVYEGVWKKYSLTVAVKTL--KEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVC 71
Query: 441 QDEVHTYLVLELLKGGELLDRIRQKGRCGFTENEASRIMRQLVAAVHFMHSRGVVHRDLK 500
E Y++ E + G LLD +R+ R + Q+ +A+ ++ + +HRDL
Sbjct: 72 TREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKNFIHRDLA 131
Query: 501 PENLLFSDPAGDN--IKVVDFGFACLKRESLHTPC----FTLQYAAPEVLRQDKSGYDEN 554
N L G+N +KV DFG + L +T F +++ APE L +K +
Sbjct: 132 ARNCL----VGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNK--FSIK 185
Query: 555 CDLWSLGVIL 564
D+W+ GV+L
Sbjct: 186 SDVWAFGVLL 195
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays a role in cell proliferation and survival. In response to DNA damage or oxidative stress, Abl is transported to the nucleus where it induces apoptosis. In chronic myelogenous leukemia (CML) patients, an aberrant translocation results in the replacement of the first exon of Abl with the BCR (breakpoint cluster region) gene. The resulting BCR-Abl fusion protein is constitutively active and associates into tetramers, resulting in a hyperactive kinase sending a continuous signal. This leads to uncontrolled proliferation, morphological transformation and anti-apoptotic effects. BCR-Abl is the target of selective inhibitors, such as imatinib (Gleevec), used in the treatment of CML. Abl2, also known as ARG (Abelson-related gene), is thought to play a cooperative role with Abl in the proper development of the nervous system. The Tel-ARG fusion protein, resulting from reciprocal translocation between chromosomes 1 and 12, is associated with acute myeloid leukemia (AML). The TEL gene is a frequent fusion partner of other tyr kinase oncogenes, including Tel/Abl, Tel/PDGFRbeta, and Tel/Jak2, found in patients with leukemia and myeloproliferative disorders. Length = 263 |
| >gnl|CDD|143378 cd07873, STKc_PCTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 72.0 bits (176), Expect = 2e-13
Identities = 75/255 (29%), Positives = 113/255 (44%), Gaps = 52/255 (20%)
Query: 373 FEQYDMDLDKAGILGDGSYSVCRRCVEKSTGQEYAVKIISRKID----CS--EEINLLRA 426
E Y + LDK LG+G+Y+ + K T A+K I + + C+ E++LL+
Sbjct: 5 LETY-IKLDK---LGEGTYATVYKGRSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKD 60
Query: 427 CQGHPNIVNLHCVFQDEVHTYLVLELLKGGELLDRIRQKGRCGFTEN--EASRIMRQLVA 484
+ H NIV LH + E LV E L D + CG + N + QL+
Sbjct: 61 LK-HANIVTLHDIIHTEKSLTLVFEYLDK----DLKQYLDDCGNSINMHNVKLFLFQLLR 115
Query: 485 AVHFMHSRGVVHRDLKPENLLFSDPAGDNIKVVDFGFACLKRESLHTPCF-----TLQYA 539
+++ H R V+HRDLKP+NLL ++ +K+ DFG A + +S+ T + TL Y
Sbjct: 116 GLNYCHRRKVLHRDLKPQNLLINERG--ELKLADFGLA--RAKSIPTKTYSNEVVTLWYR 171
Query: 540 APEVLRQDKSGYDENCDLWSLGVILVNVLRQDKSGYDENCDLWSLGVILYTMLCGRVPFH 599
P++L LG + Y D+W +G I Y M GR P
Sbjct: 172 PPDIL---------------LG----------STDYSTQIDMWGVGCIFYEMSTGR-PLF 205
Query: 600 ARSRDDSALSIMARI 614
S + L + RI
Sbjct: 206 PGSTVEEQLHFIFRI 220
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may play a role in regulating neurite outgrowth. It can also associate with Trap (Tudor repeat associator with PCTAIRE-2), a physiological partner of PCTAIRE-2; with p11, a small dimeric protein with similarity to S100; and with 14-3-3 proteins, mediators of phosphorylation-dependent interactions in many different proteins. Length = 301 |
| >gnl|CDD|173667 cd05576, STKc_RPK118_like, Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Score = 70.3 bits (172), Expect = 2e-13
Identities = 66/253 (26%), Positives = 100/253 (39%), Gaps = 43/253 (16%)
Query: 399 EKSTGQEYAVKIISRKIDCSEEINLLRACQGHPNIVNLHCVFQDEVHTYLVLELLKGGEL 458
+ T Q + +K + + + S E L PN+V LH E +LVL+ +GG+L
Sbjct: 14 DTRTQQTFILKGLRKSSEYSRE-RLTIIPHCVPNMVCLHKYIVSEDSVFLVLQHAEGGKL 72
Query: 459 LDRIRQKGRCGFTENEASRIMRQLVAAVHFMHSRGVVHRDLKPENLLFSDPAGDNIKVVD 518
I + E R ++V A+ +H G+V RDL P N+L D +I++
Sbjct: 73 WSHISKFLN--IPEECVKRWAAEMVVALDALHREGIVCRDLNPNNILLDDRG--HIQLTY 128
Query: 519 FGFACLKRESLHTPCFTLQYAAPEVLRQDKSGYDENCDLWSLGVILVNVLRQDKSGYDEN 578
F +S Y APEV G I S E
Sbjct: 129 FSRWSEVEDSCDGEAVENMYCAPEV-----------------GGI---------SEETEA 162
Query: 579 CDLWSLGVILYTMLCGRVPFHARSRDDSALSIMARIKEGQFNFDAEAWSTVSSEAKELTK 638
CD WSLG IL+ +L G+ S ++ + ++ VS EA+ L +
Sbjct: 163 CDWWSLGAILFELLTGKTLVECHP---SGINTHTTLNIPEW---------VSEEARSLLQ 210
Query: 639 SLLTVNPAQRIRM 651
LL NP +R+
Sbjct: 211 QLLQFNPTERLGA 223
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phosphate (SPP), a lipid messenger involved in many cellular events. RPK118 may be involved in transmitting SPP-mediated signaling. RPK118 also binds the antioxidant peroxiredoxin-3 (PRDX3). RPK118 may be involved in the transport of PRDX3 from the cytoplasm to its site of function in the mitochondria. Length = 237 |
| >gnl|CDD|223009 PHA03211, PHA03211, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 73.0 bits (179), Expect = 3e-13
Identities = 54/189 (28%), Positives = 91/189 (48%), Gaps = 41/189 (21%)
Query: 397 CVEKSTGQEYAVKIISRK---IDCSEEINLLRACQGHPNIV---NLHCV----------F 440
CV +S+ +Y +++ + E LLR HP ++ ++ V +
Sbjct: 184 CVFESSHPDYPQRVVVKAGWYASSVHEARLLRRLS-HPAVLALLDVRVVGGLTCLVLPKY 242
Query: 441 QDEVHTYLVLELLKGGELLDRIRQKGRCGFTENEASRIMRQLVAAVHFMHSRGVVHRDLK 500
+ +++TYL R+R G T + RQL++A+ ++H G++HRD+K
Sbjct: 243 RSDLYTYLG----------ARLRPLGLAQVTA-----VARQLLSAIDYIHGEGIIHRDIK 287
Query: 501 PENLLFSDPAGDNIKVVDFGFACLKRESLHTPCF-----TLQYAAPEVLRQDKSGYDENC 555
EN+L + P ++I + DFG AC R S TP T+ APEVL D Y +
Sbjct: 288 TENVLVNGP--EDICLGDFGAACFARGSWSTPFHYGIAGTVDTNAPEVLAGDP--YTPSV 343
Query: 556 DLWSLGVIL 564
D+WS G+++
Sbjct: 344 DIWSAGLVI 352
|
Length = 461 |
| >gnl|CDD|173763 cd08223, STKc_Nek4, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Score = 70.0 bits (171), Expect = 4e-13
Identities = 67/275 (24%), Positives = 121/275 (44%), Gaps = 47/275 (17%)
Query: 385 ILGDGSYSVCRRCVEKSTGQEYAVKII------SRKIDCSEEINLLRACQGHPNIVNLHC 438
++G GSY ++ G++Y +K + R+ +E+ L + HPNIV
Sbjct: 7 VVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVAYRE 66
Query: 439 VFQDE-VHTYLVLELLKGGELLDRIR-QKGRCGFTENEASRIMRQLVAAVHFMHSRGVVH 496
++ E Y+V+ +GG+L +++ QKG+ EN+ Q+ A+ ++H + ++H
Sbjct: 67 SWEGEDGLLYIVMGFCEGGDLYHKLKEQKGKL-LPENQVVEWFVQIAMALQYLHEKHILH 125
Query: 497 RDLKPENLLFSDPAGDNIKVVDFGFACL---KRESLHTPCFTLQYAAPEVLRQDKSGYDE 553
RDLK +N+ + + IKV D G A + + + T T Y +PE+
Sbjct: 126 RDLKTQNVFLTRT--NIIKVGDLGIARVLENQCDMASTLIGTPYYMSPELFSNKP----- 178
Query: 554 NCDLWSLGVILVNVLRQDKSGYDENCDLWSLGVILYTMLCGRVPFHARSRDDSALSIMAR 613
Y+ D+W+LG +Y M + F+A+ + S++ R
Sbjct: 179 ---------------------YNYKSDVWALGCCVYEMATLKHAFNAKDMN----SLVYR 213
Query: 614 IKEGQFNFDAEAWSTVSSEAKELTKSLLTVNPAQR 648
I EG+ S E EL ++L+ P +R
Sbjct: 214 IIEGKL---PPMPKDYSPELGELIATMLSKRPEKR 245
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. Length = 257 |
| >gnl|CDD|143382 cd07877, STKc_p38alpha_MAPK14, Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 71.2 bits (174), Expect = 4e-13
Identities = 58/198 (29%), Positives = 101/198 (51%), Gaps = 25/198 (12%)
Query: 386 LGDGSY-SVCRRCVEKSTGQEYAVKIISRKID-------CSEEINLLRACQGHPNIVNLH 437
+G G+Y SVC + TG AVK +SR E+ LL+ + H N++ L
Sbjct: 25 VGSGAYGSVCA-AFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMK-HENVIGLL 82
Query: 438 CVF------QDEVHTYLVLELLKGGELLDRIR-QKGRCGFTENEASRIMRQLVAAVHFMH 490
VF ++ YLV L+ G +L + ++ QK T++ ++ Q++ + ++H
Sbjct: 83 DVFTPARSLEEFNDVYLVTHLM-GADLNNIVKCQK----LTDDHVQFLIYQILRGLKYIH 137
Query: 491 SRGVVHRDLKPENLLFSDPAGDNIKVVDFGFACLKRESLHTPCFTLQYAAPEVLRQDKSG 550
S ++HRDLKP NL ++ +K++DFG A + + T Y APE++ +
Sbjct: 138 SADIIHRDLKPSNLAVNEDC--ELKILDFGLARHTDDEMTGYVATRWYRAPEIM-LNWMH 194
Query: 551 YDENCDLWSLGVILVNVL 568
Y++ D+WS+G I+ +L
Sbjct: 195 YNQTVDIWSVGCIMAELL 212
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14, is expressed in most tissues and is the major isoform involved in the immune and inflammatory response. It is the central p38 MAPK involved in myogenesis. It plays a role in regulating cell cycle check-point transition and promoting cell differentiation. p38alpha also regulates cell proliferation and death through crosstalk with the JNK pathway. Its substrates include MAPK activated protein kinase 2 (MK2), MK5, and the transcription factors ATF2 and Mitf. Length = 345 |
| >gnl|CDD|234389 TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclase fusion protein | Back alignment and domain information |
|---|
Score = 73.0 bits (179), Expect = 5e-13
Identities = 59/196 (30%), Positives = 85/196 (43%), Gaps = 43/196 (21%)
Query: 402 TGQEYAVKIISRKIDCSEEINL-------LRACQG--HPNIVNLHCVFQDEVHT-----Y 447
TG E A+K++ + D EE + C HPNIV L D +
Sbjct: 2 TGHEVAIKLL--RTDAPEEEHQRARFRRETALCARLYHPNIVAL----LDSGEAPPGLLF 55
Query: 448 LVLELLKGGELLDRIRQKGRCGFTENEASRIMRQLVAAVHFMHSRGVVHRDLKPENLLFS 507
V E + G L + + G E R+M Q++ A+ H++G+VHRDLKP+N++ S
Sbjct: 56 AVFEYVPGRTLREVLAADG--ALPAGETGRLMLQVLDALACAHNQGIVHRDLKPQNIMVS 113
Query: 508 DPAGD-NIKVVDFGFACL--------------KRESLHTPCFTLQYAAPEVLRQDKSGYD 552
+ KV+DFG L E L TP Y APE LR +
Sbjct: 114 QTGVRPHAKVLDFGIGTLLPGVRDADVATLTRTTEVLGTP----TYCAPEQLRGEPV--T 167
Query: 553 ENCDLWSLGVILVNVL 568
N DL++ G+I + L
Sbjct: 168 PNSDLYAWGLIFLECL 183
|
This model represents proteins of 1350 in length, in multiple species of Burkholderia, in Acidovorax avenae subsp. citrulli AAC00-1 and Delftia acidovorans SPH-1, and in multiple copies in Sorangium cellulosum, in genomic neighborhoods that include a cyclodehydratase/docking scaffold fusion protein (TIGR03882) and a member of the thiazole/oxazole modified metabolite (TOMM) precursor family TIGR03795. It has a kinase domain in the N-terminal 300 amino acids, followed by a cyclase homology domain, followed by regions without named domain definitions. It is a probable bacteriocin-like metabolite biosynthesis protein [Cellular processes, Toxin production and resistance]. Length = 1266 |
| >gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Score = 69.5 bits (171), Expect = 6e-13
Identities = 22/78 (28%), Positives = 40/78 (51%), Gaps = 4/78 (5%)
Query: 888 RSRYNVHTYLVLELLKGGELLDRIRQKGRCGFTENEASRIMRQLVAAVHFMHSRGVVHRD 947
R + LE + GG L +++ G+ E + RQ++ + ++HS G+VHRD
Sbjct: 69 RDEEKNTLNIFLEYVSGGSLSSLLKKFGK--LPEPVIRKYTRQILEGLAYLHSNGIVHRD 126
Query: 948 LKPENLLLSGISGNLIKI 965
+K N+L+ G +K+
Sbjct: 127 IKGANILVDS-DGV-VKL 142
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260 |
| >gnl|CDD|143363 cd07858, STKc_TEY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 70.9 bits (174), Expect = 6e-13
Identities = 61/205 (29%), Positives = 95/205 (46%), Gaps = 34/205 (16%)
Query: 386 LGDGSYSVCRRCVEKSTGQEYAVKIISR----KIDCSE---EINLLRACQGHPNIVNLHC 438
+G G+Y + T ++ A+K I+ +ID EI LLR H N++ +
Sbjct: 13 IGRGAYGIVCSAKNSETNEKVAIKKIANAFDNRIDAKRTLREIKLLRHLD-HENVIAIKD 71
Query: 439 V--------FQDEVHTYLVLELLKGGELLDRIRQKGRCGFTENEASRIMRQLVAAVHFMH 490
+ F D Y+V EL+ +L IR +++ + QL+ + ++H
Sbjct: 72 IMPPPHREAFND---VYIVYELMDT-DLHQIIRSSQ--TLSDDHCQYFLYQLLRGLKYIH 125
Query: 491 SRGVVHRDLKPENLLFSDPAGDNIKVVDFGFACLKRESLHTPCF------TLQYAAPEVL 544
S V+HRDLKP NLL + A ++K+ DFG A R + F T Y APE+L
Sbjct: 126 SANVLHRDLKPSNLLLN--ANCDLKICDFGLA---RTTSEKGDFMTEYVVTRWYRAPELL 180
Query: 545 RQDKSGYDENCDLWSLGVILVNVLR 569
+ S Y D+WS+G I +L
Sbjct: 181 -LNCSEYTTAIDVWSVGCIFAELLG 204
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. This subfamily represents the TEY subtype and is further subdivided into three groups (A, B, and C). Group A is represented by AtMPK3, AtMPK6, Nicotiana tabacum BTF4 (NtNTF4), among others. They are mostly involved in environmental and hormonal responses. AtMPK3 and AtMPK6 are also key regulators for stomatal development and patterning. Group B is represented by AtMPK4, AtMPK13, and NtNTF6, among others. They may be involved in both cell division and environmental stress response. AtMPK4 also participates in regulating innate immunity. Group C is represented by AtMPK1, AtMPK2, NtNTF3, Oryza sativa MAPK4 (OsMAPK4), among others. They may also be involved in stress responses. AtMPK1 and AtMPK2 are activated following mechanical injury and in the presence of stress chemicals such as jasmonic acid, hydrogen peroxide and abscisic acid. OsMAPK4 is also called OsMSRMK3 for Multiple Stress-Responsive MAPK3. Length = 337 |
| >gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 69.4 bits (170), Expect = 7e-13
Identities = 36/143 (25%), Positives = 72/143 (50%), Gaps = 8/143 (5%)
Query: 430 HPNIVNLHCVFQDEVHTYLVLELLKGGELLDRIRQKGRCGFTENEASRIMRQLVAAVHFM 489
HP ++ L+ V E Y+V EL+K G LL+ ++ + + Q+ + + ++
Sbjct: 60 HPKLIQLYAVCTLEEPIYIVTELMKYGSLLEYLQGGAGRALKLPQLIDMAAQVASGMAYL 119
Query: 490 HSRGVVHRDLKPENLLFSDPAGDNIKVVDFGFACLKRESLHTPC----FTLQYAAPEVLR 545
++ +HRDL N+L + + KV DFG A + +E ++ F +++ APE
Sbjct: 120 EAQNYIHRDLAARNVLVGE--NNICKVADFGLARVIKEDIYEAREGAKFPIKWTAPEAAL 177
Query: 546 QDKSGYDENCDLWSLGVILVNVL 568
++ + D+WS G++L ++
Sbjct: 178 YNR--FSIKSDVWSFGILLTEIV 198
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Frk, also known as Rak, is specifically expressed in liver, lung, kidney, intestine, mammary glands, and the islets of Langerhans. Rodent homologs were previously referred to as GTK (gastrointestinal tyr kinase), BSK (beta-cell Src-like kinase), or IYK (intestinal tyr kinase). Studies in mice reveal that Frk is not essential for viability. It plays a role in the signaling that leads to cytokine-induced beta-cell death in Type I diabetes. It also regulates beta-cell number during embryogenesis and early in life. Length = 261 |
| >gnl|CDD|132953 cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 69.9 bits (171), Expect = 7e-13
Identities = 68/280 (24%), Positives = 117/280 (41%), Gaps = 38/280 (13%)
Query: 379 DLDKAGILGDGSYSVCRRCVEKSTGQEYAVKIISRKIDCSE------EINLLRACQGHPN 432
+++ LG G+Y + + + TG A+K I ++D S+ E+++L P
Sbjct: 2 EIEVLDELGKGNYGSVYKVLHRPTGVTMAMKEIRLELDESKFNQIIMELDILHKAVS-PY 60
Query: 433 IVNLHCVFQDEVHTYLVLELLKGGELLDRIRQKGRC--GFTENEASRIMRQLVAAVHFMH 490
IV+ + F E Y+ +E + G L D++ G G E+ RI +V + F+
Sbjct: 61 IVDFYGAFFIEGAVYMCMEYMDAGSL-DKLYAGGVATEGIPEDVLRRITYAVVKGLKFLK 119
Query: 491 SR-GVVHRDLKPENLLFSDPAGDNIKVVDFGFACLKRESLHTPCFTLQ-YAAPEVLRQDK 548
++HRD+KP N+L + +K+ DFG + SL Q Y APE ++
Sbjct: 120 EEHNIIHRDVKPTNVLVN--GNGQVKLCDFGVSGNLVASLAKTNIGCQSYMAPERIK--- 174
Query: 549 SGYDENCDLWSLGVILVNVLRQDKSGYDENCDLWSLGVILYTMLCGRVPFHARSRDDSAL 608
S G Y D+WSLG+ + M GR P+ + +
Sbjct: 175 ----------SGGP-------NQNPTYTVQSDVWSLGLSILEMALGRYPYPPETY-ANIF 216
Query: 609 SIMARIKEGQFNFDAEAWSTVSSEAKELTKSLLTVNPAQR 648
+ ++ I +G S S +A++ L P +R
Sbjct: 217 AQLSAIVDGD---PPTLPSGYSDDAQDFVAKCLNKIPNRR 253
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Polymyxin B resistance protein 2 (PBS2) from Saccharomyces cerevisiae, Wis1 from Schizosaccharomyces pombe, and related proteins. PBS2 and Wis1 are components of stress-activated MAPK cascades in budding and fission yeast, respectively. PBS2 is the specific activator of the MAPK Hog1, which plays a central role in the response of budding yeast to stress including exposure to arsenite and hyperosmotic environments. Wis1 phosphorylates and activates the MAPK Sty1 (also called Spc1 or Phh1), which stimulates a transcriptional response to a wide range of cellular insults through the bZip transcription factors Atf1, Pcr1, and Pap1. Length = 286 |
| >gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 69.9 bits (172), Expect = 8e-13
Identities = 30/60 (50%), Positives = 40/60 (66%), Gaps = 2/60 (3%)
Query: 896 YLVLELLKGGELLDRIRQKGRCGFTENEASRIMRQLVAAVHFMHSRGVVHRDLKPENLLL 955
YLV+E + GGEL +R+ GR F E A Q+V A+ ++HS +V+RDLKPENLLL
Sbjct: 77 YLVMEYVPGGELFSHLRKSGR--FPEPVARFYAAQVVLALEYLHSLDIVYRDLKPENLLL 134
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290 |
| >gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 69.4 bits (171), Expect = 8e-13
Identities = 24/74 (32%), Positives = 38/74 (51%), Gaps = 12/74 (16%)
Query: 896 YLVLEL----LKGGELLDRIRQKGRCGFTENEASRIMRQLVAAVHFMHSRGVVHRDLKPE 951
YLV E LK LD+ + N IM QL+ + + HS ++HRDLKP+
Sbjct: 74 YLVFEYCDMDLKK--YLDKRPGP----LSPNLIKSIMYQLLRGLAYCHSHRILHRDLKPQ 127
Query: 952 NLLLSGISGNLIKI 965
N+L++ ++K+
Sbjct: 128 NILIN--RDGVLKL 139
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282 |
| >gnl|CDD|173718 cd05629, STKc_NDR_like_fungal, Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 71.0 bits (174), Expect = 8e-13
Identities = 45/137 (32%), Positives = 72/137 (52%), Gaps = 11/137 (8%)
Query: 231 GIECVFFSSSLIIFFIILSFTLSFIHDYYHIQYRRILKTEPPI--PED--LSPDVADFIS 286
G EC ++S I+F ++ + F + H YR+I+ + P+D LS + D I
Sbjct: 226 GQECDWWSLGAIMFECLIGWP-PFCSENSHETYRKIINWRETLYFPDDIHLSVEAEDLIR 284
Query: 287 RLLVKDPRRRLGGGELDAEELKRHPFFNVIDWDDLATKRIPAPFVPKISNELDVSNF-SD 345
RL+ + RLG G A E+K HPFF +DWD + ++I APF+P++ + D S F +D
Sbjct: 285 RLIT-NAENRLGRG--GAHEIKSHPFFRGVDWDTI--RQIRAPFIPQLKSITDTSYFPTD 339
Query: 346 EFTKMIPADSPAIVPPN 362
E ++ A + P
Sbjct: 340 ELEQVPEAPALKQAAPA 356
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of Ace2p activity and cellular morphogenesis) network. CBK1 and Orb6 play similar roles in coordinating cell morphology with cell cycle progression. Ukc1 is involved in morphogenesis, pathogenicity, and pigment formation. Cot1 plays a role in polar tip extension. Length = 377 |
| >gnl|CDD|143383 cd07878, STKc_p38beta_MAPK11, Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 70.5 bits (172), Expect = 8e-13
Identities = 56/199 (28%), Positives = 102/199 (51%), Gaps = 25/199 (12%)
Query: 386 LGDGSY-SVCRRCVEKSTGQEYAVKIISRKID-------CSEEINLLRACQGHPNIVNLH 437
+G G+Y SVC + Q+ AVK +SR E+ LL+ + H N++ L
Sbjct: 23 VGSGAYGSVCS-AYDTRLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHMK-HENVIGLL 80
Query: 438 CVF------QDEVHTYLVLELLKGGELLDRIR-QKGRCGFTENEASRIMRQLVAAVHFMH 490
VF ++ YLV L+ G +L + ++ QK ++ ++ QL+ + ++H
Sbjct: 81 DVFTPATSIENFNEVYLVTNLM-GADLNNIVKCQK----LSDEHVQFLIYQLLRGLKYIH 135
Query: 491 SRGVVHRDLKPENLLFSDPAGDNIKVVDFGFACLKRESLHTPCFTLQYAAPEVLRQDKSG 550
S G++HRDLKP N+ ++ ++++DFG A + + T Y APE++ +
Sbjct: 136 SAGIIHRDLKPSNVAVNEDC--ELRILDFGLARQADDEMTGYVATRWYRAPEIM-LNWMH 192
Query: 551 YDENCDLWSLGVILVNVLR 569
Y++ D+WS+G I+ +L+
Sbjct: 193 YNQTVDIWSVGCIMAELLK 211
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is widely expressed in tissues and shows more similarity with p38alpha than with the other isoforms. Both are sensitive to pyridinylimidazoles and share some common substrates such as MAPK activated protein kinase 2 (MK2) and the transcription factors ATF2, c-Fos and, ELK-1. p38beta is involved in regulating the activation of the cyclooxygenase-2 promoter and the expression of TGFbeta-induced alpha-smooth muscle cell actin. Length = 343 |
| >gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Score = 68.3 bits (167), Expect = 2e-12
Identities = 25/69 (36%), Positives = 36/69 (52%)
Query: 264 RRILKTEPPIPEDLSPDVADFISRLLVKDPRRRLGGGELDAEELKRHPFFNVIDWDDLAT 323
RR L+ P+ SP+ D LL KDP +RLG A+E++ HP F ++W L
Sbjct: 208 RRTLEMAVEYPDKFSPEAKDLCEALLQKDPEKRLGCRGGSADEVREHPLFKDLNWRRLEA 267
Query: 324 KRIPAPFVP 332
+ PF+P
Sbjct: 268 GMLEPPFIP 276
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of G protein signaling) homology (RH) domain and several motifs. The C-terminus diverges among different groups of GRKs. There are seven types of GRKs, named GRK1 to GRK7. They are subdivided into three main groups: visual (GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is widespread while GRK1/4/7 show a limited tissue distribution. The substrate spectrum of the widely expressed GRKs partially overlaps. GRKs play important roles in the cardiovascular, immune, respiratory, skeletal, and nervous systems. Length = 277 |
| >gnl|CDD|173756 cd08216, PK_STRAD, Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Score = 68.9 bits (169), Expect = 2e-12
Identities = 53/182 (29%), Positives = 84/182 (46%), Gaps = 24/182 (13%)
Query: 400 KSTGQEYAVKIISRKIDCSE-------EINLLRACQGHPNIVNLHCVFQDEVHTYLVLEL 452
K T AVK I+ E EI R Q HPNI+ F + Y+V L
Sbjct: 22 KPTNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQ-HPNILPYVTSFIVDSELYVVSPL 80
Query: 453 LKGGELLDRIRQKGRCGFTENEASRIMRQLVAAVHFMHSRGVVHRDLKPENLLFSDPAGD 512
+ G D ++ G E + I++ ++ A+ ++HS+G +HR +K ++L S GD
Sbjct: 81 MAYGSCEDLLKTHFPEGLPELAIAFILKDVLNALDYIHSKGFIHRSVKASHILLS---GD 137
Query: 513 NIKVVDFGF--AC--LKRESLHTP--CFT------LQYAAPEVLRQDKSGYDENCDLWSL 560
KVV G + +K F L + +PEVL+Q+ GY+E D++S+
Sbjct: 138 G-KVVLSGLRYSVSMIKHGKRQRVVHDFPKSSVKNLPWLSPEVLQQNLQGYNEKSDIYSV 196
Query: 561 GV 562
G+
Sbjct: 197 GI 198
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha stabilized through ATP and MO25 may be needed to activate LKB1. Length = 314 |
| >gnl|CDD|173694 cd05603, STKc_SGK2, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Score = 68.5 bits (167), Expect = 3e-12
Identities = 35/92 (38%), Positives = 50/92 (54%), Gaps = 2/92 (2%)
Query: 263 YRRILKTEPPIPEDLSPDVADFISRLLVKDPRRRLGGGELDAEELKRHPFFNVIDWDDLA 322
Y IL +P + D + LL KD RRRLG + D E+K H FF+ I+WDDL
Sbjct: 205 YDNILHKPLQLPGGKTVAACDLLVGLLHKDQRRRLGA-KADFLEIKNHVFFSPINWDDLY 263
Query: 323 TKRIPAPFVPKISNELDVSNFSDEFTK-MIPA 353
KRI P+ P ++ D+ +F EFT+ + +
Sbjct: 264 HKRITPPYNPNVAGPADLRHFDPEFTQEAVSS 295
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. Length = 321 |
| >gnl|CDD|173695 cd05604, STKc_SGK3, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Score = 68.5 bits (167), Expect = 3e-12
Identities = 34/90 (37%), Positives = 44/90 (48%), Gaps = 1/90 (1%)
Query: 260 HIQYRRILKTEPPIPEDLSPDVADFISRLLVKDPRRRLGGGELDAEELKRHPFFNVIDWD 319
Y IL + S + LL KD +RRLG E D E++ HPFF + W
Sbjct: 202 AEMYDNILHKPLVLRPGASLTAWSILEELLEKDRQRRLGAKE-DFLEIQEHPFFESLSWT 260
Query: 320 DLATKRIPAPFVPKISNELDVSNFSDEFTK 349
DL K+IP PF P + D+SNF FT+
Sbjct: 261 DLEQKKIPPPFNPNVEGPDDISNFDAVFTE 290
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, and receptors. It plays a critical role in hair follicle morphogenesis and hair cycling. Length = 325 |
| >gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Score = 67.6 bits (166), Expect = 4e-12
Identities = 26/56 (46%), Positives = 33/56 (58%), Gaps = 2/56 (3%)
Query: 258 YYHIQYRRILKTEPPIPEDLSPDVADFISRLLVKDPRRRLGGGELDAEELKRHPFF 313
Y +++ILK E P + PD D I +LLV DP+ RLG E +ELK HPFF
Sbjct: 227 EYLT-FQKILKLEYSFPPNFPPDAKDLIEKLLVLDPQDRLGVNE-GYDELKAHPFF 280
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280 |
| >gnl|CDD|132988 cd06657, STKc_PAK4, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Score = 67.7 bits (165), Expect = 4e-12
Identities = 57/210 (27%), Positives = 108/210 (51%), Gaps = 24/210 (11%)
Query: 380 LDKAGILGDGSYSVCRRCVEKSTGQEYAVKIIS-RKIDCSE----EINLLRACQGHPNIV 434
LD +G+GS + KS+G+ AVK + RK E E+ ++R Q H N+V
Sbjct: 22 LDNFIKIGEGSTGIVCIATVKSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQ-HENVV 80
Query: 435 NLHCVFQDEVHTYLVLELLKGGELLDRIRQKGRCGFTENEASRIMRQLVAAVHFMHSRGV 494
++ + ++V+E L+GG L D + E + + + ++ A+ +H++GV
Sbjct: 81 EMYNSYLVGDELWVVMEFLEGGALTDIVTHTR---MNEEQIAAVCLAVLKALSVLHAQGV 137
Query: 495 VHRDLKPENLLFSDPAGDNIKVVDFGFACL------KRESL-HTPCFTLQYAAPEVLRQD 547
+HRD+K +++L + +K+ DFGF +R+SL TP + APE++
Sbjct: 138 IHRDIKSDSILLTHDG--RVKLSDFGFCAQVSKEVPRRKSLVGTP----YWMAPELI--S 189
Query: 548 KSGYDENCDLWSLGVILVNVLRQDKSGYDE 577
+ Y D+WSLG++++ ++ + ++E
Sbjct: 190 RLPYGPEVDIWSLGIMVIEMVDGEPPYFNE 219
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell morphology and cytoskeletal organization. It is essential for embryonic viability and proper neural development. Mice lacking PAK4 die due to defects in the fetal heart. In addition, their spinal cord motor neurons showed failure to differentiate and migrate. PAK4 also plays a role in cell survival and tumorigenesis. It is overexpressed in many primary tumors including colon, esophageal, and mammary tumors. PAK4 has also been implicated in viral and bacterial infection pathways. Length = 292 |
| >gnl|CDD|143371 cd07866, STKc_BUR1, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Score = 67.7 bits (166), Expect = 4e-12
Identities = 53/217 (24%), Positives = 91/217 (41%), Gaps = 53/217 (24%)
Query: 386 LGDGSYSVCRRCVEKSTGQEYAVKII---SRK----IDCSEEINLLRACQGHPNIVNL-- 436
LG+G++ + + TG+ A+K I + K I EI +L+ + HPN+V L
Sbjct: 16 LGEGTFGEVYKARQIKTGRVVALKKILMHNEKDGFPITALREIKILKKLK-HPNVVPLID 74
Query: 437 -------------HCVFQDEVHTYLVLELLKGGELLDRIRQKGRCGFTENEASRIMRQLV 483
V+ V Y+ +L LL+ K TE++ M QL+
Sbjct: 75 MAVERPDKSKRKRGSVYM--VTPYMDHDL---SGLLENPSVK----LTESQIKCYMLQLL 125
Query: 484 AAVHFMHSRGVVHRDLKPENLLFSDPAGDNIKVVDFGFA---------------CLKRES 528
++++H ++HRD+K N+L + +K+ DFG A R+
Sbjct: 126 EGINYLHENHILHRDIKAANILIDNQG--ILKIADFGLARPYDGPPPNPKGGGGGGTRK- 182
Query: 529 LHTPC-FTLQYAAPEVLRQDKSGYDENCDLWSLGVIL 564
+T T Y PE+L ++ Y D+W +G +
Sbjct: 183 -YTNLVVTRWYRPPELLLGERR-YTTAVDIWGIGCVF 217
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic screen as factors involved in general transcription. The BUR1/BUR2 complex phosphorylates the C-terminal domain of RNA polymerase II. In addition, this complex regulates histone modification by phosporylating Rad6 and mediating the association of the Paf1 complex with chromatin. Length = 311 |
| >gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 67.2 bits (165), Expect = 5e-12
Identities = 27/76 (35%), Positives = 42/76 (55%), Gaps = 3/76 (3%)
Query: 890 RYNVHTYLVLELLKGGELLDRIRQKGRCGFTENEASRIMRQLVAAVHFMHSRGVVHRDLK 949
R N Y V E ++G L ++ + F+E+ I+ Q++ + +H G HRDLK
Sbjct: 68 RENDELYFVFEYMEG-NLYQLMKDRKGKPFSESVIRSIIYQILQGLAHIHKHGFFHRDLK 126
Query: 950 PENLLLSGISGNLIKI 965
PENLL+SG ++KI
Sbjct: 127 PENLLVSG--PEVVKI 140
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283 |
| >gnl|CDD|143377 cd07872, STKc_PCTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 67.7 bits (165), Expect = 5e-12
Identities = 69/233 (29%), Positives = 106/233 (45%), Gaps = 47/233 (20%)
Query: 386 LGDGSYSVCRRCVEKSTGQEYAVKIISRKID----CS--EEINLLRACQGHPNIVNLHCV 439
LG+G+Y+ + K T A+K I + + C+ E++LL+ + H NIV LH
Sbjct: 14 LGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKDLK-HANIVTLH-- 70
Query: 440 FQDEVHTYLVLELLKGGELLDR-IRQ-KGRCG--FTENEASRIMRQLVAAVHFMHSRGVV 495
D VHT L L+ E LD+ ++Q CG + + + Q++ + + H R V+
Sbjct: 71 --DIVHTDKSLTLVF--EYLDKDLKQYMDDCGNIMSMHNVKIFLYQILRGLAYCHRRKVL 126
Query: 496 HRDLKPENLLFSDPAGDNIKVVDFGFACLKR---ESLHTPCFTLQYAAPEVLRQDKSGYD 552
HRDLKP+NLL ++ +K+ DFG A K ++ TL Y P+VL
Sbjct: 127 HRDLKPQNLLINERG--ELKLADFGLARAKSVPTKTYSNEVVTLWYRPPDVL-------- 176
Query: 553 ENCDLWSLGVILVNVLRQDKSGYDENCDLWSLGVILYTMLCGRVPFHARSRDD 605
LG S Y D+W +G I + M GR F + +D
Sbjct: 177 -------LG----------SSEYSTQIDMWGVGCIFFEMASGRPLFPGSTVED 212
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play a role in regulating mitochondrial function in neurons. Length = 309 |
| >gnl|CDD|173663 cd05572, STKc_cGK_PKG, Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 66.1 bits (162), Expect = 8e-12
Identities = 29/75 (38%), Positives = 45/75 (60%), Gaps = 6/75 (8%)
Query: 882 RRTFVNRSRYNVHTYLVLELLKGGELLDRIRQKGRCGFTENEASRIMRQLVAAVHFMHSR 941
RTF ++ + Y+++E GGEL +R +G F E A + +V A ++H+R
Sbjct: 59 YRTFKDKK----YIYMLMEYCLGGELWTILRDRGL--FDEYTARFYIACVVLAFEYLHNR 112
Query: 942 GVVHRDLKPENLLLS 956
G+++RDLKPENLLL
Sbjct: 113 GIIYRDLKPENLLLD 127
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowing autophosphorylation and activation of the kinase. cGKI is a soluble protein expressed in all smooth muscles, platelets, cerebellum, and kidney. It is also expressed at lower concentrations in other tissues. cGKII is a membrane-bound protein that is most abundantly expressed in the intestine. It is also present in the brain nuclei, adrenal cortex, kidney, lung, and prostate. cGKI is involved in the regulation of smooth muscle tone, smooth cell proliferation, and platelet activation. cGKII plays a role in the regulation of secretion, such as renin secretion by the kidney and aldosterone secretion by the adrenal. It also regulates bone growth and the circadian rhythm. Length = 262 |
| >gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Score = 66.5 bits (163), Expect = 9e-12
Identities = 24/63 (38%), Positives = 37/63 (58%), Gaps = 2/63 (3%)
Query: 894 HTYLVLELLKGGELLDRIRQKGRCGFTENEASRIMRQLVAAVHFMHSRGVVHRDLKPENL 953
LV+E + +L + +R + R E + MR L+ V +MH+ G++HRDLKP NL
Sbjct: 73 GFVLVMEYM-PSDLSEVLRDEER-PLPEAQVKSYMRMLLKGVAYMHANGIMHRDLKPANL 130
Query: 954 LLS 956
L+S
Sbjct: 131 LIS 133
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286 |
| >gnl|CDD|132947 cd06616, PKc_MKK4, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Score = 66.6 bits (163), Expect = 1e-11
Identities = 54/206 (26%), Positives = 88/206 (42%), Gaps = 24/206 (11%)
Query: 379 DLDKAGILGDGSYSVCRRCVEKSTGQEYAVKIISRKIDCSEEINLLR------ACQGHPN 432
DL G +G G++ + + K +G AVK I +D E+ LL P
Sbjct: 5 DLKDLGEIGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDEKEQKRLLMDLDVVMRSSDCPY 64
Query: 433 IVNLHCVFQDEVHTYLVLELLKGG--ELLDRIRQKGRCGFTENEASRIMRQLVAAVHFMH 490
IV + E ++ +EL+ + + + + E +I V A++++
Sbjct: 65 IVKFYGALFREGDCWICMELMDISLDKFYKYVYEVLKSVIPEEILGKIAVATVKALNYLK 124
Query: 491 SR-GVVHRDLKPENLLFSDPAGDNIKVVDFGFACLKRESLHT-------PCFTLQYAAPE 542
++HRD+KP N+L NIK+ DFG + +S+ P Y APE
Sbjct: 125 EELKIIHRDVKPSNILLDR--NGNIKLCDFGISGQLVDSIAKTRDAGCRP-----YMAPE 177
Query: 543 -VLRQDKSGYDENCDLWSLGVILVNV 567
+ + GYD D+WSLG+ L V
Sbjct: 178 RIDPSARDGYDVRSDVWSLGITLYEV 203
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates the downstream targets, c-Jun N-terminal kinase (JNK) and p38 MAPK, on specific threonine and tyrosine residues. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. Their activation is associated with the induction of cell death. Mice deficient in MKK4 die during embryogenesis and display anemia, severe liver hemorrhage, and abnormal hepatogenesis. MKK4 may also play roles in the immune system and in cardiac hypertrophy. It plays a major role in cancer as a tumor and metastasis suppressor. Under certain conditions, MKK4 is pro-oncogenic. Length = 288 |
| >gnl|CDD|133213 cd05082, PTKc_Csk, Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Score = 65.8 bits (160), Expect = 1e-11
Identities = 42/137 (30%), Positives = 70/137 (51%), Gaps = 7/137 (5%)
Query: 430 HPNIVNLHCVF-QDEVHTYLVLELLKGGELLDRIRQKGRCGFTENEASRIMRQLVAAVHF 488
H N+V L V +++ Y+V E + G L+D +R +GR + + + A+ +
Sbjct: 58 HSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEY 117
Query: 489 MHSRGVVHRDLKPENLLFSDPAGDNI-KVVDFGFACLKRESLHTPCFTLQYAAPEVLRQD 547
+ + VHRDL N+L S+ DN+ KV DFG + T +++ APE LR+
Sbjct: 118 LEANNFVHRDLAARNVLVSE---DNVAKVSDFGLTKEASSTQDTGKLPVKWTAPEALREK 174
Query: 548 KSGYDENCDLWSLGVIL 564
K + D+WS G++L
Sbjct: 175 K--FSTKSDVWSFGILL 189
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Csk is expressed in a wide variety of tissues. As a negative regulator of Src, Csk plays a role in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. In addition, Csk also shows Src-independent functions. It is a critical component in G-protein signaling, and plays a role in cytoskeletal reorganization and cell migration. Length = 256 |
| >gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Score = 65.2 bits (160), Expect = 2e-11
Identities = 45/197 (22%), Positives = 71/197 (36%), Gaps = 71/197 (36%)
Query: 123 ILGDGSYSVCRRCVEKSTGQEYAVKIISRKIDCSEEINLLRACQGHPNICRRCVEKSTGQ 182
LG+GS+ +K TG+ A+K+I +K + +LR
Sbjct: 6 KLGEGSFGKVYLARDKKTGKLVAIKVIKKKKIKKDRERILR------------------- 46
Query: 183 EYAVKIISRKIDCSEEINLLRACQGHPNIVNLHCVFQD--------EVIDWDD-FSRGIE 233
EI +L+ + HPNIV L+ VF+D E + D F +
Sbjct: 47 ---------------EIKILKKLK-HPNIVRLYDVFEDEDKLYLVMEYCEGGDLFDLLKK 90
Query: 234 CVFFSSSLIIFFI--ILSFTLSFIHDYYHIQYRRILKTEPPIPEDLSPD----------- 280
S F++ ILS L ++H I +R DL P+
Sbjct: 91 RGRLSEDEARFYLRQILS-ALEYLHS-KGIVHR-----------DLKPENILLDEDGHVK 137
Query: 281 VADF-ISRLLVKDPRRR 296
+ADF ++R L +
Sbjct: 138 LADFGLARQLDPGEKLT 154
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254 |
| >gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Score = 64.6 bits (158), Expect = 2e-11
Identities = 25/60 (41%), Positives = 44/60 (73%), Gaps = 2/60 (3%)
Query: 896 YLVLELLKGGELLDRIRQKGRCGFTENEASRIMRQLVAAVHFMHSRGVVHRDLKPENLLL 955
YLV++LL GG+L + QK + F+E + + ++V A+ ++HS+G++HRD+KP+N+LL
Sbjct: 76 YLVVDLLLGGDLRYHLSQKVK--FSEEQVKFWICEIVLALEYLHSKGIIHRDIKPDNILL 133
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258 |
| >gnl|CDD|173709 cd05619, STKc_nPKC_theta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Score = 66.1 bits (161), Expect = 2e-11
Identities = 32/90 (35%), Positives = 47/90 (52%), Gaps = 4/90 (4%)
Query: 263 YRRILKTEPPIPEDLSPDVADFISRLLVKDPRRRLGGGELDAEELKRHPFFNVIDWDDLA 322
++ I P P L+ + D + +L V++P RRLG ++++HPFF IDW L
Sbjct: 205 FQSIRMDNPCYPRWLTREAKDILVKLFVREPERRLGV----KGDIRQHPFFREIDWSALE 260
Query: 323 TKRIPAPFVPKISNELDVSNFSDEFTKMIP 352
+ I PF PK+ + D SNF EF P
Sbjct: 261 EREIEPPFKPKVKSANDCSNFDKEFLNEKP 290
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. Although T-cells also express other PKC isoforms, PKC-theta is unique in that upon antigen stimulation, it is translocated to the plasma membrane at the immunological synapse, where it mediates signals essential for T-cell activation. It is essential for TCR-induced proliferation, cytokine production, T-cell survival, and the differentiation and effector function of T-helper (Th) cells, particularly Th2 and Th17. PKC-theta is being developed as a therapeutic target for Th2-mediated allergic inflammation and Th17-mediated autoimmune diseases. Length = 316 |
| >gnl|CDD|173700 cd05609, STKc_MAST, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Score = 65.6 bits (160), Expect = 2e-11
Identities = 31/69 (44%), Positives = 41/69 (59%), Gaps = 4/69 (5%)
Query: 275 EDLSPDVADFISRLLVKDPRRRLGGGELDAEELKRHPFFNVIDWDDLATKRIPAPFVPKI 334
E L D D ISRLL ++P RLG G A E+K+H FF +DW+ L R A F+P++
Sbjct: 240 EALPADAQDLISRLLRQNPLERLGTG--GAFEVKQHRFFLGLDWNGLL--RQKAEFIPQL 295
Query: 335 SNELDVSNF 343
+E D S F
Sbjct: 296 ESEDDTSYF 304
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. MAST1, MAST2, and MAST3 bind and phosphorylate the tumor suppressor PTEN, and may contribute to the regulation and stabilization of PTEN. MAST2 is involved in the regulation of the Fc-gamma receptor of the innate immune response in macrophages, and may also be involved in the regulation of the Na+/H+ exchanger NHE3. Length = 305 |
| >gnl|CDD|173729 cd06617, PKc_MKK3_6, Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Score = 65.5 bits (160), Expect = 2e-11
Identities = 57/206 (27%), Positives = 97/206 (47%), Gaps = 24/206 (11%)
Query: 379 DLDKAGILGDGSYSVCRRCVEKSTGQEYAVKIISRKIDCSEEINLL------RACQGHPN 432
DL+ LG G+Y V + TG AVK I ++ E+ LL P
Sbjct: 2 DLEVIEELGRGAYGVVDKMRHVPTGTIMAVKRIRATVNSQEQKRLLMDLDISMRSVDCPY 61
Query: 433 IVNLHCVFQDEVHTYLVLELLKGGELLDRI-RQKGRCGFT--ENEASRIMRQLVAAVHFM 489
V + E ++ +E++ LD+ ++ G T E+ +I +V A+ ++
Sbjct: 62 TVTFYGALFREGDVWICMEVMDTS--LDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYL 119
Query: 490 HSR-GVVHRDLKPENLLFSDPAGDNIKVVDFGFACLKRESLHTPCFTLQ-----YAAPEV 543
HS+ V+HRD+KP N+L + G +K+ DFG + +S+ T+ Y APE
Sbjct: 120 HSKLSVIHRDVKPSNVLI-NRNG-QVKLCDFGISGYLVDSVAK---TIDAGCKPYMAPER 174
Query: 544 L--RQDKSGYDENCDLWSLGVILVNV 567
+ ++ GYD D+WSLG+ ++ +
Sbjct: 175 INPELNQKGYDVKSDVWSLGITMIEL 200
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs that phosphorylate and activate their downstream target, p38 MAPK, on specific threonine and tyrosine residues. MKK3/6 plays roles in the regulation of cell cycle progression, cytokine- and stress-induced apoptosis, oncogenic transformation, and adult tissue regeneration. In addition, MKK6 plays a critical role in osteoclast survival in inflammatory disease while MKK3 is associated with tumor invasion, progression, and poor patient survival in glioma. Length = 283 |
| >gnl|CDD|173637 cd05059, PTKc_Tec_like, Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 65.2 bits (159), Expect = 2e-11
Identities = 62/218 (28%), Positives = 98/218 (44%), Gaps = 22/218 (10%)
Query: 386 LGDGSYSVCRRCVEKSTGQEYAVKIISRKI----DCSEEINLLRACQGHPNIVNLHCVFQ 441
LG G + V + A+K+I D EE ++ HPN+V L+ V
Sbjct: 12 LGSGQFGVVHLGKWRGKID-VAIKMIREGAMSEDDFIEEAKVMMKLS-HPNLVQLYGVCT 69
Query: 442 DEVHTYLVLELLKGGELLDRIRQKGRCGFTENEASRIMRQLVAAVHFMHSRGVVHRDLKP 501
+ ++V E + G LL+ +R++ TE + + A+ ++ S G +HRDL
Sbjct: 70 KQRPIFIVTEYMANGCLLNYLRERKGKLGTEWLLD-MCSDVCEAMEYLESNGFIHRDLAA 128
Query: 502 ENLLFSDPAGDN-IKVVDFGFACLKRESLHTPC----FTLQYAAPEVLRQDKSGYDENCD 556
N L + DN +KV DFG A + +T F +++A PEV D S + D
Sbjct: 129 RNCLVGE---DNVVKVSDFGLARYVLDDQYTSSQGTKFPVKWAPPEVF--DYSRFSSKSD 183
Query: 557 LWSLGVILVNVLRQDKSGYD-----ENCDLWSLGVILY 589
+WS GV++ V + K Y+ E + S G LY
Sbjct: 184 VWSFGVLMWEVFSEGKMPYERFSNSEVVESVSAGYRLY 221
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, some members contain the Tec homology (TH) domain, which contains proline-rich and zinc-binding regions. Tec kinases form the second largest subfamily of nRTKs and are expressed mainly by haematopoietic cells, although Tec and Bmx are also found in endothelial cells. B-cells express Btk and Tec, while T-cells express Itk, Txk, and Tec. Collectively, Tec kinases are expressed in a variety of myeloid cells such as mast cells, platelets, macrophages, and dendritic cells. Each Tec kinase shows a distinct cell-type pattern of expression. The function of Tec kinases in lymphoid cells have been studied extensively. They play important roles in the development, differentiation, maturation, regulation, survival, and function of B-cells and T-cells. Mutations in Btk cause the severe B-cell immunodeficiency, X-linked agammaglobulinaemia (XLA). Length = 256 |
| >gnl|CDD|173679 cd05588, STKc_aPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Score = 65.6 bits (160), Expect = 3e-11
Identities = 35/98 (35%), Positives = 51/98 (52%), Gaps = 7/98 (7%)
Query: 263 YRRILKTEPPIPEDLSPDVADFISRLLVKDPRRRLG----GGELDAEELKRHPFFNVIDW 318
++ IL+ + IP LS + + L KDP+ RLG G D +K HPFF IDW
Sbjct: 214 FQVILEKQIRIPRSLSVKASSVLKGFLNKDPKERLGCHPQTGFRD---IKSHPFFRNIDW 270
Query: 319 DDLATKRIPAPFVPKISNELDVSNFSDEFTKMIPADSP 356
D L K++ P+ P I ++ D+ NF +FT +P
Sbjct: 271 DLLEQKQVLPPYKPNIESDRDLDNFDPQFTDEPVQLTP 308
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions including proliferation, migration, apoptosis, polarity maintenance and cytoskeletal regulation. They also play a critical role in the regulation of glucose metabolism and in the pathogenesis of type 2 diabetes. Length = 329 |
| >gnl|CDD|173689 cd05598, STKc_LATS, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Score = 66.0 bits (161), Expect = 3e-11
Identities = 29/67 (43%), Positives = 38/67 (56%), Gaps = 4/67 (5%)
Query: 277 LSPDVADFISRLLVKDPRRRLGGGELDAEELKRHPFFNVIDWDDLATKRIPAPFVPKISN 336
LS + +D I RL RLG D E+K HPFF ID+ L +R AP++PKI++
Sbjct: 271 LSREASDLILRL-CCGAEDRLGKNGAD--EIKAHPFFKGIDFASLI-RRQKAPYIPKITH 326
Query: 337 ELDVSNF 343
D SNF
Sbjct: 327 PTDTSNF 333
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Length = 376 |
| >gnl|CDD|173657 cd05113, PTKc_Btk_Bmx, Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Score = 64.5 bits (157), Expect = 3e-11
Identities = 40/151 (26%), Positives = 73/151 (48%), Gaps = 9/151 (5%)
Query: 430 HPNIVNLHCVFQDEVHTYLVLELLKGGELLDRIRQKGRCGFTENEASRIMRQLVAAVHFM 489
H +V L+ V + Y+V E + G LL+ +R+ G+ F ++ + + + + ++
Sbjct: 58 HEKLVQLYGVCTKQRPIYIVTEYMSNGCLLNYLREHGK-RFQPSQLLEMCKDVCEGMAYL 116
Query: 490 HSRGVVHRDLKPENLLFSDPAGDNIKVVDFGFACLKRESLHTPC----FTLQYAAPEVLR 545
S+ +HRDL N L D +KV DFG + + +T F ++++ PEVL
Sbjct: 117 ESKQFIHRDLAARNCLVDDQG--CVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLL 174
Query: 546 QDKSGYDENCDLWSLGVILVNVLRQDKSGYD 576
K + D+W+ GV++ V K Y+
Sbjct: 175 YSK--FSSKSDVWAFGVLMWEVYSLGKMPYE 203
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Btk contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Btk is expressed in B-cells, and a variety of myeloid cells including mast cells, platelets, neutrophils, and dendrictic cells. It interacts with a variety of partners, from cytosolic proteins to nuclear transcription factors, suggesting a diversity of functions. Stimulation of a diverse array of cell surface receptors, including antigen engagement of the B-cell receptor (BCR), leads to PH-mediated membrane translocation of Btk and subsequent phosphorylation by Src kinase and activation. Btk plays an important role in the life cycle of B-cells including their development, differentiation, proliferation, survival, and apoptosis. Mutations in Btk cause the primary immunodeficiency disease, X-linked agammaglobulinaemia (XLA) in humans. Bmx is primarily expressed in bone marrow and the arterial endothelium, and plays an important role in ischemia-induced angiogenesis. It facilitates arterial growth, capillary formation, vessel maturation, and bone marrow-derived endothelial progenitor cell mobilization. Length = 256 |
| >gnl|CDD|132964 cd06633, STKc_TAO3, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Score = 65.4 bits (159), Expect = 3e-11
Identities = 53/204 (25%), Positives = 95/204 (46%), Gaps = 19/204 (9%)
Query: 386 LGDGSYSVCRRCVEKSTGQEYAVKIIS--------RKIDCSEEINLLRACQGHPNIVNLH 437
+G GS+ T + AVK +S + D +E+ L+ + HPN +
Sbjct: 29 IGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLK-HPNTIEYK 87
Query: 438 CVFQDEVHTYLVLELLKGG--ELLDRIRQKGRCGFTENEASRIMRQLVAAVHFMHSRGVV 495
+ E +LV+E G +LL+ ++ E E + I + + ++HS ++
Sbjct: 88 GCYLKEHTAWLVMEYCLGSASDLLEVHKKP----LQEVEIAAITHGALQGLAYLHSHNMI 143
Query: 496 HRDLKPENLLFSDPAGDNIKVVDFGFACLKRESLHTPCFTLQYAAPEV-LRQDKSGYDEN 554
HRD+K N+L ++P +K+ DFG A + ++ T + APEV L D+ YD
Sbjct: 144 HRDIKAGNILLTEPG--QVKLADFGSASKSSPA-NSFVGTPYWMAPEVILAMDEGQYDGK 200
Query: 555 CDLWSLGVILVNVLRQDKSGYDEN 578
D+WSLG+ + + + ++ N
Sbjct: 201 VDVWSLGITCIELAERKPPLFNMN 224
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a component of the RAM (regulation of Ace2p activity and cellular morphogenesis) signaling pathway. TAO3 is upregulated in retinal ganglion cells after axotomy, and may play a role in apoptosis. Length = 313 |
| >gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Score = 65.5 bits (158), Expect = 4e-11
Identities = 31/76 (40%), Positives = 53/76 (69%), Gaps = 2/76 (2%)
Query: 891 YNVHTYLVLELLKGGELLDRIRQKGRCG-FTENEASRIMRQLVAAVHFMHSRGVVHRDLK 949
YLV+E + GG L D +++ GR G +E+EA I+ Q+++A+ ++HS+G++HRD+K
Sbjct: 69 DEGSLYLVMEYVDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLHSKGIIHRDIK 128
Query: 950 PENLLLSGISGNLIKI 965
PEN+LL G ++K+
Sbjct: 129 PENILLD-RDGRVVKL 143
|
Length = 384 |
| >gnl|CDD|173645 cd05084, PTKc_Fes, Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Score = 63.9 bits (155), Expect = 5e-11
Identities = 39/140 (27%), Positives = 72/140 (51%), Gaps = 10/140 (7%)
Query: 430 HPNIVNLHCVFQDEVHTYLVLELLKGGELLDRIRQKGRCGFTENEASRIMRQLVAAVHFM 489
HPNIV L V + Y+V+EL++GG+ L +R +G E +++ A + ++
Sbjct: 52 HPNIVRLIGVCTQKQPIYIVMELVQGGDFLTFLRTEG-PRLKVKELIQMVENAAAGMEYL 110
Query: 490 HSRGVVHRDLKPENLLFSDPAGDNIKVVDFGFACLKRESLHTPC-----FTLQYAAPEVL 544
S+ +HRDL N L ++ + +K+ DFG + + + ++ +++ APE L
Sbjct: 111 ESKHCIHRDLAARNCLVTEK--NVLKISDFGMSREEEDGVYASTGGMKQIPVKWTAPEAL 168
Query: 545 RQDKSGYDENCDLWSLGVIL 564
+ Y D+WS G++L
Sbjct: 169 NYGR--YSSESDVWSFGILL 186
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular endothelial, epithelial, and neuronal cells. It plays important roles in cell growth and differentiation, angiogenesis, inflammation and immunity, and cytoskeletal regulation. A recent study implicates Fes kinase as a tumor suppressor in colorectal cancer. Length = 252 |
| >gnl|CDD|173688 cd05597, STKc_DMPK_like, Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 64.8 bits (158), Expect = 6e-11
Identities = 36/100 (36%), Positives = 52/100 (52%), Gaps = 10/100 (10%)
Query: 271 PPIPEDLSPDVADFISRLLVKDPRRRLGGGELDAEELKRHPFFNVIDWDDLATKRIPAPF 330
PP D+S + D I RL+ P RLG L ++ K HPFF IDWD++ + AP+
Sbjct: 230 PPDVTDVSEEAKDLIRRLICS-PETRLGRNGL--QDFKDHPFFEGIDWDNI--RNSTAPY 284
Query: 331 VPKISNELDVSNFS-DEFTKMIPADSPAIVPPNFDKIFKG 369
VP++S+ D SNF D+ + +PP+ F G
Sbjct: 285 VPEVSSPTDTSNFDVDDDD----LRNTESLPPSSHGAFSG 320
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, and cardiac conduction defects. The genetic basis for DM1 is the mutational expansion of a CTG repeat in the 3'-UTR of DMPK. DMPK is expressed in skeletal and cardiac muscles, and in central nervous tissues. The functional role of DMPK is not fully understood. It may play a role in the signal transduction and homeostasis of calcium. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKgamma is expressed in heart and skeletal muscles, unlike MRCKalpha and MRCKbeta, which are expressed ubiquitously. Length = 331 |
| >gnl|CDD|88519 cd05618, STKc_aPKC_iota, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Score = 64.7 bits (157), Expect = 6e-11
Identities = 32/87 (36%), Positives = 48/87 (55%), Gaps = 1/87 (1%)
Query: 263 YRRILKTEPPIPEDLSPDVADFISRLLVKDPRRRLGG-GELDAEELKRHPFFNVIDWDDL 321
++ IL+ + IP LS A + L KDP+ RLG + +++ HPFF +DWD +
Sbjct: 214 FQVILEKQIRIPRSLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGHPFFRNVDWDLM 273
Query: 322 ATKRIPAPFVPKISNELDVSNFSDEFT 348
K++ PF P IS E + NF +FT
Sbjct: 274 EQKQVVPPFKPNISGEFGLDNFDAQFT 300
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target of tumor-specific gene amplification in many human cancers, and has been identified as a human oncogene. In addition to its role in transformed growth, PKC-iota also promotes invasion, chemoresistance, and tumor cell survival. Expression profiling of PKC-iota is a prognostic marker of poor clinical outcome in several human cancers. PKC-iota also plays a role in establishing cell polarity, and has critical embryonic functions. Length = 329 |
| >gnl|CDD|133243 cd05112, PTKc_Itk, Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Score = 63.8 bits (155), Expect = 6e-11
Identities = 42/151 (27%), Positives = 71/151 (47%), Gaps = 9/151 (5%)
Query: 430 HPNIVNLHCVFQDEVHTYLVLELLKGGELLDRIRQKGRCGFTENEASRIMRQLVAAVHFM 489
HP +V L+ V + LV E ++ G L D +R + R F++ + + + ++
Sbjct: 58 HPKLVQLYGVCTERSPICLVFEFMEHGCLSDYLRAQ-RGKFSQETLLGMCLDVCEGMAYL 116
Query: 490 HSRGVVHRDLKPENLLFSDPAGDNIKVVDFGFACL----KRESLHTPCFTLQYAAPEVLR 545
S V+HRDL N L + +KV DFG + S F +++++PEV
Sbjct: 117 ESSNVIHRDLAARNCLVGE--NQVVKVSDFGMTRFVLDDQYTSSTGTKFPVKWSSPEVFS 174
Query: 546 QDKSGYDENCDLWSLGVILVNVLRQDKSGYD 576
K Y D+WS GV++ V + K+ Y+
Sbjct: 175 FSK--YSSKSDVWSFGVLMWEVFSEGKTPYE 203
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Itk contains the Tec homology (TH) domain containing one proline-rich region and a zinc-binding region. Tec kinases are expressed mainly by haematopoietic cells. Itk is expressed in T-cells and mast cells, and is important in their development and differentiation. Of the three Tec kinases expressed in T-cells, Itk plays the predominant role in T-cell receptor (TCR) signaling. It is activated by phosphorylation upon TCR crosslinking and is involved in the pathway resulting in phospholipase C-gamma1 activation and actin polymerization. It also plays a role in the downstream signaling of the T-cell costimulatory receptor CD28, the T-cell surface receptor CD2, and the chemokine receptor CXCR4. In addition, Itk is crucial for the development of T-helper(Th)2 effector responses. Length = 256 |
| >gnl|CDD|173640 cd05067, PTKc_Lck_Blk, Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Score = 63.7 bits (155), Expect = 6e-11
Identities = 42/154 (27%), Positives = 78/154 (50%), Gaps = 10/154 (6%)
Query: 419 EEINLLRACQGHPNIVNLHCVFQDEVHTYLVLELLKGGELLDRIRQKGRCGFTENEASRI 478
E NL++ Q HP +V L+ V E Y++ E ++ G L+D ++ T N+ +
Sbjct: 50 AEANLMKQLQ-HPRLVRLYAVVTQE-PIYIITEYMENGSLVDFLKTPEGIKLTINKLIDM 107
Query: 479 MRQLVAAVHFMHSRGVVHRDLKPENLLFSDPAGDNIKVVDFGFACLKRESLHT----PCF 534
Q+ + F+ + +HRDL+ N+L S+ K+ DFG A L ++ +T F
Sbjct: 108 AAQIAEGMAFIERKNYIHRDLRAANILVSETL--CCKIADFGLARLIEDNEYTAREGAKF 165
Query: 535 TLQYAAPEVLRQDKSGYDENCDLWSLGVILVNVL 568
+++ APE + + + D+WS G++L ++
Sbjct: 166 PIKWTAPEAI--NYGTFTIKSDVWSFGILLTEIV 197
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lck is expressed in T-cells and natural killer (NK) cells. It plays a critical role in T-cell maturation, activation, and T-cell receptor (TCR) signaling. Lck phosphorylates ITAM (immunoreceptor tyr activation motif) sequences on several subunits of TCRs, leading to the activation of different second messenger cascades. Phosphorylated ITAMs serve as binding sites for other signaling factor such as Syk and ZAP-70, leading to their activation and propagation of downstream events. In addition, Lck regulates drug-induced apoptosis by interfering with the mitochondrial death pathway. The apototic role of Lck is independent of its primary function in T-cell signaling. Blk is expressed specifically in B-cells. It is involved in pre-BCR (B-cell receptor) signaling. Length = 260 |
| >gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Score = 63.4 bits (155), Expect = 7e-11
Identities = 24/62 (38%), Positives = 39/62 (62%), Gaps = 2/62 (3%)
Query: 896 YLVLELLKGGELLDRIRQKGRCGFTENEASRIMRQLVAAVHFMHSRGVVHRDLKPENLLL 955
YLV+E L GG+L + G E+ A + ++V A+ ++HS G++HRDLKP+N+L+
Sbjct: 69 YLVMEYLPGGDLASLLENVG--SLDEDVARIYIAEIVLALEYLHSNGIIHRDLKPDNILI 126
Query: 956 SG 957
Sbjct: 127 DS 128
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265 |
| >gnl|CDD|165478 PHA03212, PHA03212, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 65.0 bits (158), Expect = 7e-11
Identities = 55/193 (28%), Positives = 91/193 (47%), Gaps = 18/193 (9%)
Query: 397 CVEKSTGQEYAVKIISRKIDCSEEINLLRACQGHPNIVNLHCVFQDEVHTYLVLELLKGG 456
C++ T + +K R + E ++LRA HP+I+ L F T L+L K
Sbjct: 111 CIDNKTCEHVVIKAGQRG-GTATEAHILRAIN-HPSIIQLKGTFTYNKFTCLILPRYKT- 167
Query: 457 ELLDRIRQKGRCGFTENEASRIMRQLVAAVHFMHSRGVVHRDLKPENLLFSDPAGDNIKV 516
+L + K + A I R ++ A+ ++H ++HRD+K EN+ + P GD + +
Sbjct: 168 DLYCYLAAKRNIAICDILA--IERSVLRAIQYLHENRIIHRDIKAENIFINHP-GD-VCL 223
Query: 517 VDFGFAC----LKRESLHTPCFTLQYAAPEVLRQDKSGYDENCDLWSLGVILVNVLRQ-- 570
DFG AC + + T+ APE+L +D Y D+WS G++L +
Sbjct: 224 GDFGAACFPVDINANKYYGWAGTIATNAPELLARDP--YGPAVDIWSAGIVLFEMATCHD 281
Query: 571 ---DKSGYDENCD 580
+K G D +CD
Sbjct: 282 SLFEKDGLDGDCD 294
|
Length = 391 |
| >gnl|CDD|165473 PHA03207, PHA03207, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 64.5 bits (157), Expect = 9e-11
Identities = 53/213 (24%), Positives = 93/213 (43%), Gaps = 37/213 (17%)
Query: 408 VKIISRKIDCSEEINLLRACQGHPNIVNLHCVFQDEVHTYLVLELLKGGELLDRIRQKGR 467
VK ++ EI++L+ H I+NL ++ + +V+ K +L + + G
Sbjct: 124 VKAVTGGKTPGREIDILKTIS-HRAIINLIHAYRWKSTVCMVMPKYKC-DLFTYVDRSGP 181
Query: 468 CGFTENEASRIMRQLVAAVHFMHSRGVVHRDLKPENLLFSDPAGDNIKVVDFGFACLKRE 527
+A I R+L+ A+ ++H RG++HRD+K EN+ +P +N + DFG AC
Sbjct: 182 LPL--EQAITIQRRLLEALAYLHGRGIIHRDVKTENIFLDEP--ENAVLGDFGAACKLDA 237
Query: 528 SLHTP-CF----TLQYAAPEVLRQDKSGYDENCDLWSLGVILVNVLRQDKSGYDENCDLW 582
TP C+ TL+ +PE+L D Y D+W
Sbjct: 238 HPDTPQCYGWSGTLETNSPELLALDP--------------------------YCAKTDIW 271
Query: 583 SLGVILYTMLCGRVPFHARSRDDSALSIMARIK 615
S G++L+ M V + S+ + + I+
Sbjct: 272 SAGLVLFEMSVKNVTLFGKQVKSSSSQLRSIIR 304
|
Length = 392 |
| >gnl|CDD|173707 cd05616, STKc_cPKC_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Score = 63.5 bits (154), Expect = 1e-10
Identities = 30/100 (30%), Positives = 47/100 (47%), Gaps = 5/100 (5%)
Query: 263 YRRILKTEPPIPEDLSPDVADFISRLLVKDPRRRLGGGELDAEELKRHPFFNVIDWDDLA 322
++ I++ P+ +S + L+ K P +RLG G ++K H FF IDW+ L
Sbjct: 210 FQSIMEHNVAYPKSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKEHAFFRYIDWEKLE 269
Query: 323 TKRIPAPFVPKISNELDVSNFSDEFTKMIPADSPAIVPPN 362
K + P+ PK D NF FT+ P + PP+
Sbjct: 270 RKEVQPPYKPKACGR-DAENFDKFFTR----HPPVLTPPD 304
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. The PKC beta isoforms (I and II), generated by alternative splicing of a single gene, are preferentially activated by hyperglycemia-induced DAG in retinal tissues. This is implicated in diabetic microangiopathy such as ischemia, neovascularization, and abnormal vasodilator function. PKC-beta also plays an important role in VEGF signaling. In addition, glucose regulates proliferation in retinal endothelial cells via PKC-betaI. PKC-beta is also being explored as a therapeutic target in cancer. It contributes to tumor formation and is involved in the tumor host mechanisms of inflammation and angiogenesis. Length = 323 |
| >gnl|CDD|173691 cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 64.0 bits (156), Expect = 1e-10
Identities = 30/86 (34%), Positives = 50/86 (58%), Gaps = 10/86 (11%)
Query: 264 RRILKTEPPIPEDLSPDVADFISRLLVKDPRRRLGGGELDAEELKRHPFFNVIDWDDLAT 323
+R + +P +LS + D I++L+ DP RR G E++K HPFF +DW++L
Sbjct: 218 QRPVYDDPRF--NLSDEAWDLITKLI-NDPSRRFGS----LEDIKNHPFFKEVDWNEL-- 268
Query: 324 KRIPAPFVPKISNELDVSNFSDEFTK 349
+ + PFVP++ +E+D F D+F
Sbjct: 269 RELKPPFVPELESEIDTGYF-DDFEN 293
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. Dbf2p is important in regulating the mitotic exit network (MEN) and in cytokinesis. Length = 333 |
| >gnl|CDD|173696 cd05605, STKc_GRK4_like, Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 63.3 bits (154), Expect = 1e-10
Identities = 24/69 (34%), Positives = 32/69 (46%)
Query: 264 RRILKTEPPIPEDLSPDVADFISRLLVKDPRRRLGGGELDAEELKRHPFFNVIDWDDLAT 323
RR+ + + E S +LL KDP RLG AEE+K HPFF ++ L
Sbjct: 215 RRVKEDQEEYSEKFSEAARSICRQLLTKDPGFRLGCRGEGAEEVKAHPFFRTANFKRLEA 274
Query: 324 KRIPAPFVP 332
+ PF P
Sbjct: 275 GMLEPPFCP 283
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, GRK6, and similar GRKs. GRKs in this group contain an N-terminal RGS homology (RH) domain and a catalytic domain, but lack a G protein betagamma-subunit binding domain. They are localized to the plasma membrane through post-translational lipid modification or direct binding to PIP2. Length = 285 |
| >gnl|CDD|132966 cd06635, STKc_TAO1, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Score = 63.6 bits (154), Expect = 1e-10
Identities = 52/204 (25%), Positives = 97/204 (47%), Gaps = 19/204 (9%)
Query: 386 LGDGSYSVCRRCVEKSTGQEYAVKIIS--------RKIDCSEEINLLRACQGHPNIVNLH 437
+G GS+ + T + A+K +S + D +E+ L+ + HPN +
Sbjct: 33 IGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIK-HPNSIEYK 91
Query: 438 CVFQDEVHTYLVLELLKGG--ELLDRIRQKGRCGFTENEASRIMRQLVAAVHFMHSRGVV 495
+ E +LV+E G +LL+ ++ E E + I + + ++HS ++
Sbjct: 92 GCYLREHTAWLVMEYCLGSASDLLEVHKKP----LQEVEIAAITHGALQGLAYLHSHNMI 147
Query: 496 HRDLKPENLLFSDPAGDNIKVVDFGFACLKRESLHTPCFTLQYAAPEV-LRQDKSGYDEN 554
HRD+K N+L ++P +K+ DFG A + + ++ T + APEV L D+ YD
Sbjct: 148 HRDIKAGNILLTEPG--QVKLADFGSASIASPA-NSFVGTPYWMAPEVILAMDEGQYDGK 204
Query: 555 CDLWSLGVILVNVLRQDKSGYDEN 578
D+WSLG+ + + + ++ N
Sbjct: 205 VDVWSLGITCIELAERKPPLFNMN 228
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuronal apoptosis. TAO1 interacts with the checkpoint proteins BubR1 and Mad2, and plays an important role in regulating mitotic progression, which is required for both chromosome congression and checkpoint-induced anaphase delay. TAO1 may play a role in protecting genomic stability. Length = 317 |
| >gnl|CDD|173641 cd05072, PTKc_Lyn, Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Score = 62.7 bits (152), Expect = 1e-10
Identities = 47/212 (22%), Positives = 92/212 (43%), Gaps = 54/212 (25%)
Query: 419 EEINLLRACQGHPNIVNLHCVFQDEVHTYLVLELLKGGELLDRIRQKGRCGFTENEASRI 478
EE NL++ Q H +V L+ V E Y++ E + G LLD ++ +E ++
Sbjct: 50 EEANLMKTLQ-HDKLVRLYAVVTKEEPIYIITEYMAKGSLLDFLKS--------DEGGKV 100
Query: 479 M--------RQLVAAVHFMHSRGVVHRDLKPENLLFSDPAGDNIKVVDFGFACLKRESLH 530
+ Q+ + ++ + +HRDL+ N+L S+ K+ DFG A + ++ +
Sbjct: 101 LLPKLIDFSAQIAEGMAYIERKNYIHRDLRAANVLVSESL--MCKIADFGLARVIEDNEY 158
Query: 531 T----PCFTLQYAAPEVLRQDKSGYDENCDLWSLGVILVNVLRQDKSGYDENCDLWSLGV 586
T F +++ APE + + + D+WS G+
Sbjct: 159 TAREGAKFPIKWTAPEAI--------------------------NFGSFTIKSDVWSFGI 192
Query: 587 ILYTMLC-GRVPFHARSRDDSALSIMARIKEG 617
+LY ++ G++P+ S D +M+ ++ G
Sbjct: 193 LLYEIVTYGKIPYPGMSNSD----VMSALQRG 220
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lyn is expressed in B lymphocytes and myeloid cells. It exhibits both positive and negative regulatory roles in B cell receptor (BCR) signaling. Lyn, as well as Fyn and Blk, promotes B cell activation by phosphorylating ITAMs (immunoreceptor tyr activation motifs) in CD19 and in Ig components of BCR. It negatively regulates signaling by its unique ability to phosphorylate ITIMs (immunoreceptor tyr inhibition motifs) in cell surface receptors like CD22 and CD5. Lyn also plays an important role in G-CSF receptor signaling by phosphorylating a variety of adaptor molecules. Length = 261 |
| >gnl|CDD|143359 cd07854, STKc_MAPK4_6, Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Score = 63.6 bits (155), Expect = 1e-10
Identities = 70/295 (23%), Positives = 118/295 (40%), Gaps = 46/295 (15%)
Query: 386 LGDGSYSVCRRCVEKSTGQEYAVKIISRKIDCSE------EINLLRACQGHPNIVNLHCV 439
LG GS + V+ + AVK I D EI ++R H NIV ++ V
Sbjct: 13 LGCGSNGLVFSAVDSDCDKRVAVKKIVLT-DPQSVKHALREIKIIRRLD-HDNIVKVYEV 70
Query: 440 FQDEVH--------------TYLVLELLKGGELLDRIRQKGRCGFTENEASRIMRQLVAA 485
Y+V E ++ L + ++G +E A M QL+
Sbjct: 71 LGPSGSDLTEDVGSLTELNSVYIVQEYMETD--LANVLEQGP--LSEEHARLFMYQLLRG 126
Query: 486 VHFMHSRGVVHRDLKPENLLFSDPAGDNIKVVDFGFACL------KRESLHTPCFTLQYA 539
+ ++HS V+HRDLKP N +F + +K+ DFG A + + L T Y
Sbjct: 127 LKYIHSANVLHRDLKPAN-VFINTEDLVLKIGDFGLARIVDPHYSHKGYLSEGLVTKWYR 185
Query: 540 APEVLRQDKSGYDENCDLWSLGVILVNVLRQDKSGYDENCDLWSLGVILYTMLCGRVPFH 599
+P +L + Y + D+W+ G I +L K + +L + +IL + VP
Sbjct: 186 SPRLLLSPNN-YTKAIDMWAAGCIFAEML-TGKPLFAGAHELEQMQLILES-----VPVV 238
Query: 600 ARSRDDSALSIMARIKEGQFNFD-----AEAWSTVSSEAKELTKSLLTVNPAQRI 649
+ L+++ + + V+ EA + + +LT NP R+
Sbjct: 239 REEDRNELLNVIP-SFVRNDGGEPRRPLRDLLPGVNPEALDFLEQILTFNPMDRL 292
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progression in certain conditions. It may also play a role in glucose-induced insulin secretion. MAPK6 and MAPK4 cooperate to regulate the activity of MAPK-activated protein kinase 5 (MK5), leading to its relocation to the cytoplasm and exclusion from the nucleus. The MAPK6/MK5 and MAPK4/MK5 pathways may play critical roles in embryonic and post-natal development. Length = 342 |
| >gnl|CDD|173665 cd05574, STKc_phototropin_like, Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 63.1 bits (154), Expect = 2e-10
Identities = 28/75 (37%), Positives = 40/75 (53%), Gaps = 9/75 (12%)
Query: 263 YRRILKTEPPIPED--LSPDVADFISRLLVKDPRRRLG--GGELDAEELKRHPFFNVIDW 318
+ ILK E P +S D I +LLVKDP +RLG G A E+K+HPFF ++W
Sbjct: 241 FSNILKKEVTFPGSPPVSSSARDLIRKLLVKDPSKRLGSKRG---AAEIKQHPFFRGVNW 297
Query: 319 DDLATKRIPAPFVPK 333
+ + P +P+
Sbjct: 298 ALI--RHTTPPIIPR 310
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-terminal photosensory domain and a C-terminal catalytic domain. The N-terminal domain contains two LOV (Light, Oxygen or Voltage) domains that binds FMN. Photoexcitation of the LOV domains results in autophosphorylation at multiple sites and activation of the catalytic domain. Neurospora crassa nrc-2 plays a role in growth and development by controlling entry into the conidiation program. Length = 316 |
| >gnl|CDD|173636 cd05057, PTKc_EGFR_like, Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 62.0 bits (151), Expect = 2e-10
Identities = 50/210 (23%), Positives = 89/210 (42%), Gaps = 36/210 (17%)
Query: 377 DMDLDKAGILGDGSYSVCRRCVEKSTGQ----EYAVKIISRKIDCSEEINLLR-----AC 427
+ +L+K +LG G++ + V G+ A+K++ + +L A
Sbjct: 6 ETELEKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYVMAS 65
Query: 428 QGHPNIVNLHCVFQDEVHTYLVLELLKGGELLDRIRQ-KGRCGFTENEASRIM----RQL 482
HP++V L + L+ +L+ G LLD +R K G S+ + Q+
Sbjct: 66 VDHPHVVRLLGICLSSQVQ-LITQLMPLGCLLDYVRNHKDNIG------SQYLLNWCVQI 118
Query: 483 VAAVHFMHSRGVVHRDLKPENLLFSDPAGDNIKVVDFGFACL---KRESLH-----TPCF 534
+ ++ + +VHRDL N+L P ++K+ DFG A L + H P
Sbjct: 119 AKGMSYLEEKRLVHRDLAARNVLVKTP--QHVKITDFGLAKLLDVDEKEYHAEGGKVP-- 174
Query: 535 TLQYAAPEVLRQDKSGYDENCDLWSLGVIL 564
+++ A E + Y D+WS GV +
Sbjct: 175 -IKWMALESILHRI--YTHKSDVWSYGVTV 201
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, resulting in the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Collectively, they can recognize a variety of ligands including EGF, TGFalpha, and neuregulins, among others. All four subfamily members can form homo- or heterodimers. HER3 contains an impaired kinase domain and depends on its heterodimerization partner for activation. EGFR subfamily members are involved in signaling pathways leading to a broad range of cellular responses including cell proliferation, differentiation, migration, growth inhibition, and apoptosis. Gain of function alterations, through their overexpression, deletions, or point mutations in their kinase domains, have been implicated in various cancers. These receptors are targets of many small molecule inhibitors and monoclonal antibodies used in cancer therapy. Length = 279 |
| >gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Score = 61.9 bits (151), Expect = 3e-10
Identities = 26/59 (44%), Positives = 34/59 (57%), Gaps = 5/59 (8%)
Query: 260 HIQYRRILKTEPPIPEDLSPDVADFISRLLVKDPRRRLGGGELDAEELKRHPFFNVIDW 318
+I +I E P ++S + D IS+LLV DP +RLG EE+K HPFF IDW
Sbjct: 212 NILNGKI---EWPEDVEVSDEAIDLISKLLVPDPEKRLGAK--SIEEIKNHPFFKGIDW 265
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265 |
| >gnl|CDD|173708 cd05617, STKc_aPKC_zeta, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Score = 62.4 bits (151), Expect = 3e-10
Identities = 34/107 (31%), Positives = 55/107 (51%), Gaps = 6/107 (5%)
Query: 263 YRRILKTEPPIPEDLSPDVADFISRLLVKDPRRRLGGG-ELDAEELKRHPFFNVIDWDDL 321
++ IL+ IP LS + + L KDP+ RLG + ++K H FF IDWD L
Sbjct: 212 FQVILEKPIRIPRFLSVKASHVLKGFLNKDPKERLGCQPQTGFSDIKSHTFFRSIDWDLL 271
Query: 322 ATKRIPAPFVPKISNELDVSNFSDEFTKMIPADSPAIVPPNFDKIFK 368
K++ PF P+I+++ + NF +FT P + P+ + + K
Sbjct: 272 EKKQVTPPFKPQITDDYGLENFDTQFT-----SEPVQLTPDDEDVIK 313
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways. PKC-zeta also plays a central role in maintaining cell polarity in yeast and mammalian cells. In addition, it affects actin remodeling in muscle cells. Length = 327 |
| >gnl|CDD|143373 cd07868, STKc_CDK8, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Score = 62.4 bits (151), Expect = 3e-10
Identities = 56/207 (27%), Positives = 90/207 (43%), Gaps = 23/207 (11%)
Query: 386 LGDGSYSVCRRCVEK--STGQEYAVKIISR---KIDCSEEINLLRACQGHPNIVNLHCVF 440
+G G+Y + K ++YA+K I + EI LLR + HPN+++L VF
Sbjct: 9 VGRGTYGHVYKAKRKDGKDDRDYALKQIEGTGISMSACREIALLRELK-HPNVISLQKVF 67
Query: 441 QDEVHTYLVLELLKGGELLDRIRQKGRCGFTENEASRIMR--------QLVAAVHFMHSR 492
+ L L I + R + ++ R Q++ +H++H+
Sbjct: 68 LSHADRKVWLLFDYAEHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHAN 127
Query: 493 GVVHRDLKPENLLF--SDPAGDNIKVVDFGFACLKRE------SLHTPCFTLQYAAPEVL 544
V+HRDLKP N+L P +K+ D GFA L L T Y APE+L
Sbjct: 128 WVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVTFWYRAPELL 187
Query: 545 RQDKSGYDENCDLWSLGVILVNVLRQD 571
+ Y + D+W++G I +L +
Sbjct: 188 LGARH-YTKAIDIWAIGCIFAELLTSE 213
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDK8 phosphorylates cyclin H, a subunit of the general transcription factor TFIIH, which results in the inhibition of TFIIH-dependent phosphorylation of the C-terminal domain (CTD) of RNAP II, facilitating the inhibition of transcription. It has also been shown to promote transcription by a mechanism that is likely to involve RNAP II phosphorylation. CDK8 also functions as a stimulus-specific positive coregulator of p53 transcriptional responses. Length = 317 |
| >gnl|CDD|133216 cd05085, PTKc_Fer, Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Score = 61.6 bits (149), Expect = 3e-10
Identities = 55/209 (26%), Positives = 95/209 (45%), Gaps = 37/209 (17%)
Query: 362 NFDKIFKGSLFFEQYDMDLDKAGILGDGSYSVCRRCVEKSTGQEYAVKIISRKIDCSEEI 421
NF ++FKG+L DK V + ++ QE +K +S E
Sbjct: 7 NFGEVFKGTL--------KDKT--------PVAVKTCKEDLPQELKIKFLS-------EA 43
Query: 422 NLLRACQGHPNIVNLHCVFQDEVHTYLVLELLKGGELLDRIRQKGRCGFTENEASRIMRQ 481
+L+ HPNIV L V Y+V+EL+ GG+ L +R+K + + +
Sbjct: 44 RILKQYD-HPNIVKLIGVCTQRQPIYIVMELVPGGDFLSFLRKK-KDELKTKQLVKFALD 101
Query: 482 LVAAVHFMHSRGVVHRDLKPENLLFSDPAGDN--IKVVDFGFACLKRESLHTPC----FT 535
A + ++ S+ +HRDL N L G+N +K+ DFG + + + +++
Sbjct: 102 AAAGMAYLESKNCIHRDLAARNCL----VGENNVLKISDFGMSRQEDDGIYSSSGLKQIP 157
Query: 536 LQYAAPEVLRQDKSGYDENCDLWSLGVIL 564
+++ APE L + Y D+WS G++L
Sbjct: 158 IKWTAPEALNYGR--YSSESDVWSYGILL 184
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-cell interactions mediated by adherens junctions and focal adhesions. Fer kinase also regulates cell cycle progression in malignant cells. Length = 250 |
| >gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Score = 61.8 bits (151), Expect = 4e-10
Identities = 21/73 (28%), Positives = 41/73 (56%), Gaps = 1/73 (1%)
Query: 884 TFVNRSRYNVHTYLVLELLKGGELLDRIRQKGRCGFTENEASRIMRQLVAAVHFMHSRGV 943
+ + ++V+E + GG L D I Q E + + + R+++ + ++HS+ V
Sbjct: 79 DYYDSYLVGDELWVVMEYMDGGSLTDIITQNFVR-MNEPQIAYVCREVLQGLEYLHSQNV 137
Query: 944 VHRDLKPENLLLS 956
+HRD+K +N+LLS
Sbjct: 138 IHRDIKSDNILLS 150
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286 |
| >gnl|CDD|143372 cd07867, STKc_CDC2L6, Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Score = 62.0 bits (150), Expect = 4e-10
Identities = 56/208 (26%), Positives = 93/208 (44%), Gaps = 25/208 (12%)
Query: 386 LGDGSYSVCRRCVEKSTG--QEYAVKIISR---KIDCSEEINLLRACQGHPNIVNLHCVF 440
+G G+Y + K +EYA+K I + EI LLR + HPN++ L VF
Sbjct: 9 VGRGTYGHVYKAKRKDGKDEKEYALKQIEGTGISMSACREIALLRELK-HPNVIALQKVF 67
Query: 441 --QDEVHTYLVLELLKGGELLDRIR-------QKGRCGFTENEASRIMRQLVAAVHFMHS 491
+ +L+ + + +L I+ K + ++ Q++ +H++H+
Sbjct: 68 LSHSDRKVWLLFDYAEH-DLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLHA 126
Query: 492 RGVVHRDLKPENLLF--SDPAGDNIKVVDFGFACLKRE------SLHTPCFTLQYAAPEV 543
V+HRDLKP N+L P +K+ D GFA L L T Y APE+
Sbjct: 127 NWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVTFWYRAPEL 186
Query: 544 LRQDKSGYDENCDLWSLGVILVNVLRQD 571
L + Y + D+W++G I +L +
Sbjct: 187 LLGARH-YTKAIDIWAIGCIFAELLTSE 213
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as the caspase-processed CDK11(p46). CDK11(p110), CDK11(p58), and CDK11(p46)do not belong to this subfamily. CDC2L6 is an associated protein of Mediator, a multiprotein complex that provides a platform to connect transcriptional and chromatin regulators and cofactors, in order to activate and mediate RNA polymerase II transcription. CDC2L6 is localized mainly in the nucleus amd exerts an opposing effect to CDK8 in VP16-dependent transcriptional activation by being a negative regulator. Length = 317 |
| >gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 61.4 bits (150), Expect = 5e-10
Identities = 27/75 (36%), Positives = 42/75 (56%), Gaps = 12/75 (16%)
Query: 895 TYLVLEL----LKGGELLDRIRQKGRCGFTENEASRIMRQLVAAVHFMHSRGVVHRDLKP 950
Y+V E L G LLD K FTE++ M+QL+ + ++HS G++HRD+K
Sbjct: 75 IYMVFEYMDHDLTG--LLDSPEVK----FTESQIKCYMKQLLEGLQYLHSNGILHRDIKG 128
Query: 951 ENLLLSGISGNLIKI 965
N+L++ G L K+
Sbjct: 129 SNILINN-DGVL-KL 141
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287 |
| >gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Score = 60.9 bits (148), Expect = 6e-10
Identities = 40/168 (23%), Positives = 75/168 (44%), Gaps = 17/168 (10%)
Query: 407 AVKIISRKI-----DCSEEINLLRACQGHPNIVNLHCVFQDEVHTYLVLELLKGGELLDR 461
A+KI+ D +E+ L+ + H ++++L V Y++ EL++ G LL
Sbjct: 34 AIKILKSDDLLKQQDFQKEVQALKRLR-HKHLISLFAVCSVGEPVYIITELMEKGSLLAF 92
Query: 462 IRQKGRCGFTENEASRIMRQLVAAVHFMHSRGVVHRDLKPENLLFSDPAGDNI--KVVDF 519
+R + Q+ + ++ + +HRDL N+L G+++ KV DF
Sbjct: 93 LRSPEGQVLPVASLIDMACQVAEGMAYLEEQNSIHRDLAARNIL----VGEDLVCKVADF 148
Query: 520 GFACLKRESLHTPCFT---LQYAAPEVLRQDKSGYDENCDLWSLGVIL 564
G A L +E ++ ++ APE + D+WS G++L
Sbjct: 149 GLARLIKEDVYLSSDKKIPYKWTAPEAASHGT--FSTKSDVWSFGILL 194
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261 |
| >gnl|CDD|133204 cd05073, PTKc_Hck, Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Score = 60.4 bits (146), Expect = 8e-10
Identities = 42/161 (26%), Positives = 76/161 (47%), Gaps = 10/161 (6%)
Query: 419 EEINLLRACQGHPNIVNLHCVFQDEVHTYLVLELLKGGELLDRIRQKGRCGFTENEASRI 478
E N+++ Q H +V LH V E Y++ E + G LLD ++ +
Sbjct: 50 AEANVMKTLQ-HDKLVKLHAVVTKE-PIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDF 107
Query: 479 MRQLVAAVHFMHSRGVVHRDLKPENLLFSDPAGDNIKVVDFGFACLKRESLHT----PCF 534
Q+ + F+ R +HRDL+ N+L S A K+ DFG A + ++ +T F
Sbjct: 108 SAQIAEGMAFIEQRNYIHRDLRAANILVS--ASLVCKIADFGLARVIEDNEYTAREGAKF 165
Query: 535 TLQYAAPEVLRQDKSGYDENCDLWSLGVILVNVLRQDKSGY 575
+++ APE + + + D+WS G++L+ ++ + Y
Sbjct: 166 PIKWTAPEAI--NFGSFTIKSDVWSFGILLMEIVTYGRIPY 204
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Hck is present in myeloid and lymphoid cells that play a role in the development of cancer. It may be important in the oncogenic signaling of the protein Tel-Abl, which induces a chronic myelogenous leukemia (CML)-like disease. Hck also acts as a negative regulator of granulocyte colony-stimulating factor (G-CSF)-induced proliferation of granulocytic precursors, suggesting a possible role in the development of acute myeloid leukemia (AML). In addition, Hck is essential in regulating the degranulation of polymorphonuclear leukocytes (PMNs). Genetic polymorphisms affect the expression level of Hck, which affects PMN mediator release and influences the development of chronic obstructive pulmonary disease (COPD). Length = 260 |
| >gnl|CDD|173706 cd05615, STKc_cPKC_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Score = 60.8 bits (147), Expect = 9e-10
Identities = 33/105 (31%), Positives = 51/105 (48%), Gaps = 3/105 (2%)
Query: 263 YRRILKTEPPIPEDLSPDVADFISRLLVKDPRRRLGGGELDAEELKRHPFFNVIDWDDLA 322
++ I++ P+ LS + L+ K P +RLG G +++ H FF IDWD L
Sbjct: 210 FQSIMEHNVSYPKSLSKEAVSICKGLMTKHPSKRLGCGPEGERDIREHAFFRRIDWDKLE 269
Query: 323 TKRIPAPFVPKISNELDVSNFSDEFTKMIPADSPA--IVPPNFDK 365
+ I PF PK+ + NF FT+ P +P +V N D+
Sbjct: 270 NREIQPPFKPKVCGK-GAENFDKFFTRGQPVLTPPDQLVIANIDQ 313
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. PKC-alpha is expressed in many tissues and is associated with cell proliferation, apoptosis, and cell motility. It plays a role in the signaling of the growth factors PDGF, VEGF, EGF, and FGF. Abnormal levels of PKC-alpha have been detected in many transformed cell lines and several human tumors. In addition, PKC-alpha is required for HER2 dependent breast cancer invasion. Length = 323 |
| >gnl|CDD|140289 PTZ00263, PTZ00263, protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 61.0 bits (148), Expect = 1e-09
Identities = 25/81 (30%), Positives = 38/81 (46%)
Query: 263 YRRILKTEPPIPEDLSPDVADFISRLLVKDPRRRLGGGELDAEELKRHPFFNVIDWDDLA 322
Y +IL P D + LL D +RLG + ++K HP+F+ +WD L
Sbjct: 224 YEKILAGRLKFPNWFDGRARDLVKGLLQTDHTKRLGTLKGGVADVKNHPYFHGANWDKLY 283
Query: 323 TKRIPAPFVPKISNELDVSNF 343
+ PAP ++ + D SNF
Sbjct: 284 ARYYPAPIPVRVKSPGDTSNF 304
|
Length = 329 |
| >gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Score = 59.5 bits (145), Expect = 1e-09
Identities = 19/61 (31%), Positives = 40/61 (65%), Gaps = 1/61 (1%)
Query: 896 YLVLELLKGGELLDRIRQKGRCGFTENEASRIMRQLVAAVHFMHSRGVVHRDLKPENLLL 955
++V+E GG L D ++ + TE++ + + ++L+ + ++HS G++HRD+K N+LL
Sbjct: 73 WIVMEFCSGGSLKDLLKSTNQT-LTESQIAYVCKELLKGLEYLHSNGIIHRDIKAANILL 131
Query: 956 S 956
+
Sbjct: 132 T 132
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253 |
| >gnl|CDD|173713 cd05624, STKc_MRCK_beta, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Score = 60.8 bits (147), Expect = 1e-09
Identities = 42/146 (28%), Positives = 71/146 (48%), Gaps = 18/146 (12%)
Query: 231 GIECVFFSSSLIIFFIILSFTLSFIHDYYHIQYRRILKTE-----PPIPEDLSPDVADFI 285
G EC ++S + ++ ++ T F + Y +I+ E P D+S + D I
Sbjct: 186 GPECDWWSLGVCMYEMLYGET-PFYAESLVETYGKIMNHEERFQFPSHITDVSEEAKDLI 244
Query: 286 SRLLVKDPRRRLGGGELDAEELKRHPFFNVIDWDDLATKRIPAPFVPKISNELDVSNF-- 343
RL+ RR G+ E+ K+H FF IDW+++ + + AP++P +S+ D SNF
Sbjct: 245 QRLICSRERRL---GQNGIEDFKKHAFFEGIDWENI--RNLEAPYIPDVSSPSDTSNFDV 299
Query: 344 SDEFTKMIPADSPAIVPPNFDKIFKG 369
D+ + +P I PP+ F G
Sbjct: 300 DDDVLR-----NPEIAPPSSHTGFSG 320
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. Length = 331 |
| >gnl|CDD|173693 cd05602, STKc_SGK1, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Score = 60.8 bits (147), Expect = 1e-09
Identities = 32/80 (40%), Positives = 46/80 (57%), Gaps = 5/80 (6%)
Query: 274 PEDLSPDVAD----FISRLLVKDPRRRLGGGELDAEELKRHPFFNVIDWDDLATKRIPAP 329
P L P++ + + LL KD +RLG + D E+K H FF+ I+WDDL K+I P
Sbjct: 212 PLQLKPNITNSARHLLEGLLQKDRTKRLGAKD-DFMEIKNHIFFSPINWDDLINKKITPP 270
Query: 330 FVPKISNELDVSNFSDEFTK 349
F P +S D+ +F EFT+
Sbjct: 271 FNPNVSGPNDLRHFDPEFTE 290
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt sensitivity, memory consolidation, and cardiac repolarization. A common SGK1 variant is associated with increased blood pressure and body weight. SGK1 may also contribute to tumor growth, neurodegeneration, fibrosing disease, and ischemia. Length = 325 |
| >gnl|CDD|173658 cd05114, PTKc_Tec_Rlk, Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Score = 59.5 bits (144), Expect = 1e-09
Identities = 39/147 (26%), Positives = 70/147 (47%), Gaps = 9/147 (6%)
Query: 430 HPNIVNLHCVFQDEVHTYLVLELLKGGELLDRIRQKGRCGFTENEASRIMRQLVAAVHFM 489
HP +V L+ V + Y+V E ++ G LL+ +RQ+ + +++ + + + + ++
Sbjct: 58 HPKLVQLYGVCTQQKPLYIVTEFMENGCLLNYLRQR-QGKLSKDMLLSMCQDVCEGMEYL 116
Query: 490 HSRGVVHRDLKPENLLFSDPAGDNIKVVDFGFACLKRESLHTPC----FTLQYAAPEVLR 545
+HRDL N L S +KV DFG + +T F ++++ PEV
Sbjct: 117 ERNSFIHRDLAARNCLVSSTG--VVKVSDFGMTRYVLDDEYTSSSGAKFPVKWSPPEVFN 174
Query: 546 QDKSGYDENCDLWSLGVILVNVLRQDK 572
K Y D+WS GV++ V + K
Sbjct: 175 FSK--YSSKSDVWSFGVLMWEVFTEGK 199
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. Instead of PH, Rlk contains an N-terminal cysteine-rich region. In addition to PH, Tec also contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Tec is more widely-expressed than other Tec subfamily kinases. It is found in endothelial cells, both B- and T-cells, and a variety of myeloid cells including mast cells, erythroid cells, platelets, macrophages and neutrophils. Rlk is expressed in T-cells and mast cell lines. Tec and Rlk are both key components of T-cell receptor (TCR) signaling. They are important in TCR-stimulated proliferation, IL-2 production and phopholipase C-gamma1 activation. Length = 256 |
| >gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 59.4 bits (144), Expect = 2e-09
Identities = 24/63 (38%), Positives = 40/63 (63%), Gaps = 2/63 (3%)
Query: 894 HTYLVLELLKGGELLDRIRQKGRCGFTENEASRIMRQLVAAVHFMHSRGVVHRDLKPENL 953
Y+++E + GGEL +R GR F+ + ++V A+ ++HS+ +V+RDLKPEN+
Sbjct: 75 FLYMLMEYVPGGELFSYLRNSGR--FSNSTGLFYASEIVCALEYLHSKEIVYRDLKPENI 132
Query: 954 LLS 956
LL
Sbjct: 133 LLD 135
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291 |
| >gnl|CDD|173692 cd05601, STKc_CRIK, Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Score = 59.8 bits (145), Expect = 2e-09
Identities = 41/123 (33%), Positives = 60/123 (48%), Gaps = 14/123 (11%)
Query: 231 GIECVFFSSSLIIFFIILSFTLSFIHDYYHIQYRRILKTEPPI--PEDL--SPDVADFIS 286
G+EC ++S +I + +I + F Y I+ + + PED S D D I
Sbjct: 187 GVECDWWSLGVIAYEMIYGRS-PFHEGTSAKTYNNIMNFQRFLKFPEDPKVSSDFLDLIQ 245
Query: 287 RLLVKDPRRRLGGGELDAEELKRHPFFNVIDWDDLATKRIPAPFVPKISNELDVSNFSDE 346
LL + RLG E L HPFF+ IDW+++ + PFVP + ++ D SNF DE
Sbjct: 246 SLLC-GQKERLG-----YEGLCCHPFFSKIDWNNI--RNSLPPFVPTLKSDDDTSNF-DE 296
Query: 347 FTK 349
K
Sbjct: 297 PEK 299
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnormal cytokinesis and massive apoptosis in neuronal precursors. A Down syndrome critical region protein TTC3 interacts with CRIK and inhibits CRIK-dependent neuronal differentiation and neurite extension. Length = 330 |
| >gnl|CDD|173741 cd07843, STKc_CDC2L1, Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Score = 59.9 bits (146), Expect = 2e-09
Identities = 23/67 (34%), Positives = 38/67 (56%), Gaps = 10/67 (14%)
Query: 894 HTYLVLEL----LKGGELLDRIRQKGRCGFTENEASRIMRQLVAAVHFMHSRGVVHRDLK 949
Y+V+E LK L++ ++Q F ++E +M QL++ V +H ++HRDLK
Sbjct: 80 KIYMVMEYVEHDLKS--LMETMKQ----PFLQSEVKCLMLQLLSGVAHLHDNWILHRDLK 133
Query: 950 PENLLLS 956
NLLL+
Sbjct: 134 TSNLLLN 140
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the major isoform, associates with cyclin L and is expressed throughout the cell cycle. It is involved in RNA processing and the regulation of transcription. CDK11(p58) associates with cyclin D3 and is expressed during the G2/M phase of the cell cycle. It plays roles in spindle morphogenesis, centrosome maturation, sister chromatid cohesion, and the completion of mitosis. CDK11(p46) is formed from the larger isoforms by caspases during TNFalpha- and Fas-induced apoptosis. It functions as a downstream effector kinase in apoptotic signaling pathways and interacts with eukaryotic initiation factor 3f (eIF3f), p21-activated kinase (PAK1), and Ran-binding protein (RanBPM). Length = 293 |
| >gnl|CDD|173710 cd05620, STKc_nPKC_delta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Score = 60.0 bits (145), Expect = 2e-09
Identities = 28/85 (32%), Positives = 42/85 (49%), Gaps = 4/85 (4%)
Query: 263 YRRILKTEPPIPEDLSPDVADFISRLLVKDPRRRLGGGELDAEELKRHPFFNVIDWDDLA 322
+ I P P ++ + D + +L +DP RRLG ++ HPFF I+W L
Sbjct: 205 FESIRVDTPHYPRWITKESKDILEKLFERDPTRRLG----VVGNIRGHPFFKTINWTALE 260
Query: 323 TKRIPAPFVPKISNELDVSNFSDEF 347
+ + PF PK+ + D SNF EF
Sbjct: 261 KRELDPPFKPKVKSPSDYSNFDREF 285
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. It slows down cell proliferation, inducing cell cycle arrest and enhancing cell differentiation. PKC-delta is also involved in the regulation of transcription as well as immune and inflammatory responses. It plays a central role in the genotoxic stress response that leads to DNA damaged-induced apoptosis. Length = 316 |
| >gnl|CDD|173699 cd05608, STKc_GRK1, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Score = 59.1 bits (143), Expect = 2e-09
Identities = 26/69 (37%), Positives = 36/69 (52%)
Query: 264 RRILKTEPPIPEDLSPDVADFISRLLVKDPRRRLGGGELDAEELKRHPFFNVIDWDDLAT 323
+RIL P+ SP F LL KDP +RLG + + + L+ HP F ++W L
Sbjct: 211 QRILNDSVTYPDKFSPASKSFCEALLAKDPEKRLGFRDGNCDGLRTHPLFRDLNWRQLEA 270
Query: 324 KRIPAPFVP 332
+P PFVP
Sbjct: 271 GMLPPPFVP 279
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual group of GRKs and is expressed in retinal cells. It phosphorylates rhodopsin in rod cells, which leads to termination of the phototransduction cascade. Mutations in GRK1 are associated to a recessively inherited form of stationary nightblindness called Oguchi disease. Length = 280 |
| >gnl|CDD|173630 cd05044, PTKc_c-ros, Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Score = 59.5 bits (144), Expect = 2e-09
Identities = 51/186 (27%), Positives = 77/186 (41%), Gaps = 26/186 (13%)
Query: 404 QEYAVKIISRKIDCSEEINLLRACQ-----GHPNIVNLHCVFQDEVHTYLVLELLKGGEL 458
AVK + + E+ L+ HPNIV L V Y+++EL++GG+L
Sbjct: 27 IRVAVKTLRKGATDQEKKEFLKEAHLMSNFNHPNIVKLLGVCLLNEPQYIIMELMEGGDL 86
Query: 459 LD-----RIRQKGRCGFTENEASRIMRQLVAAVHFMHSRGVVHRDLKPENLLFSDPAGDN 513
L R+ + G T E I + ++ +HRDL N L S+ D
Sbjct: 87 LSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYLEQMHFIHRDLAARNCLVSEKGYDA 146
Query: 514 IKVV---DFGFA--------CLKRESLHTPCFTLQYAAPEVLRQDKSGYDENCDLWSLGV 562
+VV DFG A K P +++ APE L K + D+WS GV
Sbjct: 147 DRVVKIGDFGLARDIYKSDYYRKEGEGLLP---VRWMAPESLLDGK--FTTQSDVWSFGV 201
Query: 563 ILVNVL 568
++ +L
Sbjct: 202 LMWEIL 207
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male mice bearing inactive mutations of c-ros lack the initial segment of the epididymis and are infertile. The Drosophila protein, Sevenless, is required for the specification of the R7 photoreceptor cell during eye development. Length = 269 |
| >gnl|CDD|132965 cd06634, STKc_TAO2, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Score = 59.7 bits (144), Expect = 2e-09
Identities = 44/155 (28%), Positives = 78/155 (50%), Gaps = 11/155 (7%)
Query: 416 DCSEEINLLRACQGHPNIVNLHCVFQDEVHTYLVLELLKGG--ELLDRIRQKGRCGFTEN 473
D +E+ L+ + HPN + + E +LV+E G +LL+ ++ E
Sbjct: 61 DIIKEVRFLQKLR-HPNTIQYRGCYLREHTAWLVMEYCLGSASDLLEVHKKP----LQEV 115
Query: 474 EASRIMRQLVAAVHFMHSRGVVHRDLKPENLLFSDPAGDNIKVVDFGFACLKRESLHTPC 533
E + + + + ++HS ++HRD+K N+L S+P +K+ DFG A + + +
Sbjct: 116 EIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLSEPG--LVKLGDFGSASIMAPA-NXFV 172
Query: 534 FTLQYAAPEV-LRQDKSGYDENCDLWSLGVILVNV 567
T + APEV L D+ YD D+WSLG+ + +
Sbjct: 173 GTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIEL 207
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. TAO2 contains a long C-terminal extension with autoinhibitory segments. It is activated by the release of this inhibition and the phosphorylation of its activation loop serine. TAO2 functions as a regulator of actin cytoskeletal and microtubule organization. In addition, it regulates the transforming growth factor-activated kinase 1 (TAK1), which is a MAPKKK that plays an essential role in the signaling pathways of tumor necrosis factor (TNF), interleukin 1 (IL-1), and Toll-like receptor (TLR). Length = 308 |
| >gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Score = 58.7 bits (143), Expect = 3e-09
Identities = 29/76 (38%), Positives = 42/76 (55%), Gaps = 9/76 (11%)
Query: 242 IIFFIILSFTLSFIHDY-YHIQYRRILKTEPPIPE---DLSPDVADFISRLLVKDPRRRL 297
+I + +L+ F D +++I K +PP P D+SP+ D I +LLVKDP +RL
Sbjct: 184 VILYELLTGKPPFPGDDQLLELFKKIGKPKPPFPPPEWDISPEAKDLIRKLLVKDPEKRL 243
Query: 298 GGGELDAEELKRHPFF 313
AEE +HPFF
Sbjct: 244 T-----AEEALQHPFF 254
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254 |
| >gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain | Back alignment and domain information |
|---|
Score = 58.4 bits (142), Expect = 3e-09
Identities = 33/148 (22%), Positives = 47/148 (31%), Gaps = 48/148 (32%)
Query: 122 GILGDGSYSVCRRCVEKSTGQEYAVKIIS-RKIDCSEEINLLRACQGHPNICRRCVEKST 180
LG GS+ + K TG+ AVKI+ R ++ R
Sbjct: 5 RKLGSGSFGTVYKAKHKGTGKIVAVKILKKRSEKSKKDQTARR----------------- 47
Query: 181 GQEYAVKIISRKIDCSEEINLLRACQGHPNIVNLHCVFQDE-----VIDW----DDFSRG 231
EI +LR HPNIV L F+D+ V+++ D F
Sbjct: 48 -----------------EIRILRRLS-HPNIVRLIDAFEDKDHLYLVMEYCEGGDLFDYL 89
Query: 232 IECVFFSSSLIIFFI--ILSFTLSFIHD 257
S IL L ++H
Sbjct: 90 SRGGPLSEDEAKKIALQILR-GLEYLHS 116
|
Length = 260 |
| >gnl|CDD|140289 PTZ00263, PTZ00263, protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 59.4 bits (144), Expect = 3e-09
Identities = 29/70 (41%), Positives = 44/70 (62%), Gaps = 4/70 (5%)
Query: 896 YLVLELLKGGELLDRIRQKGRCGFTENEASRIMRQLVAAVHFMHSRGVVHRDLKPENLLL 955
Y +LE + GGEL +R+ GR F + A +LV A ++HS+ +++RDLKPENLLL
Sbjct: 94 YFLLEFVVGGELFTHLRKAGR--FPNDVAKFYHAELVLAFEYLHSKDIIYRDLKPENLLL 151
Query: 956 SGISGNLIKI 965
G+ +K+
Sbjct: 152 DN-KGH-VKV 159
|
Length = 329 |
| >gnl|CDD|173664 cd05573, STKc_ROCK_NDR_like, Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 59.6 bits (145), Expect = 3e-09
Identities = 27/72 (37%), Positives = 45/72 (62%), Gaps = 4/72 (5%)
Query: 894 HTYLVLELLKGGELLDRIRQKGRCGFTENEASRIMRQLVAAVHFMHSRGVVHRDLKPENL 953
H YLV+E + GG+L++ + +K F E A + +LV A+ +H G +HRD+KP+N+
Sbjct: 75 HLYLVMEYMPGGDLMNLLIRKDV--FPEETARFYIAELVLALDSVHKLGFIHRDIKPDNI 132
Query: 954 LLSGISGNLIKI 965
L+ G+ IK+
Sbjct: 133 LI-DADGH-IKL 142
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Proteins in this subfamily are involved in regulating many cellular functions including contraction, motility, division, proliferation, apoptosis, morphogenesis, and cytokinesis. Length = 350 |
| >gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Score = 60.7 bits (147), Expect = 3e-09
Identities = 46/139 (33%), Positives = 74/139 (53%), Gaps = 17/139 (12%)
Query: 400 KSTGQEYAVKIISRKID---------CSEEINLLRACQGHPNIVNLHCVFQDEVHTYLVL 450
K+ + YAVK++ +K D E + L A P IV+L+ Q + YLV+
Sbjct: 26 KNNSKLYAVKVV-KKADMINKNMVHQVQAERDAL-ALSKSPFIVHLYYSLQSANNVYLVM 83
Query: 451 ELLKGGELLDRIRQKGRCGFTENEASRIMRQLVAAVHFMHSRGVVHRDLKPENLLFSDPA 510
E L GG++ + G F E A + + ++ A+ ++H G++HRDLKP+N+L S+
Sbjct: 84 EYLIGGDVKSLLHIYGY--FDEEMAVKYISEVALALDYLHRHGIIHRDLKPDNMLISNEG 141
Query: 511 GDNIKVVDFGFA--CLKRE 527
+IK+ DFG + L RE
Sbjct: 142 --HIKLTDFGLSKVTLNRE 158
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669 |
| >gnl|CDD|173333 PTZ00036, PTZ00036, glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Score = 60.0 bits (145), Expect = 3e-09
Identities = 55/200 (27%), Positives = 92/200 (46%), Gaps = 23/200 (11%)
Query: 385 ILGDGSYSVCRRCVEKSTGQEYAVKIISRKIDCSEEINLLRACQGHPNIVNL------HC 438
I+G+GS+ V + T ++ A+K + + L+ H NI+ L C
Sbjct: 73 IIGNGSFGVVYEAICIDTSEKVAIKKVLQDPQYKNRELLIMKNLNHINIIFLKDYYYTEC 132
Query: 439 VFQDEVHTYLVLELLKGGELLDRIRQKGRCGFTENEASRIM-------RQLVAAVHFMHS 491
++E + +L + + E + + K + N + + QL A+ ++HS
Sbjct: 133 FKKNEKNIFLNVVM----EFIPQTVHKYMKHYARNNHALPLFLVKLYSYQLCRALAYIHS 188
Query: 492 RGVVHRDLKPENLLFSDPAGDNIKVVDFGFA---CLKRESLHTPCFTLQYAAPEVLRQDK 548
+ + HRDLKP+NLL DP +K+ DFG A + S+ C Y APE L
Sbjct: 189 KFICHRDLKPQNLLI-DPNTHTLKLCDFGSAKNLLAGQRSVSYICSRF-YRAPE-LMLGA 245
Query: 549 SGYDENCDLWSLGVILVNVL 568
+ Y + DLWSLG I+ ++
Sbjct: 246 TNYTTHIDLWSLGCIIAEMI 265
|
Length = 440 |
| >gnl|CDD|173735 cd07831, STKc_MOK, Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Score = 58.4 bits (142), Expect = 4e-09
Identities = 23/66 (34%), Positives = 34/66 (51%), Gaps = 2/66 (3%)
Query: 897 LVLELLKGGELLDRIRQKGRCGFTENEASRIMRQLVAAVHFMHSRGVVHRDLKPENLLLS 956
LV EL+ L + I+ + R E M QL+ ++ MH G+ HRD+KPEN+L+
Sbjct: 77 LVFELMDM-NLYELIKGRKRP-LPEKRVKSYMYQLLKSLDHMHRNGIFHRDIKPENILIK 134
Query: 957 GISGNL 962
L
Sbjct: 135 DDILKL 140
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. Length = 282 |
| >gnl|CDD|223069 PHA03390, pk1, serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Score = 58.3 bits (142), Expect = 4e-09
Identities = 24/68 (35%), Positives = 45/68 (66%), Gaps = 6/68 (8%)
Query: 891 YNVHT----YLVLELLKGGELLDRIRQKGRCGFTENEASRIMRQLVAAVHFMHSRGVVHR 946
Y+V T L+++ +K G+L D ++++G+ +E E +I+RQLV A++ +H ++H
Sbjct: 76 YSVTTLKGHVLIMDYIKDGDLFDLLKKEGK--LSEAEVKKIIRQLVEALNDLHKHNIIHN 133
Query: 947 DLKPENLL 954
D+K EN+L
Sbjct: 134 DIKLENVL 141
|
Length = 267 |
| >gnl|CDD|173675 cd05584, STKc_p70S6K, Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 58.7 bits (142), Expect = 5e-09
Identities = 25/61 (40%), Positives = 40/61 (65%), Gaps = 2/61 (3%)
Query: 896 YLVLELLKGGELLDRIRQKGRCGFTENEASRIMRQLVAAVHFMHSRGVVHRDLKPENLLL 955
YL+LE L GGEL + ++G F E+ A + ++ A+ +H +G+++RDLKPEN+LL
Sbjct: 76 YLILEYLSGGELFMHLEREGI--FMEDTACFYLSEISLALEHLHQQGIIYRDLKPENILL 133
Query: 956 S 956
Sbjct: 134 D 134
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the insulin receptor substrate IRS-1, among others. Mammals contain two isoforms of p70S6K, named S6K1 and S6K2 (or S6K-beta). Length = 323 |
| >gnl|CDD|133186 cd05055, PTKc_PDGFR, Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 58.7 bits (142), Expect = 5e-09
Identities = 44/172 (25%), Positives = 76/172 (44%), Gaps = 21/172 (12%)
Query: 407 AVKIISRKIDCSE------EINLLRACQGHPNIVNLHCVFQDEVHTYLVLELLKGGELLD 460
AVK++ SE E+ ++ H NIVNL ++ E G+LL+
Sbjct: 69 AVKMLKPTAHSSEREALMSELKIMSHLGNHENIVNLLGACTIGGPILVITEYCCYGDLLN 128
Query: 461 RIRQKGRCGFTENEASRIMRQLVAAVHFMHSRGVVHRDLKPENLLFSDPAGDNIKVVDFG 520
+R+K T + Q+ + F+ S+ +HRDL N+L + G +K+ DFG
Sbjct: 129 FLRRKRESFLTLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNVLLTH--GKIVKICDFG 186
Query: 521 FACLKRESLHTPCFT--------LQYAAPEVLRQDKSGYDENCDLWSLGVIL 564
A R+ ++ + +++ APE + Y D+WS G++L
Sbjct: 187 LA---RDIMNDSNYVVKGNARLPVKWMAPESIFNCV--YTFESDVWSYGILL 233
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR subfamily receptors are important in the development of a variety of cells. PDGFRs are expressed in a many cells including fibroblasts, neurons, endometrial cells, mammary epithelial cells, and vascular smooth muscle cells. PDGFR signaling is critical in normal embryonic development, angiogenesis, and wound healing. PDGFRs transduce mitogenic signals for connective tissue cells and are important for cell shape and motility. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. Mammalian FLT3 plays an important role in the survival, proliferation, and differentiation of stem cells. Length = 302 |
| >gnl|CDD|173625 cd05032, PTKc_InsR_like, Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 58.1 bits (141), Expect = 5e-09
Identities = 44/208 (21%), Positives = 83/208 (39%), Gaps = 39/208 (18%)
Query: 386 LGDGSYS-----VCRRCVEKSTGQEYAVKIISRKIDCSEEINLLRA--------CQGHPN 432
LG GS+ + + V+ A+K ++ E I L C +
Sbjct: 14 LGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEFLNEASVMKEFNC---HH 70
Query: 433 IVNLHCVFQDEVHTYLVLELLKGGELLDRIRQK-----GRCGFTENEASRIMR---QLVA 484
+V L V T +V+EL+ G+L +R + G + ++ ++
Sbjct: 71 VVRLLGVVSTGQPTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIAD 130
Query: 485 AVHFMHSRGVVHRDLKPENLLFSDPAGDNIKVVDFGFACLKRESLHTPCFT--------L 536
+ ++ ++ VHRDL N + ++ +K+ DFG R+ T + +
Sbjct: 131 GMAYLAAKKFVHRDLAARNCMVAE--DLTVKIGDFGMT---RDIYETDYYRKGGKGLLPV 185
Query: 537 QYAAPEVLRQDKSGYDENCDLWSLGVIL 564
++ APE L+ + D+WS GV+L
Sbjct: 186 RWMAPESLKDGV--FTTKSDVWSFGVVL 211
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR and IGF-1R, which share 84% sequence identity in their kinase domains, display physiologically distinct yet overlapping functions in cell growth, differentiation, and metabolism. InsR activation leads primarily to metabolic effects while IGF-1R activation stimulates mitogenic pathways. In cells expressing both receptors, InsR/IGF-1R hybrids are found together with classical receptors. Both receptors can interact with common adaptor molecules such as IRS-1 and IRS-2. Length = 277 |
| >gnl|CDD|133168 cd05036, PTKc_ALK_LTK, Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Score = 58.2 bits (141), Expect = 5e-09
Identities = 35/134 (26%), Positives = 57/134 (42%), Gaps = 17/134 (12%)
Query: 404 QEYAVKIISRKIDCSE--EINLLR--ACQG---HPNIVNLHCVFQDEVHTYLVLELLKGG 456
E V + + CSE E + L H NIV L V + + +++LEL+ GG
Sbjct: 35 VELQVAVKTLPESCSEQDESDFLMEALIMSKFNHQNIVRLIGVSFERLPRFILLELMAGG 94
Query: 457 ELLDRIRQKGRCGFTENEASRIMRQLV-------AAVHFMHSRGVVHRDLKPENLLFSDP 509
+L +R+ R E +S M+ L+ ++ +HRD+ N L +
Sbjct: 95 DLKSFLRE-NR-PRPERPSSLTMKDLLFCARDVAKGCKYLEENHFIHRDIAARNCLLTCK 152
Query: 510 AGDNI-KVVDFGFA 522
+ K+ DFG A
Sbjct: 153 GPGRVAKIADFGMA 166
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well as visceral muscle differentiation in Drosophila. ALK is aberrantly expressed as fusion proteins, due to chromosomal translocations, in about 60% of anaplastic large cell lymphomas (ALCLs). ALK fusion proteins are also found in rare cases of diffuse large B cell lymphomas (DLBCLs). LTK is mainly expressed in B lymphocytes and neuronal tissues. It is important in cell proliferation and survival. Transgenic mice expressing TLK display retarded growth and high mortality rate. In addition, a polymorphism in mouse and human LTK is implicated in the pathogenesis of systemic lupus erythematosus. Length = 277 |
| >gnl|CDD|177557 PHA03209, PHA03209, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 58.7 bits (142), Expect = 6e-09
Identities = 32/109 (29%), Positives = 62/109 (56%), Gaps = 12/109 (11%)
Query: 474 EASRIMRQLVAAVHFMHSRGVVHRDLKPENLLFSDPAGDNIKVVDFGFACLKRESLHTPC 533
+A I +Q++ + ++H++ ++HRD+K EN+ +D D + + D G A + + P
Sbjct: 158 QALIIEKQILEGLRYLHAQRIIHRDVKTENIFINDV--DQVCIGDLGAA---QFPVVAPA 212
Query: 534 F-----TLQYAAPEVLRQDKSGYDENCDLWSLGVILVNVLRQDKSGYDE 577
F T++ APEVL +DK Y+ D+WS G++L +L + +++
Sbjct: 213 FLGLAGTVETNAPEVLARDK--YNSKADIWSAGIVLFEMLAYPSTIFED 259
|
Length = 357 |
| >gnl|CDD|165476 PHA03210, PHA03210, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 58.9 bits (142), Expect = 7e-09
Identities = 36/104 (34%), Positives = 57/104 (54%), Gaps = 12/104 (11%)
Query: 474 EASRIMRQLVAAVHFMHSRGVVHRDLKPENLLFSDPAGDNIKVV-DFGFACLKRESLHTP 532
+ IM+QL+ AV ++H + ++HRD+K EN+ + D V+ DFG A + E
Sbjct: 268 QTRAIMKQLLCAVEYIHDKKLIHRDIKLENIFLN---CDGKIVLGDFGTA-MPFEKEREA 323
Query: 533 -----CFTLQYAAPEVLRQDKSGYDENCDLWSLGVILVNVLRQD 571
T+ +PE+L D GY E D+WS G+IL+++L D
Sbjct: 324 FDYGWVGTVATNSPEILAGD--GYCEITDIWSCGLILLDMLSHD 365
|
Length = 501 |
| >gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 57.6 bits (139), Expect = 9e-09
Identities = 60/216 (27%), Positives = 96/216 (44%), Gaps = 44/216 (20%)
Query: 380 LDKAGILGDGSYS----VCRRCVEKSTGQEYAVKIISRKIDCSE--------EINLLRAC 427
L K +LG+G + C TG+ AVK + K +C + EIN+L+
Sbjct: 6 LKKIRVLGEGHFGKVSLYCYDPANDGTGEMVAVK--TLKRECGQQNTSGWKKEINILKTL 63
Query: 428 QGHPNIVNLH--CVFQDEVHTYLVLELLKGGELLDRIRQKGRCGFTENEASRIM---RQL 482
H NIV C Q L++E + G L D + K + ++++ +Q+
Sbjct: 64 Y-HENIVKYKGCCSEQGGKGLQLIMEYVPLGSLRDYL-PKHKLNL-----AQLLLFAQQI 116
Query: 483 VAAVHFMHSRGVVHRDLKPENLLFSDPAGDN-IKVVDFGFA---------CLKRESLHTP 532
+ ++HS+ +HRDL N+L + D +K+ DFG A RE +P
Sbjct: 117 CEGMAYLHSQHYIHRDLAARNVLLDN---DRLVKIGDFGLAKAVPEGHEYYRVREDGDSP 173
Query: 533 CFTLQYAAPEVLRQDKSGYDENCDLWSLGVILVNVL 568
F + A E L+++K Y D+WS GV L +L
Sbjct: 174 VF---WYAVECLKENKFSYAS--DVWSFGVTLYELL 204
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 283 |
| >gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 57.4 bits (139), Expect = 9e-09
Identities = 56/207 (27%), Positives = 86/207 (41%), Gaps = 44/207 (21%)
Query: 386 LGDGSYSVCRRC----VEKSTGQEYAVKIISR------KIDCSEEINLLRACQGHPNIVN 435
LG+G + C + +TG++ AVK ++ + D EI +LR H NIV
Sbjct: 12 LGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLD-HENIVK 70
Query: 436 LH--CVFQDEVHTYLVLELLKGGELLDRIR-QKGRCGFTENEASRIMR---QLVAAVHFM 489
C L++E L G L D ++ + + R++ Q+ + ++
Sbjct: 71 YKGVCEKPGGRSLRLIMEYLPSGSLRDYLQRHRDQ-----INLKRLLLFSSQICKGMDYL 125
Query: 490 HSRGVVHRDLKPENLLFSDPAGDNIKVVDFGFACL------------KRESLHTPCFTLQ 537
S+ +HRDL N+L D +K+ DFG A + ES P F
Sbjct: 126 GSQRYIHRDLAARNILVESE--DLVKISDFGLAKVLPEDKDYYYVKEPGES---PIF--- 177
Query: 538 YAAPEVLRQDKSGYDENCDLWSLGVIL 564
+ APE LR K D+WS GV L
Sbjct: 178 WYAPECLRTSKFSSAS--DVWSFGVTL 202
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284 |
| >gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 56.7 bits (137), Expect = 1e-08
Identities = 26/61 (42%), Positives = 39/61 (63%), Gaps = 2/61 (3%)
Query: 896 YLVLELLKGGELLDRIRQKGRCGFTENEASRIMRQLVAAVHFMHSRGVVHRDLKPENLLL 955
YLV+E L GG+ I+ G G E+ A + + ++V V +H RG++HRD+KPENLL+
Sbjct: 73 YLVMEYLNGGDCASLIKTLG--GLPEDWAKQYIAEVVLGVEDLHQRGIIHRDIKPENLLI 130
Query: 956 S 956
Sbjct: 131 D 131
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260 |
| >gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 56.5 bits (137), Expect = 1e-08
Identities = 18/63 (28%), Positives = 36/63 (57%), Gaps = 2/63 (3%)
Query: 894 HTYLVLELLKGGELLDRIRQKGRCGFTENEASRIMRQLVAAVHFMHSRGVVHRDLKPENL 953
Y++LE + G L I++ G E+ + + Q++ + ++H +GV+HRD+K N+
Sbjct: 73 SLYIILEYAENGSLRQIIKKFGPFP--ESLVAVYVYQVLQGLAYLHEQGVIHRDIKAANI 130
Query: 954 LLS 956
L +
Sbjct: 131 LTT 133
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254 |
| >gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Score = 56.8 bits (138), Expect = 1e-08
Identities = 18/70 (25%), Positives = 36/70 (51%), Gaps = 2/70 (2%)
Query: 896 YLVLELLKGGELLDRIRQKGRCGFTENEASRIMRQLVAAVHFMHSRGVVHRDLKPENLLL 955
+V+E + GG+LLD +R+ + ++ Q+ + ++ S+ +HRDL N L+
Sbjct: 77 MIVMEYMPGGDLLDYLRKNRPKELSLSDLLSFALQIARGMEYLESKNFIHRDLAARNCLV 136
Query: 956 SGISGNLIKI 965
++KI
Sbjct: 137 G--ENLVVKI 144
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258 |
| >gnl|CDD|133202 cd05071, PTKc_Src, Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Score = 57.0 bits (137), Expect = 1e-08
Identities = 43/161 (26%), Positives = 74/161 (45%), Gaps = 31/161 (19%)
Query: 430 HPNIVNLHCVFQDEVHTYLVLELLKGGELLDRIRQKGRCGFTENEASRIMR--------- 480
H +V L+ V +E Y+V E + G LLD F + E + +R
Sbjct: 60 HEKLVQLYAVVSEE-PIYIVTEYMSKGSLLD---------FLKGEMGKYLRLPQLVDMAA 109
Query: 481 QLVAAVHFMHSRGVVHRDLKPENLLFSDPAGDNI--KVVDFGFACLKRESLHT----PCF 534
Q+ + + ++ VHRDL+ N+L G+N+ KV DFG A L ++ +T F
Sbjct: 110 QIASGMAYVERMNYVHRDLRAANIL----VGENLVCKVADFGLARLIEDNEYTARQGAKF 165
Query: 535 TLQYAAPEVLRQDKSGYDENCDLWSLGVILVNVLRQDKSGY 575
+++ APE + + D+WS G++L + + + Y
Sbjct: 166 PIKWTAPEAALYGR--FTIKSDVWSFGILLTELTTKGRVPY 204
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Src also play a role in regulating cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Elevated levels of Src kinase activity have been reported in a variety of human cancers. Several inhibitors of Src have been developed as anti-cancer drugs. Src is also implicated in acute inflammatory responses and osteoclast function. Length = 262 |
| >gnl|CDD|173673 cd05582, STKc_RSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 57.1 bits (138), Expect = 2e-08
Identities = 28/75 (37%), Positives = 46/75 (61%), Gaps = 6/75 (8%)
Query: 885 FVNRSRYNVHT----YLVLELLKGGELLDRIRQKGRCGFTENEASRIMRQLVAAVHFMHS 940
F+ + Y T YL+L+ L+GG+L R+ ++ FTE + + +L A+ +HS
Sbjct: 59 FIVKLHYAFQTEGKLYLILDFLRGGDLFTRLSKE--VMFTEEDVKFYLAELALALDHLHS 116
Query: 941 RGVVHRDLKPENLLL 955
G+++RDLKPEN+LL
Sbjct: 117 LGIIYRDLKPENILL 131
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylates all known RSK substrates. RSKs act as downstream effectors of mitogen-activated protein kinase (MAPK) and play key roles in mitogen-activated cell growth, differentiation, and survival. Mammals possess four RSK isoforms (RSK1-4) from distinct genes. RSK proteins are also referred to as MAP kinase-activated protein kinases (MAPKAPKs), p90-RSKs, or p90S6Ks. Length = 318 |
| >gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 56.2 bits (136), Expect = 2e-08
Identities = 25/76 (32%), Positives = 42/76 (55%), Gaps = 4/76 (5%)
Query: 890 RYNVHTYLVLELLKGGELLDRIRQKGRCGFTENEASRIMRQLVAAVHFMHSRGVVHRDLK 949
R+ YLV E + L ++ + + G E+ + QL+ + F HS G++HRDLK
Sbjct: 68 RHKGDLYLVFEFMD--TDLYKLIKDRQRGLPESLIKSYLYQLLQGLAFCHSHGILHRDLK 125
Query: 950 PENLLLSGISGNLIKI 965
PENLL++ ++K+
Sbjct: 126 PENLLINTEG--VLKL 139
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283 |
| >gnl|CDD|173665 cd05574, STKc_phototropin_like, Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 56.9 bits (138), Expect = 2e-08
Identities = 25/63 (39%), Positives = 39/63 (61%), Gaps = 2/63 (3%)
Query: 894 HTYLVLELLKGGELLD-RIRQKGRCGFTENEASRIMRQLVAAVHFMHSRGVVHRDLKPEN 952
+ LV++ GGEL RQ G+C +E A +++ A+ ++H G+V+RDLKPEN
Sbjct: 75 YLCLVMDYCPGGELFRLLQRQPGKC-LSEEVARFYAAEVLLALEYLHLLGIVYRDLKPEN 133
Query: 953 LLL 955
+LL
Sbjct: 134 ILL 136
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-terminal photosensory domain and a C-terminal catalytic domain. The N-terminal domain contains two LOV (Light, Oxygen or Voltage) domains that binds FMN. Photoexcitation of the LOV domains results in autophosphorylation at multiple sites and activation of the catalytic domain. Neurospora crassa nrc-2 plays a role in growth and development by controlling entry into the conidiation program. Length = 316 |
| >gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Score = 56.4 bits (137), Expect = 2e-08
Identities = 26/78 (33%), Positives = 43/78 (55%), Gaps = 13/78 (16%)
Query: 896 YLVLELLKGGELLDRIRQKGRCGFTENEASRIMRQLVAAVHFMHS-RGVVHRDLKPENLL 954
+VLE + GG L D +++ G E + I RQ++ + ++H+ R ++HRD+KP NLL
Sbjct: 75 SIVLEYMDGGSLADLLKKVG--KIPEPVLAYIARQILKGLDYLHTKRHIIHRDIKPSNLL 132
Query: 955 LS----------GISGNL 962
++ GIS L
Sbjct: 133 INSKGEVKIADFGISKVL 150
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264 |
| >gnl|CDD|173616 PTZ00426, PTZ00426, cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 56.5 bits (136), Expect = 2e-08
Identities = 28/81 (34%), Positives = 42/81 (51%)
Query: 263 YRRILKTEPPIPEDLSPDVADFISRLLVKDPRRRLGGGELDAEELKRHPFFNVIDWDDLA 322
Y++IL+ P+ L + + +LL D +R G + A+ +K HP+F IDW L
Sbjct: 237 YQKILEGIIYFPKFLDNNCKHLMKKLLSHDLTKRYGNLKKGAQNVKEHPWFGNIDWVSLL 296
Query: 323 TKRIPAPFVPKISNELDVSNF 343
K + P+ PK N D SNF
Sbjct: 297 HKNVEVPYKPKYKNVFDSSNF 317
|
Length = 340 |
| >gnl|CDD|88524 cd05623, STKc_MRCK_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Score = 57.0 bits (137), Expect = 2e-08
Identities = 35/117 (29%), Positives = 58/117 (49%), Gaps = 9/117 (7%)
Query: 231 GIECVFFSSSLIIFFIILS----FTLSFIHDYYHIQYRRILKTEPPIPEDLSPDVADFIS 286
G EC ++S + ++ ++ + S + Y I + P D+S D D I
Sbjct: 186 GPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKERFQFPAQVTDVSEDAKDLIR 245
Query: 287 RLLVKDPRRRLGGGELDAEELKRHPFFNVIDWDDLATKRIPAPFVPKISNELDVSNF 343
RL+ R G+ E+ K+HPFF IDWD++ + AP++P++S+ D SNF
Sbjct: 246 RLICSREHRL---GQNGIEDFKQHPFFTGIDWDNI--RNCEAPYIPEVSSPTDTSNF 297
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathway. Length = 332 |
| >gnl|CDD|173715 cd05626, STKc_LATS2, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Score = 56.9 bits (137), Expect = 2e-08
Identities = 31/83 (37%), Positives = 46/83 (55%), Gaps = 6/83 (7%)
Query: 261 IQYRRILKTEPPIPEDLSPDVADFISRLLVKDPRRRLGGGELDAEELKRHPFFNVIDWDD 320
I + L P + LSP+ D I++L RLG A+++K HPFF+ +D+
Sbjct: 261 INWENTLHIPPQV--KLSPEAVDLITKLCCS-AEERLGRN--GADDIKAHPFFSEVDFSS 315
Query: 321 LATKRIPAPFVPKISNELDVSNF 343
+ PAP+VPKIS+ +D SNF
Sbjct: 316 -DIRTQPAPYVPKISHPMDTSNF 337
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with poor prognosis in acute lymphoblastic leukemia and breast cancer. Length = 381 |
| >gnl|CDD|173502 PTZ00266, PTZ00266, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 58.6 bits (141), Expect = 2e-08
Identities = 67/257 (26%), Positives = 111/257 (43%), Gaps = 60/257 (23%)
Query: 420 EINLLRACQGHPNIVNLHCVFQDEVHT--YLVLELLKGGELLDRIRQ--KGRCGFTENEA 475
E+N++R + H NIV F ++ + Y+++E G+L I++ K E+
Sbjct: 62 EVNVMRELK-HKNIVRYIDRFLNKANQKLYILMEFCDAGDLSRNIQKCYKMFGKIEEHAI 120
Query: 476 SRIMRQLVAAVHFMHS-------RGVVHRDLKPENLLFSD---------PAGDNI----- 514
I RQL+ A+ + H+ V+HRDLKP+N+ S +N+
Sbjct: 121 VDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKITAQANNLNGRPI 180
Query: 515 -KVVDFGFA-CLKRESLHTPCF-TLQYAAPEVLRQDKSGYDENCDLWSLGVILVNVLRQD 571
K+ DFG + + ES+ C T Y +PE+L L +
Sbjct: 181 AKIGDFGLSKNIGIESMAHSCVGTPYYWSPELL-----------------------LHET 217
Query: 572 KSGYDENCDLWSLGVILYTMLCGRVPFHARSRDDSALSIMARIKEGQFNFDAEAWSTVSS 631
KS YD+ D+W+LG I+Y + G+ PFH + +S + R + S
Sbjct: 218 KS-YDDKSDMWALGCIIYELCSGKTPFHKANNFSQLISELKRGPDLPIKGK-------SK 269
Query: 632 EAKELTKSLLTVNPAQR 648
E L K+LL ++ +R
Sbjct: 270 ELNILIKNLLNLSAKER 286
|
Length = 1021 |
| >gnl|CDD|240159 cd05120, APH_ChoK_like, Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family | Back alignment and domain information |
|---|
Score = 53.9 bits (130), Expect = 2e-08
Identities = 28/132 (21%), Positives = 55/132 (41%), Gaps = 18/132 (13%)
Query: 400 KSTGQEYAVKIIS---RKIDCSEEINLLRACQGHPNIV-NLHCVFQDEVHTYLVLELLKG 455
+ ++Y +KI + D E+ +L+ V + + + +YL++E ++G
Sbjct: 18 GTKDEDYVLKINPSREKGADREREVAILQLLARKGLPVPKVLASGESDGWSYLLMEWIEG 77
Query: 456 GELLDRIRQKGRCGFTENEASRIMRQLVAAVHFMHS---RGVVHRDLKPENLLFSDPAGD 512
L + +E E I QL + +H + H DL P N+L D G
Sbjct: 78 ETLDEV---------SEEEKEDIAEQLAELLAKLHQLPLLVLCHGDLHPGNILVDD--GK 126
Query: 513 NIKVVDFGFACL 524
+ ++D+ +A
Sbjct: 127 ILGIIDWEYAGY 138
|
The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves as precursors to the synthesis of important biological compounds, such as the major phospholipids, phosphatidylcholine and phosphatidylethanolamine and the amino acids, threonine, methionine, and isoleucine. Length = 155 |
| >gnl|CDD|173697 cd05606, STKc_beta_ARK, Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Score = 55.7 bits (134), Expect = 3e-08
Identities = 24/69 (34%), Positives = 37/69 (53%)
Query: 264 RRILKTEPPIPEDLSPDVADFISRLLVKDPRRRLGGGELDAEELKRHPFFNVIDWDDLAT 323
R L +P+ SP++ + LL +D RRLG A+E+K HPFF +DW +
Sbjct: 209 RMTLTMAVELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKEHPFFRSLDWQMVFL 268
Query: 324 KRIPAPFVP 332
++ P P +P
Sbjct: 269 QKYPPPLIP 277
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is composed of GRK2, GRK3, and similar proteins. GRK2 and GRK3 are both widely expressed in many tissues, although GRK2 is present at higher levels. They contain an N-terminal RGS homology (RH) domain, a central catalytic domain, and C-terminal pleckstrin homology (PH) domain that mediates PIP2 and G protein betagamma-subunit translocation to the membrane. GRK2 (also called beta-ARK or beta-ARK1) is important in regulating several cardiac receptor responses. It plays a role in cardiac development and in hypertension. Deletion of GRK2 in mice results in embryonic lethality, caused by hypoplasia of the ventricular myocardium. GRK2 also plays important roles in the liver (as a regulator of portal blood pressure), in immune cells, and in the nervous system. Altered GRK2 expression has been reported in several disorders including major depression, schizophrenia, bipolar disorder, and Parkinsonism. Length = 278 |
| >gnl|CDD|173748 cd07853, STKc_NLK, Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Score = 56.3 bits (136), Expect = 3e-08
Identities = 33/92 (35%), Positives = 51/92 (55%), Gaps = 7/92 (7%)
Query: 481 QLVAAVHFMHSRGVVHRDLKPENLLFSDPAGDNIKVVDFGFACLK--RESLHTP--CFTL 536
Q++ + ++HS G++HRD+KP NLL + +K+ DFG A ++ ES H T
Sbjct: 111 QILRGLKYLHSAGILHRDIKPGNLLVNSNC--VLKICDFGLARVEEPDESKHMTQEVVTQ 168
Query: 537 QYAAPEVLRQDKSGYDENCDLWSLGVILVNVL 568
Y APE+L + Y D+WS+G I +L
Sbjct: 169 YYRAPEILMGSRH-YTSAVDIWSVGCIFAELL 199
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription factors from the TCF/LEF family, inhibiting their ability to activate the transcription of target genes. In prostate cancer cells, NLK is involved in regulating androgen receptor-mediated transcription and its expression is altered during cancer progression. Length = 372 |
| >gnl|CDD|215638 PLN03225, PLN03225, Serine/threonine-protein kinase SNT7; Provisional | Back alignment and domain information |
|---|
Score = 57.1 bits (138), Expect = 3e-08
Identities = 39/114 (34%), Positives = 60/114 (52%), Gaps = 28/114 (24%)
Query: 440 FQDEVHTYLVLE---LLKGGELLDRIRQKGRCGFTENEASRIMRQLVAAVHFMHSRGVVH 496
F V YL+ + L KG E ++I Q IMRQ++ A+ +HS G+VH
Sbjct: 231 FPYNVEPYLLGKVQDLPKGLERENKIIQ------------TIMRQILFALDGLHSTGIVH 278
Query: 497 RDLKPENLLFSDPAGDNIKVVD--------FGFACLKRESLHTPCFTLQYAAPE 542
RD+KP+N++FS+ +G + K++D G + +E L P +YAAPE
Sbjct: 279 RDVKPQNIIFSEGSG-SFKIIDLGAAADLRVGINYIPKEFLLDP----RYAAPE 327
|
Length = 566 |
| >gnl|CDD|173692 cd05601, STKc_CRIK, Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Score = 56.0 bits (135), Expect = 4e-08
Identities = 27/63 (42%), Positives = 41/63 (65%), Gaps = 3/63 (4%)
Query: 894 HTYLVLELLKGGELLDRI-RQKGRCGFTENEASRIMRQLVAAVHFMHSRGVVHRDLKPEN 952
+ YLV+E GG+LL + R + + F E+ A + +LV A+H +H G VHRD+KPEN
Sbjct: 75 NLYLVMEYQPGGDLLSLLNRYEDQ--FDEDMAQFYLAELVLAIHSVHQMGYVHRDIKPEN 132
Query: 953 LLL 955
+L+
Sbjct: 133 VLI 135
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnormal cytokinesis and massive apoptosis in neuronal precursors. A Down syndrome critical region protein TTC3 interacts with CRIK and inhibits CRIK-dependent neuronal differentiation and neurite extension. Length = 330 |
| >gnl|CDD|173770 cd08528, STKc_Nek10, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Score = 55.6 bits (134), Expect = 4e-08
Identities = 32/94 (34%), Positives = 54/94 (57%), Gaps = 9/94 (9%)
Query: 866 VTLFEEQLLGPITRARRRTFVNRSRYNVHTYLVLELLKG---GELLDRIRQKGRCGFTEN 922
VT+ +EQL P +TF+ R Y+V++L++G GE + +++K + FTE
Sbjct: 59 VTIIKEQLRHPNIVRYYKTFLENDRL----YIVMDLIEGAPLGEHFNSLKEKKQ-RFTEE 113
Query: 923 EASRIMRQLVAAVHFMH-SRGVVHRDLKPENLLL 955
I Q+V A+ ++H + +VHRDL P N++L
Sbjct: 114 RIWNIFVQMVLALRYLHKEKRIVHRDLTPNNIML 147
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. Length = 269 |
| >gnl|CDD|173747 cd07852, STKc_MAPK15, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Score = 56.0 bits (136), Expect = 4e-08
Identities = 17/30 (56%), Positives = 24/30 (80%)
Query: 927 IMRQLVAAVHFMHSRGVVHRDLKPENLLLS 956
IM QL+ A+ ++HS V+HRDLKP N+LL+
Sbjct: 112 IMYQLLKALKYIHSGNVIHRDLKPSNILLN 141
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimuli whereas ERK8 shows low basal activity and is activated by DNA-damaging agents. ERK7 and ERK8 also have different substrate profiles. Genome analysis shows that they are orthologs with similar gene structures. ERK7 and ERK 8 may be involved in the signaling of some nuclear receptor transcription factors. ERK7 regulates hormone-dependent degradation of estrogen receptor alpha while ERK8 down-regulates the transcriptional co-activation androgen and glucocorticoid receptors. Length = 337 |
| >gnl|CDD|133220 cd05089, PTKc_Tie1, Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Score = 55.8 bits (134), Expect = 4e-08
Identities = 56/216 (25%), Positives = 93/216 (43%), Gaps = 40/216 (18%)
Query: 379 DLDKAGILGDGSYSVCRRCVEKSTGQEYAVKIISRKIDCSE--------EINLLRACQGH 430
D+ ++G+G++ R + K G + I K SE E+ +L H
Sbjct: 3 DIKFEDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGHH 62
Query: 431 PNIVNLHCVFQDEVHTYLVLELLKGGELLDRIRQKGRC-----------GFTENEASRIM 479
PNI+NL ++ + Y+ +E G LLD +R K R G S+ +
Sbjct: 63 PNIINLLGACENRGYLYIAIEYAPYGNLLDFLR-KSRVLETDPAFAKEHGTASTLTSQQL 121
Query: 480 RQLVAAV----HFMHSRGVVHRDLKPENLLFSDPAGDNI--KVVDFGFA-----CLKRES 528
Q + V ++ + +HRDL N+L G+N+ K+ DFG + +K+
Sbjct: 122 LQFASDVATGMQYLSEKQFIHRDLAARNVL----VGENLASKIADFGLSRGEEVYVKKTM 177
Query: 529 LHTPCFTLQYAAPEVLRQDKSGYDENCDLWSLGVIL 564
P +++ A E L + S Y D+WS GV+L
Sbjct: 178 GRLP---VRWMAIESL--NYSVYTTKSDVWSFGVLL 208
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. In vivo studies of Tie1 show that it is critical in vascular development. Length = 297 |
| >gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 54.8 bits (132), Expect = 5e-08
Identities = 27/59 (45%), Positives = 34/59 (57%), Gaps = 3/59 (5%)
Query: 261 IQYRRILKTEPPIPEDLSPDVADFISRLLVKDPRRRLGGGELDAEELKRHPFFNVIDWD 319
I RRI E + E SP+ D I+RLL DP +RLG +E+K HPFF I+WD
Sbjct: 205 ILSRRINWPEE-VKEFCSPEAVDLINRLLCMDPAKRLGAN--GYQEIKSHPFFKSINWD 260
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260 |
| >gnl|CDD|173674 cd05583, STKc_MSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Score = 55.2 bits (133), Expect = 5e-08
Identities = 31/95 (32%), Positives = 50/95 (52%), Gaps = 9/95 (9%)
Query: 867 TLFEEQLLGPITRARRRTFVNRSRYNVHT----YLVLELLKGGELLDRIRQKGRCGFTEN 922
T E Q+L RR F+ Y T +L+L+ + GGEL + Q+ FTE+
Sbjct: 51 TRTERQVL---EAVRRCPFLVTLHYAFQTDTKLHLILDYVNGGELFTHLYQREH--FTES 105
Query: 923 EASRIMRQLVAAVHFMHSRGVVHRDLKPENLLLSG 957
E + ++V A+ +H G+++RD+K EN+LL
Sbjct: 106 EVRVYIAEIVLALDHLHQLGIIYRDIKLENILLDS 140
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines. This triggers phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) in the C-terminal extension of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSKs are predominantly nuclear proteins. They are widely expressed in many tissues including heart, brain, lung, liver, kidney, and pancreas. There are two isoforms of MSK, called MSK1 and MSK2. Length = 288 |
| >gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 54.9 bits (133), Expect = 5e-08
Identities = 22/81 (27%), Positives = 40/81 (49%), Gaps = 13/81 (16%)
Query: 892 NVHTYLVLELLKGGELLDRIRQKGRCGFTENEASRIMRQLVAAVHFMHSRGVVHRDLKPE 951
++++E GG LD ++ E + I+R+++ + ++H G +HRD+K
Sbjct: 71 GSKLWIIMEYCGGGSCLDLLK---PGKLDETYIAFILREVLLGLEYLHEEGKIHRDIKAA 127
Query: 952 NLLLS----------GISGNL 962
N+LLS G+SG L
Sbjct: 128 NILLSEEGDVKLADFGVSGQL 148
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274 |
| >gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Score = 54.9 bits (133), Expect = 7e-08
Identities = 30/99 (30%), Positives = 44/99 (44%), Gaps = 32/99 (32%)
Query: 123 ILGDGSYSVCRRCVEKSTGQEYAVKIISRKIDCSEEINLLRACQGHPNICRRCVEKSTGQ 182
I+G+GS+S EK T +EYA+KI+ ++ L++ EK +
Sbjct: 8 IIGEGSFSTVVLAKEKETNKEYAIKILDKR-------QLIK-------------EK---K 44
Query: 183 EYAVKIISRKIDCSEEINLLRACQGHPNIVNLHCVFQDE 221
VKI E +L GHP I+ L+ FQDE
Sbjct: 45 VKYVKI---------EKEVLTRLNGHPGIIKLYYTFQDE 74
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280 |
| >gnl|CDD|173683 cd05592, STKc_nPKC_theta_delta, Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Score = 54.8 bits (132), Expect = 7e-08
Identities = 23/62 (37%), Positives = 39/62 (62%), Gaps = 2/62 (3%)
Query: 894 HTYLVLELLKGGELLDRIRQKGRCGFTENEASRIMRQLVAAVHFMHSRGVVHRDLKPENL 953
H + V+E L GG+L+ I+ GR F E A +++ + F+H +G+++RDLK +N+
Sbjct: 70 HLFFVMEYLNGGDLMFHIQSSGR--FDEARARFYAAEIICGLQFLHKKGIIYRDLKLDNV 127
Query: 954 LL 955
LL
Sbjct: 128 LL 129
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. Length = 316 |
| >gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Score = 54.8 bits (132), Expect = 7e-08
Identities = 25/59 (42%), Positives = 35/59 (59%)
Query: 897 LVLELLKGGELLDRIRQKGRCGFTENEASRIMRQLVAAVHFMHSRGVVHRDLKPENLLL 955
LV+ L+ GG+L I G GF E A Q++ + +H R +V+RDLKPEN+LL
Sbjct: 70 LVMTLMNGGDLKYHIYNVGEPGFPEARAIFYAAQIICGLEHLHQRRIVYRDLKPENVLL 128
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of G protein signaling) homology (RH) domain and several motifs. The C-terminus diverges among different groups of GRKs. There are seven types of GRKs, named GRK1 to GRK7. They are subdivided into three main groups: visual (GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is widespread while GRK1/4/7 show a limited tissue distribution. The substrate spectrum of the widely expressed GRKs partially overlaps. GRKs play important roles in the cardiovascular, immune, respiratory, skeletal, and nervous systems. Length = 277 |
| >gnl|CDD|132981 cd06650, PKc_MEK1, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Score = 55.0 bits (132), Expect = 7e-08
Identities = 56/232 (24%), Positives = 97/232 (41%), Gaps = 39/232 (16%)
Query: 374 EQYDMDLDKAGILGDGSYSVCRRCVEKSTGQEYAVKIISRKIDCS------EEINLLRAC 427
E D D +K LG G+ V + K +G A K+I +I + E+ +L C
Sbjct: 1 ELKDDDFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHEC 60
Query: 428 QGHPNIVNLHCVFQDEVHTYLVLELLKGGELLDRIRQKGRCGFTENEASRIMRQLVAAVH 487
P IV + F + + +E + GG L +++ GR E ++ ++ +
Sbjct: 61 NS-PYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGR--IPEQILGKVSIAVIKGLT 117
Query: 488 FMHSR-GVVHRDLKPENLLFSDPAGDNIKVVDFGFACLKRESL-HTPCFTLQYAAPEVLR 545
++ + ++HRD+KP N+L + IK+ DFG + +S+ ++ T Y +PE
Sbjct: 118 YLREKHKIMHRDVKPSNILVNSRG--EIKLCDFGVSGQLIDSMANSFVGTRSYMSPE--- 172
Query: 546 QDKSGYDENCDLWSLGVILVNVLRQDKSGYDENCDLWSLGVILYTMLCGRVP 597
R + Y D+WS+G+ L M GR P
Sbjct: 173 -----------------------RLQGTHYSVQSDIWSMGLSLVEMAIGRYP 201
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. MEK1 also plays a role in cell cycle control. Length = 333 |
| >gnl|CDD|133201 cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Score = 54.2 bits (130), Expect = 8e-08
Identities = 41/163 (25%), Positives = 77/163 (47%), Gaps = 14/163 (8%)
Query: 419 EEINLLRACQGHPNIVNLHCVFQDEVHTYLVLELLKGGELLDRIRQKGRCGFTENEASRI 478
EE +++ + H +V L+ V +E Y+V E + G LLD ++ +
Sbjct: 50 EEAQIMKKLR-HDKLVQLYAVVSEE-PIYIVTEYMSKGSLLDFLKDGEGRALKLPNLVDM 107
Query: 479 MRQLVAAVHFMHSRGVVHRDLKPENLLFSDPAGDNI--KVVDFGFACLKRESLHT----P 532
Q+ A + ++ +HRDL+ N+L GD + K+ DFG A L ++ +T
Sbjct: 108 AAQVAAGMAYIERMNYIHRDLRSANIL----VGDGLVCKIADFGLARLIEDNEYTARQGA 163
Query: 533 CFTLQYAAPEVLRQDKSGYDENCDLWSLGVILVNVLRQDKSGY 575
F +++ APE + + D+WS G++L ++ + + Y
Sbjct: 164 KFPIKWTAPEAALYGR--FTIKSDVWSFGILLTELVTKGRVPY 204
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Fyn, together with Lck, plays a critical role in T-cell signal transduction by phosphorylating ITAM (immunoreceptor tyr activation motif) sequences on T-cell receptors, ultimately leading to the proliferation and differentiation of T-cells. In addition, Fyn is involved in the myelination of neurons, and is implicated in Alzheimer's and Parkinson's diseases. Yrk has been detected only in chickens. It is primarily found in neuronal and epithelial cells and in macrophages. It may play a role in inflammation and in response to injury. Length = 260 |
| >gnl|CDD|133200 cd05069, PTKc_Yes, Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Score = 54.3 bits (130), Expect = 8e-08
Identities = 40/163 (24%), Positives = 79/163 (48%), Gaps = 14/163 (8%)
Query: 419 EEINLLRACQGHPNIVNLHCVFQDEVHTYLVLELLKGGELLDRIRQKGRCGFTENEASRI 478
+E +++ + H +V L+ V +E Y+V E + G LLD +++ + +
Sbjct: 50 QEAQIMKKLR-HDKLVPLYAVVSEE-PIYIVTEFMGKGSLLDFLKEGDGKYLKLPQLVDM 107
Query: 479 MRQLVAAVHFMHSRGVVHRDLKPENLLFSDPAGDNI--KVVDFGFACLKRESLHT----P 532
Q+ + ++ +HRDL+ N+L GDN+ K+ DFG A L ++ +T
Sbjct: 108 AAQIADGMAYIERMNYIHRDLRAANIL----VGDNLVCKIADFGLARLIEDNEYTARQGA 163
Query: 533 CFTLQYAAPEVLRQDKSGYDENCDLWSLGVILVNVLRQDKSGY 575
F +++ APE + + D+WS G++L ++ + + Y
Sbjct: 164 KFPIKWTAPEAALYGR--FTIKSDVWSFGILLTELVTKGRVPY 204
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. c-Yes kinase is the cellular homolog of the oncogenic protein (v-Yes) encoded by the Yamaguchi 73 and Esh sarcoma viruses. It displays functional overlap with other Src subfamily members, particularly Src. It also shows some unique functions such as binding to occludins, transmembrane proteins that regulate extracellular interactions in tight junctions. Yes also associates with a number of proteins in different cell types that Src does not interact with, like JAK2 and gp130 in pre-adipocytes, and Pyk2 in treated pulmonary vein endothelial cells. Although the biological function of Yes remains unclear, it appears to have a role in regulating cell-cell interactions and vesicle trafficking in polarized cells. Length = 260 |
| >gnl|CDD|173690 cd05599, STKc_NDR_like, Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 55.1 bits (133), Expect = 9e-08
Identities = 23/60 (38%), Positives = 38/60 (63%), Gaps = 2/60 (3%)
Query: 896 YLVLELLKGGELLDRIRQKGRCGFTENEASRIMRQLVAAVHFMHSRGVVHRDLKPENLLL 955
YL++E L GG+++ + +K FTE E + + + A+ +H G +HRD+KP+NLLL
Sbjct: 77 YLIMEYLPGGDMMTLLMKKDT--FTEEETRFYIAETILAIDSIHKLGYIHRDIKPDNLLL 134
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplication. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. This subfamily also contains fungal NDR-like kinases. Length = 364 |
| >gnl|CDD|173721 cd05632, STKc_GRK5, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Score = 54.6 bits (131), Expect = 9e-08
Identities = 28/69 (40%), Positives = 38/69 (55%)
Query: 264 RRILKTEPPIPEDLSPDVADFISRLLVKDPRRRLGGGELDAEELKRHPFFNVIDWDDLAT 323
RR+L+TE S + LL KDP++RLG E A E+KRHPFF +++ L
Sbjct: 215 RRVLETEEVYSAKFSEEAKSICKMLLTKDPKQRLGCQEEGAGEVKRHPFFRNMNFKRLEA 274
Query: 324 KRIPAPFVP 332
+ PFVP
Sbjct: 275 GMLDPPFVP 283
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with the membrane though an N-terminal PIP2 binding domain and also binds phospholipids via its C-terminus. GRK5 deficiency is associated with early Alzheimer's disease in humans and mouse models. GRK5 also plays a crucial role in the pathogenesis of sporadic Parkinson's disease. It participates in the regulation and desensitization of PDGFRbeta, a receptor tyrosine kinase involved in a variety of downstream cellular effects including cell growth, chemotaxis, apoptosis, and angiogenesis. GRK5 also regulates Toll-like receptor 4, which is involved in innate and adaptive immunity. Length = 285 |
| >gnl|CDD|132946 cd06615, PKc_MEK, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Score = 54.7 bits (132), Expect = 9e-08
Identities = 58/227 (25%), Positives = 99/227 (43%), Gaps = 39/227 (17%)
Query: 379 DLDKAGILGDGSYSVCRRCVEKSTGQEYAVKIISRKIDCS------EEINLLRACQGHPN 432
D +K G LG G+ V + + + +G A K+I +I + E+ +L C P
Sbjct: 2 DFEKLGELGAGNGGVVTKVLHRPSGLIMARKLIHLEIKPAIRNQIIRELKVLHECNS-PY 60
Query: 433 IVNLHCVFQDEVHTYLVLELLKGGELLDRIRQKGRCGFTENEASRIMRQLVAAVHFMHS- 491
IV + F + + +E + GG L +++ GR EN +I ++ + ++
Sbjct: 61 IVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGR--IPENILGKISIAVLRGLTYLREK 118
Query: 492 RGVVHRDLKPENLLFSDPAGDNIKVVDFGFACLKRESL-HTPCFTLQYAAPEVLRQDKSG 550
++HRD+KP N+L + G+ IK+ DFG + +S+ ++ T Y +PE
Sbjct: 119 HKIMHRDVKPSNILVNS-RGE-IKLCDFGVSGQLIDSMANSFVGTRSYMSPE-------- 168
Query: 551 YDENCDLWSLGVILVNVLRQDKSGYDENCDLWSLGVILYTMLCGRVP 597
R + Y D+WSLG+ L M GR P
Sbjct: 169 ------------------RLQGTHYTVQSDIWSLGLSLVEMAIGRYP 197
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the downstream targets, ERK(extracellular signal-regulated kinase) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1/2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. This cascade has also been implicated in synaptic plasticity, migration, morphological determination, and stress response immunological reactions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1/2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 308 |
| >gnl|CDD|173638 cd05065, PTKc_EphR_B, Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Score = 54.1 bits (130), Expect = 9e-08
Identities = 51/204 (25%), Positives = 93/204 (45%), Gaps = 29/204 (14%)
Query: 385 ILGDGSY-SVCRRCVEKSTGQEYAVKIISRKIDCSE--------EINLLRACQGHPNIVN 435
++G G + VCR ++ +E V I + K +E E +++ HPNI++
Sbjct: 11 VIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFD-HPNIIH 69
Query: 436 LHCVFQDEVHTYLVLELLKGGELLDRIRQK-GRCGFTENEASRIMRQLVAAVHFMHSRGV 494
L V ++ E ++ G L +RQ G+ FT + ++R + A + ++
Sbjct: 70 LEGVVTKSRPVMIITEFMENGALDSFLRQNDGQ--FTVIQLVGMLRGIAAGMKYLSEMNY 127
Query: 495 VHRDLKPENLLFSDPAGDNI--KVVDFGFACLKRESLHTPCFT--------LQYAAPEVL 544
VHRDL N+L + N+ KV DFG + + P +T +++ APE +
Sbjct: 128 VHRDLAARNILVN----SNLVCKVSDFGLSRFLEDDTSDPTYTSSLGGKIPIRWTAPEAI 183
Query: 545 RQDKSGYDENCDLWSLGVILVNVL 568
K + D+WS G+++ V+
Sbjct: 184 AYRK--FTSASDVWSYGIVMWEVM 205
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion. EphBRs play important roles in synapse formation and plasticity, spine morphogenesis, axon guidance, and angiogenesis. In the intestinal epithelium, EphBRs are Wnt signaling target genes that control cell compartmentalization. They function as suppressors of color cancer progression. Length = 269 |
| >gnl|CDD|173661 cd05570, STKc_PKC, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Score = 54.3 bits (131), Expect = 1e-07
Identities = 23/64 (35%), Positives = 39/64 (60%), Gaps = 2/64 (3%)
Query: 894 HTYLVLELLKGGELLDRIRQKGRCGFTENEASRIMRQLVAAVHFMHSRGVVHRDLKPENL 953
+ V+E + GG+L+ I++ GR F E A ++V + F+H RG+++RDLK +N+
Sbjct: 70 RLFFVMEYVNGGDLMFHIQRSGR--FDEPRARFYAAEIVLGLQFLHERGIIYRDLKLDNV 127
Query: 954 LLSG 957
LL
Sbjct: 128 LLDS 131
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only require PS. PKCs phosphorylate and modify the activities of a wide variety of cellular proteins including receptors, enzymes, cytoskeletal proteins, transcription factors, and other kinases. They play a central role in signal transduction pathways that regulate cell migration and polarity, proliferation, differentiation, and apoptosis. Also included in this subfamily are the PKC-like proteins, called PKNs. Length = 318 |
| >gnl|CDD|173739 cd07838, STKc_CDK4_6_like, Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 53.8 bits (130), Expect = 1e-07
Identities = 21/48 (43%), Positives = 30/48 (62%), Gaps = 2/48 (4%)
Query: 918 GFTENEASRIMRQLVAAVHFMHSRGVVHRDLKPENLLLSGISGNLIKI 965
G +MRQL+ V F+HS +VHRDLKP+N+L++ S +KI
Sbjct: 103 GLPPETIKDLMRQLLRGVDFLHSHRIVHRDLKPQNILVT--SDGQVKI 148
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both expressed ubiquitously, associate with all three D cyclins (D1, D2 and D3), and phosphorylate the retinoblastoma (pRb) protein. They are also regulated by the INK4 family of inhibitors which associate with either the CDK alone or the CDK/cyclin complex. CDK4 and CDK6 show differences in subcellular localization, sensitivity to some inhibitors, timing in activation, tumor selectivity, and possibly substrate profiles. Although CDK4 and CDK6 seem to show some redundancy, they also have discrete, nonoverlapping functions. CDK6 plays an important role in cell differentiation. Length = 287 |
| >gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Score = 53.7 bits (130), Expect = 1e-07
Identities = 19/70 (27%), Positives = 38/70 (54%), Gaps = 3/70 (4%)
Query: 896 YLVLELLKGGELLDRIRQKGRCGFTENEASRIMRQLVAAVHFMHSRGVVHRDLKPENLLL 955
Y+V+E ++GG+LL +R+ R + ++ Q+ + ++ S+ +HRDL N L+
Sbjct: 77 YIVMEYMEGGDLLSYLRKN-RPKLSLSDLLSFALQIARGMEYLESKNFIHRDLAARNCLV 135
Query: 956 SGISGNLIKI 965
++KI
Sbjct: 136 G--ENLVVKI 143
|
Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257 |
| >gnl|CDD|143342 cd07837, STKc_CdkB_plant, Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Score = 54.4 bits (131), Expect = 1e-07
Identities = 25/72 (34%), Positives = 33/72 (45%), Gaps = 3/72 (4%)
Query: 896 YLVLELLKGG--ELLDRIRQKGRCGFTENEASRIMRQLVAAVHFMHSRGVVHRDLKPENL 953
YLV E L + +D + M QL+ V H GV+HRDLKP+NL
Sbjct: 82 YLVFEYLDSDLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAHCHKHGVMHRDLKPQNL 141
Query: 954 LLSGISGNLIKI 965
L+ L+KI
Sbjct: 142 LVDK-QKGLLKI 152
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developmental pathways, such as stomata and leaf development. CdkB has been shown to associate with both cyclin B, which controls G2/M transition, and cyclin D, which acts as a mediator in linking extracellular signals to the cell cycle. Length = 295 |
| >gnl|CDD|173714 cd05625, STKc_LATS1, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Score = 54.6 bits (131), Expect = 1e-07
Identities = 31/73 (42%), Positives = 44/73 (60%), Gaps = 6/73 (8%)
Query: 272 PIPEDLSPDVADFISRLLVKDPRRRLGGGELDAEELKRHPFFNVIDWD-DLATKRIPAPF 330
P LSP+ +D I +L + P RLG A+E+K HPFF ID+ DL ++ AP+
Sbjct: 270 PPQAKLSPEASDLIIKL-CRGPEDRLGKN--GADEIKAHPFFKTIDFSSDL--RQQSAPY 324
Query: 331 VPKISNELDVSNF 343
+PKI++ D SNF
Sbjct: 325 IPKITHPTDTSNF 337
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype and poor prognosis. LATS1 induces G2 arrest and promotes cytokinesis. It may be a component of the mitotic exit network in higher eukaryotes. Length = 382 |
| >gnl|CDD|132951 cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 54.0 bits (130), Expect = 1e-07
Identities = 57/237 (24%), Positives = 99/237 (41%), Gaps = 39/237 (16%)
Query: 379 DLDKAGILGDGSYSVCRRCVEKSTGQEYAVKIISRKIDCS------EEINLLRACQGHPN 432
DL+ LG G+ + TG A K++ S E+ ++ C+ P
Sbjct: 6 DLETISDLGAGNGGSVSKVKHIPTGTVMAKKVVHIGAKSSVRKQILRELQIMHECRS-PY 64
Query: 433 IVNLHCVFQDEVHTYLVLELLKGGELLDRIRQKGRCGFTENEASRIMRQLVAAVHFMHSR 492
IV+ + F +E + + +E + G L DRI +KG +I +V + ++++
Sbjct: 65 IVSFYGAFLNENNICMCMEFMDCGSL-DRIYKKGG-PIPVEILGKIAVAVVEGLTYLYNV 122
Query: 493 -GVVHRDLKPENLLFSDPAGDNIKVVDFGFACLKRESL-HTPCFTLQYAAPEVLRQDKSG 550
++HRD+KP N+L + + IK+ DFG + S+ T T Y +PE ++ K
Sbjct: 123 HRIMHRDIKPSNILVN--SRGQIKLCDFGVSGELINSIADTFVGTSTYMSPERIQGGK-- 178
Query: 551 YDENCDLWSLGVILVNVLRQDKSGYDENCDLWSLGVILYTMLCGRVPFHARSRDDSA 607
Y D+WSLG+ + + G+ PF + DD
Sbjct: 179 ------------------------YTVKSDVWSLGISIIELALGKFPFAFSNIDDDG 211
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Byr1 from Schizosaccharomyces pombe, FUZ7 from Ustilago maydis, and related proteins. Byr1 phosphorylates its downstream target, the MAPK Spk1, and is regulated by the MAPKKK Byr2. The Spk1 cascade is pheromone-responsive and is essential for sporulation and sexual differentiation in fission yeast. FUZ7 phosphorylates and activates its target, the MAPK Crk1, which is required in mating and virulence in U. maydis. Length = 284 |
| >gnl|CDD|173663 cd05572, STKc_cGK_PKG, Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 53.4 bits (129), Expect = 2e-07
Identities = 19/60 (31%), Positives = 31/60 (51%), Gaps = 2/60 (3%)
Query: 263 YRRILKTEPPI--PEDLSPDVADFISRLLVKDPRRRLGGGELDAEELKRHPFFNVIDWDD 320
Y ILK + P + D I +LL ++P RLG + +++K+H +FN DW+
Sbjct: 203 YNDILKGNGKLEFPNYIDKAAKDLIKQLLRRNPEERLGNLKGGIKDIKKHKWFNGFDWEG 262
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowing autophosphorylation and activation of the kinase. cGKI is a soluble protein expressed in all smooth muscles, platelets, cerebellum, and kidney. It is also expressed at lower concentrations in other tissues. cGKII is a membrane-bound protein that is most abundantly expressed in the intestine. It is also present in the brain nuclei, adrenal cortex, kidney, lung, and prostate. cGKI is involved in the regulation of smooth muscle tone, smooth cell proliferation, and platelet activation. cGKII plays a role in the regulation of secretion, such as renin secretion by the kidney and aldosterone secretion by the adrenal. It also regulates bone growth and the circadian rhythm. Length = 262 |
| >gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Score = 52.9 bits (128), Expect = 2e-07
Identities = 20/55 (36%), Positives = 28/55 (50%), Gaps = 8/55 (14%)
Query: 259 YHIQYRRILKTEPPIPEDLSPDVADFISRLLVKDPRRRLGGGELDAEELKRHPFF 313
Y I P IPE LS + DF+ + L +DP++R A+EL +HPF
Sbjct: 214 YKIGS---SGEPPEIPEHLSEEAKDFLRKCLRRDPKKR-----PTADELLQHPFL 260
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260 |
| >gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Score = 53.1 bits (128), Expect = 2e-07
Identities = 20/61 (32%), Positives = 37/61 (60%), Gaps = 1/61 (1%)
Query: 896 YLVLELLKGGELLDRIRQKGRCG-FTENEASRIMRQLVAAVHFMHSRGVVHRDLKPENLL 954
+LV+ L GG LLD ++ G E + ++++++ + ++HS G +HRD+K N+L
Sbjct: 75 WLVMPYLSGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYLHSNGQIHRDIKAGNIL 134
Query: 955 L 955
L
Sbjct: 135 L 135
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267 |
| >gnl|CDD|173710 cd05620, STKc_nPKC_delta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Score = 53.4 bits (128), Expect = 2e-07
Identities = 24/64 (37%), Positives = 41/64 (64%), Gaps = 2/64 (3%)
Query: 894 HTYLVLELLKGGELLDRIRQKGRCGFTENEASRIMRQLVAAVHFMHSRGVVHRDLKPENL 953
H + V+E L GG+L+ I+ KGR F A+ ++V + F+HS+G+++RDLK +N+
Sbjct: 70 HLFFVMEFLNGGDLMFHIQDKGR--FDLYRATFYAAEIVCGLQFLHSKGIIYRDLKLDNV 127
Query: 954 LLSG 957
+L
Sbjct: 128 MLDR 131
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. It slows down cell proliferation, inducing cell cycle arrest and enhancing cell differentiation. PKC-delta is also involved in the regulation of transcription as well as immune and inflammatory responses. It plays a central role in the genotoxic stress response that leads to DNA damaged-induced apoptosis. Length = 316 |
| >gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 52.9 bits (127), Expect = 2e-07
Identities = 25/85 (29%), Positives = 43/85 (50%), Gaps = 2/85 (2%)
Query: 870 EEQLLGPITRARRRTFVNRSRYNVHTYLVLELLKGGELLDRIRQKGRCGFTENEASRIMR 929
E QLL + R + R + + +E + GG + D+++ G TE + R
Sbjct: 54 EIQLLKNLQHERIVQYYGCLRDDETLSIFMEYMPGGSVKDQLKAYG--ALTETVTRKYTR 111
Query: 930 QLVAAVHFMHSRGVVHRDLKPENLL 954
Q++ V ++HS +VHRD+K N+L
Sbjct: 112 QILEGVEYLHSNMIVHRDIKGANIL 136
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263 |
| >gnl|CDD|173694 cd05603, STKc_SGK2, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Score = 53.8 bits (129), Expect = 2e-07
Identities = 28/78 (35%), Positives = 45/78 (57%), Gaps = 6/78 (7%)
Query: 882 RRTFVNRSRYNVHT----YLVLELLKGGELLDRIRQKGRCGFTENEASRIMRQLVAAVHF 937
+ F+ Y+ T Y VL+ + GGEL + Q+ RC F E A ++ +A+ +
Sbjct: 54 KHPFLVGLHYSFQTAEKLYFVLDYVNGGELFFHL-QRERC-FLEPRARFYAAEVASAIGY 111
Query: 938 MHSRGVVHRDLKPENLLL 955
+HS +++RDLKPEN+LL
Sbjct: 112 LHSLNIIYRDLKPENILL 129
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. Length = 321 |
| >gnl|CDD|173676 cd05585, STKc_YPK1_like, Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 53.4 bits (128), Expect = 2e-07
Identities = 25/60 (41%), Positives = 38/60 (63%), Gaps = 2/60 (3%)
Query: 896 YLVLELLKGGELLDRIRQKGRCGFTENEASRIMRQLVAAVHFMHSRGVVHRDLKPENLLL 955
YLVL + GGEL ++++GR F + A +L+ A+ +H V++RDLKPEN+LL
Sbjct: 69 YLVLAFINGGELFHHLQREGR--FDLSRARFYTAELLCALENLHKFNVIYRDLKPENILL 126
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It plays a role in cell growth and sexual development. Length = 312 |
| >gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase | Back alignment and domain information |
|---|
Score = 53.3 bits (129), Expect = 2e-07
Identities = 22/70 (31%), Positives = 39/70 (55%), Gaps = 3/70 (4%)
Query: 896 YLVLELLKGGELLDRIRQKGRCGFTENEASRIMRQLVAAVHFMHSRGVVHRDLKPENLLL 955
Y+V E + GG+LLD +R+ G T + ++ Q+ + ++ S+ VHRDL N L+
Sbjct: 77 YIVTEYMPGGDLLDFLRKHGEK-LTLKDLLQMALQIAKGMEYLESKNFVHRDLAARNCLV 135
Query: 956 SGISGNLIKI 965
+ ++KI
Sbjct: 136 T--ENLVVKI 143
|
Length = 258 |
| >gnl|CDD|173762 cd08222, STKc_Nek11, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Score = 53.4 bits (128), Expect = 2e-07
Identities = 40/134 (29%), Positives = 63/134 (47%), Gaps = 14/134 (10%)
Query: 839 KKKKADRQPAKQEEKQ-PVPQTTPPTDLVTLFEEQLLG----PITRARRRTFVNRSRYNV 893
K KKA + + K+ PV + P + E QLL P +F+ R + +
Sbjct: 20 KDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAIVKFHASFLERDAFCI 79
Query: 894 HTYLVLELLKGGELLDRIRQKGRCG--FTENEASRIMRQLVAAVHFMHSRGVVHRDLKPE 951
T E +G +L ++ + G +EN+ QL+ VH+MH R ++HRDLK +
Sbjct: 80 IT----EYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMHQRRILHRDLKAK 135
Query: 952 NLLLSGISGNLIKI 965
N+ L NL+KI
Sbjct: 136 NIFL---KNNLLKI 146
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M checkpoint. Nek11 may also play a role in the S-phase checkpoint as well as in DNA replication and genotoxic stress responses. Length = 260 |
| >gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 52.8 bits (127), Expect = 2e-07
Identities = 20/45 (44%), Positives = 24/45 (53%), Gaps = 5/45 (11%)
Query: 268 KTEPPIPEDLSPDVADFISRLLVKDPRRRLGGGELDAEELKRHPF 312
K PPIP+ LS + DFI + L +DP R A EL HPF
Sbjct: 218 KELPPIPDHLSDEAKDFILKCLQRDPSLR-----PTAAELLEHPF 257
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258 |
| >gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Score = 54.5 bits (131), Expect = 2e-07
Identities = 30/84 (35%), Positives = 46/84 (54%), Gaps = 10/84 (11%)
Query: 263 YRRILKTEPPIP---EDLSPDVADFISRLLVKDPRRRLGGGELDAEELKRHPFFNVIDWD 319
++ IL + P P E LS + + I LL DP +R G +ELK+HP F+ +DW+
Sbjct: 589 FQNILNRDIPWPEGEEKLSVNAQNAIEILLTMDPTKRAG-----LKELKQHPLFHGVDWE 643
Query: 320 DLATKRIPAPFVPKISNELDVSNF 343
+L + PF+P+ +E D S F
Sbjct: 644 NLQNQ--TMPFIPQPDDETDTSYF 665
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669 |
| >gnl|CDD|215638 PLN03225, PLN03225, Serine/threonine-protein kinase SNT7; Provisional | Back alignment and domain information |
|---|
Score = 54.8 bits (132), Expect = 2e-07
Identities = 29/73 (39%), Positives = 42/73 (57%), Gaps = 15/73 (20%)
Query: 891 YNVHTYLVLE---LLKGGELLDRIRQKGRCGFTENEASRIMRQLVAAVHFMHSRGVVHRD 947
YNV YL+ + L KG E ++I Q IMRQ++ A+ +HS G+VHRD
Sbjct: 233 YNVEPYLLGKVQDLPKGLERENKIIQ------------TIMRQILFALDGLHSTGIVHRD 280
Query: 948 LKPENLLLSGISG 960
+KP+N++ S SG
Sbjct: 281 VKPQNIIFSEGSG 293
|
Length = 566 |
| >gnl|CDD|173766 cd08226, PK_STRAD_beta, Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Score = 54.2 bits (130), Expect = 2e-07
Identities = 41/178 (23%), Positives = 81/178 (45%), Gaps = 20/178 (11%)
Query: 402 TGQEYAVKIISRKIDCSEEINLLRACQG---------HPNIVNLHCVFQDEVHTYLVLEL 452
TG V+I + +C+EE L+A Q HPNI+ VF +++
Sbjct: 24 TGTLVTVRITDLE-NCTEE--HLKALQNEVVLSHFFRHPNIMTSWTVFTTGSWLWVISPF 80
Query: 453 LKGGELLDRIRQKGRCGFTENEASRIMRQLVAAVHFMHSRGVVHRDLKPENLLFSDPAGD 512
+ G ++ G +E I+ + ++++H G +HR++K ++L S
Sbjct: 81 MAYGSANSLLKTYFPEGMSEALIGNILFGALRGLNYLHQNGYIHRNIKASHILISGDGLV 140
Query: 513 NIKVVDFGFACLKRESLHT-----PCFT---LQYAAPEVLRQDKSGYDENCDLWSLGV 562
++ + ++ ++ P F+ L + +PE+LRQD GY+ D++S+G+
Sbjct: 141 SLSGLSHLYSLVRNGQKAKVVYDFPQFSTSVLPWLSPELLRQDLYGYNVKSDIYSVGI 198
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. STRAD-beta is also referred to as ALS2CR2 (Amyotrophic lateral sclerosis 2 chromosomal region candidate gene 2 protein), since the human gene encoding it is located within the juvenile ALS2 critical region on chromosome 2q33-q34. It is not linked to the development of ALS2. Length = 328 |
| >gnl|CDD|173677 cd05586, STKc_Sck1_like, Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 53.0 bits (127), Expect = 3e-07
Identities = 26/60 (43%), Positives = 41/60 (68%), Gaps = 2/60 (3%)
Query: 896 YLVLELLKGGELLDRIRQKGRCGFTENEASRIMRQLVAAVHFMHSRGVVHRDLKPENLLL 955
YLV + + GGEL ++++GR F+E+ A + +LV A+ +H +V+RDLKPEN+LL
Sbjct: 72 YLVTDYMSGGELFWHLQKEGR--FSEDRAKFYIAELVLALEHLHKYDIVYRDLKPENILL 129
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of yeast to environmental changes. Length = 330 |
| >gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 53.1 bits (128), Expect = 3e-07
Identities = 24/66 (36%), Positives = 35/66 (53%), Gaps = 12/66 (18%)
Query: 896 YLVLE-----LLKGGELLDRIRQKGRCGFTENEASRIMRQLVAAVHFMHSRGVVHRDLKP 950
YLV E LL ELL+ G + + QL+ A+ + HS ++HRD+KP
Sbjct: 76 YLVFEYVERTLL---ELLEASPG----GLPPDAVRSYIWQLLQAIAYCHSHNIIHRDIKP 128
Query: 951 ENLLLS 956
EN+L+S
Sbjct: 129 ENILVS 134
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288 |
| >gnl|CDD|173712 cd05622, STKc_ROCK1, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Score = 53.1 bits (127), Expect = 4e-07
Identities = 35/119 (29%), Positives = 57/119 (47%), Gaps = 8/119 (6%)
Query: 231 GIECVFFSSSLIIFFIILSFTLSFIHDYYHIQYRRILKTEP----PIPEDLSPDVADFIS 286
G EC ++S + ++ +++ T F D Y +I+ + P D+S + + I
Sbjct: 225 GRECDWWSVGVFLYEMLVGDT-PFYADSLVGTYSKIMNHKNSLTFPDDNDISKEAKNLIC 283
Query: 287 RLLVKDPRRRLGGGELDAEELKRHPFFNVIDWDDLATKRIPAPFVPKISNELDVSNFSD 345
L D RLG ++ E+KRH FF W + AP VP +S+++D SNF D
Sbjct: 284 AFLT-DREVRLGRNGVE--EIKRHLFFKNDQWAWETLRDTVAPVVPDLSSDIDTSNFDD 339
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, and kidney. It mediates signaling from Rho to the actin cytoskeleton. It is implicated in the development of cardiac fibrosis, cardiomyocyte apoptosis, and hyperglycemia. Mice deficient with ROCK1 display eyelids open at birth (EOB) and omphalocele phenotypes due to the disorganization of actin filaments in the eyelids and the umbilical ring. Length = 371 |
| >gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 52.2 bits (126), Expect = 4e-07
Identities = 22/77 (28%), Positives = 39/77 (50%), Gaps = 9/77 (11%)
Query: 896 YLVLELLKGGELLDRIRQKGRCGFTENEAS-------RIMRQLVAAVHFMHSRGVVHRDL 948
YLVLE ++GG+LLD +R+ + +++ Q+ + ++ S+ VHRDL
Sbjct: 72 YLVLEYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLASKKFVHRDL 131
Query: 949 KPENLLLSGISGNLIKI 965
N L+ ++KI
Sbjct: 132 AARNCLVG--EDLVVKI 146
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262 |
| >gnl|CDD|88330 cd05047, PTKc_Tie, Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 52.4 bits (125), Expect = 4e-07
Identities = 58/223 (26%), Positives = 97/223 (43%), Gaps = 44/223 (19%)
Query: 385 ILGDGSYSVCRRCVEKSTG----------QEYAVKIISRKIDCSEEINLLRACQGHPNIV 434
++G+G++ + K G +EYA K R D + E+ +L HPNI+
Sbjct: 2 VIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHR--DFAGELEVLCKLGHHPNII 59
Query: 435 NLHCVFQDEVHTYLVLELLKGGELLDRIRQKGRCGFTENEASR--------IMRQLVA-- 484
NL + + YL +E G LLD +R K R T+ + +QL+
Sbjct: 60 NLLGACEHRGYLYLAIEYAPHGNLLDFLR-KSRVLETDPAFAIANSTASTLSSQQLLHFA 118
Query: 485 -----AVHFMHSRGVVHRDLKPENLLFSDPAGDNI--KVVDFGFA-----CLKRESLHTP 532
+ ++ + +HRDL N+L G+N K+ DFG + +K+ P
Sbjct: 119 ADVARGMDYLSQKQFIHRDLAARNIL----VGENYVAKIADFGLSRGQEVYVKKTMGRLP 174
Query: 533 CFTLQYAAPEVLRQDKSGYDENCDLWSLGVILVNVLRQDKSGY 575
+++ A E L + S Y N D+WS GV+L ++ + Y
Sbjct: 175 ---VRWMAIESL--NYSVYTTNSDVWSYGVLLWEIVSLGGTPY 212
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific ligand has been identified for Tie1. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. In vivo studies of Tie1 show that it is critical in vascular development. Length = 270 |
| >gnl|CDD|173704 cd05613, STKc_MSK1_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Score = 52.3 bits (125), Expect = 5e-07
Identities = 31/93 (33%), Positives = 49/93 (52%), Gaps = 9/93 (9%)
Query: 867 TLFEEQLLGPITRARRRTFVNRSRYNVHT----YLVLELLKGGELLDRIRQKGRCGFTEN 922
T E Q+L I R+ F+ Y T +L+L+ + GGEL + Q+ R F E
Sbjct: 51 TRTERQVLEHI---RQSPFLVTLHYAFQTDTKLHLILDYINGGELFTHLSQRER--FKEQ 105
Query: 923 EASRIMRQLVAAVHFMHSRGVVHRDLKPENLLL 955
E ++V A+ +H G+++RD+K EN+LL
Sbjct: 106 EVQIYSGEIVLALEHLHKLGIIYRDIKLENILL 138
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK1 plays a role in the regulation of translational control and transcriptional activation. It phosphorylates the transcription factors, CREB and NFkappaB. It also phosphorylates the nucleosomal proteins H3 and HMG-14. Increased phosphorylation of MEK1 is associated with the development of cerebral ischemic/hypoxic preconditioning. Length = 290 |
| >gnl|CDD|132950 cd06619, PKc_MKK5, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Score = 52.2 bits (125), Expect = 5e-07
Identities = 53/191 (27%), Positives = 85/191 (44%), Gaps = 18/191 (9%)
Query: 379 DLDKAGILGDGSYSVCRRCVEKSTGQEYAVKIISRKIDCS------EEINLLRACQGHPN 432
D+ ILG G+ + T + AVK+I I E+ +L C P
Sbjct: 2 DIQYQEILGHGNGGTVYKAYHLLTRRILAVKVIPLDITVELQKQIMSELEILYKCDS-PY 60
Query: 433 IVNLHCVFQDEVHTYLVLELLKGGELLDRIRQKGRCGFTENEASRIMRQLVAAVHFMHSR 492
I+ + F E + E + GG L D R+ E+ RI +V + ++ S
Sbjct: 61 IIGFYGAFFVENRISICTEFMDGGSL-DVYRK-----IPEHVLGRIAVAVVKGLTYLWSL 114
Query: 493 GVVHRDLKPENLLFSDPAGDNIKVVDFGFACLKRESL-HTPCFTLQYAAPEVLRQDKSGY 551
++HRD+KP N+L + +K+ DFG + S+ T T Y APE + ++ Y
Sbjct: 115 KILHRDVKPSNMLVNTRG--QVKLCDFGVSTQLVNSIAKTYVGTNAYMAPERISGEQ--Y 170
Query: 552 DENCDLWSLGV 562
+ D+WSLG+
Sbjct: 171 GIHSDVWSLGI 181
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that phosphorylates its downstream target, extracellular signal-regulated kinase 5 (ERK5), on specific threonine and tyrosine residues. MKK5 is activated by MEKK2 and MEKK3 in response to mitogenic and stress stimuli. The ERK5 cascade promotes cell proliferation, differentiation, neuronal survival, and neuroprotection. This cascade plays an essential role in heart development. Mice deficient in either ERK5 or MKK5 die around embryonic day 10 due to cardiovascular defects including underdevelopment of the myocardium. In addition, MKK5 is associated with metastasis and unfavorable prognosis in prostate cancer. Length = 279 |
| >gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Score = 51.7 bits (124), Expect = 6e-07
Identities = 26/72 (36%), Positives = 40/72 (55%), Gaps = 4/72 (5%)
Query: 896 YLVLELLKGGELLDRI--RQKGRCGFTENEASRIMRQLVAAVHFMHSRGVVHRDLKPENL 953
+V+E G+L I R+K R E E RI QL+ + +H + ++HRDLK N+
Sbjct: 75 CIVMEYAPFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALHEQKILHRDLKSANI 134
Query: 954 LLSGISGNLIKI 965
LL + +L+KI
Sbjct: 135 LLV--ANDLVKI 144
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256 |
| >gnl|CDD|240344 PTZ00283, PTZ00283, serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 52.9 bits (127), Expect = 6e-07
Identities = 26/71 (36%), Positives = 43/71 (60%), Gaps = 4/71 (5%)
Query: 897 LVLELLKGGELLDRIRQKGRCG--FTENEASRIMRQLVAAVHFMHSRGVVHRDLKPENLL 954
LVL+ G+L I+ + + F E+EA + Q++ AVH +HS+ ++HRD+K N+L
Sbjct: 116 LVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFIQVLLAVHHVHSKHMIHRDIKSANIL 175
Query: 955 LSGISGNLIKI 965
L S L+K+
Sbjct: 176 LC--SNGLVKL 184
|
Length = 496 |
| >gnl|CDD|133165 cd05033, PTKc_EphR, Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 51.6 bits (124), Expect = 6e-07
Identities = 47/199 (23%), Positives = 90/199 (45%), Gaps = 22/199 (11%)
Query: 385 ILGDGSY-SVCRRCVEKSTGQEYAVKIISRKIDCSEE--INLLRACQ-----GHPNIVNL 436
++G G + VCR ++ +E V I + K S++ ++ L HPNI+ L
Sbjct: 11 VIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDFLTEASIMGQFDHPNIIRL 70
Query: 437 HCVFQDEVHTYLVLELLKGGELLDRIRQKGRCGFTENEASRIMRQLVAAVHFMHSRGVVH 496
V ++ E ++ G L D+ ++ FT + ++R + + + ++ VH
Sbjct: 71 EGVVTKSRPVMIITEYMENGSL-DKFLRENDGKFTVGQLVGMLRGIASGMKYLSEMNYVH 129
Query: 497 RDLKPENLLFSDPAGDNIKVVDFGFACLKRESLHTPCFT-------LQYAAPEVLRQDKS 549
RDL N+L + + KV DFG + +S +T +++ APE + K
Sbjct: 130 RDLAARNILVN--SNLVCKVSDFGLSRRLEDS--EATYTTKGGKIPIRWTAPEAIAYRK- 184
Query: 550 GYDENCDLWSLGVILVNVL 568
+ D+WS G+++ V+
Sbjct: 185 -FTSASDVWSFGIVMWEVM 202
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. This allows ephrin/EphR dimers to form, leading to the activation of the intracellular tyr kinase domain. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). The main effect of ephrin/EphR interaction is cell-cell repulsion or adhesion. Ephrin/EphR signaling is important in neural development and plasticity, cell morphogenesis and proliferation, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|173767 cd08227, PK_STRAD_alpha, Pseudokinase domain of STE20-related kinase adapter protein alpha | Back alignment and domain information |
|---|
Score = 52.3 bits (125), Expect = 6e-07
Identities = 47/187 (25%), Positives = 82/187 (43%), Gaps = 34/187 (18%)
Query: 400 KSTGQEYAVKIISRKIDCSEEINLLRACQ-------GHPNIVNLHCVFQDEVHTYLVLEL 452
K TG+ V+ I+ + +E + L+ + HPNIV F + ++V
Sbjct: 22 KPTGEYVTVRRINLEACTNEMVTFLQ-GELHVSKLFNHPNIVPYRATFIADNELWVVTSF 80
Query: 453 LKGGELLDRIRQKGRCGFTENEASRIMRQLVAAVHFMHSRGVVHRDLKPENLLFSDPA-- 510
+ G D I G +E + I++ ++ A+ ++H G VHR +K ++L S
Sbjct: 81 MAYGSAKDLICTHFMDGMSELAIAYILQGVLKALDYIHHMGYVHRSVKASHILISVDGKV 140
Query: 511 --------------GDNIKVV-DFGFACLKRESLHTPCFTLQYAAPEVLRQDKSGYDENC 555
G ++VV DF +K L + +PEVL+Q+ GYD
Sbjct: 141 YLSGLRSNLSMINHGQRLRVVHDFPKYSVK---------VLPWLSPEVLQQNLQGYDAKS 191
Query: 556 DLWSLGV 562
D++S+G+
Sbjct: 192 DIYSVGI 198
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha, stabilized through ATP and MO25, may be needed to activate LKB1. A mutation which results in a truncation of a C-terminal part of the human STRAD-alpha pseudokinase domain and disrupts its association with LKB1, leads to PMSE (polyhydramnios, megalencephaly, symptomatic epilepsy) syndrome. Several splice variants of STRAD-alpha exist which exhibit different effects on the localization and activation of LKB1. Length = 327 |
| >gnl|CDD|173678 cd05587, STKc_cPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Score = 52.1 bits (125), Expect = 7e-07
Identities = 22/60 (36%), Positives = 39/60 (65%), Gaps = 2/60 (3%)
Query: 896 YLVLELLKGGELLDRIRQKGRCGFTENEASRIMRQLVAAVHFMHSRGVVHRDLKPENLLL 955
Y V+E + GG+L+ I+Q G+ F E A ++ + F+HS+G+++RDLK +N++L
Sbjct: 77 YFVMEYVNGGDLMYHIQQVGK--FKEPHAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVML 134
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory domain. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. cPKCs are potent kinases for histones, myelin basic protein, and protamine. PKC-gamma is mainly expressed in neuronal tissues. It plays a role in protection from ischemia. Length = 324 |
| >gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain | Back alignment and domain information |
|---|
Score = 51.1 bits (123), Expect = 8e-07
Identities = 23/79 (29%), Positives = 34/79 (43%), Gaps = 12/79 (15%)
Query: 242 IIFFIILSFTLSFIHDYYHIQ---YRRILKTEPPIPE----DLSPDVADFISRLLVKDPR 294
+I + +L+ F + Q RRIL E S + D I + L KDP
Sbjct: 187 VILYELLTGKPPFSGENILDQLQLIRRILGPPLEFDEPKWSSGSEEAKDLIKKCLNKDPS 246
Query: 295 RRLGGGELDAEELKRHPFF 313
+R AEE+ +HP+F
Sbjct: 247 KRPT-----AEEILQHPWF 260
|
Length = 260 |
| >gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Score = 51.4 bits (123), Expect = 9e-07
Identities = 23/67 (34%), Positives = 42/67 (62%), Gaps = 4/67 (5%)
Query: 896 YLVLELLKGGELLDRIRQKGRCGFTENEASRIMRQLVAAVHFMHSRGVVHRDLKPENLLL 955
++V+E L GG L D + + E + + + R+ + A+ F+HS V+HRD+K +N+LL
Sbjct: 92 WVVMEYLAGGSLTDVVTE---TCMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILL 148
Query: 956 SGISGNL 962
G+ G++
Sbjct: 149 -GMDGSV 154
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293 |
| >gnl|CDD|132980 cd06649, PKc_MEK2, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Score = 51.6 bits (123), Expect = 9e-07
Identities = 59/240 (24%), Positives = 97/240 (40%), Gaps = 55/240 (22%)
Query: 374 EQYDMDLDKAGILGDGSYSVCRRCVEKSTGQEYAVKIISRKIDCS------EEINLLRAC 427
E D D ++ LG G+ V + K +G A K+I +I + E+ +L C
Sbjct: 1 ELKDDDFERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHEC 60
Query: 428 QGHPNIVNLHCVFQDEVHTYLVLELLKGGELLDRIRQKGRCGFTENEASRIMRQLVAAVH 487
P IV + F + + +E + GG L D++ + EA RI +++ V
Sbjct: 61 NS-PYIVGFYGAFYSDGEISICMEHMDGGSL-DQVLK---------EAKRIPEEILGKVS 109
Query: 488 FMHSRG---------VVHRDLKPENLLFSDPAGDNIKVVDFGFACLKRESL-HTPCFTLQ 537
RG ++HRD+KP N+L + IK+ DFG + +S+ ++ T
Sbjct: 110 IAVLRGLAYLREKHQIMHRDVKPSNILVNSRG--EIKLCDFGVSGQLIDSMANSFVGTRS 167
Query: 538 YAAPEVLRQDKSGYDENCDLWSLGVILVNVLRQDKSGYDENCDLWSLGVILYTMLCGRVP 597
Y +PE R + Y D+WS+G+ L + GR P
Sbjct: 168 YMSPE--------------------------RLQGTHYSVQSDIWSMGLSLVELAIGRYP 201
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 331 |
| >gnl|CDD|133212 cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 51.3 bits (123), Expect = 9e-07
Identities = 55/197 (27%), Positives = 87/197 (44%), Gaps = 34/197 (17%)
Query: 389 GSYSVCR-RCVEKSTGQEYAVKII-----SRKIDCSEEINLLRACQGHPNIVNLH--CVF 440
GS +CR ++ +TG+ AVK + D EI +L++ Q H NIV C
Sbjct: 18 GSVELCRYDPLQDNTGEVVAVKKLQHSTAEHLRDFEREIEILKSLQ-HDNIVKYKGVCYS 76
Query: 441 QDEVHTYLVLELLKGGELLDR-IRQKGRCGFTENEASRIMR---QLVAAVHFMHSRGVVH 496
+ LV+E L G L D + + R + +++ Q+ + ++ S+ VH
Sbjct: 77 AGRRNLRLVMEYLPYGSLRDYLQKHRERL-----DHRKLLLYASQICKGMEYLGSKRYVH 131
Query: 497 RDLKPENLLFSDPAGDNIKVVDFGFACL---------KRESLHTPCFTLQYAAPEVLRQD 547
RDL N+L +K+ DFG + RE +P F + APE L +
Sbjct: 132 RDLATRNILVESEN--RVKIGDFGLTKVLPQDKEYYKVREPGESPIF---WYAPESLTES 186
Query: 548 KSGYDENCDLWSLGVIL 564
K + D+WS GV+L
Sbjct: 187 K--FSVASDVWSFGVVL 201
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 284 |
| >gnl|CDD|173681 cd05590, STKc_nPKC_eta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Score = 51.1 bits (122), Expect = 1e-06
Identities = 28/93 (30%), Positives = 53/93 (56%), Gaps = 9/93 (9%)
Query: 867 TLFEEQLLGPITRARRRTFVNRSRYNVHT----YLVLELLKGGELLDRIRQKGRCGFTEN 922
T+ E+++L + AR F+ + T + V+E + GG+L+ I++ R F E
Sbjct: 42 TMTEKRIL---SLARNHPFLTQLYCCFQTPDRLFFVMEFVNGGDLMFHIQKSRR--FDEA 96
Query: 923 EASRIMRQLVAAVHFMHSRGVVHRDLKPENLLL 955
A ++ +A+ F+H +G+++RDLK +N+LL
Sbjct: 97 RARFYAAEITSALMFLHDKGIIYRDLKLDNVLL 129
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signaling of cell-type specific differentiation. It is also expressed in pro-B cells and early-stage thymocytes, and acts as a key regulator in early B-cell development. PKC-eta increases glioblastoma multiforme (GBM) proliferation and resistance to radiation, and is being developed as a therapeutic target for the management of GBM. Length = 320 |
| >gnl|CDD|173687 cd05596, STKc_ROCK, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Score = 51.3 bits (123), Expect = 1e-06
Identities = 38/129 (29%), Positives = 60/129 (46%), Gaps = 8/129 (6%)
Query: 231 GIECVFFSSSLIIFFIILSFTLSFIHDYYHIQYRRIL--KTEPPIPED--LSPDVADFIS 286
G EC ++S + ++ +++ T F D Y +I+ K P+D +S D I
Sbjct: 225 GRECDWWSVGVFLYEMLVGDT-PFYADSLVGTYSKIMDHKNSLTFPDDIEISKQAKDLIC 283
Query: 287 RLLVKDPRRRLGGGELDAEELKRHPFFNVIDWDDLATKRIPAPFVPKISNELDVSNFSDE 346
L D RLG +D E+K HPFF W + AP VP++S+++D SNF D
Sbjct: 284 AFLT-DREVRLGRNGVD--EIKSHPFFKNDQWTFDNIRETVAPVVPELSSDIDTSNFDDI 340
Query: 347 FTKMIPADS 355
++
Sbjct: 341 EDDDKNEET 349
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via interaction with Rho GTPases and is involved in many cellular functions including contraction, adhesion, migration, motility, proliferation, and apoptosis. The ROCK subfamily consists of two isoforms, ROCK1 and ROCK2, which may be functionally redundant in some systems, but exhibit different tissue distributions. Both isoforms are ubiquitously expressed in most tissues, but ROCK2 is more prominent in brain and skeletal muscle while ROCK1 is more pronounced in the liver, testes, and kidney. Studies in knockout mice result in different phenotypes, suggesting that the two isoforms do not compensate for each other during embryonic development. Length = 370 |
| >gnl|CDD|173711 cd05621, STKc_ROCK2, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Score = 51.9 bits (124), Expect = 1e-06
Identities = 39/119 (32%), Positives = 60/119 (50%), Gaps = 8/119 (6%)
Query: 231 GIECVFFSSSLIIFFIILSFTLSFIHDYYHIQYRRIL--KTEPPIPED--LSPDVADFIS 286
G EC ++S + +F +++ T F D Y +I+ K PED +S + I
Sbjct: 225 GRECDWWSVGVFLFEMLVGDT-PFYADSLVGTYSKIMDHKNSLNFPEDVEISKHAKNLIC 283
Query: 287 RLLVKDPRRRLGGGELDAEELKRHPFFNVIDWDDLATKRIPAPFVPKISNELDVSNFSD 345
L D RLG + EE+K+HPFF W+ + AP VP++S+++D SNF D
Sbjct: 284 AFLT-DREVRLGRNGV--EEIKQHPFFKNDQWNWDNIRETAAPVVPELSSDIDSSNFDD 339
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found to play a role in stress fiber and focal adhesion formation. It is prominently expressed in the brain, heart, and skeletal muscles. It is implicated in vascular and neurological disorders, such as hypertension and vasospasm of the coronary and cerebral arteries. ROCK2 is also activated by caspase-2 cleavage, resulting in thrombin-induced microparticle generation in response to cell activation. Mice deficient in ROCK2 show intrauterine growth retardation and embryonic lethality because of placental dysfunction. Length = 370 |
| >gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Score = 50.6 bits (121), Expect = 1e-06
Identities = 19/59 (32%), Positives = 36/59 (61%)
Query: 897 LVLELLKGGELLDRIRQKGRCGFTENEASRIMRQLVAAVHFMHSRGVVHRDLKPENLLL 955
+V+E GG L + I+++ E+ Q++ A+H +H++ ++HRDLK +N+LL
Sbjct: 76 IVMEYAPGGTLAEYIQKRCNSLLDEDTILHFFVQILLALHHVHTKLILHRDLKTQNILL 134
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256 |
| >gnl|CDD|183880 PRK13184, pknD, serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Score = 52.5 bits (126), Expect = 1e-06
Identities = 49/202 (24%), Positives = 79/202 (39%), Gaps = 64/202 (31%)
Query: 430 HPNIVNLHCVFQDEVHTYLVLELLKG---GELLDRIRQKGRCGFTENEAS------RIMR 480
HP IV ++ + D Y + ++G LL + QK E + I
Sbjct: 61 HPGIVPVYSICSDGDPVYYTMPYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFH 120
Query: 481 QLVAAVHFMHSRGVVHRDLKPENLL---FSDPAGDNIKVVDFGFACLK------------ 525
++ A + ++HS+GV+HRDLKP+N+L F + + ++D+G A K
Sbjct: 121 KICATIEYVHSKGVLHRDLKPDNILLGLFGE-----VVILDWGAAIFKKLEEEDLLDIDV 175
Query: 526 --RESLHTPCF-------TLQYAAPEVLRQDKSGYDENCDLWSLGVILVNVLRQDKSGYD 576
R ++ T Y APE L +
Sbjct: 176 DERNICYSSMTIPGKIVGTPDYMAPERLLGVPA--------------------------S 209
Query: 577 ENCDLWSLGVILYTMLCGRVPF 598
E+ D+++LGVILY ML P+
Sbjct: 210 ESTDIYALGVILYQMLTLSFPY 231
|
Length = 932 |
| >gnl|CDD|133187 cd05056, PTKc_FAK, Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Score = 50.5 bits (121), Expect = 1e-06
Identities = 47/178 (26%), Positives = 80/178 (44%), Gaps = 31/178 (17%)
Query: 403 GQEYAVKIISRKIDCS--------EEINLLRACQGHPNIVNLHCVFQDEVHTYLVLELLK 454
++ AV + + K S +E ++R HP+IV L V + ++V+EL
Sbjct: 32 NEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFD-HPHIVKLIGVITEN-PVWIVMELAP 89
Query: 455 GGELLDRIRQKGRCGFTENEASRIM----RQLVAAVHFMHSRGVVHRDLKPENLLFSDPA 510
GEL ++ + + QL A+ ++ S+ VHRD+ N+L S P
Sbjct: 90 LGELRSYLQVN-----KYSLDLASLILYSYQLSTALAYLESKRFVHRDIAARNVLVSSP- 143
Query: 511 GDNIKVVDFGFA-CLKRESLHTPCFT---LQYAAPEVL--RQDKSGYDENCDLWSLGV 562
D +K+ DFG + L+ ES + +++ APE + R+ S D+W GV
Sbjct: 144 -DCVKLGDFGLSRYLEDESYYKASKGKLPIKWMAPESINFRRFTSA----SDVWMFGV 196
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions and at growth factor receptors. Through diverse molecular interactions, FAK functions as a biosensor or integrator to control cell motility. It is a key regulator of cell survival, proliferation, migration and invasion, and thus plays an important role in the development and progression of cancer. Src binds to autophosphorylated FAK forming the FAK-Src dual kinase complex, which is activated in a wide variety of tumor cells and generates signals promoting growth and metastasis. FAK is being developed as a target for cancer therapy. Length = 270 |
| >gnl|CDD|133219 cd05088, PTKc_Tie2, Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Score = 51.2 bits (122), Expect = 1e-06
Identities = 58/222 (26%), Positives = 96/222 (43%), Gaps = 44/222 (19%)
Query: 379 DLDKAGILGDGSYSVCRRCVEKSTG----------QEYAVKIISRKIDCSEEINLLRACQ 428
D+ ++G+G++ + K G +EYA K R D + E+ +L
Sbjct: 8 DIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHR--DFAGELEVLCKLG 65
Query: 429 GHPNIVNLHCVFQDEVHTYLVLELLKGGELLDRIRQKGRC-------GFTENEASRIMRQ 481
HPNI+NL + + YL +E G LLD +R K R + AS + Q
Sbjct: 66 HHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLR-KSRVLETDPAFAIANSTASTLSSQ 124
Query: 482 LVAA--------VHFMHSRGVVHRDLKPENLLFSDPAGDNI--KVVDFGFA-----CLKR 526
+ + ++ + +HRDL N+L G+N K+ DFG + +K+
Sbjct: 125 QLLHFAADVARGMDYLSQKQFIHRDLAARNIL----VGENYVAKIADFGLSRGQEVYVKK 180
Query: 527 ESLHTPCFTLQYAAPEVLRQDKSGYDENCDLWSLGVILVNVL 568
P +++ A E L + S Y N D+WS GV+L ++
Sbjct: 181 TMGRLP---VRWMAIESL--NYSVYTTNSDVWSYGVLLWEIV 217
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. Tie2 signaling plays key regulatory roles in vascular integrity and quiescence, and in inflammation. Length = 303 |
| >gnl|CDD|133191 cd05060, PTKc_Syk_like, Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 50.4 bits (121), Expect = 1e-06
Identities = 46/169 (27%), Positives = 75/169 (44%), Gaps = 18/169 (10%)
Query: 407 AVKIISRKIDCSEEINLLRACQ-----GHPNIVNLHCVFQDEVHTYLVLELLKGGELLDR 461
AVK + ++ + + LR HP IV L V + E LV+EL G LL
Sbjct: 27 AVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVRLIGVCKGEP-LMLVMELAPLGPLLKY 85
Query: 462 IRQKGRCGFTENEASRIMRQLVAAVHFMHSRGVVHRDLKPENLLFSDPAGDNIKVVDFGF 521
++++ ++ + Q+ + ++ S+ VHRDL N+L + K+ DFG
Sbjct: 86 LKKRRE--IPVSDLKELAHQVAMGMAYLESKHFVHRDLAARNVLLVNR--HQAKISDFGM 141
Query: 522 A-CLKRESLHTPCFT-----LQYAAPEVLRQDKSGYDENCDLWSLGVIL 564
+ L S + T L++ APE + K + D+WS GV L
Sbjct: 142 SRALGAGSDYYRATTAGRWPLKWYAPECINYGK--FSSKSDVWSYGVTL 188
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. Syk is important in B-cell receptor (BCR) signaling, while Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Syk also plays a central role in Fc receptor-mediated phagocytosis in the adaptive immune system. Shark is exclusively expressed in ectodermally derived epithelia, and is localized preferentially to the apical surface of the epithelial cells, it may play a role in a signaling pathway for epithelial cell polarity. Length = 257 |
| >gnl|CDD|173707 cd05616, STKc_cPKC_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Score = 50.4 bits (120), Expect = 2e-06
Identities = 23/60 (38%), Positives = 40/60 (66%), Gaps = 2/60 (3%)
Query: 896 YLVLELLKGGELLDRIRQKGRCGFTENEASRIMRQLVAAVHFMHSRGVVHRDLKPENLLL 955
Y V+E + GG+L+ +I+Q GR F E A ++ + F+HS+G+++RDLK +N++L
Sbjct: 77 YFVMEYVNGGDLMYQIQQVGR--FKEPHAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVML 134
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. The PKC beta isoforms (I and II), generated by alternative splicing of a single gene, are preferentially activated by hyperglycemia-induced DAG in retinal tissues. This is implicated in diabetic microangiopathy such as ischemia, neovascularization, and abnormal vasodilator function. PKC-beta also plays an important role in VEGF signaling. In addition, glucose regulates proliferation in retinal endothelial cells via PKC-betaI. PKC-beta is also being explored as a therapeutic target in cancer. It contributes to tumor formation and is involved in the tumor host mechanisms of inflammation and angiogenesis. Length = 323 |
| >gnl|CDD|173666 cd05575, STKc_SGK, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Score = 50.9 bits (122), Expect = 2e-06
Identities = 24/60 (40%), Positives = 38/60 (63%), Gaps = 2/60 (3%)
Query: 896 YLVLELLKGGELLDRIRQKGRCGFTENEASRIMRQLVAAVHFMHSRGVVHRDLKPENLLL 955
Y VL+ + GGEL + Q+ R F E A ++ +A+ ++HS +++RDLKPEN+LL
Sbjct: 72 YFVLDYVNGGELFFHL-QRERS-FPEPRARFYAAEIASALGYLHSLNIIYRDLKPENILL 129
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell proliferation, and apoptosis. Length = 323 |
| >gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 50.1 bits (120), Expect = 2e-06
Identities = 24/61 (39%), Positives = 39/61 (63%), Gaps = 1/61 (1%)
Query: 896 YLVLELLKGGELLDRIRQKGRCGFTENEASRIMRQLVAAVHFMHSRGVVHRDLKPENLLL 955
++++E GG L D I + G TE + + RQ++ A++F+HS V+HRDLK N+LL
Sbjct: 78 WILIEFCDGGAL-DSIMLELERGLTEPQIRYVCRQMLEALNFLHSHKVIHRDLKAGNILL 136
Query: 956 S 956
+
Sbjct: 137 T 137
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280 |
| >gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Score = 50.4 bits (121), Expect = 2e-06
Identities = 15/39 (38%), Positives = 26/39 (66%)
Query: 919 FTENEASRIMRQLVAAVHFMHSRGVVHRDLKPENLLLSG 957
F+E++ +M QL+ + ++H ++HRDLK NLLL+
Sbjct: 105 FSESQVKCLMLQLLRGLQYLHENFIIHRDLKVSNLLLTD 143
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309 |
| >gnl|CDD|173693 cd05602, STKc_SGK1, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Score = 50.8 bits (121), Expect = 2e-06
Identities = 26/60 (43%), Positives = 39/60 (65%), Gaps = 2/60 (3%)
Query: 896 YLVLELLKGGELLDRIRQKGRCGFTENEASRIMRQLVAAVHFMHSRGVVHRDLKPENLLL 955
Y VL+ + GGEL + Q+ RC F E A ++ +A+ ++HS +V+RDLKPEN+LL
Sbjct: 72 YFVLDYINGGELFYHL-QRERC-FLEPRARFYAAEIASALGYLHSLNIVYRDLKPENILL 129
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt sensitivity, memory consolidation, and cardiac repolarization. A common SGK1 variant is associated with increased blood pressure and body weight. SGK1 may also contribute to tumor growth, neurodegeneration, fibrosing disease, and ischemia. Length = 325 |
| >gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 50.2 bits (121), Expect = 2e-06
Identities = 12/29 (41%), Positives = 21/29 (72%)
Query: 927 IMRQLVAAVHFMHSRGVVHRDLKPENLLL 955
+ Q++ + ++HS V+HRDLKP N+L+
Sbjct: 108 FLYQILRGLKYLHSANVIHRDLKPSNILV 136
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330 |
| >gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Score = 50.1 bits (120), Expect = 2e-06
Identities = 23/67 (34%), Positives = 38/67 (56%), Gaps = 2/67 (2%)
Query: 899 LELLKGGELLDRIRQKGRCGFTENEASRIMRQLVAAVHFMHSRGVVHRDLKPENLLLSGI 958
+E GG L D+I ++ F E + Q+V+AV ++H G++HRD+K N+ L+
Sbjct: 78 MEYANGGTLYDKIVRQKGQLFEEEMVLWYLFQIVSAVSYIHKAGILHRDIKTLNIFLT-- 135
Query: 959 SGNLIKI 965
LIK+
Sbjct: 136 KAGLIKL 142
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256 |
| >gnl|CDD|173644 cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 50.3 bits (120), Expect = 2e-06
Identities = 57/205 (27%), Positives = 91/205 (44%), Gaps = 32/205 (15%)
Query: 386 LGDGSY---SVCRRCVE-KSTGQEYAVKII------SRKIDCSEEINLLRACQGHPNIVN 435
LG+G + +CR E +TG++ AVK + + D +EI +LR H NIV
Sbjct: 12 LGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLY-HENIVK 70
Query: 436 LHCVFQDEVHT--YLVLELLKGGELLDRI-RQKGRCGFTENEASRIMRQLVAAVHFMHSR 492
+ ++ L++E L G L + + R K + + + Q+ + ++ SR
Sbjct: 71 YKGICTEDGGNGIKLIMEFLPSGSLKEYLPRNKNKINL--KQQLKYAVQICKGMDYLGSR 128
Query: 493 GVVHRDLKPENLLFSDPAGDNIKVVDFGFA---------CLKRESLHTPCFTLQYAAPEV 543
VHRDL N+L +K+ DFG ++ L +P F + APE
Sbjct: 129 QYVHRDLAARNVLVESE--HQVKIGDFGLTKAIETDKEYYTVKDDLDSPVF---WYAPEC 183
Query: 544 LRQDKSGYDENCDLWSLGVILVNVL 568
L Q K + D+WS GV L +L
Sbjct: 184 LIQSK--FYIASDVWSFGVTLYELL 206
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 284 |
| >gnl|CDD|173639 cd05066, PTKc_EphR_A, Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Score = 49.9 bits (119), Expect = 2e-06
Identities = 40/147 (27%), Positives = 71/147 (48%), Gaps = 15/147 (10%)
Query: 430 HPNIVNLHCVFQDEVHTYLVLELLKGGELLDRIRQKGRCGFTENEASRIMRQLVAAVHFM 489
HPNI++L V +V E ++ G L D +K FT + ++R + + + ++
Sbjct: 64 HPNIIHLEGVVTKSKPVMIVTEYMENGSL-DAFLRKHDGQFTVIQLVGMLRGIASGMKYL 122
Query: 490 HSRGVVHRDLKPENLLFSDPAGDNI--KVVDFGFACLKR---ESLHTPC---FTLQYAAP 541
G VHRDL N+L + N+ KV DFG + + E+ +T +++ AP
Sbjct: 123 SDMGYVHRDLAARNILVN----SNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTAP 178
Query: 542 EVLRQDKSGYDENCDLWSLGVILVNVL 568
E + K + D+WS G+++ V+
Sbjct: 179 EAIAYRK--FTSASDVWSYGIVMWEVM 203
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. EphARs and ephrin-A ligands are expressed in multiple areas of the developing brain, especially in the retina and tectum. They are part of a system controlling retinotectal mapping. Length = 267 |
| >gnl|CDD|173655 cd05110, PTKc_HER4, Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Score = 50.5 bits (120), Expect = 2e-06
Identities = 51/218 (23%), Positives = 95/218 (43%), Gaps = 28/218 (12%)
Query: 377 DMDLDKAGILGDGSYSVCRRCVEKSTGQEY----AVKIISRKIDCSEEIN-----LLRAC 427
+ +L + +LG G++ + + G+ A+KI++ + L+ A
Sbjct: 6 ETELKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMAS 65
Query: 428 QGHPNIVNLHCVFQDEVHTYLVLELLKGGELLDRIRQKGRCGFTENEASRIMR----QLV 483
HP++V L V LV +L+ G LLD + + +N S+++ Q+
Sbjct: 66 MDHPHLVRLLGVCLSPT-IQLVTQLMPHGCLLDYVHEH-----KDNIGSQLLLNWCVQIA 119
Query: 484 AAVHFMHSRGVVHRDLKPENLLFSDPAGDNIKVVDFGFACL-----KRESLHTPCFTLQY 538
+ ++ R +VHRDL N+L P +++K+ DFG A L K + +++
Sbjct: 120 KGMMYLEERRLVHRDLAARNVLVKSP--NHVKITDFGLARLLEGDEKEYNADGGKMPIKW 177
Query: 539 AAPEVLRQDKSGYDENCDLWSLGVILVNVLRQDKSGYD 576
A E + K + D+WS GV + ++ YD
Sbjct: 178 MALECIHYRK--FTHQSDVWSYGVTIWELMTFGGKPYD 213
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands that bind HER4 fall into two groups, the neuregulins (or heregulins) and some EGFR (HER1) ligands including betacellulin, HBEGF, and epiregulin. All four neuregulins (NRG1-4) interact with HER4. Upon ligand binding, HER4 forms homo- or heterodimers with other HER proteins. HER4 is essential in embryonic development. It is implicated in mammary gland, cardiac, and neural development. As a postsynaptic receptor of NRG1, HER4 plays an important role in synaptic plasticity and maturation. The impairment of NRG1/HER4 signaling may contribute to schizophrenia. Length = 303 |
| >gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Score = 49.6 bits (119), Expect = 3e-06
Identities = 26/69 (37%), Positives = 39/69 (56%), Gaps = 7/69 (10%)
Query: 896 YLVLELLKGGELLDRIR--QKGRCGFTENEASRIMRQLVAAVHFMHSRG-----VVHRDL 948
Y+V+E +GG+L I+ +K R E RI+ QL+ A++ H+R V+HRDL
Sbjct: 77 YIVMEYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHNRSDPGNTVLHRDL 136
Query: 949 KPENLLLSG 957
KP N+ L
Sbjct: 137 KPANIFLDA 145
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265 |
| >gnl|CDD|173662 cd05571, STKc_PKB, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Score = 49.8 bits (119), Expect = 3e-06
Identities = 32/94 (34%), Positives = 51/94 (54%), Gaps = 12/94 (12%)
Query: 867 TLFEEQLLGPITRARRRTFVNRSRYNVHTY----LVLELLKGGELLDRIRQKGRCG-FTE 921
TL E ++L + R F+ +Y+ T+ V+E GGEL + R F+E
Sbjct: 42 TLTESRVL----QNTRHPFLTALKYSFQTHDRLCFVMEYANGGELFFHLS---RERVFSE 94
Query: 922 NEASRIMRQLVAAVHFMHSRGVVHRDLKPENLLL 955
+ A ++V+A+ ++HS VV+RDLK ENL+L
Sbjct: 95 DRARFYGAEIVSALGYLHSCDVVYRDLKLENLML 128
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having been implicated in tumor initiation, progression, and metastasis. Length = 323 |
| >gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 49.6 bits (119), Expect = 3e-06
Identities = 19/61 (31%), Positives = 32/61 (52%), Gaps = 10/61 (16%)
Query: 258 YYHIQ-----YRRILKTEPPIPEDLSPDVADFISRLLVKDPRRRLGGGELDAEELKRHPF 312
YY + +R + PP+PE +SP++ DF+ + KDP R A++L +HP+
Sbjct: 199 YYDLNPMAALFRIVQDDHPPLPEGISPELKDFLMQCFQKDPNLR-----PTAKQLLKHPW 253
Query: 313 F 313
Sbjct: 254 I 254
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254 |
| >gnl|CDD|173738 cd07835, STKc_CDK1_like, Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 49.6 bits (119), Expect = 3e-06
Identities = 25/70 (35%), Positives = 34/70 (48%), Gaps = 8/70 (11%)
Query: 896 YLVLELLKGGELLDRIRQKGRCGFTENEASRI---MRQLVAAVHFMHSRGVVHRDLKPEN 952
YLV E L LD + T + I + QL+ + + HS V+HRDLKP+N
Sbjct: 74 YLVFEFLD----LDLKKYMDSSPLTGLDPPLIKSYLYQLLQGIAYCHSHRVLHRDLKPQN 129
Query: 953 LLLSGISGNL 962
LL+ G L
Sbjct: 130 LLID-REGAL 138
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression while the CDK1/cyclin B complex is critical for G2 to M phase transition. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. Studies in knockout mice revealed that CDK1 can compensate for the loss of the cdk2 gene as it can also bind cyclin E and drive G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 283 |
| >gnl|CDD|132979 cd06648, STKc_PAK_II, Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Score = 49.4 bits (118), Expect = 3e-06
Identities = 20/61 (32%), Positives = 40/61 (65%), Gaps = 3/61 (4%)
Query: 896 YLVLELLKGGELLDRIRQKGRCGFTENEASRIMRQLVAAVHFMHSRGVVHRDLKPENLLL 955
++V+E L+GG L D + R E + + + ++ A+ F+H++GV+HRD+K +++LL
Sbjct: 92 WVVMEFLEGGALTDIVTH-TR--MNEEQIATVCLAVLKALSFLHAQGVIHRDIKSDSILL 148
Query: 956 S 956
+
Sbjct: 149 T 149
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs found in group I PAKs, such as an AID (autoinhibitory domain) and SH3 binding sites. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. While group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX, no such binding has been demonstrated for group II PAKs. Some known substrates of group II PAKs are also substrates of group I PAKs such as Raf, BAD, LIMK and GEFH1. Unique group II substrates include MARK/Par-1 and PDZ-RhoGEF. Group II PAKs play important roles in filopodia formation, neuron extension, cytoskeletal organization, and cell survival. Length = 285 |
| >gnl|CDD|173759 cd08219, STKc_Nek3, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Score = 49.6 bits (118), Expect = 3e-06
Identities = 22/64 (34%), Positives = 40/64 (62%), Gaps = 2/64 (3%)
Query: 894 HTYLVLELLKGGELLDRIR-QKGRCGFTENEASRIMRQLVAAVHFMHSRGVVHRDLKPEN 952
H Y+V+E GG+L+ +I+ Q+G+ F E+ + Q+ V +H + V+HRD+K +N
Sbjct: 72 HLYIVMEYCDGGDLMQKIKLQRGKL-FPEDTILQWFVQMCLGVQHIHEKRVLHRDIKSKN 130
Query: 953 LLLS 956
+ L+
Sbjct: 131 IFLT 134
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activation of Vav2 and contributes to prolactin-mediated motility of breast cancer cells. Length = 255 |
| >gnl|CDD|173754 cd07865, STKc_CDK9, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Score = 49.7 bits (119), Expect = 3e-06
Identities = 23/72 (31%), Positives = 39/72 (54%), Gaps = 10/72 (13%)
Query: 889 SRYNVHTYLVLEL----LKGGELLDRIRQKGRCGFTENEASRIMRQLVAAVHFMHSRGVV 944
+RY YLV E L G LL K FT +E ++M+ L+ ++++H ++
Sbjct: 88 NRYKGSFYLVFEFCEHDLAG--LLSNKNVK----FTLSEIKKVMKMLLNGLYYIHRNKIL 141
Query: 945 HRDLKPENLLLS 956
HRD+K N+L++
Sbjct: 142 HRDMKAANILIT 153
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multiple steps of gene expression including transcription elongation, mRNA synthesis, processing, export, and translation. It also plays a role in mediating cytokine induced transcription networks such as IL6-induced STAT3 signaling. In addition, the CDK9/cyclin T2a complex promotes muscle differentiation and enhances the function of some myogenic regulatory factors. Length = 310 |
| >gnl|CDD|173631 cd05045, PTKc_RET, Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Score = 50.0 bits (119), Expect = 3e-06
Identities = 46/194 (23%), Positives = 79/194 (40%), Gaps = 44/194 (22%)
Query: 407 AVKIISRKIDCSE------EINLLRACQGHPNIVNLHCVFQDEVHTYLVLELLKGGELLD 460
AVK++ SE E NLL+ HP+++ L+ + L++E K G L
Sbjct: 34 AVKMLKENASSSELRDLLSEFNLLKQVN-HPHVIKLYGACSQDGPLLLIVEYAKYGSLRS 92
Query: 461 RIR--QKGRCGFTENEASRIMR--------------------QLVAAVHFMHSRGVVHRD 498
+R +K + ++ +R Q+ + ++ +VHRD
Sbjct: 93 FLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQISRGMQYLAEMKLVHRD 152
Query: 499 LKPENLLFSDPAGDNIKVVDFGF--------ACLKRESLHTPCFTLQYAAPEVLRQDKSG 550
L N+L ++ G +K+ DFG + +KR P +++ A E L
Sbjct: 153 LAARNVLVAE--GRKMKISDFGLSRDVYEEDSYVKRSKGRIP---VKWMAIESLFDHI-- 205
Query: 551 YDENCDLWSLGVIL 564
Y D+WS GV+L
Sbjct: 206 YTTQSDVWSFGVLL 219
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leading to autophosphorylation, activation, and intracellular signaling. RET is essential for the development of the sympathetic, parasympathetic and enteric nervous systems, and the kidney. RET disruption by germline mutations causes diseases in humans including congenital aganglionosis of the gastrointestinal tract (Hirschsprung's disease) and three related inherited cancers: multiple endocrine neoplasia type 2A (MEN2A), MEN2B, and familial medullary thyroid carcinoma (FMTC). Length = 290 |
| >gnl|CDD|173634 cd05053, PTKc_FGFR, Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 50.1 bits (120), Expect = 3e-06
Identities = 50/188 (26%), Positives = 81/188 (43%), Gaps = 39/188 (20%)
Query: 407 AVKIISRKIDCSE--------EINLLRACQGHPNIVNLHCVFQDEVHTYLVLELLKGGEL 458
AVK++ K D +E E+ +++ H NI+NL V E Y+V+E G L
Sbjct: 46 AVKML--KDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGVCTQEGPLYVVVEYAAHGNL 103
Query: 459 LDRIRQKGRCGFTEN-EASRIMR-------------QLVAAVHFMHSRGVVHRDLKPENL 504
D +R + G + + R Q+ + F+ S+ +HRDL N+
Sbjct: 104 RDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFLASKKCIHRDLAARNV 163
Query: 505 LFSDPAGDNIKVVDFGFA----CL----KRESLHTPCFTLQYAAPEVLRQDKSGYDENCD 556
L ++ +K+ DFG A + K + P +++ APE L Y D
Sbjct: 164 LVTE--DHVMKIADFGLARDIHHIDYYRKTTNGRLP---VKWMAPEAL--FDRVYTHQSD 216
Query: 557 LWSLGVIL 564
+WS GV+L
Sbjct: 217 VWSFGVLL 224
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, and intracellular signaling. There are at least 23 FGFs and four types of FGFRs. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. FGF/FGFR signaling is important in the regulation of embryonic development, homeostasis, and regenerative processes. Depending on the cell type and stage, FGFR signaling produces diverse cellular responses including proliferation, growth arrest, differentiation, and apoptosis. Aberrant signaling leads to many human diseases such as skeletal, olfactory, and metabolic disorders, as well as cancer. Length = 293 |
| >gnl|CDD|173696 cd05605, STKc_GRK4_like, Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 48.7 bits (116), Expect = 6e-06
Identities = 24/59 (40%), Positives = 33/59 (55%)
Query: 897 LVLELLKGGELLDRIRQKGRCGFTENEASRIMRQLVAAVHFMHSRGVVHRDLKPENLLL 955
LVL L+ GG+L I G GF E A ++ + +H +V+RDLKPEN+LL
Sbjct: 77 LVLTLMNGGDLKFHIYNMGNPGFDEERAVFYAAEITCGLEDLHRERIVYRDLKPENILL 135
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, GRK6, and similar GRKs. GRKs in this group contain an N-terminal RGS homology (RH) domain and a catalytic domain, but lack a G protein betagamma-subunit binding domain. They are localized to the plasma membrane through post-translational lipid modification or direct binding to PIP2. Length = 285 |
| >gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Score = 48.5 bits (116), Expect = 6e-06
Identities = 22/69 (31%), Positives = 36/69 (52%), Gaps = 2/69 (2%)
Query: 897 LVLELLKGGELLDRIRQKGRCGFTENEASRIMRQLVAAVHFMHSRGVVHRDLKPENLLLS 956
+V EL G LLDR+R+ F + Q+ + ++ S+ +HRDL N+LL+
Sbjct: 72 MVTELAPLGSLLDRLRKDALGHFLISTLCDYAVQIANGMRYLESKRFIHRDLAARNILLA 131
Query: 957 GISGNLIKI 965
S + +KI
Sbjct: 132 --SDDKVKI 138
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257 |
| >gnl|CDD|173697 cd05606, STKc_beta_ARK, Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Score = 48.8 bits (116), Expect = 7e-06
Identities = 23/59 (38%), Positives = 36/59 (61%), Gaps = 2/59 (3%)
Query: 897 LVLELLKGGELLDRIRQKGRCGFTENEASRIMRQLVAAVHFMHSRGVVHRDLKPENLLL 955
+L+L+ GG+L + Q G F+E E +++ + MH+R VV+RDLKP N+LL
Sbjct: 74 FILDLMNGGDLHYHLSQHGV--FSEAEMRFYAAEIILGLEHMHNRFVVYRDLKPANILL 130
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is composed of GRK2, GRK3, and similar proteins. GRK2 and GRK3 are both widely expressed in many tissues, although GRK2 is present at higher levels. They contain an N-terminal RGS homology (RH) domain, a central catalytic domain, and C-terminal pleckstrin homology (PH) domain that mediates PIP2 and G protein betagamma-subunit translocation to the membrane. GRK2 (also called beta-ARK or beta-ARK1) is important in regulating several cardiac receptor responses. It plays a role in cardiac development and in hypertension. Deletion of GRK2 in mice results in embryonic lethality, caused by hypoplasia of the ventricular myocardium. GRK2 also plays important roles in the liver (as a regulator of portal blood pressure), in immune cells, and in the nervous system. Altered GRK2 expression has been reported in several disorders including major depression, schizophrenia, bipolar disorder, and Parkinsonism. Length = 278 |
| >gnl|CDD|173720 cd05631, STKc_GRK4, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Score = 48.5 bits (115), Expect = 7e-06
Identities = 22/69 (31%), Positives = 32/69 (46%)
Query: 264 RRILKTEPPIPEDLSPDVADFISRLLVKDPRRRLGGGELDAEELKRHPFFNVIDWDDLAT 323
RR+ + + E S D LL K+P+ RLG A +K+HP F I++ L
Sbjct: 215 RRVKEDQEEYSEKFSEDAKSICRMLLTKNPKERLGCRGNGAAGVKQHPIFKNINFKRLEA 274
Query: 324 KRIPAPFVP 332
+ PF P
Sbjct: 275 NMLEPPFCP 283
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found in the testis, but is also present in the cerebellum and kidney. It is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK4 polymorphisms are associated with hypertension and salt sensitivity, as they cause hyperphosphorylation, desensitization, and internalization of the dopamine 1 (D1) receptor while increasing the expression of the angiotensin II type 1 receptor. GRK4 plays a crucial role in the D1 receptor regulation of sodium excretion and blood pressure. Length = 285 |
| >gnl|CDD|173740 cd07842, STKc_CDK8_like, Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 48.4 bits (116), Expect = 8e-06
Identities = 18/46 (39%), Positives = 28/46 (60%)
Query: 912 RQKGRCGFTENEASRIMRQLVAAVHFMHSRGVVHRDLKPENLLLSG 957
RQ R + ++ Q++ VH++HS V+HRDLKP N+L+ G
Sbjct: 98 RQAKRVSIPPSMVKSLLWQILNGVHYLHSNWVLHRDLKPANILVMG 143
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDC2L6 also associates with Mediator in complexes lacking CDK8. In VP16-dependent transcriptional activation, CDK8 and CDC2L6 exerts opposing effects by positive and negative regulation, respectively, in similar conditions. Length = 316 |
| >gnl|CDD|173695 cd05604, STKc_SGK3, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Score = 48.5 bits (115), Expect = 9e-06
Identities = 25/60 (41%), Positives = 38/60 (63%), Gaps = 2/60 (3%)
Query: 896 YLVLELLKGGELLDRIRQKGRCGFTENEASRIMRQLVAAVHFMHSRGVVHRDLKPENLLL 955
Y VL+ + GGEL + Q+ R F E A ++ +A+ ++HS +V+RDLKPEN+LL
Sbjct: 72 YFVLDFVNGGELFFHL-QRERS-FPEPRARFYAAEIASALGYLHSINIVYRDLKPENILL 129
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, and receptors. It plays a critical role in hair follicle morphogenesis and hair cycling. Length = 325 |
| >gnl|CDD|173719 cd05630, STKc_GRK6, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Score = 48.1 bits (114), Expect = 9e-06
Identities = 24/59 (40%), Positives = 33/59 (55%)
Query: 897 LVLELLKGGELLDRIRQKGRCGFTENEASRIMRQLVAAVHFMHSRGVVHRDLKPENLLL 955
LVL L+ GG+L I G GF E A ++ + +H +V+RDLKPEN+LL
Sbjct: 77 LVLTLMNGGDLKFHIYHMGEAGFEEGRAVFYAAEICCGLEDLHQERIVYRDLKPENILL 135
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK6 plays important roles in the regulation of dopamine, M3 muscarinic, opioid, and chemokine receptor signaling. It also plays maladaptive roles in addiction and Parkinson's disease. GRK6-deficient mice exhibit altered dopamine receptor regulation, decreased lymphocyte chemotaxis, and increased acute inflammation and neutrophil chemotaxis. Length = 285 |
| >gnl|CDD|132983 cd06652, STKc_MEKK2, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Score = 48.1 bits (114), Expect = 9e-06
Identities = 20/58 (34%), Positives = 35/58 (60%), Gaps = 2/58 (3%)
Query: 897 LVLELLKGGELLDRIRQKGRCGFTENEASRIMRQLVAAVHFMHSRGVVHRDLKPENLL 954
+ +E + GG + D+++ G TEN + RQ++ V ++HS +VHRD+K N+L
Sbjct: 83 IFMEHMPGGSIKDQLKSYG--ALTENVTRKYTRQILEGVSYLHSNMIVHRDIKGANIL 138
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their respective MAPKKs MEK1/2, JNK-activating kinase 2 (JNKK2), and MKK3/6. MEKK2 plays roles in T cell receptor signaling, immune synapse formation, cytokine gene expression, as well as in EGF and FGF receptor signaling. Length = 265 |
| >gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Score = 48.0 bits (114), Expect = 9e-06
Identities = 24/84 (28%), Positives = 44/84 (52%)
Query: 873 LLGPITRARRRTFVNRSRYNVHTYLVLELLKGGELLDRIRQKGRCGFTENEASRIMRQLV 932
LL + TF + N ++V+E GG+L+ RI ++ F+E++ Q+
Sbjct: 52 LLAKMKHPNIVTFFASFQENGRLFIVMEYCDGGDLMKRINRQRGVLFSEDQILSWFVQIS 111
Query: 933 AAVHFMHSRGVVHRDLKPENLLLS 956
+ +H R ++HRD+K +N+ LS
Sbjct: 112 LGLKHIHDRKILHRDIKSQNIFLS 135
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257 |
| >gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Score = 49.1 bits (117), Expect = 9e-06
Identities = 23/61 (37%), Positives = 39/61 (63%), Gaps = 2/61 (3%)
Query: 896 YLVLELLKGGELLDRIRQKGRCGFTENEASRIMRQLVAAVHFMHSRGVVHRDLKPENLLL 955
YLV+E L GG++ + G F E A + + ++ A+ ++H G++HRDLKP+N+L+
Sbjct: 80 YLVMEYLIGGDVKSLLHIYGY--FDEEMAVKYISEVALALDYLHRHGIIHRDLKPDNMLI 137
Query: 956 S 956
S
Sbjct: 138 S 138
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669 |
| >gnl|CDD|178763 PLN03224, PLN03224, probable serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 48.9 bits (116), Expect = 9e-06
Identities = 21/50 (42%), Positives = 32/50 (64%), Gaps = 2/50 (4%)
Query: 473 NEASRIMRQLVAAVHFMHSRGVVHRDLKPENLLFSDPAGDNIKVVDFGFA 522
N +MRQ++ + +H G+VHRD+KPENLL + +K++DFG A
Sbjct: 309 NVIKGVMRQVLTGLRKLHRIGIVHRDIKPENLLVT--VDGQVKIIDFGAA 356
|
Length = 507 |
| >gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Score = 47.6 bits (114), Expect = 1e-05
Identities = 25/85 (29%), Positives = 41/85 (48%), Gaps = 15/85 (17%)
Query: 891 YNVHTYLVLELLKGGELLD--RIRQKGRCGFTENEASRIMRQLVAAVHFMHSRGVVHRDL 948
N ++V+E G + D +I K TE E + I+ Q + + ++HS +HRD+
Sbjct: 69 KNTDLWIVMEYCGAGSVSDIMKITNKT---LTEEEIAAILYQTLKGLEYLHSNKKIHRDI 125
Query: 949 KPENLLLS----------GISGNLI 963
K N+LL+ G+SG L
Sbjct: 126 KAGNILLNEEGQAKLADFGVSGQLT 150
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256 |
| >gnl|CDD|173686 cd05595, STKc_PKB_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Score = 48.5 bits (115), Expect = 1e-05
Identities = 34/102 (33%), Positives = 54/102 (52%), Gaps = 17/102 (16%)
Query: 866 VTLFEEQLLGPITRAR-----RRTFVNRSRYNVHTY----LVLELLKGGEL---LDRIRQ 913
V + ++++ +T +R R F+ +Y T+ V+E GGEL L R R
Sbjct: 32 VIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGGELFFHLSRERV 91
Query: 914 KGRCGFTENEASRIMRQLVAAVHFMHSRGVVHRDLKPENLLL 955
FTE A ++V+A+ ++HSR VV+RD+K ENL+L
Sbjct: 92 -----FTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLML 128
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in PKB-beta display normal growth weights but exhibit severe insulin resistance and diabetes, accompanied by lipoatrophy and B-cell failure. Length = 323 |
| >gnl|CDD|173706 cd05615, STKc_cPKC_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Score = 48.5 bits (115), Expect = 1e-05
Identities = 22/60 (36%), Positives = 39/60 (65%), Gaps = 2/60 (3%)
Query: 896 YLVLELLKGGELLDRIRQKGRCGFTENEASRIMRQLVAAVHFMHSRGVVHRDLKPENLLL 955
Y V+E + GG+L+ I+Q G+ F E +A ++ + F+H RG+++RDLK +N++L
Sbjct: 77 YFVMEYVNGGDLMYHIQQVGK--FKEPQAVFYAAEISVGLFFLHRRGIIYRDLKLDNVML 134
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. PKC-alpha is expressed in many tissues and is associated with cell proliferation, apoptosis, and cell motility. It plays a role in the signaling of the growth factors PDGF, VEGF, EGF, and FGF. Abnormal levels of PKC-alpha have been detected in many transformed cell lines and several human tumors. In addition, PKC-alpha is required for HER2 dependent breast cancer invasion. Length = 323 |
| >gnl|CDD|215036 PLN00034, PLN00034, mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Score = 48.7 bits (116), Expect = 1e-05
Identities = 23/69 (33%), Positives = 40/69 (57%), Gaps = 8/69 (11%)
Query: 897 LVLELLKGGELLDRIRQKGRCGFTENEASRIMRQLVAAVHFMHSRGVVHRDLKPENLLLS 956
++LE + GG L +G E + + RQ+++ + ++H R +VHRD+KP NLL++
Sbjct: 149 VLLEFMDGGSL------EGTHIADEQFLADVARQILSGIAYLHRRHIVHRDIKPSNLLIN 202
Query: 957 GISGNLIKI 965
S +KI
Sbjct: 203 --SAKNVKI 209
|
Length = 353 |
| >gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Score = 47.8 bits (114), Expect = 1e-05
Identities = 22/61 (36%), Positives = 37/61 (60%), Gaps = 2/61 (3%)
Query: 896 YLVLELLKGGELLDRIRQKGRCGFTENEASRIMRQLVAAVHFMHSRGVVHRDLKPENLLL 955
YLV E + +LD + +K G E+ + + Q++ + F HS ++HRD+KPEN+L+
Sbjct: 76 YLVFEFVDH-TVLDDL-EKYPNGLDESRVRKYLFQILRGIEFCHSHNIIHRDIKPENILV 133
Query: 956 S 956
S
Sbjct: 134 S 134
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286 |
| >gnl|CDD|173691 cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 48.2 bits (115), Expect = 1e-05
Identities = 22/63 (34%), Positives = 34/63 (53%), Gaps = 2/63 (3%)
Query: 894 HTYLVLELLKGGELLDRIRQKGRCGFTENEASRIMRQLVAAVHFMHSRGVVHRDLKPENL 953
+ YL +E + GG+ + G +E+ A M ++ AV +H G +HRDLKPEN
Sbjct: 75 YLYLAMEYVPGGDFRTLLNNLG--VLSEDHARFYMAEMFEAVDALHELGYIHRDLKPENF 132
Query: 954 LLS 956
L+
Sbjct: 133 LID 135
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. Dbf2p is important in regulating the mitotic exit network (MEN) and in cytokinesis. Length = 333 |
| >gnl|CDD|173717 cd05628, STKc_NDR1, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Score = 48.5 bits (115), Expect = 1e-05
Identities = 23/60 (38%), Positives = 37/60 (61%), Gaps = 2/60 (3%)
Query: 896 YLVLELLKGGELLDRIRQKGRCGFTENEASRIMRQLVAAVHFMHSRGVVHRDLKPENLLL 955
YL++E L GG+++ + +K TE E + + V A+ +H G +HRD+KP+NLLL
Sbjct: 77 YLIMEFLPGGDMMTLLMKKDT--LTEEETQFYIAETVLAIDSIHQLGFIHRDIKPDNLLL 134
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, muscle, lung and spleen. It is not an essential protein because mice deficient of NDR1 remain viable and fertile. However, these mice develop T-cell lymphomas and appear to be hypersenstive to carcinogenic treatment. NDR1 appears to act as a tumor suppressor. NDR1 is also called STK38. Length = 363 |
| >gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Score = 47.7 bits (114), Expect = 1e-05
Identities = 20/79 (25%), Positives = 41/79 (51%), Gaps = 12/79 (15%)
Query: 896 YLVLELLKGGELLDRIRQKGRCGFTENEASRIMRQLVAAVHFMHS-RGVVHRDLKPENLL 954
+ +E + GG L D+I ++ + E +I ++ + ++H ++HRD+KP N+L
Sbjct: 75 SICMEYMDGGSL-DKILKEVQGRIPERILGKIAVAVLKGLTYLHEKHKIIHRDVKPSNIL 133
Query: 955 LS----------GISGNLI 963
++ G+SG L+
Sbjct: 134 VNSRGQIKLCDFGVSGQLV 152
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265 |
| >gnl|CDD|173721 cd05632, STKc_GRK5, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Score = 47.7 bits (113), Expect = 1e-05
Identities = 23/59 (38%), Positives = 33/59 (55%)
Query: 897 LVLELLKGGELLDRIRQKGRCGFTENEASRIMRQLVAAVHFMHSRGVVHRDLKPENLLL 955
LVL ++ GG+L I G GF E A +++ + +H V+RDLKPEN+LL
Sbjct: 77 LVLTIMNGGDLKFHIYNMGNPGFEEERALFYAAEILCGLEDLHRENTVYRDLKPENILL 135
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with the membrane though an N-terminal PIP2 binding domain and also binds phospholipids via its C-terminus. GRK5 deficiency is associated with early Alzheimer's disease in humans and mouse models. GRK5 also plays a crucial role in the pathogenesis of sporadic Parkinson's disease. It participates in the regulation and desensitization of PDGFRbeta, a receptor tyrosine kinase involved in a variety of downstream cellular effects including cell growth, chemotaxis, apoptosis, and angiogenesis. GRK5 also regulates Toll-like receptor 4, which is involved in innate and adaptive immunity. Length = 285 |
| >gnl|CDD|173716 cd05627, STKc_NDR2, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Score = 48.1 bits (114), Expect = 1e-05
Identities = 21/60 (35%), Positives = 36/60 (60%), Gaps = 2/60 (3%)
Query: 896 YLVLELLKGGELLDRIRQKGRCGFTENEASRIMRQLVAAVHFMHSRGVVHRDLKPENLLL 955
YL++E L GG+++ + +K +E + + V A+ +H G +HRD+KP+NLLL
Sbjct: 77 YLIMEFLPGGDMMTLLMKKDT--LSEEATQFYIAETVLAIDAIHQLGFIHRDIKPDNLLL 134
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regulating neuronal growth and differentiation, as well as in facilitating neurite outgrowth. It is also implicated in fear conditioning as it contributes to the coupling of neuronal morphological changes with fear-memory consolidation. NDR2 is also referred to as STK38-like. Length = 360 |
| >gnl|CDD|173719 cd05630, STKc_GRK6, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Score = 48.1 bits (114), Expect = 1e-05
Identities = 24/69 (34%), Positives = 32/69 (46%)
Query: 264 RRILKTEPPIPEDLSPDVADFISRLLVKDPRRRLGGGELDAEELKRHPFFNVIDWDDLAT 323
R + + + E SPD LL KDP+ RLG A E+K HP F I++ L
Sbjct: 215 RLVKEVQEEYSEKFSPDARSLCKMLLCKDPKERLGCQGGGAREVKEHPLFKQINFKRLEA 274
Query: 324 KRIPAPFVP 332
+ PF P
Sbjct: 275 GMLEPPFKP 283
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK6 plays important roles in the regulation of dopamine, M3 muscarinic, opioid, and chemokine receptor signaling. It also plays maladaptive roles in addiction and Parkinson's disease. GRK6-deficient mice exhibit altered dopamine receptor regulation, decreased lymphocyte chemotaxis, and increased acute inflammation and neutrophil chemotaxis. Length = 285 |
| >gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 47.8 bits (114), Expect = 1e-05
Identities = 21/60 (35%), Positives = 34/60 (56%), Gaps = 2/60 (3%)
Query: 896 YLVLELLKGGELLDRIRQKGRCGFTENEASRIMRQLVAAVHFMHSRGVVHRDLKPENLLL 955
Y+ LEL+ GG L +++ G F E RQ++ + ++H R VHRD+K N+L+
Sbjct: 78 YIFLELVPGGSLAKLLKKYG--SFPEPVIRLYTRQILLGLEYLHDRNTVHRDIKGANILV 135
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 49.1 bits (117), Expect = 1e-05
Identities = 52/214 (24%), Positives = 83/214 (38%), Gaps = 24/214 (11%)
Query: 363 FDKIFKGSLFFEQYDMDLDKAGILGDGSYSVCRRCVEKSTGQEYAVKIISRKIDCSE-EI 421
FD S+ L + ++ G + G ++ VK I+ EI
Sbjct: 675 FDSKVSKSITINDILSSLKEENVISRGKKGASYKGKSIKNGMQFVVKEINDVNSIPSSEI 734
Query: 422 NLLRACQGHPNIVNLHCVFQDEVHTYLVLELLKGGELLDRIRQKGRCGFTENEASRIMRQ 481
+ Q HPNIV L + + E YL+ E ++G L + +R + +I
Sbjct: 735 ADMGKLQ-HPNIVKLIGLCRSEKGAYLIHEYIEGKNLSEVLR-----NLSWERRRKIAIG 788
Query: 482 LVAAVHFMH---SRGVVHRDLKPENLLFSDPAGDNIKVVDFGFACLKRESL---HTPCFT 535
+ A+ F+H S VV +L PE ++ I D L L T CF
Sbjct: 789 IAKALRFLHCRCSPAVVVGNLSPEKII--------IDGKDEPHLRLSLPGLLCTDTKCFI 840
Query: 536 LQ-YAAPEVLRQDKSGYDENCDLWSLGVILVNVL 568
Y APE ++ E D++ G+IL+ +L
Sbjct: 841 SSAYVAPET--RETKDITEKSDIYGFGLILIELL 872
|
Length = 968 |
| >gnl|CDD|140307 PTZ00284, PTZ00284, protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 48.8 bits (116), Expect = 1e-05
Identities = 57/237 (24%), Positives = 101/237 (42%), Gaps = 54/237 (22%)
Query: 385 ILGDGSYSVCRRCVEKSTGQEYAVKIISRKI-----DCSEEINLL-RACQGHPN----IV 434
+LG+G++ ++ + AVKI+ R + D EI + + Q P ++
Sbjct: 136 LLGEGTFGKVVEAWDRKRKEYCAVKIV-RNVPKYTRDAKIEIQFMEKVRQADPADRFPLM 194
Query: 435 NLHCVFQDEVHTYLVLELLKGGELLDRIRQKGRCGFTENEASRIMRQLVAAVHFMHSR-G 493
+ FQ+E ++ G LLD I + G F+ ++I+ Q A+ + H+
Sbjct: 195 KIQRYFQNETGHMCIVMPKYGPCLLDWIMKHG--PFSHRHLAQIIFQTGVALDYFHTELH 252
Query: 494 VVHRDLKPENLLFS------DPAGDN--------IKVVDFGFACLKRESLHTPCFTLQYA 539
++H DLKPEN+L DP + +++ D G C +R S T Y
Sbjct: 253 LMHTDLKPENILMETSDTVVDPVTNRALPPDPCRVRICDLGGCCDERHSRTAIVSTRHYR 312
Query: 540 APEVLRQDKSGYDENCDLWSLGVILVNVLRQDKSGYDENCDLWSLGVILYTMLCGRV 596
+PEV+ LG+ G+ + D+WS+G I+Y + G++
Sbjct: 313 SPEVV---------------LGL-----------GWMYSTDMWSMGCIIYELYTGKL 343
|
Length = 467 |
| >gnl|CDD|133179 cd05048, PTKc_Ror, Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Score = 47.8 bits (114), Expect = 1e-05
Identities = 54/224 (24%), Positives = 83/224 (37%), Gaps = 47/224 (20%)
Query: 363 FDKIFKGSLFFEQYDMDLDKAGILGDGSYSVCRRCVEKSTGQEYAVKIISRKIDCSEEIN 422
F K++KG L G K+ + K+ + + +E
Sbjct: 18 FGKVYKGELT--------------GPNERLSATSVAIKTLKENAEPKV---QQEFRQEAE 60
Query: 423 LLRACQGHPNIVNLHCVFQDEVHTYLVLELLKGGEL---LDRIRQKGRCGFTENEAS--- 476
L+ Q HPNIV L V E T ++ E L G+L L R G + +
Sbjct: 61 LMSDLQ-HPNIVCLLGVCTKEQPTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKS 119
Query: 477 --------RIMRQLVAAVHFMHSRGVVHRDLKPENLLFSDPAGDNIKVVDFGFACLKRE- 527
I Q+ A + ++ S VHRDL N L + G +K+ DFG L R+
Sbjct: 120 SLDCSDFLHIAIQIAAGMEYLSSHHFVHRDLAARNCLVGE--GLTVKISDFG---LSRDI 174
Query: 528 -------SLHTPCFTLQYAAPEVLRQDKSGYDENCDLWSLGVIL 564
+++ PE + K + D+WS GV+L
Sbjct: 175 YSADYYRVQSKSLLPVRWMPPEAILYGK--FTTESDIWSFGVVL 216
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. They play important roles in bone and heart formation. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Drosophila Ror is expressed only in the developing nervous system during neurite outgrowth and neuronal differentiation, suggesting a role for Drosophila Ror in neural development. More recently, mouse Ror1 and Ror2 have also been found to play an important role in regulating neurite growth in central neurons. Ror1 and Ror2 are believed to have some overlapping and redundant functions. Length = 283 |
| >gnl|CDD|133229 cd05098, PTKc_FGFR1, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Score = 48.1 bits (114), Expect = 1e-05
Identities = 45/183 (24%), Positives = 80/183 (43%), Gaps = 31/183 (16%)
Query: 416 DCSEEINLLRACQGHPNIVNLHCVFQDEVHTYLVLELLKGGELLDRIRQKGRCGF----- 470
D E+ +++ H NI+NL + Y+++E G L + +R + G
Sbjct: 69 DLISEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYCYN 128
Query: 471 -----TENEASRIM----RQLVAAVHFMHSRGVVHRDLKPENLLFSDPAGDNI-KVVDFG 520
E + + + Q+ + ++ S+ +HRDL N+L ++ DN+ K+ DFG
Sbjct: 129 PTQVPEEQLSFKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTE---DNVMKIADFG 185
Query: 521 FACLKRESLHTPCFT--------LQYAAPEVLRQDKSGYDENCDLWSLGVILVNVLRQDK 572
A R+ H + +++ APE L D+ Y D+WS GV+L +
Sbjct: 186 LA---RDIHHIDYYKKTTNGRLPVKWMAPEALF-DRI-YTHQSDVWSFGVLLWEIFTLGG 240
Query: 573 SGY 575
S Y
Sbjct: 241 SPY 243
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Alternative splicing of FGFR1 transcripts produces a variety of isoforms, which are differentially expressed in cells. FGFR1 binds the ligands, FGF1 and FGF2, with high affinity and has also been reported to bind FGF4, FGF6, and FGF9. FGFR1 signaling is critical in the control of cell migration during embryo development. It promotes cell proliferation in fibroblasts. Nuclear FGFR1 plays a role in the regulation of transcription. Mutations, insertions or deletions of FGFR1 have been identified in patients with Kallman's syndrome (KS), an inherited disorder characterized by hypogonadotropic hypogonadism and loss of olfaction. Aberrant FGFR1 expression has been found in some human cancers including 8P11 myeloproliferative syndrome (EMS), breast cancer, and pancreatic adenocarcinoma. Length = 307 |
| >gnl|CDD|133195 cd05064, PTKc_EphR_A10, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Score = 47.6 bits (113), Expect = 1e-05
Identities = 46/198 (23%), Positives = 81/198 (40%), Gaps = 21/198 (10%)
Query: 385 ILGDGSY-SVCRRCVEKSTGQEYAVKIISRKIDCSEEIN---LLRACQ----GHPNIVNL 436
ILG G + +CR C++ + +E V I + + CS++ L A H NIV L
Sbjct: 12 ILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSDKQRRGFLAEALTLGQFDHSNIVRL 71
Query: 437 HCVFQDEVHTYLVLELLKGGELLDRIRQKGRCGFTENEASRIMRQLVAAVHFMHSRGVVH 496
V +V E + G LD +K + ++ L + + ++ G VH
Sbjct: 72 EGVITRGNTMMIVTEYMSNG-ALDSFLRKHEGQLVAGQLMGMLPGLASGMKYLSEMGYVH 130
Query: 497 RDLKPENLLFSDPAGDNIKVVDFGFACLKRESLHTPCFTLQ------YAAPEVLRQDKSG 550
+ L +L + I GF L+ + T+ +AAPE ++
Sbjct: 131 KGLAAHKVLVNSDLVCKIS----GFRRLQEDKSEAIYTTMSGKSPVLWAAPEAIQYHH-- 184
Query: 551 YDENCDLWSLGVILVNVL 568
+ D+WS G+++ V+
Sbjct: 185 FSSASDVWSFGIVMWEVM 202
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). EphA10, which contains an inactive tyr kinase domain, may function to attenuate signals of co-clustered active receptors. EphA10 is mainly expressed in the testis. Ephrin/EphR interaction results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Score = 46.5 bits (111), Expect = 2e-05
Identities = 17/56 (30%), Positives = 29/56 (51%), Gaps = 7/56 (12%)
Query: 124 LGDGSYSVCRRCVEKSTGQEYAVKIISRK------IDCSEEINLLRACQGHPNICR 173
LG+G + +K TG++ A+KII ++ + EI +L+ HPNI +
Sbjct: 1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLN-HPNIVK 55
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215 |
| >gnl|CDD|173682 cd05591, STKc_nPKC_epsilon, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Score = 47.1 bits (112), Expect = 2e-05
Identities = 22/60 (36%), Positives = 38/60 (63%), Gaps = 2/60 (3%)
Query: 896 YLVLELLKGGELLDRIRQKGRCGFTENEASRIMRQLVAAVHFMHSRGVVHRDLKPENLLL 955
+ V+E + GG+L+ +I Q+ R F E + ++ A+ F+H GV++RDLK +N+LL
Sbjct: 72 FFVMEYVNGGDLMFQI-QRSR-KFDEPRSRFYAAEVTLALMFLHRHGVIYRDLKLDNILL 129
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to neoplastic transformation depending on the cell type. It contributes to oncogenesis by inducing disordered cell growth and inhibiting cell death. It also plays a role in tumor invasion and metastasis. PKC-epsilon has also been found to confer cardioprotection against ischemia and reperfusion-mediated damage. Other cellular functions include the regulation of gene expression, cell adhesion, and cell motility. Length = 321 |
| >gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Score = 47.6 bits (114), Expect = 2e-05
Identities = 20/65 (30%), Positives = 34/65 (52%), Gaps = 4/65 (6%)
Query: 892 NVHTYLVLELLKGGELLDRIRQKGRCGFTENEASRIMRQLVAAVHFMHSRGVVHRDLKPE 951
N++ LV E + +L I+ K T + M + + ++HS ++HRDLKP
Sbjct: 76 NIN--LVFEFM-ETDLEKVIKDK-SIVLTPADIKSYMLMTLRGLEYLHSNWILHRDLKPN 131
Query: 952 NLLLS 956
NLL++
Sbjct: 132 NLLIA 136
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298 |
| >gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Score = 46.9 bits (112), Expect = 2e-05
Identities = 20/56 (35%), Positives = 30/56 (53%), Gaps = 11/56 (19%)
Query: 900 ELLKGGELLDRIRQKGRCGFTENEASRIMRQLVAAVHFMHSRGVVHRDLKPENLLL 955
ELL+ G +LD E+ QL+ + ++HS G+VHRD+KP N+ L
Sbjct: 88 ELLEHGRILD-----------EHVIRVYTLQLLEGLAYLHSHGIVHRDIKPANIFL 132
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264 |
| >gnl|CDD|133233 cd05102, PTKc_VEGFR3, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 47.3 bits (112), Expect = 2e-05
Identities = 33/103 (32%), Positives = 50/103 (48%), Gaps = 15/103 (14%)
Query: 481 QLVAAVHFMHSRGVVHRDLKPENLLFSDPAGDNIKVVDFGFACLKRESLHTPCFT----- 535
Q+ + F+ SR +HRDL N+L S+ + +K+ DFG A R+ P +
Sbjct: 182 QVARGMEFLASRKCIHRDLAARNILLSE--NNVVKICDFGLA---RDIYKDPDYVRKGSA 236
Query: 536 ---LQYAAPEVLRQDKSGYDENCDLWSLGVILVNVLRQDKSGY 575
L++ APE + DK Y D+WS GV+L + S Y
Sbjct: 237 RLPLKWMAPESIF-DKV-YTTQSDVWSFGVLLWEIFSLGASPY 277
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. VEGFR3 preferentially binds the ligands VEGFC and VEGFD. VEGFR3 is essential for lymphatic endothelial cell (EC) development and function. It has been shown to regulate adaptive immunity during corneal transplantation. VEGFR3 is upregulated on blood vascular ECs in pathological conditions such as vascular tumors and the periphery of solid tumors. It plays a role in cancer progression and lymph node metastasis. Missense mutations in the VEGFR3 gene are associated with primary human lymphedema. Length = 338 |
| >gnl|CDD|173649 cd05093, PTKc_TrkB, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Score = 47.0 bits (111), Expect = 2e-05
Identities = 49/182 (26%), Positives = 80/182 (43%), Gaps = 32/182 (17%)
Query: 412 SRKIDCSEEINLLRACQGHPNIVNLHCVFQDEVHTYLVLELLKGGELLDRIRQKGR---- 467
+RK D E LL Q H +IV + V + +V E +K G+L +R G
Sbjct: 50 ARK-DFHREAELLTNLQ-HEHIVKFYGVCVEGDPLIMVFEYMKHGDLNKFLRAHGPDAVL 107
Query: 468 -------CGFTENEASRIMRQLVAAVHFMHSRGVVHRDLKPENLLFSDPAGDN--IKVVD 518
T+++ I +Q+ A + ++ S+ VHRDL N L G+N +K+ D
Sbjct: 108 MAEGNRPAELTQSQMLHIAQQIAAGMVYLASQHFVHRDLATRNCL----VGENLLVKIGD 163
Query: 519 FGFACLKRESLHTPCF--------TLQYAAPEVLRQDKSGYDENCDLWSLGVILVNVLRQ 570
FG + R+ T + +++ PE + K + D+WSLGV+L +
Sbjct: 164 FG---MSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRK--FTTESDVWSLGVVLWEIFTY 218
Query: 571 DK 572
K
Sbjct: 219 GK 220
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly expressed in the nervous system and in some non-neural tissues. It plays important roles in cell proliferation, differentiation, and survival. BDNF/Trk signaling plays a key role in regulating activity-dependent synaptic plasticity. TrkB also contributes to protection against gp120-induced neuronal cell death. TrkB overexpression is associated with poor prognosis in neuroblastoma (NB) and other human cancers. It acts as a suppressor of anoikis (detachment-induced apoptosis) and contributes to tumor metastasis. Length = 288 |
| >gnl|CDD|173709 cd05619, STKc_nPKC_theta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Score = 46.9 bits (111), Expect = 3e-05
Identities = 21/62 (33%), Positives = 39/62 (62%), Gaps = 2/62 (3%)
Query: 894 HTYLVLELLKGGELLDRIRQKGRCGFTENEASRIMRQLVAAVHFMHSRGVVHRDLKPENL 953
+ + V+E L GG+L+ I+ + F A+ +++ + F+HS+G+V+RDLK +N+
Sbjct: 70 NLFFVMEYLNGGDLMFHIQSCHK--FDLPRATFYAAEIICGLQFLHSKGIVYRDLKLDNI 127
Query: 954 LL 955
LL
Sbjct: 128 LL 129
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. Although T-cells also express other PKC isoforms, PKC-theta is unique in that upon antigen stimulation, it is translocated to the plasma membrane at the immunological synapse, where it mediates signals essential for T-cell activation. It is essential for TCR-induced proliferation, cytokine production, T-cell survival, and the differentiation and effector function of T-helper (Th) cells, particularly Th2 and Th17. PKC-theta is being developed as a therapeutic target for Th2-mediated allergic inflammation and Th17-mediated autoimmune diseases. Length = 316 |
| >gnl|CDD|173679 cd05588, STKc_aPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Score = 46.7 bits (111), Expect = 3e-05
Identities = 19/60 (31%), Positives = 39/60 (65%), Gaps = 2/60 (3%)
Query: 896 YLVLELLKGGELLDRIRQKGRCGFTENEASRIMRQLVAAVHFMHSRGVVHRDLKPENLLL 955
+ V+E + GG+L+ ++++ + E A ++ A++F+H RG+++RDLK +N+LL
Sbjct: 72 FFVIEFVSGGDLMFHMQRQRK--LPEEHARFYSAEISLALNFLHERGIIYRDLKLDNVLL 129
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions including proliferation, migration, apoptosis, polarity maintenance and cytoskeletal regulation. They also play a critical role in the regulation of glucose metabolism and in the pathogenesis of type 2 diabetes. Length = 329 |
| >gnl|CDD|173616 PTZ00426, PTZ00426, cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 47.3 bits (112), Expect = 3e-05
Identities = 25/62 (40%), Positives = 35/62 (56%), Gaps = 2/62 (3%)
Query: 894 HTYLVLELLKGGELLDRIRQKGRCGFTENEASRIMRQLVAAVHFMHSRGVVHRDLKPENL 953
+ YLVLE + GGE +R+ R F + Q+V ++ S +V+RDLKPENL
Sbjct: 105 YLYLVLEFVIGGEFFTFLRRNKR--FPNDVGCFYAAQIVLIFEYLQSLNIVYRDLKPENL 162
Query: 954 LL 955
LL
Sbjct: 163 LL 164
|
Length = 340 |
| >gnl|CDD|173722 cd05633, STKc_GRK3, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Score = 46.9 bits (111), Expect = 3e-05
Identities = 23/69 (33%), Positives = 36/69 (52%)
Query: 264 RRILKTEPPIPEDLSPDVADFISRLLVKDPRRRLGGGELDAEELKRHPFFNVIDWDDLAT 323
R L +P+ SP++ + LL +D +RLG A+E+K H FF IDW +
Sbjct: 209 RMTLTVNVELPDSFSPELKSLLEGLLQRDVSKRLGCLGRGAQEVKEHVFFKGIDWQQVYL 268
Query: 324 KRIPAPFVP 332
++ P P +P
Sbjct: 269 QKYPPPLIP 277
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is widely expressed in many tissues. GRK3-deficient mice show a lack of olfactory receptor desensitization and altered regulation of the M2 muscarinic airway. GRK3 is involved in modulating the cholinergic response of airway smooth muscles. It also plays a role in dopamine receptor regulation. GRK3 promoter polymorphisms may be associated with bipolar disorder. Length = 279 |
| >gnl|CDD|234389 TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclase fusion protein | Back alignment and domain information |
|---|
Score = 47.9 bits (114), Expect = 3e-05
Identities = 21/61 (34%), Positives = 36/61 (59%), Gaps = 2/61 (3%)
Query: 896 YLVLELLKGGELLDRIRQKGRCGFTENEASRIMRQLVAAVHFMHSRGVVHRDLKPENLLL 955
+ V E + G L + + G E R+M Q++ A+ H++G+VHRDLKP+N+++
Sbjct: 55 FAVFEYVPGRTLREVLAADG--ALPAGETGRLMLQVLDALACAHNQGIVHRDLKPQNIMV 112
Query: 956 S 956
S
Sbjct: 113 S 113
|
This model represents proteins of 1350 in length, in multiple species of Burkholderia, in Acidovorax avenae subsp. citrulli AAC00-1 and Delftia acidovorans SPH-1, and in multiple copies in Sorangium cellulosum, in genomic neighborhoods that include a cyclodehydratase/docking scaffold fusion protein (TIGR03882) and a member of the thiazole/oxazole modified metabolite (TOMM) precursor family TIGR03795. It has a kinase domain in the N-terminal 300 amino acids, followed by a cyclase homology domain, followed by regions without named domain definitions. It is a probable bacteriocin-like metabolite biosynthesis protein [Cellular processes, Toxin production and resistance]. Length = 1266 |
| >gnl|CDD|173647 cd05091, PTKc_Ror2, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Score = 46.6 bits (110), Expect = 3e-05
Identities = 47/189 (24%), Positives = 81/189 (42%), Gaps = 28/189 (14%)
Query: 404 QEYAVKIISRKIDCS--EEIN---LLRACQGHPNIVNLHCVFQDEVHTYLVLELLKGGEL 458
Q A+K + K + EE ++R+ HPNIV L V E ++ +L
Sbjct: 36 QAVAIKTLKDKAEGPLREEFKHEAMMRSRLQHPNIVCLLGVVTKEQPLSMIFSYCSHSDL 95
Query: 459 LDRIRQKG---RCGFTENEAS-----------RIMRQLVAAVHFMHSRGVVHRDLKPENL 504
+ + + G T+++ + I+ Q+ A + F+ S VVH+DL N+
Sbjct: 96 HEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFLSSHHVVHKDLATRNV 155
Query: 505 LFSDPAGDNIKVVDFG-----FACLKRESLHTPCFTLQYAAPEVLRQDKSGYDENCDLWS 559
L D N+K+ D G +A + + +++ +PE + K D D+WS
Sbjct: 156 LVFDKL--NVKISDLGLFREVYAADYYKLMGNSLLPIRWMSPEAIMYGKFSIDS--DIWS 211
Query: 560 LGVILVNVL 568
GV+L V
Sbjct: 212 YGVVLWEVF 220
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror2 plays important roles in skeletal and heart formation. Ror2-deficient mice show widespread bone abnormalities, ventricular defects in the heart, and respiratory dysfunction. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Ror2 is also implicated in neural development. Length = 283 |
| >gnl|CDD|133180 cd05049, PTKc_Trk, Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Score = 46.3 bits (110), Expect = 3e-05
Identities = 47/186 (25%), Positives = 78/186 (41%), Gaps = 38/186 (20%)
Query: 407 AVKII------SRKIDCSEEINLLRACQGHPNIVNLHCVFQDEVHTYLVLELLKGGELLD 460
AVK + + D E LL Q H NIV + V + +V E ++ G+L
Sbjct: 39 AVKTLKETASNDARKDFEREAELLTNFQ-HENIVKFYGVCTEGDPPIMVFEYMEHGDLNK 97
Query: 461 RIRQKGR-----------CG-FTENEASRIMRQLVAAVHFMHSRGVVHRDLKPENLLFSD 508
+R G G T ++ +I Q+ + + ++ S+ VHRDL N L
Sbjct: 98 FLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGMVYLASQHFVHRDLATRNCL--- 154
Query: 509 PAGDN--IKVVDFGFACLKRESLHTPCFT--------LQYAAPEVLRQDKSGYDENCDLW 558
G + +K+ DFG + R+ T + +++ PE + K + D+W
Sbjct: 155 -VGYDLVVKIGDFG---MSRDVYTTDYYRVGGHTMLPIRWMPPESIMYRK--FTTESDVW 208
Query: 559 SLGVIL 564
S GV+L
Sbjct: 209 SFGVVL 214
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalytic domain. Trk receptors are mainly expressed in the peripheral and central nervous systems. They play important roles in cell fate determination, neuronal survival and differentiation, as well as in the regulation of synaptic plasticity. Altered expression of Trk receptors is associated with many human diseases. Length = 280 |
| >gnl|CDD|173725 cd06608, STKc_myosinIII_like, Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 46.1 bits (110), Expect = 4e-05
Identities = 22/63 (34%), Positives = 40/63 (63%), Gaps = 4/63 (6%)
Query: 896 YLVLELLKGG---ELLDRIRQKGRCGFTENEASRIMRQLVAAVHFMHSRGVVHRDLKPEN 952
+LV+EL GG +L+ +R+KG+ E + I+R+ + + ++H V+HRD+K +N
Sbjct: 85 WLVMELCGGGSVTDLVKGLRKKGK-RLKEEWIAYILRETLRGLAYLHENKVIHRDIKGQN 143
Query: 953 LLL 955
+LL
Sbjct: 144 ILL 146
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin III may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. It may also function as a cargo carrier during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. The Drosophila class III myosin, called NinaC (Neither inactivation nor afterpotential protein C), is critical in normal adaptation and termination of photoresponse. Vertebrates contain two isoforms of class III myosin, IIIA and IIIB. This subfamily also includes mammalian NIK-like embryo-specific kinase (NESK), Traf2- and Nck-interacting kinase (TNIK), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6). MAP4Ks are involved in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Length = 275 |
| >gnl|CDD|132975 cd06644, STKc_STK10_LOK, Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Score = 46.2 bits (109), Expect = 4e-05
Identities = 22/61 (36%), Positives = 38/61 (62%), Gaps = 1/61 (1%)
Query: 896 YLVLELLKGGELLDRIRQKGRCGFTENEASRIMRQLVAAVHFMHSRGVVHRDLKPENLLL 955
++++E GG + D I + G TE + I RQ++ A+ ++HS ++HRDLK N+LL
Sbjct: 85 WIMIEFCPGGAV-DAIMLELDRGLTEPQIQVICRQMLEALQYLHSMKIIHRDLKAGNVLL 143
Query: 956 S 956
+
Sbjct: 144 T 144
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. Length = 292 |
| >gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 46.3 bits (110), Expect = 4e-05
Identities = 26/94 (27%), Positives = 51/94 (54%), Gaps = 18/94 (19%)
Query: 884 TFVNRSRYNVHTYLVLELLKGGEL---LDRIRQKG-RCGFTENEASRIMRQLVAAVHFMH 939
F++ S ++ + +E +GG L +++++G R G E +I ++ + ++H
Sbjct: 67 AFLDESSSSI--GIAMEYCEGGSLDSIYKKVKKRGGRIG--EKVLGKIAESVLKGLSYLH 122
Query: 940 SRGVVHRDLKPENLLLS----------GISGNLI 963
SR ++HRD+KP N+LL+ G+SG L+
Sbjct: 123 SRKIIHRDIKPSNILLTRKGQVKLCDFGVSGELV 156
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287 |
| >gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 45.9 bits (109), Expect = 4e-05
Identities = 21/59 (35%), Positives = 35/59 (59%), Gaps = 2/59 (3%)
Query: 897 LVLELLKGGELLDRIRQKGRCGFTENEASRIMRQLVAAVHFMHSRGVVHRDLKPENLLL 955
+ LE + GG + +R GR F E Q++ + ++HS+G++HRDLK +NLL+
Sbjct: 85 IFLEYVPGGSIGSCLRTYGR--FEEQLVRFFTEQVLEGLAYLHSKGILHRDLKADNLLV 141
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272 |
| >gnl|CDD|132985 cd06654, STKc_PAK1, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Score = 46.3 bits (109), Expect = 4e-05
Identities = 24/67 (35%), Positives = 43/67 (64%), Gaps = 4/67 (5%)
Query: 896 YLVLELLKGGELLDRIRQKGRCGFTENEASRIMRQLVAAVHFMHSRGVVHRDLKPENLLL 955
++V+E L GG L D + + C E + + + R+ + A+ F+HS V+HRD+K +N+LL
Sbjct: 93 WVVMEYLAGGSLTDVVTET--C-MDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILL 149
Query: 956 SGISGNL 962
G+ G++
Sbjct: 150 -GMDGSV 155
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK1 is important in the regulation of many cellular processes including cytoskeletal dynamics, cell motility, growth, and proliferation. Although PAK1 has been regarded mainly as a cytosolic protein, recent reports indicate that PAK1 also exists in significant amounts in the nucleus, where it is involved in transcription modulation and in cell cycle regulatory events. PAK1 is also involved in transformation and tumorigenesis. Its overexpression, hyperactivation and increased nuclear accumulation is correlated to breast cancer invasiveness and progression. Nuclear accumulation is also linked to tamoxifen resistance in breast cancer cells. Length = 296 |
| >gnl|CDD|133234 cd05103, PTKc_VEGFR2, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 46.6 bits (110), Expect = 4e-05
Identities = 32/103 (31%), Positives = 50/103 (48%), Gaps = 15/103 (14%)
Query: 481 QLVAAVHFMHSRGVVHRDLKPENLLFSDPAGDNIKVVDFGFACLKRESLHTPCFT----- 535
Q+ + F+ SR +HRDL N+L S+ + +K+ DFG A R+ P +
Sbjct: 187 QVAKGMEFLASRKCIHRDLAARNILLSE--NNVVKICDFGLA---RDIYKDPDYVRKGDA 241
Query: 536 ---LQYAAPEVLRQDKSGYDENCDLWSLGVILVNVLRQDKSGY 575
L++ APE + D+ Y D+WS GV+L + S Y
Sbjct: 242 RLPLKWMAPETIF-DRV-YTIQSDVWSFGVLLWEIFSLGASPY 282
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosphorylation and activation. VEGFR2 binds the ligands VEGFA, VEGFC, VEGFD and VEGFE. VEGFR2 signaling is implicated in all aspects of normal and pathological vascular endothelial cell biology. It induces a variety of cellular effects including migration, survival, and proliferation. It is critical in regulating embryonic vascular development and angiogenesis. VEGFR2 is the major signal transducer in pathological angiogenesis including cancer and diabetic retinopathy, and is a target for inhibition in cancer therapy. Length = 343 |
| >gnl|CDD|133217 cd05086, PTKc_Aatyk2, Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 46.0 bits (109), Expect = 4e-05
Identities = 40/150 (26%), Positives = 66/150 (44%), Gaps = 20/150 (13%)
Query: 430 HPNIVNLHCVFQ--DEVHTYLVLELLKGGELLDRIRQKG--RCGFTENEASRIMRQLVAA 485
HPNI L C+ Q + + LV E + G+L + Q+ R R+ ++ A
Sbjct: 54 HPNI--LQCLGQCVEAIPYLLVFEYCELGDLKSYLSQEQWHRRNSQLLLLQRMACEIAAG 111
Query: 486 VHFMHSRGVVHRDLKPENLLFSDPAGD-NIKVVDF--GFACLKRESLHTP---CFTLQYA 539
V MH +H DL N + D +KV D+ G + K + + T C L++
Sbjct: 112 VTHMHKHNFLHSDLALRNCFLT---SDLTVKVGDYGIGPSRYKEDYIETEDDKCVPLRWL 168
Query: 540 APEVL--RQDK---SGYDENCDLWSLGVIL 564
APE++ + + ++W+LGV L
Sbjct: 169 APELVGEFHGGLITAEQTKPSNVWALGVTL 198
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage spermatogenesis. Although it is classified as a tyr kinase based on sequence similarity and the phylogenetic tree, Aatyk2 has been characterized as a serine/threonine kinase. Length = 268 |
| >gnl|CDD|173698 cd05607, STKc_GRK7, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Score = 45.7 bits (108), Expect = 5e-05
Identities = 22/62 (35%), Positives = 32/62 (51%)
Query: 894 HTYLVLELLKGGELLDRIRQKGRCGFTENEASRIMRQLVAAVHFMHSRGVVHRDLKPENL 953
H LV+ L+ GG+L I G G Q+ + +HS +V+RD+KPEN+
Sbjct: 67 HLCLVMSLMNGGDLKYHIYNVGERGLEMERVIHYSAQITCGILHLHSMDIVYRDMKPENV 126
Query: 954 LL 955
LL
Sbjct: 127 LL 128
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual group of GRKs. It is primarily found in the retina and plays a role in the regulation of opsin light receptors. GRK7 is located in retinal cone outer segments and plays an important role in regulating photoresponse of the cones. Length = 277 |
| >gnl|CDD|143341 cd07836, STKc_Pho85, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Score = 45.9 bits (109), Expect = 5e-05
Identities = 16/42 (38%), Positives = 22/42 (52%)
Query: 916 RCGFTENEASRIMRQLVAAVHFMHSRGVVHRDLKPENLLLSG 957
R N QL+ + F H V+HRDLKP+NLL++
Sbjct: 94 RGALDPNTVKSFTYQLLKGIAFCHENRVLHRDLKPQNLLINK 135
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. It is not essential for yeast viability and is the functional homolog of mammalian CDK5, which plays a role in central nervous system development. Length = 284 |
| >gnl|CDD|173722 cd05633, STKc_GRK3, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Score = 45.8 bits (108), Expect = 5e-05
Identities = 26/69 (37%), Positives = 39/69 (56%), Gaps = 6/69 (8%)
Query: 891 YNVHT----YLVLELLKGGELLDRIRQKGRCGFTENEASRIMRQLVAAVHFMHSRGVVHR 946
Y HT +L+L+ GG+L + Q G F+E E +++ + MH+R VV+R
Sbjct: 64 YAFHTPDKLCFILDLMNGGDLHYHLSQHGV--FSEKEMRFYATEIILGLEHMHNRFVVYR 121
Query: 947 DLKPENLLL 955
DLKP N+LL
Sbjct: 122 DLKPANILL 130
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is widely expressed in many tissues. GRK3-deficient mice show a lack of olfactory receptor desensitization and altered regulation of the M2 muscarinic airway. GRK3 is involved in modulating the cholinergic response of airway smooth muscles. It also plays a role in dopamine receptor regulation. GRK3 promoter polymorphisms may be associated with bipolar disorder. Length = 279 |
| >gnl|CDD|132984 cd06653, STKc_MEKK3_like_1, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 45.8 bits (108), Expect = 5e-05
Identities = 23/66 (34%), Positives = 39/66 (59%), Gaps = 3/66 (4%)
Query: 897 LVLELLKGGELLDRIRQKGRCGFTENEASRIMRQLVAAVHFMHSRGVVHRDLKPENLLLS 956
+ +E + GG + D+++ G TEN R RQ++ V ++HS +VHRD+K N+L
Sbjct: 83 IFVEYMPGGSIKDQLKAYG--ALTENVTRRYTRQILQGVSYLHSNMIVHRDIKGANILRD 140
Query: 957 GISGNL 962
+GN+
Sbjct: 141 S-AGNV 145
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 264 |
| >gnl|CDD|140293 PTZ00267, PTZ00267, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 46.5 bits (110), Expect = 5e-05
Identities = 24/61 (39%), Positives = 36/61 (59%), Gaps = 2/61 (3%)
Query: 897 LVLELLKGGELLDRIRQ--KGRCGFTENEASRIMRQLVAAVHFMHSRGVVHRDLKPENLL 954
L++E GG+L +I+Q K F E E + Q+V A+ +HSR ++HRDLK N+
Sbjct: 142 LIMEYGSGGDLNKQIKQRLKEHLPFQEYEVGLLFYQIVLALDEVHSRKMMHRDLKSANIF 201
Query: 955 L 955
L
Sbjct: 202 L 202
|
Length = 478 |
| >gnl|CDD|132987 cd06656, STKc_PAK3, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Score = 45.9 bits (108), Expect = 5e-05
Identities = 24/67 (35%), Positives = 43/67 (64%), Gaps = 4/67 (5%)
Query: 896 YLVLELLKGGELLDRIRQKGRCGFTENEASRIMRQLVAAVHFMHSRGVVHRDLKPENLLL 955
++V+E L GG L D + + C E + + + R+ + A+ F+HS V+HRD+K +N+LL
Sbjct: 92 WVVMEYLAGGSLTDVVTET--C-MDEGQIAAVCRECLQALDFLHSNQVIHRDIKSDNILL 148
Query: 956 SGISGNL 962
G+ G++
Sbjct: 149 -GMDGSV 154
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK3 is highly expressed in the brain. It is implicated in neuronal plasticity, synapse formation, dendritic spine morphogenesis, cell cycle progression, neuronal migration, and apoptosis. Inactivating mutations in the PAK3 gene cause X-linked non-syndromic mental retardation, the severity of which depends on the site of the mutation. Length = 297 |
| >gnl|CDD|173763 cd08223, STKc_Nek4, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Score = 45.7 bits (108), Expect = 5e-05
Identities = 23/71 (32%), Positives = 44/71 (61%), Gaps = 4/71 (5%)
Query: 896 YLVLELLKGGELLDRIR-QKGRCGFTENEASRIMRQLVAAVHFMHSRGVVHRDLKPENLL 954
Y+V+ +GG+L +++ QKG+ EN+ Q+ A+ ++H + ++HRDLK +N+
Sbjct: 76 YIVMGFCEGGDLYHKLKEQKGKL-LPENQVVEWFVQIAMALQYLHEKHILHRDLKTQNVF 134
Query: 955 LSGISGNLIKI 965
L+ N+IK+
Sbjct: 135 LT--RTNIIKV 143
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. Length = 257 |
| >gnl|CDD|173744 cd07847, STKc_CDKL1_4, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Score = 45.8 bits (109), Expect = 6e-05
Identities = 16/39 (41%), Positives = 26/39 (66%)
Query: 918 GFTENEASRIMRQLVAAVHFMHSRGVVHRDLKPENLLLS 956
G E+ +I+ Q + AV+F H +HRD+KPEN+L++
Sbjct: 96 GVPEHLIKKIIWQTLQAVNFCHKHNCIHRDVKPENILIT 134
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The function of CDKL4 is unknown. Length = 286 |
| >gnl|CDD|133194 cd05063, PTKc_EphR_A2, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Score = 45.3 bits (107), Expect = 6e-05
Identities = 35/145 (24%), Positives = 65/145 (44%), Gaps = 11/145 (7%)
Query: 430 HPNIVNLHCVFQDEVHTYLVLELLKGGELLDRIRQKGRCGFTENEASRIMRQLVAAVHFM 489
H NI+ L V ++ E ++ G L D+ + F+ + ++R + A + ++
Sbjct: 65 HHNIIRLEGVVTKFKPAMIITEYMENGAL-DKYLRDHDGEFSSYQLVGMLRGIAAGMKYL 123
Query: 490 HSRGVVHRDLKPENLLFSDPAGDNIKVVDFGFACLKR---ESLHTPC---FTLQYAAPEV 543
VHRDL N+L + KV DFG + + E +T +++ APE
Sbjct: 124 SDMNYVHRDLAARNILVNSNL--ECKVSDFGLSRVLEDDPEGTYTTSGGKIPIRWTAPEA 181
Query: 544 LRQDKSGYDENCDLWSLGVILVNVL 568
+ K + D+WS G+++ V+
Sbjct: 182 IAYRK--FTSASDVWSFGIVMWEVM 204
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. The EphA2 receptor is overexpressed in tumor cells and tumor blood vessels in a variety of cancers including breast, prostate, lung, and colon. As a result, it is an attractive target for drug design since its inhibition could affect several aspects of tumor progression. Length = 268 |
| >gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Score = 44.5 bits (106), Expect = 7e-05
Identities = 20/54 (37%), Positives = 31/54 (57%), Gaps = 7/54 (12%)
Query: 174 RCVEKSTGQEYAVKIISRK------IDCSEEINLLRACQGHPNIVNLHCVFQDE 221
+K TG++ A+KII ++ + EI +L+ HPNIV L+ VF+DE
Sbjct: 11 LARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLN-HPNIVKLYGVFEDE 63
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215 |
| >gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Score = 45.3 bits (108), Expect = 7e-05
Identities = 21/54 (38%), Positives = 31/54 (57%), Gaps = 6/54 (11%)
Query: 122 GILGDGSY-SVCRRCVEKSTGQEYAVKIISRKIDCSE---EINLLRACQGHPNI 171
LG+GSY SV + + K TGQ A+K++ + D E EI++L+ C P I
Sbjct: 9 EKLGEGSYGSVYK-AIHKETGQVVAIKVVPVEEDLQEIIKEISILKQCD-SPYI 60
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256 |
| >gnl|CDD|173689 cd05598, STKc_LATS, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Score = 46.0 bits (109), Expect = 7e-05
Identities = 19/60 (31%), Positives = 37/60 (61%), Gaps = 2/60 (3%)
Query: 896 YLVLELLKGGELLDRIRQKGRCGFTENEASRIMRQLVAAVHFMHSRGVVHRDLKPENLLL 955
Y V++ + GG+++ + + G F E+ A + +L A+ +H G +HRD+KP+N+L+
Sbjct: 77 YFVMDYIPGGDMMSLLIRLGI--FEEDLARFYIAELTCAIESVHKMGFIHRDIKPDNILI 134
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Length = 376 |
| >gnl|CDD|173749 cd07855, STKc_ERK5, Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Score = 45.8 bits (109), Expect = 7e-05
Identities = 21/64 (32%), Positives = 34/64 (53%), Gaps = 3/64 (4%)
Query: 894 HTYLVLELLKGGELLDRIRQKGRCGFTENEASRIMRQLVAAVHFMHSRGVVHRDLKPENL 953
Y+V++L++ L I TE + QL+ + ++HS V+HRDLKP NL
Sbjct: 82 DVYVVMDLMESD--LHHIIH-SDQPLTEEHIRYFLYQLLRGLKYIHSANVIHRDLKPSNL 138
Query: 954 LLSG 957
L++
Sbjct: 139 LVNE 142
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the MAP2K MEK5, which in turn is regulated by the MAP3Ks MEKK2 and MEKK3. Activated ERK5 phosphorylates its targets including myocyte enhancer factor 2 (MEF2), Sap1a, c-Myc, and RSK. It plays a role in EGF-induced cell proliferation during the G1/S phase transition. Studies on knockout mice revealed that ERK5 is essential for cardiovascular development and plays an important role in angiogenesis. It is also critical for neural differentiation and survival. The ERK5 pathway has been implicated in the pathogenesis of many diseases including cancer, cardiac hypertrophy, and atherosclerosis. Length = 334 |
| >gnl|CDD|173667 cd05576, STKc_RPK118_like, Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Score = 44.8 bits (106), Expect = 7e-05
Identities = 18/45 (40%), Positives = 25/45 (55%)
Query: 269 TEPPIPEDLSPDVADFISRLLVKDPRRRLGGGELDAEELKRHPFF 313
T IPE +S + + +LL +P RLG G E++K HPFF
Sbjct: 193 TTLNIPEWVSEEARSLLQQLLQFNPTERLGAGVAGVEDIKSHPFF 237
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phosphate (SPP), a lipid messenger involved in many cellular events. RPK118 may be involved in transmitting SPP-mediated signaling. RPK118 also binds the antioxidant peroxiredoxin-3 (PRDX3). RPK118 may be involved in the transport of PRDX3 from the cytoplasm to its site of function in the mitochondria. Length = 237 |
| >gnl|CDD|133230 cd05099, PTKc_FGFR4, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Score = 45.7 bits (108), Expect = 7e-05
Identities = 47/183 (25%), Positives = 78/183 (42%), Gaps = 31/183 (16%)
Query: 416 DCSEEINLLRACQGHPNIVNLHCVFQDEVHTYLVLELLKGGELLDRIRQKGRCGFTEN-- 473
D E+ L++ H NI+NL V E Y+++E G L + +R + G
Sbjct: 63 DLISEMELMKLIGKHKNIINLLGVCTQEGPLYVIVEYAAKGNLREFLRARRPPGPDYTFD 122
Query: 474 -----EASRIMRQLVAAVH-------FMHSRGVVHRDLKPENLLFSDPAGDNI-KVVDFG 520
E + LV+ + ++ SR +HRDL N+L ++ DN+ K+ DFG
Sbjct: 123 ITKVPEEQLSFKDLVSCAYQVARGMEYLESRRCIHRDLAARNVLVTE---DNVMKIADFG 179
Query: 521 FACLKRESLHTPCFT--------LQYAAPEVLRQDKSGYDENCDLWSLGVILVNVLRQDK 572
A R + +++ APE L D+ Y D+WS G+++ +
Sbjct: 180 LA---RGVHDIDYYKKTSNGRLPVKWMAPEALF-DRV-YTHQSDVWSFGILMWEIFTLGG 234
Query: 573 SGY 575
S Y
Sbjct: 235 SPY 237
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Unlike other FGFRs, there is only one splice form of FGFR4. It binds FGF1, FGF2, FGF6, FGF19, and FGF23. FGF19 is a selective ligand for FGFR4. Although disruption of FGFR4 in mice causes no obvious phenotype, in vivo inhibition of FGFR4 in cultured skeletal muscle cells resulted in an arrest of muscle progenitor differentiation. FGF6 and FGFR4 are uniquely expressed in myofibers and satellite cells. FGF6/FGFR4 signaling appears to play a key role in the regulation of muscle regeneration. A polymorphism in FGFR4 is found in head and neck squamous cell carcinoma. Length = 314 |
| >gnl|CDD|173653 cd05105, PTKc_PDGFR_alpha, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Score = 45.8 bits (108), Expect = 7e-05
Identities = 31/117 (26%), Positives = 54/117 (46%), Gaps = 15/117 (12%)
Query: 456 GELLDRIRQKGRCGFTENEASRIMRQLVAAVHFMHSRGVVHRDLKPENLLFSDPAGDNIK 515
E+ + + G G T + Q+ + F+ S+ VHRDL N+L + G +K
Sbjct: 220 SEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFLASKNCVHRDLAARNVLLAQ--GKIVK 277
Query: 516 VVDFGFACLKRESLHTPCFT--------LQYAAPEVLRQDKSGYDENCDLWSLGVIL 564
+ DFG A R+ +H + +++ APE + + Y D+WS G++L
Sbjct: 278 ICDFGLA---RDIMHDSNYVSKGSTFLPVKWMAPESIFDNL--YTTLSDVWSYGILL 329
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-AB, and PDGF-CC induce PDGFR alpha homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR alpha signaling is important in the formation of lung alveoli, intestinal villi, mesenchymal dermis, and hair follicles, as well as in the development of oligodendrocytes, retinal astrocytes, neural crest cells, and testicular cells. Aberrant PDGFR alpha expression is associated with some human cancers. Mutations in PDGFR alpha have been found within a subset of gastrointestinal stromal tumors (GISTs). An active fusion protein FIP1L1-PDGFR alpha, derived from interstitial deletion, is associated with idiopathic hypereosinophilic syndrome (HES) and chronic eosinophilic leukemia (CEL). Length = 400 |
| >gnl|CDD|173708 cd05617, STKc_aPKC_zeta, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Score = 45.4 bits (107), Expect = 8e-05
Identities = 26/88 (29%), Positives = 48/88 (54%), Gaps = 6/88 (6%)
Query: 868 LFEEQLLGPITRARRRTFVNRSRYNVHTYLVLELLKGGELLDRIRQKGRCGFTENEASRI 927
+FE+ P F SR +LV+E + GG+L+ ++++ + E A
Sbjct: 48 VFEQASSNPFLVGLHSCFQTTSRL----FLVIEYVNGGDLMFHMQRQRK--LPEEHARFY 101
Query: 928 MRQLVAAVHFMHSRGVVHRDLKPENLLL 955
++ A++F+H RG+++RDLK +N+LL
Sbjct: 102 AAEICIALNFLHERGIIYRDLKLDNVLL 129
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways. PKC-zeta also plays a central role in maintaining cell polarity in yeast and mammalian cells. In addition, it affects actin remodeling in muscle cells. Length = 327 |
| >gnl|CDD|173652 cd05100, PTKc_FGFR3, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 45.8 bits (108), Expect = 8e-05
Identities = 44/184 (23%), Positives = 77/184 (41%), Gaps = 33/184 (17%)
Query: 416 DCSEEINLLRACQGHPNIVNLHCVFQDEVHTYLVLELLKGGELLDRIRQKGRCG------ 469
D E+ +++ H NI+NL + Y+++E G L + +R + G
Sbjct: 63 DLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVLVEYASKGNLREYLRARRPPGMDYSFD 122
Query: 470 --------FTENEASRIMRQLVAAVHFMHSRGVVHRDLKPENLLFSDPAGDNI-KVVDFG 520
T + Q+ + ++ S+ +HRDL N+L ++ DN+ K+ DFG
Sbjct: 123 TCKLPEEQLTFKDLVSCAYQVARGMEYLASQKCIHRDLAARNVLVTE---DNVMKIADFG 179
Query: 521 FACLKRESLHTPCF---------TLQYAAPEVLRQDKSGYDENCDLWSLGVILVNVLRQD 571
A +H + +++ APE L D+ Y D+WS GV+L +
Sbjct: 180 LA----RDVHNIDYYKKTTNGRLPVKWMAPEALF-DRV-YTHQSDVWSFGVLLWEIFTLG 233
Query: 572 KSGY 575
S Y
Sbjct: 234 GSPY 237
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Many FGFR3 splice variants have been reported with the IIIb and IIIc isoforms being the predominant forms. FGFR3 IIIc is the isoform expressed in chondrocytes, the cells affected in dwarfism, while IIIb is expressed in epithelial cells. FGFR3 ligands include FGF1, FGF2, FGF4, FGF8, FGF9, and FGF23. It is a negative regulator of long bone growth. In the cochlear duct and in the lens, FGFR3 is involved in differentiation while it appears to have a role in cell proliferation in epithelial cells. Germline mutations in FGFR3 are associated with skeletal disorders including several forms of dwarfism. Some missense mutations are associated with multiple myeloma and carcinomas of the bladder and cervix. Overexpression of FGFR3 is found in thyroid carcinoma. Length = 334 |
| >gnl|CDD|173700 cd05609, STKc_MAST, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Score = 45.2 bits (107), Expect = 9e-05
Identities = 24/67 (35%), Positives = 41/67 (61%), Gaps = 10/67 (14%)
Query: 894 HTYLVLELLKGGE---LLDRIRQKGRCGFTENEASRI-MRQLVAAVHFMHSRGVVHRDLK 949
H +V+E ++GG+ LL I G + +R+ + V A+ ++H+ G+VHRDLK
Sbjct: 75 HLCMVMEYVEGGDCATLLKNI------GALPVDMARMYFAETVLALEYLHNYGIVHRDLK 128
Query: 950 PENLLLS 956
P+NLL++
Sbjct: 129 PDNLLIT 135
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. MAST1, MAST2, and MAST3 bind and phosphorylate the tumor suppressor PTEN, and may contribute to the regulation and stabilization of PTEN. MAST2 is involved in the regulation of the Fc-gamma receptor of the innate immune response in macrophages, and may also be involved in the regulation of the Na+/H+ exchanger NHE3. Length = 305 |
| >gnl|CDD|143361 cd07856, STKc_Sty1_Hog1, Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Score = 45.2 bits (107), Expect = 9e-05
Identities = 25/62 (40%), Positives = 33/62 (53%), Gaps = 8/62 (12%)
Query: 896 YLVLELLKGGELLDRIRQKGRC--GFTENEASRIMRQLVAAVHFMHSRGVVHRDLKPENL 953
Y V ELL G L R+ F + +I+R L ++HS GVVHRDLKP N+
Sbjct: 86 YFVTELL--GTDLHRLLTSRPLEKQFIQYFLYQILRGL----KYVHSAGVVHRDLKPSNI 139
Query: 954 LL 955
L+
Sbjct: 140 LI 141
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and UV radiation. Sty1 is regulated by the MAP2K Wis1, which is activated by the MAP3Ks Wis4 and Win1, which receive signals of the stress condition from membrane-spanning histidine kinases Mak1-3. Activated Sty1 stabilizes the Atf1 transcription factor and induces transcription of Atf1-dependent genes of the core environmetal stress response (CESR). Hog1 is the key element in the high osmolarity glycerol (HOG) pathway and is activated upon hyperosmotic stress. Activated Hog1 accumulates in the nucleus and regulates stress-induced transcription. The HOG pathway is mediated by two transmembrane osmosensors, Sln1 and Sho1. Length = 328 |
| >gnl|CDD|215917 pfam00433, Pkinase_C, Protein kinase C terminal domain | Back alignment and domain information |
|---|
Score = 40.3 bits (95), Expect = 9e-05
Identities = 13/40 (32%), Positives = 16/40 (40%), Gaps = 3/40 (7%)
Query: 333 KISNELDVSNFSDEFTKMIPADSPAIVPPNF---DKIFKG 369
K+ + D SNF EFT P SP F+G
Sbjct: 1 KVKSPTDTSNFDPEFTSEPPKLSPPDSEVLSSIDQLEFRG 40
|
Length = 47 |
| >gnl|CDD|173687 cd05596, STKc_ROCK, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Score = 44.8 bits (106), Expect = 1e-04
Identities = 24/69 (34%), Positives = 41/69 (59%), Gaps = 4/69 (5%)
Query: 894 HTYLVLELLKGGELLDRIRQKGRCGFTENEASRIMRQLVAAVHFMHSRGVVHRDLKPENL 953
+ Y+V+E + GG+L++ + E A ++V A+ +HS G +HRD+KP+N+
Sbjct: 117 YLYMVMEYMPGGDLVNLM---SNYDIPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNM 173
Query: 954 LLSGISGNL 962
LL SG+L
Sbjct: 174 LLD-KSGHL 181
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via interaction with Rho GTPases and is involved in many cellular functions including contraction, adhesion, migration, motility, proliferation, and apoptosis. The ROCK subfamily consists of two isoforms, ROCK1 and ROCK2, which may be functionally redundant in some systems, but exhibit different tissue distributions. Both isoforms are ubiquitously expressed in most tissues, but ROCK2 is more prominent in brain and skeletal muscle while ROCK1 is more pronounced in the liver, testes, and kidney. Studies in knockout mice result in different phenotypes, suggesting that the two isoforms do not compensate for each other during embryonic development. Length = 370 |
| >gnl|CDD|173680 cd05589, STKc_PKN, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Score = 45.1 bits (107), Expect = 1e-04
Identities = 21/63 (33%), Positives = 32/63 (50%), Gaps = 3/63 (4%)
Query: 894 HTYLVLELLKGGELLDRIRQKGRCGFTENEASRIMRQLVAAVHFMHSRGVVHRDLKPENL 953
H V+E GG+L+ I F+E A +V + ++H +V+RDLK +NL
Sbjct: 76 HVCFVMEYAAGGDLMMHIHTDV---FSEPRAVFYAACVVLGLQYLHENKIVYRDLKLDNL 132
Query: 954 LLS 956
LL
Sbjct: 133 LLD 135
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved in many biological processes including cytokeletal regulation, cell adhesion, vesicle transport, glucose transport, regulation of meiotic maturation and embryonic cell cycles, signaling to the nucleus, and tumorigenesis. Length = 324 |
| >gnl|CDD|173711 cd05621, STKc_ROCK2, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Score = 45.4 bits (107), Expect = 1e-04
Identities = 21/62 (33%), Positives = 38/62 (61%), Gaps = 3/62 (4%)
Query: 894 HTYLVLELLKGGELLDRIRQKGRCGFTENEASRIMRQLVAAVHFMHSRGVVHRDLKPENL 953
+ Y+V+E + GG+L++ + E A ++V A+ +HS G++HRD+KP+N+
Sbjct: 117 YLYMVMEYMPGGDLVNLMSNYD---VPEKWAKFYTAEVVLALDAIHSMGLIHRDVKPDNM 173
Query: 954 LL 955
LL
Sbjct: 174 LL 175
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found to play a role in stress fiber and focal adhesion formation. It is prominently expressed in the brain, heart, and skeletal muscles. It is implicated in vascular and neurological disorders, such as hypertension and vasospasm of the coronary and cerebral arteries. ROCK2 is also activated by caspase-2 cleavage, resulting in thrombin-induced microparticle generation in response to cell activation. Mice deficient in ROCK2 show intrauterine growth retardation and embryonic lethality because of placental dysfunction. Length = 370 |
| >gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Score = 44.4 bits (105), Expect = 1e-04
Identities = 16/61 (26%), Positives = 33/61 (54%)
Query: 896 YLVLELLKGGELLDRIRQKGRCGFTENEASRIMRQLVAAVHFMHSRGVVHRDLKPENLLL 955
+V+E + G+L ++ + E++ R Q++ + +HS+ ++HRD+K NL L
Sbjct: 75 NIVMEYAENGDLHKLLKMQRGRPLPEDQVWRFFIQILLGLAHLHSKKILHRDIKSLNLFL 134
Query: 956 S 956
Sbjct: 135 D 135
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256 |
| >gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Score = 44.7 bits (106), Expect = 1e-04
Identities = 21/63 (33%), Positives = 36/63 (57%), Gaps = 2/63 (3%)
Query: 897 LVLELLKGGELLDRIR--QKGRCGFTENEASRIMRQLVAAVHFMHSRGVVHRDLKPENLL 954
+VLEL G+L I+ +K + E + QL +A+ MHS+ ++HRD+KP N+
Sbjct: 79 IVLELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALEHMHSKRIMHRDIKPANVF 138
Query: 955 LSG 957
++
Sbjct: 139 ITA 141
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Score = 44.6 bits (105), Expect = 1e-04
Identities = 28/89 (31%), Positives = 45/89 (50%), Gaps = 6/89 (6%)
Query: 871 EQLLGPITRARRRTFVNRSRYNVHTYLVLELLKGGELLDRIR--QKGRCGFTENEASRIM 928
+QL P +F+ + N+ VLEL G+L I+ +K + E +
Sbjct: 57 KQLNHPNVIKYYASFIEDNELNI----VLELADAGDLSRMIKHFKKQKRLIPEKTVWKYF 112
Query: 929 RQLVAAVHFMHSRGVVHRDLKPENLLLSG 957
QL +A+ MHSR V+HRD+KP N+ ++
Sbjct: 113 VQLCSALEHMHSRRVMHRDIKPANVFITA 141
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|173720 cd05631, STKc_GRK4, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Score = 44.6 bits (105), Expect = 1e-04
Identities = 23/59 (38%), Positives = 32/59 (54%)
Query: 897 LVLELLKGGELLDRIRQKGRCGFTENEASRIMRQLVAAVHFMHSRGVVHRDLKPENLLL 955
LVL ++ GG+L I G GF E A +L + + +V+RDLKPEN+LL
Sbjct: 77 LVLTIMNGGDLKFHIYNMGNPGFDEQRAIFYAAELCCGLEDLQRERIVYRDLKPENILL 135
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found in the testis, but is also present in the cerebellum and kidney. It is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK4 polymorphisms are associated with hypertension and salt sensitivity, as they cause hyperphosphorylation, desensitization, and internalization of the dopamine 1 (D1) receptor while increasing the expression of the angiotensin II type 1 receptor. GRK4 plays a crucial role in the D1 receptor regulation of sodium excretion and blood pressure. Length = 285 |
| >gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Score = 44.7 bits (105), Expect = 1e-04
Identities = 23/67 (34%), Positives = 43/67 (64%), Gaps = 4/67 (5%)
Query: 896 YLVLELLKGGELLDRIRQKGRCGFTENEASRIMRQLVAAVHFMHSRGVVHRDLKPENLLL 955
++V+E L GG L D + + C E + + + R+ + A+ F+H+ V+HRD+K +N+LL
Sbjct: 92 FVVMEYLAGGSLTDVVTET--C-MDEAQIAAVCRECLQALEFLHANQVIHRDIKSDNVLL 148
Query: 956 SGISGNL 962
G+ G++
Sbjct: 149 -GMDGSV 154
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296 |
| >gnl|CDD|173705 cd05614, STKc_MSK2_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Score = 44.6 bits (105), Expect = 2e-04
Identities = 21/60 (35%), Positives = 38/60 (63%), Gaps = 2/60 (3%)
Query: 896 YLVLELLKGGELLDRIRQKGRCGFTENEASRIMRQLVAAVHFMHSRGVVHRDLKPENLLL 955
+L+L+ + GGE+ + Q R F+E+E +++ A+ +H G+V+RD+K EN+LL
Sbjct: 81 HLILDYVSGGEMFTHLYQ--RDNFSEDEVRFYSGEIILALEHLHKLGIVYRDIKLENILL 138
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK2 and MSK1 play nonredundant roles in activating histone H3 kinases, which play pivotal roles in compaction of the chromatin fiber. MSK2 is the required H3 kinase in response to stress stimuli and activation of the p38 MAPK pathway. MSK2 also plays a role in the pathogenesis of psoriasis. Length = 332 |
| >gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Score = 44.1 bits (105), Expect = 2e-04
Identities = 21/46 (45%), Positives = 28/46 (60%), Gaps = 7/46 (15%)
Query: 271 PPI--PEDLSPDVADFISRLLVKDPRRRLGGGELDAEELKRHPFFN 314
PP+ PE SP+ DF+++ LVKDP +R AEEL +HPF
Sbjct: 234 PPLKNPEKWSPEFKDFLNKCLVKDPEKR-----PSAEELLQHPFLK 274
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286 |
| >gnl|CDD|173725 cd06608, STKc_myosinIII_like, Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 43.8 bits (104), Expect = 2e-04
Identities = 19/53 (35%), Positives = 29/53 (54%), Gaps = 4/53 (7%)
Query: 123 ILGDGSYSVCRRCVEKSTGQEYAVKIIS----RKIDCSEEINLLRACQGHPNI 171
++G+G+Y + K TGQ A+KI+ + + EE N+LR HPNI
Sbjct: 13 VIGEGTYGKVYKARHKKTGQLVAIKIMDIIEDEEEEIKEEYNILRKYSNHPNI 65
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin III may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. It may also function as a cargo carrier during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. The Drosophila class III myosin, called NinaC (Neither inactivation nor afterpotential protein C), is critical in normal adaptation and termination of photoresponse. Vertebrates contain two isoforms of class III myosin, IIIA and IIIB. This subfamily also includes mammalian NIK-like embryo-specific kinase (NESK), Traf2- and Nck-interacting kinase (TNIK), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6). MAP4Ks are involved in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Length = 275 |
| >gnl|CDD|173688 cd05597, STKc_DMPK_like, Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 44.4 bits (105), Expect = 2e-04
Identities = 24/71 (33%), Positives = 38/71 (53%), Gaps = 15/71 (21%)
Query: 892 NVHTYLVLELLKGGELL-------DRIRQKGRCGFTENEASRIMRQLVAAVHFMHSRGVV 944
+ YLV++ GG+LL DR+ E+ A + ++V A+ +H G V
Sbjct: 73 ENNLYLVMDYYVGGDLLTLLSKFEDRL--------PEDMARFYLAEMVLAIDSVHQLGYV 124
Query: 945 HRDLKPENLLL 955
HRD+KP+N+LL
Sbjct: 125 HRDIKPDNVLL 135
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, and cardiac conduction defects. The genetic basis for DM1 is the mutational expansion of a CTG repeat in the 3'-UTR of DMPK. DMPK is expressed in skeletal and cardiac muscles, and in central nervous tissues. The functional role of DMPK is not fully understood. It may play a role in the signal transduction and homeostasis of calcium. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKgamma is expressed in heart and skeletal muscles, unlike MRCKalpha and MRCKbeta, which are expressed ubiquitously. Length = 331 |
| >gnl|CDD|173713 cd05624, STKc_MRCK_beta, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Score = 44.6 bits (105), Expect = 2e-04
Identities = 23/62 (37%), Positives = 37/62 (59%), Gaps = 1/62 (1%)
Query: 894 HTYLVLELLKGGELLDRIRQKGRCGFTENEASRIMRQLVAAVHFMHSRGVVHRDLKPENL 953
+ YLV++ GG+LL + K E+ A + ++V A+H +H VHRD+KP+N+
Sbjct: 75 YLYLVMDYYVGGDLLTLL-SKFEDRLPEDMARFYIAEMVLAIHSIHQLHYVHRDIKPDNV 133
Query: 954 LL 955
LL
Sbjct: 134 LL 135
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. Length = 331 |
| >gnl|CDD|173745 cd07848, STKc_CDKL5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Score = 43.8 bits (103), Expect = 2e-04
Identities = 41/129 (31%), Positives = 58/129 (44%), Gaps = 23/129 (17%)
Query: 832 THSTPARKKKKADRQPAKQEEKQPVPQTT--PPTDLVTLFEEQLLGPITRARRRTFVNRS 889
T A KK K EE + V +TT L TL +E ++ RRR
Sbjct: 25 TKEIVAIKKFK------DSEENEEVKETTLRELKMLRTLKQENIVELKEAFRRRG----- 73
Query: 890 RYNVHTYLVLELLKGG--ELLDRIRQKGRCGFTENEASRIMRQLVAAVHFMHSRGVVHRD 947
YLV E ++ ELL+ + G + + QL+ A+H+ H +VHRD
Sbjct: 74 ----KLYLVFEYVEKNMLELLEEMPN----GVPPEKVRSYIYQLIKAIHWCHKNDIVHRD 125
Query: 948 LKPENLLLS 956
+KPENLL+S
Sbjct: 126 IKPENLLIS 134
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes cause a phenotype similar to Rett syndrome (RTT), a progressive neurodevelopmental disorder. These pathogenic mutations are located in the N-terminal portion of the protein within the kinase domain. Length = 287 |
| >gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 43.9 bits (104), Expect = 2e-04
Identities = 18/64 (28%), Positives = 31/64 (48%)
Query: 893 VHTYLVLELLKGGELLDRIRQKGRCGFTENEASRIMRQLVAAVHFMHSRGVVHRDLKPEN 952
Y+V E + G L+D +R +GR T + + + ++ + VHRDL N
Sbjct: 73 NPLYIVTEYMAKGSLVDYLRSRGRAVITLAQQLGFALDVCEGMEYLEEKNFVHRDLAARN 132
Query: 953 LLLS 956
+L+S
Sbjct: 133 VLVS 136
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256 |
| >gnl|CDD|173768 cd08228, STKc_Nek6, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Score = 43.9 bits (103), Expect = 2e-04
Identities = 24/63 (38%), Positives = 36/63 (57%), Gaps = 2/63 (3%)
Query: 897 LVLELLKGGELLDRIR--QKGRCGFTENEASRIMRQLVAAVHFMHSRGVVHRDLKPENLL 954
+VLEL G+L I+ +K + E + QL +AV MHSR V+HRD+KP N+
Sbjct: 79 IVLELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMHSRRVMHRDIKPANVF 138
Query: 955 LSG 957
++
Sbjct: 139 ITA 141
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase and anaphase, and to the midbody during cytokinesis. Length = 267 |
| >gnl|CDD|132990 cd06659, STKc_PAK6, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Score = 44.2 bits (104), Expect = 2e-04
Identities = 19/61 (31%), Positives = 40/61 (65%), Gaps = 3/61 (4%)
Query: 896 YLVLELLKGGELLDRIRQKGRCGFTENEASRIMRQLVAAVHFMHSRGVVHRDLKPENLLL 955
++++E L+GG L D + Q E + + + ++ A+ ++HS+GV+HRD+K +++LL
Sbjct: 94 WVLMEFLQGGALTDIVSQ---TRLNEEQIATVCESVLQALCYLHSQGVIHRDIKSDSILL 150
Query: 956 S 956
+
Sbjct: 151 T 151
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role in stress responses through its activation by the mitogen-activated protein kinase (MAPK) p38 and MAPK kinase 6 (MKK6) pathway. PAK6 is highly expressed in the brain. It is not required for viability, but together with PAK5, it is required for normal levels of locomotion and activity, and for learning and memory. Increased expression of PAK6 is found in primary and metastatic prostate cancer. PAK6 may play a role in the regulation of motility. Length = 297 |
| >gnl|CDD|143368 cd07863, STKc_CDK4, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Score = 44.6 bits (105), Expect = 2e-04
Identities = 18/39 (46%), Positives = 29/39 (74%), Gaps = 2/39 (5%)
Query: 927 IMRQLVAAVHFMHSRGVVHRDLKPENLLLSGISGNLIKI 965
+MRQ + + F+H+ +VHRDLKPEN+L++ SG +K+
Sbjct: 113 LMRQFLRGLDFLHANCIVHRDLKPENILVT--SGGQVKL 149
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the nucleus. CDK4 also shows kinase activity towards Smad3, a signal transducer of transforming growth factor (TGF)-beta signaling which modulates transcription and plays a role in cell proliferation and apoptosis. CDK4 is inhibited by the p21 inhibitor and is specifically mutated in human melanoma. Length = 288 |
| >gnl|CDD|173758 cd08218, STKc_Nek1, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Score = 44.1 bits (104), Expect = 2e-04
Identities = 19/65 (29%), Positives = 38/65 (58%)
Query: 892 NVHTYLVLELLKGGELLDRIRQKGRCGFTENEASRIMRQLVAAVHFMHSRGVVHRDLKPE 951
N + Y+V++ +GG+L +I + F E++ Q+ A+ +H R ++HRD+K +
Sbjct: 71 NGNLYIVMDYCEGGDLYKKINAQRGVLFPEDQILDWFVQICLALKHVHDRKILHRDIKSQ 130
Query: 952 NLLLS 956
N+ L+
Sbjct: 131 NIFLT 135
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycystic kidney disease, which is characterized by benign polycystic tumors formed by abnormal overgrowth of renal epithelial cells. It appears also to be involved in DNA damage response, and may be important for both correct DNA damage checkpoint activation and DNA repair. Length = 256 |
| >gnl|CDD|165476 PHA03210, PHA03210, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 45.1 bits (106), Expect = 2e-04
Identities = 14/35 (40%), Positives = 25/35 (71%)
Query: 923 EASRIMRQLVAAVHFMHSRGVVHRDLKPENLLLSG 957
+ IM+QL+ AV ++H + ++HRD+K EN+ L+
Sbjct: 268 QTRAIMKQLLCAVEYIHDKKLIHRDIKLENIFLNC 302
|
Length = 501 |
| >gnl|CDD|183880 PRK13184, pknD, serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Score = 45.1 bits (107), Expect = 2e-04
Identities = 15/30 (50%), Positives = 24/30 (80%)
Query: 926 RIMRQLVAAVHFMHSRGVVHRDLKPENLLL 955
I ++ A + ++HS+GV+HRDLKP+N+LL
Sbjct: 117 SIFHKICATIEYVHSKGVLHRDLKPDNILL 146
|
Length = 932 |
| >gnl|CDD|173635 cd05054, PTKc_VEGFR, Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 44.5 bits (105), Expect = 2e-04
Identities = 33/103 (32%), Positives = 50/103 (48%), Gaps = 15/103 (14%)
Query: 481 QLVAAVHFMHSRGVVHRDLKPENLLFSDPAGDNIKVVDFGFACLKRESLHTPCFT----- 535
Q+ + F+ SR +HRDL N+L S+ + +K+ DFG A R+ P +
Sbjct: 181 QVARGMEFLASRKCIHRDLAARNILLSE--NNVVKICDFGLA---RDIYKDPDYVRKGDA 235
Query: 536 ---LQYAAPEVLRQDKSGYDENCDLWSLGVILVNVLRQDKSGY 575
L++ APE + DK Y D+WS GV+L + S Y
Sbjct: 236 RLPLKWMAPESIF-DKV-YTTQSDVWSFGVLLWEIFSLGASPY 276
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. There are five VEGF ligands in mammals, which bind, in an overlapping pattern to the three VEGFRs, which can form homo or heterodimers. VEGFRs regulate the cardiovascular system. They are critical for vascular development during embryogenesis and blood vessel formation in adults. They induce cellular functions common to other growth factor receptors such as cell migration, survival, and proliferation. VEGFR1 binds VEGFA, VEGFB, and placenta growth factor (PLGF). It regulates monocyte and macrophage migration, vascular permeability, haematopoiesis, and the recruitment of haematopietic progenitor cells from the bone marrow. Length = 337 |
| >gnl|CDD|133205 cd05074, PTKc_Tyro3, Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Score = 44.1 bits (104), Expect = 2e-04
Identities = 55/228 (24%), Positives = 102/228 (44%), Gaps = 36/228 (15%)
Query: 385 ILGDGSYSVCRRC---VEKSTGQEYAVKIISRKIDCSEEI-NLLR--ACQ---GHPNI-- 433
+LG G + R E + Q+ AVK++ I S +I LR AC HPN+
Sbjct: 6 MLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDHPNVIK 65
Query: 434 ---VNLHCVFQDEVHTYLV-LELLKGGEL-----LDRIRQKGRCGFTENEAS--RIMRQL 482
V+L + + +V L +K G+L + RI G FT + R M +
Sbjct: 66 LIGVSLRSRAKGRLPIPMVILPFMKHGDLHTFLLMSRI---GEEPFTLPLQTLVRFMIDI 122
Query: 483 VAAVHFMHSRGVVHRDLKPENLLFSDPAGDNIKVVDFGFA--CLKRESLHTPCFT---LQ 537
+ + ++ S+ +HRDL N + ++ + V DFG + + C + ++
Sbjct: 123 ASGMEYLSSKNFIHRDLAARNCMLNENM--TVCVADFGLSKKIYSGDYYRQGCASKLPVK 180
Query: 538 YAAPEVLRQDKSGYDENCDLWSLGVILVNVLRQDKSGYD--ENCDLWS 583
+ A E L + Y + D+W+ GV + ++ + ++ Y EN ++++
Sbjct: 181 WLALESLADNV--YTTHSDVWAFGVTMWEIMTRGQTPYAGVENSEIYN 226
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic factor. It is also expressed in osteoclasts and has a role in bone resorption. Length = 273 |
| >gnl|CDD|173654 cd05108, PTKc_EGFR, Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Score = 44.2 bits (104), Expect = 2e-04
Identities = 36/138 (26%), Positives = 62/138 (44%), Gaps = 18/138 (13%)
Query: 448 LVLELLKGGELLDRIRQKGRCGFTENEASRIMR----QLVAAVHFMHSRGVVHRDLKPEN 503
L+ +L+ G LLD +R+ +N S+ + Q+ ++++ R +VHRDL N
Sbjct: 85 LITQLMPFGCLLDYVREH-----KDNIGSQYLLNWCVQIAKGMNYLEERRLVHRDLAARN 139
Query: 504 LLFSDPAGDNIKVVDFGFACL-----KRESLHTPCFTLQYAAPEVLRQDKSGYDENCDLW 558
+L P ++K+ DFG A L K +++ A E + Y D+W
Sbjct: 140 VLVKTP--QHVKITDFGLAKLLGADEKEYHAEGGKVPIKWMALESILH--RIYTHQSDVW 195
Query: 559 SLGVILVNVLRQDKSGYD 576
S GV + ++ YD
Sbjct: 196 SYGVTVWELMTFGSKPYD 213
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands for EGFR include EGF, heparin binding EGF-like growth factor (HBEGF), epiregulin, amphiregulin, TGFalpha, and betacellulin. Upon ligand binding, EGFR can form homo- or heterodimers with other EGFR subfamily members. The EGFR signaling pathway is one of the most important pathways regulating cell proliferation, differentiation, survival, and growth. Overexpression and mutation in the kinase domain of EGFR have been implicated in the development and progression of a variety of cancers. A number of monoclonal antibodies and small molecule inhibitors have been developed that target EGFR, including the antibodies Cetuximab and Panitumumab, which are used in combination with other therapies for the treatment of colorectal cancer and non-small cell lung carcinoma (NSCLC). The small molecule inhibitors Gefitinib (Iressa) and Erlotinib (Tarceva), already used for NSCLC, are undergoing clinical trials for other types of cancer including gastrointestinal, breast, head and neck, and bladder. Length = 316 |
| >gnl|CDD|133232 cd05101, PTKc_FGFR2, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 44.2 bits (104), Expect = 2e-04
Identities = 42/182 (23%), Positives = 76/182 (41%), Gaps = 29/182 (15%)
Query: 416 DCSEEINLLRACQGHPNIVNLHCVFQDEVHTYLVLELLKGGELLDRIRQKGRCG------ 469
D E+ +++ H NI+NL + Y+++E G L + +R + G
Sbjct: 66 DLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYD 125
Query: 470 --------FTENEASRIMRQLVAAVHFMHSRGVVHRDLKPENLLFSDPAGDNIKVVDFGF 521
T + Q+ + ++ S+ +HRDL N+L ++ + +K+ DFG
Sbjct: 126 IARVPDEQMTFKDLVSCTYQVARGMEYLASQKCIHRDLAARNVLVTE--NNVMKIADFGL 183
Query: 522 A--------CLKRESLHTPCFTLQYAAPEVLRQDKSGYDENCDLWSLGVILVNVLRQDKS 573
A K + P +++ APE L D+ Y D+WS GV++ + S
Sbjct: 184 ARDVNNIDYYKKTTNGRLP---VKWMAPEALF-DRV-YTHQSDVWSFGVLMWEIFTLGGS 238
Query: 574 GY 575
Y
Sbjct: 239 PY 240
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. There are many splice variants of FGFR2 which show differential expression and binding to FGF ligands. Disruption of either FGFR2 or FGFR2b is lethal in mice, due to defects in the placenta or severe impairment of tissue development including lung, limb, and thyroid, respectively. Disruption of FGFR2c in mice results in defective bone and skull development. Genetic alterations of FGFR2 are associated with many human skeletal disorders including Apert syndrome, Crouzon syndrome, Jackson-Weiss syndrome, and Pfeiffer syndrome. Length = 304 |
| >gnl|CDD|133189 cd05058, PTKc_Met_Ron, Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Score = 43.6 bits (103), Expect = 2e-04
Identities = 49/184 (26%), Positives = 83/184 (45%), Gaps = 22/184 (11%)
Query: 407 AVKIISRKIDCSEEINLLRACQG-------HPNIVNLHCV-FQDEVHTYLVLELLKGGEL 458
AVK ++R D E L+ +G HPN+++L + E +VL +K G+L
Sbjct: 27 AVKSLNRITDLEEVEQFLK--EGIIMKDFSHPNVLSLLGICLPSEGSPLVVLPYMKHGDL 84
Query: 459 LDRIRQKGRCGFTENEASRIMRQLVAAVHFMHSRGVVHRDLKPENLLFSDPAGDNIKVVD 518
+ IR + T + Q+ + ++ S+ VHRDL N + + +KV D
Sbjct: 85 RNFIRSETH-NPTVKDLIGFGLQVAKGMEYLASKKFVHRDLAARNCMLDESF--TVKVAD 141
Query: 519 FGFA--CLKRE--SLHTPC---FTLQYAAPEVLRQDKSGYDENCDLWSLGVILVNVLRQD 571
FG A +E S+H +++ A E L+ K + D+WS GV+L ++ +
Sbjct: 142 FGLARDIYDKEYYSVHNHTGAKLPVKWMALESLQTQK--FTTKSDVWSFGVLLWELMTRG 199
Query: 572 KSGY 575
Y
Sbjct: 200 APPY 203
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also called the HGF receptor. HGF/Met signaling plays a role in growth, transformation, cell motility, invasion, metastasis, angiogenesis, wound healing, and tissue regeneration. Aberrant expression of Met through mutations or gene amplification is associated with many human cancers including hereditary papillary renal and gastric carcinomas. The ligand for Ron is macrophage stimulating protein (MSP). Ron signaling is important in regulating cell motility, adhesion, proliferation, and apoptosis. Aberrant Ron expression is implicated in tumorigenesis and metastasis. Length = 262 |
| >gnl|CDD|165564 PHA03309, PHA03309, transcriptional regulator ICP4; Provisional | Back alignment and domain information |
|---|
Score = 44.8 bits (105), Expect = 2e-04
Identities = 52/194 (26%), Positives = 79/194 (40%), Gaps = 28/194 (14%)
Query: 692 NSRSFSSTSSSLSSSSSGTSSLKTPCSSTQPSVP-------SKPVKRINKDASSGTVFDF 744
+S S SS+SSS SS SS S TP S PS P S+ +R +D S F +
Sbjct: 1817 SSSSSSSSSSSSSSPSSRPSRSATPSLSPSPSPPRRAPVDRSRSGRRRERDRPSANPFRW 1876
Query: 745 AEARVQEYLSSLSSSSSSEHGTSPPSSSTIQLQLSPVRKK---------KKPDLTLPASN 795
A + S + S GT+ P + + L+ P R + P + P +
Sbjct: 1877 APRQ-------RSRADHSPDGTA-PGDAPLNLEDGPGRGRPIWTPSSATTLPSRSGPEDS 1928
Query: 796 KAESEQLHLAEPSTLA----GTKRKHKPDTSSQCSKSLPATHSTPARKKKKADRQPAKQE 851
E+E A P+ LA T R + S S P +P K + R+P+ ++
Sbjct: 1929 VDETETEDSAPPARLAPSPLETSRAEDSEDSEYPEYSNPRLGKSPPALKSREARRPSSKQ 1988
Query: 852 EKQPVPQTTPPTDL 865
++P TD+
Sbjct: 1989 PRRPSSGKNGHTDV 2002
|
Length = 2033 |
| >gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 43.6 bits (104), Expect = 3e-04
Identities = 28/102 (27%), Positives = 39/102 (38%), Gaps = 40/102 (39%)
Query: 120 KAGILGDGSYSVCRRCVEKSTGQEYAVKIISRKIDCSEE---INLLRACQGHPNICRRCV 176
K LG+G+Y V + +K TG+ A+K I ++D EE LR
Sbjct: 3 KLEKLGEGTYGVVYKARDKKTGEIVALKKI--RLDNEEEGIPSTALR------------- 47
Query: 177 EKSTGQEYAVKIISRKIDCSEEINLLRACQGHPNIVNLHCVF 218
EI+LL+ + HPNIV L V
Sbjct: 48 ---------------------EISLLKELK-HPNIVKLLDVI 67
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282 |
| >gnl|CDD|173716 cd05627, STKc_NDR2, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Score = 43.9 bits (103), Expect = 3e-04
Identities = 30/116 (25%), Positives = 48/116 (41%), Gaps = 10/116 (8%)
Query: 261 IQYRRILKTEPPIPEDLSPDVADFISRLLVKDPRRRLGGGELDAEELKRHPFFNVIDWDD 320
+ ++ L P +P +S D I R D R+G + EE+K HPFF +DW
Sbjct: 249 MNWKETLVFPPEVP--ISEKAKDLILRFCT-DSENRIGSNGV--EEIKSHPFFEGVDWGH 303
Query: 321 LATKRIPAPFVPKISNELDVSNFSDEFTKMIPADSPAIVPPNFDKIFKGSLFFEQY 376
+ + PA +I + D SNF + I + + P++ F Y
Sbjct: 304 IRER--PAAIPIEIKSIDDTSNFDEFPESDILQPAENTIEPDYKSK---DWVFLNY 354
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regulating neuronal growth and differentiation, as well as in facilitating neurite outgrowth. It is also implicated in fear conditioning as it contributes to the coupling of neuronal morphological changes with fear-memory consolidation. NDR2 is also referred to as STK38-like. Length = 360 |
| >gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 43.6 bits (103), Expect = 3e-04
Identities = 19/62 (30%), Positives = 38/62 (61%), Gaps = 5/62 (8%)
Query: 896 YLVLELLKGGELLDRIRQKGRCG-FTENEASRIMRQLVAAVHFMHSRGVVHRDLKPENLL 954
++++E +GG +R + G E S I+R+++ A+ ++H GV+HRD+K N+L
Sbjct: 78 WIIMEYAEGGS----VRTLMKAGPIAEKYISVIIREVLVALKYIHKVGVIHRDIKAANIL 133
Query: 955 LS 956
++
Sbjct: 134 VT 135
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277 |
| >gnl|CDD|173718 cd05629, STKc_NDR_like_fungal, Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 44.1 bits (104), Expect = 3e-04
Identities = 22/61 (36%), Positives = 37/61 (60%), Gaps = 4/61 (6%)
Query: 896 YLVLELLKGGELLDR-IRQKGRCGFTENEASRIMRQLVAAVHFMHSRGVVHRDLKPENLL 954
YL++E L GG+L+ I+ F+E+ M + V A+ +H G +HRD+KP+N+L
Sbjct: 77 YLIMEFLPGGDLMTMLIKYDT---FSEDVTRFYMAECVLAIEAVHKLGFIHRDIKPDNIL 133
Query: 955 L 955
+
Sbjct: 134 I 134
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of Ace2p activity and cellular morphogenesis) network. CBK1 and Orb6 play similar roles in coordinating cell morphology with cell cycle progression. Ukc1 is involved in morphogenesis, pathogenicity, and pigment formation. Cot1 plays a role in polar tip extension. Length = 377 |
| >gnl|CDD|173699 cd05608, STKc_GRK1, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Score = 43.3 bits (102), Expect = 3e-04
Identities = 22/61 (36%), Positives = 36/61 (59%), Gaps = 2/61 (3%)
Query: 897 LVLELLKGGELLDRIRQ--KGRCGFTENEASRIMRQLVAAVHFMHSRGVVHRDLKPENLL 954
LV+ ++ GG+L I + GF E A Q+++ + +H R +++RDLKPEN+L
Sbjct: 70 LVMTIMNGGDLRYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQRRIIYRDLKPENVL 129
Query: 955 L 955
L
Sbjct: 130 L 130
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual group of GRKs and is expressed in retinal cells. It phosphorylates rhodopsin in rod cells, which leads to termination of the phototransduction cascade. Mutations in GRK1 are associated to a recessively inherited form of stationary nightblindness called Oguchi disease. Length = 280 |
| >gnl|CDD|143356 cd07851, STKc_p38, Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 43.8 bits (104), Expect = 3e-04
Identities = 17/58 (29%), Positives = 36/58 (62%), Gaps = 4/58 (6%)
Query: 896 YLVLELLKGGELLDRIRQKGRCGFTENEASRIMRQLVAAVHFMHSRGVVHRDLKPENL 953
YLV L+ G +L + ++ + +++ ++ Q++ + ++HS G++HRDLKP N+
Sbjct: 96 YLVTHLM-GADLNNIVKCQK---LSDDHIQFLVYQILRGLKYIHSAGIIHRDLKPSNI 149
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. p38 substrates include other protein kinases and factors that regulate transcription, nuclear export, mRNA stability and translation. p38 kinases are drug targets for the inflammatory diseases psoriasis, rheumatoid arthritis, and chronic pulmonary disease. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta, which show varying substrate specificity and expression patterns. p38alpha and p38beta are ubiquitously expressed, p38gamma is predominantly found in skeletal muscle, and p38delta is found in the heart, lung, testis, pancreas, and small intestine. Length = 343 |
| >gnl|CDD|133181 cd05050, PTKc_Musk, Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Score = 43.3 bits (102), Expect = 3e-04
Identities = 38/163 (23%), Positives = 64/163 (39%), Gaps = 35/163 (21%)
Query: 430 HPNIVNLHCVFQDEVHTYLVLELLKGGELLDRIRQK--------------------GRCG 469
HPNIV L V L+ E + G+L + +R +
Sbjct: 67 HPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLP 126
Query: 470 FTENEASRIMRQLVAAVHFMHSRGVVHRDLKPENLLFSDPAGDNIKVVDFGFA------- 522
+ E I +Q+ A + ++ R VHRDL N L + +K+ DFG +
Sbjct: 127 LSCTEQLCIAKQVAAGMAYLSERKFVHRDLATRNCLVGENM--VVKIADFGLSRNIYSAD 184
Query: 523 -CLKRESLHTPCFTLQYAAPEVLRQDKSGYDENCDLWSLGVIL 564
E+ P +++ PE + ++ Y D+W+ GV+L
Sbjct: 185 YYKASENDAIP---IRWMPPESIFYNR--YTTESDVWAYGVVL 222
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates Musk autophosphorylation and activation, leading to the clustering of acetylcholine receptors (AChRs). To date, there is no evidence to suggest that agrin binds directly to Musk. Mutations in AChR, Musk and other partners are responsible for diseases of the NMJ, such as the autoimmune syndrome myasthenia gravis. Length = 288 |
| >gnl|CDD|173650 cd05094, PTKc_TrkC, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Score = 43.5 bits (102), Expect = 3e-04
Identities = 48/184 (26%), Positives = 75/184 (40%), Gaps = 30/184 (16%)
Query: 411 ISRKIDCSEEINLLRACQGHPNIVNLHCVFQDEVHTYLVLELLKGGELLDRIR------- 463
++ + D E LL Q H +IV + V D +V E +K G+L +R
Sbjct: 48 LAARKDFQREAELLTNLQ-HEHIVKFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAM 106
Query: 464 ---------QKGRCGFTENEASRIMRQLVAAVHFMHSRGVVHRDLKPENLLFSDPAGDNI 514
KG G ++ I Q+ + + ++ S+ VHRDL N L A +
Sbjct: 107 ILVDGQPRQAKGELGLSQ--MLHIASQIASGMVYLASQHFVHRDLATRNCLVG--ANLLV 162
Query: 515 KVVDFGFAC------LKRESLHTPCFTLQYAAPEVLRQDKSGYDENCDLWSLGVILVNVL 568
K+ DFG + R HT +++ PE + K + D+WS GVIL +
Sbjct: 163 KIGDFGMSRDVYSTDYYRVGGHT-MLPIRWMPPESIMYRK--FTTESDVWSFGVILWEIF 219
Query: 569 RQDK 572
K
Sbjct: 220 TYGK 223
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some non-neural tissues including the developing heart. NT3/TrkC signaling plays an important role in the innervation of the cardiac conducting system and the development of smooth muscle cells. Mice deficient with NT3 and TrkC have multiple heart defects. NT3/TrkC signaling is also critical for the development and maintenance of enteric neurons that are important for the control of gut peristalsis. Length = 291 |
| >gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 42.9 bits (102), Expect = 4e-04
Identities = 26/98 (26%), Positives = 38/98 (38%), Gaps = 33/98 (33%)
Query: 124 LGDGSYSVCRRCVEKSTGQEYAVKIISRKIDCSEEINLLRACQGHPNICRRCVEKSTGQE 183
LG GS+ +K TG+ YA+K++ +K I +R + T E
Sbjct: 1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKK-----------------KIIKRKEVEHTLTE 43
Query: 184 YAVKIISRKIDCSEEINLLRACQGHPNIVNLHCVFQDE 221
+ I +I+ HP IV LH FQ E
Sbjct: 44 ---RNILSRIN-------------HPFIVKLHYAFQTE 65
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250 |
| >gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Score = 43.0 bits (102), Expect = 4e-04
Identities = 20/61 (32%), Positives = 30/61 (49%), Gaps = 7/61 (11%)
Query: 117 DLDKAGILGDGSYSVCRRCVEKSTGQEYAVKIISRKIDCSE------EINLLRACQGHPN 170
DL++ +LG GS V + K TG+ YA+K I D E+ LR+C+ P
Sbjct: 2 DLERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRKQLLRELKTLRSCE-SPY 60
Query: 171 I 171
+
Sbjct: 61 V 61
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264 |
| >gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Score = 43.0 bits (102), Expect = 4e-04
Identities = 22/63 (34%), Positives = 29/63 (46%), Gaps = 12/63 (19%)
Query: 258 YYHIQYRRIL---KTEPP----IPEDLSPDVADFISRLLVKDPRRRLGGGELDAEELKRH 310
Y I R + +PP PE SP+ DF+ + LVKDP R A +L +H
Sbjct: 199 YSDIHPMRAIFMIPNKPPPTLSDPEKWSPEFNDFVKKCLVKDPEER-----PSAIQLLQH 253
Query: 311 PFF 313
PF
Sbjct: 254 PFI 256
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256 |
| >gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 42.9 bits (101), Expect = 4e-04
Identities = 20/77 (25%), Positives = 38/77 (49%), Gaps = 3/77 (3%)
Query: 889 SRYNVHTYLVLELLKGGELLDRIRQKGRCGFTENEASRIMRQLVAAVHFMHSRGVVHRDL 948
+ + H L +E + GG + + + G F E QL+ + ++H ++HRD+
Sbjct: 72 TCEDSHFNLFVEWMAGGSVSHLLSKYG--AFKEAVIINYTEQLLRGLSYLHENQIIHRDV 129
Query: 949 KPENLLLSGISGNLIKI 965
K NLL+ +G ++I
Sbjct: 130 KGANLLIDS-TGQRLRI 145
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268 |
| >gnl|CDD|88519 cd05618, STKc_aPKC_iota, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Score = 43.5 bits (102), Expect = 4e-04
Identities = 31/119 (26%), Positives = 58/119 (48%), Gaps = 10/119 (8%)
Query: 841 KKADRQPAKQEEKQPVPQTTPPTDLVT----LFEEQLLGPITRARRRTFVNRSRYNVHTY 896
KK +R A + K+ + D V +FE+ P F SR +
Sbjct: 17 KKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRL----F 72
Query: 897 LVLELLKGGELLDRIRQKGRCGFTENEASRIMRQLVAAVHFMHSRGVVHRDLKPENLLL 955
V+E + GG+L+ ++++ + E A ++ A++++H RG+++RDLK +N+LL
Sbjct: 73 FVIEYVNGGDLMFHMQRQRK--LPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLL 129
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target of tumor-specific gene amplification in many human cancers, and has been identified as a human oncogene. In addition to its role in transformed growth, PKC-iota also promotes invasion, chemoresistance, and tumor cell survival. Expression profiling of PKC-iota is a prognostic marker of poor clinical outcome in several human cancers. PKC-iota also plays a role in establishing cell polarity, and has critical embryonic functions. Length = 329 |
| >gnl|CDD|173752 cd07861, STKc_CDK1_euk, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Score = 43.2 bits (102), Expect = 4e-04
Identities = 22/67 (32%), Positives = 35/67 (52%), Gaps = 13/67 (19%)
Query: 899 LELLKGGELLDRIRQKGRCGFTENEASRIMRQLVAAVHFMHSRGVVHRDLKPENLLLSGI 958
L+ L G+ +D K + Q++ + F HSR V+HRDLKP+NLL+
Sbjct: 89 LDSLPKGQYMDAELVKS-----------YLYQILQGILFCHSRRVLHRDLKPQNLLID-- 135
Query: 959 SGNLIKI 965
+ +IK+
Sbjct: 136 NKGVIKL 142
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression. CDK1/cyclin A2 has also been implicated as an important regulator of S phase events. The CDK1/cyclin B complex is critical for G2 to M phase transition. It induces mitosis by activating nuclear enzymes that regulate chromatin condensation, nuclear membrane degradation, mitosis-specific microtubule and cytoskeletal reorganization. CDK1 also associates with cyclin E and plays a role in the entry into S phase. CDK1 transcription is stable throughout the cell cycle but is modulated in some pathological conditions. It may play a role in regulating apoptosis under these conditions. In breast cancer cells, HER2 can mediate apoptosis by inactivating CDK1. Activation of CDK1 may contribute to HIV-1 induced apoptosis and neuronal apoptosis in neurodegenerative diseases. Length = 285 |
| >gnl|CDD|143359 cd07854, STKc_MAPK4_6, Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Score = 43.6 bits (103), Expect = 4e-04
Identities = 20/61 (32%), Positives = 35/61 (57%), Gaps = 4/61 (6%)
Query: 896 YLVLELLKGGELLDRIRQKGRCGFTENEASRIMRQLVAAVHFMHSRGVVHRDLKPENLLL 955
Y+V E ++ L + ++G +E A M QL+ + ++HS V+HRDLKP N+ +
Sbjct: 92 YIVQEYMETD--LANVLEQGP--LSEEHARLFMYQLLRGLKYIHSANVLHRDLKPANVFI 147
Query: 956 S 956
+
Sbjct: 148 N 148
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progression in certain conditions. It may also play a role in glucose-induced insulin secretion. MAPK6 and MAPK4 cooperate to regulate the activity of MAPK-activated protein kinase 5 (MK5), leading to its relocation to the cytoplasm and exclusion from the nucleus. The MAPK6/MK5 and MAPK4/MK5 pathways may play critical roles in embryonic and post-natal development. Length = 342 |
| >gnl|CDD|133246 cd05115, PTKc_Zap-70, Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Score = 43.0 bits (101), Expect = 4e-04
Identities = 46/192 (23%), Positives = 87/192 (45%), Gaps = 19/192 (9%)
Query: 386 LGDGSYSVCRRCVEKSTGQE--YAVKIISRKIDCSEEINLLRACQ-----GHPNIVNLHC 438
LG G++ ++ V K ++ A+K++ + + S ++R + +P IV +
Sbjct: 3 LGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENEKSVRDEMMREAEIMHQLDNPYIVRMIG 62
Query: 439 VFQDEVHTYLVLELLKGGELLDRIRQKGRCGFTENEASRIMRQLVAAVHFMHSRGVVHRD 498
V + E LV+E+ GG L + K + T + +M Q+ + ++ + VHRD
Sbjct: 63 VCEAE-ALMLVMEMASGGPLNKFLSGK-KDEITVSNVVELMHQVSMGMKYLEGKNFVHRD 120
Query: 499 LKPENLLFSDPAGDNIKVVDFGF--ACLKRESLHTP----CFTLQYAAPEVLRQDKSGYD 552
L N+L + K+ DFG A +S + + L++ APE + K +
Sbjct: 121 LAARNVLLVNQ--HYAKISDFGLSKALGADDSYYKARSAGKWPLKWYAPECINFRK--FS 176
Query: 553 ENCDLWSLGVIL 564
D+WS G+ +
Sbjct: 177 SRSDVWSYGITM 188
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its phosphorylation and activation. It then phosphorylates target proteins, which propagate the signals to downstream pathways. Zap-70 is hardly detected in normal peripheral B-cells, but is present in some B-cell malignancies. It is used as a diagnostic marker for chronic lymphocytic leukemia (CLL) as it is associated with the more aggressive subtype of the disease. Length = 257 |
| >gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 42.5 bits (101), Expect = 5e-04
Identities = 48/181 (26%), Positives = 69/181 (38%), Gaps = 64/181 (35%)
Query: 124 LGDGSYSVCRRCVEKSTGQEYAVKIISRKIDCSEEINLLRACQGHPNICRRCVEKSTGQE 183
LGDG++ K TG+ A+K + +K EE LR
Sbjct: 7 LGDGTFGSVYLARNKETGELVAIKKMKKKFYSWEECMNLR-------------------- 46
Query: 184 YAVKIISRKIDCSEEINLLRACQGHPNIVNLHCVFQD--------EVIDWD--DFSRGIE 233
E+ LR HPNIV L VF++ E ++ + + +
Sbjct: 47 --------------EVKSLRKLNEHPNIVKLKEVFRENDELYFVFEYMEGNLYQLMKDRK 92
Query: 234 CVFFSSSLI--IFFIILSFTLSFIHD--YYHIQYRRILKTEPPIPEDL---SPDV---AD 283
FS S+I I + IL L+ IH ++H R LK PE+L P+V AD
Sbjct: 93 GKPFSESVIRSIIYQILQ-GLAHIHKHGFFH----RDLK-----PENLLVSGPEVVKIAD 142
Query: 284 F 284
F
Sbjct: 143 F 143
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283 |
| >gnl|CDD|173684 cd05593, STKc_PKB_gamma, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Score = 43.1 bits (101), Expect = 5e-04
Identities = 29/93 (31%), Positives = 51/93 (54%), Gaps = 10/93 (10%)
Query: 867 TLFEEQLLGPITRARRRTFVNRSRYNVHTY----LVLELLKGGELLDRIRQKGRCGFTEN 922
TL E ++L + R F+ +Y+ T V+E + GGEL + ++ F+E+
Sbjct: 42 TLTESRVL----KNTRHPFLTSLKYSFQTKDRLCFVMEYVNGGELFFHLSRERV--FSED 95
Query: 923 EASRIMRQLVAAVHFMHSRGVVHRDLKPENLLL 955
++V+A+ ++HS +V+RDLK ENL+L
Sbjct: 96 RTRFYGAEIVSALDYLHSGKIVYRDLKLENLML 128
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulated in estrogen-deficient breast cancer cells, androgen-independent prostate cancer cells, and primary ovarian tumors. It acts as a key mediator in the genesis of ovarian cancer. Length = 328 |
| >gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 42.7 bits (101), Expect = 5e-04
Identities = 20/61 (32%), Positives = 36/61 (59%), Gaps = 1/61 (1%)
Query: 896 YLVLELLKGGELLDRIRQKGRCGFTENEASRIMRQLVAAVHFMHSRGVVHRDLKPENLLL 955
++V+E GG L D I Q R +E + + + R+ + + ++H G +HRD+K N+LL
Sbjct: 76 WIVMEYCGGGSLQD-IYQVTRGPLSELQIAYVCRETLKGLAYLHETGKIHRDIKGANILL 134
Query: 956 S 956
+
Sbjct: 135 T 135
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262 |
| >gnl|CDD|132979 cd06648, STKc_PAK_II, Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Score = 42.8 bits (101), Expect = 5e-04
Identities = 19/53 (35%), Positives = 26/53 (49%), Gaps = 8/53 (15%)
Query: 264 RRILKTEPPI---PEDLSPDVADFISRLLVKDPRRRLGGGELDAEELKRHPFF 313
+RI PP +SP + F+ R+LV+DP +R A EL HPF
Sbjct: 225 KRIRDNLPPKLKNLHKVSPRLRSFLDRMLVRDPAQR-----ATAAELLNHPFL 272
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs found in group I PAKs, such as an AID (autoinhibitory domain) and SH3 binding sites. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. While group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX, no such binding has been demonstrated for group II PAKs. Some known substrates of group II PAKs are also substrates of group I PAKs such as Raf, BAD, LIMK and GEFH1. Unique group II substrates include MARK/Par-1 and PDZ-RhoGEF. Group II PAKs play important roles in filopodia formation, neuron extension, cytoskeletal organization, and cell survival. Length = 285 |
| >gnl|CDD|173714 cd05625, STKc_LATS1, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Score = 43.1 bits (101), Expect = 5e-04
Identities = 20/60 (33%), Positives = 37/60 (61%), Gaps = 2/60 (3%)
Query: 896 YLVLELLKGGELLDRIRQKGRCGFTENEASRIMRQLVAAVHFMHSRGVVHRDLKPENLLL 955
Y V++ + GG+++ + + G F E+ A + +L AV +H G +HRD+KP+N+L+
Sbjct: 77 YFVMDYIPGGDMMSLLIRMGI--FPEDLARFYIAELTCAVESVHKMGFIHRDIKPDNILI 134
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype and poor prognosis. LATS1 induces G2 arrest and promotes cytokinesis. It may be a component of the mitotic exit network in higher eukaryotes. Length = 382 |
| >gnl|CDD|173729 cd06617, PKc_MKK3_6, Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Score = 42.8 bits (101), Expect = 5e-04
Identities = 19/54 (35%), Positives = 32/54 (59%), Gaps = 11/54 (20%)
Query: 921 ENEASRIMRQLVAAVHFMHSR-GVVHRDLKPENLLLS----------GISGNLI 963
E+ +I +V A+ ++HS+ V+HRD+KP N+L++ GISG L+
Sbjct: 102 EDILGKIAVSIVKALEYLHSKLSVIHRDVKPSNVLINRNGQVKLCDFGISGYLV 155
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs that phosphorylate and activate their downstream target, p38 MAPK, on specific threonine and tyrosine residues. MKK3/6 plays roles in the regulation of cell cycle progression, cytokine- and stress-induced apoptosis, oncogenic transformation, and adult tissue regeneration. In addition, MKK6 plays a critical role in osteoclast survival in inflammatory disease while MKK3 is associated with tumor invasion, progression, and poor patient survival in glioma. Length = 283 |
| >gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Score = 42.5 bits (101), Expect = 6e-04
Identities = 28/112 (25%), Positives = 46/112 (41%), Gaps = 28/112 (25%)
Query: 177 EKSTGQEYAVKIIS-------RKIDCSEEINLLRACQGHPNIVNLHCVFQD--------E 221
KS G+ Y +K I + D E+ +L+ HPNI+ + F++ E
Sbjct: 21 RKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLN-HPNIIKYYESFEEKGKLCIVME 79
Query: 222 VIDWDDFSRGIE-----CVFFSSSLII-FFIILSFTLSFIHDYYHIQYRRIL 267
D D S+ I+ F I+ +F+ L L ++H R+IL
Sbjct: 80 YADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLHS------RKIL 125
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258 |
| >gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Score = 42.2 bits (100), Expect = 6e-04
Identities = 21/54 (38%), Positives = 25/54 (46%), Gaps = 7/54 (12%)
Query: 266 ILKTEPPIPED--LSPDVADFISRLLVKDPRRRLGGGELDAEELKRHPFFNVID 317
I PP SP+ DFIS L KDP++R A EL +HPF D
Sbjct: 215 ICDGPPPSLPAEEFSPEFRDFISACLQKDPKKR-----PSAAELLQHPFIKKAD 263
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264 |
| >gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Score = 42.3 bits (100), Expect = 6e-04
Identities = 22/62 (35%), Positives = 33/62 (53%), Gaps = 7/62 (11%)
Query: 253 SFIHDYYHIQYRRILKTEPPIPE--DLSPDVADFISRLLVKDPRRRLGGGELDAEELKRH 310
S + + + I + +PPIP+ LSP+ DF+ R L DP++R A EL +H
Sbjct: 207 SELDNEFQIMFHVGAGHKPPIPDSLQLSPEGKDFLDRCLESDPKKR-----PTASELLQH 261
Query: 311 PF 312
PF
Sbjct: 262 PF 263
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264 |
| >gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 42.5 bits (100), Expect = 6e-04
Identities = 23/72 (31%), Positives = 40/72 (55%), Gaps = 4/72 (5%)
Query: 894 HTYLVLELLKGGELLDRIRQKGRCGFTENEASRIMRQLVAAVHFMHSRGVVHRDLKPENL 953
H + LE + GG + + G F E +RQ++ ++++H+RG++HRD+K N+
Sbjct: 80 HLNIFLEYVPGGSVAALLNNYG--AFEETLVRNFVRQILKGLNYLHNRGIIHRDIKGANI 137
Query: 954 LLSGISGNLIKI 965
L+ G IKI
Sbjct: 138 LVDNKGG--IKI 147
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267 |
| >gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Score = 42.3 bits (99), Expect = 6e-04
Identities = 19/61 (31%), Positives = 38/61 (62%), Gaps = 3/61 (4%)
Query: 896 YLVLELLKGGELLDRIRQKGRCGFTENEASRIMRQLVAAVHFMHSRGVVHRDLKPENLLL 955
++++E L GG LD +R F E + + ++++++ + ++HS +HRD+K N+LL
Sbjct: 78 WIIMEYLGGGSALDLLRAGP---FDEFQIATMLKEILKGLDYLHSEKKIHRDIKAANVLL 134
Query: 956 S 956
S
Sbjct: 135 S 135
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277 |
| >gnl|CDD|178763 PLN03224, PLN03224, probable serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 42.8 bits (100), Expect = 7e-04
Identities = 16/35 (45%), Positives = 25/35 (71%)
Query: 922 NEASRIMRQLVAAVHFMHSRGVVHRDLKPENLLLS 956
N +MRQ++ + +H G+VHRD+KPENLL++
Sbjct: 309 NVIKGVMRQVLTGLRKLHRIGIVHRDIKPENLLVT 343
|
Length = 507 |
| >gnl|CDD|133175 cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Score = 42.4 bits (100), Expect = 7e-04
Identities = 36/151 (23%), Positives = 62/151 (41%), Gaps = 24/151 (15%)
Query: 430 HPNIVNLHCVFQDEVHTYLVLELLKGGELLDRIRQKGRCGFTENEASRIMRQLV------ 483
H NI+ + V ++ VL L Q+ R G N + +QLV
Sbjct: 67 HQNILPILHVCIEDGEPPFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQI 126
Query: 484 -AAVHFMHSRGVVHRDLKPENLLFSDPAGDNIKVVDFGFA---------CLKRESLHTPC 533
+ ++H RGV+H+D+ N + + +K+ D + CL ++ + P
Sbjct: 127 ACGMSYLHKRGVIHKDIAARNCVIDEEL--QVKITDNALSRDLFPMDYHCLG-DNENRP- 182
Query: 534 FTLQYAAPEVLRQDKSGYDENCDLWSLGVIL 564
+++ A E L Y D+WS GV+L
Sbjct: 183 --VKWMALESLV--NKEYSSASDVWSFGVLL 209
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It acts as a chemorepulsive axon guidance receptor of Wnt glycoproteins and is responsible for the establishment of axon tracts during the development of the central nervous system. In addition, studies in mice reveal that Ryk is essential in skeletal, craniofacial, and cardiac development. Thus, it appears Ryk is involved in signal transduction despite its lack of kinase activity. Ryk may function as an accessory protein that modulates the signals coming from catalytically active partner RTKs such as the Eph receptors. Length = 280 |
| >gnl|CDD|133238 cd05107, PTKc_PDGFR_beta, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Score = 42.7 bits (100), Expect = 7e-04
Identities = 29/105 (27%), Positives = 49/105 (46%), Gaps = 15/105 (14%)
Query: 481 QLVAAVHFMHSRGVVHRDLKPENLLFSDPAGDNIKVVDFGFACLKRESLHTPCFT----- 535
Q+ + F+ S+ VHRDL N+L + G +K+ DFG A R+ + +
Sbjct: 247 QVANGMEFLASKNCVHRDLAARNVLICE--GKLVKICDFGLA---RDIMRDSNYISKGST 301
Query: 536 ---LQYAAPEVLRQDKSGYDENCDLWSLGVILVNVLRQDKSGYDE 577
L++ APE + + Y D+WS G++L + + Y E
Sbjct: 302 FLPLKWMAPESIFN--NLYTTLSDVWSFGILLWEIFTLGGTPYPE 344
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-DD induce PDGFR beta homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR beta signaling leads to a variety of cellular effects including the stimulation of cell growth and chemotaxis, as well as the inhibition of apoptosis and GAP junctional communication. It is critical in normal angiogenesis as it is involved in the recruitment of pericytes and smooth muscle cells essential for vessel stability. Aberrant PDGFR beta expression is associated with some human cancers. The continuously-active fusion proteins of PDGFR beta with COL1A1 and TEL are associated with dermatofibrosarcoma protuberans (DFSP) and a subset of chronic myelomonocytic leukemia (CMML), respectively. Length = 401 |
| >gnl|CDD|173685 cd05594, STKc_PKB_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Score = 42.3 bits (99), Expect = 8e-04
Identities = 34/97 (35%), Positives = 53/97 (54%), Gaps = 17/97 (17%)
Query: 867 TLFEEQLLGPITRARRRTFVNRSRYNVHTY----LVLELLKGGEL---LDRIRQKGRCGF 919
TL E ++L + R F+ +Y+ T+ V+E GGEL L R R F
Sbjct: 42 TLTENRVL----QNSRHPFLTALKYSFQTHDRLCFVMEYANGGELFFHLSRERV-----F 92
Query: 920 TENEASRIMRQLVAAVHFMHS-RGVVHRDLKPENLLL 955
+E+ A ++V+A+ ++HS + VV+RDLK ENL+L
Sbjct: 93 SEDRARFYGAEIVSALDYLHSEKNVVYRDLKLENLML 129
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficient in PKB-alpha exhibit perinatal morbidity, growth retardation, reduction in body weight accompanied by reduced sizes of multiple organs, and enhanced apoptosis in some cell types. PKB-alpha activity has been reported to be frequently elevated in breast and prostate cancers. In some cancer cells, PKB-alpha may act as a suppressor of metastasis. Length = 325 |
| >gnl|CDD|143367 cd07862, STKc_CDK6, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Score = 42.3 bits (99), Expect = 8e-04
Identities = 19/39 (48%), Positives = 28/39 (71%), Gaps = 2/39 (5%)
Query: 927 IMRQLVAAVHFMHSRGVVHRDLKPENLLLSGISGNLIKI 965
+M QL+ + F+HS VVHRDLKP+N+L++ S IK+
Sbjct: 115 MMFQLLRGLDFLHSHRVVHRDLKPQNILVT--SSGQIKL 151
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytoplasm. It is also present in the ruffling edge of spreading fibroblasts and may play a role in cell spreading. It binds to the p21 inhibitor without any effect on its own activity and it is overexpressed in squamous cell carcinomas and neuroblastomas. CDK6 has also been shown to inhibit cell differentiation in many cell types. Length = 290 |
| >gnl|CDD|143354 cd07849, STKc_ERK1_2_like, Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 42.3 bits (100), Expect = 8e-04
Identities = 14/26 (53%), Positives = 20/26 (76%)
Query: 930 QLVAAVHFMHSRGVVHRDLKPENLLL 955
Q++ + ++HS V+HRDLKP NLLL
Sbjct: 114 QILRGLKYIHSANVLHRDLKPSNLLL 139
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase kinase from the Raf family. ERK1/2 have numerous substrates, many of which are nuclear and participate in transcriptional regulation of many cellular processes. They regulate cell growth, cell proliferation, and cell cycle progression from G1 to S phase. Although the distinct roles of ERK1 and ERK2 have not been fully determined, it is known that ERK2 can maintain most functions in the absence of ERK1, and that the deletion of ERK2 is embryonically lethal. The MAPK, Fus3, regulates yeast mating processes including mating-specific gene expression, G1 arrest, mating projection, and cell fusion. Length = 336 |
| >gnl|CDD|237847 PRK14879, PRK14879, serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 41.4 bits (98), Expect = 8e-04
Identities = 26/84 (30%), Positives = 41/84 (48%), Gaps = 9/84 (10%)
Query: 439 VFQDEVHTYLVLELLKGGELLDRIRQKGRCGFTENEASRIMRQLVAAVHFMHSRGVVHRD 498
F D + +V+E ++G L D I G E + R++ V +HS G++H D
Sbjct: 67 YFVDPENFIIVMEYIEGEPLKDLINSNG------MEELELSREIGRLVGKLHSAGIIHGD 120
Query: 499 LKPENLLFSDPAGDNIKVVDFGFA 522
L N++ S G I ++DFG A
Sbjct: 121 LTTSNMILS---GGKIYLIDFGLA 141
|
Length = 211 |
| >gnl|CDD|143344 cd07839, STKc_CDK5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Score = 42.0 bits (99), Expect = 9e-04
Identities = 16/30 (53%), Positives = 22/30 (73%)
Query: 928 MRQLVAAVHFMHSRGVVHRDLKPENLLLSG 957
M QL+ + F HS V+HRDLKP+NLL++
Sbjct: 105 MFQLLKGLAFCHSHNVLHRDLKPQNLLINK 134
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also important in synaptic plasticity and learning. CDK5 also participates in protecting against cell death and promoting angiogenesis. Impaired CDK5 activity is implicated in Alzheimer's disease, amyotrophic lateral sclerosis, Parkinson's disease, Huntington's disease and acute neuronal injury. Length = 284 |
| >gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Score = 41.5 bits (98), Expect = 0.001
Identities = 19/53 (35%), Positives = 31/53 (58%), Gaps = 4/53 (7%)
Query: 262 QYRRILKT-EPPIPEDLSPDVADFISRLLVKDPRRRLGGGELDAEELKRHPFF 313
Q R +T + P S + D I++LL +DP++RLG + ++LK HP+F
Sbjct: 209 QIRAKQETADVLYPATWSTEAIDAINKLLERDPQKRLGD---NLKDLKNHPYF 258
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258 |
| >gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 42.0 bits (99), Expect = 0.001
Identities = 22/56 (39%), Positives = 27/56 (48%), Gaps = 8/56 (14%)
Query: 265 RILKTEPPI---PEDLSPDVADFISRLLVKDPRRRLGGGELDAEELKRHPFFNVID 317
+ILK+EPP P S DF+ LVKDP R A EL +HPF +
Sbjct: 219 KILKSEPPTLDQPSKWSSSFNDFLKSCLVKDPDDR-----PTAAELLKHPFVSDQS 269
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280 |
| >gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 41.7 bits (99), Expect = 0.001
Identities = 17/61 (27%), Positives = 29/61 (47%), Gaps = 10/61 (16%)
Query: 261 IQYRRILKTEPPIP-EDL----SPDVADFISRLLVKDPRRRLGGGELDAEELKRHPFFNV 315
Y + L +P P L SP+ D + ++LV DP++R + A+E HP+
Sbjct: 240 RNYLKSLPKKPKKPLSKLFPGASPEAIDLLEKMLVFDPKKR-----ITADEALAHPYLAQ 294
Query: 316 I 316
+
Sbjct: 295 L 295
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330 |
| >gnl|CDD|132970 cd06639, STKc_myosinIIIB, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Score = 41.5 bits (97), Expect = 0.001
Identities = 22/67 (32%), Positives = 38/67 (56%), Gaps = 2/67 (2%)
Query: 896 YLVLELLKGGELLDRIRQKGRCGFTENEA--SRIMRQLVAAVHFMHSRGVVHRDLKPENL 953
+LVLEL GG + + ++ CG +EA S I+ + + +H+ ++HRD+K N+
Sbjct: 100 WLVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGALLGLQHLHNNRIIHRDVKGNNI 159
Query: 954 LLSGISG 960
LL+ G
Sbjct: 160 LLTTEGG 166
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also present in the brain and testis. The human class IIIB myosin gene maps to a region that overlaps the locus for Bardet-Biedl syndrome, which is characterized by dysmorphic extremities, retinal dystrophy, obesity, male hypogenitalism, and renal abnormalities. Length = 291 |
| >gnl|CDD|173698 cd05607, STKc_GRK7, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Score = 41.5 bits (97), Expect = 0.001
Identities = 23/71 (32%), Positives = 33/71 (46%), Gaps = 2/71 (2%)
Query: 264 RRILKTEPPIPED-LSPDVADFISRLLVKDPRRRLGGGELDAEELKRHPFFNVIDWDDLA 322
RR L+ E + + D L K P RLG E + ++ ++H FF I++ L
Sbjct: 208 RRTLEDEVKFEHQNFTEESKDICRLFLAKKPEDRLGSREKN-DDPRKHEFFKTINFPRLE 266
Query: 323 TKRIPAPFVPK 333
IP PFVP
Sbjct: 267 AGLIPPPFVPD 277
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual group of GRKs. It is primarily found in the retina and plays a role in the regulation of opsin light receptors. GRK7 is located in retinal cone outer segments and plays an important role in regulating photoresponse of the cones. Length = 277 |
| >gnl|CDD|177649 PLN00009, PLN00009, cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Score = 41.7 bits (98), Expect = 0.001
Identities = 36/126 (28%), Positives = 56/126 (44%), Gaps = 18/126 (14%)
Query: 832 THSTPARKKKKADRQPAKQEEKQPVPQTTPPTDLVTLFEEQLLGPITRARRRTFVNRSRY 891
T+ T A KK + + +E + VP T ++L +E G I R + + Y
Sbjct: 26 TNETIALKKIRLE------QEDEGVPSTA--IREISLLKEMQHGNIVRLQDVVHSEKRLY 77
Query: 892 NVHTYLVLELLKGGELLDRIRQKGRCGFTENE--ASRIMRQLVAAVHFMHSRGVVHRDLK 949
V YL L+L K F +N + Q++ + + HS V+HRDLK
Sbjct: 78 LVFEYLDLDLKK--------HMDSSPDFAKNPRLIKTYLYQILRGIAYCHSHRVLHRDLK 129
Query: 950 PENLLL 955
P+NLL+
Sbjct: 130 PQNLLI 135
|
Length = 294 |
| >gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Score = 41.6 bits (97), Expect = 0.001
Identities = 19/61 (31%), Positives = 36/61 (59%), Gaps = 3/61 (4%)
Query: 896 YLVLELLKGGELLDRIRQKGRCGFTENEASRIMRQLVAAVHFMHSRGVVHRDLKPENLLL 955
++++E L GG LD + E + + I+R+++ + ++HS +HRD+K N+LL
Sbjct: 78 WIIMEYLGGGSALDLLEPGP---LDETQIATILREILKGLDYLHSEKKIHRDIKAANVLL 134
Query: 956 S 956
S
Sbjct: 135 S 135
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277 |
| >gnl|CDD|132989 cd06658, STKc_PAK5, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Score = 41.6 bits (97), Expect = 0.001
Identities = 18/61 (29%), Positives = 39/61 (63%), Gaps = 3/61 (4%)
Query: 896 YLVLELLKGGELLDRIRQKGRCGFTENEASRIMRQLVAAVHFMHSRGVVHRDLKPENLLL 955
++V+E L+GG L D + E + + + ++ A+ ++H++GV+HRD+K +++LL
Sbjct: 95 WVVMEFLEGGALTDIVTHTR---MNEEQIATVCLSVLRALSYLHNQGVIHRDIKSDSILL 151
Query: 956 S 956
+
Sbjct: 152 T 152
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly expressed in the brain. It is not required for viability, but together with PAK6, it is required for normal levels of locomotion and activity, and for learning and memory. PAK5 cooperates with Inca (induced in neural crest by AP2) in the regulation of cell adhesion and cytoskeletal organization in the embryo and in neural crest cells during craniofacial development. PAK5 may also play a role in controlling the signaling of Raf-1, an effector of Ras, at the mitochondria. Length = 292 |
| >gnl|CDD|223009 PHA03211, PHA03211, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 42.2 bits (99), Expect = 0.001
Identities = 14/31 (45%), Positives = 26/31 (83%)
Query: 927 IMRQLVAAVHFMHSRGVVHRDLKPENLLLSG 957
+ RQL++A+ ++H G++HRD+K EN+L++G
Sbjct: 265 VARQLLSAIDYIHGEGIIHRDIKTENVLVNG 295
|
Length = 461 |
| >gnl|CDD|173627 cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 41.7 bits (98), Expect = 0.001
Identities = 37/155 (23%), Positives = 68/155 (43%), Gaps = 17/155 (10%)
Query: 419 EEINLLRACQGHPNIVNLH--CVFQDEVHTYLVLELLKGGELLDRIRQKGRCGFTENEAS 476
E +L+ H ++V L+ CV + +V E +K G L D + + + +
Sbjct: 50 ETASLMS-QLSHKHLVKLYGVCVRDE---NIMVEEYVKFGPL-DVFLHREKNNVSLHWKL 104
Query: 477 RIMRQLVAAVHFMHSRGVVHRDLKPENLLFS--DPAGDN---IKVVDFGFA--CLKRESL 529
+ +QL +A+H++ + +VH ++ +N+L + IK+ D G L RE
Sbjct: 105 DVAKQLASALHYLEDKKLVHGNVCGKNILVARYGLNEGYVPFIKLSDPGIPITVLSREER 164
Query: 530 HTPCFTLQYAAPEVLRQDKSGYDENCDLWSLGVIL 564
+ + APE +R ++ D WS G L
Sbjct: 165 VER---IPWIAPECIRNGQASLTIAADKWSFGTTL 196
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 259 |
| >gnl|CDD|173656 cd05111, PTK_HER3, Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Score = 41.5 bits (97), Expect = 0.001
Identities = 31/122 (25%), Positives = 56/122 (45%), Gaps = 10/122 (8%)
Query: 448 LVLELLKGGELLDRIRQKGRCGFTENEASRIMRQLVAAVHFMHSRGVVHRDLKPENLLFS 507
LV +L G LLD +RQ R Q+ ++++ +VHR+L N+L
Sbjct: 85 LVTQLSPLGSLLDHVRQH-RDSLDPQRLLNWCVQIAKGMYYLEEHRMVHRNLAARNILLK 143
Query: 508 DPAGDNIKVVDFGFACL----KRESLHTPCFT-LQYAAPEVLRQDKSGYDENCDLWSLGV 562
+ +++ DFG A L ++ ++ T +++ A E + + Y D+WS GV
Sbjct: 144 SDS--IVQIADFGVADLLYPDDKKYFYSEHKTPIKWMALESILFGR--YTHQSDVWSYGV 199
Query: 563 IL 564
+
Sbjct: 200 TV 201
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER3 binds the neuregulin ligands, NRG1 and NRG2. HER3 contains an impaired tyr kinase domain and relies on its heterodimerization partners for activity following ligand binding. The HER2-HER3 heterodimer constitutes a high affinity co-receptor capable of potent mitogenic signaling. HER3 participates in a signaling pathway involved in the proliferation, survival, adhesion, and motility of tumor cells. Length = 279 |
| >gnl|CDD|133247 cd05116, PTKc_Syk, Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Score = 41.1 bits (96), Expect = 0.001
Identities = 48/195 (24%), Positives = 87/195 (44%), Gaps = 21/195 (10%)
Query: 384 GILGDGSYSVCRRCV--EKSTGQEYAVKIISRKI-DCSEEINLLRACQ-----GHPNIVN 435
G LG G++ ++ + K + + AVKI+ D + + LLR +P IV
Sbjct: 1 GELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVR 60
Query: 436 LHCVFQDEVHTYLVLELLKGGELLDRIRQKGRCGFTENEASRIMRQLVAAVHFMHSRGVV 495
+ + + E LV+EL + G L ++ QK + TE + ++ Q+ + ++ V
Sbjct: 61 MIGICEAE-SWMLVMELAELGPL-NKFLQKNK-HVTEKNITELVHQVSMGMKYLEETNFV 117
Query: 496 HRDLKPENLLFSDPAGDNIKVVDFGFACLKRESLH------TPCFTLQYAAPEVLRQDKS 549
HRDL N+L K+ DFG + + + +++ APE + K
Sbjct: 118 HRDLAARNVLLV--TQHYAKISDFGLSKALGADENYYKAKTHGKWPVKWYAPECMNYYK- 174
Query: 550 GYDENCDLWSLGVIL 564
+ D+WS GV++
Sbjct: 175 -FSSKSDVWSFGVLM 188
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. More recently, Syk expression has been detected in other cell types (including epithelial cells, vascular endothelial cells, neurons, hepatocytes, and melanocytes), suggesting a variety of biological functions in non-immune cells. Syk plays a critical role in maintaining vascular integrity and in wound healing during embryogenesis. It also regulates Vav3, which is important in osteoclast function including bone development. In breast epithelial cells, where Syk acts as a negative regulator for epidermal growth factor receptor (EGFR) signaling, loss of Syk expression is associated with abnormal proliferation during cancer development suggesting a potential role as a tumor suppressor. In mice, Syk has been shown to inhibit malignant transformation of mammary epithelial cells induced with murine mammary tumor virus (MMTV). Length = 257 |
| >gnl|CDD|133221 cd05090, PTKc_Ror1, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Score = 41.5 bits (97), Expect = 0.001
Identities = 40/158 (25%), Positives = 66/158 (41%), Gaps = 30/158 (18%)
Query: 430 HPNIVNLHCVFQDEVHTYLVLELLKGGELLDRIRQKGR-----CGFTENEASR------- 477
HPNIV L V E ++ E L G+L + + + C E+ +
Sbjct: 66 HPNIVCLLGVVTQEQPVCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGD 125
Query: 478 ---IMRQLVAAVHFMHSRGVVHRDLKPENLLFSDPAGDNIKVVDFGFACLKRESLHTPCF 534
I Q+ A + ++ S VH+DL N+L + ++K+ D G L RE +
Sbjct: 126 FLHIAIQIAAGMEYLSSHFFVHKDLAARNILIGEQL--HVKISDLG---LSREIYSADYY 180
Query: 535 TLQ--------YAAPEVLRQDKSGYDENCDLWSLGVIL 564
+Q + PE + K + + D+WS GV+L
Sbjct: 181 RVQPKSLLPIRWMPPEAIMYGK--FSSDSDIWSFGVVL 216
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. Avian Ror1 was found to be involved in late limb development. Studies in mice reveal that Ror1 is important in the regulation of neurite growth in central neurons, as well as in respiratory development. Loss of Ror1 also enhances the heart and skeletal abnormalities found in Ror2-deficient mice. Length = 283 |
| >gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Score = 40.7 bits (96), Expect = 0.002
Identities = 15/41 (36%), Positives = 22/41 (53%), Gaps = 5/41 (12%)
Query: 272 PIPEDLSPDVADFISRLLVKDPRRRLGGGELDAEELKRHPF 312
PE S + DF+ + L K+P +R AE+L +HPF
Sbjct: 218 RNPEKWSDEFKDFLKKCLQKNPEKR-----PTAEQLLKHPF 253
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253 |
| >gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Score = 41.0 bits (97), Expect = 0.002
Identities = 19/58 (32%), Positives = 30/58 (51%), Gaps = 8/58 (13%)
Query: 123 ILGDGSYSVCRRCVEKSTGQEYAVKII------SRKIDC-SEEINLLRACQGHPNICR 173
+LG GS+ ++K TG+ AVK + +++ EI +L + Q HPNI R
Sbjct: 7 LLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQ-HPNIVR 63
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260 |
| >gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 40.9 bits (96), Expect = 0.002
Identities = 17/45 (37%), Positives = 25/45 (55%), Gaps = 5/45 (11%)
Query: 269 TEPPIPEDLSPDVADFISRLLVKDPRRRLGGGELDAEELKRHPFF 313
T P +P +SPD +F+ R V++ ++R AEEL RH F
Sbjct: 224 TNPQLPSHVSPDARNFLRRTFVENAKKR-----PSAEELLRHFFV 263
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263 |
| >gnl|CDD|173712 cd05622, STKc_ROCK1, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Score = 41.2 bits (96), Expect = 0.002
Identities = 24/69 (34%), Positives = 41/69 (59%), Gaps = 4/69 (5%)
Query: 894 HTYLVLELLKGGELLDRIRQKGRCGFTENEASRIMRQLVAAVHFMHSRGVVHRDLKPENL 953
+ Y+V+E + GG+L++ + E A ++V A+ +HS G +HRD+KP+N+
Sbjct: 117 YLYMVMEYMPGGDLVNLMSNYD---VPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNM 173
Query: 954 LLSGISGNL 962
LL SG+L
Sbjct: 174 LLDK-SGHL 181
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, and kidney. It mediates signaling from Rho to the actin cytoskeleton. It is implicated in the development of cardiac fibrosis, cardiomyocyte apoptosis, and hyperglycemia. Mice deficient with ROCK1 display eyelids open at birth (EOB) and omphalocele phenotypes due to the disorganization of actin filaments in the eyelids and the umbilical ring. Length = 371 |
| >gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Score = 40.8 bits (96), Expect = 0.002
Identities = 20/52 (38%), Positives = 26/52 (50%), Gaps = 7/52 (13%)
Query: 265 RILKTEPP-IPED-LSPDVADFISRLLVKDPRRRLGGGELDAEELKRHPFFN 314
I+ PP +P SPD DF++ L+KDPR R +EL HPF
Sbjct: 215 YIVNEPPPRLPSGKFSPDFQDFVNLCLIKDPRER-----PSYKELLEHPFIK 261
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265 |
| >gnl|CDD|132982 cd06651, STKc_MEKK3, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Score = 40.8 bits (95), Expect = 0.002
Identities = 31/110 (28%), Positives = 54/110 (49%), Gaps = 6/110 (5%)
Query: 848 AKQEEKQP-VPQTTPPTDLVTLFEEQLLGPITRARRRTFVN--RSRYNVHTYLVLELLKG 904
AKQ + P P+T+ + E QLL + R + R R + +E + G
Sbjct: 32 AKQVQFDPESPETSKEVSALEC-EIQLLKNLQHERIVQYYGCLRDRAEKTLTIFMEYMPG 90
Query: 905 GELLDRIRQKGRCGFTENEASRIMRQLVAAVHFMHSRGVVHRDLKPENLL 954
G + D+++ G TE+ + RQ++ + ++HS +VHRD+K N+L
Sbjct: 91 GSVKDQLKAYG--ALTESVTRKYTRQILEGMSYLHSNMIVHRDIKGANIL 138
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. In addition, MEKK3 is involved in interleukin-1 receptor and Toll-like receptor 4 signaling. It is also a specific regulator of the proinflammatory cytokines IL-6 and GM-CSF in some immune cells. MEKK3 also regulates calcineurin, which plays a critical role in T cell activation, apoptosis, skeletal myocyte differentiation, and cardiac hypertrophy. Length = 266 |
| >gnl|CDD|143349 cd07844, STKc_PCTAIRE_like, Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 41.2 bits (97), Expect = 0.002
Identities = 15/29 (51%), Positives = 22/29 (75%)
Query: 928 MRQLVAAVHFMHSRGVVHRDLKPENLLLS 956
+ QL+ + + H R V+HRDLKP+NLL+S
Sbjct: 109 LFQLLRGLAYCHQRRVLHRDLKPQNLLIS 137
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the membrane-associated cyclin Y. PCTAIRE-like proteins show unusual expression patterns with high levels in post-mitotic tissues, suggesting that they may be involved in regulating post-mitotic cellular events. Length = 291 |
| >gnl|CDD|132967 cd06636, STKc_MAP4K4_6, Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Score = 40.8 bits (95), Expect = 0.002
Identities = 19/62 (30%), Positives = 37/62 (59%), Gaps = 2/62 (3%)
Query: 896 YLVLELLKGGELLDRIRQ-KGRCGFTENEASRIMRQLVAAVHFMHSRGVVHRDLKPENLL 954
+LV+E G + D ++ KG E+ + I R+++ + +H+ V+HRD+K +N+L
Sbjct: 95 WLVMEFCGAGSVTDLVKNTKGNA-LKEDWIAYICREILRGLAHLHAHKVIHRDIKGQNVL 153
Query: 955 LS 956
L+
Sbjct: 154 LT 155
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K4 is also called Nck Interacting kinase (NIK). It facilitates the activation of the MAPKs, extracellular signal-regulated kinase (ERK) 1, ERK2, and c-Jun N-terminal kinase (JNK), by phosphorylating and activating MEKK1. MAP4K4 plays a role in tumor necrosis factor (TNF) alpha-induced insulin resistance. MAP4K4 silencing in skeletal muscle cells from type II diabetic patients restores insulin-mediated glucose uptake. MAP4K4, through JNK, also plays a broad role in cell motility, which impacts inflammation, homeostasis, as well as the invasion and spread of cancer. MAP4K4 is found to be highly expressed in most tumor cell lines relative to normal tissue. MAP4K6 (also called MINK for Misshapen/NIKs-related kinase) is activated after Ras induction and mediates activation of p38 MAPK. MAP4K6 plays a role in cell cycle arrest, cytoskeleton organization, cell adhesion, and cell motility. Length = 282 |
| >gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 40.5 bits (95), Expect = 0.002
Identities = 22/70 (31%), Positives = 38/70 (54%), Gaps = 3/70 (4%)
Query: 896 YLVLELLKGGELLDRIRQKGRCGFTENEASRIMRQLVAAVHFMHSRGVVHRDLKPENLLL 955
Y+V+EL+ GG LL +R+K T + ++ A + ++ S+ +HRDL N L+
Sbjct: 68 YIVMELVPGGSLLTFLRKKKN-RLTVKKLLQMSLDAAAGMEYLESKNCIHRDLAARNCLV 126
Query: 956 SGISGNLIKI 965
N++KI
Sbjct: 127 G--ENNVLKI 134
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251 |
| >gnl|CDD|132988 cd06657, STKc_PAK4, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Score = 41.2 bits (96), Expect = 0.002
Identities = 18/61 (29%), Positives = 38/61 (62%), Gaps = 3/61 (4%)
Query: 896 YLVLELLKGGELLDRIRQKGRCGFTENEASRIMRQLVAAVHFMHSRGVVHRDLKPENLLL 955
++V+E L+GG L D + E + + + ++ A+ +H++GV+HRD+K +++LL
Sbjct: 93 WVVMEFLEGGALTDIVTHTR---MNEEQIAAVCLAVLKALSVLHAQGVIHRDIKSDSILL 149
Query: 956 S 956
+
Sbjct: 150 T 150
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell morphology and cytoskeletal organization. It is essential for embryonic viability and proper neural development. Mice lacking PAK4 die due to defects in the fetal heart. In addition, their spinal cord motor neurons showed failure to differentiate and migrate. PAK4 also plays a role in cell survival and tumorigenesis. It is overexpressed in many primary tumors including colon, esophageal, and mammary tumors. PAK4 has also been implicated in viral and bacterial infection pathways. Length = 292 |
| >gnl|CDD|133186 cd05055, PTKc_PDGFR, Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 41.3 bits (97), Expect = 0.002
Identities = 20/71 (28%), Positives = 36/71 (50%), Gaps = 2/71 (2%)
Query: 895 TYLVLELLKGGELLDRIRQKGRCGFTENEASRIMRQLVAAVHFMHSRGVVHRDLKPENLL 954
++ E G+LL+ +R+K T + Q+ + F+ S+ +HRDL N+L
Sbjct: 114 ILVITEYCCYGDLLNFLRRKRESFLTLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNVL 173
Query: 955 LSGISGNLIKI 965
L+ G ++KI
Sbjct: 174 LT--HGKIVKI 182
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR subfamily receptors are important in the development of a variety of cells. PDGFRs are expressed in a many cells including fibroblasts, neurons, endometrial cells, mammary epithelial cells, and vascular smooth muscle cells. PDGFR signaling is critical in normal embryonic development, angiogenesis, and wound healing. PDGFRs transduce mitogenic signals for connective tissue cells and are important for cell shape and motility. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. Mammalian FLT3 plays an important role in the survival, proliferation, and differentiation of stem cells. Length = 302 |
| >gnl|CDD|133240 cd05109, PTKc_HER2, Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Score = 41.2 bits (96), Expect = 0.002
Identities = 36/135 (26%), Positives = 61/135 (45%), Gaps = 12/135 (8%)
Query: 448 LVLELLKGGELLDRIRQ-KGRCGFTENEASRIMRQLVAAVHFMHSRGVVHRDLKPENLLF 506
LV +L+ G LLD +R+ K R G + Q+ + ++ +VHRDL N+L
Sbjct: 85 LVTQLMPYGCLLDYVRENKDRIG--SQDLLNWCVQIAKGMSYLEEVRLVHRDLAARNVLV 142
Query: 507 SDPAGDNIKVVDFGFACL---KRESLHTPC--FTLQYAAPEVLRQDKSGYDENCDLWSLG 561
P +++K+ DFG A L H +++ A E + + + D+WS G
Sbjct: 143 KSP--NHVKITDFGLARLLDIDETEYHADGGKVPIKWMALESILHRR--FTHQSDVWSYG 198
Query: 562 VILVNVLRQDKSGYD 576
V + ++ YD
Sbjct: 199 VTVWELMTFGAKPYD 213
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER2 does not bind to any known EGFR subfamily ligands, but contributes to the kinase activity of all possible heterodimers. It acts as the preferred partner with other ligand-bound EGFR proteins and functions as a signal amplifier, with the HER2-HER3 heterodimer being the most potent pair in mitogenic signaling. HER2 plays an important role in cell development, proliferation, survival and motility. Overexpression of HER2 results in its activation and downstream signaling, even in the absence of ligand. HER2 overexpression, mainly due to gene amplification, has been shown in a variety of human cancers. Its role in breast cancer is especially well-documented. HER2 is up-regulated in about 25% of breast tumors and is associated with increases in tumor aggressiveness, recurrence and mortality. HER2 is a target for monoclonal antibodies and small molecule inhibitors, which are being developed as treatments for cancer. The first humanized antibody approved for clinical use is Trastuzumab (Herceptin), which is being used in combination with other therapies to improve the survival rates of patients with HER2-overexpressing breast cancer. Length = 279 |
| >gnl|CDD|133192 cd05061, PTKc_InsR, Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Score = 41.1 bits (96), Expect = 0.002
Identities = 48/206 (23%), Positives = 86/206 (41%), Gaps = 35/206 (16%)
Query: 386 LGDGSYS-----VCRRCVEKSTGQEYAVKIISRKIDCSEEINLL------RACQGHPNIV 434
LG GS+ R ++ AVK ++ E I L + H ++V
Sbjct: 14 LGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCH-HVV 72
Query: 435 NLHCVFQDEVHTYLVLELLKGGELLDRIR--------QKGRCGFTENEASRIMRQLVAAV 486
L V T +V+EL+ G+L +R GR T E ++ ++ +
Sbjct: 73 RLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGM 132
Query: 487 HFMHSRGVVHRDLKPENLLFSDPAGDNIKVVDFGFACLKRESLHTPCF--------TLQY 538
+++++ VHRDL N + + +K+ DFG + R+ T + +++
Sbjct: 133 AYLNAKKFVHRDLAARNCMVAH--DFTVKIGDFG---MTRDIYETDYYRKGGKGLLPVRW 187
Query: 539 AAPEVLRQDKSGYDENCDLWSLGVIL 564
APE L+ + + D+WS GV+L
Sbjct: 188 MAPESLKD--GVFTTSSDMWSFGVVL 211
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein metabolism, ion and amino acid transport, cell cycle and proliferation, cell differentiation, gene transcription, and nitric oxide synthesis. Insulin resistance, caused by abnormalities in InsR signaling, has been described in diabetes, hypertension, cardiovascular disease, metabolic syndrome, heart failure, and female infertility. Length = 288 |
| >gnl|CDD|173751 cd07860, STKc_CDK2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Score = 40.2 bits (94), Expect = 0.003
Identities = 15/26 (57%), Positives = 20/26 (76%)
Query: 930 QLVAAVHFMHSRGVVHRDLKPENLLL 955
QL+ + F HS V+HRDLKP+NLL+
Sbjct: 108 QLLQGLAFCHSHRVLHRDLKPQNLLI 133
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. CDK2, together with CDK4, also regulates embryonic cell proliferation. Despite these important roles, mice deleted for the cdk2 gene are viable and normal except for being sterile. This may be due to compensation provided by CDK1 (also called Cdc2), which can also bind cyclin E and drive the G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 284 |
| >gnl|CDD|173753 cd07864, STKc_CDK12, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Score = 40.5 bits (95), Expect = 0.003
Identities = 19/61 (31%), Positives = 34/61 (55%), Gaps = 2/61 (3%)
Query: 896 YLVLELLKGGELLDRIRQKGRCGFTENEASRIMRQLVAAVHFMHSRGVVHRDLKPENLLL 955
YLV E + L + + G F+E+ M+QL+ +++ H + +HRD+K N+LL
Sbjct: 92 YLVFEYMDHD--LMGLLESGLVHFSEDHIKSFMKQLLEGLNYCHKKNFLHRDIKCSNILL 149
Query: 956 S 956
+
Sbjct: 150 N 150
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely expressed in tissues. It interacts with cyclins L1 and L2, and plays roles in regulating transcription and alternative splicing. Length = 302 |
| >gnl|CDD|132976 cd06645, STKc_MAP4K3, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Score = 40.4 bits (94), Expect = 0.003
Identities = 18/61 (29%), Positives = 37/61 (60%), Gaps = 2/61 (3%)
Query: 896 YLVLELLKGGELLDRIRQKGRCGFTENEASRIMRQLVAAVHFMHSRGVVHRDLKPENLLL 955
++ +E GG L D G +E++ + + R+ + ++++HS+G +HRD+K N+LL
Sbjct: 82 WICMEFCGGGSLQDIYHVTGP--LSESQIAYVSRETLQGLYYLHSKGKMHRDIKGANILL 139
Query: 956 S 956
+
Sbjct: 140 T 140
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. MAP4K3 is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. mTOR regulates ribosome biogenesis and protein translation, and is frequently deregulated in cancer. Length = 267 |
| >gnl|CDD|143375 cd07870, STKc_PFTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 40.3 bits (94), Expect = 0.003
Identities = 14/29 (48%), Positives = 23/29 (79%)
Query: 928 MRQLVAAVHFMHSRGVVHRDLKPENLLLS 956
M QL+ + ++H + ++HRDLKP+NLL+S
Sbjct: 109 MFQLLRGLAYIHGQHILHRDLKPQNLLIS 137
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recessive form of juvenile ALS. The function of PFTAIRE-2 is not yet known. Length = 291 |
| >gnl|CDD|133174 cd05042, PTKc_Aatyk, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Score = 40.3 bits (94), Expect = 0.003
Identities = 40/188 (21%), Positives = 71/188 (37%), Gaps = 44/188 (23%)
Query: 419 EEINLLRACQGHPNIVNLHCVFQ-DEVHTYL-VLELLKGGELLDRIRQKGRCGFTENEAS 476
+E+ R HPN+ L C+ Q E YL VLE G+L + +R + +
Sbjct: 44 QEVQPYRELN-HPNV--LQCLGQCIESIPYLLVLEFCPLGDLKNYLR---SNRGMVAQMA 97
Query: 477 RIMRQL------VAAVHFMHSRGVVHRDLKPENLLFSDPAGDNIKVVDFGFA-CLKRESL 529
+ + + ++H +H DL N + A ++K+ D+G A E
Sbjct: 98 QKDVLQRMACEVASGLLWLHQADFIHSDLALRNCQLT--ADLSVKIGDYGLALEQYPEDY 155
Query: 530 HTP----CFTLQYAAPEVL--RQDKSGYDENCDLWSLGVILVNVLRQDKSGYDENCDLWS 583
+ L++ APE++ R + Q K ++WS
Sbjct: 156 YITKDCHAVPLRWLAPELVEIRGQD----------------LLPKDQTKKS-----NIWS 194
Query: 584 LGVILYTM 591
LGV ++ +
Sbjct: 195 LGVTMWEL 202
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kinases based on overall sequence similarity and the phylogenetic tree. However, analysis of catalytic residues suggests that Aatyk proteins may be multispecific kinases, functioning also as serine/threonine kinases. They are involved in neural differentiation, nerve growth factor (NGF) signaling, apoptosis, and spermatogenesis. Length = 269 |
| >gnl|CDD|216618 pfam01636, APH, Phosphotransferase enzyme family | Back alignment and domain information |
|---|
Score = 39.9 bits (93), Expect = 0.003
Identities = 19/48 (39%), Positives = 26/48 (54%), Gaps = 2/48 (4%)
Query: 477 RIMRQLVAAVHFMHSRGVVHRDLKPENLLFSDPAGDNIKVVDFGFACL 524
R++ L+A + + +VH DL P NLL DP G V+DF A L
Sbjct: 151 RLLAALLALLPALP-LVLVHGDLHPGNLLV-DPGGRVTGVIDFEDAGL 196
|
This family consists of bacterial antibiotic resistance proteins, which confer resistance to various aminoglycosides they include: aminoglycoside 3'-phosphotransferase or kanamycin kinase / neomycin-kanamycin phosphotransferase and streptomycin 3''-kinase or streptomycin 3''-phosphotransferase. The aminoglycoside phosphotransferases inactivate aminoglycoside antibiotics via phosphorylation. This family also includes homoserine kinase. This family is related to fructosamine kinase pfam03881. Length = 238 |
| >gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Score = 40.1 bits (92), Expect = 0.004
Identities = 23/110 (20%), Positives = 36/110 (32%), Gaps = 1/110 (0%)
Query: 268 KTEPPIPEDLSPDVADFISRLLVKDPRRRLGGGELDAEELKRHPFFNVIDWDDLATKRIP 327
P PE +S +D + +LL KDP+ RL + +L H D DL K
Sbjct: 238 PLSPSNPELISKAASDLLKKLLAKDPKNRLSSSSDLSHDLLAHLKLKESDLSDLL-KPDD 296
Query: 328 APFVPKISNELDVSNFSDEFTKMIPADSPAIVPPNFDKIFKGSLFFEQYD 377
+ + + S + I + NF K +
Sbjct: 297 SAPLRLSLPPSLEALISSLNSLAISGSDLKLDDSNFSKELAPNGVSSSPH 346
|
Length = 384 |
| >gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 39.8 bits (93), Expect = 0.004
Identities = 18/45 (40%), Positives = 21/45 (46%), Gaps = 5/45 (11%)
Query: 269 TEPPIPEDLSPDVADFISRLLVKDPRRRLGGGELDAEELKRHPFF 313
T P IPE LSP + D R L P R + EL +HP F
Sbjct: 228 TAPSIPEHLSPGLRDVTLRCLELQPEDRPP-----SRELLKHPVF 267
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268 |
| >gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Score = 40.0 bits (93), Expect = 0.004
Identities = 19/61 (31%), Positives = 36/61 (59%), Gaps = 3/61 (4%)
Query: 896 YLVLELLKGGELLDRIRQKGRCGFTENEASRIMRQLVAAVHFMHSRGVVHRDLKPENLLL 955
++++E L GG LD ++ E + I+R+++ + ++HS +HRD+K N+LL
Sbjct: 78 WIIMEYLGGGSALDLLKPGP---LEETYIATILREILKGLDYLHSERKIHRDIKAANVLL 134
Query: 956 S 956
S
Sbjct: 135 S 135
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277 |
| >gnl|CDD|143364 cd07859, STKc_TDY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 40.1 bits (94), Expect = 0.004
Identities = 13/25 (52%), Positives = 20/25 (80%)
Query: 930 QLVAAVHFMHSRGVVHRDLKPENLL 954
QL+ A+ ++H+ V HRDLKP+N+L
Sbjct: 111 QLLRALKYIHTANVFHRDLKPKNIL 135
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. Arabidopsis thaliana contains more TEY-type MAPKs than TDY-type, whereas the reverse is true for Oryza sativa. This subfamily represents the TDY subtype and is composed of Group D plant MAPKs including Arabidopsis thaliana MPK18 (AtMPK18), Oryza sativa Blast- and Wound-induced MAPK1 (OsBWMK1), OsWJUMK1 (Wound- and JA-Uninducible MAPK1), Zea mays MPK6, and the Medicago sativa TDY1 gene product. OsBWMK1 enhances resistance to pathogenic infections. It mediates stress-activated defense responses by activating a transcription factor that affects the expression of stress-related genes. AtMPK18 is involved in microtubule-related functions. Length = 338 |
| >gnl|CDD|173648 cd05092, PTKc_TrkA, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Score = 40.0 bits (93), Expect = 0.004
Identities = 51/210 (24%), Positives = 85/210 (40%), Gaps = 39/210 (18%)
Query: 386 LGDGSY-----SVCRRCVEKSTGQEYAVKII-----SRKIDCSEEINLLRACQGHPNIVN 435
LG+G++ + C + + AVK + S + D E LL Q H +IV
Sbjct: 13 LGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTVLQ-HQHIVR 71
Query: 436 LHCVFQDEVHTYLVLELLKGGELLDRIRQKG------------RCG-FTENEASRIMRQL 482
+ V + +V E ++ G+L +R G G T + I Q+
Sbjct: 72 FYGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQI 131
Query: 483 VAAVHFMHSRGVVHRDLKPENLLFSDPAGDNIKVVDFGFACLKRESLHTPCF-------- 534
+ + ++ S VHRDL N L G +K+ DFG + R+ T +
Sbjct: 132 ASGMVYLASLHFVHRDLATRNCLVGQ--GLVVKIGDFG---MSRDIYSTDYYRVGGRTML 186
Query: 535 TLQYAAPEVLRQDKSGYDENCDLWSLGVIL 564
+++ PE + K + D+WS GV+L
Sbjct: 187 PIRWMPPESILYRK--FTTESDIWSFGVVL 214
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory and sympathetic neurons of the peripheral nervous system, and in basal forebrain cholinergic neurons of the central nervous system. It is critical for neuronal growth, differentiation and survival. Alternative TrkA splicing has been implicated as a pivotal regulator of neuroblastoma (NB) behavior. Normal TrkA expression is associated with better NB prognosis, while the hypoxia-regulated TrkAIII splice variant promotes NB pathogenesis and progression. Aberrant TrkA expression has also been demonstrated in non-neural tumors including prostate, breast, lung, and pancreatic cancers. Length = 280 |
Conserved Domains Detected by HHsearch
Original result of HHsearch against CDD database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 966 | |||
| KOG0603|consensus | 612 | 100.0 | ||
| KOG0615|consensus | 475 | 100.0 | ||
| KOG0616|consensus | 355 | 100.0 | ||
| KOG0694|consensus | 694 | 100.0 | ||
| KOG0598|consensus | 357 | 100.0 | ||
| KOG0690|consensus | 516 | 100.0 | ||
| KOG0575|consensus | 592 | 100.0 | ||
| KOG0598|consensus | 357 | 100.0 | ||
| KOG0595|consensus | 429 | 100.0 | ||
| KOG0592|consensus | 604 | 100.0 | ||
| KOG0616|consensus | 355 | 100.0 | ||
| KOG0581|consensus | 364 | 100.0 | ||
| KOG0593|consensus | 396 | 100.0 | ||
| KOG0588|consensus | 786 | 100.0 | ||
| KOG0599|consensus | 411 | 100.0 | ||
| KOG0604|consensus | 400 | 100.0 | ||
| KOG0605|consensus | 550 | 100.0 | ||
| KOG0583|consensus | 370 | 100.0 | ||
| KOG0033|consensus | 355 | 100.0 | ||
| KOG0591|consensus | 375 | 100.0 | ||
| KOG0600|consensus | 560 | 100.0 | ||
| KOG0661|consensus | 538 | 100.0 | ||
| KOG0694|consensus | 694 | 100.0 | ||
| KOG0032|consensus | 382 | 100.0 | ||
| KOG0597|consensus | 808 | 100.0 | ||
| KOG0659|consensus | 318 | 100.0 | ||
| KOG0696|consensus | 683 | 100.0 | ||
| KOG0605|consensus | 550 | 100.0 | ||
| KOG0585|consensus | 576 | 100.0 | ||
| KOG0667|consensus | 586 | 100.0 | ||
| KOG0611|consensus | 668 | 100.0 | ||
| KOG0607|consensus | 463 | 100.0 | ||
| KOG0198|consensus | 313 | 100.0 | ||
| KOG0663|consensus | 419 | 100.0 | ||
| KOG0580|consensus | 281 | 100.0 | ||
| KOG0192|consensus | 362 | 100.0 | ||
| KOG0660|consensus | 359 | 100.0 | ||
| KOG0578|consensus | 550 | 100.0 | ||
| KOG0658|consensus | 364 | 100.0 | ||
| PTZ00263 | 329 | protein kinase A catalytic subunit; Provisional | 100.0 | |
| KOG0610|consensus | 459 | 100.0 | ||
| KOG1989|consensus | 738 | 100.0 | ||
| KOG4279|consensus | 1226 | 100.0 | ||
| cd05571 | 323 | STKc_PKB Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05631 | 285 | STKc_GRK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG4717|consensus | 864 | 100.0 | ||
| cd05612 | 291 | STKc_PRKX_like Catalytic domain of PRKX-like Prote | 100.0 | |
| KOG0603|consensus | 612 | 100.0 | ||
| KOG0594|consensus | 323 | 100.0 | ||
| KOG0582|consensus | 516 | 100.0 | ||
| cd05598 | 376 | STKc_LATS Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05628 | 363 | STKc_NDR1 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0690|consensus | 516 | 100.0 | ||
| cd05626 | 381 | STKc_LATS2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05614 | 332 | STKc_MSK2_N N-terminal catalytic domain of the Pro | 100.0 | |
| cd05625 | 382 | STKc_LATS1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05599 | 364 | STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel | 100.0 | |
| cd05629 | 377 | STKc_NDR_like_fungal Catalytic domain of Fungal Nu | 100.0 | |
| cd05585 | 312 | STKc_YPK1_like Catalytic domain of Yeast Protein K | 100.0 | |
| cd05600 | 333 | STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- | 100.0 | |
| cd05620 | 316 | STKc_nPKC_delta Catalytic domain of the Protein Se | 100.0 | |
| cd05590 | 320 | STKc_nPKC_eta Catalytic domain of the Protein Seri | 100.0 | |
| cd07871 | 288 | STKc_PCTAIRE3 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05616 | 323 | STKc_cPKC_beta Catalytic domain of the Protein Ser | 100.0 | |
| cd05592 | 316 | STKc_nPKC_theta_delta Catalytic domain of the Prot | 100.0 | |
| PTZ00426 | 340 | cAMP-dependent protein kinase catalytic subunit; P | 100.0 | |
| cd05575 | 323 | STKc_SGK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05588 | 329 | STKc_aPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05591 | 321 | STKc_nPKC_epsilon Catalytic domain of the Protein | 100.0 | |
| cd07869 | 303 | STKc_PFTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| KOG0201|consensus | 467 | 100.0 | ||
| cd05595 | 323 | STKc_PKB_beta Catalytic domain of the Protein Seri | 100.0 | |
| cd05596 | 370 | STKc_ROCK Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0577|consensus | 948 | 100.0 | ||
| cd05587 | 324 | STKc_cPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0579|consensus | 1187 | 100.0 | ||
| KOG4236|consensus | 888 | 100.0 | ||
| KOG0589|consensus | 426 | 100.0 | ||
| cd05586 | 330 | STKc_Sck1_like Catalytic domain of Suppressor of l | 100.0 | |
| cd05618 | 329 | STKc_aPKC_iota Catalytic domain of the Protein Ser | 100.0 | |
| cd05593 | 328 | STKc_PKB_gamma Catalytic domain of the Protein Ser | 100.0 | |
| cd05621 | 370 | STKc_ROCK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05601 | 330 | STKc_CRIK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05604 | 325 | STKc_SGK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05603 | 321 | STKc_SGK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05102 | 338 | PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05627 | 360 | STKc_NDR2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05607 | 277 | STKc_GRK7 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05582 | 318 | STKc_RSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| KOG0614|consensus | 732 | 100.0 | ||
| cd07848 | 287 | STKc_CDKL5 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd05619 | 316 | STKc_nPKC_theta Catalytic domain of the Protein Se | 100.0 | |
| cd05584 | 323 | STKc_p70S6K Catalytic domain of the Protein Serine | 100.0 | |
| cd05594 | 325 | STKc_PKB_alpha Catalytic domain of the Protein Ser | 100.0 | |
| KOG0612|consensus | 1317 | 100.0 | ||
| PTZ00036 | 440 | glycogen synthase kinase; Provisional | 100.0 | |
| KOG0695|consensus | 593 | 100.0 | ||
| cd05617 | 327 | STKc_aPKC_zeta Catalytic domain of the Protein Ser | 100.0 | |
| cd05589 | 324 | STKc_PKN Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd07862 | 290 | STKc_CDK6 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05615 | 323 | STKc_cPKC_alpha Catalytic domain of the Protein Se | 100.0 | |
| cd05570 | 318 | STKc_PKC Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05573 | 350 | STKc_ROCK_NDR_like Catalytic domain of ROCK- and N | 100.0 | |
| cd05602 | 325 | STKc_SGK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05605 | 285 | STKc_GRK4_like Catalytic domain of G protein-coupl | 100.0 | |
| cd07859 | 338 | STKc_TDY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| cd05608 | 280 | STKc_GRK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05597 | 331 | STKc_DMPK_like Catalytic domain of Myotonic Dystro | 100.0 | |
| KOG0197|consensus | 468 | 100.0 | ||
| KOG0574|consensus | 502 | 100.0 | ||
| cd05622 | 371 | STKc_ROCK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07863 | 288 | STKc_CDK4 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06649 | 331 | PKc_MEK2 Catalytic domain of the dual-specificity | 100.0 | |
| KOG0696|consensus | 683 | 100.0 | ||
| cd05624 | 331 | STKc_MRCK_beta Catalytic domain of the Protein Ser | 100.0 | |
| PHA03212 | 391 | serine/threonine kinase US3; Provisional | 100.0 | |
| KOG0986|consensus | 591 | 100.0 | ||
| PLN00034 | 353 | mitogen-activated protein kinase kinase; Provision | 100.0 | |
| PHA02988 | 283 | hypothetical protein; Provisional | 100.0 | |
| cd07872 | 309 | STKc_PCTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05623 | 332 | STKc_MRCK_alpha Catalytic domain of the Protein Se | 100.0 | |
| cd07868 | 317 | STKc_CDK8 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05106 | 374 | PTKc_CSF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| PTZ00284 | 467 | protein kinase; Provisional | 100.0 | |
| KOG0596|consensus | 677 | 100.0 | ||
| PTZ00267 | 478 | NIMA-related protein kinase; Provisional | 100.0 | |
| cd05096 | 304 | PTKc_DDR1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06650 | 333 | PKc_MEK1 Catalytic domain of the dual-specificity | 100.0 | |
| KOG0586|consensus | 596 | 100.0 | ||
| cd07853 | 372 | STKc_NLK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05632 | 285 | STKc_GRK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG4721|consensus | 904 | 100.0 | ||
| cd07876 | 359 | STKc_JNK2 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05104 | 375 | PTKc_Kit Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05630 | 285 | STKc_GRK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07878 | 343 | STKc_p38beta_MAPK11 Catalytic domain of the Serine | 100.0 | |
| cd07874 | 355 | STKc_JNK3 Catalytic domain of the Serine/Threonine | 100.0 | |
| PTZ00266 | 1021 | NIMA-related protein kinase; Provisional | 100.0 | |
| cd07873 | 301 | STKc_PCTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| PHA03207 | 392 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd07875 | 364 | STKc_JNK1 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0612|consensus | 1317 | 100.0 | ||
| cd07861 | 285 | STKc_CDK1_euk Catalytic domain of the Serine/Threo | 100.0 | |
| PTZ00283 | 496 | serine/threonine protein kinase; Provisional | 100.0 | |
| cd05048 | 283 | PTKc_Ror Catalytic Domain of the Protein Tyrosine | 100.0 | |
| cd06637 | 272 | STKc_TNIK Catalytic domain of the Protein Serine/T | 100.0 | |
| PF00069 | 260 | Pkinase: Protein kinase domain Protein kinase; unc | 100.0 | |
| KOG0671|consensus | 415 | 100.0 | ||
| KOG1035|consensus | 1351 | 100.0 | ||
| cd05064 | 266 | PTKc_EphR_A10 Catalytic domain of the Protein Tyro | 100.0 | |
| cd08219 | 255 | STKc_Nek3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05052 | 263 | PTKc_Abl Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd08227 | 327 | PK_STRAD_alpha Pseudokinase domain of STE20-relate | 100.0 | |
| KOG1187|consensus | 361 | 100.0 | ||
| cd06645 | 267 | STKc_MAP4K3 Catalytic domain of the Protein Serine | 100.0 | |
| cd05088 | 303 | PTKc_Tie2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG1151|consensus | 775 | 100.0 | ||
| cd05049 | 280 | PTKc_Trk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd08529 | 256 | STKc_FA2-like Catalytic domain of the Protein Seri | 100.0 | |
| cd06646 | 267 | STKc_MAP4K5 Catalytic domain of the Protein Serine | 100.0 | |
| cd05611 | 260 | STKc_Rim15_like Catalytic domain of fungal Rim15-l | 100.0 | |
| PHA03209 | 357 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd07867 | 317 | STKc_CDC2L6 Catalytic domain of Serine/Threonine K | 100.0 | |
| cd05105 | 400 | PTKc_PDGFR_alpha Catalytic domain of the Protein T | 100.0 | |
| cd05084 | 252 | PTKc_Fes Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0610|consensus | 459 | 100.0 | ||
| PHA03211 | 461 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05633 | 279 | STKc_GRK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05089 | 297 | PTKc_Tie1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06625 | 263 | STKc_MEKK3_like Catalytic domain of MAP/ERK kinase | 100.0 | |
| cd06619 | 279 | PKc_MKK5 Catalytic domain of the dual-specificity | 100.0 | |
| cd07839 | 284 | STKc_CDK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05093 | 288 | PTKc_TrkB Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06636 | 282 | STKc_MAP4K4_6 Catalytic domain of the Protein Seri | 100.0 | |
| PHA03390 | 267 | pk1 serine/threonine-protein kinase 1; Provisional | 100.0 | |
| cd05072 | 261 | PTKc_Lyn Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05116 | 257 | PTKc_Syk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06644 | 292 | STKc_STK10_LOK Catalytic domain of the Protein Ser | 100.0 | |
| cd05114 | 256 | PTKc_Tec_Rlk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05090 | 283 | PTKc_Ror1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06615 | 308 | PKc_MEK Catalytic domain of the dual-specificity P | 100.0 | |
| cd05082 | 256 | PTKc_Csk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07837 | 295 | STKc_CdkB_plant Catalytic domain of the Serine/Thr | 100.0 | |
| cd07847 | 286 | STKc_CDKL1_4 Catalytic domain of the Serine/Threon | 100.0 | |
| cd05108 | 316 | PTKc_EGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05055 | 302 | PTKc_PDGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05054 | 337 | PTKc_VEGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd06616 | 288 | PKc_MKK4 Catalytic domain of the dual-specificity | 100.0 | |
| cd05091 | 283 | PTKc_Ror2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06611 | 280 | STKc_SLK_like Catalytic domain of Ste20-like kinas | 100.0 | |
| cd06643 | 282 | STKc_SLK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05580 | 290 | STKc_PKA Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05047 | 270 | PTKc_Tie Catalytic domain of Tie Protein Tyrosine | 100.0 | |
| KOG0608|consensus | 1034 | 100.0 | ||
| cd05148 | 261 | PTKc_Srm_Brk Catalytic domain of the Protein Tyros | 100.0 | |
| cd08228 | 267 | STKc_Nek6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08223 | 257 | STKc_Nek4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05609 | 305 | STKc_MAST Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05098 | 307 | PTKc_FGFR1 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd08221 | 256 | STKc_Nek9 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05053 | 293 | PTKc_FGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05035 | 273 | PTKc_Axl_like Catalytic Domain of Axl-like Protein | 100.0 | |
| cd08229 | 267 | STKc_Nek7 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06617 | 283 | PKc_MKK3_6 Catalytic domain of the dual-specificit | 100.0 | |
| cd06654 | 296 | STKc_PAK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05062 | 277 | PTKc_IGF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| KOG0662|consensus | 292 | 100.0 | ||
| cd07832 | 286 | STKc_CCRK Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG4645|consensus | 1509 | 100.0 | ||
| cd06638 | 286 | STKc_myosinIIIA Catalytic domain of the Protein Se | 100.0 | |
| KOG0193|consensus | 678 | 100.0 | ||
| cd06622 | 286 | PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS | 100.0 | |
| cd05574 | 316 | STKc_phototropin_like Catalytic domain of Phototro | 100.0 | |
| cd07831 | 282 | STKc_MOK Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0983|consensus | 391 | 100.0 | ||
| cd07860 | 284 | STKc_CDK2_3 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd05051 | 296 | PTKc_DDR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06608 | 275 | STKc_myosinIII_like Catalytic domain of Class III | 100.0 | |
| KOG2345|consensus | 302 | 100.0 | ||
| KOG0194|consensus | 474 | 100.0 | ||
| cd06630 | 268 | STKc_MEKK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05059 | 256 | PTKc_Tec_like Catalytic domain of Tec-like Protein | 100.0 | |
| cd05101 | 304 | PTKc_FGFR2 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd07845 | 309 | STKc_CDK10 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd05115 | 257 | PTKc_Zap-70 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd07844 | 291 | STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like | 100.0 | |
| PRK13184 | 932 | pknD serine/threonine-protein kinase; Reviewed | 100.0 | |
| cd05068 | 261 | PTKc_Frk_like Catalytic domain of Fyn-related kina | 100.0 | |
| cd05067 | 260 | PTKc_Lck_Blk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05036 | 277 | PTKc_ALK_LTK Catalytic domain of the Protein Tyros | 100.0 | |
| cd05606 | 278 | STKc_beta_ARK Catalytic domain of the Protein Seri | 100.0 | |
| KOG0695|consensus | 593 | 100.0 | ||
| cd05097 | 295 | PTKc_DDR_like Catalytic domain of Discoidin Domain | 100.0 | |
| cd06610 | 267 | STKc_OSR1_SPAK Catalytic domain of the Protein Ser | 100.0 | |
| cd05032 | 277 | PTKc_InsR_like Catalytic domain of Insulin Recepto | 100.0 | |
| cd05099 | 314 | PTKc_FGFR4 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05071 | 262 | PTKc_Src Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05039 | 256 | PTKc_Csk_like Catalytic domain of C-terminal Src k | 100.0 | |
| cd06655 | 296 | STKc_PAK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05109 | 279 | PTKc_HER2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05111 | 279 | PTK_HER3 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| cd00192 | 262 | PTKc Catalytic domain of Protein Tyrosine Kinases. | 100.0 | |
| cd06628 | 267 | STKc_MAPKKK_Byr2_like Catalytic domain of fungal B | 100.0 | |
| cd05070 | 260 | PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros | 100.0 | |
| cd06613 | 262 | STKc_MAP4K3_like Catalytic domain of Mitogen-activ | 100.0 | |
| KOG0666|consensus | 438 | 100.0 | ||
| cd05107 | 401 | PTKc_PDGFR_beta Catalytic domain of the Protein Ty | 100.0 | |
| cd06609 | 274 | STKc_MST3_like Catalytic domain of Mammalian Ste20 | 100.0 | |
| cd05577 | 277 | STKc_GRK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06620 | 284 | PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr | 100.0 | |
| KOG0986|consensus | 591 | 100.0 | ||
| PLN00009 | 294 | cyclin-dependent kinase A; Provisional | 100.0 | |
| cd05094 | 291 | PTKc_TrkC Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05103 | 343 | PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd08224 | 267 | STKc_Nek6_Nek7 Catalytic domain of the Protein Ser | 100.0 | |
| cd08220 | 256 | STKc_Nek8 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05033 | 266 | PTKc_EphR Catalytic domain of Ephrin Receptor Prot | 100.0 | |
| cd05042 | 269 | PTKc_Aatyk Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05087 | 269 | PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein | 100.0 | |
| cd07870 | 291 | STKc_PFTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05075 | 272 | PTKc_Axl Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05092 | 280 | PTKc_TrkA Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06624 | 268 | STKc_ASK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06639 | 291 | STKc_myosinIIIB Catalytic domain of the Protein Se | 100.0 | |
| cd07841 | 298 | STKc_CDK7 Catalytic domain of the Serine/Threonine | 100.0 | |
| smart00219 | 258 | TyrKc Tyrosine kinase, catalytic domain. Phosphotr | 100.0 | |
| cd06656 | 297 | STKc_PAK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05080 | 283 | PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| cd05113 | 256 | PTKc_Btk_Bmx Catalytic domain of the Protein Tyros | 100.0 | |
| cd06631 | 265 | STKc_YSK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05045 | 290 | PTKc_RET Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06612 | 256 | STKc_MST1_2 Catalytic domain of the Protein Serine | 100.0 | |
| cd05078 | 258 | PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain | 100.0 | |
| cd05095 | 296 | PTKc_DDR2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd08218 | 256 | STKc_Nek1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06629 | 272 | STKc_MAPKKK_Bck1_like Catalytic domain of fungal B | 100.0 | |
| KOG0592|consensus | 604 | 100.0 | ||
| cd05060 | 257 | PTKc_Syk_like Catalytic domain of Spleen Tyrosine | 100.0 | |
| cd05085 | 250 | PTKc_Fer Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05083 | 254 | PTKc_Chk Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0614|consensus | 732 | 100.0 | ||
| cd05040 | 257 | PTKc_Ack_like Catalytic domain of the Protein Tyro | 100.0 | |
| cd06651 | 266 | STKc_MEKK3 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05063 | 268 | PTKc_EphR_A2 Catalytic domain of the Protein Tyros | 100.0 | |
| cd06640 | 277 | STKc_MST4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05079 | 284 | PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| cd05069 | 260 | PTKc_Yes Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05066 | 267 | PTKc_EphR_A Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd07843 | 293 | STKc_CDC2L1 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd06917 | 277 | STKc_NAK1_like Catalytic domain of Fungal Nak1-lik | 100.0 | |
| cd07846 | 286 | STKc_CDKL2_3 Catalytic domain of the Serine/Threon | 100.0 | |
| cd07836 | 284 | STKc_Pho85 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd05034 | 261 | PTKc_Src_like Catalytic domain of Src kinase-like | 100.0 | |
| cd07842 | 316 | STKc_CDK8_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd06658 | 292 | STKc_PAK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06642 | 277 | STKc_STK25-YSK1 Catalytic domain of the Protein Se | 100.0 | |
| cd05061 | 288 | PTKc_InsR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05050 | 288 | PTKc_Musk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05065 | 269 | PTKc_EphR_B Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd06659 | 297 | STKc_PAK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| PF07714 | 259 | Pkinase_Tyr: Protein tyrosine kinase Protein kinas | 100.0 | |
| cd06605 | 265 | PKc_MAPKK Catalytic domain of the dual-specificity | 100.0 | |
| cd07835 | 283 | STKc_CDK1_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd05077 | 262 | PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| cd05100 | 334 | PTKc_FGFR3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05578 | 258 | STKc_Yank1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05613 | 290 | STKc_MSK1_N N-terminal catalytic domain of the Pro | 100.0 | |
| cd07850 | 353 | STKc_JNK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06652 | 265 | STKc_MEKK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd08226 | 328 | PK_STRAD_beta Pseudokinase domain of STE20-related | 100.0 | |
| cd07865 | 310 | STKc_CDK9 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05044 | 269 | PTKc_c-ros Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05076 | 274 | PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| KOG4250|consensus | 732 | 100.0 | ||
| cd05572 | 262 | STKc_cGK_PKG Catalytic domain of the Protein Serin | 100.0 | |
| KOG1026|consensus | 774 | 100.0 | ||
| cd05058 | 262 | PTKc_Met_Ron Catalytic domain of the Protein Tyros | 100.0 | |
| PHA03210 | 501 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd06621 | 287 | PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek | 100.0 | |
| cd06632 | 258 | STKc_MEKK1_plant Catalytic domain of the Protein S | 100.0 | |
| cd08217 | 265 | STKc_Nek2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05112 | 256 | PTKc_Itk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06607 | 307 | STKc_TAO Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05576 | 237 | STKc_RPK118_like Catalytic domain of the Protein S | 100.0 | |
| PHA02882 | 294 | putative serine/threonine kinase; Provisional | 100.0 | |
| cd05081 | 284 | PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of | 100.0 | |
| cd07838 | 287 | STKc_CDK4_6_like Catalytic domain of Cyclin-Depend | 100.0 | |
| cd07849 | 336 | STKc_ERK1_2_like Catalytic domain of Extracellular | 100.0 | |
| cd05037 | 259 | PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the | 100.0 | |
| cd05041 | 251 | PTKc_Fes_like Catalytic domain of Fes-like Protein | 100.0 | |
| cd08225 | 257 | STKc_Nek5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05086 | 268 | PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd06626 | 264 | STKc_MEKK4 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05057 | 279 | PTKc_EGFR_like Catalytic domain of Epidermal Growt | 100.0 | |
| cd05056 | 270 | PTKc_FAK Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05046 | 275 | PTK_CCK4 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| cd07855 | 334 | STKc_ERK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05073 | 260 | PTKc_Hck Catalytic domain of the Protein Tyrosine | 100.0 | |
| PTZ00024 | 335 | cyclin-dependent protein kinase; Provisional | 100.0 | |
| cd07880 | 343 | STKc_p38gamma_MAPK12 Catalytic domain of the Serin | 100.0 | |
| cd06641 | 277 | STKc_MST3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06623 | 264 | PKc_MAPKK_plant_like Catalytic domain of Plant dua | 100.0 | |
| cd05043 | 280 | PTK_Ryk Pseudokinase domain of Ryk (Receptor relat | 100.0 | |
| cd07858 | 337 | STKc_TEY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| cd07833 | 288 | STKc_CDKL Catalytic domain of Cyclin-Dependent pro | 100.0 | |
| cd06648 | 285 | STKc_PAK_II Catalytic domain of the Protein Serine | 100.0 | |
| cd06647 | 293 | STKc_PAK_I Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07830 | 283 | STKc_MAK_like Catalytic domain of Male germ cell-A | 100.0 | |
| cd05579 | 265 | STKc_MAST_like Catalytic domain of Microtubule-ass | 100.0 | |
| cd05038 | 284 | PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P | 100.0 | |
| cd05110 | 303 | PTKc_HER4 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd08528 | 269 | STKc_Nek10 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05583 | 288 | STKc_MSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| cd07866 | 311 | STKc_BUR1 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0668|consensus | 338 | 100.0 | ||
| cd07857 | 332 | STKc_MPK1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07840 | 287 | STKc_CDK9_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd07852 | 337 | STKc_MAPK15 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd07864 | 302 | STKc_CDK12 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd06635 | 317 | STKc_TAO1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05122 | 253 | PKc_STE Catalytic domain of STE family Protein Kin | 100.0 | |
| cd08216 | 314 | PK_STRAD Pseudokinase domain of STE20-related kina | 100.0 | |
| KOG0584|consensus | 632 | 100.0 | ||
| KOG0587|consensus | 953 | 100.0 | ||
| cd07879 | 342 | STKc_p38delta_MAPK13 Catalytic domain of the Serin | 100.0 | |
| cd05118 | 283 | STKc_CMGC Catalytic domain of CMGC family Serine/T | 100.0 | |
| cd07854 | 342 | STKc_MAPK4_6 Catalytic domain of the Serine/Threon | 100.0 | |
| cd06653 | 264 | STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina | 100.0 | |
| cd07877 | 345 | STKc_p38alpha_MAPK14 Catalytic domain of the Serin | 100.0 | |
| cd06657 | 292 | STKc_PAK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05581 | 280 | STKc_PDK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07856 | 328 | STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre | 100.0 | |
| cd05610 | 669 | STKc_MASTL Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG0669|consensus | 376 | 100.0 | ||
| cd06618 | 296 | PKc_MKK7 Catalytic domain of the dual-specificity | 100.0 | |
| cd06633 | 313 | STKc_TAO3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06606 | 260 | STKc_MAPKKK Catalytic domain of the Protein Serine | 100.0 | |
| cd08215 | 258 | STKc_Nek Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06614 | 286 | STKc_PAK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06627 | 254 | STKc_Cdc7_like Catalytic domain of Cell division c | 100.0 | |
| cd08530 | 256 | STKc_CNK2-like Catalytic domain of the Protein Ser | 100.0 | |
| cd07834 | 330 | STKc_MAPK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07851 | 343 | STKc_p38 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05074 | 273 | PTKc_Tyro3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| KOG1290|consensus | 590 | 100.0 | ||
| cd06634 | 308 | STKc_TAO2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05123 | 250 | STKc_AGC Catalytic domain of AGC family Protein Se | 100.0 | |
| KOG1095|consensus | 1025 | 100.0 | ||
| cd07829 | 282 | STKc_CDK_like Catalytic domain of Cyclin-Dependent | 100.0 | |
| KOG1006|consensus | 361 | 100.0 | ||
| cd08222 | 260 | STKc_Nek11 Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG0608|consensus | 1034 | 100.0 | ||
| KOG4278|consensus | 1157 | 100.0 | ||
| KOG0670|consensus | 752 | 100.0 | ||
| PLN03225 | 566 | Serine/threonine-protein kinase SNT7; Provisional | 99.98 | |
| KOG1345|consensus | 378 | 99.98 | ||
| KOG4257|consensus | 974 | 99.98 | ||
| PLN00113 | 968 | leucine-rich repeat receptor-like protein kinase; | 99.97 | |
| KOG0199|consensus | 1039 | 99.97 | ||
| KOG1094|consensus | 807 | 99.97 | ||
| KOG1027|consensus | 903 | 99.97 | ||
| PLN03224 | 507 | probable serine/threonine protein kinase; Provisio | 99.97 | |
| KOG0606|consensus | 1205 | 99.97 | ||
| KOG0664|consensus | 449 | 99.97 | ||
| KOG0984|consensus | 282 | 99.97 | ||
| KOG1152|consensus | 772 | 99.97 | ||
| KOG0196|consensus | 996 | 99.97 | ||
| KOG0665|consensus | 369 | 99.96 | ||
| smart00220 | 244 | S_TKc Serine/Threonine protein kinases, catalytic | 99.96 | |
| KOG0576|consensus | 829 | 99.96 | ||
| KOG0200|consensus | 609 | 99.96 | ||
| KOG2052|consensus | 513 | 99.96 | ||
| KOG1167|consensus | 418 | 99.96 | ||
| KOG0590|consensus | 601 | 99.96 | ||
| KOG1025|consensus | 1177 | 99.95 | ||
| KOG3653|consensus | 534 | 99.95 | ||
| cd00180 | 215 | PKc Catalytic domain of Protein Kinases. Protein K | 99.94 | |
| cd05616 | 323 | STKc_cPKC_beta Catalytic domain of the Protein Ser | 99.94 | |
| cd05615 | 323 | STKc_cPKC_alpha Catalytic domain of the Protein Se | 99.94 | |
| smart00221 | 225 | STYKc Protein kinase; unclassified specificity. Ph | 99.94 | |
| cd05587 | 324 | STKc_cPKC Catalytic domain of the Protein Serine/T | 99.93 | |
| KOG0590|consensus | 601 | 99.93 | ||
| PTZ00263 | 329 | protein kinase A catalytic subunit; Provisional | 99.93 | |
| cd05590 | 320 | STKc_nPKC_eta Catalytic domain of the Protein Seri | 99.93 | |
| cd05571 | 323 | STKc_PKB Catalytic domain of the Protein Serine/Th | 99.93 | |
| cd05612 | 291 | STKc_PRKX_like Catalytic domain of PRKX-like Prote | 99.93 | |
| PTZ00426 | 340 | cAMP-dependent protein kinase catalytic subunit; P | 99.93 | |
| PLN00181 | 793 | protein SPA1-RELATED; Provisional | 99.92 | |
| cd05589 | 324 | STKc_PKN Catalytic domain of the Protein Serine/Th | 99.92 | |
| cd05628 | 363 | STKc_NDR1 Catalytic domain of the Protein Serine/T | 99.92 | |
| cd05591 | 321 | STKc_nPKC_epsilon Catalytic domain of the Protein | 99.92 | |
| cd05617 | 327 | STKc_aPKC_zeta Catalytic domain of the Protein Ser | 99.92 | |
| cd05593 | 328 | STKc_PKB_gamma Catalytic domain of the Protein Ser | 99.92 | |
| KOG0580|consensus | 281 | 99.91 | ||
| cd05588 | 329 | STKc_aPKC Catalytic domain of the Protein Serine/T | 99.91 | |
| smart00750 | 176 | KIND kinase non-catalytic C-lobe domain. It is an | 99.91 | |
| cd05620 | 316 | STKc_nPKC_delta Catalytic domain of the Protein Se | 99.91 | |
| cd05592 | 316 | STKc_nPKC_theta_delta Catalytic domain of the Prot | 99.91 | |
| cd05619 | 316 | STKc_nPKC_theta Catalytic domain of the Protein Se | 99.91 | |
| cd05627 | 360 | STKc_NDR2 Catalytic domain of the Protein Serine/T | 99.91 | |
| KOG0585|consensus | 576 | 99.91 | ||
| cd05614 | 332 | STKc_MSK2_N N-terminal catalytic domain of the Pro | 99.91 | |
| KOG0575|consensus | 592 | 99.91 | ||
| cd05618 | 329 | STKc_aPKC_iota Catalytic domain of the Protein Ser | 99.91 | |
| cd05625 | 382 | STKc_LATS1 Catalytic domain of the Protein Serine/ | 99.91 | |
| cd05570 | 318 | STKc_PKC Catalytic domain of the Protein Serine/Th | 99.9 | |
| cd05595 | 323 | STKc_PKB_beta Catalytic domain of the Protein Seri | 99.9 | |
| COG0515 | 384 | SPS1 Serine/threonine protein kinase [General func | 99.9 | |
| KOG0615|consensus | 475 | 99.9 | ||
| cd05585 | 312 | STKc_YPK1_like Catalytic domain of Yeast Protein K | 99.9 | |
| KOG1164|consensus | 322 | 99.9 | ||
| cd05604 | 325 | STKc_SGK3 Catalytic domain of the Protein Serine/T | 99.9 | |
| cd05575 | 323 | STKc_SGK Catalytic domain of the Protein Serine/Th | 99.9 | |
| cd05629 | 377 | STKc_NDR_like_fungal Catalytic domain of Fungal Nu | 99.9 | |
| cd05602 | 325 | STKc_SGK1 Catalytic domain of the Protein Serine/T | 99.9 | |
| cd05626 | 381 | STKc_LATS2 Catalytic domain of the Protein Serine/ | 99.9 | |
| KOG1163|consensus | 341 | 99.89 | ||
| cd05631 | 285 | STKc_GRK4 Catalytic domain of the Protein Serine/T | 99.89 | |
| cd05594 | 325 | STKc_PKB_alpha Catalytic domain of the Protein Ser | 99.89 | |
| KOG1024|consensus | 563 | 99.89 | ||
| cd05584 | 323 | STKc_p70S6K Catalytic domain of the Protein Serine | 99.89 | |
| cd05603 | 321 | STKc_SGK2 Catalytic domain of the Protein Serine/T | 99.89 | |
| PRK09188 | 365 | serine/threonine protein kinase; Provisional | 99.89 | |
| cd05599 | 364 | STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel | 99.89 | |
| KOG0588|consensus | 786 | 99.89 | ||
| KOG1165|consensus | 449 | 99.88 | ||
| cd05621 | 370 | STKc_ROCK2 Catalytic domain of the Protein Serine/ | 99.88 | |
| cd05582 | 318 | STKc_RSK_N N-terminal catalytic domain of the Prot | 99.88 | |
| KOG0583|consensus | 370 | 99.88 | ||
| cd05596 | 370 | STKc_ROCK Catalytic domain of the Protein Serine/T | 99.88 | |
| cd05586 | 330 | STKc_Sck1_like Catalytic domain of Suppressor of l | 99.87 | |
| cd05622 | 371 | STKc_ROCK1 Catalytic domain of the Protein Serine/ | 99.87 | |
| cd05598 | 376 | STKc_LATS Catalytic domain of the Protein Serine/T | 99.87 | |
| KOG0597|consensus | 808 | 99.87 | ||
| KOG0606|consensus | 1205 | 99.87 | ||
| cd05573 | 350 | STKc_ROCK_NDR_like Catalytic domain of ROCK- and N | 99.86 | |
| cd05580 | 290 | STKc_PKA Catalytic domain of the Protein Serine/Th | 99.86 | |
| cd05624 | 331 | STKc_MRCK_beta Catalytic domain of the Protein Ser | 99.85 | |
| KOG4717|consensus | 864 | 99.85 | ||
| cd05147 | 190 | RIO1_euk RIO kinase family; eukaryotic RIO1, catal | 99.85 | |
| cd05600 | 333 | STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- | 99.84 | |
| cd05605 | 285 | STKc_GRK4_like Catalytic domain of G protein-coupl | 99.84 | |
| cd05601 | 330 | STKc_CRIK Catalytic domain of the Protein Serine/T | 99.84 | |
| cd05623 | 332 | STKc_MRCK_alpha Catalytic domain of the Protein Se | 99.84 | |
| KOG0033|consensus | 355 | 99.84 | ||
| cd05145 | 190 | RIO1_like RIO kinase family; RIO1, RIO3 and simila | 99.84 | |
| KOG0599|consensus | 411 | 99.84 | ||
| KOG0607|consensus | 463 | 99.83 | ||
| cd05608 | 280 | STKc_GRK1 Catalytic domain of the Protein Serine/T | 99.83 | |
| cd05597 | 331 | STKc_DMPK_like Catalytic domain of Myotonic Dystro | 99.83 | |
| PRK10345 | 210 | hypothetical protein; Provisional | 99.83 | |
| KOG0032|consensus | 382 | 99.82 | ||
| KOG0611|consensus | 668 | 99.82 | ||
| cd05630 | 285 | STKc_GRK6 Catalytic domain of the Protein Serine/T | 99.82 | |
| KOG0581|consensus | 364 | 99.82 | ||
| cd05607 | 277 | STKc_GRK7 Catalytic domain of the Protein Serine/T | 99.81 | |
| cd05632 | 285 | STKc_GRK5 Catalytic domain of the Protein Serine/T | 99.81 | |
| PRK12274 | 218 | serine/threonine protein kinase; Provisional | 99.8 | |
| KOG0595|consensus | 429 | 99.78 | ||
| PRK10359 | 232 | lipopolysaccharide core biosynthesis protein; Prov | 99.78 |
| >KOG0603|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-72 Score=638.78 Aligned_cols=485 Identities=38% Similarity=0.613 Sum_probs=414.9
Q ss_pred eecccccceEEEEEE---cCCCCEEEEEeccccc-------hhhHHHHHHHHhhCCCcccccccccccc-----------
Q psy11767 123 ILGDGSYSVCRRCVE---KSTGQEYAVKIISRKI-------DCSEEINLLRACQGHPNICRRCVEKSTG----------- 181 (966)
Q Consensus 123 ~LG~GsFGkV~La~~---k~tg~~yAiKvl~K~~-------~~~~E~~il~~~~~~pfi~~~~~~~~~~----------- 181 (966)
++|+|+||+|.||+. .+.|+.||||+++|.. +...|+.++.-++.|||+++....+++.
T Consensus 1 vlg~g~~gkvfLvrk~~g~da~~~yamkvl~k~t~~~~~~~~t~~er~il~~~~~~~f~v~lhyafqt~~kl~l~ld~~r 80 (612)
T KOG0603|consen 1 VLGQGSYGKVFLVRKAGGADAGHLYAMKVLKKATLKVRDRTHTKQERIILAFVHNTPFLVKLHYAFQTDGKLYLILDFLR 80 (612)
T ss_pred CCCcCCCcchHHHHHhccccccchhhhhcccccccccccccccccHHHHHhhccCCCceeeeeeeeccccchhHhhhhcc
Confidence 689999999999984 6789999999999852 5688999999999999999744444332
Q ss_pred -------------------hhHHHHHHHh----------hcccchhhhHhhhccCCceEEecCcccc-------------
Q psy11767 182 -------------------QEYAVKIISR----------KIDCSEEINLLRACQGHPNIVNLHCVFQ------------- 219 (966)
Q Consensus 182 -------------------~~~~~~~v~~----------~~~~~~e~nil~~~~gh~~iv~l~~~~~------------- 219 (966)
++|.++.+.+ +.+.++| |++++.+||.++.|++.+..
T Consensus 81 gg~lft~l~~~~~f~~~~~~~~~aelaLald~lh~l~iiyrd~k~e-nilld~~Ghi~~tdfglske~v~~~~~cgt~ey 159 (612)
T KOG0603|consen 81 GGDLFTRLSKEVMFDELDVAFYLAELALALDHLHKLGIAYRDYKLE-NVLLLLEGHIKLTDFGLSKEAVKEKIACGTYEY 159 (612)
T ss_pred cchhhhccccCCchHHHHHHHHHHHHHHHHhhcchhHHHHhccccc-ceeecccCccccCCchhhhHhHhhhhcccchhh
Confidence 3333333222 2244445 99999999999999886532
Q ss_pred --ccccccccCCCcceeeechhhHHHHHHHhhCCCCCCCCcHHHHHHHHHhCCCCCCCCCCHHHHHHHHhhcccCCCccc
Q psy11767 220 --DEVIDWDDFSRGIECVFFSSSLIIFFIILSFTLSFIHDYYHIQYRRILKTEPPIPEDLSPDVADFISRLLVKDPRRRL 297 (966)
Q Consensus 220 --~e~i~~~~y~~~~d~~~~~~~~il~~~m~~g~~pf~~~~~~~~~~~I~~~~~~~P~~~s~~a~dli~~LL~kdp~~RL 297 (966)
+|++. ++...+| ||..++++|+|++|..||.. ++-.+|+..++.+|..++.+|++++..|+.++|.+||
T Consensus 160 mApEI~~--gh~~a~D---~ws~gvl~felltg~~pf~~----~~~~~Il~~~~~~p~~l~~~a~~~~~~l~~r~p~nrL 230 (612)
T KOG0603|consen 160 RAPEIIN--GHLSAAD---WWSFGVLAFELLTGTLPFGG----DTMKRILKAELEMPRELSAEARSLFRQLFKRNPENRL 230 (612)
T ss_pred hhhHhhh--ccCCccc---chhhhhhHHHHhhCCCCCch----HHHHHHhhhccCCchhhhHHHHHHHHHHHhhCHHHHh
Confidence 34555 6667777 56778999999999999998 5678999999999999999999999999999999999
Q ss_pred CCCCCCHHHHhcCCceeeeCccccccCCCCCCCCccccccccccccccccccCcCCCCCCCCCCCCc-ccccccc-----
Q psy11767 298 GGGELDAEELKRHPFFNVIDWDDLATKRIPAPFVPKISNELDVSNFSDEFTKMIPADSPAIVPPNFD-KIFKGSL----- 371 (966)
Q Consensus 298 G~~~~g~~~Ik~HpfF~~idW~~l~~k~~~pP~~P~i~~~~D~snFd~ef~~~~p~dSp~ivp~~~d-~if~G~~----- 371 (966)
|.+..|+.+||+|+||..|||+++..++++|||.|.+..+.|..+||++|+...|.++|...++..+ .+|.|..
T Consensus 231 g~~~~~~~eik~h~f~~~i~~~~l~~r~~~~~fkp~~~~e~~~~~fd~eft~~~P~dsp~~~~~~s~~~if~g~sfva~~ 310 (612)
T KOG0603|consen 231 GAGPDGVDEIKQHEFFQSIDWNELEARSRPPPFKPGSITERDVAQFDPEFTSQVPADSPLLSASGSDHTIFSGPSFVAPG 310 (612)
T ss_pred ccCcchhHHHhccchheeeeHhhHhhcCCCCCCCCcccchhhhhhcCchhccCCcccCCCCCCCccccchhcCCCccChH
Confidence 9988899999999999999999999999999999999999999999999999999999988777665 6777633
Q ss_pred ---------eecccccccccccccccccccEEEEEEEcCCCcEEEEEEeccc-cChHHHHHHHHHhcCCCCceEEEEEEE
Q psy11767 372 ---------FFEQYDMDLDKAGILGDGSYSVCRRCVEKSTGQEYAVKIISRK-IDCSEEINLLRACQGHPNIVNLHCVFQ 441 (966)
Q Consensus 372 ---------~~~~~~i~~~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~-~~~~~Ei~iL~~l~~HpnIV~l~~~~~ 441 (966)
|.+.|.++ ..+|.|+||.|..|.+..+++.+|+|++.+. .+..+|+.++....+||||+++++.+.
T Consensus 311 il~~~~~~~~~~~y~~~----~~~~~gs~s~~~~~~~~~t~~~~~vkii~~~~~~~~~e~~~~~~~~~h~niv~~~~v~~ 386 (612)
T KOG0603|consen 311 VLEDAVTAPFTESYEFR----EELGEGSFSAVKYCESSPTDQEPAVKIISKRADDNQDEIPISLLVRDHPNIVKSHDVYE 386 (612)
T ss_pred HhhccccCCcchhhccc----cccCCCCccceeeeeccccccchhheeccccccccccccchhhhhcCCCcceeecceec
Confidence 44555553 4599999999999999999999999999876 567789988888889999999999999
Q ss_pred eCCeEEEEEEccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCcEEEecCCCCCEEEEeecc
Q psy11767 442 DEVHTYLVLELLKGGELLDRIRQKGRCGFTENEASRIMRQLVAAVHFMHSRGVVHRDLKPENLLFSDPAGDNIKVVDFGF 521 (966)
Q Consensus 442 ~~~~~~lVmEy~~gg~L~~~l~~~~~~~l~e~~~~~i~~Qil~aL~yLHs~~IiHRDLKP~NILl~~~~~~~iKL~DFGl 521 (966)
+..+.|+|||++.|+.|.+.+.... ....++..|+.||+.|++|||++|||||||||+|||+. ...++++|+|||.
T Consensus 387 ~~~~~~~v~e~l~g~ell~ri~~~~---~~~~e~~~w~~~lv~Av~~LH~~gvvhRDLkp~NIL~~-~~~g~lrltyFG~ 462 (612)
T KOG0603|consen 387 DGKEIYLVMELLDGGELLRRIRSKP---EFCSEASQWAAELVSAVDYLHEQGVVHRDLKPGNILLD-GSAGHLRLTYFGF 462 (612)
T ss_pred CCceeeeeehhccccHHHHHHHhcc---hhHHHHHHHHHHHHHHHHHHHhcCeeecCCChhheeec-CCCCcEEEEEech
Confidence 9999999999999999999987764 23378889999999999999999999999999999995 2466899999999
Q ss_pred cccccCCCccccccccccCchhhccCCCCCCCcccchhhhhhhhhhhhcCCCCCCCcCcchhHHHHHHHHhcCCCCCCCC
Q psy11767 522 ACLKRESLHTPCFTLQYAAPEVLRQDKSGYDENCDLWSLGVILVNVLRQDKSGYDENCDLWSLGVILYTMLCGRVPFHAR 601 (966)
Q Consensus 522 a~~~~~~~~~~~gT~~Y~APEvl~~~~~~~~~~~Di~SlGvil~el~~~~~~~y~~~~DIWSlGvilyemltG~~Pf~~~ 601 (966)
++.......++|.|..|.|||++. ..+|+.+|||||||++||+||+|+.||...
T Consensus 463 a~~~~~~~~tp~~t~~y~APEvl~--------------------------~~~yt~acD~WSLGvlLy~ML~G~tp~~~~ 516 (612)
T KOG0603|consen 463 WSELERSCDTPALTLQYVAPEVLA--------------------------IQEYTEACDWWSLGVLLYEMLTGRTLFAAH 516 (612)
T ss_pred hhhCchhhcccchhhcccChhhhc--------------------------cCCCCcchhhHHHHHHHHHHHhCCCccccC
Confidence 998877777889999999999985 345899999999999999999999999876
Q ss_pred CCchhHHHHHHHHHcCCCCCCchhhccCCHHHHHHHHHhcccCccccCChHHHHHHhhhhH
Q psy11767 602 SRDDSALSIMARIKEGQFNFDAEAWSTVSSEAKELTKSLLTVNPAQRIRMMRVKLTFHAFH 662 (966)
Q Consensus 602 ~~~~~~~~~~~~i~~~~~~~~~~~~~~is~e~~~Li~~~L~~dP~~R~t~~~v~~~~~~~~ 662 (966)
..+ .+++.+|..+.+. ..+|.+|++||..||+.||.+|+++.++ ..|+|.
T Consensus 517 P~~---~ei~~~i~~~~~s------~~vS~~AKdLl~~LL~~dP~~Rl~~~~i--~~h~w~ 566 (612)
T KOG0603|consen 517 PAG---IEIHTRIQMPKFS------ECVSDEAKDLLQQLLQVDPALRLGADEI--GAHPWF 566 (612)
T ss_pred Cch---HHHHHhhcCCccc------cccCHHHHHHHHHhccCChhhCcChhhh--ccCcch
Confidence 654 4677888877765 4699999999999999999999999976 345554
|
|
| >KOG0615|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-54 Score=464.90 Aligned_cols=257 Identities=35% Similarity=0.646 Sum_probs=225.4
Q ss_pred eecccccccccccccccccccEEEEEEEcCCCcEEEEEEecccc------------ChHHHHHHHHHhcCCCCceEEEEE
Q psy11767 372 FFEQYDMDLDKAGILGDGSYSVCRRCVEKSTGQEYAVKIISRKI------------DCSEEINLLRACQGHPNIVNLHCV 439 (966)
Q Consensus 372 ~~~~~~i~~~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~------------~~~~Ei~iL~~l~~HpnIV~l~~~ 439 (966)
|.+.|.+ .+.||+|+||.|.+|.++.||+.||||++.++. ...+|+++|+++ +|||||+++++
T Consensus 170 ~~d~yii----~~~LGsGafg~Vkla~e~~tgk~vAiKIi~krk~~~~s~~~~~~~~v~~EieILkkL-~HP~IV~~~d~ 244 (475)
T KOG0615|consen 170 FNDYYII----SKTLGSGAFGLVKLAYEKKTGKQVAIKIINKRKSTGCSRAIAKTRDVQNEIEILKKL-SHPNIVRIKDF 244 (475)
T ss_pred hcceeEe----eeeecCCceeEEEEEEEcccCcEEEeeeeehhhcccccccccchhhhHHHHHHHHhc-CCCCEEEEeee
Confidence 4455555 478999999999999999999999999997542 235899999999 59999999999
Q ss_pred EEeCCeEEEEEEccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCcEEEecC-CCCCEEEEe
Q psy11767 440 FQDEVHTYLVLELLKGGELLDRIRQKGRCGFTENEASRIMRQLVAAVHFMHSRGVVHRDLKPENLLFSDP-AGDNIKVVD 518 (966)
Q Consensus 440 ~~~~~~~~lVmEy~~gg~L~~~l~~~~~~~l~e~~~~~i~~Qil~aL~yLHs~~IiHRDLKP~NILl~~~-~~~~iKL~D 518 (966)
|+.....||||||++||+|++.+-.++ .+.+..-+.+++|++.||.|||++||+||||||+|||+.+. ....+||+|
T Consensus 245 f~~~ds~YmVlE~v~GGeLfd~vv~nk--~l~ed~~K~~f~Qll~avkYLH~~GI~HRDiKPeNILl~~~~e~~llKItD 322 (475)
T KOG0615|consen 245 FEVPDSSYMVLEYVEGGELFDKVVANK--YLREDLGKLLFKQLLTAVKYLHSQGIIHRDIKPENILLSNDAEDCLLKITD 322 (475)
T ss_pred eecCCceEEEEEEecCccHHHHHHhcc--ccccchhHHHHHHHHHHHHHHHHcCcccccCCcceEEeccCCcceEEEecc
Confidence 999999999999999999999998776 58899999999999999999999999999999999999864 345799999
Q ss_pred ecccccccC--CCccccccccccCchhhccCCCCCCCcccchhhhhhhhhhhhcCCCCCCCcCcchhHHHHHHHHhcCCC
Q psy11767 519 FGFACLKRE--SLHTPCFTLQYAAPEVLRQDKSGYDENCDLWSLGVILVNVLRQDKSGYDENCDLWSLGVILYTMLCGRV 596 (966)
Q Consensus 519 FGla~~~~~--~~~~~~gT~~Y~APEvl~~~~~~~~~~~Di~SlGvil~el~~~~~~~y~~~~DIWSlGvilyemltG~~ 596 (966)
||+|+..++ -..+.||||.|.|||++.... ...|..++||||+||+||.+|+|.+
T Consensus 323 FGlAK~~g~~sfm~TlCGTpsYvAPEVl~~kg-----------------------~~~~~~kVDiWSlGcvLfvcLsG~p 379 (475)
T KOG0615|consen 323 FGLAKVSGEGSFMKTLCGTPSYVAPEVLASKG-----------------------VEYYPSKVDIWSLGCVLFVCLSGYP 379 (475)
T ss_pred cchhhccccceehhhhcCCccccChhheecCC-----------------------eecccchheeeeccceEEEEeccCC
Confidence 999998754 456899999999999997543 2335569999999999999999999
Q ss_pred CCCCCCCchhHHHHHHHHHcCCCCCCchhhccCCHHHHHHHHHhcccCccccCChHHHHHHhhhhHH
Q psy11767 597 PFHARSRDDSALSIMARIKEGQFNFDAEAWSTVSSEAKELTKSLLTVNPAQRIRMMRVKLTFHAFHQ 663 (966)
Q Consensus 597 Pf~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~is~e~~~Li~~~L~~dP~~R~t~~~v~~~~~~~~~ 663 (966)
||.+..... .+.++|..|.|.+-+..|..+|+++++||.+||..||++|||+.++ ..|||++
T Consensus 380 PFS~~~~~~---sl~eQI~~G~y~f~p~~w~~Iseea~dlI~~mL~VdP~~R~s~~ea--L~hpW~~ 441 (475)
T KOG0615|consen 380 PFSEEYTDP---SLKEQILKGRYAFGPLQWDRISEEALDLINWMLVVDPENRPSADEA--LNHPWFK 441 (475)
T ss_pred CcccccCCc---cHHHHHhcCcccccChhhhhhhHHHHHHHHHhhEeCcccCcCHHHH--hcChhhh
Confidence 998766543 3567899999999999999999999999999999999999999865 5678875
|
|
| >KOG0616|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-53 Score=444.58 Aligned_cols=228 Identities=27% Similarity=0.498 Sum_probs=212.7
Q ss_pred ccC-CcceeeeecccccceEEEEEEcCCCCEEEEEeccccc--------hhhHHHHHHHHhhCCCcccc-----------
Q psy11767 114 YDM-DLDKAGILGDGSYSVCRRCVEKSTGQEYAVKIISRKI--------DCSEEINLLRACQGHPNICR----------- 173 (966)
Q Consensus 114 ~~~-df~~~~~LG~GsFGkV~La~~k~tg~~yAiKvl~K~~--------~~~~E~~il~~~~~~pfi~~----------- 173 (966)
|.+ ||+++++||+||||||+|||+|.+|.+||||+|+|+. |+.+|++||+.+. |||+++
T Consensus 41 ~~l~dfe~~~tlGtGSFGrV~LVr~k~~g~yYAmKvL~k~~vVklKQveH~~nEk~vL~~v~-~PFlv~l~~t~~d~~~l 119 (355)
T KOG0616|consen 41 YSLQDFERLKTLGTGSFGRVHLVREKHSGNYYAMKVLDKQKVVKLKQVEHTHNEKRVLKAVS-HPFLVKLYGTFKDNSNL 119 (355)
T ss_pred cchhhhhheeeeccCccceEEEEEEccCCceeehhhcCHHHHHHHHHHHHHhhHHHHHhhcc-CceeEEEEEeeccCCeE
Confidence 445 9999999999999999999999999999999999973 6789999999986 999975
Q ss_pred -------------------cccccccchhHHHHHHHh----------hcccchhhhHhhhccCCceEEecCccc------
Q psy11767 174 -------------------RCVEKSTGQEYAVKIISR----------KIDCSEEINLLRACQGHPNIVNLHCVF------ 218 (966)
Q Consensus 174 -------------------~~~~~~~~~~~~~~~v~~----------~~~~~~e~nil~~~~gh~~iv~l~~~~------ 218 (966)
+.|.++.++||+++++++ +.|+++| |||+|.+||.+|+||+++.
T Consensus 120 ymvmeyv~GGElFS~Lrk~~rF~e~~arFYAAeivlAleylH~~~iiYRDLKPE-NiLlD~~G~iKitDFGFAK~v~~rT 198 (355)
T KOG0616|consen 120 YMVMEYVPGGELFSYLRKSGRFSEPHARFYAAEIVLALEYLHSLDIIYRDLKPE-NLLLDQNGHIKITDFGFAKRVSGRT 198 (355)
T ss_pred EEEEeccCCccHHHHHHhcCCCCchhHHHHHHHHHHHHHHHHhcCeeeccCChH-HeeeccCCcEEEEeccceEEecCcE
Confidence 578888899999999877 3477778 9999999999999999875
Q ss_pred ----------cccccccccCCCcceeeechhhHHHHHHHhhCCCCCCCCcHHHHHHHHHhCCCCCCCCCCHHHHHHHHhh
Q psy11767 219 ----------QDEVIDWDDFSRGIECVFFSSSLIIFFIILSFTLSFIHDYYHIQYRRILKTEPPIPEDLSPDVADFISRL 288 (966)
Q Consensus 219 ----------~~e~i~~~~y~~~~d~~~~~~~~il~~~m~~g~~pf~~~~~~~~~~~I~~~~~~~P~~~s~~a~dli~~L 288 (966)
.+|+|..++|++++| ||+.|||+|||+.|.|||+++++..||++|++++++||++||++++|||++|
T Consensus 199 ~TlCGTPeYLAPEii~sk~ynkavD---WWalGVLIYEMlaG~pPF~~~~~~~iY~KI~~~~v~fP~~fs~~~kdLl~~L 275 (355)
T KOG0616|consen 199 WTLCGTPEYLAPEIIQSKGYNKAVD---WWALGVLIYEMLAGYPPFYDDNPIQIYEKILEGKVKFPSYFSSDAKDLLKKL 275 (355)
T ss_pred EEecCCccccChHHhhcCCCCcchh---HHHHHHHHHHHHcCCCCCcCCChHHHHHHHHhCcccCCcccCHHHHHHHHHH
Confidence 368999999999998 7799999999999999999999999999999999999999999999999999
Q ss_pred cccCCCcccCCCCCCHHHHhcCCceeeeCccccccCCCCCCCCc-cccccccccccccc
Q psy11767 289 LVKDPRRRLGGGELDAEELKRHPFFNVIDWDDLATKRIPAPFVP-KISNELDVSNFSDE 346 (966)
Q Consensus 289 L~kdp~~RLG~~~~g~~~Ik~HpfF~~idW~~l~~k~~~pP~~P-~i~~~~D~snFd~e 346 (966)
|++|-++|+|+..+|..|||+||||++++|+++++++++|||.| .+....|++|||+.
T Consensus 276 L~vD~t~R~gnlknG~~dIk~H~wF~~v~W~~i~~r~ie~P~~pp~~~~~gdtsnfd~y 334 (355)
T KOG0616|consen 276 LQVDLTKRFGNLKNGVEDIKNHPWFKGVDWEAILQRKIEPPFEPPNIHGPGDTSNFDDY 334 (355)
T ss_pred HhhhhHhhhcCcCCCccccccCcccccccHHHHhhccccCCCCCccccCCccccccccc
Confidence 99999999999999999999999999999999999999999998 88899999999975
|
|
| >KOG0694|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-51 Score=467.07 Aligned_cols=236 Identities=32% Similarity=0.523 Sum_probs=216.6
Q ss_pred CcceeeeecccccceEEEEEEcCCCCEEEEEeccccc--------hhhHHHHHHHHhhCCCcccc---------------
Q psy11767 117 DLDKAGILGDGSYSVCRRCVEKSTGQEYAVKIISRKI--------DCSEEINLLRACQGHPNICR--------------- 173 (966)
Q Consensus 117 df~~~~~LG~GsFGkV~La~~k~tg~~yAiKvl~K~~--------~~~~E~~il~~~~~~pfi~~--------------- 173 (966)
||.+++|||+|+||||+||+.|.|+++||||+|||.. .++.|+.|++.+.+||||++
T Consensus 369 ~F~~l~vLGkGsFGkV~lae~k~~~e~yAIK~LKK~~Il~~d~Ve~~~~EkrI~~la~~HPFL~~L~~~fQT~~~l~fvm 448 (694)
T KOG0694|consen 369 DFRLLAVLGRGSFGKVLLAELKGTNEYYAIKVLKKGDILQRDEVESLMCEKRIFELANRHPFLVNLFSCFQTKEHLFFVM 448 (694)
T ss_pred ceEEEEEeccCcCceEEEEEEcCCCcEEEEEEeeccceeccccHHHHHHHHHHHHHhccCCeEeecccccccCCeEEEEE
Confidence 9999999999999999999999999999999999974 35889999999999999986
Q ss_pred --------------cccccccchhHHHHHHHh----------hcccchhhhHhhhccCCceEEecCccc-----------
Q psy11767 174 --------------RCVEKSTGQEYAVKIISR----------KIDCSEEINLLRACQGHPNIVNLHCVF----------- 218 (966)
Q Consensus 174 --------------~~~~~~~~~~~~~~~v~~----------~~~~~~e~nil~~~~gh~~iv~l~~~~----------- 218 (966)
..|.+..++||+++++++ +.|++.+ |||+|.+||.+|.|++.+.
T Consensus 449 ey~~Ggdm~~~~~~~~F~e~rarfyaAev~l~L~fLH~~~IIYRDlKLd-NiLLD~eGh~kiADFGlcKe~m~~g~~TsT 527 (694)
T KOG0694|consen 449 EYVAGGDLMHHIHTDVFSEPRARFYAAEVVLGLQFLHENGIIYRDLKLD-NLLLDTEGHVKIADFGLCKEGMGQGDRTST 527 (694)
T ss_pred EecCCCcEEEEEecccccHHHHHHHHHHHHHHHHHHHhcCceeeecchh-heEEcccCcEEecccccccccCCCCCcccc
Confidence 455566668999888766 2355555 9999999999999998664
Q ss_pred --------cccccccccCCCcceeeechhhHHHHHHHhhCCCCCCCCcHHHHHHHHHhCCCCCCCCCCHHHHHHHHhhcc
Q psy11767 219 --------QDEVIDWDDFSRGIECVFFSSSLIIFFIILSFTLSFIHDYYHIQYRRILKTEPPIPEDLSPDVADFISRLLV 290 (966)
Q Consensus 219 --------~~e~i~~~~y~~~~d~~~~~~~~il~~~m~~g~~pf~~~~~~~~~~~I~~~~~~~P~~~s~~a~dli~~LL~ 290 (966)
.+|++.-..|+.+|| ||+.|||+||||.|.+||.+++.+++|+.|+++++.||.++|.||.+|+++||.
T Consensus 528 fCGTpey~aPEil~e~~Yt~aVD---WW~lGVLlyeML~Gq~PF~gddEee~FdsI~~d~~~yP~~ls~ea~~il~~ll~ 604 (694)
T KOG0694|consen 528 FCGTPEFLAPEVLTEQSYTRAVD---WWGLGVLLYEMLVGESPFPGDDEEEVFDSIVNDEVRYPRFLSKEAIAIMRRLLR 604 (694)
T ss_pred ccCChhhcChhhhccCcccchhh---HHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhcCCCCCCCcccHHHHHHHHHHhc
Confidence 357888999999998 778999999999999999999999999999999999999999999999999999
Q ss_pred cCCCcccCCCCCCHHHHhcCCceeeeCccccccCCCCCCCCccccccccccccccccccCcCCCCC
Q psy11767 291 KDPRRRLGGGELDAEELKRHPFFNVIDWDDLATKRIPAPFVPKISNELDVSNFSDEFTKMIPADSP 356 (966)
Q Consensus 291 kdp~~RLG~~~~g~~~Ik~HpfF~~idW~~l~~k~~~pP~~P~i~~~~D~snFd~ef~~~~p~dSp 356 (966)
|||++|||++++|+++||.||||+.|||++|++|+++|||+|.+.+..|.+|||+||+...+.-+|
T Consensus 605 k~p~kRLG~~e~d~~~i~~hpFFr~i~w~~L~~r~i~PPf~P~i~~~~D~snFd~eFt~e~p~Lt~ 670 (694)
T KOG0694|consen 605 KNPEKRLGSGERDAEDIKKHPFFRSIDWDDLLNRRIKPPFVPTIKGPEDVSNFDEEFTSEKPALTP 670 (694)
T ss_pred cCcccccCCCCCCchhhhhCCccccCCHHHHhhccCCCCCCcccCChhhhcccchhhhcCCCccCC
Confidence 999999999999999999999999999999999999999999999999999999999988776664
|
|
| >KOG0598|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-50 Score=431.20 Aligned_cols=246 Identities=37% Similarity=0.654 Sum_probs=211.9
Q ss_pred ccccccccccccccEEEEEEEcCCCcEEEEEEecccc--------ChHHHHHHHHHhcCCCCceEEEEEEEeCCeEEEEE
Q psy11767 379 DLDKAGILGDGSYSVCRRCVEKSTGQEYAVKIISRKI--------DCSEEINLLRACQGHPNIVNLHCVFQDEVHTYLVL 450 (966)
Q Consensus 379 ~~~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~--------~~~~Ei~iL~~l~~HpnIV~l~~~~~~~~~~~lVm 450 (966)
||+.+++||+|+||+|+.++.+.|++.||+|+++++. ....|..+|..+ +||.||+|+..|++..++|||+
T Consensus 26 dF~~lkviGkG~fGkV~~Vrk~dt~kiYAmKvl~K~~iv~~~e~~~~~~Er~IL~~v-~hPFiv~l~ysFQt~~kLylVl 104 (357)
T KOG0598|consen 26 DFEILKVIGKGSFGKVFQVRKKDTGKIYAMKVLKKKKIVEKKEVRHTKAERNILSKI-KHPFIVKLIYSFQTEEKLYLVL 104 (357)
T ss_pred heeeeeeeeccCCceEEEEEEcccCceeehhhhhhhHhhhhhhHHHHHHHHHHHHhC-CCCcEeeeEEecccCCeEEEEE
Confidence 4566899999999999999999999999999997653 134599999997 6999999999999999999999
Q ss_pred EccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCcEEEecCCCCCEEEEeeccccccc---C
Q psy11767 451 ELLKGGELLDRIRQKGRCGFTENEASRIMRQLVAAVHFMHSRGVVHRDLKPENLLFSDPAGDNIKVVDFGFACLKR---E 527 (966)
Q Consensus 451 Ey~~gg~L~~~l~~~~~~~l~e~~~~~i~~Qil~aL~yLHs~~IiHRDLKP~NILl~~~~~~~iKL~DFGla~~~~---~ 527 (966)
||+.||+|+.+|.+.+ .|+|..++.|+.+|+.||.|||++|||||||||+||||++ .|+++|+||||++... .
T Consensus 105 d~~~GGeLf~hL~~eg--~F~E~~arfYlaEi~lAL~~LH~~gIiyRDlKPENILLd~--~GHi~LtDFgL~k~~~~~~~ 180 (357)
T KOG0598|consen 105 DYLNGGELFYHLQREG--RFSEDRARFYLAEIVLALGYLHSKGIIYRDLKPENILLDE--QGHIKLTDFGLCKEDLKDGD 180 (357)
T ss_pred eccCCccHHHHHHhcC--CcchhHHHHHHHHHHHHHHHHHhCCeeeccCCHHHeeecC--CCcEEEeccccchhcccCCC
Confidence 9999999999998876 5999999999999999999999999999999999999985 6799999999997542 3
Q ss_pred CCccccccccccCchhhccCCCCCCCcccchhhhhhhhhhhhcCCCCCCCcCcchhHHHHHHHHhcCCCCCCCCCCchhH
Q psy11767 528 SLHTPCFTLQYAAPEVLRQDKSGYDENCDLWSLGVILVNVLRQDKSGYDENCDLWSLGVILYTMLCGRVPFHARSRDDSA 607 (966)
Q Consensus 528 ~~~~~~gT~~Y~APEvl~~~~~~~~~~~Di~SlGvil~el~~~~~~~y~~~~DIWSlGvilyemltG~~Pf~~~~~~~~~ 607 (966)
...+.|||+.|||||++.. .+|+..+|+|||||++|+||+|.+||.+.+.
T Consensus 181 ~t~tfcGT~eYmAPEil~~--------------------------~gy~~~vDWWsLGillYeML~G~pPF~~~~~---- 230 (357)
T KOG0598|consen 181 ATRTFCGTPEYMAPEILLG--------------------------KGYDKAVDWWSLGILLYEMLTGKPPFYAEDV---- 230 (357)
T ss_pred ccccccCCccccChHHHhc--------------------------CCCCcccchHhHHHHHHHHhhCCCCCcCccH----
Confidence 4667899999999999963 3689999999999999999999999998664
Q ss_pred HHHHHHHHcCCCCCCchhhccCCHHHHHHHHHhcccCccccCC--hHHHHHHhhhhH
Q psy11767 608 LSIMARIKEGQFNFDAEAWSTVSSEAKELTKSLLTVNPAQRIR--MMRVKLTFHAFH 662 (966)
Q Consensus 608 ~~~~~~i~~~~~~~~~~~~~~is~e~~~Li~~~L~~dP~~R~t--~~~v~~~~~~~~ 662 (966)
..+.++|..+.....+ ..+|.++++|++++|..||++|.. ......+.|+|+
T Consensus 231 ~~~~~~I~~~k~~~~p---~~ls~~ardll~~LL~rdp~~RLg~~~d~~~ik~HpfF 284 (357)
T KOG0598|consen 231 KKMYDKILKGKLPLPP---GYLSEEARDLLKKLLKRDPRQRLGGPGDAEEIKRHPFF 284 (357)
T ss_pred HHHHHHHhcCcCCCCC---ccCCHHHHHHHHHHhccCHHHhcCCCCChHHhhcCccc
Confidence 3456777777643332 237999999999999999999984 222234667765
|
|
| >KOG0690|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-50 Score=426.22 Aligned_cols=234 Identities=32% Similarity=0.577 Sum_probs=210.6
Q ss_pred ccC-CcceeeeecccccceEEEEEEcCCCCEEEEEeccccc--------hhhHHHHHHHHhhCCCcccc-----------
Q psy11767 114 YDM-DLDKAGILGDGSYSVCRRCVEKSTGQEYAVKIISRKI--------DCSEEINLLRACQGHPNICR----------- 173 (966)
Q Consensus 114 ~~~-df~~~~~LG~GsFGkV~La~~k~tg~~yAiKvl~K~~--------~~~~E~~il~~~~~~pfi~~----------- 173 (966)
.-| |||++|+||+|+||||.||++|+||++||||||+|+. |...|-.+|..+ +|||+..
T Consensus 165 vTm~dFdfLKvLGkGTFGKVIL~rEKat~k~YAiKIlkKeviiakdEVAHTlTE~RVL~~~-~HPFLt~LKYsFQt~drl 243 (516)
T KOG0690|consen 165 VTMEDFDFLKVLGKGTFGKVILCREKATGKLYAIKILKKEVIIAKDEVAHTLTENRVLQNC-RHPFLTSLKYSFQTQDRL 243 (516)
T ss_pred eccchhhHHHHhcCCccceEEEEeecccCceeehhhhhhhheeehHHhhhhhhHHHHHHhc-cCcHHHHhhhhhccCceE
Confidence 446 9999999999999999999999999999999999974 457788888777 6999964
Q ss_pred -------------------cccccccchhHHHHHHHh----------hcccchhhhHhhhccCCceEEecCccc------
Q psy11767 174 -------------------RCVEKSTGQEYAVKIISR----------KIDCSEEINLLRACQGHPNIVNLHCVF------ 218 (966)
Q Consensus 174 -------------------~~~~~~~~~~~~~~~v~~----------~~~~~~e~nil~~~~gh~~iv~l~~~~------ 218 (966)
+.|.+..++||.++||++ +.|++.| |+|+|.+||++|+||+++.
T Consensus 244 CFVMeyanGGeLf~HLsrer~FsE~RtRFYGaEIvsAL~YLHs~~ivYRDlKLE-NLlLDkDGHIKitDFGLCKE~I~~g 322 (516)
T KOG0690|consen 244 CFVMEYANGGELFFHLSRERVFSEDRTRFYGAEIVSALGYLHSRNIVYRDLKLE-NLLLDKDGHIKITDFGLCKEEIKYG 322 (516)
T ss_pred EEEEEEccCceEeeehhhhhcccchhhhhhhHHHHHHhhhhhhCCeeeeechhh-hheeccCCceEeeecccchhccccc
Confidence 456666678999998877 2355556 9999999999999998664
Q ss_pred -------------cccccccccCCCcceeeechhhHHHHHHHhhCCCCCCCCcHHHHHHHHHhCCCCCCCCCCHHHHHHH
Q psy11767 219 -------------QDEVIDWDDFSRGIECVFFSSSLIIFFIILSFTLSFIHDYYHIQYRRILKTEPPIPEDLSPDVADFI 285 (966)
Q Consensus 219 -------------~~e~i~~~~y~~~~d~~~~~~~~il~~~m~~g~~pf~~~~~~~~~~~I~~~~~~~P~~~s~~a~dli 285 (966)
++|+++-.|||.++| ||-.||++|||++|.+||++.+...+|+-|+.++++||..+|++|+.||
T Consensus 323 ~t~kTFCGTPEYLAPEVleDnDYgraVD---WWG~GVVMYEMmCGRLPFyn~dh~kLFeLIl~ed~kFPr~ls~eAktLL 399 (516)
T KOG0690|consen 323 DTTKTFCGTPEYLAPEVLEDNDYGRAVD---WWGVGVVMYEMMCGRLPFYNKDHEKLFELILMEDLKFPRTLSPEAKTLL 399 (516)
T ss_pred ceeccccCChhhcCchhhccccccceee---hhhhhHHHHHHHhccCcccccchhHHHHHHHhhhccCCccCCHHHHHHH
Confidence 357899999999988 5567788899999999999999999999999999999999999999999
Q ss_pred HhhcccCCCcccCCCCCCHHHHhcCCceeeeCccccccCCCCCCCCccccccccccccccccccCcC
Q psy11767 286 SRLLVKDPRRRLGGGELDAEELKRHPFFNVIDWDDLATKRIPAPFVPKISNELDVSNFSDEFTKMIP 352 (966)
Q Consensus 286 ~~LL~kdp~~RLG~~~~g~~~Ik~HpfF~~idW~~l~~k~~~pP~~P~i~~~~D~snFd~ef~~~~p 352 (966)
.+||.|||++|||+|+.++.||++|+||++|||+++..|+++|||.|++.+++|+++||.||+.+..
T Consensus 400 sGLL~kdP~kRLGgGpdDakEi~~h~FF~~v~W~~~~~Kki~PPfKPqVtSetDTryFD~EFT~q~v 466 (516)
T KOG0690|consen 400 SGLLKKDPKKRLGGGPDDAKEIMRHRFFASVDWEATYRKKIEPPFKPQVTSETDTRYFDEEFTSQPV 466 (516)
T ss_pred HHHhhcChHhhcCCCchhHHHHHhhhhhccCCHHHHHHhccCCCCCCCcccccchhhhhhhhhccee
Confidence 9999999999999999999999999999999999999999999999999999999999999987643
|
|
| >KOG0575|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-49 Score=447.43 Aligned_cols=243 Identities=37% Similarity=0.662 Sum_probs=216.4
Q ss_pred ccccccccccccccEEEEEEEcCCCcEEEEEEecccc--------ChHHHHHHHHHhcCCCCceEEEEEEEeCCeEEEEE
Q psy11767 379 DLDKAGILGDGSYSVCRRCVEKSTGQEYAVKIISRKI--------DCSEEINLLRACQGHPNIVNLHCVFQDEVHTYLVL 450 (966)
Q Consensus 379 ~~~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~--------~~~~Ei~iL~~l~~HpnIV~l~~~~~~~~~~~lVm 450 (966)
.|++.+.||+|||+.||.+++..+|+.||+|++.++. ...+||+|.+.+ +|||||+++++|++..++|||+
T Consensus 19 ~Y~~g~~LGkGgFA~cYe~~~~~tge~~A~KvVpk~~l~k~~~reKv~~EIeIHr~L-~HpnIV~f~~~FEDs~nVYivL 97 (592)
T KOG0575|consen 19 RYKRGRFLGKGGFARCYEARDLDTGEVVAVKVVPKKLLKKPKQREKVLNEIEIHRSL-KHPNIVQFYHFFEDSNNVYIVL 97 (592)
T ss_pred eeeeeeeeccCcceEEEEEEEcCCCcEEEEEEeehHHhcCcchHHHHHHHHHHHHhc-CCCcEEeeeeEeecCCceEEEE
Confidence 4555788999999999999999999999999998632 245799999999 5999999999999999999999
Q ss_pred EccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCcEEEecCCCCCEEEEeeccccccc---C
Q psy11767 451 ELLKGGELLDRIRQKGRCGFTENEASRIMRQLVAAVHFMHSRGVVHRDLKPENLLFSDPAGDNIKVVDFGFACLKR---E 527 (966)
Q Consensus 451 Ey~~gg~L~~~l~~~~~~~l~e~~~~~i~~Qil~aL~yLHs~~IiHRDLKP~NILl~~~~~~~iKL~DFGla~~~~---~ 527 (966)
|+|+.++|..+++++. .++|.+++.|++||+.||.|||+++|||||||..||+|++ +.+|||+|||||.... +
T Consensus 98 ELC~~~sL~el~Krrk--~ltEpEary~l~QIv~GlkYLH~~~IiHRDLKLGNlfL~~--~~~VKIgDFGLAt~le~~~E 173 (592)
T KOG0575|consen 98 ELCHRGSLMELLKRRK--PLTEPEARYFLRQIVEGLKYLHSLGIIHRDLKLGNLFLNE--NMNVKIGDFGLATQLEYDGE 173 (592)
T ss_pred EecCCccHHHHHHhcC--CCCcHHHHHHHHHHHHHHHHHHhcCceecccchhheeecC--cCcEEecccceeeeecCccc
Confidence 9999999999998544 6999999999999999999999999999999999999985 4599999999998765 4
Q ss_pred CCccccccccccCchhhccCCCCCCCcccchhhhhhhhhhhhcCCCCCCCcCcchhHHHHHHHHhcCCCCCCCCCCchhH
Q psy11767 528 SLHTPCFTLQYAAPEVLRQDKSGYDENCDLWSLGVILVNVLRQDKSGYDENCDLWSLGVILYTMLCGRVPFHARSRDDSA 607 (966)
Q Consensus 528 ~~~~~~gT~~Y~APEvl~~~~~~~~~~~Di~SlGvil~el~~~~~~~y~~~~DIWSlGvilyemltG~~Pf~~~~~~~~~ 607 (966)
...+.||||.|.|||++. +.+|+..+||||+|||||.||+|++||...+ .
T Consensus 174 rk~TlCGTPNYIAPEVl~--------------------------k~gHsfEvDiWSlGcvmYtLL~G~PPFetk~----v 223 (592)
T KOG0575|consen 174 RKKTLCGTPNYIAPEVLN--------------------------KSGHSFEVDIWSLGCVMYTLLVGRPPFETKT----V 223 (592)
T ss_pred ccceecCCCcccChhHhc--------------------------cCCCCCchhhhhhhhHHHhhhhCCCCcccch----H
Confidence 567899999999999995 4557888999999999999999999998643 4
Q ss_pred HHHHHHHHcCCCCCCchhhccCCHHHHHHHHHhcccCccccCChHHHHHHhhhhH
Q psy11767 608 LSIMARIKEGQFNFDAEAWSTVSSEAKELTKSLLTVNPAQRIRMMRVKLTFHAFH 662 (966)
Q Consensus 608 ~~~~~~i~~~~~~~~~~~~~~is~e~~~Li~~~L~~dP~~R~t~~~v~~~~~~~~ 662 (966)
...+.+|+...+.++. .+|.+|++||.+||+.||.+|||+.++ ..|+|+
T Consensus 224 kety~~Ik~~~Y~~P~----~ls~~A~dLI~~lL~~~P~~Rpsl~~v--L~h~Ff 272 (592)
T KOG0575|consen 224 KETYNKIKLNEYSMPS----HLSAEAKDLIRKLLRPNPSERPSLDEV--LDHPFF 272 (592)
T ss_pred HHHHHHHHhcCccccc----ccCHHHHHHHHHHhcCCcccCCCHHHH--hcCHhh
Confidence 4678899999988765 689999999999999999999999976 456666
|
|
| >KOG0598|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-50 Score=431.27 Aligned_cols=236 Identities=32% Similarity=0.541 Sum_probs=213.1
Q ss_pred CcceeeeecccccceEEEEEEcCCCCEEEEEeccccc--------hhhHHHHHHHHhhCCCcccc---------------
Q psy11767 117 DLDKAGILGDGSYSVCRRCVEKSTGQEYAVKIISRKI--------DCSEEINLLRACQGHPNICR--------------- 173 (966)
Q Consensus 117 df~~~~~LG~GsFGkV~La~~k~tg~~yAiKvl~K~~--------~~~~E~~il~~~~~~pfi~~--------------- 173 (966)
||+++++||+|+||||++||+++||++||||+|+|+. ++..|++||..+ +|||||.
T Consensus 26 dF~~lkviGkG~fGkV~~Vrk~dt~kiYAmKvl~K~~iv~~~e~~~~~~Er~IL~~v-~hPFiv~l~ysFQt~~kLylVl 104 (357)
T KOG0598|consen 26 DFEILKVIGKGSFGKVFQVRKKDTGKIYAMKVLKKKKIVEKKEVRHTKAERNILSKI-KHPFIVKLIYSFQTEEKLYLVL 104 (357)
T ss_pred heeeeeeeeccCCceEEEEEEcccCceeehhhhhhhHhhhhhhHHHHHHHHHHHHhC-CCCcEeeeEEecccCCeEEEEE
Confidence 9999999999999999999999999999999999973 568899999995 7999997
Q ss_pred ---------------cccccccchhHHHHHHHh----------hcccchhhhHhhhccCCceEEecCcccc---------
Q psy11767 174 ---------------RCVEKSTGQEYAVKIISR----------KIDCSEEINLLRACQGHPNIVNLHCVFQ--------- 219 (966)
Q Consensus 174 ---------------~~~~~~~~~~~~~~~v~~----------~~~~~~e~nil~~~~gh~~iv~l~~~~~--------- 219 (966)
+.|.+.+++||.++++.+ +.|+++| |||+|.+||.+|+||+.+.+
T Consensus 105 d~~~GGeLf~hL~~eg~F~E~~arfYlaEi~lAL~~LH~~gIiyRDlKPE-NILLd~~GHi~LtDFgL~k~~~~~~~~t~ 183 (357)
T KOG0598|consen 105 DYLNGGELFYHLQREGRFSEDRARFYLAEIVLALGYLHSKGIIYRDLKPE-NILLDEQGHIKLTDFGLCKEDLKDGDATR 183 (357)
T ss_pred eccCCccHHHHHHhcCCcchhHHHHHHHHHHHHHHHHHhCCeeeccCCHH-HeeecCCCcEEEeccccchhcccCCCccc
Confidence 455566668888888776 3477777 99999999999999997653
Q ss_pred ----------ccccccccCCCcceeeechhhHHHHHHHhhCCCCCCCCcHHHHHHHHHhCC-CCCCCCCCHHHHHHHHhh
Q psy11767 220 ----------DEVIDWDDFSRGIECVFFSSSLIIFFIILSFTLSFIHDYYHIQYRRILKTE-PPIPEDLSPDVADFISRL 288 (966)
Q Consensus 220 ----------~e~i~~~~y~~~~d~~~~~~~~il~~~m~~g~~pf~~~~~~~~~~~I~~~~-~~~P~~~s~~a~dli~~L 288 (966)
+|++...+|++.+| ||++||++|+|++|.|||+..+...+|++|+.++ +.+|.++|.+++|||++|
T Consensus 184 tfcGT~eYmAPEil~~~gy~~~vD---WWsLGillYeML~G~pPF~~~~~~~~~~~I~~~k~~~~p~~ls~~ardll~~L 260 (357)
T KOG0598|consen 184 TFCGTPEYMAPEILLGKGYDKAVD---WWSLGILLYEMLTGKPPFYAEDVKKMYDKILKGKLPLPPGYLSEEARDLLKKL 260 (357)
T ss_pred cccCCccccChHHHhcCCCCcccc---hHhHHHHHHHHhhCCCCCcCccHHHHHHHHhcCcCCCCCccCCHHHHHHHHHH
Confidence 57788889999888 7789999999999999999999999999999999 667777999999999999
Q ss_pred cccCCCcccCCCCCCHHHHhcCCceeeeCccccccCCCCCCCCccccccccccccccccccCcCCCCCCC
Q psy11767 289 LVKDPRRRLGGGELDAEELKRHPFFNVIDWDDLATKRIPAPFVPKISNELDVSNFSDEFTKMIPADSPAI 358 (966)
Q Consensus 289 L~kdp~~RLG~~~~g~~~Ik~HpfF~~idW~~l~~k~~~pP~~P~i~~~~D~snFd~ef~~~~p~dSp~i 358 (966)
|++||.+||| +..|+++|++||||++|||++|.+|+++|||.|.+.+..|++|||.+|+...+..++..
T Consensus 261 L~rdp~~RLg-~~~d~~~ik~HpfF~~inW~~l~~k~l~PpF~P~~~~~~~~~~Fd~eft~~~~~~~~~~ 329 (357)
T KOG0598|consen 261 LKRDPRQRLG-GPGDAEEIKRHPFFKGINWEKLLAKKLSPPFKPNVTGLEDTSNFDNEFTSYTVDYSPVD 329 (357)
T ss_pred hccCHHHhcC-CCCChHHhhcCcccccCCHHHHHhcCCCCCeecCCCCccccccccHHHHhccccCCccc
Confidence 9999999999 56799999999999999999999999999999999999999999999998877766654
|
|
| >KOG0595|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-48 Score=424.59 Aligned_cols=238 Identities=38% Similarity=0.626 Sum_probs=204.6
Q ss_pred cccccccccccEEEEEEEcCCCcEEEEEEecccc-------ChHHHHHHHHHhcCCCCceEEEEEEEeCCeEEEEEEccC
Q psy11767 382 KAGILGDGSYSVCRRCVEKSTGQEYAVKIISRKI-------DCSEEINLLRACQGHPNIVNLHCVFQDEVHTYLVLELLK 454 (966)
Q Consensus 382 ~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~-------~~~~Ei~iL~~l~~HpnIV~l~~~~~~~~~~~lVmEy~~ 454 (966)
..+.||.|+||+||+|+++.++..||||.+.++. ....||++|+.+. |||||+|++++++++++|||||||.
T Consensus 14 ~~~~iG~GsfavVykg~h~~~~~~VAIK~i~~~~l~~k~~e~L~~Ei~iLkel~-H~nIV~l~d~~~~~~~i~lVMEyC~ 92 (429)
T KOG0595|consen 14 LSREIGSGSFAVVYKGRHKKSGTEVAIKCIAKKKLNKKLVELLLSEIKILKELK-HPNIVRLLDCIEDDDFIYLVMEYCN 92 (429)
T ss_pred ehhhccCcceEEEEEeEeccCCceEEeeeehhhccCHHHHHHHHHHHHHHHhcC-CcceeeEEEEEecCCeEEEEEEeCC
Confidence 3566999999999999999999999999997663 1356999999995 9999999999999999999999999
Q ss_pred CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCcEEEecC-CC---CCEEEEeecccccccC--C
Q psy11767 455 GGELLDRIRQKGRCGFTENEASRIMRQLVAAVHFMHSRGVVHRDLKPENLLFSDP-AG---DNIKVVDFGFACLKRE--S 528 (966)
Q Consensus 455 gg~L~~~l~~~~~~~l~e~~~~~i~~Qil~aL~yLHs~~IiHRDLKP~NILl~~~-~~---~~iKL~DFGla~~~~~--~ 528 (966)
||||.+||++++ .++|..++.++.||+.||++||+++||||||||+||||+.. .. -.+||+|||+|+.... .
T Consensus 93 gGDLs~yi~~~~--~l~e~t~r~Fm~QLA~alq~L~~~~IiHRDLKPQNiLLs~~~~~~~~~~LKIADFGfAR~L~~~~~ 170 (429)
T KOG0595|consen 93 GGDLSDYIRRRG--RLPEATARHFMQQLASALQFLHENNIIHRDLKPQNILLSTTARNDTSPVLKIADFGFARFLQPGSM 170 (429)
T ss_pred CCCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCCeeeccCCcceEEeccCCCCCCCceEEecccchhhhCCchhH
Confidence 999999999887 59999999999999999999999999999999999999864 22 3689999999987654 3
Q ss_pred CccccccccccCchhhccCCCCCCCcccchhhhhhhhhhhhcCCCCCCCcCcchhHHHHHHHHhcCCCCCCCCCCchhHH
Q psy11767 529 LHTPCFTLQYAAPEVLRQDKSGYDENCDLWSLGVILVNVLRQDKSGYDENCDLWSLGVILYTMLCGRVPFHARSRDDSAL 608 (966)
Q Consensus 529 ~~~~~gT~~Y~APEvl~~~~~~~~~~~Di~SlGvil~el~~~~~~~y~~~~DIWSlGvilyemltG~~Pf~~~~~~~~~~ 608 (966)
..+.||+|.|||||+++. ..|+.|+|+||+|+|+|+|++|++||+..+..
T Consensus 171 a~tlcGSplYMAPEV~~~--------------------------~~YdAKADLWSiG~Ilyq~l~g~~Pf~a~t~~---- 220 (429)
T KOG0595|consen 171 AETLCGSPLYMAPEVIMS--------------------------QQYDAKADLWSIGTILYQCLTGKPPFDAETPK---- 220 (429)
T ss_pred HHHhhCCccccCHHHHHh--------------------------ccccchhhHHHHHHHHHHHHhCCCCccccCHH----
Confidence 568899999999999963 34899999999999999999999999987654
Q ss_pred HHHHHHHcCCCCCCchhhccCCHHHHHHHHHhcccCccccCChHH
Q psy11767 609 SIMARIKEGQFNFDAEAWSTVSSEAKELTKSLLTVNPAQRIRMMR 653 (966)
Q Consensus 609 ~~~~~i~~~~~~~~~~~~~~is~e~~~Li~~~L~~dP~~R~t~~~ 653 (966)
+++..++.+....+. ....++....+|+..+|+.||.+|.+..+
T Consensus 221 eL~~~~~k~~~~~~~-~~~~~s~~~~~Ll~~ll~~~~~~~~~~~~ 264 (429)
T KOG0595|consen 221 ELLLYIKKGNEIVPV-LPAELSNPLRELLISLLQRNPKDRISFED 264 (429)
T ss_pred HHHHHHhccccccCc-hhhhccCchhhhhhHHHhcCccccCchHH
Confidence 344566666544332 22346777789999999999999998763
|
|
| >KOG0592|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-47 Score=426.69 Aligned_cols=245 Identities=38% Similarity=0.659 Sum_probs=213.4
Q ss_pred ccccccccccccccEEEEEEEcCCCcEEEEEEecccc--------ChHHHHHHHHHhcCCCCceEEEEEEEeCCeEEEEE
Q psy11767 379 DLDKAGILGDGSYSVCRRCVEKSTGQEYAVKIISRKI--------DCSEEINLLRACQGHPNIVNLHCVFQDEVHTYLVL 450 (966)
Q Consensus 379 ~~~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~--------~~~~Ei~iL~~l~~HpnIV~l~~~~~~~~~~~lVm 450 (966)
||.-.++||.|+|++|++|+++.++++||||++.++. -...|-.+|..|.+||.||+|+..|+|+..+|+|+
T Consensus 74 DF~Fg~~lGeGSYStV~~A~~~~t~keYAiKVl~K~~Iike~KvkYV~~Ek~~l~~L~~hPgivkLy~TFQD~~sLYFvL 153 (604)
T KOG0592|consen 74 DFKFGKILGEGSYSTVVLAREKATGKEYAIKVLDKRYIIKEKKVKYVTREKEALTQLSGHPGIVKLYFTFQDEESLYFVL 153 (604)
T ss_pred hcchhheeccccceeEEEeeecCCCceeeHhhhhHHHHHhhcccchhhHHHHHHHHhhCCCCeEEEEEEeecccceEEEE
Confidence 4555789999999999999999999999999987642 14568889999989999999999999999999999
Q ss_pred EccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCcEEEecCCCCCEEEEeecccccccCC--
Q psy11767 451 ELLKGGELLDRIRQKGRCGFTENEASRIMRQLVAAVHFMHSRGVVHRDLKPENLLFSDPAGDNIKVVDFGFACLKRES-- 528 (966)
Q Consensus 451 Ey~~gg~L~~~l~~~~~~~l~e~~~~~i~~Qil~aL~yLHs~~IiHRDLKP~NILl~~~~~~~iKL~DFGla~~~~~~-- 528 (966)
||+++|+|+++|.+.+ .|++..++.|+.||+.||+|||++|||||||||+||||+. ++++||+|||.|+.....
T Consensus 154 e~A~nGdll~~i~K~G--sfde~caR~YAAeIldAleylH~~GIIHRDlKPENILLd~--dmhikITDFGsAK~l~~~~~ 229 (604)
T KOG0592|consen 154 EYAPNGDLLDLIKKYG--SFDETCARFYAAEILDALEYLHSNGIIHRDLKPENILLDK--DGHIKITDFGSAKILSPSQK 229 (604)
T ss_pred EecCCCcHHHHHHHhC--cchHHHHHHHHHHHHHHHHHHHhcCceeccCChhheeEcC--CCcEEEeeccccccCChhhc
Confidence 9999999999999887 5999999999999999999999999999999999999985 679999999999764321
Q ss_pred ----------C----ccccccccccCchhhccCCCCCCCcccchhhhhhhhhhhhcCCCCCCCcCcchhHHHHHHHHhcC
Q psy11767 529 ----------L----HTPCFTLQYAAPEVLRQDKSGYDENCDLWSLGVILVNVLRQDKSGYDENCDLWSLGVILYTMLCG 594 (966)
Q Consensus 529 ----------~----~~~~gT~~Y~APEvl~~~~~~~~~~~Di~SlGvil~el~~~~~~~y~~~~DIWSlGvilyemltG 594 (966)
. .+++||..|.+||+|.... .+..+|+|+||||||.|+.|
T Consensus 230 ~~~~~~~~~~a~s~~~SFVGTAeYVSPElL~~~~--------------------------~~~~sDiWAlGCilyQmlaG 283 (604)
T KOG0592|consen 230 SQENPVDPNQASSRRSSFVGTAEYVSPELLNDSP--------------------------AGPSSDLWALGCILYQMLAG 283 (604)
T ss_pred cccCccCcccccCcccceeeeecccCHHHhcCCC--------------------------CCcccchHHHHHHHHHHhcC
Confidence 1 3478999999999996432 46789999999999999999
Q ss_pred CCCCCCCCCchhHHHHHHHHHcCCCCCCchhhccCCHHHHHHHHHhcccCccccCChHHHHHHhhhhHH
Q psy11767 595 RVPFHARSRDDSALSIMARIKEGQFNFDAEAWSTVSSEAKELTKSLLTVNPAQRIRMMRVKLTFHAFHQ 663 (966)
Q Consensus 595 ~~Pf~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~is~e~~~Li~~~L~~dP~~R~t~~~v~~~~~~~~~ 663 (966)
.+||.+.+. ..++++|..-.+.|+. ..++.++|||+++|..||.+|+|+.++ ..|+|+.
T Consensus 284 ~PPFra~Ne----yliFqkI~~l~y~fp~----~fp~~a~dLv~KLLv~dp~~Rlt~~qI--k~HpFF~ 342 (604)
T KOG0592|consen 284 QPPFRAANE----YLIFQKIQALDYEFPE----GFPEDARDLIKKLLVRDPSDRLTSQQI--KAHPFFE 342 (604)
T ss_pred CCCCccccH----HHHHHHHHHhcccCCC----CCCHHHHHHHHHHHccCccccccHHHH--hhCcccc
Confidence 999998654 4567888887777764 567999999999999999999999876 4567653
|
|
| >KOG0616|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-47 Score=400.72 Aligned_cols=233 Identities=37% Similarity=0.668 Sum_probs=212.7
Q ss_pred ccccccccccccccEEEEEEEcCCCcEEEEEEeccccC--------hHHHHHHHHHhcCCCCceEEEEEEEeCCeEEEEE
Q psy11767 379 DLDKAGILGDGSYSVCRRCVEKSTGQEYAVKIISRKID--------CSEEINLLRACQGHPNIVNLHCVFQDEVHTYLVL 450 (966)
Q Consensus 379 ~~~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~~--------~~~Ei~iL~~l~~HpnIV~l~~~~~~~~~~~lVm 450 (966)
+|+.++.||.|+||.|.+++++.+|..||+|++++..- ..+|..+|+.+. ||++|+|++.|.+..++||||
T Consensus 45 dfe~~~tlGtGSFGrV~LVr~k~~g~yYAmKvL~k~~vVklKQveH~~nEk~vL~~v~-~PFlv~l~~t~~d~~~lymvm 123 (355)
T KOG0616|consen 45 DFERLKTLGTGSFGRVHLVREKHSGNYYAMKVLDKQKVVKLKQVEHTHNEKRVLKAVS-HPFLVKLYGTFKDNSNLYMVM 123 (355)
T ss_pred hhhheeeeccCccceEEEEEEccCCceeehhhcCHHHHHHHHHHHHHhhHHHHHhhcc-CceeEEEEEeeccCCeEEEEE
Confidence 45668999999999999999999999999999976532 346899999885 999999999999999999999
Q ss_pred EccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCcEEEecCCCCCEEEEeecccccccCCCc
Q psy11767 451 ELLKGGELLDRIRQKGRCGFTENEASRIMRQLVAAVHFMHSRGVVHRDLKPENLLFSDPAGDNIKVVDFGFACLKRESLH 530 (966)
Q Consensus 451 Ey~~gg~L~~~l~~~~~~~l~e~~~~~i~~Qil~aL~yLHs~~IiHRDLKP~NILl~~~~~~~iKL~DFGla~~~~~~~~ 530 (966)
||++||.|+.++++.+ .|++..++.|+.||+.||+|||+++|++||||||||||+. +|++||+|||+|+.......
T Consensus 124 eyv~GGElFS~Lrk~~--rF~e~~arFYAAeivlAleylH~~~iiYRDLKPENiLlD~--~G~iKitDFGFAK~v~~rT~ 199 (355)
T KOG0616|consen 124 EYVPGGELFSYLRKSG--RFSEPHARFYAAEIVLALEYLHSLDIIYRDLKPENLLLDQ--NGHIKITDFGFAKRVSGRTW 199 (355)
T ss_pred eccCCccHHHHHHhcC--CCCchhHHHHHHHHHHHHHHHHhcCeeeccCChHHeeecc--CCcEEEEeccceEEecCcEE
Confidence 9999999999999876 5999999999999999999999999999999999999985 67999999999998888888
Q ss_pred cccccccccCchhhccCCCCCCCcccchhhhhhhhhhhhcCCCCCCCcCcchhHHHHHHHHhcCCCCCCCCCCchhHHHH
Q psy11767 531 TPCFTLQYAAPEVLRQDKSGYDENCDLWSLGVILVNVLRQDKSGYDENCDLWSLGVILYTMLCGRVPFHARSRDDSALSI 610 (966)
Q Consensus 531 ~~~gT~~Y~APEvl~~~~~~~~~~~Di~SlGvil~el~~~~~~~y~~~~DIWSlGvilyemltG~~Pf~~~~~~~~~~~~ 610 (966)
+.||||.|+|||++.. .+|+.++|+|||||++|||+.|.+||.+.+. ..+
T Consensus 200 TlCGTPeYLAPEii~s--------------------------k~ynkavDWWalGVLIYEMlaG~pPF~~~~~----~~i 249 (355)
T KOG0616|consen 200 TLCGTPEYLAPEIIQS--------------------------KGYNKAVDWWALGVLIYEMLAGYPPFYDDNP----IQI 249 (355)
T ss_pred EecCCccccChHHhhc--------------------------CCCCcchhHHHHHHHHHHHHcCCCCCcCCCh----HHH
Confidence 9999999999999963 4588999999999999999999999997654 577
Q ss_pred HHHHHcCCCCCCchhhccCCHHHHHHHHHhcccCccccCC
Q psy11767 611 MARIKEGQFNFDAEAWSTVSSEAKELTKSLLTVNPAQRIR 650 (966)
Q Consensus 611 ~~~i~~~~~~~~~~~~~~is~e~~~Li~~~L~~dP~~R~t 650 (966)
..+|.+|++.++. ..|+++++||.++|+.|-.+|..
T Consensus 250 Y~KI~~~~v~fP~----~fs~~~kdLl~~LL~vD~t~R~g 285 (355)
T KOG0616|consen 250 YEKILEGKVKFPS----YFSSDAKDLLKKLLQVDLTKRFG 285 (355)
T ss_pred HHHHHhCcccCCc----ccCHHHHHHHHHHHhhhhHhhhc
Confidence 8899999998874 57999999999999999999954
|
|
| >KOG0581|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-47 Score=408.32 Aligned_cols=252 Identities=28% Similarity=0.494 Sum_probs=215.5
Q ss_pred ccccccccccccccEEEEEEEcCCCcEEEEEEecccc------ChHHHHHHHHHhcCCCCceEEEEEEEeCC-eEEEEEE
Q psy11767 379 DLDKAGILGDGSYSVCRRCVEKSTGQEYAVKIISRKI------DCSEEINLLRACQGHPNIVNLHCVFQDEV-HTYLVLE 451 (966)
Q Consensus 379 ~~~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~------~~~~Ei~iL~~l~~HpnIV~l~~~~~~~~-~~~lVmE 451 (966)
+.+.++.||+|..|+||+|+|+.|++.+|+|+|.... ...+|+++|+.+ +|||||++|++|.+++ ..+|+||
T Consensus 80 dle~~~~lG~G~gG~V~kv~Hk~t~~i~AlK~I~~~~~~~~~~Qi~rEl~il~~~-~spyIV~~ygaF~~~~~~isI~mE 158 (364)
T KOG0581|consen 80 DLERLGVLGSGNGGTVYKVRHKPTGKIYALKVILLNIDPALQKQILRELEILRSC-QSPYIVGFYGAFYSNGEEISICME 158 (364)
T ss_pred HhhhhhhcccCCCcEEEEEEEcCCCeEEEEEeecccCCHHHHHHHHHHHHHHhhC-CCCCeeeEeEEEEeCCceEEeehh
Confidence 4556889999999999999999999999999995432 346799999999 6999999999999999 4999999
Q ss_pred ccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHh-cCceeccCCCCcEEEecCCCCCEEEEeecccccccCC-C
Q psy11767 452 LLKGGELLDRIRQKGRCGFTENEASRIMRQLVAAVHFMHS-RGVVHRDLKPENLLFSDPAGDNIKVVDFGFACLKRES-L 529 (966)
Q Consensus 452 y~~gg~L~~~l~~~~~~~l~e~~~~~i~~Qil~aL~yLHs-~~IiHRDLKP~NILl~~~~~~~iKL~DFGla~~~~~~-~ 529 (966)
||+||+|.+.+...+ .++|.....++.++++||.|||+ .+||||||||+|||+.. .|+|||||||.+.....+ .
T Consensus 159 YMDgGSLd~~~k~~g--~i~E~~L~~ia~~VL~GL~YLh~~~~IIHRDIKPsNlLvNs--kGeVKicDFGVS~~lvnS~a 234 (364)
T KOG0581|consen 159 YMDGGSLDDILKRVG--RIPEPVLGKIARAVLRGLSYLHEERKIIHRDIKPSNLLVNS--KGEVKICDFGVSGILVNSIA 234 (364)
T ss_pred hcCCCCHHHHHhhcC--CCCHHHHHHHHHHHHHHHHHHhhccCeeeccCCHHHeeecc--CCCEEeccccccHHhhhhhc
Confidence 999999999998765 59999999999999999999995 89999999999999974 679999999999876554 4
Q ss_pred ccccccccccCchhhccCCCCCCCcccchhhhhhhhhhhhcCCCCCCCcCcchhHHHHHHHHhcCCCCCCCC-CCchhHH
Q psy11767 530 HTPCFTLQYAAPEVLRQDKSGYDENCDLWSLGVILVNVLRQDKSGYDENCDLWSLGVILYTMLCGRVPFHAR-SRDDSAL 608 (966)
Q Consensus 530 ~~~~gT~~Y~APEvl~~~~~~~~~~~Di~SlGvil~el~~~~~~~y~~~~DIWSlGvilyemltG~~Pf~~~-~~~~~~~ 608 (966)
.+.+||..|||||-+.. ..|+.++||||||+++.||++|++||... .......
T Consensus 235 ~tfvGT~~YMsPERi~g--------------------------~~Ys~~sDIWSLGLsllE~a~GrfP~~~~~~~~~~~~ 288 (364)
T KOG0581|consen 235 NTFVGTSAYMSPERISG--------------------------ESYSVKSDIWSLGLSLLELAIGRFPYPPPNPPYLDIF 288 (364)
T ss_pred ccccccccccChhhhcC--------------------------CcCCcccceecccHHHHHHhhCCCCCCCcCCCCCCHH
Confidence 78899999999998863 34788899999999999999999999875 2234556
Q ss_pred HHHHHHHcCCCCCCchhhccCCHHHHHHHHHhcccCccccCChHHHHHHhhhhHHhh
Q psy11767 609 SIMARIKEGQFNFDAEAWSTVSSEAKELTKSLLTVNPAQRIRMMRVKLTFHAFHQAQ 665 (966)
Q Consensus 609 ~~~~~i~~~~~~~~~~~~~~is~e~~~Li~~~L~~dP~~R~t~~~v~~~~~~~~~~~ 665 (966)
+++..|..+...-.++. ..|+++++++..||++||.+|+++.++ ..|+|.+..
T Consensus 289 ~Ll~~Iv~~ppP~lP~~--~fS~ef~~FV~~CL~Kdp~~R~s~~qL--l~Hpfi~~~ 341 (364)
T KOG0581|consen 289 ELLCAIVDEPPPRLPEG--EFSPEFRSFVSCCLRKDPSERPSAKQL--LQHPFIKKF 341 (364)
T ss_pred HHHHHHhcCCCCCCCcc--cCCHHHHHHHHHHhcCCcccCCCHHHH--hcCHHHhhc
Confidence 77888877544322221 489999999999999999999999865 668887543
|
|
| >KOG0593|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-47 Score=397.62 Aligned_cols=251 Identities=29% Similarity=0.510 Sum_probs=208.6
Q ss_pred cccccccccccccEEEEEEEcCCCcEEEEEEeccccC-------hHHHHHHHHHhcCCCCceEEEEEEEeCCeEEEEEEc
Q psy11767 380 LDKAGILGDGSYSVCRRCVEKSTGQEYAVKIISRKID-------CSEEINLLRACQGHPNIVNLHCVFQDEVHTYLVLEL 452 (966)
Q Consensus 380 ~~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~~-------~~~Ei~iL~~l~~HpnIV~l~~~~~~~~~~~lVmEy 452 (966)
|+.++++|+|+||+||+|+++.||+.||||++....+ +.+||++|+++. |+|+|.|+++|.....++||+||
T Consensus 4 YE~LgkvGEGSYGvV~KCrnk~TgqIVAIKkF~Esedd~~VkKIAlREIrmLKqLk-H~NLVnLiEVFrrkrklhLVFE~ 82 (396)
T KOG0593|consen 4 YEKLGKVGEGSYGVVMKCRNKDTGQIVAIKKFVESEDDPVVKKIALREIRMLKQLK-HENLVNLIEVFRRKRKLHLVFEY 82 (396)
T ss_pred HhhhhccccCcceEEEEeccCCcccEEEEEeeccCCccHHHHHHHHHHHHHHHhcc-cchHHHHHHHHHhcceeEEEeee
Confidence 4558999999999999999999999999999865433 568999999995 99999999999999999999999
Q ss_pred cCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCcEEEecCCCCCEEEEeecccccccC---CC
Q psy11767 453 LKGGELLDRIRQKGRCGFTENEASRIMRQLVAAVHFMHSRGVVHRDLKPENLLFSDPAGDNIKVVDFGFACLKRE---SL 529 (966)
Q Consensus 453 ~~gg~L~~~l~~~~~~~l~e~~~~~i~~Qil~aL~yLHs~~IiHRDLKP~NILl~~~~~~~iKL~DFGla~~~~~---~~ 529 (966)
|+ -++++-|.... .++++..++.|++|++.|+.|||+++||||||||+|||+.. ++.+||||||+|+.... ..
T Consensus 83 ~d-hTvL~eLe~~p-~G~~~~~vk~~l~Q~l~ai~~cHk~n~IHRDIKPENILit~--~gvvKLCDFGFAR~L~~pgd~Y 158 (396)
T KOG0593|consen 83 CD-HTVLHELERYP-NGVPSELVKKYLYQLLKAIHFCHKNNCIHRDIKPENILITQ--NGVVKLCDFGFARTLSAPGDNY 158 (396)
T ss_pred cc-hHHHHHHHhcc-CCCCHHHHHHHHHHHHHHhhhhhhcCeecccCChhheEEec--CCcEEeccchhhHhhcCCcchh
Confidence 96 46666666654 47999999999999999999999999999999999999985 67999999999987542 34
Q ss_pred ccccccccccCchhhccCCCCCCCcccchhhhhhhhhhhhcCCCCCCCcCcchhHHHHHHHHhcCCCCCCCCCCchhHHH
Q psy11767 530 HTPCFTLQYAAPEVLRQDKSGYDENCDLWSLGVILVNVLRQDKSGYDENCDLWSLGVILYTMLCGRVPFHARSRDDSALS 609 (966)
Q Consensus 530 ~~~~gT~~Y~APEvl~~~~~~~~~~~Di~SlGvil~el~~~~~~~y~~~~DIWSlGvilyemltG~~Pf~~~~~~~~~~~ 609 (966)
+..+.|.||+|||++.+ +..|+.++||||+||++.||++|.+-|.+.++.++...
T Consensus 159 TDYVATRWYRaPELLvG-------------------------DtqYG~pVDiWAiGCv~aEl~~G~pL~PG~SDiDQLy~ 213 (396)
T KOG0593|consen 159 TDYVATRWYRAPELLVG-------------------------DTQYGKPVDIWAIGCVFAELLTGEPLWPGRSDIDQLYL 213 (396)
T ss_pred hhhhhhhhccChhhhcc-------------------------cCcCCCcccchhhhHHHHHHhcCCcCCCCcchHHHHHH
Confidence 45678999999999863 45699999999999999999999999999988776555
Q ss_pred HHHHHHc----------C-C-C---CC--------CchhhccCCHHHHHHHHHhcccCccccCChHHHHHHhhhhH
Q psy11767 610 IMARIKE----------G-Q-F---NF--------DAEAWSTVSSEAKELTKSLLTVNPAQRIRMMRVKLTFHAFH 662 (966)
Q Consensus 610 ~~~~i~~----------~-~-~---~~--------~~~~~~~is~e~~~Li~~~L~~dP~~R~t~~~v~~~~~~~~ 662 (966)
+...+.. . . | .+ ....++.+|.-+.||+++||..||++|++..++ ..|+++
T Consensus 214 I~ktLG~L~prhq~iF~~N~~F~Gv~lP~~~~~epLe~k~p~~s~~~ld~~k~cL~~dP~~R~sc~ql--l~H~yF 287 (396)
T KOG0593|consen 214 IRKTLGNLIPRHQSIFSSNPFFHGVRLPEPEHPEPLERKYPKISNVLLDLLKKCLKMDPDDRLSCEQL--LHHPYF 287 (396)
T ss_pred HHHHHcccCHHHHHHhccCCceeeeecCCCCCccchhhhcccchHHHHHHHHHHhcCCccccccHHHH--hcChHH
Confidence 4432210 0 0 0 00 112346788899999999999999999999865 455555
|
|
| >KOG0588|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-46 Score=427.68 Aligned_cols=242 Identities=38% Similarity=0.657 Sum_probs=215.4
Q ss_pred cccccccccccEEEEEEEcCCCcEEEEEEecccc--------ChHHHHHHHHHhcCCCCceEEEEEEEeCCeEEEEEEcc
Q psy11767 382 KAGILGDGSYSVCRRCVEKSTGQEYAVKIISRKI--------DCSEEINLLRACQGHPNIVNLHCVFQDEVHTYLVLELL 453 (966)
Q Consensus 382 ~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~--------~~~~Ei~iL~~l~~HpnIV~l~~~~~~~~~~~lVmEy~ 453 (966)
..+.||.|+-|.|.+|+|..||+.+|||+|.+.. ...+||-+|+.+ .||||++||++|++..++|||+||+
T Consensus 16 LgkTLG~Gstg~vrlakh~~TGqlaaiKii~k~~~~s~s~~~~IerEIviMkLi-~HpnVl~LydVwe~~~~lylvlEyv 94 (786)
T KOG0588|consen 16 LGKTLGKGSTGCVRLAKHAETGQLAAIKIIPKRSELSSSQPAGIEREIVIMKLI-EHPNVLRLYDVWENKQHLYLVLEYV 94 (786)
T ss_pred ccccccCCCCceehhhhcccccceeEEEeeccccccccccccchhhhhHHHHHh-cCCCeeeeeeeeccCceEEEEEEec
Confidence 3678999999999999999999999999998762 256899999877 5999999999999999999999999
Q ss_pred CCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCcEEEecCCCCCEEEEeecccccccC--CCcc
Q psy11767 454 KGGELLDRIRQKGRCGFTENEASRIMRQLVAAVHFMHSRGVVHRDLKPENLLFSDPAGDNIKVVDFGFACLKRE--SLHT 531 (966)
Q Consensus 454 ~gg~L~~~l~~~~~~~l~e~~~~~i~~Qil~aL~yLHs~~IiHRDLKP~NILl~~~~~~~iKL~DFGla~~~~~--~~~~ 531 (966)
+||.|++++..++ +|++.++.+++.||+.|+.|||..+|+||||||+|+||+.. ++|||+|||+|....+ -+.+
T Consensus 95 ~gGELFdylv~kG--~l~e~eaa~ff~QIi~gv~yCH~~~icHRDLKpENlLLd~~--~nIKIADFGMAsLe~~gklLeT 170 (786)
T KOG0588|consen 95 PGGELFDYLVRKG--PLPEREAAHFFRQILDGVSYCHAFNICHRDLKPENLLLDVK--NNIKIADFGMASLEVPGKLLET 170 (786)
T ss_pred CCchhHHHHHhhC--CCCCHHHHHHHHHHHHHHHHHhhhcceeccCCchhhhhhcc--cCEeeeccceeecccCCccccc
Confidence 9999999999887 69999999999999999999999999999999999999864 3599999999976443 4678
Q ss_pred ccccccccCchhhccCCCCCCCcccchhhhhhhhhhhhcCCCCCCCcCcchhHHHHHHHHhcCCCCCCCCCCchhHHHHH
Q psy11767 532 PCFTLQYAAPEVLRQDKSGYDENCDLWSLGVILVNVLRQDKSGYDENCDLWSLGVILYTMLCGRVPFHARSRDDSALSIM 611 (966)
Q Consensus 532 ~~gT~~Y~APEvl~~~~~~~~~~~Di~SlGvil~el~~~~~~~y~~~~DIWSlGvilyemltG~~Pf~~~~~~~~~~~~~ 611 (966)
.||+|.|+|||++.+.++ -+.++||||+|||||.||+|++||++. ....++
T Consensus 171 SCGSPHYA~PEIV~G~pY-------------------------dG~~sDVWSCGVILfALLtG~LPFdDd----Nir~LL 221 (786)
T KOG0588|consen 171 SCGSPHYAAPEIVSGRPY-------------------------DGRPSDVWSCGVILFALLTGKLPFDDD----NIRVLL 221 (786)
T ss_pred cCCCcccCCchhhcCCCC-------------------------CCCccccchhHHHHHHHHhCCCCCCCc----cHHHHH
Confidence 999999999999975431 256899999999999999999999853 456788
Q ss_pred HHHHcCCCCCCchhhccCCHHHHHHHHHhcccCccccCChHHHHHHhhhhHH
Q psy11767 612 ARIKEGQFNFDAEAWSTVSSEAKELTKSLLTVNPAQRIRMMRVKLTFHAFHQ 663 (966)
Q Consensus 612 ~~i~~~~~~~~~~~~~~is~e~~~Li~~~L~~dP~~R~t~~~v~~~~~~~~~ 663 (966)
.++++|.|.++ ..+|+++++||.+||.+||++|+|+.+| ..|||..
T Consensus 222 lKV~~G~f~MP----s~Is~eaQdLLr~ml~VDp~~RiT~~eI--~kHP~l~ 267 (786)
T KOG0588|consen 222 LKVQRGVFEMP----SNISSEAQDLLRRMLDVDPSTRITTEEI--LKHPFLS 267 (786)
T ss_pred HHHHcCcccCC----CcCCHHHHHHHHHHhccCccccccHHHH--hhCchhh
Confidence 99999999876 5799999999999999999999999987 4567753
|
|
| >KOG0599|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-47 Score=391.94 Aligned_cols=258 Identities=41% Similarity=0.768 Sum_probs=225.7
Q ss_pred ceecccccccccccccccccccEEEEEEEcCCCcEEEEEEecccc-------------ChHHHHHHHHHhcCCCCceEEE
Q psy11767 371 LFFEQYDMDLDKAGILGDGSYSVCRRCVEKSTGQEYAVKIISRKI-------------DCSEEINLLRACQGHPNIVNLH 437 (966)
Q Consensus 371 ~~~~~~~i~~~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~-------------~~~~Ei~iL~~l~~HpnIV~l~ 437 (966)
.|++.|+- .++||+|..++|.+|.++.||+.+|+|++.... ...+|+.||+++.+||||++|+
T Consensus 14 ~fy~~y~p----keilgrgvss~vrRci~k~t~~e~a~kii~~~at~~~~e~~~~~~EaT~~Ev~ILRqv~GHP~II~l~ 89 (411)
T KOG0599|consen 14 GFYAKYEP----KEILGRGVSSVVRRCIHKETGKEFAVKIIDVTATTESGETPYEMREATRQEISILRQVMGHPYIIDLQ 89 (411)
T ss_pred hHHhhcCh----HHHhcccchhhhhhhhhcccccceeEEEEEecccccCCccHHHHHHHHHHHHHHHHHhcCCCcEEEee
Confidence 34555443 578999999999999999999999999985321 1345999999999999999999
Q ss_pred EEEEeCCeEEEEEEccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCcEEEecCCCCCEEEE
Q psy11767 438 CVFQDEVHTYLVLELLKGGELLDRIRQKGRCGFTENEASRIMRQLVAAVHFMHSRGVVHRDLKPENLLFSDPAGDNIKVV 517 (966)
Q Consensus 438 ~~~~~~~~~~lVmEy~~gg~L~~~l~~~~~~~l~e~~~~~i~~Qil~aL~yLHs~~IiHRDLKP~NILl~~~~~~~iKL~ 517 (966)
++|+.+..+++|+|+|+.|.|+|+|...- .++|.+++.|++|++.|++|||.++|+||||||+|||+++ +.++||+
T Consensus 90 D~yes~sF~FlVFdl~prGELFDyLts~V--tlSEK~tR~iMrqlfegVeylHa~~IVHRDLKpENILldd--n~~i~is 165 (411)
T KOG0599|consen 90 DVYESDAFVFLVFDLMPRGELFDYLTSKV--TLSEKETRRIMRQLFEGVEYLHARNIVHRDLKPENILLDD--NMNIKIS 165 (411)
T ss_pred eeccCcchhhhhhhhcccchHHHHhhhhe--eecHHHHHHHHHHHHHHHHHHHHhhhhhcccChhheeecc--ccceEEe
Confidence 99999999999999999999999998765 6999999999999999999999999999999999999986 5589999
Q ss_pred eecccccccC--CCccccccccccCchhhccCCCCCCCcccchhhhhhhhhhhhcCCCCCCCcCcchhHHHHHHHHhcCC
Q psy11767 518 DFGFACLKRE--SLHTPCFTLQYAAPEVLRQDKSGYDENCDLWSLGVILVNVLRQDKSGYDENCDLWSLGVILYTMLCGR 595 (966)
Q Consensus 518 DFGla~~~~~--~~~~~~gT~~Y~APEvl~~~~~~~~~~~Di~SlGvil~el~~~~~~~y~~~~DIWSlGvilyemltG~ 595 (966)
|||+|+.... .....||||+|+|||++...-. .+.++|+..+|+||+|||+|.||.|.
T Consensus 166 DFGFa~~l~~GekLrelCGTPgYLAPEtikC~m~--------------------e~~pGYs~EVD~Wa~GVImyTLLaGc 225 (411)
T KOG0599|consen 166 DFGFACQLEPGEKLRELCGTPGYLAPETIKCSMY--------------------ENHPGYSKEVDEWACGVIMYTLLAGC 225 (411)
T ss_pred ccceeeccCCchhHHHhcCCCcccChhheeeecc--------------------cCCCCccchhhHHHHHHHHHHHHcCC
Confidence 9999987653 4567899999999999975321 24678999999999999999999999
Q ss_pred CCCCCCCCchhHHHHHHHHHcCCCCCCchhhccCCHHHHHHHHHhcccCccccCChHHHHHHhhhhH
Q psy11767 596 VPFHARSRDDSALSIMARIKEGQFNFDAEAWSTVSSEAKELTKSLLTVNPAQRIRMMRVKLTFHAFH 662 (966)
Q Consensus 596 ~Pf~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~is~e~~~Li~~~L~~dP~~R~t~~~v~~~~~~~~ 662 (966)
+||.... ...++..|.+|+|.|..+.|.++|.+.+|||.+||+.||.+|+|+.++ ..|+|+
T Consensus 226 pPFwHRk----QmlMLR~ImeGkyqF~speWadis~~~KdLIsrlLqVdp~~Ritake~--LaHpff 286 (411)
T KOG0599|consen 226 PPFWHRK----QMLMLRMIMEGKYQFRSPEWADISATVKDLISRLLQVDPTKRITAKEA--LAHPFF 286 (411)
T ss_pred CchhHHH----HHHHHHHHHhcccccCCcchhhccccHHHHHHHHHeeCchhcccHHHH--hcChHH
Confidence 9997532 245567899999999999999999999999999999999999999875 456765
|
|
| >KOG0604|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-47 Score=397.01 Aligned_cols=265 Identities=40% Similarity=0.724 Sum_probs=233.8
Q ss_pred cccccceecccccccccccccccccccEEEEEEEcCCCcEEEEEEeccccChHHHHHHHHHhcCCCCceEEEEEEEe---
Q psy11767 366 IFKGSLFFEQYDMDLDKAGILGDGSYSVCRRCVEKSTGQEYAVKIISRKIDCSEEINLLRACQGHPNIVNLHCVFQD--- 442 (966)
Q Consensus 366 if~G~~~~~~~~i~~~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~~~~~Ei~iL~~l~~HpnIV~l~~~~~~--- 442 (966)
.|+.....+.|.+.. .+||-|-.|+|..|.++.||+.+|+|++.....+.+|+++.-...+|||||.++++|++
T Consensus 53 ~~k~~~itedY~is~---qvLG~GinGkV~~C~~k~T~ekfALKvL~Ds~KARrEVeLHw~~s~h~~iV~IidVyeNs~~ 129 (400)
T KOG0604|consen 53 DFKEYSITEDYSISW---QVLGAGINGKVVQCVHKRTQEKFALKVLLDSPKARREVELHWMASGHPHIVSIIDVYENSYQ 129 (400)
T ss_pred chhcccchhhheehh---hhhccccCCceEEEEeccchhhhHHHHHhcCHHHHhHhhhhhhhcCCCceEEeehhhhhhcc
Confidence 345566677788864 57999999999999999999999999998877888999988888899999999999874
Q ss_pred -CCeEEEEEEccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCcEEEecCC-CCCEEEEeec
Q psy11767 443 -EVHTYLVLELLKGGELLDRIRQKGRCGFTENEASRIMRQLVAAVHFMHSRGVVHRDLKPENLLFSDPA-GDNIKVVDFG 520 (966)
Q Consensus 443 -~~~~~lVmEy~~gg~L~~~l~~~~~~~l~e~~~~~i~~Qil~aL~yLHs~~IiHRDLKP~NILl~~~~-~~~iKL~DFG 520 (966)
...+.+|||+|+||+|+..|+.++...|+|.++..|+.||+.|+.|||+.+|.||||||+|+|..... +..+||+|||
T Consensus 130 ~rkcLLiVmE~meGGeLfsriq~~g~~afTErea~eI~~qI~~Av~~lH~~nIAHRDlKpENLLyt~t~~na~lKLtDfG 209 (400)
T KOG0604|consen 130 GRKCLLIVMECMEGGELFSRIQDRGDQAFTEREASEIMKQIGLAVRYLHSMNIAHRDLKPENLLYTTTSPNAPLKLTDFG 209 (400)
T ss_pred CceeeEeeeecccchHHHHHHHHcccccchHHHHHHHHHHHHHHHHHHHhcchhhccCChhheeeecCCCCcceEecccc
Confidence 34678999999999999999999988899999999999999999999999999999999999997633 4579999999
Q ss_pred cccccc--CCCccccccccccCchhhccCCCCCCCcccchhhhhhhhhhhhcCCCCCCCcCcchhHHHHHHHHhcCCCCC
Q psy11767 521 FACLKR--ESLHTPCFTLQYAAPEVLRQDKSGYDENCDLWSLGVILVNVLRQDKSGYDENCDLWSLGVILYTMLCGRVPF 598 (966)
Q Consensus 521 la~~~~--~~~~~~~gT~~Y~APEvl~~~~~~~~~~~Di~SlGvil~el~~~~~~~y~~~~DIWSlGvilyemltG~~Pf 598 (966)
+|+... ....++|.||+|.|||++.. ..|+..+|+||+||++|.||+|.+||
T Consensus 210 FAK~t~~~~~L~TPc~TPyYvaPevlg~--------------------------eKydkscdmwSlgVimYIlLCGyPPF 263 (400)
T KOG0604|consen 210 FAKETQEPGDLMTPCFTPYYVAPEVLGP--------------------------EKYDKSCDMWSLGVIMYILLCGYPPF 263 (400)
T ss_pred cccccCCCccccCCcccccccCHHHhCc--------------------------hhcCCCCCccchhHHHHHhhcCCCcc
Confidence 998765 46789999999999999842 34889999999999999999999999
Q ss_pred CCCCCchhHHHHHHHHHcCCCCCCchhhccCCHHHHHHHHHhcccCccccCChHHHHHHhhhh
Q psy11767 599 HARSRDDSALSIMARIKEGQFNFDAEAWSTVSSEAKELTKSLLTVNPAQRIRMMRVKLTFHAF 661 (966)
Q Consensus 599 ~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~is~e~~~Li~~~L~~dP~~R~t~~~v~~~~~~~ 661 (966)
+........-..-.+|..|.|.|+.+.|..+|++++|+|+++|..+|.+|+|+.++ +-|+|
T Consensus 264 YS~hg~aispgMk~rI~~gqy~FP~pEWs~VSe~aKdlIR~LLkt~PteRlTI~~~--m~hpw 324 (400)
T KOG0604|consen 264 YSNHGLAISPGMKRRIRTGQYEFPEPEWSCVSEAAKDLIRKLLKTEPTERLTIEEV--MDHPW 324 (400)
T ss_pred cccCCccCChhHHhHhhccCccCCChhHhHHHHHHHHHHHHHhcCCchhheeHHHh--hcCch
Confidence 98765443345567899999999999999999999999999999999999999876 34555
|
|
| >KOG0605|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-46 Score=419.88 Aligned_cols=247 Identities=33% Similarity=0.580 Sum_probs=206.1
Q ss_pred ccccccccccccccEEEEEEEcCCCcEEEEEEeccccC--------hHHHHHHHHHhcCCCCceEEEEEEEeCCeEEEEE
Q psy11767 379 DLDKAGILGDGSYSVCRRCVEKSTGQEYAVKIISRKID--------CSEEINLLRACQGHPNIVNLHCVFQDEVHTYLVL 450 (966)
Q Consensus 379 ~~~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~~--------~~~Ei~iL~~l~~HpnIV~l~~~~~~~~~~~lVm 450 (966)
||+.+++||+|+||.||+|+.+.||+.||+|++++... ...|.++|... +.|+||+||..|++..++||||
T Consensus 142 DFe~Lk~IgkGAfGeVrLarKk~Tg~iyAmK~LkKS~M~~~~Qv~hV~aERdiL~~~-ds~~vVKLyYsFQD~~~LYLiM 220 (550)
T KOG0605|consen 142 DFELLKVIGKGAFGEVRLARKKDTGEIYAMKILKKSEMLKKNQVEHVRAERDILAEV-DSPWVVKLYYSFQDKEYLYLIM 220 (550)
T ss_pred cchhheeeccccceeEEEEEEccCCcEEeeecccHHHHHhhhhHHHHHHHHHHhhhc-CCCcEEEEEEEecCCCeeEEEE
Confidence 45668999999999999999999999999999976532 34588888774 7999999999999999999999
Q ss_pred EccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCcEEEecCCCCCEEEEeeccccccc----
Q psy11767 451 ELLKGGELLDRIRQKGRCGFTENEASRIMRQLVAAVHFMHSRGVVHRDLKPENLLFSDPAGDNIKVVDFGFACLKR---- 526 (966)
Q Consensus 451 Ey~~gg~L~~~l~~~~~~~l~e~~~~~i~~Qil~aL~yLHs~~IiHRDLKP~NILl~~~~~~~iKL~DFGla~~~~---- 526 (966)
||++|||+...|.+.+ .|++.++++|+.+++.|++.||..|+|||||||+|+||+. .|++||+||||+.-..
T Consensus 221 EylPGGD~mTLL~~~~--~L~e~~arfYiaE~vlAI~~iH~~gyIHRDIKPdNlLiD~--~GHiKLSDFGLs~gl~~~~~ 296 (550)
T KOG0605|consen 221 EYLPGGDMMTLLMRKD--TLTEDWARFYIAETVLAIESIHQLGYIHRDIKPDNLLIDA--KGHIKLSDFGLSTGLDKKHR 296 (550)
T ss_pred EecCCccHHHHHHhcC--cCchHHHHHHHHHHHHHHHHHHHcCcccccCChhheeecC--CCCEeeccccccchhhhhhh
Confidence 9999999999998876 6999999999999999999999999999999999999984 6799999999983100
Q ss_pred ----------------------CC------------------------CccccccccccCchhhccCCCCCCCcccchhh
Q psy11767 527 ----------------------ES------------------------LHTPCFTLQYAAPEVLRQDKSGYDENCDLWSL 560 (966)
Q Consensus 527 ----------------------~~------------------------~~~~~gT~~Y~APEvl~~~~~~~~~~~Di~Sl 560 (966)
.. ....+|||-|||||++..
T Consensus 297 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~w~~nrr~~a~StVGTPDYiAPEVll~-------------- 362 (550)
T KOG0605|consen 297 IESYRLDEQMQINLSEAKPSDFPKFNTPRSTMSRREQLQTWKRNRRQLAYSTVGTPDYIAPEVLLG-------------- 362 (550)
T ss_pred hhhhcchhhhhhhhccCCCccccccccccchhhHHHHHHHHHhhhhhhhhcccCCccccchHHHhc--------------
Confidence 00 012478999999999963
Q ss_pred hhhhhhhhhcCCCCCCCcCcchhHHHHHHHHhcCCCCCCCCCCchhHHHHHHHHHcCC--CCCCchhhccCCHHHHHHHH
Q psy11767 561 GVILVNVLRQDKSGYDENCDLWSLGVILYTMLCGRVPFHARSRDDSALSIMARIKEGQ--FNFDAEAWSTVSSEAKELTK 638 (966)
Q Consensus 561 Gvil~el~~~~~~~y~~~~DIWSlGvilyemltG~~Pf~~~~~~~~~~~~~~~i~~~~--~~~~~~~~~~is~e~~~Li~ 638 (966)
.+|+..+|+||||||+||||.|.+||.+.+..+ ...+|.... +.++.+. .+|++|+|||.
T Consensus 363 ------------kgY~~~cDwWSLG~ImyEmLvGyPPF~s~tp~~----T~rkI~nwr~~l~fP~~~--~~s~eA~DLI~ 424 (550)
T KOG0605|consen 363 ------------KGYGKECDWWSLGCIMYEMLVGYPPFCSETPQE----TYRKIVNWRETLKFPEEV--DLSDEAKDLIT 424 (550)
T ss_pred ------------CCCCccccHHHHHHHHHHHHhCCCCCCCCCHHH----HHHHHHHHhhhccCCCcC--cccHHHHHHHH
Confidence 458899999999999999999999999877654 344554433 4444443 57899999999
Q ss_pred HhcccCccccCChHHH-HHHhhhhHH
Q psy11767 639 SLLTVNPAQRIRMMRV-KLTFHAFHQ 663 (966)
Q Consensus 639 ~~L~~dP~~R~t~~~v-~~~~~~~~~ 663 (966)
+||. ||++|+....+ +...|||++
T Consensus 425 rll~-d~~~RLG~~G~~EIK~HPfF~ 449 (550)
T KOG0605|consen 425 RLLC-DPENRLGSKGAEEIKKHPFFK 449 (550)
T ss_pred HHhc-CHHHhcCcccHHHHhcCCccc
Confidence 9999 99999974333 335678764
|
|
| >KOG0583|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-45 Score=419.80 Aligned_cols=244 Identities=41% Similarity=0.734 Sum_probs=213.6
Q ss_pred ccccccccccEEEEEEEcCCCcEEEEEEeccc-----c-----ChHHHHHHHHHhcCCCCceEEEEEEEeCCeEEEEEEc
Q psy11767 383 AGILGDGSYSVCRRCVEKSTGQEYAVKIISRK-----I-----DCSEEINLLRACQGHPNIVNLHCVFQDEVHTYLVLEL 452 (966)
Q Consensus 383 ~~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~-----~-----~~~~Ei~iL~~l~~HpnIV~l~~~~~~~~~~~lVmEy 452 (966)
.+.||+|+||+|++|.+..+|..||||++.++ . ...+|+.+|+.+..||||+++++++....++|+||||
T Consensus 22 ~~~lG~GsfgkV~~a~~~~t~~~vAiKii~~~~~~~~~~~~~~~i~rEi~~~~~~~~HpnI~~l~ev~~t~~~~~ivmEy 101 (370)
T KOG0583|consen 22 GRTLGSGSFGKVKLAKHRLTGEKVAIKIIDRKKVSSKSQKLDELIKREISILRRLRSHPNIIRLLEVFATPTKIYIVMEY 101 (370)
T ss_pred eeeecCCCCeeEEEeeeccCCCeEEEEEechhcccccccccchhhHHHHHHHHHhccCCCEeEEEEEEecCCeEEEEEEe
Confidence 67899999999999999999999999988764 1 1337999999997799999999999999999999999
Q ss_pred cCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCcEEEecCCCCCEEEEeecccccc---cCCC
Q psy11767 453 LKGGELLDRIRQKGRCGFTENEASRIMRQLVAAVHFMHSRGVVHRDLKPENLLFSDPAGDNIKVVDFGFACLK---RESL 529 (966)
Q Consensus 453 ~~gg~L~~~l~~~~~~~l~e~~~~~i~~Qil~aL~yLHs~~IiHRDLKP~NILl~~~~~~~iKL~DFGla~~~---~~~~ 529 (966)
|.||+|++++.+.+ .+.|.+++.+|+||++||+|||++||+||||||+|||++... +++||+|||++... ....
T Consensus 102 ~~gGdL~~~i~~~g--~l~E~~ar~~F~Qlisav~y~H~~gi~HRDLK~ENilld~~~-~~~Kl~DFG~s~~~~~~~~~l 178 (370)
T KOG0583|consen 102 CSGGDLFDYIVNKG--RLKEDEARKYFRQLISAVAYCHSRGIVHRDLKPENILLDGNE-GNLKLSDFGLSAISPGEDGLL 178 (370)
T ss_pred cCCccHHHHHHHcC--CCChHHHHHHHHHHHHHHHHHHhCCEeeCCCCHHHEEecCCC-CCEEEeccccccccCCCCCcc
Confidence 99999999999855 699999999999999999999999999999999999998642 79999999999876 3457
Q ss_pred ccccccccccCchhhccCCCCCCCcccchhhhhhhhhhhhcCCCCC-CCcCcchhHHHHHHHHhcCCCCCCCCCCchhHH
Q psy11767 530 HTPCFTLQYAAPEVLRQDKSGYDENCDLWSLGVILVNVLRQDKSGY-DENCDLWSLGVILYTMLCGRVPFHARSRDDSAL 608 (966)
Q Consensus 530 ~~~~gT~~Y~APEvl~~~~~~~~~~~Di~SlGvil~el~~~~~~~y-~~~~DIWSlGvilyemltG~~Pf~~~~~~~~~~ 608 (966)
.+.|||+.|+|||++.... .| +.++||||+||+||.|++|+.||+..+ ..
T Consensus 179 ~t~cGsp~Y~aPEvl~~~~-------------------------~Y~g~~aDvWS~GViLy~ml~G~~PF~d~~----~~ 229 (370)
T KOG0583|consen 179 KTFCGSPAYAAPEVLSGKG-------------------------TYSGKAADVWSLGVILYVLLCGRLPFDDSN----VP 229 (370)
T ss_pred cCCCCCcccCCHHHhCCCC-------------------------CcCCchhhhhhhHHHHHHHHhCCCCCCCcc----HH
Confidence 7899999999999996422 14 468999999999999999999998733 23
Q ss_pred HHHHHHHcCCCCCCchhhccC-CHHHHHHHHHhcccCccccCChHHHHHHhhhhHHh
Q psy11767 609 SIMARIKEGQFNFDAEAWSTV-SSEAKELTKSLLTVNPAQRIRMMRVKLTFHAFHQA 664 (966)
Q Consensus 609 ~~~~~i~~~~~~~~~~~~~~i-s~e~~~Li~~~L~~dP~~R~t~~~v~~~~~~~~~~ 664 (966)
.+..+|..+.+.++.. + |+++++|+.+||..||.+|+|+.++. .|+|++.
T Consensus 230 ~l~~ki~~~~~~~p~~----~~S~~~~~Li~~mL~~~P~~R~t~~~i~--~h~w~~~ 280 (370)
T KOG0583|consen 230 NLYRKIRKGEFKIPSY----LLSPEARSLIEKMLVPDPSTRITLLEIL--EHPWFQK 280 (370)
T ss_pred HHHHHHhcCCccCCCC----cCCHHHHHHHHHHcCCCcccCCCHHHHh--hChhhcc
Confidence 4566789998887643 4 99999999999999999999999875 6777654
|
|
| >KOG0033|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-47 Score=391.13 Aligned_cols=254 Identities=42% Similarity=0.725 Sum_probs=221.4
Q ss_pred ceecccccccccccccccccccEEEEEEEcCCCcEEEEEEecccc-------ChHHHHHHHHHhcCCCCceEEEEEEEeC
Q psy11767 371 LFFEQYDMDLDKAGILGDGSYSVCRRCVEKSTGQEYAVKIISRKI-------DCSEEINLLRACQGHPNIVNLHCVFQDE 443 (966)
Q Consensus 371 ~~~~~~~i~~~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~-------~~~~Ei~iL~~l~~HpnIV~l~~~~~~~ 443 (966)
.|-++|++ -.+||+|.|+.||+|.+..||+.+|+|++..+. +..+|+.|-+.++ |||||+|++.+..+
T Consensus 8 ~f~d~y~l----~e~igkG~FSvVrRc~~~~tg~~fa~kiin~~k~~~~~~e~l~rEarIC~~Lq-HP~IvrL~~ti~~~ 82 (355)
T KOG0033|consen 8 KFSDNYDV----KEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQ-HPNIVRLHDSIQEE 82 (355)
T ss_pred ccchhhhH----HHHHccCchHHHHHHHhccchHHHHHHHhhhhhhccccHHHHHHHHHHHHhcC-CCcEeehhhhhccc
Confidence 34456665 468999999999999999999999999986432 3557999999885 99999999999999
Q ss_pred CeEEEEEEccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCcEEEecCC-CCCEEEEeeccc
Q psy11767 444 VHTYLVLELLKGGELLDRIRQKGRCGFTENEASRIMRQLVAAVHFMHSRGVVHRDLKPENLLFSDPA-GDNIKVVDFGFA 522 (966)
Q Consensus 444 ~~~~lVmEy~~gg~L~~~l~~~~~~~l~e~~~~~i~~Qil~aL~yLHs~~IiHRDLKP~NILl~~~~-~~~iKL~DFGla 522 (966)
+..|||+|+|.|++|..-|-++. .++|..+..+++||+.||+|||.+||||||+||+|+||.... +.-+||+|||+|
T Consensus 83 ~~~ylvFe~m~G~dl~~eIV~R~--~ySEa~aSH~~rQiLeal~yCH~n~IvHRDvkP~nllLASK~~~A~vKL~~FGvA 160 (355)
T KOG0033|consen 83 SFHYLVFDLVTGGELFEDIVARE--FYSEADASHCIQQILEALAYCHSNGIVHRDLKPENLLLASKAKGAAVKLADFGLA 160 (355)
T ss_pred ceeEEEEecccchHHHHHHHHHH--HHHHHHHHHHHHHHHHHHHHHHhcCceeccCChhheeeeeccCCCceeecccceE
Confidence 99999999999999988887663 589999999999999999999999999999999999996533 457999999999
Q ss_pred ccccC--CCccccccccccCchhhccCCCCCCCcccchhhhhhhhhhhhcCCCCCCCcCcchhHHHHHHHHhcCCCCCCC
Q psy11767 523 CLKRE--SLHTPCFTLQYAAPEVLRQDKSGYDENCDLWSLGVILVNVLRQDKSGYDENCDLWSLGVILYTMLCGRVPFHA 600 (966)
Q Consensus 523 ~~~~~--~~~~~~gT~~Y~APEvl~~~~~~~~~~~Di~SlGvil~el~~~~~~~y~~~~DIWSlGvilyemltG~~Pf~~ 600 (966)
..... .....+|||+|||||++. +.+|+..+|||+.|||||-||.|.+||.+
T Consensus 161 i~l~~g~~~~G~~GtP~fmaPEvvr--------------------------kdpy~kpvDiW~cGViLfiLL~G~~PF~~ 214 (355)
T KOG0033|consen 161 IEVNDGEAWHGFAGTPGYLSPEVLK--------------------------KDPYSKPVDIWACGVILYILLVGYPPFWD 214 (355)
T ss_pred EEeCCccccccccCCCcccCHHHhh--------------------------cCCCCCcchhhhhhHHHHHHHhCCCCCCC
Confidence 77653 234678999999999996 44588999999999999999999999998
Q ss_pred CCCchhHHHHHHHHHcCCCCCCchhhccCCHHHHHHHHHhcccCccccCChHHHHHHhhhhHH
Q psy11767 601 RSRDDSALSIMARIKEGQFNFDAEAWSTVSSEAKELTKSLLTVNPAQRIRMMRVKLTFHAFHQ 663 (966)
Q Consensus 601 ~~~~~~~~~~~~~i~~~~~~~~~~~~~~is~e~~~Li~~~L~~dP~~R~t~~~v~~~~~~~~~ 663 (966)
.+. ..+.++|+.|.+.+++..|+++++++++|+++||..||.+|+|+.|. ..|+|..
T Consensus 215 ~~~----~rlye~I~~g~yd~~~~~w~~is~~Ak~LvrrML~~dP~kRIta~EA--L~HpWi~ 271 (355)
T KOG0033|consen 215 EDQ----HRLYEQIKAGAYDYPSPEWDTVTPEAKSLIRRMLTVNPKKRITADEA--LKHPWIC 271 (355)
T ss_pred ccH----HHHHHHHhccccCCCCcccCcCCHHHHHHHHHHhccChhhhccHHHH--hCCchhc
Confidence 554 35788999999999999999999999999999999999999999864 4566653
|
|
| >KOG0591|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-46 Score=390.22 Aligned_cols=237 Identities=30% Similarity=0.491 Sum_probs=204.4
Q ss_pred cccccccccccccEEEEEEEcCCCcEEEEEEeccc-------cChHHHHHHHHHhcCCCCceEEEE-EEEeCCe-EEEEE
Q psy11767 380 LDKAGILGDGSYSVCRRCVEKSTGQEYAVKIISRK-------IDCSEEINLLRACQGHPNIVNLHC-VFQDEVH-TYLVL 450 (966)
Q Consensus 380 ~~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~-------~~~~~Ei~iL~~l~~HpnIV~l~~-~~~~~~~-~~lVm 450 (966)
|+.+++||+|+||.||++.+..+|..||.|.+.-. .+...|+.+|++| +|||||++++ .|.+++. ++|||
T Consensus 21 y~Il~~IG~GsFg~vykv~~~~~g~l~a~K~i~f~~md~k~rq~~v~Ei~lLkQL-~HpNIVqYy~~~f~~~~evlnivm 99 (375)
T KOG0591|consen 21 YQILKKIGRGSFGEVYKVQCLLDGKLVALKKIQFGMMDAKARQDCVKEISLLKQL-NHPNIVQYYAHSFIEDNEVLNIVM 99 (375)
T ss_pred HHHHHHHcCCcchheEEeeeccCcchhhhhhcchhhccHHHHHHHHHHHHHHHhc-CCchHHHHHHHhhhccchhhHHHH
Confidence 44478999999999999999999999999988632 2355799999999 5999999998 6766666 89999
Q ss_pred EccCCCCHHHHHHh--cCCCCCCHHHHHHHHHHHHHHHHHHHh--cC--ceeccCCCCcEEEecCCCCCEEEEeeccccc
Q psy11767 451 ELLKGGELLDRIRQ--KGRCGFTENEASRIMRQLVAAVHFMHS--RG--VVHRDLKPENLLFSDPAGDNIKVVDFGFACL 524 (966)
Q Consensus 451 Ey~~gg~L~~~l~~--~~~~~l~e~~~~~i~~Qil~aL~yLHs--~~--IiHRDLKP~NILl~~~~~~~iKL~DFGla~~ 524 (966)
|||.+|||.+.|+. +.+..++|..+++++.|+|.||..||+ .. |+||||||.||.|+. +|.+||+||||++.
T Consensus 100 E~c~~GDLsqmIk~~K~qkr~ipE~~Vwk~f~QL~~AL~~cH~~~~r~~VmHRDIKPaNIFl~~--~gvvKLGDfGL~r~ 177 (375)
T KOG0591|consen 100 ELCDAGDLSQMIKHFKKQKRLIPEKTVWKYFVQLCRALYHCHSKIPRGTVMHRDIKPANIFLTA--NGVVKLGDFGLGRF 177 (375)
T ss_pred HhhcccCHHHHHHHHHhccccCchHHHHHHHHHHHHHHHHHhccccccceeeccCcchheEEcC--CCceeeccchhHhH
Confidence 99999999998864 334469999999999999999999999 45 999999999999984 67999999999988
Q ss_pred ccCC---CccccccccccCchhhccCCCCCCCcccchhhhhhhhhhhhcCCCCCCCcCcchhHHHHHHHHhcCCCCCCCC
Q psy11767 525 KRES---LHTPCFTLQYAAPEVLRQDKSGYDENCDLWSLGVILVNVLRQDKSGYDENCDLWSLGVILYTMLCGRVPFHAR 601 (966)
Q Consensus 525 ~~~~---~~~~~gT~~Y~APEvl~~~~~~~~~~~Di~SlGvil~el~~~~~~~y~~~~DIWSlGvilyemltG~~Pf~~~ 601 (966)
.... .++.+|||.||+||.+.. .+|+.++||||+||++|||+.-++||.+.
T Consensus 178 l~s~~tfA~S~VGTPyYMSPE~i~~--------------------------~~Y~~kSDiWslGCllyEMcaL~~PF~g~ 231 (375)
T KOG0591|consen 178 LSSKTTFAHSLVGTPYYMSPERIHE--------------------------SGYNFKSDIWSLGCLLYEMCALQSPFYGD 231 (375)
T ss_pred hcchhHHHHhhcCCCcccCHHHHhc--------------------------CCCCcchhHHHHHHHHHHHHhcCCCcccc
Confidence 7643 356789999999999963 46899999999999999999999999986
Q ss_pred CCchhHHHHHHHHHcCCCCCCchhhccCCHHHHHHHHHhcccCccccCCh
Q psy11767 602 SRDDSALSIMARIKEGQFNFDAEAWSTVSSEAKELTKSLLTVNPAQRIRM 651 (966)
Q Consensus 602 ~~~~~~~~~~~~i~~~~~~~~~~~~~~is~e~~~Li~~~L~~dP~~R~t~ 651 (966)
...++..+|.+|++..-+. ...|.++..||..|+..||++||+.
T Consensus 232 ----n~~~L~~KI~qgd~~~~p~--~~YS~~l~~li~~ci~vd~~~RP~t 275 (375)
T KOG0591|consen 232 ----NLLSLCKKIEQGDYPPLPD--EHYSTDLRELINMCIAVDPEQRPDT 275 (375)
T ss_pred ----cHHHHHHHHHcCCCCCCcH--HHhhhHHHHHHHHHccCCcccCCCc
Confidence 3567888999998764332 2478999999999999999999984
|
|
| >KOG0600|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-45 Score=403.17 Aligned_cols=253 Identities=27% Similarity=0.474 Sum_probs=208.8
Q ss_pred eecccccccccccccccccccEEEEEEEcCCCcEEEEEEecccc-------ChHHHHHHHHHhcCCCCceEEEEEEEeC-
Q psy11767 372 FFEQYDMDLDKAGILGDGSYSVCRRCVEKSTGQEYAVKIISRKI-------DCSEEINLLRACQGHPNIVNLHCVFQDE- 443 (966)
Q Consensus 372 ~~~~~~i~~~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~-------~~~~Ei~iL~~l~~HpnIV~l~~~~~~~- 443 (966)
+..+....|+++++||+|+||.||+|++..||+.||+|.+.-.. ...+||.||+++ +|||||+|.+...+.
T Consensus 111 w~~r~~~~feki~kIGeGTyg~VYkAr~~~tgkivALKKvr~d~~~~~~~~t~~REI~ILr~l-~HpNIikL~eivt~~~ 189 (560)
T KOG0600|consen 111 WGPRRADSFEKIEKIGEGTYGQVYKARDLETGKIVALKKVRFDNEKEGFPITAIREIKILRRL-DHPNIIKLEEIVTSKL 189 (560)
T ss_pred ccccchHHHHHHHHhcCcchhheeEeeecccCcEEEEEEeecccCCCcchHHHHHHHHHHHhc-CCCcccceeeEEEecC
Confidence 33444456777899999999999999999999999999986543 256899999999 599999999998876
Q ss_pred -CeEEEEEEccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCcEEEecCCCCCEEEEeeccc
Q psy11767 444 -VHTYLVLELLKGGELLDRIRQKGRCGFTENEASRIMRQLVAAVHFMHSRGVVHRDLKPENLLFSDPAGDNIKVVDFGFA 522 (966)
Q Consensus 444 -~~~~lVmEy~~gg~L~~~l~~~~~~~l~e~~~~~i~~Qil~aL~yLHs~~IiHRDLKP~NILl~~~~~~~iKL~DFGla 522 (966)
+.+|||+|||+ .||.-++...+ ..|++.+++.|+.||+.||+|||++||+|||||.+||||++ +|.+||+|||||
T Consensus 190 ~~siYlVFeYMd-hDL~GLl~~p~-vkft~~qIKc~mkQLl~Gl~~cH~~gvlHRDIK~SNiLidn--~G~LKiaDFGLA 265 (560)
T KOG0600|consen 190 SGSIYLVFEYMD-HDLSGLLSSPG-VKFTEPQIKCYMKQLLEGLEYCHSRGVLHRDIKGSNILIDN--NGVLKIADFGLA 265 (560)
T ss_pred CceEEEEEeccc-chhhhhhcCCC-cccChHHHHHHHHHHHHHHHHHhhcCeeeccccccceEEcC--CCCEEeccccce
Confidence 78999999995 58877776543 46999999999999999999999999999999999999985 679999999999
Q ss_pred ccccC----CCccccccccccCchhhccCCCCCCCcccchhhhhhhhhhhhcCCCCCCCcCcchhHHHHHHHHhcCCCCC
Q psy11767 523 CLKRE----SLHTPCFTLQYAAPEVLRQDKSGYDENCDLWSLGVILVNVLRQDKSGYDENCDLWSLGVILYTMLCGRVPF 598 (966)
Q Consensus 523 ~~~~~----~~~~~~gT~~Y~APEvl~~~~~~~~~~~Di~SlGvil~el~~~~~~~y~~~~DIWSlGvilyemltG~~Pf 598 (966)
++... ..+..+.|+||+|||+|++ ...|+.++|+||.||||.||++|++.|
T Consensus 266 r~y~~~~~~~~T~rVvTLWYRpPELLLG-------------------------~t~Yg~aVDlWS~GCIl~El~~gkPI~ 320 (560)
T KOG0600|consen 266 RFYTPSGSAPYTSRVVTLWYRPPELLLG-------------------------ATSYGTAVDLWSVGCILAELFLGKPIL 320 (560)
T ss_pred eeccCCCCcccccceEEeeccChHHhcC-------------------------CcccccceeehhhhHHHHHHHcCCCCc
Confidence 86543 3456678999999999963 356999999999999999999999999
Q ss_pred CCCCCchhHHHHHHHHHcC---CCC---CC---------------chhhccCCHHHHHHHHHhcccCccccCChHHH
Q psy11767 599 HARSRDDSALSIMARIKEG---QFN---FD---------------AEAWSTVSSEAKELTKSLLTVNPAQRIRMMRV 654 (966)
Q Consensus 599 ~~~~~~~~~~~~~~~i~~~---~~~---~~---------------~~~~~~is~e~~~Li~~~L~~dP~~R~t~~~v 654 (966)
.+.+..++...++...... .|. ++ .+.+..+++.+.+|+..||.+||.+|.|+.++
T Consensus 321 ~G~tEveQl~kIfklcGSP~e~~W~~~kLP~~~~~kp~~~y~r~l~E~~~~~~~~~l~Ll~~lL~ldP~kR~tA~~a 397 (560)
T KOG0600|consen 321 QGRTEVEQLHKIFKLCGSPTEDYWPVSKLPHATIFKPQQPYKRRLRETFKDFPASALDLLEKLLSLDPDKRGTASSA 397 (560)
T ss_pred CCccHHHHHHHHHHHhCCCChhccccccCCcccccCCCCcccchHHHHhccCCHHHHHHHHHHhccCccccccHHHH
Confidence 9988766655544322110 010 00 12345678999999999999999999999875
|
|
| >KOG0661|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-45 Score=405.83 Aligned_cols=258 Identities=32% Similarity=0.507 Sum_probs=216.9
Q ss_pred ceecccccccccccccccccccEEEEEEEcCCCcEEEEEEeccccC------hHHHHHHHHHhcCCCCceEEEEEEEeCC
Q psy11767 371 LFFEQYDMDLDKAGILGDGSYSVCRRCVEKSTGQEYAVKIISRKID------CSEEINLLRACQGHPNIVNLHCVFQDEV 444 (966)
Q Consensus 371 ~~~~~~~i~~~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~~------~~~Ei~iL~~l~~HpnIV~l~~~~~~~~ 444 (966)
.+.++|.+ ++.||.|+||.||+|+.+.+|..||||.++++.. ..||++.|+++..|||||+|++++.+..
T Consensus 7 ~~m~RY~~----i~klGDGTfGsV~la~~~~~~~~VAIK~MK~Kf~s~ee~~nLREvksL~kln~hpniikL~Evi~d~~ 82 (538)
T KOG0661|consen 7 IFMDRYTV----IRKLGDGTFGSVYLAKSKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNPHPNIIKLKEVIRDND 82 (538)
T ss_pred hHHHHHHH----HHHhcCCcceeEEEeeecCCCceeeHHHHHhhhccHHHHHHHHHHHHHHhcCCCCcchhhHHHhhccC
Confidence 35567766 7899999999999999999999999999987753 4579999999967999999999999888
Q ss_pred -eEEEEEEccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCcEEEecCCCCCEEEEeecccc
Q psy11767 445 -HTYLVLELLKGGELLDRIRQKGRCGFTENEASRIMRQLVAAVHFMHSRGVVHRDLKPENLLFSDPAGDNIKVVDFGFAC 523 (966)
Q Consensus 445 -~~~lVmEy~~gg~L~~~l~~~~~~~l~e~~~~~i~~Qil~aL~yLHs~~IiHRDLKP~NILl~~~~~~~iKL~DFGla~ 523 (966)
.+|+|||||+ .+|++.++.+ ...|++..++.|++||+.||+|+|.+|+.||||||||||+.. ...|||+|||||+
T Consensus 83 ~~L~fVfE~Md-~NLYqLmK~R-~r~fse~~irnim~QilqGL~hiHk~GfFHRDlKPENiLi~~--~~~iKiaDFGLAR 158 (538)
T KOG0661|consen 83 RILYFVFEFMD-CNLYQLMKDR-NRLFSESDIRNIMYQILQGLAHIHKHGFFHRDLKPENILISG--NDVIKIADFGLAR 158 (538)
T ss_pred ceEeeeHHhhh-hhHHHHHhhc-CCcCCHHHHHHHHHHHHHHHHHHHhcCcccccCChhheEecc--cceeEeccccccc
Confidence 9999999995 6999999888 458999999999999999999999999999999999999974 4589999999998
Q ss_pred ccc--CCCccccccccccCchhhccCCCCCCCcccchhhhhhhhhhhhcCCCCCCCcCcchhHHHHHHHHhcCCCCCCCC
Q psy11767 524 LKR--ESLHTPCFTLQYAAPEVLRQDKSGYDENCDLWSLGVILVNVLRQDKSGYDENCDLWSLGVILYTMLCGRVPFHAR 601 (966)
Q Consensus 524 ~~~--~~~~~~~gT~~Y~APEvl~~~~~~~~~~~Di~SlGvil~el~~~~~~~y~~~~DIWSlGvilyemltG~~Pf~~~ 601 (966)
... ...+..+-|.||+|||+|... ..|+.++||||+|||++|+++-++-|.|.
T Consensus 159 ev~SkpPYTeYVSTRWYRAPEvLLrs-------------------------~~Ys~pvD~wA~GcI~aEl~sLrPLFPG~ 213 (538)
T KOG0661|consen 159 EVRSKPPYTEYVSTRWYRAPEVLLRS-------------------------GYYSSPVDMWAVGCIMAELYSLRPLFPGA 213 (538)
T ss_pred ccccCCCcchhhhcccccchHHhhhc-------------------------cccCCchHHHHHHHHHHHHHHhcccCCCC
Confidence 764 345667889999999999742 34899999999999999999999999999
Q ss_pred CCchhHHHHHHHHHcCC---------------CCCC-------chhhccCCHHHHHHHHHhcccCccccCChHHHHHHhh
Q psy11767 602 SRDDSALSIMARIKEGQ---------------FNFD-------AEAWSTVSSEAKELTKSLLTVNPAQRIRMMRVKLTFH 659 (966)
Q Consensus 602 ~~~~~~~~~~~~i~~~~---------------~~~~-------~~~~~~is~e~~~Li~~~L~~dP~~R~t~~~v~~~~~ 659 (966)
+.-|+...+.+-+.... +.++ ....+..++++.+||.+||.+||++|||+.+. ..|
T Consensus 214 sE~Dqi~KIc~VLGtP~~~~~~eg~~La~~mnf~~P~~~~~~l~~L~p~~s~~~~~li~~ll~WDP~kRpTA~~a--l~~ 291 (538)
T KOG0661|consen 214 SEIDQIYKICEVLGTPDKDSWPEGYNLASAMNFRFPQVKPSPLKDLLPNASSEAASLIERLLAWDPDKRPTASQA--LQH 291 (538)
T ss_pred cHHHHHHHHHHHhCCCccccchhHHHHHHHhccCCCcCCCCChHHhCcccCHHHHHHHHHHhcCCCccCccHHHH--hcC
Confidence 88777666554432211 1111 12234579999999999999999999999865 446
Q ss_pred hhHH
Q psy11767 660 AFHQ 663 (966)
Q Consensus 660 ~~~~ 663 (966)
+|++
T Consensus 292 pffq 295 (538)
T KOG0661|consen 292 PFFQ 295 (538)
T ss_pred cccc
Confidence 6664
|
|
| >KOG0694|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-45 Score=417.12 Aligned_cols=257 Identities=30% Similarity=0.536 Sum_probs=216.3
Q ss_pred ccccccccccccccEEEEEEEcCCCcEEEEEEeccccC--------hHHHHHHHHHhcCCCCceEEEEEEEeCCeEEEEE
Q psy11767 379 DLDKAGILGDGSYSVCRRCVEKSTGQEYAVKIISRKID--------CSEEINLLRACQGHPNIVNLHCVFQDEVHTYLVL 450 (966)
Q Consensus 379 ~~~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~~--------~~~Ei~iL~~l~~HpnIV~l~~~~~~~~~~~lVm 450 (966)
+|..+++||+|+||+|++|..+.+++.||||++++..- ...|-+|++...+||.+++|+.+|++..++|+||
T Consensus 369 ~F~~l~vLGkGsFGkV~lae~k~~~e~yAIK~LKK~~Il~~d~Ve~~~~EkrI~~la~~HPFL~~L~~~fQT~~~l~fvm 448 (694)
T KOG0694|consen 369 DFRLLAVLGRGSFGKVLLAELKGTNEYYAIKVLKKGDILQRDEVESLMCEKRIFELANRHPFLVNLFSCFQTKEHLFFVM 448 (694)
T ss_pred ceEEEEEeccCcCceEEEEEEcCCCcEEEEEEeeccceeccccHHHHHHHHHHHHHhccCCeEeecccccccCCeEEEEE
Confidence 34557999999999999999999999999999987531 3458888888778999999999999999999999
Q ss_pred EccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCcEEEecCCCCCEEEEeecccccc---cC
Q psy11767 451 ELLKGGELLDRIRQKGRCGFTENEASRIMRQLVAAVHFMHSRGVVHRDLKPENLLFSDPAGDNIKVVDFGFACLK---RE 527 (966)
Q Consensus 451 Ey~~gg~L~~~l~~~~~~~l~e~~~~~i~~Qil~aL~yLHs~~IiHRDLKP~NILl~~~~~~~iKL~DFGla~~~---~~ 527 (966)
||+.|||+..+.+. ..|++..++.|+.+|+.||+|||++|||+||||.+||||+. .|++||+||||++.. +.
T Consensus 449 ey~~Ggdm~~~~~~---~~F~e~rarfyaAev~l~L~fLH~~~IIYRDlKLdNiLLD~--eGh~kiADFGlcKe~m~~g~ 523 (694)
T KOG0694|consen 449 EYVAGGDLMHHIHT---DVFSEPRARFYAAEVVLGLQFLHENGIIYRDLKLDNLLLDT--EGHVKIADFGLCKEGMGQGD 523 (694)
T ss_pred EecCCCcEEEEEec---ccccHHHHHHHHHHHHHHHHHHHhcCceeeecchhheEEcc--cCcEEecccccccccCCCCC
Confidence 99999995444332 25999999999999999999999999999999999999984 679999999999864 34
Q ss_pred CCccccccccccCchhhccCCCCCCCcccchhhhhhhhhhhhcCCCCCCCcCcchhHHHHHHHHhcCCCCCCCCCCchhH
Q psy11767 528 SLHTPCFTLQYAAPEVLRQDKSGYDENCDLWSLGVILVNVLRQDKSGYDENCDLWSLGVILYTMLCGRVPFHARSRDDSA 607 (966)
Q Consensus 528 ~~~~~~gT~~Y~APEvl~~~~~~~~~~~Di~SlGvil~el~~~~~~~y~~~~DIWSlGvilyemltG~~Pf~~~~~~~~~ 607 (966)
.+.|.||||.|||||++.. ..|+.++|+|||||+|||||+|..||.+.+.+
T Consensus 524 ~TsTfCGTpey~aPEil~e--------------------------~~Yt~aVDWW~lGVLlyeML~Gq~PF~gddEe--- 574 (694)
T KOG0694|consen 524 RTSTFCGTPEFLAPEVLTE--------------------------QSYTRAVDWWGLGVLLYEMLVGESPFPGDDEE--- 574 (694)
T ss_pred ccccccCChhhcChhhhcc--------------------------CcccchhhHHHHHHHHHHHHcCCCCCCCCCHH---
Confidence 6778999999999999964 34899999999999999999999999987654
Q ss_pred HHHHHHHHcCCCCCCchhhccCCHHHHHHHHHhcccCccccCChH---HHHHHhhhhHHhhhccccccccchHHHHHhh
Q psy11767 608 LSIMARIKEGQFNFDAEAWSTVSSEAKELTKSLLTVNPAQRIRMM---RVKLTFHAFHQAQKEGFRLQDVTSAKLAQRR 683 (966)
Q Consensus 608 ~~~~~~i~~~~~~~~~~~~~~is~e~~~Li~~~L~~dP~~R~t~~---~v~~~~~~~~~~~~~~~~~~~~~~~~l~~~~ 683 (966)
++++.|...++.++. .+|.|+.++|+++|+.||++|+.+. +-....|||++ .+.+..+.+++
T Consensus 575 -e~FdsI~~d~~~yP~----~ls~ea~~il~~ll~k~p~kRLG~~e~d~~~i~~hpFFr---------~i~w~~L~~r~ 639 (694)
T KOG0694|consen 575 -EVFDSIVNDEVRYPR----FLSKEAIAIMRRLLRKNPEKRLGSGERDAEDIKKHPFFR---------SIDWDDLLNRR 639 (694)
T ss_pred -HHHHHHhcCCCCCCC----cccHHHHHHHHHHhccCcccccCCCCCCchhhhhCCccc---------cCCHHHHhhcc
Confidence 456777766665543 4899999999999999999999873 11345677764 45566666544
|
|
| >KOG0032|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-43 Score=401.40 Aligned_cols=246 Identities=43% Similarity=0.752 Sum_probs=221.1
Q ss_pred ccccccccccEEEEEEEcCCCcEEEEEEecccc--------ChHHHHHHHHHhcCCCCceEEEEEEEeCCeEEEEEEccC
Q psy11767 383 AGILGDGSYSVCRRCVEKSTGQEYAVKIISRKI--------DCSEEINLLRACQGHPNIVNLHCVFQDEVHTYLVLELLK 454 (966)
Q Consensus 383 ~~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~--------~~~~Ei~iL~~l~~HpnIV~l~~~~~~~~~~~lVmEy~~ 454 (966)
.+.||+|.||+||+|+++.||+.+|+|++.+.. ...+|+.+|+.+.+|||||+++++|++...+|+|||+|.
T Consensus 40 ~~~lG~G~Fg~v~~~~~~~tg~~~A~K~i~k~~~~~~~~~~~v~~Ev~il~~l~~hpniv~l~~~~e~~~~~~lvmEL~~ 119 (382)
T KOG0032|consen 40 GRELGRGQFGVVYLCREKSTGKEVACKVIPKRKLRGKEDREDVRREVAILQQLSGHPNIVQLKDAFEDPDSVYLVMELCE 119 (382)
T ss_pred hhhhCCCCceEEEEEEecCCCceeEEEEeehhhccccccHHHHHHHHHHHHhccCCCCEEEEEEEEEcCCeEEEEEEecC
Confidence 478999999999999999999999999997642 356799999999889999999999999999999999999
Q ss_pred CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCcEEEecCCC--CCEEEEeecccccccC--CCc
Q psy11767 455 GGELLDRIRQKGRCGFTENEASRIMRQLVAAVHFMHSRGVVHRDLKPENLLFSDPAG--DNIKVVDFGFACLKRE--SLH 530 (966)
Q Consensus 455 gg~L~~~l~~~~~~~l~e~~~~~i~~Qil~aL~yLHs~~IiHRDLKP~NILl~~~~~--~~iKL~DFGla~~~~~--~~~ 530 (966)
||+|++.|... .++|.++..++.||+.|++|||+.||+||||||+|+|+..... +.+|++|||+|..... ...
T Consensus 120 GGeLfd~i~~~---~~sE~da~~~~~~il~av~~lH~~gvvHrDlKpEN~L~~~~~~~~~~ik~~DFGla~~~~~~~~~~ 196 (382)
T KOG0032|consen 120 GGELFDRIVKK---HYSERDAAGIIRQILEAVKYLHSLGVVHRDLKPENLLLASKDEGSGRIKLIDFGLAKFIKPGERLH 196 (382)
T ss_pred CchHHHHHHHc---cCCHHHHHHHHHHHHHHHHHHHhCCceeccCCHHHeeeccccCCCCcEEEeeCCCceEccCCceEe
Confidence 99999999887 3999999999999999999999999999999999999986543 4799999999987654 567
Q ss_pred cccccccccCchhhccCCCCCCCcccchhhhhhhhhhhhcCCCCCCCcCcchhHHHHHHHHhcCCCCCCCCCCchhHHHH
Q psy11767 531 TPCFTLQYAAPEVLRQDKSGYDENCDLWSLGVILVNVLRQDKSGYDENCDLWSLGVILYTMLCGRVPFHARSRDDSALSI 610 (966)
Q Consensus 531 ~~~gT~~Y~APEvl~~~~~~~~~~~Di~SlGvil~el~~~~~~~y~~~~DIWSlGvilyemltG~~Pf~~~~~~~~~~~~ 610 (966)
..|||+.|+|||++.. .+|+..+||||+||++|.|++|.+||.+.+.. ..
T Consensus 197 ~~~Gtp~y~APEvl~~--------------------------~~y~~~~DiWS~Gvi~yiLL~G~~PF~~~~~~----~~ 246 (382)
T KOG0032|consen 197 TIVGTPEYVAPEVLGG--------------------------RPYGDEVDVWSIGVILYILLSGVPPFWGETEF----EI 246 (382)
T ss_pred eecCCccccCchhhcC--------------------------CCCCcccchhHHHHHHHHHhhCCCCCcCCChh----HH
Confidence 8899999999999852 35889999999999999999999999987654 34
Q ss_pred HHHHHcCCCCCCchhhccCCHHHHHHHHHhcccCccccCChHHHHHHhhhhHH
Q psy11767 611 MARIKEGQFNFDAEAWSTVSSEAKELTKSLLTVNPAQRIRMMRVKLTFHAFHQ 663 (966)
Q Consensus 611 ~~~i~~~~~~~~~~~~~~is~e~~~Li~~~L~~dP~~R~t~~~v~~~~~~~~~ 663 (966)
...|..+.+.+..+.|+.+|..++++|++||..||.+|+|+.++. .|||..
T Consensus 247 ~~~i~~~~~~f~~~~w~~is~~akd~i~~ll~~dp~~R~ta~~~L--~HpWi~ 297 (382)
T KOG0032|consen 247 FLAILRGDFDFTSEPWDDISESAKDFIRKLLEFDPRKRLTAAQAL--QHPWIK 297 (382)
T ss_pred HHHHHcCCCCCCCCCccccCHHHHHHHHHhcccCcccCCCHHHHh--cCcccc
Confidence 458899999999999999999999999999999999999998763 367743
|
|
| >KOG0597|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-44 Score=399.57 Aligned_cols=241 Identities=34% Similarity=0.556 Sum_probs=209.3
Q ss_pred ccccccccccEEEEEEEcCCCcEEEEEEeccccC-------hHHHHHHHHHhcCCCCceEEEEEEEeCCeEEEEEEccCC
Q psy11767 383 AGILGDGSYSVCRRCVEKSTGQEYAVKIISRKID-------CSEEINLLRACQGHPNIVNLHCVFQDEVHTYLVLELLKG 455 (966)
Q Consensus 383 ~~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~~-------~~~Ei~iL~~l~~HpnIV~l~~~~~~~~~~~lVmEy~~g 455 (966)
...||+|+||.||+|+.+.|.+.||||.+.+... ..+|++|++.++ |||||.+++.|++..++|+|.|||.|
T Consensus 7 ~e~iG~Gsfg~VYKgrrK~t~~~vAik~i~K~gr~~k~l~~l~~ev~i~r~lk-Hpniv~m~esfEt~~~~~vVte~a~g 85 (808)
T KOG0597|consen 7 YEMIGEGSFGRVYKGRRKYTIQVVAIKFIDKSGRNEKELKNLRQEVRILRSLK-HPNIVEMLESFETSAHLWVVTEYAVG 85 (808)
T ss_pred HHHhcCCccceeeecccccceeEEEEEEehhcCCchHHHHHHHHHHHHHHhcC-CcchhhHHHhhcccceEEEEehhhhh
Confidence 5679999999999999999999999999976432 457999999995 99999999999999999999999976
Q ss_pred CCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCcEEEecCCCCCEEEEeecccccccCC---Cccc
Q psy11767 456 GELLDRIRQKGRCGFTENEASRIMRQLVAAVHFMHSRGVVHRDLKPENLLFSDPAGDNIKVVDFGFACLKRES---LHTP 532 (966)
Q Consensus 456 g~L~~~l~~~~~~~l~e~~~~~i~~Qil~aL~yLHs~~IiHRDLKP~NILl~~~~~~~iKL~DFGla~~~~~~---~~~~ 532 (966)
+|+.+|...+ .|+|+.++.|++|+++||.|||+.+|+|||+||.|||++. ++.+|+||||+|+..... ....
T Consensus 86 -~L~~il~~d~--~lpEe~v~~~a~~LVsaL~yLhs~rilhrd~kPqniLl~~--~~~~KlcdFg~Ar~m~~~t~vltsi 160 (808)
T KOG0597|consen 86 -DLFTILEQDG--KLPEEQVRAIAYDLVSALYYLHSNRILHRDMKPQNILLEK--GGTLKLCDFGLARAMSTNTSVLTSI 160 (808)
T ss_pred -hHHHHHHhcc--CCCHHHHHHHHHHHHHHHHHHHhcCcccccCCcceeeecC--CCceeechhhhhhhcccCceeeeec
Confidence 9999998776 5999999999999999999999999999999999999984 679999999999876542 2345
Q ss_pred cccccccCchhhccCCCCCCCcccchhhhhhhhhhhhcCCCCCCCcCcchhHHHHHHHHhcCCCCCCCCCCchhHHHHHH
Q psy11767 533 CFTLQYAAPEVLRQDKSGYDENCDLWSLGVILVNVLRQDKSGYDENCDLWSLGVILYTMLCGRVPFHARSRDDSALSIMA 612 (966)
Q Consensus 533 ~gT~~Y~APEvl~~~~~~~~~~~Di~SlGvil~el~~~~~~~y~~~~DIWSlGvilyemltG~~Pf~~~~~~~~~~~~~~ 612 (966)
.|||.|||||++.. ..|+..+|+||||||+|||.+|++||...+ ..++..
T Consensus 161 kGtPlYmAPElv~e--------------------------~pyd~~sDlWslGcilYE~~~G~PPF~a~s----i~~Lv~ 210 (808)
T KOG0597|consen 161 KGTPLYMAPELVEE--------------------------QPYDHTSDLWSLGCILYELYVGQPPFYARS----ITQLVK 210 (808)
T ss_pred cCcccccCHHHHcC--------------------------CCccchhhHHHHHHHHHHHhcCCCCchHHH----HHHHHH
Confidence 79999999999863 347888999999999999999999998643 455666
Q ss_pred HHHcCCCCCCchhhccCCHHHHHHHHHhcccCccccCChHHHHHHhhhhHHhh
Q psy11767 613 RIKEGQFNFDAEAWSTVSSEAKELTKSLLTVNPAQRIRMMRVKLTFHAFHQAQ 665 (966)
Q Consensus 613 ~i~~~~~~~~~~~~~~is~e~~~Li~~~L~~dP~~R~t~~~v~~~~~~~~~~~ 665 (966)
.|......++ .++|.+++.|++.+|.+||.+|+|+.++ ..|+|++..
T Consensus 211 ~I~~d~v~~p----~~~S~~f~nfl~gLL~kdP~~RltW~~L--l~HpF~k~~ 257 (808)
T KOG0597|consen 211 SILKDPVKPP----STASSSFVNFLQGLLIKDPAQRLTWTDL--LGHPFWKGK 257 (808)
T ss_pred HHhcCCCCCc----ccccHHHHHHHHHHhhcChhhcccHHHH--hcChHHhhh
Confidence 7766554433 3789999999999999999999999864 678887543
|
|
| >KOG0659|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-43 Score=365.78 Aligned_cols=245 Identities=29% Similarity=0.450 Sum_probs=204.5
Q ss_pred cccccccccccccEEEEEEEcCCCcEEEEEEecccc-------ChHHHHHHHHHhcCCCCceEEEEEEEeCCeEEEEEEc
Q psy11767 380 LDKAGILGDGSYSVCRRCVEKSTGQEYAVKIISRKI-------DCSEEINLLRACQGHPNIVNLHCVFQDEVHTYLVLEL 452 (966)
Q Consensus 380 ~~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~-------~~~~Ei~iL~~l~~HpnIV~l~~~~~~~~~~~lVmEy 452 (966)
|..++.||+|.||+||+|++..||+.||||.|+... .+.+||+.|+.+. |+|||.|+++|-+.+.+.||+||
T Consensus 4 Y~~~~~lGEG~~gvVyka~d~~t~~~VAIKKIkl~~~kdGi~~talREIK~Lqel~-h~nIi~LiD~F~~~~~l~lVfEf 82 (318)
T KOG0659|consen 4 YEKLEKLGEGTYGVVYKARDTETGKRVAIKKIKLGNAKDGINRTALREIKLLQELK-HPNIIELIDVFPHKSNLSLVFEF 82 (318)
T ss_pred hhhhhhhcCcceEEEEEEEecCCCcEEEEEEeeccccccCccHHHHHHHHHHHHcc-CcchhhhhhhccCCCceEEEEEe
Confidence 345788999999999999999999999999997432 3678999999995 99999999999999999999999
Q ss_pred cCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCcEEEecCCCCCEEEEeecccccccCC---C
Q psy11767 453 LKGGELLDRIRQKGRCGFTENEASRIMRQLVAAVHFMHSRGVVHRDLKPENLLFSDPAGDNIKVVDFGFACLKRES---L 529 (966)
Q Consensus 453 ~~gg~L~~~l~~~~~~~l~e~~~~~i~~Qil~aL~yLHs~~IiHRDLKP~NILl~~~~~~~iKL~DFGla~~~~~~---~ 529 (966)
|+ .+|+..|+.+.. .|+..+++.|+.|+++||+|||++.|+||||||.|+|++. +|.+||+|||+|+..... .
T Consensus 83 m~-tdLe~vIkd~~i-~l~pa~iK~y~~m~LkGl~y~H~~~IlHRDlKPnNLLis~--~g~lKiADFGLAr~f~~p~~~~ 158 (318)
T KOG0659|consen 83 MP-TDLEVVIKDKNI-ILSPADIKSYMLMTLKGLAYCHSKWILHRDLKPNNLLISS--DGQLKIADFGLARFFGSPNRIQ 158 (318)
T ss_pred cc-ccHHHHhccccc-ccCHHHHHHHHHHHHHHHHHHHhhhhhcccCCccceEEcC--CCcEEeecccchhccCCCCccc
Confidence 95 689988877654 7999999999999999999999999999999999999985 679999999999987643 2
Q ss_pred ccccccccccCchhhccCCCCCCCcccchhhhhhhhhhhhcCCCCCCCcCcchhHHHHHHHHhcCCCCCCCCCCchhHHH
Q psy11767 530 HTPCFTLQYAAPEVLRQDKSGYDENCDLWSLGVILVNVLRQDKSGYDENCDLWSLGVILYTMLCGRVPFHARSRDDSALS 609 (966)
Q Consensus 530 ~~~~gT~~Y~APEvl~~~~~~~~~~~Di~SlGvil~el~~~~~~~y~~~~DIWSlGvilyemltG~~Pf~~~~~~~~~~~ 609 (966)
...+.|.+|+|||++.+ ...|+..+||||.|||+.||+.|.+-|.+.++-++...
T Consensus 159 ~~~V~TRWYRAPELLfG-------------------------sr~Yg~~VDmWavGCI~AELllr~P~fpG~sDidQL~~ 213 (318)
T KOG0659|consen 159 THQVVTRWYRAPELLFG-------------------------SRQYGTGVDMWAVGCIFAELLLRVPFFPGDSDIDQLSK 213 (318)
T ss_pred ccceeeeeccChHHhcc-------------------------chhcCCcchhhhHHHHHHHHHccCCCCCCCchHHHHHH
Confidence 23368999999999863 34588999999999999999999999988877665544
Q ss_pred HHHHHHcCC---C---------------CCC--chhhccCCHHHHHHHHHhcccCccccCChHHH
Q psy11767 610 IMARIKEGQ---F---------------NFD--AEAWSTVSSEAKELTKSLLTVNPAQRIRMMRV 654 (966)
Q Consensus 610 ~~~~i~~~~---~---------------~~~--~~~~~~is~e~~~Li~~~L~~dP~~R~t~~~v 654 (966)
++..+.... | ..+ ...++..++++.||+.+||.+||.+|+|+.++
T Consensus 214 If~~LGTP~~~~WP~~~~lpdY~~~~~~P~~~~~~lf~aas~d~ldLl~~m~~ynP~~Rita~qa 278 (318)
T KOG0659|consen 214 IFRALGTPTPDQWPEMTSLPDYVKIQQFPKPPLNNLFPAASSDALDLLSKMLTYNPKKRITASQA 278 (318)
T ss_pred HHHHcCCCCcccCccccccccHHHHhcCCCCccccccccccHHHHHHHHhhhccCchhcccHHHH
Confidence 444322111 0 000 11345578899999999999999999999875
|
|
| >KOG0696|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-44 Score=389.28 Aligned_cols=234 Identities=24% Similarity=0.405 Sum_probs=207.4
Q ss_pred CcceeeeecccccceEEEEEEcCCCCEEEEEeccccch--------hhHHHHHHHHhhCCCcccc---------------
Q psy11767 117 DLDKAGILGDGSYSVCRRCVEKSTGQEYAVKIISRKID--------CSEEINLLRACQGHPNICR--------------- 173 (966)
Q Consensus 117 df~~~~~LG~GsFGkV~La~~k~tg~~yAiKvl~K~~~--------~~~E~~il~~~~~~pfi~~--------------- 173 (966)
||+|+.|||+||||||+||..|.|.++||||||+|..+ .+.|+.+|....+-||++.
T Consensus 350 DFnFl~VlGKGSFGKVlLaerkgtdELyAiKiLkKDViiQdDDvectm~EKrvLAL~~kppFL~qlHScFQTmDRLyFVM 429 (683)
T KOG0696|consen 350 DFNFLMVLGKGSFGKVLLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLVQLHSCFQTMDRLYFVM 429 (683)
T ss_pred ccceEEEeccCccceeeeecccCcchhhhhhhhccceeeecCcccceehhhhheecCCCCchHHHHHHHhhhhhheeeEE
Confidence 99999999999999999999999999999999999742 3789999999889999976
Q ss_pred ---------------cccccccchhHHHHHHHhh----------cccchhhhHhhhccCCceEEecCccc----------
Q psy11767 174 ---------------RCVEKSTGQEYAVKIISRK----------IDCSEEINLLRACQGHPNIVNLHCVF---------- 218 (966)
Q Consensus 174 ---------------~~~~~~~~~~~~~~~v~~~----------~~~~~e~nil~~~~gh~~iv~l~~~~---------- 218 (966)
+.|-+..+-||+++|.... .|++ ..|+|+|.+||.+|+||+...
T Consensus 430 EyvnGGDLMyhiQQ~GkFKEp~AvFYAaEiaigLFFLh~kgIiYRDLK-LDNvmLd~eGHiKi~DFGmcKEni~~~~TTk 508 (683)
T KOG0696|consen 430 EYVNGGDLMYHIQQVGKFKEPVAVFYAAEIAIGLFFLHSKGIIYRDLK-LDNVMLDSEGHIKIADFGMCKENIFDGVTTK 508 (683)
T ss_pred EEecCchhhhHHHHhcccCCchhhhhhHHHHHHhhhhhcCCeeeeecc-ccceEeccCCceEeeecccccccccCCccee
Confidence 3445555567776553321 1332 339999999999999998543
Q ss_pred ---------cccccccccCCCcceeeechhhHHHHHHHhhCCCCCCCCcHHHHHHHHHhCCCCCCCCCCHHHHHHHHhhc
Q psy11767 219 ---------QDEVIDWDDFSRGIECVFFSSSLIIFFIILSFTLSFIHDYYHIQYRRILKTEPPIPEDLSPDVADFISRLL 289 (966)
Q Consensus 219 ---------~~e~i~~~~y~~~~d~~~~~~~~il~~~m~~g~~pf~~~~~~~~~~~I~~~~~~~P~~~s~~a~dli~~LL 289 (966)
++|+|.+..||+++| ||+.|||+|||+.|.|||..++.+++|+.|+...+.||.++|.+|.+++++||
T Consensus 509 TFCGTPdYiAPEIi~YqPYgksvD---WWa~GVLLyEmlaGQpPFdGeDE~elF~aI~ehnvsyPKslSkEAv~ickg~l 585 (683)
T KOG0696|consen 509 TFCGTPDYIAPEIIAYQPYGKSVD---WWAFGVLLYEMLAGQPPFDGEDEDELFQAIMEHNVSYPKSLSKEAVAICKGLL 585 (683)
T ss_pred eecCCCcccccceEEecccccchh---HHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHccCcCcccccHHHHHHHHHHh
Confidence 468999999999998 66888999999999999999999999999999999999999999999999999
Q ss_pred ccCCCcccCCCCCCHHHHhcCCceeeeCccccccCCCCCCCCccccccccccccccccccCcCCC
Q psy11767 290 VKDPRRRLGGGELDAEELKRHPFFNVIDWDDLATKRIPAPFVPKISNELDVSNFSDEFTKMIPAD 354 (966)
Q Consensus 290 ~kdp~~RLG~~~~g~~~Ik~HpfF~~idW~~l~~k~~~pP~~P~i~~~~D~snFd~ef~~~~p~d 354 (966)
.|.|.+|||+|..|..+|+.||||+.|||+++++++|+|||.|++....+.+|||..|+...+.-
T Consensus 586 tK~P~kRLGcg~~ge~di~~H~FFR~iDWek~E~~eiqPPfkPk~k~~r~~eNFD~~Ft~~~~~l 650 (683)
T KOG0696|consen 586 TKHPGKRLGCGPEGERDIREHPFFRRIDWEKLERREIQPPFKPKIKCGRDAENFDKFFTREPTDL 650 (683)
T ss_pred hcCCccccCCCCccccchhhCcchhhccHHHHhhccCCCCCCCccccCCchhhhhHHHhcCCCCC
Confidence 99999999999999999999999999999999999999999999999999999999998765543
|
|
| >KOG0605|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-44 Score=399.98 Aligned_cols=222 Identities=32% Similarity=0.552 Sum_probs=190.8
Q ss_pred CcceeeeecccccceEEEEEEcCCCCEEEEEecccc--------chhhHHHHHHHHhhCCCccccccccccc--------
Q psy11767 117 DLDKAGILGDGSYSVCRRCVEKSTGQEYAVKIISRK--------IDCSEEINLLRACQGHPNICRRCVEKST-------- 180 (966)
Q Consensus 117 df~~~~~LG~GsFGkV~La~~k~tg~~yAiKvl~K~--------~~~~~E~~il~~~~~~pfi~~~~~~~~~-------- 180 (966)
||+++++||+|+||.|+|||.|+||++||||+|+|. .|+..||+||.. .++||||+.+.+|+.
T Consensus 142 DFe~Lk~IgkGAfGeVrLarKk~Tg~iyAmK~LkKS~M~~~~Qv~hV~aERdiL~~-~ds~~vVKLyYsFQD~~~LYLiM 220 (550)
T KOG0605|consen 142 DFELLKVIGKGAFGEVRLARKKDTGEIYAMKILKKSEMLKKNQVEHVRAERDILAE-VDSPWVVKLYYSFQDKEYLYLIM 220 (550)
T ss_pred cchhheeeccccceeEEEEEEccCCcEEeeecccHHHHHhhhhHHHHHHHHHHhhh-cCCCcEEEEEEEecCCCeeEEEE
Confidence 999999999999999999999999999999999996 378999999999 689999985555554
Q ss_pred ----------------------chhHHHHHHHh--------h--cccchhhhHhhhccCCceEEecCccc----------
Q psy11767 181 ----------------------GQEYAVKIISR--------K--IDCSEEINLLRACQGHPNIVNLHCVF---------- 218 (966)
Q Consensus 181 ----------------------~~~~~~~~v~~--------~--~~~~~e~nil~~~~gh~~iv~l~~~~---------- 218 (966)
++||++++|.+ + .|++++ |+|+|..||.+|+||+++.
T Consensus 221 EylPGGD~mTLL~~~~~L~e~~arfYiaE~vlAI~~iH~~gyIHRDIKPd-NlLiD~~GHiKLSDFGLs~gl~~~~~~~~ 299 (550)
T KOG0605|consen 221 EYLPGGDMMTLLMRKDTLTEDWARFYIAETVLAIESIHQLGYIHRDIKPD-NLLIDAKGHIKLSDFGLSTGLDKKHRIES 299 (550)
T ss_pred EecCCccHHHHHHhcCcCchHHHHHHHHHHHHHHHHHHHcCcccccCChh-heeecCCCCEeeccccccchhhhhhhhhh
Confidence 47888877765 1 256666 9999999999999988541
Q ss_pred --------------------------------------------------------cccccccccCCCcceeeechhhHH
Q psy11767 219 --------------------------------------------------------QDEVIDWDDFSRGIECVFFSSSLI 242 (966)
Q Consensus 219 --------------------------------------------------------~~e~i~~~~y~~~~d~~~~~~~~i 242 (966)
++||+...+|++. || ||++|+
T Consensus 300 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~w~~nrr~~a~StVGTPDYiAPEVll~kgY~~~--cD-wWSLG~ 376 (550)
T KOG0605|consen 300 YRLDEQMQINLSEAKPSDFPKFNTPRSTMSRREQLQTWKRNRRQLAYSTVGTPDYIAPEVLLGKGYGKE--CD-WWSLGC 376 (550)
T ss_pred hcchhhhhhhhccCCCccccccccccchhhHHHHHHHHHhhhhhhhhcccCCccccchHHHhcCCCCcc--cc-HHHHHH
Confidence 1245666777554 44 557778
Q ss_pred HHHHHhhCCCCCCCCcHHHHHHHHHhCC--CCCCC--CCCHHHHHHHHhhcccCCCcccCCCCCCHHHHhcCCceeeeCc
Q psy11767 243 IFFIILSFTLSFIHDYYHIQYRRILKTE--PPIPE--DLSPDVADFISRLLVKDPRRRLGGGELDAEELKRHPFFNVIDW 318 (966)
Q Consensus 243 l~~~m~~g~~pf~~~~~~~~~~~I~~~~--~~~P~--~~s~~a~dli~~LL~kdp~~RLG~~~~g~~~Ik~HpfF~~idW 318 (966)
|+||||.|.|||+++++.++|++|++.+ ++||. .+|++|+|||.+||+ ||.+|||+ +|++|||.||||++|||
T Consensus 377 ImyEmLvGyPPF~s~tp~~T~rkI~nwr~~l~fP~~~~~s~eA~DLI~rll~-d~~~RLG~--~G~~EIK~HPfF~~v~W 453 (550)
T KOG0605|consen 377 IMYEMLVGYPPFCSETPQETYRKIVNWRETLKFPEEVDLSDEAKDLITRLLC-DPENRLGS--KGAEEIKKHPFFKGVDW 453 (550)
T ss_pred HHHHHHhCCCCCCCCCHHHHHHHHHHHhhhccCCCcCcccHHHHHHHHHHhc-CHHHhcCc--ccHHHHhcCCccccCCc
Confidence 8899999999999999999999999876 88997 478999999999999 99999994 59999999999999999
Q ss_pred cccccCCCCCCCCcccccccccccccccccc
Q psy11767 319 DDLATKRIPAPFVPKISNELDVSNFSDEFTK 349 (966)
Q Consensus 319 ~~l~~k~~~pP~~P~i~~~~D~snFd~ef~~ 349 (966)
+.|. +.+|||+|.+.++.|+.|||+ |..
T Consensus 454 ~~l~--~~~apfvP~v~~~~DT~yFdd-F~e 481 (550)
T KOG0605|consen 454 DHLR--EMPAPFVPQVNSELDTQYFDD-FPE 481 (550)
T ss_pred chhh--cCCCCCCCCCCCccccccccc-Ccc
Confidence 9995 556999999999999999995 543
|
|
| >KOG0585|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-43 Score=390.35 Aligned_cols=254 Identities=31% Similarity=0.545 Sum_probs=209.4
Q ss_pred ccceecccccccccccccccccccEEEEEEEcCCCcEEEEEEecccc-------------------ChHHHHHHHHHhcC
Q psy11767 369 GSLFFEQYDMDLDKAGILGDGSYSVCRRCVEKSTGQEYAVKIISRKI-------------------DCSEEINLLRACQG 429 (966)
Q Consensus 369 G~~~~~~~~i~~~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~-------------------~~~~Ei~iL~~l~~ 429 (966)
+....++|.+ .+.||+|.||+|.+|++..+++.||||++.+.. ...+||.+|++| .
T Consensus 92 ~~k~lNqy~l----~~eiG~G~yGkVkLar~~~~~~l~AiKil~K~~~~~~~~~~~~~a~~~~~~ekv~~EIailKkl-~ 166 (576)
T KOG0585|consen 92 DRKQLNQYEL----IKEIGSGQYGKVKLARDEVDGKLYAIKILPKKELRRQYGFPRQPAMKLMPIEKVRREIAILKKL-H 166 (576)
T ss_pred cceehhheeh----hhhhcCCccceEEEEeecCCCcEEEEEeechhhhhhhcccccccccccCcHHHHHHHHHHHHhc-C
Confidence 4455566666 688999999999999999999999999997531 245799999999 4
Q ss_pred CCCceEEEEEEEeC--CeEEEEEEccCCCCHHHHHHhcCCCC-CCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCcEEE
Q psy11767 430 HPNIVNLHCVFQDE--VHTYLVLELLKGGELLDRIRQKGRCG-FTENEASRIMRQLVAAVHFMHSRGVVHRDLKPENLLF 506 (966)
Q Consensus 430 HpnIV~l~~~~~~~--~~~~lVmEy~~gg~L~~~l~~~~~~~-l~e~~~~~i~~Qil~aL~yLHs~~IiHRDLKP~NILl 506 (966)
|||||+|+++..+. ..+|||+|||..|.+... ..... |++.+++.|++.++.||+|||.+|||||||||+|+||
T Consensus 167 H~nVV~LiEvLDDP~s~~~YlVley~s~G~v~w~---p~d~~els~~~Ar~ylrDvv~GLEYLH~QgiiHRDIKPsNLLl 243 (576)
T KOG0585|consen 167 HPNVVKLIEVLDDPESDKLYLVLEYCSKGEVKWC---PPDKPELSEQQARKYLRDVVLGLEYLHYQGIIHRDIKPSNLLL 243 (576)
T ss_pred CcCeeEEEEeecCcccCceEEEEEeccCCccccC---CCCcccccHHHHHHHHHHHHHHHHHHHhcCeeccccchhheEE
Confidence 99999999999865 579999999999987532 12224 8999999999999999999999999999999999999
Q ss_pred ecCCCCCEEEEeecccccccC--------CCccccccccccCchhhccCCCCCCCcccchhhhhhhhhhhhcCCCCCCCc
Q psy11767 507 SDPAGDNIKVVDFGFACLKRE--------SLHTPCFTLQYAAPEVLRQDKSGYDENCDLWSLGVILVNVLRQDKSGYDEN 578 (966)
Q Consensus 507 ~~~~~~~iKL~DFGla~~~~~--------~~~~~~gT~~Y~APEvl~~~~~~~~~~~Di~SlGvil~el~~~~~~~y~~~ 578 (966)
++ .+++||+|||.+..... .+....|||.|+|||.+..+.. ....+.+
T Consensus 244 ~~--~g~VKIsDFGVs~~~~~~~~~~~d~~L~~tvGTPAF~APE~c~~~~~----------------------~~~~g~a 299 (576)
T KOG0585|consen 244 SS--DGTVKISDFGVSNEFPQGSDEGSDDQLSRTVGTPAFFAPELCSGGNS----------------------FSYSGFA 299 (576)
T ss_pred cC--CCcEEeeccceeeecccCCccccHHHHhhcCCCccccchHhhcCCCC----------------------ccccchh
Confidence 85 57999999999976521 1234679999999999865331 1123568
Q ss_pred CcchhHHHHHHHHhcCCCCCCCCCCchhHHHHHHHHHcCCCCCCchhhccCCHHHHHHHHHhcccCccccCChHHHHHHh
Q psy11767 579 CDLWSLGVILYTMLCGRVPFHARSRDDSALSIMARIKEGQFNFDAEAWSTVSSEAKELTKSLLTVNPAQRIRMMRVKLTF 658 (966)
Q Consensus 579 ~DIWSlGvilyemltG~~Pf~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~is~e~~~Li~~~L~~dP~~R~t~~~v~~~~ 658 (966)
.||||+||+||.|+.|++||.+. ..+.+..+|.+..+.++.. +.++++++|||.+||++||++|+++.+++ .
T Consensus 300 ~DiWalGVTLYCllfG~~PF~~~----~~~~l~~KIvn~pL~fP~~--pe~~e~~kDli~~lL~KdP~~Ri~l~~ik--~ 371 (576)
T KOG0585|consen 300 LDIWALGVTLYCLLFGQLPFFDD----FELELFDKIVNDPLEFPEN--PEINEDLKDLIKRLLEKDPEQRITLPDIK--L 371 (576)
T ss_pred hhhhhhhhhHHHhhhccCCcccc----hHHHHHHHHhcCcccCCCc--ccccHHHHHHHHHHhhcChhheeehhhhe--e
Confidence 89999999999999999999864 3467788998887776643 46899999999999999999999999874 4
Q ss_pred hhhH
Q psy11767 659 HAFH 662 (966)
Q Consensus 659 ~~~~ 662 (966)
|+|.
T Consensus 372 Hpwv 375 (576)
T KOG0585|consen 372 HPWV 375 (576)
T ss_pred ccee
Confidence 6664
|
|
| >KOG0667|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-43 Score=400.69 Aligned_cols=257 Identities=30% Similarity=0.470 Sum_probs=214.8
Q ss_pred cccccccccccccccccccEEEEEEEcCCCcEEEEEEeccccC----hHHHHHHHHHhcCC-----CCceEEEEEEEeCC
Q psy11767 374 EQYDMDLDKAGILGDGSYSVCRRCVEKSTGQEYAVKIISRKID----CSEEINLLRACQGH-----PNIVNLHCVFQDEV 444 (966)
Q Consensus 374 ~~~~i~~~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~~----~~~Ei~iL~~l~~H-----pnIV~l~~~~~~~~ 444 (966)
-+|.| ++.||+|+||+|.+|.+..|++.||||+++++.. ...|+.+|..+..| -|||+++++|...+
T Consensus 186 ~rY~V----~e~LGkGtFGQVvk~~d~~T~e~VAIKIiKN~k~f~~Q~~~Ei~iL~~ln~~d~~~~~n~Vrm~d~F~fr~ 261 (586)
T KOG0667|consen 186 YRYEV----LEVLGKGSFGQVVKAYDHKTGEIVAIKIIKNKKRFLRQAQIEIRILELLNKHDPDDKYNIVRMLDYFYFRN 261 (586)
T ss_pred EEEEE----EEEecccccceeEEEEecCCCcEEEEEeeccChHHHHHHHHHHHHHHHHhccCCCCCeeEEEeeecccccc
Confidence 35655 6899999999999999999999999999987754 44699999988744 48999999999999
Q ss_pred eEEEEEEccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCcEEEecCCCCCEEEEeeccccc
Q psy11767 445 HTYLVLELLKGGELLDRIRQKGRCGFTENEASRIMRQLVAAVHFMHSRGVVHRDLKPENLLFSDPAGDNIKVVDFGFACL 524 (966)
Q Consensus 445 ~~~lVmEy~~gg~L~~~l~~~~~~~l~e~~~~~i~~Qil~aL~yLHs~~IiHRDLKP~NILl~~~~~~~iKL~DFGla~~ 524 (966)
|+|||+|++ +.+|+++|+++...+|+...++.|+.||+.||.+||+.||||+|||||||||.+.....|||+|||+|+.
T Consensus 262 HlciVfELL-~~NLYellK~n~f~Glsl~~ir~~~~Qil~~L~~L~~l~IIHcDLKPENILL~~~~r~~vKVIDFGSSc~ 340 (586)
T KOG0667|consen 262 HLCIVFELL-STNLYELLKNNKFRGLSLPLVRKFAQQILTALLFLHELGIIHCDLKPENILLKDPKRSRIKVIDFGSSCF 340 (586)
T ss_pred ceeeeehhh-hhhHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCChhheeeccCCcCceeEEecccccc
Confidence 999999999 6799999999888899999999999999999999999999999999999999998888999999999999
Q ss_pred ccCCCccccccccccCchhhccCCCCCCCcccchhhhhhhhhhhhcCCCCCCCcCcchhHHHHHHHHhcCCCCCCCCCCc
Q psy11767 525 KRESLHTPCFTLQYAAPEVLRQDKSGYDENCDLWSLGVILVNVLRQDKSGYDENCDLWSLGVILYTMLCGRVPFHARSRD 604 (966)
Q Consensus 525 ~~~~~~~~~gT~~Y~APEvl~~~~~~~~~~~Di~SlGvil~el~~~~~~~y~~~~DIWSlGvilyemltG~~Pf~~~~~~ 604 (966)
......+.+.+..|+|||+|.+ .+|+.+.||||||||++||++|.+-|.+.+..
T Consensus 341 ~~q~vytYiQSRfYRAPEVILG--------------------------lpY~~~IDmWSLGCIlAEL~tG~PLfpG~ne~ 394 (586)
T KOG0667|consen 341 ESQRVYTYIQSRFYRAPEVILG--------------------------LPYDTAIDMWSLGCILAELFTGEPLFPGDNEY 394 (586)
T ss_pred cCCcceeeeeccccccchhhcc--------------------------CCCCCccceeehhhhHHhHhcCccccCCCCHH
Confidence 8888788899999999999973 45899999999999999999999999998876
Q ss_pred hhHHHHHHHHH------------------c--CCCC----------------------------CC--chhh----c-cC
Q psy11767 605 DSALSIMARIK------------------E--GQFN----------------------------FD--AEAW----S-TV 629 (966)
Q Consensus 605 ~~~~~~~~~i~------------------~--~~~~----------------------------~~--~~~~----~-~i 629 (966)
++...+++-+. . +.+. .+ ...+ . .-
T Consensus 395 DQl~~I~e~lG~Pp~~mL~~~~~~~kff~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~P~~~~~l~~~~~~~~ 474 (586)
T KOG0667|consen 395 DQLARIIEVLGLPPPKMLDTAKKAHKFFTSLKGFPRLCVETSAPRGTKSPEVRKYYRKARLERRGPPGSRSLESGLPKAD 474 (586)
T ss_pred HHHHHHHHHhCCCCHHHHHhccccceehhccCCceeeeeeecccccccchhhhhhhhhhcccccCCCCCcccchhccccc
Confidence 66554443210 0 0000 00 0000 0 11
Q ss_pred CHHHHHHHHHhcccCccccCChHHHHHHhhhhHH
Q psy11767 630 SSEAKELTKSLLTVNPAQRIRMMRVKLTFHAFHQ 663 (966)
Q Consensus 630 s~e~~~Li~~~L~~dP~~R~t~~~v~~~~~~~~~ 663 (966)
...+.|+|++||.+||.+|+|..+. ..|+|..
T Consensus 475 ~~~F~dflk~~L~~dP~~R~tp~qa--l~Hpfl~ 506 (586)
T KOG0667|consen 475 DKLFIDFLKRCLEWDPAERITPAQA--LNHPFLT 506 (586)
T ss_pred HHHHHHHHHHHhccCchhcCCHHHH--hcCcccc
Confidence 2356899999999999999999865 5677764
|
|
| >KOG0611|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-43 Score=380.88 Aligned_cols=244 Identities=34% Similarity=0.637 Sum_probs=211.5
Q ss_pred eecccccccccccccccccccEEEEEEEcCCCcEEEEEEecccc--------ChHHHHHHHHHhcCCCCceEEEEEEEeC
Q psy11767 372 FFEQYDMDLDKAGILGDGSYSVCRRCVEKSTGQEYAVKIISRKI--------DCSEEINLLRACQGHPNIVNLHCVFQDE 443 (966)
Q Consensus 372 ~~~~~~i~~~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~--------~~~~Ei~iL~~l~~HpnIV~l~~~~~~~ 443 (966)
...+|++ .+.||+|+||+|-+|.+...|+.||||.|++.. ...+||+||..| +|||||++|++|++.
T Consensus 51 lkHRyE~----~etLGkGTYGKVk~A~e~~sgR~VAiKsIrKdkIkdeqDlvhIRREIeIMSsL-NHPhII~IyEVFENk 125 (668)
T KOG0611|consen 51 LKHRYEI----TETLGKGTYGKVKLAYEHKSGREVAIKSIRKDKIKDEQDLVHIRREIEIMSSL-NHPHIIQIYEVFENK 125 (668)
T ss_pred hhhHHHH----HHHhcCCcccceeehhhccCCcEeehhhhhhhhcccHHHHHHHHHHHHHHhhc-CCCceeehhhhhcCC
Confidence 3345555 578999999999999999999999999987642 145799999998 699999999999999
Q ss_pred CeEEEEEEccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCcEEEecCCCCCEEEEeecccc
Q psy11767 444 VHTYLVLELLKGGELLDRIRQKGRCGFTENEASRIMRQLVAAVHFMHSRGVVHRDLKPENLLFSDPAGDNIKVVDFGFAC 523 (966)
Q Consensus 444 ~~~~lVmEy~~gg~L~~~l~~~~~~~l~e~~~~~i~~Qil~aL~yLHs~~IiHRDLKP~NILl~~~~~~~iKL~DFGla~ 523 (966)
+.+.|||||..+|+|++|+.+++ .|+|.+++.||+||.+|+.|||.++++|||||.+||||++ ++++||+||||+.
T Consensus 126 dKIvivMEYaS~GeLYDYiSer~--~LsErEaRhfFRQIvSAVhYCHknrVvHRDLKLENILLD~--N~NiKIADFGLSN 201 (668)
T KOG0611|consen 126 DKIVIVMEYASGGELYDYISERG--SLSEREARHFFRQIVSAVHYCHKNRVVHRDLKLENILLDQ--NNNIKIADFGLSN 201 (668)
T ss_pred ceEEEEEEecCCccHHHHHHHhc--cccHHHHHHHHHHHHHHHHHHhhccceecccchhheeecC--CCCeeeeccchhh
Confidence 99999999999999999999887 5999999999999999999999999999999999999985 5699999999997
Q ss_pred cccC--CCccccccccccCchhhccCCCCCCCcccchhhhhhhhhhhhcCCCCCCCcCcchhHHHHHHHHhcCCCCCCCC
Q psy11767 524 LKRE--SLHTPCFTLQYAAPEVLRQDKSGYDENCDLWSLGVILVNVLRQDKSGYDENCDLWSLGVILYTMLCGRVPFHAR 601 (966)
Q Consensus 524 ~~~~--~~~~~~gT~~Y~APEvl~~~~~~~~~~~Di~SlGvil~el~~~~~~~y~~~~DIWSlGvilyemltG~~Pf~~~ 601 (966)
...+ -+.++||+|-|.+||++.+.+ .-++.+|.|||||+||.|+.|..||++.
T Consensus 202 ly~~~kfLqTFCGSPLYASPEIvNG~P-------------------------Y~GPEVDsWsLGvLLYtLVyGtMPFDG~ 256 (668)
T KOG0611|consen 202 LYADKKFLQTFCGSPLYASPEIVNGTP-------------------------YKGPEVDSWSLGVLLYTLVYGTMPFDGR 256 (668)
T ss_pred hhccccHHHHhcCCcccCCccccCCCC-------------------------CCCCccchhhHHHHHHHHhhcccccCCc
Confidence 6554 357899999999999996432 1256799999999999999999999987
Q ss_pred CCchhHHHHHHHHHcCCCCCCchhhccCCHHHHHHHHHhcccCccccCChHHHHHHh
Q psy11767 602 SRDDSALSIMARIKEGQFNFDAEAWSTVSSEAKELTKSLLTVNPAQRIRMMRVKLTF 658 (966)
Q Consensus 602 ~~~~~~~~~~~~i~~~~~~~~~~~~~~is~e~~~Li~~~L~~dP~~R~t~~~v~~~~ 658 (966)
+-. .+..+|.+|.|.-+ .-++++.-||+.||.+||++|.|+.++...|
T Consensus 257 Dhk----~lvrQIs~GaYrEP-----~~PSdA~gLIRwmLmVNP~RRATieDiAsHW 304 (668)
T KOG0611|consen 257 DHK----RLVRQISRGAYREP-----ETPSDASGLIRWMLMVNPERRATIEDIASHW 304 (668)
T ss_pred hHH----HHHHHhhcccccCC-----CCCchHHHHHHHHHhcCcccchhHHHHhhhh
Confidence 643 45678889988543 3467889999999999999999999885433
|
|
| >KOG0607|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-43 Score=373.52 Aligned_cols=266 Identities=39% Similarity=0.736 Sum_probs=227.8
Q ss_pred ceecccccccccccccccccccEEEEEEEcCCCcEEEEEEecccc-----ChHHHHHHHHHhcCCCCceEEEEEEEeCCe
Q psy11767 371 LFFEQYDMDLDKAGILGDGSYSVCRRCVEKSTGQEYAVKIISRKI-----DCSEEINLLRACQGHPNIVNLHCVFQDEVH 445 (966)
Q Consensus 371 ~~~~~~~i~~~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~-----~~~~Ei~iL~~l~~HpnIV~l~~~~~~~~~ 445 (966)
.|.+.|++. ..+||+|+|+.|--|....||.+||||+|.+.- ...+|++++..+++|+||++|+++|+++..
T Consensus 74 ~F~d~YkLt---~e~LGeGAyasVqtcv~i~t~~EYAVKiidKq~gHsR~RvfREVe~f~~Cqgh~nilqLiefFEdd~~ 150 (463)
T KOG0607|consen 74 KFEDMYKLT---SELLGEGAYASVQTCVSIQTGKEYAVKIIDKQPGHSRSRVFREVETFYQCQGHKNILQLIEFFEDDTR 150 (463)
T ss_pred hHHHHHHhH---HHHhcCccceeeeeeeeeccchhhhhhhhhcCCchHHHHHHHHHHHHHHhcCCccHHHHHHHhcccce
Confidence 366677663 468999999999999999999999999998653 255799999999999999999999999999
Q ss_pred EEEEEEccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCcEEEecCCC-CCEEEEeeccccc
Q psy11767 446 TYLVLELLKGGELLDRIRQKGRCGFTENEASRIMRQLVAAVHFMHSRGVVHRDLKPENLLFSDPAG-DNIKVVDFGFACL 524 (966)
Q Consensus 446 ~~lVmEy~~gg~L~~~l~~~~~~~l~e~~~~~i~~Qil~aL~yLHs~~IiHRDLKP~NILl~~~~~-~~iKL~DFGla~~ 524 (966)
.|||||-|.||.|+.+|.++. .|+|.++.+++..|+.||+|||.+||.||||||+|||..+++. .-+|||||.|+..
T Consensus 151 FYLVfEKm~GGplLshI~~~~--~F~E~EAs~vvkdia~aLdFlH~kgIAHRDlKPENiLC~~pn~vsPvKiCDfDLgSg 228 (463)
T KOG0607|consen 151 FYLVFEKMRGGPLLSHIQKRK--HFNEREASRVVKDIASALDFLHTKGIAHRDLKPENILCESPNKVSPVKICDFDLGSG 228 (463)
T ss_pred EEEEEecccCchHHHHHHHhh--hccHHHHHHHHHHHHHHHHHHhhcCcccccCCccceeecCCCCcCceeeeccccccc
Confidence 999999999999999998876 6999999999999999999999999999999999999976442 3589999999743
Q ss_pred cc----------CCCccccccccccCchhhccCCCCCCCcccchhhhhhhhhhhhcCCCCCCCcCcchhHHHHHHHHhcC
Q psy11767 525 KR----------ESLHTPCFTLQYAAPEVLRQDKSGYDENCDLWSLGVILVNVLRQDKSGYDENCDLWSLGVILYTMLCG 594 (966)
Q Consensus 525 ~~----------~~~~~~~gT~~Y~APEvl~~~~~~~~~~~Di~SlGvil~el~~~~~~~y~~~~DIWSlGvilyemltG 594 (966)
.. ....+++|+..|||||+.. ++-.....|+.++|.||||||||.||.|
T Consensus 229 ~k~~~~~spastP~L~tPvGSAEfMAPEVVd---------------------~fv~qA~~YDKrCDlwSLGvIlYImLsG 287 (463)
T KOG0607|consen 229 IKLNNDCSPASTPELLTPVGSAEFMAPEVVD---------------------VFVDQATFYDKRCDLWSLGVILYIMLSG 287 (463)
T ss_pred cccCCCCCCCCCccccCcccchhhcchhHHh---------------------hhccccccccccccHHHHHHHHHHHHhC
Confidence 21 2345788999999999873 3344567799999999999999999999
Q ss_pred CCCCCCCCCch-----------hHHHHHHHHHcCCCCCCchhhccCCHHHHHHHHHhcccCccccCChHHHHHHhhhhHH
Q psy11767 595 RVPFHARSRDD-----------SALSIMARIKEGQFNFDAEAWSTVSSEAKELTKSLLTVNPAQRIRMMRVKLTFHAFHQ 663 (966)
Q Consensus 595 ~~Pf~~~~~~~-----------~~~~~~~~i~~~~~~~~~~~~~~is~e~~~Li~~~L~~dP~~R~t~~~v~~~~~~~~~ 663 (966)
.+||.+.-..+ =...++..|.+|.|.|+...|..+|.+++||+..+|..|+.+|.++.++ ..|||.+
T Consensus 288 YpPFvG~Cg~dCGWdrGe~Cr~CQ~~LFesIQEGkYeFPdkdWahIS~eakdlisnLlvrda~~rlsa~~v--lnhPw~~ 365 (463)
T KOG0607|consen 288 YPPFVGHCGADCGWDRGEVCRVCQNKLFESIQEGKYEFPDKDWAHISSEAKDLISNLLVRDAKQRLSAAQV--LNHPWVQ 365 (463)
T ss_pred CCCccCccCCcCCccCCCccHHHHHHHHHHHhccCCcCChhhhHHhhHHHHHHHHHHHhccHHhhhhhhhc--cCCcccc
Confidence 99998643211 1335678899999999999999999999999999999999999998765 4566654
Q ss_pred h
Q psy11767 664 A 664 (966)
Q Consensus 664 ~ 664 (966)
.
T Consensus 366 ~ 366 (463)
T KOG0607|consen 366 R 366 (463)
T ss_pred c
Confidence 3
|
|
| >KOG0198|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.3e-43 Score=382.62 Aligned_cols=250 Identities=29% Similarity=0.440 Sum_probs=203.2
Q ss_pred ccccccccccccccEEEEEEEcCCCcEEEEEEecccc-----ChHHHHHHHHHhcCCCCceEEEEEEEeCC--eEEEEEE
Q psy11767 379 DLDKAGILGDGSYSVCRRCVEKSTGQEYAVKIISRKI-----DCSEEINLLRACQGHPNIVNLHCVFQDEV--HTYLVLE 451 (966)
Q Consensus 379 ~~~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~-----~~~~Ei~iL~~l~~HpnIV~l~~~~~~~~--~~~lVmE 451 (966)
.+...+.||+|+||.||++.+..+|..+|||.+.... ...+|+.+|..+. |||||++++...... .+++.||
T Consensus 18 ~~~~~~~lG~Gs~G~V~l~~~~~~g~~~AvK~v~~~~~~~~~~l~~Ei~iL~~l~-~p~IV~~~G~~~~~~~~~~~i~mE 96 (313)
T KOG0198|consen 18 NWSKGKLLGRGSFGSVYLATNKKTGELMAVKSVELEDSPTSESLEREIRILSRLN-HPNIVQYYGSSSSRENDEYNIFME 96 (313)
T ss_pred hhhhhccccCccceEEEEEEecCCCcceeeeeeecccchhHHHHHHHHHHHHhCC-CCCEEeeCCccccccCeeeEeeee
Confidence 3556789999999999999999999999999987652 2578999999997 999999999754443 6899999
Q ss_pred ccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCcEEEecCCCCCEEEEeecccccccC----
Q psy11767 452 LLKGGELLDRIRQKGRCGFTENEASRIMRQLVAAVHFMHSRGVVHRDLKPENLLFSDPAGDNIKVVDFGFACLKRE---- 527 (966)
Q Consensus 452 y~~gg~L~~~l~~~~~~~l~e~~~~~i~~Qil~aL~yLHs~~IiHRDLKP~NILl~~~~~~~iKL~DFGla~~~~~---- 527 (966)
|++||+|.+++.+.+. .|+|..++.+.+||++||+|||++|||||||||+|||++.. ++.+||+|||+++....
T Consensus 97 y~~~GsL~~~~~~~g~-~l~E~~v~~ytr~iL~GL~ylHs~g~vH~DiK~~NiLl~~~-~~~~KlaDFG~a~~~~~~~~~ 174 (313)
T KOG0198|consen 97 YAPGGSLSDLIKRYGG-KLPEPLVRRYTRQILEGLAYLHSKGIVHCDIKPANILLDPS-NGDVKLADFGLAKKLESKGTK 174 (313)
T ss_pred ccCCCcHHHHHHHcCC-CCCHHHHHHHHHHHHHHHHHHHhCCEeccCcccceEEEeCC-CCeEEeccCcccccccccccc
Confidence 9999999999998876 79999999999999999999999999999999999999742 46999999999976542
Q ss_pred --CCccccccccccCchhhccCCCCCCCcccchhhhhhhhhhhhcCCCCCCCcCcchhHHHHHHHHhcCCCCCCCCCCch
Q psy11767 528 --SLHTPCFTLQYAAPEVLRQDKSGYDENCDLWSLGVILVNVLRQDKSGYDENCDLWSLGVILYTMLCGRVPFHARSRDD 605 (966)
Q Consensus 528 --~~~~~~gT~~Y~APEvl~~~~~~~~~~~Di~SlGvil~el~~~~~~~y~~~~DIWSlGvilyemltG~~Pf~~~~~~~ 605 (966)
......||+.|||||++..+. .-..++|||||||++.||+||+.||... .+
T Consensus 175 ~~~~~~~~Gtp~~maPEvi~~g~-------------------------~~~~~sDiWSlGCtVvEM~Tg~~PW~~~--~~ 227 (313)
T KOG0198|consen 175 SDSELSVQGTPNYMAPEVIRNGE-------------------------VARRESDIWSLGCTVVEMLTGKPPWSEF--FE 227 (313)
T ss_pred ccccccccCCccccCchhhcCCC-------------------------cCCccchhhhcCCEEEeccCCCCcchhh--cc
Confidence 123467999999999996311 0124799999999999999999999863 11
Q ss_pred hHHHHHHHHHcCCCCCCchhhccCCHHHHHHHHHhcccCccccCChHHHHHHhhhhHH
Q psy11767 606 SALSIMARIKEGQFNFDAEAWSTVSSEAKELTKSLLTVNPAQRIRMMRVKLTFHAFHQ 663 (966)
Q Consensus 606 ~~~~~~~~i~~~~~~~~~~~~~~is~e~~~Li~~~L~~dP~~R~t~~~v~~~~~~~~~ 663 (966)
. ...+..+..... .+.....+|++++++|.+||..||++|||+.++ ..|+|..
T Consensus 228 ~-~~~~~~ig~~~~--~P~ip~~ls~~a~~Fl~~C~~~~p~~Rpta~eL--L~hpf~~ 280 (313)
T KOG0198|consen 228 E-AEALLLIGREDS--LPEIPDSLSDEAKDFLRKCFKRDPEKRPTAEEL--LEHPFLK 280 (313)
T ss_pred h-HHHHHHHhccCC--CCCCCcccCHHHHHHHHHHhhcCcccCcCHHHH--hhChhhh
Confidence 1 122333443331 224455799999999999999999999999865 5567654
|
|
| >KOG0663|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-42 Score=367.59 Aligned_cols=251 Identities=28% Similarity=0.448 Sum_probs=205.9
Q ss_pred cccccccccccccEEEEEEEcCCCcEEEEEEecccc-------ChHHHHHHHHHhcCCCCceEEEEEEEeC--CeEEEEE
Q psy11767 380 LDKAGILGDGSYSVCRRCVEKSTGQEYAVKIISRKI-------DCSEEINLLRACQGHPNIVNLHCVFQDE--VHTYLVL 450 (966)
Q Consensus 380 ~~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~-------~~~~Ei~iL~~l~~HpnIV~l~~~~~~~--~~~~lVm 450 (966)
|+.+..|++|+||.||+|+++.|++.||+|.++-.. ...+||.+|.+++ |||||.+-++.... +.+||||
T Consensus 78 fe~lnrI~EGtyGiVYRakdk~t~eIVALKr~kmekek~GFPItsLREIniLl~~~-H~NIV~vkEVVvG~~~d~iy~VM 156 (419)
T KOG0663|consen 78 FEKLNRIEEGTYGVVYRAKDKKTDEIVALKRLKMEKEKEGFPITSLREINILLKAR-HPNIVEVKEVVVGSNMDKIYIVM 156 (419)
T ss_pred HHHHhhcccCcceeEEEeccCCcceeEEeeecccccccCCCcchhHHHHHHHHhcC-CCCeeeeEEEEeccccceeeeeH
Confidence 455889999999999999999999999999997543 2578999999995 99999999887643 5699999
Q ss_pred EccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCcEEEecCCCCCEEEEeecccccccCC--
Q psy11767 451 ELLKGGELLDRIRQKGRCGFTENEASRIMRQLVAAVHFMHSRGVVHRDLKPENLLFSDPAGDNIKVVDFGFACLKRES-- 528 (966)
Q Consensus 451 Ey~~gg~L~~~l~~~~~~~l~e~~~~~i~~Qil~aL~yLHs~~IiHRDLKP~NILl~~~~~~~iKL~DFGla~~~~~~-- 528 (966)
|||+ .||...+.+-. .+|...+++.++.|++.||+|||.+.|+||||||+|+|+.+ .|.+||+|||||+.....
T Consensus 157 e~~E-hDLksl~d~m~-q~F~~~evK~L~~QlL~glk~lH~~wilHRDLK~SNLLm~~--~G~lKiaDFGLAR~ygsp~k 232 (419)
T KOG0663|consen 157 EYVE-HDLKSLMETMK-QPFLPGEVKTLMLQLLRGLKHLHDNWILHRDLKTSNLLLSH--KGILKIADFGLAREYGSPLK 232 (419)
T ss_pred HHHH-hhHHHHHHhcc-CCCchHHHHHHHHHHHHHHHHHhhceeEecccchhheeecc--CCcEEecccchhhhhcCCcc
Confidence 9995 58888887765 37999999999999999999999999999999999999985 679999999999987765
Q ss_pred -CccccccccccCchhhccCCCCCCCcccchhhhhhhhhhhhcCCCCCCCcCcchhHHHHHHHHhcCCCCCCCCCCchhH
Q psy11767 529 -LHTPCFTLQYAAPEVLRQDKSGYDENCDLWSLGVILVNVLRQDKSGYDENCDLWSLGVILYTMLCGRVPFHARSRDDSA 607 (966)
Q Consensus 529 -~~~~~gT~~Y~APEvl~~~~~~~~~~~Di~SlGvil~el~~~~~~~y~~~~DIWSlGvilyemltG~~Pf~~~~~~~~~ 607 (966)
.+..+.|.||+|||+|.+ ...|++++||||+|||+.||+++++-|.+.+.-++.
T Consensus 233 ~~T~lVVTLWYRaPELLLG-------------------------~~tyst~iDMWSvGCI~aE~l~~kPlf~G~sE~dQl 287 (419)
T KOG0663|consen 233 PYTPLVVTLWYRAPELLLG-------------------------AKTYSTAVDMWSVGCIFAELLTQKPLFPGKSEIDQL 287 (419)
T ss_pred cCcceEEEeeecCHHHhcC-------------------------CcccCcchhhhhHHHHHHHHHhcCCCCCCCchHHHH
Confidence 455677999999999974 345899999999999999999999999998876665
Q ss_pred HHHHHHHHcCC---------------CCCCc-------hhhc--cCCHHHHHHHHHhcccCccccCChHHHHHHhhhhH
Q psy11767 608 LSIMARIKEGQ---------------FNFDA-------EAWS--TVSSEAKELTKSLLTVNPAQRIRMMRVKLTFHAFH 662 (966)
Q Consensus 608 ~~~~~~i~~~~---------------~~~~~-------~~~~--~is~e~~~Li~~~L~~dP~~R~t~~~v~~~~~~~~ 662 (966)
..++..+.... +.+.. ..+. .+|+...+|+.++|.+||.+|+|+.+. ..|.|+
T Consensus 288 ~~If~llGtPte~iwpg~~~lp~~k~~~f~~~pyn~lr~kF~~~~lse~g~~Lln~llt~dP~kR~tA~~~--L~h~~F 364 (419)
T KOG0663|consen 288 DKIFKLLGTPSEAIWPGYSELPAVKKMTFSEHPYNNLRKKFGALSLSEQGFDLLNKLLTYDPGKRITAEDG--LKHEYF 364 (419)
T ss_pred HHHHHHhCCCccccCCCccccchhhccccCCCCchhhhhhccccccchhHHHHHHHHhccCccccccHHHh--hccccc
Confidence 55554332110 01110 0111 256899999999999999999999864 345554
|
|
| >KOG0580|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-43 Score=356.27 Aligned_cols=245 Identities=33% Similarity=0.560 Sum_probs=212.5
Q ss_pred ccccccccccccccEEEEEEEcCCCcEEEEEEecccc--------ChHHHHHHHHHhcCCCCceEEEEEEEeCCeEEEEE
Q psy11767 379 DLDKAGILGDGSYSVCRRCVEKSTGQEYAVKIISRKI--------DCSEEINLLRACQGHPNIVNLHCVFQDEVHTYLVL 450 (966)
Q Consensus 379 ~~~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~--------~~~~Ei~iL~~l~~HpnIV~l~~~~~~~~~~~lVm 450 (966)
+|+..+.||+|-||.||+|+.+.++-.||+|++.+.. ...+|++|-..| .||||.++|++|.++...||++
T Consensus 23 dfeigr~LgkgkFG~vYlarekks~~IvalKVlfKsqi~~~~v~~qlrREiEIqs~L-~hpnilrlY~~fhd~~riyLil 101 (281)
T KOG0580|consen 23 DFEIGRPLGKGKFGNVYLAREKKSLFIVALKVLFKSQILKTQVEHQLRREIEIQSHL-RHPNILRLYGYFHDSKRIYLIL 101 (281)
T ss_pred hccccccccCCccccEeEeeeccCCcEEEEeeeeHHHHHHhcchhhhhheeEeeccc-CCccHHhhhhheeccceeEEEE
Confidence 4556789999999999999999999999999986542 345677776677 5999999999999999999999
Q ss_pred EccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCcEEEecCCCCCEEEEeeccccccc-CCC
Q psy11767 451 ELLKGGELLDRIRQKGRCGFTENEASRIMRQLVAAVHFMHSRGVVHRDLKPENLLFSDPAGDNIKVVDFGFACLKR-ESL 529 (966)
Q Consensus 451 Ey~~gg~L~~~l~~~~~~~l~e~~~~~i~~Qil~aL~yLHs~~IiHRDLKP~NILl~~~~~~~iKL~DFGla~~~~-~~~ 529 (966)
||..+|+|+..|.......+++..+..|+.|++.||.|||.++||||||||+|+|++. .+.+||+|||.+.... ...
T Consensus 102 Eya~~gel~k~L~~~~~~~f~e~~~a~Yi~q~A~Al~y~h~k~VIhRdiKpenlLlg~--~~~lkiAdfGwsV~~p~~kR 179 (281)
T KOG0580|consen 102 EYAPRGELYKDLQEGRMKRFDEQRAATYIKQLANALLYCHLKRVIHRDIKPENLLLGS--AGELKIADFGWSVHAPSNKR 179 (281)
T ss_pred EecCCchHHHHHHhcccccccccchhHHHHHHHHHHHHhccCCcccCCCCHHHhccCC--CCCeeccCCCceeecCCCCc
Confidence 9999999999998655557999999999999999999999999999999999999984 6699999999987653 345
Q ss_pred ccccccccccCchhhccCCCCCCCcccchhhhhhhhhhhhcCCCCCCCcCcchhHHHHHHHHhcCCCCCCCCCCchhHHH
Q psy11767 530 HTPCFTLQYAAPEVLRQDKSGYDENCDLWSLGVILVNVLRQDKSGYDENCDLWSLGVILYTMLCGRVPFHARSRDDSALS 609 (966)
Q Consensus 530 ~~~~gT~~Y~APEvl~~~~~~~~~~~Di~SlGvil~el~~~~~~~y~~~~DIWSlGvilyemltG~~Pf~~~~~~~~~~~ 609 (966)
.+.|||.-|.+||+.. ...|+..+|+|++||++||+++|.+||...+.+ .
T Consensus 180 ~tlcgt~dyl~pEmv~--------------------------~~~hd~~Vd~w~lgvl~yeflvg~ppFes~~~~----e 229 (281)
T KOG0580|consen 180 KTLCGTLDYLPPEMVE--------------------------GRGHDKFVDLWSLGVLCYEFLVGLPPFESQSHS----E 229 (281)
T ss_pred eeeecccccCCHhhcC--------------------------CCCccchhhHHHHHHHHHHHHhcCCchhhhhhH----H
Confidence 6889999999999985 345789999999999999999999999876633 4
Q ss_pred HHHHHHcCCCCCCchhhccCCHHHHHHHHHhcccCccccCChHHHHHHhhhhH
Q psy11767 610 IMARIKEGQFNFDAEAWSTVSSEAKELTKSLLTVNPAQRIRMMRVKLTFHAFH 662 (966)
Q Consensus 610 ~~~~i~~~~~~~~~~~~~~is~e~~~Li~~~L~~dP~~R~t~~~v~~~~~~~~ 662 (966)
...+|..-.+.++ ..+|.++.|||.+||.++|.+|++..++ ..|+|.
T Consensus 230 tYkrI~k~~~~~p----~~is~~a~dlI~~ll~~~p~~r~~l~~v--~~hpwI 276 (281)
T KOG0580|consen 230 TYKRIRKVDLKFP----STISGGAADLISRLLVKNPIERLALTEV--MDHPWI 276 (281)
T ss_pred HHHHHHHccccCC----cccChhHHHHHHHHhccCccccccHHHH--hhhHHH
Confidence 5667777776655 4799999999999999999999999876 345554
|
|
| >KOG0192|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-41 Score=383.17 Aligned_cols=245 Identities=27% Similarity=0.457 Sum_probs=201.8
Q ss_pred ccccccccccEEEEEEEcCCCcE-EEEEEecccc-------ChHHHHHHHHHhcCCCCceEEEEEEEeCC-eEEEEEEcc
Q psy11767 383 AGILGDGSYSVCRRCVEKSTGQE-YAVKIISRKI-------DCSEEINLLRACQGHPNIVNLHCVFQDEV-HTYLVLELL 453 (966)
Q Consensus 383 ~~~LG~G~fG~Vy~a~~~~tg~~-vAvK~i~~~~-------~~~~Ei~iL~~l~~HpnIV~l~~~~~~~~-~~~lVmEy~ 453 (966)
...||.|+||+||++..+ |+. ||||++.... .+.+|+.+|.++ +|||||+|++++.+.. .++|||||+
T Consensus 46 ~~~iG~G~~g~V~~~~~~--g~~~vavK~~~~~~~~~~~~~~f~~E~~il~~l-~HpNIV~f~G~~~~~~~~~~iVtEy~ 122 (362)
T KOG0192|consen 46 EEVLGSGSFGTVYKGKWR--GTDVVAVKIISDPDFDDESRKAFRREASLLSRL-RHPNIVQFYGACTSPPGSLCIVTEYM 122 (362)
T ss_pred hhhcccCCceeEEEEEeC--CceeEEEEEecchhcChHHHHHHHHHHHHHHhC-CCCCeeeEEEEEcCCCCceEEEEEeC
Confidence 345999999999999877 455 9999997643 567899999998 5999999999999887 799999999
Q ss_pred CCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcC-ceeccCCCCcEEEecCCCC-CEEEEeecccccccC---C
Q psy11767 454 KGGELLDRIRQKGRCGFTENEASRIMRQLVAAVHFMHSRG-VVHRDLKPENLLFSDPAGD-NIKVVDFGFACLKRE---S 528 (966)
Q Consensus 454 ~gg~L~~~l~~~~~~~l~e~~~~~i~~Qil~aL~yLHs~~-IiHRDLKP~NILl~~~~~~-~iKL~DFGla~~~~~---~ 528 (966)
++|+|.+++.......|+...+..++.||+.||+|||+++ ||||||||+|||++. .. ++||||||+++.... .
T Consensus 123 ~~GsL~~~l~~~~~~~l~~~~~l~~aldiArGm~YLH~~~~iIHrDLK~~NiLv~~--~~~~~KI~DFGlsr~~~~~~~~ 200 (362)
T KOG0192|consen 123 PGGSLSVLLHKKRKRKLPLKVRLRIALDIARGMEYLHSEGPIIHRDLKSDNILVDL--KGKTLKIADFGLSREKVISKTS 200 (362)
T ss_pred CCCcHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHhcCCCeeecccChhhEEEcC--CCCEEEECCCccceeecccccc
Confidence 9999999998843447999999999999999999999999 999999999999985 43 899999999987653 3
Q ss_pred CccccccccccCchhhccCCCCCCCcccchhhhhhhhhhhhcCCCCCCCcCcchhHHHHHHHHhcCCCCCCCCCCchhHH
Q psy11767 529 LHTPCFTLQYAAPEVLRQDKSGYDENCDLWSLGVILVNVLRQDKSGYDENCDLWSLGVILYTMLCGRVPFHARSRDDSAL 608 (966)
Q Consensus 529 ~~~~~gT~~Y~APEvl~~~~~~~~~~~Di~SlGvil~el~~~~~~~y~~~~DIWSlGvilyemltG~~Pf~~~~~~~~~~ 608 (966)
.....||+.|||||++.+. +..|+.|+|||||||+||||+||+.||......
T Consensus 201 ~~~~~GT~~wMAPEv~~~~------------------------~~~~~~K~DvySFgIvlWEl~t~~~Pf~~~~~~---- 252 (362)
T KOG0192|consen 201 MTSVAGTYRWMAPEVLRGE------------------------KSPYTEKSDVYSFGIVLWELLTGEIPFEDLAPV---- 252 (362)
T ss_pred ccCCCCCccccChhhhcCC------------------------CCcCCccchhhhHHHHHHHHHHCCCCCCCCCHH----
Confidence 3346899999999999632 245899999999999999999999999987642
Q ss_pred HHHHHHHcCCCCCCchhhccCCHHHHHHHHHhcccCccccCChHHHHHHhhhhH
Q psy11767 609 SIMARIKEGQFNFDAEAWSTVSSEAKELTKSLLTVNPAQRIRMMRVKLTFHAFH 662 (966)
Q Consensus 609 ~~~~~i~~~~~~~~~~~~~~is~e~~~Li~~~L~~dP~~R~t~~~v~~~~~~~~ 662 (966)
++...+..+... +......++.+..||.+||..||.+||++.++...+..+.
T Consensus 253 ~~~~~v~~~~~R--p~~p~~~~~~l~~l~~~CW~~dp~~RP~f~ei~~~l~~~~ 304 (362)
T KOG0192|consen 253 QVASAVVVGGLR--PPIPKECPPHLSSLMERCWLVDPSRRPSFLEIVSRLESIM 304 (362)
T ss_pred HHHHHHHhcCCC--CCCCccCCHHHHHHHHHhCCCCCCcCCCHHHHHHHHHHHH
Confidence 222223222211 1222347889999999999999999999999876665543
|
|
| >KOG0660|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-42 Score=371.29 Aligned_cols=247 Identities=30% Similarity=0.493 Sum_probs=202.7
Q ss_pred ccccccccccEEEEEEEcCCCcEEEEEEeccccC-------hHHHHHHHHHhcCCCCceEEEEEEEe-----CCeEEEEE
Q psy11767 383 AGILGDGSYSVCRRCVEKSTGQEYAVKIISRKID-------CSEEINLLRACQGHPNIVNLHCVFQD-----EVHTYLVL 450 (966)
Q Consensus 383 ~~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~~-------~~~Ei~iL~~l~~HpnIV~l~~~~~~-----~~~~~lVm 450 (966)
++.||+|+||.|..|.++.||+.||||.+.+... ..+|+++|+.++ |+|||.+++++.. -..+|+|+
T Consensus 27 ~~~iG~GAyGvVcsA~~~~t~~~VAIKKi~~~F~~~~~akRtlRElklLr~~~-HeNIi~l~di~~p~~~~~f~DvYiV~ 105 (359)
T KOG0660|consen 27 IEPIGRGAYGVVCSAKDKRTGEKVAIKKILNPFENQIDAKRTLRELKLLRHLR-HENIIGLLDIFRPPSRDKFNDVYLVF 105 (359)
T ss_pred cccccCcceeeEEEEEEcCCCCEeehhhhhhhhhchHHHHHHHHHHHHHHHhc-CCCcceEEeecccccccccceeEEeh
Confidence 5789999999999999999999999999875432 457999999996 9999999999875 34689999
Q ss_pred EccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCcEEEecCCCCCEEEEeeccccccc----
Q psy11767 451 ELLKGGELLDRIRQKGRCGFTENEASRIMRQLVAAVHFMHSRGVVHRDLKPENLLFSDPAGDNIKVVDFGFACLKR---- 526 (966)
Q Consensus 451 Ey~~gg~L~~~l~~~~~~~l~e~~~~~i~~Qil~aL~yLHs~~IiHRDLKP~NILl~~~~~~~iKL~DFGla~~~~---- 526 (966)
|+| +.||.+.|+... .|++..+..+++||+.||.|+|+.+|+||||||+|+|++. +..+||||||||+...
T Consensus 106 elM-etDL~~iik~~~--~L~d~H~q~f~YQiLrgLKyiHSAnViHRDLKPsNll~n~--~c~lKI~DFGLAR~~~~~~~ 180 (359)
T KOG0660|consen 106 ELM-ETDLHQIIKSQQ--DLTDDHAQYFLYQILRGLKYIHSANVIHRDLKPSNLLLNA--DCDLKICDFGLARYLDKFFE 180 (359)
T ss_pred hHH-hhHHHHHHHcCc--cccHHHHHHHHHHHHHhcchhhcccccccccchhheeecc--CCCEEeccccceeeccccCc
Confidence 999 678888887654 4999999999999999999999999999999999999974 5689999999998763
Q ss_pred -CCCccccccccccCchhhccCCCCCCCcccchhhhhhhhhhhhcCCCCCCCcCcchhHHHHHHHHhcCCCCCCCCCCch
Q psy11767 527 -ESLHTPCFTLQYAAPEVLRQDKSGYDENCDLWSLGVILVNVLRQDKSGYDENCDLWSLGVILYTMLCGRVPFHARSRDD 605 (966)
Q Consensus 527 -~~~~~~~gT~~Y~APEvl~~~~~~~~~~~Di~SlGvil~el~~~~~~~y~~~~DIWSlGvilyemltG~~Pf~~~~~~~ 605 (966)
...+..+.|.+|+|||++.. ...|+..+||||+|||+.|||+|++-|.+.+..+
T Consensus 181 ~~~mTeYVaTRWYRAPElll~-------------------------~~~Yt~aiDiWSvGCI~AEmL~gkplFpG~d~v~ 235 (359)
T KOG0660|consen 181 DGFMTEYVATRWYRAPELLLN-------------------------SSEYTKAIDIWSVGCILAEMLTGKPLFPGKDYVH 235 (359)
T ss_pred ccchhcceeeeeecCHHHHhc-------------------------cccccchhhhhhhhHHHHHHHcCCCCCCCCchHH
Confidence 22345677999999999853 3458999999999999999999999999987655
Q ss_pred hHHHHHHH-----------HH--------cCCCCCC----chhhccCCHHHHHHHHHhcccCccccCChHHHHHHhhhhH
Q psy11767 606 SALSIMAR-----------IK--------EGQFNFD----AEAWSTVSSEAKELTKSLLTVNPAQRIRMMRVKLTFHAFH 662 (966)
Q Consensus 606 ~~~~~~~~-----------i~--------~~~~~~~----~~~~~~is~e~~~Li~~~L~~dP~~R~t~~~v~~~~~~~~ 662 (966)
+...++.- |. ......+ ...++..++++.||+.+||..||.+|+|+.+. ..||+.
T Consensus 236 Ql~lI~~~lGtP~~e~l~~i~s~~ar~yi~slp~~p~~~f~~~fp~a~p~AidLlekmL~fdP~kRita~eA--L~hPYl 313 (359)
T KOG0660|consen 236 QLQLILELLGTPSEEDLQKIRSEKARPYIKSLPQIPKQPFSSIFPNANPLAIDLLEKMLVFDPKKRITAEEA--LAHPYL 313 (359)
T ss_pred HHHHHHHhcCCCCHHHHHHhccHHHHHHHHhCCCCCCCCHHHHcCCCCHHHHHHHHHHhccCccccCCHHHH--hcChhh
Confidence 54433321 11 0000111 23456889999999999999999999999865 445554
|
|
| >KOG0578|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-42 Score=386.65 Aligned_cols=244 Identities=29% Similarity=0.468 Sum_probs=208.1
Q ss_pred cccccccccccEEEEEEEcCCCcEEEEEEeccccC-----hHHHHHHHHHhcCCCCceEEEEEEEeCCeEEEEEEccCCC
Q psy11767 382 KAGILGDGSYSVCRRCVEKSTGQEYAVKIISRKID-----CSEEINLLRACQGHPNIVNLHCVFQDEVHTYLVLELLKGG 456 (966)
Q Consensus 382 ~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~~-----~~~Ei~iL~~l~~HpnIV~l~~~~~~~~~~~lVmEy~~gg 456 (966)
....||+|+-|.||.|+...+++.||||.+..... ..+|+.+|+.. .|+|||++++.|.-.+.+|+|||||+||
T Consensus 277 ~~~kigqgaSG~vy~A~~~~~~~~VaiK~m~l~~Q~~keLilnEi~Vm~~~-~H~NiVnfl~Sylv~deLWVVMEym~gg 355 (550)
T KOG0578|consen 277 DFKKIGQGATGGVYVARKISTKQEVAIKRMDLRKQPKKELLLNEILVMRDL-HHPNIVNFLDSYLVGDELWVVMEYMEGG 355 (550)
T ss_pred chhhhccccccceeeeeeccCCceEEEEEEEeccCCchhhhHHHHHHHHhc-cchHHHHHHHHhcccceeEEEEeecCCC
Confidence 35679999999999999999999999999875432 55799999998 4999999999999889999999999999
Q ss_pred CHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCcEEEecCCCCCEEEEeecccccccC---CCcccc
Q psy11767 457 ELLDRIRQKGRCGFTENEASRIMRQLVAAVHFMHSRGVVHRDLKPENLLFSDPAGDNIKVVDFGFACLKRE---SLHTPC 533 (966)
Q Consensus 457 ~L~~~l~~~~~~~l~e~~~~~i~~Qil~aL~yLHs~~IiHRDLKP~NILl~~~~~~~iKL~DFGla~~~~~---~~~~~~ 533 (966)
+|.+.+... .|+|.++..|++++|.||+|||.+||||||||.+|||++. ++.+||+|||++..... ...+.+
T Consensus 356 sLTDvVt~~---~~~E~qIA~Icre~l~aL~fLH~~gIiHrDIKSDnILL~~--~g~vKltDFGFcaqi~~~~~KR~TmV 430 (550)
T KOG0578|consen 356 SLTDVVTKT---RMTEGQIAAICREILQGLKFLHARGIIHRDIKSDNILLTM--DGSVKLTDFGFCAQISEEQSKRSTMV 430 (550)
T ss_pred chhhhhhcc---cccHHHHHHHHHHHHHHHHHHHhcceeeeccccceeEecc--CCcEEEeeeeeeeccccccCcccccc
Confidence 999998765 4999999999999999999999999999999999999985 66899999999976543 235678
Q ss_pred ccccccCchhhccCCCCCCCcccchhhhhhhhhhhhcCCCCCCCcCcchhHHHHHHHHhcCCCCCCCCCCchhHHHHHHH
Q psy11767 534 FTLQYAAPEVLRQDKSGYDENCDLWSLGVILVNVLRQDKSGYDENCDLWSLGVILYTMLCGRVPFHARSRDDSALSIMAR 613 (966)
Q Consensus 534 gT~~Y~APEvl~~~~~~~~~~~Di~SlGvil~el~~~~~~~y~~~~DIWSlGvilyemltG~~Pf~~~~~~~~~~~~~~~ 613 (966)
|||+|||||++. ...|+.++||||||++++||+.|.+||...+. +..+..
T Consensus 431 GTPYWMAPEVvt--------------------------rk~YG~KVDIWSLGIMaIEMveGEPPYlnE~P----lrAlyL 480 (550)
T KOG0578|consen 431 GTPYWMAPEVVT--------------------------RKPYGPKVDIWSLGIMAIEMVEGEPPYLNENP----LRALYL 480 (550)
T ss_pred CCCCccchhhhh--------------------------hcccCccccchhhhhHHHHHhcCCCCccCCCh----HHHHHH
Confidence 999999999986 34589999999999999999999999986443 233444
Q ss_pred HH-cCCCCCCchhhccCCHHHHHHHHHhcccCccccCChHHHHHHhhhhHHhh
Q psy11767 614 IK-EGQFNFDAEAWSTVSSEAKELTKSLLTVNPAQRIRMMRVKLTFHAFHQAQ 665 (966)
Q Consensus 614 i~-~~~~~~~~~~~~~is~e~~~Li~~~L~~dP~~R~t~~~v~~~~~~~~~~~ 665 (966)
|. +|...+ ..+..+|++++||+.+||+.|+++|+++.++ ..|+|.+..
T Consensus 481 Ia~ng~P~l--k~~~klS~~~kdFL~~cL~~dv~~RasA~eL--L~HpFl~~a 529 (550)
T KOG0578|consen 481 IATNGTPKL--KNPEKLSPELKDFLDRCLVVDVEQRASAKEL--LEHPFLKMA 529 (550)
T ss_pred HhhcCCCCc--CCccccCHHHHHHHHHHhhcchhcCCCHHHH--hcChhhhhc
Confidence 43 344333 3456899999999999999999999999965 668887543
|
|
| >KOG0658|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-42 Score=370.92 Aligned_cols=259 Identities=29% Similarity=0.461 Sum_probs=209.7
Q ss_pred cccccccccccccccEEEEEEEcCCCcEEEEEEecc-ccChHHHHHHHHHhcCCCCceEEEEEEEeC-----CeEEEEEE
Q psy11767 378 MDLDKAGILGDGSYSVCRRCVEKSTGQEYAVKIISR-KIDCSEEINLLRACQGHPNIVNLHCVFQDE-----VHTYLVLE 451 (966)
Q Consensus 378 i~~~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~-~~~~~~Ei~iL~~l~~HpnIV~l~~~~~~~-----~~~~lVmE 451 (966)
+.+...+++|.|+||.||+|....+++.||||.+-. +.-..+|+.+|+.+ .|||||+|..+|... .+..||||
T Consensus 24 i~~~~~~liG~GsFg~Vyq~~~~e~~~~vAIKKv~~d~r~knrEl~im~~l-~HpNIV~L~~~f~~~~~~d~~~lnlVle 102 (364)
T KOG0658|consen 24 ISYEAVRLIGSGSFGVVYQAKLRETEEEVAIKKVLQDKRYKNRELQIMRKL-DHPNIVRLLYFFSSSTESDEVYLNLVLE 102 (364)
T ss_pred EEEEeeEEEeecccceEEEEEEcCCCceeEEEEecCCCCcCcHHHHHHHhc-CCcCeeeEEEEEEecCCCchhHHHHHHH
Confidence 445557899999999999999999999999998744 34467899999977 699999999888643 24568999
Q ss_pred ccCCCCHHHHHHhc--CCCCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCcEEEecCCCCCEEEEeeccccccc--C
Q psy11767 452 LLKGGELLDRIRQK--GRCGFTENEASRIMRQLVAAVHFMHSRGVVHRDLKPENLLFSDPAGDNIKVVDFGFACLKR--E 527 (966)
Q Consensus 452 y~~gg~L~~~l~~~--~~~~l~e~~~~~i~~Qil~aL~yLHs~~IiHRDLKP~NILl~~~~~~~iKL~DFGla~~~~--~ 527 (966)
||+ .+|.+.++.. ....++.-.++-++.||++||.|||+.||+||||||+|||++. ..+.+||||||.|+... +
T Consensus 103 ymP-~tL~~~~r~~~~~~~~mp~~~iKLYt~Qlfrgl~yLh~~~IcHRDIKPqNlLvD~-~tg~LKicDFGSAK~L~~~e 180 (364)
T KOG0658|consen 103 YMP-ETLYRVIRHYTRANQRMPLLEIKLYTYQLFRGLAYLHSHGICHRDIKPQNLLVDP-DTGVLKICDFGSAKVLVKGE 180 (364)
T ss_pred hch-HHHHHHHHHHhhcCCCCceeeeHHHHHHHHHHHHHHHhcCcccCCCChheEEEcC-CCCeEEeccCCcceeeccCC
Confidence 996 5899888742 2336899999999999999999999999999999999999964 56899999999998653 4
Q ss_pred CCccccccccccCchhhccCCCCCCCcccchhhhhhhhhhhhcCCCCCCCcCcchhHHHHHHHHhcCCCCCCCCCCchhH
Q psy11767 528 SLHTPCFTLQYAAPEVLRQDKSGYDENCDLWSLGVILVNVLRQDKSGYDENCDLWSLGVILYTMLCGRVPFHARSRDDSA 607 (966)
Q Consensus 528 ~~~~~~gT~~Y~APEvl~~~~~~~~~~~Di~SlGvil~el~~~~~~~y~~~~DIWSlGvilyemltG~~Pf~~~~~~~~~ 607 (966)
...+...|..|+|||.+.+ ...|+.++||||.|||++||+.|++-|.+.+..++.
T Consensus 181 pniSYicSRyYRaPELifg-------------------------a~~Yt~~IDiWSaGCV~aELl~g~plFpG~s~~dQL 235 (364)
T KOG0658|consen 181 PNISYICSRYYRAPELIFG-------------------------ATEYTTSIDIWSAGCVMAELLKGQPLFPGDSSVDQL 235 (364)
T ss_pred CceeEEEeccccCHHHHcC-------------------------ccccCceeEEhhhhHHHHHHhcCCcccCCCCHHHHH
Confidence 4566778999999999963 356999999999999999999999999998887766
Q ss_pred HHHHHH--------HHcCCCC--------CCchhh-----ccCCHHHHHHHHHhcccCccccCChHHHHHHhhhhHHhhh
Q psy11767 608 LSIMAR--------IKEGQFN--------FDAEAW-----STVSSEAKELTKSLLTVNPAQRIRMMRVKLTFHAFHQAQK 666 (966)
Q Consensus 608 ~~~~~~--------i~~~~~~--------~~~~~~-----~~is~e~~~Li~~~L~~dP~~R~t~~~v~~~~~~~~~~~~ 666 (966)
..+... |.....+ +....| ..+++++.+|+.++|+++|.+|.++.++ ..|+|+...+
T Consensus 236 ~eIik~lG~Pt~e~I~~mn~~y~~~~~p~ik~~~~~~~~~~~~~~d~~dll~~~L~Y~P~~R~~~~~~--l~h~fFdelr 313 (364)
T KOG0658|consen 236 VEIIKVLGTPTREDIKSMNPNYTEFKFPQIKAHPWHKVFFKRLPPDALDLLSKLLQYSPSKRLSALEA--LAHPFFDELR 313 (364)
T ss_pred HHHHHHhCCCCHHHHhhcCcccccccCcccccccceeecccCCCHHHHHHHHHHhccChhhcCCHHHH--hcchhhHHhh
Confidence 655532 2222221 112222 3578999999999999999999999864 6778876543
|
|
| >PTZ00263 protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-41 Score=377.41 Aligned_cols=242 Identities=35% Similarity=0.649 Sum_probs=205.1
Q ss_pred ccccccccccccEEEEEEEcCCCcEEEEEEecccc--------ChHHHHHHHHHhcCCCCceEEEEEEEeCCeEEEEEEc
Q psy11767 381 DKAGILGDGSYSVCRRCVEKSTGQEYAVKIISRKI--------DCSEEINLLRACQGHPNIVNLHCVFQDEVHTYLVLEL 452 (966)
Q Consensus 381 ~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~--------~~~~Ei~iL~~l~~HpnIV~l~~~~~~~~~~~lVmEy 452 (966)
+..+.||+|+||.||+|++..+|+.||||++.+.. ...+|+.+|+.+ +||||+++++++.++...|+||||
T Consensus 21 ~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l-~hp~iv~~~~~~~~~~~~~lv~e~ 99 (329)
T PTZ00263 21 EMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMEL-SHPFIVNMMCSFQDENRVYFLLEF 99 (329)
T ss_pred EEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhC-CCCCCCcEEEEEEcCCEEEEEEcC
Confidence 34678999999999999999999999999986431 245689999988 599999999999999999999999
Q ss_pred cCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCcEEEecCCCCCEEEEeecccccccCCCccc
Q psy11767 453 LKGGELLDRIRQKGRCGFTENEASRIMRQLVAAVHFMHSRGVVHRDLKPENLLFSDPAGDNIKVVDFGFACLKRESLHTP 532 (966)
Q Consensus 453 ~~gg~L~~~l~~~~~~~l~e~~~~~i~~Qil~aL~yLHs~~IiHRDLKP~NILl~~~~~~~iKL~DFGla~~~~~~~~~~ 532 (966)
++||+|.+++...+ .+++..++.++.||+.||+|||++||+||||||+|||++. ++.+||+|||++........+.
T Consensus 100 ~~~~~L~~~l~~~~--~~~~~~~~~~~~qi~~aL~~LH~~~ivH~dlkp~NIll~~--~~~~kl~Dfg~~~~~~~~~~~~ 175 (329)
T PTZ00263 100 VVGGELFTHLRKAG--RFPNDVAKFYHAELVLAFEYLHSKDIIYRDLKPENLLLDN--KGHVKVTDFGFAKKVPDRTFTL 175 (329)
T ss_pred CCCChHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHEEECC--CCCEEEeeccCceEcCCCccee
Confidence 99999999998765 5899999999999999999999999999999999999975 5689999999998766555567
Q ss_pred cccccccCchhhccCCCCCCCcccchhhhhhhhhhhhcCCCCCCCcCcchhHHHHHHHHhcCCCCCCCCCCchhHHHHHH
Q psy11767 533 CFTLQYAAPEVLRQDKSGYDENCDLWSLGVILVNVLRQDKSGYDENCDLWSLGVILYTMLCGRVPFHARSRDDSALSIMA 612 (966)
Q Consensus 533 ~gT~~Y~APEvl~~~~~~~~~~~Di~SlGvil~el~~~~~~~y~~~~DIWSlGvilyemltG~~Pf~~~~~~~~~~~~~~ 612 (966)
+||+.|+|||++.. ..++.++|||||||++|+|++|+.||.+.+. .....
T Consensus 176 ~gt~~y~aPE~~~~--------------------------~~~~~~~DiwslG~il~elltg~~pf~~~~~----~~~~~ 225 (329)
T PTZ00263 176 CGTPEYLAPEVIQS--------------------------KGHGKAVDWWTMGVLLYEFIAGYPPFFDDTP----FRIYE 225 (329)
T ss_pred cCChhhcCHHHHcC--------------------------CCCCCcceeechHHHHHHHHcCCCCCCCCCH----HHHHH
Confidence 89999999999852 2367889999999999999999999986542 34456
Q ss_pred HHHcCCCCCCchhhccCCHHHHHHHHHhcccCccccCCh-----HHHHHHhhhhHH
Q psy11767 613 RIKEGQFNFDAEAWSTVSSEAKELTKSLLTVNPAQRIRM-----MRVKLTFHAFHQ 663 (966)
Q Consensus 613 ~i~~~~~~~~~~~~~~is~e~~~Li~~~L~~dP~~R~t~-----~~v~~~~~~~~~ 663 (966)
.+..+.+.++ ..++.++++||.+||+.||.+|++. .+ ...|+|+.
T Consensus 226 ~i~~~~~~~p----~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~--ll~hp~f~ 275 (329)
T PTZ00263 226 KILAGRLKFP----NWFDGRARDLVKGLLQTDHTKRLGTLKGGVAD--VKNHPYFH 275 (329)
T ss_pred HHhcCCcCCC----CCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHH--HhcCCccC
Confidence 6666665443 2478999999999999999999973 43 34566653
|
|
| >KOG0610|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-41 Score=367.47 Aligned_cols=248 Identities=28% Similarity=0.473 Sum_probs=210.3
Q ss_pred ccccccccccccccEEEEEEEcCCCcEEEEEEecccc--------ChHHHHHHHHHhcCCCCceEEEEEEEeCCeEEEEE
Q psy11767 379 DLDKAGILGDGSYSVCRRCVEKSTGQEYAVKIISRKI--------DCSEEINLLRACQGHPNIVNLHCVFQDEVHTYLVL 450 (966)
Q Consensus 379 ~~~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~--------~~~~Ei~iL~~l~~HpnIV~l~~~~~~~~~~~lVm 450 (966)
+|+.++.||.|.-|+||+|+.+.++..+|+|++.+.. .+..|.+||..+ +||.+++||..|+.+.+.||||
T Consensus 78 ~f~llk~LG~GdiG~VyL~~l~~t~~~fAmKVmdK~~l~~rkKl~Ra~tE~eIL~~l-DHPFlPTLYa~fet~~~~cl~m 156 (459)
T KOG0610|consen 78 HFRLLKRLGCGDIGTVYLVELRGTNCLFAMKVMDKESLASRKKLKRAQTEREILSLL-DHPFLPTLYASFETDKYSCLVM 156 (459)
T ss_pred HHHHHHHcCCCCceeEEEEEecCCCceEEEEEecHHHHhhhhHHHHHHHHHHHHHhc-CCCccchhhheeeccceeEEEE
Confidence 3456889999999999999999999999999997642 244588899877 6999999999999999999999
Q ss_pred EccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCcEEEecCCCCCEEEEeeccccccc----
Q psy11767 451 ELLKGGELLDRIRQKGRCGFTENEASRIMRQLVAAVHFMHSRGVVHRDLKPENLLFSDPAGDNIKVVDFGFACLKR---- 526 (966)
Q Consensus 451 Ey~~gg~L~~~l~~~~~~~l~e~~~~~i~~Qil~aL~yLHs~~IiHRDLKP~NILl~~~~~~~iKL~DFGla~~~~---- 526 (966)
|||+||+|....+++....|++..+++|+.+++.||+|||-.|||.||||||||||-+ +|+|-|+||-|+....
T Consensus 157 eyCpGGdL~~LrqkQp~~~fse~~aRFYaAEvl~ALEYLHmlGivYRDLKPENILvre--dGHIMLsDFDLS~~~~~~Pt 234 (459)
T KOG0610|consen 157 EYCPGGDLHSLRQKQPGKRFSESAARFYAAEVLLALEYLHMLGIVYRDLKPENILVRE--DGHIMLSDFDLSLRCPVSPT 234 (459)
T ss_pred ecCCCccHHHHHhhCCCCccchhhHHHHHHHHHHHHHHHHhhceeeccCCcceeEEec--CCcEEeeeccccccCCCCCe
Confidence 9999999999999888888999999999999999999999999999999999999975 6799999999872100
Q ss_pred --------------------------------C-----------------------CCccccccccccCchhhccCCCCC
Q psy11767 527 --------------------------------E-----------------------SLHTPCFTLQYAAPEVLRQDKSGY 551 (966)
Q Consensus 527 --------------------------------~-----------------------~~~~~~gT~~Y~APEvl~~~~~~~ 551 (966)
. ..+.++||-.|+|||++.+
T Consensus 235 ~~~s~~~~~~~~~~~~~~~~~s~f~~r~~~~~~~~~k~~~~~~~~~p~~~aep~~~RSnSFVGThEYlAPEvI~G----- 309 (459)
T KOG0610|consen 235 LVKSSSPRSSGSQPSCRSRQPSCFSPRCLSSSKKRKKKDESASRSLPELVAEPTGARSNSFVGTHEYLAPEVIRG----- 309 (459)
T ss_pred eeccCCCCCCCCCcccccccccccccchhccccccccccccccccchhhhcCCCCccccccccccccccceeeec-----
Confidence 0 0123467888999999963
Q ss_pred CCcccchhhhhhhhhhhhcCCCCCCCcCcchhHHHHHHHHhcCCCCCCCCCCchhHHHHHHHHHcCCCCCCchhhccCCH
Q psy11767 552 DENCDLWSLGVILVNVLRQDKSGYDENCDLWSLGVILYTMLCGRVPFHARSRDDSALSIMARIKEGQFNFDAEAWSTVSS 631 (966)
Q Consensus 552 ~~~~Di~SlGvil~el~~~~~~~y~~~~DIWSlGvilyemltG~~Pf~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~is~ 631 (966)
.+++.++|+|+|||++||||.|..||.+.+..+ .+.+|......++.. +.+|.
T Consensus 310 ---------------------~GHgsAVDWWtfGIflYEmLyG~TPFKG~~~~~----Tl~NIv~~~l~Fp~~--~~vs~ 362 (459)
T KOG0610|consen 310 ---------------------EGHGSAVDWWTFGIFLYEMLYGTTPFKGSNNKE----TLRNIVGQPLKFPEE--PEVSS 362 (459)
T ss_pred ---------------------CCCCchhhHHHHHHHHHHHHhCCCCcCCCCchh----hHHHHhcCCCcCCCC--Ccchh
Confidence 357889999999999999999999999987764 355566666666544 37899
Q ss_pred HHHHHHHHhcccCccccCC----hHHHHHHhhhhHH
Q psy11767 632 EAKELTKSLLTVNPAQRIR----MMRVKLTFHAFHQ 663 (966)
Q Consensus 632 e~~~Li~~~L~~dP~~R~t----~~~v~~~~~~~~~ 663 (966)
.++|||+++|.+||.+|+. +.+| ..|+|++
T Consensus 363 ~akDLIr~LLvKdP~kRlg~~rGA~eI--K~HpFF~ 396 (459)
T KOG0610|consen 363 AAKDLIRKLLVKDPSKRLGSKRGAAEI--KRHPFFE 396 (459)
T ss_pred HHHHHHHHHhccChhhhhccccchHHh--hcCcccc
Confidence 9999999999999999998 5555 4577764
|
|
| >KOG1989|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-40 Score=393.86 Aligned_cols=256 Identities=30% Similarity=0.469 Sum_probs=208.5
Q ss_pred ccccccccee-cccccccccccccccccccEEEEEEEcCCCcEEEEEEecccc-----ChHHHHHHHHHhcCCCCceEEE
Q psy11767 364 DKIFKGSLFF-EQYDMDLDKAGILGDGSYSVCRRCVEKSTGQEYAVKIISRKI-----DCSEEINLLRACQGHPNIVNLH 437 (966)
Q Consensus 364 d~if~G~~~~-~~~~i~~~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~-----~~~~Ei~iL~~l~~HpnIV~l~ 437 (966)
...+.|..|- ..+.+ ...+.|.+|||+.||+|.+...|..||+|++--.. ...+||++|+.|.+|+|||.|+
T Consensus 24 ~~~~~G~~~~Vg~~~v--~V~~vLAEGGFa~VYla~~~~~~~~~AlKrm~~~de~~L~~v~~EI~~MK~L~gh~nIV~yi 101 (738)
T KOG1989|consen 24 ENYFVGQTFTVGSHRV--TVEKVLAEGGFAQVYLAQDVKGGKKYALKRMYVNDEEALNAVKREIDIMKLLSGHKNIVSYI 101 (738)
T ss_pred ccCCCceEEEECCEEE--EEEEEEccCCcEEEEEEEecCCCceeeeeeeecCCHHHHHHHHHHHHHHHHhcCCCceeeEe
Confidence 3445554332 23333 34578999999999999999988999999875432 2567999999999999999999
Q ss_pred EE-EEe------CCeEEEEEEccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcC--ceeccCCCCcEEEec
Q psy11767 438 CV-FQD------EVHTYLVLELLKGGELLDRIRQKGRCGFTENEASRIMRQLVAAVHFMHSRG--VVHRDLKPENLLFSD 508 (966)
Q Consensus 438 ~~-~~~------~~~~~lVmEy~~gg~L~~~l~~~~~~~l~e~~~~~i~~Qil~aL~yLHs~~--IiHRDLKP~NILl~~ 508 (966)
+. ... .-.++|.||||.||.|.+++.++....|+|.++++||+|+|+|+++||... |||||||-|||||++
T Consensus 102 dss~~~~~~~~~~~EvllLmEyC~gg~Lvd~mn~Rlq~~lte~eVLkIf~dv~~AVa~mH~~~pPiIHRDLKiENvLls~ 181 (738)
T KOG1989|consen 102 DSSAINRSSNNGVWEVLLLMEYCKGGSLVDFMNTRLQTRLTEDEVLKIFYDVCEAVAAMHYLKPPIIHRDLKIENVLLSA 181 (738)
T ss_pred ccccccccCCCceeEEEeehhhccCCcHHHHHHHHHhccCChHHHHHHHHHHHHHHHHHhcCCCccchhhhhhhheEEcC
Confidence 93 221 135789999999999999998877777999999999999999999999997 999999999999985
Q ss_pred CCCCCEEEEeecccccccCCC-c-----------cccccccccCchhhccCCCCCCCcccchhhhhhhhhhhhcCCCCCC
Q psy11767 509 PAGDNIKVVDFGFACLKRESL-H-----------TPCFTLQYAAPEVLRQDKSGYDENCDLWSLGVILVNVLRQDKSGYD 576 (966)
Q Consensus 509 ~~~~~iKL~DFGla~~~~~~~-~-----------~~~gT~~Y~APEvl~~~~~~~~~~~Di~SlGvil~el~~~~~~~y~ 576 (966)
++.+||||||.|+...... . ....|+.|+|||++ |+|| +.+.+
T Consensus 182 --~g~~KLCDFGSatt~~~~~~~~~e~~~ve~eI~k~TTp~YRsPEMI-----------Dlys------------g~pI~ 236 (738)
T KOG1989|consen 182 --DGNYKLCDFGSATTKILSPTSAQEVNYVEEEIEKYTTPQYRSPEMI-----------DLYS------------GLPIG 236 (738)
T ss_pred --CCCEEeCcccccccccCCCccHHHHHHHHHHHHhhCCccccChHHH-----------hhhc------------CCCCc
Confidence 5699999999996432211 0 12359999999998 4554 45679
Q ss_pred CcCcchhHHHHHHHHhcCCCCCCCCCCchhHHHHHHHHHcCCCCCCchhhccCCHHHHHHHHHhcccCccccCChHHHHH
Q psy11767 577 ENCDLWSLGVILYTMLCGRVPFHARSRDDSALSIMARIKEGQFNFDAEAWSTVSSEAKELTKSLLTVNPAQRIRMMRVKL 656 (966)
Q Consensus 577 ~~~DIWSlGvilyemltG~~Pf~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~is~e~~~Li~~~L~~dP~~R~t~~~v~~ 656 (966)
+|+|||||||+||-|+....||..... ..|..|.|.+++- +.+|..+++||+.||+.||++||++.++..
T Consensus 237 eKsDIWALGclLYkLCy~t~PFe~sg~--------laIlng~Y~~P~~--p~ys~~l~~LI~~mL~~nP~~RPnI~Qv~~ 306 (738)
T KOG1989|consen 237 EKSDIWALGCLLYKLCYFTTPFEESGK--------LAILNGNYSFPPF--PNYSDRLKDLIRTMLQPNPDERPNIYQVLE 306 (738)
T ss_pred chhHHHHHHHHHHHHHHhCCCcCcCcc--------eeEEeccccCCCC--ccHHHHHHHHHHHHhccCcccCCCHHHHHH
Confidence 999999999999999999999986432 3577888887753 578999999999999999999999988743
|
|
| >KOG4279|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-41 Score=383.36 Aligned_cols=245 Identities=28% Similarity=0.424 Sum_probs=209.1
Q ss_pred ccccccccEEEEEEEcCCCcEEEEEEeccccC-----hHHHHHHHHHhcCCCCceEEEEEEEeCCeEEEEEEccCCCCHH
Q psy11767 385 ILGDGSYSVCRRCVEKSTGQEYAVKIISRKID-----CSEEINLLRACQGHPNIVNLHCVFQDEVHTYLVLELLKGGELL 459 (966)
Q Consensus 385 ~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~~-----~~~Ei~iL~~l~~HpnIV~l~~~~~~~~~~~lVmEy~~gg~L~ 459 (966)
+||+|+||+||.|+|+.|....|||-|..+.. ..+||.+.+.+. |.|||++++++..+++.-|.||-++||+|.
T Consensus 582 VLGKGTYG~VYA~RD~~tqvrIaIKEIpekdsr~~QPLhEEIaLH~~Lr-HkNIVrYLGs~senGf~kIFMEqVPGGSLS 660 (1226)
T KOG4279|consen 582 VLGKGTYGTVYAARDMDTQVRIAIKEIPEKDSREVQPLHEEIALHSTLR-HKNIVRYLGSVSENGFFKIFMEQVPGGSLS 660 (1226)
T ss_pred EeecCceeEEEeeccccceeEEEeeecccccchhhccHHHHHHHHHHHh-hHhHHHHhhccCCCCeEEEEeecCCCCcHH
Confidence 89999999999999999999999999976532 457999888885 999999999999999999999999999999
Q ss_pred HHHHhcCCCCC--CHHHHHHHHHHHHHHHHHHHhcCceeccCCCCcEEEecCCCCCEEEEeecccccc---cCCCccccc
Q psy11767 460 DRIRQKGRCGF--TENEASRIMRQLVAAVHFMHSRGVVHRDLKPENLLFSDPAGDNIKVVDFGFACLK---RESLHTPCF 534 (966)
Q Consensus 460 ~~l~~~~~~~l--~e~~~~~i~~Qil~aL~yLHs~~IiHRDLKP~NILl~~~~~~~iKL~DFGla~~~---~~~~~~~~g 534 (966)
+.|+.+=+ +| +|..+..|.+||++||.|||++.|||||||-+|+|+.. ..|.+||+|||-++.. .....++.|
T Consensus 661 sLLrskWG-PlKDNEstm~fYtkQILeGLkYLHen~IVHRDIKGDNVLvNT-ySGvlKISDFGTsKRLAginP~TETFTG 738 (1226)
T KOG4279|consen 661 SLLRSKWG-PLKDNESTMNFYTKQILEGLKYLHENKIVHRDIKGDNVLVNT-YSGVLKISDFGTSKRLAGINPCTETFTG 738 (1226)
T ss_pred HHHHhccC-CCccchhHHHHHHHHHHHHhhhhhhcceeeccccCCcEEEee-ccceEEecccccchhhccCCcccccccc
Confidence 99986532 56 89999999999999999999999999999999999964 5789999999988653 234567889
Q ss_pred cccccCchhhccCCCCCCCcccchhhhhhhhhhhhcCCCCCCCcCcchhHHHHHHHHhcCCCCCCCCCCchhHHHHHHHH
Q psy11767 535 TLQYAAPEVLRQDKSGYDENCDLWSLGVILVNVLRQDKSGYDENCDLWSLGVILYTMLCGRVPFHARSRDDSALSIMARI 614 (966)
Q Consensus 535 T~~Y~APEvl~~~~~~~~~~~Di~SlGvil~el~~~~~~~y~~~~DIWSlGvilyemltG~~Pf~~~~~~~~~~~~~~~i 614 (966)
|.+|||||++..+. .+|+.++|||||||++.||.||++||....... + +..
T Consensus 739 TLQYMAPEvIDqG~------------------------RGYG~aADIWS~GCT~vEMATGrPPF~Elgspq---A--AMF 789 (1226)
T KOG4279|consen 739 TLQYMAPEVIDQGP------------------------RGYGKAADIWSFGCTMVEMATGRPPFVELGSPQ---A--AMF 789 (1226)
T ss_pred chhhhChHhhccCC------------------------cCCCchhhhhhccceeEeeccCCCCeeecCChh---H--hhh
Confidence 99999999997544 458889999999999999999999998654322 2 223
Q ss_pred HcCCCCCCchhhccCCHHHHHHHHHhcccCccccCChHHHHHHhhhhHH
Q psy11767 615 KEGQFNFDAEAWSTVSSEAKELTKSLLTVNPAQRIRMMRVKLTFHAFHQ 663 (966)
Q Consensus 615 ~~~~~~~~~~~~~~is~e~~~Li~~~L~~dP~~R~t~~~v~~~~~~~~~ 663 (966)
+-|-|...++.+..+|.+++.+|.+|+..||.+||++.++ .-.+|.+
T Consensus 790 kVGmyKvHP~iPeelsaeak~FilrcFepd~~~R~sA~~L--L~DpFlq 836 (1226)
T KOG4279|consen 790 KVGMYKVHPPIPEELSAEAKNFILRCFEPDPCDRPSAKDL--LQDPFLQ 836 (1226)
T ss_pred hhcceecCCCCcHHHHHHHHHHHHHHcCCCcccCccHHHh--ccCcccc
Confidence 4466766777777899999999999999999999999875 3345543
|
|
| >cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-41 Score=375.38 Aligned_cols=238 Identities=34% Similarity=0.588 Sum_probs=198.7
Q ss_pred cccccccccEEEEEEEcCCCcEEEEEEecccc--------ChHHHHHHHHHhcCCCCceEEEEEEEeCCeEEEEEEccCC
Q psy11767 384 GILGDGSYSVCRRCVEKSTGQEYAVKIISRKI--------DCSEEINLLRACQGHPNIVNLHCVFQDEVHTYLVLELLKG 455 (966)
Q Consensus 384 ~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~--------~~~~Ei~iL~~l~~HpnIV~l~~~~~~~~~~~lVmEy~~g 455 (966)
++||+|+||.||+|.+..+|+.||||++.+.. ...+|+.+|+.+ +||||++++++|.++...|+||||++|
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l-~hp~i~~~~~~~~~~~~~~lv~e~~~~ 79 (323)
T cd05571 1 KLLGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNT-RHPFLTALKYSFQTHDRLCFVMEYANG 79 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhC-CCCCCCCEEEEEEcCCEEEEEEeCCCC
Confidence 36999999999999999999999999987532 134588889888 599999999999999999999999999
Q ss_pred CCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCcEEEecCCCCCEEEEeeccccccc---CCCccc
Q psy11767 456 GELLDRIRQKGRCGFTENEASRIMRQLVAAVHFMHSRGVVHRDLKPENLLFSDPAGDNIKVVDFGFACLKR---ESLHTP 532 (966)
Q Consensus 456 g~L~~~l~~~~~~~l~e~~~~~i~~Qil~aL~yLHs~~IiHRDLKP~NILl~~~~~~~iKL~DFGla~~~~---~~~~~~ 532 (966)
|+|.+++.... .+++..++.++.||+.||+|||++||+||||||+|||++. ++.+||+|||+++... ......
T Consensus 80 ~~L~~~l~~~~--~~~~~~~~~~~~qi~~~L~~lH~~~ivHrDlkp~NIll~~--~~~~kl~DfG~a~~~~~~~~~~~~~ 155 (323)
T cd05571 80 GELFFHLSRER--VFSEDRARFYGAEIVSALGYLHSCDVVYRDLKLENLMLDK--DGHIKITDFGLCKEGISDGATMKTF 155 (323)
T ss_pred CcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHhCCeEeCCCCHHHEEECC--CCCEEEeeCCCCcccccCCCcccce
Confidence 99999997654 5899999999999999999999999999999999999975 5689999999986532 223346
Q ss_pred cccccccCchhhccCCCCCCCcccchhhhhhhhhhhhcCCCCCCCcCcchhHHHHHHHHhcCCCCCCCCCCchhHHHHHH
Q psy11767 533 CFTLQYAAPEVLRQDKSGYDENCDLWSLGVILVNVLRQDKSGYDENCDLWSLGVILYTMLCGRVPFHARSRDDSALSIMA 612 (966)
Q Consensus 533 ~gT~~Y~APEvl~~~~~~~~~~~Di~SlGvil~el~~~~~~~y~~~~DIWSlGvilyemltG~~Pf~~~~~~~~~~~~~~ 612 (966)
+||+.|+|||++.. ..|+.++|||||||++|+|++|+.||...+. .....
T Consensus 156 ~gt~~y~aPE~~~~--------------------------~~~~~~~DiwSlG~il~elltg~~Pf~~~~~----~~~~~ 205 (323)
T cd05571 156 CGTPEYLAPEVLED--------------------------NDYGRAVDWWGLGVVMYEMMCGRLPFYNQDH----EKLFE 205 (323)
T ss_pred ecCccccChhhhcC--------------------------CCCCccccCcccchhhhhhhcCCCCCCCCCH----HHHHH
Confidence 78999999999852 3478899999999999999999999986543 23344
Q ss_pred HHHcCCCCCCchhhccCCHHHHHHHHHhcccCccccC-----ChHHHHHHhhhhH
Q psy11767 613 RIKEGQFNFDAEAWSTVSSEAKELTKSLLTVNPAQRI-----RMMRVKLTFHAFH 662 (966)
Q Consensus 613 ~i~~~~~~~~~~~~~~is~e~~~Li~~~L~~dP~~R~-----t~~~v~~~~~~~~ 662 (966)
.+..+...++ ..+++++.+||.+||..||++|| ++.++ ..|+|+
T Consensus 206 ~~~~~~~~~p----~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~l--l~h~~f 254 (323)
T cd05571 206 LILMEEIRFP----RTLSPEAKSLLAGLLKKDPKQRLGGGPEDAKEI--MEHRFF 254 (323)
T ss_pred HHHcCCCCCC----CCCCHHHHHHHHHHccCCHHHcCCCCCCCHHHH--HcCCCc
Confidence 5555554433 35899999999999999999999 56654 456665
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be |
| >cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-40 Score=365.05 Aligned_cols=247 Identities=30% Similarity=0.485 Sum_probs=201.5
Q ss_pred ccccccccccccEEEEEEEcCCCcEEEEEEecccc--------ChHHHHHHHHHhcCCCCceEEEEEEEeCCeEEEEEEc
Q psy11767 381 DKAGILGDGSYSVCRRCVEKSTGQEYAVKIISRKI--------DCSEEINLLRACQGHPNIVNLHCVFQDEVHTYLVLEL 452 (966)
Q Consensus 381 ~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~--------~~~~Ei~iL~~l~~HpnIV~l~~~~~~~~~~~lVmEy 452 (966)
+..+.||+|+||.||+|.+..+|+.||||++.... ...+|+.+|+.+ +|+||+++++++.++...|+||||
T Consensus 3 ~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l-~~~~iv~~~~~~~~~~~~~lv~e~ 81 (285)
T cd05631 3 RHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKV-NSRFVVSLAYAYETKDALCLVLTI 81 (285)
T ss_pred eEEEEEecCCCEEEEEEEEecCCceEEEEEeeHhhhhhhhhHHHHHHHHHHHHhc-CCCcEEEEEEEEccCCeEEEEEEe
Confidence 34678999999999999999999999999986432 134688999888 599999999999999999999999
Q ss_pred cCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCcEEEecCCCCCEEEEeecccccccC--CCc
Q psy11767 453 LKGGELLDRIRQKGRCGFTENEASRIMRQLVAAVHFMHSRGVVHRDLKPENLLFSDPAGDNIKVVDFGFACLKRE--SLH 530 (966)
Q Consensus 453 ~~gg~L~~~l~~~~~~~l~e~~~~~i~~Qil~aL~yLHs~~IiHRDLKP~NILl~~~~~~~iKL~DFGla~~~~~--~~~ 530 (966)
|++|+|.+++.......+++..+..++.||+.||+|||++||+||||||+|||+++ .+.+||+|||++..... ...
T Consensus 82 ~~~g~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~iiH~dikp~Nill~~--~~~~kl~Dfg~~~~~~~~~~~~ 159 (285)
T cd05631 82 MNGGDLKFHIYNMGNPGFDEQRAIFYAAELCCGLEDLQRERIVYRDLKPENILLDD--RGHIRISDLGLAVQIPEGETVR 159 (285)
T ss_pred cCCCcHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCCCHHHEEECC--CCCEEEeeCCCcEEcCCCCeec
Confidence 99999998887655446999999999999999999999999999999999999975 56899999999976432 223
Q ss_pred cccccccccCchhhccCCCCCCCcccchhhhhhhhhhhhcCCCCCCCcCcchhHHHHHHHHhcCCCCCCCCCCchhHHHH
Q psy11767 531 TPCFTLQYAAPEVLRQDKSGYDENCDLWSLGVILVNVLRQDKSGYDENCDLWSLGVILYTMLCGRVPFHARSRDDSALSI 610 (966)
Q Consensus 531 ~~~gT~~Y~APEvl~~~~~~~~~~~Di~SlGvil~el~~~~~~~y~~~~DIWSlGvilyemltG~~Pf~~~~~~~~~~~~ 610 (966)
...||+.|+|||++.. ..|+.++|||||||++|+|++|+.||...........+
T Consensus 160 ~~~g~~~y~aPE~~~~--------------------------~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~~ 213 (285)
T cd05631 160 GRVGTVGYMAPEVINN--------------------------EKYTFSPDWWGLGCLIYEMIQGQSPFRKRKERVKREEV 213 (285)
T ss_pred CCCCCCCccCHhhhcC--------------------------CCCCcccCchhHHHHHHHHHhCCCCCCCCCcchhHHHH
Confidence 4578999999999852 24788999999999999999999999876543322233
Q ss_pred HHHHHcCCCCCCchhhccCCHHHHHHHHHhcccCccccCC-----hHHHHHHhhhhH
Q psy11767 611 MARIKEGQFNFDAEAWSTVSSEAKELTKSLLTVNPAQRIR-----MMRVKLTFHAFH 662 (966)
Q Consensus 611 ~~~i~~~~~~~~~~~~~~is~e~~~Li~~~L~~dP~~R~t-----~~~v~~~~~~~~ 662 (966)
...+...... ....+++++.+||.+||..||++||+ +.++ ..|+|+
T Consensus 214 ~~~~~~~~~~----~~~~~s~~~~~li~~~l~~~P~~R~~~~~~~~~~~--~~h~~~ 264 (285)
T cd05631 214 DRRVKEDQEE----YSEKFSEDAKSICRMLLTKNPKERLGCRGNGAAGV--KQHPIF 264 (285)
T ss_pred HHHhhccccc----CCccCCHHHHHHHHHHhhcCHHHhcCCCCCCHHHH--hcCHhh
Confidence 3334333332 23457999999999999999999997 4544 346664
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i |
| >KOG4717|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-41 Score=371.57 Aligned_cols=249 Identities=37% Similarity=0.639 Sum_probs=214.1
Q ss_pred cccccccccccccccccccEEEEEEEcCCCcEEEEEEeccccC-------hHHHHHHHHHhcCCCCceEEEEEEEeCCeE
Q psy11767 374 EQYDMDLDKAGILGDGSYSVCRRCVEKSTGQEYAVKIISRKID-------CSEEINLLRACQGHPNIVNLHCVFQDEVHT 446 (966)
Q Consensus 374 ~~~~i~~~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~~-------~~~Ei~iL~~l~~HpnIV~l~~~~~~~~~~ 446 (966)
.-|++ .+.||+|.|.+|-+|+|.-||..||||++.+.+. ...|++.|+.++ |||||+||++..+...+
T Consensus 18 GLYDL----ekTlG~GHFAVVKLArHVFTGekVAVKviDKTKlD~~st~hlfqEVRCMKLVQ-HpNiVRLYEViDTQTKl 92 (864)
T KOG4717|consen 18 GLYDL----EKTLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDTLSTGHLFQEVRCMKLVQ-HPNIVRLYEVIDTQTKL 92 (864)
T ss_pred eeehh----hhhhcCCceehhhhhhhhcccceeEEEEecccccchhhhhHHHHHHHHHHHhc-CcCeeeeeehhcccceE
Confidence 34555 4789999999999999999999999999987532 457999998774 99999999999999999
Q ss_pred EEEEEccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCcEEEecCCCCCEEEEeecccccc-
Q psy11767 447 YLVLELLKGGELLDRIRQKGRCGFTENEASRIMRQLVAAVHFMHSRGVVHRDLKPENLLFSDPAGDNIKVVDFGFACLK- 525 (966)
Q Consensus 447 ~lVmEy~~gg~L~~~l~~~~~~~l~e~~~~~i~~Qil~aL~yLHs~~IiHRDLKP~NILl~~~~~~~iKL~DFGla~~~- 525 (966)
|||+|+-++|+|++||.++.. ++.|..+++||.||+.|+.|||...+|||||||+|+.+-+ .-|-+||+|||++..+
T Consensus 93 yLiLELGD~GDl~DyImKHe~-Gl~E~La~kYF~QI~~AI~YCHqLHVVHRDLKPENVVFFE-KlGlVKLTDFGFSNkf~ 170 (864)
T KOG4717|consen 93 YLILELGDGGDLFDYIMKHEE-GLNEDLAKKYFAQIVHAISYCHQLHVVHRDLKPENVVFFE-KLGLVKLTDFGFSNKFQ 170 (864)
T ss_pred EEEEEecCCchHHHHHHhhhc-cccHHHHHHHHHHHHHHHHHHhhhhhhcccCCcceeEEee-ecCceEeeeccccccCC
Confidence 999999999999999988765 7999999999999999999999999999999999999876 4578999999999654
Q ss_pred -cCCCccccccccccCchhhccCCCCCCCcccchhhhhhhhhhhhcCCCCCC-CcCcchhHHHHHHHHhcCCCCCCCCCC
Q psy11767 526 -RESLHTPCFTLQYAAPEVLRQDKSGYDENCDLWSLGVILVNVLRQDKSGYD-ENCDLWSLGVILYTMLCGRVPFHARSR 603 (966)
Q Consensus 526 -~~~~~~~~gT~~Y~APEvl~~~~~~~~~~~Di~SlGvil~el~~~~~~~y~-~~~DIWSlGvilyemltG~~Pf~~~~~ 603 (966)
+....+.||+..|-|||+|.+.. |+ +++||||||||||-|++|++||+..+.
T Consensus 171 PG~kL~TsCGSLAYSAPEILLGDs--------------------------YDAPAVDiWSLGVILyMLVCGq~PFqeAND 224 (864)
T KOG4717|consen 171 PGKKLTTSCGSLAYSAPEILLGDS--------------------------YDAPAVDIWSLGVILYMLVCGQPPFQEAND 224 (864)
T ss_pred CcchhhcccchhhccCchhhhcCc--------------------------cCCcchhhhHHHHHHHHHHhCCCccccccc
Confidence 34678999999999999997432 43 579999999999999999999998776
Q ss_pred chhHHHHHHHHHcCCCCCCchhhccCCHHHHHHHHHhcccCccccCChHHHHHHhhhhHHhh
Q psy11767 604 DDSALSIMARIKEGQFNFDAEAWSTVSSEAKELTKSLLTVNPAQRIRMMRVKLTFHAFHQAQ 665 (966)
Q Consensus 604 ~~~~~~~~~~i~~~~~~~~~~~~~~is~e~~~Li~~~L~~dP~~R~t~~~v~~~~~~~~~~~ 665 (966)
.+ .+..|..+.|..+ ..+|.++++||.+||..||.+|.+..++. -++|.++.
T Consensus 225 SE----TLTmImDCKYtvP----shvS~eCrdLI~sMLvRdPkkRAslEeI~--s~~Wlq~~ 276 (864)
T KOG4717|consen 225 SE----TLTMIMDCKYTVP----SHVSKECRDLIQSMLVRDPKKRASLEEIV--STSWLQAG 276 (864)
T ss_pred hh----hhhhhhcccccCc----hhhhHHHHHHHHHHHhcCchhhccHHHHh--ccccccCC
Confidence 54 3556777777655 35899999999999999999999998764 34555443
|
|
| >cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-40 Score=368.22 Aligned_cols=242 Identities=31% Similarity=0.591 Sum_probs=203.8
Q ss_pred cccccccccccccEEEEEEEcCCCcEEEEEEecccc--------ChHHHHHHHHHhcCCCCceEEEEEEEeCCeEEEEEE
Q psy11767 380 LDKAGILGDGSYSVCRRCVEKSTGQEYAVKIISRKI--------DCSEEINLLRACQGHPNIVNLHCVFQDEVHTYLVLE 451 (966)
Q Consensus 380 ~~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~--------~~~~Ei~iL~~l~~HpnIV~l~~~~~~~~~~~lVmE 451 (966)
|+..+.||+|+||.||+|.+..+|+.||||++.... ...+|+.+|+.+ +||||+++++++.++...|+|||
T Consensus 3 y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l-~hp~iv~~~~~~~~~~~~~lv~e 81 (291)
T cd05612 3 LERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEV-SHPFIIRLFWTEHDQRFLYMLME 81 (291)
T ss_pred ceeeeeeecCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhhHHHHHHHHHHHHHHhC-CCCcHhhhHhhhccCCeEEEEEe
Confidence 344688999999999999999999999999986421 244689999988 59999999999999999999999
Q ss_pred ccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCcEEEecCCCCCEEEEeecccccccCCCcc
Q psy11767 452 LLKGGELLDRIRQKGRCGFTENEASRIMRQLVAAVHFMHSRGVVHRDLKPENLLFSDPAGDNIKVVDFGFACLKRESLHT 531 (966)
Q Consensus 452 y~~gg~L~~~l~~~~~~~l~e~~~~~i~~Qil~aL~yLHs~~IiHRDLKP~NILl~~~~~~~iKL~DFGla~~~~~~~~~ 531 (966)
|+++|+|.+++...+ .+++..++.++.||+.||+|||++||+||||||+|||+++ .+.+||+|||++.........
T Consensus 82 ~~~~~~L~~~~~~~~--~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~NIli~~--~~~~kl~Dfg~~~~~~~~~~~ 157 (291)
T cd05612 82 YVPGGELFSYLRNSG--RFSNSTGLFYASEIVCALEYLHSKEIVYRDLKPENILLDK--EGHIKLTDFGFAKKLRDRTWT 157 (291)
T ss_pred CCCCCCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHeEECC--CCCEEEEecCcchhccCCccc
Confidence 999999999997765 5899999999999999999999999999999999999974 568999999999776555556
Q ss_pred ccccccccCchhhccCCCCCCCcccchhhhhhhhhhhhcCCCCCCCcCcchhHHHHHHHHhcCCCCCCCCCCchhHHHHH
Q psy11767 532 PCFTLQYAAPEVLRQDKSGYDENCDLWSLGVILVNVLRQDKSGYDENCDLWSLGVILYTMLCGRVPFHARSRDDSALSIM 611 (966)
Q Consensus 532 ~~gT~~Y~APEvl~~~~~~~~~~~Di~SlGvil~el~~~~~~~y~~~~DIWSlGvilyemltG~~Pf~~~~~~~~~~~~~ 611 (966)
.+||+.|+|||++.. ..++.++|||||||++|+|++|+.||.+.+. ..+.
T Consensus 158 ~~gt~~y~aPE~~~~--------------------------~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~----~~~~ 207 (291)
T cd05612 158 LCGTPEYLAPEVIQS--------------------------KGHNKAVDWWALGILIYEMLVGYPPFFDDNP----FGIY 207 (291)
T ss_pred ccCChhhcCHHHHcC--------------------------CCCCchhhHHHHHHHHHHHHhCCCCCCCCCH----HHHH
Confidence 679999999998852 2367889999999999999999999987543 2345
Q ss_pred HHHHcCCCCCCchhhccCCHHHHHHHHHhcccCccccCC-----hHHHHHHhhhhH
Q psy11767 612 ARIKEGQFNFDAEAWSTVSSEAKELTKSLLTVNPAQRIR-----MMRVKLTFHAFH 662 (966)
Q Consensus 612 ~~i~~~~~~~~~~~~~~is~e~~~Li~~~L~~dP~~R~t-----~~~v~~~~~~~~ 662 (966)
..+..+...++ ..+++++++||++||+.||.+|++ +.++ ..|+|+
T Consensus 208 ~~i~~~~~~~~----~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~--l~h~~~ 257 (291)
T cd05612 208 EKILAGKLEFP----RHLDLYAKDLIKKLLVVDRTRRLGNMKNGADDV--KNHRWF 257 (291)
T ss_pred HHHHhCCcCCC----ccCCHHHHHHHHHHcCCCHHHccCCccCCHHHH--hcCccc
Confidence 55666655443 246889999999999999999996 5544 355654
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt |
| >KOG0603|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-41 Score=384.14 Aligned_cols=438 Identities=30% Similarity=0.464 Sum_probs=303.4
Q ss_pred ccccccccEEEEEEE---cCCCcEEEEEEeccccC-------hHHHHHHHHHhcCCCCceEEEEEEEeCCeEEEEEEccC
Q psy11767 385 ILGDGSYSVCRRCVE---KSTGQEYAVKIISRKID-------CSEEINLLRACQGHPNIVNLHCVFQDEVHTYLVLELLK 454 (966)
Q Consensus 385 ~LG~G~fG~Vy~a~~---~~tg~~vAvK~i~~~~~-------~~~Ei~iL~~l~~HpnIV~l~~~~~~~~~~~lVmEy~~ 454 (966)
++|+|+||.|++++- ...|+.+|+|+..+... ...|..++..+.+||.+|+++.+|+.++..|++++|..
T Consensus 1 vlg~g~~gkvfLvrk~~g~da~~~yamkvl~k~t~~~~~~~~t~~er~il~~~~~~~f~v~lhyafqt~~kl~l~ld~~r 80 (612)
T KOG0603|consen 1 VLGQGSYGKVFLVRKAGGADAGHLYAMKVLKKATLKVRDRTHTKQERIILAFVHNTPFLVKLHYAFQTDGKLYLILDFLR 80 (612)
T ss_pred CCCcCCCcchHHHHHhccccccchhhhhcccccccccccccccccHHHHHhhccCCCceeeeeeeeccccchhHhhhhcc
Confidence 489999999987643 35688999999875432 33588888888889999999999999999999999999
Q ss_pred CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCcEEEecCCCCCEEEEeecccccccCCCccccc
Q psy11767 455 GGELLDRIRQKGRCGFTENEASRIMRQLVAAVHFMHSRGVVHRDLKPENLLFSDPAGDNIKVVDFGFACLKRESLHTPCF 534 (966)
Q Consensus 455 gg~L~~~l~~~~~~~l~e~~~~~i~~Qil~aL~yLHs~~IiHRDLKP~NILl~~~~~~~iKL~DFGla~~~~~~~~~~~g 534 (966)
||+|+..+.+.. .+.+...+.+...++.|++++|+.+|+|||+|++||+++. .|++|+.|||+++...+.... ||
T Consensus 81 gg~lft~l~~~~--~f~~~~~~~~~aelaLald~lh~l~iiyrd~k~enilld~--~Ghi~~tdfglske~v~~~~~-cg 155 (612)
T KOG0603|consen 81 GGDLFTRLSKEV--MFDELDVAFYLAELALALDHLHKLGIAYRDYKLENVLLLL--EGHIKLTDFGLSKEAVKEKIA-CG 155 (612)
T ss_pred cchhhhccccCC--chHHHHHHHHHHHHHHHHhhcchhHHHHhcccccceeecc--cCccccCCchhhhHhHhhhhc-cc
Confidence 999999887654 6899999999999999999999999999999999999984 679999999999876543333 99
Q ss_pred cccccCchhhccCCCCCCCcccchhhhhhhhhhhhcCCCCCCCcCcchhHHHHHHHHhcCCCCCCCCCCchhHHHHHHHH
Q psy11767 535 TLQYAAPEVLRQDKSGYDENCDLWSLGVILVNVLRQDKSGYDENCDLWSLGVILYTMLCGRVPFHARSRDDSALSIMARI 614 (966)
Q Consensus 535 T~~Y~APEvl~~~~~~~~~~~Di~SlGvil~el~~~~~~~y~~~~DIWSlGvilyemltG~~Pf~~~~~~~~~~~~~~~i 614 (966)
|..|||||++. ++...+|+||+|+++|+|++|..||.. .++.+|
T Consensus 156 t~eymApEI~~----------------------------gh~~a~D~ws~gvl~felltg~~pf~~--------~~~~~I 199 (612)
T KOG0603|consen 156 TYEYRAPEIIN----------------------------GHLSAADWWSFGVLAFELLTGTLPFGG--------DTMKRI 199 (612)
T ss_pred chhhhhhHhhh----------------------------ccCCcccchhhhhhHHHHhhCCCCCch--------HHHHHH
Confidence 99999999985 256789999999999999999999986 355667
Q ss_pred HcCCCCCCchhhccCCHHHHHHHHHhcccCccccCChH--HH-HHHhhhhHHhhhccccccccchHHHHHhhhcCCCCCC
Q psy11767 615 KEGQFNFDAEAWSTVSSEAKELTKSLLTVNPAQRIRMM--RV-KLTFHAFHQAQKEGFRLQDVTSAKLAQRRKNKNVSND 691 (966)
Q Consensus 615 ~~~~~~~~~~~~~~is~e~~~Li~~~L~~dP~~R~t~~--~v-~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~ 691 (966)
...++.++. .++.++++++..++..+|..|.... .+ ....|.|. +.+.+..+..+.......
T Consensus 200 l~~~~~~p~----~l~~~a~~~~~~l~~r~p~nrLg~~~~~~~eik~h~f~---------~~i~~~~l~~r~~~~~fk-- 264 (612)
T KOG0603|consen 200 LKAELEMPR----ELSAEARSLFRQLFKRNPENRLGAGPDGVDEIKQHEFF---------QSIDWNELEARSRPPPFK-- 264 (612)
T ss_pred hhhccCCch----hhhHHHHHHHHHHHhhCHHHHhccCcchhHHHhccchh---------eeeeHhhHhhcCCCCCCC--
Confidence 666665554 4678999999999999999998663 11 22334443 334444444332211110
Q ss_pred CCCccccCCCCCCCCC--CCCCCCCCCCCCCCCCCCCCcccccccCCCCCccchhhhhhhhhcccccccCCCCCCCCCCC
Q psy11767 692 NSRSFSSTSSSLSSSS--SGTSSLKTPCSSTQPSVPSKPVKRINKDASSGTVFDFAEARVQEYLSSLSSSSSSEHGTSPP 769 (966)
Q Consensus 692 ~s~~~ss~~s~~~sss--s~~s~~~~~~~s~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~s~~~~~~~~~~ 769 (966)
+......... +..-+..+|..++..+.+ ++.+.+|+ ..+.++.+.... +.++
T Consensus 265 ------p~~~~e~~~~~fd~eft~~~P~dsp~~~~~----------~s~~~if~--------g~sfva~~il~~-~~~~- 318 (612)
T KOG0603|consen 265 ------PGSITERDVAQFDPEFTSQVPADSPLLSAS----------GSDHTIFS--------GPSFVAPGVLED-AVTA- 318 (612)
T ss_pred ------CcccchhhhhhcCchhccCCcccCCCCCCC----------ccccchhc--------CCCccChHHhhc-cccC-
Confidence 0000000000 000001112221111111 01111121 001110000000 0000
Q ss_pred CCcccccccccccccCCCCCCCCCCCccccccccccccccccccccCCCCCCccccccccccCCC-chhhhh-hhhcccc
Q psy11767 770 SSSTIQLQLSPVRKKKKPDLTLPASNKAESEQLHLAEPSTLAGTKRKHKPDTSSQCSKSLPATHS-TPARKK-KKADRQP 847 (966)
Q Consensus 770 ~~~~~~a~~~~~~~~~~~~~~lp~~~~~~s~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~-~~~~~~~ 847 (966)
+ ..++ +..+.+.+.++++.|.+|.+.++. ++++|. .+...+.
T Consensus 319 ----------~-----------------~~~~---------y~~~~~~~~gs~s~~~~~~~~~t~~~~~vkii~~~~~~~ 362 (612)
T KOG0603|consen 319 ----------P-----------------FTES---------YEFREELGEGSFSAVKYCESSPTDQEPAVKIISKRADDN 362 (612)
T ss_pred ----------C-----------------cchh---------hccccccCCCCccceeeeeccccccchhheecccccccc
Confidence 0 0011 112344667889999999988877 667764 3322222
Q ss_pred ccccccCCCCCCCCCchhhHhhHHHHhCCcCCCcceeeeeccccCceEEEEEeccCCCCHHHHHHhhCCCCCCHHHHHHH
Q psy11767 848 AKQEEKQPVPQTTPPTDLVTLFEEQLLGPITRARRRTFVNRSRYNVHTYLVLELLKGGELLDRIRQKGRCGFTENEASRI 927 (966)
Q Consensus 848 ~~~~~~~~~~~~~~~~~~~~l~e~~il~~l~~~~i~~~~~~~~~~~~~yLVmEy~~gg~L~~~i~~~~~~~~~~~~~~~~ 927 (966)
+.+ ..+ .+.-..|+++++..+.+..+.+.|+|||++.|+.+++.+..... +. .++..|
T Consensus 363 ~~e------------~~~-------~~~~~~h~niv~~~~v~~~~~~~~~v~e~l~g~ell~ri~~~~~--~~-~e~~~w 420 (612)
T KOG0603|consen 363 QDE------------IPI-------SLLVRDHPNIVKSHDVYEDGKEIYLVMELLDGGELLRRIRSKPE--FC-SEASQW 420 (612)
T ss_pred ccc------------cch-------hhhhcCCCcceeecceecCCceeeeeehhccccHHHHHHHhcch--hH-HHHHHH
Confidence 111 001 22335899999999999999999999999999999999986642 33 888899
Q ss_pred HHHHHHHHHHHHhCCCcccCCCCCCeEeecCCCCe
Q psy11767 928 MRQLVAAVHFMHSRGVVHRDLKPENLLLSGISGNL 962 (966)
Q Consensus 928 ~~qi~~al~ylH~~gIiHRDlKPeNILl~~~~~~~ 962 (966)
++||+.|+.|||++|||||||||+|||+.+..|++
T Consensus 421 ~~~lv~Av~~LH~~gvvhRDLkp~NIL~~~~~g~l 455 (612)
T KOG0603|consen 421 AAELVSAVDYLHEQGVVHRDLKPGNILLDGSAGHL 455 (612)
T ss_pred HHHHHHHHHHHHhcCeeecCCChhheeecCCCCcE
Confidence 99999999999999999999999999997545554
|
|
| >KOG0594|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-40 Score=358.77 Aligned_cols=252 Identities=33% Similarity=0.536 Sum_probs=205.5
Q ss_pred cccccccccccccEEEEEEEcCCCcEEEEEEeccccC-------hHHHHHHHHHhcCCCC-ceEEEEEEEeCC------e
Q psy11767 380 LDKAGILGDGSYSVCRRCVEKSTGQEYAVKIISRKID-------CSEEINLLRACQGHPN-IVNLHCVFQDEV------H 445 (966)
Q Consensus 380 ~~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~~-------~~~Ei~iL~~l~~Hpn-IV~l~~~~~~~~------~ 445 (966)
|+.+++||+|+||+||+|+++.+|+.||+|.+....+ ..+|+.+|+.+. |+| ||.|++++.+.. .
T Consensus 13 ~~~~eklGeGtyg~Vykar~~~~g~~VALKkirl~~~~EG~P~taiREisllk~L~-~~~~iv~L~dv~~~~~~~~~~~~ 91 (323)
T KOG0594|consen 13 YEKVEKLGEGTYGVVYKARSKRTGKFVALKKIRLEFEEEGVPSTAIREISLLKRLS-HANHIVRLHDVIHTSNNHRGIGK 91 (323)
T ss_pred HHHHHHhCCCCceEEEEEEEecCCCEEEEEEEeccccccCCCchhhHHHHHHHHhC-CCcceEEEEeeeeecccccccce
Confidence 4557789999999999999999999999999975433 578999999994 999 999999999877 7
Q ss_pred EEEEEEccCCCCHHHHHHhcCC--CCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCcEEEecCCCCCEEEEeecccc
Q psy11767 446 TYLVLELLKGGELLDRIRQKGR--CGFTENEASRIMRQLVAAVHFMHSRGVVHRDLKPENLLFSDPAGDNIKVVDFGFAC 523 (966)
Q Consensus 446 ~~lVmEy~~gg~L~~~l~~~~~--~~l~e~~~~~i~~Qil~aL~yLHs~~IiHRDLKP~NILl~~~~~~~iKL~DFGla~ 523 (966)
+++|+||+ .-+|..++..... .+++...++.+++||+.||+|||+++|+||||||+|||++. .+.+||+|||+|+
T Consensus 92 l~lvfe~~-d~DL~~ymd~~~~~~~g~~~~~ik~~m~Qll~gl~~~H~~~IlHRDLKPQNlLi~~--~G~lKlaDFGlAr 168 (323)
T KOG0594|consen 92 LYLVFEFL-DRDLKKYMDSLPKKPQGLPPRLIKSFMRQLLRGLAFLHSHGILHRDLKPQNLLISS--SGVLKLADFGLAR 168 (323)
T ss_pred EEEEEEee-cccHHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHHhCCeecccCCcceEEECC--CCcEeeeccchHH
Confidence 99999999 4699999987663 36888999999999999999999999999999999999985 6799999999997
Q ss_pred cccC---CCccccccccccCchhhccCCCCCCCcccchhhhhhhhhhhhcCCCCCCCcCcchhHHHHHHHHhcCCCCCCC
Q psy11767 524 LKRE---SLHTPCFTLQYAAPEVLRQDKSGYDENCDLWSLGVILVNVLRQDKSGYDENCDLWSLGVILYTMLCGRVPFHA 600 (966)
Q Consensus 524 ~~~~---~~~~~~gT~~Y~APEvl~~~~~~~~~~~Di~SlGvil~el~~~~~~~y~~~~DIWSlGvilyemltG~~Pf~~ 600 (966)
...- ...+.++|.+|+|||++.+. ..|+..+||||+|||++||+++++-|.+
T Consensus 169 a~~ip~~~yt~evvTlWYRaPEvLlGs-------------------------~~Ys~~vDiWs~GcIfaEm~~~~~LFpG 223 (323)
T KOG0594|consen 169 AFSIPMRTYTPEVVTLWYRAPEVLLGS-------------------------TSYSTSVDIWSLGCIFAEMFTRRPLFPG 223 (323)
T ss_pred HhcCCcccccccEEEeeccCHHHhcCC-------------------------CcCCCCcchHhHHHHHHHHHhCCCCCCC
Confidence 6542 24456789999999998642 3488999999999999999999999999
Q ss_pred CCCchhHHHHHHHHHcC------------CCC--CC--------chhhccCCHHHHHHHHHhcccCccccCChHHHHHHh
Q psy11767 601 RSRDDSALSIMARIKEG------------QFN--FD--------AEAWSTVSSEAKELTKSLLTVNPAQRIRMMRVKLTF 658 (966)
Q Consensus 601 ~~~~~~~~~~~~~i~~~------------~~~--~~--------~~~~~~is~e~~~Li~~~L~~dP~~R~t~~~v~~~~ 658 (966)
.+..++...++..+... .+. +. ....+..++++.+++.+||+++|.+|+|+..+ ..
T Consensus 224 ~se~~ql~~If~~lGtP~e~~Wp~v~~~~~~k~~f~~~~~~~~l~~~~~~~~~~~~dll~~~L~y~p~~R~Sa~~a--l~ 301 (323)
T KOG0594|consen 224 DSEIDQLFRIFRLLGTPNEKDWPGVSSLPDYKAPFPKWPGPKDLSSILPKLDPDGIELLSKLLQYDPAKRISAKGA--LT 301 (323)
T ss_pred CcHHHHHHHHHHHcCCCCccCCCCccccccccccCcCCCCccchHHhccccCccHHHHHHHHhccCcccCcCHHHH--hc
Confidence 87765555555433211 011 11 01223455689999999999999999999854 33
Q ss_pred hhhH
Q psy11767 659 HAFH 662 (966)
Q Consensus 659 ~~~~ 662 (966)
|+++
T Consensus 302 h~yf 305 (323)
T KOG0594|consen 302 HPYF 305 (323)
T ss_pred Chhh
Confidence 4444
|
|
| >KOG0582|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-40 Score=363.81 Aligned_cols=253 Identities=27% Similarity=0.467 Sum_probs=211.0
Q ss_pred ccccccccccccEEEEEEEcCCCcEEEEEEecccc------ChHHHHHHHHHhcCCCCceEEEEEEEeCCeEEEEEEccC
Q psy11767 381 DKAGILGDGSYSVCRRCVEKSTGQEYAVKIISRKI------DCSEEINLLRACQGHPNIVNLHCVFQDEVHTYLVLELLK 454 (966)
Q Consensus 381 ~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~------~~~~Ei~iL~~l~~HpnIV~l~~~~~~~~~~~lVmEy~~ 454 (966)
+...+||.|.-++||+|+...+++.||||++.-+. ...+|+..|..+ +|||||+++.+|..+..+|+||.||.
T Consensus 29 eL~e~IG~G~sa~V~~A~c~p~~e~VAIK~inLEkc~~~ld~l~kE~~~msl~-~HPNIv~~~~sFvv~~~LWvVmpfMa 107 (516)
T KOG0582|consen 29 ELQEVIGVGASAVVYLARCIPTNEVVAIKIINLEKCNNDLDALRKEVQTMSLI-DHPNIVTYHCSFVVDSELWVVMPFMA 107 (516)
T ss_pred eEEEEEeccceeEeeeeeecccCCEEEEEEeehhhhhhhHHHHHHHHHHhhhc-CCCCcceEEEEEEecceeEEeehhhc
Confidence 33568999999999999999999999999997432 245688888877 69999999999999999999999999
Q ss_pred CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCcEEEecCCCCCEEEEeecccccccC-------
Q psy11767 455 GGELLDRIRQKGRCGFTENEASRIMRQLVAAVHFMHSRGVVHRDLKPENLLFSDPAGDNIKVVDFGFACLKRE------- 527 (966)
Q Consensus 455 gg~L~~~l~~~~~~~l~e~~~~~i~~Qil~aL~yLHs~~IiHRDLKP~NILl~~~~~~~iKL~DFGla~~~~~------- 527 (966)
+|++++.++.....+|+|..+..|++++++||.|||.+|.||||||+.||||++ +|.|||+|||.+.....
T Consensus 108 ~GS~ldIik~~~~~Gl~E~~Ia~iLre~LkaL~YLH~~G~IHRdvKAgnILi~~--dG~VkLadFgvsa~l~~~G~R~~~ 185 (516)
T KOG0582|consen 108 GGSLLDIIKTYYPDGLEEASIATILREVLKALDYLHQNGHIHRDVKAGNILIDS--DGTVKLADFGVSASLFDSGDRQVT 185 (516)
T ss_pred CCcHHHHHHHHccccccHHHHHHHHHHHHHHHHHHHhcCceecccccccEEEcC--CCcEEEcCceeeeeecccCceeeE
Confidence 999999999988888999999999999999999999999999999999999985 67999999998743211
Q ss_pred CCccccccccccCchhhccCCCCCCCcccchhhhhhhhhhhhcCCCCCCCcCcchhHHHHHHHHhcCCCCCCCCCCchhH
Q psy11767 528 SLHTPCFTLQYAAPEVLRQDKSGYDENCDLWSLGVILVNVLRQDKSGYDENCDLWSLGVILYTMLCGRVPFHARSRDDSA 607 (966)
Q Consensus 528 ~~~~~~gT~~Y~APEvl~~~~~~~~~~~Di~SlGvil~el~~~~~~~y~~~~DIWSlGvilyemltG~~Pf~~~~~~~~~ 607 (966)
..++.+|||.|||||++.++. .+|+.|+||||||++..||.+|..||.......
T Consensus 186 rf~tfvgtp~wmAPEvl~q~~------------------------~GYdfKaDIwSfGITA~ELA~G~aPf~k~pPmk-- 239 (516)
T KOG0582|consen 186 RFNTFVGTPCWMAPEVLMQQL------------------------HGYDFKADIWSFGITACELAHGHAPFSKYPPMK-- 239 (516)
T ss_pred eeccccCcccccChHHhhhcc------------------------cCccchhhhhhhhHHHHHHhcCCCCcccCChHH--
Confidence 125678999999999986543 468899999999999999999999998765432
Q ss_pred HHHHHHHHcCCC-----CCCchhhccCCHHHHHHHHHhcccCccccCChHHHHHHhhhhHHhh
Q psy11767 608 LSIMARIKEGQF-----NFDAEAWSTVSSEAKELTKSLLTVNPAQRIRMMRVKLTFHAFHQAQ 665 (966)
Q Consensus 608 ~~~~~~i~~~~~-----~~~~~~~~~is~e~~~Li~~~L~~dP~~R~t~~~v~~~~~~~~~~~ 665 (966)
.++..+....+ .++.+.....+..+++++..||+.||.+|||+.++ ..|+|++..
T Consensus 240 -vLl~tLqn~pp~~~t~~~~~d~~k~~~ksf~e~i~~CL~kDP~kRptAskL--lkh~FFk~~ 299 (516)
T KOG0582|consen 240 -VLLLTLQNDPPTLLTSGLDKDEDKKFSKSFREMIALCLVKDPSKRPTASKL--LKHAFFKKA 299 (516)
T ss_pred -HHHHHhcCCCCCcccccCChHHhhhhcHHHHHHHHHHhhcCcccCCCHHHH--hccHHHhhc
Confidence 34444444333 22334445677889999999999999999999854 567777543
|
|
| >cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-40 Score=380.71 Aligned_cols=246 Identities=29% Similarity=0.495 Sum_probs=198.5
Q ss_pred cccccccccccccEEEEEEEcCCCcEEEEEEecccc--------ChHHHHHHHHHhcCCCCceEEEEEEEeCCeEEEEEE
Q psy11767 380 LDKAGILGDGSYSVCRRCVEKSTGQEYAVKIISRKI--------DCSEEINLLRACQGHPNIVNLHCVFQDEVHTYLVLE 451 (966)
Q Consensus 380 ~~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~--------~~~~Ei~iL~~l~~HpnIV~l~~~~~~~~~~~lVmE 451 (966)
|+.++.||+|+||.||+|++..+++.||||++.+.. ...+|+.+|+.+ +||||+++++.|.+++.+|+|||
T Consensus 3 y~~~~~lG~G~~g~V~~a~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l-~h~~iv~~~~~~~~~~~~~lv~E 81 (376)
T cd05598 3 FVKIKTIGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAEA-DNEWVVKLYYSFQDKDNLYFVMD 81 (376)
T ss_pred ceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEcHHHHHhhhhHHHHHHHHHHHHhC-CCCCcceEEEEEEcCCEEEEEEe
Confidence 455789999999999999999999999999986421 244699999988 59999999999999999999999
Q ss_pred ccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCcEEEecCCCCCEEEEeecccccccC----
Q psy11767 452 LLKGGELLDRIRQKGRCGFTENEASRIMRQLVAAVHFMHSRGVVHRDLKPENLLFSDPAGDNIKVVDFGFACLKRE---- 527 (966)
Q Consensus 452 y~~gg~L~~~l~~~~~~~l~e~~~~~i~~Qil~aL~yLHs~~IiHRDLKP~NILl~~~~~~~iKL~DFGla~~~~~---- 527 (966)
||+||+|.+++.+.+ .+++..++.++.||+.||+|||++||+||||||+|||++. .+.+||+|||+|.....
T Consensus 82 ~~~~g~L~~~i~~~~--~~~~~~~~~~~~qi~~al~~lH~~~ivHrDlkp~Nill~~--~~~ikL~DFG~a~~~~~~~~~ 157 (376)
T cd05598 82 YIPGGDMMSLLIRLG--IFEEDLARFYIAELTCAIESVHKMGFIHRDIKPDNILIDR--DGHIKLTDFGLCTGFRWTHDS 157 (376)
T ss_pred CCCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCCHHHEEECC--CCCEEEEeCCCCccccccccc
Confidence 999999999997754 5899999999999999999999999999999999999974 56899999999742110
Q ss_pred ------------------------------------------CCccccccccccCchhhccCCCCCCCcccchhhhhhhh
Q psy11767 528 ------------------------------------------SLHTPCFTLQYAAPEVLRQDKSGYDENCDLWSLGVILV 565 (966)
Q Consensus 528 ------------------------------------------~~~~~~gT~~Y~APEvl~~~~~~~~~~~Di~SlGvil~ 565 (966)
.....+||+.|||||++..
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~------------------- 218 (376)
T cd05598 158 KYYQKGDHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLR------------------- 218 (376)
T ss_pred cccccccccccccccccccccccccccccchhhhhhhhcccccccccCCCccccCHHHHcC-------------------
Confidence 0113468999999999852
Q ss_pred hhhhcCCCCCCCcCcchhHHHHHHHHhcCCCCCCCCCCchhHHHHHHHHHcCCCCCCchhhccCCHHHHHHHHHhcccCc
Q psy11767 566 NVLRQDKSGYDENCDLWSLGVILYTMLCGRVPFHARSRDDSALSIMARIKEGQFNFDAEAWSTVSSEAKELTKSLLTVNP 645 (966)
Q Consensus 566 el~~~~~~~y~~~~DIWSlGvilyemltG~~Pf~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~is~e~~~Li~~~L~~dP 645 (966)
..|+.++|||||||++|+|++|+.||.+....+ ....+...........+..+++++.+||.+|+ .+|
T Consensus 219 -------~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~----~~~~i~~~~~~~~~~~~~~~s~~~~~li~~l~-~~p 286 (376)
T cd05598 219 -------TGYTQLCDWWSVGVILYEMLVGQPPFLADTPAE----TQLKVINWETTLHIPSQAKLSREASDLILRLC-CGA 286 (376)
T ss_pred -------CCCCcceeeeeccceeeehhhCCCCCCCCCHHH----HHHHHhccCccccCCCCCCCCHHHHHHHHHHh-cCH
Confidence 346889999999999999999999998765432 22233332222222233468999999999987 599
Q ss_pred cccC---ChHHHHHHhhhhHH
Q psy11767 646 AQRI---RMMRVKLTFHAFHQ 663 (966)
Q Consensus 646 ~~R~---t~~~v~~~~~~~~~ 663 (966)
.+|+ ++.++ ..|+|+.
T Consensus 287 ~~R~~~~t~~el--l~h~~~~ 305 (376)
T cd05598 287 EDRLGKNGADEI--KAHPFFK 305 (376)
T ss_pred hhcCCCCCHHHH--hCCCCcC
Confidence 9999 66655 4566653
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. |
| >cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-40 Score=376.90 Aligned_cols=244 Identities=30% Similarity=0.546 Sum_probs=197.8
Q ss_pred cccccccccccccEEEEEEEcCCCcEEEEEEecccc--------ChHHHHHHHHHhcCCCCceEEEEEEEeCCeEEEEEE
Q psy11767 380 LDKAGILGDGSYSVCRRCVEKSTGQEYAVKIISRKI--------DCSEEINLLRACQGHPNIVNLHCVFQDEVHTYLVLE 451 (966)
Q Consensus 380 ~~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~--------~~~~Ei~iL~~l~~HpnIV~l~~~~~~~~~~~lVmE 451 (966)
|+..+.||+|+||+||+|.+..+++.||||++.+.. ...+|+.+|..+ +||||+++++++.++..+|||||
T Consensus 3 y~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~~-~~~~iv~~~~~~~~~~~~~lv~E 81 (363)
T cd05628 3 FESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEA-DSLWVVKMFYSFQDKLNLYLIME 81 (363)
T ss_pred ceEeEEEEeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHhC-CCCCcceEEEEEecCCeEEEEEc
Confidence 455789999999999999999999999999996532 134588888888 59999999999999999999999
Q ss_pred ccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCcEEEecCCCCCEEEEeecccccccCC---
Q psy11767 452 LLKGGELLDRIRQKGRCGFTENEASRIMRQLVAAVHFMHSRGVVHRDLKPENLLFSDPAGDNIKVVDFGFACLKRES--- 528 (966)
Q Consensus 452 y~~gg~L~~~l~~~~~~~l~e~~~~~i~~Qil~aL~yLHs~~IiHRDLKP~NILl~~~~~~~iKL~DFGla~~~~~~--- 528 (966)
||+||+|.+++.+.+ .+++.+++.++.||+.||+|||++||+||||||+|||++. .+.+||+|||+++.....
T Consensus 82 ~~~gg~L~~~l~~~~--~l~~~~~~~~~~qi~~aL~~lH~~givHrDlKp~NILi~~--~~~vkL~DFGla~~~~~~~~~ 157 (363)
T cd05628 82 FLPGGDMMTLLMKKD--TLTEEETQFYIAETVLAIDSIHQLGFIHRDIKPDNLLLDS--KGHVKLSDFGLCTGLKKAHRT 157 (363)
T ss_pred CCCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCeEecCCCHHHeEECC--CCCEEEeeccCcccccccccc
Confidence 999999999998754 5999999999999999999999999999999999999975 568999999998643210
Q ss_pred -----------------------------------CccccccccccCchhhccCCCCCCCcccchhhhhhhhhhhhcCCC
Q psy11767 529 -----------------------------------LHTPCFTLQYAAPEVLRQDKSGYDENCDLWSLGVILVNVLRQDKS 573 (966)
Q Consensus 529 -----------------------------------~~~~~gT~~Y~APEvl~~~~~~~~~~~Di~SlGvil~el~~~~~~ 573 (966)
..+.+||+.|+|||++.. .
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~--------------------------~ 211 (363)
T cd05628 158 EFYRNLNHSLPSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQ--------------------------T 211 (363)
T ss_pred cccccccccccccccccccccccccchhhhccccccccccCCccccCHHHHcC--------------------------C
Confidence 123579999999999852 2
Q ss_pred CCCCcCcchhHHHHHHHHhcCCCCCCCCCCchhHHHHHHHHHcCC--CCCCchhhccCCHHHHHHHHHhcccCcccc---
Q psy11767 574 GYDENCDLWSLGVILYTMLCGRVPFHARSRDDSALSIMARIKEGQ--FNFDAEAWSTVSSEAKELTKSLLTVNPAQR--- 648 (966)
Q Consensus 574 ~y~~~~DIWSlGvilyemltG~~Pf~~~~~~~~~~~~~~~i~~~~--~~~~~~~~~~is~e~~~Li~~~L~~dP~~R--- 648 (966)
.|+.++|||||||++|+|++|+.||.+.+.. ....++.... ..++. ...+++++++||.+|+. +|.+|
T Consensus 212 ~~~~~~DvwSlGvil~ell~G~~Pf~~~~~~----~~~~~i~~~~~~~~~p~--~~~~s~~~~~li~~l~~-~~~~r~~r 284 (363)
T cd05628 212 GYNKLCDWWSLGVIMYEMLIGYPPFCSETPQ----ETYKKVMNWKETLIFPP--EVPISEKAKDLILRFCC-EWEHRIGA 284 (363)
T ss_pred CCCCchhhhhhHHHHHHHHhCCCCCCCCCHH----HHHHHHHcCcCcccCCC--cCCCCHHHHHHHHHHcC-ChhhcCCC
Confidence 4788999999999999999999999875533 3344454422 22322 23579999999999875 56655
Q ss_pred CChHHHHHHhhhhHH
Q psy11767 649 IRMMRVKLTFHAFHQ 663 (966)
Q Consensus 649 ~t~~~v~~~~~~~~~ 663 (966)
|++.++ ..|+|+.
T Consensus 285 ~~~~ei--~~hp~f~ 297 (363)
T cd05628 285 PGVEEI--KTNPFFE 297 (363)
T ss_pred CCHHHH--hCCCCCC
Confidence 677766 4566653
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus |
| >KOG0690|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-41 Score=357.81 Aligned_cols=245 Identities=34% Similarity=0.619 Sum_probs=209.2
Q ss_pred cccccccccccccEEEEEEEcCCCcEEEEEEeccccC--------hHHHHHHHHHhcCCCCceEEEEEEEeCCeEEEEEE
Q psy11767 380 LDKAGILGDGSYSVCRRCVEKSTGQEYAVKIISRKID--------CSEEINLLRACQGHPNIVNLHCVFQDEVHTYLVLE 451 (966)
Q Consensus 380 ~~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~~--------~~~Ei~iL~~l~~HpnIV~l~~~~~~~~~~~lVmE 451 (966)
|+-+++||+|.||+|-+|+.+.+|+.||||++++..- ...|-++|+.+. ||.+..|...|+...++|+|||
T Consensus 170 FdfLKvLGkGTFGKVIL~rEKat~k~YAiKIlkKeviiakdEVAHTlTE~RVL~~~~-HPFLt~LKYsFQt~drlCFVMe 248 (516)
T KOG0690|consen 170 FDFLKVLGKGTFGKVILCREKATGKLYAIKILKKEVIIAKDEVAHTLTENRVLQNCR-HPFLTSLKYSFQTQDRLCFVME 248 (516)
T ss_pred hhHHHHhcCCccceEEEEeecccCceeehhhhhhhheeehHHhhhhhhHHHHHHhcc-CcHHHHhhhhhccCceEEEEEE
Confidence 3447899999999999999999999999999976532 234778888885 9999999999999999999999
Q ss_pred ccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCcEEEecCCCCCEEEEeecccccc---cCC
Q psy11767 452 LLKGGELLDRIRQKGRCGFTENEASRIMRQLVAAVHFMHSRGVVHRDLKPENLLFSDPAGDNIKVVDFGFACLK---RES 528 (966)
Q Consensus 452 y~~gg~L~~~l~~~~~~~l~e~~~~~i~~Qil~aL~yLHs~~IiHRDLKP~NILl~~~~~~~iKL~DFGla~~~---~~~ 528 (966)
|+.||+|+-+|.... .|+|..++.+-.+|++||.|||+++||.||||.+|+||+. +|++||+||||++.. +..
T Consensus 249 yanGGeLf~HLsrer--~FsE~RtRFYGaEIvsAL~YLHs~~ivYRDlKLENLlLDk--DGHIKitDFGLCKE~I~~g~t 324 (516)
T KOG0690|consen 249 YANGGELFFHLSRER--VFSEDRTRFYGAEIVSALGYLHSRNIVYRDLKLENLLLDK--DGHIKITDFGLCKEEIKYGDT 324 (516)
T ss_pred EccCceEeeehhhhh--cccchhhhhhhHHHHHHhhhhhhCCeeeeechhhhheecc--CCceEeeecccchhcccccce
Confidence 999999999987654 6999999999999999999999999999999999999984 679999999999753 345
Q ss_pred CccccccccccCchhhccCCCCCCCcccchhhhhhhhhhhhcCCCCCCCcCcchhHHHHHHHHhcCCCCCCCCCCchhHH
Q psy11767 529 LHTPCFTLQYAAPEVLRQDKSGYDENCDLWSLGVILVNVLRQDKSGYDENCDLWSLGVILYTMLCGRVPFHARSRDDSAL 608 (966)
Q Consensus 529 ~~~~~gT~~Y~APEvl~~~~~~~~~~~Di~SlGvil~el~~~~~~~y~~~~DIWSlGvilyemltG~~Pf~~~~~~~~~~ 608 (966)
..+.||||.|+|||++.. ..|+.++|+|.+||++|||++|++||...+..
T Consensus 325 ~kTFCGTPEYLAPEVleD--------------------------nDYgraVDWWG~GVVMYEMmCGRLPFyn~dh~---- 374 (516)
T KOG0690|consen 325 TKTFCGTPEYLAPEVLED--------------------------NDYGRAVDWWGVGVVMYEMMCGRLPFYNKDHE---- 374 (516)
T ss_pred eccccCChhhcCchhhcc--------------------------ccccceeehhhhhHHHHHHHhccCcccccchh----
Confidence 678999999999999953 34889999999999999999999999976543
Q ss_pred HHHHHHHcCCCCCCchhhccCCHHHHHHHHHhcccCccccCChH--HH-HHHhhhhHH
Q psy11767 609 SIMARIKEGQFNFDAEAWSTVSSEAKELTKSLLTVNPAQRIRMM--RV-KLTFHAFHQ 663 (966)
Q Consensus 609 ~~~~~i~~~~~~~~~~~~~~is~e~~~Li~~~L~~dP~~R~t~~--~v-~~~~~~~~~ 663 (966)
.++..|..+...|+ ..+|++++.|+..+|..||.+|+.-. ++ +.+.|.|+.
T Consensus 375 kLFeLIl~ed~kFP----r~ls~eAktLLsGLL~kdP~kRLGgGpdDakEi~~h~FF~ 428 (516)
T KOG0690|consen 375 KLFELILMEDLKFP----RTLSPEAKTLLSGLLKKDPKKRLGGGPDDAKEIMRHRFFA 428 (516)
T ss_pred HHHHHHHhhhccCC----ccCCHHHHHHHHHHhhcChHhhcCCCchhHHHHHhhhhhc
Confidence 45666666766665 36899999999999999999998532 22 335566653
|
|
| >cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-39 Score=374.23 Aligned_cols=247 Identities=30% Similarity=0.461 Sum_probs=197.4
Q ss_pred cccccccccccccEEEEEEEcCCCcEEEEEEecccc--------ChHHHHHHHHHhcCCCCceEEEEEEEeCCeEEEEEE
Q psy11767 380 LDKAGILGDGSYSVCRRCVEKSTGQEYAVKIISRKI--------DCSEEINLLRACQGHPNIVNLHCVFQDEVHTYLVLE 451 (966)
Q Consensus 380 ~~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~--------~~~~Ei~iL~~l~~HpnIV~l~~~~~~~~~~~lVmE 451 (966)
|+.++.||+|+||+||+|++..+++.||||++.+.. ...+|+.+|+.+ +|||||+++++|.++.+.|+|||
T Consensus 3 f~~~~~LG~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l-~h~~iv~l~~~~~~~~~~~lv~E 81 (381)
T cd05626 3 FVKIKTLGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEA-DNEWVVKLYYSFQDKDNLYFVMD 81 (381)
T ss_pred ceEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhc-CCCCeeeeEEEEecCCEEEEEEe
Confidence 445789999999999999999999999999996532 134688999888 59999999999999999999999
Q ss_pred ccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCcEEEecCCCCCEEEEeecccccccC----
Q psy11767 452 LLKGGELLDRIRQKGRCGFTENEASRIMRQLVAAVHFMHSRGVVHRDLKPENLLFSDPAGDNIKVVDFGFACLKRE---- 527 (966)
Q Consensus 452 y~~gg~L~~~l~~~~~~~l~e~~~~~i~~Qil~aL~yLHs~~IiHRDLKP~NILl~~~~~~~iKL~DFGla~~~~~---- 527 (966)
||+||+|.+++.+.. .+++..++.++.||+.||+|||+.||+||||||+|||++. .+.+||+|||++.....
T Consensus 82 ~~~gg~L~~~l~~~~--~~~e~~~~~~~~qi~~aL~~LH~~givHrDlKp~Nili~~--~~~~kL~DFGl~~~~~~~~~~ 157 (381)
T cd05626 82 YIPGGDMMSLLIRME--VFPEVLARFYIAELTLAIESVHKMGFIHRDIKPDNILIDL--DGHIKLTDFGLCTGFRWTHNS 157 (381)
T ss_pred cCCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCeeecCCcHHHEEECC--CCCEEEeeCcCCccccccccc
Confidence 999999999997754 5899999999999999999999999999999999999974 56999999999743210
Q ss_pred ----------------------------------------------CCccccccccccCchhhccCCCCCCCcccchhhh
Q psy11767 528 ----------------------------------------------SLHTPCFTLQYAAPEVLRQDKSGYDENCDLWSLG 561 (966)
Q Consensus 528 ----------------------------------------------~~~~~~gT~~Y~APEvl~~~~~~~~~~~Di~SlG 561 (966)
...+.+||+.|+|||++..
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~--------------- 222 (381)
T cd05626 158 KYYQKGSHIRQDSMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLR--------------- 222 (381)
T ss_pred ccccccccccccccCcccccccccccccccccchhhccccccccccccccccCCccccCHHHHcC---------------
Confidence 0123478999999999852
Q ss_pred hhhhhhhhcCCCCCCCcCcchhHHHHHHHHhcCCCCCCCCCCchhHHHHHHHHHcCCCCCCchhhccCCHHHHHHHHHhc
Q psy11767 562 VILVNVLRQDKSGYDENCDLWSLGVILYTMLCGRVPFHARSRDDSALSIMARIKEGQFNFDAEAWSTVSSEAKELTKSLL 641 (966)
Q Consensus 562 vil~el~~~~~~~y~~~~DIWSlGvilyemltG~~Pf~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~is~e~~~Li~~~L 641 (966)
..|+.++|||||||++|||++|++||...+..+. ...+.........+.+..+++++++||.+||
T Consensus 223 -----------~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~----~~~i~~~~~~~~~~~~~~~s~~~~dli~~ll 287 (381)
T cd05626 223 -----------KGYTQLCDWWSVGVILFEMLVGQPPFLAPTPTET----QLKVINWENTLHIPPQVKLSPEAVDLITKLC 287 (381)
T ss_pred -----------CCCCCccceeehhhHHHHHHhCCCCCcCCCHHHH----HHHHHccccccCCCCCCCCCHHHHHHHHHHc
Confidence 3478899999999999999999999987654322 2233322212222233468999999999966
Q ss_pred cc--CccccCChHHHHHHhhhhHH
Q psy11767 642 TV--NPAQRIRMMRVKLTFHAFHQ 663 (966)
Q Consensus 642 ~~--dP~~R~t~~~v~~~~~~~~~ 663 (966)
.. +|..|+++.++. .|+|+.
T Consensus 288 ~~~~~~~~R~~~~~~l--~hp~f~ 309 (381)
T cd05626 288 CSAEERLGRNGADDIK--AHPFFS 309 (381)
T ss_pred cCcccccCCCCHHHHh--cCcccC
Confidence 54 455599998763 466653
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po |
| >cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-39 Score=365.80 Aligned_cols=248 Identities=29% Similarity=0.535 Sum_probs=200.1
Q ss_pred cccccccccccccEEEEEEEc---CCCcEEEEEEecccc---------ChHHHHHHHHHhcCCCCceEEEEEEEeCCeEE
Q psy11767 380 LDKAGILGDGSYSVCRRCVEK---STGQEYAVKIISRKI---------DCSEEINLLRACQGHPNIVNLHCVFQDEVHTY 447 (966)
Q Consensus 380 ~~~~~~LG~G~fG~Vy~a~~~---~tg~~vAvK~i~~~~---------~~~~Ei~iL~~l~~HpnIV~l~~~~~~~~~~~ 447 (966)
|+..+.||+|+||+||+|++. .+|+.||+|++.+.. ....|+.+|+.+.+||||++++++|.++...|
T Consensus 2 y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~ 81 (332)
T cd05614 2 FELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVRQSPFLVTLHYAFQTEAKLH 81 (332)
T ss_pred ceEEEEEeecCCEEEEEEEEcccCCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHHhccCCCCcccEEEEEecCCEEE
Confidence 445788999999999999874 578999999986421 13458899999888999999999999999999
Q ss_pred EEEEccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCcEEEecCCCCCEEEEeecccccccC
Q psy11767 448 LVLELLKGGELLDRIRQKGRCGFTENEASRIMRQLVAAVHFMHSRGVVHRDLKPENLLFSDPAGDNIKVVDFGFACLKRE 527 (966)
Q Consensus 448 lVmEy~~gg~L~~~l~~~~~~~l~e~~~~~i~~Qil~aL~yLHs~~IiHRDLKP~NILl~~~~~~~iKL~DFGla~~~~~ 527 (966)
+||||++||+|.+++.+.. .+++.+++.++.||+.||+|||++||+||||||+|||++. ++.+||+|||+++....
T Consensus 82 lv~e~~~~g~L~~~l~~~~--~~~~~~~~~~~~qi~~~l~~lH~~~ivHrDlkp~Nili~~--~~~~kl~DfG~~~~~~~ 157 (332)
T cd05614 82 LILDYVSGGEMFTHLYQRD--NFSEDEVRFYSGEIILALEHLHKLGIVYRDIKLENILLDS--EGHVVLTDFGLSKEFLS 157 (332)
T ss_pred EEEeCCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCHHHeEECC--CCCEEEeeCcCCccccc
Confidence 9999999999999997654 5899999999999999999999999999999999999975 56899999999975322
Q ss_pred ----CCccccccccccCchhhccCCCCCCCcccchhhhhhhhhhhhcCCCCCCCcCcchhHHHHHHHHhcCCCCCCCCCC
Q psy11767 528 ----SLHTPCFTLQYAAPEVLRQDKSGYDENCDLWSLGVILVNVLRQDKSGYDENCDLWSLGVILYTMLCGRVPFHARSR 603 (966)
Q Consensus 528 ----~~~~~~gT~~Y~APEvl~~~~~~~~~~~Di~SlGvil~el~~~~~~~y~~~~DIWSlGvilyemltG~~Pf~~~~~ 603 (966)
.....+||+.|+|||++.. ...++.++|||||||++|+|++|+.||.....
T Consensus 158 ~~~~~~~~~~gt~~y~aPE~~~~-------------------------~~~~~~~~DiwslG~il~elltg~~pf~~~~~ 212 (332)
T cd05614 158 EEKERTYSFCGTIEYMAPEIIRG-------------------------KGGHGKAVDWWSLGILIFELLTGASPFTLEGE 212 (332)
T ss_pred cCCCccccccCCccccCHHHhcC-------------------------CCCCCCccccccchhhhhhhhcCCCCCCCCCC
Confidence 2234578999999999852 22367789999999999999999999976543
Q ss_pred chhHHHHHHHHHcCCCCCCchhhccCCHHHHHHHHHhcccCccccCC-----hHHHHHHhhhhH
Q psy11767 604 DDSALSIMARIKEGQFNFDAEAWSTVSSEAKELTKSLLTVNPAQRIR-----MMRVKLTFHAFH 662 (966)
Q Consensus 604 ~~~~~~~~~~i~~~~~~~~~~~~~~is~e~~~Li~~~L~~dP~~R~t-----~~~v~~~~~~~~ 662 (966)
......+...+......+ ...+++++.+||.+||..||++|++ +.++ ..|+|+
T Consensus 213 ~~~~~~~~~~~~~~~~~~----~~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~--l~h~~~ 270 (332)
T cd05614 213 RNTQSEVSRRILKCDPPF----PSFIGPEAQDLLHKLLRKDPKKRLGAGPQGASEI--KEHPFF 270 (332)
T ss_pred CCCHHHHHHHHhcCCCCC----CCCCCHHHHHHHHHHcCCCHHHcCCCCCCCHHHH--HcCCCc
Confidence 333333344444433322 3457899999999999999999995 4443 455654
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-40 Score=378.33 Aligned_cols=245 Identities=31% Similarity=0.509 Sum_probs=197.8
Q ss_pred cccccccccccccEEEEEEEcCCCcEEEEEEecccc--------ChHHHHHHHHHhcCCCCceEEEEEEEeCCeEEEEEE
Q psy11767 380 LDKAGILGDGSYSVCRRCVEKSTGQEYAVKIISRKI--------DCSEEINLLRACQGHPNIVNLHCVFQDEVHTYLVLE 451 (966)
Q Consensus 380 ~~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~--------~~~~Ei~iL~~l~~HpnIV~l~~~~~~~~~~~lVmE 451 (966)
|+.++.||+|+||+||+|++..+++.||||++.+.. ...+|+.+|+.+ +|||||+++++|.++...|+|||
T Consensus 3 f~~~~~LG~G~~g~Vy~a~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~~-~h~~iv~~~~~~~~~~~~~lv~E 81 (382)
T cd05625 3 FVKIKTLGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEA-DNEWVVRLYYSFQDKDNLYFVMD 81 (382)
T ss_pred cEEEEEEEeCCCEEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhC-CCCcCCeEEEEEEeCCEEEEEEe
Confidence 445789999999999999999999999999986532 244688999888 59999999999999999999999
Q ss_pred ccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCcEEEecCCCCCEEEEeecccccccC----
Q psy11767 452 LLKGGELLDRIRQKGRCGFTENEASRIMRQLVAAVHFMHSRGVVHRDLKPENLLFSDPAGDNIKVVDFGFACLKRE---- 527 (966)
Q Consensus 452 y~~gg~L~~~l~~~~~~~l~e~~~~~i~~Qil~aL~yLHs~~IiHRDLKP~NILl~~~~~~~iKL~DFGla~~~~~---- 527 (966)
||+||+|.+++.+.+ .+++..++.++.||+.||+|||++||+||||||+|||++. ++.+||+|||+|.....
T Consensus 82 ~~~gg~L~~~l~~~~--~~~e~~~~~~~~qi~~al~~lH~~~ivHrDlKp~NILl~~--~g~~kL~DFGla~~~~~~~~~ 157 (382)
T cd05625 82 YIPGGDMMSLLIRMG--IFPEDLARFYIAELTCAVESVHKMGFIHRDIKPDNILIDR--DGHIKLTDFGLCTGFRWTHDS 157 (382)
T ss_pred CCCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECC--CCCEEEeECCCCccccccccc
Confidence 999999999997654 5899999999999999999999999999999999999974 56999999999742110
Q ss_pred ----------------------------------------------CCccccccccccCchhhccCCCCCCCcccchhhh
Q psy11767 528 ----------------------------------------------SLHTPCFTLQYAAPEVLRQDKSGYDENCDLWSLG 561 (966)
Q Consensus 528 ----------------------------------------------~~~~~~gT~~Y~APEvl~~~~~~~~~~~Di~SlG 561 (966)
...+.+||+.|+|||++..
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~--------------- 222 (382)
T cd05625 158 KYYQSGDHVRQDSMDFSNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLR--------------- 222 (382)
T ss_pred cccccccccccccccccccccccccccccccccchhhhhccccccccccccccCcccCCHHHhcC---------------
Confidence 0113468999999999852
Q ss_pred hhhhhhhhcCCCCCCCcCcchhHHHHHHHHhcCCCCCCCCCCchhHHHHHHHHHcCCCCCCchhhccCCHHHHHHHHHhc
Q psy11767 562 VILVNVLRQDKSGYDENCDLWSLGVILYTMLCGRVPFHARSRDDSALSIMARIKEGQFNFDAEAWSTVSSEAKELTKSLL 641 (966)
Q Consensus 562 vil~el~~~~~~~y~~~~DIWSlGvilyemltG~~Pf~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~is~e~~~Li~~~L 641 (966)
..|+.++|||||||++|||++|++||.+.+..+ ....+.........+.+..+++++.++|.+|+
T Consensus 223 -----------~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~----~~~~i~~~~~~~~~p~~~~~s~~~~~li~~l~ 287 (382)
T cd05625 223 -----------TGYTQLCDWWSVGVILYEMLVGQPPFLAQTPLE----TQMKVINWQTSLHIPPQAKLSPEASDLIIKLC 287 (382)
T ss_pred -----------CCCCCeeeEEechHHHHHHHhCCCCCCCCCHHH----HHHHHHccCCCcCCCCcccCCHHHHHHHHHHc
Confidence 347889999999999999999999998765432 22233332222222234568999999999986
Q ss_pred ccCccccCC---hHHHHHHhhhhH
Q psy11767 642 TVNPAQRIR---MMRVKLTFHAFH 662 (966)
Q Consensus 642 ~~dP~~R~t---~~~v~~~~~~~~ 662 (966)
.||.+|++ +.++ ..|+|+
T Consensus 288 -~~p~~R~~~~~~~ei--~~hp~f 308 (382)
T cd05625 288 -RGPEDRLGKNGADEI--KAHPFF 308 (382)
T ss_pred -cCHhHcCCCCCHHHH--hcCCCc
Confidence 59999998 5544 456665
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an |
| >cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-40 Score=376.09 Aligned_cols=246 Identities=33% Similarity=0.569 Sum_probs=199.6
Q ss_pred cccccccccccccEEEEEEEcCCCcEEEEEEecccc--------ChHHHHHHHHHhcCCCCceEEEEEEEeCCeEEEEEE
Q psy11767 380 LDKAGILGDGSYSVCRRCVEKSTGQEYAVKIISRKI--------DCSEEINLLRACQGHPNIVNLHCVFQDEVHTYLVLE 451 (966)
Q Consensus 380 ~~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~--------~~~~Ei~iL~~l~~HpnIV~l~~~~~~~~~~~lVmE 451 (966)
|+.++.||+|+||+||+|++..+|+.||||++.... ...+|+.+|+.+ +||||++++++|.++.+.|||||
T Consensus 3 y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~l-~h~~iv~~~~~~~~~~~~~lv~E 81 (364)
T cd05599 3 FESIKVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEA-DNPWVVKLYYSFQDENYLYLIME 81 (364)
T ss_pred ceEEEEEEecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhC-CCCCCcceEEEEEcCCeEEEEEC
Confidence 455789999999999999999999999999996431 134689999988 59999999999999999999999
Q ss_pred ccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCcEEEecCCCCCEEEEeecccccccCC---
Q psy11767 452 LLKGGELLDRIRQKGRCGFTENEASRIMRQLVAAVHFMHSRGVVHRDLKPENLLFSDPAGDNIKVVDFGFACLKRES--- 528 (966)
Q Consensus 452 y~~gg~L~~~l~~~~~~~l~e~~~~~i~~Qil~aL~yLHs~~IiHRDLKP~NILl~~~~~~~iKL~DFGla~~~~~~--- 528 (966)
||+||+|.+++...+ .+++..++.++.||+.||+|||++||+||||||+|||++. ++.+||+|||++......
T Consensus 82 ~~~~g~L~~~l~~~~--~l~~~~~~~~~~qi~~aL~~lH~~~ivH~Dlkp~NIl~~~--~~~~kl~Dfg~~~~~~~~~~~ 157 (364)
T cd05599 82 YLPGGDMMTLLMKKD--TFTEEETRFYIAETILAIDSIHKLGYIHRDIKPDNLLLDA--KGHIKLSDFGLCTGLKKSHRT 157 (364)
T ss_pred CCCCcHHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeEECC--CCCEEEeecccceeccccccc
Confidence 999999999997754 5999999999999999999999999999999999999975 568999999998542210
Q ss_pred --------------------------------------CccccccccccCchhhccCCCCCCCcccchhhhhhhhhhhhc
Q psy11767 529 --------------------------------------LHTPCFTLQYAAPEVLRQDKSGYDENCDLWSLGVILVNVLRQ 570 (966)
Q Consensus 529 --------------------------------------~~~~~gT~~Y~APEvl~~~~~~~~~~~Di~SlGvil~el~~~ 570 (966)
....+||+.|+|||++..
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~------------------------ 213 (364)
T cd05599 158 EFYRILSHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQ------------------------ 213 (364)
T ss_pred cccccccccccccccccccccccccccccchhhcccccccccccCccccCHHHHcC------------------------
Confidence 012468999999998852
Q ss_pred CCCCCCCcCcchhHHHHHHHHhcCCCCCCCCCCchhHHHHHHHHHcCCCCCCchhhccCCHHHHHHHHHhcccCccccCC
Q psy11767 571 DKSGYDENCDLWSLGVILYTMLCGRVPFHARSRDDSALSIMARIKEGQFNFDAEAWSTVSSEAKELTKSLLTVNPAQRIR 650 (966)
Q Consensus 571 ~~~~y~~~~DIWSlGvilyemltG~~Pf~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~is~e~~~Li~~~L~~dP~~R~t 650 (966)
..|+.++|||||||++|+|++|.+||...+.. .....+......+.......+++++++||.+||. +|.+|++
T Consensus 214 --~~~~~~~DiwSlG~il~el~~G~~Pf~~~~~~----~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~ll~-~p~~R~~ 286 (364)
T cd05599 214 --TGYNKECDWWSLGVIMYEMLVGYPPFCSDNPQ----ETYRKIINWKETLQFPDEVPLSPEAKDLIKRLCC-EAERRLG 286 (364)
T ss_pred --CCCCCeeeeecchhHHHHhhcCCCCCCCCCHH----HHHHHHHcCCCccCCCCCCCCCHHHHHHHHHHcc-CHhhcCC
Confidence 34788999999999999999999999876532 2333444333222222223579999999999997 9999998
Q ss_pred ---hHHHHHHhhhhHH
Q psy11767 651 ---MMRVKLTFHAFHQ 663 (966)
Q Consensus 651 ---~~~v~~~~~~~~~ 663 (966)
+.++ ..|+|+.
T Consensus 287 ~~~~~~l--l~h~~~~ 300 (364)
T cd05599 287 NNGVNEI--KSHPFFK 300 (364)
T ss_pred CCCHHHH--hcCCCcC
Confidence 6654 4566653
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica |
| >cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-39 Score=373.44 Aligned_cols=246 Identities=30% Similarity=0.533 Sum_probs=196.1
Q ss_pred cccccccccccccEEEEEEEcCCCcEEEEEEecccc--------ChHHHHHHHHHhcCCCCceEEEEEEEeCCeEEEEEE
Q psy11767 380 LDKAGILGDGSYSVCRRCVEKSTGQEYAVKIISRKI--------DCSEEINLLRACQGHPNIVNLHCVFQDEVHTYLVLE 451 (966)
Q Consensus 380 ~~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~--------~~~~Ei~iL~~l~~HpnIV~l~~~~~~~~~~~lVmE 451 (966)
|..++.||+|+||+||+|.+..+|+.||||++.+.. ...+|+++|+.+ +|||||+++++|.+..+.|||||
T Consensus 3 y~~~~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l-~hp~iv~~~~~~~~~~~~~lv~E 81 (377)
T cd05629 3 FHTVKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAES-DSPWVVSLYYSFQDAQYLYLIME 81 (377)
T ss_pred ceEeEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHHHHhHHHHHHHHHHHHHHhC-CCCCcceEEEEEEcCCeeEEEEe
Confidence 344688999999999999999999999999986431 134588888887 69999999999999999999999
Q ss_pred ccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCcEEEecCCCCCEEEEeecccccccCC---
Q psy11767 452 LLKGGELLDRIRQKGRCGFTENEASRIMRQLVAAVHFMHSRGVVHRDLKPENLLFSDPAGDNIKVVDFGFACLKRES--- 528 (966)
Q Consensus 452 y~~gg~L~~~l~~~~~~~l~e~~~~~i~~Qil~aL~yLHs~~IiHRDLKP~NILl~~~~~~~iKL~DFGla~~~~~~--- 528 (966)
||+||+|.+++.... .+++..++.++.|++.||+|||+.||+||||||+|||++. .+.+||+|||+++.....
T Consensus 82 ~~~gg~L~~~l~~~~--~~~~~~~~~~~~ql~~aL~~LH~~givHrDlkp~NIll~~--~~~~kl~DfGla~~~~~~~~~ 157 (377)
T cd05629 82 FLPGGDLMTMLIKYD--TFSEDVTRFYMAECVLAIEAVHKLGFIHRDIKPDNILIDR--GGHIKLSDFGLSTGFHKQHDS 157 (377)
T ss_pred CCCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEECC--CCCEEEeeccccccccccccc
Confidence 999999999997654 5899999999999999999999999999999999999974 568999999998532100
Q ss_pred -----------------------------------------------CccccccccccCchhhccCCCCCCCcccchhhh
Q psy11767 529 -----------------------------------------------LHTPCFTLQYAAPEVLRQDKSGYDENCDLWSLG 561 (966)
Q Consensus 529 -----------------------------------------------~~~~~gT~~Y~APEvl~~~~~~~~~~~Di~SlG 561 (966)
....+||+.|+|||++..
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--------------- 222 (377)
T cd05629 158 AYYQKLLQGKSNKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQ--------------- 222 (377)
T ss_pred ccccccccccccccccccccccccccccccccchhhhhhhhhcccccccccCCCccccCHHHHcc---------------
Confidence 012468999999999852
Q ss_pred hhhhhhhhcCCCCCCCcCcchhHHHHHHHHhcCCCCCCCCCCchhHHHHHHHHHcCCCCCCchhhccCCHHHHHHHHHhc
Q psy11767 562 VILVNVLRQDKSGYDENCDLWSLGVILYTMLCGRVPFHARSRDDSALSIMARIKEGQFNFDAEAWSTVSSEAKELTKSLL 641 (966)
Q Consensus 562 vil~el~~~~~~~y~~~~DIWSlGvilyemltG~~Pf~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~is~e~~~Li~~~L 641 (966)
..|+.++|||||||++|||++|.+||.+.+.. ..+..+......+.......++.++++||.+||
T Consensus 223 -----------~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~----~~~~~i~~~~~~~~~p~~~~~s~~~~dli~~lL 287 (377)
T cd05629 223 -----------QGYGQECDWWSLGAIMFECLIGWPPFCSENSH----ETYRKIINWRETLYFPDDIHLSVEAEDLIRRLI 287 (377)
T ss_pred -----------CCCCCceeeEecchhhhhhhcCCCCCCCCCHH----HHHHHHHccCCccCCCCCCCCCHHHHHHHHHHh
Confidence 24788999999999999999999999875543 223334332211211122357899999999999
Q ss_pred ccCccccC---ChHHHHHHhhhhHH
Q psy11767 642 TVNPAQRI---RMMRVKLTFHAFHQ 663 (966)
Q Consensus 642 ~~dP~~R~---t~~~v~~~~~~~~~ 663 (966)
. +|.+|+ ++.++ ..|+|+.
T Consensus 288 ~-~~~~r~~r~~~~~~--l~hp~~~ 309 (377)
T cd05629 288 T-NAENRLGRGGAHEI--KSHPFFR 309 (377)
T ss_pred c-CHhhcCCCCCHHHH--hcCCCcC
Confidence 8 788775 77654 4566653
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of |
| >cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-40 Score=366.10 Aligned_cols=238 Identities=32% Similarity=0.552 Sum_probs=198.1
Q ss_pred cccccccEEEEEEEcCCCcEEEEEEecccc--------ChHHHHHHHHHhcCCCCceEEEEEEEeCCeEEEEEEccCCCC
Q psy11767 386 LGDGSYSVCRRCVEKSTGQEYAVKIISRKI--------DCSEEINLLRACQGHPNIVNLHCVFQDEVHTYLVLELLKGGE 457 (966)
Q Consensus 386 LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~--------~~~~Ei~iL~~l~~HpnIV~l~~~~~~~~~~~lVmEy~~gg~ 457 (966)
||+|+||.||+|++..+++.||||++.+.. ...+|+.+|+.+ +|||||++++++.++...|+||||++||+
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~e~~~~g~ 79 (312)
T cd05585 1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQV-NCPFIVPLKFSFQSPEKLYLVLAFINGGE 79 (312)
T ss_pred CCcCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhC-CCCcEeceeeEEecCCeEEEEEcCCCCCc
Confidence 799999999999999999999999986431 134588899888 69999999999999999999999999999
Q ss_pred HHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCcEEEecCCCCCEEEEeecccccccC---CCccccc
Q psy11767 458 LLDRIRQKGRCGFTENEASRIMRQLVAAVHFMHSRGVVHRDLKPENLLFSDPAGDNIKVVDFGFACLKRE---SLHTPCF 534 (966)
Q Consensus 458 L~~~l~~~~~~~l~e~~~~~i~~Qil~aL~yLHs~~IiHRDLKP~NILl~~~~~~~iKL~DFGla~~~~~---~~~~~~g 534 (966)
|.+++...+ .+++..++.++.||+.||+|||++||+||||||+|||++. ++.+||+|||+++.... .....+|
T Consensus 80 L~~~l~~~~--~~~~~~~~~~~~qi~~~l~~lH~~~i~HrDlkp~Nili~~--~~~~kl~Dfg~~~~~~~~~~~~~~~~g 155 (312)
T cd05585 80 LFHHLQREG--RFDLSRARFYTAELLCALENLHKFNVIYRDLKPENILLDY--QGHIALCDFGLCKLNMKDDDKTNTFCG 155 (312)
T ss_pred HHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCeEeCCCCHHHeEECC--CCcEEEEECcccccCccCCCccccccC
Confidence 999997754 5899999999999999999999999999999999999975 56899999999875322 2234578
Q ss_pred cccccCchhhccCCCCCCCcccchhhhhhhhhhhhcCCCCCCCcCcchhHHHHHHHHhcCCCCCCCCCCchhHHHHHHHH
Q psy11767 535 TLQYAAPEVLRQDKSGYDENCDLWSLGVILVNVLRQDKSGYDENCDLWSLGVILYTMLCGRVPFHARSRDDSALSIMARI 614 (966)
Q Consensus 535 T~~Y~APEvl~~~~~~~~~~~Di~SlGvil~el~~~~~~~y~~~~DIWSlGvilyemltG~~Pf~~~~~~~~~~~~~~~i 614 (966)
|+.|+|||++.. ..|+.++||||+||++|+|++|+.||.+.+. ......+
T Consensus 156 t~~y~aPE~~~~--------------------------~~~~~~~DvwslGvil~el~tg~~pf~~~~~----~~~~~~~ 205 (312)
T cd05585 156 TPEYLAPELLLG--------------------------HGYTKAVDWWTLGVLLYEMLTGLPPFYDENV----NEMYRKI 205 (312)
T ss_pred CcccCCHHHHcC--------------------------CCCCCccceechhHHHHHHHhCCCCcCCCCH----HHHHHHH
Confidence 999999998852 2478899999999999999999999986543 2344555
Q ss_pred HcCCCCCCchhhccCCHHHHHHHHHhcccCccccCChHHH-HHHhhhhH
Q psy11767 615 KEGQFNFDAEAWSTVSSEAKELTKSLLTVNPAQRIRMMRV-KLTFHAFH 662 (966)
Q Consensus 615 ~~~~~~~~~~~~~~is~e~~~Li~~~L~~dP~~R~t~~~v-~~~~~~~~ 662 (966)
..+...++ ..+++++++||.+||..||++||+...+ ....|+|+
T Consensus 206 ~~~~~~~~----~~~~~~~~~li~~~L~~dp~~R~~~~~~~e~l~hp~~ 250 (312)
T cd05585 206 LQEPLRFP----DGFDRDAKDLLIGLLSRDPTRRLGYNGAQEIKNHPFF 250 (312)
T ss_pred HcCCCCCC----CcCCHHHHHHHHHHcCCCHHHcCCCCCHHHHHcCCCc
Confidence 55554433 3578999999999999999999875332 34566665
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl |
| >cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-40 Score=369.12 Aligned_cols=246 Identities=29% Similarity=0.478 Sum_probs=202.4
Q ss_pred cccccccccccccEEEEEEEcCCCcEEEEEEecccc--------ChHHHHHHHHHhcCCCCceEEEEEEEeCCeEEEEEE
Q psy11767 380 LDKAGILGDGSYSVCRRCVEKSTGQEYAVKIISRKI--------DCSEEINLLRACQGHPNIVNLHCVFQDEVHTYLVLE 451 (966)
Q Consensus 380 ~~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~--------~~~~Ei~iL~~l~~HpnIV~l~~~~~~~~~~~lVmE 451 (966)
|+..+.||+|+||.||+|++..+|+.||||++.... ...+|+.+|..+. ||||+++++++.++.+.|||||
T Consensus 3 y~~~~~ig~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~-h~~iv~~~~~~~~~~~~~lv~e 81 (333)
T cd05600 3 FQILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTK-SEWLVKLLYAFQDDEYLYLAME 81 (333)
T ss_pred cEEEEEEeecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhCC-CCCCccEEEEEEcCCEEEEEEe
Confidence 344788999999999999999999999999986432 1346888998884 9999999999999999999999
Q ss_pred ccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCcEEEecCCCCCEEEEeecccccccCCCcc
Q psy11767 452 LLKGGELLDRIRQKGRCGFTENEASRIMRQLVAAVHFMHSRGVVHRDLKPENLLFSDPAGDNIKVVDFGFACLKRESLHT 531 (966)
Q Consensus 452 y~~gg~L~~~l~~~~~~~l~e~~~~~i~~Qil~aL~yLHs~~IiHRDLKP~NILl~~~~~~~iKL~DFGla~~~~~~~~~ 531 (966)
|++||+|.+++...+ .+++..++.++.||+.||+|||++||+||||||+|||++. .+.+||+|||++.........
T Consensus 82 ~~~g~~L~~~l~~~~--~l~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~--~~~~kL~Dfg~a~~~~~~~~~ 157 (333)
T cd05600 82 YVPGGDFRTLLNNLG--VLSEDHARFYMAEMFEAVDALHELGYIHRDLKPENFLIDA--SGHIKLTDFGLSKGIVTYANS 157 (333)
T ss_pred CCCCCCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEECC--CCCEEEEeCcCCcccccccCC
Confidence 999999999997654 5899999999999999999999999999999999999975 568999999999766555556
Q ss_pred ccccccccCchhhccCCCCCCCcccchhhhhhhhhhhhcCCCCCCCcCcchhHHHHHHHHhcCCCCCCCCCCchhHHHHH
Q psy11767 532 PCFTLQYAAPEVLRQDKSGYDENCDLWSLGVILVNVLRQDKSGYDENCDLWSLGVILYTMLCGRVPFHARSRDDSALSIM 611 (966)
Q Consensus 532 ~~gT~~Y~APEvl~~~~~~~~~~~Di~SlGvil~el~~~~~~~y~~~~DIWSlGvilyemltG~~Pf~~~~~~~~~~~~~ 611 (966)
.+||+.|+|||++.. ..|+.++|||||||++|+|++|..||...+..+ .+
T Consensus 158 ~~gt~~y~aPE~~~~--------------------------~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~----~~ 207 (333)
T cd05600 158 VVGSPDYMAPEVLRG--------------------------KGYDFTVDYWSLGCMLYEFLCGFPPFSGSTPNE----TW 207 (333)
T ss_pred cccCccccChhHhcC--------------------------CCCCCccceecchHHHhhhhhCCCCCCCCCHHH----HH
Confidence 789999999999852 247889999999999999999999998765432 22
Q ss_pred HHHHcCCCCCCchhh----ccCCHHHHHHHHHhcccCccccCChHHHHHHhhhhH
Q psy11767 612 ARIKEGQFNFDAEAW----STVSSEAKELTKSLLTVNPAQRIRMMRVKLTFHAFH 662 (966)
Q Consensus 612 ~~i~~~~~~~~~~~~----~~is~e~~~Li~~~L~~dP~~R~t~~~v~~~~~~~~ 662 (966)
..+......+....+ ..+++++.+||.+||..+|++|+++.++ ..|+|+
T Consensus 208 ~~i~~~~~~~~~~~~~~~~~~~s~~~~~li~~~l~~~~~rr~s~~~l--l~h~~~ 260 (333)
T cd05600 208 ENLKYWKETLQRPVYDDPRFNLSDEAWDLITKLINDPSRRFGSLEDI--KNHPFF 260 (333)
T ss_pred HHHHhccccccCCCCCccccccCHHHHHHHHHHhhChhhhcCCHHHH--HhCccc
Confidence 233322111111111 2578999999999999999999999876 345554
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. |
| >cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-40 Score=366.13 Aligned_cols=240 Identities=31% Similarity=0.582 Sum_probs=197.3
Q ss_pred cccccccccEEEEEEEcCCCcEEEEEEecccc--------ChHHHHHHHHHhcCCCCceEEEEEEEeCCeEEEEEEccCC
Q psy11767 384 GILGDGSYSVCRRCVEKSTGQEYAVKIISRKI--------DCSEEINLLRACQGHPNIVNLHCVFQDEVHTYLVLELLKG 455 (966)
Q Consensus 384 ~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~--------~~~~Ei~iL~~l~~HpnIV~l~~~~~~~~~~~lVmEy~~g 455 (966)
++||+|+||.||+|.+..+|+.||||++.+.. ....|+.+|....+||||++++++|.++++.|+||||+.|
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E~~~~ 80 (316)
T cd05620 1 KVLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHLYCTFQTKEHLFFVMEFLNG 80 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCCccCeeEEEEeCCEEEEEECCCCC
Confidence 36999999999999999999999999997532 1334777777666899999999999999999999999999
Q ss_pred CCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCcEEEecCCCCCEEEEeeccccccc---CCCccc
Q psy11767 456 GELLDRIRQKGRCGFTENEASRIMRQLVAAVHFMHSRGVVHRDLKPENLLFSDPAGDNIKVVDFGFACLKR---ESLHTP 532 (966)
Q Consensus 456 g~L~~~l~~~~~~~l~e~~~~~i~~Qil~aL~yLHs~~IiHRDLKP~NILl~~~~~~~iKL~DFGla~~~~---~~~~~~ 532 (966)
|+|.+++.... .+++.++..++.||+.||+|||++||+||||||+|||++. ++.+||+|||++.... ......
T Consensus 81 g~L~~~i~~~~--~~~~~~~~~~~~qi~~~l~~lH~~~ivHrDlkp~Nil~~~--~~~~kl~Dfg~~~~~~~~~~~~~~~ 156 (316)
T cd05620 81 GDLMFHIQDKG--RFDLYRATFYAAEIVCGLQFLHSKGIIYRDLKLDNVMLDR--DGHIKIADFGMCKENVFGDNRASTF 156 (316)
T ss_pred CcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEECC--CCCEEeCccCCCeecccCCCceecc
Confidence 99999987754 5899999999999999999999999999999999999975 5689999999986421 223456
Q ss_pred cccccccCchhhccCCCCCCCcccchhhhhhhhhhhhcCCCCCCCcCcchhHHHHHHHHhcCCCCCCCCCCchhHHHHHH
Q psy11767 533 CFTLQYAAPEVLRQDKSGYDENCDLWSLGVILVNVLRQDKSGYDENCDLWSLGVILYTMLCGRVPFHARSRDDSALSIMA 612 (966)
Q Consensus 533 ~gT~~Y~APEvl~~~~~~~~~~~Di~SlGvil~el~~~~~~~y~~~~DIWSlGvilyemltG~~Pf~~~~~~~~~~~~~~ 612 (966)
+||+.|+|||++.. ..|+.++|||||||++|+|++|+.||.+.+.. .+..
T Consensus 157 ~gt~~y~aPE~~~~--------------------------~~~~~~~DiwslGvil~el~~g~~Pf~~~~~~----~~~~ 206 (316)
T cd05620 157 CGTPDYIAPEILQG--------------------------LKYTFSVDWWSFGVLLYEMLIGQSPFHGDDED----ELFE 206 (316)
T ss_pred CCCcCccCHHHHcC--------------------------CCCCcccchhhhHHHHHHHHhCCCCCCCCCHH----HHHH
Confidence 78999999999852 23678899999999999999999999865432 3344
Q ss_pred HHHcCCCCCCchhhccCCHHHHHHHHHhcccCccccCChHHHHHHhhhhH
Q psy11767 613 RIKEGQFNFDAEAWSTVSSEAKELTKSLLTVNPAQRIRMMRVKLTFHAFH 662 (966)
Q Consensus 613 ~i~~~~~~~~~~~~~~is~e~~~Li~~~L~~dP~~R~t~~~v~~~~~~~~ 662 (966)
.+..+...++ ..++.++++||.+||..||++|+++.+. ...|+|+
T Consensus 207 ~~~~~~~~~~----~~~~~~~~~li~~~l~~dP~~R~~~~~~-~~~h~~f 251 (316)
T cd05620 207 SIRVDTPHYP----RWITKESKDILEKLFERDPTRRLGVVGN-IRGHPFF 251 (316)
T ss_pred HHHhCCCCCC----CCCCHHHHHHHHHHccCCHHHcCCChHH-HHcCCCc
Confidence 5554443332 2478999999999999999999998532 2345664
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I |
| >cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-40 Score=366.62 Aligned_cols=240 Identities=31% Similarity=0.596 Sum_probs=198.8
Q ss_pred ccccccccEEEEEEEcCCCcEEEEEEecccc--------ChHHHHHHHHHhcCCCCceEEEEEEEeCCeEEEEEEccCCC
Q psy11767 385 ILGDGSYSVCRRCVEKSTGQEYAVKIISRKI--------DCSEEINLLRACQGHPNIVNLHCVFQDEVHTYLVLELLKGG 456 (966)
Q Consensus 385 ~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~--------~~~~Ei~iL~~l~~HpnIV~l~~~~~~~~~~~lVmEy~~gg 456 (966)
+||+|+||+||+|+++.+++.||||++.+.. ....|+.++..+.+||||++++++|.+....|+||||++||
T Consensus 2 ~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~~~iv~Ey~~~g 81 (320)
T cd05590 2 VLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLYCCFQTPDRLFFVMEFVNGG 81 (320)
T ss_pred eeeeCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhccCCCchhceeeEEEcCCEEEEEEcCCCCc
Confidence 6999999999999999999999999986431 12357788877768999999999999999999999999999
Q ss_pred CHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCcEEEecCCCCCEEEEeeccccccc---CCCcccc
Q psy11767 457 ELLDRIRQKGRCGFTENEASRIMRQLVAAVHFMHSRGVVHRDLKPENLLFSDPAGDNIKVVDFGFACLKR---ESLHTPC 533 (966)
Q Consensus 457 ~L~~~l~~~~~~~l~e~~~~~i~~Qil~aL~yLHs~~IiHRDLKP~NILl~~~~~~~iKL~DFGla~~~~---~~~~~~~ 533 (966)
+|.+++.+.. .+++..+..++.||+.||+|||++||+||||||+|||++. ++.+||+|||++.... ......+
T Consensus 82 ~L~~~i~~~~--~l~~~~~~~~~~ql~~~L~~lH~~~ivH~dlkp~NIli~~--~~~~kL~DfG~~~~~~~~~~~~~~~~ 157 (320)
T cd05590 82 DLMFHIQKSR--RFDEARARFYAAEITSALMFLHDKGIIYRDLKLDNVLLDH--EGHCKLADFGMCKEGIFNGKTTSTFC 157 (320)
T ss_pred hHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCCHHHeEECC--CCcEEEeeCCCCeecCcCCCcccccc
Confidence 9999987654 5899999999999999999999999999999999999975 5689999999986532 1233457
Q ss_pred ccccccCchhhccCCCCCCCcccchhhhhhhhhhhhcCCCCCCCcCcchhHHHHHHHHhcCCCCCCCCCCchhHHHHHHH
Q psy11767 534 FTLQYAAPEVLRQDKSGYDENCDLWSLGVILVNVLRQDKSGYDENCDLWSLGVILYTMLCGRVPFHARSRDDSALSIMAR 613 (966)
Q Consensus 534 gT~~Y~APEvl~~~~~~~~~~~Di~SlGvil~el~~~~~~~y~~~~DIWSlGvilyemltG~~Pf~~~~~~~~~~~~~~~ 613 (966)
||+.|+|||++.. ..|+.++|||||||++|+|++|+.||.+.+.. .+...
T Consensus 158 gt~~y~aPE~~~~--------------------------~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~----~~~~~ 207 (320)
T cd05590 158 GTPDYIAPEILQE--------------------------MLYGPSVDWWAMGVLLYEMLCGHAPFEAENED----DLFEA 207 (320)
T ss_pred cCccccCHHHHcC--------------------------CCCCCccchhhhHHHHHHHhhCCCCCCCCCHH----HHHHH
Confidence 8999999998852 23678899999999999999999999875432 34555
Q ss_pred HHcCCCCCCchhhccCCHHHHHHHHHhcccCccccCChHH----HHHHhhhhH
Q psy11767 614 IKEGQFNFDAEAWSTVSSEAKELTKSLLTVNPAQRIRMMR----VKLTFHAFH 662 (966)
Q Consensus 614 i~~~~~~~~~~~~~~is~e~~~Li~~~L~~dP~~R~t~~~----v~~~~~~~~ 662 (966)
+..+...++ ..++.++++||.+||+.||++|+++.+ -....|+|+
T Consensus 208 i~~~~~~~~----~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~~~~h~~f 256 (320)
T cd05590 208 ILNDEVVYP----TWLSQDAVDILKAFMTKNPTMRLGSLTLGGEEAILRHPFF 256 (320)
T ss_pred HhcCCCCCC----CCCCHHHHHHHHHHcccCHHHCCCCCCCCCHHHHHcCCCc
Confidence 655554433 247899999999999999999999832 123456665
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal |
| >cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-39 Score=359.38 Aligned_cols=245 Identities=29% Similarity=0.447 Sum_probs=195.6
Q ss_pred cccccccccccccEEEEEEEcCCCcEEEEEEecccc------ChHHHHHHHHHhcCCCCceEEEEEEEeCCeEEEEEEcc
Q psy11767 380 LDKAGILGDGSYSVCRRCVEKSTGQEYAVKIISRKI------DCSEEINLLRACQGHPNIVNLHCVFQDEVHTYLVLELL 453 (966)
Q Consensus 380 ~~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~------~~~~Ei~iL~~l~~HpnIV~l~~~~~~~~~~~lVmEy~ 453 (966)
|...+.||.|+||.||+|++..+++.||+|++.... ...+|+.+|+.+ +||||+++++++.++...|+||||+
T Consensus 7 y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~lv~e~~ 85 (288)
T cd07871 7 YVKLDKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKNL-KHANIVTLHDIIHTERCLTLVFEYL 85 (288)
T ss_pred ceEeeEEecCCCEEEEEEEECCCCCEEEEEEecccccCCcchhHHHHHHHHHhC-CCCCEeeEEEEEcCCCeEEEEEeCC
Confidence 344688999999999999999999999999986432 245799999998 5999999999999999999999999
Q ss_pred CCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCcEEEecCCCCCEEEEeecccccccC---CCc
Q psy11767 454 KGGELLDRIRQKGRCGFTENEASRIMRQLVAAVHFMHSRGVVHRDLKPENLLFSDPAGDNIKVVDFGFACLKRE---SLH 530 (966)
Q Consensus 454 ~gg~L~~~l~~~~~~~l~e~~~~~i~~Qil~aL~yLHs~~IiHRDLKP~NILl~~~~~~~iKL~DFGla~~~~~---~~~ 530 (966)
+ |+|.+++...+. .+++..++.++.||+.||+|||++||+||||||+|||++. .+.+||+|||+++.... ...
T Consensus 86 ~-~~l~~~l~~~~~-~~~~~~~~~~~~qi~~aL~~LH~~~ivH~dlkp~Nil~~~--~~~~kl~DfG~~~~~~~~~~~~~ 161 (288)
T cd07871 86 D-SDLKQYLDNCGN-LMSMHNVKIFMFQLLRGLSYCHKRKILHRDLKPQNLLINE--KGELKLADFGLARAKSVPTKTYS 161 (288)
T ss_pred C-cCHHHHHHhcCC-CCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECC--CCCEEECcCcceeeccCCCcccc
Confidence 7 599998876543 5899999999999999999999999999999999999975 56899999999865432 223
Q ss_pred cccccccccCchhhccCCCCCCCcccchhhhhhhhhhhhcCCCCCCCcCcchhHHHHHHHHhcCCCCCCCCCCchhHHHH
Q psy11767 531 TPCFTLQYAAPEVLRQDKSGYDENCDLWSLGVILVNVLRQDKSGYDENCDLWSLGVILYTMLCGRVPFHARSRDDSALSI 610 (966)
Q Consensus 531 ~~~gT~~Y~APEvl~~~~~~~~~~~Di~SlGvil~el~~~~~~~y~~~~DIWSlGvilyemltG~~Pf~~~~~~~~~~~~ 610 (966)
...+|+.|+|||++.. ...|+.++||||+||++|+|++|++||.+.+..+....+
T Consensus 162 ~~~~~~~y~aPE~~~~-------------------------~~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~~~~~~ 216 (288)
T cd07871 162 NEVVTLWYRPPDVLLG-------------------------STEYSTPIDMWGVGCILYEMATGRPMFPGSTVKEELHLI 216 (288)
T ss_pred CceecccccChHHhcC-------------------------CcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHH
Confidence 4567999999998752 234678899999999999999999999876544332222
Q ss_pred HHHHHcCC---------------CCCC-------chhhccCCHHHHHHHHHhcccCccccCChHHH
Q psy11767 611 MARIKEGQ---------------FNFD-------AEAWSTVSSEAKELTKSLLTVNPAQRIRMMRV 654 (966)
Q Consensus 611 ~~~i~~~~---------------~~~~-------~~~~~~is~e~~~Li~~~L~~dP~~R~t~~~v 654 (966)
...+.... +.++ ....+.+++++++||.+||..||.+|||+.++
T Consensus 217 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dp~~R~t~~~~ 282 (288)
T cd07871 217 FRLLGTPTEETWPGITSNEEFRSYLFPQYRAQPLINHAPRLDTDGIDLLSSLLLYETKSRISAEAA 282 (288)
T ss_pred HHHhCCCChHHhhccccchhhhccccCccCCCchHHhCCCCCHHHHHHHHHhcCcCcccCCCHHHH
Confidence 22111000 0000 01123578899999999999999999999876
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament |
| >cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-39 Score=366.26 Aligned_cols=234 Identities=31% Similarity=0.570 Sum_probs=197.0
Q ss_pred cccccccccccccEEEEEEEcCCCcEEEEEEeccccC--------hHHHHHHHHHhcCCCCceEEEEEEEeCCeEEEEEE
Q psy11767 380 LDKAGILGDGSYSVCRRCVEKSTGQEYAVKIISRKID--------CSEEINLLRACQGHPNIVNLHCVFQDEVHTYLVLE 451 (966)
Q Consensus 380 ~~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~~--------~~~Ei~iL~~l~~HpnIV~l~~~~~~~~~~~lVmE 451 (966)
|...+.||+|+||.||+|++..+++.||||++.+... ...|..++..+..|++|+++++++.+....|+|||
T Consensus 2 f~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E 81 (323)
T cd05616 2 FNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPPFLTQLHSCFQTMDRLYFVME 81 (323)
T ss_pred ceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCeEeeEEEEEecCCEEEEEEc
Confidence 4557889999999999999999999999999875321 23466777777679999999999999999999999
Q ss_pred ccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCcEEEecCCCCCEEEEeeccccccc---CC
Q psy11767 452 LLKGGELLDRIRQKGRCGFTENEASRIMRQLVAAVHFMHSRGVVHRDLKPENLLFSDPAGDNIKVVDFGFACLKR---ES 528 (966)
Q Consensus 452 y~~gg~L~~~l~~~~~~~l~e~~~~~i~~Qil~aL~yLHs~~IiHRDLKP~NILl~~~~~~~iKL~DFGla~~~~---~~ 528 (966)
|+++|+|.+++...+ .+++.++..++.||+.||+|||++||+||||||+|||++. ++.+||+|||++.... ..
T Consensus 82 ~~~~g~L~~~~~~~~--~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~Nill~~--~~~~kL~DfG~~~~~~~~~~~ 157 (323)
T cd05616 82 YVNGGDLMYQIQQVG--RFKEPHAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVMLDS--EGHIKIADFGMCKENMWDGVT 157 (323)
T ss_pred CCCCCCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCCEEecCCCHHHeEECC--CCcEEEccCCCceecCCCCCc
Confidence 999999999987654 5899999999999999999999999999999999999985 5689999999987532 12
Q ss_pred CccccccccccCchhhccCCCCCCCcccchhhhhhhhhhhhcCCCCCCCcCcchhHHHHHHHHhcCCCCCCCCCCchhHH
Q psy11767 529 LHTPCFTLQYAAPEVLRQDKSGYDENCDLWSLGVILVNVLRQDKSGYDENCDLWSLGVILYTMLCGRVPFHARSRDDSAL 608 (966)
Q Consensus 529 ~~~~~gT~~Y~APEvl~~~~~~~~~~~Di~SlGvil~el~~~~~~~y~~~~DIWSlGvilyemltG~~Pf~~~~~~~~~~ 608 (966)
....+||+.|+|||++.. ..|+.++|||||||++|+|++|+.||.+.+..
T Consensus 158 ~~~~~gt~~y~aPE~~~~--------------------------~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~---- 207 (323)
T cd05616 158 TKTFCGTPDYIAPEIIAY--------------------------QPYGKSVDWWAFGVLLYEMLAGQAPFEGEDED---- 207 (323)
T ss_pred cccCCCChhhcCHHHhcC--------------------------CCCCCccchhchhHHHHHHHhCCCCCCCCCHH----
Confidence 335678999999999852 24788999999999999999999999875432
Q ss_pred HHHHHHHcCCCCCCchhhccCCHHHHHHHHHhcccCccccCCh
Q psy11767 609 SIMARIKEGQFNFDAEAWSTVSSEAKELTKSLLTVNPAQRIRM 651 (966)
Q Consensus 609 ~~~~~i~~~~~~~~~~~~~~is~e~~~Li~~~L~~dP~~R~t~ 651 (966)
.+...+..+...++ ..++.++.+|+.+||+.||++|++.
T Consensus 208 ~~~~~i~~~~~~~p----~~~s~~~~~li~~~l~~~p~~R~~~ 246 (323)
T cd05616 208 ELFQSIMEHNVAYP----KSMSKEAVAICKGLMTKHPGKRLGC 246 (323)
T ss_pred HHHHHHHhCCCCCC----CcCCHHHHHHHHHHcccCHHhcCCC
Confidence 34455665555433 3579999999999999999999985
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and |
| >cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-39 Score=364.66 Aligned_cols=239 Identities=32% Similarity=0.599 Sum_probs=195.3
Q ss_pred ccccccccEEEEEEEcCCCcEEEEEEeccccC--------hHHHHHHHHHhcCCCCceEEEEEEEeCCeEEEEEEccCCC
Q psy11767 385 ILGDGSYSVCRRCVEKSTGQEYAVKIISRKID--------CSEEINLLRACQGHPNIVNLHCVFQDEVHTYLVLELLKGG 456 (966)
Q Consensus 385 ~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~~--------~~~Ei~iL~~l~~HpnIV~l~~~~~~~~~~~lVmEy~~gg 456 (966)
.||+|+||+||+|.+..+++.||||++..... ...|..++..+.+||||+++++++.++...|+||||++||
T Consensus 2 ~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~gg 81 (316)
T cd05592 2 VLGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTHLFCTFQTKEHLFFVMEYLNGG 81 (316)
T ss_pred eeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCCC
Confidence 69999999999999999999999999875321 2346667766668999999999999999999999999999
Q ss_pred CHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCcEEEecCCCCCEEEEeeccccccc---CCCcccc
Q psy11767 457 ELLDRIRQKGRCGFTENEASRIMRQLVAAVHFMHSRGVVHRDLKPENLLFSDPAGDNIKVVDFGFACLKR---ESLHTPC 533 (966)
Q Consensus 457 ~L~~~l~~~~~~~l~e~~~~~i~~Qil~aL~yLHs~~IiHRDLKP~NILl~~~~~~~iKL~DFGla~~~~---~~~~~~~ 533 (966)
+|.+++.... .+++..+..++.||+.||+|||++||+||||||+|||++. ++.+||+|||++.... ......+
T Consensus 82 ~L~~~~~~~~--~~~~~~~~~~~~qi~~al~~LH~~~ivH~dlkp~Nill~~--~~~~kL~Dfg~a~~~~~~~~~~~~~~ 157 (316)
T cd05592 82 DLMFHIQSSG--RFDEARARFYAAEIICGLQFLHKKGIIYRDLKLDNVLLDK--DGHIKIADFGMCKENMNGEGKASTFC 157 (316)
T ss_pred cHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCCEEeCCCCHHHeEECC--CCCEEEccCcCCeECCCCCCcccccc
Confidence 9999987654 5899999999999999999999999999999999999975 5689999999996532 1233457
Q ss_pred ccccccCchhhccCCCCCCCcccchhhhhhhhhhhhcCCCCCCCcCcchhHHHHHHHHhcCCCCCCCCCCchhHHHHHHH
Q psy11767 534 FTLQYAAPEVLRQDKSGYDENCDLWSLGVILVNVLRQDKSGYDENCDLWSLGVILYTMLCGRVPFHARSRDDSALSIMAR 613 (966)
Q Consensus 534 gT~~Y~APEvl~~~~~~~~~~~Di~SlGvil~el~~~~~~~y~~~~DIWSlGvilyemltG~~Pf~~~~~~~~~~~~~~~ 613 (966)
||+.|+|||++.. ..|+.++|||||||++|+|++|+.||.+.+.. .+...
T Consensus 158 gt~~y~aPE~~~~--------------------------~~~~~~~DvwslG~il~ell~G~~Pf~~~~~~----~~~~~ 207 (316)
T cd05592 158 GTPDYIAPEILKG--------------------------QKYNESVDWWSFGVLLYEMLIGQSPFHGEDED----ELFDS 207 (316)
T ss_pred CCccccCHHHHcC--------------------------CCCCCcccchhHHHHHHHHHhCCCCCCCCCHH----HHHHH
Confidence 8999999998852 23678899999999999999999999876532 33344
Q ss_pred HHcCCCCCCchhhccCCHHHHHHHHHhcccCccccCChHHHHHHhhhhH
Q psy11767 614 IKEGQFNFDAEAWSTVSSEAKELTKSLLTVNPAQRIRMMRVKLTFHAFH 662 (966)
Q Consensus 614 i~~~~~~~~~~~~~~is~e~~~Li~~~L~~dP~~R~t~~~v~~~~~~~~ 662 (966)
+......++ ..++.++.+||.+||..||++|+++.+. ...|+|+
T Consensus 208 i~~~~~~~~----~~~~~~~~~ll~~~l~~~P~~R~~~~~~-l~~h~~~ 251 (316)
T cd05592 208 ILNDRPHFP----RWISKEAKDCLSKLFERDPTKRLGVDGD-IRQHPFF 251 (316)
T ss_pred HHcCCCCCC----CCCCHHHHHHHHHHccCCHHHcCCChHH-HHcCccc
Confidence 444333222 3578999999999999999999997532 2335554
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp |
| >PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-40 Score=369.93 Aligned_cols=241 Identities=33% Similarity=0.505 Sum_probs=201.7
Q ss_pred ccccccccccccEEEEEEEcCCC-cEEEEEEecccc--------ChHHHHHHHHHhcCCCCceEEEEEEEeCCeEEEEEE
Q psy11767 381 DKAGILGDGSYSVCRRCVEKSTG-QEYAVKIISRKI--------DCSEEINLLRACQGHPNIVNLHCVFQDEVHTYLVLE 451 (966)
Q Consensus 381 ~~~~~LG~G~fG~Vy~a~~~~tg-~~vAvK~i~~~~--------~~~~Ei~iL~~l~~HpnIV~l~~~~~~~~~~~lVmE 451 (966)
+..+.||+|+||.||+|.+..++ ..||+|++.... ...+|+.+|+.+ +|||||++++++.++...|+|||
T Consensus 33 ~~~~~ig~G~~g~Vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~hp~Iv~~~~~~~~~~~~~lv~E 111 (340)
T PTZ00426 33 NFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYI-NHPFCVNLYGSFKDESYLYLVLE 111 (340)
T ss_pred EEEEEEeecCCeEEEEEEEECCCCeEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhC-CCCCCcceEEEEEeCCEEEEEEe
Confidence 34688999999999999977665 789999986421 134689999888 59999999999999999999999
Q ss_pred ccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCcEEEecCCCCCEEEEeecccccccCCCcc
Q psy11767 452 LLKGGELLDRIRQKGRCGFTENEASRIMRQLVAAVHFMHSRGVVHRDLKPENLLFSDPAGDNIKVVDFGFACLKRESLHT 531 (966)
Q Consensus 452 y~~gg~L~~~l~~~~~~~l~e~~~~~i~~Qil~aL~yLHs~~IiHRDLKP~NILl~~~~~~~iKL~DFGla~~~~~~~~~ 531 (966)
|++||+|.+++.... .+++..+..++.||+.||+|||++||+||||||+|||++. ++.+||+|||++........+
T Consensus 112 y~~~g~L~~~i~~~~--~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDLkp~NILl~~--~~~ikL~DFG~a~~~~~~~~~ 187 (340)
T PTZ00426 112 FVIGGEFFTFLRRNK--RFPNDVGCFYAAQIVLIFEYLQSLNIVYRDLKPENLLLDK--DGFIKMTDFGFAKVVDTRTYT 187 (340)
T ss_pred CCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCCeEccCCCHHHEEECC--CCCEEEecCCCCeecCCCcce
Confidence 999999999997654 5899999999999999999999999999999999999974 569999999999776555556
Q ss_pred ccccccccCchhhccCCCCCCCcccchhhhhhhhhhhhcCCCCCCCcCcchhHHHHHHHHhcCCCCCCCCCCchhHHHHH
Q psy11767 532 PCFTLQYAAPEVLRQDKSGYDENCDLWSLGVILVNVLRQDKSGYDENCDLWSLGVILYTMLCGRVPFHARSRDDSALSIM 611 (966)
Q Consensus 532 ~~gT~~Y~APEvl~~~~~~~~~~~Di~SlGvil~el~~~~~~~y~~~~DIWSlGvilyemltG~~Pf~~~~~~~~~~~~~ 611 (966)
.+||+.|+|||++.. ..|+.++|||||||++|+|++|.+||.+.+. ....
T Consensus 188 ~~gt~~y~aPE~~~~--------------------------~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~----~~~~ 237 (340)
T PTZ00426 188 LCGTPEYIAPEILLN--------------------------VGHGKAADWWTLGIFIYEILVGCPPFYANEP----LLIY 237 (340)
T ss_pred ecCChhhcCHHHHhC--------------------------CCCCccccccchhhHHHHHhcCCCCCCCCCH----HHHH
Confidence 789999999999852 2367889999999999999999999986543 2345
Q ss_pred HHHHcCCCCCCchhhccCCHHHHHHHHHhcccCccccC-----ChHHHHHHhhhhH
Q psy11767 612 ARIKEGQFNFDAEAWSTVSSEAKELTKSLLTVNPAQRI-----RMMRVKLTFHAFH 662 (966)
Q Consensus 612 ~~i~~~~~~~~~~~~~~is~e~~~Li~~~L~~dP~~R~-----t~~~v~~~~~~~~ 662 (966)
..+..+...++ ..++++++++|++||+.||++|+ ++.++ ..|+|+
T Consensus 238 ~~i~~~~~~~p----~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~--~~hp~f 287 (340)
T PTZ00426 238 QKILEGIIYFP----KFLDNNCKHLMKKLLSHDLTKRYGNLKKGAQNV--KEHPWF 287 (340)
T ss_pred HHHhcCCCCCC----CCCCHHHHHHHHHHcccCHHHcCCCCCCCHHHH--HcCCCc
Confidence 56666655443 35789999999999999999996 66655 356664
|
|
| >cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-39 Score=361.33 Aligned_cols=241 Identities=32% Similarity=0.558 Sum_probs=194.2
Q ss_pred cccccccccEEEEEEEcCCCcEEEEEEeccccC--------hHHHHHHHHHhcCCCCceEEEEEEEeCCeEEEEEEccCC
Q psy11767 384 GILGDGSYSVCRRCVEKSTGQEYAVKIISRKID--------CSEEINLLRACQGHPNIVNLHCVFQDEVHTYLVLELLKG 455 (966)
Q Consensus 384 ~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~~--------~~~Ei~iL~~l~~HpnIV~l~~~~~~~~~~~lVmEy~~g 455 (966)
++||+|+||+||+|++..+|+.||||++.+... ...|+.++....+||||+++++++.+....|+||||++|
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~ 80 (323)
T cd05575 1 KVIGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTADKLYFVLDYVNG 80 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhhCCCCCCCCeeEEEEeCCEEEEEEcCCCC
Confidence 369999999999999999999999999864321 223444433333699999999999999999999999999
Q ss_pred CCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCcEEEecCCCCCEEEEeecccccccC---CCccc
Q psy11767 456 GELLDRIRQKGRCGFTENEASRIMRQLVAAVHFMHSRGVVHRDLKPENLLFSDPAGDNIKVVDFGFACLKRE---SLHTP 532 (966)
Q Consensus 456 g~L~~~l~~~~~~~l~e~~~~~i~~Qil~aL~yLHs~~IiHRDLKP~NILl~~~~~~~iKL~DFGla~~~~~---~~~~~ 532 (966)
|+|.+++.... .+++..++.++.||+.||+|||++||+||||||+|||+++ ++.+||+|||++..... .....
T Consensus 81 g~L~~~l~~~~--~~~~~~~~~~~~qi~~~l~~lH~~givH~dikp~NIll~~--~~~~kl~Dfg~~~~~~~~~~~~~~~ 156 (323)
T cd05575 81 GELFFHLQRER--SFPEPRARFYAAEIASALGYLHSLNIIYRDLKPENILLDS--QGHVVLTDFGLCKEGIEHSKTTSTF 156 (323)
T ss_pred CCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCCHHHeEECC--CCcEEEeccCCCcccccCCCccccc
Confidence 99999987654 5899999999999999999999999999999999999975 56899999999865321 22345
Q ss_pred cccccccCchhhccCCCCCCCcccchhhhhhhhhhhhcCCCCCCCcCcchhHHHHHHHHhcCCCCCCCCCCchhHHHHHH
Q psy11767 533 CFTLQYAAPEVLRQDKSGYDENCDLWSLGVILVNVLRQDKSGYDENCDLWSLGVILYTMLCGRVPFHARSRDDSALSIMA 612 (966)
Q Consensus 533 ~gT~~Y~APEvl~~~~~~~~~~~Di~SlGvil~el~~~~~~~y~~~~DIWSlGvilyemltG~~Pf~~~~~~~~~~~~~~ 612 (966)
+||+.|+|||++.. ..|+.++|||||||++|+|++|+.||...+. .....
T Consensus 157 ~gt~~y~aPE~~~~--------------------------~~~~~~~DvwslG~il~ell~g~~pf~~~~~----~~~~~ 206 (323)
T cd05575 157 CGTPEYLAPEVLRK--------------------------QPYDRTVDWWCLGAVLYEMLYGLPPFYSRDT----AEMYD 206 (323)
T ss_pred cCChhhcChhhhcC--------------------------CCCCccccccccchhhhhhhcCCCCCCCCCH----HHHHH
Confidence 78999999998852 2367889999999999999999999987543 23445
Q ss_pred HHHcCCCCCCchhhccCCHHHHHHHHHhcccCccccCChHH-H-HHHhhhhH
Q psy11767 613 RIKEGQFNFDAEAWSTVSSEAKELTKSLLTVNPAQRIRMMR-V-KLTFHAFH 662 (966)
Q Consensus 613 ~i~~~~~~~~~~~~~~is~e~~~Li~~~L~~dP~~R~t~~~-v-~~~~~~~~ 662 (966)
.+..+..... +.++.++.++|.+||+.||.+||++.+ . ....|+|+
T Consensus 207 ~i~~~~~~~~----~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~il~~~~~ 254 (323)
T cd05575 207 NILNKPLRLK----PNISVSARHLLEGLLQKDRTKRLGAKDDFLEIKNHVFF 254 (323)
T ss_pred HHHcCCCCCC----CCCCHHHHHHHHHHhhcCHHhCCCCCCCHHHHHcCCCc
Confidence 5555544332 457999999999999999999999852 1 22445554
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr |
| >cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-39 Score=364.62 Aligned_cols=234 Identities=30% Similarity=0.557 Sum_probs=193.4
Q ss_pred cccccccccEEEEEEEcCCCcEEEEEEecccc--------ChHHHHHHHHHhcCCCCceEEEEEEEeCCeEEEEEEccCC
Q psy11767 384 GILGDGSYSVCRRCVEKSTGQEYAVKIISRKI--------DCSEEINLLRACQGHPNIVNLHCVFQDEVHTYLVLELLKG 455 (966)
Q Consensus 384 ~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~--------~~~~Ei~iL~~l~~HpnIV~l~~~~~~~~~~~lVmEy~~g 455 (966)
++||+|+||.||+|.+..+++.||||++++.. ...+|+.+++.+.+||||++++++|.++...|+|||||+|
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~il~~~~~hp~Iv~~~~~~~~~~~~~lv~e~~~~ 80 (329)
T cd05588 1 RVIGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGLHSCFQTESRLFFVIEFVSG 80 (329)
T ss_pred CeEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCCCCceEEEEEcCCEEEEEEeCCCC
Confidence 36999999999999999999999999997532 1345888888887899999999999999999999999999
Q ss_pred CCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCcEEEecCCCCCEEEEeeccccccc---CCCccc
Q psy11767 456 GELLDRIRQKGRCGFTENEASRIMRQLVAAVHFMHSRGVVHRDLKPENLLFSDPAGDNIKVVDFGFACLKR---ESLHTP 532 (966)
Q Consensus 456 g~L~~~l~~~~~~~l~e~~~~~i~~Qil~aL~yLHs~~IiHRDLKP~NILl~~~~~~~iKL~DFGla~~~~---~~~~~~ 532 (966)
|+|.+++.+.+ .+++..++.++.||+.||+|||++||+||||||+|||++. .+.+||+|||+++... ......
T Consensus 81 g~L~~~~~~~~--~l~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nili~~--~~~~kL~Dfg~~~~~~~~~~~~~~~ 156 (329)
T cd05588 81 GDLMFHMQRQR--KLPEEHARFYSAEISLALNFLHERGIIYRDLKLDNVLLDA--EGHIKLTDYGMCKEGIRPGDTTSTF 156 (329)
T ss_pred CCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEECC--CCCEEECcCccccccccCCCccccc
Confidence 99999887654 5999999999999999999999999999999999999975 5689999999986421 223456
Q ss_pred cccccccCchhhccCCCCCCCcccchhhhhhhhhhhhcCCCCCCCcCcchhHHHHHHHHhcCCCCCCCCCCch-----hH
Q psy11767 533 CFTLQYAAPEVLRQDKSGYDENCDLWSLGVILVNVLRQDKSGYDENCDLWSLGVILYTMLCGRVPFHARSRDD-----SA 607 (966)
Q Consensus 533 ~gT~~Y~APEvl~~~~~~~~~~~Di~SlGvil~el~~~~~~~y~~~~DIWSlGvilyemltG~~Pf~~~~~~~-----~~ 607 (966)
+||+.|+|||++.. ..|+.++|||||||++|+|++|+.||......+ ..
T Consensus 157 ~gt~~y~aPE~~~~--------------------------~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~~~~ 210 (329)
T cd05588 157 CGTPNYIAPEILRG--------------------------EDYGFSVDWWALGVLMFEMMAGRSPFDIVGMSDNPDQNTE 210 (329)
T ss_pred cCCccccCHHHHcC--------------------------CCCCCccceechHHHHHHHHHCCCCcccccccccccccch
Confidence 78999999999852 236788999999999999999999997432111 11
Q ss_pred HHHHHHHHcCCCCCCchhhccCCHHHHHHHHHhcccCccccCCh
Q psy11767 608 LSIMARIKEGQFNFDAEAWSTVSSEAKELTKSLLTVNPAQRIRM 651 (966)
Q Consensus 608 ~~~~~~i~~~~~~~~~~~~~~is~e~~~Li~~~L~~dP~~R~t~ 651 (966)
......+..+...++ ..++.++.+||.+||..||.+|+++
T Consensus 211 ~~~~~~~~~~~~~~p----~~~~~~~~~li~~~L~~dP~~R~~~ 250 (329)
T cd05588 211 DYLFQVILEKQIRIP----RSLSVKASSVLKGFLNKDPKERLGC 250 (329)
T ss_pred HHHHHHHHcCCCCCC----CCCCHHHHHHHHHHhccCHHHcCCC
Confidence 123344555544433 3578999999999999999999984
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl |
| >cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-39 Score=363.19 Aligned_cols=239 Identities=31% Similarity=0.556 Sum_probs=198.0
Q ss_pred cccccccccEEEEEEEcCCCcEEEEEEecccc--------ChHHHHHHHHHhcCCCCceEEEEEEEeCCeEEEEEEccCC
Q psy11767 384 GILGDGSYSVCRRCVEKSTGQEYAVKIISRKI--------DCSEEINLLRACQGHPNIVNLHCVFQDEVHTYLVLELLKG 455 (966)
Q Consensus 384 ~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~--------~~~~Ei~iL~~l~~HpnIV~l~~~~~~~~~~~lVmEy~~g 455 (966)
++||+|+||.||+|.+..+|+.||||++.+.. ....|+++|..+.+||||++++++|.++...|+||||++|
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~ 80 (321)
T cd05591 1 KVLGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTALHCCFQTKDRLFFVMEYVNG 80 (321)
T ss_pred CccccCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCeEEEEEeCCCC
Confidence 36999999999999999999999999987532 1335788887777899999999999999999999999999
Q ss_pred CCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCcEEEecCCCCCEEEEeecccccccC---CCccc
Q psy11767 456 GELLDRIRQKGRCGFTENEASRIMRQLVAAVHFMHSRGVVHRDLKPENLLFSDPAGDNIKVVDFGFACLKRE---SLHTP 532 (966)
Q Consensus 456 g~L~~~l~~~~~~~l~e~~~~~i~~Qil~aL~yLHs~~IiHRDLKP~NILl~~~~~~~iKL~DFGla~~~~~---~~~~~ 532 (966)
|+|..++.... .+++..+..++.||+.||+|||++||+||||||+|||++. ++.+||+|||++..... .....
T Consensus 81 ~~L~~~l~~~~--~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~Nill~~--~~~~kL~Dfg~~~~~~~~~~~~~~~ 156 (321)
T cd05591 81 GDLMFQIQRSR--KFDEPRSRFYAAEVTLALMFLHRHGVIYRDLKLDNILLDA--EGHCKLADFGMCKEGILNGVTTTTF 156 (321)
T ss_pred CcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECC--CCCEEEeecccceecccCCcccccc
Confidence 99999987654 5899999999999999999999999999999999999975 56899999999865321 23345
Q ss_pred cccccccCchhhccCCCCCCCcccchhhhhhhhhhhhcCCCCCCCcCcchhHHHHHHHHhcCCCCCCCCCCchhHHHHHH
Q psy11767 533 CFTLQYAAPEVLRQDKSGYDENCDLWSLGVILVNVLRQDKSGYDENCDLWSLGVILYTMLCGRVPFHARSRDDSALSIMA 612 (966)
Q Consensus 533 ~gT~~Y~APEvl~~~~~~~~~~~Di~SlGvil~el~~~~~~~y~~~~DIWSlGvilyemltG~~Pf~~~~~~~~~~~~~~ 612 (966)
+||+.|+|||++.. ..|+.++|||||||++|+|++|+.||...+.. ..+.
T Consensus 157 ~gt~~y~aPE~~~~--------------------------~~~~~~~DvwslG~il~el~tg~~Pf~~~~~~----~~~~ 206 (321)
T cd05591 157 CGTPDYIAPEILQE--------------------------LEYGPSVDWWALGVLMYEMMAGQPPFEADNED----DLFE 206 (321)
T ss_pred ccCccccCHHHHcC--------------------------CCCCCccceechhHHHHHHhcCCCCCCCCCHH----HHHH
Confidence 78999999998852 24678999999999999999999999876532 3445
Q ss_pred HHHcCCCCCCchhhccCCHHHHHHHHHhcccCccccC-------ChHHHHHHhhhhH
Q psy11767 613 RIKEGQFNFDAEAWSTVSSEAKELTKSLLTVNPAQRI-------RMMRVKLTFHAFH 662 (966)
Q Consensus 613 ~i~~~~~~~~~~~~~~is~e~~~Li~~~L~~dP~~R~-------t~~~v~~~~~~~~ 662 (966)
.+..+...++ ..++.++.+||.+||+.||++|+ ++.++ ..|+|+
T Consensus 207 ~i~~~~~~~p----~~~~~~~~~ll~~~L~~dp~~R~~~~~~~~~~~~~--~~hp~~ 257 (321)
T cd05591 207 SILHDDVLYP----VWLSKEAVSILKAFMTKNPNKRLGCVASQGGEDAI--KQHPFF 257 (321)
T ss_pred HHHcCCCCCC----CCCCHHHHHHHHHHhccCHHHcCCCCCCCCCHHHH--hcCCcc
Confidence 5665554433 24789999999999999999999 55544 345654
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to |
| >cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-39 Score=358.40 Aligned_cols=252 Identities=28% Similarity=0.476 Sum_probs=196.9
Q ss_pred cccccccccccccEEEEEEEcCCCcEEEEEEecccc------ChHHHHHHHHHhcCCCCceEEEEEEEeCCeEEEEEEcc
Q psy11767 380 LDKAGILGDGSYSVCRRCVEKSTGQEYAVKIISRKI------DCSEEINLLRACQGHPNIVNLHCVFQDEVHTYLVLELL 453 (966)
Q Consensus 380 ~~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~------~~~~Ei~iL~~l~~HpnIV~l~~~~~~~~~~~lVmEy~ 453 (966)
|+..+.||+|+||.||+|.+..+|+.||||++.... ...+|+.+|+.+ +||||+++++++.++...|+||||+
T Consensus 7 y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~lv~e~~ 85 (303)
T cd07869 7 YEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTAIREASLLKGL-KHANIVLLHDIIHTKETLTLVFEYV 85 (303)
T ss_pred ceEeeeEEecCCEEEEEEEECCCCCEEEEEEeccccccccchhHHHHHHHHhhC-CCCCcCeEEEEEecCCeEEEEEECC
Confidence 344788999999999999999999999999986432 245799999998 5999999999999999999999999
Q ss_pred CCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCcEEEecCCCCCEEEEeecccccccC---CCc
Q psy11767 454 KGGELLDRIRQKGRCGFTENEASRIMRQLVAAVHFMHSRGVVHRDLKPENLLFSDPAGDNIKVVDFGFACLKRE---SLH 530 (966)
Q Consensus 454 ~gg~L~~~l~~~~~~~l~e~~~~~i~~Qil~aL~yLHs~~IiHRDLKP~NILl~~~~~~~iKL~DFGla~~~~~---~~~ 530 (966)
. ++|.+++.... ..+++..++.++.||+.||+|||++||+||||||+|||+++ .+.+||+|||++..... ...
T Consensus 86 ~-~~l~~~~~~~~-~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dlkp~Nill~~--~~~~kl~Dfg~~~~~~~~~~~~~ 161 (303)
T cd07869 86 H-TDLCQYMDKHP-GGLHPENVKLFLFQLLRGLSYIHQRYILHRDLKPQNLLISD--TGELKLADFGLARAKSVPSHTYS 161 (303)
T ss_pred C-cCHHHHHHhCC-CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECC--CCCEEECCCCcceeccCCCccCC
Confidence 5 68888887653 35899999999999999999999999999999999999975 56899999999865332 223
Q ss_pred cccccccccCchhhccCCCCCCCcccchhhhhhhhhhhhcCCCCCCCcCcchhHHHHHHHHhcCCCCCCCCCCchhHHHH
Q psy11767 531 TPCFTLQYAAPEVLRQDKSGYDENCDLWSLGVILVNVLRQDKSGYDENCDLWSLGVILYTMLCGRVPFHARSRDDSALSI 610 (966)
Q Consensus 531 ~~~gT~~Y~APEvl~~~~~~~~~~~Di~SlGvil~el~~~~~~~y~~~~DIWSlGvilyemltG~~Pf~~~~~~~~~~~~ 610 (966)
..++|+.|+|||++.. ...|+.++|||||||++|+|++|..||.+..........
T Consensus 162 ~~~~~~~y~aPE~~~~-------------------------~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~ 216 (303)
T cd07869 162 NEVVTLWYRPPDVLLG-------------------------STEYSTCLDMWGVGCIFVEMIQGVAAFPGMKDIQDQLER 216 (303)
T ss_pred CCcccCCCCChHHHcC-------------------------CCCCCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHHHHH
Confidence 4568999999998742 224678899999999999999999999875432221211
Q ss_pred HHHHHcCCC-----------CCCc------------hhhc--cCCHHHHHHHHHhcccCccccCChHHHHHHhhhhHH
Q psy11767 611 MARIKEGQF-----------NFDA------------EAWS--TVSSEAKELTKSLLTVNPAQRIRMMRVKLTFHAFHQ 663 (966)
Q Consensus 611 ~~~i~~~~~-----------~~~~------------~~~~--~is~e~~~Li~~~L~~dP~~R~t~~~v~~~~~~~~~ 663 (966)
+..+..... .+.+ ..|. ..+.++++|+.+||+.||++|||+.++ ..|+|+.
T Consensus 217 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dp~~R~s~~~~--l~h~~f~ 292 (303)
T cd07869 217 IFLVLGTPNEDTWPGVHSLPHFKPERFTLYSPKNLRQAWNKLSYVNHAEDLASKLLQCFPKNRLSAQAA--LSHEYFS 292 (303)
T ss_pred HHHHhCCCChhhccchhhccccccccccccCCccHHHHhhccCCChHHHHHHHHHhccCchhccCHHHH--hcCcccc
Confidence 111110000 0000 0111 245789999999999999999999876 4577764
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an |
| >KOG0201|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-40 Score=363.21 Aligned_cols=246 Identities=28% Similarity=0.461 Sum_probs=205.7
Q ss_pred cccccccccccccEEEEEEEcCCCcEEEEEEecccc------ChHHHHHHHHHhcCCCCceEEEEEEEeCCeEEEEEEcc
Q psy11767 380 LDKAGILGDGSYSVCRRCVEKSTGQEYAVKIISRKI------DCSEEINLLRACQGHPNIVNLHCVFQDEVHTYLVLELL 453 (966)
Q Consensus 380 ~~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~------~~~~Ei~iL~~l~~HpnIV~l~~~~~~~~~~~lVmEy~ 453 (966)
|.....||+|+||.||+|.+..|++.||+|++.-.. +..+|+.+|..+. ++||.++|+.|..+..++++||||
T Consensus 15 ~~~~~~IgrGsfG~Vyk~~d~~t~k~vAiKii~Le~~~deIediqqei~~Ls~~~-~~~it~yygsyl~g~~LwiiMey~ 93 (467)
T KOG0201|consen 15 YTKLELIGRGSFGEVYKAIDNKTKKVVAIKIIDLEEAEDEIEDIQQEISVLSQCD-SPNITEYYGSYLKGTKLWIIMEYC 93 (467)
T ss_pred cccchhccccccceeeeeeeccccceEEEEEechhhcchhhHHHHHHHHHHHhcC-cchHHhhhhheeecccHHHHHHHh
Confidence 344578999999999999999999999999997543 3457999999985 899999999999999999999999
Q ss_pred CCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCcEEEecCCCCCEEEEeecccccccC---CCc
Q psy11767 454 KGGELLDRIRQKGRCGFTENEASRIMRQLVAAVHFMHSRGVVHRDLKPENLLFSDPAGDNIKVVDFGFACLKRE---SLH 530 (966)
Q Consensus 454 ~gg~L~~~l~~~~~~~l~e~~~~~i~~Qil~aL~yLHs~~IiHRDLKP~NILl~~~~~~~iKL~DFGla~~~~~---~~~ 530 (966)
.||++.+.++..+ .+.|.++..++++++.||.|||+++.+|||||+.|||+.. .+.+||+|||++.+... ...
T Consensus 94 ~gGsv~~lL~~~~--~~~E~~i~~ilre~l~~l~ylH~~~kiHrDIKaanil~s~--~g~vkl~DfgVa~ql~~~~~rr~ 169 (467)
T KOG0201|consen 94 GGGSVLDLLKSGN--ILDEFEIAVILREVLKGLDYLHSEKKIHRDIKAANILLSE--SGDVKLADFGVAGQLTNTVKRRK 169 (467)
T ss_pred cCcchhhhhccCC--CCccceeeeehHHHHHHhhhhhhcceecccccccceeEec--cCcEEEEecceeeeeechhhccc
Confidence 9999999997654 4689999999999999999999999999999999999985 47999999999976543 236
Q ss_pred cccccccccCchhhccCCCCCCCcccchhhhhhhhhhhhcCCCCCCCcCcchhHHHHHHHHhcCCCCCCCCCCchhHHHH
Q psy11767 531 TPCFTLQYAAPEVLRQDKSGYDENCDLWSLGVILVNVLRQDKSGYDENCDLWSLGVILYTMLCGRVPFHARSRDDSALSI 610 (966)
Q Consensus 531 ~~~gT~~Y~APEvl~~~~~~~~~~~Di~SlGvil~el~~~~~~~y~~~~DIWSlGvilyemltG~~Pf~~~~~~~~~~~~ 610 (966)
+++|||.|||||++.. .+|+.++||||||++.+||++|.+||...+.. .+
T Consensus 170 tfvGTPfwMAPEVI~~--------------------------~~Y~~KADIWSLGITaiEla~GePP~s~~hPm----rv 219 (467)
T KOG0201|consen 170 TFVGTPFWMAPEVIKQ--------------------------SGYDTKADIWSLGITAIELAKGEPPHSKLHPM----RV 219 (467)
T ss_pred cccccccccchhhhcc--------------------------ccccchhhhhhhhHHHHHHhcCCCCCcccCcc----eE
Confidence 8899999999999962 35899999999999999999999999877652 22
Q ss_pred HHHHHcCCCCCCchhhccCCHHHHHHHHHhcccCccccCChHHHHHHhhhhHHhh
Q psy11767 611 MARIKEGQFNFDAEAWSTVSSEAKELTKSLLTVNPAQRIRMMRVKLTFHAFHQAQ 665 (966)
Q Consensus 611 ~~~i~~~~~~~~~~~~~~is~e~~~Li~~~L~~dP~~R~t~~~v~~~~~~~~~~~ 665 (966)
+..|.+..++ ..-...|+.+++|+..||.+||+.||++.++ ..|.|.+..
T Consensus 220 lflIpk~~PP---~L~~~~S~~~kEFV~~CL~k~P~~RpsA~~L--LKh~FIk~a 269 (467)
T KOG0201|consen 220 LFLIPKSAPP---RLDGDFSPPFKEFVEACLDKNPEFRPSAKEL--LKHKFIKRA 269 (467)
T ss_pred EEeccCCCCC---ccccccCHHHHHHHHHHhhcCcccCcCHHHH--hhhHHHHhc
Confidence 2233332221 1122578999999999999999999999865 456666543
|
|
| >cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-39 Score=359.13 Aligned_cols=238 Identities=35% Similarity=0.609 Sum_probs=196.3
Q ss_pred cccccccccEEEEEEEcCCCcEEEEEEecccc--------ChHHHHHHHHHhcCCCCceEEEEEEEeCCeEEEEEEccCC
Q psy11767 384 GILGDGSYSVCRRCVEKSTGQEYAVKIISRKI--------DCSEEINLLRACQGHPNIVNLHCVFQDEVHTYLVLELLKG 455 (966)
Q Consensus 384 ~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~--------~~~~Ei~iL~~l~~HpnIV~l~~~~~~~~~~~lVmEy~~g 455 (966)
++||+|+||.||+|++..+|+.||+|++.... ...+|+.+|+.+ +||||++++++|.++...||||||+++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l-~hp~i~~~~~~~~~~~~~~lv~E~~~~ 79 (323)
T cd05595 1 KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNT-RHPFLTALKYAFQTHDRLCFVMEYANG 79 (323)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhC-CCCCCcceeeEEecCCEEEEEEeCCCC
Confidence 36999999999999999999999999986532 123588889888 599999999999999999999999999
Q ss_pred CCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCcEEEecCCCCCEEEEeecccccccC---CCccc
Q psy11767 456 GELLDRIRQKGRCGFTENEASRIMRQLVAAVHFMHSRGVVHRDLKPENLLFSDPAGDNIKVVDFGFACLKRE---SLHTP 532 (966)
Q Consensus 456 g~L~~~l~~~~~~~l~e~~~~~i~~Qil~aL~yLHs~~IiHRDLKP~NILl~~~~~~~iKL~DFGla~~~~~---~~~~~ 532 (966)
|+|..++.... .+++..++.++.||+.||+|||++||+||||||+|||+++ ++.+||+|||++..... .....
T Consensus 80 ~~L~~~l~~~~--~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~--~~~~kL~Dfg~~~~~~~~~~~~~~~ 155 (323)
T cd05595 80 GELFFHLSRER--VFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLDK--DGHIKITDFGLCKEGISDGATMKTF 155 (323)
T ss_pred CcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHEEEcC--CCCEEecccHHhccccCCCCccccc
Confidence 99999887654 5899999999999999999999999999999999999975 56899999999865322 22345
Q ss_pred cccccccCchhhccCCCCCCCcccchhhhhhhhhhhhcCCCCCCCcCcchhHHHHHHHHhcCCCCCCCCCCchhHHHHHH
Q psy11767 533 CFTLQYAAPEVLRQDKSGYDENCDLWSLGVILVNVLRQDKSGYDENCDLWSLGVILYTMLCGRVPFHARSRDDSALSIMA 612 (966)
Q Consensus 533 ~gT~~Y~APEvl~~~~~~~~~~~Di~SlGvil~el~~~~~~~y~~~~DIWSlGvilyemltG~~Pf~~~~~~~~~~~~~~ 612 (966)
+||+.|+|||++.. ..|+.++|||||||++|+|++|+.||...+.. ....
T Consensus 156 ~gt~~y~aPE~~~~--------------------------~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~----~~~~ 205 (323)
T cd05595 156 CGTPEYLAPEVLED--------------------------NDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHE----RLFE 205 (323)
T ss_pred cCCcCcCCcccccC--------------------------CCCCchhchhhhHHHHHHHHhCCCCCCCCCHH----HHHH
Confidence 78999999998852 23678899999999999999999999865432 2334
Q ss_pred HHHcCCCCCCchhhccCCHHHHHHHHHhcccCccccC-----ChHHHHHHhhhhH
Q psy11767 613 RIKEGQFNFDAEAWSTVSSEAKELTKSLLTVNPAQRI-----RMMRVKLTFHAFH 662 (966)
Q Consensus 613 ~i~~~~~~~~~~~~~~is~e~~~Li~~~L~~dP~~R~-----t~~~v~~~~~~~~ 662 (966)
.+..+...++ ..+++++.+||.+||+.||++|+ ++.++ ..|+|+
T Consensus 206 ~~~~~~~~~p----~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~--l~h~~~ 254 (323)
T cd05595 206 LILMEEIRFP----RTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEV--MEHRFF 254 (323)
T ss_pred HHhcCCCCCC----CCCCHHHHHHHHHHccCCHHHhCCCCCCCHHHH--HcCCCc
Confidence 4444444333 35789999999999999999998 55554 345554
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in |
| >cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-39 Score=371.00 Aligned_cols=249 Identities=31% Similarity=0.494 Sum_probs=202.8
Q ss_pred cccccccccccccEEEEEEEcCCCcEEEEEEecccc--------ChHHHHHHHHHhcCCCCceEEEEEEEeCCeEEEEEE
Q psy11767 380 LDKAGILGDGSYSVCRRCVEKSTGQEYAVKIISRKI--------DCSEEINLLRACQGHPNIVNLHCVFQDEVHTYLVLE 451 (966)
Q Consensus 380 ~~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~--------~~~~Ei~iL~~l~~HpnIV~l~~~~~~~~~~~lVmE 451 (966)
|+..+.||+|+||.||+|++..+++.||||++.+.. ...+|+.+|+.+ +||||+++++++.++.+.|+|||
T Consensus 45 y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~-~h~~iv~~~~~~~~~~~~~lv~E 123 (370)
T cd05596 45 FDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEERDIMAHA-NSEWIVQLHYAFQDDKYLYMVME 123 (370)
T ss_pred cEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhC-CCCCcceEEEEEecCCEEEEEEc
Confidence 344688999999999999999999999999986421 134688888887 69999999999999999999999
Q ss_pred ccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCcEEEecCCCCCEEEEeecccccccCC---
Q psy11767 452 LLKGGELLDRIRQKGRCGFTENEASRIMRQLVAAVHFMHSRGVVHRDLKPENLLFSDPAGDNIKVVDFGFACLKRES--- 528 (966)
Q Consensus 452 y~~gg~L~~~l~~~~~~~l~e~~~~~i~~Qil~aL~yLHs~~IiHRDLKP~NILl~~~~~~~iKL~DFGla~~~~~~--- 528 (966)
||+||+|.+++... .+++..+..++.||+.||+|||++||+||||||+|||++. ++.+||+|||++......
T Consensus 124 y~~gg~L~~~l~~~---~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDLkp~NILl~~--~~~~kL~DfG~~~~~~~~~~~ 198 (370)
T cd05596 124 YMPGGDLVNLMSNY---DIPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLDK--SGHLKLADFGTCMKMDANGMV 198 (370)
T ss_pred CCCCCcHHHHHHhc---CCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEEcC--CCCEEEEeccceeeccCCCcc
Confidence 99999999998654 4899999999999999999999999999999999999975 569999999999754321
Q ss_pred -CccccccccccCchhhccCCCCCCCcccchhhhhhhhhhhhcCCCCCCCcCcchhHHHHHHHHhcCCCCCCCCCCchhH
Q psy11767 529 -LHTPCFTLQYAAPEVLRQDKSGYDENCDLWSLGVILVNVLRQDKSGYDENCDLWSLGVILYTMLCGRVPFHARSRDDSA 607 (966)
Q Consensus 529 -~~~~~gT~~Y~APEvl~~~~~~~~~~~Di~SlGvil~el~~~~~~~y~~~~DIWSlGvilyemltG~~Pf~~~~~~~~~ 607 (966)
....+||+.|+|||++.... ....|+.++|||||||++|+|++|++||.+.+..
T Consensus 199 ~~~~~~gt~~y~aPE~~~~~~----------------------~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~--- 253 (370)
T cd05596 199 RCDTAVGTPDYISPEVLKSQG----------------------GDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLV--- 253 (370)
T ss_pred cCCCCCCCcCeECHHHhccCC----------------------CCCCCCCceeeeehhHHHHHHHhCCCCcCCCCHH---
Confidence 23457899999999986321 1234788999999999999999999999876532
Q ss_pred HHHHHHHHcCCCCCCchhhccCCHHHHHHHHHhcccCccc--cCChHHHHHHhhhhH
Q psy11767 608 LSIMARIKEGQFNFDAEAWSTVSSEAKELTKSLLTVNPAQ--RIRMMRVKLTFHAFH 662 (966)
Q Consensus 608 ~~~~~~i~~~~~~~~~~~~~~is~e~~~Li~~~L~~dP~~--R~t~~~v~~~~~~~~ 662 (966)
..+..+..+...+..+....+|.++++||.+||..+|++ |+++.++ ..|+|+
T Consensus 254 -~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~~p~r~~R~s~~el--l~h~~~ 307 (370)
T cd05596 254 -GTYSKIMDHKNSLTFPDDIEISKQAKDLICAFLTDREVRLGRNGVDEI--KSHPFF 307 (370)
T ss_pred -HHHHHHHcCCCcCCCCCcCCCCHHHHHHHHHHccChhhccCCCCHHHH--hcCccc
Confidence 334455544322222233468999999999999999988 9999876 446665
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in |
| >KOG0577|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-40 Score=367.53 Aligned_cols=248 Identities=24% Similarity=0.378 Sum_probs=204.7
Q ss_pred cccccccccccccEEEEEEEcCCCcEEEEEEecccc--------ChHHHHHHHHHhcCCCCceEEEEEEEeCCeEEEEEE
Q psy11767 380 LDKAGILGDGSYSVCRRCVEKSTGQEYAVKIISRKI--------DCSEEINLLRACQGHPNIVNLHCVFQDEVHTYLVLE 451 (966)
Q Consensus 380 ~~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~--------~~~~Ei~iL~~l~~HpnIV~l~~~~~~~~~~~lVmE 451 (966)
|.++..||.|+||.||-|++..+.+.||||.++-.. +...|++.|+.+. |||+|.+.+||-.+...|||||
T Consensus 28 f~dLrEIGHGSFGAVYfArd~~n~evVAIKKMsySGKQs~EKWqDIlKEVrFL~~l~-HPntieYkgCyLre~TaWLVME 106 (948)
T KOG0577|consen 28 FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDILKEVRFLRQLR-HPNTIEYKGCYLREHTAWLVME 106 (948)
T ss_pred HHHHHHhcCCccceeEEeeccCccceeeeeeccccccccHHHHHHHHHHHHHHHhcc-CCCcccccceeeccchHHHHHH
Confidence 445788999999999999999999999999986432 3567999999995 9999999999999999999999
Q ss_pred ccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCcEEEecCCCCCEEEEeecccccccCCCcc
Q psy11767 452 LLKGGELLDRIRQKGRCGFTENEASRIMRQLVAAVHFMHSRGVVHRDLKPENLLFSDPAGDNIKVVDFGFACLKRESLHT 531 (966)
Q Consensus 452 y~~gg~L~~~l~~~~~~~l~e~~~~~i~~Qil~aL~yLHs~~IiHRDLKP~NILl~~~~~~~iKL~DFGla~~~~~~~~~ 531 (966)
||-| +-.|.+.-... +|-+.++..|+.+.+.||+|||+.+.||||||..||||.+ .+.|||+|||.|.... +.++
T Consensus 107 YClG-SAsDlleVhkK-plqEvEIAAi~~gaL~gLaYLHS~~~IHRDiKAGNILLse--~g~VKLaDFGSAsi~~-PAns 181 (948)
T KOG0577|consen 107 YCLG-SASDLLEVHKK-PLQEVEIAAITHGALQGLAYLHSHNRIHRDIKAGNILLSE--PGLVKLADFGSASIMA-PANS 181 (948)
T ss_pred HHhc-cHHHHHHHHhc-cchHHHHHHHHHHHHHHHHHHHHhhHHhhhccccceEecC--CCeeeeccccchhhcC-chhc
Confidence 9964 55555543322 6999999999999999999999999999999999999996 5699999999997654 5678
Q ss_pred ccccccccCchhhccCCCCCCCcccchhhhhhhhhhhhcCCCCCCCcCcchhHHHHHHHHhcCCCCCCCCCCchhHHHHH
Q psy11767 532 PCFTLQYAAPEVLRQDKSGYDENCDLWSLGVILVNVLRQDKSGYDENCDLWSLGVILYTMLCGRVPFHARSRDDSALSIM 611 (966)
Q Consensus 532 ~~gT~~Y~APEvl~~~~~~~~~~~Di~SlGvil~el~~~~~~~y~~~~DIWSlGvilyemltG~~Pf~~~~~~~~~~~~~ 611 (966)
++|||+|||||+|.. .+...|+-++|||||||++.||...++|....+. ...+
T Consensus 182 FvGTPywMAPEVILA-----------------------MDEGqYdgkvDvWSLGITCIELAERkPPlFnMNA----MSAL 234 (948)
T KOG0577|consen 182 FVGTPYWMAPEVILA-----------------------MDEGQYDGKVDVWSLGITCIELAERKPPLFNMNA----MSAL 234 (948)
T ss_pred ccCCccccchhHhee-----------------------ccccccCCccceeeccchhhhhhhcCCCccCchH----HHHH
Confidence 999999999999963 2355799999999999999999999999886542 3445
Q ss_pred HHHHcCCC-CCCchhhccCCHHHHHHHHHhcccCccccCChHHHHHHhhhhHHhh
Q psy11767 612 ARIKEGQF-NFDAEAWSTVSSEAKELTKSLLTVNPAQRIRMMRVKLTFHAFHQAQ 665 (966)
Q Consensus 612 ~~i~~~~~-~~~~~~~~~is~e~~~Li~~~L~~dP~~R~t~~~v~~~~~~~~~~~ 665 (966)
.-|..... .+.. ...|..+..++..||++-|.+|||..++ ..|+|....
T Consensus 235 YHIAQNesPtLqs---~eWS~~F~~Fvd~CLqKipqeRptse~l--l~H~fv~R~ 284 (948)
T KOG0577|consen 235 YHIAQNESPTLQS---NEWSDYFRNFVDSCLQKIPQERPTSEEL--LKHRFVLRE 284 (948)
T ss_pred HHHHhcCCCCCCC---chhHHHHHHHHHHHHhhCcccCCcHHHH--hhcchhccC
Confidence 55554433 2333 3458899999999999999999999754 556665443
|
|
| >cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-39 Score=363.01 Aligned_cols=234 Identities=32% Similarity=0.569 Sum_probs=195.3
Q ss_pred cccccccccccccEEEEEEEcCCCcEEEEEEecccc--------ChHHHHHHHHHhcCCCCceEEEEEEEeCCeEEEEEE
Q psy11767 380 LDKAGILGDGSYSVCRRCVEKSTGQEYAVKIISRKI--------DCSEEINLLRACQGHPNIVNLHCVFQDEVHTYLVLE 451 (966)
Q Consensus 380 ~~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~--------~~~~Ei~iL~~l~~HpnIV~l~~~~~~~~~~~lVmE 451 (966)
|+.++.||+|+||.||+|.+..+++.||||++.+.. ....|+.+|..+..|++|++++++|.+....|+|||
T Consensus 2 y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E 81 (324)
T cd05587 2 FNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVME 81 (324)
T ss_pred ceEEEEEeeccCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhcCCCCceeeeEEEEEcCCEEEEEEc
Confidence 445788999999999999999999999999986532 123577888887656779999999999999999999
Q ss_pred ccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCcEEEecCCCCCEEEEeeccccccc---CC
Q psy11767 452 LLKGGELLDRIRQKGRCGFTENEASRIMRQLVAAVHFMHSRGVVHRDLKPENLLFSDPAGDNIKVVDFGFACLKR---ES 528 (966)
Q Consensus 452 y~~gg~L~~~l~~~~~~~l~e~~~~~i~~Qil~aL~yLHs~~IiHRDLKP~NILl~~~~~~~iKL~DFGla~~~~---~~ 528 (966)
|++||+|.+++.... .+++..++.++.||+.||+|||++||+||||||+|||++. ++.+||+|||++.... ..
T Consensus 82 ~~~~g~L~~~~~~~~--~~~~~~~~~~~~qi~~al~~lH~~~ivH~dlkp~Nill~~--~~~~kL~Dfg~~~~~~~~~~~ 157 (324)
T cd05587 82 YVNGGDLMYHIQQVG--KFKEPHAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVMLDA--EGHIKIADFGMCKENIFGGKT 157 (324)
T ss_pred CCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEEcC--CCCEEEeecCcceecCCCCCc
Confidence 999999999997654 5899999999999999999999999999999999999975 5689999999986422 12
Q ss_pred CccccccccccCchhhccCCCCCCCcccchhhhhhhhhhhhcCCCCCCCcCcchhHHHHHHHHhcCCCCCCCCCCchhHH
Q psy11767 529 LHTPCFTLQYAAPEVLRQDKSGYDENCDLWSLGVILVNVLRQDKSGYDENCDLWSLGVILYTMLCGRVPFHARSRDDSAL 608 (966)
Q Consensus 529 ~~~~~gT~~Y~APEvl~~~~~~~~~~~Di~SlGvil~el~~~~~~~y~~~~DIWSlGvilyemltG~~Pf~~~~~~~~~~ 608 (966)
....+||+.|+|||++.. ..|+.++||||+||++|+|++|+.||.+.+..
T Consensus 158 ~~~~~gt~~y~aPE~~~~--------------------------~~~~~~~DiwslGvil~elltG~~pf~~~~~~---- 207 (324)
T cd05587 158 TRTFCGTPDYIAPEIIAY--------------------------QPYGKSVDWWAFGVLLYEMLAGQPPFDGEDED---- 207 (324)
T ss_pred eeeecCCccccChhhhcC--------------------------CCCCcccchhhhHHHHHHHHhCCCCCCCCCHH----
Confidence 234578999999999853 23678899999999999999999999875432
Q ss_pred HHHHHHHcCCCCCCchhhccCCHHHHHHHHHhcccCccccCCh
Q psy11767 609 SIMARIKEGQFNFDAEAWSTVSSEAKELTKSLLTVNPAQRIRM 651 (966)
Q Consensus 609 ~~~~~i~~~~~~~~~~~~~~is~e~~~Li~~~L~~dP~~R~t~ 651 (966)
.....+......++ ..+++++.+++.+||..||.+|++.
T Consensus 208 ~~~~~i~~~~~~~~----~~~~~~~~~li~~~l~~~P~~R~~~ 246 (324)
T cd05587 208 ELFQSIMEHNVSYP----KSLSKEAVSICKGLLTKHPAKRLGC 246 (324)
T ss_pred HHHHHHHcCCCCCC----CCCCHHHHHHHHHHhhcCHHHcCCC
Confidence 34455555544332 3579999999999999999999986
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory |
| >KOG0579|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-40 Score=368.91 Aligned_cols=252 Identities=29% Similarity=0.436 Sum_probs=209.8
Q ss_pred ccccccccccccEEEEEEEcCCCcEEEEEEecccc-----ChHHHHHHHHHhcCCCCceEEEEEEEeCCeEEEEEEccCC
Q psy11767 381 DKAGILGDGSYSVCRRCVEKSTGQEYAVKIISRKI-----DCSEEINLLRACQGHPNIVNLHCVFQDEVHTYLVLELLKG 455 (966)
Q Consensus 381 ~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~-----~~~~Ei~iL~~l~~HpnIV~l~~~~~~~~~~~lVmEy~~g 455 (966)
++++.||.|+||+||+|.++.++-..|-|+|..+. +..-||+||..|. ||+||+|++.|..++.+||..|||.|
T Consensus 35 eIiGELGDGAFGKVyKA~nket~~lAAaKvIetkseEELEDylVEIeILa~Cd-HP~ivkLl~ayy~enkLwiliEFC~G 113 (1187)
T KOG0579|consen 35 EIIGELGDGAFGKVYKAVNKETKLLAAAKVIETKSEEELEDYLVEIEILAECD-HPVIVKLLSAYYFENKLWILIEFCGG 113 (1187)
T ss_pred HHHhhhcCccchhhhhhhcccchhhhhhhhhcccchhHHhhhhhhhhhhhcCC-ChHHHHHHHHHhccCceEEEEeecCC
Confidence 44799999999999999999999999999986543 3455999999995 99999999999999999999999999
Q ss_pred CCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCcEEEecCCCCCEEEEeeccccccc---CCCccc
Q psy11767 456 GELLDRIRQKGRCGFTENEASRIMRQLVAAVHFMHSRGVVHRDLKPENLLFSDPAGDNIKVVDFGFACLKR---ESLHTP 532 (966)
Q Consensus 456 g~L~~~l~~~~~~~l~e~~~~~i~~Qil~aL~yLHs~~IiHRDLKP~NILl~~~~~~~iKL~DFGla~~~~---~~~~~~ 532 (966)
|.+...+..-++ +|++.++.-+++|+|.||.|||+++|||||||..|||+.. +|.|+|+|||.+.... ....++
T Consensus 114 GAVDaimlEL~r-~LtE~QIqvvc~q~ldALn~LHs~~iIHRDLKAGNiL~Tl--dGdirLADFGVSAKn~~t~qkRDsF 190 (1187)
T KOG0579|consen 114 GAVDAIMLELGR-VLTEDQIQVVCYQVLDALNWLHSQNIIHRDLKAGNILLTL--DGDIRLADFGVSAKNKSTRQKRDSF 190 (1187)
T ss_pred chHhHHHHHhcc-ccchHHHHHHHHHHHHHHHHHhhcchhhhhccccceEEEe--cCcEeeecccccccchhHHhhhccc
Confidence 999888877664 7999999999999999999999999999999999999985 6799999999974422 234678
Q ss_pred cccccccCchhhccCCCCCCCcccchhhhhhhhhhhhcCCCCCCCcCcchhHHHHHHHHhcCCCCCCCCCCchhHHHHHH
Q psy11767 533 CFTLQYAAPEVLRQDKSGYDENCDLWSLGVILVNVLRQDKSGYDENCDLWSLGVILYTMLCGRVPFHARSRDDSALSIMA 612 (966)
Q Consensus 533 ~gT~~Y~APEvl~~~~~~~~~~~Di~SlGvil~el~~~~~~~y~~~~DIWSlGvilyemltG~~Pf~~~~~~~~~~~~~~ 612 (966)
+|||+|||||+..... ....+|++++||||||++|.||..+.+|.+..+.. .++-
T Consensus 191 IGTPYWMAPEVvmCET---------------------~KD~PYDykaDiWSlGITLIEMAqiEPPHhelnpM----RVll 245 (1187)
T KOG0579|consen 191 IGTPYWMAPEVVMCET---------------------FKDQPYDYKADIWSLGITLIEMAQIEPPHHELNPM----RVLL 245 (1187)
T ss_pred cCCcccccchheeecc---------------------ccCCCchhhhhHHhhhhHHHHHhccCCCccccchH----HHHH
Confidence 9999999999986432 23578999999999999999999999998876542 3344
Q ss_pred HHHcCCCCCCchhhccCCHHHHHHHHHhcccCccccCChHHHHHHhhhhHHh
Q psy11767 613 RIKEGQFNFDAEAWSTVSSEAKELTKSLLTVNPAQRIRMMRVKLTFHAFHQA 664 (966)
Q Consensus 613 ~i~~~~~~~~~~~~~~is~e~~~Li~~~L~~dP~~R~t~~~v~~~~~~~~~~ 664 (966)
+|.....+ ....+...|..+.|++++||..||..||++.++ ..|+|...
T Consensus 246 KiaKSePP-TLlqPS~Ws~~F~DfLk~cL~Knp~~Rp~aaql--l~Hpfv~~ 294 (1187)
T KOG0579|consen 246 KIAKSEPP-TLLQPSHWSRSFSDFLKRCLVKNPRNRPPAAQL--LKHPFVQN 294 (1187)
T ss_pred HHhhcCCC-cccCcchhhhHHHHHHHHHHhcCCccCCCHHHH--hhCccccc
Confidence 55443322 111224568899999999999999999999865 56777753
|
|
| >KOG4236|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-40 Score=364.74 Aligned_cols=290 Identities=30% Similarity=0.527 Sum_probs=231.9
Q ss_pred CCCCccccccccccccccccccCcCCCCCCCCCCCCcccccccceecccccccccccccccccccEEEEEEEcCCCcEEE
Q psy11767 328 APFVPKISNELDVSNFSDEFTKMIPADSPAIVPPNFDKIFKGSLFFEQYDMDLDKAGILGDGSYSVCRRCVEKSTGQEYA 407 (966)
Q Consensus 328 pP~~P~i~~~~D~snFd~ef~~~~p~dSp~ivp~~~d~if~G~~~~~~~~i~~~~~~~LG~G~fG~Vy~a~~~~tg~~vA 407 (966)
.|..|+-++..-..+|..+-. +..+ ....++.....|...|++.- .++||+|.||+||-|+|+.+|+.||
T Consensus 524 MpV~pqsss~~~g~~~~k~~~---~s~s-----~s~~qiqe~vd~stvYQif~--devLGSGQFG~VYgg~hRktGrdVA 593 (888)
T KOG4236|consen 524 MPVTPQSSSVGMGKQFHKDSS---QSIS-----VSNCQIQENVDISTVYQIFA--DEVLGSGQFGTVYGGKHRKTGRDVA 593 (888)
T ss_pred cccccCCCCCCccccchhhcc---CCcc-----ccchhhhhhhhHHHHHHhhh--HhhccCCcceeeecceecccCceee
Confidence 455666555555555554311 1111 11223333344555666633 2689999999999999999999999
Q ss_pred EEEecccc-------ChHHHHHHHHHhcCCCCceEEEEEEEeCCeEEEEEEccCCCCHHHHHHhcCCCCCCHHHHHHHHH
Q psy11767 408 VKIISRKI-------DCSEEINLLRACQGHPNIVNLHCVFQDEVHTYLVLELLKGGELLDRIRQKGRCGFTENEASRIMR 480 (966)
Q Consensus 408 vK~i~~~~-------~~~~Ei~iL~~l~~HpnIV~l~~~~~~~~~~~lVmEy~~gg~L~~~l~~~~~~~l~e~~~~~i~~ 480 (966)
||+|.+.. ....|+.||+.+ .||.||.|-..|++...+++|||-+ .||.++.|.......|++...++++.
T Consensus 594 vKvIdKlrFp~kqesqlR~EVaILq~l-~HPGiV~le~M~ET~ervFVVMEKl-~GDMLEMILSsEkgRL~er~TkFlvt 671 (888)
T KOG4236|consen 594 VKVIDKLRFPTKQESQLRNEVAILQNL-HHPGIVNLECMFETPERVFVVMEKL-HGDMLEMILSSEKGRLPERITKFLVT 671 (888)
T ss_pred eeeeecccCCCchHHHHHHHHHHHHhc-CCCCeeEEEEeecCCceEEEEehhh-cchHHHHHHHhhcccchHHHHHHHHH
Confidence 99997532 245699999998 5999999999999999999999999 56666666555555799999999999
Q ss_pred HHHHHHHHHHhcCceeccCCCCcEEEecCC-CCCEEEEeecccccccCCC--ccccccccccCchhhccCCCCCCCcccc
Q psy11767 481 QLVAAVHFMHSRGVVHRDLKPENLLFSDPA-GDNIKVVDFGFACLKRESL--HTPCFTLQYAAPEVLRQDKSGYDENCDL 557 (966)
Q Consensus 481 Qil~aL~yLHs~~IiHRDLKP~NILl~~~~-~~~iKL~DFGla~~~~~~~--~~~~gT~~Y~APEvl~~~~~~~~~~~Di 557 (966)
||+.||.|||.+||+|+||||+||||.+.. --.+||||||+|++..+.. .+.+|||.|+|||+++
T Consensus 672 QIL~ALr~LH~knIvHCDLKPENVLLas~~~FPQvKlCDFGfARiIgEksFRrsVVGTPAYLaPEVLr------------ 739 (888)
T KOG4236|consen 672 QILVALRYLHFKNIVHCDLKPENVLLASASPFPQVKLCDFGFARIIGEKSFRRSVVGTPAYLAPEVLR------------ 739 (888)
T ss_pred HHHHHHHHhhhcceeeccCCchheeeccCCCCCceeeccccceeecchhhhhhhhcCCccccCHHHHh------------
Confidence 999999999999999999999999997532 2479999999999987753 3568999999999997
Q ss_pred hhhhhhhhhhhhcCCCCCCCcCcchhHHHHHHHHhcCCCCCCCCCCchhHHHHHHHHHcCCCCCCchhhccCCHHHHHHH
Q psy11767 558 WSLGVILVNVLRQDKSGYDENCDLWSLGVILYTMLCGRVPFHARSRDDSALSIMARIKEGQFNFDAEAWSTVSSEAKELT 637 (966)
Q Consensus 558 ~SlGvil~el~~~~~~~y~~~~DIWSlGvilyemltG~~Pf~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~is~e~~~Li 637 (966)
+.+|+.+-|+||.|||+|.-|.|.+||.... .+-.+|.+..|.+++..|..+|+++.|||
T Consensus 740 --------------nkGyNrSLDMWSVGVIiYVsLSGTFPFNEdE------dIndQIQNAaFMyPp~PW~eis~~AidlI 799 (888)
T KOG4236|consen 740 --------------NKGYNRSLDMWSVGVIIYVSLSGTFPFNEDE------DINDQIQNAAFMYPPNPWSEISPEAIDLI 799 (888)
T ss_pred --------------hccccccccceeeeEEEEEEecccccCCCcc------chhHHhhccccccCCCchhhcCHHHHHHH
Confidence 3468899999999999999999999997532 35567888999999999999999999999
Q ss_pred HHhcccCccccCChHHHHHHhhhhHH
Q psy11767 638 KSLLTVNPAQRIRMMRVKLTFHAFHQ 663 (966)
Q Consensus 638 ~~~L~~dP~~R~t~~~v~~~~~~~~~ 663 (966)
..+|++.-.+|.+... ..-|+|.+
T Consensus 800 n~LLqVkm~kRysvdk--~lsh~Wlq 823 (888)
T KOG4236|consen 800 NNLLQVKMRKRYSVDK--SLSHPWLQ 823 (888)
T ss_pred HHHHHHHHHHhcchHh--hccchhhh
Confidence 9999999999999873 34556653
|
|
| >KOG0589|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-39 Score=364.99 Aligned_cols=241 Identities=29% Similarity=0.480 Sum_probs=210.3
Q ss_pred ccccccccccccEEEEEEEcCCCcEEEEEEecccc-------ChHHHHHHHHHhcCCCCceEEEEEEEeCCe-EEEEEEc
Q psy11767 381 DKAGILGDGSYSVCRRCVEKSTGQEYAVKIISRKI-------DCSEEINLLRACQGHPNIVNLHCVFQDEVH-TYLVLEL 452 (966)
Q Consensus 381 ~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~-------~~~~Ei~iL~~l~~HpnIV~l~~~~~~~~~-~~lVmEy 452 (966)
..++.+|+|+||.+++++++.+++.|++|.|.-.. .+..|+.++.+++ |||||.+.+.|+.++. ++|||+|
T Consensus 7 e~~~~iG~GafG~a~lvrhk~~~~~~vlK~I~l~~~t~~~r~~A~~E~~lis~~~-hP~iv~y~ds~~~~~~~l~Ivm~Y 85 (426)
T KOG0589|consen 7 EVLRQVGRGAFGSALLVRHKSDDKLYVLKKINLEKLTEPERRSAIQEMDLLSKLL-HPNIVEYKDSFEEDGQLLCIVMEY 85 (426)
T ss_pred hhhhhcCccccchhhhhhhccCCceEEEEEEeccccCchhhHHHHHHHHHHHhcc-CCCeeeeccchhcCCceEEEEEee
Confidence 34788999999999999999999999999986432 3567999999975 9999999999998888 9999999
Q ss_pred cCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCcEEEecCCCCCEEEEeecccccccCC---C
Q psy11767 453 LKGGELLDRIRQKGRCGFTENEASRIMRQLVAAVHFMHSRGVVHRDLKPENLLFSDPAGDNIKVVDFGFACLKRES---L 529 (966)
Q Consensus 453 ~~gg~L~~~l~~~~~~~l~e~~~~~i~~Qil~aL~yLHs~~IiHRDLKP~NILl~~~~~~~iKL~DFGla~~~~~~---~ 529 (966)
|+||+|.+.|.+..+..|+|+.+..++.||+.||.|||+++|+|||||+.||++.. .+.|||.|||+|+..... .
T Consensus 86 ~eGg~l~~~i~~~k~~~f~E~~i~~~~~Q~~~av~ylH~~~iLHRDlK~~Nifltk--~~~VkLgDfGlaK~l~~~~~~a 163 (426)
T KOG0589|consen 86 CEGGDLAQLIKEQKGVLFPEERILKWFVQILLAVNYLHENRVLHRDLKCANIFLTK--DKKVKLGDFGLAKILNPEDSLA 163 (426)
T ss_pred cCCCCHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHhhhhhcccchhhhhhccc--cCceeecchhhhhhcCCchhhh
Confidence 99999999998877667999999999999999999999999999999999999985 457899999999887643 3
Q ss_pred ccccccccccCchhhccCCCCCCCcccchhhhhhhhhhhhcCCCCCCCcCcchhHHHHHHHHhcCCCCCCCCCCchhHHH
Q psy11767 530 HTPCFTLQYAAPEVLRQDKSGYDENCDLWSLGVILVNVLRQDKSGYDENCDLWSLGVILYTMLCGRVPFHARSRDDSALS 609 (966)
Q Consensus 530 ~~~~gT~~Y~APEvl~~~~~~~~~~~Di~SlGvil~el~~~~~~~y~~~~DIWSlGvilyemltG~~Pf~~~~~~~~~~~ 609 (966)
.+.+|||.||.||++.+ .+|+.|+|||||||++|||++-+++|.+.+.. .
T Consensus 164 ~tvvGTp~YmcPEil~d--------------------------~pYn~KSDiWsLGC~~yEm~~lk~aF~a~~m~----~ 213 (426)
T KOG0589|consen 164 STVVGTPYYMCPEILSD--------------------------IPYNEKSDIWSLGCCLYEMCTLKPAFKASNMS----E 213 (426)
T ss_pred heecCCCcccCHHHhCC--------------------------CCCCccCcchhhcchHHHHHhcccccCccchH----H
Confidence 56789999999999963 45899999999999999999999999986643 4
Q ss_pred HHHHHHcCCCCCCchhhccCCHHHHHHHHHhcccCccccCChHHHHHH
Q psy11767 610 IMARIKEGQFNFDAEAWSTVSSEAKELTKSLLTVNPAQRIRMMRVKLT 657 (966)
Q Consensus 610 ~~~~i~~~~~~~~~~~~~~is~e~~~Li~~~L~~dP~~R~t~~~v~~~ 657 (966)
+..+|.++.+...+ ...|.+++.||..||+.+|..||++.++...
T Consensus 214 Li~ki~~~~~~Plp---~~ys~el~~lv~~~l~~~P~~RPsa~~LL~~ 258 (426)
T KOG0589|consen 214 LILKINRGLYSPLP---SMYSSELRSLVKSMLRKNPEHRPSALELLRR 258 (426)
T ss_pred HHHHHhhccCCCCC---ccccHHHHHHHHHHhhcCCccCCCHHHHhhC
Confidence 55667777654433 3579999999999999999999999987544
|
|
| >cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-39 Score=362.14 Aligned_cols=241 Identities=35% Similarity=0.612 Sum_probs=195.8
Q ss_pred cccccccEEEEEEEcCCCcEEEEEEeccccC--------hHHHHHHHHHhc--CCCCceEEEEEEEeCCeEEEEEEccCC
Q psy11767 386 LGDGSYSVCRRCVEKSTGQEYAVKIISRKID--------CSEEINLLRACQ--GHPNIVNLHCVFQDEVHTYLVLELLKG 455 (966)
Q Consensus 386 LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~~--------~~~Ei~iL~~l~--~HpnIV~l~~~~~~~~~~~lVmEy~~g 455 (966)
||+|+||+||+|++..+|+.||||++.+... ...|..++..+. +||||++++++|.+....|+||||+++
T Consensus 1 lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~p~i~~~~~~~~~~~~~~lv~e~~~~ 80 (330)
T cd05586 1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVGLKFSFQTDSDLYLVTDYMSG 80 (330)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEEeHHHHhhhhHHHHHHHHHHHHHHhccCCCCcCcceEEEEecCCeEEEEEcCCCC
Confidence 7999999999999999999999999864321 223566666554 799999999999999999999999999
Q ss_pred CCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCcEEEecCCCCCEEEEeecccccccC---CCccc
Q psy11767 456 GELLDRIRQKGRCGFTENEASRIMRQLVAAVHFMHSRGVVHRDLKPENLLFSDPAGDNIKVVDFGFACLKRE---SLHTP 532 (966)
Q Consensus 456 g~L~~~l~~~~~~~l~e~~~~~i~~Qil~aL~yLHs~~IiHRDLKP~NILl~~~~~~~iKL~DFGla~~~~~---~~~~~ 532 (966)
|+|.+++.+.+ .+++..++.++.||+.||+|||++||+||||||+|||++. ++.+||+|||++..... .....
T Consensus 81 g~L~~~l~~~~--~~~~~~~~~~~~qil~al~~LH~~~ivHrDlkp~Nili~~--~~~~kl~Dfg~a~~~~~~~~~~~~~ 156 (330)
T cd05586 81 GELFWHLQKEG--RFSEDRAKFYIAELVLALEHLHKYDIVYRDLKPENILLDA--TGHIALCDFGLSKANLTDNKTTNTF 156 (330)
T ss_pred ChHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeEECC--CCCEEEecCCcCcCCCCCCCCccCc
Confidence 99999987654 5899999999999999999999999999999999999975 56899999999865321 23356
Q ss_pred cccccccCchhhccCCCCCCCcccchhhhhhhhhhhhcCCCCCCCcCcchhHHHHHHHHhcCCCCCCCCCCchhHHHHHH
Q psy11767 533 CFTLQYAAPEVLRQDKSGYDENCDLWSLGVILVNVLRQDKSGYDENCDLWSLGVILYTMLCGRVPFHARSRDDSALSIMA 612 (966)
Q Consensus 533 ~gT~~Y~APEvl~~~~~~~~~~~Di~SlGvil~el~~~~~~~y~~~~DIWSlGvilyemltG~~Pf~~~~~~~~~~~~~~ 612 (966)
+||+.|+|||++.. ...|+.++|||||||++|+|++|+.||.+.+. ...+.
T Consensus 157 ~gt~~y~aPE~~~~-------------------------~~~~~~~~DvwslGvil~elltG~~Pf~~~~~----~~~~~ 207 (330)
T cd05586 157 CGTTEYLAPEVLLD-------------------------EKGYTKHVDFWSLGVLVFEMCCGWSPFYAEDT----QQMYR 207 (330)
T ss_pred cCCccccCHHHHcC-------------------------CCCCCCccceeccccEEEEeccCCCCCCCCCH----HHHHH
Confidence 78999999998852 22467889999999999999999999987543 23455
Q ss_pred HHHcCCCCCCchhhccCCHHHHHHHHHhcccCccccCChHH--HHHHhhhhH
Q psy11767 613 RIKEGQFNFDAEAWSTVSSEAKELTKSLLTVNPAQRIRMMR--VKLTFHAFH 662 (966)
Q Consensus 613 ~i~~~~~~~~~~~~~~is~e~~~Li~~~L~~dP~~R~t~~~--v~~~~~~~~ 662 (966)
.+..+...++. ..+++++.+||.+||..||++||++.+ .....|+|+
T Consensus 208 ~i~~~~~~~~~---~~~~~~~~~li~~~L~~~P~~R~~~~~~~~~ll~h~~~ 256 (330)
T cd05586 208 NIAFGKVRFPK---NVLSDEGRQFVKGLLNRNPQHRLGAHRDAVELKEHPFF 256 (330)
T ss_pred HHHcCCCCCCC---ccCCHHHHHHHHHHcCCCHHHCCCCCCCHHHHhcCccc
Confidence 66666555443 247899999999999999999995321 123456664
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of |
| >cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-39 Score=362.33 Aligned_cols=234 Identities=29% Similarity=0.552 Sum_probs=192.5
Q ss_pred cccccccccEEEEEEEcCCCcEEEEEEecccc--------ChHHHHHHHHHhcCCCCceEEEEEEEeCCeEEEEEEccCC
Q psy11767 384 GILGDGSYSVCRRCVEKSTGQEYAVKIISRKI--------DCSEEINLLRACQGHPNIVNLHCVFQDEVHTYLVLELLKG 455 (966)
Q Consensus 384 ~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~--------~~~~Ei~iL~~l~~HpnIV~l~~~~~~~~~~~lVmEy~~g 455 (966)
++||+|+||+||+|++..+++.||+|++.+.. ...+|+.++..+.+|||||++++++.++...|+||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~E~~~~ 80 (329)
T cd05618 1 RVIGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYVNG 80 (329)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEhhHhcchhHHHHHHHHHHHHHhcCCCCcCCceeeEEEeCCEEEEEEeCCCC
Confidence 36999999999999999999999999997532 1345778887777899999999999999999999999999
Q ss_pred CCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCcEEEecCCCCCEEEEeeccccccc---CCCccc
Q psy11767 456 GELLDRIRQKGRCGFTENEASRIMRQLVAAVHFMHSRGVVHRDLKPENLLFSDPAGDNIKVVDFGFACLKR---ESLHTP 532 (966)
Q Consensus 456 g~L~~~l~~~~~~~l~e~~~~~i~~Qil~aL~yLHs~~IiHRDLKP~NILl~~~~~~~iKL~DFGla~~~~---~~~~~~ 532 (966)
|+|..++.... .+++..++.++.||+.||+|||++||+||||||+|||++. ++.+||+|||+++... ......
T Consensus 81 ~~L~~~~~~~~--~l~~~~~~~i~~qi~~~l~~lH~~~ivH~Dikp~Nili~~--~~~~kL~DfG~~~~~~~~~~~~~~~ 156 (329)
T cd05618 81 GDLMFHMQRQR--KLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLDS--EGHIKLTDYGMCKEGLRPGDTTSTF 156 (329)
T ss_pred CCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEECC--CCCEEEeeCCccccccCCCCccccc
Confidence 99999887654 5999999999999999999999999999999999999975 5689999999986532 223346
Q ss_pred cccccccCchhhccCCCCCCCcccchhhhhhhhhhhhcCCCCCCCcCcchhHHHHHHHHhcCCCCCCCCCCc-----hhH
Q psy11767 533 CFTLQYAAPEVLRQDKSGYDENCDLWSLGVILVNVLRQDKSGYDENCDLWSLGVILYTMLCGRVPFHARSRD-----DSA 607 (966)
Q Consensus 533 ~gT~~Y~APEvl~~~~~~~~~~~Di~SlGvil~el~~~~~~~y~~~~DIWSlGvilyemltG~~Pf~~~~~~-----~~~ 607 (966)
+||+.|+|||++.. ..|+.++|||||||++|+|++|+.||...... ...
T Consensus 157 ~gt~~y~aPE~~~~--------------------------~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~~~~ 210 (329)
T cd05618 157 CGTPNYIAPEILRG--------------------------EDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTE 210 (329)
T ss_pred cCCccccCHHHHcC--------------------------CCCCCccceecccHHHHHHhhCCCCCccCCCcCCcccccH
Confidence 78999999999852 23678899999999999999999999632111 111
Q ss_pred HHHHHHHHcCCCCCCchhhccCCHHHHHHHHHhcccCccccCCh
Q psy11767 608 LSIMARIKEGQFNFDAEAWSTVSSEAKELTKSLLTVNPAQRIRM 651 (966)
Q Consensus 608 ~~~~~~i~~~~~~~~~~~~~~is~e~~~Li~~~L~~dP~~R~t~ 651 (966)
..+...+..+...++ ..++.++.+||.+||..||++|+++
T Consensus 211 ~~~~~~i~~~~~~~p----~~~~~~~~~ll~~~L~~dP~~R~~~ 250 (329)
T cd05618 211 DYLFQVILEKQIRIP----RSLSVKAASVLKSFLNKDPKERLGC 250 (329)
T ss_pred HHHHHHHhcCCCCCC----CCCCHHHHHHHHHHhcCCHHHcCCC
Confidence 223344555444333 3578999999999999999999985
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o |
| >cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-39 Score=362.63 Aligned_cols=238 Identities=32% Similarity=0.603 Sum_probs=197.0
Q ss_pred cccccccccEEEEEEEcCCCcEEEEEEecccc--------ChHHHHHHHHHhcCCCCceEEEEEEEeCCeEEEEEEccCC
Q psy11767 384 GILGDGSYSVCRRCVEKSTGQEYAVKIISRKI--------DCSEEINLLRACQGHPNIVNLHCVFQDEVHTYLVLELLKG 455 (966)
Q Consensus 384 ~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~--------~~~~Ei~iL~~l~~HpnIV~l~~~~~~~~~~~lVmEy~~g 455 (966)
++||+|+||.||+|.+..+|+.||||++.+.. ...+|+.+|+.+ +||||+++++++.++...|+||||+++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l-~hp~iv~~~~~~~~~~~~~lv~Ey~~~ 79 (328)
T cd05593 1 KLLGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNT-RHPFLTSLKYSFQTKDRLCFVMEYVNG 79 (328)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhC-CCCCCcceEEEEEcCCEEEEEEeCCCC
Confidence 36999999999999999999999999997532 134588888887 599999999999999999999999999
Q ss_pred CCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCcEEEecCCCCCEEEEeecccccccC---CCccc
Q psy11767 456 GELLDRIRQKGRCGFTENEASRIMRQLVAAVHFMHSRGVVHRDLKPENLLFSDPAGDNIKVVDFGFACLKRE---SLHTP 532 (966)
Q Consensus 456 g~L~~~l~~~~~~~l~e~~~~~i~~Qil~aL~yLHs~~IiHRDLKP~NILl~~~~~~~iKL~DFGla~~~~~---~~~~~ 532 (966)
|+|.+++.... .+++.+++.++.||+.||+|||++||+||||||+|||++. ++.+||+|||++..... .....
T Consensus 80 g~L~~~l~~~~--~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~NIll~~--~~~~kL~DfG~~~~~~~~~~~~~~~ 155 (328)
T cd05593 80 GELFFHLSRER--VFSEDRTRFYGAEIVSALDYLHSGKIVYRDLKLENLMLDK--DGHIKITDFGLCKEGITDAATMKTF 155 (328)
T ss_pred CCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCeEecccCHHHeEECC--CCcEEEecCcCCccCCCcccccccc
Confidence 99999887654 5899999999999999999999999999999999999975 56899999999875322 22345
Q ss_pred cccccccCchhhccCCCCCCCcccchhhhhhhhhhhhcCCCCCCCcCcchhHHHHHHHHhcCCCCCCCCCCchhHHHHHH
Q psy11767 533 CFTLQYAAPEVLRQDKSGYDENCDLWSLGVILVNVLRQDKSGYDENCDLWSLGVILYTMLCGRVPFHARSRDDSALSIMA 612 (966)
Q Consensus 533 ~gT~~Y~APEvl~~~~~~~~~~~Di~SlGvil~el~~~~~~~y~~~~DIWSlGvilyemltG~~Pf~~~~~~~~~~~~~~ 612 (966)
+||+.|+|||++.. ..|+.++|||||||++|+|++|+.||...+.. ....
T Consensus 156 ~gt~~y~aPE~~~~--------------------------~~~~~~~DiwslGvil~elltG~~Pf~~~~~~----~~~~ 205 (328)
T cd05593 156 CGTPEYLAPEVLED--------------------------NDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHE----KLFE 205 (328)
T ss_pred cCCcCccChhhhcC--------------------------CCCCccCCccccchHHHHHhhCCCCCCCCCHH----HHHH
Confidence 78999999999852 23678999999999999999999999865432 3344
Q ss_pred HHHcCCCCCCchhhccCCHHHHHHHHHhcccCccccC-----ChHHHHHHhhhhH
Q psy11767 613 RIKEGQFNFDAEAWSTVSSEAKELTKSLLTVNPAQRI-----RMMRVKLTFHAFH 662 (966)
Q Consensus 613 ~i~~~~~~~~~~~~~~is~e~~~Li~~~L~~dP~~R~-----t~~~v~~~~~~~~ 662 (966)
.+..+...++ ..+++++.+||.+||..||++|+ ++.++ ..|+|+
T Consensus 206 ~~~~~~~~~p----~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~i--l~h~~~ 254 (328)
T cd05593 206 LILMEDIKFP----RTLSADAKSLLSGLLIKDPNKRLGGGPDDAKEI--MRHSFF 254 (328)
T ss_pred HhccCCccCC----CCCCHHHHHHHHHHcCCCHHHcCCCCCCCHHHH--hcCCCc
Confidence 4544444433 35799999999999999999998 56654 345554
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate |
| >cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-39 Score=369.06 Aligned_cols=250 Identities=30% Similarity=0.509 Sum_probs=199.6
Q ss_pred cccccccccccccEEEEEEEcCCCcEEEEEEecccc--------ChHHHHHHHHHhcCCCCceEEEEEEEeCCeEEEEEE
Q psy11767 380 LDKAGILGDGSYSVCRRCVEKSTGQEYAVKIISRKI--------DCSEEINLLRACQGHPNIVNLHCVFQDEVHTYLVLE 451 (966)
Q Consensus 380 ~~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~--------~~~~Ei~iL~~l~~HpnIV~l~~~~~~~~~~~lVmE 451 (966)
|+..+.||+|+||.||+|.+..+++.||+|++.+.. ...+|+.+++.+ +||||++++++|.++...|+|||
T Consensus 45 y~~~~~lG~G~fg~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~-~hp~iv~~~~~~~~~~~~~lv~E 123 (370)
T cd05621 45 YDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFA-NSPWVVQLFCAFQDDKYLYMVME 123 (370)
T ss_pred CeEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhC-CCCCEeeEEEEEEcCCEEEEEEc
Confidence 344688999999999999999999999999986421 134688888777 69999999999999999999999
Q ss_pred ccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCcEEEecCCCCCEEEEeecccccccCC---
Q psy11767 452 LLKGGELLDRIRQKGRCGFTENEASRIMRQLVAAVHFMHSRGVVHRDLKPENLLFSDPAGDNIKVVDFGFACLKRES--- 528 (966)
Q Consensus 452 y~~gg~L~~~l~~~~~~~l~e~~~~~i~~Qil~aL~yLHs~~IiHRDLKP~NILl~~~~~~~iKL~DFGla~~~~~~--- 528 (966)
||+||+|.+++... .+++.+++.++.||+.||+|||++||+||||||+|||++. .+.+||+|||+|......
T Consensus 124 y~~gg~L~~~l~~~---~~~~~~~~~~~~qil~aL~~LH~~~IvHrDLKp~NILl~~--~~~~kL~DFG~a~~~~~~~~~ 198 (370)
T cd05621 124 YMPGGDLVNLMSNY---DVPEKWAKFYTAEVVLALDAIHSMGLIHRDVKPDNMLLDK--HGHLKLADFGTCMKMDETGMV 198 (370)
T ss_pred CCCCCcHHHHHHhc---CCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHEEECC--CCCEEEEecccceecccCCce
Confidence 99999999998654 4899999999999999999999999999999999999974 569999999999764322
Q ss_pred -CccccccccccCchhhccCCCCCCCcccchhhhhhhhhhhhcCCCCCCCcCcchhHHHHHHHHhcCCCCCCCCCCchhH
Q psy11767 529 -LHTPCFTLQYAAPEVLRQDKSGYDENCDLWSLGVILVNVLRQDKSGYDENCDLWSLGVILYTMLCGRVPFHARSRDDSA 607 (966)
Q Consensus 529 -~~~~~gT~~Y~APEvl~~~~~~~~~~~Di~SlGvil~el~~~~~~~y~~~~DIWSlGvilyemltG~~Pf~~~~~~~~~ 607 (966)
..+.+||+.|+|||++.... ....|+.++||||+||++|+|++|++||.+.+..
T Consensus 199 ~~~~~~gt~~Y~aPE~~~~~~----------------------~~~~~~~~~DiwSlG~ilyell~G~~Pf~~~~~~--- 253 (370)
T cd05621 199 RCDTAVGTPDYISPEVLKSQG----------------------GDGYYGRECDWWSVGVFLFEMLVGDTPFYADSLV--- 253 (370)
T ss_pred ecccCCCCcccCCHHHHhccC----------------------CCCCCCcccCEEeehHHHHHHHhCCCCCCCCCHH---
Confidence 23567999999999985321 1223678999999999999999999999876532
Q ss_pred HHHHHHHHcCCCCCCchhhccCCHHHHHHHHHhcccCccc--cCChHHHHHHhhhhHH
Q psy11767 608 LSIMARIKEGQFNFDAEAWSTVSSEAKELTKSLLTVNPAQ--RIRMMRVKLTFHAFHQ 663 (966)
Q Consensus 608 ~~~~~~i~~~~~~~~~~~~~~is~e~~~Li~~~L~~dP~~--R~t~~~v~~~~~~~~~ 663 (966)
..+..+......+..+....++..+++++.+||..++.+ |+++.++ ..|+|++
T Consensus 254 -~~~~~i~~~~~~~~~p~~~~~s~~~~~li~~~L~~~~~r~~R~~~~e~--l~hp~~~ 308 (370)
T cd05621 254 -GTYSKIMDHKNSLNFPEDVEISKHAKNLICAFLTDREVRLGRNGVEEI--KQHPFFK 308 (370)
T ss_pred -HHHHHHHhCCcccCCCCcccCCHHHHHHHHHHccCchhccCCCCHHHH--hcCcccC
Confidence 234445443322222222357999999999999855543 7888865 4466653
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found |
| >cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-39 Score=361.15 Aligned_cols=253 Identities=35% Similarity=0.545 Sum_probs=202.0
Q ss_pred cccccccccccccEEEEEEEcCCCcEEEEEEeccccC--------hHHHHHHHHHhcCCCCceEEEEEEEeCCeEEEEEE
Q psy11767 380 LDKAGILGDGSYSVCRRCVEKSTGQEYAVKIISRKID--------CSEEINLLRACQGHPNIVNLHCVFQDEVHTYLVLE 451 (966)
Q Consensus 380 ~~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~~--------~~~Ei~iL~~l~~HpnIV~l~~~~~~~~~~~lVmE 451 (966)
|+..+.||+|+||+||+|++..+|+.||||++..... ..+|+.+++.+ +||||+++++++.++...|+|||
T Consensus 3 y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~-~~~~i~~~~~~~~~~~~~~lv~e 81 (330)
T cd05601 3 FDVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSIS-NSPWIPQLQYAFQDKDNLYLVME 81 (330)
T ss_pred ceEEEEEEeccCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhC-CCCCCcceeeEEecCCeEEEEEC
Confidence 3446889999999999999999999999999975321 34577888776 69999999999999999999999
Q ss_pred ccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCcEEEecCCCCCEEEEeecccccccCC---
Q psy11767 452 LLKGGELLDRIRQKGRCGFTENEASRIMRQLVAAVHFMHSRGVVHRDLKPENLLFSDPAGDNIKVVDFGFACLKRES--- 528 (966)
Q Consensus 452 y~~gg~L~~~l~~~~~~~l~e~~~~~i~~Qil~aL~yLHs~~IiHRDLKP~NILl~~~~~~~iKL~DFGla~~~~~~--- 528 (966)
|++||+|.+++.+... .+++..++.++.||+.||+|||++||+||||||+|||++. .+.+||+|||++......
T Consensus 82 ~~~~~~L~~~l~~~~~-~l~~~~~~~~~~qi~~aL~~lH~~~i~H~Dlkp~NIll~~--~~~~kL~Dfg~a~~~~~~~~~ 158 (330)
T cd05601 82 YQPGGDLLSLLNRYED-QFDEDMAQFYLAELVLAIHSVHQMGYVHRDIKPENVLIDR--TGHIKLADFGSAARLTANKMV 158 (330)
T ss_pred CCCCCCHHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCCeEcccCchHheEECC--CCCEEeccCCCCeECCCCCce
Confidence 9999999999977532 6999999999999999999999999999999999999975 568999999999754321
Q ss_pred -CccccccccccCchhhccCCCCCCCcccchhhhhhhhhhhhcCCCCCCCcCcchhHHHHHHHHhcCCCCCCCCCCchhH
Q psy11767 529 -LHTPCFTLQYAAPEVLRQDKSGYDENCDLWSLGVILVNVLRQDKSGYDENCDLWSLGVILYTMLCGRVPFHARSRDDSA 607 (966)
Q Consensus 529 -~~~~~gT~~Y~APEvl~~~~~~~~~~~Di~SlGvil~el~~~~~~~y~~~~DIWSlGvilyemltG~~Pf~~~~~~~~~ 607 (966)
....++|+.|+|||++..... .....|+.++|||||||++|+|++|+.||...+..
T Consensus 159 ~~~~~~gt~~y~aPE~~~~~~~--------------------~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~--- 215 (330)
T cd05601 159 NSKLPVGTPDYIAPEVLTTMNG--------------------DGKGTYGVECDWWSLGVIAYEMIYGRSPFHEGTSA--- 215 (330)
T ss_pred eeecccCCccccCHHHhccccc--------------------cccCCCCCcceeecccceeeeeccCCCCCCCCCHH---
Confidence 123468999999999853210 01345788999999999999999999999865432
Q ss_pred HHHHHHHHcCCCCCCchhhccCCHHHHHHHHHhcccCccccCChHHHHHHhhhhHH
Q psy11767 608 LSIMARIKEGQFNFDAEAWSTVSSEAKELTKSLLTVNPAQRIRMMRVKLTFHAFHQ 663 (966)
Q Consensus 608 ~~~~~~i~~~~~~~~~~~~~~is~e~~~Li~~~L~~dP~~R~t~~~v~~~~~~~~~ 663 (966)
..+..+..............+++++.+||.+||. ||++|||+.++ ..|+|+.
T Consensus 216 -~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~ll~-~p~~R~t~~~l--~~h~~~~ 267 (330)
T cd05601 216 -KTYNNIMNFQRFLKFPEDPKVSSDFLDLIQSLLC-GQKERLGYEGL--CCHPFFS 267 (330)
T ss_pred -HHHHHHHcCCCccCCCCCCCCCHHHHHHHHHHcc-ChhhCCCHHHH--hCCCCcC
Confidence 2333443322111111224689999999999998 99999999865 4566653
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor |
| >cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-39 Score=359.55 Aligned_cols=241 Identities=32% Similarity=0.537 Sum_probs=194.7
Q ss_pred cccccccccEEEEEEEcCCCcEEEEEEeccccC--------hHHHHHHHHHhcCCCCceEEEEEEEeCCeEEEEEEccCC
Q psy11767 384 GILGDGSYSVCRRCVEKSTGQEYAVKIISRKID--------CSEEINLLRACQGHPNIVNLHCVFQDEVHTYLVLELLKG 455 (966)
Q Consensus 384 ~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~~--------~~~Ei~iL~~l~~HpnIV~l~~~~~~~~~~~lVmEy~~g 455 (966)
+.||+|+||+||+|++..+|+.||||++.+... ...|..++....+||||++++++|..+...|+||||++|
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~hp~iv~~~~~~~~~~~~~lv~e~~~~ 80 (325)
T cd05604 1 KVIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTTEKLYFVLDFVNG 80 (325)
T ss_pred CceeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHHhCCCCCCccEEEEEecCCEEEEEEcCCCC
Confidence 369999999999999999999999999965421 223444443334799999999999999999999999999
Q ss_pred CCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCcEEEecCCCCCEEEEeeccccccc---CCCccc
Q psy11767 456 GELLDRIRQKGRCGFTENEASRIMRQLVAAVHFMHSRGVVHRDLKPENLLFSDPAGDNIKVVDFGFACLKR---ESLHTP 532 (966)
Q Consensus 456 g~L~~~l~~~~~~~l~e~~~~~i~~Qil~aL~yLHs~~IiHRDLKP~NILl~~~~~~~iKL~DFGla~~~~---~~~~~~ 532 (966)
|+|..++.... .+++..++.++.||+.||+|||++||+||||||+|||+++ ++.+||+|||++.... ......
T Consensus 81 ~~L~~~l~~~~--~~~~~~~~~~~~qi~~al~~lH~~givH~Dlkp~NIll~~--~~~~kL~DfG~~~~~~~~~~~~~~~ 156 (325)
T cd05604 81 GELFFHLQRER--SFPEPRARFYAAEIASALGYLHSINIVYRDLKPENILLDS--QGHVVLTDFGLCKEGIAQSDTTTTF 156 (325)
T ss_pred CCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHeEECC--CCCEEEeecCCcccCCCCCCCcccc
Confidence 99999887654 5899999999999999999999999999999999999985 5689999999986532 223345
Q ss_pred cccccccCchhhccCCCCCCCcccchhhhhhhhhhhhcCCCCCCCcCcchhHHHHHHHHhcCCCCCCCCCCchhHHHHHH
Q psy11767 533 CFTLQYAAPEVLRQDKSGYDENCDLWSLGVILVNVLRQDKSGYDENCDLWSLGVILYTMLCGRVPFHARSRDDSALSIMA 612 (966)
Q Consensus 533 ~gT~~Y~APEvl~~~~~~~~~~~Di~SlGvil~el~~~~~~~y~~~~DIWSlGvilyemltG~~Pf~~~~~~~~~~~~~~ 612 (966)
+||+.|+|||++.. ..|+.++|||||||++|+|++|+.||...+.. .+..
T Consensus 157 ~gt~~y~aPE~~~~--------------------------~~~~~~~DvwslG~il~el~~G~~pf~~~~~~----~~~~ 206 (325)
T cd05604 157 CGTPEYLAPEVIRK--------------------------QPYDNTVDWWCLGAVLYEMLYGLPPFYCRDVA----EMYD 206 (325)
T ss_pred cCChhhCCHHHHcC--------------------------CCCCCcCccccccceehhhhcCCCCCCCCCHH----HHHH
Confidence 78999999999852 23678899999999999999999999875432 3444
Q ss_pred HHHcCCCCCCchhhccCCHHHHHHHHHhcccCccccCChHH-H-HHHhhhhH
Q psy11767 613 RIKEGQFNFDAEAWSTVSSEAKELTKSLLTVNPAQRIRMMR-V-KLTFHAFH 662 (966)
Q Consensus 613 ~i~~~~~~~~~~~~~~is~e~~~Li~~~L~~dP~~R~t~~~-v-~~~~~~~~ 662 (966)
.+..+..... +.++.++.++|.+||+.||.+||++.+ + ....|+|+
T Consensus 207 ~~~~~~~~~~----~~~~~~~~~ll~~ll~~~p~~R~~~~~~~~~i~~h~~f 254 (325)
T cd05604 207 NILHKPLVLR----PGASLTAWSILEELLEKDRQRRLGAKEDFLEIQEHPFF 254 (325)
T ss_pred HHHcCCccCC----CCCCHHHHHHHHHHhccCHHhcCCCCCCHHHHhcCCCc
Confidence 5555544332 357899999999999999999998752 1 23445554
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, |
| >cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-38 Score=356.71 Aligned_cols=230 Identities=33% Similarity=0.548 Sum_probs=189.1
Q ss_pred cccccccccEEEEEEEcCCCcEEEEEEeccccC--------hHHHHH-HHHHhcCCCCceEEEEEEEeCCeEEEEEEccC
Q psy11767 384 GILGDGSYSVCRRCVEKSTGQEYAVKIISRKID--------CSEEIN-LLRACQGHPNIVNLHCVFQDEVHTYLVLELLK 454 (966)
Q Consensus 384 ~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~~--------~~~Ei~-iL~~l~~HpnIV~l~~~~~~~~~~~lVmEy~~ 454 (966)
++||+|+||+||+|++..+|+.||+|++.+... ...|+. +++.+ +|||||+++++|.+....|+|||||+
T Consensus 1 ~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~-~h~~iv~~~~~~~~~~~~~lv~e~~~ 79 (321)
T cd05603 1 KVIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNL-KHPFLVGLHYSFQTAEKLYFVLDYVN 79 (321)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHHhC-CCCCccceeeEEEcCCEEEEEEcCCC
Confidence 369999999999999999999999999865321 223444 34555 69999999999999999999999999
Q ss_pred CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCcEEEecCCCCCEEEEeecccccccC---CCcc
Q psy11767 455 GGELLDRIRQKGRCGFTENEASRIMRQLVAAVHFMHSRGVVHRDLKPENLLFSDPAGDNIKVVDFGFACLKRE---SLHT 531 (966)
Q Consensus 455 gg~L~~~l~~~~~~~l~e~~~~~i~~Qil~aL~yLHs~~IiHRDLKP~NILl~~~~~~~iKL~DFGla~~~~~---~~~~ 531 (966)
||+|...+.... .+++..++.++.||+.||+|||++||+||||||+|||++. ++.+||+|||++..... ....
T Consensus 80 ~~~L~~~l~~~~--~~~~~~~~~~~~qi~~~L~~lH~~~ivH~Dlkp~NIll~~--~~~~kl~Dfg~~~~~~~~~~~~~~ 155 (321)
T cd05603 80 GGELFFHLQRER--CFLEPRARFYAAEVASAIGYLHSLNIIYRDLKPENILLDS--QGHVVLTDFGLCKEGVEPEETTST 155 (321)
T ss_pred CCCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeEECC--CCCEEEccCCCCccCCCCCCcccc
Confidence 999999887654 5899999999999999999999999999999999999975 56899999999865322 2234
Q ss_pred ccccccccCchhhccCCCCCCCcccchhhhhhhhhhhhcCCCCCCCcCcchhHHHHHHHHhcCCCCCCCCCCchhHHHHH
Q psy11767 532 PCFTLQYAAPEVLRQDKSGYDENCDLWSLGVILVNVLRQDKSGYDENCDLWSLGVILYTMLCGRVPFHARSRDDSALSIM 611 (966)
Q Consensus 532 ~~gT~~Y~APEvl~~~~~~~~~~~Di~SlGvil~el~~~~~~~y~~~~DIWSlGvilyemltG~~Pf~~~~~~~~~~~~~ 611 (966)
.+||+.|+|||++.. ..|+.++|||||||++|+|++|.+||...+. ....
T Consensus 156 ~~gt~~y~aPE~~~~--------------------------~~~~~~~DiwslG~il~el~~g~~pf~~~~~----~~~~ 205 (321)
T cd05603 156 FCGTPEYLAPEVLRK--------------------------EPYDRTVDWWCLGAVLYEMLYGLPPFYSRDV----SQMY 205 (321)
T ss_pred ccCCcccCCHHHhcC--------------------------CCCCCcCcccccchhhhhhhcCCCCCCCCCH----HHHH
Confidence 578999999998852 2367889999999999999999999987543 2344
Q ss_pred HHHHcCCCCCCchhhccCCHHHHHHHHHhcccCccccCChH
Q psy11767 612 ARIKEGQFNFDAEAWSTVSSEAKELTKSLLTVNPAQRIRMM 652 (966)
Q Consensus 612 ~~i~~~~~~~~~~~~~~is~e~~~Li~~~L~~dP~~R~t~~ 652 (966)
..+..+...++ ...+.++.++|.+||+.||.+|+++.
T Consensus 206 ~~i~~~~~~~~----~~~~~~~~~li~~~l~~~p~~R~~~~ 242 (321)
T cd05603 206 DNILHKPLQLP----GGKTVAACDLLVGLLHKDQRRRLGAK 242 (321)
T ss_pred HHHhcCCCCCC----CCCCHHHHHHHHHHccCCHhhcCCCC
Confidence 55555544332 35688999999999999999999864
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. |
| >cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-39 Score=361.12 Aligned_cols=244 Identities=24% Similarity=0.381 Sum_probs=192.9
Q ss_pred cccccccccccEEEEEEE-----cCCCcEEEEEEecccc------ChHHHHHHHHHhcCCCCceEEEEEEEeC-CeEEEE
Q psy11767 382 KAGILGDGSYSVCRRCVE-----KSTGQEYAVKIISRKI------DCSEEINLLRACQGHPNIVNLHCVFQDE-VHTYLV 449 (966)
Q Consensus 382 ~~~~LG~G~fG~Vy~a~~-----~~tg~~vAvK~i~~~~------~~~~Ei~iL~~l~~HpnIV~l~~~~~~~-~~~~lV 449 (966)
..+.||+|+||.||+|.+ ..+++.||||++.... ...+|+.+|..+.+|||||++++++... ...|+|
T Consensus 11 ~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~~lv 90 (338)
T cd05102 11 LGKVLGHGAFGKVVEASAFGIDKKSSCNTVAVKMLKEGATASEHKALMSELKILIHIGNHLNVVNLLGACTKPNGPLMVI 90 (338)
T ss_pred eeeEeccCCcceEEEEEEeccCCcccchhhheeccccccchHHHHHHHHHHHHHHHhccCcceeeEEeEecCCCCceEEE
Confidence 367899999999999985 3456789999986532 2446999999987799999999988764 458999
Q ss_pred EEccCCCCHHHHHHhcC------------------------------------------------------------CCC
Q psy11767 450 LELLKGGELLDRIRQKG------------------------------------------------------------RCG 469 (966)
Q Consensus 450 mEy~~gg~L~~~l~~~~------------------------------------------------------------~~~ 469 (966)
||||++|+|.+++.... ...
T Consensus 91 ~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 170 (338)
T cd05102 91 VEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQSRVDRRIEAGQASVLFSRFQPSTSGSTNPPQETDDLWKSP 170 (338)
T ss_pred EecCCCCcHHHHHHhcchhcccccccchhhhhhhhhhhhhhccccccccccCCccccccccccCcccccchhccccccCC
Confidence 99999999999997532 124
Q ss_pred CCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCcEEEecCCCCCEEEEeecccccccCC-----CccccccccccCchhh
Q psy11767 470 FTENEASRIMRQLVAAVHFMHSRGVVHRDLKPENLLFSDPAGDNIKVVDFGFACLKRES-----LHTPCFTLQYAAPEVL 544 (966)
Q Consensus 470 l~e~~~~~i~~Qil~aL~yLHs~~IiHRDLKP~NILl~~~~~~~iKL~DFGla~~~~~~-----~~~~~gT~~Y~APEvl 544 (966)
+++.++..++.||+.||+|||++||+||||||+|||+++ ++.+||+|||+++..... .....+|+.|+|||++
T Consensus 171 l~~~~~~~~~~qi~~aL~~LH~~~ivHrDiKp~Nil~~~--~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~~~y~aPE~~ 248 (338)
T cd05102 171 LTMEDLICYSFQVARGMEFLASRKCIHRDLAARNILLSE--NNVVKICDFGLARDIYKDPDYVRKGSARLPLKWMAPESI 248 (338)
T ss_pred CCHHHHHHHHHHHHHHHHHHHHCCEECCCCccceEEEcC--CCcEEEeecccccccccCcchhcccCCCCCccccCcHHh
Confidence 788899999999999999999999999999999999975 568999999999754221 1123456789999988
Q ss_pred ccCCCCCCCcccchhhhhhhhhhhhcCCCCCCCcCcchhHHHHHHHHhc-CCCCCCCCCCchhHHHHHHHHHcCCCCCCc
Q psy11767 545 RQDKSGYDENCDLWSLGVILVNVLRQDKSGYDENCDLWSLGVILYTMLC-GRVPFHARSRDDSALSIMARIKEGQFNFDA 623 (966)
Q Consensus 545 ~~~~~~~~~~~Di~SlGvil~el~~~~~~~y~~~~DIWSlGvilyemlt-G~~Pf~~~~~~~~~~~~~~~i~~~~~~~~~ 623 (966)
.. ..|+.++|||||||++|||++ |..||.+....+. ....+..+....
T Consensus 249 ~~--------------------------~~~~~~sDiwslG~il~el~~~g~~pf~~~~~~~~---~~~~~~~~~~~~-- 297 (338)
T cd05102 249 FD--------------------------KVYTTQSDVWSFGVLLWEIFSLGASPYPGVQINEE---FCQRLKDGTRMR-- 297 (338)
T ss_pred hc--------------------------CCCCcccCHHHHHHHHHHHHhCCCCCCCCCCccHH---HHHHHhcCCCCC--
Confidence 52 237889999999999999996 9999987554322 223344443221
Q ss_pred hhhccCCHHHHHHHHHhcccCccccCChHHHHHHhh
Q psy11767 624 EAWSTVSSEAKELTKSLLTVNPAQRIRMMRVKLTFH 659 (966)
Q Consensus 624 ~~~~~is~e~~~Li~~~L~~dP~~R~t~~~v~~~~~ 659 (966)
....+++++.+|+.+||..||++|||+.++...+.
T Consensus 298 -~~~~~~~~l~~li~~cl~~dp~~RPs~~el~~~l~ 332 (338)
T cd05102 298 -APENATPEIYRIMLACWQGDPKERPTFSALVEILG 332 (338)
T ss_pred -CCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHH
Confidence 12357889999999999999999999998865443
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V |
| >cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-39 Score=369.40 Aligned_cols=246 Identities=30% Similarity=0.558 Sum_probs=197.5
Q ss_pred cccccccccccccEEEEEEEcCCCcEEEEEEecccc--------ChHHHHHHHHHhcCCCCceEEEEEEEeCCeEEEEEE
Q psy11767 380 LDKAGILGDGSYSVCRRCVEKSTGQEYAVKIISRKI--------DCSEEINLLRACQGHPNIVNLHCVFQDEVHTYLVLE 451 (966)
Q Consensus 380 ~~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~--------~~~~Ei~iL~~l~~HpnIV~l~~~~~~~~~~~lVmE 451 (966)
|+.++.||+|+||+||+|.+..+++.||||++.... ....|+.+|..+ +||||+++++.|.++.+.|||||
T Consensus 3 f~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l-~~~~iv~~~~~~~~~~~~~lv~E 81 (360)
T cd05627 3 FESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEA-DGAWVVKMFYSFQDKRNLYLIME 81 (360)
T ss_pred ceEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhC-CCCCEeeEEEEEEcCCEEEEEEe
Confidence 455789999999999999999999999999986421 134588888887 59999999999999999999999
Q ss_pred ccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCcEEEecCCCCCEEEEeecccccccCC---
Q psy11767 452 LLKGGELLDRIRQKGRCGFTENEASRIMRQLVAAVHFMHSRGVVHRDLKPENLLFSDPAGDNIKVVDFGFACLKRES--- 528 (966)
Q Consensus 452 y~~gg~L~~~l~~~~~~~l~e~~~~~i~~Qil~aL~yLHs~~IiHRDLKP~NILl~~~~~~~iKL~DFGla~~~~~~--- 528 (966)
||+||+|.+++.+.+ .+++..++.++.||+.||+|||++||+||||||+|||++. .+.+||+|||++......
T Consensus 82 ~~~gg~L~~~l~~~~--~l~~~~~~~~~~qi~~~L~~lH~~givHrDLkp~NIli~~--~~~vkL~DfG~~~~~~~~~~~ 157 (360)
T cd05627 82 FLPGGDMMTLLMKKD--TLSEEATQFYIAETVLAIDAIHQLGFIHRDIKPDNLLLDA--KGHVKLSDFGLCTGLKKAHRT 157 (360)
T ss_pred CCCCccHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCeEccCCCHHHEEECC--CCCEEEeeccCCccccccccc
Confidence 999999999997654 5899999999999999999999999999999999999974 569999999998532110
Q ss_pred -----------------------------------CccccccccccCchhhccCCCCCCCcccchhhhhhhhhhhhcCCC
Q psy11767 529 -----------------------------------LHTPCFTLQYAAPEVLRQDKSGYDENCDLWSLGVILVNVLRQDKS 573 (966)
Q Consensus 529 -----------------------------------~~~~~gT~~Y~APEvl~~~~~~~~~~~Di~SlGvil~el~~~~~~ 573 (966)
..+.+||+.|+|||++.. .
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~--------------------------~ 211 (360)
T cd05627 158 EFYRNLTHNPPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQ--------------------------T 211 (360)
T ss_pred ccccccccCCcccccccccccccccccccccccccccccCCCccccCHHHHcC--------------------------C
Confidence 113478999999999852 3
Q ss_pred CCCCcCcchhHHHHHHHHhcCCCCCCCCCCchhHHHHHHHHHcCC--CCCCchhhccCCHHHHHHHHHhcccCccccCCh
Q psy11767 574 GYDENCDLWSLGVILYTMLCGRVPFHARSRDDSALSIMARIKEGQ--FNFDAEAWSTVSSEAKELTKSLLTVNPAQRIRM 651 (966)
Q Consensus 574 ~y~~~~DIWSlGvilyemltG~~Pf~~~~~~~~~~~~~~~i~~~~--~~~~~~~~~~is~e~~~Li~~~L~~dP~~R~t~ 651 (966)
.|+.++|||||||++|+|++|++||.+.+..+ ....+.... ..++. ...+++++++||.+|+. ||.+|++.
T Consensus 212 ~~~~~~DiwSlGvilyel~tG~~Pf~~~~~~~----~~~~i~~~~~~~~~p~--~~~~s~~~~~li~~l~~-~p~~R~~~ 284 (360)
T cd05627 212 GYNKLCDWWSLGVIMYEMLIGYPPFCSETPQE----TYRKVMNWKETLVFPP--EVPISEKAKDLILRFCT-DSENRIGS 284 (360)
T ss_pred CCCCcceeccccceeeecccCCCCCCCCCHHH----HHHHHHcCCCceecCC--CCCCCHHHHHHHHHhcc-ChhhcCCC
Confidence 47889999999999999999999998765432 333443322 22222 22478999999999874 99999964
Q ss_pred HHH-HHHhhhhHH
Q psy11767 652 MRV-KLTFHAFHQ 663 (966)
Q Consensus 652 ~~v-~~~~~~~~~ 663 (966)
..+ ....|+|+.
T Consensus 285 ~~~~ei~~hp~f~ 297 (360)
T cd05627 285 NGVEEIKSHPFFE 297 (360)
T ss_pred CCHHHHhcCCCCC
Confidence 322 335577753
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul |
| >cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-38 Score=349.47 Aligned_cols=246 Identities=28% Similarity=0.489 Sum_probs=199.7
Q ss_pred cccccccEEEEEEEcCCCcEEEEEEecccc--------ChHHHHHHHHHhcCCCCceEEEEEEEeCCeEEEEEEccCCCC
Q psy11767 386 LGDGSYSVCRRCVEKSTGQEYAVKIISRKI--------DCSEEINLLRACQGHPNIVNLHCVFQDEVHTYLVLELLKGGE 457 (966)
Q Consensus 386 LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~--------~~~~Ei~iL~~l~~HpnIV~l~~~~~~~~~~~lVmEy~~gg~ 457 (966)
||+|+||.||++.++.+|+.||+|.+.... ....|+++|+.+ +||||++++++++++.+.|+||||++|++
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~il~~l-~hp~i~~~~~~~~~~~~~~lv~e~~~g~~ 79 (277)
T cd05607 1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKV-NSPFIVNLAYAFESKTHLCLVMSLMNGGD 79 (277)
T ss_pred CCCCCceEEEEEEEccCCcEEEEEEEcHHHhhcchhhHHHHHHHHHHHhc-CCCcEEEEEEEEecCCeEEEEEecCCCCC
Confidence 799999999999999999999999986421 134588999998 69999999999999999999999999999
Q ss_pred HHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCcEEEecCCCCCEEEEeecccccccCC--Ccccccc
Q psy11767 458 LLDRIRQKGRCGFTENEASRIMRQLVAAVHFMHSRGVVHRDLKPENLLFSDPAGDNIKVVDFGFACLKRES--LHTPCFT 535 (966)
Q Consensus 458 L~~~l~~~~~~~l~e~~~~~i~~Qil~aL~yLHs~~IiHRDLKP~NILl~~~~~~~iKL~DFGla~~~~~~--~~~~~gT 535 (966)
|.+++.......+++..+..++.||+.||+|||+.||+||||||+|||+++ .+.++|+|||++...... .....+|
T Consensus 80 L~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dikp~Nili~~--~~~~~l~Dfg~~~~~~~~~~~~~~~~~ 157 (277)
T cd05607 80 LKYHIYNVGERGLEMERVIHYSAQITCGILHLHSMDIVYRDMKPENVLLDD--QGNCRLSDLGLAVELKDGKTITQRAGT 157 (277)
T ss_pred HHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHHCCEEEccCChHhEEEcC--CCCEEEeeceeeeecCCCceeeccCCC
Confidence 999887666556899999999999999999999999999999999999985 568999999998654432 2235689
Q ss_pred ccccCchhhccCCCCCCCcccchhhhhhhhhhhhcCCCCCCCcCcchhHHHHHHHHhcCCCCCCCCCCchhHHHHHHHHH
Q psy11767 536 LQYAAPEVLRQDKSGYDENCDLWSLGVILVNVLRQDKSGYDENCDLWSLGVILYTMLCGRVPFHARSRDDSALSIMARIK 615 (966)
Q Consensus 536 ~~Y~APEvl~~~~~~~~~~~Di~SlGvil~el~~~~~~~y~~~~DIWSlGvilyemltG~~Pf~~~~~~~~~~~~~~~i~ 615 (966)
+.|+|||++.. ..|+.++||||+||++|+|++|+.||...........+...+.
T Consensus 158 ~~y~aPE~~~~--------------------------~~~~~~~DvwslGv~l~el~~g~~p~~~~~~~~~~~~~~~~~~ 211 (277)
T cd05607 158 NGYMAPEILKE--------------------------EPYSYPVDWFAMGCSIYEMVAGRTPFKDHKEKVAKEELKRRTL 211 (277)
T ss_pred CCccCHHHHcc--------------------------CCCCCchhHHHHHHHHHHHHhCCCCCCCCcchhhHHHHHHHhh
Confidence 99999998852 2378899999999999999999999976543222233334444
Q ss_pred cCCCCCCchhhccCCHHHHHHHHHhcccCccccCChHHH--HHHhhhhHH
Q psy11767 616 EGQFNFDAEAWSTVSSEAKELTKSLLTVNPAQRIRMMRV--KLTFHAFHQ 663 (966)
Q Consensus 616 ~~~~~~~~~~~~~is~e~~~Li~~~L~~dP~~R~t~~~v--~~~~~~~~~ 663 (966)
.+...+. ...+++++++||.+||+.||++||++.++ ....|+|++
T Consensus 212 ~~~~~~~---~~~~~~~~~~li~~~L~~~P~~R~~~~~~~~~~~~h~~f~ 258 (277)
T cd05607 212 EDEVKFE---HQNFTEESKDICRLFLAKKPEDRLGSREKNDDPRKHEFFK 258 (277)
T ss_pred ccccccc---cccCCHHHHHHHHHHhccCHhhCCCCccchhhhhcChhhc
Confidence 4333222 23579999999999999999999999653 345566653
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr |
| >cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-39 Score=359.78 Aligned_cols=231 Identities=34% Similarity=0.629 Sum_probs=193.4
Q ss_pred cccccccccEEEEEEE---cCCCcEEEEEEecccc-------ChHHHHHHHHHhcCCCCceEEEEEEEeCCeEEEEEEcc
Q psy11767 384 GILGDGSYSVCRRCVE---KSTGQEYAVKIISRKI-------DCSEEINLLRACQGHPNIVNLHCVFQDEVHTYLVLELL 453 (966)
Q Consensus 384 ~~LG~G~fG~Vy~a~~---~~tg~~vAvK~i~~~~-------~~~~Ei~iL~~l~~HpnIV~l~~~~~~~~~~~lVmEy~ 453 (966)
+.||+|+||.||++++ ..+|+.||+|++.+.. ....|+++|+.+ +||||++++++|.++...|+||||+
T Consensus 2 ~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~lv~e~~ 80 (318)
T cd05582 2 KVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKMERDILAEV-NHPFIVKLHYAFQTEGKLYLILDFL 80 (318)
T ss_pred ceeeeCCCEEEEEEEEeccCCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhC-CCCCcccEEEEEEcCCEEEEEEcCC
Confidence 5799999999999986 4679999999997532 134588999888 5999999999999999999999999
Q ss_pred CCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCcEEEecCCCCCEEEEeecccccccCC---Cc
Q psy11767 454 KGGELLDRIRQKGRCGFTENEASRIMRQLVAAVHFMHSRGVVHRDLKPENLLFSDPAGDNIKVVDFGFACLKRES---LH 530 (966)
Q Consensus 454 ~gg~L~~~l~~~~~~~l~e~~~~~i~~Qil~aL~yLHs~~IiHRDLKP~NILl~~~~~~~iKL~DFGla~~~~~~---~~ 530 (966)
++|+|.+++.+.. .+++.+++.++.||+.||+|||++||+||||||+|||+++ ++.+||+|||++...... ..
T Consensus 81 ~~~~L~~~l~~~~--~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~--~~~~kL~Dfg~~~~~~~~~~~~~ 156 (318)
T cd05582 81 RGGDLFTRLSKEV--MFTEEDVKFYLAELALALDHLHSLGIIYRDLKPENILLDE--EGHIKLTDFGLSKESIDHEKKAY 156 (318)
T ss_pred CCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHeEECC--CCcEEEeeccCCcccCCCCCcee
Confidence 9999999997654 5899999999999999999999999999999999999975 568999999998754322 23
Q ss_pred cccccccccCchhhccCCCCCCCcccchhhhhhhhhhhhcCCCCCCCcCcchhHHHHHHHHhcCCCCCCCCCCchhHHHH
Q psy11767 531 TPCFTLQYAAPEVLRQDKSGYDENCDLWSLGVILVNVLRQDKSGYDENCDLWSLGVILYTMLCGRVPFHARSRDDSALSI 610 (966)
Q Consensus 531 ~~~gT~~Y~APEvl~~~~~~~~~~~Di~SlGvil~el~~~~~~~y~~~~DIWSlGvilyemltG~~Pf~~~~~~~~~~~~ 610 (966)
..+||+.|+|||++.. ..++.++|||||||++|+|++|+.||...+.. ..
T Consensus 157 ~~~g~~~y~aPE~~~~--------------------------~~~~~~~DiwslG~il~el~tg~~p~~~~~~~----~~ 206 (318)
T cd05582 157 SFCGTVEYMAPEVVNR--------------------------RGHTQSADWWSFGVLMFEMLTGSLPFQGKDRK----ET 206 (318)
T ss_pred cccCChhhcCHHHHcC--------------------------CCCCCccceeccceEeeeeccCCCCCCCCCHH----HH
Confidence 4578999999998852 23678899999999999999999999865432 33
Q ss_pred HHHHHcCCCCCCchhhccCCHHHHHHHHHhcccCccccCChHH
Q psy11767 611 MARIKEGQFNFDAEAWSTVSSEAKELTKSLLTVNPAQRIRMMR 653 (966)
Q Consensus 611 ~~~i~~~~~~~~~~~~~~is~e~~~Li~~~L~~dP~~R~t~~~ 653 (966)
+..+..+...++ ..+++++.+||.+||+.||++||++.+
T Consensus 207 ~~~i~~~~~~~p----~~~~~~~~~li~~~l~~~P~~R~~a~~ 245 (318)
T cd05582 207 MTMILKAKLGMP----QFLSPEAQSLLRALFKRNPANRLGAGP 245 (318)
T ss_pred HHHHHcCCCCCC----CCCCHHHHHHHHHHhhcCHhHcCCCCC
Confidence 445555554433 357899999999999999999999654
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate |
| >KOG0614|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-40 Score=367.60 Aligned_cols=232 Identities=25% Similarity=0.427 Sum_probs=211.7
Q ss_pred cchhccC-CcceeeeecccccceEEEEEEcCCCCEEEEEeccccc--------hhhHHHHHHHHhhCCCcccc-------
Q psy11767 110 FFEQYDM-DLDKAGILGDGSYSVCRRCVEKSTGQEYAVKIISRKI--------DCSEEINLLRACQGHPNICR------- 173 (966)
Q Consensus 110 ~~~~~~~-df~~~~~LG~GsFGkV~La~~k~tg~~yAiKvl~K~~--------~~~~E~~il~~~~~~pfi~~------- 173 (966)
|+...++ |++.+.+||.|+||+|-||+.+.....||||+|+|.. |+-.|++||+++. .||||+
T Consensus 413 e~a~v~l~dl~~iaTLGvGgFGRVELV~~~~~~~~fAlKilkK~hIVdtkQqeHv~sEr~Im~~~~-s~fIvrLYrTfrd 491 (732)
T KOG0614|consen 413 EFAQVKLSDLKRIATLGVGGFGRVELVKVNSQKATFALKILKKKHIVDTKQQEHVFSERNIMMECR-SDFIVRLYRTFRD 491 (732)
T ss_pred hhcccchhhhhhhhhcccCccceEEEEEecccchHHHHHHHhHhhccchhHHHHHHhHHHHHHhcC-chHHHHHHHHhcc
Confidence 4455555 9999999999999999999998877789999999862 6789999999985 999986
Q ss_pred -----------------------cccccccchhHHHHHHHh----------hcccchhhhHhhhccCCceEEecCccc--
Q psy11767 174 -----------------------RCVEKSTGQEYAVKIISR----------KIDCSEEINLLRACQGHPNIVNLHCVF-- 218 (966)
Q Consensus 174 -----------------------~~~~~~~~~~~~~~~v~~----------~~~~~~e~nil~~~~gh~~iv~l~~~~-- 218 (966)
++|.+.+++||.++++.+ +.|+++| |+|+|..|+++||||+++.
T Consensus 492 ~kyvYmLmEaClGGElWTiLrdRg~Fdd~tarF~~acv~EAfeYLH~k~iIYRDLKPE-NllLd~~Gy~KLVDFGFAKki 570 (732)
T KOG0614|consen 492 SKYVYMLMEACLGGELWTILRDRGSFDDYTARFYVACVLEAFEYLHRKGIIYRDLKPE-NLLLDNRGYLKLVDFGFAKKI 570 (732)
T ss_pred chhhhhhHHhhcCchhhhhhhhcCCcccchhhhhHHHHHHHHHHHHhcCceeccCChh-heeeccCCceEEeehhhHHHh
Confidence 778888999998876644 3478888 9999999999999999764
Q ss_pred ----------------cccccccccCCCcceeeechhhHHHHHHHhhCCCCCCCCcHHHHHHHHHhC--CCCCCCCCCHH
Q psy11767 219 ----------------QDEVIDWDDFSRGIECVFFSSSLIIFFIILSFTLSFIHDYYHIQYRRILKT--EPPIPEDLSPD 280 (966)
Q Consensus 219 ----------------~~e~i~~~~y~~~~d~~~~~~~~il~~~m~~g~~pf~~~~~~~~~~~I~~~--~~~~P~~~s~~ 280 (966)
.+|+|...+++.++| ||++||++|||++|.|||...|++.+|+.|++| .+.||..++..
T Consensus 571 ~~g~KTwTFcGTpEYVAPEIILnKGHD~avD---yWaLGIli~ELL~G~pPFs~~dpmktYn~ILkGid~i~~Pr~I~k~ 647 (732)
T KOG0614|consen 571 GSGRKTWTFCGTPEYVAPEIILNKGHDRAVD---YWALGILIYELLTGSPPFSGVDPMKTYNLILKGIDKIEFPRRITKT 647 (732)
T ss_pred ccCCceeeecCCcccccchhhhccCcchhhH---HHHHHHHHHHHHcCCCCCCCCchHHHHHHHHhhhhhhhcccccchh
Confidence 368999999999998 779999999999999999999999999999985 78999999999
Q ss_pred HHHHHHhhcccCCCcccCCCCCCHHHHhcCCceeeeCccccccCCCCCCCCccccccccccccccc
Q psy11767 281 VADFISRLLVKDPRRRLGGGELDAEELKRHPFFNVIDWDDLATKRIPAPFVPKISNELDVSNFSDE 346 (966)
Q Consensus 281 a~dli~~LL~kdp~~RLG~~~~g~~~Ik~HpfF~~idW~~l~~k~~~pP~~P~i~~~~D~snFd~e 346 (966)
|.|||++|+.-+|+.|||+..+|..|||+|.||.++||+.|..+.++||++|.+.+.+|++|||..
T Consensus 648 a~~Lik~LCr~~P~ERLG~~~~gI~DIkkH~Wf~gfdweglr~~~L~pPi~~~va~ptD~s~Fd~~ 713 (732)
T KOG0614|consen 648 ATDLIKKLCRDNPTERLGYQKGGINDIKKHRWFEGFDWEGLRSRTLPPPIIPSVANPTDVSNFDNF 713 (732)
T ss_pred HHHHHHHHHhcCcHhhhccccCChHHHHhhhhhhcCChhhhhhccCCCCccccCCCcccchhccCC
Confidence 999999999999999999999999999999999999999999999999999999999999999974
|
|
| >cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-39 Score=351.94 Aligned_cols=247 Identities=30% Similarity=0.466 Sum_probs=193.1
Q ss_pred ccccccccccccEEEEEEEcCCCcEEEEEEecccc-------ChHHHHHHHHHhcCCCCceEEEEEEEeCCeEEEEEEcc
Q psy11767 381 DKAGILGDGSYSVCRRCVEKSTGQEYAVKIISRKI-------DCSEEINLLRACQGHPNIVNLHCVFQDEVHTYLVLELL 453 (966)
Q Consensus 381 ~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~-------~~~~Ei~iL~~l~~HpnIV~l~~~~~~~~~~~lVmEy~ 453 (966)
+..+.||+|+||.||+|++..+++.||||++.... ...+|+.+++.+ +||||++++++|.++...|+||||+
T Consensus 4 ~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~e~~ 82 (287)
T cd07848 4 EVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTL-KQENIVELKEAFRRRGKLYLVFEYV 82 (287)
T ss_pred eEEEEecccCCEEEEEEEECCCCcEEEEEEEecccccccchhhHHHHHHHHHhC-CCccccchhhhEecCCEEEEEEecC
Confidence 34688999999999999999999999999986432 235699999988 5999999999999999999999999
Q ss_pred CCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCcEEEecCCCCCEEEEeecccccccCC----C
Q psy11767 454 KGGELLDRIRQKGRCGFTENEASRIMRQLVAAVHFMHSRGVVHRDLKPENLLFSDPAGDNIKVVDFGFACLKRES----L 529 (966)
Q Consensus 454 ~gg~L~~~l~~~~~~~l~e~~~~~i~~Qil~aL~yLHs~~IiHRDLKP~NILl~~~~~~~iKL~DFGla~~~~~~----~ 529 (966)
+++.+..+. ... ..+++..++.++.||+.||+|||+.||+||||||+|||++. ++.+||+|||++...... .
T Consensus 83 ~~~~l~~~~-~~~-~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dlkp~Nill~~--~~~~kl~Dfg~~~~~~~~~~~~~ 158 (287)
T cd07848 83 EKNMLELLE-EMP-NGVPPEKVRSYIYQLIKAIHWCHKNDIVHRDIKPENLLISH--NDVLKLCDFGFARNLSEGSNANY 158 (287)
T ss_pred CCCHHHHHH-hcC-CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcC--CCcEEEeeccCcccccccccccc
Confidence 887665443 322 36899999999999999999999999999999999999974 568999999999764321 2
Q ss_pred ccccccccccCchhhccCCCCCCCcccchhhhhhhhhhhhcCCCCCCCcCcchhHHHHHHHHhcCCCCCCCCCCchhHHH
Q psy11767 530 HTPCFTLQYAAPEVLRQDKSGYDENCDLWSLGVILVNVLRQDKSGYDENCDLWSLGVILYTMLCGRVPFHARSRDDSALS 609 (966)
Q Consensus 530 ~~~~gT~~Y~APEvl~~~~~~~~~~~Di~SlGvil~el~~~~~~~y~~~~DIWSlGvilyemltG~~Pf~~~~~~~~~~~ 609 (966)
....+|+.|+|||++.. ..|+.++||||+||++|+|++|++||.+.+..+....
T Consensus 159 ~~~~~~~~y~aPE~~~~--------------------------~~~~~~~DiwslGvil~el~~g~~pf~~~~~~~~~~~ 212 (287)
T cd07848 159 TEYVATRWYRSPELLLG--------------------------APYGKAVDMWSVGCILGELSDGQPLFPGESEIDQLFT 212 (287)
T ss_pred cccccccccCCcHHHcC--------------------------CCCCCchhHHhHHHHHHHHHhCCCCCCCCCHHHHHHH
Confidence 23468999999998852 2367889999999999999999999987654332221
Q ss_pred HHHHHHcC-----------C-----CCCC---------chhhccCCHHHHHHHHHhcccCccccCChHHHHHHhhhh
Q psy11767 610 IMARIKEG-----------Q-----FNFD---------AEAWSTVSSEAKELTKSLLTVNPAQRIRMMRVKLTFHAF 661 (966)
Q Consensus 610 ~~~~i~~~-----------~-----~~~~---------~~~~~~is~e~~~Li~~~L~~dP~~R~t~~~v~~~~~~~ 661 (966)
+. .+... . ..++ ...+..+|.++++||++||+.||++|||+.++ ..|+|
T Consensus 213 ~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~~P~~R~s~~~~--l~hp~ 286 (287)
T cd07848 213 IQ-KVLGPLPAEQMKLFYSNPRFHGLRFPAVNHPQSLERRYLGILSGVLLDLMKNLLKLNPTDRYLTEQC--LNHPA 286 (287)
T ss_pred HH-HhhCCCCHHHHHhhhccchhcccccCcccCcccHHHhhhcccCHHHHHHHHHHccCCcccCCCHHHH--hcCCC
Confidence 11 11000 0 0000 01123478899999999999999999999876 33554
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes |
| >cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-39 Score=358.11 Aligned_cols=239 Identities=31% Similarity=0.553 Sum_probs=196.5
Q ss_pred cccccccccEEEEEEEcCCCcEEEEEEecccc--------ChHHHHHHHHHhcCCCCceEEEEEEEeCCeEEEEEEccCC
Q psy11767 384 GILGDGSYSVCRRCVEKSTGQEYAVKIISRKI--------DCSEEINLLRACQGHPNIVNLHCVFQDEVHTYLVLELLKG 455 (966)
Q Consensus 384 ~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~--------~~~~Ei~iL~~l~~HpnIV~l~~~~~~~~~~~lVmEy~~g 455 (966)
+.||+|+||+||+|.+..+++.||||++.... ....|..++..+.+||||+++++++.++...|+||||++|
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~ey~~~ 80 (316)
T cd05619 1 KMLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHLYCTFQTKENLFFVMEYLNG 80 (316)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCcCcceEEEEEeCCEEEEEEeCCCC
Confidence 36999999999999999999999999987542 1234777777666899999999999999999999999999
Q ss_pred CCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCcEEEecCCCCCEEEEeeccccccc---CCCccc
Q psy11767 456 GELLDRIRQKGRCGFTENEASRIMRQLVAAVHFMHSRGVVHRDLKPENLLFSDPAGDNIKVVDFGFACLKR---ESLHTP 532 (966)
Q Consensus 456 g~L~~~l~~~~~~~l~e~~~~~i~~Qil~aL~yLHs~~IiHRDLKP~NILl~~~~~~~iKL~DFGla~~~~---~~~~~~ 532 (966)
|+|.+++.... .+++.++..++.||+.||+|||++||+||||||+|||++. ++.+||+|||++.... ......
T Consensus 81 g~L~~~l~~~~--~~~~~~~~~~~~qi~~al~~LH~~~ivHrdikp~Nil~~~--~~~~kl~Dfg~~~~~~~~~~~~~~~ 156 (316)
T cd05619 81 GDLMFHIQSCH--KFDLPRATFYAAEIICGLQFLHSKGIVYRDLKLDNILLDT--DGHIKIADFGMCKENMLGDAKTCTF 156 (316)
T ss_pred CcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHhCCeEeCCCCHHHEEECC--CCCEEEccCCcceECCCCCCceeee
Confidence 99999997654 5899999999999999999999999999999999999975 5689999999986432 223345
Q ss_pred cccccccCchhhccCCCCCCCcccchhhhhhhhhhhhcCCCCCCCcCcchhHHHHHHHHhcCCCCCCCCCCchhHHHHHH
Q psy11767 533 CFTLQYAAPEVLRQDKSGYDENCDLWSLGVILVNVLRQDKSGYDENCDLWSLGVILYTMLCGRVPFHARSRDDSALSIMA 612 (966)
Q Consensus 533 ~gT~~Y~APEvl~~~~~~~~~~~Di~SlGvil~el~~~~~~~y~~~~DIWSlGvilyemltG~~Pf~~~~~~~~~~~~~~ 612 (966)
+||+.|+|||++.. ..|+.++||||+||++|+|++|+.||.+.+.. .++.
T Consensus 157 ~gt~~y~aPE~~~~--------------------------~~~~~~~DvwslG~il~el~~G~~pf~~~~~~----~~~~ 206 (316)
T cd05619 157 CGTPDYIAPEILLG--------------------------QKYNTSVDWWSFGVLLYEMLIGQSPFHGHDEE----ELFQ 206 (316)
T ss_pred cCCccccCHHHHcC--------------------------CCCCchhhhhhHHHHHHHHHhCCCCCCCCCHH----HHHH
Confidence 78999999999852 23788999999999999999999999875432 3344
Q ss_pred HHHcCCCCCCchhhccCCHHHHHHHHHhcccCccccCChH-HHHHHhhhhH
Q psy11767 613 RIKEGQFNFDAEAWSTVSSEAKELTKSLLTVNPAQRIRMM-RVKLTFHAFH 662 (966)
Q Consensus 613 ~i~~~~~~~~~~~~~~is~e~~~Li~~~L~~dP~~R~t~~-~v~~~~~~~~ 662 (966)
.+..+...++ ..++.+++++|.+||+.||++|+++. ++ ..|+|+
T Consensus 207 ~i~~~~~~~~----~~~~~~~~~li~~~l~~~P~~R~~~~~~l--~~h~~~ 251 (316)
T cd05619 207 SIRMDNPCYP----RWLTREAKDILVKLFVREPERRLGVKGDI--RQHPFF 251 (316)
T ss_pred HHHhCCCCCC----ccCCHHHHHHHHHHhccCHhhcCCChHHH--HcCccc
Confidence 4444433322 24789999999999999999999996 33 345554
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in |
| >cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-39 Score=358.83 Aligned_cols=238 Identities=36% Similarity=0.646 Sum_probs=196.4
Q ss_pred cccccccccEEEEEEEc---CCCcEEEEEEecccc---------ChHHHHHHHHHhcCCCCceEEEEEEEeCCeEEEEEE
Q psy11767 384 GILGDGSYSVCRRCVEK---STGQEYAVKIISRKI---------DCSEEINLLRACQGHPNIVNLHCVFQDEVHTYLVLE 451 (966)
Q Consensus 384 ~~LG~G~fG~Vy~a~~~---~tg~~vAvK~i~~~~---------~~~~Ei~iL~~l~~HpnIV~l~~~~~~~~~~~lVmE 451 (966)
+.||+|+||.||+|++. .+++.||||++.+.. ....|+.+|+.+ +||||++++++|.+++..|+|||
T Consensus 2 ~~lg~G~~g~V~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~il~~l-~hp~iv~~~~~~~~~~~~~lv~e 80 (323)
T cd05584 2 KVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAV-KHPFIVDLIYAFQTGGKLYLILE 80 (323)
T ss_pred ceeeecCCeEEEEEEEcccCCCCCEEEEEEEEHHHHHhhhhhHHHHHHHHHHHHhC-CCCchhceeeEEecCCeEEEEEe
Confidence 57999999999999874 578999999986421 134688999988 59999999999999999999999
Q ss_pred ccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCcEEEecCCCCCEEEEeecccccccC---C
Q psy11767 452 LLKGGELLDRIRQKGRCGFTENEASRIMRQLVAAVHFMHSRGVVHRDLKPENLLFSDPAGDNIKVVDFGFACLKRE---S 528 (966)
Q Consensus 452 y~~gg~L~~~l~~~~~~~l~e~~~~~i~~Qil~aL~yLHs~~IiHRDLKP~NILl~~~~~~~iKL~DFGla~~~~~---~ 528 (966)
|++||+|.+++...+ .+++..+..++.||+.||+|||++||+||||||+|||++. ++.+||+|||+++.... .
T Consensus 81 ~~~~~~L~~~~~~~~--~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~--~~~~kl~Dfg~~~~~~~~~~~ 156 (323)
T cd05584 81 YLSGGELFMHLEREG--IFMEDTACFYLSEISLALEHLHQQGIIYRDLKPENILLDA--QGHVKLTDFGLCKESIHEGTV 156 (323)
T ss_pred CCCCchHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECC--CCCEEEeeCcCCeecccCCCc
Confidence 999999999997755 5899999999999999999999999999999999999975 56899999999864321 2
Q ss_pred CccccccccccCchhhccCCCCCCCcccchhhhhhhhhhhhcCCCCCCCcCcchhHHHHHHHHhcCCCCCCCCCCchhHH
Q psy11767 529 LHTPCFTLQYAAPEVLRQDKSGYDENCDLWSLGVILVNVLRQDKSGYDENCDLWSLGVILYTMLCGRVPFHARSRDDSAL 608 (966)
Q Consensus 529 ~~~~~gT~~Y~APEvl~~~~~~~~~~~Di~SlGvil~el~~~~~~~y~~~~DIWSlGvilyemltG~~Pf~~~~~~~~~~ 608 (966)
....+||+.|+|||++.. ..++.++|||||||++|+|++|+.||...+..
T Consensus 157 ~~~~~gt~~y~aPE~~~~--------------------------~~~~~~~DiwslG~il~ell~G~~pf~~~~~~---- 206 (323)
T cd05584 157 THTFCGTIEYMAPEILMR--------------------------SGHGKAVDWWSLGALMYDMLTGAPPFTAENRK---- 206 (323)
T ss_pred ccccCCCccccChhhccC--------------------------CCCCCcceecccHHHHHHHhcCCCCCCCCCHH----
Confidence 234578999999998852 23678899999999999999999999875432
Q ss_pred HHHHHHHcCCCCCCchhhccCCHHHHHHHHHhcccCccccC-----ChHHHHHHhhhhH
Q psy11767 609 SIMARIKEGQFNFDAEAWSTVSSEAKELTKSLLTVNPAQRI-----RMMRVKLTFHAFH 662 (966)
Q Consensus 609 ~~~~~i~~~~~~~~~~~~~~is~e~~~Li~~~L~~dP~~R~-----t~~~v~~~~~~~~ 662 (966)
..+..+..+...++ ..+++++.+||.+||+.||++|+ ++.++ ..|+|+
T Consensus 207 ~~~~~~~~~~~~~~----~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~l--~~h~~~ 259 (323)
T cd05584 207 KTIDKILKGKLNLP----PYLTPEARDLLKKLLKRNPSSRLGAGPGDAAEV--QSHPFF 259 (323)
T ss_pred HHHHHHHcCCCCCC----CCCCHHHHHHHHHHcccCHhHcCCCCCCCHHHH--hcCCCc
Confidence 34455666655433 35789999999999999999999 56544 345554
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in |
| >cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-39 Score=361.09 Aligned_cols=238 Identities=34% Similarity=0.608 Sum_probs=195.7
Q ss_pred cccccccccEEEEEEEcCCCcEEEEEEecccc--------ChHHHHHHHHHhcCCCCceEEEEEEEeCCeEEEEEEccCC
Q psy11767 384 GILGDGSYSVCRRCVEKSTGQEYAVKIISRKI--------DCSEEINLLRACQGHPNIVNLHCVFQDEVHTYLVLELLKG 455 (966)
Q Consensus 384 ~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~--------~~~~Ei~iL~~l~~HpnIV~l~~~~~~~~~~~lVmEy~~g 455 (966)
+.||+|+||+||+|.+..+|+.||+|++.+.. ...+|+++|+.+ +||||++++++|.++...||||||++|
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~~-~hp~i~~~~~~~~~~~~~~lv~E~~~~ 79 (325)
T cd05594 1 KLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNS-RHPFLTALKYSFQTHDRLCFVMEYANG 79 (325)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhC-CCCCCCceEEEEEcCCEEEEEEeCCCC
Confidence 36999999999999999999999999997532 123577888777 599999999999999999999999999
Q ss_pred CCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHh-cCceeccCCCCcEEEecCCCCCEEEEeeccccccc---CCCcc
Q psy11767 456 GELLDRIRQKGRCGFTENEASRIMRQLVAAVHFMHS-RGVVHRDLKPENLLFSDPAGDNIKVVDFGFACLKR---ESLHT 531 (966)
Q Consensus 456 g~L~~~l~~~~~~~l~e~~~~~i~~Qil~aL~yLHs-~~IiHRDLKP~NILl~~~~~~~iKL~DFGla~~~~---~~~~~ 531 (966)
|+|.+++.... .+++..++.++.||+.||+|||+ +||+||||||+|||++. ++.+||+|||++.... .....
T Consensus 80 ~~L~~~l~~~~--~l~~~~~~~~~~qi~~aL~~lH~~~~ivHrDikp~NIll~~--~~~~kL~Dfg~~~~~~~~~~~~~~ 155 (325)
T cd05594 80 GELFFHLSRER--VFSEDRARFYGAEIVSALDYLHSEKNVVYRDLKLENLMLDK--DGHIKITDFGLCKEGIKDGATMKT 155 (325)
T ss_pred CcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhcCCEEecCCCCCeEEECC--CCCEEEecCCCCeecCCCCccccc
Confidence 99999887654 58999999999999999999997 79999999999999975 5689999999986432 12234
Q ss_pred ccccccccCchhhccCCCCCCCcccchhhhhhhhhhhhcCCCCCCCcCcchhHHHHHHHHhcCCCCCCCCCCchhHHHHH
Q psy11767 532 PCFTLQYAAPEVLRQDKSGYDENCDLWSLGVILVNVLRQDKSGYDENCDLWSLGVILYTMLCGRVPFHARSRDDSALSIM 611 (966)
Q Consensus 532 ~~gT~~Y~APEvl~~~~~~~~~~~Di~SlGvil~el~~~~~~~y~~~~DIWSlGvilyemltG~~Pf~~~~~~~~~~~~~ 611 (966)
.+||+.|+|||++.. ..|+.++|||||||++|+|++|+.||.+.+.. ...
T Consensus 156 ~~gt~~y~aPE~~~~--------------------------~~~~~~~DiwslG~il~el~tG~~Pf~~~~~~----~~~ 205 (325)
T cd05594 156 FCGTPEYLAPEVLED--------------------------NDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHE----KLF 205 (325)
T ss_pred ccCCcccCCHHHHcc--------------------------CCCCCccccccccceeeeeccCCCCCCCCCHH----HHH
Confidence 578999999999852 23678999999999999999999999865432 334
Q ss_pred HHHHcCCCCCCchhhccCCHHHHHHHHHhcccCccccC-----ChHHHHHHhhhhH
Q psy11767 612 ARIKEGQFNFDAEAWSTVSSEAKELTKSLLTVNPAQRI-----RMMRVKLTFHAFH 662 (966)
Q Consensus 612 ~~i~~~~~~~~~~~~~~is~e~~~Li~~~L~~dP~~R~-----t~~~v~~~~~~~~ 662 (966)
..+..+...++ ..+++++.+||.+||+.||++|+ ++.++ ..|+|+
T Consensus 206 ~~i~~~~~~~p----~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~i--l~h~~~ 255 (325)
T cd05594 206 ELILMEEIRFP----RTLSPEAKSLLSGLLKKDPKQRLGGGPDDAKEI--MQHKFF 255 (325)
T ss_pred HHHhcCCCCCC----CCCCHHHHHHHHHHhhcCHHHhCCCCCCCHHHH--hcCCCc
Confidence 44544444433 35789999999999999999997 66654 345554
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien |
| >KOG0612|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-40 Score=391.07 Aligned_cols=250 Identities=34% Similarity=0.551 Sum_probs=209.0
Q ss_pred ccccccccccccccEEEEEEEcCCCcEEEEEEeccc-----c---ChHHHHHHHHHhcCCCCceEEEEEEEeCCeEEEEE
Q psy11767 379 DLDKAGILGDGSYSVCRRCVEKSTGQEYAVKIISRK-----I---DCSEEINLLRACQGHPNIVNLHCVFQDEVHTYLVL 450 (966)
Q Consensus 379 ~~~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~-----~---~~~~Ei~iL~~l~~HpnIV~l~~~~~~~~~~~lVm 450 (966)
||+.+++||+|+||.|.+++++.|++.||+|++++- . -+.+|..+|-.. +.+=||+|+.+|+|+.++|+||
T Consensus 76 DfeilKvIGrGaFGEV~lVr~k~t~~VYAMK~lnK~eMlKr~~tA~F~EERDimv~~-ns~Wiv~LhyAFQD~~~LYlVM 154 (1317)
T KOG0612|consen 76 DFEILKVIGRGAFGEVALVRHKSTEKVYAMKILNKWEMLKRAETACFREERDIMVFG-NSEWIVQLHYAFQDERYLYLVM 154 (1317)
T ss_pred hhHHHHHhcccccceeEEEEeeccccchhHHHhhHHHHhhchhHHHHHHHhHHHHcC-CcHHHHHHHHHhcCccceEEEE
Confidence 567789999999999999999999999999999751 1 145677888654 4778999999999999999999
Q ss_pred EccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCcEEEecCCCCCEEEEeecccccccC---
Q psy11767 451 ELLKGGELLDRIRQKGRCGFTENEASRIMRQLVAAVHFMHSRGVVHRDLKPENLLFSDPAGDNIKVVDFGFACLKRE--- 527 (966)
Q Consensus 451 Ey~~gg~L~~~l~~~~~~~l~e~~~~~i~~Qil~aL~yLHs~~IiHRDLKP~NILl~~~~~~~iKL~DFGla~~~~~--- 527 (966)
|||+||||...+.+.. .+|+..+++|+.+|+.||+-||+.|+|||||||+||||+- .|+|||+|||.+-....
T Consensus 155 dY~pGGDlltLlSk~~--~~pE~~ArFY~aEiVlAldslH~mgyVHRDiKPDNvLld~--~GHikLADFGsClkm~~dG~ 230 (1317)
T KOG0612|consen 155 DYMPGGDLLTLLSKFD--RLPEDWARFYTAEIVLALDSLHSMGYVHRDIKPDNVLLDK--SGHIKLADFGSCLKMDADGT 230 (1317)
T ss_pred ecccCchHHHHHhhcC--CChHHHHHHHHHHHHHHHHHHHhccceeccCCcceeEecc--cCcEeeccchhHHhcCCCCc
Confidence 9999999999998876 6999999999999999999999999999999999999984 77999999998754332
Q ss_pred -CCccccccccccCchhhccCCCCCCCcccchhhhhhhhhhhhcCCCCCCCcCcchhHHHHHHHHhcCCCCCCCCCCchh
Q psy11767 528 -SLHTPCFTLQYAAPEVLRQDKSGYDENCDLWSLGVILVNVLRQDKSGYDENCDLWSLGVILYTMLCGRVPFHARSRDDS 606 (966)
Q Consensus 528 -~~~~~~gT~~Y~APEvl~~~~~~~~~~~Di~SlGvil~el~~~~~~~y~~~~DIWSlGvilyemltG~~Pf~~~~~~~~ 606 (966)
.....+|||-|.+||+|.... .++..|+..||+||+||++|||+.|..||+..+-
T Consensus 231 V~s~~aVGTPDYISPEvLqs~~---------------------~~~g~yG~ecDwWSlGV~~YEMlyG~TPFYadsl--- 286 (1317)
T KOG0612|consen 231 VRSSVAVGTPDYISPEVLQSQG---------------------DGKGEYGRECDWWSLGVFMYEMLYGETPFYADSL--- 286 (1317)
T ss_pred EEeccccCCCCccCHHHHHhhc---------------------CCccccCCccchhhhHHHHHHHHcCCCcchHHHH---
Confidence 235678999999999997532 2346799999999999999999999999997544
Q ss_pred HHHHHHHHHcC--CCCCCchhhccCCHHHHHHHHHhcccCccccCC---hHHHHHHhhhhHH
Q psy11767 607 ALSIMARIKEG--QFNFDAEAWSTVSSEAKELTKSLLTVNPAQRIR---MMRVKLTFHAFHQ 663 (966)
Q Consensus 607 ~~~~~~~i~~~--~~~~~~~~~~~is~e~~~Li~~~L~~dP~~R~t---~~~v~~~~~~~~~ 663 (966)
.....+|... .+.|+.+ ..+|+++++||.++|. +|+.|+. +.++ ..|||+.
T Consensus 287 -veTY~KIm~hk~~l~FP~~--~~VSeeakdLI~~ll~-~~e~RLgrngiedi--k~HpFF~ 342 (1317)
T KOG0612|consen 287 -VETYGKIMNHKESLSFPDE--TDVSEEAKDLIEALLC-DREVRLGRNGIEDI--KNHPFFE 342 (1317)
T ss_pred -HHHHHHHhchhhhcCCCcc--cccCHHHHHHHHHHhc-ChhhhcccccHHHH--HhCcccc
Confidence 3445556544 5666643 3599999999999885 8899998 6654 4677763
|
|
| >PTZ00036 glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-38 Score=373.67 Aligned_cols=255 Identities=23% Similarity=0.369 Sum_probs=196.5
Q ss_pred cccccccccccccEEEEEEEcCCCcEEEEEEecccc-ChHHHHHHHHHhcCCCCceEEEEEEEeC--------CeEEEEE
Q psy11767 380 LDKAGILGDGSYSVCRRCVEKSTGQEYAVKIISRKI-DCSEEINLLRACQGHPNIVNLHCVFQDE--------VHTYLVL 450 (966)
Q Consensus 380 ~~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~-~~~~Ei~iL~~l~~HpnIV~l~~~~~~~--------~~~~lVm 450 (966)
|+..+.||+|+||+||+|.+..+++.||||++.... ...+|+.+|+.+ +|||||+++++|... ..+++||
T Consensus 68 y~~~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~Ei~il~~l-~h~niv~l~~~~~~~~~~~~~~~~~l~lvm 146 (440)
T PTZ00036 68 YKLGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQDPQYKNRELLIMKNL-NHINIIFLKDYYYTECFKKNEKNIFLNVVM 146 (440)
T ss_pred EEEeEEEEeCCCEEEEEEEECCCCCEEEEEEEecCcchHHHHHHHHHhc-CCCCCcceeeeEeecccccCCCceEEEEEE
Confidence 444789999999999999999999999999886543 345799999998 599999999887542 2578999
Q ss_pred EccCCCCHHHHHHh--cCCCCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCcEEEecCCCCCEEEEeecccccccC-
Q psy11767 451 ELLKGGELLDRIRQ--KGRCGFTENEASRIMRQLVAAVHFMHSRGVVHRDLKPENLLFSDPAGDNIKVVDFGFACLKRE- 527 (966)
Q Consensus 451 Ey~~gg~L~~~l~~--~~~~~l~e~~~~~i~~Qil~aL~yLHs~~IiHRDLKP~NILl~~~~~~~iKL~DFGla~~~~~- 527 (966)
||++ ++|.+++.. .....+++..++.++.||+.||+|||++||+||||||+|||++. .++.+||+|||+|+....
T Consensus 147 E~~~-~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~gL~yLH~~~IiHrDLKp~NILl~~-~~~~vkL~DFGla~~~~~~ 224 (440)
T PTZ00036 147 EFIP-QTVHKYMKHYARNNHALPLFLVKLYSYQLCRALAYIHSKFICHRDLKPQNLLIDP-NTHTLKLCDFGSAKNLLAG 224 (440)
T ss_pred ecCC-ccHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCcCHHHEEEcC-CCCceeeeccccchhccCC
Confidence 9996 477777653 22336999999999999999999999999999999999999974 344799999999975432
Q ss_pred -CCccccccccccCchhhccCCCCCCCcccchhhhhhhhhhhhcCCCCCCCcCcchhHHHHHHHHhcCCCCCCCCCCchh
Q psy11767 528 -SLHTPCFTLQYAAPEVLRQDKSGYDENCDLWSLGVILVNVLRQDKSGYDENCDLWSLGVILYTMLCGRVPFHARSRDDS 606 (966)
Q Consensus 528 -~~~~~~gT~~Y~APEvl~~~~~~~~~~~Di~SlGvil~el~~~~~~~y~~~~DIWSlGvilyemltG~~Pf~~~~~~~~ 606 (966)
.....++|+.|+|||++.. ...|+.++|||||||++|+|++|.+||.+.+..+.
T Consensus 225 ~~~~~~~~t~~y~aPE~~~~-------------------------~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~ 279 (440)
T PTZ00036 225 QRSVSYICSRFYRAPELMLG-------------------------ATNYTTHIDLWSLGCIIAEMILGYPIFSGQSSVDQ 279 (440)
T ss_pred CCcccCCCCcCccCHHHhcC-------------------------CCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHH
Confidence 2334578999999998752 23478899999999999999999999988765443
Q ss_pred HHHHHHHHHc----------C---CCCCCc---h-----hhccCCHHHHHHHHHhcccCccccCChHHHHHHhhhhHHh
Q psy11767 607 ALSIMARIKE----------G---QFNFDA---E-----AWSTVSSEAKELTKSLLTVNPAQRIRMMRVKLTFHAFHQA 664 (966)
Q Consensus 607 ~~~~~~~i~~----------~---~~~~~~---~-----~~~~is~e~~~Li~~~L~~dP~~R~t~~~v~~~~~~~~~~ 664 (966)
...++..+.. . .+.++. . .....++++++||.+||++||.+|||+.++ ..|+|+..
T Consensus 280 ~~~i~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~l~~~~p~~~~~~~~~li~~~L~~dP~~R~ta~e~--l~hp~f~~ 356 (440)
T PTZ00036 280 LVRIIQVLGTPTEDQLKEMNPNYADIKFPDVKPKDLKKVFPKGTPDDAINFISQFLKYEPLKRLNPIEA--LADPFFDD 356 (440)
T ss_pred HHHHHHHhCCCCHHHHHHhchhhhcccCCccCchhHHHHhccCCCHHHHHHHHHHCCCChhHCcCHHHH--hCChhHHh
Confidence 3333221110 0 001110 0 112367899999999999999999999876 56777643
|
|
| >KOG0695|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-40 Score=344.51 Aligned_cols=236 Identities=24% Similarity=0.427 Sum_probs=204.8
Q ss_pred CcceeeeecccccceEEEEEEcCCCCEEEEEeccccc--------hhhHHHHHHHHhhCCCcccc---------------
Q psy11767 117 DLDKAGILGDGSYSVCRRCVEKSTGQEYAVKIISRKI--------DCSEEINLLRACQGHPNICR--------------- 173 (966)
Q Consensus 117 df~~~~~LG~GsFGkV~La~~k~tg~~yAiKvl~K~~--------~~~~E~~il~~~~~~pfi~~--------------- 173 (966)
||++++|||+|||.||.||++++|.++|||||+||+. -+.+|+.+.+++.+|||+|.
T Consensus 251 df~ll~vigrgsyakvl~~~~~~t~qiyamkvvkkel~nddedidwvqtek~vfe~asn~pflvglhscfqtesrlffvi 330 (593)
T KOG0695|consen 251 DFDLLRVIGRGSYAKVLLVRLKKTDQIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNNPFLVGLHSCFQTESRLFFVI 330 (593)
T ss_pred cceeeeeecCcchhhhhheehcccceeeehhhHHHHhcCCcccchhHHhhHHHHHhccCCCeEEehhhhhcccceEEEEE
Confidence 9999999999999999999999999999999999973 25899999999999999985
Q ss_pred ---------------cccccccchhHHHHHHHhh----------cccchhhhHhhhccCCceEEecCcc-----------
Q psy11767 174 ---------------RCVEKSTGQEYAVKIISRK----------IDCSEEINLLRACQGHPNIVNLHCV----------- 217 (966)
Q Consensus 174 ---------------~~~~~~~~~~~~~~~v~~~----------~~~~~e~nil~~~~gh~~iv~l~~~----------- 217 (966)
+.+.+..++||.++|..+. .|++ ..|+|+|++||.+++|.+-.
T Consensus 331 eyv~ggdlmfhmqrqrklpeeharfys~ei~lal~flh~rgiiyrdlk-ldnvlldaeghikltdygmcke~l~~gd~ts 409 (593)
T KOG0695|consen 331 EYVNGGDLMFHMQRQRKLPEEHARFYSAEICLALNFLHERGIIYRDLK-LDNVLLDAEGHIKLTDYGMCKEGLGPGDTTS 409 (593)
T ss_pred EEecCcceeeehhhhhcCcHHHhhhhhHHHHHHHHHHhhcCeeeeecc-ccceEEccCCceeecccchhhcCCCCCcccc
Confidence 4455556688887776551 2333 33999999999999996532
Q ss_pred --------ccccccccccCCCcceeeechhhHHHHHHHhhCCCCCCC--------CcHHHHHHHHHhCCCCCCCCCCHHH
Q psy11767 218 --------FQDEVIDWDDFSRGIECVFFSSSLIIFFIILSFTLSFIH--------DYYHIQYRRILKTEPPIPEDLSPDV 281 (966)
Q Consensus 218 --------~~~e~i~~~~y~~~~d~~~~~~~~il~~~m~~g~~pf~~--------~~~~~~~~~I~~~~~~~P~~~s~~a 281 (966)
..+|++.-.+||.++| ||++||+++||+.|..||.- +...-+||-|++..+.+|..+|..|
T Consensus 410 tfcgtpnyiapeilrgeeygfsvd---wwalgvlmfemmagrspfdivgm~n~d~ntedylfqvilekqiriprslsvka 486 (593)
T KOG0695|consen 410 TFCGTPNYIAPEILRGEEYGFSVD---WWALGVLMFEMMAGRSPFDIVGMDNPDMNTEDYLFQVILEKQIRIPRSLSVKA 486 (593)
T ss_pred cccCCCcccchhhhcccccCceeh---HHHHHHHHHHHHcCCCCcceecCCCcccchhHHHHHHHhhhcccccceeehhh
Confidence 2468888999999998 77899999999999999961 2334589999999999999999999
Q ss_pred HHHHHhhcccCCCcccCCCC-CCHHHHhcCCceeeeCccccccCCCCCCCCccccccccccccccccccCcCCCCC
Q psy11767 282 ADFISRLLVKDPRRRLGGGE-LDAEELKRHPFFNVIDWDDLATKRIPAPFVPKISNELDVSNFSDEFTKMIPADSP 356 (966)
Q Consensus 282 ~dli~~LL~kdp~~RLG~~~-~g~~~Ik~HpfF~~idW~~l~~k~~~pP~~P~i~~~~D~snFd~ef~~~~p~dSp 356 (966)
..+++++|.|||+.|||+.. .|+.|||.|+||+.|||+.|++|++-|||.|.+++..+..|||..|+++.+.-+|
T Consensus 487 s~vlkgflnkdp~erlgc~~~~g~~dik~h~ffr~idwd~leqk~v~ppf~p~i~~d~~l~~fd~qft~e~~qltp 562 (593)
T KOG0695|consen 487 SHVLKGFLNKDPKERLGCRPQTGFSDIKSHAFFRSIDWDLLEQKQVLPPFQPQITDDYGLDNFDTQFTSEPVQLTP 562 (593)
T ss_pred HHHHHHhhcCCcHHhcCCCcccchhhhhcchhhhhCCHHHHhhcccCCCCCCccccccCccccccccccCCcccCC
Confidence 99999999999999999964 4999999999999999999999999999999999999999999999876654443
|
|
| >cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-38 Score=357.79 Aligned_cols=235 Identities=29% Similarity=0.540 Sum_probs=194.0
Q ss_pred cccccccccEEEEEEEcCCCcEEEEEEeccccC--------hHHHHHHHHHhcCCCCceEEEEEEEeCCeEEEEEEccCC
Q psy11767 384 GILGDGSYSVCRRCVEKSTGQEYAVKIISRKID--------CSEEINLLRACQGHPNIVNLHCVFQDEVHTYLVLELLKG 455 (966)
Q Consensus 384 ~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~~--------~~~Ei~iL~~l~~HpnIV~l~~~~~~~~~~~lVmEy~~g 455 (966)
+.||+|+||+||+|.+..+++.||||++.+... ..+|+.++..+.+||||+++++++.+....|+||||++|
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (327)
T cd05617 1 RVIGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGLHSCFQTTSRLFLVIEYVNG 80 (327)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhhcCCCCEeeEEEEEEeCCEEEEEEeCCCC
Confidence 369999999999999999999999999975421 346888888887899999999999999999999999999
Q ss_pred CCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCcEEEecCCCCCEEEEeeccccccc---CCCccc
Q psy11767 456 GELLDRIRQKGRCGFTENEASRIMRQLVAAVHFMHSRGVVHRDLKPENLLFSDPAGDNIKVVDFGFACLKR---ESLHTP 532 (966)
Q Consensus 456 g~L~~~l~~~~~~~l~e~~~~~i~~Qil~aL~yLHs~~IiHRDLKP~NILl~~~~~~~iKL~DFGla~~~~---~~~~~~ 532 (966)
|+|.+++.... .+++..++.++.||+.||+|||++||+||||||+|||++. ++.+||+|||++.... ......
T Consensus 81 ~~L~~~~~~~~--~l~~~~~~~~~~qi~~al~~lH~~~ivHrDlkp~Nili~~--~~~~kl~Dfg~~~~~~~~~~~~~~~ 156 (327)
T cd05617 81 GDLMFHMQRQR--KLPEEHARFYAAEICIALNFLHERGIIYRDLKLDNVLLDA--DGHIKLTDYGMCKEGLGPGDTTSTF 156 (327)
T ss_pred CcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEEeC--CCCEEEeccccceeccCCCCceecc
Confidence 99999887654 5999999999999999999999999999999999999985 5689999999986422 223456
Q ss_pred cccccccCchhhccCCCCCCCcccchhhhhhhhhhhhcCCCCCCCcCcchhHHHHHHHHhcCCCCCCCCCCc---hhHHH
Q psy11767 533 CFTLQYAAPEVLRQDKSGYDENCDLWSLGVILVNVLRQDKSGYDENCDLWSLGVILYTMLCGRVPFHARSRD---DSALS 609 (966)
Q Consensus 533 ~gT~~Y~APEvl~~~~~~~~~~~Di~SlGvil~el~~~~~~~y~~~~DIWSlGvilyemltG~~Pf~~~~~~---~~~~~ 609 (966)
+||+.|+|||++.. ..|+.++|||||||++|+|++|+.||...... .....
T Consensus 157 ~gt~~y~aPE~~~~--------------------------~~~~~~~DiwslGvil~ell~g~~pf~~~~~~~~~~~~~~ 210 (327)
T cd05617 157 CGTPNYIAPEILRG--------------------------EEYGFSVDWWALGVLMFEMMAGRSPFDIITDNPDMNTEDY 210 (327)
T ss_pred cCCcccCCHHHHCC--------------------------CCCCchheeehhHHHHHHHHhCCCCCCccCCCcccccHHH
Confidence 78999999999852 24678899999999999999999999653321 11122
Q ss_pred HHHHHHcCCCCCCchhhccCCHHHHHHHHHhcccCccccCChH
Q psy11767 610 IMARIKEGQFNFDAEAWSTVSSEAKELTKSLLTVNPAQRIRMM 652 (966)
Q Consensus 610 ~~~~i~~~~~~~~~~~~~~is~e~~~Li~~~L~~dP~~R~t~~ 652 (966)
+...+......++ ..++.++.++|.+||..||++|+++.
T Consensus 211 ~~~~~~~~~~~~p----~~~~~~~~~li~~~L~~dP~~R~~~~ 249 (327)
T cd05617 211 LFQVILEKPIRIP----RFLSVKASHVLKGFLNKDPKERLGCQ 249 (327)
T ss_pred HHHHHHhCCCCCC----CCCCHHHHHHHHHHhccCHHHcCCCC
Confidence 3344444443332 35789999999999999999999863
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways |
| >cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.7e-39 Score=358.56 Aligned_cols=231 Identities=31% Similarity=0.528 Sum_probs=190.1
Q ss_pred cccccccccccEEEEEEEcCCCcEEEEEEecccc--------ChHHHHHHHHHh--cCCCCceEEEEEEEeCCeEEEEEE
Q psy11767 382 KAGILGDGSYSVCRRCVEKSTGQEYAVKIISRKI--------DCSEEINLLRAC--QGHPNIVNLHCVFQDEVHTYLVLE 451 (966)
Q Consensus 382 ~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~--------~~~~Ei~iL~~l--~~HpnIV~l~~~~~~~~~~~lVmE 451 (966)
.++.||+|+||.||+|.+..+|+.||||++.+.. ...+|++++..+ .+||||+++++++.+..+.|+|||
T Consensus 3 i~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~l~~e~~~~~~~~~l~hp~i~~~~~~~~~~~~~~lv~E 82 (324)
T cd05589 3 CLAVLGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPFLVNLFACFQTEDHVCFVME 82 (324)
T ss_pred EEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccccCCCChhceeeEEEcCCEEEEEEc
Confidence 4678999999999999999999999999997432 123455555432 259999999999999999999999
Q ss_pred ccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCcEEEecCCCCCEEEEeeccccccc---CC
Q psy11767 452 LLKGGELLDRIRQKGRCGFTENEASRIMRQLVAAVHFMHSRGVVHRDLKPENLLFSDPAGDNIKVVDFGFACLKR---ES 528 (966)
Q Consensus 452 y~~gg~L~~~l~~~~~~~l~e~~~~~i~~Qil~aL~yLHs~~IiHRDLKP~NILl~~~~~~~iKL~DFGla~~~~---~~ 528 (966)
|++||+|..++... .+++..++.++.||+.||+|||++||+||||||+|||++. ++.+||+|||++.... ..
T Consensus 83 ~~~~~~L~~~~~~~---~l~~~~~~~~~~qi~~al~~lH~~~ivHrdlkp~Nill~~--~~~~kL~Dfg~~~~~~~~~~~ 157 (324)
T cd05589 83 YAAGGDLMMHIHTD---VFSEPRAVFYAACVVLGLQYLHENKIVYRDLKLDNLLLDT--EGFVKIADFGLCKEGMGFGDR 157 (324)
T ss_pred CCCCCcHHHHhhcC---CCCHHHHHHHHHHHHHHHHHHHhCCeEecCCCHHHeEECC--CCcEEeCcccCCccCCCCCCc
Confidence 99999999887543 5899999999999999999999999999999999999975 5699999999986432 22
Q ss_pred CccccccccccCchhhccCCCCCCCcccchhhhhhhhhhhhcCCCCCCCcCcchhHHHHHHHHhcCCCCCCCCCCchhHH
Q psy11767 529 LHTPCFTLQYAAPEVLRQDKSGYDENCDLWSLGVILVNVLRQDKSGYDENCDLWSLGVILYTMLCGRVPFHARSRDDSAL 608 (966)
Q Consensus 529 ~~~~~gT~~Y~APEvl~~~~~~~~~~~Di~SlGvil~el~~~~~~~y~~~~DIWSlGvilyemltG~~Pf~~~~~~~~~~ 608 (966)
....+||+.|+|||++.. ..|+.++|||||||++|+|++|+.||.+.+..
T Consensus 158 ~~~~~g~~~y~aPE~~~~--------------------------~~~~~~~DiwslG~il~el~~G~~pf~~~~~~---- 207 (324)
T cd05589 158 TSTFCGTPEFLAPEVLTE--------------------------TSYTRAVDWWGLGVLIYEMLVGESPFPGDDEE---- 207 (324)
T ss_pred ccccccCccccCHhHhcC--------------------------CCCCcccchhhHHHHHHHHHhCCCCCCCCCHH----
Confidence 335678999999998852 23678899999999999999999999875432
Q ss_pred HHHHHHHcCCCCCCchhhccCCHHHHHHHHHhcccCccccCCh
Q psy11767 609 SIMARIKEGQFNFDAEAWSTVSSEAKELTKSLLTVNPAQRIRM 651 (966)
Q Consensus 609 ~~~~~i~~~~~~~~~~~~~~is~e~~~Li~~~L~~dP~~R~t~ 651 (966)
.....+..+...++ ..++.++.++|.+||..||.+||++
T Consensus 208 ~~~~~i~~~~~~~p----~~~~~~~~~li~~~L~~dP~~R~~~ 246 (324)
T cd05589 208 EVFDSIVNDEVRYP----RFLSREAISIMRRLLRRNPERRLGS 246 (324)
T ss_pred HHHHHHHhCCCCCC----CCCCHHHHHHHHHHhhcCHhHcCCC
Confidence 33445555544332 3578999999999999999999954
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved |
| >cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-38 Score=348.45 Aligned_cols=243 Identities=31% Similarity=0.454 Sum_probs=190.6
Q ss_pred ccccccccccEEEEEEEcC-CCcEEEEEEecccc-------ChHHHHHHHHHhc--CCCCceEEEEEEE-----eCCeEE
Q psy11767 383 AGILGDGSYSVCRRCVEKS-TGQEYAVKIISRKI-------DCSEEINLLRACQ--GHPNIVNLHCVFQ-----DEVHTY 447 (966)
Q Consensus 383 ~~~LG~G~fG~Vy~a~~~~-tg~~vAvK~i~~~~-------~~~~Ei~iL~~l~--~HpnIV~l~~~~~-----~~~~~~ 447 (966)
.+.||+|+||+||+|++.. +|+.||||++.... ...+|+.+++.+. .||||+++++++. .....+
T Consensus 6 ~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~hpniv~~~~~~~~~~~~~~~~~~ 85 (290)
T cd07862 6 VAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDRETKLT 85 (290)
T ss_pred eeEeccCCCeEEEEEEEcCCCCeEEEEEEEecccCCCCchHHHHHHHHHHHhhcccCCCCcceEEEEEecccCCCCCcEE
Confidence 6789999999999999865 57889999986432 2346888877664 5999999999985 345689
Q ss_pred EEEEccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCcEEEecCCCCCEEEEeecccccccC
Q psy11767 448 LVLELLKGGELLDRIRQKGRCGFTENEASRIMRQLVAAVHFMHSRGVVHRDLKPENLLFSDPAGDNIKVVDFGFACLKRE 527 (966)
Q Consensus 448 lVmEy~~gg~L~~~l~~~~~~~l~e~~~~~i~~Qil~aL~yLHs~~IiHRDLKP~NILl~~~~~~~iKL~DFGla~~~~~ 527 (966)
+||||+. ++|.+++.......+++..++.++.||+.||+|||++||+||||||+|||++. ++.+||+|||++.....
T Consensus 86 lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~iiH~dlkp~Nil~~~--~~~~kl~Dfg~~~~~~~ 162 (290)
T cd07862 86 LVFEHVD-QDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTS--SGQIKLADFGLARIYSF 162 (290)
T ss_pred EEEccCC-CCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEEcC--CCCEEEccccceEeccC
Confidence 9999995 69999997765556999999999999999999999999999999999999975 56899999999975432
Q ss_pred C--CccccccccccCchhhccCCCCCCCcccchhhhhhhhhhhhcCCCCCCCcCcchhHHHHHHHHhcCCCCCCCCCCch
Q psy11767 528 S--LHTPCFTLQYAAPEVLRQDKSGYDENCDLWSLGVILVNVLRQDKSGYDENCDLWSLGVILYTMLCGRVPFHARSRDD 605 (966)
Q Consensus 528 ~--~~~~~gT~~Y~APEvl~~~~~~~~~~~Di~SlGvil~el~~~~~~~y~~~~DIWSlGvilyemltG~~Pf~~~~~~~ 605 (966)
. .....+|+.|+|||++.. ..|+.++|||||||++|+|++|++||.+....+
T Consensus 163 ~~~~~~~~~~~~y~aPE~~~~--------------------------~~~~~~~DiwslG~il~el~~g~~~f~~~~~~~ 216 (290)
T cd07862 163 QMALTSVVVTLWYRAPEVLLQ--------------------------SSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVD 216 (290)
T ss_pred CcccccccccccccChHHHhC--------------------------CCCCCccchHHHHHHHHHHHcCCCCcCCCCHHH
Confidence 2 234568999999998852 236788999999999999999999998766544
Q ss_pred hHHHHHHHHHcC---CC-----------C-----CCchhhccCCHHHHHHHHHhcccCccccCChHHH
Q psy11767 606 SALSIMARIKEG---QF-----------N-----FDAEAWSTVSSEAKELTKSLLTVNPAQRIRMMRV 654 (966)
Q Consensus 606 ~~~~~~~~i~~~---~~-----------~-----~~~~~~~~is~e~~~Li~~~L~~dP~~R~t~~~v 654 (966)
....+...+... .+ . ......+.+++.+++|+.+||+.||++|||+.++
T Consensus 217 ~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~ 284 (290)
T cd07862 217 QLGKILDVIGLPGEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSA 284 (290)
T ss_pred HHHHHHHHhCCCChhhchhhhcccchhccCCCCCCHHHHccCCCHHHHHHHHHHhccCchhcCCHHHH
Confidence 333332221100 00 0 0001224578899999999999999999999876
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla |
| >cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-38 Score=357.74 Aligned_cols=235 Identities=31% Similarity=0.558 Sum_probs=196.2
Q ss_pred cccccccccccccEEEEEEEcCCCcEEEEEEecccc--------ChHHHHHHHHHhcCCCCceEEEEEEEeCCeEEEEEE
Q psy11767 380 LDKAGILGDGSYSVCRRCVEKSTGQEYAVKIISRKI--------DCSEEINLLRACQGHPNIVNLHCVFQDEVHTYLVLE 451 (966)
Q Consensus 380 ~~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~--------~~~~Ei~iL~~l~~HpnIV~l~~~~~~~~~~~lVmE 451 (966)
|+..+.||+|+||+||+|.++.+|+.||||++.+.. ....|+.++..+.+|++|++++++|.++...|+|||
T Consensus 2 f~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E 81 (323)
T cd05615 2 FNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPPFLTQLHSCFQTVDRLYFVME 81 (323)
T ss_pred ceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCchhheeeEEecCCEEEEEEc
Confidence 445688999999999999999999999999987532 133577788777678899999999999999999999
Q ss_pred ccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCcEEEecCCCCCEEEEeecccccccC---C
Q psy11767 452 LLKGGELLDRIRQKGRCGFTENEASRIMRQLVAAVHFMHSRGVVHRDLKPENLLFSDPAGDNIKVVDFGFACLKRE---S 528 (966)
Q Consensus 452 y~~gg~L~~~l~~~~~~~l~e~~~~~i~~Qil~aL~yLHs~~IiHRDLKP~NILl~~~~~~~iKL~DFGla~~~~~---~ 528 (966)
|++||+|.+++...+ .+++.+++.++.||+.||+|||++||+||||||+|||++. ++.+||+|||++..... .
T Consensus 82 y~~~g~L~~~i~~~~--~l~~~~~~~i~~qi~~al~~lH~~~ivHrDikp~Nill~~--~~~ikL~Dfg~~~~~~~~~~~ 157 (323)
T cd05615 82 YVNGGDLMYHIQQVG--KFKEPQAVFYAAEISVGLFFLHRRGIIYRDLKLDNVMLDS--EGHIKIADFGMCKEHMVDGVT 157 (323)
T ss_pred CCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECC--CCCEEEeccccccccCCCCcc
Confidence 999999999997654 5999999999999999999999999999999999999985 56899999999865322 2
Q ss_pred CccccccccccCchhhccCCCCCCCcccchhhhhhhhhhhhcCCCCCCCcCcchhHHHHHHHHhcCCCCCCCCCCchhHH
Q psy11767 529 LHTPCFTLQYAAPEVLRQDKSGYDENCDLWSLGVILVNVLRQDKSGYDENCDLWSLGVILYTMLCGRVPFHARSRDDSAL 608 (966)
Q Consensus 529 ~~~~~gT~~Y~APEvl~~~~~~~~~~~Di~SlGvil~el~~~~~~~y~~~~DIWSlGvilyemltG~~Pf~~~~~~~~~~ 608 (966)
....+||+.|+|||++.. ..|+.++||||+||++|+|++|++||.+....
T Consensus 158 ~~~~~gt~~y~aPE~~~~--------------------------~~~~~~~DiwslGvil~elltG~~pf~~~~~~---- 207 (323)
T cd05615 158 TRTFCGTPDYIAPEIIAY--------------------------QPYGKSVDWWAYGVLLYEMLAGQPPFDGEDED---- 207 (323)
T ss_pred ccCccCCccccCHHHHcC--------------------------CCCCCccchhhhHHHHHHHHhCCCCCCCCCHH----
Confidence 234568999999998852 23678999999999999999999999875432
Q ss_pred HHHHHHHcCCCCCCchhhccCCHHHHHHHHHhcccCccccCChH
Q psy11767 609 SIMARIKEGQFNFDAEAWSTVSSEAKELTKSLLTVNPAQRIRMM 652 (966)
Q Consensus 609 ~~~~~i~~~~~~~~~~~~~~is~e~~~Li~~~L~~dP~~R~t~~ 652 (966)
.+...+..+...++ ..++.++.+++.+||..||.+|++..
T Consensus 208 ~~~~~i~~~~~~~p----~~~~~~~~~li~~~l~~~p~~R~~~~ 247 (323)
T cd05615 208 ELFQSIMEHNVSYP----KSLSKEAVSICKGLMTKHPSKRLGCG 247 (323)
T ss_pred HHHHHHHhCCCCCC----ccCCHHHHHHHHHHcccCHhhCCCCC
Confidence 34455555554433 35789999999999999999999853
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a |
| >cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-38 Score=356.90 Aligned_cols=230 Identities=34% Similarity=0.597 Sum_probs=193.7
Q ss_pred cccccccccEEEEEEEcCCCcEEEEEEecccc--------ChHHHHHHHHHhcCCCCceEEEEEEEeCCeEEEEEEccCC
Q psy11767 384 GILGDGSYSVCRRCVEKSTGQEYAVKIISRKI--------DCSEEINLLRACQGHPNIVNLHCVFQDEVHTYLVLELLKG 455 (966)
Q Consensus 384 ~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~--------~~~~Ei~iL~~l~~HpnIV~l~~~~~~~~~~~lVmEy~~g 455 (966)
+.||+|+||+||+|.+..+++.||||++.+.. ....|+.+++.+.+||||+++++++.+..+.|+||||++|
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (318)
T cd05570 1 KVLGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQLHSCFQTKDRLFFVMEYVNG 80 (318)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 36999999999999999999999999997532 1235778888776899999999999999999999999999
Q ss_pred CCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCcEEEecCCCCCEEEEeeccccccc---CCCccc
Q psy11767 456 GELLDRIRQKGRCGFTENEASRIMRQLVAAVHFMHSRGVVHRDLKPENLLFSDPAGDNIKVVDFGFACLKR---ESLHTP 532 (966)
Q Consensus 456 g~L~~~l~~~~~~~l~e~~~~~i~~Qil~aL~yLHs~~IiHRDLKP~NILl~~~~~~~iKL~DFGla~~~~---~~~~~~ 532 (966)
|+|.+++.+.. .+++.++..++.||+.||+|||++||+||||||+|||++. ++.+||+|||++.... ......
T Consensus 81 ~~L~~~~~~~~--~l~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~Nill~~--~~~~kl~Dfg~~~~~~~~~~~~~~~ 156 (318)
T cd05570 81 GDLMFHIQRSG--RFDEPRARFYAAEIVLGLQFLHERGIIYRDLKLDNVLLDS--EGHIKIADFGMCKEGILGGVTTSTF 156 (318)
T ss_pred CCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHhCCeEccCCCHHHeEECC--CCcEEecccCCCeecCcCCCcccce
Confidence 99999987664 5999999999999999999999999999999999999975 5689999999986432 123345
Q ss_pred cccccccCchhhccCCCCCCCcccchhhhhhhhhhhhcCCCCCCCcCcchhHHHHHHHHhcCCCCCCCCCCchhHHHHHH
Q psy11767 533 CFTLQYAAPEVLRQDKSGYDENCDLWSLGVILVNVLRQDKSGYDENCDLWSLGVILYTMLCGRVPFHARSRDDSALSIMA 612 (966)
Q Consensus 533 ~gT~~Y~APEvl~~~~~~~~~~~Di~SlGvil~el~~~~~~~y~~~~DIWSlGvilyemltG~~Pf~~~~~~~~~~~~~~ 612 (966)
++|+.|+|||++.. ..|+.++|||||||++|+|++|+.||.+.+.. ....
T Consensus 157 ~g~~~y~aPE~~~~--------------------------~~~~~~~DiwslGvil~~l~~G~~pf~~~~~~----~~~~ 206 (318)
T cd05570 157 CGTPDYIAPEILSY--------------------------QPYGPAVDWWALGVLLYEMLAGQSPFEGDDED----ELFQ 206 (318)
T ss_pred ecCccccCHHHhcC--------------------------CCCCcchhhhhHHHHHHHHhhCCCCCCCCCHH----HHHH
Confidence 78999999999852 23678999999999999999999999865432 3344
Q ss_pred HHHcCCCCCCchhhccCCHHHHHHHHHhcccCccccCCh
Q psy11767 613 RIKEGQFNFDAEAWSTVSSEAKELTKSLLTVNPAQRIRM 651 (966)
Q Consensus 613 ~i~~~~~~~~~~~~~~is~e~~~Li~~~L~~dP~~R~t~ 651 (966)
.+......++ ..++.++.+||.+||..||++||++
T Consensus 207 ~i~~~~~~~~----~~~~~~~~~li~~~l~~dP~~R~s~ 241 (318)
T cd05570 207 SILEDEVRYP----RWLSKEAKSILKSFLTKNPEKRLGC 241 (318)
T ss_pred HHHcCCCCCC----CcCCHHHHHHHHHHccCCHHHcCCC
Confidence 5555544332 3578999999999999999999998
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re |
| >cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-39 Score=362.66 Aligned_cols=243 Identities=35% Similarity=0.595 Sum_probs=199.6
Q ss_pred cccccccccccccEEEEEEEcCCCcEEEEEEecccc--------ChHHHHHHHHHhcCCCCceEEEEEEEeCCeEEEEEE
Q psy11767 380 LDKAGILGDGSYSVCRRCVEKSTGQEYAVKIISRKI--------DCSEEINLLRACQGHPNIVNLHCVFQDEVHTYLVLE 451 (966)
Q Consensus 380 ~~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~--------~~~~Ei~iL~~l~~HpnIV~l~~~~~~~~~~~lVmE 451 (966)
|...+.||+|+||+||+|++..+|+.||||++.... ...+|+.+|..+ +||||+++++++.++.+.|+|||
T Consensus 3 y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~-~~~~i~~~~~~~~~~~~~~lv~e 81 (350)
T cd05573 3 FEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADA-DSPWIVKLYYSFQDEEHLYLVME 81 (350)
T ss_pred ceEEEEEEeCCcEEEEEEEECCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhc-CCCCccchhhheecCCeEEEEEc
Confidence 344688999999999999999999999999986431 134688889888 59999999999999999999999
Q ss_pred ccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCcEEEecCCCCCEEEEeecccccccCC---
Q psy11767 452 LLKGGELLDRIRQKGRCGFTENEASRIMRQLVAAVHFMHSRGVVHRDLKPENLLFSDPAGDNIKVVDFGFACLKRES--- 528 (966)
Q Consensus 452 y~~gg~L~~~l~~~~~~~l~e~~~~~i~~Qil~aL~yLHs~~IiHRDLKP~NILl~~~~~~~iKL~DFGla~~~~~~--- 528 (966)
|++||+|.+++.+.+ .+++..++.++.||+.||+|||++||+||||||+|||++. ++.+||+|||++......
T Consensus 82 ~~~~~~L~~~l~~~~--~l~~~~~~~i~~qi~~aL~~LH~~giiH~Dlkp~NIll~~--~~~~kL~Dfg~~~~~~~~~~~ 157 (350)
T cd05573 82 YMPGGDLMNLLIRKD--VFPEETARFYIAELVLALDSVHKLGFIHRDIKPDNILIDA--DGHIKLADFGLCKKMNKAKDR 157 (350)
T ss_pred CCCCCCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECC--CCCEEeecCCCCccCcccCcc
Confidence 999999999998763 6999999999999999999999999999999999999975 568999999998654322
Q ss_pred -----------------------------CccccccccccCchhhccCCCCCCCcccchhhhhhhhhhhhcCCCCCCCcC
Q psy11767 529 -----------------------------LHTPCFTLQYAAPEVLRQDKSGYDENCDLWSLGVILVNVLRQDKSGYDENC 579 (966)
Q Consensus 529 -----------------------------~~~~~gT~~Y~APEvl~~~~~~~~~~~Di~SlGvil~el~~~~~~~y~~~~ 579 (966)
.....||+.|+|||++.. ..|+.++
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--------------------------~~~~~~~ 211 (350)
T cd05573 158 EYYLNDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRG--------------------------TPYGLEC 211 (350)
T ss_pred cccccccccccccccccccccccccccccccccccCccccCHHHHcC--------------------------CCCCCce
Confidence 123468999999999853 2478899
Q ss_pred cchhHHHHHHHHhcCCCCCCCCCCchhHHHHHHHHHc--CCCCCCchhhccCCHHHHHHHHHhcccCccccCC-hHHHHH
Q psy11767 580 DLWSLGVILYTMLCGRVPFHARSRDDSALSIMARIKE--GQFNFDAEAWSTVSSEAKELTKSLLTVNPAQRIR-MMRVKL 656 (966)
Q Consensus 580 DIWSlGvilyemltG~~Pf~~~~~~~~~~~~~~~i~~--~~~~~~~~~~~~is~e~~~Li~~~L~~dP~~R~t-~~~v~~ 656 (966)
|||||||++|+|++|+.||...... ....++.. ..+.++ ....+++++.+||.+||. ||.+|++ +.++
T Consensus 212 DiwSlG~il~ell~g~~Pf~~~~~~----~~~~~i~~~~~~~~~p--~~~~~~~~~~~li~~ll~-dp~~R~~s~~~l-- 282 (350)
T cd05573 212 DWWSLGVILYEMLYGFPPFYSDTLQ----ETYNKIINWKESLRFP--PDPPVSPEAIDLICRLLC-DPEDRLGSFEEI-- 282 (350)
T ss_pred eeEecchhhhhhccCCCCCCCCCHH----HHHHHHhccCCcccCC--CCCCCCHHHHHHHHHHcc-ChhhcCCCHHHH--
Confidence 9999999999999999999876532 23334443 222222 223479999999999997 9999999 8866
Q ss_pred HhhhhH
Q psy11767 657 TFHAFH 662 (966)
Q Consensus 657 ~~~~~~ 662 (966)
..|+|+
T Consensus 283 l~hp~~ 288 (350)
T cd05573 283 KSHPFF 288 (350)
T ss_pred hcCCCc
Confidence 345654
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the |
| >cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-38 Score=358.01 Aligned_cols=231 Identities=32% Similarity=0.564 Sum_probs=189.9
Q ss_pred cccccccccEEEEEEEcCCCcEEEEEEecccc--------ChHHHHHH-HHHhcCCCCceEEEEEEEeCCeEEEEEEccC
Q psy11767 384 GILGDGSYSVCRRCVEKSTGQEYAVKIISRKI--------DCSEEINL-LRACQGHPNIVNLHCVFQDEVHTYLVLELLK 454 (966)
Q Consensus 384 ~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~--------~~~~Ei~i-L~~l~~HpnIV~l~~~~~~~~~~~lVmEy~~ 454 (966)
+.||+|+||+||+|++..+++.||+|++.+.. ....|+.. ++.+ +||||+++++++.+++..|+||||++
T Consensus 1 ~~lg~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~-~h~~Iv~~~~~~~~~~~~~lv~e~~~ 79 (325)
T cd05602 1 KVIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNV-KHPFLVGLHFSFQTADKLYFVLDYIN 79 (325)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHHhhhHHHHHHHHHHHHHHhC-CCCCCCceeEEEEcCCeEEEEEeCCC
Confidence 36999999999999999999999999986532 11223333 3444 69999999999999999999999999
Q ss_pred CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCcEEEecCCCCCEEEEeecccccccC---CCcc
Q psy11767 455 GGELLDRIRQKGRCGFTENEASRIMRQLVAAVHFMHSRGVVHRDLKPENLLFSDPAGDNIKVVDFGFACLKRE---SLHT 531 (966)
Q Consensus 455 gg~L~~~l~~~~~~~l~e~~~~~i~~Qil~aL~yLHs~~IiHRDLKP~NILl~~~~~~~iKL~DFGla~~~~~---~~~~ 531 (966)
||+|.+++.... .+++..++.++.||+.||+|||++||+||||||+|||++. ++.+||+|||++..... ....
T Consensus 80 ~~~L~~~~~~~~--~~~~~~~~~~~~qi~~~L~~lH~~giiHrDlkp~Nili~~--~~~~kl~DfG~a~~~~~~~~~~~~ 155 (325)
T cd05602 80 GGELFYHLQRER--CFLEPRARFYAAEIASALGYLHSLNIVYRDLKPENILLDS--QGHIVLTDFGLCKENIEHNGTTST 155 (325)
T ss_pred CCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEECC--CCCEEEccCCCCcccccCCCCccc
Confidence 999999997654 5899999999999999999999999999999999999975 56899999999864321 2334
Q ss_pred ccccccccCchhhccCCCCCCCcccchhhhhhhhhhhhcCCCCCCCcCcchhHHHHHHHHhcCCCCCCCCCCchhHHHHH
Q psy11767 532 PCFTLQYAAPEVLRQDKSGYDENCDLWSLGVILVNVLRQDKSGYDENCDLWSLGVILYTMLCGRVPFHARSRDDSALSIM 611 (966)
Q Consensus 532 ~~gT~~Y~APEvl~~~~~~~~~~~Di~SlGvil~el~~~~~~~y~~~~DIWSlGvilyemltG~~Pf~~~~~~~~~~~~~ 611 (966)
.+||+.|+|||++.. ..|+.++|||||||++|+|++|++||.+.+.. ..+
T Consensus 156 ~~gt~~y~aPE~~~~--------------------------~~~~~~~DiwslG~il~el~~g~~pf~~~~~~----~~~ 205 (325)
T cd05602 156 FCGTPEYLAPEVLHK--------------------------QPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTA----EMY 205 (325)
T ss_pred ccCCccccCHHHHcC--------------------------CCCCCccccccccHHHHHHhcCCCCCCCCCHH----HHH
Confidence 578999999998852 23678899999999999999999999865432 334
Q ss_pred HHHHcCCCCCCchhhccCCHHHHHHHHHhcccCccccCChHH
Q psy11767 612 ARIKEGQFNFDAEAWSTVSSEAKELTKSLLTVNPAQRIRMMR 653 (966)
Q Consensus 612 ~~i~~~~~~~~~~~~~~is~e~~~Li~~~L~~dP~~R~t~~~ 653 (966)
..+......+ .+.++.++.++|.+||+.||.+|+++.+
T Consensus 206 ~~i~~~~~~~----~~~~~~~~~~li~~~l~~~p~~R~~~~~ 243 (325)
T cd05602 206 DNILNKPLQL----KPNITNSARHLLEGLLQKDRTKRLGAKD 243 (325)
T ss_pred HHHHhCCcCC----CCCCCHHHHHHHHHHcccCHHHCCCCCC
Confidence 4454444332 2468999999999999999999999763
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt |
| >cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-38 Score=348.53 Aligned_cols=247 Identities=30% Similarity=0.504 Sum_probs=200.5
Q ss_pred ccccccccccccEEEEEEEcCCCcEEEEEEecccc--------ChHHHHHHHHHhcCCCCceEEEEEEEeCCeEEEEEEc
Q psy11767 381 DKAGILGDGSYSVCRRCVEKSTGQEYAVKIISRKI--------DCSEEINLLRACQGHPNIVNLHCVFQDEVHTYLVLEL 452 (966)
Q Consensus 381 ~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~--------~~~~Ei~iL~~l~~HpnIV~l~~~~~~~~~~~lVmEy 452 (966)
+..++||+|+||+||++.+..+++.||||++.... ...+|+.+|+.+ +||||+++++++.++.+.|+||||
T Consensus 3 ~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~e~ 81 (285)
T cd05605 3 RHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKV-NSRFVVSLAYAYETKDALCLVLTL 81 (285)
T ss_pred eEEEEEecCCCeEEEEEEEcCCCceEEEEEEehhhhhhhhhHHHHHHHHHHHHhc-CCCCEeeeeeeecCCCeEEEEEec
Confidence 44678999999999999999999999999986431 134689999988 599999999999999999999999
Q ss_pred cCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCcEEEecCCCCCEEEEeecccccccC--CCc
Q psy11767 453 LKGGELLDRIRQKGRCGFTENEASRIMRQLVAAVHFMHSRGVVHRDLKPENLLFSDPAGDNIKVVDFGFACLKRE--SLH 530 (966)
Q Consensus 453 ~~gg~L~~~l~~~~~~~l~e~~~~~i~~Qil~aL~yLHs~~IiHRDLKP~NILl~~~~~~~iKL~DFGla~~~~~--~~~ 530 (966)
+++|+|.+++.......+++..+..++.|++.||+|||++||+||||||+|||+++ .+.++|+|||++..... ...
T Consensus 82 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~--~~~~~l~Dfg~~~~~~~~~~~~ 159 (285)
T cd05605 82 MNGGDLKFHIYNMGNPGFDEERAVFYAAEITCGLEDLHRERIVYRDLKPENILLDD--YGHIRISDLGLAVEIPEGETIR 159 (285)
T ss_pred cCCCcHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCHHHEEECC--CCCEEEeeCCCceecCCCCccc
Confidence 99999999887655456999999999999999999999999999999999999975 56899999999876432 223
Q ss_pred cccccccccCchhhccCCCCCCCcccchhhhhhhhhhhhcCCCCCCCcCcchhHHHHHHHHhcCCCCCCCCCCchhHHHH
Q psy11767 531 TPCFTLQYAAPEVLRQDKSGYDENCDLWSLGVILVNVLRQDKSGYDENCDLWSLGVILYTMLCGRVPFHARSRDDSALSI 610 (966)
Q Consensus 531 ~~~gT~~Y~APEvl~~~~~~~~~~~Di~SlGvil~el~~~~~~~y~~~~DIWSlGvilyemltG~~Pf~~~~~~~~~~~~ 610 (966)
..++|+.|+|||++.. ..++.++||||+||++|+|++|+.||.+.........+
T Consensus 160 ~~~~~~~y~aPE~~~~--------------------------~~~~~~~Diws~G~~l~el~~g~~pf~~~~~~~~~~~~ 213 (285)
T cd05605 160 GRVGTVGYMAPEVVKN--------------------------ERYTFSPDWWGLGCLIYEMIEGKSPFRQRKEKVKREEV 213 (285)
T ss_pred cccCCCCccCcHHhcC--------------------------CCCCccccchhHHHHHHHHHHCCCCCCCCchhhHHHHH
Confidence 4578999999998852 23678899999999999999999999876543322233
Q ss_pred HHHHHcCCCCCCchhhccCCHHHHHHHHHhcccCccccC-----ChHHHHHHhhhhH
Q psy11767 611 MARIKEGQFNFDAEAWSTVSSEAKELTKSLLTVNPAQRI-----RMMRVKLTFHAFH 662 (966)
Q Consensus 611 ~~~i~~~~~~~~~~~~~~is~e~~~Li~~~L~~dP~~R~-----t~~~v~~~~~~~~ 662 (966)
...+..+...+ +..++..+.+||.+||..||++|| ++.++ ..|+|+
T Consensus 214 ~~~~~~~~~~~----~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l--~~~~~~ 264 (285)
T cd05605 214 ERRVKEDQEEY----SEKFSEAARSICRQLLTKDPGFRLGCRGEGAEEV--KAHPFF 264 (285)
T ss_pred HHHhhhccccc----CcccCHHHHHHHHHHccCCHHHhcCCCCCCHHHH--hcCcCc
Confidence 33344333222 235789999999999999999999 56554 345554
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, |
| >cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-38 Score=356.71 Aligned_cols=250 Identities=27% Similarity=0.428 Sum_probs=194.0
Q ss_pred cccccccccccEEEEEEEcCCCcEEEEEEecccc-------ChHHHHHHHHHhcCCCCceEEEEEEEeC-----CeEEEE
Q psy11767 382 KAGILGDGSYSVCRRCVEKSTGQEYAVKIISRKI-------DCSEEINLLRACQGHPNIVNLHCVFQDE-----VHTYLV 449 (966)
Q Consensus 382 ~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~-------~~~~Ei~iL~~l~~HpnIV~l~~~~~~~-----~~~~lV 449 (966)
..+.||+|+||.||+|++..+|+.||||++.... ...+|+.+|+.+ +||||+++++++... ...|+|
T Consensus 4 i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l-~hpniv~~~~~~~~~~~~~~~~~~lv 82 (338)
T cd07859 4 IQEVIGKGSYGVVCSAIDTHTGEKVAIKKINDVFEHVSDATRILREIKLLRLL-RHPDIVEIKHIMLPPSRREFKDIYVV 82 (338)
T ss_pred EEEEEeecCCeEEEEEEECCCCCEEEEEEechhhccchhHHHHHHHHHHHHhC-CCCCEeeecceEeccCCCCCceEEEE
Confidence 3678999999999999999999999999986421 245699999988 599999999988643 358999
Q ss_pred EEccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCcEEEecCCCCCEEEEeecccccccCC-
Q psy11767 450 LELLKGGELLDRIRQKGRCGFTENEASRIMRQLVAAVHFMHSRGVVHRDLKPENLLFSDPAGDNIKVVDFGFACLKRES- 528 (966)
Q Consensus 450 mEy~~gg~L~~~l~~~~~~~l~e~~~~~i~~Qil~aL~yLHs~~IiHRDLKP~NILl~~~~~~~iKL~DFGla~~~~~~- 528 (966)
|||| +++|.+++.... .+++..++.++.||+.||+|||++||+||||||+|||++. ++.+||+|||+++.....
T Consensus 83 ~e~~-~~~L~~~l~~~~--~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIll~~--~~~~kL~Dfg~~~~~~~~~ 157 (338)
T cd07859 83 FELM-ESDLHQVIKAND--DLTPEHHQFFLYQLLRALKYIHTANVFHRDLKPKNILANA--DCKLKICDFGLARVAFNDT 157 (338)
T ss_pred EecC-CCCHHHHHHhcc--cCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECC--CCcEEEccCcccccccccc
Confidence 9999 578999887654 5899999999999999999999999999999999999975 568999999999753211
Q ss_pred -----CccccccccccCchhhccCCCCCCCcccchhhhhhhhhhhhcCCCCCCCcCcchhHHHHHHHHhcCCCCCCCCCC
Q psy11767 529 -----LHTPCFTLQYAAPEVLRQDKSGYDENCDLWSLGVILVNVLRQDKSGYDENCDLWSLGVILYTMLCGRVPFHARSR 603 (966)
Q Consensus 529 -----~~~~~gT~~Y~APEvl~~~~~~~~~~~Di~SlGvil~el~~~~~~~y~~~~DIWSlGvilyemltG~~Pf~~~~~ 603 (966)
....++|+.|+|||++... ...|+.++|||||||++|+|++|++||.+.+.
T Consensus 158 ~~~~~~~~~~~t~~y~aPE~~~~~------------------------~~~~~~~~DvwSlGvvl~el~tg~~pf~~~~~ 213 (338)
T cd07859 158 PTAIFWTDYVATRWYRAPELCGSF------------------------FSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNV 213 (338)
T ss_pred CccccccCCCCCCCcCCHHHHhcc------------------------ccccCchhHHHHHHHHHHHHHcCCCCCCCCCh
Confidence 1234689999999987421 13478899999999999999999999987543
Q ss_pred chhHHHHH-----------------------HHHHcCCCCCCchhhccCCHHHHHHHHHhcccCccccCChHHHHHHhhh
Q psy11767 604 DDSALSIM-----------------------ARIKEGQFNFDAEAWSTVSSEAKELTKSLLTVNPAQRIRMMRVKLTFHA 660 (966)
Q Consensus 604 ~~~~~~~~-----------------------~~i~~~~~~~~~~~~~~is~e~~~Li~~~L~~dP~~R~t~~~v~~~~~~ 660 (966)
......+. ..+...........++.+++++.++|.+||+.||++|||+.++ ..|+
T Consensus 214 ~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~e~--l~hp 291 (338)
T cd07859 214 VHQLDLITDLLGTPSPETISRVRNEKARRYLSSMRKKQPVPFSQKFPNADPLALRLLERLLAFDPKDRPTAEEA--LADP 291 (338)
T ss_pred HHHHHHHHHHhCCCCHHHHHHhhhhhHHHHHHhhcccCCCchHHhcCCCChHHHHHHHHHcCcCcccCCCHHHH--hcCc
Confidence 22111000 0011111111112334678899999999999999999999876 3466
Q ss_pred hHH
Q psy11767 661 FHQ 663 (966)
Q Consensus 661 ~~~ 663 (966)
|+.
T Consensus 292 ~f~ 294 (338)
T cd07859 292 YFK 294 (338)
T ss_pred hhh
Confidence 653
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos |
| >cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-38 Score=346.21 Aligned_cols=243 Identities=29% Similarity=0.485 Sum_probs=194.8
Q ss_pred cccccccEEEEEEEcCCCcEEEEEEecccc--------ChHHHHHHHHHhcCCCCceEEEEEEEeCCeEEEEEEccCCCC
Q psy11767 386 LGDGSYSVCRRCVEKSTGQEYAVKIISRKI--------DCSEEINLLRACQGHPNIVNLHCVFQDEVHTYLVLELLKGGE 457 (966)
Q Consensus 386 LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~--------~~~~Ei~iL~~l~~HpnIV~l~~~~~~~~~~~lVmEy~~gg~ 457 (966)
||+|+||+||+|.+..+|+.||+|++.... ....|+.+|+.+ +||||++++++|.++...|+||||++||+
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l-~~~~i~~~~~~~~~~~~~~lv~e~~~~g~ 79 (280)
T cd05608 1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKV-HSRFIVSLAYAFQTKTDLCLVMTIMNGGD 79 (280)
T ss_pred CCCCCceeEEEEEEccCCcEEEEEeeeHHHHhhhHHHHHHHHHHHHHHhC-CCCcEeeeeEEEcCCCeEEEEEeCCCCCC
Confidence 799999999999999999999999986432 124588899888 69999999999999999999999999999
Q ss_pred HHHHHHhc--CCCCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCcEEEecCCCCCEEEEeecccccccCC---Cccc
Q psy11767 458 LLDRIRQK--GRCGFTENEASRIMRQLVAAVHFMHSRGVVHRDLKPENLLFSDPAGDNIKVVDFGFACLKRES---LHTP 532 (966)
Q Consensus 458 L~~~l~~~--~~~~l~e~~~~~i~~Qil~aL~yLHs~~IiHRDLKP~NILl~~~~~~~iKL~DFGla~~~~~~---~~~~ 532 (966)
|.+++... ....+++..+..++.||+.||+|||++||+||||||+|||+++ ++.+||+|||++...... ....
T Consensus 80 L~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nili~~--~~~~~l~dfg~~~~~~~~~~~~~~~ 157 (280)
T cd05608 80 LRYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQRRIIYRDLKPENVLLDN--DGNVRISDLGLAVELKDGQSKTKGY 157 (280)
T ss_pred HHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECC--CCCEEEeeCccceecCCCCcccccc
Confidence 98887542 2235899999999999999999999999999999999999975 568999999998654322 2345
Q ss_pred cccccccCchhhccCCCCCCCcccchhhhhhhhhhhhcCCCCCCCcCcchhHHHHHHHHhcCCCCCCCCCCchhHHHHHH
Q psy11767 533 CFTLQYAAPEVLRQDKSGYDENCDLWSLGVILVNVLRQDKSGYDENCDLWSLGVILYTMLCGRVPFHARSRDDSALSIMA 612 (966)
Q Consensus 533 ~gT~~Y~APEvl~~~~~~~~~~~Di~SlGvil~el~~~~~~~y~~~~DIWSlGvilyemltG~~Pf~~~~~~~~~~~~~~ 612 (966)
.+|+.|+|||++.. ..|+.++||||+||++|+|++|+.||..............
T Consensus 158 ~g~~~y~aPE~~~~--------------------------~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~~~ 211 (280)
T cd05608 158 AGTPGFMAPELLQG--------------------------EEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQ 211 (280)
T ss_pred CCCcCccCHHHhcC--------------------------CCCCccccHHHHHHHHHHHHhCCCCCCCCCcchhHHHHHH
Confidence 68999999999853 2367889999999999999999999986543322222333
Q ss_pred HHHcCCCCCCchhhccCCHHHHHHHHHhcccCccccCC-----hHHHHHHhhhhHH
Q psy11767 613 RIKEGQFNFDAEAWSTVSSEAKELTKSLLTVNPAQRIR-----MMRVKLTFHAFHQ 663 (966)
Q Consensus 613 ~i~~~~~~~~~~~~~~is~e~~~Li~~~L~~dP~~R~t-----~~~v~~~~~~~~~ 663 (966)
.+..+... ....+++++.+++.+||+.||++||+ +.++ ..|+|++
T Consensus 212 ~~~~~~~~----~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~~--l~h~~~~ 261 (280)
T cd05608 212 RILNDSVT----YPDKFSPASKSFCEALLAKDPEKRLGFRDGNCDGL--RTHPLFR 261 (280)
T ss_pred hhcccCCC----CcccCCHHHHHHHHHHhcCCHHHhcCCCCCCHHHH--hcChhhh
Confidence 33333222 22458899999999999999999995 4443 4566653
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g |
| >cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-38 Score=352.93 Aligned_cols=251 Identities=32% Similarity=0.525 Sum_probs=196.7
Q ss_pred cccccccccccccEEEEEEEcCCCcEEEEEEecccc--------ChHHHHHHHHHhcCCCCceEEEEEEEeCCeEEEEEE
Q psy11767 380 LDKAGILGDGSYSVCRRCVEKSTGQEYAVKIISRKI--------DCSEEINLLRACQGHPNIVNLHCVFQDEVHTYLVLE 451 (966)
Q Consensus 380 ~~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~--------~~~~Ei~iL~~l~~HpnIV~l~~~~~~~~~~~lVmE 451 (966)
|+..+.||+|+||+||+|++..+++.||||++.+.. ...+|+.++..+ +||||++++++|.++.+.|+|||
T Consensus 3 y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~-~~~~i~~~~~~~~~~~~~~lv~e 81 (331)
T cd05597 3 FEILKVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDVLVNG-DRRWITNLHYAFQDENNLYLVMD 81 (331)
T ss_pred ceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhC-CCCCCCceEEEEecCCeEEEEEe
Confidence 344788999999999999999999999999986421 134577888776 69999999999999999999999
Q ss_pred ccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCcEEEecCCCCCEEEEeecccccccCC---
Q psy11767 452 LLKGGELLDRIRQKGRCGFTENEASRIMRQLVAAVHFMHSRGVVHRDLKPENLLFSDPAGDNIKVVDFGFACLKRES--- 528 (966)
Q Consensus 452 y~~gg~L~~~l~~~~~~~l~e~~~~~i~~Qil~aL~yLHs~~IiHRDLKP~NILl~~~~~~~iKL~DFGla~~~~~~--- 528 (966)
|++||+|.+++.+... .+++..++.++.||+.||+|||++||+||||||+|||++. ++.+||+|||++......
T Consensus 82 ~~~g~~L~~~l~~~~~-~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nill~~--~~~~kl~Dfg~~~~~~~~~~~ 158 (331)
T cd05597 82 YYVGGDLLTLLSKFED-RLPEDMARFYLAEMVLAIDSVHQLGYVHRDIKPDNVLLDK--NGHIRLADFGSCLRLLADGTV 158 (331)
T ss_pred cCCCCcHHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCeEECCCCHHHEEECC--CCCEEEEECCceeecCCCCCc
Confidence 9999999999976432 5899999999999999999999999999999999999974 568999999998654321
Q ss_pred -CccccccccccCchhhccCCCCCCCcccchhhhhhhhhhhhcCCCCCCCcCcchhHHHHHHHHhcCCCCCCCCCCchhH
Q psy11767 529 -LHTPCFTLQYAAPEVLRQDKSGYDENCDLWSLGVILVNVLRQDKSGYDENCDLWSLGVILYTMLCGRVPFHARSRDDSA 607 (966)
Q Consensus 529 -~~~~~gT~~Y~APEvl~~~~~~~~~~~Di~SlGvil~el~~~~~~~y~~~~DIWSlGvilyemltG~~Pf~~~~~~~~~ 607 (966)
....+||+.|+|||++..... +...|+.++||||+||++|+|++|+.||.+.+..+
T Consensus 159 ~~~~~~gt~~y~aPE~~~~~~~---------------------~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~-- 215 (331)
T cd05597 159 QSNVAVGTPDYISPEILQAMED---------------------GKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVE-- 215 (331)
T ss_pred cccceeccccccCHHHHhhccc---------------------cccCCCCcceeehhhhHHHHHhhCCCCCCCCCHHH--
Confidence 122468999999999853211 12346789999999999999999999998754332
Q ss_pred HHHHHHHHcC--CCCCCchhhccCCHHHHHHHHHhcccCccc--cCChHHHHHHhhhhH
Q psy11767 608 LSIMARIKEG--QFNFDAEAWSTVSSEAKELTKSLLTVNPAQ--RIRMMRVKLTFHAFH 662 (966)
Q Consensus 608 ~~~~~~i~~~--~~~~~~~~~~~is~e~~~Li~~~L~~dP~~--R~t~~~v~~~~~~~~ 662 (966)
....+... .+.++. ....++.++++||++||..++++ |+++.++ ..|+|+
T Consensus 216 --~~~~i~~~~~~~~~~~-~~~~~~~~~~~li~~ll~~~~~r~~r~~~~~~--l~hp~~ 269 (331)
T cd05597 216 --TYGKIMNHKEHFQFPP-DVTDVSEEAKDLIRRLICSPETRLGRNGLQDF--KDHPFF 269 (331)
T ss_pred --HHHHHHcCCCcccCCC-ccCCCCHHHHHHHHHHccCcccccCCCCHHHH--hcCCCC
Confidence 23334332 222222 23458999999999999764433 6677755 456664
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, |
| >KOG0197|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-38 Score=358.43 Aligned_cols=243 Identities=24% Similarity=0.403 Sum_probs=204.3
Q ss_pred cccccccccccEEEEEEEcCCCcEEEEEEeccc----cChHHHHHHHHHhcCCCCceEEEEEEEeCCeEEEEEEccCCCC
Q psy11767 382 KAGILGDGSYSVCRRCVEKSTGQEYAVKIISRK----IDCSEEINLLRACQGHPNIVNLHCVFQDEVHTYLVLELLKGGE 457 (966)
Q Consensus 382 ~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~----~~~~~Ei~iL~~l~~HpnIV~l~~~~~~~~~~~lVmEy~~gg~ 457 (966)
.++.||+|-||.||.|....+ ..||+|.++.. .++.+|+++|++|. |+|||+|++++..+..+|||||||+.|+
T Consensus 210 l~~~LG~G~FG~V~~g~~~~~-~~vavk~ik~~~m~~~~f~~Ea~iMk~L~-H~~lV~l~gV~~~~~piyIVtE~m~~Gs 287 (468)
T KOG0197|consen 210 LIRELGSGQFGEVWLGKWNGS-TKVAVKTIKEGSMSPEAFLREAQIMKKLR-HEKLVKLYGVCTKQEPIYIVTEYMPKGS 287 (468)
T ss_pred HHHHhcCCccceEEEEEEcCC-CcccceEEeccccChhHHHHHHHHHHhCc-ccCeEEEEEEEecCCceEEEEEecccCc
Confidence 467899999999999998643 37999998753 34668999999995 9999999999999889999999999999
Q ss_pred HHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCcEEEecCCCCCEEEEeecccccccCCCc----ccc
Q psy11767 458 LLDRIRQKGRCGFTENEASRIMRQLVAAVHFMHSRGVVHRDLKPENLLFSDPAGDNIKVVDFGFACLKRESLH----TPC 533 (966)
Q Consensus 458 L~~~l~~~~~~~l~e~~~~~i~~Qil~aL~yLHs~~IiHRDLKP~NILl~~~~~~~iKL~DFGla~~~~~~~~----~~~ 533 (966)
|.++|+...+..+...+.+.++.|||+|++||+++++|||||-..|||+++ +..+||+|||||+...+... ...
T Consensus 288 Ll~yLr~~~~~~l~~~~Ll~~a~qIaeGM~YLes~~~IHRDLAARNiLV~~--~~~vKIsDFGLAr~~~d~~Y~~~~~~k 365 (468)
T KOG0197|consen 288 LLDYLRTREGGLLNLPQLLDFAAQIAEGMAYLESKNYIHRDLAARNILVDE--DLVVKISDFGLARLIGDDEYTASEGGK 365 (468)
T ss_pred HHHHhhhcCCCccchHHHHHHHHHHHHHHHHHHhCCccchhhhhhheeecc--CceEEEcccccccccCCCceeecCCCC
Confidence 999999866667999999999999999999999999999999999999986 56999999999996544322 223
Q ss_pred ccccccCchhhccCCCCCCCcccchhhhhhhhhhhhcCCCCCCCcCcchhHHHHHHHHhc-CCCCCCCCCCchhHHHHHH
Q psy11767 534 FTLQYAAPEVLRQDKSGYDENCDLWSLGVILVNVLRQDKSGYDENCDLWSLGVILYTMLC-GRVPFHARSRDDSALSIMA 612 (966)
Q Consensus 534 gT~~Y~APEvl~~~~~~~~~~~Di~SlGvil~el~~~~~~~y~~~~DIWSlGvilyemlt-G~~Pf~~~~~~~~~~~~~~ 612 (966)
.+..|.|||.+..+ .++.++|||||||+|+||+| |+.|+.+.+. ..++.
T Consensus 366 fPIkWtAPEa~~~~--------------------------~FS~kSDVWSFGVlL~E~fT~G~~py~~msn----~ev~~ 415 (468)
T KOG0197|consen 366 FPIKWTAPEALNYG--------------------------KFSSKSDVWSFGVLLWELFTYGRVPYPGMSN----EEVLE 415 (468)
T ss_pred CCceecCHHHHhhC--------------------------CcccccceeehhhhHHHHhccCCCCCCCCCH----HHHHH
Confidence 46789999999643 37889999999999999997 9999987664 35667
Q ss_pred HHHcCCCCCCchhhccCCHHHHHHHHHhcccCccccCChHHHHHHhhhh
Q psy11767 613 RIKEGQFNFDAEAWSTVSSEAKELTKSLLTVNPAQRIRMMRVKLTFHAF 661 (966)
Q Consensus 613 ~i~~~~~~~~~~~~~~is~e~~~Li~~~L~~dP~~R~t~~~v~~~~~~~ 661 (966)
.+.+|.--+.+ ...++++-++|..||..+|++|||...+...+..+
T Consensus 416 ~le~GyRlp~P---~~CP~~vY~lM~~CW~~~P~~RPtF~~L~~~l~~~ 461 (468)
T KOG0197|consen 416 LLERGYRLPRP---EGCPDEVYELMKSCWHEDPEDRPTFETLREVLEDF 461 (468)
T ss_pred HHhccCcCCCC---CCCCHHHHHHHHHHhhCCcccCCCHHHHHHHHHHh
Confidence 77777543333 46899999999999999999999998665544443
|
|
| >KOG0574|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-40 Score=347.42 Aligned_cols=250 Identities=27% Similarity=0.474 Sum_probs=208.9
Q ss_pred cccccccccccccEEEEEEEcCCCcEEEEEEeccccCh---HHHHHHHHHhcCCCCceEEEEEEEeCCeEEEEEEccCCC
Q psy11767 380 LDKAGILGDGSYSVCRRCVEKSTGQEYAVKIISRKIDC---SEEINLLRACQGHPNIVNLHCVFQDEVHTYLVLELLKGG 456 (966)
Q Consensus 380 ~~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~~~---~~Ei~iL~~l~~HpnIV~l~~~~~~~~~~~lVmEy~~gg 456 (966)
|+.+++||+|+||.||+|.|+.+|+.+|||.+.-..+. ..||.+|++|. .|+||++|+.+.....+|||||||-.|
T Consensus 35 FDi~~KLGEGSYGSV~KAIH~EsG~v~AIK~VPV~sDLQEIIKEISIMQQC~-S~yVVKYYGSYFK~sDLWIVMEYCGAG 113 (502)
T KOG0574|consen 35 FDIVGKLGEGSYGSVHKAIHRESGHVLAIKKVPVDTDLQEIIKEISIMQQCK-SKYVVKYYGSYFKHSDLWIVMEYCGAG 113 (502)
T ss_pred HHHHHHhcCCcchHHHHHHHhccCcEEEEEecCccchHHHHHHHHHHHHHcC-CchhhhhhhhhccCCceEeehhhcCCC
Confidence 44578999999999999999999999999999877654 46999999995 999999999999889999999999999
Q ss_pred CHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCcEEEecCCCCCEEEEeecccccccC---CCcccc
Q psy11767 457 ELLDRIRQKGRCGFTENEASRIMRQLVAAVHFMHSRGVVHRDLKPENLLFSDPAGDNIKVVDFGFACLKRE---SLHTPC 533 (966)
Q Consensus 457 ~L~~~l~~~~~~~l~e~~~~~i~~Qil~aL~yLHs~~IiHRDLKP~NILl~~~~~~~iKL~DFGla~~~~~---~~~~~~ 533 (966)
++.+.++.++. +|+|.++..+++..++||+|||...-||||||..||||. ..|..||+|||.|.+..+ ..++..
T Consensus 114 SiSDI~R~R~K-~L~E~EIs~iL~~TLKGL~YLH~~~KIHRDIKAGNILLN--T~G~AKLADFGVAGQLTDTMAKRNTVI 190 (502)
T KOG0574|consen 114 SISDIMRARRK-PLSEQEISAVLRDTLKGLQYLHDLKKIHRDIKAGNILLN--TDGIAKLADFGVAGQLTDTMAKRNTVI 190 (502)
T ss_pred cHHHHHHHhcC-CccHHHHHHHHHHHHhHHHHHHHHHHHHhhcccccEEEc--ccchhhhhhccccchhhhhHHhhCccc
Confidence 99999987665 799999999999999999999999999999999999997 467999999999976543 346788
Q ss_pred ccccccCchhhccCCCCCCCcccchhhhhhhhhhhhcCCCCCCCcCcchhHHHHHHHHhcCCCCCCCCCCchhHHHHHHH
Q psy11767 534 FTLQYAAPEVLRQDKSGYDENCDLWSLGVILVNVLRQDKSGYDENCDLWSLGVILYTMLCGRVPFHARSRDDSALSIMAR 613 (966)
Q Consensus 534 gT~~Y~APEvl~~~~~~~~~~~Di~SlGvil~el~~~~~~~y~~~~DIWSlGvilyemltG~~Pf~~~~~~~~~~~~~~~ 613 (966)
|||.|||||++.. .+|+.++||||||++..||..|++||........ + -.
T Consensus 191 GTPFWMAPEVI~E--------------------------IGY~~~ADIWSLGITaIEMAEG~PPYsDIHPMRA---I-FM 240 (502)
T KOG0574|consen 191 GTPFWMAPEVIEE--------------------------IGYDTKADIWSLGITAIEMAEGRPPYSDIHPMRA---I-FM 240 (502)
T ss_pred cCcccccHHHHHH--------------------------hccchhhhHhhhcchhhhhhcCCCCcccccccce---e-Ee
Confidence 9999999999963 3589999999999999999999999987654321 1 11
Q ss_pred HHcC-CCCCCchhhccCCHHHHHHHHHhcccCccccCChHHHHHHhhhhHHhhhc
Q psy11767 614 IKEG-QFNFDAEAWSTVSSEAKELTKSLLTVNPAQRIRMMRVKLTFHAFHQAQKE 667 (966)
Q Consensus 614 i~~~-~~~~~~~~~~~is~e~~~Li~~~L~~dP~~R~t~~~v~~~~~~~~~~~~~ 667 (966)
|... ...|. .....|+++.|++++||.++|++|-|+.+ +..|+|.+..+.
T Consensus 241 IPT~PPPTF~--KPE~WS~~F~DFi~~CLiK~PE~R~TA~~--L~~H~FiknA~g 291 (502)
T KOG0574|consen 241 IPTKPPPTFK--KPEEWSSEFNDFIRSCLIKKPEERKTALR--LCEHTFIKNAPG 291 (502)
T ss_pred ccCCCCCCCC--ChHhhhhHHHHHHHHHhcCCHHHHHHHHH--HhhhhhhcCCCc
Confidence 2221 11121 12245889999999999999999999874 467888765443
|
|
| >cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-38 Score=361.64 Aligned_cols=248 Identities=30% Similarity=0.493 Sum_probs=197.5
Q ss_pred cccccccccccccEEEEEEEcCCCcEEEEEEecccc--------ChHHHHHHHHHhcCCCCceEEEEEEEeCCeEEEEEE
Q psy11767 380 LDKAGILGDGSYSVCRRCVEKSTGQEYAVKIISRKI--------DCSEEINLLRACQGHPNIVNLHCVFQDEVHTYLVLE 451 (966)
Q Consensus 380 ~~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~--------~~~~Ei~iL~~l~~HpnIV~l~~~~~~~~~~~lVmE 451 (966)
|+..+.||+|+||.||+|++..+++.||+|++.+.. ...+|+.+++.+ +||||+++++++.++.+.|+|||
T Consensus 45 y~i~~~lG~G~fg~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~i~~~~-~hp~iv~~~~~~~~~~~~~lv~E 123 (371)
T cd05622 45 YEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFA-NSPWVVQLFYAFQDDRYLYMVME 123 (371)
T ss_pred cEEEEEEeecCCeEEEEEEECCCCcEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhC-CCCCCCeEEEEEEcCCEEEEEEc
Confidence 344688999999999999999999999999986421 134678888777 69999999999999999999999
Q ss_pred ccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCcEEEecCCCCCEEEEeecccccccCC---
Q psy11767 452 LLKGGELLDRIRQKGRCGFTENEASRIMRQLVAAVHFMHSRGVVHRDLKPENLLFSDPAGDNIKVVDFGFACLKRES--- 528 (966)
Q Consensus 452 y~~gg~L~~~l~~~~~~~l~e~~~~~i~~Qil~aL~yLHs~~IiHRDLKP~NILl~~~~~~~iKL~DFGla~~~~~~--- 528 (966)
||+||+|.+++... .+++..++.++.||+.||+|||++||+||||||+|||++. .+.+||+|||++......
T Consensus 124 y~~gg~L~~~~~~~---~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDLkp~NIll~~--~~~ikL~DfG~a~~~~~~~~~ 198 (371)
T cd05622 124 YMPGGDLVNLMSNY---DVPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLDK--SGHLKLADFGTCMKMNKEGMV 198 (371)
T ss_pred CCCCCcHHHHHHhc---CCCHHHHHHHHHHHHHHHHHHHHCCEEeCCCCHHHEEECC--CCCEEEEeCCceeEcCcCCcc
Confidence 99999999998654 4899999999999999999999999999999999999975 568999999999754321
Q ss_pred -CccccccccccCchhhccCCCCCCCcccchhhhhhhhhhhhcCCCCCCCcCcchhHHHHHHHHhcCCCCCCCCCCchhH
Q psy11767 529 -LHTPCFTLQYAAPEVLRQDKSGYDENCDLWSLGVILVNVLRQDKSGYDENCDLWSLGVILYTMLCGRVPFHARSRDDSA 607 (966)
Q Consensus 529 -~~~~~gT~~Y~APEvl~~~~~~~~~~~Di~SlGvil~el~~~~~~~y~~~~DIWSlGvilyemltG~~Pf~~~~~~~~~ 607 (966)
..+.+||+.|+|||++.... ....|+.++|||||||++|+|++|++||.+.+..
T Consensus 199 ~~~~~~gt~~y~aPE~l~~~~----------------------~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~--- 253 (371)
T cd05622 199 RCDTAVGTPDYISPEVLKSQG----------------------GDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLV--- 253 (371)
T ss_pred cccCcccCccccCHHHHhccC----------------------CCccCCCccceeehhHHHHHHHhCCCCCCCCCHH---
Confidence 23567899999999986321 1223788999999999999999999999875532
Q ss_pred HHHHHHHHcCCCCCCchhhccCCHHHHHHHHHhcccCccc---cCChHHHHHHhhhhH
Q psy11767 608 LSIMARIKEGQFNFDAEAWSTVSSEAKELTKSLLTVNPAQ---RIRMMRVKLTFHAFH 662 (966)
Q Consensus 608 ~~~~~~i~~~~~~~~~~~~~~is~e~~~Li~~~L~~dP~~---R~t~~~v~~~~~~~~ 662 (966)
.....|......+.......++.++++||.+||. +|.. |+++.++ ..|+|+
T Consensus 254 -~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~-~~~~r~~r~~~~ei--~~h~~~ 307 (371)
T cd05622 254 -GTYSKIMNHKNSLTFPDDNDISKEAKNLICAFLT-DREVRLGRNGVEEI--KRHLFF 307 (371)
T ss_pred -HHHHHHHcCCCcccCCCcCCCCHHHHHHHHHHcC-ChhhhcCCCCHHHH--hcCccc
Confidence 3344554433222222334689999999999998 5555 5677665 344554
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an |
| >cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-38 Score=345.85 Aligned_cols=245 Identities=31% Similarity=0.494 Sum_probs=192.4
Q ss_pred ccccccccccccEEEEEEEcCCCcEEEEEEecccc-------ChHHHHHHHHHhc--CCCCceEEEEEEEe-----CCeE
Q psy11767 381 DKAGILGDGSYSVCRRCVEKSTGQEYAVKIISRKI-------DCSEEINLLRACQ--GHPNIVNLHCVFQD-----EVHT 446 (966)
Q Consensus 381 ~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~-------~~~~Ei~iL~~l~--~HpnIV~l~~~~~~-----~~~~ 446 (966)
+..+.||+|+||+||+|.++.+|+.||+|++.... ...+|+.+++.+. +||||+++++++.+ ....
T Consensus 3 ~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~ni~~~~~~~~~~~~~~~~~~ 82 (288)
T cd07863 3 EPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVRLMDVCATSRTDRETKV 82 (288)
T ss_pred eEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCcCCCCCchHHHHHHHHHHHhhhcCCCCeeeeeeeeccccCCCCceE
Confidence 34678999999999999999999999999986431 2346888877664 69999999999864 3458
Q ss_pred EEEEEccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCcEEEecCCCCCEEEEeeccccccc
Q psy11767 447 YLVLELLKGGELLDRIRQKGRCGFTENEASRIMRQLVAAVHFMHSRGVVHRDLKPENLLFSDPAGDNIKVVDFGFACLKR 526 (966)
Q Consensus 447 ~lVmEy~~gg~L~~~l~~~~~~~l~e~~~~~i~~Qil~aL~yLHs~~IiHRDLKP~NILl~~~~~~~iKL~DFGla~~~~ 526 (966)
++||||+. ++|.+++.......+++.+++.++.||+.||+|||++||+||||||+|||+++ ++.+||+|||++....
T Consensus 83 ~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dikp~Nili~~--~~~~kl~dfg~~~~~~ 159 (288)
T cd07863 83 TLVFEHVD-QDLRTYLDKVPPPGLPAETIKDLMRQFLRGLDFLHANCIVHRDLKPENILVTS--GGQVKLADFGLARIYS 159 (288)
T ss_pred EEEEcccc-cCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECC--CCCEEECccCcccccc
Confidence 99999997 58999887765556999999999999999999999999999999999999975 5689999999997654
Q ss_pred CC--CccccccccccCchhhccCCCCCCCcccchhhhhhhhhhhhcCCCCCCCcCcchhHHHHHHHHhcCCCCCCCCCCc
Q psy11767 527 ES--LHTPCFTLQYAAPEVLRQDKSGYDENCDLWSLGVILVNVLRQDKSGYDENCDLWSLGVILYTMLCGRVPFHARSRD 604 (966)
Q Consensus 527 ~~--~~~~~gT~~Y~APEvl~~~~~~~~~~~Di~SlGvil~el~~~~~~~y~~~~DIWSlGvilyemltG~~Pf~~~~~~ 604 (966)
.. .....+|+.|+|||++.. ..|+.++||||+||++|+|++|++||.+....
T Consensus 160 ~~~~~~~~~~~~~y~aPE~~~~--------------------------~~~~~~~DiwslG~~l~~l~~g~~~f~~~~~~ 213 (288)
T cd07863 160 CQMALTPVVVTLWYRAPEVLLQ--------------------------STYATPVDMWSVGCIFAEMFRRKPLFCGNSEA 213 (288)
T ss_pred CcccCCCccccccccCchHhhC--------------------------CCCCCcchhhhHHHHHHHHHhCCcCcCCCCHH
Confidence 22 233467899999998852 23688999999999999999999999876543
Q ss_pred hhHHHHHHHHHc--------------CCCC-----CCchhhccCCHHHHHHHHHhcccCccccCChHHH
Q psy11767 605 DSALSIMARIKE--------------GQFN-----FDAEAWSTVSSEAKELTKSLLTVNPAQRIRMMRV 654 (966)
Q Consensus 605 ~~~~~~~~~i~~--------------~~~~-----~~~~~~~~is~e~~~Li~~~L~~dP~~R~t~~~v 654 (966)
+....+...+.. ..+. ......+.++.++.+||.+||+.||++|||+.++
T Consensus 214 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~ 282 (288)
T cd07863 214 DQLGKIFDLIGLPPEDDWPRDVTLPRGAFSPRGPRPVQSVVPEIEESGAQLLLEMLTFNPHKRISAFRA 282 (288)
T ss_pred HHHHHHHHHhCCCChhhCcccccccccccCCCCCCchHHhCcCcCHHHHHHHHHHhccCcccCCCHHHH
Confidence 332222221110 0000 0011234578899999999999999999999876
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou |
| >cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-38 Score=352.02 Aligned_cols=250 Identities=24% Similarity=0.415 Sum_probs=199.6
Q ss_pred ccccccccccccccEEEEEEEcCCCcEEEEEEecccc------ChHHHHHHHHHhcCCCCceEEEEEEEeCCeEEEEEEc
Q psy11767 379 DLDKAGILGDGSYSVCRRCVEKSTGQEYAVKIISRKI------DCSEEINLLRACQGHPNIVNLHCVFQDEVHTYLVLEL 452 (966)
Q Consensus 379 ~~~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~------~~~~Ei~iL~~l~~HpnIV~l~~~~~~~~~~~lVmEy 452 (966)
+|+.++.||+|+||.||+|++..+|..||+|++.... ...+|+++|+.+ +||||+++++++.+++..++||||
T Consensus 6 ~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~e~ 84 (331)
T cd06649 6 DFERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHEC-NSPYIVGFYGAFYSDGEISICMEH 84 (331)
T ss_pred cceEEEeecCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHC-CCCCCCeEEEEEEECCEEEEEeec
Confidence 3445788999999999999999999999999986542 245799999998 599999999999999999999999
Q ss_pred cCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhc-CceeccCCCCcEEEecCCCCCEEEEeecccccccC-CCc
Q psy11767 453 LKGGELLDRIRQKGRCGFTENEASRIMRQLVAAVHFMHSR-GVVHRDLKPENLLFSDPAGDNIKVVDFGFACLKRE-SLH 530 (966)
Q Consensus 453 ~~gg~L~~~l~~~~~~~l~e~~~~~i~~Qil~aL~yLHs~-~IiHRDLKP~NILl~~~~~~~iKL~DFGla~~~~~-~~~ 530 (966)
++||+|.+++.... .+++..+..++.|++.||.|||++ +|+||||||+|||++. ++.+||+|||++..... ...
T Consensus 85 ~~~~~L~~~l~~~~--~~~~~~~~~~~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~--~~~~kl~Dfg~~~~~~~~~~~ 160 (331)
T cd06649 85 MDGGSLDQVLKEAK--RIPEEILGKVSIAVLRGLAYLREKHQIMHRDVKPSNILVNS--RGEIKLCDFGVSGQLIDSMAN 160 (331)
T ss_pred CCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHhhcCCEEcCCCChhhEEEcC--CCcEEEccCcccccccccccc
Confidence 99999999997654 589999999999999999999986 6999999999999975 56899999999865433 234
Q ss_pred cccccccccCchhhccCCCCCCCcccchhhhhhhhhhhhcCCCCCCCcCcchhHHHHHHHHhcCCCCCCCCCCchhHHHH
Q psy11767 531 TPCFTLQYAAPEVLRQDKSGYDENCDLWSLGVILVNVLRQDKSGYDENCDLWSLGVILYTMLCGRVPFHARSRDDSALSI 610 (966)
Q Consensus 531 ~~~gT~~Y~APEvl~~~~~~~~~~~Di~SlGvil~el~~~~~~~y~~~~DIWSlGvilyemltG~~Pf~~~~~~~~~~~~ 610 (966)
...+|+.|+|||++.. ..|+.++|||||||++|+|++|+.||......+. ..+
T Consensus 161 ~~~g~~~y~aPE~~~~--------------------------~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~-~~~ 213 (331)
T cd06649 161 SFVGTRSYMSPERLQG--------------------------THYSVQSDIWSMGLSLVELAIGRYPIPPPDAKEL-EAI 213 (331)
T ss_pred cCCCCcCcCCHhHhcC--------------------------CCCCchHhHHHHHHHHHHHHhCCCCCCCCCHHHH-HHH
Confidence 4578999999998852 2367889999999999999999999975443211 011
Q ss_pred H-------------------------------------------HHHHcCCCCCCchhhccCCHHHHHHHHHhcccCccc
Q psy11767 611 M-------------------------------------------ARIKEGQFNFDAEAWSTVSSEAKELTKSLLTVNPAQ 647 (966)
Q Consensus 611 ~-------------------------------------------~~i~~~~~~~~~~~~~~is~e~~~Li~~~L~~dP~~ 647 (966)
+ ..+..... +......+++++++||.+||+.||++
T Consensus 214 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~l~~li~~~L~~~P~~ 291 (331)
T cd06649 214 FGRPVVDGEEGEPHSISPRPRPPGRPVSGHGMDSRPAMAIFELLDYIVNEPP--PKLPNGVFTPDFQEFVNKCLIKNPAE 291 (331)
T ss_pred hcccccccccCCccccCcccccccccccccccccccchhHHHHHHHHHhCCC--cCCCCccccHHHHHHHHHHccCCccc
Confidence 0 01111000 00011246889999999999999999
Q ss_pred cCChHHHHHHhhhhHHh
Q psy11767 648 RIRMMRVKLTFHAFHQA 664 (966)
Q Consensus 648 R~t~~~v~~~~~~~~~~ 664 (966)
|||+.++ ..|+|...
T Consensus 292 Rpt~~el--l~h~~~~~ 306 (331)
T cd06649 292 RADLKML--MNHTFIKR 306 (331)
T ss_pred CCCHHHH--hcChHHhh
Confidence 9999976 45777653
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst |
| >KOG0696|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-39 Score=349.15 Aligned_cols=247 Identities=32% Similarity=0.554 Sum_probs=210.2
Q ss_pred ccccccccccccccEEEEEEEcCCCcEEEEEEeccccC--------hHHHHHHHHHhcCCCCceEEEEEEEeCCeEEEEE
Q psy11767 379 DLDKAGILGDGSYSVCRRCVEKSTGQEYAVKIISRKID--------CSEEINLLRACQGHPNIVNLHCVFQDEVHTYLVL 450 (966)
Q Consensus 379 ~~~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~~--------~~~Ei~iL~~l~~HpnIV~l~~~~~~~~~~~lVm 450 (966)
||.-+.+||+|+||+|.+|..+.|.+.||||++++..- ...|-++|.....-|.+|+|+.+|++-+.+|+||
T Consensus 350 DFnFl~VlGKGSFGKVlLaerkgtdELyAiKiLkKDViiQdDDvectm~EKrvLAL~~kppFL~qlHScFQTmDRLyFVM 429 (683)
T KOG0696|consen 350 DFNFLMVLGKGSFGKVLLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLVQLHSCFQTMDRLYFVM 429 (683)
T ss_pred ccceEEEeccCccceeeeecccCcchhhhhhhhccceeeecCcccceehhhhheecCCCCchHHHHHHHhhhhhheeeEE
Confidence 56668899999999999999999999999999976531 2346677765556789999999999999999999
Q ss_pred EccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCcEEEecCCCCCEEEEeecccccc---cC
Q psy11767 451 ELLKGGELLDRIRQKGRCGFTENEASRIMRQLVAAVHFMHSRGVVHRDLKPENLLFSDPAGDNIKVVDFGFACLK---RE 527 (966)
Q Consensus 451 Ey~~gg~L~~~l~~~~~~~l~e~~~~~i~~Qil~aL~yLHs~~IiHRDLKP~NILl~~~~~~~iKL~DFGla~~~---~~ 527 (966)
||+.||+|..+|++.+ .|.|..+..|+.+|+-||-|||++|||.||||.+||||+. .|++||+|||+++.. ..
T Consensus 430 EyvnGGDLMyhiQQ~G--kFKEp~AvFYAaEiaigLFFLh~kgIiYRDLKLDNvmLd~--eGHiKi~DFGmcKEni~~~~ 505 (683)
T KOG0696|consen 430 EYVNGGDLMYHIQQVG--KFKEPVAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVMLDS--EGHIKIADFGMCKENIFDGV 505 (683)
T ss_pred EEecCchhhhHHHHhc--ccCCchhhhhhHHHHHHhhhhhcCCeeeeeccccceEecc--CCceEeeecccccccccCCc
Confidence 9999999999999887 5999999999999999999999999999999999999984 679999999999753 23
Q ss_pred CCccccccccccCchhhccCCCCCCCcccchhhhhhhhhhhhcCCCCCCCcCcchhHHHHHHHHhcCCCCCCCCCCchhH
Q psy11767 528 SLHTPCFTLQYAAPEVLRQDKSGYDENCDLWSLGVILVNVLRQDKSGYDENCDLWSLGVILYTMLCGRVPFHARSRDDSA 607 (966)
Q Consensus 528 ~~~~~~gT~~Y~APEvl~~~~~~~~~~~Di~SlGvil~el~~~~~~~y~~~~DIWSlGvilyemltG~~Pf~~~~~~~~~ 607 (966)
...+.||||.|+|||++..+ +|+.++|+||+||+|||||.|++||++.+.+
T Consensus 506 TTkTFCGTPdYiAPEIi~Yq--------------------------PYgksvDWWa~GVLLyEmlaGQpPFdGeDE~--- 556 (683)
T KOG0696|consen 506 TTKTFCGTPDYIAPEIIAYQ--------------------------PYGKSVDWWAFGVLLYEMLAGQPPFDGEDED--- 556 (683)
T ss_pred ceeeecCCCcccccceEEec--------------------------ccccchhHHHHHHHHHHHHcCCCCCCCCCHH---
Confidence 45688999999999999743 4888999999999999999999999998765
Q ss_pred HHHHHHHHcCCCCCCchhhccCCHHHHHHHHHhcccCccccCChH---HHHHHhhhhHH
Q psy11767 608 LSIMARIKEGQFNFDAEAWSTVSSEAKELTKSLLTVNPAQRIRMM---RVKLTFHAFHQ 663 (966)
Q Consensus 608 ~~~~~~i~~~~~~~~~~~~~~is~e~~~Li~~~L~~dP~~R~t~~---~v~~~~~~~~~ 663 (966)
+++..|.+....++ ..+|.|+.++.+.+|..+|.+|+... +-....|+|++
T Consensus 557 -elF~aI~ehnvsyP----KslSkEAv~ickg~ltK~P~kRLGcg~~ge~di~~H~FFR 610 (683)
T KOG0696|consen 557 -ELFQAIMEHNVSYP----KSLSKEAVAICKGLLTKHPGKRLGCGPEGERDIREHPFFR 610 (683)
T ss_pred -HHHHHHHHccCcCc----ccccHHHHHHHHHHhhcCCccccCCCCccccchhhCcchh
Confidence 45566666665554 46899999999999999999998653 22345677764
|
|
| >cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-37 Score=350.44 Aligned_cols=251 Identities=31% Similarity=0.489 Sum_probs=196.0
Q ss_pred cccccccccccccEEEEEEEcCCCcEEEEEEecccc--------ChHHHHHHHHHhcCCCCceEEEEEEEeCCeEEEEEE
Q psy11767 380 LDKAGILGDGSYSVCRRCVEKSTGQEYAVKIISRKI--------DCSEEINLLRACQGHPNIVNLHCVFQDEVHTYLVLE 451 (966)
Q Consensus 380 ~~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~--------~~~~Ei~iL~~l~~HpnIV~l~~~~~~~~~~~lVmE 451 (966)
|+..+.||+|+||.||+|++..+++.||||++.+.. ...+|+.++..+ +|+||++++++++++++.|+|||
T Consensus 3 y~i~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~-~~~~i~~l~~~~~~~~~~~lv~E 81 (331)
T cd05624 3 FEIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVNG-DCQWITTLHYAFQDENYLYLVMD 81 (331)
T ss_pred ceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHHHhhHHHHHHHHHHHHHHhC-CCCCEeeEEEEEEcCCEEEEEEe
Confidence 344688999999999999999999999999986421 133567777766 69999999999999999999999
Q ss_pred ccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCcEEEecCCCCCEEEEeecccccccCC---
Q psy11767 452 LLKGGELLDRIRQKGRCGFTENEASRIMRQLVAAVHFMHSRGVVHRDLKPENLLFSDPAGDNIKVVDFGFACLKRES--- 528 (966)
Q Consensus 452 y~~gg~L~~~l~~~~~~~l~e~~~~~i~~Qil~aL~yLHs~~IiHRDLKP~NILl~~~~~~~iKL~DFGla~~~~~~--- 528 (966)
|++||+|.+++.+... .+++..++.++.||+.||+|||++||+||||||+|||++. .+.+||+|||++......
T Consensus 82 y~~gg~L~~~l~~~~~-~l~~~~~~~~~~qi~~~L~~lH~~~iiHrDlkp~Nill~~--~~~~kl~DfG~a~~~~~~~~~ 158 (331)
T cd05624 82 YYVGGDLLTLLSKFED-RLPEDMARFYIAEMVLAIHSIHQLHYVHRDIKPDNVLLDM--NGHIRLADFGSCLKMNQDGTV 158 (331)
T ss_pred CCCCCcHHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCCeeeccCchHHEEEcC--CCCEEEEeccceeeccCCCce
Confidence 9999999999976432 5899999999999999999999999999999999999974 568999999998654322
Q ss_pred -CccccccccccCchhhccCCCCCCCcccchhhhhhhhhhhhcCCCCCCCcCcchhHHHHHHHHhcCCCCCCCCCCchhH
Q psy11767 529 -LHTPCFTLQYAAPEVLRQDKSGYDENCDLWSLGVILVNVLRQDKSGYDENCDLWSLGVILYTMLCGRVPFHARSRDDSA 607 (966)
Q Consensus 529 -~~~~~gT~~Y~APEvl~~~~~~~~~~~Di~SlGvil~el~~~~~~~y~~~~DIWSlGvilyemltG~~Pf~~~~~~~~~ 607 (966)
....+||+.|+|||++..... ....|+.++||||+||++|+|++|+.||...+..
T Consensus 159 ~~~~~~gt~~y~aPE~~~~~~~---------------------~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~--- 214 (331)
T cd05624 159 QSSVAVGTPDYISPEILQAMED---------------------GMGKYGPECDWWSLGVCMYEMLYGETPFYAESLV--- 214 (331)
T ss_pred eeccccCCcccCCHHHHhcccc---------------------CCCCCCCcccEEeeehhhhhhhhCCCCccCCCHH---
Confidence 123568999999999853211 1134678899999999999999999999865432
Q ss_pred HHHHHHHHcCC--CCCCchhhccCCHHHHHHHHHhcccCccc--cCChHHHHHHhhhhH
Q psy11767 608 LSIMARIKEGQ--FNFDAEAWSTVSSEAKELTKSLLTVNPAQ--RIRMMRVKLTFHAFH 662 (966)
Q Consensus 608 ~~~~~~i~~~~--~~~~~~~~~~is~e~~~Li~~~L~~dP~~--R~t~~~v~~~~~~~~ 662 (966)
.....+.... +.++ ..+..+++++++||.+||..++++ |+++.++ ..|+|+
T Consensus 215 -~~~~~i~~~~~~~~~p-~~~~~~~~~~~~li~~ll~~~~~~~~~~~~~~~--~~h~~f 269 (331)
T cd05624 215 -ETYGKIMNHEERFQFP-SHITDVSEEAKDLIQRLICSRERRLGQNGIEDF--KKHAFF 269 (331)
T ss_pred -HHHHHHHcCCCcccCC-CccccCCHHHHHHHHHHccCchhhcCCCCHHHH--hcCCCc
Confidence 2334444322 2222 233467999999999999976544 3456544 345554
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. |
| >PHA03212 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-38 Score=362.66 Aligned_cols=249 Identities=22% Similarity=0.351 Sum_probs=194.5
Q ss_pred cccccccccccccEEEEEEEcCCCcEEEEEEeccccChHHHHHHHHHhcCCCCceEEEEEEEeCCeEEEEEEccCCCCHH
Q psy11767 380 LDKAGILGDGSYSVCRRCVEKSTGQEYAVKIISRKIDCSEEINLLRACQGHPNIVNLHCVFQDEVHTYLVLELLKGGELL 459 (966)
Q Consensus 380 ~~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~~~~~Ei~iL~~l~~HpnIV~l~~~~~~~~~~~lVmEy~~gg~L~ 459 (966)
|+.++.||+|+||.||+|++..+++.||||...+ ....+|+.+|+.+ +|||||+++++|..+...|+|||++ +++|.
T Consensus 94 y~~~~~lg~G~~g~V~~~~d~~~~~~vaiK~~~~-~~~~~E~~il~~l-~HpnIv~~~~~~~~~~~~~lv~e~~-~~~L~ 170 (391)
T PHA03212 94 FSILETFTPGAEGFAFACIDNKTCEHVVIKAGQR-GGTATEAHILRAI-NHPSIIQLKGTFTYNKFTCLILPRY-KTDLY 170 (391)
T ss_pred cEEEEEEcCCCCeEEEEEEECCCCCEEEEechhh-hhhHHHHHHHHhC-CCCCCCCEeEEEEECCeeEEEEecC-CCCHH
Confidence 4447899999999999999999999999998653 3467899999998 5999999999999999999999999 57899
Q ss_pred HHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCcEEEecCCCCCEEEEeecccccccC----CCcccccc
Q psy11767 460 DRIRQKGRCGFTENEASRIMRQLVAAVHFMHSRGVVHRDLKPENLLFSDPAGDNIKVVDFGFACLKRE----SLHTPCFT 535 (966)
Q Consensus 460 ~~l~~~~~~~l~e~~~~~i~~Qil~aL~yLHs~~IiHRDLKP~NILl~~~~~~~iKL~DFGla~~~~~----~~~~~~gT 535 (966)
.++.... .+++.+++.++.||+.||+|||++||+||||||+|||++. .+.+||+|||+|+.... .....+||
T Consensus 171 ~~l~~~~--~l~~~~~~~i~~qi~~aL~ylH~~~IvHrDiKP~NIll~~--~~~vkL~DFG~a~~~~~~~~~~~~~~~gt 246 (391)
T PHA03212 171 CYLAAKR--NIAICDILAIERSVLRAIQYLHENRIIHRDIKAENIFINH--PGDVCLGDFGAACFPVDINANKYYGWAGT 246 (391)
T ss_pred HHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChHhEEEcC--CCCEEEEeCCcccccccccccccccccCc
Confidence 9887654 5899999999999999999999999999999999999975 56899999999965322 22345789
Q ss_pred ccccCchhhccCCCCCCCcccchhhhhhhhhhhhcCCCCCCCcCcchhHHHHHHHHhcCCCCCCCCCCc------h-hHH
Q psy11767 536 LQYAAPEVLRQDKSGYDENCDLWSLGVILVNVLRQDKSGYDENCDLWSLGVILYTMLCGRVPFHARSRD------D-SAL 608 (966)
Q Consensus 536 ~~Y~APEvl~~~~~~~~~~~Di~SlGvil~el~~~~~~~y~~~~DIWSlGvilyemltG~~Pf~~~~~~------~-~~~ 608 (966)
+.|+|||++.. ..|+.++|||||||++|+|++|+.||...... . ...
T Consensus 247 ~~y~aPE~~~~--------------------------~~~~~~~DiwSlGvil~elltg~~p~~~~~~~~~~~~~~~~l~ 300 (391)
T PHA03212 247 IATNAPELLAR--------------------------DPYGPAVDIWSAGIVLFEMATCHDSLFEKDGLDGDCDSDRQIK 300 (391)
T ss_pred cCCCChhhhcC--------------------------CCCCcHHHHHHHHHHHHHHHHCCCCcCCcccccccCchhHHHH
Confidence 99999998852 24788999999999999999999887643211 0 001
Q ss_pred HHHHHHH----------------------cCCCC--CCchhh---ccCCHHHHHHHHHhcccCccccCChHHHHHHhhhh
Q psy11767 609 SIMARIK----------------------EGQFN--FDAEAW---STVSSEAKELTKSLLTVNPAQRIRMMRVKLTFHAF 661 (966)
Q Consensus 609 ~~~~~i~----------------------~~~~~--~~~~~~---~~is~e~~~Li~~~L~~dP~~R~t~~~v~~~~~~~ 661 (966)
.++.... ..... .....| ..++.++.+||.+||+.||++|||+.++ ..|+|
T Consensus 301 ~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~mL~~dP~~Rpta~el--L~hp~ 378 (391)
T PHA03212 301 LIIRRSGTHPNEFPIDAQANLDEIYIGLAKKSSRKPGSRPLWTNLYELPIDLEYLICKMLAFDAHHRPSAEAL--LDFAA 378 (391)
T ss_pred HHHHHhcCChhhcCcchhHHHHHHHHHHHhccCCCCCCCCCHHHHhhhhhhHHHHHHHHhcCChhhCCCHHHH--hcChh
Confidence 1111100 00000 000111 2356789999999999999999999976 34666
Q ss_pred HH
Q psy11767 662 HQ 663 (966)
Q Consensus 662 ~~ 663 (966)
++
T Consensus 379 f~ 380 (391)
T PHA03212 379 FQ 380 (391)
T ss_pred hc
Confidence 53
|
|
| >KOG0986|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-39 Score=353.68 Aligned_cols=247 Identities=32% Similarity=0.531 Sum_probs=207.8
Q ss_pred cccccccccEEEEEEEcCCCcEEEEEEecccc--------ChHHHHHHHHHhcCCCCceEEEEEEEeCCeEEEEEEccCC
Q psy11767 384 GILGDGSYSVCRRCVEKSTGQEYAVKIISRKI--------DCSEEINLLRACQGHPNIVNLHCVFQDEVHTYLVLELLKG 455 (966)
Q Consensus 384 ~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~--------~~~~Ei~iL~~l~~HpnIV~l~~~~~~~~~~~lVmEy~~g 455 (966)
++||+||||.|+-|+-+.||+.||+|.+.++. .+..|-.+|..+ +-+.||.|-.+|++.+.+||||..|.|
T Consensus 191 RvlGkGGFGEV~acqvraTGKMYAcKkL~KKRiKkr~ge~maLnEk~iL~kV-~s~FiVslaYAfeTkd~LClVLtlMNG 269 (591)
T KOG0986|consen 191 RVLGKGGFGEVCACQVRATGKMYACKKLDKKRIKKRKGETMALNEKQILEKV-SSPFIVSLAYAFETKDALCLVLTLMNG 269 (591)
T ss_pred EEEecccccceeEEEEecchhhHHHHHHHHHHHHHhhhhHHhhHHHHHHHHh-ccCcEEEEeeeecCCCceEEEEEeecC
Confidence 56999999999999999999999999886542 245688888887 589999999999999999999999999
Q ss_pred CCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCcEEEecCCCCCEEEEeecccccccC--CCcccc
Q psy11767 456 GELLDRIRQKGRCGFTENEASRIMRQLVAAVHFMHSRGVVHRDLKPENLLFSDPAGDNIKVVDFGFACLKRE--SLHTPC 533 (966)
Q Consensus 456 g~L~~~l~~~~~~~l~e~~~~~i~~Qil~aL~yLHs~~IiHRDLKP~NILl~~~~~~~iKL~DFGla~~~~~--~~~~~~ 533 (966)
|||.-+|.+.+..+|++..+++|+.||+.||++||..+||.|||||+|||||+ .|++.|+|.|||+...+ .....+
T Consensus 270 GDLkfHiyn~g~~gF~e~ra~FYAAEi~cGLehlH~~~iVYRDLKPeNILLDd--~GhvRISDLGLAvei~~g~~~~~rv 347 (591)
T KOG0986|consen 270 GDLKFHIYNHGNPGFDEQRARFYAAEIICGLEHLHRRRIVYRDLKPENILLDD--HGHVRISDLGLAVEIPEGKPIRGRV 347 (591)
T ss_pred CceeEEeeccCCCCCchHHHHHHHHHHHhhHHHHHhcceeeccCChhheeecc--CCCeEeeccceEEecCCCCcccccc
Confidence 99999999988888999999999999999999999999999999999999986 67999999999987653 445568
Q ss_pred ccccccCchhhccCCCCCCCcccchhhhhhhhhhhhcCCCCCCCcCcchhHHHHHHHHhcCCCCCCCCCCchhHHHHHHH
Q psy11767 534 FTLQYAAPEVLRQDKSGYDENCDLWSLGVILVNVLRQDKSGYDENCDLWSLGVILYTMLCGRVPFHARSRDDSALSIMAR 613 (966)
Q Consensus 534 gT~~Y~APEvl~~~~~~~~~~~Di~SlGvil~el~~~~~~~y~~~~DIWSlGvilyemltG~~Pf~~~~~~~~~~~~~~~ 613 (966)
||.+|||||++..+ .|+.++|+|||||+||||+.|+.||...-......++-.+
T Consensus 348 GT~GYMAPEvl~ne--------------------------~Y~~s~Dwf~lGCllYemi~G~sPFr~~KeKvk~eEvdrr 401 (591)
T KOG0986|consen 348 GTVGYMAPEVLQNE--------------------------VYDFSPDWFSLGCLLYEMIAGHSPFRQRKEKVKREEVDRR 401 (591)
T ss_pred CcccccCHHHHcCC--------------------------cccCCccHHHHHhHHHHHHcccCchhhhhhhhhHHHHHHH
Confidence 99999999999643 3888999999999999999999999866544333344444
Q ss_pred HHcCCCCCCchhhccCCHHHHHHHHHhcccCccccCChHH---HHHHhhhhHH
Q psy11767 614 IKEGQFNFDAEAWSTVSSEAKELTKSLLTVNPAQRIRMMR---VKLTFHAFHQ 663 (966)
Q Consensus 614 i~~~~~~~~~~~~~~is~e~~~Li~~~L~~dP~~R~t~~~---v~~~~~~~~~ 663 (966)
+.+....+ ....|+++++|.+.+|+.||++|+.... -....|||++
T Consensus 402 ~~~~~~ey----~~kFS~eakslc~~LL~Kdp~~RLGcrg~ga~evk~HpfFk 450 (591)
T KOG0986|consen 402 TLEDPEEY----SDKFSEEAKSLCEGLLTKDPEKRLGCRGEGAQEVKEHPFFK 450 (591)
T ss_pred Hhcchhhc----ccccCHHHHHHHHHHHccCHHHhccCCCcCcchhhhCcccc
Confidence 55443333 3568999999999999999999986541 1234567654
|
|
| >PLN00034 mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-38 Score=356.77 Aligned_cols=247 Identities=30% Similarity=0.516 Sum_probs=194.9
Q ss_pred cccccccccccccEEEEEEEcCCCcEEEEEEecccc------ChHHHHHHHHHhcCCCCceEEEEEEEeCCeEEEEEEcc
Q psy11767 380 LDKAGILGDGSYSVCRRCVEKSTGQEYAVKIISRKI------DCSEEINLLRACQGHPNIVNLHCVFQDEVHTYLVLELL 453 (966)
Q Consensus 380 ~~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~------~~~~Ei~iL~~l~~HpnIV~l~~~~~~~~~~~lVmEy~ 453 (966)
++.++.||+|+||.||+|.+..+|+.||||++.... ...+|+++|+.+ +|+||+++++++.+++..|+|||||
T Consensus 76 ~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~e~~ 154 (353)
T PLN00034 76 LERVNRIGSGAGGTVYKVIHRPTGRLYALKVIYGNHEDTVRRQICREIEILRDV-NHPNVVKCHDMFDHNGEIQVLLEFM 154 (353)
T ss_pred HhhhhhccCCCCeEEEEEEECCCCCEEEEEEEecCCcHHHHHHHHHHHHHHHhC-CCCCcceeeeEeccCCeEEEEEecC
Confidence 345688999999999999999999999999986432 245799999988 5999999999999999999999999
Q ss_pred CCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCcEEEecCCCCCEEEEeecccccccCC---Cc
Q psy11767 454 KGGELLDRIRQKGRCGFTENEASRIMRQLVAAVHFMHSRGVVHRDLKPENLLFSDPAGDNIKVVDFGFACLKRES---LH 530 (966)
Q Consensus 454 ~gg~L~~~l~~~~~~~l~e~~~~~i~~Qil~aL~yLHs~~IiHRDLKP~NILl~~~~~~~iKL~DFGla~~~~~~---~~ 530 (966)
++|+|.+. ..+++..+..++.||+.||+|||++||+||||||+|||+++ ++.+||+|||++...... ..
T Consensus 155 ~~~~L~~~------~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~--~~~~kL~DfG~~~~~~~~~~~~~ 226 (353)
T PLN00034 155 DGGSLEGT------HIADEQFLADVARQILSGIAYLHRRHIVHRDIKPSNLLINS--AKNVKIADFGVSRILAQTMDPCN 226 (353)
T ss_pred CCCccccc------ccCCHHHHHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEcC--CCCEEEcccccceeccccccccc
Confidence 99998643 13678889999999999999999999999999999999975 568999999999765432 23
Q ss_pred cccccccccCchhhccCCCCCCCcccchhhhhhhhhhhhcCCCCCCCcCcchhHHHHHHHHhcCCCCCCCCCCchhHHHH
Q psy11767 531 TPCFTLQYAAPEVLRQDKSGYDENCDLWSLGVILVNVLRQDKSGYDENCDLWSLGVILYTMLCGRVPFHARSRDDSALSI 610 (966)
Q Consensus 531 ~~~gT~~Y~APEvl~~~~~~~~~~~Di~SlGvil~el~~~~~~~y~~~~DIWSlGvilyemltG~~Pf~~~~~~~~~~~~ 610 (966)
...||+.|+|||++..... ....++.++|||||||++|+|++|+.||......+. ...
T Consensus 227 ~~~gt~~y~aPE~~~~~~~---------------------~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~-~~~ 284 (353)
T PLN00034 227 SSVGTIAYMSPERINTDLN---------------------HGAYDGYAGDIWSLGVSILEFYLGRFPFGVGRQGDW-ASL 284 (353)
T ss_pred ccccCccccCccccccccc---------------------cCcCCCcchhHHHHHHHHHHHHhCCCCCCCCCCccH-HHH
Confidence 4578999999998743210 112245689999999999999999999984433222 222
Q ss_pred HHHHHcCCCCCCchhhccCCHHHHHHHHHhcccCccccCChHHHHHHhhhhH
Q psy11767 611 MARIKEGQFNFDAEAWSTVSSEAKELTKSLLTVNPAQRIRMMRVKLTFHAFH 662 (966)
Q Consensus 611 ~~~i~~~~~~~~~~~~~~is~e~~~Li~~~L~~dP~~R~t~~~v~~~~~~~~ 662 (966)
...+.... .......++.++++||.+||..||++||++.++ ..|+|.
T Consensus 285 ~~~~~~~~---~~~~~~~~~~~l~~li~~~l~~~P~~Rpt~~el--l~hp~~ 331 (353)
T PLN00034 285 MCAICMSQ---PPEAPATASREFRHFISCCLQREPAKRWSAMQL--LQHPFI 331 (353)
T ss_pred HHHHhccC---CCCCCCccCHHHHHHHHHHccCChhhCcCHHHH--hcCccc
Confidence 22232221 122334678999999999999999999999876 345554
|
|
| >PHA02988 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-37 Score=343.60 Aligned_cols=245 Identities=15% Similarity=0.198 Sum_probs=197.9
Q ss_pred ccccccccccccccEEEEEEEcCCCcEEEEEEecccc--------ChHHHHHHHHHhcCCCCceEEEEEEEe----CCeE
Q psy11767 379 DLDKAGILGDGSYSVCRRCVEKSTGQEYAVKIISRKI--------DCSEEINLLRACQGHPNIVNLHCVFQD----EVHT 446 (966)
Q Consensus 379 ~~~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~--------~~~~Ei~iL~~l~~HpnIV~l~~~~~~----~~~~ 446 (966)
+......||+|++|.||+|.. +|+.||||.+.... ...+|+.+|+.+ .|||||++++++.+ ....
T Consensus 21 ~~~~~~~i~~g~~~~v~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~nIv~~~g~~~~~~~~~~~~ 97 (283)
T PHA02988 21 DKYTSVLIKENDQNSIYKGIF--NNKEVIIRTFKKFHKGHKVLIDITENEIKNLRRI-DSNNILKIYGFIIDIVDDLPRL 97 (283)
T ss_pred CCCCCeEEeeCCceEEEEEEE--CCEEEEEEeccccccccHHHHHHHHHHHHHHHhc-CCCCEEEEeeeEEecccCCCce
Confidence 333446799999999999987 68999999986532 133799999998 59999999999877 3578
Q ss_pred EEEEEccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhc-CceeccCCCCcEEEecCCCCCEEEEeecccccc
Q psy11767 447 YLVLELLKGGELLDRIRQKGRCGFTENEASRIMRQLVAAVHFMHSR-GVVHRDLKPENLLFSDPAGDNIKVVDFGFACLK 525 (966)
Q Consensus 447 ~lVmEy~~gg~L~~~l~~~~~~~l~e~~~~~i~~Qil~aL~yLHs~-~IiHRDLKP~NILl~~~~~~~iKL~DFGla~~~ 525 (966)
++|||||+||+|.+++.+.. .+++.....++.|++.||.|||+. +++||||||+|||+++ ++.+||+|||++...
T Consensus 98 ~lv~Ey~~~g~L~~~l~~~~--~~~~~~~~~i~~~i~~~l~~lH~~~~~~Hrdlkp~nill~~--~~~~kl~dfg~~~~~ 173 (283)
T PHA02988 98 SLILEYCTRGYLREVLDKEK--DLSFKTKLDMAIDCCKGLYNLYKYTNKPYKNLTSVSFLVTE--NYKLKIICHGLEKIL 173 (283)
T ss_pred EEEEEeCCCCcHHHHHhhCC--CCChhHHHHHHHHHHHHHHHHHhcCCCCCCcCChhhEEECC--CCcEEEcccchHhhh
Confidence 99999999999999997754 589999999999999999999984 9999999999999985 568999999999765
Q ss_pred cCCCccccccccccCchhhccCCCCCCCcccchhhhhhhhhhhhcCCCCCCCcCcchhHHHHHHHHhcCCCCCCCCCCch
Q psy11767 526 RESLHTPCFTLQYAAPEVLRQDKSGYDENCDLWSLGVILVNVLRQDKSGYDENCDLWSLGVILYTMLCGRVPFHARSRDD 605 (966)
Q Consensus 526 ~~~~~~~~gT~~Y~APEvl~~~~~~~~~~~Di~SlGvil~el~~~~~~~y~~~~DIWSlGvilyemltG~~Pf~~~~~~~ 605 (966)
........+|+.|+|||++... ...|+.++|||||||++|||++|+.||.+.+..
T Consensus 174 ~~~~~~~~~~~~y~aPE~~~~~------------------------~~~~~~k~Di~SlGvil~el~~g~~Pf~~~~~~- 228 (283)
T PHA02988 174 SSPPFKNVNFMVYFSYKMLNDI------------------------FSEYTIKDDIYSLGVVLWEIFTGKIPFENLTTK- 228 (283)
T ss_pred ccccccccCcccccCHHHhhhc------------------------cccccchhhhhHHHHHHHHHHHCCCCCCCCCHH-
Confidence 5444456789999999988521 134788999999999999999999999875432
Q ss_pred hHHHHHHHHHcCCCCCCchhhccCCHHHHHHHHHhcccCccccCChHHHHHHhhh
Q psy11767 606 SALSIMARIKEGQFNFDAEAWSTVSSEAKELTKSLLTVNPAQRIRMMRVKLTFHA 660 (966)
Q Consensus 606 ~~~~~~~~i~~~~~~~~~~~~~~is~e~~~Li~~~L~~dP~~R~t~~~v~~~~~~ 660 (966)
.+...+..+...+. .....++++++|+.+||+.||++|||+.++...++.
T Consensus 229 ---~~~~~i~~~~~~~~--~~~~~~~~l~~li~~cl~~dp~~Rps~~ell~~l~~ 278 (283)
T PHA02988 229 ---EIYDLIINKNNSLK--LPLDCPLEIKCIVEACTSHDSIKRPNIKEILYNLSL 278 (283)
T ss_pred ---HHHHHHHhcCCCCC--CCCcCcHHHHHHHHHHhcCCcccCcCHHHHHHHHHH
Confidence 23334433322222 112578999999999999999999999998655544
|
|
| >cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-37 Score=346.38 Aligned_cols=252 Identities=29% Similarity=0.457 Sum_probs=198.8
Q ss_pred ccccccccccccEEEEEEEcCCCcEEEEEEecccc------ChHHHHHHHHHhcCCCCceEEEEEEEeCCeEEEEEEccC
Q psy11767 381 DKAGILGDGSYSVCRRCVEKSTGQEYAVKIISRKI------DCSEEINLLRACQGHPNIVNLHCVFQDEVHTYLVLELLK 454 (966)
Q Consensus 381 ~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~------~~~~Ei~iL~~l~~HpnIV~l~~~~~~~~~~~lVmEy~~ 454 (966)
...+.||+|+||.||+|++..+++.||||.+.... ...+|+.+|+.+ +||||+++++++.++...|+||||++
T Consensus 9 ~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~e~~~ 87 (309)
T cd07872 9 IKLEKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKDL-KHANIVTLHDIVHTDKSLTLVFEYLD 87 (309)
T ss_pred EEEEEecccCCEEEEEEEecCCCCeEEEEEeeccccCCcchhHHHHHHHHHhC-CCCCcceEEEEEeeCCeEEEEEeCCC
Confidence 34688999999999999999999999999986432 245799999988 59999999999999999999999996
Q ss_pred CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCcEEEecCCCCCEEEEeecccccccCC---Ccc
Q psy11767 455 GGELLDRIRQKGRCGFTENEASRIMRQLVAAVHFMHSRGVVHRDLKPENLLFSDPAGDNIKVVDFGFACLKRES---LHT 531 (966)
Q Consensus 455 gg~L~~~l~~~~~~~l~e~~~~~i~~Qil~aL~yLHs~~IiHRDLKP~NILl~~~~~~~iKL~DFGla~~~~~~---~~~ 531 (966)
++|.+++...+. .+++..++.++.||+.||+|||++||+||||||+|||++. .+.+||+|||++...... ...
T Consensus 88 -~~l~~~~~~~~~-~~~~~~~~~~~~qi~~aL~~lH~~~ivH~dlkp~Nill~~--~~~~kl~Dfg~~~~~~~~~~~~~~ 163 (309)
T cd07872 88 -KDLKQYMDDCGN-IMSMHNVKIFLYQILRGLAYCHRRKVLHRDLKPQNLLINE--RGELKLADFGLARAKSVPTKTYSN 163 (309)
T ss_pred -CCHHHHHHhcCC-CCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECC--CCCEEECccccceecCCCcccccc
Confidence 588888876543 5899999999999999999999999999999999999975 568999999998654321 223
Q ss_pred ccccccccCchhhccCCCCCCCcccchhhhhhhhhhhhcCCCCCCCcCcchhHHHHHHHHhcCCCCCCCCCCchhHHHHH
Q psy11767 532 PCFTLQYAAPEVLRQDKSGYDENCDLWSLGVILVNVLRQDKSGYDENCDLWSLGVILYTMLCGRVPFHARSRDDSALSIM 611 (966)
Q Consensus 532 ~~gT~~Y~APEvl~~~~~~~~~~~Di~SlGvil~el~~~~~~~y~~~~DIWSlGvilyemltG~~Pf~~~~~~~~~~~~~ 611 (966)
..+|+.|+|||++.. ...|+.++|||||||++|+|++|++||.+.+..+....++
T Consensus 164 ~~~~~~y~aPE~~~~-------------------------~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~ 218 (309)
T cd07872 164 EVVTLWYRPPDVLLG-------------------------SSEYSTQIDMWGVGCIFFEMASGRPLFPGSTVEDELHLIF 218 (309)
T ss_pred ccccccccCCHHHhC-------------------------CCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHH
Confidence 467899999998752 1236788999999999999999999998765443322222
Q ss_pred HHHHcC---------------CCCCC-------chhhccCCHHHHHHHHHhcccCccccCChHHHHHHhhhhHHh
Q psy11767 612 ARIKEG---------------QFNFD-------AEAWSTVSSEAKELTKSLLTVNPAQRIRMMRVKLTFHAFHQA 664 (966)
Q Consensus 612 ~~i~~~---------------~~~~~-------~~~~~~is~e~~~Li~~~L~~dP~~R~t~~~v~~~~~~~~~~ 664 (966)
..+... .+.++ ....+.+++++++||.+||..||.+|||+.++ ..|+|++.
T Consensus 219 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~--l~h~~~~~ 291 (309)
T cd07872 219 RLLGTPTEETWPGISSNDEFKNYNFPKYKPQPLINHAPRLDTEGIELLTKFLQYESKKRISAEEA--MKHAYFRS 291 (309)
T ss_pred HHhCCCCHHHHhhhcchhhhhhhhcCccCCCchhhhccCCCHHHHHHHHHhccCChhhCCCHHHH--hcChhhhh
Confidence 211100 00000 01123578999999999999999999999876 45677643
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play |
| >cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-37 Score=347.74 Aligned_cols=252 Identities=29% Similarity=0.473 Sum_probs=197.7
Q ss_pred cccccccccccccEEEEEEEcCCCcEEEEEEecccc--------ChHHHHHHHHHhcCCCCceEEEEEEEeCCeEEEEEE
Q psy11767 380 LDKAGILGDGSYSVCRRCVEKSTGQEYAVKIISRKI--------DCSEEINLLRACQGHPNIVNLHCVFQDEVHTYLVLE 451 (966)
Q Consensus 380 ~~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~--------~~~~Ei~iL~~l~~HpnIV~l~~~~~~~~~~~lVmE 451 (966)
|+..++||+|+||.||++++..+++.||+|++.+.. ...+|+.++..+ +|+||+++++++.++...|+|||
T Consensus 3 y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~-~~~~i~~~~~~~~~~~~~~lv~e 81 (332)
T cd05623 3 FEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNG-DNQWITTLHYAFQDENNLYLVMD 81 (332)
T ss_pred ceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEeHHHHHHhhHHHHHHHHHHHHhhC-CCCCEeeEEEEEecCCEEEEEEe
Confidence 444688999999999999999999999999986421 134577777776 69999999999999999999999
Q ss_pred ccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCcEEEecCCCCCEEEEeecccccccCC---
Q psy11767 452 LLKGGELLDRIRQKGRCGFTENEASRIMRQLVAAVHFMHSRGVVHRDLKPENLLFSDPAGDNIKVVDFGFACLKRES--- 528 (966)
Q Consensus 452 y~~gg~L~~~l~~~~~~~l~e~~~~~i~~Qil~aL~yLHs~~IiHRDLKP~NILl~~~~~~~iKL~DFGla~~~~~~--- 528 (966)
|+++|+|.+++.+... .+++..++.++.||+.||+|||++||+||||||+|||++. ++.+||+|||++......
T Consensus 82 y~~~g~L~~~l~~~~~-~l~~~~~~~~~~qi~~al~~lH~~~iiHrDlkp~Nili~~--~~~~kL~DfG~a~~~~~~~~~ 158 (332)
T cd05623 82 YYVGGDLLTLLSKFED-RLPEDMARFYLAEMVIAIDSVHQLHYVHRDIKPDNILMDM--NGHIRLADFGSCLKLMEDGTV 158 (332)
T ss_pred ccCCCcHHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHEEECC--CCCEEEeecchheecccCCcc
Confidence 9999999999976432 5899999999999999999999999999999999999974 568999999998653221
Q ss_pred -CccccccccccCchhhccCCCCCCCcccchhhhhhhhhhhhcCCCCCCCcCcchhHHHHHHHHhcCCCCCCCCCCchhH
Q psy11767 529 -LHTPCFTLQYAAPEVLRQDKSGYDENCDLWSLGVILVNVLRQDKSGYDENCDLWSLGVILYTMLCGRVPFHARSRDDSA 607 (966)
Q Consensus 529 -~~~~~gT~~Y~APEvl~~~~~~~~~~~Di~SlGvil~el~~~~~~~y~~~~DIWSlGvilyemltG~~Pf~~~~~~~~~ 607 (966)
....+||+.|+|||++.... .+...|+.++|||||||++|+|++|+.||...+..
T Consensus 159 ~~~~~~gt~~y~aPE~~~~~~---------------------~~~~~~~~~~DvwSlGvil~ell~g~~Pf~~~~~~--- 214 (332)
T cd05623 159 QSSVAVGTPDYISPEILQAME---------------------DGKGKYGPECDWWSLGVCMYEMLYGETPFYAESLV--- 214 (332)
T ss_pred eecccccCccccCHHHHhccc---------------------cCCCCCCCcCCEEeeHHHHHHHhcCCCCCCCCCHH---
Confidence 12357899999999985321 11335788999999999999999999999875432
Q ss_pred HHHHHHHHcCCCCCC-chhhccCCHHHHHHHHHhcccCccc--cCChHHHHHHhhhhH
Q psy11767 608 LSIMARIKEGQFNFD-AEAWSTVSSEAKELTKSLLTVNPAQ--RIRMMRVKLTFHAFH 662 (966)
Q Consensus 608 ~~~~~~i~~~~~~~~-~~~~~~is~e~~~Li~~~L~~dP~~--R~t~~~v~~~~~~~~ 662 (966)
..+.++......+. +.....+++++++||.+||..++++ |+++.++ ..|+|+
T Consensus 215 -~~~~~i~~~~~~~~~p~~~~~~s~~~~~li~~ll~~~~~r~~r~~~~~~--~~h~~f 269 (332)
T cd05623 215 -ETYGKIMNHKERFQFPAQVTDVSEDAKDLIRRLICSREHRLGQNGIEDF--KQHPFF 269 (332)
T ss_pred -HHHHHHhCCCccccCCCccccCCHHHHHHHHHHccChhhhcCCCCHHHH--hCCCCc
Confidence 23344443322111 1223468999999999999765544 4677655 456664
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw |
| >cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-37 Score=346.63 Aligned_cols=250 Identities=28% Similarity=0.489 Sum_probs=187.0
Q ss_pred ccccccccccEEEEEEEc--CCCcEEEEEEecccc---ChHHHHHHHHHhcCCCCceEEEEEEEe--CCeEEEEEEccCC
Q psy11767 383 AGILGDGSYSVCRRCVEK--STGQEYAVKIISRKI---DCSEEINLLRACQGHPNIVNLHCVFQD--EVHTYLVLELLKG 455 (966)
Q Consensus 383 ~~~LG~G~fG~Vy~a~~~--~tg~~vAvK~i~~~~---~~~~Ei~iL~~l~~HpnIV~l~~~~~~--~~~~~lVmEy~~g 455 (966)
..+||+|+||+||+|+++ .+++.||+|.+.... ...+|+.+|+.+ +|||||+++++|.. +...|+||||+.
T Consensus 6 ~~~lG~G~~g~Vy~~~~~~~~~~~~~aiK~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~~~lv~e~~~- 83 (317)
T cd07868 6 GCKVGRGTYGHVYKAKRKDGKDDRDYALKQIEGTGISMSACREIALLREL-KHPNVISLQKVFLSHADRKVWLLFDYAE- 83 (317)
T ss_pred ccccccCCCeEEEEEEEccCCCCceEEEEEECCCCCcHHHHHHHHHHHhc-CCCCCcceeeeEecCCCcEEEEEEeccC-
Confidence 468999999999999976 467899999987543 356799999998 59999999999864 456899999984
Q ss_pred CCHHHHHHhcC-------CCCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCcEEEecC--CCCCEEEEeeccccccc
Q psy11767 456 GELLDRIRQKG-------RCGFTENEASRIMRQLVAAVHFMHSRGVVHRDLKPENLLFSDP--AGDNIKVVDFGFACLKR 526 (966)
Q Consensus 456 g~L~~~l~~~~-------~~~l~e~~~~~i~~Qil~aL~yLHs~~IiHRDLKP~NILl~~~--~~~~iKL~DFGla~~~~ 526 (966)
++|.+++.... ...+++..++.++.||+.||+|||++||+||||||+|||+... ..+.+||+|||+|+...
T Consensus 84 ~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~ivHrDlkp~Nil~~~~~~~~~~~kl~DfG~a~~~~ 163 (317)
T cd07868 84 HDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFN 163 (317)
T ss_pred CCHHHHHHhcccccccCCcccCCHHHHHHHHHHHHHHHHHHHhCCEEcCCCCHHHEEEecCCCCcCcEEEeecCceeccC
Confidence 68888875321 1248999999999999999999999999999999999999532 34689999999997643
Q ss_pred CC------CccccccccccCchhhccCCCCCCCcccchhhhhhhhhhhhcCCCCCCCcCcchhHHHHHHHHhcCCCCCCC
Q psy11767 527 ES------LHTPCFTLQYAAPEVLRQDKSGYDENCDLWSLGVILVNVLRQDKSGYDENCDLWSLGVILYTMLCGRVPFHA 600 (966)
Q Consensus 527 ~~------~~~~~gT~~Y~APEvl~~~~~~~~~~~Di~SlGvil~el~~~~~~~y~~~~DIWSlGvilyemltG~~Pf~~ 600 (966)
.. ....++|+.|+|||++.. ...|+.++||||+||++|+|++|++||..
T Consensus 164 ~~~~~~~~~~~~~~t~~y~aPE~~~~-------------------------~~~~~~~~DiwslG~il~el~~g~~~f~~ 218 (317)
T cd07868 164 SPLKPLADLDPVVVTFWYRAPELLLG-------------------------ARHYTKAIDIWAIGCIFAELLTSEPIFHC 218 (317)
T ss_pred CCCccccccCCccccccccCCHHHcC-------------------------CCCcCchhhHHHHHHHHHHHHhCCCCccC
Confidence 21 234568999999999853 22478889999999999999999999975
Q ss_pred CCCchh-----HHHHHHHHHc--C--------------------------CCC------CCchhhccCCHHHHHHHHHhc
Q psy11767 601 RSRDDS-----ALSIMARIKE--G--------------------------QFN------FDAEAWSTVSSEAKELTKSLL 641 (966)
Q Consensus 601 ~~~~~~-----~~~~~~~i~~--~--------------------------~~~------~~~~~~~~is~e~~~Li~~~L 641 (966)
...... ....+..+.. + .+. +........+.++.+||.+||
T Consensus 219 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL 298 (317)
T cd07868 219 RQEDIKTSNPYHHDQLDRIFNVMGFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHLLQKLL 298 (317)
T ss_pred CcccccccccccHHHHHHHHHhcCCCChHHhHHHhhccchhhhhhhhhccccCcccccchHHhcCCCCChHHHHHHHHHh
Confidence 442110 0011111100 0 000 000001123567899999999
Q ss_pred ccCccccCChHHHHHHhhhh
Q psy11767 642 TVNPAQRIRMMRVKLTFHAF 661 (966)
Q Consensus 642 ~~dP~~R~t~~~v~~~~~~~ 661 (966)
+.||.+|||+.++ ..|+|
T Consensus 299 ~~dP~~R~t~~e~--l~hp~ 316 (317)
T cd07868 299 TMDPIKRITSEQA--MQDPY 316 (317)
T ss_pred ccCcccCCCHHHH--hcCCC
Confidence 9999999999976 33554
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p |
| >cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-37 Score=356.32 Aligned_cols=245 Identities=22% Similarity=0.394 Sum_probs=193.2
Q ss_pred cccccccccccccEEEEEEEcCCC-----cEEEEEEecccc------ChHHHHHHHHHhcCCCCceEEEEEEEeCCeEEE
Q psy11767 380 LDKAGILGDGSYSVCRRCVEKSTG-----QEYAVKIISRKI------DCSEEINLLRACQGHPNIVNLHCVFQDEVHTYL 448 (966)
Q Consensus 380 ~~~~~~LG~G~fG~Vy~a~~~~tg-----~~vAvK~i~~~~------~~~~Ei~iL~~l~~HpnIV~l~~~~~~~~~~~l 448 (966)
|+..+.||+|+||.||+|++..+| ..||||++.... ...+|+.+|+.+.+|||||+++++|.+....|+
T Consensus 40 ~~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~~h~nIv~~~~~~~~~~~~~l 119 (374)
T cd05106 40 LQFGKTLGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASAHTDEREALMSELKILSHLGQHKNIVNLLGACTHGGPVLV 119 (374)
T ss_pred ceehheecCCCcccEEEEEEecCCcccccceeEEEeccCCCCHHHHHHHHHHHHHHHhhccCCceeeEeeEecCCCCeEE
Confidence 344688999999999999975544 579999996532 244699999988679999999999999999999
Q ss_pred EEEccCCCCHHHHHHhcC--------------------------------------------------------------
Q psy11767 449 VLELLKGGELLDRIRQKG-------------------------------------------------------------- 466 (966)
Q Consensus 449 VmEy~~gg~L~~~l~~~~-------------------------------------------------------------- 466 (966)
|||||++|+|.+++....
T Consensus 120 v~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 199 (374)
T cd05106 120 ITEYCCYGDLLNFLRKKAETFLNFVMALPEISETSSDYKNITLEKKYIRSDSGFSSQGSDTYVEMRPVSSSSSQSSDSKD 199 (374)
T ss_pred eHhhccCCcHHHHHHhhhhhhccccccccccccccccccccchhcccccccccccccccccccccCCccccccccccccc
Confidence 999999999999986532
Q ss_pred ------CCCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCcEEEecCCCCCEEEEeecccccccCCC-----cccccc
Q psy11767 467 ------RCGFTENEASRIMRQLVAAVHFMHSRGVVHRDLKPENLLFSDPAGDNIKVVDFGFACLKRESL-----HTPCFT 535 (966)
Q Consensus 467 ------~~~l~e~~~~~i~~Qil~aL~yLHs~~IiHRDLKP~NILl~~~~~~~iKL~DFGla~~~~~~~-----~~~~gT 535 (966)
...+++.+++.++.||+.||+|||++||+||||||+|||+++ ++.+||+|||+++...... .+..++
T Consensus 200 ~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~giiHrDLkp~Nil~~~--~~~~kL~DfGla~~~~~~~~~~~~~~~~~~ 277 (374)
T cd05106 200 EEDTEDSWPLDLDDLLRFSSQVAQGMDFLASKNCIHRDVAARNVLLTD--GRVAKICDFGLARDIMNDSNYVVKGNARLP 277 (374)
T ss_pred hhccCCCCCcCHHHHHHHHHHHHHHHHHHHHCCEEeccCchheEEEeC--CCeEEEeeceeeeeccCCcceeeccCCCCc
Confidence 124788999999999999999999999999999999999985 5689999999997543211 122345
Q ss_pred ccccCchhhccCCCCCCCcccchhhhhhhhhhhhcCCCCCCCcCcchhHHHHHHHHhc-CCCCCCCCCCchhHHHHHHHH
Q psy11767 536 LQYAAPEVLRQDKSGYDENCDLWSLGVILVNVLRQDKSGYDENCDLWSLGVILYTMLC-GRVPFHARSRDDSALSIMARI 614 (966)
Q Consensus 536 ~~Y~APEvl~~~~~~~~~~~Di~SlGvil~el~~~~~~~y~~~~DIWSlGvilyemlt-G~~Pf~~~~~~~~~~~~~~~i 614 (966)
+.|||||++.. ..|+.++|||||||++|+|++ |+.||........ ....+
T Consensus 278 ~~y~aPE~~~~--------------------------~~~~~~~DvwSlGvil~ellt~G~~Pf~~~~~~~~---~~~~~ 328 (374)
T cd05106 278 VKWMAPESIFD--------------------------CVYTVQSDVWSYGILLWEIFSLGKSPYPGILVNSK---FYKMV 328 (374)
T ss_pred cceeCHHHhcC--------------------------CCCCccccHHHHHHHHHHHHhCCCCCCccccccHH---HHHHH
Confidence 67999998842 237889999999999999997 9999986543321 12222
Q ss_pred HcCCCCCCchhhccCCHHHHHHHHHhcccCccccCChHHHHHHh
Q psy11767 615 KEGQFNFDAEAWSTVSSEAKELTKSLLTVNPAQRIRMMRVKLTF 658 (966)
Q Consensus 615 ~~~~~~~~~~~~~~is~e~~~Li~~~L~~dP~~R~t~~~v~~~~ 658 (966)
..+ +... ....+++++.+++.+||+.||++||++.++...+
T Consensus 329 ~~~-~~~~--~~~~~~~~l~~li~~cl~~dp~~RPs~~~l~~~l 369 (374)
T cd05106 329 KRG-YQMS--RPDFAPPEIYSIMKMCWNLEPTERPTFSQISQLI 369 (374)
T ss_pred Hcc-cCcc--CCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHH
Confidence 222 2211 1224689999999999999999999999885544
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti |
| >PTZ00284 protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-38 Score=368.72 Aligned_cols=252 Identities=25% Similarity=0.429 Sum_probs=192.6
Q ss_pred cccccccccccccEEEEEEEcCCCcEEEEEEecccc----ChHHHHHHHHHhc-----CCCCceEEEEEEEeC-CeEEEE
Q psy11767 380 LDKAGILGDGSYSVCRRCVEKSTGQEYAVKIISRKI----DCSEEINLLRACQ-----GHPNIVNLHCVFQDE-VHTYLV 449 (966)
Q Consensus 380 ~~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~----~~~~Ei~iL~~l~-----~HpnIV~l~~~~~~~-~~~~lV 449 (966)
|+.+++||+|+||+||+|.+..+++.||||++.... ....|+.+|+.+. +|++|++++++|..+ .+.|+|
T Consensus 131 y~i~~~lG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~i~~i~~~~~~~~~~~~iv 210 (467)
T PTZ00284 131 FKILSLLGEGTFGKVVEAWDRKRKEYCAVKIVRNVPKYTRDAKIEIQFMEKVRQADPADRFPLMKIQRYFQNETGHMCIV 210 (467)
T ss_pred EEEEEEEEeccCEEEEEEEEcCCCeEEEEEEEecchhhHHHHHHHHHHHHHHhhcCcccCcceeeeEEEEEcCCceEEEE
Confidence 445789999999999999999999999999996432 2345777777653 356799999998865 578999
Q ss_pred EEccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHh-cCceeccCCCCcEEEecCCC--------------CCE
Q psy11767 450 LELLKGGELLDRIRQKGRCGFTENEASRIMRQLVAAVHFMHS-RGVVHRDLKPENLLFSDPAG--------------DNI 514 (966)
Q Consensus 450 mEy~~gg~L~~~l~~~~~~~l~e~~~~~i~~Qil~aL~yLHs-~~IiHRDLKP~NILl~~~~~--------------~~i 514 (966)
||++ |++|.+++.+.+ .+++..++.|+.||+.||+|||+ .|||||||||+|||++.... ..+
T Consensus 211 ~~~~-g~~l~~~l~~~~--~l~~~~~~~i~~qi~~aL~yLH~~~gIiHrDlKP~NILl~~~~~~~~~~~~~~~~~~~~~v 287 (467)
T PTZ00284 211 MPKY-GPCLLDWIMKHG--PFSHRHLAQIIFQTGVALDYFHTELHLMHTDLKPENILMETSDTVVDPVTNRALPPDPCRV 287 (467)
T ss_pred Eecc-CCCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHhcCCeecCCCCHHHEEEecCCcccccccccccCCCCceE
Confidence 9998 889999997764 59999999999999999999998 59999999999999975321 259
Q ss_pred EEEeecccccccCCCccccccccccCchhhccCCCCCCCcccchhhhhhhhhhhhcCCCCCCCcCcchhHHHHHHHHhcC
Q psy11767 515 KVVDFGFACLKRESLHTPCFTLQYAAPEVLRQDKSGYDENCDLWSLGVILVNVLRQDKSGYDENCDLWSLGVILYTMLCG 594 (966)
Q Consensus 515 KL~DFGla~~~~~~~~~~~gT~~Y~APEvl~~~~~~~~~~~Di~SlGvil~el~~~~~~~y~~~~DIWSlGvilyemltG 594 (966)
||+|||+++.........+||+.|+|||++.. ..|+.++|||||||++|||++|
T Consensus 288 kl~DfG~~~~~~~~~~~~~gt~~Y~APE~~~~--------------------------~~~~~~~DiwSlGvil~elltG 341 (467)
T PTZ00284 288 RICDLGGCCDERHSRTAIVSTRHYRSPEVVLG--------------------------LGWMYSTDMWSMGCIIYELYTG 341 (467)
T ss_pred EECCCCccccCccccccccCCccccCcHHhhc--------------------------CCCCcHHHHHHHHHHHHHHHhC
Confidence 99999998765545556789999999999853 2478899999999999999999
Q ss_pred CCCCCCCCCchhHHHHHHHHHc----------------------CCC--CCCchh---------h--ccCCHHHHHHHHH
Q psy11767 595 RVPFHARSRDDSALSIMARIKE----------------------GQF--NFDAEA---------W--STVSSEAKELTKS 639 (966)
Q Consensus 595 ~~Pf~~~~~~~~~~~~~~~i~~----------------------~~~--~~~~~~---------~--~~is~e~~~Li~~ 639 (966)
++||.+.+..+... .+..+.. +.. ...+.. + ...++.+.|||.+
T Consensus 342 ~~pf~~~~~~~~~~-~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~ 420 (467)
T PTZ00284 342 KLLYDTHDNLEHLH-LMEKTLGRLPSEWAGRCGTEEARLLYNSAGQLRPCTDPKHLARIARARPVREVIRDDLLCDLIYG 420 (467)
T ss_pred CCCCCCCChHHHHH-HHHHHcCCCCHHHHhhccchhHHHHhhhcccccccCCHHHHHhhhcccchhhhhchHHHHHHHHH
Confidence 99998765432221 1111110 000 000000 0 0114567899999
Q ss_pred hcccCccccCChHHHHHHhhhhHH
Q psy11767 640 LLTVNPAQRIRMMRVKLTFHAFHQ 663 (966)
Q Consensus 640 ~L~~dP~~R~t~~~v~~~~~~~~~ 663 (966)
||++||++|||+.++ ..|+|+.
T Consensus 421 mL~~dP~~R~ta~e~--L~Hp~~~ 442 (467)
T PTZ00284 421 LLHYDRQKRLNARQM--TTHPYVL 442 (467)
T ss_pred hCCcChhhCCCHHHH--hcCcccc
Confidence 999999999999976 4577764
|
|
| >KOG0596|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-38 Score=349.00 Aligned_cols=264 Identities=26% Similarity=0.382 Sum_probs=199.5
Q ss_pred eecccccccccccccccccccEEEEEEEcCCCcEEEEEEec-cccC------hHHHHHHHHHhcCCCCceEEEEEEEeCC
Q psy11767 372 FFEQYDMDLDKAGILGDGSYSVCRRCVEKSTGQEYAVKIIS-RKID------CSEEINLLRACQGHPNIVNLHCVFQDEV 444 (966)
Q Consensus 372 ~~~~~~i~~~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~-~~~~------~~~Ei~iL~~l~~HpnIV~l~~~~~~~~ 444 (966)
++..-.-.|++++.||.||-+.||+++.-. .+.||+|.+. ...+ ...||++|.++++|.+||+|++|-..++
T Consensus 355 ~i~Vkg~~Yeilk~iG~GGSSkV~kV~~s~-~~iyalkkv~~~~~D~qtl~gy~nEI~lL~KLkg~~~IIqL~DYEv~d~ 433 (677)
T KOG0596|consen 355 IIKVKGREYEILKQIGSGGSSKVFKVLNSD-KQIYALKKVVLLEADNQTLDGYRNEIALLNKLKGHDKIIQLYDYEVTDG 433 (677)
T ss_pred eEEECcchhhHHHhhcCCCcceeeeeecCC-CcchhhhHHHHhhcCHHHHHHHHHHHHHHHHhcCCceEEEEeeeeccCc
Confidence 333333456678999999999999998754 4566666553 2222 4579999999999999999999999999
Q ss_pred eEEEEEEccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCcEEEecCCCCCEEEEeeccccc
Q psy11767 445 HTYLVLELLKGGELLDRIRQKGRCGFTENEASRIMRQLVAAVHFMHSRGVVHRDLKPENLLFSDPAGDNIKVVDFGFACL 524 (966)
Q Consensus 445 ~~~lVmEy~~gg~L~~~l~~~~~~~l~e~~~~~i~~Qil~aL~yLHs~~IiHRDLKP~NILl~~~~~~~iKL~DFGla~~ 524 (966)
++||||||= ..||..+|.++.. .++.-.++.|..|++.|+.++|..||||.||||.|+|+. .|.+||+|||+|..
T Consensus 434 ~lYmvmE~G-d~DL~kiL~k~~~-~~~~~~lk~ywkqML~aV~~IH~~gIVHSDLKPANFLlV---kG~LKLIDFGIA~a 508 (677)
T KOG0596|consen 434 YLYMVMECG-DIDLNKILKKKKS-IDPDWFLKFYWKQMLLAVKTIHQHGIVHSDLKPANFLLV---KGRLKLIDFGIANA 508 (677)
T ss_pred eEEEEeecc-cccHHHHHHhccC-CCchHHHHHHHHHHHHHHHHHHHhceeecCCCcccEEEE---eeeEEeeeechhcc
Confidence 999999985 5799999987764 345458999999999999999999999999999999997 57999999999987
Q ss_pred ccCCC-----ccccccccccCchhhccCCCCCCCcccchhhhhhhhhhhhcCCCCCCCcCcchhHHHHHHHHhcCCCCCC
Q psy11767 525 KRESL-----HTPCFTLQYAAPEVLRQDKSGYDENCDLWSLGVILVNVLRQDKSGYDENCDLWSLGVILYTMLCGRVPFH 599 (966)
Q Consensus 525 ~~~~~-----~~~~gT~~Y~APEvl~~~~~~~~~~~Di~SlGvil~el~~~~~~~y~~~~DIWSlGvilyemltG~~Pf~ 599 (966)
...+. .+.+||+.||+||.+....++ .. -.+.+...+.++||||||||||+|+.|++||.
T Consensus 509 I~~DTTsI~kdsQvGT~NYMsPEAl~~~~s~--~~-------------~~~~k~Ki~r~SDvWSLGCILYqMvYgktPf~ 573 (677)
T KOG0596|consen 509 IQPDTTSIVKDSQVGTVNYMSPEALTDMSSS--RE-------------NGKSKIKISRKSDVWSLGCILYQMVYGKTPFG 573 (677)
T ss_pred cCccccceeeccccCcccccCHHHHhhcccc--cc-------------CCCcceeecCccchhhhhhHHHHHHhcCCchH
Confidence 65443 357899999999999754321 00 01123346789999999999999999999997
Q ss_pred CCCCchhHHHHHHHHHcCCC--CCCchhhccCCHHHHHHHHHhcccCccccCChHHHHHHhhhhHHh
Q psy11767 600 ARSRDDSALSIMARIKEGQF--NFDAEAWSTVSSEAKELTKSLLTVNPAQRIRMMRVKLTFHAFHQA 664 (966)
Q Consensus 600 ~~~~~~~~~~~~~~i~~~~~--~~~~~~~~~is~e~~~Li~~~L~~dP~~R~t~~~v~~~~~~~~~~ 664 (966)
.... ...-+..|....- .|+.. .-..++.++++.||+.||++|+|+.++ ..|+|.+.
T Consensus 574 ~~~n---~~aKl~aI~~P~~~Iefp~~---~~~~~li~~mK~CL~rdPkkR~si~eL--LqhpFl~~ 632 (677)
T KOG0596|consen 574 QIIN---QIAKLHAITDPNHEIEFPDI---PENDELIDVMKCCLARDPKKRWSIPEL--LQHPFLQI 632 (677)
T ss_pred HHHH---HHHHHHhhcCCCccccccCC---CCchHHHHHHHHHHhcCcccCCCcHHH--hcCccccc
Confidence 4321 1222333433311 22111 012249999999999999999999865 56777655
|
|
| >PTZ00267 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-37 Score=367.11 Aligned_cols=238 Identities=31% Similarity=0.456 Sum_probs=197.9
Q ss_pred cccccccccccEEEEEEEcCC-CcEEEEEEecccc-----ChHHHHHHHHHhcCCCCceEEEEEEEeCCeEEEEEEccCC
Q psy11767 382 KAGILGDGSYSVCRRCVEKST-GQEYAVKIISRKI-----DCSEEINLLRACQGHPNIVNLHCVFQDEVHTYLVLELLKG 455 (966)
Q Consensus 382 ~~~~LG~G~fG~Vy~a~~~~t-g~~vAvK~i~~~~-----~~~~Ei~iL~~l~~HpnIV~l~~~~~~~~~~~lVmEy~~g 455 (966)
..+.||+|+||.||+|.+..+ ++.||+|.+.... ...+|+.+|+.+ +|||||+++++|.++++.||||||++|
T Consensus 71 ~~~~lg~G~~g~vy~a~~~~~~~~~vv~K~~~~~~~~~~~~~~~E~~~l~~l-~Hpniv~~~~~~~~~~~~~lv~E~~~g 149 (478)
T PTZ00267 71 LTTLVGRNPTTAAFVATRGSDPKEKVVAKFVMLNDERQAAYARSELHCLAAC-DHFGIVKHFDDFKSDDKLLLIMEYGSG 149 (478)
T ss_pred EEEEEEeCCCcEEEEEEEcCCCCeEEEEEEcccCCHHHHHHHHHHHHHHHhC-CCCCEeEEEEEEEECCEEEEEEECCCC
Confidence 357899999999999999888 7889999774332 234699999888 599999999999999999999999999
Q ss_pred CCHHHHHHhc--CCCCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCcEEEecCCCCCEEEEeecccccccCC-----
Q psy11767 456 GELLDRIRQK--GRCGFTENEASRIMRQLVAAVHFMHSRGVVHRDLKPENLLFSDPAGDNIKVVDFGFACLKRES----- 528 (966)
Q Consensus 456 g~L~~~l~~~--~~~~l~e~~~~~i~~Qil~aL~yLHs~~IiHRDLKP~NILl~~~~~~~iKL~DFGla~~~~~~----- 528 (966)
|+|.+++.+. ....+++.++..++.||+.||+|||++||+||||||+|||++. .+.+||+|||+++.....
T Consensus 150 g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDlkp~NIll~~--~~~~kL~DFgla~~~~~~~~~~~ 227 (478)
T PTZ00267 150 GDLNKQIKQRLKEHLPFQEYEVGLLFYQIVLALDEVHSRKMMHRDLKSANIFLMP--TGIIKLGDFGFSKQYSDSVSLDV 227 (478)
T ss_pred CCHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCEEECCcCHHhEEECC--CCcEEEEeCcCceecCCcccccc
Confidence 9999988642 2335899999999999999999999999999999999999985 568999999999765432
Q ss_pred CccccccccccCchhhccCCCCCCCcccchhhhhhhhhhhhcCCCCCCCcCcchhHHHHHHHHhcCCCCCCCCCCchhHH
Q psy11767 529 LHTPCFTLQYAAPEVLRQDKSGYDENCDLWSLGVILVNVLRQDKSGYDENCDLWSLGVILYTMLCGRVPFHARSRDDSAL 608 (966)
Q Consensus 529 ~~~~~gT~~Y~APEvl~~~~~~~~~~~Di~SlGvil~el~~~~~~~y~~~~DIWSlGvilyemltG~~Pf~~~~~~~~~~ 608 (966)
....+||+.|+|||++.. ..|+.++|||||||++|+|++|+.||.+.+. .
T Consensus 228 ~~~~~gt~~y~aPE~~~~--------------------------~~~~~~~Dv~slG~~l~el~tg~~Pf~~~~~----~ 277 (478)
T PTZ00267 228 ASSFCGTPYYLAPELWER--------------------------KRYSKKADMWSLGVILYELLTLHRPFKGPSQ----R 277 (478)
T ss_pred ccccCCCccccCHhHhCC--------------------------CCCCcHHhHHHHHHHHHHHHhCCCCCCCCCH----H
Confidence 234578999999998852 2478889999999999999999999986543 2
Q ss_pred HHHHHHHcCCCCCCchhhccCCHHHHHHHHHhcccCccccCChHHHH
Q psy11767 609 SIMARIKEGQFNFDAEAWSTVSSEAKELTKSLLTVNPAQRIRMMRVK 655 (966)
Q Consensus 609 ~~~~~i~~~~~~~~~~~~~~is~e~~~Li~~~L~~dP~~R~t~~~v~ 655 (966)
.++..+..+.+.. ....++.++.+||.+||..||++||++.++.
T Consensus 278 ~~~~~~~~~~~~~---~~~~~s~~~~~li~~~L~~dP~~Rps~~~~l 321 (478)
T PTZ00267 278 EIMQQVLYGKYDP---FPCPVSSGMKALLDPLLSKNPALRPTTQQLL 321 (478)
T ss_pred HHHHHHHhCCCCC---CCccCCHHHHHHHHHHhccChhhCcCHHHHH
Confidence 4455555555432 1235789999999999999999999998763
|
|
| >cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-37 Score=342.55 Aligned_cols=245 Identities=19% Similarity=0.283 Sum_probs=188.2
Q ss_pred ccccccccccEEEEEEEcC----------------CCcEEEEEEecccc------ChHHHHHHHHHhcCCCCceEEEEEE
Q psy11767 383 AGILGDGSYSVCRRCVEKS----------------TGQEYAVKIISRKI------DCSEEINLLRACQGHPNIVNLHCVF 440 (966)
Q Consensus 383 ~~~LG~G~fG~Vy~a~~~~----------------tg~~vAvK~i~~~~------~~~~Ei~iL~~l~~HpnIV~l~~~~ 440 (966)
.+.||+|+||.||+|.+.. ++..||||++.... ...+|+++|..+ +||||+++++++
T Consensus 10 ~~~lg~G~fg~V~~~~~~~~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~ 88 (304)
T cd05096 10 KEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDANKNARNDFLKEVKILSRL-KDPNIIRLLGVC 88 (304)
T ss_pred eeEecccCCeEEEEEEeccCcccccccccccccCCcceEEEEEEecCCCCHHHHHHHHHHHHHHhhc-CCCCeeEEEEEE
Confidence 5789999999999998643 34579999986532 245699999988 599999999999
Q ss_pred EeCCeEEEEEEccCCCCHHHHHHhcCC-----------------CCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCc
Q psy11767 441 QDEVHTYLVLELLKGGELLDRIRQKGR-----------------CGFTENEASRIMRQLVAAVHFMHSRGVVHRDLKPEN 503 (966)
Q Consensus 441 ~~~~~~~lVmEy~~gg~L~~~l~~~~~-----------------~~l~e~~~~~i~~Qil~aL~yLHs~~IiHRDLKP~N 503 (966)
.+....|+||||+++|+|.+++..... ..+++..+..++.||+.||+|||+.||+||||||+|
T Consensus 89 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~ivH~dlkp~N 168 (304)
T cd05096 89 VDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLSSLNFVHRDLATRN 168 (304)
T ss_pred ecCCceEEEEecCCCCcHHHHHHhccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHHHCCccccCcchhh
Confidence 999999999999999999999865321 236788899999999999999999999999999999
Q ss_pred EEEecCCCCCEEEEeecccccccCC-----CccccccccccCchhhccCCCCCCCcccchhhhhhhhhhhhcCCCCCCCc
Q psy11767 504 LLFSDPAGDNIKVVDFGFACLKRES-----LHTPCFTLQYAAPEVLRQDKSGYDENCDLWSLGVILVNVLRQDKSGYDEN 578 (966)
Q Consensus 504 ILl~~~~~~~iKL~DFGla~~~~~~-----~~~~~gT~~Y~APEvl~~~~~~~~~~~Di~SlGvil~el~~~~~~~y~~~ 578 (966)
||+++ .+.+||+|||++...... .....++..|+|||++.. ..|+.+
T Consensus 169 ill~~--~~~~kl~DfG~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~--------------------------~~~~~~ 220 (304)
T cd05096 169 CLVGE--NLTIKIADFGMSRNLYAGDYYRIQGRAVLPIRWMAWECILM--------------------------GKFTTA 220 (304)
T ss_pred eEEcC--CccEEECCCccceecccCceeEecCcCCCCccccCHHHHhc--------------------------CCCCch
Confidence 99985 568999999998654221 122345788999998752 236789
Q ss_pred CcchhHHHHHHHHhc--CCCCCCCCCCchhHHHHHHHHHcCCCCCCchhhccCCHHHHHHHHHhcccCccccCChHHHHH
Q psy11767 579 CDLWSLGVILYTMLC--GRVPFHARSRDDSALSIMARIKEGQFNFDAEAWSTVSSEAKELTKSLLTVNPAQRIRMMRVKL 656 (966)
Q Consensus 579 ~DIWSlGvilyemlt--G~~Pf~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~is~e~~~Li~~~L~~dP~~R~t~~~v~~ 656 (966)
+|||||||++|+|++ |..||...+..+.....................+.++..+.+|+.+||..||++|||+.++..
T Consensus 221 ~Dv~slG~~l~el~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~RPs~~~i~~ 300 (304)
T cd05096 221 SDVWAFGVTLWEILMLCKEQPYGELTDEQVIENAGEFFRDQGRQVYLFRPPPCPQGLYELMLQCWSRDCRERPSFSDIHA 300 (304)
T ss_pred hhhHHHHHHHHHHHHccCCCCCCcCCHHHHHHHHHHHhhhccccccccCCCCCCHHHHHHHHHHccCCchhCcCHHHHHH
Confidence 999999999999986 678887654332211111111111111111122356889999999999999999999998843
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k |
| >cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-37 Score=347.58 Aligned_cols=249 Identities=24% Similarity=0.426 Sum_probs=197.6
Q ss_pred cccccccccccccEEEEEEEcCCCcEEEEEEecccc------ChHHHHHHHHHhcCCCCceEEEEEEEeCCeEEEEEEcc
Q psy11767 380 LDKAGILGDGSYSVCRRCVEKSTGQEYAVKIISRKI------DCSEEINLLRACQGHPNIVNLHCVFQDEVHTYLVLELL 453 (966)
Q Consensus 380 ~~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~------~~~~Ei~iL~~l~~HpnIV~l~~~~~~~~~~~lVmEy~ 453 (966)
|+..+.||+|+||.||+|.+..+|..+|+|++.... ...+|+++|+.+ +|||||+++++|.++++.|+||||+
T Consensus 7 y~~~~~lg~g~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~e~~ 85 (333)
T cd06650 7 FEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHEC-NSPYIVGFYGAFYSDGEISICMEHM 85 (333)
T ss_pred hheeccccCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHC-CCCcccceeEEEEECCEEEEEEecC
Confidence 444788999999999999999999999999986542 245799999998 5999999999999999999999999
Q ss_pred CCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhc-CceeccCCCCcEEEecCCCCCEEEEeecccccccC-CCcc
Q psy11767 454 KGGELLDRIRQKGRCGFTENEASRIMRQLVAAVHFMHSR-GVVHRDLKPENLLFSDPAGDNIKVVDFGFACLKRE-SLHT 531 (966)
Q Consensus 454 ~gg~L~~~l~~~~~~~l~e~~~~~i~~Qil~aL~yLHs~-~IiHRDLKP~NILl~~~~~~~iKL~DFGla~~~~~-~~~~ 531 (966)
++|+|.+++...+ .+++..+..++.|++.||+|||+. +|+||||||+|||+++ .+.+||+|||++..... ....
T Consensus 86 ~~~~L~~~l~~~~--~~~~~~~~~~~~~l~~~l~~lH~~~~ivH~dlkp~Nili~~--~~~~kL~Dfg~~~~~~~~~~~~ 161 (333)
T cd06650 86 DGGSLDQVLKKAG--RIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNS--RGEIKLCDFGVSGQLIDSMANS 161 (333)
T ss_pred CCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHhcCCEEecCCChhhEEEcC--CCCEEEeeCCcchhhhhhcccc
Confidence 9999999997754 589999999999999999999985 7999999999999975 56899999999865432 2234
Q ss_pred ccccccccCchhhccCCCCCCCcccchhhhhhhhhhhhcCCCCCCCcCcchhHHHHHHHHhcCCCCCCCCCCchhHHHHH
Q psy11767 532 PCFTLQYAAPEVLRQDKSGYDENCDLWSLGVILVNVLRQDKSGYDENCDLWSLGVILYTMLCGRVPFHARSRDDSALSIM 611 (966)
Q Consensus 532 ~~gT~~Y~APEvl~~~~~~~~~~~Di~SlGvil~el~~~~~~~y~~~~DIWSlGvilyemltG~~Pf~~~~~~~~~~~~~ 611 (966)
..+|+.|+|||++.. ..++.++|||||||++|+|++|+.||......+. ...+
T Consensus 162 ~~~~~~y~aPE~~~~--------------------------~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~-~~~~ 214 (333)
T cd06650 162 FVGTRSYMSPERLQG--------------------------THYSVQSDIWSMGLSLVEMAIGRYPIPPPDAKEL-ELMF 214 (333)
T ss_pred CCCCccccCHHHhcC--------------------------CCCCcHHHHHHHHHHHHHHHHCCCCCCCcchhHH-HHHh
Confidence 568999999998852 2367789999999999999999999976433211 0000
Q ss_pred -----------------------------------------HHHHcCCCCCCchhhccCCHHHHHHHHHhcccCccccCC
Q psy11767 612 -----------------------------------------ARIKEGQFNFDAEAWSTVSSEAKELTKSLLTVNPAQRIR 650 (966)
Q Consensus 612 -----------------------------------------~~i~~~~~~~~~~~~~~is~e~~~Li~~~L~~dP~~R~t 650 (966)
..+...... .......+.++++||.+||+.||++|||
T Consensus 215 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~li~~~L~~~P~~Rpt 292 (333)
T cd06650 215 GCPVEGDPAESETSPRPRPPGRPLSSYGPDSRPPMAIFELLDYIVNEPPP--KLPSGVFGAEFQDFVNKCLIKNPAERAD 292 (333)
T ss_pred cCcccCCccccccCcccCCccchhhhhcccccccccHHHHHHHHhcCCCc--cCCCCCcCHHHHHHHHHhccCCcccCcC
Confidence 000000000 0000135788999999999999999999
Q ss_pred hHHHHHHhhhhHHh
Q psy11767 651 MMRVKLTFHAFHQA 664 (966)
Q Consensus 651 ~~~v~~~~~~~~~~ 664 (966)
+.++ ..|+|.+.
T Consensus 293 ~~el--l~h~~~~~ 304 (333)
T cd06650 293 LKQL--MVHAFIKR 304 (333)
T ss_pred HHHH--hhCHHHhc
Confidence 9976 45777653
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst |
| >KOG0586|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-38 Score=358.63 Aligned_cols=235 Identities=35% Similarity=0.639 Sum_probs=203.9
Q ss_pred cccccccccccEEEEEEEcCCCcEEEEEEecccc-------ChHHHHHHHHHhcCCCCceEEEEEEEeCCeEEEEEEccC
Q psy11767 382 KAGILGDGSYSVCRRCVEKSTGQEYAVKIISRKI-------DCSEEINLLRACQGHPNIVNLHCVFQDEVHTYLVLELLK 454 (966)
Q Consensus 382 ~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~-------~~~~Ei~iL~~l~~HpnIV~l~~~~~~~~~~~lVmEy~~ 454 (966)
..+.||+|.|++|.+|++..||..||||++.+.. ...+|+++|+.+ +|||||+|+.+.+.+..+|+||||+.
T Consensus 60 i~~tig~g~f~~V~La~~~~t~~~VaiK~idkt~ln~~~~~k~~rev~imk~l-~HPnIvkl~~v~~t~~~lylV~eya~ 138 (596)
T KOG0586|consen 60 IIKTIGKGNFAKVKLARHILTGTEVAIKIIDKTQLNPSKRQKLGREVDIMKSL-NHPNIVKLFSVIETEATLYLVMEYAS 138 (596)
T ss_pred eeeeeccceeEEEEeeEecCCCceEEEEEehhcccChHHHHHHHHHHHHHHhc-CCcceeeeeeeeeecceeEEEEEecc
Confidence 3689999999999999999999999999997643 245799999988 59999999999999999999999999
Q ss_pred CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCcEEEecCCCCCEEEEeeccccccc--CCCccc
Q psy11767 455 GGELLDRIRQKGRCGFTENEASRIMRQLVAAVHFMHSRGVVHRDLKPENLLFSDPAGDNIKVVDFGFACLKR--ESLHTP 532 (966)
Q Consensus 455 gg~L~~~l~~~~~~~l~e~~~~~i~~Qil~aL~yLHs~~IiHRDLKP~NILl~~~~~~~iKL~DFGla~~~~--~~~~~~ 532 (966)
+|++++++.+.+ .+.+.+++.++.|+++|++|||+++|+|||||++||||+. +.++||+|||++.... ....+.
T Consensus 139 ~ge~~~yl~~~g--r~~e~~ar~~F~q~vsaveYcH~k~ivHrdLk~eNilL~~--~mnikIaDfgfS~~~~~~~~lqt~ 214 (596)
T KOG0586|consen 139 GGELFDYLVKHG--RMKEKEARAKFRQIVSAVEYCHSKNIVHRDLKAENILLDE--NMNIKIADFGFSTFFDYGLMLQTF 214 (596)
T ss_pred CchhHHHHHhcc--cchhhhhhhhhHHHHHHHHHHhhcceeccccchhhccccc--ccceeeeccccceeeccccccccc
Confidence 999999999987 4788999999999999999999999999999999999985 4479999999997764 346789
Q ss_pred cccccccCchhhccCCCCCCCcccchhhhhhhhhhhhcCCCCCCCcCcchhHHHHHHHHhcCCCCCCCCCCchhHHHHHH
Q psy11767 533 CFTLQYAAPEVLRQDKSGYDENCDLWSLGVILVNVLRQDKSGYDENCDLWSLGVILYTMLCGRVPFHARSRDDSALSIMA 612 (966)
Q Consensus 533 ~gT~~Y~APEvl~~~~~~~~~~~Di~SlGvil~el~~~~~~~y~~~~DIWSlGvilyemltG~~Pf~~~~~~~~~~~~~~ 612 (966)
||++.|.|||++.+.. .-++.+|+||+|++||.|+.|.+||++.+..+ +-.
T Consensus 215 cgsppyAaPEl~~g~~-------------------------y~gpe~D~Wslgvvly~LV~GsLPFDG~~lk~----Lr~ 265 (596)
T KOG0586|consen 215 CGSPPYAAPELFNGKK-------------------------YDGPEVDIWSLGVVLYALVEGSLPFDGQNLKE----LRP 265 (596)
T ss_pred CCCCCccChHhhcCcc-------------------------cCCcceehhhhhhhheeeeecccccCCccccc----ccc
Confidence 9999999999986432 12568999999999999999999999866432 234
Q ss_pred HHHcCCCCCCchhhccCCHHHHHHHHHhcccCccccCChHHH
Q psy11767 613 RIKEGQFNFDAEAWSTVSSEAKELTKSLLTVNPAQRIRMMRV 654 (966)
Q Consensus 613 ~i~~~~~~~~~~~~~~is~e~~~Li~~~L~~dP~~R~t~~~v 654 (966)
+...|.+.++- .+|.++++||+++|..+|.+|+++.++
T Consensus 266 rvl~gk~rIp~----~ms~dce~lLrk~lvl~Pskr~~~dqi 303 (596)
T KOG0586|consen 266 RVLRGKYRIPF----YMSCDCEDLLRKFLVLNPSKRGPCDQI 303 (596)
T ss_pred hheeeeecccc----eeechhHHHHHHhhccCccccCCHHHh
Confidence 45566665432 478999999999999999999999876
|
|
| >cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-37 Score=354.77 Aligned_cols=251 Identities=25% Similarity=0.424 Sum_probs=196.8
Q ss_pred cccccccccccccEEEEEEEcCCCcEEEEEEecccc-------ChHHHHHHHHHhcCCCCceEEEEEEEeCC-----eEE
Q psy11767 380 LDKAGILGDGSYSVCRRCVEKSTGQEYAVKIISRKI-------DCSEEINLLRACQGHPNIVNLHCVFQDEV-----HTY 447 (966)
Q Consensus 380 ~~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~-------~~~~Ei~iL~~l~~HpnIV~l~~~~~~~~-----~~~ 447 (966)
|+..+.||+|+||+||+|.+..+|+.||||++.... ...+|+.+|+.+ +||||+++++++.... ..|
T Consensus 2 ~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~~~~~~ 80 (372)
T cd07853 2 VEPDRPIGYGAFGVVWSVTDPRDGKRVALKKMPNVFQNLVSCKRVFRELKMLCFF-KHDNVLSALDILQPPHIDPFEEIY 80 (372)
T ss_pred CcccceeeeCCCEEEEEEEECCCCCEEEEEeccccccchHHHHHHHHHHHHHHhC-CCCCcCCHhheecCCCccccceEE
Confidence 456789999999999999999999999999986432 245699999988 5999999999998876 789
Q ss_pred EEEEccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCcEEEecCCCCCEEEEeecccccccC
Q psy11767 448 LVLELLKGGELLDRIRQKGRCGFTENEASRIMRQLVAAVHFMHSRGVVHRDLKPENLLFSDPAGDNIKVVDFGFACLKRE 527 (966)
Q Consensus 448 lVmEy~~gg~L~~~l~~~~~~~l~e~~~~~i~~Qil~aL~yLHs~~IiHRDLKP~NILl~~~~~~~iKL~DFGla~~~~~ 527 (966)
+||||+. ++|.+.+.... .+++..++.++.||+.||+|||++||+||||||+|||++. ++.+||+|||++.....
T Consensus 81 lv~e~~~-~~l~~~~~~~~--~l~~~~~~~~~~qi~~aL~~LH~~~ivH~dlkp~Nili~~--~~~~kL~Dfg~a~~~~~ 155 (372)
T cd07853 81 VVTELMQ-SDLHKIIVSPQ--PLSSDHVKVFLYQILRGLKYLHSAGILHRDIKPGNLLVNS--NCVLKICDFGLARVEEP 155 (372)
T ss_pred EEeeccc-cCHHHHHhcCC--CCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChHHEEECC--CCCEEeccccceeeccc
Confidence 9999995 68888886543 5899999999999999999999999999999999999985 56999999999975432
Q ss_pred C----CccccccccccCchhhccCCCCCCCcccchhhhhhhhhhhhcCCCCCCCcCcchhHHHHHHHHhcCCCCCCCCCC
Q psy11767 528 S----LHTPCFTLQYAAPEVLRQDKSGYDENCDLWSLGVILVNVLRQDKSGYDENCDLWSLGVILYTMLCGRVPFHARSR 603 (966)
Q Consensus 528 ~----~~~~~gT~~Y~APEvl~~~~~~~~~~~Di~SlGvil~el~~~~~~~y~~~~DIWSlGvilyemltG~~Pf~~~~~ 603 (966)
. .....+|+.|+|||++.. ...|+.++||||+||++|+|++|++||.+.+.
T Consensus 156 ~~~~~~~~~~~~~~y~aPE~~~~-------------------------~~~~~~~~DiwslG~il~el~~g~~pf~~~~~ 210 (372)
T cd07853 156 DESKHMTQEVVTQYYRAPEILMG-------------------------SRHYTSAVDIWSVGCIFAELLGRRILFQAQSP 210 (372)
T ss_pred CccccCCCCCcCCCcCCHHHHcC-------------------------CCCCCcHHHHHhHHHHHHHHHcCCCCCCCCCH
Confidence 1 223457899999998852 22367889999999999999999999987654
Q ss_pred chhHHHHHHH-------------------HHcCCCCCCc-----hhhccCCHHHHHHHHHhcccCccccCChHHHHHHhh
Q psy11767 604 DDSALSIMAR-------------------IKEGQFNFDA-----EAWSTVSSEAKELTKSLLTVNPAQRIRMMRVKLTFH 659 (966)
Q Consensus 604 ~~~~~~~~~~-------------------i~~~~~~~~~-----~~~~~is~e~~~Li~~~L~~dP~~R~t~~~v~~~~~ 659 (966)
.+....+... +.......+. ......++++.+||.+||+.||++|||+.++ ..|
T Consensus 211 ~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~--l~h 288 (372)
T cd07853 211 IQQLDLITDLLGTPSLEAMRSACEGARAHILRGPHKPPSLPVLYTLSSQATHEAVHLLCRMLVFDPDKRISAADA--LAH 288 (372)
T ss_pred HHHHHHHHHHcCCCCHHHHHHhhHHHHHHHHhCCCCCCchHHhcccCCCCCHHHHHHHHHhCCCChhhCcCHHHH--hcC
Confidence 3322221110 1111111110 1123468899999999999999999999876 456
Q ss_pred hhHH
Q psy11767 660 AFHQ 663 (966)
Q Consensus 660 ~~~~ 663 (966)
+|..
T Consensus 289 p~~~ 292 (372)
T cd07853 289 PYLD 292 (372)
T ss_pred HhhC
Confidence 6653
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription |
| >cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-37 Score=338.41 Aligned_cols=238 Identities=32% Similarity=0.495 Sum_probs=196.3
Q ss_pred cccccccccccEEEEEEEcCCCcEEEEEEecccc--------ChHHHHHHHHHhcCCCCceEEEEEEEeCCeEEEEEEcc
Q psy11767 382 KAGILGDGSYSVCRRCVEKSTGQEYAVKIISRKI--------DCSEEINLLRACQGHPNIVNLHCVFQDEVHTYLVLELL 453 (966)
Q Consensus 382 ~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~--------~~~~Ei~iL~~l~~HpnIV~l~~~~~~~~~~~lVmEy~ 453 (966)
..+.||+|+||+||+|.+..+++.||+|++.... ...+|+.+|+.+ +|+||+.+++++.++...|+||||+
T Consensus 4 ~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l-~~~~i~~~~~~~~~~~~~~lv~e~~ 82 (285)
T cd05632 4 QYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKV-NSQFVVNLAYAYETKDALCLVLTIM 82 (285)
T ss_pred EEEEEecCCCeEEEEEEECCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHHc-CCcCceeEEEEEecCCEEEEEEEec
Confidence 4578999999999999999999999999986431 134689999988 5999999999999999999999999
Q ss_pred CCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCcEEEecCCCCCEEEEeecccccccC--CCcc
Q psy11767 454 KGGELLDRIRQKGRCGFTENEASRIMRQLVAAVHFMHSRGVVHRDLKPENLLFSDPAGDNIKVVDFGFACLKRE--SLHT 531 (966)
Q Consensus 454 ~gg~L~~~l~~~~~~~l~e~~~~~i~~Qil~aL~yLHs~~IiHRDLKP~NILl~~~~~~~iKL~DFGla~~~~~--~~~~ 531 (966)
++++|.+++...+...+++..+..++.|++.||+|||+.||+||||||+|||+++ .+.+||+|||++..... ....
T Consensus 83 ~~~~L~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~iiH~dikp~Nili~~--~~~~kl~Dfg~~~~~~~~~~~~~ 160 (285)
T cd05632 83 NGGDLKFHIYNMGNPGFEEERALFYAAEILCGLEDLHRENTVYRDLKPENILLDD--YGHIRISDLGLAVKIPEGESIRG 160 (285)
T ss_pred cCccHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCHHHEEECC--CCCEEEecCCcceecCCCCcccC
Confidence 9999999887655456999999999999999999999999999999999999975 45899999999865432 2234
Q ss_pred ccccccccCchhhccCCCCCCCcccchhhhhhhhhhhhcCCCCCCCcCcchhHHHHHHHHhcCCCCCCCCCCchhHHHHH
Q psy11767 532 PCFTLQYAAPEVLRQDKSGYDENCDLWSLGVILVNVLRQDKSGYDENCDLWSLGVILYTMLCGRVPFHARSRDDSALSIM 611 (966)
Q Consensus 532 ~~gT~~Y~APEvl~~~~~~~~~~~Di~SlGvil~el~~~~~~~y~~~~DIWSlGvilyemltG~~Pf~~~~~~~~~~~~~ 611 (966)
..+|+.|+|||++.. ..|+.++|+||+||++|+|++|..||.+.........+.
T Consensus 161 ~~g~~~~~aPE~~~~--------------------------~~~~~~~Di~slG~~l~~l~~g~~P~~~~~~~~~~~~~~ 214 (285)
T cd05632 161 RVGTVGYMAPEVLNN--------------------------QRYTLSPDYWGLGCLIYEMIEGQSPFRGRKEKVKREEVD 214 (285)
T ss_pred CCCCcCccChHHhcC--------------------------CCCCcccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH
Confidence 568999999999852 236788999999999999999999998765433323333
Q ss_pred HHHHcCCCCCCchhhccCCHHHHHHHHHhcccCccccCChH
Q psy11767 612 ARIKEGQFNFDAEAWSTVSSEAKELTKSLLTVNPAQRIRMM 652 (966)
Q Consensus 612 ~~i~~~~~~~~~~~~~~is~e~~~Li~~~L~~dP~~R~t~~ 652 (966)
..+..+... ....++.++.+|+.+||..||++||++.
T Consensus 215 ~~~~~~~~~----~~~~~~~~~~~li~~~l~~~P~~R~~~~ 251 (285)
T cd05632 215 RRVLETEEV----YSAKFSEEAKSICKMLLTKDPKQRLGCQ 251 (285)
T ss_pred Hhhhccccc----cCccCCHHHHHHHHHHccCCHhHcCCCc
Confidence 344443322 2345788999999999999999999954
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with |
| >KOG4721|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-38 Score=353.00 Aligned_cols=242 Identities=24% Similarity=0.397 Sum_probs=199.0
Q ss_pred ccccccc---cccccccccccEEEEEEEcCCCcEEEEEEeccccChHHHHHHHHHhcCCCCceEEEEEEEeCCeEEEEEE
Q psy11767 375 QYDMDLD---KAGILGDGSYSVCRRCVEKSTGQEYAVKIISRKIDCSEEINLLRACQGHPNIVNLHCVFQDEVHTYLVLE 451 (966)
Q Consensus 375 ~~~i~~~---~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~~~~~Ei~iL~~l~~HpnIV~l~~~~~~~~~~~lVmE 451 (966)
.|+|-|+ ++..||.|+-|.||+|+.. ++.||||.++. ....+|+.|++|. |||||++.++|...-.+|||||
T Consensus 118 ~WeiPFe~IsELeWlGSGaQGAVF~Grl~--netVAVKKV~e--lkETdIKHLRkLk-H~NII~FkGVCtqsPcyCIiME 192 (904)
T KOG4721|consen 118 LWEIPFEEISELEWLGSGAQGAVFLGRLH--NETVAVKKVRE--LKETDIKHLRKLK-HPNIITFKGVCTQSPCYCIIME 192 (904)
T ss_pred hccCCHHHhhhhhhhccCcccceeeeecc--CceehhHHHhh--hhhhhHHHHHhcc-CcceeeEeeeecCCceeEEeee
Confidence 3444444 4678999999999999865 67999998743 2456899999995 9999999999999999999999
Q ss_pred ccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCcEEEecCCCCCEEEEeecccccccCC--C
Q psy11767 452 LLKGGELLDRIRQKGRCGFTENEASRIMRQLVAAVHFMHSRGVVHRDLKPENLLFSDPAGDNIKVVDFGFACLKRES--L 529 (966)
Q Consensus 452 y~~gg~L~~~l~~~~~~~l~e~~~~~i~~Qil~aL~yLHs~~IiHRDLKP~NILl~~~~~~~iKL~DFGla~~~~~~--~ 529 (966)
||..|.|+..|+... .++......+..+|+.|+.|||.++|||||||.-||||.. +..|||+|||-++...+. .
T Consensus 193 fCa~GqL~~VLka~~--~itp~llv~Wsk~IA~GM~YLH~hKIIHRDLKSPNiLIs~--~d~VKIsDFGTS~e~~~~STk 268 (904)
T KOG4721|consen 193 FCAQGQLYEVLKAGR--PITPSLLVDWSKGIAGGMNYLHLHKIIHRDLKSPNILISY--DDVVKISDFGTSKELSDKSTK 268 (904)
T ss_pred ccccccHHHHHhccC--ccCHHHHHHHHHHhhhhhHHHHHhhHhhhccCCCceEeec--cceEEeccccchHhhhhhhhh
Confidence 999999999997754 6899999999999999999999999999999999999985 559999999998765442 3
Q ss_pred ccccccccccCchhhccCCCCCCCcccchhhhhhhhhhhhcCCCCCCCcCcchhHHHHHHHHhcCCCCCCCCCCchhHHH
Q psy11767 530 HTPCFTLQYAAPEVLRQDKSGYDENCDLWSLGVILVNVLRQDKSGYDENCDLWSLGVILYTMLCGRVPFHARSRDDSALS 609 (966)
Q Consensus 530 ~~~~gT~~Y~APEvl~~~~~~~~~~~Di~SlGvil~el~~~~~~~y~~~~DIWSlGvilyemltG~~Pf~~~~~~~~~~~ 609 (966)
..++||..|||||+|+ +.++++|+|||||||||||||||..||...+.. +
T Consensus 269 MSFaGTVaWMAPEvIr--------------------------nePcsEKVDIwSfGVVLWEmLT~EiPYkdVdss----A 318 (904)
T KOG4721|consen 269 MSFAGTVAWMAPEVIR--------------------------NEPCSEKVDIWSFGVVLWEMLTGEIPYKDVDSS----A 318 (904)
T ss_pred hhhhhhHhhhCHHHhh--------------------------cCCcccccceehhHHHHHHHHhcCCCccccchh----e
Confidence 4689999999999997 345899999999999999999999999764432 1
Q ss_pred HHHHHHcCCCCCCchhhccCCHHHHHHHHHhcccCccccCChHHHHHH
Q psy11767 610 IMARIKEGQFNFDAEAWSTVSSEAKELTKSLLTVNPAQRIRMMRVKLT 657 (966)
Q Consensus 610 ~~~~i~~~~~~~~~~~~~~is~e~~~Li~~~L~~dP~~R~t~~~v~~~ 657 (966)
++--+.... +........+.-++-||+.||.-.|..||++.++...
T Consensus 319 IIwGVGsNs--L~LpvPstcP~GfklL~Kqcw~sKpRNRPSFrqil~H 364 (904)
T KOG4721|consen 319 IIWGVGSNS--LHLPVPSTCPDGFKLLLKQCWNSKPRNRPSFRQILLH 364 (904)
T ss_pred eEEeccCCc--ccccCcccCchHHHHHHHHHHhcCCCCCccHHHHHHH
Confidence 221122222 2223445678889999999999999999998765433
|
|
| >cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-37 Score=350.79 Aligned_cols=250 Identities=28% Similarity=0.507 Sum_probs=191.1
Q ss_pred ecccccccccccccccccccEEEEEEEcCCCcEEEEEEecccc-------ChHHHHHHHHHhcCCCCceEEEEEEEeCC-
Q psy11767 373 FEQYDMDLDKAGILGDGSYSVCRRCVEKSTGQEYAVKIISRKI-------DCSEEINLLRACQGHPNIVNLHCVFQDEV- 444 (966)
Q Consensus 373 ~~~~~i~~~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~-------~~~~Ei~iL~~l~~HpnIV~l~~~~~~~~- 444 (966)
.++|.+ .+.||+|+||.||+|.+..+|+.||||++.+.. ...+|+.+|+.+ +||||++++++|....
T Consensus 20 ~~~y~~----~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~ 94 (359)
T cd07876 20 LKRYQQ----LKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAYRELVLLKCV-NHKNIISLLNVFTPQKS 94 (359)
T ss_pred hhceEE----EEEeecCCCEEEEEEEEcCCCceeEEEEecccccchhHHHHHHHHHHHHHhC-CCCCEeeeeeeeccCCC
Confidence 345554 688999999999999999999999999986432 234688999888 5999999999987543
Q ss_pred -----eEEEEEEccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCcEEEecCCCCCEEEEee
Q psy11767 445 -----HTYLVLELLKGGELLDRIRQKGRCGFTENEASRIMRQLVAAVHFMHSRGVVHRDLKPENLLFSDPAGDNIKVVDF 519 (966)
Q Consensus 445 -----~~~lVmEy~~gg~L~~~l~~~~~~~l~e~~~~~i~~Qil~aL~yLHs~~IiHRDLKP~NILl~~~~~~~iKL~DF 519 (966)
..|+||||+. ++|.+.+.. .+++..+..++.||+.||+|||++||+||||||+|||++. ++.+||+||
T Consensus 95 ~~~~~~~~lv~e~~~-~~l~~~~~~----~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~NIl~~~--~~~~kl~Df 167 (359)
T cd07876 95 LEEFQDVYLVMELMD-ANLCQVIHM----ELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKS--DCTLKILDF 167 (359)
T ss_pred ccccceeEEEEeCCC-cCHHHHHhc----cCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECC--CCCEEEecC
Confidence 5799999996 467766643 4889999999999999999999999999999999999975 568999999
Q ss_pred cccccccC--CCccccccccccCchhhccCCCCCCCcccchhhhhhhhhhhhcCCCCCCCcCcchhHHHHHHHHhcCCCC
Q psy11767 520 GFACLKRE--SLHTPCFTLQYAAPEVLRQDKSGYDENCDLWSLGVILVNVLRQDKSGYDENCDLWSLGVILYTMLCGRVP 597 (966)
Q Consensus 520 Gla~~~~~--~~~~~~gT~~Y~APEvl~~~~~~~~~~~Di~SlGvil~el~~~~~~~y~~~~DIWSlGvilyemltG~~P 597 (966)
|+++.... ......+|+.|+|||++.. ..|+.++|||||||++|+|++|+.|
T Consensus 168 g~a~~~~~~~~~~~~~~t~~y~aPE~~~~--------------------------~~~~~~~DiwSlG~il~el~tg~~p 221 (359)
T cd07876 168 GLARTACTNFMMTPYVVTRYYRAPEVILG--------------------------MGYKENVDIWSVGCIMGELVKGSVI 221 (359)
T ss_pred CCccccccCccCCCCcccCCCCCchhccC--------------------------CCCCcchhhHHHHHHHHHHHhCCCC
Confidence 99975432 2234568999999999852 2367889999999999999999999
Q ss_pred CCCCCCchhHHHHHHHH------------------HcCCCCCC----------------chhhccCCHHHHHHHHHhccc
Q psy11767 598 FHARSRDDSALSIMARI------------------KEGQFNFD----------------AEAWSTVSSEAKELTKSLLTV 643 (966)
Q Consensus 598 f~~~~~~~~~~~~~~~i------------------~~~~~~~~----------------~~~~~~is~e~~~Li~~~L~~ 643 (966)
|.+.+..+....++..+ ......+. .......++++++||.+||..
T Consensus 222 f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~ 301 (359)
T cd07876 222 FQGTDHIDQWNKVIEQLGTPSAEFMNRLQPTVRNYVENRPQYPGISFEELFPDWIFPSESERDKLKTSQARDLLSKMLVI 301 (359)
T ss_pred CCCCCHHHHHHHHHHhcCCCcHHHHHHHHHHHHHHHhhCCCCCCcchhhhccccccccccccccccchhHHHHHHHHhcc
Confidence 98765332211111110 00000000 001112467899999999999
Q ss_pred CccccCChHHHHHHhhhhH
Q psy11767 644 NPAQRIRMMRVKLTFHAFH 662 (966)
Q Consensus 644 dP~~R~t~~~v~~~~~~~~ 662 (966)
||++|||+.++ ..|+|.
T Consensus 302 dP~~R~t~~e~--l~hp~~ 318 (359)
T cd07876 302 DPDKRISVDEA--LRHPYI 318 (359)
T ss_pred CcccCCCHHHH--hcCchh
Confidence 99999999976 446654
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-37 Score=353.09 Aligned_cols=242 Identities=24% Similarity=0.380 Sum_probs=192.6
Q ss_pred cccccccccccEEEEEEE-----cCCCcEEEEEEecccc------ChHHHHHHHHHhcCCCCceEEEEEEEeCCeEEEEE
Q psy11767 382 KAGILGDGSYSVCRRCVE-----KSTGQEYAVKIISRKI------DCSEEINLLRACQGHPNIVNLHCVFQDEVHTYLVL 450 (966)
Q Consensus 382 ~~~~LG~G~fG~Vy~a~~-----~~tg~~vAvK~i~~~~------~~~~Ei~iL~~l~~HpnIV~l~~~~~~~~~~~lVm 450 (966)
..+.||+|+||+||+|.+ ..++..||||+++... ...+|+.+|+.+.+|||||+++++|.+....|+||
T Consensus 39 ~~~~LG~G~fG~V~~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~il~~l~~HpnIv~l~~~~~~~~~~~lv~ 118 (375)
T cd05104 39 FGKTLGAGAFGKVVEATAYGLFKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHINIVNLLGACTVGGPTLVIT 118 (375)
T ss_pred hhheecCCccceEEEEEEeccccCccceeEEEEeccCCcCcHHHHHHHHHHHHHHHhcCCcceeeeeeeeccCCcceeee
Confidence 368899999999999974 3567799999986432 24569999998867999999999999999999999
Q ss_pred EccCCCCHHHHHHhcCC---------------------------------------------------------------
Q psy11767 451 ELLKGGELLDRIRQKGR--------------------------------------------------------------- 467 (966)
Q Consensus 451 Ey~~gg~L~~~l~~~~~--------------------------------------------------------------- 467 (966)
|||+||+|.+++.....
T Consensus 119 E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 198 (375)
T cd05104 119 EYCCYGDLLNFLRRKRDSFICPKHEDHAEAALYKNLLHQREMSCDSLNEYMDMKPGVSYVVPTKADKRRSVRSGSYIDQD 198 (375)
T ss_pred hhccCCcHHHHHHhcccccccccccchhhhHHHHhhhhhhcccchhhhhhhhcCCCcccccccccccccccccceecccc
Confidence 99999999999975321
Q ss_pred ----------CCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCcEEEecCCCCCEEEEeecccccccCCC-----ccc
Q psy11767 468 ----------CGFTENEASRIMRQLVAAVHFMHSRGVVHRDLKPENLLFSDPAGDNIKVVDFGFACLKRESL-----HTP 532 (966)
Q Consensus 468 ----------~~l~e~~~~~i~~Qil~aL~yLHs~~IiHRDLKP~NILl~~~~~~~iKL~DFGla~~~~~~~-----~~~ 532 (966)
..+++..+..++.||+.||+|||++||+||||||+|||+++ ++.+||+|||++....... ...
T Consensus 199 ~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nill~~--~~~~kl~DfG~a~~~~~~~~~~~~~~~ 276 (375)
T cd05104 199 VTSEILEEDELALDTEDLLSFSYQVAKGMSFLASKNCIHRDLAARNILLTH--GRITKICDFGLARDIRNDSNYVVKGNA 276 (375)
T ss_pred cHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCchhhEEEEC--CCcEEEecCccceeccCcccccccCCC
Confidence 24788999999999999999999999999999999999985 5689999999997543211 122
Q ss_pred cccccccCchhhccCCCCCCCcccchhhhhhhhhhhhcCCCCCCCcCcchhHHHHHHHHhc-CCCCCCCCCCchhHHHHH
Q psy11767 533 CFTLQYAAPEVLRQDKSGYDENCDLWSLGVILVNVLRQDKSGYDENCDLWSLGVILYTMLC-GRVPFHARSRDDSALSIM 611 (966)
Q Consensus 533 ~gT~~Y~APEvl~~~~~~~~~~~Di~SlGvil~el~~~~~~~y~~~~DIWSlGvilyemlt-G~~Pf~~~~~~~~~~~~~ 611 (966)
.++..|+|||++.. ..|+.++|||||||++|+|++ |..||....... ...
T Consensus 277 ~~~~~y~aPE~~~~--------------------------~~~~~~sDi~slG~~l~ellt~g~~p~~~~~~~~---~~~ 327 (375)
T cd05104 277 RLPVKWMAPESIFN--------------------------CVYTFESDVWSYGILLWEIFSLGSSPYPGMPVDS---KFY 327 (375)
T ss_pred CCCcceeChhHhcC--------------------------CCCCCCCCHHHHHHHHHHHHhcCCCCCCCCCchH---HHH
Confidence 34567999998852 236789999999999999997 899997654332 223
Q ss_pred HHHHcCCCCCCchhhccCCHHHHHHHHHhcccCccccCChHHHHHH
Q psy11767 612 ARIKEGQFNFDAEAWSTVSSEAKELTKSLLTVNPAQRIRMMRVKLT 657 (966)
Q Consensus 612 ~~i~~~~~~~~~~~~~~is~e~~~Li~~~L~~dP~~R~t~~~v~~~ 657 (966)
..+..+.... .+...+.++.+||.+||..||++||++.++...
T Consensus 328 ~~~~~~~~~~---~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~ 370 (375)
T cd05104 328 KMIKEGYRML---SPECAPSEMYDIMKSCWDADPLKRPTFKQIVQL 370 (375)
T ss_pred HHHHhCccCC---CCCCCCHHHHHHHHHHccCChhHCcCHHHHHHH
Confidence 3334332211 123467899999999999999999999988543
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce |
| >cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-37 Score=337.68 Aligned_cols=247 Identities=30% Similarity=0.503 Sum_probs=197.3
Q ss_pred ccccccccccccEEEEEEEcCCCcEEEEEEecccc--------ChHHHHHHHHHhcCCCCceEEEEEEEeCCeEEEEEEc
Q psy11767 381 DKAGILGDGSYSVCRRCVEKSTGQEYAVKIISRKI--------DCSEEINLLRACQGHPNIVNLHCVFQDEVHTYLVLEL 452 (966)
Q Consensus 381 ~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~--------~~~~Ei~iL~~l~~HpnIV~l~~~~~~~~~~~lVmEy 452 (966)
+..+.||+|+||.||+|.+..+++.||||.+.... ....|+.+|+.+ +|+||+.+++.+.++...|+||||
T Consensus 3 ~~~~~ig~G~~g~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l-~~~~i~~~~~~~~~~~~~~lv~e~ 81 (285)
T cd05630 3 RQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKV-NSRFVVSLAYAYETKDALCLVLTL 81 (285)
T ss_pred eeeEEeecCCCeEEEEEEEcCCCceEEEEEEehhhccchHHHHHHHHHHHHHHhC-CCCCeeeeeEEEecCCEEEEEEEe
Confidence 34578999999999999999999999999986432 134588999888 599999999999999999999999
Q ss_pred cCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCcEEEecCCCCCEEEEeecccccccC--CCc
Q psy11767 453 LKGGELLDRIRQKGRCGFTENEASRIMRQLVAAVHFMHSRGVVHRDLKPENLLFSDPAGDNIKVVDFGFACLKRE--SLH 530 (966)
Q Consensus 453 ~~gg~L~~~l~~~~~~~l~e~~~~~i~~Qil~aL~yLHs~~IiHRDLKP~NILl~~~~~~~iKL~DFGla~~~~~--~~~ 530 (966)
++|++|.+++...+...+++..+..++.|++.||+|||+.||+||||||+|||++. .+.++|+|||++..... ...
T Consensus 82 ~~g~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~iiH~dikp~Nil~~~--~~~~~l~Dfg~~~~~~~~~~~~ 159 (285)
T cd05630 82 MNGGDLKFHIYHMGEAGFEEGRAVFYAAEICCGLEDLHQERIVYRDLKPENILLDD--HGHIRISDLGLAVHVPEGQTIK 159 (285)
T ss_pred cCCCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCCCHHHEEECC--CCCEEEeeccceeecCCCcccc
Confidence 99999999987655556999999999999999999999999999999999999975 56899999999865432 223
Q ss_pred cccccccccCchhhccCCCCCCCcccchhhhhhhhhhhhcCCCCCCCcCcchhHHHHHHHHhcCCCCCCCCCCchhHHHH
Q psy11767 531 TPCFTLQYAAPEVLRQDKSGYDENCDLWSLGVILVNVLRQDKSGYDENCDLWSLGVILYTMLCGRVPFHARSRDDSALSI 610 (966)
Q Consensus 531 ~~~gT~~Y~APEvl~~~~~~~~~~~Di~SlGvil~el~~~~~~~y~~~~DIWSlGvilyemltG~~Pf~~~~~~~~~~~~ 610 (966)
...||+.|+|||++.. ..++.++||||+||++|+|++|++||............
T Consensus 160 ~~~g~~~y~aPE~~~~--------------------------~~~~~~~DiwslG~~l~~l~~g~~Pf~~~~~~~~~~~~ 213 (285)
T cd05630 160 GRVGTVGYMAPEVVKN--------------------------ERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEV 213 (285)
T ss_pred CCCCCccccChHHHcC--------------------------CCCCCccccHHHHHHHHHHHhCCCCCCCCCccchHHHH
Confidence 3568999999999852 23678899999999999999999999865432111111
Q ss_pred HHHHHcCCCCCCchhhccCCHHHHHHHHHhcccCccccCC-----hHHHHHHhhhhH
Q psy11767 611 MARIKEGQFNFDAEAWSTVSSEAKELTKSLLTVNPAQRIR-----MMRVKLTFHAFH 662 (966)
Q Consensus 611 ~~~i~~~~~~~~~~~~~~is~e~~~Li~~~L~~dP~~R~t-----~~~v~~~~~~~~ 662 (966)
...+... .......+++++.+|+.+||+.||++||| +.++ ..|+|+
T Consensus 214 ~~~~~~~----~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~~~--~~h~~~ 264 (285)
T cd05630 214 ERLVKEV----QEEYSEKFSPDARSLCKMLLCKDPKERLGCQGGGAREV--KEHPLF 264 (285)
T ss_pred Hhhhhhh----hhhcCccCCHHHHHHHHHHhhcCHHHccCCCCCchHHH--HcChhh
Confidence 1111111 11123457899999999999999999999 5544 445665
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as |
| >cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-37 Score=350.55 Aligned_cols=247 Identities=25% Similarity=0.465 Sum_probs=194.0
Q ss_pred cccccccccccEEEEEEEcCCCcEEEEEEecccc-------ChHHHHHHHHHhcCCCCceEEEEEEEeC------CeEEE
Q psy11767 382 KAGILGDGSYSVCRRCVEKSTGQEYAVKIISRKI-------DCSEEINLLRACQGHPNIVNLHCVFQDE------VHTYL 448 (966)
Q Consensus 382 ~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~-------~~~~Ei~iL~~l~~HpnIV~l~~~~~~~------~~~~l 448 (966)
.++.||+|+||+||+|.+..+++.||||++.... ...+|+.+|+.+ +||||++++++|... ...|+
T Consensus 19 ~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~~~~~~~~ 97 (343)
T cd07878 19 NLTPVGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHM-KHENVIGLLDVFTPATSIENFNEVYL 97 (343)
T ss_pred hheecccCCCeEEEEEEECCCCCEEEEEEeCchhhhhHHHHHHHHHHHHHHhc-CCCchhhhhhhhcccccccccCcEEE
Confidence 3688999999999999999999999999986532 134699999998 599999999988643 45799
Q ss_pred EEEccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCcEEEecCCCCCEEEEeecccccccCC
Q psy11767 449 VLELLKGGELLDRIRQKGRCGFTENEASRIMRQLVAAVHFMHSRGVVHRDLKPENLLFSDPAGDNIKVVDFGFACLKRES 528 (966)
Q Consensus 449 VmEy~~gg~L~~~l~~~~~~~l~e~~~~~i~~Qil~aL~yLHs~~IiHRDLKP~NILl~~~~~~~iKL~DFGla~~~~~~ 528 (966)
+||++ +++|.+++... .+++..++.++.||+.||+|||++||+||||||+|||+++ ++.+||+|||++......
T Consensus 98 ~~~~~-~~~l~~~~~~~---~l~~~~~~~i~~qi~~aL~~LH~~~ivHrdikp~Nil~~~--~~~~kl~Dfg~~~~~~~~ 171 (343)
T cd07878 98 VTNLM-GADLNNIVKCQ---KLSDEHVQFLIYQLLRGLKYIHSAGIIHRDLKPSNVAVNE--DCELRILDFGLARQADDE 171 (343)
T ss_pred EeecC-CCCHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCCeecccCChhhEEECC--CCCEEEcCCccceecCCC
Confidence 99998 78998877543 5999999999999999999999999999999999999975 568999999999876655
Q ss_pred CccccccccccCchhhccCCCCCCCcccchhhhhhhhhhhhcCCCCCCCcCcchhHHHHHHHHhcCCCCCCCCCCchhHH
Q psy11767 529 LHTPCFTLQYAAPEVLRQDKSGYDENCDLWSLGVILVNVLRQDKSGYDENCDLWSLGVILYTMLCGRVPFHARSRDDSAL 608 (966)
Q Consensus 529 ~~~~~gT~~Y~APEvl~~~~~~~~~~~Di~SlGvil~el~~~~~~~y~~~~DIWSlGvilyemltG~~Pf~~~~~~~~~~ 608 (966)
....++|+.|+|||++.. ...|+.++|||||||++|+|++|+.||.+....+...
T Consensus 172 ~~~~~~t~~y~aPE~~~~-------------------------~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~ 226 (343)
T cd07878 172 MTGYVATRWYRAPEIMLN-------------------------WMHYNQTVDIWSVGCIMAELLKGKALFPGNDYIDQLK 226 (343)
T ss_pred cCCccccccccCchHhcC-------------------------CccCCchhhhHhHHHHHHHHHHCCCCCCCCCHHHHHH
Confidence 566778999999998852 1246789999999999999999999998654332222
Q ss_pred HHHHHHHcCC------------------C-CCC----chhhccCCHHHHHHHHHhcccCccccCChHHHHHHhhhhH
Q psy11767 609 SIMARIKEGQ------------------F-NFD----AEAWSTVSSEAKELTKSLLTVNPAQRIRMMRVKLTFHAFH 662 (966)
Q Consensus 609 ~~~~~i~~~~------------------~-~~~----~~~~~~is~e~~~Li~~~L~~dP~~R~t~~~v~~~~~~~~ 662 (966)
.+........ . ... ...+...++.+.+||.+||..||++|||+.++ ..|+|+
T Consensus 227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dp~~R~s~~el--l~hp~~ 301 (343)
T cd07878 227 RIMEVVGTPSPEVLKKISSEHARKYIQSLPHMPQQDLKKIFRGANPLAIDLLEKMLVLDSDKRISASEA--LAHPYF 301 (343)
T ss_pred HHHHHhCCCCHHHHHhcchhhHHHHhhccccccchhHHHhccCCCHHHHHHHHHHcCCChhhCCCHHHH--hcCcch
Confidence 1111100000 0 000 01123467788999999999999999999876 346665
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is |
| >cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-37 Score=349.40 Aligned_cols=245 Identities=29% Similarity=0.514 Sum_probs=189.7
Q ss_pred cccccccccccEEEEEEEcCCCcEEEEEEecccc-------ChHHHHHHHHHhcCCCCceEEEEEEEeC------CeEEE
Q psy11767 382 KAGILGDGSYSVCRRCVEKSTGQEYAVKIISRKI-------DCSEEINLLRACQGHPNIVNLHCVFQDE------VHTYL 448 (966)
Q Consensus 382 ~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~-------~~~~Ei~iL~~l~~HpnIV~l~~~~~~~------~~~~l 448 (966)
..+.||+|+||.||+|.+..+++.||||++.... ...+|+.+|+.+ +||||++++++|... ...|+
T Consensus 21 ~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~~~~~~~l 99 (355)
T cd07874 21 NLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCV-NHKNIISLLNVFTPQKSLEEFQDVYL 99 (355)
T ss_pred EEEEeeecCCEEEEEEEecCCCceEEEEEeCCcccChHHHHHHHHHHHHHHHh-CCCchhceeeeeeccccccccceeEE
Confidence 3688999999999999999999999999987532 234688888887 599999999998654 35799
Q ss_pred EEEccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCcEEEecCCCCCEEEEeecccccccCC
Q psy11767 449 VLELLKGGELLDRIRQKGRCGFTENEASRIMRQLVAAVHFMHSRGVVHRDLKPENLLFSDPAGDNIKVVDFGFACLKRES 528 (966)
Q Consensus 449 VmEy~~gg~L~~~l~~~~~~~l~e~~~~~i~~Qil~aL~yLHs~~IiHRDLKP~NILl~~~~~~~iKL~DFGla~~~~~~ 528 (966)
||||++ ++|.+.+.. .+++..+..++.||+.||+|||++||+||||||+|||++. ++.+||+|||+++.....
T Consensus 100 v~e~~~-~~l~~~~~~----~l~~~~~~~~~~qi~~aL~~LH~~givHrDikp~Nill~~--~~~~kl~Dfg~~~~~~~~ 172 (355)
T cd07874 100 VMELMD-ANLCQVIQM----ELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKS--DCTLKILDFGLARTAGTS 172 (355)
T ss_pred Ehhhhc-ccHHHHHhh----cCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChHHEEECC--CCCEEEeeCcccccCCCc
Confidence 999996 467777643 4889999999999999999999999999999999999975 568999999999765432
Q ss_pred --CccccccccccCchhhccCCCCCCCcccchhhhhhhhhhhhcCCCCCCCcCcchhHHHHHHHHhcCCCCCCCCCCchh
Q psy11767 529 --LHTPCFTLQYAAPEVLRQDKSGYDENCDLWSLGVILVNVLRQDKSGYDENCDLWSLGVILYTMLCGRVPFHARSRDDS 606 (966)
Q Consensus 529 --~~~~~gT~~Y~APEvl~~~~~~~~~~~Di~SlGvil~el~~~~~~~y~~~~DIWSlGvilyemltG~~Pf~~~~~~~~ 606 (966)
.....+|+.|+|||++.. ..|+.++|||||||++|+|++|+.||.+.+..+.
T Consensus 173 ~~~~~~~~t~~y~aPE~~~~--------------------------~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~ 226 (355)
T cd07874 173 FMMTPYVVTRYYRAPEVILG--------------------------MGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQ 226 (355)
T ss_pred cccCCccccCCccCHHHHcC--------------------------CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH
Confidence 234578999999998852 2467889999999999999999999987653332
Q ss_pred HHHHHHHHH------------------cCC----------------CCCCchhhccCCHHHHHHHHHhcccCccccCChH
Q psy11767 607 ALSIMARIK------------------EGQ----------------FNFDAEAWSTVSSEAKELTKSLLTVNPAQRIRMM 652 (966)
Q Consensus 607 ~~~~~~~i~------------------~~~----------------~~~~~~~~~~is~e~~~Li~~~L~~dP~~R~t~~ 652 (966)
....+..+. ... +..........+.++++||.+||..||++|||+.
T Consensus 227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rps~~ 306 (355)
T cd07874 227 WNKVIEQLGTPCPEFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVD 306 (355)
T ss_pred HHHHHHHhCCCCHHHHHhhcHHHHHHHhcCCccccccchhhccccccccccccccccchHHHHHHHHHhcCCchhcCCHH
Confidence 222211110 000 0001111223467889999999999999999999
Q ss_pred HHHHHhhhhH
Q psy11767 653 RVKLTFHAFH 662 (966)
Q Consensus 653 ~v~~~~~~~~ 662 (966)
++ ..|+|.
T Consensus 307 el--l~hp~~ 314 (355)
T cd07874 307 EA--LQHPYI 314 (355)
T ss_pred HH--hcCcch
Confidence 76 346665
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok |
| >PTZ00266 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-36 Score=372.75 Aligned_cols=257 Identities=27% Similarity=0.432 Sum_probs=200.4
Q ss_pred ccceecccccccccccccccccccEEEEEEEcCCCcEEEEEEecccc-------ChHHHHHHHHHhcCCCCceEEEEEEE
Q psy11767 369 GSLFFEQYDMDLDKAGILGDGSYSVCRRCVEKSTGQEYAVKIISRKI-------DCSEEINLLRACQGHPNIVNLHCVFQ 441 (966)
Q Consensus 369 G~~~~~~~~i~~~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~-------~~~~Ei~iL~~l~~HpnIV~l~~~~~ 441 (966)
+..+.+.|.+ ++.||+|+||+||+|.+..+++.||+|++.... .+..|+.+|+.+ .|||||+++++|.
T Consensus 8 ge~~l~~YeI----l~kLG~GgFGtVYLAkdk~tg~~vAlKvIk~~~l~e~~~~~~~~EI~IL~~L-~HPNIVrl~d~f~ 82 (1021)
T PTZ00266 8 GESRLNEYEV----IKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGLKEREKSQLVIEVNVMREL-KHKNIVRYIDRFL 82 (1021)
T ss_pred CccccCCEEE----EEEEecCCCeEEEEEEECCCCeEEEEEEEeccccCHHHHHHHHHHHHHHHHc-CCCCcCeEEEEEE
Confidence 3444455555 688999999999999999999999999986432 244699999998 5999999999986
Q ss_pred eC--CeEEEEEEccCCCCHHHHHHhcC--CCCCCHHHHHHHHHHHHHHHHHHHhc-------CceeccCCCCcEEEecC-
Q psy11767 442 DE--VHTYLVLELLKGGELLDRIRQKG--RCGFTENEASRIMRQLVAAVHFMHSR-------GVVHRDLKPENLLFSDP- 509 (966)
Q Consensus 442 ~~--~~~~lVmEy~~gg~L~~~l~~~~--~~~l~e~~~~~i~~Qil~aL~yLHs~-------~IiHRDLKP~NILl~~~- 509 (966)
+. ..+|||||||++|+|.++|.... ...+++..++.|+.||+.||+|||+. +||||||||+||||+..
T Consensus 83 de~~~~lyIVMEY~~gGSL~~lL~k~~~~~g~L~E~~Il~Ia~QIL~ALaYLHs~g~~~~~k~IVHRDLKPeNILL~s~~ 162 (1021)
T PTZ00266 83 NKANQKLYILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGI 162 (1021)
T ss_pred ecCCCEEEEEEeCCCCCcHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhcccccccCCceeccCcHHHeEeecCc
Confidence 53 56899999999999999997532 23599999999999999999999984 49999999999999631
Q ss_pred --------------CCCCEEEEeecccccccCC--CccccccccccCchhhccCCCCCCCcccchhhhhhhhhhhhcCCC
Q psy11767 510 --------------AGDNIKVVDFGFACLKRES--LHTPCFTLQYAAPEVLRQDKSGYDENCDLWSLGVILVNVLRQDKS 573 (966)
Q Consensus 510 --------------~~~~iKL~DFGla~~~~~~--~~~~~gT~~Y~APEvl~~~~~~~~~~~Di~SlGvil~el~~~~~~ 573 (966)
....+||+|||++...... ....++|+.|+|||++... ..
T Consensus 163 ~~lg~i~~~~~n~ng~~iVKLsDFGlAr~l~~~s~~~s~vGTp~YmAPEvL~ge------------------------~~ 218 (1021)
T PTZ00266 163 RHIGKITAQANNLNGRPIAKIGDFGLSKNIGIESMAHSCVGTPYYWSPELLLHE------------------------TK 218 (1021)
T ss_pred cccccccccccccCCCCceEEccCCccccccccccccccCCCccccCHHHHhcc------------------------CC
Confidence 1235899999999764322 2345689999999998532 23
Q ss_pred CCCCcCcchhHHHHHHHHhcCCCCCCCCCCchhHHHHHHHHHcCCCCCCchhhccCCHHHHHHHHHhcccCccccCChHH
Q psy11767 574 GYDENCDLWSLGVILYTMLCGRVPFHARSRDDSALSIMARIKEGQFNFDAEAWSTVSSEAKELTKSLLTVNPAQRIRMMR 653 (966)
Q Consensus 574 ~y~~~~DIWSlGvilyemltG~~Pf~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~is~e~~~Li~~~L~~dP~~R~t~~~ 653 (966)
.|+.++||||||||||+|++|+.||....... .++..+..+. .+ .....+.++.+||.+||..+|.+||++.+
T Consensus 219 ~~s~KSDVWSLG~ILYELLTGk~PF~~~~~~~---qli~~lk~~p-~l---pi~~~S~eL~dLI~~~L~~dPeeRPSa~Q 291 (1021)
T PTZ00266 219 SYDDKSDMWALGCIIYELCSGKTPFHKANNFS---QLISELKRGP-DL---PIKGKSKELNILIKNLLNLSAKERPSALQ 291 (1021)
T ss_pred CCCchhHHHHHHHHHHHHHHCCCCCCcCCcHH---HHHHHHhcCC-CC---CcCCCCHHHHHHHHHHhcCChhHCcCHHH
Confidence 46889999999999999999999997654322 2333343332 11 12346889999999999999999999987
Q ss_pred HHHHhhhhHH
Q psy11767 654 VKLTFHAFHQ 663 (966)
Q Consensus 654 v~~~~~~~~~ 663 (966)
+. .++|..
T Consensus 292 lL--~h~~ik 299 (1021)
T PTZ00266 292 CL--GYQIIK 299 (1021)
T ss_pred Hh--ccHHHh
Confidence 63 344543
|
|
| >cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-37 Score=338.35 Aligned_cols=254 Identities=28% Similarity=0.457 Sum_probs=199.0
Q ss_pred ccccccccccccEEEEEEEcCCCcEEEEEEecccc------ChHHHHHHHHHhcCCCCceEEEEEEEeCCeEEEEEEccC
Q psy11767 381 DKAGILGDGSYSVCRRCVEKSTGQEYAVKIISRKI------DCSEEINLLRACQGHPNIVNLHCVFQDEVHTYLVLELLK 454 (966)
Q Consensus 381 ~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~------~~~~Ei~iL~~l~~HpnIV~l~~~~~~~~~~~lVmEy~~ 454 (966)
...+.||.|+||.||+|.+..+++.||+|.+.... ...+|+.+|+.+ +||||+++++++.++...|+||||+.
T Consensus 9 ~~~~~lg~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l-~h~nI~~~~~~~~~~~~~~lv~e~~~ 87 (301)
T cd07873 9 IKLDKLGEGTYATVYKGRSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDL-KHANIVTLHDIIHTEKSLTLVFEYLD 87 (301)
T ss_pred EEeeEeccCcCEEEEEEEEcCCCcEEEEEEEecccccCchhHHHHHHHHHHhc-CCCCcceEEEEEecCCeEEEEEeccc
Confidence 34688999999999999999999999999986432 245799999998 59999999999999999999999996
Q ss_pred CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCcEEEecCCCCCEEEEeecccccccCC---Ccc
Q psy11767 455 GGELLDRIRQKGRCGFTENEASRIMRQLVAAVHFMHSRGVVHRDLKPENLLFSDPAGDNIKVVDFGFACLKRES---LHT 531 (966)
Q Consensus 455 gg~L~~~l~~~~~~~l~e~~~~~i~~Qil~aL~yLHs~~IiHRDLKP~NILl~~~~~~~iKL~DFGla~~~~~~---~~~ 531 (966)
++|.+++..... .+++..++.++.||+.||+|||+.||+||||||+|||+++ ++.+||+|||++...... ...
T Consensus 88 -~~l~~~l~~~~~-~~~~~~~~~~~~qi~~aL~~lH~~~i~H~dlkp~Nil~~~--~~~~kl~dfg~~~~~~~~~~~~~~ 163 (301)
T cd07873 88 -KDLKQYLDDCGN-SINMHNVKLFLFQLLRGLNYCHRRKVLHRDLKPQNLLINE--RGELKLADFGLARAKSIPTKTYSN 163 (301)
T ss_pred -cCHHHHHHhcCC-CCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCHHHEEECC--CCcEEECcCcchhccCCCCCcccc
Confidence 689988876543 5899999999999999999999999999999999999975 568999999998654321 223
Q ss_pred ccccccccCchhhccCCCCCCCcccchhhhhhhhhhhhcCCCCCCCcCcchhHHHHHHHHhcCCCCCCCCCCchhHHHHH
Q psy11767 532 PCFTLQYAAPEVLRQDKSGYDENCDLWSLGVILVNVLRQDKSGYDENCDLWSLGVILYTMLCGRVPFHARSRDDSALSIM 611 (966)
Q Consensus 532 ~~gT~~Y~APEvl~~~~~~~~~~~Di~SlGvil~el~~~~~~~y~~~~DIWSlGvilyemltG~~Pf~~~~~~~~~~~~~ 611 (966)
..+++.|+|||++.. ...++.++|||||||++|+|++|++||...+..+....+.
T Consensus 164 ~~~~~~y~~PE~~~~-------------------------~~~~~~~~Dv~slG~~l~el~tg~~~f~~~~~~~~~~~~~ 218 (301)
T cd07873 164 EVVTLWYRPPDILLG-------------------------STDYSTQIDMWGVGCIFYEMSTGRPLFPGSTVEEQLHFIF 218 (301)
T ss_pred cceeecccCcHHHhC-------------------------CCCCccHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH
Confidence 456889999998752 2236778999999999999999999998765433222211
Q ss_pred HHHHc---------------CCCCCC-------chhhccCCHHHHHHHHHhcccCccccCChHHHHHHhhhhHHhhh
Q psy11767 612 ARIKE---------------GQFNFD-------AEAWSTVSSEAKELTKSLLTVNPAQRIRMMRVKLTFHAFHQAQK 666 (966)
Q Consensus 612 ~~i~~---------------~~~~~~-------~~~~~~is~e~~~Li~~~L~~dP~~R~t~~~v~~~~~~~~~~~~ 666 (966)
..+.. ..+.++ ......+++++++||.+||..||.+|||+.++ ..|+|++...
T Consensus 219 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~ei--l~h~~f~~~~ 293 (301)
T cd07873 219 RILGTPTEETWPGILSNEEFKSYNYPKYRADCLHNHAPRLDSDGAELLSKLLQFEGRKRISAEEA--MKHPYFHCLG 293 (301)
T ss_pred HHcCCCChhhchhhhccccccccccCccccccHHhhcCCCCHHHHHHHHHHhcCCcccCcCHHHH--hcCccccccc
Confidence 11100 000000 01123578899999999999999999999876 4567765443
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl |
| >PHA03207 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-37 Score=352.37 Aligned_cols=250 Identities=23% Similarity=0.372 Sum_probs=196.4
Q ss_pred cccccccccccccEEEEEEEc--CCCcEEEEEEeccccChHHHHHHHHHhcCCCCceEEEEEEEeCCeEEEEEEccCCCC
Q psy11767 380 LDKAGILGDGSYSVCRRCVEK--STGQEYAVKIISRKIDCSEEINLLRACQGHPNIVNLHCVFQDEVHTYLVLELLKGGE 457 (966)
Q Consensus 380 ~~~~~~LG~G~fG~Vy~a~~~--~tg~~vAvK~i~~~~~~~~Ei~iL~~l~~HpnIV~l~~~~~~~~~~~lVmEy~~gg~ 457 (966)
|...+.||+|+||.||+|... .++..||+|.+.......+|+++|+.+ +|||||+++++|..+...|+|||++. ++
T Consensus 94 y~i~~~Lg~G~~g~Vy~~~~~~~~~~~~v~vK~~~~~~~~~~E~~il~~l-~h~~iv~~~~~~~~~~~~~lv~e~~~-~~ 171 (392)
T PHA03207 94 YNILSSLTPGSEGEVFVCTKHGDEQRKKVIVKAVTGGKTPGREIDILKTI-SHRAIINLIHAYRWKSTVCMVMPKYK-CD 171 (392)
T ss_pred eEEEEeecCCCCeEEEEEEEcCCccceeEEEEeccccccHHHHHHHHHhc-CCCCccceeeeEeeCCEEEEEehhcC-CC
Confidence 444789999999999999764 457889999998776778899999998 59999999999999999999999994 78
Q ss_pred HHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCcEEEecCCCCCEEEEeecccccccCC-----Cccc
Q psy11767 458 LLDRIRQKGRCGFTENEASRIMRQLVAAVHFMHSRGVVHRDLKPENLLFSDPAGDNIKVVDFGFACLKRES-----LHTP 532 (966)
Q Consensus 458 L~~~l~~~~~~~l~e~~~~~i~~Qil~aL~yLHs~~IiHRDLKP~NILl~~~~~~~iKL~DFGla~~~~~~-----~~~~ 532 (966)
|.+++.... .+++.+++.++.||+.||+|||++||+||||||+|||++. .+.+||+|||+++..... ....
T Consensus 172 l~~~l~~~~--~l~~~~~~~i~~ql~~aL~~LH~~givHrDlkp~Nill~~--~~~~~l~DfG~a~~~~~~~~~~~~~~~ 247 (392)
T PHA03207 172 LFTYVDRSG--PLPLEQAITIQRRLLEALAYLHGRGIIHRDVKTENIFLDE--PENAVLGDFGAACKLDAHPDTPQCYGW 247 (392)
T ss_pred HHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEcC--CCCEEEccCccccccCccccccccccc
Confidence 999885443 6999999999999999999999999999999999999975 568999999999754332 1234
Q ss_pred cccccccCchhhccCCCCCCCcccchhhhhhhhhhhhcCCCCCCCcCcchhHHHHHHHHhcCCCCCCCCCCchhH---HH
Q psy11767 533 CFTLQYAAPEVLRQDKSGYDENCDLWSLGVILVNVLRQDKSGYDENCDLWSLGVILYTMLCGRVPFHARSRDDSA---LS 609 (966)
Q Consensus 533 ~gT~~Y~APEvl~~~~~~~~~~~Di~SlGvil~el~~~~~~~y~~~~DIWSlGvilyemltG~~Pf~~~~~~~~~---~~ 609 (966)
.||+.|+|||++.. ..|+.++|||||||++|+|++|+.||.+....... ..
T Consensus 248 ~gt~~y~aPE~~~~--------------------------~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~l~~ 301 (392)
T PHA03207 248 SGTLETNSPELLAL--------------------------DPYCAKTDIWSAGLVLFEMSVKNVTLFGKQVKSSSSQLRS 301 (392)
T ss_pred ccccCccCHhHhcC--------------------------CCCCchhhHHHHHHHHHHHHHCCCCCCCCCCCCcHHHHHH
Confidence 68999999998852 23778899999999999999999999876532211 11
Q ss_pred HHHHHHcCCCCCCc------------------------hh--hccCCHHHHHHHHHhcccCccccCChHHHHHHhhhhHH
Q psy11767 610 IMARIKEGQFNFDA------------------------EA--WSTVSSEAKELTKSLLTVNPAQRIRMMRVKLTFHAFHQ 663 (966)
Q Consensus 610 ~~~~i~~~~~~~~~------------------------~~--~~~is~e~~~Li~~~L~~dP~~R~t~~~v~~~~~~~~~ 663 (966)
+...+......++. .. ...++.++.++|.+||..||++|||+.++ ..|+|+.
T Consensus 302 i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~Rpsa~e~--l~~p~f~ 379 (392)
T PHA03207 302 IIRCMQVHPLEFPQNGSTNLCKHFKQYAIVLRPPYTIPPVIRKYGMHMDVEYLIAKMLTFDQEFRPSAQDI--LSLPLFT 379 (392)
T ss_pred HHHHhccCccccCCccchhHHHHHHhhcccccCCccccchhhccCcchhHHHHHHHHhccChhhCCCHHHH--hhCchhh
Confidence 11111111100000 00 01346788999999999999999999976 4566653
|
|
| >cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-37 Score=348.60 Aligned_cols=244 Identities=28% Similarity=0.497 Sum_probs=189.4
Q ss_pred ccccccccccEEEEEEEcCCCcEEEEEEecccc-------ChHHHHHHHHHhcCCCCceEEEEEEEeC------CeEEEE
Q psy11767 383 AGILGDGSYSVCRRCVEKSTGQEYAVKIISRKI-------DCSEEINLLRACQGHPNIVNLHCVFQDE------VHTYLV 449 (966)
Q Consensus 383 ~~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~-------~~~~Ei~iL~~l~~HpnIV~l~~~~~~~------~~~~lV 449 (966)
.+.||+|+||.||+|.+..+++.||||++.... ...+|+.+++.+ +||||+++++++... ...|+|
T Consensus 29 ~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~ii~~~~~~~~~~~~~~~~~~~lv 107 (364)
T cd07875 29 LKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCV-NHKNIIGLLNVFTPQKSLEEFQDVYIV 107 (364)
T ss_pred EEEeecCCCeEEEEEEECCCCcEEEEEEeCccccCchhHHHHHHHHHHHHhc-CCCCccccceeecccccccccCeEEEE
Confidence 688999999999999999999999999986532 234688888887 599999999988643 357999
Q ss_pred EEccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCcEEEecCCCCCEEEEeecccccccCC-
Q psy11767 450 LELLKGGELLDRIRQKGRCGFTENEASRIMRQLVAAVHFMHSRGVVHRDLKPENLLFSDPAGDNIKVVDFGFACLKRES- 528 (966)
Q Consensus 450 mEy~~gg~L~~~l~~~~~~~l~e~~~~~i~~Qil~aL~yLHs~~IiHRDLKP~NILl~~~~~~~iKL~DFGla~~~~~~- 528 (966)
|||++ ++|.+.+.. .+++..+..++.|++.||+|||++||+||||||+|||++. ++.+||+|||+++.....
T Consensus 108 ~e~~~-~~l~~~~~~----~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~--~~~~kL~DfG~a~~~~~~~ 180 (364)
T cd07875 108 MELMD-ANLCQVIQM----ELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKS--DCTLKILDFGLARTAGTSF 180 (364)
T ss_pred EeCCC-CCHHHHHHh----cCCHHHHHHHHHHHHHHHHHHhhCCeecCCCCHHHEEECC--CCcEEEEeCCCccccCCCC
Confidence 99996 577777743 3789999999999999999999999999999999999975 568999999999765432
Q ss_pred -CccccccccccCchhhccCCCCCCCcccchhhhhhhhhhhhcCCCCCCCcCcchhHHHHHHHHhcCCCCCCCCCCchhH
Q psy11767 529 -LHTPCFTLQYAAPEVLRQDKSGYDENCDLWSLGVILVNVLRQDKSGYDENCDLWSLGVILYTMLCGRVPFHARSRDDSA 607 (966)
Q Consensus 529 -~~~~~gT~~Y~APEvl~~~~~~~~~~~Di~SlGvil~el~~~~~~~y~~~~DIWSlGvilyemltG~~Pf~~~~~~~~~ 607 (966)
.....+|+.|+|||++.. ..|+.++|||||||++|+|++|+.||.+.+..+..
T Consensus 181 ~~~~~~~t~~y~aPE~~~~--------------------------~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~ 234 (364)
T cd07875 181 MMTPYVVTRYYRAPEVILG--------------------------MGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQW 234 (364)
T ss_pred cccCCcccCCcCCHHHHhC--------------------------CCCCchhhHHhHHHHHHHHHhCCCCCCCCCHHHHH
Confidence 234568999999999852 23678899999999999999999999876543322
Q ss_pred HHHHHHHHc------------------CC----------------CCCCchhhccCCHHHHHHHHHhcccCccccCChHH
Q psy11767 608 LSIMARIKE------------------GQ----------------FNFDAEAWSTVSSEAKELTKSLLTVNPAQRIRMMR 653 (966)
Q Consensus 608 ~~~~~~i~~------------------~~----------------~~~~~~~~~~is~e~~~Li~~~L~~dP~~R~t~~~ 653 (966)
..++..+.. .. +..........+.++++||.+||+.||.+|||+.+
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~R~t~~e 314 (364)
T cd07875 235 NKVIEQLGTPCPEFMKKLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDE 314 (364)
T ss_pred HHHHHhcCCCCHHHHHhhhHHHHHHHhhCCCcCCCChHhhCccccccccccccccccHHHHHHHHHhcCcCcccCCCHHH
Confidence 222211100 00 00001111224578999999999999999999997
Q ss_pred HHHHhhhhH
Q psy11767 654 VKLTFHAFH 662 (966)
Q Consensus 654 v~~~~~~~~ 662 (966)
+ ..|+|.
T Consensus 315 ~--L~hp~~ 321 (364)
T cd07875 315 A--LQHPYI 321 (364)
T ss_pred H--hcCccc
Confidence 6 345654
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >KOG0612|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-38 Score=377.70 Aligned_cols=248 Identities=26% Similarity=0.425 Sum_probs=196.5
Q ss_pred CcceeeeecccccceEEEEEEcCCCCEEEEEeccccc--------hhhHHHHHHHHhhCCCcccccc-------------
Q psy11767 117 DLDKAGILGDGSYSVCRRCVEKSTGQEYAVKIISRKI--------DCSEEINLLRACQGHPNICRRC------------- 175 (966)
Q Consensus 117 df~~~~~LG~GsFGkV~La~~k~tg~~yAiKvl~K~~--------~~~~E~~il~~~~~~pfi~~~~------------- 175 (966)
||+++|+||+|+||.|.||++|.|+++||||+|+|-. .-.+||.||--. +.+||+...
T Consensus 76 DfeilKvIGrGaFGEV~lVr~k~t~~VYAMK~lnK~eMlKr~~tA~F~EERDimv~~-ns~Wiv~LhyAFQD~~~LYlVM 154 (1317)
T KOG0612|consen 76 DFEILKVIGRGAFGEVALVRHKSTEKVYAMKILNKWEMLKRAETACFREERDIMVFG-NSEWIVQLHYAFQDERYLYLVM 154 (1317)
T ss_pred hhHHHHHhcccccceeEEEEeeccccchhHHHhhHHHHhhchhHHHHHHHhHHHHcC-CcHHHHHHHHHhcCccceEEEE
Confidence 9999999999999999999999999999999999942 237799999775 589998632
Q ss_pred -----------------cccccchhHHHHHHHhh----------cccchhhhHhhhccCCceEEecCccc----------
Q psy11767 176 -----------------VEKSTGQEYAVKIISRK----------IDCSEEINLLRACQGHPNIVNLHCVF---------- 218 (966)
Q Consensus 176 -----------------~~~~~~~~~~~~~v~~~----------~~~~~e~nil~~~~gh~~iv~l~~~~---------- 218 (966)
+.+..++||.+++|.+. .|+++. |+|+|.+||.+|.|||-+.
T Consensus 155 dY~pGGDlltLlSk~~~~pE~~ArFY~aEiVlAldslH~mgyVHRDiKPD-NvLld~~GHikLADFGsClkm~~dG~V~s 233 (1317)
T KOG0612|consen 155 DYMPGGDLLTLLSKFDRLPEDWARFYTAEIVLALDSLHSMGYVHRDIKPD-NVLLDKSGHIKLADFGSCLKMDADGTVRS 233 (1317)
T ss_pred ecccCchHHHHHhhcCCChHHHHHHHHHHHHHHHHHHHhccceeccCCcc-eeEecccCcEeeccchhHHhcCCCCcEEe
Confidence 44555689999888661 255555 9999999999999998442
Q ss_pred ----------cccccccc-----cCCCcceeeechhhHHHHHHHhhCCCCCCCCcHHHHHHHHHhC--CCCCC--CCCCH
Q psy11767 219 ----------QDEVIDWD-----DFSRGIECVFFSSSLIIFFIILSFTLSFIHDYYHIQYRRILKT--EPPIP--EDLSP 279 (966)
Q Consensus 219 ----------~~e~i~~~-----~y~~~~d~~~~~~~~il~~~m~~g~~pf~~~~~~~~~~~I~~~--~~~~P--~~~s~ 279 (966)
.||++.-. -| |.+|| ||+.||++|||++|.+|||.+.-.++|-+|++- .+.|| ..+|+
T Consensus 234 ~~aVGTPDYISPEvLqs~~~~~g~y--G~ecD-wWSlGV~~YEMlyG~TPFYadslveTY~KIm~hk~~l~FP~~~~VSe 310 (1317)
T KOG0612|consen 234 SVAVGTPDYISPEVLQSQGDGKGEY--GRECD-WWSLGVFMYEMLYGETPFYADSLVETYGKIMNHKESLSFPDETDVSE 310 (1317)
T ss_pred ccccCCCCccCHHHHHhhcCCcccc--CCccc-hhhhHHHHHHHHcCCCcchHHHHHHHHHHHhchhhhcCCCcccccCH
Confidence 13444322 24 66787 556889999999999999999999999999975 89999 56899
Q ss_pred HHHHHHHhhcccCCCcccCCCCCCHHHHhcCCceeeeCccccccCCCCCCCCccccccccccccccccccCcC-CCCCCC
Q psy11767 280 DVADFISRLLVKDPRRRLGGGELDAEELKRHPFFNVIDWDDLATKRIPAPFVPKISNELDVSNFSDEFTKMIP-ADSPAI 358 (966)
Q Consensus 280 ~a~dli~~LL~kdp~~RLG~~~~g~~~Ik~HpfF~~idW~~l~~k~~~pP~~P~i~~~~D~snFd~ef~~~~p-~dSp~i 358 (966)
+|+|||++||+ +|..|||. +|++|||.||||.++||+.+ |+..|||+|.+++..|++|||..-....+ ...|..
T Consensus 311 eakdLI~~ll~-~~e~RLgr--ngiedik~HpFF~g~~W~~i--R~~~pP~vPevssd~DTsnFd~~~dd~~~~e~~p~~ 385 (1317)
T KOG0612|consen 311 EAKDLIEALLC-DREVRLGR--NGIEDIKNHPFFEGIDWDNI--RESVPPVVPEVSSDDDTSNFDVDEDDLRDAETFPPR 385 (1317)
T ss_pred HHHHHHHHHhc-Chhhhccc--ccHHHHHhCccccCCChhhh--hhcCCCCCCcCCCCCccccccccccccchhhccCCC
Confidence 99999999998 99999994 69999999999999999998 77899999999999999999643221111 111212
Q ss_pred CCC---CCcccccccceec
Q psy11767 359 VPP---NFDKIFKGSLFFE 374 (966)
Q Consensus 359 vp~---~~d~if~G~~~~~ 374 (966)
.|. +.+-.|.|+.|..
T Consensus 386 ~~~~f~Gn~LPFIGfTy~~ 404 (1317)
T KOG0612|consen 386 IPKAFSGNHLPFIGFTYTH 404 (1317)
T ss_pred CCCCCcCCcCCeeeeeecc
Confidence 222 3345677776653
|
|
| >cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-36 Score=333.61 Aligned_cols=246 Identities=31% Similarity=0.453 Sum_probs=193.8
Q ss_pred cccccccccccccEEEEEEEcCCCcEEEEEEecccc-------ChHHHHHHHHHhcCCCCceEEEEEEEeCCeEEEEEEc
Q psy11767 380 LDKAGILGDGSYSVCRRCVEKSTGQEYAVKIISRKI-------DCSEEINLLRACQGHPNIVNLHCVFQDEVHTYLVLEL 452 (966)
Q Consensus 380 ~~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~-------~~~~Ei~iL~~l~~HpnIV~l~~~~~~~~~~~lVmEy 452 (966)
|...+.||+|+||.||+|.+..+|+.||||++.... ...+|+.+|+.+ +||||+++++++.++...|+||||
T Consensus 2 y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~~v~e~ 80 (285)
T cd07861 2 YTKIEKIGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIREISLLKEL-QHPNIVCLQDVLMQESRLYLIFEF 80 (285)
T ss_pred ceEeeEecccCceEEEEEEECCCCcEEEEEEeccccccCCchHHHHHHHHHHHhc-CCCCEeeeEEEEeeCCeEEEEEec
Confidence 445678999999999999999999999999986321 245699999988 599999999999999999999999
Q ss_pred cCCCCHHHHHHhcCC-CCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCcEEEecCCCCCEEEEeecccccccCC---
Q psy11767 453 LKGGELLDRIRQKGR-CGFTENEASRIMRQLVAAVHFMHSRGVVHRDLKPENLLFSDPAGDNIKVVDFGFACLKRES--- 528 (966)
Q Consensus 453 ~~gg~L~~~l~~~~~-~~l~e~~~~~i~~Qil~aL~yLHs~~IiHRDLKP~NILl~~~~~~~iKL~DFGla~~~~~~--- 528 (966)
++ ++|.+++..... ..+++..++.++.||+.||+|||++||+||||||+|||+++ ++.+||+|||++......
T Consensus 81 ~~-~~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~nil~~~--~~~~~l~dfg~~~~~~~~~~~ 157 (285)
T cd07861 81 LS-MDLKKYLDSLPKGQYMDAELVKSYLYQILQGILFCHSRRVLHRDLKPQNLLIDN--KGVIKLADFGLARAFGIPVRV 157 (285)
T ss_pred CC-CCHHHHHhcCCCCCcCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCHHHEEEcC--CCcEEECcccceeecCCCccc
Confidence 97 689888865432 46899999999999999999999999999999999999975 568999999998654321
Q ss_pred CccccccccccCchhhccCCCCCCCcccchhhhhhhhhhhhcCCCCCCCcCcchhHHHHHHHHhcCCCCCCCCCCchhHH
Q psy11767 529 LHTPCFTLQYAAPEVLRQDKSGYDENCDLWSLGVILVNVLRQDKSGYDENCDLWSLGVILYTMLCGRVPFHARSRDDSAL 608 (966)
Q Consensus 529 ~~~~~gT~~Y~APEvl~~~~~~~~~~~Di~SlGvil~el~~~~~~~y~~~~DIWSlGvilyemltG~~Pf~~~~~~~~~~ 608 (966)
.....+++.|+|||++.. ...++.++|||||||++|+|++|++||.+....+...
T Consensus 158 ~~~~~~~~~y~aPE~~~~-------------------------~~~~~~~~Dv~slG~il~~l~tg~~~~~~~~~~~~~~ 212 (285)
T cd07861 158 YTHEVVTLWYRAPEVLLG-------------------------SPRYSTPVDIWSIGTIFAEMATKKPLFHGDSEIDQLF 212 (285)
T ss_pred ccCCcccccccChHHhcC-------------------------CCCcCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHH
Confidence 123456889999998742 2236778999999999999999999998765432222
Q ss_pred HHHHHHHc---------------------CCCCCCchhhccCCHHHHHHHHHhcccCccccCChHHH
Q psy11767 609 SIMARIKE---------------------GQFNFDAEAWSTVSSEAKELTKSLLTVNPAQRIRMMRV 654 (966)
Q Consensus 609 ~~~~~i~~---------------------~~~~~~~~~~~~is~e~~~Li~~~L~~dP~~R~t~~~v 654 (966)
........ ............+++++++||.+||..||++|||+.++
T Consensus 213 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~~l 279 (285)
T cd07861 213 RIFRILGTPTEDVWPGVTSLPDYKNTFPKWKKGSLRSAVKNLDEDGLDLLEKMLIYDPAKRISAKKA 279 (285)
T ss_pred HHHHHhCCCChhhhhcchhhHHHHhhccccCcchhHHhcCCCCHHHHHHHHHHhcCChhhCCCHHHH
Confidence 22111100 00000111234578999999999999999999999876
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 |
| >PTZ00283 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-37 Score=362.06 Aligned_cols=237 Identities=30% Similarity=0.499 Sum_probs=194.9
Q ss_pred ccccccccccEEEEEEEcCCCcEEEEEEecccc-------ChHHHHHHHHHhcCCCCceEEEEEEEeCC--------eEE
Q psy11767 383 AGILGDGSYSVCRRCVEKSTGQEYAVKIISRKI-------DCSEEINLLRACQGHPNIVNLHCVFQDEV--------HTY 447 (966)
Q Consensus 383 ~~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~-------~~~~Ei~iL~~l~~HpnIV~l~~~~~~~~--------~~~ 447 (966)
.+.||+|+||+||+|++..+|+.||||++.... ...+|+.+|..+ +|+||+++++.+.... .++
T Consensus 37 ~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~~-~h~~iv~~~~~~~~~~~~~~~~~~~i~ 115 (496)
T PTZ00283 37 SRVLGSGATGTVLCAKRVSDGEPFAVKVVDMEGMSEADKNRAQAEVCCLLNC-DFFSIVKCHEDFAKKDPRNPENVLMIA 115 (496)
T ss_pred EEEEecCCCEEEEEEEEcCCCCEEEEEEEecccCCHHHHHHHHHHHHHHhcC-CCCcEEEeecceecccccCcccceEEE
Confidence 578999999999999999999999999986542 134578888877 5999999998875432 368
Q ss_pred EEEEccCCCCHHHHHHhcC--CCCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCcEEEecCCCCCEEEEeecccccc
Q psy11767 448 LVLELLKGGELLDRIRQKG--RCGFTENEASRIMRQLVAAVHFMHSRGVVHRDLKPENLLFSDPAGDNIKVVDFGFACLK 525 (966)
Q Consensus 448 lVmEy~~gg~L~~~l~~~~--~~~l~e~~~~~i~~Qil~aL~yLHs~~IiHRDLKP~NILl~~~~~~~iKL~DFGla~~~ 525 (966)
+||||+++|+|.+++..+. ...+++..+..++.||+.||+|||++||+||||||+|||++. ++.+||+|||+++..
T Consensus 116 lV~Ey~~~gsL~~~l~~~~~~~~~l~e~~~~~i~~qll~aL~~lH~~~IiHrDLKP~NILl~~--~~~vkL~DFGls~~~ 193 (496)
T PTZ00283 116 LVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFIQVLLAVHHVHSKHMIHRDIKSANILLCS--NGLVKLGDFGFSKMY 193 (496)
T ss_pred EEEeCCCCCcHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEeC--CCCEEEEecccCeec
Confidence 9999999999999997532 236899999999999999999999999999999999999985 568999999998754
Q ss_pred cC-----CCccccccccccCchhhccCCCCCCCcccchhhhhhhhhhhhcCCCCCCCcCcchhHHHHHHHHhcCCCCCCC
Q psy11767 526 RE-----SLHTPCFTLQYAAPEVLRQDKSGYDENCDLWSLGVILVNVLRQDKSGYDENCDLWSLGVILYTMLCGRVPFHA 600 (966)
Q Consensus 526 ~~-----~~~~~~gT~~Y~APEvl~~~~~~~~~~~Di~SlGvil~el~~~~~~~y~~~~DIWSlGvilyemltG~~Pf~~ 600 (966)
.. ...+.+||+.|+|||++.. ..|+.++|||||||++|+|++|+.||.+
T Consensus 194 ~~~~~~~~~~~~~Gt~~Y~aPE~~~~--------------------------~~~s~k~DVwSlGvilyeLltG~~Pf~~ 247 (496)
T PTZ00283 194 AATVSDDVGRTFCGTPYYVAPEIWRR--------------------------KPYSKKADMFSLGVLLYELLTLKRPFDG 247 (496)
T ss_pred cccccccccccccCCcceeCHHHhCC--------------------------CCCCcHHHHHHHHHHHHHHHHCCCCCCC
Confidence 32 1234678999999999852 2378899999999999999999999986
Q ss_pred CCCchhHHHHHHHHHcCCCCCCchhhccCCHHHHHHHHHhcccCccccCChHHHH
Q psy11767 601 RSRDDSALSIMARIKEGQFNFDAEAWSTVSSEAKELTKSLLTVNPAQRIRMMRVK 655 (966)
Q Consensus 601 ~~~~~~~~~~~~~i~~~~~~~~~~~~~~is~e~~~Li~~~L~~dP~~R~t~~~v~ 655 (966)
.+. ..++..+..+.+.. ....+++++.+|+.+||..||.+||++.++.
T Consensus 248 ~~~----~~~~~~~~~~~~~~---~~~~~~~~l~~li~~~L~~dP~~RPs~~ell 295 (496)
T PTZ00283 248 ENM----EEVMHKTLAGRYDP---LPPSISPEMQEIVTALLSSDPKRRPSSSKLL 295 (496)
T ss_pred CCH----HHHHHHHhcCCCCC---CCCCCCHHHHHHHHHHcccChhhCcCHHHHH
Confidence 543 23445555554432 2246789999999999999999999998763
|
|
| >cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-36 Score=331.41 Aligned_cols=244 Identities=22% Similarity=0.378 Sum_probs=198.4
Q ss_pred cccccccccccccEEEEEEEcCCC-----cEEEEEEeccccC------hHHHHHHHHHhcCCCCceEEEEEEEeCCeEEE
Q psy11767 380 LDKAGILGDGSYSVCRRCVEKSTG-----QEYAVKIISRKID------CSEEINLLRACQGHPNIVNLHCVFQDEVHTYL 448 (966)
Q Consensus 380 ~~~~~~LG~G~fG~Vy~a~~~~tg-----~~vAvK~i~~~~~------~~~Ei~iL~~l~~HpnIV~l~~~~~~~~~~~l 448 (966)
|+..+.||+|+||.||+|.+...+ ..||+|.+..... ..+|+.+|+.+ +||||+++++++.+....|+
T Consensus 7 ~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~v~~K~~~~~~~~~~~~~~~~ei~~l~~l-~h~~i~~~~~~~~~~~~~~~ 85 (283)
T cd05048 7 VRFLEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQEAELMSDL-QHPNIVCLLGVCTKEQPTCM 85 (283)
T ss_pred cchhhcccCccCCcEEEEEEecCCCCcceeeEEEEecccCCCHHHHHHHHHHHHHHHhc-CCcccceEEEEEcCCCceEE
Confidence 444788999999999999987655 7899999864432 35688999888 59999999999999999999
Q ss_pred EEEccCCCCHHHHHHhcCC--------------CCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCcEEEecCCCCCE
Q psy11767 449 VLELLKGGELLDRIRQKGR--------------CGFTENEASRIMRQLVAAVHFMHSRGVVHRDLKPENLLFSDPAGDNI 514 (966)
Q Consensus 449 VmEy~~gg~L~~~l~~~~~--------------~~l~e~~~~~i~~Qil~aL~yLHs~~IiHRDLKP~NILl~~~~~~~i 514 (966)
+|||+++|+|.+++..... ..+++.++..++.|++.||+|||++||+||||||+|||+++ ++.+
T Consensus 86 ~~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~al~~lH~~~i~H~dlkp~Nil~~~--~~~~ 163 (283)
T cd05048 86 LFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIAAGMEYLSSHHFVHRDLAARNCLVGE--GLTV 163 (283)
T ss_pred EEecCCCCcHHHHHHhcCCCcccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccccceEEEcC--CCcE
Confidence 9999999999999976421 35889999999999999999999999999999999999985 5689
Q ss_pred EEEeecccccccCC-----CccccccccccCchhhccCCCCCCCcccchhhhhhhhhhhhcCCCCCCCcCcchhHHHHHH
Q psy11767 515 KVVDFGFACLKRES-----LHTPCFTLQYAAPEVLRQDKSGYDENCDLWSLGVILVNVLRQDKSGYDENCDLWSLGVILY 589 (966)
Q Consensus 515 KL~DFGla~~~~~~-----~~~~~gT~~Y~APEvl~~~~~~~~~~~Di~SlGvil~el~~~~~~~y~~~~DIWSlGvily 589 (966)
||+|||++...... .....+|+.|+|||.+.. ..++.++|||||||++|
T Consensus 164 ~L~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~--------------------------~~~~~~sDv~slG~il~ 217 (283)
T cd05048 164 KISDFGLSRDIYSADYYRVQSKSLLPVRWMPPEAILY--------------------------GKFTTESDIWSFGVVLW 217 (283)
T ss_pred EECCCcceeeccccccccccCCCcccccccCHHHhcc--------------------------CcCchhhhHHHHHHHHH
Confidence 99999998654221 123456788999998752 23678899999999999
Q ss_pred HHhc-CCCCCCCCCCchhHHHHHHHHHcCCCCCCchhhccCCHHHHHHHHHhcccCccccCChHHHHHHhh
Q psy11767 590 TMLC-GRVPFHARSRDDSALSIMARIKEGQFNFDAEAWSTVSSEAKELTKSLLTVNPAQRIRMMRVKLTFH 659 (966)
Q Consensus 590 emlt-G~~Pf~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~is~e~~~Li~~~L~~dP~~R~t~~~v~~~~~ 659 (966)
||++ |..||.+.... .+...+..+.... ....++.++.+|+.+||..||++||++.++...+.
T Consensus 218 el~~~g~~p~~~~~~~----~~~~~i~~~~~~~---~~~~~~~~~~~l~~~c~~~~p~~Rp~~~~i~~~l~ 281 (283)
T cd05048 218 EIFSYGLQPYYGFSNQ----EVIEMIRSRQLLP---CPEDCPARVYALMIECWNEIPARRPRFKDIHTRLR 281 (283)
T ss_pred HHHcCCCCCCCCCCHH----HHHHHHHcCCcCC---CcccCCHHHHHHHHHHccCChhhCcCHHHHHHHHh
Confidence 9997 99999876543 3444555544322 22467899999999999999999999998865543
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer |
| >cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-36 Score=328.36 Aligned_cols=243 Identities=26% Similarity=0.383 Sum_probs=194.7
Q ss_pred ccccccccccEEEEEEEcCCCcEEEEEEecccc----ChHHHHHHHHHhcCCCCceEEEEEEEeC------CeEEEEEEc
Q psy11767 383 AGILGDGSYSVCRRCVEKSTGQEYAVKIISRKI----DCSEEINLLRACQGHPNIVNLHCVFQDE------VHTYLVLEL 452 (966)
Q Consensus 383 ~~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~----~~~~Ei~iL~~l~~HpnIV~l~~~~~~~------~~~~lVmEy 452 (966)
.+.||+|+||.||+|.+..+++.||+|++.... ....|+.+|+.+.+||||++++++|... ...|+||||
T Consensus 11 ~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~~~~iv~e~ 90 (272)
T cd06637 11 VELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMDDQLWLVMEF 90 (272)
T ss_pred HHheeecCCeEEEEEEEcCCCcEEEEEEEEcCCccHHHHHHHHHHHHHhcCCCCeeeEeeEEeecCCCCCCcEEEEEEEc
Confidence 567999999999999999999999999986542 2456888898887799999999998753 468999999
Q ss_pred cCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCcEEEecCCCCCEEEEeecccccccC---CC
Q psy11767 453 LKGGELLDRIRQKGRCGFTENEASRIMRQLVAAVHFMHSRGVVHRDLKPENLLFSDPAGDNIKVVDFGFACLKRE---SL 529 (966)
Q Consensus 453 ~~gg~L~~~l~~~~~~~l~e~~~~~i~~Qil~aL~yLHs~~IiHRDLKP~NILl~~~~~~~iKL~DFGla~~~~~---~~ 529 (966)
+.+|+|.+++.......+++..+..++.|++.||+|||+++|+||||||+||++++ ++.+||+|||++..... ..
T Consensus 91 ~~~~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~LH~~~ivh~dl~~~nili~~--~~~~~l~Dfg~~~~~~~~~~~~ 168 (272)
T cd06637 91 CGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQHKVIHRDIKGQNVLLTE--NAEVKLVDFGVSAQLDRTVGRR 168 (272)
T ss_pred CCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCHHHEEECC--CCCEEEccCCCceecccccccC
Confidence 99999999998755456899999999999999999999999999999999999985 55899999999875432 22
Q ss_pred ccccccccccCchhhccCCCCCCCcccchhhhhhhhhhhhcCCCCCCCcCcchhHHHHHHHHhcCCCCCCCCCCchhHHH
Q psy11767 530 HTPCFTLQYAAPEVLRQDKSGYDENCDLWSLGVILVNVLRQDKSGYDENCDLWSLGVILYTMLCGRVPFHARSRDDSALS 609 (966)
Q Consensus 530 ~~~~gT~~Y~APEvl~~~~~~~~~~~Di~SlGvil~el~~~~~~~y~~~~DIWSlGvilyemltG~~Pf~~~~~~~~~~~ 609 (966)
....+++.|+|||++..... ....|+.++||||+||++|+|++|..||........
T Consensus 169 ~~~~g~~~y~aPE~~~~~~~---------------------~~~~~~~~~Dv~slGv~l~el~~g~~p~~~~~~~~~--- 224 (272)
T cd06637 169 NTFIGTPYWMAPEVIACDEN---------------------PDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRA--- 224 (272)
T ss_pred CcccccccccCHhHhccccC---------------------cCCCCCchhhHHHHHHHHHHHHhCCCCccccCHHHH---
Confidence 34568999999999853210 123578899999999999999999999975443211
Q ss_pred HHHHHHcCCCCCCchhhccCCHHHHHHHHHhcccCccccCChHHH
Q psy11767 610 IMARIKEGQFNFDAEAWSTVSSEAKELTKSLLTVNPAQRIRMMRV 654 (966)
Q Consensus 610 ~~~~i~~~~~~~~~~~~~~is~e~~~Li~~~L~~dP~~R~t~~~v 654 (966)
...+..... .......++.++.+|+.+||..||.+|||+.++
T Consensus 225 -~~~~~~~~~--~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~i 266 (272)
T cd06637 225 -LFLIPRNPA--PRLKSKKWSKKFQSFIESCLVKNHSQRPTTEQL 266 (272)
T ss_pred -HHHHhcCCC--CCCCCCCcCHHHHHHHHHHcCCChhhCCCHHHH
Confidence 112222111 111223578899999999999999999999876
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ |
| >PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-37 Score=330.29 Aligned_cols=242 Identities=36% Similarity=0.617 Sum_probs=195.3
Q ss_pred cccccccccccEEEEEEEcCCCcEEEEEEeccccC-------hHHHHHHHHHhcCCCCceEEEEEEEeCCeEEEEEEccC
Q psy11767 382 KAGILGDGSYSVCRRCVEKSTGQEYAVKIISRKID-------CSEEINLLRACQGHPNIVNLHCVFQDEVHTYLVLELLK 454 (966)
Q Consensus 382 ~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~~-------~~~Ei~iL~~l~~HpnIV~l~~~~~~~~~~~lVmEy~~ 454 (966)
..+.||+|+||+||+|.+..+++.||+|++..... ..+|+.+++.+ .||||+++++++.+....++||||+.
T Consensus 3 ~~~~lg~G~~g~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~~~~l-~~~~i~~~~~~~~~~~~~~~v~~~~~ 81 (260)
T PF00069_consen 3 LVKKLGSGGFGTVYKAKNKKNGQKVAVKIIDKSEIEEEEREENIREIKILRRL-RHPNIVQILDVFQDDNYLYIVMEYCP 81 (260)
T ss_dssp EEEEEEEESSEEEEEEEETTTTEEEEEEEEESTTHHHHHHHHHHHHHHHHHHH-TBTTBCHEEEEEEESSEEEEEEEEET
T ss_pred EeEEEEeCCCEEEEEEEECCCCeEEEEEEeccccccccccchhhhhhhccccc-cccccccccccccccccccccccccc
Confidence 36789999999999999999999999999976532 23488899998 69999999999999999999999999
Q ss_pred CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCcEEEecCCCCCEEEEeecccccc---cCCCcc
Q psy11767 455 GGELLDRIRQKGRCGFTENEASRIMRQLVAAVHFMHSRGVVHRDLKPENLLFSDPAGDNIKVVDFGFACLK---RESLHT 531 (966)
Q Consensus 455 gg~L~~~l~~~~~~~l~e~~~~~i~~Qil~aL~yLHs~~IiHRDLKP~NILl~~~~~~~iKL~DFGla~~~---~~~~~~ 531 (966)
+++|.+++.... .+++.++..++.||+.||+|||++||+||||||+|||++. ++.++|+|||++... ......
T Consensus 82 ~~~L~~~l~~~~--~~~~~~~~~~~~qi~~~L~~Lh~~~i~H~dikp~NIl~~~--~~~~~l~Dfg~~~~~~~~~~~~~~ 157 (260)
T PF00069_consen 82 GGSLQDYLQKNK--PLSEEEILKIAYQILEALAYLHSKGIVHRDIKPENILLDE--NGEVKLIDFGSSVKLSENNENFNP 157 (260)
T ss_dssp TEBHHHHHHHHS--SBBHHHHHHHHHHHHHHHHHHHHTTEEESSBSGGGEEEST--TSEEEESSGTTTEESTSTTSEBSS
T ss_pred cccccccccccc--cccccccccccccccccccccccccccccccccccccccc--cccccccccccccccccccccccc
Confidence 999999998544 5899999999999999999999999999999999999984 568999999998642 223345
Q ss_pred ccccccccCchhhccCCCCCCCcccchhhhhhhhhhhhcCCCCCCCcCcchhHHHHHHHHhcCCCCCCCCCCchhHHHHH
Q psy11767 532 PCFTLQYAAPEVLRQDKSGYDENCDLWSLGVILVNVLRQDKSGYDENCDLWSLGVILYTMLCGRVPFHARSRDDSALSIM 611 (966)
Q Consensus 532 ~~gT~~Y~APEvl~~~~~~~~~~~Di~SlGvil~el~~~~~~~y~~~~DIWSlGvilyemltG~~Pf~~~~~~~~~~~~~ 611 (966)
..+|+.|+|||++.. ...++.++||||||+++|+|++|..||...... .....+
T Consensus 158 ~~~~~~y~aPE~~~~-------------------------~~~~~~~~Di~slG~il~~l~~~~~p~~~~~~~-~~~~~~ 211 (260)
T PF00069_consen 158 FVGTPEYMAPEVLQQ-------------------------GKKYTRKSDIWSLGIILYELLTGKLPFEESNSD-DQLEII 211 (260)
T ss_dssp SSSSGGGSCHHHHTT-------------------------TSSBSTHHHHHHHHHHHHHHHHSSSSSTTSSHH-HHHHHH
T ss_pred ccccccccccccccc-------------------------cccccccccccccccccccccccccccccccch-hhhhhh
Confidence 678999999999751 233678899999999999999999999876222 222333
Q ss_pred HHHHcCCCCCCchhhccCCHHHHHHHHHhcccCccccCChHHH
Q psy11767 612 ARIKEGQFNFDAEAWSTVSSEAKELTKSLLTVNPAQRIRMMRV 654 (966)
Q Consensus 612 ~~i~~~~~~~~~~~~~~is~e~~~Li~~~L~~dP~~R~t~~~v 654 (966)
..............+...+.++.++|.+||..||++||++.++
T Consensus 212 ~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~R~~~~~l 254 (260)
T PF00069_consen 212 EKILKRPLPSSSQQSREKSEELRDLIKKMLSKDPEQRPSAEEL 254 (260)
T ss_dssp HHHHHTHHHHHTTSHTTSHHHHHHHHHHHSSSSGGGSTTHHHH
T ss_pred hhcccccccccccccchhHHHHHHHHHHHccCChhHCcCHHHH
Confidence 3332221111111112234799999999999999999999876
|
Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A .... |
| >KOG0671|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-37 Score=336.57 Aligned_cols=262 Identities=29% Similarity=0.516 Sum_probs=210.7
Q ss_pred ccceecccccccccccccccccccEEEEEEEcCCCcEEEEEEecccc----ChHHHHHHHHHhcCC-CC----ceEEEEE
Q psy11767 369 GSLFFEQYDMDLDKAGILGDGSYSVCRRCVEKSTGQEYAVKIISRKI----DCSEEINLLRACQGH-PN----IVNLHCV 439 (966)
Q Consensus 369 G~~~~~~~~i~~~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~----~~~~Ei~iL~~l~~H-pn----IV~l~~~ 439 (966)
|+.+..+|.+ ++.||+|+||+|-.|.+..++..||||+++... .+.-|+++|+++..+ || +|++.++
T Consensus 84 gD~l~~Ry~i----~~~lGeGtFGkV~ec~D~~~~~~vAlKIik~V~kYreAa~iEi~vLqki~~~DP~g~~rcv~m~~w 159 (415)
T KOG0671|consen 84 GDILTNRYEI----VDLLGEGTFGKVVECWDRETKEHVALKIIKNVDKYREAALIEIEVLQKINESDPNGKFRCVQMRDW 159 (415)
T ss_pred ccccccceeh----hhhhcCCcccceEEEeecCCCceehHHHHHHHHHHhhHHHHHHHHHHHHHhcCCCCceEEEeeehh
Confidence 4555666666 789999999999999999999999999997532 345599999988533 33 8889999
Q ss_pred EEeCCeEEEEEEccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCcEEEecCC---------
Q psy11767 440 FQDEVHTYLVLELLKGGELLDRIRQKGRCGFTENEASRIMRQLVAAVHFMHSRGVVHRDLKPENLLFSDPA--------- 510 (966)
Q Consensus 440 ~~~~~~~~lVmEy~~gg~L~~~l~~~~~~~l~e~~~~~i~~Qil~aL~yLHs~~IiHRDLKP~NILl~~~~--------- 510 (966)
|...++.|||+|.+ |-+++++|.+++..+++..+++.+.+||+.+++|||+.+++|.||||+|||+.+..
T Consensus 160 FdyrghiCivfell-G~S~~dFlk~N~y~~fpi~~ir~m~~QL~~sv~fLh~~kl~HTDLKPENILfvss~~~~~~~~k~ 238 (415)
T KOG0671|consen 160 FDYRGHICIVFELL-GLSTFDFLKENNYIPFPIDHIRHMGYQLLESVAFLHDLKLTHTDLKPENILFVSSEYFKTYNPKK 238 (415)
T ss_pred hhccCceEEEEecc-ChhHHHHhccCCccccchHHHHHHHHHHHHHHHHHHhcceeecCCChheEEEeccceEEEeccCC
Confidence 99999999999998 67999999998888899999999999999999999999999999999999985321
Q ss_pred ---------CCCEEEEeecccccccCCCccccccccccCchhhccCCCCCCCcccchhhhhhhhhhhhcCCCCCCCcCcc
Q psy11767 511 ---------GDNIKVVDFGFACLKRESLHTPCFTLQYAAPEVLRQDKSGYDENCDLWSLGVILVNVLRQDKSGYDENCDL 581 (966)
Q Consensus 511 ---------~~~iKL~DFGla~~~~~~~~~~~gT~~Y~APEvl~~~~~~~~~~~Di~SlGvil~el~~~~~~~y~~~~DI 581 (966)
+..|+|+|||.|....+...+.+.|..|+|||++++ .+|+.++||
T Consensus 239 ~~~~~r~~ks~~I~vIDFGsAtf~~e~hs~iVsTRHYRAPEViLg--------------------------LGwS~pCDv 292 (415)
T KOG0671|consen 239 KVCFIRPLKSTAIKVIDFGSATFDHEHHSTIVSTRHYRAPEVILG--------------------------LGWSQPCDV 292 (415)
T ss_pred ccceeccCCCcceEEEecCCcceeccCcceeeeccccCCchheec--------------------------cCcCCccCc
Confidence 236899999999988877777888999999999973 458889999
Q ss_pred hhHHHHHHHHhcCCCCCCCCCCchhHHHHHHHHHcCC------------------CCCCc------------------hh
Q psy11767 582 WSLGVILYTMLCGRVPFHARSRDDSALSIMARIKEGQ------------------FNFDA------------------EA 625 (966)
Q Consensus 582 WSlGvilyemltG~~Pf~~~~~~~~~~~~~~~i~~~~------------------~~~~~------------------~~ 625 (966)
||+||||+|+.+|..-|+..+..+. +++|++|.... ...+. ..
T Consensus 293 WSiGCIL~ElytG~~LFqtHen~EH-LaMMerIlGp~P~~mi~r~~~~Kyf~~~rldw~e~~~~~~~k~v~~~ckpl~~~ 371 (415)
T KOG0671|consen 293 WSIGCILVELYTGETLFQTHENLEH-LAMMERILGPIPSRMIKKTRKEKYFRRGRLDWPEVSSKGKSKYVFEPCKPLKKY 371 (415)
T ss_pred eeeeeEEEEeeccceecccCCcHHH-HHHHHHhhCCCcHHHhhhhhhHhhhhcccccCccccccccchhhhcCCccHHHH
Confidence 9999999999999999988764443 45666553311 10000 00
Q ss_pred hccCC---HHHHHHHHHhcccCccccCChHHHHHHhhhhHHh
Q psy11767 626 WSTVS---SEAKELTKSLLTVNPAQRIRMMRVKLTFHAFHQA 664 (966)
Q Consensus 626 ~~~is---~e~~~Li~~~L~~dP~~R~t~~~v~~~~~~~~~~ 664 (966)
....+ .++.|||++||.+||.+|+|+.|+ ..|+|+..
T Consensus 372 ~~~~d~e~~~LfDLl~~mL~fDP~~RiTl~EA--L~HpFF~~ 411 (415)
T KOG0671|consen 372 MLQDDLEHVQLFDLLRRMLEFDPARRITLREA--LSHPFFAR 411 (415)
T ss_pred hccCcHHHhHHHHHHHHHHccCccccccHHHH--hcCHHhhc
Confidence 00112 246699999999999999999975 56888753
|
|
| >KOG1035|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-37 Score=368.44 Aligned_cols=314 Identities=29% Similarity=0.510 Sum_probs=230.9
Q ss_pred HHHHHHHhhcccCCCcccCCCCCCHHHHhcCCceeeeCccccccCCCCCCCCccccccccccccccccccCcCCCCCCCC
Q psy11767 280 DVADFISRLLVKDPRRRLGGGELDAEELKRHPFFNVIDWDDLATKRIPAPFVPKISNELDVSNFSDEFTKMIPADSPAIV 359 (966)
Q Consensus 280 ~a~dli~~LL~kdp~~RLG~~~~g~~~Ik~HpfF~~idW~~l~~k~~~pP~~P~i~~~~D~snFd~ef~~~~p~dSp~iv 359 (966)
+..|.+.+.+..|+++||+ +.++..|+|-+.=. ..-.++|.|... ....+|--.|. ...+
T Consensus 409 ~~~d~~~~~~~~~~~~Rl~-----~~~ll~~~f~~~~~------~~~~~~~~~~~~--~~~~~~~~r~~---~~~s---- 468 (1351)
T KOG1035|consen 409 ELLDALPKCLDEDSEERLS-----ALELLTHPFLRFPT------DNESSEFAPNDE--TSVPQFRLRFS---GAMS---- 468 (1351)
T ss_pred hhhhhhhhhcchhhhhccc-----hhhhhhchhccccc------ccccccccCccc--cccCccCCCCc---cccC----
Confidence 6678899999999999996 67899999864211 112223332211 00111110000 0000
Q ss_pred CCCCcccccccceecccccccccccccccccccEEEEEEEcCCCcEEEEEEecccc------ChHHHHHHHHHhcCCCCc
Q psy11767 360 PPNFDKIFKGSLFFEQYDMDLDKAGILGDGSYSVCRRCVEKSTGQEYAVKIISRKI------DCSEEINLLRACQGHPNI 433 (966)
Q Consensus 360 p~~~d~if~G~~~~~~~~i~~~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~------~~~~Ei~iL~~l~~HpnI 433 (966)
+. ..-+.+|..||+++.+||+||||.||+|+++-+|+.||||.|.-+. ...+|+.+|..+ +||||
T Consensus 469 -------~~-~r~~SRY~~DFEEL~lLGkGGFG~VvkVRNKlDGr~YAIKKIpl~~s~~~~skI~rEVk~LArL-nHpNV 539 (1351)
T KOG1035|consen 469 -------PL-QRQFSRYLNDFEELELLGKGGFGSVVKVRNKLDGREYAIKKIPLKASDKLYSKILREVKLLARL-NHPNV 539 (1351)
T ss_pred -------cc-ccchhhHhhhhHHHHHhcCCCCceEEEEeecccchhhhhhhccCchHHHHHHHHHHHHHHHhhc-CCcce
Confidence 00 1122789999999999999999999999999999999999997552 245799999998 69999
Q ss_pred eEEEEEEEe-----------------------------------------------------------------------
Q psy11767 434 VNLHCVFQD----------------------------------------------------------------------- 442 (966)
Q Consensus 434 V~l~~~~~~----------------------------------------------------------------------- 442 (966)
|++|..|.+
T Consensus 540 VRYysAWVEs~~~~~~~ei~~~~~~~~sQs~s~~~~~~~~~q~t~~p~~~~~~~~~~~~dd~sss~~~~~~~~~~~~d~e 619 (1351)
T KOG1035|consen 540 VRYYSAWVESTAELTVLEIVASDSESRSQSASKYNGVDIRYQPTSSPSLTLSELDSEDEDDKSSSYTTRKASYESSTDEE 619 (1351)
T ss_pred eeeehhhhccCCccccccccccchhhhcccCCCcccceeeeccCCCcccCcchhhccccCccccccccccccccccCCcc
Confidence 999854310
Q ss_pred ----------------------------------------C--------CeEEEEEEccCCCCHHHHHHhcCCCCCCHHH
Q psy11767 443 ----------------------------------------E--------VHTYLVLELLKGGELLDRIRQKGRCGFTENE 474 (966)
Q Consensus 443 ----------------------------------------~--------~~~~lVmEy~~gg~L~~~l~~~~~~~l~e~~ 474 (966)
+ ..+||-||||+.-.|.+++..+... =....
T Consensus 620 ~~d~dedg~~~S~tS~~e~~~~~d~~~ess~s~~~~~n~~e~~~~~q~~~~LYIQMEyCE~~ll~~iI~~N~~~-~~~d~ 698 (1351)
T KOG1035|consen 620 NDDSDEDGRNLSNTSDSEGSVILDDTSESSESIPKTENSSEPMVPVQKPLILYIQMEYCEKTLLRDIIRRNHFN-SQRDE 698 (1351)
T ss_pred cccccccccccccccccCCccccCcchhhhhhccccCCccccccccccceEEEEEHhhhhhhHHHHHHHhcccc-hhhHH
Confidence 0 1358999999887777777654311 14788
Q ss_pred HHHHHHHHHHHHHHHHhcCceeccCCCCcEEEecCCCCCEEEEeeccccccc--------------------C-CCcccc
Q psy11767 475 ASRIMRQLVAAVHFMHSRGVVHRDLKPENLLFSDPAGDNIKVVDFGFACLKR--------------------E-SLHTPC 533 (966)
Q Consensus 475 ~~~i~~Qil~aL~yLHs~~IiHRDLKP~NILl~~~~~~~iKL~DFGla~~~~--------------------~-~~~~~~ 533 (966)
++++++||++||+|+|++|||||||||.||.|+. .+.|||+|||+|+... . ..++.+
T Consensus 699 ~wrLFreIlEGLaYIH~~giIHRDLKP~NIFLd~--~~~VKIGDFGLAt~~~~~~~~~d~~~~~~~~~~g~~~~~~Ts~V 776 (1351)
T KOG1035|consen 699 AWRLFREILEGLAYIHDQGIIHRDLKPRNIFLDS--RNSVKIGDFGLATDLKENLESIDQDLSFSTNRAGSNDGDLTSQV 776 (1351)
T ss_pred HHHHHHHHHHHHHHHHhCceeeccCCcceeEEcC--CCCeeecccccchhhhhhhhhHhhccCccccccCCCCccccccc
Confidence 9999999999999999999999999999999984 5699999999997510 0 224567
Q ss_pred ccccccCchhhccCCCCCCCcccchhhhhhhhhhhhcCCCCCCCcCcchhHHHHHHHHhcCCCCCCCCCCchhHHHHHHH
Q psy11767 534 FTLQYAAPEVLRQDKSGYDENCDLWSLGVILVNVLRQDKSGYDENCDLWSLGVILYTMLCGRVPFHARSRDDSALSIMAR 613 (966)
Q Consensus 534 gT~~Y~APEvl~~~~~~~~~~~Di~SlGvil~el~~~~~~~y~~~~DIWSlGvilyemltG~~Pf~~~~~~~~~~~~~~~ 613 (966)
||.-|+|||++.... ...|+.|+||||||||+|||+. ||...- +. ..++..
T Consensus 777 GTalYvAPEll~~~~-----------------------~~~Yn~KiDmYSLGIVlFEM~y---PF~TsM--ER-a~iL~~ 827 (1351)
T KOG1035|consen 777 GTALYVAPELLSDTS-----------------------SNKYNSKIDMYSLGIVLFEMLY---PFGTSM--ER-ASILTN 827 (1351)
T ss_pred ceeeeecHHHhcccc-----------------------cccccchhhhHHHHHHHHHHhc---cCCchH--HH-HHHHHh
Confidence 899999999985321 2359999999999999999984 565322 22 345677
Q ss_pred HHcCCCCCCchhhccCCHHHHHHHHHhcccCccccCChHHH
Q psy11767 614 IKEGQFNFDAEAWSTVSSEAKELTKSLLTVNPAQRIRMMRV 654 (966)
Q Consensus 614 i~~~~~~~~~~~~~~is~e~~~Li~~~L~~dP~~R~t~~~v 654 (966)
++.|.++.++..+..--+.-..+|++||+.||.+|||+.++
T Consensus 828 LR~g~iP~~~~f~~~~~~~e~slI~~Ll~hdP~kRPtA~eL 868 (1351)
T KOG1035|consen 828 LRKGSIPEPADFFDPEHPEEASLIRWLLSHDPSKRPTATEL 868 (1351)
T ss_pred cccCCCCCCcccccccchHHHHHHHHHhcCCCccCCCHHHH
Confidence 78888887766665566777889999999999999999876
|
|
| >cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-36 Score=328.49 Aligned_cols=241 Identities=18% Similarity=0.294 Sum_probs=193.3
Q ss_pred ccccccccccccEEEEEEEc---CCCcEEEEEEeccccC------hHHHHHHHHHhcCCCCceEEEEEEEeCCeEEEEEE
Q psy11767 381 DKAGILGDGSYSVCRRCVEK---STGQEYAVKIISRKID------CSEEINLLRACQGHPNIVNLHCVFQDEVHTYLVLE 451 (966)
Q Consensus 381 ~~~~~LG~G~fG~Vy~a~~~---~tg~~vAvK~i~~~~~------~~~Ei~iL~~l~~HpnIV~l~~~~~~~~~~~lVmE 451 (966)
+..+.||+|+||.||+|.+. ..+..||+|.++.... ..+|+.+|+.+ +||||+++++++..+.+.|+|||
T Consensus 8 ~~~~~ig~G~fg~V~~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~e 86 (266)
T cd05064 8 KIERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSDKQRRGFLAEALTLGQF-DHSNIVRLEGVITRGNTMMIVTE 86 (266)
T ss_pred EEeeeecccCCCeEEEEEEecCCCceeeEEEEecCCCCCHHHHHHHHHHHHHHhcC-CCCCcCeEEEEEecCCCcEEEEE
Confidence 34678999999999999875 4567999999875432 34688888887 69999999999999999999999
Q ss_pred ccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCcEEEecCCCCCEEEEeecccccccCC---
Q psy11767 452 LLKGGELLDRIRQKGRCGFTENEASRIMRQLVAAVHFMHSRGVVHRDLKPENLLFSDPAGDNIKVVDFGFACLKRES--- 528 (966)
Q Consensus 452 y~~gg~L~~~l~~~~~~~l~e~~~~~i~~Qil~aL~yLHs~~IiHRDLKP~NILl~~~~~~~iKL~DFGla~~~~~~--- 528 (966)
|+++|+|.+++.... ..+++..++.++.||+.||+|||++|++||||||+|||++. ++.+|++|||++......
T Consensus 87 ~~~~~~L~~~l~~~~-~~l~~~~~~~~~~~i~~al~~lH~~~iiH~dikp~nili~~--~~~~~l~dfg~~~~~~~~~~~ 163 (266)
T cd05064 87 YMSNGALDSFLRKHE-GQLVAGQLMGMLPGLASGMKYLSEMGYVHKGLAAHKVLVNS--DLVCKISGFRRLQEDKSEAIY 163 (266)
T ss_pred eCCCCcHHHHHHhCC-CCCCHHHHHHHHHHHHHHHHHHHHCCEeeccccHhhEEEcC--CCcEEECCCcccccccccchh
Confidence 999999999997653 26899999999999999999999999999999999999975 568999999987543221
Q ss_pred -CccccccccccCchhhccCCCCCCCcccchhhhhhhhhhhhcCCCCCCCcCcchhHHHHHHHHh-cCCCCCCCCCCchh
Q psy11767 529 -LHTPCFTLQYAAPEVLRQDKSGYDENCDLWSLGVILVNVLRQDKSGYDENCDLWSLGVILYTML-CGRVPFHARSRDDS 606 (966)
Q Consensus 529 -~~~~~gT~~Y~APEvl~~~~~~~~~~~Di~SlGvil~el~~~~~~~y~~~~DIWSlGvilyeml-tG~~Pf~~~~~~~~ 606 (966)
.....++..|+|||++.. ..|+.++|||||||++|+|+ +|..||......
T Consensus 164 ~~~~~~~~~~y~aPE~~~~--------------------------~~~~~~~Di~slG~~l~ell~~g~~p~~~~~~~-- 215 (266)
T cd05064 164 TTMSGKSPVLWAAPEAIQY--------------------------HHFSSASDVWSFGIVMWEVMSYGERPYWDMSGQ-- 215 (266)
T ss_pred cccCCCCceeecCHHHHhh--------------------------CCccchhHHHHHHHHHHHHhcCCCCCcCcCCHH--
Confidence 112234678999998752 23678999999999999977 499999865432
Q ss_pred HHHHHHHHHcCCCCCCchhhccCCHHHHHHHHHhcccCccccCChHHHHHHh
Q psy11767 607 ALSIMARIKEGQFNFDAEAWSTVSSEAKELTKSLLTVNPAQRIRMMRVKLTF 658 (966)
Q Consensus 607 ~~~~~~~i~~~~~~~~~~~~~~is~e~~~Li~~~L~~dP~~R~t~~~v~~~~ 658 (966)
.....+.++... .....++..+.+++.+||+.+|++||++.++...+
T Consensus 216 --~~~~~~~~~~~~---~~~~~~~~~~~~li~~c~~~~p~~RP~~~~i~~~l 262 (266)
T cd05064 216 --DVIKAVEDGFRL---PAPRNCPNLLHQLMLDCWQKERGERPRFSQIHSIL 262 (266)
T ss_pred --HHHHHHHCCCCC---CCCCCCCHHHHHHHHHHcCCCchhCCCHHHHHHHH
Confidence 234445444321 12346788999999999999999999999875443
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor |
| >cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-36 Score=325.12 Aligned_cols=239 Identities=29% Similarity=0.495 Sum_probs=198.0
Q ss_pred cccccccccccccEEEEEEEcCCCcEEEEEEecccc------ChHHHHHHHHHhcCCCCceEEEEEEEeCCeEEEEEEcc
Q psy11767 380 LDKAGILGDGSYSVCRRCVEKSTGQEYAVKIISRKI------DCSEEINLLRACQGHPNIVNLHCVFQDEVHTYLVLELL 453 (966)
Q Consensus 380 ~~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~------~~~~Ei~iL~~l~~HpnIV~l~~~~~~~~~~~lVmEy~ 453 (966)
|+..+.||+|+||.||++.+..+++.||+|.+.... ....|+.+++.+ +||||++++++++++.+.|+||||+
T Consensus 2 y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~ 80 (255)
T cd08219 2 YNVLRVVGEGSFGRALLVQHVNSDQKYAMKEIRLPKSSSAVEDSRKEAVLLAKM-KHPNIVAFKESFEADGHLYIVMEYC 80 (255)
T ss_pred ceEEEEeeccCCeEEEEEEEcCCCceEEEEEEEcCcchHHHHHHHHHHHHHHhC-CCCCcceEEEEEEECCEEEEEEeeC
Confidence 344688999999999999999999999999985432 234588888887 5999999999999999999999999
Q ss_pred CCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCcEEEecCCCCCEEEEeecccccccCC---Cc
Q psy11767 454 KGGELLDRIRQKGRCGFTENEASRIMRQLVAAVHFMHSRGVVHRDLKPENLLFSDPAGDNIKVVDFGFACLKRES---LH 530 (966)
Q Consensus 454 ~gg~L~~~l~~~~~~~l~e~~~~~i~~Qil~aL~yLHs~~IiHRDLKP~NILl~~~~~~~iKL~DFGla~~~~~~---~~ 530 (966)
++|+|.+++.......+++..++.++.||+.||.|||++||+|+||||+|||+++ ++.++|+|||++...... ..
T Consensus 81 ~~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~H~dl~p~nili~~--~~~~~l~dfg~~~~~~~~~~~~~ 158 (255)
T cd08219 81 DGGDLMQKIKLQRGKLFPEDTILQWFVQMCLGVQHIHEKRVLHRDIKSKNIFLTQ--NGKVKLGDFGSARLLTSPGAYAC 158 (255)
T ss_pred CCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCcceEEECC--CCcEEEcccCcceeecccccccc
Confidence 9999999987654446899999999999999999999999999999999999975 568999999998654321 22
Q ss_pred cccccccccCchhhccCCCCCCCcccchhhhhhhhhhhhcCCCCCCCcCcchhHHHHHHHHhcCCCCCCCCCCchhHHHH
Q psy11767 531 TPCFTLQYAAPEVLRQDKSGYDENCDLWSLGVILVNVLRQDKSGYDENCDLWSLGVILYTMLCGRVPFHARSRDDSALSI 610 (966)
Q Consensus 531 ~~~gT~~Y~APEvl~~~~~~~~~~~Di~SlGvil~el~~~~~~~y~~~~DIWSlGvilyemltG~~Pf~~~~~~~~~~~~ 610 (966)
...+++.|+|||++.. ..++.++|+||+||++|+|++|..||...+.. ..
T Consensus 159 ~~~~~~~~~aPE~~~~--------------------------~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~----~~ 208 (255)
T cd08219 159 TYVGTPYYVPPEIWEN--------------------------MPYNNKSDIWSLGCILYELCTLKHPFQANSWK----NL 208 (255)
T ss_pred cccCCccccCHHHHcc--------------------------CCcCchhhhhhhchhheehhhccCCCCCCCHH----HH
Confidence 3467889999998742 23678899999999999999999999865432 23
Q ss_pred HHHHHcCCCCCCchhhccCCHHHHHHHHHhcccCccccCChHHH
Q psy11767 611 MARIKEGQFNFDAEAWSTVSSEAKELTKSLLTVNPAQRIRMMRV 654 (966)
Q Consensus 611 ~~~i~~~~~~~~~~~~~~is~e~~~Li~~~L~~dP~~R~t~~~v 654 (966)
...+..+.+...+ ..++.++.+||.+||..||++||++.++
T Consensus 209 ~~~~~~~~~~~~~---~~~~~~~~~li~~~l~~~P~~Rp~~~~i 249 (255)
T cd08219 209 ILKVCQGSYKPLP---SHYSYELRSLIKQMFKRNPRSRPSATTI 249 (255)
T ss_pred HHHHhcCCCCCCC---cccCHHHHHHHHHHHhCCcccCCCHHHH
Confidence 4445555443222 3578899999999999999999999876
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati |
| >cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-36 Score=326.77 Aligned_cols=244 Identities=24% Similarity=0.421 Sum_probs=198.5
Q ss_pred cccccccccccccEEEEEEEcCCCcEEEEEEeccccC----hHHHHHHHHHhcCCCCceEEEEEEEeCCeEEEEEEccCC
Q psy11767 380 LDKAGILGDGSYSVCRRCVEKSTGQEYAVKIISRKID----CSEEINLLRACQGHPNIVNLHCVFQDEVHTYLVLELLKG 455 (966)
Q Consensus 380 ~~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~~----~~~Ei~iL~~l~~HpnIV~l~~~~~~~~~~~lVmEy~~g 455 (966)
+...+.||+|+||.||+|.+..+++.||+|++..... ..+|+++|+.+ .||||+++++++..+...++||||+++
T Consensus 8 ~~~~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~ 86 (263)
T cd05052 8 ITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEI-KHPNLVQLLGVCTREPPFYIITEFMTY 86 (263)
T ss_pred eEEeeecCCcccceEEEEEEecCCceEEEEEecCCchHHHHHHHHHHHHHhC-CCCChhheEEEEcCCCCcEEEEEeCCC
Confidence 3345789999999999999999999999999875432 45689999998 599999999999999999999999999
Q ss_pred CCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCcEEEecCCCCCEEEEeecccccccCCCc----c
Q psy11767 456 GELLDRIRQKGRCGFTENEASRIMRQLVAAVHFMHSRGVVHRDLKPENLLFSDPAGDNIKVVDFGFACLKRESLH----T 531 (966)
Q Consensus 456 g~L~~~l~~~~~~~l~e~~~~~i~~Qil~aL~yLHs~~IiHRDLKP~NILl~~~~~~~iKL~DFGla~~~~~~~~----~ 531 (966)
++|.+++.......+++..++.++.|++.||+|||++||+||||||+|||+++ ++.+||+|||++........ .
T Consensus 87 ~~L~~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~dlkp~nil~~~--~~~~kl~df~~~~~~~~~~~~~~~~ 164 (263)
T cd05052 87 GNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGE--NHLVKVADFGLSRLMTGDTYTAHAG 164 (263)
T ss_pred CcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeecccCcceEEEcC--CCcEEeCCCccccccccceeeccCC
Confidence 99999997765556899999999999999999999999999999999999975 56899999999876543211 1
Q ss_pred ccccccccCchhhccCCCCCCCcccchhhhhhhhhhhhcCCCCCCCcCcchhHHHHHHHHhc-CCCCCCCCCCchhHHHH
Q psy11767 532 PCFTLQYAAPEVLRQDKSGYDENCDLWSLGVILVNVLRQDKSGYDENCDLWSLGVILYTMLC-GRVPFHARSRDDSALSI 610 (966)
Q Consensus 532 ~~gT~~Y~APEvl~~~~~~~~~~~Di~SlGvil~el~~~~~~~y~~~~DIWSlGvilyemlt-G~~Pf~~~~~~~~~~~~ 610 (966)
..+++.|+|||++.. ..++.++|||||||++|+|++ |..||.+.... ..
T Consensus 165 ~~~~~~y~aPE~~~~--------------------------~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~----~~ 214 (263)
T cd05052 165 AKFPIKWTAPESLAY--------------------------NKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLS----QV 214 (263)
T ss_pred CCCccccCCHHHhcc--------------------------CCCCchhHHHHHHHHHHHHHcCCCCCCCCCCHH----HH
Confidence 223567999998752 235778999999999999998 99999875432 22
Q ss_pred HHHHHcCCCCCCchhhccCCHHHHHHHHHhcccCccccCChHHHHHHhh
Q psy11767 611 MARIKEGQFNFDAEAWSTVSSEAKELTKSLLTVNPAQRIRMMRVKLTFH 659 (966)
Q Consensus 611 ~~~i~~~~~~~~~~~~~~is~e~~~Li~~~L~~dP~~R~t~~~v~~~~~ 659 (966)
...+..+ +. .+....++.++.+++.+||..||++||++.++...+.
T Consensus 215 ~~~~~~~-~~--~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~l~~~l~ 260 (263)
T cd05052 215 YELLEKG-YR--MERPEGCPPKVYELMRACWQWNPSDRPSFAEIHQAFE 260 (263)
T ss_pred HHHHHCC-CC--CCCCCCCCHHHHHHHHHHccCCcccCCCHHHHHHHHH
Confidence 3334332 11 1223457899999999999999999999998855443
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays |
| >cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-36 Score=339.21 Aligned_cols=249 Identities=22% Similarity=0.342 Sum_probs=193.4
Q ss_pred ccccccc--cccEEEEEEEcCCCcEEEEEEecccc-------ChHHHHHHHHHhcCCCCceEEEEEEEeCCeEEEEEEcc
Q psy11767 383 AGILGDG--SYSVCRRCVEKSTGQEYAVKIISRKI-------DCSEEINLLRACQGHPNIVNLHCVFQDEVHTYLVLELL 453 (966)
Q Consensus 383 ~~~LG~G--~fG~Vy~a~~~~tg~~vAvK~i~~~~-------~~~~Ei~iL~~l~~HpnIV~l~~~~~~~~~~~lVmEy~ 453 (966)
+++||+| +||+||++.++.+|+.||||++.... ...+|+.+++.+ +|||||+++++|.+++..|+||||+
T Consensus 3 ~~~ig~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l-~hpniv~~~~~~~~~~~~~lv~e~~ 81 (327)
T cd08227 3 LTVIGRGFEDLMTVNLARYKPTGEYVTVRRINLEACTNEMVTFLQGELHVSKLF-NHPNIVPYRATFIADNELWVVTSFM 81 (327)
T ss_pred hhhccccccceEEEEEEeecccCcEEEEEEechhhccHHHHHHHHHHHHHHHhc-CCCCeeeEEEEEEECCEEEEEEecc
Confidence 5689999 78899999999999999999997542 134588888887 6999999999999999999999999
Q ss_pred CCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCcEEEecCCCCCEEEEeecccccccC------
Q psy11767 454 KGGELLDRIRQKGRCGFTENEASRIMRQLVAAVHFMHSRGVVHRDLKPENLLFSDPAGDNIKVVDFGFACLKRE------ 527 (966)
Q Consensus 454 ~gg~L~~~l~~~~~~~l~e~~~~~i~~Qil~aL~yLHs~~IiHRDLKP~NILl~~~~~~~iKL~DFGla~~~~~------ 527 (966)
++|+|.+++.......+++..++.++.||+.||+|||++||+||||||+|||++. ++.++++|||.+.....
T Consensus 82 ~~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiH~dlkp~Nil~~~--~~~~~l~~~~~~~~~~~~~~~~~ 159 (327)
T cd08227 82 AYGSAKDLICTHFMDGMSELAIAYILQGVLKALDYIHHMGYVHRSVKASHILISV--DGKVYLSGLRSNLSMINHGQRLR 159 (327)
T ss_pred CCCcHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCChhhEEEec--CCcEEEcccchhhcccccccccc
Confidence 9999999997654446999999999999999999999999999999999999985 55899999987532211
Q ss_pred ----CCccccccccccCchhhccCCCCCCCcccchhhhhhhhhhhhcCCCCCCCcCcchhHHHHHHHHhcCCCCCCCCCC
Q psy11767 528 ----SLHTPCFTLQYAAPEVLRQDKSGYDENCDLWSLGVILVNVLRQDKSGYDENCDLWSLGVILYTMLCGRVPFHARSR 603 (966)
Q Consensus 528 ----~~~~~~gT~~Y~APEvl~~~~~~~~~~~Di~SlGvil~el~~~~~~~y~~~~DIWSlGvilyemltG~~Pf~~~~~ 603 (966)
......++..|+|||++... ...|+.++|||||||++|+|++|+.||.....
T Consensus 160 ~~~~~~~~~~~~~~y~aPE~~~~~------------------------~~~~~~~~DiwslG~il~el~~g~~pf~~~~~ 215 (327)
T cd08227 160 VVHDFPKYSVKVLPWLSPEVLQQN------------------------LQGYDAKSDIYSVGITACELANGHVPFKDMPA 215 (327)
T ss_pred ccccccccccceecccChHHhhcc------------------------cCCCCchhhHHHHHHHHHHHHHCCCCCCCcch
Confidence 01123457789999998532 13478899999999999999999999976443
Q ss_pred chhHHHHHHHHHcCCCCC------------------------------------------CchhhccCCHHHHHHHHHhc
Q psy11767 604 DDSALSIMARIKEGQFNF------------------------------------------DAEAWSTVSSEAKELTKSLL 641 (966)
Q Consensus 604 ~~~~~~~~~~i~~~~~~~------------------------------------------~~~~~~~is~e~~~Li~~~L 641 (966)
.... ...+ .+.... ..+....+++++.+||.+||
T Consensus 216 ~~~~---~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l 291 (327)
T cd08227 216 TQML---LEKL-NGTVPCLLDTTTIPAEELTMKPSRSGANSGLGESTTVSTPRPSNGESSSHPYNRTFSPHFHHFVEQCL 291 (327)
T ss_pred hHHH---HHHh-cCCccccccccchhhhhcccCCcccCCcCCCCcccccCCcCccccCCcccccccccCHHHHHHHHHHH
Confidence 2211 1111 110000 00011235788999999999
Q ss_pred ccCccccCChHHHHHHhhhhHHh
Q psy11767 642 TVNPAQRIRMMRVKLTFHAFHQA 664 (966)
Q Consensus 642 ~~dP~~R~t~~~v~~~~~~~~~~ 664 (966)
+.||++|||+.++ ..|+|++.
T Consensus 292 ~~dP~~Rpt~~el--l~~p~f~~ 312 (327)
T cd08227 292 QRNPDARPSASTL--LNHSFFKQ 312 (327)
T ss_pred hhCchhcCCHHHH--hcChhhhh
Confidence 9999999999976 45677643
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype |
| >KOG1187|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-36 Score=342.39 Aligned_cols=250 Identities=26% Similarity=0.420 Sum_probs=193.2
Q ss_pred ccccccccccccccEEEEEEEcCCCcEEEEEEecccc-----ChHHHHHHHHHhcCCCCceEEEEEEEeCC-eEEEEEEc
Q psy11767 379 DLDKAGILGDGSYSVCRRCVEKSTGQEYAVKIISRKI-----DCSEEINLLRACQGHPNIVNLHCVFQDEV-HTYLVLEL 452 (966)
Q Consensus 379 ~~~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~-----~~~~Ei~iL~~l~~HpnIV~l~~~~~~~~-~~~lVmEy 452 (966)
.|....+||+|+||.||+|.... |..||||.+.... ++..|+.+|..+. |||+|+|++||.+.. +.+||+||
T Consensus 76 ~Fs~~~~ig~Ggfg~VYkG~l~~-~~~vAVK~~~~~~~~~~~eF~~Ei~~ls~l~-H~Nlv~LlGyC~e~~~~~~LVYEy 153 (361)
T KOG1187|consen 76 NFSESNLIGEGGFGTVYKGVLSD-GTVVAVKRLSSNSGQGEREFLNEVEILSRLR-HPNLVKLLGYCLEGGEHRLLVYEY 153 (361)
T ss_pred CCchhcceecCCCeEEEEEEECC-CCEEEEEEecCCCCcchhHHHHHHHHHhcCC-CcCcccEEEEEecCCceEEEEEEc
Confidence 34455789999999999998765 4899999886532 4678999999996 999999999999988 59999999
Q ss_pred cCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcC---ceeccCCCCcEEEecCCCCCEEEEeecccccccC-C
Q psy11767 453 LKGGELLDRIRQKGRCGFTENEASRIMRQLVAAVHFMHSRG---VVHRDLKPENLLFSDPAGDNIKVVDFGFACLKRE-S 528 (966)
Q Consensus 453 ~~gg~L~~~l~~~~~~~l~e~~~~~i~~Qil~aL~yLHs~~---IiHRDLKP~NILl~~~~~~~iKL~DFGla~~~~~-~ 528 (966)
|++|+|.++|.......|+|....+|+.+++.||+|||+.. ||||||||+|||||. +.+.||+|||+|+.... .
T Consensus 154 m~nGsL~d~L~~~~~~~L~W~~R~kIa~g~A~gL~yLH~~~~~~iiHrDiKssNILLD~--~~~aKlsDFGLa~~~~~~~ 231 (361)
T KOG1187|consen 154 MPNGSLEDHLHGKKGEPLDWETRLKIALGAARGLAYLHEGCPPPIIHRDIKSSNILLDE--DFNAKLSDFGLAKLGPEGD 231 (361)
T ss_pred cCCCCHHHHhCCCCCCCCCHHHHHHHHHHHHHHHHHHccCCCCCEecCCCCHHHeeECC--CCCEEccCccCcccCCccc
Confidence 99999999998755326899999999999999999999864 999999999999985 56999999999977654 3
Q ss_pred Cc--cc-cccccccCchhhccCCCCCCCcccchhhhhhhhhhhhcCCCCCCCcCcchhHHHHHHHHhcCCCCCCCCC-Cc
Q psy11767 529 LH--TP-CFTLQYAAPEVLRQDKSGYDENCDLWSLGVILVNVLRQDKSGYDENCDLWSLGVILYTMLCGRVPFHARS-RD 604 (966)
Q Consensus 529 ~~--~~-~gT~~Y~APEvl~~~~~~~~~~~Di~SlGvil~el~~~~~~~y~~~~DIWSlGvilyemltG~~Pf~~~~-~~ 604 (966)
.. +. .||.+|+|||++..+ ..+.++|||||||+|.||++|+.|.+... ..
T Consensus 232 ~~~~~~~~gt~gY~~PEy~~~g--------------------------~lt~KsDVySFGVvllElitgr~~~d~~~~~~ 285 (361)
T KOG1187|consen 232 TSVSTTVMGTFGYLAPEYASTG--------------------------KLTEKSDVYSFGVVLLELITGRKAVDQSRPRG 285 (361)
T ss_pred cceeeecCCCCccCChhhhccC--------------------------CcCcccccccchHHHHHHHhCCcccCCCCCcc
Confidence 22 22 799999999988532 25789999999999999999999887543 11
Q ss_pred hhHHH--HHHHHHcCCCC--CCchhh-ccCC--HH---HHHHHHHhcccCccccCChHHHHHHh
Q psy11767 605 DSALS--IMARIKEGQFN--FDAEAW-STVS--SE---AKELTKSLLTVNPAQRIRMMRVKLTF 658 (966)
Q Consensus 605 ~~~~~--~~~~i~~~~~~--~~~~~~-~~is--~e---~~~Li~~~L~~dP~~R~t~~~v~~~~ 658 (966)
+..+. ....+.++.+. .++... .... .+ +..+..+|++.+|..||+|.+|...+
T Consensus 286 ~~~l~~w~~~~~~~~~~~eiiD~~l~~~~~~~~~~~~~~~~~a~~C~~~~~~~RP~m~~Vv~~L 349 (361)
T KOG1187|consen 286 ELSLVEWAKPLLEEGKLREIVDPRLKEGEYPDEKEVKKLAELALRCLRPDPKERPTMSQVVKEL 349 (361)
T ss_pred cccHHHHHHHHHHCcchhheeCCCccCCCCChHHHHHHHHHHHHHHcCcCCCcCcCHHHHHHHH
Confidence 11111 12233333221 111111 1222 22 45678899999999999999975443
|
|
| >cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-36 Score=325.54 Aligned_cols=242 Identities=24% Similarity=0.426 Sum_probs=194.4
Q ss_pred ccccccccccccEEEEEEEcCCCcEEEEEEecccc-----ChHHHHHHHHHhcCCCCceEEEEEEEeCCeEEEEEEccCC
Q psy11767 381 DKAGILGDGSYSVCRRCVEKSTGQEYAVKIISRKI-----DCSEEINLLRACQGHPNIVNLHCVFQDEVHTYLVLELLKG 455 (966)
Q Consensus 381 ~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~-----~~~~Ei~iL~~l~~HpnIV~l~~~~~~~~~~~lVmEy~~g 455 (966)
...+.||+|+||.||+|.+..+++.||+|+++... ...+|+.+++.+ +||||+++++++.+....|+||||+++
T Consensus 12 ~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~~~~l-~h~~ii~~~~~~~~~~~~~lv~e~~~~ 90 (267)
T cd06645 12 ELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEPGEDFAVVQQEIIMMKDC-KHSNIVAYFGSYLRRDKLWICMEFCGG 90 (267)
T ss_pred HHHHHhCCCCCeEEEEEEEcCCCcEEEEEEEecCchhHHHHHHHHHHHHHhC-CCCCeeeEEEEEEeCCEEEEEEeccCC
Confidence 34678999999999999999999999999986542 134688888888 599999999999999999999999999
Q ss_pred CCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCcEEEecCCCCCEEEEeecccccccCC---Cccc
Q psy11767 456 GELLDRIRQKGRCGFTENEASRIMRQLVAAVHFMHSRGVVHRDLKPENLLFSDPAGDNIKVVDFGFACLKRES---LHTP 532 (966)
Q Consensus 456 g~L~~~l~~~~~~~l~e~~~~~i~~Qil~aL~yLHs~~IiHRDLKP~NILl~~~~~~~iKL~DFGla~~~~~~---~~~~ 532 (966)
++|.+++...+ .+++.+++.++.|++.||+|||++||+||||||+|||++. .+.+||+|||++...... ....
T Consensus 91 ~~L~~~~~~~~--~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nili~~--~~~~~l~dfg~~~~~~~~~~~~~~~ 166 (267)
T cd06645 91 GSLQDIYHVTG--PLSESQIAYVSRETLQGLYYLHSKGKMHRDIKGANILLTD--NGHVKLADFGVSAQITATIAKRKSF 166 (267)
T ss_pred CcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECC--CCCEEECcceeeeEccCcccccccc
Confidence 99999987665 5899999999999999999999999999999999999974 568999999998654322 2345
Q ss_pred cccccccCchhhccCCCCCCCcccchhhhhhhhhhhhcCCCCCCCcCcchhHHHHHHHHhcCCCCCCCCCCchhHHHHHH
Q psy11767 533 CFTLQYAAPEVLRQDKSGYDENCDLWSLGVILVNVLRQDKSGYDENCDLWSLGVILYTMLCGRVPFHARSRDDSALSIMA 612 (966)
Q Consensus 533 ~gT~~Y~APEvl~~~~~~~~~~~Di~SlGvil~el~~~~~~~y~~~~DIWSlGvilyemltG~~Pf~~~~~~~~~~~~~~ 612 (966)
.+|+.|+|||++... ....++.++|+|||||++|+|++|..||........ ..
T Consensus 167 ~~~~~y~aPE~~~~~-----------------------~~~~~~~~~DvwSlG~il~~l~~~~~p~~~~~~~~~----~~ 219 (267)
T cd06645 167 IGTPYWMAPEVAAVE-----------------------RKGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRA----LF 219 (267)
T ss_pred cCcccccChhhhccc-----------------------cCCCCCchhhhHHHHHHHHHHhcCCCCcccccchhh----HH
Confidence 689999999987421 123467899999999999999999999975443211 11
Q ss_pred HHHcCCCCCCc-hhhccCCHHHHHHHHHhcccCccccCChHHH
Q psy11767 613 RIKEGQFNFDA-EAWSTVSSEAKELTKSLLTVNPAQRIRMMRV 654 (966)
Q Consensus 613 ~i~~~~~~~~~-~~~~~is~e~~~Li~~~L~~dP~~R~t~~~v 654 (966)
.+....+.... .....++..+.++|.+||..||++||++.++
T Consensus 220 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~l 262 (267)
T cd06645 220 LMTKSNFQPPKLKDKMKWSNSFHHFVKMALTKNPKKRPTAEKL 262 (267)
T ss_pred hhhccCCCCCcccccCCCCHHHHHHHHHHccCCchhCcCHHHH
Confidence 12222222111 1112467899999999999999999999876
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-36 Score=333.28 Aligned_cols=245 Identities=22% Similarity=0.402 Sum_probs=193.3
Q ss_pred ccccccccccccEEEEEEEcCCCcE--EEEEEecccc------ChHHHHHHHHHhcCCCCceEEEEEEEeCCeEEEEEEc
Q psy11767 381 DKAGILGDGSYSVCRRCVEKSTGQE--YAVKIISRKI------DCSEEINLLRACQGHPNIVNLHCVFQDEVHTYLVLEL 452 (966)
Q Consensus 381 ~~~~~LG~G~fG~Vy~a~~~~tg~~--vAvK~i~~~~------~~~~Ei~iL~~l~~HpnIV~l~~~~~~~~~~~lVmEy 452 (966)
+..+.||+|+||.||+|.+..+|.. +|+|.+.... ...+|+.+|..+.+||||+++++++.+++..|+||||
T Consensus 10 ~~~~~lg~G~~g~V~~a~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~Ei~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~ 89 (303)
T cd05088 10 KFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEY 89 (303)
T ss_pred eeeeeecCCCCceEEEEEEccCCceeeEEEEEecccCCHHHHHHHHHHHHHHHHhcCCCCcceEEEEECCCCCceEEEEe
Confidence 3357899999999999999888764 5777765422 1345899999987799999999999999999999999
Q ss_pred cCCCCHHHHHHhcC--------------CCCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCcEEEecCCCCCEEEEe
Q psy11767 453 LKGGELLDRIRQKG--------------RCGFTENEASRIMRQLVAAVHFMHSRGVVHRDLKPENLLFSDPAGDNIKVVD 518 (966)
Q Consensus 453 ~~gg~L~~~l~~~~--------------~~~l~e~~~~~i~~Qil~aL~yLHs~~IiHRDLKP~NILl~~~~~~~iKL~D 518 (966)
+++|+|.+++.+.. ...+++..++.++.||+.||+|||++||+||||||+|||+++ .+.+||+|
T Consensus 90 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~gi~H~dlkp~Nili~~--~~~~kl~d 167 (303)
T cd05088 90 APHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGE--NYVAKIAD 167 (303)
T ss_pred CCCCcHHHHHHhcccccccccccccccccCcCCHHHHHHHHHHHHHHHHHHHhCCccccccchheEEecC--CCcEEeCc
Confidence 99999999997543 125889999999999999999999999999999999999975 56899999
Q ss_pred ecccccccCCCc--cccccccccCchhhccCCCCCCCcccchhhhhhhhhhhhcCCCCCCCcCcchhHHHHHHHHhc-CC
Q psy11767 519 FGFACLKRESLH--TPCFTLQYAAPEVLRQDKSGYDENCDLWSLGVILVNVLRQDKSGYDENCDLWSLGVILYTMLC-GR 595 (966)
Q Consensus 519 FGla~~~~~~~~--~~~gT~~Y~APEvl~~~~~~~~~~~Di~SlGvil~el~~~~~~~y~~~~DIWSlGvilyemlt-G~ 595 (966)
||++........ ...++..|+|||++.. ..++.++|||||||++|+|++ |.
T Consensus 168 fg~~~~~~~~~~~~~~~~~~~y~aPE~~~~--------------------------~~~~~~~Di~slG~il~ellt~g~ 221 (303)
T cd05088 168 FGLSRGQEVYVKKTMGRLPVRWMAIESLNY--------------------------SVYTTNSDVWSYGVLLWEIVSLGG 221 (303)
T ss_pred cccCcccchhhhcccCCCcccccCHHHHhc--------------------------cCCcccccchhhhhHHHHHHhcCC
Confidence 999864322111 2234667999998742 236788999999999999998 99
Q ss_pred CCCCCCCCchhHHHHHHHHHcCCCCCCchhhccCCHHHHHHHHHhcccCccccCChHHHHHHhhh
Q psy11767 596 VPFHARSRDDSALSIMARIKEGQFNFDAEAWSTVSSEAKELTKSLLTVNPAQRIRMMRVKLTFHA 660 (966)
Q Consensus 596 ~Pf~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~is~e~~~Li~~~L~~dP~~R~t~~~v~~~~~~ 660 (966)
+||...+.. .....+..+. ..+.+..+++++.+|+.+||..||++||++.++...+..
T Consensus 222 ~p~~~~~~~----~~~~~~~~~~---~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~l~~ 279 (303)
T cd05088 222 TPYCGMTCA----ELYEKLPQGY---RLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNR 279 (303)
T ss_pred CCcccCChH----HHHHHHhcCC---cCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHH
Confidence 999765432 2233343321 111223578899999999999999999999987655443
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A |
| >KOG1151|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-37 Score=335.06 Aligned_cols=251 Identities=28% Similarity=0.437 Sum_probs=203.4
Q ss_pred ecccccccccccccccccccEEEEEEEcCCCcEEEEEEecccc------------ChHHHHHHHHHhcCCCCceEEEEEE
Q psy11767 373 FEQYDMDLDKAGILGDGSYSVCRRCVEKSTGQEYAVKIISRKI------------DCSEEINLLRACQGHPNIVNLHCVF 440 (966)
Q Consensus 373 ~~~~~i~~~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~------------~~~~Ei~iL~~l~~HpnIV~l~~~~ 440 (966)
.++|-+ +.+||+|||+.||+|.+....+.||||+-.... .+.+|.+|.+.| +||.||++|++|
T Consensus 462 n~RYLl----LhLLGrGGFSEVyKAFDl~EqRYvAvKIHqlNK~WrdEKKeNYhKHAcREyrIHKeL-DHpRIVKlYDyf 536 (775)
T KOG1151|consen 462 NDRYLL----LHLLGRGGFSEVYKAFDLTEQRYVAVKIHQLNKNWRDEKKENYHKHACREYRIHKEL-DHPRIVKLYDYF 536 (775)
T ss_pred HHHHHH----HHHhccccHHHHHHhcccchhheeeEeeehhccchhhHhhhhHHHHHHHHHhhhhcc-Ccceeeeeeeee
Confidence 345554 678999999999999999999999999865332 144688888888 699999999999
Q ss_pred Ee-CCeEEEEEEccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhc--CceeccCCCCcEEEec-CCCCCEEE
Q psy11767 441 QD-EVHTYLVLELLKGGELLDRIRQKGRCGFTENEASRIMRQLVAAVHFMHSR--GVVHRDLKPENLLFSD-PAGDNIKV 516 (966)
Q Consensus 441 ~~-~~~~~lVmEy~~gg~L~~~l~~~~~~~l~e~~~~~i~~Qil~aL~yLHs~--~IiHRDLKP~NILl~~-~~~~~iKL 516 (966)
.- ....|-|+|||+|.+|.-||+++. .++|.+++.|+-||+.||.||.+. .|||-||||.||||.+ ...|.|||
T Consensus 537 slDtdsFCTVLEYceGNDLDFYLKQhk--lmSEKEARSIiMQiVnAL~YLNEikpPIIHYDLKPgNILLv~GtacGeIKI 614 (775)
T KOG1151|consen 537 SLDTDSFCTVLEYCEGNDLDFYLKQHK--LMSEKEARSIIMQIVNALKYLNEIKPPIIHYDLKPGNILLVNGTACGEIKI 614 (775)
T ss_pred eeccccceeeeeecCCCchhHHHHhhh--hhhHHHHHHHHHHHHHHHHHHhccCCCeeeeccCCccEEEecCcccceeEe
Confidence 74 456789999999999999998876 589999999999999999999987 4999999999999865 34678999
Q ss_pred EeecccccccCCC----------ccccccccccCchhhccCCCCCCCcccchhhhhhhhhhhhcCCCCCCCcCcchhHHH
Q psy11767 517 VDFGFACLKRESL----------HTPCFTLQYAAPEVLRQDKSGYDENCDLWSLGVILVNVLRQDKSGYDENCDLWSLGV 586 (966)
Q Consensus 517 ~DFGla~~~~~~~----------~~~~gT~~Y~APEvl~~~~~~~~~~~Di~SlGvil~el~~~~~~~y~~~~DIWSlGv 586 (966)
+||||+++..+.. ....||.||++||.+.-+ .+.+..+.++||||+||
T Consensus 615 TDFGLSKIMdddSy~~vdGmeLTSQgAGTYWYLPPEcFvVg----------------------kePPKIsnKVDVWSvGV 672 (775)
T KOG1151|consen 615 TDFGLSKIMDDDSYNSVDGMELTSQGAGTYWYLPPECFVVG----------------------KEPPKISNKVDVWSVGV 672 (775)
T ss_pred eecchhhhccCCccCcccceeeecccCceeeecCcceeecC----------------------CCCCccccceeeEeeeh
Confidence 9999998865422 235689999999988532 23456788999999999
Q ss_pred HHHHHhcCCCCCCCCCCchhHHHHHHHHHcCCCCCCchhhccCCHHHHHHHHHhcccCccccCChHHH
Q psy11767 587 ILYTMLCGRVPFHARSRDDSALSIMARIKEGQFNFDAEAWSTVSSEAKELTKSLLTVNPAQRIRMMRV 654 (966)
Q Consensus 587 ilyemltG~~Pf~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~is~e~~~Li~~~L~~dP~~R~t~~~v 654 (966)
|+|.++.|+.||.........+..-..++.....|++. +.+|++++++|++||++--++|+...++
T Consensus 673 IFyQClYGrKPFGhnqsQQdILqeNTIlkAtEVqFP~K--PvVsseAkaFIRRCLaYRKeDR~DV~qL 738 (775)
T KOG1151|consen 673 IFYQCLYGRKPFGHNQSQQDILQENTILKATEVQFPPK--PVVSSEAKAFIRRCLAYRKEDRIDVQQL 738 (775)
T ss_pred hhhhhhccCCCCCCchhHHHHHhhhchhcceeccCCCC--CccCHHHHHHHHHHHHhhhhhhhhHHHH
Confidence 99999999999976554433333223344555556554 4699999999999999999999887654
|
|
| >cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-36 Score=327.12 Aligned_cols=242 Identities=23% Similarity=0.363 Sum_probs=196.8
Q ss_pred cccccccccccccEEEEEEEcC-----CCcEEEEEEecccc------ChHHHHHHHHHhcCCCCceEEEEEEEeCCeEEE
Q psy11767 380 LDKAGILGDGSYSVCRRCVEKS-----TGQEYAVKIISRKI------DCSEEINLLRACQGHPNIVNLHCVFQDEVHTYL 448 (966)
Q Consensus 380 ~~~~~~LG~G~fG~Vy~a~~~~-----tg~~vAvK~i~~~~------~~~~Ei~iL~~l~~HpnIV~l~~~~~~~~~~~l 448 (966)
|...+.||+|+||.||+|.+.. +++.||||++.... ...+|+++|+.+ +||||+++++++......|+
T Consensus 7 ~~~~~~lg~g~~~~v~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~~~~l 85 (280)
T cd05049 7 IVLKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTNF-QHENIVKFYGVCTEGDPPIM 85 (280)
T ss_pred hhHHhhccccCCceEeeeeeccccCcCCcceEEEEeecccCCHHHHHHHHHHHHHHHhc-CCCCchheeeEEecCCCeEE
Confidence 3446889999999999998753 46889999986542 244699999988 59999999999999999999
Q ss_pred EEEccCCCCHHHHHHhcC------------CCCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCcEEEecCCCCCEEE
Q psy11767 449 VLELLKGGELLDRIRQKG------------RCGFTENEASRIMRQLVAAVHFMHSRGVVHRDLKPENLLFSDPAGDNIKV 516 (966)
Q Consensus 449 VmEy~~gg~L~~~l~~~~------------~~~l~e~~~~~i~~Qil~aL~yLHs~~IiHRDLKP~NILl~~~~~~~iKL 516 (966)
||||+++++|.+++...+ ...+++..+..++.||+.||+|||++||+||||||+|||++. ++.+||
T Consensus 86 v~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~i~h~dlkp~nili~~--~~~~kl 163 (280)
T cd05049 86 VFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGMVYLASQHFVHRDLATRNCLVGY--DLVVKI 163 (280)
T ss_pred EEecCCCCCHHHHHHhcCCchhhhcccccccccccHHHHHHHHHHHHHHHHHHhhCCeeccccccceEEEcC--CCeEEE
Confidence 999999999999997643 134789999999999999999999999999999999999985 569999
Q ss_pred EeecccccccCC-----CccccccccccCchhhccCCCCCCCcccchhhhhhhhhhhhcCCCCCCCcCcchhHHHHHHHH
Q psy11767 517 VDFGFACLKRES-----LHTPCFTLQYAAPEVLRQDKSGYDENCDLWSLGVILVNVLRQDKSGYDENCDLWSLGVILYTM 591 (966)
Q Consensus 517 ~DFGla~~~~~~-----~~~~~gT~~Y~APEvl~~~~~~~~~~~Di~SlGvil~el~~~~~~~y~~~~DIWSlGvilyem 591 (966)
+|||++...... .....+++.|+|||++.. ..++.++|||||||++|+|
T Consensus 164 ~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~--------------------------~~~~~~~Di~slG~il~e~ 217 (280)
T cd05049 164 GDFGMSRDVYTTDYYRVGGHTMLPIRWMPPESIMY--------------------------RKFTTESDVWSFGVVLWEI 217 (280)
T ss_pred CCcccceecccCcceecCCCCcccceecChhhhcc--------------------------CCcchhhhHHHHHHHHHHH
Confidence 999998653211 122345778999998852 2367889999999999999
Q ss_pred hc-CCCCCCCCCCchhHHHHHHHHHcCCCCCCchhhccCCHHHHHHHHHhcccCccccCChHHHHHH
Q psy11767 592 LC-GRVPFHARSRDDSALSIMARIKEGQFNFDAEAWSTVSSEAKELTKSLLTVNPAQRIRMMRVKLT 657 (966)
Q Consensus 592 lt-G~~Pf~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~is~e~~~Li~~~L~~dP~~R~t~~~v~~~ 657 (966)
++ |..||...... .....+..+...... ..++.++.+++.+||..||++||++.++...
T Consensus 218 ~~~g~~p~~~~~~~----~~~~~~~~~~~~~~~---~~~~~~~~~li~~~l~~~p~~Rp~~~eil~~ 277 (280)
T cd05049 218 FTYGKQPWYGLSNE----EVIECITQGRLLQRP---RTCPSEVYDIMLGCWKRDPQQRINIKDIHER 277 (280)
T ss_pred HhcCCCCCCCCCHH----HHHHHHHcCCcCCCC---CCCCHHHHHHHHHHcCCCcccCCCHHHHHHH
Confidence 98 99999765432 334555555543322 3578999999999999999999999988544
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt |
| >cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-35 Score=319.80 Aligned_cols=239 Identities=27% Similarity=0.438 Sum_probs=198.4
Q ss_pred cccccccccccccEEEEEEEcCCCcEEEEEEecccc-------ChHHHHHHHHHhcCCCCceEEEEEEEeCCeEEEEEEc
Q psy11767 380 LDKAGILGDGSYSVCRRCVEKSTGQEYAVKIISRKI-------DCSEEINLLRACQGHPNIVNLHCVFQDEVHTYLVLEL 452 (966)
Q Consensus 380 ~~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~-------~~~~Ei~iL~~l~~HpnIV~l~~~~~~~~~~~lVmEy 452 (966)
|...+.||+|+||.||+|.+..+|+.||+|.+.... ...+|+.+|+.+ +||||+++++++.++...|+||||
T Consensus 2 ~~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~ 80 (256)
T cd08529 2 FEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKL-DSSYIIRYYESFLDKGKLNIVMEY 80 (256)
T ss_pred ceEeEEecCCCCeEEEEEEEcCCCcEEEEEEeehhhCCHHHHHHHHHHHHHHHhc-CCCCeehheeeeccCCEEEEEEEe
Confidence 344678999999999999999999999999986431 244688888888 599999999999999999999999
Q ss_pred cCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCcEEEecCCCCCEEEEeecccccccCC---C
Q psy11767 453 LKGGELLDRIRQKGRCGFTENEASRIMRQLVAAVHFMHSRGVVHRDLKPENLLFSDPAGDNIKVVDFGFACLKRES---L 529 (966)
Q Consensus 453 ~~gg~L~~~l~~~~~~~l~e~~~~~i~~Qil~aL~yLHs~~IiHRDLKP~NILl~~~~~~~iKL~DFGla~~~~~~---~ 529 (966)
++|++|.+++.......+++..+..++.|++.||.|||+.||+||||||+||+++. ++.++|+|||++...... .
T Consensus 81 ~~~~~L~~~l~~~~~~~~~~~~~~~i~~~l~~al~~lH~~~i~h~dl~~~nili~~--~~~~~l~df~~~~~~~~~~~~~ 158 (256)
T cd08529 81 AENGDLHKLLKMQRGRPLPEDQVWRFFIQILLGLAHLHSKKILHRDIKSLNLFLDA--YDNVKIGDLGVAKLLSDNTNFA 158 (256)
T ss_pred CCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcceEEEeC--CCCEEEcccccceeccCccchh
Confidence 99999999998764457999999999999999999999999999999999999985 568999999998754332 2
Q ss_pred ccccccccccCchhhccCCCCCCCcccchhhhhhhhhhhhcCCCCCCCcCcchhHHHHHHHHhcCCCCCCCCCCchhHHH
Q psy11767 530 HTPCFTLQYAAPEVLRQDKSGYDENCDLWSLGVILVNVLRQDKSGYDENCDLWSLGVILYTMLCGRVPFHARSRDDSALS 609 (966)
Q Consensus 530 ~~~~gT~~Y~APEvl~~~~~~~~~~~Di~SlGvil~el~~~~~~~y~~~~DIWSlGvilyemltG~~Pf~~~~~~~~~~~ 609 (966)
...++++.|+|||++.. ..++.++|+|||||++|+|++|+.||...+. ..
T Consensus 159 ~~~~~~~~y~aPE~~~~--------------------------~~~~~~~Di~slG~il~~l~~g~~p~~~~~~----~~ 208 (256)
T cd08529 159 NTIVGTPYYLSPELCED--------------------------KPYNEKSDVWALGVVLYECCTGKHPFDANNQ----GA 208 (256)
T ss_pred hccccCccccCHHHhcC--------------------------CCCCCccchHHHHHHHHHHHhCCCCCCCCCH----HH
Confidence 23467899999998853 2367789999999999999999999986542 23
Q ss_pred HHHHHHcCCCCCCchhhccCCHHHHHHHHHhcccCccccCChHHH
Q psy11767 610 IMARIKEGQFNFDAEAWSTVSSEAKELTKSLLTVNPAQRIRMMRV 654 (966)
Q Consensus 610 ~~~~i~~~~~~~~~~~~~~is~e~~~Li~~~L~~dP~~R~t~~~v 654 (966)
....+..+.+.... ..++.++.+++.+||+.+|++||++.++
T Consensus 209 ~~~~~~~~~~~~~~---~~~~~~~~~~i~~~l~~~p~~Rp~~~~l 250 (256)
T cd08529 209 LILKIIRGVFPPVS---QMYSQQLAQLIDQCLTKDYRQRPDTFQL 250 (256)
T ss_pred HHHHHHcCCCCCCc---cccCHHHHHHHHHHccCCcccCcCHHHH
Confidence 34445555433221 2578899999999999999999999876
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc |
| >cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-36 Score=326.21 Aligned_cols=244 Identities=26% Similarity=0.422 Sum_probs=195.1
Q ss_pred ccccccccccccccEEEEEEEcCCCcEEEEEEecccc-----ChHHHHHHHHHhcCCCCceEEEEEEEeCCeEEEEEEcc
Q psy11767 379 DLDKAGILGDGSYSVCRRCVEKSTGQEYAVKIISRKI-----DCSEEINLLRACQGHPNIVNLHCVFQDEVHTYLVLELL 453 (966)
Q Consensus 379 ~~~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~-----~~~~Ei~iL~~l~~HpnIV~l~~~~~~~~~~~lVmEy~ 453 (966)
+|+..+.||+|+||.||+|.+..+|+.||+|++.... ...+|+.+|+.+ +||||+++++++..+...|+||||+
T Consensus 10 ~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~~~~~~~~~~e~~~l~~~-~h~~ii~~~~~~~~~~~~~iv~e~~ 88 (267)
T cd06646 10 DYELIQRVGSGTYGDVYKARNLHTGELAAVKIIKLEPGDDFSLIQQEIFMVKEC-KHCNIVAYFGSYLSREKLWICMEYC 88 (267)
T ss_pred hcchhheeecCCCeEEEEEEECCCCeEEEEEEEecCccchHHHHHHHHHHHHhc-CCCCeeeeeEEEEeCCEEEEEEeCC
Confidence 3445789999999999999999999999999986432 134688999887 5999999999999999999999999
Q ss_pred CCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCcEEEecCCCCCEEEEeecccccccCC---Cc
Q psy11767 454 KGGELLDRIRQKGRCGFTENEASRIMRQLVAAVHFMHSRGVVHRDLKPENLLFSDPAGDNIKVVDFGFACLKRES---LH 530 (966)
Q Consensus 454 ~gg~L~~~l~~~~~~~l~e~~~~~i~~Qil~aL~yLHs~~IiHRDLKP~NILl~~~~~~~iKL~DFGla~~~~~~---~~ 530 (966)
++++|.+++.... .+++.++..++.|++.||+|||+.||+||||||+|||+++ .+.+||+|||++...... ..
T Consensus 89 ~~~~L~~~~~~~~--~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nill~~--~~~~~l~dfg~~~~~~~~~~~~~ 164 (267)
T cd06646 89 GGGSLQDIYHVTG--PLSELQIAYVCRETLQGLAYLHSKGKMHRDIKGANILLTD--NGDVKLADFGVAAKITATIAKRK 164 (267)
T ss_pred CCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEECC--CCCEEECcCccceeecccccccC
Confidence 9999999987654 5899999999999999999999999999999999999975 558999999998754321 23
Q ss_pred cccccccccCchhhccCCCCCCCcccchhhhhhhhhhhhcCCCCCCCcCcchhHHHHHHHHhcCCCCCCCCCCchhHHHH
Q psy11767 531 TPCFTLQYAAPEVLRQDKSGYDENCDLWSLGVILVNVLRQDKSGYDENCDLWSLGVILYTMLCGRVPFHARSRDDSALSI 610 (966)
Q Consensus 531 ~~~gT~~Y~APEvl~~~~~~~~~~~Di~SlGvil~el~~~~~~~y~~~~DIWSlGvilyemltG~~Pf~~~~~~~~~~~~ 610 (966)
...+++.|+|||.+... ....++.++|+||+||++|+|++|+.||......+.
T Consensus 165 ~~~~~~~y~~PE~~~~~-----------------------~~~~~~~~~Dvws~G~il~el~~g~~p~~~~~~~~~---- 217 (267)
T cd06646 165 SFIGTPYWMAPEVAAVE-----------------------KNGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRA---- 217 (267)
T ss_pred ccccCccccCHhHcccc-----------------------cCCCCcchhhHHHHHHHHHHHHhCCCCccccchhhh----
Confidence 34678999999987421 123467789999999999999999999975432211
Q ss_pred HHHHHcCCCCCCc-hhhccCCHHHHHHHHHhcccCccccCChHHH
Q psy11767 611 MARIKEGQFNFDA-EAWSTVSSEAKELTKSLLTVNPAQRIRMMRV 654 (966)
Q Consensus 611 ~~~i~~~~~~~~~-~~~~~is~e~~~Li~~~L~~dP~~R~t~~~v 654 (966)
...+....+..+. .....++.++.+||.+||..||++||++.++
T Consensus 218 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~i 262 (267)
T cd06646 218 LFLMSKSNFQPPKLKDKTKWSSTFHNFVKISLTKNPKKRPTAERL 262 (267)
T ss_pred heeeecCCCCCCCCccccccCHHHHHHHHHHhhCChhhCcCHHHH
Confidence 1112222222111 1112468899999999999999999999876
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-36 Score=323.41 Aligned_cols=245 Identities=31% Similarity=0.521 Sum_probs=197.8
Q ss_pred cccccccccEEEEEEEcCCCcEEEEEEeccccC--------hHHHHHHHHHhcCCCCceEEEEEEEeCCeEEEEEEccCC
Q psy11767 384 GILGDGSYSVCRRCVEKSTGQEYAVKIISRKID--------CSEEINLLRACQGHPNIVNLHCVFQDEVHTYLVLELLKG 455 (966)
Q Consensus 384 ~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~~--------~~~Ei~iL~~l~~HpnIV~l~~~~~~~~~~~lVmEy~~g 455 (966)
+.||.|+||.||+|.+..+|+.||||++.+... ...|..++....+||||+++++++..+...|+||||++|
T Consensus 2 ~~l~~g~~~~v~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 81 (260)
T cd05611 2 KPISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLYYSFQSKDYLYLVMEYLNG 81 (260)
T ss_pred ccCCcCCCeeEEEEEecCCCCeEEEEEecchhhhHHHHHHHHHHHHHHHhhcCCCCCeeeeeeeEEcCCeEEEEEeccCC
Confidence 469999999999999999999999999865321 123444454455799999999999999999999999999
Q ss_pred CCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCcEEEecCCCCCEEEEeecccccccCCCcccccc
Q psy11767 456 GELLDRIRQKGRCGFTENEASRIMRQLVAAVHFMHSRGVVHRDLKPENLLFSDPAGDNIKVVDFGFACLKRESLHTPCFT 535 (966)
Q Consensus 456 g~L~~~l~~~~~~~l~e~~~~~i~~Qil~aL~yLHs~~IiHRDLKP~NILl~~~~~~~iKL~DFGla~~~~~~~~~~~gT 535 (966)
++|.+++.... .+++..+..++.||+.||.|||+.||+||||+|+|||+++ .+.+||+|||++..... .....++
T Consensus 82 ~~L~~~l~~~~--~~~~~~~~~i~~qi~~aL~~lH~~~i~H~dl~p~nil~~~--~~~~~l~dfg~~~~~~~-~~~~~~~ 156 (260)
T cd05611 82 GDCASLIKTLG--GLPEDWAKQYIAEVVLGVEDLHQRGIIHRDIKPENLLIDQ--TGHLKLTDFGLSRNGLE-NKKFVGT 156 (260)
T ss_pred CCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECC--CCcEEEeecccceeccc-cccCCCC
Confidence 99999997654 5899999999999999999999999999999999999975 56899999999865432 2344678
Q ss_pred ccccCchhhccCCCCCCCcccchhhhhhhhhhhhcCCCCCCCcCcchhHHHHHHHHhcCCCCCCCCCCchhHHHHHHHHH
Q psy11767 536 LQYAAPEVLRQDKSGYDENCDLWSLGVILVNVLRQDKSGYDENCDLWSLGVILYTMLCGRVPFHARSRDDSALSIMARIK 615 (966)
Q Consensus 536 ~~Y~APEvl~~~~~~~~~~~Di~SlGvil~el~~~~~~~y~~~~DIWSlGvilyemltG~~Pf~~~~~~~~~~~~~~~i~ 615 (966)
+.|+|||.+.. ..++.++||||+||++|+|++|.+||...+.. .....+.
T Consensus 157 ~~y~~pe~~~~--------------------------~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~----~~~~~~~ 206 (260)
T cd05611 157 PDYLAPETILG--------------------------VGDDKMSDWWSLGCVIFEFLFGYPPFHAETPD----AVFDNIL 206 (260)
T ss_pred cCccChhhhcC--------------------------CCCcchhhhHHHHHHHHHHHHCCCCCCCCCHH----HHHHHHH
Confidence 89999998752 12678899999999999999999999765432 3344455
Q ss_pred cCCCCCCchhhccCCHHHHHHHHHhcccCccccCChHHH-HHHhhhhHH
Q psy11767 616 EGQFNFDAEAWSTVSSEAKELTKSLLTVNPAQRIRMMRV-KLTFHAFHQ 663 (966)
Q Consensus 616 ~~~~~~~~~~~~~is~e~~~Li~~~L~~dP~~R~t~~~v-~~~~~~~~~ 663 (966)
.+...+.......+++++.+++.+||..||++||++.++ +...|+|+.
T Consensus 207 ~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~~~l~~~~~~ 255 (260)
T cd05611 207 SRRINWPEEVKEFCSPEAVDLINRLLCMDPAKRLGANGYQEIKSHPFFK 255 (260)
T ss_pred hcccCCCCcccccCCHHHHHHHHHHccCCHHHccCCCcHHHHHcChHhh
Confidence 555444444444689999999999999999999987544 335566653
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do |
| >PHA03209 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-36 Score=343.34 Aligned_cols=249 Identities=21% Similarity=0.329 Sum_probs=191.2
Q ss_pred cccccccccccccEEEEEEEcCCCcEEEEEEeccccChHHHHHHHHHhcCCCCceEEEEEEEeCCeEEEEEEccCCCCHH
Q psy11767 380 LDKAGILGDGSYSVCRRCVEKSTGQEYAVKIISRKIDCSEEINLLRACQGHPNIVNLHCVFQDEVHTYLVLELLKGGELL 459 (966)
Q Consensus 380 ~~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~~~~~Ei~iL~~l~~HpnIV~l~~~~~~~~~~~lVmEy~~gg~L~ 459 (966)
|..++.||+|+||.||+|.+..+++.||+|+.... ....|+.+|+.+ +|||||++++++.+....|+||||+ .++|.
T Consensus 68 y~~~~~lg~G~~g~Vy~~~~~~~~~~valK~~~~~-~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~e~~-~~~l~ 144 (357)
T PHA03209 68 YTVIKTLTPGSEGRVFVATKPGQPDPVVLKIGQKG-TTLIEAMLLQNV-NHPSVIRMKDTLVSGAITCMVLPHY-SSDLY 144 (357)
T ss_pred cEEEEEecCCCCeEEEEEEECCCCceEEEEeCCcc-ccHHHHHHHHhC-CCCCCcChhheEEeCCeeEEEEEcc-CCcHH
Confidence 45578999999999999999999999999986433 456799999988 5999999999999999999999999 56899
Q ss_pred HHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCcEEEecCCCCCEEEEeecccccccC--CCcccccccc
Q psy11767 460 DRIRQKGRCGFTENEASRIMRQLVAAVHFMHSRGVVHRDLKPENLLFSDPAGDNIKVVDFGFACLKRE--SLHTPCFTLQ 537 (966)
Q Consensus 460 ~~l~~~~~~~l~e~~~~~i~~Qil~aL~yLHs~~IiHRDLKP~NILl~~~~~~~iKL~DFGla~~~~~--~~~~~~gT~~ 537 (966)
+++..... .+++.+++.++.||+.||+|||++||+||||||+|||++. .+.+||+|||+++.... ......||+.
T Consensus 145 ~~l~~~~~-~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~Nill~~--~~~~kl~DfG~a~~~~~~~~~~~~~gt~~ 221 (357)
T PHA03209 145 TYLTKRSR-PLPIDQALIIEKQILEGLRYLHAQRIIHRDVKTENIFIND--VDQVCIGDLGAAQFPVVAPAFLGLAGTVE 221 (357)
T ss_pred HHHHhccC-CCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECC--CCCEEEecCccccccccCccccccccccc
Confidence 98876543 6899999999999999999999999999999999999975 56899999999975332 2234568999
Q ss_pred ccCchhhccCCCCCCCcccchhhhhhhhhhhhcCCCCCCCcCcchhHHHHHHHHhcCCCCC-CCCCCchh---------H
Q psy11767 538 YAAPEVLRQDKSGYDENCDLWSLGVILVNVLRQDKSGYDENCDLWSLGVILYTMLCGRVPF-HARSRDDS---------A 607 (966)
Q Consensus 538 Y~APEvl~~~~~~~~~~~Di~SlGvil~el~~~~~~~y~~~~DIWSlGvilyemltG~~Pf-~~~~~~~~---------~ 607 (966)
|+|||++.. ..|+.++|||||||++|||+++..|+ ........ .
T Consensus 222 y~aPE~~~~--------------------------~~~~~~~DiwSlGvvl~ell~~~~~~f~~~~~~~~~~~~~~~~~l 275 (357)
T PHA03209 222 TNAPEVLAR--------------------------DKYNSKADIWSAGIVLFEMLAYPSTIFEDPPSTPEEYVKSCHSHL 275 (357)
T ss_pred ccCCeecCC--------------------------CCCCchhhHHHHHHHHHHHHHcCCccccCCCCcHHHHHHHHHHHH
Confidence 999998852 23678899999999999999865444 43221100 0
Q ss_pred HHHHHHHHcCCCCCC--------------------------chhhccCCHHHHHHHHHhcccCccccCChHHHHHHhhhh
Q psy11767 608 LSIMARIKEGQFNFD--------------------------AEAWSTVSSEAKELTKSLLTVNPAQRIRMMRVKLTFHAF 661 (966)
Q Consensus 608 ~~~~~~i~~~~~~~~--------------------------~~~~~~is~e~~~Li~~~L~~dP~~R~t~~~v~~~~~~~ 661 (966)
..++..+......+. ......++.++.+||.+||+.||++|||+.++ ..|+|
T Consensus 276 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rpta~e~--l~hp~ 353 (357)
T PHA03209 276 LKIISTLKVHPEEFPRDPGSRLVRGFIEYASLERQPYTRYPCFQRVNLPIDGEFLVHKMLTFDAAMRPSAEEI--LNYPM 353 (357)
T ss_pred HHHHHHhccChhhcCCCCccHHHHHHHhhcccCCCcccccHHHhccCCCchHHHHHHHHHcCCcccCcCHHHH--hcCch
Confidence 001111100000000 00112457788899999999999999999876 45666
Q ss_pred H
Q psy11767 662 H 662 (966)
Q Consensus 662 ~ 662 (966)
+
T Consensus 354 f 354 (357)
T PHA03209 354 F 354 (357)
T ss_pred h
Confidence 5
|
|
| >cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-36 Score=334.17 Aligned_cols=250 Identities=27% Similarity=0.458 Sum_probs=184.9
Q ss_pred ccccccccccEEEEEEEcC--CCcEEEEEEecccc---ChHHHHHHHHHhcCCCCceEEEEEEE--eCCeEEEEEEccCC
Q psy11767 383 AGILGDGSYSVCRRCVEKS--TGQEYAVKIISRKI---DCSEEINLLRACQGHPNIVNLHCVFQ--DEVHTYLVLELLKG 455 (966)
Q Consensus 383 ~~~LG~G~fG~Vy~a~~~~--tg~~vAvK~i~~~~---~~~~Ei~iL~~l~~HpnIV~l~~~~~--~~~~~~lVmEy~~g 455 (966)
..+||+|+||+||+|.+.. ++..||+|.+.... ...+|+.+|+.+ +||||+++++++. .+...|+||||+.
T Consensus 6 g~~lG~G~~g~Vy~~~~~~~~~~~~~a~k~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~~~lv~e~~~- 83 (317)
T cd07867 6 GCKVGRGTYGHVYKAKRKDGKDEKEYALKQIEGTGISMSACREIALLREL-KHPNVIALQKVFLSHSDRKVWLLFDYAE- 83 (317)
T ss_pred ceEeccCCCeeEEEEEecCCCccceEEEEEecCCCCcHHHHHHHHHHHhC-CCCCeeeEEEEEeccCCCeEEEEEeeeC-
Confidence 3579999999999999764 67899999987543 356799999998 5999999999985 3567899999985
Q ss_pred CCHHHHHHhc-------CCCCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCcEEEecC--CCCCEEEEeeccccccc
Q psy11767 456 GELLDRIRQK-------GRCGFTENEASRIMRQLVAAVHFMHSRGVVHRDLKPENLLFSDP--AGDNIKVVDFGFACLKR 526 (966)
Q Consensus 456 g~L~~~l~~~-------~~~~l~e~~~~~i~~Qil~aL~yLHs~~IiHRDLKP~NILl~~~--~~~~iKL~DFGla~~~~ 526 (966)
++|.+++... ....+++..++.++.||+.||+|||++||+||||||+|||+... ..+.+||+|||+++...
T Consensus 84 ~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~~kl~DfG~a~~~~ 163 (317)
T cd07867 84 HDLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFN 163 (317)
T ss_pred CcHHHHHHhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhCCEEcCCCCHHHEEEccCCCCCCcEEEeeccceeccC
Confidence 5788877532 12248999999999999999999999999999999999999532 34689999999997643
Q ss_pred CC------CccccccccccCchhhccCCCCCCCcccchhhhhhhhhhhhcCCCCCCCcCcchhHHHHHHHHhcCCCCCCC
Q psy11767 527 ES------LHTPCFTLQYAAPEVLRQDKSGYDENCDLWSLGVILVNVLRQDKSGYDENCDLWSLGVILYTMLCGRVPFHA 600 (966)
Q Consensus 527 ~~------~~~~~gT~~Y~APEvl~~~~~~~~~~~Di~SlGvil~el~~~~~~~y~~~~DIWSlGvilyemltG~~Pf~~ 600 (966)
.. .....+|+.|+|||++.. ...|+.++|||||||++|+|++|++||..
T Consensus 164 ~~~~~~~~~~~~~~t~~y~aPE~~~~-------------------------~~~~~~~~DiwSlG~il~el~tg~~~f~~ 218 (317)
T cd07867 164 SPLKPLADLDPVVVTFWYRAPELLLG-------------------------ARHYTKAIDIWAIGCIFAELLTSEPIFHC 218 (317)
T ss_pred CCcccccccCcceecccccCcHHhcC-------------------------CCccCcHHHHHhHHHHHHHHHhCCCCccc
Confidence 22 223467999999998852 12367889999999999999999999975
Q ss_pred CCCchh-----HHHHHHHHHc----------------------------CCCCC------CchhhccCCHHHHHHHHHhc
Q psy11767 601 RSRDDS-----ALSIMARIKE----------------------------GQFNF------DAEAWSTVSSEAKELTKSLL 641 (966)
Q Consensus 601 ~~~~~~-----~~~~~~~i~~----------------------------~~~~~------~~~~~~~is~e~~~Li~~~L 641 (966)
...+.. ....+..+.. ..+.. ........+..+.+||.+||
T Consensus 219 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l 298 (317)
T cd07867 219 RQEDIKTSNPFHHDQLDRIFSVMGFPADKDWEDIRKMPEYPTLQKDFRRTTYANSSLIKYMEKHKVKPDSKVFLLLQKLL 298 (317)
T ss_pred ccccccccccccHHHHHHHHHhcCCCChhhhhhhhhcccchhhhhhhcccccCCchhhhhhhcccCCCChHHHHHHHHHh
Confidence 432110 0000000000 00000 00001124567889999999
Q ss_pred ccCccccCChHHHHHHhhhh
Q psy11767 642 TVNPAQRIRMMRVKLTFHAF 661 (966)
Q Consensus 642 ~~dP~~R~t~~~v~~~~~~~ 661 (966)
+.||.+|||+.++ ..|+|
T Consensus 299 ~~dP~~R~t~~e~--l~hp~ 316 (317)
T cd07867 299 TMDPTKRITSEQA--LQDPY 316 (317)
T ss_pred ccCcccccCHHHH--hcCCC
Confidence 9999999999876 33544
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as |
| >cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-36 Score=345.60 Aligned_cols=244 Identities=22% Similarity=0.380 Sum_probs=193.4
Q ss_pred cccccccccccEEEEEEEcCC-----CcEEEEEEeccccC------hHHHHHHHHHhcCCCCceEEEEEEEeCCeEEEEE
Q psy11767 382 KAGILGDGSYSVCRRCVEKST-----GQEYAVKIISRKID------CSEEINLLRACQGHPNIVNLHCVFQDEVHTYLVL 450 (966)
Q Consensus 382 ~~~~LG~G~fG~Vy~a~~~~t-----g~~vAvK~i~~~~~------~~~Ei~iL~~l~~HpnIV~l~~~~~~~~~~~lVm 450 (966)
..+.||+|+||.||+|.+... +..||||++..... ..+|+++|..+..|||||++++++.+....||||
T Consensus 41 ~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~~l~~l~~HpnIv~l~~~~~~~~~~~lv~ 120 (400)
T cd05105 41 LGRILGSGAFGKVVEGTAYGLSRSQPVMKVAVKMLKPTARSSEKQALMSELKIMTHLGPHLNIVNLLGACTKSGPIYIIT 120 (400)
T ss_pred hhheecCCCCceEEEEEEcccCCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCCeeeEEEEEccCCceEEEE
Confidence 467899999999999987543 35799999964322 4469999998866999999999999999999999
Q ss_pred EccCCCCHHHHHHhcC----------------------------------------------------------------
Q psy11767 451 ELLKGGELLDRIRQKG---------------------------------------------------------------- 466 (966)
Q Consensus 451 Ey~~gg~L~~~l~~~~---------------------------------------------------------------- 466 (966)
|||++|+|.++|.+..
T Consensus 121 Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 200 (400)
T cd05105 121 EYCFYGDLVNYLHKNRDNFLSRHPEKPKKDLDIFGINPADESTRSYVILSFENKGDYMDMKQADTTQYVPMLEIKEASKY 200 (400)
T ss_pred EecCCCcHHHHHHHhhhhhhccccccccccccccCCCcccccccchhhhhhcccccccccccccccccchhhhhhhhhhh
Confidence 9999999999986532
Q ss_pred ------------------------------CCCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCcEEEecCCCCCEEE
Q psy11767 467 ------------------------------RCGFTENEASRIMRQLVAAVHFMHSRGVVHRDLKPENLLFSDPAGDNIKV 516 (966)
Q Consensus 467 ------------------------------~~~l~e~~~~~i~~Qil~aL~yLHs~~IiHRDLKP~NILl~~~~~~~iKL 516 (966)
...+++.++..++.||+.||+|||+++|+||||||+|||+++ ++.+||
T Consensus 201 ~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivH~dikp~Nill~~--~~~~kL 278 (400)
T cd05105 201 SDIQRSNYDRPASYKGSNDSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFLASKNCVHRDLAARNVLLAQ--GKIVKI 278 (400)
T ss_pred hhcccCcccccccccCcchhhHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChHhEEEeC--CCEEEE
Confidence 124788899999999999999999999999999999999985 558999
Q ss_pred EeecccccccCC-----CccccccccccCchhhccCCCCCCCcccchhhhhhhhhhhhcCCCCCCCcCcchhHHHHHHHH
Q psy11767 517 VDFGFACLKRES-----LHTPCFTLQYAAPEVLRQDKSGYDENCDLWSLGVILVNVLRQDKSGYDENCDLWSLGVILYTM 591 (966)
Q Consensus 517 ~DFGla~~~~~~-----~~~~~gT~~Y~APEvl~~~~~~~~~~~Di~SlGvil~el~~~~~~~y~~~~DIWSlGvilyem 591 (966)
+|||+++..... .....+++.|+|||++.. ..|+.++|||||||++|+|
T Consensus 279 ~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~--------------------------~~~~~~~DiwSlGvil~el 332 (400)
T cd05105 279 CDFGLARDIMHDSNYVSKGSTFLPVKWMAPESIFD--------------------------NLYTTLSDVWSYGILLWEI 332 (400)
T ss_pred EeCCcceeccccccccccCCcCCCcceEChhhhcC--------------------------CCCCchhhHHHHHHHHHHH
Confidence 999998754321 122345778999998842 2367899999999999999
Q ss_pred hc-CCCCCCCCCCchhHHHHHHHHHcCCCCCCchhhccCCHHHHHHHHHhcccCccccCChHHHHHHhh
Q psy11767 592 LC-GRVPFHARSRDDSALSIMARIKEGQFNFDAEAWSTVSSEAKELTKSLLTVNPAQRIRMMRVKLTFH 659 (966)
Q Consensus 592 lt-G~~Pf~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~is~e~~~Li~~~L~~dP~~R~t~~~v~~~~~ 659 (966)
++ |..||......+ .....+..+. ... ....++.++.+++.+||..||++||++.++...+.
T Consensus 333 lt~g~~P~~~~~~~~---~~~~~~~~~~-~~~--~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~l~ 395 (400)
T cd05105 333 FSLGGTPYPGMIVDS---TFYNKIKSGY-RMA--KPDHATQEVYDIMVKCWNSEPEKRPSFLHLSDIVE 395 (400)
T ss_pred HHCCCCCCcccchhH---HHHHHHhcCC-CCC--CCccCCHHHHHHHHHHCccCHhHCcCHHHHHHHHH
Confidence 96 999998654332 2233344432 111 22357889999999999999999999998755443
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF- |
| >cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-36 Score=321.83 Aligned_cols=235 Identities=24% Similarity=0.448 Sum_probs=189.7
Q ss_pred ccccccccEEEEEEEcCCCcEEEEEEecccc------ChHHHHHHHHHhcCCCCceEEEEEEEeCCeEEEEEEccCCCCH
Q psy11767 385 ILGDGSYSVCRRCVEKSTGQEYAVKIISRKI------DCSEEINLLRACQGHPNIVNLHCVFQDEVHTYLVLELLKGGEL 458 (966)
Q Consensus 385 ~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~------~~~~Ei~iL~~l~~HpnIV~l~~~~~~~~~~~lVmEy~~gg~L 458 (966)
.||+|+||.||+|.+..+|+.||+|.+.... ...+|+++|+.+ +||||+++++++.+....|+||||+++++|
T Consensus 2 ~lg~g~~g~vy~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (252)
T cd05084 2 RIGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLKAKFLQEARILKQY-SHPNIVRLIGVCTQKQPIYIVMELVQGGDF 80 (252)
T ss_pred ccCcccCccEEEEEEecCCceEEEEecCccCCHHHHHHHHHHHHHHHhC-CCCCcceEEEEEcCCCCeEEEEeeccCCcH
Confidence 5999999999999999999999999876432 245689999888 699999999999999999999999999999
Q ss_pred HHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCcEEEecCCCCCEEEEeecccccccCCCcc-----cc
Q psy11767 459 LDRIRQKGRCGFTENEASRIMRQLVAAVHFMHSRGVVHRDLKPENLLFSDPAGDNIKVVDFGFACLKRESLHT-----PC 533 (966)
Q Consensus 459 ~~~l~~~~~~~l~e~~~~~i~~Qil~aL~yLHs~~IiHRDLKP~NILl~~~~~~~iKL~DFGla~~~~~~~~~-----~~ 533 (966)
.+++.... ..+++.+++.++.|++.||+|||++||+||||||+|||++. ++.+||+|||++......... ..
T Consensus 81 ~~~~~~~~-~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~nil~~~--~~~~kl~dfg~~~~~~~~~~~~~~~~~~ 157 (252)
T cd05084 81 LTFLRTEG-PRLKVKELIQMVENAAAGMEYLESKHCIHRDLAARNCLVTE--KNVLKISDFGMSREEEDGVYASTGGMKQ 157 (252)
T ss_pred HHHHHhCC-CCCCHHHHHHHHHHHHHHHHHHHhCCccccccchheEEEcC--CCcEEECccccCcccccccccccCCCCC
Confidence 99997654 25899999999999999999999999999999999999975 568999999998654322111 12
Q ss_pred ccccccCchhhccCCCCCCCcccchhhhhhhhhhhhcCCCCCCCcCcchhHHHHHHHHhc-CCCCCCCCCCchhHHHHHH
Q psy11767 534 FTLQYAAPEVLRQDKSGYDENCDLWSLGVILVNVLRQDKSGYDENCDLWSLGVILYTMLC-GRVPFHARSRDDSALSIMA 612 (966)
Q Consensus 534 gT~~Y~APEvl~~~~~~~~~~~Di~SlGvil~el~~~~~~~y~~~~DIWSlGvilyemlt-G~~Pf~~~~~~~~~~~~~~ 612 (966)
.+..|+|||.+.. ..++.++|||||||++|+|++ |.+||...... ....
T Consensus 158 ~~~~y~aPE~~~~--------------------------~~~~~~~Dv~slG~il~e~~~~~~~p~~~~~~~----~~~~ 207 (252)
T cd05084 158 IPVKWTAPEALNY--------------------------GRYSSESDVWSFGILLWEAFSLGAVPYANLSNQ----QTRE 207 (252)
T ss_pred CceeecCchhhcC--------------------------CCCChHHHHHHHHHHHHHHHhCCCCCccccCHH----HHHH
Confidence 2456999998742 236778999999999999997 99999765432 2223
Q ss_pred HHHcCCCCCCchhhccCCHHHHHHHHHhcccCccccCChHHHHH
Q psy11767 613 RIKEGQFNFDAEAWSTVSSEAKELTKSLLTVNPAQRIRMMRVKL 656 (966)
Q Consensus 613 ~i~~~~~~~~~~~~~~is~e~~~Li~~~L~~dP~~R~t~~~v~~ 656 (966)
.+..+... ......+.++.+|+.+||..||++|||+.++..
T Consensus 208 ~~~~~~~~---~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~ 248 (252)
T cd05084 208 AIEQGVRL---PCPELCPDAVYRLMERCWEYDPGQRPSFSTVHQ 248 (252)
T ss_pred HHHcCCCC---CCcccCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 33332111 122356889999999999999999999998743
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular |
| >KOG0610|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-37 Score=335.86 Aligned_cols=214 Identities=25% Similarity=0.386 Sum_probs=186.0
Q ss_pred CcceeeeecccccceEEEEEEcCCCCEEEEEeccccc--------hhhHHHHHHHHhhCCCcccc---------------
Q psy11767 117 DLDKAGILGDGSYSVCRRCVEKSTGQEYAVKIISRKI--------DCSEEINLLRACQGHPNICR--------------- 173 (966)
Q Consensus 117 df~~~~~LG~GsFGkV~La~~k~tg~~yAiKvl~K~~--------~~~~E~~il~~~~~~pfi~~--------------- 173 (966)
+|++++.||.|.=|+|+||+.+.|+.+||||||.|+. .+..|++||..+ +|||+..
T Consensus 78 ~f~llk~LG~GdiG~VyL~~l~~t~~~fAmKVmdK~~l~~rkKl~Ra~tE~eIL~~l-DHPFlPTLYa~fet~~~~cl~m 156 (459)
T KOG0610|consen 78 HFRLLKRLGCGDIGTVYLVELRGTNCLFAMKVMDKESLASRKKLKRAQTEREILSLL-DHPFLPTLYASFETDKYSCLVM 156 (459)
T ss_pred HHHHHHHcCCCCceeEEEEEecCCCceEEEEEecHHHHhhhhHHHHHHHHHHHHHhc-CCCccchhhheeeccceeEEEE
Confidence 8999999999999999999999999999999999963 458899999887 8999954
Q ss_pred -----------------cccccccchhHHHHHHHh----------hcccchhhhHhhhccCCceEEecCccc--------
Q psy11767 174 -----------------RCVEKSTGQEYAVKIISR----------KIDCSEEINLLRACQGHPNIVNLHCVF-------- 218 (966)
Q Consensus 174 -----------------~~~~~~~~~~~~~~~v~~----------~~~~~~e~nil~~~~gh~~iv~l~~~~-------- 218 (966)
.+|.++.++||+++++.+ +.|+++| |||...+||+-|+||.+++
T Consensus 157 eyCpGGdL~~LrqkQp~~~fse~~aRFYaAEvl~ALEYLHmlGivYRDLKPE-NILvredGHIMLsDFDLS~~~~~~Pt~ 235 (459)
T KOG0610|consen 157 EYCPGGDLHSLRQKQPGKRFSESAARFYAAEVLLALEYLHMLGIVYRDLKPE-NILVREDGHIMLSDFDLSLRCPVSPTL 235 (459)
T ss_pred ecCCCccHHHHHhhCCCCccchhhHHHHHHHHHHHHHHHHhhceeeccCCcc-eeEEecCCcEEeeeccccccCCCCCee
Confidence 677788889999988766 3488888 9999999999998865331
Q ss_pred -------------------------------------------------------------------cccccccccCCCc
Q psy11767 219 -------------------------------------------------------------------QDEVIDWDDFSRG 231 (966)
Q Consensus 219 -------------------------------------------------------------------~~e~i~~~~y~~~ 231 (966)
++|+|.-.|+|.+
T Consensus 236 ~~s~~~~~~~~~~~~~~~~~s~f~~r~~~~~~~~~k~~~~~~~~~p~~~aep~~~RSnSFVGThEYlAPEvI~G~GHgsA 315 (459)
T KOG0610|consen 236 VKSSSPRSSGSQPSCRSRQPSCFSPRCLSSSKKRKKKDESASRSLPELVAEPTGARSNSFVGTHEYLAPEVIRGEGHGSA 315 (459)
T ss_pred eccCCCCCCCCCcccccccccccccchhccccccccccccccccchhhhcCCCCccccccccccccccceeeecCCCCch
Confidence 1245666777777
Q ss_pred ceeeechhhHHHHHHHhhCCCCCCCCcHHHHHHHHHhCCCCCCCC--CCHHHHHHHHhhcccCCCcccCCCCCCHHHHhc
Q psy11767 232 IECVFFSSSLIIFFIILSFTLSFIHDYYHIQYRRILKTEPPIPED--LSPDVADFISRLLVKDPRRRLGGGELDAEELKR 309 (966)
Q Consensus 232 ~d~~~~~~~~il~~~m~~g~~pf~~~~~~~~~~~I~~~~~~~P~~--~s~~a~dli~~LL~kdp~~RLG~~~~g~~~Ik~ 309 (966)
|| ||..||++|||++|.+||.+.+..+++.+|+..++.||.. +|.+|+|||++||+|||++|||+. .|+.|||+
T Consensus 316 VD---WWtfGIflYEmLyG~TPFKG~~~~~Tl~NIv~~~l~Fp~~~~vs~~akDLIr~LLvKdP~kRlg~~-rGA~eIK~ 391 (459)
T KOG0610|consen 316 VD---WWTFGIFLYEMLYGTTPFKGSNNKETLRNIVGQPLKFPEEPEVSSAAKDLIRKLLVKDPSKRLGSK-RGAAEIKR 391 (459)
T ss_pred hh---HHHHHHHHHHHHhCCCCcCCCCchhhHHHHhcCCCcCCCCCcchhHHHHHHHHHhccChhhhhccc-cchHHhhc
Confidence 77 7788999999999999999999999999999999999974 789999999999999999999984 69999999
Q ss_pred CCceeeeCccccccCCCCCCCCccccccc
Q psy11767 310 HPFFNVIDWDDLATKRIPAPFVPKISNEL 338 (966)
Q Consensus 310 HpfF~~idW~~l~~k~~~pP~~P~i~~~~ 338 (966)
||||++|||.-+ +-..||++|......
T Consensus 392 HpFF~gVnWaLi--r~~~PP~iP~~~d~~ 418 (459)
T KOG0610|consen 392 HPFFEGVNWALI--RCARPPEIPKPVDGG 418 (459)
T ss_pred CccccCCChhhe--eccCCCcCCCccccC
Confidence 999999999833 667899999875443
|
|
| >PHA03211 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-36 Score=351.03 Aligned_cols=248 Identities=26% Similarity=0.366 Sum_probs=193.6
Q ss_pred ccccccccccccEEEEEEEcCCCcEEEEEEeccccChHHHHHHHHHhcCCCCceEEEEEEEeCCeEEEEEEccCCCCHHH
Q psy11767 381 DKAGILGDGSYSVCRRCVEKSTGQEYAVKIISRKIDCSEEINLLRACQGHPNIVNLHCVFQDEVHTYLVLELLKGGELLD 460 (966)
Q Consensus 381 ~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~~~~~Ei~iL~~l~~HpnIV~l~~~~~~~~~~~lVmEy~~gg~L~~ 460 (966)
...+.||+|+||.||+|.+..+++.||||.... ....+|+++|+.+ +|||||++++++..++..|||||++ .++|.+
T Consensus 172 ~i~~~Lg~G~~G~Vy~a~~~~~~~~vavK~~~~-~~~~~E~~iL~~L-~HpnIv~l~~~~~~~~~~~lv~e~~-~~~L~~ 248 (461)
T PHA03211 172 AIHRALTPGSEGCVFESSHPDYPQRVVVKAGWY-ASSVHEARLLRRL-SHPAVLALLDVRVVGGLTCLVLPKY-RSDLYT 248 (461)
T ss_pred EEEEEEccCCCeEEEEEEECCCCCEEEEecccc-cCHHHHHHHHHHC-CCCCCCcEEEEEEECCEEEEEEEcc-CCCHHH
Confidence 336789999999999999999999999997532 3456899999998 5999999999999999999999999 579999
Q ss_pred HHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCcEEEecCCCCCEEEEeecccccccCC-----Ccccccc
Q psy11767 461 RIRQKGRCGFTENEASRIMRQLVAAVHFMHSRGVVHRDLKPENLLFSDPAGDNIKVVDFGFACLKRES-----LHTPCFT 535 (966)
Q Consensus 461 ~l~~~~~~~l~e~~~~~i~~Qil~aL~yLHs~~IiHRDLKP~NILl~~~~~~~iKL~DFGla~~~~~~-----~~~~~gT 535 (966)
++..... .+++.+++.++.||+.||+|||++||+||||||+|||++. .+.+||+|||+++..... ....+||
T Consensus 249 ~l~~~~~-~l~~~~~~~i~~qi~~aL~yLH~~gIvHrDLKP~NILl~~--~~~vkL~DFGla~~~~~~~~~~~~~~~~GT 325 (461)
T PHA03211 249 YLGARLR-PLGLAQVTAVARQLLSAIDYIHGEGIIHRDIKTENVLVNG--PEDICLGDFGAACFARGSWSTPFHYGIAGT 325 (461)
T ss_pred HHHhcCC-CCCHHHHHHHHHHHHHHHHHHHHCCEEECcCCHHHEEECC--CCCEEEcccCCceecccccccccccccCCC
Confidence 8876433 6999999999999999999999999999999999999975 568999999999764321 1234689
Q ss_pred ccccCchhhccCCCCCCCcccchhhhhhhhhhhhcCCCCCCCcCcchhHHHHHHHHhcCCCCCCCCCCc----hhHHHHH
Q psy11767 536 LQYAAPEVLRQDKSGYDENCDLWSLGVILVNVLRQDKSGYDENCDLWSLGVILYTMLCGRVPFHARSRD----DSALSIM 611 (966)
Q Consensus 536 ~~Y~APEvl~~~~~~~~~~~Di~SlGvil~el~~~~~~~y~~~~DIWSlGvilyemltG~~Pf~~~~~~----~~~~~~~ 611 (966)
+.|+|||++.. ..|+.++|||||||++|||++|..|+...... .....+.
T Consensus 326 ~~Y~APE~~~~--------------------------~~~~~~sDvwSlGviL~El~~g~~~lf~~~~~~~~~~~~~~l~ 379 (461)
T PHA03211 326 VDTNAPEVLAG--------------------------DPYTPSVDIWSAGLVIFEAAVHTASLFSASRGDERRPYDAQIL 379 (461)
T ss_pred cCCcCHHHHcC--------------------------CCCCchHHHHHHHHHHHHHHHcCCCcccCCcccccCCcHHHHH
Confidence 99999999852 23678899999999999999988766543211 0111122
Q ss_pred HHHHcCCCC---------------------------CCchhhc---cCCHHHHHHHHHhcccCccccCChHHHHHHhhhh
Q psy11767 612 ARIKEGQFN---------------------------FDAEAWS---TVSSEAKELTKSLLTVNPAQRIRMMRVKLTFHAF 661 (966)
Q Consensus 612 ~~i~~~~~~---------------------------~~~~~~~---~is~e~~~Li~~~L~~dP~~R~t~~~v~~~~~~~ 661 (966)
..+....+. .....|. .++.++.+||.+||+.||.+|||+.++ ..|+|
T Consensus 380 ~~i~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~DP~~RPsa~el--L~hp~ 457 (461)
T PHA03211 380 RIIRQAQVHVDEFPQHAGSRLVSQYRHRAARNRRPAYTRPAWTRYYKLDLDVEYLVCRALTFDGARRPSAAEL--LRLPL 457 (461)
T ss_pred HHHHhhccccccCCCCcchHHHHHHHhhhhcccCCccCCcchhhhccccchHHHHHHHHcccChhhCcCHHHH--hhCcc
Confidence 222221110 0111222 456789999999999999999999976 44555
Q ss_pred H
Q psy11767 662 H 662 (966)
Q Consensus 662 ~ 662 (966)
+
T Consensus 458 f 458 (461)
T PHA03211 458 F 458 (461)
T ss_pred c
Confidence 4
|
|
| >cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.3e-36 Score=327.15 Aligned_cols=243 Identities=30% Similarity=0.515 Sum_probs=190.0
Q ss_pred ccccccccEEEEEEEcCCCcEEEEEEeccccC--------hHHHHHHHHHh--cCCCCceEEEEEEEeCCeEEEEEEccC
Q psy11767 385 ILGDGSYSVCRRCVEKSTGQEYAVKIISRKID--------CSEEINLLRAC--QGHPNIVNLHCVFQDEVHTYLVLELLK 454 (966)
Q Consensus 385 ~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~~--------~~~Ei~iL~~l--~~HpnIV~l~~~~~~~~~~~lVmEy~~ 454 (966)
+||+|+||.||+|.+..+|+.||||.+.+... ..+|..+++.+ .+||||+.+++++..++..|+||||++
T Consensus 1 ~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~ 80 (279)
T cd05633 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMTYAFHTPDKLCFILDLMN 80 (279)
T ss_pred CcccCCCeEEEEEEECCCCcEEEEEEEEccccccchHHHHHHHHHHHHHHHhhCCCCcEeEEEEEEecCCeEEEEEecCC
Confidence 48999999999999999999999999865321 12333333332 369999999999999999999999999
Q ss_pred CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCcEEEecCCCCCEEEEeecccccccC-CCcccc
Q psy11767 455 GGELLDRIRQKGRCGFTENEASRIMRQLVAAVHFMHSRGVVHRDLKPENLLFSDPAGDNIKVVDFGFACLKRE-SLHTPC 533 (966)
Q Consensus 455 gg~L~~~l~~~~~~~l~e~~~~~i~~Qil~aL~yLHs~~IiHRDLKP~NILl~~~~~~~iKL~DFGla~~~~~-~~~~~~ 533 (966)
||+|.+++...+ .+++..+..++.|++.||+|||+++|+||||||+|||+++ ++.++|+|||++..... ......
T Consensus 81 ~~~L~~~i~~~~--~l~~~~~~~i~~qi~~al~~lH~~~ivH~dikp~Nil~~~--~~~~~l~dfg~~~~~~~~~~~~~~ 156 (279)
T cd05633 81 GGDLHYHLSQHG--VFSEKEMRFYATEIILGLEHMHNRFVVYRDLKPANILLDE--HGHVRISDLGLACDFSKKKPHASV 156 (279)
T ss_pred CCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCcCCCCCCHHHEEECC--CCCEEEccCCcceeccccCccCcC
Confidence 999999987655 5999999999999999999999999999999999999975 56899999999865432 223346
Q ss_pred ccccccCchhhccCCCCCCCcccchhhhhhhhhhhhcCCCCCCCcCcchhHHHHHHHHhcCCCCCCCCCCchhHHHHHHH
Q psy11767 534 FTLQYAAPEVLRQDKSGYDENCDLWSLGVILVNVLRQDKSGYDENCDLWSLGVILYTMLCGRVPFHARSRDDSALSIMAR 613 (966)
Q Consensus 534 gT~~Y~APEvl~~~~~~~~~~~Di~SlGvil~el~~~~~~~y~~~~DIWSlGvilyemltG~~Pf~~~~~~~~~~~~~~~ 613 (966)
+|+.|+|||++.. ...++.++||||+||++|+|++|..||........ ..+...
T Consensus 157 ~~~~y~aPE~~~~-------------------------~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~-~~~~~~ 210 (279)
T cd05633 157 GTHGYMAPEVLQK-------------------------GTAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDK-HEIDRM 210 (279)
T ss_pred CCcCccCHHHhcC-------------------------CCCCCchhhhHHHHHHHHHHHhCCCCcCCCCCcCH-HHHHHH
Confidence 8999999998742 12367889999999999999999999976543221 111111
Q ss_pred HHcCCCCCCchhhccCCHHHHHHHHHhcccCccccCC-----hHHHHHHhhhhHH
Q psy11767 614 IKEGQFNFDAEAWSTVSSEAKELTKSLLTVNPAQRIR-----MMRVKLTFHAFHQ 663 (966)
Q Consensus 614 i~~~~~~~~~~~~~~is~e~~~Li~~~L~~dP~~R~t-----~~~v~~~~~~~~~ 663 (966)
. .......+..++.++.++|.+||..||++|++ +.++ ..|+|++
T Consensus 211 ~----~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~~--~~h~~~~ 259 (279)
T cd05633 211 T----LTVNVELPDSFSPELKSLLEGLLQRDVSKRLGCLGRGAQEV--KEHVFFK 259 (279)
T ss_pred h----hcCCcCCccccCHHHHHHHHHHhcCCHHHhcCCCCCCHHHH--HhCcccc
Confidence 1 11222233467899999999999999999994 7655 4456653
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi |
| >cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.7e-36 Score=329.60 Aligned_cols=247 Identities=22% Similarity=0.407 Sum_probs=195.6
Q ss_pred ccccccccccccEEEEEEEcCCCc--EEEEEEecccc------ChHHHHHHHHHhcCCCCceEEEEEEEeCCeEEEEEEc
Q psy11767 381 DKAGILGDGSYSVCRRCVEKSTGQ--EYAVKIISRKI------DCSEEINLLRACQGHPNIVNLHCVFQDEVHTYLVLEL 452 (966)
Q Consensus 381 ~~~~~LG~G~fG~Vy~a~~~~tg~--~vAvK~i~~~~------~~~~Ei~iL~~l~~HpnIV~l~~~~~~~~~~~lVmEy 452 (966)
+..++||+|+||+||+|....++. .+|+|.++... ...+|+.++.++.+||||+++++++.+....|+||||
T Consensus 5 ~~~~~lg~g~~g~v~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv~e~ 84 (297)
T cd05089 5 KFEDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGHHPNIINLLGACENRGYLYIAIEY 84 (297)
T ss_pred eeeeeecCCCcceEEEEEecCCCCcceeEEEEccccCCHHHHHHHHHHHHHHHhhcCCCchhheEEEEccCCcceEEEEe
Confidence 335789999999999999987775 46888876422 2456899998887799999999999999999999999
Q ss_pred cCCCCHHHHHHhcCC--------------CCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCcEEEecCCCCCEEEEe
Q psy11767 453 LKGGELLDRIRQKGR--------------CGFTENEASRIMRQLVAAVHFMHSRGVVHRDLKPENLLFSDPAGDNIKVVD 518 (966)
Q Consensus 453 ~~gg~L~~~l~~~~~--------------~~l~e~~~~~i~~Qil~aL~yLHs~~IiHRDLKP~NILl~~~~~~~iKL~D 518 (966)
+++|+|.+++.+... ..+++..++.++.||+.||+|||++||+||||||+|||+++ ++.+||+|
T Consensus 85 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~ivH~dlkp~Nill~~--~~~~kl~d 162 (297)
T cd05089 85 APYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVATGMQYLSEKQFIHRDLAARNVLVGE--NLASKIAD 162 (297)
T ss_pred cCCCcHHHHHHhccccccccccccccCccCCCCHHHHHHHHHHHHHHHHHHHHCCcccCcCCcceEEECC--CCeEEECC
Confidence 999999999975421 24889999999999999999999999999999999999975 56899999
Q ss_pred ecccccccCCCc--cccccccccCchhhccCCCCCCCcccchhhhhhhhhhhhcCCCCCCCcCcchhHHHHHHHHhc-CC
Q psy11767 519 FGFACLKRESLH--TPCFTLQYAAPEVLRQDKSGYDENCDLWSLGVILVNVLRQDKSGYDENCDLWSLGVILYTMLC-GR 595 (966)
Q Consensus 519 FGla~~~~~~~~--~~~gT~~Y~APEvl~~~~~~~~~~~Di~SlGvil~el~~~~~~~y~~~~DIWSlGvilyemlt-G~ 595 (966)
||++........ ....+..|+|||++.. ..|+.++|||||||++|+|++ |.
T Consensus 163 fg~~~~~~~~~~~~~~~~~~~y~aPE~~~~--------------------------~~~~~~~DvwSlG~il~el~t~g~ 216 (297)
T cd05089 163 FGLSRGEEVYVKKTMGRLPVRWMAIESLNY--------------------------SVYTTKSDVWSFGVLLWEIVSLGG 216 (297)
T ss_pred cCCCccccceeccCCCCcCccccCchhhcc--------------------------CCCCchhhHHHHHHHHHHHHcCCC
Confidence 999864322211 1223557999998742 236788999999999999997 99
Q ss_pred CCCCCCCCchhHHHHHHHHHcCCCCCCchhhccCCHHHHHHHHHhcccCccccCChHHHHHHhhhhH
Q psy11767 596 VPFHARSRDDSALSIMARIKEGQFNFDAEAWSTVSSEAKELTKSLLTVNPAQRIRMMRVKLTFHAFH 662 (966)
Q Consensus 596 ~Pf~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~is~e~~~Li~~~L~~dP~~R~t~~~v~~~~~~~~ 662 (966)
+||...... .....+..+.. ......++.++.+|+.+||..||.+||++.++...+..+.
T Consensus 217 ~pf~~~~~~----~~~~~~~~~~~---~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~~ 276 (297)
T cd05089 217 TPYCGMTCA----ELYEKLPQGYR---MEKPRNCDDEVYELMRQCWRDRPYERPPFAQISVQLSRML 276 (297)
T ss_pred CCCCCCCHH----HHHHHHhcCCC---CCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHH
Confidence 999875533 23344444321 1122357899999999999999999999998865555443
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. |
| >cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-35 Score=321.61 Aligned_cols=238 Identities=26% Similarity=0.435 Sum_probs=194.2
Q ss_pred ccccccccccccEEEEEEEcCCCcEEEEEEecccc----------ChHHHHHHHHHhcCCCCceEEEEEEEeCCeEEEEE
Q psy11767 381 DKAGILGDGSYSVCRRCVEKSTGQEYAVKIISRKI----------DCSEEINLLRACQGHPNIVNLHCVFQDEVHTYLVL 450 (966)
Q Consensus 381 ~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~----------~~~~Ei~iL~~l~~HpnIV~l~~~~~~~~~~~lVm 450 (966)
+..+.||+|+||.||+|.+..+++.||||.+.... ...+|+++++.+ +||||++++++++++...|+||
T Consensus 5 ~~~~~lg~g~~~~vy~~~~~~~~~~~~lk~~~~~~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~~~~~v~ 83 (263)
T cd06625 5 RRGKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNL-QHERIVQYYGCLRDDETLSIFM 83 (263)
T ss_pred cccceecCCCceEEEEEEEcCCCcEEEEEEEeecccchhhHHHHHHHHHHHHHHHhC-CCCCeeeeEEEEccCCeEEEEE
Confidence 34688999999999999999999999999886431 234588899888 5999999999999999999999
Q ss_pred EccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCcEEEecCCCCCEEEEeecccccccCCC-
Q psy11767 451 ELLKGGELLDRIRQKGRCGFTENEASRIMRQLVAAVHFMHSRGVVHRDLKPENLLFSDPAGDNIKVVDFGFACLKRESL- 529 (966)
Q Consensus 451 Ey~~gg~L~~~l~~~~~~~l~e~~~~~i~~Qil~aL~yLHs~~IiHRDLKP~NILl~~~~~~~iKL~DFGla~~~~~~~- 529 (966)
||++|++|.+.+.... .+++..++.++.|++.||+|||+.||+||||||+||++++ ++.++|+|||++.......
T Consensus 84 e~~~~~~l~~~~~~~~--~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dl~p~nilv~~--~~~~~l~dfg~~~~~~~~~~ 159 (263)
T cd06625 84 EYMPGGSVKDQLKAYG--ALTETVTRKYTRQILEGVEYLHSNMIVHRDIKGANILRDS--AGNVKLGDFGASKRLQTICS 159 (263)
T ss_pred EECCCCcHHHHHHHhC--CCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcC--CCCEEEeecccceecccccc
Confidence 9999999999997754 5899999999999999999999999999999999999974 5689999999986533211
Q ss_pred -----ccccccccccCchhhccCCCCCCCcccchhhhhhhhhhhhcCCCCCCCcCcchhHHHHHHHHhcCCCCCCCCCCc
Q psy11767 530 -----HTPCFTLQYAAPEVLRQDKSGYDENCDLWSLGVILVNVLRQDKSGYDENCDLWSLGVILYTMLCGRVPFHARSRD 604 (966)
Q Consensus 530 -----~~~~gT~~Y~APEvl~~~~~~~~~~~Di~SlGvil~el~~~~~~~y~~~~DIWSlGvilyemltG~~Pf~~~~~~ 604 (966)
....++..|+|||++.. ..++.++|||||||++|+|++|+.||......
T Consensus 160 ~~~~~~~~~~~~~y~aPE~~~~--------------------------~~~~~~~Di~slG~il~el~~g~~p~~~~~~~ 213 (263)
T cd06625 160 SGTGMKSVTGTPYWMSPEVISG--------------------------EGYGRKADVWSVGCTVVEMLTEKPPWAEFEAM 213 (263)
T ss_pred ccccccCCCcCccccCcceecc--------------------------CCCCchhhhHHHHHHHHHHHhCCCCccccchH
Confidence 23457889999999853 22678899999999999999999999765332
Q ss_pred hhHHHHHHHHHcCCCCCCchhhccCCHHHHHHHHHhcccCccccCChHHHH
Q psy11767 605 DSALSIMARIKEGQFNFDAEAWSTVSSEAKELTKSLLTVNPAQRIRMMRVK 655 (966)
Q Consensus 605 ~~~~~~~~~i~~~~~~~~~~~~~~is~e~~~Li~~~L~~dP~~R~t~~~v~ 655 (966)
. ....+...... ......++.++.++|.+||..||++|||+.++.
T Consensus 214 ~----~~~~~~~~~~~--~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll 258 (263)
T cd06625 214 A----AIFKIATQPTN--PQLPSHVSPDARNFLRRTFVENAKKRPSAEELL 258 (263)
T ss_pred H----HHHHHhccCCC--CCCCccCCHHHHHHHHHHhhcCcccCCCHHHHh
Confidence 1 12222222211 122346789999999999999999999998763
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t |
| >cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-35 Score=325.95 Aligned_cols=243 Identities=25% Similarity=0.377 Sum_probs=193.7
Q ss_pred ccccccccccccEEEEEEEcCCCcEEEEEEecccc------ChHHHHHHHHHhcCCCCceEEEEEEEeCCeEEEEEEccC
Q psy11767 381 DKAGILGDGSYSVCRRCVEKSTGQEYAVKIISRKI------DCSEEINLLRACQGHPNIVNLHCVFQDEVHTYLVLELLK 454 (966)
Q Consensus 381 ~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~------~~~~Ei~iL~~l~~HpnIV~l~~~~~~~~~~~lVmEy~~ 454 (966)
+..++||+|+||.||+|.+..+++.||||++.... ...+|+++|+.+ +||||+++++++..+...++||||++
T Consensus 4 ~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~e~~~ 82 (279)
T cd06619 4 QYQEILGHGNGGTVYKAYHLLTRRILAVKVIPLDITVELQKQIMSELEILYKC-DSPYIIGFYGAFFVENRISICTEFMD 82 (279)
T ss_pred hheeeeccCCCeEEEEEEEcCCCcEEEEEEEecCCChHHHHHHHHHHHHHHhC-CCCCeeeEEEEEEECCEEEEEEecCC
Confidence 44678999999999999999999999999986542 234688889888 59999999999999999999999999
Q ss_pred CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCcEEEecCCCCCEEEEeecccccccCC-Ccccc
Q psy11767 455 GGELLDRIRQKGRCGFTENEASRIMRQLVAAVHFMHSRGVVHRDLKPENLLFSDPAGDNIKVVDFGFACLKRES-LHTPC 533 (966)
Q Consensus 455 gg~L~~~l~~~~~~~l~e~~~~~i~~Qil~aL~yLHs~~IiHRDLKP~NILl~~~~~~~iKL~DFGla~~~~~~-~~~~~ 533 (966)
+++|..+. .+++..+..++.|++.||+|||+.||+|+||||+|||++. ++.+||+|||++...... ....+
T Consensus 83 ~~~l~~~~------~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nill~~--~~~~~l~dfg~~~~~~~~~~~~~~ 154 (279)
T cd06619 83 GGSLDVYR------KIPEHVLGRIAVAVVKGLTYLWSLKILHRDVKPSNMLVNT--RGQVKLCDFGVSTQLVNSIAKTYV 154 (279)
T ss_pred CCChHHhh------cCCHHHHHHHHHHHHHHHHHHHHCCEeeCCCCHHHEEECC--CCCEEEeeCCcceecccccccCCC
Confidence 99986542 4789999999999999999999999999999999999975 568999999999754432 33457
Q ss_pred ccccccCchhhccCCCCCCCcccchhhhhhhhhhhhcCCCCCCCcCcchhHHHHHHHHhcCCCCCCCCCCchh---HHHH
Q psy11767 534 FTLQYAAPEVLRQDKSGYDENCDLWSLGVILVNVLRQDKSGYDENCDLWSLGVILYTMLCGRVPFHARSRDDS---ALSI 610 (966)
Q Consensus 534 gT~~Y~APEvl~~~~~~~~~~~Di~SlGvil~el~~~~~~~y~~~~DIWSlGvilyemltG~~Pf~~~~~~~~---~~~~ 610 (966)
+|..|+|||++.. ..++.++|+|||||++|+|++|+.||......+. ....
T Consensus 155 ~~~~y~aPE~~~~--------------------------~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~ 208 (279)
T cd06619 155 GTNAYMAPERISG--------------------------EQYGIHSDVWSLGISFMELALGRFPYPQIQKNQGSLMPLQL 208 (279)
T ss_pred CChhhcCceeecC--------------------------CCCCCcchHHHHHHHHHHHHhCCCCchhhcccccccchHHH
Confidence 8999999998852 2367889999999999999999999975432211 1122
Q ss_pred HHHHHcCCCCCCchhhccCCHHHHHHHHHhcccCccccCChHHHHHHhhhhH
Q psy11767 611 MARIKEGQFNFDAEAWSTVSSEAKELTKSLLTVNPAQRIRMMRVKLTFHAFH 662 (966)
Q Consensus 611 ~~~i~~~~~~~~~~~~~~is~e~~~Li~~~L~~dP~~R~t~~~v~~~~~~~~ 662 (966)
...+...... .......++++.+++.+||+.||++||++.++. .|+|.
T Consensus 209 ~~~~~~~~~~--~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~eil--~~~~~ 256 (279)
T cd06619 209 LQCIVDEDPP--VLPVGQFSEKFVHFITQCMRKQPKERPAPENLM--DHPFI 256 (279)
T ss_pred HHHHhccCCC--CCCCCcCCHHHHHHHHHHhhCChhhCCCHHHHh--cCccc
Confidence 2222222111 111235788999999999999999999998763 45554
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p |
| >cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-36 Score=328.98 Aligned_cols=244 Identities=27% Similarity=0.414 Sum_probs=190.5
Q ss_pred ccccccccccccEEEEEEEcCCCcEEEEEEecccc-------ChHHHHHHHHHhcCCCCceEEEEEEEeCCeEEEEEEcc
Q psy11767 381 DKAGILGDGSYSVCRRCVEKSTGQEYAVKIISRKI-------DCSEEINLLRACQGHPNIVNLHCVFQDEVHTYLVLELL 453 (966)
Q Consensus 381 ~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~-------~~~~Ei~iL~~l~~HpnIV~l~~~~~~~~~~~lVmEy~ 453 (966)
+..+.||+|+||.||+|++..+|+.||+|.+.... ...+|+.+++.+ +||||+++++++.+....|+||||+
T Consensus 3 ~~~~~l~~g~~~~vy~~~~~~~g~~~~~k~~~~~~~~~~~~~~~~~ei~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~ 81 (284)
T cd07839 3 EKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKEL-KHKNIVRLYDVLHSDKKLTLVFEYC 81 (284)
T ss_pred eeEEEecccCCeEEEEEEECCCCcEEEEEEeecccccccCccchhHHHHHHHhc-CCCCeeeHHHHhccCCceEEEEecC
Confidence 34678999999999999999999999999986431 245799999988 5999999999999999999999999
Q ss_pred CCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCcEEEecCCCCCEEEEeecccccccCC---Cc
Q psy11767 454 KGGELLDRIRQKGRCGFTENEASRIMRQLVAAVHFMHSRGVVHRDLKPENLLFSDPAGDNIKVVDFGFACLKRES---LH 530 (966)
Q Consensus 454 ~gg~L~~~l~~~~~~~l~e~~~~~i~~Qil~aL~yLHs~~IiHRDLKP~NILl~~~~~~~iKL~DFGla~~~~~~---~~ 530 (966)
. ++|.+++.... ..+++..++.++.||+.||+|||++||+||||||+|||++. ++.+||+|||++...... ..
T Consensus 82 ~-~~l~~~~~~~~-~~~~~~~~~~~~~qi~~al~~LH~~~i~H~dl~~~nil~~~--~~~~~l~dfg~~~~~~~~~~~~~ 157 (284)
T cd07839 82 D-QDLKKYFDSCN-GDIDPEIVKSFMFQLLKGLAFCHSHNVLHRDLKPQNLLINK--NGELKLADFGLARAFGIPVRCYS 157 (284)
T ss_pred C-CCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEEcC--CCcEEECccchhhccCCCCCCcC
Confidence 6 58888876543 25899999999999999999999999999999999999985 568999999998754322 22
Q ss_pred cccccccccCchhhccCCCCCCCcccchhhhhhhhhhhhcCCCCCCCcCcchhHHHHHHHHhcCCCCCCCCCCchhHHHH
Q psy11767 531 TPCFTLQYAAPEVLRQDKSGYDENCDLWSLGVILVNVLRQDKSGYDENCDLWSLGVILYTMLCGRVPFHARSRDDSALSI 610 (966)
Q Consensus 531 ~~~gT~~Y~APEvl~~~~~~~~~~~Di~SlGvil~el~~~~~~~y~~~~DIWSlGvilyemltG~~Pf~~~~~~~~~~~~ 610 (966)
...+++.|+|||++.. ...++.++|||||||++|+|++|..||......+.....
T Consensus 158 ~~~~~~~y~aPE~~~~-------------------------~~~~~~~~DiwslG~il~~l~tg~~p~~~~~~~~~~~~~ 212 (284)
T cd07839 158 AEVVTLWYRPPDVLFG-------------------------AKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKR 212 (284)
T ss_pred CCccccCCcChHHHhC-------------------------CcccCcHHHHHHHHHHHHHHHhcCCCCcCCCCHHHHHHH
Confidence 3456889999998752 223678899999999999999999886543332211111
Q ss_pred H-HHHHc------------CCC---C-CC-----chhhccCCHHHHHHHHHhcccCccccCChHHH
Q psy11767 611 M-ARIKE------------GQF---N-FD-----AEAWSTVSSEAKELTKSLLTVNPAQRIRMMRV 654 (966)
Q Consensus 611 ~-~~i~~------------~~~---~-~~-----~~~~~~is~e~~~Li~~~L~~dP~~R~t~~~v 654 (966)
+ ..+.. ..+ . +. ....+.+++++.+||++||..||.+|||+.++
T Consensus 213 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~i 278 (284)
T cd07839 213 IFRLLGTPTEESWPGVSKLPDYKPYPMYPATTSLVNVVPKLNSTGRDLLQNLLVCNPVQRISAEEA 278 (284)
T ss_pred HHHHhCCCChHHhHHhhhcccccccCCCCCcchhhhhcccCCHHHHHHHHHHhcCChhhcCCHHHH
Confidence 1 11000 000 0 00 01123578999999999999999999999876
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also |
| >cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-35 Score=325.85 Aligned_cols=246 Identities=23% Similarity=0.359 Sum_probs=197.2
Q ss_pred cccccccccccccEEEEEEEc-----CCCcEEEEEEecccc-----ChHHHHHHHHHhcCCCCceEEEEEEEeCCeEEEE
Q psy11767 380 LDKAGILGDGSYSVCRRCVEK-----STGQEYAVKIISRKI-----DCSEEINLLRACQGHPNIVNLHCVFQDEVHTYLV 449 (966)
Q Consensus 380 ~~~~~~LG~G~fG~Vy~a~~~-----~tg~~vAvK~i~~~~-----~~~~Ei~iL~~l~~HpnIV~l~~~~~~~~~~~lV 449 (966)
|...+.||+|+||+||++.+. .++..+|+|.+.... ...+|+.+|+.+ +||||+++++++......|+|
T Consensus 7 ~~~~~~lg~G~~~~v~~~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv 85 (288)
T cd05093 7 IVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNL-QHEHIVKFYGVCVEGDPLIMV 85 (288)
T ss_pred eeeccccCCcCCeeEEeeEeccCCCCCcceEEEEEecCCcCHHHHHHHHHHHHHHHhC-CCCCcceEEEEEecCCccEEE
Confidence 344678999999999999863 346679999986532 245699999998 599999999999999999999
Q ss_pred EEccCCCCHHHHHHhcCC-----------CCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCcEEEecCCCCCEEEEe
Q psy11767 450 LELLKGGELLDRIRQKGR-----------CGFTENEASRIMRQLVAAVHFMHSRGVVHRDLKPENLLFSDPAGDNIKVVD 518 (966)
Q Consensus 450 mEy~~gg~L~~~l~~~~~-----------~~l~e~~~~~i~~Qil~aL~yLHs~~IiHRDLKP~NILl~~~~~~~iKL~D 518 (966)
|||+++++|.+++...+. ..+++..++.++.||+.||+|||++||+||||||+|||+++ .+.+||+|
T Consensus 86 ~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~lH~~~i~H~dlkp~Nili~~--~~~~kl~d 163 (288)
T cd05093 86 FEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLASQHFVHRDLATRNCLVGE--NLLVKIGD 163 (288)
T ss_pred EEcCCCCCHHHHHHHcCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccCcceEEEcc--CCcEEecc
Confidence 999999999999975431 24899999999999999999999999999999999999975 56899999
Q ss_pred ecccccccCCC-----ccccccccccCchhhccCCCCCCCcccchhhhhhhhhhhhcCCCCCCCcCcchhHHHHHHHHhc
Q psy11767 519 FGFACLKRESL-----HTPCFTLQYAAPEVLRQDKSGYDENCDLWSLGVILVNVLRQDKSGYDENCDLWSLGVILYTMLC 593 (966)
Q Consensus 519 FGla~~~~~~~-----~~~~gT~~Y~APEvl~~~~~~~~~~~Di~SlGvil~el~~~~~~~y~~~~DIWSlGvilyemlt 593 (966)
||++....... ....+++.|+|||++.. ..++.++|||||||++|+|++
T Consensus 164 fg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~--------------------------~~~~~~sDiwslG~il~~l~t 217 (288)
T cd05093 164 FGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMY--------------------------RKFTTESDVWSLGVVLWEIFT 217 (288)
T ss_pred CCccccccCCceeecCCCCCccccccCHHHhcc--------------------------CCCCchhhHHHHHHHHHHHHh
Confidence 99987543211 12234778999998852 236788999999999999998
Q ss_pred -CCCCCCCCCCchhHHHHHHHHHcCCCCCCchhhccCCHHHHHHHHHhcccCccccCChHHHHHHhhhh
Q psy11767 594 -GRVPFHARSRDDSALSIMARIKEGQFNFDAEAWSTVSSEAKELTKSLLTVNPAQRIRMMRVKLTFHAF 661 (966)
Q Consensus 594 -G~~Pf~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~is~e~~~Li~~~L~~dP~~R~t~~~v~~~~~~~ 661 (966)
|.+||...... .....+..+..... ....+.++.+|+.+||+.||.+|||+.++...+..+
T Consensus 218 ~g~~p~~~~~~~----~~~~~i~~~~~~~~---~~~~~~~l~~li~~~l~~~p~~Rpt~~~v~~~l~~~ 279 (288)
T cd05093 218 YGKQPWYQLSNN----EVIECITQGRVLQR---PRTCPKEVYDLMLGCWQREPHMRLNIKEIHSLLQNL 279 (288)
T ss_pred CCCCCCCCCCHH----HHHHHHHcCCcCCC---CCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHH
Confidence 99999765432 34455666553322 235788999999999999999999999885554433
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly |
| >cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.3e-36 Score=326.33 Aligned_cols=243 Identities=24% Similarity=0.369 Sum_probs=193.9
Q ss_pred ccccccccccEEEEEEEcCCCcEEEEEEecccc----ChHHHHHHHHHhcCCCCceEEEEEEEe------CCeEEEEEEc
Q psy11767 383 AGILGDGSYSVCRRCVEKSTGQEYAVKIISRKI----DCSEEINLLRACQGHPNIVNLHCVFQD------EVHTYLVLEL 452 (966)
Q Consensus 383 ~~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~----~~~~Ei~iL~~l~~HpnIV~l~~~~~~------~~~~~lVmEy 452 (966)
.+.||.|+||.||+|.+..+++.||+|++.... ....|+.+++.+.+||||++++++|.. ....|+||||
T Consensus 21 ~~~lg~g~~~~v~~~~~~~~~~~~a~K~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~~~~iv~e~ 100 (282)
T cd06636 21 VEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVTEDEEEEIKLEINMLKKYSHHRNIATYYGAFIKKSPPGHDDQLWLVMEF 100 (282)
T ss_pred heeeccCCCeEEEEEEEcCCCcEEEEEEEecChHHHHHHHHHHHHHHHhcCCCcEEEEeeehhcccccCCCCEEEEEEEe
Confidence 578999999999999999999999999986542 234588888888789999999999853 4678999999
Q ss_pred cCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCcEEEecCCCCCEEEEeecccccccC---CC
Q psy11767 453 LKGGELLDRIRQKGRCGFTENEASRIMRQLVAAVHFMHSRGVVHRDLKPENLLFSDPAGDNIKVVDFGFACLKRE---SL 529 (966)
Q Consensus 453 ~~gg~L~~~l~~~~~~~l~e~~~~~i~~Qil~aL~yLHs~~IiHRDLKP~NILl~~~~~~~iKL~DFGla~~~~~---~~ 529 (966)
+.+|+|.+++.......+++..+..++.||+.||+|||+.||+||||||+||++++ .+.++|+|||++..... ..
T Consensus 101 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~ivH~dl~~~nili~~--~~~~~l~dfg~~~~~~~~~~~~ 178 (282)
T cd06636 101 CGAGSVTDLVKNTKGNALKEDWIAYICREILRGLAHLHAHKVIHRDIKGQNVLLTE--NAEVKLVDFGVSAQLDRTVGRR 178 (282)
T ss_pred CCCCcHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECC--CCCEEEeeCcchhhhhccccCC
Confidence 99999999997755456899999999999999999999999999999999999985 56899999999865432 12
Q ss_pred ccccccccccCchhhccCCCCCCCcccchhhhhhhhhhhhcCCCCCCCcCcchhHHHHHHHHhcCCCCCCCCCCchhHHH
Q psy11767 530 HTPCFTLQYAAPEVLRQDKSGYDENCDLWSLGVILVNVLRQDKSGYDENCDLWSLGVILYTMLCGRVPFHARSRDDSALS 609 (966)
Q Consensus 530 ~~~~gT~~Y~APEvl~~~~~~~~~~~Di~SlGvil~el~~~~~~~y~~~~DIWSlGvilyemltG~~Pf~~~~~~~~~~~ 609 (966)
....+++.|+|||++..... ....|+.++|+|||||++|+|++|..||........
T Consensus 179 ~~~~~~~~y~aPE~l~~~~~---------------------~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~~~~--- 234 (282)
T cd06636 179 NTFIGTPYWMAPEVIACDEN---------------------PDATYDYRSDIWSLGITAIEMAEGAPPLCDMHPMRA--- 234 (282)
T ss_pred CcccccccccCHhhcCcccC---------------------cCcCCCcccchhHHHHHHHHHHhCCCCccccCHHhh---
Confidence 34568899999998853210 134578899999999999999999999976543211
Q ss_pred HHHHHHcCCCCCCchhhccCCHHHHHHHHHhcccCccccCChHHH
Q psy11767 610 IMARIKEGQFNFDAEAWSTVSSEAKELTKSLLTVNPAQRIRMMRV 654 (966)
Q Consensus 610 ~~~~i~~~~~~~~~~~~~~is~e~~~Li~~~L~~dP~~R~t~~~v 654 (966)
...+..... .......++.++.+||.+||..||.+|||+.++
T Consensus 235 -~~~~~~~~~--~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~el 276 (282)
T cd06636 235 -LFLIPRNPP--PKLKSKKWSKKFIDFIEGCLVKNYLSRPSTEQL 276 (282)
T ss_pred -hhhHhhCCC--CCCcccccCHHHHHHHHHHhCCChhhCcCHHHH
Confidence 111222111 111123578899999999999999999999876
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea |
| >PHA03390 pk1 serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-35 Score=322.76 Aligned_cols=241 Identities=27% Similarity=0.456 Sum_probs=191.8
Q ss_pred cccccccEEEEEEEcCCCcEEEEEEeccccChHHHHHHHHHhcCCCCceEEEEEEEeCCeEEEEEEccCCCCHHHHHHhc
Q psy11767 386 LGDGSYSVCRRCVEKSTGQEYAVKIISRKIDCSEEINLLRACQGHPNIVNLHCVFQDEVHTYLVLELLKGGELLDRIRQK 465 (966)
Q Consensus 386 LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~~~~~Ei~iL~~l~~HpnIV~l~~~~~~~~~~~lVmEy~~gg~L~~~l~~~ 465 (966)
||+|+||.||+|.++.++..+|+|++........|+.....+.+||||++++++|..++..|+||||+++++|.+++...
T Consensus 24 lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~e~~~~~~~~~h~~iv~~~~~~~~~~~~~iv~e~~~~~~L~~~l~~~ 103 (267)
T PHA03390 24 LIDGKFGKVSVLKHKPTQKLFVQKIIKAKNFNAIEPMVHQLMKDNPNFIKLYYSVTTLKGHVLIMDYIKDGDLFDLLKKE 103 (267)
T ss_pred ecCCCceEEEEEEEcCCCcEEEEEEEehhhcchhhHHHHHHhhcCCCEEEEEEEEecCCeeEEEEEcCCCCcHHHHHHhc
Confidence 69999999999999999999999998765433335544444457999999999999999999999999999999999776
Q ss_pred CCCCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCcEEEecCCCCCEEEEeecccccccCCCccccccccccCchhhc
Q psy11767 466 GRCGFTENEASRIMRQLVAAVHFMHSRGVVHRDLKPENLLFSDPAGDNIKVVDFGFACLKRESLHTPCFTLQYAAPEVLR 545 (966)
Q Consensus 466 ~~~~l~e~~~~~i~~Qil~aL~yLHs~~IiHRDLKP~NILl~~~~~~~iKL~DFGla~~~~~~~~~~~gT~~Y~APEvl~ 545 (966)
. .+++.++..++.||++||+|||+.||+||||||+||+++. .++.++|+|||++...... ....++..|+|||++.
T Consensus 104 ~--~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nil~~~-~~~~~~l~dfg~~~~~~~~-~~~~~~~~y~aPE~~~ 179 (267)
T PHA03390 104 G--KLSEAEVKKIIRQLVEALNDLHKHNIIHNDIKLENVLYDR-AKDRIYLCDYGLCKIIGTP-SCYDGTLDYFSPEKIK 179 (267)
T ss_pred C--CCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEEeC-CCCeEEEecCccceecCCC-ccCCCCCcccChhhhc
Confidence 4 6999999999999999999999999999999999999975 2238999999998655432 3446789999999885
Q ss_pred cCCCCCCCcccchhhhhhhhhhhhcCCCCCCCcCcchhHHHHHHHHhcCCCCCCCCCCchhHHHHHHHHHcCCCCCCchh
Q psy11767 546 QDKSGYDENCDLWSLGVILVNVLRQDKSGYDENCDLWSLGVILYTMLCGRVPFHARSRDDSALSIMARIKEGQFNFDAEA 625 (966)
Q Consensus 546 ~~~~~~~~~~Di~SlGvil~el~~~~~~~y~~~~DIWSlGvilyemltG~~Pf~~~~~~~~~~~~~~~i~~~~~~~~~~~ 625 (966)
. ..++.++||||+||++|+|++|+.||......+.....+...... ....
T Consensus 180 ~--------------------------~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~----~~~~ 229 (267)
T PHA03390 180 G--------------------------HNYDVSFDWWAVGVLTYELLTGKHPFKEDEDEELDLESLLKRQQK----KLPF 229 (267)
T ss_pred C--------------------------CCCCchhhHHHHHHHHHHHHHCCCCCCCCCcchhhHHHHHHhhcc----cCCc
Confidence 2 236778999999999999999999998554332211222221121 1123
Q ss_pred hccCCHHHHHHHHHhcccCccccCCh-HHHHHHhhhhH
Q psy11767 626 WSTVSSEAKELTKSLLTVNPAQRIRM-MRVKLTFHAFH 662 (966)
Q Consensus 626 ~~~is~e~~~Li~~~L~~dP~~R~t~-~~v~~~~~~~~ 662 (966)
+..+++.+.++|.+||+.||.+|++. .++ ..|+|+
T Consensus 230 ~~~~~~~~~~li~~~l~~~p~~R~~~~~~~--l~h~~~ 265 (267)
T PHA03390 230 IKNVSKNANDFVQSMLKYNINYRLTNYNEI--IKHPFL 265 (267)
T ss_pred ccccCHHHHHHHHHHhccChhhCCchHHHH--hcCCcc
Confidence 34689999999999999999999964 654 345553
|
|
| >cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-35 Score=320.91 Aligned_cols=242 Identities=21% Similarity=0.412 Sum_probs=195.2
Q ss_pred cccccccccccccEEEEEEEcCCCcEEEEEEecccc----ChHHHHHHHHHhcCCCCceEEEEEEEeCCeEEEEEEccCC
Q psy11767 380 LDKAGILGDGSYSVCRRCVEKSTGQEYAVKIISRKI----DCSEEINLLRACQGHPNIVNLHCVFQDEVHTYLVLELLKG 455 (966)
Q Consensus 380 ~~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~----~~~~Ei~iL~~l~~HpnIV~l~~~~~~~~~~~lVmEy~~g 455 (966)
|+..++||+|+||.||+|.+. +++.||+|.+.... ...+|+.+++.+ +|+||+++++++.+....|+||||+++
T Consensus 8 ~~~~~~lg~g~~g~v~~~~~~-~~~~v~iK~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~ 85 (261)
T cd05072 8 IKLVKKLGAGQFGEVWMGYYN-NSTKVAVKTLKPGTMSVQAFLEEANLMKTL-QHDKLVRLYAVVTKEEPIYIITEYMAK 85 (261)
T ss_pred eEEeeecCCcCCceEEEEEec-CCceEEEEEccCCchhHHHHHHHHHHHHhC-CCCCeeeEEEEEcCCCCcEEEEecCCC
Confidence 445788999999999999865 56789999886432 245689999988 599999999999999999999999999
Q ss_pred CCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCcEEEecCCCCCEEEEeecccccccCCC----cc
Q psy11767 456 GELLDRIRQKGRCGFTENEASRIMRQLVAAVHFMHSRGVVHRDLKPENLLFSDPAGDNIKVVDFGFACLKRESL----HT 531 (966)
Q Consensus 456 g~L~~~l~~~~~~~l~e~~~~~i~~Qil~aL~yLHs~~IiHRDLKP~NILl~~~~~~~iKL~DFGla~~~~~~~----~~ 531 (966)
|+|.+++.......+++..+..++.|++.||+|||+.+++||||||+|||+++ .+.+||+|||++....... ..
T Consensus 86 ~~L~~~l~~~~~~~~~~~~~~~~~~~l~~~l~~LH~~~i~H~dl~p~nili~~--~~~~~l~dfg~~~~~~~~~~~~~~~ 163 (261)
T cd05072 86 GSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYIERKNYIHRDLRAANVLVSE--SLMCKIADFGLARVIEDNEYTAREG 163 (261)
T ss_pred CcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccchhhEEecC--CCcEEECCCccceecCCCceeccCC
Confidence 99999997755456899999999999999999999999999999999999985 5689999999997644321 12
Q ss_pred ccccccccCchhhccCCCCCCCcccchhhhhhhhhhhhcCCCCCCCcCcchhHHHHHHHHhc-CCCCCCCCCCchhHHHH
Q psy11767 532 PCFTLQYAAPEVLRQDKSGYDENCDLWSLGVILVNVLRQDKSGYDENCDLWSLGVILYTMLC-GRVPFHARSRDDSALSI 610 (966)
Q Consensus 532 ~~gT~~Y~APEvl~~~~~~~~~~~Di~SlGvil~el~~~~~~~y~~~~DIWSlGvilyemlt-G~~Pf~~~~~~~~~~~~ 610 (966)
..++..|+|||++.. ..++.++|||||||++|+|++ |..||...... ..
T Consensus 164 ~~~~~~y~aPE~~~~--------------------------~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~----~~ 213 (261)
T cd05072 164 AKFPIKWTAPEAINF--------------------------GSFTIKSDVWSFGILLYEIVTYGKIPYPGMSNS----DV 213 (261)
T ss_pred CccceecCCHHHhcc--------------------------CCCChhhhhhhhHHHHHHHHccCCCCCCCCCHH----HH
Confidence 234678999998742 235778999999999999998 99999765432 23
Q ss_pred HHHHHcCCCCCCchhhccCCHHHHHHHHHhcccCccccCChHHHHHHh
Q psy11767 611 MARIKEGQFNFDAEAWSTVSSEAKELTKSLLTVNPAQRIRMMRVKLTF 658 (966)
Q Consensus 611 ~~~i~~~~~~~~~~~~~~is~e~~~Li~~~L~~dP~~R~t~~~v~~~~ 658 (966)
...+..+. .. +....++.++.+++.+||..||++||++.++...+
T Consensus 214 ~~~~~~~~-~~--~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l 258 (261)
T cd05072 214 MSALQRGY-RM--PRMENCPDELYDIMKTCWKEKAEERPTFDYLQSVL 258 (261)
T ss_pred HHHHHcCC-CC--CCCCCCCHHHHHHHHHHccCCcccCcCHHHHHHHH
Confidence 34444432 22 12245788999999999999999999999875443
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa |
| >cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-35 Score=320.10 Aligned_cols=237 Identities=22% Similarity=0.392 Sum_probs=189.9
Q ss_pred ccccccccEEEEEEE--cCCCcEEEEEEecccc-------ChHHHHHHHHHhcCCCCceEEEEEEEeCCeEEEEEEccCC
Q psy11767 385 ILGDGSYSVCRRCVE--KSTGQEYAVKIISRKI-------DCSEEINLLRACQGHPNIVNLHCVFQDEVHTYLVLELLKG 455 (966)
Q Consensus 385 ~LG~G~fG~Vy~a~~--~~tg~~vAvK~i~~~~-------~~~~Ei~iL~~l~~HpnIV~l~~~~~~~~~~~lVmEy~~g 455 (966)
.||+|+||.||+|.. ..++..||+|++.... ...+|+.+|+.+ +||||+++++++.. ...++||||+++
T Consensus 2 ~lg~G~~g~v~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~-~~~~lv~e~~~~ 79 (257)
T cd05116 2 ELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQL-DNPYIVRMIGICEA-ESWMLVMELAEL 79 (257)
T ss_pred cCCCcCCcceEEeEEecCCCceEEEEEEccCCCCcHHHHHHHHHHHHHHHhC-CCCCcceEEEEEcC-CCcEEEEecCCC
Confidence 599999999999965 4578999999986442 234688888887 69999999998864 467999999999
Q ss_pred CCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCcEEEecCCCCCEEEEeecccccccCCC------
Q psy11767 456 GELLDRIRQKGRCGFTENEASRIMRQLVAAVHFMHSRGVVHRDLKPENLLFSDPAGDNIKVVDFGFACLKRESL------ 529 (966)
Q Consensus 456 g~L~~~l~~~~~~~l~e~~~~~i~~Qil~aL~yLHs~~IiHRDLKP~NILl~~~~~~~iKL~DFGla~~~~~~~------ 529 (966)
|+|.+++.... .+++..+..++.|++.||+|||++||+||||||+|||+++ ++.+||+|||++.......
T Consensus 80 ~~L~~~l~~~~--~~~~~~~~~i~~qi~~al~~lH~~~i~H~dlkp~nill~~--~~~~kl~Dfg~~~~~~~~~~~~~~~ 155 (257)
T cd05116 80 GPLNKFLQKNK--HVTEKNITELVHQVSMGMKYLEETNFVHRDLAARNVLLVT--QHYAKISDFGLSKALGADENYYKAK 155 (257)
T ss_pred CcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCEeecccchhhEEEcC--CCeEEECCCccccccCCCCCeeeec
Confidence 99999997654 5899999999999999999999999999999999999985 5689999999986543221
Q ss_pred ccccccccccCchhhccCCCCCCCcccchhhhhhhhhhhhcCCCCCCCcCcchhHHHHHHHHhc-CCCCCCCCCCchhHH
Q psy11767 530 HTPCFTLQYAAPEVLRQDKSGYDENCDLWSLGVILVNVLRQDKSGYDENCDLWSLGVILYTMLC-GRVPFHARSRDDSAL 608 (966)
Q Consensus 530 ~~~~gT~~Y~APEvl~~~~~~~~~~~Di~SlGvil~el~~~~~~~y~~~~DIWSlGvilyemlt-G~~Pf~~~~~~~~~~ 608 (966)
....+++.|+|||.+.. ..++.++|||||||++|||++ |.+||......
T Consensus 156 ~~~~~~~~y~aPE~~~~--------------------------~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~---- 205 (257)
T cd05116 156 THGKWPVKWYAPECMNY--------------------------YKFSSKSDVWSFGVLMWEAFSYGQKPYKGMKGN---- 205 (257)
T ss_pred CCCCCCccccCHhHhcc--------------------------CCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHH----
Confidence 12233578999998742 236778999999999999997 99999865432
Q ss_pred HHHHHHHcCCCCCCchhhccCCHHHHHHHHHhcccCccccCChHHHHHHhhh
Q psy11767 609 SIMARIKEGQFNFDAEAWSTVSSEAKELTKSLLTVNPAQRIRMMRVKLTFHA 660 (966)
Q Consensus 609 ~~~~~i~~~~~~~~~~~~~~is~e~~~Li~~~L~~dP~~R~t~~~v~~~~~~ 660 (966)
.+...+..+... +....++++++++|.+||+.||++||++.+|...+..
T Consensus 206 ~~~~~i~~~~~~---~~~~~~~~~l~~li~~~~~~~p~~Rp~~~~i~~~l~~ 254 (257)
T cd05116 206 EVTQMIESGERM---ECPQRCPPEMYDLMKLCWTYGVDERPGFAVVELRLRN 254 (257)
T ss_pred HHHHHHHCCCCC---CCCCCCCHHHHHHHHHHhccCchhCcCHHHHHHHHhc
Confidence 344555554321 1223578999999999999999999999988655443
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio |
| >cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-35 Score=326.15 Aligned_cols=249 Identities=29% Similarity=0.442 Sum_probs=198.1
Q ss_pred ccccccccccEEEEEEEcCCCcEEEEEEeccccC-----hHHHHHHHHHhcCCCCceEEEEEEEeCCeEEEEEEccCCCC
Q psy11767 383 AGILGDGSYSVCRRCVEKSTGQEYAVKIISRKID-----CSEEINLLRACQGHPNIVNLHCVFQDEVHTYLVLELLKGGE 457 (966)
Q Consensus 383 ~~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~~-----~~~Ei~iL~~l~~HpnIV~l~~~~~~~~~~~lVmEy~~gg~ 457 (966)
++.||.|+||.||+|.+..+++.||+|++..... ..+|+.+++.+ +||||+++++++..++..|+||||++|++
T Consensus 17 ~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~~~ 95 (292)
T cd06644 17 IGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYMVEIEILATC-NHPYIVKLLGAFYWDGKLWIMIEFCPGGA 95 (292)
T ss_pred hheecCCCCeEEEEEEECCCCceEEEEEeccCCHHHHHHHHHHHHHHHhC-CCCcEeeeEEEEEeCCeEEEEEecCCCCc
Confidence 6789999999999999999999999999865432 34588889888 59999999999999999999999999999
Q ss_pred HHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCcEEEecCCCCCEEEEeecccccccCC---Cccccc
Q psy11767 458 LLDRIRQKGRCGFTENEASRIMRQLVAAVHFMHSRGVVHRDLKPENLLFSDPAGDNIKVVDFGFACLKRES---LHTPCF 534 (966)
Q Consensus 458 L~~~l~~~~~~~l~e~~~~~i~~Qil~aL~yLHs~~IiHRDLKP~NILl~~~~~~~iKL~DFGla~~~~~~---~~~~~g 534 (966)
|..++.+.. ..+++..+..++.||+.||+|||+.||+||||||+|||++. ++.+||+|||++...... .....+
T Consensus 96 l~~~~~~~~-~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~dlkp~Nili~~--~~~~kl~dfg~~~~~~~~~~~~~~~~~ 172 (292)
T cd06644 96 VDAIMLELD-RGLTEPQIQVICRQMLEALQYLHSMKIIHRDLKAGNVLLTL--DGDIKLADFGVSAKNVKTLQRRDSFIG 172 (292)
T ss_pred HHHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHhcCCeeecCCCcceEEEcC--CCCEEEccCccceeccccccccceecC
Confidence 988876544 35899999999999999999999999999999999999974 568999999998653221 223457
Q ss_pred cccccCchhhccCCCCCCCcccchhhhhhhhhhhhcCCCCCCCcCcchhHHHHHHHHhcCCCCCCCCCCchhHHHHHHHH
Q psy11767 535 TLQYAAPEVLRQDKSGYDENCDLWSLGVILVNVLRQDKSGYDENCDLWSLGVILYTMLCGRVPFHARSRDDSALSIMARI 614 (966)
Q Consensus 535 T~~Y~APEvl~~~~~~~~~~~Di~SlGvil~el~~~~~~~y~~~~DIWSlGvilyemltG~~Pf~~~~~~~~~~~~~~~i 614 (966)
++.|+|||++..... ....|+.++|+|||||++|+|++|.+||...+.. ....++
T Consensus 173 ~~~y~aPE~~~~~~~---------------------~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~----~~~~~~ 227 (292)
T cd06644 173 TPYWMAPEVVMCETM---------------------KDTPYDYKADIWSLGITLIEMAQIEPPHHELNPM----RVLLKI 227 (292)
T ss_pred CccccCceeeccccc---------------------cCCCCCchhhhHhHHHHHHHHhcCCCCCccccHH----HHHHHH
Confidence 889999998853210 1234788999999999999999999999765432 222333
Q ss_pred HcCCCCCCchhhccCCHHHHHHHHHhcccCccccCChHHHHHHhhhhHH
Q psy11767 615 KEGQFNFDAEAWSTVSSEAKELTKSLLTVNPAQRIRMMRVKLTFHAFHQ 663 (966)
Q Consensus 615 ~~~~~~~~~~~~~~is~e~~~Li~~~L~~dP~~R~t~~~v~~~~~~~~~ 663 (966)
..+.... ......++.++.++|.+||..||++||++.++. .|+|..
T Consensus 228 ~~~~~~~-~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il--~~~~~~ 273 (292)
T cd06644 228 AKSEPPT-LSQPSKWSMEFRDFLKTALDKHPETRPSAAQLL--EHPFVS 273 (292)
T ss_pred hcCCCcc-CCCCcccCHHHHHHHHHHhcCCcccCcCHHHHh--cCcccc
Confidence 3322211 111235788999999999999999999998763 355543
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. |
| >cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-35 Score=318.86 Aligned_cols=239 Identities=24% Similarity=0.428 Sum_probs=193.0
Q ss_pred cccccccccccccEEEEEEEcCCCcEEEEEEecccc----ChHHHHHHHHHhcCCCCceEEEEEEEeCCeEEEEEEccCC
Q psy11767 380 LDKAGILGDGSYSVCRRCVEKSTGQEYAVKIISRKI----DCSEEINLLRACQGHPNIVNLHCVFQDEVHTYLVLELLKG 455 (966)
Q Consensus 380 ~~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~----~~~~Ei~iL~~l~~HpnIV~l~~~~~~~~~~~lVmEy~~g 455 (966)
|+..+.||+|+||.||++.... +..+|+|.+.... +..+|+.+|+.+ +||||+++++++.+....|+||||+++
T Consensus 6 ~~~~~~lg~G~~~~vy~~~~~~-~~~~a~K~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~iv~e~~~~ 83 (256)
T cd05114 6 LTFMKELGSGQFGVVHLGKWRA-QIKVAIKAINEGAMSEEDFIEEAKVMMKL-SHPKLVQLYGVCTQQKPLYIVTEFMEN 83 (256)
T ss_pred cEEeeEecCCcCceEEEEEecc-CceEEEEecccCCccHHHHHHHHHHHHHC-CCCCceeEEEEEccCCCEEEEEEcCCC
Confidence 3446789999999999998754 5689999886432 345699999998 599999999999999999999999999
Q ss_pred CCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCcEEEecCCCCCEEEEeecccccccCCC----cc
Q psy11767 456 GELLDRIRQKGRCGFTENEASRIMRQLVAAVHFMHSRGVVHRDLKPENLLFSDPAGDNIKVVDFGFACLKRESL----HT 531 (966)
Q Consensus 456 g~L~~~l~~~~~~~l~e~~~~~i~~Qil~aL~yLHs~~IiHRDLKP~NILl~~~~~~~iKL~DFGla~~~~~~~----~~ 531 (966)
|+|.+++..... .+++..+..++.|++.||+|||++||+||||||+||++++ ++.+||+|||++....... ..
T Consensus 84 ~~L~~~~~~~~~-~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~ni~i~~--~~~~kl~d~g~~~~~~~~~~~~~~~ 160 (256)
T cd05114 84 GCLLNYLRQRQG-KLSKDMLLSMCQDVCEGMEYLERNSFIHRDLAARNCLVSS--TGVVKVSDFGMTRYVLDDEYTSSSG 160 (256)
T ss_pred CcHHHHHHhCcc-CCCHHHHHHHHHHHHHHHHHHHHCCccccccCcceEEEcC--CCeEEECCCCCccccCCCceeccCC
Confidence 999999876432 5899999999999999999999999999999999999975 5689999999986543211 12
Q ss_pred ccccccccCchhhccCCCCCCCcccchhhhhhhhhhhhcCCCCCCCcCcchhHHHHHHHHhc-CCCCCCCCCCchhHHHH
Q psy11767 532 PCFTLQYAAPEVLRQDKSGYDENCDLWSLGVILVNVLRQDKSGYDENCDLWSLGVILYTMLC-GRVPFHARSRDDSALSI 610 (966)
Q Consensus 532 ~~gT~~Y~APEvl~~~~~~~~~~~Di~SlGvil~el~~~~~~~y~~~~DIWSlGvilyemlt-G~~Pf~~~~~~~~~~~~ 610 (966)
..++..|+|||++.. ..++.++|||||||++|+|++ |+.||...+. ...
T Consensus 161 ~~~~~~y~aPE~~~~--------------------------~~~~~~~Di~s~G~~l~el~~~g~~p~~~~~~----~~~ 210 (256)
T cd05114 161 AKFPVKWSPPEVFNF--------------------------SKYSSKSDVWSFGVLMWEVFTEGKMPFEKKSN----YEV 210 (256)
T ss_pred CCCchhhCChhhccc--------------------------CccchhhhhHHHHHHHHHHHcCCCCCCCCCCH----HHH
Confidence 234567999998742 236778999999999999999 9999976543 234
Q ss_pred HHHHHcCCCCCCchhhccCCHHHHHHHHHhcccCccccCChHHHHH
Q psy11767 611 MARIKEGQFNFDAEAWSTVSSEAKELTKSLLTVNPAQRIRMMRVKL 656 (966)
Q Consensus 611 ~~~i~~~~~~~~~~~~~~is~e~~~Li~~~L~~dP~~R~t~~~v~~ 656 (966)
...+.++.....+ ...+.++.+++.+||..||++||++.++..
T Consensus 211 ~~~i~~~~~~~~~---~~~~~~~~~li~~c~~~~p~~Rps~~~l~~ 253 (256)
T cd05114 211 VEMISRGFRLYRP---KLASMTVYEVMYSCWHEKPEGRPTFAELLR 253 (256)
T ss_pred HHHHHCCCCCCCC---CCCCHHHHHHHHHHccCCcccCcCHHHHHH
Confidence 4555555433222 246788999999999999999999998743
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h |
| >cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-35 Score=324.51 Aligned_cols=244 Identities=20% Similarity=0.357 Sum_probs=194.2
Q ss_pred cccccccccccccEEEEEEEc----CCCcEEEEEEecccc------ChHHHHHHHHHhcCCCCceEEEEEEEeCCeEEEE
Q psy11767 380 LDKAGILGDGSYSVCRRCVEK----STGQEYAVKIISRKI------DCSEEINLLRACQGHPNIVNLHCVFQDEVHTYLV 449 (966)
Q Consensus 380 ~~~~~~LG~G~fG~Vy~a~~~----~tg~~vAvK~i~~~~------~~~~Ei~iL~~l~~HpnIV~l~~~~~~~~~~~lV 449 (966)
++..+.||+|+||+||+|... .+++.||+|.+.... ...+|+.+|+.+ +||||+++++++..+...|+|
T Consensus 7 ~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~lv 85 (283)
T cd05090 7 VRFMEELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQQEASLMAEL-HHPNIVCLLGVVTQEQPVCML 85 (283)
T ss_pred ceeeeeccccCCcceEEEEEecCCCCCcceEEEEeccCCCCHHHHHHHHHHHHHHhhC-CCCCeeeEEEEEecCCceEEE
Confidence 344678999999999999853 456899999986432 245689999998 599999999999999999999
Q ss_pred EEccCCCCHHHHHHhcC---------------CCCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCcEEEecCCCCCE
Q psy11767 450 LELLKGGELLDRIRQKG---------------RCGFTENEASRIMRQLVAAVHFMHSRGVVHRDLKPENLLFSDPAGDNI 514 (966)
Q Consensus 450 mEy~~gg~L~~~l~~~~---------------~~~l~e~~~~~i~~Qil~aL~yLHs~~IiHRDLKP~NILl~~~~~~~i 514 (966)
|||+++++|.+++.... ...+++.++..++.|++.||+|||++||+||||||+|||+++ .+.+
T Consensus 86 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~i~H~dlkp~nili~~--~~~~ 163 (283)
T cd05090 86 FEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYLSSHFFVHKDLAARNILIGE--QLHV 163 (283)
T ss_pred EEcCCCCcHHHHHHhcCCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHhcCeehhccccceEEEcC--CCcE
Confidence 99999999999986432 124789999999999999999999999999999999999985 5589
Q ss_pred EEEeecccccccCC-----CccccccccccCchhhccCCCCCCCcccchhhhhhhhhhhhcCCCCCCCcCcchhHHHHHH
Q psy11767 515 KVVDFGFACLKRES-----LHTPCFTLQYAAPEVLRQDKSGYDENCDLWSLGVILVNVLRQDKSGYDENCDLWSLGVILY 589 (966)
Q Consensus 515 KL~DFGla~~~~~~-----~~~~~gT~~Y~APEvl~~~~~~~~~~~Di~SlGvil~el~~~~~~~y~~~~DIWSlGvily 589 (966)
||+|||++...... .....++..|+|||++.. ..++.++|||||||++|
T Consensus 164 kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~--------------------------~~~~~~~Dv~slG~il~ 217 (283)
T cd05090 164 KISDLGLSREIYSADYYRVQPKSLLPIRWMPPEAIMY--------------------------GKFSSDSDIWSFGVVLW 217 (283)
T ss_pred EeccccccccccCCcceecccCCCccceecChHHhcc--------------------------CCCCchhhhHHHHHHHH
Confidence 99999999654221 122345678999998742 23678899999999999
Q ss_pred HHhc-CCCCCCCCCCchhHHHHHHHHHcCCCCCCchhhccCCHHHHHHHHHhcccCccccCChHHHHHHhh
Q psy11767 590 TMLC-GRVPFHARSRDDSALSIMARIKEGQFNFDAEAWSTVSSEAKELTKSLLTVNPAQRIRMMRVKLTFH 659 (966)
Q Consensus 590 emlt-G~~Pf~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~is~e~~~Li~~~L~~dP~~R~t~~~v~~~~~ 659 (966)
+|++ |.+||.+... ..+...+..+... ..+..+++++.+++.+||+.||++||++.++...+.
T Consensus 218 el~~~g~~p~~~~~~----~~~~~~~~~~~~~---~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~ 281 (283)
T cd05090 218 EIFSFGLQPYYGFSN----QEVIEMVRKRQLL---PCSEDCPPRMYSLMTECWQEGPSRRPRFKDIHTRLR 281 (283)
T ss_pred HHHcCCCCCCCCCCH----HHHHHHHHcCCcC---CCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHHhh
Confidence 9998 9999976543 2334444443322 123457899999999999999999999998855443
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-35 Score=330.06 Aligned_cols=247 Identities=26% Similarity=0.445 Sum_probs=196.1
Q ss_pred cccccccccccccEEEEEEEcCCCcEEEEEEecccc------ChHHHHHHHHHhcCCCCceEEEEEEEeCCeEEEEEEcc
Q psy11767 380 LDKAGILGDGSYSVCRRCVEKSTGQEYAVKIISRKI------DCSEEINLLRACQGHPNIVNLHCVFQDEVHTYLVLELL 453 (966)
Q Consensus 380 ~~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~------~~~~Ei~iL~~l~~HpnIV~l~~~~~~~~~~~lVmEy~ 453 (966)
|+..+.||+|+||.||++.+..+|..||+|.+.... ...+|+++|+.+ +||||++++++|.++++.|+||||+
T Consensus 3 ~~~~~~lg~G~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~ey~ 81 (308)
T cd06615 3 FEKLGELGAGNGGVVTKVLHRPSGLIMARKLIHLEIKPAIRNQIIRELKVLHEC-NSPYIVGFYGAFYSDGEISICMEHM 81 (308)
T ss_pred ceEEeeccCCCCeEEEEEEEcCCCeEEEEEEeccccCHHHHHHHHHHHHHHHhC-CCCCCCeEEEEEeeCCEEEEEeecc
Confidence 455788999999999999999999999999986542 245699999998 6999999999999999999999999
Q ss_pred CCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHh-cCceeccCCCCcEEEecCCCCCEEEEeecccccccC-CCcc
Q psy11767 454 KGGELLDRIRQKGRCGFTENEASRIMRQLVAAVHFMHS-RGVVHRDLKPENLLFSDPAGDNIKVVDFGFACLKRE-SLHT 531 (966)
Q Consensus 454 ~gg~L~~~l~~~~~~~l~e~~~~~i~~Qil~aL~yLHs-~~IiHRDLKP~NILl~~~~~~~iKL~DFGla~~~~~-~~~~ 531 (966)
+|++|.+++.+.. .+++..+..++.||+.||+|||+ .+|+||||||+|||+++ ++.+||+|||++..... ....
T Consensus 82 ~~~~L~~~l~~~~--~~~~~~~~~~~~~i~~~l~~lH~~~~i~H~dl~p~nil~~~--~~~~~l~dfg~~~~~~~~~~~~ 157 (308)
T cd06615 82 DGGSLDQVLKKAG--RIPENILGKISIAVLRGLTYLREKHKIMHRDVKPSNILVNS--RGEIKLCDFGVSGQLIDSMANS 157 (308)
T ss_pred CCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhhCCEEECCCChHHEEEec--CCcEEEccCCCccccccccccc
Confidence 9999999997764 58999999999999999999998 59999999999999975 56899999999865432 2344
Q ss_pred ccccccccCchhhccCCCCCCCcccchhhhhhhhhhhhcCCCCCCCcCcchhHHHHHHHHhcCCCCCCCCCCchhHHHHH
Q psy11767 532 PCFTLQYAAPEVLRQDKSGYDENCDLWSLGVILVNVLRQDKSGYDENCDLWSLGVILYTMLCGRVPFHARSRDDSALSIM 611 (966)
Q Consensus 532 ~~gT~~Y~APEvl~~~~~~~~~~~Di~SlGvil~el~~~~~~~y~~~~DIWSlGvilyemltG~~Pf~~~~~~~~~~~~~ 611 (966)
.++++.|+|||++.. ..++.++|+|||||++|+|++|+.||...+.... ...+
T Consensus 158 ~~~~~~~~aPE~~~~--------------------------~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~-~~~~ 210 (308)
T cd06615 158 FVGTRSYMSPERLQG--------------------------THYTVQSDIWSLGLSLVEMAIGRYPIPPPDAKEL-EAMF 210 (308)
T ss_pred CCCCcCccChhHhcC--------------------------CCCCccchHHHHHHHHHHHHhCCCCCCCcchhhH-HHhh
Confidence 578999999998742 2367789999999999999999999975442211 1111
Q ss_pred H---------------------------------HHHcCCCCCCchhhccCCHHHHHHHHHhcccCccccCChHHHHHHh
Q psy11767 612 A---------------------------------RIKEGQFNFDAEAWSTVSSEAKELTKSLLTVNPAQRIRMMRVKLTF 658 (966)
Q Consensus 612 ~---------------------------------~i~~~~~~~~~~~~~~is~e~~~Li~~~L~~dP~~R~t~~~v~~~~ 658 (966)
. .+..... +......++.++++|+.+||..||++|||+.++ ..
T Consensus 211 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~l--l~ 286 (308)
T cd06615 211 GRPVSEGEAKESHRPVSGHPPDSPRPMAIFELLDYIVNEPP--PKLPSGAFSDEFQDFVDKCLKKNPKERADLKEL--TK 286 (308)
T ss_pred cCccccccccCCcccccCCCCCccchhhHHHHHHHHhcCCC--ccCcCcccCHHHHHHHHHHccCChhhCcCHHHH--hc
Confidence 0 0000000 000011367889999999999999999999876 44
Q ss_pred hhhH
Q psy11767 659 HAFH 662 (966)
Q Consensus 659 ~~~~ 662 (966)
|+|+
T Consensus 287 ~~~~ 290 (308)
T cd06615 287 HPFI 290 (308)
T ss_pred Chhh
Confidence 5654
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down |
| >cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-35 Score=318.91 Aligned_cols=239 Identities=24% Similarity=0.450 Sum_probs=193.4
Q ss_pred cccccccccccccEEEEEEEcCCCcEEEEEEeccccC---hHHHHHHHHHhcCCCCceEEEEEE-EeCCeEEEEEEccCC
Q psy11767 380 LDKAGILGDGSYSVCRRCVEKSTGQEYAVKIISRKID---CSEEINLLRACQGHPNIVNLHCVF-QDEVHTYLVLELLKG 455 (966)
Q Consensus 380 ~~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~~---~~~Ei~iL~~l~~HpnIV~l~~~~-~~~~~~~lVmEy~~g 455 (966)
|+..+.||+|+||.||++... |..||+|.+..... ..+|+.+++.+ +|+||+++++++ .++...|+||||+++
T Consensus 8 ~~~~~~lg~g~~~~v~~~~~~--~~~~~~k~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~~~~~lv~e~~~~ 84 (256)
T cd05082 8 LKLLQTIGKGEFGDVMLGDYR--GNKVAVKCIKNDATAQAFLAEASVMTQL-RHSNLVQLLGVIVEEKGGLYIVTEYMAK 84 (256)
T ss_pred CeeeeeecccCCCeEEEEEEc--CCcEEEEEeCCCchHHHHHHHHHHHHhC-CCCCeeeEEEEEEcCCCceEEEEECCCC
Confidence 344688999999999999764 78899999865432 45699999988 599999999875 455678999999999
Q ss_pred CCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCcEEEecCCCCCEEEEeecccccccCCCcccccc
Q psy11767 456 GELLDRIRQKGRCGFTENEASRIMRQLVAAVHFMHSRGVVHRDLKPENLLFSDPAGDNIKVVDFGFACLKRESLHTPCFT 535 (966)
Q Consensus 456 g~L~~~l~~~~~~~l~e~~~~~i~~Qil~aL~yLHs~~IiHRDLKP~NILl~~~~~~~iKL~DFGla~~~~~~~~~~~gT 535 (966)
++|.+++.+.....+++..+..++.||+.||+|||++||+||||||+|||+++ ++.+||+|||++...........++
T Consensus 85 ~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nil~~~--~~~~kl~dfg~~~~~~~~~~~~~~~ 162 (256)
T cd05082 85 GSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEANNFVHRDLAARNVLVSE--DNVAKVSDFGLTKEASSTQDTGKLP 162 (256)
T ss_pred CcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeccccchheEEEcC--CCcEEecCCccceeccccCCCCccc
Confidence 99999998766556899999999999999999999999999999999999985 5689999999987654443444556
Q ss_pred ccccCchhhccCCCCCCCcccchhhhhhhhhhhhcCCCCCCCcCcchhHHHHHHHHhc-CCCCCCCCCCchhHHHHHHHH
Q psy11767 536 LQYAAPEVLRQDKSGYDENCDLWSLGVILVNVLRQDKSGYDENCDLWSLGVILYTMLC-GRVPFHARSRDDSALSIMARI 614 (966)
Q Consensus 536 ~~Y~APEvl~~~~~~~~~~~Di~SlGvil~el~~~~~~~y~~~~DIWSlGvilyemlt-G~~Pf~~~~~~~~~~~~~~~i 614 (966)
..|+|||++.. ..++.++|||||||++|+|++ |++||...... .+...+
T Consensus 163 ~~y~aPE~~~~--------------------------~~~~~~~Dv~slG~i~~~l~~~g~~p~~~~~~~----~~~~~~ 212 (256)
T cd05082 163 VKWTAPEALRE--------------------------KKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLK----DVVPRV 212 (256)
T ss_pred eeecCHHHHcc--------------------------CCCCchhhhHHHHHHHHHHHhCCCCCCCCCCHH----HHHHHH
Confidence 78999998742 236778999999999999997 99999754332 233444
Q ss_pred HcCCCCCCchhhccCCHHHHHHHHHhcccCccccCChHHHHH
Q psy11767 615 KEGQFNFDAEAWSTVSSEAKELTKSLLTVNPAQRIRMMRVKL 656 (966)
Q Consensus 615 ~~~~~~~~~~~~~~is~e~~~Li~~~L~~dP~~R~t~~~v~~ 656 (966)
..+. . ......+++++.+++.+||..||++|||+.++..
T Consensus 213 ~~~~-~--~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~ 251 (256)
T cd05082 213 EKGY-K--MDAPDGCPPVVYDVMKQCWHLDAATRPSFLQLRE 251 (256)
T ss_pred hcCC-C--CCCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHH
Confidence 4332 1 1223467899999999999999999999998754
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re |
| >cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-35 Score=327.09 Aligned_cols=253 Identities=29% Similarity=0.406 Sum_probs=195.7
Q ss_pred cccccccccccccEEEEEEEcCCCcEEEEEEecccc-------ChHHHHHHHHHhcCCCCceEEEEEEEeCCe-----EE
Q psy11767 380 LDKAGILGDGSYSVCRRCVEKSTGQEYAVKIISRKI-------DCSEEINLLRACQGHPNIVNLHCVFQDEVH-----TY 447 (966)
Q Consensus 380 ~~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~-------~~~~Ei~iL~~l~~HpnIV~l~~~~~~~~~-----~~ 447 (966)
|+..+.||+|+||.||+|.+..+|+.||||++.... ...+|+.+++.+.+||||+++++++..... .|
T Consensus 3 y~~~~~lg~g~~g~vy~~~~~~~~~~v~lK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~~~~ 82 (295)
T cd07837 3 YEKLEKIGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALREISLLQMLSESIYIVRLLDVEHVEEKNGKPSLY 82 (295)
T ss_pred ceEeeEecccCCeEEEEEEECCCCcEEEEEeehhhccccCCchHHHHHHHHHHHccCCCCccceeeeEeecCCCCCceEE
Confidence 344678999999999999999999999999876432 245799999999778999999999987665 89
Q ss_pred EEEEccCCCCHHHHHHhcC---CCCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCcEEEecCCCCCEEEEeeccccc
Q psy11767 448 LVLELLKGGELLDRIRQKG---RCGFTENEASRIMRQLVAAVHFMHSRGVVHRDLKPENLLFSDPAGDNIKVVDFGFACL 524 (966)
Q Consensus 448 lVmEy~~gg~L~~~l~~~~---~~~l~e~~~~~i~~Qil~aL~yLHs~~IiHRDLKP~NILl~~~~~~~iKL~DFGla~~ 524 (966)
+||||+++ +|.+++.... ...+++..++.++.||+.||+|||++||+||||||+|||++. .++.+||+|||++..
T Consensus 83 lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dl~~~nil~~~-~~~~~kl~dfg~~~~ 160 (295)
T cd07837 83 LVFEYLDS-DLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAHCHKHGVMHRDLKPQNLLVDK-QKGLLKIADLGLGRA 160 (295)
T ss_pred EEeeccCc-CHHHHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCChHHEEEec-CCCeEEEeeccccee
Confidence 99999975 8988886543 235899999999999999999999999999999999999975 356899999999865
Q ss_pred ccCC---CccccccccccCchhhccCCCCCCCcccchhhhhhhhhhhhcCCCCCCCcCcchhHHHHHHHHhcCCCCCCCC
Q psy11767 525 KRES---LHTPCFTLQYAAPEVLRQDKSGYDENCDLWSLGVILVNVLRQDKSGYDENCDLWSLGVILYTMLCGRVPFHAR 601 (966)
Q Consensus 525 ~~~~---~~~~~gT~~Y~APEvl~~~~~~~~~~~Di~SlGvil~el~~~~~~~y~~~~DIWSlGvilyemltG~~Pf~~~ 601 (966)
.... .....+++.|+|||++.. ...++.++|||||||++|+|++|..||.+.
T Consensus 161 ~~~~~~~~~~~~~~~~~~aPE~~~~-------------------------~~~~~~~~Di~slG~~l~~l~~g~~~~~~~ 215 (295)
T cd07837 161 FSIPVKSYTHEIVTLWYRAPEVLLG-------------------------STHYSTPVDIWSVGCIFAEMSRKQPLFPGD 215 (295)
T ss_pred cCCCccccCCcccccCCCChHHhhC-------------------------CCCCCchHHHHHHHHHHHHHHcCCCCCCCC
Confidence 4321 223356889999998742 123678899999999999999999999876
Q ss_pred CCchhHHHHHHHHHcCC------------------C--CCCchhhccCCHHHHHHHHHhcccCccccCChHHHHHHhhhh
Q psy11767 602 SRDDSALSIMARIKEGQ------------------F--NFDAEAWSTVSSEAKELTKSLLTVNPAQRIRMMRVKLTFHAF 661 (966)
Q Consensus 602 ~~~~~~~~~~~~i~~~~------------------~--~~~~~~~~~is~e~~~Li~~~L~~dP~~R~t~~~v~~~~~~~ 661 (966)
+..+....++..+.... + .......+.+++++.++|.+||..||.+||++.++ ..|+|
T Consensus 216 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~R~~~~ei--l~~~~ 293 (295)
T cd07837 216 SELQQLLHIFKLLGTPTEQVWPGVSKLRDWHEFPQWKPQDLSRAVPDLSPEGLDLLQKMLRYDPAKRISAKAA--LTHPY 293 (295)
T ss_pred CHHHHHHHHHHHhCCCChhhCcchhhccchhhcCcccchhHHHhccccCHHHHHHHHHHccCChhhcCCHHHH--hcCCC
Confidence 54332222222211100 0 00011123578999999999999999999999876 34554
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm |
| >cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-35 Score=323.34 Aligned_cols=244 Identities=30% Similarity=0.491 Sum_probs=192.8
Q ss_pred ccccccccccccEEEEEEEcCCCcEEEEEEecccc-------ChHHHHHHHHHhcCCCCceEEEEEEEeCCeEEEEEEcc
Q psy11767 381 DKAGILGDGSYSVCRRCVEKSTGQEYAVKIISRKI-------DCSEEINLLRACQGHPNIVNLHCVFQDEVHTYLVLELL 453 (966)
Q Consensus 381 ~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~-------~~~~Ei~iL~~l~~HpnIV~l~~~~~~~~~~~lVmEy~ 453 (966)
+..+.||+|+||.||+|.+..+|+.||+|++.... ...+|+.+++.+ .||||+++++++......++||||+
T Consensus 4 ~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~-~h~~i~~~~~~~~~~~~~~~v~e~~ 82 (286)
T cd07847 4 EKLSKIGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIALREIRMLKQL-KHPNLVNLIEVFRRKRKLHLVFEYC 82 (286)
T ss_pred eeeeeecccCCeEEEEEEECCCCcEEEEEEEeecccCccccHHHHHHHHHHHhC-CCCCEeeeeeEEeeCCEEEEEEecc
Confidence 34678999999999999999999999999885432 135699999998 5999999999999999999999999
Q ss_pred CCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCcEEEecCCCCCEEEEeecccccccCC---Cc
Q psy11767 454 KGGELLDRIRQKGRCGFTENEASRIMRQLVAAVHFMHSRGVVHRDLKPENLLFSDPAGDNIKVVDFGFACLKRES---LH 530 (966)
Q Consensus 454 ~gg~L~~~l~~~~~~~l~e~~~~~i~~Qil~aL~yLHs~~IiHRDLKP~NILl~~~~~~~iKL~DFGla~~~~~~---~~ 530 (966)
+++.|..++.... .+++.+++.++.||+.||+|||++||+||||||+|||++. .+.+||+|||++...... ..
T Consensus 83 ~~~~l~~~~~~~~--~~~~~~~~~~~~ql~~~l~~LH~~~i~H~dl~p~nil~~~--~~~~~l~dfg~~~~~~~~~~~~~ 158 (286)
T cd07847 83 DHTVLNELEKNPR--GVPEHLIKKIIWQTLQAVNFCHKHNCIHRDVKPENILITK--QGQIKLCDFGFARILTGPGDDYT 158 (286)
T ss_pred CccHHHHHHhCCC--CCCHHHHHHHHHHHHHHHHHHHHCCceecCCChhhEEEcC--CCcEEECccccceecCCCccccc
Confidence 9888777665433 5899999999999999999999999999999999999975 568999999999764332 22
Q ss_pred cccccccccCchhhccCCCCCCCcccchhhhhhhhhhhhcCCCCCCCcCcchhHHHHHHHHhcCCCCCCCCCCchhHHHH
Q psy11767 531 TPCFTLQYAAPEVLRQDKSGYDENCDLWSLGVILVNVLRQDKSGYDENCDLWSLGVILYTMLCGRVPFHARSRDDSALSI 610 (966)
Q Consensus 531 ~~~gT~~Y~APEvl~~~~~~~~~~~Di~SlGvil~el~~~~~~~y~~~~DIWSlGvilyemltG~~Pf~~~~~~~~~~~~ 610 (966)
...++..|+|||++.. ...++.++||||+||++|+|++|++||.+....+....+
T Consensus 159 ~~~~~~~~~aPE~~~~-------------------------~~~~~~~~Di~slG~i~~~l~~g~~p~~~~~~~~~~~~~ 213 (286)
T cd07847 159 DYVATRWYRAPELLVG-------------------------DTQYGPPVDVWAIGCVFAELLTGQPLWPGKSDVDQLYLI 213 (286)
T ss_pred CcccccccCCHHHHhC-------------------------CCCcCchhhhHHHHHHHHHHHhCCCCCCCCChHHHHHHH
Confidence 3456889999998752 123677899999999999999999999876543322222
Q ss_pred HHHHHc-----------CCC-----CCC-------chhhccCCHHHHHHHHHhcccCccccCChHHH
Q psy11767 611 MARIKE-----------GQF-----NFD-------AEAWSTVSSEAKELTKSLLTVNPAQRIRMMRV 654 (966)
Q Consensus 611 ~~~i~~-----------~~~-----~~~-------~~~~~~is~e~~~Li~~~L~~dP~~R~t~~~v 654 (966)
...+.. ..+ ... ...++.++..+.+|+.+||..||++||++.++
T Consensus 214 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~ei 280 (286)
T cd07847 214 RKTLGDLIPRHQQIFSTNQFFKGLSIPEPETREPLESKFPNISSPALSFLKGCLQMDPTERLSCEEL 280 (286)
T ss_pred HHHhCCCChHHhhhcccccccccccCCCcccccCHHHHhccCCHHHHHHHHHHhcCCccccCCHHHH
Confidence 111100 000 000 01234678899999999999999999999876
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio |
| >cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-35 Score=330.83 Aligned_cols=241 Identities=19% Similarity=0.370 Sum_probs=190.6
Q ss_pred ccccccccccccccEEEEEEEcCCCcE----EEEEEecccc------ChHHHHHHHHHhcCCCCceEEEEEEEeCCeEEE
Q psy11767 379 DLDKAGILGDGSYSVCRRCVEKSTGQE----YAVKIISRKI------DCSEEINLLRACQGHPNIVNLHCVFQDEVHTYL 448 (966)
Q Consensus 379 ~~~~~~~LG~G~fG~Vy~a~~~~tg~~----vAvK~i~~~~------~~~~Ei~iL~~l~~HpnIV~l~~~~~~~~~~~l 448 (966)
+|+..+.||+|+||+||+|.+..+|+. ||||++.... ...+|+.+++.+ +||||+++++++... ..++
T Consensus 8 ~f~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~g~~~~~-~~~~ 85 (316)
T cd05108 8 EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV-DNPHVCRLLGICLTS-TVQL 85 (316)
T ss_pred hceeeeeeecCCCceEEEEEEecCCCccceeEEEEeccccCCHHHHHHHHHHHHHHHhC-CCCCCCeEEEEEcCC-Ccee
Confidence 455678999999999999998776664 8999986432 234588888888 599999999999875 5789
Q ss_pred EEEccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCcEEEecCCCCCEEEEeecccccccCC
Q psy11767 449 VLELLKGGELLDRIRQKGRCGFTENEASRIMRQLVAAVHFMHSRGVVHRDLKPENLLFSDPAGDNIKVVDFGFACLKRES 528 (966)
Q Consensus 449 VmEy~~gg~L~~~l~~~~~~~l~e~~~~~i~~Qil~aL~yLHs~~IiHRDLKP~NILl~~~~~~~iKL~DFGla~~~~~~ 528 (966)
|+||+++|+|.+++.+... .+++..+..++.||+.||+|||++||+||||||+|||+++ ++.+||+|||+++.....
T Consensus 86 v~e~~~~g~l~~~l~~~~~-~~~~~~~~~~~~qi~~~L~~LH~~~iiH~dlkp~Nill~~--~~~~kl~DfG~a~~~~~~ 162 (316)
T cd05108 86 ITQLMPFGCLLDYVREHKD-NIGSQYLLNWCVQIAKGMNYLEERRLVHRDLAARNVLVKT--PQHVKITDFGLAKLLGAD 162 (316)
T ss_pred eeecCCCCCHHHHHHhccc-cCCHHHHHHHHHHHHHHHHHHHhcCeeccccchhheEecC--CCcEEEccccccccccCC
Confidence 9999999999999987543 5899999999999999999999999999999999999975 568999999999765322
Q ss_pred C-----ccccccccccCchhhccCCCCCCCcccchhhhhhhhhhhhcCCCCCCCcCcchhHHHHHHHHhc-CCCCCCCCC
Q psy11767 529 L-----HTPCFTLQYAAPEVLRQDKSGYDENCDLWSLGVILVNVLRQDKSGYDENCDLWSLGVILYTMLC-GRVPFHARS 602 (966)
Q Consensus 529 ~-----~~~~gT~~Y~APEvl~~~~~~~~~~~Di~SlGvil~el~~~~~~~y~~~~DIWSlGvilyemlt-G~~Pf~~~~ 602 (966)
. ....++..|+|||++.. ..++.++|||||||++|+|++ |..||.+..
T Consensus 163 ~~~~~~~~~~~~~~y~apE~~~~--------------------------~~~~~~~Di~slGv~l~el~t~g~~p~~~~~ 216 (316)
T cd05108 163 EKEYHAEGGKVPIKWMALESILH--------------------------RIYTHQSDVWSYGVTVWELMTFGSKPYDGIP 216 (316)
T ss_pred CcceeccCCccceeecChHHhcc--------------------------CCCCchhhhHHHHHHHHHHHcCCCCCCCCCC
Confidence 1 12234678999998852 236789999999999999997 999998654
Q ss_pred CchhHHHHHHHHHcCCCCCCchhhccCCHHHHHHHHHhcccCccccCChHHHHHH
Q psy11767 603 RDDSALSIMARIKEGQFNFDAEAWSTVSSEAKELTKSLLTVNPAQRIRMMRVKLT 657 (966)
Q Consensus 603 ~~~~~~~~~~~i~~~~~~~~~~~~~~is~e~~~Li~~~L~~dP~~R~t~~~v~~~ 657 (966)
..+ +...+..+. .+. .....+.++.+++.+||..||++||++.++...
T Consensus 217 ~~~----~~~~~~~~~-~~~--~~~~~~~~~~~li~~cl~~~p~~Rps~~~l~~~ 264 (316)
T cd05108 217 ASE----ISSILEKGE-RLP--QPPICTIDVYMIMVKCWMIDADSRPKFRELIIE 264 (316)
T ss_pred HHH----HHHHHhCCC-CCC--CCCCCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence 321 222222222 111 123467889999999999999999999987543
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor |
| >cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-35 Score=328.14 Aligned_cols=243 Identities=23% Similarity=0.367 Sum_probs=194.2
Q ss_pred ccccccccccccEEEEEEE-----cCCCcEEEEEEeccccC------hHHHHHHHHHhcCCCCceEEEEEEEeCCeEEEE
Q psy11767 381 DKAGILGDGSYSVCRRCVE-----KSTGQEYAVKIISRKID------CSEEINLLRACQGHPNIVNLHCVFQDEVHTYLV 449 (966)
Q Consensus 381 ~~~~~LG~G~fG~Vy~a~~-----~~tg~~vAvK~i~~~~~------~~~Ei~iL~~l~~HpnIV~l~~~~~~~~~~~lV 449 (966)
...+.||+|+||.||+|.+ ..++..||||++..... ..+|+.+|+.+.+||||+++++++...+..|+|
T Consensus 38 ~~~~~ig~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv 117 (302)
T cd05055 38 SFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMSELKIMSHLGNHENIVNLLGACTIGGPILVI 117 (302)
T ss_pred EEcceeeccCCeeEEEEEEecCCCCCceeEEEEEecCccCChHHHHHHHHHHHHHHhccCCCCcceEEEEEecCCceEEE
Confidence 3467899999999999975 34566899999865432 446999999986799999999999999999999
Q ss_pred EEccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCcEEEecCCCCCEEEEeecccccccCCC
Q psy11767 450 LELLKGGELLDRIRQKGRCGFTENEASRIMRQLVAAVHFMHSRGVVHRDLKPENLLFSDPAGDNIKVVDFGFACLKRESL 529 (966)
Q Consensus 450 mEy~~gg~L~~~l~~~~~~~l~e~~~~~i~~Qil~aL~yLHs~~IiHRDLKP~NILl~~~~~~~iKL~DFGla~~~~~~~ 529 (966)
|||+.+|+|.+++.......+++.++..++.||+.||+|||+++|+||||||+|||+++ ++.+||+|||++.......
T Consensus 118 ~e~~~~~~L~~~i~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~~~--~~~~~l~dfg~~~~~~~~~ 195 (302)
T cd05055 118 TEYCCYGDLLNFLRRKRESFLTLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNVLLTH--GKIVKICDFGLARDIMNDS 195 (302)
T ss_pred EEcCCCCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeehhhhccceEEEcC--CCeEEECCCcccccccCCC
Confidence 99999999999997654445899999999999999999999999999999999999974 5689999999986543211
Q ss_pred -----ccccccccccCchhhccCCCCCCCcccchhhhhhhhhhhhcCCCCCCCcCcchhHHHHHHHHhc-CCCCCCCCCC
Q psy11767 530 -----HTPCFTLQYAAPEVLRQDKSGYDENCDLWSLGVILVNVLRQDKSGYDENCDLWSLGVILYTMLC-GRVPFHARSR 603 (966)
Q Consensus 530 -----~~~~gT~~Y~APEvl~~~~~~~~~~~Di~SlGvil~el~~~~~~~y~~~~DIWSlGvilyemlt-G~~Pf~~~~~ 603 (966)
....+++.|+|||++.. ..++.++||||+||++|+|++ |..||.....
T Consensus 196 ~~~~~~~~~~~~~y~aPE~~~~--------------------------~~~~~~~DiwslGvil~el~t~g~~p~~~~~~ 249 (302)
T cd05055 196 NYVVKGNARLPVKWMAPESIFN--------------------------CVYTFESDVWSYGILLWEIFSLGSNPYPGMPV 249 (302)
T ss_pred ceeecCCCCcccccCCHhhhcc--------------------------CCCCcHhHHHHHHHHHHHHHhCCCCCcCCCCc
Confidence 12235678999998852 236778999999999999998 9999987654
Q ss_pred chhHHHHHHHHHcCCCCCCchhhccCCHHHHHHHHHhcccCccccCChHHHHHH
Q psy11767 604 DDSALSIMARIKEGQFNFDAEAWSTVSSEAKELTKSLLTVNPAQRIRMMRVKLT 657 (966)
Q Consensus 604 ~~~~~~~~~~i~~~~~~~~~~~~~~is~e~~~Li~~~L~~dP~~R~t~~~v~~~ 657 (966)
.+. ....+..+. ... .....++++.+++.+||..+|++|||+.++...
T Consensus 250 ~~~---~~~~~~~~~-~~~--~~~~~~~~~~~li~~cl~~~p~~Rpt~~ell~~ 297 (302)
T cd05055 250 DSK---FYKLIKEGY-RMA--QPEHAPAEIYDIMKTCWDADPLKRPTFKQIVQL 297 (302)
T ss_pred hHH---HHHHHHcCC-cCC--CCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHH
Confidence 332 222233332 111 223468899999999999999999999987543
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept |
| >cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-35 Score=333.63 Aligned_cols=244 Identities=24% Similarity=0.351 Sum_probs=191.1
Q ss_pred cccccccccccEEEEEEEc-----CCCcEEEEEEeccccC------hHHHHHHHHHhcCCCCceEEEEEEEe-CCeEEEE
Q psy11767 382 KAGILGDGSYSVCRRCVEK-----STGQEYAVKIISRKID------CSEEINLLRACQGHPNIVNLHCVFQD-EVHTYLV 449 (966)
Q Consensus 382 ~~~~LG~G~fG~Vy~a~~~-----~tg~~vAvK~i~~~~~------~~~Ei~iL~~l~~HpnIV~l~~~~~~-~~~~~lV 449 (966)
..+.||+|+||.||+|.+. .+++.||+|++..... ...|+.+++.+.+||||+++++++.. +..+++|
T Consensus 11 i~~~lG~G~fg~Vy~a~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~~~~l~~h~niv~~~~~~~~~~~~~~~v 90 (337)
T cd05054 11 LGKPLGRGAFGKVIQASAFGIEKSASCRTVAVKMLKEGATASEYKALMTELKILIHIGHHLNVVNLLGACTKPGGPLMVI 90 (337)
T ss_pred hhcccccCcCceEEeccccccccccccceeeeeeccCCCCHHHHHHHHHHHHHHHhhccCcchhheeeeEecCCCCEEEE
Confidence 3689999999999999754 3568999999864321 34588999988779999999998764 4578999
Q ss_pred EEccCCCCHHHHHHhcCC-----------------------------------------------------------CCC
Q psy11767 450 LELLKGGELLDRIRQKGR-----------------------------------------------------------CGF 470 (966)
Q Consensus 450 mEy~~gg~L~~~l~~~~~-----------------------------------------------------------~~l 470 (966)
|||+++|+|.+++..... ..+
T Consensus 91 ~ey~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 170 (337)
T cd05054 91 VEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQRLDSVSSSQSSASSGFIEDKSLSDVEEDEEGDELYKEPL 170 (337)
T ss_pred EecCCCCCHHHHHHhccccccccccccccccccccccccccccccCCccccccccccccCcchhhcccchhhhHHhhcCC
Confidence 999999999999864321 258
Q ss_pred CHHHHHHHHHHHHHHHHHHHhcCceeccCCCCcEEEecCCCCCEEEEeecccccccCC-----CccccccccccCchhhc
Q psy11767 471 TENEASRIMRQLVAAVHFMHSRGVVHRDLKPENLLFSDPAGDNIKVVDFGFACLKRES-----LHTPCFTLQYAAPEVLR 545 (966)
Q Consensus 471 ~e~~~~~i~~Qil~aL~yLHs~~IiHRDLKP~NILl~~~~~~~iKL~DFGla~~~~~~-----~~~~~gT~~Y~APEvl~ 545 (966)
++..+..++.||+.||+|||++||+||||||+|||+++ .+.+||+|||++...... .....++..|+|||++.
T Consensus 171 ~~~~~~~~~~qi~~aL~~lH~~~ivHrDikp~Nill~~--~~~vkL~DfG~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~ 248 (337)
T cd05054 171 TLEDLISYSFQVARGMEFLASRKCIHRDLAARNILLSE--NNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPESIF 248 (337)
T ss_pred CHHHHHHHHHHHHHHHHHHHhCCeecCCCCcceEEEeC--CCcEEEeccccchhcccCcchhhccCCCCCccccCcHHhc
Confidence 99999999999999999999999999999999999985 568999999999754221 11234467899999885
Q ss_pred cCCCCCCCcccchhhhhhhhhhhhcCCCCCCCcCcchhHHHHHHHHhc-CCCCCCCCCCchhHHHHHHHHHcCCCCCCch
Q psy11767 546 QDKSGYDENCDLWSLGVILVNVLRQDKSGYDENCDLWSLGVILYTMLC-GRVPFHARSRDDSALSIMARIKEGQFNFDAE 624 (966)
Q Consensus 546 ~~~~~~~~~~Di~SlGvil~el~~~~~~~y~~~~DIWSlGvilyemlt-G~~Pf~~~~~~~~~~~~~~~i~~~~~~~~~~ 624 (966)
. ..|+.++|||||||++|+|++ |..||.+....+. ....+..+.....
T Consensus 249 ~--------------------------~~~~~~~Di~SlGv~l~el~t~g~~p~~~~~~~~~---~~~~~~~~~~~~~-- 297 (337)
T cd05054 249 D--------------------------KVYTTQSDVWSFGVLLWEIFSLGASPYPGVQIDEE---FCRRLKEGTRMRA-- 297 (337)
T ss_pred C--------------------------CCCCccccHHHHHHHHHHHHHcCCCCCCCCCccHH---HHHHHhccCCCCC--
Confidence 2 347889999999999999997 9999987543332 2223333322211
Q ss_pred hhccCCHHHHHHHHHhcccCccccCChHHHHHHhh
Q psy11767 625 AWSTVSSEAKELTKSLLTVNPAQRIRMMRVKLTFH 659 (966)
Q Consensus 625 ~~~~is~e~~~Li~~~L~~dP~~R~t~~~v~~~~~ 659 (966)
....++++.+++.+||+.+|++||++.++...+.
T Consensus 298 -~~~~~~~~~~l~~~cl~~~p~~RPs~~ell~~l~ 331 (337)
T cd05054 298 -PEYATPEIYSIMLDCWHNNPEDRPTFSELVEILG 331 (337)
T ss_pred -CccCCHHHHHHHHHHccCChhhCcCHHHHHHHHH
Confidence 2356889999999999999999999998855443
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto |
| >cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-35 Score=325.71 Aligned_cols=253 Identities=23% Similarity=0.401 Sum_probs=195.3
Q ss_pred cccccccccccccEEEEEEEcCCCcEEEEEEecccc------ChHHHHHHHHHhcCCCCceEEEEEEEeCCeEEEEEEcc
Q psy11767 380 LDKAGILGDGSYSVCRRCVEKSTGQEYAVKIISRKI------DCSEEINLLRACQGHPNIVNLHCVFQDEVHTYLVLELL 453 (966)
Q Consensus 380 ~~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~------~~~~Ei~iL~~l~~HpnIV~l~~~~~~~~~~~lVmEy~ 453 (966)
++..+.||+|+||.||++.+..+|+.||||.+.... ...+|+.+|..+.+|||||++++++.++...++||||+
T Consensus 6 ~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~~~~~~~iv~~~~~~~~~~~~~~~~e~~ 85 (288)
T cd06616 6 LKDLGEIGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDEKEQKRLLMDLDVVMRSSDCPYIVKFYGALFREGDCWICMELM 85 (288)
T ss_pred hHHHHHhCCCCceEEEEEEECCCCCEEEEEEehhccChHHHHHHHHHHHHHHHhcCCCCEeeeeeEEecCCcEEEEEecc
Confidence 345678999999999999999999999999986532 23468888888867999999999999999999999998
Q ss_pred CCCCHHH---HHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhc-CceeccCCCCcEEEecCCCCCEEEEeecccccccCC-
Q psy11767 454 KGGELLD---RIRQKGRCGFTENEASRIMRQLVAAVHFMHSR-GVVHRDLKPENLLFSDPAGDNIKVVDFGFACLKRES- 528 (966)
Q Consensus 454 ~gg~L~~---~l~~~~~~~l~e~~~~~i~~Qil~aL~yLHs~-~IiHRDLKP~NILl~~~~~~~iKL~DFGla~~~~~~- 528 (966)
. ++|.+ .+.......+++..+..++.|++.||+|||+. +|+||||||+|||++. .+.+||+|||++......
T Consensus 86 ~-~~l~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~i~H~dlkp~Nil~~~--~~~~kl~dfg~~~~~~~~~ 162 (288)
T cd06616 86 D-ISLDKFYKYVYEVLKSVIPEEILGKIAVATVKALNYLKEELKIIHRDVKPSNILLDR--NGNIKLCDFGISGQLVDSI 162 (288)
T ss_pred c-CCHHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhcCCeeccCCCHHHEEEcc--CCcEEEeecchhHHhccCC
Confidence 5 44443 33333334699999999999999999999975 9999999999999975 568999999998654322
Q ss_pred -CccccccccccCchhhccCCCCCCCcccchhhhhhhhhhhhcCCCCCCCcCcchhHHHHHHHHhcCCCCCCCCCCchhH
Q psy11767 529 -LHTPCFTLQYAAPEVLRQDKSGYDENCDLWSLGVILVNVLRQDKSGYDENCDLWSLGVILYTMLCGRVPFHARSRDDSA 607 (966)
Q Consensus 529 -~~~~~gT~~Y~APEvl~~~~~~~~~~~Di~SlGvil~el~~~~~~~y~~~~DIWSlGvilyemltG~~Pf~~~~~~~~~ 607 (966)
.....+|+.|+|||++.... ...|+.++||||+||++|+|++|++||..... .
T Consensus 163 ~~~~~~~~~~y~aPE~~~~~~-----------------------~~~~~~~~Di~slG~il~el~~g~~p~~~~~~---~ 216 (288)
T cd06616 163 AKTRDAGCRPYMAPERIDPSA-----------------------RDGYDVRSDVWSLGITLYEVATGKFPYPKWNS---V 216 (288)
T ss_pred ccccccCccCccCHHHhcccc-----------------------ccCCcchhhhhHHHHHHHHHHhCCCCchhcch---H
Confidence 23346788999999985321 13478899999999999999999999976431 1
Q ss_pred HHHHHHHHcCC-CCCCchhhccCCHHHHHHHHHhcccCccccCChHHHHHHhhhhHH
Q psy11767 608 LSIMARIKEGQ-FNFDAEAWSTVSSEAKELTKSLLTVNPAQRIRMMRVKLTFHAFHQ 663 (966)
Q Consensus 608 ~~~~~~i~~~~-~~~~~~~~~~is~e~~~Li~~~L~~dP~~R~t~~~v~~~~~~~~~ 663 (966)
...+..+..+. .......+..++.++.+||.+||..||++|||+.++ ..|+|++
T Consensus 217 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~i--~~~~~~~ 271 (288)
T cd06616 217 FDQLTQVVKGDPPILSNSEEREFSPSFVNFINLCLIKDESKRPKYKEL--LEHPFIK 271 (288)
T ss_pred HHHHhhhcCCCCCcCCCcCCCccCHHHHHHHHHHccCChhhCcCHHHH--hcChhhh
Confidence 22222332222 122222234588999999999999999999999976 3455553
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates |
| >cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-35 Score=324.19 Aligned_cols=244 Identities=21% Similarity=0.321 Sum_probs=194.2
Q ss_pred cccccccccccccEEEEEEEcCC-----CcEEEEEEeccccC------hHHHHHHHHHhcCCCCceEEEEEEEeCCeEEE
Q psy11767 380 LDKAGILGDGSYSVCRRCVEKST-----GQEYAVKIISRKID------CSEEINLLRACQGHPNIVNLHCVFQDEVHTYL 448 (966)
Q Consensus 380 ~~~~~~LG~G~fG~Vy~a~~~~t-----g~~vAvK~i~~~~~------~~~Ei~iL~~l~~HpnIV~l~~~~~~~~~~~l 448 (966)
+...+.||+|+||.||+|.+..+ ++.||||++..... ..+|+.++..+ +|||||++++++.+....++
T Consensus 7 ~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l-~h~~iv~~~~~~~~~~~~~~ 85 (283)
T cd05091 7 VRFMEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLREEFKHEAMMRSRL-QHPNIVCLLGVVTKEQPLSM 85 (283)
T ss_pred HHHHHHhCCCCCCeEEEEEEecCCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHhcC-CCCCcCeEEEEEcCCCceEE
Confidence 33467899999999999987643 57899999975432 34577777777 59999999999999999999
Q ss_pred EEEccCCCCHHHHHHhcC--------------CCCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCcEEEecCCCCCE
Q psy11767 449 VLELLKGGELLDRIRQKG--------------RCGFTENEASRIMRQLVAAVHFMHSRGVVHRDLKPENLLFSDPAGDNI 514 (966)
Q Consensus 449 VmEy~~gg~L~~~l~~~~--------------~~~l~e~~~~~i~~Qil~aL~yLHs~~IiHRDLKP~NILl~~~~~~~i 514 (966)
++||+.+++|.+++.... ...+++..+..++.|++.||+|||++||+||||||+|||+++ .+.+
T Consensus 86 ~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~aL~~lH~~gi~H~dlkp~Nil~~~--~~~~ 163 (283)
T cd05091 86 IFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFLSSHHVVHKDLATRNVLVFD--KLNV 163 (283)
T ss_pred EEEcCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHcCccccccchhheEecC--CCce
Confidence 999999999999985321 124889999999999999999999999999999999999975 4589
Q ss_pred EEEeecccccccCC-----CccccccccccCchhhccCCCCCCCcccchhhhhhhhhhhhcCCCCCCCcCcchhHHHHHH
Q psy11767 515 KVVDFGFACLKRES-----LHTPCFTLQYAAPEVLRQDKSGYDENCDLWSLGVILVNVLRQDKSGYDENCDLWSLGVILY 589 (966)
Q Consensus 515 KL~DFGla~~~~~~-----~~~~~gT~~Y~APEvl~~~~~~~~~~~Di~SlGvil~el~~~~~~~y~~~~DIWSlGvily 589 (966)
||+|||+++..... .....+++.|+|||++... .++.++|||||||++|
T Consensus 164 kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~--------------------------~~~~~~Dv~slG~~l~ 217 (283)
T cd05091 164 KISDLGLFREVYAADYYKLMGNSLLPIRWMSPEAIMYG--------------------------KFSIDSDIWSYGVVLW 217 (283)
T ss_pred EecccccccccccchheeeccCccCCccccCHHHHhcC--------------------------CCCcchhHHHHHHHHH
Confidence 99999998654321 1233457789999987522 2577899999999999
Q ss_pred HHhc-CCCCCCCCCCchhHHHHHHHHHcCCCCCCchhhccCCHHHHHHHHHhcccCccccCChHHHHHHhh
Q psy11767 590 TMLC-GRVPFHARSRDDSALSIMARIKEGQFNFDAEAWSTVSSEAKELTKSLLTVNPAQRIRMMRVKLTFH 659 (966)
Q Consensus 590 emlt-G~~Pf~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~is~e~~~Li~~~L~~dP~~R~t~~~v~~~~~ 659 (966)
||++ |..||.+... ..+...+..+..... ....+.++.+|+.+||+.+|++||++.++...+.
T Consensus 218 el~~~g~~p~~~~~~----~~~~~~i~~~~~~~~---~~~~~~~~~~li~~cl~~~p~~RP~~~~i~~~l~ 281 (283)
T cd05091 218 EVFSYGLQPYCGYSN----QDVIEMIRNRQVLPC---PDDCPAWVYTLMLECWNEFPSRRPRFKDIHSRLR 281 (283)
T ss_pred HHHcCCCCCCCCCCH----HHHHHHHHcCCcCCC---CCCCCHHHHHHHHHHhCCCcccCCCHHHHHHHhh
Confidence 9998 8899976543 234555655544322 2357889999999999999999999998865443
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-35 Score=324.10 Aligned_cols=251 Identities=31% Similarity=0.467 Sum_probs=201.8
Q ss_pred ccccccccccccEEEEEEEcCCCcEEEEEEecccc-----ChHHHHHHHHHhcCCCCceEEEEEEEeCCeEEEEEEccCC
Q psy11767 381 DKAGILGDGSYSVCRRCVEKSTGQEYAVKIISRKI-----DCSEEINLLRACQGHPNIVNLHCVFQDEVHTYLVLELLKG 455 (966)
Q Consensus 381 ~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~-----~~~~Ei~iL~~l~~HpnIV~l~~~~~~~~~~~lVmEy~~g 455 (966)
+..+.||.|+||.||+|.+..+++.||+|++.... ....|+++|+.+. ||||+++++.+.++...|+||||+++
T Consensus 8 ~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~~lv~e~~~~ 86 (280)
T cd06611 8 EIIGELGDGAFGKVYKAQHKETGLFAAAKIIQIESEEELEDFMVEIDILSECK-HPNIVGLYEAYFYENKLWILIEFCDG 86 (280)
T ss_pred HHHHHhcCCCCceEEEEEEcCCCcEEEEEEEeeCCHHHHHHHHHHHHHHHhCC-CCceeEEEEEEecCCeEEEEeeccCC
Confidence 33678999999999999999999999999986432 2446899999985 99999999999999999999999999
Q ss_pred CCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCcEEEecCCCCCEEEEeecccccccCC---Cccc
Q psy11767 456 GELLDRIRQKGRCGFTENEASRIMRQLVAAVHFMHSRGVVHRDLKPENLLFSDPAGDNIKVVDFGFACLKRES---LHTP 532 (966)
Q Consensus 456 g~L~~~l~~~~~~~l~e~~~~~i~~Qil~aL~yLHs~~IiHRDLKP~NILl~~~~~~~iKL~DFGla~~~~~~---~~~~ 532 (966)
++|.+++..... .+++..++.++.|++.||.|||++||+||||||+||+++. .+.++|+|||++...... ....
T Consensus 87 ~~L~~~~~~~~~-~l~~~~~~~~~~ql~~~l~~lh~~~i~h~dl~p~nili~~--~~~~~l~d~g~~~~~~~~~~~~~~~ 163 (280)
T cd06611 87 GALDSIMLELER-GLTEPQIRYVCRQMLEALNFLHSHKVIHRDLKAGNILLTL--DGDVKLADFGVSAKNKSTLQKRDTF 163 (280)
T ss_pred CcHHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChhhEEECC--CCCEEEccCccchhhccccccccee
Confidence 999999876543 6999999999999999999999999999999999999975 568999999998654321 2334
Q ss_pred cccccccCchhhccCCCCCCCcccchhhhhhhhhhhhcCCCCCCCcCcchhHHHHHHHHhcCCCCCCCCCCchhHHHHHH
Q psy11767 533 CFTLQYAAPEVLRQDKSGYDENCDLWSLGVILVNVLRQDKSGYDENCDLWSLGVILYTMLCGRVPFHARSRDDSALSIMA 612 (966)
Q Consensus 533 ~gT~~Y~APEvl~~~~~~~~~~~Di~SlGvil~el~~~~~~~y~~~~DIWSlGvilyemltG~~Pf~~~~~~~~~~~~~~ 612 (966)
.+|+.|+|||++..+.. ....++.++|+|||||++|+|++|++||...... ..+.
T Consensus 164 ~~~~~y~~PE~~~~~~~---------------------~~~~~~~~sDi~slG~il~~l~~g~~p~~~~~~~----~~~~ 218 (280)
T cd06611 164 IGTPYWMAPEVVACETF---------------------KDNPYDYKADIWSLGITLIELAQMEPPHHELNPM----RVLL 218 (280)
T ss_pred ecchhhcCHHHHhhccc---------------------CCCCCCccccHHHHHHHHHHHHhCCCCcccCCHH----HHHH
Confidence 67899999999853221 1234678999999999999999999999865432 2233
Q ss_pred HHHcCCCCCCchhhccCCHHHHHHHHHhcccCccccCChHHHHHHhhhhHH
Q psy11767 613 RIKEGQFNFDAEAWSTVSSEAKELTKSLLTVNPAQRIRMMRVKLTFHAFHQ 663 (966)
Q Consensus 613 ~i~~~~~~~~~~~~~~is~e~~~Li~~~L~~dP~~R~t~~~v~~~~~~~~~ 663 (966)
.+..+.... ......++.++.++|.+||..||++||++.++ ..|+|..
T Consensus 219 ~~~~~~~~~-~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~i--l~~~~~~ 266 (280)
T cd06611 219 KILKSEPPT-LDQPSKWSSSFNDFLKSCLVKDPDDRPTAAEL--LKHPFVS 266 (280)
T ss_pred HHhcCCCCC-cCCcccCCHHHHHHHHHHhccChhhCcCHHHH--hcChhhc
Confidence 444443211 11223578899999999999999999999876 4456653
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti |
| >cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-35 Score=322.66 Aligned_cols=249 Identities=30% Similarity=0.438 Sum_probs=198.3
Q ss_pred cccccccccccEEEEEEEcCCCcEEEEEEecccc-----ChHHHHHHHHHhcCCCCceEEEEEEEeCCeEEEEEEccCCC
Q psy11767 382 KAGILGDGSYSVCRRCVEKSTGQEYAVKIISRKI-----DCSEEINLLRACQGHPNIVNLHCVFQDEVHTYLVLELLKGG 456 (966)
Q Consensus 382 ~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~-----~~~~Ei~iL~~l~~HpnIV~l~~~~~~~~~~~lVmEy~~gg 456 (966)
..+.||+|+||.||+|.+..++..+|+|.+.... ...+|+++++.+ +||||++++++|..+...|+||||++++
T Consensus 9 i~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l-~h~~ii~~~~~~~~~~~~~~v~e~~~~~ 87 (282)
T cd06643 9 IIGELGDGAFGKVYKAQNKETGVLAAAKVIDTKSEEELEDYMVEIDILASC-DHPNIVKLLDAFYYENNLWILIEFCAGG 87 (282)
T ss_pred HHhhcccCCCeEEEEEEECCCCeEEEEEEeCCCCHHHHHHHHHHHHHHHHC-CCCCeeeEEEEEeeCCEEEEEEEecCCC
Confidence 3678999999999999999999999999986542 234688889888 5999999999999999999999999999
Q ss_pred CHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCcEEEecCCCCCEEEEeecccccccC---CCcccc
Q psy11767 457 ELLDRIRQKGRCGFTENEASRIMRQLVAAVHFMHSRGVVHRDLKPENLLFSDPAGDNIKVVDFGFACLKRE---SLHTPC 533 (966)
Q Consensus 457 ~L~~~l~~~~~~~l~e~~~~~i~~Qil~aL~yLHs~~IiHRDLKP~NILl~~~~~~~iKL~DFGla~~~~~---~~~~~~ 533 (966)
+|..++.+.. ..+++..+..++.||+.||+|||+.||+||||||+|||++. ++.+||+|||++..... ......
T Consensus 88 ~l~~~~~~~~-~~l~~~~~~~~~~qi~~~L~~LH~~~i~H~dlkp~nili~~--~~~~kl~dfg~~~~~~~~~~~~~~~~ 164 (282)
T cd06643 88 AVDAVMLELE-RPLTEPQIRVVCKQTLEALNYLHENKIIHRDLKAGNILFTL--DGDIKLADFGVSAKNTRTIQRRDSFI 164 (282)
T ss_pred cHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCcccEEEcc--CCCEEEcccccccccccccccccccc
Confidence 9988876533 36899999999999999999999999999999999999975 56899999999865432 123456
Q ss_pred ccccccCchhhccCCCCCCCcccchhhhhhhhhhhhcCCCCCCCcCcchhHHHHHHHHhcCCCCCCCCCCchhHHHHHHH
Q psy11767 534 FTLQYAAPEVLRQDKSGYDENCDLWSLGVILVNVLRQDKSGYDENCDLWSLGVILYTMLCGRVPFHARSRDDSALSIMAR 613 (966)
Q Consensus 534 gT~~Y~APEvl~~~~~~~~~~~Di~SlGvil~el~~~~~~~y~~~~DIWSlGvilyemltG~~Pf~~~~~~~~~~~~~~~ 613 (966)
+|+.|+|||++..... ....++.++||||+||++|+|++|++||...+..+ ....
T Consensus 165 ~~~~y~aPE~~~~~~~---------------------~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~----~~~~ 219 (282)
T cd06643 165 GTPYWMAPEVVMCETS---------------------KDRPYDYKADVWSLGITLIEMAQIEPPHHELNPMR----VLLK 219 (282)
T ss_pred ccccccCHhhccccCC---------------------CCCCCCccchhhhHHHHHHHHccCCCCccccCHHH----HHHH
Confidence 7899999999853210 12346789999999999999999999998654322 2222
Q ss_pred HHcCCCCCCchhhccCCHHHHHHHHHhcccCccccCChHHHHHHhhhhH
Q psy11767 614 IKEGQFNFDAEAWSTVSSEAKELTKSLLTVNPAQRIRMMRVKLTFHAFH 662 (966)
Q Consensus 614 i~~~~~~~~~~~~~~is~e~~~Li~~~L~~dP~~R~t~~~v~~~~~~~~ 662 (966)
+..+.... ......++.++++||.+||..||.+||++.++ ..|+|.
T Consensus 220 ~~~~~~~~-~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i--l~~~~~ 265 (282)
T cd06643 220 IAKSEPPT-LAQPSRWSSEFKDFLKKCLEKNVDARWTTTQL--LQHPFV 265 (282)
T ss_pred HhhcCCCC-CCCccccCHHHHHHHHHHccCChhhCcCHHHH--hcCCCE
Confidence 32222211 11223578899999999999999999999876 345554
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. |
| >cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-35 Score=324.60 Aligned_cols=241 Identities=37% Similarity=0.639 Sum_probs=200.6
Q ss_pred ccccccccccccEEEEEEEcCCCcEEEEEEecccc--------ChHHHHHHHHHhcCCCCceEEEEEEEeCCeEEEEEEc
Q psy11767 381 DKAGILGDGSYSVCRRCVEKSTGQEYAVKIISRKI--------DCSEEINLLRACQGHPNIVNLHCVFQDEVHTYLVLEL 452 (966)
Q Consensus 381 ~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~--------~~~~Ei~iL~~l~~HpnIV~l~~~~~~~~~~~lVmEy 452 (966)
...+.||+|+||.||+|.+..+++.||+|++.+.. ...+|+++|+.+. ||||+++++++.++...|+||||
T Consensus 4 ~~~~~ig~g~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~~~v~e~ 82 (290)
T cd05580 4 EFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIR-HPFLVNLYGSFQDDSNLYLVMEY 82 (290)
T ss_pred EEEEEeecCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCC-CCCccceeeEEEcCCeEEEEEec
Confidence 34678999999999999999999999999986431 2446889999885 99999999999999999999999
Q ss_pred cCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCcEEEecCCCCCEEEEeecccccccCCCccc
Q psy11767 453 LKGGELLDRIRQKGRCGFTENEASRIMRQLVAAVHFMHSRGVVHRDLKPENLLFSDPAGDNIKVVDFGFACLKRESLHTP 532 (966)
Q Consensus 453 ~~gg~L~~~l~~~~~~~l~e~~~~~i~~Qil~aL~yLHs~~IiHRDLKP~NILl~~~~~~~iKL~DFGla~~~~~~~~~~ 532 (966)
+++++|.+++.... .+++..+..++.||+.||+|||+.||+||||||+|||+++ ++.+||+|||++..........
T Consensus 83 ~~~~~L~~~~~~~~--~l~~~~~~~~~~qil~~l~~lH~~~i~H~dl~p~nili~~--~~~~kl~dfg~~~~~~~~~~~~ 158 (290)
T cd05580 83 VPGGELFSHLRKSG--RFPEPVARFYAAQVVLALEYLHSLDIVYRDLKPENLLLDS--DGYIKITDFGFAKRVKGRTYTL 158 (290)
T ss_pred CCCCCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEECC--CCCEEEeeCCCccccCCCCCCC
Confidence 99999999997764 6899999999999999999999999999999999999975 5689999999997765554556
Q ss_pred cccccccCchhhccCCCCCCCcccchhhhhhhhhhhhcCCCCCCCcCcchhHHHHHHHHhcCCCCCCCCCCchhHHHHHH
Q psy11767 533 CFTLQYAAPEVLRQDKSGYDENCDLWSLGVILVNVLRQDKSGYDENCDLWSLGVILYTMLCGRVPFHARSRDDSALSIMA 612 (966)
Q Consensus 533 ~gT~~Y~APEvl~~~~~~~~~~~Di~SlGvil~el~~~~~~~y~~~~DIWSlGvilyemltG~~Pf~~~~~~~~~~~~~~ 612 (966)
++++.|+|||.+.. ..++.++|||||||++|+|++|+.||...+. .....
T Consensus 159 ~~~~~y~aPE~~~~--------------------------~~~~~~~Di~slG~il~~l~~g~~p~~~~~~----~~~~~ 208 (290)
T cd05580 159 CGTPEYLAPEIILS--------------------------KGYGKAVDWWALGILIYEMLAGYPPFFDDNP----IQIYE 208 (290)
T ss_pred CCCccccChhhhcC--------------------------CCCCccccHHHHHHHHHHHHhCCCCCCCCCH----HHHHH
Confidence 78999999998742 1356789999999999999999999976542 23344
Q ss_pred HHHcCCCCCCchhhccCCHHHHHHHHHhcccCccccC-----ChHHHHHHhhhhH
Q psy11767 613 RIKEGQFNFDAEAWSTVSSEAKELTKSLLTVNPAQRI-----RMMRVKLTFHAFH 662 (966)
Q Consensus 613 ~i~~~~~~~~~~~~~~is~e~~~Li~~~L~~dP~~R~-----t~~~v~~~~~~~~ 662 (966)
.+..+...++ ..+++.++++|.+||..||.+|+ ++.++ ..|+|+
T Consensus 209 ~~~~~~~~~~----~~~~~~l~~li~~~l~~~p~~R~~~~~~~~~~l--~~~~~~ 257 (290)
T cd05580 209 KILEGKVRFP----SFFSPDAKDLIRNLLQVDLTKRLGNLKNGVNDI--KNHPWF 257 (290)
T ss_pred HHhcCCccCC----ccCCHHHHHHHHHHccCCHHHccCcccCCHHHH--HcCccc
Confidence 4555544433 34689999999999999999999 55544 345554
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi |
| >cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-35 Score=320.82 Aligned_cols=240 Identities=22% Similarity=0.418 Sum_probs=191.0
Q ss_pred ccccccccEEEEEEEcCCCc--EEEEEEecccc------ChHHHHHHHHHhcCCCCceEEEEEEEeCCeEEEEEEccCCC
Q psy11767 385 ILGDGSYSVCRRCVEKSTGQ--EYAVKIISRKI------DCSEEINLLRACQGHPNIVNLHCVFQDEVHTYLVLELLKGG 456 (966)
Q Consensus 385 ~LG~G~fG~Vy~a~~~~tg~--~vAvK~i~~~~------~~~~Ei~iL~~l~~HpnIV~l~~~~~~~~~~~lVmEy~~gg 456 (966)
+||+|+||.||+|.+..++. .+|+|.+.... ...+|+.++..+.+||||+++++++......|+||||+++|
T Consensus 2 ~lg~g~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~~~ 81 (270)
T cd05047 2 VIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPHG 81 (270)
T ss_pred cCCCCCCceEEEEEEcCCCCeeEEEEEEccccCCHHHHHHHHHHHHHHHhhccCCCeeeEEEEEecCCCceEEEEeCCCC
Confidence 69999999999999988876 46888876432 23468999998878999999999999999999999999999
Q ss_pred CHHHHHHhcC--------------CCCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCcEEEecCCCCCEEEEeeccc
Q psy11767 457 ELLDRIRQKG--------------RCGFTENEASRIMRQLVAAVHFMHSRGVVHRDLKPENLLFSDPAGDNIKVVDFGFA 522 (966)
Q Consensus 457 ~L~~~l~~~~--------------~~~l~e~~~~~i~~Qil~aL~yLHs~~IiHRDLKP~NILl~~~~~~~iKL~DFGla 522 (966)
+|.+++.... ...+++.+++.++.|++.||+|||+.||+||||||+|||+++ ++.+||+|||++
T Consensus 82 ~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~al~~lH~~~i~H~dikp~nili~~--~~~~kl~dfgl~ 159 (270)
T cd05047 82 NLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGE--NYVAKIADFGLS 159 (270)
T ss_pred cHHHHHHhccccccccccccccCCcCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccccceEEEcC--CCeEEECCCCCc
Confidence 9999997542 124789999999999999999999999999999999999975 568999999998
Q ss_pred ccccCCC--ccccccccccCchhhccCCCCCCCcccchhhhhhhhhhhhcCCCCCCCcCcchhHHHHHHHHhc-CCCCCC
Q psy11767 523 CLKRESL--HTPCFTLQYAAPEVLRQDKSGYDENCDLWSLGVILVNVLRQDKSGYDENCDLWSLGVILYTMLC-GRVPFH 599 (966)
Q Consensus 523 ~~~~~~~--~~~~gT~~Y~APEvl~~~~~~~~~~~Di~SlGvil~el~~~~~~~y~~~~DIWSlGvilyemlt-G~~Pf~ 599 (966)
....... .....+..|+|||++.. ..++.++|||||||++|+|++ |..||.
T Consensus 160 ~~~~~~~~~~~~~~~~~y~apE~~~~--------------------------~~~~~~~Di~slG~il~el~~~g~~pf~ 213 (270)
T cd05047 160 RGQEVYVKKTMGRLPVRWMAIESLNY--------------------------SVYTTNSDVWSYGVLLWEIVSLGGTPYC 213 (270)
T ss_pred cccchhhhccCCCCccccCChHHHcc--------------------------CCCCchhhHHHHHHHHHHHHcCCCCCcc
Confidence 5332111 12234667999998742 236788999999999999996 999997
Q ss_pred CCCCchhHHHHHHHHHcCCCCCCchhhccCCHHHHHHHHHhcccCccccCChHHHHHHhh
Q psy11767 600 ARSRDDSALSIMARIKEGQFNFDAEAWSTVSSEAKELTKSLLTVNPAQRIRMMRVKLTFH 659 (966)
Q Consensus 600 ~~~~~~~~~~~~~~i~~~~~~~~~~~~~~is~e~~~Li~~~L~~dP~~R~t~~~v~~~~~ 659 (966)
+.+.. .....+..+. . .+....++.++.+|+.+||..||.+|||+.++...+.
T Consensus 214 ~~~~~----~~~~~~~~~~-~--~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~l~ 266 (270)
T cd05047 214 GMTCA----ELYEKLPQGY-R--LEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLN 266 (270)
T ss_pred ccCHH----HHHHHHhCCC-C--CCCCCcCCHHHHHHHHHHcccChhhCCCHHHHHHHHH
Confidence 65432 2333444332 1 1122357889999999999999999999998855543
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l |
| >KOG0608|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-36 Score=340.82 Aligned_cols=249 Identities=29% Similarity=0.500 Sum_probs=201.5
Q ss_pred cccccccccccccEEEEEEEcCCCcEEEEEEeccccC--------hHHHHHHHHHhcCCCCceEEEEEEEeCCeEEEEEE
Q psy11767 380 LDKAGILGDGSYSVCRRCVEKSTGQEYAVKIISRKID--------CSEEINLLRACQGHPNIVNLHCVFQDEVHTYLVLE 451 (966)
Q Consensus 380 ~~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~~--------~~~Ei~iL~~l~~HpnIV~l~~~~~~~~~~~lVmE 451 (966)
|.+++.||-|+||+|.+++...|...||+|.+.++.. ...|..||... +.+=||+||..|++.+.+|+|||
T Consensus 631 Fvkik~iGvGAFGeV~Lv~KvDT~~lYAmKTLrKaDVl~rnQvaHVKAERDILAEA-Dn~WVVrLyySFQDkdnLYFVMd 709 (1034)
T KOG0608|consen 631 FVKIKTIGVGAFGEVCLVRKVDTRALYAMKTLRKADVLMRNQVAHVKAERDILAEA-DNEWVVRLYYSFQDKDNLYFVMD 709 (1034)
T ss_pred eEEEeeecccccceeEEEeecchhhHHHHhhhHHHHHHhhhhhhhhhhhhhhHhhc-CCcceEEEEEEeccCCceEEEEe
Confidence 4567899999999999999999999999999876532 33588888876 58899999999999999999999
Q ss_pred ccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCcEEEecCCCCCEEEEeecccccc---cC-
Q psy11767 452 LLKGGELLDRIRQKGRCGFTENEASRIMRQLVAAVHFMHSRGVVHRDLKPENLLFSDPAGDNIKVVDFGFACLK---RE- 527 (966)
Q Consensus 452 y~~gg~L~~~l~~~~~~~l~e~~~~~i~~Qil~aL~yLHs~~IiHRDLKP~NILl~~~~~~~iKL~DFGla~~~---~~- 527 (966)
|++|||+..+|.+.+ .|+|..+++|+.++.+|+++.|..|+|||||||+||||+. +|+|||+||||+.-+ ++
T Consensus 710 YIPGGDmMSLLIrmg--IFeE~LARFYIAEltcAiesVHkmGFIHRDiKPDNILIDr--dGHIKLTDFGLCTGfRWTHds 785 (1034)
T KOG0608|consen 710 YIPGGDMMSLLIRMG--IFEEDLARFYIAELTCAIESVHKMGFIHRDIKPDNILIDR--DGHIKLTDFGLCTGFRWTHDS 785 (1034)
T ss_pred ccCCccHHHHHHHhc--cCHHHHHHHHHHHHHHHHHHHHhccceecccCccceEEcc--CCceeeeeccccccceecccc
Confidence 999999999998877 5999999999999999999999999999999999999985 679999999998321 00
Q ss_pred ------------C-----------------------------CccccccccccCchhhccCCCCCCCcccchhhhhhhhh
Q psy11767 528 ------------S-----------------------------LHTPCFTLQYAAPEVLRQDKSGYDENCDLWSLGVILVN 566 (966)
Q Consensus 528 ------------~-----------------------------~~~~~gT~~Y~APEvl~~~~~~~~~~~Di~SlGvil~e 566 (966)
+ .+..+||+.|+|||+|.
T Consensus 786 kYYq~gdH~RqDSmep~~e~~d~~~~lkvL~~ra~~~h~r~~ahslvgt~nyiapevl~--------------------- 844 (1034)
T KOG0608|consen 786 KYYQEGDHHRQDSMEPSPEWADISKCLKVLERRAMRQHQRILAHSLVGTPNYIAPEVLA--------------------- 844 (1034)
T ss_pred ccccCCCccccccCCCchhhccccccchHHHHHHHhhhhhhhhhhhcCCCcccChHHhc---------------------
Confidence 0 01246899999999995
Q ss_pred hhhcCCCCCCCcCcchhHHHHHHHHhcCCCCCCCCCCchhHHHHHHHHHcCCCCCCchhhccCCHHHHHHHHHhcccCcc
Q psy11767 567 VLRQDKSGYDENCDLWSLGVILYTMLCGRVPFHARSRDDSALSIMARIKEGQFNFDAEAWSTVSSEAKELTKSLLTVNPA 646 (966)
Q Consensus 567 l~~~~~~~y~~~~DIWSlGvilyemltG~~Pf~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~is~e~~~Li~~~L~~dP~ 646 (966)
+.+|+..||+||.|||||||+.|++||...+..+....+..+-. .+.-....++|.|+.+||.++ ..+++
T Consensus 845 -----r~g~~q~cdwws~gvil~em~~g~~pf~~~tp~~tq~kv~nw~~----~l~~~~~~~ls~e~~~li~kL-c~sad 914 (1034)
T KOG0608|consen 845 -----RTGYTQLCDWWSVGVILYEMLVGQPPFLADTPGETQYKVINWRN----FLHIPYQGNLSKEALDLIQKL-CCSAD 914 (1034)
T ss_pred -----ccCccccchhhHhhHHHHHHhhCCCCccCCCCCcceeeeeehhh----ccccccccccCHHHHHHHHHH-hcChh
Confidence 45689999999999999999999999998877654333332211 112223357899999999986 57899
Q ss_pred ccCChHHH-HHHhhhhHHh
Q psy11767 647 QRIRMMRV-KLTFHAFHQA 664 (966)
Q Consensus 647 ~R~t~~~v-~~~~~~~~~~ 664 (966)
.|+.-.-. ....|+|++.
T Consensus 915 ~RLGkng~d~vKaHpfFkg 933 (1034)
T KOG0608|consen 915 SRLGKNGADQVKAHPFFKG 933 (1034)
T ss_pred hhhcccchhhhhcCccccc
Confidence 99864422 2356777653
|
|
| >cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-35 Score=320.06 Aligned_cols=243 Identities=21% Similarity=0.393 Sum_probs=198.3
Q ss_pred ccccccccccccccEEEEEEEcCCCcEEEEEEeccccC-----hHHHHHHHHHhcCCCCceEEEEEEEeCCeEEEEEEcc
Q psy11767 379 DLDKAGILGDGSYSVCRRCVEKSTGQEYAVKIISRKID-----CSEEINLLRACQGHPNIVNLHCVFQDEVHTYLVLELL 453 (966)
Q Consensus 379 ~~~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~~-----~~~Ei~iL~~l~~HpnIV~l~~~~~~~~~~~lVmEy~ 453 (966)
+|+..+.||.|+||.||+|.+.. ++.+|+|++..... ...|+.+|+.+ +||||+++++++.+....|+||||+
T Consensus 7 ~y~~~~~ig~g~~~~vy~~~~~~-~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~~~~lv~e~~ 84 (261)
T cd05148 7 EFTLERKLGSGYFGEVWEGLWKN-RVRVAIKILKSDDLLKQQDFQKEVQALKRL-RHKHLISLFAVCSVGEPVYIITELM 84 (261)
T ss_pred HHHHhhhhccCCCccEEEeEecC-CCcEEEEeccccchhhHHHHHHHHHHHhcC-CCcchhheeeeEecCCCeEEEEeec
Confidence 45557899999999999999988 88999999875432 45688999888 5999999999999999999999999
Q ss_pred CCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCcEEEecCCCCCEEEEeecccccccCCC---c
Q psy11767 454 KGGELLDRIRQKGRCGFTENEASRIMRQLVAAVHFMHSRGVVHRDLKPENLLFSDPAGDNIKVVDFGFACLKRESL---H 530 (966)
Q Consensus 454 ~gg~L~~~l~~~~~~~l~e~~~~~i~~Qil~aL~yLHs~~IiHRDLKP~NILl~~~~~~~iKL~DFGla~~~~~~~---~ 530 (966)
++++|.+++.......+++..+..++.||+.||+|||++||+||||||+|||+++ ++.+||+|||++....... .
T Consensus 85 ~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~h~dl~~~nilv~~--~~~~kl~d~g~~~~~~~~~~~~~ 162 (261)
T cd05148 85 EKGSLLAFLRSPEGQVLPVASLIDMACQVAEGMAYLEEQNSIHRDLAARNILVGE--DLVCKVADFGLARLIKEDVYLSS 162 (261)
T ss_pred ccCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccCcceEEEcC--CceEEEccccchhhcCCcccccc
Confidence 9999999998755556899999999999999999999999999999999999985 5689999999996543321 1
Q ss_pred cccccccccCchhhccCCCCCCCcccchhhhhhhhhhhhcCCCCCCCcCcchhHHHHHHHHhc-CCCCCCCCCCchhHHH
Q psy11767 531 TPCFTLQYAAPEVLRQDKSGYDENCDLWSLGVILVNVLRQDKSGYDENCDLWSLGVILYTMLC-GRVPFHARSRDDSALS 609 (966)
Q Consensus 531 ~~~gT~~Y~APEvl~~~~~~~~~~~Di~SlGvil~el~~~~~~~y~~~~DIWSlGvilyemlt-G~~Pf~~~~~~~~~~~ 609 (966)
...++..|+|||++.. ..++.++|||||||++|+|++ |+.||...+.. .
T Consensus 163 ~~~~~~~~~~PE~~~~--------------------------~~~~~~~DiwslG~~l~~l~~~g~~p~~~~~~~----~ 212 (261)
T cd05148 163 DKKIPYKWTAPEAASH--------------------------GTFSTKSDVWSFGILLYEMFTYGQVPYPGMNNH----E 212 (261)
T ss_pred CCCCceEecCHHHHcc--------------------------CCCCchhhHHHHHHHHHHHHcCCCCCCCcCCHH----H
Confidence 2334678999998742 236778999999999999998 89999765532 2
Q ss_pred HHHHHHcCCCCCCchhhccCCHHHHHHHHHhcccCccccCChHHHHHHh
Q psy11767 610 IMARIKEGQFNFDAEAWSTVSSEAKELTKSLLTVNPAQRIRMMRVKLTF 658 (966)
Q Consensus 610 ~~~~i~~~~~~~~~~~~~~is~e~~~Li~~~L~~dP~~R~t~~~v~~~~ 658 (966)
.+..+..+. . .......++++.+++.+||..||++|||+.++...+
T Consensus 213 ~~~~~~~~~-~--~~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~l~~~L 258 (261)
T cd05148 213 VYDQITAGY-R--MPCPAKCPQEIYKIMLECWAAEPEDRPSFKALREEL 258 (261)
T ss_pred HHHHHHhCC-c--CCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHH
Confidence 333343321 1 112246789999999999999999999999875444
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom |
| >cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-35 Score=318.67 Aligned_cols=244 Identities=28% Similarity=0.437 Sum_probs=196.5
Q ss_pred cccccccccccccEEEEEEEcCCCcEEEEEEecccc--------ChHHHHHHHHHhcCCCCceEEEEEEEeCCeEEEEEE
Q psy11767 380 LDKAGILGDGSYSVCRRCVEKSTGQEYAVKIISRKI--------DCSEEINLLRACQGHPNIVNLHCVFQDEVHTYLVLE 451 (966)
Q Consensus 380 ~~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~--------~~~~Ei~iL~~l~~HpnIV~l~~~~~~~~~~~lVmE 451 (966)
|+..+.||+|+||.||+|++..+++.||||.+.... ...+|+.+|+.+ +||||+++++++.+.+..|+|||
T Consensus 4 ~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~~v~e 82 (267)
T cd08228 4 FQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQL-NHPNVIKYLDSFIEDNELNIVLE 82 (267)
T ss_pred eeeeeeeccCCCeeEEEEEEeCCCCEEEEEEeeccccCCHHHHHHHHHHHHHHHhC-CCcceeeeeeeEEECCeEEEEEE
Confidence 334678999999999999999999999999875321 134689999988 59999999999999999999999
Q ss_pred ccCCCCHHHHHHhc--CCCCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCcEEEecCCCCCEEEEeecccccccCC-
Q psy11767 452 LLKGGELLDRIRQK--GRCGFTENEASRIMRQLVAAVHFMHSRGVVHRDLKPENLLFSDPAGDNIKVVDFGFACLKRES- 528 (966)
Q Consensus 452 y~~gg~L~~~l~~~--~~~~l~e~~~~~i~~Qil~aL~yLHs~~IiHRDLKP~NILl~~~~~~~iKL~DFGla~~~~~~- 528 (966)
|+++|+|.+++... ....+++..+..++.||+.||+|||++||+||||||+|||++. .+.++|+|||++......
T Consensus 83 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~~~nil~~~--~~~~~l~d~g~~~~~~~~~ 160 (267)
T cd08228 83 LADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMHSRRVMHRDIKPANVFITA--TGVVKLGDLGLGRFFSSKT 160 (267)
T ss_pred ecCCCcHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhCCeeCCCCCHHHEEEcC--CCCEEECccccceeccchh
Confidence 99999999888532 2235899999999999999999999999999999999999975 568999999998754321
Q ss_pred --CccccccccccCchhhccCCCCCCCcccchhhhhhhhhhhhcCCCCCCCcCcchhHHHHHHHHhcCCCCCCCCCCchh
Q psy11767 529 --LHTPCFTLQYAAPEVLRQDKSGYDENCDLWSLGVILVNVLRQDKSGYDENCDLWSLGVILYTMLCGRVPFHARSRDDS 606 (966)
Q Consensus 529 --~~~~~gT~~Y~APEvl~~~~~~~~~~~Di~SlGvil~el~~~~~~~y~~~~DIWSlGvilyemltG~~Pf~~~~~~~~ 606 (966)
.....+++.|+|||.+.. ..++.++|+||+||++|+|++|+.||......
T Consensus 161 ~~~~~~~~~~~~~aPE~~~~--------------------------~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~-- 212 (267)
T cd08228 161 TAAHSLVGTPYYMSPERIHE--------------------------NGYNFKSDIWSLGCLLYEMAALQSPFYGDKMN-- 212 (267)
T ss_pred HHHhcCCCCccccChhhhcc--------------------------CCCCchhhHHHHHHHHHHHhcCCCCCcccccc--
Confidence 223467889999998852 23567899999999999999999999754332
Q ss_pred HHHHHHHHHcCCCCCCchhhccCCHHHHHHHHHhcccCccccCChHHHHH
Q psy11767 607 ALSIMARIKEGQFNFDAEAWSTVSSEAKELTKSLLTVNPAQRIRMMRVKL 656 (966)
Q Consensus 607 ~~~~~~~i~~~~~~~~~~~~~~is~e~~~Li~~~L~~dP~~R~t~~~v~~ 656 (966)
.......+..+.+. +.....++.++.+++.+||..+|++||++.++..
T Consensus 213 ~~~~~~~~~~~~~~--~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~vl~ 260 (267)
T cd08228 213 LFSLCQKIEQCDYP--PLPTEHYSEKLRELVSMCIYPDPDQRPDIGYVHQ 260 (267)
T ss_pred HHHHHHHHhcCCCC--CCChhhcCHHHHHHHHHHCCCCcccCcCHHHHHH
Confidence 12334444443322 2222357789999999999999999999998754
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase |
| >cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-35 Score=316.37 Aligned_cols=238 Identities=26% Similarity=0.467 Sum_probs=194.5
Q ss_pred ccccccccccccEEEEEEEcCCCcEEEEEEecccc-------ChHHHHHHHHHhcCCCCceEEEEEEEe-CCeEEEEEEc
Q psy11767 381 DKAGILGDGSYSVCRRCVEKSTGQEYAVKIISRKI-------DCSEEINLLRACQGHPNIVNLHCVFQD-EVHTYLVLEL 452 (966)
Q Consensus 381 ~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~-------~~~~Ei~iL~~l~~HpnIV~l~~~~~~-~~~~~lVmEy 452 (966)
+..+.||+|+||.||++.+..+++.||+|.+.... ...+|+++++.+ +||||+++++.+.. +...|+||||
T Consensus 3 ~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~~~~~lv~e~ 81 (257)
T cd08223 3 CFVRVVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQL-KHPNIVAYRESWEGEDGLLYIVMGF 81 (257)
T ss_pred eEEEEecCCCCeEEEEEEEcCCCcEEEEEEEehhhcCHHHHHHHHHHHHHHHhC-CCCCeeeeeeeecCCCCEEEEEecc
Confidence 44688999999999999999999999999986432 134588888888 59999999998874 4568999999
Q ss_pred cCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCcEEEecCCCCCEEEEeecccccccC---CC
Q psy11767 453 LKGGELLDRIRQKGRCGFTENEASRIMRQLVAAVHFMHSRGVVHRDLKPENLLFSDPAGDNIKVVDFGFACLKRE---SL 529 (966)
Q Consensus 453 ~~gg~L~~~l~~~~~~~l~e~~~~~i~~Qil~aL~yLHs~~IiHRDLKP~NILl~~~~~~~iKL~DFGla~~~~~---~~ 529 (966)
+++++|.+++.......+++.++..++.|++.||+|||++||+||||||+|||+++ .+.++|+|||++..... ..
T Consensus 82 ~~~~~l~~~l~~~~~~~l~~~~~~~~~~~l~~~l~~lH~~~i~H~di~p~nil~~~--~~~~~l~df~~~~~~~~~~~~~ 159 (257)
T cd08223 82 CEGGDLYHKLKEQKGKLLPENQVVEWFVQIAMALQYLHEKHILHRDLKTQNVFLTR--TNIIKVGDLGIARVLENQCDMA 159 (257)
T ss_pred cCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCchhEEEec--CCcEEEecccceEEecccCCcc
Confidence 99999999998754446899999999999999999999999999999999999975 56899999999865432 12
Q ss_pred ccccccccccCchhhccCCCCCCCcccchhhhhhhhhhhhcCCCCCCCcCcchhHHHHHHHHhcCCCCCCCCCCchhHHH
Q psy11767 530 HTPCFTLQYAAPEVLRQDKSGYDENCDLWSLGVILVNVLRQDKSGYDENCDLWSLGVILYTMLCGRVPFHARSRDDSALS 609 (966)
Q Consensus 530 ~~~~gT~~Y~APEvl~~~~~~~~~~~Di~SlGvil~el~~~~~~~y~~~~DIWSlGvilyemltG~~Pf~~~~~~~~~~~ 609 (966)
....+++.|+|||++.. ..++.++|+||+||++|+|++|+.||...+.. .
T Consensus 160 ~~~~~~~~y~aPE~~~~--------------------------~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~----~ 209 (257)
T cd08223 160 STLIGTPYYMSPELFSN--------------------------KPYNYKSDVWALGCCVYEMATLKHAFNAKDMN----S 209 (257)
T ss_pred ccccCCcCccChhHhcC--------------------------CCCCchhhhHHHHHHHHHHHcCCCCCCCCCHH----H
Confidence 34467899999998752 23677899999999999999999999865432 2
Q ss_pred HHHHHHcCCCCCCchhhccCCHHHHHHHHHhcccCccccCChHHH
Q psy11767 610 IMARIKEGQFNFDAEAWSTVSSEAKELTKSLLTVNPAQRIRMMRV 654 (966)
Q Consensus 610 ~~~~i~~~~~~~~~~~~~~is~e~~~Li~~~L~~dP~~R~t~~~v 654 (966)
....+..+.... ....+++++.+++.+||..||++||++.++
T Consensus 210 ~~~~~~~~~~~~---~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~ 251 (257)
T cd08223 210 LVYRIIEGKLPP---MPKDYSPELGELIATMLSKRPEKRPSVKSI 251 (257)
T ss_pred HHHHHHhcCCCC---CccccCHHHHHHHHHHhccCcccCCCHHHH
Confidence 233444443321 223578999999999999999999999876
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. |
| >cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-35 Score=327.72 Aligned_cols=247 Identities=28% Similarity=0.564 Sum_probs=198.7
Q ss_pred cccccccccccccEEEEEEEcCCCcEEEEEEecccc--------ChHHHHHHHHHhcCCCCceEEEEEEEeCCeEEEEEE
Q psy11767 380 LDKAGILGDGSYSVCRRCVEKSTGQEYAVKIISRKI--------DCSEEINLLRACQGHPNIVNLHCVFQDEVHTYLVLE 451 (966)
Q Consensus 380 ~~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~--------~~~~Ei~iL~~l~~HpnIV~l~~~~~~~~~~~lVmE 451 (966)
|+..+.||+|+||.||+|.+..+++.||||.+.... ...+|+++++.+ +||||+++++.+.++.+.|+|||
T Consensus 3 y~~~~~l~~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~e~~~l~~~-~~~~i~~~~~~~~~~~~~~lv~e 81 (305)
T cd05609 3 FETIKLISNGAYGAVYLVRHKETRQRFAMKKINKQNLILRNQIQQVFVERDILTFA-ENPFVVSMFCSFETKRHLCMVME 81 (305)
T ss_pred ceEeeEeecCCCeeEEEEEECCCCcEEEEEEeehhhhhhHHHHHHHHHHHHHHHhC-CCCCeeeeEEEEecCCEEEEEEe
Confidence 445688999999999999999999999999986432 133688888887 59999999999999999999999
Q ss_pred ccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCcEEEecCCCCCEEEEeecccccccCC---
Q psy11767 452 LLKGGELLDRIRQKGRCGFTENEASRIMRQLVAAVHFMHSRGVVHRDLKPENLLFSDPAGDNIKVVDFGFACLKRES--- 528 (966)
Q Consensus 452 y~~gg~L~~~l~~~~~~~l~e~~~~~i~~Qil~aL~yLHs~~IiHRDLKP~NILl~~~~~~~iKL~DFGla~~~~~~--- 528 (966)
|++|++|.+++...+ .+++..+..++.|++.||+|||+.||+||||||+|||+++ .+.+||+|||+++.....
T Consensus 82 ~~~g~~L~~~l~~~~--~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~NIll~~--~~~~~l~dfg~~~~~~~~~~~ 157 (305)
T cd05609 82 YVEGGDCATLLKNIG--ALPVDMARMYFAETVLALEYLHNYGIVHRDLKPDNLLITS--MGHIKLTDFGLSKIGLMSLTT 157 (305)
T ss_pred cCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCCccccCCchHHEEECC--CCCEEEeeCCCccccCcCccc
Confidence 999999999997654 5899999999999999999999999999999999999975 568999999998632100
Q ss_pred ---------------CccccccccccCchhhccCCCCCCCcccchhhhhhhhhhhhcCCCCCCCcCcchhHHHHHHHHhc
Q psy11767 529 ---------------LHTPCFTLQYAAPEVLRQDKSGYDENCDLWSLGVILVNVLRQDKSGYDENCDLWSLGVILYTMLC 593 (966)
Q Consensus 529 ---------------~~~~~gT~~Y~APEvl~~~~~~~~~~~Di~SlGvil~el~~~~~~~y~~~~DIWSlGvilyemlt 593 (966)
.....++..|+|||.+.. ..++.++|+|||||++|+|++
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~--------------------------~~~~~~~Di~slG~vl~el~~ 211 (305)
T cd05609 158 NLYEGHIEKDTREFLDKQVCGTPEYIAPEVILR--------------------------QGYGKPVDWWAMGIILYEFLV 211 (305)
T ss_pred cccccccccchhhccccCCccCccccCchhccC--------------------------CCCCchhhHHHHHHHHHHHHh
Confidence 012346788999998742 236788999999999999999
Q ss_pred CCCCCCCCCCchhHHHHHHHHHcCCCCCCchhhccCCHHHHHHHHHhcccCccccCChHHH-HHHhhhhH
Q psy11767 594 GRVPFHARSRDDSALSIMARIKEGQFNFDAEAWSTVSSEAKELTKSLLTVNPAQRIRMMRV-KLTFHAFH 662 (966)
Q Consensus 594 G~~Pf~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~is~e~~~Li~~~L~~dP~~R~t~~~v-~~~~~~~~ 662 (966)
|..||.+.... .++..+..+....+... ..++.++.++|.+||..||++||++.++ .+..|+|+
T Consensus 212 g~~pf~~~~~~----~~~~~~~~~~~~~~~~~-~~~~~~~~~li~~~l~~~P~~R~~~~~~~~ll~~~~~ 276 (305)
T cd05609 212 GCVPFFGDTPE----ELFGQVISDDIEWPEGD-EALPADAQDLISRLLRQNPLERLGTGGAFEVKQHRFF 276 (305)
T ss_pred CCCCCCCCCHH----HHHHHHHhcccCCCCcc-ccCCHHHHHHHHHHhccChhhccCccCHHHHHhCccc
Confidence 99999865432 34445554444333322 2578999999999999999999996433 34555654
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a |
| >cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-35 Score=326.71 Aligned_cols=246 Identities=21% Similarity=0.375 Sum_probs=195.1
Q ss_pred cccccccccccEEEEEEEcC-------CCcEEEEEEecccc------ChHHHHHHHHHhcCCCCceEEEEEEEeCCeEEE
Q psy11767 382 KAGILGDGSYSVCRRCVEKS-------TGQEYAVKIISRKI------DCSEEINLLRACQGHPNIVNLHCVFQDEVHTYL 448 (966)
Q Consensus 382 ~~~~LG~G~fG~Vy~a~~~~-------tg~~vAvK~i~~~~------~~~~Ei~iL~~l~~HpnIV~l~~~~~~~~~~~l 448 (966)
..+.||+|+||.||+|.+.. ++..||+|++.... ...+|+++++.+.+||||+++++++.++...|+
T Consensus 22 i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~l 101 (307)
T cd05098 22 LGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQDGPLYV 101 (307)
T ss_pred EeeeeccCCCeeEEEeEEeccCCcccCccceEEEEeccCCCChHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecCCceEE
Confidence 36789999999999998753 34579999987532 134588899888779999999999999999999
Q ss_pred EEEccCCCCHHHHHHhcCC--------------CCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCcEEEecCCCCCE
Q psy11767 449 VLELLKGGELLDRIRQKGR--------------CGFTENEASRIMRQLVAAVHFMHSRGVVHRDLKPENLLFSDPAGDNI 514 (966)
Q Consensus 449 VmEy~~gg~L~~~l~~~~~--------------~~l~e~~~~~i~~Qil~aL~yLHs~~IiHRDLKP~NILl~~~~~~~i 514 (966)
||||+++|+|.+++..... ..+++.+++.++.||+.||+|||++||+||||||+|||++. ++.+
T Consensus 102 v~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~gi~H~dlkp~Nill~~--~~~~ 179 (307)
T cd05098 102 IVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTE--DNVM 179 (307)
T ss_pred EEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCCcccccccHHheEEcC--CCcE
Confidence 9999999999999976431 24889999999999999999999999999999999999975 4689
Q ss_pred EEEeecccccccCC-----CccccccccccCchhhccCCCCCCCcccchhhhhhhhhhhhcCCCCCCCcCcchhHHHHHH
Q psy11767 515 KVVDFGFACLKRES-----LHTPCFTLQYAAPEVLRQDKSGYDENCDLWSLGVILVNVLRQDKSGYDENCDLWSLGVILY 589 (966)
Q Consensus 515 KL~DFGla~~~~~~-----~~~~~gT~~Y~APEvl~~~~~~~~~~~Di~SlGvil~el~~~~~~~y~~~~DIWSlGvily 589 (966)
||+|||++...... .....+++.|+|||++.. ..++.++|||||||++|
T Consensus 180 kL~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~--------------------------~~~~~~~DvwslG~~l~ 233 (307)
T cd05098 180 KIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFD--------------------------RIYTHQSDVWSFGVLLW 233 (307)
T ss_pred EECCCcccccccccchhhccccCCCccceeChHHhcc--------------------------CCCCcHHHHHHHHHHHH
Confidence 99999998654321 112234568999998852 23678899999999999
Q ss_pred HHhc-CCCCCCCCCCchhHHHHHHHHHcCCCCCCchhhccCCHHHHHHHHHhcccCccccCChHHHHHHhhhhH
Q psy11767 590 TMLC-GRVPFHARSRDDSALSIMARIKEGQFNFDAEAWSTVSSEAKELTKSLLTVNPAQRIRMMRVKLTFHAFH 662 (966)
Q Consensus 590 emlt-G~~Pf~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~is~e~~~Li~~~L~~dP~~R~t~~~v~~~~~~~~ 662 (966)
+|++ |..||.+.... .+...+..+.. .+....++.++++|+.+||..+|++||++.++...+..+.
T Consensus 234 el~~~g~~p~~~~~~~----~~~~~~~~~~~---~~~~~~~~~~~~~li~~~l~~~p~~Rps~~evl~~l~~~~ 300 (307)
T cd05098 234 EIFTLGGSPYPGVPVE----ELFKLLKEGHR---MDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIL 300 (307)
T ss_pred HHHcCCCCCCCcCCHH----HHHHHHHcCCC---CCCCCcCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHH
Confidence 9998 89999764432 23334444322 1223457899999999999999999999999866665443
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-35 Score=315.48 Aligned_cols=240 Identities=28% Similarity=0.426 Sum_probs=200.8
Q ss_pred cccccccccccccEEEEEEEcCCCcEEEEEEecccc-------ChHHHHHHHHHhcCCCCceEEEEEEEeCCeEEEEEEc
Q psy11767 380 LDKAGILGDGSYSVCRRCVEKSTGQEYAVKIISRKI-------DCSEEINLLRACQGHPNIVNLHCVFQDEVHTYLVLEL 452 (966)
Q Consensus 380 ~~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~-------~~~~Ei~iL~~l~~HpnIV~l~~~~~~~~~~~lVmEy 452 (966)
|+..+.||.|+||.||.+++..+++.+|+|.+.... ...+|+.+|+.+ +|+||+++++++.++...++||||
T Consensus 2 y~~~~~ig~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~~-~h~~i~~~~~~~~~~~~~~~~~e~ 80 (256)
T cd08221 2 YIPIRVLGKGAFGEATLYRRTEDDSLVVWKEVNLTRLSEKERRDALNEIVILSLL-QHPNIIAYYNHFMDDNTLLIEMEY 80 (256)
T ss_pred ceEeeEecccCCceEEEEEEcCCCcEEEEEEEeecccchhHHHHHHHHHHHHHhC-CCCCeeEEEeEEecCCeEEEEEEe
Confidence 344789999999999999999999999999876432 245799999998 699999999999999999999999
Q ss_pred cCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCcEEEecCCCCCEEEEeecccccccCC---C
Q psy11767 453 LKGGELLDRIRQKGRCGFTENEASRIMRQLVAAVHFMHSRGVVHRDLKPENLLFSDPAGDNIKVVDFGFACLKRES---L 529 (966)
Q Consensus 453 ~~gg~L~~~l~~~~~~~l~e~~~~~i~~Qil~aL~yLHs~~IiHRDLKP~NILl~~~~~~~iKL~DFGla~~~~~~---~ 529 (966)
|++++|.+++.......+++..+..++.|++.||+|||+.|++||||||+||++++ ++.+||+|||++...... .
T Consensus 81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~p~ni~~~~--~~~~kl~d~~~~~~~~~~~~~~ 158 (256)
T cd08221 81 ANGGTLYDKIVRQKGQLFEEEMVLWYLFQIVSAVSYIHKAGILHRDIKTLNIFLTK--AGLIKLGDFGISKILGSEYSMA 158 (256)
T ss_pred cCCCcHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhCCccccCCChHhEEEeC--CCCEEECcCcceEEcccccccc
Confidence 99999999998764446899999999999999999999999999999999999985 568999999998765332 2
Q ss_pred ccccccccccCchhhccCCCCCCCcccchhhhhhhhhhhhcCCCCCCCcCcchhHHHHHHHHhcCCCCCCCCCCchhHHH
Q psy11767 530 HTPCFTLQYAAPEVLRQDKSGYDENCDLWSLGVILVNVLRQDKSGYDENCDLWSLGVILYTMLCGRVPFHARSRDDSALS 609 (966)
Q Consensus 530 ~~~~gT~~Y~APEvl~~~~~~~~~~~Di~SlGvil~el~~~~~~~y~~~~DIWSlGvilyemltG~~Pf~~~~~~~~~~~ 609 (966)
....+++.|+|||++.. ..++.++|+||+||++|+|++|..||..... ..
T Consensus 159 ~~~~~~~~y~ape~~~~--------------------------~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~----~~ 208 (256)
T cd08221 159 ETVVGTPYYMSPELCQG--------------------------VKYNFKSDIWALGCVLYELLTLKRTFDATNP----LN 208 (256)
T ss_pred cccCCCccccCHhhcCC--------------------------CCCCCcchhHHHHHHHHHHHHCCCCCCCCCH----HH
Confidence 34567899999998752 2256789999999999999999999976543 23
Q ss_pred HHHHHHcCCCCCCchhhccCCHHHHHHHHHhcccCccccCChHHHH
Q psy11767 610 IMARIKEGQFNFDAEAWSTVSSEAKELTKSLLTVNPAQRIRMMRVK 655 (966)
Q Consensus 610 ~~~~i~~~~~~~~~~~~~~is~e~~~Li~~~L~~dP~~R~t~~~v~ 655 (966)
....+..+.+.... ..++.++.+++.+||..||++||++.++.
T Consensus 209 ~~~~~~~~~~~~~~---~~~~~~~~~~i~~~l~~~p~~R~s~~~ll 251 (256)
T cd08221 209 LVVKIVQGNYTPVV---SVYSSELISLVHSLLQQDPEKRPTADEVL 251 (256)
T ss_pred HHHHHHcCCCCCCc---cccCHHHHHHHHHHcccCcccCCCHHHHh
Confidence 44455555544322 45789999999999999999999998763
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa |
| >cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-35 Score=323.12 Aligned_cols=243 Identities=24% Similarity=0.398 Sum_probs=193.9
Q ss_pred ccccccccccccEEEEEEEcCC-----CcEEEEEEeccccC------hHHHHHHHHHhcCCCCceEEEEEEEeCCeEEEE
Q psy11767 381 DKAGILGDGSYSVCRRCVEKST-----GQEYAVKIISRKID------CSEEINLLRACQGHPNIVNLHCVFQDEVHTYLV 449 (966)
Q Consensus 381 ~~~~~LG~G~fG~Vy~a~~~~t-----g~~vAvK~i~~~~~------~~~Ei~iL~~l~~HpnIV~l~~~~~~~~~~~lV 449 (966)
+..+.||+|+||.||++.+... ...+|+|++..... ..+|+.+++.+.+||||+++++++..+...|+|
T Consensus 15 ~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~li 94 (293)
T cd05053 15 TLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGVCTQEGPLYVV 94 (293)
T ss_pred EEeeEecccccccEEEEEEecCCCCCCceeEEEEEccCCCCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEcCCCCeEEE
Confidence 3467899999999999998744 37899999875422 346888998886799999999999999999999
Q ss_pred EEccCCCCHHHHHHhcC--------------CCCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCcEEEecCCCCCEE
Q psy11767 450 LELLKGGELLDRIRQKG--------------RCGFTENEASRIMRQLVAAVHFMHSRGVVHRDLKPENLLFSDPAGDNIK 515 (966)
Q Consensus 450 mEy~~gg~L~~~l~~~~--------------~~~l~e~~~~~i~~Qil~aL~yLHs~~IiHRDLKP~NILl~~~~~~~iK 515 (966)
|||+++|+|.+++.... ...+++..++.++.||+.||+|||++||+||||||+|||+++ ++.+|
T Consensus 95 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~ivH~dlkp~Nil~~~--~~~~k 172 (293)
T cd05053 95 VEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFLASKKCIHRDLAARNVLVTE--DHVMK 172 (293)
T ss_pred EEeCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHCCccccccceeeEEEcC--CCeEE
Confidence 99999999999997531 235899999999999999999999999999999999999975 56899
Q ss_pred EEeecccccccCC-----CccccccccccCchhhccCCCCCCCcccchhhhhhhhhhhhcCCCCCCCcCcchhHHHHHHH
Q psy11767 516 VVDFGFACLKRES-----LHTPCFTLQYAAPEVLRQDKSGYDENCDLWSLGVILVNVLRQDKSGYDENCDLWSLGVILYT 590 (966)
Q Consensus 516 L~DFGla~~~~~~-----~~~~~gT~~Y~APEvl~~~~~~~~~~~Di~SlGvil~el~~~~~~~y~~~~DIWSlGvilye 590 (966)
|+|||++...... .....++..|+|||++.. ..++.++|||||||++|+
T Consensus 173 L~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~--------------------------~~~~~~~Di~slG~il~e 226 (293)
T cd05053 173 IADFGLARDIHHIDYYRKTTNGRLPVKWMAPEALFD--------------------------RVYTHQSDVWSFGVLLWE 226 (293)
T ss_pred eCccccccccccccceeccCCCCCCccccCHHHhcc--------------------------CCcCcccceeehhhHHHH
Confidence 9999999754321 112234567999998742 236788999999999999
Q ss_pred Hhc-CCCCCCCCCCchhHHHHHHHHHcCCCCCCchhhccCCHHHHHHHHHhcccCccccCChHHHHHHh
Q psy11767 591 MLC-GRVPFHARSRDDSALSIMARIKEGQFNFDAEAWSTVSSEAKELTKSLLTVNPAQRIRMMRVKLTF 658 (966)
Q Consensus 591 mlt-G~~Pf~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~is~e~~~Li~~~L~~dP~~R~t~~~v~~~~ 658 (966)
|++ |..||...... .....+..+... ......+.++.+|+.+||..||++|||+.++...+
T Consensus 227 l~~~g~~p~~~~~~~----~~~~~~~~~~~~---~~~~~~~~~~~~li~~~l~~~p~~Rps~~eil~~l 288 (293)
T cd05053 227 IFTLGGSPYPGIPVE----ELFKLLKEGYRM---EKPQNCTQELYHLMRDCWHEVPSQRPTFKQLVEDL 288 (293)
T ss_pred HhcCCCCCCCCCCHH----HHHHHHHcCCcC---CCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHHH
Confidence 997 99999865432 233334433211 12235688999999999999999999999885544
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, |
| >cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-35 Score=317.27 Aligned_cols=241 Identities=19% Similarity=0.334 Sum_probs=190.2
Q ss_pred cccccccccccEEEEEEEcCC---CcEEEEEEecccc-------ChHHHHHHHHHhcCCCCceEEEEEEEeCCe------
Q psy11767 382 KAGILGDGSYSVCRRCVEKST---GQEYAVKIISRKI-------DCSEEINLLRACQGHPNIVNLHCVFQDEVH------ 445 (966)
Q Consensus 382 ~~~~LG~G~fG~Vy~a~~~~t---g~~vAvK~i~~~~-------~~~~Ei~iL~~l~~HpnIV~l~~~~~~~~~------ 445 (966)
..+.||+|+||.||+|....+ +..||||++.... ...+|+.+|+.+ +||||+++++++.+...
T Consensus 3 ~~~~lg~G~~g~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~~~~~ 81 (273)
T cd05035 3 LGKILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDF-DHPNVMKLIGVCFEASSLQKIPK 81 (273)
T ss_pred cccccCcCCCceEEEEEEecCCCCcceEEEEEeccCcCCHHHHHHHHHHHHHHHhC-CCCCeeeEEeeeccCCccccCcc
Confidence 467899999999999987653 4789999987532 134588888887 59999999998765543
Q ss_pred EEEEEEccCCCCHHHHHHhcC----CCCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCcEEEecCCCCCEEEEeecc
Q psy11767 446 TYLVLELLKGGELLDRIRQKG----RCGFTENEASRIMRQLVAAVHFMHSRGVVHRDLKPENLLFSDPAGDNIKVVDFGF 521 (966)
Q Consensus 446 ~~lVmEy~~gg~L~~~l~~~~----~~~l~e~~~~~i~~Qil~aL~yLHs~~IiHRDLKP~NILl~~~~~~~iKL~DFGl 521 (966)
.++||||+++|+|..++.... ...+++..+..++.|++.||+|||+++|+||||||+|||+++ .+.+||+|||+
T Consensus 82 ~~~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~aL~~lH~~~i~H~dlkp~Nil~~~--~~~~kl~dfg~ 159 (273)
T cd05035 82 PMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGMEYLSNRNFIHRDLAARNCMLRE--DMTVCVADFGL 159 (273)
T ss_pred cEEEEeccCCCCHHHHHHHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhCCeeccccchheEEECC--CCeEEECCccc
Confidence 799999999999999885432 235899999999999999999999999999999999999975 56899999999
Q ss_pred cccccCCC-----ccccccccccCchhhccCCCCCCCcccchhhhhhhhhhhhcCCCCCCCcCcchhHHHHHHHHhc-CC
Q psy11767 522 ACLKRESL-----HTPCFTLQYAAPEVLRQDKSGYDENCDLWSLGVILVNVLRQDKSGYDENCDLWSLGVILYTMLC-GR 595 (966)
Q Consensus 522 a~~~~~~~-----~~~~gT~~Y~APEvl~~~~~~~~~~~Di~SlGvil~el~~~~~~~y~~~~DIWSlGvilyemlt-G~ 595 (966)
++...... ....++..|+|||++.. ..++.++|||||||++|||++ |.
T Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~--------------------------~~~~~~~Dv~SlG~il~el~~~g~ 213 (273)
T cd05035 160 SKKIYSGDYYRQGRIAKMPVKWIAIESLAD--------------------------RVYTSKSDVWAFGVTMWEIATRGQ 213 (273)
T ss_pred eeeccccccccccccccCCccccCHhhccc--------------------------CCCCcccchHHHHHHHHHHHhCCC
Confidence 87543211 12234678999998742 236788999999999999999 89
Q ss_pred CCCCCCCCchhHHHHHHHHHcCCCCCCchhhccCCHHHHHHHHHhcccCccccCChHHHHHHh
Q psy11767 596 VPFHARSRDDSALSIMARIKEGQFNFDAEAWSTVSSEAKELTKSLLTVNPAQRIRMMRVKLTF 658 (966)
Q Consensus 596 ~Pf~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~is~e~~~Li~~~L~~dP~~R~t~~~v~~~~ 658 (966)
+||.+.... .+...+..+.... .....+.++.+++.+||+.||++||++.++...+
T Consensus 214 ~p~~~~~~~----~~~~~~~~~~~~~---~~~~~~~~~~~li~~~l~~~p~~Rp~~~e~~~~l 269 (273)
T cd05035 214 TPYPGVENH----EIYDYLRHGNRLK---QPEDCLDELYDLMYSCWRADPKDRPTFTKLREVL 269 (273)
T ss_pred CCCCCCCHH----HHHHHHHcCCCCC---CCcCCCHHHHHHHHHHcCCChhhCcCHHHHHHHH
Confidence 999765432 3344444443221 2235789999999999999999999999885544
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu |
| >cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-35 Score=318.54 Aligned_cols=244 Identities=27% Similarity=0.440 Sum_probs=197.1
Q ss_pred ccccccccccccEEEEEEEcCCCcEEEEEEecccc--------ChHHHHHHHHHhcCCCCceEEEEEEEeCCeEEEEEEc
Q psy11767 381 DKAGILGDGSYSVCRRCVEKSTGQEYAVKIISRKI--------DCSEEINLLRACQGHPNIVNLHCVFQDEVHTYLVLEL 452 (966)
Q Consensus 381 ~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~--------~~~~Ei~iL~~l~~HpnIV~l~~~~~~~~~~~lVmEy 452 (966)
+..+.||+|+||.||+|.+..+|+.||||.+.... ...+|+.+++.+ +||||++++++|.+++..++||||
T Consensus 5 ~~~~~ig~g~~g~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~-~h~~i~~~~~~~~~~~~~~~v~e~ 83 (267)
T cd08229 5 RIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQL-NHPNVIKYYASFIEDNELNIVLEL 83 (267)
T ss_pred hhhhhhcccCCeEEEEEeecCCCceEEEEeeeehhhhhHHHHHHHHHHHHHHHHc-cCCchhhhhheeEeCCeEEEEEEe
Confidence 34678999999999999999999999999875421 234688999888 599999999999999999999999
Q ss_pred cCCCCHHHHHHhc--CCCCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCcEEEecCCCCCEEEEeecccccccCC--
Q psy11767 453 LKGGELLDRIRQK--GRCGFTENEASRIMRQLVAAVHFMHSRGVVHRDLKPENLLFSDPAGDNIKVVDFGFACLKRES-- 528 (966)
Q Consensus 453 ~~gg~L~~~l~~~--~~~~l~e~~~~~i~~Qil~aL~yLHs~~IiHRDLKP~NILl~~~~~~~iKL~DFGla~~~~~~-- 528 (966)
+++++|.+++... ....+++..+..++.||+.||.|||++||+|+||||+||+++. ++.++|+|||++......
T Consensus 84 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~p~nili~~--~~~~~l~dfg~~~~~~~~~~ 161 (267)
T cd08229 84 ADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMHSRRVMHRDIKPANVFITA--TGVVKLGDLGLGRFFSSKTT 161 (267)
T ss_pred cCCCCHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcC--CCCEEECcchhhhccccCCc
Confidence 9999999988642 2235899999999999999999999999999999999999975 568999999998654322
Q ss_pred -CccccccccccCchhhccCCCCCCCcccchhhhhhhhhhhhcCCCCCCCcCcchhHHHHHHHHhcCCCCCCCCCCchhH
Q psy11767 529 -LHTPCFTLQYAAPEVLRQDKSGYDENCDLWSLGVILVNVLRQDKSGYDENCDLWSLGVILYTMLCGRVPFHARSRDDSA 607 (966)
Q Consensus 529 -~~~~~gT~~Y~APEvl~~~~~~~~~~~Di~SlGvil~el~~~~~~~y~~~~DIWSlGvilyemltG~~Pf~~~~~~~~~ 607 (966)
.....++..|+|||++.. ..++.++|+|||||++|+|++|..||.+.... .
T Consensus 162 ~~~~~~~~~~~~ape~~~~--------------------------~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~--~ 213 (267)
T cd08229 162 AAHSLVGTPYYMSPERIHE--------------------------NGYNFKSDIWSLGCLLYEMAALQSPFYGDKMN--L 213 (267)
T ss_pred ccccccCCcCccCHHHhcC--------------------------CCccchhhHHHHHHHHHHHHhCCCCcccccch--H
Confidence 224468899999998852 23567899999999999999999999764432 1
Q ss_pred HHHHHHHHcCCCCCCchhhccCCHHHHHHHHHhcccCccccCChHHHHHH
Q psy11767 608 LSIMARIKEGQFNFDAEAWSTVSSEAKELTKSLLTVNPAQRIRMMRVKLT 657 (966)
Q Consensus 608 ~~~~~~i~~~~~~~~~~~~~~is~e~~~Li~~~L~~dP~~R~t~~~v~~~ 657 (966)
......+....+. +..+...++++++++.+||..||++|||+.++...
T Consensus 214 ~~~~~~~~~~~~~--~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~i~~~ 261 (267)
T cd08229 214 YSLCKKIEQCDYP--PLPSDHYSEELRQLVNMCINPDPEKRPDITYVYDV 261 (267)
T ss_pred HHHhhhhhcCCCC--CCCcccccHHHHHHHHHhcCCCcccCCCHHHHHHH
Confidence 2333444443322 22234578899999999999999999999977443
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. |
| >cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-35 Score=319.89 Aligned_cols=252 Identities=24% Similarity=0.410 Sum_probs=194.7
Q ss_pred cccccccccccccEEEEEEEcCCCcEEEEEEeccccC------hHHHHHHHHHhcCCCCceEEEEEEEeCCeEEEEEEcc
Q psy11767 380 LDKAGILGDGSYSVCRRCVEKSTGQEYAVKIISRKID------CSEEINLLRACQGHPNIVNLHCVFQDEVHTYLVLELL 453 (966)
Q Consensus 380 ~~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~~------~~~Ei~iL~~l~~HpnIV~l~~~~~~~~~~~lVmEy~ 453 (966)
|+..+.||+|+||.||+|.+..+|+.||||++..... ...|+.++.+..+||||+++++++..+...|+||||+
T Consensus 3 ~~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~iv~~~~~~~~~~~~~lv~e~~ 82 (283)
T cd06617 3 LEVIEELGRGAYGVVDKMRHVPTGTIMAVKRIRATVNSQEQKRLLMDLDISMRSVDCPYTVTFYGALFREGDVWICMEVM 82 (283)
T ss_pred ceEEEEecccCCeEEEEEEEcCCCcEEEEEEEecCCCcHHHHHHHHHHHHHHHHcCCCCeeeeeEEEecCCcEEEEhhhh
Confidence 4456889999999999999999999999999875432 2335555455558999999999999999999999999
Q ss_pred CCCCHHHHHHhc--CCCCCCHHHHHHHHHHHHHHHHHHHhc-CceeccCCCCcEEEecCCCCCEEEEeecccccccCC--
Q psy11767 454 KGGELLDRIRQK--GRCGFTENEASRIMRQLVAAVHFMHSR-GVVHRDLKPENLLFSDPAGDNIKVVDFGFACLKRES-- 528 (966)
Q Consensus 454 ~gg~L~~~l~~~--~~~~l~e~~~~~i~~Qil~aL~yLHs~-~IiHRDLKP~NILl~~~~~~~iKL~DFGla~~~~~~-- 528 (966)
+ |+|.+++... ....+++..++.++.||+.||+|||++ +++||||||+|||++. ++.+||+|||++......
T Consensus 83 ~-~~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~i~h~dlkp~nil~~~--~~~~kl~dfg~~~~~~~~~~ 159 (283)
T cd06617 83 D-TSLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLHSKLSVIHRDVKPSNVLINR--NGQVKLCDFGISGYLVDSVA 159 (283)
T ss_pred c-ccHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhcCCeecCCCCHHHEEECC--CCCEEEeecccccccccccc
Confidence 6 6888777542 223689999999999999999999997 9999999999999975 568999999998754332
Q ss_pred CccccccccccCchhhccCCCCCCCcccchhhhhhhhhhhhcCCCCCCCcCcchhHHHHHHHHhcCCCCCCCCCCchhHH
Q psy11767 529 LHTPCFTLQYAAPEVLRQDKSGYDENCDLWSLGVILVNVLRQDKSGYDENCDLWSLGVILYTMLCGRVPFHARSRDDSAL 608 (966)
Q Consensus 529 ~~~~~gT~~Y~APEvl~~~~~~~~~~~Di~SlGvil~el~~~~~~~y~~~~DIWSlGvilyemltG~~Pf~~~~~~~~~~ 608 (966)
.....++..|+|||++.... ....++.++|+||+||++|+|++|+.||...... .
T Consensus 160 ~~~~~~~~~y~aPE~~~~~~----------------------~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~---~ 214 (283)
T cd06617 160 KTIDAGCKPYMAPERINPEL----------------------NQKGYDVKSDVWSLGITMIELATGRFPYDSWKTP---F 214 (283)
T ss_pred cccccCCccccChhhcCCcc----------------------cccccCccccchhhHHHHHHHHhCCCCCCccccC---H
Confidence 12245788999999875311 1245778999999999999999999999753321 1
Q ss_pred HHHHHHHcC-CCCCCchhhccCCHHHHHHHHHhcccCccccCChHHHHHHhhhhHHh
Q psy11767 609 SIMARIKEG-QFNFDAEAWSTVSSEAKELTKSLLTVNPAQRIRMMRVKLTFHAFHQA 664 (966)
Q Consensus 609 ~~~~~i~~~-~~~~~~~~~~~is~e~~~Li~~~L~~dP~~R~t~~~v~~~~~~~~~~ 664 (966)
..+..+..+ ...++. ..+|.++.++|.+||..+|++||++.++ ..|+|+..
T Consensus 215 ~~~~~~~~~~~~~~~~---~~~~~~l~~li~~~l~~~p~~Rp~~~~i--l~~~~~~~ 266 (283)
T cd06617 215 QQLKQVVEEPSPQLPA---EKFSPEFQDFVNKCLKKNYKERPNYPEL--LQHPFFEL 266 (283)
T ss_pred HHHHHHHhcCCCCCCc---cccCHHHHHHHHHHccCChhhCcCHHHH--hcCchhhh
Confidence 122222222 222211 2478999999999999999999999876 34666543
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs |
| >cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-35 Score=324.18 Aligned_cols=244 Identities=25% Similarity=0.421 Sum_probs=196.3
Q ss_pred ccccccccccccEEEEEEEcCCCcEEEEEEecccc-----ChHHHHHHHHHhcCCCCceEEEEEEEeCCeEEEEEEccCC
Q psy11767 381 DKAGILGDGSYSVCRRCVEKSTGQEYAVKIISRKI-----DCSEEINLLRACQGHPNIVNLHCVFQDEVHTYLVLELLKG 455 (966)
Q Consensus 381 ~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~-----~~~~Ei~iL~~l~~HpnIV~l~~~~~~~~~~~lVmEy~~g 455 (966)
+..+.||+|+||.||+|++..+++.||+|.+.... ...+|+.+++.+ +||||+++++.|.++.+.|+||||++|
T Consensus 23 ~~~~~lg~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~e~~~l~~~-~h~~v~~~~~~~~~~~~~~lv~e~~~~ 101 (296)
T cd06654 23 TRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMREN-KNPNIVNYLDSYLVGDELWVVMEYLAG 101 (296)
T ss_pred eeEEEecCCCCeEEEEEEECCCCcEEEEEEEecCCcchHHHHHHHHHHHHhC-CCCCEeeEEEEEEeCCEEEEeecccCC
Confidence 33678999999999999999999999999986543 234688888887 699999999999999999999999999
Q ss_pred CCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCcEEEecCCCCCEEEEeecccccccCC---Cccc
Q psy11767 456 GELLDRIRQKGRCGFTENEASRIMRQLVAAVHFMHSRGVVHRDLKPENLLFSDPAGDNIKVVDFGFACLKRES---LHTP 532 (966)
Q Consensus 456 g~L~~~l~~~~~~~l~e~~~~~i~~Qil~aL~yLHs~~IiHRDLKP~NILl~~~~~~~iKL~DFGla~~~~~~---~~~~ 532 (966)
++|.+++.+. .+++.++..++.|++.||+|||+.||+||||||+|||++. ++.+||+|||++...... ....
T Consensus 102 ~~L~~~~~~~---~~~~~~~~~i~~ql~~aL~~LH~~gi~H~dLkp~Nill~~--~~~~kl~dfg~~~~~~~~~~~~~~~ 176 (296)
T cd06654 102 GSLTDVVTET---CMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGM--DGSVKLTDFGFCAQITPEQSKRSTM 176 (296)
T ss_pred CCHHHHHHhc---CCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEcC--CCCEEECccccchhccccccccCcc
Confidence 9999998653 4899999999999999999999999999999999999975 568999999998653321 2234
Q ss_pred cccccccCchhhccCCCCCCCcccchhhhhhhhhhhhcCCCCCCCcCcchhHHHHHHHHhcCCCCCCCCCCchhHHHHHH
Q psy11767 533 CFTLQYAAPEVLRQDKSGYDENCDLWSLGVILVNVLRQDKSGYDENCDLWSLGVILYTMLCGRVPFHARSRDDSALSIMA 612 (966)
Q Consensus 533 ~gT~~Y~APEvl~~~~~~~~~~~Di~SlGvil~el~~~~~~~y~~~~DIWSlGvilyemltG~~Pf~~~~~~~~~~~~~~ 612 (966)
.+++.|+|||.+.. ..++.++|||||||++|+|++|+.||........ ...
T Consensus 177 ~~~~~y~aPE~~~~--------------------------~~~~~~~Dv~s~Gvil~~l~~g~~pf~~~~~~~~---~~~ 227 (296)
T cd06654 177 VGTPYWMAPEVVTR--------------------------KAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRA---LYL 227 (296)
T ss_pred cCCccccCHHHHcC--------------------------CCCCccchHHHHHHHHHHHHhCCCCCCCCCHHHh---HHH
Confidence 67899999998752 2356789999999999999999999986543221 112
Q ss_pred HHHcCCCCCCchhhccCCHHHHHHHHHhcccCccccCChHHHHHHhhhhHH
Q psy11767 613 RIKEGQFNFDAEAWSTVSSEAKELTKSLLTVNPAQRIRMMRVKLTFHAFHQ 663 (966)
Q Consensus 613 ~i~~~~~~~~~~~~~~is~e~~~Li~~~L~~dP~~R~t~~~v~~~~~~~~~ 663 (966)
....+.... .....++..+.+++.+||..||++||++.++. .++|..
T Consensus 228 ~~~~~~~~~--~~~~~~~~~l~~li~~~l~~~p~~Rpt~~eil--~~~~~~ 274 (296)
T cd06654 228 IATNGTPEL--QNPEKLSAIFRDFLNRCLDMDVEKRGSAKELL--QHQFLK 274 (296)
T ss_pred HhcCCCCCC--CCccccCHHHHHHHHHHCcCCcccCcCHHHHh--hChhhh
Confidence 222222111 12245788999999999999999999998763 355543
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-35 Score=320.54 Aligned_cols=240 Identities=19% Similarity=0.348 Sum_probs=189.7
Q ss_pred ccccccccccccEEEEEEEcC-----CCcEEEEEEeccccC------hHHHHHHHHHhcCCCCceEEEEEEEeCCeEEEE
Q psy11767 381 DKAGILGDGSYSVCRRCVEKS-----TGQEYAVKIISRKID------CSEEINLLRACQGHPNIVNLHCVFQDEVHTYLV 449 (966)
Q Consensus 381 ~~~~~LG~G~fG~Vy~a~~~~-----tg~~vAvK~i~~~~~------~~~Ei~iL~~l~~HpnIV~l~~~~~~~~~~~lV 449 (966)
+..+.||+|+||.||+|.+.. ++..||||.+..... ..+|+.+++.+ +||||+++++++.++...++|
T Consensus 9 ~~~~~ig~G~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l-~~~~iv~~~~~~~~~~~~~lv 87 (277)
T cd05062 9 TMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEF-NCHHVVRLLGVVSQGQPTLVI 87 (277)
T ss_pred eeeeeeccccCCeEEEEEeccCCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhC-CCCCeeeEEEEEcCCCCeEEE
Confidence 335789999999999998752 457899999864322 34688888887 599999999999999999999
Q ss_pred EEccCCCCHHHHHHhcCC--------CCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCcEEEecCCCCCEEEEeecc
Q psy11767 450 LELLKGGELLDRIRQKGR--------CGFTENEASRIMRQLVAAVHFMHSRGVVHRDLKPENLLFSDPAGDNIKVVDFGF 521 (966)
Q Consensus 450 mEy~~gg~L~~~l~~~~~--------~~l~e~~~~~i~~Qil~aL~yLHs~~IiHRDLKP~NILl~~~~~~~iKL~DFGl 521 (966)
|||+++|+|.+++..... ..+++..+..++.|++.||+|||+.|++||||||+|||+++ ++.+||+|||+
T Consensus 88 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~vH~dlkp~Nil~~~--~~~~~l~dfg~ 165 (277)
T cd05062 88 MELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAE--DFTVKIGDFGM 165 (277)
T ss_pred EecCCCCCHHHHHHHcCccccccccccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCcchheEEEcC--CCCEEECCCCC
Confidence 999999999999975321 23678889999999999999999999999999999999985 56899999999
Q ss_pred cccccCC-----CccccccccccCchhhccCCCCCCCcccchhhhhhhhhhhhcCCCCCCCcCcchhHHHHHHHHhc-CC
Q psy11767 522 ACLKRES-----LHTPCFTLQYAAPEVLRQDKSGYDENCDLWSLGVILVNVLRQDKSGYDENCDLWSLGVILYTMLC-GR 595 (966)
Q Consensus 522 a~~~~~~-----~~~~~gT~~Y~APEvl~~~~~~~~~~~Di~SlGvil~el~~~~~~~y~~~~DIWSlGvilyemlt-G~ 595 (966)
+...... .....+++.|+|||++.. ..++.++|||||||++|+|++ |.
T Consensus 166 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~--------------------------~~~~~~~Di~slG~~l~el~~~~~ 219 (277)
T cd05062 166 TRDIYETDYYRKGGKGLLPVRWMSPESLKD--------------------------GVFTTYSDVWSFGVVLWEIATLAE 219 (277)
T ss_pred ccccCCcceeecCCCCccCHhhcChhHhhc--------------------------CCcCchhHHHHHHHHHHHHHcCCC
Confidence 8643221 112345778999998852 236788999999999999998 78
Q ss_pred CCCCCCCCchhHHHHHHHHHcCCCCCCchhhccCCHHHHHHHHHhcccCccccCChHHHHH
Q psy11767 596 VPFHARSRDDSALSIMARIKEGQFNFDAEAWSTVSSEAKELTKSLLTVNPAQRIRMMRVKL 656 (966)
Q Consensus 596 ~Pf~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~is~e~~~Li~~~L~~dP~~R~t~~~v~~ 656 (966)
.||.+.... .....+..+..... ...++.++.+++.+||+.||++|||+.++..
T Consensus 220 ~p~~~~~~~----~~~~~~~~~~~~~~---~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~ 273 (277)
T cd05062 220 QPYQGMSNE----QVLRFVMEGGLLDK---PDNCPDMLFELMRMCWQYNPKMRPSFLEIIS 273 (277)
T ss_pred CCCCCCCHH----HHHHHHHcCCcCCC---CCCCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 999765432 23333334332211 2356889999999999999999999998743
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh |
| >KOG0662|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-36 Score=294.19 Aligned_cols=245 Identities=30% Similarity=0.478 Sum_probs=198.8
Q ss_pred cccccccccccccEEEEEEEcCCCcEEEEEEecccc-------ChHHHHHHHHHhcCCCCceEEEEEEEeCCeEEEEEEc
Q psy11767 380 LDKAGILGDGSYSVCRRCVEKSTGQEYAVKIISRKI-------DCSEEINLLRACQGHPNIVNLHCVFQDEVHTYLVLEL 452 (966)
Q Consensus 380 ~~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~-------~~~~Ei~iL~~l~~HpnIV~l~~~~~~~~~~~lVmEy 452 (966)
+++.++||+|+||+|++|+++.+++.||+|.+.... .+.+||.+|+.+. |.|||+|+++...+..+-+|+||
T Consensus 4 ydkmekigegtygtvfkarn~~t~eivalkrvrlddddegvpssalreicllkelk-hknivrl~dvlhsdkkltlvfe~ 82 (292)
T KOG0662|consen 4 YDKMEKIGEGTYGTVFKARNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELK-HKNIVRLHDVLHSDKKLTLVFEF 82 (292)
T ss_pred hHHHHhhcCCcceeeEecccCCccceEEEEEEeccCCCCCCcHHHHHHHHHHHHhh-hcceeehhhhhccCceeEEeHHH
Confidence 445788999999999999999999999999987543 2568999999995 99999999999999999999999
Q ss_pred cCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCcEEEecCCCCCEEEEeecccccccCCC---
Q psy11767 453 LKGGELLDRIRQKGRCGFTENEASRIMRQLVAAVHFMHSRGVVHRDLKPENLLFSDPAGDNIKVVDFGFACLKRESL--- 529 (966)
Q Consensus 453 ~~gg~L~~~l~~~~~~~l~e~~~~~i~~Qil~aL~yLHs~~IiHRDLKP~NILl~~~~~~~iKL~DFGla~~~~~~~--- 529 (966)
| ..+|..+....++ .++.+.++.++.|++.||.|||+++++||||||.|+||.. +|.+||+|||+|+-++-+.
T Consensus 83 c-dqdlkkyfdslng-~~d~~~~rsfmlqllrgl~fchshnvlhrdlkpqnllin~--ngelkladfglarafgipvrcy 158 (292)
T KOG0662|consen 83 C-DQDLKKYFDSLNG-DLDPEIVRSFMLQLLRGLGFCHSHNVLHRDLKPQNLLINR--NGELKLADFGLARAFGIPVRCY 158 (292)
T ss_pred h-hHHHHHHHHhcCC-cCCHHHHHHHHHHHHhhhhhhhhhhhhhccCCcceEEecc--CCcEEecccchhhhcCCceEee
Confidence 9 4688888776553 5899999999999999999999999999999999999974 6799999999998765443
Q ss_pred ccccccccccCchhhccCCCCCCCcccchhhhhhhhhhhhcCCCCCCCcCcchhHHHHHHHHhc-CCCCCCCCCCchhHH
Q psy11767 530 HTPCFTLQYAAPEVLRQDKSGYDENCDLWSLGVILVNVLRQDKSGYDENCDLWSLGVILYTMLC-GRVPFHARSRDDSAL 608 (966)
Q Consensus 530 ~~~~gT~~Y~APEvl~~~~~~~~~~~Di~SlGvil~el~~~~~~~y~~~~DIWSlGvilyemlt-G~~Pf~~~~~~~~~~ 608 (966)
...+.|.+|++|.++.+ ..-|+++.|+||.|||+.|+.. |++-|.+.+-+++..
T Consensus 159 saevvtlwyrppdvlfg-------------------------akly~tsidmwsagcifaelanagrplfpg~dvddqlk 213 (292)
T KOG0662|consen 159 SAEVVTLWYRPPDVLFG-------------------------AKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLK 213 (292)
T ss_pred eceeeeeeccCcceeee-------------------------eehhccchHhhhcchHHHHHhhcCCCCCCCCcHHHHHH
Confidence 23456999999999853 2348899999999999999985 788888877666555
Q ss_pred HHHHHHHc---CCCC-------------CC-chhh----ccCCHHHHHHHHHhcccCccccCChHHH
Q psy11767 609 SIMARIKE---GQFN-------------FD-AEAW----STVSSEAKELTKSLLTVNPAQRIRMMRV 654 (966)
Q Consensus 609 ~~~~~i~~---~~~~-------------~~-~~~~----~~is~e~~~Li~~~L~~dP~~R~t~~~v 654 (966)
.++..+.. .++. ++ ...| +.++...+||++++|..+|.+|+++.+.
T Consensus 214 rif~~lg~p~ed~wps~t~lpdyk~yp~ypattswsqivp~lns~grdllqkll~cnp~qrisaeaa 280 (292)
T KOG0662|consen 214 RIFRLLGTPTEDQWPSMTKLPDYKPYPIYPATTSWSQIVPKLNSTGRDLLQKLLKCNPAQRISAEAA 280 (292)
T ss_pred HHHHHhCCCccccCCccccCCCCcccCCccccchHHHHhhhhcchhHHHHHHHhccCcccccCHHHH
Confidence 45443321 1111 00 0112 3456778899999999999999998753
|
|
| >cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-35 Score=322.79 Aligned_cols=249 Identities=31% Similarity=0.525 Sum_probs=196.7
Q ss_pred ccccccccccccEEEEEEEcCCCcEEEEEEecccc-------ChHHHHHHHHHhcCCCCceEEEEEEEeCCeEEEEEEcc
Q psy11767 381 DKAGILGDGSYSVCRRCVEKSTGQEYAVKIISRKI-------DCSEEINLLRACQGHPNIVNLHCVFQDEVHTYLVLELL 453 (966)
Q Consensus 381 ~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~-------~~~~Ei~iL~~l~~HpnIV~l~~~~~~~~~~~lVmEy~ 453 (966)
+..+.||+|+||.||+|.+..+|+.||||++.... ...+|+.+++.+. ||||+++++++.++...|+||||+
T Consensus 3 ~~~~~l~~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~~~-~~~i~~~~~~~~~~~~~~~v~e~~ 81 (286)
T cd07832 3 KILGRIGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQ-HPYVVKLLDVFPHGSGFVLVMEYM 81 (286)
T ss_pred eEEeecccCCCcEEEEEEECCCCceEEEEEEEcccccchhhHHHHHHHHHHHhCC-CCCCcceeeEEecCCeeEEEeccc
Confidence 34678999999999999999999999999986543 2456899999885 999999999999999999999999
Q ss_pred CCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCcEEEecCCCCCEEEEeecccccccCC----C
Q psy11767 454 KGGELLDRIRQKGRCGFTENEASRIMRQLVAAVHFMHSRGVVHRDLKPENLLFSDPAGDNIKVVDFGFACLKRES----L 529 (966)
Q Consensus 454 ~gg~L~~~l~~~~~~~l~e~~~~~i~~Qil~aL~yLHs~~IiHRDLKP~NILl~~~~~~~iKL~DFGla~~~~~~----~ 529 (966)
+++|.+++.... ..+++.+++.++.||+.||+|||+.||+|+||||+||+++. .+.++|+|||++...... .
T Consensus 82 -~~~L~~~~~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~ni~~~~--~~~~~l~dfg~~~~~~~~~~~~~ 157 (286)
T cd07832 82 -PSDLSEVLRDEE-RPLPEAQVKSYMRMLLKGVAYMHANGIMHRDLKPANLLISA--DGVLKIADFGLARLFSEEEPRLY 157 (286)
T ss_pred -CCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCcCHHHEEEcC--CCcEEEeeeeecccccCCCCCcc
Confidence 999999987654 36999999999999999999999999999999999999985 568999999998765432 2
Q ss_pred ccccccccccCchhhccCCCCCCCcccchhhhhhhhhhhhcCCCCCCCcCcchhHHHHHHHHhcCCCCCCCCCCchhHHH
Q psy11767 530 HTPCFTLQYAAPEVLRQDKSGYDENCDLWSLGVILVNVLRQDKSGYDENCDLWSLGVILYTMLCGRVPFHARSRDDSALS 609 (966)
Q Consensus 530 ~~~~gT~~Y~APEvl~~~~~~~~~~~Di~SlGvil~el~~~~~~~y~~~~DIWSlGvilyemltG~~Pf~~~~~~~~~~~ 609 (966)
....++..|+|||++.. ...++.++||||+||++|+|++|.+||.+.........
T Consensus 158 ~~~~~~~~y~aPE~~~~-------------------------~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~~~ 212 (286)
T cd07832 158 SHQVATRWYRAPELLYG-------------------------ARKYDPGVDLWAVGCIFAELLNGSPLFPGENDIEQLAI 212 (286)
T ss_pred ccccCcccccCceeeec-------------------------cccCCchhHHHHHHHHHHHHHcCCcCcCCCCHHHHHHH
Confidence 34567899999998742 22357789999999999999999988876553322222
Q ss_pred HHHHHHcC---------------CCCCC-------chhhccCCHHHHHHHHHhcccCccccCChHHHHHHhhhh
Q psy11767 610 IMARIKEG---------------QFNFD-------AEAWSTVSSEAKELTKSLLTVNPAQRIRMMRVKLTFHAF 661 (966)
Q Consensus 610 ~~~~i~~~---------------~~~~~-------~~~~~~is~e~~~Li~~~L~~dP~~R~t~~~v~~~~~~~ 661 (966)
++..+... ...+. ....+..+.++.+||++||..||++|||+.++ ..|+|
T Consensus 213 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~--l~h~~ 284 (286)
T cd07832 213 VFRTLGTPNEETWPGLTSLPDYNKITFPESKPIPLEEIFPDASPEALDLLKGLLVYDPSKRLSAAEA--LRHPY 284 (286)
T ss_pred HHHHcCCCChHHHhhccCcchhhcccCCCCCcchHHHhCCCccHHHHHHHHHHhccChhhCCCHHHH--hhCcC
Confidence 22111100 00000 11224567899999999999999999999876 33444
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea |
| >KOG4645|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-37 Score=370.02 Aligned_cols=247 Identities=27% Similarity=0.422 Sum_probs=206.9
Q ss_pred cccccccccccccccccccEEEEEEEcCCCcEEEEEEeccc-------cChHHHHHHHHHhcCCCCceEEEEEEEeCCeE
Q psy11767 374 EQYDMDLDKAGILGDGSYSVCRRCVEKSTGQEYAVKIISRK-------IDCSEEINLLRACQGHPNIVNLHCVFQDEVHT 446 (966)
Q Consensus 374 ~~~~i~~~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~-------~~~~~Ei~iL~~l~~HpnIV~l~~~~~~~~~~ 446 (966)
....+.++....||.|.||.||-|.+..||...|+|-+.-. ....+|.++|..+ +|||+|++|++-.+....
T Consensus 1231 snV~~rWqrg~~Ig~G~fG~VYtavN~~tGellAvKEI~iq~~~~k~~~~i~eEm~vlE~l-nHpNlV~YyGVEvHRekv 1309 (1509)
T KOG4645|consen 1231 SNVTFRWQRGNFIGGGTFGKVYTAVNLDTGELLAVKEIKIQDSDHKTFKLIAEEMKVLEGL-NHPNLVRYYGVEVHREKV 1309 (1509)
T ss_pred ccceeeeccccccCCcceeeeEEeecCCccchhhhhhhhcCccccccCcchHHHHHHHHhc-cCccccccCceeecHHHH
Confidence 33445566677899999999999999999999999987532 1256799999888 599999999999999999
Q ss_pred EEEEEccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCcEEEecCCCCCEEEEeeccccccc
Q psy11767 447 YLVLELLKGGELLDRIRQKGRCGFTENEASRIMRQLVAAVHFMHSRGVVHRDLKPENLLFSDPAGDNIKVVDFGFACLKR 526 (966)
Q Consensus 447 ~lVmEy~~gg~L~~~l~~~~~~~l~e~~~~~i~~Qil~aL~yLHs~~IiHRDLKP~NILl~~~~~~~iKL~DFGla~~~~ 526 (966)
+|-||||+||+|.+.+...+ -.+|...+.+..|++.|++|||+.|||||||||+||||+. +|.+|++|||.|....
T Consensus 1310 ~IFMEyC~~GsLa~ll~~gr--i~dE~vt~vyt~qll~gla~LH~~gIVHRDIK~aNI~Ld~--~g~iK~~DFGsa~ki~ 1385 (1509)
T KOG4645|consen 1310 YIFMEYCEGGSLASLLEHGR--IEDEMVTRVYTKQLLEGLAYLHEHGIVHRDIKPANILLDF--NGLIKYGDFGSAVKIK 1385 (1509)
T ss_pred HHHHHHhccCcHHHHHHhcc--hhhhhHHHHHHHHHHHHHHHHHhcCceecCCCccceeeec--CCcEEeecccceeEec
Confidence 99999999999999886533 4788889999999999999999999999999999999985 6699999999997654
Q ss_pred CCC-------ccccccccccCchhhccCCCCCCCcccchhhhhhhhhhhhcCCCCCCCcCcchhHHHHHHHHhcCCCCCC
Q psy11767 527 ESL-------HTPCFTLQYAAPEVLRQDKSGYDENCDLWSLGVILVNVLRQDKSGYDENCDLWSLGVILYTMLCGRVPFH 599 (966)
Q Consensus 527 ~~~-------~~~~gT~~Y~APEvl~~~~~~~~~~~Di~SlGvil~el~~~~~~~y~~~~DIWSlGvilyemltG~~Pf~ 599 (966)
... ....||+.|||||++...+ ..+...++||||||||+.||+||+.||.
T Consensus 1386 ~~~~~~~~el~~~~GT~~YMAPEvit~t~-----------------------~kG~~~A~DiWslGCVVlEM~tGkrPW~ 1442 (1509)
T KOG4645|consen 1386 NNAQTMPGELQSMMGTPMYMAPEVITGTK-----------------------GKGHGGAADIWSLGCVVLEMATGKRPWA 1442 (1509)
T ss_pred CchhcCCHHHHhhcCCchhcCchhhcccc-----------------------cCCCCcchhhhcccceEEEeecCCCchh
Confidence 332 3457899999999996432 2455678999999999999999999998
Q ss_pred CCCCchhHHHHHHHHHcCCCCCCchhhccCCHHHHHHHHHhcccCccccCChHHH
Q psy11767 600 ARSRDDSALSIMARIKEGQFNFDAEAWSTVSSEAKELTKSLLTVNPAQRIRMMRV 654 (966)
Q Consensus 600 ~~~~~~~~~~~~~~i~~~~~~~~~~~~~~is~e~~~Li~~~L~~dP~~R~t~~~v 654 (966)
..+. ..++|..+..|.-+--+ ..+|++.+|+|.+||+.||++|-++.++
T Consensus 1443 ~~dn---e~aIMy~V~~gh~Pq~P---~~ls~~g~dFle~Cl~~dP~~Rw~~~ql 1491 (1509)
T KOG4645|consen 1443 ELDN---EWAIMYHVAAGHKPQIP---ERLSSEGRDFLEHCLEQDPKMRWTASQL 1491 (1509)
T ss_pred hccc---hhHHHhHHhccCCCCCc---hhhhHhHHHHHHHHHhcCchhhhHHHHH
Confidence 6543 46788888887654333 3599999999999999999999777544
|
|
| >cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-35 Score=322.50 Aligned_cols=247 Identities=26% Similarity=0.402 Sum_probs=192.8
Q ss_pred ccccccccccccEEEEEEEcCCCcEEEEEEecccc----ChHHHHHHHHHhcCCCCceEEEEEEE-----eCCeEEEEEE
Q psy11767 381 DKAGILGDGSYSVCRRCVEKSTGQEYAVKIISRKI----DCSEEINLLRACQGHPNIVNLHCVFQ-----DEVHTYLVLE 451 (966)
Q Consensus 381 ~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~----~~~~Ei~iL~~l~~HpnIV~l~~~~~-----~~~~~~lVmE 451 (966)
+..+.||+|+||+||+|.+..+++.||+|++.... ...+|+.+++.+.+||||+++++++. ++...|+|||
T Consensus 21 ~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~~~~lv~e 100 (286)
T cd06638 21 EIIETIGKGTYGKVFKVLNKKNGSKAAVKILDPIHDIDEEIEAEYNILKALSDHPNVVKFYGMYYKKDVKNGDQLWLVLE 100 (286)
T ss_pred eeeeeeccCCCcEEEEEEECCCCceeEEEeeccccchHHHHHHHHHHHHHHhcCCCeeeeeeeeeecccCCCCeEEEEEe
Confidence 34678999999999999999999999999986532 24468899998877999999999874 4467899999
Q ss_pred ccCCCCHHHHHHhc--CCCCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCcEEEecCCCCCEEEEeecccccccC--
Q psy11767 452 LLKGGELLDRIRQK--GRCGFTENEASRIMRQLVAAVHFMHSRGVVHRDLKPENLLFSDPAGDNIKVVDFGFACLKRE-- 527 (966)
Q Consensus 452 y~~gg~L~~~l~~~--~~~~l~e~~~~~i~~Qil~aL~yLHs~~IiHRDLKP~NILl~~~~~~~iKL~DFGla~~~~~-- 527 (966)
|++|++|.+++... ....+++..+..++.|++.||.|||+.+|+||||||+||++++ .+.+||+|||++.....
T Consensus 101 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nili~~--~~~~kl~dfg~~~~~~~~~ 178 (286)
T cd06638 101 LCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGLQHLHVNKTIHRDVKGNNILLTT--EGGVKLVDFGVSAQLTSTR 178 (286)
T ss_pred ecCCCCHHHHHHHhhccCccccHHHHHHHHHHHHHHHHHHHhCCccccCCCHHhEEECC--CCCEEEccCCceeecccCC
Confidence 99999999987642 2235899999999999999999999999999999999999985 45799999999865432
Q ss_pred -CCccccccccccCchhhccCCCCCCCcccchhhhhhhhhhhhcCCCCCCCcCcchhHHHHHHHHhcCCCCCCCCCCchh
Q psy11767 528 -SLHTPCFTLQYAAPEVLRQDKSGYDENCDLWSLGVILVNVLRQDKSGYDENCDLWSLGVILYTMLCGRVPFHARSRDDS 606 (966)
Q Consensus 528 -~~~~~~gT~~Y~APEvl~~~~~~~~~~~Di~SlGvil~el~~~~~~~y~~~~DIWSlGvilyemltG~~Pf~~~~~~~~ 606 (966)
......+++.|+|||++.... .....|+.++||||+||++|+|++|+.||.......
T Consensus 179 ~~~~~~~~~~~y~aPE~~~~~~---------------------~~~~~~~~~~Dv~slGvi~~el~~g~~p~~~~~~~~- 236 (286)
T cd06638 179 LRRNTSVGTPFWMAPEVIACEQ---------------------QLDSTYDARCDVWSLGITAIELGDGDPPLADLHPMR- 236 (286)
T ss_pred CccccccCCCcccChhhhchhh---------------------hccccccchhhhhhHHHHHHHHhcCCCCCCCCchhH-
Confidence 123446899999999985321 012347889999999999999999999997654322
Q ss_pred HHHHHHHHHcCCCCCCchhhccCCHHHHHHHHHhcccCccccCChHHHH
Q psy11767 607 ALSIMARIKEGQFNFDAEAWSTVSSEAKELTKSLLTVNPAQRIRMMRVK 655 (966)
Q Consensus 607 ~~~~~~~i~~~~~~~~~~~~~~is~e~~~Li~~~L~~dP~~R~t~~~v~ 655 (966)
.+..+..+... ........+.++.+||.+||..||++|||+.++.
T Consensus 237 ---~~~~~~~~~~~-~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell 281 (286)
T cd06638 237 ---ALFKIPRNPPP-TLHQPELWSNEFNDFIRKCLTKDYEKRPTVSDLL 281 (286)
T ss_pred ---HHhhccccCCC-cccCCCCcCHHHHHHHHHHccCCcccCCCHHHHh
Confidence 11122221111 1011123578899999999999999999998873
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear |
| >KOG0193|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-36 Score=341.02 Aligned_cols=240 Identities=23% Similarity=0.433 Sum_probs=198.4
Q ss_pred cccccccccccEEEEEEEcCCCcEEEEEEecccc-------ChHHHHHHHHHhcCCCCceEEEEEEEeCCeEEEEEEccC
Q psy11767 382 KAGILGDGSYSVCRRCVEKSTGQEYAVKIISRKI-------DCSEEINLLRACQGHPNIVNLHCVFQDEVHTYLVLELLK 454 (966)
Q Consensus 382 ~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~-------~~~~Ei~iL~~l~~HpnIV~l~~~~~~~~~~~lVmEy~~ 454 (966)
....||+|+||+||+|++.. .||||++.-.. .+..|+.+|++-+ |.||+=+.+++..+.. .||.-+|+
T Consensus 396 l~~rIGsGsFGtV~Rg~whG---dVAVK~Lnv~~pt~~qlqaFKnEVa~lkkTR-H~NIlLFMG~~~~p~~-AIiTqwCe 470 (678)
T KOG0193|consen 396 LGERIGSGSFGTVYRGRWHG---DVAVKLLNVDDPTPEQLQAFKNEVAVLKKTR-HENILLFMGACMNPPL-AIITQWCE 470 (678)
T ss_pred ccceeccccccceeeccccc---ceEEEEEecCCCCHHHHHHHHHHHHHHhhcc-hhhheeeehhhcCCce-eeeehhcc
Confidence 45689999999999998764 59999997542 2567999999985 9999999999999887 99999999
Q ss_pred CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCcEEEecCCCCCEEEEeeccccccc-----CCC
Q psy11767 455 GGELLDRIRQKGRCGFTENEASRIMRQLVAAVHFMHSRGVVHRDLKPENLLFSDPAGDNIKVVDFGFACLKR-----ESL 529 (966)
Q Consensus 455 gg~L~~~l~~~~~~~l~e~~~~~i~~Qil~aL~yLHs~~IiHRDLKP~NILl~~~~~~~iKL~DFGla~~~~-----~~~ 529 (966)
|-+|+.+|+-.. ..|.....+.|++||+.|+.|||.++|||||||..||+|.+ ++.|||+||||+.... ...
T Consensus 471 GsSLY~hlHv~e-tkfdm~~~idIAqQiaqGM~YLHAK~IIHrDLKSnNIFl~~--~~kVkIgDFGLatvk~~w~g~~q~ 547 (678)
T KOG0193|consen 471 GSSLYTHLHVQE-TKFDMNTTIDIAQQIAQGMDYLHAKNIIHRDLKSNNIFLHE--DLKVKIGDFGLATVKTRWSGEQQL 547 (678)
T ss_pred Cchhhhhccchh-hhhhHHHHHHHHHHHHHhhhhhhhhhhhhhhccccceEEcc--CCcEEEecccceeeeeeecccccc
Confidence 999999997654 36999999999999999999999999999999999999975 4799999999996532 234
Q ss_pred ccccccccccCchhhccCCCCCCCcccchhhhhhhhhhhhcCCCCCCCcCcchhHHHHHHHHhcCCCCCCCCCCchhHHH
Q psy11767 530 HTPCFTLQYAAPEVLRQDKSGYDENCDLWSLGVILVNVLRQDKSGYDENCDLWSLGVILYTMLCGRVPFHARSRDDSALS 609 (966)
Q Consensus 530 ~~~~gT~~Y~APEvl~~~~~~~~~~~Di~SlGvil~el~~~~~~~y~~~~DIWSlGvilyemltG~~Pf~~~~~~~~~~~ 609 (966)
....|..-|||||+++.+ +..+|+..+||||||||+|||++|.+||.....+ +
T Consensus 548 ~qp~gsilwmAPEvIRmq-----------------------d~nPfS~qSDVYaFGiV~YELltg~lPysi~~~d----q 600 (678)
T KOG0193|consen 548 EQPHGSLLWMAPEVIRMQ-----------------------DDNPFSFQSDVYAFGIVWYELLTGELPYSIQNRD----Q 600 (678)
T ss_pred CCCccchhhhcHHHHhhc-----------------------ccCCCCcccchhhhhHHHHHHHhCcCCcCCCChh----h
Confidence 556788899999999743 3567999999999999999999999999843332 3
Q ss_pred HHHHHHcCCCCCCchh-hccCCHHHHHHHHHhcccCccccCChHHHHH
Q psy11767 610 IMARIKEGQFNFDAEA-WSTVSSEAKELTKSLLTVNPAQRIRMMRVKL 656 (966)
Q Consensus 610 ~~~~i~~~~~~~~~~~-~~~is~e~~~Li~~~L~~dP~~R~t~~~v~~ 656 (966)
++-.+.+|....+... ..+...++++|+..||.+++++||...++..
T Consensus 601 IifmVGrG~l~pd~s~~~s~~pk~mk~Ll~~C~~~~~~eRP~F~~il~ 648 (678)
T KOG0193|consen 601 IIFMVGRGYLMPDLSKIRSNCPKAMKRLLSDCWKFDREERPLFPQLLS 648 (678)
T ss_pred eEEEecccccCccchhhhccCHHHHHHHHHHHHhcCcccCccHHHHHH
Confidence 4445666654443322 2345569999999999999999999987744
|
|
| >cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-35 Score=322.91 Aligned_cols=255 Identities=24% Similarity=0.399 Sum_probs=202.5
Q ss_pred cccccccccccccEEEEEEEcCCCcEEEEEEecccc------ChHHHHHHHHHhcCCCCceEEEEEEEeCCeEEEEEEcc
Q psy11767 380 LDKAGILGDGSYSVCRRCVEKSTGQEYAVKIISRKI------DCSEEINLLRACQGHPNIVNLHCVFQDEVHTYLVLELL 453 (966)
Q Consensus 380 ~~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~------~~~~Ei~iL~~l~~HpnIV~l~~~~~~~~~~~lVmEy~ 453 (966)
|+.++.||+|+||.||+|.+..+|+.||+|.+.... ...+|+.+|+.+ +||||+++++++..++..|+||||+
T Consensus 3 ~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~~-~~~~i~~~~~~~~~~~~~~lv~e~~ 81 (286)
T cd06622 3 IEVLDELGKGNYGSVYKVLHRPTGVTMAMKEIRLELDESKFNQIIMELDILHKA-VSPYIVDFYGAFFIEGAVYMCMEYM 81 (286)
T ss_pred hhhhhhhcccCCeEEEEEEEcCCCcEEEEEEeecccCHHHHHHHHHHHHHHHhc-CCCcHHhhhhheecCCeEEEEEeec
Confidence 445789999999999999999999999999886432 234688999888 5999999999999999999999999
Q ss_pred CCCCHHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHHh-cCceeccCCCCcEEEecCCCCCEEEEeecccccccC-CCc
Q psy11767 454 KGGELLDRIRQKG-RCGFTENEASRIMRQLVAAVHFMHS-RGVVHRDLKPENLLFSDPAGDNIKVVDFGFACLKRE-SLH 530 (966)
Q Consensus 454 ~gg~L~~~l~~~~-~~~l~e~~~~~i~~Qil~aL~yLHs-~~IiHRDLKP~NILl~~~~~~~iKL~DFGla~~~~~-~~~ 530 (966)
++++|.+++.... ...+++..+..++.||+.||.|||+ .||+||||||+|||++. ++.+||+|||++..... ...
T Consensus 82 ~~~~l~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~i~H~dl~p~nil~~~--~~~~~l~dfg~~~~~~~~~~~ 159 (286)
T cd06622 82 DAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKEEHNIIHRDVKPTNVLVNG--NGQVKLCDFGVSGNLVASLAK 159 (286)
T ss_pred CCCCHHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCEeeCCCCHHHEEECC--CCCEEEeecCCcccccCCccc
Confidence 9999998886531 2258999999999999999999997 59999999999999985 56899999999865432 233
Q ss_pred cccccccccCchhhccCCCCCCCcccchhhhhhhhhhhhcCCCCCCCcCcchhHHHHHHHHhcCCCCCCCCCCchhHHHH
Q psy11767 531 TPCFTLQYAAPEVLRQDKSGYDENCDLWSLGVILVNVLRQDKSGYDENCDLWSLGVILYTMLCGRVPFHARSRDDSALSI 610 (966)
Q Consensus 531 ~~~gT~~Y~APEvl~~~~~~~~~~~Di~SlGvil~el~~~~~~~y~~~~DIWSlGvilyemltG~~Pf~~~~~~~~~~~~ 610 (966)
...+++.|+|||++...... ....++.++|+|||||++|+|++|+.||....... ....
T Consensus 160 ~~~~~~~y~aPE~~~~~~~~--------------------~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~-~~~~ 218 (286)
T cd06622 160 TNIGCQSYMAPERIKSGGPN--------------------QNPTYTVQSDVWSLGLSILEMALGRYPYPPETYAN-IFAQ 218 (286)
T ss_pred cCCCccCccCcchhcCCCCC--------------------ccCCCCcccchHhHHHHHHHHHhCCCCCCCcchhh-HHHH
Confidence 45678899999988532210 12346889999999999999999999997654322 2223
Q ss_pred HHHHHcCCCCCCchhhccCCHHHHHHHHHhcccCccccCChHHHHHHhhhhHH
Q psy11767 611 MARIKEGQFNFDAEAWSTVSSEAKELTKSLLTVNPAQRIRMMRVKLTFHAFHQ 663 (966)
Q Consensus 611 ~~~i~~~~~~~~~~~~~~is~e~~~Li~~~L~~dP~~R~t~~~v~~~~~~~~~ 663 (966)
+..+..+.. ...+..+++++.++|.+||..+|++||++.++. .|+|..
T Consensus 219 ~~~~~~~~~---~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~--~~~~~~ 266 (286)
T cd06622 219 LSAIVDGDP---PTLPSGYSDDAQDFVAKCLNKIPNRRPTYAQLL--EHPWLV 266 (286)
T ss_pred HHHHhhcCC---CCCCcccCHHHHHHHHHHcccCcccCCCHHHHh--cChhhh
Confidence 333433332 122345889999999999999999999998764 356653
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-35 Score=327.35 Aligned_cols=246 Identities=30% Similarity=0.513 Sum_probs=198.1
Q ss_pred cccccccccccccEEEEEEEcCCCcEEEEEEecccc--------ChHHHHHHHHHhcCCCCceEEEEEEEeCCeEEEEEE
Q psy11767 380 LDKAGILGDGSYSVCRRCVEKSTGQEYAVKIISRKI--------DCSEEINLLRACQGHPNIVNLHCVFQDEVHTYLVLE 451 (966)
Q Consensus 380 ~~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~--------~~~~Ei~iL~~l~~HpnIV~l~~~~~~~~~~~lVmE 451 (966)
|+..+.||+|+||.||+|.+..+++.||||.+.... ...+|+++|+.+ +||||+++++.+.+....|+|||
T Consensus 3 y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~~~~lv~e 81 (316)
T cd05574 3 FKKIKLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATL-DHPFLPTLYASFQTETYLCLVMD 81 (316)
T ss_pred eEEeeeecCCccEEEEEEEEcCCCcEEEEEEEeccccchHHHHHHHHHHHHHHHhC-CCCCchhheeeeecCCEEEEEEE
Confidence 445688999999999999999999999999987542 134588888888 49999999999999999999999
Q ss_pred ccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCcEEEecCCCCCEEEEeecccccccCC---
Q psy11767 452 LLKGGELLDRIRQKGRCGFTENEASRIMRQLVAAVHFMHSRGVVHRDLKPENLLFSDPAGDNIKVVDFGFACLKRES--- 528 (966)
Q Consensus 452 y~~gg~L~~~l~~~~~~~l~e~~~~~i~~Qil~aL~yLHs~~IiHRDLKP~NILl~~~~~~~iKL~DFGla~~~~~~--- 528 (966)
|+.|++|.+++.......+++..++.++.||+.||+|||+.||+||||||+|||++. ++.++|+|||++......
T Consensus 82 ~~~~~~L~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nili~~--~~~~~l~dfg~~~~~~~~~~~ 159 (316)
T cd05574 82 YCPGGELFRLLQRQPGKCLSEEVARFYAAEVLLALEYLHLLGIVYRDLKPENILLHE--SGHIMLSDFDLSKQSDVEPPP 159 (316)
T ss_pred ecCCCCHHHHHHhCCCCccCHHHHHHHHHHHHHHHHHHHHCCeeccCCChHHeEEcC--CCCEEEeecchhhcccccccc
Confidence 999999999987654457999999999999999999999999999999999999985 568999999998543210
Q ss_pred -----------------------------CccccccccccCchhhccCCCCCCCcccchhhhhhhhhhhhcCCCCCCCcC
Q psy11767 529 -----------------------------LHTPCFTLQYAAPEVLRQDKSGYDENCDLWSLGVILVNVLRQDKSGYDENC 579 (966)
Q Consensus 529 -----------------------------~~~~~gT~~Y~APEvl~~~~~~~~~~~Di~SlGvil~el~~~~~~~y~~~~ 579 (966)
.....||..|+|||++.. ..++.++
T Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~--------------------------~~~~~~~ 213 (316)
T cd05574 160 VSKALRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISG--------------------------DGHGSAV 213 (316)
T ss_pred cccccccccccccccccchhhhcccccCCCCCCcCccCCcCHHHHcC--------------------------CCCCchH
Confidence 112357888999998852 2357789
Q ss_pred cchhHHHHHHHHhcCCCCCCCCCCchhHHHHHHHHHcCCCCCCchhhccCCHHHHHHHHHhcccCccccCC----hHHHH
Q psy11767 580 DLWSLGVILYTMLCGRVPFHARSRDDSALSIMARIKEGQFNFDAEAWSTVSSEAKELTKSLLTVNPAQRIR----MMRVK 655 (966)
Q Consensus 580 DIWSlGvilyemltG~~Pf~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~is~e~~~Li~~~L~~dP~~R~t----~~~v~ 655 (966)
|||||||++|+|++|+.||.+.+... .+..+......+.. ...++.++.++|.+||..||++||+ +.++
T Consensus 214 Di~slG~ll~~l~~g~~pf~~~~~~~----~~~~~~~~~~~~~~--~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~l- 286 (316)
T cd05574 214 DWWTLGILLYEMLYGTTPFKGSNRDE----TFSNILKKEVTFPG--SPPVSSSARDLIRKLLVKDPSKRLGSKRGAAEI- 286 (316)
T ss_pred HHHHHHHHHHHHhhCCCCCCCCchHH----HHHHHhcCCccCCC--ccccCHHHHHHHHHHccCCHhHCCCchhhHHHH-
Confidence 99999999999999999998765432 23333333333322 1237899999999999999999999 6554
Q ss_pred HHhhhhH
Q psy11767 656 LTFHAFH 662 (966)
Q Consensus 656 ~~~~~~~ 662 (966)
..|+|+
T Consensus 287 -l~~~~~ 292 (316)
T cd05574 287 -KQHPFF 292 (316)
T ss_pred -HcCchh
Confidence 335554
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin |
| >cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-35 Score=320.29 Aligned_cols=243 Identities=30% Similarity=0.478 Sum_probs=191.4
Q ss_pred cccccccccccEEEEEEEcCCCcEEEEEEeccccC------hHHHHHHHHHhcCCCCceEEEEEEEeC--CeEEEEEEcc
Q psy11767 382 KAGILGDGSYSVCRRCVEKSTGQEYAVKIISRKID------CSEEINLLRACQGHPNIVNLHCVFQDE--VHTYLVLELL 453 (966)
Q Consensus 382 ~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~~------~~~Ei~iL~~l~~HpnIV~l~~~~~~~--~~~~lVmEy~ 453 (966)
..+.||+|+||.||+|.+..+++.||+|++..... ..+|+.+|+.+.+||||+++++++.++ +..++||||+
T Consensus 3 ~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~lv~e~~ 82 (282)
T cd07831 3 ILGKIGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSLEQVNNLREIQALRRLSPHPNILRLIEVLFDRKTGRLALVFELM 82 (282)
T ss_pred eEeeccccccceEEEEEEcCCCcEEEEEEehhccCCchhhhHHHHHHHHhhcCCCCCccceEEEEecCCCCcEEEEEecC
Confidence 35789999999999999999999999999865421 235888888887899999999999988 8899999999
Q ss_pred CCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCcEEEecCCCCCEEEEeecccccccCC--Ccc
Q psy11767 454 KGGELLDRIRQKGRCGFTENEASRIMRQLVAAVHFMHSRGVVHRDLKPENLLFSDPAGDNIKVVDFGFACLKRES--LHT 531 (966)
Q Consensus 454 ~gg~L~~~l~~~~~~~l~e~~~~~i~~Qil~aL~yLHs~~IiHRDLKP~NILl~~~~~~~iKL~DFGla~~~~~~--~~~ 531 (966)
. |+|.+.+.... ..+++..++.++.||+.||+|||+.||+||||||+||++++ +.+||+|||++...... ...
T Consensus 83 ~-~~l~~~l~~~~-~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dl~p~ni~l~~---~~~kl~dfg~~~~~~~~~~~~~ 157 (282)
T cd07831 83 D-MNLYELIKGRK-RPLPEKRVKSYMYQLLKSLDHMHRNGIFHRDIKPENILIKD---DILKLADFGSCRGIYSKPPYTE 157 (282)
T ss_pred C-ccHHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHHCCceecccCHHHEEEcC---CCeEEEecccccccccCCCcCC
Confidence 6 68888887643 25899999999999999999999999999999999999985 69999999999764322 223
Q ss_pred ccccccccCchhhccCCCCCCCcccchhhhhhhhhhhhcCCCCCCCcCcchhHHHHHHHHhcCCCCCCCCCCchhHHHHH
Q psy11767 532 PCFTLQYAAPEVLRQDKSGYDENCDLWSLGVILVNVLRQDKSGYDENCDLWSLGVILYTMLCGRVPFHARSRDDSALSIM 611 (966)
Q Consensus 532 ~~gT~~Y~APEvl~~~~~~~~~~~Di~SlGvil~el~~~~~~~y~~~~DIWSlGvilyemltG~~Pf~~~~~~~~~~~~~ 611 (966)
..+++.|+|||++... ..++.++||||+||++|+|++|.+||.+.+..+....+.
T Consensus 158 ~~~~~~y~aPE~~~~~-------------------------~~~~~~~Di~slGv~l~el~~~~~p~~~~~~~~~~~~~~ 212 (282)
T cd07831 158 YISTRWYRAPECLLTD-------------------------GYYGPKMDIWAVGCVFFEILSLFPLFPGTNELDQIAKIH 212 (282)
T ss_pred CCCCcccCChhHhhcC-------------------------CCCCcchhHHHHHHHHHHHHcCCcCCCCCCHHHHHHHHH
Confidence 4578899999986421 235678999999999999999999998765433222221
Q ss_pred HHH-----------H---cCCCCCCc-------hhhccCCHHHHHHHHHhcccCccccCChHHH
Q psy11767 612 ARI-----------K---EGQFNFDA-------EAWSTVSSEAKELTKSLLTVNPAQRIRMMRV 654 (966)
Q Consensus 612 ~~i-----------~---~~~~~~~~-------~~~~~is~e~~~Li~~~L~~dP~~R~t~~~v 654 (966)
..+ . ...+.++. .....++.++.+||.+||..||++||++.++
T Consensus 213 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~ 276 (282)
T cd07831 213 DVLGTPDAEVLKKFRKSRHMNYNFPSKKGTGLRKLLPNASAEGLDLLKKLLAYDPDERITAKQA 276 (282)
T ss_pred HHcCCCCHHHHHhhcccccccccCcccccccHHHHcccccHHHHHHHHHHhccCcccccCHHHH
Confidence 111 0 01111111 0113568999999999999999999999876
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. |
| >KOG0983|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-36 Score=310.40 Aligned_cols=256 Identities=25% Similarity=0.447 Sum_probs=200.8
Q ss_pred cccccc---ccccccccccccEEEEEEEcCCCcEEEEEEeccccChHH------HHHHHHHhcCCCCceEEEEEEEeCCe
Q psy11767 375 QYDMDL---DKAGILGDGSYSVCRRCVEKSTGQEYAVKIISRKIDCSE------EINLLRACQGHPNIVNLHCVFQDEVH 445 (966)
Q Consensus 375 ~~~i~~---~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~~~~~------Ei~iL~~l~~HpnIV~l~~~~~~~~~ 445 (966)
+|..|. +.++.||.|+.|+||+++.+++|..+|||.+.+.....+ .+.++....+.|.||+-+++|..+..
T Consensus 86 r~~~dindl~~l~dlGsGtcG~V~k~~~rs~~~iiAVK~M~rt~Nkee~kRILmDldvv~~s~dcpyIV~c~GyFi~n~d 165 (391)
T KOG0983|consen 86 RYQADINDLENLGDLGSGTCGQVWKMRFRSTGHIIAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVQCFGYFITNTD 165 (391)
T ss_pred ccccChHHhhhHHhhcCCCccceEEEEEcccceEEEEEeecccCCHHHHHHHHHhhhHHhhccCCCeeeeeeeEEeeCch
Confidence 455543 346789999999999999999999999999987654333 34444444457999999999999999
Q ss_pred EEEEEEccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhc-CceeccCCCCcEEEecCCCCCEEEEeeccccc
Q psy11767 446 TYLVLELLKGGELLDRIRQKGRCGFTENEASRIMRQLVAAVHFMHSR-GVVHRDLKPENLLFSDPAGDNIKVVDFGFACL 524 (966)
Q Consensus 446 ~~lVmEy~~gg~L~~~l~~~~~~~l~e~~~~~i~~Qil~aL~yLHs~-~IiHRDLKP~NILl~~~~~~~iKL~DFGla~~ 524 (966)
+++.||.|. .-.+.|.++-..+++|..+-++..-+++||.||-++ ||||||+||+|||+++ .|++||||||++..
T Consensus 166 V~IcMelMs--~C~ekLlkrik~piPE~ilGk~tva~v~AL~YLKeKH~viHRDvKPSNILlDe--~GniKlCDFGIsGr 241 (391)
T KOG0983|consen 166 VFICMELMS--TCAEKLLKRIKGPIPERILGKMTVAIVKALYYLKEKHGVIHRDVKPSNILLDE--RGNIKLCDFGISGR 241 (391)
T ss_pred HHHHHHHHH--HHHHHHHHHhcCCchHHhhhhhHHHHHHHHHHHHHhcceeecccCccceEEcc--CCCEEeecccccce
Confidence 999999983 334444444445799999999999999999999975 8999999999999986 67999999999966
Q ss_pred ccCC--CccccccccccCchhhccCCCCCCCcccchhhhhhhhhhhhcCCCCCCCcCcchhHHHHHHHHhcCCCCCCCCC
Q psy11767 525 KRES--LHTPCFTLQYAAPEVLRQDKSGYDENCDLWSLGVILVNVLRQDKSGYDENCDLWSLGVILYTMLCGRVPFHARS 602 (966)
Q Consensus 525 ~~~~--~~~~~gT~~Y~APEvl~~~~~~~~~~~Di~SlGvil~el~~~~~~~y~~~~DIWSlGvilyemltG~~Pf~~~~ 602 (966)
..++ .....|-+.|||||-+... ++..|+-++||||||+.++||.||+.||.+..
T Consensus 242 lvdSkAhtrsAGC~~YMaPERidp~-----------------------~~~kYDiRaDVWSlGITlveLaTg~yPy~~c~ 298 (391)
T KOG0983|consen 242 LVDSKAHTRSAGCAAYMAPERIDPP-----------------------DKPKYDIRADVWSLGITLVELATGQYPYKGCK 298 (391)
T ss_pred eecccccccccCCccccCccccCCC-----------------------CCCccchhhhhhhhccchhhhhcccCCCCCCC
Confidence 5443 2334677899999988532 25668999999999999999999999999876
Q ss_pred CchhHHHHHHHHHcCCCCCCchhhccCCHHHHHHHHHhcccCccccCChHHHHHHhhhhHH
Q psy11767 603 RDDSALSIMARIKEGQFNFDAEAWSTVSSEAKELTKSLLTVNPAQRIRMMRVKLTFHAFHQ 663 (966)
Q Consensus 603 ~~~~~~~~~~~i~~~~~~~~~~~~~~is~e~~~Li~~~L~~dP~~R~t~~~v~~~~~~~~~ 663 (966)
.+ ...+.+|.+......+.. ...|+.+.+++..||+.|+.+||.-.++ ..|+|..
T Consensus 299 td---Fe~ltkvln~ePP~L~~~-~gFSp~F~~fv~~CL~kd~r~RP~Y~~L--l~h~Fi~ 353 (391)
T KOG0983|consen 299 TD---FEVLTKVLNEEPPLLPGH-MGFSPDFQSFVKDCLTKDHRKRPKYNKL--LEHPFIK 353 (391)
T ss_pred cc---HHHHHHHHhcCCCCCCcc-cCcCHHHHHHHHHHhhcCcccCcchHHH--hcCccee
Confidence 54 455666666443222222 2489999999999999999999988754 5566653
|
|
| >cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-35 Score=323.58 Aligned_cols=246 Identities=31% Similarity=0.476 Sum_probs=194.5
Q ss_pred cccccccccccccEEEEEEEcCCCcEEEEEEecccc-------ChHHHHHHHHHhcCCCCceEEEEEEEeCCeEEEEEEc
Q psy11767 380 LDKAGILGDGSYSVCRRCVEKSTGQEYAVKIISRKI-------DCSEEINLLRACQGHPNIVNLHCVFQDEVHTYLVLEL 452 (966)
Q Consensus 380 ~~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~-------~~~~Ei~iL~~l~~HpnIV~l~~~~~~~~~~~lVmEy 452 (966)
|+..+.||.|+||.||+|++..+|+.||||.+.... ...+|+++|+.+ +||||+++++++.++...|+||||
T Consensus 2 y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~~~~~~~v~e~ 80 (284)
T cd07860 2 FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKEL-NHPNIVKLLDVIHTENKLYLVFEF 80 (284)
T ss_pred ceeeeeecCCCceEEEEEEECCCCCEEEEEEccccccccccchHHHHHHHHHHhc-CCCCCcchhhhcccCCcEEEEeec
Confidence 445788999999999999999999999999886432 245699999998 599999999999999999999999
Q ss_pred cCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCcEEEecCCCCCEEEEeecccccccCC---C
Q psy11767 453 LKGGELLDRIRQKGRCGFTENEASRIMRQLVAAVHFMHSRGVVHRDLKPENLLFSDPAGDNIKVVDFGFACLKRES---L 529 (966)
Q Consensus 453 ~~gg~L~~~l~~~~~~~l~e~~~~~i~~Qil~aL~yLHs~~IiHRDLKP~NILl~~~~~~~iKL~DFGla~~~~~~---~ 529 (966)
+. ++|.+++.......+++..++.++.|++.||+|||+.||+||||||+||++++ ++.+||+|||++...... .
T Consensus 81 ~~-~~l~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~i~H~~l~p~nill~~--~~~~~l~dfg~~~~~~~~~~~~ 157 (284)
T cd07860 81 LH-QDLKKFMDASPLSGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINT--EGAIKLADFGLARAFGVPVRTY 157 (284)
T ss_pred cc-cCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECC--CCCEEEeeccchhhcccCcccc
Confidence 95 68999887655557999999999999999999999999999999999999985 568999999998654321 2
Q ss_pred ccccccccccCchhhccCCCCCCCcccchhhhhhhhhhhhcCCCCCCCcCcchhHHHHHHHHhcCCCCCCCCCCchhHHH
Q psy11767 530 HTPCFTLQYAAPEVLRQDKSGYDENCDLWSLGVILVNVLRQDKSGYDENCDLWSLGVILYTMLCGRVPFHARSRDDSALS 609 (966)
Q Consensus 530 ~~~~gT~~Y~APEvl~~~~~~~~~~~Di~SlGvil~el~~~~~~~y~~~~DIWSlGvilyemltG~~Pf~~~~~~~~~~~ 609 (966)
....+++.|+|||++... ..++.++|||||||++|+|++|+.||...+..+....
T Consensus 158 ~~~~~~~~y~aPE~~~~~-------------------------~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~ 212 (284)
T cd07860 158 THEVVTLWYRAPEILLGC-------------------------KYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFR 212 (284)
T ss_pred ccccccccccCCeEEecC-------------------------CCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHH
Confidence 234568899999987421 2256789999999999999999999987554332222
Q ss_pred HHHHHHcCC--------------CCCC-------chhhccCCHHHHHHHHHhcccCccccCChHHH
Q psy11767 610 IMARIKEGQ--------------FNFD-------AEAWSTVSSEAKELTKSLLTVNPAQRIRMMRV 654 (966)
Q Consensus 610 ~~~~i~~~~--------------~~~~-------~~~~~~is~e~~~Li~~~L~~dP~~R~t~~~v 654 (966)
+........ ..+. ....+.++++++++|.+||+.||++|||+.++
T Consensus 213 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~ 278 (284)
T cd07860 213 IFRTLGTPDEVVWPGVTSLPDYKPSFPKWARQDFSKVVPPLDEDGRDLLSQMLHYDPNKRISAKAA 278 (284)
T ss_pred HHHHhCCCChhhhhhhhHHHHHHhhcccccccCHHHHcccCCHHHHHHHHHhcCCCcccCCCHHHH
Confidence 221111000 0000 01123578899999999999999999999876
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex |
| >cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-35 Score=321.98 Aligned_cols=243 Identities=19% Similarity=0.308 Sum_probs=190.9
Q ss_pred ccccccccccccEEEEEEEcCCC----------------cEEEEEEecccc------ChHHHHHHHHHhcCCCCceEEEE
Q psy11767 381 DKAGILGDGSYSVCRRCVEKSTG----------------QEYAVKIISRKI------DCSEEINLLRACQGHPNIVNLHC 438 (966)
Q Consensus 381 ~~~~~LG~G~fG~Vy~a~~~~tg----------------~~vAvK~i~~~~------~~~~Ei~iL~~l~~HpnIV~l~~ 438 (966)
...+.||+|+||.||+|.+..++ ..||+|.+.... ...+|+++|+.+ .||||+++++
T Consensus 8 ~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~ 86 (296)
T cd05051 8 NFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASDNAREDFLKEVKILSRL-SDPNIARLLG 86 (296)
T ss_pred cccccccCCCCccEEEEEeccCCcccccccccccccCCceeEEEEEecCccCHHHHHHHHHHHHHHHhc-CCCCEeEEEE
Confidence 34688999999999999887644 568999987543 234689999998 5999999999
Q ss_pred EEEeCCeEEEEEEccCCCCHHHHHHhcC---------CCCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCcEEEecC
Q psy11767 439 VFQDEVHTYLVLELLKGGELLDRIRQKG---------RCGFTENEASRIMRQLVAAVHFMHSRGVVHRDLKPENLLFSDP 509 (966)
Q Consensus 439 ~~~~~~~~~lVmEy~~gg~L~~~l~~~~---------~~~l~e~~~~~i~~Qil~aL~yLHs~~IiHRDLKP~NILl~~~ 509 (966)
++.++...++||||+++++|.+++.+.. ...+++..++.++.|++.||+|||+.||+||||||+|||+++
T Consensus 87 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~~i~H~dlkp~Nili~~- 165 (296)
T cd05051 87 VCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLESLNFVHRDLATRNCLVGK- 165 (296)
T ss_pred EEecCCCcEEEEecCCCCCHHHHHHhcccccccccccCCCCCHHHHHHHHHHHHHHHHHHHHcCccccccchhceeecC-
Confidence 9999999999999999999999997643 125899999999999999999999999999999999999985
Q ss_pred CCCCEEEEeecccccccCC-----CccccccccccCchhhccCCCCCCCcccchhhhhhhhhhhhcCCCCCCCcCcchhH
Q psy11767 510 AGDNIKVVDFGFACLKRES-----LHTPCFTLQYAAPEVLRQDKSGYDENCDLWSLGVILVNVLRQDKSGYDENCDLWSL 584 (966)
Q Consensus 510 ~~~~iKL~DFGla~~~~~~-----~~~~~gT~~Y~APEvl~~~~~~~~~~~Di~SlGvil~el~~~~~~~y~~~~DIWSl 584 (966)
.+.++|+|||++...... .....+|+.|+|||++.. ..++.++|||||
T Consensus 166 -~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~--------------------------~~~~~~~Dv~sl 218 (296)
T cd05051 166 -NYTIKIADFGMSRNLYSSDYYRVQGRAPLPIRWMAWESVLL--------------------------GKFTTKSDVWAF 218 (296)
T ss_pred -CCceEEccccceeecccCcceeecCcCCCCceecCHHHhhc--------------------------CCCCccchhhhh
Confidence 468999999998653221 123445778999998752 236788999999
Q ss_pred HHHHHHHhc--CCCCCCCCCCchhHHHHHHHHHcC----CCCCCchhhccCCHHHHHHHHHhcccCccccCChHHHHH
Q psy11767 585 GVILYTMLC--GRVPFHARSRDDSALSIMARIKEG----QFNFDAEAWSTVSSEAKELTKSLLTVNPAQRIRMMRVKL 656 (966)
Q Consensus 585 Gvilyemlt--G~~Pf~~~~~~~~~~~~~~~i~~~----~~~~~~~~~~~is~e~~~Li~~~L~~dP~~R~t~~~v~~ 656 (966)
||++|+|++ |..||......+ .+..+... ............+.++.+++.+||+.||++|||+.++..
T Consensus 219 G~~l~el~~~~~~~p~~~~~~~~----~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rpt~~el~~ 292 (296)
T cd05051 219 GVTLWEILTLCREQPYEHLTDQQ----VIENAGHFFRDDGRQIYLPRPPNCPKDIYELMLECWRRDEEDRPTFREIHL 292 (296)
T ss_pred HHHHHHHHhcCCCCCCCCcChHH----HHHHHHhccccccccccCCCccCCCHHHHHHHHHHhccChhcCCCHHHHHH
Confidence 999999998 788987654322 22222211 111111122346789999999999999999999998743
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke |
| >cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-35 Score=318.50 Aligned_cols=246 Identities=27% Similarity=0.413 Sum_probs=195.5
Q ss_pred cccccccccccEEEEEEEcCCCcEEEEEEecccc----ChHHHHHHHHHhcCCCCceEEEEEEEeCC------eEEEEEE
Q psy11767 382 KAGILGDGSYSVCRRCVEKSTGQEYAVKIISRKI----DCSEEINLLRACQGHPNIVNLHCVFQDEV------HTYLVLE 451 (966)
Q Consensus 382 ~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~----~~~~Ei~iL~~l~~HpnIV~l~~~~~~~~------~~~lVmE 451 (966)
..+.||+|+||.||+|.+..+++.||+|++.... ...+|+.+++.+.+|+||++++++|.+.. ..|+|||
T Consensus 10 ~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~~~~lv~e 89 (275)
T cd06608 10 LVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIEDEEEEIKEEYNILRKYSNHPNIATFYGAFIKKNPPGNDDQLWLVME 89 (275)
T ss_pred heeeecCCCCeEEEEEEECCCCcEEEEEEEecCchhHHHHHHHHHHHHHhcCCCChheEEEEEEecCCCCcceEEEEEEE
Confidence 3678999999999999999999999999987543 24568999998878999999999997654 4899999
Q ss_pred ccCCCCHHHHHHhcC--CCCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCcEEEecCCCCCEEEEeecccccccC--
Q psy11767 452 LLKGGELLDRIRQKG--RCGFTENEASRIMRQLVAAVHFMHSRGVVHRDLKPENLLFSDPAGDNIKVVDFGFACLKRE-- 527 (966)
Q Consensus 452 y~~gg~L~~~l~~~~--~~~l~e~~~~~i~~Qil~aL~yLHs~~IiHRDLKP~NILl~~~~~~~iKL~DFGla~~~~~-- 527 (966)
|+++++|.+++.... ...+++..++.++.|++.||+|||+.||+|+||+|+||++++ ++.+||+|||++.....
T Consensus 90 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~~~i~H~~l~p~ni~~~~--~~~~~l~d~~~~~~~~~~~ 167 (275)
T cd06608 90 LCGGGSVTDLVKGLRKKGKRLKEEWIAYILRETLRGLAYLHENKVIHRDIKGQNILLTK--NAEVKLVDFGVSAQLDSTL 167 (275)
T ss_pred cCCCCcHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCHHHEEEcc--CCeEEECCCccceecccch
Confidence 999999999886533 346899999999999999999999999999999999999985 56899999999865432
Q ss_pred -CCccccccccccCchhhccCCCCCCCcccchhhhhhhhhhhhcCCCCCCCcCcchhHHHHHHHHhcCCCCCCCCCCchh
Q psy11767 528 -SLHTPCFTLQYAAPEVLRQDKSGYDENCDLWSLGVILVNVLRQDKSGYDENCDLWSLGVILYTMLCGRVPFHARSRDDS 606 (966)
Q Consensus 528 -~~~~~~gT~~Y~APEvl~~~~~~~~~~~Di~SlGvil~el~~~~~~~y~~~~DIWSlGvilyemltG~~Pf~~~~~~~~ 606 (966)
......+++.|+|||++..... ....|+.++|||||||++|+|++|++||.......
T Consensus 168 ~~~~~~~~~~~y~aPE~~~~~~~---------------------~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~- 225 (275)
T cd06608 168 GRRNTFIGTPYWMAPEVIACDEQ---------------------PDASYDARSDVWSLGITAIELADGKPPLCDMHPMR- 225 (275)
T ss_pred hhhcCccccccccCHhHhccccc---------------------ccCCccccccHHHhHHHHHHHHhCCCCccccchHH-
Confidence 1234567899999998853221 13457789999999999999999999997543322
Q ss_pred HHHHHHHHHcCCCCCCchhhccCCHHHHHHHHHhcccCccccCChHHHH
Q psy11767 607 ALSIMARIKEGQFNFDAEAWSTVSSEAKELTKSLLTVNPAQRIRMMRVK 655 (966)
Q Consensus 607 ~~~~~~~i~~~~~~~~~~~~~~is~e~~~Li~~~L~~dP~~R~t~~~v~ 655 (966)
....+..+.... .......+.++++||.+||..||++|||+.++.
T Consensus 226 ---~~~~~~~~~~~~-~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~ll 270 (275)
T cd06608 226 ---ALFKIPRNPPPT-LKSPENWSKKFNDFISECLIKNYEQRPFMEELL 270 (275)
T ss_pred ---HHHHhhccCCCC-CCchhhcCHHHHHHHHHHhhcChhhCcCHHHHh
Confidence 222333332211 111123678999999999999999999998763
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I |
| >KOG2345|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-36 Score=311.80 Aligned_cols=250 Identities=28% Similarity=0.441 Sum_probs=196.9
Q ss_pred cccccccccccccccccccEEEEEEEcCCCcEEEEEEecccc-----ChHHHHHHHHHhcCCCCceEEEEEEEeC-----
Q psy11767 374 EQYDMDLDKAGILGDGSYSVCRRCVEKSTGQEYAVKIISRKI-----DCSEEINLLRACQGHPNIVNLHCVFQDE----- 443 (966)
Q Consensus 374 ~~~~i~~~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~-----~~~~Ei~iL~~l~~HpnIV~l~~~~~~~----- 443 (966)
++|.+ .+.||+|||+.||++.+..+++.||+|.+.-.. ...+|++.-+.+ +||||++++++...+
T Consensus 21 ~Ryri----~~~LgeGGfsfv~LV~~~s~~~~YAlKkI~c~~~~~~e~~~rEid~~rkf-~s~~vl~l~dh~l~~~~D~~ 95 (302)
T KOG2345|consen 21 KRYRI----QRLLGEGGFSFVDLVKGLSTGHLYALKKILCHSQEDIEEALREIDNHRKF-NSPNVLRLVDHQLREEKDGK 95 (302)
T ss_pred ceEEE----eeeecCCCceeeeeecccCcccchhhheeeccchHHHHHHHHHHHHHHhh-CCcchHHHHHHHHHhhccCc
Confidence 35655 478999999999999999999999999885332 256789988888 599999998775433
Q ss_pred CeEEEEEEccCCCCHHHHHHhcC--CCCCCHHHHHHHHHHHHHHHHHHHhcC--ceeccCCCCcEEEecCCCCCEEEEee
Q psy11767 444 VHTYLVLELLKGGELLDRIRQKG--RCGFTENEASRIMRQLVAAVHFMHSRG--VVHRDLKPENLLFSDPAGDNIKVVDF 519 (966)
Q Consensus 444 ~~~~lVmEy~~gg~L~~~l~~~~--~~~l~e~~~~~i~~Qil~aL~yLHs~~--IiHRDLKP~NILl~~~~~~~iKL~DF 519 (966)
...||++.|...|+|.+.+.... +..++|.+++.|+.+|++||++||+.. ..||||||.|||+++ .+.++|.||
T Consensus 96 ~~~yll~Pyy~~Gsl~d~i~~~k~kg~~~sE~~iL~if~gic~gL~~lH~~~~~yAH~DiKP~NILls~--~~~~vl~D~ 173 (302)
T KOG2345|consen 96 HEAYLLLPYYKRGSLLDEIERLKIKGNFVSEAQILWIFLGICRGLEALHEKEPPYAHRDIKPANILLSD--SGLPVLMDL 173 (302)
T ss_pred eeEEEEeehhccccHHHHHHHHhhcCCccCHHHHHHHHHHHHHHHHHHhccCCcccccCCCcceeEecC--CCceEEEec
Confidence 34899999999999999997643 335999999999999999999999998 999999999999986 569999999
Q ss_pred cccccccCCC------------ccccccccccCchhhccCCCCCCCcccchhhhhhhhhhhhcCCCCCCCcCcchhHHHH
Q psy11767 520 GFACLKRESL------------HTPCFTLQYAAPEVLRQDKSGYDENCDLWSLGVILVNVLRQDKSGYDENCDLWSLGVI 587 (966)
Q Consensus 520 Gla~~~~~~~------------~~~~gT~~Y~APEvl~~~~~~~~~~~Di~SlGvil~el~~~~~~~y~~~~DIWSlGvi 587 (966)
|.++...-.. .....|..|+|||.+.-.. ..-.++++|||||||+
T Consensus 174 GS~~~a~i~i~~~~~a~~lQe~a~e~Ct~pyRAPELf~vk~-----------------------~~ti~ertDIWSLGCt 230 (302)
T KOG2345|consen 174 GSATQAPIQIEGSRQALRLQEWAEERCTIPYRAPELFNVKS-----------------------HCTITERTDIWSLGCT 230 (302)
T ss_pred cCccccceEeechHHHHHHHHHHHHhCCCcccCchheeccc-----------------------CcccccccchhhhhHH
Confidence 9986542110 1123588999999985321 1224789999999999
Q ss_pred HHHHhcCCCCCCCCCCchhHHHHHHHHHcCCCCCCchhhccCCHHHHHHHHHhcccCccccCChHHHHHH
Q psy11767 588 LYTMLCGRVPFHARSRDDSALSIMARIKEGQFNFDAEAWSTVSSEAKELTKSLLTVNPAQRIRMMRVKLT 657 (966)
Q Consensus 588 lyemltG~~Pf~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~is~e~~~Li~~~L~~dP~~R~t~~~v~~~ 657 (966)
||+|+.|..||+..-.... .+.-.+..+++.++... .+|+.+.+||+.||+.||.+||++.++...
T Consensus 231 LYa~mf~~sPfe~~~~~Gg--SlaLAv~n~q~s~P~~~--~yse~l~~lik~mlqvdP~qRP~i~~ll~~ 296 (302)
T KOG2345|consen 231 LYAMMFGESPFERIYQQGG--SLALAVQNAQISIPNSS--RYSEALHQLIKSMLQVDPNQRPTIPELLSK 296 (302)
T ss_pred HHHHHHcCCcchHHhhcCC--eEEEeeeccccccCCCC--CccHHHHHHHHHHhcCCcccCCCHHHHHHH
Confidence 9999999999974321110 11123455666666543 489999999999999999999999887443
|
|
| >KOG0194|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-35 Score=340.59 Aligned_cols=256 Identities=24% Similarity=0.411 Sum_probs=206.1
Q ss_pred cccceecccccccccccccccccccEEEEEEEcCCCc---E-EEEEEecccc--------ChHHHHHHHHHhcCCCCceE
Q psy11767 368 KGSLFFEQYDMDLDKAGILGDGSYSVCRRCVEKSTGQ---E-YAVKIISRKI--------DCSEEINLLRACQGHPNIVN 435 (966)
Q Consensus 368 ~G~~~~~~~~i~~~~~~~LG~G~fG~Vy~a~~~~tg~---~-vAvK~i~~~~--------~~~~Ei~iL~~l~~HpnIV~ 435 (966)
...+.+...++.+. ++||+|+||.||+|..+..+. . ||||...... +...|.++|+.+ +|||||+
T Consensus 149 r~~Wel~H~~v~l~--kkLGeGaFGeV~~G~l~~~~~~~~~~VAvK~~k~~~~~~~~~~~e~m~EArvMr~l-~H~NVVr 225 (474)
T KOG0194|consen 149 RQKWELSHSDIELG--KKLGEGAFGEVFKGKLKLKNGFKVVPVAVKTTKGSSELTKEQIKEFMKEARVMRQL-NHPNVVR 225 (474)
T ss_pred ccccEEeccCcccc--ceeecccccEEEEEEEEecCCceeeeeEEEeecccccccHHHHHHHHHHHHHHHhC-CCCCEEE
Confidence 44555566666554 899999999999998876533 3 8999887422 245699999997 6999999
Q ss_pred EEEEEEeCCeEEEEEEccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCcEEEecCCCCCEE
Q psy11767 436 LHCVFQDEVHTYLVLELLKGGELLDRIRQKGRCGFTENEASRIMRQLVAAVHFMHSRGVVHRDLKPENLLFSDPAGDNIK 515 (966)
Q Consensus 436 l~~~~~~~~~~~lVmEy~~gg~L~~~l~~~~~~~l~e~~~~~i~~Qil~aL~yLHs~~IiHRDLKP~NILl~~~~~~~iK 515 (966)
+||+..++..+|||||+|.||+|.++|++.+. .++..+...++.|.+.||+|||++++|||||-..|+|++. ++.+|
T Consensus 226 ~yGVa~~~~Pl~ivmEl~~gGsL~~~L~k~~~-~v~~~ek~~~~~~AA~Gl~YLh~k~~IHRDIAARNcL~~~--~~~vK 302 (474)
T KOG0194|consen 226 FYGVAVLEEPLMLVMELCNGGSLDDYLKKNKK-SLPTLEKLRFCYDAARGLEYLHSKNCIHRDIAARNCLYSK--KGVVK 302 (474)
T ss_pred EEEEEcCCCccEEEEEecCCCcHHHHHHhCCC-CCCHHHHHHHHHHHHhHHHHHHHCCCcchhHhHHHheecC--CCeEE
Confidence 99999999999999999999999999998764 5999999999999999999999999999999999999984 44689
Q ss_pred EEeecccccccCCCc---cccccccccCchhhccCCCCCCCcccchhhhhhhhhhhhcCCCCCCCcCcchhHHHHHHHHh
Q psy11767 516 VVDFGFACLKRESLH---TPCFTLQYAAPEVLRQDKSGYDENCDLWSLGVILVNVLRQDKSGYDENCDLWSLGVILYTML 592 (966)
Q Consensus 516 L~DFGla~~~~~~~~---~~~gT~~Y~APEvl~~~~~~~~~~~Di~SlGvil~el~~~~~~~y~~~~DIWSlGvilyeml 592 (966)
|+||||++....... .......|+|||.+... -|+.++|||||||++||+.
T Consensus 303 ISDFGLs~~~~~~~~~~~~~klPirWLAPEtl~~~--------------------------~~s~kTDV~sfGV~~~Eif 356 (474)
T KOG0194|consen 303 ISDFGLSRAGSQYVMKKFLKKLPIRWLAPETLNTG--------------------------IFSFKTDVWSFGVLLWEIF 356 (474)
T ss_pred eCccccccCCcceeeccccccCcceecChhhhccC--------------------------ccccccchhheeeeEEeee
Confidence 999999976542111 11246789999998632 3789999999999999999
Q ss_pred c-CCCCCCCCCCchhHHHHHHHHHcCCCCCCchhhccCCHHHHHHHHHhcccCccccCChHHHHHHhhhh
Q psy11767 593 C-GRVPFHARSRDDSALSIMARIKEGQFNFDAEAWSTVSSEAKELTKSLLTVNPAQRIRMMRVKLTFHAF 661 (966)
Q Consensus 593 t-G~~Pf~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~is~e~~~Li~~~L~~dP~~R~t~~~v~~~~~~~ 661 (966)
+ |..||.+... ..+..+|....+....+ ...+.++..++.+|+..||++|++|.++...+..+
T Consensus 357 ~~g~~Py~g~~~----~~v~~kI~~~~~r~~~~--~~~p~~~~~~~~~c~~~~p~~R~tm~~i~~~l~~~ 420 (474)
T KOG0194|consen 357 ENGAEPYPGMKN----YEVKAKIVKNGYRMPIP--SKTPKELAKVMKQCWKKDPEDRPTMSTIKKKLEAL 420 (474)
T ss_pred ccCCCCCCCCCH----HHHHHHHHhcCccCCCC--CCCHHHHHHHHHHhccCChhhccCHHHHHHHHHHH
Confidence 8 8889988654 34566674444433322 25677889999999999999999999886655544
|
|
| >cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-35 Score=318.11 Aligned_cols=242 Identities=26% Similarity=0.470 Sum_probs=194.5
Q ss_pred cccccccccccccEEEEEEEcCCCcEEEEEEecccc-----------ChHHHHHHHHHhcCCCCceEEEEEEEeCCeEEE
Q psy11767 380 LDKAGILGDGSYSVCRRCVEKSTGQEYAVKIISRKI-----------DCSEEINLLRACQGHPNIVNLHCVFQDEVHTYL 448 (966)
Q Consensus 380 ~~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~-----------~~~~Ei~iL~~l~~HpnIV~l~~~~~~~~~~~l 448 (966)
|+..+.||+|+||.||+|.+..+++.||+|++.... ....|+++|+.+ +||||+++++++.+..+.++
T Consensus 2 ~~~~~~lg~g~~~~v~~~~~~~~~~~~alk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~~ 80 (268)
T cd06630 2 WLKGQQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARL-NHPHIIRMLGATCEDSHFNL 80 (268)
T ss_pred ccccceecCcCceEEEEEEEcCCCcEEEEEEeecccCCchhHHHHHHHHHHHHHHHHHc-CCCceehhhceeccCCeEEE
Confidence 345678999999999999999999999999986432 234688999988 59999999999999999999
Q ss_pred EEEccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCcEEEecCCCCCEEEEeecccccccCC
Q psy11767 449 VLELLKGGELLDRIRQKGRCGFTENEASRIMRQLVAAVHFMHSRGVVHRDLKPENLLFSDPAGDNIKVVDFGFACLKRES 528 (966)
Q Consensus 449 VmEy~~gg~L~~~l~~~~~~~l~e~~~~~i~~Qil~aL~yLHs~~IiHRDLKP~NILl~~~~~~~iKL~DFGla~~~~~~ 528 (966)
||||++|++|.+++.+.. .+++..+..++.||+.||+|||++|++||||||+||+++. .+..+||+|||++......
T Consensus 81 v~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~ql~~al~~LH~~~i~H~~i~~~nil~~~-~~~~~~l~dfg~~~~~~~~ 157 (268)
T cd06630 81 FVEWMAGGSVSHLLSKYG--AFKEAVIINYTEQLLRGLSYLHENQIIHRDVKGANLLIDS-TGQRLRIADFGAAARLAAK 157 (268)
T ss_pred EEeccCCCcHHHHHHHhC--CCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcC-CCCEEEEcccccccccccc
Confidence 999999999999997654 5899999999999999999999999999999999999964 2346999999998654321
Q ss_pred -------CccccccccccCchhhccCCCCCCCcccchhhhhhhhhhhhcCCCCCCCcCcchhHHHHHHHHhcCCCCCCCC
Q psy11767 529 -------LHTPCFTLQYAAPEVLRQDKSGYDENCDLWSLGVILVNVLRQDKSGYDENCDLWSLGVILYTMLCGRVPFHAR 601 (966)
Q Consensus 529 -------~~~~~gT~~Y~APEvl~~~~~~~~~~~Di~SlGvil~el~~~~~~~y~~~~DIWSlGvilyemltG~~Pf~~~ 601 (966)
.....+|..|+|||++.. ..++.++|+||+||++|+|++|..||...
T Consensus 158 ~~~~~~~~~~~~~~~~~~~PE~~~~--------------------------~~~~~~~Dv~slG~~l~~l~~g~~p~~~~ 211 (268)
T cd06630 158 GTGAGEFQGQLLGTIAFMAPEVLRG--------------------------EQYGRSCDVWSVGCVIIEMATAKPPWNAE 211 (268)
T ss_pred cccCCccccccccccceeCHhHhcc--------------------------CCCCcccchHHHHHHHHHHHhCCCCCCCC
Confidence 112357889999998742 23577899999999999999999999754
Q ss_pred CCchhHHHHHHHHHcCCCCCCchhhccCCHHHHHHHHHhcccCccccCChHHH
Q psy11767 602 SRDDSALSIMARIKEGQFNFDAEAWSTVSSEAKELTKSLLTVNPAQRIRMMRV 654 (966)
Q Consensus 602 ~~~~~~~~~~~~i~~~~~~~~~~~~~~is~e~~~Li~~~L~~dP~~R~t~~~v 654 (966)
..... ......+..... .......+++++.+++.+||..||++||++.++
T Consensus 212 ~~~~~-~~~~~~~~~~~~--~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~l 261 (268)
T cd06630 212 KHSNH-LALIFKIASATT--APSIPEHLSPGLRDVTLRCLELQPEDRPPSREL 261 (268)
T ss_pred CCcch-HHHHHHHhccCC--CCCCchhhCHHHHHHHHHHcCCCcccCcCHHHH
Confidence 43222 122222222111 122234578999999999999999999999876
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their |
| >cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-35 Score=316.43 Aligned_cols=238 Identities=24% Similarity=0.424 Sum_probs=192.2
Q ss_pred cccccccccccccEEEEEEEcCCCcEEEEEEecccc----ChHHHHHHHHHhcCCCCceEEEEEEEeCCeEEEEEEccCC
Q psy11767 380 LDKAGILGDGSYSVCRRCVEKSTGQEYAVKIISRKI----DCSEEINLLRACQGHPNIVNLHCVFQDEVHTYLVLELLKG 455 (966)
Q Consensus 380 ~~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~----~~~~Ei~iL~~l~~HpnIV~l~~~~~~~~~~~lVmEy~~g 455 (966)
+...+.||+|+||.||+|.+. ++..+|+|++.+.. ...+|+++++.+ +||||+++++++.+....|+||||++|
T Consensus 6 ~~~~~~lg~G~~~~v~~~~~~-~~~~~~iK~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~~~~lv~e~~~~ 83 (256)
T cd05059 6 LTFLKELGSGQFGVVHLGKWR-GKIDVAIKMIREGAMSEDDFIEEAKVMMKL-SHPNLVQLYGVCTKQRPIFIVTEYMAN 83 (256)
T ss_pred cchhhhhccCCCceEEEeEec-CCccEEEEEeccCCCCHHHHHHHHHHHHhC-CCCCEEEEEEEEcCCCceEEEEecCCC
Confidence 445678999999999999886 46789999986532 245699999988 599999999999999999999999999
Q ss_pred CCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCcEEEecCCCCCEEEEeecccccccCCC-cc---
Q psy11767 456 GELLDRIRQKGRCGFTENEASRIMRQLVAAVHFMHSRGVVHRDLKPENLLFSDPAGDNIKVVDFGFACLKRESL-HT--- 531 (966)
Q Consensus 456 g~L~~~l~~~~~~~l~e~~~~~i~~Qil~aL~yLHs~~IiHRDLKP~NILl~~~~~~~iKL~DFGla~~~~~~~-~~--- 531 (966)
++|.+++..... .+++..+..++.||+.||+|||++||+||||||+||++++ ++.+||+|||+++...+.. ..
T Consensus 84 ~~L~~~l~~~~~-~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dl~p~ni~i~~--~~~~kl~dfg~~~~~~~~~~~~~~~ 160 (256)
T cd05059 84 GCLLNYLRERKG-KLGTEWLLDMCSDVCEAMEYLESNGFIHRDLAARNCLVGE--DNVVKVSDFGLARYVLDDQYTSSQG 160 (256)
T ss_pred CCHHHHHHhccc-CCCHHHHHHHHHHHHHHHHHHHHCCcccccccHhhEEECC--CCcEEECCcccceecccccccccCC
Confidence 999999976543 5899999999999999999999999999999999999985 5689999999987543321 11
Q ss_pred ccccccccCchhhccCCCCCCCcccchhhhhhhhhhhhcCCCCCCCcCcchhHHHHHHHHhc-CCCCCCCCCCchhHHHH
Q psy11767 532 PCFTLQYAAPEVLRQDKSGYDENCDLWSLGVILVNVLRQDKSGYDENCDLWSLGVILYTMLC-GRVPFHARSRDDSALSI 610 (966)
Q Consensus 532 ~~gT~~Y~APEvl~~~~~~~~~~~Di~SlGvil~el~~~~~~~y~~~~DIWSlGvilyemlt-G~~Pf~~~~~~~~~~~~ 610 (966)
..++..|+|||++.. ..|+.++|||||||++|+|++ |++||...+.. ..
T Consensus 161 ~~~~~~y~~Pe~~~~--------------------------~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~----~~ 210 (256)
T cd05059 161 TKFPVKWAPPEVFDY--------------------------SRFSSKSDVWSFGVLMWEVFSEGKMPYERFSNS----EV 210 (256)
T ss_pred CCCCccccCHHHhcc--------------------------CCCCchhhHHHHHHHHHHHhccCCCCCCCCCHH----HH
Confidence 123457999998852 236778999999999999998 89999765432 23
Q ss_pred HHHHHcCCCCCCchhhccCCHHHHHHHHHhcccCccccCChHHHH
Q psy11767 611 MARIKEGQFNFDAEAWSTVSSEAKELTKSLLTVNPAQRIRMMRVK 655 (966)
Q Consensus 611 ~~~i~~~~~~~~~~~~~~is~e~~~Li~~~L~~dP~~R~t~~~v~ 655 (966)
...+..+.. .......+.++.+++.+||..+|++|||+.++.
T Consensus 211 ~~~~~~~~~---~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~~~l 252 (256)
T cd05059 211 VESVSAGYR---LYRPKLAPTEVYTIMYSCWHEKPEDRPAFKKLL 252 (256)
T ss_pred HHHHHcCCc---CCCCCCCCHHHHHHHHHHhcCChhhCcCHHHHH
Confidence 344444321 112235789999999999999999999998874
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows |
| >cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-35 Score=323.66 Aligned_cols=246 Identities=20% Similarity=0.364 Sum_probs=195.5
Q ss_pred ccccccccccccEEEEEEEc-------CCCcEEEEEEecccc------ChHHHHHHHHHhcCCCCceEEEEEEEeCCeEE
Q psy11767 381 DKAGILGDGSYSVCRRCVEK-------STGQEYAVKIISRKI------DCSEEINLLRACQGHPNIVNLHCVFQDEVHTY 447 (966)
Q Consensus 381 ~~~~~LG~G~fG~Vy~a~~~-------~tg~~vAvK~i~~~~------~~~~Ei~iL~~l~~HpnIV~l~~~~~~~~~~~ 447 (966)
.....||+|+||.||+|++. .++..||+|.+.... ...+|+.+++.+.+||||+++++++......|
T Consensus 18 ~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~ 97 (304)
T cd05101 18 TLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLY 97 (304)
T ss_pred eecceeeccCCceEEEEEEeccCCCCCCcceeEEeeecccccchHHHHHHHHHHHHHHhhccCCCchheeEEEecCCceE
Confidence 34678999999999999753 245689999986432 24468999988867999999999999999999
Q ss_pred EEEEccCCCCHHHHHHhcCC--------------CCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCcEEEecCCCCC
Q psy11767 448 LVLELLKGGELLDRIRQKGR--------------CGFTENEASRIMRQLVAAVHFMHSRGVVHRDLKPENLLFSDPAGDN 513 (966)
Q Consensus 448 lVmEy~~gg~L~~~l~~~~~--------------~~l~e~~~~~i~~Qil~aL~yLHs~~IiHRDLKP~NILl~~~~~~~ 513 (966)
+||||+++|+|.+++..... ..+++.++..++.||+.||+|||++||+||||||+|||+++ ++.
T Consensus 98 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~givH~dlkp~Nili~~--~~~ 175 (304)
T cd05101 98 VIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLASQKCIHRDLAARNVLVTE--NNV 175 (304)
T ss_pred EEEecCCCCcHHHHHHhcCCcccccccccccCCcccccHHHHHHHHHHHHHHHHHHHHCCeeecccccceEEEcC--CCc
Confidence 99999999999999976421 24788899999999999999999999999999999999975 568
Q ss_pred EEEEeecccccccCC-----CccccccccccCchhhccCCCCCCCcccchhhhhhhhhhhhcCCCCCCCcCcchhHHHHH
Q psy11767 514 IKVVDFGFACLKRES-----LHTPCFTLQYAAPEVLRQDKSGYDENCDLWSLGVILVNVLRQDKSGYDENCDLWSLGVIL 588 (966)
Q Consensus 514 iKL~DFGla~~~~~~-----~~~~~gT~~Y~APEvl~~~~~~~~~~~Di~SlGvil~el~~~~~~~y~~~~DIWSlGvil 588 (966)
+||+|||+++..... .....+++.|+|||++.. ..|+.++|||||||++
T Consensus 176 ~kl~D~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~--------------------------~~~~~~~Di~slG~~l 229 (304)
T cd05101 176 MKIADFGLARDVNNIDYYKKTTNGRLPVKWMAPEALFD--------------------------RVYTHQSDVWSFGVLM 229 (304)
T ss_pred EEECCCccceecccccccccccCCCCCceeeCchhhcc--------------------------CCCCchhhHHHHHHHH
Confidence 999999999754321 122345678999998842 2367889999999999
Q ss_pred HHHhc-CCCCCCCCCCchhHHHHHHHHHcCCCCCCchhhccCCHHHHHHHHHhcccCccccCChHHHHHHhhhh
Q psy11767 589 YTMLC-GRVPFHARSRDDSALSIMARIKEGQFNFDAEAWSTVSSEAKELTKSLLTVNPAQRIRMMRVKLTFHAF 661 (966)
Q Consensus 589 yemlt-G~~Pf~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~is~e~~~Li~~~L~~dP~~R~t~~~v~~~~~~~ 661 (966)
|+|++ |..||.+.+.. .+...+..+.... .....+.++++|+.+||..+|++||++.++...+..+
T Consensus 230 ~el~~~g~~p~~~~~~~----~~~~~~~~~~~~~---~~~~~~~~~~~li~~cl~~~p~~Rps~~e~l~~l~~~ 296 (304)
T cd05101 230 WEIFTLGGSPYPGIPVE----ELFKLLKEGHRMD---KPANCTNELYMMMRDCWHAIPSHRPTFKQLVEDLDRI 296 (304)
T ss_pred HHHHcCCCCCcccCCHH----HHHHHHHcCCcCC---CCCCCCHHHHHHHHHHcccChhhCCCHHHHHHHHHHH
Confidence 99998 88999765432 3344454443221 1235789999999999999999999999886655443
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-35 Score=326.47 Aligned_cols=252 Identities=27% Similarity=0.442 Sum_probs=194.8
Q ss_pred cccccccccccccEEEEEEEcCCCcEEEEEEecccc-------ChHHHHHHHHHhcCCCCceEEEEEEEeC--CeEEEEE
Q psy11767 380 LDKAGILGDGSYSVCRRCVEKSTGQEYAVKIISRKI-------DCSEEINLLRACQGHPNIVNLHCVFQDE--VHTYLVL 450 (966)
Q Consensus 380 ~~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~-------~~~~Ei~iL~~l~~HpnIV~l~~~~~~~--~~~~lVm 450 (966)
|+..+.||+|+||.||+|.+..+|+.||+|.+.... ...+|+.+|+.+ +|+||+++++++.+. ...|+||
T Consensus 9 y~~~~~ig~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~~~~~~~~lv~ 87 (309)
T cd07845 9 FEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLREITLLLNL-RHPNIVELKEVVVGKHLDSIFLVM 87 (309)
T ss_pred eeEeeeeeecCCEEEEEEEECCCCcEEEEEEEEeccCCCCCcchhhHHHHHHHhC-CCCCCcceEEEEecCCCCeEEEEE
Confidence 344688999999999999999999999999986332 235799999998 599999999999765 4689999
Q ss_pred EccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCcEEEecCCCCCEEEEeecccccccCC--
Q psy11767 451 ELLKGGELLDRIRQKGRCGFTENEASRIMRQLVAAVHFMHSRGVVHRDLKPENLLFSDPAGDNIKVVDFGFACLKRES-- 528 (966)
Q Consensus 451 Ey~~gg~L~~~l~~~~~~~l~e~~~~~i~~Qil~aL~yLHs~~IiHRDLKP~NILl~~~~~~~iKL~DFGla~~~~~~-- 528 (966)
||+. ++|.+++.... ..+++.+++.++.||+.||+|||+.||+||||||+|||+++ .+.+||+|||++......
T Consensus 88 e~~~-~~l~~~l~~~~-~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nil~~~--~~~~kL~dfg~~~~~~~~~~ 163 (309)
T cd07845 88 EYCE-QDLASLLDNMP-TPFSESQVKCLMLQLLRGLQYLHENFIIHRDLKVSNLLLTD--KGCLKIADFGLARTYGLPAK 163 (309)
T ss_pred ecCC-CCHHHHHHhcc-cCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECC--CCCEEECccceeeecCCccC
Confidence 9996 58888886543 36899999999999999999999999999999999999975 568999999999765432
Q ss_pred -CccccccccccCchhhccCCCCCCCcccchhhhhhhhhhhhcCCCCCCCcCcchhHHHHHHHHhcCCCCCCCCCCchhH
Q psy11767 529 -LHTPCFTLQYAAPEVLRQDKSGYDENCDLWSLGVILVNVLRQDKSGYDENCDLWSLGVILYTMLCGRVPFHARSRDDSA 607 (966)
Q Consensus 529 -~~~~~gT~~Y~APEvl~~~~~~~~~~~Di~SlGvil~el~~~~~~~y~~~~DIWSlGvilyemltG~~Pf~~~~~~~~~ 607 (966)
.....+++.|+|||++.. ...++.++|||||||++|+|++|++||.+.+..+..
T Consensus 164 ~~~~~~~~~~y~aPE~~~~-------------------------~~~~~~~~DvwslG~il~el~~g~~~f~~~~~~~~~ 218 (309)
T cd07845 164 PMTPKVVTLWYRAPELLLG-------------------------CTTYTTAIDMWAVGCILAELLAHKPLLPGKSEIEQL 218 (309)
T ss_pred CCCcccccccccChhhhcC-------------------------CCCcCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHH
Confidence 122345788999998752 223678899999999999999999999876543322
Q ss_pred HHHHHHHHc---------------CCCCCC-------chhhccCCHHHHHHHHHhcccCccccCChHHHHHHhhhhHH
Q psy11767 608 LSIMARIKE---------------GQFNFD-------AEAWSTVSSEAKELTKSLLTVNPAQRIRMMRVKLTFHAFHQ 663 (966)
Q Consensus 608 ~~~~~~i~~---------------~~~~~~-------~~~~~~is~e~~~Li~~~L~~dP~~R~t~~~v~~~~~~~~~ 663 (966)
..+...... +.+... ......+++++.+||.+||..||++|||+.++. .|+|+.
T Consensus 219 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~~il--~h~~f~ 294 (309)
T cd07845 219 DLIIQLLGTPNESIWPGFSDLPLVGKFTLPKQPYNNLKHKFPWLSEAGLRLLNFLLMYDPKKRATAEEAL--ESSYFK 294 (309)
T ss_pred HHHHHhcCCCChhhchhhhcccccccccccCCCCCchHHhccccCHHHHHHHHHHhcCChhhCcCHHHHh--cChhhc
Confidence 222221100 011111 011123688999999999999999999999763 466653
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing |
| >cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-35 Score=315.43 Aligned_cols=237 Identities=22% Similarity=0.387 Sum_probs=187.9
Q ss_pred ccccccccEEEEEEEc--CCCcEEEEEEeccccC------hHHHHHHHHHhcCCCCceEEEEEEEeCCeEEEEEEccCCC
Q psy11767 385 ILGDGSYSVCRRCVEK--STGQEYAVKIISRKID------CSEEINLLRACQGHPNIVNLHCVFQDEVHTYLVLELLKGG 456 (966)
Q Consensus 385 ~LG~G~fG~Vy~a~~~--~tg~~vAvK~i~~~~~------~~~Ei~iL~~l~~HpnIV~l~~~~~~~~~~~lVmEy~~gg 456 (966)
.||+|+||.||+|.+. .++..||+|++..... ..+|+.+|+.+ +||||++++++++. ...++||||+++|
T Consensus 2 ~ig~G~~g~v~~~~~~~~~~~~~vavk~~~~~~~~~~~~~~~~E~~~l~~l-~h~~ii~~~~~~~~-~~~~lv~e~~~~~ 79 (257)
T cd05115 2 ELGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENEKSVRDEMMREAEIMHQL-DNPYIVRMIGVCEA-EALMLVMEMASGG 79 (257)
T ss_pred ccCCCCcccEEEEEEecCCCceeEEEEEcccccChHHHHHHHHHHHHHHhc-CCCCeEEEEEEEcC-CCeEEEEEeCCCC
Confidence 3899999999999775 4566799999865432 44688999998 59999999998864 4689999999999
Q ss_pred CHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCcEEEecCCCCCEEEEeecccccccCCC------c
Q psy11767 457 ELLDRIRQKGRCGFTENEASRIMRQLVAAVHFMHSRGVVHRDLKPENLLFSDPAGDNIKVVDFGFACLKRESL------H 530 (966)
Q Consensus 457 ~L~~~l~~~~~~~l~e~~~~~i~~Qil~aL~yLHs~~IiHRDLKP~NILl~~~~~~~iKL~DFGla~~~~~~~------~ 530 (966)
+|.+++.... ..+++..++.++.||+.||+|||++|++||||||+|||++. ++.+||+|||++....... .
T Consensus 80 ~L~~~l~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nil~~~--~~~~kl~dfg~~~~~~~~~~~~~~~~ 156 (257)
T cd05115 80 PLNKFLSGKK-DEITVSNVVELMHQVSMGMKYLEGKNFVHRDLAARNVLLVN--QHYAKISDFGLSKALGADDSYYKARS 156 (257)
T ss_pred CHHHHHHhCC-CCCCHHHHHHHHHHHHHHHHHHHhcCeeecccchheEEEcC--CCcEEeccCCccccccCCccceeccC
Confidence 9999987543 36899999999999999999999999999999999999975 5689999999986433211 1
Q ss_pred cccccccccCchhhccCCCCCCCcccchhhhhhhhhhhhcCCCCCCCcCcchhHHHHHHHHhc-CCCCCCCCCCchhHHH
Q psy11767 531 TPCFTLQYAAPEVLRQDKSGYDENCDLWSLGVILVNVLRQDKSGYDENCDLWSLGVILYTMLC-GRVPFHARSRDDSALS 609 (966)
Q Consensus 531 ~~~gT~~Y~APEvl~~~~~~~~~~~Di~SlGvil~el~~~~~~~y~~~~DIWSlGvilyemlt-G~~Pf~~~~~~~~~~~ 609 (966)
...+++.|+|||++.. ..++.++|||||||++|+|++ |..||...... .
T Consensus 157 ~~~~~~~y~aPE~~~~--------------------------~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~----~ 206 (257)
T cd05115 157 AGKWPLKWYAPECINF--------------------------RKFSSRSDVWSYGITMWEAFSYGQKPYKKMKGP----E 206 (257)
T ss_pred CCCCCcccCCHHHHcc--------------------------CCCCchhhHHHHHHHHHHHhcCCCCCcCcCCHH----H
Confidence 1223578999998752 236778999999999999996 99999865432 2
Q ss_pred HHHHHHcCCCCCCchhhccCCHHHHHHHHHhcccCccccCChHHHHHHhh
Q psy11767 610 IMARIKEGQFNFDAEAWSTVSSEAKELTKSLLTVNPAQRIRMMRVKLTFH 659 (966)
Q Consensus 610 ~~~~i~~~~~~~~~~~~~~is~e~~~Li~~~L~~dP~~R~t~~~v~~~~~ 659 (966)
+...+..+... ......++++.++|.+||..||++||++.++...+.
T Consensus 207 ~~~~~~~~~~~---~~~~~~~~~l~~li~~c~~~~~~~Rp~~~~i~~~l~ 253 (257)
T cd05115 207 VMSFIEQGKRL---DCPAECPPEMYALMKDCWIYKWEDRPNFAKVEERMR 253 (257)
T ss_pred HHHHHHCCCCC---CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHh
Confidence 33444443321 122356899999999999999999999998865443
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho |
| >cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-35 Score=322.19 Aligned_cols=244 Identities=31% Similarity=0.497 Sum_probs=190.0
Q ss_pred ccccccccccccEEEEEEEcCCCcEEEEEEecccc------ChHHHHHHHHHhcCCCCceEEEEEEEeCCeEEEEEEccC
Q psy11767 381 DKAGILGDGSYSVCRRCVEKSTGQEYAVKIISRKI------DCSEEINLLRACQGHPNIVNLHCVFQDEVHTYLVLELLK 454 (966)
Q Consensus 381 ~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~------~~~~Ei~iL~~l~~HpnIV~l~~~~~~~~~~~lVmEy~~ 454 (966)
+..+.||+|+||.||+|.++.+++.||||.+.... ...+|+++|+.+ +||||+++++++.++.+.|+||||+.
T Consensus 8 ~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~ 86 (291)
T cd07844 8 KKLDKLGEGSYATVYKGRSKLTGQLVALKEIRLEHEEGAPFTAIREASLLKDL-KHANIVTLHDIIHTKKTLTLVFEYLD 86 (291)
T ss_pred eEEEEEeecCCeEEEEEEEcCCCcEEEEEEEecccccCCchhHHHHHHHHhhC-CCcceeeEEEEEecCCeEEEEEecCC
Confidence 34688999999999999999999999999986432 235699999998 59999999999999999999999997
Q ss_pred CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCcEEEecCCCCCEEEEeecccccccCC---Ccc
Q psy11767 455 GGELLDRIRQKGRCGFTENEASRIMRQLVAAVHFMHSRGVVHRDLKPENLLFSDPAGDNIKVVDFGFACLKRES---LHT 531 (966)
Q Consensus 455 gg~L~~~l~~~~~~~l~e~~~~~i~~Qil~aL~yLHs~~IiHRDLKP~NILl~~~~~~~iKL~DFGla~~~~~~---~~~ 531 (966)
++|.+++..... .+++..++.++.||+.||.|||++||+||||||+|||++. .+.+||+|||++...... ...
T Consensus 87 -~~L~~~~~~~~~-~~~~~~~~~~~~ql~~al~~lH~~~i~H~dl~p~nil~~~--~~~~kl~dfg~~~~~~~~~~~~~~ 162 (291)
T cd07844 87 -TDLKQYMDDCGG-GLSMHNVRLFLFQLLRGLAYCHQRRVLHRDLKPQNLLISE--RGELKLADFGLARAKSVPSKTYSN 162 (291)
T ss_pred -CCHHHHHHhCCC-CCCHHHHHHHHHHHHHHHHHHHhCCeecccCCHHHEEEcC--CCCEEECccccccccCCCCccccc
Confidence 599998876543 6899999999999999999999999999999999999975 568999999998653321 122
Q ss_pred ccccccccCchhhccCCCCCCCcccchhhhhhhhhhhhcCCCCCCCcCcchhHHHHHHHHhcCCCCCCCCCCchhHHHHH
Q psy11767 532 PCFTLQYAAPEVLRQDKSGYDENCDLWSLGVILVNVLRQDKSGYDENCDLWSLGVILYTMLCGRVPFHARSRDDSALSIM 611 (966)
Q Consensus 532 ~~gT~~Y~APEvl~~~~~~~~~~~Di~SlGvil~el~~~~~~~y~~~~DIWSlGvilyemltG~~Pf~~~~~~~~~~~~~ 611 (966)
..++..|+|||++.. ...++.++||||+||++|+|++|+.||.............
T Consensus 163 ~~~~~~~~aPE~~~~-------------------------~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~~~~~~~ 217 (291)
T cd07844 163 EVVTLWYRPPDVLLG-------------------------STEYSTSLDMWGVGCIFYEMATGRPLFPGSTDVEDQLHKI 217 (291)
T ss_pred cccccccCCcHHhhc-------------------------CcccCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHHHHHH
Confidence 346888999998742 1236778999999999999999999997654221111111
Q ss_pred HHHHcC----------------CCCC----C---chhhccCC--HHHHHHHHHhcccCccccCChHHH
Q psy11767 612 ARIKEG----------------QFNF----D---AEAWSTVS--SEAKELTKSLLTVNPAQRIRMMRV 654 (966)
Q Consensus 612 ~~i~~~----------------~~~~----~---~~~~~~is--~e~~~Li~~~L~~dP~~R~t~~~v 654 (966)
...... .... . ......++ .++.+++.+||..||++|||+.++
T Consensus 218 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~p~~Rps~~e~ 285 (291)
T cd07844 218 FRVLGTPTEETWPGVSSNPEFKPYSFPFYPPRPLINHAPRLDRIPHGEELALKFLQYEPKKRISAAEA 285 (291)
T ss_pred HHhcCCCChhhhhhhhhccccccccccccCChhHHHhCcCCCCchhHHHHHHHHhccCcccccCHHHH
Confidence 111000 0000 0 01112344 889999999999999999999876
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the |
| >PRK13184 pknD serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-35 Score=358.70 Aligned_cols=246 Identities=23% Similarity=0.359 Sum_probs=191.5
Q ss_pred cccccccccccEEEEEEEcCCCcEEEEEEecccc--------ChHHHHHHHHHhcCCCCceEEEEEEEeCCeEEEEEEcc
Q psy11767 382 KAGILGDGSYSVCRRCVEKSTGQEYAVKIISRKI--------DCSEEINLLRACQGHPNIVNLHCVFQDEVHTYLVLELL 453 (966)
Q Consensus 382 ~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~--------~~~~Ei~iL~~l~~HpnIV~l~~~~~~~~~~~lVmEy~ 453 (966)
..++||+|+||.||+|.+..+|+.||||++.... ...+|+++++.+ +|||||++++++.+++..|+||||+
T Consensus 6 Ii~~LGkGgfG~VYlA~d~~tg~~VAIK~I~~~l~~~e~~~~rflrEi~ILs~L-~HPNIVkl~~v~~d~~~lyLVMEY~ 84 (932)
T PRK13184 6 IIRLIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADL-IHPGIVPVYSICSDGDPVYYTMPYI 84 (932)
T ss_pred EEEEEecCCCEEEEEEEECCCCcEEEEEEECcccccCHHHHHHHHHHHHHHHhC-CCcCcCeEEEEEeeCCEEEEEEEcC
Confidence 3688999999999999999999999999986432 234689999888 5999999999999999999999999
Q ss_pred CCCCHHHHHHhcC---------CCCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCcEEEecCCCCCEEEEeeccccc
Q psy11767 454 KGGELLDRIRQKG---------RCGFTENEASRIMRQLVAAVHFMHSRGVVHRDLKPENLLFSDPAGDNIKVVDFGFACL 524 (966)
Q Consensus 454 ~gg~L~~~l~~~~---------~~~l~e~~~~~i~~Qil~aL~yLHs~~IiHRDLKP~NILl~~~~~~~iKL~DFGla~~ 524 (966)
+||+|.+++.... ...++...+..++.||+.||+|||++||+||||||+|||++. .+.+||+|||+|..
T Consensus 85 eGGSL~~lL~s~~~~~~l~e~~~~~lsv~~iL~I~~QIa~AL~yLHs~GIIHRDLKPeNILLd~--dg~vKLiDFGLAk~ 162 (932)
T PRK13184 85 EGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIEYVHSKGVLHRDLKPDNILLGL--FGEVVILDWGAAIF 162 (932)
T ss_pred CCCCHHHHHHHhhhccccchhhhcccCHHHHHHHHHHHHHHHHHHHHCCccccCCchheEEEcC--CCCEEEEecCccee
Confidence 9999999986421 123566788999999999999999999999999999999975 56899999999975
Q ss_pred ccC---------------------CCccccccccccCchhhccCCCCCCCcccchhhhhhhhhhhhcCCCCCCCcCcchh
Q psy11767 525 KRE---------------------SLHTPCFTLQYAAPEVLRQDKSGYDENCDLWSLGVILVNVLRQDKSGYDENCDLWS 583 (966)
Q Consensus 525 ~~~---------------------~~~~~~gT~~Y~APEvl~~~~~~~~~~~Di~SlGvil~el~~~~~~~y~~~~DIWS 583 (966)
... .....+||+.|||||++.. ..++.++||||
T Consensus 163 i~~~~~~~~~l~~~~~~s~~s~~t~~g~~vGT~~YmAPE~l~g--------------------------~~~S~kSDIWS 216 (932)
T PRK13184 163 KKLEEEDLLDIDVDERNICYSSMTIPGKIVGTPDYMAPERLLG--------------------------VPASESTDIYA 216 (932)
T ss_pred cccccccccccccccccccccccccCCCCCCCCCCCCHHHhcC--------------------------CCCCcHhHHHH
Confidence 410 0012468999999998852 23678999999
Q ss_pred HHHHHHHHhcCCCCCCCCCCchhHHHHHHHHHcCCCCCCchhhccCCHHHHHHHHHhcccCccccCChHH-HHHHhhhh
Q psy11767 584 LGVILYTMLCGRVPFHARSRDDSALSIMARIKEGQFNFDAEAWSTVSSEAKELTKSLLTVNPAQRIRMMR-VKLTFHAF 661 (966)
Q Consensus 584 lGvilyemltG~~Pf~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~is~e~~~Li~~~L~~dP~~R~t~~~-v~~~~~~~ 661 (966)
+||++|+|++|+.||......... ....+.. .. ....+..+++.+.+++.+||..||++|++..+ +...+..+
T Consensus 217 LGVILyELLTG~~PF~~~~~~ki~--~~~~i~~-P~--~~~p~~~iP~~L~~LI~rcL~~DP~kR~ss~eeLl~~Le~~ 290 (932)
T PRK13184 217 LGVILYQMLTLSFPYRRKKGRKIS--YRDVILS-PI--EVAPYREIPPFLSQIAMKALAVDPAERYSSVQELKQDLEPH 290 (932)
T ss_pred HHHHHHHHHHCCCCCCCcchhhhh--hhhhccC-hh--hccccccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHH
Confidence 999999999999999764432111 0011111 00 11123467899999999999999999987653 43334443
|
|
| >cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-35 Score=315.28 Aligned_cols=241 Identities=21% Similarity=0.418 Sum_probs=193.8
Q ss_pred ccccccccccccEEEEEEEcCCCcEEEEEEecccc----ChHHHHHHHHHhcCCCCceEEEEEEEeCCeEEEEEEccCCC
Q psy11767 381 DKAGILGDGSYSVCRRCVEKSTGQEYAVKIISRKI----DCSEEINLLRACQGHPNIVNLHCVFQDEVHTYLVLELLKGG 456 (966)
Q Consensus 381 ~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~----~~~~Ei~iL~~l~~HpnIV~l~~~~~~~~~~~lVmEy~~gg 456 (966)
+..+.||+|+||.||+|.+.. ++.||||.+.... ...+|+.+|+.+. ||||+++++++......|+||||++++
T Consensus 9 ~~~~~lg~g~~~~v~~~~~~~-~~~v~iK~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~~lv~e~~~~~ 86 (261)
T cd05068 9 QLLRKLGAGQFGEVWEGLWNN-TTPVAVKTLKPGTMDPKDFLAEAQIMKKLR-HPKLIQLYAVCTLEEPIYIVTELMKYG 86 (261)
T ss_pred eeEEEecccCCccEEEEEecC-CeEEEEEeeCCCcccHHHHHHHHHHHHHCC-CCCccceeEEEecCCCeeeeeecccCC
Confidence 346789999999999999754 5789999986532 2456899999984 999999999999999999999999999
Q ss_pred CHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCcEEEecCCCCCEEEEeecccccccCCC-cc---c
Q psy11767 457 ELLDRIRQKGRCGFTENEASRIMRQLVAAVHFMHSRGVVHRDLKPENLLFSDPAGDNIKVVDFGFACLKRESL-HT---P 532 (966)
Q Consensus 457 ~L~~~l~~~~~~~l~e~~~~~i~~Qil~aL~yLHs~~IiHRDLKP~NILl~~~~~~~iKL~DFGla~~~~~~~-~~---~ 532 (966)
+|.+++.......+++..+..++.|++.||.|||++||+||||||+|||+++ .+.+||+|||++....... .. .
T Consensus 87 ~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~--~~~~~l~dfg~~~~~~~~~~~~~~~~ 164 (261)
T cd05068 87 SLLEYLQGGAGRALKLPQLIDMAAQVASGMAYLEAQNYIHRDLAARNVLVGE--NNICKVADFGLARVIKEDIYEAREGA 164 (261)
T ss_pred cHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCcceEEEcC--CCCEEECCcceEEEccCCcccccCCC
Confidence 9999997755446899999999999999999999999999999999999985 5689999999997654221 11 1
Q ss_pred cccccccCchhhccCCCCCCCcccchhhhhhhhhhhhcCCCCCCCcCcchhHHHHHHHHhc-CCCCCCCCCCchhHHHHH
Q psy11767 533 CFTLQYAAPEVLRQDKSGYDENCDLWSLGVILVNVLRQDKSGYDENCDLWSLGVILYTMLC-GRVPFHARSRDDSALSIM 611 (966)
Q Consensus 533 ~gT~~Y~APEvl~~~~~~~~~~~Di~SlGvil~el~~~~~~~y~~~~DIWSlGvilyemlt-G~~Pf~~~~~~~~~~~~~ 611 (966)
..+..|+|||++.. ..++.++|||||||++|+|++ |+.||.+.... ..+
T Consensus 165 ~~~~~y~aPE~~~~--------------------------~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~----~~~ 214 (261)
T cd05068 165 KFPIKWTAPEAALY--------------------------NRFSIKSDVWSFGILLTEIVTYGRMPYPGMTNA----EVL 214 (261)
T ss_pred cCceeccCcccccc--------------------------CCCCchhhHHHHHHHHHHHHhcCCCCCCCCCHH----HHH
Confidence 22457999998742 236788999999999999999 99999865432 233
Q ss_pred HHHHcCCCCCCchhhccCCHHHHHHHHHhcccCccccCChHHHHHHh
Q psy11767 612 ARIKEGQFNFDAEAWSTVSSEAKELTKSLLTVNPAQRIRMMRVKLTF 658 (966)
Q Consensus 612 ~~i~~~~~~~~~~~~~~is~e~~~Li~~~L~~dP~~R~t~~~v~~~~ 658 (966)
..+..+. ... ....++..+.+++.+||..||++||++.++...+
T Consensus 215 ~~~~~~~-~~~--~~~~~~~~~~~li~~~l~~~P~~Rp~~~~l~~~l 258 (261)
T cd05068 215 QQVDQGY-RMP--CPPGCPKELYDIMLDCWKEDPDDRPTFETLQWKL 258 (261)
T ss_pred HHHHcCC-CCC--CCCcCCHHHHHHHHHHhhcCcccCCCHHHHHHHH
Confidence 4444332 111 1235788999999999999999999999875443
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a |
| >cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-35 Score=315.37 Aligned_cols=241 Identities=22% Similarity=0.417 Sum_probs=192.8
Q ss_pred cccccccccccccEEEEEEEcCCCcEEEEEEecccc----ChHHHHHHHHHhcCCCCceEEEEEEEeCCeEEEEEEccCC
Q psy11767 380 LDKAGILGDGSYSVCRRCVEKSTGQEYAVKIISRKI----DCSEEINLLRACQGHPNIVNLHCVFQDEVHTYLVLELLKG 455 (966)
Q Consensus 380 ~~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~----~~~~Ei~iL~~l~~HpnIV~l~~~~~~~~~~~lVmEy~~g 455 (966)
|+..++||+|+||.||+|... +++.||+|.+.... ...+|+.+|+.+ +||||+++++++. ....|+||||+.+
T Consensus 8 ~~~~~~ig~G~~g~v~~~~~~-~~~~~a~K~~~~~~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~-~~~~~~v~e~~~~ 84 (260)
T cd05067 8 LKLVKKLGAGQFGEVWMGYYN-GHTKVAIKSLKQGSMSPEAFLAEANLMKQL-QHPRLVRLYAVVT-QEPIYIITEYMEN 84 (260)
T ss_pred ceeeeeeccCccceEEeeecC-CCceEEEEEecCCCCcHHHHHHHHHHHHhc-CCcCeeeEEEEEc-cCCcEEEEEcCCC
Confidence 444789999999999999865 57889999987533 245699999988 5999999999875 4568999999999
Q ss_pred CCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCcEEEecCCCCCEEEEeecccccccC-CC---cc
Q psy11767 456 GELLDRIRQKGRCGFTENEASRIMRQLVAAVHFMHSRGVVHRDLKPENLLFSDPAGDNIKVVDFGFACLKRE-SL---HT 531 (966)
Q Consensus 456 g~L~~~l~~~~~~~l~e~~~~~i~~Qil~aL~yLHs~~IiHRDLKP~NILl~~~~~~~iKL~DFGla~~~~~-~~---~~ 531 (966)
++|.+++.......+++.++..++.|++.||+|||+.|++||||||+||++++ ++.++|+|||++..... .. ..
T Consensus 85 ~~L~~~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~i~H~dl~p~ni~i~~--~~~~~l~dfg~~~~~~~~~~~~~~~ 162 (260)
T cd05067 85 GSLVDFLKTPEGIKLTINKLIDMAAQIAEGMAFIERKNYIHRDLRAANILVSE--TLCCKIADFGLARLIEDNEYTAREG 162 (260)
T ss_pred CCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCeecccccHHhEEEcC--CCCEEEccCcceeecCCCCcccccC
Confidence 99999997765556899999999999999999999999999999999999985 56899999999865442 11 12
Q ss_pred ccccccccCchhhccCCCCCCCcccchhhhhhhhhhhhcCCCCCCCcCcchhHHHHHHHHhc-CCCCCCCCCCchhHHHH
Q psy11767 532 PCFTLQYAAPEVLRQDKSGYDENCDLWSLGVILVNVLRQDKSGYDENCDLWSLGVILYTMLC-GRVPFHARSRDDSALSI 610 (966)
Q Consensus 532 ~~gT~~Y~APEvl~~~~~~~~~~~Di~SlGvil~el~~~~~~~y~~~~DIWSlGvilyemlt-G~~Pf~~~~~~~~~~~~ 610 (966)
..++..|+|||++.. ..++.++|||||||++|+|++ |++||.+.+.. ..
T Consensus 163 ~~~~~~y~~pe~~~~--------------------------~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~----~~ 212 (260)
T cd05067 163 AKFPIKWTAPEAINY--------------------------GTFTIKSDVWSFGILLTEIVTYGRIPYPGMTNP----EV 212 (260)
T ss_pred CcccccccCHHHhcc--------------------------CCcCcccchHHHHHHHHHHHhCCCCCCCCCChH----HH
Confidence 335678999998742 235778999999999999998 99999865432 22
Q ss_pred HHHHHcCCCCCCchhhccCCHHHHHHHHHhcccCccccCChHHHHHHh
Q psy11767 611 MARIKEGQFNFDAEAWSTVSSEAKELTKSLLTVNPAQRIRMMRVKLTF 658 (966)
Q Consensus 611 ~~~i~~~~~~~~~~~~~~is~e~~~Li~~~L~~dP~~R~t~~~v~~~~ 658 (966)
...+..+.. .+.....+.++.+++.+||..||++||++.++...+
T Consensus 213 ~~~~~~~~~---~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l 257 (260)
T cd05067 213 IQNLERGYR---MPRPDNCPEELYELMRLCWKEKPEERPTFEYLRSVL 257 (260)
T ss_pred HHHHHcCCC---CCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHh
Confidence 333333321 122345788999999999999999999999875443
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr |
| >cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-35 Score=319.23 Aligned_cols=242 Identities=20% Similarity=0.371 Sum_probs=192.4
Q ss_pred ccccccccccccEEEEEEEcC-----CCcEEEEEEecccc------ChHHHHHHHHHhcCCCCceEEEEEEEeCCeEEEE
Q psy11767 381 DKAGILGDGSYSVCRRCVEKS-----TGQEYAVKIISRKI------DCSEEINLLRACQGHPNIVNLHCVFQDEVHTYLV 449 (966)
Q Consensus 381 ~~~~~LG~G~fG~Vy~a~~~~-----tg~~vAvK~i~~~~------~~~~Ei~iL~~l~~HpnIV~l~~~~~~~~~~~lV 449 (966)
+..+.||+|+||.||+|.+.. ++..||+|.+.... ....|+.+++.+ +|+||+++++++.+....|+|
T Consensus 9 ~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~~~~lv 87 (277)
T cd05036 9 TLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALIMSKF-NHQNIVRLIGVSFERLPRFIL 87 (277)
T ss_pred EeeeECCCCCCCcEEEEEEecCCCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhC-CCCCEeeEEEEEccCCCcEEE
Confidence 346789999999999999987 78899999886432 245688888888 599999999999999999999
Q ss_pred EEccCCCCHHHHHHhcCC-----CCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCcEEEecCC-CCCEEEEeecccc
Q psy11767 450 LELLKGGELLDRIRQKGR-----CGFTENEASRIMRQLVAAVHFMHSRGVVHRDLKPENLLFSDPA-GDNIKVVDFGFAC 523 (966)
Q Consensus 450 mEy~~gg~L~~~l~~~~~-----~~l~e~~~~~i~~Qil~aL~yLHs~~IiHRDLKP~NILl~~~~-~~~iKL~DFGla~ 523 (966)
|||++|++|.+++..... ..+++..+..++.||+.||+|||+++++||||||+|||+++.. ...+||+|||+++
T Consensus 88 ~e~~~g~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~nil~~~~~~~~~~kl~dfg~~~ 167 (277)
T cd05036 88 LELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLEENHFIHRDIAARNCLLTCKGPGRVAKIADFGMAR 167 (277)
T ss_pred EecCCCCCHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccchheEEEeccCCCcceEeccCcccc
Confidence 999999999999976532 2489999999999999999999999999999999999997532 2369999999997
Q ss_pred cccCCC-----ccccccccccCchhhccCCCCCCCcccchhhhhhhhhhhhcCCCCCCCcCcchhHHHHHHHHhc-CCCC
Q psy11767 524 LKRESL-----HTPCFTLQYAAPEVLRQDKSGYDENCDLWSLGVILVNVLRQDKSGYDENCDLWSLGVILYTMLC-GRVP 597 (966)
Q Consensus 524 ~~~~~~-----~~~~gT~~Y~APEvl~~~~~~~~~~~Di~SlGvil~el~~~~~~~y~~~~DIWSlGvilyemlt-G~~P 597 (966)
...... .....++.|+|||++.. ..++.++|||||||++|+|++ |..|
T Consensus 168 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~--------------------------~~~~~~~DiwslG~il~el~~~g~~p 221 (277)
T cd05036 168 DIYRASYYRKGGRAMLPIKWMPPEAFLD--------------------------GIFTSKTDVWSFGVLLWEIFSLGYMP 221 (277)
T ss_pred ccCCccceecCCCCCccHhhCCHHHHhc--------------------------CCcCchhHHHHHHHHHHHHHcCCCCC
Confidence 543211 12223567999999852 236889999999999999996 9999
Q ss_pred CCCCCCchhHHHHHHHHHcCCCCCCchhhccCCHHHHHHHHHhcccCccccCChHHHHH
Q psy11767 598 FHARSRDDSALSIMARIKEGQFNFDAEAWSTVSSEAKELTKSLLTVNPAQRIRMMRVKL 656 (966)
Q Consensus 598 f~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~is~e~~~Li~~~L~~dP~~R~t~~~v~~ 656 (966)
|...... .++..+..+.. ......++.++.+++.+||+.||++||++.++..
T Consensus 222 f~~~~~~----~~~~~~~~~~~---~~~~~~~~~~~~~~i~~cl~~~p~~Rps~~~vl~ 273 (277)
T cd05036 222 YPGRTNQ----EVMEFVTGGGR---LDPPKGCPGPVYRIMTDCWQHTPEDRPNFATILE 273 (277)
T ss_pred CCCCCHH----HHHHHHHcCCc---CCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHH
Confidence 9875533 22333332211 1112357889999999999999999999998743
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well |
| >cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-35 Score=319.99 Aligned_cols=242 Identities=31% Similarity=0.495 Sum_probs=190.3
Q ss_pred ccccccccEEEEEEEcCCCcEEEEEEeccccC--------hHHHHHHHHHh--cCCCCceEEEEEEEeCCeEEEEEEccC
Q psy11767 385 ILGDGSYSVCRRCVEKSTGQEYAVKIISRKID--------CSEEINLLRAC--QGHPNIVNLHCVFQDEVHTYLVLELLK 454 (966)
Q Consensus 385 ~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~~--------~~~Ei~iL~~l--~~HpnIV~l~~~~~~~~~~~lVmEy~~ 454 (966)
+||+|+||.||+|.+..+|+.||||++.++.. ...|..+++.+ .+||||++++++|.++...|+||||++
T Consensus 1 ~ig~g~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~ 80 (278)
T cd05606 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMN 80 (278)
T ss_pred CcccCCCeEEEEEEEecCCCEEEEEEeeccccccchhHHHHHHHHHHHHHHHhCCCCcEeeeeeeeecCCEEEEEEecCC
Confidence 48999999999999999999999999865321 12233333322 369999999999999999999999999
Q ss_pred CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCcEEEecCCCCCEEEEeecccccccC-CCcccc
Q psy11767 455 GGELLDRIRQKGRCGFTENEASRIMRQLVAAVHFMHSRGVVHRDLKPENLLFSDPAGDNIKVVDFGFACLKRE-SLHTPC 533 (966)
Q Consensus 455 gg~L~~~l~~~~~~~l~e~~~~~i~~Qil~aL~yLHs~~IiHRDLKP~NILl~~~~~~~iKL~DFGla~~~~~-~~~~~~ 533 (966)
||+|.+++...+ .+++..++.++.|++.||+|||+.+|+||||||+|||++. ++.+||+|||++..... .....+
T Consensus 81 g~~L~~~l~~~~--~l~~~~~~~~~~ql~~~l~~lH~~~i~H~di~p~nili~~--~~~~kl~dfg~~~~~~~~~~~~~~ 156 (278)
T cd05606 81 GGDLHYHLSQHG--VFSEAEMRFYAAEIILGLEHMHNRFVVYRDLKPANILLDE--HGHVRISDLGLACDFSKKKPHASV 156 (278)
T ss_pred CCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCEEcCCCCHHHEEECC--CCCEEEccCcCccccCccCCcCcC
Confidence 999999887654 5999999999999999999999999999999999999975 56899999999865432 223457
Q ss_pred ccccccCchhhccCCCCCCCcccchhhhhhhhhhhhcCCCCCCCcCcchhHHHHHHHHhcCCCCCCCCCCchhHHHHHHH
Q psy11767 534 FTLQYAAPEVLRQDKSGYDENCDLWSLGVILVNVLRQDKSGYDENCDLWSLGVILYTMLCGRVPFHARSRDDSALSIMAR 613 (966)
Q Consensus 534 gT~~Y~APEvl~~~~~~~~~~~Di~SlGvil~el~~~~~~~y~~~~DIWSlGvilyemltG~~Pf~~~~~~~~~~~~~~~ 613 (966)
+|..|+|||++.. ...|+.++||||+||++|+|++|+.||........ ......
T Consensus 157 ~~~~y~aPE~~~~-------------------------~~~~~~~~Di~s~G~~l~~l~~g~~p~~~~~~~~~-~~~~~~ 210 (278)
T cd05606 157 GTHGYMAPEVLQK-------------------------GVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDK-HEIDRM 210 (278)
T ss_pred CCcCCcCcHHhcC-------------------------CCCCCcccchHhHHHHHHHHHhCCCCCCCCCccch-HHHHHH
Confidence 8999999998752 12367889999999999999999999986543221 122222
Q ss_pred HHcCCCCCCchhhccCCHHHHHHHHHhcccCccccC-----ChHHHHHHhhhhH
Q psy11767 614 IKEGQFNFDAEAWSTVSSEAKELTKSLLTVNPAQRI-----RMMRVKLTFHAFH 662 (966)
Q Consensus 614 i~~~~~~~~~~~~~~is~e~~~Li~~~L~~dP~~R~-----t~~~v~~~~~~~~ 662 (966)
+..... ..+..+|.++.+++.+||..||.+|+ ++.++. .|+|+
T Consensus 211 ~~~~~~----~~~~~~s~~~~~li~~~l~~~p~~R~~~~~~~~~~ll--~~~~~ 258 (278)
T cd05606 211 TLTMAV----ELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVK--EHPFF 258 (278)
T ss_pred hhccCC----CCCCcCCHHHHHHHHHHhhcCHHhccCCCCCCHHHHH--hCccc
Confidence 222222 22345789999999999999999999 777663 35554
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co |
| >KOG0695|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-36 Score=317.39 Aligned_cols=239 Identities=30% Similarity=0.554 Sum_probs=202.3
Q ss_pred ccccccccccccccEEEEEEEcCCCcEEEEEEeccccC--------hHHHHHHHHHhcCCCCceEEEEEEEeCCeEEEEE
Q psy11767 379 DLDKAGILGDGSYSVCRRCVEKSTGQEYAVKIISRKID--------CSEEINLLRACQGHPNIVNLHCVFQDEVHTYLVL 450 (966)
Q Consensus 379 ~~~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~~--------~~~Ei~iL~~l~~HpnIV~l~~~~~~~~~~~lVm 450 (966)
||..+.+||+|+|.+|.++++++|.+.||+|++++... ...|-.+..+..+||.+|.|+.+|+++..+++|.
T Consensus 251 df~ll~vigrgsyakvl~~~~~~t~qiyamkvvkkel~nddedidwvqtek~vfe~asn~pflvglhscfqtesrlffvi 330 (593)
T KOG0695|consen 251 DFDLLRVIGRGSYAKVLLVRLKKTDQIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNNPFLVGLHSCFQTESRLFFVI 330 (593)
T ss_pred cceeeeeecCcchhhhhheehcccceeeehhhHHHHhcCCcccchhHHhhHHHHHhccCCCeEEehhhhhcccceEEEEE
Confidence 56668999999999999999999999999999976521 3457778888889999999999999999999999
Q ss_pred EccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCcEEEecCCCCCEEEEeecccccc---cC
Q psy11767 451 ELLKGGELLDRIRQKGRCGFTENEASRIMRQLVAAVHFMHSRGVVHRDLKPENLLFSDPAGDNIKVVDFGFACLK---RE 527 (966)
Q Consensus 451 Ey~~gg~L~~~l~~~~~~~l~e~~~~~i~~Qil~aL~yLHs~~IiHRDLKP~NILl~~~~~~~iKL~DFGla~~~---~~ 527 (966)
||++||+|.-+++++. .|||+.++.+..+|+.||.|||+.|||.||||.+|+|++. .+++||+|+|+++.. ++
T Consensus 331 eyv~ggdlmfhmqrqr--klpeeharfys~ei~lal~flh~rgiiyrdlkldnvllda--eghikltdygmcke~l~~gd 406 (593)
T KOG0695|consen 331 EYVNGGDLMFHMQRQR--KLPEEHARFYSAEICLALNFLHERGIIYRDLKLDNVLLDA--EGHIKLTDYGMCKEGLGPGD 406 (593)
T ss_pred EEecCcceeeehhhhh--cCcHHHhhhhhHHHHHHHHHHhhcCeeeeeccccceEEcc--CCceeecccchhhcCCCCCc
Confidence 9999999998887665 6999999999999999999999999999999999999984 679999999999753 34
Q ss_pred CCccccccccccCchhhccCCCCCCCcccchhhhhhhhhhhhcCCCCCCCcCcchhHHHHHHHHhcCCCCCCCCC---Cc
Q psy11767 528 SLHTPCFTLQYAAPEVLRQDKSGYDENCDLWSLGVILVNVLRQDKSGYDENCDLWSLGVILYTMLCGRVPFHARS---RD 604 (966)
Q Consensus 528 ~~~~~~gT~~Y~APEvl~~~~~~~~~~~Di~SlGvil~el~~~~~~~y~~~~DIWSlGvilyemltG~~Pf~~~~---~~ 604 (966)
...+.||||.|.|||+++.. .|+.++|+|+|||+++||+.|+.||+-.. .+
T Consensus 407 ~tstfcgtpnyiapeilrge--------------------------eygfsvdwwalgvlmfemmagrspfdivgm~n~d 460 (593)
T KOG0695|consen 407 TTSTFCGTPNYIAPEILRGE--------------------------EYGFSVDWWALGVLMFEMMAGRSPFDIVGMDNPD 460 (593)
T ss_pred ccccccCCCcccchhhhccc--------------------------ccCceehHHHHHHHHHHHHcCCCCcceecCCCcc
Confidence 56789999999999999743 36778999999999999999999997321 11
Q ss_pred h-hHHHHHHHHHcCCCCCCchhhccCCHHHHHHHHHhcccCccccCCh
Q psy11767 605 D-SALSIMARIKEGQFNFDAEAWSTVSSEAKELTKSLLTVNPAQRIRM 651 (966)
Q Consensus 605 ~-~~~~~~~~i~~~~~~~~~~~~~~is~e~~~Li~~~L~~dP~~R~t~ 651 (966)
. ..--++.-|.+.++.++. .+|-.+..+++..|.+||.+|+..
T Consensus 461 ~ntedylfqvilekqiripr----slsvkas~vlkgflnkdp~erlgc 504 (593)
T KOG0695|consen 461 MNTEDYLFQVILEKQIRIPR----SLSVKASHVLKGFLNKDPKERLGC 504 (593)
T ss_pred cchhHHHHHHHhhhcccccc----eeehhhHHHHHHhhcCCcHHhcCC
Confidence 1 112234556666665443 578888999999999999999764
|
|
| >cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-35 Score=323.30 Aligned_cols=245 Identities=19% Similarity=0.309 Sum_probs=188.4
Q ss_pred ccccccccccEEEEEEEcCCC--------------cEEEEEEecccc------ChHHHHHHHHHhcCCCCceEEEEEEEe
Q psy11767 383 AGILGDGSYSVCRRCVEKSTG--------------QEYAVKIISRKI------DCSEEINLLRACQGHPNIVNLHCVFQD 442 (966)
Q Consensus 383 ~~~LG~G~fG~Vy~a~~~~tg--------------~~vAvK~i~~~~------~~~~Ei~iL~~l~~HpnIV~l~~~~~~ 442 (966)
.+.||+|+||.||+|++..++ ..||||.+.... ...+|+++|+.+ +||||+++++++..
T Consensus 10 ~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~ei~~l~~l-~h~~i~~~~~~~~~ 88 (295)
T cd05097 10 KEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTKTARNDFLKEIKIMSRL-KNPNIIRLLGVCVS 88 (295)
T ss_pred hhccCCCCCceEEecccccchhhccccCcccCCCceEEEEEecCCCCCHHHHHHHHHHHHHHHhC-CCCCcCeEEEEEcC
Confidence 578999999999999886532 358999986542 244699999998 59999999999999
Q ss_pred CCeEEEEEEccCCCCHHHHHHhcCC----------CCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCcEEEecCCCC
Q psy11767 443 EVHTYLVLELLKGGELLDRIRQKGR----------CGFTENEASRIMRQLVAAVHFMHSRGVVHRDLKPENLLFSDPAGD 512 (966)
Q Consensus 443 ~~~~~lVmEy~~gg~L~~~l~~~~~----------~~l~e~~~~~i~~Qil~aL~yLHs~~IiHRDLKP~NILl~~~~~~ 512 (966)
....|+||||+++++|.+++..... ..+++..+..++.|++.||+|||++|++||||||+|||+++ ++
T Consensus 89 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~i~H~dlkp~Nill~~--~~ 166 (295)
T cd05097 89 DDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLASLNFVHRDLATRNCLVGN--HY 166 (295)
T ss_pred CCccEEEEecCCCCcHHHHHHhccccccccccccCCcccHHHHHHHHHHHHHHHHHHHhcCeeccccChhhEEEcC--CC
Confidence 9999999999999999999865321 13688999999999999999999999999999999999975 55
Q ss_pred CEEEEeecccccccCC-----CccccccccccCchhhccCCCCCCCcccchhhhhhhhhhhhcCCCCCCCcCcchhHHHH
Q psy11767 513 NIKVVDFGFACLKRES-----LHTPCFTLQYAAPEVLRQDKSGYDENCDLWSLGVILVNVLRQDKSGYDENCDLWSLGVI 587 (966)
Q Consensus 513 ~iKL~DFGla~~~~~~-----~~~~~gT~~Y~APEvl~~~~~~~~~~~Di~SlGvil~el~~~~~~~y~~~~DIWSlGvi 587 (966)
.+||+|||++...... .....+++.|+|||++.. ..++.++|||||||+
T Consensus 167 ~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~--------------------------~~~~~~~DvwSlG~~ 220 (295)
T cd05097 167 TIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMAWESILL--------------------------GKFTTASDVWAFGVT 220 (295)
T ss_pred cEEecccccccccccCcceeccCcCcCceeecChhhhcc--------------------------CCcCchhhHHHHHHH
Confidence 8999999998653221 112234678999998752 236788999999999
Q ss_pred HHHHhc--CCCCCCCCCCchhHHHHHHHHHc-CCCCCCchhhccCCHHHHHHHHHhcccCccccCChHHHHHH
Q psy11767 588 LYTMLC--GRVPFHARSRDDSALSIMARIKE-GQFNFDAEAWSTVSSEAKELTKSLLTVNPAQRIRMMRVKLT 657 (966)
Q Consensus 588 lyemlt--G~~Pf~~~~~~~~~~~~~~~i~~-~~~~~~~~~~~~is~e~~~Li~~~L~~dP~~R~t~~~v~~~ 657 (966)
+|+|++ |..||...+..+........... +...+ ....+..++.+.+|+.+||+.||++||++.++...
T Consensus 221 l~el~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~i~~~ 292 (295)
T cd05097 221 LWEMFTLCKEQPYSLLSDEQVIENTGEFFRNQGRQIY-LSQTPLCPSPVFKLMMRCWSRDIKDRPTFNKIHHF 292 (295)
T ss_pred HHHHHHcCCCCCCcccChHHHHHHHHHhhhhcccccc-CCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHH
Confidence 999987 67888876543322211111111 11111 11223568899999999999999999999988543
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including |
| >cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-35 Score=315.09 Aligned_cols=244 Identities=23% Similarity=0.443 Sum_probs=196.9
Q ss_pred cccccccccccccEEEEEEEcCCCcEEEEEEecccc------ChHHHHHHHHHhcCCCCceEEEEEEEeCCeEEEEEEcc
Q psy11767 380 LDKAGILGDGSYSVCRRCVEKSTGQEYAVKIISRKI------DCSEEINLLRACQGHPNIVNLHCVFQDEVHTYLVLELL 453 (966)
Q Consensus 380 ~~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~------~~~~Ei~iL~~l~~HpnIV~l~~~~~~~~~~~lVmEy~ 453 (966)
|+..+.||.|+||+||+|....++..+|+|++.... ...+|+++|+.+ .|+||+++++.+..+...|+||||+
T Consensus 3 y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~~~~iv~e~~ 81 (267)
T cd06610 3 YELIEVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTSVDELRKEVQAMSQC-NHPNVVKYYTSFVVGDELWLVMPYL 81 (267)
T ss_pred ceeeeeecCCCCeEEEEEEEcCCCcEEEEEEeccCCcchHHHHHHHHHHHHHhc-CCCCEEEEEEEEeeCCEEEEEEecc
Confidence 344688999999999999999999999999986432 245688888887 5999999999999999999999999
Q ss_pred CCCCHHHHHHhcCC-CCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCcEEEecCCCCCEEEEeecccccccCCC---
Q psy11767 454 KGGELLDRIRQKGR-CGFTENEASRIMRQLVAAVHFMHSRGVVHRDLKPENLLFSDPAGDNIKVVDFGFACLKRESL--- 529 (966)
Q Consensus 454 ~gg~L~~~l~~~~~-~~l~e~~~~~i~~Qil~aL~yLHs~~IiHRDLKP~NILl~~~~~~~iKL~DFGla~~~~~~~--- 529 (966)
+|++|.+++..... ..+++..++.++.||+.||+|||+.||+||||||+||++++ ++.++|+|||++.......
T Consensus 82 ~~~~l~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lh~~~i~h~~l~p~ni~~~~--~~~~~l~df~~~~~~~~~~~~~ 159 (267)
T cd06610 82 SGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYLHSNGQIHRDIKAGNILLGE--DGSVKIADFGVSASLADGGDRT 159 (267)
T ss_pred CCCcHHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHhEEEcC--CCCEEEcccchHHHhccCcccc
Confidence 99999999976432 46899999999999999999999999999999999999985 4689999999986543221
Q ss_pred ----ccccccccccCchhhccCCCCCCCcccchhhhhhhhhhhhcCCCCCCCcCcchhHHHHHHHHhcCCCCCCCCCCch
Q psy11767 530 ----HTPCFTLQYAAPEVLRQDKSGYDENCDLWSLGVILVNVLRQDKSGYDENCDLWSLGVILYTMLCGRVPFHARSRDD 605 (966)
Q Consensus 530 ----~~~~gT~~Y~APEvl~~~~~~~~~~~Di~SlGvil~el~~~~~~~y~~~~DIWSlGvilyemltG~~Pf~~~~~~~ 605 (966)
....++..|+|||++... ..++.++|+|||||++|+|++|+.||...+...
T Consensus 160 ~~~~~~~~~~~~y~~Pe~~~~~-------------------------~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~ 214 (267)
T cd06610 160 RKVRKTFVGTPCWMAPEVMEQV-------------------------HGYDFKADIWSFGITAIELATGAAPYSKYPPMK 214 (267)
T ss_pred ccccccccCChhhcChHHHccc-------------------------cCcCcccchHhHhHHHHHHHhCCCCccccChhh
Confidence 223578899999988532 236788999999999999999999998654432
Q ss_pred hHHHHHHHHHcCCC-CCCc-hhhccCCHHHHHHHHHhcccCccccCChHHHH
Q psy11767 606 SALSIMARIKEGQF-NFDA-EAWSTVSSEAKELTKSLLTVNPAQRIRMMRVK 655 (966)
Q Consensus 606 ~~~~~~~~i~~~~~-~~~~-~~~~~is~e~~~Li~~~L~~dP~~R~t~~~v~ 655 (966)
.+..+..... .+.. ..+..+++++.+++.+||..||++||++.++.
T Consensus 215 ----~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~ll 262 (267)
T cd06610 215 ----VLMLTLQNDPPSLETGADYKKYSKSFRKMISLCLQKDPSKRPTAEELL 262 (267)
T ss_pred ----hHHHHhcCCCCCcCCccccccccHHHHHHHHHHcCCChhhCcCHHHHh
Confidence 2222222211 1111 11246789999999999999999999998763
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 |
| >cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-35 Score=318.21 Aligned_cols=241 Identities=20% Similarity=0.354 Sum_probs=192.3
Q ss_pred cccccccccccccEEEEEEEcCC-----CcEEEEEEeccccC------hHHHHHHHHHhcCCCCceEEEEEEEeCCeEEE
Q psy11767 380 LDKAGILGDGSYSVCRRCVEKST-----GQEYAVKIISRKID------CSEEINLLRACQGHPNIVNLHCVFQDEVHTYL 448 (966)
Q Consensus 380 ~~~~~~LG~G~fG~Vy~a~~~~t-----g~~vAvK~i~~~~~------~~~Ei~iL~~l~~HpnIV~l~~~~~~~~~~~l 448 (966)
|...+.||+|+||.||+|.+... +..||+|.+..... ..+|+.+|+.+ +||||+++++++......|+
T Consensus 8 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~~-~~~~i~~~~~~~~~~~~~~~ 86 (277)
T cd05032 8 ITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEFLNEASVMKEF-NCHHVVRLLGVVSTGQPTLV 86 (277)
T ss_pred eeEEeEecCCCCceEEEEEEeccCCCCcceeEEEEecCCccCHHHHHHHHHHHHHHHhC-CCCceeEEEEEEcCCCCcEE
Confidence 34468899999999999998754 48899999864432 34688888887 69999999999999999999
Q ss_pred EEEccCCCCHHHHHHhcCC--------CCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCcEEEecCCCCCEEEEeec
Q psy11767 449 VLELLKGGELLDRIRQKGR--------CGFTENEASRIMRQLVAAVHFMHSRGVVHRDLKPENLLFSDPAGDNIKVVDFG 520 (966)
Q Consensus 449 VmEy~~gg~L~~~l~~~~~--------~~l~e~~~~~i~~Qil~aL~yLHs~~IiHRDLKP~NILl~~~~~~~iKL~DFG 520 (966)
||||+++|+|.+++..... ..+++..+..++.||+.||.|||+.+|+||||||+|||++. ++.+||+|||
T Consensus 87 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~di~p~nill~~--~~~~kl~dfg 164 (277)
T cd05032 87 VMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMAYLAAKKFVHRDLAARNCMVAE--DLTVKIGDFG 164 (277)
T ss_pred EEecCCCCCHHHHHHhcccchhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccccChheEEEcC--CCCEEECCcc
Confidence 9999999999999975321 23788899999999999999999999999999999999985 5689999999
Q ss_pred ccccccCC-----CccccccccccCchhhccCCCCCCCcccchhhhhhhhhhhhcCCCCCCCcCcchhHHHHHHHHhc-C
Q psy11767 521 FACLKRES-----LHTPCFTLQYAAPEVLRQDKSGYDENCDLWSLGVILVNVLRQDKSGYDENCDLWSLGVILYTMLC-G 594 (966)
Q Consensus 521 la~~~~~~-----~~~~~gT~~Y~APEvl~~~~~~~~~~~Di~SlGvil~el~~~~~~~y~~~~DIWSlGvilyemlt-G 594 (966)
+++..... .....+|..|+|||.+.. ..++.++|||||||++|+|++ |
T Consensus 165 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~--------------------------~~~~~~~Di~slG~il~el~t~g 218 (277)
T cd05032 165 MTRDIYETDYYRKGGKGLLPVRWMAPESLKD--------------------------GVFTTKSDVWSFGVVLWEMATLA 218 (277)
T ss_pred cchhhccCcccccCCCCCccccccCHHHHhc--------------------------CCCCcccchHHHHHHHHHhhccC
Confidence 98654321 123345788999998742 236778999999999999998 9
Q ss_pred CCCCCCCCCchhHHHHHHHHHcCCCCCCchhhccCCHHHHHHHHHhcccCccccCChHHHHH
Q psy11767 595 RVPFHARSRDDSALSIMARIKEGQFNFDAEAWSTVSSEAKELTKSLLTVNPAQRIRMMRVKL 656 (966)
Q Consensus 595 ~~Pf~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~is~e~~~Li~~~L~~dP~~R~t~~~v~~ 656 (966)
..||.+.+.. .....+..+.... .....+.++.+++.+||..+|++|||+.++..
T Consensus 219 ~~p~~~~~~~----~~~~~~~~~~~~~---~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~ 273 (277)
T cd05032 219 EQPYQGLSNE----EVLKFVIDGGHLD---LPENCPDKLLELMRMCWQYNPKMRPTFLEIVS 273 (277)
T ss_pred CCCCccCCHH----HHHHHHhcCCCCC---CCCCCCHHHHHHHHHHcCCChhhCCCHHHHHH
Confidence 9999765432 2333444332211 12346889999999999999999999998744
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological |
| >cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-34 Score=323.39 Aligned_cols=243 Identities=22% Similarity=0.392 Sum_probs=193.1
Q ss_pred cccccccccccEEEEEEEcC-------CCcEEEEEEeccccC------hHHHHHHHHHhcCCCCceEEEEEEEeCCeEEE
Q psy11767 382 KAGILGDGSYSVCRRCVEKS-------TGQEYAVKIISRKID------CSEEINLLRACQGHPNIVNLHCVFQDEVHTYL 448 (966)
Q Consensus 382 ~~~~LG~G~fG~Vy~a~~~~-------tg~~vAvK~i~~~~~------~~~Ei~iL~~l~~HpnIV~l~~~~~~~~~~~l 448 (966)
..+.||+|+||.||+|.+.. .+..||+|++..... ...|+++|+.+.+||||+++++++.++...|+
T Consensus 16 ~~~~lg~G~~g~vy~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~l 95 (314)
T cd05099 16 LGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKDLADLISEMELMKLIGKHKNIINLLGVCTQEGPLYV 95 (314)
T ss_pred eeeeecCCCcccEEEeeecccCCccCCcceEEEEEecCCCCChHHHHHHHHHHHHHHhccCCCCeeeEEEEEccCCceEE
Confidence 46889999999999998642 355799999875432 34688999888779999999999999999999
Q ss_pred EEEccCCCCHHHHHHhcCC--------------CCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCcEEEecCCCCCE
Q psy11767 449 VLELLKGGELLDRIRQKGR--------------CGFTENEASRIMRQLVAAVHFMHSRGVVHRDLKPENLLFSDPAGDNI 514 (966)
Q Consensus 449 VmEy~~gg~L~~~l~~~~~--------------~~l~e~~~~~i~~Qil~aL~yLHs~~IiHRDLKP~NILl~~~~~~~i 514 (966)
||||+++|+|.+++..... ..+++.++..++.||+.||+|||++||+||||||+|||+++ ++.+
T Consensus 96 v~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~gi~H~dlkp~Nill~~--~~~~ 173 (314)
T cd05099 96 IVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLESRRCIHRDLAARNVLVTE--DNVM 173 (314)
T ss_pred EEecCCCCcHHHHHHhcCCCcccccccccCCcccccCHHHHHHHHHHHHHHHHHHHHCCeeeccccceeEEEcC--CCcE
Confidence 9999999999999976421 24889999999999999999999999999999999999975 5689
Q ss_pred EEEeecccccccCC-----CccccccccccCchhhccCCCCCCCcccchhhhhhhhhhhhcCCCCCCCcCcchhHHHHHH
Q psy11767 515 KVVDFGFACLKRES-----LHTPCFTLQYAAPEVLRQDKSGYDENCDLWSLGVILVNVLRQDKSGYDENCDLWSLGVILY 589 (966)
Q Consensus 515 KL~DFGla~~~~~~-----~~~~~gT~~Y~APEvl~~~~~~~~~~~Di~SlGvil~el~~~~~~~y~~~~DIWSlGvily 589 (966)
||+|||+++..... .....+++.|+|||++.. ..|+.++|||||||++|
T Consensus 174 kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~--------------------------~~~~~~~DiwslG~~l~ 227 (314)
T cd05099 174 KIADFGLARGVHDIDYYKKTSNGRLPVKWMAPEALFD--------------------------RVYTHQSDVWSFGILMW 227 (314)
T ss_pred EEccccccccccccccccccccCCCCccccCHHHHcc--------------------------CCcCccchhhHHHHHHH
Confidence 99999999754321 112234567999998852 23678899999999999
Q ss_pred HHhc-CCCCCCCCCCchhHHHHHHHHHcCCCCCCchhhccCCHHHHHHHHHhcccCccccCChHHHHHHhh
Q psy11767 590 TMLC-GRVPFHARSRDDSALSIMARIKEGQFNFDAEAWSTVSSEAKELTKSLLTVNPAQRIRMMRVKLTFH 659 (966)
Q Consensus 590 emlt-G~~Pf~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~is~e~~~Li~~~L~~dP~~R~t~~~v~~~~~ 659 (966)
+|++ |..||.+.... .....+..+... +....++.++++++.+||..||++||++.++...+.
T Consensus 228 el~~~g~~p~~~~~~~----~~~~~~~~~~~~---~~~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~~l~ 291 (314)
T cd05099 228 EIFTLGGSPYPGIPVE----ELFKLLREGHRM---DKPSNCTHELYMLMRECWHAVPTQRPTFKQLVEALD 291 (314)
T ss_pred HHHhCCCCCCCCCCHH----HHHHHHHcCCCC---CCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHH
Confidence 9998 89999765432 233444443211 122357889999999999999999999998755444
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-35 Score=315.82 Aligned_cols=240 Identities=21% Similarity=0.355 Sum_probs=191.2
Q ss_pred ccccccccccEEEEEEEcCCCcEEEEEEeccccC----hHHHHHHHHHhcCCCCceEEEEEEEeCCeEEEEEEccCCCCH
Q psy11767 383 AGILGDGSYSVCRRCVEKSTGQEYAVKIISRKID----CSEEINLLRACQGHPNIVNLHCVFQDEVHTYLVLELLKGGEL 458 (966)
Q Consensus 383 ~~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~~----~~~Ei~iL~~l~~HpnIV~l~~~~~~~~~~~lVmEy~~gg~L 458 (966)
.+.||+|+||.||+|.+..+ ..||||++..... ..+|+.+++.+ +||||+++++.+.. ...|+||||+++|+|
T Consensus 11 ~~~lg~g~~~~v~~~~~~~~-~~valK~~~~~~~~~~~~~~E~~~l~~l-~~~~i~~~~~~~~~-~~~~lv~e~~~~~~L 87 (262)
T cd05071 11 EVKLGQGCFGEVWMGTWNGT-TRVAIKTLKPGTMSPEAFLQEAQVMKKL-RHEKLVQLYAVVSE-EPIYIVTEYMSKGSL 87 (262)
T ss_pred eeecCCCCCCcEEEEEecCC-ceEEEEecccCccCHHHHHHHHHHHHhC-CCCCcceEEEEECC-CCcEEEEEcCCCCcH
Confidence 57899999999999988765 4699999875332 45689999988 59999999998754 568999999999999
Q ss_pred HHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCcEEEecCCCCCEEEEeecccccccCCC----ccccc
Q psy11767 459 LDRIRQKGRCGFTENEASRIMRQLVAAVHFMHSRGVVHRDLKPENLLFSDPAGDNIKVVDFGFACLKRESL----HTPCF 534 (966)
Q Consensus 459 ~~~l~~~~~~~l~e~~~~~i~~Qil~aL~yLHs~~IiHRDLKP~NILl~~~~~~~iKL~DFGla~~~~~~~----~~~~g 534 (966)
.+++.+.....+++..+..++.|++.||+|||+.+|+||||||+|||+++ ++.+||+|||++....... ....+
T Consensus 88 ~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~i~H~dl~p~Nill~~--~~~~~L~dfg~~~~~~~~~~~~~~~~~~ 165 (262)
T cd05071 88 LDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGE--NLVCKVADFGLARLIEDNEYTARQGAKF 165 (262)
T ss_pred HHHHhhccccCCCHHHHHHHHHHHHHHHHHHHHCCccccccCcccEEEcC--CCcEEeccCCceeeccccccccccCCcc
Confidence 99998654446899999999999999999999999999999999999985 5689999999997543221 12335
Q ss_pred cccccCchhhccCCCCCCCcccchhhhhhhhhhhhcCCCCCCCcCcchhHHHHHHHHhc-CCCCCCCCCCchhHHHHHHH
Q psy11767 535 TLQYAAPEVLRQDKSGYDENCDLWSLGVILVNVLRQDKSGYDENCDLWSLGVILYTMLC-GRVPFHARSRDDSALSIMAR 613 (966)
Q Consensus 535 T~~Y~APEvl~~~~~~~~~~~Di~SlGvil~el~~~~~~~y~~~~DIWSlGvilyemlt-G~~Pf~~~~~~~~~~~~~~~ 613 (966)
+..|+|||++.. ..++.++|||||||++|+|++ |.+||.+.... .....
T Consensus 166 ~~~y~~PE~~~~--------------------------~~~~~~~DvwslG~~l~ellt~g~~p~~~~~~~----~~~~~ 215 (262)
T cd05071 166 PIKWTAPEAALY--------------------------GRFTIKSDVWSFGILLTELTTKGRVPYPGMVNR----EVLDQ 215 (262)
T ss_pred cceecCHhHhcc--------------------------CCCCchhhHHHHHHHHHHHHcCCCCCCCCCChH----HHHHH
Confidence 678999998742 236788999999999999999 89999765432 23334
Q ss_pred HHcCCCCCCchhhccCCHHHHHHHHHhcccCccccCChHHHHHHhhh
Q psy11767 614 IKEGQFNFDAEAWSTVSSEAKELTKSLLTVNPAQRIRMMRVKLTFHA 660 (966)
Q Consensus 614 i~~~~~~~~~~~~~~is~e~~~Li~~~L~~dP~~R~t~~~v~~~~~~ 660 (966)
+..+.. .. ....++..+.+++.+||+.||++||++.++...++.
T Consensus 216 ~~~~~~-~~--~~~~~~~~l~~li~~~l~~~p~~Rp~~~~~~~~l~~ 259 (262)
T cd05071 216 VERGYR-MP--CPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLED 259 (262)
T ss_pred HhcCCC-CC--CccccCHHHHHHHHHHccCCcccCCCHHHHHHHHHH
Confidence 433321 11 123578899999999999999999999988655544
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo |
| >cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-35 Score=314.61 Aligned_cols=240 Identities=25% Similarity=0.458 Sum_probs=195.6
Q ss_pred cccccccccccccEEEEEEEcCCCcEEEEEEeccccC----hHHHHHHHHHhcCCCCceEEEEEEEeCCeEEEEEEccCC
Q psy11767 380 LDKAGILGDGSYSVCRRCVEKSTGQEYAVKIISRKID----CSEEINLLRACQGHPNIVNLHCVFQDEVHTYLVLELLKG 455 (966)
Q Consensus 380 ~~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~~----~~~Ei~iL~~l~~HpnIV~l~~~~~~~~~~~lVmEy~~g 455 (966)
++..+.||.|+||.||+|... |+.||||.+..... ..+|+.+++.+ +|+||+++++++.+....|+||||+++
T Consensus 8 ~~~~~~ig~g~~g~v~~~~~~--~~~v~iK~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~~~~~v~e~~~~ 84 (256)
T cd05039 8 LKLGATIGKGEFGDVMLGDYR--GQKVAVKCLKDDSTAAQAFLAEASVMTTL-RHPNLVQLLGVVLQGNPLYIVTEYMAK 84 (256)
T ss_pred ccceeeeecCCCceEEEEEec--CcEEEEEEeccchhHHHHHHHHHHHHHhc-CCcceeeeEEEEcCCCCeEEEEEecCC
Confidence 344678999999999999875 88999999976543 44689999998 599999999999999999999999999
Q ss_pred CCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCcEEEecCCCCCEEEEeecccccccCCCcccccc
Q psy11767 456 GELLDRIRQKGRCGFTENEASRIMRQLVAAVHFMHSRGVVHRDLKPENLLFSDPAGDNIKVVDFGFACLKRESLHTPCFT 535 (966)
Q Consensus 456 g~L~~~l~~~~~~~l~e~~~~~i~~Qil~aL~yLHs~~IiHRDLKP~NILl~~~~~~~iKL~DFGla~~~~~~~~~~~gT 535 (966)
++|.+++.......+++..+..++.|++.||.|||++||+||||||+|||+++ ++.+||+|||++............+
T Consensus 85 ~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~p~Nili~~--~~~~~l~d~g~~~~~~~~~~~~~~~ 162 (256)
T cd05039 85 GSLVDYLRSRGRAVITLAQQLGFALDVCEGMEYLEEKNFVHRDLAARNVLVSE--DLVAKVSDFGLAKEASQGQDSGKLP 162 (256)
T ss_pred CcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccchhcccceEEEeC--CCCEEEcccccccccccccccCCCc
Confidence 99999998766556899999999999999999999999999999999999985 5689999999997654433334456
Q ss_pred ccccCchhhccCCCCCCCcccchhhhhhhhhhhhcCCCCCCCcCcchhHHHHHHHHhc-CCCCCCCCCCchhHHHHHHHH
Q psy11767 536 LQYAAPEVLRQDKSGYDENCDLWSLGVILVNVLRQDKSGYDENCDLWSLGVILYTMLC-GRVPFHARSRDDSALSIMARI 614 (966)
Q Consensus 536 ~~Y~APEvl~~~~~~~~~~~Di~SlGvil~el~~~~~~~y~~~~DIWSlGvilyemlt-G~~Pf~~~~~~~~~~~~~~~i 614 (966)
..|+|||.+.. ..++.++|||||||++|+|++ |..||...... .+...+
T Consensus 163 ~~~~ape~~~~--------------------------~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~----~~~~~~ 212 (256)
T cd05039 163 VKWTAPEALRE--------------------------KKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLK----DVVPHV 212 (256)
T ss_pred ccccCchhhcC--------------------------CcCCcHHHHHHHHHHHHHHHhcCCCCCCCCCHH----HHHHHH
Confidence 67999998742 235678999999999999997 99999765432 233333
Q ss_pred HcCCCCCCchhhccCCHHHHHHHHHhcccCccccCChHHHHHH
Q psy11767 615 KEGQFNFDAEAWSTVSSEAKELTKSLLTVNPAQRIRMMRVKLT 657 (966)
Q Consensus 615 ~~~~~~~~~~~~~~is~e~~~Li~~~L~~dP~~R~t~~~v~~~ 657 (966)
..+. .. ......++++.++|.+||..+|++||++.++...
T Consensus 213 ~~~~-~~--~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~ 252 (256)
T cd05039 213 EKGY-RM--EAPEGCPPEVYKVMKDCWELDPAKRPTFKQLREQ 252 (256)
T ss_pred hcCC-CC--CCccCCCHHHHHHHHHHhccChhhCcCHHHHHHH
Confidence 3321 11 1223578999999999999999999999987543
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk |
| >cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-35 Score=322.59 Aligned_cols=246 Identities=25% Similarity=0.414 Sum_probs=198.7
Q ss_pred ccccccccccccEEEEEEEcCCCcEEEEEEeccccC-----hHHHHHHHHHhcCCCCceEEEEEEEeCCeEEEEEEccCC
Q psy11767 381 DKAGILGDGSYSVCRRCVEKSTGQEYAVKIISRKID-----CSEEINLLRACQGHPNIVNLHCVFQDEVHTYLVLELLKG 455 (966)
Q Consensus 381 ~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~~-----~~~Ei~iL~~l~~HpnIV~l~~~~~~~~~~~lVmEy~~g 455 (966)
+..+.||.|+||.||+|.+..+|+.||||.+..... ..+|+.+++.+ +||||+++++++..+...|+||||+++
T Consensus 22 ~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~e~~~~ 100 (296)
T cd06655 22 TRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQKQPKKELIINEILVMKEL-KNPNIVNFLDSFLVGDELFVVMEYLAG 100 (296)
T ss_pred EEEEEEecCCCeEEEEEEEcCCCcEEEEEEEecccCchHHHHHHHHHHHHhc-CCCceeeeeeeEecCceEEEEEEecCC
Confidence 346789999999999999999999999999864322 34688889888 599999999999999999999999999
Q ss_pred CCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCcEEEecCCCCCEEEEeecccccccCC---Cccc
Q psy11767 456 GELLDRIRQKGRCGFTENEASRIMRQLVAAVHFMHSRGVVHRDLKPENLLFSDPAGDNIKVVDFGFACLKRES---LHTP 532 (966)
Q Consensus 456 g~L~~~l~~~~~~~l~e~~~~~i~~Qil~aL~yLHs~~IiHRDLKP~NILl~~~~~~~iKL~DFGla~~~~~~---~~~~ 532 (966)
++|.+++... .+++.++..++.|++.||+|||++||+||||||+||+++. ++.+||+|||++...... ....
T Consensus 101 ~~L~~~~~~~---~l~~~~~~~i~~~l~~al~~LH~~~i~H~dL~p~Nili~~--~~~~kl~dfg~~~~~~~~~~~~~~~ 175 (296)
T cd06655 101 GSLTDVVTET---CMDEAQIAAVCRECLQALEFLHANQVIHRDIKSDNVLLGM--DGSVKLTDFGFCAQITPEQSKRSTM 175 (296)
T ss_pred CcHHHHHHhc---CCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECC--CCCEEEccCccchhcccccccCCCc
Confidence 9999988654 4899999999999999999999999999999999999975 568999999998654321 2234
Q ss_pred cccccccCchhhccCCCCCCCcccchhhhhhhhhhhhcCCCCCCCcCcchhHHHHHHHHhcCCCCCCCCCCchhHHHHHH
Q psy11767 533 CFTLQYAAPEVLRQDKSGYDENCDLWSLGVILVNVLRQDKSGYDENCDLWSLGVILYTMLCGRVPFHARSRDDSALSIMA 612 (966)
Q Consensus 533 ~gT~~Y~APEvl~~~~~~~~~~~Di~SlGvil~el~~~~~~~y~~~~DIWSlGvilyemltG~~Pf~~~~~~~~~~~~~~ 612 (966)
.+++.|+|||.+.. ..++.++|+|||||++|+|++|+.||...+.... +.
T Consensus 176 ~~~~~y~aPE~~~~--------------------------~~~~~~~Dv~slGvil~~lltg~~pf~~~~~~~~----~~ 225 (296)
T cd06655 176 VGTPYWMAPEVVTR--------------------------KAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRA----LY 225 (296)
T ss_pred CCCccccCcchhcC--------------------------CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH----HH
Confidence 67889999998752 2357789999999999999999999987654322 12
Q ss_pred HHHcCCCCCCchhhccCCHHHHHHHHHhcccCccccCChHHHHHHhhhhHHhh
Q psy11767 613 RIKEGQFNFDAEAWSTVSSEAKELTKSLLTVNPAQRIRMMRVKLTFHAFHQAQ 665 (966)
Q Consensus 613 ~i~~~~~~~~~~~~~~is~e~~~Li~~~L~~dP~~R~t~~~v~~~~~~~~~~~ 665 (966)
.+..... .....+..+++++.++|.+||..||++||++.++ ..|+|....
T Consensus 226 ~~~~~~~-~~~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~i--l~~~~~~~~ 275 (296)
T cd06655 226 LIATNGT-PELQNPEKLSPIFRDFLNRCLEMDVEKRGSAKEL--LQHPFLKLA 275 (296)
T ss_pred HHHhcCC-cccCCcccCCHHHHHHHHHHhhcChhhCCCHHHH--hhChHhhhc
Confidence 2222111 1111234678999999999999999999999876 456666543
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-35 Score=318.26 Aligned_cols=241 Identities=20% Similarity=0.344 Sum_probs=190.1
Q ss_pred ccccccccccccccEEEEEEEcCCCc----EEEEEEeccccC------hHHHHHHHHHhcCCCCceEEEEEEEeCCeEEE
Q psy11767 379 DLDKAGILGDGSYSVCRRCVEKSTGQ----EYAVKIISRKID------CSEEINLLRACQGHPNIVNLHCVFQDEVHTYL 448 (966)
Q Consensus 379 ~~~~~~~LG~G~fG~Vy~a~~~~tg~----~vAvK~i~~~~~------~~~Ei~iL~~l~~HpnIV~l~~~~~~~~~~~l 448 (966)
+|+..+.||+|+||+||+|.+..+|+ .||+|++..... ..+|+.+++.+ +||||+++++++... ..++
T Consensus 8 ~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~~-~~~~i~~~~~~~~~~-~~~l 85 (279)
T cd05109 8 ELKKVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGV-GSPYVCRLLGICLTS-TVQL 85 (279)
T ss_pred heeeeeecCCCCCceEEEEEEecCCCccceEEEEEEecCCCCHHHHHHHHHHHHHHHhc-CCCCCceEEEEEcCC-CcEE
Confidence 34557899999999999999887776 489999865432 33577777777 599999999998764 5789
Q ss_pred EEEccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCcEEEecCCCCCEEEEeecccccccCC
Q psy11767 449 VLELLKGGELLDRIRQKGRCGFTENEASRIMRQLVAAVHFMHSRGVVHRDLKPENLLFSDPAGDNIKVVDFGFACLKRES 528 (966)
Q Consensus 449 VmEy~~gg~L~~~l~~~~~~~l~e~~~~~i~~Qil~aL~yLHs~~IiHRDLKP~NILl~~~~~~~iKL~DFGla~~~~~~ 528 (966)
+|||+++|+|.+++.... ..+++..+..++.||+.||+|||+++|+||||||+|||+++ ++.+||+|||+++.....
T Consensus 86 ~~~~~~~g~l~~~l~~~~-~~~~~~~~~~~~~qi~~~L~~lH~~~iiH~dlkp~Nil~~~--~~~~kL~dfG~~~~~~~~ 162 (279)
T cd05109 86 VTQLMPYGCLLDYVRENK-DRIGSQDLLNWCVQIAKGMSYLEEVRLVHRDLAARNVLVKS--PNHVKITDFGLARLLDID 162 (279)
T ss_pred EEEcCCCCCHHHHHhhcc-CCCCHHHHHHHHHHHHHHHHHHHHCCeeccccccceEEEcC--CCcEEECCCCceeecccc
Confidence 999999999999997643 25899999999999999999999999999999999999975 458999999999764321
Q ss_pred C-----ccccccccccCchhhccCCCCCCCcccchhhhhhhhhhhhcCCCCCCCcCcchhHHHHHHHHhc-CCCCCCCCC
Q psy11767 529 L-----HTPCFTLQYAAPEVLRQDKSGYDENCDLWSLGVILVNVLRQDKSGYDENCDLWSLGVILYTMLC-GRVPFHARS 602 (966)
Q Consensus 529 ~-----~~~~gT~~Y~APEvl~~~~~~~~~~~Di~SlGvil~el~~~~~~~y~~~~DIWSlGvilyemlt-G~~Pf~~~~ 602 (966)
. ....+++.|+|||.+.. ..++.++|||||||++|||++ |..||....
T Consensus 163 ~~~~~~~~~~~~~~y~~PE~~~~--------------------------~~~~~~~Di~slG~~l~el~t~g~~p~~~~~ 216 (279)
T cd05109 163 ETEYHADGGKVPIKWMALESILH--------------------------RRFTHQSDVWSYGVTVWELMTFGAKPYDGIP 216 (279)
T ss_pred cceeecCCCccchhhCCHHHhcc--------------------------CCCCchhHHHHHHHHHHHHHcCCCCCCCCCC
Confidence 1 11234678999998742 236788999999999999998 999997644
Q ss_pred CchhHHHHHHHHHcCCCCCCchhhccCCHHHHHHHHHhcccCccccCChHHHHHH
Q psy11767 603 RDDSALSIMARIKEGQFNFDAEAWSTVSSEAKELTKSLLTVNPAQRIRMMRVKLT 657 (966)
Q Consensus 603 ~~~~~~~~~~~i~~~~~~~~~~~~~~is~e~~~Li~~~L~~dP~~R~t~~~v~~~ 657 (966)
.. .+...+..+.... .....+.++.+++.+||..||++||++.++...
T Consensus 217 ~~----~~~~~~~~~~~~~---~~~~~~~~~~~li~~~l~~dp~~Rp~~~~l~~~ 264 (279)
T cd05109 217 AR----EIPDLLEKGERLP---QPPICTIDVYMIMVKCWMIDSECRPRFRELVDE 264 (279)
T ss_pred HH----HHHHHHHCCCcCC---CCccCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 32 2233344433221 224578899999999999999999999987543
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve |
| >cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-34 Score=318.39 Aligned_cols=242 Identities=20% Similarity=0.338 Sum_probs=187.9
Q ss_pred cccccccccccccEEEEEEEcCCCcE----EEEEEeccccC------hHHHHHHHHHhcCCCCceEEEEEEEeCCeEEEE
Q psy11767 380 LDKAGILGDGSYSVCRRCVEKSTGQE----YAVKIISRKID------CSEEINLLRACQGHPNIVNLHCVFQDEVHTYLV 449 (966)
Q Consensus 380 ~~~~~~LG~G~fG~Vy~a~~~~tg~~----vAvK~i~~~~~------~~~Ei~iL~~l~~HpnIV~l~~~~~~~~~~~lV 449 (966)
|+..+.||+|+||+||+|....+|+. ||+|.+..... ...|+.++..+ +||||+++++++.. ...++|
T Consensus 9 ~~~~~~lg~G~~~~vy~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~l~~l-~h~~iv~~~~~~~~-~~~~~i 86 (279)
T cd05111 9 LRKLKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQEITDHMLAMGSL-DHAYIVRLLGICPG-ASLQLV 86 (279)
T ss_pred ceeccccCccCCcceEEEEEcCCCCceeeEEEEeecccccchHHHHHHHHHHHHHhcC-CCCCcceEEEEECC-CccEEE
Confidence 44578899999999999999888774 77777753321 22355566666 69999999998764 457899
Q ss_pred EEccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCcEEEecCCCCCEEEEeecccccccCC-
Q psy11767 450 LELLKGGELLDRIRQKGRCGFTENEASRIMRQLVAAVHFMHSRGVVHRDLKPENLLFSDPAGDNIKVVDFGFACLKRES- 528 (966)
Q Consensus 450 mEy~~gg~L~~~l~~~~~~~l~e~~~~~i~~Qil~aL~yLHs~~IiHRDLKP~NILl~~~~~~~iKL~DFGla~~~~~~- 528 (966)
|||+++|+|.+++..... .+++..+..++.||+.||+|||++|++||||||+|||+++ ++.+||+|||+++.....
T Consensus 87 ~e~~~~gsL~~~l~~~~~-~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~nili~~--~~~~kl~Dfg~~~~~~~~~ 163 (279)
T cd05111 87 TQLSPLGSLLDHVRQHRD-SLDPQRLLNWCVQIAKGMYYLEEHRMVHRNLAARNILLKS--DSIVQIADFGVADLLYPDD 163 (279)
T ss_pred EEeCCCCcHHHHHHhccc-CCCHHHHHHHHHHHHHHHHHHHHCCEeccccCcceEEEcC--CCcEEEcCCccceeccCCC
Confidence 999999999999976543 5899999999999999999999999999999999999975 568999999999754321
Q ss_pred ----CccccccccccCchhhccCCCCCCCcccchhhhhhhhhhhhcCCCCCCCcCcchhHHHHHHHHhc-CCCCCCCCCC
Q psy11767 529 ----LHTPCFTLQYAAPEVLRQDKSGYDENCDLWSLGVILVNVLRQDKSGYDENCDLWSLGVILYTMLC-GRVPFHARSR 603 (966)
Q Consensus 529 ----~~~~~gT~~Y~APEvl~~~~~~~~~~~Di~SlGvil~el~~~~~~~y~~~~DIWSlGvilyemlt-G~~Pf~~~~~ 603 (966)
.....++..|+|||++.. ..|+.++|||||||++|||++ |..||.+...
T Consensus 164 ~~~~~~~~~~~~~y~~pE~~~~--------------------------~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~ 217 (279)
T cd05111 164 KKYFYSEHKTPIKWMALESILF--------------------------GRYTHQSDVWSYGVTVWEMMSYGAEPYAGMRP 217 (279)
T ss_pred cccccCCCCCcccccCHHHhcc--------------------------CCcCchhhHHHHHHHHHHHHcCCCCCCCCCCH
Confidence 122345778999998852 236789999999999999998 9999987543
Q ss_pred chhHHHHHHHHHcCCCCCCchhhccCCHHHHHHHHHhcccCccccCChHHHHHHhh
Q psy11767 604 DDSALSIMARIKEGQFNFDAEAWSTVSSEAKELTKSLLTVNPAQRIRMMRVKLTFH 659 (966)
Q Consensus 604 ~~~~~~~~~~i~~~~~~~~~~~~~~is~e~~~Li~~~L~~dP~~R~t~~~v~~~~~ 659 (966)
. .....+..+.....+ ...+.++.+++.+||..||++|||+.++...+.
T Consensus 218 ~----~~~~~~~~~~~~~~~---~~~~~~~~~li~~c~~~~p~~Rps~~el~~~l~ 266 (279)
T cd05111 218 H----EVPDLLEKGERLAQP---QICTIDVYMVMVKCWMIDENVRPTFKELANEFT 266 (279)
T ss_pred H----HHHHHHHCCCcCCCC---CCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHH
Confidence 2 222333444332221 235678899999999999999999998855443
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r |
| >cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-35 Score=312.55 Aligned_cols=237 Identities=25% Similarity=0.442 Sum_probs=195.5
Q ss_pred cccccccccEEEEEEEcCC---CcEEEEEEeccccC------hHHHHHHHHHhcCCCCceEEEEEEEeCCeEEEEEEccC
Q psy11767 384 GILGDGSYSVCRRCVEKST---GQEYAVKIISRKID------CSEEINLLRACQGHPNIVNLHCVFQDEVHTYLVLELLK 454 (966)
Q Consensus 384 ~~LG~G~fG~Vy~a~~~~t---g~~vAvK~i~~~~~------~~~Ei~iL~~l~~HpnIV~l~~~~~~~~~~~lVmEy~~ 454 (966)
+.||+|+||.||+|.+... +..||+|++..... ..+|+++++.+. |+||+++++++.+....++||||++
T Consensus 1 ~~ig~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~-~~~i~~~~~~~~~~~~~~lv~e~~~ 79 (262)
T cd00192 1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLG-HPNVVRLLGVCTEEEPLYLVLEYME 79 (262)
T ss_pred CccccCCceEEEEEEEecCCCCCceEEeEeeccccchhHHHHHHHHHHHHhhcC-CCChheeeeeecCCCceEEEEEecc
Confidence 3699999999999999876 89999999875432 346889999885 9999999999999999999999999
Q ss_pred CCCHHHHHHhcC-------CCCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCcEEEecCCCCCEEEEeecccccccC
Q psy11767 455 GGELLDRIRQKG-------RCGFTENEASRIMRQLVAAVHFMHSRGVVHRDLKPENLLFSDPAGDNIKVVDFGFACLKRE 527 (966)
Q Consensus 455 gg~L~~~l~~~~-------~~~l~e~~~~~i~~Qil~aL~yLHs~~IiHRDLKP~NILl~~~~~~~iKL~DFGla~~~~~ 527 (966)
+++|.+++.... ...+++.++..++.|++.||+|||++||+||||||+||+++. ++.+||+|||++.....
T Consensus 80 ~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~di~p~nili~~--~~~~~l~dfg~~~~~~~ 157 (262)
T cd00192 80 GGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLASKKFVHRDLAARNCLVGE--DLVVKISDFGLSRDVYD 157 (262)
T ss_pred CCcHHHHHhhccccccccccccCCHHHHHHHHHHHHHHHHHHHcCCcccCccCcceEEECC--CCcEEEccccccccccc
Confidence 999999998751 236899999999999999999999999999999999999985 46999999999976543
Q ss_pred C-----CccccccccccCchhhccCCCCCCCcccchhhhhhhhhhhhcCCCCCCCcCcchhHHHHHHHHhc-CCCCCCCC
Q psy11767 528 S-----LHTPCFTLQYAAPEVLRQDKSGYDENCDLWSLGVILVNVLRQDKSGYDENCDLWSLGVILYTMLC-GRVPFHAR 601 (966)
Q Consensus 528 ~-----~~~~~gT~~Y~APEvl~~~~~~~~~~~Di~SlGvil~el~~~~~~~y~~~~DIWSlGvilyemlt-G~~Pf~~~ 601 (966)
. .....+++.|+|||.+.. ..++.++|||||||++|+|++ |..||...
T Consensus 158 ~~~~~~~~~~~~~~~y~aPE~~~~--------------------------~~~~~~~Di~slG~il~~l~~~g~~p~~~~ 211 (262)
T cd00192 158 DDYYRKKTGGKLPIRWMAPESLKD--------------------------GIFTSKSDVWSFGVLLWEIFTLGATPYPGL 211 (262)
T ss_pred ccccccccCCCcCccccCHHHhcc--------------------------CCcchhhccHHHHHHHHHHHhcCCCCCCCC
Confidence 2 223456889999998752 136788999999999999998 69999876
Q ss_pred CCchhHHHHHHHHHcCCCCCCchhhccCCHHHHHHHHHhcccCccccCChHHHHH
Q psy11767 602 SRDDSALSIMARIKEGQFNFDAEAWSTVSSEAKELTKSLLTVNPAQRIRMMRVKL 656 (966)
Q Consensus 602 ~~~~~~~~~~~~i~~~~~~~~~~~~~~is~e~~~Li~~~L~~dP~~R~t~~~v~~ 656 (966)
... .+...+..+... .....+++++.+++.+||..||++||++.++..
T Consensus 212 ~~~----~~~~~~~~~~~~---~~~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~ 259 (262)
T cd00192 212 SNE----EVLEYLRKGYRL---PKPEYCPDELYELMLSCWQLDPEDRPTFSELVE 259 (262)
T ss_pred CHH----HHHHHHHcCCCC---CCCccCChHHHHHHHHHccCCcccCcCHHHHHH
Confidence 432 334445443322 122356899999999999999999999988743
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan |
| >cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-35 Score=316.51 Aligned_cols=236 Identities=28% Similarity=0.478 Sum_probs=192.6
Q ss_pred cccccccccccEEEEEEEcCCCcEEEEEEecccc--------------ChHHHHHHHHHhcCCCCceEEEEEEEeCCeEE
Q psy11767 382 KAGILGDGSYSVCRRCVEKSTGQEYAVKIISRKI--------------DCSEEINLLRACQGHPNIVNLHCVFQDEVHTY 447 (966)
Q Consensus 382 ~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~--------------~~~~Ei~iL~~l~~HpnIV~l~~~~~~~~~~~ 447 (966)
..+.||+|+||.||+|.+..+++.||+|.+.... ...+|+.+++.+ +||||+++++++.++...+
T Consensus 4 ~~~~ig~g~~~~v~~a~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~ 82 (267)
T cd06628 4 KGALIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKEL-QHENIVQYLGSSLDADHLN 82 (267)
T ss_pred ccceeecCCCeEEEEEEecCCCcEEEEEEecCCCcccchhHHHHHHHHHHHHHHHHHHhc-CCCCeeeEEEEEEeCCccE
Confidence 3578999999999999999999999999885431 134688889888 5999999999999999999
Q ss_pred EEEEccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCcEEEecCCCCCEEEEeecccccccC
Q psy11767 448 LVLELLKGGELLDRIRQKGRCGFTENEASRIMRQLVAAVHFMHSRGVVHRDLKPENLLFSDPAGDNIKVVDFGFACLKRE 527 (966)
Q Consensus 448 lVmEy~~gg~L~~~l~~~~~~~l~e~~~~~i~~Qil~aL~yLHs~~IiHRDLKP~NILl~~~~~~~iKL~DFGla~~~~~ 527 (966)
+||||+++++|.+++...+ .+++..+..++.|++.||+|||++|++||||||+|||+++ .+.++|+|||++.....
T Consensus 83 lv~e~~~~~~L~~~l~~~~--~l~~~~~~~~~~~l~~~l~~lH~~~ivH~di~p~nil~~~--~~~~~l~dfg~~~~~~~ 158 (267)
T cd06628 83 IFLEYVPGGSVAALLNNYG--AFEETLVRNFVRQILKGLNYLHNRGIIHRDIKGANILVDN--KGGIKISDFGISKKLEA 158 (267)
T ss_pred EEEEecCCCCHHHHHHhcc--CccHHHHHHHHHHHHHHHHHHHhcCcccccCCHHHEEEcC--CCCEEecccCCCccccc
Confidence 9999999999999997754 5899999999999999999999999999999999999975 56899999999865431
Q ss_pred C---------CccccccccccCchhhccCCCCCCCcccchhhhhhhhhhhhcCCCCCCCcCcchhHHHHHHHHhcCCCCC
Q psy11767 528 S---------LHTPCFTLQYAAPEVLRQDKSGYDENCDLWSLGVILVNVLRQDKSGYDENCDLWSLGVILYTMLCGRVPF 598 (966)
Q Consensus 528 ~---------~~~~~gT~~Y~APEvl~~~~~~~~~~~Di~SlGvil~el~~~~~~~y~~~~DIWSlGvilyemltG~~Pf 598 (966)
. .....+++.|+|||.+.. ..++.++|+||+||++|+|++|+.||
T Consensus 159 ~~~~~~~~~~~~~~~~~~~y~~pe~~~~--------------------------~~~~~~~Dv~slG~il~~l~~g~~p~ 212 (267)
T cd06628 159 NSLSTKTNGARPSLQGSVFWMAPEVVKQ--------------------------TSYTRKADIWSLGCLVVEMLTGKHPF 212 (267)
T ss_pred ccccCCccccccccCCCcCccChhHhcc--------------------------CCCCchhhhHHHHHHHHHHhhCCCCC
Confidence 1 112357889999998752 23577899999999999999999999
Q ss_pred CCCCCchhHHHHHHHHHcCCCCCCchhhccCCHHHHHHHHHhcccCccccCChHHHH
Q psy11767 599 HARSRDDSALSIMARIKEGQFNFDAEAWSTVSSEAKELTKSLLTVNPAQRIRMMRVK 655 (966)
Q Consensus 599 ~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~is~e~~~Li~~~L~~dP~~R~t~~~v~ 655 (966)
....... ....+..... +.....++.++.++|.+||+.||.+||++.++.
T Consensus 213 ~~~~~~~----~~~~~~~~~~---~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il 262 (267)
T cd06628 213 PDCTQLQ----AIFKIGENAS---PEIPSNISSEAIDFLEKTFEIDHNKRPTAAELL 262 (267)
T ss_pred CCccHHH----HHHHHhccCC---CcCCcccCHHHHHHHHHHccCCchhCcCHHHHh
Confidence 8654321 2222322211 122245789999999999999999999998763
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate |
| >cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.5e-35 Score=314.52 Aligned_cols=240 Identities=23% Similarity=0.398 Sum_probs=190.8
Q ss_pred ccccccccccccEEEEEEEcCCCcEEEEEEecccc----ChHHHHHHHHHhcCCCCceEEEEEEEeCCeEEEEEEccCCC
Q psy11767 381 DKAGILGDGSYSVCRRCVEKSTGQEYAVKIISRKI----DCSEEINLLRACQGHPNIVNLHCVFQDEVHTYLVLELLKGG 456 (966)
Q Consensus 381 ~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~----~~~~Ei~iL~~l~~HpnIV~l~~~~~~~~~~~lVmEy~~gg 456 (966)
+..+.||+|+||.||+|.+. .+..||+|.+.... ...+|+.+|+.+ +||||+++++++. +...|+||||++++
T Consensus 9 ~~~~~ig~g~~~~v~~~~~~-~~~~~~~k~~~~~~~~~~~~~~E~~~l~~l-~~~~i~~~~~~~~-~~~~~lv~e~~~~~ 85 (260)
T cd05070 9 QLIKKLGNGQFGEVWMGTWN-GNTKVAVKTLKPGTMSPESFLEEAQIMKKL-RHDKLVQLYAVVS-EEPIYIVTEYMSKG 85 (260)
T ss_pred hhhheeccccCceEEEEEec-CCceeEEEEecCCCCCHHHHHHHHHHHHhc-CCCceEEEEeEEC-CCCcEEEEEecCCC
Confidence 34688999999999999876 56779999986532 245799999998 5999999999885 45689999999999
Q ss_pred CHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCcEEEecCCCCCEEEEeecccccccCCC----ccc
Q psy11767 457 ELLDRIRQKGRCGFTENEASRIMRQLVAAVHFMHSRGVVHRDLKPENLLFSDPAGDNIKVVDFGFACLKRESL----HTP 532 (966)
Q Consensus 457 ~L~~~l~~~~~~~l~e~~~~~i~~Qil~aL~yLHs~~IiHRDLKP~NILl~~~~~~~iKL~DFGla~~~~~~~----~~~ 532 (966)
+|.+++.......+++..++.++.|++.||+|||+.+|+||||||+|||+++ ++.++|+|||++....... ...
T Consensus 86 ~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~di~p~Nili~~--~~~~~l~dfg~~~~~~~~~~~~~~~~ 163 (260)
T cd05070 86 SLLDFLKDGEGRALKLPNLVDMAAQVAAGMAYIERMNYIHRDLRSANILVGD--GLVCKIADFGLARLIEDNEYTARQGA 163 (260)
T ss_pred cHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCccceEEEeC--CceEEeCCceeeeeccCcccccccCC
Confidence 9999997654446899999999999999999999999999999999999985 5689999999996543211 122
Q ss_pred cccccccCchhhccCCCCCCCcccchhhhhhhhhhhhcCCCCCCCcCcchhHHHHHHHHhc-CCCCCCCCCCchhHHHHH
Q psy11767 533 CFTLQYAAPEVLRQDKSGYDENCDLWSLGVILVNVLRQDKSGYDENCDLWSLGVILYTMLC-GRVPFHARSRDDSALSIM 611 (966)
Q Consensus 533 ~gT~~Y~APEvl~~~~~~~~~~~Di~SlGvil~el~~~~~~~y~~~~DIWSlGvilyemlt-G~~Pf~~~~~~~~~~~~~ 611 (966)
.++..|+|||++.. ..++.++|||||||++|+|++ |.+||.+.... ...
T Consensus 164 ~~~~~y~aPE~~~~--------------------------~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~----~~~ 213 (260)
T cd05070 164 KFPIKWTAPEAALY--------------------------GRFTIKSDVWSFGILLTELVTKGRVPYPGMNNR----EVL 213 (260)
T ss_pred CCCccccChHHHhc--------------------------CCCcchhhhHHHHHHHHHHHhcCCCCCCCCCHH----HHH
Confidence 34567999998742 236778999999999999999 89999765432 233
Q ss_pred HHHHcCCCCCCchhhccCCHHHHHHHHHhcccCccccCChHHHHHHh
Q psy11767 612 ARIKEGQFNFDAEAWSTVSSEAKELTKSLLTVNPAQRIRMMRVKLTF 658 (966)
Q Consensus 612 ~~i~~~~~~~~~~~~~~is~e~~~Li~~~L~~dP~~R~t~~~v~~~~ 658 (966)
..+..+. .. +.....+.++.+|+.+||..||++|||+.++...+
T Consensus 214 ~~~~~~~-~~--~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l 257 (260)
T cd05070 214 EQVERGY-RM--PCPQDCPISLHELMLQCWKKDPEERPTFEYLQSFL 257 (260)
T ss_pred HHHHcCC-CC--CCCCcCCHHHHHHHHHHcccCcccCcCHHHHHHHH
Confidence 4444331 11 12245788999999999999999999999875433
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r |
| >cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-35 Score=314.20 Aligned_cols=244 Identities=25% Similarity=0.434 Sum_probs=196.5
Q ss_pred cccccccccccccEEEEEEEcCCCcEEEEEEecccc-----ChHHHHHHHHHhcCCCCceEEEEEEEeCCeEEEEEEccC
Q psy11767 380 LDKAGILGDGSYSVCRRCVEKSTGQEYAVKIISRKI-----DCSEEINLLRACQGHPNIVNLHCVFQDEVHTYLVLELLK 454 (966)
Q Consensus 380 ~~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~-----~~~~Ei~iL~~l~~HpnIV~l~~~~~~~~~~~lVmEy~~ 454 (966)
|+..+.||.|+||.||+|.+..+++.+|+|++.... ...+|+.+++.+ +||||+++++++.++...|++|||++
T Consensus 5 ~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~~-~h~~i~~~~~~~~~~~~~~l~~e~~~ 83 (262)
T cd06613 5 YELIQRIGSGTYGDVYKARDIATGELVAIKVIKLEPGDDFEIIQQEISMLKEC-RHPNIVAYFGSYLRRDKLWIVMEYCG 83 (262)
T ss_pred eEEEEEecCCCceEEEEeEecCCCCEEEEEEEEcCchhhHHHHHHHHHHHHhC-CCCChhceEEEEEeCCEEEEEEeCCC
Confidence 334678999999999999999999999999987542 245688999888 59999999999999999999999999
Q ss_pred CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCcEEEecCCCCCEEEEeecccccccCC---Ccc
Q psy11767 455 GGELLDRIRQKGRCGFTENEASRIMRQLVAAVHFMHSRGVVHRDLKPENLLFSDPAGDNIKVVDFGFACLKRES---LHT 531 (966)
Q Consensus 455 gg~L~~~l~~~~~~~l~e~~~~~i~~Qil~aL~yLHs~~IiHRDLKP~NILl~~~~~~~iKL~DFGla~~~~~~---~~~ 531 (966)
+++|.+++.... ..+++.++..++.|++.||+|||++||+|+||||+||++++ ++.+||+|||++...... ...
T Consensus 84 ~~~l~~~~~~~~-~~l~~~~~~~~~~ql~~~l~~lh~~~i~h~dl~p~ni~i~~--~~~~~l~d~g~~~~~~~~~~~~~~ 160 (262)
T cd06613 84 GGSLQDIYQVTR-GPLSELQIAYVCRETLKGLAYLHETGKIHRDIKGANILLTE--DGDVKLADFGVSAQLTATIAKRKS 160 (262)
T ss_pred CCcHHHHHHhhc-cCCCHHHHHHHHHHHHHHHHHHHhCCceecCCChhhEEECC--CCCEEECccccchhhhhhhhcccc
Confidence 999999887652 26999999999999999999999999999999999999985 568999999998654322 234
Q ss_pred ccccccccCchhhccCCCCCCCcccchhhhhhhhhhhhcCCCCCCCcCcchhHHHHHHHHhcCCCCCCCCCCchhHHHHH
Q psy11767 532 PCFTLQYAAPEVLRQDKSGYDENCDLWSLGVILVNVLRQDKSGYDENCDLWSLGVILYTMLCGRVPFHARSRDDSALSIM 611 (966)
Q Consensus 532 ~~gT~~Y~APEvl~~~~~~~~~~~Di~SlGvil~el~~~~~~~y~~~~DIWSlGvilyemltG~~Pf~~~~~~~~~~~~~ 611 (966)
..++..|+|||++.... ...++.++|+|||||++|+|++|++||...+.... .
T Consensus 161 ~~~~~~y~~Pe~~~~~~-----------------------~~~~~~~~Di~slG~~l~~~~tg~~p~~~~~~~~~----~ 213 (262)
T cd06613 161 FIGTPYWMAPEVAAVER-----------------------KGGYDGKCDIWALGITAIELAELQPPMFDLHPMRA----L 213 (262)
T ss_pred ccCCccccCchhhcccc-----------------------cCCcCchhhhHHHHHHHHHHHhCCCCCCCCCHHHH----H
Confidence 46788999999875321 12467889999999999999999999987654322 1
Q ss_pred HHHHcCCCCCC-chhhccCCHHHHHHHHHhcccCccccCChHHH
Q psy11767 612 ARIKEGQFNFD-AEAWSTVSSEAKELTKSLLTVNPAQRIRMMRV 654 (966)
Q Consensus 612 ~~i~~~~~~~~-~~~~~~is~e~~~Li~~~L~~dP~~R~t~~~v 654 (966)
..+....+... ......++.++.+++.+||..||.+|||+.++
T Consensus 214 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~i 257 (262)
T cd06613 214 FLISKSNFPPPKLKDKEKWSPVFHDFIKKCLTKDPKKRPTATKL 257 (262)
T ss_pred HHHHhccCCCccccchhhhhHHHHHHHHHHcCCChhhCCCHHHH
Confidence 22222222111 11123467889999999999999999999876
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ |
| >KOG0666|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-36 Score=317.23 Aligned_cols=255 Identities=30% Similarity=0.512 Sum_probs=195.3
Q ss_pred cccccccccccccEEEEEEEcCCCc----EEEEEEeccccC-------hHHHHHHHHHhcCCCCceEEEEEEEe-CCeEE
Q psy11767 380 LDKAGILGDGSYSVCRRCVEKSTGQ----EYAVKIISRKID-------CSEEINLLRACQGHPNIVNLHCVFQD-EVHTY 447 (966)
Q Consensus 380 ~~~~~~LG~G~fG~Vy~a~~~~tg~----~vAvK~i~~~~~-------~~~Ei~iL~~l~~HpnIV~l~~~~~~-~~~~~ 447 (966)
|+..+.||+|+||.||+|....++. .+|||.++...+ +-+|+.+++.+. |||||.|..+|.. +..++
T Consensus 26 ye~ig~Ig~GTYG~VykA~~~~~n~kr~k~yAiKkfk~~kd~tGiS~SAcREiaL~REl~-h~nvi~Lv~Vfl~~d~~v~ 104 (438)
T KOG0666|consen 26 YEGIGKIGRGTYGKVYKAVRKNTNDKRTKEYAIKKFKGEKDGTGISMSACREIALLRELK-HPNVISLVKVFLSHDKKVW 104 (438)
T ss_pred hhccceecccccceeeEeeeccCCcccchhhHHHHHhccCCCCCcCHHHHHHHHHHHHhc-CCcchhHHHHHhccCceEE
Confidence 4457899999999999997766543 789999976532 568999999995 9999999999876 88999
Q ss_pred EEEEccCCCCHHHHHHhcC---CCCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCcEEEec--CCCCCEEEEeeccc
Q psy11767 448 LVLELLKGGELLDRIRQKG---RCGFTENEASRIMRQLVAAVHFMHSRGVVHRDLKPENLLFSD--PAGDNIKVVDFGFA 522 (966)
Q Consensus 448 lVmEy~~gg~L~~~l~~~~---~~~l~e~~~~~i~~Qil~aL~yLHs~~IiHRDLKP~NILl~~--~~~~~iKL~DFGla 522 (966)
|++||.+ -||.+.|+-+. ...++...++.|+.||+.|+.|||++=|+||||||.|||+.. +..|.|||+|||+|
T Consensus 105 l~fdYAE-hDL~~II~fHr~~~~~~lp~~mvKsilwQil~Gv~YLH~NWvlHRDLKPaNIlvmgdgperG~VKIaDlGla 183 (438)
T KOG0666|consen 105 LLFDYAE-HDLWHIIKFHRASKAKQLPRSMVKSILWQILDGVHYLHSNWVLHRDLKPANILVMGDGPERGRVKIADLGLA 183 (438)
T ss_pred EEehhhh-hhHHHHHHHhccchhccCCHHHHHHHHHHHHhhhHHHhhhheeeccCCcceEEEeccCCccCeeEeecccHH
Confidence 9999995 68988886432 235899999999999999999999999999999999999964 23479999999999
Q ss_pred ccccCCC------ccccccccccCchhhccCCCCCCCcccchhhhhhhhhhhhcCCCCCCCcCcchhHHHHHHHHhcCCC
Q psy11767 523 CLKRESL------HTPCFTLQYAAPEVLRQDKSGYDENCDLWSLGVILVNVLRQDKSGYDENCDLWSLGVILYTMLCGRV 596 (966)
Q Consensus 523 ~~~~~~~------~~~~gT~~Y~APEvl~~~~~~~~~~~Di~SlGvil~el~~~~~~~y~~~~DIWSlGvilyemltG~~ 596 (966)
+...... ...+.|.+|+|||++.+ ...|+.++||||+|||+.|||+-.+
T Consensus 184 R~~~~plkpl~s~d~VVVTiWYRAPELLLG-------------------------a~hYT~AiDvWAiGCIfaElLtl~P 238 (438)
T KOG0666|consen 184 RLFNNPLKPLASLDPVVVTIWYRAPELLLG-------------------------ARHYTKAIDVWAIGCIFAELLTLEP 238 (438)
T ss_pred HHhhccccccccCCceEEEEEecChHHhcc-------------------------cccccchhhhHHHHHHHHHHHccCc
Confidence 9876543 23456999999999963 3469999999999999999999998
Q ss_pred CCCCCCCc-----hhHHHHHHHHHc--C-----CCC--------------CCchh------------hccCCHHHHHHHH
Q psy11767 597 PFHARSRD-----DSALSIMARIKE--G-----QFN--------------FDAEA------------WSTVSSEAKELTK 638 (966)
Q Consensus 597 Pf~~~~~~-----~~~~~~~~~i~~--~-----~~~--------------~~~~~------------~~~is~e~~~Li~ 638 (966)
-|.+...+ .-....+.+|.+ | .|. +.... +..-++.+.+|+.
T Consensus 239 lF~g~E~k~~~~~Pfq~dQl~rIf~vLG~Pt~~~Wp~lkk~Pe~q~~ls~f~~~~~~n~sL~~~~~~~k~k~~~a~~LL~ 318 (438)
T KOG0666|consen 239 LFKGREEKIKTKNPFQHDQLDRIFEVLGTPTDKDWPDLKKMPEYQTLLSDFRRHYYDNVSLHKYYHKHKVKDPSALDLLQ 318 (438)
T ss_pred cccchhhhcccCCCchHHHHHHHHHHcCCCccccchhhhhCcchHHHHHHhHHhhcCcchHHHHHHHhcCCCchHHHHHH
Confidence 88765321 111122223221 1 000 00011 1223556889999
Q ss_pred HhcccCccccCChHHHHHHhhhhHH
Q psy11767 639 SLLTVNPAQRIRMMRVKLTFHAFHQ 663 (966)
Q Consensus 639 ~~L~~dP~~R~t~~~v~~~~~~~~~ 663 (966)
+||.+||.+|+|+.+. ..|.++.
T Consensus 319 klL~yDP~kRIta~qA--leh~yF~ 341 (438)
T KOG0666|consen 319 KLLTYDPIKRITAEQA--LEHPYFT 341 (438)
T ss_pred HHhccCchhhccHHHH--hcccccc
Confidence 9999999999999864 3455543
|
|
| >cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-35 Score=336.71 Aligned_cols=243 Identities=22% Similarity=0.367 Sum_probs=193.0
Q ss_pred cccccccccccEEEEEEEc-----CCCcEEEEEEecccc------ChHHHHHHHHHhcCCCCceEEEEEEEeCCeEEEEE
Q psy11767 382 KAGILGDGSYSVCRRCVEK-----STGQEYAVKIISRKI------DCSEEINLLRACQGHPNIVNLHCVFQDEVHTYLVL 450 (966)
Q Consensus 382 ~~~~LG~G~fG~Vy~a~~~-----~tg~~vAvK~i~~~~------~~~~Ei~iL~~l~~HpnIV~l~~~~~~~~~~~lVm 450 (966)
..+.||+|+||.||+|++. .+++.||||++.... ...+|+++|..+..|||||++++++..+...|+||
T Consensus 41 ~~~~lG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~~H~niv~~~~~~~~~~~~~iv~ 120 (401)
T cd05107 41 LGRTLGSGAFGRVVEATAHGLSHSQSTMKVAVKMLKSTARSSEKQALMSELKIMSHLGPHLNIVNLLGACTKGGPIYIIT 120 (401)
T ss_pred hhhhccCCCceeEEEEEEcCCCCCCCceEEEEEecCCCCChhHHHHHHHHHHHHHhcCCCCCeEEEEEEEccCCCcEEEE
Confidence 3578999999999999964 356789999997542 23468999998866999999999999999999999
Q ss_pred EccCCCCHHHHHHhcCC---------------------------------------------------------------
Q psy11767 451 ELLKGGELLDRIRQKGR--------------------------------------------------------------- 467 (966)
Q Consensus 451 Ey~~gg~L~~~l~~~~~--------------------------------------------------------------- 467 (966)
|||++|+|.+++.+...
T Consensus 121 E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 200 (401)
T cd05107 121 EYCRYGDLVDYLHRNKHTFLQYYLDKNRDDGSLISGGSTPLSQRKSHVSLGSESDGGYMDMSKDESADYVPMQDMKGTVK 200 (401)
T ss_pred eccCCCcHHHHHHhccccchhhhcccccccccccccccccccccccchhhhhccCccccccCCccccCccchhcchhhhh
Confidence 99999999999975321
Q ss_pred ---------------------------------CCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCcEEEecCCCCCE
Q psy11767 468 ---------------------------------CGFTENEASRIMRQLVAAVHFMHSRGVVHRDLKPENLLFSDPAGDNI 514 (966)
Q Consensus 468 ---------------------------------~~l~e~~~~~i~~Qil~aL~yLHs~~IiHRDLKP~NILl~~~~~~~i 514 (966)
..+++..+..|+.||+.||+|||+.+|+||||||+|||+++ .+.+
T Consensus 201 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrdlkp~NiLl~~--~~~~ 278 (401)
T cd05107 201 YADIESSNYESPYDQYLPSAPERTRRDTLINESPALSYMDLVGFSYQVANGMEFLASKNCVHRDLAARNVLICE--GKLV 278 (401)
T ss_pred hhhhhccCcCCchhhhhcccCCCcchhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCcCcccCCcceEEEeC--CCEE
Confidence 23677888999999999999999999999999999999985 5689
Q ss_pred EEEeecccccccCC-----CccccccccccCchhhccCCCCCCCcccchhhhhhhhhhhhcCCCCCCCcCcchhHHHHHH
Q psy11767 515 KVVDFGFACLKRES-----LHTPCFTLQYAAPEVLRQDKSGYDENCDLWSLGVILVNVLRQDKSGYDENCDLWSLGVILY 589 (966)
Q Consensus 515 KL~DFGla~~~~~~-----~~~~~gT~~Y~APEvl~~~~~~~~~~~Di~SlGvil~el~~~~~~~y~~~~DIWSlGvily 589 (966)
||+|||+++..... .....+++.|+|||++.. ..++.++|||||||++|
T Consensus 279 kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~--------------------------~~~~~~~DvwslGvil~ 332 (401)
T cd05107 279 KICDFGLARDIMRDSNYISKGSTFLPLKWMAPESIFN--------------------------NLYTTLSDVWSFGILLW 332 (401)
T ss_pred EEEecCcceecccccccccCCCcCCCCceeChHHhcC--------------------------CCCCcHhHHHHHHHHHH
Confidence 99999999753211 122346788999998852 23678899999999999
Q ss_pred HHhc-CCCCCCCCCCchhHHHHHHHHHcCCCCCCchhhccCCHHHHHHHHHhcccCccccCChHHHHHHh
Q psy11767 590 TMLC-GRVPFHARSRDDSALSIMARIKEGQFNFDAEAWSTVSSEAKELTKSLLTVNPAQRIRMMRVKLTF 658 (966)
Q Consensus 590 emlt-G~~Pf~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~is~e~~~Li~~~L~~dP~~R~t~~~v~~~~ 658 (966)
||++ |..||......+. ....+..+. .. ..+..++.++.+|+.+||..+|.+||++.++...+
T Consensus 333 e~l~~g~~P~~~~~~~~~---~~~~~~~~~-~~--~~p~~~~~~l~~li~~cl~~~P~~RPs~~ell~~L 396 (401)
T cd05107 333 EIFTLGGTPYPELPMNEQ---FYNAIKRGY-RM--AKPAHASDEIYEIMQKCWEEKFEIRPDFSQLVHLV 396 (401)
T ss_pred HHHHcCCCCCCCCCchHH---HHHHHHcCC-CC--CCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHH
Confidence 9998 8999976543322 223333332 11 12335789999999999999999999999885544
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D |
| >cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-35 Score=317.51 Aligned_cols=244 Identities=27% Similarity=0.453 Sum_probs=199.5
Q ss_pred ccccccccccccEEEEEEEcCCCcEEEEEEecccc------ChHHHHHHHHHhcCCCCceEEEEEEEeCCeEEEEEEccC
Q psy11767 381 DKAGILGDGSYSVCRRCVEKSTGQEYAVKIISRKI------DCSEEINLLRACQGHPNIVNLHCVFQDEVHTYLVLELLK 454 (966)
Q Consensus 381 ~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~------~~~~Ei~iL~~l~~HpnIV~l~~~~~~~~~~~lVmEy~~ 454 (966)
+..+.||.|+||.||+|++..+++.||+|++.... ...+|+.+++.+. ||||+++++++.++...|+|+||++
T Consensus 4 ~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~~~v~e~~~ 82 (274)
T cd06609 4 TLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAEDEIEDIQQEIQFLSQCR-SPYITKYYGSFLKGSKLWIIMEYCG 82 (274)
T ss_pred hhhhhhcCCCCeEEEEEEECCCCeEEEEEEeeccccchHHHHHHHHHHHHHHcC-CCCeeeeeEEEEECCeEEEEEEeeC
Confidence 34678999999999999999999999999986543 2356889999885 9999999999999999999999999
Q ss_pred CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCcEEEecCCCCCEEEEeecccccccCC---Ccc
Q psy11767 455 GGELLDRIRQKGRCGFTENEASRIMRQLVAAVHFMHSRGVVHRDLKPENLLFSDPAGDNIKVVDFGFACLKRES---LHT 531 (966)
Q Consensus 455 gg~L~~~l~~~~~~~l~e~~~~~i~~Qil~aL~yLHs~~IiHRDLKP~NILl~~~~~~~iKL~DFGla~~~~~~---~~~ 531 (966)
+++|.+++... .+++..++.++.|++.||+|||+++|+||||+|+||++++ ++.++|+|||++...... ...
T Consensus 83 ~~~L~~~~~~~---~~~~~~~~~~~~ql~~~l~~lh~~~i~h~dl~p~ni~i~~--~~~~~l~d~g~~~~~~~~~~~~~~ 157 (274)
T cd06609 83 GGSCLDLLKPG---KLDETYIAFILREVLLGLEYLHEEGKIHRDIKAANILLSE--EGDVKLADFGVSGQLTSTMSKRNT 157 (274)
T ss_pred CCcHHHHHhhc---CCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECC--CCCEEEcccccceeeccccccccc
Confidence 99999998764 5899999999999999999999999999999999999985 568999999999765432 234
Q ss_pred ccccccccCchhhccCCCCCCCcccchhhhhhhhhhhhcCCCCCCCcCcchhHHHHHHHHhcCCCCCCCCCCchhHHHHH
Q psy11767 532 PCFTLQYAAPEVLRQDKSGYDENCDLWSLGVILVNVLRQDKSGYDENCDLWSLGVILYTMLCGRVPFHARSRDDSALSIM 611 (966)
Q Consensus 532 ~~gT~~Y~APEvl~~~~~~~~~~~Di~SlGvil~el~~~~~~~y~~~~DIWSlGvilyemltG~~Pf~~~~~~~~~~~~~ 611 (966)
..+++.|+|||++.. ..++.++|||||||++|+|++|++||...+.. ...
T Consensus 158 ~~~~~~y~~PE~~~~--------------------------~~~~~~sDv~slG~il~~l~tg~~p~~~~~~~----~~~ 207 (274)
T cd06609 158 FVGTPFWMAPEVIKQ--------------------------SGYDEKADIWSLGITAIELAKGEPPLSDLHPM----RVL 207 (274)
T ss_pred ccCCccccChhhhcc--------------------------CCCCchhhHHHHHHHHHHHHhCCCCcccCchH----HHH
Confidence 567889999998853 22678999999999999999999999765432 222
Q ss_pred HHHHcCCCCCCchhhccCCHHHHHHHHHhcccCccccCChHHHHHHhhhhHHh
Q psy11767 612 ARIKEGQFNFDAEAWSTVSSEAKELTKSLLTVNPAQRIRMMRVKLTFHAFHQA 664 (966)
Q Consensus 612 ~~i~~~~~~~~~~~~~~is~e~~~Li~~~L~~dP~~R~t~~~v~~~~~~~~~~ 664 (966)
..+..+...... ...+++++.+++.+||..||++|||+.++ ..|+|...
T Consensus 208 ~~~~~~~~~~~~--~~~~~~~~~~~l~~~l~~~p~~Rpt~~~i--l~~~~~~~ 256 (274)
T cd06609 208 FLIPKNNPPSLE--GNKFSKPFKDFVSLCLNKDPKERPSAKEL--LKHKFIKK 256 (274)
T ss_pred HHhhhcCCCCCc--ccccCHHHHHHHHHHhhCChhhCcCHHHH--hhChhhcC
Confidence 333333221111 11278899999999999999999999977 34666543
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) |
| >cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-35 Score=318.89 Aligned_cols=242 Identities=33% Similarity=0.516 Sum_probs=194.4
Q ss_pred cccccccEEEEEEEcCCCcEEEEEEecccc--------ChHHHHHHHHHhcCCCCceEEEEEEEeCCeEEEEEEccCCCC
Q psy11767 386 LGDGSYSVCRRCVEKSTGQEYAVKIISRKI--------DCSEEINLLRACQGHPNIVNLHCVFQDEVHTYLVLELLKGGE 457 (966)
Q Consensus 386 LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~--------~~~~Ei~iL~~l~~HpnIV~l~~~~~~~~~~~lVmEy~~gg~ 457 (966)
||+|+||+||+|.+..+|+.||+|++.... ....|+++|+.+. ||||++++++|+..+..|+||||+++++
T Consensus 1 lg~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~~~~~~lv~e~~~~~~ 79 (277)
T cd05577 1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVS-SRFIVSLAYAFETKDDLCLVMTLMNGGD 79 (277)
T ss_pred CCCCCceeEEEEEEcCCCcEEEEEEEehhhhhhhhhhHHHHHHHHHHHhCC-CCCEeeeeeEEecCCeEEEEEecCCCCc
Confidence 699999999999999999999999986421 1346889998884 9999999999999999999999999999
Q ss_pred HHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCcEEEecCCCCCEEEEeecccccccC--CCcccccc
Q psy11767 458 LLDRIRQKGRCGFTENEASRIMRQLVAAVHFMHSRGVVHRDLKPENLLFSDPAGDNIKVVDFGFACLKRE--SLHTPCFT 535 (966)
Q Consensus 458 L~~~l~~~~~~~l~e~~~~~i~~Qil~aL~yLHs~~IiHRDLKP~NILl~~~~~~~iKL~DFGla~~~~~--~~~~~~gT 535 (966)
|.+++.+.....+++.++..++.|++.||.|||+.||+||||||+|||+++ ++.+||+|||++..... ......++
T Consensus 80 L~~~l~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~di~p~Nil~~~--~~~~~l~dfg~~~~~~~~~~~~~~~~~ 157 (277)
T cd05577 80 LKYHIYNVGEPGFPEARAIFYAAQIICGLEHLHQRRIVYRDLKPENVLLDD--HGNVRISDLGLAVELKGGKKIKGRAGT 157 (277)
T ss_pred HHHHHHHcCcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECC--CCCEEEccCcchhhhccCCccccccCC
Confidence 999998766556999999999999999999999999999999999999975 56899999999865432 12234567
Q ss_pred ccccCchhhccCCCCCCCcccchhhhhhhhhhhhcCCCCCCCcCcchhHHHHHHHHhcCCCCCCCCCCchhHHHHHHHHH
Q psy11767 536 LQYAAPEVLRQDKSGYDENCDLWSLGVILVNVLRQDKSGYDENCDLWSLGVILYTMLCGRVPFHARSRDDSALSIMARIK 615 (966)
Q Consensus 536 ~~Y~APEvl~~~~~~~~~~~Di~SlGvil~el~~~~~~~y~~~~DIWSlGvilyemltG~~Pf~~~~~~~~~~~~~~~i~ 615 (966)
..|+|||++.. ..++.++||||+||++|+|++|+.||...........+...+.
T Consensus 158 ~~y~~PE~~~~--------------------------~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~ 211 (277)
T cd05577 158 PGYMAPEVLQG--------------------------EVYDFSVDWFALGCTLYEMIAGRSPFRQRKEKVEKEELKRRTL 211 (277)
T ss_pred CCcCCHHHhcC--------------------------CCCCchhhhHHHHHHHHHHhhCCCCCCCCcccccHHHHHhccc
Confidence 89999998752 1267789999999999999999999976544222122222222
Q ss_pred cCCCCCCchhhccCCHHHHHHHHHhcccCccccC-----ChHHHHHHhhhhH
Q psy11767 616 EGQFNFDAEAWSTVSSEAKELTKSLLTVNPAQRI-----RMMRVKLTFHAFH 662 (966)
Q Consensus 616 ~~~~~~~~~~~~~is~e~~~Li~~~L~~dP~~R~-----t~~~v~~~~~~~~ 662 (966)
. ........+++++.++|.+||+.||++|| ++.++ ..|+|+
T Consensus 212 ~----~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~l--l~h~~~ 257 (277)
T cd05577 212 E----MAVEYPDKFSPEAKDLCEALLQKDPEKRLGCRGGSADEV--REHPLF 257 (277)
T ss_pred c----ccccCCccCCHHHHHHHHHHccCChhHccCCCcccHHHH--HhChhh
Confidence 2 22223345789999999999999999999 55544 446665
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of |
| >cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-35 Score=320.68 Aligned_cols=243 Identities=23% Similarity=0.393 Sum_probs=194.6
Q ss_pred cccccccccccccEEEEEEEcCCCcEEEEEEecccc------ChHHHHHHHHHhcCCCCceEEEEEEEeCCeEEEEEEcc
Q psy11767 380 LDKAGILGDGSYSVCRRCVEKSTGQEYAVKIISRKI------DCSEEINLLRACQGHPNIVNLHCVFQDEVHTYLVLELL 453 (966)
Q Consensus 380 ~~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~------~~~~Ei~iL~~l~~HpnIV~l~~~~~~~~~~~lVmEy~ 453 (966)
|+..+.||+|+||+||+|.+..+|+.||+|++.... ...+|+++++.+ +||||+++++++.+....|+||||+
T Consensus 7 ~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~ 85 (284)
T cd06620 7 LETISDLGAGNGGSVSKVKHIPTGTVMAKKVVHIGAKSSVRKQILRELQIMHEC-RSPYIVSFYGAFLNENNICMCMEFM 85 (284)
T ss_pred HHHHHHcCCCCCeEEEEEEEcCCCcEEEEEEEEecCcchHHHHHHHHHHHHHHc-CCCCcceEeeeEecCCEEEEEEecC
Confidence 445789999999999999999999999999876432 234689999888 5999999999999999999999999
Q ss_pred CCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHh-cCceeccCCCCcEEEecCCCCCEEEEeecccccccC-CCcc
Q psy11767 454 KGGELLDRIRQKGRCGFTENEASRIMRQLVAAVHFMHS-RGVVHRDLKPENLLFSDPAGDNIKVVDFGFACLKRE-SLHT 531 (966)
Q Consensus 454 ~gg~L~~~l~~~~~~~l~e~~~~~i~~Qil~aL~yLHs-~~IiHRDLKP~NILl~~~~~~~iKL~DFGla~~~~~-~~~~ 531 (966)
++++|.+++.+.+ .+++..+..++.|++.||.|||+ .+|+||||||+|||+++ .+.++|+|||++..... ....
T Consensus 86 ~~~~L~~~~~~~~--~~~~~~~~~~~~~i~~~l~~LH~~~~i~H~dl~p~nil~~~--~~~~~l~d~gl~~~~~~~~~~~ 161 (284)
T cd06620 86 DCGSLDRIYKKGG--PIPVEILGKIAVAVVEGLTYLYNVHRIMHRDIKPSNILVNS--RGQIKLCDFGVSGELINSIADT 161 (284)
T ss_pred CCCCHHHHHHhcc--CCCHHHHHHHHHHHHHHHHHHHHhcCeeccCCCHHHEEECC--CCcEEEccCCcccchhhhccCc
Confidence 9999999987654 58999999999999999999997 59999999999999975 56899999999865322 2234
Q ss_pred ccccccccCchhhccCCCCCCCcccchhhhhhhhhhhhcCCCCCCCcCcchhHHHHHHHHhcCCCCCCCCCCch------
Q psy11767 532 PCFTLQYAAPEVLRQDKSGYDENCDLWSLGVILVNVLRQDKSGYDENCDLWSLGVILYTMLCGRVPFHARSRDD------ 605 (966)
Q Consensus 532 ~~gT~~Y~APEvl~~~~~~~~~~~Di~SlGvil~el~~~~~~~y~~~~DIWSlGvilyemltG~~Pf~~~~~~~------ 605 (966)
.++|..|+|||++.. ..++.++|+||+||++|+|++|+.||......+
T Consensus 162 ~~~~~~~~aPE~~~~--------------------------~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~ 215 (284)
T cd06620 162 FVGTSTYMSPERIQG--------------------------GKYTVKSDVWSLGISIIELALGKFPFAFSNIDDDGQDDP 215 (284)
T ss_pred cccCcccCCHHHHcc--------------------------CCCCccchHHHHHHHHHHHHhCCCCCcccchhhhhhhhh
Confidence 578999999998752 236778999999999999999999998654320
Q ss_pred -hHHHHHHHHHcCCCCCCchhhccCCHHHHHHHHHhcccCccccCChHHHH
Q psy11767 606 -SALSIMARIKEGQFNFDAEAWSTVSSEAKELTKSLLTVNPAQRIRMMRVK 655 (966)
Q Consensus 606 -~~~~~~~~i~~~~~~~~~~~~~~is~e~~~Li~~~L~~dP~~R~t~~~v~ 655 (966)
........+...... ......++.++.+|+.+||..||++|||+.++.
T Consensus 216 ~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~e~~ 264 (284)
T cd06620 216 MGILDLLQQIVQEPPP--RLPSSDFPEDLRDFVDACLLKDPTERPTPQQLC 264 (284)
T ss_pred hHHHHHHHHHhhccCC--CCCchhcCHHHHHHHHHHhcCCcccCcCHHHHh
Confidence 111222222222111 001123678999999999999999999998873
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >KOG0986|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.9e-37 Score=333.69 Aligned_cols=223 Identities=26% Similarity=0.423 Sum_probs=195.8
Q ss_pred CcceeeeecccccceEEEEEEcCCCCEEEEEeccccc--------hhhHHHHHHHHhhCCCcccc---------------
Q psy11767 117 DLDKAGILGDGSYSVCRRCVEKSTGQEYAVKIISRKI--------DCSEEINLLRACQGHPNICR--------------- 173 (966)
Q Consensus 117 df~~~~~LG~GsFGkV~La~~k~tg~~yAiKvl~K~~--------~~~~E~~il~~~~~~pfi~~--------------- 173 (966)
+|...+|||+|+||.|+-|+-++||+.||+|.|.|+. ..++|+.||+++ ..||||.
T Consensus 186 ~F~~~RvlGkGGFGEV~acqvraTGKMYAcKkL~KKRiKkr~ge~maLnEk~iL~kV-~s~FiVslaYAfeTkd~LClVL 264 (591)
T KOG0986|consen 186 TFRVYRVLGKGGFGEVCACQVRATGKMYACKKLDKKRIKKRKGETMALNEKQILEKV-SSPFIVSLAYAFETKDALCLVL 264 (591)
T ss_pred ceeeeEEEecccccceeEEEEecchhhHHHHHHHHHHHHHhhhhHHhhHHHHHHHHh-ccCcEEEEeeeecCCCceEEEE
Confidence 8999999999999999999999999999999999763 348899999998 5899986
Q ss_pred -----------------cccccccchhHHHHHHHh----------hcccchhhhHhhhccCCceEEecCccc--------
Q psy11767 174 -----------------RCVEKSTGQEYAVKIISR----------KIDCSEEINLLRACQGHPNIVNLHCVF-------- 218 (966)
Q Consensus 174 -----------------~~~~~~~~~~~~~~~v~~----------~~~~~~e~nil~~~~gh~~iv~l~~~~-------- 218 (966)
.-|.++.+.||+++|++. +.|+++| |||+|..||..|.||+++.
T Consensus 265 tlMNGGDLkfHiyn~g~~gF~e~ra~FYAAEi~cGLehlH~~~iVYRDLKPe-NILLDd~GhvRISDLGLAvei~~g~~~ 343 (591)
T KOG0986|consen 265 TLMNGGDLKFHIYNHGNPGFDEQRARFYAAEIICGLEHLHRRRIVYRDLKPE-NILLDDHGHVRISDLGLAVEIPEGKPI 343 (591)
T ss_pred EeecCCceeEEeeccCCCCCchHHHHHHHHHHHhhHHHHHhcceeeccCChh-heeeccCCCeEeeccceEEecCCCCcc
Confidence 246666778999888754 3477777 9999999999999998763
Q ss_pred ----------cccccccccCCCcceeeechhhHHHHHHHhhCCCCCCC----CcHHHHHHHHHhCCCCCCCCCCHHHHHH
Q psy11767 219 ----------QDEVIDWDDFSRGIECVFFSSSLIIFFIILSFTLSFIH----DYYHIQYRRILKTEPPIPEDLSPDVADF 284 (966)
Q Consensus 219 ----------~~e~i~~~~y~~~~d~~~~~~~~il~~~m~~g~~pf~~----~~~~~~~~~I~~~~~~~P~~~s~~a~dl 284 (966)
++|++....|+.+.| ||+.|+++|||+.|..||.. ..++++=++|++...+||+.||++|+||
T Consensus 344 ~~rvGT~GYMAPEvl~ne~Y~~s~D---wf~lGCllYemi~G~sPFr~~KeKvk~eEvdrr~~~~~~ey~~kFS~eaksl 420 (591)
T KOG0986|consen 344 RGRVGTVGYMAPEVLQNEVYDFSPD---WFSLGCLLYEMIAGHSPFRQRKEKVKREEVDRRTLEDPEEYSDKFSEEAKSL 420 (591)
T ss_pred ccccCcccccCHHHHcCCcccCCcc---HHHHHhHHHHHHcccCchhhhhhhhhHHHHHHHHhcchhhcccccCHHHHHH
Confidence 468898888998988 66889999999999999974 3445788999999999999999999999
Q ss_pred HHhhcccCCCcccCCCCCCHHHHhcCCceeeeCccccccCCCCCCCCccc-----cccccccccc
Q psy11767 285 ISRLLVKDPRRRLGGGELDAEELKRHPFFNVIDWDDLATKRIPAPFVPKI-----SNELDVSNFS 344 (966)
Q Consensus 285 i~~LL~kdp~~RLG~~~~g~~~Ik~HpfF~~idW~~l~~k~~~pP~~P~i-----~~~~D~snFd 344 (966)
++.||+|||.+|||+...|+++||.||||+++||..|+...++|||+|.. .+..|..+|+
T Consensus 421 c~~LL~Kdp~~RLGcrg~ga~evk~HpfFk~lnw~rleagml~PPfiPdp~aVyakDv~DIeqFs 485 (591)
T KOG0986|consen 421 CEGLLTKDPEKRLGCRGEGAQEVKEHPFFKDLNWRRLEAGMLEPPFIPDPGAVYAKDVLDIEQFS 485 (591)
T ss_pred HHHHHccCHHHhccCCCcCcchhhhCcccccCCHhHHhccCCCCCCCCCccccchhhhhhhhhcc
Confidence 99999999999999987799999999999999999999999999999975 3455667776
|
|
| >PLN00009 cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.3e-35 Score=320.62 Aligned_cols=253 Identities=28% Similarity=0.433 Sum_probs=196.5
Q ss_pred ccccccccccccEEEEEEEcCCCcEEEEEEecccc-------ChHHHHHHHHHhcCCCCceEEEEEEEeCCeEEEEEEcc
Q psy11767 381 DKAGILGDGSYSVCRRCVEKSTGQEYAVKIISRKI-------DCSEEINLLRACQGHPNIVNLHCVFQDEVHTYLVLELL 453 (966)
Q Consensus 381 ~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~-------~~~~Ei~iL~~l~~HpnIV~l~~~~~~~~~~~lVmEy~ 453 (966)
+..+.||+|+||.||+|.+..+|+.||||.+.... ...+|+++++.+ +||||+++++++.++.+.|+||||+
T Consensus 5 ~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~ 83 (294)
T PLN00009 5 EKVEKIGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEM-QHGNIVRLQDVVHSEKRLYLVFEYL 83 (294)
T ss_pred EEEEEecCCCCEEEEEEEecCCCcEEEEEehhhccccccchHHHHHHHHHHHhc-cCCCEeeEEEEEecCCeEEEEEecc
Confidence 34678999999999999999999999999885431 245699999998 5999999999999999999999999
Q ss_pred CCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCcEEEecCCCCCEEEEeecccccccCC---Cc
Q psy11767 454 KGGELLDRIRQKGRCGFTENEASRIMRQLVAAVHFMHSRGVVHRDLKPENLLFSDPAGDNIKVVDFGFACLKRES---LH 530 (966)
Q Consensus 454 ~gg~L~~~l~~~~~~~l~e~~~~~i~~Qil~aL~yLHs~~IiHRDLKP~NILl~~~~~~~iKL~DFGla~~~~~~---~~ 530 (966)
+ ++|.+++.......+++..++.++.||+.||+|||++||+||||||+|||++. .++.+||+|||++...... ..
T Consensus 84 ~-~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~i~H~dl~p~nill~~-~~~~~kl~dfg~~~~~~~~~~~~~ 161 (294)
T PLN00009 84 D-LDLKKHMDSSPDFAKNPRLIKTYLYQILRGIAYCHSHRVLHRDLKPQNLLIDR-RTNALKLADFGLARAFGIPVRTFT 161 (294)
T ss_pred c-ccHHHHHHhCCCCCcCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCcceEEEEC-CCCEEEEcccccccccCCCccccc
Confidence 5 68888887655445789999999999999999999999999999999999974 3457999999999654322 22
Q ss_pred cccccccccCchhhccCCCCCCCcccchhhhhhhhhhhhcCCCCCCCcCcchhHHHHHHHHhcCCCCCCCCCCchhHHHH
Q psy11767 531 TPCFTLQYAAPEVLRQDKSGYDENCDLWSLGVILVNVLRQDKSGYDENCDLWSLGVILYTMLCGRVPFHARSRDDSALSI 610 (966)
Q Consensus 531 ~~~gT~~Y~APEvl~~~~~~~~~~~Di~SlGvil~el~~~~~~~y~~~~DIWSlGvilyemltG~~Pf~~~~~~~~~~~~ 610 (966)
...+++.|+|||++.. ...++.++||||+||++|+|++|++||......+....+
T Consensus 162 ~~~~~~~y~~PE~~~~-------------------------~~~~~~~~Dv~slG~i~~~l~tg~~pf~~~~~~~~~~~~ 216 (294)
T PLN00009 162 HEVVTLWYRAPEILLG-------------------------SRHYSTPVDIWSVGCIFAEMVNQKPLFPGDSEIDELFKI 216 (294)
T ss_pred cCceeecccCHHHHhC-------------------------CCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHH
Confidence 3456889999998742 123677899999999999999999999875543322222
Q ss_pred HHHHHcCC-------------------C--CCCchhhccCCHHHHHHHHHhcccCccccCChHHHHHHhhhhHH
Q psy11767 611 MARIKEGQ-------------------F--NFDAEAWSTVSSEAKELTKSLLTVNPAQRIRMMRVKLTFHAFHQ 663 (966)
Q Consensus 611 ~~~i~~~~-------------------~--~~~~~~~~~is~e~~~Li~~~L~~dP~~R~t~~~v~~~~~~~~~ 663 (966)
+..+.... + .......+.+++++.+++.+||..||++||++.++. .|+|+.
T Consensus 217 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~~l--~~~~~~ 288 (294)
T PLN00009 217 FRILGTPNEETWPGVTSLPDYKSAFPKWPPKDLATVVPTLEPAGVDLLSKMLRLDPSKRITARAAL--EHEYFK 288 (294)
T ss_pred HHHhCCCChhhccccccchhhhhhcccCCCCCHHHhCcCCChHHHHHHHHHccCChhhCcCHHHHh--cCchHh
Confidence 22111100 0 000011245789999999999999999999998763 356554
|
|
| >cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-35 Score=320.74 Aligned_cols=243 Identities=23% Similarity=0.341 Sum_probs=195.2
Q ss_pred ccccccccccccEEEEEEEc-----CCCcEEEEEEecccc-----ChHHHHHHHHHhcCCCCceEEEEEEEeCCeEEEEE
Q psy11767 381 DKAGILGDGSYSVCRRCVEK-----STGQEYAVKIISRKI-----DCSEEINLLRACQGHPNIVNLHCVFQDEVHTYLVL 450 (966)
Q Consensus 381 ~~~~~LG~G~fG~Vy~a~~~-----~tg~~vAvK~i~~~~-----~~~~Ei~iL~~l~~HpnIV~l~~~~~~~~~~~lVm 450 (966)
...+.||+|+||.||+|.+. .++..+|+|.+.... ...+|+.+++.+ +||||+++++++.+....++||
T Consensus 8 ~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~ 86 (291)
T cd05094 8 VLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNL-QHEHIVKFYGVCGDGDPLIMVF 86 (291)
T ss_pred EEeeeecccCCCeEEEeEeeccCCCCcceeeEEEecCCccHHHHHHHHHHHHHHhcC-CCCCcceEEEEEccCCceEEEE
Confidence 34578999999999999864 356679999986442 355788999888 5999999999999999999999
Q ss_pred EccCCCCHHHHHHhcCC--------------CCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCcEEEecCCCCCEEE
Q psy11767 451 ELLKGGELLDRIRQKGR--------------CGFTENEASRIMRQLVAAVHFMHSRGVVHRDLKPENLLFSDPAGDNIKV 516 (966)
Q Consensus 451 Ey~~gg~L~~~l~~~~~--------------~~l~e~~~~~i~~Qil~aL~yLHs~~IiHRDLKP~NILl~~~~~~~iKL 516 (966)
||+++++|.+++..... ..+++..++.++.||+.||+|||++||+||||||+|||+++ ++.++|
T Consensus 87 e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~i~H~dlkp~Nil~~~--~~~~~l 164 (291)
T cd05094 87 EYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLASQHFVHRDLATRNCLVGA--NLLVKI 164 (291)
T ss_pred ecCCCCcHHHHHHhcCcccccccccccccCcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccCcceEEEcc--CCcEEE
Confidence 99999999999976431 24899999999999999999999999999999999999985 568999
Q ss_pred EeecccccccCC-----CccccccccccCchhhccCCCCCCCcccchhhhhhhhhhhhcCCCCCCCcCcchhHHHHHHHH
Q psy11767 517 VDFGFACLKRES-----LHTPCFTLQYAAPEVLRQDKSGYDENCDLWSLGVILVNVLRQDKSGYDENCDLWSLGVILYTM 591 (966)
Q Consensus 517 ~DFGla~~~~~~-----~~~~~gT~~Y~APEvl~~~~~~~~~~~Di~SlGvil~el~~~~~~~y~~~~DIWSlGvilyem 591 (966)
+|||+++..... .....+++.|+|||++.. ..++.++|||||||++|+|
T Consensus 165 ~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~--------------------------~~~~~~~Di~slG~il~el 218 (291)
T cd05094 165 GDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMY--------------------------RKFTTESDVWSFGVILWEI 218 (291)
T ss_pred CCCCcccccCCCceeecCCCCCcceeecChHHhcc--------------------------CCCCchhhHHHHHHHHHHH
Confidence 999999654321 122345788999998752 2367789999999999999
Q ss_pred hc-CCCCCCCCCCchhHHHHHHHHHcCCCCCCchhhccCCHHHHHHHHHhcccCccccCChHHHHHHhh
Q psy11767 592 LC-GRVPFHARSRDDSALSIMARIKEGQFNFDAEAWSTVSSEAKELTKSLLTVNPAQRIRMMRVKLTFH 659 (966)
Q Consensus 592 lt-G~~Pf~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~is~e~~~Li~~~L~~dP~~R~t~~~v~~~~~ 659 (966)
++ |+.||...+.. ..+..+..+..... ....+.++.+++.+||..||++||++.++...+.
T Consensus 219 ~t~g~~p~~~~~~~----~~~~~~~~~~~~~~---~~~~~~~~~~li~~~l~~~P~~Rpt~~~v~~~l~ 280 (291)
T cd05094 219 FTYGKQPWFQLSNT----EVIECITQGRVLER---PRVCPKEVYDIMLGCWQREPQQRLNIKEIYKILH 280 (291)
T ss_pred HhCCCCCCCCCCHH----HHHHHHhCCCCCCC---CccCCHHHHHHHHHHcccChhhCcCHHHHHHHHH
Confidence 98 99999765432 23444555443221 2346889999999999999999999998855444
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n |
| >cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-35 Score=329.41 Aligned_cols=246 Identities=24% Similarity=0.341 Sum_probs=191.3
Q ss_pred ccccccccccccEEEEEEE-----cCCCcEEEEEEeccccC------hHHHHHHHHHhcCCCCceEEEEEEEeC-CeEEE
Q psy11767 381 DKAGILGDGSYSVCRRCVE-----KSTGQEYAVKIISRKID------CSEEINLLRACQGHPNIVNLHCVFQDE-VHTYL 448 (966)
Q Consensus 381 ~~~~~LG~G~fG~Vy~a~~-----~~tg~~vAvK~i~~~~~------~~~Ei~iL~~l~~HpnIV~l~~~~~~~-~~~~l 448 (966)
+..+.||+|+||+||+|.+ ..+++.||||++..... ..+|+.+|..+.+|||||++++++... ...++
T Consensus 10 ~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~~l 89 (343)
T cd05103 10 KLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGPLMV 89 (343)
T ss_pred cccccccCCccceEEEEeeccCCccccceeEEEEEeccCCChHHHHHHHHHHHHHHhccCCccHhhhcceeecCCCceEE
Confidence 3468899999999999985 35688999999965321 346999999997799999999987654 56799
Q ss_pred EEEccCCCCHHHHHHhcCC-------------------------------------------------------------
Q psy11767 449 VLELLKGGELLDRIRQKGR------------------------------------------------------------- 467 (966)
Q Consensus 449 VmEy~~gg~L~~~l~~~~~------------------------------------------------------------- 467 (966)
|||||++|+|.+++.....
T Consensus 90 v~ey~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 169 (343)
T cd05103 90 IVEFCKFGNLSNYLRSKRGEFVPYKTKDARFRQGKSGYGDISEDLKRRLDSITSSQSSASSGFVEEKSLSDVEEEEAEQE 169 (343)
T ss_pred EEeccCCCcHHHHHHhcCCccccccccccccccccccccchhhhhhhhccccccccccccccccCCCccccchhhhhhhh
Confidence 9999999999999875321
Q ss_pred ----CCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCcEEEecCCCCCEEEEeecccccccCC-----Cccccccccc
Q psy11767 468 ----CGFTENEASRIMRQLVAAVHFMHSRGVVHRDLKPENLLFSDPAGDNIKVVDFGFACLKRES-----LHTPCFTLQY 538 (966)
Q Consensus 468 ----~~l~e~~~~~i~~Qil~aL~yLHs~~IiHRDLKP~NILl~~~~~~~iKL~DFGla~~~~~~-----~~~~~gT~~Y 538 (966)
..+++..+..++.||+.||+|||++||+||||||+|||++. ++.+||+|||++...... .....+++.|
T Consensus 170 ~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dikp~Nil~~~--~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y 247 (343)
T cd05103 170 DLYKKVLTLEDLICYSFQVAKGMEFLASRKCIHRDLAARNILLSE--NNVVKICDFGLARDIYKDPDYVRKGDARLPLKW 247 (343)
T ss_pred hhhhccCCHHHHHHHHHHHHHHHHHHHhCCeecCCCccCeEEEcC--CCcEEEEecccccccccCcchhhcCCCCCCcce
Confidence 23688889999999999999999999999999999999975 568999999998754221 1122346779
Q ss_pred cCchhhccCCCCCCCcccchhhhhhhhhhhhcCCCCCCCcCcchhHHHHHHHHhc-CCCCCCCCCCchhHHHHHHHHHcC
Q psy11767 539 AAPEVLRQDKSGYDENCDLWSLGVILVNVLRQDKSGYDENCDLWSLGVILYTMLC-GRVPFHARSRDDSALSIMARIKEG 617 (966)
Q Consensus 539 ~APEvl~~~~~~~~~~~Di~SlGvil~el~~~~~~~y~~~~DIWSlGvilyemlt-G~~Pf~~~~~~~~~~~~~~~i~~~ 617 (966)
+|||++.. ..|+.++|||||||++|+|++ |..||........ ....+..+
T Consensus 248 ~aPE~~~~--------------------------~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~---~~~~~~~~ 298 (343)
T cd05103 248 MAPETIFD--------------------------RVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEE---FCRRLKEG 298 (343)
T ss_pred ECcHHhcC--------------------------CCCCchhhHHHHHHHHHHHHHCCCCCCCCccccHH---HHHHHhcc
Confidence 99998742 236788999999999999996 9999976543322 22333333
Q ss_pred CCCCCchhhccCCHHHHHHHHHhcccCccccCChHHHHHHhhh
Q psy11767 618 QFNFDAEAWSTVSSEAKELTKSLLTVNPAQRIRMMRVKLTFHA 660 (966)
Q Consensus 618 ~~~~~~~~~~~is~e~~~Li~~~L~~dP~~R~t~~~v~~~~~~ 660 (966)
..... ...+++++.+++.+||..||++|||+.++...+..
T Consensus 299 ~~~~~---~~~~~~~~~~~~~~cl~~~p~~Rps~~eil~~l~~ 338 (343)
T cd05103 299 TRMRA---PDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGN 338 (343)
T ss_pred CCCCC---CCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHH
Confidence 32111 12367899999999999999999999988655443
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp |
| >cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-34 Score=312.91 Aligned_cols=245 Identities=27% Similarity=0.439 Sum_probs=198.0
Q ss_pred ccccccccccccEEEEEEEcCCCcEEEEEEeccc--------cChHHHHHHHHHhcCCCCceEEEEEEEeCCeEEEEEEc
Q psy11767 381 DKAGILGDGSYSVCRRCVEKSTGQEYAVKIISRK--------IDCSEEINLLRACQGHPNIVNLHCVFQDEVHTYLVLEL 452 (966)
Q Consensus 381 ~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~--------~~~~~Ei~iL~~l~~HpnIV~l~~~~~~~~~~~lVmEy 452 (966)
+..+.||+|+||.||+|.+..+|+.||+|.++.. ....+|+++|+.+ +|+||+++++++.+....++||||
T Consensus 5 ~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~ei~~l~~~-~~~~i~~~~~~~~~~~~~~lv~e~ 83 (267)
T cd08224 5 KIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQL-DHPNVIKYLASFIENNELNIVLEL 83 (267)
T ss_pred eeeeeeccCCceEEEEEEEcCCCCEEEEEEeecccccchhhHHHHHHHHHHHHhC-CCCCeeeeeeeeecCCeEEEEEec
Confidence 3357899999999999999999999999988531 1244689999998 599999999999999999999999
Q ss_pred cCCCCHHHHHHhc--CCCCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCcEEEecCCCCCEEEEeecccccccCC--
Q psy11767 453 LKGGELLDRIRQK--GRCGFTENEASRIMRQLVAAVHFMHSRGVVHRDLKPENLLFSDPAGDNIKVVDFGFACLKRES-- 528 (966)
Q Consensus 453 ~~gg~L~~~l~~~--~~~~l~e~~~~~i~~Qil~aL~yLHs~~IiHRDLKP~NILl~~~~~~~iKL~DFGla~~~~~~-- 528 (966)
+++|+|.+++... ....+++..+..++.||+.||+|||+.||+||||||+||+++. ++.++|+|||++......
T Consensus 84 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~p~nil~~~--~~~~~l~d~~~~~~~~~~~~ 161 (267)
T cd08224 84 ADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALEHMHSKRIMHRDIKPANVFITA--TGVVKLGDLGLGRFFSSKTT 161 (267)
T ss_pred CCCCCHHHHHHHhcccCCCcCHHHHHHHHHHHHHHHHHHHhCCEecCCcChhhEEECC--CCcEEEeccceeeeccCCCc
Confidence 9999999998652 2335899999999999999999999999999999999999975 568999999998654322
Q ss_pred -CccccccccccCchhhccCCCCCCCcccchhhhhhhhhhhhcCCCCCCCcCcchhHHHHHHHHhcCCCCCCCCCCchhH
Q psy11767 529 -LHTPCFTLQYAAPEVLRQDKSGYDENCDLWSLGVILVNVLRQDKSGYDENCDLWSLGVILYTMLCGRVPFHARSRDDSA 607 (966)
Q Consensus 529 -~~~~~gT~~Y~APEvl~~~~~~~~~~~Di~SlGvil~el~~~~~~~y~~~~DIWSlGvilyemltG~~Pf~~~~~~~~~ 607 (966)
.....+++.|+|||++.. ..++.++|+|||||++|+|++|+.||...... .
T Consensus 162 ~~~~~~~~~~y~apE~~~~--------------------------~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~--~ 213 (267)
T cd08224 162 AAHSLVGTPYYMSPERIHE--------------------------NGYNFKSDIWSLGCLLYEMAALQSPFYGDKMN--L 213 (267)
T ss_pred ccceecCCccccCHHHhcc--------------------------CCCCchhcHHHHHHHHHHHHHCCCCcccCCcc--H
Confidence 223467889999998752 23677899999999999999999999765422 2
Q ss_pred HHHHHHHHcCCCCCCchhhccCCHHHHHHHHHhcccCccccCChHHHHHHh
Q psy11767 608 LSIMARIKEGQFNFDAEAWSTVSSEAKELTKSLLTVNPAQRIRMMRVKLTF 658 (966)
Q Consensus 608 ~~~~~~i~~~~~~~~~~~~~~is~e~~~Li~~~L~~dP~~R~t~~~v~~~~ 658 (966)
......+..+.+... .....+.++.++|.+||..+|++|||+.++...+
T Consensus 214 ~~~~~~~~~~~~~~~--~~~~~~~~~~~~i~~cl~~~p~~Rp~~~~il~~~ 262 (267)
T cd08224 214 YSLCKKIEKCDYPPL--PADHYSEELRDLVSRCINPDPEKRPDISYVLQVA 262 (267)
T ss_pred HHHHhhhhcCCCCCC--ChhhcCHHHHHHHHHHcCCCcccCCCHHHHHHHH
Confidence 233444444443222 1235788999999999999999999999875443
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a |
| >cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.9e-35 Score=312.43 Aligned_cols=239 Identities=25% Similarity=0.469 Sum_probs=196.9
Q ss_pred ccccccccccccEEEEEEEcCCCcEEEEEEecccc-------ChHHHHHHHHHhcCCCCceEEEEEEEeCCeEEEEEEcc
Q psy11767 381 DKAGILGDGSYSVCRRCVEKSTGQEYAVKIISRKI-------DCSEEINLLRACQGHPNIVNLHCVFQDEVHTYLVLELL 453 (966)
Q Consensus 381 ~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~-------~~~~Ei~iL~~l~~HpnIV~l~~~~~~~~~~~lVmEy~ 453 (966)
+..+.||+|+||.||+|.+..+++.||||.+.... ...+|+.+|+.+ +||||+++++.+..+...++||||+
T Consensus 3 ~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~~-~~~~i~~~~~~~~~~~~~~lv~e~~ 81 (256)
T cd08220 3 EKIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLL-SHPNIIEYYENFLEDKALMIVMEYA 81 (256)
T ss_pred eEEEEecccCceEEEEEEEcCCCcEEEEEEEeccccccHHHHHHHHHHHHHhhC-CCCchhheeeeEecCCEEEEEEecC
Confidence 44678999999999999999999999999986532 244688999888 5999999999999999999999999
Q ss_pred CCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCcEEEecCCCCCEEEEeecccccccCC--Ccc
Q psy11767 454 KGGELLDRIRQKGRCGFTENEASRIMRQLVAAVHFMHSRGVVHRDLKPENLLFSDPAGDNIKVVDFGFACLKRES--LHT 531 (966)
Q Consensus 454 ~gg~L~~~l~~~~~~~l~e~~~~~i~~Qil~aL~yLHs~~IiHRDLKP~NILl~~~~~~~iKL~DFGla~~~~~~--~~~ 531 (966)
++++|.+++.......+++..+..++.|++.||+|||++||+||||||+||++++ .++.+||+|||++...... ...
T Consensus 82 ~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~nil~~~-~~~~~~l~d~~~~~~~~~~~~~~~ 160 (256)
T cd08220 82 PGGTLAEYIQKRCNSLLDEDTILHFFVQILLALHHVHTKLILHRDLKTQNILLDK-HKMVVKIGDFGISKILSSKSKAYT 160 (256)
T ss_pred CCCCHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcC-CCCEEEEccCCCceecCCCccccc
Confidence 9999999998765556899999999999999999999999999999999999974 3456899999998765432 223
Q ss_pred ccccccccCchhhccCCCCCCCcccchhhhhhhhhhhhcCCCCCCCcCcchhHHHHHHHHhcCCCCCCCCCCchhHHHHH
Q psy11767 532 PCFTLQYAAPEVLRQDKSGYDENCDLWSLGVILVNVLRQDKSGYDENCDLWSLGVILYTMLCGRVPFHARSRDDSALSIM 611 (966)
Q Consensus 532 ~~gT~~Y~APEvl~~~~~~~~~~~Di~SlGvil~el~~~~~~~y~~~~DIWSlGvilyemltG~~Pf~~~~~~~~~~~~~ 611 (966)
..+++.|+|||.+.. ..++.++||||+||++|+|++|+.||...+... ..
T Consensus 161 ~~~~~~y~aPE~~~~--------------------------~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~----~~ 210 (256)
T cd08220 161 VVGTPCYISPELCEG--------------------------KPYNQKSDIWALGCVLYELASLKRAFEAANLPA----LV 210 (256)
T ss_pred cccCCcccCchhccC--------------------------CCCCcccchHHHHHHHHHHHhCCCCcccCchHH----HH
Confidence 467889999998742 235778999999999999999999997654322 22
Q ss_pred HHHHcCCCCCCchhhccCCHHHHHHHHHhcccCccccCChHHH
Q psy11767 612 ARIKEGQFNFDAEAWSTVSSEAKELTKSLLTVNPAQRIRMMRV 654 (966)
Q Consensus 612 ~~i~~~~~~~~~~~~~~is~e~~~Li~~~L~~dP~~R~t~~~v 654 (966)
..+..+... .....++.++.+++.+||..||++|||+.++
T Consensus 211 ~~~~~~~~~---~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~l 250 (256)
T cd08220 211 LKIMSGTFA---PISDRYSPDLRQLILSMLNLDPSKRPQLSQI 250 (256)
T ss_pred HHHHhcCCC---CCCCCcCHHHHHHHHHHccCChhhCCCHHHH
Confidence 333333222 1223578999999999999999999999976
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with |
| >cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-34 Score=313.37 Aligned_cols=242 Identities=20% Similarity=0.366 Sum_probs=193.8
Q ss_pred cccccccccccccEEEEEEEcCC---CcEEEEEEeccccC------hHHHHHHHHHhcCCCCceEEEEEEEeCCeEEEEE
Q psy11767 380 LDKAGILGDGSYSVCRRCVEKST---GQEYAVKIISRKID------CSEEINLLRACQGHPNIVNLHCVFQDEVHTYLVL 450 (966)
Q Consensus 380 ~~~~~~LG~G~fG~Vy~a~~~~t---g~~vAvK~i~~~~~------~~~Ei~iL~~l~~HpnIV~l~~~~~~~~~~~lVm 450 (966)
|+..+.||+|+||+||+|.+..+ ...||||++..... ..+|+.+|+.+ +||||+++++.+.+....|+||
T Consensus 6 ~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~iv~ 84 (266)
T cd05033 6 VTIEKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDFLTEASIMGQF-DHPNIIRLEGVVTKSRPVMIIT 84 (266)
T ss_pred ceeeeEecCCccceEEEEEEccCCCCcceEEEEEcCCCCChHHHHHHHHHHHHHHhC-CCCCcceEeEEEecCCceEEEE
Confidence 34467899999999999998754 46899999865432 34588899888 5999999999999999999999
Q ss_pred EccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCcEEEecCCCCCEEEEeecccccccCCC-
Q psy11767 451 ELLKGGELLDRIRQKGRCGFTENEASRIMRQLVAAVHFMHSRGVVHRDLKPENLLFSDPAGDNIKVVDFGFACLKRESL- 529 (966)
Q Consensus 451 Ey~~gg~L~~~l~~~~~~~l~e~~~~~i~~Qil~aL~yLHs~~IiHRDLKP~NILl~~~~~~~iKL~DFGla~~~~~~~- 529 (966)
||+++++|.+++..... .+++..+..++.|++.||+|||+++|+||||||+|||+++ ++.++|+|||++.......
T Consensus 85 e~~~~~~L~~~~~~~~~-~~~~~~~~~~~~~l~~~l~~Lh~~~i~H~di~p~nili~~--~~~~~l~dfg~~~~~~~~~~ 161 (266)
T cd05033 85 EYMENGSLDKFLRENDG-KFTVGQLVGMLRGIASGMKYLSEMNYVHRDLAARNILVNS--NLVCKVSDFGLSRRLEDSEA 161 (266)
T ss_pred EcCCCCCHHHHHHhccC-CCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCcceEEEcC--CCCEEECccchhhccccccc
Confidence 99999999999976543 6899999999999999999999999999999999999985 5689999999997653211
Q ss_pred ----ccccccccccCchhhccCCCCCCCcccchhhhhhhhhhhhcCCCCCCCcCcchhHHHHHHHHhc-CCCCCCCCCCc
Q psy11767 530 ----HTPCFTLQYAAPEVLRQDKSGYDENCDLWSLGVILVNVLRQDKSGYDENCDLWSLGVILYTMLC-GRVPFHARSRD 604 (966)
Q Consensus 530 ----~~~~gT~~Y~APEvl~~~~~~~~~~~Di~SlGvil~el~~~~~~~y~~~~DIWSlGvilyemlt-G~~Pf~~~~~~ 604 (966)
....+++.|+|||.+.. ..++.++|||||||++|+|++ |..||......
T Consensus 162 ~~~~~~~~~~~~y~~Pe~~~~--------------------------~~~~~~~Dv~slG~~l~~l~~~g~~p~~~~~~~ 215 (266)
T cd05033 162 TYTTKGGKIPIRWTAPEAIAY--------------------------RKFTSASDVWSFGIVMWEVMSYGERPYWDMSNQ 215 (266)
T ss_pred ceeccCCCCCccccChhhhcc--------------------------CCCccccchHHHHHHHHHHHccCCCCCCCCCHH
Confidence 12234678999998752 236778999999999999997 99999764422
Q ss_pred hhHHHHHHHHHcCCCCCCchhhccCCHHHHHHHHHhcccCccccCChHHHHHHh
Q psy11767 605 DSALSIMARIKEGQFNFDAEAWSTVSSEAKELTKSLLTVNPAQRIRMMRVKLTF 658 (966)
Q Consensus 605 ~~~~~~~~~i~~~~~~~~~~~~~~is~e~~~Li~~~L~~dP~~R~t~~~v~~~~ 658 (966)
.....+..+... + .....++.+.+|+.+||+.||++||++.++...+
T Consensus 216 ----~~~~~~~~~~~~-~--~~~~~~~~l~~li~~cl~~~p~~Rp~~~ei~~~l 262 (266)
T cd05033 216 ----DVIKAVEDGYRL-P--PPMDCPSALYQLMLDCWQKDRNERPTFSQIVSTL 262 (266)
T ss_pred ----HHHHHHHcCCCC-C--CCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHH
Confidence 234444443221 1 1235788999999999999999999999885443
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment |
| >cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-34 Score=315.29 Aligned_cols=246 Identities=17% Similarity=0.279 Sum_probs=186.0
Q ss_pred ccccccccEEEEEEEcC--CCcEEEEEEeccccC------hHHHHHHHHHhcCCCCceEEEEEEEeCCeEEEEEEccCCC
Q psy11767 385 ILGDGSYSVCRRCVEKS--TGQEYAVKIISRKID------CSEEINLLRACQGHPNIVNLHCVFQDEVHTYLVLELLKGG 456 (966)
Q Consensus 385 ~LG~G~fG~Vy~a~~~~--tg~~vAvK~i~~~~~------~~~Ei~iL~~l~~HpnIV~l~~~~~~~~~~~lVmEy~~gg 456 (966)
.||+|+||+||+|.... ....+|+|.+..... ..+|+.+++.+ +||||+++++.+.+....|+||||+++|
T Consensus 2 ~lg~G~fg~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l-~h~nii~~~~~~~~~~~~~lv~e~~~~g 80 (269)
T cd05042 2 EIGNGWFGKVLLGEAHRGMSKARVVVKELRASATPDEQLLFLQEVQPYREL-NHPNVLQCLGQCIESIPYLLVLEFCPLG 80 (269)
T ss_pred cCCccCCceEEEEEEecCCCCeEEEEeecCccCChHHHHHHHHHHHHHHhC-CCCCcceEEEEECCCCceEEEEEeCCCC
Confidence 59999999999996433 456789998754322 34688888887 6999999999999999999999999999
Q ss_pred CHHHHHHhcCC---CCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCcEEEecCCCCCEEEEeecccccccCC-----
Q psy11767 457 ELLDRIRQKGR---CGFTENEASRIMRQLVAAVHFMHSRGVVHRDLKPENLLFSDPAGDNIKVVDFGFACLKRES----- 528 (966)
Q Consensus 457 ~L~~~l~~~~~---~~l~e~~~~~i~~Qil~aL~yLHs~~IiHRDLKP~NILl~~~~~~~iKL~DFGla~~~~~~----- 528 (966)
+|.+++..... ..+++..++.++.||+.||+|||++||+||||||+|||+++ ++.+||+|||++......
T Consensus 81 ~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nill~~--~~~~kl~dfg~~~~~~~~~~~~~ 158 (269)
T cd05042 81 DLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQADFIHSDLALRNCQLTA--DLSVKIGDYGLALEQYPEDYYIT 158 (269)
T ss_pred cHHHHHHhccccccccccHHHHHHHHHHHHHHHHHHHhcCEecccccHhheEecC--CCcEEEeccccccccccchheec
Confidence 99999976432 23568889999999999999999999999999999999985 568999999998643211
Q ss_pred CccccccccccCchhhccCCCCCCCcccchhhhhhhhhhhhcCCCCCCCcCcchhHHHHHHHHhc-CCCCCCCCCCchhH
Q psy11767 529 LHTPCFTLQYAAPEVLRQDKSGYDENCDLWSLGVILVNVLRQDKSGYDENCDLWSLGVILYTMLC-GRVPFHARSRDDSA 607 (966)
Q Consensus 529 ~~~~~gT~~Y~APEvl~~~~~~~~~~~Di~SlGvil~el~~~~~~~y~~~~DIWSlGvilyemlt-G~~Pf~~~~~~~~~ 607 (966)
.....+++.|+|||++....... ....++.++|||||||++|+|++ |.+||......+
T Consensus 159 ~~~~~~~~~y~aPE~~~~~~~~~-------------------~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~-- 217 (269)
T cd05042 159 KDCHAVPLRWLAPELVEIRGQDL-------------------LPKDQTKKSNIWSLGVTMWELFTAADQPYPDLSDEQ-- 217 (269)
T ss_pred cCCCCCcccccCHHHHhhccccc-------------------cccccchhhHHHHHHHHHHHHHhCCCCCCCcCCHHH--
Confidence 12234567899999986322100 12346789999999999999998 788987654322
Q ss_pred HHHHHHHHcCCCCCCch-hhccCCHHHHHHHHHhcccCccccCChHHHHH
Q psy11767 608 LSIMARIKEGQFNFDAE-AWSTVSSEAKELTKSLLTVNPAQRIRMMRVKL 656 (966)
Q Consensus 608 ~~~~~~i~~~~~~~~~~-~~~~is~e~~~Li~~~L~~dP~~R~t~~~v~~ 656 (966)
.....+..+...++.. ....++....+++..|+ .||++|||+.++..
T Consensus 218 -~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~dp~~Rpt~~~v~~ 265 (269)
T cd05042 218 -VLKQVVREQDIKLPKPQLDLKYSDRWYEVMQFCW-LDPETRPTAEEVHE 265 (269)
T ss_pred -HHHHHhhccCccCCCCcccccCCHHHHHHHHHHh-cCcccccCHHHHHH
Confidence 1122233333333222 22357888999999998 59999999998754
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina |
| >cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-34 Score=314.81 Aligned_cols=247 Identities=19% Similarity=0.279 Sum_probs=187.0
Q ss_pred cccccccccEEEEEEEc--CCCcEEEEEEecccc------ChHHHHHHHHHhcCCCCceEEEEEEEeCCeEEEEEEccCC
Q psy11767 384 GILGDGSYSVCRRCVEK--STGQEYAVKIISRKI------DCSEEINLLRACQGHPNIVNLHCVFQDEVHTYLVLELLKG 455 (966)
Q Consensus 384 ~~LG~G~fG~Vy~a~~~--~tg~~vAvK~i~~~~------~~~~Ei~iL~~l~~HpnIV~l~~~~~~~~~~~lVmEy~~g 455 (966)
+.||+|+||.||+|... .++..+|+|.+.... ...+|+.+++.+ +||||+++++++.+....|+||||+++
T Consensus 1 ~~lg~G~~g~Vy~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~e~~~~ 79 (269)
T cd05087 1 KEIGNGWFGKVILGEVNSGYTPAQVVVKELRVSASVQEQMKFLEEAQPYRSL-QHSNLLQCLGQCTEVTPYLLVMEFCPL 79 (269)
T ss_pred CcccccCCceEEEEEEcCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhC-CCCCEeeEEEEEcCCCCcEEEEECCCC
Confidence 35999999999999754 456789999886543 234588888888 599999999999999999999999999
Q ss_pred CCHHHHHHhcCC---CCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCcEEEecCCCCCEEEEeecccccccCC----
Q psy11767 456 GELLDRIRQKGR---CGFTENEASRIMRQLVAAVHFMHSRGVVHRDLKPENLLFSDPAGDNIKVVDFGFACLKRES---- 528 (966)
Q Consensus 456 g~L~~~l~~~~~---~~l~e~~~~~i~~Qil~aL~yLHs~~IiHRDLKP~NILl~~~~~~~iKL~DFGla~~~~~~---- 528 (966)
|+|.+++..... ..+++..++.++.|++.||+|||+.+|+||||||+|||++. .+.+||+|||++......
T Consensus 80 g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dlkp~nil~~~--~~~~kL~dfg~~~~~~~~~~~~ 157 (269)
T cd05087 80 GDLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHKNNFIHSDLALRNCLLTA--DLTVKIGDYGLSHNKYKEDYYV 157 (269)
T ss_pred CcHHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCCEeccccCcceEEEcC--CCcEEECCccccccccCcceee
Confidence 999999975321 24577888899999999999999999999999999999975 568999999998653221
Q ss_pred -CccccccccccCchhhccCCCCCCCcccchhhhhhhhhhhhcCCCCCCCcCcchhHHHHHHHHhc-CCCCCCCCCCchh
Q psy11767 529 -LHTPCFTLQYAAPEVLRQDKSGYDENCDLWSLGVILVNVLRQDKSGYDENCDLWSLGVILYTMLC-GRVPFHARSRDDS 606 (966)
Q Consensus 529 -~~~~~gT~~Y~APEvl~~~~~~~~~~~Di~SlGvil~el~~~~~~~y~~~~DIWSlGvilyemlt-G~~Pf~~~~~~~~ 606 (966)
.....+++.|+|||++...... .....++.++|||||||++|+|++ |+.||......+.
T Consensus 158 ~~~~~~~~~~y~aPE~~~~~~~~-------------------~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~~~ 218 (269)
T cd05087 158 TPDQLWVPLRWIAPELVDEVHGN-------------------LLVVDQTKESNVWSLGVTIWELFELGSQPYRHLSDEQV 218 (269)
T ss_pred cCCCcCCcccccCHhHhcccccc-------------------ccccCCCccchhHHHHHHHHHHHhCCCCCCCCCChHHH
Confidence 1233567889999998532100 001246789999999999999996 9999976543221
Q ss_pred HHHHHHHHHcCCCCCCchh-hccCCHHHHHHHHHhcccCccccCChHHHHH
Q psy11767 607 ALSIMARIKEGQFNFDAEA-WSTVSSEAKELTKSLLTVNPAQRIRMMRVKL 656 (966)
Q Consensus 607 ~~~~~~~i~~~~~~~~~~~-~~~is~e~~~Li~~~L~~dP~~R~t~~~v~~ 656 (966)
....+......+.... ....+..+.+++.+|+ .+|++|||+.++..
T Consensus 219 ---~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~c~-~~P~~Rpt~~~l~~ 265 (269)
T cd05087 219 ---LTYTVREQQLKLPKPRLKLPLSDRWYEVMQFCW-LQPEQRPSAEEVHL 265 (269)
T ss_pred ---HHHHhhcccCCCCCCccCCCCChHHHHHHHHHh-cCcccCCCHHHHHH
Confidence 1122222222222211 1246788999999999 68999999998853
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells |
| >cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-34 Score=319.80 Aligned_cols=241 Identities=30% Similarity=0.478 Sum_probs=187.9
Q ss_pred ccccccccccccEEEEEEEcCCCcEEEEEEecccc------ChHHHHHHHHHhcCCCCceEEEEEEEeCCeEEEEEEccC
Q psy11767 381 DKAGILGDGSYSVCRRCVEKSTGQEYAVKIISRKI------DCSEEINLLRACQGHPNIVNLHCVFQDEVHTYLVLELLK 454 (966)
Q Consensus 381 ~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~------~~~~Ei~iL~~l~~HpnIV~l~~~~~~~~~~~lVmEy~~ 454 (966)
...+.||+|+||.||+|.+..+|+.||||++.... ...+|+.+|+.+ +|+||+++++++.++...|+||||+.
T Consensus 8 ~~~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l-~h~ni~~~~~~~~~~~~~~lv~e~~~ 86 (291)
T cd07870 8 LNLEKLGEGSYATVYKGISRINGQLVALKVISMKTEEGVPFTAIREASLLKGL-KHANIVLLHDIIHTKETLTFVFEYMH 86 (291)
T ss_pred EEEEEEEecCCEEEEEEEEcCCCcEEEEEEecccCcCCCcHHHHHHHHHHHhc-CCCCEeEEEEEEecCCeEEEEEeccc
Confidence 34678999999999999999999999999986432 245799999988 59999999999999999999999995
Q ss_pred CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCcEEEecCCCCCEEEEeecccccccC---CCcc
Q psy11767 455 GGELLDRIRQKGRCGFTENEASRIMRQLVAAVHFMHSRGVVHRDLKPENLLFSDPAGDNIKVVDFGFACLKRE---SLHT 531 (966)
Q Consensus 455 gg~L~~~l~~~~~~~l~e~~~~~i~~Qil~aL~yLHs~~IiHRDLKP~NILl~~~~~~~iKL~DFGla~~~~~---~~~~ 531 (966)
++|.+++.... ..+++..++.++.||+.||+|||+.||+||||||+|||++. .+.+||+|||+++.... ....
T Consensus 87 -~~l~~~~~~~~-~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dlkp~Nil~~~--~~~~~l~Dfg~~~~~~~~~~~~~~ 162 (291)
T cd07870 87 -TDLAQYMIQHP-GGLHPYNVRLFMFQLLRGLAYIHGQHILHRDLKPQNLLISY--LGELKLADFGLARAKSIPSQTYSS 162 (291)
T ss_pred -CCHHHHHHhCC-CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChHHEEEcC--CCcEEEeccccccccCCCCCCCCC
Confidence 78887776543 25889999999999999999999999999999999999974 56899999999865332 1223
Q ss_pred ccccccccCchhhccCCCCCCCcccchhhhhhhhhhhhcCCCCCCCcCcchhHHHHHHHHhcCCCCCCCCCCchhHHHHH
Q psy11767 532 PCFTLQYAAPEVLRQDKSGYDENCDLWSLGVILVNVLRQDKSGYDENCDLWSLGVILYTMLCGRVPFHARSRDDSALSIM 611 (966)
Q Consensus 532 ~~gT~~Y~APEvl~~~~~~~~~~~Di~SlGvil~el~~~~~~~y~~~~DIWSlGvilyemltG~~Pf~~~~~~~~~~~~~ 611 (966)
..+++.|+|||++.. ...++.++|||||||++|+|++|..||.+..... ..+
T Consensus 163 ~~~~~~y~aPE~~~~-------------------------~~~~~~~~Dv~slG~~l~~l~~g~~~f~~~~~~~---~~~ 214 (291)
T cd07870 163 EVVTLWYRPPDVLLG-------------------------ATDYSSALDIWGAGCIFIEMLQGQPAFPGVSDVF---EQL 214 (291)
T ss_pred ccccccccCCceeec-------------------------CCCCCcHHHHHHHHHHHHHHHhCCCCCCCchhHH---HHH
Confidence 456889999998742 1235678999999999999999999998654321 111
Q ss_pred HHHHc--CC------------CCCC------------chhhc--cCCHHHHHHHHHhcccCccccCChHHH
Q psy11767 612 ARIKE--GQ------------FNFD------------AEAWS--TVSSEAKELTKSLLTVNPAQRIRMMRV 654 (966)
Q Consensus 612 ~~i~~--~~------------~~~~------------~~~~~--~is~e~~~Li~~~L~~dP~~R~t~~~v 654 (966)
..+.. +. ..+. ...|. ..+.++.+++.+||..||.+|||+.++
T Consensus 215 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dp~~R~t~~~~ 285 (291)
T cd07870 215 EKIWTVLGVPTEDTWPGVSKLPNYKPEWFLPCKPQQLRVVWKRLSRPPKAEDLASQMLMMFPKDRISAQDA 285 (291)
T ss_pred HHHHHHcCCCChhhhhhhhhcccccchhccccCCcchhhhccccCCChHHHHHHHHHhCcCcccCcCHHHH
Confidence 11100 00 0000 00111 125788999999999999999999876
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess |
| >cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-34 Score=314.40 Aligned_cols=240 Identities=20% Similarity=0.334 Sum_probs=188.9
Q ss_pred ccccccccccEEEEEEEcCCCc--EEEEEEecccc-------ChHHHHHHHHHhcCCCCceEEEEEEEeC------CeEE
Q psy11767 383 AGILGDGSYSVCRRCVEKSTGQ--EYAVKIISRKI-------DCSEEINLLRACQGHPNIVNLHCVFQDE------VHTY 447 (966)
Q Consensus 383 ~~~LG~G~fG~Vy~a~~~~tg~--~vAvK~i~~~~-------~~~~Ei~iL~~l~~HpnIV~l~~~~~~~------~~~~ 447 (966)
.+.||+|+||.||+|.+..++. .||+|.++... ...+|+.+|+.+ +||||+++++++... ...+
T Consensus 4 ~~~ig~G~~g~V~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~~~~~~~ 82 (272)
T cd05075 4 GKTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEF-DHPNVMRLIGVCLQTVESEGYPSPV 82 (272)
T ss_pred ccccCcccCceEEEeEEccCCCeeeEEEEecccCcCCHHHHHHHHHHHHHHHhC-CCCCcceEEEEEccCCcccCCCCcE
Confidence 4689999999999999988776 69999886432 234588888888 699999999876432 2468
Q ss_pred EEEEccCCCCHHHHHHhc----CCCCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCcEEEecCCCCCEEEEeecccc
Q psy11767 448 LVLELLKGGELLDRIRQK----GRCGFTENEASRIMRQLVAAVHFMHSRGVVHRDLKPENLLFSDPAGDNIKVVDFGFAC 523 (966)
Q Consensus 448 lVmEy~~gg~L~~~l~~~----~~~~l~e~~~~~i~~Qil~aL~yLHs~~IiHRDLKP~NILl~~~~~~~iKL~DFGla~ 523 (966)
+||||+++|+|.+++... ....+++..+..++.||+.||+|||+++|+||||||+|||++. ++.+||+|||+++
T Consensus 83 ~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~--~~~~kl~Dfg~~~ 160 (272)
T cd05075 83 VILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGMEYLSSKSFIHRDLAARNCMLNE--NMNVCVADFGLSK 160 (272)
T ss_pred EEEEeCCCCcHHHHHHHhcccCCcccCCHHHHHHHHHHHHHHHHHHHHCCeeccccchhheEEcC--CCCEEECCCCccc
Confidence 999999999999887432 1235899999999999999999999999999999999999974 5689999999997
Q ss_pred cccCCC-----ccccccccccCchhhccCCCCCCCcccchhhhhhhhhhhhcCCCCCCCcCcchhHHHHHHHHhc-CCCC
Q psy11767 524 LKRESL-----HTPCFTLQYAAPEVLRQDKSGYDENCDLWSLGVILVNVLRQDKSGYDENCDLWSLGVILYTMLC-GRVP 597 (966)
Q Consensus 524 ~~~~~~-----~~~~gT~~Y~APEvl~~~~~~~~~~~Di~SlGvil~el~~~~~~~y~~~~DIWSlGvilyemlt-G~~P 597 (966)
...... ....+++.|+|||++.. ..++.++|||||||++|+|++ |++|
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~pe~~~~--------------------------~~~~~~~Di~slG~il~el~~~g~~p 214 (272)
T cd05075 161 KIYNGDYYRQGRIAKMPVKWIAIESLAD--------------------------RVYTTKSDVWSFGVTMWEIATRGQTP 214 (272)
T ss_pred ccCcccceecCCcccCCcccCCHHHccC--------------------------CCcChHHHHHHHHHHHHHHHcCCCCC
Confidence 653221 12245678999998742 236788999999999999999 8999
Q ss_pred CCCCCCchhHHHHHHHHHcCCCCCCchhhccCCHHHHHHHHHhcccCccccCChHHHHHHh
Q psy11767 598 FHARSRDDSALSIMARIKEGQFNFDAEAWSTVSSEAKELTKSLLTVNPAQRIRMMRVKLTF 658 (966)
Q Consensus 598 f~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~is~e~~~Li~~~L~~dP~~R~t~~~v~~~~ 658 (966)
|.+... ..+...+..+.... ....++..+.++|.+||+.||++|||+.++...+
T Consensus 215 ~~~~~~----~~~~~~~~~~~~~~---~~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~l 268 (272)
T cd05075 215 YPGVEN----SEIYDYLRQGNRLK---QPPDCLDGLYSLMSSCWLLNPKDRPSFETLRCEL 268 (272)
T ss_pred CCCCCH----HHHHHHHHcCCCCC---CCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHH
Confidence 976543 23445555544321 1235788999999999999999999999885443
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor |
| >cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-34 Score=317.71 Aligned_cols=240 Identities=23% Similarity=0.346 Sum_probs=191.8
Q ss_pred cccccccccccEEEEEEEc-----CCCcEEEEEEecccc-----ChHHHHHHHHHhcCCCCceEEEEEEEeCCeEEEEEE
Q psy11767 382 KAGILGDGSYSVCRRCVEK-----STGQEYAVKIISRKI-----DCSEEINLLRACQGHPNIVNLHCVFQDEVHTYLVLE 451 (966)
Q Consensus 382 ~~~~LG~G~fG~Vy~a~~~-----~tg~~vAvK~i~~~~-----~~~~Ei~iL~~l~~HpnIV~l~~~~~~~~~~~lVmE 451 (966)
..++||+|+||.||+|... .++..+|+|.+.... ...+|+++++.+ +||||+++++++.+....|+|||
T Consensus 9 ~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e 87 (280)
T cd05092 9 LKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTVL-QHQHIVRFYGVCTEGRPLLMVFE 87 (280)
T ss_pred eccccCCccCCeEEEeEEecCCCCCCceEEEEEecCcCCHHHHHHHHHHHHHHhcC-CCCCCceEEEEEecCCceEEEEe
Confidence 3578999999999999743 357789999886532 355689999888 69999999999999999999999
Q ss_pred ccCCCCHHHHHHhcCC-------------CCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCcEEEecCCCCCEEEEe
Q psy11767 452 LLKGGELLDRIRQKGR-------------CGFTENEASRIMRQLVAAVHFMHSRGVVHRDLKPENLLFSDPAGDNIKVVD 518 (966)
Q Consensus 452 y~~gg~L~~~l~~~~~-------------~~l~e~~~~~i~~Qil~aL~yLHs~~IiHRDLKP~NILl~~~~~~~iKL~D 518 (966)
|+++|+|.+++..... ..+++..++.++.||+.||+|||+.||+||||||+|||+++ .+.+||+|
T Consensus 88 ~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~i~H~dlkp~nil~~~--~~~~kL~d 165 (280)
T cd05092 88 YMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYLASLHFVHRDLATRNCLVGQ--GLVVKIGD 165 (280)
T ss_pred cCCCCCHHHHHHhcCcchhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHHCCeecccccHhhEEEcC--CCCEEECC
Confidence 9999999999976432 24889999999999999999999999999999999999985 56899999
Q ss_pred ecccccccCC-----CccccccccccCchhhccCCCCCCCcccchhhhhhhhhhhhcCCCCCCCcCcchhHHHHHHHHhc
Q psy11767 519 FGFACLKRES-----LHTPCFTLQYAAPEVLRQDKSGYDENCDLWSLGVILVNVLRQDKSGYDENCDLWSLGVILYTMLC 593 (966)
Q Consensus 519 FGla~~~~~~-----~~~~~gT~~Y~APEvl~~~~~~~~~~~Di~SlGvil~el~~~~~~~y~~~~DIWSlGvilyemlt 593 (966)
||++...... .....+++.|+|||++.. ..++.++|||||||++|+|++
T Consensus 166 fg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~--------------------------~~~~~~~Di~slG~il~el~~ 219 (280)
T cd05092 166 FGMSRDIYSTDYYRVGGRTMLPIRWMPPESILY--------------------------RKFTTESDIWSFGVVLWEIFT 219 (280)
T ss_pred CCceeEcCCCceeecCCCccccccccCHHHhcc--------------------------CCcCchhhHHHHHHHHHHHHc
Confidence 9998654321 112234678999998752 236788999999999999998
Q ss_pred -CCCCCCCCCCchhHHHHHHHHHcCCCCCCchhhccCCHHHHHHHHHhcccCccccCChHHHHHH
Q psy11767 594 -GRVPFHARSRDDSALSIMARIKEGQFNFDAEAWSTVSSEAKELTKSLLTVNPAQRIRMMRVKLT 657 (966)
Q Consensus 594 -G~~Pf~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~is~e~~~Li~~~L~~dP~~R~t~~~v~~~ 657 (966)
|.+||...... .....+..+... .....+++.+.+|+.+||+.||++||++.++...
T Consensus 220 ~g~~p~~~~~~~----~~~~~~~~~~~~---~~~~~~~~~~~~li~~cl~~~P~~Rp~~~~l~~~ 277 (280)
T cd05092 220 YGKQPWYQLSNT----EAIECITQGREL---ERPRTCPPEVYAIMQGCWQREPQQRMVIKDIHSR 277 (280)
T ss_pred CCCCCCccCCHH----HHHHHHHcCccC---CCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHH
Confidence 99999765432 223334333221 1223578999999999999999999999987543
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory |
| >cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-34 Score=314.67 Aligned_cols=239 Identities=28% Similarity=0.415 Sum_probs=190.7
Q ss_pred cccccccccEEEEEEEcCCCcEEEEEEecccc-----ChHHHHHHHHHhcCCCCceEEEEEEEeCCeEEEEEEccCCCCH
Q psy11767 384 GILGDGSYSVCRRCVEKSTGQEYAVKIISRKI-----DCSEEINLLRACQGHPNIVNLHCVFQDEVHTYLVLELLKGGEL 458 (966)
Q Consensus 384 ~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~-----~~~~Ei~iL~~l~~HpnIV~l~~~~~~~~~~~lVmEy~~gg~L 458 (966)
..||+|+||.||+|.+..++..||+|.+.... ...+|+.+++.+ +|+||+++++++.++...++||||+++++|
T Consensus 14 ~~lg~g~~g~v~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L 92 (268)
T cd06624 14 VVLGKGTYGIVYAARDLSTQVRIAIKEIPERDSRYVQPLHEEIALHSYL-KHRNIVQYLGSDSENGFFKIFMEQVPGGSL 92 (268)
T ss_pred EEEecCCceEEEEeEecCCCcEEEEEEecCCCHHHHHHHHHHHHHHHhc-CCCCeeeeeeeeccCCEEEEEEecCCCCCH
Confidence 47999999999999999999999999986543 245688999888 599999999999999999999999999999
Q ss_pred HHHHHhcCCCCC--CHHHHHHHHHHHHHHHHHHHhcCceeccCCCCcEEEecCCCCCEEEEeecccccccC---CCcccc
Q psy11767 459 LDRIRQKGRCGF--TENEASRIMRQLVAAVHFMHSRGVVHRDLKPENLLFSDPAGDNIKVVDFGFACLKRE---SLHTPC 533 (966)
Q Consensus 459 ~~~l~~~~~~~l--~e~~~~~i~~Qil~aL~yLHs~~IiHRDLKP~NILl~~~~~~~iKL~DFGla~~~~~---~~~~~~ 533 (966)
.+++..... .+ ++..+..++.||+.||+|||++||+||||||+|||++. ..+.++|+|||++..... ......
T Consensus 93 ~~~l~~~~~-~~~~~~~~~~~~~~qi~~al~~lH~~~i~h~dl~p~nil~~~-~~~~~~l~dfg~~~~~~~~~~~~~~~~ 170 (268)
T cd06624 93 SALLRSKWG-PLKDNEQTIIFYTKQILEGLKYLHDNQIVHRDIKGDNVLVNT-YSGVVKISDFGTSKRLAGINPCTETFT 170 (268)
T ss_pred HHHHHHhcc-cCCCcHHHHHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEcC-CCCeEEEecchhheecccCCCccccCC
Confidence 999976432 35 88999999999999999999999999999999999964 345899999999865422 122345
Q ss_pred ccccccCchhhccCCCCCCCcccchhhhhhhhhhhhcCCCCCCCcCcchhHHHHHHHHhcCCCCCCCCCCchhHHHHHHH
Q psy11767 534 FTLQYAAPEVLRQDKSGYDENCDLWSLGVILVNVLRQDKSGYDENCDLWSLGVILYTMLCGRVPFHARSRDDSALSIMAR 613 (966)
Q Consensus 534 gT~~Y~APEvl~~~~~~~~~~~Di~SlGvil~el~~~~~~~y~~~~DIWSlGvilyemltG~~Pf~~~~~~~~~~~~~~~ 613 (966)
+++.|+|||++... ...++.++|+||+||++|+|++|+.||........ . ...
T Consensus 171 ~~~~~~aPE~~~~~------------------------~~~~~~~~Dv~slGvvl~~l~~g~~p~~~~~~~~~--~-~~~ 223 (268)
T cd06624 171 GTLQYMAPEVIDKG------------------------PRGYGAPADIWSLGCTIVEMATGKPPFIELGEPQA--A-MFK 223 (268)
T ss_pred CCccccChhhhccc------------------------cccCCchhhhHHHHHHHHHHHhCCCCCccccChhh--h-Hhh
Confidence 78899999987532 22367789999999999999999999975432211 1 111
Q ss_pred HHcCCCCCCchhhccCCHHHHHHHHHhcccCccccCChHHH
Q psy11767 614 IKEGQFNFDAEAWSTVSSEAKELTKSLLTVNPAQRIRMMRV 654 (966)
Q Consensus 614 i~~~~~~~~~~~~~~is~e~~~Li~~~L~~dP~~R~t~~~v 654 (966)
+. .....+.....+++++++++.+||..+|++|||+.++
T Consensus 224 ~~--~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l 262 (268)
T cd06624 224 VG--MFKIHPEIPESLSAEAKNFILRCFEPDPDKRASAHDL 262 (268)
T ss_pred hh--hhccCCCCCcccCHHHHHHHHHHcCCCchhCCCHHHH
Confidence 11 1111122234578899999999999999999999876
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina |
| >cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-34 Score=318.73 Aligned_cols=246 Identities=24% Similarity=0.373 Sum_probs=193.4
Q ss_pred ccccccccccccEEEEEEEcCCCcEEEEEEecccc----ChHHHHHHHHHhcCCCCceEEEEEEEeC-----CeEEEEEE
Q psy11767 381 DKAGILGDGSYSVCRRCVEKSTGQEYAVKIISRKI----DCSEEINLLRACQGHPNIVNLHCVFQDE-----VHTYLVLE 451 (966)
Q Consensus 381 ~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~----~~~~Ei~iL~~l~~HpnIV~l~~~~~~~-----~~~~lVmE 451 (966)
+....||+|+||.||+|.+..+++.||+|++.... ...+|+.+++.+.+||||++++++|... ...|+|||
T Consensus 25 ~~~~~l~~g~~~~vy~~~~~~~~~~~aik~~~~~~~~~~~~~~e~~~l~~l~~h~ni~~~~~~~~~~~~~~~~~~~lv~e 104 (291)
T cd06639 25 EIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPISDVDEEIEAEYNILQSLPNHPNVVKFYGMFYKADKLVGGQLWLVLE 104 (291)
T ss_pred EEEEEeecCCCeEEEEEEECCCCCEEEEEEecccccHHHHHHHHHHHHHHhcCCCCeEEEEEEEEeccccCCCeeEEEEE
Confidence 33678999999999999999999999999986532 2346888998887899999999998753 36899999
Q ss_pred ccCCCCHHHHHHhc--CCCCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCcEEEecCCCCCEEEEeecccccccC--
Q psy11767 452 LLKGGELLDRIRQK--GRCGFTENEASRIMRQLVAAVHFMHSRGVVHRDLKPENLLFSDPAGDNIKVVDFGFACLKRE-- 527 (966)
Q Consensus 452 y~~gg~L~~~l~~~--~~~~l~e~~~~~i~~Qil~aL~yLHs~~IiHRDLKP~NILl~~~~~~~iKL~DFGla~~~~~-- 527 (966)
|++||+|.+++... ....+++..++.++.|++.||+|||+.||+||||||+|||+++ .+.+||+|||++.....
T Consensus 105 y~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dlkp~nili~~--~~~~kl~dfg~~~~~~~~~ 182 (291)
T cd06639 105 LCNGGSVTELVKGLLICGQRLDEAMISYILYGALLGLQHLHNNRIIHRDVKGNNILLTT--EGGVKLVDFGVSAQLTSTR 182 (291)
T ss_pred ECCCCcHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEEcC--CCCEEEeecccchhccccc
Confidence 99999999988642 2235899999999999999999999999999999999999975 56899999999865432
Q ss_pred -CCccccccccccCchhhccCCCCCCCcccchhhhhhhhhhhhcCCCCCCCcCcchhHHHHHHHHhcCCCCCCCCCCchh
Q psy11767 528 -SLHTPCFTLQYAAPEVLRQDKSGYDENCDLWSLGVILVNVLRQDKSGYDENCDLWSLGVILYTMLCGRVPFHARSRDDS 606 (966)
Q Consensus 528 -~~~~~~gT~~Y~APEvl~~~~~~~~~~~Di~SlGvil~el~~~~~~~y~~~~DIWSlGvilyemltG~~Pf~~~~~~~~ 606 (966)
......++..|+|||++..... ....++.++|||||||++|+|++|++||......
T Consensus 183 ~~~~~~~~~~~y~aPE~~~~~~~---------------------~~~~~~~~~Di~slGvi~~el~~g~~p~~~~~~~-- 239 (291)
T cd06639 183 LRRNTSVGTPFWMAPEVIACEQQ---------------------YDYSYDARCDVWSLGITAIELGDGDPPLFDMHPV-- 239 (291)
T ss_pred ccccCccCCccccChhhhcCCCC---------------------cccccCCccchHHHHHHHHHHhhCCCCCCCCcHH--
Confidence 1234567889999998853210 1224678999999999999999999999865432
Q ss_pred HHHHHHHHHcCCCCCCchhhccCCHHHHHHHHHhcccCccccCChHHH
Q psy11767 607 ALSIMARIKEGQFNFDAEAWSTVSSEAKELTKSLLTVNPAQRIRMMRV 654 (966)
Q Consensus 607 ~~~~~~~i~~~~~~~~~~~~~~is~e~~~Li~~~L~~dP~~R~t~~~v 654 (966)
..+..+..+... .......++.++.+||.+||..||++||++.++
T Consensus 240 --~~~~~~~~~~~~-~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~i 284 (291)
T cd06639 240 --KTLFKIPRNPPP-TLLHPEKWCRSFNHFISQCLIKDFEARPSVTHL 284 (291)
T ss_pred --HHHHHHhcCCCC-CCCcccccCHHHHHHHHHHhhcChhhCcCHHHH
Confidence 122333333211 111123467889999999999999999999976
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre |
| >cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-35 Score=321.47 Aligned_cols=250 Identities=30% Similarity=0.449 Sum_probs=194.8
Q ss_pred ccccccccccccEEEEEEEcCCCcEEEEEEeccccC----------hHHHHHHHHHhcCCCCceEEEEEEEeCCeEEEEE
Q psy11767 381 DKAGILGDGSYSVCRRCVEKSTGQEYAVKIISRKID----------CSEEINLLRACQGHPNIVNLHCVFQDEVHTYLVL 450 (966)
Q Consensus 381 ~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~~----------~~~Ei~iL~~l~~HpnIV~l~~~~~~~~~~~lVm 450 (966)
+..+.||+|+||.||+|.+..+|+.||||.+..... ...|+++++.+. |+||+++++++.++...|+||
T Consensus 3 ~~~~~lg~g~~~~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~e~~~l~~~~-h~~i~~~~~~~~~~~~~~lv~ 81 (298)
T cd07841 3 EKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELK-HPNIIGLLDVFGHKSNINLVF 81 (298)
T ss_pred eeeeeeeeccccEEEEEEECCCCcEEEEEEEeccccccccchhhHHHHHHHHHHhhcC-CCCChhhhheeecCCEEEEEE
Confidence 345789999999999999999999999999865321 245889998885 999999999999999999999
Q ss_pred EccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCcEEEecCCCCCEEEEeecccccccCC--
Q psy11767 451 ELLKGGELLDRIRQKGRCGFTENEASRIMRQLVAAVHFMHSRGVVHRDLKPENLLFSDPAGDNIKVVDFGFACLKRES-- 528 (966)
Q Consensus 451 Ey~~gg~L~~~l~~~~~~~l~e~~~~~i~~Qil~aL~yLHs~~IiHRDLKP~NILl~~~~~~~iKL~DFGla~~~~~~-- 528 (966)
||+ +|+|.+++.... ..+++..+..++.||++||+|||++||+|+||||+|||++. ++.++|+|||++......
T Consensus 82 e~~-~~~L~~~i~~~~-~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dl~p~nill~~--~~~~~l~dfg~~~~~~~~~~ 157 (298)
T cd07841 82 EFM-ETDLEKVIKDKS-IVLTPADIKSYMLMTLRGLEYLHSNWILHRDLKPNNLLIAS--DGVLKLADFGLARSFGSPNR 157 (298)
T ss_pred ccc-CCCHHHHHhccC-CCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCChhhEEEcC--CCCEEEccceeeeeccCCCc
Confidence 999 999999997654 35899999999999999999999999999999999999985 568999999999765432
Q ss_pred -CccccccccccCchhhccCCCCCCCcccchhhhhhhhhhhhcCCCCCCCcCcchhHHHHHHHHhcCCCCCCCCCCchhH
Q psy11767 529 -LHTPCFTLQYAAPEVLRQDKSGYDENCDLWSLGVILVNVLRQDKSGYDENCDLWSLGVILYTMLCGRVPFHARSRDDSA 607 (966)
Q Consensus 529 -~~~~~gT~~Y~APEvl~~~~~~~~~~~Di~SlGvil~el~~~~~~~y~~~~DIWSlGvilyemltG~~Pf~~~~~~~~~ 607 (966)
.....+++.|+|||++.. ...++.++|+|||||++|+|++|.+||.+....+..
T Consensus 158 ~~~~~~~~~~y~aPE~~~~-------------------------~~~~~~~~Dv~slG~il~e~~~g~~~~~~~~~~~~~ 212 (298)
T cd07841 158 KMTHQVVTRWYRAPELLFG-------------------------ARHYGVGVDMWSVGCIFAELLLRVPFLPGDSDIDQL 212 (298)
T ss_pred cccccccceeeeCHHHHhC-------------------------CCCCCcHHHHHHHHHHHHHHHcCCccccCCccHHHH
Confidence 223346788999998742 123677899999999999999998888765543221
Q ss_pred HHHHHHHHcC------------CC-------C-CCchhhccCCHHHHHHHHHhcccCccccCChHHHHHHhhhhH
Q psy11767 608 LSIMARIKEG------------QF-------N-FDAEAWSTVSSEAKELTKSLLTVNPAQRIRMMRVKLTFHAFH 662 (966)
Q Consensus 608 ~~~~~~i~~~------------~~-------~-~~~~~~~~is~e~~~Li~~~L~~dP~~R~t~~~v~~~~~~~~ 662 (966)
..+...+... .+ . .....+...+.++.++|.+||..||++|||+.++. .|+|+
T Consensus 213 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~e~l--~~~~~ 285 (298)
T cd07841 213 GKIFEALGTPTEENWPGVTSLPDYVEFKPFPPTPLKQIFPAASDDALDLLQRLLTLNPNKRITARQAL--EHPYF 285 (298)
T ss_pred HHHHHHcCCCchhhhhhcccccccccccccCCcchhhhcccccHHHHHHHHHHhcCCcccCcCHHHHh--hCccc
Confidence 1111111000 00 0 00011234678999999999999999999999873 35554
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is |
| >smart00219 TyrKc Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-34 Score=310.36 Aligned_cols=237 Identities=24% Similarity=0.429 Sum_probs=194.2
Q ss_pred ccccccccccEEEEEEEcCCC----cEEEEEEecccc------ChHHHHHHHHHhcCCCCceEEEEEEEeCCeEEEEEEc
Q psy11767 383 AGILGDGSYSVCRRCVEKSTG----QEYAVKIISRKI------DCSEEINLLRACQGHPNIVNLHCVFQDEVHTYLVLEL 452 (966)
Q Consensus 383 ~~~LG~G~fG~Vy~a~~~~tg----~~vAvK~i~~~~------~~~~Ei~iL~~l~~HpnIV~l~~~~~~~~~~~lVmEy 452 (966)
.+.||.|+||.||+|.+..++ ..||+|++.... ....|+.+|+.+ +|+||+++++++.+.+..|++|||
T Consensus 4 ~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~~~~~i~e~ 82 (258)
T smart00219 4 GKKLGEGAFGEVYKGTLKGLSGEKEVEVAVKTLKEDADEQQIEEFLREARIMRKL-DHPNIVKLLGVCTEEEPLMIVMEY 82 (258)
T ss_pred cceeccCCCcceEEEEecCCCCCCCceEEEEEccCCCChHHHHHHHHHHHHHHhc-CCCchheEEEEEcCCCeeEEEEec
Confidence 568999999999999998876 899999996543 234588999988 799999999999999999999999
Q ss_pred cCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCcEEEecCCCCCEEEEeecccccccCCCc--
Q psy11767 453 LKGGELLDRIRQKGRCGFTENEASRIMRQLVAAVHFMHSRGVVHRDLKPENLLFSDPAGDNIKVVDFGFACLKRESLH-- 530 (966)
Q Consensus 453 ~~gg~L~~~l~~~~~~~l~e~~~~~i~~Qil~aL~yLHs~~IiHRDLKP~NILl~~~~~~~iKL~DFGla~~~~~~~~-- 530 (966)
+++++|.+++.......+++..+..++.|++.||+|||+.|++||||||+||++++ ++.++|+|||++........
T Consensus 83 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lh~~~~~h~dl~~~nil~~~--~~~~~l~dfg~~~~~~~~~~~~ 160 (258)
T smart00219 83 MEGGDLLDYLRKNRPKELSLSDLLSFALQIARGMEYLESKNFIHRDLAARNCLVGE--NLVVKISDFGLSRDLYDDDYYK 160 (258)
T ss_pred cCCCCHHHHHHhhhhccCCHHHHHHHHHHHHHHHHHHhcCCeeecccccceEEEcc--CCeEEEcccCCceecccccccc
Confidence 99999999997654323899999999999999999999999999999999999985 55899999999976543211
Q ss_pred --cccccccccCchhhccCCCCCCCcccchhhhhhhhhhhhcCCCCCCCcCcchhHHHHHHHHhc-CCCCCCCCCCchhH
Q psy11767 531 --TPCFTLQYAAPEVLRQDKSGYDENCDLWSLGVILVNVLRQDKSGYDENCDLWSLGVILYTMLC-GRVPFHARSRDDSA 607 (966)
Q Consensus 531 --~~~gT~~Y~APEvl~~~~~~~~~~~Di~SlGvil~el~~~~~~~y~~~~DIWSlGvilyemlt-G~~Pf~~~~~~~~~ 607 (966)
...+++.|+|||.+.. ..++.++||||+||++|+|++ |.+||...+..
T Consensus 161 ~~~~~~~~~y~~Pe~~~~--------------------------~~~~~~~Di~slG~i~~~l~~~g~~p~~~~~~~--- 211 (258)
T smart00219 161 KKGGKLPIRWMAPESLKD--------------------------GKFTSKSDVWSFGVLLWEIFTLGESPYPGMSNE--- 211 (258)
T ss_pred cccCCCcccccChHHhcc--------------------------CCCCcchhHHHHHHHHHHHHhCCCCCCCCCCHH---
Confidence 1236788999998742 236788999999999999998 89999764432
Q ss_pred HHHHHHHHcCCCCCCchhhccCCHHHHHHHHHhcccCccccCChHHHH
Q psy11767 608 LSIMARIKEGQFNFDAEAWSTVSSEAKELTKSLLTVNPAQRIRMMRVK 655 (966)
Q Consensus 608 ~~~~~~i~~~~~~~~~~~~~~is~e~~~Li~~~L~~dP~~R~t~~~v~ 655 (966)
.....+..+..... ...++.++.+++.+||..||++|||+.++.
T Consensus 212 -~~~~~~~~~~~~~~---~~~~~~~~~~~i~~~l~~~p~~Rpt~~~ll 255 (258)
T smart00219 212 -EVLEYLKKGYRLPK---PENCPPEIYKLMLQCWAEDPEDRPTFSELV 255 (258)
T ss_pred -HHHHHHhcCCCCCC---CCcCCHHHHHHHHHHCcCChhhCcCHHHHH
Confidence 33444544433222 234789999999999999999999998874
|
Phosphotransferases. Tyrosine-specific kinase subfamily. |
| >cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-35 Score=322.54 Aligned_cols=245 Identities=25% Similarity=0.423 Sum_probs=196.5
Q ss_pred ccccccccccccEEEEEEEcCCCcEEEEEEeccccC-----hHHHHHHHHHhcCCCCceEEEEEEEeCCeEEEEEEccCC
Q psy11767 381 DKAGILGDGSYSVCRRCVEKSTGQEYAVKIISRKID-----CSEEINLLRACQGHPNIVNLHCVFQDEVHTYLVLELLKG 455 (966)
Q Consensus 381 ~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~~-----~~~Ei~iL~~l~~HpnIV~l~~~~~~~~~~~lVmEy~~g 455 (966)
...+.||+|+||.||+|.+..+|+.||||.+..... ..+|+.+++.+ +||||++++++|..+.+.|+||||++|
T Consensus 22 ~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~~-~h~~i~~~~~~~~~~~~~~lv~e~~~~ 100 (297)
T cd06656 22 TRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQPKKELIINEILVMREN-KNPNIVNYLDSYLVGDELWVVMEYLAG 100 (297)
T ss_pred eeeeeeccCCCeEEEEEEECCCCCEEEEEEEecCccchHHHHHHHHHHHHhC-CCCCEeeEEEEEecCCEEEEeecccCC
Confidence 336789999999999999999999999999865332 34588888887 699999999999999999999999999
Q ss_pred CCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCcEEEecCCCCCEEEEeecccccccCC---Cccc
Q psy11767 456 GELLDRIRQKGRCGFTENEASRIMRQLVAAVHFMHSRGVVHRDLKPENLLFSDPAGDNIKVVDFGFACLKRES---LHTP 532 (966)
Q Consensus 456 g~L~~~l~~~~~~~l~e~~~~~i~~Qil~aL~yLHs~~IiHRDLKP~NILl~~~~~~~iKL~DFGla~~~~~~---~~~~ 532 (966)
++|.+++.+. .+++.++..++.|++.||.|||+.||+||||||+|||++. ++.++|+|||++...... ....
T Consensus 101 ~~L~~~~~~~---~~~~~~~~~~~~~l~~~L~~LH~~~i~H~dL~p~Nili~~--~~~~~l~Dfg~~~~~~~~~~~~~~~ 175 (297)
T cd06656 101 GSLTDVVTET---CMDEGQIAAVCRECLQALDFLHSNQVIHRDIKSDNILLGM--DGSVKLTDFGFCAQITPEQSKRSTM 175 (297)
T ss_pred CCHHHHHHhC---CCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECC--CCCEEECcCccceEccCCccCcCcc
Confidence 9999998653 4899999999999999999999999999999999999974 568999999998654322 2234
Q ss_pred cccccccCchhhccCCCCCCCcccchhhhhhhhhhhhcCCCCCCCcCcchhHHHHHHHHhcCCCCCCCCCCchhHHHHHH
Q psy11767 533 CFTLQYAAPEVLRQDKSGYDENCDLWSLGVILVNVLRQDKSGYDENCDLWSLGVILYTMLCGRVPFHARSRDDSALSIMA 612 (966)
Q Consensus 533 ~gT~~Y~APEvl~~~~~~~~~~~Di~SlGvil~el~~~~~~~y~~~~DIWSlGvilyemltG~~Pf~~~~~~~~~~~~~~ 612 (966)
.+++.|+|||.+.. ..++.++|+||+||++|+|++|..||...+.... ...
T Consensus 176 ~~~~~y~aPE~~~~--------------------------~~~~~~~Di~slGvil~~l~tg~~pf~~~~~~~~---~~~ 226 (297)
T cd06656 176 VGTPYWMAPEVVTR--------------------------KAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRA---LYL 226 (297)
T ss_pred cCCccccCHHHHcC--------------------------CCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcchh---eee
Confidence 67889999998852 2357789999999999999999999976543221 111
Q ss_pred HHHcCCCCCCchhhccCCHHHHHHHHHhcccCccccCChHHHHHHhhhhHHh
Q psy11767 613 RIKEGQFNFDAEAWSTVSSEAKELTKSLLTVNPAQRIRMMRVKLTFHAFHQA 664 (966)
Q Consensus 613 ~i~~~~~~~~~~~~~~is~e~~~Li~~~L~~dP~~R~t~~~v~~~~~~~~~~ 664 (966)
....+... ......++..+.+|+.+||..||++||++.++ ..|+|...
T Consensus 227 ~~~~~~~~--~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~i--l~~~~~~~ 274 (297)
T cd06656 227 IATNGTPE--LQNPERLSAVFRDFLNRCLEMDVDRRGSAKEL--LQHPFLKL 274 (297)
T ss_pred eccCCCCC--CCCccccCHHHHHHHHHHccCChhhCcCHHHH--hcCchhcc
Confidence 11112111 11224578899999999999999999999976 34666543
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-34 Score=315.05 Aligned_cols=243 Identities=22% Similarity=0.343 Sum_probs=186.6
Q ss_pred cccccccccccEEEEEE----EcCCCcEEEEEEeccccC------hHHHHHHHHHhcCCCCceEEEEEEEeC--CeEEEE
Q psy11767 382 KAGILGDGSYSVCRRCV----EKSTGQEYAVKIISRKID------CSEEINLLRACQGHPNIVNLHCVFQDE--VHTYLV 449 (966)
Q Consensus 382 ~~~~LG~G~fG~Vy~a~----~~~tg~~vAvK~i~~~~~------~~~Ei~iL~~l~~HpnIV~l~~~~~~~--~~~~lV 449 (966)
..+.||+|+||+||++. ...+++.||+|++..... ..+|+++|+.+ +||||+++++++... ...|+|
T Consensus 8 ~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~~~~~~~~lv 86 (283)
T cd05080 8 KIRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQQNTSGWKKEINILKTL-YHENIVKYKGCCSEQGGKGLQLI 86 (283)
T ss_pred eceecccCCCcEEEEeeEccccCCCCceEEEEEeccccChHHHHHHHHHHHHHHhC-CCCCEeeEEEEEecCCCceEEEE
Confidence 36789999999998765 345788999999875422 34699999998 599999999988653 468999
Q ss_pred EEccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCcEEEecCCCCCEEEEeecccccccCCC
Q psy11767 450 LELLKGGELLDRIRQKGRCGFTENEASRIMRQLVAAVHFMHSRGVVHRDLKPENLLFSDPAGDNIKVVDFGFACLKRESL 529 (966)
Q Consensus 450 mEy~~gg~L~~~l~~~~~~~l~e~~~~~i~~Qil~aL~yLHs~~IiHRDLKP~NILl~~~~~~~iKL~DFGla~~~~~~~ 529 (966)
|||+++|+|.+++... .+++.+++.++.|++.||+|||++||+||||||+|||+++ ++.+||+|||++.......
T Consensus 87 ~e~~~~~~l~~~~~~~---~l~~~~~~~i~~~l~~~l~~lH~~~i~H~dlkp~Nili~~--~~~~~l~dfg~~~~~~~~~ 161 (283)
T cd05080 87 MEYVPLGSLRDYLPKH---KLNLAQLLLFAQQICEGMAYLHSQHYIHRDLAARNVLLDN--DRLVKIGDFGLAKAVPEGH 161 (283)
T ss_pred ecCCCCCCHHHHHHHc---CCCHHHHHHHHHHHHHHHHHHHHCCeeccccChheEEEcC--CCcEEEeecccccccCCcc
Confidence 9999999999998764 4899999999999999999999999999999999999975 5689999999987543211
Q ss_pred ------ccccccccccCchhhccCCCCCCCcccchhhhhhhhhhhhcCCCCCCCcCcchhHHHHHHHHhcCCCCCCCCCC
Q psy11767 530 ------HTPCFTLQYAAPEVLRQDKSGYDENCDLWSLGVILVNVLRQDKSGYDENCDLWSLGVILYTMLCGRVPFHARSR 603 (966)
Q Consensus 530 ------~~~~gT~~Y~APEvl~~~~~~~~~~~Di~SlGvil~el~~~~~~~y~~~~DIWSlGvilyemltG~~Pf~~~~~ 603 (966)
....++..|+|||++.. ..++.++|||||||++|+|++|..||.....
T Consensus 162 ~~~~~~~~~~~~~~~~~PE~~~~--------------------------~~~~~~~Di~slG~~l~el~tg~~p~~~~~~ 215 (283)
T cd05080 162 EYYRVREDGDSPVFWYAVECLKE--------------------------NKFSYASDVWSFGVTLYELLTHCDSKQSPPK 215 (283)
T ss_pred hhhccCCCCCCCceeeCHhHhcc--------------------------cCCCcccccHHHHHHHHHHHhCCCCCCCCcc
Confidence 12235667999998742 2357889999999999999999999865432
Q ss_pred chhH-----------HHHHHHHHcCCCCCCchhhccCCHHHHHHHHHhcccCccccCChHHHHHHhh
Q psy11767 604 DDSA-----------LSIMARIKEGQFNFDAEAWSTVSSEAKELTKSLLTVNPAQRIRMMRVKLTFH 659 (966)
Q Consensus 604 ~~~~-----------~~~~~~i~~~~~~~~~~~~~~is~e~~~Li~~~L~~dP~~R~t~~~v~~~~~ 659 (966)
.... ......+..+. . .......+.++.+++.+||..||++|||+.++...+.
T Consensus 216 ~~~~~~~~~~~~~~~~~~~~~~~~~~-~--~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~i~~~l~ 279 (283)
T cd05080 216 KFEEMIGPKQGQMTVVRLIELLERGM-R--LPCPKNCPQEVYILMKNCWETEAKFRPTFRSLIPILK 279 (283)
T ss_pred hhhhhhcccccccchhhhhhhhhcCC-C--CCCCCCCCHHHHHHHHHHhccChhhCCCHHHHHHHHH
Confidence 1000 00000111111 1 1112356789999999999999999999998855443
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign |
| >cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-34 Score=313.04 Aligned_cols=238 Identities=22% Similarity=0.427 Sum_probs=191.4
Q ss_pred cccccccccccccEEEEEEEcCCCcEEEEEEecccc----ChHHHHHHHHHhcCCCCceEEEEEEEeCCeEEEEEEccCC
Q psy11767 380 LDKAGILGDGSYSVCRRCVEKSTGQEYAVKIISRKI----DCSEEINLLRACQGHPNIVNLHCVFQDEVHTYLVLELLKG 455 (966)
Q Consensus 380 ~~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~----~~~~Ei~iL~~l~~HpnIV~l~~~~~~~~~~~lVmEy~~g 455 (966)
|...+.||+|+||+||+|.... +..||||.+.... ...+|+.+++.+ +||||+++++++.+....|+||||+.+
T Consensus 6 ~~~~~~lg~G~~~~vy~~~~~~-~~~~aik~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~ 83 (256)
T cd05113 6 LTFLKELGTGQFGVVKYGKWRG-QYDVAIKMIKEGSMSEDEFIEEAKVMMKL-SHEKLVQLYGVCTKQRPIYIVTEYMSN 83 (256)
T ss_pred eEEeeEecCcccceEEEEEecC-CCcEEEEEcCCCcccHHHHHHHHHHHhcC-CCCCeeeEEEEEccCCCcEEEEEcCCC
Confidence 3446789999999999997754 4569999886532 245689999888 599999999999999999999999999
Q ss_pred CCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCcEEEecCCCCCEEEEeecccccccCCC-c---c
Q psy11767 456 GELLDRIRQKGRCGFTENEASRIMRQLVAAVHFMHSRGVVHRDLKPENLLFSDPAGDNIKVVDFGFACLKRESL-H---T 531 (966)
Q Consensus 456 g~L~~~l~~~~~~~l~e~~~~~i~~Qil~aL~yLHs~~IiHRDLKP~NILl~~~~~~~iKL~DFGla~~~~~~~-~---~ 531 (966)
|+|.+++..... .+++..++.++.||+.||+|||+.||+||||||+|||+++ ++.+||+|||++....... . .
T Consensus 84 ~~l~~~i~~~~~-~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~nili~~--~~~~kl~d~g~~~~~~~~~~~~~~~ 160 (256)
T cd05113 84 GCLLNYLREHGK-RFQPSQLLEMCKDVCEGMAYLESKQFIHRDLAARNCLVDD--QGCVKVSDFGLSRYVLDDEYTSSVG 160 (256)
T ss_pred CcHHHHHHhcCC-CCCHHHHHHHHHHHHHHHHHHHhCCeeccccCcceEEEcC--CCCEEECCCccceecCCCceeecCC
Confidence 999999976543 6899999999999999999999999999999999999975 5689999999986543221 1 1
Q ss_pred ccccccccCchhhccCCCCCCCcccchhhhhhhhhhhhcCCCCCCCcCcchhHHHHHHHHhc-CCCCCCCCCCchhHHHH
Q psy11767 532 PCFTLQYAAPEVLRQDKSGYDENCDLWSLGVILVNVLRQDKSGYDENCDLWSLGVILYTMLC-GRVPFHARSRDDSALSI 610 (966)
Q Consensus 532 ~~gT~~Y~APEvl~~~~~~~~~~~Di~SlGvil~el~~~~~~~y~~~~DIWSlGvilyemlt-G~~Pf~~~~~~~~~~~~ 610 (966)
..++..|+|||++.. ..|+.++|||||||++|+|++ |..||...... ..
T Consensus 161 ~~~~~~y~~pe~~~~--------------------------~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~----~~ 210 (256)
T cd05113 161 SKFPVRWSPPEVLLY--------------------------SKFSSKSDVWAFGVLMWEVYSLGKMPYERFNNS----ET 210 (256)
T ss_pred CccChhhCCHHHHhc--------------------------CcccchhHHHHHHHHHHHHhcCCCCCcCcCCHH----HH
Confidence 234567999998842 236778999999999999998 99999765432 23
Q ss_pred HHHHHcCCCCCCchhhccCCHHHHHHHHHhcccCccccCChHHHH
Q psy11767 611 MARIKEGQFNFDAEAWSTVSSEAKELTKSLLTVNPAQRIRMMRVK 655 (966)
Q Consensus 611 ~~~i~~~~~~~~~~~~~~is~e~~~Li~~~L~~dP~~R~t~~~v~ 655 (966)
...+..+...... ...+.++.+++.+||..||.+||++.++.
T Consensus 211 ~~~~~~~~~~~~~---~~~~~~~~~li~~cl~~~p~~Rp~~~~ll 252 (256)
T cd05113 211 VEKVSQGLRLYRP---HLASEKVYAIMYSCWHEKAEERPTFQQLL 252 (256)
T ss_pred HHHHhcCCCCCCC---CCCCHHHHHHHHHHcCCCcccCCCHHHHH
Confidence 3444444333222 24688999999999999999999998874
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds |
| >cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-34 Score=314.37 Aligned_cols=238 Identities=27% Similarity=0.419 Sum_probs=191.4
Q ss_pred cccccccccccccEEEEEEEcCCCcEEEEEEecccc-----------ChHHHHHHHHHhcCCCCceEEEEEEEeCCeEEE
Q psy11767 380 LDKAGILGDGSYSVCRRCVEKSTGQEYAVKIISRKI-----------DCSEEINLLRACQGHPNIVNLHCVFQDEVHTYL 448 (966)
Q Consensus 380 ~~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~-----------~~~~Ei~iL~~l~~HpnIV~l~~~~~~~~~~~l 448 (966)
|+..+.||+|+||.||+|.. .+|+.+|||.+.... ...+|+.+|+.+ +|+||+++++++.+....|+
T Consensus 2 ~~~~~~ig~g~~~~v~~~~~-~~~~~~avk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~~~~l 79 (265)
T cd06631 2 WTKGEVLGKGAYGTVYCGLT-NQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSL-KHVNIVQYLGTCLDDNTISI 79 (265)
T ss_pred ccccceEeccCCeEEEEEEE-cCCCeEEEEEeecCccchhhHHHHHHHHHHHHHHHHhc-CCCCEeeEeeEeecCCeEEE
Confidence 34467899999999999986 478999999886431 134588899888 59999999999999999999
Q ss_pred EEEccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCcEEEecCCCCCEEEEeecccccccC-
Q psy11767 449 VLELLKGGELLDRIRQKGRCGFTENEASRIMRQLVAAVHFMHSRGVVHRDLKPENLLFSDPAGDNIKVVDFGFACLKRE- 527 (966)
Q Consensus 449 VmEy~~gg~L~~~l~~~~~~~l~e~~~~~i~~Qil~aL~yLHs~~IiHRDLKP~NILl~~~~~~~iKL~DFGla~~~~~- 527 (966)
||||++|++|.+++.+.. .+++..+..++.|++.||+|||+.+|+|+||||+||++++ .+.++|+|||++.....
T Consensus 80 v~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nil~~~--~~~~~l~dfg~~~~~~~~ 155 (265)
T cd06631 80 FMEFVPGGSISSILNRFG--PLPEPVFCKYTKQILDGVAYLHNNCVVHRDIKGNNVMLMP--NGIIKLIDFGCARRLAWV 155 (265)
T ss_pred EEecCCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCcccCCcCHHhEEECC--CCeEEeccchhhHhhhhc
Confidence 999999999999997654 5899999999999999999999999999999999999974 56899999999865321
Q ss_pred --------CCccccccccccCchhhccCCCCCCCcccchhhhhhhhhhhhcCCCCCCCcCcchhHHHHHHHHhcCCCCCC
Q psy11767 528 --------SLHTPCFTLQYAAPEVLRQDKSGYDENCDLWSLGVILVNVLRQDKSGYDENCDLWSLGVILYTMLCGRVPFH 599 (966)
Q Consensus 528 --------~~~~~~gT~~Y~APEvl~~~~~~~~~~~Di~SlGvil~el~~~~~~~y~~~~DIWSlGvilyemltG~~Pf~ 599 (966)
......++..|+|||++.. ..++.++|+|||||++|+|++|..||.
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~pe~~~~--------------------------~~~~~~~Dv~slG~~~~~l~~g~~p~~ 209 (265)
T cd06631 156 GLHGTHSNMLKSMHGTPYWMAPEVINE--------------------------SGYGRKSDIWSIGCTVFEMATGKPPLA 209 (265)
T ss_pred cccccccccccccCCCccccChhhhcC--------------------------CCCcchhhHHHHHHHHHHHHhCCCccc
Confidence 1123457889999998752 236788999999999999999999997
Q ss_pred CCCCchhHHHHHHHHHcCCCCCCchhhccCCHHHHHHHHHhcccCccccCChHHH
Q psy11767 600 ARSRDDSALSIMARIKEGQFNFDAEAWSTVSSEAKELTKSLLTVNPAQRIRMMRV 654 (966)
Q Consensus 600 ~~~~~~~~~~~~~~i~~~~~~~~~~~~~~is~e~~~Li~~~L~~dP~~R~t~~~v 654 (966)
..+.... ...+...... .+.....++.++.++|++||..||++||++.++
T Consensus 210 ~~~~~~~----~~~~~~~~~~-~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~ 259 (265)
T cd06631 210 SMDRLAA----MFYIGAHRGL-MPRLPDSFSAAAIDFVTSCLTRDQHERPSALQL 259 (265)
T ss_pred cCChHHH----HHHhhhccCC-CCCCCCCCCHHHHHHHHHHhcCCcccCCCHHHH
Confidence 6543211 1122222111 112234578999999999999999999999876
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. |
| >cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-34 Score=317.79 Aligned_cols=243 Identities=22% Similarity=0.382 Sum_probs=192.5
Q ss_pred ccccccccccccEEEEEEEcC-----CCcEEEEEEeccccC------hHHHHHHHHHhcCCCCceEEEEEEEeCCeEEEE
Q psy11767 381 DKAGILGDGSYSVCRRCVEKS-----TGQEYAVKIISRKID------CSEEINLLRACQGHPNIVNLHCVFQDEVHTYLV 449 (966)
Q Consensus 381 ~~~~~LG~G~fG~Vy~a~~~~-----tg~~vAvK~i~~~~~------~~~Ei~iL~~l~~HpnIV~l~~~~~~~~~~~lV 449 (966)
+..+.||+|+||.||+|.+.. ....+|+|.+..... ..+|+.+|+.+ +||||+++++.+..+...|+|
T Consensus 3 ~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~lv 81 (290)
T cd05045 3 VLGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQV-NHPHVIKLYGACSQDGPLLLI 81 (290)
T ss_pred cccccccCcCCcceEEEEEecCCCCCcceeEEEEecCCCCCHHHHHHHHHHHHHHhhC-CCCCEeeEEEEEecCCCcEEE
Confidence 446789999999999998753 336799998865432 44689999888 599999999999999999999
Q ss_pred EEccCCCCHHHHHHhcC----------------------CCCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCcEEEe
Q psy11767 450 LELLKGGELLDRIRQKG----------------------RCGFTENEASRIMRQLVAAVHFMHSRGVVHRDLKPENLLFS 507 (966)
Q Consensus 450 mEy~~gg~L~~~l~~~~----------------------~~~l~e~~~~~i~~Qil~aL~yLHs~~IiHRDLKP~NILl~ 507 (966)
|||+.+|+|.+++.... ...+++..+..++.|++.||+|||+.||+||||||+|||++
T Consensus 82 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~dikp~nill~ 161 (290)
T cd05045 82 VEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQISRGMQYLAEMKLVHRDLAARNVLVA 161 (290)
T ss_pred EEecCCCCHHHHHHhcCCccccccccccccccccccCccccccCHHHHHHHHHHHHHHHHHHHHCCeehhhhhhheEEEc
Confidence 99999999999986421 12478999999999999999999999999999999999997
Q ss_pred cCCCCCEEEEeecccccccCC-----CccccccccccCchhhccCCCCCCCcccchhhhhhhhhhhhcCCCCCCCcCcch
Q psy11767 508 DPAGDNIKVVDFGFACLKRES-----LHTPCFTLQYAAPEVLRQDKSGYDENCDLWSLGVILVNVLRQDKSGYDENCDLW 582 (966)
Q Consensus 508 ~~~~~~iKL~DFGla~~~~~~-----~~~~~gT~~Y~APEvl~~~~~~~~~~~Di~SlGvil~el~~~~~~~y~~~~DIW 582 (966)
+ ++.+||+|||+++..... .....++..|+|||.+.. ..++.++|||
T Consensus 162 ~--~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~--------------------------~~~~~~~Di~ 213 (290)
T cd05045 162 E--GRKMKISDFGLSRDVYEEDSYVKRSKGRIPVKWMAIESLFD--------------------------HIYTTQSDVW 213 (290)
T ss_pred C--CCcEEeccccccccccCccchhcccCCCCCccccCHHHHcc--------------------------CCcchHhHHH
Confidence 5 568999999998653221 122345678999998742 2367889999
Q ss_pred hHHHHHHHHhc-CCCCCCCCCCchhHHHHHHHHHcCCCCCCchhhccCCHHHHHHHHHhcccCccccCChHHHHHHhh
Q psy11767 583 SLGVILYTMLC-GRVPFHARSRDDSALSIMARIKEGQFNFDAEAWSTVSSEAKELTKSLLTVNPAQRIRMMRVKLTFH 659 (966)
Q Consensus 583 SlGvilyemlt-G~~Pf~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~is~e~~~Li~~~L~~dP~~R~t~~~v~~~~~ 659 (966)
||||++|+|++ |..||.+.... .+...+..+ +..+ ....++.++.+++.+||+.||++||++.++...+.
T Consensus 214 slG~~l~el~t~g~~p~~~~~~~----~~~~~~~~~-~~~~--~~~~~~~~~~~~i~~cl~~~P~~Rp~~~~i~~~l~ 284 (290)
T cd05045 214 SFGVLLWEIVTLGGNPYPGIAPE----RLFNLLKTG-YRME--RPENCSEEMYNLMLTCWKQEPDKRPTFADISKELE 284 (290)
T ss_pred HHHHHHHHHHhcCCCCCCCCCHH----HHHHHHhCC-CCCC--CCCCCCHHHHHHHHHHccCCcccCCCHHHHHHHHH
Confidence 99999999998 99999765432 233334332 2221 22457889999999999999999999998855443
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi |
| >cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-34 Score=311.63 Aligned_cols=241 Identities=26% Similarity=0.457 Sum_probs=195.9
Q ss_pred cccccccccccccEEEEEEEcCCCcEEEEEEecccc---ChHHHHHHHHHhcCCCCceEEEEEEEeCCeEEEEEEccCCC
Q psy11767 380 LDKAGILGDGSYSVCRRCVEKSTGQEYAVKIISRKI---DCSEEINLLRACQGHPNIVNLHCVFQDEVHTYLVLELLKGG 456 (966)
Q Consensus 380 ~~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~---~~~~Ei~iL~~l~~HpnIV~l~~~~~~~~~~~lVmEy~~gg 456 (966)
|+..+.||+|+||.||+|.+..+++.||+|.+.... ...+|+++++.+ +||||+++++++.++.+.|++|||++++
T Consensus 5 y~~~~~i~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~e~~~~~~l-~~~~i~~~~~~~~~~~~~~l~~e~~~~~ 83 (256)
T cd06612 5 FDILEKLGEGSYGSVYKAIHKETGQVVAIKVVPVEEDLQEIIKEISILKQC-DSPYIVKYYGSYFKNTDLWIVMEYCGAG 83 (256)
T ss_pred chhhhhhcCCCCeEEEEEEEcCCCcEEEEEEeecHHHHHHHHHHHHHHHhC-CCCcEeeeeeeeecCCcEEEEEecCCCC
Confidence 344678999999999999999999999999987543 355799999988 6999999999999999999999999999
Q ss_pred CHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCcEEEecCCCCCEEEEeecccccccCCC---cccc
Q psy11767 457 ELLDRIRQKGRCGFTENEASRIMRQLVAAVHFMHSRGVVHRDLKPENLLFSDPAGDNIKVVDFGFACLKRESL---HTPC 533 (966)
Q Consensus 457 ~L~~~l~~~~~~~l~e~~~~~i~~Qil~aL~yLHs~~IiHRDLKP~NILl~~~~~~~iKL~DFGla~~~~~~~---~~~~ 533 (966)
+|.+++.... ..+++..++.++.|++.||.|||+.+|+||||+|+||++++ .+.++|+|||++....... ....
T Consensus 84 ~L~~~l~~~~-~~l~~~~~~~~~~~l~~~l~~lh~~~i~H~dl~~~ni~~~~--~~~~~l~dfg~~~~~~~~~~~~~~~~ 160 (256)
T cd06612 84 SVSDIMKITN-KTLTEEEIAAILYQTLKGLEYLHSNKKIHRDIKAGNILLNE--EGQAKLADFGVSGQLTDTMAKRNTVI 160 (256)
T ss_pred cHHHHHHhCc-cCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcceEEECC--CCcEEEcccccchhcccCcccccccc
Confidence 9999987644 36899999999999999999999999999999999999985 5689999999987644321 2344
Q ss_pred ccccccCchhhccCCCCCCCcccchhhhhhhhhhhhcCCCCCCCcCcchhHHHHHHHHhcCCCCCCCCCCchhHHHHHHH
Q psy11767 534 FTLQYAAPEVLRQDKSGYDENCDLWSLGVILVNVLRQDKSGYDENCDLWSLGVILYTMLCGRVPFHARSRDDSALSIMAR 613 (966)
Q Consensus 534 gT~~Y~APEvl~~~~~~~~~~~Di~SlGvil~el~~~~~~~y~~~~DIWSlGvilyemltG~~Pf~~~~~~~~~~~~~~~ 613 (966)
++..|+|||++.. ..++.++||||+||++|+|++|+.||........ ...
T Consensus 161 ~~~~y~~PE~~~~--------------------------~~~~~~~Di~s~G~il~~l~~g~~p~~~~~~~~~----~~~ 210 (256)
T cd06612 161 GTPFWMAPEVIQE--------------------------IGYNNKADIWSLGITAIEMAEGKPPYSDIHPMRA----IFM 210 (256)
T ss_pred CCccccCHHHHhc--------------------------CCCCchhhHHHHHHHHHHHHhCCCCCCCcchhhh----hhh
Confidence 7889999998742 2367889999999999999999999986543221 111
Q ss_pred HHcCCCCCCchhhccCCHHHHHHHHHhcccCccccCChHHHH
Q psy11767 614 IKEGQFNFDAEAWSTVSSEAKELTKSLLTVNPAQRIRMMRVK 655 (966)
Q Consensus 614 i~~~~~~~~~~~~~~is~e~~~Li~~~L~~dP~~R~t~~~v~ 655 (966)
+...... .......++.++.++|.+||+.||++|||+.++.
T Consensus 211 ~~~~~~~-~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~il 251 (256)
T cd06612 211 IPNKPPP-TLSDPEKWSPEFNDFVKKCLVKDPEERPSAIQLL 251 (256)
T ss_pred hccCCCC-CCCchhhcCHHHHHHHHHHHhcChhhCcCHHHHh
Confidence 2111111 1111235678999999999999999999998763
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a |
| >cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-35 Score=317.33 Aligned_cols=235 Identities=18% Similarity=0.294 Sum_probs=184.2
Q ss_pred ccccccccEEEEEEEcCCCc-------EEEEEEecccc-----ChHHHHHHHHHhcCCCCceEEEEEEEeCCeEEEEEEc
Q psy11767 385 ILGDGSYSVCRRCVEKSTGQ-------EYAVKIISRKI-----DCSEEINLLRACQGHPNIVNLHCVFQDEVHTYLVLEL 452 (966)
Q Consensus 385 ~LG~G~fG~Vy~a~~~~tg~-------~vAvK~i~~~~-----~~~~Ei~iL~~l~~HpnIV~l~~~~~~~~~~~lVmEy 452 (966)
.||+|+||.||+|.+..++. .||+|.+.... ...+|+.+|+.+ +|||||++++++..+...++||||
T Consensus 2 ~lg~G~~~~Vy~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~~-~h~~iv~~~~~~~~~~~~~lv~e~ 80 (258)
T cd05078 2 SLGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSHRNYSESFFEAASMMSQL-SHKHLVLNYGVCVCGDESIMVQEY 80 (258)
T ss_pred CCCcccchhheeeeecccccccccccchhhHHhhcchhHHHHHHHHHHHHHHHhC-CCCChhheeeEEEeCCCcEEEEec
Confidence 59999999999999876554 48888875432 234577888877 599999999999999999999999
Q ss_pred cCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCcEEEecCCC------CCEEEEeeccccccc
Q psy11767 453 LKGGELLDRIRQKGRCGFTENEASRIMRQLVAAVHFMHSRGVVHRDLKPENLLFSDPAG------DNIKVVDFGFACLKR 526 (966)
Q Consensus 453 ~~gg~L~~~l~~~~~~~l~e~~~~~i~~Qil~aL~yLHs~~IiHRDLKP~NILl~~~~~------~~iKL~DFGla~~~~ 526 (966)
+++|+|.+++..... .+++..++.++.||+.||+|||++||+||||||+|||++.... ..++++|||++....
T Consensus 81 ~~~g~L~~~l~~~~~-~~~~~~~~~~~~qi~~~l~~lH~~~iiH~dlkp~nili~~~~~~~~~~~~~~~l~d~g~~~~~~ 159 (258)
T cd05078 81 VKFGSLDTYLKKNKN-LINISWKLEVAKQLAWALHFLEDKGLTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGISITVL 159 (258)
T ss_pred CCCCcHHHHHhcCCC-CCCHHHHHHHHHHHHHHHHHHHHCCeecCCCccceEEEecccccccCCCceEEecccccccccC
Confidence 999999999976543 5899999999999999999999999999999999999975321 137999999986543
Q ss_pred CCCccccccccccCchhhccCCCCCCCcccchhhhhhhhhhhhcCCCCCCCcCcchhHHHHHHHHhcC-CCCCCCCCCch
Q psy11767 527 ESLHTPCFTLQYAAPEVLRQDKSGYDENCDLWSLGVILVNVLRQDKSGYDENCDLWSLGVILYTMLCG-RVPFHARSRDD 605 (966)
Q Consensus 527 ~~~~~~~gT~~Y~APEvl~~~~~~~~~~~Di~SlGvil~el~~~~~~~y~~~~DIWSlGvilyemltG-~~Pf~~~~~~~ 605 (966)
. .....+++.|+|||++.. ...++.++|||||||++|+|++| .+||.......
T Consensus 160 ~-~~~~~~~~~y~aPE~~~~-------------------------~~~~~~~~DiwslG~~l~~l~~g~~~~~~~~~~~~ 213 (258)
T cd05078 160 P-KEILLERIPWVPPECIEN-------------------------PQNLSLAADKWSFGTTLWEIFSGGDKPLSALDSQK 213 (258)
T ss_pred C-chhccccCCccCchhccC-------------------------CCCCCchhhHHHHHHHHHHHHcCCCCChhhccHHH
Confidence 2 233567889999998852 12367789999999999999999 46665543221
Q ss_pred hHHHHHHHHHcCCCCCCchhhccCCHHHHHHHHHhcccCccccCChHHHHH
Q psy11767 606 SALSIMARIKEGQFNFDAEAWSTVSSEAKELTKSLLTVNPAQRIRMMRVKL 656 (966)
Q Consensus 606 ~~~~~~~~i~~~~~~~~~~~~~~is~e~~~Li~~~L~~dP~~R~t~~~v~~ 656 (966)
.. .+......++ ...+.++.+|+.+||+.||++|||+.++..
T Consensus 214 ----~~-~~~~~~~~~~----~~~~~~~~~li~~~l~~~p~~Rps~~~il~ 255 (258)
T cd05078 214 ----KL-QFYEDRHQLP----APKWTELANLINQCMDYEPDFRPSFRAIIR 255 (258)
T ss_pred ----HH-HHHHccccCC----CCCcHHHHHHHHHHhccChhhCCCHHHHHH
Confidence 11 1122222222 235678999999999999999999998743
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity |
| >cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-34 Score=318.95 Aligned_cols=246 Identities=18% Similarity=0.287 Sum_probs=187.7
Q ss_pred cccccccccccEEEEEEEcC----------------CCcEEEEEEecccc------ChHHHHHHHHHhcCCCCceEEEEE
Q psy11767 382 KAGILGDGSYSVCRRCVEKS----------------TGQEYAVKIISRKI------DCSEEINLLRACQGHPNIVNLHCV 439 (966)
Q Consensus 382 ~~~~LG~G~fG~Vy~a~~~~----------------tg~~vAvK~i~~~~------~~~~Ei~iL~~l~~HpnIV~l~~~ 439 (966)
..+.||+|+||.||+|.+.. ++..||+|++.... ...+|+.+|+.+ +||||++++++
T Consensus 9 ~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~E~~~l~~l-~~~~i~~~~~~ 87 (296)
T cd05095 9 FKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDANKNARNDFLKEIKIMSRL-KDPNIIRLLAV 87 (296)
T ss_pred eeeeccCCCCCeEEecccccccccccccccccCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhC-CCCCcceEEEE
Confidence 36789999999999986543 34579999987532 245699999998 59999999999
Q ss_pred EEeCCeEEEEEEccCCCCHHHHHHhcCC---------CCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCcEEEecCC
Q psy11767 440 FQDEVHTYLVLELLKGGELLDRIRQKGR---------CGFTENEASRIMRQLVAAVHFMHSRGVVHRDLKPENLLFSDPA 510 (966)
Q Consensus 440 ~~~~~~~~lVmEy~~gg~L~~~l~~~~~---------~~l~e~~~~~i~~Qil~aL~yLHs~~IiHRDLKP~NILl~~~~ 510 (966)
+.++...|+||||+++|+|.+++..... ..+++..+..++.||+.||+|||+.||+||||||+|||+++
T Consensus 88 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~H~dlkp~Nili~~-- 165 (296)
T cd05095 88 CITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLSSLNFVHRDLATRNCLVGK-- 165 (296)
T ss_pred EecCCccEEEEEeCCCCcHHHHHHhcCcccccccccccccCHHHHHHHHHHHHHHHHHHHHCCeecccCChheEEEcC--
Confidence 9999999999999999999999976431 23678899999999999999999999999999999999975
Q ss_pred CCCEEEEeecccccccCC-----CccccccccccCchhhccCCCCCCCcccchhhhhhhhhhhhcCCCCCCCcCcchhHH
Q psy11767 511 GDNIKVVDFGFACLKRES-----LHTPCFTLQYAAPEVLRQDKSGYDENCDLWSLGVILVNVLRQDKSGYDENCDLWSLG 585 (966)
Q Consensus 511 ~~~iKL~DFGla~~~~~~-----~~~~~gT~~Y~APEvl~~~~~~~~~~~Di~SlGvil~el~~~~~~~y~~~~DIWSlG 585 (966)
++.++|+|||++...... .....+++.|+|||+... ..|+.++||||||
T Consensus 166 ~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~--------------------------~~~~~~~DiwSlG 219 (296)
T cd05095 166 NYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMSWESILL--------------------------GKFTTASDVWAFG 219 (296)
T ss_pred CCCEEeccCcccccccCCcceeccCcCcCccccCCHHHHhc--------------------------CCccchhhhhHHH
Confidence 568999999998654221 112334678999997642 2367899999999
Q ss_pred HHHHHHhc--CCCCCCCCCCchhHHHHHHHHHcCCCCCCchhhccCCHHHHHHHHHhcccCccccCChHHHHH
Q psy11767 586 VILYTMLC--GRVPFHARSRDDSALSIMARIKEGQFNFDAEAWSTVSSEAKELTKSLLTVNPAQRIRMMRVKL 656 (966)
Q Consensus 586 vilyemlt--G~~Pf~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~is~e~~~Li~~~L~~dP~~R~t~~~v~~ 656 (966)
|++|||++ |..||...+..+..................+.....++.+.+|+.+||+.||++||++.++..
T Consensus 220 ~~l~el~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~ 292 (296)
T cd05095 220 VTLWEILTLCKEQPYSQLSDEQVIENTGEFFRDQGRQVYLPKPALCPDSLYKLMLSCWRRNAKERPSFQEIHA 292 (296)
T ss_pred HHHHHHHHhCCCCCccccChHHHHHHHHHHHhhccccccCCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHH
Confidence 99999998 789997655433211111111111000011112346789999999999999999999998744
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit |
| >cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-34 Score=311.45 Aligned_cols=240 Identities=27% Similarity=0.482 Sum_probs=197.6
Q ss_pred cccccccccccccEEEEEEEcCCCcEEEEEEecccc-------ChHHHHHHHHHhcCCCCceEEEEEEEeCCeEEEEEEc
Q psy11767 380 LDKAGILGDGSYSVCRRCVEKSTGQEYAVKIISRKI-------DCSEEINLLRACQGHPNIVNLHCVFQDEVHTYLVLEL 452 (966)
Q Consensus 380 ~~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~-------~~~~Ei~iL~~l~~HpnIV~l~~~~~~~~~~~lVmEy 452 (966)
|+..+.||+|+||.||++.+..+|+.||+|.+.... ...+|+.+++.+ +||||+++++++.+..+.|+||||
T Consensus 2 y~~~~~lg~g~~g~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~~~~lv~e~ 80 (256)
T cd08218 2 YVKVKKIGEGSFGKAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNM-KHPNIVQYQESFEENGNLYIVMDY 80 (256)
T ss_pred ceEEEEeccCCceEEEEEEEcCCCCEEEEEEEEhHhCChHHHHHHHHHHHHHHhC-CCCCeeeeEeeecCCCeEEEEEec
Confidence 344688999999999999999999999999986321 245688999988 599999999999999999999999
Q ss_pred cCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCcEEEecCCCCCEEEEeecccccccCC---C
Q psy11767 453 LKGGELLDRIRQKGRCGFTENEASRIMRQLVAAVHFMHSRGVVHRDLKPENLLFSDPAGDNIKVVDFGFACLKRES---L 529 (966)
Q Consensus 453 ~~gg~L~~~l~~~~~~~l~e~~~~~i~~Qil~aL~yLHs~~IiHRDLKP~NILl~~~~~~~iKL~DFGla~~~~~~---~ 529 (966)
+++++|.+++.......+++.++..++.|++.||+|||++|++|+||+|+|||++. ++.++|+|||++...... .
T Consensus 81 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~~l~~~nil~~~--~~~~~l~d~~~~~~~~~~~~~~ 158 (256)
T cd08218 81 CEGGDLYKKINAQRGVLFPEDQILDWFVQICLALKHVHDRKILHRDIKSQNIFLTK--DGTIKLGDFGIARVLNSTVELA 158 (256)
T ss_pred CCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcC--CCCEEEeeccceeecCcchhhh
Confidence 99999999997755446899999999999999999999999999999999999975 568999999998654321 1
Q ss_pred ccccccccccCchhhccCCCCCCCcccchhhhhhhhhhhhcCCCCCCCcCcchhHHHHHHHHhcCCCCCCCCCCchhHHH
Q psy11767 530 HTPCFTLQYAAPEVLRQDKSGYDENCDLWSLGVILVNVLRQDKSGYDENCDLWSLGVILYTMLCGRVPFHARSRDDSALS 609 (966)
Q Consensus 530 ~~~~gT~~Y~APEvl~~~~~~~~~~~Di~SlGvil~el~~~~~~~y~~~~DIWSlGvilyemltG~~Pf~~~~~~~~~~~ 609 (966)
....+++.|+|||++.. ..++.++|+|||||++|+|++|+.||...... .
T Consensus 159 ~~~~~~~~~~~pe~~~~--------------------------~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~----~ 208 (256)
T cd08218 159 RTCIGTPYYLSPEICEN--------------------------RPYNNKSDIWALGCVLYEMCTLKHAFEAGNMK----N 208 (256)
T ss_pred hhccCCccccCHHHhCC--------------------------CCCCCccchhHHHHHHHHHHcCCCCccCCCHH----H
Confidence 23457888999998742 22567899999999999999999999764432 3
Q ss_pred HHHHHHcCCCCCCchhhccCCHHHHHHHHHhcccCccccCChHHHH
Q psy11767 610 IMARIKEGQFNFDAEAWSTVSSEAKELTKSLLTVNPAQRIRMMRVK 655 (966)
Q Consensus 610 ~~~~i~~~~~~~~~~~~~~is~e~~~Li~~~L~~dP~~R~t~~~v~ 655 (966)
....+..+.... ....++.++.++|.+||..+|++||++.++.
T Consensus 209 ~~~~~~~~~~~~---~~~~~~~~~~~li~~~l~~~p~~Rp~~~~vl 251 (256)
T cd08218 209 LVLKIIRGSYPP---VSSHYSYDLRNLVSQLFKRNPRDRPSVNSIL 251 (256)
T ss_pred HHHHHhcCCCCC---CcccCCHHHHHHHHHHhhCChhhCcCHHHHh
Confidence 334444444322 1235788999999999999999999999873
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti |
| >cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-34 Score=314.72 Aligned_cols=242 Identities=26% Similarity=0.414 Sum_probs=194.4
Q ss_pred ccccccccccccEEEEEEEcCCCcEEEEEEecccc---------------ChHHHHHHHHHhcCCCCceEEEEEEEeCCe
Q psy11767 381 DKAGILGDGSYSVCRRCVEKSTGQEYAVKIISRKI---------------DCSEEINLLRACQGHPNIVNLHCVFQDEVH 445 (966)
Q Consensus 381 ~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~---------------~~~~Ei~iL~~l~~HpnIV~l~~~~~~~~~ 445 (966)
...+.||.|+||.||+|.+..+|+.||||.+.... ...+|+.+|+.+ +||||+++++++.....
T Consensus 4 ~~~~~lg~g~~~~vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~ 82 (272)
T cd06629 4 VKGELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDL-DHLNIVQYLGFETTEEY 82 (272)
T ss_pred eecceecccCceEEEEEeecCCCceeeeeeeechhhhhcccchHHHHHHHHHHHHHHHHHhc-CCCCcceEEEEeccCCc
Confidence 34678999999999999999999999999875310 124588888888 59999999999999999
Q ss_pred EEEEEEccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCcEEEecCCCCCEEEEeecccccc
Q psy11767 446 TYLVLELLKGGELLDRIRQKGRCGFTENEASRIMRQLVAAVHFMHSRGVVHRDLKPENLLFSDPAGDNIKVVDFGFACLK 525 (966)
Q Consensus 446 ~~lVmEy~~gg~L~~~l~~~~~~~l~e~~~~~i~~Qil~aL~yLHs~~IiHRDLKP~NILl~~~~~~~iKL~DFGla~~~ 525 (966)
.++||||+++++|.+++.+.+ .+++..++.++.||+.||.|||+++++||||||+||+++. ++.++|+|||++...
T Consensus 83 ~~lv~e~~~~~~L~~~l~~~~--~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~~~nil~~~--~~~~~l~d~~~~~~~ 158 (272)
T cd06629 83 LSIFLEYVPGGSIGSCLRTYG--RFEEQLVRFFTEQVLEGLAYLHSKGILHRDLKADNLLVDA--DGICKISDFGISKKS 158 (272)
T ss_pred eEEEEecCCCCcHHHHHhhcc--CCCHHHHHHHHHHHHHHHHHHhhCCeeecCCChhhEEEcC--CCeEEEeeccccccc
Confidence 999999999999999997764 6899999999999999999999999999999999999975 568999999998654
Q ss_pred cCC-----CccccccccccCchhhccCCCCCCCcccchhhhhhhhhhhhcCCCCCCCcCcchhHHHHHHHHhcCCCCCCC
Q psy11767 526 RES-----LHTPCFTLQYAAPEVLRQDKSGYDENCDLWSLGVILVNVLRQDKSGYDENCDLWSLGVILYTMLCGRVPFHA 600 (966)
Q Consensus 526 ~~~-----~~~~~gT~~Y~APEvl~~~~~~~~~~~Di~SlGvil~el~~~~~~~y~~~~DIWSlGvilyemltG~~Pf~~ 600 (966)
... .....++..|+|||++.... ..++.++|+|||||++|+|++|..||..
T Consensus 159 ~~~~~~~~~~~~~~~~~y~~PE~~~~~~------------------------~~~~~~~Dv~slG~~l~~l~~g~~p~~~ 214 (272)
T cd06629 159 DDIYDNDQNMSMQGSVFWMAPEVIHSYS------------------------QGYSAKVDIWSLGCVVLEMFAGRRPWSD 214 (272)
T ss_pred cccccccccccccCCccccCHHHhcccc------------------------CCCCccchhHHHHHHHHHHHhCCCCCcC
Confidence 321 12345788999999885321 2367889999999999999999999965
Q ss_pred CCCchhHHHHHHHH-HcCCCCCCchhhccCCHHHHHHHHHhcccCccccCChHHH
Q psy11767 601 RSRDDSALSIMARI-KEGQFNFDAEAWSTVSSEAKELTKSLLTVNPAQRIRMMRV 654 (966)
Q Consensus 601 ~~~~~~~~~~~~~i-~~~~~~~~~~~~~~is~e~~~Li~~~L~~dP~~R~t~~~v 654 (966)
....+ ...... ......++......++.++.++|.+||..+|++||++.++
T Consensus 215 ~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~i 266 (272)
T cd06629 215 EEAIA---AMFKLGNKRSAPPIPPDVSMNLSPVALDFLNACFTINPDNRPTAREL 266 (272)
T ss_pred cchHH---HHHHhhccccCCcCCccccccCCHHHHHHHHHHhcCChhhCCCHHHH
Confidence 43221 111111 1112223333445678999999999999999999999876
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte |
| >KOG0592|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.9e-36 Score=333.24 Aligned_cols=207 Identities=29% Similarity=0.483 Sum_probs=172.3
Q ss_pred CcceeeeecccccceEEEEEEcCCCCEEEEEeccccch--------hhHHHHHHHHhhCCCcccccccccccc-------
Q psy11767 117 DLDKAGILGDGSYSVCRRCVEKSTGQEYAVKIISRKID--------CSEEINLLRACQGHPNICRRCVEKSTG------- 181 (966)
Q Consensus 117 df~~~~~LG~GsFGkV~La~~k~tg~~yAiKvl~K~~~--------~~~E~~il~~~~~~pfi~~~~~~~~~~------- 181 (966)
||.|+++||+|||++|+||+.++|++.||||||.|+.+ +..|+++|.++..||+|++.+++|+.+
T Consensus 74 DF~Fg~~lGeGSYStV~~A~~~~t~keYAiKVl~K~~Iike~KvkYV~~Ek~~l~~L~~hPgivkLy~TFQD~~sLYFvL 153 (604)
T KOG0592|consen 74 DFKFGKILGEGSYSTVVLAREKATGKEYAIKVLDKRYIIKEKKVKYVTREKEALTQLSGHPGIVKLYFTFQDEESLYFVL 153 (604)
T ss_pred hcchhheeccccceeEEEeeecCCCceeeHhhhhHHHHHhhcccchhhHHHHHHHHhhCCCCeEEEEEEeecccceEEEE
Confidence 99999999999999999999999999999999999742 577999999999999999877666664
Q ss_pred -----------------------hhHHHHHHHhh----------cccchhhhHhhhccCCceEEecCcccc---------
Q psy11767 182 -----------------------QEYAVKIISRK----------IDCSEEINLLRACQGHPNIVNLHCVFQ--------- 219 (966)
Q Consensus 182 -----------------------~~~~~~~v~~~----------~~~~~e~nil~~~~gh~~iv~l~~~~~--------- 219 (966)
|+|+++||.+. .|+++| |||+|.+||.+|+||+-+..
T Consensus 154 e~A~nGdll~~i~K~Gsfde~caR~YAAeIldAleylH~~GIIHRDlKPE-NILLd~dmhikITDFGsAK~l~~~~~~~~ 232 (604)
T KOG0592|consen 154 EYAPNGDLLDLIKKYGSFDETCARFYAAEILDALEYLHSNGIIHRDLKPE-NILLDKDGHIKITDFGSAKILSPSQKSQE 232 (604)
T ss_pred EecCCCcHHHHHHHhCcchHHHHHHHHHHHHHHHHHHHhcCceeccCChh-heeEcCCCcEEEeeccccccCChhhcccc
Confidence 78888777551 266777 99999999999999986531
Q ss_pred -----------------------ccccccccCCCcceeeechhhHHHHHHHhhCCCCCCCCcHHHHHHHHHhCCCCCCCC
Q psy11767 220 -----------------------DEVIDWDDFSRGIECVFFSSSLIIFFIILSFTLSFIHDYYHIQYRRILKTEPPIPED 276 (966)
Q Consensus 220 -----------------------~e~i~~~~y~~~~d~~~~~~~~il~~~m~~g~~pf~~~~~~~~~~~I~~~~~~~P~~ 276 (966)
+|++....-+.+ +|.| +.|+|+|.|+.|.|||.+.+.-.+|++|+.-++.||+.
T Consensus 233 ~~~~~~~a~s~~~SFVGTAeYVSPElL~~~~~~~~--sDiW-AlGCilyQmlaG~PPFra~NeyliFqkI~~l~y~fp~~ 309 (604)
T KOG0592|consen 233 NPVDPNQASSRRSSFVGTAEYVSPELLNDSPAGPS--SDLW-ALGCILYQMLAGQPPFRAANEYLIFQKIQALDYEFPEG 309 (604)
T ss_pred CccCcccccCcccceeeeecccCHHHhcCCCCCcc--cchH-HHHHHHHHHhcCCCCCccccHHHHHHHHHHhcccCCCC
Confidence 122222222223 4444 56678889999999999999999999999999999999
Q ss_pred CCHHHHHHHHhhcccCCCcccCCCCCCHHHHhcCCceeeeCccccccCCCCCCCCcc
Q psy11767 277 LSPDVADFISRLLVKDPRRRLGGGELDAEELKRHPFFNVIDWDDLATKRIPAPFVPK 333 (966)
Q Consensus 277 ~s~~a~dli~~LL~kdp~~RLG~~~~g~~~Ik~HpfF~~idW~~l~~k~~~pP~~P~ 333 (966)
|+++|+|||++||++||+.||| .++||+||||++|||+.|.+.. ||+..|.
T Consensus 310 fp~~a~dLv~KLLv~dp~~Rlt-----~~qIk~HpFF~~Vdw~nlw~~~-PP~l~py 360 (604)
T KOG0592|consen 310 FPEDARDLIKKLLVRDPSDRLT-----SQQIKAHPFFEGVDWENLWQQT-PPKLQPY 360 (604)
T ss_pred CCHHHHHHHHHHHccCcccccc-----HHHHhhCcccccCChhhhhhcC-CCcccCC
Confidence 9999999999999999999996 6899999999999999986554 4434333
|
|
| >cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-34 Score=310.09 Aligned_cols=236 Identities=23% Similarity=0.379 Sum_probs=188.8
Q ss_pred cccccccccEEEEEEEcCCC---cEEEEEEeccccC------hHHHHHHHHHhcCCCCceEEEEEEEeCCeEEEEEEccC
Q psy11767 384 GILGDGSYSVCRRCVEKSTG---QEYAVKIISRKID------CSEEINLLRACQGHPNIVNLHCVFQDEVHTYLVLELLK 454 (966)
Q Consensus 384 ~~LG~G~fG~Vy~a~~~~tg---~~vAvK~i~~~~~------~~~Ei~iL~~l~~HpnIV~l~~~~~~~~~~~lVmEy~~ 454 (966)
++||+|+||.||+|....++ ..||+|.+..... ..+|+.+|+.+ +|||||++++++.. ...++||||++
T Consensus 1 ~~ig~G~~g~v~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~-~~~~~v~e~~~ 78 (257)
T cd05060 1 KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQL-DHPCIVRLIGVCKG-EPLMLVMELAP 78 (257)
T ss_pred CccCccCceeEEEeEeeccCCCcceEEEEecccccchHHHHHHHHHHHHHHhc-CCCCeeeEEEEEcC-CceEEEEEeCC
Confidence 36999999999999876655 7899999875432 34688899887 59999999998764 46899999999
Q ss_pred CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCcEEEecCCCCCEEEEeecccccccCCCc----
Q psy11767 455 GGELLDRIRQKGRCGFTENEASRIMRQLVAAVHFMHSRGVVHRDLKPENLLFSDPAGDNIKVVDFGFACLKRESLH---- 530 (966)
Q Consensus 455 gg~L~~~l~~~~~~~l~e~~~~~i~~Qil~aL~yLHs~~IiHRDLKP~NILl~~~~~~~iKL~DFGla~~~~~~~~---- 530 (966)
+|+|.+++.... .+++..+..++.|++.||+|||+.+|+||||||+|||+++ ++.+||+|||+++.......
T Consensus 79 ~~~L~~~l~~~~--~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~p~nili~~--~~~~kl~df~~~~~~~~~~~~~~~ 154 (257)
T cd05060 79 LGPLLKYLKKRR--EIPVSDLKELAHQVAMGMAYLESKHFVHRDLAARNVLLVN--RHQAKISDFGMSRALGAGSDYYRA 154 (257)
T ss_pred CCcHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHhhcCeeccCcccceEEEcC--CCcEEeccccccceeecCCccccc
Confidence 999999998754 5899999999999999999999999999999999999975 56899999999875432211
Q ss_pred --cccccccccCchhhccCCCCCCCcccchhhhhhhhhhhhcCCCCCCCcCcchhHHHHHHHHhc-CCCCCCCCCCchhH
Q psy11767 531 --TPCFTLQYAAPEVLRQDKSGYDENCDLWSLGVILVNVLRQDKSGYDENCDLWSLGVILYTMLC-GRVPFHARSRDDSA 607 (966)
Q Consensus 531 --~~~gT~~Y~APEvl~~~~~~~~~~~Di~SlGvil~el~~~~~~~y~~~~DIWSlGvilyemlt-G~~Pf~~~~~~~~~ 607 (966)
...++..|+|||.+.. ..++.++|||||||++|+|++ |.+||...+..
T Consensus 155 ~~~~~~~~~y~aPE~~~~--------------------------~~~~~~~Di~slG~~l~~~~~~g~~p~~~~~~~--- 205 (257)
T cd05060 155 TTAGRWPLKWYAPECINY--------------------------GKFSSKSDVWSYGVTLWEAFSYGAKPYGEMKGA--- 205 (257)
T ss_pred ccCccccccccCHHHhcC--------------------------CCCCccchHHHHHHHHHHHHcCCCCCcccCCHH---
Confidence 1122467999998742 236788999999999999997 99999765432
Q ss_pred HHHHHHHHcCCCCCCchhhccCCHHHHHHHHHhcccCccccCChHHHHHHh
Q psy11767 608 LSIMARIKEGQFNFDAEAWSTVSSEAKELTKSLLTVNPAQRIRMMRVKLTF 658 (966)
Q Consensus 608 ~~~~~~i~~~~~~~~~~~~~~is~e~~~Li~~~L~~dP~~R~t~~~v~~~~ 658 (966)
.....+..+... .....++..++++|.+||..||++||++.++...+
T Consensus 206 -~~~~~~~~~~~~---~~~~~~~~~l~~li~~cl~~~p~~Rp~~~~l~~~l 252 (257)
T cd05060 206 -EVIAMLESGERL---PRPEECPQEIYSIMLSCWKYRPEDRPTFSELESTF 252 (257)
T ss_pred -HHHHHHHcCCcC---CCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHH
Confidence 233444444321 12245788999999999999999999999885444
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi |
| >cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-34 Score=308.87 Aligned_cols=234 Identities=22% Similarity=0.448 Sum_probs=189.1
Q ss_pred ccccccccEEEEEEEcCCCcEEEEEEeccccC------hHHHHHHHHHhcCCCCceEEEEEEEeCCeEEEEEEccCCCCH
Q psy11767 385 ILGDGSYSVCRRCVEKSTGQEYAVKIISRKID------CSEEINLLRACQGHPNIVNLHCVFQDEVHTYLVLELLKGGEL 458 (966)
Q Consensus 385 ~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~~------~~~Ei~iL~~l~~HpnIV~l~~~~~~~~~~~lVmEy~~gg~L 458 (966)
+||+|+||.||+|.+. +++.||+|++..... ..+|+.+++.+ +||||+++++++......++||||+++++|
T Consensus 2 ~ig~g~~g~vy~~~~~-~~~~~a~K~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 79 (250)
T cd05085 2 LLGKGNFGEVFKGTLK-DKTPVAVKTCKEDLPQELKIKFLSEARILKQY-DHPNIVKLIGVCTQRQPIYIVMELVPGGDF 79 (250)
T ss_pred ccCCCCCceEEEEEec-CCcEEEEEecCCcCCHHHHHHHHHHHHHHHhC-CCCCcCeEEEEEecCCccEEEEECCCCCcH
Confidence 6999999999999865 688999999865432 44688899888 599999999999999999999999999999
Q ss_pred HHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCcEEEecCCCCCEEEEeecccccccCCCc----cccc
Q psy11767 459 LDRIRQKGRCGFTENEASRIMRQLVAAVHFMHSRGVVHRDLKPENLLFSDPAGDNIKVVDFGFACLKRESLH----TPCF 534 (966)
Q Consensus 459 ~~~l~~~~~~~l~e~~~~~i~~Qil~aL~yLHs~~IiHRDLKP~NILl~~~~~~~iKL~DFGla~~~~~~~~----~~~g 534 (966)
.+++.... ..+++..+..++.|++.||.|||++|++||||||+||++++ ++.+||+|||++........ ...+
T Consensus 80 ~~~~~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~~~H~dl~p~nili~~--~~~~~l~d~g~~~~~~~~~~~~~~~~~~ 156 (250)
T cd05085 80 LSFLRKKK-DELKTKQLVKFALDAAAGMAYLESKNCIHRDLAARNCLVGE--NNVLKISDFGMSRQEDDGIYSSSGLKQI 156 (250)
T ss_pred HHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHhCCeeecccChheEEEcC--CCeEEECCCccceeccccccccCCCCCC
Confidence 99987654 35899999999999999999999999999999999999975 56899999999865432211 1233
Q ss_pred cccccCchhhccCCCCCCCcccchhhhhhhhhhhhcCCCCCCCcCcchhHHHHHHHHhc-CCCCCCCCCCchhHHHHHHH
Q psy11767 535 TLQYAAPEVLRQDKSGYDENCDLWSLGVILVNVLRQDKSGYDENCDLWSLGVILYTMLC-GRVPFHARSRDDSALSIMAR 613 (966)
Q Consensus 535 T~~Y~APEvl~~~~~~~~~~~Di~SlGvil~el~~~~~~~y~~~~DIWSlGvilyemlt-G~~Pf~~~~~~~~~~~~~~~ 613 (966)
++.|+|||++.. ..++.++|||||||++|+|++ |..||...... .....
T Consensus 157 ~~~y~aPE~~~~--------------------------~~~~~~~Di~slG~ll~~~~~~g~~p~~~~~~~----~~~~~ 206 (250)
T cd05085 157 PIKWTAPEALNY--------------------------GRYSSESDVWSYGILLWETFSLGVCPYPGMTNQ----QAREQ 206 (250)
T ss_pred cccccCHHHhcc--------------------------CCCCchhHHHHHHHHHHHHhcCCCCCCCCCCHH----HHHHH
Confidence 567999998852 235778999999999999998 99999765432 22334
Q ss_pred HHcCCCCCCchhhccCCHHHHHHHHHhcccCccccCChHHHHH
Q psy11767 614 IKEGQFNFDAEAWSTVSSEAKELTKSLLTVNPAQRIRMMRVKL 656 (966)
Q Consensus 614 i~~~~~~~~~~~~~~is~e~~~Li~~~L~~dP~~R~t~~~v~~ 656 (966)
+..+.. ......++.++.+++.+||..||++||++.++..
T Consensus 207 ~~~~~~---~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~ 246 (250)
T cd05085 207 VEKGYR---MSCPQKCPDDVYKVMQRCWDYKPENRPKFSELQK 246 (250)
T ss_pred HHcCCC---CCCCCCCCHHHHHHHHHHcccCcccCCCHHHHHH
Confidence 443321 1223457899999999999999999999998743
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c |
| >cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-34 Score=311.55 Aligned_cols=238 Identities=25% Similarity=0.471 Sum_probs=191.6
Q ss_pred ccccccccccccEEEEEEEcCCCcEEEEEEecccc---ChHHHHHHHHHhcCCCCceEEEEEEEeCCeEEEEEEccCCCC
Q psy11767 381 DKAGILGDGSYSVCRRCVEKSTGQEYAVKIISRKI---DCSEEINLLRACQGHPNIVNLHCVFQDEVHTYLVLELLKGGE 457 (966)
Q Consensus 381 ~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~---~~~~Ei~iL~~l~~HpnIV~l~~~~~~~~~~~lVmEy~~gg~ 457 (966)
+..+.||+|+||.||++. .+++.||+|++.... ...+|+.+|+.+ +||||+++++++..+. .|+||||+++++
T Consensus 9 ~~~~~lg~g~~g~v~~~~--~~~~~~~iK~~~~~~~~~~~~~e~~~l~~~-~~~~i~~~~~~~~~~~-~~~v~e~~~~~~ 84 (254)
T cd05083 9 TLGEIIGEGEFGAVLQGE--YTGQKVAVKNIKCDVTAQAFLEETAVMTKL-HHKNLVRLLGVILHNG-LYIVMELMSKGN 84 (254)
T ss_pred eeeeeeccCCCCceEecc--cCCCceEEEeecCcchHHHHHHHHHHHHhC-CCCCcCeEEEEEcCCC-cEEEEECCCCCC
Confidence 346789999999999986 468899999986542 245689999888 5999999999987654 799999999999
Q ss_pred HHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCcEEEecCCCCCEEEEeecccccccCCCcccccccc
Q psy11767 458 LLDRIRQKGRCGFTENEASRIMRQLVAAVHFMHSRGVVHRDLKPENLLFSDPAGDNIKVVDFGFACLKRESLHTPCFTLQ 537 (966)
Q Consensus 458 L~~~l~~~~~~~l~e~~~~~i~~Qil~aL~yLHs~~IiHRDLKP~NILl~~~~~~~iKL~DFGla~~~~~~~~~~~gT~~ 537 (966)
|.+++.......+++..+..++.|++.||+|||+.|++||||||+|||++. ++.+||+|||++............+..
T Consensus 85 L~~~l~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~~~H~dl~p~nili~~--~~~~kl~Dfg~~~~~~~~~~~~~~~~~ 162 (254)
T cd05083 85 LVNFLRTRGRALVSVIQLLQFSLDVAEGMEYLESKKLVHRDLAARNILVSE--DGVAKVSDFGLARVGSMGVDNSKLPVK 162 (254)
T ss_pred HHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccCcceEEEcC--CCcEEECCCccceeccccCCCCCCCce
Confidence 999998765556899999999999999999999999999999999999975 568999999998764433333344678
Q ss_pred ccCchhhccCCCCCCCcccchhhhhhhhhhhhcCCCCCCCcCcchhHHHHHHHHhc-CCCCCCCCCCchhHHHHHHHHHc
Q psy11767 538 YAAPEVLRQDKSGYDENCDLWSLGVILVNVLRQDKSGYDENCDLWSLGVILYTMLC-GRVPFHARSRDDSALSIMARIKE 616 (966)
Q Consensus 538 Y~APEvl~~~~~~~~~~~Di~SlGvil~el~~~~~~~y~~~~DIWSlGvilyemlt-G~~Pf~~~~~~~~~~~~~~~i~~ 616 (966)
|+|||++.. ..++.++|+|||||++|+|++ |++||...+.. .....+..
T Consensus 163 y~~pe~~~~--------------------------~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~----~~~~~~~~ 212 (254)
T cd05083 163 WTAPEALKH--------------------------KKFSSKSDVWSYGVLLWEVFSYGRAPYPKMSLK----EVKECVEK 212 (254)
T ss_pred ecCHHHhcc--------------------------CCcCchhhHHHHHHHHHHHHhCCCCCCccCCHH----HHHHHHhC
Confidence 999998742 236778999999999999997 99999865532 22333433
Q ss_pred CCCCCCchhhccCCHHHHHHHHHhcccCccccCChHHHHHH
Q psy11767 617 GQFNFDAEAWSTVSSEAKELTKSLLTVNPAQRIRMMRVKLT 657 (966)
Q Consensus 617 ~~~~~~~~~~~~is~e~~~Li~~~L~~dP~~R~t~~~v~~~ 657 (966)
+ +... ....++.++.+++.+||..+|++||++.++...
T Consensus 213 ~-~~~~--~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~ 250 (254)
T cd05083 213 G-YRME--PPEGCPADVYVLMTSCWETEPKKRPSFHKLREK 250 (254)
T ss_pred C-CCCC--CCCcCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 3 2222 224578999999999999999999999987543
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki |
| >KOG0614|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-36 Score=336.52 Aligned_cols=235 Identities=31% Similarity=0.538 Sum_probs=200.6
Q ss_pred ccccccccccccccEEEEEEEcCCCcEEEEEEeccccC--------hHHHHHHHHHhcCCCCceEEEEEEEeCCeEEEEE
Q psy11767 379 DLDKAGILGDGSYSVCRRCVEKSTGQEYAVKIISRKID--------CSEEINLLRACQGHPNIVNLHCVFQDEVHTYLVL 450 (966)
Q Consensus 379 ~~~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~~--------~~~Ei~iL~~l~~HpnIV~l~~~~~~~~~~~lVm 450 (966)
+++++..||-||||.|-++........+|+|+++++.- ...|-++|..+. .|.||+||..|.++.++|+.|
T Consensus 421 dl~~iaTLGvGgFGRVELV~~~~~~~~fAlKilkK~hIVdtkQqeHv~sEr~Im~~~~-s~fIvrLYrTfrd~kyvYmLm 499 (732)
T KOG0614|consen 421 DLKRIATLGVGGFGRVELVKVNSQKATFALKILKKKHIVDTKQQEHVFSERNIMMECR-SDFIVRLYRTFRDSKYVYMLM 499 (732)
T ss_pred hhhhhhhcccCccceEEEEEecccchHHHHHHHhHhhccchhHHHHHHhHHHHHHhcC-chHHHHHHHHhccchhhhhhH
Confidence 45567889999999999988777666799999976531 234888999985 899999999999999999999
Q ss_pred EccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCcEEEecCCCCCEEEEeecccccccC--C
Q psy11767 451 ELLKGGELLDRIRQKGRCGFTENEASRIMRQLVAAVHFMHSRGVVHRDLKPENLLFSDPAGDNIKVVDFGFACLKRE--S 528 (966)
Q Consensus 451 Ey~~gg~L~~~l~~~~~~~l~e~~~~~i~~Qil~aL~yLHs~~IiHRDLKP~NILl~~~~~~~iKL~DFGla~~~~~--~ 528 (966)
|-|-||+|...|+.++ .|.+..+++|+..+++|++|||++|||.|||||+|+||+. .|.+||.|||+|+.... .
T Consensus 500 EaClGGElWTiLrdRg--~Fdd~tarF~~acv~EAfeYLH~k~iIYRDLKPENllLd~--~Gy~KLVDFGFAKki~~g~K 575 (732)
T KOG0614|consen 500 EACLGGELWTILRDRG--SFDDYTARFYVACVLEAFEYLHRKGIIYRDLKPENLLLDN--RGYLKLVDFGFAKKIGSGRK 575 (732)
T ss_pred HhhcCchhhhhhhhcC--CcccchhhhhHHHHHHHHHHHHhcCceeccCChhheeecc--CCceEEeehhhHHHhccCCc
Confidence 9999999999998877 6999999999999999999999999999999999999985 67999999999987653 4
Q ss_pred CccccccccccCchhhccCCCCCCCcccchhhhhhhhhhhhcCCCCCCCcCcchhHHHHHHHHhcCCCCCCCCCCchhHH
Q psy11767 529 LHTPCFTLQYAAPEVLRQDKSGYDENCDLWSLGVILVNVLRQDKSGYDENCDLWSLGVILYTMLCGRVPFHARSRDDSAL 608 (966)
Q Consensus 529 ~~~~~gT~~Y~APEvl~~~~~~~~~~~Di~SlGvil~el~~~~~~~y~~~~DIWSlGvilyemltG~~Pf~~~~~~~~~~ 608 (966)
+-++||||.|.|||++.+ .+++.++|.||||+++||||+|.+||.+.+..
T Consensus 576 TwTFcGTpEYVAPEIILn--------------------------KGHD~avDyWaLGIli~ELL~G~pPFs~~dpm---- 625 (732)
T KOG0614|consen 576 TWTFCGTPEYVAPEIILN--------------------------KGHDRAVDYWALGILIYELLTGSPPFSGVDPM---- 625 (732)
T ss_pred eeeecCCcccccchhhhc--------------------------cCcchhhHHHHHHHHHHHHHcCCCCCCCCchH----
Confidence 568999999999999973 45789999999999999999999999987654
Q ss_pred HHHHHHHcCCCCCCchhhccCCHHHHHHHHHhcccCccccCC
Q psy11767 609 SIMARIKEGQFNFDAEAWSTVSSEAKELTKSLLTVNPAQRIR 650 (966)
Q Consensus 609 ~~~~~i~~~~~~~~~~~~~~is~e~~~Li~~~L~~dP~~R~t 650 (966)
.....|..|.-.+. .+..++..+.+||+++-+.+|.+|+.
T Consensus 626 ktYn~ILkGid~i~--~Pr~I~k~a~~Lik~LCr~~P~ERLG 665 (732)
T KOG0614|consen 626 KTYNLILKGIDKIE--FPRRITKTATDLIKKLCRDNPTERLG 665 (732)
T ss_pred HHHHHHHhhhhhhh--cccccchhHHHHHHHHHhcCcHhhhc
Confidence 33444444432111 12468899999999999999999987
|
|
| >cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-34 Score=310.43 Aligned_cols=236 Identities=25% Similarity=0.414 Sum_probs=189.2
Q ss_pred ccccccccEEEEEEEcC-CCc--EEEEEEeccccC------hHHHHHHHHHhcCCCCceEEEEEEEeCCeEEEEEEccCC
Q psy11767 385 ILGDGSYSVCRRCVEKS-TGQ--EYAVKIISRKID------CSEEINLLRACQGHPNIVNLHCVFQDEVHTYLVLELLKG 455 (966)
Q Consensus 385 ~LG~G~fG~Vy~a~~~~-tg~--~vAvK~i~~~~~------~~~Ei~iL~~l~~HpnIV~l~~~~~~~~~~~lVmEy~~g 455 (966)
.||+|+||.||+|.+.. .++ .||||.+..... ..+|+.+|+.+ .||||+++++.+.+ ...++||||+++
T Consensus 2 ~ig~g~~~~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~-~~~~~v~e~~~~ 79 (257)
T cd05040 2 KLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSL-DHENLIRLYGVVLT-HPLMMVTELAPL 79 (257)
T ss_pred cCCccCcccEEeeeEecCCCCceEEEEeecCCcccHHHHHHHHHHHHHHhhc-CCCCccceeEEEcC-CeEEEEEEecCC
Confidence 68999999999999866 333 699999876533 34688999888 59999999999988 889999999999
Q ss_pred CCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCcEEEecCCCCCEEEEeecccccccCC------C
Q psy11767 456 GELLDRIRQKGRCGFTENEASRIMRQLVAAVHFMHSRGVVHRDLKPENLLFSDPAGDNIKVVDFGFACLKRES------L 529 (966)
Q Consensus 456 g~L~~~l~~~~~~~l~e~~~~~i~~Qil~aL~yLHs~~IiHRDLKP~NILl~~~~~~~iKL~DFGla~~~~~~------~ 529 (966)
|+|.+++.+.....+++..+..++.|++.||+|||++|++||||||+|||++. ++.+||+|||++...... .
T Consensus 80 ~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~di~p~nil~~~--~~~~kl~dfg~~~~~~~~~~~~~~~ 157 (257)
T cd05040 80 GSLLDRLRKDALGHFLISTLCDYAVQIANGMRYLESKRFIHRDLAARNILLAS--DDKVKIGDFGLMRALPQNEDHYVME 157 (257)
T ss_pred CcHHHHHHhcccccCcHHHHHHHHHHHHHHHHHHHhCCccccccCcccEEEec--CCEEEeccccccccccccccceecc
Confidence 99999998765346899999999999999999999999999999999999985 468999999998754321 1
Q ss_pred ccccccccccCchhhccCCCCCCCcccchhhhhhhhhhhhcCCCCCCCcCcchhHHHHHHHHhc-CCCCCCCCCCchhHH
Q psy11767 530 HTPCFTLQYAAPEVLRQDKSGYDENCDLWSLGVILVNVLRQDKSGYDENCDLWSLGVILYTMLC-GRVPFHARSRDDSAL 608 (966)
Q Consensus 530 ~~~~gT~~Y~APEvl~~~~~~~~~~~Di~SlGvil~el~~~~~~~y~~~~DIWSlGvilyemlt-G~~Pf~~~~~~~~~~ 608 (966)
....++..|+|||.+.. ..++.++|||||||++|+|++ |..||...+..+
T Consensus 158 ~~~~~~~~y~~pE~~~~--------------------------~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~--- 208 (257)
T cd05040 158 EHLKVPFAWCAPESLRT--------------------------RTFSHASDVWMFGVTLWEMFTYGEEPWAGLSGSQ--- 208 (257)
T ss_pred cCCCCCceecCHHHhcc--------------------------cCcCchhhhHHHHHHHHHHHhCCCCCCCCCCHHH---
Confidence 12346778999998752 236788999999999999998 999997654332
Q ss_pred HHHHHHHcCCCCCCchhhccCCHHHHHHHHHhcccCccccCChHHHHH
Q psy11767 609 SIMARIKEGQFNFDAEAWSTVSSEAKELTKSLLTVNPAQRIRMMRVKL 656 (966)
Q Consensus 609 ~~~~~i~~~~~~~~~~~~~~is~e~~~Li~~~L~~dP~~R~t~~~v~~ 656 (966)
....+........ .....+..+.+++.+||..+|++||++.++..
T Consensus 209 -~~~~~~~~~~~~~--~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~ 253 (257)
T cd05040 209 -ILKKIDKEGERLE--RPEACPQDIYNVMLQCWAHNPADRPTFAALRE 253 (257)
T ss_pred -HHHHHHhcCCcCC--CCccCCHHHHHHHHHHCCCCcccCCCHHHHHH
Confidence 2333322111111 12346789999999999999999999998743
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and |
| >cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-34 Score=314.23 Aligned_cols=244 Identities=26% Similarity=0.452 Sum_probs=191.6
Q ss_pred ccccccccccccccEEEEEEEcCCCcEEEEEEecccc----------ChHHHHHHHHHhcCCCCceEEEEEEEe--CCeE
Q psy11767 379 DLDKAGILGDGSYSVCRRCVEKSTGQEYAVKIISRKI----------DCSEEINLLRACQGHPNIVNLHCVFQD--EVHT 446 (966)
Q Consensus 379 ~~~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~----------~~~~Ei~iL~~l~~HpnIV~l~~~~~~--~~~~ 446 (966)
+|+..+.||+|+||.||+|.+..+|..||+|++.... ...+|+.+|+.+ +||||+++++++.+ +...
T Consensus 3 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~~ 81 (266)
T cd06651 3 NWRRGKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNL-QHERIVQYYGCLRDRAEKTL 81 (266)
T ss_pred CccccceecCCCCEEEEEEEEcCCCcEEEEEEeecCcCCchhHHHHHHHHHHHHHHHHc-CCCCeeeEEEEEEcCCCCEE
Confidence 4556789999999999999999999999999885321 134588899998 59999999999876 3678
Q ss_pred EEEEEccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCcEEEecCCCCCEEEEeeccccccc
Q psy11767 447 YLVLELLKGGELLDRIRQKGRCGFTENEASRIMRQLVAAVHFMHSRGVVHRDLKPENLLFSDPAGDNIKVVDFGFACLKR 526 (966)
Q Consensus 447 ~lVmEy~~gg~L~~~l~~~~~~~l~e~~~~~i~~Qil~aL~yLHs~~IiHRDLKP~NILl~~~~~~~iKL~DFGla~~~~ 526 (966)
+++|||+++++|.+++.... .+++..++.++.|++.||+|||+.+|+||||||+||++++ ++.+||+|||++....
T Consensus 82 ~l~~e~~~~~~L~~~l~~~~--~l~~~~~~~~~~qi~~~l~~LH~~~i~H~~l~p~nil~~~--~~~~~l~dfg~~~~~~ 157 (266)
T cd06651 82 TIFMEYMPGGSVKDQLKAYG--ALTESVTRKYTRQILEGMSYLHSNMIVHRDIKGANILRDS--AGNVKLGDFGASKRLQ 157 (266)
T ss_pred EEEEeCCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEECC--CCCEEEccCCCccccc
Confidence 99999999999999997654 5899999999999999999999999999999999999974 5689999999986432
Q ss_pred C------CCccccccccccCchhhccCCCCCCCcccchhhhhhhhhhhhcCCCCCCCcCcchhHHHHHHHHhcCCCCCCC
Q psy11767 527 E------SLHTPCFTLQYAAPEVLRQDKSGYDENCDLWSLGVILVNVLRQDKSGYDENCDLWSLGVILYTMLCGRVPFHA 600 (966)
Q Consensus 527 ~------~~~~~~gT~~Y~APEvl~~~~~~~~~~~Di~SlGvil~el~~~~~~~y~~~~DIWSlGvilyemltG~~Pf~~ 600 (966)
. ......++..|+|||++.. ..++.++||||+||++|+|++|+.||..
T Consensus 158 ~~~~~~~~~~~~~~~~~y~aPE~~~~--------------------------~~~~~~~Dv~slG~i~~el~~g~~pf~~ 211 (266)
T cd06651 158 TICMSGTGIRSVTGTPYWMSPEVISG--------------------------EGYGRKADVWSLGCTVVEMLTEKPPWAE 211 (266)
T ss_pred cccccCCccccCCccccccCHHHhCC--------------------------CCCCchhhhHHHHHHHHHHHHCCCCccc
Confidence 2 1122457889999998742 2357789999999999999999999986
Q ss_pred CCCchhHHHHHHHHHcCCCCCCchhhccCCHHHHHHHHHhcccCccccCChHHHHHHhhhhH
Q psy11767 601 RSRDDSALSIMARIKEGQFNFDAEAWSTVSSEAKELTKSLLTVNPAQRIRMMRVKLTFHAFH 662 (966)
Q Consensus 601 ~~~~~~~~~~~~~i~~~~~~~~~~~~~~is~e~~~Li~~~L~~dP~~R~t~~~v~~~~~~~~ 662 (966)
..... .+. .+..... .+.....+++.+++++ +||..||++||++.++ ..|+|+
T Consensus 212 ~~~~~---~~~-~~~~~~~--~~~~~~~~~~~~~~li-~~~~~~p~~Rp~~~ei--l~hp~~ 264 (266)
T cd06651 212 YEAMA---AIF-KIATQPT--NPQLPSHISEHARDFL-GCIFVEARHRPSAEEL--LRHPFA 264 (266)
T ss_pred cchHH---HHH-HHhcCCC--CCCCchhcCHHHHHHH-HHhcCChhhCcCHHHH--hcCccc
Confidence 53322 122 2211111 1122235688899999 5777899999999987 345553
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development |
| >cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-34 Score=312.21 Aligned_cols=240 Identities=22% Similarity=0.388 Sum_probs=192.2
Q ss_pred ccccccccccccEEEEEEEcCCCc---EEEEEEeccccC------hHHHHHHHHHhcCCCCceEEEEEEEeCCeEEEEEE
Q psy11767 381 DKAGILGDGSYSVCRRCVEKSTGQ---EYAVKIISRKID------CSEEINLLRACQGHPNIVNLHCVFQDEVHTYLVLE 451 (966)
Q Consensus 381 ~~~~~LG~G~fG~Vy~a~~~~tg~---~vAvK~i~~~~~------~~~Ei~iL~~l~~HpnIV~l~~~~~~~~~~~lVmE 451 (966)
+..+.||+|+||.||+|.+..+++ .+|||.+..... ...|+++++.+ +||||+++++++.+.+..|+|||
T Consensus 8 ~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e 86 (268)
T cd05063 8 TKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQF-SHHNIIRLEGVVTKFKPAMIITE 86 (268)
T ss_pred eEeeEecCCCCccEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHhcC-CCCCeeEEEEEEccCCCcEEEEE
Confidence 346789999999999999987665 799999865432 34588888888 59999999999999999999999
Q ss_pred ccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCcEEEecCCCCCEEEEeecccccccCCCc-
Q psy11767 452 LLKGGELLDRIRQKGRCGFTENEASRIMRQLVAAVHFMHSRGVVHRDLKPENLLFSDPAGDNIKVVDFGFACLKRESLH- 530 (966)
Q Consensus 452 y~~gg~L~~~l~~~~~~~l~e~~~~~i~~Qil~aL~yLHs~~IiHRDLKP~NILl~~~~~~~iKL~DFGla~~~~~~~~- 530 (966)
|+++++|.+++.... ..+++.++..++.|++.||+|||+.||+||||||+|||+++ ++.+||+|||++........
T Consensus 87 ~~~~~~L~~~~~~~~-~~~~~~~~~~~~~~l~~al~~lH~~~i~H~dlkp~Nili~~--~~~~kl~dfg~~~~~~~~~~~ 163 (268)
T cd05063 87 YMENGALDKYLRDHD-GEFSSYQLVGMLRGIAAGMKYLSDMNYVHRDLAARNILVNS--NLECKVSDFGLSRVLEDDPEG 163 (268)
T ss_pred cCCCCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHCCeeccccchhhEEEcC--CCcEEECCCccceeccccccc
Confidence 999999999987653 35899999999999999999999999999999999999975 56899999999865432111
Q ss_pred -----cccccccccCchhhccCCCCCCCcccchhhhhhhhhhhhcCCCCCCCcCcchhHHHHHHHHhc-CCCCCCCCCCc
Q psy11767 531 -----TPCFTLQYAAPEVLRQDKSGYDENCDLWSLGVILVNVLRQDKSGYDENCDLWSLGVILYTMLC-GRVPFHARSRD 604 (966)
Q Consensus 531 -----~~~gT~~Y~APEvl~~~~~~~~~~~Di~SlGvil~el~~~~~~~y~~~~DIWSlGvilyemlt-G~~Pf~~~~~~ 604 (966)
....++.|+|||++.. ..++.++|||||||++|+|++ |+.||......
T Consensus 164 ~~~~~~~~~~~~y~~PE~~~~--------------------------~~~~~~~Dv~slG~il~ell~~g~~p~~~~~~~ 217 (268)
T cd05063 164 TYTTSGGKIPIRWTAPEAIAY--------------------------RKFTSASDVWSFGIVMWEVMSFGERPYWDMSNH 217 (268)
T ss_pred ceeccCCCcCceecCHHHhhc--------------------------CCcChHhHHHHHHHHHHHHHhCCCCCCCcCCHH
Confidence 1123457999998752 236788999999999999997 99999765432
Q ss_pred hhHHHHHHHHHcCCCCCCchhhccCCHHHHHHHHHhcccCccccCChHHHHHH
Q psy11767 605 DSALSIMARIKEGQFNFDAEAWSTVSSEAKELTKSLLTVNPAQRIRMMRVKLT 657 (966)
Q Consensus 605 ~~~~~~~~~i~~~~~~~~~~~~~~is~e~~~Li~~~L~~dP~~R~t~~~v~~~ 657 (966)
.....+..+.... .....+.++.+++.+||..+|++||++.++...
T Consensus 218 ----~~~~~i~~~~~~~---~~~~~~~~~~~li~~c~~~~p~~Rp~~~~i~~~ 263 (268)
T cd05063 218 ----EVMKAINDGFRLP---APMDCPSAVYQLMLQCWQQDRARRPRFVDIVNL 263 (268)
T ss_pred ----HHHHHHhcCCCCC---CCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHH
Confidence 3344444432211 123568899999999999999999999987543
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored |
| >cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-34 Score=315.87 Aligned_cols=242 Identities=27% Similarity=0.454 Sum_probs=195.6
Q ss_pred cccccccccccccEEEEEEEcCCCcEEEEEEecccc------ChHHHHHHHHHhcCCCCceEEEEEEEeCCeEEEEEEcc
Q psy11767 380 LDKAGILGDGSYSVCRRCVEKSTGQEYAVKIISRKI------DCSEEINLLRACQGHPNIVNLHCVFQDEVHTYLVLELL 453 (966)
Q Consensus 380 ~~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~------~~~~Ei~iL~~l~~HpnIV~l~~~~~~~~~~~lVmEy~ 453 (966)
|+..+.||.|+||.||+|.+..+++.||||++.... ...+|+.+++.+ +||||+++++++.++...|+||||+
T Consensus 6 y~~~~~lg~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~ 84 (277)
T cd06640 6 FTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQC-DSPYVTKYYGSYLKGTKLWIIMEYL 84 (277)
T ss_pred hhhhhhcccCCCeEEEEEEEccCCEEEEEEEEeccccHHHHHHHHHHHHHHHhC-CCCCEeeEEEEEEECCEEEEEEecC
Confidence 344678999999999999999999999999987543 234688888888 5999999999999999999999999
Q ss_pred CCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCcEEEecCCCCCEEEEeecccccccCC---Cc
Q psy11767 454 KGGELLDRIRQKGRCGFTENEASRIMRQLVAAVHFMHSRGVVHRDLKPENLLFSDPAGDNIKVVDFGFACLKRES---LH 530 (966)
Q Consensus 454 ~gg~L~~~l~~~~~~~l~e~~~~~i~~Qil~aL~yLHs~~IiHRDLKP~NILl~~~~~~~iKL~DFGla~~~~~~---~~ 530 (966)
+||+|.+++... .+++.++..++.|++.||+|||+.+++|+||+|+||+++. ++.++|+|||++...... ..
T Consensus 85 ~~~~L~~~i~~~---~l~~~~~~~~~~~l~~~l~~lh~~~ivH~dl~p~Nil~~~--~~~~~l~dfg~~~~~~~~~~~~~ 159 (277)
T cd06640 85 GGGSALDLLRAG---PFDEFQIATMLKEILKGLDYLHSEKKIHRDIKAANVLLSE--QGDVKLADFGVAGQLTDTQIKRN 159 (277)
T ss_pred CCCcHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhCCccCcCCChhhEEEcC--CCCEEEcccccceeccCCccccc
Confidence 999999998653 5899999999999999999999999999999999999985 568999999998654321 12
Q ss_pred cccccccccCchhhccCCCCCCCcccchhhhhhhhhhhhcCCCCCCCcCcchhHHHHHHHHhcCCCCCCCCCCchhHHHH
Q psy11767 531 TPCFTLQYAAPEVLRQDKSGYDENCDLWSLGVILVNVLRQDKSGYDENCDLWSLGVILYTMLCGRVPFHARSRDDSALSI 610 (966)
Q Consensus 531 ~~~gT~~Y~APEvl~~~~~~~~~~~Di~SlGvil~el~~~~~~~y~~~~DIWSlGvilyemltG~~Pf~~~~~~~~~~~~ 610 (966)
...++..|+|||++.. ..++.++|+|||||++|+|++|.+||....... .
T Consensus 160 ~~~~~~~y~apE~~~~--------------------------~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~----~ 209 (277)
T cd06640 160 TFVGTPFWMAPEVIQQ--------------------------SAYDSKADIWSLGITAIELAKGEPPNSDMHPMR----V 209 (277)
T ss_pred cccCcccccCHhHhcc--------------------------CCCccHHHHHHHHHHHHHHHHCCCCCCCcChHh----H
Confidence 3457888999998752 225778999999999999999999998654321 2
Q ss_pred HHHHHcCCCCCCchhhccCCHHHHHHHHHhcccCccccCChHHHHHHhhhhH
Q psy11767 611 MARIKEGQFNFDAEAWSTVSSEAKELTKSLLTVNPAQRIRMMRVKLTFHAFH 662 (966)
Q Consensus 611 ~~~i~~~~~~~~~~~~~~is~e~~~Li~~~L~~dP~~R~t~~~v~~~~~~~~ 662 (966)
...+..+.. +.....++.++.+++.+||..||++||++.++ ..|+|.
T Consensus 210 ~~~~~~~~~---~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i--l~~~~~ 256 (277)
T cd06640 210 LFLIPKNNP---PTLTGEFSKPFKEFIDACLNKDPSFRPTAKEL--LKHKFI 256 (277)
T ss_pred hhhhhcCCC---CCCchhhhHHHHHHHHHHcccCcccCcCHHHH--HhChHh
Confidence 222222221 12223567889999999999999999999877 334554
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter |
| >cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-34 Score=314.98 Aligned_cols=245 Identities=24% Similarity=0.364 Sum_probs=189.9
Q ss_pred ccccccccccccEEEEEEE----cCCCcEEEEEEecccc------ChHHHHHHHHHhcCCCCceEEEEEEEeC--CeEEE
Q psy11767 381 DKAGILGDGSYSVCRRCVE----KSTGQEYAVKIISRKI------DCSEEINLLRACQGHPNIVNLHCVFQDE--VHTYL 448 (966)
Q Consensus 381 ~~~~~LG~G~fG~Vy~a~~----~~tg~~vAvK~i~~~~------~~~~Ei~iL~~l~~HpnIV~l~~~~~~~--~~~~l 448 (966)
+.++.||+|+||.||+|.. ..++..||+|.+.... ...+|+.+|+.+ +||||+++++++.+. ...++
T Consensus 7 ~~~~~lg~g~~g~v~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~~~l 85 (284)
T cd05079 7 KRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNL-YHENIVKYKGICTEDGGNGIKL 85 (284)
T ss_pred hhceecCCCCceeEEEEEEccCCCCccceEEEEEcCccccHHHHHHHHHHHHHHHhC-CCCCeeeeeeEEecCCCCceEE
Confidence 4578899999999999974 4678999999986432 245699999988 599999999998875 56899
Q ss_pred EEEccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCcEEEecCCCCCEEEEeecccccccCC
Q psy11767 449 VLELLKGGELLDRIRQKGRCGFTENEASRIMRQLVAAVHFMHSRGVVHRDLKPENLLFSDPAGDNIKVVDFGFACLKRES 528 (966)
Q Consensus 449 VmEy~~gg~L~~~l~~~~~~~l~e~~~~~i~~Qil~aL~yLHs~~IiHRDLKP~NILl~~~~~~~iKL~DFGla~~~~~~ 528 (966)
||||++|++|.+++.+... .+++.++..++.||+.||+|||++||+||||||+|||+++ ++.+||+|||++......
T Consensus 86 v~e~~~g~~L~~~l~~~~~-~~~~~~~~~i~~~i~~aL~~lH~~gi~H~dlkp~Nil~~~--~~~~~l~dfg~~~~~~~~ 162 (284)
T cd05079 86 IMEFLPSGSLKEYLPRNKN-KINLKQQLKYAVQICKGMDYLGSRQYVHRDLAARNVLVES--EHQVKIGDFGLTKAIETD 162 (284)
T ss_pred EEEccCCCCHHHHHHhccC-CCCHHHHHHHHHHHHHHHHHHHHCCeeecccchheEEEcC--CCCEEECCCccccccccC
Confidence 9999999999999866532 5899999999999999999999999999999999999975 568999999998754321
Q ss_pred ------CccccccccccCchhhccCCCCCCCcccchhhhhhhhhhhhcCCCCCCCcCcchhHHHHHHHHhcCCCCCCCCC
Q psy11767 529 ------LHTPCFTLQYAAPEVLRQDKSGYDENCDLWSLGVILVNVLRQDKSGYDENCDLWSLGVILYTMLCGRVPFHARS 602 (966)
Q Consensus 529 ------~~~~~gT~~Y~APEvl~~~~~~~~~~~Di~SlGvil~el~~~~~~~y~~~~DIWSlGvilyemltG~~Pf~~~~ 602 (966)
.....++..|+|||++.. ..++.++|||||||++|+|++|+.|+....
T Consensus 163 ~~~~~~~~~~~~~~~y~apE~~~~--------------------------~~~~~~~Di~slG~il~ellt~~~~~~~~~ 216 (284)
T cd05079 163 KEYYTVKDDLDSPVFWYAPECLIQ--------------------------SKFYIASDVWSFGVTLYELLTYCDSESSPM 216 (284)
T ss_pred ccceeecCCCCCCccccCHHHhcc--------------------------CCCCccccchhhhhhhhhhhcCCCCCcccc
Confidence 123445678999998742 236788999999999999999887654321
Q ss_pred Cc----------h-hHHHHHHHHHcCCCCCCchhhccCCHHHHHHHHHhcccCccccCChHHHHHHh
Q psy11767 603 RD----------D-SALSIMARIKEGQFNFDAEAWSTVSSEAKELTKSLLTVNPAQRIRMMRVKLTF 658 (966)
Q Consensus 603 ~~----------~-~~~~~~~~i~~~~~~~~~~~~~~is~e~~~Li~~~L~~dP~~R~t~~~v~~~~ 658 (966)
.. + ........+..+.. .+.+..++.++.+|+.+||+.||++||++.++...+
T Consensus 217 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l 280 (284)
T cd05079 217 TLFLKMIGPTHGQMTVTRLVRVLEEGKR---LPRPPNCPEEVYQLMRKCWEFQPSKRTTFQNLIEGF 280 (284)
T ss_pred chhhhhcccccccccHHHHHHHHHcCcc---CCCCCCCCHHHHHHHHHHccCCcccCcCHHHHHHHH
Confidence 10 0 00111122222221 112346789999999999999999999999875443
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a |
| >cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-34 Score=311.58 Aligned_cols=238 Identities=21% Similarity=0.379 Sum_probs=189.0
Q ss_pred ccccccccccEEEEEEEcCCCcEEEEEEeccccC----hHHHHHHHHHhcCCCCceEEEEEEEeCCeEEEEEEccCCCCH
Q psy11767 383 AGILGDGSYSVCRRCVEKSTGQEYAVKIISRKID----CSEEINLLRACQGHPNIVNLHCVFQDEVHTYLVLELLKGGEL 458 (966)
Q Consensus 383 ~~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~~----~~~Ei~iL~~l~~HpnIV~l~~~~~~~~~~~lVmEy~~gg~L 458 (966)
...||+|+||.||+|.+..+ ..+|+|++..... ..+|+.+|+.+ +||||+++++++.. ...|+||||+.+|+|
T Consensus 11 ~~~ig~g~~~~v~~~~~~~~-~~~~lK~~~~~~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~-~~~~~v~e~~~~~~L 87 (260)
T cd05069 11 DVKLGQGCFGEVWMGTWNGT-TKVAIKTLKPGTMMPEAFLQEAQIMKKL-RHDKLVPLYAVVSE-EPIYIVTEFMGKGSL 87 (260)
T ss_pred eeeecCcCCCeEEEEEEcCC-ceEEEEEcccCCccHHHHHHHHHHHHhC-CCCCeeeEEEEEcC-CCcEEEEEcCCCCCH
Confidence 46799999999999988665 4699998865432 35699999988 59999999998854 568999999999999
Q ss_pred HHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCcEEEecCCCCCEEEEeecccccccCCC----ccccc
Q psy11767 459 LDRIRQKGRCGFTENEASRIMRQLVAAVHFMHSRGVVHRDLKPENLLFSDPAGDNIKVVDFGFACLKRESL----HTPCF 534 (966)
Q Consensus 459 ~~~l~~~~~~~l~e~~~~~i~~Qil~aL~yLHs~~IiHRDLKP~NILl~~~~~~~iKL~DFGla~~~~~~~----~~~~g 534 (966)
.+++.......+++..+..++.|++.||+|||+.||+||||||+|||+++ ++.++|+|||++....... ....+
T Consensus 88 ~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~dl~~~Nill~~--~~~~~l~dfg~~~~~~~~~~~~~~~~~~ 165 (260)
T cd05069 88 LDFLKEGDGKYLKLPQLVDMAAQIADGMAYIERMNYIHRDLRAANILVGD--NLVCKIADFGLARLIEDNEYTARQGAKF 165 (260)
T ss_pred HHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeecccCcceEEEcC--CCeEEECCCccceEccCCcccccCCCcc
Confidence 99997755445899999999999999999999999999999999999985 5689999999997543221 12234
Q ss_pred cccccCchhhccCCCCCCCcccchhhhhhhhhhhhcCCCCCCCcCcchhHHHHHHHHhc-CCCCCCCCCCchhHHHHHHH
Q psy11767 535 TLQYAAPEVLRQDKSGYDENCDLWSLGVILVNVLRQDKSGYDENCDLWSLGVILYTMLC-GRVPFHARSRDDSALSIMAR 613 (966)
Q Consensus 535 T~~Y~APEvl~~~~~~~~~~~Di~SlGvil~el~~~~~~~y~~~~DIWSlGvilyemlt-G~~Pf~~~~~~~~~~~~~~~ 613 (966)
+..|+|||++.. ..++.++|||||||++|+|++ |.+||.+.... .....
T Consensus 166 ~~~y~~Pe~~~~--------------------------~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~----~~~~~ 215 (260)
T cd05069 166 PIKWTAPEAALY--------------------------GRFTIKSDVWSFGILLTELVTKGRVPYPGMVNR----EVLEQ 215 (260)
T ss_pred chhhCCHHHhcc--------------------------CCcChHHHHHHHHHHHHHHHhCCCCCCCCCCHH----HHHHH
Confidence 678999998742 225778999999999999999 99999875432 22333
Q ss_pred HHcCCCCCCchhhccCCHHHHHHHHHhcccCccccCChHHHHHHh
Q psy11767 614 IKEGQFNFDAEAWSTVSSEAKELTKSLLTVNPAQRIRMMRVKLTF 658 (966)
Q Consensus 614 i~~~~~~~~~~~~~~is~e~~~Li~~~L~~dP~~R~t~~~v~~~~ 658 (966)
+..+. . ...+..++.++.+++.+||..||++||++.++...+
T Consensus 216 ~~~~~-~--~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l 257 (260)
T cd05069 216 VERGY-R--MPCPQGCPESLHELMKLCWKKDPDERPTFEYIQSFL 257 (260)
T ss_pred HHcCC-C--CCCCcccCHHHHHHHHHHccCCcccCcCHHHHHHHH
Confidence 43331 1 122345788999999999999999999999875443
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an |
| >cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-34 Score=312.19 Aligned_cols=240 Identities=21% Similarity=0.401 Sum_probs=192.0
Q ss_pred ccccccccccccEEEEEEEcCCCc---EEEEEEecccc------ChHHHHHHHHHhcCCCCceEEEEEEEeCCeEEEEEE
Q psy11767 381 DKAGILGDGSYSVCRRCVEKSTGQ---EYAVKIISRKI------DCSEEINLLRACQGHPNIVNLHCVFQDEVHTYLVLE 451 (966)
Q Consensus 381 ~~~~~LG~G~fG~Vy~a~~~~tg~---~vAvK~i~~~~------~~~~Ei~iL~~l~~HpnIV~l~~~~~~~~~~~lVmE 451 (966)
+..+.||+|+||.||+|.+..++. .+|+|.+.... ...+|+.+|+.+ +||||+++++++.++...|+|||
T Consensus 7 ~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e 85 (267)
T cd05066 7 KIEKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQRRDFLSEASIMGQF-DHPNIIHLEGVVTKSKPVMIVTE 85 (267)
T ss_pred EeeeeecccCCCceEEEEEecCCCCceEEEEEECCCCCCHHHHHHHHHHHHHHHhC-CCCCcceEEEEEecCCccEEEEE
Confidence 346789999999999999875544 79999986532 235688889888 59999999999999999999999
Q ss_pred ccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCcEEEecCCCCCEEEEeecccccccCCC--
Q psy11767 452 LLKGGELLDRIRQKGRCGFTENEASRIMRQLVAAVHFMHSRGVVHRDLKPENLLFSDPAGDNIKVVDFGFACLKRESL-- 529 (966)
Q Consensus 452 y~~gg~L~~~l~~~~~~~l~e~~~~~i~~Qil~aL~yLHs~~IiHRDLKP~NILl~~~~~~~iKL~DFGla~~~~~~~-- 529 (966)
|+++++|.+++..... .+++.++..++.|++.||+|||++||+||||||+|||++. ++.++|+|||++.......
T Consensus 86 ~~~~~~L~~~~~~~~~-~~~~~~~~~i~~~i~~~l~~lH~~~i~h~dlkp~nili~~--~~~~~l~dfg~~~~~~~~~~~ 162 (267)
T cd05066 86 YMENGSLDAFLRKHDG-QFTVIQLVGMLRGIASGMKYLSDMGYVHRDLAARNILVNS--NLVCKVSDFGLSRVLEDDPEA 162 (267)
T ss_pred cCCCCCHHHHHHhcCC-CCCHHHHHHHHHHHHHHHHHHHHCCEeehhhchhcEEECC--CCeEEeCCCCcccccccccce
Confidence 9999999999976543 5899999999999999999999999999999999999974 5689999999987543221
Q ss_pred ----ccccccccccCchhhccCCCCCCCcccchhhhhhhhhhhhcCCCCCCCcCcchhHHHHHHHHhc-CCCCCCCCCCc
Q psy11767 530 ----HTPCFTLQYAAPEVLRQDKSGYDENCDLWSLGVILVNVLRQDKSGYDENCDLWSLGVILYTMLC-GRVPFHARSRD 604 (966)
Q Consensus 530 ----~~~~gT~~Y~APEvl~~~~~~~~~~~Di~SlGvil~el~~~~~~~y~~~~DIWSlGvilyemlt-G~~Pf~~~~~~ 604 (966)
....++..|+|||++.. ..++.++|+|||||++|++++ |..||......
T Consensus 163 ~~~~~~~~~~~~y~~pe~~~~--------------------------~~~~~~~Dv~slG~~l~ell~~g~~p~~~~~~~ 216 (267)
T cd05066 163 AYTTRGGKIPIRWTAPEAIAY--------------------------RKFTSASDVWSYGIVMWEVMSYGERPYWEMSNQ 216 (267)
T ss_pred eeecCCCccceeecCHhHhcc--------------------------CccCchhhhHHHHHHHHHHhcCCCCCcccCCHH
Confidence 11123567999998852 236788999999999999886 99999865432
Q ss_pred hhHHHHHHHHHcCCCCCCchhhccCCHHHHHHHHHhcccCccccCChHHHHHH
Q psy11767 605 DSALSIMARIKEGQFNFDAEAWSTVSSEAKELTKSLLTVNPAQRIRMMRVKLT 657 (966)
Q Consensus 605 ~~~~~~~~~i~~~~~~~~~~~~~~is~e~~~Li~~~L~~dP~~R~t~~~v~~~ 657 (966)
.....+.++. ..+ ....+++.+.+++.+||+.+|.+||++.++...
T Consensus 217 ----~~~~~~~~~~-~~~--~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~ 262 (267)
T cd05066 217 ----DVIKAIEEGY-RLP--APMDCPAALHQLMLDCWQKDRNERPKFEQIVSI 262 (267)
T ss_pred ----HHHHHHhCCC-cCC--CCCCCCHHHHHHHHHHcccCchhCCCHHHHHHH
Confidence 2334444432 221 223578899999999999999999999987543
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul |
| >cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-34 Score=317.76 Aligned_cols=245 Identities=30% Similarity=0.459 Sum_probs=191.7
Q ss_pred cccccccccccccEEEEEEEcCCCcEEEEEEecccc-------ChHHHHHHHHHhcCCCCceEEEEEEEeC--CeEEEEE
Q psy11767 380 LDKAGILGDGSYSVCRRCVEKSTGQEYAVKIISRKI-------DCSEEINLLRACQGHPNIVNLHCVFQDE--VHTYLVL 450 (966)
Q Consensus 380 ~~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~-------~~~~Ei~iL~~l~~HpnIV~l~~~~~~~--~~~~lVm 450 (966)
|+..+.||.|+||.||+|.+..+++.||+|.++... ...+|+.+|+.+. ||||+++++++... ...|+||
T Consensus 7 y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~-h~ni~~~~~~~~~~~~~~~~lv~ 85 (293)
T cd07843 7 YEKLNRIEEGTYGVVYRARDKKTGEIVALKKLKMEKEKEGFPITSLREINILLKLQ-HPNIVTVKEVVVGSNLDKIYMVM 85 (293)
T ss_pred hhhhhhhcCCCCeEEEEEEECCCCcEEEEEEEeeccccccchhhHHHHHHHHHhcC-CCCEEEEEEEEEecCCCcEEEEe
Confidence 344678999999999999999999999999986432 2346999999985 99999999999877 8999999
Q ss_pred EccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCcEEEecCCCCCEEEEeecccccccCC--
Q psy11767 451 ELLKGGELLDRIRQKGRCGFTENEASRIMRQLVAAVHFMHSRGVVHRDLKPENLLFSDPAGDNIKVVDFGFACLKRES-- 528 (966)
Q Consensus 451 Ey~~gg~L~~~l~~~~~~~l~e~~~~~i~~Qil~aL~yLHs~~IiHRDLKP~NILl~~~~~~~iKL~DFGla~~~~~~-- 528 (966)
||+. ++|.+.+..... .+++.+++.++.||+.||+|||++||+||||||+|||+++ ++.+||+|||++......
T Consensus 86 e~~~-~~L~~~~~~~~~-~l~~~~~~~i~~qi~~aL~~LH~~~i~H~dl~p~nili~~--~~~~~l~d~g~~~~~~~~~~ 161 (293)
T cd07843 86 EYVE-HDLKSLMETMKQ-PFLQSEVKCLMLQLLSGVAHLHDNWILHRDLKTSNLLLNN--RGILKICDFGLAREYGSPLK 161 (293)
T ss_pred hhcC-cCHHHHHHhccC-CCCHHHHHHHHHHHHHHHHHHHHCCeeeccCCHHHEEECC--CCcEEEeecCceeeccCCcc
Confidence 9996 589888876543 5899999999999999999999999999999999999985 568999999998765432
Q ss_pred -CccccccccccCchhhccCCCCCCCcccchhhhhhhhhhhhcCCCCCCCcCcchhHHHHHHHHhcCCCCCCCCCCchhH
Q psy11767 529 -LHTPCFTLQYAAPEVLRQDKSGYDENCDLWSLGVILVNVLRQDKSGYDENCDLWSLGVILYTMLCGRVPFHARSRDDSA 607 (966)
Q Consensus 529 -~~~~~gT~~Y~APEvl~~~~~~~~~~~Di~SlGvil~el~~~~~~~y~~~~DIWSlGvilyemltG~~Pf~~~~~~~~~ 607 (966)
.....+++.|+|||++... ..++.++|+||+||++|+|++|.+||......+..
T Consensus 162 ~~~~~~~~~~~~aPE~~~~~-------------------------~~~~~~~Di~slG~~l~~l~~g~~~f~~~~~~~~~ 216 (293)
T cd07843 162 PYTQLVVTLWYRAPELLLGA-------------------------KEYSTAIDMWSVGCIFAELLTKKPLFPGKSEIDQL 216 (293)
T ss_pred ccccccccccccCchhhcCC-------------------------ccccchhhHHHHHHHHHHHHhCCCCCCCCChHHHH
Confidence 2234568899999987521 22567899999999999999999999876543322
Q ss_pred HHHHHHHHc-----------------C-----CCCCCchhhcc--CCHHHHHHHHHhcccCccccCChHHH
Q psy11767 608 LSIMARIKE-----------------G-----QFNFDAEAWST--VSSEAKELTKSLLTVNPAQRIRMMRV 654 (966)
Q Consensus 608 ~~~~~~i~~-----------------~-----~~~~~~~~~~~--is~e~~~Li~~~L~~dP~~R~t~~~v 654 (966)
..+...... . .+......++. +++.+.++|++||..||++|||+.++
T Consensus 217 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~t~~el 287 (293)
T cd07843 217 NKIFKLLGTPTEKIWPGFSELPGAKKKTFTKYPYNQLRKKFPALSLSDNGFDLLNRLLTYDPAKRISAEDA 287 (293)
T ss_pred HHHHHHhCCCchHHHHHhhccchhcccccccccchhhhccccccCCChHHHHHHHHHhccCccccCCHHHH
Confidence 222111100 0 00000011122 48889999999999999999999876
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the |
| >cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-34 Score=314.06 Aligned_cols=245 Identities=27% Similarity=0.445 Sum_probs=196.3
Q ss_pred ccccccccccccEEEEEEEcCCCcEEEEEEecccc------ChHHHHHHHHHhc--CCCCceEEEEEEEeCCeEEEEEEc
Q psy11767 381 DKAGILGDGSYSVCRRCVEKSTGQEYAVKIISRKI------DCSEEINLLRACQ--GHPNIVNLHCVFQDEVHTYLVLEL 452 (966)
Q Consensus 381 ~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~------~~~~Ei~iL~~l~--~HpnIV~l~~~~~~~~~~~lVmEy 452 (966)
+..+.||+|+||.||+|.+..+++.||+|.+.... ...+|+.+++.+. .||||+++++++.++...|+||||
T Consensus 4 ~~~~~l~~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~vi~~~~~~~~~~~~~lv~e~ 83 (277)
T cd06917 4 QRLELIGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQREVALLSQLRQSQPPNITKYYGSYLKGPRLWIIMEY 83 (277)
T ss_pred hhhhheeccCCceEEEEEEcCCCcEEEEEEecCCCCchhHHHHHHHHHHHHHhccCCCCCeeeEeeeeeeCCEEEEEEec
Confidence 34678999999999999999999999999986432 2446888888885 599999999999999999999999
Q ss_pred cCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCcEEEecCCCCCEEEEeecccccccCC---C
Q psy11767 453 LKGGELLDRIRQKGRCGFTENEASRIMRQLVAAVHFMHSRGVVHRDLKPENLLFSDPAGDNIKVVDFGFACLKRES---L 529 (966)
Q Consensus 453 ~~gg~L~~~l~~~~~~~l~e~~~~~i~~Qil~aL~yLHs~~IiHRDLKP~NILl~~~~~~~iKL~DFGla~~~~~~---~ 529 (966)
++|++|.+++... .+++..+..++.|++.||.|||+.||+||||+|+||++++ .+.++|+|||++...... .
T Consensus 84 ~~~~~L~~~~~~~---~l~~~~~~~i~~~i~~~l~~lh~~~i~H~dl~p~ni~i~~--~~~~~l~dfg~~~~~~~~~~~~ 158 (277)
T cd06917 84 AEGGSVRTLMKAG---PIAEKYISVIIREVLVALKYIHKVGVIHRDIKAANILVTN--TGNVKLCDFGVAALLNQNSSKR 158 (277)
T ss_pred CCCCcHHHHHHcc---CCCHHHHHHHHHHHHHHHHHHHhCCcccCCcCHHHEEEcC--CCCEEEccCCceeecCCCcccc
Confidence 9999999988653 5899999999999999999999999999999999999985 568999999998654332 2
Q ss_pred ccccccccccCchhhccCCCCCCCcccchhhhhhhhhhhhcCCCCCCCcCcchhHHHHHHHHhcCCCCCCCCCCchhHHH
Q psy11767 530 HTPCFTLQYAAPEVLRQDKSGYDENCDLWSLGVILVNVLRQDKSGYDENCDLWSLGVILYTMLCGRVPFHARSRDDSALS 609 (966)
Q Consensus 530 ~~~~gT~~Y~APEvl~~~~~~~~~~~Di~SlGvil~el~~~~~~~y~~~~DIWSlGvilyemltG~~Pf~~~~~~~~~~~ 609 (966)
....++..|+|||++.. ...++.++|+|||||++|+|++|..||.+.....
T Consensus 159 ~~~~~~~~y~aPE~~~~-------------------------~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~---- 209 (277)
T cd06917 159 STFVGTPYWMAPEVITE-------------------------GKYYDTKADIWSLGITIYEMATGNPPYSDVDAFR---- 209 (277)
T ss_pred ccccCCcceeCHHHhcc-------------------------CCccccchhHHHHHHHHHHHHhCCCCCCCCChhh----
Confidence 23467889999998742 1235778999999999999999999997654321
Q ss_pred HHHHHHcCCCCCCchhhccCCHHHHHHHHHhcccCccccCChHHHHHHhhhhHH
Q psy11767 610 IMARIKEGQFNFDAEAWSTVSSEAKELTKSLLTVNPAQRIRMMRVKLTFHAFHQ 663 (966)
Q Consensus 610 ~~~~i~~~~~~~~~~~~~~is~e~~~Li~~~L~~dP~~R~t~~~v~~~~~~~~~ 663 (966)
....+..... +.......+.++.+++.+||..||++||++.++. .++|.+
T Consensus 210 ~~~~~~~~~~--~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~il--~~~~~~ 259 (277)
T cd06917 210 AMMLIPKSKP--PRLEDNGYSKLLREFVAACLDEEPKERLSAEELL--KSKWIK 259 (277)
T ss_pred hhhccccCCC--CCCCcccCCHHHHHHHHHHcCCCcccCcCHHHHh--hChHhh
Confidence 1112222111 1111123678999999999999999999998774 356653
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent |
| >cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-35 Score=319.28 Aligned_cols=244 Identities=30% Similarity=0.499 Sum_probs=191.5
Q ss_pred ccccccccccccEEEEEEEcCCCcEEEEEEecccc-------ChHHHHHHHHHhcCCCCceEEEEEEEeCCeEEEEEEcc
Q psy11767 381 DKAGILGDGSYSVCRRCVEKSTGQEYAVKIISRKI-------DCSEEINLLRACQGHPNIVNLHCVFQDEVHTYLVLELL 453 (966)
Q Consensus 381 ~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~-------~~~~Ei~iL~~l~~HpnIV~l~~~~~~~~~~~lVmEy~ 453 (966)
+..+.||+|+||.||+|.+..+++.||+|++.... ...+|+++|+.+ +||||+++++++.++...|+||||+
T Consensus 4 ~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~ 82 (286)
T cd07846 4 ENLGLVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQL-RHENLVNLIEVFRRKKRLYLVFEFV 82 (286)
T ss_pred eEeeeeccCCCeEEEEEEECCCCCEEEEEeHhhccCcchhhHHHHHHHHHHHhc-CCcchhhHHHhcccCCeEEEEEecC
Confidence 34688999999999999999999999999875432 234689999888 5999999999999999999999999
Q ss_pred CCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCcEEEecCCCCCEEEEeecccccccCC---Cc
Q psy11767 454 KGGELLDRIRQKGRCGFTENEASRIMRQLVAAVHFMHSRGVVHRDLKPENLLFSDPAGDNIKVVDFGFACLKRES---LH 530 (966)
Q Consensus 454 ~gg~L~~~l~~~~~~~l~e~~~~~i~~Qil~aL~yLHs~~IiHRDLKP~NILl~~~~~~~iKL~DFGla~~~~~~---~~ 530 (966)
+++.|.++..... .+++.+++.++.||+.||+|||+.||+||||+|+||++++ ++.++|+|||++...... ..
T Consensus 83 ~~~~l~~~~~~~~--~~~~~~~~~~~~~i~~~l~~LH~~~i~h~~l~p~ni~~~~--~~~~~l~dfg~~~~~~~~~~~~~ 158 (286)
T cd07846 83 DHTVLDDLEKYPN--GLDESRVRKYLFQILRGIEFCHSHNIIHRDIKPENILVSQ--SGVVKLCDFGFARTLAAPGEVYT 158 (286)
T ss_pred CccHHHHHHhccC--CCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEECC--CCcEEEEeeeeeeeccCCccccC
Confidence 9888877665433 4899999999999999999999999999999999999975 568999999998654321 22
Q ss_pred cccccccccCchhhccCCCCCCCcccchhhhhhhhhhhhcCCCCCCCcCcchhHHHHHHHHhcCCCCCCCCCCchhHHHH
Q psy11767 531 TPCFTLQYAAPEVLRQDKSGYDENCDLWSLGVILVNVLRQDKSGYDENCDLWSLGVILYTMLCGRVPFHARSRDDSALSI 610 (966)
Q Consensus 531 ~~~gT~~Y~APEvl~~~~~~~~~~~Di~SlGvil~el~~~~~~~y~~~~DIWSlGvilyemltG~~Pf~~~~~~~~~~~~ 610 (966)
...++..|+|||++.. ...++.++|||||||++|+|++|++||......+....+
T Consensus 159 ~~~~~~~y~aPE~~~~-------------------------~~~~~~~~Dv~slG~~l~el~~g~~~~~~~~~~~~~~~~ 213 (286)
T cd07846 159 DYVATRWYRAPELLVG-------------------------DTKYGRAVDIWAVGCLVTEMLTGEPLFPGDSDIDQLYHI 213 (286)
T ss_pred cccceeeccCcHHhcc-------------------------ccccCchHhHHHHHHHHHHHHcCCCCCCCCchHHHHHHH
Confidence 3457889999998742 123567899999999999999999999765432221111
Q ss_pred HHHHHc----------------CC----CC---CCchhhccCCHHHHHHHHHhcccCccccCChHHH
Q psy11767 611 MARIKE----------------GQ----FN---FDAEAWSTVSSEAKELTKSLLTVNPAQRIRMMRV 654 (966)
Q Consensus 611 ~~~i~~----------------~~----~~---~~~~~~~~is~e~~~Li~~~L~~dP~~R~t~~~v 654 (966)
...+.. +. .. .....++.++..+.+|+.+||..||++||++.++
T Consensus 214 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~i 280 (286)
T cd07846 214 IKCLGNLIPRHQEIFQKNPLFAGMRLPEVKEIEPLEKRFPKLSGLVLDLAKQCLRIDPDDRPSSSQL 280 (286)
T ss_pred HHHhCCCchhhHHHhccchHhhccccccccCcchHHHhCCCcCHHHHHHHHHHhcCCcccchhHHHH
Confidence 111000 00 00 0001234678899999999999999999999876
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI |
| >cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-34 Score=315.26 Aligned_cols=246 Identities=30% Similarity=0.491 Sum_probs=193.8
Q ss_pred cccccccccccccEEEEEEEcCCCcEEEEEEecccc------ChHHHHHHHHHhcCCCCceEEEEEEEeCCeEEEEEEcc
Q psy11767 380 LDKAGILGDGSYSVCRRCVEKSTGQEYAVKIISRKI------DCSEEINLLRACQGHPNIVNLHCVFQDEVHTYLVLELL 453 (966)
Q Consensus 380 ~~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~------~~~~Ei~iL~~l~~HpnIV~l~~~~~~~~~~~lVmEy~ 453 (966)
|+..+.||.|+||.||+|.+..+|+.||||++.... ...+|+.+++.+ +||||+++++++.+.+..|+||||+
T Consensus 2 y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~ 80 (284)
T cd07836 2 FKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAIREISLMKEL-KHENIVRLHDVIHTENKLMLVFEYM 80 (284)
T ss_pred ceEeeeeccCCceEEEEEEECCCCeEEEEEEecccccccchHHHHHHHHHHHhh-cCCCEeeeeeeEeeCCcEEEEEecC
Confidence 445788999999999999999999999999986432 234689999998 5999999999999999999999999
Q ss_pred CCCCHHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCcEEEecCCCCCEEEEeecccccccCC---C
Q psy11767 454 KGGELLDRIRQKG-RCGFTENEASRIMRQLVAAVHFMHSRGVVHRDLKPENLLFSDPAGDNIKVVDFGFACLKRES---L 529 (966)
Q Consensus 454 ~gg~L~~~l~~~~-~~~l~e~~~~~i~~Qil~aL~yLHs~~IiHRDLKP~NILl~~~~~~~iKL~DFGla~~~~~~---~ 529 (966)
+ ++|.+++.... ...+++..+..++.||+.||+|||+.||+||||||+||++++ .+.++|+|||++...... .
T Consensus 81 ~-~~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~h~dl~p~ni~~~~--~~~~~l~d~g~~~~~~~~~~~~ 157 (284)
T cd07836 81 D-KDLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFCHENRVLHRDLKPQNLLINK--RGELKLADFGLARAFGIPVNTF 157 (284)
T ss_pred C-ccHHHHHHhcCCCCCcCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEECC--CCcEEEeecchhhhhcCCcccc
Confidence 7 48888887644 235899999999999999999999999999999999999975 568999999998654322 2
Q ss_pred ccccccccccCchhhccCCCCCCCcccchhhhhhhhhhhhcCCCCCCCcCcchhHHHHHHHHhcCCCCCCCCCCchhHHH
Q psy11767 530 HTPCFTLQYAAPEVLRQDKSGYDENCDLWSLGVILVNVLRQDKSGYDENCDLWSLGVILYTMLCGRVPFHARSRDDSALS 609 (966)
Q Consensus 530 ~~~~gT~~Y~APEvl~~~~~~~~~~~Di~SlGvil~el~~~~~~~y~~~~DIWSlGvilyemltG~~Pf~~~~~~~~~~~ 609 (966)
....+|+.|+|||++.. ...++.++|||||||++|+|++|+.||.+.+..+....
T Consensus 158 ~~~~~~~~y~~PE~~~~-------------------------~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~ 212 (284)
T cd07836 158 SNEVVTLWYRAPDVLLG-------------------------SRTYSTSIDIWSVGCIMAEMITGRPLFPGTNNEDQLLK 212 (284)
T ss_pred ccccccccccChHHhcC-------------------------CCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHH
Confidence 23456889999998742 12357789999999999999999999987665433222
Q ss_pred HHHHH-----------Hc-----CCCCCC-----chhhccCCHHHHHHHHHhcccCccccCChHHH
Q psy11767 610 IMARI-----------KE-----GQFNFD-----AEAWSTVSSEAKELTKSLLTVNPAQRIRMMRV 654 (966)
Q Consensus 610 ~~~~i-----------~~-----~~~~~~-----~~~~~~is~e~~~Li~~~L~~dP~~R~t~~~v 654 (966)
++... .. ..+... ....+.++.++.+++.+||+.||.+||++.++
T Consensus 213 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~ 278 (284)
T cd07836 213 IFRIMGTPTESTWPGISQLPEYKPTFPRYPPQDLQQLFPHADPLGIDLLHRLLQLNPELRISAHDA 278 (284)
T ss_pred HHHHhCCCChhhHHHHhcCchhcccccCCChHHHHHHhhhcCcHHHHHHHHHhcCCcccCCCHHHH
Confidence 22110 00 000000 00113467899999999999999999999876
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. |
| >cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-34 Score=310.31 Aligned_cols=241 Identities=22% Similarity=0.376 Sum_probs=194.0
Q ss_pred ccccccccccccEEEEEEEcCCCcEEEEEEecccc----ChHHHHHHHHHhcCCCCceEEEEEEEeCCeEEEEEEccCCC
Q psy11767 381 DKAGILGDGSYSVCRRCVEKSTGQEYAVKIISRKI----DCSEEINLLRACQGHPNIVNLHCVFQDEVHTYLVLELLKGG 456 (966)
Q Consensus 381 ~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~----~~~~Ei~iL~~l~~HpnIV~l~~~~~~~~~~~lVmEy~~gg 456 (966)
...+.||+|+||.||+|.+. .++.||||.+.... ...+|+.+++.+ +||||+++++++.++...++||||++++
T Consensus 9 ~i~~~ig~g~~~~v~~~~~~-~~~~~~vK~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~~v~e~~~~~ 86 (261)
T cd05034 9 KLERKLGAGQFGEVWMGTWN-GTTKVAVKTLKPGTMSPEAFLQEAQIMKKL-RHDKLVQLYAVCSEEEPIYIVTEYMSKG 86 (261)
T ss_pred eeeeeeccCcceEEEEEEEc-CCceEEEEEecCCccCHHHHHHHHHHHhhC-CCCCEeeeeeeeecCCceEEEEeccCCC
Confidence 33678999999999999976 45789999987542 245799999988 4999999999999989999999999999
Q ss_pred CHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCcEEEecCCCCCEEEEeecccccccCCC----ccc
Q psy11767 457 ELLDRIRQKGRCGFTENEASRIMRQLVAAVHFMHSRGVVHRDLKPENLLFSDPAGDNIKVVDFGFACLKRESL----HTP 532 (966)
Q Consensus 457 ~L~~~l~~~~~~~l~e~~~~~i~~Qil~aL~yLHs~~IiHRDLKP~NILl~~~~~~~iKL~DFGla~~~~~~~----~~~ 532 (966)
+|.+++.+.....+++..+..++.||+.||+|||++||+|+||||+|||+++ ++.+||+|||++....... ...
T Consensus 87 ~L~~~i~~~~~~~~~~~~~~~~~~~i~~al~~lh~~~i~h~di~p~nili~~--~~~~~l~d~g~~~~~~~~~~~~~~~~ 164 (261)
T cd05034 87 SLLDFLKSGEGKKLRLPQLVDMAAQIAEGMAYLESRNYIHRDLAARNILVGE--NLVCKIADFGLARLIEDDEYTAREGA 164 (261)
T ss_pred CHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCcchheEEEcC--CCCEEECccccceeccchhhhhhhcc
Confidence 9999998765456899999999999999999999999999999999999985 5699999999987544211 122
Q ss_pred cccccccCchhhccCCCCCCCcccchhhhhhhhhhhhcCCCCCCCcCcchhHHHHHHHHhc-CCCCCCCCCCchhHHHHH
Q psy11767 533 CFTLQYAAPEVLRQDKSGYDENCDLWSLGVILVNVLRQDKSGYDENCDLWSLGVILYTMLC-GRVPFHARSRDDSALSIM 611 (966)
Q Consensus 533 ~gT~~Y~APEvl~~~~~~~~~~~Di~SlGvil~el~~~~~~~y~~~~DIWSlGvilyemlt-G~~Pf~~~~~~~~~~~~~ 611 (966)
.++..|+|||.+.. ..++.++|+||+||++|+|++ |+.||.+.... ..+
T Consensus 165 ~~~~~y~~PE~~~~--------------------------~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~----~~~ 214 (261)
T cd05034 165 KFPIKWTAPEAANY--------------------------GRFTIKSDVWSFGILLTEIVTYGRVPYPGMTNR----EVL 214 (261)
T ss_pred CCCccccCHHHhcc--------------------------CCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHH----HHH
Confidence 23567999998852 235778999999999999998 99999765432 234
Q ss_pred HHHHcCCCCCCchhhccCCHHHHHHHHHhcccCccccCChHHHHHHh
Q psy11767 612 ARIKEGQFNFDAEAWSTVSSEAKELTKSLLTVNPAQRIRMMRVKLTF 658 (966)
Q Consensus 612 ~~i~~~~~~~~~~~~~~is~e~~~Li~~~L~~dP~~R~t~~~v~~~~ 658 (966)
..+..+... ......+.++.+++.+||..||++||++.++...+
T Consensus 215 ~~~~~~~~~---~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~~l 258 (261)
T cd05034 215 EQVERGYRM---PRPPNCPEELYDLMLQCWDKDPEERPTFEYLQSFL 258 (261)
T ss_pred HHHHcCCCC---CCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHH
Confidence 444433211 11234688999999999999999999999875443
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t |
| >cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-34 Score=320.88 Aligned_cols=247 Identities=28% Similarity=0.460 Sum_probs=188.9
Q ss_pred ccccccccccccEEEEEEEcC--CCcEEEEEEecccc--------ChHHHHHHHHHhcCCCCceEEEEEEEeC--CeEEE
Q psy11767 381 DKAGILGDGSYSVCRRCVEKS--TGQEYAVKIISRKI--------DCSEEINLLRACQGHPNIVNLHCVFQDE--VHTYL 448 (966)
Q Consensus 381 ~~~~~LG~G~fG~Vy~a~~~~--tg~~vAvK~i~~~~--------~~~~Ei~iL~~l~~HpnIV~l~~~~~~~--~~~~l 448 (966)
+..+.||+|+||.||+|.+.. +++.||||++.... ...+|+.+++.+ +||||+++++++.+. ...|+
T Consensus 3 ~~~~~ig~g~~g~v~~~~~~~~~~~~~~alK~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~~~l 81 (316)
T cd07842 3 EIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLREL-KHENVVSLVEVFLEHADKSVYL 81 (316)
T ss_pred eEEEEeccCCcEEEEEEEecCCCCCCeEEEEEeccccccccCccHHHHHHHHHHHhc-CCCCccceEEEEeCCCCceEEE
Confidence 346789999999999999998 89999999987632 245699999988 599999999999988 88999
Q ss_pred EEEccCCCCHHHHHHhcC---CCCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCcEEEecC--CCCCEEEEeecccc
Q psy11767 449 VLELLKGGELLDRIRQKG---RCGFTENEASRIMRQLVAAVHFMHSRGVVHRDLKPENLLFSDP--AGDNIKVVDFGFAC 523 (966)
Q Consensus 449 VmEy~~gg~L~~~l~~~~---~~~l~e~~~~~i~~Qil~aL~yLHs~~IiHRDLKP~NILl~~~--~~~~iKL~DFGla~ 523 (966)
||||++ ++|.+.+.... ...+++..++.++.||+.||+|||+++|+||||||+|||++.. ..+.+||+|||++.
T Consensus 82 v~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~h~dlkp~Nil~~~~~~~~~~~kl~Dfg~~~ 160 (316)
T cd07842 82 LFDYAE-HDLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVHYLHSNWVLHRDLKPANILVMGEGPERGVVKIGDLGLAR 160 (316)
T ss_pred EEeCCC-cCHHHHHHhhccCCCcCcCHHHHHHHHHHHHHHHHHHHhCCEeeCCCCHHHEEEcCCCCccceEEECCCcccc
Confidence 999996 57777765332 2258999999999999999999999999999999999999741 14689999999987
Q ss_pred cccCC------CccccccccccCchhhccCCCCCCCcccchhhhhhhhhhhhcCCCCCCCcCcchhHHHHHHHHhcCCCC
Q psy11767 524 LKRES------LHTPCFTLQYAAPEVLRQDKSGYDENCDLWSLGVILVNVLRQDKSGYDENCDLWSLGVILYTMLCGRVP 597 (966)
Q Consensus 524 ~~~~~------~~~~~gT~~Y~APEvl~~~~~~~~~~~Di~SlGvil~el~~~~~~~y~~~~DIWSlGvilyemltG~~P 597 (966)
..... ....++|+.|+|||++.. ...++.++|||||||++|+|++|++|
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-------------------------~~~~~~~~Dv~slG~~l~~l~~~~~~ 215 (316)
T cd07842 161 LFNAPLKPLADLDPVVVTIWYRAPELLLG-------------------------ARHYTKAIDIWAIGCIFAELLTLEPI 215 (316)
T ss_pred ccCCCcccccccCCccccccccCHHHHhC-------------------------CCCCCcHHHHHHHHHHHHHHHhcCCC
Confidence 64322 123467889999998742 22367889999999999999999999
Q ss_pred CCCCCCch---------hHHHHHHHHH----------------------cCCCCCC-------chhhccCCHHHHHHHHH
Q psy11767 598 FHARSRDD---------SALSIMARIK----------------------EGQFNFD-------AEAWSTVSSEAKELTKS 639 (966)
Q Consensus 598 f~~~~~~~---------~~~~~~~~i~----------------------~~~~~~~-------~~~~~~is~e~~~Li~~ 639 (966)
|.+..... ....++..+. .....+. .+.+...+.++.+++.+
T Consensus 216 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~ 295 (316)
T cd07842 216 FKGREAKIKKSNPFQRDQLERIFEVLGTPTEKDWPDIKKMPEYDTLMKDFKTKTYPSNSLAKWMEKHKKPDSQGFDLLRK 295 (316)
T ss_pred CcCCcccccccchhHHHHHHHHHHHhCCCchhHHHHHhhcccchhhhhhccCCCCCCccHHHHHHhccCCCHHHHHHHHH
Confidence 98654322 0001111000 0000000 00111567889999999
Q ss_pred hcccCccccCChHHH
Q psy11767 640 LLTVNPAQRIRMMRV 654 (966)
Q Consensus 640 ~L~~dP~~R~t~~~v 654 (966)
||+.||++|||+.++
T Consensus 296 ~l~~~P~~Rps~~ei 310 (316)
T cd07842 296 LLEYDPTKRITAEEA 310 (316)
T ss_pred HhcCCcccCcCHHHH
Confidence 999999999999876
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the |
| >cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-34 Score=320.96 Aligned_cols=242 Identities=26% Similarity=0.460 Sum_probs=194.3
Q ss_pred ccccccccccEEEEEEEcCCCcEEEEEEecccc-----ChHHHHHHHHHhcCCCCceEEEEEEEeCCeEEEEEEccCCCC
Q psy11767 383 AGILGDGSYSVCRRCVEKSTGQEYAVKIISRKI-----DCSEEINLLRACQGHPNIVNLHCVFQDEVHTYLVLELLKGGE 457 (966)
Q Consensus 383 ~~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~-----~~~~Ei~iL~~l~~HpnIV~l~~~~~~~~~~~lVmEy~~gg~ 457 (966)
...||+|+||.||++.+..++..||||.+.... ...+|+.+++.+ +||||+++++.+...++.|+||||+++++
T Consensus 27 ~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l-~h~~ii~~~~~~~~~~~~~lv~e~~~~~~ 105 (292)
T cd06658 27 FIKIGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRRELLFNEVVIMRDY-HHENVVDMYNSYLVGDELWVVMEFLEGGA 105 (292)
T ss_pred hhcccCCCCeEEEEEEECCCCCEEEEEEEecchHHHHHHHHHHHHHHHhC-CCCcHHHHHHheecCCeEEEEEeCCCCCc
Confidence 356999999999999999999999999986432 244688888887 59999999999999999999999999999
Q ss_pred HHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCcEEEecCCCCCEEEEeecccccccCC---Cccccc
Q psy11767 458 LLDRIRQKGRCGFTENEASRIMRQLVAAVHFMHSRGVVHRDLKPENLLFSDPAGDNIKVVDFGFACLKRES---LHTPCF 534 (966)
Q Consensus 458 L~~~l~~~~~~~l~e~~~~~i~~Qil~aL~yLHs~~IiHRDLKP~NILl~~~~~~~iKL~DFGla~~~~~~---~~~~~g 534 (966)
|.+++... .+++.++..++.||+.||+|||++||+||||||+|||+++ ++.++|+|||++...... .....+
T Consensus 106 L~~~~~~~---~l~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~Nill~~--~~~~kL~dfg~~~~~~~~~~~~~~~~~ 180 (292)
T cd06658 106 LTDIVTHT---RMNEEQIATVCLSVLRALSYLHNQGVIHRDIKSDSILLTS--DGRIKLSDFGFCAQVSKEVPKRKSLVG 180 (292)
T ss_pred HHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEcC--CCCEEEccCcchhhcccccccCceeec
Confidence 99987543 4899999999999999999999999999999999999975 468999999998653221 233467
Q ss_pred cccccCchhhccCCCCCCCcccchhhhhhhhhhhhcCCCCCCCcCcchhHHHHHHHHhcCCCCCCCCCCchhHHHHHHHH
Q psy11767 535 TLQYAAPEVLRQDKSGYDENCDLWSLGVILVNVLRQDKSGYDENCDLWSLGVILYTMLCGRVPFHARSRDDSALSIMARI 614 (966)
Q Consensus 535 T~~Y~APEvl~~~~~~~~~~~Di~SlGvil~el~~~~~~~y~~~~DIWSlGvilyemltG~~Pf~~~~~~~~~~~~~~~i 614 (966)
++.|+|||++.. ..++.++|+||+||++|+|++|+.||...+.. ..+..+
T Consensus 181 ~~~y~aPE~~~~--------------------------~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~----~~~~~~ 230 (292)
T cd06658 181 TPYWMAPEVISR--------------------------LPYGTEVDIWSLGIMVIEMIDGEPPYFNEPPL----QAMRRI 230 (292)
T ss_pred CccccCHHHHcc--------------------------CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH----HHHHHH
Confidence 899999998742 23677899999999999999999999865432 222233
Q ss_pred HcCCCCCCchhhccCCHHHHHHHHHhcccCccccCChHHHHHHhhhhHH
Q psy11767 615 KEGQFNFDAEAWSTVSSEAKELTKSLLTVNPAQRIRMMRVKLTFHAFHQ 663 (966)
Q Consensus 615 ~~~~~~~~~~~~~~is~e~~~Li~~~L~~dP~~R~t~~~v~~~~~~~~~ 663 (966)
.... .........++..+.+++.+||..||.+|||+.++. .|+|+.
T Consensus 231 ~~~~-~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~il--~~~~~~ 276 (292)
T cd06658 231 RDNL-PPRVKDSHKVSSVLRGFLDLMLVREPSQRATAQELL--QHPFLK 276 (292)
T ss_pred HhcC-CCccccccccCHHHHHHHHHHccCChhHCcCHHHHh--hChhhh
Confidence 2221 111112235788999999999999999999998764 355543
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express |
| >cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-34 Score=316.98 Aligned_cols=243 Identities=27% Similarity=0.437 Sum_probs=195.5
Q ss_pred cccccccccccccEEEEEEEcCCCcEEEEEEecccc------ChHHHHHHHHHhcCCCCceEEEEEEEeCCeEEEEEEcc
Q psy11767 380 LDKAGILGDGSYSVCRRCVEKSTGQEYAVKIISRKI------DCSEEINLLRACQGHPNIVNLHCVFQDEVHTYLVLELL 453 (966)
Q Consensus 380 ~~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~------~~~~Ei~iL~~l~~HpnIV~l~~~~~~~~~~~lVmEy~ 453 (966)
|+..+.||+|+||.||+|.+..+++.||+|++.... ...+|+.+++.+ +||||+++++++.++...|+||||+
T Consensus 6 y~~~~~l~~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~ 84 (277)
T cd06642 6 FTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQC-DSPYITRYYGSYLKGTKLWIIMEYL 84 (277)
T ss_pred HHHHHHhcCCCCeeEEEEEEcCCCeEEEEEEeccccchHHHHHHHHHHHHHHcC-CCCccHhhhcccccCCceEEEEEcc
Confidence 334678999999999999999999999999986432 245688999888 5999999999999999999999999
Q ss_pred CCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCcEEEecCCCCCEEEEeecccccccCC---Cc
Q psy11767 454 KGGELLDRIRQKGRCGFTENEASRIMRQLVAAVHFMHSRGVVHRDLKPENLLFSDPAGDNIKVVDFGFACLKRES---LH 530 (966)
Q Consensus 454 ~gg~L~~~l~~~~~~~l~e~~~~~i~~Qil~aL~yLHs~~IiHRDLKP~NILl~~~~~~~iKL~DFGla~~~~~~---~~ 530 (966)
++++|.+++... .+++..++.++.||+.||.|||++||+|+||+|+||++++ ++.++|+|||++...... ..
T Consensus 85 ~~~~L~~~~~~~---~~~~~~~~~~~~~i~~~l~~lH~~~ivH~dl~p~ni~i~~--~~~~~l~dfg~~~~~~~~~~~~~ 159 (277)
T cd06642 85 GGGSALDLLKPG---PLEETYIATILREILKGLDYLHSERKIHRDIKAANVLLSE--QGDVKLADFGVAGQLTDTQIKRN 159 (277)
T ss_pred CCCcHHHHhhcC---CCCHHHHHHHHHHHHHHHHHHhcCCeeccCCChheEEEeC--CCCEEEccccccccccCcchhhh
Confidence 999999988643 5899999999999999999999999999999999999985 568999999998654322 12
Q ss_pred cccccccccCchhhccCCCCCCCcccchhhhhhhhhhhhcCCCCCCCcCcchhHHHHHHHHhcCCCCCCCCCCchhHHHH
Q psy11767 531 TPCFTLQYAAPEVLRQDKSGYDENCDLWSLGVILVNVLRQDKSGYDENCDLWSLGVILYTMLCGRVPFHARSRDDSALSI 610 (966)
Q Consensus 531 ~~~gT~~Y~APEvl~~~~~~~~~~~Di~SlGvil~el~~~~~~~y~~~~DIWSlGvilyemltG~~Pf~~~~~~~~~~~~ 610 (966)
...++..|+|||++.. ..++.++|+|||||++|+|++|+.||....... .
T Consensus 160 ~~~~~~~y~aPE~~~~--------------------------~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~----~ 209 (277)
T cd06642 160 TFVGTPFWMAPEVIKQ--------------------------SAYDFKADIWSLGITAIELAKGEPPNSDLHPMR----V 209 (277)
T ss_pred cccCcccccCHHHhCc--------------------------CCCchhhhHHHHHHHHHHHHhCCCCCcccchhh----H
Confidence 3457889999998852 235778999999999999999999997544321 2
Q ss_pred HHHHHcCCCCCCchhhccCCHHHHHHHHHhcccCccccCChHHHHHHhhhhHH
Q psy11767 611 MARIKEGQFNFDAEAWSTVSSEAKELTKSLLTVNPAQRIRMMRVKLTFHAFHQ 663 (966)
Q Consensus 611 ~~~i~~~~~~~~~~~~~~is~e~~~Li~~~L~~dP~~R~t~~~v~~~~~~~~~ 663 (966)
...+..+... .....++.++.++|.+||..+|++||++.++.. |+|..
T Consensus 210 ~~~~~~~~~~---~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~--~~~~~ 257 (277)
T cd06642 210 LFLIPKNSPP---TLEGQYSKPFKEFVEACLNKDPRFRPTAKELLK--HKFIT 257 (277)
T ss_pred HhhhhcCCCC---CCCcccCHHHHHHHHHHccCCcccCcCHHHHHH--hHHHH
Confidence 2223322211 111246788999999999999999999998743 45543
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 |
| >cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-34 Score=315.02 Aligned_cols=240 Identities=20% Similarity=0.362 Sum_probs=188.7
Q ss_pred ccccccccccccEEEEEEEcC-----CCcEEEEEEeccccC------hHHHHHHHHHhcCCCCceEEEEEEEeCCeEEEE
Q psy11767 381 DKAGILGDGSYSVCRRCVEKS-----TGQEYAVKIISRKID------CSEEINLLRACQGHPNIVNLHCVFQDEVHTYLV 449 (966)
Q Consensus 381 ~~~~~LG~G~fG~Vy~a~~~~-----tg~~vAvK~i~~~~~------~~~Ei~iL~~l~~HpnIV~l~~~~~~~~~~~lV 449 (966)
+..+.||+|+||.||+|.++. .+..||+|.+..... ..+|+.+++.+ +||||+++++++.+....|+|
T Consensus 9 ~i~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~~~~lv 87 (288)
T cd05061 9 TLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGF-TCHHVVRLLGVVSKGQPTLVV 87 (288)
T ss_pred eeeeeecCCCCcEEEEEEEeccCCCCcceEEEEEECCCcCCHHHHHHHHHHHHHHHhC-CCCCeeeEEEEEcCCCCcEEE
Confidence 346889999999999997652 355899999864432 34577888887 599999999999999999999
Q ss_pred EEccCCCCHHHHHHhcC--------CCCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCcEEEecCCCCCEEEEeecc
Q psy11767 450 LELLKGGELLDRIRQKG--------RCGFTENEASRIMRQLVAAVHFMHSRGVVHRDLKPENLLFSDPAGDNIKVVDFGF 521 (966)
Q Consensus 450 mEy~~gg~L~~~l~~~~--------~~~l~e~~~~~i~~Qil~aL~yLHs~~IiHRDLKP~NILl~~~~~~~iKL~DFGl 521 (966)
|||+++|+|.+++.+.. ...++...+..++.||+.||+|||+++|+||||||+|||+++ ++.+||+|||+
T Consensus 88 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dikp~nili~~--~~~~~L~Dfg~ 165 (288)
T cd05061 88 MELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNAKKFVHRDLAARNCMVAH--DFTVKIGDFGM 165 (288)
T ss_pred EeCCCCCCHHHHHHHhccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCcCCCCChheEEEcC--CCcEEECcCCc
Confidence 99999999999997532 123567889999999999999999999999999999999985 56899999999
Q ss_pred cccccCC-----CccccccccccCchhhccCCCCCCCcccchhhhhhhhhhhhcCCCCCCCcCcchhHHHHHHHHhc-CC
Q psy11767 522 ACLKRES-----LHTPCFTLQYAAPEVLRQDKSGYDENCDLWSLGVILVNVLRQDKSGYDENCDLWSLGVILYTMLC-GR 595 (966)
Q Consensus 522 a~~~~~~-----~~~~~gT~~Y~APEvl~~~~~~~~~~~Di~SlGvil~el~~~~~~~y~~~~DIWSlGvilyemlt-G~ 595 (966)
++..... .....++..|+|||.+.. ..++.++|+|||||++|+|++ |.
T Consensus 166 ~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~--------------------------~~~~~~~DvwslG~~l~el~~~~~ 219 (288)
T cd05061 166 TRDIYETDYYRKGGKGLLPVRWMAPESLKD--------------------------GVFTTSSDMWSFGVVLWEITSLAE 219 (288)
T ss_pred cccccccccccccCCCcccccccCHHHhcc--------------------------CCCChHhHHHHHHHHHHHHHhCCC
Confidence 8653221 112234678999998752 236778999999999999998 79
Q ss_pred CCCCCCCCchhHHHHHHHHHcCCCCCCchhhccCCHHHHHHHHHhcccCccccCChHHHHH
Q psy11767 596 VPFHARSRDDSALSIMARIKEGQFNFDAEAWSTVSSEAKELTKSLLTVNPAQRIRMMRVKL 656 (966)
Q Consensus 596 ~Pf~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~is~e~~~Li~~~L~~dP~~R~t~~~v~~ 656 (966)
.||.+.... .....+..+..... ....++++.+++.+||..||++|||+.++..
T Consensus 220 ~p~~~~~~~----~~~~~~~~~~~~~~---~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~ 273 (288)
T cd05061 220 QPYQGLSNE----QVLKFVMDGGYLDQ---PDNCPERVTDLMRMCWQFNPKMRPTFLEIVN 273 (288)
T ss_pred CCCCCCCHH----HHHHHHHcCCCCCC---CCCCCHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence 999865432 23344444432211 1245789999999999999999999988743
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta |
| >cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-34 Score=315.44 Aligned_cols=241 Identities=21% Similarity=0.364 Sum_probs=193.1
Q ss_pred cccccccccccccEEEEEEEc-----CCCcEEEEEEeccccC------hHHHHHHHHHhcCCCCceEEEEEEEeCCeEEE
Q psy11767 380 LDKAGILGDGSYSVCRRCVEK-----STGQEYAVKIISRKID------CSEEINLLRACQGHPNIVNLHCVFQDEVHTYL 448 (966)
Q Consensus 380 ~~~~~~LG~G~fG~Vy~a~~~-----~tg~~vAvK~i~~~~~------~~~Ei~iL~~l~~HpnIV~l~~~~~~~~~~~l 448 (966)
|+..+.||+|+||.||+|.+. .++..||+|++..... ..+|+.++..+ +||||+++++++.++...|+
T Consensus 7 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~ei~~l~~l-~h~~iv~~~~~~~~~~~~~l 85 (288)
T cd05050 7 IEYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEF-DHPNIVKLLGVCAVGKPMCL 85 (288)
T ss_pred ceecccccccccccEEEEEEcccCCCCcceeEEEEecCCCcCHHHHHHHHHHHHHHHhc-CCCchheEEEEEcCCCccEE
Confidence 445688999999999999875 3678999999865432 44688999888 59999999999999999999
Q ss_pred EEEccCCCCHHHHHHhcC--------------------CCCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCcEEEec
Q psy11767 449 VLELLKGGELLDRIRQKG--------------------RCGFTENEASRIMRQLVAAVHFMHSRGVVHRDLKPENLLFSD 508 (966)
Q Consensus 449 VmEy~~gg~L~~~l~~~~--------------------~~~l~e~~~~~i~~Qil~aL~yLHs~~IiHRDLKP~NILl~~ 508 (966)
||||+++|+|.+++.... ...+++.+++.++.||+.||+|||+++++||||||+|||+++
T Consensus 86 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~aL~~lH~~~i~H~dl~p~nil~~~ 165 (288)
T cd05050 86 LFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYLSERKFVHRDLATRNCLVGE 165 (288)
T ss_pred EEecCCCCCHHHHHHHcCccccccccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCCeecccccHhheEecC
Confidence 999999999999997532 124788999999999999999999999999999999999975
Q ss_pred CCCCCEEEEeecccccccCC-----CccccccccccCchhhccCCCCCCCcccchhhhhhhhhhhhcCCCCCCCcCcchh
Q psy11767 509 PAGDNIKVVDFGFACLKRES-----LHTPCFTLQYAAPEVLRQDKSGYDENCDLWSLGVILVNVLRQDKSGYDENCDLWS 583 (966)
Q Consensus 509 ~~~~~iKL~DFGla~~~~~~-----~~~~~gT~~Y~APEvl~~~~~~~~~~~Di~SlGvil~el~~~~~~~y~~~~DIWS 583 (966)
.+.+||+|||++...... ......++.|+|||++.. ..|+.++||||
T Consensus 166 --~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~--------------------------~~~~~~~Dv~s 217 (288)
T cd05050 166 --NMVVKIADFGLSRNIYSADYYKASENDAIPIRWMPPESIFY--------------------------NRYTTESDVWA 217 (288)
T ss_pred --CCceEECccccceecccCccccccCCCccChhhcCHHHHhc--------------------------CCCCchhHHHH
Confidence 568999999998643211 112234667999998742 23678899999
Q ss_pred HHHHHHHHhc-CCCCCCCCCCchhHHHHHHHHHcCCCCCCchhhccCCHHHHHHHHHhcccCccccCChHHHHH
Q psy11767 584 LGVILYTMLC-GRVPFHARSRDDSALSIMARIKEGQFNFDAEAWSTVSSEAKELTKSLLTVNPAQRIRMMRVKL 656 (966)
Q Consensus 584 lGvilyemlt-G~~Pf~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~is~e~~~Li~~~L~~dP~~R~t~~~v~~ 656 (966)
|||++|+|++ |..||.+.... .....+..+..... ...++.++.+||.+||+.||++|||+.++..
T Consensus 218 lG~il~el~~~~~~p~~~~~~~----~~~~~~~~~~~~~~---~~~~~~~l~~li~~~l~~~p~~Rpt~~el~~ 284 (288)
T cd05050 218 YGVVLWEIFSYGMQPYYGMAHE----EVIYYVRDGNVLSC---PDNCPLELYNLMRLCWSKLPSDRPSFASINR 284 (288)
T ss_pred HHHHHHHHHhCCCCCCCCCCHH----HHHHHHhcCCCCCC---CCCCCHHHHHHHHHHcccCcccCCCHHHHHH
Confidence 9999999997 88999765432 33445555543211 2356889999999999999999999998743
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M |
| >cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-34 Score=311.55 Aligned_cols=239 Identities=21% Similarity=0.404 Sum_probs=190.9
Q ss_pred cccccccccccEEEEEEEcCCCc---EEEEEEecccc------ChHHHHHHHHHhcCCCCceEEEEEEEeCCeEEEEEEc
Q psy11767 382 KAGILGDGSYSVCRRCVEKSTGQ---EYAVKIISRKI------DCSEEINLLRACQGHPNIVNLHCVFQDEVHTYLVLEL 452 (966)
Q Consensus 382 ~~~~LG~G~fG~Vy~a~~~~tg~---~vAvK~i~~~~------~~~~Ei~iL~~l~~HpnIV~l~~~~~~~~~~~lVmEy 452 (966)
..+.||+|+||.||+|.+..++. .||||++.... ....|+.+++.+ +||||+++++++.++...++||||
T Consensus 8 ~~~~lg~g~~g~vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l-~h~ni~~~~~~~~~~~~~~lv~e~ 86 (269)
T cd05065 8 IEEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQF-DHPNIIHLEGVVTKSRPVMIITEF 86 (269)
T ss_pred EEeEecCCCCCeEEEEEEecCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhC-CCcCcceEEEEECCCCceEEEEec
Confidence 46789999999999999987765 69999986542 234588999888 599999999999999999999999
Q ss_pred cCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCcEEEecCCCCCEEEEeecccccccCCCc--
Q psy11767 453 LKGGELLDRIRQKGRCGFTENEASRIMRQLVAAVHFMHSRGVVHRDLKPENLLFSDPAGDNIKVVDFGFACLKRESLH-- 530 (966)
Q Consensus 453 ~~gg~L~~~l~~~~~~~l~e~~~~~i~~Qil~aL~yLHs~~IiHRDLKP~NILl~~~~~~~iKL~DFGla~~~~~~~~-- 530 (966)
+++|+|.+++..... .+++.+++.++.|++.||+|||++|++||||||+|||++. ++.+||+|||++........
T Consensus 87 ~~~~~L~~~l~~~~~-~~~~~~~~~i~~~l~~al~~lH~~g~~H~dl~p~nili~~--~~~~kl~dfg~~~~~~~~~~~~ 163 (269)
T cd05065 87 MENGALDSFLRQNDG-QFTVIQLVGMLRGIAAGMKYLSEMNYVHRDLAARNILVNS--NLVCKVSDFGLSRFLEDDTSDP 163 (269)
T ss_pred CCCCcHHHHHhhCCC-CCCHHHHHHHHHHHHHHHHHHHHCCEeecccChheEEEcC--CCcEEECCCccccccccCcccc
Confidence 999999999876543 5899999999999999999999999999999999999974 56899999999865432111
Q ss_pred ---cc---cccccccCchhhccCCCCCCCcccchhhhhhhhhhhhcCCCCCCCcCcchhHHHHHHHHhc-CCCCCCCCCC
Q psy11767 531 ---TP---CFTLQYAAPEVLRQDKSGYDENCDLWSLGVILVNVLRQDKSGYDENCDLWSLGVILYTMLC-GRVPFHARSR 603 (966)
Q Consensus 531 ---~~---~gT~~Y~APEvl~~~~~~~~~~~Di~SlGvil~el~~~~~~~y~~~~DIWSlGvilyemlt-G~~Pf~~~~~ 603 (966)
.. ..+..|+|||++.. ..++.++||||+||++|||++ |..||...+.
T Consensus 164 ~~~~~~~~~~~~~y~~PE~~~~--------------------------~~~~~~~DvwslG~~l~e~l~~g~~p~~~~~~ 217 (269)
T cd05065 164 TYTSSLGGKIPIRWTAPEAIAY--------------------------RKFTSASDVWSYGIVMWEVMSYGERPYWDMSN 217 (269)
T ss_pred ccccccCCCcceeecCHhHhcc--------------------------CcccchhhhhhhHHHHHHHhcCCCCCCCCCCH
Confidence 11 12457999998752 236788999999999999886 9999976543
Q ss_pred chhHHHHHHHHHcCCCCCCchhhccCCHHHHHHHHHhcccCccccCChHHHHHH
Q psy11767 604 DDSALSIMARIKEGQFNFDAEAWSTVSSEAKELTKSLLTVNPAQRIRMMRVKLT 657 (966)
Q Consensus 604 ~~~~~~~~~~i~~~~~~~~~~~~~~is~e~~~Li~~~L~~dP~~R~t~~~v~~~ 657 (966)
. .....+... +..+ ....++.++.+++.+||..||++||++.++...
T Consensus 218 ~----~~~~~i~~~-~~~~--~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~ 264 (269)
T cd05065 218 Q----DVINAIEQD-YRLP--PPMDCPTALHQLMLDCWQKDRNARPKFGQIVST 264 (269)
T ss_pred H----HHHHHHHcC-CcCC--CcccCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 2 233344332 2211 224578899999999999999999999987543
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr |
| >cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-34 Score=319.57 Aligned_cols=240 Identities=25% Similarity=0.476 Sum_probs=194.5
Q ss_pred cccccccccEEEEEEEcCCCcEEEEEEecccc-----ChHHHHHHHHHhcCCCCceEEEEEEEeCCeEEEEEEccCCCCH
Q psy11767 384 GILGDGSYSVCRRCVEKSTGQEYAVKIISRKI-----DCSEEINLLRACQGHPNIVNLHCVFQDEVHTYLVLELLKGGEL 458 (966)
Q Consensus 384 ~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~-----~~~~Ei~iL~~l~~HpnIV~l~~~~~~~~~~~lVmEy~~gg~L 458 (966)
..||+|+||.||+|.+..+++.||||++.... ...+|+.+++.+ +||||++++++|..+...|+||||+++++|
T Consensus 27 ~~ig~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l-~hp~i~~~~~~~~~~~~~~iv~e~~~~~~L 105 (297)
T cd06659 27 IKIGEGSTGIVCIAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDY-QHQNVVEMYKSYLVGEELWVLMEFLQGGAL 105 (297)
T ss_pred hhcCCCCceeEEEEEEcCCCCEEEEEEEEecccchHHHHHHHHHHHHhC-CCCchhhhhhheeeCCeEEEEEecCCCCCH
Confidence 46999999999999999999999999986432 234688888888 599999999999999999999999999999
Q ss_pred HHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCcEEEecCCCCCEEEEeecccccccCC---Ccccccc
Q psy11767 459 LDRIRQKGRCGFTENEASRIMRQLVAAVHFMHSRGVVHRDLKPENLLFSDPAGDNIKVVDFGFACLKRES---LHTPCFT 535 (966)
Q Consensus 459 ~~~l~~~~~~~l~e~~~~~i~~Qil~aL~yLHs~~IiHRDLKP~NILl~~~~~~~iKL~DFGla~~~~~~---~~~~~gT 535 (966)
.+++... .+++..++.++.|++.||+|||++||+||||||+|||++. ++.+||+|||++...... ....+++
T Consensus 106 ~~~~~~~---~~~~~~~~~~~~qi~~~L~~LH~~~ivH~dl~p~Nill~~--~~~~kL~dfg~~~~~~~~~~~~~~~~~~ 180 (297)
T cd06659 106 TDIVSQT---RLNEEQIATVCESVLQALCYLHSQGVIHRDIKSDSILLTL--DGRVKLSDFGFCAQISKDVPKRKSLVGT 180 (297)
T ss_pred HHHHhhc---CCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHeEEcc--CCcEEEeechhHhhcccccccccceecC
Confidence 9887553 4899999999999999999999999999999999999975 568999999998644321 2345688
Q ss_pred ccccCchhhccCCCCCCCcccchhhhhhhhhhhhcCCCCCCCcCcchhHHHHHHHHhcCCCCCCCCCCchhHHHHHHHHH
Q psy11767 536 LQYAAPEVLRQDKSGYDENCDLWSLGVILVNVLRQDKSGYDENCDLWSLGVILYTMLCGRVPFHARSRDDSALSIMARIK 615 (966)
Q Consensus 536 ~~Y~APEvl~~~~~~~~~~~Di~SlGvil~el~~~~~~~y~~~~DIWSlGvilyemltG~~Pf~~~~~~~~~~~~~~~i~ 615 (966)
+.|+|||++.. ..++.++||||+||++|+|++|+.||...... ..+..+.
T Consensus 181 ~~y~aPE~~~~--------------------------~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~----~~~~~~~ 230 (297)
T cd06659 181 PYWMAPEVISR--------------------------TPYGTEVDIWSLGIMVIEMVDGEPPYFSDSPV----QAMKRLR 230 (297)
T ss_pred ccccCHHHHcc--------------------------CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH----HHHHHHh
Confidence 99999998852 23677899999999999999999999865432 2223333
Q ss_pred cCCCCCCchhhccCCHHHHHHHHHhcccCccccCChHHHHHHhhhhH
Q psy11767 616 EGQFNFDAEAWSTVSSEAKELTKSLLTVNPAQRIRMMRVKLTFHAFH 662 (966)
Q Consensus 616 ~~~~~~~~~~~~~is~e~~~Li~~~L~~dP~~R~t~~~v~~~~~~~~ 662 (966)
..... ....+..++.++.++|.+||+.+|++||++.++.. |+|.
T Consensus 231 ~~~~~-~~~~~~~~~~~l~~~i~~~l~~~P~~Rps~~~ll~--~~~~ 274 (297)
T cd06659 231 DSPPP-KLKNAHKISPVLRDFLERMLTREPQERATAQELLD--HPFL 274 (297)
T ss_pred ccCCC-CccccCCCCHHHHHHHHHHhcCCcccCcCHHHHhh--Chhh
Confidence 32211 12233467889999999999999999999997643 4444
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i |
| >PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-34 Score=315.06 Aligned_cols=237 Identities=29% Similarity=0.496 Sum_probs=187.4
Q ss_pred ccccccccccEEEEEEEc----CCCcEEEEEEecccc------ChHHHHHHHHHhcCCCCceEEEEEEEeCCeEEEEEEc
Q psy11767 383 AGILGDGSYSVCRRCVEK----STGQEYAVKIISRKI------DCSEEINLLRACQGHPNIVNLHCVFQDEVHTYLVLEL 452 (966)
Q Consensus 383 ~~~LG~G~fG~Vy~a~~~----~tg~~vAvK~i~~~~------~~~~Ei~iL~~l~~HpnIV~l~~~~~~~~~~~lVmEy 452 (966)
.+.||.|+||.||+|... ..+..||||+++... ...+|++.|+.+ +||||+++++++.+....++||||
T Consensus 4 ~~~ig~G~fg~v~~~~~~~~~~~~~~~V~vk~~~~~~~~~~~~~~~~e~~~l~~l-~h~ni~~~~g~~~~~~~~~lv~e~ 82 (259)
T PF07714_consen 4 IKQIGEGSFGKVYRAEWKQKDNDKNQPVAVKILKPSSSEEEEEEFLNEIQILRKL-RHPNIVKLYGFCIENEPLFLVMEY 82 (259)
T ss_dssp EEEEEEESSEEEEEEEEESTTTSSEEEEEEEEESTTSSHHHHHHHHHHHHHHHTH-SBTTBE-EEEEEESSSSEEEEEE-
T ss_pred eeEEccCCCcEEEEEEEEcccCCCCEEEEEEEeccccccccceeeeecccccccc-cccccccccccccccccccccccc
Confidence 467999999999999988 456789999995432 244688999888 799999999999988889999999
Q ss_pred cCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCcEEEecCCCCCEEEEeecccccccCC----
Q psy11767 453 LKGGELLDRIRQKGRCGFTENEASRIMRQLVAAVHFMHSRGVVHRDLKPENLLFSDPAGDNIKVVDFGFACLKRES---- 528 (966)
Q Consensus 453 ~~gg~L~~~l~~~~~~~l~e~~~~~i~~Qil~aL~yLHs~~IiHRDLKP~NILl~~~~~~~iKL~DFGla~~~~~~---- 528 (966)
|++|+|.++|.......+++.....++.||+.||.|||+++|+|+||+|+|||+++ ++.+||+|||++......
T Consensus 83 ~~~g~L~~~L~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~iiH~~l~~~nill~~--~~~~Kl~~f~~~~~~~~~~~~~ 160 (259)
T PF07714_consen 83 CPGGSLDDYLKSKNKEPLSEQQRLSIAIQIAEALSYLHSNNIIHGNLSPSNILLDS--NGQVKLSDFGLSRPISEKSKYK 160 (259)
T ss_dssp -TTEBHHHHHHHTCTTTSBHHHHHHHHHHHHHHHHHHHHTTEEEST-SGGGEEEET--TTEEEEESTTTGEETTTSSSEE
T ss_pred cccccccccccccccccccccccccccccccccccccccccccccccccccccccc--cccccccccccccccccccccc
Confidence 99999999999874457999999999999999999999999999999999999985 569999999999765211
Q ss_pred -CccccccccccCchhhccCCCCCCCcccchhhhhhhhhhhhcCCCCCCCcCcchhHHHHHHHHhc-CCCCCCCCCCchh
Q psy11767 529 -LHTPCFTLQYAAPEVLRQDKSGYDENCDLWSLGVILVNVLRQDKSGYDENCDLWSLGVILYTMLC-GRVPFHARSRDDS 606 (966)
Q Consensus 529 -~~~~~gT~~Y~APEvl~~~~~~~~~~~Di~SlGvil~el~~~~~~~y~~~~DIWSlGvilyemlt-G~~Pf~~~~~~~~ 606 (966)
.........|+|||.+... .++.++||||||+++|||++ |+.||...+.
T Consensus 161 ~~~~~~~~~~~~aPE~~~~~--------------------------~~~~ksDVysfG~~l~ei~~~~~~p~~~~~~--- 211 (259)
T PF07714_consen 161 NDSSQQLPLRYLAPEVLKDG--------------------------EYTKKSDVYSFGMLLYEILTLGKFPFSDYDN--- 211 (259)
T ss_dssp ESTTSESGGGGS-HHHHHHS--------------------------EESHHHHHHHHHHHHHHHHTTSSGTTTTSCH---
T ss_pred cccccccccccccccccccc--------------------------ccccccccccccccccccccccccccccccc---
Confidence 1223457789999998632 26789999999999999999 7899976533
Q ss_pred HHHHHHHHHcCCCCCCchhhccCCHHHHHHHHHhcccCccccCChHHHH
Q psy11767 607 ALSIMARIKEGQFNFDAEAWSTVSSEAKELTKSLLTVNPAQRIRMMRVK 655 (966)
Q Consensus 607 ~~~~~~~i~~~~~~~~~~~~~~is~e~~~Li~~~L~~dP~~R~t~~~v~ 655 (966)
..+...+.++.... ....++..+.++|.+||..||++||++.++.
T Consensus 212 -~~~~~~~~~~~~~~---~~~~~~~~~~~li~~C~~~~p~~RPs~~~i~ 256 (259)
T PF07714_consen 212 -EEIIEKLKQGQRLP---IPDNCPKDIYSLIQQCWSHDPEKRPSFQEIL 256 (259)
T ss_dssp -HHHHHHHHTTEETT---SBTTSBHHHHHHHHHHT-SSGGGS--HHHHH
T ss_pred -ccccccccccccce---eccchhHHHHHHHHHHcCCChhhCcCHHHHH
Confidence 23445555443322 2235788999999999999999999999874
|
Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A .... |
| >cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-34 Score=310.84 Aligned_cols=250 Identities=26% Similarity=0.444 Sum_probs=200.5
Q ss_pred cccccccccccccEEEEEEEcCCCcEEEEEEeccccC------hHHHHHHHHHhcCCCCceEEEEEEEeCCeEEEEEEcc
Q psy11767 380 LDKAGILGDGSYSVCRRCVEKSTGQEYAVKIISRKID------CSEEINLLRACQGHPNIVNLHCVFQDEVHTYLVLELL 453 (966)
Q Consensus 380 ~~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~~------~~~Ei~iL~~l~~HpnIV~l~~~~~~~~~~~lVmEy~ 453 (966)
|+..+.||.|+||.||+|.+..+++.||+|++..... ..+|+++++.+. ||||+++++.+..+...|+||||+
T Consensus 3 ~~~~~~ig~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~-~~~i~~~~~~~~~~~~~~lv~e~~ 81 (265)
T cd06605 3 LEYLGELGAGNSGVVSKVLHRPTGKIMAVKTIRLEINEAIQKQILRELDILHKCN-SPYIVGFYGAFYNNGDISICMEYM 81 (265)
T ss_pred chHHHHhcCCCCeEEEEEEEcCCCcEEEEEEEecccChHHHHHHHHHHHHHHHCC-CCchhhhheeeecCCEEEEEEEec
Confidence 3446789999999999999999999999999876532 346888888885 999999999999999999999999
Q ss_pred CCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHh-cCceeccCCCCcEEEecCCCCCEEEEeecccccccCC-Ccc
Q psy11767 454 KGGELLDRIRQKGRCGFTENEASRIMRQLVAAVHFMHS-RGVVHRDLKPENLLFSDPAGDNIKVVDFGFACLKRES-LHT 531 (966)
Q Consensus 454 ~gg~L~~~l~~~~~~~l~e~~~~~i~~Qil~aL~yLHs-~~IiHRDLKP~NILl~~~~~~~iKL~DFGla~~~~~~-~~~ 531 (966)
++++|.+++.... ..+++..+..++.|++.||+|||+ .|++||||||+||++++ ++.++|+|||++...... ...
T Consensus 82 ~~~~L~~~~~~~~-~~~~~~~~~~~~~~l~~~l~~lH~~~~i~H~dl~~~ni~~~~--~~~~~l~d~g~~~~~~~~~~~~ 158 (265)
T cd06605 82 DGGSLDKILKEVQ-GRIPERILGKIAVAVLKGLTYLHEKHKIIHRDVKPSNILVNS--RGQIKLCDFGVSGQLVNSLAKT 158 (265)
T ss_pred CCCcHHHHHHHcc-CCCCHHHHHHHHHHHHHHHHHHcCCCCeecCCCCHHHEEECC--CCCEEEeecccchhhHHHHhhc
Confidence 9999999997653 368999999999999999999999 99999999999999985 568999999998654321 122
Q ss_pred ccccccccCchhhccCCCCCCCcccchhhhhhhhhhhhcCCCCCCCcCcchhHHHHHHHHhcCCCCCCCCCC-chhHHHH
Q psy11767 532 PCFTLQYAAPEVLRQDKSGYDENCDLWSLGVILVNVLRQDKSGYDENCDLWSLGVILYTMLCGRVPFHARSR-DDSALSI 610 (966)
Q Consensus 532 ~~gT~~Y~APEvl~~~~~~~~~~~Di~SlGvil~el~~~~~~~y~~~~DIWSlGvilyemltG~~Pf~~~~~-~~~~~~~ 610 (966)
..++..|+|||++.. ..++.++|||||||++|+|++|+.||..... .+.....
T Consensus 159 ~~~~~~y~~PE~~~~--------------------------~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~ 212 (265)
T cd06605 159 FVGTSSYMAPERIQG--------------------------NDYSVKSDIWSLGLSLIELATGRFPYPPENDPPDGIFEL 212 (265)
T ss_pred ccCChhccCHHHHcC--------------------------CCCCchhhHHHHHHHHHHHHhCCCCCCccccccccHHHH
Confidence 567889999998852 2367889999999999999999999976532 1222333
Q ss_pred HHHHHcCCCCCCchhhccCCHHHHHHHHHhcccCccccCChHHHHHHhhhhHH
Q psy11767 611 MARIKEGQFNFDAEAWSTVSSEAKELTKSLLTVNPAQRIRMMRVKLTFHAFHQ 663 (966)
Q Consensus 611 ~~~i~~~~~~~~~~~~~~is~e~~~Li~~~L~~dP~~R~t~~~v~~~~~~~~~ 663 (966)
+..+..+...... ...++.++.++|.+||..||++|||+.++ ..|+|++
T Consensus 213 ~~~~~~~~~~~~~--~~~~~~~~~~li~~~l~~~p~~Rpt~~~l--l~~~~~~ 261 (265)
T cd06605 213 LQYIVNEPPPRLP--SGKFSPDFQDFVNLCLIKDPRERPSYKEL--LEHPFIK 261 (265)
T ss_pred HHHHhcCCCCCCC--hhhcCHHHHHHHHHHcCCCchhCcCHHHH--hhCchhh
Confidence 4444433221111 11278899999999999999999999876 4556653
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity |
| >cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-34 Score=315.46 Aligned_cols=245 Identities=30% Similarity=0.453 Sum_probs=194.0
Q ss_pred ccccccccccccEEEEEEEcCCCcEEEEEEecccc-------ChHHHHHHHHHhcCCCCceEEEEEEEeCCeEEEEEEcc
Q psy11767 381 DKAGILGDGSYSVCRRCVEKSTGQEYAVKIISRKI-------DCSEEINLLRACQGHPNIVNLHCVFQDEVHTYLVLELL 453 (966)
Q Consensus 381 ~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~-------~~~~Ei~iL~~l~~HpnIV~l~~~~~~~~~~~lVmEy~ 453 (966)
+..+.||.|++|.||+|.+..+|+.||||++.... ...+|+.+++.+ +||||+++++++.++...|+||||+
T Consensus 2 ~~~~~l~~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l-~~~~iv~~~~~~~~~~~~~iv~e~~ 80 (283)
T cd07835 2 QKVEKIGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTAIREISLLKEL-NHPNIVRLLDVVHSENKLYLVFEFL 80 (283)
T ss_pred chheEecCCCCeEEEEEEEcCCCCEEEEEEeecccccccchhHHHHHHHHHHhc-CCCCccCHhheeccCCeEEEEEecc
Confidence 34678999999999999999999999999986432 245699999988 4999999999999999999999999
Q ss_pred CCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCcEEEecCCCCCEEEEeecccccccCC---Cc
Q psy11767 454 KGGELLDRIRQKGRCGFTENEASRIMRQLVAAVHFMHSRGVVHRDLKPENLLFSDPAGDNIKVVDFGFACLKRES---LH 530 (966)
Q Consensus 454 ~gg~L~~~l~~~~~~~l~e~~~~~i~~Qil~aL~yLHs~~IiHRDLKP~NILl~~~~~~~iKL~DFGla~~~~~~---~~ 530 (966)
+++|.+++.......+++..+..++.|++.||+|||+++++||||+|+|||++. ++.++|+|||++...... ..
T Consensus 81 -~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~L~~lH~~~~~H~dl~p~nil~~~--~~~~~l~df~~~~~~~~~~~~~~ 157 (283)
T cd07835 81 -DLDLKKYMDSSPLTGLDPPLIKSYLYQLLQGIAYCHSHRVLHRDLKPQNLLIDR--EGALKLADFGLARAFGVPVRTYT 157 (283)
T ss_pred -CcCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCHHHEEEcC--CCcEEEeecccccccCCCccccC
Confidence 578999987765446899999999999999999999999999999999999985 569999999998654321 12
Q ss_pred cccccccccCchhhccCCCCCCCcccchhhhhhhhhhhhcCCCCCCCcCcchhHHHHHHHHhcCCCCCCCCCCchhHHHH
Q psy11767 531 TPCFTLQYAAPEVLRQDKSGYDENCDLWSLGVILVNVLRQDKSGYDENCDLWSLGVILYTMLCGRVPFHARSRDDSALSI 610 (966)
Q Consensus 531 ~~~gT~~Y~APEvl~~~~~~~~~~~Di~SlGvil~el~~~~~~~y~~~~DIWSlGvilyemltG~~Pf~~~~~~~~~~~~ 610 (966)
...+++.|+|||++.. ...++.++|||||||++|+|++|++||...+..+....+
T Consensus 158 ~~~~~~~~~aPE~~~~-------------------------~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~ 212 (283)
T cd07835 158 HEVVTLWYRAPEILLG-------------------------SRQYSTPVDIWSIGCIFAEMVNRRPLFPGDSEIDQLFRI 212 (283)
T ss_pred ccccccCCCCCceeec-------------------------CcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHH
Confidence 3456889999998742 123577899999999999999999999875543222222
Q ss_pred HHHHH---------------------cCCCCCCchhhccCCHHHHHHHHHhcccCccccCChHHH
Q psy11767 611 MARIK---------------------EGQFNFDAEAWSTVSSEAKELTKSLLTVNPAQRIRMMRV 654 (966)
Q Consensus 611 ~~~i~---------------------~~~~~~~~~~~~~is~e~~~Li~~~L~~dP~~R~t~~~v 654 (966)
+.... ...........+.++.++.++|.+||+.||++|||+.++
T Consensus 213 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~i 277 (283)
T cd07835 213 FRTLGTPDEDVWPGVTSLPDYKPTFPKWARQDLSKVVPNLDEDGLDLLSKMLVYDPAKRISAKAA 277 (283)
T ss_pred HHHhCCCChHHhhhhhhchhhhhhcccccccchhhhcCCCCHHHHHHHHHHhcCChhhCcCHHHH
Confidence 11100 000011112234678899999999999999999999876
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc |
| >cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-34 Score=310.79 Aligned_cols=234 Identities=21% Similarity=0.299 Sum_probs=181.6
Q ss_pred ccccccccEEEEEEEcC------------CCcEEEEEEeccccC-----hHHHHHHHHHhcCCCCceEEEEEEEeCCeEE
Q psy11767 385 ILGDGSYSVCRRCVEKS------------TGQEYAVKIISRKID-----CSEEINLLRACQGHPNIVNLHCVFQDEVHTY 447 (966)
Q Consensus 385 ~LG~G~fG~Vy~a~~~~------------tg~~vAvK~i~~~~~-----~~~Ei~iL~~l~~HpnIV~l~~~~~~~~~~~ 447 (966)
.||+|+||.||+|.... ....||+|.+..... ..+|+.+|+.+ +||||+++++++.++...+
T Consensus 2 ~lg~G~~~~vy~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~l~~l-~hp~iv~~~~~~~~~~~~~ 80 (262)
T cd05077 2 HLGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPSHRDISLAFFETASMMRQV-SHKHIVLLYGVCVRDVENI 80 (262)
T ss_pred ccccCCcceEeeeecccCCCccccccchhhceeEEEeecChhhhhHHHHHHHHHHHHHhC-CCCCEeeEEEEEecCCCCE
Confidence 58999999999998532 233689998764322 34577888777 5999999999999999999
Q ss_pred EEEEccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCcEEEecCCC-----CCEEEEeeccc
Q psy11767 448 LVLELLKGGELLDRIRQKGRCGFTENEASRIMRQLVAAVHFMHSRGVVHRDLKPENLLFSDPAG-----DNIKVVDFGFA 522 (966)
Q Consensus 448 lVmEy~~gg~L~~~l~~~~~~~l~e~~~~~i~~Qil~aL~yLHs~~IiHRDLKP~NILl~~~~~-----~~iKL~DFGla 522 (966)
+||||+++|+|..++.... ..+++..+..++.||+.||+|||++||+||||||+|||++.... ..+|++|||++
T Consensus 81 lv~e~~~~~~l~~~~~~~~-~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~Nill~~~~~~~~~~~~~~l~d~g~~ 159 (262)
T cd05077 81 MVEEFVEFGPLDLFMHRKS-DVLTTPWKFKVAKQLASALSYLEDKDLVHGNVCTKNILLAREGIDGECGPFIKLSDPGIP 159 (262)
T ss_pred EEEecccCCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHhhhCCeECCCCCcccEEEecCCccCCCCceeEeCCCCCC
Confidence 9999999999988886543 25899999999999999999999999999999999999974221 13899999998
Q ss_pred ccccCCCccccccccccCchhhccCCCCCCCcccchhhhhhhhhhhhcCCCCCCCcCcchhHHHHHHHHh-cCCCCCCCC
Q psy11767 523 CLKRESLHTPCFTLQYAAPEVLRQDKSGYDENCDLWSLGVILVNVLRQDKSGYDENCDLWSLGVILYTML-CGRVPFHAR 601 (966)
Q Consensus 523 ~~~~~~~~~~~gT~~Y~APEvl~~~~~~~~~~~Di~SlGvil~el~~~~~~~y~~~~DIWSlGvilyeml-tG~~Pf~~~ 601 (966)
..... .....++..|+|||++.. ...|+.++|||||||++|+|+ .|..||...
T Consensus 160 ~~~~~-~~~~~~~~~y~aPE~~~~-------------------------~~~~~~~~DiwslG~~l~el~~~~~~p~~~~ 213 (262)
T cd05077 160 ITVLS-RQECVERIPWIAPECVED-------------------------SKNLSIAADKWSFGTTLWEICYNGEIPLKDK 213 (262)
T ss_pred ccccC-cccccccccccChhhhcC-------------------------CCCCCchhHHHHHHHHHHHHHhCCCCCCCCc
Confidence 65432 233457888999998742 223678899999999999997 589998764
Q ss_pred CCchhHHHHHHHHHcCCCCCCchhhccCCHHHHHHHHHhcccCccccCChHHHH
Q psy11767 602 SRDDSALSIMARIKEGQFNFDAEAWSTVSSEAKELTKSLLTVNPAQRIRMMRVK 655 (966)
Q Consensus 602 ~~~~~~~~~~~~i~~~~~~~~~~~~~~is~e~~~Li~~~L~~dP~~R~t~~~v~ 655 (966)
...+ ......+.+... ...+.++.+||.+||..||.+||++.++.
T Consensus 214 ~~~~-----~~~~~~~~~~~~----~~~~~~~~~li~~cl~~dp~~Rp~~~~il 258 (262)
T cd05077 214 TLAE-----KERFYEGQCMLV----TPSCKELADLMTHCMNYDPNQRPFFRAIM 258 (262)
T ss_pred chhH-----HHHHHhcCccCC----CCChHHHHHHHHHHcCCChhhCcCHHHHH
Confidence 3221 122223332221 23467899999999999999999998874
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom |
| >cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-34 Score=321.63 Aligned_cols=244 Identities=21% Similarity=0.376 Sum_probs=192.8
Q ss_pred ccccccccccccEEEEEEEcCC-------CcEEEEEEecccc------ChHHHHHHHHHhcCCCCceEEEEEEEeCCeEE
Q psy11767 381 DKAGILGDGSYSVCRRCVEKST-------GQEYAVKIISRKI------DCSEEINLLRACQGHPNIVNLHCVFQDEVHTY 447 (966)
Q Consensus 381 ~~~~~LG~G~fG~Vy~a~~~~t-------g~~vAvK~i~~~~------~~~~Ei~iL~~l~~HpnIV~l~~~~~~~~~~~ 447 (966)
+..+.||+|+||.||+|.+... +..||+|++.... ...+|+++++.+.+||||+++++++.++...|
T Consensus 15 ~i~~~ig~G~~g~v~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~ 94 (334)
T cd05100 15 TLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLY 94 (334)
T ss_pred eecceeccccCCcEEEEEEeccCCccCCcceeEEEEEcccccCHHHHHHHHHHHHHHHhhcCCCCeeeeeEEEccCCceE
Confidence 3468899999999999986532 3479999886432 24468999998877999999999999999999
Q ss_pred EEEEccCCCCHHHHHHhcC--------------CCCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCcEEEecCCCCC
Q psy11767 448 LVLELLKGGELLDRIRQKG--------------RCGFTENEASRIMRQLVAAVHFMHSRGVVHRDLKPENLLFSDPAGDN 513 (966)
Q Consensus 448 lVmEy~~gg~L~~~l~~~~--------------~~~l~e~~~~~i~~Qil~aL~yLHs~~IiHRDLKP~NILl~~~~~~~ 513 (966)
+||||+++|+|.+++.+.. ...+++.++..++.||+.||+|||++||+||||||+|||+++ ++.
T Consensus 95 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~givH~dlkp~Nill~~--~~~ 172 (334)
T cd05100 95 VLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLASQKCIHRDLAARNVLVTE--DNV 172 (334)
T ss_pred EEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCCeeccccccceEEEcC--CCc
Confidence 9999999999999997642 124788899999999999999999999999999999999975 568
Q ss_pred EEEEeecccccccCC-----CccccccccccCchhhccCCCCCCCcccchhhhhhhhhhhhcCCCCCCCcCcchhHHHHH
Q psy11767 514 IKVVDFGFACLKRES-----LHTPCFTLQYAAPEVLRQDKSGYDENCDLWSLGVILVNVLRQDKSGYDENCDLWSLGVIL 588 (966)
Q Consensus 514 iKL~DFGla~~~~~~-----~~~~~gT~~Y~APEvl~~~~~~~~~~~Di~SlGvil~el~~~~~~~y~~~~DIWSlGvil 588 (966)
+||+|||+++..... .....++..|+|||++.. ..|+.++|||||||++
T Consensus 173 ~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~--------------------------~~~~~~~Di~slG~il 226 (334)
T cd05100 173 MKIADFGLARDVHNIDYYKKTTNGRLPVKWMAPEALFD--------------------------RVYTHQSDVWSFGVLL 226 (334)
T ss_pred EEECCcccceecccccccccccCCCcCceEcCHHHhcc--------------------------CCcCchhhhHHHHHHH
Confidence 999999998754321 112234567999998852 2367889999999999
Q ss_pred HHHhc-CCCCCCCCCCchhHHHHHHHHHcCCCCCCchhhccCCHHHHHHHHHhcccCccccCChHHHHHHhh
Q psy11767 589 YTMLC-GRVPFHARSRDDSALSIMARIKEGQFNFDAEAWSTVSSEAKELTKSLLTVNPAQRIRMMRVKLTFH 659 (966)
Q Consensus 589 yemlt-G~~Pf~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~is~e~~~Li~~~L~~dP~~R~t~~~v~~~~~ 659 (966)
|+|++ |..||.+.+.. .....+..+... +.....+.++.+|+.+||..+|++||++.++...+.
T Consensus 227 ~el~~~g~~p~~~~~~~----~~~~~~~~~~~~---~~~~~~~~~l~~li~~cl~~~p~~Rps~~ell~~l~ 291 (334)
T cd05100 227 WEIFTLGGSPYPGIPVE----ELFKLLKEGHRM---DKPANCTHELYMIMRECWHAVPSQRPTFKQLVEDLD 291 (334)
T ss_pred HHHHhcCCCCCCCCCHH----HHHHHHHcCCCC---CCCCCCCHHHHHHHHHHcccChhhCcCHHHHHHHHH
Confidence 99998 89999765432 233344443221 122356889999999999999999999998855443
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-34 Score=312.79 Aligned_cols=238 Identities=31% Similarity=0.528 Sum_probs=195.2
Q ss_pred ccccccccccccEEEEEEEcCCCcEEEEEEecccc--------ChHHHHHHHHHhcCCCCceEEEEEEEeCCeEEEEEEc
Q psy11767 381 DKAGILGDGSYSVCRRCVEKSTGQEYAVKIISRKI--------DCSEEINLLRACQGHPNIVNLHCVFQDEVHTYLVLEL 452 (966)
Q Consensus 381 ~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~--------~~~~Ei~iL~~l~~HpnIV~l~~~~~~~~~~~lVmEy 452 (966)
+..+.||.|+||.||+|.+..+++.||+|++.+.. ...+|+++++.+ +||||+++++++.++...|+||||
T Consensus 3 ~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~ 81 (258)
T cd05578 3 ELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQEL-NHPFLVNLWYSFQDEENMYLVVDL 81 (258)
T ss_pred eEEEEeccCCCceEEEEEEccCCcEEEEEEEehhhhcchhHHHHHHHHHHHHHhC-CCCChHHHHHhhcCCCeEEEEEeC
Confidence 44688999999999999999999999999986432 234688899888 699999999999999999999999
Q ss_pred cCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCcEEEecCCCCCEEEEeecccccccCC--Cc
Q psy11767 453 LKGGELLDRIRQKGRCGFTENEASRIMRQLVAAVHFMHSRGVVHRDLKPENLLFSDPAGDNIKVVDFGFACLKRES--LH 530 (966)
Q Consensus 453 ~~gg~L~~~l~~~~~~~l~e~~~~~i~~Qil~aL~yLHs~~IiHRDLKP~NILl~~~~~~~iKL~DFGla~~~~~~--~~ 530 (966)
+.|++|.+++.... .+++..+..++.||+.||+|||++||+|+||||+||++++ ++.++|+|||++...... ..
T Consensus 82 ~~~~~L~~~l~~~~--~l~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~nil~~~--~~~~~l~d~~~~~~~~~~~~~~ 157 (258)
T cd05578 82 LLGGDLRYHLSQKV--KFSEEQVKFWICEIVLALEYLHSKGIIHRDIKPDNILLDE--QGHVHITDFNIATKVTPDTLTT 157 (258)
T ss_pred CCCCCHHHHHHhcC--CcCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeEEcC--CCCEEEeecccccccCCCcccc
Confidence 99999999997763 6899999999999999999999999999999999999985 568999999998765432 23
Q ss_pred cccccccccCchhhccCCCCCCCcccchhhhhhhhhhhhcCCCCCCCcCcchhHHHHHHHHhcCCCCCCCCCCchhHHHH
Q psy11767 531 TPCFTLQYAAPEVLRQDKSGYDENCDLWSLGVILVNVLRQDKSGYDENCDLWSLGVILYTMLCGRVPFHARSRDDSALSI 610 (966)
Q Consensus 531 ~~~gT~~Y~APEvl~~~~~~~~~~~Di~SlGvil~el~~~~~~~y~~~~DIWSlGvilyemltG~~Pf~~~~~~~~~~~~ 610 (966)
...++..|+|||++.. ..++.++|+|||||++|+|++|..||...+... ....
T Consensus 158 ~~~~~~~y~~PE~~~~--------------------------~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~-~~~~ 210 (258)
T cd05578 158 STSGTPGYMAPEVLCR--------------------------QGYSVAVDWWSLGVTAYECLRGKRPYRGHSRTI-RDQI 210 (258)
T ss_pred ccCCChhhcCHHHHcc--------------------------cCCCCcccchhhHHHHHHHHhCCCCCCCCCccH-HHHH
Confidence 4567889999998852 226788999999999999999999998765421 1122
Q ss_pred HHHHHcCCCCCCchhhccCCHHHHHHHHHhcccCccccCCh--HHH
Q psy11767 611 MARIKEGQFNFDAEAWSTVSSEAKELTKSLLTVNPAQRIRM--MRV 654 (966)
Q Consensus 611 ~~~i~~~~~~~~~~~~~~is~e~~~Li~~~L~~dP~~R~t~--~~v 654 (966)
.......... ....++.++.++|.+||..||.+||+. .++
T Consensus 211 ~~~~~~~~~~----~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~l 252 (258)
T cd05578 211 RAKQETADVL----YPATWSTEAIDAINKLLERDPQKRLGDNLKDL 252 (258)
T ss_pred HHHhcccccc----CcccCcHHHHHHHHHHccCChhHcCCccHHHH
Confidence 2222222222 223578999999999999999999999 654
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. |
| >cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-34 Score=314.53 Aligned_cols=238 Identities=29% Similarity=0.547 Sum_probs=192.1
Q ss_pred ccccccccccccEEEEEEEc---CCCcEEEEEEecccc---------ChHHHHHHHHHhcCCCCceEEEEEEEeCCeEEE
Q psy11767 381 DKAGILGDGSYSVCRRCVEK---STGQEYAVKIISRKI---------DCSEEINLLRACQGHPNIVNLHCVFQDEVHTYL 448 (966)
Q Consensus 381 ~~~~~LG~G~fG~Vy~a~~~---~tg~~vAvK~i~~~~---------~~~~Ei~iL~~l~~HpnIV~l~~~~~~~~~~~l 448 (966)
+..+.||.|+||.||+|.+. .+|+.||+|++.... ...+|+.+|+.+.+|+||++++++|+.+...|+
T Consensus 3 ~~~~~lg~G~~g~v~~~~~~~~~~~g~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~l 82 (290)
T cd05613 3 ELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTDTKLHL 82 (290)
T ss_pred eeeeeeccCCcceEEEEEeccCCCCCceEEEEEeehhhhhhcchHHHHHHHHHHHHHhcccCCChhceeeEeecCCeEEE
Confidence 34678999999999999885 479999999986421 134689999998789999999999999999999
Q ss_pred EEEccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCcEEEecCCCCCEEEEeecccccccCC
Q psy11767 449 VLELLKGGELLDRIRQKGRCGFTENEASRIMRQLVAAVHFMHSRGVVHRDLKPENLLFSDPAGDNIKVVDFGFACLKRES 528 (966)
Q Consensus 449 VmEy~~gg~L~~~l~~~~~~~l~e~~~~~i~~Qil~aL~yLHs~~IiHRDLKP~NILl~~~~~~~iKL~DFGla~~~~~~ 528 (966)
||||+++++|.+++.... .+++..+..++.||+.||+|||+.|++||||||+|||++. ++.+||+|||++......
T Consensus 83 v~e~~~~~~L~~~l~~~~--~l~~~~~~~~~~qi~~al~~lH~~~i~H~dl~p~nil~~~--~~~~kl~dfg~~~~~~~~ 158 (290)
T cd05613 83 ILDYINGGELFTHLSQRE--RFKEQEVQIYSGEIVLALEHLHKLGIIYRDIKLENILLDS--NGHVVLTDFGLSKEFHED 158 (290)
T ss_pred EEecCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeEECC--CCCEEEeeCccceecccc
Confidence 999999999999997754 5899999999999999999999999999999999999975 568999999998654321
Q ss_pred ----CccccccccccCchhhccCCCCCCCcccchhhhhhhhhhhhcCCCCCCCcCcchhHHHHHHHHhcCCCCCCCCCCc
Q psy11767 529 ----LHTPCFTLQYAAPEVLRQDKSGYDENCDLWSLGVILVNVLRQDKSGYDENCDLWSLGVILYTMLCGRVPFHARSRD 604 (966)
Q Consensus 529 ----~~~~~gT~~Y~APEvl~~~~~~~~~~~Di~SlGvil~el~~~~~~~y~~~~DIWSlGvilyemltG~~Pf~~~~~~ 604 (966)
.....++..|+|||.+... ...++.++|||||||++|+|++|..||......
T Consensus 159 ~~~~~~~~~~~~~y~aPE~~~~~------------------------~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~ 214 (290)
T cd05613 159 EVERAYSFCGTIEYMAPDIVRGG------------------------DGGHDKAVDWWSMGVLMYELLTGASPFTVDGEK 214 (290)
T ss_pred cccccccccCCcccCChhhccCC------------------------CCCCCccccHHHHHHHHHHHhcCCCCCCcCCcc
Confidence 2234678999999987532 123577899999999999999999999754332
Q ss_pred hhHHHHHHHHHcCCCCCCchhhccCCHHHHHHHHHhcccCccccCC
Q psy11767 605 DSALSIMARIKEGQFNFDAEAWSTVSSEAKELTKSLLTVNPAQRIR 650 (966)
Q Consensus 605 ~~~~~~~~~i~~~~~~~~~~~~~~is~e~~~Li~~~L~~dP~~R~t 650 (966)
.....+...+......+ ...+++.+.+++.+||..||++|++
T Consensus 215 ~~~~~~~~~~~~~~~~~----~~~~~~~~~~ll~~~l~~~p~~R~~ 256 (290)
T cd05613 215 NSQAEISRRILKSEPPY----PQEMSALAKDIIQRLLMKDPKKRLG 256 (290)
T ss_pred ccHHHHHHHhhccCCCC----CccCCHHHHHHHHHHhcCCHHHhcC
Confidence 22233333333332222 2357889999999999999999984
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-34 Score=325.65 Aligned_cols=247 Identities=29% Similarity=0.512 Sum_probs=189.2
Q ss_pred ccccccccccccEEEEEEEcCCCcEEEEEEecccc-------ChHHHHHHHHHhcCCCCceEEEEEEEeC------CeEE
Q psy11767 381 DKAGILGDGSYSVCRRCVEKSTGQEYAVKIISRKI-------DCSEEINLLRACQGHPNIVNLHCVFQDE------VHTY 447 (966)
Q Consensus 381 ~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~-------~~~~Ei~iL~~l~~HpnIV~l~~~~~~~------~~~~ 447 (966)
+..+.||+|+||+||+|.+..+|+.||||++.+.. ...+|+.+++.+ +||||++++++|... .+.|
T Consensus 19 ~~~~~lg~g~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~~~~~~~ 97 (353)
T cd07850 19 QNLKPIGSGAQGIVCAAYDTVTGQNVAIKKLSRPFQNVTHAKRAYRELVLMKLV-NHKNIIGLLNVFTPQKSLEEFQDVY 97 (353)
T ss_pred EEEEEeccCCCEEEEEEEECCCCCEEEEEecCccccChhHHHHHHHHHHHHHhc-CCCCCcceeeeeccCCCccccCcEE
Confidence 34688999999999999999999999999986432 133689999888 599999999998644 3579
Q ss_pred EEEEccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCcEEEecCCCCCEEEEeecccccccC
Q psy11767 448 LVLELLKGGELLDRIRQKGRCGFTENEASRIMRQLVAAVHFMHSRGVVHRDLKPENLLFSDPAGDNIKVVDFGFACLKRE 527 (966)
Q Consensus 448 lVmEy~~gg~L~~~l~~~~~~~l~e~~~~~i~~Qil~aL~yLHs~~IiHRDLKP~NILl~~~~~~~iKL~DFGla~~~~~ 527 (966)
+||||+. ++|.+.+... +++..+..++.||+.||+|||++||+||||||+|||++. ++.+||+|||++.....
T Consensus 98 lv~e~~~-~~l~~~~~~~----l~~~~~~~~~~ql~~aL~~LH~~gi~H~dlkp~Nil~~~--~~~~kL~Dfg~~~~~~~ 170 (353)
T cd07850 98 LVMELMD-ANLCQVIQMD----LDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKS--DCTLKILDFGLARTAGT 170 (353)
T ss_pred EEEeccC-CCHHHHHhhc----CCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEECC--CCCEEEccCccceeCCC
Confidence 9999995 5888887542 899999999999999999999999999999999999975 56899999999976543
Q ss_pred C--CccccccccccCchhhccCCCCCCCcccchhhhhhhhhhhhcCCCCCCCcCcchhHHHHHHHHhcCCCCCCCCCCch
Q psy11767 528 S--LHTPCFTLQYAAPEVLRQDKSGYDENCDLWSLGVILVNVLRQDKSGYDENCDLWSLGVILYTMLCGRVPFHARSRDD 605 (966)
Q Consensus 528 ~--~~~~~gT~~Y~APEvl~~~~~~~~~~~Di~SlGvil~el~~~~~~~y~~~~DIWSlGvilyemltG~~Pf~~~~~~~ 605 (966)
. .....+|+.|+|||++.. ..++.++|||||||++|+|++|+.||...+..+
T Consensus 171 ~~~~~~~~~~~~y~aPE~~~~--------------------------~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~ 224 (353)
T cd07850 171 SFMMTPYVVTRYYRAPEVILG--------------------------MGYKENVDIWSVGCIMGEMIRGTVLFPGTDHID 224 (353)
T ss_pred CCCCCCCcccccccCHHHHhC--------------------------CCCCCchhhHhHHHHHHHHHHCCCCCCCCCHHH
Confidence 2 223457889999998852 246788999999999999999999998664322
Q ss_pred hHHHHHHHHHc------------------CCCC--------------CCc---hhhccCCHHHHHHHHHhcccCccccCC
Q psy11767 606 SALSIMARIKE------------------GQFN--------------FDA---EAWSTVSSEAKELTKSLLTVNPAQRIR 650 (966)
Q Consensus 606 ~~~~~~~~i~~------------------~~~~--------------~~~---~~~~~is~e~~~Li~~~L~~dP~~R~t 650 (966)
....++..+.. .... ++. ......++++.+||.+||+.||++|||
T Consensus 225 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t 304 (353)
T cd07850 225 QWNKIIEQLGTPSDEFMSRLQPTVRNYVENRPKYAGYSFEELFPDVLFPPDSESHNKLKASQARDLLSKMLVIDPEKRIS 304 (353)
T ss_pred HHHHHHHhcCCCCHHHHHHhhhhhhHHhhcCCCCCCcchhhhCcccccCcccccccccchhHHHHHHHHHcCCChhhCcC
Confidence 21111110000 0000 000 001134667899999999999999999
Q ss_pred hHHHHHHhhhhHH
Q psy11767 651 MMRVKLTFHAFHQ 663 (966)
Q Consensus 651 ~~~v~~~~~~~~~ 663 (966)
+.++ ..|+|..
T Consensus 305 ~~ei--L~~~~~~ 315 (353)
T cd07850 305 VDDA--LQHPYIN 315 (353)
T ss_pred HHHH--hcChhHh
Confidence 9976 3456543
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK |
| >cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-34 Score=310.86 Aligned_cols=238 Identities=26% Similarity=0.418 Sum_probs=189.0
Q ss_pred cccccccccccccEEEEEEEcCCCcEEEEEEecccc----------ChHHHHHHHHHhcCCCCceEEEEEEEeC--CeEE
Q psy11767 380 LDKAGILGDGSYSVCRRCVEKSTGQEYAVKIISRKI----------DCSEEINLLRACQGHPNIVNLHCVFQDE--VHTY 447 (966)
Q Consensus 380 ~~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~----------~~~~Ei~iL~~l~~HpnIV~l~~~~~~~--~~~~ 447 (966)
|...+.||+|+||.||+|.+..+|+.||||.+.... ...+|+.+|+.+ .||||+++++++.+. ..+|
T Consensus 4 ~~~~~~l~~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~~~~~~~~ 82 (265)
T cd06652 4 WRLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNL-LHERIVQYYGCLRDPMERTLS 82 (265)
T ss_pred ceEeeEEecCCceEEEEEEEcCCCcEEEEEEeecCcCCcccHHHHHHHHHHHHHHHhc-CCCCeeeEEeEeccCCCceEE
Confidence 344678999999999999999999999999875321 134588999888 599999999998764 5688
Q ss_pred EEEEccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCcEEEecCCCCCEEEEeecccccccC
Q psy11767 448 LVLELLKGGELLDRIRQKGRCGFTENEASRIMRQLVAAVHFMHSRGVVHRDLKPENLLFSDPAGDNIKVVDFGFACLKRE 527 (966)
Q Consensus 448 lVmEy~~gg~L~~~l~~~~~~~l~e~~~~~i~~Qil~aL~yLHs~~IiHRDLKP~NILl~~~~~~~iKL~DFGla~~~~~ 527 (966)
+||||++|++|.+++.+.. .+++..+..++.|++.||+|||+++|+|+||||+|||++. ++.++|+|||++.....
T Consensus 83 ~v~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dl~p~nil~~~--~~~~~l~Dfg~~~~~~~ 158 (265)
T cd06652 83 IFMEHMPGGSIKDQLKSYG--ALTENVTRKYTRQILEGVSYLHSNMIVHRDIKGANILRDS--VGNVKLGDFGASKRLQT 158 (265)
T ss_pred EEEEecCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEecC--CCCEEECcCcccccccc
Confidence 9999999999999997654 4899999999999999999999999999999999999974 56899999999865321
Q ss_pred ------CCccccccccccCchhhccCCCCCCCcccchhhhhhhhhhhhcCCCCCCCcCcchhHHHHHHHHhcCCCCCCCC
Q psy11767 528 ------SLHTPCFTLQYAAPEVLRQDKSGYDENCDLWSLGVILVNVLRQDKSGYDENCDLWSLGVILYTMLCGRVPFHAR 601 (966)
Q Consensus 528 ------~~~~~~gT~~Y~APEvl~~~~~~~~~~~Di~SlGvil~el~~~~~~~y~~~~DIWSlGvilyemltG~~Pf~~~ 601 (966)
......++..|+|||++.. ..++.++|||||||++|+|++|+.||...
T Consensus 159 ~~~~~~~~~~~~~~~~y~aPE~~~~--------------------------~~~~~~~Dv~slG~il~el~~g~~p~~~~ 212 (265)
T cd06652 159 ICLSGTGMKSVTGTPYWMSPEVISG--------------------------EGYGRKADIWSVGCTVVEMLTEKPPWAEF 212 (265)
T ss_pred ccccccccccCCCCccccChhhhcC--------------------------CCCCcchhHHHHHHHHHHHhhCCCCCCcc
Confidence 1223457889999998742 23577899999999999999999999764
Q ss_pred CCchhHHHHHHHHHcCCCCCCchhhccCCHHHHHHHHHhcccCccccCChHHHH
Q psy11767 602 SRDDSALSIMARIKEGQFNFDAEAWSTVSSEAKELTKSLLTVNPAQRIRMMRVK 655 (966)
Q Consensus 602 ~~~~~~~~~~~~i~~~~~~~~~~~~~~is~e~~~Li~~~L~~dP~~R~t~~~v~ 655 (966)
... ..+ ..+..... .+.....++..+.++|.+||. +|++||++.++.
T Consensus 213 ~~~---~~~-~~~~~~~~--~~~~~~~~~~~~~~~i~~~l~-~p~~Rp~~~~il 259 (265)
T cd06652 213 EAM---AAI-FKIATQPT--NPVLPPHVSDHCRDFLKRIFV-EAKLRPSADELL 259 (265)
T ss_pred chH---HHH-HHHhcCCC--CCCCchhhCHHHHHHHHHHhc-ChhhCCCHHHHh
Confidence 322 112 22222111 111223578889999999995 999999998763
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re |
| >cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-34 Score=321.77 Aligned_cols=248 Identities=21% Similarity=0.351 Sum_probs=188.8
Q ss_pred ccccc--cccEEEEEEEcCCCcEEEEEEeccccC-------hHHHHHHHHHhcCCCCceEEEEEEEeCCeEEEEEEccCC
Q psy11767 385 ILGDG--SYSVCRRCVEKSTGQEYAVKIISRKID-------CSEEINLLRACQGHPNIVNLHCVFQDEVHTYLVLELLKG 455 (966)
Q Consensus 385 ~LG~G--~fG~Vy~a~~~~tg~~vAvK~i~~~~~-------~~~Ei~iL~~l~~HpnIV~l~~~~~~~~~~~lVmEy~~g 455 (966)
.||+| +||+||+|.+..+|+.||||++..... ..+|+.+++.+ +||||++++++|..+...|+||||+.+
T Consensus 5 ~ig~g~~~~~~v~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l-~h~niv~~~~~~~~~~~~~~v~e~~~~ 83 (328)
T cd08226 5 EIGRGFCNLTSVYLARHTPTGTLVTVRITDLENCTEEHLKALQNEVVLSHFF-RHPNIMTSWTVFTTGSWLWVISPFMAY 83 (328)
T ss_pred HhCCcccCceeEEEEEEcCCCcEEEEEEeccccCCHHHHHHHHHHHHHHHhC-CCCCcceEeeeEecCCceEEEEecccC
Confidence 46666 999999999999999999999864321 23567766666 599999999999999999999999999
Q ss_pred CCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCcEEEecCCCCCEEEEeecccccccC---C----
Q psy11767 456 GELLDRIRQKGRCGFTENEASRIMRQLVAAVHFMHSRGVVHRDLKPENLLFSDPAGDNIKVVDFGFACLKRE---S---- 528 (966)
Q Consensus 456 g~L~~~l~~~~~~~l~e~~~~~i~~Qil~aL~yLHs~~IiHRDLKP~NILl~~~~~~~iKL~DFGla~~~~~---~---- 528 (966)
++|.+++.+.....+++..+..++.||+.||+|||++||+||||||+|||++. .+.+|++|||.+..... .
T Consensus 84 ~~l~~~l~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~ivHrDlkp~Nill~~--~~~~~~~~~~~~~~~~~~~~~~~~~ 161 (328)
T cd08226 84 GSANSLLKTYFPEGMSEALIGNILFGALRGLNYLHQNGYIHRNIKASHILISG--DGLVSLSGLSHLYSLVRNGQKAKVV 161 (328)
T ss_pred CCHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEeC--CCcEEEechHHHhhhhccCcccccc
Confidence 99999998765556999999999999999999999999999999999999985 56899999986532111 0
Q ss_pred ---CccccccccccCchhhccCCCCCCCcccchhhhhhhhhhhhcCCCCCCCcCcchhHHHHHHHHhcCCCCCCCCCCch
Q psy11767 529 ---LHTPCFTLQYAAPEVLRQDKSGYDENCDLWSLGVILVNVLRQDKSGYDENCDLWSLGVILYTMLCGRVPFHARSRDD 605 (966)
Q Consensus 529 ---~~~~~gT~~Y~APEvl~~~~~~~~~~~Di~SlGvil~el~~~~~~~y~~~~DIWSlGvilyemltG~~Pf~~~~~~~ 605 (966)
.....++..|+|||++... ...|+.++||||+||++|+|++|++||.......
T Consensus 162 ~~~~~~~~~~~~y~aPE~~~~~------------------------~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~ 217 (328)
T cd08226 162 YDFPQFSTSVLPWLSPELLRQD------------------------LYGYNVKSDIYSVGITACELATGRVPFQDMLRTQ 217 (328)
T ss_pred ccccccccCccCccChhhhcCC------------------------CCCCCchhhHHHHHHHHHHHHhCCCCCCCcChHH
Confidence 0112245679999998532 1246788999999999999999999998654322
Q ss_pred hHHHHHHHHHcCCC------------------------------------------CCCchhhccCCHHHHHHHHHhccc
Q psy11767 606 SALSIMARIKEGQF------------------------------------------NFDAEAWSTVSSEAKELTKSLLTV 643 (966)
Q Consensus 606 ~~~~~~~~i~~~~~------------------------------------------~~~~~~~~~is~e~~~Li~~~L~~ 643 (966)
.. ...+....+ ..........++++++||++||+.
T Consensus 218 ~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~ 294 (328)
T cd08226 218 ML---LQKLKGPPYSPLDITTFPCEESRMKNSQSGVDSGIGESVVAAGMTQTMTSERLRTPSSKTFSPAFQNLVELCLQQ 294 (328)
T ss_pred HH---HHHhcCCCCCCccccccchhhhhhccchhhhhcccccchhccccccccccccccchhhhhhhHHHHHHHHHHccC
Confidence 21 111111000 000111223577899999999999
Q ss_pred CccccCChHHHHHHhhhhHHh
Q psy11767 644 NPAQRIRMMRVKLTFHAFHQA 664 (966)
Q Consensus 644 dP~~R~t~~~v~~~~~~~~~~ 664 (966)
||++|||+.++ ..|+|+..
T Consensus 295 dP~~Rpta~e~--l~~~~~~~ 313 (328)
T cd08226 295 DPEKRPSASSL--LSHAFFKQ 313 (328)
T ss_pred CcccCCCHHHH--hhCHHHHH
Confidence 99999999976 34666543
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig |
| >cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-34 Score=317.36 Aligned_cols=242 Identities=25% Similarity=0.420 Sum_probs=186.2
Q ss_pred ccccccccccccEEEEEEEcCCCcEEEEEEecccc-------ChHHHHHHHHHhcCCCCceEEEEEEEeCC--------e
Q psy11767 381 DKAGILGDGSYSVCRRCVEKSTGQEYAVKIISRKI-------DCSEEINLLRACQGHPNIVNLHCVFQDEV--------H 445 (966)
Q Consensus 381 ~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~-------~~~~Ei~iL~~l~~HpnIV~l~~~~~~~~--------~ 445 (966)
+..+.||+|+||.||+|.+..+++.||||++.... ...+|+++++.+ .||||+++++++.... .
T Consensus 15 ~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~~~~~~~ 93 (310)
T cd07865 15 EKLAKIGQGTFGEVFKARHKKTKQIVALKKVLMENEKEGFPITALREIKILQLL-KHENVVNLIEICRTKATPYNRYKGS 93 (310)
T ss_pred EEEEEeecCCCEEEEEEEECCCCcEEEEEEEeccCCcCCchhHHHHHHHHHHhC-CCCCccceEEEEecccccccCCCce
Confidence 34688999999999999999999999999885432 134699999988 5999999999987654 4
Q ss_pred EEEEEEccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCcEEEecCCCCCEEEEeecccccc
Q psy11767 446 TYLVLELLKGGELLDRIRQKGRCGFTENEASRIMRQLVAAVHFMHSRGVVHRDLKPENLLFSDPAGDNIKVVDFGFACLK 525 (966)
Q Consensus 446 ~~lVmEy~~gg~L~~~l~~~~~~~l~e~~~~~i~~Qil~aL~yLHs~~IiHRDLKP~NILl~~~~~~~iKL~DFGla~~~ 525 (966)
.|+||||+. ++|.+.+.... ..+++.+++.++.||+.||+|||++||+||||||+|||++. ++.+||+|||++...
T Consensus 94 ~~lv~e~~~-~~l~~~l~~~~-~~~~~~~~~~i~~qi~~al~~lH~~~i~H~dl~p~nil~~~--~~~~kl~dfg~~~~~ 169 (310)
T cd07865 94 FYLVFEFCE-HDLAGLLSNKN-VKFTLSEIKKVMKMLLNGLYYIHRNKILHRDMKAANILITK--DGILKLADFGLARAF 169 (310)
T ss_pred EEEEEcCCC-cCHHHHHHhcc-cCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEECC--CCcEEECcCCCcccc
Confidence 599999995 58888886653 25899999999999999999999999999999999999975 568999999998654
Q ss_pred cCC-------CccccccccccCchhhccCCCCCCCcccchhhhhhhhhhhhcCCCCCCCcCcchhHHHHHHHHhcCCCCC
Q psy11767 526 RES-------LHTPCFTLQYAAPEVLRQDKSGYDENCDLWSLGVILVNVLRQDKSGYDENCDLWSLGVILYTMLCGRVPF 598 (966)
Q Consensus 526 ~~~-------~~~~~gT~~Y~APEvl~~~~~~~~~~~Di~SlGvil~el~~~~~~~y~~~~DIWSlGvilyemltG~~Pf 598 (966)
... .....++..|+|||++.. ...++.++||||+||++|+|++|++||
T Consensus 170 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~-------------------------~~~~~~~~Di~slG~~l~el~t~~~~~ 224 (310)
T cd07865 170 SLSKNSKPNRYTNRVVTLWYRPPELLLG-------------------------ERDYGPPIDMWGAGCIMAEMWTRSPIM 224 (310)
T ss_pred cCCcccCCCCccCcccCccccCcHHhcC-------------------------CcccCchhhhHHHHHHHHHHHhCCCCC
Confidence 321 123356788999998742 123567899999999999999999999
Q ss_pred CCCCCchhHHHHHHHHHcCCCC-----------------CCc--------hh-hccCCHHHHHHHHHhcccCccccCChH
Q psy11767 599 HARSRDDSALSIMARIKEGQFN-----------------FDA--------EA-WSTVSSEAKELTKSLLTVNPAQRIRMM 652 (966)
Q Consensus 599 ~~~~~~~~~~~~~~~i~~~~~~-----------------~~~--------~~-~~~is~e~~~Li~~~L~~dP~~R~t~~ 652 (966)
.+.+.... ...+..+.. .+. +.. .. ....+..+.+||.+||..||++|||+.
T Consensus 225 ~~~~~~~~-~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~dli~~~l~~~P~~R~t~~ 302 (310)
T cd07865 225 QGNTEQHQ-LTLISQLCG-SITPEVWPGVDKLELFKKMELPQGQKRKVKERLKPYVKDPHALDLIDKLLVLDPAKRIDAD 302 (310)
T ss_pred CCCCHHHH-HHHHHHHhC-CCChhhcccccchhhhhhccCCCccchhhHHhcccccCCHHHHHHHHHHhcCChhhccCHH
Confidence 87653221 222222211 000 000 00 012357788999999999999999998
Q ss_pred HH
Q psy11767 653 RV 654 (966)
Q Consensus 653 ~v 654 (966)
++
T Consensus 303 e~ 304 (310)
T cd07865 303 TA 304 (310)
T ss_pred HH
Confidence 76
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl |
| >cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-34 Score=312.49 Aligned_cols=238 Identities=24% Similarity=0.407 Sum_probs=188.5
Q ss_pred ccccccccEEEEEEEcCCC------cEEEEEEecccc------ChHHHHHHHHHhcCCCCceEEEEEEEeCCeEEEEEEc
Q psy11767 385 ILGDGSYSVCRRCVEKSTG------QEYAVKIISRKI------DCSEEINLLRACQGHPNIVNLHCVFQDEVHTYLVLEL 452 (966)
Q Consensus 385 ~LG~G~fG~Vy~a~~~~tg------~~vAvK~i~~~~------~~~~Ei~iL~~l~~HpnIV~l~~~~~~~~~~~lVmEy 452 (966)
.||+|+||.||+|.+...+ +.||||.+.... ...+|+.+|+.+ +||||+++++++.+....|+||||
T Consensus 2 ~lg~g~~g~vy~~~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~~v~e~ 80 (269)
T cd05044 2 FLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNF-NHPNIVKLLGVCLLNEPQYIIMEL 80 (269)
T ss_pred ccccccceeEEeeeecccccCcccceeehhhhhhcccchhhHHHHHHHHHHHHhc-CCCCeeeEeeeecCCCCeEEEEec
Confidence 5999999999999986544 789999886542 244688889888 599999999999999999999999
Q ss_pred cCCCCHHHHHHhcC-----CCCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCcEEEecCC---CCCEEEEeeccccc
Q psy11767 453 LKGGELLDRIRQKG-----RCGFTENEASRIMRQLVAAVHFMHSRGVVHRDLKPENLLFSDPA---GDNIKVVDFGFACL 524 (966)
Q Consensus 453 ~~gg~L~~~l~~~~-----~~~l~e~~~~~i~~Qil~aL~yLHs~~IiHRDLKP~NILl~~~~---~~~iKL~DFGla~~ 524 (966)
+++++|.+++.... ...+++.++..++.||+.||+|||+.+++|+||||+|||++... ...+||+|||++..
T Consensus 81 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dl~p~nil~~~~~~~~~~~~~l~dfg~~~~ 160 (269)
T cd05044 81 MEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYLEQMHFIHRDLAARNCLVSEKGYDADRVVKIGDFGLARD 160 (269)
T ss_pred cCCCcHHHHHHHhhhcccCCccccHHHHHHHHHHHHHHHHHHHhCCcccCCCChheEEEecCCCCCCcceEECCcccccc
Confidence 99999999997532 22478999999999999999999999999999999999998522 12799999999865
Q ss_pred ccCC-----CccccccccccCchhhccCCCCCCCcccchhhhhhhhhhhhcCCCCCCCcCcchhHHHHHHHHhc-CCCCC
Q psy11767 525 KRES-----LHTPCFTLQYAAPEVLRQDKSGYDENCDLWSLGVILVNVLRQDKSGYDENCDLWSLGVILYTMLC-GRVPF 598 (966)
Q Consensus 525 ~~~~-----~~~~~gT~~Y~APEvl~~~~~~~~~~~Di~SlGvil~el~~~~~~~y~~~~DIWSlGvilyemlt-G~~Pf 598 (966)
.... .....++..|+|||++.. ..++.++|||||||++|+|++ |..||
T Consensus 161 ~~~~~~~~~~~~~~~~~~y~aPE~~~~--------------------------~~~~~~~Dv~slG~il~ellt~g~~p~ 214 (269)
T cd05044 161 IYKSDYYRKEGEGLLPVRWMAPESLLD--------------------------GKFTTQSDVWSFGVLMWEILTLGQQPY 214 (269)
T ss_pred cccccccccCcccCCCccccCHHHHcc--------------------------CCcccchhHHHHHHHHHHHHHcCCCCC
Confidence 3221 112345678999998852 235788999999999999998 99999
Q ss_pred CCCCCchhHHHHHHHHHcCCCCCCchhhccCCHHHHHHHHHhcccCccccCChHHHHH
Q psy11767 599 HARSRDDSALSIMARIKEGQFNFDAEAWSTVSSEAKELTKSLLTVNPAQRIRMMRVKL 656 (966)
Q Consensus 599 ~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~is~e~~~Li~~~L~~dP~~R~t~~~v~~ 656 (966)
...... .....+..+... ..+..++.++.++|.+||..+|++||++.++..
T Consensus 215 ~~~~~~----~~~~~~~~~~~~---~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~ 265 (269)
T cd05044 215 PALNNQ----EVLQHVTAGGRL---QKPENCPDKIYQLMTNCWAQDPSERPTFDRIQE 265 (269)
T ss_pred cccCHH----HHHHHHhcCCcc---CCcccchHHHHHHHHHHcCCCcccCCCHHHHHH
Confidence 754422 233344333211 122457889999999999999999999998754
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male |
| >cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-34 Score=313.53 Aligned_cols=234 Identities=19% Similarity=0.278 Sum_probs=180.9
Q ss_pred ccccccccEEEEEEEcCC------------------------CcEEEEEEecccc-----ChHHHHHHHHHhcCCCCceE
Q psy11767 385 ILGDGSYSVCRRCVEKST------------------------GQEYAVKIISRKI-----DCSEEINLLRACQGHPNIVN 435 (966)
Q Consensus 385 ~LG~G~fG~Vy~a~~~~t------------------------g~~vAvK~i~~~~-----~~~~Ei~iL~~l~~HpnIV~ 435 (966)
.||+|+||.||+|....+ ...||+|++.... ...+|+.+++.+ +||||++
T Consensus 2 ~lG~G~~~~vy~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~~~~l-~h~niv~ 80 (274)
T cd05076 2 HLGQGTRTNIYDGRLRVEGGGEPEEDEMEDEDPLVEGNNNGRELRVVLKVLDPSHRDIALAFFETASLMSQV-SHIHLAF 80 (274)
T ss_pred CcCcccccceecceeEeccCCCCcccccccccccccccCCCeeeeEEEEecChHHHHHHHHHHHHHHHHhcC-CCCCeee
Confidence 599999999999975432 2358899886432 234577777776 5999999
Q ss_pred EEEEEEeCCeEEEEEEccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCcEEEecCC-----
Q psy11767 436 LHCVFQDEVHTYLVLELLKGGELLDRIRQKGRCGFTENEASRIMRQLVAAVHFMHSRGVVHRDLKPENLLFSDPA----- 510 (966)
Q Consensus 436 l~~~~~~~~~~~lVmEy~~gg~L~~~l~~~~~~~l~e~~~~~i~~Qil~aL~yLHs~~IiHRDLKP~NILl~~~~----- 510 (966)
+++++.++...|+||||+++|+|..++.+.. ..+++..+..++.||+.||+|||++||+||||||+|||++...
T Consensus 81 ~~~~~~~~~~~~lv~ey~~~g~L~~~l~~~~-~~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~Nill~~~~~~~~~ 159 (274)
T cd05076 81 VHGVCVRGSENIMVEEFVEHGPLDVCLRKEK-GRVPVAWKITVAQQLASALSYLEDKNLVHGNVCAKNILLARLGLAEGT 159 (274)
T ss_pred EEEEEEeCCceEEEEecCCCCcHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHcCCccCCCCCcccEEEeccCcccCc
Confidence 9999999999999999999999998886543 3689999999999999999999999999999999999997421
Q ss_pred CCCEEEEeecccccccCCCccccccccccCchhhccCCCCCCCcccchhhhhhhhhhhhcCCCCCCCcCcchhHHHHHHH
Q psy11767 511 GDNIKVVDFGFACLKRESLHTPCFTLQYAAPEVLRQDKSGYDENCDLWSLGVILVNVLRQDKSGYDENCDLWSLGVILYT 590 (966)
Q Consensus 511 ~~~iKL~DFGla~~~~~~~~~~~gT~~Y~APEvl~~~~~~~~~~~Di~SlGvil~el~~~~~~~y~~~~DIWSlGvilye 590 (966)
...+||+|||++...... ....++..|+|||.+... ..++.++|||||||++||
T Consensus 160 ~~~~kl~d~g~~~~~~~~-~~~~~~~~~~aPe~~~~~-------------------------~~~~~~~Dv~slG~~l~e 213 (274)
T cd05076 160 SPFIKLSDPGVSFTALSR-EERVERIPWIAPECVPGG-------------------------NSLSTAADKWSFGTTLLE 213 (274)
T ss_pred cceeeecCCccccccccc-cccccCCcccCchhhcCC-------------------------CCCCcHHHHHHHHHHHHH
Confidence 224899999998543221 233567889999987521 236788999999999999
Q ss_pred Hh-cCCCCCCCCCCchhHHHHHHHHHcCCCCCCchhhccCCHHHHHHHHHhcccCccccCChHHHH
Q psy11767 591 ML-CGRVPFHARSRDDSALSIMARIKEGQFNFDAEAWSTVSSEAKELTKSLLTVNPAQRIRMMRVK 655 (966)
Q Consensus 591 ml-tG~~Pf~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~is~e~~~Li~~~L~~dP~~R~t~~~v~ 655 (966)
|+ +|..||......+. .. .+ ......+ ...++++.++|.+||+.+|++||++.++.
T Consensus 214 l~~~g~~p~~~~~~~~~-~~---~~-~~~~~~~----~~~~~~~~~li~~cl~~~p~~Rps~~~il 270 (274)
T cd05076 214 ICFDGEVPLKERTPSEK-ER---FY-EKKHRLP----EPSCKELATLISQCLTYEPTQRPSFRTIL 270 (274)
T ss_pred HHhCCCCCccccChHHH-HH---HH-HhccCCC----CCCChHHHHHHHHHcccChhhCcCHHHHH
Confidence 94 79999987654321 11 11 1111211 23467899999999999999999998874
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt |
| >KOG4250|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-35 Score=338.72 Aligned_cols=240 Identities=30% Similarity=0.463 Sum_probs=185.9
Q ss_pred cccccccccEEEEEEEcCCCcEEEEEEeccccC------hHHHHHHHHHhcCCCCceEEEEEEEeCC------eEEEEEE
Q psy11767 384 GILGDGSYSVCRRCVEKSTGQEYAVKIISRKID------CSEEINLLRACQGHPNIVNLHCVFQDEV------HTYLVLE 451 (966)
Q Consensus 384 ~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~~------~~~Ei~iL~~l~~HpnIV~l~~~~~~~~------~~~lVmE 451 (966)
..||+||||.||+++++.||+.||||.+..... ..+|+++|+++. |||||+++++-++.. ...+|||
T Consensus 19 e~LG~Ga~g~V~rgrnketG~~vAvK~~~~~~~~r~~e~~~~EieilkKLn-h~NIVk~f~iee~~~~~~~~~~~vlvmE 97 (732)
T KOG4250|consen 19 ERLGKGAFGNVYRGRNKETGRLVAVKTFNKESSLRPRERWCREIEILKKLN-HPNIVKLFDIEETKFLGLVTRLPVLVME 97 (732)
T ss_pred hhhcCCccceeeeecccccccchhHHhhhhhcccchHHHHHHHHHHHHHcC-chhhhhhcccCCccccCcccccceEEEe
Confidence 579999999999999999999999999875321 346999999996 999999999877654 4689999
Q ss_pred ccCCCCHHHHHHhc-CCCCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCcEEEecCC--CCCEEEEeecccccccCC
Q psy11767 452 LLKGGELLDRIRQK-GRCGFTENEASRIMRQLVAAVHFMHSRGVVHRDLKPENLLFSDPA--GDNIKVVDFGFACLKRES 528 (966)
Q Consensus 452 y~~gg~L~~~l~~~-~~~~l~e~~~~~i~~Qil~aL~yLHs~~IiHRDLKP~NILl~~~~--~~~iKL~DFGla~~~~~~ 528 (966)
||.||+|...|.+- +..+|+|.+.+.++..++.||.|||++||+||||||.||++-... ..-.||+|||.|+...+.
T Consensus 98 yC~gGsL~~~L~~PEN~~GLpE~e~l~lL~d~~~al~~LrEn~IvHRDlKP~NIvl~~Gedgq~IyKLtDfG~Arel~d~ 177 (732)
T KOG4250|consen 98 YCSGGSLRKVLNSPENAYGLPESEFLDLLSDLVSALRHLRENGIVHRDLKPGNIVLQIGEDGQSIYKLTDFGAARELDDN 177 (732)
T ss_pred ecCCCcHHHHhcCcccccCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEeecCCCceEEeeecccccccCCCC
Confidence 99999999999752 234799999999999999999999999999999999999985432 234799999999876543
Q ss_pred --CccccccccccCchhhccCCCCCCCcccchhhhhhhhhhhhcCCCCCCCcCcchhHHHHHHHHhcCCCCCCCCCCchh
Q psy11767 529 --LHTPCFTLQYAAPEVLRQDKSGYDENCDLWSLGVILVNVLRQDKSGYDENCDLWSLGVILYTMLCGRVPFHARSRDDS 606 (966)
Q Consensus 529 --~~~~~gT~~Y~APEvl~~~~~~~~~~~Di~SlGvil~el~~~~~~~y~~~~DIWSlGvilyemltG~~Pf~~~~~~~~ 606 (966)
..+..||+.|.|||+... ...|+.-+|.|||||++|+++||.+||........
T Consensus 178 s~~~S~vGT~~YLhPel~E~-------------------------q~~y~~tVDLWS~GvtlY~caTG~lPF~p~~~pk~ 232 (732)
T KOG4250|consen 178 SLFTSLVGTEEYLHPELYER-------------------------QKKYTATVDLWSFGVTLYECATGELPFIPFGGPKN 232 (732)
T ss_pred CeeeeecCchhhcChHHHhh-------------------------ccCcCceeehhhhhhHHHHHhccCCCCCcCCCccc
Confidence 456789999999998752 23478889999999999999999999975443322
Q ss_pred HHHHHHHHHc---------------CCCCCCc--hhhccCCHH----HHHHHHHhcccCccccC
Q psy11767 607 ALSIMARIKE---------------GQFNFDA--EAWSTVSSE----AKELTKSLLTVNPAQRI 649 (966)
Q Consensus 607 ~~~~~~~i~~---------------~~~~~~~--~~~~~is~e----~~~Li~~~L~~dP~~R~ 649 (966)
...++..+.. |.+.+.. +....+++- +...+..+|..||++|-
T Consensus 233 ~~~~~~~~~tkkp~~v~i~~~~~eNgpv~~s~~lP~p~~Ls~~l~~~~~kwLa~~L~~~~~~~~ 296 (732)
T KOG4250|consen 233 NKEIMWHIITKKPSGVAIGAQEEENGPVEWSSTLPQPNHLSRGLATRLTKWLASMLEWNPRKRG 296 (732)
T ss_pred cchhhhhhhccCCCceeEeeecccCCceeeeccCCCcccccHHHHhhhhHHHHHHHhhhHHHhC
Confidence 2223322221 1111111 111233443 33568889999999996
|
|
| >cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-34 Score=307.38 Aligned_cols=241 Identities=35% Similarity=0.617 Sum_probs=195.0
Q ss_pred cccccccEEEEEEEcCCCcEEEEEEecccc--------ChHHHHHHHHHhcCCCCceEEEEEEEeCCeEEEEEEccCCCC
Q psy11767 386 LGDGSYSVCRRCVEKSTGQEYAVKIISRKI--------DCSEEINLLRACQGHPNIVNLHCVFQDEVHTYLVLELLKGGE 457 (966)
Q Consensus 386 LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~--------~~~~Ei~iL~~l~~HpnIV~l~~~~~~~~~~~lVmEy~~gg~ 457 (966)
||.|+||.||+|.+..+++.||+|++.+.. ...+|+.+++.+ +||||+++++.+.++...|+||||+++++
T Consensus 1 lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~~~ 79 (262)
T cd05572 1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEEC-NHPFIVKLYRTFKDKKYIYMLMEYCLGGE 79 (262)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEEehhcchhhhHHHHHHHHHHHHHhC-CCCCEeeeeeeEEcCCccEEEEecCCCCc
Confidence 799999999999999999999999986532 134588888888 69999999999999999999999999999
Q ss_pred HHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCcEEEecCCCCCEEEEeecccccccCC--Ccccccc
Q psy11767 458 LLDRIRQKGRCGFTENEASRIMRQLVAAVHFMHSRGVVHRDLKPENLLFSDPAGDNIKVVDFGFACLKRES--LHTPCFT 535 (966)
Q Consensus 458 L~~~l~~~~~~~l~e~~~~~i~~Qil~aL~yLHs~~IiHRDLKP~NILl~~~~~~~iKL~DFGla~~~~~~--~~~~~gT 535 (966)
|.+++.+.. .+++..+..++.||+.||+|||+++++|+||||+||+++. ++.++|+|||++...... .....++
T Consensus 80 L~~~l~~~~--~l~~~~~~~~~~~i~~~l~~lH~~~~~h~dl~~~nilv~~--~~~~~l~df~~~~~~~~~~~~~~~~~~ 155 (262)
T cd05572 80 LWTILRDRG--LFDEYTARFYIACVVLAFEYLHNRGIIYRDLKPENLLLDS--NGYVKLVDFGFAKKLKSGQKTWTFCGT 155 (262)
T ss_pred HHHHHhhcC--CCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCHHHEEEcC--CCCEEEeeCCcccccCcccccccccCC
Confidence 999997654 4899999999999999999999999999999999999975 568999999998765432 2334678
Q ss_pred ccccCchhhccCCCCCCCcccchhhhhhhhhhhhcCCCCCCCcCcchhHHHHHHHHhcCCCCCCCCCCchhHHHHHHHHH
Q psy11767 536 LQYAAPEVLRQDKSGYDENCDLWSLGVILVNVLRQDKSGYDENCDLWSLGVILYTMLCGRVPFHARSRDDSALSIMARIK 615 (966)
Q Consensus 536 ~~Y~APEvl~~~~~~~~~~~Di~SlGvil~el~~~~~~~y~~~~DIWSlGvilyemltG~~Pf~~~~~~~~~~~~~~~i~ 615 (966)
+.|+|||.+.. ..++.++|+||+||++|+|++|..||.....+ ....+..+.
T Consensus 156 ~~~~~PE~~~~--------------------------~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~--~~~~~~~~~ 207 (262)
T cd05572 156 PEYVAPEIILN--------------------------KGYDFSVDYWSLGILLYELLTGRPPFGEDDED--PMEIYNDIL 207 (262)
T ss_pred cCccChhHhcC--------------------------CCCCChhhhhhhHHHHHHHHhCCCCcCCCCCC--HHHHHHHHh
Confidence 89999998742 23677899999999999999999999866532 223344444
Q ss_pred cCCCCCCchhhccCCHHHHHHHHHhcccCccccCC-----hHHHHHHhhhhHH
Q psy11767 616 EGQFNFDAEAWSTVSSEAKELTKSLLTVNPAQRIR-----MMRVKLTFHAFHQ 663 (966)
Q Consensus 616 ~~~~~~~~~~~~~is~e~~~Li~~~L~~dP~~R~t-----~~~v~~~~~~~~~ 663 (966)
.+..... .....++++.++|.+||..||++|++ +.++ ..|+|+.
T Consensus 208 ~~~~~~~--~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~~~~l--~~~~~~~ 256 (262)
T cd05572 208 KGNGKLE--FPNYIDKAAKDLIKQLLRRNPEERLGNLKGGIKDI--KKHKWFN 256 (262)
T ss_pred ccCCCCC--CCcccCHHHHHHHHHHccCChhhCcCCcccCHHHH--hcChhhh
Confidence 2221111 11234889999999999999999999 4443 4566654
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi |
| >KOG1026|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-35 Score=343.11 Aligned_cols=245 Identities=25% Similarity=0.421 Sum_probs=206.2
Q ss_pred ccccccccccEEEEEEEcC-----CCcEEEEEEecccc------ChHHHHHHHHHhcCCCCceEEEEEEEeCCeEEEEEE
Q psy11767 383 AGILGDGSYSVCRRCVEKS-----TGQEYAVKIISRKI------DCSEEINLLRACQGHPNIVNLHCVFQDEVHTYLVLE 451 (966)
Q Consensus 383 ~~~LG~G~fG~Vy~a~~~~-----tg~~vAvK~i~~~~------~~~~Ei~iL~~l~~HpnIV~l~~~~~~~~~~~lVmE 451 (966)
...||+|+||+||+|+-.. +.+.||||.++... ++.+|+++|..+ +|||||+|++++..+..+|+|+|
T Consensus 491 ~~eLGegaFGkVf~a~~~~l~p~~~~~lVAVK~LKd~a~~~~~~dF~REaeLla~l-~H~nIVrLlGVC~~~~P~~MvFE 569 (774)
T KOG1026|consen 491 KEELGEGAFGKVFLAEAYGLLPGQDEQLVAVKALKDKAENQARQDFRREAELLAEL-QHPNIVRLLGVCREGDPLCMVFE 569 (774)
T ss_pred hhhhcCchhhhhhhhhccCCCCCccceehhHhhhcccccHHHHHHHHHHHHHHHhc-cCCCeEEEEEEEccCCeeEEEEE
Confidence 5689999999999997653 34689999997654 467899999998 59999999999999999999999
Q ss_pred ccCCCCHHHHHHhcCC------------CCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCcEEEecCCCCCEEEEee
Q psy11767 452 LLKGGELLDRIRQKGR------------CGFTENEASRIMRQLVAAVHFMHSRGVVHRDLKPENLLFSDPAGDNIKVVDF 519 (966)
Q Consensus 452 y~~gg~L~~~l~~~~~------------~~l~e~~~~~i~~Qil~aL~yLHs~~IiHRDLKP~NILl~~~~~~~iKL~DF 519 (966)
||..|||.++|+.+.. ..|+..+.+.|+.||+.|++||-++.+|||||-..|+|+++ +-.|||+||
T Consensus 570 Ym~~GDL~eFLra~sP~a~~~~~g~~~~~~L~~~q~L~iA~QIAaGM~YLs~~~FVHRDLATRNCLVge--~l~VKIsDf 647 (774)
T KOG1026|consen 570 YMDHGDLHEFLRARSPKADKLASGQDTPPPLSTSQFLHIATQIAAGMEYLSSHHFVHRDLATRNCLVGE--NLVVKISDF 647 (774)
T ss_pred ecccccHHHHHHhhCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCcccccchhhhhceecc--ceEEEeccc
Confidence 9999999999976432 23889999999999999999999999999999999999985 568999999
Q ss_pred cccccccC-CCc----cccccccccCchhhccCCCCCCCcccchhhhhhhhhhhhcCCCCCCCcCcchhHHHHHHHHhc-
Q psy11767 520 GFACLKRE-SLH----TPCFTLQYAAPEVLRQDKSGYDENCDLWSLGVILVNVLRQDKSGYDENCDLWSLGVILYTMLC- 593 (966)
Q Consensus 520 Gla~~~~~-~~~----~~~gT~~Y~APEvl~~~~~~~~~~~Di~SlGvil~el~~~~~~~y~~~~DIWSlGvilyemlt- 593 (966)
||++..-. +.. .......|||||.|..++ |++++||||+||+|||+++
T Consensus 648 GLsRdiYssDYYk~~~~t~lPIRWMppEsIly~k--------------------------FTteSDVWs~GVvLWEIFsy 701 (774)
T KOG1026|consen 648 GLSRDIYSSDYYKVRGNTLLPIRWMPPESILYGK--------------------------FTTESDVWSFGVVLWEIFSY 701 (774)
T ss_pred ccchhhhhhhhhcccCCceeeeecCCHHHhhcCc--------------------------ccchhhhhhhhhhhhhhhcc
Confidence 99975421 111 223367899999997543 7899999999999999986
Q ss_pred CCCCCCCCCCchhHHHHHHHHHcCCCCCCchhhccCCHHHHHHHHHhcccCccccCChHHHHHHhhhhHH
Q psy11767 594 GRVPFHARSRDDSALSIMARIKEGQFNFDAEAWSTVSSEAKELTKSLLTVNPAQRIRMMRVKLTFHAFHQ 663 (966)
Q Consensus 594 G~~Pf~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~is~e~~~Li~~~L~~dP~~R~t~~~v~~~~~~~~~ 663 (966)
|+-||.+.+.. ++++.|.+|.. +. ...+.+.++-+||..||..+|++||++.++...+..+..
T Consensus 702 G~QPy~glSn~----EVIe~i~~g~l-L~--~Pe~CP~~vY~LM~~CW~~~P~~RPsF~eI~~~L~~~~~ 764 (774)
T KOG1026|consen 702 GKQPYYGLSNQ----EVIECIRAGQL-LS--CPENCPTEVYSLMLECWNENPKRRPSFKEIHSRLQAWAQ 764 (774)
T ss_pred ccCcccccchH----HHHHHHHcCCc-cc--CCCCCCHHHHHHHHHHhhcCcccCCCHHHHHHHHHHHHh
Confidence 99999988754 56788888887 22 234688999999999999999999999999776665543
|
|
| >cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-34 Score=307.28 Aligned_cols=238 Identities=21% Similarity=0.334 Sum_probs=183.4
Q ss_pred ccccccccEEEEEEEcC---CCcEEEEEEecccc------ChHHHHHHHHHhcCCCCceEEEEEEE-eCCeEEEEEEccC
Q psy11767 385 ILGDGSYSVCRRCVEKS---TGQEYAVKIISRKI------DCSEEINLLRACQGHPNIVNLHCVFQ-DEVHTYLVLELLK 454 (966)
Q Consensus 385 ~LG~G~fG~Vy~a~~~~---tg~~vAvK~i~~~~------~~~~Ei~iL~~l~~HpnIV~l~~~~~-~~~~~~lVmEy~~ 454 (966)
.||+|+||.||+|.+.. .+..||||.+.... ...+|+.+++.+ +||||+++++++. .+...|+||||+.
T Consensus 2 ~lg~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~~lv~e~~~ 80 (262)
T cd05058 2 VIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDF-SHPNVLSLLGICLPSEGSPLVVLPYMK 80 (262)
T ss_pred cccccCCceEEEEEEecCCCceEEEEEEecCccCCHHHHHHHHHHHHHHccC-CCCCcceEEEEeecCCCCcEEEEecCC
Confidence 68999999999998754 34689999985432 234588888877 6999999999765 4566899999999
Q ss_pred CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCcEEEecCCCCCEEEEeecccccccCC------
Q psy11767 455 GGELLDRIRQKGRCGFTENEASRIMRQLVAAVHFMHSRGVVHRDLKPENLLFSDPAGDNIKVVDFGFACLKRES------ 528 (966)
Q Consensus 455 gg~L~~~l~~~~~~~l~e~~~~~i~~Qil~aL~yLHs~~IiHRDLKP~NILl~~~~~~~iKL~DFGla~~~~~~------ 528 (966)
+|+|.+++.+... .+++..+..++.||+.||+|||+.+|+||||||+|||+++ .+.+||+|||+++.....
T Consensus 81 ~~~L~~~~~~~~~-~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlk~~nili~~--~~~~kl~dfg~~~~~~~~~~~~~~ 157 (262)
T cd05058 81 HGDLRNFIRSETH-NPTVKDLIGFGLQVAKGMEYLASKKFVHRDLAARNCMLDE--SFTVKVADFGLARDIYDKEYYSVH 157 (262)
T ss_pred CCCHHHHHHhcCC-CCCHHHHHHHHHHHHHHHHHHHhCCccccccCcceEEEcC--CCcEEECCccccccccCCcceeec
Confidence 9999999976543 4678888999999999999999999999999999999985 568999999998653221
Q ss_pred -CccccccccccCchhhccCCCCCCCcccchhhhhhhhhhhhcCCCCCCCcCcchhHHHHHHHHhcC-CCCCCCCCCchh
Q psy11767 529 -LHTPCFTLQYAAPEVLRQDKSGYDENCDLWSLGVILVNVLRQDKSGYDENCDLWSLGVILYTMLCG-RVPFHARSRDDS 606 (966)
Q Consensus 529 -~~~~~gT~~Y~APEvl~~~~~~~~~~~Di~SlGvil~el~~~~~~~y~~~~DIWSlGvilyemltG-~~Pf~~~~~~~~ 606 (966)
.....+++.|+|||++.. ..++.++|||||||++|+|++| .+||.....
T Consensus 158 ~~~~~~~~~~y~aPE~~~~--------------------------~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~--- 208 (262)
T cd05058 158 NHTGAKLPVKWMALESLQT--------------------------QKFTTKSDVWSFGVLLWELMTRGAPPYPDVDS--- 208 (262)
T ss_pred ccccCcCCccccChhHhcc--------------------------CccchHHHHHHHHHHHHHHHcCCCCCCCCCCH---
Confidence 112345678999998742 2367789999999999999995 666754332
Q ss_pred HHHHHHHHHcCCCCCCchhhccCCHHHHHHHHHhcccCccccCChHHHHHHhh
Q psy11767 607 ALSIMARIKEGQFNFDAEAWSTVSSEAKELTKSLLTVNPAQRIRMMRVKLTFH 659 (966)
Q Consensus 607 ~~~~~~~i~~~~~~~~~~~~~~is~e~~~Li~~~L~~dP~~R~t~~~v~~~~~ 659 (966)
......+..+..... ...+++.+.+++.+||..+|++||++.++...+.
T Consensus 209 -~~~~~~~~~~~~~~~---~~~~~~~~~~li~~cl~~~p~~Rp~~~~il~~l~ 257 (262)
T cd05058 209 -FDITVYLLQGRRLLQ---PEYCPDPLYEVMLSCWHPKPEMRPTFSELVSRIE 257 (262)
T ss_pred -HHHHHHHhcCCCCCC---CCcCCHHHHHHHHHHcCCChhhCCCHHHHHHHHH
Confidence 223334444332111 1246789999999999999999999998865444
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca |
| >PHA03210 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-34 Score=341.92 Aligned_cols=259 Identities=21% Similarity=0.292 Sum_probs=184.5
Q ss_pred ccceecccccccccccccccccccEEEEEEEcCCC-cEEEEEE--------------ecc----c----cChHHHHHHHH
Q psy11767 369 GSLFFEQYDMDLDKAGILGDGSYSVCRRCVEKSTG-QEYAVKI--------------ISR----K----IDCSEEINLLR 425 (966)
Q Consensus 369 G~~~~~~~~i~~~~~~~LG~G~fG~Vy~a~~~~tg-~~vAvK~--------------i~~----~----~~~~~Ei~iL~ 425 (966)
+..+.++|.+ ++.||+|+||+||+|..+... ..+++|. +.+ . ....+|+.+|+
T Consensus 143 ~~~~~~~Y~i----i~~LG~G~fG~Vyl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~Ei~il~ 218 (501)
T PHA03210 143 DDEFLAHFRV----IDDLPAGAFGKIFICALRASTEEAEARRGVNSTNQGKPKCERLIAKRVKAGSRAAIQLENEILALG 218 (501)
T ss_pred chhhhhccEE----EeEecCCCCcceEEEEEeccchhhhhhhccccccccchhhhhhHhHHhhcchHHHHHHHHHHHHHH
Confidence 3445556655 788999999999999765432 2222221 111 1 11356999999
Q ss_pred HhcCCCCceEEEEEEEeCCeEEEEEEccCCCCHHHHHHhcC---CCCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCC
Q psy11767 426 ACQGHPNIVNLHCVFQDEVHTYLVLELLKGGELLDRIRQKG---RCGFTENEASRIMRQLVAAVHFMHSRGVVHRDLKPE 502 (966)
Q Consensus 426 ~l~~HpnIV~l~~~~~~~~~~~lVmEy~~gg~L~~~l~~~~---~~~l~e~~~~~i~~Qil~aL~yLHs~~IiHRDLKP~ 502 (966)
.+ +|||||++++++.++...|+|||++ +++|.+++.... .......+++.|+.||+.||+|||++|||||||||+
T Consensus 219 ~l-~HpnIv~l~~~~~~~~~~~lv~e~~-~~~l~~~l~~~~~~~~~~~~~~~~~~i~~ql~~aL~yLH~~gIiHrDLKP~ 296 (501)
T PHA03210 219 RL-NHENILKIEEILRSEANTYMITQKY-DFDLYSFMYDEAFDWKDRPLLKQTRAIMKQLLCAVEYIHDKKLIHRDIKLE 296 (501)
T ss_pred hC-CCCCcCcEeEEEEECCeeEEEEecc-ccCHHHHHhhccccccccccHHHHHHHHHHHHHHHHHHHhCCeecCCCCHH
Confidence 98 5999999999999999999999998 568888775432 112346778899999999999999999999999999
Q ss_pred cEEEecCCCCCEEEEeecccccccCC----CccccccccccCchhhccCCCCCCCcccchhhhhhhhhhhhcCCCCCCCc
Q psy11767 503 NLLFSDPAGDNIKVVDFGFACLKRES----LHTPCFTLQYAAPEVLRQDKSGYDENCDLWSLGVILVNVLRQDKSGYDEN 578 (966)
Q Consensus 503 NILl~~~~~~~iKL~DFGla~~~~~~----~~~~~gT~~Y~APEvl~~~~~~~~~~~Di~SlGvil~el~~~~~~~y~~~ 578 (966)
|||++. .+.+||+|||+++..... ....+||+.|+|||++.. ..|+.+
T Consensus 297 NILl~~--~~~vkL~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~--------------------------~~~~~~ 348 (501)
T PHA03210 297 NIFLNC--DGKIVLGDFGTAMPFEKEREAFDYGWVGTVATNSPEILAG--------------------------DGYCEI 348 (501)
T ss_pred HEEECC--CCCEEEEeCCCceecCcccccccccccCCcCCCCchhhcC--------------------------CCCCcH
Confidence 999975 568999999999765432 224578999999999852 247788
Q ss_pred CcchhHHHHHHHHhcCCCCCCCCCCchhHHHHHHHHHc---CCCCCCc----------------------h--hhccCCH
Q psy11767 579 CDLWSLGVILYTMLCGRVPFHARSRDDSALSIMARIKE---GQFNFDA----------------------E--AWSTVSS 631 (966)
Q Consensus 579 ~DIWSlGvilyemltG~~Pf~~~~~~~~~~~~~~~i~~---~~~~~~~----------------------~--~~~~is~ 631 (966)
+|||||||++|||++|..|+...........+...+.. ....++. . ....++.
T Consensus 349 ~DiwSlGvil~ell~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~ 428 (501)
T PHA03210 349 TDIWSCGLILLDMLSHDFCPIGDGGGKPGKQLLKIIDSLSVCDEEFPDPPCKLFDYIDSAEIDHAGHSVPPLIRNLGLPA 428 (501)
T ss_pred HHHHHHHHHHHHHHHCCCCCccCCCCCHHHHHHHHHHhcccChhhcCCcHHHHHHHhhhhhcccCccchhhHHHhcCCCh
Confidence 99999999999999987654332222211122221110 0000000 0 0113567
Q ss_pred HHHHHHHHhcccCccccCChHHHHHHhhhhHH
Q psy11767 632 EAKELTKSLLTVNPAQRIRMMRVKLTFHAFHQ 663 (966)
Q Consensus 632 e~~~Li~~~L~~dP~~R~t~~~v~~~~~~~~~ 663 (966)
++.++|.+||.+||.+|||+.++ ..|+|+.
T Consensus 429 ~~~~li~kmL~~DP~~Rpsa~el--L~hp~f~ 458 (501)
T PHA03210 429 DFEYPLVKMLTFDWHLRPGAAEL--LALPLFS 458 (501)
T ss_pred HHHHHHHHHhccCcccCcCHHHH--hhChhhh
Confidence 78899999999999999999976 4577764
|
|
| >cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-34 Score=313.48 Aligned_cols=252 Identities=26% Similarity=0.409 Sum_probs=194.3
Q ss_pred cccccccccccccEEEEEEEcCCCcEEEEEEeccccC------hHHHHHHHHHhcCCCCceEEEEEEEeC--CeEEEEEE
Q psy11767 380 LDKAGILGDGSYSVCRRCVEKSTGQEYAVKIISRKID------CSEEINLLRACQGHPNIVNLHCVFQDE--VHTYLVLE 451 (966)
Q Consensus 380 ~~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~~------~~~Ei~iL~~l~~HpnIV~l~~~~~~~--~~~~lVmE 451 (966)
|+..+.||.|+||.||+|.+..+++.||+|++..... ..+|+++|+.+ +||||++++++|.+. ...|+|||
T Consensus 3 ~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~~~lv~e 81 (287)
T cd06621 3 IVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDPNPDLQKQILRELEINKSC-KSPYIVKYYGAFLDESSSSIGIAME 81 (287)
T ss_pred eEEEEEeccCCceEEEEEEECCCCeEEEEEEEecCCchHHHHHHHHHHHHHHhC-CCCCeeeeeeEEEccCCCeEEEEEE
Confidence 3456789999999999999999999999999875422 45689999888 599999999988653 47899999
Q ss_pred ccCCCCHHHHHHhc--CCCCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCcEEEecCCCCCEEEEeecccccccCC-
Q psy11767 452 LLKGGELLDRIRQK--GRCGFTENEASRIMRQLVAAVHFMHSRGVVHRDLKPENLLFSDPAGDNIKVVDFGFACLKRES- 528 (966)
Q Consensus 452 y~~gg~L~~~l~~~--~~~~l~e~~~~~i~~Qil~aL~yLHs~~IiHRDLKP~NILl~~~~~~~iKL~DFGla~~~~~~- 528 (966)
|++|++|.+++... ....+++..+..++.||+.||+|||+.|++|+||+|+||++++ .+.++|+|||++......
T Consensus 82 ~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~i~H~dl~~~nil~~~--~~~~~l~dfg~~~~~~~~~ 159 (287)
T cd06621 82 YCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYLHSRKIIHRDIKPSNILLTR--KGQVKLCDFGVSGELVNSL 159 (287)
T ss_pred ecCCCCHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEec--CCeEEEeeccccccccccc
Confidence 99999998887542 2235899999999999999999999999999999999999985 558999999998654322
Q ss_pred CccccccccccCchhhccCCCCCCCcccchhhhhhhhhhhhcCCCCCCCcCcchhHHHHHHHHhcCCCCCCCCCC-chhH
Q psy11767 529 LHTPCFTLQYAAPEVLRQDKSGYDENCDLWSLGVILVNVLRQDKSGYDENCDLWSLGVILYTMLCGRVPFHARSR-DDSA 607 (966)
Q Consensus 529 ~~~~~gT~~Y~APEvl~~~~~~~~~~~Di~SlGvil~el~~~~~~~y~~~~DIWSlGvilyemltG~~Pf~~~~~-~~~~ 607 (966)
.....++..|+|||.+.. ..|+.++|||||||++|+|++|+.||..... ....
T Consensus 160 ~~~~~~~~~y~~pE~~~~--------------------------~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~ 213 (287)
T cd06621 160 AGTFTGTSFYMAPERIQG--------------------------KPYSITSDVWSLGLTLLEVAQNRFPFPPEGEPPLGP 213 (287)
T ss_pred cccccCCccccCHHHhcC--------------------------CCCCchhhHHHHHHHHHHHHhCCCCCCcccCCCCCh
Confidence 223456889999998752 2367889999999999999999999986532 0111
Q ss_pred HHHHHHHHcCCC-CCCchhh--ccCCHHHHHHHHHhcccCccccCChHHHHHHhhhhH
Q psy11767 608 LSIMARIKEGQF-NFDAEAW--STVSSEAKELTKSLLTVNPAQRIRMMRVKLTFHAFH 662 (966)
Q Consensus 608 ~~~~~~i~~~~~-~~~~~~~--~~is~e~~~Li~~~L~~dP~~R~t~~~v~~~~~~~~ 662 (966)
......+..... .+..... ...++++.++|.+||..||++|||+.++ ..|+|.
T Consensus 214 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~ei--l~~~~~ 269 (287)
T cd06621 214 IELLSYIVNMPNPELKDEPGNGIKWSEEFKDFIKQCLEKDPTRRPTPWDM--LEHPWI 269 (287)
T ss_pred HHHHHHHhcCCchhhccCCCCCCchHHHHHHHHHHHcCCCcccCCCHHHH--HhCccc
Confidence 223333333111 1111100 1346789999999999999999999876 345554
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-34 Score=306.45 Aligned_cols=237 Identities=30% Similarity=0.448 Sum_probs=193.4
Q ss_pred cccccccccccEEEEEEEcCCCcEEEEEEecccc----------ChHHHHHHHHHhcCCCCceEEEEEEEeCCeEEEEEE
Q psy11767 382 KAGILGDGSYSVCRRCVEKSTGQEYAVKIISRKI----------DCSEEINLLRACQGHPNIVNLHCVFQDEVHTYLVLE 451 (966)
Q Consensus 382 ~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~----------~~~~Ei~iL~~l~~HpnIV~l~~~~~~~~~~~lVmE 451 (966)
..+.||+|+||+||+|.+..+++.||+|.+.... ...+|+.+|+.+ +||||+++++++.++...|+|||
T Consensus 4 ~~~~ig~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~e~~~l~~~-~h~~i~~~~~~~~~~~~~~lv~e 82 (258)
T cd06632 4 KGELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKL-QHPNIVQYLGTEREEDNLYIFLE 82 (258)
T ss_pred ccceeeecCCceEEEEEEcCCCcEEEEEEEEEccccccchHHHHHHHHHHHHHHhc-CCCCchheeeeEecCCeEEEEEE
Confidence 3578999999999999999999999999986432 134688889888 69999999999999999999999
Q ss_pred ccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCcEEEecCCCCCEEEEeecccccccCC--C
Q psy11767 452 LLKGGELLDRIRQKGRCGFTENEASRIMRQLVAAVHFMHSRGVVHRDLKPENLLFSDPAGDNIKVVDFGFACLKRES--L 529 (966)
Q Consensus 452 y~~gg~L~~~l~~~~~~~l~e~~~~~i~~Qil~aL~yLHs~~IiHRDLKP~NILl~~~~~~~iKL~DFGla~~~~~~--~ 529 (966)
|+++++|.+++.+.. .+++..+..++.||+.||+|||+.||+|+||||+||+++. ++.+||+|||++...... .
T Consensus 83 ~~~~~~L~~~~~~~~--~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~~~ni~~~~--~~~~kl~d~~~~~~~~~~~~~ 158 (258)
T cd06632 83 LVPGGSLAKLLKKYG--SFPEPVIRLYTRQILLGLEYLHDRNTVHRDIKGANILVDT--NGVVKLADFGMAKQVVEFSFA 158 (258)
T ss_pred ecCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECC--CCCEEEccCccceeccccccc
Confidence 999999999997654 5899999999999999999999999999999999999975 568999999998654322 2
Q ss_pred ccccccccccCchhhccCCCCCCCcccchhhhhhhhhhhhcCCCCCCCcCcchhHHHHHHHHhcCCCCCCCCCCchhHHH
Q psy11767 530 HTPCFTLQYAAPEVLRQDKSGYDENCDLWSLGVILVNVLRQDKSGYDENCDLWSLGVILYTMLCGRVPFHARSRDDSALS 609 (966)
Q Consensus 530 ~~~~gT~~Y~APEvl~~~~~~~~~~~Di~SlGvil~el~~~~~~~y~~~~DIWSlGvilyemltG~~Pf~~~~~~~~~~~ 609 (966)
....+++.|+|||.+... ..++.++|+|||||++|+|++|+.||...... .
T Consensus 159 ~~~~~~~~y~~pe~~~~~-------------------------~~~~~~~D~~slG~~l~~l~~g~~pf~~~~~~----~ 209 (258)
T cd06632 159 KSFKGSPYWMAPEVIAQQ-------------------------GGYGLAADIWSLGCTVLEMATGKPPWSQLEGV----A 209 (258)
T ss_pred cccCCCcceeCHHHhcCC-------------------------CCCCchhhhHHHHHHHHHHHhCCCCcccCcHH----H
Confidence 345678999999987421 12677899999999999999999999765421 1
Q ss_pred HHHHHHcCCCCCCchhhccCCHHHHHHHHHhcccCccccCChHHH
Q psy11767 610 IMARIKEGQFNFDAEAWSTVSSEAKELTKSLLTVNPAQRIRMMRV 654 (966)
Q Consensus 610 ~~~~i~~~~~~~~~~~~~~is~e~~~Li~~~L~~dP~~R~t~~~v 654 (966)
....+.... ..+..+..+++++.+++.+||..||++||++.++
T Consensus 210 ~~~~~~~~~--~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~ 252 (258)
T cd06632 210 AVFKIGRSK--ELPPIPDHLSDEAKDFILKCLQRDPSLRPTAAEL 252 (258)
T ss_pred HHHHHHhcc--cCCCcCCCcCHHHHHHHHHHhhcCcccCcCHHHH
Confidence 122222211 1112234678999999999999999999999876
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops |
| >cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-34 Score=305.46 Aligned_cols=240 Identities=35% Similarity=0.509 Sum_probs=195.2
Q ss_pred cccccccccccccEEEEEEEcCCCcEEEEEEeccccC-------hHHHHHHHHHhcCCCCceEEEEEEEe--CCeEEEEE
Q psy11767 380 LDKAGILGDGSYSVCRRCVEKSTGQEYAVKIISRKID-------CSEEINLLRACQGHPNIVNLHCVFQD--EVHTYLVL 450 (966)
Q Consensus 380 ~~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~~-------~~~Ei~iL~~l~~HpnIV~l~~~~~~--~~~~~lVm 450 (966)
|+..+.||.|+||.||+|.+..+|+.||+|++..... ...|+.+|+.+ +||||+++++++.. +...|++|
T Consensus 2 y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~~~~~~~~~ 80 (265)
T cd08217 2 YEVLETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILREL-KHPNIVRYYDRIIDRSNQTLYIVM 80 (265)
T ss_pred ceeeeeeccCCCeEEEEeeecCCCCEEEEEEEecccCCHHHHHHHHHHHHHHHhc-CCCccceeeeeeecCCCCEEEEEe
Confidence 3446889999999999999999999999999864321 33588888888 59999999998764 45689999
Q ss_pred EccCCCCHHHHHHhcC--CCCCCHHHHHHHHHHHHHHHHHHH-----hcCceeccCCCCcEEEecCCCCCEEEEeecccc
Q psy11767 451 ELLKGGELLDRIRQKG--RCGFTENEASRIMRQLVAAVHFMH-----SRGVVHRDLKPENLLFSDPAGDNIKVVDFGFAC 523 (966)
Q Consensus 451 Ey~~gg~L~~~l~~~~--~~~l~e~~~~~i~~Qil~aL~yLH-----s~~IiHRDLKP~NILl~~~~~~~iKL~DFGla~ 523 (966)
||+++++|.+++.... ...+++..++.++.||+.||+||| +.+|+|+||||+|||+++ .+.+||+|||++.
T Consensus 81 e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~~~i~h~dl~p~nili~~--~~~~kl~d~g~~~ 158 (265)
T cd08217 81 EYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHNRSDPGNTVLHRDLKPANIFLDA--NNNVKLGDFGLAK 158 (265)
T ss_pred hhccCCCHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhcCccccCcceecCCCHHHEEEec--CCCEEEecccccc
Confidence 9999999999987531 236899999999999999999999 899999999999999985 5699999999987
Q ss_pred cccCC---CccccccccccCchhhccCCCCCCCcccchhhhhhhhhhhhcCCCCCCCcCcchhHHHHHHHHhcCCCCCCC
Q psy11767 524 LKRES---LHTPCFTLQYAAPEVLRQDKSGYDENCDLWSLGVILVNVLRQDKSGYDENCDLWSLGVILYTMLCGRVPFHA 600 (966)
Q Consensus 524 ~~~~~---~~~~~gT~~Y~APEvl~~~~~~~~~~~Di~SlGvil~el~~~~~~~y~~~~DIWSlGvilyemltG~~Pf~~ 600 (966)
..... .....+++.|+|||++.. ..++.++|+|||||++|+|++|+.||..
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~pE~~~~--------------------------~~~~~~~Dv~slG~il~~l~~g~~p~~~ 212 (265)
T cd08217 159 ILGHDSSFAKTYVGTPYYMSPEQLNH--------------------------MSYDEKSDIWSLGCLIYELCALSPPFTA 212 (265)
T ss_pred cccCCcccccccccCCCccChhhhcC--------------------------CCCCchhHHHHHHHHHHHHHHCCCcccC
Confidence 65432 224467899999998852 2257789999999999999999999987
Q ss_pred CCCchhHHHHHHHHHcCCCCCCchhhccCCHHHHHHHHHhcccCccccCChHHHH
Q psy11767 601 RSRDDSALSIMARIKEGQFNFDAEAWSTVSSEAKELTKSLLTVNPAQRIRMMRVK 655 (966)
Q Consensus 601 ~~~~~~~~~~~~~i~~~~~~~~~~~~~~is~e~~~Li~~~L~~dP~~R~t~~~v~ 655 (966)
.+. ......+..+.+.. .....+.++.+++.+||..+|++||++.++.
T Consensus 213 ~~~----~~~~~~~~~~~~~~---~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~il 260 (265)
T cd08217 213 RNQ----LQLASKIKEGKFRR---IPYRYSSELNEVIKSMLNVDPDKRPSTEELL 260 (265)
T ss_pred cCH----HHHHHHHhcCCCCC---CccccCHHHHHHHHHHccCCcccCCCHHHHh
Confidence 542 23344555554322 2235788999999999999999999999863
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi |
| >cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-34 Score=305.83 Aligned_cols=238 Identities=24% Similarity=0.432 Sum_probs=191.8
Q ss_pred cccccccccccccEEEEEEEcCCCcEEEEEEecccc----ChHHHHHHHHHhcCCCCceEEEEEEEeCCeEEEEEEccCC
Q psy11767 380 LDKAGILGDGSYSVCRRCVEKSTGQEYAVKIISRKI----DCSEEINLLRACQGHPNIVNLHCVFQDEVHTYLVLELLKG 455 (966)
Q Consensus 380 ~~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~----~~~~Ei~iL~~l~~HpnIV~l~~~~~~~~~~~lVmEy~~g 455 (966)
++..+.||+|+||.||+|.+. .+..+|+|++.... ....|+++++.+ +||||+++++++......|+||||+++
T Consensus 6 ~~~~~~ig~g~~g~v~~~~~~-~~~~~~~k~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~~~~~v~e~~~~ 83 (256)
T cd05112 6 LTLVQEIGSGQFGLVWLGYWL-EKRKVAIKTIREGAMSEEDFIEEAQVMMKL-SHPKLVQLYGVCTERSPICLVFEFMEH 83 (256)
T ss_pred eEEEeeecCcccceEEEEEEe-CCCeEEEEECCCCCCCHHHHHHHHHHHHhC-CCCCeeeEEEEEccCCceEEEEEcCCC
Confidence 334678999999999999875 47789999987542 345799999998 599999999999999999999999999
Q ss_pred CCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCcEEEecCCCCCEEEEeecccccccCCC----cc
Q psy11767 456 GELLDRIRQKGRCGFTENEASRIMRQLVAAVHFMHSRGVVHRDLKPENLLFSDPAGDNIKVVDFGFACLKRESL----HT 531 (966)
Q Consensus 456 g~L~~~l~~~~~~~l~e~~~~~i~~Qil~aL~yLHs~~IiHRDLKP~NILl~~~~~~~iKL~DFGla~~~~~~~----~~ 531 (966)
++|.+++..... .+++..++.++.|++.||+|||+.+++||||||+||+++. ++.+||+|||++....... ..
T Consensus 84 ~~L~~~~~~~~~-~~~~~~~~~~~~~l~~~l~~lH~~~i~h~dl~p~ni~i~~--~~~~~l~d~g~~~~~~~~~~~~~~~ 160 (256)
T cd05112 84 GCLSDYLRAQRG-KFSQETLLGMCLDVCEGMAYLESSNVIHRDLAARNCLVGE--NQVVKVSDFGMTRFVLDDQYTSSTG 160 (256)
T ss_pred CcHHHHHHhCcc-CCCHHHHHHHHHHHHHHHHHHHHCCccccccccceEEEcC--CCeEEECCCcceeecccCcccccCC
Confidence 999999876432 5899999999999999999999999999999999999974 5689999999986543221 12
Q ss_pred ccccccccCchhhccCCCCCCCcccchhhhhhhhhhhhcCCCCCCCcCcchhHHHHHHHHhc-CCCCCCCCCCchhHHHH
Q psy11767 532 PCFTLQYAAPEVLRQDKSGYDENCDLWSLGVILVNVLRQDKSGYDENCDLWSLGVILYTMLC-GRVPFHARSRDDSALSI 610 (966)
Q Consensus 532 ~~gT~~Y~APEvl~~~~~~~~~~~Di~SlGvil~el~~~~~~~y~~~~DIWSlGvilyemlt-G~~Pf~~~~~~~~~~~~ 610 (966)
..++..|+|||++.. ..++.++|||||||++|+|++ |..||...... ..
T Consensus 161 ~~~~~~~~aPe~~~~--------------------------~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~----~~ 210 (256)
T cd05112 161 TKFPVKWSSPEVFSF--------------------------SKYSSKSDVWSFGVLMWEVFSEGKTPYENRSNS----EV 210 (256)
T ss_pred CccchhhcCHhHhcc--------------------------CCcChHHHHHHHHHHHHHHHcCCCCCCCcCCHH----HH
Confidence 234678999998752 236778999999999999998 99999765432 33
Q ss_pred HHHHHcCCCCCCchhhccCCHHHHHHHHHhcccCccccCChHHHH
Q psy11767 611 MARIKEGQFNFDAEAWSTVSSEAKELTKSLLTVNPAQRIRMMRVK 655 (966)
Q Consensus 611 ~~~i~~~~~~~~~~~~~~is~e~~~Li~~~L~~dP~~R~t~~~v~ 655 (966)
...+..+...+.+ ...+.++.+|+.+||..+|++|||+.++.
T Consensus 211 ~~~~~~~~~~~~~---~~~~~~~~~l~~~~l~~~p~~Rp~~~~~l 252 (256)
T cd05112 211 VETINAGFRLYKP---RLASQSVYELMQHCWKERPEDRPSFSLLL 252 (256)
T ss_pred HHHHhCCCCCCCC---CCCCHHHHHHHHHHcccChhhCCCHHHHH
Confidence 4444444222221 23578999999999999999999998874
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ |
| >cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-33 Score=314.83 Aligned_cols=244 Identities=24% Similarity=0.357 Sum_probs=194.0
Q ss_pred cccccccccccEEEEEEEcCCCcEEEEEEecccc--------ChHHHHHHHHHhcCCCCceEEEEEEEeCCeEEEEEEcc
Q psy11767 382 KAGILGDGSYSVCRRCVEKSTGQEYAVKIISRKI--------DCSEEINLLRACQGHPNIVNLHCVFQDEVHTYLVLELL 453 (966)
Q Consensus 382 ~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~--------~~~~Ei~iL~~l~~HpnIV~l~~~~~~~~~~~lVmEy~ 453 (966)
..+.||+|+||.||+|.+..+|+.||+|++.... ...+|+.+++.+ +||||+++++++.++...|+||||+
T Consensus 19 ~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~Ei~~l~~l-~h~niv~~~~~~~~~~~~~lv~e~~ 97 (307)
T cd06607 19 DLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQL-RHPNTIEYKGCYLREHTAWLVMEYC 97 (307)
T ss_pred hheeecCCCCeEEEEEEEcCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHHhC-CCCCEEEEEEEEEeCCeEEEEHHhh
Confidence 3578999999999999999999999999986432 234688899988 5999999999999999999999999
Q ss_pred CCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCcEEEecCCCCCEEEEeecccccccCCCcccc
Q psy11767 454 KGGELLDRIRQKGRCGFTENEASRIMRQLVAAVHFMHSRGVVHRDLKPENLLFSDPAGDNIKVVDFGFACLKRESLHTPC 533 (966)
Q Consensus 454 ~gg~L~~~l~~~~~~~l~e~~~~~i~~Qil~aL~yLHs~~IiHRDLKP~NILl~~~~~~~iKL~DFGla~~~~~~~~~~~ 533 (966)
. |+|.+.+..... .+++..+..++.||+.||.|||+.||+||||+|+||++++ ++.+||+|||++..... .....
T Consensus 98 ~-g~l~~~~~~~~~-~l~~~~~~~~~~ql~~~L~~LH~~~i~H~dl~p~nIl~~~--~~~~kL~dfg~~~~~~~-~~~~~ 172 (307)
T cd06607 98 L-GSASDILEVHKK-PLQEVEIAAICHGALQGLAYLHSHERIHRDIKAGNILLTE--PGTVKLADFGSASLVSP-ANSFV 172 (307)
T ss_pred C-CCHHHHHHHccc-CCCHHHHHHHHHHHHHHHHHHHHCCceecCCCcccEEECC--CCCEEEeecCcceecCC-CCCcc
Confidence 6 677777765433 5899999999999999999999999999999999999985 56899999999865432 23456
Q ss_pred ccccccCchhhccCCCCCCCcccchhhhhhhhhhhhcCCCCCCCcCcchhHHHHHHHHhcCCCCCCCCCCchhHHHHHHH
Q psy11767 534 FTLQYAAPEVLRQDKSGYDENCDLWSLGVILVNVLRQDKSGYDENCDLWSLGVILYTMLCGRVPFHARSRDDSALSIMAR 613 (966)
Q Consensus 534 gT~~Y~APEvl~~~~~~~~~~~Di~SlGvil~el~~~~~~~y~~~~DIWSlGvilyemltG~~Pf~~~~~~~~~~~~~~~ 613 (966)
+++.|+|||++... ....++.++|||||||++|+|++|++||...+... ....
T Consensus 173 ~~~~y~aPE~~~~~-----------------------~~~~~~~~sDv~s~G~il~el~tg~~p~~~~~~~~----~~~~ 225 (307)
T cd06607 173 GTPYWMAPEVILAM-----------------------DEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMS----ALYH 225 (307)
T ss_pred CCccccCceeeecc-----------------------CCCCCCcccchHHHHHHHHHHHcCCCCCCCccHHH----HHHH
Confidence 78899999987421 12346788999999999999999999997654321 1222
Q ss_pred HHcC-CCCCCchhhccCCHHHHHHHHHhcccCccccCChHHHHHHhhhhHH
Q psy11767 614 IKEG-QFNFDAEAWSTVSSEAKELTKSLLTVNPAQRIRMMRVKLTFHAFHQ 663 (966)
Q Consensus 614 i~~~-~~~~~~~~~~~is~e~~~Li~~~L~~dP~~R~t~~~v~~~~~~~~~ 663 (966)
+... ...... ...+.++.++|.+||..||++||++.++. .|+|..
T Consensus 226 ~~~~~~~~~~~---~~~~~~~~~li~~~l~~~p~~Rp~~~~il--~~~~~~ 271 (307)
T cd06607 226 IAQNDSPTLSS---NDWSDYFRNFVDSCLQKIPQDRPSSEELL--KHRFVL 271 (307)
T ss_pred HhcCCCCCCCc---hhhCHHHHHHHHHHhcCChhhCcCHHHHh--cChhhc
Confidence 2222 222222 23578899999999999999999999874 356654
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily |
| >cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-34 Score=308.89 Aligned_cols=221 Identities=29% Similarity=0.418 Sum_probs=181.3
Q ss_pred ccccEEEEEEEcCCCcEEEEEEeccccChHHHHHHHHHhcCCCCceEEEEEEEeCCeEEEEEEccCCCCHHHHHHhcCCC
Q psy11767 389 GSYSVCRRCVEKSTGQEYAVKIISRKIDCSEEINLLRACQGHPNIVNLHCVFQDEVHTYLVLELLKGGELLDRIRQKGRC 468 (966)
Q Consensus 389 G~fG~Vy~a~~~~tg~~vAvK~i~~~~~~~~Ei~iL~~l~~HpnIV~l~~~~~~~~~~~lVmEy~~gg~L~~~l~~~~~~ 468 (966)
|.||.||+|++..+|+.||+|.+.......+|...+... .||||+++++++.+....|+||||++||+|.+++.+..
T Consensus 4 g~~~~v~~~~~~~~~~~~~~K~i~~~~~~~~~~~~~~~~-~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~-- 80 (237)
T cd05576 4 GVIDKVLLVMDTRTQQTFILKGLRKSSEYSRERLTIIPH-CVPNMVCLHKYIVSEDSVFLVLQHAEGGKLWSHISKFL-- 80 (237)
T ss_pred cccceEEEEEEccCCcEEEEEeecchhhhhhHHHHHHhc-CCCceeehhhheecCCeEEEEEecCCCCCHHHHHHHhc--
Confidence 899999999999999999999997765555665555544 59999999999999999999999999999999997654
Q ss_pred CCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCcEEEecCCCCCEEEEeecccccccCCCccccccccccCchhhccCC
Q psy11767 469 GFTENEASRIMRQLVAAVHFMHSRGVVHRDLKPENLLFSDPAGDNIKVVDFGFACLKRESLHTPCFTLQYAAPEVLRQDK 548 (966)
Q Consensus 469 ~l~e~~~~~i~~Qil~aL~yLHs~~IiHRDLKP~NILl~~~~~~~iKL~DFGla~~~~~~~~~~~gT~~Y~APEvl~~~~ 548 (966)
.+++..+..++.|++.||+|||++||+||||||+|||++. .+.++|+|||++...........++..|+|||.+..
T Consensus 81 ~l~~~~~~~~~~ql~~~l~~lH~~~i~H~dlkp~Nil~~~--~~~~~l~df~~~~~~~~~~~~~~~~~~y~aPE~~~~-- 156 (237)
T cd05576 81 NIPEECVKRWAAEMVVALDALHREGIVCRDLNPNNILLDD--RGHIQLTYFSRWSEVEDSCDGEAVENMYCAPEVGGI-- 156 (237)
T ss_pred CCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEEcC--CCCEEEecccchhccccccccCCcCccccCCcccCC--
Confidence 5899999999999999999999999999999999999985 568999999988655444444556788999998742
Q ss_pred CCCCCcccchhhhhhhhhhhhcCCCCCCCcCcchhHHHHHHHHhcCCCCCCCCCCchhHHHHHHHHHcCCCCCCchhhcc
Q psy11767 549 SGYDENCDLWSLGVILVNVLRQDKSGYDENCDLWSLGVILYTMLCGRVPFHARSRDDSALSIMARIKEGQFNFDAEAWST 628 (966)
Q Consensus 549 ~~~~~~~Di~SlGvil~el~~~~~~~y~~~~DIWSlGvilyemltG~~Pf~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~ 628 (966)
..++.++|+||+||++|+|++|+.||...... +.. ...+ .....
T Consensus 157 ------------------------~~~~~~~DvwslG~il~el~~g~~~~~~~~~~---------~~~-~~~~--~~~~~ 200 (237)
T cd05576 157 ------------------------SEETEACDWWSLGAILFELLTGKTLVECHPSG---------INT-HTTL--NIPEW 200 (237)
T ss_pred ------------------------CCCCchhhHHHHHHHHHHHHHCcchhhcCchh---------ccc-cccc--CCccc
Confidence 23577899999999999999999988643211 000 0011 11234
Q ss_pred CCHHHHHHHHHhcccCccccCChH
Q psy11767 629 VSSEAKELTKSLLTVNPAQRIRMM 652 (966)
Q Consensus 629 is~e~~~Li~~~L~~dP~~R~t~~ 652 (966)
++++++++|.+||..||++|+++.
T Consensus 201 ~~~~~~~li~~~l~~dp~~R~~~~ 224 (237)
T cd05576 201 VSEEARSLLQQLLQFNPTERLGAG 224 (237)
T ss_pred CCHHHHHHHHHHccCCHHHhcCCC
Confidence 789999999999999999999973
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha |
| >PHA02882 putative serine/threonine kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-34 Score=314.41 Aligned_cols=238 Identities=16% Similarity=0.230 Sum_probs=178.1
Q ss_pred cccccccccccEEEEEEEcCC---CcEEEEEEeccccC-hHHH------------HH---HHHHhcCCCCceEEEEEEEe
Q psy11767 382 KAGILGDGSYSVCRRCVEKST---GQEYAVKIISRKID-CSEE------------IN---LLRACQGHPNIVNLHCVFQD 442 (966)
Q Consensus 382 ~~~~LG~G~fG~Vy~a~~~~t---g~~vAvK~i~~~~~-~~~E------------i~---iL~~l~~HpnIV~l~~~~~~ 442 (966)
..++||+|+||+||+|.+..+ +..+|+|+...... ...| +. .+..+ .|+||+++++++..
T Consensus 16 i~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~k~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~-~h~~i~~~~~~~~~ 94 (294)
T PHA02882 16 IDKLIGCGGFGCVYETQCASDHCINNQAVAKIENLENETIVMETLVYNNIYDIDKIALWKNIHNI-DHLGIPKYYGCGSF 94 (294)
T ss_pred EeeEEecCCCceEEEEEEcCCcccccceEEEeccccCCchhhHHHHHHhhhhHHHHHHHHHhccC-CCCCCCcEEEeeeE
Confidence 368899999999999999887 77888887543221 1111 11 12223 69999999988765
Q ss_pred CC----eEEEEEEccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCcEEEecCCCCCEEEEe
Q psy11767 443 EV----HTYLVLELLKGGELLDRIRQKGRCGFTENEASRIMRQLVAAVHFMHSRGVVHRDLKPENLLFSDPAGDNIKVVD 518 (966)
Q Consensus 443 ~~----~~~lVmEy~~gg~L~~~l~~~~~~~l~e~~~~~i~~Qil~aL~yLHs~~IiHRDLKP~NILl~~~~~~~iKL~D 518 (966)
.. ..+++||++. .++.+.+.... .+++..++.++.|++.||+|||+++|+||||||+|||++. .+.++|+|
T Consensus 95 ~~~~~~~~~~~~~~~~-~~~~~~~~~~~--~~~~~~~~~i~~qi~~~l~~lH~~~iiHrDiKp~Nill~~--~~~~~l~D 169 (294)
T PHA02882 95 KRCRMYYRFILLEKLV-ENTKEIFKRIK--CKNKKLIKNIMKDMLTTLEYIHEHGISHGDIKPENIMVDG--NNRGYIID 169 (294)
T ss_pred ecCCceEEEEEEehhc-cCHHHHHHhhc--cCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcC--CCcEEEEE
Confidence 43 4578899874 46666665432 3688999999999999999999999999999999999974 56899999
Q ss_pred ecccccccC----------CCccccccccccCchhhccCCCCCCCcccchhhhhhhhhhhhcCCCCCCCcCcchhHHHHH
Q psy11767 519 FGFACLKRE----------SLHTPCFTLQYAAPEVLRQDKSGYDENCDLWSLGVILVNVLRQDKSGYDENCDLWSLGVIL 588 (966)
Q Consensus 519 FGla~~~~~----------~~~~~~gT~~Y~APEvl~~~~~~~~~~~Di~SlGvil~el~~~~~~~y~~~~DIWSlGvil 588 (966)
||+|+.... ......||+.|+|||++.. ..|+.++|||||||++
T Consensus 170 FGla~~~~~~~~~~~~~~~~~~~~~gt~~y~ape~~~~--------------------------~~~~~~~DiwSlG~~l 223 (294)
T PHA02882 170 YGIASHFIIHGKHIEYSKEQKDLHRGTLYYAGLDAHNG--------------------------ACVTRRGDLESLGYCM 223 (294)
T ss_pred cCCceeeccCCcccccccccccccCCCccccCHHHhCC--------------------------CCCCcHHHHHHHHHHH
Confidence 999965421 1123468999999998752 3478899999999999
Q ss_pred HHHhcCCCCCCCCCCchhHH-----HHHHHHHcCCCCCCchhhccCCHHHHHHHHHhcccCccccCChHHHHH
Q psy11767 589 YTMLCGRVPFHARSRDDSAL-----SIMARIKEGQFNFDAEAWSTVSSEAKELTKSLLTVNPAQRIRMMRVKL 656 (966)
Q Consensus 589 yemltG~~Pf~~~~~~~~~~-----~~~~~i~~~~~~~~~~~~~~is~e~~~Li~~~L~~dP~~R~t~~~v~~ 656 (966)
|+|++|++||.+........ ....++..+...+ +..+.++.++++.|+..+|++||++.++..
T Consensus 224 ~el~~g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-----~~~~~~~~~~~~~~~~~~~~~rp~~~~l~~ 291 (294)
T PHA02882 224 LKWAGIKLPWKGFGHNGNLIHAAKCDFIKRLHEGKIKI-----KNANKFIYDFIECVTKLSYEEKPDYDALIK 291 (294)
T ss_pred HHHHhCCCCCCccccchHHHHHhHHHHHHHhhhhhhcc-----CCCCHHHHHHHHHHHhCCCCCCCCHHHHHH
Confidence 99999999998764322211 1223344443322 345789999999999999999999998754
|
|
| >cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-34 Score=311.18 Aligned_cols=246 Identities=24% Similarity=0.371 Sum_probs=187.2
Q ss_pred cccccccccccccEEEEEE----EcCCCcEEEEEEecccc-----ChHHHHHHHHHhcCCCCceEEEEEEEe--CCeEEE
Q psy11767 380 LDKAGILGDGSYSVCRRCV----EKSTGQEYAVKIISRKI-----DCSEEINLLRACQGHPNIVNLHCVFQD--EVHTYL 448 (966)
Q Consensus 380 ~~~~~~LG~G~fG~Vy~a~----~~~tg~~vAvK~i~~~~-----~~~~Ei~iL~~l~~HpnIV~l~~~~~~--~~~~~l 448 (966)
++.++.||+|+||.||+|. +..+++.||||.+.... ...+|+++|+.+ .||||+++++++.. ....|+
T Consensus 6 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~~~l 84 (284)
T cd05081 6 LKFIQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHSTAEHLRDFEREIEILKSL-QHDNIVKYKGVCYSAGRRNLRL 84 (284)
T ss_pred ceeeeeccCCCCceEEEEEecCCcCCCCcEEEEEEeccCCHHHHHHHHHHHHHHHhC-CCCCeeEEEEEEccCCCCceEE
Confidence 4457889999999999997 45678999999986543 245699999998 59999999998754 346899
Q ss_pred EEEccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCcEEEecCCCCCEEEEeecccccccCC
Q psy11767 449 VLELLKGGELLDRIRQKGRCGFTENEASRIMRQLVAAVHFMHSRGVVHRDLKPENLLFSDPAGDNIKVVDFGFACLKRES 528 (966)
Q Consensus 449 VmEy~~gg~L~~~l~~~~~~~l~e~~~~~i~~Qil~aL~yLHs~~IiHRDLKP~NILl~~~~~~~iKL~DFGla~~~~~~ 528 (966)
||||+++|+|.+++.+.. ..+++..+..++.|++.||+|||++||+||||||+|||+++ ++.+||+|||++......
T Consensus 85 v~e~~~~~~L~~~l~~~~-~~l~~~~~~~~~~~l~~aL~~LH~~~i~H~dlkp~nili~~--~~~~~l~dfg~~~~~~~~ 161 (284)
T cd05081 85 VMEYLPYGSLRDYLQKHR-ERLDHRKLLLYASQICKGMEYLGSKRYVHRDLATRNILVES--ENRVKIGDFGLTKVLPQD 161 (284)
T ss_pred EEEecCCCCHHHHHHhcC-cCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCHhhEEECC--CCeEEECCCcccccccCC
Confidence 999999999999997643 25899999999999999999999999999999999999975 568999999999754322
Q ss_pred Cc------cccccccccCchhhccCCCCCCCcccchhhhhhhhhhhhcCCCCCCCcCcchhHHHHHHHHhcCCCCCCCCC
Q psy11767 529 LH------TPCFTLQYAAPEVLRQDKSGYDENCDLWSLGVILVNVLRQDKSGYDENCDLWSLGVILYTMLCGRVPFHARS 602 (966)
Q Consensus 529 ~~------~~~gT~~Y~APEvl~~~~~~~~~~~Di~SlGvil~el~~~~~~~y~~~~DIWSlGvilyemltG~~Pf~~~~ 602 (966)
.. ...++..|+|||++.. ..++.++|||||||++|||++|..|+....
T Consensus 162 ~~~~~~~~~~~~~~~y~aPE~~~~--------------------------~~~~~~~Di~slG~~l~el~~~~~~~~~~~ 215 (284)
T cd05081 162 KEYYKVREPGESPIFWYAPESLTE--------------------------SKFSVASDVWSFGVVLYELFTYSDKSCSPP 215 (284)
T ss_pred CcceeecCCCCCceEeeCHHHhcc--------------------------CCcChHHHHHHHHHHHHHHhhcCCcCCCcc
Confidence 11 1123456999998752 236778999999999999999987765332
Q ss_pred Cch------------hHHHHHHHHHcCCCCCCchhhccCCHHHHHHHHHhcccCccccCChHHHHHHh
Q psy11767 603 RDD------------SALSIMARIKEGQFNFDAEAWSTVSSEAKELTKSLLTVNPAQRIRMMRVKLTF 658 (966)
Q Consensus 603 ~~~------------~~~~~~~~i~~~~~~~~~~~~~~is~e~~~Li~~~L~~dP~~R~t~~~v~~~~ 658 (966)
... ....+...+..+. .++ ....++.++.+|+.+||..+|++|||+.++...+
T Consensus 216 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~--~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l 280 (284)
T cd05081 216 AEFMRMMGNDKQGQMIVYHLIELLKNNG-RLP--APPGCPAEIYAIMKECWNNDPSQRPSFSELALQV 280 (284)
T ss_pred hhhhhhcccccccccchHHHHHHHhcCC-cCC--CCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHH
Confidence 110 0001111122211 111 1235788999999999999999999999885543
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th |
| >cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.4e-34 Score=310.12 Aligned_cols=245 Identities=32% Similarity=0.496 Sum_probs=191.9
Q ss_pred ccccccccccccEEEEEEEcCCCcEEEEEEecccc-------ChHHHHHHHHHhc--CCCCceEEEEEEEeCCe-----E
Q psy11767 381 DKAGILGDGSYSVCRRCVEKSTGQEYAVKIISRKI-------DCSEEINLLRACQ--GHPNIVNLHCVFQDEVH-----T 446 (966)
Q Consensus 381 ~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~-------~~~~Ei~iL~~l~--~HpnIV~l~~~~~~~~~-----~ 446 (966)
+..+.||+|+||.||+|.+..+++.||||++.... ...+|+.+++.+. +||||+++++++.+... .
T Consensus 2 ~~~~~l~~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~~~~~~ 81 (287)
T cd07838 2 EELAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFEHPNIVRLLDVCHGPRTDRELKL 81 (287)
T ss_pred eEEEEecccCceEEEEEEECCCCCEEEEEEeccccccchhhhhHHHHHHHHHHhhccCCCCcceEEEEEeeccCCCCcee
Confidence 34678999999999999999999999999986432 2335777777664 59999999999988776 9
Q ss_pred EEEEEccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCcEEEecCCCCCEEEEeeccccccc
Q psy11767 447 YLVLELLKGGELLDRIRQKGRCGFTENEASRIMRQLVAAVHFMHSRGVVHRDLKPENLLFSDPAGDNIKVVDFGFACLKR 526 (966)
Q Consensus 447 ~lVmEy~~gg~L~~~l~~~~~~~l~e~~~~~i~~Qil~aL~yLHs~~IiHRDLKP~NILl~~~~~~~iKL~DFGla~~~~ 526 (966)
+++|||+. ++|.+++.......+++..++.++.||+.||+|||+.+|+|+||||+|||++. ++.+||+|||++....
T Consensus 82 ~l~~e~~~-~~l~~~l~~~~~~~l~~~~~~~~~~~i~~al~~LH~~~i~h~~l~~~nili~~--~~~~~l~dfg~~~~~~ 158 (287)
T cd07838 82 TLVFEHVD-QDLATYLSKCPKPGLPPETIKDLMRQLLRGVDFLHSHRIVHRDLKPQNILVTS--DGQVKIADFGLARIYS 158 (287)
T ss_pred EEEehhcc-cCHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCChhhEEEcc--CCCEEEeccCcceecc
Confidence 99999996 58999887655446999999999999999999999999999999999999986 4689999999986643
Q ss_pred CC--CccccccccccCchhhccCCCCCCCcccchhhhhhhhhhhhcCCCCCCCcCcchhHHHHHHHHhcCCCCCCCCCCc
Q psy11767 527 ES--LHTPCFTLQYAAPEVLRQDKSGYDENCDLWSLGVILVNVLRQDKSGYDENCDLWSLGVILYTMLCGRVPFHARSRD 604 (966)
Q Consensus 527 ~~--~~~~~gT~~Y~APEvl~~~~~~~~~~~Di~SlGvil~el~~~~~~~y~~~~DIWSlGvilyemltG~~Pf~~~~~~ 604 (966)
.. .....+++.|+|||++.. ..++.++|+||+||++|+|++|.+||.+....
T Consensus 159 ~~~~~~~~~~~~~~~~PE~~~~--------------------------~~~~~~~Di~s~G~~l~~l~~~~~~~~~~~~~ 212 (287)
T cd07838 159 FEMALTSVVVTLWYRAPEVLLQ--------------------------SSYATPVDMWSVGCIFAELFRRRPLFRGTSEA 212 (287)
T ss_pred CCcccccccccccccChHHhcc--------------------------CCCCCcchhhhHHHHHHHHHhCCCcccCCChH
Confidence 22 223456888999998852 23577899999999999999999999876654
Q ss_pred hhHHHHHHHHHc-CC-------------C-----CCCchhhccCCHHHHHHHHHhcccCccccCChHHH
Q psy11767 605 DSALSIMARIKE-GQ-------------F-----NFDAEAWSTVSSEAKELTKSLLTVNPAQRIRMMRV 654 (966)
Q Consensus 605 ~~~~~~~~~i~~-~~-------------~-----~~~~~~~~~is~e~~~Li~~~L~~dP~~R~t~~~v 654 (966)
+....++..... +. + .......+.+++++.++|.+||..||++||++.++
T Consensus 213 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~i 281 (287)
T cd07838 213 DQLDKIFDVIGLPSEEEWPRNVSLPRSSFPSYTPRSFKSFVPEICEEGLDLLKKMLTFNPHKRISAFEA 281 (287)
T ss_pred HHHHHHHHHcCCCChHhcCCCcccchhhcccccccchhhhhhhhhHHHHHHHHHHhccCCccCCCHHHH
Confidence 333333222110 00 0 00011123467889999999999999999999876
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both |
| >cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-34 Score=324.42 Aligned_cols=248 Identities=28% Similarity=0.489 Sum_probs=188.9
Q ss_pred ccccccccccccEEEEEEEcCCCcEEEEEEecccc------ChHHHHHHHHHhcCCCCceEEEEEEEeC-----CeEEEE
Q psy11767 381 DKAGILGDGSYSVCRRCVEKSTGQEYAVKIISRKI------DCSEEINLLRACQGHPNIVNLHCVFQDE-----VHTYLV 449 (966)
Q Consensus 381 ~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~------~~~~Ei~iL~~l~~HpnIV~l~~~~~~~-----~~~~lV 449 (966)
+..+.||+|+||.||+|.+..+|+.||||++.... ...+|+.+|+.+. ||||+++++++... .+.|+|
T Consensus 8 ~i~~~lg~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~~~~~~~~lv 86 (336)
T cd07849 8 QNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFEHQTFCQRTLREIKILRRFK-HENIIGILDIIRPPSFESFNDVYIV 86 (336)
T ss_pred EEEEEEEecCCeEEEEEEEcCCCCeEEEEEecccccchhHHHHHHHHHHHHhCC-CCCcCchhheeecccccccceEEEE
Confidence 34688999999999999999999999999986321 1345899999885 99999999887644 358999
Q ss_pred EEccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCcEEEecCCCCCEEEEeecccccccCC-
Q psy11767 450 LELLKGGELLDRIRQKGRCGFTENEASRIMRQLVAAVHFMHSRGVVHRDLKPENLLFSDPAGDNIKVVDFGFACLKRES- 528 (966)
Q Consensus 450 mEy~~gg~L~~~l~~~~~~~l~e~~~~~i~~Qil~aL~yLHs~~IiHRDLKP~NILl~~~~~~~iKL~DFGla~~~~~~- 528 (966)
|||+. ++|.+.+... .+++..++.++.|++.||+|||+.||+||||||+|||++. .+.+||+|||++......
T Consensus 87 ~e~~~-~~l~~~~~~~---~l~~~~~~~i~~ql~~aL~~LH~~~ivH~dlkp~Nill~~--~~~~kl~dfg~~~~~~~~~ 160 (336)
T cd07849 87 QELME-TDLYKLIKTQ---HLSNDHIQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNT--NCDLKICDFGLARIADPEH 160 (336)
T ss_pred ehhcc-cCHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEECC--CCCEEECcccceeeccccc
Confidence 99995 5888877543 5899999999999999999999999999999999999975 568999999998654321
Q ss_pred -----CccccccccccCchhhccCCCCCCCcccchhhhhhhhhhhhcCCCCCCCcCcchhHHHHHHHHhcCCCCCCCCCC
Q psy11767 529 -----LHTPCFTLQYAAPEVLRQDKSGYDENCDLWSLGVILVNVLRQDKSGYDENCDLWSLGVILYTMLCGRVPFHARSR 603 (966)
Q Consensus 529 -----~~~~~gT~~Y~APEvl~~~~~~~~~~~Di~SlGvil~el~~~~~~~y~~~~DIWSlGvilyemltG~~Pf~~~~~ 603 (966)
....++|+.|+|||++.. ...++.++||||+||++|+|++|+.||.+.+.
T Consensus 161 ~~~~~~~~~~~~~~y~aPE~~~~-------------------------~~~~~~~~DvwslGvil~el~~G~~~f~~~~~ 215 (336)
T cd07849 161 DHTGFLTEYVATRWYRAPEIMLN-------------------------SKGYTKAIDIWSVGCILAEMLSNRPLFPGKDY 215 (336)
T ss_pred cccCCcCCcCcCCCccChHHhhC-------------------------CCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCH
Confidence 123467899999998742 22367889999999999999999999976543
Q ss_pred chhHHHHHHHH-----------H---------cCCCCCC---chhhccCCHHHHHHHHHhcccCccccCChHHHHHHhhh
Q psy11767 604 DDSALSIMARI-----------K---------EGQFNFD---AEAWSTVSSEAKELTKSLLTVNPAQRIRMMRVKLTFHA 660 (966)
Q Consensus 604 ~~~~~~~~~~i-----------~---------~~~~~~~---~~~~~~is~e~~~Li~~~L~~dP~~R~t~~~v~~~~~~ 660 (966)
......+...+ . ....... ....+.+++++.++|.+||+.||++|||+.++ ..|+
T Consensus 216 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~e~--l~hp 293 (336)
T cd07849 216 LHQLNLILGVLGTPSQEDLNCIISLRARNYIKSLPFKPKVPWNKLFPNADPKALDLLDKMLTFNPHKRITVEEA--LAHP 293 (336)
T ss_pred HHHHHHHHHHcCCCCHHHHHHhhchhhhhHHhhcCcCCcccHHHHhcccCcHHHHHHHHHcCCChhhCcCHHHH--hcCc
Confidence 22111111100 0 0000000 01123568899999999999999999999876 3455
Q ss_pred hH
Q psy11767 661 FH 662 (966)
Q Consensus 661 ~~ 662 (966)
|.
T Consensus 294 ~~ 295 (336)
T cd07849 294 YL 295 (336)
T ss_pred cc
Confidence 53
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase |
| >cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-34 Score=306.71 Aligned_cols=234 Identities=19% Similarity=0.280 Sum_probs=183.7
Q ss_pred ccccccccEEEEEEEcCCC----------cEEEEEEecccc----ChHHHHHHHHHhcCCCCceEEEEEEEeCCeEEEEE
Q psy11767 385 ILGDGSYSVCRRCVEKSTG----------QEYAVKIISRKI----DCSEEINLLRACQGHPNIVNLHCVFQDEVHTYLVL 450 (966)
Q Consensus 385 ~LG~G~fG~Vy~a~~~~tg----------~~vAvK~i~~~~----~~~~Ei~iL~~l~~HpnIV~l~~~~~~~~~~~lVm 450 (966)
.||+|+||.||+|.+..++ ..||+|++.... ...+|+.+|+.+ +||||+++++++.. ...++||
T Consensus 2 ~lg~G~~~~v~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~-~~~~lv~ 79 (259)
T cd05037 2 HLGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRDSLAFFETASLMSQL-SHKHLVKLYGVCVR-DENIMVE 79 (259)
T ss_pred cccccccceEEEEEEeccCCccccCCccceeeeeeccccchhhHHHHHHHHHHHHcC-CCcchhheeeEEec-CCcEEEE
Confidence 5999999999999998877 458888875433 244688888888 59999999999988 7789999
Q ss_pred EccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCcEEEecCCCC-----CEEEEeecccccc
Q psy11767 451 ELLKGGELLDRIRQKGRCGFTENEASRIMRQLVAAVHFMHSRGVVHRDLKPENLLFSDPAGD-----NIKVVDFGFACLK 525 (966)
Q Consensus 451 Ey~~gg~L~~~l~~~~~~~l~e~~~~~i~~Qil~aL~yLHs~~IiHRDLKP~NILl~~~~~~-----~iKL~DFGla~~~ 525 (966)
||+++|+|.+++..... .+++..+..++.||+.||+|||++||+||||||+|||++..... .+||+|||++...
T Consensus 80 e~~~~~~L~~~l~~~~~-~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dlkp~Nill~~~~~~~~~~~~~kl~Dfg~a~~~ 158 (259)
T cd05037 80 EYVKFGPLDVFLHREKN-NVSLHWKLDVAKQLASALHYLEDKKLVHGNVCGKNILVARYGLNEGYVPFIKLSDPGIPITV 158 (259)
T ss_pred EcCCCCcHHHHHHhhcc-CCCHHHHHHHHHHHHHHHHHHhhCCeecccCccceEEEecCccccCCceeEEeCCCCccccc
Confidence 99999999999976543 58999999999999999999999999999999999999853211 6999999998764
Q ss_pred cCCCccccccccccCchhhccCCCCCCCcccchhhhhhhhhhhhcCCCCCCCcCcchhHHHHHHHHhc-CCCCCCCCCCc
Q psy11767 526 RESLHTPCFTLQYAAPEVLRQDKSGYDENCDLWSLGVILVNVLRQDKSGYDENCDLWSLGVILYTMLC-GRVPFHARSRD 604 (966)
Q Consensus 526 ~~~~~~~~gT~~Y~APEvl~~~~~~~~~~~Di~SlGvil~el~~~~~~~y~~~~DIWSlGvilyemlt-G~~Pf~~~~~~ 604 (966)
.. .....++..|+|||++... ...++.++|||||||++|+|++ |..||......
T Consensus 159 ~~-~~~~~~~~~y~aPE~~~~~------------------------~~~~~~~~Di~slG~~~~~l~~~~~~p~~~~~~~ 213 (259)
T cd05037 159 LS-REERVERIPWIAPECIRNG------------------------QASLTIAADKWSFGTTLLEICSNGEEPLSTLSSS 213 (259)
T ss_pred cc-ccccccCCCccChhhhcCC------------------------CCCcchhhHHHHHHHHHHHHHhCCCCCcccCCch
Confidence 43 2234467789999988532 1246788999999999999999 68888765432
Q ss_pred hhHHHHHHHHHcCCCCCCchhhccCCHHHHHHHHHhcccCccccCChHHHH
Q psy11767 605 DSALSIMARIKEGQFNFDAEAWSTVSSEAKELTKSLLTVNPAQRIRMMRVK 655 (966)
Q Consensus 605 ~~~~~~~~~i~~~~~~~~~~~~~~is~e~~~Li~~~L~~dP~~R~t~~~v~ 655 (966)
+. ......... .. ...+.++.++|.+||..||.+|||+.++.
T Consensus 214 ~~----~~~~~~~~~-~~----~~~~~~~~~li~~~l~~~p~~Rpt~~~il 255 (259)
T cd05037 214 EK----ERFYQDQHR-LP----MPDCAELANLINQCWTYDPTKRPSFRAIL 255 (259)
T ss_pred hH----HHHHhcCCC-CC----CCCchHHHHHHHHHhccChhhCCCHHHHH
Confidence 21 111111111 11 11237889999999999999999998874
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki |
| >cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-33 Score=303.95 Aligned_cols=235 Identities=26% Similarity=0.465 Sum_probs=189.6
Q ss_pred cccccccccEEEEEEEcCCCcEEEEEEeccccC------hHHHHHHHHHhcCCCCceEEEEEEEeCCeEEEEEEccCCCC
Q psy11767 384 GILGDGSYSVCRRCVEKSTGQEYAVKIISRKID------CSEEINLLRACQGHPNIVNLHCVFQDEVHTYLVLELLKGGE 457 (966)
Q Consensus 384 ~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~~------~~~Ei~iL~~l~~HpnIV~l~~~~~~~~~~~lVmEy~~gg~ 457 (966)
++||+|+||.||+|.+.. ++.||+|++..... ..+|+++++.+ +||||+++++++.+....|+||||+.|++
T Consensus 1 ~~lg~g~~g~v~~~~~~~-~~~v~~K~~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~~~~~v~e~~~~~~ 78 (251)
T cd05041 1 EKIGKGNFGDVYKGVLKG-NTEVAVKTCRSTLPPDLKRKFLQEAEILKQY-DHPNIVKLIGVCVQKQPIYIVMELVPGGS 78 (251)
T ss_pred CccccCCCceEEEEEEeC-CCcEEEEeccccCCHHHHHHHHHHHHHHHhC-CCCCeEEEEEEEecCCCeEEEEEcCCCCc
Confidence 369999999999999988 99999999865432 34688999888 59999999999999999999999999999
Q ss_pred HHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCcEEEecCCCCCEEEEeecccccccCCC-----ccc
Q psy11767 458 LLDRIRQKGRCGFTENEASRIMRQLVAAVHFMHSRGVVHRDLKPENLLFSDPAGDNIKVVDFGFACLKRESL-----HTP 532 (966)
Q Consensus 458 L~~~l~~~~~~~l~e~~~~~i~~Qil~aL~yLHs~~IiHRDLKP~NILl~~~~~~~iKL~DFGla~~~~~~~-----~~~ 532 (966)
|.+++..... .+++..+..++.|++.||+|||+++|+||||||+|||+++ ++.+||+|||++....... ...
T Consensus 79 l~~~l~~~~~-~~~~~~~~~~~~~~~~~l~~lH~~~i~h~di~p~nili~~--~~~~~l~d~g~~~~~~~~~~~~~~~~~ 155 (251)
T cd05041 79 LLTFLRKKKN-RLTVKKLLQMSLDAAAGMEYLESKNCIHRDLAARNCLVGE--NNVLKISDFGMSREEEGGIYTVSDGLK 155 (251)
T ss_pred HHHHHHhcCC-CCCHHHHHHHHHHHHHHHHHHHhCCEehhhcCcceEEEcC--CCcEEEeeccccccccCCcceeccccC
Confidence 9999976543 5899999999999999999999999999999999999975 5689999999987543211 112
Q ss_pred cccccccCchhhccCCCCCCCcccchhhhhhhhhhhhcCCCCCCCcCcchhHHHHHHHHhc-CCCCCCCCCCchhHHHHH
Q psy11767 533 CFTLQYAAPEVLRQDKSGYDENCDLWSLGVILVNVLRQDKSGYDENCDLWSLGVILYTMLC-GRVPFHARSRDDSALSIM 611 (966)
Q Consensus 533 ~gT~~Y~APEvl~~~~~~~~~~~Di~SlGvil~el~~~~~~~y~~~~DIWSlGvilyemlt-G~~Pf~~~~~~~~~~~~~ 611 (966)
..+..|+|||++.. ..++.++|+|||||++|+|++ |..||...... ...
T Consensus 156 ~~~~~y~~PE~~~~--------------------------~~~~~~~Di~slG~i~~~l~t~~~~p~~~~~~~----~~~ 205 (251)
T cd05041 156 QIPIKWTAPEALNY--------------------------GRYTSESDVWSYGILLWETFSLGDTPYPGMSNQ----QTR 205 (251)
T ss_pred cceeccCChHhhcc--------------------------CCCCcchhHHHHHHHHHHHHhccCCCCccCCHH----HHH
Confidence 33567999998742 236788999999999999998 89999765432 122
Q ss_pred HHHHcCCCCCCchhhccCCHHHHHHHHHhcccCccccCChHHHHH
Q psy11767 612 ARIKEGQFNFDAEAWSTVSSEAKELTKSLLTVNPAQRIRMMRVKL 656 (966)
Q Consensus 612 ~~i~~~~~~~~~~~~~~is~e~~~Li~~~L~~dP~~R~t~~~v~~ 656 (966)
..+..+ ... .....++.++.+++.+||..+|++|||+.++..
T Consensus 206 ~~~~~~-~~~--~~~~~~~~~~~~li~~~l~~~p~~Rp~~~ell~ 247 (251)
T cd05041 206 ERIESG-YRM--PAPQLCPEEIYRLMLQCWAYDPENRPSFSEIYN 247 (251)
T ss_pred HHHhcC-CCC--CCCccCCHHHHHHHHHHhccChhhCcCHHHHHH
Confidence 233322 111 122357889999999999999999999998744
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k |
| >cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-34 Score=307.66 Aligned_cols=239 Identities=28% Similarity=0.490 Sum_probs=195.5
Q ss_pred ccccccccccccEEEEEEEcCCCcEEEEEEeccc-------cChHHHHHHHHHhcCCCCceEEEEEEEeCCeEEEEEEcc
Q psy11767 381 DKAGILGDGSYSVCRRCVEKSTGQEYAVKIISRK-------IDCSEEINLLRACQGHPNIVNLHCVFQDEVHTYLVLELL 453 (966)
Q Consensus 381 ~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~-------~~~~~Ei~iL~~l~~HpnIV~l~~~~~~~~~~~lVmEy~ 453 (966)
+..+.||+|+||.||+|.+..+|..||+|.+... ....+|+.+++.+ +|+||+++++.+.+....|+|+||+
T Consensus 3 ~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~~-~h~~i~~~~~~~~~~~~~~lv~e~~ 81 (257)
T cd08225 3 EIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKM-KHPNIVTFFASFQENGRLFIVMEYC 81 (257)
T ss_pred eEEEEecCCCcceEEEEEEcCCCceEEEEEeeHhhccchhhHHHHHHHHHHHhC-CCCChhhhhheeccCCeEEEEEecC
Confidence 3467899999999999999999999999998543 1244689999988 5999999999999999999999999
Q ss_pred CCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCcEEEecCCCCCEEEEeecccccccCCC---c
Q psy11767 454 KGGELLDRIRQKGRCGFTENEASRIMRQLVAAVHFMHSRGVVHRDLKPENLLFSDPAGDNIKVVDFGFACLKRESL---H 530 (966)
Q Consensus 454 ~gg~L~~~l~~~~~~~l~e~~~~~i~~Qil~aL~yLHs~~IiHRDLKP~NILl~~~~~~~iKL~DFGla~~~~~~~---~ 530 (966)
++++|.+++.......+++..+..++.|++.||+|||+.+|+|+||||+|||+++ .+..+||+|||++....... .
T Consensus 82 ~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~H~dl~~~nil~~~-~~~~~~l~d~~~~~~~~~~~~~~~ 160 (257)
T cd08225 82 DGGDLMKRINRQRGVLFSEDQILSWFVQISLGLKHIHDRKILHRDIKSQNIFLSK-NGMVAKLGDFGIARQLNDSMELAY 160 (257)
T ss_pred CCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCHHHEEEcC-CCCeEEecccccchhccCCccccc
Confidence 9999999997755446899999999999999999999999999999999999975 23467999999987654321 2
Q ss_pred cccccccccCchhhccCCCCCCCcccchhhhhhhhhhhhcCCCCCCCcCcchhHHHHHHHHhcCCCCCCCCCCchhHHHH
Q psy11767 531 TPCFTLQYAAPEVLRQDKSGYDENCDLWSLGVILVNVLRQDKSGYDENCDLWSLGVILYTMLCGRVPFHARSRDDSALSI 610 (966)
Q Consensus 531 ~~~gT~~Y~APEvl~~~~~~~~~~~Di~SlGvil~el~~~~~~~y~~~~DIWSlGvilyemltG~~Pf~~~~~~~~~~~~ 610 (966)
...+++.|+|||++.. ..++.++|+|||||++|+|++|..||...+..+ .
T Consensus 161 ~~~~~~~~~ape~~~~--------------------------~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~----~ 210 (257)
T cd08225 161 TCVGTPYYLSPEICQN--------------------------RPYNNKTDIWSLGCVLYELCTLKHPFEGNNLHQ----L 210 (257)
T ss_pred ccCCCccccCHHHHcC--------------------------CCCCchhhHHHHHHHHHHHHhCCCCCCCccHHH----H
Confidence 3457889999998742 236778999999999999999999997654322 2
Q ss_pred HHHHHcCCCCCCchhhccCCHHHHHHHHHhcccCccccCChHHH
Q psy11767 611 MARIKEGQFNFDAEAWSTVSSEAKELTKSLLTVNPAQRIRMMRV 654 (966)
Q Consensus 611 ~~~i~~~~~~~~~~~~~~is~e~~~Li~~~L~~dP~~R~t~~~v 654 (966)
...+..+.+. ...+.++.++.++|.+||..+|++|||+.++
T Consensus 211 ~~~~~~~~~~---~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~l 251 (257)
T cd08225 211 VLKICQGYFA---PISPNFSRDLRSLISQLFKVSPRDRPSITSI 251 (257)
T ss_pred HHHHhcccCC---CCCCCCCHHHHHHHHHHhccChhhCcCHHHH
Confidence 2233333322 1223578899999999999999999999877
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. |
| >cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-33 Score=307.13 Aligned_cols=244 Identities=20% Similarity=0.310 Sum_probs=182.6
Q ss_pred ccccccccEEEEEEEcCC--CcEEEEEEecccc------ChHHHHHHHHHhcCCCCceEEEEEEEeCCeEEEEEEccCCC
Q psy11767 385 ILGDGSYSVCRRCVEKST--GQEYAVKIISRKI------DCSEEINLLRACQGHPNIVNLHCVFQDEVHTYLVLELLKGG 456 (966)
Q Consensus 385 ~LG~G~fG~Vy~a~~~~t--g~~vAvK~i~~~~------~~~~Ei~iL~~l~~HpnIV~l~~~~~~~~~~~lVmEy~~gg 456 (966)
.||+|+||.||+|..... ...+++|.+.... ...+|+.+++.+ +||||+++++.+.+....|+||||+++|
T Consensus 2 ~lg~G~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l-~h~~iv~~~~~~~~~~~~~lv~e~~~~~ 80 (268)
T cd05086 2 EIGNGWFGKVLLSEIYTDTGVARVVVKELKANASSKEQNEFLQQGDPYRIL-QHPNILQCLGQCVEAIPYLLVFEYCELG 80 (268)
T ss_pred cCCCCcCceEEEEEEEcCCCcceEEEEEecCCCChHHHHHHHHHHHHHhcc-CCcchhheEEEecCCCccEEEEecCCCC
Confidence 599999999999975433 3456777765432 244577778777 6999999999999999999999999999
Q ss_pred CHHHHHHhcC--CCCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCcEEEecCCCCCEEEEeecccccccC-----CC
Q psy11767 457 ELLDRIRQKG--RCGFTENEASRIMRQLVAAVHFMHSRGVVHRDLKPENLLFSDPAGDNIKVVDFGFACLKRE-----SL 529 (966)
Q Consensus 457 ~L~~~l~~~~--~~~l~e~~~~~i~~Qil~aL~yLHs~~IiHRDLKP~NILl~~~~~~~iKL~DFGla~~~~~-----~~ 529 (966)
+|.+++.+.. ...+++..++.++.||+.||+|||+++|+||||||+|||++. .+.+||+|||++..... ..
T Consensus 81 ~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~H~dikp~nil~~~--~~~~~l~Dfg~~~~~~~~~~~~~~ 158 (268)
T cd05086 81 DLKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHMHKHNFLHSDLALRNCFLTS--DLTVKVGDYGIGPSRYKEDYIETE 158 (268)
T ss_pred cHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCCeeccCCccceEEEcC--CccEEecccccccccCcchhhhcc
Confidence 9999997642 224677888999999999999999999999999999999975 56899999999854211 12
Q ss_pred ccccccccccCchhhccCCCCCCCcccchhhhhhhhhhhhcCCCCCCCcCcchhHHHHHHHHhc-CCCCCCCCCCchhHH
Q psy11767 530 HTPCFTLQYAAPEVLRQDKSGYDENCDLWSLGVILVNVLRQDKSGYDENCDLWSLGVILYTMLC-GRVPFHARSRDDSAL 608 (966)
Q Consensus 530 ~~~~gT~~Y~APEvl~~~~~~~~~~~Di~SlGvil~el~~~~~~~y~~~~DIWSlGvilyemlt-G~~Pf~~~~~~~~~~ 608 (966)
...++++.|+|||++.....+. ....++.++|||||||++|+|++ |..||......+
T Consensus 159 ~~~~~~~~y~aPE~~~~~~~~~-------------------~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~--- 216 (268)
T cd05086 159 DDKCVPLRWLAPELVGEFHGGL-------------------ITAEQTKPSNVWALGVTLWELFENAAQPYSHLSDRE--- 216 (268)
T ss_pred cCCcCcccccCchhcccccCcc-------------------ccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCHHH---
Confidence 2456788999999885321100 02246788999999999999996 577887544322
Q ss_pred HHHHH-HHcCCCCC-CchhhccCCHHHHHHHHHhcccCccccCChHHHH
Q psy11767 609 SIMAR-IKEGQFNF-DAEAWSTVSSEAKELTKSLLTVNPAQRIRMMRVK 655 (966)
Q Consensus 609 ~~~~~-i~~~~~~~-~~~~~~~is~e~~~Li~~~L~~dP~~R~t~~~v~ 655 (966)
.+.. +..+.... .+.....+++.+.+++.+|| .+|++||++.++.
T Consensus 217 -~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~c~-~~P~~Rp~~~~i~ 263 (268)
T cd05086 217 -VLNHVIKDQQVKLFKPQLELPYSERWYEVLQFCW-LSPEKRATAEEVH 263 (268)
T ss_pred -HHHHHHhhcccccCCCccCCCCcHHHHHHHHHHh-hCcccCCCHHHHH
Confidence 2222 22222222 22222357889999999999 7899999999874
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage |
| >cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-33 Score=304.43 Aligned_cols=241 Identities=27% Similarity=0.452 Sum_probs=194.9
Q ss_pred cccccccccccEEEEEEEcCCCcEEEEEEeccccC-------hHHHHHHHHHhcCCCCceEEEEEEEeCCeEEEEEEccC
Q psy11767 382 KAGILGDGSYSVCRRCVEKSTGQEYAVKIISRKID-------CSEEINLLRACQGHPNIVNLHCVFQDEVHTYLVLELLK 454 (966)
Q Consensus 382 ~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~~-------~~~Ei~iL~~l~~HpnIV~l~~~~~~~~~~~lVmEy~~ 454 (966)
..+.||+|+||.||+|.+..+++.||+|.+..... ..+|+.+++.+ +|+||+++++++.+....++|+||++
T Consensus 4 ~~~~lg~G~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~~~~l-~~~~i~~~~~~~~~~~~~~lv~e~~~ 82 (264)
T cd06626 4 RGNKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELL-KHPNLVKYYGVEVHREKVYIFMEYCS 82 (264)
T ss_pred eeeEeecCCCcEEEEEEECCCCcEEEEEEEECcccchHHHHHHHHHHHHHHhC-CCCChhheeeeEecCCEEEEEEecCC
Confidence 35789999999999999999999999999875432 34688899888 59999999999999999999999999
Q ss_pred CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCcEEEecCCCCCEEEEeecccccccCC------
Q psy11767 455 GGELLDRIRQKGRCGFTENEASRIMRQLVAAVHFMHSRGVVHRDLKPENLLFSDPAGDNIKVVDFGFACLKRES------ 528 (966)
Q Consensus 455 gg~L~~~l~~~~~~~l~e~~~~~i~~Qil~aL~yLHs~~IiHRDLKP~NILl~~~~~~~iKL~DFGla~~~~~~------ 528 (966)
+++|.+++.... .+++..++.++.|++.||+|||+.||+|+||||+||++++ ++.+||+|||++......
T Consensus 83 ~~~L~~~~~~~~--~~~~~~~~~i~~~i~~~l~~lh~~~i~H~dl~~~nil~~~--~~~~kl~d~g~~~~~~~~~~~~~~ 158 (264)
T cd06626 83 GGTLEELLEHGR--ILDEHVIRVYTLQLLEGLAYLHSHGIVHRDIKPANIFLDH--NGVIKLGDFGCAVKLKNNTTTMGE 158 (264)
T ss_pred CCcHHHHHhhcC--CCChHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECC--CCCEEEcccccccccCCCCCcccc
Confidence 999999997653 4899999999999999999999999999999999999985 568999999998654321
Q ss_pred -CccccccccccCchhhccCCCCCCCcccchhhhhhhhhhhhcCCCCCCCcCcchhHHHHHHHHhcCCCCCCCCCCchhH
Q psy11767 529 -LHTPCFTLQYAAPEVLRQDKSGYDENCDLWSLGVILVNVLRQDKSGYDENCDLWSLGVILYTMLCGRVPFHARSRDDSA 607 (966)
Q Consensus 529 -~~~~~gT~~Y~APEvl~~~~~~~~~~~Di~SlGvil~el~~~~~~~y~~~~DIWSlGvilyemltG~~Pf~~~~~~~~~ 607 (966)
.....+++.|+|||++.... ...++.++||||+||++|+|++|+.||......
T Consensus 159 ~~~~~~~~~~~~~PE~~~~~~-----------------------~~~~~~~~Dv~s~G~il~~l~~g~~pf~~~~~~--- 212 (264)
T cd06626 159 EVQSLAGTPAYMAPEVITGGK-----------------------GKGHGRAADIWSLGCVVLEMATGKRPWSELDNE--- 212 (264)
T ss_pred cccCCcCCcCccChhhccCCC-----------------------CCCCCcccchHHHHHHHHHHHhCCCCccCCcch---
Confidence 11345688999999985321 123678899999999999999999999765422
Q ss_pred HHHHHHHHcCCCCCCchhhccCCHHHHHHHHHhcccCccccCChHHH
Q psy11767 608 LSIMARIKEGQFNFDAEAWSTVSSEAKELTKSLLTVNPAQRIRMMRV 654 (966)
Q Consensus 608 ~~~~~~i~~~~~~~~~~~~~~is~e~~~Li~~~L~~dP~~R~t~~~v 654 (966)
......+..+.. .....+..+++.+.++|.+||+.||++||++.++
T Consensus 213 ~~~~~~~~~~~~-~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~i 258 (264)
T cd06626 213 FQIMFHVGAGHK-PPIPDSLQLSPEGKDFLDRCLESDPKKRPTASEL 258 (264)
T ss_pred HHHHHHHhcCCC-CCCCcccccCHHHHHHHHHHccCCcccCCCHHHH
Confidence 122222332221 1112233568999999999999999999999876
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4 |
| >cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-33 Score=307.75 Aligned_cols=242 Identities=20% Similarity=0.352 Sum_probs=192.2
Q ss_pred cccccccccccccEEEEEEEcCCCc----EEEEEEeccccC------hHHHHHHHHHhcCCCCceEEEEEEEeCCeEEEE
Q psy11767 380 LDKAGILGDGSYSVCRRCVEKSTGQ----EYAVKIISRKID------CSEEINLLRACQGHPNIVNLHCVFQDEVHTYLV 449 (966)
Q Consensus 380 ~~~~~~LG~G~fG~Vy~a~~~~tg~----~vAvK~i~~~~~------~~~Ei~iL~~l~~HpnIV~l~~~~~~~~~~~lV 449 (966)
++..+.||+|+||+||+|.++.+|+ .||+|.+..... ..+|+.+|..+ +||||+++++++.. ...++|
T Consensus 9 ~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~-~~~~~v 86 (279)
T cd05057 9 LEKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYVMASV-DHPHVVRLLGICLS-SQVQLI 86 (279)
T ss_pred cEEcceecCCCCccEEEEEEecCCCCcceEEEEEeccCCCCHHHHHHHHHHHHHHHhC-CCCCcceEEEEEec-CceEEE
Confidence 3446889999999999999887765 589998865432 34688899888 69999999999987 788999
Q ss_pred EEccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCcEEEecCCCCCEEEEeecccccccCCC
Q psy11767 450 LELLKGGELLDRIRQKGRCGFTENEASRIMRQLVAAVHFMHSRGVVHRDLKPENLLFSDPAGDNIKVVDFGFACLKRESL 529 (966)
Q Consensus 450 mEy~~gg~L~~~l~~~~~~~l~e~~~~~i~~Qil~aL~yLHs~~IiHRDLKP~NILl~~~~~~~iKL~DFGla~~~~~~~ 529 (966)
|||+++|+|.+++.+... .+++..+..++.||+.||+|||+.||+||||||+|||+++ .+.+||+|||+++......
T Consensus 87 ~e~~~~g~L~~~l~~~~~-~~~~~~~~~~~~qi~~~l~~LH~~~i~H~di~p~nil~~~--~~~~kL~dfg~~~~~~~~~ 163 (279)
T cd05057 87 TQLMPLGCLLDYVRNHKD-NIGSQYLLNWCVQIAKGMSYLEEKRLVHRDLAARNVLVKT--PQHVKITDFGLAKLLDVDE 163 (279)
T ss_pred EecCCCCcHHHHHHhccC-CCCHHHHHHHHHHHHHHHHHHHhCCEEecccCcceEEEcC--CCeEEECCCcccccccCcc
Confidence 999999999999977543 5899999999999999999999999999999999999975 5589999999997543221
Q ss_pred c-----cccccccccCchhhccCCCCCCCcccchhhhhhhhhhhhcCCCCCCCcCcchhHHHHHHHHhc-CCCCCCCCCC
Q psy11767 530 H-----TPCFTLQYAAPEVLRQDKSGYDENCDLWSLGVILVNVLRQDKSGYDENCDLWSLGVILYTMLC-GRVPFHARSR 603 (966)
Q Consensus 530 ~-----~~~gT~~Y~APEvl~~~~~~~~~~~Di~SlGvil~el~~~~~~~y~~~~DIWSlGvilyemlt-G~~Pf~~~~~ 603 (966)
. ...++..|+|||.+.. ..++.++|+|||||++|+|++ |+.||.+...
T Consensus 164 ~~~~~~~~~~~~~y~~PE~~~~--------------------------~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~ 217 (279)
T cd05057 164 KEYHAEGGKVPIKWMALESILH--------------------------RIYTHKSDVWSYGVTVWELMTFGAKPYEGIPA 217 (279)
T ss_pred cceecCCCcccccccCHHHhhc--------------------------CCcCchhhHHHHHHHHHHHhcCCCCCCCCCCH
Confidence 1 1223567999998742 236778999999999999998 9999987643
Q ss_pred chhHHHHHHHHHcCCCCCCchhhccCCHHHHHHHHHhcccCccccCChHHHHHHhh
Q psy11767 604 DDSALSIMARIKEGQFNFDAEAWSTVSSEAKELTKSLLTVNPAQRIRMMRVKLTFH 659 (966)
Q Consensus 604 ~~~~~~~~~~i~~~~~~~~~~~~~~is~e~~~Li~~~L~~dP~~R~t~~~v~~~~~ 659 (966)
. .+...+..+.... .....+.++.+++.+||..||++||++.++...+.
T Consensus 218 ~----~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~l~~~p~~Rp~~~~l~~~l~ 266 (279)
T cd05057 218 V----EIPDLLEKGERLP---QPPICTIDVYMVLVKCWMIDAESRPTFKELINEFS 266 (279)
T ss_pred H----HHHHHHhCCCCCC---CCCCCCHHHHHHHHHHcCCChhhCCCHHHHHHHHH
Confidence 2 2333444432211 11246788999999999999999999998755444
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea |
| >cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-33 Score=307.39 Aligned_cols=241 Identities=23% Similarity=0.376 Sum_probs=191.0
Q ss_pred cccccccccccEEEEEEEcCC---CcEEEEEEeccccC------hHHHHHHHHHhcCCCCceEEEEEEEeCCeEEEEEEc
Q psy11767 382 KAGILGDGSYSVCRRCVEKST---GQEYAVKIISRKID------CSEEINLLRACQGHPNIVNLHCVFQDEVHTYLVLEL 452 (966)
Q Consensus 382 ~~~~LG~G~fG~Vy~a~~~~t---g~~vAvK~i~~~~~------~~~Ei~iL~~l~~HpnIV~l~~~~~~~~~~~lVmEy 452 (966)
..+.||+|+||.||+|.+... ...||||....... ..+|+.+++.+ +||||+++++++.+ ...|+||||
T Consensus 10 ~~~~lg~g~~g~v~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~~-~h~~i~~~~~~~~~-~~~~lv~e~ 87 (270)
T cd05056 10 LGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQF-DHPHIVKLIGVITE-NPVWIVMEL 87 (270)
T ss_pred eeeeeCCccceeEEEEEEecCCCCCcceEEEecCCcCCHHHHHHHHHHHHHHHhC-CCCchhceeEEEcC-CCcEEEEEc
Confidence 357899999999999987654 45799998865432 44688899888 59999999999876 457899999
Q ss_pred cCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCcEEEecCCCCCEEEEeecccccccCCC---
Q psy11767 453 LKGGELLDRIRQKGRCGFTENEASRIMRQLVAAVHFMHSRGVVHRDLKPENLLFSDPAGDNIKVVDFGFACLKRESL--- 529 (966)
Q Consensus 453 ~~gg~L~~~l~~~~~~~l~e~~~~~i~~Qil~aL~yLHs~~IiHRDLKP~NILl~~~~~~~iKL~DFGla~~~~~~~--- 529 (966)
+++|+|.+++.+... .+++..++.++.|++.||+|||+.|++||||||+|||++. .+.+||+|||++.......
T Consensus 88 ~~~~~L~~~l~~~~~-~~~~~~~~~~~~~l~~~l~~lH~~~~~H~dl~p~nili~~--~~~~~l~d~g~~~~~~~~~~~~ 164 (270)
T cd05056 88 APLGELRSYLQVNKY-SLDLASLILYSYQLSTALAYLESKRFVHRDIAARNVLVSS--PDCVKLGDFGLSRYLEDESYYK 164 (270)
T ss_pred CCCCcHHHHHHhCCC-CCCHHHHHHHHHHHHHHHHHHHhCCeeccccChheEEEec--CCCeEEccCceeeeccccccee
Confidence 999999999976543 5899999999999999999999999999999999999985 5689999999986543221
Q ss_pred -ccccccccccCchhhccCCCCCCCcccchhhhhhhhhhhhcCCCCCCCcCcchhHHHHHHHHhc-CCCCCCCCCCchhH
Q psy11767 530 -HTPCFTLQYAAPEVLRQDKSGYDENCDLWSLGVILVNVLRQDKSGYDENCDLWSLGVILYTMLC-GRVPFHARSRDDSA 607 (966)
Q Consensus 530 -~~~~gT~~Y~APEvl~~~~~~~~~~~Di~SlGvil~el~~~~~~~y~~~~DIWSlGvilyemlt-G~~Pf~~~~~~~~~ 607 (966)
....+++.|+|||.+.. ..++.++|||||||++|+|++ |..||......
T Consensus 165 ~~~~~~~~~y~aPE~~~~--------------------------~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~--- 215 (270)
T cd05056 165 ASKGKLPIKWMAPESINF--------------------------RRFTSASDVWMFGVCMWEILMLGVKPFQGVKNN--- 215 (270)
T ss_pred cCCCCccccccChhhhcc--------------------------CCCCchhhhHHHHHHHHHHHHcCCCCCCCCCHH---
Confidence 12223567999998742 236788999999999999986 99999876532
Q ss_pred HHHHHHHHcCCCCCCchhhccCCHHHHHHHHHhcccCccccCChHHHHHHhhh
Q psy11767 608 LSIMARIKEGQFNFDAEAWSTVSSEAKELTKSLLTVNPAQRIRMMRVKLTFHA 660 (966)
Q Consensus 608 ~~~~~~i~~~~~~~~~~~~~~is~e~~~Li~~~L~~dP~~R~t~~~v~~~~~~ 660 (966)
.....+..+.... .+..++.++.++|.+||..+|++|||+.++...+..
T Consensus 216 -~~~~~~~~~~~~~---~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~~~~l~~ 264 (270)
T cd05056 216 -DVIGRIENGERLP---MPPNCPPTLYSLMTKCWAYDPSKRPRFTELKAQLSD 264 (270)
T ss_pred -HHHHHHHcCCcCC---CCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHH
Confidence 2334444443221 234678999999999999999999999887555443
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions |
| >cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-33 Score=308.31 Aligned_cols=242 Identities=22% Similarity=0.402 Sum_probs=194.2
Q ss_pred cccccccccccccEEEEEEEcC-----CCcEEEEEEeccccC------hHHHHHHHHHhcCCCCceEEEEEEEeCCeEEE
Q psy11767 380 LDKAGILGDGSYSVCRRCVEKS-----TGQEYAVKIISRKID------CSEEINLLRACQGHPNIVNLHCVFQDEVHTYL 448 (966)
Q Consensus 380 ~~~~~~LG~G~fG~Vy~a~~~~-----tg~~vAvK~i~~~~~------~~~Ei~iL~~l~~HpnIV~l~~~~~~~~~~~l 448 (966)
|+....||+|+||.||+|+.+. +.+.||+|.+..... ..+|+.+|+.+ +||||+++++++.+....|+
T Consensus 7 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~l 85 (275)
T cd05046 7 LQEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFRRELDMFRKL-SHKNVVRLLGLCREAEPHYM 85 (275)
T ss_pred ceeeeeecccceeEEEEEEeccCCcCCCcceEEEEccCCccchHHHHHHHHHHHHHHhc-CCcceeeeEEEECCCCcceE
Confidence 4457889999999999999764 356899998865432 45699999998 59999999999999999999
Q ss_pred EEEccCCCCHHHHHHhcCC-------CCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCcEEEecCCCCCEEEEeecc
Q psy11767 449 VLELLKGGELLDRIRQKGR-------CGFTENEASRIMRQLVAAVHFMHSRGVVHRDLKPENLLFSDPAGDNIKVVDFGF 521 (966)
Q Consensus 449 VmEy~~gg~L~~~l~~~~~-------~~l~e~~~~~i~~Qil~aL~yLHs~~IiHRDLKP~NILl~~~~~~~iKL~DFGl 521 (966)
||||+++|+|.+++..... ..+++..+..++.||+.||+|||+.+|+||||||+|||++. .+.++|+|||+
T Consensus 86 v~e~~~~~~L~~~i~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~~i~H~dlkp~Nili~~--~~~~~l~~~~~ 163 (275)
T cd05046 86 ILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDHLSNARFVHRDLAARNCLVSS--QREVKVSLLSL 163 (275)
T ss_pred EEEecCCCcHHHHHHhcccccccccccCCCHHHHHHHHHHHHHHHHHhhhcCcccCcCccceEEEeC--CCcEEEccccc
Confidence 9999999999999976541 15899999999999999999999999999999999999975 56899999999
Q ss_pred cccccC----CCccccccccccCchhhccCCCCCCCcccchhhhhhhhhhhhcCCCCCCCcCcchhHHHHHHHHhc-CCC
Q psy11767 522 ACLKRE----SLHTPCFTLQYAAPEVLRQDKSGYDENCDLWSLGVILVNVLRQDKSGYDENCDLWSLGVILYTMLC-GRV 596 (966)
Q Consensus 522 a~~~~~----~~~~~~gT~~Y~APEvl~~~~~~~~~~~Di~SlGvil~el~~~~~~~y~~~~DIWSlGvilyemlt-G~~ 596 (966)
+..... ......++..|+|||.+... .++.++|||||||++|+|++ |..
T Consensus 164 ~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~--------------------------~~~~~~Di~slG~~l~~l~~~~~~ 217 (275)
T cd05046 164 SKDVYNSEYYKLRNALIPLRWLAPEAVQED--------------------------DFSTKSDVWSFGVLMWEVFTQGEL 217 (275)
T ss_pred ccccCcccccccCCceeEEeecChhhhccC--------------------------CCCchhhHHHHHHHHHHHHhCCCC
Confidence 864321 12233457789999987521 24678999999999999998 889
Q ss_pred CCCCCCCchhHHHHHHHHHcCCCCCCchhhccCCHHHHHHHHHhcccCccccCChHHHHH
Q psy11767 597 PFHARSRDDSALSIMARIKEGQFNFDAEAWSTVSSEAKELTKSLLTVNPAQRIRMMRVKL 656 (966)
Q Consensus 597 Pf~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~is~e~~~Li~~~L~~dP~~R~t~~~v~~ 656 (966)
||...... .....+..+...... ...++..+.+++.+||..||++||++.++..
T Consensus 218 p~~~~~~~----~~~~~~~~~~~~~~~--~~~~~~~l~~~i~~~l~~~p~~Rp~~~~~l~ 271 (275)
T cd05046 218 PFYGLSDE----EVLNRLQAGKLELPV--PEGCPSRLYKLMTRCWAVNPKDRPSFSELVS 271 (275)
T ss_pred CccccchH----HHHHHHHcCCcCCCC--CCCCCHHHHHHHHHHcCCCcccCCCHHHHHH
Confidence 99754432 344455555443322 2357889999999999999999999988743
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s |
| >cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-34 Score=322.83 Aligned_cols=251 Identities=27% Similarity=0.464 Sum_probs=193.2
Q ss_pred cccccccccccccEEEEEEEcCCCcEEEEEEecccc-------ChHHHHHHHHHhcCCCCceEEEEEEEe----CCeEEE
Q psy11767 380 LDKAGILGDGSYSVCRRCVEKSTGQEYAVKIISRKI-------DCSEEINLLRACQGHPNIVNLHCVFQD----EVHTYL 448 (966)
Q Consensus 380 ~~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~-------~~~~Ei~iL~~l~~HpnIV~l~~~~~~----~~~~~l 448 (966)
|+..+.||+|+||.||+|.+..+|+.||+|++.... ...+|+.+|+.+. ||||++++++|.. ....|+
T Consensus 7 y~~~~~lg~g~~g~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~~~~~~~~~~~l 85 (334)
T cd07855 7 YKPIENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVPTLAKRTLRELKILRHFK-HDNIIAIRDILRPPGADFKDVYV 85 (334)
T ss_pred eeeeeeeecCCCeEEEEEEEcCCCCEEEEEEeccccccccchHHHHHHHHHHHhcC-CCCccCHHHhccccCCCCceEEE
Confidence 334578999999999999999999999999987542 1346899999985 9999999998863 356899
Q ss_pred EEEccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCcEEEecCCCCCEEEEeecccccccCC
Q psy11767 449 VLELLKGGELLDRIRQKGRCGFTENEASRIMRQLVAAVHFMHSRGVVHRDLKPENLLFSDPAGDNIKVVDFGFACLKRES 528 (966)
Q Consensus 449 VmEy~~gg~L~~~l~~~~~~~l~e~~~~~i~~Qil~aL~yLHs~~IiHRDLKP~NILl~~~~~~~iKL~DFGla~~~~~~ 528 (966)
||||+. ++|.+++.... .+++..++.++.||+.||+|||++||+||||||+|||+++ ++.+||+|||++......
T Consensus 86 v~e~~~-~~l~~~~~~~~--~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~Nil~~~--~~~~kl~dfg~~~~~~~~ 160 (334)
T cd07855 86 VMDLME-SDLHHIIHSDQ--PLTEEHIRYFLYQLLRGLKYIHSANVIHRDLKPSNLLVNE--DCELRIGDFGMARGLSSS 160 (334)
T ss_pred EEehhh-hhHHHHhccCC--CCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcC--CCcEEecccccceeeccc
Confidence 999995 68988886544 5899999999999999999999999999999999999985 568999999998654221
Q ss_pred -------CccccccccccCchhhccCCCCCCCcccchhhhhhhhhhhhcCCCCCCCcCcchhHHHHHHHHhcCCCCCCCC
Q psy11767 529 -------LHTPCFTLQYAAPEVLRQDKSGYDENCDLWSLGVILVNVLRQDKSGYDENCDLWSLGVILYTMLCGRVPFHAR 601 (966)
Q Consensus 529 -------~~~~~gT~~Y~APEvl~~~~~~~~~~~Di~SlGvil~el~~~~~~~y~~~~DIWSlGvilyemltG~~Pf~~~ 601 (966)
.....++..|+|||++.. ...++.++|||||||++|+|++|++||.+.
T Consensus 161 ~~~~~~~~~~~~~~~~y~~PE~~~~-------------------------~~~~~~~~Di~slG~~l~el~~g~~pf~~~ 215 (334)
T cd07855 161 PTEHKYFMTEYVATRWYRAPELLLS-------------------------LPEYTTAIDMWSVGCIFAEMLGRRQLFPGK 215 (334)
T ss_pred CcCCCcccccccccccccChHHhcC-------------------------CcccccccchHHHHHHHHHHHcCCCccCCC
Confidence 123467889999998742 123678899999999999999999999876
Q ss_pred CCchhHHHHHHHHHcC------------------CCC----CC-chhhccCCHHHHHHHHHhcccCccccCChHHHHHHh
Q psy11767 602 SRDDSALSIMARIKEG------------------QFN----FD-AEAWSTVSSEAKELTKSLLTVNPAQRIRMMRVKLTF 658 (966)
Q Consensus 602 ~~~~~~~~~~~~i~~~------------------~~~----~~-~~~~~~is~e~~~Li~~~L~~dP~~R~t~~~v~~~~ 658 (966)
+.......+....... .+. .. ....+.+++++.++|++||+.||++||++.++ ..
T Consensus 216 ~~~~~~~~~~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~--l~ 293 (334)
T cd07855 216 NYVHQLKLILSVLGSPSEEVLNRIGSDRVRKYIQNLPRKQPVPWSKIFPKASPEALDLLSQMLQFDPEERITVEQA--LQ 293 (334)
T ss_pred ChHHHHHHHHHHhCCChhHhhhhhchhhHHHHHhhcccCCCCCHHHHcccCCHHHHHHHHHHccCChhhCcCHHHH--Hh
Confidence 5432211111110000 000 00 11224578999999999999999999999875 34
Q ss_pred hhhHH
Q psy11767 659 HAFHQ 663 (966)
Q Consensus 659 ~~~~~ 663 (966)
|+|..
T Consensus 294 ~~~~~ 298 (334)
T cd07855 294 HPFLA 298 (334)
T ss_pred Chhhh
Confidence 66653
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the |
| >cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-33 Score=305.80 Aligned_cols=239 Identities=21% Similarity=0.398 Sum_probs=190.9
Q ss_pred cccccccccccEEEEEEEcCCCcEEEEEEecccc----ChHHHHHHHHHhcCCCCceEEEEEEEeCCeEEEEEEccCCCC
Q psy11767 382 KAGILGDGSYSVCRRCVEKSTGQEYAVKIISRKI----DCSEEINLLRACQGHPNIVNLHCVFQDEVHTYLVLELLKGGE 457 (966)
Q Consensus 382 ~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~----~~~~Ei~iL~~l~~HpnIV~l~~~~~~~~~~~lVmEy~~gg~ 457 (966)
..+.||+|+||.||++.+. .+..+|+|.+.... ...+|+.+|+.+ +|+||+++++++.+ ...|+||||+++++
T Consensus 10 ~~~~lg~g~~~~vy~~~~~-~~~~~~iK~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~-~~~~~v~e~~~~~~ 86 (260)
T cd05073 10 LEKKLGAGQFGEVWMATYN-KHTKVAVKTMKPGSMSVEAFLAEANVMKTL-QHDKLVKLHAVVTK-EPIYIITEFMAKGS 86 (260)
T ss_pred EEeEecCccceEEEEEEec-CCccEEEEecCCChhHHHHHHHHHHHHHhc-CCCCcceEEEEEcC-CCeEEEEEeCCCCc
Confidence 3678999999999999865 45679999886532 245699999998 59999999999988 77899999999999
Q ss_pred HHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCcEEEecCCCCCEEEEeecccccccCCC----cccc
Q psy11767 458 LLDRIRQKGRCGFTENEASRIMRQLVAAVHFMHSRGVVHRDLKPENLLFSDPAGDNIKVVDFGFACLKRESL----HTPC 533 (966)
Q Consensus 458 L~~~l~~~~~~~l~e~~~~~i~~Qil~aL~yLHs~~IiHRDLKP~NILl~~~~~~~iKL~DFGla~~~~~~~----~~~~ 533 (966)
|.+++.+.....+++..+..++.||+.||+|||+.|++||||||+||+++. .+.+||+|||++....... ....
T Consensus 87 L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~i~H~dl~p~ni~i~~--~~~~~l~d~~~~~~~~~~~~~~~~~~~ 164 (260)
T cd05073 87 LLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRNYIHRDLRAANILVSA--SLVCKIADFGLARVIEDNEYTAREGAK 164 (260)
T ss_pred HHHHHHhCCccccCHHHHHHHHHHHHHHHHHHHhCCccccccCcceEEEcC--CCcEEECCCcceeeccCCCcccccCCc
Confidence 999998755456889999999999999999999999999999999999975 5699999999986543211 1223
Q ss_pred ccccccCchhhccCCCCCCCcccchhhhhhhhhhhhcCCCCCCCcCcchhHHHHHHHHhc-CCCCCCCCCCchhHHHHHH
Q psy11767 534 FTLQYAAPEVLRQDKSGYDENCDLWSLGVILVNVLRQDKSGYDENCDLWSLGVILYTMLC-GRVPFHARSRDDSALSIMA 612 (966)
Q Consensus 534 gT~~Y~APEvl~~~~~~~~~~~Di~SlGvil~el~~~~~~~y~~~~DIWSlGvilyemlt-G~~Pf~~~~~~~~~~~~~~ 612 (966)
++..|+|||++.. ..++.++|+|||||++|+|++ |++||.+.+.. ....
T Consensus 165 ~~~~y~~PE~~~~--------------------------~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~----~~~~ 214 (260)
T cd05073 165 FPIKWTAPEAINF--------------------------GSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNP----EVIR 214 (260)
T ss_pred ccccccCHhHhcc--------------------------CCcCccccchHHHHHHHHHHhcCCCCCCCCCHH----HHHH
Confidence 4567999998852 235778999999999999998 99999865432 2333
Q ss_pred HHHcCCCCCCchhhccCCHHHHHHHHHhcccCccccCChHHHHHHh
Q psy11767 613 RIKEGQFNFDAEAWSTVSSEAKELTKSLLTVNPAQRIRMMRVKLTF 658 (966)
Q Consensus 613 ~i~~~~~~~~~~~~~~is~e~~~Li~~~L~~dP~~R~t~~~v~~~~ 658 (966)
.+..+. .. +.....+.++.+++.+||..||++||++.++...+
T Consensus 215 ~~~~~~-~~--~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~~L 257 (260)
T cd05073 215 ALERGY-RM--PRPENCPEELYNIMMRCWKNRPEERPTFEYIQSVL 257 (260)
T ss_pred HHhCCC-CC--CCcccCCHHHHHHHHHHcccCcccCcCHHHHHHHH
Confidence 444432 21 12246788999999999999999999998875443
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa |
| >PTZ00024 cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-34 Score=320.18 Aligned_cols=248 Identities=25% Similarity=0.424 Sum_probs=194.6
Q ss_pred ccccccccccEEEEEEEcCCCcEEEEEEecccc-------------------ChHHHHHHHHHhcCCCCceEEEEEEEeC
Q psy11767 383 AGILGDGSYSVCRRCVEKSTGQEYAVKIISRKI-------------------DCSEEINLLRACQGHPNIVNLHCVFQDE 443 (966)
Q Consensus 383 ~~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~-------------------~~~~Ei~iL~~l~~HpnIV~l~~~~~~~ 443 (966)
.+.||.|+||+||+|.+..+++.||||++.... ...+|+++|+.+ +||||+++++++..+
T Consensus 14 ~~~ig~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~ 92 (335)
T PTZ00024 14 GAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNEI-KHENIMGLVDVYVEG 92 (335)
T ss_pred hhcccCCCceeEEEEEECCCCCeEEEEEeeccccccccccchhhhcccccchhHHHHHHHHHhC-CCcceeeeeEEEecC
Confidence 357999999999999999999999999985431 134799999998 599999999999999
Q ss_pred CeEEEEEEccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCcEEEecCCCCCEEEEeecccc
Q psy11767 444 VHTYLVLELLKGGELLDRIRQKGRCGFTENEASRIMRQLVAAVHFMHSRGVVHRDLKPENLLFSDPAGDNIKVVDFGFAC 523 (966)
Q Consensus 444 ~~~~lVmEy~~gg~L~~~l~~~~~~~l~e~~~~~i~~Qil~aL~yLHs~~IiHRDLKP~NILl~~~~~~~iKL~DFGla~ 523 (966)
...|+||||+. |+|.+++.... .+++..+..++.|++.||+|||+.||+||||||+|||+++ .+.+||+|||++.
T Consensus 93 ~~~~lv~e~~~-~~l~~~l~~~~--~~~~~~~~~~~~ql~~aL~~LH~~~i~H~dl~~~nill~~--~~~~kl~dfg~~~ 167 (335)
T PTZ00024 93 DFINLVMDIMA-SDLKKVVDRKI--RLTESQVKCILLQILNGLNVLHKWYFMHRDLSPANIFINS--KGICKIADFGLAR 167 (335)
T ss_pred CcEEEEEeccc-cCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCeecccccHHHeEECC--CCCEEECCcccee
Confidence 99999999996 68999987644 5899999999999999999999999999999999999975 5689999999986
Q ss_pred cccC-----------------CCccccccccccCchhhccCCCCCCCcccchhhhhhhhhhhhcCCCCCCCcCcchhHHH
Q psy11767 524 LKRE-----------------SLHTPCFTLQYAAPEVLRQDKSGYDENCDLWSLGVILVNVLRQDKSGYDENCDLWSLGV 586 (966)
Q Consensus 524 ~~~~-----------------~~~~~~gT~~Y~APEvl~~~~~~~~~~~Di~SlGvil~el~~~~~~~y~~~~DIWSlGv 586 (966)
.... ......+++.|+|||++.. ...++.++|+|||||
T Consensus 168 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-------------------------~~~~~~~~Dv~slG~ 222 (335)
T PTZ00024 168 RYGYPPYSDTLSKDETMQRREEMTSKVVTLWYRAPELLMG-------------------------AEKYHFAVDMWSVGC 222 (335)
T ss_pred ecccccccccccccccccccccccccccccCCCCChhccc-------------------------CCCCCcHHHHHHHHH
Confidence 5431 1112345788999998742 123577899999999
Q ss_pred HHHHHhcCCCCCCCCCCchhHHHHHHHHHcCCCC-C----------------C---chhhccCCHHHHHHHHHhcccCcc
Q psy11767 587 ILYTMLCGRVPFHARSRDDSALSIMARIKEGQFN-F----------------D---AEAWSTVSSEAKELTKSLLTVNPA 646 (966)
Q Consensus 587 ilyemltG~~Pf~~~~~~~~~~~~~~~i~~~~~~-~----------------~---~~~~~~is~e~~~Li~~~L~~dP~ 646 (966)
++|+|++|++||.+....+....+...+...... + + .......+.++.++|.+||..||+
T Consensus 223 ~l~el~tg~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~ 302 (335)
T PTZ00024 223 IFAELLTGKPLFPGENEIDQLGRIFELLGTPNEDNWPQAKKLPLYTEFTPRKPKDLKTIFPNASDDAIDLLQSLLKLNPL 302 (335)
T ss_pred HHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCchhhCcchhhcccccccCcCCcccHHHhCcCCChHHHHHHHHHcCCCch
Confidence 9999999999998766443322222221111000 0 0 011234688899999999999999
Q ss_pred ccCChHHHHHHhhhhHH
Q psy11767 647 QRIRMMRVKLTFHAFHQ 663 (966)
Q Consensus 647 ~R~t~~~v~~~~~~~~~ 663 (966)
+||++.++. .|+|++
T Consensus 303 ~R~s~~~~l--~~~~~~ 317 (335)
T PTZ00024 303 ERISAKEAL--KHEYFK 317 (335)
T ss_pred hccCHHHHh--cCcccC
Confidence 999998773 466664
|
|
| >cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-34 Score=321.82 Aligned_cols=250 Identities=25% Similarity=0.474 Sum_probs=195.4
Q ss_pred ccccccccccccEEEEEEEcCCCcEEEEEEecccc-------ChHHHHHHHHHhcCCCCceEEEEEEEeCC------eEE
Q psy11767 381 DKAGILGDGSYSVCRRCVEKSTGQEYAVKIISRKI-------DCSEEINLLRACQGHPNIVNLHCVFQDEV------HTY 447 (966)
Q Consensus 381 ~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~-------~~~~Ei~iL~~l~~HpnIV~l~~~~~~~~------~~~ 447 (966)
+..+.||+|+||.||+|.+..+|+.||||++.+.. ...+|+.+|+.+ +||||++++++|..+. ..|
T Consensus 18 ~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~~~~~~~ 96 (343)
T cd07880 18 RDLKQVGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHM-KHENVIGLLDVFTPDLSLDRFHDFY 96 (343)
T ss_pred EEEEEeeecCCeEEEEEEECCCCcEEEEEEecccccchHHHHHHHHHHHHHHhc-CCCCccceeeeecCCccccccceEE
Confidence 34688999999999999999999999999986432 134689999988 5999999999997654 458
Q ss_pred EEEEccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCcEEEecCCCCCEEEEeecccccccC
Q psy11767 448 LVLELLKGGELLDRIRQKGRCGFTENEASRIMRQLVAAVHFMHSRGVVHRDLKPENLLFSDPAGDNIKVVDFGFACLKRE 527 (966)
Q Consensus 448 lVmEy~~gg~L~~~l~~~~~~~l~e~~~~~i~~Qil~aL~yLHs~~IiHRDLKP~NILl~~~~~~~iKL~DFGla~~~~~ 527 (966)
+||||+ |++|.+++... .+++..++.++.||+.||+|||+.||+||||||+|||+++ ++.+||+|||++.....
T Consensus 97 lv~e~~-~~~l~~~~~~~---~l~~~~~~~i~~qi~~al~~LH~~gi~H~dlkp~Nill~~--~~~~kl~dfg~~~~~~~ 170 (343)
T cd07880 97 LVMPFM-GTDLGKLMKHE---KLSEDRIQFLVYQMLKGLKYIHAAGIIHRDLKPGNLAVNE--DCELKILDFGLARQTDS 170 (343)
T ss_pred EEEecC-CCCHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcC--CCCEEEeeccccccccc
Confidence 999999 78998887643 5899999999999999999999999999999999999975 56899999999976655
Q ss_pred CCccccccccccCchhhccCCCCCCCcccchhhhhhhhhhhhcCCCCCCCcCcchhHHHHHHHHhcCCCCCCCCCCchhH
Q psy11767 528 SLHTPCFTLQYAAPEVLRQDKSGYDENCDLWSLGVILVNVLRQDKSGYDENCDLWSLGVILYTMLCGRVPFHARSRDDSA 607 (966)
Q Consensus 528 ~~~~~~gT~~Y~APEvl~~~~~~~~~~~Di~SlGvil~el~~~~~~~y~~~~DIWSlGvilyemltG~~Pf~~~~~~~~~ 607 (966)
......+++.|+|||++.. ...++.++|+|||||++|+|++|+.||.........
T Consensus 171 ~~~~~~~~~~y~aPE~~~~-------------------------~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~ 225 (343)
T cd07880 171 EMTGYVVTRWYRAPEVILN-------------------------WMHYTQTVDIWSVGCIMAEMLTGKPLFKGHDHLDQL 225 (343)
T ss_pred CccccccCCcccCHHHHhC-------------------------CCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHH
Confidence 4455567899999998842 123577899999999999999999999865432222
Q ss_pred HHHHHHH-----------HcC--------CCCC----CchhhccCCHHHHHHHHHhcccCccccCChHHHHHHhhhhHHh
Q psy11767 608 LSIMARI-----------KEG--------QFNF----DAEAWSTVSSEAKELTKSLLTVNPAQRIRMMRVKLTFHAFHQA 664 (966)
Q Consensus 608 ~~~~~~i-----------~~~--------~~~~----~~~~~~~is~e~~~Li~~~L~~dP~~R~t~~~v~~~~~~~~~~ 664 (966)
..++... ... ...+ ....++.+++++.++|.+||..||++|||+.++. .|+|++.
T Consensus 226 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~t~~~~l--~~~~~~~ 303 (343)
T cd07880 226 MEIMKVTGTPSKEFVQKLQSEDAKNYVKKLPRFRKKDFRSLLPNANPLAVNVLEKMLVLDAESRITAAEAL--AHPYFEE 303 (343)
T ss_pred HHHHHhcCCCCHHHHHhhcchhHHHHHHhccccCcchHHHhccCCChHHHHHHHHHcCCChhhCCCHHHHh--cCccHhh
Confidence 2211100 000 0000 0112346788999999999999999999998763 4666654
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12 |
| >cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-33 Score=308.01 Aligned_cols=242 Identities=26% Similarity=0.452 Sum_probs=195.2
Q ss_pred ccccccccccccEEEEEEEcCCCcEEEEEEecccc------ChHHHHHHHHHhcCCCCceEEEEEEEeCCeEEEEEEccC
Q psy11767 381 DKAGILGDGSYSVCRRCVEKSTGQEYAVKIISRKI------DCSEEINLLRACQGHPNIVNLHCVFQDEVHTYLVLELLK 454 (966)
Q Consensus 381 ~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~------~~~~Ei~iL~~l~~HpnIV~l~~~~~~~~~~~lVmEy~~ 454 (966)
+..+.||.|+||.||+|.+..+++.||||++.... ...+|+.+++.+ +||||+++++++.++...|+||||++
T Consensus 7 ~~~~~ig~G~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~e~~~ 85 (277)
T cd06641 7 TKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQC-DSPYVTKYYGSYLKDTKLWIIMEYLG 85 (277)
T ss_pred hhheeEeecCCeEEEEEEECCCCcEEEEEEeccccchHHHHHHHHHHHHHHhc-CCCCEeEEEEEEEeCCeEEEEEEeCC
Confidence 34678999999999999999999999999976432 244688888887 59999999999999999999999999
Q ss_pred CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCcEEEecCCCCCEEEEeecccccccCC---Ccc
Q psy11767 455 GGELLDRIRQKGRCGFTENEASRIMRQLVAAVHFMHSRGVVHRDLKPENLLFSDPAGDNIKVVDFGFACLKRES---LHT 531 (966)
Q Consensus 455 gg~L~~~l~~~~~~~l~e~~~~~i~~Qil~aL~yLHs~~IiHRDLKP~NILl~~~~~~~iKL~DFGla~~~~~~---~~~ 531 (966)
+++|.+++... .+++..+..++.|++.||.|||+.||+|+||||+||++++ ++.++|+|||++...... ...
T Consensus 86 ~~~l~~~i~~~---~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~p~Ni~i~~--~~~~~l~dfg~~~~~~~~~~~~~~ 160 (277)
T cd06641 86 GGSALDLLEPG---PLDETQIATILREILKGLDYLHSEKKIHRDIKAANVLLSE--HGEVKLADFGVAGQLTDTQIKRNT 160 (277)
T ss_pred CCcHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHccCCeecCCCCHHhEEECC--CCCEEEeecccceecccchhhhcc
Confidence 99999998643 5899999999999999999999999999999999999975 568999999998654321 123
Q ss_pred ccccccccCchhhccCCCCCCCcccchhhhhhhhhhhhcCCCCCCCcCcchhHHHHHHHHhcCCCCCCCCCCchhHHHHH
Q psy11767 532 PCFTLQYAAPEVLRQDKSGYDENCDLWSLGVILVNVLRQDKSGYDENCDLWSLGVILYTMLCGRVPFHARSRDDSALSIM 611 (966)
Q Consensus 532 ~~gT~~Y~APEvl~~~~~~~~~~~Di~SlGvil~el~~~~~~~y~~~~DIWSlGvilyemltG~~Pf~~~~~~~~~~~~~ 611 (966)
..++..|+|||.+.. ..++.++|+||+||++|+|++|.+||...... ...
T Consensus 161 ~~~~~~y~~PE~~~~--------------------------~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~----~~~ 210 (277)
T cd06641 161 FVGTPFWMAPEVIKQ--------------------------SAYDSKADIWSLGITAIELAKGEPPHSELHPM----KVL 210 (277)
T ss_pred ccCCccccChhhhcc--------------------------CCCCchhhHHHHHHHHHHHHcCCCCCCccchH----HHH
Confidence 457889999998742 12467899999999999999999999764432 222
Q ss_pred HHHHcCCCCCCchhhccCCHHHHHHHHHhcccCccccCChHHHHHHhhhhHH
Q psy11767 612 ARIKEGQFNFDAEAWSTVSSEAKELTKSLLTVNPAQRIRMMRVKLTFHAFHQ 663 (966)
Q Consensus 612 ~~i~~~~~~~~~~~~~~is~e~~~Li~~~L~~dP~~R~t~~~v~~~~~~~~~ 663 (966)
..+..+... .....++.++.+++.+||..+|++||++.++.. |+|..
T Consensus 211 ~~~~~~~~~---~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~--~~~~~ 257 (277)
T cd06641 211 FLIPKNNPP---TLEGNYSKPLKEFVEACLNKEPSFRPTAKELLK--HKFIV 257 (277)
T ss_pred HHHhcCCCC---CCCcccCHHHHHHHHHHccCChhhCcCHHHHHh--CHHHh
Confidence 333333221 112356889999999999999999999998743 55553
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int |
| >cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-33 Score=303.09 Aligned_cols=246 Identities=30% Similarity=0.525 Sum_probs=200.0
Q ss_pred cccccccccccccEEEEEEEcCCCcEEEEEEeccccC------hHHHHHHHHHhcCCCCceEEEEEEEeCCeEEEEEEcc
Q psy11767 380 LDKAGILGDGSYSVCRRCVEKSTGQEYAVKIISRKID------CSEEINLLRACQGHPNIVNLHCVFQDEVHTYLVLELL 453 (966)
Q Consensus 380 ~~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~~------~~~Ei~iL~~l~~HpnIV~l~~~~~~~~~~~lVmEy~ 453 (966)
|+..+.||+|+||.||+|.+..+|+.||||++..... ..+|+..+..+. ||||+++++++......++||||+
T Consensus 3 ~~~~~~i~~g~~~~v~~~~~~~~~~~~~vk~~~~~~~~~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~~~~~~lv~e~~ 81 (264)
T cd06623 3 LERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRKQLLRELKTLRSCE-SPYVVKCYGAFYKEGEISIVLEYM 81 (264)
T ss_pred ceeeeeeeecCCeEEEEEEEcCCCcEEEEEEeccCcchHHHHHHHHHHHHHHhcC-CCCeeeEEEEEccCCeEEEEEEec
Confidence 4456889999999999999999999999999875532 446888888885 999999999999999999999999
Q ss_pred CCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHh-cCceeccCCCCcEEEecCCCCCEEEEeecccccccCCC---
Q psy11767 454 KGGELLDRIRQKGRCGFTENEASRIMRQLVAAVHFMHS-RGVVHRDLKPENLLFSDPAGDNIKVVDFGFACLKRESL--- 529 (966)
Q Consensus 454 ~gg~L~~~l~~~~~~~l~e~~~~~i~~Qil~aL~yLHs-~~IiHRDLKP~NILl~~~~~~~iKL~DFGla~~~~~~~--- 529 (966)
++++|.+++.... .+++..+..++.|++.||+|||+ .|++||||+|+||+++. ++.++|+|||++.......
T Consensus 82 ~~~~L~~~l~~~~--~l~~~~~~~~~~~l~~~l~~lh~~~~~~H~~l~~~ni~~~~--~~~~~l~df~~~~~~~~~~~~~ 157 (264)
T cd06623 82 DGGSLADLLKKVG--KIPEPVLAYIARQILKGLDYLHTKRHIIHRDIKPSNLLINS--KGEVKIADFGISKVLENTLDQC 157 (264)
T ss_pred CCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHhccCCCccCCCCHHHEEECC--CCCEEEccCccceecccCCCcc
Confidence 9999999997653 68999999999999999999999 99999999999999975 5689999999987654322
Q ss_pred ccccccccccCchhhccCCCCCCCcccchhhhhhhhhhhhcCCCCCCCcCcchhHHHHHHHHhcCCCCCCCCCCchhHHH
Q psy11767 530 HTPCFTLQYAAPEVLRQDKSGYDENCDLWSLGVILVNVLRQDKSGYDENCDLWSLGVILYTMLCGRVPFHARSRDDSALS 609 (966)
Q Consensus 530 ~~~~gT~~Y~APEvl~~~~~~~~~~~Di~SlGvil~el~~~~~~~y~~~~DIWSlGvilyemltG~~Pf~~~~~~~~~~~ 609 (966)
....++..|+|||.+.. ..++.++|+||||+++|+|++|+.||...... ....
T Consensus 158 ~~~~~~~~y~~pE~~~~--------------------------~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~-~~~~ 210 (264)
T cd06623 158 NTFVGTVTYMSPERIQG--------------------------ESYSYAADIWSLGLTLLECALGKFPFLPPGQP-SFFE 210 (264)
T ss_pred cceeecccccCHhhhCC--------------------------CCCCchhhHHHHHHHHHHHHhCCCCCcccccc-CHHH
Confidence 23457889999998742 23678899999999999999999999876421 1223
Q ss_pred HHHHHHcCCCCCCchhhcc-CCHHHHHHHHHhcccCccccCChHHHHHHhhhhH
Q psy11767 610 IMARIKEGQFNFDAEAWST-VSSEAKELTKSLLTVNPAQRIRMMRVKLTFHAFH 662 (966)
Q Consensus 610 ~~~~i~~~~~~~~~~~~~~-is~e~~~Li~~~L~~dP~~R~t~~~v~~~~~~~~ 662 (966)
....+....... .... ++..+.++|.+||..+|++||++.++. .++|.
T Consensus 211 ~~~~~~~~~~~~---~~~~~~~~~l~~li~~~l~~~p~~R~~~~~ll--~~~~~ 259 (264)
T cd06623 211 LMQAICDGPPPS---LPAEEFSPEFRDFISACLQKDPKKRPSAAELL--QHPFI 259 (264)
T ss_pred HHHHHhcCCCCC---CCcccCCHHHHHHHHHHccCChhhCCCHHHHH--hCHHH
Confidence 334444322211 1123 788999999999999999999998763 34554
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of |
| >cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-33 Score=308.69 Aligned_cols=244 Identities=18% Similarity=0.311 Sum_probs=193.4
Q ss_pred cccccccccccEEEEEEEcC----CCcEEEEEEeccccC------hHHHHHHHHHhcCCCCceEEEEEEEe-CCeEEEEE
Q psy11767 382 KAGILGDGSYSVCRRCVEKS----TGQEYAVKIISRKID------CSEEINLLRACQGHPNIVNLHCVFQD-EVHTYLVL 450 (966)
Q Consensus 382 ~~~~LG~G~fG~Vy~a~~~~----tg~~vAvK~i~~~~~------~~~Ei~iL~~l~~HpnIV~l~~~~~~-~~~~~lVm 450 (966)
..++||+|+||.||+|.+.. ++..||+|++..... ..+|+.+|+.+ +||||+++++++.. +...++++
T Consensus 10 ~~~~i~~g~~g~V~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~e~~~l~~l-~h~ni~~~~~~~~~~~~~~~~~~ 88 (280)
T cd05043 10 LSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDHASEIQVTLLLQESCLLYGL-SHQNILPILHVCIEDGEPPFVLY 88 (280)
T ss_pred EeeeecccCCceEEEEEEecCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHHhC-CCCCCCeEEEEEecCCCCCEEEE
Confidence 35789999999999999886 368899999865432 34688888888 69999999998765 56789999
Q ss_pred EccCCCCHHHHHHhcCC------CCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCcEEEecCCCCCEEEEeeccccc
Q psy11767 451 ELLKGGELLDRIRQKGR------CGFTENEASRIMRQLVAAVHFMHSRGVVHRDLKPENLLFSDPAGDNIKVVDFGFACL 524 (966)
Q Consensus 451 Ey~~gg~L~~~l~~~~~------~~l~e~~~~~i~~Qil~aL~yLHs~~IiHRDLKP~NILl~~~~~~~iKL~DFGla~~ 524 (966)
||+++|+|.+++..... ..+++..+..++.||+.||+|||+++|+||||||+|||+++ .+.+||+|||+++.
T Consensus 89 ~~~~~~~L~~~l~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~di~p~nil~~~--~~~~kl~d~g~~~~ 166 (280)
T cd05043 89 PYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLHKRGVIHKDIAARNCVIDE--ELQVKITDNALSRD 166 (280)
T ss_pred EcCCCCcHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHHCCEeecccCHhhEEEcC--CCcEEECCCCCccc
Confidence 99999999999976432 35899999999999999999999999999999999999975 46899999999975
Q ss_pred ccCCC-----ccccccccccCchhhccCCCCCCCcccchhhhhhhhhhhhcCCCCCCCcCcchhHHHHHHHHhc-CCCCC
Q psy11767 525 KRESL-----HTPCFTLQYAAPEVLRQDKSGYDENCDLWSLGVILVNVLRQDKSGYDENCDLWSLGVILYTMLC-GRVPF 598 (966)
Q Consensus 525 ~~~~~-----~~~~gT~~Y~APEvl~~~~~~~~~~~Di~SlGvil~el~~~~~~~y~~~~DIWSlGvilyemlt-G~~Pf 598 (966)
..... ....++..|+|||++.. ..++.++|||||||++|++++ |++||
T Consensus 167 ~~~~~~~~~~~~~~~~~~y~apE~~~~--------------------------~~~~~~~Di~slG~~l~el~~~g~~p~ 220 (280)
T cd05043 167 LFPMDYHCLGDNENRPVKWMALESLVN--------------------------KEYSSASDVWSFGVLLWELMTLGQTPY 220 (280)
T ss_pred ccCCceEEeCCCCCcchhccCHHHHhc--------------------------CCCCchhhHHHhHHHHHHHhcCCCCCc
Confidence 42211 12334677999998842 236788999999999999998 99999
Q ss_pred CCCCCchhHHHHHHHHHcCCCCCCchhhccCCHHHHHHHHHhcccCccccCChHHHHHHhhhh
Q psy11767 599 HARSRDDSALSIMARIKEGQFNFDAEAWSTVSSEAKELTKSLLTVNPAQRIRMMRVKLTFHAF 661 (966)
Q Consensus 599 ~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~is~e~~~Li~~~L~~dP~~R~t~~~v~~~~~~~ 661 (966)
..... ..+...+..+. .+. ....+++++.+++.+||..||++|||+.++...+..+
T Consensus 221 ~~~~~----~~~~~~~~~~~-~~~--~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~~~ 276 (280)
T cd05043 221 VEIDP----FEMAAYLKDGY-RLA--QPINCPDELFAVMACCWALDPEERPSFSQLVQCLTDF 276 (280)
T ss_pred CcCCH----HHHHHHHHcCC-CCC--CCCcCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHH
Confidence 76533 22334444432 221 2235688999999999999999999999986665543
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It |
| >cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-34 Score=321.45 Aligned_cols=249 Identities=27% Similarity=0.437 Sum_probs=192.3
Q ss_pred ccccccccccccEEEEEEEcCCCcEEEEEEecccc-------ChHHHHHHHHHhcCCCCceEEEEEEEeC-----CeEEE
Q psy11767 381 DKAGILGDGSYSVCRRCVEKSTGQEYAVKIISRKI-------DCSEEINLLRACQGHPNIVNLHCVFQDE-----VHTYL 448 (966)
Q Consensus 381 ~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~-------~~~~Ei~iL~~l~~HpnIV~l~~~~~~~-----~~~~l 448 (966)
...+.||+|+||+||+|++..+|+.||||.+.... ...+|+.+|+.+ +||||+++++++... ...|+
T Consensus 8 ~~~~~lg~G~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~ni~~~~~~~~~~~~~~~~~~~l 86 (337)
T cd07858 8 VPIKPIGRGAYGIVCSAKNSETNEKVAIKKIANAFDNRIDAKRTLREIKLLRHL-DHENVIAIKDIMPPPHREAFNDVYI 86 (337)
T ss_pred eEEEEeccCCCeEEEEEEecCCCCeEEEEEecccccccchhHHHHHHHHHHHhc-CCCCccchHHheecccccccCcEEE
Confidence 34678999999999999999999999999986431 234688999888 599999999988654 35899
Q ss_pred EEEccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCcEEEecCCCCCEEEEeecccccccCC
Q psy11767 449 VLELLKGGELLDRIRQKGRCGFTENEASRIMRQLVAAVHFMHSRGVVHRDLKPENLLFSDPAGDNIKVVDFGFACLKRES 528 (966)
Q Consensus 449 VmEy~~gg~L~~~l~~~~~~~l~e~~~~~i~~Qil~aL~yLHs~~IiHRDLKP~NILl~~~~~~~iKL~DFGla~~~~~~ 528 (966)
||||+. ++|.+++...+ .+++..+..++.||+.||.|||+++|+||||||+|||++. ++.+||+|||++......
T Consensus 87 v~e~~~-~~L~~~~~~~~--~l~~~~~~~i~~qi~~aL~~LH~~~i~H~dlkp~Nil~~~--~~~~kL~Dfg~~~~~~~~ 161 (337)
T cd07858 87 VYELMD-TDLHQIIRSSQ--TLSDDHCQYFLYQLLRGLKYIHSANVLHRDLKPSNLLLNA--NCDLKICDFGLARTTSEK 161 (337)
T ss_pred EEeCCC-CCHHHHHhcCC--CCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcC--CCCEEECcCccccccCCC
Confidence 999995 78998887654 5999999999999999999999999999999999999975 568999999999754322
Q ss_pred ---CccccccccccCchhhccCCCCCCCcccchhhhhhhhhhhhcCCCCCCCcCcchhHHHHHHHHhcCCCCCCCCCCch
Q psy11767 529 ---LHTPCFTLQYAAPEVLRQDKSGYDENCDLWSLGVILVNVLRQDKSGYDENCDLWSLGVILYTMLCGRVPFHARSRDD 605 (966)
Q Consensus 529 ---~~~~~gT~~Y~APEvl~~~~~~~~~~~Di~SlGvil~el~~~~~~~y~~~~DIWSlGvilyemltG~~Pf~~~~~~~ 605 (966)
.....+|..|+|||++... ..++.++|||||||++|+|++|++||.+.+...
T Consensus 162 ~~~~~~~~~~~~y~aPE~~~~~-------------------------~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~ 216 (337)
T cd07858 162 GDFMTEYVVTRWYRAPELLLNC-------------------------SEYTTAIDVWSVGCIFAELLGRKPLFPGKDYVH 216 (337)
T ss_pred cccccccccccCccChHHHhcC-------------------------CCCCCcccHHHHHHHHHHHHcCCCCCCCCChHH
Confidence 2334678899999987521 236788999999999999999999997654322
Q ss_pred hHHHHHHH--------------------HHc---CCCCCCchhhccCCHHHHHHHHHhcccCccccCChHHHHHHhhhhH
Q psy11767 606 SALSIMAR--------------------IKE---GQFNFDAEAWSTVSSEAKELTKSLLTVNPAQRIRMMRVKLTFHAFH 662 (966)
Q Consensus 606 ~~~~~~~~--------------------i~~---~~~~~~~~~~~~is~e~~~Li~~~L~~dP~~R~t~~~v~~~~~~~~ 662 (966)
....+... +.. .........++.+++++.+||++||+.||++|||+.++ ..|+|.
T Consensus 217 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rps~~el--l~h~~~ 294 (337)
T cd07858 217 QLKLITELLGSPSEEDLGFIRNEKARRYIRSLPYTPRQSFARLFPHANPLAIDLLEKMLVFDPSKRITVEEA--LAHPYL 294 (337)
T ss_pred HHHHHHHHhCCCChHHhhhcCchhhhHHHHhcCcccccCHHHHcccCCHHHHHHHHHHhcCChhhccCHHHH--HcCcch
Confidence 11111110 000 00000012235689999999999999999999999876 345554
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati |
| >cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-34 Score=311.91 Aligned_cols=244 Identities=32% Similarity=0.535 Sum_probs=190.3
Q ss_pred ccccccccccccEEEEEEEcCCCcEEEEEEecccc-------ChHHHHHHHHHhcCCCCceEEEEEEEeCCeEEEEEEcc
Q psy11767 381 DKAGILGDGSYSVCRRCVEKSTGQEYAVKIISRKI-------DCSEEINLLRACQGHPNIVNLHCVFQDEVHTYLVLELL 453 (966)
Q Consensus 381 ~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~-------~~~~Ei~iL~~l~~HpnIV~l~~~~~~~~~~~lVmEy~ 453 (966)
+..+.||+|+||.||+|.+..+++.||||++.... ...+|+++|+.+. |+||+++++++.++...|+||||+
T Consensus 4 ~~~~~i~~g~~~~v~~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~~~~~~iv~e~~ 82 (288)
T cd07833 4 EVLGVVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQLR-HENIVNLKEAFRRKGRLYLVFEYV 82 (288)
T ss_pred eEEEEecccCCeeEEEEEeCCCCcEEEEehhhhhcccccchhHHHHHHHHHHhcC-CCCeeehhheEEECCEEEEEEecC
Confidence 34678999999999999999999999999886431 2457999999885 999999999999999999999999
Q ss_pred CCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCcEEEecCCCCCEEEEeecccccccCC----C
Q psy11767 454 KGGELLDRIRQKGRCGFTENEASRIMRQLVAAVHFMHSRGVVHRDLKPENLLFSDPAGDNIKVVDFGFACLKRES----L 529 (966)
Q Consensus 454 ~gg~L~~~l~~~~~~~l~e~~~~~i~~Qil~aL~yLHs~~IiHRDLKP~NILl~~~~~~~iKL~DFGla~~~~~~----~ 529 (966)
+++.+...+.+.. .+++.++..++.||+.||+|||+++|+||||||+||++++ ++.+||+|||++...... .
T Consensus 83 ~~~~l~~~~~~~~--~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~~~ni~~~~--~~~~kl~d~g~~~~~~~~~~~~~ 158 (288)
T cd07833 83 ERTLLELLEASPG--GLPPDAVRSYIWQLLQAIAYCHSHNIIHRDIKPENILVSE--SGVLKLCDFGFARALRARPASPL 158 (288)
T ss_pred CCCHHHHHHhcCC--CCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECC--CCCEEEEeeecccccCCCccccc
Confidence 8766655544332 5899999999999999999999999999999999999985 668999999998764432 2
Q ss_pred ccccccccccCchhhccCCCCCCCcccchhhhhhhhhhhhcCCCCCCCcCcchhHHHHHHHHhcCCCCCCCCCCchhHHH
Q psy11767 530 HTPCFTLQYAAPEVLRQDKSGYDENCDLWSLGVILVNVLRQDKSGYDENCDLWSLGVILYTMLCGRVPFHARSRDDSALS 609 (966)
Q Consensus 530 ~~~~gT~~Y~APEvl~~~~~~~~~~~Di~SlGvil~el~~~~~~~y~~~~DIWSlGvilyemltG~~Pf~~~~~~~~~~~ 609 (966)
....++..|+|||++... ..++.++|||||||++|+|++|++||.+....+....
T Consensus 159 ~~~~~~~~~~~PE~~~~~-------------------------~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~ 213 (288)
T cd07833 159 TDYVATRWYRAPELLVGD-------------------------TNYGKPVDVWAIGCIMAELLDGEPLFPGDSDIDQLYL 213 (288)
T ss_pred cCcccccCCcCCchhcCC-------------------------CCcCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHH
Confidence 235678899999998532 2467899999999999999999999986544322211
Q ss_pred HHHHHH------------cCCC---CCC----c----hhh-ccCCHHHHHHHHHhcccCccccCChHHH
Q psy11767 610 IMARIK------------EGQF---NFD----A----EAW-STVSSEAKELTKSLLTVNPAQRIRMMRV 654 (966)
Q Consensus 610 ~~~~i~------------~~~~---~~~----~----~~~-~~is~e~~~Li~~~L~~dP~~R~t~~~v 654 (966)
+...+. ...+ .+. . ..+ ..++.++.+||++||..||++||++.++
T Consensus 214 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~i 282 (288)
T cd07833 214 IQKCLGPLPPSHQELFSSNPRFAGVAFPEPSQPESLERRYPGKVSSPALDFLKACLRMDPKERLTCDEL 282 (288)
T ss_pred HHHHhCCCCHHHhhhcccCccccccccCCCCCcHHHHHhcCCccchHHHHHHHHHhccCchhcccHHHH
Confidence 111000 0000 000 0 011 1248899999999999999999999876
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning |
| >cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-33 Score=309.83 Aligned_cols=241 Identities=27% Similarity=0.480 Sum_probs=195.3
Q ss_pred ccccccccccEEEEEEEcCCCcEEEEEEecccc-----ChHHHHHHHHHhcCCCCceEEEEEEEeCCeEEEEEEccCCCC
Q psy11767 383 AGILGDGSYSVCRRCVEKSTGQEYAVKIISRKI-----DCSEEINLLRACQGHPNIVNLHCVFQDEVHTYLVLELLKGGE 457 (966)
Q Consensus 383 ~~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~-----~~~~Ei~iL~~l~~HpnIV~l~~~~~~~~~~~lVmEy~~gg~ 457 (966)
.+.||+|+||.||++.+..+++.||+|.+.... ...+|+.+++.+ +||||+++++++....+.|+|+||++|++
T Consensus 24 ~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~~-~h~~vv~~~~~~~~~~~~~~v~e~~~~~~ 102 (285)
T cd06648 24 FVKIGEGSTGIVCIATDKSTGRQVAVKKMDLRKQQRRELLFNEVVIMRDY-QHPNIVEMYSSYLVGDELWVVMEFLEGGA 102 (285)
T ss_pred ceEeccCCCeEEEEEEECCCCCEEEEEEEeccchhHHHHHHHHHHHHHHc-CCCChheEEEEEEcCCeEEEEEeccCCCC
Confidence 468999999999999999999999999885432 235688888887 59999999999999999999999999999
Q ss_pred HHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCcEEEecCCCCCEEEEeecccccccCC---Cccccc
Q psy11767 458 LLDRIRQKGRCGFTENEASRIMRQLVAAVHFMHSRGVVHRDLKPENLLFSDPAGDNIKVVDFGFACLKRES---LHTPCF 534 (966)
Q Consensus 458 L~~~l~~~~~~~l~e~~~~~i~~Qil~aL~yLHs~~IiHRDLKP~NILl~~~~~~~iKL~DFGla~~~~~~---~~~~~g 534 (966)
|.+++... .+++.++..++.|++.||+|||++||+||||||+||+++. ++.++|+|||++...... .....+
T Consensus 103 L~~~~~~~---~~~~~~~~~~~~ql~~~l~~lH~~~i~H~dl~p~Nil~~~--~~~~~l~d~g~~~~~~~~~~~~~~~~~ 177 (285)
T cd06648 103 LTDIVTHT---RMNEEQIATVCLAVLKALSFLHAQGVIHRDIKSDSILLTS--DGRVKLSDFGFCAQVSKEVPRRKSLVG 177 (285)
T ss_pred HHHHHHhC---CCCHHHHHHHHHHHHHHHHHHHhCCeecCCCChhhEEEcC--CCcEEEcccccchhhccCCcccccccC
Confidence 99998762 5899999999999999999999999999999999999975 568999999988654321 123457
Q ss_pred cccccCchhhccCCCCCCCcccchhhhhhhhhhhhcCCCCCCCcCcchhHHHHHHHHhcCCCCCCCCCCchhHHHHHHHH
Q psy11767 535 TLQYAAPEVLRQDKSGYDENCDLWSLGVILVNVLRQDKSGYDENCDLWSLGVILYTMLCGRVPFHARSRDDSALSIMARI 614 (966)
Q Consensus 535 T~~Y~APEvl~~~~~~~~~~~Di~SlGvil~el~~~~~~~y~~~~DIWSlGvilyemltG~~Pf~~~~~~~~~~~~~~~i 614 (966)
++.|+|||++.. ..++.++||||+||++|+|++|+.||...+.. ..+..+
T Consensus 178 ~~~y~aPE~~~~--------------------------~~~~~~~Dv~slGv~l~ell~g~~p~~~~~~~----~~~~~~ 227 (285)
T cd06648 178 TPYWMAPEVISR--------------------------LPYGTEVDIWSLGIMVIEMVDGEPPYFNEPPL----QAMKRI 227 (285)
T ss_pred CccccCHHHhcC--------------------------CCCCCcccHHHHHHHHHHHHhCCCCCcCCCHH----HHHHHH
Confidence 899999998752 23677899999999999999999999765432 233444
Q ss_pred HcCCCCCCchhhccCCHHHHHHHHHhcccCccccCChHHHHHHhhhhH
Q psy11767 615 KEGQFNFDAEAWSTVSSEAKELTKSLLTVNPAQRIRMMRVKLTFHAFH 662 (966)
Q Consensus 615 ~~~~~~~~~~~~~~is~e~~~Li~~~L~~dP~~R~t~~~v~~~~~~~~ 662 (966)
..+..... .....++.++.+++.+||..||++||++.++. .|+|.
T Consensus 228 ~~~~~~~~-~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il--~~~~~ 272 (285)
T cd06648 228 RDNLPPKL-KNLHKVSPRLRSFLDRMLVRDPAQRATAAELL--NHPFL 272 (285)
T ss_pred HhcCCCCC-cccccCCHHHHHHHHHHcccChhhCcCHHHHc--cCccc
Confidence 44322111 11224788999999999999999999998763 35554
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun |
| >cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.5e-34 Score=313.44 Aligned_cols=251 Identities=26% Similarity=0.427 Sum_probs=199.4
Q ss_pred ccccccccccccEEEEEEEcCCCcEEEEEEeccccC-----hHHHHHHHHHhcCCCCceEEEEEEEeCCeEEEEEEccCC
Q psy11767 381 DKAGILGDGSYSVCRRCVEKSTGQEYAVKIISRKID-----CSEEINLLRACQGHPNIVNLHCVFQDEVHTYLVLELLKG 455 (966)
Q Consensus 381 ~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~~-----~~~Ei~iL~~l~~HpnIV~l~~~~~~~~~~~lVmEy~~g 455 (966)
+..+.||+|+||.||++.+..+++.||+|.+..... ..+|+.+++.+ +||||+++++++......|+||||+++
T Consensus 22 ~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l-~hp~i~~~~~~~~~~~~~~lv~e~~~~ 100 (293)
T cd06647 22 TRFEKIGQGASGTVYTAIDVATGQEVAIKQMNLQQQPKKELIINEILVMREN-KHPNIVNYLDSYLVGDELWVVMEYLAG 100 (293)
T ss_pred eeeeEecCCCCeEEEEEEEcCCCCEEEEEEeccccchHHHHHHHHHHHHhhc-CCCCeeehhheeeeCCcEEEEEecCCC
Confidence 336789999999999999999999999999864322 34688888888 599999999999999999999999999
Q ss_pred CCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCcEEEecCCCCCEEEEeecccccccCC---Cccc
Q psy11767 456 GELLDRIRQKGRCGFTENEASRIMRQLVAAVHFMHSRGVVHRDLKPENLLFSDPAGDNIKVVDFGFACLKRES---LHTP 532 (966)
Q Consensus 456 g~L~~~l~~~~~~~l~e~~~~~i~~Qil~aL~yLHs~~IiHRDLKP~NILl~~~~~~~iKL~DFGla~~~~~~---~~~~ 532 (966)
++|.+++.+. .+++.++..++.|++.||.|||++|++||||||+||+++. ++.+||+|||++...... ....
T Consensus 101 ~~L~~~~~~~---~l~~~~~~~i~~~l~~al~~LH~~gi~H~dL~p~Nili~~--~~~~kL~dfg~~~~~~~~~~~~~~~ 175 (293)
T cd06647 101 GSLTDVVTET---CMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGM--DGSVKLTDFGFCAQITPEQSKRSTM 175 (293)
T ss_pred CcHHHHHhhc---CCCHHHHHHHHHHHHHHHHHHHhCCEeeccCCHHHEEEcC--CCCEEEccCcceecccccccccccc
Confidence 9999998754 4889999999999999999999999999999999999975 568999999998644321 2234
Q ss_pred cccccccCchhhccCCCCCCCcccchhhhhhhhhhhhcCCCCCCCcCcchhHHHHHHHHhcCCCCCCCCCCchhHHHHHH
Q psy11767 533 CFTLQYAAPEVLRQDKSGYDENCDLWSLGVILVNVLRQDKSGYDENCDLWSLGVILYTMLCGRVPFHARSRDDSALSIMA 612 (966)
Q Consensus 533 ~gT~~Y~APEvl~~~~~~~~~~~Di~SlGvil~el~~~~~~~y~~~~DIWSlGvilyemltG~~Pf~~~~~~~~~~~~~~ 612 (966)
.+++.|+|||.+.. ..++.++|+|||||++|+|++|+.||...+..+. ..
T Consensus 176 ~~~~~y~~PE~~~~--------------------------~~~~~~~Dv~slG~ll~~ll~g~~pf~~~~~~~~----~~ 225 (293)
T cd06647 176 VGTPYWMAPEVVTR--------------------------KAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRA----LY 225 (293)
T ss_pred cCChhhcCchhhcc--------------------------CCCCchhhHHHHHHHHHHHHhCCCCCCCCChhhh----ee
Confidence 57889999998742 2357789999999999999999999986543221 11
Q ss_pred HHH-cCCCCCCchhhccCCHHHHHHHHHhcccCccccCChHHHHHHhhhhHHhhhccccc
Q psy11767 613 RIK-EGQFNFDAEAWSTVSSEAKELTKSLLTVNPAQRIRMMRVKLTFHAFHQAQKEGFRL 671 (966)
Q Consensus 613 ~i~-~~~~~~~~~~~~~is~e~~~Li~~~L~~dP~~R~t~~~v~~~~~~~~~~~~~~~~~ 671 (966)
.+. .+...+. .+..++.+++++|.+||..+|++||++.++ ..|+|++..+.-.++
T Consensus 226 ~~~~~~~~~~~--~~~~~~~~l~~li~~~l~~~p~~Rp~~~~i--l~h~~~~~~~~~~~~ 281 (293)
T cd06647 226 LIATNGTPELQ--NPEKLSAIFRDFLNRCLEMDVEKRGSAKEL--LQHPFLKIAKPLSSL 281 (293)
T ss_pred ehhcCCCCCCC--CccccCHHHHHHHHHHccCChhhCcCHHHH--hcCHHHhcCcccccc
Confidence 111 1221111 233578899999999999999999999876 457777655543333
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi |
| >cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-34 Score=311.38 Aligned_cols=245 Identities=31% Similarity=0.481 Sum_probs=193.8
Q ss_pred cccccccccccEEEEEEEcCCCcEEEEEEeccccC------hHHHHHHHHHhcCCCCceEEEEEEEeCCeEEEEEEccCC
Q psy11767 382 KAGILGDGSYSVCRRCVEKSTGQEYAVKIISRKID------CSEEINLLRACQGHPNIVNLHCVFQDEVHTYLVLELLKG 455 (966)
Q Consensus 382 ~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~~------~~~Ei~iL~~l~~HpnIV~l~~~~~~~~~~~lVmEy~~g 455 (966)
..+.||+|+||+||+|....+++.||||.+..... ..+|+..++.+.+||||+++++++.++...|+||||+ +
T Consensus 3 ~~~~ig~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~e~~-~ 81 (283)
T cd07830 3 VIKQLGDGTFGSVYLARNKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNEHPNIVKLKEVFRENDELYFVFEYM-E 81 (283)
T ss_pred eheeeccCCceEEEEEEECCCCcEEEEEEehhhccchhHHHHHHHHHHHHhccCCCCchhHHHHhhcCCcEEEEEecC-C
Confidence 35789999999999999999999999999865432 2358888888866999999999999999999999999 8
Q ss_pred CCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCcEEEecCCCCCEEEEeecccccccCC--Ccccc
Q psy11767 456 GELLDRIRQKGRCGFTENEASRIMRQLVAAVHFMHSRGVVHRDLKPENLLFSDPAGDNIKVVDFGFACLKRES--LHTPC 533 (966)
Q Consensus 456 g~L~~~l~~~~~~~l~e~~~~~i~~Qil~aL~yLHs~~IiHRDLKP~NILl~~~~~~~iKL~DFGla~~~~~~--~~~~~ 533 (966)
|+|.+++.......+++.++..++.|++.||.|||++||+|+||||+||++++ ++.++|+|||++...... .....
T Consensus 82 ~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~Lh~~~i~H~dl~~~ni~i~~--~~~~~l~d~~~~~~~~~~~~~~~~~ 159 (283)
T cd07830 82 GNLYQLMKDRKGKPFSESVIRSIIYQILQGLAHIHKHGFFHRDLKPENLLVSG--PEVVKIADFGLAREIRSRPPYTDYV 159 (283)
T ss_pred CCHHHHHHhcccccCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChhhEEEcC--CCCEEEeecccceeccCCCCcCCCC
Confidence 89999997765446899999999999999999999999999999999999985 569999999999755432 22345
Q ss_pred ccccccCchhhccCCCCCCCcccchhhhhhhhhhhhcCCCCCCCcCcchhHHHHHHHHhcCCCCCCCCCCchhHHHHHHH
Q psy11767 534 FTLQYAAPEVLRQDKSGYDENCDLWSLGVILVNVLRQDKSGYDENCDLWSLGVILYTMLCGRVPFHARSRDDSALSIMAR 613 (966)
Q Consensus 534 gT~~Y~APEvl~~~~~~~~~~~Di~SlGvil~el~~~~~~~y~~~~DIWSlGvilyemltG~~Pf~~~~~~~~~~~~~~~ 613 (966)
++..|+|||++.. ...++.++|+|||||++++|++|++||......+........
T Consensus 160 ~~~~~~aPE~~~~-------------------------~~~~~~~~Di~s~G~~l~el~~g~~~~~~~~~~~~~~~~~~~ 214 (283)
T cd07830 160 STRWYRAPEILLR-------------------------STSYSSPVDIWALGCIMAELYTLRPLFPGSSEIDQLYKICSV 214 (283)
T ss_pred CcccccCceeeec-------------------------CcCcCCccchhhHHHHHHHHHhCCCccCCCChHHHHHHHHHh
Confidence 7889999998752 123678899999999999999999999876543332221110
Q ss_pred HH---------------cCCCCC-------CchhhccCCHHHHHHHHHhcccCccccCChHHH
Q psy11767 614 IK---------------EGQFNF-------DAEAWSTVSSEAKELTKSLLTVNPAQRIRMMRV 654 (966)
Q Consensus 614 i~---------------~~~~~~-------~~~~~~~is~e~~~Li~~~L~~dP~~R~t~~~v 654 (966)
+. .....+ .....+..+.++.++|.+||..||++|||+.++
T Consensus 215 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei 277 (283)
T cd07830 215 LGTPTKQDWPEGYKLASKLGFRFPQFAPTSLHQLIPNASPEAIDLIKDMLRWDPKKRPTASQA 277 (283)
T ss_pred cCCCChhhhhhHhhhhccccccccccccccHHHHcccCCHHHHHHHHHhcccCcccCCCHHHH
Confidence 00 000000 011122346889999999999999999999876
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili |
| >cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-34 Score=306.13 Aligned_cols=240 Identities=33% Similarity=0.596 Sum_probs=194.9
Q ss_pred cccccccEEEEEEEcCCCcEEEEEEecccc--------ChHHHHHHHHHhcCCCCceEEEEEEEeCCeEEEEEEccCCCC
Q psy11767 386 LGDGSYSVCRRCVEKSTGQEYAVKIISRKI--------DCSEEINLLRACQGHPNIVNLHCVFQDEVHTYLVLELLKGGE 457 (966)
Q Consensus 386 LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~--------~~~~Ei~iL~~l~~HpnIV~l~~~~~~~~~~~lVmEy~~gg~ 457 (966)
||.|+||.||+|.+..+|+.||+|++.... ...+|+++++.+. ||||+++++.+.++...|+||||+++++
T Consensus 1 lg~g~~~~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~~~-h~~i~~~~~~~~~~~~~~lv~e~~~~~~ 79 (265)
T cd05579 1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQ-SPYVVKLYYSFQGKKNLYLVMEYLPGGD 79 (265)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEecchhhhhhhHHHHHHHHHHHHHhCC-CcchhHHHHheecCcEEEEEEecCCCCc
Confidence 699999999999999999999999986432 2345788888884 9999999999999999999999999999
Q ss_pred HHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCcEEEecCCCCCEEEEeecccccccCC---------
Q psy11767 458 LLDRIRQKGRCGFTENEASRIMRQLVAAVHFMHSRGVVHRDLKPENLLFSDPAGDNIKVVDFGFACLKRES--------- 528 (966)
Q Consensus 458 L~~~l~~~~~~~l~e~~~~~i~~Qil~aL~yLHs~~IiHRDLKP~NILl~~~~~~~iKL~DFGla~~~~~~--------- 528 (966)
|.+++...+ .+++..+..++.||+.||+|||++||+||||+|+||++++ ++.++|+|||++......
T Consensus 80 L~~~l~~~~--~~~~~~~~~i~~qi~~~L~~lH~~~i~H~di~~~nil~~~--~~~~~l~dfg~~~~~~~~~~~~~~~~~ 155 (265)
T cd05579 80 LASLLENVG--SLDEDVARIYIAEIVLALEYLHSNGIIHRDLKPDNILIDS--NGHLKLTDFGLSKVGLVRRQINLNDDE 155 (265)
T ss_pred HHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHcCeecCCCCHHHeEEcC--CCCEEEEecccchhcccCccccccccc
Confidence 999997755 5899999999999999999999999999999999999985 568999999998653221
Q ss_pred --CccccccccccCchhhccCCCCCCCcccchhhhhhhhhhhhcCCCCCCCcCcchhHHHHHHHHhcCCCCCCCCCCchh
Q psy11767 529 --LHTPCFTLQYAAPEVLRQDKSGYDENCDLWSLGVILVNVLRQDKSGYDENCDLWSLGVILYTMLCGRVPFHARSRDDS 606 (966)
Q Consensus 529 --~~~~~gT~~Y~APEvl~~~~~~~~~~~Di~SlGvil~el~~~~~~~y~~~~DIWSlGvilyemltG~~Pf~~~~~~~~ 606 (966)
.....++..|+|||++... .++.++|||||||++|+|++|..||......
T Consensus 156 ~~~~~~~~~~~~~~Pe~~~~~--------------------------~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~-- 207 (265)
T cd05579 156 KEDKRIVGTPDYIAPEVILGQ--------------------------GHSKTVDWWSLGCILYEFLVGIPPFHGETPE-- 207 (265)
T ss_pred ccccCcccCccccCHHHhcCC--------------------------CCCcchhhHHHHHHHHHHHhCCCCCCCCCHH--
Confidence 1223568889999987521 2567899999999999999999999865532
Q ss_pred HHHHHHHHHcCCCCCCchhhccCCHHHHHHHHHhcccCccccCChHHH-HHHhhhhH
Q psy11767 607 ALSIMARIKEGQFNFDAEAWSTVSSEAKELTKSLLTVNPAQRIRMMRV-KLTFHAFH 662 (966)
Q Consensus 607 ~~~~~~~i~~~~~~~~~~~~~~is~e~~~Li~~~L~~dP~~R~t~~~v-~~~~~~~~ 662 (966)
.....+..+.+.++.. ..++.++.+++.+||+.+|++|||+..+ ....|+|+
T Consensus 208 --~~~~~~~~~~~~~~~~--~~~~~~~~~~i~~~l~~~p~~Rpt~~~~~~~l~~~~~ 260 (265)
T cd05579 208 --EIFQNILNGKIEWPED--VEVSDEAIDLISKLLVPDPEKRLGAKSIEEIKNHPFF 260 (265)
T ss_pred --HHHHHHhcCCcCCCcc--ccCCHHHHHHHHHHhcCCHhhcCCCccHHHHhcCccc
Confidence 3344455554443321 2358999999999999999999999544 23445554
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re |
| >cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-33 Score=307.57 Aligned_cols=247 Identities=25% Similarity=0.401 Sum_probs=192.2
Q ss_pred cccccccccccccEEEEEEEc----CCCcEEEEEEeccccC------hHHHHHHHHHhcCCCCceEEEEEEEe--CCeEE
Q psy11767 380 LDKAGILGDGSYSVCRRCVEK----STGQEYAVKIISRKID------CSEEINLLRACQGHPNIVNLHCVFQD--EVHTY 447 (966)
Q Consensus 380 ~~~~~~LG~G~fG~Vy~a~~~----~tg~~vAvK~i~~~~~------~~~Ei~iL~~l~~HpnIV~l~~~~~~--~~~~~ 447 (966)
++..+.||+|+||.||+|... .++..||||++..... ..+|+++++.+ .||||+++++++.. ....+
T Consensus 6 ~~~~~~ig~g~~~~v~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~ei~~l~~l-~~~~i~~~~~~~~~~~~~~~~ 84 (284)
T cd05038 6 LKFIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTL-DHENIVKYKGVCEKPGGRSLR 84 (284)
T ss_pred chhheeeccCCCeeEEEeeecCCCCCCceEEEEEEeccccchHHHHHHHHHHHHHHhC-CCCChheEEeeeecCCCCceE
Confidence 344678999999999999864 3588999999875433 45688999888 59999999999887 56789
Q ss_pred EEEEccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCcEEEecCCCCCEEEEeecccccccC
Q psy11767 448 LVLELLKGGELLDRIRQKGRCGFTENEASRIMRQLVAAVHFMHSRGVVHRDLKPENLLFSDPAGDNIKVVDFGFACLKRE 527 (966)
Q Consensus 448 lVmEy~~gg~L~~~l~~~~~~~l~e~~~~~i~~Qil~aL~yLHs~~IiHRDLKP~NILl~~~~~~~iKL~DFGla~~~~~ 527 (966)
+||||+++++|.+++..... .+++..+..++.||+.||+|||++||+||||||+|||++. ++.++|+|||++.....
T Consensus 85 lv~e~~~~~~l~~~l~~~~~-~~~~~~~~~~~~~l~~aL~~lH~~~i~H~dl~p~nil~~~--~~~~~l~dfg~~~~~~~ 161 (284)
T cd05038 85 LIMEYLPSGSLRDYLQRHRD-QINLKRLLLFSSQICKGMDYLGSQRYIHRDLAARNILVES--EDLVKISDFGLAKVLPE 161 (284)
T ss_pred EEEecCCCCCHHHHHHhCcc-ccCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHhEEEcC--CCCEEEccccccccccc
Confidence 99999999999999976543 5899999999999999999999999999999999999975 56899999999976542
Q ss_pred CCc------cccccccccCchhhccCCCCCCCcccchhhhhhhhhhhhcCCCCCCCcCcchhHHHHHHHHhcCCCCCCCC
Q psy11767 528 SLH------TPCFTLQYAAPEVLRQDKSGYDENCDLWSLGVILVNVLRQDKSGYDENCDLWSLGVILYTMLCGRVPFHAR 601 (966)
Q Consensus 528 ~~~------~~~gT~~Y~APEvl~~~~~~~~~~~Di~SlGvil~el~~~~~~~y~~~~DIWSlGvilyemltG~~Pf~~~ 601 (966)
... ...++..|+|||.+... .++.++|||||||++|+|++|..||...
T Consensus 162 ~~~~~~~~~~~~~~~~~~~Pe~~~~~--------------------------~~~~~~Di~slG~~l~el~tg~~p~~~~ 215 (284)
T cd05038 162 DKDYYYVKEPGESPIFWYAPECLRTS--------------------------KFSSASDVWSFGVTLYELFTYGDPSQSP 215 (284)
T ss_pred CCcceeccCCCCCcccccCcHHHccC--------------------------CCCcccchHHHhhhhheeeccCCCcccc
Confidence 111 12335679999987422 3567899999999999999999998754
Q ss_pred CCchh-----------HHHHHHHHHcCCCCCCchhhccCCHHHHHHHHHhcccCccccCChHHHHHHhh
Q psy11767 602 SRDDS-----------ALSIMARIKEGQFNFDAEAWSTVSSEAKELTKSLLTVNPAQRIRMMRVKLTFH 659 (966)
Q Consensus 602 ~~~~~-----------~~~~~~~i~~~~~~~~~~~~~~is~e~~~Li~~~L~~dP~~R~t~~~v~~~~~ 659 (966)
..... .......+..+. ... .....+.++.+|+.+||..||++|||+.++...++
T Consensus 216 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~--~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l~ 281 (284)
T cd05038 216 PAEFLRMIGIAQGQMIVTRLLELLKEGE-RLP--RPPSCPDEVYDLMKLCWEAEPQDRPSFADLILIVD 281 (284)
T ss_pred cchhccccccccccccHHHHHHHHHcCC-cCC--CCccCCHHHHHHHHHHhccChhhCCCHHHHHHHHh
Confidence 32210 111122222221 111 12346788999999999999999999999865554
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut |
| >cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-33 Score=313.63 Aligned_cols=243 Identities=20% Similarity=0.388 Sum_probs=190.2
Q ss_pred ccccccccccccccEEEEEEEcCCCc----EEEEEEeccccC------hHHHHHHHHHhcCCCCceEEEEEEEeCCeEEE
Q psy11767 379 DLDKAGILGDGSYSVCRRCVEKSTGQ----EYAVKIISRKID------CSEEINLLRACQGHPNIVNLHCVFQDEVHTYL 448 (966)
Q Consensus 379 ~~~~~~~LG~G~fG~Vy~a~~~~tg~----~vAvK~i~~~~~------~~~Ei~iL~~l~~HpnIV~l~~~~~~~~~~~l 448 (966)
+|+..+.||+|+||.||+|.+..+|. .||+|++..... ..+|+.+++.+ +||||+++++++... ..++
T Consensus 8 ~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l-~h~niv~~~~~~~~~-~~~~ 85 (303)
T cd05110 8 ELKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASM-DHPHLVRLLGVCLSP-TIQL 85 (303)
T ss_pred hceeccccccCCCccEEEEEEecCCCcceeeEEEEeccccCCHHHHHHHHHHHHHHHhC-CCCCcccEEEEEcCC-Ccee
Confidence 34557889999999999999988886 478898865432 34678888887 699999999998764 4689
Q ss_pred EEEccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCcEEEecCCCCCEEEEeecccccccCC
Q psy11767 449 VLELLKGGELLDRIRQKGRCGFTENEASRIMRQLVAAVHFMHSRGVVHRDLKPENLLFSDPAGDNIKVVDFGFACLKRES 528 (966)
Q Consensus 449 VmEy~~gg~L~~~l~~~~~~~l~e~~~~~i~~Qil~aL~yLHs~~IiHRDLKP~NILl~~~~~~~iKL~DFGla~~~~~~ 528 (966)
|+||+++|+|.+++..... .+++..+..++.|++.||+|||++||+||||||+|||+++ .+.+||+|||+++.....
T Consensus 86 v~e~~~~g~l~~~~~~~~~-~~~~~~~~~~~~qi~~~L~~LH~~~ivH~dikp~Nill~~--~~~~kL~Dfg~~~~~~~~ 162 (303)
T cd05110 86 VTQLMPHGCLLDYVHEHKD-NIGSQLLLNWCVQIAKGMMYLEERRLVHRDLAARNVLVKS--PNHVKITDFGLARLLEGD 162 (303)
T ss_pred eehhcCCCCHHHHHHhccc-CCCHHHHHHHHHHHHHHHHHHhhcCeeccccccceeeecC--CCceEEccccccccccCc
Confidence 9999999999999876542 5899999999999999999999999999999999999975 458999999999754321
Q ss_pred -----CccccccccccCchhhccCCCCCCCcccchhhhhhhhhhhhcCCCCCCCcCcchhHHHHHHHHhc-CCCCCCCCC
Q psy11767 529 -----LHTPCFTLQYAAPEVLRQDKSGYDENCDLWSLGVILVNVLRQDKSGYDENCDLWSLGVILYTMLC-GRVPFHARS 602 (966)
Q Consensus 529 -----~~~~~gT~~Y~APEvl~~~~~~~~~~~Di~SlGvil~el~~~~~~~y~~~~DIWSlGvilyemlt-G~~Pf~~~~ 602 (966)
.....++..|+|||++.. ..++.++|||||||++|+|++ |..||.+..
T Consensus 163 ~~~~~~~~~~~~~~y~~PE~~~~--------------------------~~~~~~~DiwslG~~l~el~t~g~~p~~~~~ 216 (303)
T cd05110 163 EKEYNADGGKMPIKWMALECIHY--------------------------RKFTHQSDVWSYGVTIWELMTFGGKPYDGIP 216 (303)
T ss_pred ccccccCCCccccccCCHHHhcc--------------------------CCCChHHHHHHHHHHHHHHHhCCCCCCCCCC
Confidence 112334678999998742 236788999999999999997 999997654
Q ss_pred CchhHHHHHHHHHcCCCCCCchhhccCCHHHHHHHHHhcccCccccCChHHHHHHhh
Q psy11767 603 RDDSALSIMARIKEGQFNFDAEAWSTVSSEAKELTKSLLTVNPAQRIRMMRVKLTFH 659 (966)
Q Consensus 603 ~~~~~~~~~~~i~~~~~~~~~~~~~~is~e~~~Li~~~L~~dP~~R~t~~~v~~~~~ 659 (966)
.. .....+..+.. +. .....+..+.+++.+||..||++||++.++...+.
T Consensus 217 ~~----~~~~~~~~~~~-~~--~~~~~~~~~~~li~~c~~~~p~~Rp~~~~l~~~l~ 266 (303)
T cd05110 217 TR----EIPDLLEKGER-LP--QPPICTIDVYMVMVKCWMIDADSRPKFKELAAEFS 266 (303)
T ss_pred HH----HHHHHHHCCCC-CC--CCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHH
Confidence 22 12222333221 11 12346788999999999999999999998755443
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin |
| >cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-33 Score=305.50 Aligned_cols=243 Identities=28% Similarity=0.492 Sum_probs=193.9
Q ss_pred cccccccccccccEEEEEEEcC-CCcEEEEEEecccc---------------ChHHHHHHHHHhcCCCCceEEEEEEEeC
Q psy11767 380 LDKAGILGDGSYSVCRRCVEKS-TGQEYAVKIISRKI---------------DCSEEINLLRACQGHPNIVNLHCVFQDE 443 (966)
Q Consensus 380 ~~~~~~LG~G~fG~Vy~a~~~~-tg~~vAvK~i~~~~---------------~~~~Ei~iL~~l~~HpnIV~l~~~~~~~ 443 (966)
|+..+.||+|+||.||+|.+.. +++.+|+|.+.... ....|+.++....+||||+++++++.++
T Consensus 2 y~~~~~ig~G~~~~v~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~ 81 (269)
T cd08528 2 YAVLEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLRHPNIVRYYKTFLEN 81 (269)
T ss_pred chhhhhhcCCCCceEEEEEEcCCCCceeeeeEeeccccccccccccchHHHHHHHHHHHHHhhcCCCCCeeeEEeeEccC
Confidence 3446889999999999999988 78899999875321 1234777777656799999999999999
Q ss_pred CeEEEEEEccCCCCHHHHHHhc--CCCCCCHHHHHHHHHHHHHHHHHHHh-cCceeccCCCCcEEEecCCCCCEEEEeec
Q psy11767 444 VHTYLVLELLKGGELLDRIRQK--GRCGFTENEASRIMRQLVAAVHFMHS-RGVVHRDLKPENLLFSDPAGDNIKVVDFG 520 (966)
Q Consensus 444 ~~~~lVmEy~~gg~L~~~l~~~--~~~~l~e~~~~~i~~Qil~aL~yLHs-~~IiHRDLKP~NILl~~~~~~~iKL~DFG 520 (966)
.+.|+||||++|++|.+++... ....+++..++.++.|++.||+|||+ .+|+|+||||+|||++. .+.+||+|||
T Consensus 82 ~~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~i~H~dl~~~nil~~~--~~~~~l~dfg 159 (269)
T cd08528 82 DRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLALRYLHKEKRIVHRDLTPNNIMLGE--DDKVTITDFG 159 (269)
T ss_pred CeEEEEEecCCCCcHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHhccCCceeecCCCHHHEEECC--CCcEEEeccc
Confidence 9999999999999999887542 22358999999999999999999996 68999999999999975 5689999999
Q ss_pred ccccccCC--CccccccccccCchhhccCCCCCCCcccchhhhhhhhhhhhcCCCCCCCcCcchhHHHHHHHHhcCCCCC
Q psy11767 521 FACLKRES--LHTPCFTLQYAAPEVLRQDKSGYDENCDLWSLGVILVNVLRQDKSGYDENCDLWSLGVILYTMLCGRVPF 598 (966)
Q Consensus 521 la~~~~~~--~~~~~gT~~Y~APEvl~~~~~~~~~~~Di~SlGvil~el~~~~~~~y~~~~DIWSlGvilyemltG~~Pf 598 (966)
++...... .....++..|+|||++.. ..++.++|+|||||++|+|++|++||
T Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~Pe~~~~--------------------------~~~~~~~Dv~slG~ll~~l~~g~~p~ 213 (269)
T cd08528 160 LAKQKQPESKLTSVVGTILYSCPEIVKN--------------------------EPYGEKADVWAFGCILYQMCTLQPPF 213 (269)
T ss_pred ceeecccccccccccCcccCcChhhhcC--------------------------CCCchHHHHHHHHHHHHHHHhCCCcc
Confidence 98654332 234467889999998852 22577899999999999999999999
Q ss_pred CCCCCchhHHHHHHHHHcCCCCCCchhhccCCHHHHHHHHHhcccCccccCChHHHHH
Q psy11767 599 HARSRDDSALSIMARIKEGQFNFDAEAWSTVSSEAKELTKSLLTVNPAQRIRMMRVKL 656 (966)
Q Consensus 599 ~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~is~e~~~Li~~~L~~dP~~R~t~~~v~~ 656 (966)
..... ......+..+.+... ....+++++.++|.+||+.||++||++.++..
T Consensus 214 ~~~~~----~~~~~~~~~~~~~~~--~~~~~~~~l~~li~~cl~~~p~~Rp~~~e~~~ 265 (269)
T cd08528 214 YSTNM----LSLATKIVEAVYEPL--PEGMYSEDVTDVITSCLTPDAEARPDIIQVSA 265 (269)
T ss_pred cccCH----HHHHHHHhhccCCcC--CcccCCHHHHHHHHHHCCCCCccCCCHHHHHH
Confidence 75432 223344444443321 12257889999999999999999999998743
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. |
| >cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-33 Score=310.67 Aligned_cols=250 Identities=30% Similarity=0.527 Sum_probs=196.6
Q ss_pred ccccccccccccEEEEEEEc---CCCcEEEEEEecccc---------ChHHHHHHHHHhcCCCCceEEEEEEEeCCeEEE
Q psy11767 381 DKAGILGDGSYSVCRRCVEK---STGQEYAVKIISRKI---------DCSEEINLLRACQGHPNIVNLHCVFQDEVHTYL 448 (966)
Q Consensus 381 ~~~~~LG~G~fG~Vy~a~~~---~tg~~vAvK~i~~~~---------~~~~Ei~iL~~l~~HpnIV~l~~~~~~~~~~~l 448 (966)
+..+.||+|+||.||+|.+. .+++.||||++.+.. ...+|+.++..+.+||||+++++++.++...|+
T Consensus 3 ~~~~~ig~G~~~~vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~~~~~~~~l 82 (288)
T cd05583 3 ELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVRRCPFLVTLHYAFQTDTKLHL 82 (288)
T ss_pred eEEEEeccCCCceEEEEEEeccccCCcEEEEEEEehHHHHhhhhHHHHHHHHHHHHHhccCCcchhhhheeeecCCEEEE
Confidence 34678999999999999864 467899999986421 134688999999889999999999999999999
Q ss_pred EEEccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCcEEEecCCCCCEEEEeecccccccCC
Q psy11767 449 VLELLKGGELLDRIRQKGRCGFTENEASRIMRQLVAAVHFMHSRGVVHRDLKPENLLFSDPAGDNIKVVDFGFACLKRES 528 (966)
Q Consensus 449 VmEy~~gg~L~~~l~~~~~~~l~e~~~~~i~~Qil~aL~yLHs~~IiHRDLKP~NILl~~~~~~~iKL~DFGla~~~~~~ 528 (966)
||||+++|+|.+++.... .+++..++.++.|++.||+|||+.+++||||||+|||++. ++.++|+|||++......
T Consensus 83 v~e~~~~~~L~~~~~~~~--~~~~~~~~~~~~ql~~~l~~lH~~~~~H~dl~p~nil~~~--~~~~~l~dfg~~~~~~~~ 158 (288)
T cd05583 83 ILDYVNGGELFTHLYQRE--HFTESEVRVYIAEIVLALDHLHQLGIIYRDIKLENILLDS--EGHVVLTDFGLSKEFLAE 158 (288)
T ss_pred EEecCCCCcHHHHHhhcC--CcCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECC--CCCEEEEECccccccccc
Confidence 999999999999987653 5899999999999999999999999999999999999975 568999999998654321
Q ss_pred ----CccccccccccCchhhccCCCCCCCcccchhhhhhhhhhhhcCCCCCCCcCcchhHHHHHHHHhcCCCCCCCCCCc
Q psy11767 529 ----LHTPCFTLQYAAPEVLRQDKSGYDENCDLWSLGVILVNVLRQDKSGYDENCDLWSLGVILYTMLCGRVPFHARSRD 604 (966)
Q Consensus 529 ----~~~~~gT~~Y~APEvl~~~~~~~~~~~Di~SlGvil~el~~~~~~~y~~~~DIWSlGvilyemltG~~Pf~~~~~~ 604 (966)
....++++.|+|||.+... ...++.++|+||||+++|+|++|..||......
T Consensus 159 ~~~~~~~~~~~~~y~aPE~~~~~------------------------~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~ 214 (288)
T cd05583 159 EEERAYSFCGTIEYMAPEVIRGG------------------------SGGHDKAVDWWSLGVLTFELLTGASPFTVDGEQ 214 (288)
T ss_pred cccccccccCCccccCHHHhcCC------------------------CCCCcchhhhHHHHHHHHHHHhCCCCcccCccc
Confidence 1234578899999987432 123567899999999999999999999754322
Q ss_pred hhHHHHHHHHHcCCCCCCchhhccCCHHHHHHHHHhcccCccccCChHHHH-HHhhhhH
Q psy11767 605 DSALSIMARIKEGQFNFDAEAWSTVSSEAKELTKSLLTVNPAQRIRMMRVK-LTFHAFH 662 (966)
Q Consensus 605 ~~~~~~~~~i~~~~~~~~~~~~~~is~e~~~Li~~~L~~dP~~R~t~~~v~-~~~~~~~ 662 (966)
.....+...+...... ....++.++.++|.+||+.||++|||+.++. ...|+|.
T Consensus 215 ~~~~~~~~~~~~~~~~----~~~~~~~~l~~li~~~l~~~p~~R~t~~~~~~~l~~~~~ 269 (288)
T cd05583 215 NSQSEISRRILKSKPP----FPKTMSAEARDFIQKLLEKDPKKRLGANGADEIKNHPFF 269 (288)
T ss_pred chHHHHHHHHHccCCC----CCcccCHHHHHHHHHHhcCCHhhccCcchHHHHhcCccc
Confidence 2222223333333222 2235788999999999999999999987663 3445554
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines |
| >cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-34 Score=314.92 Aligned_cols=243 Identities=24% Similarity=0.419 Sum_probs=186.0
Q ss_pred cccccccccccEEEEEEEcCCCcEEEEEEecccc-------ChHHHHHHHHHhcCCCCceEEEEEEEeC--------CeE
Q psy11767 382 KAGILGDGSYSVCRRCVEKSTGQEYAVKIISRKI-------DCSEEINLLRACQGHPNIVNLHCVFQDE--------VHT 446 (966)
Q Consensus 382 ~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~-------~~~~Ei~iL~~l~~HpnIV~l~~~~~~~--------~~~ 446 (966)
..+.||+|+||.||+|.+..+++.||||++.... ...+|+++|+.+ +||||+++++++.+. ..+
T Consensus 12 ~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~~~~~~~~ 90 (311)
T cd07866 12 ILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEKDGFPITALREIKILKKL-KHPNVVPLIDMAVERPDKSKRKRGSV 90 (311)
T ss_pred EEEEeccCCCEEEEEEEECCCCcEEEEEEEEeccCCCCcchhHHHHHHHHHhc-CCCCccchhhheecccccccccCceE
Confidence 3678999999999999999999999999885421 245799999988 599999999887543 346
Q ss_pred EEEEEccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCcEEEecCCCCCEEEEeeccccccc
Q psy11767 447 YLVLELLKGGELLDRIRQKGRCGFTENEASRIMRQLVAAVHFMHSRGVVHRDLKPENLLFSDPAGDNIKVVDFGFACLKR 526 (966)
Q Consensus 447 ~lVmEy~~gg~L~~~l~~~~~~~l~e~~~~~i~~Qil~aL~yLHs~~IiHRDLKP~NILl~~~~~~~iKL~DFGla~~~~ 526 (966)
|+||||+. ++|...+.... ..+++..++.++.||+.||+|||++||+||||||+|||+++ ++.+||+|||++....
T Consensus 91 ~lv~~~~~-~~l~~~~~~~~-~~~~~~~~~~i~~~l~~al~~lH~~~i~H~dl~p~nil~~~--~~~~~l~dfg~~~~~~ 166 (311)
T cd07866 91 YMVTPYMD-HDLSGLLENPS-VKLTESQIKCYMLQLLEGINYLHENHILHRDIKAANILIDN--QGILKIADFGLARPYD 166 (311)
T ss_pred EEEEecCC-cCHHHHHhccc-cCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECC--CCCEEECcCccchhcc
Confidence 99999995 57777776543 36999999999999999999999999999999999999975 5689999999986532
Q ss_pred CCC--------------ccccccccccCchhhccCCCCCCCcccchhhhhhhhhhhhcCCCCCCCcCcchhHHHHHHHHh
Q psy11767 527 ESL--------------HTPCFTLQYAAPEVLRQDKSGYDENCDLWSLGVILVNVLRQDKSGYDENCDLWSLGVILYTML 592 (966)
Q Consensus 527 ~~~--------------~~~~gT~~Y~APEvl~~~~~~~~~~~Di~SlGvil~el~~~~~~~y~~~~DIWSlGvilyeml 592 (966)
... ....+++.|+|||++.. ...++.++|||||||++|+|+
T Consensus 167 ~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-------------------------~~~~~~~~Dv~slG~il~el~ 221 (311)
T cd07866 167 GPPPNPKGGGGGGTRKYTNLVVTRWYRPPELLLG-------------------------ERRYTTAVDIWGIGCVFAEMF 221 (311)
T ss_pred CCCcccccCCcccccccccceeccCcCChHHhhC-------------------------CCccCchhHhHHHHHHHHHHH
Confidence 211 12245788999998742 123677899999999999999
Q ss_pred cCCCCCCCCCCchhHHHHHHHHHcCC---C----------------CCC---chhhccCCHHHHHHHHHhcccCccccCC
Q psy11767 593 CGRVPFHARSRDDSALSIMARIKEGQ---F----------------NFD---AEAWSTVSSEAKELTKSLLTVNPAQRIR 650 (966)
Q Consensus 593 tG~~Pf~~~~~~~~~~~~~~~i~~~~---~----------------~~~---~~~~~~is~e~~~Li~~~L~~dP~~R~t 650 (966)
+|++||.+.+.......+........ + ..+ ...+..+++++.++|.+||..||++|||
T Consensus 222 ~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~t 301 (311)
T cd07866 222 TRRPILQGKSDIDQLHLIFKLCGTPTEETWPGWRSLPGCEGVHSFTNYPRTLEERFGKLGPEGLDLLSKLLSLDPYKRLT 301 (311)
T ss_pred hCCCCCCCCCHHHHHHHHHHHhCCCChhhchhhhhcccccccccCCCCCccHHHHcccCChhHHHHHHHHcccCcccCcC
Confidence 99999987654332222222110000 0 000 0112345678899999999999999999
Q ss_pred hHHH
Q psy11767 651 MMRV 654 (966)
Q Consensus 651 ~~~v 654 (966)
+.++
T Consensus 302 ~~el 305 (311)
T cd07866 302 ASDA 305 (311)
T ss_pred HHHH
Confidence 9876
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic |
| >KOG0668|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-35 Score=294.89 Aligned_cols=254 Identities=24% Similarity=0.442 Sum_probs=200.9
Q ss_pred ccccccccccccccEEEEEEEcCCCcEEEEEEecc--ccChHHHHHHHHHhcCCCCceEEEEEEEeCC--eEEEEEEccC
Q psy11767 379 DLDKAGILGDGSYSVCRRCVEKSTGQEYAVKIISR--KIDCSEEINLLRACQGHPNIVNLHCVFQDEV--HTYLVLELLK 454 (966)
Q Consensus 379 ~~~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~--~~~~~~Ei~iL~~l~~HpnIV~l~~~~~~~~--~~~lVmEy~~ 454 (966)
+|+..+.+|+|.|+.|+.|++..+++.++||+++. +....+|+++|+.+.+|||||+|+++..+.. ...||+||+.
T Consensus 39 dYeivrk~GRGKYSEVFeg~~~~~~eK~ViKiLKPVkkkKIkREikIL~nL~gg~NIi~L~DiV~Dp~SktpaLiFE~v~ 118 (338)
T KOG0668|consen 39 DYEIVRKVGRGKYSEVFEGINITNNEKCVIKILKPVKKKKIKREIKILQNLRGGPNIIKLLDIVKDPESKTPSLIFEYVN 118 (338)
T ss_pred hHHHHHHHcCccHhhHhcccccCCCceEEEeeechHHHHHHHHHHHHHHhccCCCCeeehhhhhcCccccCchhHhhhhc
Confidence 45557899999999999999999999999999974 3457799999999999999999999998764 4679999998
Q ss_pred CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCcEEEecCCCCCEEEEeecccccccC--CCccc
Q psy11767 455 GGELLDRIRQKGRCGFTENEASRIMRQLVAAVHFMHSRGVVHRDLKPENLLFSDPAGDNIKVVDFGFACLKRE--SLHTP 532 (966)
Q Consensus 455 gg~L~~~l~~~~~~~l~e~~~~~i~~Qil~aL~yLHs~~IiHRDLKP~NILl~~~~~~~iKL~DFGla~~~~~--~~~~~ 532 (966)
+.+...... .|+..+++.++.|+++||+||||+||+|||+||.|++|+. ....++|+|+|||-+.+. ..+..
T Consensus 119 n~Dfk~ly~-----tl~d~dIryY~~elLkALdyCHS~GImHRDVKPhNvmIdh-~~rkLrlIDWGLAEFYHp~~eYnVR 192 (338)
T KOG0668|consen 119 NTDFKQLYP-----TLTDYDIRYYIYELLKALDYCHSMGIMHRDVKPHNVMIDH-ELRKLRLIDWGLAEFYHPGKEYNVR 192 (338)
T ss_pred cccHHHHhh-----hhchhhHHHHHHHHHHHHhHHHhcCcccccCCcceeeech-hhceeeeeecchHhhcCCCceeeee
Confidence 877654432 4889999999999999999999999999999999999975 456899999999977654 23455
Q ss_pred cccccccCchhhccCCCCCCCcccchhhhhhhhhhhhcCCCCCCCcCcchhHHHHHHHHhcCCCCCCCCCCchhHHHHHH
Q psy11767 533 CFTLQYAAPEVLRQDKSGYDENCDLWSLGVILVNVLRQDKSGYDENCDLWSLGVILYTMLCGRVPFHARSRDDSALSIMA 612 (966)
Q Consensus 533 ~gT~~Y~APEvl~~~~~~~~~~~Di~SlGvil~el~~~~~~~y~~~~DIWSlGvilyemltG~~Pf~~~~~~~~~~~~~~ 612 (966)
+.+..|.-||++-. -..|+.+-|+|||||+|..|+..+-||.....+...+.-++
T Consensus 193 VASRyfKGPELLVd-------------------------y~~YDYSLD~WS~GcmlA~miFrkepFFhG~dN~DQLVkIa 247 (338)
T KOG0668|consen 193 VASRYFKGPELLVD-------------------------YQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVKIA 247 (338)
T ss_pred eehhhcCCchheee-------------------------chhccccHHHHHHHHHHHHHHhccCcccCCCCCHHHHHHHH
Confidence 67889999999853 23488899999999999999999988865544333333233
Q ss_pred HHH----------cCCCCCC--------------------chhhccCCHHHHHHHHHhcccCccccCChHHHHHHhhhhH
Q psy11767 613 RIK----------EGQFNFD--------------------AEAWSTVSSEAKELTKSLLTVNPAQRIRMMRVKLTFHAFH 662 (966)
Q Consensus 613 ~i~----------~~~~~~~--------------------~~~~~~is~e~~~Li~~~L~~dP~~R~t~~~v~~~~~~~~ 662 (966)
++. .-...++ ++....+++++.||+.++|++|..+|+|+.|. +-|+++
T Consensus 248 kVLGt~el~~Yl~KY~i~Ldp~~~~i~~~~~rk~w~~Fi~~~n~hl~~peaiDlldklLrYDHqeRlTakEa--m~HpyF 325 (338)
T KOG0668|consen 248 KVLGTDELYAYLNKYQIDLDPQFEDILGRHSRKPWSRFINSENQHLVSPEAIDLLDKLLRYDHQERLTAKEA--MAHPYF 325 (338)
T ss_pred HHhChHHHHHHHHHHccCCChhHhhHhhccccccHHHhCCccccccCChHHHHHHHHHHhhccccccchHHH--hcCchH
Confidence 221 1111111 11223468999999999999999999999864 567776
Q ss_pred Hhh
Q psy11767 663 QAQ 665 (966)
Q Consensus 663 ~~~ 665 (966)
...
T Consensus 326 ~~~ 328 (338)
T KOG0668|consen 326 APV 328 (338)
T ss_pred HHH
Confidence 543
|
|
| >cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-33 Score=317.39 Aligned_cols=250 Identities=28% Similarity=0.398 Sum_probs=191.2
Q ss_pred ccccccccccccEEEEEEEcCC--CcEEEEEEecccc-------ChHHHHHHHHHhcCCCCceEEEEEEEeC----CeEE
Q psy11767 381 DKAGILGDGSYSVCRRCVEKST--GQEYAVKIISRKI-------DCSEEINLLRACQGHPNIVNLHCVFQDE----VHTY 447 (966)
Q Consensus 381 ~~~~~LG~G~fG~Vy~a~~~~t--g~~vAvK~i~~~~-------~~~~Ei~iL~~l~~HpnIV~l~~~~~~~----~~~~ 447 (966)
+..+.||+|+||.||+|.+..+ ++.||||++.... ...+|+.+++.+.+||||+++++.+... ...|
T Consensus 3 ~~~~~lg~G~~g~vy~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~~~~~ 82 (332)
T cd07857 3 ELIKELGQGAYGIVCSARNAETSEEETVAIKKITNVFSKKILAKRALRELKLLRHFRGHKNITCLYDMDIVFPGNFNELY 82 (332)
T ss_pred eEEEEccccCCeEEEEEEeCCCCcCceEEEEEeccccccchhHHHHHHHHHHHHHhcCCCChheeeeeeeeccccCCcEE
Confidence 3357899999999999999988 9999999986432 2356899999887899999999875432 4578
Q ss_pred EEEEccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCcEEEecCCCCCEEEEeecccccccC
Q psy11767 448 LVLELLKGGELLDRIRQKGRCGFTENEASRIMRQLVAAVHFMHSRGVVHRDLKPENLLFSDPAGDNIKVVDFGFACLKRE 527 (966)
Q Consensus 448 lVmEy~~gg~L~~~l~~~~~~~l~e~~~~~i~~Qil~aL~yLHs~~IiHRDLKP~NILl~~~~~~~iKL~DFGla~~~~~ 527 (966)
++|||+. ++|.+++.... .+++..++.++.||+.||+|||++||+||||||+|||+++ ++.+||+|||++.....
T Consensus 83 ~~~e~~~-~~L~~~l~~~~--~~~~~~~~~~~~qi~~aL~~LH~~givH~dlkp~Nili~~--~~~~kl~Dfg~a~~~~~ 157 (332)
T cd07857 83 LYEELME-ADLHQIIRSGQ--PLTDAHFQSFIYQILCGLKYIHSANVLHRDLKPGNLLVNA--DCELKICDFGLARGFSE 157 (332)
T ss_pred EEEeccc-CCHHHHHhcCC--CCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHeEEcC--CCCEEeCcCCCceeccc
Confidence 9999985 78999886543 6899999999999999999999999999999999999975 56899999999965432
Q ss_pred C-------CccccccccccCchhhccCCCCCCCcccchhhhhhhhhhhhcCCCCCCCcCcchhHHHHHHHHhcCCCCCCC
Q psy11767 528 S-------LHTPCFTLQYAAPEVLRQDKSGYDENCDLWSLGVILVNVLRQDKSGYDENCDLWSLGVILYTMLCGRVPFHA 600 (966)
Q Consensus 528 ~-------~~~~~gT~~Y~APEvl~~~~~~~~~~~Di~SlGvil~el~~~~~~~y~~~~DIWSlGvilyemltG~~Pf~~ 600 (966)
. .....+|+.|+|||++.. ...++.++||||+||++|+|++|++||..
T Consensus 158 ~~~~~~~~~~~~~g~~~y~aPE~~~~-------------------------~~~~~~~~Di~slGv~l~~l~~g~~pf~~ 212 (332)
T cd07857 158 NPGENAGFMTEYVATRWYRAPEIMLS-------------------------FQSYTKAIDVWSVGCILAELLGRKPVFKG 212 (332)
T ss_pred ccccccccccCcccCccccCcHHHhC-------------------------CCCCCcHHHHHHHHHHHHHHHhCCcCCCC
Confidence 1 123467899999998742 23467889999999999999999999986
Q ss_pred CCCchhHHHHHHH-----------HH------------cCCCCCCchhhccCCHHHHHHHHHhcccCccccCChHHHHHH
Q psy11767 601 RSRDDSALSIMAR-----------IK------------EGQFNFDAEAWSTVSSEAKELTKSLLTVNPAQRIRMMRVKLT 657 (966)
Q Consensus 601 ~~~~~~~~~~~~~-----------i~------------~~~~~~~~~~~~~is~e~~~Li~~~L~~dP~~R~t~~~v~~~ 657 (966)
.+.......++.. +. ..........++.++.++.+|+.+||+.||++|||+.++ .
T Consensus 213 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~l--l 290 (332)
T cd07857 213 KDYVDQLNQILQVLGTPDEETLSRIGSPKAQNYIRSLPNIPKKPFESIFPNANPLALDLLEKLLAFDPTKRISVEEA--L 290 (332)
T ss_pred CCHHHHHHHHHHHhCCCCHHHHHhhhhhhHHHHHHhccccCCcchHhhCCCCCHHHHHHHHHHccCCcccCCCHHHH--h
Confidence 5432211111110 00 000000112234568899999999999999999999876 3
Q ss_pred hhhhH
Q psy11767 658 FHAFH 662 (966)
Q Consensus 658 ~~~~~ 662 (966)
.|+|.
T Consensus 291 ~~~~~ 295 (332)
T cd07857 291 EHPYL 295 (332)
T ss_pred cChhh
Confidence 45654
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co |
| >cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-33 Score=308.39 Aligned_cols=244 Identities=28% Similarity=0.507 Sum_probs=191.4
Q ss_pred ccccccccccccEEEEEEEcCCCcEEEEEEecccc-------ChHHHHHHHHHhcCCCCceEEEEEEEeC--CeEEEEEE
Q psy11767 381 DKAGILGDGSYSVCRRCVEKSTGQEYAVKIISRKI-------DCSEEINLLRACQGHPNIVNLHCVFQDE--VHTYLVLE 451 (966)
Q Consensus 381 ~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~-------~~~~Ei~iL~~l~~HpnIV~l~~~~~~~--~~~~lVmE 451 (966)
+..+.||.|+||.||+|.+..+|+.||+|++.... ...+|+.+++.+. ||||+++++++.+. ...|+|||
T Consensus 2 ~~~~~l~~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~~~~~~~~lv~e 80 (287)
T cd07840 2 EKIAQIGEGTYGQVYKARNKKTGELVALKKIRMENEKEGFPITAIREIKLLQKLR-HPNIVRLKEIVTSKGKGSIYMVFE 80 (287)
T ss_pred eeeEEeccCCCeEEEEEEECCCCeEEEEEEEecccccccchHHHHHHHHHHHhcc-CCCeeeheeeEecCCCCcEEEEec
Confidence 34678999999999999999999999999997542 2456899999885 99999999999988 89999999
Q ss_pred ccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCcEEEecCCCCCEEEEeecccccccCC---
Q psy11767 452 LLKGGELLDRIRQKGRCGFTENEASRIMRQLVAAVHFMHSRGVVHRDLKPENLLFSDPAGDNIKVVDFGFACLKRES--- 528 (966)
Q Consensus 452 y~~gg~L~~~l~~~~~~~l~e~~~~~i~~Qil~aL~yLHs~~IiHRDLKP~NILl~~~~~~~iKL~DFGla~~~~~~--- 528 (966)
|++ ++|.+++.... ..+++..++.++.||+.||+|||+.|++|+||||+|||+++ ++.+||+|||++......
T Consensus 81 ~~~-~~l~~~~~~~~-~~~~~~~~~~i~~~i~~al~~LH~~~~~h~dl~p~nil~~~--~~~~~l~d~g~~~~~~~~~~~ 156 (287)
T cd07840 81 YMD-HDLTGLLDSPE-VKFTESQIKCYMKQLLEGLQYLHSNGILHRDIKGSNILINN--DGVLKLADFGLARPYTKRNSA 156 (287)
T ss_pred ccc-ccHHHHHhccC-CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCcHHHeEEcC--CCCEEEccccceeeccCCCcc
Confidence 996 58988886653 36899999999999999999999999999999999999985 568999999999755432
Q ss_pred -CccccccccccCchhhccCCCCCCCcccchhhhhhhhhhhhcCCCCCCCcCcchhHHHHHHHHhcCCCCCCCCCCchhH
Q psy11767 529 -LHTPCFTLQYAAPEVLRQDKSGYDENCDLWSLGVILVNVLRQDKSGYDENCDLWSLGVILYTMLCGRVPFHARSRDDSA 607 (966)
Q Consensus 529 -~~~~~gT~~Y~APEvl~~~~~~~~~~~Di~SlGvil~el~~~~~~~y~~~~DIWSlGvilyemltG~~Pf~~~~~~~~~ 607 (966)
.....++..|+|||.+.. ...++.++|||||||++|+|++|+.||.........
T Consensus 157 ~~~~~~~~~~y~~PE~~~~-------------------------~~~~~~~~Dv~slG~~l~el~t~~~p~~~~~~~~~~ 211 (287)
T cd07840 157 DYTNRVITLWYRPPELLLG-------------------------ATRYGPEVDMWSVGCILAELFLGKPIFQGSTELEQL 211 (287)
T ss_pred cccccccccccCCceeeEc-------------------------cccCChHHHHHHHHHHHHHHHhCCCCCCCCChHHHH
Confidence 223456888999997742 123678899999999999999999999876543222
Q ss_pred HHHHHHHHcC---CC----------------CCC---chhhcc-CCHHHHHHHHHhcccCccccCChHHH
Q psy11767 608 LSIMARIKEG---QF----------------NFD---AEAWST-VSSEAKELTKSLLTVNPAQRIRMMRV 654 (966)
Q Consensus 608 ~~~~~~i~~~---~~----------------~~~---~~~~~~-is~e~~~Li~~~L~~dP~~R~t~~~v 654 (966)
..+....... .+ ... .+.... ++.++.+++.+||..||.+||++.++
T Consensus 212 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~ 281 (287)
T cd07840 212 EKIFELCGSPTDENWPGVSKLPWFENLKPKKPYKRRLREFFKHLIDPSALDLLDKLLTLDPKKRISADQA 281 (287)
T ss_pred HHHHHHhCCCchhhccccccchhhhhccccccchhHHHHHhcccCCHHHHHHHHHHcCCChhhCcCHHHH
Confidence 2222111000 00 000 011122 38899999999999999999999876
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po |
| >cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-33 Score=317.50 Aligned_cols=249 Identities=32% Similarity=0.464 Sum_probs=191.9
Q ss_pred ccccccccccccEEEEEEEcCCCcEEEEEEecccc-------ChHHHHHHHHHhcCCCCceEEEEEEEeC--CeEEEEEE
Q psy11767 381 DKAGILGDGSYSVCRRCVEKSTGQEYAVKIISRKI-------DCSEEINLLRACQGHPNIVNLHCVFQDE--VHTYLVLE 451 (966)
Q Consensus 381 ~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~-------~~~~Ei~iL~~l~~HpnIV~l~~~~~~~--~~~~lVmE 451 (966)
+..+.||+|+||.||+|.+..+|+.||||.+.... ...+|+.+++.+.+||||++++++|... ...|+|||
T Consensus 10 ~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~ni~~~~~~~~~~~~~~~~lv~e 89 (337)
T cd07852 10 EILQKLGKGAYGIVWKAIDRRTKEVVALKKIFDAFRNATDAQRTFREIMFLQELGDHPNIVKLLNVIKAENDKDIYLVFE 89 (337)
T ss_pred HHhHhhcCCCCeeEEEEEEcCCCeEEEEEeeccccCcchhhhhhhHHHHHHHHhcCCCCccceeeeeccCCCceEEEEec
Confidence 34678999999999999999999999999885421 2346899999986799999999998653 46899999
Q ss_pred ccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCcEEEecCCCCCEEEEeecccccccCC---
Q psy11767 452 LLKGGELLDRIRQKGRCGFTENEASRIMRQLVAAVHFMHSRGVVHRDLKPENLLFSDPAGDNIKVVDFGFACLKRES--- 528 (966)
Q Consensus 452 y~~gg~L~~~l~~~~~~~l~e~~~~~i~~Qil~aL~yLHs~~IiHRDLKP~NILl~~~~~~~iKL~DFGla~~~~~~--- 528 (966)
|+. ++|.+++... .+++..++.++.||+.||+|||++||+||||||+|||++. ++.+||+|||++......
T Consensus 90 ~~~-~~L~~~~~~~---~~~~~~~~~i~~qi~~~L~~LH~~~i~H~dl~p~nill~~--~~~~kl~d~g~~~~~~~~~~~ 163 (337)
T cd07852 90 YME-TDLHAVIRAN---ILEDVHKRYIMYQLLKALKYIHSGNVIHRDLKPSNILLNS--DCRVKLADFGLARSLSELEEN 163 (337)
T ss_pred ccc-cCHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcC--CCcEEEeeccchhcccccccc
Confidence 996 5999888654 5889999999999999999999999999999999999985 569999999998654321
Q ss_pred -----CccccccccccCchhhccCCCCCCCcccchhhhhhhhhhhhcCCCCCCCcCcchhHHHHHHHHhcCCCCCCCCCC
Q psy11767 529 -----LHTPCFTLQYAAPEVLRQDKSGYDENCDLWSLGVILVNVLRQDKSGYDENCDLWSLGVILYTMLCGRVPFHARSR 603 (966)
Q Consensus 529 -----~~~~~gT~~Y~APEvl~~~~~~~~~~~Di~SlGvil~el~~~~~~~y~~~~DIWSlGvilyemltG~~Pf~~~~~ 603 (966)
.....+|+.|+|||++.. ...++.++|||||||++|+|++|++||.+...
T Consensus 164 ~~~~~~~~~~~~~~y~aPE~~~~-------------------------~~~~~~~sDi~slG~~l~el~tg~~pf~~~~~ 218 (337)
T cd07852 164 PENPVLTDYVATRWYRAPEILLG-------------------------STRYTKGVDMWSVGCILGEMLLGKPLFPGTST 218 (337)
T ss_pred ccCcchhcccccccccCceeeec-------------------------cccccccchHHHHHHHHHHHHhCCCCCCCCCh
Confidence 123457889999998742 12357789999999999999999999976554
Q ss_pred chhHHHHHHH-----------------------HHcCCCCCCchhhccCCHHHHHHHHHhcccCccccCChHHHHHHhhh
Q psy11767 604 DDSALSIMAR-----------------------IKEGQFNFDAEAWSTVSSEAKELTKSLLTVNPAQRIRMMRVKLTFHA 660 (966)
Q Consensus 604 ~~~~~~~~~~-----------------------i~~~~~~~~~~~~~~is~e~~~Li~~~L~~dP~~R~t~~~v~~~~~~ 660 (966)
.+....+... +............+.++.++.++|.+||+.||++|||+.++. .|+
T Consensus 219 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rps~~~il--~~~ 296 (337)
T cd07852 219 LNQLEKIIEVIGPPSAEDIESIKSPFAATMLDSLPSRPRKPLDELLPKASDDALDLLKKLLVFNPNKRLTAEEAL--EHP 296 (337)
T ss_pred HHHHHHHHHHhCCCCHHHHHHHHhhhHHHhhhhcccccccchhhhccCCCHHHHHHHHHhccCCcccccCHHHHh--hCh
Confidence 3221111110 111111111122345789999999999999999999998763 344
Q ss_pred hH
Q psy11767 661 FH 662 (966)
Q Consensus 661 ~~ 662 (966)
|.
T Consensus 297 ~~ 298 (337)
T cd07852 297 YV 298 (337)
T ss_pred hh
Confidence 43
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul |
| >cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-33 Score=310.73 Aligned_cols=245 Identities=29% Similarity=0.466 Sum_probs=190.2
Q ss_pred cccccccccccccEEEEEEEcCCCcEEEEEEecccc-------ChHHHHHHHHHhcCCCCceEEEEEEEeCC--------
Q psy11767 380 LDKAGILGDGSYSVCRRCVEKSTGQEYAVKIISRKI-------DCSEEINLLRACQGHPNIVNLHCVFQDEV-------- 444 (966)
Q Consensus 380 ~~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~-------~~~~Ei~iL~~l~~HpnIV~l~~~~~~~~-------- 444 (966)
|+..+.||+|+||.||+|.+..+|+.||||++.... ...+|+.+++.+ +||||+++++++.+..
T Consensus 9 ~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l-~h~~i~~~~~~~~~~~~~~~~~~~ 87 (302)
T cd07864 9 FDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEKEGFPITAIREIKILRQL-NHRNIVNLKEIVTDKQDALDFKKD 87 (302)
T ss_pred hheeeeecccCCEEEEEEEECCCCcEEEEEEEeecccccCchHHHHHHHHHHHhC-CCCCeeeeeheecCcchhhhcccc
Confidence 344688999999999999999999999999986432 234689999988 5999999999987654
Q ss_pred --eEEEEEEccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCcEEEecCCCCCEEEEeeccc
Q psy11767 445 --HTYLVLELLKGGELLDRIRQKGRCGFTENEASRIMRQLVAAVHFMHSRGVVHRDLKPENLLFSDPAGDNIKVVDFGFA 522 (966)
Q Consensus 445 --~~~lVmEy~~gg~L~~~l~~~~~~~l~e~~~~~i~~Qil~aL~yLHs~~IiHRDLKP~NILl~~~~~~~iKL~DFGla 522 (966)
..|+||||+++ +|.+.+.... ..+++..++.++.||+.||+|||+.||+||||||+||++++ ++.+||+|||++
T Consensus 88 ~~~~~lv~e~~~~-~l~~~l~~~~-~~~~~~~~~~i~~qi~~aL~~LH~~~i~H~dl~p~nili~~--~~~~kl~dfg~~ 163 (302)
T cd07864 88 KGAFYLVFEYMDH-DLMGLLESGL-VHFSEDHIKSFMKQLLEGLNYCHKKNFLHRDIKCSNILLNN--KGQIKLADFGLA 163 (302)
T ss_pred CCcEEEEEcccCc-cHHHHHhcCC-CCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECC--CCcEEeCccccc
Confidence 78999999975 7777776542 36899999999999999999999999999999999999975 568999999998
Q ss_pred ccccCCC----ccccccccccCchhhccCCCCCCCcccchhhhhhhhhhhhcCCCCCCCcCcchhHHHHHHHHhcCCCCC
Q psy11767 523 CLKRESL----HTPCFTLQYAAPEVLRQDKSGYDENCDLWSLGVILVNVLRQDKSGYDENCDLWSLGVILYTMLCGRVPF 598 (966)
Q Consensus 523 ~~~~~~~----~~~~gT~~Y~APEvl~~~~~~~~~~~Di~SlGvil~el~~~~~~~y~~~~DIWSlGvilyemltG~~Pf 598 (966)
....... ....++..|+|||++.. ...++.++|||||||++|+|++|++||
T Consensus 164 ~~~~~~~~~~~~~~~~~~~y~~PE~~~~-------------------------~~~~~~~~Di~slG~~~~el~~g~~~~ 218 (302)
T cd07864 164 RLYNSEESRPYTNKVITLWYRPPELLLG-------------------------EERYGPAIDVWSCGCILGELFTKKPIF 218 (302)
T ss_pred ccccCCcccccccceeccCccChHHhcC-------------------------CCCCCchhHHHHHHHHHHHHHhCCCCC
Confidence 7543221 22345778999998742 123567899999999999999999999
Q ss_pred CCCCCchhHHHHHHHHHcCCCC-----------------------CCchhhccCCHHHHHHHHHhcccCccccCChHHHH
Q psy11767 599 HARSRDDSALSIMARIKEGQFN-----------------------FDAEAWSTVSSEAKELTKSLLTVNPAQRIRMMRVK 655 (966)
Q Consensus 599 ~~~~~~~~~~~~~~~i~~~~~~-----------------------~~~~~~~~is~e~~~Li~~~L~~dP~~R~t~~~v~ 655 (966)
......+....+ .....+... .....+..++.++.+++.+||..||++||++.++.
T Consensus 219 ~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il 297 (302)
T cd07864 219 QANQELAQLELI-SRLCGSPCPAVWPDVIKLPYFNTMKPKKQYRRRLREEFSFIPTPALDLLDHMLTLDPSKRCTAEEAL 297 (302)
T ss_pred CCCChHHHHHHH-HHHhCCCChhhcccccccccccccccccccccchhhhcCCCCHHHHHHHHHHccCChhhCCCHHHHh
Confidence 865443322222 222111100 00012335789999999999999999999998763
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely |
| >cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-33 Score=311.63 Aligned_cols=241 Identities=23% Similarity=0.336 Sum_probs=192.8
Q ss_pred cccccccccccccEEEEEEEcCCCcEEEEEEecccc--------ChHHHHHHHHHhcCCCCceEEEEEEEeCCeEEEEEE
Q psy11767 380 LDKAGILGDGSYSVCRRCVEKSTGQEYAVKIISRKI--------DCSEEINLLRACQGHPNIVNLHCVFQDEVHTYLVLE 451 (966)
Q Consensus 380 ~~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~--------~~~~Ei~iL~~l~~HpnIV~l~~~~~~~~~~~lVmE 451 (966)
|+..+.||+|+||.||+|++..+|+.||+|++.... ...+|+.+|+.+ +||||+++++++.++...|+|||
T Consensus 27 f~~~~~lg~G~~~~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~e 105 (317)
T cd06635 27 FTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRI-KHPNSIEYKGCYLREHTAWLVME 105 (317)
T ss_pred hhhhheeccCCCeEEEEEEEcCCCcEEEEEEEecCCCCchHHHHHHHHHHHHHHhC-CCCCEEEEEEEEeeCCeEEEEEe
Confidence 445788999999999999999999999999986432 134588888888 59999999999999999999999
Q ss_pred ccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCcEEEecCCCCCEEEEeecccccccCCCcc
Q psy11767 452 LLKGGELLDRIRQKGRCGFTENEASRIMRQLVAAVHFMHSRGVVHRDLKPENLLFSDPAGDNIKVVDFGFACLKRESLHT 531 (966)
Q Consensus 452 y~~gg~L~~~l~~~~~~~l~e~~~~~i~~Qil~aL~yLHs~~IiHRDLKP~NILl~~~~~~~iKL~DFGla~~~~~~~~~ 531 (966)
|+. |+|.+.+.... ..+++.++..++.||+.||.|||+.||+||||||+||++++ .+.+||+|||++..... ...
T Consensus 106 ~~~-g~l~~~~~~~~-~~l~~~~~~~i~~~i~~~l~~lH~~~i~H~dL~p~Nil~~~--~~~~kl~dfg~~~~~~~-~~~ 180 (317)
T cd06635 106 YCL-GSASDLLEVHK-KPLQEVEIAAITHGALQGLAYLHSHNMIHRDIKAGNILLTE--PGQVKLADFGSASIASP-ANS 180 (317)
T ss_pred CCC-CCHHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcccEEECC--CCCEEEecCCCccccCC-ccc
Confidence 996 57888776543 35899999999999999999999999999999999999975 56899999999865432 334
Q ss_pred ccccccccCchhhccCCCCCCCcccchhhhhhhhhhhhcCCCCCCCcCcchhHHHHHHHHhcCCCCCCCCCCchhHHHHH
Q psy11767 532 PCFTLQYAAPEVLRQDKSGYDENCDLWSLGVILVNVLRQDKSGYDENCDLWSLGVILYTMLCGRVPFHARSRDDSALSIM 611 (966)
Q Consensus 532 ~~gT~~Y~APEvl~~~~~~~~~~~Di~SlGvil~el~~~~~~~y~~~~DIWSlGvilyemltG~~Pf~~~~~~~~~~~~~ 611 (966)
..+++.|+|||++.... ...++.++||||+||++|+|++|+.||...... ...
T Consensus 181 ~~~~~~y~aPE~~~~~~-----------------------~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~----~~~ 233 (317)
T cd06635 181 FVGTPYWMAPEVILAMD-----------------------EGQYDGKVDVWSLGITCIELAERKPPLFNMNAM----SAL 233 (317)
T ss_pred ccCCccccChhhhhcCC-----------------------CCCCCccccHHHHHHHHHHHHhCCCCCCCccHH----HHH
Confidence 56789999999874211 223678899999999999999999999765322 222
Q ss_pred HHHHcCCCCCCchhhccCCHHHHHHHHHhcccCccccCChHHHH
Q psy11767 612 ARIKEGQFNFDAEAWSTVSSEAKELTKSLLTVNPAQRIRMMRVK 655 (966)
Q Consensus 612 ~~i~~~~~~~~~~~~~~is~e~~~Li~~~L~~dP~~R~t~~~v~ 655 (966)
..+..+..... ....+++.+++++.+||+.+|.+||++.++.
T Consensus 234 ~~~~~~~~~~~--~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il 275 (317)
T cd06635 234 YHIAQNESPTL--QSNEWSDYFRNFVDSCLQKIPQDRPTSEELL 275 (317)
T ss_pred HHHHhccCCCC--CCccccHHHHHHHHHHccCCcccCcCHHHHH
Confidence 23332222111 1234678899999999999999999999874
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron |
| >cd05122 PKc_STE Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-33 Score=296.89 Aligned_cols=240 Identities=27% Similarity=0.486 Sum_probs=195.9
Q ss_pred cccccccccccccEEEEEEEcCCCcEEEEEEecccc-----ChHHHHHHHHHhcCCCCceEEEEEEEeCCeEEEEEEccC
Q psy11767 380 LDKAGILGDGSYSVCRRCVEKSTGQEYAVKIISRKI-----DCSEEINLLRACQGHPNIVNLHCVFQDEVHTYLVLELLK 454 (966)
Q Consensus 380 ~~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~-----~~~~Ei~iL~~l~~HpnIV~l~~~~~~~~~~~lVmEy~~ 454 (966)
|...+.||+|+||.||++.+..+++.||+|++.... ...+|+.+++.+. ||||+++++++..+...++++||++
T Consensus 2 y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~~~~~~l~~e~~~ 80 (253)
T cd05122 2 FEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESKEKKEKIINEIQILKKCK-HPNIVKYYGSYLKKDELWIVMEFCS 80 (253)
T ss_pred ceeeeeeccCCceEEEEEEECCCCcEEEEEEecccchhHHHHHHHHHHHHHhCC-CCCEeEEEEEEecCCeEEEEEecCC
Confidence 444678999999999999999999999999987654 2556899998885 9999999999999999999999999
Q ss_pred CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCcEEEecCCCCCEEEEeecccccccCCC--ccc
Q psy11767 455 GGELLDRIRQKGRCGFTENEASRIMRQLVAAVHFMHSRGVVHRDLKPENLLFSDPAGDNIKVVDFGFACLKRESL--HTP 532 (966)
Q Consensus 455 gg~L~~~l~~~~~~~l~e~~~~~i~~Qil~aL~yLHs~~IiHRDLKP~NILl~~~~~~~iKL~DFGla~~~~~~~--~~~ 532 (966)
+++|.+++.... ..+++..+..++.|++.||+|||+.|++|+||+|+||++++ ++.++|+|||++....... ...
T Consensus 81 ~~~L~~~~~~~~-~~~~~~~~~~i~~~i~~~l~~lh~~~i~h~dl~p~ni~i~~--~~~~~l~d~~~~~~~~~~~~~~~~ 157 (253)
T cd05122 81 GGSLKDLLKSTN-QTLTESQIAYVCKELLKGLEYLHSNGIIHRDIKAANILLTS--DGEVKLIDFGLSAQLSDTKARNTM 157 (253)
T ss_pred CCcHHHHHhhcC-CCCCHHHHHHHHHHHHHHHHHhhcCCEecCCCCHHHEEEcc--CCeEEEeeccccccccccccccce
Confidence 999999987753 36899999999999999999999999999999999999985 5689999999987654432 455
Q ss_pred cccccccCchhhccCCCCCCCcccchhhhhhhhhhhhcCCCCCCCcCcchhHHHHHHHHhcCCCCCCCCCCchhHHHHHH
Q psy11767 533 CFTLQYAAPEVLRQDKSGYDENCDLWSLGVILVNVLRQDKSGYDENCDLWSLGVILYTMLCGRVPFHARSRDDSALSIMA 612 (966)
Q Consensus 533 ~gT~~Y~APEvl~~~~~~~~~~~Di~SlGvil~el~~~~~~~y~~~~DIWSlGvilyemltG~~Pf~~~~~~~~~~~~~~ 612 (966)
.++..|+|||++... .++.++|+|||||++|+|++|+.||...+.... +.
T Consensus 158 ~~~~~~~~PE~~~~~--------------------------~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~----~~ 207 (253)
T cd05122 158 VGTPYWMAPEVINGK--------------------------PYDYKADIWSLGITAIELAEGKPPYSELPPMKA----LF 207 (253)
T ss_pred ecCCcccCHHHHcCC--------------------------CCCccccHHHHHHHHHHHHhCCCCCCCCchHHH----HH
Confidence 678999999988521 257789999999999999999999986543221 11
Q ss_pred HHHcCCCCCCchhhccCCHHHHHHHHHhcccCccccCChHHH
Q psy11767 613 RIKEGQFNFDAEAWSTVSSEAKELTKSLLTVNPAQRIRMMRV 654 (966)
Q Consensus 613 ~i~~~~~~~~~~~~~~is~e~~~Li~~~L~~dP~~R~t~~~v 654 (966)
.+......... ....++.++.++|.+||..||++|||+.++
T Consensus 208 ~~~~~~~~~~~-~~~~~~~~~~~~i~~~l~~~p~~R~t~~~~ 248 (253)
T cd05122 208 KIATNGPPGLR-NPEKWSDEFKDFLKKCLQKNPEKRPTAEQL 248 (253)
T ss_pred HHHhcCCCCcC-cccccCHHHHHHHHHHccCChhhCCCHHHH
Confidence 22221111111 112248899999999999999999999876
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core |
| >cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-33 Score=314.55 Aligned_cols=246 Identities=23% Similarity=0.367 Sum_probs=188.9
Q ss_pred cccc--cccEEEEEEEcCCCcEEEEEEecccc-------ChHHHHHHHHHhcCCCCceEEEEEEEeCCeEEEEEEccCCC
Q psy11767 386 LGDG--SYSVCRRCVEKSTGQEYAVKIISRKI-------DCSEEINLLRACQGHPNIVNLHCVFQDEVHTYLVLELLKGG 456 (966)
Q Consensus 386 LG~G--~fG~Vy~a~~~~tg~~vAvK~i~~~~-------~~~~Ei~iL~~l~~HpnIV~l~~~~~~~~~~~lVmEy~~gg 456 (966)
||+| ++|.||.+++..+|+.||||++.... ...+|+.+|+.+ +||||++++++|.++...|++|||+++|
T Consensus 6 i~~~~~~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~Ei~~l~~l-~h~~i~~~~~~~~~~~~~~~~~e~~~~~ 84 (314)
T cd08216 6 IGKCFEDLMIVHLAKHKPTNTLVAVKKINLDSCSKEDLKLLQQEIITSRQL-QHPNILPYVTSFIVDSELYVVSPLMAYG 84 (314)
T ss_pred hhHhhcCCceEEEEEecCCCCEEEEEEEeccccchhHHHHHHHHHHHHHhc-CCcchhhhhheeecCCeEEEEEeccCCC
Confidence 4444 55677777788899999999986541 245689999988 5999999999999999999999999999
Q ss_pred CHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCcEEEecCCCCCEEEEeecccccccC---------
Q psy11767 457 ELLDRIRQKGRCGFTENEASRIMRQLVAAVHFMHSRGVVHRDLKPENLLFSDPAGDNIKVVDFGFACLKRE--------- 527 (966)
Q Consensus 457 ~L~~~l~~~~~~~l~e~~~~~i~~Qil~aL~yLHs~~IiHRDLKP~NILl~~~~~~~iKL~DFGla~~~~~--------- 527 (966)
+|.+++.......+++..+..++.|++.||+|||+++|+||||||+|||+++ ++.+||+|||.+.....
T Consensus 85 ~l~~~l~~~~~~~~~~~~~~~~~~~l~~~L~~LH~~~ivH~dlk~~Nili~~--~~~~kl~d~~~~~~~~~~~~~~~~~~ 162 (314)
T cd08216 85 SCEDLLKTHFPEGLPELAIAFILKDVLNALDYIHSKGFIHRSVKASHILLSG--DGKVVLSGLRYSVSMIKHGKRQRVVH 162 (314)
T ss_pred CHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCcceEEEec--CCceEEecCccceeeccccccccccc
Confidence 9999998755456999999999999999999999999999999999999985 56899999998854321
Q ss_pred -CCccccccccccCchhhccCCCCCCCcccchhhhhhhhhhhhcCCCCCCCcCcchhHHHHHHHHhcCCCCCCCCCCchh
Q psy11767 528 -SLHTPCFTLQYAAPEVLRQDKSGYDENCDLWSLGVILVNVLRQDKSGYDENCDLWSLGVILYTMLCGRVPFHARSRDDS 606 (966)
Q Consensus 528 -~~~~~~gT~~Y~APEvl~~~~~~~~~~~Di~SlGvil~el~~~~~~~y~~~~DIWSlGvilyemltG~~Pf~~~~~~~~ 606 (966)
......++..|+|||++... ...|+.++||||+||++|+|++|+.||.......
T Consensus 163 ~~~~~~~~~~~y~aPE~~~~~------------------------~~~~~~~~Diws~G~il~el~~g~~pf~~~~~~~- 217 (314)
T cd08216 163 DFPKSSVKNLPWLSPEVLQQN------------------------LQGYNEKSDIYSVGITACELANGHVPFKDMPATQ- 217 (314)
T ss_pred cccccccccccccCHHHhcCC------------------------CCCCCcchhHHHHHHHHHHHHhCCCCCCCCCHHH-
Confidence 11223467789999998532 1347788999999999999999999998654322
Q ss_pred HHHHHHHHHcCCC--------C---------------------CCchhhccCCHHHHHHHHHhcccCccccCChHHHHHH
Q psy11767 607 ALSIMARIKEGQF--------N---------------------FDAEAWSTVSSEAKELTKSLLTVNPAQRIRMMRVKLT 657 (966)
Q Consensus 607 ~~~~~~~i~~~~~--------~---------------------~~~~~~~~is~e~~~Li~~~L~~dP~~R~t~~~v~~~ 657 (966)
.....+..... . ........++.++.+|+.+||..||++|||+.++ .
T Consensus 218 --~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~l--l 293 (314)
T cd08216 218 --MLLEKVRGTVPCLLDKSTYPLYEDSMSQSRSSNEHPNNRDSVDHPYTRTFSEHFHQFVELCLQRDPESRPSASQL--L 293 (314)
T ss_pred --HHHHHHhccCccccccCchhhhcCCcCcccccccccchhhhhhcchhhHHHHHHHHHHHHHhhcCCCcCcCHHHH--h
Confidence 12222211100 0 0000112345788999999999999999999876 3
Q ss_pred hhhhHH
Q psy11767 658 FHAFHQ 663 (966)
Q Consensus 658 ~~~~~~ 663 (966)
.|+|+.
T Consensus 294 ~~p~~~ 299 (314)
T cd08216 294 NHSFFK 299 (314)
T ss_pred cCchHh
Confidence 466654
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc |
| >KOG0584|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-34 Score=329.18 Aligned_cols=242 Identities=22% Similarity=0.415 Sum_probs=202.0
Q ss_pred cccccccccEEEEEEEcCCCcEEEEEEeccc---------cChHHHHHHHHHhcCCCCceEEEEEEEeCCe--EEEEEEc
Q psy11767 384 GILGDGSYSVCRRCVEKSTGQEYAVKIISRK---------IDCSEEINLLRACQGHPNIVNLHCVFQDEVH--TYLVLEL 452 (966)
Q Consensus 384 ~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~---------~~~~~Ei~iL~~l~~HpnIV~l~~~~~~~~~--~~lVmEy 452 (966)
.+||+|+|-+||+|.|..+|.+||.=.++-. ..+..|+.+|+.| +|||||++|++|.+... ..+|.|+
T Consensus 46 evLGrGafKtVYka~De~~giEVAWnqvk~~d~~q~~~~leR~~~Ev~lLKsL-~H~NIirfy~SW~d~~n~~in~iTEL 124 (632)
T KOG0584|consen 46 EVLGRGAFKTVYKAFDEEEGIEVAWNQVKIRDVTQSPEELERLYSEVHLLKSL-KHPNIIRFYDSWVDTDNKTINFITEL 124 (632)
T ss_pred hhcccccceeeeeccccccchhhHHHHHhHHHhhcChHHHHHHHHHHHHHccC-CCCceeeeeeheecCCCceeeeeeec
Confidence 3799999999999999999999987544321 1244699999998 49999999999997765 7789999
Q ss_pred cCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcC--ceeccCCCCcEEEecCCCCCEEEEeecccccccCCC-
Q psy11767 453 LKGGELLDRIRQKGRCGFTENEASRIMRQLVAAVHFMHSRG--VVHRDLKPENLLFSDPAGDNIKVVDFGFACLKRESL- 529 (966)
Q Consensus 453 ~~gg~L~~~l~~~~~~~l~e~~~~~i~~Qil~aL~yLHs~~--IiHRDLKP~NILl~~~~~~~iKL~DFGla~~~~~~~- 529 (966)
+..|+|..|+++.+ .++...++.|++||++||.|||++. |||||||.+||+|.. ..|.|||+|+|||.....+.
T Consensus 125 ~TSGtLr~Y~kk~~--~vn~kaik~W~RQILkGL~yLHs~~PPIIHRDLKCDNIFinG-~~G~VKIGDLGLAtl~r~s~a 201 (632)
T KOG0584|consen 125 FTSGTLREYRKKHR--RVNIKAIKSWCRQILKGLVYLHSQDPPIIHRDLKCDNIFVNG-NLGEVKIGDLGLATLLRKSHA 201 (632)
T ss_pred ccCCcHHHHHHHhc--cCCHHHHHHHHHHHHHHhhhhhcCCCCccccccccceEEEcC-CcCceeecchhHHHHhhcccc
Confidence 99999999999887 4889999999999999999999984 999999999999975 46799999999998876554
Q ss_pred ccccccccccCchhhccCCCCCCCcccchhhhhhhhhhhhcCCCCCCCcCcchhHHHHHHHHhcCCCCCCCCCCchhHHH
Q psy11767 530 HTPCFTLQYAAPEVLRQDKSGYDENCDLWSLGVILVNVLRQDKSGYDENCDLWSLGVILYTMLCGRVPFHARSRDDSALS 609 (966)
Q Consensus 530 ~~~~gT~~Y~APEvl~~~~~~~~~~~Di~SlGvil~el~~~~~~~y~~~~DIWSlGvilyemltG~~Pf~~~~~~~~~~~ 609 (966)
...+|||.|||||+.. ..|++.+||||||+++.||+|+..||..... ..+
T Consensus 202 ksvIGTPEFMAPEmYE---------------------------E~YnE~VDVYaFGMCmLEMvT~eYPYsEC~n---~AQ 251 (632)
T KOG0584|consen 202 KSVIGTPEFMAPEMYE---------------------------ENYNELVDVYAFGMCMLEMVTSEYPYSECTN---PAQ 251 (632)
T ss_pred ceeccCccccChHHHh---------------------------hhcchhhhhhhhhHHHHHHHhccCChhhhCC---HHH
Confidence 3458999999999873 4589999999999999999999999986543 346
Q ss_pred HHHHHHcCCCCCCchhhcc-CCHHHHHHHHHhcccCccccCChHHHHHHhhhhHHhh
Q psy11767 610 IMARIKEGQFNFDAEAWST-VSSEAKELTKSLLTVNPAQRIRMMRVKLTFHAFHQAQ 665 (966)
Q Consensus 610 ~~~~i~~~~~~~~~~~~~~-is~e~~~Li~~~L~~dP~~R~t~~~v~~~~~~~~~~~ 665 (966)
+..++..|.- +..+.. -.++++++|.+||.. .++|+|+.++ ..++|+...
T Consensus 252 IYKKV~SGiK---P~sl~kV~dPevr~fIekCl~~-~~~R~sa~eL--L~d~Ff~~d 302 (632)
T KOG0584|consen 252 IYKKVTSGIK---PAALSKVKDPEVREFIEKCLAT-KSERLSAKEL--LKDPFFDED 302 (632)
T ss_pred HHHHHHcCCC---HHHhhccCCHHHHHHHHHHhcC-chhccCHHHH--hhChhhccc
Confidence 7778877753 222222 368999999999999 8999999865 567777553
|
|
| >KOG0587|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-34 Score=333.46 Aligned_cols=251 Identities=26% Similarity=0.397 Sum_probs=208.0
Q ss_pred ccccccccccEEEEEEEcCCCcEEEEEEeccccCh----HHHHHHHHHhcCCCCceEEEEEEE-----eCCeEEEEEEcc
Q psy11767 383 AGILGDGSYSVCRRCVEKSTGQEYAVKIISRKIDC----SEEINLLRACQGHPNIVNLHCVFQ-----DEVHTYLVLELL 453 (966)
Q Consensus 383 ~~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~~~----~~Ei~iL~~l~~HpnIV~l~~~~~-----~~~~~~lVmEy~ 453 (966)
..+||.|.||+||+++++.+|+.+|+||+....+. ..|.++|+....|||++.++++|. .++.+|||||||
T Consensus 24 ~evig~Gtygkv~k~k~~~~~~~aa~kI~~~~~d~deEiE~eynil~~~~~hpnv~~fyg~~~k~~~~~~DqLWLVMEfC 103 (953)
T KOG0587|consen 24 IEVIGNGTYGKVYKGRHVKTGQLAAIKIMDPTEDEEEEIELEYNMLKKYSHHPNVATFYGAFIKKDPGNGDQLWLVMEFC 103 (953)
T ss_pred EEEEeeccceeEEEEeeeecCceeeeEeecCCccccHHHHHHHHHHHhccCCCCcceEEEEEEEecCCCCCeEEEEeecc
Confidence 46799999999999999999999999998765443 346678988889999999999986 346899999999
Q ss_pred CCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCcEEEecCCCCCEEEEeecccccccC---CCc
Q psy11767 454 KGGELLDRIRQKGRCGFTENEASRIMRQLVAAVHFMHSRGVVHRDLKPENLLFSDPAGDNIKVVDFGFACLKRE---SLH 530 (966)
Q Consensus 454 ~gg~L~~~l~~~~~~~l~e~~~~~i~~Qil~aL~yLHs~~IiHRDLKP~NILl~~~~~~~iKL~DFGla~~~~~---~~~ 530 (966)
.||+..|.+++.....+.|..+..|++.+|.||.+||.+.+||||||-.|||+.. ++.|||+|||++.+... ..+
T Consensus 104 ~gGSVTDLVKn~~g~rl~E~~IaYI~re~lrgl~HLH~nkviHRDikG~NiLLT~--e~~VKLvDFGvSaQldsT~grRn 181 (953)
T KOG0587|consen 104 GGGSVTDLVKNTKGNRLKEEWIAYILREILRGLAHLHNNKVIHRDIKGQNVLLTE--NAEVKLVDFGVSAQLDSTVGRRN 181 (953)
T ss_pred CCccHHHHHhhhcccchhhHHHHHHHHHHHHHHHHHhhcceeeecccCceEEEec--cCcEEEeeeeeeeeeeccccccc
Confidence 9999999998766667999999999999999999999999999999999999985 66999999999876542 356
Q ss_pred cccccccccCchhhccCCCCCCCcccchhhhhhhhhhhhcCCCCCCCcCcchhHHHHHHHHhcCCCCCCCCCCchhHHHH
Q psy11767 531 TPCFTLQYAAPEVLRQDKSGYDENCDLWSLGVILVNVLRQDKSGYDENCDLWSLGVILYTMLCGRVPFHARSRDDSALSI 610 (966)
Q Consensus 531 ~~~gT~~Y~APEvl~~~~~~~~~~~Di~SlGvil~el~~~~~~~y~~~~DIWSlGvilyemltG~~Pf~~~~~~~~~~~~ 610 (966)
+.+|||.|||||++..... -...|+..+|+||||++..||..|.+|+...... ..+
T Consensus 182 T~iGtP~WMAPEViac~e~---------------------~d~tyd~R~D~WsLGITaIEladG~PPl~DmHPm---raL 237 (953)
T KOG0587|consen 182 TFIGTPYWMAPEVIACDES---------------------PDATYDYRSDLWSLGITAIEMAEGAPPLCDMHPM---RAL 237 (953)
T ss_pred CcCCCcccccceeeecccC---------------------CCCCcccccchhhccceeehhcCCCCCccCcchh---hhh
Confidence 7889999999999975432 1345888999999999999999999999876543 222
Q ss_pred HHHHHcCCCCCCchhhccCCHHHHHHHHHhcccCccccCChHHHHHHhhhhHH
Q psy11767 611 MARIKEGQFNFDAEAWSTVSSEAKELTKSLLTVNPAQRIRMMRVKLTFHAFHQ 663 (966)
Q Consensus 611 ~~~i~~~~~~~~~~~~~~is~e~~~Li~~~L~~dP~~R~t~~~v~~~~~~~~~ 663 (966)
+ .|.+.. .+....|...+.++.++|..||..|-++||++.+ +..|+|..
T Consensus 238 F-~IpRNP-PPkLkrp~kWs~~FndFIs~cL~Kd~e~RP~~~~--ll~hpFi~ 286 (953)
T KOG0587|consen 238 F-LIPRNP-PPKLKRPKKWSKKFNDFISTCLVKDYEQRPSTEE--LLKHPFIT 286 (953)
T ss_pred c-cCCCCC-CccccchhhHHHHHHHHHHHHHhhccccCcchhh--hccCCccc
Confidence 2 333321 2222345677999999999999999999999975 46677765
|
|
| >cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-33 Score=319.54 Aligned_cols=247 Identities=26% Similarity=0.503 Sum_probs=190.9
Q ss_pred cccccccccccEEEEEEEcCCCcEEEEEEecccc-------ChHHHHHHHHHhcCCCCceEEEEEEEeCC------eEEE
Q psy11767 382 KAGILGDGSYSVCRRCVEKSTGQEYAVKIISRKI-------DCSEEINLLRACQGHPNIVNLHCVFQDEV------HTYL 448 (966)
Q Consensus 382 ~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~-------~~~~Ei~iL~~l~~HpnIV~l~~~~~~~~------~~~l 448 (966)
..+.||+|+||.||+|.+..+|+.||||++.+.. ...+|+.+|+.+ .||||++++++|.... ..|+
T Consensus 19 ~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~~~~~~~l 97 (342)
T cd07879 19 SLKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAYRELTLLKHM-QHENVIGLLDVFTSAVSGDEFQDFYL 97 (342)
T ss_pred EEEEeeecCCeEEEEEEeCCCCcEEEEEEecCccccccchhHHHHHHHHHHhc-CCCCccchhheecccccCCCCceEEE
Confidence 3678999999999999999999999999986531 245799999988 5999999999987543 4699
Q ss_pred EEEccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCcEEEecCCCCCEEEEeecccccccCC
Q psy11767 449 VLELLKGGELLDRIRQKGRCGFTENEASRIMRQLVAAVHFMHSRGVVHRDLKPENLLFSDPAGDNIKVVDFGFACLKRES 528 (966)
Q Consensus 449 VmEy~~gg~L~~~l~~~~~~~l~e~~~~~i~~Qil~aL~yLHs~~IiHRDLKP~NILl~~~~~~~iKL~DFGla~~~~~~ 528 (966)
||||+. ++|..++. ..+++..+..++.|++.||+|||++||+||||||+|||++. ++.+||+|||++......
T Consensus 98 v~e~~~-~~l~~~~~----~~~~~~~~~~~~~qi~~aL~~LH~~~i~H~dlkp~NIll~~--~~~~kL~dfg~~~~~~~~ 170 (342)
T cd07879 98 VMPYMQ-TDLQKIMG----HPLSEDKVQYLVYQMLCGLKYIHSAGIIHRDLKPGNLAVNE--DCELKILDFGLARHADAE 170 (342)
T ss_pred Eecccc-cCHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECC--CCCEEEeeCCCCcCCCCC
Confidence 999995 46766542 25899999999999999999999999999999999999975 568999999999765544
Q ss_pred CccccccccccCchhhccCCCCCCCcccchhhhhhhhhhhhcCCCCCCCcCcchhHHHHHHHHhcCCCCCCCCCCchhHH
Q psy11767 529 LHTPCFTLQYAAPEVLRQDKSGYDENCDLWSLGVILVNVLRQDKSGYDENCDLWSLGVILYTMLCGRVPFHARSRDDSAL 608 (966)
Q Consensus 529 ~~~~~gT~~Y~APEvl~~~~~~~~~~~Di~SlGvil~el~~~~~~~y~~~~DIWSlGvilyemltG~~Pf~~~~~~~~~~ 608 (966)
.....+|+.|+|||++.. ...++.++|||||||++|+|++|+.||.+.+......
T Consensus 171 ~~~~~~~~~y~aPE~~~~-------------------------~~~~~~~~Dv~slGvil~el~~g~~pf~~~~~~~~~~ 225 (342)
T cd07879 171 MTGYVVTRWYRAPEVILN-------------------------WMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLT 225 (342)
T ss_pred CCCceeeecccChhhhcC-------------------------ccccCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHH
Confidence 445567899999998752 1236788999999999999999999998754322211
Q ss_pred HHHHH-----------HHc--------CCCCCC----chhhccCCHHHHHHHHHhcccCccccCChHHHHHHhhhhHH
Q psy11767 609 SIMAR-----------IKE--------GQFNFD----AEAWSTVSSEAKELTKSLLTVNPAQRIRMMRVKLTFHAFHQ 663 (966)
Q Consensus 609 ~~~~~-----------i~~--------~~~~~~----~~~~~~is~e~~~Li~~~L~~dP~~R~t~~~v~~~~~~~~~ 663 (966)
.++.. +.. ...... ...++..+.++.+||.+||+.||++||++.++ ..|+|+.
T Consensus 226 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~~~~e~--l~h~~f~ 301 (342)
T cd07879 226 QILKVTGVPGPEFVQKLEDKAAKSYIKSLPKYPRKDFSTLFPKASPQAVDLLEKMLELDVDKRLTATEA--LEHPYFD 301 (342)
T ss_pred HHHHhcCCCCHHHHHHhcccchHHHHhhcCCcccchHHHHhcCCCHHHHHHHHHHcCCChhhCcCHHHH--hcCcchh
Confidence 11110 000 000000 11234578899999999999999999999876 3466654
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13 |
| >cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-33 Score=307.72 Aligned_cols=243 Identities=33% Similarity=0.548 Sum_probs=193.4
Q ss_pred cccccccccccEEEEEEEcCCCcEEEEEEeccccC-------hHHHHHHHHHhcCCCCceEEEEEEEeCCeEEEEEEccC
Q psy11767 382 KAGILGDGSYSVCRRCVEKSTGQEYAVKIISRKID-------CSEEINLLRACQGHPNIVNLHCVFQDEVHTYLVLELLK 454 (966)
Q Consensus 382 ~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~~-------~~~Ei~iL~~l~~HpnIV~l~~~~~~~~~~~lVmEy~~ 454 (966)
..+.||+|+||.||+|.+..+|+.+|+|.+..... ...|+.+|+.+. ||||+++++++.++...|+||||++
T Consensus 3 ~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~~~~~~~v~e~~~ 81 (283)
T cd05118 3 KLGKIGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELN-HPNIIKLLDVFRHKGDLYLVFEFMD 81 (283)
T ss_pred cceeeecCCCceEEEEEcCCCCcEEEEEEeccccccchhHHHHHHHHHHHHHhc-CCCcchHHHhhccCCCEEEEEeccC
Confidence 35789999999999999999999999999865432 346889999885 9999999999999999999999996
Q ss_pred CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCcEEEecCCCCCEEEEeecccccccCCC---cc
Q psy11767 455 GGELLDRIRQKGRCGFTENEASRIMRQLVAAVHFMHSRGVVHRDLKPENLLFSDPAGDNIKVVDFGFACLKRESL---HT 531 (966)
Q Consensus 455 gg~L~~~l~~~~~~~l~e~~~~~i~~Qil~aL~yLHs~~IiHRDLKP~NILl~~~~~~~iKL~DFGla~~~~~~~---~~ 531 (966)
++|.+++.... ..+++..+..++.||+.||+|||++||+|+||||+||++++ ++.+||+|||.+....... ..
T Consensus 82 -~~l~~~l~~~~-~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~p~nili~~--~~~~~l~df~~~~~~~~~~~~~~~ 157 (283)
T cd05118 82 -TDLYKLIKDRQ-RGLPESLIKSYLYQLLQGLAFCHSHGILHRDLKPENLLINT--EGVLKLADFGLARSFGSPVRPYTH 157 (283)
T ss_pred -CCHHHHHHhhc-ccCCHHHHHHHHHHHHHHHHHHHHCCeeecCcCHHHEEECC--CCcEEEeeeeeeEecCCCcccccC
Confidence 48888887654 36899999999999999999999999999999999999985 5689999999986654322 23
Q ss_pred ccccccccCchhhccCCCCCCCcccchhhhhhhhhhhhcCCCCCCCcCcchhHHHHHHHHhcCCCCCCCCCCchhHHHHH
Q psy11767 532 PCFTLQYAAPEVLRQDKSGYDENCDLWSLGVILVNVLRQDKSGYDENCDLWSLGVILYTMLCGRVPFHARSRDDSALSIM 611 (966)
Q Consensus 532 ~~gT~~Y~APEvl~~~~~~~~~~~Di~SlGvil~el~~~~~~~y~~~~DIWSlGvilyemltG~~Pf~~~~~~~~~~~~~ 611 (966)
..++..|+|||.+.. ...++.++|+|||||++|+|++|+.||...+..+....+.
T Consensus 158 ~~~~~~~~~PE~~~~-------------------------~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~~~~~ 212 (283)
T cd05118 158 YVVTRWYRAPELLLG-------------------------DKGYSTPVDIWSVGCIFAELLSRRPLFPGKSEIDQLFKIF 212 (283)
T ss_pred ccCcccccCcHHHhc-------------------------CCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH
Confidence 456788999998742 1236788999999999999999999998765433222221
Q ss_pred HHHHcC---------------CCC-------CCchhhccCCHHHHHHHHHhcccCccccCChHHH
Q psy11767 612 ARIKEG---------------QFN-------FDAEAWSTVSSEAKELTKSLLTVNPAQRIRMMRV 654 (966)
Q Consensus 612 ~~i~~~---------------~~~-------~~~~~~~~is~e~~~Li~~~L~~dP~~R~t~~~v 654 (966)
..+... .+. .....++.++.++.++|.+||..||.+||++.++
T Consensus 213 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~l 277 (283)
T cd05118 213 RTLGTPDPEVWPKFTSLARNYKFSFPKKAGMPLPKLFPNASPQALDLLSQMLHYDPHKRITAEQA 277 (283)
T ss_pred HHcCCCchHhcccchhhhhhhhhhhccccccCHHHhhhhhCHHHHHHHHHHhccCcccCcCHHHH
Confidence 111110 000 0012334578899999999999999999999876
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They |
| >cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-33 Score=319.97 Aligned_cols=251 Identities=26% Similarity=0.403 Sum_probs=191.1
Q ss_pred cccccccccccccEEEEEEEcCCCcEEEEEEecccc-----ChHHHHHHHHHhcCCCCceEEEEEEEeC-----------
Q psy11767 380 LDKAGILGDGSYSVCRRCVEKSTGQEYAVKIISRKI-----DCSEEINLLRACQGHPNIVNLHCVFQDE----------- 443 (966)
Q Consensus 380 ~~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~-----~~~~Ei~iL~~l~~HpnIV~l~~~~~~~----------- 443 (966)
|...+.||.|+||.||+|.+..+|+.||+|.+.... ...+|+++|+.+ +||||+++++++...
T Consensus 7 y~~~~~Lg~g~~g~vy~~~~~~~~~~v~iK~i~~~~~~~~~~~~~Ei~~l~~l-~h~~i~~~~~~~~~~~~~~~~~~~~~ 85 (342)
T cd07854 7 YMDLRPLGCGSNGLVFSAVDSDCDKRVAVKKIVLTDPQSVKHALREIKIIRRL-DHDNIVKVYEVLGPSGSDLTEDVGSL 85 (342)
T ss_pred eEEEEEecCCCCEEEEEEEECCCCcEEEEEEEecCCCchHHHHHHHHHHHHhc-CCCcchhhHhhhcccccccccccccc
Confidence 344688999999999999999999999999986532 245699999998 699999999876644
Q ss_pred ---CeEEEEEEccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCcEEEecCCCCCEEEEeec
Q psy11767 444 ---VHTYLVLELLKGGELLDRIRQKGRCGFTENEASRIMRQLVAAVHFMHSRGVVHRDLKPENLLFSDPAGDNIKVVDFG 520 (966)
Q Consensus 444 ---~~~~lVmEy~~gg~L~~~l~~~~~~~l~e~~~~~i~~Qil~aL~yLHs~~IiHRDLKP~NILl~~~~~~~iKL~DFG 520 (966)
...|+||||+. ++|.+++... .+++..++.++.||+.||+|||+.||+||||||+|||++. .+..+||+|||
T Consensus 86 ~~~~~~~lv~e~~~-~~L~~~~~~~---~l~~~~~~~~~~qi~~aL~~LH~~givH~dikp~Nili~~-~~~~~kl~dfg 160 (342)
T cd07854 86 TELNSVYIVQEYME-TDLANVLEQG---PLSEEHARLFMYQLLRGLKYIHSANVLHRDLKPANVFINT-EDLVLKIGDFG 160 (342)
T ss_pred cccceEEEEeeccc-ccHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEcC-CCceEEECCcc
Confidence 35799999996 5888887543 5899999999999999999999999999999999999964 34579999999
Q ss_pred ccccccCC------CccccccccccCchhhccCCCCCCCcccchhhhhhhhhhhhcCCCCCCCcCcchhHHHHHHHHhcC
Q psy11767 521 FACLKRES------LHTPCFTLQYAAPEVLRQDKSGYDENCDLWSLGVILVNVLRQDKSGYDENCDLWSLGVILYTMLCG 594 (966)
Q Consensus 521 la~~~~~~------~~~~~gT~~Y~APEvl~~~~~~~~~~~Di~SlGvil~el~~~~~~~y~~~~DIWSlGvilyemltG 594 (966)
++...... .....++..|+|||++.. ...++.++|||||||++|+|++|
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-------------------------~~~~~~~~DiwSlGvil~el~~g 215 (342)
T cd07854 161 LARIVDPHYSHKGYLSEGLVTKWYRSPRLLLS-------------------------PNNYTKAIDMWAAGCIFAEMLTG 215 (342)
T ss_pred cceecCCccccccccccccccccccCHHHHhC-------------------------ccccCchhhHHHHHHHHHHHHhC
Confidence 98654221 112356889999998742 12367889999999999999999
Q ss_pred CCCCCCCCCchhHHHHHHHH-------------------HcCCCCC---CchhhccCCHHHHHHHHHhcccCccccCChH
Q psy11767 595 RVPFHARSRDDSALSIMARI-------------------KEGQFNF---DAEAWSTVSSEAKELTKSLLTVNPAQRIRMM 652 (966)
Q Consensus 595 ~~Pf~~~~~~~~~~~~~~~i-------------------~~~~~~~---~~~~~~~is~e~~~Li~~~L~~dP~~R~t~~ 652 (966)
+.||.+....+.....+..+ ....... .....+.++.++.+||.+||..||++|||+.
T Consensus 216 ~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ 295 (342)
T cd07854 216 KPLFAGAHELEQMQLILESVPVVREEDRNELLNVIPSFVRNDGGEPRRPLRDLLPGVNPEALDFLEQILTFNPMDRLTAE 295 (342)
T ss_pred CCCCCCCCHHHHHHHHHHhcCCCChHHhhhhhhhhhhhhhhcccccCCCHHHHccCCCHHHHHHHHHHhCCCchhccCHH
Confidence 99998665432222111110 0000000 0111235788999999999999999999999
Q ss_pred HHHHHhhhhHH
Q psy11767 653 RVKLTFHAFHQ 663 (966)
Q Consensus 653 ~v~~~~~~~~~ 663 (966)
++ ..|+|++
T Consensus 296 el--l~h~~~~ 304 (342)
T cd07854 296 EA--LMHPYMS 304 (342)
T ss_pred HH--hCCCccc
Confidence 76 3466653
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi |
| >cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-33 Score=302.43 Aligned_cols=237 Identities=26% Similarity=0.430 Sum_probs=189.3
Q ss_pred cccccccccccccEEEEEEEcCCCcEEEEEEecccc----------ChHHHHHHHHHhcCCCCceEEEEEEEeC--CeEE
Q psy11767 380 LDKAGILGDGSYSVCRRCVEKSTGQEYAVKIISRKI----------DCSEEINLLRACQGHPNIVNLHCVFQDE--VHTY 447 (966)
Q Consensus 380 ~~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~----------~~~~Ei~iL~~l~~HpnIV~l~~~~~~~--~~~~ 447 (966)
|...+.||+|+||.||+|.+..+|+.||+|++.... ...+|+.+++.+ +||||+++++++.+. ...+
T Consensus 4 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~ei~~l~~l-~h~~i~~~~~~~~~~~~~~~~ 82 (264)
T cd06653 4 WRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNL-RHDRIVQYYGCLRDPEEKKLS 82 (264)
T ss_pred eeeeeeEccCCCeEEEEEEEcCCCCEEEEEEEecCcccchhhHHHHHHHHHHHHHHHc-CCCCcceEEEEEEcCCCCEEE
Confidence 444688999999999999999999999999874321 234588999988 599999999998764 4689
Q ss_pred EEEEccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCcEEEecCCCCCEEEEeecccccccC
Q psy11767 448 LVLELLKGGELLDRIRQKGRCGFTENEASRIMRQLVAAVHFMHSRGVVHRDLKPENLLFSDPAGDNIKVVDFGFACLKRE 527 (966)
Q Consensus 448 lVmEy~~gg~L~~~l~~~~~~~l~e~~~~~i~~Qil~aL~yLHs~~IiHRDLKP~NILl~~~~~~~iKL~DFGla~~~~~ 527 (966)
+||||+++++|.+++...+ .+++..++.++.||+.||.|||++||+||||||+||++++ ++.++|+|||++.....
T Consensus 83 ~v~e~~~~~~L~~~~~~~~--~l~~~~~~~~~~~i~~al~~LH~~~i~H~dl~p~ni~i~~--~~~~~l~dfg~~~~~~~ 158 (264)
T cd06653 83 IFVEYMPGGSIKDQLKAYG--ALTENVTRRYTRQILQGVSYLHSNMIVHRDIKGANILRDS--AGNVKLGDFGASKRIQT 158 (264)
T ss_pred EEEEeCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcC--CCCEEECcccccccccc
Confidence 9999999999999997654 4899999999999999999999999999999999999975 56899999999975432
Q ss_pred ------CCccccccccccCchhhccCCCCCCCcccchhhhhhhhhhhhcCCCCCCCcCcchhHHHHHHHHhcCCCCCCCC
Q psy11767 528 ------SLHTPCFTLQYAAPEVLRQDKSGYDENCDLWSLGVILVNVLRQDKSGYDENCDLWSLGVILYTMLCGRVPFHAR 601 (966)
Q Consensus 528 ------~~~~~~gT~~Y~APEvl~~~~~~~~~~~Di~SlGvil~el~~~~~~~y~~~~DIWSlGvilyemltG~~Pf~~~ 601 (966)
......++..|+|||++.. ..++.++|+|||||++|+|++|+.||...
T Consensus 159 ~~~~~~~~~~~~~~~~y~aPE~~~~--------------------------~~~~~~~Di~slG~il~~l~~g~~p~~~~ 212 (264)
T cd06653 159 ICMSGTGIKSVTGTPYWMSPEVISG--------------------------EGYGRKADVWSVACTVVEMLTEKPPWAEY 212 (264)
T ss_pred ccccCccccccCCcccccCHhhhcC--------------------------CCCCccccHHHHHHHHHHHHhCCCCCCcc
Confidence 1123457889999998852 23567899999999999999999999764
Q ss_pred CCchhHHHHHHHHHcCCCCCCchhhccCCHHHHHHHHHhcccCccccCChHHH
Q psy11767 602 SRDDSALSIMARIKEGQFNFDAEAWSTVSSEAKELTKSLLTVNPAQRIRMMRV 654 (966)
Q Consensus 602 ~~~~~~~~~~~~i~~~~~~~~~~~~~~is~e~~~Li~~~L~~dP~~R~t~~~v 654 (966)
... ..+. ++.... ..+..+..+++++.++|.+||. +|..||++.++
T Consensus 213 ~~~---~~~~-~~~~~~--~~~~~p~~~~~~~~~~i~~~l~-~~~~r~~~~~~ 258 (264)
T cd06653 213 EAM---AAIF-KIATQP--TKPMLPDGVSDACRDFLKQIFV-EEKRRPTAEFL 258 (264)
T ss_pred CHH---HHHH-HHHcCC--CCCCCCcccCHHHHHHHHHHhc-CcccCccHHHH
Confidence 322 1222 222211 1122335688999999999999 57999999865
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho |
| >cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-33 Score=316.35 Aligned_cols=248 Identities=27% Similarity=0.455 Sum_probs=191.0
Q ss_pred cccccccccccEEEEEEEcCCCcEEEEEEecccc-------ChHHHHHHHHHhcCCCCceEEEEEEEeC------CeEEE
Q psy11767 382 KAGILGDGSYSVCRRCVEKSTGQEYAVKIISRKI-------DCSEEINLLRACQGHPNIVNLHCVFQDE------VHTYL 448 (966)
Q Consensus 382 ~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~-------~~~~Ei~iL~~l~~HpnIV~l~~~~~~~------~~~~l 448 (966)
..+.||+|+||.||+|.+..+|+.||+|++.+.. ...+|+.+++.+ +||||+++++++... ...|+
T Consensus 21 ~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l-~h~~iv~~~~~~~~~~~~~~~~~~~l 99 (345)
T cd07877 21 NLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHM-KHENVIGLLDVFTPARSLEEFNDVYL 99 (345)
T ss_pred EEEEeeecCCeEEEEEEEcCCCeEEEEEEecCcchhhHHHHHHHHHHHHHHHc-CCCcccceeeeeeecccccccccEEE
Confidence 3678999999999999999999999999986532 134588999888 599999999988643 34788
Q ss_pred EEEccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCcEEEecCCCCCEEEEeecccccccCC
Q psy11767 449 VLELLKGGELLDRIRQKGRCGFTENEASRIMRQLVAAVHFMHSRGVVHRDLKPENLLFSDPAGDNIKVVDFGFACLKRES 528 (966)
Q Consensus 449 VmEy~~gg~L~~~l~~~~~~~l~e~~~~~i~~Qil~aL~yLHs~~IiHRDLKP~NILl~~~~~~~iKL~DFGla~~~~~~ 528 (966)
+++++ |++|.+.+... .+++..++.++.||+.||+|||++||+||||||+||++++ ++.+||+|||++......
T Consensus 100 v~~~~-~~~L~~~~~~~---~l~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIll~~--~~~~kl~dfg~~~~~~~~ 173 (345)
T cd07877 100 VTHLM-GADLNNIVKCQ---KLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNE--DCELKILDFGLARHTDDE 173 (345)
T ss_pred Eehhc-ccCHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCCeeecCCChHHEEEcC--CCCEEEeccccccccccc
Confidence 99987 78998877543 4899999999999999999999999999999999999985 568999999999766554
Q ss_pred CccccccccccCchhhccCCCCCCCcccchhhhhhhhhhhhcCCCCCCCcCcchhHHHHHHHHhcCCCCCCCCCCchhHH
Q psy11767 529 LHTPCFTLQYAAPEVLRQDKSGYDENCDLWSLGVILVNVLRQDKSGYDENCDLWSLGVILYTMLCGRVPFHARSRDDSAL 608 (966)
Q Consensus 529 ~~~~~gT~~Y~APEvl~~~~~~~~~~~Di~SlGvil~el~~~~~~~y~~~~DIWSlGvilyemltG~~Pf~~~~~~~~~~ 608 (966)
.....+|+.|+|||++.. ...++.++||||+||++|+|++|++||...+......
T Consensus 174 ~~~~~~~~~y~aPE~~~~-------------------------~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~ 228 (345)
T cd07877 174 MTGYVATRWYRAPEIMLN-------------------------WMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLK 228 (345)
T ss_pred ccccccCCCccCHHHHhC-------------------------ccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHH
Confidence 455677899999998742 1236788999999999999999999997654322211
Q ss_pred HHHHHHH--------------------cCCCCC---CchhhccCCHHHHHHHHHhcccCccccCChHHHHHHhhhhHH
Q psy11767 609 SIMARIK--------------------EGQFNF---DAEAWSTVSSEAKELTKSLLTVNPAQRIRMMRVKLTFHAFHQ 663 (966)
Q Consensus 609 ~~~~~i~--------------------~~~~~~---~~~~~~~is~e~~~Li~~~L~~dP~~R~t~~~v~~~~~~~~~ 663 (966)
.+..... .-.... ....+...++++.+||.+||..||.+|+++.++ ..|+|+.
T Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~--l~h~~f~ 304 (345)
T cd07877 229 LILRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQA--LAHAYFA 304 (345)
T ss_pred HHHHHhCCCCHHHHhhcccHhHHHHHHHhcccCCcchhhhcCCCCHHHHHHHHHHcCCChhhcCCHHHH--hcChhhh
Confidence 1111000 000000 001122468899999999999999999999876 3455543
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14 |
| >cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-33 Score=308.42 Aligned_cols=242 Identities=26% Similarity=0.435 Sum_probs=193.5
Q ss_pred ccccccccccEEEEEEEcCCCcEEEEEEecccc-----ChHHHHHHHHHhcCCCCceEEEEEEEeCCeEEEEEEccCCCC
Q psy11767 383 AGILGDGSYSVCRRCVEKSTGQEYAVKIISRKI-----DCSEEINLLRACQGHPNIVNLHCVFQDEVHTYLVLELLKGGE 457 (966)
Q Consensus 383 ~~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~-----~~~~Ei~iL~~l~~HpnIV~l~~~~~~~~~~~lVmEy~~gg~ 457 (966)
..+||+|+||.||++.+..+|+.||||.+.... ...+|+.+++.+ +|+||++++++|..+.+.|+||||+++++
T Consensus 25 ~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~e~~~~~~ 103 (292)
T cd06657 25 FIKIGEGSTGIVCIATVKSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDY-QHENVVEMYNSYLVGDELWVVMEFLEGGA 103 (292)
T ss_pred HHHcCCCCCeEEEEEEEcCCCeEEEEEEecccchhHHHHHHHHHHHHHhc-CCcchhheeeEEEeCCEEEEEEecCCCCc
Confidence 457999999999999999999999999985432 244688888887 59999999999999999999999999999
Q ss_pred HHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCcEEEecCCCCCEEEEeecccccccCC---Cccccc
Q psy11767 458 LLDRIRQKGRCGFTENEASRIMRQLVAAVHFMHSRGVVHRDLKPENLLFSDPAGDNIKVVDFGFACLKRES---LHTPCF 534 (966)
Q Consensus 458 L~~~l~~~~~~~l~e~~~~~i~~Qil~aL~yLHs~~IiHRDLKP~NILl~~~~~~~iKL~DFGla~~~~~~---~~~~~g 534 (966)
|.+++... .+++..++.++.|++.||+|||+.||+|+||||+||+++. ++.++|+|||++...... .....+
T Consensus 104 L~~~~~~~---~~~~~~~~~~~~ql~~~l~~lH~~givH~dl~p~Nilv~~--~~~~~l~dfg~~~~~~~~~~~~~~~~~ 178 (292)
T cd06657 104 LTDIVTHT---RMNEEQIAAVCLAVLKALSVLHAQGVIHRDIKSDSILLTH--DGRVKLSDFGFCAQVSKEVPRRKSLVG 178 (292)
T ss_pred HHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECC--CCCEEEcccccceeccccccccccccc
Confidence 99887543 4899999999999999999999999999999999999975 568999999998654322 123457
Q ss_pred cccccCchhhccCCCCCCCcccchhhhhhhhhhhhcCCCCCCCcCcchhHHHHHHHHhcCCCCCCCCCCchhHHHHHHHH
Q psy11767 535 TLQYAAPEVLRQDKSGYDENCDLWSLGVILVNVLRQDKSGYDENCDLWSLGVILYTMLCGRVPFHARSRDDSALSIMARI 614 (966)
Q Consensus 535 T~~Y~APEvl~~~~~~~~~~~Di~SlGvil~el~~~~~~~y~~~~DIWSlGvilyemltG~~Pf~~~~~~~~~~~~~~~i 614 (966)
|+.|+|||.+.. ..++.++|+||+||++|+|++|..||.+..... ....+
T Consensus 179 ~~~y~~pE~~~~--------------------------~~~~~~~Dv~slGvil~el~tg~~p~~~~~~~~----~~~~~ 228 (292)
T cd06657 179 TPYWMAPELISR--------------------------LPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLK----AMKMI 228 (292)
T ss_pred CccccCHHHhcC--------------------------CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH----HHHHH
Confidence 899999998742 225678999999999999999999998654321 22222
Q ss_pred HcCCCCCCchhhccCCHHHHHHHHHhcccCccccCChHHHHHHhhhhHH
Q psy11767 615 KEGQFNFDAEAWSTVSSEAKELTKSLLTVNPAQRIRMMRVKLTFHAFHQ 663 (966)
Q Consensus 615 ~~~~~~~~~~~~~~is~e~~~Li~~~L~~dP~~R~t~~~v~~~~~~~~~ 663 (966)
..+... .......++.++.+++.+||..||.+||++.++. .|+|+.
T Consensus 229 ~~~~~~-~~~~~~~~~~~l~~li~~~l~~~P~~R~~~~~ll--~~~~~~ 274 (292)
T cd06657 229 RDNLPP-KLKNLHKVSPSLKGFLDRLLVRDPAQRATAAELL--KHPFLA 274 (292)
T ss_pred HhhCCc-ccCCcccCCHHHHHHHHHHHhCCcccCcCHHHHh--cChHHh
Confidence 222111 1112235788999999999999999999999763 366654
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo |
| >cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-33 Score=307.12 Aligned_cols=233 Identities=35% Similarity=0.625 Sum_probs=192.6
Q ss_pred ccccccccccccEEEEEEEcCCCcEEEEEEecccc--------ChHHHHHHHHHhcCCCCceEEEEEEEeCCeEEEEEEc
Q psy11767 381 DKAGILGDGSYSVCRRCVEKSTGQEYAVKIISRKI--------DCSEEINLLRACQGHPNIVNLHCVFQDEVHTYLVLEL 452 (966)
Q Consensus 381 ~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~--------~~~~Ei~iL~~l~~HpnIV~l~~~~~~~~~~~lVmEy 452 (966)
...+.||+|+||.||+|.+..+|+.||+|++.... ...+|+.+++.+.+||||+++++++.++...++||||
T Consensus 4 ~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv~e~ 83 (280)
T cd05581 4 KFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHPGIIKLYYTFQDEENLYFVLEY 83 (280)
T ss_pred eEeeeecCCCceEEEEEEEcCCCCEEEEEEechHhccchHHHHHHHHHHHHHHhcccCCCchhHHHHhcCCceEEEEEcC
Confidence 34678999999999999999999999999986521 2345788888885699999999999999999999999
Q ss_pred cCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCcEEEecCCCCCEEEEeecccccccCCC---
Q psy11767 453 LKGGELLDRIRQKGRCGFTENEASRIMRQLVAAVHFMHSRGVVHRDLKPENLLFSDPAGDNIKVVDFGFACLKRESL--- 529 (966)
Q Consensus 453 ~~gg~L~~~l~~~~~~~l~e~~~~~i~~Qil~aL~yLHs~~IiHRDLKP~NILl~~~~~~~iKL~DFGla~~~~~~~--- 529 (966)
+++++|.+++.+.+ .+++..++.++.|++.||+|||+.|++|+||||+||+++. ++.++|+|||++.......
T Consensus 84 ~~~~~L~~~l~~~~--~l~~~~~~~i~~ql~~~l~~Lh~~~~~H~dl~~~ni~i~~--~~~~~l~df~~~~~~~~~~~~~ 159 (280)
T cd05581 84 APNGELLQYIRKYG--SLDEKCTRFYAAEILLALEYLHSKGIIHRDLKPENILLDK--DMHIKITDFGTAKVLDPNSSPE 159 (280)
T ss_pred CCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHeEECC--CCCEEecCCccccccCCccccc
Confidence 99999999998764 5999999999999999999999999999999999999974 5689999999986543211
Q ss_pred --------------------ccccccccccCchhhccCCCCCCCcccchhhhhhhhhhhhcCCCCCCCcCcchhHHHHHH
Q psy11767 530 --------------------HTPCFTLQYAAPEVLRQDKSGYDENCDLWSLGVILVNVLRQDKSGYDENCDLWSLGVILY 589 (966)
Q Consensus 530 --------------------~~~~gT~~Y~APEvl~~~~~~~~~~~Di~SlGvil~el~~~~~~~y~~~~DIWSlGvily 589 (966)
....++..|+|||++.. ..++.++|+|||||+++
T Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~--------------------------~~~~~~~Di~slG~~l~ 213 (280)
T cd05581 160 SNKGDATNIDSQIEKNRRRFASFVGTAEYVSPELLNE--------------------------KPAGKSSDLWALGCIIY 213 (280)
T ss_pred cCCCCCccccccccccccccccccCCccccCHHHhCC--------------------------CCCChhhhHHHHHHHHH
Confidence 12346788999998742 12567899999999999
Q ss_pred HHhcCCCCCCCCCCchhHHHHHHHHHcCCCCCCchhhccCCHHHHHHHHHhcccCccccCCh
Q psy11767 590 TMLCGRVPFHARSRDDSALSIMARIKEGQFNFDAEAWSTVSSEAKELTKSLLTVNPAQRIRM 651 (966)
Q Consensus 590 emltG~~Pf~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~is~e~~~Li~~~L~~dP~~R~t~ 651 (966)
+|++|+.||..... ......+....+.++ ..+++.+.++|.+||..||++||++
T Consensus 214 ~l~~g~~p~~~~~~----~~~~~~~~~~~~~~~----~~~~~~~~~li~~~l~~~p~~R~~~ 267 (280)
T cd05581 214 QMLTGKPPFRGSNE----YLTFQKILKLEYSFP----PNFPPDAKDLIEKLLVLDPQDRLGV 267 (280)
T ss_pred HHHhCCCCCCCccH----HHHHHHHHhcCCCCC----CccCHHHHHHHHHHhcCCHhhCCCc
Confidence 99999999987652 223334444443332 3468899999999999999999999
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto |
| >cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-33 Score=314.79 Aligned_cols=249 Identities=27% Similarity=0.444 Sum_probs=192.5
Q ss_pred cccccccccccccEEEEEEEcCCCcEEEEEEecccc-------ChHHHHHHHHHhcCCCCceEEEEEEEe-CCeEEEEEE
Q psy11767 380 LDKAGILGDGSYSVCRRCVEKSTGQEYAVKIISRKI-------DCSEEINLLRACQGHPNIVNLHCVFQD-EVHTYLVLE 451 (966)
Q Consensus 380 ~~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~-------~~~~Ei~iL~~l~~HpnIV~l~~~~~~-~~~~~lVmE 451 (966)
|+..+.||.|+||.||+|.+..+|+.||||++.+.. ....|+.+|+.+ +||||++++++|.. ....|+|||
T Consensus 12 y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l-~hpniv~~~~~~~~~~~~~~lv~e 90 (328)
T cd07856 12 YVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYRELKLLKHL-RHENIISLSDIFISPLEDIYFVTE 90 (328)
T ss_pred eEEEEeecccCCeEEEEEEECCCCCEEEEEEecccccccchhHHHHHHHHHHHhc-CCCCeeeEeeeEecCCCcEEEEee
Confidence 344689999999999999999999999999875421 244699999988 59999999999876 567899999
Q ss_pred ccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCcEEEecCCCCCEEEEeecccccccCCCcc
Q psy11767 452 LLKGGELLDRIRQKGRCGFTENEASRIMRQLVAAVHFMHSRGVVHRDLKPENLLFSDPAGDNIKVVDFGFACLKRESLHT 531 (966)
Q Consensus 452 y~~gg~L~~~l~~~~~~~l~e~~~~~i~~Qil~aL~yLHs~~IiHRDLKP~NILl~~~~~~~iKL~DFGla~~~~~~~~~ 531 (966)
|+ +++|.+++... .+++..+..++.||+.||+|||++||+||||||+|||+++ .+.+||+|||++.........
T Consensus 91 ~~-~~~L~~~~~~~---~~~~~~~~~~~~ql~~aL~~LH~~~iiH~dl~p~Nili~~--~~~~~l~dfg~~~~~~~~~~~ 164 (328)
T cd07856 91 LL-GTDLHRLLTSR---PLEKQFIQYFLYQILRGLKYVHSAGVVHRDLKPSNILINE--NCDLKICDFGLARIQDPQMTG 164 (328)
T ss_pred hh-ccCHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEeECC--CCCEEeCccccccccCCCcCC
Confidence 98 67888887643 4889999999999999999999999999999999999975 568999999999765444445
Q ss_pred ccccccccCchhhccCCCCCCCcccchhhhhhhhhhhhcCCCCCCCcCcchhHHHHHHHHhcCCCCCCCCCCchhHHHHH
Q psy11767 532 PCFTLQYAAPEVLRQDKSGYDENCDLWSLGVILVNVLRQDKSGYDENCDLWSLGVILYTMLCGRVPFHARSRDDSALSIM 611 (966)
Q Consensus 532 ~~gT~~Y~APEvl~~~~~~~~~~~Di~SlGvil~el~~~~~~~y~~~~DIWSlGvilyemltG~~Pf~~~~~~~~~~~~~ 611 (966)
..+++.|+|||++.. ...++.++|||||||++|+|++|++||...........+.
T Consensus 165 ~~~~~~y~aPE~~~~-------------------------~~~~~~~~Dv~slG~il~el~tg~~~f~~~~~~~~~~~~~ 219 (328)
T cd07856 165 YVSTRYYRAPEIMLT-------------------------WQKYDVEVDIWSAGCIFAEMLEGKPLFPGKDHVNQFSIIT 219 (328)
T ss_pred CcccccccCceeeec-------------------------cCCcCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH
Confidence 567889999998742 1236788999999999999999999997654321111111
Q ss_pred HH-----------------------HHcCCCCCCchhhccCCHHHHHHHHHhcccCccccCChHHHHHHhhhhH
Q psy11767 612 AR-----------------------IKEGQFNFDAEAWSTVSSEAKELTKSLLTVNPAQRIRMMRVKLTFHAFH 662 (966)
Q Consensus 612 ~~-----------------------i~~~~~~~~~~~~~~is~e~~~Li~~~L~~dP~~R~t~~~v~~~~~~~~ 662 (966)
+. ..........+..+.++.++.++|.+||+.+|++|||+.++ ..|+|.
T Consensus 220 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~el--l~~~~~ 291 (328)
T cd07856 220 DLLGTPPDDVINTICSENTLRFVQSLPKREPVPFSEKFKNADPSAIDLLEKMLVFDPQKRISAAEA--LAHPYL 291 (328)
T ss_pred HHhCCCCHHHHHhccchhhHHHHhhccccCCCcHHHHcCCCCHHHHHHHHHHcCCChhhCCCHHHH--hcCCcc
Confidence 00 00000001111224578899999999999999999999876 344444
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U |
| >cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-33 Score=342.21 Aligned_cols=139 Identities=29% Similarity=0.520 Sum_probs=124.3
Q ss_pred cccccccccccEEEEEEEcCCCcEEEEEEecccc--------ChHHHHHHHHHhcCCCCceEEEEEEEeCCeEEEEEEcc
Q psy11767 382 KAGILGDGSYSVCRRCVEKSTGQEYAVKIISRKI--------DCSEEINLLRACQGHPNIVNLHCVFQDEVHTYLVLELL 453 (966)
Q Consensus 382 ~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~--------~~~~Ei~iL~~l~~HpnIV~l~~~~~~~~~~~lVmEy~ 453 (966)
.++.||+|+||+||+|.+..+++.||||++.... ....|+.++..+ .||||+++++++.+..+.||||||+
T Consensus 8 i~~~LG~G~fg~Vy~a~~~~~~~~vAiKvi~~~~~~~~~~~~~~~~E~~~l~~l-~hp~Iv~~~~~~~~~~~~~lVmEy~ 86 (669)
T cd05610 8 IVKPISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALS-KSPFIVHLYYSLQSANNVYLVMEYL 86 (669)
T ss_pred EEEEEecCCCeEEEEEEECCCCcEEEEEEEehhhccCHHHHHHHHHHHHHHHhc-CCCCcCeEEEEEEECCEEEEEEeCC
Confidence 3678999999999999999999999999996532 244678888776 5999999999999999999999999
Q ss_pred CCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCcEEEecCCCCCEEEEeecccccc
Q psy11767 454 KGGELLDRIRQKGRCGFTENEASRIMRQLVAAVHFMHSRGVVHRDLKPENLLFSDPAGDNIKVVDFGFACLK 525 (966)
Q Consensus 454 ~gg~L~~~l~~~~~~~l~e~~~~~i~~Qil~aL~yLHs~~IiHRDLKP~NILl~~~~~~~iKL~DFGla~~~ 525 (966)
.|++|.+++...+ .+++..++.|+.||+.||+|||++|||||||||+|||++. .+.+||+|||+++..
T Consensus 87 ~g~~L~~li~~~~--~l~~~~~~~i~~qil~aL~yLH~~gIiHrDLKP~NILl~~--~g~vkL~DFGls~~~ 154 (669)
T cd05610 87 IGGDVKSLLHIYG--YFDEEMAVKYISEVALALDYLHRHGIIHRDLKPDNMLISN--EGHIKLTDFGLSKVT 154 (669)
T ss_pred CCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCEEeCCccHHHEEEcC--CCCEEEEeCCCCccc
Confidence 9999999997654 5899999999999999999999999999999999999974 568999999999753
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481 |
| >KOG0669|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-35 Score=302.13 Aligned_cols=242 Identities=25% Similarity=0.482 Sum_probs=190.9
Q ss_pred cccccccccccccEEEEEEEcCCCcEEEEEEeccc-------cChHHHHHHHHHhcCCCCceEEEEEEEe--------CC
Q psy11767 380 LDKAGILGDGSYSVCRRCVEKSTGQEYAVKIISRK-------IDCSEEINLLRACQGHPNIVNLHCVFQD--------EV 444 (966)
Q Consensus 380 ~~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~-------~~~~~Ei~iL~~l~~HpnIV~l~~~~~~--------~~ 444 (966)
++++.+||+|.||.||+|+.+.+|+.||+|++--. ....+|+++|..+. |+|++.|++.|.. ..
T Consensus 19 yek~~kigqGtfgeVFkAr~~n~~kkvalkkvlmeneKeGfpitalreikiL~~lk-Henv~nliEic~tk~Tp~~r~r~ 97 (376)
T KOG0669|consen 19 YEKLAKIGQGTFGEVFKARSKNTGKKVALKKVLMENEKEGFPITALREIKILQLLK-HENVVNLIEICRTKATPTNRDRA 97 (376)
T ss_pred HHHHHhcCCchHHHHHHHhhcCccchhHHHHHHHhccccCCcHHHHHHHHHHHHhc-chhHHHHHHHHhhccCCcccccc
Confidence 34568899999999999999999999999876321 23678999999885 9999999887643 34
Q ss_pred eEEEEEEccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCcEEEecCCCCCEEEEeeccccc
Q psy11767 445 HTYLVLELLKGGELLDRIRQKGRCGFTENEASRIMRQLVAAVHFMHSRGVVHRDLKPENLLFSDPAGDNIKVVDFGFACL 524 (966)
Q Consensus 445 ~~~lVmEy~~gg~L~~~l~~~~~~~l~e~~~~~i~~Qil~aL~yLHs~~IiHRDLKP~NILl~~~~~~~iKL~DFGla~~ 524 (966)
..|+||++|+ .+|.-.|.... ..|+..++.+++.++++||.|+|...|+|||+||+|+||+. ++.+||+|||+|+.
T Consensus 98 t~ylVf~~ce-hDLaGlLsn~~-vr~sls~Ikk~Mk~Lm~GL~~iHr~kilHRDmKaaNvLIt~--dgilklADFGlar~ 173 (376)
T KOG0669|consen 98 TFYLVFDFCE-HDLAGLLSNRK-VRFSLSEIKKVMKGLMNGLYYIHRNKILHRDMKAANVLITK--DGILKLADFGLARA 173 (376)
T ss_pred eeeeeHHHhh-hhHHHHhcCcc-ccccHHHHHHHHHHHHHHHHHHHHhhHHhhcccHhhEEEcC--CceEEeeccccccc
Confidence 5899999995 58888886553 36999999999999999999999999999999999999984 57999999999965
Q ss_pred ccC-------CCccccccccccCchhhccCCCCCCCcccchhhhhhhhhhhhcCCCCCCCcCcchhHHHHHHHHhcCCCC
Q psy11767 525 KRE-------SLHTPCFTLQYAAPEVLRQDKSGYDENCDLWSLGVILVNVLRQDKSGYDENCDLWSLGVILYTMLCGRVP 597 (966)
Q Consensus 525 ~~~-------~~~~~~gT~~Y~APEvl~~~~~~~~~~~Di~SlGvil~el~~~~~~~y~~~~DIWSlGvilyemltG~~P 597 (966)
+.. .....+.|.+|++||.+.+ ...|+++.|||..|||+.||.+|.+-
T Consensus 174 fs~~~n~~kprytnrvvTLwYrppEllLG-------------------------~r~yg~~iDiWgAgCimaeMwtrspi 228 (376)
T KOG0669|consen 174 FSTSKNVVKPRYTNRVVTLWYRPPELLLG-------------------------DREYGPPIDIWGAGCIMAEMWTRSPI 228 (376)
T ss_pred eecccccCCCCcccceeeeecCCHHHhhc-------------------------ccccCCcchhHhHHHHHHHHHccCcc
Confidence 432 2334566999999999964 34589999999999999999999999
Q ss_pred CCCCCCchhHHHHHHHHHcCCCCCCchhhcc-------------------------------CCHHHHHHHHHhcccCcc
Q psy11767 598 FHARSRDDSALSIMARIKEGQFNFDAEAWST-------------------------------VSSEAKELTKSLLTVNPA 646 (966)
Q Consensus 598 f~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~-------------------------------is~e~~~Li~~~L~~dP~ 646 (966)
|.+.+...+ +..+..+ -|.+ ..+.|++ -.+++.||+.+||.+||.
T Consensus 229 mqgnteqqq-l~~Is~L-cGs~--tkevWP~~d~lpL~~sie~ePl~~~~~rkv~n~~kp~~kd~~a~dLle~ll~~DP~ 304 (376)
T KOG0669|consen 229 MQGNTEQQQ-LHLISQL-CGSI--TKEVWPNVDNLPLYQSIELEPLPKGQKRKVKNRLKPYVKDDEALDLLEKLLKLDPT 304 (376)
T ss_pred ccCChHHHH-HHHHHHH-hccC--CcccCCCcccchHHHhccCCCCCcchhhhhhhhcccccCChhHHHHHHHHhccCcc
Confidence 988664332 2222222 1222 1222221 134788999999999999
Q ss_pred ccCChHHHH
Q psy11767 647 QRIRMMRVK 655 (966)
Q Consensus 647 ~R~t~~~v~ 655 (966)
+|+++.++.
T Consensus 305 kR~~ad~al 313 (376)
T KOG0669|consen 305 KRIDADQAL 313 (376)
T ss_pred cCcchHhhh
Confidence 999998763
|
|
| >cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-33 Score=307.77 Aligned_cols=250 Identities=23% Similarity=0.387 Sum_probs=192.7
Q ss_pred ccccccccccccEEEEEEEcCCCcEEEEEEeccccC------hHHHHHHHHHhcCCCCceEEEEEEEeCCeEEEEEEccC
Q psy11767 381 DKAGILGDGSYSVCRRCVEKSTGQEYAVKIISRKID------CSEEINLLRACQGHPNIVNLHCVFQDEVHTYLVLELLK 454 (966)
Q Consensus 381 ~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~~------~~~Ei~iL~~l~~HpnIV~l~~~~~~~~~~~lVmEy~~ 454 (966)
+..+.||+|+||.||+|.+..+++.||||++..... ..+|+.++..+.+||||+++++++.++...|+||||+.
T Consensus 18 ~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~ 97 (296)
T cd06618 18 ENLGEIGSGTCGQVYKMRFKKTGHVMAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVKCYGYFITDSDVFICMELMS 97 (296)
T ss_pred eeeeEeeccCCeEEEEEEECCCCeEEEEEEEeccCChHHHHHHHHHHHHHHhccCCCchHhhheeeecCCeEEEEeeccC
Confidence 446889999999999999999999999999875422 23466667677679999999999999999999999984
Q ss_pred CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHh-cCceeccCCCCcEEEecCCCCCEEEEeecccccccCC--Ccc
Q psy11767 455 GGELLDRIRQKGRCGFTENEASRIMRQLVAAVHFMHS-RGVVHRDLKPENLLFSDPAGDNIKVVDFGFACLKRES--LHT 531 (966)
Q Consensus 455 gg~L~~~l~~~~~~~l~e~~~~~i~~Qil~aL~yLHs-~~IiHRDLKP~NILl~~~~~~~iKL~DFGla~~~~~~--~~~ 531 (966)
+.|.+.+..... .+++..+..++.||+.||+|||+ .||+||||||+|||+++ ++.+||+|||++...... ...
T Consensus 98 -~~l~~l~~~~~~-~l~~~~~~~i~~~i~~~l~~lH~~~~i~H~dl~p~nill~~--~~~~kL~dfg~~~~~~~~~~~~~ 173 (296)
T cd06618 98 -TCLDKLLKRIQG-PIPEDILGKMTVAIVKALHYLKEKHGVIHRDVKPSNILLDA--SGNVKLCDFGISGRLVDSKAKTR 173 (296)
T ss_pred -cCHHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhhCCEecCCCcHHHEEEcC--CCCEEECccccchhccCCCcccC
Confidence 577766655332 68999999999999999999997 59999999999999974 568999999998654321 123
Q ss_pred ccccccccCchhhccCCCCCCCcccchhhhhhhhhhhhcCCCCCCCcCcchhHHHHHHHHhcCCCCCCCCCCchhHHHHH
Q psy11767 532 PCFTLQYAAPEVLRQDKSGYDENCDLWSLGVILVNVLRQDKSGYDENCDLWSLGVILYTMLCGRVPFHARSRDDSALSIM 611 (966)
Q Consensus 532 ~~gT~~Y~APEvl~~~~~~~~~~~Di~SlGvil~el~~~~~~~y~~~~DIWSlGvilyemltG~~Pf~~~~~~~~~~~~~ 611 (966)
..+++.|+|||.+.... ....++.++|||||||++|+|++|+.||...... ...+
T Consensus 174 ~~~~~~y~aPE~~~~~~----------------------~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~---~~~~ 228 (296)
T cd06618 174 SAGCAAYMAPERIDPPD----------------------PNPKYDIRADVWSLGISLVELATGQFPYKNCKTE---FEVL 228 (296)
T ss_pred CCCCccccCHhhcCCCC----------------------CccccccchhHHHHHHHHHHHHhCCCCCCcchhH---HHHH
Confidence 34678899999885321 0234678899999999999999999999754322 2233
Q ss_pred HHHHcCCCCCCchhhccCCHHHHHHHHHhcccCccccCChHHHHHHhhhhH
Q psy11767 612 ARIKEGQFNFDAEAWSTVSSEAKELTKSLLTVNPAQRIRMMRVKLTFHAFH 662 (966)
Q Consensus 612 ~~i~~~~~~~~~~~~~~is~e~~~Li~~~L~~dP~~R~t~~~v~~~~~~~~ 662 (966)
..+........ .....++.++.+|+.+||..||++||++.++. .|+|.
T Consensus 229 ~~~~~~~~~~~-~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il--~~~~~ 276 (296)
T cd06618 229 TKILQEEPPSL-PPNEGFSPDFCSFVDLCLTKDHRKRPKYRELL--QHPFI 276 (296)
T ss_pred HHHhcCCCCCC-CCCCCCCHHHHHHHHHHccCChhhCCCHHHHh--cChhh
Confidence 33333321111 11124688999999999999999999998763 34554
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it |
| >cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-32 Score=307.99 Aligned_cols=245 Identities=23% Similarity=0.352 Sum_probs=194.4
Q ss_pred cccccccccccEEEEEEEcCCCcEEEEEEecccc--------ChHHHHHHHHHhcCCCCceEEEEEEEeCCeEEEEEEcc
Q psy11767 382 KAGILGDGSYSVCRRCVEKSTGQEYAVKIISRKI--------DCSEEINLLRACQGHPNIVNLHCVFQDEVHTYLVLELL 453 (966)
Q Consensus 382 ~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~--------~~~~Ei~iL~~l~~HpnIV~l~~~~~~~~~~~lVmEy~ 453 (966)
..+.||+|+||+||+|.+..+|+.||+|++.... ...+|+.+++.+ +||||+++++++.+....|+||||+
T Consensus 25 ~~~~lg~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~e~~ 103 (313)
T cd06633 25 GLHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQL-KHPNTIEYKGCYLKEHTAWLVMEYC 103 (313)
T ss_pred cceeeccCCCeEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHHhC-CCCCCccEEEEEEeCCEEEEEEecC
Confidence 3567999999999999999999999999986432 134688889888 5999999999999999999999999
Q ss_pred CCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCcEEEecCCCCCEEEEeecccccccCCCcccc
Q psy11767 454 KGGELLDRIRQKGRCGFTENEASRIMRQLVAAVHFMHSRGVVHRDLKPENLLFSDPAGDNIKVVDFGFACLKRESLHTPC 533 (966)
Q Consensus 454 ~gg~L~~~l~~~~~~~l~e~~~~~i~~Qil~aL~yLHs~~IiHRDLKP~NILl~~~~~~~iKL~DFGla~~~~~~~~~~~ 533 (966)
. |+|.+.+..... .+++.++..++.||+.||.|||++||+||||||+||++++ ++.+||+|||++.... ......
T Consensus 104 ~-~~l~~~l~~~~~-~l~~~~~~~~~~qi~~al~~LH~~gi~H~dl~p~nili~~--~~~~kL~dfg~~~~~~-~~~~~~ 178 (313)
T cd06633 104 L-GSASDLLEVHKK-PLQEVEIAAITHGALQGLAYLHSHNMIHRDIKAGNILLTE--PGQVKLADFGSASKSS-PANSFV 178 (313)
T ss_pred C-CCHHHHHHhcCC-CCCHHHHHHHHHHHHHHHHHHHHCCeecCCCChhhEEECC--CCCEEEeecCCCcccC-CCCCcc
Confidence 5 678888765443 5899999999999999999999999999999999999975 5689999999986533 233456
Q ss_pred ccccccCchhhccCCCCCCCcccchhhhhhhhhhhhcCCCCCCCcCcchhHHHHHHHHhcCCCCCCCCCCchhHHHHHHH
Q psy11767 534 FTLQYAAPEVLRQDKSGYDENCDLWSLGVILVNVLRQDKSGYDENCDLWSLGVILYTMLCGRVPFHARSRDDSALSIMAR 613 (966)
Q Consensus 534 gT~~Y~APEvl~~~~~~~~~~~Di~SlGvil~el~~~~~~~y~~~~DIWSlGvilyemltG~~Pf~~~~~~~~~~~~~~~ 613 (966)
++..|+|||++... ....++.++|||||||++|+|++|.+||....... ....
T Consensus 179 ~~~~y~aPE~~~~~-----------------------~~~~~~~~sDv~slGvil~el~~g~~p~~~~~~~~----~~~~ 231 (313)
T cd06633 179 GTPYWMAPEVILAM-----------------------DEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMS----ALYH 231 (313)
T ss_pred ccccccChhhcccc-----------------------CCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHH----HHHH
Confidence 88999999987421 12236778999999999999999999998654322 2222
Q ss_pred HHcCCCCCCchhhccCCHHHHHHHHHhcccCccccCChHHHHHHhhhhHH
Q psy11767 614 IKEGQFNFDAEAWSTVSSEAKELTKSLLTVNPAQRIRMMRVKLTFHAFHQ 663 (966)
Q Consensus 614 i~~~~~~~~~~~~~~is~e~~~Li~~~L~~dP~~R~t~~~v~~~~~~~~~ 663 (966)
+...... ......++..+++|+.+||+.+|.+||++.++ ..|+|..
T Consensus 232 ~~~~~~~--~~~~~~~~~~l~~li~~~l~~~P~~Rp~~~~~--l~~~~~~ 277 (313)
T cd06633 232 IAQNDSP--TLQSNEWTDSFRGFVDYCLQKIPQERPASAEL--LRHDFVR 277 (313)
T ss_pred HHhcCCC--CCCccccCHHHHHHHHHHccCChhhCcCHHHH--hcCcccC
Confidence 3222221 11223467889999999999999999999876 3456654
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co |
| >cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-32 Score=295.22 Aligned_cols=239 Identities=29% Similarity=0.463 Sum_probs=196.4
Q ss_pred cccccccccccccEEEEEEEcCCCcEEEEEEeccccC-------hHHHHHHHHHhcCCCCceEEEEEEEeC--CeEEEEE
Q psy11767 380 LDKAGILGDGSYSVCRRCVEKSTGQEYAVKIISRKID-------CSEEINLLRACQGHPNIVNLHCVFQDE--VHTYLVL 450 (966)
Q Consensus 380 ~~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~~-------~~~Ei~iL~~l~~HpnIV~l~~~~~~~--~~~~lVm 450 (966)
|...+.||+|+||.||+|.+..+++.|++|++..... ..+|+.+++.+. ||||+++++.+.+. ...++||
T Consensus 2 ~~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~~~~~~~~lv~ 80 (260)
T cd06606 2 WTRGELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQ-HPNIVRYYGSERDEEKNTLNIFL 80 (260)
T ss_pred ceeeeEeeecCceEEEEEEECCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHcC-CCCEeeEEEEEecCCCCeEEEEE
Confidence 3446789999999999999999999999999865542 456889999885 99999999999988 8899999
Q ss_pred EccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCcEEEecCCCCCEEEEeecccccccCC--
Q psy11767 451 ELLKGGELLDRIRQKGRCGFTENEASRIMRQLVAAVHFMHSRGVVHRDLKPENLLFSDPAGDNIKVVDFGFACLKRES-- 528 (966)
Q Consensus 451 Ey~~gg~L~~~l~~~~~~~l~e~~~~~i~~Qil~aL~yLHs~~IiHRDLKP~NILl~~~~~~~iKL~DFGla~~~~~~-- 528 (966)
||+++++|.+++.+.. .+++.++..++.|++.||+|||+.|++|+||+|+||+++. ++.++|+|||.+......
T Consensus 81 e~~~~~~L~~~~~~~~--~~~~~~~~~~~~~l~~~l~~lh~~~~~h~dl~p~ni~i~~--~~~~~l~d~~~~~~~~~~~~ 156 (260)
T cd06606 81 EYVSGGSLSSLLKKFG--KLPEPVIRKYTRQILEGLAYLHSNGIVHRDIKGANILVDS--DGVVKLADFGCAKRLGDIET 156 (260)
T ss_pred EecCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEcC--CCCEEEcccccEEecccccc
Confidence 9999999999998765 6899999999999999999999999999999999999985 568999999998765443
Q ss_pred ---CccccccccccCchhhccCCCCCCCcccchhhhhhhhhhhhcCCCCCCCcCcchhHHHHHHHHhcCCCCCCCCCCch
Q psy11767 529 ---LHTPCFTLQYAAPEVLRQDKSGYDENCDLWSLGVILVNVLRQDKSGYDENCDLWSLGVILYTMLCGRVPFHARSRDD 605 (966)
Q Consensus 529 ---~~~~~gT~~Y~APEvl~~~~~~~~~~~Di~SlGvil~el~~~~~~~y~~~~DIWSlGvilyemltG~~Pf~~~~~~~ 605 (966)
.....++..|+|||.+... .++.++|||||||++|+|++|..||.....
T Consensus 157 ~~~~~~~~~~~~y~~pE~~~~~--------------------------~~~~~~Dv~slG~il~~l~~g~~p~~~~~~-- 208 (260)
T cd06606 157 GEGTGSVRGTPYWMAPEVIRGE--------------------------EYGRAADIWSLGCTVIEMATGKPPWSELGN-- 208 (260)
T ss_pred cccccCCCCCccccCHhhhcCC--------------------------CCCchhhHHHHHHHHHHHHhCCCCCCCCCc--
Confidence 2345678899999987522 257789999999999999999999987652
Q ss_pred hHHHHHHHHHcCCCCCCchhhccCCHHHHHHHHHhcccCccccCChHHH
Q psy11767 606 SALSIMARIKEGQFNFDAEAWSTVSSEAKELTKSLLTVNPAQRIRMMRV 654 (966)
Q Consensus 606 ~~~~~~~~i~~~~~~~~~~~~~~is~e~~~Li~~~L~~dP~~R~t~~~v 654 (966)
.......+..+.. .......++.++.++|.+||..||++||++.++
T Consensus 209 -~~~~~~~~~~~~~--~~~~~~~~~~~l~~~i~~~l~~~p~~Rp~~~~l 254 (260)
T cd06606 209 -PMAALYKIGSSGE--PPEIPEHLSEEAKDFLRKCLRRDPKKRPTADEL 254 (260)
T ss_pred -hHHHHHhccccCC--CcCCCcccCHHHHHHHHHhCcCChhhCCCHHHH
Confidence 1222223322111 111223568999999999999999999999876
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK |
| >cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-32 Score=294.58 Aligned_cols=238 Identities=29% Similarity=0.487 Sum_probs=196.6
Q ss_pred ccccccccccccEEEEEEEcCCCcEEEEEEeccccC-------hHHHHHHHHHhcCCCCceEEEEEEEeCCeEEEEEEcc
Q psy11767 381 DKAGILGDGSYSVCRRCVEKSTGQEYAVKIISRKID-------CSEEINLLRACQGHPNIVNLHCVFQDEVHTYLVLELL 453 (966)
Q Consensus 381 ~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~~-------~~~Ei~iL~~l~~HpnIV~l~~~~~~~~~~~lVmEy~ 453 (966)
...+.||.|+||.||+|.+..+++.||+|++..... ..+|+++++.+. |||++++++.+.+....++||||+
T Consensus 3 ~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~-~~~~~~~~~~~~~~~~~~lv~e~~ 81 (258)
T cd08215 3 EIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLN-HPNIIKYYESFEEKGKLCIVMEYA 81 (258)
T ss_pred eEEeeeccCCCeEEEEEEEcCCCcEEEEEEeecccCChHHHHHHHHHHHHHHhcC-CCChhheEEEEecCCEEEEEEEec
Confidence 346789999999999999999999999999865422 446889999885 999999999999999999999999
Q ss_pred CCCCHHHHHHhcC--CCCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCcEEEecCCCCCEEEEeecccccccCC---
Q psy11767 454 KGGELLDRIRQKG--RCGFTENEASRIMRQLVAAVHFMHSRGVVHRDLKPENLLFSDPAGDNIKVVDFGFACLKRES--- 528 (966)
Q Consensus 454 ~gg~L~~~l~~~~--~~~l~e~~~~~i~~Qil~aL~yLHs~~IiHRDLKP~NILl~~~~~~~iKL~DFGla~~~~~~--- 528 (966)
++++|.+++.... ...+++..+..++.|++.||+|||++|++|+||+|+|||+++ ++.++|+|||++......
T Consensus 82 ~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~H~dl~~~nil~~~--~~~~~l~d~~~~~~~~~~~~~ 159 (258)
T cd08215 82 DGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLHSRKILHRDIKPQNIFLTS--NGLVKLGDFGISKVLSSTVDL 159 (258)
T ss_pred CCCcHHHHHHHhhccCCCcCHHHHHHHHHHHHHHHHHHHhCCEecccCChHHeEEcC--CCcEEECCccceeecccCcce
Confidence 9999999997753 246999999999999999999999999999999999999985 568999999998664432
Q ss_pred CccccccccccCchhhccCCCCCCCcccchhhhhhhhhhhhcCCCCCCCcCcchhHHHHHHHHhcCCCCCCCCCCchhHH
Q psy11767 529 LHTPCFTLQYAAPEVLRQDKSGYDENCDLWSLGVILVNVLRQDKSGYDENCDLWSLGVILYTMLCGRVPFHARSRDDSAL 608 (966)
Q Consensus 529 ~~~~~gT~~Y~APEvl~~~~~~~~~~~Di~SlGvil~el~~~~~~~y~~~~DIWSlGvilyemltG~~Pf~~~~~~~~~~ 608 (966)
.....+++.|+|||.+.. ..++.++|+||+|+++|+|++|+.||......
T Consensus 160 ~~~~~~~~~y~~pe~~~~--------------------------~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~---- 209 (258)
T cd08215 160 AKTVVGTPYYLSPELCQN--------------------------KPYNYKSDIWSLGCVLYELCTLKHPFEGENLL---- 209 (258)
T ss_pred ecceeeeecccChhHhcc--------------------------CCCCccccHHHHHHHHHHHHcCCCCCCCCcHH----
Confidence 223467889999998742 23577899999999999999999999765422
Q ss_pred HHHHHHHcCCCCCCchhhccCCHHHHHHHHHhcccCccccCChHHH
Q psy11767 609 SIMARIKEGQFNFDAEAWSTVSSEAKELTKSLLTVNPAQRIRMMRV 654 (966)
Q Consensus 609 ~~~~~i~~~~~~~~~~~~~~is~e~~~Li~~~L~~dP~~R~t~~~v 654 (966)
.+...+..+..... ...++.++.+++.+||..||++|||+.++
T Consensus 210 ~~~~~~~~~~~~~~---~~~~~~~~~~~i~~~l~~~p~~Rp~~~~l 252 (258)
T cd08215 210 ELALKILKGQYPPI---PSQYSSELRNLVSSLLQKDPEERPSIAQI 252 (258)
T ss_pred HHHHHHhcCCCCCC---CCCCCHHHHHHHHHHcCCChhhCcCHHHH
Confidence 23333444333221 22578899999999999999999999876
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They |
| >cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-32 Score=302.89 Aligned_cols=243 Identities=26% Similarity=0.455 Sum_probs=196.4
Q ss_pred ccccccccccEEEEEEEcCCCcEEEEEEecccc----ChHHHHHHHHHhcCCCCceEEEEEEEeCCeEEEEEEccCCCCH
Q psy11767 383 AGILGDGSYSVCRRCVEKSTGQEYAVKIISRKI----DCSEEINLLRACQGHPNIVNLHCVFQDEVHTYLVLELLKGGEL 458 (966)
Q Consensus 383 ~~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~----~~~~Ei~iL~~l~~HpnIV~l~~~~~~~~~~~lVmEy~~gg~L 458 (966)
...||+|+||.||+|.+..+++.||+|++.... ...+|+.+|+.+ +|+||+++++++..+...|+|+||++|++|
T Consensus 24 ~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L 102 (286)
T cd06614 24 LEKIGEGASGEVYKATDRATGKEVAIKKMRLRKQNKELIINEILIMKDC-KHPNIVDYYDSYLVGDELWVVMEYMDGGSL 102 (286)
T ss_pred hHhccCCCCeEEEEEEEccCCcEEEEEEEecCchhHHHHHHHHHHHHHC-CCCCeeEEEEEEEECCEEEEEEeccCCCcH
Confidence 578999999999999999999999999987543 245688999888 599999999999999999999999999999
Q ss_pred HHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCcEEEecCCCCCEEEEeecccccccCC---Ccccccc
Q psy11767 459 LDRIRQKGRCGFTENEASRIMRQLVAAVHFMHSRGVVHRDLKPENLLFSDPAGDNIKVVDFGFACLKRES---LHTPCFT 535 (966)
Q Consensus 459 ~~~l~~~~~~~l~e~~~~~i~~Qil~aL~yLHs~~IiHRDLKP~NILl~~~~~~~iKL~DFGla~~~~~~---~~~~~gT 535 (966)
.+++.... ..+++..+..++.|++.||+|||+.||+|+||||+||+++. ++.++|+|||++...... .....++
T Consensus 103 ~~~l~~~~-~~l~~~~~~~i~~~i~~~L~~lH~~gi~H~dl~p~ni~i~~--~~~~~l~d~~~~~~~~~~~~~~~~~~~~ 179 (286)
T cd06614 103 TDIITQNF-VRMNEPQIAYVCREVLQGLEYLHSQNVIHRDIKSDNILLSK--DGSVKLADFGFAAQLTKEKSKRNSVVGT 179 (286)
T ss_pred HHHHHHhc-cCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCChhhEEEcC--CCCEEECccchhhhhccchhhhccccCC
Confidence 99998765 35899999999999999999999999999999999999974 568999999998543321 1234568
Q ss_pred ccccCchhhccCCCCCCCcccchhhhhhhhhhhhcCCCCCCCcCcchhHHHHHHHHhcCCCCCCCCCCchhHHHHHHHHH
Q psy11767 536 LQYAAPEVLRQDKSGYDENCDLWSLGVILVNVLRQDKSGYDENCDLWSLGVILYTMLCGRVPFHARSRDDSALSIMARIK 615 (966)
Q Consensus 536 ~~Y~APEvl~~~~~~~~~~~Di~SlGvil~el~~~~~~~y~~~~DIWSlGvilyemltG~~Pf~~~~~~~~~~~~~~~i~ 615 (966)
+.|+|||++.. ..++.++|+|||||++|+|++|+.||....... ....+.
T Consensus 180 ~~y~~PE~~~~--------------------------~~~~~~~Dv~slGvil~~l~~g~~p~~~~~~~~----~~~~~~ 229 (286)
T cd06614 180 PYWMAPEVIKR--------------------------KDYGPKVDIWSLGIMCIEMAEGEPPYLREPPLR----ALFLIT 229 (286)
T ss_pred cccCCHhHhcC--------------------------CCCCCccccHHHHHHHHHHHhCCCCCCCCCHHH----HHHHHH
Confidence 89999998742 236788999999999999999999997654321 222232
Q ss_pred cCCCCCCchhhccCCHHHHHHHHHhcccCccccCChHHHHHHhhhhH
Q psy11767 616 EGQFNFDAEAWSTVSSEAKELTKSLLTVNPAQRIRMMRVKLTFHAFH 662 (966)
Q Consensus 616 ~~~~~~~~~~~~~is~e~~~Li~~~L~~dP~~R~t~~~v~~~~~~~~ 662 (966)
..... .......++.+++++|.+||+.+|.+||++.++. .++|.
T Consensus 230 ~~~~~-~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il--~~~~~ 273 (286)
T cd06614 230 TKGIP-PLKNPEKWSPEFKDFLNKCLVKDPEKRPSAEELL--QHPFL 273 (286)
T ss_pred hcCCC-CCcchhhCCHHHHHHHHHHhccChhhCcCHHHHh--hChHh
Confidence 22221 1112234788999999999999999999998763 34444
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou |
| >cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-32 Score=293.46 Aligned_cols=236 Identities=27% Similarity=0.437 Sum_probs=194.9
Q ss_pred ccccccccccccEEEEEEEcCCCcEEEEEEeccccC-------hHHHHHHHHHhcCCCCceEEEEEEEeCCeEEEEEEcc
Q psy11767 381 DKAGILGDGSYSVCRRCVEKSTGQEYAVKIISRKID-------CSEEINLLRACQGHPNIVNLHCVFQDEVHTYLVLELL 453 (966)
Q Consensus 381 ~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~~-------~~~Ei~iL~~l~~HpnIV~l~~~~~~~~~~~lVmEy~ 453 (966)
+..+.||+|+||.||+|.+..+++.||+|.+..... ..+|+++++.+ .||||+++++++.++...|+||||+
T Consensus 3 ~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~~~~~v~e~~ 81 (254)
T cd06627 3 QLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNL-KHPNIVKYIGSIETSDSLYIILEYA 81 (254)
T ss_pred eeeeEEcccCCeEEEEEEEcCCCcEEEEEEecccccCHHHHHHHHHHHHHHHhC-CCCCccEEEEEEEeCCEEEEEEecC
Confidence 346789999999999999999999999999865532 45688889888 5999999999999999999999999
Q ss_pred CCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCcEEEecCCCCCEEEEeecccccccCCC---c
Q psy11767 454 KGGELLDRIRQKGRCGFTENEASRIMRQLVAAVHFMHSRGVVHRDLKPENLLFSDPAGDNIKVVDFGFACLKRESL---H 530 (966)
Q Consensus 454 ~gg~L~~~l~~~~~~~l~e~~~~~i~~Qil~aL~yLHs~~IiHRDLKP~NILl~~~~~~~iKL~DFGla~~~~~~~---~ 530 (966)
++++|.+++.... .+++..+..++.|++.||.|||+.||+||||||+||+++. .+.++|+|||++....... .
T Consensus 82 ~~~~L~~~~~~~~--~l~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~ni~i~~--~~~~~l~d~~~~~~~~~~~~~~~ 157 (254)
T cd06627 82 ENGSLRQIIKKFG--PFPESLVAVYVYQVLQGLAYLHEQGVIHRDIKAANILTTK--DGVVKLADFGVATKLNDVSKDDA 157 (254)
T ss_pred CCCcHHHHHHhcc--CCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCHHHEEECC--CCCEEEeccccceecCCCccccc
Confidence 9999999997764 6899999999999999999999999999999999999985 5689999999997654322 2
Q ss_pred cccccccccCchhhccCCCCCCCcccchhhhhhhhhhhhcCCCCCCCcCcchhHHHHHHHHhcCCCCCCCCCCchhHHHH
Q psy11767 531 TPCFTLQYAAPEVLRQDKSGYDENCDLWSLGVILVNVLRQDKSGYDENCDLWSLGVILYTMLCGRVPFHARSRDDSALSI 610 (966)
Q Consensus 531 ~~~gT~~Y~APEvl~~~~~~~~~~~Di~SlGvil~el~~~~~~~y~~~~DIWSlGvilyemltG~~Pf~~~~~~~~~~~~ 610 (966)
...++..|+|||.+.. ..++.++||||+|+++|+|++|..||...... ..
T Consensus 158 ~~~~~~~y~~pe~~~~--------------------------~~~~~~~Dv~~lG~~l~~l~~g~~p~~~~~~~----~~ 207 (254)
T cd06627 158 SVVGTPYWMAPEVIEM--------------------------SGASTASDIWSLGCTVIELLTGNPPYYDLNPM----AA 207 (254)
T ss_pred ccccchhhcCHhhhcC--------------------------CCCCcchhHHHHHHHHHHHHhCCCCCCCccHH----HH
Confidence 3467889999998742 12577899999999999999999999865422 22
Q ss_pred HHHHHcCCCCCCchhhccCCHHHHHHHHHhcccCccccCChHHH
Q psy11767 611 MARIKEGQFNFDAEAWSTVSSEAKELTKSLLTVNPAQRIRMMRV 654 (966)
Q Consensus 611 ~~~i~~~~~~~~~~~~~~is~e~~~Li~~~L~~dP~~R~t~~~v 654 (966)
...+...... .....+++++.+++.+||..+|++||++.++
T Consensus 208 ~~~~~~~~~~---~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~ 248 (254)
T cd06627 208 LFRIVQDDHP---PLPEGISPELKDFLMQCFQKDPNLRPTAKQL 248 (254)
T ss_pred HHHHhccCCC---CCCCCCCHHHHHHHHHHHhCChhhCcCHHHH
Confidence 2222222221 1234678999999999999999999999876
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast |
| >cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-33 Score=297.59 Aligned_cols=238 Identities=30% Similarity=0.472 Sum_probs=196.1
Q ss_pred ccccccccccccEEEEEEEcCCCcEEEEEEecccc-------ChHHHHHHHHHhcCCCCceEEEEEEEeCCeEEEEEEcc
Q psy11767 381 DKAGILGDGSYSVCRRCVEKSTGQEYAVKIISRKI-------DCSEEINLLRACQGHPNIVNLHCVFQDEVHTYLVLELL 453 (966)
Q Consensus 381 ~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~-------~~~~Ei~iL~~l~~HpnIV~l~~~~~~~~~~~lVmEy~ 453 (966)
+..+.||+|+||.||++.+..+++.+|+|.+.... ...+|+.+++.+. ||||+++++++.+....|+||||+
T Consensus 3 ~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~~~~~~~v~e~~ 81 (256)
T cd08530 3 KVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVN-HPNIISYKEAFLDGNKLCIVMEYA 81 (256)
T ss_pred eEeeeecCCCceeEEEEEECCCCCEEEEEEEehhhccHHHHHHHHHHHHHHHhCC-CCCchhhhhhhccCCEEEEEehhc
Confidence 44678999999999999999999999999986432 2346888898885 999999999999999999999999
Q ss_pred CCCCHHHHHHhcC--CCCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCcEEEecCCCCCEEEEeecccccccCC-Cc
Q psy11767 454 KGGELLDRIRQKG--RCGFTENEASRIMRQLVAAVHFMHSRGVVHRDLKPENLLFSDPAGDNIKVVDFGFACLKRES-LH 530 (966)
Q Consensus 454 ~gg~L~~~l~~~~--~~~l~e~~~~~i~~Qil~aL~yLHs~~IiHRDLKP~NILl~~~~~~~iKL~DFGla~~~~~~-~~ 530 (966)
++++|.+++.... ...+++..+..++.|++.||+|||+.|++|+||||+||++++ .+.+||+|||++...... ..
T Consensus 82 ~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lh~~~i~h~~l~~~ni~~~~--~~~~kl~d~g~~~~~~~~~~~ 159 (256)
T cd08530 82 PFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALHEQKILHRDLKSANILLVA--NDLVKIGDLGISKVLKKNMAK 159 (256)
T ss_pred CCCCHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCcceEEEec--CCcEEEeeccchhhhccCCcc
Confidence 9999999986621 235899999999999999999999999999999999999986 568999999999765432 22
Q ss_pred cccccccccCchhhccCCCCCCCcccchhhhhhhhhhhhcCCCCCCCcCcchhHHHHHHHHhcCCCCCCCCCCchhHHHH
Q psy11767 531 TPCFTLQYAAPEVLRQDKSGYDENCDLWSLGVILVNVLRQDKSGYDENCDLWSLGVILYTMLCGRVPFHARSRDDSALSI 610 (966)
Q Consensus 531 ~~~gT~~Y~APEvl~~~~~~~~~~~Di~SlGvil~el~~~~~~~y~~~~DIWSlGvilyemltG~~Pf~~~~~~~~~~~~ 610 (966)
...+++.|+|||.+.. ..++.++|+||||+++|+|++|+.||...+.. ..
T Consensus 160 ~~~~~~~~~~Pe~~~~--------------------------~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~~----~~ 209 (256)
T cd08530 160 TQIGTPHYMAPEVWKG--------------------------RPYSYKSDIWSLGCLLYEMATFAPPFEARSMQ----DL 209 (256)
T ss_pred cccCCccccCHHHHCC--------------------------CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH----HH
Confidence 3457889999998742 23567899999999999999999999865432 23
Q ss_pred HHHHHcCCCCCCchhhccCCHHHHHHHHHhcccCccccCChHHH
Q psy11767 611 MARIKEGQFNFDAEAWSTVSSEAKELTKSLLTVNPAQRIRMMRV 654 (966)
Q Consensus 611 ~~~i~~~~~~~~~~~~~~is~e~~~Li~~~L~~dP~~R~t~~~v 654 (966)
...+..+.+.... ...+.++++++.+||..+|++||++.++
T Consensus 210 ~~~~~~~~~~~~~---~~~~~~~~~li~~~l~~~p~~Rp~~~~~ 250 (256)
T cd08530 210 RYKVQRGKYPPIP---PIYSQDLQNFIRSMLQVKPKLRPNCDKI 250 (256)
T ss_pred HHHHhcCCCCCCc---hhhCHHHHHHHHHHcCCCcccCCCHHHH
Confidence 3344444443222 2578899999999999999999999876
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an |
| >cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-33 Score=314.24 Aligned_cols=250 Identities=29% Similarity=0.459 Sum_probs=195.8
Q ss_pred ccccccccccccEEEEEEEcCCCcEEEEEEecccc-------ChHHHHHHHHHhcCCCCceEEEEEEEeCC-----eEEE
Q psy11767 381 DKAGILGDGSYSVCRRCVEKSTGQEYAVKIISRKI-------DCSEEINLLRACQGHPNIVNLHCVFQDEV-----HTYL 448 (966)
Q Consensus 381 ~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~-------~~~~Ei~iL~~l~~HpnIV~l~~~~~~~~-----~~~l 448 (966)
+..+.||.|+||.||+|.+..+|+.||||++.... ...+|+.+|+.+ +||||+++++++.+.. ..|+
T Consensus 3 ~i~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~~~~~~~~~l 81 (330)
T cd07834 3 ELLKPIGSGAYGVVCSAVDKRTGRKVAIKKISNVFDDLIDAKRILREIKLLRHL-RHENIIGLLDILRPPSPEDFNDVYI 81 (330)
T ss_pred eeeeeecCCCCeEEEEEEeCCCCcEEEEEeeccccccchhhhhHHHHHHHHHhc-CCcchhhhhhhhcccCcccccceEE
Confidence 34678999999999999999999999999986532 245699999988 5999999999998775 7899
Q ss_pred EEEccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCcEEEecCCCCCEEEEeecccccccCC
Q psy11767 449 VLELLKGGELLDRIRQKGRCGFTENEASRIMRQLVAAVHFMHSRGVVHRDLKPENLLFSDPAGDNIKVVDFGFACLKRES 528 (966)
Q Consensus 449 VmEy~~gg~L~~~l~~~~~~~l~e~~~~~i~~Qil~aL~yLHs~~IiHRDLKP~NILl~~~~~~~iKL~DFGla~~~~~~ 528 (966)
||||+. ++|.+++.... .+++..++.++.||+.||+|||+.||+||||||+|||++. ++.++|+|||++......
T Consensus 82 v~e~~~-~~l~~~l~~~~--~l~~~~~~~i~~~l~~~l~~LH~~gi~H~dlkp~nili~~--~~~~~L~dfg~~~~~~~~ 156 (330)
T cd07834 82 VTELME-TDLHKVIKSPQ--PLTDDHIQYFLYQILRGLKYLHSANVIHRDLKPSNILVNS--NCDLKICDFGLARGVDPD 156 (330)
T ss_pred Eecchh-hhHHHHHhCCC--CCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcC--CCCEEEcccCceEeeccc
Confidence 999996 58988886654 6999999999999999999999999999999999999985 469999999999765432
Q ss_pred ------CccccccccccCchhhccCCCCCCCcccchhhhhhhhhhhhcCCCCCCCcCcchhHHHHHHHHhcCCCCCCCCC
Q psy11767 529 ------LHTPCFTLQYAAPEVLRQDKSGYDENCDLWSLGVILVNVLRQDKSGYDENCDLWSLGVILYTMLCGRVPFHARS 602 (966)
Q Consensus 529 ------~~~~~gT~~Y~APEvl~~~~~~~~~~~Di~SlGvil~el~~~~~~~y~~~~DIWSlGvilyemltG~~Pf~~~~ 602 (966)
.....+|+.|+|||++... ..++.++|+||+||++|+|++|++||.+.+
T Consensus 157 ~~~~~~~~~~~~~~~y~aPE~~~~~-------------------------~~~~~~sDi~slG~il~~l~~g~~pf~~~~ 211 (330)
T cd07834 157 EDEKGFLTEYVVTRWYRAPELLLSS-------------------------SRYTKAIDIWSVGCIFAELLTRKPLFPGRD 211 (330)
T ss_pred ccccccccccccccCcCCceeeecc-------------------------cCCCcchhHHHHHHHHHHHHcCCCCcCCCC
Confidence 2234578899999988532 146788999999999999999999998765
Q ss_pred CchhHHHHHHHHHcCC-----------------------CCCCchhhccCCHHHHHHHHHhcccCccccCChHHHHHHhh
Q psy11767 603 RDDSALSIMARIKEGQ-----------------------FNFDAEAWSTVSSEAKELTKSLLTVNPAQRIRMMRVKLTFH 659 (966)
Q Consensus 603 ~~~~~~~~~~~i~~~~-----------------------~~~~~~~~~~is~e~~~Li~~~L~~dP~~R~t~~~v~~~~~ 659 (966)
..+....++....... ........+.++.++.++|.+||+.||++||++.++ ..|
T Consensus 212 ~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~l--l~~ 289 (330)
T cd07834 212 YIDQLNLIVEVLGTPSEEDLKFITSEKARNYLKSLPKKPKKPLSKLFPGASPEAIDLLEKMLVFDPKKRITADEA--LAH 289 (330)
T ss_pred HHHHHHHHHHhcCCCChhHhhhccccchhhHHhhcccCCcchhHHhcccCCHHHHHHHHHHccCChhhCCCHHHH--HhC
Confidence 4322222211110000 000001123478899999999999999999999876 456
Q ss_pred hhHH
Q psy11767 660 AFHQ 663 (966)
Q Consensus 660 ~~~~ 663 (966)
+|+.
T Consensus 290 ~~~~ 293 (330)
T cd07834 290 PYLA 293 (330)
T ss_pred ccHH
Confidence 6654
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and |
| >cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-33 Score=317.81 Aligned_cols=248 Identities=26% Similarity=0.489 Sum_probs=194.0
Q ss_pred cccccccccccEEEEEEEcCCCcEEEEEEecccc-------ChHHHHHHHHHhcCCCCceEEEEEEEeCCe------EEE
Q psy11767 382 KAGILGDGSYSVCRRCVEKSTGQEYAVKIISRKI-------DCSEEINLLRACQGHPNIVNLHCVFQDEVH------TYL 448 (966)
Q Consensus 382 ~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~-------~~~~Ei~iL~~l~~HpnIV~l~~~~~~~~~------~~l 448 (966)
....||+|+||.||+|++..+++.||||++.... ...+|+.+++.+ .||||+++++++..... .|+
T Consensus 19 ~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~~~~~~~l 97 (343)
T cd07851 19 NLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSAIHAKRTYRELRLLKHM-DHENVIGLLDVFTPASSLEDFQDVYL 97 (343)
T ss_pred EEEEeccCCceEEEEEEECCCCcEEEEEecccccchhhHHHHHHHHHHHHHhc-cCCCHHHHHHHhhccccccccccEEE
Confidence 3678999999999999999999999999986431 234689999988 69999999988876554 899
Q ss_pred EEEccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCcEEEecCCCCCEEEEeecccccccCC
Q psy11767 449 VLELLKGGELLDRIRQKGRCGFTENEASRIMRQLVAAVHFMHSRGVVHRDLKPENLLFSDPAGDNIKVVDFGFACLKRES 528 (966)
Q Consensus 449 VmEy~~gg~L~~~l~~~~~~~l~e~~~~~i~~Qil~aL~yLHs~~IiHRDLKP~NILl~~~~~~~iKL~DFGla~~~~~~ 528 (966)
|+||+ +++|.+++... .+++..++.++.||+.||+|||+.||+||||||+|||+++ ++.+||+|||++......
T Consensus 98 v~e~~-~~~L~~~~~~~---~l~~~~~~~~~~ql~~aL~~LH~~gi~H~dlkp~Nill~~--~~~~kL~dfg~~~~~~~~ 171 (343)
T cd07851 98 VTHLM-GADLNNIVKCQ---KLSDDHIQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNE--DCELKILDFGLARHTDDE 171 (343)
T ss_pred EEecC-CCCHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECC--CCCEEEcccccccccccc
Confidence 99999 77999988653 5899999999999999999999999999999999999985 568999999999766544
Q ss_pred CccccccccccCchhhccCCCCCCCcccchhhhhhhhhhhhcCCCCCCCcCcchhHHHHHHHHhcCCCCCCCCCCchhHH
Q psy11767 529 LHTPCFTLQYAAPEVLRQDKSGYDENCDLWSLGVILVNVLRQDKSGYDENCDLWSLGVILYTMLCGRVPFHARSRDDSAL 608 (966)
Q Consensus 529 ~~~~~gT~~Y~APEvl~~~~~~~~~~~Di~SlGvil~el~~~~~~~y~~~~DIWSlGvilyemltG~~Pf~~~~~~~~~~ 608 (966)
.....+|..|+|||++... ..++.++|||||||++|+|++|+.||.+....+...
T Consensus 172 ~~~~~~~~~y~aPE~~~~~-------------------------~~~~~~~DvwslGv~l~elltg~~pf~~~~~~~~~~ 226 (343)
T cd07851 172 MTGYVATRWYRAPEIMLNW-------------------------MHYNQTVDIWSVGCIMAELLTGKTLFPGSDHIDQLK 226 (343)
T ss_pred ccCCcccccccCHHHHhCC-------------------------CCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHH
Confidence 4556778999999987421 236788999999999999999999998654332211
Q ss_pred HHHHHHHcC-------------------CCCCC----chhhccCCHHHHHHHHHhcccCccccCChHHHHHHhhhhHH
Q psy11767 609 SIMARIKEG-------------------QFNFD----AEAWSTVSSEAKELTKSLLTVNPAQRIRMMRVKLTFHAFHQ 663 (966)
Q Consensus 609 ~~~~~i~~~-------------------~~~~~----~~~~~~is~e~~~Li~~~L~~dP~~R~t~~~v~~~~~~~~~ 663 (966)
.++...... ..... ...+...+.++.++|.+||..||++|||+.++ ..|+|+.
T Consensus 227 ~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~dli~~~l~~~P~~Rpt~~el--l~h~~~~ 302 (343)
T cd07851 227 RIMNLVGTPDEELLQKISSESARNYIQSLPQMPKKDFKEVFSGANPLAIDLLEKMLVLDPDKRITAAEA--LAHPYLA 302 (343)
T ss_pred HHHHhcCCCCHHHHhhccchhHHHHHHhccccCCCCHHHHhccCCHHHHHHHHHhCCCChhhCCCHHHH--hcCCCcc
Confidence 111110000 00000 01123468999999999999999999999976 4556553
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK |
| >cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-32 Score=299.94 Aligned_cols=241 Identities=20% Similarity=0.340 Sum_probs=186.7
Q ss_pred cccccccccccEEEEEEEcC---CCcEEEEEEeccccC-------hHHHHHHHHHhcCCCCceEEEEEEEeCC------e
Q psy11767 382 KAGILGDGSYSVCRRCVEKS---TGQEYAVKIISRKID-------CSEEINLLRACQGHPNIVNLHCVFQDEV------H 445 (966)
Q Consensus 382 ~~~~LG~G~fG~Vy~a~~~~---tg~~vAvK~i~~~~~-------~~~Ei~iL~~l~~HpnIV~l~~~~~~~~------~ 445 (966)
..++||+|+||.||+|.... +++.||||++..... ..+|+++|+.+ +||||+++++++.... .
T Consensus 3 ~~~~ig~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~~~~~~~~~~ 81 (273)
T cd05074 3 LGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEF-DHPNVIKLIGVSLRSRAKGRLPI 81 (273)
T ss_pred chhcccCCCCCCEEeeEeeccCCCceEEEEEEeccccCChHHHHHHHHHHHHHhcC-CCCCcceEEEEEccCCCCCcccc
Confidence 35789999999999998653 678999999865431 34688999888 5999999999886532 2
Q ss_pred EEEEEEccCCCCHHHHHHhcC----CCCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCcEEEecCCCCCEEEEeecc
Q psy11767 446 TYLVLELLKGGELLDRIRQKG----RCGFTENEASRIMRQLVAAVHFMHSRGVVHRDLKPENLLFSDPAGDNIKVVDFGF 521 (966)
Q Consensus 446 ~~lVmEy~~gg~L~~~l~~~~----~~~l~e~~~~~i~~Qil~aL~yLHs~~IiHRDLKP~NILl~~~~~~~iKL~DFGl 521 (966)
.++++||+.+|+|.+++.... ...+++..++.++.||+.||+|||+.||+||||||+|||+++ ++.+||+|||+
T Consensus 82 ~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~nili~~--~~~~kl~dfg~ 159 (273)
T cd05074 82 PMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGMEYLSSKNFIHRDLAARNCMLNE--NMTVCVADFGL 159 (273)
T ss_pred eEEEEecCCCCcHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeecccchhhEEEcC--CCCEEECcccc
Confidence 478999999999988875321 124789999999999999999999999999999999999974 56899999999
Q ss_pred cccccCC-----CccccccccccCchhhccCCCCCCCcccchhhhhhhhhhhhcCCCCCCCcCcchhHHHHHHHHhc-CC
Q psy11767 522 ACLKRES-----LHTPCFTLQYAAPEVLRQDKSGYDENCDLWSLGVILVNVLRQDKSGYDENCDLWSLGVILYTMLC-GR 595 (966)
Q Consensus 522 a~~~~~~-----~~~~~gT~~Y~APEvl~~~~~~~~~~~Di~SlGvil~el~~~~~~~y~~~~DIWSlGvilyemlt-G~ 595 (966)
++..... .....+++.|++||.+.. ..++.++|||||||++|+|++ |+
T Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~--------------------------~~~~~~sDi~slG~il~el~~~g~ 213 (273)
T cd05074 160 SKKIYSGDYYRQGCASKLPVKWLALESLAD--------------------------NVYTTHSDVWAFGVTMWEIMTRGQ 213 (273)
T ss_pred cccccCCcceecCCCccCchhhcCHhHHhc--------------------------CccchhhhhHHHHHHHHHHhhCCC
Confidence 8754321 112234678999998742 236778999999999999998 89
Q ss_pred CCCCCCCCchhHHHHHHHHHcCCCCCCchhhccCCHHHHHHHHHhcccCccccCChHHHHHHh
Q psy11767 596 VPFHARSRDDSALSIMARIKEGQFNFDAEAWSTVSSEAKELTKSLLTVNPAQRIRMMRVKLTF 658 (966)
Q Consensus 596 ~Pf~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~is~e~~~Li~~~L~~dP~~R~t~~~v~~~~ 658 (966)
+||...... .....+..+.... .....+.++.+++.+||..+|++||++.++...+
T Consensus 214 ~p~~~~~~~----~~~~~~~~~~~~~---~~~~~~~~~~~l~~~~l~~~p~~Rps~~~~~~~l 269 (273)
T cd05074 214 TPYAGVENS----EIYNYLIKGNRLK---QPPDCLEDVYELMCQCWSPEPKCRPSFQHLRDQL 269 (273)
T ss_pred CCCCCCCHH----HHHHHHHcCCcCC---CCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHH
Confidence 999765432 2333343332211 1134678999999999999999999999885544
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac |
| >KOG1290|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-33 Score=308.55 Aligned_cols=276 Identities=25% Similarity=0.471 Sum_probs=215.5
Q ss_pred CCCCCCCCCccccccccee-cccccccccccccccccccEEEEEEEcCCCcEEEEEEecccc----ChHHHHHHHHHhcC
Q psy11767 355 SPAIVPPNFDKIFKGSLFF-EQYDMDLDKAGILGDGSYSVCRRCVEKSTGQEYAVKIISRKI----DCSEEINLLRACQG 429 (966)
Q Consensus 355 Sp~ivp~~~d~if~G~~~~-~~~~i~~~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~----~~~~Ei~iL~~l~~ 429 (966)
...+...+++.+..|..|. .+|.+ .++||.|-|++||+|.|..+.+.||+|+.+... .+..||++|+++..
T Consensus 58 ~~dY~kGGYHpV~IGD~F~~gRY~v----~rKLGWGHFSTVWLawDtq~~r~VAlKVvKSAqhYtEaAlDEIklL~~v~~ 133 (590)
T KOG1290|consen 58 PEDYRKGGYHPVRIGDVFNGGRYHV----QRKLGWGHFSTVWLAWDTQNKRYVALKVVKSAQHYTEAALDEIKLLQQVRE 133 (590)
T ss_pred hhhhhcCCCceeeccccccCceEEE----EEeccccccceeEEEeeccCCeEEEEEEEehhhHHHHHHHHHHHHHHHHHh
Confidence 3445677888999999999 78887 578999999999999999999999999997543 35679999998864
Q ss_pred CC-------CceEEEEEEEe----CCeEEEEEEccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhc-Cceec
Q psy11767 430 HP-------NIVNLHCVFQD----EVHTYLVLELLKGGELLDRIRQKGRCGFTENEASRIMRQLVAAVHFMHSR-GVVHR 497 (966)
Q Consensus 430 Hp-------nIV~l~~~~~~----~~~~~lVmEy~~gg~L~~~l~~~~~~~l~e~~~~~i~~Qil~aL~yLHs~-~IiHR 497 (966)
+. +||+|++.|.. +.|+|+|+|++ |.+|+.+|......+++...++.|++|||.||+|||.. ||||.
T Consensus 134 ~Dp~~~~~~~VV~LlD~FkhsGpNG~HVCMVfEvL-GdnLLklI~~s~YrGlpl~~VK~I~~qvL~GLdYLH~ecgIIHT 212 (590)
T KOG1290|consen 134 GDPNDPGKKCVVQLLDHFKHSGPNGQHVCMVFEVL-GDNLLKLIKYSNYRGLPLSCVKEICRQVLTGLDYLHRECGIIHT 212 (590)
T ss_pred cCCCCCCCceeeeeeccceecCCCCcEEEEEehhh-hhHHHHHHHHhCCCCCcHHHHHHHHHHHHHHHHHHHHhcCcccc
Confidence 33 69999999985 45899999999 88999999998888999999999999999999999975 99999
Q ss_pred cCCCCcEEEecC--------------------------------------------------------------------
Q psy11767 498 DLKPENLLFSDP-------------------------------------------------------------------- 509 (966)
Q Consensus 498 DLKP~NILl~~~-------------------------------------------------------------------- 509 (966)
||||+|||+...
T Consensus 213 DlKPENvLl~~~e~~~~~~~~~a~e~~~~~p~~s~s~~~t~~d~~~~~~~~~~s~~~~k~~~kk~~r~~~~~~~~l~~~~ 292 (590)
T KOG1290|consen 213 DLKPENVLLCSTEIDPAKDAREAGEATTSLPKMSPSAVSTRPDALQRMAAEPMSKSKFKKMKKKLKRQAKKLEASLAGLE 292 (590)
T ss_pred CCCcceeeeeccccchhhhhhhhccccccCCCCCcccccccccccchhhccccchhhHHHHHHHHhhhhhhhhhhhcccc
Confidence 999999996100
Q ss_pred ---------------------------------------------C----------------------------------
Q psy11767 510 ---------------------------------------------A---------------------------------- 510 (966)
Q Consensus 510 ---------------------------------------------~---------------------------------- 510 (966)
.
T Consensus 293 ~~~~~~~~~s~n~~~~~n~~~~~v~~~~~~~~~~~~~~~~n~~~k~~e~~~~~~~sl~~~~~~~~~t~~~~~~~s~~s~~ 372 (590)
T KOG1290|consen 293 GIEEEPNQESYNNEPRINGNESTVERSTLEEDSNENGNRENLPIKSPENFRGNNTSLPESQLRDSATPSDGSLSSPSSPG 372 (590)
T ss_pred cccccccccccccccCCCccccchhhcccccccccccCCccccccCccccccccccccchhcccccccccccccCcCCcc
Confidence 0
Q ss_pred -----------------CCCEEEEeecccccccCCCccccccccccCchhhccCCCCCCCcccchhhhhhhhhhhhcCCC
Q psy11767 511 -----------------GDNIKVVDFGFACLKRESLHTPCFTLQYAAPEVLRQDKSGYDENCDLWSLGVILVNVLRQDKS 573 (966)
Q Consensus 511 -----------------~~~iKL~DFGla~~~~~~~~~~~gT~~Y~APEvl~~~~~~~~~~~Di~SlGvil~el~~~~~~ 573 (966)
.-.+||+|||-||+.....+..+.|.+|+|||+|.+ .
T Consensus 373 ~~~~n~~v~p~~~~~~~di~vKIaDlGNACW~~khFT~DIQTRQYRapEVllG--------------------------s 426 (590)
T KOG1290|consen 373 TIASNPLVNPDIPLPECDIRVKIADLGNACWVHKHFTEDIQTRQYRAPEVLLG--------------------------S 426 (590)
T ss_pred ccccccccCCCCCCCccceeEEEeeccchhhhhhhhchhhhhhhccCcceeec--------------------------C
Confidence 003789999999998877777888999999999973 4
Q ss_pred CCCCcCcchhHHHHHHHHhcCCCCCCCCCC-----chhHHH-HHHH--------HHcCCCC---C----------Cchhh
Q psy11767 574 GYDENCDLWSLGVILYTMLCGRVPFHARSR-----DDSALS-IMAR--------IKEGQFN---F----------DAEAW 626 (966)
Q Consensus 574 ~y~~~~DIWSlGvilyemltG~~Pf~~~~~-----~~~~~~-~~~~--------i~~~~~~---~----------~~~~~ 626 (966)
+|++.+||||++|++|||+||..-|+..+. ++.-.+ +++. +..|.+. | ....|
T Consensus 427 gY~~~ADiWS~AC~~FELaTGDyLFePhsG~~Y~rDEDHiA~i~ELLG~iPr~ia~~Gk~SRdFFnr~G~LrhI~~LK~W 506 (590)
T KOG1290|consen 427 GYSTSADIWSTACMAFELATGDYLFEPHSGENYSRDEDHIALIMELLGKIPRKIALGGKYSRDFFNRRGELRHIRRLKPW 506 (590)
T ss_pred CCCCchhHHHHHHHHHHhhcCceeecCCCCCCCCccHHHHHHHHHHHhhccHHHHhcCcchHhhhccccceecccccCCC
Confidence 588999999999999999999988864322 222222 2221 1122221 0 01122
Q ss_pred c---------cC----CHHHHHHHHHhcccCccccCChHHHHHHhhhhHH
Q psy11767 627 S---------TV----SSEAKELTKSLLTVNPAQRIRMMRVKLTFHAFHQ 663 (966)
Q Consensus 627 ~---------~i----s~e~~~Li~~~L~~dP~~R~t~~~v~~~~~~~~~ 663 (966)
+ .. ..++.++|.-||+.+|++|+|+.+. ..|||..
T Consensus 507 pL~~VL~eKY~~s~e~A~~fsdFL~PmLef~PeKR~tA~~c--l~hPwLn 554 (590)
T KOG1290|consen 507 PLYEVLIEKYEWSEEDAQQFSDFLSPMLEFDPEKRPTAAQC--LKHPWLN 554 (590)
T ss_pred cHHHHHHHHhCCCHHHHHHHHHHHHHHHhcCccccccHHHH--hcCcccc
Confidence 1 11 3356789999999999999999864 4467654
|
|
| >cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-32 Score=306.97 Aligned_cols=246 Identities=22% Similarity=0.310 Sum_probs=194.1
Q ss_pred cccccccccccccEEEEEEEcCCCcEEEEEEecccc--------ChHHHHHHHHHhcCCCCceEEEEEEEeCCeEEEEEE
Q psy11767 380 LDKAGILGDGSYSVCRRCVEKSTGQEYAVKIISRKI--------DCSEEINLLRACQGHPNIVNLHCVFQDEVHTYLVLE 451 (966)
Q Consensus 380 ~~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~--------~~~~Ei~iL~~l~~HpnIV~l~~~~~~~~~~~lVmE 451 (966)
|+..+.||+|+||.||+|++..+++.||||.+.... ...+|+++|+.+ +|+||+++++++......|+|||
T Consensus 17 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e 95 (308)
T cd06634 17 FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKL-RHPNTIQYRGCYLREHTAWLVME 95 (308)
T ss_pred HHHHHheeeCCCEEEEEEEEcCCCcEEEEEEEecccccChHHHHHHHHHHHHHHhC-CCCCcccEEEEEEcCCeeEEEEE
Confidence 344678999999999999999999999999986321 134688999988 59999999999999999999999
Q ss_pred ccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCcEEEecCCCCCEEEEeecccccccCCCcc
Q psy11767 452 LLKGGELLDRIRQKGRCGFTENEASRIMRQLVAAVHFMHSRGVVHRDLKPENLLFSDPAGDNIKVVDFGFACLKRESLHT 531 (966)
Q Consensus 452 y~~gg~L~~~l~~~~~~~l~e~~~~~i~~Qil~aL~yLHs~~IiHRDLKP~NILl~~~~~~~iKL~DFGla~~~~~~~~~ 531 (966)
|+. |+|.+.+.... ..+++.++..++.|++.||.|||+.+++||||||+|||+++ ++.+||+|||++..... ...
T Consensus 96 ~~~-~~l~~~~~~~~-~~l~~~~~~~~~~~l~~~l~~LH~~~i~H~dl~p~nil~~~--~~~~kl~dfg~~~~~~~-~~~ 170 (308)
T cd06634 96 YCL-GSASDLLEVHK-KPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLSE--PGLVKLGDFGSASIMAP-ANX 170 (308)
T ss_pred ccC-CCHHHHHHHcC-CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHhEEECC--CCcEEECCcccceeecC-ccc
Confidence 996 68888776544 35899999999999999999999999999999999999975 56899999999865433 234
Q ss_pred ccccccccCchhhccCCCCCCCcccchhhhhhhhhhhhcCCCCCCCcCcchhHHHHHHHHhcCCCCCCCCCCchhHHHHH
Q psy11767 532 PCFTLQYAAPEVLRQDKSGYDENCDLWSLGVILVNVLRQDKSGYDENCDLWSLGVILYTMLCGRVPFHARSRDDSALSIM 611 (966)
Q Consensus 532 ~~gT~~Y~APEvl~~~~~~~~~~~Di~SlGvil~el~~~~~~~y~~~~DIWSlGvilyemltG~~Pf~~~~~~~~~~~~~ 611 (966)
..+++.|+|||++.... ...++.++|||||||++|+|++|..||......+ ..
T Consensus 171 ~~~~~~y~aPE~~~~~~-----------------------~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~----~~ 223 (308)
T cd06634 171 FVGTPYWMAPEVILAMD-----------------------EGQYDGKVDVWSLGITCIELAERKPPLFNMNAMS----AL 223 (308)
T ss_pred ccCCccccCHHHHhhcc-----------------------cCCCCcccchHHHHHHHHHHHcCCCCCccccHHH----HH
Confidence 56789999999874211 1235778999999999999999999997643221 22
Q ss_pred HHHHcCCCCCCchhhccCCHHHHHHHHHhcccCccccCChHHHHHHhhhhH
Q psy11767 612 ARIKEGQFNFDAEAWSTVSSEAKELTKSLLTVNPAQRIRMMRVKLTFHAFH 662 (966)
Q Consensus 612 ~~i~~~~~~~~~~~~~~is~e~~~Li~~~L~~dP~~R~t~~~v~~~~~~~~ 662 (966)
..+..+..... .....+.++.+||.+||..+|++||++.++. .|+|.
T Consensus 224 ~~~~~~~~~~~--~~~~~~~~~~~li~~cl~~~P~~Rp~~~~ll--~~~~~ 270 (308)
T cd06634 224 YHIAQNESPAL--QSGHWSEYFRNFVDSCLQKIPQDRPTSEVLL--KHRFV 270 (308)
T ss_pred HHHhhcCCCCc--CcccccHHHHHHHHHHhhCCcccCCCHHHHh--hCccc
Confidence 22333222111 1125688899999999999999999998763 34443
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin |
| >cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-32 Score=295.40 Aligned_cols=228 Identities=40% Similarity=0.666 Sum_probs=190.7
Q ss_pred cccccccEEEEEEEcCCCcEEEEEEecccc--------ChHHHHHHHHHhcCCCCceEEEEEEEeCCeEEEEEEccCCCC
Q psy11767 386 LGDGSYSVCRRCVEKSTGQEYAVKIISRKI--------DCSEEINLLRACQGHPNIVNLHCVFQDEVHTYLVLELLKGGE 457 (966)
Q Consensus 386 LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~--------~~~~Ei~iL~~l~~HpnIV~l~~~~~~~~~~~lVmEy~~gg~ 457 (966)
||.|+||.||+|.+..+++.||+|++.+.. ....|+.+++.+. ||||+++++.++++...|+||||+++++
T Consensus 1 lg~G~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~~~v~e~~~~~~ 79 (250)
T cd05123 1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRIN-HPFIVKLHYAFQTEEKLYLVLEYAPGGE 79 (250)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEeehhhhcchHHHHHHHHHHHHHHHcC-CCcHHHHHHHeecCCeeEEEEecCCCCc
Confidence 799999999999999999999999986542 2456888998884 9999999999999999999999999999
Q ss_pred HHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCcEEEecCCCCCEEEEeecccccccCC---Cccccc
Q psy11767 458 LLDRIRQKGRCGFTENEASRIMRQLVAAVHFMHSRGVVHRDLKPENLLFSDPAGDNIKVVDFGFACLKRES---LHTPCF 534 (966)
Q Consensus 458 L~~~l~~~~~~~l~e~~~~~i~~Qil~aL~yLHs~~IiHRDLKP~NILl~~~~~~~iKL~DFGla~~~~~~---~~~~~g 534 (966)
|.+++.... .+++..+..++.|++.||.|||+.+++|+||||+||++++ .+.++|+|||++...... .....+
T Consensus 80 L~~~l~~~~--~l~~~~~~~~~~qi~~~l~~lh~~~~~H~~l~p~ni~~~~--~~~~~l~d~~~~~~~~~~~~~~~~~~~ 155 (250)
T cd05123 80 LFSHLSKEG--RFSEERARFYAAEIVLALEYLHSLGIIYRDLKPENILLDA--DGHIKLTDFGLAKELSSEGSRTNTFCG 155 (250)
T ss_pred HHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCceecCCCcceEEEcC--CCcEEEeecCcceecccCCCcccCCcC
Confidence 999997764 5899999999999999999999999999999999999985 568999999998764432 334567
Q ss_pred cccccCchhhccCCCCCCCcccchhhhhhhhhhhhcCCCCCCCcCcchhHHHHHHHHhcCCCCCCCCCCchhHHHHHHHH
Q psy11767 535 TLQYAAPEVLRQDKSGYDENCDLWSLGVILVNVLRQDKSGYDENCDLWSLGVILYTMLCGRVPFHARSRDDSALSIMARI 614 (966)
Q Consensus 535 T~~Y~APEvl~~~~~~~~~~~Di~SlGvil~el~~~~~~~y~~~~DIWSlGvilyemltG~~Pf~~~~~~~~~~~~~~~i 614 (966)
+..|+|||.+... .++.++|+||||+++|+|++|..||...+. ......+
T Consensus 156 ~~~~~~Pe~~~~~--------------------------~~~~~~D~~slG~~~~~l~~g~~p~~~~~~----~~~~~~~ 205 (250)
T cd05123 156 TPEYLAPEVLLGK--------------------------GYGKAVDWWSLGVLLYEMLTGKPPFYAEDR----KEIYEKI 205 (250)
T ss_pred CccccChHHhCCC--------------------------CCCchhhHHHHHHHHHHHHHCCCCCCCCCH----HHHHHHH
Confidence 8899999987521 256789999999999999999999976543 2334444
Q ss_pred HcCCCCCCchhhccCCHHHHHHHHHhcccCccccCChH
Q psy11767 615 KEGQFNFDAEAWSTVSSEAKELTKSLLTVNPAQRIRMM 652 (966)
Q Consensus 615 ~~~~~~~~~~~~~~is~e~~~Li~~~L~~dP~~R~t~~ 652 (966)
..+.+.++ ..++.++.+++++||..||++||++.
T Consensus 206 ~~~~~~~~----~~~~~~l~~~i~~~l~~~p~~R~~~~ 239 (250)
T cd05123 206 LKDPLRFP----EFLSPEARDLISGLLQKDPTKRLGSG 239 (250)
T ss_pred hcCCCCCC----CCCCHHHHHHHHHHhcCCHhhCCCcc
Confidence 44444332 34588999999999999999999993
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the |
| >KOG1095|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-33 Score=337.34 Aligned_cols=242 Identities=24% Similarity=0.414 Sum_probs=194.2
Q ss_pred cccccccccccEEEEEEEcCC-Cc----EEEEEEeccccC------hHHHHHHHHHhcCCCCceEEEEEEEeCCeEEEEE
Q psy11767 382 KAGILGDGSYSVCRRCVEKST-GQ----EYAVKIISRKID------CSEEINLLRACQGHPNIVNLHCVFQDEVHTYLVL 450 (966)
Q Consensus 382 ~~~~LG~G~fG~Vy~a~~~~t-g~----~vAvK~i~~~~~------~~~Ei~iL~~l~~HpnIV~l~~~~~~~~~~~lVm 450 (966)
....||+|.||.||.|....- |. .||||.+.+..+ +.+|..+|..+ +|||||+|++++.+....+|++
T Consensus 696 l~~~lG~G~FG~VY~g~~~~~~~~~~~~~vaiK~l~~~~~~~~~~~Fl~Ea~~m~~f-~HpNiv~liGv~l~~~~~~i~l 774 (1025)
T KOG1095|consen 696 LLRVLGKGAFGEVYEGTYSDVPGSVSPIQVAVKSLKRLSSEQEVSDFLKEALLMSKF-DHPNIVSLIGVCLDSGPPLILL 774 (1025)
T ss_pred eeeeeccccccceEEEEEecCCCCccceEEEEEeccccCCHHHHHHHHHHHHHHhcC-CCcceeeEEEeecCCCCcEEEe
Confidence 356899999999999987643 32 499999876543 45677777777 6999999999999999999999
Q ss_pred EccCCCCHHHHHHhcC-----CCCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCcEEEecCCCCCEEEEeecccccc
Q psy11767 451 ELLKGGELLDRIRQKG-----RCGFTENEASRIMRQLVAAVHFMHSRGVVHRDLKPENLLFSDPAGDNIKVVDFGFACLK 525 (966)
Q Consensus 451 Ey~~gg~L~~~l~~~~-----~~~l~e~~~~~i~~Qil~aL~yLHs~~IiHRDLKP~NILl~~~~~~~iKL~DFGla~~~ 525 (966)
|||+||||..+|++.. ...|+..+...++.||++|+.||+++++|||||-..|+||+. ...+||+|||+|+..
T Consensus 775 eyM~gGDL~sflr~~r~~~~~~~~L~~~dLl~~a~dvA~G~~YLe~~~fvHRDLAaRNCLL~~--~r~VKIaDFGlArDi 852 (1025)
T KOG1095|consen 775 EYMEGGDLLSFLRESRPAPFQPSNLSMRDLLAFALDVAKGMNYLESKHFVHRDLAARNCLLDE--RRVVKIADFGLARDI 852 (1025)
T ss_pred hhcccCcHHHHHHhcccccCCCCCCCHHHHHHHHHHHhhhhHHHHhCCCcCcchhhhheeecc--cCcEEEcccchhHhh
Confidence 9999999999998762 235899999999999999999999999999999999999986 469999999999843
Q ss_pred cC-CCc---cc-cccccccCchhhccCCCCCCCcccchhhhhhhhhhhhcCCCCCCCcCcchhHHHHHHHHhc-CCCCCC
Q psy11767 526 RE-SLH---TP-CFTLQYAAPEVLRQDKSGYDENCDLWSLGVILVNVLRQDKSGYDENCDLWSLGVILYTMLC-GRVPFH 599 (966)
Q Consensus 526 ~~-~~~---~~-~gT~~Y~APEvl~~~~~~~~~~~Di~SlGvil~el~~~~~~~y~~~~DIWSlGvilyemlt-G~~Pf~ 599 (966)
.. ... .. .-...|||||.+.. ..++.++|||||||+|||+++ |..||.
T Consensus 853 y~~~yyr~~~~a~lPvkWm~PEsl~d--------------------------~iFtskSDvWsFGVllWEifslG~~PY~ 906 (1025)
T KOG1095|consen 853 YDKDYYRKHGEAMLPVKWMPPESLKD--------------------------GIFTSKSDVWSFGVLLWEIFSLGATPYP 906 (1025)
T ss_pred hhchheeccCccccceecCCHHHHhh--------------------------cccccccchhhhHHHHHHHHhCCCCCCC
Confidence 22 111 11 23568999999963 237899999999999999997 899998
Q ss_pred CCCCchhHHHHHHHHHcCCCCCCchhhccCCHHHHHHHHHhcccCccccCChHHHHHHhh
Q psy11767 600 ARSRDDSALSIMARIKEGQFNFDAEAWSTVSSEAKELTKSLLTVNPAQRIRMMRVKLTFH 659 (966)
Q Consensus 600 ~~~~~~~~~~~~~~i~~~~~~~~~~~~~~is~e~~~Li~~~L~~dP~~R~t~~~v~~~~~ 659 (966)
+.+.. +++..+.+|- .++. +...++.+.++|..||+.+|++||+...+..+.+
T Consensus 907 ~~~n~----~v~~~~~~gg-RL~~--P~~CP~~ly~lM~~CW~~~pe~RP~F~~i~~q~~ 959 (1025)
T KOG1095|consen 907 SRSNF----EVLLDVLEGG-RLDP--PSYCPEKLYQLMLQCWKHDPEDRPSFRTIVEQDP 959 (1025)
T ss_pred CcchH----HHHHHHHhCC-ccCC--CCCCChHHHHHHHHHccCChhhCccHHHHHhhhh
Confidence 76643 3444333333 2222 2457888899999999999999999988755443
|
|
| >cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-32 Score=298.64 Aligned_cols=243 Identities=32% Similarity=0.482 Sum_probs=192.4
Q ss_pred cccccccccccEEEEEEEcCCCcEEEEEEecccc-------ChHHHHHHHHHhcCCCCceEEEEEEEeCCeEEEEEEccC
Q psy11767 382 KAGILGDGSYSVCRRCVEKSTGQEYAVKIISRKI-------DCSEEINLLRACQGHPNIVNLHCVFQDEVHTYLVLELLK 454 (966)
Q Consensus 382 ~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~-------~~~~Ei~iL~~l~~HpnIV~l~~~~~~~~~~~lVmEy~~ 454 (966)
..+.||+|+||.||+|.+..+++.||+|++.... ....|+.+++.+ +|+||+++++++.+....++||||+.
T Consensus 3 ~~~~ig~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~-~~~~i~~~~~~~~~~~~~~~v~e~~~ 81 (282)
T cd07829 3 KLEKLGEGTYGVVYKARDKKTGEIVALKKIRLDNEEEGIPSTALREISLLKEL-KHPNIVKLLDVIHTERKLYLVFEYCD 81 (282)
T ss_pred eehcccccCcceEEEeeecCCCcEEEEEEeccccccccccHHHHHHHHHHHhc-CCCCHHHHHhhhhcCCceEEEecCcC
Confidence 3567999999999999999999999999987542 134688999888 49999999999999999999999997
Q ss_pred CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCcEEEecCCCCCEEEEeecccccccCC---Ccc
Q psy11767 455 GGELLDRIRQKGRCGFTENEASRIMRQLVAAVHFMHSRGVVHRDLKPENLLFSDPAGDNIKVVDFGFACLKRES---LHT 531 (966)
Q Consensus 455 gg~L~~~l~~~~~~~l~e~~~~~i~~Qil~aL~yLHs~~IiHRDLKP~NILl~~~~~~~iKL~DFGla~~~~~~---~~~ 531 (966)
++|.+++.+.. ..+++..+..++.|++.||+|||++||+||||+|+||++++ ++.+||+|||++...... ...
T Consensus 82 -~~l~~~i~~~~-~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~~l~~~ni~~~~--~~~~~l~d~g~~~~~~~~~~~~~~ 157 (282)
T cd07829 82 -MDLKKYLDKRP-GPLSPNLIKSIMYQLLRGLAYCHSHRILHRDLKPQNILINR--DGVLKLADFGLARAFGIPLRTYTH 157 (282)
T ss_pred -cCHHHHHHhhc-cCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChheEEEcC--CCCEEEecCCcccccCCCccccCc
Confidence 58999998763 25999999999999999999999999999999999999985 568999999998654332 223
Q ss_pred ccccccccCchhhccCCCCCCCcccchhhhhhhhhhhhcCCCCCCCcCcchhHHHHHHHHhcCCCCCCCCCCchhHHHHH
Q psy11767 532 PCFTLQYAAPEVLRQDKSGYDENCDLWSLGVILVNVLRQDKSGYDENCDLWSLGVILYTMLCGRVPFHARSRDDSALSIM 611 (966)
Q Consensus 532 ~~gT~~Y~APEvl~~~~~~~~~~~Di~SlGvil~el~~~~~~~y~~~~DIWSlGvilyemltG~~Pf~~~~~~~~~~~~~ 611 (966)
...+..|+|||++... ..++.++|||||||++|+|++|++||......+....+.
T Consensus 158 ~~~~~~~~aPE~~~~~-------------------------~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~ 212 (282)
T cd07829 158 EVVTLWYRAPEILLGS-------------------------KHYSTAVDIWSVGCIFAEMITGKPLFPGDSEIDQLFKIF 212 (282)
T ss_pred cccCcCcCChHHhcCC-------------------------cCCCccccHHHHHHHHHHHHhCCCCCCCccHHHHHHHHH
Confidence 3457789999987521 236778999999999999999999998765432222221
Q ss_pred HHHH----------------cCCC-----CCCchhhccCCHHHHHHHHHhcccCccccCChHHH
Q psy11767 612 ARIK----------------EGQF-----NFDAEAWSTVSSEAKELTKSLLTVNPAQRIRMMRV 654 (966)
Q Consensus 612 ~~i~----------------~~~~-----~~~~~~~~~is~e~~~Li~~~L~~dP~~R~t~~~v 654 (966)
.... ...+ ......++.++.++.++|.+||..||++||++.++
T Consensus 213 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~ 276 (282)
T cd07829 213 QILGTPTEESWPGVTKLPDYKPTFPKFPPKDLEKVLPRLDPEGIDLLSKMLQYNPAKRISAKEA 276 (282)
T ss_pred HHhCCCcHHHHHhhcccccccccccccCccchHHhcccccHHHHHHHHHhhccCcccCCCHHHH
Confidence 1110 0000 00112234568899999999999999999999876
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the |
| >KOG1006|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-34 Score=297.34 Aligned_cols=246 Identities=23% Similarity=0.398 Sum_probs=195.0
Q ss_pred ccccccccccccccEEEEEEEcCCCcEEEEEEeccccC------hHHHHHHHHHhcCCCCceEEEEEEEeCCeEEEEEEc
Q psy11767 379 DLDKAGILGDGSYSVCRRCVEKSTGQEYAVKIISRKID------CSEEINLLRACQGHPNIVNLHCVFQDEVHTYLVLEL 452 (966)
Q Consensus 379 ~~~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~~------~~~Ei~iL~~l~~HpnIV~l~~~~~~~~~~~lVmEy 452 (966)
+.+.++.||.|+||+|++-.|+.+|+.+|||.|+.... ...|.+...+..+.||||++|++...++..||.||+
T Consensus 65 ~Lqdlg~iG~G~fG~V~KM~hk~sg~~mAVKrIr~~n~~keq~rll~e~d~~mks~~cp~IVkfyGa~F~EGdcWiCMEL 144 (361)
T KOG1006|consen 65 NLQDLGEIGNGAFGTVNKMLHKPSGKLMAVKRIRSNNIEKEQKRLLMEHDTVMKSSNCPNIVKFYGALFSEGDCWICMEL 144 (361)
T ss_pred hHHHHHHhcCCcchhhhhhhcCccCcEEEEEEeeeccchHHHHHHHHHHHHHHhhcCCcHHHHHhhhhhcCCceeeeHHH
Confidence 34568899999999999999999999999999976543 223555545555799999999999999999999999
Q ss_pred cCCCCH---HHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHh-cCceeccCCCCcEEEecCCCCCEEEEeecccccccCC
Q psy11767 453 LKGGEL---LDRIRQKGRCGFTENEASRIMRQLVAAVHFMHS-RGVVHRDLKPENLLFSDPAGDNIKVVDFGFACLKRES 528 (966)
Q Consensus 453 ~~gg~L---~~~l~~~~~~~l~e~~~~~i~~Qil~aL~yLHs-~~IiHRDLKP~NILl~~~~~~~iKL~DFGla~~~~~~ 528 (966)
|+ .+| +.++.......++|+.+-.|..-++.||+||-. .+|||||+||+||||+. .|.+||||||++....++
T Consensus 145 Md-~SlDklYk~vy~vq~~~ipE~Ilg~ItvatV~AL~yLK~~lkiIHRDvKPSNILldr--~G~vKLCDFGIcGqLv~S 221 (361)
T KOG1006|consen 145 MD-ISLDKLYKRVYSVQKSRIPENILGHITVATVDALDYLKEELKIIHRDVKPSNILLDR--HGDVKLCDFGICGQLVDS 221 (361)
T ss_pred Hh-hhHHHHHHHHHHHHhccCcHhhhhheeeeehhHHHHHHHHhhhhhccCChhheEEec--CCCEeeecccchHhHHHH
Confidence 94 444 333333334469999999999999999999986 58999999999999985 679999999998665443
Q ss_pred C--ccccccccccCchhhccCCCCCCCcccchhhhhhhhhhhhcCCCCCCCcCcchhHHHHHHHHhcCCCCCCCCCCchh
Q psy11767 529 L--HTPCFTLQYAAPEVLRQDKSGYDENCDLWSLGVILVNVLRQDKSGYDENCDLWSLGVILYTMLCGRVPFHARSRDDS 606 (966)
Q Consensus 529 ~--~~~~gT~~Y~APEvl~~~~~~~~~~~Di~SlGvil~el~~~~~~~y~~~~DIWSlGvilyemltG~~Pf~~~~~~~~ 606 (966)
. +...|-..|||||-+... ..+|+-++|+||||++|||+.||..|+..-+.
T Consensus 222 iAkT~daGCrpYmAPERi~p~------------------------~~gyDiRSDvWSLGITL~EvAtG~fPyr~w~s--- 274 (361)
T KOG1006|consen 222 IAKTVDAGCRPYMAPERIDPS------------------------DKGYDIRSDVWSLGITLYEVATGNFPYRKWDS--- 274 (361)
T ss_pred HHhhhccCCccccChhccCCc------------------------cCCcchhhhhhhhcceEeeeecCCCCcchHHH---
Confidence 2 234566789999988532 23688899999999999999999999987542
Q ss_pred HHHHHHHHHcCCCCCCc--hhhccCCHHHHHHHHHhcccCccccCChHHH
Q psy11767 607 ALSIMARIKEGQFNFDA--EAWSTVSSEAKELTKSLLTVNPAQRIRMMRV 654 (966)
Q Consensus 607 ~~~~~~~i~~~~~~~~~--~~~~~is~e~~~Li~~~L~~dP~~R~t~~~v 654 (966)
.+..+..+..|.++... ...-..|..+..+|.-||.+|-..||...++
T Consensus 275 vfeql~~Vv~gdpp~l~~~~~~~~~s~~~~~fintCl~Kd~~~Rpky~~L 324 (361)
T KOG1006|consen 275 VFEQLCQVVIGDPPILLFDKECVHYSFSMVRFINTCLIKDRSDRPKYDDL 324 (361)
T ss_pred HHHHHHHHHcCCCCeecCcccccccCHHHHHHHHHHhhcccccCcchhhh
Confidence 34555666666654221 1123578999999999999999999998865
|
|
| >cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-32 Score=297.96 Aligned_cols=235 Identities=31% Similarity=0.484 Sum_probs=189.2
Q ss_pred ccccccccccEEEEEEEcCCCcEEEEEEecccc----------ChHHHHHHHHHhcCCCCceEEEEEEEeCCeEEEEEEc
Q psy11767 383 AGILGDGSYSVCRRCVEKSTGQEYAVKIISRKI----------DCSEEINLLRACQGHPNIVNLHCVFQDEVHTYLVLEL 452 (966)
Q Consensus 383 ~~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~----------~~~~Ei~iL~~l~~HpnIV~l~~~~~~~~~~~lVmEy 452 (966)
.+.||+|+||.||++.+..++..+++|+++... ....|+.+++.+ +||||+++++++.+....++||||
T Consensus 5 ~~~ig~g~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~ 83 (260)
T cd08222 5 QQRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKL-DHPAIVKFHASFLERDAFCIITEY 83 (260)
T ss_pred eeeecCCCCceEEEEEecCCCCcceEEEeccccccccCcchHHHHHHHHHHHHhC-CCCcHHHHHHHHhcCCceEEEEEe
Confidence 578999999999999999888888888765311 133578888887 599999999999999999999999
Q ss_pred cCCCCHHHHHHhc--CCCCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCcEEEecCCCCCEEEEeecccccccCC--
Q psy11767 453 LKGGELLDRIRQK--GRCGFTENEASRIMRQLVAAVHFMHSRGVVHRDLKPENLLFSDPAGDNIKVVDFGFACLKRES-- 528 (966)
Q Consensus 453 ~~gg~L~~~l~~~--~~~~l~e~~~~~i~~Qil~aL~yLHs~~IiHRDLKP~NILl~~~~~~~iKL~DFGla~~~~~~-- 528 (966)
+++++|.+.+.+. ....+++.+++.++.|++.||+|||+.||+|+||||+||++++ +.+||+|||++......
T Consensus 84 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~h~~l~~~nili~~---~~~~l~d~g~~~~~~~~~~ 160 (260)
T cd08222 84 CEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMHQRRILHRDLKAKNIFLKN---NLLKIGDFGVSRLLMGSCD 160 (260)
T ss_pred CCCCCHHHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHHcCccccCCChhheEeec---CCEeecccCceeecCCCcc
Confidence 9999999988642 2236899999999999999999999999999999999999973 46999999998654321
Q ss_pred -CccccccccccCchhhccCCCCCCCcccchhhhhhhhhhhhcCCCCCCCcCcchhHHHHHHHHhcCCCCCCCCCCchhH
Q psy11767 529 -LHTPCFTLQYAAPEVLRQDKSGYDENCDLWSLGVILVNVLRQDKSGYDENCDLWSLGVILYTMLCGRVPFHARSRDDSA 607 (966)
Q Consensus 529 -~~~~~gT~~Y~APEvl~~~~~~~~~~~Di~SlGvil~el~~~~~~~y~~~~DIWSlGvilyemltG~~Pf~~~~~~~~~ 607 (966)
.....+++.|+|||.+.. ..++.++|+||+|+++|+|++|..||.....
T Consensus 161 ~~~~~~~~~~~~~pe~~~~--------------------------~~~~~~~Dv~slG~~~~~l~~~~~~~~~~~~---- 210 (260)
T cd08222 161 LATTFTGTPYYMSPEALKH--------------------------QGYDSKSDIWSLGCILYEMCCLAHAFEGQNF---- 210 (260)
T ss_pred cccCCCCCcCccCHHHHcc--------------------------CCCCchhhHHHHHHHHHHHHhCCCCCCCccH----
Confidence 223457889999998742 2356789999999999999999999975432
Q ss_pred HHHHHHHHcCCCCCCchhhccCCHHHHHHHHHhcccCccccCChHHH
Q psy11767 608 LSIMARIKEGQFNFDAEAWSTVSSEAKELTKSLLTVNPAQRIRMMRV 654 (966)
Q Consensus 608 ~~~~~~i~~~~~~~~~~~~~~is~e~~~Li~~~L~~dP~~R~t~~~v 654 (966)
......+..+..... ...++.++.++|.+||..||++||++.++
T Consensus 211 ~~~~~~~~~~~~~~~---~~~~~~~~~~li~~~l~~~p~~Rp~~~~i 254 (260)
T cd08222 211 LSVVLRIVEGPTPSL---PETYSRQLNSIMQSMLNKDPSLRPSAAEI 254 (260)
T ss_pred HHHHHHHHcCCCCCC---cchhcHHHHHHHHHHhcCChhhCcCHHHH
Confidence 233344444433221 23568899999999999999999999876
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check |
| >KOG0608|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-34 Score=319.89 Aligned_cols=220 Identities=23% Similarity=0.359 Sum_probs=183.4
Q ss_pred CcceeeeecccccceEEEEEEcCCCCEEEEEeccccc--------hhhHHHHHHHHhhCCCccccc--------------
Q psy11767 117 DLDKAGILGDGSYSVCRRCVEKSTGQEYAVKIISRKI--------DCSEEINLLRACQGHPNICRR-------------- 174 (966)
Q Consensus 117 df~~~~~LG~GsFGkV~La~~k~tg~~yAiKvl~K~~--------~~~~E~~il~~~~~~pfi~~~-------------- 174 (966)
=|-.++.||.|+||+|.||+.-+|..+||||.|+|.. |+..||.||... +.+|||+.
T Consensus 630 mFvkik~iGvGAFGeV~Lv~KvDT~~lYAmKTLrKaDVl~rnQvaHVKAERDILAEA-Dn~WVVrLyySFQDkdnLYFVM 708 (1034)
T KOG0608|consen 630 MFVKIKTIGVGAFGEVCLVRKVDTRALYAMKTLRKADVLMRNQVAHVKAERDILAEA-DNEWVVRLYYSFQDKDNLYFVM 708 (1034)
T ss_pred ceEEEeeecccccceeEEEeecchhhHHHHhhhHHHHHHhhhhhhhhhhhhhhHhhc-CCcceEEEEEEeccCCceEEEE
Confidence 4789999999999999999999999999999999862 789999999886 89999984
Q ss_pred ----------------ccccccchhHHHHHHHh------h----cccchhhhHhhhccCCceEEecCccc----------
Q psy11767 175 ----------------CVEKSTGQEYAVKIISR------K----IDCSEEINLLRACQGHPNIVNLHCVF---------- 218 (966)
Q Consensus 175 ----------------~~~~~~~~~~~~~~v~~------~----~~~~~e~nil~~~~gh~~iv~l~~~~---------- 218 (966)
.|++..++||.+++-++ . .|++ ..|||.|.+||++|+||+++.
T Consensus 709 dYIPGGDmMSLLIrmgIFeE~LARFYIAEltcAiesVHkmGFIHRDiK-PDNILIDrdGHIKLTDFGLCTGfRWTHdskY 787 (1034)
T KOG0608|consen 709 DYIPGGDMMSLLIRMGIFEEDLARFYIAELTCAIESVHKMGFIHRDIK-PDNILIDRDGHIKLTDFGLCTGFRWTHDSKY 787 (1034)
T ss_pred eccCCccHHHHHHHhccCHHHHHHHHHHHHHHHHHHHHhccceecccC-ccceEEccCCceeeeeccccccceecccccc
Confidence 45555567887655433 1 1333 449999999999999998542
Q ss_pred ---------------------------------------------------cccccccccCCCcceeeechhhHHHHHHH
Q psy11767 219 ---------------------------------------------------QDEVIDWDDFSRGIECVFFSSSLIIFFII 247 (966)
Q Consensus 219 ---------------------------------------------------~~e~i~~~~y~~~~d~~~~~~~~il~~~m 247 (966)
.+|+|..++|....| ||+.|||+|||
T Consensus 788 Yq~gdH~RqDSmep~~e~~d~~~~lkvL~~ra~~~h~r~~ahslvgt~nyiapevl~r~g~~q~cd---wws~gvil~em 864 (1034)
T KOG0608|consen 788 YQEGDHHRQDSMEPSPEWADISKCLKVLERRAMRQHQRILAHSLVGTPNYIAPEVLARTGYTQLCD---WWSVGVILYEM 864 (1034)
T ss_pred ccCCCccccccCCCchhhccccccchHHHHHHHhhhhhhhhhhhcCCCcccChHHhcccCccccch---hhHhhHHHHHH
Confidence 124677788877665 66888999999
Q ss_pred hhCCCCCCCCcHHHHHHHHHh--CCCCCCC--CCCHHHHHHHHhhcccCCCcccCCCCCCHHHHhcCCceeeeCcccccc
Q psy11767 248 LSFTLSFIHDYYHIQYRRILK--TEPPIPE--DLSPDVADFISRLLVKDPRRRLGGGELDAEELKRHPFFNVIDWDDLAT 323 (966)
Q Consensus 248 ~~g~~pf~~~~~~~~~~~I~~--~~~~~P~--~~s~~a~dli~~LL~kdp~~RLG~~~~g~~~Ik~HpfF~~idW~~l~~ 323 (966)
+.|.+||..+.+.++..+|++ ..+.||. .+|+||.|+|.+|++ ++.+|||. +|+++||.||||++|||..|
T Consensus 865 ~~g~~pf~~~tp~~tq~kv~nw~~~l~~~~~~~ls~e~~~li~kLc~-sad~RLGk--ng~d~vKaHpfFkgIDfssl-- 939 (1034)
T KOG0608|consen 865 LVGQPPFLADTPGETQYKVINWRNFLHIPYQGNLSKEALDLIQKLCC-SADSRLGK--NGADQVKAHPFFKGIDFSSL-- 939 (1034)
T ss_pred hhCCCCccCCCCCcceeeeeehhhccccccccccCHHHHHHHHHHhc-Chhhhhcc--cchhhhhcCccccccchHhh--
Confidence 999999999998887777775 4456664 699999999999987 99999995 68999999999999999996
Q ss_pred CCCCCCCCccccccccccccccc
Q psy11767 324 KRIPAPFVPKISNELDVSNFSDE 346 (966)
Q Consensus 324 k~~~pP~~P~i~~~~D~snFd~e 346 (966)
++.++||+|.++..+|++|||+-
T Consensus 940 Rkq~ApYIP~ItHptDTSNFdpv 962 (1034)
T KOG0608|consen 940 RKQRAPYIPRITHPTDTSNFDPV 962 (1034)
T ss_pred hhccCCcCccccCCCccccCCcC
Confidence 66789999999999999999973
|
|
| >KOG4278|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-33 Score=309.80 Aligned_cols=251 Identities=24% Similarity=0.429 Sum_probs=208.6
Q ss_pred cccccccc---cccccccccccEEEEEEEcCCCcEEEEEEecccc----ChHHHHHHHHHhcCCCCceEEEEEEEeCCeE
Q psy11767 374 EQYDMDLD---KAGILGDGSYSVCRRCVEKSTGQEYAVKIISRKI----DCSEEINLLRACQGHPNIVNLHCVFQDEVHT 446 (966)
Q Consensus 374 ~~~~i~~~---~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~----~~~~Ei~iL~~l~~HpnIV~l~~~~~~~~~~ 446 (966)
+.|+++.. ...+||.|.||.||.+.++...-.||||.++... ++..|..+|+.+. |||+|+|+++|..+-..
T Consensus 260 DkWEmeRtdItMkhKLGGGQYGeVYeGvWKkyslTvAVKtLKEDtMeveEFLkEAAvMKeik-HpNLVqLLGVCT~EpPF 338 (1157)
T KOG4278|consen 260 DKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIK-HPNLVQLLGVCTHEPPF 338 (1157)
T ss_pred chhhccchheeeeeccCCCcccceeeeeeeccceeeehhhhhhcchhHHHHHHHHHHHHhhc-CccHHHHhhhhccCCCe
Confidence 44444433 2458999999999999999999999999997653 3567999999995 99999999999999999
Q ss_pred EEEEEccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCcEEEecCCCCCEEEEeeccccccc
Q psy11767 447 YLVLELLKGGELLDRIRQKGRCGFTENEASRIMRQLVAAVHFMHSRGVVHRDLKPENLLFSDPAGDNIKVVDFGFACLKR 526 (966)
Q Consensus 447 ~lVmEy~~gg~L~~~l~~~~~~~l~e~~~~~i~~Qil~aL~yLHs~~IiHRDLKP~NILl~~~~~~~iKL~DFGla~~~~ 526 (966)
|||.|||..|+|++||++..+..++.-..+.++.||.+|++||..+++|||||-..|+|+++ +..+||+||||++...
T Consensus 339 YIiTEfM~yGNLLdYLRecnr~ev~avvLlyMAtQIsSaMeYLEkknFIHRDLAARNCLVgE--nhiVKvADFGLsRlMt 416 (1157)
T KOG4278|consen 339 YIITEFMCYGNLLDYLRECNRSEVPAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGE--NHIVKVADFGLSRLMT 416 (1157)
T ss_pred EEEEecccCccHHHHHHHhchhhcchhHHHHHHHHHHHHHHHHHHhhhhhhhhhhhhccccc--cceEEeeccchhhhhc
Confidence 99999999999999999988777888889999999999999999999999999999999985 5589999999999876
Q ss_pred CCCcc----ccccccccCchhhccCCCCCCCcccchhhhhhhhhhhhcCCCCCCCcCcchhHHHHHHHHhc-CCCCCCCC
Q psy11767 527 ESLHT----PCFTLQYAAPEVLRQDKSGYDENCDLWSLGVILVNVLRQDKSGYDENCDLWSLGVILYTMLC-GRVPFHAR 601 (966)
Q Consensus 527 ~~~~~----~~gT~~Y~APEvl~~~~~~~~~~~Di~SlGvil~el~~~~~~~y~~~~DIWSlGvilyemlt-G~~Pf~~~ 601 (966)
.+..+ ..+...|.|||-|... .++-|+|||+|||+|||+.| |-.||.+.
T Consensus 417 gDTYTAHAGAKFPIKWTAPEsLAyN--------------------------tFSiKSDVWAFGVLLWEIATYGMsPYPGi 470 (1157)
T KOG4278|consen 417 GDTYTAHAGAKFPIKWTAPESLAYN--------------------------TFSIKSDVWAFGVLLWEIATYGMSPYPGI 470 (1157)
T ss_pred CCceecccCccCcccccCccccccc--------------------------ccccchhhHHHHHHHHHHHhcCCCCCCCc
Confidence 65433 2347789999988632 25678999999999999986 89999986
Q ss_pred CCchhHHHHHHHHHcCCCCCCchhhccCCHHHHHHHHHhcccCccccCChHHHHHHhhh
Q psy11767 602 SRDDSALSIMARIKEGQFNFDAEAWSTVSSEAKELTKSLLTVNPAQRIRMMRVKLTFHA 660 (966)
Q Consensus 602 ~~~~~~~~~~~~i~~~~~~~~~~~~~~is~e~~~Li~~~L~~dP~~R~t~~~v~~~~~~ 660 (966)
+.. ....+.+..|.++. ...+++..-+||+.||.++|.+||++.++...++.
T Consensus 471 dlS-----qVY~LLEkgyRM~~--PeGCPpkVYeLMraCW~WsPsDRPsFaeiHqafEt 522 (1157)
T KOG4278|consen 471 DLS-----QVYGLLEKGYRMDG--PEGCPPKVYELMRACWNWSPSDRPSFAEIHQAFET 522 (1157)
T ss_pred cHH-----HHHHHHhccccccC--CCCCCHHHHHHHHHHhcCCcccCccHHHHHHHHHH
Confidence 532 22333444455443 34688999999999999999999999988665544
|
|
| >KOG0670|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-33 Score=312.33 Aligned_cols=266 Identities=29% Similarity=0.512 Sum_probs=208.8
Q ss_pred CcccccccceecccccccccccccccccccEEEEEEEcCCCcEEEEEEecccc----ChHHHHHHHHHhc-----CCCCc
Q psy11767 363 FDKIFKGSLFFEQYDMDLDKAGILGDGSYSVCRRCVEKSTGQEYAVKIISRKI----DCSEEINLLRACQ-----GHPNI 433 (966)
Q Consensus 363 ~d~if~G~~~~~~~~i~~~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~----~~~~Ei~iL~~l~-----~HpnI 433 (966)
+.....|..+-.+|.+ .+..|+|-||+|.+|.+..-|+.||||||.... ....|+++|++|. +--|+
T Consensus 421 YYrv~igE~LD~RY~V----~~~~GkGvFs~Vvra~D~~r~~~vAiKIIRnNE~M~KtGl~EleiLkKL~~AD~Edk~Hc 496 (752)
T KOG0670|consen 421 YYRVRIGELLDSRYEV----QGYTGKGVFSTVVRARDQARGQEVAIKIIRNNEVMHKTGLKELEILKKLNDADPEDKFHC 496 (752)
T ss_pred eEEEehhhhhcceeEE----EeccccceeeeeeeccccCCCCeeEEEEeecchHHhhhhhHHHHHHHHhhccCchhhhHH
Confidence 3333445555556665 688999999999999999999999999997653 3457999999986 34589
Q ss_pred eEEEEEEEeCCeEEEEEEccCCCCHHHHHHhcCC-CCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCcEEEecCCCC
Q psy11767 434 VNLHCVFQDEVHTYLVLELLKGGELLDRIRQKGR-CGFTENEASRIMRQLVAAVHFMHSRGVVHRDLKPENLLFSDPAGD 512 (966)
Q Consensus 434 V~l~~~~~~~~~~~lVmEy~~gg~L~~~l~~~~~-~~l~e~~~~~i~~Qil~aL~yLHs~~IiHRDLKP~NILl~~~~~~ 512 (966)
++|+..|.+.+|+|||+|-+ .-+|.+.|++.+. .+|....++.|+.|++.||..|-..||+|+||||+|||+.. ...
T Consensus 497 lrl~r~F~hknHLClVFE~L-slNLRevLKKyG~nvGL~ikaVRsYaqQLflALklLK~c~vlHaDIKPDNiLVNE-~k~ 574 (752)
T KOG0670|consen 497 LRLFRHFKHKNHLCLVFEPL-SLNLREVLKKYGRNVGLHIKAVRSYAQQLFLALKLLKKCGVLHADIKPDNILVNE-SKN 574 (752)
T ss_pred HHHHHHhhhcceeEEEehhh-hchHHHHHHHhCcccceeehHHHHHHHHHHHHHHHHHhcCeeecccCccceEecc-Ccc
Confidence 99999999999999999998 5789999988764 46899999999999999999999999999999999999975 456
Q ss_pred CEEEEeecccccccCCCcc-ccccccccCchhhccCCCCCCCcccchhhhhhhhhhhhcCCCCCCCcCcchhHHHHHHHH
Q psy11767 513 NIKVVDFGFACLKRESLHT-PCFTLQYAAPEVLRQDKSGYDENCDLWSLGVILVNVLRQDKSGYDENCDLWSLGVILYTM 591 (966)
Q Consensus 513 ~iKL~DFGla~~~~~~~~~-~~gT~~Y~APEvl~~~~~~~~~~~Di~SlGvil~el~~~~~~~y~~~~DIWSlGvilyem 591 (966)
.+||||||.|....+...+ ...+..|+|||++.+ .+|+...|+||+||+||||
T Consensus 575 iLKLCDfGSA~~~~eneitPYLVSRFYRaPEIiLG--------------------------~~yd~~iD~WSvgctLYEl 628 (752)
T KOG0670|consen 575 ILKLCDFGSASFASENEITPYLVSRFYRAPEIILG--------------------------LPYDYPIDTWSVGCTLYEL 628 (752)
T ss_pred eeeeccCccccccccccccHHHHHHhccCcceeec--------------------------CcccCCccceeeceeeEEe
Confidence 8999999999776554333 345778999999963 3588899999999999999
Q ss_pred hcCCCCCCCCCCchhHHHHHH--------HHHcCCCC---CC--------------------------c------h--hh
Q psy11767 592 LCGRVPFHARSRDDSALSIMA--------RIKEGQFN---FD--------------------------A------E--AW 626 (966)
Q Consensus 592 ltG~~Pf~~~~~~~~~~~~~~--------~i~~~~~~---~~--------------------------~------~--~~ 626 (966)
.||+.-|.+.+.+++..-.|. .+..|.|. |+ + + ..
T Consensus 629 YtGkIlFpG~TNN~MLrl~me~KGk~p~KmlRKgqF~dqHFD~d~nf~~~e~D~vT~r~~~~vm~~vkPtkdl~s~l~~~ 708 (752)
T KOG0670|consen 629 YTGKILFPGRTNNQMLRLFMELKGKFPNKMLRKGQFKDQHFDQDLNFLYIEVDKVTEREKRTVMVNVKPTKDLGSELIAV 708 (752)
T ss_pred eccceecCCCCcHHHHHHHHHhcCCCcHHHhhhcchhhhhcccccceEEEeccccccceeEEEecccCcchhHHHHHhcc
Confidence 999999999887655433322 13333331 10 0 0 00
Q ss_pred -------ccCCHHHHHHHHHhcccCccccCChHHHHHHhhhhH
Q psy11767 627 -------STVSSEAKELTKSLLTVNPAQRIRMMRVKLTFHAFH 662 (966)
Q Consensus 627 -------~~is~e~~~Li~~~L~~dP~~R~t~~~v~~~~~~~~ 662 (966)
+.+-..+++|+.+||.+||++|+|..+. ..|||.
T Consensus 709 q~~~deq~~~~~~~rdLLdkml~LdP~KRit~nqA--L~HpFi 749 (752)
T KOG0670|consen 709 QRLPDEQPKIVQQLRDLLDKMLILDPEKRITVNQA--LKHPFI 749 (752)
T ss_pred CCCCchhHHHHHHHHHHHHHHhccChhhcCCHHHH--hcCCcc
Confidence 0112357799999999999999999854 457765
|
|
| >PLN03225 Serine/threonine-protein kinase SNT7; Provisional | Back alignment and domain information |
|---|
Probab=99.98 E-value=2.5e-32 Score=327.54 Aligned_cols=269 Identities=22% Similarity=0.289 Sum_probs=174.9
Q ss_pred ccccccccccccEEEEEEEcCC----CcEEEEEEeccccChHHHHHHHHHhc--CCCCceEEEEE------EEeCCeEEE
Q psy11767 381 DKAGILGDGSYSVCRRCVEKST----GQEYAVKIISRKIDCSEEINLLRACQ--GHPNIVNLHCV------FQDEVHTYL 448 (966)
Q Consensus 381 ~~~~~LG~G~fG~Vy~a~~~~t----g~~vAvK~i~~~~~~~~Ei~iL~~l~--~HpnIV~l~~~------~~~~~~~~l 448 (966)
+..+.||+|+||.||+|.+..+ +..||||.+..... .|+.+...+. .+.+++.+... ..++...+|
T Consensus 135 ~l~~~LG~G~FG~VYka~~~~~~~~~~~~vAvK~~~~~~~--~e~~~~e~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~L 212 (566)
T PLN03225 135 VLGKKLGEGAFGVVYKASLVNKQSKKEGKYVLKKATEYGA--VEIWMNERVRRACPNSCADFVYGFLEPVSSKKEDEYWL 212 (566)
T ss_pred EEeEEEeeCCCeEEEEEEEcCCccccCcEEEEEEecccch--hHHHHHHHHHhhchhhHHHHHHhhhcccccccCCceEE
Confidence 3467899999999999999999 99999998864322 2222222211 13333333322 235567899
Q ss_pred EEEccCCCCHHHHHHhcCCC------------------CCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCcEEEecCC
Q psy11767 449 VLELLKGGELLDRIRQKGRC------------------GFTENEASRIMRQLVAAVHFMHSRGVVHRDLKPENLLFSDPA 510 (966)
Q Consensus 449 VmEy~~gg~L~~~l~~~~~~------------------~l~e~~~~~i~~Qil~aL~yLHs~~IiHRDLKP~NILl~~~~ 510 (966)
||||+.+++|.+++...... ...+..+..++.||+.||+|||+++|+||||||+|||+++ .
T Consensus 213 V~ey~~~gsL~~~l~~~~~~~~v~~~l~~~~~~l~~~~~r~~~~i~~i~~qll~aL~yLH~~gIiHRDLKP~NILl~~-~ 291 (566)
T PLN03225 213 VWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLPKGLERENKIIQTIMRQILFALDGLHSTGIVHRDVKPQNIIFSE-G 291 (566)
T ss_pred EEEecCCCcHHHHHHhcCCchhHHHHhccchhhccccchhhHHHHHHHHHHHHHHHHHHHHCCEEeCcCCHHHEEEeC-C
Confidence 99999999999998754310 1123456789999999999999999999999999999974 3
Q ss_pred CCCEEEEeecccccccC----CCccccccccccCchhhccCCCCCCCcccchhhhhhhhhhhhcCCCCCCCcCcchhHHH
Q psy11767 511 GDNIKVVDFGFACLKRE----SLHTPCFTLQYAAPEVLRQDKSGYDENCDLWSLGVILVNVLRQDKSGYDENCDLWSLGV 586 (966)
Q Consensus 511 ~~~iKL~DFGla~~~~~----~~~~~~gT~~Y~APEvl~~~~~~~~~~~Di~SlGvil~el~~~~~~~y~~~~DIWSlGv 586 (966)
.+.+||+|||+|+.... .....++|+.|||||.+....... ..........+...+. ...|+.++||||+||
T Consensus 292 ~~~~KL~DFGlA~~l~~~~~~~~~~~~~t~~Y~APE~~~~~~~~~--~~~~~~~~~~~sp~l~--~~~~~~k~DVwSlGv 367 (566)
T PLN03225 292 SGSFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTP--SAPSAPVATALSPVLW--QLNLPDRFDIYSAGL 367 (566)
T ss_pred CCcEEEEeCCCccccccccccCCcccccCCCccChHHhhccCCCC--CCccccccccccchhc--cccCCCCcccHHHHH
Confidence 45899999999975422 223567899999999775332111 1111111111111111 124678899999999
Q ss_pred HHHHHhcCCCCCCCCCCchhHHHHHHHHHcCCCCC-----------Cc------hhhccCCHHHHHHHHHhcccCccccC
Q psy11767 587 ILYTMLCGRVPFHARSRDDSALSIMARIKEGQFNF-----------DA------EAWSTVSSEAKELTKSLLTVNPAQRI 649 (966)
Q Consensus 587 ilyemltG~~Pf~~~~~~~~~~~~~~~i~~~~~~~-----------~~------~~~~~is~e~~~Li~~~L~~dP~~R~ 649 (966)
+||||+++.+|+... .......+....... .. +........+.+||.+||+.||++||
T Consensus 368 iL~el~~~~~~~~~~-----~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~dLi~~mL~~dP~kR~ 442 (566)
T PLN03225 368 IFLQMAFPNLRSDSN-----LIQFNRQLKRNDYDLVAWRKLVEPRASPDLRRGFEVLDLDGGAGWELLKSMMRFKGRQRI 442 (566)
T ss_pred HHHHHHhCcCCCchH-----HHHHHHHHHhcCCcHHHHHHhhccccchhhhhhhhhccccchHHHHHHHHHccCCcccCC
Confidence 999999987775431 111111222211110 00 00111233466999999999999999
Q ss_pred ChHHHHHHhhhhHH
Q psy11767 650 RMMRVKLTFHAFHQ 663 (966)
Q Consensus 650 t~~~v~~~~~~~~~ 663 (966)
|+.++ ..|+|+.
T Consensus 443 ta~e~--L~Hpff~ 454 (566)
T PLN03225 443 SAKAA--LAHPYFD 454 (566)
T ss_pred CHHHH--hCCcCcC
Confidence 99976 4477753
|
|
| >KOG1345|consensus | Back alignment and domain information |
|---|
Probab=99.98 E-value=1e-32 Score=285.69 Aligned_cols=255 Identities=24% Similarity=0.361 Sum_probs=203.5
Q ss_pred eecccccccccccccccccccEEEEEEEcCCCcEEEEEEecccc----ChHHHHHHHHHhcCCCCceEEEE-EEEeCCeE
Q psy11767 372 FFEQYDMDLDKAGILGDGSYSVCRRCVEKSTGQEYAVKIISRKI----DCSEEINLLRACQGHPNIVNLHC-VFQDEVHT 446 (966)
Q Consensus 372 ~~~~~~i~~~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~----~~~~Ei~iL~~l~~HpnIV~l~~-~~~~~~~~ 446 (966)
+.++|.| .+.||+|-||++-+|.|+.+++.+++|.+.+.. ++.+|...--.|..|.|||.-|+ .|++.+.+
T Consensus 22 l~d~y~I----~k~lgeG~FgkIlL~eHr~s~t~ivlKavp~p~tt~~dF~rEfhY~~~Ls~H~hIi~tY~vaFqt~d~Y 97 (378)
T KOG1345|consen 22 LEDVYTI----NKQLGEGRFGKILLAEHRQSKTRIVLKAVPRPQTTQADFVREFHYSFFLSPHQHIIDTYEVAFQTSDAY 97 (378)
T ss_pred hhhhhhH----HHHhcccceeeEEeeeccCCceEEEeeccCcchhhHHHHHHHhccceeeccchhhhHHHHHHhhcCceE
Confidence 4455555 688999999999999999999999999998764 34556655445667999998775 48888899
Q ss_pred EEEEEccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCcEEEecCCCCCEEEEeeccccccc
Q psy11767 447 YLVLELLKGGELLDRIRQKGRCGFTENEASRIMRQLVAAVHFMHSRGVVHRDLKPENLLFSDPAGDNIKVVDFGFACLKR 526 (966)
Q Consensus 447 ~lVmEy~~gg~L~~~l~~~~~~~l~e~~~~~i~~Qil~aL~yLHs~~IiHRDLKP~NILl~~~~~~~iKL~DFGla~~~~ 526 (966)
+++|||++-|+|.+.+... ++-|.-.+.++.|+++||+|+|++++||||||.+||||-+.+...+||||||+.+..+
T Consensus 98 vF~qE~aP~gdL~snv~~~---GigE~~~K~v~~ql~SAi~fMHsknlVHRdlK~eNiLif~~df~rvKlcDFG~t~k~g 174 (378)
T KOG1345|consen 98 VFVQEFAPRGDLRSNVEAA---GIGEANTKKVFAQLLSAIEFMHSKNLVHRDLKAENILIFDADFYRVKLCDFGLTRKVG 174 (378)
T ss_pred EEeeccCccchhhhhcCcc---cccHHHHHHHHHHHHHHHHHhhccchhhcccccceEEEecCCccEEEeeecccccccC
Confidence 9999999999999887654 5889999999999999999999999999999999999988777799999999987665
Q ss_pred CCCccccccccccCchhhccCCCCCCCcccchhhhhhhhhhhhcCCCCCCCcCcchhHHHHHHHHhcCCCCCCCCCCchh
Q psy11767 527 ESLHTPCFTLQYAAPEVLRQDKSGYDENCDLWSLGVILVNVLRQDKSGYDENCDLWSLGVILYTMLCGRVPFHARSRDDS 606 (966)
Q Consensus 527 ~~~~~~~gT~~Y~APEvl~~~~~~~~~~~Di~SlGvil~el~~~~~~~y~~~~DIWSlGvilyemltG~~Pf~~~~~~~~ 606 (966)
......--+..|-|||+...- ..++...++.+|+|.||+++|.+|||++||+.....+.
T Consensus 175 ~tV~~~~~~~~y~~pe~~~~~---------------------~ne~~~~~ps~D~WqfGIi~f~cltG~~PWQka~~~d~ 233 (378)
T KOG1345|consen 175 TTVKYLEYVNNYHAPELCDTV---------------------VNEKLVVNPSTDIWQFGIIFFYCLTGKFPWQKASIMDK 233 (378)
T ss_pred ceehhhhhhcccCCcHHHhhc---------------------cccceEecccccchheeeeeeeeecCCCcchhhhccCc
Confidence 444333446679999987432 22344457889999999999999999999997766555
Q ss_pred HHHHHHHHHcCCCCCCchhhccCCHHHHHHHHHhcccCccccCChHHH
Q psy11767 607 ALSIMARIKEGQFNFDAEAWSTVSSEAKELTKSLLTVNPAQRIRMMRV 654 (966)
Q Consensus 607 ~~~~~~~i~~~~~~~~~~~~~~is~e~~~Li~~~L~~dP~~R~t~~~v 654 (966)
....+.+...+.-.-.+..+...|+.+..+.++-|..+|++|-...++
T Consensus 234 ~Y~~~~~w~~rk~~~~P~~F~~fs~~a~r~Fkk~lt~~~~drcki~~~ 281 (378)
T KOG1345|consen 234 PYWEWEQWLKRKNPALPKKFNPFSEKALRLFKKSLTPRFKDRCKIWTA 281 (378)
T ss_pred hHHHHHHHhcccCccCchhhcccCHHHHHHHHHhcCCcccccchhHHH
Confidence 444444444444334455667789999999999999999999554443
|
|
| >KOG4257|consensus | Back alignment and domain information |
|---|
Probab=99.98 E-value=7.5e-32 Score=303.36 Aligned_cols=243 Identities=23% Similarity=0.427 Sum_probs=199.3
Q ss_pred ccccccccccEEEEEEEcCC--C--cEEEEEEecccc------ChHHHHHHHHHhcCCCCceEEEEEEEeCCeEEEEEEc
Q psy11767 383 AGILGDGSYSVCRRCVEKST--G--QEYAVKIISRKI------DCSEEINLLRACQGHPNIVNLHCVFQDEVHTYLVLEL 452 (966)
Q Consensus 383 ~~~LG~G~fG~Vy~a~~~~t--g--~~vAvK~i~~~~------~~~~Ei~iL~~l~~HpnIV~l~~~~~~~~~~~lVmEy 452 (966)
.++||.|-||.||+|..... | --||||..+... .+..|.-+|+.+ +|||||+|++++.+. ..|||||+
T Consensus 394 ~r~iG~GqFGdVy~gvYt~~~kge~iaVAvKtCK~d~t~d~tekflqEa~iMrnf-dHphIikLIGv~~e~-P~WivmEL 471 (974)
T KOG4257|consen 394 KRLIGEGQFGDVYKGVYTDPEKGERIAVAVKTCKTDCTPDDTEKFLQEASIMRNF-DHPHIIKLIGVCVEQ-PMWIVMEL 471 (974)
T ss_pred HHhhcCCcccceeeeEecccccCcceeeeeehhccCCChhhHHHHHHHHHHHHhC-CCcchhheeeeeecc-ceeEEEec
Confidence 46899999999999986543 3 358889887643 255688999988 599999999999874 58999999
Q ss_pred cCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCcEEEecCCCCCEEEEeecccccccCCC---
Q psy11767 453 LKGGELLDRIRQKGRCGFTENEASRIMRQLVAAVHFMHSRGVVHRDLKPENLLFSDPAGDNIKVVDFGFACLKRESL--- 529 (966)
Q Consensus 453 ~~gg~L~~~l~~~~~~~l~e~~~~~i~~Qil~aL~yLHs~~IiHRDLKP~NILl~~~~~~~iKL~DFGla~~~~~~~--- 529 (966)
++-|.|..||+.+.. .|+......|++||+.||.|||++++|||||-..|||+..+ ..+||+||||++...+..
T Consensus 472 ~~~GELr~yLq~nk~-sL~l~tL~ly~~Qi~talaYLeSkrfVHRDIAaRNiLVsSp--~CVKLaDFGLSR~~ed~~yYk 548 (974)
T KOG4257|consen 472 APLGELREYLQQNKD-SLPLRTLTLYCYQICTALAYLESKRFVHRDIAARNILVSSP--QCVKLADFGLSRYLEDDAYYK 548 (974)
T ss_pred ccchhHHHHHHhccc-cchHHHHHHHHHHHHHHHHHHHhhchhhhhhhhhheeecCc--ceeeecccchhhhccccchhh
Confidence 999999999987654 69999999999999999999999999999999999999864 489999999998765431
Q ss_pred -ccccccccccCchhhccCCCCCCCcccchhhhhhhhhhhhcCCCCCCCcCcchhHHHHHHHHh-cCCCCCCCCCCchhH
Q psy11767 530 -HTPCFTLQYAAPEVLRQDKSGYDENCDLWSLGVILVNVLRQDKSGYDENCDLWSLGVILYTML-CGRVPFHARSRDDSA 607 (966)
Q Consensus 530 -~~~~gT~~Y~APEvl~~~~~~~~~~~Di~SlGvil~el~~~~~~~y~~~~DIWSlGvilyeml-tG~~Pf~~~~~~~~~ 607 (966)
.....+..|||||-+.- ..++.++|||-|||.+||++ .|..||.+....+
T Consensus 549 aS~~kLPIKWmaPESINf--------------------------RrFTtASDVWMFgVCmWEIl~lGvkPfqgvkNsD-- 600 (974)
T KOG4257|consen 549 ASRGKLPIKWMAPESINF--------------------------RRFTTASDVWMFGVCMWEILSLGVKPFQGVKNSD-- 600 (974)
T ss_pred ccccccceeecCccccch--------------------------hcccchhhHHHHHHHHHHHHHhcCCccccccccc--
Confidence 22234678999998852 34788999999999999987 5999999876554
Q ss_pred HHHHHHHHcCCCCCCchhhccCCHHHHHHHHHhcccCccccCChHHHHHHhhhhHH
Q psy11767 608 LSIMARIKEGQFNFDAEAWSTVSSEAKELTKSLLTVNPAQRIRMMRVKLTFHAFHQ 663 (966)
Q Consensus 608 ~~~~~~i~~~~~~~~~~~~~~is~e~~~Li~~~L~~dP~~R~t~~~v~~~~~~~~~ 663 (966)
++-.|.+|.--+ .+++.++.+-.|+.+||+++|.+||+..+++..++...+
T Consensus 601 --VI~~iEnGeRlP---~P~nCPp~LYslmskcWayeP~kRPrftei~~~lsdv~q 651 (974)
T KOG4257|consen 601 --VIGHIENGERLP---CPPNCPPALYSLMSKCWAYEPSKRPRFTEIKAILSDVLQ 651 (974)
T ss_pred --eEEEecCCCCCC---CCCCCChHHHHHHHHHhccCcccCCcHHHHHHHHHHHHH
Confidence 233455665432 335688899999999999999999999999888776654
|
|
| >PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=3e-31 Score=339.67 Aligned_cols=242 Identities=22% Similarity=0.307 Sum_probs=182.2
Q ss_pred ccccccccccccEEEEEEEcCCCcEEEEEEeccccC-hHHHHHHHHHhcCCCCceEEEEEEEeCCeEEEEEEccCCCCHH
Q psy11767 381 DKAGILGDGSYSVCRRCVEKSTGQEYAVKIISRKID-CSEEINLLRACQGHPNIVNLHCVFQDEVHTYLVLELLKGGELL 459 (966)
Q Consensus 381 ~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~~-~~~Ei~iL~~l~~HpnIV~l~~~~~~~~~~~lVmEy~~gg~L~ 459 (966)
....+||+|+||.||+|.+..+|..||||.+..... ...|+++|+.+ +|||||++++++.++...|+|||||++|+|.
T Consensus 693 ~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~l~~l-~HpnIv~~~~~~~~~~~~~lv~Ey~~~g~L~ 771 (968)
T PLN00113 693 KEENVISRGKKGASYKGKSIKNGMQFVVKEINDVNSIPSSEIADMGKL-QHPNIVKLIGLCRSEKGAYLIHEYIEGKNLS 771 (968)
T ss_pred CcccEEccCCCeeEEEEEECCCCcEEEEEEccCCccccHHHHHHHhhC-CCCCcceEEEEEEcCCCCEEEEeCCCCCcHH
Confidence 345689999999999999999999999999865432 35678999888 5999999999999999999999999999999
Q ss_pred HHHHhcCCCCCCHHHHHHHHHHHHHHHHHHH---hcCceeccCCCCcEEEecCCCCCEEEEeecccccccCCCccccccc
Q psy11767 460 DRIRQKGRCGFTENEASRIMRQLVAAVHFMH---SRGVVHRDLKPENLLFSDPAGDNIKVVDFGFACLKRESLHTPCFTL 536 (966)
Q Consensus 460 ~~l~~~~~~~l~e~~~~~i~~Qil~aL~yLH---s~~IiHRDLKP~NILl~~~~~~~iKL~DFGla~~~~~~~~~~~gT~ 536 (966)
++++ .+++..+..++.||+.||+||| +.+|+||||||+|||++. ....++. ||.+..... .....+|+
T Consensus 772 ~~l~-----~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlkp~Nil~~~--~~~~~~~-~~~~~~~~~-~~~~~~t~ 842 (968)
T PLN00113 772 EVLR-----NLSWERRRKIAIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDG--KDEPHLR-LSLPGLLCT-DTKCFISS 842 (968)
T ss_pred HHHh-----cCCHHHHHHHHHHHHHHHHHhccCCCCCeecCCCCHHhEEECC--CCceEEE-ecccccccc-CCCccccc
Confidence 9985 2789999999999999999999 669999999999999975 3355554 666543221 12346789
Q ss_pred cccCchhhccCCCCCCCcccchhhhhhhhhhhhcCCCCCCCcCcchhHHHHHHHHhcCCCCCCCCCCch-hHHHHHHHHH
Q psy11767 537 QYAAPEVLRQDKSGYDENCDLWSLGVILVNVLRQDKSGYDENCDLWSLGVILYTMLCGRVPFHARSRDD-SALSIMARIK 615 (966)
Q Consensus 537 ~Y~APEvl~~~~~~~~~~~Di~SlGvil~el~~~~~~~y~~~~DIWSlGvilyemltG~~Pf~~~~~~~-~~~~~~~~i~ 615 (966)
.|||||++.. ..|+.++||||+||++|||++|+.||+...... ..........
T Consensus 843 ~y~aPE~~~~--------------------------~~~~~~sDv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~ 896 (968)
T PLN00113 843 AYVAPETRET--------------------------KDITEKSDIYGFGLILIELLTGKSPADAEFGVHGSIVEWARYCY 896 (968)
T ss_pred cccCcccccC--------------------------CCCCcccchhhHHHHHHHHHhCCCCCCcccCCCCcHHHHHHHhc
Confidence 9999998742 247889999999999999999999996433211 1111111100
Q ss_pred -cC--------CCCCCchhhccCCHHHHHHHHHhcccCccccCChHHHHHHh
Q psy11767 616 -EG--------QFNFDAEAWSTVSSEAKELTKSLLTVNPAQRIRMMRVKLTF 658 (966)
Q Consensus 616 -~~--------~~~~~~~~~~~is~e~~~Li~~~L~~dP~~R~t~~~v~~~~ 658 (966)
.. ..............++.+++.+||+.||++||||.++...+
T Consensus 897 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~L 948 (968)
T PLN00113 897 SDCHLDMWIDPSIRGDVSVNQNEIVEVMNLALHCTATDPTARPCANDVLKTL 948 (968)
T ss_pred CccchhheeCccccCCCCccHHHHHHHHHHHHhhCcCCchhCcCHHHHHHHH
Confidence 00 00000000001123567899999999999999999885444
|
|
| >KOG0199|consensus | Back alignment and domain information |
|---|
Probab=99.97 E-value=9e-32 Score=306.16 Aligned_cols=236 Identities=27% Similarity=0.449 Sum_probs=195.9
Q ss_pred ccccccccccEEEEEEEcCC-C--cEEEEEEecccc------ChHHHHHHHHHhcCCCCceEEEEEEEeCCeEEEEEEcc
Q psy11767 383 AGILGDGSYSVCRRCVEKST-G--QEYAVKIISRKI------DCSEEINLLRACQGHPNIVNLHCVFQDEVHTYLVLELL 453 (966)
Q Consensus 383 ~~~LG~G~fG~Vy~a~~~~t-g--~~vAvK~i~~~~------~~~~Ei~iL~~l~~HpnIV~l~~~~~~~~~~~lVmEy~ 453 (966)
.++||+|+||+|++|.+... | -.||||++.... ++.+|+.+|.+++ |||+|+||++..+ ..+.+|||++
T Consensus 115 ~e~LG~GsFgvV~rg~Wt~psgk~V~VAVKclr~d~l~~~mddflrEas~M~~L~-H~hliRLyGvVl~-qp~mMV~ELa 192 (1039)
T KOG0199|consen 115 YELLGEGSFGVVKRGTWTQPSGKHVNVAVKCLRDDSLNAIMDDFLREASHMLKLQ-HPHLIRLYGVVLD-QPAMMVFELA 192 (1039)
T ss_pred HHHhcCcceeeEeeccccCCCCcEEeEEEEeccCCccchhHHHHHHHHHHHHhcc-CcceeEEeeeecc-chhhHHhhhc
Confidence 56799999999999987753 3 358999986542 4678999999995 9999999999988 6688999999
Q ss_pred CCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCcEEEecCCCCCEEEEeecccccccCCCccc-
Q psy11767 454 KGGELLDRIRQKGRCGFTENEASRIMRQLVAAVHFMHSRGVVHRDLKPENLLFSDPAGDNIKVVDFGFACLKRESLHTP- 532 (966)
Q Consensus 454 ~gg~L~~~l~~~~~~~l~e~~~~~i~~Qil~aL~yLHs~~IiHRDLKP~NILl~~~~~~~iKL~DFGla~~~~~~~~~~- 532 (966)
+.|+|++.|++-.+..|.......|+.||+.||.||.++++|||||-..|+||.. ...||||||||.+-........
T Consensus 193 plGSLldrLrka~~~~llv~~Lcdya~QiA~aM~YLeskrlvHRDLAARNlllas--prtVKI~DFGLmRaLg~ned~Yv 270 (1039)
T KOG0199|consen 193 PLGSLLDRLRKAKKAILLVSRLCDYAMQIAKAMQYLESKRLVHRDLAARNLLLAS--PRTVKICDFGLMRALGENEDMYV 270 (1039)
T ss_pred ccchHHHHHhhccccceeHHHHHHHHHHHHHHHHHHhhhhhhhhhhhhhhheecc--cceeeeecccceeccCCCCcceE
Confidence 9999999999855557889999999999999999999999999999999999975 4589999999997654322221
Q ss_pred -----cccccccCchhhccCCCCCCCcccchhhhhhhhhhhhcCCCCCCCcCcchhHHHHHHHHhc-CCCCCCCCCCchh
Q psy11767 533 -----CFTLQYAAPEVLRQDKSGYDENCDLWSLGVILVNVLRQDKSGYDENCDLWSLGVILYTMLC-GRVPFHARSRDDS 606 (966)
Q Consensus 533 -----~gT~~Y~APEvl~~~~~~~~~~~Di~SlGvil~el~~~~~~~y~~~~DIWSlGvilyemlt-G~~Pf~~~~~~~~ 606 (966)
.....|.|||.|+.. .++.++|||++||++|||++ |.-||.+...
T Consensus 271 m~p~rkvPfAWCaPEsLrh~--------------------------kFShaSDvWmyGVTiWEMFtyGEePW~G~~g--- 321 (1039)
T KOG0199|consen 271 MAPQRKVPFAWCAPESLRHR--------------------------KFSHASDVWMYGVTIWEMFTYGEEPWVGCRG--- 321 (1039)
T ss_pred ecCCCcCcccccCHhHhccc--------------------------cccccchhhhhhhhHHhhhccCCCCCCCCCH---
Confidence 235679999999743 26788999999999999997 7999998764
Q ss_pred HHHHHHHHHcCCCCCCchhhccCCHHHHHHHHHhcccCccccCChHHHH
Q psy11767 607 ALSIMARIKEGQFNFDAEAWSTVSSEAKELTKSLLTVNPAQRIRMMRVK 655 (966)
Q Consensus 607 ~~~~~~~i~~~~~~~~~~~~~~is~e~~~Li~~~L~~dP~~R~t~~~v~ 655 (966)
..++.+|.++..-..+ +..++++-+++++||..+|++|||+..+.
T Consensus 322 -~qIL~~iD~~erLpRP---k~csedIY~imk~cWah~paDRptFsair 366 (1039)
T KOG0199|consen 322 -IQILKNIDAGERLPRP---KYCSEDIYQIMKNCWAHNPADRPTFSAIR 366 (1039)
T ss_pred -HHHHHhccccccCCCC---CCChHHHHHHHHHhccCCccccccHHHHH
Confidence 3567777766543333 34788899999999999999999998763
|
|
| >KOG1094|consensus | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.3e-31 Score=300.54 Aligned_cols=244 Identities=21% Similarity=0.322 Sum_probs=190.9
Q ss_pred ccccccccccEEEEEEEcCCCcEEEEEEeccc------cChHHHHHHHHHhcCCCCceEEEEEEEeCCeEEEEEEccCCC
Q psy11767 383 AGILGDGSYSVCRRCVEKSTGQEYAVKIISRK------IDCSEEINLLRACQGHPNIVNLHCVFQDEVHTYLVLELLKGG 456 (966)
Q Consensus 383 ~~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~------~~~~~Ei~iL~~l~~HpnIV~l~~~~~~~~~~~lVmEy~~gg 456 (966)
.++||+|-||.|.+|.-.. +..||||+++.. .++.+||++|.+| .|||||.|+++|..+..+++|||||++|
T Consensus 543 ~ekiGeGqFGEVhLCeveg-~lkVAVK~Lr~~a~~~~r~~F~kEIkiLsqL-khPNIveLvGVC~~DePicmI~EYmEnG 620 (807)
T KOG1094|consen 543 KEKIGEGQFGEVHLCEVEG-PLKVAVKILRPDATKNARNDFLKEIKILSRL-KHPNIVELLGVCVQDDPLCMITEYMENG 620 (807)
T ss_pred hhhhcCcccceeEEEEecC-ceEEEEeecCcccchhHHHHHHHHHHHHhcc-CCCCeeEEEeeeecCCchHHHHHHHhcC
Confidence 4689999999999998654 689999999643 3466899999999 5999999999999999999999999999
Q ss_pred CHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCcEEEecCCCCCEEEEeecccccc-cCCC----cc
Q psy11767 457 ELLDRIRQKGRCGFTENEASRIMRQLVAAVHFMHSRGVVHRDLKPENLLFSDPAGDNIKVVDFGFACLK-RESL----HT 531 (966)
Q Consensus 457 ~L~~~l~~~~~~~l~e~~~~~i~~Qil~aL~yLHs~~IiHRDLKP~NILl~~~~~~~iKL~DFGla~~~-~~~~----~~ 531 (966)
+|-+++.++....+.-.....|+.||++|++||.+.++|||||.+.|+|++. +.++||+|||+++.. .... ..
T Consensus 621 DLnqFl~aheapt~~t~~~vsi~tqiasgmaYLes~nfVHrd~a~rNcLv~~--e~~iKiadfgmsR~lysg~yy~vqgr 698 (807)
T KOG1094|consen 621 DLNQFLSAHELPTAETAPGVSICTQIASGMAYLESLNFVHRDLATRNCLVDG--EFTIKIADFGMSRNLYSGDYYRVQGR 698 (807)
T ss_pred cHHHHHHhccCcccccchhHHHHHHHHHHHHHHHhhchhhccccccceeecC--cccEEecCcccccccccCCceeeecc
Confidence 9999998875433455566779999999999999999999999999999985 569999999999742 1111 12
Q ss_pred ccccccccCchhhccCCCCCCCcccchhhhhhhhhhhhcCCCCCCCcCcchhHHHHHHHHh--cCCCCCCCCCCchhHHH
Q psy11767 532 PCFTLQYAAPEVLRQDKSGYDENCDLWSLGVILVNVLRQDKSGYDENCDLWSLGVILYTML--CGRVPFHARSRDDSALS 609 (966)
Q Consensus 532 ~~gT~~Y~APEvl~~~~~~~~~~~Di~SlGvil~el~~~~~~~y~~~~DIWSlGvilyeml--tG~~Pf~~~~~~~~~~~ 609 (966)
.+.+..|||||.+..++ +++++|+|++||++||++ +...||...+.++....
T Consensus 699 ~vlpiRwmawEsillgk--------------------------FttaSDvWafgvTlwE~~~~C~e~Py~~lt~e~vven 752 (807)
T KOG1094|consen 699 AVLPIRWMAWESILLGK--------------------------FTTASDVWAFGVTLWEVFMLCREQPYSQLTDEQVVEN 752 (807)
T ss_pred eeeeeeehhHHHHHhcc--------------------------ccchhhhhhhHHHHHHHHHHHhhCchhhhhHHHHHHh
Confidence 34578899999886443 688999999999999985 57889987665432222
Q ss_pred HHHHHHcCCCCCCchhhccCCHHHHHHHHHhcccCccccCChHHHHH
Q psy11767 610 IMARIKEGQFNFDAEAWSTVSSEAKELTKSLLTVNPAQRIRMMRVKL 656 (966)
Q Consensus 610 ~~~~i~~~~~~~~~~~~~~is~e~~~Li~~~L~~dP~~R~t~~~v~~ 656 (966)
.-.....+....-...++-.+.++-+||.+||..|-++||+..++.+
T Consensus 753 ~~~~~~~~~~~~~l~~P~~cp~~lyelml~Cw~~es~~RPsFe~lh~ 799 (807)
T KOG1094|consen 753 AGEFFRDQGRQVVLSRPPACPQGLYELMLRCWRRESEQRPSFEQLHL 799 (807)
T ss_pred hhhhcCCCCcceeccCCCcCcHHHHHHHHHHhchhhhcCCCHHHHHH
Confidence 11111111111111122346778889999999999999999998744
|
|
| >KOG1027|consensus | Back alignment and domain information |
|---|
Probab=99.97 E-value=8.2e-32 Score=313.94 Aligned_cols=244 Identities=32% Similarity=0.451 Sum_probs=191.7
Q ss_pred cccccccccccccE-EEEEEEcCCCcEEEEEEecccc--ChHHHHHHHHHhcCCCCceEEEEEEEeCCeEEEEEEccCCC
Q psy11767 380 LDKAGILGDGSYSV-CRRCVEKSTGQEYAVKIISRKI--DCSEEINLLRACQGHPNIVNLHCVFQDEVHTYLVLELLKGG 456 (966)
Q Consensus 380 ~~~~~~LG~G~fG~-Vy~a~~~~tg~~vAvK~i~~~~--~~~~Ei~iL~~l~~HpnIV~l~~~~~~~~~~~lVmEy~~gg 456 (966)
|...+++|.|+-|+ ||+|... |+.||||.+-... -+.+||..|+....|||||++|+.-.++.+.||+.|+| ..
T Consensus 511 ~~~~eilG~Gs~Gt~Vf~G~ye--~R~VAVKrll~e~~~~A~rEi~lL~eSD~H~NviRyyc~E~d~qF~YIalELC-~~ 587 (903)
T KOG1027|consen 511 FSPKEILGYGSNGTVVFRGVYE--GREVAVKRLLEEFFDFAQREIQLLQESDEHPNVIRYYCSEQDRQFLYIALELC-AC 587 (903)
T ss_pred eccHHHcccCCCCcEEEEEeeC--CceehHHHHhhHhHHHHHHHHHHHHhccCCCceEEEEeeccCCceEEEEehHh-hh
Confidence 33456899999986 6888764 7899999886554 36789999999999999999999999999999999999 57
Q ss_pred CHHHHHHhcCC--CCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCcEEEecC---CCCCEEEEeecccccccC----
Q psy11767 457 ELLDRIRQKGR--CGFTENEASRIMRQLVAAVHFMHSRGVVHRDLKPENLLFSDP---AGDNIKVVDFGFACLKRE---- 527 (966)
Q Consensus 457 ~L~~~l~~~~~--~~l~e~~~~~i~~Qil~aL~yLHs~~IiHRDLKP~NILl~~~---~~~~iKL~DFGla~~~~~---- 527 (966)
+|.+++...+. ........+..+.|+++||++||+.+||||||||.||||.-+ ....++|+|||+++....
T Consensus 588 sL~dlie~~~~d~~~~~~i~~~~~l~q~~~GlaHLHsl~iVHRDLkPQNILI~~~~~~~~~ra~iSDfglsKkl~~~~sS 667 (903)
T KOG1027|consen 588 SLQDLIESSGLDVEMQSDIDPISVLSQIASGLAHLHSLKIVHRDLKPQNILISVPSADGTLRAKISDFGLSKKLAGGKSS 667 (903)
T ss_pred hHHHHHhccccchhhcccccHHHHHHHHHHHHHHHHhcccccccCCCceEEEEccCCCcceeEEecccccccccCCCcch
Confidence 99999987411 111114567889999999999999999999999999999863 335789999999976432
Q ss_pred --CCccccccccccCchhhccCCCCCCCcccchhhhhhhhhhhhcCCCCCCCcCcchhHHHHHHHHhcC-CCCCCCCCCc
Q psy11767 528 --SLHTPCFTLQYAAPEVLRQDKSGYDENCDLWSLGVILVNVLRQDKSGYDENCDLWSLGVILYTMLCG-RVPFHARSRD 604 (966)
Q Consensus 528 --~~~~~~gT~~Y~APEvl~~~~~~~~~~~Di~SlGvil~el~~~~~~~y~~~~DIWSlGvilyemltG-~~Pf~~~~~~ 604 (966)
...+..||-+|+|||++.... -+.++||+|+||++|+.++| ..||...-
T Consensus 668 ~~r~s~~sGt~GW~APE~L~~~~--------------------------~~~avDiFslGCvfyYvltgG~HpFGd~~-- 719 (903)
T KOG1027|consen 668 FSRLSGGSGTSGWQAPEQLREDR--------------------------KTQAVDIFSLGCVFYYVLTGGSHPFGDSL-- 719 (903)
T ss_pred hhcccCCCCcccccCHHHHhccc--------------------------cCcccchhhcCceEEEEecCCccCCCchH--
Confidence 234567899999999997532 14479999999999999986 99997532
Q ss_pred hhHHHHHHHHHcCCCCCCchhhccCCHHHHHHHHHhcccCccccCChHHHHHHhhhh
Q psy11767 605 DSALSIMARIKEGQFNFDAEAWSTVSSEAKELTKSLLTVNPAQRIRMMRVKLTFHAF 661 (966)
Q Consensus 605 ~~~~~~~~~i~~~~~~~~~~~~~~is~e~~~Li~~~L~~dP~~R~t~~~v~~~~~~~ 661 (966)
.....|..|.+....-.. ....+|+|||.+||..+|..||++.+|. .|||
T Consensus 720 ----~R~~NIl~~~~~L~~L~~-~~d~eA~dLI~~ml~~dP~~RPsa~~VL--~HPl 769 (903)
T KOG1027|consen 720 ----ERQANILTGNYTLVHLEP-LPDCEAKDLISRMLNPDPQLRPSATDVL--NHPL 769 (903)
T ss_pred ----HhhhhhhcCccceeeecc-CchHHHHHHHHHhcCCCcccCCCHHHHh--CCCc
Confidence 334567777765443221 1122899999999999999999999873 4554
|
|
| >PLN03224 probable serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.5e-30 Score=303.82 Aligned_cols=272 Identities=19% Similarity=0.255 Sum_probs=187.0
Q ss_pred cccccccccccccEEEEEEEc----------------CCCcEEEEEEeccccC-------------------hHHHHHHH
Q psy11767 380 LDKAGILGDGSYSVCRRCVEK----------------STGQEYAVKIISRKID-------------------CSEEINLL 424 (966)
Q Consensus 380 ~~~~~~LG~G~fG~Vy~a~~~----------------~tg~~vAvK~i~~~~~-------------------~~~Ei~iL 424 (966)
|+..++||+|+||+||+|... ..++.||||.+..... ...|+.++
T Consensus 147 F~i~~~LG~GgFG~VYkG~~~~~~~~~v~~~~~~~~~~~~r~VAVK~l~~~~~~~~~~fl~e~~~~~~~~e~~~vE~~~l 226 (507)
T PLN03224 147 FQLRDKLGGGNFGITFEGLRLQADDQGVTQRSKLTAEQKKRRVVLKRVNMDRQGVRQDFLKTGTLAKGSAETGMVEAYMC 226 (507)
T ss_pred ceEeeEeecCCCeEEEEEEecccccchhhhhccccccccCceEEEEEecccchhhHHHHHhhhhhhhcccchhHHHHHHH
Confidence 344688999999999999753 3456899999853211 12255555
Q ss_pred HHhcCCCC-----ceEEEEEEEe--------CCeEEEEEEccCCCCHHHHHHhcCC----------------------CC
Q psy11767 425 RACQGHPN-----IVNLHCVFQD--------EVHTYLVLELLKGGELLDRIRQKGR----------------------CG 469 (966)
Q Consensus 425 ~~l~~Hpn-----IV~l~~~~~~--------~~~~~lVmEy~~gg~L~~~l~~~~~----------------------~~ 469 (966)
..+. |.| +++++++|.. ++..||||||+++++|.+++..... ..
T Consensus 227 ~~l~-~~~l~~~~~~~~lg~~~~~~~~g~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~L~e~l~~g~~l~~~~~~~~ 305 (507)
T PLN03224 227 AKIK-RNPIAAASCAEYLGYFTSNTADGAFTKGSQWLVWKFESDATLGDALDGKLGPFPGCLEEFMMAGKKIPDNMPQDK 305 (507)
T ss_pred HHhh-cccchhhhhhhhhhhcccccccccccCCceEEEEEcCCCCcHHHHHhhccCCCcchHHHHHhcCCchhhhccccc
Confidence 5554 433 4677777653 3568999999999999999864311 12
Q ss_pred CCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCcEEEecCCCCCEEEEeecccccccCC--Cc--cccccccccCchhhc
Q psy11767 470 FTENEASRIMRQLVAAVHFMHSRGVVHRDLKPENLLFSDPAGDNIKVVDFGFACLKRES--LH--TPCFTLQYAAPEVLR 545 (966)
Q Consensus 470 l~e~~~~~i~~Qil~aL~yLHs~~IiHRDLKP~NILl~~~~~~~iKL~DFGla~~~~~~--~~--~~~gT~~Y~APEvl~ 545 (966)
+++..++.++.|++.||+|||+.+|+||||||+|||++. .+.+||+|||++...... .. ...+|+.|+|||++.
T Consensus 306 ~~~~~~~~i~~ql~~aL~~lH~~~ivHrDLKp~NILl~~--~~~~kL~DFGla~~~~~~~~~~~~~g~~tp~Y~aPE~l~ 383 (507)
T PLN03224 306 RDINVIKGVMRQVLTGLRKLHRIGIVHRDIKPENLLVTV--DGQVKIIDFGAAVDMCTGINFNPLYGMLDPRYSPPEELV 383 (507)
T ss_pred CCHHHHHHHHHHHHHHHHHHHHCCeecCCCchHhEEECC--CCcEEEEeCcCccccccCCccCccccCCCcceeChhhhc
Confidence 466788999999999999999999999999999999975 468999999999654321 11 223488999999986
Q ss_pred cCCCCCCCcccchhhhhhhhhhhhcCCCCCCCcCcchhHHHHHHHHhcCCC-CCCCCCCchhH-------HHHHHHHHcC
Q psy11767 546 QDKSGYDENCDLWSLGVILVNVLRQDKSGYDENCDLWSLGVILYTMLCGRV-PFHARSRDDSA-------LSIMARIKEG 617 (966)
Q Consensus 546 ~~~~~~~~~~Di~SlGvil~el~~~~~~~y~~~~DIWSlGvilyemltG~~-Pf~~~~~~~~~-------~~~~~~i~~~ 617 (966)
... .....+.++.+..+....... +...+.||||+||++|+|++|.+ ||......... ...+..+...
T Consensus 384 ~~~--~~~~~~~~~~~~~l~~~~~~y--g~~~~~DvwSlGvil~em~~~~l~p~~~~~~f~~~~~~~~~~~~~~r~~~~~ 459 (507)
T PLN03224 384 MPQ--SCPRAPAPAMAALLSPFAWLY--GRPDLFDSYTAGVLLMQMCVPELRPVANIRLFNTELRQYDNDLNRWRMYKGQ 459 (507)
T ss_pred CCC--CCCccchhhhhhhhhhhHHhc--CCCCccchhhHHHHHHHHHhCCCCCccchhhhhhHHhhccchHHHHHhhccc
Confidence 432 233444444444333322211 12345899999999999999986 77543211111 1112223334
Q ss_pred CCCCCchhhccCCHHHHHHHHHhcccCc---cccCChHHHHHHhhhhH
Q psy11767 618 QFNFDAEAWSTVSSEAKELTKSLLTVNP---AQRIRMMRVKLTFHAFH 662 (966)
Q Consensus 618 ~~~~~~~~~~~is~e~~~Li~~~L~~dP---~~R~t~~~v~~~~~~~~ 662 (966)
.+.+. .+..++++++||+.+||..+| .+|+|+.++ ..|+|+
T Consensus 460 ~~~~~--~~d~~s~~~~dLi~~LL~~~~~~~~~RlSa~ea--L~Hp~f 503 (507)
T PLN03224 460 KYDFS--LLDRNKEAGWDLACKLITKRDQANRGRLSVGQA--LSHRFF 503 (507)
T ss_pred CCCcc--cccccChHHHHHHHHHhccCCCCcccCCCHHHH--hCCCCc
Confidence 44443 466789999999999999876 689999876 456665
|
|
| >KOG0606|consensus | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.8e-31 Score=313.90 Aligned_cols=219 Identities=27% Similarity=0.464 Sum_probs=178.0
Q ss_pred ccCCcceeeeecccccceEEEEEEcCCCCEEEEEeccccchhhHHHHHHHHhhCCCccccccccccc-------chhHHH
Q psy11767 114 YDMDLDKAGILGDGSYSVCRRCVEKSTGQEYAVKIISRKIDCSEEINLLRACQGHPNICRRCVEKST-------GQEYAV 186 (966)
Q Consensus 114 ~~~df~~~~~LG~GsFGkV~La~~k~tg~~yAiKvl~K~~~~~~E~~il~~~~~~pfi~~~~~~~~~-------~~~~~~ 186 (966)
-|.||+.+|+|-.|+||.||||+||.|-+.||||+-|+..+. |+||.- .+.||+|..+.+--- +.-+++
T Consensus 81 ~e~df~~IklisngAygavylvrh~~trqrfa~kiNkq~lil---Rnilt~-a~npfvvgDc~tllk~~g~lPvdmvla~ 156 (1205)
T KOG0606|consen 81 SESDFNTIKLISNGAYGAVYLVRHKETRQRFAMKINKQNLIL---RNILTF-AGNPFVVGDCATLLKNIGPLPVDMVLAV 156 (1205)
T ss_pred CccccceeEeeccCCCCceeeeeccccccchhhcccccchhh---hccccc-cCCcceechhhhhcccCCCCcchhhHHh
Confidence 567999999999999999999999999999999876665433 335554 478999652211110 112444
Q ss_pred HHHHhh----cccchhhhHhhhccCCceEEecCccc----------------------------------cccccccccC
Q psy11767 187 KIISRK----IDCSEEINLLRACQGHPNIVNLHCVF----------------------------------QDEVIDWDDF 228 (966)
Q Consensus 187 ~~v~~~----~~~~~e~nil~~~~gh~~iv~l~~~~----------------------------------~~e~i~~~~y 228 (966)
+.++.+ .|++ +.|+|...-||.+++|++... .+|||+..||
T Consensus 157 Eylh~ygivhrdlk-pdnllIT~mGhiKlTDfgLsk~GLms~atnl~eg~I~k~t~Ef~dKqvcgTPeyiaPeVilrqgy 235 (1205)
T KOG0606|consen 157 EYLHSYGIVHRDLK-PDNLLITSMGHIKLTDFGLSKKGLMSLATNLKEGHIEKDTHEFQDKQVCGTPEYIAPEVILRQGY 235 (1205)
T ss_pred HhhccCCeecCCCC-CCcceeeecccccccchhhhhhhhhhccchhhhcchHHHHHHhhhccccCCccccChhhhhhhcc
Confidence 444443 2344 449999889999999987432 2468999999
Q ss_pred CCcceeeechhhHHHHHHHhhCCCCCCCCcHHHHHHHHHhCCCCCCCC---CCHHHHHHHHhhcccCCCcccCCCCCCHH
Q psy11767 229 SRGIECVFFSSSLIIFFIILSFTLSFIHDYYHIQYRRILKTEPPIPED---LSPDVADFISRLLVKDPRRRLGGGELDAE 305 (966)
Q Consensus 229 ~~~~d~~~~~~~~il~~~m~~g~~pf~~~~~~~~~~~I~~~~~~~P~~---~s~~a~dli~~LL~kdp~~RLG~~~~g~~ 305 (966)
|+-|| ||+.|||.||.+.|..||..+.++++|...+.+.+.||+. +.+||+|+|++||+.+|..|||.+ |+-
T Consensus 236 gkpvd---wwamGiIlyeFLVgcvpffGdtpeelfg~visd~i~wpE~dea~p~Ea~dli~~LL~qnp~~Rlgt~--ga~ 310 (1205)
T KOG0606|consen 236 GKPVD---WWAMGIILYEFLVGCVPFFGDTPEELFGQVISDDIEWPEEDEALPPEAQDLIEQLLRQNPLCRLGTG--GAL 310 (1205)
T ss_pred CCCcc---HHHHHHHHHHHheeeeeccCCCHHHHHhhhhhhhccccccCcCCCHHHHHHHHHHHHhChHhhcccc--hhh
Confidence 99998 7799999999999999999999999999999999999975 679999999999999999999964 899
Q ss_pred HHhcCCceeeeCccccccCCCCCCCCccccccccccccc
Q psy11767 306 ELKRHPFFNVIDWDDLATKRIPAPFVPKISNELDVSNFS 344 (966)
Q Consensus 306 ~Ik~HpfF~~idW~~l~~k~~~pP~~P~i~~~~D~snFd 344 (966)
+||.|+||..+||..|++++ ++|+|......|+++||
T Consensus 311 evk~h~ff~~LDw~~llRqk--aefvpql~~eddtsyfd 347 (1205)
T KOG0606|consen 311 EVKQHGFFQLLDWKSLLRQK--AEFVPQLESEDDTSYFD 347 (1205)
T ss_pred hhhhccceeecccchhhhhh--ccccccccccccchhhc
Confidence 99999999999999998875 77899887777777776
|
|
| >KOG0664|consensus | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.7e-32 Score=280.19 Aligned_cols=245 Identities=24% Similarity=0.440 Sum_probs=187.6
Q ss_pred ccccccccccccccEEEEEEEcCCCcEEEEEEecccc-------ChHHHHHHHHHhcCCCCceEEEEEEEeCC-----eE
Q psy11767 379 DLDKAGILGDGSYSVCRRCVEKSTGQEYAVKIISRKI-------DCSEEINLLRACQGHPNIVNLHCVFQDEV-----HT 446 (966)
Q Consensus 379 ~~~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~-------~~~~Ei~iL~~l~~HpnIV~l~~~~~~~~-----~~ 446 (966)
|.+.-+.||.|+||+||.+.|..+|+.||+|.+..-. ...+|+++|-..+ |.||..+++..+-.. .+
T Consensus 54 Di~PDRPIGYGAFGVVWsVTDPRdgrrvalkK~pnvfq~L~s~krvFre~kmLcfFk-HdNVLSaLDILQPph~dfFqEi 132 (449)
T KOG0664|consen 54 DIQPDRPIGYGAFGVVWSVTDPRSGKRVALKKMPNVFQNLASCKRVFREIKMLSSFR-HDNVLSLLDILQPANPSFFQEL 132 (449)
T ss_pred cCCCCCcccccceeEEEeccCCCCccchhHhhcchHHHHHHHHHHHHHHHHHHHhhc-cccHHHHHHhcCCCCchHHHHH
Confidence 3445578999999999999999999999999886532 2457999998774 999999998876543 36
Q ss_pred EEEEEccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCcEEEecCCCCCEEEEeeccccccc
Q psy11767 447 YLVLELLKGGELLDRIRQKGRCGFTENEASRIMRQLVAAVHFMHSRGVVHRDLKPENLLFSDPAGDNIKVVDFGFACLKR 526 (966)
Q Consensus 447 ~lVmEy~~gg~L~~~l~~~~~~~l~e~~~~~i~~Qil~aL~yLHs~~IiHRDLKP~NILl~~~~~~~iKL~DFGla~~~~ 526 (966)
|+|.|+|. .||...|-.- ..|+...++-+++||+.||+|||+.||+||||||.|+|+.. +..+||||||||+...
T Consensus 133 YV~TELmQ-SDLHKIIVSP--Q~Ls~DHvKVFlYQILRGLKYLHsA~ILHRDIKPGNLLVNS--NCvLKICDFGLARvee 207 (449)
T KOG0664|consen 133 YVLTELMQ-SDLHKIIVSP--QALTPDHVKVFVYQILRGLKYLHTANILHRDIKPGNLLVNS--NCILKICDFGLARTWD 207 (449)
T ss_pred HHHHHHHH-hhhhheeccC--CCCCcchhhhhHHHHHhhhHHHhhcchhhccCCCccEEecc--CceEEecccccccccc
Confidence 88899984 5777766543 36999999999999999999999999999999999999974 6689999999998765
Q ss_pred CC----CccccccccccCchhhccCCCCCCCcccchhhhhhhhhhhhcCCCCCCCcCcchhHHHHHHHHhcCCCCCCCCC
Q psy11767 527 ES----LHTPCFTLQYAAPEVLRQDKSGYDENCDLWSLGVILVNVLRQDKSGYDENCDLWSLGVILYTMLCGRVPFHARS 602 (966)
Q Consensus 527 ~~----~~~~~gT~~Y~APEvl~~~~~~~~~~~Di~SlGvil~el~~~~~~~y~~~~DIWSlGvilyemltG~~Pf~~~~ 602 (966)
.. ....+.|-+|+|||++.+ ...|+..+||||.|||+.|+|..+.-|...+
T Consensus 208 ~d~~~hMTqEVVTQYYRAPEiLMG-------------------------aRhYs~AvDiWSVGCIFaELLgRrILFQAq~ 262 (449)
T KOG0664|consen 208 QRDRLNMTHEVVTQYYRAPELLMG-------------------------ARRYTGAVDIWSVGCIFAELLQRKILFQAAG 262 (449)
T ss_pred hhhhhhhHHHHHHHHhccHHHhhc-------------------------chhhcCccceehhhHHHHHHHhhhhhhhccC
Confidence 32 223456889999999963 3468999999999999999999999998877
Q ss_pred CchhHHHHHHH-------------------HHcCCCCCCc-hh-h-----ccCCHHHHHHHHHhcccCccccCChHHH
Q psy11767 603 RDDSALSIMAR-------------------IKEGQFNFDA-EA-W-----STVSSEAKELTKSLLTVNPAQRIRMMRV 654 (966)
Q Consensus 603 ~~~~~~~~~~~-------------------i~~~~~~~~~-~~-~-----~~is~e~~~Li~~~L~~dP~~R~t~~~v 654 (966)
..++..-+.+. +.++....+. .. + ..-.-++.+++..+|..||+.|++..+.
T Consensus 263 PiqQL~lItdLLGTPs~EaMr~ACEGAk~H~LR~~~k~Ps~~vLYtlsS~~~~~heav~~~~~~l~~d~dkris~~~A 340 (449)
T KOG0664|consen 263 PIEQLQMIIDLLGTPSQEAMKYACEGAKNHVLRAGLRAPDTQRLYKIASPDDKNHEAVDLLQKLLHFDPDKRISVEEA 340 (449)
T ss_pred hHHHHHHHHHHhCCCcHHHHHHHhhhhHHHhhccCCCCCCccceeeecCCcccchHHHHHHHHHhCCCCcccccHhhh
Confidence 65443222211 1111111110 00 0 1223478899999999999999987654
|
|
| >KOG0984|consensus | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.7e-30 Score=257.14 Aligned_cols=199 Identities=27% Similarity=0.464 Sum_probs=161.6
Q ss_pred cccccccccccccEEEEEEEcCCCcEEEEEEeccccCh------HHHHHHHHHhcCCCCceEEEEEEEeCCeEEEEEEcc
Q psy11767 380 LDKAGILGDGSYSVCRRCVEKSTGQEYAVKIISRKIDC------SEEINLLRACQGHPNIVNLHCVFQDEVHTYLVLELL 453 (966)
Q Consensus 380 ~~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~~~------~~Ei~iL~~l~~HpnIV~l~~~~~~~~~~~lVmEy~ 453 (966)
...+..||+|+||+|-+-+|..+|+..|+|.+...... .+|+++...+...|.+|.+|+.+.+++..|+.||.|
T Consensus 48 L~~i~elGrGayG~vekmrh~~sg~imAvKri~~tvn~q~q~r~L~dldi~~r~~~CPf~V~FyGa~~regdvwIcME~M 127 (282)
T KOG0984|consen 48 LVGIEELGRGAYGVVEKMRHIQSGTIMAVKRIRATVNSQEQKRLLMDLDIIMRTVDCPFTVHFYGALFREGDVWICMELM 127 (282)
T ss_pred hhhhhhhcCCccchhhheeeccCCeEEEEeeehhhcChHHHHHHHHhhhhhccCCCCCeEEEeehhhhccccEEEeHHHh
Confidence 33456799999999999999999999999999765432 346666666667999999999999999999999999
Q ss_pred CCCCHHHHHHh--cCCCCCCHHHHHHHHHHHHHHHHHHHhc-CceeccCCCCcEEEecCCCCCEEEEeecccccccCCCc
Q psy11767 454 KGGELLDRIRQ--KGRCGFTENEASRIMRQLVAAVHFMHSR-GVVHRDLKPENLLFSDPAGDNIKVVDFGFACLKRESLH 530 (966)
Q Consensus 454 ~gg~L~~~l~~--~~~~~l~e~~~~~i~~Qil~aL~yLHs~-~IiHRDLKP~NILl~~~~~~~iKL~DFGla~~~~~~~~ 530 (966)
. .+|..+-++ .....++|..+-+|+..++.||.|||++ .|||||+||+|||++. .|++|+||||.+....++..
T Consensus 128 ~-tSldkfy~~v~~~g~~ipE~vlGkIa~Svv~al~~L~~kL~vIHRDvKPsNiLIn~--~GqVKiCDFGIsG~L~dSiA 204 (282)
T KOG0984|consen 128 D-TSLDKFYRKVLKKGGTIPEDVLGKIAVSVVHALEFLHSKLSVIHRDVKPSNILINY--DGQVKICDFGISGYLVDSIA 204 (282)
T ss_pred h-hhHHHHHHHHHhcCCcCchHHhhHhHHHHHHHHHHHHHHhhhhhccCCcceEEEcc--CCcEEEcccccceeehhhhH
Confidence 4 566554432 1223689999999999999999999987 8999999999999974 67999999999976554432
Q ss_pred -c-ccccccccCchhhccCCCCCCCcccchhhhhhhhhhhhcCCCCCCCcCcchhHHHHHHHHhcCCCCCCCCCC
Q psy11767 531 -T-PCFTLQYAAPEVLRQDKSGYDENCDLWSLGVILVNVLRQDKSGYDENCDLWSLGVILYTMLCGRVPFHARSR 603 (966)
Q Consensus 531 -~-~~gT~~Y~APEvl~~~~~~~~~~~Di~SlGvil~el~~~~~~~y~~~~DIWSlGvilyemltG~~Pf~~~~~ 603 (966)
+ ..|--.|||||.+..+. ...+|+-++||||||+.++||.+++.||..-..
T Consensus 205 kt~daGCkpYmaPEri~~e~----------------------n~~gY~vksDvWSLGItmiElA~lr~PY~~w~t 257 (282)
T KOG0984|consen 205 KTMDAGCKPYMAPERINPEL----------------------NQKGYSVKSDVWSLGITMIEMAILRFPYESWGT 257 (282)
T ss_pred HHHhcCCCccCChhhcCccc----------------------CcccceeehhhhhhhhhhhhhhhccccccccCC
Confidence 2 34556799999986432 234799999999999999999999999986543
|
|
| >KOG1152|consensus | Back alignment and domain information |
|---|
Probab=99.97 E-value=8.7e-31 Score=293.78 Aligned_cols=193 Identities=33% Similarity=0.549 Sum_probs=168.6
Q ss_pred ccccccccccccccEEEEEEEcCCCcEEEEEEeccccC-------------hHHHHHHHHHhc--CCCCceEEEEEEEeC
Q psy11767 379 DLDKAGILGDGSYSVCRRCVEKSTGQEYAVKIISRKID-------------CSEEINLLRACQ--GHPNIVNLHCVFQDE 443 (966)
Q Consensus 379 ~~~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~~-------------~~~Ei~iL~~l~--~HpnIV~l~~~~~~~ 443 (966)
+|..++.||.|+||+|++|.|+.....|+||.|.+..- ...||.||..+. .|+||++++++|+++
T Consensus 562 ~yttlq~lG~GAyGkV~lai~K~n~~eVViK~I~KeRIL~DtWvrDrkLGtVp~EIqIla~l~~~sH~NIlKlLdfFEdd 641 (772)
T KOG1152|consen 562 DYTTLQPLGEGAYGKVNLAIHKENNYEVVIKMIFKERILVDTWVRDRKLGTVPSEIQILATLNKHSHENILKLLDFFEDD 641 (772)
T ss_pred cceeeeeccccccceEEEeeecccceEEEeeehhhhhhhhhhhhcccccCccchhHHHHHHhhhcCccchhhhhheeecC
Confidence 56778999999999999999999999999999976431 346999998874 499999999999999
Q ss_pred CeEEEEEEcc-CCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCcEEEecCCCCCEEEEeeccc
Q psy11767 444 VHTYLVLELL-KGGELLDRIRQKGRCGFTENEASRIMRQLVAAVHFMHSRGVVHRDLKPENLLFSDPAGDNIKVVDFGFA 522 (966)
Q Consensus 444 ~~~~lVmEy~-~gg~L~~~l~~~~~~~l~e~~~~~i~~Qil~aL~yLHs~~IiHRDLKP~NILl~~~~~~~iKL~DFGla 522 (966)
+++||+||-- +|-+|+++|..+. .++|.++..|+.|++.|+++||++||||||||-+|+.++. +|-+||+|||.|
T Consensus 642 d~yyl~te~hg~gIDLFd~IE~kp--~m~E~eAk~IFkQV~agi~hlh~~~ivhrdikdenvivd~--~g~~klidfgsa 717 (772)
T KOG1152|consen 642 DYYYLETEVHGEGIDLFDFIEFKP--RMDEPEAKLIFKQVVAGIKHLHDQGIVHRDIKDENVIVDS--NGFVKLIDFGSA 717 (772)
T ss_pred CeeEEEecCCCCCcchhhhhhccC--ccchHHHHHHHHHHHhccccccccCceecccccccEEEec--CCeEEEeeccch
Confidence 9999999975 5669999998765 5999999999999999999999999999999999999984 679999999998
Q ss_pred ccc-cCCCccccccccccCchhhccCCCCCCCcccchhhhhhhhhhhhcCCCCCCCcCcchhHHHHHHHHhcCCCCCCC
Q psy11767 523 CLK-RESLHTPCFTLQYAAPEVLRQDKSGYDENCDLWSLGVILVNVLRQDKSGYDENCDLWSLGVILYTMLCGRVPFHA 600 (966)
Q Consensus 523 ~~~-~~~~~~~~gT~~Y~APEvl~~~~~~~~~~~Di~SlGvil~el~~~~~~~y~~~~DIWSlGvilyemltG~~Pf~~ 600 (966)
... ..+...+.||..|.|||++.+.+ ..+..-|||+||++||.++....||+.
T Consensus 718 a~~ksgpfd~f~gtv~~aapevl~g~~-------------------------y~gk~qdiwalgillytivykenpyyn 771 (772)
T KOG1152|consen 718 AYTKSGPFDVFVGTVDYAAPEVLGGEK-------------------------YLGKPQDIWALGILLYTIVYKENPYYN 771 (772)
T ss_pred hhhcCCCcceeeeeccccchhhhCCCc-------------------------cCCCcchhhhhhheeeEEEeccCCCcC
Confidence 654 44677889999999999996443 125567999999999999999999863
|
|
| >KOG0196|consensus | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.5e-30 Score=300.33 Aligned_cols=242 Identities=21% Similarity=0.395 Sum_probs=201.2
Q ss_pred cccccccccccEEEEEEEcCCC---cEEEEEEeccc------cChHHHHHHHHHhcCCCCceEEEEEEEeCCeEEEEEEc
Q psy11767 382 KAGILGDGSYSVCRRCVEKSTG---QEYAVKIISRK------IDCSEEINLLRACQGHPNIVNLHCVFQDEVHTYLVLEL 452 (966)
Q Consensus 382 ~~~~LG~G~fG~Vy~a~~~~tg---~~vAvK~i~~~------~~~~~Ei~iL~~l~~HpnIV~l~~~~~~~~~~~lVmEy 452 (966)
+.++||.|.||.|++|+.+..| ..||||.++.. .++..|..||-+. +|||||+|.++......+.||.||
T Consensus 633 Ie~VIGaGEFGEVc~GrLk~pgkre~~VAIKTLK~GytekqrrdFL~EAsIMGQF-dHPNIIrLEGVVTks~PvMIiTEy 711 (996)
T KOG0196|consen 633 IEKVIGAGEFGEVCSGRLKLPGKREITVAIKTLKAGYTEKQRRDFLSEASIMGQF-DHPNIIRLEGVVTKSKPVMIITEY 711 (996)
T ss_pred EEEEEecccccceecccccCCCCcceeEEEeeeccCccHHHHhhhhhhhhhcccC-CCCcEEEEEEEEecCceeEEEhhh
Confidence 3578999999999999998776 47999999743 3567799999887 599999999999999999999999
Q ss_pred cCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCcEEEecCCCCCEEEEeecccccccCCCc--
Q psy11767 453 LKGGELLDRIRQKGRCGFTENEASRIMRQLVAAVHFMHSRGVVHRDLKPENLLFSDPAGDNIKVVDFGFACLKRESLH-- 530 (966)
Q Consensus 453 ~~gg~L~~~l~~~~~~~l~e~~~~~i~~Qil~aL~yLHs~~IiHRDLKP~NILl~~~~~~~iKL~DFGla~~~~~~~~-- 530 (966)
|++|+|..+|+++.. .|+.-+...+++.|+.|+.||-+.|.|||||-..|||++. +-.+||+||||++...+...
T Consensus 712 MENGsLDsFLR~~DG-qftviQLVgMLrGIAsGMkYLsdm~YVHRDLAARNILVNs--nLvCKVsDFGLSRvledd~~~~ 788 (996)
T KOG0196|consen 712 MENGSLDSFLRQNDG-QFTVIQLVGMLRGIASGMKYLSDMNYVHRDLAARNILVNS--NLVCKVSDFGLSRVLEDDPEAA 788 (996)
T ss_pred hhCCcHHHHHhhcCC-ceEeehHHHHHHHHHHHhHHHhhcCchhhhhhhhheeecc--ceEEEeccccceeecccCCCcc
Confidence 999999999998775 4999999999999999999999999999999999999974 56899999999987654331
Q ss_pred --ccc--ccccccCchhhccCCCCCCCcccchhhhhhhhhhhhcCCCCCCCcCcchhHHHHHHHHh-cCCCCCCCCCCch
Q psy11767 531 --TPC--FTLQYAAPEVLRQDKSGYDENCDLWSLGVILVNVLRQDKSGYDENCDLWSLGVILYTML-CGRVPFHARSRDD 605 (966)
Q Consensus 531 --~~~--gT~~Y~APEvl~~~~~~~~~~~Di~SlGvil~el~~~~~~~y~~~~DIWSlGvilyeml-tG~~Pf~~~~~~~ 605 (966)
+.. ....|.|||.|... .++.++||||+||+|||.+ .|..||-..+..
T Consensus 789 ytt~GGKIPiRWTAPEAIa~R--------------------------KFTsASDVWSyGIVmWEVmSyGERPYWdmSNQ- 841 (996)
T KOG0196|consen 789 YTTLGGKIPIRWTAPEAIAYR--------------------------KFTSASDVWSYGIVMWEVMSYGERPYWDMSNQ- 841 (996)
T ss_pred ccccCCccceeecChhHhhhc--------------------------ccCchhhccccceEEEEecccCCCcccccchH-
Confidence 222 25789999999643 2678899999999999965 599998766543
Q ss_pred hHHHHHHHHHcCCCCCCchhhccCCHHHHHHHHHhcccCccccCChHHHHHHhhh
Q psy11767 606 SALSIMARIKEGQFNFDAEAWSTVSSEAKELTKSLLTVNPAQRIRMMRVKLTFHA 660 (966)
Q Consensus 606 ~~~~~~~~i~~~~~~~~~~~~~~is~e~~~Li~~~L~~dP~~R~t~~~v~~~~~~ 660 (966)
.+++.|.+| |.+++ +.+.+..+-.|+..||++|-.+||+..++...++.
T Consensus 842 ---dVIkaIe~g-yRLPp--PmDCP~aL~qLMldCWqkdR~~RP~F~qiV~~lDk 890 (996)
T KOG0196|consen 842 ---DVIKAIEQG-YRLPP--PMDCPAALYQLMLDCWQKDRNRRPKFAQIVSTLDK 890 (996)
T ss_pred ---HHHHHHHhc-cCCCC--CCCCcHHHHHHHHHHHHHHhhcCCCHHHHHHHHHH
Confidence 456666654 34443 34688899999999999999999999988765553
|
|
| >KOG0665|consensus | Back alignment and domain information |
|---|
Probab=99.96 E-value=4.5e-30 Score=272.36 Aligned_cols=245 Identities=28% Similarity=0.517 Sum_probs=189.4
Q ss_pred cccccccccccEEEEEEEcCCCcEEEEEEecccc-------ChHHHHHHHHHhcCCCCceEEEEEEEeC------CeEEE
Q psy11767 382 KAGILGDGSYSVCRRCVEKSTGQEYAVKIISRKI-------DCSEEINLLRACQGHPNIVNLHCVFQDE------VHTYL 448 (966)
Q Consensus 382 ~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~-------~~~~Ei~iL~~l~~HpnIV~l~~~~~~~------~~~~l 448 (966)
.+..+|.|.= .|..|.|.-+++.||+|.+.... .+.+|..++..+ +|+|||+++.+|.-. ...|+
T Consensus 21 nL~p~~~g~~-~v~~a~D~v~~~~v~ikk~~~pf~n~~~akra~rel~l~~~v-~~~nii~l~n~ftP~~~l~~~~e~y~ 98 (369)
T KOG0665|consen 21 NLKPIGSGAQ-IVVAAFDQVLGRPVAIKKLSRPFQNQTHAKRAYRELKLMKCV-NHKNIISLLNVFTPQKTLEEFQEVYL 98 (369)
T ss_pred eecccCCCCc-eEEecchhhccCceehhhhcCccccCccchhhhhhhhhhhhh-cccceeeeeeccCccccHHHHHhHHH
Confidence 4677888887 78889999999999999886542 255799999887 599999999999644 35799
Q ss_pred EEEccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCcEEEecCCCCCEEEEeecccccccCC
Q psy11767 449 VLELLKGGELLDRIRQKGRCGFTENEASRIMRQLVAAVHFMHSRGVVHRDLKPENLLFSDPAGDNIKVVDFGFACLKRES 528 (966)
Q Consensus 449 VmEy~~gg~L~~~l~~~~~~~l~e~~~~~i~~Qil~aL~yLHs~~IiHRDLKP~NILl~~~~~~~iKL~DFGla~~~~~~ 528 (966)
||||| .++|.+.+.. .++-..+..++.|++.|++|||+.||+||||||+||++.. .+.+||.|||+|+.....
T Consensus 99 v~e~m-~~nl~~vi~~----elDH~tis~i~yq~~~~ik~lhs~~IihRdLkPsnivv~~--~~~lKi~dfg~ar~e~~~ 171 (369)
T KOG0665|consen 99 VMELM-DANLCQVILM----ELDHETISYILYQMLCGIKHLHSAGIIHRDLKPSNIVVNS--DCTLKILDFGLARTEDTD 171 (369)
T ss_pred HHHhh-hhHHHHHHHH----hcchHHHHHHHHHHHHHHHHHHhcceeecccCcccceecc--hhheeeccchhhcccCcc
Confidence 99999 5688888863 3677889999999999999999999999999999999974 669999999999765543
Q ss_pred --CccccccccccCchhhccCCCCCCCcccchhhhhhhhhhhhcCCCCCCCcCcchhHHHHHHHHhcCCCCCCCCCCchh
Q psy11767 529 --LHTPCFTLQYAAPEVLRQDKSGYDENCDLWSLGVILVNVLRQDKSGYDENCDLWSLGVILYTMLCGRVPFHARSRDDS 606 (966)
Q Consensus 529 --~~~~~gT~~Y~APEvl~~~~~~~~~~~Di~SlGvil~el~~~~~~~y~~~~DIWSlGvilyemltG~~Pf~~~~~~~~ 606 (966)
.+..+.|..|+|||++.+ .+|.+.+||||+||++.||++|+.-|.+.+.-++
T Consensus 172 ~~mtpyVvtRyyrapevil~--------------------------~~~ke~vdiwSvGci~gEli~~~Vlf~g~d~idQ 225 (369)
T KOG0665|consen 172 FMMTPYVVTRYYRAPEVILG--------------------------MGYKENVDIWSVGCIMGELILGTVLFPGKDHIDQ 225 (369)
T ss_pred cccCchhheeeccCchheec--------------------------cCCcccchhhhhhhHHHHHhhceEEecCchHHHH
Confidence 334567999999999862 3378899999999999999999999988765444
Q ss_pred HHHHHHHHHcCC-----------------------CC----CCchhh-------ccCCHHHHHHHHHhcccCccccCChH
Q psy11767 607 ALSIMARIKEGQ-----------------------FN----FDAEAW-------STVSSEAKELTKSLLTVNPAQRIRMM 652 (966)
Q Consensus 607 ~~~~~~~i~~~~-----------------------~~----~~~~~~-------~~is~e~~~Li~~~L~~dP~~R~t~~ 652 (966)
...+........ ++ ++...| +.-+..+.+|+.+||..||++|+++.
T Consensus 226 ~~ki~~~lgtpd~~F~~qL~~~~r~yv~~~~~y~~~~f~~~fpD~~f~~~~e~~~~~~~~ardll~~MLvi~pe~Risv~ 305 (369)
T KOG0665|consen 226 WNKIIEQLGTPDPSFMKQLQPTVRNYVENRPQYQAISFSELFPDSLFPVVLEGSKLDCSLARDLLSKMLVIDPEKRISVD 305 (369)
T ss_pred HHHHHHHhcCCCHHHHHHhhHHHHHHhhcChHhhccchhhhCCcccccccccCCccchHHHHHHHHHhhccChhhcccHH
Confidence 333222111000 11 111111 12356789999999999999999998
Q ss_pred HHHHHhhhhHH
Q psy11767 653 RVKLTFHAFHQ 663 (966)
Q Consensus 653 ~v~~~~~~~~~ 663 (966)
++ ..||+.+
T Consensus 306 da--L~HPY~~ 314 (369)
T KOG0665|consen 306 DA--LRHPYIK 314 (369)
T ss_pred HH--hcCCeee
Confidence 65 4466543
|
|
| >smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Probab=99.96 E-value=7.3e-29 Score=262.15 Aligned_cols=231 Identities=38% Similarity=0.643 Sum_probs=190.2
Q ss_pred cccEEEEEEEcCCCcEEEEEEecccc------ChHHHHHHHHHhcCCCCceEEEEEEEeCCeEEEEEEccCCCCHHHHHH
Q psy11767 390 SYSVCRRCVEKSTGQEYAVKIISRKI------DCSEEINLLRACQGHPNIVNLHCVFQDEVHTYLVLELLKGGELLDRIR 463 (966)
Q Consensus 390 ~fG~Vy~a~~~~tg~~vAvK~i~~~~------~~~~Ei~iL~~l~~HpnIV~l~~~~~~~~~~~lVmEy~~gg~L~~~l~ 463 (966)
+||.||+|.+..+|+.+|+|++.... ...+|+..++.+ +|+||+++++++......++||||+.+++|.+++.
T Consensus 1 ~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l-~~~~i~~~~~~~~~~~~~~l~~e~~~~~~L~~~~~ 79 (244)
T smart00220 1 SFGKVYLARDKKTGKLVAIKVIKKEKIKKKRERILREISILKKL-KHPNIVRLYDVFEDEDKLYLVMEYCDGGDLFDLLK 79 (244)
T ss_pred CceEEEEEEECCCCcEEEEEEecccccccHHHHHHHHHHHHHhC-CCCcHHHHHhheeeCCEEEEEEeCCCCCCHHHHHH
Confidence 58999999999999999999986542 345688988888 79999999999999999999999999999999987
Q ss_pred hcCCCCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCcEEEecCCCCCEEEEeecccccccC--CCccccccccccCc
Q psy11767 464 QKGRCGFTENEASRIMRQLVAAVHFMHSRGVVHRDLKPENLLFSDPAGDNIKVVDFGFACLKRE--SLHTPCFTLQYAAP 541 (966)
Q Consensus 464 ~~~~~~l~e~~~~~i~~Qil~aL~yLHs~~IiHRDLKP~NILl~~~~~~~iKL~DFGla~~~~~--~~~~~~gT~~Y~AP 541 (966)
... .+++..+..++.|++.||.|||+.+|+|+||+|+||++++ ++.++|+|||++..... ......++..|++|
T Consensus 80 ~~~--~~~~~~~~~~~~~l~~~l~~lh~~~i~h~~i~~~ni~~~~--~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~p 155 (244)
T smart00220 80 KRG--RLSEDEARFYARQILSALEYLHSNGIIHRDLKPENILLDE--DGHVKLADFGLARQLDPGGLLTTFVGTPEYMAP 155 (244)
T ss_pred hcc--CCCHHHHHHHHHHHHHHHHHHHHcCeecCCcCHHHeEECC--CCcEEEccccceeeeccccccccccCCcCCCCH
Confidence 654 3899999999999999999999999999999999999985 46999999999976544 23445678899999
Q ss_pred hhhccCCCCCCCcccchhhhhhhhhhhhcCCCCCCCcCcchhHHHHHHHHhcCCCCCCCCCCchhHHHHHHHHHcCCCCC
Q psy11767 542 EVLRQDKSGYDENCDLWSLGVILVNVLRQDKSGYDENCDLWSLGVILYTMLCGRVPFHARSRDDSALSIMARIKEGQFNF 621 (966)
Q Consensus 542 Evl~~~~~~~~~~~Di~SlGvil~el~~~~~~~y~~~~DIWSlGvilyemltG~~Pf~~~~~~~~~~~~~~~i~~~~~~~ 621 (966)
|.+.. ..++.++||||+|+++++|++|..||...... ..+...+..+....
T Consensus 156 E~~~~--------------------------~~~~~~~Di~slG~~l~~l~~~~~p~~~~~~~---~~~~~~~~~~~~~~ 206 (244)
T smart00220 156 EVLLG--------------------------KGYGKAVDVWSLGVILYELLTGKPPFPGDDQL---LELFKKIGKPKPPF 206 (244)
T ss_pred HHHcc--------------------------CCCCchhhHHHHHHHHHHHHhCCCCCCCCCcH---HHHHHHHhccCCCC
Confidence 98742 23577899999999999999999999763322 23344444444433
Q ss_pred CchhhccCCHHHHHHHHHhcccCccccCChHHHH
Q psy11767 622 DAEAWSTVSSEAKELTKSLLTVNPAQRIRMMRVK 655 (966)
Q Consensus 622 ~~~~~~~is~e~~~Li~~~L~~dP~~R~t~~~v~ 655 (966)
.. .+..++.++.+++.+||..||++||++.++.
T Consensus 207 ~~-~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~~ 239 (244)
T smart00220 207 PP-PEWKISPEAKDLIRKLLVKDPEKRLTAEEAL 239 (244)
T ss_pred cc-ccccCCHHHHHHHHHHccCCchhccCHHHHh
Confidence 22 1222788999999999999999999998774
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. |
| >KOG0576|consensus | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.1e-30 Score=297.20 Aligned_cols=249 Identities=26% Similarity=0.443 Sum_probs=200.7
Q ss_pred cccccccccccccEEEEEEEcCCCcEEEEEEecccc-----ChHHHHHHHHHhcCCCCceEEEEEEEeCCeEEEEEEccC
Q psy11767 380 LDKAGILGDGSYSVCRRCVEKSTGQEYAVKIISRKI-----DCSEEINLLRACQGHPNIVNLHCVFQDEVHTYLVLELLK 454 (966)
Q Consensus 380 ~~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~-----~~~~Ei~iL~~l~~HpnIV~l~~~~~~~~~~~lVmEy~~ 454 (966)
|+.+..+|.|+||.||+|+++.+++..|+|+++..- ....||-+++.+. |||||-|++.+.....+|++||||.
T Consensus 17 yellqrvgsgTygdvyKaRd~~s~elaavkvVkLep~dd~~~iqqei~~~~dc~-h~nivay~gsylr~dklwicMEycg 95 (829)
T KOG0576|consen 17 YELLQRVGSGTYGDVYKARDKRSGELAAVKVVKLEPGDDFSGIQQEIGMLRDCR-HPNIVAYFGSYLRRDKLWICMEYCG 95 (829)
T ss_pred hhheeeecCCcccchhhhcccccCchhhheeeeccCCccccccccceeeeecCC-CcChHHHHhhhhhhcCcEEEEEecC
Confidence 344678999999999999999999999999997542 2457899999985 9999999999999999999999999
Q ss_pred CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCcEEEecCCCCCEEEEeecccccccC---CCcc
Q psy11767 455 GGELLDRIRQKGRCGFTENEASRIMRQLVAAVHFMHSRGVVHRDLKPENLLFSDPAGDNIKVVDFGFACLKRE---SLHT 531 (966)
Q Consensus 455 gg~L~~~l~~~~~~~l~e~~~~~i~~Qil~aL~yLHs~~IiHRDLKP~NILl~~~~~~~iKL~DFGla~~~~~---~~~~ 531 (966)
||+|.+.-+-.+ +++|.++...+++.+.||+|||++|=+|||||-.|||+.+ .+.+|++|||.+..... ....
T Consensus 96 ggslQdiy~~Tg--plselqiayvcRetl~gl~ylhs~gk~hRdiKGanilltd--~gDvklaDfgvsaqitati~Krks 171 (829)
T KOG0576|consen 96 GGSLQDIYHVTG--PLSELQIAYVCRETLQGLKYLHSQGKIHRDIKGANILLTD--EGDVKLADFGVSAQITATIAKRKS 171 (829)
T ss_pred CCcccceeeecc--cchhHHHHHHHhhhhccchhhhcCCcccccccccceeecc--cCceeecccCchhhhhhhhhhhhc
Confidence 999988765544 6999999999999999999999999999999999999986 56999999999866543 2356
Q ss_pred ccccccccCchhhccCCCCCCCcccchhhhhhhhhhhhcCCCCCCCcCcchhHHHHHHHHhcCCCCCCCCCCchhHHHHH
Q psy11767 532 PCFTLQYAAPEVLRQDKSGYDENCDLWSLGVILVNVLRQDKSGYDENCDLWSLGVILYTMLCGRVPFHARSRDDSALSIM 611 (966)
Q Consensus 532 ~~gT~~Y~APEvl~~~~~~~~~~~Di~SlGvil~el~~~~~~~y~~~~DIWSlGvilyemltG~~Pf~~~~~~~~~~~~~ 611 (966)
+.|||+|||||+-.-+ .+.+|...+|||++|+...|+-.-++|........ . +
T Consensus 172 fiGtpywmapEvaave-----------------------rkggynqlcdiwa~gitAiel~eLqpplfdlhpmr---~-l 224 (829)
T KOG0576|consen 172 FIGTPYWMAPEVAAVE-----------------------RKGGYNQLCDIWALGITAIELGELQPPLFDLHPMR---A-L 224 (829)
T ss_pred ccCCccccchhHHHHH-----------------------hcccccccccccccccchhhhhhcCCcccccchHH---H-H
Confidence 7899999999987432 24579999999999999999988888876654421 1 1
Q ss_pred HHHHcCCCC-CCchhhccCCHHHHHHHHHhcccCccccCChHHHHHHhhhhH
Q psy11767 612 ARIKEGQFN-FDAEAWSTVSSEAKELTKSLLTVNPAQRIRMMRVKLTFHAFH 662 (966)
Q Consensus 612 ~~i~~~~~~-~~~~~~~~is~e~~~Li~~~L~~dP~~R~t~~~v~~~~~~~~ 662 (966)
.......|. +..+.-...++-+-+|++.+|..||++||++..+ ..|+|.
T Consensus 225 ~LmTkS~~qpp~lkDk~kws~~fh~fvK~altknpKkRptaekl--L~h~fv 274 (829)
T KOG0576|consen 225 FLMTKSGFQPPTLKDKTKWSEFFHNFVKGALTKNPKKRPTAEKL--LQHPFV 274 (829)
T ss_pred HHhhccCCCCCcccCCccchHHHHHHHHHHhcCCCccCCChhhh--eeceee
Confidence 112222222 2222234568899999999999999999998743 225553
|
|
| >KOG0200|consensus | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.5e-28 Score=297.57 Aligned_cols=242 Identities=25% Similarity=0.434 Sum_probs=196.3
Q ss_pred cccccccccEEEEEEEcC-------CCcEEEEEEeccccC------hHHHHHHHHHhcCCCCceEEEEEEEeCCeEEEEE
Q psy11767 384 GILGDGSYSVCRRCVEKS-------TGQEYAVKIISRKID------CSEEINLLRACQGHPNIVNLHCVFQDEVHTYLVL 450 (966)
Q Consensus 384 ~~LG~G~fG~Vy~a~~~~-------tg~~vAvK~i~~~~~------~~~Ei~iL~~l~~HpnIV~l~~~~~~~~~~~lVm 450 (966)
+.||+|.||+|++|.-.. ....||||.++.... ...|+++|+.+..|||||.|++++...+.+++|+
T Consensus 302 ~~lg~g~fG~v~~~~~~~~~~~~~~~~~~VaVK~~k~~~~~~~~~~~~~El~~m~~~g~H~niv~llG~~t~~~~~~~v~ 381 (609)
T KOG0200|consen 302 KYLGEGAFGQVVKALLFGLSKALLSIYVTVAVKMLKENASSSEKKDLMSELNVLKELGKHPNIVNLLGACTQDGPLYVIV 381 (609)
T ss_pred ceeecccccceEeEEEeecccccccceEEEEEEecccccCcHHHHHHHHHHHHHHHhcCCcchhhheeeeccCCceEEEE
Confidence 489999999999997431 146799999875432 4569999999989999999999999999999999
Q ss_pred EccCCCCHHHHHHhcC------C--------CCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCcEEEecCCCCCEEE
Q psy11767 451 ELLKGGELLDRIRQKG------R--------CGFTENEASRIMRQLVAAVHFMHSRGVVHRDLKPENLLFSDPAGDNIKV 516 (966)
Q Consensus 451 Ey~~gg~L~~~l~~~~------~--------~~l~e~~~~~i~~Qil~aL~yLHs~~IiHRDLKP~NILl~~~~~~~iKL 516 (966)
|||..|+|.++++.+. . ..++..+...++.||+.|++||++.++|||||-..|||+.. +..+||
T Consensus 382 Ey~~~G~L~~~Lr~~r~~~~~~~~~~~~~~~~~L~~~dLlsfa~QIa~GMe~L~~~~~vHRDLAaRNVLi~~--~~~~kI 459 (609)
T KOG0200|consen 382 EYAEHGDLLEFLRKKRVTESIDGSGVFPNERDALTTKDLLSFAYQIANGMEYLASVPCVHRDLAARNVLITK--NKVIKI 459 (609)
T ss_pred EeccCCcHHHHHHhccccccccccCCCccccCCcCHHHHHHHHHHHHHHHHHHhhCCccchhhhhhhEEecC--CCEEEE
Confidence 9999999999998765 0 13899999999999999999999999999999999999985 458999
Q ss_pred EeecccccccCC-C---cccc--ccccccCchhhccCCCCCCCcccchhhhhhhhhhhhcCCCCCCCcCcchhHHHHHHH
Q psy11767 517 VDFGFACLKRES-L---HTPC--FTLQYAAPEVLRQDKSGYDENCDLWSLGVILVNVLRQDKSGYDENCDLWSLGVILYT 590 (966)
Q Consensus 517 ~DFGla~~~~~~-~---~~~~--gT~~Y~APEvl~~~~~~~~~~~Di~SlGvil~el~~~~~~~y~~~~DIWSlGvilye 590 (966)
+|||+|+..... . .... ....|||||.+.. .-|+.++||||+||+|||
T Consensus 460 aDFGlar~~~~~~~y~~~~~~~~LP~kWmApEsl~~--------------------------~~ft~kSDVWSfGI~L~E 513 (609)
T KOG0200|consen 460 ADFGLARDHYNKDYYRTKSSAGTLPVKWMAPESLFD--------------------------RVFTSKSDVWSFGILLWE 513 (609)
T ss_pred ccccceeccCCCCceEecCCCCccceeecCHHHhcc--------------------------CcccccchhhHHHHHHHH
Confidence 999999853321 1 1112 2446999999853 347899999999999999
Q ss_pred Hhc-CCCCCCCCCCchhHHHHHHHHHcCCCCCCchhhccCCHHHHHHHHHhcccCccccCChHHHHHHhh
Q psy11767 591 MLC-GRVPFHARSRDDSALSIMARIKEGQFNFDAEAWSTVSSEAKELTKSLLTVNPAQRIRMMRVKLTFH 659 (966)
Q Consensus 591 mlt-G~~Pf~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~is~e~~~Li~~~L~~dP~~R~t~~~v~~~~~ 659 (966)
|.+ |..||.+.... ..++..++.|.-...+ ...+.++-++++.||..+|++||+..++...+.
T Consensus 514 ifsLG~~PYp~~~~~---~~l~~~l~~G~r~~~P---~~c~~eiY~iM~~CW~~~p~~RP~F~~~~~~~~ 577 (609)
T KOG0200|consen 514 IFTLGGTPYPGIPPT---EELLEFLKEGNRMEQP---EHCSDEIYDLMKSCWNADPEDRPTFSECVEFFE 577 (609)
T ss_pred HhhCCCCCCCCCCcH---HHHHHHHhcCCCCCCC---CCCCHHHHHHHHHHhCCCcccCCCHHHHHHHHH
Confidence 987 89999874322 2345677777654333 346899999999999999999999998755443
|
|
| >KOG2052|consensus | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.2e-28 Score=270.79 Aligned_cols=250 Identities=22% Similarity=0.387 Sum_probs=186.1
Q ss_pred ccccccccccEEEEEEEcCCCcEEEEEEeccccC--hHHHHHHHHH-hcCCCCceEEEEEEEeC----CeEEEEEEccCC
Q psy11767 383 AGILGDGSYSVCRRCVEKSTGQEYAVKIISRKID--CSEEINLLRA-CQGHPNIVNLHCVFQDE----VHTYLVLELLKG 455 (966)
Q Consensus 383 ~~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~~--~~~Ei~iL~~-l~~HpnIV~l~~~~~~~----~~~~lVmEy~~g 455 (966)
.+.||+|-||.||+|+.+ |+.||||++....+ ..+|.+|.+. +..|+||..++..-..+ .++|||.+|-+.
T Consensus 216 ~e~IGkGRyGEVwrG~wr--Ge~VAVKiF~srdE~SWfrEtEIYqTvmLRHENILgFIaaD~~~~gs~TQLwLvTdYHe~ 293 (513)
T KOG2052|consen 216 QEIIGKGRFGEVWRGRWR--GEDVAVKIFSSRDERSWFRETEIYQTVMLRHENILGFIAADNKDNGSWTQLWLVTDYHEH 293 (513)
T ss_pred EEEecCccccceeecccc--CCceEEEEecccchhhhhhHHHHHHHHHhccchhhhhhhccccCCCceEEEEEeeecccC
Confidence 578999999999999876 88999999975543 4567777663 33699999999876543 368999999999
Q ss_pred CCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhc--------CceeccCCCCcEEEecCCCCCEEEEeecccccccC
Q psy11767 456 GELLDRIRQKGRCGFTENEASRIMRQLVAAVHFMHSR--------GVVHRDLKPENLLFSDPAGDNIKVVDFGFACLKRE 527 (966)
Q Consensus 456 g~L~~~l~~~~~~~l~e~~~~~i~~Qil~aL~yLHs~--------~IiHRDLKP~NILl~~~~~~~iKL~DFGla~~~~~ 527 (966)
|+|+|||.+. .++.+...+++.-+++||++||-. .|.|||||..|||+.. ++..-|+|+|||.....
T Consensus 294 GSL~DyL~r~---tv~~~~ml~LalS~AsGLaHLH~eI~GTqgKPaIAHRDlKSKNILVKk--n~~C~IADLGLAv~h~~ 368 (513)
T KOG2052|consen 294 GSLYDYLNRN---TVTTEGMLKLALSIASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKK--NGTCCIADLGLAVRHDS 368 (513)
T ss_pred CcHHHHHhhc---cCCHHHHHHHHHHHhhhHHHHHHHHhcCCCCchhhccccccccEEEcc--CCcEEEeeceeeEEecc
Confidence 9999999874 599999999999999999999953 4999999999999984 67999999999965432
Q ss_pred -------CCccccccccccCchhhccCCCCCCCcccchhhhhhhhhhhhcCCCCCCCcCcchhHHHHHHHHhc-------
Q psy11767 528 -------SLHTPCFTLQYAAPEVLRQDKSGYDENCDLWSLGVILVNVLRQDKSGYDENCDLWSLGVILYTMLC------- 593 (966)
Q Consensus 528 -------~~~~~~gT~~Y~APEvl~~~~~~~~~~~Di~SlGvil~el~~~~~~~y~~~~DIWSlGvilyemlt------- 593 (966)
..+..+||-.|||||+|...-.. -.. ..| ..+||||||.|+||++-
T Consensus 369 ~t~~idi~~N~rVGTKRYMAPEvLdetin~------------~~F-------esy-k~ADIYafgLVlWEiarRc~~ggi 428 (513)
T KOG2052|consen 369 DTDTIDIPPNPRVGTKRYMAPEVLDETINM------------KHF-------ESY-KRADIYAFGLVLWEIARRCESGGI 428 (513)
T ss_pred cCCcccCCCCCccceeeccChHHhhhhcCh------------hhh-------hhh-hHHHHHHHHHHHHHHHHHhhcCCE
Confidence 23567899999999999642110 000 011 24789999999998852
Q ss_pred ---CCCCCCCCCCchhHHHHHHHH---HcCCCCCCchhhccC--CHHHHHHHHHhcccCccccCChHHHHHHhhh
Q psy11767 594 ---GRVPFHARSRDDSALSIMARI---KEGQFNFDAEAWSTV--SSEAKELTKSLLTVNPAQRIRMMRVKLTFHA 660 (966)
Q Consensus 594 ---G~~Pf~~~~~~~~~~~~~~~i---~~~~~~~~~~~~~~i--s~e~~~Li~~~L~~dP~~R~t~~~v~~~~~~ 660 (966)
-++||.+....+...+.|.++ .+-..+ .+..|... -..+-.||+.||..||..|.|+..++..+..
T Consensus 429 ~eey~~Pyyd~Vp~DPs~eeMrkVVCv~~~RP~-ipnrW~s~~~l~~m~klMkeCW~~Np~aRltALriKKtl~~ 502 (513)
T KOG2052|consen 429 VEEYQLPYYDVVPSDPSFEEMRKVVCVQKLRPN-IPNRWKSDPALRVMAKLMKECWYANPAARLTALRIKKTLAK 502 (513)
T ss_pred ehhhcCCcccCCCCCCCHHHHhcceeecccCCC-CCcccccCHHHHHHHHHHHHhhcCCchhhhHHHHHHHHHHH
Confidence 258998776655545555442 121111 12334322 1234578999999999999999888766554
|
|
| >KOG1167|consensus | Back alignment and domain information |
|---|
Probab=99.96 E-value=7.2e-29 Score=272.22 Aligned_cols=253 Identities=29% Similarity=0.424 Sum_probs=192.9
Q ss_pred cccccccccccccEEEEEEEcC---CCcEEEEEEeccccC---hHHHHHHHHHhcCCCCceEEEEEEEeCCeEEEEEEcc
Q psy11767 380 LDKAGILGDGSYSVCRRCVEKS---TGQEYAVKIISRKID---CSEEINLLRACQGHPNIVNLHCVFQDEVHTYLVLELL 453 (966)
Q Consensus 380 ~~~~~~LG~G~fG~Vy~a~~~~---tg~~vAvK~i~~~~~---~~~Ei~iL~~l~~HpnIV~l~~~~~~~~~~~lVmEy~ 453 (966)
|..+.+||.|+|++||+|.+.. .++.||+|.+..... ...|+++|..+.++.||+++.+++..++...+||||+
T Consensus 38 ~~~v~kigeGsFssv~~a~~~~~~~~~~~valk~i~~ts~p~ri~~El~~L~~~gG~~ni~~~~~~~rnnd~v~ivlp~~ 117 (418)
T KOG1167|consen 38 YKVVNKIGEGSFSSVYKATDIEQDTKRRYVALKAIYRTSSPSRILNELEMLYRLGGSDNIIKLNGCFRNNDQVAIVLPYF 117 (418)
T ss_pred hhhhccccccchhhhhhhhHhhhccccceEeeeecccccCchHHHHHHHHHHHhccchhhhcchhhhccCCeeEEEeccc
Confidence 3346889999999999999988 789999999876543 5679999999999999999999999999999999999
Q ss_pred CCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCcEEEecCCCCCEEEEeecccccc--------
Q psy11767 454 KGGELLDRIRQKGRCGFTENEASRIMRQLVAAVHFMHSRGVVHRDLKPENLLFSDPAGDNIKVVDFGFACLK-------- 525 (966)
Q Consensus 454 ~gg~L~~~l~~~~~~~l~e~~~~~i~~Qil~aL~yLHs~~IiHRDLKP~NILl~~~~~~~iKL~DFGla~~~-------- 525 (966)
+..+..+++.. ++..+++.+++.++.||.++|.+|||||||||+|+|.+. ..+.-.|+|||||...
T Consensus 118 ~H~~f~~l~~~-----l~~~~i~~Yl~~ll~Al~~~h~~GIvHRDiKpsNFL~n~-~t~rg~LvDFgLA~~~d~~~~~~~ 191 (418)
T KOG1167|consen 118 EHDRFRDLYRS-----LSLAEIRWYLRNLLKALAHLHKNGIVHRDIKPSNFLYNR-RTQRGVLVDFGLAQRYDGYQQTEH 191 (418)
T ss_pred CccCHHHHHhc-----CCHHHHHHHHHHHHHHhhhhhccCccccCCCcccccccc-ccCCceEEechhHHHHHhhhhhhh
Confidence 88887777643 778999999999999999999999999999999999965 3457789999998510
Q ss_pred ---------cC---------C---------------------CccccccccccCchhhccCCCCCCCcccchhhhhhhhh
Q psy11767 526 ---------RE---------S---------------------LHTPCFTLQYAAPEVLRQDKSGYDENCDLWSLGVILVN 566 (966)
Q Consensus 526 ---------~~---------~---------------------~~~~~gT~~Y~APEvl~~~~~~~~~~~Di~SlGvil~e 566 (966)
.. . .....||++|+|||++....
T Consensus 192 s~~~~~~~~~~~~g~~~~~~~~~~~~~p~g~~~~~~~~r~~~~anrAGT~GfRaPEvL~k~~------------------ 253 (418)
T KOG1167|consen 192 SRSYSGRHATPAMGKDVHCQSVATASKPAGYYRRCNDGRPSERANRAGTPGFRAPEVLFRCP------------------ 253 (418)
T ss_pred hhhhhcccCCccccCcccccccccccCCCCceeccCCCccceecccCCCCCCCchHHHhhcc------------------
Confidence 00 0 00135799999999996432
Q ss_pred hhhcCCCCCCCcCcchhHHHHHHHHhcCCCCCCCCCCchhHHHHHHHH-----------HcCC------CC---------
Q psy11767 567 VLRQDKSGYDENCDLWSLGVILYTMLCGRVPFHARSRDDSALSIMARI-----------KEGQ------FN--------- 620 (966)
Q Consensus 567 l~~~~~~~y~~~~DIWSlGvilyemltG~~Pf~~~~~~~~~~~~~~~i-----------~~~~------~~--------- 620 (966)
.-++++||||.|||+..+++++.||.....+-.+..-+..| ..|. -+
T Consensus 254 -------~QttaiDiws~GVI~Lslls~~~PFf~a~dd~~al~ei~tifG~~~mrk~A~l~g~~~l~~ksn~~~~~e~~~ 326 (418)
T KOG1167|consen 254 -------RQTTAIDIWSAGVILLSLLSRRYPFFKAKDDADALAEIATIFGSAEMRKCAALPGRILLWQKSNIPTIPELRV 326 (418)
T ss_pred -------CcCCccceeeccceeehhhccccccccCccccchHHHHHHHhChHHHHHHhhcCCceeeeccccccccHHHHh
Confidence 23678899999999999999999987654432222211111 0111 00
Q ss_pred -----------------CCchhhcc-CCHHHHHHHHHhcccCccccCChHHHHHHhhhhHHhh
Q psy11767 621 -----------------FDAEAWST-VSSEAKELTKSLLTVNPAQRIRMMRVKLTFHAFHQAQ 665 (966)
Q Consensus 621 -----------------~~~~~~~~-is~e~~~Li~~~L~~dP~~R~t~~~v~~~~~~~~~~~ 665 (966)
...+.|.. .+..+.||+.+||+.||.+|+|+.+. ..|+|+...
T Consensus 327 ~f~s~~~~~~~~~~q~n~~~~~~~d~~~~~~~dlLdk~le~np~kRitAEeA--LkHpFF~~~ 387 (418)
T KOG1167|consen 327 NFETLHIESIYKSRQPNTEREIGSDVFPALLLDLLDKCLELNPQKRITAEDA--LKHPFFDEA 387 (418)
T ss_pred chhccChhhcccccccceeeccccccccHHHHHHHHHHccCChhhcccHHHH--hcCcCCcch
Confidence 01112222 34578899999999999999999864 567776543
|
|
| >KOG0590|consensus | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.5e-29 Score=303.30 Aligned_cols=463 Identities=23% Similarity=0.328 Sum_probs=299.3
Q ss_pred cCCcceeeeecccccceEEEEEE-cCCCCEEEEEeccccc-------hhhHHHHHHHHhhCCCcccccc-----------
Q psy11767 115 DMDLDKAGILGDGSYSVCRRCVE-KSTGQEYAVKIISRKI-------DCSEEINLLRACQGHPNICRRC----------- 175 (966)
Q Consensus 115 ~~df~~~~~LG~GsFGkV~La~~-k~tg~~yAiKvl~K~~-------~~~~E~~il~~~~~~pfi~~~~----------- 175 (966)
...|.+.+.||+|+||.|.++.. +.+...+|+|.++... ++..|..+-.++..|+.+++..
T Consensus 19 ~~~~~~~~~ig~gs~~~~~~~~~~~~~~~~~a~~~~s~~~~~~~~~~~i~~e~~~~~~~s~h~n~~~~~~~~~~~~~~~~ 98 (601)
T KOG0590|consen 19 NSQYKLSRSIGKGSFSSSALASNSRDPESSSATKPISIPPKSEDSSEHIDTETDIQKKLSKHSNTVHMIEPSSSPRSYLL 98 (601)
T ss_pred cccccccccccccccchhhhhhhcCCCcceeeccCCCCCCCccchhhhcCccccccccccccccccccCCccCCCccccc
Confidence 44668899999999999999987 6777788999887531 2344555444555577776510
Q ss_pred ----------cc-----------cccchhHHHHHHHh-----------hcccchhhhHhhhccC-CceEEecCcccc---
Q psy11767 176 ----------VE-----------KSTGQEYAVKIISR-----------KIDCSEEINLLRACQG-HPNIVNLHCVFQ--- 219 (966)
Q Consensus 176 ----------~~-----------~~~~~~~~~~~v~~-----------~~~~~~e~nil~~~~g-h~~iv~l~~~~~--- 219 (966)
+. ...++.|+.+.+.. ..+.+++ |.+++..| ..++.|++.+..
T Consensus 99 ~~~~s~g~~~f~~i~~~~~~~~~~~~~~~~~~ql~s~l~~~H~~~~~~h~~ikP~-n~~l~~s~~~l~~~df~~At~~~~ 177 (601)
T KOG0590|consen 99 SLSYSDGGSLFSKISHPDSTGTSSSSASRYLPQLNSGLSYLHPENGVTHRDIKPS-NSLLDESGSALKIADFGLATAYRN 177 (601)
T ss_pred ccCcccccccccccccCCccCCCCcchhhhhhhhccCccccCcccccccCCCCCc-cchhccCCCcccCCCchhhccccc
Confidence 11 11123444333222 1345667 89998888 778888765522
Q ss_pred -c-------------------cccccccCCCcceeeechhhHHHHHHHhhCCCCCCCCcHH-HHHHHHHhC----CCCCC
Q psy11767 220 -D-------------------EVIDWDDFSRGIECVFFSSSLIIFFIILSFTLSFIHDYYH-IQYRRILKT----EPPIP 274 (966)
Q Consensus 220 -~-------------------e~i~~~~y~~~~d~~~~~~~~il~~~m~~g~~pf~~~~~~-~~~~~I~~~----~~~~P 274 (966)
+ |+.....|. +.-.+.|+. |+++.-|+.|..|....... .-|-.-... ....+
T Consensus 178 ~~g~~~~~~~~~g~s~~y~a~E~~~~~~~~-~~~~d~~S~-g~~l~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 255 (601)
T KOG0590|consen 178 KNGAERSLKDRCGSSPPYGAPEHLSGKAYR-GPSVDVWSL-GIVLSAMLTGELPWDFPSRKDGRYSSWKSNKGRFTQLPW 255 (601)
T ss_pred cCCcceeeecccCCCCCCCCcccccchhhc-CCCcccccc-cccccccccCCCCccccccccccceeecccccccccCcc
Confidence 1 111110111 111223554 45555555666555432221 112222221 35566
Q ss_pred CCCCHHHHHHHHhhcccCCCcccCCCCCCHHHHhcCCceeeeCccccccCCCCCCCCccccccccccccccccccCcCCC
Q psy11767 275 EDLSPDVADFISRLLVKDPRRRLGGGELDAEELKRHPFFNVIDWDDLATKRIPAPFVPKISNELDVSNFSDEFTKMIPAD 354 (966)
Q Consensus 275 ~~~s~~a~dli~~LL~kdp~~RLG~~~~g~~~Ik~HpfF~~idW~~l~~k~~~pP~~P~i~~~~D~snFd~ef~~~~p~d 354 (966)
..++..+.+++.+.|..+|..|++ .++++.+||+.. |.. ...... ...+. .....
T Consensus 256 ~~~~~~~~~~l~k~l~~~~~~r~s-----~~~~~~d~~~~~--~~~---~~~~~n-----------~~~~~----~~~~~ 310 (601)
T KOG0590|consen 256 NSISDQAHDLLHKILKENPSNRLS-----IEELKLDNWLSS--KRN---GFSKSN-----------PCADS----LTIAK 310 (601)
T ss_pred ccCChhhhhcccccccCCchhccc-----cccccccccccc--ccc---cccccc-----------ccccc----ccccc
Confidence 789999999999999999999985 689999999976 100 000000 00000 00011
Q ss_pred CCCCCCCCCcccccccceecccccccccccccccccccEEEEEEEcCCCcEEEEEEecc---ccChHH--------HHHH
Q psy11767 355 SPAIVPPNFDKIFKGSLFFEQYDMDLDKAGILGDGSYSVCRRCVEKSTGQEYAVKIISR---KIDCSE--------EINL 423 (966)
Q Consensus 355 Sp~ivp~~~d~if~G~~~~~~~~i~~~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~---~~~~~~--------Ei~i 423 (966)
.+ ..|.+.|.. ...++|.|+||.|+.+........++.|.... ..+..+ |..+
T Consensus 311 ~~-------------~~~~~~y~~---~~~~~g~ga~g~~~~~~~~~~~~~~~~~~~r~~~~~~~s~~~~~~~i~sE~~i 374 (601)
T KOG0590|consen 311 SP-------------IGFSEKYGK---PGRVLGSGAYGSVRIAKRRSDLKSFPEKEFRVRVKPTESERKYNYNITSEFCI 374 (601)
T ss_pred Cc-------------cccccccCC---ccceeeecccCceEEEEecCCCccchhhhhhcccCCcccHHHHhhhhhhheee
Confidence 10 112222322 24689999999888888887777777775431 111111 2212
Q ss_pred HHHhcCCCCceEEEEEEEeCCeEEEEEEccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCc
Q psy11767 424 LRACQGHPNIVNLHCVFQDEVHTYLVLELLKGGELLDRIRQKGRCGFTENEASRIMRQLVAAVHFMHSRGVVHRDLKPEN 503 (966)
Q Consensus 424 L~~l~~HpnIV~l~~~~~~~~~~~lVmEy~~gg~L~~~l~~~~~~~l~e~~~~~i~~Qil~aL~yLHs~~IiHRDLKP~N 503 (966)
=..+ .|||++..+..+.+....+-+||||++ ||+..+...+ .++..++..++.|++.||+|||+.||.||||||+|
T Consensus 375 ~~~l-~h~~~~e~l~~~~~~~~~~~~mE~~~~-Dlf~~~~~~~--~~~~~e~~c~fKqL~~Gv~y~h~~GiahrdlK~en 450 (601)
T KOG0590|consen 375 GSSL-SHPNIIETLDIVQEIDGILQSMEYCPY-DLFSLVMSNG--KLTPLEADCFFKQLLRGVKYLHSMGLAHRDLKLEN 450 (601)
T ss_pred cccc-cCCchhhhHHHHhhcccchhhhhcccH-HHHHHHhccc--ccchhhhhHHHHHHHHHHHHHHhcCceeccCcccc
Confidence 2223 699998877666665555556999999 9999998764 48899999999999999999999999999999999
Q ss_pred EEEecCCCCCEEEEeecccccccCC-------CccccccccccCchhhccCCCCCCCcccchhhhhhhhhhhhcCCCCCC
Q psy11767 504 LLFSDPAGDNIKVVDFGFACLKRES-------LHTPCFTLQYAAPEVLRQDKSGYDENCDLWSLGVILVNVLRQDKSGYD 576 (966)
Q Consensus 504 ILl~~~~~~~iKL~DFGla~~~~~~-------~~~~~gT~~Y~APEvl~~~~~~~~~~~Di~SlGvil~el~~~~~~~y~ 576 (966)
+|+.. ++.+||+|||.+..+... ....+|+..|+|||++... .|+
T Consensus 451 ll~~~--~g~lki~Dfg~~~vf~~~~e~~~~~~~g~~gS~pY~apE~~~~~--------------------------~yd 502 (601)
T KOG0590|consen 451 LLVTE--NGILKIIDFGAASVFRYPWEKNIHESSGIVGSDPYLAPEVLTGK--------------------------EYD 502 (601)
T ss_pred EEEec--CCceEEeecCcceeeccCcchhhhhhcCcccCCcCcCccccccc--------------------------ccC
Confidence 99984 569999999998654321 2356789999999998532 344
Q ss_pred C-cCcchhHHHHHHHHhcCCCCCCCCCCchhHHHHHHHHHcCCCC---CCchhhccCCHHHHHHHHHhcccCccccCChH
Q psy11767 577 E-NCDLWSLGVILYTMLCGRVPFHARSRDDSALSIMARIKEGQFN---FDAEAWSTVSSEAKELTKSLLTVNPAQRIRMM 652 (966)
Q Consensus 577 ~-~~DIWSlGvilyemltG~~Pf~~~~~~~~~~~~~~~i~~~~~~---~~~~~~~~is~e~~~Li~~~L~~dP~~R~t~~ 652 (966)
+ .+||||.|++++.|++|+.||......+... ......+.++ -....+..++.+.+.+|.+||+.||.+|+|+.
T Consensus 503 pr~vDiwS~~ii~~~m~~~~~~Wk~a~~~~~~~--~~~~~~~~~~~~~~~~~~~~~lp~~~~~~~~~~l~~~P~~R~ti~ 580 (601)
T KOG0590|consen 503 PRAVDVWSCGIIYICMILGRFPWKVAKKSDNSF--KTNNYSDQRNIFEGPNRLLSLLPRETRIIIYRMLQLDPTKRITIE 580 (601)
T ss_pred cchhhhhhccceEEEEecCCCccccccccccch--hhhccccccccccChHHHHHhchhhHHHHHHHHccCChhheecHH
Confidence 3 6899999999999999999998766544321 1111111111 11234567888999999999999999999999
Q ss_pred HHH
Q psy11767 653 RVK 655 (966)
Q Consensus 653 ~v~ 655 (966)
++.
T Consensus 581 ~i~ 583 (601)
T KOG0590|consen 581 QIL 583 (601)
T ss_pred HHh
Confidence 873
|
|
| >KOG1025|consensus | Back alignment and domain information |
|---|
Probab=99.95 E-value=8.2e-29 Score=286.38 Aligned_cols=243 Identities=22% Similarity=0.402 Sum_probs=193.2
Q ss_pred cccccccccccccEEEEEEEcCCCc----EEEEEEecccc------ChHHHHHHHHHhcCCCCceEEEEEEEeCCeEEEE
Q psy11767 380 LDKAGILGDGSYSVCRRCVEKSTGQ----EYAVKIISRKI------DCSEEINLLRACQGHPNIVNLHCVFQDEVHTYLV 449 (966)
Q Consensus 380 ~~~~~~LG~G~fG~Vy~a~~~~tg~----~vAvK~i~~~~------~~~~Ei~iL~~l~~HpnIV~l~~~~~~~~~~~lV 449 (966)
..+.++||+|+||+||+|...-.|+ +||||++.... ...+|+-+|.++ +|||+++|++++.... +.||
T Consensus 698 lkk~kvLGsgAfGtV~kGiw~Pege~vKipVaiKvl~~~t~~~~s~e~LdeAl~masl-dHpnl~RLLgvc~~s~-~qlv 775 (1177)
T KOG1025|consen 698 LKKDKVLGSGAFGTVYKGIWIPEGENVKIPVAIKVLIEFTSPKASIELLDEALRMASL-DHPNLLRLLGVCMLST-LQLV 775 (1177)
T ss_pred hhhhceeccccceeEEeeeEecCCceecceeEEEEeeccCCchhhHHHHHHHHHHhcC-CCchHHHHhhhcccch-HHHH
Confidence 3456899999999999998876554 68999885432 244677777777 6999999999998876 8899
Q ss_pred EEccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCcEEEecCCCCCEEEEeecccccccCCC
Q psy11767 450 LELLKGGELLDRIRQKGRCGFTENEASRIMRQLVAAVHFMHSRGVVHRDLKPENLLFSDPAGDNIKVVDFGFACLKRESL 529 (966)
Q Consensus 450 mEy~~gg~L~~~l~~~~~~~l~e~~~~~i~~Qil~aL~yLHs~~IiHRDLKP~NILl~~~~~~~iKL~DFGla~~~~~~~ 529 (966)
++|++.|.|.++++.+.. .+-....+.|..||++||.|||+++++||||-..|+|+..+ ..+||.|||+|+......
T Consensus 776 tq~mP~G~LlDyvr~hr~-~igsq~lLnw~~QIAkgM~YLe~qrlVHrdLaaRNVLVksP--~hvkitdfgla~ll~~d~ 852 (1177)
T KOG1025|consen 776 TQLMPLGCLLDYVREHRD-NIGSQDLLNWCYQIAKGMKYLEEQRLVHRDLAARNVLVKSP--NHVKITDFGLAKLLAPDE 852 (1177)
T ss_pred HHhcccchHHHHHHHhhc-cccHHHHHHHHHHHHHHHHHHHhcchhhhhhhhhheeecCC--CeEEEEecchhhccCccc
Confidence 999999999999988654 68899999999999999999999999999999999999864 499999999998754322
Q ss_pred ---ccc--cccccccCchhhccCCCCCCCcccchhhhhhhhhhhhcCCCCCCCcCcchhHHHHHHHHhc-CCCCCCCCCC
Q psy11767 530 ---HTP--CFTLQYAAPEVLRQDKSGYDENCDLWSLGVILVNVLRQDKSGYDENCDLWSLGVILYTMLC-GRVPFHARSR 603 (966)
Q Consensus 530 ---~~~--~gT~~Y~APEvl~~~~~~~~~~~Di~SlGvil~el~~~~~~~y~~~~DIWSlGvilyemlt-G~~Pf~~~~~ 603 (966)
... ...+.|||=|.++ ...|+.++||||+||++||++| |..|+++...
T Consensus 853 ~ey~~~~gK~pikwmale~i~--------------------------~~~~thqSDVWsfGVtiWElmTFGa~Py~gi~~ 906 (1177)
T KOG1025|consen 853 KEYSAPGGKVPIKWMALESIR--------------------------IRKYTHQSDVWSFGVTIWELMTFGAKPYDGIPA 906 (1177)
T ss_pred ccccccccccCcHHHHHHHhh--------------------------ccCCCchhhhhhhhhhHHHHHhcCCCccCCCCH
Confidence 122 2255677777664 3458999999999999999987 9999998765
Q ss_pred chhHHHHHHHHHcCCCCCCchhhccCCHHHHHHHHHhcccCccccCChHHHHHHhhh
Q psy11767 604 DDSALSIMARIKEGQFNFDAEAWSTVSSEAKELTKSLLTVNPAQRIRMMRVKLTFHA 660 (966)
Q Consensus 604 ~~~~~~~~~~i~~~~~~~~~~~~~~is~e~~~Li~~~L~~dP~~R~t~~~v~~~~~~ 660 (966)
. ++-..+..|.- +. .++..+-+..-++.+||..|++.||++.++...+..
T Consensus 907 ~----eI~dlle~geR-Ls--qPpiCtiDVy~~mvkCwmid~~~rp~fkel~~~fs~ 956 (1177)
T KOG1025|consen 907 E----EIPDLLEKGER-LS--QPPICTIDVYMVMVKCWMIDADSRPTFKELAEEFSR 956 (1177)
T ss_pred H----HhhHHHhcccc-CC--CCCCccHHHHHHHHHHhccCcccCccHHHHHHHHHH
Confidence 3 33344444443 22 234678899999999999999999999877554443
|
|
| >KOG3653|consensus | Back alignment and domain information |
|---|
Probab=99.95 E-value=2.9e-28 Score=269.61 Aligned_cols=246 Identities=22% Similarity=0.311 Sum_probs=176.7
Q ss_pred ccccccccccEEEEEEEcCCCcEEEEEEecccc--ChHHHHHHHHHh-cCCCCceEEEEEEEeCC----eEEEEEEccCC
Q psy11767 383 AGILGDGSYSVCRRCVEKSTGQEYAVKIISRKI--DCSEEINLLRAC-QGHPNIVNLHCVFQDEV----HTYLVLELLKG 455 (966)
Q Consensus 383 ~~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~--~~~~Ei~iL~~l-~~HpnIV~l~~~~~~~~----~~~lVmEy~~g 455 (966)
..+||+|.||.||+|... ++.||||++.... ....|-+|.... ..|+||++++++-+... .++||+||.+.
T Consensus 215 ~eli~~Grfg~V~KaqL~--~~~VAVKifp~~~kqs~~~Ek~Iy~lp~m~h~nIl~Fi~~ekr~t~~~~eywLVt~fh~k 292 (534)
T KOG3653|consen 215 LELIGRGRFGCVWKAQLD--NRLVAVKIFPEQEKQSFQNEKNIYSLPGMKHENILQFIGAEKRGTADRMEYWLVTEFHPK 292 (534)
T ss_pred HHHhhcCccceeehhhcc--CceeEEEecCHHHHHHHHhHHHHHhccCccchhHHHhhchhccCCccccceeEEeeeccC
Confidence 568999999999999754 6899999997543 345566665532 25999999998877555 78999999999
Q ss_pred CCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhc---------CceeccCCCCcEEEecCCCCCEEEEeeccccccc
Q psy11767 456 GELLDRIRQKGRCGFTENEASRIMRQLVAAVHFMHSR---------GVVHRDLKPENLLFSDPAGDNIKVVDFGFACLKR 526 (966)
Q Consensus 456 g~L~~~l~~~~~~~l~e~~~~~i~~Qil~aL~yLHs~---------~IiHRDLKP~NILl~~~~~~~iKL~DFGla~~~~ 526 (966)
|+|.++|..+ .+++....+++.-++.||+|||+. .|+|||||..|||+.+ +....|+|||||....
T Consensus 293 GsL~dyL~~n---tisw~~~cria~SmarGLa~LHee~p~~d~~Kp~IaHRDlkSkNVLvK~--DlTccIaDFGLAl~~~ 367 (534)
T KOG3653|consen 293 GSLCDYLKAN---TISWNSLCRIAESMARGLAHLHEELPRGDHHKPPIAHRDLKSKNVLVKN--DLTCCIADFGLALRLE 367 (534)
T ss_pred CcHHHHHHhc---cccHHHHHHHHHHHHHHHHHhcccCCcCCCCCCccccccccccceEEcc--CCcEEeeccceeEEec
Confidence 9999999876 589999999999999999999973 5999999999999984 6799999999996643
Q ss_pred -----CCCccccccccccCchhhccCCCCCCCcccchhhhhhhhhhhhcCCCCCCCcCcchhHHHHHHHHhcCC------
Q psy11767 527 -----ESLHTPCFTLQYAAPEVLRQDKSGYDENCDLWSLGVILVNVLRQDKSGYDENCDLWSLGVILYTMLCGR------ 595 (966)
Q Consensus 527 -----~~~~~~~gT~~Y~APEvl~~~~~~~~~~~Di~SlGvil~el~~~~~~~y~~~~DIWSlGvilyemltG~------ 595 (966)
......+||..|||||+|...- .+. + ..-=..+||||+|.|||||++..
T Consensus 368 p~~~~~d~~~qVGT~RYMAPEvLEgai-nl~------------------d-~~Afkr~DvYamgLVLWEi~SRC~~~~~~ 427 (534)
T KOG3653|consen 368 PGKPQGDTHGQVGTRRYMAPEVLEGAI-NLQ------------------D-RDAFKRIDVYAMGLVLWEIASRCTDADPG 427 (534)
T ss_pred CCCCCcchhhhhhhhhhcCHHHHhhhc-ccc------------------c-HHHHHHHHHHHHHHHHHHHHhhcccccCC
Confidence 2345578999999999995321 110 0 00013578888888888886532
Q ss_pred ------CCCCCCCC-chhHHHHHHHH--HcCCCCCCchhhccC--CHHHHHHHHHhcccCccccCChHHHHH
Q psy11767 596 ------VPFHARSR-DDSALSIMARI--KEGQFNFDAEAWSTV--SSEAKELTKSLLTVNPAQRIRMMRVKL 656 (966)
Q Consensus 596 ------~Pf~~~~~-~~~~~~~~~~i--~~~~~~~~~~~~~~i--s~e~~~Li~~~L~~dP~~R~t~~~v~~ 656 (966)
+||...-. ......+.+.+ ++... .-++.|..- -.-+++.+.-||..||+.|+|+.-+..
T Consensus 428 ~vp~Yqlpfe~evG~hPt~e~mq~~VV~kK~RP-~~p~~W~~h~~~~~l~et~EeCWDhDaeARLTA~Cv~e 498 (534)
T KOG3653|consen 428 PVPEYQLPFEAEVGNHPTLEEMQELVVRKKQRP-KIPDAWRKHAGMAVLCETIEECWDHDAEARLTAGCVEE 498 (534)
T ss_pred CCCcccCchhHHhcCCCCHHHHHHHHHhhccCC-CChhhhhcCccHHHHHHHHHHHcCCchhhhhhhHHHHH
Confidence 34431111 11111111211 12222 223445332 335678999999999999999986643
|
|
| >cd00180 PKc Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Probab=99.94 E-value=4.7e-26 Score=234.01 Aligned_cols=202 Identities=40% Similarity=0.693 Sum_probs=174.8
Q ss_pred cccccccEEEEEEEcCCCcEEEEEEeccccC------hHHHHHHHHHhcCCCCceEEEEEEEeCCeEEEEEEccCCCCHH
Q psy11767 386 LGDGSYSVCRRCVEKSTGQEYAVKIISRKID------CSEEINLLRACQGHPNIVNLHCVFQDEVHTYLVLELLKGGELL 459 (966)
Q Consensus 386 LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~~------~~~Ei~iL~~l~~HpnIV~l~~~~~~~~~~~lVmEy~~gg~L~ 459 (966)
||+|+||.||++.+..+|+.+++|++..... ..+|+..++.+. |++|+++++++......+++||++.|++|.
T Consensus 1 l~~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~e~~~~~~l~-~~~i~~~~~~~~~~~~~~~~~e~~~~~~l~ 79 (215)
T cd00180 1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLN-HPNIVKLYGVFEDENHLYLVMEYCEGGSLK 79 (215)
T ss_pred CCcCCceEEEEEEecCCCcEEEEEEeccccchhHHHHHHHHHHHHHhcC-CCCeeeEeeeeecCCeEEEEEecCCCCcHH
Confidence 6899999999999998899999999976643 567999999984 899999999999999999999999999999
Q ss_pred HHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCcEEEecCCCCCEEEEeecccccccCC---Cccccccc
Q psy11767 460 DRIRQKGRCGFTENEASRIMRQLVAAVHFMHSRGVVHRDLKPENLLFSDPAGDNIKVVDFGFACLKRES---LHTPCFTL 536 (966)
Q Consensus 460 ~~l~~~~~~~l~e~~~~~i~~Qil~aL~yLHs~~IiHRDLKP~NILl~~~~~~~iKL~DFGla~~~~~~---~~~~~gT~ 536 (966)
+++.... ..+++..+..++.|++.+|+|||+.|++|+||+|.||+++.. .+.++|+|||.+...... .....+..
T Consensus 80 ~~~~~~~-~~~~~~~~~~~~~~l~~~l~~lh~~~~~H~dl~~~ni~~~~~-~~~~~l~d~~~~~~~~~~~~~~~~~~~~~ 157 (215)
T cd00180 80 DLLKENE-GKLSEDEILRILLQILEGLEYLHSNGIIHRDLKPENILLDSD-NGKVKLADFGLSKLLTSDKSLLKTIVGTP 157 (215)
T ss_pred HHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHhhEEEeCC-CCcEEEecCCceEEccCCcchhhcccCCC
Confidence 9987652 258999999999999999999999999999999999999741 468999999999765443 23445688
Q ss_pred cccCchhhccCCCCCCCcccchhhhhhhhhhhhcCCCCCCCcCcchhHHHHHHHHhcCCCCCCCCCCchhHHHHHHHHHc
Q psy11767 537 QYAAPEVLRQDKSGYDENCDLWSLGVILVNVLRQDKSGYDENCDLWSLGVILYTMLCGRVPFHARSRDDSALSIMARIKE 616 (966)
Q Consensus 537 ~Y~APEvl~~~~~~~~~~~Di~SlGvil~el~~~~~~~y~~~~DIWSlGvilyemltG~~Pf~~~~~~~~~~~~~~~i~~ 616 (966)
.|++||.+... ..++.+.|+|++|+++++|
T Consensus 158 ~~~~pe~~~~~-------------------------~~~~~~~D~~~lg~~~~~l------------------------- 187 (215)
T cd00180 158 AYMAPEVLLGK-------------------------GYYSEKSDIWSLGVILYEL------------------------- 187 (215)
T ss_pred CccChhHhccc-------------------------CCCCchhhhHHHHHHHHHH-------------------------
Confidence 89999987521 1356789999999999998
Q ss_pred CCCCCCchhhccCCHHHHHHHHHhcccCccccCChHHH
Q psy11767 617 GQFNFDAEAWSTVSSEAKELTKSLLTVNPAQRIRMMRV 654 (966)
Q Consensus 617 ~~~~~~~~~~~~is~e~~~Li~~~L~~dP~~R~t~~~v 654 (966)
..+.+++.+||..||++||++.++
T Consensus 188 --------------~~~~~~l~~~l~~~p~~R~~~~~l 211 (215)
T cd00180 188 --------------PELKDLIRKMLQKDPEKRPSAKEI 211 (215)
T ss_pred --------------HHHHHHHHHHhhCCcccCcCHHHH
Confidence 467889999999999999999876
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which |
| >cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Probab=99.94 E-value=3e-26 Score=257.21 Aligned_cols=227 Identities=23% Similarity=0.411 Sum_probs=180.5
Q ss_pred CcceeeeecccccceEEEEEEcCCCCEEEEEeccccc--------hhhHHHHHHHHhhCCCcccccccccc---------
Q psy11767 117 DLDKAGILGDGSYSVCRRCVEKSTGQEYAVKIISRKI--------DCSEEINLLRACQGHPNICRRCVEKS--------- 179 (966)
Q Consensus 117 df~~~~~LG~GsFGkV~La~~k~tg~~yAiKvl~K~~--------~~~~E~~il~~~~~~pfi~~~~~~~~--------- 179 (966)
||+++++||+|+||+|++|+++.+++.||||+++|.. ....|+.+|....+||+|+.....+.
T Consensus 1 df~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (323)
T cd05616 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPPFLTQLHSCFQTMDRLYFVM 80 (323)
T ss_pred CceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCeEeeEEEEEecCCEEEEEE
Confidence 7999999999999999999999999999999999752 23567888888888999875211111
Q ss_pred ---------------------cchhHHHHHHHh----------hcccchhhhHhhhccCCceEEecCccc----------
Q psy11767 180 ---------------------TGQEYAVKIISR----------KIDCSEEINLLRACQGHPNIVNLHCVF---------- 218 (966)
Q Consensus 180 ---------------------~~~~~~~~~v~~----------~~~~~~e~nil~~~~gh~~iv~l~~~~---------- 218 (966)
....++.+++.+ ..|++++ |||.+.+|+++|+||+.+.
T Consensus 81 E~~~~g~L~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~-Nill~~~~~~kL~DfG~~~~~~~~~~~~~ 159 (323)
T cd05616 81 EYVNGGDLMYQIQQVGRFKEPHAVFYAAEIAIGLFFLHSKGIIYRDLKLD-NVMLDSEGHIKIADFGMCKENMWDGVTTK 159 (323)
T ss_pred cCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEEecCCCHH-HeEECCCCcEEEccCCCceecCCCCCccc
Confidence 011122222222 1234444 9999999999999998553
Q ss_pred ---------cccccccccCCCcceeeechhhHHHHHHHhhCCCCCCCCcHHHHHHHHHhCCCCCCCCCCHHHHHHHHhhc
Q psy11767 219 ---------QDEVIDWDDFSRGIECVFFSSSLIIFFIILSFTLSFIHDYYHIQYRRILKTEPPIPEDLSPDVADFISRLL 289 (966)
Q Consensus 219 ---------~~e~i~~~~y~~~~d~~~~~~~~il~~~m~~g~~pf~~~~~~~~~~~I~~~~~~~P~~~s~~a~dli~~LL 289 (966)
.+|++....|+...| +|+.|+++|+|++|.+||...+...+++.|....+.+|..+++++++||++||
T Consensus 160 ~~~gt~~y~aPE~~~~~~~~~~~D---iwSlGvil~elltg~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li~~~l 236 (323)
T cd05616 160 TFCGTPDYIAPEIIAYQPYGKSVD---WWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEHNVAYPKSMSKEAVAICKGLM 236 (323)
T ss_pred cCCCChhhcCHHHhcCCCCCCccc---hhchhHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCCcCCHHHHHHHHHHc
Confidence 135555556655544 44567888889999999999999999999999999999999999999999999
Q ss_pred ccCCCcccCCCCCCHHHHhcCCceeeeCccccccCCCCCCCCccccccccccccccccc
Q psy11767 290 VKDPRRRLGGGELDAEELKRHPFFNVIDWDDLATKRIPAPFVPKISNELDVSNFSDEFT 348 (966)
Q Consensus 290 ~kdp~~RLG~~~~g~~~Ik~HpfF~~idW~~l~~k~~~pP~~P~i~~~~D~snFd~ef~ 348 (966)
++||.+|+++...+..+|+.||||+.+||+.+..++++||+.|... ..|..+|+..|.
T Consensus 237 ~~~p~~R~~~~~~~~~~i~~h~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~ 294 (323)
T cd05616 237 TKHPGKRLGCGPEGERDIKEHAFFRYIDWEKLERKEVQPPYKPKAC-GRDAENFDKFFT 294 (323)
T ss_pred ccCHHhcCCCCCCCHHHHhcCCCcCCCCHHHHHhCCCCCCcCCcCC-CchhhhcCchhc
Confidence 9999999998767889999999999999999999999999999875 467788887665
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and |
| >cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Probab=99.94 E-value=4.7e-26 Score=255.87 Aligned_cols=229 Identities=24% Similarity=0.425 Sum_probs=179.9
Q ss_pred CcceeeeecccccceEEEEEEcCCCCEEEEEeccccc--------hhhHHHHHHHHhhCCCccccccccccc--------
Q psy11767 117 DLDKAGILGDGSYSVCRRCVEKSTGQEYAVKIISRKI--------DCSEEINLLRACQGHPNICRRCVEKST-------- 180 (966)
Q Consensus 117 df~~~~~LG~GsFGkV~La~~k~tg~~yAiKvl~K~~--------~~~~E~~il~~~~~~pfi~~~~~~~~~-------- 180 (966)
||++.++||+|+||+|++|+++.+|+.||||+++|.. ....|..++....+||+|+.....+..
T Consensus 1 ~f~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (323)
T cd05615 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPPFLTQLHSCFQTVDRLYFVM 80 (323)
T ss_pred CceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCchhheeeEEecCCEEEEEE
Confidence 6899999999999999999999999999999998742 245688888888788998652211111
Q ss_pred ----------------------chhHHHHHHHh----------hcccchhhhHhhhccCCceEEecCcccc---------
Q psy11767 181 ----------------------GQEYAVKIISR----------KIDCSEEINLLRACQGHPNIVNLHCVFQ--------- 219 (966)
Q Consensus 181 ----------------------~~~~~~~~v~~----------~~~~~~e~nil~~~~gh~~iv~l~~~~~--------- 219 (966)
...++.+++.+ ..|++++ |+|.+.+|+++|+||+.+..
T Consensus 81 Ey~~~g~L~~~i~~~~~l~~~~~~~i~~qi~~al~~lH~~~ivHrDikp~-Nill~~~~~ikL~Dfg~~~~~~~~~~~~~ 159 (323)
T cd05615 81 EYVNGGDLMYHIQQVGKFKEPQAVFYAAEISVGLFFLHRRGIIYRDLKLD-NVMLDSEGHIKIADFGMCKEHMVDGVTTR 159 (323)
T ss_pred cCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHH-HeEECCCCCEEEeccccccccCCCCcccc
Confidence 11122222221 1134444 99999999999999985421
Q ss_pred ----------ccccccccCCCcceeeechhhHHHHHHHhhCCCCCCCCcHHHHHHHHHhCCCCCCCCCCHHHHHHHHhhc
Q psy11767 220 ----------DEVIDWDDFSRGIECVFFSSSLIIFFIILSFTLSFIHDYYHIQYRRILKTEPPIPEDLSPDVADFISRLL 289 (966)
Q Consensus 220 ----------~e~i~~~~y~~~~d~~~~~~~~il~~~m~~g~~pf~~~~~~~~~~~I~~~~~~~P~~~s~~a~dli~~LL 289 (966)
+|++....|+...| +|+.|+++|+|++|.+||...+...+++.|+...+.+|..+++++++||.++|
T Consensus 160 ~~~gt~~y~aPE~~~~~~~~~~~D---iwslGvil~elltG~~pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~li~~~l 236 (323)
T cd05615 160 TFCGTPDYIAPEIIAYQPYGKSVD---WWAYGVLLYEMLAGQPPFDGEDEDELFQSIMEHNVSYPKSLSKEAVSICKGLM 236 (323)
T ss_pred CccCCccccCHHHHcCCCCCCccc---hhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCccCCHHHHHHHHHHc
Confidence 34555555655444 44567888889999999999999999999999999999999999999999999
Q ss_pred ccCCCcccCCCCCCHHHHhcCCceeeeCccccccCCCCCCCCccccccccccccccccccC
Q psy11767 290 VKDPRRRLGGGELDAEELKRHPFFNVIDWDDLATKRIPAPFVPKISNELDVSNFSDEFTKM 350 (966)
Q Consensus 290 ~kdp~~RLG~~~~g~~~Ik~HpfF~~idW~~l~~k~~~pP~~P~i~~~~D~snFd~ef~~~ 350 (966)
++||.+|++....+.++|+.||||+.++|+.+..+.+++|+.|..... ...+|+..+...
T Consensus 237 ~~~p~~R~~~~~~~~~~i~~h~~f~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~ 296 (323)
T cd05615 237 TKHPSKRLGCGPEGERDIREHAFFRRIDWDKLENREIQPPFKPKVCGK-GAENFDKFFTRG 296 (323)
T ss_pred ccCHhhCCCCCCCCHHHHhcCcccCCCCHHHHhcCCCCcCccCccCCC-chhhcCcccccc
Confidence 999999999876678999999999999999999999999999986553 478888776543
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a |
| >smart00221 STYKc Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=99.94 E-value=8.4e-26 Score=237.04 Aligned_cols=205 Identities=40% Similarity=0.650 Sum_probs=170.0
Q ss_pred ccccccccccEEEEEEEcCCCcEEEEEEecccc------ChHHHHHHHHHhcCCCCceEEEEEEEeCCeEEEEEEccCCC
Q psy11767 383 AGILGDGSYSVCRRCVEKSTGQEYAVKIISRKI------DCSEEINLLRACQGHPNIVNLHCVFQDEVHTYLVLELLKGG 456 (966)
Q Consensus 383 ~~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~------~~~~Ei~iL~~l~~HpnIV~l~~~~~~~~~~~lVmEy~~gg 456 (966)
...||.|+||.||+|.+..+++.+|+|.+.... ....|++.++.+ .|+||+++++++......++++||++++
T Consensus 4 ~~~i~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~~~~~-~~~~i~~~~~~~~~~~~~~~v~e~~~~~ 82 (225)
T smart00221 4 GKKLGEGAFGKVYLARDKGTGELVAVKVLKKEKTEKQREEFLREIRILKKL-KHPNIVKLYGVFEDPEPLYLVMEYCEGG 82 (225)
T ss_pred eeEeecCCCeEEEEEEEcCCCcEEEEEeeccccchHHHHHHHHHHHHHHhC-CCCChhhheeeeecCCceEEEEeccCCC
Confidence 467999999999999999999999999997542 244588888888 6999999999999999999999999999
Q ss_pred CHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCcEEEecCCCCCEEEEeecccccccCCC----ccc
Q psy11767 457 ELLDRIRQKGRCGFTENEASRIMRQLVAAVHFMHSRGVVHRDLKPENLLFSDPAGDNIKVVDFGFACLKRESL----HTP 532 (966)
Q Consensus 457 ~L~~~l~~~~~~~l~e~~~~~i~~Qil~aL~yLHs~~IiHRDLKP~NILl~~~~~~~iKL~DFGla~~~~~~~----~~~ 532 (966)
+|.+++..... .+++..+..++.|++.+|.|||+.+++|+||+|.||+++. .+.++|+|||++....... ...
T Consensus 83 ~L~~~~~~~~~-~~~~~~~~~~~~~l~~~l~~lh~~~i~h~di~~~ni~v~~--~~~~~l~d~g~~~~~~~~~~~~~~~~ 159 (225)
T smart00221 83 DLFDYLRKKGG-KLSEEEARFYLRQILEALEYLHSLGIVHRDLKPENILLGM--DGLVKLADFGLARFIHRDLAALLKTV 159 (225)
T ss_pred CHHHHHHhccc-CCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcC--CCCEEEeeCceeeEecCcccccccce
Confidence 99999976542 2899999999999999999999999999999999999985 4699999999987655432 445
Q ss_pred cccccccCchhhccCCCCCCCcccchhhhhhhhhhhhcCCCCCCCcCcchhHHHHHHHHhcCCCCCCCCCCchhHHHHHH
Q psy11767 533 CFTLQYAAPEVLRQDKSGYDENCDLWSLGVILVNVLRQDKSGYDENCDLWSLGVILYTMLCGRVPFHARSRDDSALSIMA 612 (966)
Q Consensus 533 ~gT~~Y~APEvl~~~~~~~~~~~Di~SlGvil~el~~~~~~~y~~~~DIWSlGvilyemltG~~Pf~~~~~~~~~~~~~~ 612 (966)
.++..|++||.+. . ...++.++|+||||+++++|++|+.||.... +....+.+
T Consensus 160 ~~~~~~~~pe~~~-~------------------------~~~~~~~~Dv~~lG~~~~~l~~g~~pf~~~~--~~~~~~~~ 212 (225)
T smart00221 160 KGTPFYLAPEVLL-G------------------------GKGYGEAVDIWSLGVILYELLWGPEPFSGEG--EFTSLLSD 212 (225)
T ss_pred eccCCcCCHhHhc-C------------------------CCCCCchhhHHHHHHHHHHHHHCCCCccccc--hhHHHHHH
Confidence 6788899999873 1 2346678999999999999999999996621 12234556
Q ss_pred HHHcCC
Q psy11767 613 RIKEGQ 618 (966)
Q Consensus 613 ~i~~~~ 618 (966)
.|..+.
T Consensus 213 ~~~~~~ 218 (225)
T smart00221 213 VWSFGV 218 (225)
T ss_pred HHhcCC
Confidence 666554
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. |
| >cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Probab=99.93 E-value=7e-26 Score=254.38 Aligned_cols=229 Identities=24% Similarity=0.418 Sum_probs=182.0
Q ss_pred CcceeeeecccccceEEEEEEcCCCCEEEEEeccccc--------hhhHHHHHHHHhhCCCccccccccccc--------
Q psy11767 117 DLDKAGILGDGSYSVCRRCVEKSTGQEYAVKIISRKI--------DCSEEINLLRACQGHPNICRRCVEKST-------- 180 (966)
Q Consensus 117 df~~~~~LG~GsFGkV~La~~k~tg~~yAiKvl~K~~--------~~~~E~~il~~~~~~pfi~~~~~~~~~-------- 180 (966)
||++++.||+|+||+||+|+.+.+++.||||+++|.. ....|..+|.....|++|+.....+..
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (324)
T cd05587 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVM 80 (324)
T ss_pred CceEEEEEeeccCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhcCCCCceeeeEEEEEcCCEEEEEE
Confidence 7899999999999999999999999999999998742 246688888888778888652211110
Q ss_pred ----------------------chhHHHHHHHh----------hcccchhhhHhhhccCCceEEecCccc----------
Q psy11767 181 ----------------------GQEYAVKIISR----------KIDCSEEINLLRACQGHPNIVNLHCVF---------- 218 (966)
Q Consensus 181 ----------------------~~~~~~~~v~~----------~~~~~~e~nil~~~~gh~~iv~l~~~~---------- 218 (966)
...++.+++.+ ..|++++ |||.+.+|+++|+||+.+.
T Consensus 81 E~~~~g~L~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dlkp~-Nill~~~~~~kL~Dfg~~~~~~~~~~~~~ 159 (324)
T cd05587 81 EYVNGGDLMYHIQQVGKFKEPHAVFYAAEIAIGLFFLHSKGIIYRDLKLD-NVMLDAEGHIKIADFGMCKENIFGGKTTR 159 (324)
T ss_pred cCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHH-HeEEcCCCCEEEeecCcceecCCCCCcee
Confidence 11112222222 1144444 9999999999999998542
Q ss_pred ---------cccccccccCCCcceeeechhhHHHHHHHhhCCCCCCCCcHHHHHHHHHhCCCCCCCCCCHHHHHHHHhhc
Q psy11767 219 ---------QDEVIDWDDFSRGIECVFFSSSLIIFFIILSFTLSFIHDYYHIQYRRILKTEPPIPEDLSPDVADFISRLL 289 (966)
Q Consensus 219 ---------~~e~i~~~~y~~~~d~~~~~~~~il~~~m~~g~~pf~~~~~~~~~~~I~~~~~~~P~~~s~~a~dli~~LL 289 (966)
.+|++....|+...| +|+.|+++|+|++|.+||...+...+++.|....+.+|..+++++++||+++|
T Consensus 160 ~~~gt~~y~aPE~~~~~~~~~~~D---iwslGvil~elltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~li~~~l 236 (324)
T cd05587 160 TFCGTPDYIAPEIIAYQPYGKSVD---WWAFGVLLYEMLAGQPPFDGEDEDELFQSIMEHNVSYPKSLSKEAVSICKGLL 236 (324)
T ss_pred eecCCccccChhhhcCCCCCcccc---hhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCCCCCHHHHHHHHHHh
Confidence 134555555654444 44567788888999999999999999999999999999999999999999999
Q ss_pred ccCCCcccCCCCCCHHHHhcCCceeeeCccccccCCCCCCCCcccccccccccccccccc
Q psy11767 290 VKDPRRRLGGGELDAEELKRHPFFNVIDWDDLATKRIPAPFVPKISNELDVSNFSDEFTK 349 (966)
Q Consensus 290 ~kdp~~RLG~~~~g~~~Ik~HpfF~~idW~~l~~k~~~pP~~P~i~~~~D~snFd~ef~~ 349 (966)
.+||.+|+++.....++|++||||+.+||+.+..+++++|+.|.+....+.++|+..+..
T Consensus 237 ~~~P~~R~~~~~~~~~~~~~hp~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 296 (324)
T cd05587 237 TKHPAKRLGCGPTGERDIREHAFFRRIDWEKLERREIQPPFKPKVKGRRSAENFDKFFTR 296 (324)
T ss_pred hcCHHHcCCCCCCCHHHHhcCCCcCCCCHHHHHhCCCCCCccCcCCCcchhhhcCccccc
Confidence 999999999766677999999999999999999999999999999888889999876543
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory |
| >KOG0590|consensus | Back alignment and domain information |
|---|
Probab=99.93 E-value=3.6e-27 Score=282.71 Aligned_cols=242 Identities=29% Similarity=0.497 Sum_probs=185.6
Q ss_pred ccccccccccEEEEEEEcC-CCcEEEEEEecccc---C----hHHHHHHHHHhcCCCCceEEEEEEEeCCeEEEEEEccC
Q psy11767 383 AGILGDGSYSVCRRCVEKS-TGQEYAVKIISRKI---D----CSEEINLLRACQGHPNIVNLHCVFQDEVHTYLVLELLK 454 (966)
Q Consensus 383 ~~~LG~G~fG~Vy~a~~~~-tg~~vAvK~i~~~~---~----~~~Ei~iL~~l~~HpnIV~l~~~~~~~~~~~lVmEy~~ 454 (966)
...||+|+|+.|-.+.... +...+|+|.+.... . ...|..+=+.+.+|+|++++++...+....++++||..
T Consensus 25 ~~~ig~gs~~~~~~~~~~~~~~~~~a~~~~s~~~~~~~~~~~i~~e~~~~~~~s~h~n~~~~~~~~~~~~~~~~~~~~s~ 104 (601)
T KOG0590|consen 25 SRSIGKGSFSSSALASNSRDPESSSATKPISIPPKSEDSSEHIDTETDIQKKLSKHSNTVHMIEPSSSPRSYLLSLSYSD 104 (601)
T ss_pred cccccccccchhhhhhhcCCCcceeeccCCCCCCCccchhhhcCccccccccccccccccccCCccCCCcccccccCccc
Confidence 4669999999998887643 45567778775442 1 11255544455559999999999999999999999999
Q ss_pred CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHH-hcCceeccCCCCcEEEecCCCC-CEEEEeecccccccC-----
Q psy11767 455 GGELLDRIRQKGRCGFTENEASRIMRQLVAAVHFMH-SRGVVHRDLKPENLLFSDPAGD-NIKVVDFGFACLKRE----- 527 (966)
Q Consensus 455 gg~L~~~l~~~~~~~l~e~~~~~i~~Qil~aL~yLH-s~~IiHRDLKP~NILl~~~~~~-~iKL~DFGla~~~~~----- 527 (966)
|+++++.+........+...+..++.|+..++.|+| ..++.||||||+|.+++. .+ .+|++|||+|.....
T Consensus 105 g~~~f~~i~~~~~~~~~~~~~~~~~~ql~s~l~~~H~~~~~~h~~ikP~n~~l~~--s~~~l~~~df~~At~~~~~~g~~ 182 (601)
T KOG0590|consen 105 GGSLFSKISHPDSTGTSSSSASRYLPQLNSGLSYLHPENGVTHRDIKPSNSLLDE--SGSALKIADFGLATAYRNKNGAE 182 (601)
T ss_pred ccccccccccCCccCCCCcchhhhhhhhccCccccCcccccccCCCCCccchhcc--CCCcccCCCchhhccccccCCcc
Confidence 999999883222225788899999999999999999 999999999999999985 44 899999999965433
Q ss_pred -CCccccc-cccccCchhhccCCCCCCCcccchhhhhhhhhhhhcCCCCCCCcCcchhHHHHHHHHhcCCCCCCCCCCch
Q psy11767 528 -SLHTPCF-TLQYAAPEVLRQDKSGYDENCDLWSLGVILVNVLRQDKSGYDENCDLWSLGVILYTMLCGRVPFHARSRDD 605 (966)
Q Consensus 528 -~~~~~~g-T~~Y~APEvl~~~~~~~~~~~Di~SlGvil~el~~~~~~~y~~~~DIWSlGvilyemltG~~Pf~~~~~~~ 605 (966)
.....+| ++.|+|||..... ....+..|+||+|+++..|++|..||......+
T Consensus 183 ~~~~~~~g~s~~y~a~E~~~~~-------------------------~~~~~~~d~~S~g~~l~~~~~g~~p~~~~~~~~ 237 (601)
T KOG0590|consen 183 RSLKDRCGSSPPYGAPEHLSGK-------------------------AYRGPSVDVWSLGIVLSAMLTGELPWDFPSRKD 237 (601)
T ss_pred eeeecccCCCCCCCCcccccch-------------------------hhcCCCcccccccccccccccCCCCcccccccc
Confidence 1234678 9999999988532 123567899999999999999999998665433
Q ss_pred hHHHHHHHHHcCCCCCCchhhccCCHHHHHHHHHhcccCccccCChHHH
Q psy11767 606 SALSIMARIKEGQFNFDAEAWSTVSSEAKELTKSLLTVNPAQRIRMMRV 654 (966)
Q Consensus 606 ~~~~~~~~i~~~~~~~~~~~~~~is~e~~~Li~~~L~~dP~~R~t~~~v 654 (966)
... ...+ .....+....|..++..+.+++.++|..+|..|.+..++
T Consensus 238 ~~~--~~~~-~~~~~~~~~~~~~~~~~~~~~l~k~l~~~~~~r~s~~~~ 283 (601)
T KOG0590|consen 238 GRY--SSWK-SNKGRFTQLPWNSISDQAHDLLHKILKENPSNRLSIEEL 283 (601)
T ss_pred ccc--eeec-ccccccccCccccCChhhhhcccccccCCchhccccccc
Confidence 211 1111 111223345678899999999999999999999988755
|
|
| >PTZ00263 protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=99.93 E-value=1.4e-25 Score=252.60 Aligned_cols=227 Identities=24% Similarity=0.431 Sum_probs=181.8
Q ss_pred ccC-CcceeeeecccccceEEEEEEcCCCCEEEEEeccccc--------hhhHHHHHHHHhhCCCccccccccccc----
Q psy11767 114 YDM-DLDKAGILGDGSYSVCRRCVEKSTGQEYAVKIISRKI--------DCSEEINLLRACQGHPNICRRCVEKST---- 180 (966)
Q Consensus 114 ~~~-df~~~~~LG~GsFGkV~La~~k~tg~~yAiKvl~K~~--------~~~~E~~il~~~~~~pfi~~~~~~~~~---- 180 (966)
+.+ ||++.+.||+|+||+|++|+++.+|+.||||++++.. ...+|..+|+++ +||+|++.+-.+..
T Consensus 15 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l-~hp~iv~~~~~~~~~~~~ 93 (329)
T PTZ00263 15 WKLSDFEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMEL-SHPFIVNMMCSFQDENRV 93 (329)
T ss_pred CCchheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhC-CCCCCCcEEEEEEcCCEE
Confidence 444 8899999999999999999999999999999998752 356799999988 69999862211111
Q ss_pred --------------------------chhHHHHHHHh----------hcccchhhhHhhhccCCceEEecCccc------
Q psy11767 181 --------------------------GQEYAVKIISR----------KIDCSEEINLLRACQGHPNIVNLHCVF------ 218 (966)
Q Consensus 181 --------------------------~~~~~~~~v~~----------~~~~~~e~nil~~~~gh~~iv~l~~~~------ 218 (966)
...+..+++.+ ..|++++ |||.+.+|+.+|.||+.+.
T Consensus 94 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~dlkp~-NIll~~~~~~kl~Dfg~~~~~~~~~ 172 (329)
T PTZ00263 94 YFLLEFVVGGELFTHLRKAGRFPNDVAKFYHAELVLAFEYLHSKDIIYRDLKPE-NLLLDNKGHVKVTDFGFAKKVPDRT 172 (329)
T ss_pred EEEEcCCCCChHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHH-HEEECCCCCEEEeeccCceEcCCCc
Confidence 11111222221 1134444 9999999999999998653
Q ss_pred ----------cccccccccCCCcceeeechhhHHHHHHHhhCCCCCCCCcHHHHHHHHHhCCCCCCCCCCHHHHHHHHhh
Q psy11767 219 ----------QDEVIDWDDFSRGIECVFFSSSLIIFFIILSFTLSFIHDYYHIQYRRILKTEPPIPEDLSPDVADFISRL 288 (966)
Q Consensus 219 ----------~~e~i~~~~y~~~~d~~~~~~~~il~~~m~~g~~pf~~~~~~~~~~~I~~~~~~~P~~~s~~a~dli~~L 288 (966)
.+|++....++...| .| +.|+++|+|++|.+||...+...++++|..+.+.+|..++.+++|||+++
T Consensus 173 ~~~~gt~~y~aPE~~~~~~~~~~~D--iw-slG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~li~~~ 249 (329)
T PTZ00263 173 FTLCGTPEYLAPEVIQSKGHGKAVD--WW-TMGVLLYEFIAGYPPFFDDTPFRIYEKILAGRLKFPNWFDGRARDLVKGL 249 (329)
T ss_pred ceecCChhhcCHHHHcCCCCCCcce--ee-chHHHHHHHHcCCCCCCCCCHHHHHHHHhcCCcCCCCCCCHHHHHHHHHH
Confidence 245555555655555 34 56788888999999999999889999999999999999999999999999
Q ss_pred cccCCCcccCCCCCCHHHHhcCCceeeeCccccccCCCCCCCCcccccccccccccc
Q psy11767 289 LVKDPRRRLGGGELDAEELKRHPFFNVIDWDDLATKRIPAPFVPKISNELDVSNFSD 345 (966)
Q Consensus 289 L~kdp~~RLG~~~~g~~~Ik~HpfF~~idW~~l~~k~~~pP~~P~i~~~~D~snFd~ 345 (966)
|++||.+|+++....+++|+.||||++++|+.+..+++++|+.+.+....+..+|+.
T Consensus 250 L~~dP~~R~~~~~~~~~~ll~hp~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 306 (329)
T PTZ00263 250 LQTDHTKRLGTLKGGVADVKNHPYFHGANWDKLYARYYPAPIPVRVKSPGDTSNFEK 306 (329)
T ss_pred hhcCHHHcCCCCCCCHHHHhcCCccCCCCHHHHHhCCCCCCcCCCCCCcccchhccC
Confidence 999999999987778999999999999999999999999999888888888888875
|
|
| >cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Probab=99.93 E-value=1.6e-25 Score=251.23 Aligned_cols=230 Identities=27% Similarity=0.438 Sum_probs=179.4
Q ss_pred eeecccccceEEEEEEcCCCCEEEEEeccccc--------hhhHHHHHHHHhhCCCcccccccccccc------------
Q psy11767 122 GILGDGSYSVCRRCVEKSTGQEYAVKIISRKI--------DCSEEINLLRACQGHPNICRRCVEKSTG------------ 181 (966)
Q Consensus 122 ~~LG~GsFGkV~La~~k~tg~~yAiKvl~K~~--------~~~~E~~il~~~~~~pfi~~~~~~~~~~------------ 181 (966)
++||+|+||+|++|+++.+|+.||||+++|.. ....|..+|....+||+|+..+..+...
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~~~iv~Ey~~~ 80 (320)
T cd05590 1 RVLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLYCCFQTPDRLFFVMEFVNG 80 (320)
T ss_pred CeeeeCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhccCCCchhceeeEEEcCCEEEEEEcCCCC
Confidence 47999999999999999999999999998742 2356888888887899998732221111
Q ss_pred ------------------hhHHHHHHHh----------hcccchhhhHhhhccCCceEEecCcccc--------------
Q psy11767 182 ------------------QEYAVKIISR----------KIDCSEEINLLRACQGHPNIVNLHCVFQ-------------- 219 (966)
Q Consensus 182 ------------------~~~~~~~v~~----------~~~~~~e~nil~~~~gh~~iv~l~~~~~-------------- 219 (966)
..++.+++.+ ..|+++ .|||.+.+|.++|+||+.+..
T Consensus 81 g~L~~~i~~~~~l~~~~~~~~~~ql~~~L~~lH~~~ivH~dlkp-~NIli~~~~~~kL~DfG~~~~~~~~~~~~~~~~gt 159 (320)
T cd05590 81 GDLMFHIQKSRRFDEARARFYAAEITSALMFLHDKGIIYRDLKL-DNVLLDHEGHCKLADFGMCKEGIFNGKTTSTFCGT 159 (320)
T ss_pred chHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCCH-HHeEECCCCcEEEeeCCCCeecCcCCCcccccccC
Confidence 1111122211 013333 399999999999999985431
Q ss_pred -----ccccccccCCCcceeeechhhHHHHHHHhhCCCCCCCCcHHHHHHHHHhCCCCCCCCCCHHHHHHHHhhcccCCC
Q psy11767 220 -----DEVIDWDDFSRGIECVFFSSSLIIFFIILSFTLSFIHDYYHIQYRRILKTEPPIPEDLSPDVADFISRLLVKDPR 294 (966)
Q Consensus 220 -----~e~i~~~~y~~~~d~~~~~~~~il~~~m~~g~~pf~~~~~~~~~~~I~~~~~~~P~~~s~~a~dli~~LL~kdp~ 294 (966)
+|++....|+...| .| +.|+++|+|++|.+||...+...+++.|+.+.+.+|..++.++++||+++|++||.
T Consensus 160 ~~y~aPE~~~~~~~~~~~D--iw-slG~il~el~~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~li~~~L~~dP~ 236 (320)
T cd05590 160 PDYIAPEILQEMLYGPSVD--WW-AMGVLLYEMLCGHAPFEAENEDDLFEAILNDEVVYPTWLSQDAVDILKAFMTKNPT 236 (320)
T ss_pred ccccCHHHHcCCCCCCccc--hh-hhHHHHHHHhhCCCCCCCCCHHHHHHHHhcCCCCCCCCCCHHHHHHHHHHcccCHH
Confidence 34444445544444 34 55778888999999999999999999999999999999999999999999999999
Q ss_pred cccCCCC-CCHHHHhcCCceeeeCccccccCCCCCCCCccccccccccccccccccCcCCCC
Q psy11767 295 RRLGGGE-LDAEELKRHPFFNVIDWDDLATKRIPAPFVPKISNELDVSNFSDEFTKMIPADS 355 (966)
Q Consensus 295 ~RLG~~~-~g~~~Ik~HpfF~~idW~~l~~k~~~pP~~P~i~~~~D~snFd~ef~~~~p~dS 355 (966)
+|+++.. .|.++|+.||||.+++|+.+..+.++||+.|.+.+..|.+||++++....+..+
T Consensus 237 ~R~~~~~~~~~~~~~~h~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 298 (320)
T cd05590 237 MRLGSLTLGGEEAILRHPFFKELDWEKLNRRQIEPPFRPRIKSREDVSNFDPDFIKEDPVLT 298 (320)
T ss_pred HCCCCCCCCCHHHHHcCCCcCCCCHHHHHhCCCCCCcCCCCCCcchhhhcCcccccCCccCC
Confidence 9998743 367999999999999999999999999999999999999999987766544433
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal |
| >cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Probab=99.93 E-value=1.3e-25 Score=252.12 Aligned_cols=225 Identities=30% Similarity=0.537 Sum_probs=178.8
Q ss_pred eeecccccceEEEEEEcCCCCEEEEEeccccc--------hhhHHHHHHHHhhCCCccccccccccc-------------
Q psy11767 122 GILGDGSYSVCRRCVEKSTGQEYAVKIISRKI--------DCSEEINLLRACQGHPNICRRCVEKST------------- 180 (966)
Q Consensus 122 ~~LG~GsFGkV~La~~k~tg~~yAiKvl~K~~--------~~~~E~~il~~~~~~pfi~~~~~~~~~------------- 180 (966)
++||+|+||+|++|+++.+|+.||||++++.. ...+|..+|.++ +||+|+.....+..
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l-~hp~i~~~~~~~~~~~~~~lv~e~~~~ 79 (323)
T cd05571 1 KLLGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNT-RHPFLTALKYSFQTHDRLCFVMEYANG 79 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhC-CCCCCCCEEEEEEcCCEEEEEEeCCCC
Confidence 57999999999999999999999999998742 345688888887 69999762211111
Q ss_pred -----------------chhHHHHHHHh----------hcccchhhhHhhhccCCceEEecCcccc--------------
Q psy11767 181 -----------------GQEYAVKIISR----------KIDCSEEINLLRACQGHPNIVNLHCVFQ-------------- 219 (966)
Q Consensus 181 -----------------~~~~~~~~v~~----------~~~~~~e~nil~~~~gh~~iv~l~~~~~-------------- 219 (966)
...+..+++.+ ..|++++ |||.+.+|.++|+||+.+..
T Consensus 80 ~~L~~~l~~~~~~~~~~~~~~~~qi~~~L~~lH~~~ivHrDlkp~-NIll~~~~~~kl~DfG~a~~~~~~~~~~~~~~gt 158 (323)
T cd05571 80 GELFFHLSRERVFSEDRARFYGAEIVSALGYLHSCDVVYRDLKLE-NLMLDKDGHIKITDFGLCKEGISDGATMKTFCGT 158 (323)
T ss_pred CcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCeEeCCCCHH-HEEECCCCCEEEeeCCCCcccccCCCcccceecC
Confidence 11111222221 0144444 99999999999999986532
Q ss_pred -----ccccccccCCCcceeeechhhHHHHHHHhhCCCCCCCCcHHHHHHHHHhCCCCCCCCCCHHHHHHHHhhcccCCC
Q psy11767 220 -----DEVIDWDDFSRGIECVFFSSSLIIFFIILSFTLSFIHDYYHIQYRRILKTEPPIPEDLSPDVADFISRLLVKDPR 294 (966)
Q Consensus 220 -----~e~i~~~~y~~~~d~~~~~~~~il~~~m~~g~~pf~~~~~~~~~~~I~~~~~~~P~~~s~~a~dli~~LL~kdp~ 294 (966)
+|++....|+...| .|+.|+++|+|++|.+||...+...+++.|..+.+.+|..+++++++||+++|++||.
T Consensus 159 ~~y~aPE~~~~~~~~~~~D---iwSlG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~~li~~~L~~dP~ 235 (323)
T cd05571 159 PEYLAPEVLEDNDYGRAVD---WWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEIRFPRTLSPEAKSLLAGLLKKDPK 235 (323)
T ss_pred ccccChhhhcCCCCCcccc---CcccchhhhhhhcCCCCCCCCCHHHHHHHHHcCCCCCCCCCCHHHHHHHHHHccCCHH
Confidence 34555555655555 3356688888899999999999999999999999999999999999999999999999
Q ss_pred cccCCCCCCHHHHhcCCceeeeCccccccCCCCCCCCccccccccccccccccccCc
Q psy11767 295 RRLGGGELDAEELKRHPFFNVIDWDDLATKRIPAPFVPKISNELDVSNFSDEFTKMI 351 (966)
Q Consensus 295 ~RLG~~~~g~~~Ik~HpfF~~idW~~l~~k~~~pP~~P~i~~~~D~snFd~ef~~~~ 351 (966)
+|++.....+.+|++||||.+++|+.+..+.++||+.|.+....|..+|+++++...
T Consensus 236 ~R~~~~~~~~~~ll~h~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 292 (323)
T cd05571 236 QRLGGGPEDAKEIMEHRFFASINWQDVVQKKLEPPFKPQVTSETDTRYFDEEFTAQS 292 (323)
T ss_pred HcCCCCCCCHHHHHcCCCcCCCCHHHHHhCCCCCCcCCCCCCcchhhhcCcccccCC
Confidence 999876567999999999999999999999999999999999999999998876643
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be |
| >cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.93 E-value=2.9e-25 Score=245.50 Aligned_cols=224 Identities=28% Similarity=0.477 Sum_probs=180.1
Q ss_pred CcceeeeecccccceEEEEEEcCCCCEEEEEeccccc--------hhhHHHHHHHHhhCCCccccccccccc--------
Q psy11767 117 DLDKAGILGDGSYSVCRRCVEKSTGQEYAVKIISRKI--------DCSEEINLLRACQGHPNICRRCVEKST-------- 180 (966)
Q Consensus 117 df~~~~~LG~GsFGkV~La~~k~tg~~yAiKvl~K~~--------~~~~E~~il~~~~~~pfi~~~~~~~~~-------- 180 (966)
||++.++||+|+||+|++|+++.+|+.||||++++.. ...+|..+|+++ +||+|++.+.....
T Consensus 2 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l-~hp~iv~~~~~~~~~~~~~lv~ 80 (291)
T cd05612 2 DLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEV-SHPFIIRLFWTEHDQRFLYMLM 80 (291)
T ss_pred CceeeeeeecCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhhHHHHHHHHHHHHHHhC-CCCcHhhhHhhhccCCeEEEEE
Confidence 6899999999999999999999999999999997531 356788999887 69999862211110
Q ss_pred ----------------------chhHHHHHHHhh----------cccchhhhHhhhccCCceEEecCccc----------
Q psy11767 181 ----------------------GQEYAVKIISRK----------IDCSEEINLLRACQGHPNIVNLHCVF---------- 218 (966)
Q Consensus 181 ----------------------~~~~~~~~v~~~----------~~~~~e~nil~~~~gh~~iv~l~~~~---------- 218 (966)
...++.+++.+. .|++++ |||.+.+|.++|+||+.+.
T Consensus 81 e~~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~-NIli~~~~~~kl~Dfg~~~~~~~~~~~~~ 159 (291)
T cd05612 81 EYVPGGELFSYLRNSGRFSNSTGLFYASEIVCALEYLHSKEIVYRDLKPE-NILLDKEGHIKLTDFGFAKKLRDRTWTLC 159 (291)
T ss_pred eCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHH-HeEECCCCCEEEEecCcchhccCCccccc
Confidence 011112222220 133334 9999999999999998653
Q ss_pred ------cccccccccCCCcceeeechhhHHHHHHHhhCCCCCCCCcHHHHHHHHHhCCCCCCCCCCHHHHHHHHhhcccC
Q psy11767 219 ------QDEVIDWDDFSRGIECVFFSSSLIIFFIILSFTLSFIHDYYHIQYRRILKTEPPIPEDLSPDVADFISRLLVKD 292 (966)
Q Consensus 219 ------~~e~i~~~~y~~~~d~~~~~~~~il~~~m~~g~~pf~~~~~~~~~~~I~~~~~~~P~~~s~~a~dli~~LL~kd 292 (966)
.+|++....++...| .|+.|+++|+|++|.+||...+...+++.|..+.+.+|..++++++|||+++|++|
T Consensus 160 gt~~y~aPE~~~~~~~~~~~D---iwSlG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~li~~~l~~d 236 (291)
T cd05612 160 GTPEYLAPEVIQSKGHNKAVD---WWALGILIYEMLVGYPPFFDDNPFGIYEKILAGKLEFPRHLDLYAKDLIKKLLVVD 236 (291)
T ss_pred CChhhcCHHHHcCCCCCchhh---HHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCcCCCccCCHHHHHHHHHHcCCC
Confidence 245555555654444 34567888888999999999999999999999999999999999999999999999
Q ss_pred CCcccCCCCCCHHHHhcCCceeeeCccccccCCCCCCCCcccccccccccccc
Q psy11767 293 PRRRLGGGELDAEELKRHPFFNVIDWDDLATKRIPAPFVPKISNELDVSNFSD 345 (966)
Q Consensus 293 p~~RLG~~~~g~~~Ik~HpfF~~idW~~l~~k~~~pP~~P~i~~~~D~snFd~ 345 (966)
|.+|+++....+++++.||||..++|..+..++..||..|.+....|+.||++
T Consensus 237 p~~R~~~~~~~~~~~l~h~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~ 289 (291)
T cd05612 237 RTRRLGNMKNGADDVKNHRWFKSVDWDDVPQRKLKPPIVPKVSHDGDTSNFDD 289 (291)
T ss_pred HHHccCCccCCHHHHhcCccccCCCHHHHhcCCCCCCEeCCCCCccccccccC
Confidence 99999877778999999999999999999999999999999999999999986
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt |
| >PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=99.93 E-value=4.1e-25 Score=250.36 Aligned_cols=224 Identities=25% Similarity=0.334 Sum_probs=178.0
Q ss_pred CcceeeeecccccceEEEEEEcCCC-CEEEEEeccccc--------hhhHHHHHHHHhhCCCccccccccccc-------
Q psy11767 117 DLDKAGILGDGSYSVCRRCVEKSTG-QEYAVKIISRKI--------DCSEEINLLRACQGHPNICRRCVEKST------- 180 (966)
Q Consensus 117 df~~~~~LG~GsFGkV~La~~k~tg-~~yAiKvl~K~~--------~~~~E~~il~~~~~~pfi~~~~~~~~~------- 180 (966)
||++.+.||+|+||+|++|+++.++ ..||+|++++.. ...+|..+|+.+ +||+|++..-.+..
T Consensus 31 ~y~~~~~ig~G~~g~Vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~hp~Iv~~~~~~~~~~~~~lv 109 (340)
T PTZ00426 31 DFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYI-NHPFCVNLYGSFKDESYLYLV 109 (340)
T ss_pred hcEEEEEEeecCCeEEEEEEEECCCCeEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhC-CCCCCcceEEEEEeCCEEEEE
Confidence 7899999999999999999987765 789999997642 345688999887 69999862111111
Q ss_pred -----------------------chhHHHHHHHh----------hcccchhhhHhhhccCCceEEecCcccc--------
Q psy11767 181 -----------------------GQEYAVKIISR----------KIDCSEEINLLRACQGHPNIVNLHCVFQ-------- 219 (966)
Q Consensus 181 -----------------------~~~~~~~~v~~----------~~~~~~e~nil~~~~gh~~iv~l~~~~~-------- 219 (966)
...++.+++.+ ..|++++ |||.+.+|+++|.||+.+..
T Consensus 110 ~Ey~~~g~L~~~i~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDLkp~-NILl~~~~~ikL~DFG~a~~~~~~~~~~ 188 (340)
T PTZ00426 110 LEFVIGGEFFTFLRRNKRFPNDVGCFYAAQIVLIFEYLQSLNIVYRDLKPE-NLLLDKDGFIKMTDFGFAKVVDTRTYTL 188 (340)
T ss_pred EeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEccCCCHH-HEEECCCCCEEEecCCCCeecCCCccee
Confidence 11122222211 1234444 99999999999999987632
Q ss_pred --------ccccccccCCCcceeeechhhHHHHHHHhhCCCCCCCCcHHHHHHHHHhCCCCCCCCCCHHHHHHHHhhccc
Q psy11767 220 --------DEVIDWDDFSRGIECVFFSSSLIIFFIILSFTLSFIHDYYHIQYRRILKTEPPIPEDLSPDVADFISRLLVK 291 (966)
Q Consensus 220 --------~e~i~~~~y~~~~d~~~~~~~~il~~~m~~g~~pf~~~~~~~~~~~I~~~~~~~P~~~s~~a~dli~~LL~k 291 (966)
+|++....|+...| +|+.|+++|+|++|.+||...+...++++|+.+.+.+|..+++++++||+++|++
T Consensus 189 ~gt~~y~aPE~~~~~~~~~~~D---iwSlGvil~ell~G~~Pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~li~~~l~~ 265 (340)
T PTZ00426 189 CGTPEYIAPEILLNVGHGKAAD---WWTLGIFIYEILVGCPPFYANEPLLIYQKILEGIIYFPKFLDNNCKHLMKKLLSH 265 (340)
T ss_pred cCChhhcCHHHHhCCCCCcccc---ccchhhHHHHHhcCCCCCCCCCHHHHHHHHhcCCCCCCCCCCHHHHHHHHHHccc
Confidence 34555555554444 4466788888999999999999999999999999999999999999999999999
Q ss_pred CCCcccCCCCCCHHHHhcCCceeeeCccccccCCCCCCCCcccccccccccccc
Q psy11767 292 DPRRRLGGGELDAEELKRHPFFNVIDWDDLATKRIPAPFVPKISNELDVSNFSD 345 (966)
Q Consensus 292 dp~~RLG~~~~g~~~Ik~HpfF~~idW~~l~~k~~~pP~~P~i~~~~D~snFd~ 345 (966)
||.+|+++...++++|+.||||.+++|..+..+.+++|+.|......+.++|..
T Consensus 266 dp~~R~~~~~~~~~~~~~hp~f~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~ 319 (340)
T PTZ00426 266 DLTKRYGNLKKGAQNVKEHPWFGNIDWVSLLHKNVEVPYKPKYKNVFDSSNFER 319 (340)
T ss_pred CHHHcCCCCCCCHHHHHcCCCcCCCCHHHHHhCCCCCCcCCCCCCCcchhhcCC
Confidence 999999877678999999999999999999999999999999988888888864
|
|
| >PLN00181 protein SPA1-RELATED; Provisional | Back alignment and domain information |
|---|
Probab=99.92 E-value=5.2e-26 Score=285.05 Aligned_cols=194 Identities=19% Similarity=0.228 Sum_probs=141.7
Q ss_pred C-CCceEEEEEE-------EeCCeEEEEEEccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCC
Q psy11767 430 H-PNIVNLHCVF-------QDEVHTYLVLELLKGGELLDRIRQKGRCGFTENEASRIMRQLVAAVHFMHSRGVVHRDLKP 501 (966)
Q Consensus 430 H-pnIV~l~~~~-------~~~~~~~lVmEy~~gg~L~~~l~~~~~~~l~e~~~~~i~~Qil~aL~yLHs~~IiHRDLKP 501 (966)
| +||++++++| .+...++++|||+ +++|.++|.... ..+++.+++.|+.||+.||+|||++||+||||||
T Consensus 31 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~-~~~L~~~l~~~~-~~~~~~~~~~i~~qi~~al~~lH~~gIvHrDlKP 108 (793)
T PLN00181 31 HIDYVRSLLGSHKEGNLDGLDDDSIVRALECE-DVSLRQWLDNPD-RSVDAFECFHVFRQIVEIVNAAHSQGIVVHNVRP 108 (793)
T ss_pred HHHHHHHhhcccCCccccccccchhhhhhccC-CccHHHHHhccc-ccccHHHHHHHHHHHHHHHHHHHhCCeeeccCCc
Confidence 5 6888888887 2334577889987 679999997543 3699999999999999999999999999999999
Q ss_pred CcEEEec-----------------CCCCCEEEEeecccccccCC-------------------CccccccccccCchhhc
Q psy11767 502 ENLLFSD-----------------PAGDNIKVVDFGFACLKRES-------------------LHTPCFTLQYAAPEVLR 545 (966)
Q Consensus 502 ~NILl~~-----------------~~~~~iKL~DFGla~~~~~~-------------------~~~~~gT~~Y~APEvl~ 545 (966)
+||||+. ...+.+||+|||+++..... ....++|++|||||++.
T Consensus 109 ~NiLl~~~~~~k~~d~~~~~~~~~~~~~~~ki~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~ 188 (793)
T PLN00181 109 SCFVMSSFNHVSFIESASCSDSGSDEDATTKSREIGSSRREEILSERRIEKLEEVKKQPFPMKQILAMEMSWYTSPEEDN 188 (793)
T ss_pred hhEEEcccCcEEEeeccccCcccccccCcccccccccccccccccccchhhhhccccCCCcccccccCCCcceEChhhhc
Confidence 9999953 12346788888887532110 01235789999999985
Q ss_pred cCCCCCCCcccchhhhhhhhhhhhcCCCCCCCcCcchhHHHHHHHHhcCCCCCCCCCCchhHHHHHHHHHcCCCCCCchh
Q psy11767 546 QDKSGYDENCDLWSLGVILVNVLRQDKSGYDENCDLWSLGVILYTMLCGRVPFHARSRDDSALSIMARIKEGQFNFDAEA 625 (966)
Q Consensus 546 ~~~~~~~~~~Di~SlGvil~el~~~~~~~y~~~~DIWSlGvilyemltG~~Pf~~~~~~~~~~~~~~~i~~~~~~~~~~~ 625 (966)
. ..|+.++|||||||+||||++|.+|+.... ..+..+..... ++ .
T Consensus 189 ~--------------------------~~~~~~sDVwSlGviL~ELl~~~~~~~~~~------~~~~~~~~~~~--~~-~ 233 (793)
T PLN00181 189 G--------------------------SSSNCASDVYRLGVLLFELFCPVSSREEKS------RTMSSLRHRVL--PP-Q 233 (793)
T ss_pred c--------------------------CCCCchhhhhhHHHHHHHHhhCCCchhhHH------HHHHHHHHhhc--Ch-h
Confidence 2 237889999999999999999999876421 11222222111 11 1
Q ss_pred hccCCHHHHHHHHHhcccCccccCChHHHHHHhhhhH
Q psy11767 626 WSTVSSEAKELTKSLLTVNPAQRIRMMRVKLTFHAFH 662 (966)
Q Consensus 626 ~~~is~e~~~Li~~~L~~dP~~R~t~~~v~~~~~~~~ 662 (966)
+....++..+++.+||..||.+||++.++. .|+|.
T Consensus 234 ~~~~~~~~~~~~~~~L~~~P~~Rps~~eil--~h~~~ 268 (793)
T PLN00181 234 ILLNWPKEASFCLWLLHPEPSCRPSMSELL--QSEFI 268 (793)
T ss_pred hhhcCHHHHHHHHHhCCCChhhCcChHHHh--hchhh
Confidence 112345677899999999999999999863 34444
|
|
| >cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Probab=99.92 E-value=7.5e-25 Score=246.05 Aligned_cols=234 Identities=29% Similarity=0.469 Sum_probs=182.0
Q ss_pred cceeeeecccccceEEEEEEcCCCCEEEEEeccccc--------hhhHHHHHHHHh--hCCCccccccccccc-------
Q psy11767 118 LDKAGILGDGSYSVCRRCVEKSTGQEYAVKIISRKI--------DCSEEINLLRAC--QGHPNICRRCVEKST------- 180 (966)
Q Consensus 118 f~~~~~LG~GsFGkV~La~~k~tg~~yAiKvl~K~~--------~~~~E~~il~~~--~~~pfi~~~~~~~~~------- 180 (966)
|+++++||+|+||+|++|+++.+|+.||||++++.. ....|+.++... .+||+|++....+..
T Consensus 1 y~i~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~l~~e~~~~~~~~~l~hp~i~~~~~~~~~~~~~~lv 80 (324)
T cd05589 1 FRCLAVLGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPFLVNLFACFQTEDHVCFV 80 (324)
T ss_pred CeEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccccCCCChhceeeEEEcCCEEEEE
Confidence 678999999999999999999999999999998642 245667766543 369999862211111
Q ss_pred ----------------------chhHHHHHHHhh----------cccchhhhHhhhccCCceEEecCcccc---------
Q psy11767 181 ----------------------GQEYAVKIISRK----------IDCSEEINLLRACQGHPNIVNLHCVFQ--------- 219 (966)
Q Consensus 181 ----------------------~~~~~~~~v~~~----------~~~~~e~nil~~~~gh~~iv~l~~~~~--------- 219 (966)
...++.+++.+. .|++++ |||.+.+|.++|.||+.+..
T Consensus 81 ~E~~~~~~L~~~~~~~~l~~~~~~~~~~qi~~al~~lH~~~ivHrdlkp~-Nill~~~~~~kL~Dfg~~~~~~~~~~~~~ 159 (324)
T cd05589 81 MEYAAGGDLMMHIHTDVFSEPRAVFYAACVVLGLQYLHENKIVYRDLKLD-NLLLDTEGFVKIADFGLCKEGMGFGDRTS 159 (324)
T ss_pred EcCCCCCcHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEecCCCHH-HeEECCCCcEEeCcccCCccCCCCCCccc
Confidence 111222222210 134444 99999999999999985432
Q ss_pred ----------ccccccccCCCcceeeechhhHHHHHHHhhCCCCCCCCcHHHHHHHHHhCCCCCCCCCCHHHHHHHHhhc
Q psy11767 220 ----------DEVIDWDDFSRGIECVFFSSSLIIFFIILSFTLSFIHDYYHIQYRRILKTEPPIPEDLSPDVADFISRLL 289 (966)
Q Consensus 220 ----------~e~i~~~~y~~~~d~~~~~~~~il~~~m~~g~~pf~~~~~~~~~~~I~~~~~~~P~~~s~~a~dli~~LL 289 (966)
+|++....|+... |.| +.|+++|+|++|.+||...+...++++|..+.+.+|..+++++.+||+++|
T Consensus 160 ~~~g~~~y~aPE~~~~~~~~~~~--Diw-slG~il~el~~G~~pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~li~~~L 236 (324)
T cd05589 160 TFCGTPEFLAPEVLTETSYTRAV--DWW-GLGVLIYEMLVGESPFPGDDEEEVFDSIVNDEVRYPRFLSREAISIMRRLL 236 (324)
T ss_pred ccccCccccCHhHhcCCCCCccc--chh-hHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCCCCCHHHHHHHHHHh
Confidence 3444444554333 344 557788888899999999999999999999999999999999999999999
Q ss_pred ccCCCcccCCCCCCHHHHhcCCceeeeCccccccCCCCCCCCccccccccccccccccccCcCCCC
Q psy11767 290 VKDPRRRLGGGELDAEELKRHPFFNVIDWDDLATKRIPAPFVPKISNELDVSNFSDEFTKMIPADS 355 (966)
Q Consensus 290 ~kdp~~RLG~~~~g~~~Ik~HpfF~~idW~~l~~k~~~pP~~P~i~~~~D~snFd~ef~~~~p~dS 355 (966)
++||.+|++.....+.+|+.||||++++|+.+..+.++||+.|.+....|.++|+.++....+...
T Consensus 237 ~~dP~~R~~~~~~~~~~l~~~~~f~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~ 302 (324)
T cd05589 237 RRNPERRLGSGEKDAEDVKKQPFFRDINWDDLLARKIKPPFVPTIKGPEDVSNFDEEFTSEAPVLT 302 (324)
T ss_pred hcCHhHcCCCCCCCHHHHhhCCCcCCCCHHHHHhCCCCcCccCCCCCcchhhhcCccccccccccC
Confidence 999999998877789999999999999999999999999999999999999999988766554433
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved |
| >cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Probab=99.92 E-value=1.1e-24 Score=248.77 Aligned_cols=221 Identities=22% Similarity=0.377 Sum_probs=168.6
Q ss_pred CcceeeeecccccceEEEEEEcCCCCEEEEEeccccc--------hhhHHHHHHHHhhCCCccccccccccc--------
Q psy11767 117 DLDKAGILGDGSYSVCRRCVEKSTGQEYAVKIISRKI--------DCSEEINLLRACQGHPNICRRCVEKST-------- 180 (966)
Q Consensus 117 df~~~~~LG~GsFGkV~La~~k~tg~~yAiKvl~K~~--------~~~~E~~il~~~~~~pfi~~~~~~~~~-------- 180 (966)
||+++++||+|+||+|++|+++.+|+.||||+++|.. ....|+.+|.++ +||+|+..+..+..
T Consensus 2 ~y~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~~-~~~~iv~~~~~~~~~~~~~lv~ 80 (363)
T cd05628 2 DFESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEA-DSLWVVKMFYSFQDKLNLYLIM 80 (363)
T ss_pred CceEeEEEEeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHhC-CCCCcceEEEEEecCCeEEEEE
Confidence 7899999999999999999999999999999998742 356788999887 69999862222111
Q ss_pred ----------------------chhHHHHHHHh----------hcccchhhhHhhhccCCceEEecCccc----------
Q psy11767 181 ----------------------GQEYAVKIISR----------KIDCSEEINLLRACQGHPNIVNLHCVF---------- 218 (966)
Q Consensus 181 ----------------------~~~~~~~~v~~----------~~~~~~e~nil~~~~gh~~iv~l~~~~---------- 218 (966)
.+.++.+++.+ ..|++++ |||.+.+|+++|+||+.+.
T Consensus 81 E~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH~~givHrDlKp~-NILi~~~~~vkL~DFGla~~~~~~~~~~~ 159 (363)
T cd05628 81 EFLPGGDMMTLLMKKDTLTEEETQFYIAETVLAIDSIHQLGFIHRDIKPD-NLLLDSKGHVKLSDFGLCTGLKKAHRTEF 159 (363)
T ss_pred cCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEecCCCHH-HeEECCCCCEEEeeccCcccccccccccc
Confidence 12222333322 1245555 9999999999999998642
Q ss_pred --------------------------------------------cccccccccCCCcceeeechhhHHHHHHHhhCCCCC
Q psy11767 219 --------------------------------------------QDEVIDWDDFSRGIECVFFSSSLIIFFIILSFTLSF 254 (966)
Q Consensus 219 --------------------------------------------~~e~i~~~~y~~~~d~~~~~~~~il~~~m~~g~~pf 254 (966)
.+|++...+|+...| +|+.|+++|+|++|.+||
T Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~D---vwSlGvil~ell~G~~Pf 236 (363)
T cd05628 160 YRNLNHSLPSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCD---WWSLGVIMYEMLIGYPPF 236 (363)
T ss_pred cccccccccccccccccccccccchhhhccccccccccCCccccCHHHHcCCCCCCchh---hhhhHHHHHHHHhCCCCC
Confidence 134444445554444 456778889999999999
Q ss_pred CCCcHHHHHHHHHh--CCCCCCCC--CCHHHHHHHHhhcccCCCcccCCCCCCHHHHhcCCceeeeCccccccCCCCCCC
Q psy11767 255 IHDYYHIQYRRILK--TEPPIPED--LSPDVADFISRLLVKDPRRRLGGGELDAEELKRHPFFNVIDWDDLATKRIPAPF 330 (966)
Q Consensus 255 ~~~~~~~~~~~I~~--~~~~~P~~--~s~~a~dli~~LL~kdp~~RLG~~~~g~~~Ik~HpfF~~idW~~l~~k~~~pP~ 330 (966)
...+...++++|++ ..+.||+. +|++++|||.+||+ +|.+|++. .++++|++||||+++||+.+..+..++|+
T Consensus 237 ~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~~li~~l~~-~~~~r~~r--~~~~ei~~hp~f~~~~~~~~~~~~~~~~~ 313 (363)
T cd05628 237 CSETPQETYKKVMNWKETLIFPPEVPISEKAKDLILRFCC-EWEHRIGA--PGVEEIKTNPFFEGVDWEHIRERPAAIPI 313 (363)
T ss_pred CCCCHHHHHHHHHcCcCcccCCCcCCCCHHHHHHHHHHcC-ChhhcCCC--CCHHHHhCCCCCCCCCHHHHHhCCCCCCc
Confidence 99999999999997 45678864 79999999999986 89999874 47999999999999999999877666554
Q ss_pred Ccccccccccccccccc
Q psy11767 331 VPKISNELDVSNFSDEF 347 (966)
Q Consensus 331 ~P~i~~~~D~snFd~ef 347 (966)
.+.+..|.++|+...
T Consensus 314 --~~~~~~~~~~~~~~~ 328 (363)
T cd05628 314 --EIKSIDDTSNFDEFP 328 (363)
T ss_pred --cCCCcchhhccCCCC
Confidence 456677888888643
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus |
| >cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Probab=99.92 E-value=7.3e-25 Score=245.79 Aligned_cols=227 Identities=25% Similarity=0.443 Sum_probs=177.5
Q ss_pred eeecccccceEEEEEEcCCCCEEEEEeccccc--------hhhHHHHHHHHhhCCCccccccccccc-------------
Q psy11767 122 GILGDGSYSVCRRCVEKSTGQEYAVKIISRKI--------DCSEEINLLRACQGHPNICRRCVEKST------------- 180 (966)
Q Consensus 122 ~~LG~GsFGkV~La~~k~tg~~yAiKvl~K~~--------~~~~E~~il~~~~~~pfi~~~~~~~~~------------- 180 (966)
++||+|+||+|++|+++.+|+.||||++++.. ....|..+|....+||+|+.....+..
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~ 80 (321)
T cd05591 1 KVLGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTALHCCFQTKDRLFFVMEYVNG 80 (321)
T ss_pred CccccCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCeEEEEEeCCCC
Confidence 47999999999999999999999999998742 235688888888899999762211111
Q ss_pred -----------------chhHHHHHHHh----------hcccchhhhHhhhccCCceEEecCcccc--------------
Q psy11767 181 -----------------GQEYAVKIISR----------KIDCSEEINLLRACQGHPNIVNLHCVFQ-------------- 219 (966)
Q Consensus 181 -----------------~~~~~~~~v~~----------~~~~~~e~nil~~~~gh~~iv~l~~~~~-------------- 219 (966)
...++.+++.+ ..|++++ |||.+.+|+++|.||+.+..
T Consensus 81 ~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~-Nill~~~~~~kL~Dfg~~~~~~~~~~~~~~~~gt 159 (321)
T cd05591 81 GDLMFQIQRSRKFDEPRSRFYAAEVTLALMFLHRHGVIYRDLKLD-NILLDAEGHCKLADFGMCKEGILNGVTTTTFCGT 159 (321)
T ss_pred CcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHH-HeEECCCCCEEEeecccceecccCCccccccccC
Confidence 01111222211 1134444 99999999999999985431
Q ss_pred -----ccccccccCCCcceeeechhhHHHHHHHhhCCCCCCCCcHHHHHHHHHhCCCCCCCCCCHHHHHHHHhhcccCCC
Q psy11767 220 -----DEVIDWDDFSRGIECVFFSSSLIIFFIILSFTLSFIHDYYHIQYRRILKTEPPIPEDLSPDVADFISRLLVKDPR 294 (966)
Q Consensus 220 -----~e~i~~~~y~~~~d~~~~~~~~il~~~m~~g~~pf~~~~~~~~~~~I~~~~~~~P~~~s~~a~dli~~LL~kdp~ 294 (966)
+|++....|+...| .| +.|+++|+|++|.+||...+...+++.|+.+.+.+|..+++++++||+++|++||.
T Consensus 160 ~~y~aPE~~~~~~~~~~~D--vw-slG~il~el~tg~~Pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~ll~~~L~~dp~ 236 (321)
T cd05591 160 PDYIAPEILQELEYGPSVD--WW-ALGVLMYEMMAGQPPFEADNEDDLFESILHDDVLYPVWLSKEAVSILKAFMTKNPN 236 (321)
T ss_pred ccccCHHHHcCCCCCCccc--ee-chhHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCCCCCCCHHHHHHHHHHhccCHH
Confidence 34444445554444 34 56777888899999999999999999999999999999999999999999999999
Q ss_pred cccCCCCC--CHHHHhcCCceeeeCccccccCCCCCCCCccccccccccccccccccCcC
Q psy11767 295 RRLGGGEL--DAEELKRHPFFNVIDWDDLATKRIPAPFVPKISNELDVSNFSDEFTKMIP 352 (966)
Q Consensus 295 ~RLG~~~~--g~~~Ik~HpfF~~idW~~l~~k~~~pP~~P~i~~~~D~snFd~ef~~~~p 352 (966)
+|+++... .+++|++||||.+++|+.+..+++.+|+.|......+.++|+..|....+
T Consensus 237 ~R~~~~~~~~~~~~~~~hp~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 296 (321)
T cd05591 237 KRLGCVASQGGEDAIKQHPFFKEIDWVLLEQRKIKPPFKPKIKTKRDVNNFDQDFTKEEP 296 (321)
T ss_pred HcCCCCCCCCCHHHHhcCCccCCCCHHHHHhCCCCCCCCCCCCCcchhhhcCCccccCcc
Confidence 99987432 68999999999999999999999999999999888888999887765433
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to |
| >cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Probab=99.92 E-value=1.1e-24 Score=245.08 Aligned_cols=224 Identities=24% Similarity=0.431 Sum_probs=173.3
Q ss_pred eeecccccceEEEEEEcCCCCEEEEEeccccc--------hhhHHHHHHHHhhCCCccccccccccc-------------
Q psy11767 122 GILGDGSYSVCRRCVEKSTGQEYAVKIISRKI--------DCSEEINLLRACQGHPNICRRCVEKST------------- 180 (966)
Q Consensus 122 ~~LG~GsFGkV~La~~k~tg~~yAiKvl~K~~--------~~~~E~~il~~~~~~pfi~~~~~~~~~------------- 180 (966)
++||+|+||+|++|+.+.+++.||+|+++|.. ....|..++.++.+||+|+.....+..
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (327)
T cd05617 1 RVIGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGLHSCFQTTSRLFLVIEYVNG 80 (327)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhhcCCCCEeeEEEEEEeCCEEEEEEeCCCC
Confidence 47999999999999999999999999999752 246788999999899999762211111
Q ss_pred -----------------chhHHHHHHHh----------hcccchhhhHhhhccCCceEEecCcccc--------------
Q psy11767 181 -----------------GQEYAVKIISR----------KIDCSEEINLLRACQGHPNIVNLHCVFQ-------------- 219 (966)
Q Consensus 181 -----------------~~~~~~~~v~~----------~~~~~~e~nil~~~~gh~~iv~l~~~~~-------------- 219 (966)
...++.+++.+ ..|++++ |||.+.+|+++|+||+.+..
T Consensus 81 ~~L~~~~~~~~~l~~~~~~~~~~qi~~al~~lH~~~ivHrDlkp~-Nili~~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt 159 (327)
T cd05617 81 GDLMFHMQRQRKLPEEHARFYAAEICIALNFLHERGIIYRDLKLD-NVLLDADGHIKLTDYGMCKEGLGPGDTTSTFCGT 159 (327)
T ss_pred CcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHH-HEEEeCCCCEEEeccccceeccCCCCceecccCC
Confidence 11222222222 1244444 99999999999999985532
Q ss_pred -----ccccccccCCCcceeeechhhHHHHHHHhhCCCCCCC-------CcHHHHHHHHHhCCCCCCCCCCHHHHHHHHh
Q psy11767 220 -----DEVIDWDDFSRGIECVFFSSSLIIFFIILSFTLSFIH-------DYYHIQYRRILKTEPPIPEDLSPDVADFISR 287 (966)
Q Consensus 220 -----~e~i~~~~y~~~~d~~~~~~~~il~~~m~~g~~pf~~-------~~~~~~~~~I~~~~~~~P~~~s~~a~dli~~ 287 (966)
+|++....|+...| .| +.|+++|+|++|.+||.. +....+++.|+...+.+|..+++++++||++
T Consensus 160 ~~y~aPE~~~~~~~~~~~D--iw-slGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~li~~ 236 (327)
T cd05617 160 PNYIAPEILRGEEYGFSVD--WW-ALGVLMFEMMAGRSPFDIITDNPDMNTEDYLFQVILEKPIRIPRFLSVKASHVLKG 236 (327)
T ss_pred cccCCHHHHCCCCCCchhe--ee-hhHHHHHHHHhCCCCCCccCCCcccccHHHHHHHHHhCCCCCCCCCCHHHHHHHHH
Confidence 34454455554444 34 567888888899999952 3345678899999999999999999999999
Q ss_pred hcccCCCcccCCC-CCCHHHHhcCCceeeeCccccccCCCCCCCCcccccccccccccccccc
Q psy11767 288 LLVKDPRRRLGGG-ELDAEELKRHPFFNVIDWDDLATKRIPAPFVPKISNELDVSNFSDEFTK 349 (966)
Q Consensus 288 LL~kdp~~RLG~~-~~g~~~Ik~HpfF~~idW~~l~~k~~~pP~~P~i~~~~D~snFd~ef~~ 349 (966)
||++||.+|+++. ..++++|+.||||++++|+.+..++++|||.|.+....+.++|+..+..
T Consensus 237 ~L~~dP~~R~~~~~~~~~~~i~~h~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 299 (327)
T cd05617 237 FLNKDPKERLGCQPQTGFSDIKSHTFFRSIDWDLLEKKQVTPPFKPQITDDYGLENFDTQFTS 299 (327)
T ss_pred HhccCHHHcCCCCCCCCHHHHHcCCCCCCCCHHHHHhCCCCCCccCCCCCCcchhhcCCcccc
Confidence 9999999999863 2478999999999999999999999999999999888888999876643
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways |
| >cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Probab=99.92 E-value=1.7e-24 Score=243.90 Aligned_cols=225 Identities=30% Similarity=0.533 Sum_probs=177.7
Q ss_pred eeecccccceEEEEEEcCCCCEEEEEeccccc--------hhhHHHHHHHHhhCCCcccccccccccc------------
Q psy11767 122 GILGDGSYSVCRRCVEKSTGQEYAVKIISRKI--------DCSEEINLLRACQGHPNICRRCVEKSTG------------ 181 (966)
Q Consensus 122 ~~LG~GsFGkV~La~~k~tg~~yAiKvl~K~~--------~~~~E~~il~~~~~~pfi~~~~~~~~~~------------ 181 (966)
++||+|+||+|++|+++.+|+.||||++++.. ...+|..+|+.+ +||+|+.....+...
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l-~hp~iv~~~~~~~~~~~~~lv~Ey~~~ 79 (328)
T cd05593 1 KLLGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNT-RHPFLTSLKYSFQTKDRLCFVMEYVNG 79 (328)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhC-CCCCCcceEEEEEcCCEEEEEEeCCCC
Confidence 57999999999999999999999999998752 245678888776 699997622111110
Q ss_pred ------------------hhHHHHHHHh----------hcccchhhhHhhhccCCceEEecCcccc--------------
Q psy11767 182 ------------------QEYAVKIISR----------KIDCSEEINLLRACQGHPNIVNLHCVFQ-------------- 219 (966)
Q Consensus 182 ------------------~~~~~~~v~~----------~~~~~~e~nil~~~~gh~~iv~l~~~~~-------------- 219 (966)
..++.+++.+ ..|++++ |||.+.+|.++|+||+.+..
T Consensus 80 g~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~-NIll~~~~~~kL~DfG~~~~~~~~~~~~~~~~gt 158 (328)
T cd05593 80 GELFFHLSRERVFSEDRTRFYGAEIVSALDYLHSGKIVYRDLKLE-NLMLDKDGHIKITDFGLCKEGITDAATMKTFCGT 158 (328)
T ss_pred CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEecccCHH-HeEECCCCcEEEecCcCCccCCCcccccccccCC
Confidence 1111222221 0134444 99999999999999986432
Q ss_pred -----ccccccccCCCcceeeechhhHHHHHHHhhCCCCCCCCcHHHHHHHHHhCCCCCCCCCCHHHHHHHHhhcccCCC
Q psy11767 220 -----DEVIDWDDFSRGIECVFFSSSLIIFFIILSFTLSFIHDYYHIQYRRILKTEPPIPEDLSPDVADFISRLLVKDPR 294 (966)
Q Consensus 220 -----~e~i~~~~y~~~~d~~~~~~~~il~~~m~~g~~pf~~~~~~~~~~~I~~~~~~~P~~~s~~a~dli~~LL~kdp~ 294 (966)
+|++....|+...| +|+.|+++|+|++|.+||...+...+++.|+...+.+|..+++++++||+++|++||.
T Consensus 159 ~~y~aPE~~~~~~~~~~~D---iwslGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~~li~~~L~~dP~ 235 (328)
T cd05593 159 PEYLAPEVLEDNDYGRAVD---WWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEDIKFPRTLSADAKSLLSGLLIKDPN 235 (328)
T ss_pred cCccChhhhcCCCCCccCC---ccccchHHHHHhhCCCCCCCCCHHHHHHHhccCCccCCCCCCHHHHHHHHHHcCCCHH
Confidence 34454455554444 3356678888889999999988888999999999999999999999999999999999
Q ss_pred cccCCCCCCHHHHhcCCceeeeCccccccCCCCCCCCccccccccccccccccccCc
Q psy11767 295 RRLGGGELDAEELKRHPFFNVIDWDDLATKRIPAPFVPKISNELDVSNFSDEFTKMI 351 (966)
Q Consensus 295 ~RLG~~~~g~~~Ik~HpfF~~idW~~l~~k~~~pP~~P~i~~~~D~snFd~ef~~~~ 351 (966)
+|+++....+.+|++||||.+++|..+..+.+.||+.|...+..+..+|+.+|+...
T Consensus 236 ~R~~~~~~~~~~il~h~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 292 (328)
T cd05593 236 KRLGGGPDDAKEIMRHSFFTGVNWQDVYDKKLVPPFKPQVTSETDTRYFDEEFTAQT 292 (328)
T ss_pred HcCCCCCCCHHHHhcCCCcCCCCHHHHHhCCCCCCcCCcCCCcchhhhcCcccccCC
Confidence 999876668999999999999999999999999999999999999999998886543
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate |
| >KOG0580|consensus | Back alignment and domain information |
|---|
Probab=99.91 E-value=6.1e-25 Score=225.40 Aligned_cols=192 Identities=25% Similarity=0.363 Sum_probs=157.6
Q ss_pred hccC-CcceeeeecccccceEEEEEEcCCCCEEEEEeccccc--------hhhHHHHHHHHhhCCCcccc----------
Q psy11767 113 QYDM-DLDKAGILGDGSYSVCRRCVEKSTGQEYAVKIISRKI--------DCSEEINLLRACQGHPNICR---------- 173 (966)
Q Consensus 113 ~~~~-df~~~~~LG~GsFGkV~La~~k~tg~~yAiKvl~K~~--------~~~~E~~il~~~~~~pfi~~---------- 173 (966)
...+ ||++.+.||+|-||.||||++|.++.++|+||+.|++ .+.+|.+|-..+ +||.|.+
T Consensus 18 ~~~l~dfeigr~LgkgkFG~vYlarekks~~IvalKVlfKsqi~~~~v~~qlrREiEIqs~L-~hpnilrlY~~fhd~~r 96 (281)
T KOG0580|consen 18 TWTLDDFEIGRPLGKGKFGNVYLAREKKSLFIVALKVLFKSQILKTQVEHQLRREIEIQSHL-RHPNILRLYGYFHDSKR 96 (281)
T ss_pred ccchhhccccccccCCccccEeEeeeccCCcEEEEeeeeHHHHHHhcchhhhhheeEeeccc-CCccHHhhhhheeccce
Confidence 3444 9999999999999999999999999999999999974 245566665555 6898864
Q ss_pred ----------------------cccccccchhHHHHHHHhh----------cccchhhhHhhhccCCceEEecCcccc--
Q psy11767 174 ----------------------RCVEKSTGQEYAVKIISRK----------IDCSEEINLLRACQGHPNIVNLHCVFQ-- 219 (966)
Q Consensus 174 ----------------------~~~~~~~~~~~~~~~v~~~----------~~~~~e~nil~~~~gh~~iv~l~~~~~-- 219 (966)
..|.++.+..|..++..+. .|.++| |+|+.+.|-.+|.||+.+-.
T Consensus 97 iyLilEya~~gel~k~L~~~~~~~f~e~~~a~Yi~q~A~Al~y~h~k~VIhRdiKpe-nlLlg~~~~lkiAdfGwsV~~p 175 (281)
T KOG0580|consen 97 IYLILEYAPRGELYKDLQEGRMKRFDEQRAATYIKQLANALLYCHLKRVIHRDIKPE-NLLLGSAGELKIADFGWSVHAP 175 (281)
T ss_pred eEEEEEecCCchHHHHHHhcccccccccchhHHHHHHHHHHHHhccCCcccCCCCHH-HhccCCCCCeeccCCCceeecC
Confidence 2244444444443333221 155666 99999999999999986643
Q ss_pred ---------------ccccccccCCCcceeeechhhHHHHHHHhhCCCCCCCCcHHHHHHHHHhCCCCCCCCCCHHHHHH
Q psy11767 220 ---------------DEVIDWDDFSRGIECVFFSSSLIIFFIILSFTLSFIHDYYHIQYRRILKTEPPIPEDLSPDVADF 284 (966)
Q Consensus 220 ---------------~e~i~~~~y~~~~d~~~~~~~~il~~~m~~g~~pf~~~~~~~~~~~I~~~~~~~P~~~s~~a~dl 284 (966)
+|++...+|+..+|. |+.||+.||++.|.|||.+....++|++|..-++.||..+|.+|+||
T Consensus 176 ~~kR~tlcgt~dyl~pEmv~~~~hd~~Vd~---w~lgvl~yeflvg~ppFes~~~~etYkrI~k~~~~~p~~is~~a~dl 252 (281)
T KOG0580|consen 176 SNKRKTLCGTLDYLPPEMVEGRGHDKFVDL---WSLGVLCYEFLVGLPPFESQSHSETYKRIRKVDLKFPSTISGGAADL 252 (281)
T ss_pred CCCceeeecccccCCHhhcCCCCccchhhH---HHHHHHHHHHHhcCCchhhhhhHHHHHHHHHccccCCcccChhHHHH
Confidence 467778888888884 48999999999999999999999999999999999999999999999
Q ss_pred HHhhcccCCCcccCCCCCCHHHHhcCCcee
Q psy11767 285 ISRLLVKDPRRRLGGGELDAEELKRHPFFN 314 (966)
Q Consensus 285 i~~LL~kdp~~RLG~~~~g~~~Ik~HpfF~ 314 (966)
|.+||.++|.+|+. ..|++.|||..
T Consensus 253 I~~ll~~~p~~r~~-----l~~v~~hpwI~ 277 (281)
T KOG0580|consen 253 ISRLLVKNPIERLA-----LTEVMDHPWIV 277 (281)
T ss_pred HHHHhccCcccccc-----HHHHhhhHHHH
Confidence 99999999999984 78999999964
|
|
| >cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Probab=99.91 E-value=3.1e-24 Score=241.75 Aligned_cols=227 Identities=25% Similarity=0.425 Sum_probs=173.7
Q ss_pred eeecccccceEEEEEEcCCCCEEEEEeccccc--------hhhHHHHHHHHhhCCCccccccccccc-------------
Q psy11767 122 GILGDGSYSVCRRCVEKSTGQEYAVKIISRKI--------DCSEEINLLRACQGHPNICRRCVEKST------------- 180 (966)
Q Consensus 122 ~~LG~GsFGkV~La~~k~tg~~yAiKvl~K~~--------~~~~E~~il~~~~~~pfi~~~~~~~~~------------- 180 (966)
++||+|+||+|++|+++.+|+.||||+++|.. ....|+.+|.++.+||+|++....+..
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~il~~~~~hp~Iv~~~~~~~~~~~~~lv~e~~~~ 80 (329)
T cd05588 1 RVIGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGLHSCFQTESRLFFVIEFVSG 80 (329)
T ss_pred CeEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCCCCceEEEEEcCCEEEEEEeCCCC
Confidence 57999999999999999999999999999742 246789999998899999862211111
Q ss_pred -----------------chhHHHHHHHh----------hcccchhhhHhhhccCCceEEecCcccc--------------
Q psy11767 181 -----------------GQEYAVKIISR----------KIDCSEEINLLRACQGHPNIVNLHCVFQ-------------- 219 (966)
Q Consensus 181 -----------------~~~~~~~~v~~----------~~~~~~e~nil~~~~gh~~iv~l~~~~~-------------- 219 (966)
...++.+++.+ ..|++++ |+|.+.+|+++|+||+.+..
T Consensus 81 g~L~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~-Nili~~~~~~kL~Dfg~~~~~~~~~~~~~~~~gt 159 (329)
T cd05588 81 GDLMFHMQRQRKLPEEHARFYSAEISLALNFLHERGIIYRDLKLD-NVLLDAEGHIKLTDYGMCKEGIRPGDTTSTFCGT 159 (329)
T ss_pred CCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHH-HeEECCCCCEEECcCccccccccCCCccccccCC
Confidence 11112222221 1134444 99999999999999986531
Q ss_pred -----ccccccccCCCcceeeechhhHHHHHHHhhCCCCCCC---------CcHHHHHHHHHhCCCCCCCCCCHHHHHHH
Q psy11767 220 -----DEVIDWDDFSRGIECVFFSSSLIIFFIILSFTLSFIH---------DYYHIQYRRILKTEPPIPEDLSPDVADFI 285 (966)
Q Consensus 220 -----~e~i~~~~y~~~~d~~~~~~~~il~~~m~~g~~pf~~---------~~~~~~~~~I~~~~~~~P~~~s~~a~dli 285 (966)
+|++....|+...| +|+.|+++|+|++|.+||.. .....+++.|+...+.+|..+++++++||
T Consensus 160 ~~y~aPE~~~~~~~~~~~D---iwslG~~l~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~li 236 (329)
T cd05588 160 PNYIAPEILRGEDYGFSVD---WWALGVLMFEMMAGRSPFDIVGMSDNPDQNTEDYLFQVILEKQIRIPRSLSVKASSVL 236 (329)
T ss_pred ccccCHHHHcCCCCCCccc---eechHHHHHHHHHCCCCcccccccccccccchHHHHHHHHcCCCCCCCCCCHHHHHHH
Confidence 34555555654444 33567888888899999952 23345788999999999999999999999
Q ss_pred HhhcccCCCcccCCCC-CCHHHHhcCCceeeeCccccccCCCCCCCCccccccccccccccccccCcC
Q psy11767 286 SRLLVKDPRRRLGGGE-LDAEELKRHPFFNVIDWDDLATKRIPAPFVPKISNELDVSNFSDEFTKMIP 352 (966)
Q Consensus 286 ~~LL~kdp~~RLG~~~-~g~~~Ik~HpfF~~idW~~l~~k~~~pP~~P~i~~~~D~snFd~ef~~~~p 352 (966)
+++|++||.+|+++.. .++++|+.||||..++|+.+..+++.||+.|.+....+..+|+..|.....
T Consensus 237 ~~~L~~dP~~R~~~~~~~~~~~i~~hp~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 304 (329)
T cd05588 237 KGFLNKDPKERLGCHPQTGFRDIKSHPFFRNIDWDLLEQKQVLPPYKPNIESDRDLDNFDPQFTDEPV 304 (329)
T ss_pred HHHhccCHHHcCCCCCCCCHHHHhcCCCCCCCCHHHHHhCCCCCCccccCCCcchhhhcCCccccCcc
Confidence 9999999999998632 368999999999999999999999999999999888888999987755443
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl |
| >smart00750 KIND kinase non-catalytic C-lobe domain | Back alignment and domain information |
|---|
Probab=99.91 E-value=5e-24 Score=217.24 Aligned_cols=161 Identities=22% Similarity=0.327 Sum_probs=120.0
Q ss_pred CCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCcEEEecCCCCCEEEEeecccccccCCCcccccc
Q psy11767 456 GELLDRIRQKGRCGFTENEASRIMRQLVAAVHFMHSRGVVHRDLKPENLLFSDPAGDNIKVVDFGFACLKRESLHTPCFT 535 (966)
Q Consensus 456 g~L~~~l~~~~~~~l~e~~~~~i~~Qil~aL~yLHs~~IiHRDLKP~NILl~~~~~~~iKL~DFGla~~~~~~~~~~~gT 535 (966)
|+|.+++..++. .+++.+++.++.||+.||+|||+++ ||+|||+++ ++.+|+ ||++...... ...||
T Consensus 1 GsL~~~l~~~~~-~l~~~~~~~i~~qi~~~L~~lH~~~------kp~Nil~~~--~~~~~~--fG~~~~~~~~--~~~g~ 67 (176)
T smart00750 1 VSLADILEVRGR-PLNEEEIWAVCLQCLRALRELHRQA------KSGNILLTW--DGLLKL--DGSVAFKTPE--QSRVD 67 (176)
T ss_pred CcHHHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHHhcC------CcccEeEcC--ccceee--ccceEeeccc--cCCCc
Confidence 789999976543 6999999999999999999999998 999999975 558888 9998765432 23689
Q ss_pred ccccCchhhccCCCCCCCcccchhhhhhhhhhhhcCCCCCCCcCcchhHHHHHHHHhcCCCCCCCCCCchhHHH-HHHHH
Q psy11767 536 LQYAAPEVLRQDKSGYDENCDLWSLGVILVNVLRQDKSGYDENCDLWSLGVILYTMLCGRVPFHARSRDDSALS-IMARI 614 (966)
Q Consensus 536 ~~Y~APEvl~~~~~~~~~~~Di~SlGvil~el~~~~~~~y~~~~DIWSlGvilyemltG~~Pf~~~~~~~~~~~-~~~~i 614 (966)
+.|||||++.. ..|+.++|||||||++|||++|+.||........... +....
T Consensus 68 ~~y~aPE~~~~--------------------------~~~~~~~DiwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~ 121 (176)
T smart00750 68 PYFMAPEVIQG--------------------------QSYTEKADIYSLGITLYEALDYELPYNEERELSAILEILLNGM 121 (176)
T ss_pred ccccChHHhcC--------------------------CCCcchhhHHHHHHHHHHHHhCCCCccccchhcHHHHHHHHHh
Confidence 99999999853 2477899999999999999999999976543221111 11111
Q ss_pred HcCCCCCCchhhccCCH--HHHHHHHHhcccCccccCChHHHHH
Q psy11767 615 KEGQFNFDAEAWSTVSS--EAKELTKSLLTVNPAQRIRMMRVKL 656 (966)
Q Consensus 615 ~~~~~~~~~~~~~~is~--e~~~Li~~~L~~dP~~R~t~~~v~~ 656 (966)
.... .........++. +++++|.+||..||++||++.++..
T Consensus 122 ~~~~-~~~~~~~~~~~~~~~~~~~i~~cl~~~p~~Rp~~~~ll~ 164 (176)
T smart00750 122 PADD-PRDRSNLESVSAARSFADFMRVCASRLPQRREAANHYLA 164 (176)
T ss_pred ccCC-ccccccHHHHHhhhhHHHHHHHHHhcccccccCHHHHHH
Confidence 1111 000011123344 6999999999999999999998743
|
It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features |
| >cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Probab=99.91 E-value=4.7e-24 Score=238.96 Aligned_cols=226 Identities=25% Similarity=0.406 Sum_probs=176.5
Q ss_pred eeecccccceEEEEEEcCCCCEEEEEeccccc--------hhhHHHHHHHHhhCCCcccccccccccc------------
Q psy11767 122 GILGDGSYSVCRRCVEKSTGQEYAVKIISRKI--------DCSEEINLLRACQGHPNICRRCVEKSTG------------ 181 (966)
Q Consensus 122 ~~LG~GsFGkV~La~~k~tg~~yAiKvl~K~~--------~~~~E~~il~~~~~~pfi~~~~~~~~~~------------ 181 (966)
++||+|+||+|++|+++.+|+.||||++++.. ....|+.+|....+||+|++.+..+...
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E~~~~ 80 (316)
T cd05620 1 KVLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHLYCTFQTKEHLFFVMEFLNG 80 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCCccCeeEEEEeCCEEEEEECCCCC
Confidence 57999999999999999999999999998752 2456788888777899998622111111
Q ss_pred ------------------hhHHHHHHHh----------hcccchhhhHhhhccCCceEEecCccc---------------
Q psy11767 182 ------------------QEYAVKIISR----------KIDCSEEINLLRACQGHPNIVNLHCVF--------------- 218 (966)
Q Consensus 182 ------------------~~~~~~~v~~----------~~~~~~e~nil~~~~gh~~iv~l~~~~--------------- 218 (966)
..++.+++.+ ..|++++ |||.+.+|+++|+||+.+.
T Consensus 81 g~L~~~i~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivHrDlkp~-Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt 159 (316)
T cd05620 81 GDLMFHIQDKGRFDLYRATFYAAEIVCGLQFLHSKGIIYRDLKLD-NVMLDRDGHIKIADFGMCKENVFGDNRASTFCGT 159 (316)
T ss_pred CcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHH-HeEECCCCCEEeCccCCCeecccCCCceeccCCC
Confidence 1111222211 1134444 9999999999999998542
Q ss_pred ----cccccccccCCCcceeeechhhHHHHHHHhhCCCCCCCCcHHHHHHHHHhCCCCCCCCCCHHHHHHHHhhcccCCC
Q psy11767 219 ----QDEVIDWDDFSRGIECVFFSSSLIIFFIILSFTLSFIHDYYHIQYRRILKTEPPIPEDLSPDVADFISRLLVKDPR 294 (966)
Q Consensus 219 ----~~e~i~~~~y~~~~d~~~~~~~~il~~~m~~g~~pf~~~~~~~~~~~I~~~~~~~P~~~s~~a~dli~~LL~kdp~ 294 (966)
.+|++....|+...| +|+.|+++|+|++|.+||...+...+++.|....+.+|..++.++++||+++|++||.
T Consensus 160 ~~y~aPE~~~~~~~~~~~D---iwslGvil~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~ 236 (316)
T cd05620 160 PDYIAPEILQGLKYTFSVD---WWSFGVLLYEMLIGQSPFHGDDEDELFESIRVDTPHYPRWITKESKDILEKLFERDPT 236 (316)
T ss_pred cCccCHHHHcCCCCCcccc---hhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCCCCCHHHHHHHHHHccCCHH
Confidence 135555555654444 4466788888889999999999899999999999999999999999999999999999
Q ss_pred cccCCCCCCHHHHhcCCceeeeCccccccCCCCCCCCccccccccccccccccccCcCCCC
Q psy11767 295 RRLGGGELDAEELKRHPFFNVIDWDDLATKRIPAPFVPKISNELDVSNFSDEFTKMIPADS 355 (966)
Q Consensus 295 ~RLG~~~~g~~~Ik~HpfF~~idW~~l~~k~~~pP~~P~i~~~~D~snFd~ef~~~~p~dS 355 (966)
+|++. .++|+.||||++++|..+..+++.+|+.|......+.++|+.++....+..+
T Consensus 237 ~R~~~----~~~~~~h~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 293 (316)
T cd05620 237 RRLGV----VGNIRGHPFFKTINWTALEKRELDPPFKPKVKSPSDYSNFDREFLSEKPRLS 293 (316)
T ss_pred HcCCC----hHHHHcCCCcCCCCHHHHHhCCCCCCcCCCCCCcchhhhcCccccccCcccC
Confidence 99963 4789999999999999999999999999999999999999988765544433
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I |
| >cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Probab=99.91 E-value=4.5e-24 Score=239.11 Aligned_cols=227 Identities=28% Similarity=0.471 Sum_probs=176.0
Q ss_pred eeecccccceEEEEEEcCCCCEEEEEeccccc--------hhhHHHHHHHHhhCCCcccccccccccc------------
Q psy11767 122 GILGDGSYSVCRRCVEKSTGQEYAVKIISRKI--------DCSEEINLLRACQGHPNICRRCVEKSTG------------ 181 (966)
Q Consensus 122 ~~LG~GsFGkV~La~~k~tg~~yAiKvl~K~~--------~~~~E~~il~~~~~~pfi~~~~~~~~~~------------ 181 (966)
++||+|+||+|++|+++.+++.||||++++.. ....|+.+|....+||+|++....+...
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~g 80 (316)
T cd05592 1 KVLGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTHLFCTFQTKEHLFFVMEYLNG 80 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 47999999999999999999999999998752 2355777887777899998622111111
Q ss_pred ------------------hhHHHHHHHh----------hcccchhhhHhhhccCCceEEecCcccc--------------
Q psy11767 182 ------------------QEYAVKIISR----------KIDCSEEINLLRACQGHPNIVNLHCVFQ-------------- 219 (966)
Q Consensus 182 ------------------~~~~~~~v~~----------~~~~~~e~nil~~~~gh~~iv~l~~~~~-------------- 219 (966)
..++.+++.+ ..|++++ |||.+.+|.++|+||+.+..
T Consensus 81 g~L~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~ivH~dlkp~-Nill~~~~~~kL~Dfg~a~~~~~~~~~~~~~~gt 159 (316)
T cd05592 81 GDLMFHIQSSGRFDEARARFYAAEIICGLQFLHKKGIIYRDLKLD-NVLLDKDGHIKIADFGMCKENMNGEGKASTFCGT 159 (316)
T ss_pred CcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEEeCCCCHH-HeEECCCCCEEEccCcCCeECCCCCCccccccCC
Confidence 1111222221 0133434 99999999999999986532
Q ss_pred -----ccccccccCCCcceeeechhhHHHHHHHhhCCCCCCCCcHHHHHHHHHhCCCCCCCCCCHHHHHHHHhhcccCCC
Q psy11767 220 -----DEVIDWDDFSRGIECVFFSSSLIIFFIILSFTLSFIHDYYHIQYRRILKTEPPIPEDLSPDVADFISRLLVKDPR 294 (966)
Q Consensus 220 -----~e~i~~~~y~~~~d~~~~~~~~il~~~m~~g~~pf~~~~~~~~~~~I~~~~~~~P~~~s~~a~dli~~LL~kdp~ 294 (966)
+|++....|+...| .| +.|+++|+|++|.+||...+...+++.|....+.+|..++.++++||+++|.+||.
T Consensus 160 ~~y~aPE~~~~~~~~~~~D--vw-slG~il~ell~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ll~~~l~~~P~ 236 (316)
T cd05592 160 PDYIAPEILKGQKYNESVD--WW-SFGVLLYEMLIGQSPFHGEDEDELFDSILNDRPHFPRWISKEAKDCLSKLFERDPT 236 (316)
T ss_pred ccccCHHHHcCCCCCCccc--ch-hHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCCCCCHHHHHHHHHHccCCHH
Confidence 23444344544444 34 55677788889999999999899999999999999999999999999999999999
Q ss_pred cccCCCCCCHHHHhcCCceeeeCccccccCCCCCCCCccccccccccccccccccCcCCCCC
Q psy11767 295 RRLGGGELDAEELKRHPFFNVIDWDDLATKRIPAPFVPKISNELDVSNFSDEFTKMIPADSP 356 (966)
Q Consensus 295 ~RLG~~~~g~~~Ik~HpfF~~idW~~l~~k~~~pP~~P~i~~~~D~snFd~ef~~~~p~dSp 356 (966)
+|++. .++++.||||..++|+.+..++++||+.|......+.++|+.+|+......++
T Consensus 237 ~R~~~----~~~l~~h~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 294 (316)
T cd05592 237 KRLGV----DGDIRQHPFFRGIDWERLEKREIPPPFKPKVKSPSDASNFDREFTNEKVRLSP 294 (316)
T ss_pred HcCCC----hHHHHcCcccCCCCHHHHHhCCCCCCcCCCCCCcchhhhcCcccccccccCCC
Confidence 99963 56899999999999999999999999999999999999999988766554443
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp |
| >cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Probab=99.91 E-value=5.7e-24 Score=238.35 Aligned_cols=224 Identities=27% Similarity=0.428 Sum_probs=174.7
Q ss_pred eeecccccceEEEEEEcCCCCEEEEEeccccc--------hhhHHHHHHHHhhCCCcccccccccccc------------
Q psy11767 122 GILGDGSYSVCRRCVEKSTGQEYAVKIISRKI--------DCSEEINLLRACQGHPNICRRCVEKSTG------------ 181 (966)
Q Consensus 122 ~~LG~GsFGkV~La~~k~tg~~yAiKvl~K~~--------~~~~E~~il~~~~~~pfi~~~~~~~~~~------------ 181 (966)
++||+|+||+|++|+++.+++.||||++++.. ....|+.+|....+||+|+.....+.+.
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~ey~~~ 80 (316)
T cd05619 1 KMLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHLYCTFQTKENLFFVMEYLNG 80 (316)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCcCcceEEEEEeCCEEEEEEeCCCC
Confidence 47999999999999999999999999998752 2356788888777999998622111111
Q ss_pred ------------------hhHHHHHHHh----------hcccchhhhHhhhccCCceEEecCcccc--------------
Q psy11767 182 ------------------QEYAVKIISR----------KIDCSEEINLLRACQGHPNIVNLHCVFQ-------------- 219 (966)
Q Consensus 182 ------------------~~~~~~~v~~----------~~~~~~e~nil~~~~gh~~iv~l~~~~~-------------- 219 (966)
..++.+++.+ ..|+++ .|+|.+.+|+++|.||+.+..
T Consensus 81 g~L~~~l~~~~~~~~~~~~~~~~qi~~al~~LH~~~ivHrdikp-~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt 159 (316)
T cd05619 81 GDLMFHIQSCHKFDLPRATFYAAEIICGLQFLHSKGIVYRDLKL-DNILLDTDGHIKIADFGMCKENMLGDAKTCTFCGT 159 (316)
T ss_pred CcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCeEeCCCCH-HHEEECCCCCEEEccCCcceECCCCCCceeeecCC
Confidence 1111222221 013333 399999999999999986532
Q ss_pred -----ccccccccCCCcceeeechhhHHHHHHHhhCCCCCCCCcHHHHHHHHHhCCCCCCCCCCHHHHHHHHhhcccCCC
Q psy11767 220 -----DEVIDWDDFSRGIECVFFSSSLIIFFIILSFTLSFIHDYYHIQYRRILKTEPPIPEDLSPDVADFISRLLVKDPR 294 (966)
Q Consensus 220 -----~e~i~~~~y~~~~d~~~~~~~~il~~~m~~g~~pf~~~~~~~~~~~I~~~~~~~P~~~s~~a~dli~~LL~kdp~ 294 (966)
+|++....|+...| .|+.|+++|+|++|.+||...+...+++.|....+.+|..++.+++|||.++|++||.
T Consensus 160 ~~y~aPE~~~~~~~~~~~D---vwslG~il~el~~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~li~~~l~~~P~ 236 (316)
T cd05619 160 PDYIAPEILLGQKYNTSVD---WWSFGVLLYEMLIGQSPFHGHDEEELFQSIRMDNPCYPRWLTREAKDILVKLFVREPE 236 (316)
T ss_pred ccccCHHHHcCCCCCchhh---hhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCccCCHHHHHHHHHHhccCHh
Confidence 34444445554444 3456777788889999999988889999999999999999999999999999999999
Q ss_pred cccCCCCCCHHHHhcCCceeeeCccccccCCCCCCCCccccccccccccccccccCcCC
Q psy11767 295 RRLGGGELDAEELKRHPFFNVIDWDDLATKRIPAPFVPKISNELDVSNFSDEFTKMIPA 353 (966)
Q Consensus 295 ~RLG~~~~g~~~Ik~HpfF~~idW~~l~~k~~~pP~~P~i~~~~D~snFd~ef~~~~p~ 353 (966)
+|++. .++|+.||||+.++|..+..+.++||+.|...+..+.++|+.++....+.
T Consensus 237 ~R~~~----~~~l~~h~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 291 (316)
T cd05619 237 RRLGV----KGDIRQHPFFREIDWSALEEREIEPPFKPKVKSANDCSNFDKEFLNEKPR 291 (316)
T ss_pred hcCCC----hHHHHcCcccCCCCHHHHHhCCCCCCcCCCCCCccchhhcChhhhcCCcc
Confidence 99974 35899999999999999999999999999999999999999988765443
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in |
| >cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Probab=99.91 E-value=3.3e-24 Score=244.44 Aligned_cols=219 Identities=24% Similarity=0.411 Sum_probs=166.7
Q ss_pred CcceeeeecccccceEEEEEEcCCCCEEEEEeccccc--------hhhHHHHHHHHhhCCCccccccccccc--------
Q psy11767 117 DLDKAGILGDGSYSVCRRCVEKSTGQEYAVKIISRKI--------DCSEEINLLRACQGHPNICRRCVEKST-------- 180 (966)
Q Consensus 117 df~~~~~LG~GsFGkV~La~~k~tg~~yAiKvl~K~~--------~~~~E~~il~~~~~~pfi~~~~~~~~~-------- 180 (966)
||+++++||+|+||+|++|+++.+|+.||||++++.. ....|+.+|.++ +||+|+..+..+..
T Consensus 2 ~f~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l-~~~~iv~~~~~~~~~~~~~lv~ 80 (360)
T cd05627 2 DFESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEA-DGAWVVKMFYSFQDKRNLYLIM 80 (360)
T ss_pred CceEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhC-CCCCEeeEEEEEEcCCEEEEEE
Confidence 7899999999999999999999999999999998642 346788999887 69999863222211
Q ss_pred ----------------------chhHHHHHHHh----------hcccchhhhHhhhccCCceEEecCccc----------
Q psy11767 181 ----------------------GQEYAVKIISR----------KIDCSEEINLLRACQGHPNIVNLHCVF---------- 218 (966)
Q Consensus 181 ----------------------~~~~~~~~v~~----------~~~~~~e~nil~~~~gh~~iv~l~~~~---------- 218 (966)
.+.++.+++.+ ..|++++ |||.+.+|+++|+||+.+.
T Consensus 81 E~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~~L~~lH~~givHrDLkp~-NIli~~~~~vkL~DfG~~~~~~~~~~~~~ 159 (360)
T cd05627 81 EFLPGGDMMTLLMKKDTLSEEATQFYIAETVLAIDAIHQLGFIHRDIKPD-NLLLDAKGHVKLSDFGLCTGLKKAHRTEF 159 (360)
T ss_pred eCCCCccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEccCCCHH-HEEECCCCCEEEeeccCCccccccccccc
Confidence 12222222221 1244444 9999999999999998542
Q ss_pred --------------------------------------------cccccccccCCCcceeeechhhHHHHHHHhhCCCCC
Q psy11767 219 --------------------------------------------QDEVIDWDDFSRGIECVFFSSSLIIFFIILSFTLSF 254 (966)
Q Consensus 219 --------------------------------------------~~e~i~~~~y~~~~d~~~~~~~~il~~~m~~g~~pf 254 (966)
.+|++...+|+...| +|+.|+++|+|++|.+||
T Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~D---iwSlGvilyel~tG~~Pf 236 (360)
T cd05627 160 YRNLTHNPPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCD---WWSLGVIMYEMLIGYPPF 236 (360)
T ss_pred ccccccCCcccccccccccccccccccccccccccccCCCccccCHHHHcCCCCCCcce---eccccceeeecccCCCCC
Confidence 134455555655444 445678888899999999
Q ss_pred CCCcHHHHHHHHHh--CCCCCCCC--CCHHHHHHHHhhcccCCCcccCCCCCCHHHHhcCCceeeeCccccccCCCCCCC
Q psy11767 255 IHDYYHIQYRRILK--TEPPIPED--LSPDVADFISRLLVKDPRRRLGGGELDAEELKRHPFFNVIDWDDLATKRIPAPF 330 (966)
Q Consensus 255 ~~~~~~~~~~~I~~--~~~~~P~~--~s~~a~dli~~LL~kdp~~RLG~~~~g~~~Ik~HpfF~~idW~~l~~k~~~pP~ 330 (966)
...+...++++|++ ..+.+|.. +|++++|||.+||. ||.+|++. .++++|+.||||.++||+.+..+..++|+
T Consensus 237 ~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~~li~~l~~-~p~~R~~~--~~~~ei~~hp~f~~~~~~~~~~~~~~~~~ 313 (360)
T cd05627 237 CSETPQETYRKVMNWKETLVFPPEVPISEKAKDLILRFCT-DSENRIGS--NGVEEIKSHPFFEGVDWGHIRERPAAIPI 313 (360)
T ss_pred CCCCHHHHHHHHHcCCCceecCCCCCCCHHHHHHHHHhcc-ChhhcCCC--CCHHHHhcCCCCCCCCHHHHhcCCCCCCc
Confidence 99999999999986 34667764 79999999999874 99999985 37999999999999999999887666664
Q ss_pred Ccccccccccccccc
Q psy11767 331 VPKISNELDVSNFSD 345 (966)
Q Consensus 331 ~P~i~~~~D~snFd~ 345 (966)
.+.+..|.++|+.
T Consensus 314 --~~~~~~~~~~~~~ 326 (360)
T cd05627 314 --EIKSIDDTSNFDE 326 (360)
T ss_pred --cCCCcchhhhcCC
Confidence 4566778888874
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul |
| >KOG0585|consensus | Back alignment and domain information |
|---|
Probab=99.91 E-value=9.9e-25 Score=241.45 Aligned_cols=189 Identities=24% Similarity=0.436 Sum_probs=151.8
Q ss_pred CcceeeeecccccceEEEEEEcCCCCEEEEEeccccc-------------------hhhHHHHHHHHhhCCCcccc----
Q psy11767 117 DLDKAGILGDGSYSVCRRCVEKSTGQEYAVKIISRKI-------------------DCSEEINLLRACQGHPNICR---- 173 (966)
Q Consensus 117 df~~~~~LG~GsFGkV~La~~k~tg~~yAiKvl~K~~-------------------~~~~E~~il~~~~~~pfi~~---- 173 (966)
.|.+++.||+|+||+|.||+.-.+|++||||||.|.. .+..|..||+++ +||.||+
T Consensus 98 qy~l~~eiG~G~yGkVkLar~~~~~~l~AiKil~K~~~~~~~~~~~~~a~~~~~~ekv~~EIailKkl-~H~nVV~LiEv 176 (576)
T KOG0585|consen 98 QYELIKEIGSGQYGKVKLARDEVDGKLYAIKILPKKELRRQYGFPRQPAMKLMPIEKVRREIAILKKL-HHPNVVKLIEV 176 (576)
T ss_pred heehhhhhcCCccceEEEEeecCCCcEEEEEeechhhhhhhcccccccccccCcHHHHHHHHHHHHhc-CCcCeeEEEEe
Confidence 7899999999999999999999999999999999851 367899999998 6899986
Q ss_pred ---------------------------cc-cccccchhHHHHHHHh--h--------cccchhhhHhhhccCCceEEecC
Q psy11767 174 ---------------------------RC-VEKSTGQEYAVKIISR--K--------IDCSEEINLLRACQGHPNIVNLH 215 (966)
Q Consensus 174 ---------------------------~~-~~~~~~~~~~~~~v~~--~--------~~~~~e~nil~~~~gh~~iv~l~ 215 (966)
.. +.+++++.|...++.. + .|. +.-|+|+..+||.||.||+
T Consensus 177 LDDP~s~~~YlVley~s~G~v~w~p~d~~els~~~Ar~ylrDvv~GLEYLH~QgiiHRDI-KPsNLLl~~~g~VKIsDFG 255 (576)
T KOG0585|consen 177 LDDPESDKLYLVLEYCSKGEVKWCPPDKPELSEQQARKYLRDVVLGLEYLHYQGIIHRDI-KPSNLLLSSDGTVKISDFG 255 (576)
T ss_pred ecCcccCceEEEEEeccCCccccCCCCcccccHHHHHHHHHHHHHHHHHHHhcCeecccc-chhheEEcCCCcEEeeccc
Confidence 22 5666677776544322 0 122 3559999999999999998
Q ss_pred ccc------------------------cccccccc-cC-CCcceeeechhhHHHHHHHhhCCCCCCCCcHHHHHHHHHhC
Q psy11767 216 CVF------------------------QDEVIDWD-DF-SRGIECVFFSSSLIIFFIILSFTLSFIHDYYHIQYRRILKT 269 (966)
Q Consensus 216 ~~~------------------------~~e~i~~~-~y-~~~~d~~~~~~~~il~~~m~~g~~pf~~~~~~~~~~~I~~~ 269 (966)
-+. ++|.+... ++ .-|...| -|+.||.+|.|+.|..||.++...++|++|++.
T Consensus 256 Vs~~~~~~~~~~~d~~L~~tvGTPAF~APE~c~~~~~~~~~g~a~D-iWalGVTLYCllfG~~PF~~~~~~~l~~KIvn~ 334 (576)
T KOG0585|consen 256 VSNEFPQGSDEGSDDQLSRTVGTPAFFAPELCSGGNSFSYSGFALD-IWALGVTLYCLLFGQLPFFDDFELELFDKIVND 334 (576)
T ss_pred eeeecccCCccccHHHHhhcCCCccccchHhhcCCCCccccchhhh-hhhhhhhHHHhhhccCCcccchHHHHHHHHhcC
Confidence 442 23444331 11 1122223 457889999999999999999999999999999
Q ss_pred CCCCCCC--CCHHHHHHHHhhcccCCCcccCCCCCCHHHHhcCCce
Q psy11767 270 EPPIPED--LSPDVADFISRLLVKDPRRRLGGGELDAEELKRHPFF 313 (966)
Q Consensus 270 ~~~~P~~--~s~~a~dli~~LL~kdp~~RLG~~~~g~~~Ik~HpfF 313 (966)
.+.||.. +.++++|||++||+|||.+|++ ..|||.|||-
T Consensus 335 pL~fP~~pe~~e~~kDli~~lL~KdP~~Ri~-----l~~ik~Hpwv 375 (576)
T KOG0585|consen 335 PLEFPENPEINEDLKDLIKRLLEKDPEQRIT-----LPDIKLHPWV 375 (576)
T ss_pred cccCCCcccccHHHHHHHHHHhhcChhheee-----hhhheeccee
Confidence 9999987 8999999999999999999995 7899999985
|
|
| >cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Probab=99.91 E-value=8.4e-24 Score=238.10 Aligned_cols=252 Identities=33% Similarity=0.574 Sum_probs=188.6
Q ss_pred CcceeeeecccccceEEEEEEc---CCCCEEEEEeccccc---------hhhHHHHHHHHhhCCCcccccccccccc---
Q psy11767 117 DLDKAGILGDGSYSVCRRCVEK---STGQEYAVKIISRKI---------DCSEEINLLRACQGHPNICRRCVEKSTG--- 181 (966)
Q Consensus 117 df~~~~~LG~GsFGkV~La~~k---~tg~~yAiKvl~K~~---------~~~~E~~il~~~~~~pfi~~~~~~~~~~--- 181 (966)
||++++.||+|+||+|++|+.. .+|+.||||+++|.. ....|.++|+++.+||+|+.....+...
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~ 80 (332)
T cd05614 1 NFELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVRQSPFLVTLHYAFQTEAKL 80 (332)
T ss_pred CceEEEEEeecCCEEEEEEEEcccCCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHHhccCCCCcccEEEEEecCCEE
Confidence 6899999999999999999874 689999999998641 3467899999998999998632111111
Q ss_pred ---------------------------hhHHHHHHHh----------hcccchhhhHhhhccCCceEEecCcccc-----
Q psy11767 182 ---------------------------QEYAVKIISR----------KIDCSEEINLLRACQGHPNIVNLHCVFQ----- 219 (966)
Q Consensus 182 ---------------------------~~~~~~~v~~----------~~~~~~e~nil~~~~gh~~iv~l~~~~~----- 219 (966)
..+..+++.+ ..|++++ |||.+.+|.++|+||+.+..
T Consensus 81 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivHrDlkp~-Nili~~~~~~kl~DfG~~~~~~~~~ 159 (332)
T cd05614 81 HLILDYVSGGEMFTHLYQRDNFSEDEVRFYSGEIILALEHLHKLGIVYRDIKLE-NILLDSEGHVVLTDFGLSKEFLSEE 159 (332)
T ss_pred EEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCHH-HeEECCCCCEEEeeCcCCccccccC
Confidence 1111122211 0134444 99999999999999986531
Q ss_pred ---------------ccccccc-cCCCcceeeechhhHHHHHHHhhCCCCCCC----CcHHHHHHHHHhCCCCCCCCCCH
Q psy11767 220 ---------------DEVIDWD-DFSRGIECVFFSSSLIIFFIILSFTLSFIH----DYYHIQYRRILKTEPPIPEDLSP 279 (966)
Q Consensus 220 ---------------~e~i~~~-~y~~~~d~~~~~~~~il~~~m~~g~~pf~~----~~~~~~~~~I~~~~~~~P~~~s~ 279 (966)
+|++... .++...| .| +.|+++|+|++|.+||.. .....+.++|+...+.+|..+++
T Consensus 160 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~D--iw-slG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (332)
T cd05614 160 KERTYSFCGTIEYMAPEIIRGKGGHGKAVD--WW-SLGILIFELLTGASPFTLEGERNTQSEVSRRILKCDPPFPSFIGP 236 (332)
T ss_pred CCccccccCCccccCHHHhcCCCCCCCccc--cc-cchhhhhhhhcCCCCCCCCCCCCCHHHHHHHHhcCCCCCCCCCCH
Confidence 2333321 2433334 34 556778889999999963 34456778888999999999999
Q ss_pred HHHHHHHhhcccCCCcccCCCCCCHHHHhcCCceeeeCccccccCCCCCCCCccccccccccccccccccCcCCCCCCCC
Q psy11767 280 DVADFISRLLVKDPRRRLGGGELDAEELKRHPFFNVIDWDDLATKRIPAPFVPKISNELDVSNFSDEFTKMIPADSPAIV 359 (966)
Q Consensus 280 ~a~dli~~LL~kdp~~RLG~~~~g~~~Ik~HpfF~~idW~~l~~k~~~pP~~P~i~~~~D~snFd~ef~~~~p~dSp~iv 359 (966)
++++||+++|.+||.+|+++....++++.+||||++++|+.+..+++.+|+.|......+..+|.+++....+..+|...
T Consensus 237 ~~~~li~~~l~~dp~~R~~~~~~~~~~~l~h~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 316 (332)
T cd05614 237 EAQDLLHKLLRKDPKKRLGAGPQGASEIKEHPFFKGLDWEALALRKVNPPFRPSIRNELDVGNFAEEFTNLEPVYSPAGT 316 (332)
T ss_pred HHHHHHHHHcCCCHHHcCCCCCCCHHHHHcCCCcCCCCHHHHHhCCCCCCcCCCCCCcchhhhcCcccccCCcccCCCCC
Confidence 99999999999999999987666799999999999999999999999999999999889999998887766666665555
Q ss_pred CCCCcccccccce
Q psy11767 360 PPNFDKIFKGSLF 372 (966)
Q Consensus 360 p~~~d~if~G~~~ 372 (966)
++.....|.|..|
T Consensus 317 ~~~~~~~~~~~~~ 329 (332)
T cd05614 317 PPSGARVFQGYSF 329 (332)
T ss_pred CcccccccCCcee
Confidence 5554455555443
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >KOG0575|consensus | Back alignment and domain information |
|---|
Probab=99.91 E-value=2.2e-24 Score=246.28 Aligned_cols=187 Identities=24% Similarity=0.379 Sum_probs=160.5
Q ss_pred CcceeeeecccccceEEEEEEcCCCCEEEEEeccccc--------hhhHHHHHHHHhhCCCcccc---------------
Q psy11767 117 DLDKAGILGDGSYSVCRRCVEKSTGQEYAVKIISRKI--------DCSEEINLLRACQGHPNICR--------------- 173 (966)
Q Consensus 117 df~~~~~LG~GsFGkV~La~~k~tg~~yAiKvl~K~~--------~~~~E~~il~~~~~~pfi~~--------------- 173 (966)
.|...++||+|+|.+||.++..+||+.||+||+.|.. .+.+|.+|.+++ .||.||+
T Consensus 19 ~Y~~g~~LGkGgFA~cYe~~~~~tge~~A~KvVpk~~l~k~~~reKv~~EIeIHr~L-~HpnIV~f~~~FEDs~nVYivL 97 (592)
T KOG0575|consen 19 RYKRGRFLGKGGFARCYEARDLDTGEVVAVKVVPKKLLKKPKQREKVLNEIEIHRSL-KHPNIVQFYHFFEDSNNVYIVL 97 (592)
T ss_pred eeeeeeeeccCcceEEEEEEEcCCCcEEEEEEeehHHhcCcchHHHHHHHHHHHHhc-CCCcEEeeeeEeecCCceEEEE
Confidence 4789999999999999999999999999999999852 468899999998 5999986
Q ss_pred ---------------cccccccchhHHHHHHHhhc----------ccchhhhHhhhccCCceEEecCccc----------
Q psy11767 174 ---------------RCVEKSTGQEYAVKIISRKI----------DCSEEINLLRACQGHPNIVNLHCVF---------- 218 (966)
Q Consensus 174 ---------------~~~~~~~~~~~~~~~v~~~~----------~~~~e~nil~~~~gh~~iv~l~~~~---------- 218 (966)
..++|..+++|..+|+...+ |++ .=|+|++.+-+.||-||+++.
T Consensus 98 ELC~~~sL~el~Krrk~ltEpEary~l~QIv~GlkYLH~~~IiHRDLK-LGNlfL~~~~~VKIgDFGLAt~le~~~Erk~ 176 (592)
T KOG0575|consen 98 ELCHRGSLMELLKRRKPLTEPEARYFLRQIVEGLKYLHSLGIIHRDLK-LGNLFLNENMNVKIGDFGLATQLEYDGERKK 176 (592)
T ss_pred EecCCccHHHHHHhcCCCCcHHHHHHHHHHHHHHHHHHhcCceecccc-hhheeecCcCcEEecccceeeeecCcccccc
Confidence 44666666777766654411 222 229999999999999999774
Q ss_pred ---------cccccccccCCCcceeeechhhHHHHHHHhhCCCCCCCCcHHHHHHHHHhCCCCCCCCCCHHHHHHHHhhc
Q psy11767 219 ---------QDEVIDWDDFSRGIECVFFSSSLIIFFIILSFTLSFIHDYYHIQYRRILKTEPPIPEDLSPDVADFISRLL 289 (966)
Q Consensus 219 ---------~~e~i~~~~y~~~~d~~~~~~~~il~~~m~~g~~pf~~~~~~~~~~~I~~~~~~~P~~~s~~a~dli~~LL 289 (966)
.+||+...+|+..+|. |+.|+++|-||.|.|||..++..++|++|...++.+|.++|.+|+|||.+||
T Consensus 177 TlCGTPNYIAPEVl~k~gHsfEvDi---WSlGcvmYtLL~G~PPFetk~vkety~~Ik~~~Y~~P~~ls~~A~dLI~~lL 253 (592)
T KOG0575|consen 177 TLCGTPNYIAPEVLNKSGHSFEVDI---WSLGCVMYTLLVGRPPFETKTVKETYNKIKLNEYSMPSHLSAEAKDLIRKLL 253 (592)
T ss_pred eecCCCcccChhHhccCCCCCchhh---hhhhhHHHhhhhCCCCcccchHHHHHHHHHhcCcccccccCHHHHHHHHHHh
Confidence 3578998999887773 3677889999999999999999999999999999999999999999999999
Q ss_pred ccCCCcccCCCCCCHHHHhcCCce
Q psy11767 290 VKDPRRRLGGGELDAEELKRHPFF 313 (966)
Q Consensus 290 ~kdp~~RLG~~~~g~~~Ik~HpfF 313 (966)
.+||.+|. .+++|..|+||
T Consensus 254 ~~~P~~Rp-----sl~~vL~h~Ff 272 (592)
T KOG0575|consen 254 RPNPSERP-----SLDEVLDHPFF 272 (592)
T ss_pred cCCcccCC-----CHHHHhcCHhh
Confidence 99999998 48999999999
|
|
| >cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Probab=99.91 E-value=8.8e-24 Score=238.20 Aligned_cols=224 Identities=25% Similarity=0.443 Sum_probs=170.6
Q ss_pred eeecccccceEEEEEEcCCCCEEEEEeccccc--------hhhHHHHHHHHhhCCCccccccccccc-------------
Q psy11767 122 GILGDGSYSVCRRCVEKSTGQEYAVKIISRKI--------DCSEEINLLRACQGHPNICRRCVEKST------------- 180 (966)
Q Consensus 122 ~~LG~GsFGkV~La~~k~tg~~yAiKvl~K~~--------~~~~E~~il~~~~~~pfi~~~~~~~~~------------- 180 (966)
++||+|+||+|++|+++.+++.||+|+++|.. ...+|..+|.+..+||+|+.....+..
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~E~~~~ 80 (329)
T cd05618 1 RVIGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYVNG 80 (329)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEhhHhcchhHHHHHHHHHHHHHhcCCCCcCCceeeEEEeCCEEEEEEeCCCC
Confidence 47999999999999999999999999999752 245788888888889999862211111
Q ss_pred -----------------chhHHHHHHHh----------hcccchhhhHhhhccCCceEEecCcccc--------------
Q psy11767 181 -----------------GQEYAVKIISR----------KIDCSEEINLLRACQGHPNIVNLHCVFQ-------------- 219 (966)
Q Consensus 181 -----------------~~~~~~~~v~~----------~~~~~~e~nil~~~~gh~~iv~l~~~~~-------------- 219 (966)
...++.+++.+ ..|++++ |||.+.+|+++|.||+.+..
T Consensus 81 ~~L~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~ivH~Dikp~-Nili~~~~~~kL~DfG~~~~~~~~~~~~~~~~gt 159 (329)
T cd05618 81 GDLMFHMQRQRKLPEEHARFYSAEISLALNYLHERGIIYRDLKLD-NVLLDSEGHIKLTDYGMCKEGLRPGDTTSTFCGT 159 (329)
T ss_pred CCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHH-HEEECCCCCEEEeeCCccccccCCCCccccccCC
Confidence 11112222221 1134444 99999999999999985531
Q ss_pred -----ccccccccCCCcceeeechhhHHHHHHHhhCCCCCCC---------CcHHHHHHHHHhCCCCCCCCCCHHHHHHH
Q psy11767 220 -----DEVIDWDDFSRGIECVFFSSSLIIFFIILSFTLSFIH---------DYYHIQYRRILKTEPPIPEDLSPDVADFI 285 (966)
Q Consensus 220 -----~e~i~~~~y~~~~d~~~~~~~~il~~~m~~g~~pf~~---------~~~~~~~~~I~~~~~~~P~~~s~~a~dli 285 (966)
+|++....|+...| +|+.|+++|+|++|.+||.. .....+++.|+...+.+|..++.++++||
T Consensus 160 ~~y~aPE~~~~~~~~~~~D---iwslG~il~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~i~~~~~~~p~~~~~~~~~ll 236 (329)
T cd05618 160 PNYIAPEILRGEDYGFSVD---WWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIRIPRSLSVKAASVL 236 (329)
T ss_pred ccccCHHHHcCCCCCCccc---eecccHHHHHHhhCCCCCccCCCcCCcccccHHHHHHHHhcCCCCCCCCCCHHHHHHH
Confidence 34555555655555 33556778888899999952 23345788899999999999999999999
Q ss_pred HhhcccCCCcccCCC-CCCHHHHhcCCceeeeCccccccCCCCCCCCcccccccccccccccccc
Q psy11767 286 SRLLVKDPRRRLGGG-ELDAEELKRHPFFNVIDWDDLATKRIPAPFVPKISNELDVSNFSDEFTK 349 (966)
Q Consensus 286 ~~LL~kdp~~RLG~~-~~g~~~Ik~HpfF~~idW~~l~~k~~~pP~~P~i~~~~D~snFd~ef~~ 349 (966)
+++|++||.+|+++. ..|.++|++||||++++|+.+..+++.||+.|.+....+..+|++.+..
T Consensus 237 ~~~L~~dP~~R~~~~~~~~~~~i~~hp~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 301 (329)
T cd05618 237 KSFLNKDPKERLGCHPQTGFADIQGHPFFRNVDWDLMEQKQVVPPFKPNISGEFGLDNFDAQFTN 301 (329)
T ss_pred HHHhcCCHHHcCCCCCCCCHHHHhcCCCCCCCCHHHHHcCCCCcCccCCCCCcccchhcCccccc
Confidence 999999999999863 2368999999999999999999999999999999888888888765443
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o |
| >cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Probab=99.91 E-value=1.2e-23 Score=241.94 Aligned_cols=221 Identities=24% Similarity=0.389 Sum_probs=169.0
Q ss_pred CcceeeeecccccceEEEEEEcCCCCEEEEEeccccc--------hhhHHHHHHHHhhCCCccccccccccc--------
Q psy11767 117 DLDKAGILGDGSYSVCRRCVEKSTGQEYAVKIISRKI--------DCSEEINLLRACQGHPNICRRCVEKST-------- 180 (966)
Q Consensus 117 df~~~~~LG~GsFGkV~La~~k~tg~~yAiKvl~K~~--------~~~~E~~il~~~~~~pfi~~~~~~~~~-------- 180 (966)
+|+++++||+|+||+|++|+++.+++.||||++.|.. ...+|+.+|+++ +||+|++.+..+..
T Consensus 2 ~f~~~~~LG~G~~g~Vy~a~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~~-~h~~iv~~~~~~~~~~~~~lv~ 80 (382)
T cd05625 2 MFVKIKTLGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEA-DNEWVVRLYYSFQDKDNLYFVM 80 (382)
T ss_pred CcEEEEEEEeCCCEEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhC-CCCcCCeEEEEEEeCCEEEEEE
Confidence 4789999999999999999999999999999998742 457799999887 69999873222211
Q ss_pred ----------------------chhHHHHHHHh----------hcccchhhhHhhhccCCceEEecCccc----------
Q psy11767 181 ----------------------GQEYAVKIISR----------KIDCSEEINLLRACQGHPNIVNLHCVF---------- 218 (966)
Q Consensus 181 ----------------------~~~~~~~~v~~----------~~~~~~e~nil~~~~gh~~iv~l~~~~---------- 218 (966)
.+.+..+++.+ ..|++++ |||.+.+|+++|+||+.+.
T Consensus 81 E~~~gg~L~~~l~~~~~~~e~~~~~~~~qi~~al~~lH~~~ivHrDlKp~-NILl~~~g~~kL~DFGla~~~~~~~~~~~ 159 (382)
T cd05625 81 DYIPGGDMMSLLIRMGIFPEDLARFYIAELTCAVESVHKMGFIHRDIKPD-NILIDRDGHIKLTDFGLCTGFRWTHDSKY 159 (382)
T ss_pred eCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHH-HEEECCCCCEEEeECCCCccccccccccc
Confidence 12222222222 1244444 9999999999999998631
Q ss_pred --------------------------------------------------------cccccccccCCCcceeeechhhHH
Q psy11767 219 --------------------------------------------------------QDEVIDWDDFSRGIECVFFSSSLI 242 (966)
Q Consensus 219 --------------------------------------------------------~~e~i~~~~y~~~~d~~~~~~~~i 242 (966)
.+|++...+|+...| +| +.|+
T Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~D--iw-SlGv 236 (382)
T cd05625 160 YQSGDHVRQDSMDFSNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCD--WW-SVGV 236 (382)
T ss_pred cccccccccccccccccccccccccccccccchhhhhccccccccccccccCcccCCHHHhcCCCCCCeee--EE-echH
Confidence 134454555654444 34 5567
Q ss_pred HHHHHhhCCCCCCCCcHHHHHHHHHhC--CCCCCC--CCCHHHHHHHHhhcccCCCcccCCCCCCHHHHhcCCceeeeCc
Q psy11767 243 IFFIILSFTLSFIHDYYHIQYRRILKT--EPPIPE--DLSPDVADFISRLLVKDPRRRLGGGELDAEELKRHPFFNVIDW 318 (966)
Q Consensus 243 l~~~m~~g~~pf~~~~~~~~~~~I~~~--~~~~P~--~~s~~a~dli~~LL~kdp~~RLG~~~~g~~~Ik~HpfF~~idW 318 (966)
++|||++|.+||...+......+|++. .+.+|. .++++++|||.+|+ +||.+|++. .++++|+.||||++++|
T Consensus 237 il~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~~li~~l~-~~p~~R~~~--~~~~ei~~hp~f~~~~~ 313 (382)
T cd05625 237 ILYEMLVGQPPFLAQTPLETQMKVINWQTSLHIPPQAKLSPEASDLIIKLC-RGPEDRLGK--NGADEIKAHPFFKTIDF 313 (382)
T ss_pred HHHHHHhCCCCCCCCCHHHHHHHHHccCCCcCCCCcccCCHHHHHHHHHHc-cCHhHcCCC--CCHHHHhcCCCcCCcCh
Confidence 888889999999998888888888863 455554 68999999999987 599999973 47999999999999999
Q ss_pred cccccCCCCCCCCccccccccccccccc
Q psy11767 319 DDLATKRIPAPFVPKISNELDVSNFSDE 346 (966)
Q Consensus 319 ~~l~~k~~~pP~~P~i~~~~D~snFd~e 346 (966)
.... .+..+|+.|.+....|+++|++.
T Consensus 314 ~~~~-~~~~~~~~~~~~~~~~~~~~~~~ 340 (382)
T cd05625 314 SSDL-RQQSAPYIPKITHPTDTSNFDPV 340 (382)
T ss_pred HHHH-hcCCCCccCcCCCcchhhhcCCC
Confidence 8865 45789999999999999999864
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an |
| >cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Probab=99.90 E-value=1.1e-23 Score=235.96 Aligned_cols=228 Identities=30% Similarity=0.486 Sum_probs=178.1
Q ss_pred eeecccccceEEEEEEcCCCCEEEEEeccccc--------hhhHHHHHHHHhhCCCcccccccccccc------------
Q psy11767 122 GILGDGSYSVCRRCVEKSTGQEYAVKIISRKI--------DCSEEINLLRACQGHPNICRRCVEKSTG------------ 181 (966)
Q Consensus 122 ~~LG~GsFGkV~La~~k~tg~~yAiKvl~K~~--------~~~~E~~il~~~~~~pfi~~~~~~~~~~------------ 181 (966)
++||+|+||+|++|+++.+++.||||+++|.. ....|..+|+...+||+|++..-.+...
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (318)
T cd05570 1 KVLGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQLHSCFQTKDRLFFVMEYVNG 80 (318)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 57999999999999999999999999999752 2356888888887899998722211111
Q ss_pred ------------------hhHHHHHHHh----------hcccchhhhHhhhccCCceEEecCcccc--------------
Q psy11767 182 ------------------QEYAVKIISR----------KIDCSEEINLLRACQGHPNIVNLHCVFQ-------------- 219 (966)
Q Consensus 182 ------------------~~~~~~~v~~----------~~~~~~e~nil~~~~gh~~iv~l~~~~~-------------- 219 (966)
..+..+++.+ ..|+++ .|||.+.+|.++|.|++.+..
T Consensus 81 ~~L~~~~~~~~~l~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp-~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~g~ 159 (318)
T cd05570 81 GDLMFHIQRSGRFDEPRARFYAAEIVLGLQFLHERGIIYRDLKL-DNVLLDSEGHIKIADFGMCKEGILGGVTTSTFCGT 159 (318)
T ss_pred CCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCeEccCCCH-HHeEECCCCcEEecccCCCeecCcCCCcccceecC
Confidence 1111122211 013333 399999999999999985421
Q ss_pred -----ccccccccCCCcceeeechhhHHHHHHHhhCCCCCCCCcHHHHHHHHHhCCCCCCCCCCHHHHHHHHhhcccCCC
Q psy11767 220 -----DEVIDWDDFSRGIECVFFSSSLIIFFIILSFTLSFIHDYYHIQYRRILKTEPPIPEDLSPDVADFISRLLVKDPR 294 (966)
Q Consensus 220 -----~e~i~~~~y~~~~d~~~~~~~~il~~~m~~g~~pf~~~~~~~~~~~I~~~~~~~P~~~s~~a~dli~~LL~kdp~ 294 (966)
+|++....|+...| .| +.|+++|+|++|.+||...+...+++.|....+.+|..++.+++|||+++|++||.
T Consensus 160 ~~y~aPE~~~~~~~~~~~D--iw-slGvil~~l~~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~li~~~l~~dP~ 236 (318)
T cd05570 160 PDYIAPEILSYQPYGPAVD--WW-ALGVLLYEMLAGQSPFEGDDEDELFQSILEDEVRYPRWLSKEAKSILKSFLTKNPE 236 (318)
T ss_pred ccccCHHHhcCCCCCcchh--hh-hHHHHHHHHhhCCCCCCCCCHHHHHHHHHcCCCCCCCcCCHHHHHHHHHHccCCHH
Confidence 34444445554444 34 45677888888999999988899999999999999999999999999999999999
Q ss_pred cccCCCCCCHHHHhcCCceeeeCccccccCCCCCCCCccccccccccccccccccCcCC
Q psy11767 295 RRLGGGELDAEELKRHPFFNVIDWDDLATKRIPAPFVPKISNELDVSNFSDEFTKMIPA 353 (966)
Q Consensus 295 ~RLG~~~~g~~~Ik~HpfF~~idW~~l~~k~~~pP~~P~i~~~~D~snFd~ef~~~~p~ 353 (966)
+|++.......+++.||||+.++|+.+..+++.||+.|.+....+.+||+..|....+.
T Consensus 237 ~R~s~~~~~~~~ll~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 295 (318)
T cd05570 237 KRLGCLPTGEQDIKGHPFFREIDWDKLERKEIKPPFKPKIKGRFDVSNFDDEFTKEKPV 295 (318)
T ss_pred HcCCCCCCCHHHHhcCCCcCCCCHHHHHhCCCCCCcCCCCCCcchhhhcCchhccCccc
Confidence 99987555679999999999999999999999999999999999999999887655443
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re |
| >cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Probab=99.90 E-value=1.3e-23 Score=236.24 Aligned_cols=225 Identities=31% Similarity=0.533 Sum_probs=177.2
Q ss_pred eeecccccceEEEEEEcCCCCEEEEEeccccc--------hhhHHHHHHHHhhCCCcccccccccccc------------
Q psy11767 122 GILGDGSYSVCRRCVEKSTGQEYAVKIISRKI--------DCSEEINLLRACQGHPNICRRCVEKSTG------------ 181 (966)
Q Consensus 122 ~~LG~GsFGkV~La~~k~tg~~yAiKvl~K~~--------~~~~E~~il~~~~~~pfi~~~~~~~~~~------------ 181 (966)
++||+|+||+|++|+++.+|+.||||++++.. ...+|..+|+.+ +||+|+.....+...
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l-~hp~i~~~~~~~~~~~~~~lv~E~~~~ 79 (323)
T cd05595 1 KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNT-RHPFLTALKYAFQTHDRLCFVMEYANG 79 (323)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhC-CCCCCcceeeEEecCCEEEEEEeCCCC
Confidence 57999999999999999999999999998752 235688888877 699997622111111
Q ss_pred ------------------hhHHHHHHHhh----------cccchhhhHhhhccCCceEEecCccc---------------
Q psy11767 182 ------------------QEYAVKIISRK----------IDCSEEINLLRACQGHPNIVNLHCVF--------------- 218 (966)
Q Consensus 182 ------------------~~~~~~~v~~~----------~~~~~e~nil~~~~gh~~iv~l~~~~--------------- 218 (966)
..++.+++.+. .|++++ |||.+.+|.++|+||+.+.
T Consensus 80 ~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dlkp~-NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~gt 158 (323)
T cd05595 80 GELFFHLSRERVFTEERARFYGAEIVSALEYLHSRDVVYRDIKLE-NLMLDKDGHIKITDFGLCKEGISDGATMKTFCGT 158 (323)
T ss_pred CcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHH-HEEEcCCCCEEecccHHhccccCCCCccccccCC
Confidence 11112222210 134444 9999999999999988542
Q ss_pred ----cccccccccCCCcceeeechhhHHHHHHHhhCCCCCCCCcHHHHHHHHHhCCCCCCCCCCHHHHHHHHhhcccCCC
Q psy11767 219 ----QDEVIDWDDFSRGIECVFFSSSLIIFFIILSFTLSFIHDYYHIQYRRILKTEPPIPEDLSPDVADFISRLLVKDPR 294 (966)
Q Consensus 219 ----~~e~i~~~~y~~~~d~~~~~~~~il~~~m~~g~~pf~~~~~~~~~~~I~~~~~~~P~~~s~~a~dli~~LL~kdp~ 294 (966)
.+|++....|+...| .|+.|+++|+|++|.+||...+...+++.|....+.+|..+++++++||+++|++||.
T Consensus 159 ~~y~aPE~~~~~~~~~~~D---iwSlGvil~ell~g~~Pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~~li~~~L~~dP~ 235 (323)
T cd05595 159 PEYLAPEVLEDNDYGRAVD---WWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEIRFPRTLSPEAKSLLAGLLKKDPK 235 (323)
T ss_pred cCcCCcccccCCCCCchhc---hhhhHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCCCCCCCCCHHHHHHHHHHccCCHH
Confidence 134444445544444 3456778888999999999999899999999999999999999999999999999999
Q ss_pred cccCCCCCCHHHHhcCCceeeeCccccccCCCCCCCCccccccccccccccccccCc
Q psy11767 295 RRLGGGELDAEELKRHPFFNVIDWDDLATKRIPAPFVPKISNELDVSNFSDEFTKMI 351 (966)
Q Consensus 295 ~RLG~~~~g~~~Ik~HpfF~~idW~~l~~k~~~pP~~P~i~~~~D~snFd~ef~~~~ 351 (966)
+|++.+...+.+|+.||||.+++|..+..+.+.||+.|...+..+...|+++++...
T Consensus 236 ~R~~~~~~~~~~~l~h~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 292 (323)
T cd05595 236 QRLGGGPSDAKEVMEHRFFLSINWQDVVQKKLLPPFKPQVTSEVDTRYFDDEFTAQS 292 (323)
T ss_pred HhCCCCCCCHHHHHcCCCcCCCCHHHHHhCCCCCCcCCCCCChhhhhhcCcccccCC
Confidence 999877778999999999999999999999999999999999999999998876543
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in |
| >COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Probab=99.90 E-value=1.6e-22 Score=219.54 Aligned_cols=244 Identities=33% Similarity=0.539 Sum_probs=185.6
Q ss_pred ccccccccccEEEEEEEcCCCcEEEEEEeccccC--------hHHHHHHHHHhcCCCCceEEEEEEEeCCeEEEEEEccC
Q psy11767 383 AGILGDGSYSVCRRCVEKSTGQEYAVKIISRKID--------CSEEINLLRACQGHPNIVNLHCVFQDEVHTYLVLELLK 454 (966)
Q Consensus 383 ~~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~~--------~~~Ei~iL~~l~~HpnIV~l~~~~~~~~~~~lVmEy~~ 454 (966)
...||.|+||.||++.+. ..+|+|.+..... ..+|+.++..+..|+||+++++.+......+++++|+.
T Consensus 5 ~~~l~~g~~~~v~~~~~~---~~~~~k~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~ 81 (384)
T COG0515 5 LRKLGEGSFGEVYLARDR---KLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKLYDFFQDEGSLYLVMEYVD 81 (384)
T ss_pred EEeecCCCCeEEEEEEec---cEEEEEeechhhccchhHHHHHHHHHHHHHHccCCcceeeEEEEEecCCEEEEEEecCC
Confidence 567999999999999988 7899999865422 44688888888644489999999988888899999999
Q ss_pred CCCHHHHHHhcCC-CCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCcEEEecCCCC-CEEEEeecccccccCC----
Q psy11767 455 GGELLDRIRQKGR-CGFTENEASRIMRQLVAAVHFMHSRGVVHRDLKPENLLFSDPAGD-NIKVVDFGFACLKRES---- 528 (966)
Q Consensus 455 gg~L~~~l~~~~~-~~l~e~~~~~i~~Qil~aL~yLHs~~IiHRDLKP~NILl~~~~~~-~iKL~DFGla~~~~~~---- 528 (966)
++++.+.+..... ..+++..+..++.|++.++.|+|+.+++||||||+|||++. .+ .++++|||++......
T Consensus 82 ~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~H~~~~~hrd~kp~nil~~~--~~~~~~l~dfg~~~~~~~~~~~~ 159 (384)
T COG0515 82 GGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLHSKGIIHRDIKPENILLDR--DGRVVKLIDFGLAKLLPDPGSTS 159 (384)
T ss_pred CCcHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeeecC--CCCeEEEeccCcceecCCCCccc
Confidence 9999977765431 15899999999999999999999999999999999999974 33 6999999998744321
Q ss_pred -----CccccccccccCchhhccCCCCCCCcccchhhhhhhhhhhhcCCCCCCCcCcchhHHHHHHHHhcCCCCCCCCCC
Q psy11767 529 -----LHTPCFTLQYAAPEVLRQDKSGYDENCDLWSLGVILVNVLRQDKSGYDENCDLWSLGVILYTMLCGRVPFHARSR 603 (966)
Q Consensus 529 -----~~~~~gT~~Y~APEvl~~~~~~~~~~~Di~SlGvil~el~~~~~~~y~~~~DIWSlGvilyemltG~~Pf~~~~~ 603 (966)
....++|..|+|||.+.... ...++...|+||+|++++++++|..||.....
T Consensus 160 ~~~~~~~~~~~t~~~~~pe~~~~~~-----------------------~~~~~~~~D~~s~g~~~~~~~~~~~p~~~~~~ 216 (384)
T COG0515 160 SIPALPSTSVGTPGYMAPEVLLGLS-----------------------LAYASSSSDIWSLGITLYELLTGLPPFEGEKN 216 (384)
T ss_pred cccccccccccccccCCHHHhcCCC-----------------------CCCCCchHhHHHHHHHHHHHHhCCCCCCCCCc
Confidence 24567899999999885310 02356789999999999999999999876653
Q ss_pred chhHHHHHHHHHcCCCC-CCchhhcc----CCHHHHHHHHHhcccCccccCChHHH
Q psy11767 604 DDSALSIMARIKEGQFN-FDAEAWST----VSSEAKELTKSLLTVNPAQRIRMMRV 654 (966)
Q Consensus 604 ~~~~~~~~~~i~~~~~~-~~~~~~~~----is~e~~~Li~~~L~~dP~~R~t~~~v 654 (966)
..........+...... ........ ....+.+++.+++..+|..|.++...
T Consensus 217 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~~ 272 (384)
T COG0515 217 SSATSQTLKIILELPTPSLASPLSPSNPELISKAASDLLKKLLAKDPKNRLSSSSD 272 (384)
T ss_pred cccHHHHHHHHHhcCCcccccccCccccchhhHHHHHHHHHHHhcCchhcCCHHHH
Confidence 10112223333332222 11111111 12578899999999999999988754
|
|
| >KOG0615|consensus | Back alignment and domain information |
|---|
Probab=99.90 E-value=1.2e-24 Score=237.73 Aligned_cols=195 Identities=27% Similarity=0.430 Sum_probs=150.6
Q ss_pred cchhccCCcceeeeecccccceEEEEEEcCCCCEEEEEeccccc------------hhhHHHHHHHHhhCCCcccc----
Q psy11767 110 FFEQYDMDLDKAGILGDGSYSVCRRCVEKSTGQEYAVKIISRKI------------DCSEEINLLRACQGHPNICR---- 173 (966)
Q Consensus 110 ~~~~~~~df~~~~~LG~GsFGkV~La~~k~tg~~yAiKvl~K~~------------~~~~E~~il~~~~~~pfi~~---- 173 (966)
|++.| -+.++||.|+||.|.||.+|.||+.|||||++|+. .+.+|.+||+++ .||.||+
T Consensus 170 ~~d~y----ii~~~LGsGafg~Vkla~e~~tgk~vAiKIi~krk~~~~s~~~~~~~~v~~EieILkkL-~HP~IV~~~d~ 244 (475)
T KOG0615|consen 170 FNDYY----IISKTLGSGAFGLVKLAYEKKTGKQVAIKIINKRKSTGCSRAIAKTRDVQNEIEILKKL-SHPNIVRIKDF 244 (475)
T ss_pred hccee----EeeeeecCCceeEEEEEEEcccCcEEEeeeeehhhcccccccccchhhhHHHHHHHHhc-CCCCEEEEeee
Confidence 55555 67889999999999999999999999999999973 246899999998 5999987
Q ss_pred --------------------------cccccccchhHHHHHHHh----------hcccchhhhHhhhcc---CCceEEec
Q psy11767 174 --------------------------RCVEKSTGQEYAVKIISR----------KIDCSEEINLLRACQ---GHPNIVNL 214 (966)
Q Consensus 174 --------------------------~~~~~~~~~~~~~~~v~~----------~~~~~~e~nil~~~~---gh~~iv~l 214 (966)
.++.+...+.++.+++.+ ..|+++| |||+..+ =+.+|+||
T Consensus 245 f~~~ds~YmVlE~v~GGeLfd~vv~nk~l~ed~~K~~f~Qll~avkYLH~~GI~HRDiKPe-NILl~~~~e~~llKItDF 323 (475)
T KOG0615|consen 245 FEVPDSSYMVLEYVEGGELFDKVVANKYLREDLGKLLFKQLLTAVKYLHSQGIIHRDIKPE-NILLSNDAEDCLLKITDF 323 (475)
T ss_pred eecCCceEEEEEEecCccHHHHHHhccccccchhHHHHHHHHHHHHHHHHcCcccccCCcc-eEEeccCCcceEEEeccc
Confidence 233333334444444433 1366677 9988554 57899998
Q ss_pred Cccc------------------cccccccccCC---CcceeeechhhHHHHHHHhhCCCCCCCCcHHH-HHHHHHhCCCC
Q psy11767 215 HCVF------------------QDEVIDWDDFS---RGIECVFFSSSLIIFFIILSFTLSFIHDYYHI-QYRRILKTEPP 272 (966)
Q Consensus 215 ~~~~------------------~~e~i~~~~y~---~~~d~~~~~~~~il~~~m~~g~~pf~~~~~~~-~~~~I~~~~~~ 272 (966)
+.+. ++|++...|+. ..||+ |+.|+++|.+++|.|||....... +++.|+.|++.
T Consensus 324 GlAK~~g~~sfm~TlCGTpsYvAPEVl~~kg~~~~~~kVDi---WSlGcvLfvcLsG~pPFS~~~~~~sl~eQI~~G~y~ 400 (475)
T KOG0615|consen 324 GLAKVSGEGSFMKTLCGTPSYVAPEVLASKGVEYYPSKVDI---WSLGCVLFVCLSGYPPFSEEYTDPSLKEQILKGRYA 400 (475)
T ss_pred chhhccccceehhhhcCCccccChhheecCCeecccchhee---eeccceEEEEeccCCCcccccCCccHHHHHhcCccc
Confidence 8663 36777766543 33453 366778889999999998765554 89999999887
Q ss_pred C-C---CCCCHHHHHHHHhhcccCCCcccCCCCCCHHHHhcCCceeeeCc
Q psy11767 273 I-P---EDLSPDVADFISRLLVKDPRRRLGGGELDAEELKRHPFFNVIDW 318 (966)
Q Consensus 273 ~-P---~~~s~~a~dli~~LL~kdp~~RLG~~~~g~~~Ik~HpfF~~idW 318 (966)
| | ..+|.+|+|||.+||+.||.+|.. ++|..+||||+.+.-
T Consensus 401 f~p~~w~~Iseea~dlI~~mL~VdP~~R~s-----~~eaL~hpW~~~~~~ 445 (475)
T KOG0615|consen 401 FGPLQWDRISEEALDLINWMLVVDPENRPS-----ADEALNHPWFKDAPC 445 (475)
T ss_pred ccChhhhhhhHHHHHHHHHhhEeCcccCcC-----HHHHhcChhhhcccc
Confidence 6 2 358999999999999999999984 899999999997763
|
|
| >cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.90 E-value=1.7e-23 Score=233.77 Aligned_cols=224 Identities=28% Similarity=0.497 Sum_probs=176.2
Q ss_pred ecccccceEEEEEEcCCCCEEEEEeccccc--------hhhHHHHHHHHhhCCCcccccccccccc--------------
Q psy11767 124 LGDGSYSVCRRCVEKSTGQEYAVKIISRKI--------DCSEEINLLRACQGHPNICRRCVEKSTG-------------- 181 (966)
Q Consensus 124 LG~GsFGkV~La~~k~tg~~yAiKvl~K~~--------~~~~E~~il~~~~~~pfi~~~~~~~~~~-------------- 181 (966)
||+|+||+|++|+++.+++.||||++++.. ....|..+|.++ +||+|+.....+...
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~e~~~~g~ 79 (312)
T cd05585 1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQV-NCPFIVPLKFSFQSPEKLYLVLAFINGGE 79 (312)
T ss_pred CCcCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhC-CCCcEeceeeEEecCCeEEEEEcCCCCCc
Confidence 799999999999999999999999998642 245688888887 699998622111111
Q ss_pred ----------------hhHHHHHHHh----------hcccchhhhHhhhccCCceEEecCcccc----------------
Q psy11767 182 ----------------QEYAVKIISR----------KIDCSEEINLLRACQGHPNIVNLHCVFQ---------------- 219 (966)
Q Consensus 182 ----------------~~~~~~~v~~----------~~~~~~e~nil~~~~gh~~iv~l~~~~~---------------- 219 (966)
..+..+++.+ ..|++++ |||.+.+|.++|+||+.+..
T Consensus 80 L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~HrDlkp~-Nili~~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt~~ 158 (312)
T cd05585 80 LFHHLQREGRFDLSRARFYTAELLCALENLHKFNVIYRDLKPE-NILLDYQGHIALCDFGLCKLNMKDDDKTNTFCGTPE 158 (312)
T ss_pred HHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEeCCCCHH-HeEECCCCcEEEEECcccccCccCCCccccccCCcc
Confidence 1111122211 0134434 99999999999999986532
Q ss_pred ---ccccccccCCCcceeeechhhHHHHHHHhhCCCCCCCCcHHHHHHHHHhCCCCCCCCCCHHHHHHHHhhcccCCCcc
Q psy11767 220 ---DEVIDWDDFSRGIECVFFSSSLIIFFIILSFTLSFIHDYYHIQYRRILKTEPPIPEDLSPDVADFISRLLVKDPRRR 296 (966)
Q Consensus 220 ---~e~i~~~~y~~~~d~~~~~~~~il~~~m~~g~~pf~~~~~~~~~~~I~~~~~~~P~~~s~~a~dli~~LL~kdp~~R 296 (966)
+|++....|+...| .| +.|+++|+|++|.+||...+...++++|+.+.+.+|..+++++++||.++|.+||.+|
T Consensus 159 y~aPE~~~~~~~~~~~D--vw-slGvil~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R 235 (312)
T cd05585 159 YLAPELLLGHGYTKAVD--WW-TLGVLLYEMLTGLPPFYDENVNEMYRKILQEPLRFPDGFDRDAKDLLIGLLSRDPTRR 235 (312)
T ss_pred cCCHHHHcCCCCCCccc--ee-chhHHHHHHHhCCCCcCCCCHHHHHHHHHcCCCCCCCcCCHHHHHHHHHHcCCCHHHc
Confidence 34444445554444 33 5668888899999999999999999999999999999999999999999999999999
Q ss_pred cCCCCCCHHHHhcCCceeeeCccccccCCCCCCCCccccccccccccccccccCcCCC
Q psy11767 297 LGGGELDAEELKRHPFFNVIDWDDLATKRIPAPFVPKISNELDVSNFSDEFTKMIPAD 354 (966)
Q Consensus 297 LG~~~~g~~~Ik~HpfF~~idW~~l~~k~~~pP~~P~i~~~~D~snFd~ef~~~~p~d 354 (966)
++. .++.+++.||||..++|..+..+.+++|+.|.+.+..+.++|+++++...+.+
T Consensus 236 ~~~--~~~~e~l~hp~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 291 (312)
T cd05585 236 LGY--NGAQEIKNHPFFSQLSWKKLLMKGIQPPFKPAVSSAIDTSNFDEEFTREKPID 291 (312)
T ss_pred CCC--CCHHHHHcCCCcCCCCHHHHHhCCCCCCcCCCCCCccchhhcCcccccccccc
Confidence 975 36899999999999999999999999999999999999999999887655443
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl |
| >KOG1164|consensus | Back alignment and domain information |
|---|
Probab=99.90 E-value=2.1e-22 Score=226.53 Aligned_cols=245 Identities=23% Similarity=0.280 Sum_probs=183.4
Q ss_pred cccccccccccccEEEEEEEcCCC-cEEEEEEecccc-----ChHHHHHHHHHhcC---CCCceEEEEEE-EeCCeEEEE
Q psy11767 380 LDKAGILGDGSYSVCRRCVEKSTG-QEYAVKIISRKI-----DCSEEINLLRACQG---HPNIVNLHCVF-QDEVHTYLV 449 (966)
Q Consensus 380 ~~~~~~LG~G~fG~Vy~a~~~~tg-~~vAvK~i~~~~-----~~~~Ei~iL~~l~~---HpnIV~l~~~~-~~~~~~~lV 449 (966)
|...+.||+|+||.||+|.+..++ ..+|+|+..... ....|+.+|..+.. -+++.++++.+ ..+.+.|+|
T Consensus 20 ~~i~~~iG~G~fG~V~~v~~~~~~~~~~a~K~e~~~~~~~~~~l~~E~~vl~~l~~~~~~~~~~~~~~~G~~~~~~~~iV 99 (322)
T KOG1164|consen 20 YKLGKKIGEGGFGAVYLVSDKSEKNKEYAKKLEKKELGSKPSVLKIEIQVLKKLEKKNGPSHFPKLLDHGRSTEDFNFIV 99 (322)
T ss_pred eEEeeeccccCCceEEEEEecCCCCeeEEEEEEEecccCCCccchhHHHHHHHHhhhcCCCCCCEEEEeccCCCceeEEE
Confidence 334689999999999999998875 689999876532 35679999988862 36999999999 588899999
Q ss_pred EEccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCcEEEecCC-C--CCEEEEeeccccccc
Q psy11767 450 LELLKGGELLDRIRQKGRCGFTENEASRIMRQLVAAVHFMHSRGVVHRDLKPENLLFSDPA-G--DNIKVVDFGFACLKR 526 (966)
Q Consensus 450 mEy~~gg~L~~~l~~~~~~~l~e~~~~~i~~Qil~aL~yLHs~~IiHRDLKP~NILl~~~~-~--~~iKL~DFGla~~~~ 526 (966)
|+++ |.+|.+.........|+..++..++.|++.+|++||+.|++||||||+|++++... . ..+.|.|||+|+...
T Consensus 100 M~l~-G~sL~dl~~~~~~~~fs~~T~l~ia~q~l~~l~~lH~~G~iHRDiKp~N~~~g~~~~~~~~~~~llDfGlar~~~ 178 (322)
T KOG1164|consen 100 MSLL-GPSLEDLRKRNPPGRFSRKTVLRIAIQNLNALEDLHSKGFIHRDIKPENFVVGQSSRSEVRTLYLLDFGLARRFK 178 (322)
T ss_pred Eecc-CccHHHHHHhCCCCCcCHhHHHHHHHHHHHHHHHHHhcCcccCCcCHHHeeecCCCCcccceEEEEecCCCcccc
Confidence 9998 88999987666555799999999999999999999999999999999999998643 1 469999999998221
Q ss_pred --C-C----------CccccccccccCchhhccCCCCCCCcccchhhhhhhhhhhhcCCCCCCCcCcchhHHHHHHHHhc
Q psy11767 527 --E-S----------LHTPCFTLQYAAPEVLRQDKSGYDENCDLWSLGVILVNVLRQDKSGYDENCDLWSLGVILYTMLC 593 (966)
Q Consensus 527 --~-~----------~~~~~gT~~Y~APEvl~~~~~~~~~~~Di~SlGvil~el~~~~~~~y~~~~DIWSlGvilyemlt 593 (966)
. . .....||..|+++.+-.. ...+.+.|+||++.++.+|+.
T Consensus 179 ~~~~~~~~~~~~r~~~~~~rGT~ry~S~~~H~~--------------------------~e~~r~DDles~~Y~l~el~~ 232 (322)
T KOG1164|consen 179 YVGDSGGNLRPPRPQKGLFRGTLRYASINVHLG--------------------------IEQGRRDDLESLFYMLLELLK 232 (322)
T ss_pred ccCCCCcccccCCCCccCCCCccccccHHHhCC--------------------------CccCCchhhhhHHHHHHHHhc
Confidence 1 0 112348888998886542 224678899999999999999
Q ss_pred CCCCCCCCCCchhHHHHHHHHHcCCCCCCchhhccCCHHHHHHHHHhcccCccccCChHHH
Q psy11767 594 GRVPFHARSRDDSALSIMARIKEGQFNFDAEAWSTVSSEAKELTKSLLTVNPAQRIRMMRV 654 (966)
Q Consensus 594 G~~Pf~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~is~e~~~Li~~~L~~dP~~R~t~~~v 654 (966)
|.+||.+....... ..+........... .....+.+..++...+-..+...+|....+
T Consensus 233 g~LPW~~~~~~~~~-~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~Pdy~~~ 290 (322)
T KOG1164|consen 233 GSLPWEALEMTDLK-SKFEKDPRKLLTDR--FGDLKPEEFAKILEYIDSLDYEDKPDYEKL 290 (322)
T ss_pred CCCCCccccccchH-HHHHHHhhhhcccc--ccCCChHHHHHHHHHhhccCCcCCCCHHHH
Confidence 99999776543221 11222211111100 112344567777777777888899987655
|
|
| >cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Probab=99.90 E-value=1.4e-23 Score=235.81 Aligned_cols=225 Identities=29% Similarity=0.427 Sum_probs=174.1
Q ss_pred eeecccccceEEEEEEcCCCCEEEEEeccccc--------hhhHHHHHHHHhhCCCccccccccccc-------------
Q psy11767 122 GILGDGSYSVCRRCVEKSTGQEYAVKIISRKI--------DCSEEINLLRACQGHPNICRRCVEKST------------- 180 (966)
Q Consensus 122 ~~LG~GsFGkV~La~~k~tg~~yAiKvl~K~~--------~~~~E~~il~~~~~~pfi~~~~~~~~~------------- 180 (966)
++||+|+||+|++|+++.+|+.||||+++|.. ....|+.++.+..+||+|++....+..
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~hp~iv~~~~~~~~~~~~~lv~e~~~~ 80 (325)
T cd05604 1 KVIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTTEKLYFVLDFVNG 80 (325)
T ss_pred CceeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHHhCCCCCCccEEEEEecCCEEEEEEcCCCC
Confidence 57999999999999999999999999998652 234566666565689999862211111
Q ss_pred -----------------chhHHHHHHHh----------hcccchhhhHhhhccCCceEEecCcccc--------------
Q psy11767 181 -----------------GQEYAVKIISR----------KIDCSEEINLLRACQGHPNIVNLHCVFQ-------------- 219 (966)
Q Consensus 181 -----------------~~~~~~~~v~~----------~~~~~~e~nil~~~~gh~~iv~l~~~~~-------------- 219 (966)
...++.+++.+ ..|++++ |||.+.+|+++|.||+.+..
T Consensus 81 ~~L~~~l~~~~~~~~~~~~~~~~qi~~al~~lH~~givH~Dlkp~-NIll~~~~~~kL~DfG~~~~~~~~~~~~~~~~gt 159 (325)
T cd05604 81 GELFFHLQRERSFPEPRARFYAAEIASALGYLHSINIVYRDLKPE-NILLDSQGHVVLTDFGLCKEGIAQSDTTTTFCGT 159 (325)
T ss_pred CCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHH-HeEECCCCCEEEeecCCcccCCCCCCCcccccCC
Confidence 11111222221 0133444 99999999999999986532
Q ss_pred -----ccccccccCCCcceeeechhhHHHHHHHhhCCCCCCCCcHHHHHHHHHhCCCCCCCCCCHHHHHHHHhhcccCCC
Q psy11767 220 -----DEVIDWDDFSRGIECVFFSSSLIIFFIILSFTLSFIHDYYHIQYRRILKTEPPIPEDLSPDVADFISRLLVKDPR 294 (966)
Q Consensus 220 -----~e~i~~~~y~~~~d~~~~~~~~il~~~m~~g~~pf~~~~~~~~~~~I~~~~~~~P~~~s~~a~dli~~LL~kdp~ 294 (966)
+|++....|+...| +|+.|+++|+|++|.+||...+...++++++...+.++...+.++.++|++||++||.
T Consensus 160 ~~y~aPE~~~~~~~~~~~D---vwslG~il~el~~G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~ll~~~p~ 236 (325)
T cd05604 160 PEYLAPEVIRKQPYDNTVD---WWCLGAVLYEMLYGLPPFYCRDVAEMYDNILHKPLVLRPGASLTAWSILEELLEKDRQ 236 (325)
T ss_pred hhhCCHHHHcCCCCCCcCc---cccccceehhhhcCCCCCCCCCHHHHHHHHHcCCccCCCCCCHHHHHHHHHHhccCHH
Confidence 24444445554444 3456788888999999999999999999999999999999999999999999999999
Q ss_pred cccCCCCCCHHHHhcCCceeeeCccccccCCCCCCCCccccccccccccccccccCc
Q psy11767 295 RRLGGGELDAEELKRHPFFNVIDWDDLATKRIPAPFVPKISNELDVSNFSDEFTKMI 351 (966)
Q Consensus 295 ~RLG~~~~g~~~Ik~HpfF~~idW~~l~~k~~~pP~~P~i~~~~D~snFd~ef~~~~ 351 (966)
+|++.. ..+.+|+.||||.+++|..+..+++++|+.|......+.++|+..+....
T Consensus 237 ~R~~~~-~~~~~i~~h~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 292 (325)
T cd05604 237 RRLGAK-EDFLEIQEHPFFESLSWTDLEQKKIPPPFNPNVEGPDDISNFDAVFTEET 292 (325)
T ss_pred hcCCCC-CCHHHHhcCCCcCCCCHHHHHhCCCCCCcCCcCCCcchhhhcCCccccCC
Confidence 999863 36899999999999999999999999999999988889999998765543
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, |
| >cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Probab=99.90 E-value=2.1e-23 Score=234.24 Aligned_cols=225 Identities=28% Similarity=0.437 Sum_probs=173.7
Q ss_pred eeecccccceEEEEEEcCCCCEEEEEeccccc--------hhhHHHHHHHHhhCCCcccccccccccc------------
Q psy11767 122 GILGDGSYSVCRRCVEKSTGQEYAVKIISRKI--------DCSEEINLLRACQGHPNICRRCVEKSTG------------ 181 (966)
Q Consensus 122 ~~LG~GsFGkV~La~~k~tg~~yAiKvl~K~~--------~~~~E~~il~~~~~~pfi~~~~~~~~~~------------ 181 (966)
++||+|+||+|++|+++.+|+.||||++.+.. ....|+.++.+.-+||+|++....+...
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~ 80 (323)
T cd05575 1 KVIGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTADKLYFVLDYVNG 80 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhhCCCCCCCCeeEEEEeCCEEEEEEcCCCC
Confidence 57999999999999999999999999998642 2345666555555899998632111110
Q ss_pred ------------------hhHHHHHHHhh----------cccchhhhHhhhccCCceEEecCcccc--------------
Q psy11767 182 ------------------QEYAVKIISRK----------IDCSEEINLLRACQGHPNIVNLHCVFQ-------------- 219 (966)
Q Consensus 182 ------------------~~~~~~~v~~~----------~~~~~e~nil~~~~gh~~iv~l~~~~~-------------- 219 (966)
..++.+++.+. .|++ ..|||.+.+|.++|+||+.+..
T Consensus 81 g~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~givH~dik-p~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt 159 (323)
T cd05575 81 GELFFHLQRERSFPEPRARFYAAEIASALGYLHSLNIIYRDLK-PENILLDSQGHVVLTDFGLCKEGIEHSKTTSTFCGT 159 (323)
T ss_pred CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCC-HHHeEECCCCcEEEeccCCCcccccCCCccccccCC
Confidence 11111222110 1333 3499999999999999986532
Q ss_pred -----ccccccccCCCcceeeechhhHHHHHHHhhCCCCCCCCcHHHHHHHHHhCCCCCCCCCCHHHHHHHHhhcccCCC
Q psy11767 220 -----DEVIDWDDFSRGIECVFFSSSLIIFFIILSFTLSFIHDYYHIQYRRILKTEPPIPEDLSPDVADFISRLLVKDPR 294 (966)
Q Consensus 220 -----~e~i~~~~y~~~~d~~~~~~~~il~~~m~~g~~pf~~~~~~~~~~~I~~~~~~~P~~~s~~a~dli~~LL~kdp~ 294 (966)
+|++....|+...| .| +.|+++|+|++|.+||...+...++++|+.+.+.+|..+++++.+||++||++||.
T Consensus 160 ~~y~aPE~~~~~~~~~~~D--vw-slG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~li~~~l~~~p~ 236 (323)
T cd05575 160 PEYLAPEVLRKQPYDRTVD--WW-CLGAVLYEMLYGLPPFYSRDTAEMYDNILNKPLRLKPNISVSARHLLEGLLQKDRT 236 (323)
T ss_pred hhhcChhhhcCCCCCcccc--cc-ccchhhhhhhcCCCCCCCCCHHHHHHHHHcCCCCCCCCCCHHHHHHHHHHhhcCHH
Confidence 34444445554444 33 56788888999999999999999999999999999999999999999999999999
Q ss_pred cccCCCCCCHHHHhcCCceeeeCccccccCCCCCCCCccccccccccccccccccCc
Q psy11767 295 RRLGGGELDAEELKRHPFFNVIDWDDLATKRIPAPFVPKISNELDVSNFSDEFTKMI 351 (966)
Q Consensus 295 ~RLG~~~~g~~~Ik~HpfF~~idW~~l~~k~~~pP~~P~i~~~~D~snFd~ef~~~~ 351 (966)
+|++.. ..+.+|..||||.+++|+.+..+++.+|+.|.+....+..+|+++|....
T Consensus 237 ~R~~~~-~~~~~il~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 292 (323)
T cd05575 237 KRLGAK-DDFLEIKNHVFFSSINWDDLVNKKITPPFNPNVSGPMDLKHFDPEFTEEP 292 (323)
T ss_pred hCCCCC-CCHHHHHcCCCcCCCCHHHHhhccCCCCcCCCCCCcchhhhcCccccccc
Confidence 999864 46889999999999999999999999999999988888899988776543
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr |
| >cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.90 E-value=2.5e-23 Score=238.81 Aligned_cols=222 Identities=26% Similarity=0.446 Sum_probs=170.1
Q ss_pred CcceeeeecccccceEEEEEEcCCCCEEEEEeccccc--------hhhHHHHHHHHhhCCCccccccccccc--------
Q psy11767 117 DLDKAGILGDGSYSVCRRCVEKSTGQEYAVKIISRKI--------DCSEEINLLRACQGHPNICRRCVEKST-------- 180 (966)
Q Consensus 117 df~~~~~LG~GsFGkV~La~~k~tg~~yAiKvl~K~~--------~~~~E~~il~~~~~~pfi~~~~~~~~~-------- 180 (966)
||.+++.||+|+||+||+|+.+.+|+.||||++.|.. ...+|..+|+++ +||+|++.+..+..
T Consensus 2 ~y~~~~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l-~hp~iv~~~~~~~~~~~~~lv~ 80 (377)
T cd05629 2 DFHTVKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAES-DSPWVVSLYYSFQDAQYLYLIM 80 (377)
T ss_pred CceEeEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHHHHhHHHHHHHHHHHHHHhC-CCCCcceEEEEEEcCCeeEEEE
Confidence 6899999999999999999999999999999997642 346789999886 79999863222111
Q ss_pred ----------------------chhHHHHHHHh----------hcccchhhhHhhhccCCceEEecCccc----------
Q psy11767 181 ----------------------GQEYAVKIISR----------KIDCSEEINLLRACQGHPNIVNLHCVF---------- 218 (966)
Q Consensus 181 ----------------------~~~~~~~~v~~----------~~~~~~e~nil~~~~gh~~iv~l~~~~---------- 218 (966)
.+.++.+++.+ ..|++++ |||.+.+|+++|.||+.+.
T Consensus 81 E~~~gg~L~~~l~~~~~~~~~~~~~~~~ql~~aL~~LH~~givHrDlkp~-NIll~~~~~~kl~DfGla~~~~~~~~~~~ 159 (377)
T cd05629 81 EFLPGGDLMTMLIKYDTFSEDVTRFYMAECVLAIEAVHKLGFIHRDIKPD-NILIDRGGHIKLSDFGLSTGFHKQHDSAY 159 (377)
T ss_pred eCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHH-HEEECCCCCEEEeeccccccccccccccc
Confidence 12222233222 1244444 9999999999999998552
Q ss_pred --------------------------------------------------------cccccccccCCCcceeeechhhHH
Q psy11767 219 --------------------------------------------------------QDEVIDWDDFSRGIECVFFSSSLI 242 (966)
Q Consensus 219 --------------------------------------------------------~~e~i~~~~y~~~~d~~~~~~~~i 242 (966)
.+|++....|+...| +| +.|+
T Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~D--iw-SlGv 236 (377)
T cd05629 160 YQKLLQGKSNKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQGYGQECD--WW-SLGA 236 (377)
T ss_pred ccccccccccccccccccccccccccccccchhhhhhhhhcccccccccCCCccccCHHHHccCCCCCcee--eE-ecch
Confidence 133444445554444 34 4567
Q ss_pred HHHHHhhCCCCCCCCcHHHHHHHHHh--CCCCCCC--CCCHHHHHHHHhhcccCCCcccCCCCCCHHHHhcCCceeeeCc
Q psy11767 243 IFFIILSFTLSFIHDYYHIQYRRILK--TEPPIPE--DLSPDVADFISRLLVKDPRRRLGGGELDAEELKRHPFFNVIDW 318 (966)
Q Consensus 243 l~~~m~~g~~pf~~~~~~~~~~~I~~--~~~~~P~--~~s~~a~dli~~LL~kdp~~RLG~~~~g~~~Ik~HpfF~~idW 318 (966)
++|+|++|.+||...+...++++|+. ..+.+|. .++.+++|||++||+ +|.+|++. .++.+++.||||++++|
T Consensus 237 il~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~dli~~lL~-~~~~r~~r--~~~~~~l~hp~~~~~~~ 313 (377)
T cd05629 237 IMFECLIGWPPFCSENSHETYRKIINWRETLYFPDDIHLSVEAEDLIRRLIT-NAENRLGR--GGAHEIKSHPFFRGVDW 313 (377)
T ss_pred hhhhhhcCCCCCCCCCHHHHHHHHHccCCccCCCCCCCCCHHHHHHHHHHhc-CHhhcCCC--CCHHHHhcCCCcCCCCH
Confidence 78889999999999888888999986 4566776 489999999999997 99999975 47999999999999999
Q ss_pred cccccCCCCCCCCccccccccccccccccc
Q psy11767 319 DDLATKRIPAPFVPKISNELDVSNFSDEFT 348 (966)
Q Consensus 319 ~~l~~k~~~pP~~P~i~~~~D~snFd~ef~ 348 (966)
+.+ +++.+|++|......+..+|.....
T Consensus 314 ~~~--~~~~~~~~~~~~~~~~~~~~~~~~~ 341 (377)
T cd05629 314 DTI--RQIRAPFIPQLKSITDTSYFPTDEL 341 (377)
T ss_pred HHH--ccCCCCcccCCCCccccccCCcccc
Confidence 999 6789999999988888888866543
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of |
| >cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Probab=99.90 E-value=4.1e-23 Score=232.03 Aligned_cols=223 Identities=28% Similarity=0.429 Sum_probs=171.4
Q ss_pred eeecccccceEEEEEEcCCCCEEEEEeccccc--------hhhHHHHHHHHhhCCCcccccccccccc------------
Q psy11767 122 GILGDGSYSVCRRCVEKSTGQEYAVKIISRKI--------DCSEEINLLRACQGHPNICRRCVEKSTG------------ 181 (966)
Q Consensus 122 ~~LG~GsFGkV~La~~k~tg~~yAiKvl~K~~--------~~~~E~~il~~~~~~pfi~~~~~~~~~~------------ 181 (966)
++||+|+||+|++|+++.+++.||+|++++.. ....|+.++.+..+||+|++....+...
T Consensus 1 ~~lg~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~Iv~~~~~~~~~~~~~lv~e~~~~ 80 (325)
T cd05602 1 KVIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYFVLDYING 80 (325)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHHhhhHHHHHHHHHHHHHHhCCCCCCCceeEEEEcCCeEEEEEeCCCC
Confidence 47999999999999999999999999998642 2344555444445899998622211111
Q ss_pred ------------------hhHHHHHHHh----------hcccchhhhHhhhccCCceEEecCcccc--------------
Q psy11767 182 ------------------QEYAVKIISR----------KIDCSEEINLLRACQGHPNIVNLHCVFQ-------------- 219 (966)
Q Consensus 182 ------------------~~~~~~~v~~----------~~~~~~e~nil~~~~gh~~iv~l~~~~~-------------- 219 (966)
+.++.+++.+ ..|++++ |||.+.+|.++|+||+.+..
T Consensus 81 ~~L~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~giiHrDlkp~-Nili~~~~~~kl~DfG~a~~~~~~~~~~~~~~gt 159 (325)
T cd05602 81 GELFYHLQRERCFLEPRARFYAAEIASALGYLHSLNIVYRDLKPE-NILLDSQGHIVLTDFGLCKENIEHNGTTSTFCGT 159 (325)
T ss_pred CcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHH-HeEECCCCCEEEccCCCCcccccCCCCcccccCC
Confidence 1111222211 0144444 99999999999999986531
Q ss_pred -----ccccccccCCCcceeeechhhHHHHHHHhhCCCCCCCCcHHHHHHHHHhCCCCCCCCCCHHHHHHHHhhcccCCC
Q psy11767 220 -----DEVIDWDDFSRGIECVFFSSSLIIFFIILSFTLSFIHDYYHIQYRRILKTEPPIPEDLSPDVADFISRLLVKDPR 294 (966)
Q Consensus 220 -----~e~i~~~~y~~~~d~~~~~~~~il~~~m~~g~~pf~~~~~~~~~~~I~~~~~~~P~~~s~~a~dli~~LL~kdp~ 294 (966)
+|++....|+...| +|+.|+++|+|++|.+||...+...++++|......++..+++++++||++||++||.
T Consensus 160 ~~y~aPE~~~~~~~~~~~D---iwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~li~~~l~~~p~ 236 (325)
T cd05602 160 PEYLAPEVLHKQPYDRTVD---WWCLGAVLYEMLYGLPPFYSRNTAEMYDNILNKPLQLKPNITNSARHLLEGLLQKDRT 236 (325)
T ss_pred ccccCHHHHcCCCCCCccc---cccccHHHHHHhcCCCCCCCCCHHHHHHHHHhCCcCCCCCCCHHHHHHHHHHcccCHH
Confidence 34444445554444 3456788888999999999999999999999999999999999999999999999999
Q ss_pred cccCCCCCCHHHHhcCCceeeeCccccccCCCCCCCCcccccccccccccccccc
Q psy11767 295 RRLGGGELDAEELKRHPFFNVIDWDDLATKRIPAPFVPKISNELDVSNFSDEFTK 349 (966)
Q Consensus 295 ~RLG~~~~g~~~Ik~HpfF~~idW~~l~~k~~~pP~~P~i~~~~D~snFd~ef~~ 349 (966)
+|++.. ..+.+|++|+||..++|+.+..+++.+|+.|......+..+|++.+..
T Consensus 237 ~R~~~~-~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 290 (325)
T cd05602 237 KRLGAK-DDFMEIKNHIFFSPINWDDLINKKITPPFNPNVSGPNDLRHFDPEFTE 290 (325)
T ss_pred HCCCCC-CCHHHHhcCcccCCCCHHHHHhCCCCcCcCCCCCCcchhhhcCCcccc
Confidence 999864 368899999999999999999999999999999888888889877654
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt |
| >cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Probab=99.90 E-value=5.6e-23 Score=236.36 Aligned_cols=221 Identities=24% Similarity=0.393 Sum_probs=165.1
Q ss_pred CcceeeeecccccceEEEEEEcCCCCEEEEEeccccc--------hhhHHHHHHHHhhCCCccccccccccc--------
Q psy11767 117 DLDKAGILGDGSYSVCRRCVEKSTGQEYAVKIISRKI--------DCSEEINLLRACQGHPNICRRCVEKST-------- 180 (966)
Q Consensus 117 df~~~~~LG~GsFGkV~La~~k~tg~~yAiKvl~K~~--------~~~~E~~il~~~~~~pfi~~~~~~~~~-------- 180 (966)
+|.+++.||+|+||+|++|+++.+|+.||||++++.. ....|..+|+++ +||+|++.+..+..
T Consensus 2 ~f~~~~~LG~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l-~h~~iv~l~~~~~~~~~~~lv~ 80 (381)
T cd05626 2 MFVKIKTLGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEA-DNEWVVKLYYSFQDKDNLYFVM 80 (381)
T ss_pred CceEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhc-CCCCeeeeEEEEecCCEEEEEE
Confidence 5899999999999999999999999999999998642 346788999887 69999872221111
Q ss_pred ----------------------chhHHHHHHHh----------hcccchhhhHhhhccCCceEEecCccc----------
Q psy11767 181 ----------------------GQEYAVKIISR----------KIDCSEEINLLRACQGHPNIVNLHCVF---------- 218 (966)
Q Consensus 181 ----------------------~~~~~~~~v~~----------~~~~~~e~nil~~~~gh~~iv~l~~~~---------- 218 (966)
.+.++.+++.+ ..|++++ |||.+.+|+.+|+||+.+.
T Consensus 81 E~~~gg~L~~~l~~~~~~~e~~~~~~~~qi~~aL~~LH~~givHrDlKp~-Nili~~~~~~kL~DFGl~~~~~~~~~~~~ 159 (381)
T cd05626 81 DYIPGGDMMSLLIRMEVFPEVLARFYIAELTLAIESVHKMGFIHRDIKPD-NILIDLDGHIKLTDFGLCTGFRWTHNSKY 159 (381)
T ss_pred ecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCcHH-HEEECCCCCEEEeeCcCCccccccccccc
Confidence 12222232222 1244444 9999999999999998531
Q ss_pred --------------------------------------------------------cccccccccCCCcceeeechhhHH
Q psy11767 219 --------------------------------------------------------QDEVIDWDDFSRGIECVFFSSSLI 242 (966)
Q Consensus 219 --------------------------------------------------------~~e~i~~~~y~~~~d~~~~~~~~i 242 (966)
.+|++...+|+...| .| +.|+
T Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~D--iw-SlG~ 236 (381)
T cd05626 160 YQKGSHIRQDSMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYTQLCD--WW-SVGV 236 (381)
T ss_pred ccccccccccccCcccccccccccccccccchhhccccccccccccccccCCccccCHHHHcCCCCCCccc--ee-ehhh
Confidence 134444445554444 33 5678
Q ss_pred HHHHHhhCCCCCCCCcHHHHHHHHHh--CCCCCCC--CCCHHHHHHHHhhcccCCCcccCCCCCCHHHHhcCCceeeeCc
Q psy11767 243 IFFIILSFTLSFIHDYYHIQYRRILK--TEPPIPE--DLSPDVADFISRLLVKDPRRRLGGGELDAEELKRHPFFNVIDW 318 (966)
Q Consensus 243 l~~~m~~g~~pf~~~~~~~~~~~I~~--~~~~~P~--~~s~~a~dli~~LL~kdp~~RLG~~~~g~~~Ik~HpfF~~idW 318 (966)
++|+|++|.+||...+......+|+. ..+.+|. .++++++|||.+||+.++ +|++. .++++|+.||||..++|
T Consensus 237 il~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~dli~~ll~~~~-~~~~R--~~~~~~l~hp~f~~~~~ 313 (381)
T cd05626 237 ILFEMLVGQPPFLAPTPTETQLKVINWENTLHIPPQVKLSPEAVDLITKLCCSAE-ERLGR--NGADDIKAHPFFSEVDF 313 (381)
T ss_pred HHHHHHhCCCCCcCCCHHHHHHHHHccccccCCCCCCCCCHHHHHHHHHHccCcc-cccCC--CCHHHHhcCcccCCCCh
Confidence 88999999999998888777778874 4566775 589999999999998544 33332 36899999999999999
Q ss_pred cccccCCCCCCCCccccccccccccccc
Q psy11767 319 DDLATKRIPAPFVPKISNELDVSNFSDE 346 (966)
Q Consensus 319 ~~l~~k~~~pP~~P~i~~~~D~snFd~e 346 (966)
.... +..++|+.|.+....++++|++.
T Consensus 314 ~~~~-~~~~~~~~p~~~~~~~~~~~~~~ 340 (381)
T cd05626 314 SSDI-RTQPAPYVPKISHPMDTSNFDPV 340 (381)
T ss_pred hHHh-hcCCCCccCcCCCcchhhhcCCC
Confidence 8865 46789999999999999999864
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po |
| >KOG1163|consensus | Back alignment and domain information |
|---|
Probab=99.89 E-value=1.9e-22 Score=206.71 Aligned_cols=247 Identities=22% Similarity=0.297 Sum_probs=185.2
Q ss_pred ccccccccccEEEEEEEcCCCcEEEEEEecccc---ChHHHHHHHHHhcCCCCceEEEEEEEeCCeEEEEEEccCCCCHH
Q psy11767 383 AGILGDGSYSVCRRCVEKSTGQEYAVKIISRKI---DCSEEINLLRACQGHPNIVNLHCVFQDEVHTYLVLELLKGGELL 459 (966)
Q Consensus 383 ~~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~---~~~~Ei~iL~~l~~HpnIV~l~~~~~~~~~~~lVmEy~~gg~L~ 459 (966)
++.||.|+||.+|+|.+..+|..||||+-+.+. ....|.++.+.+++-..|..+..++.+..+..+|||++ |.+|.
T Consensus 20 vrkiGsGSFGdIy~~~~i~~ge~VAiK~Es~~a~hpqL~yEskvY~iL~~g~GiP~i~~y~~e~~ynvlVMdLL-GPsLE 98 (341)
T KOG1163|consen 20 VRKIGSGSFGDIYLGISITSGEEVAIKLESSKAKHPQLLYESKVYRILQGGVGIPHIRHYGTEKDYNVLVMDLL-GPSLE 98 (341)
T ss_pred EEeecCCchhheeeeeeccCCceEEEEeecccCCCcchhHHHHHHHHhccCCCCchhhhhccccccceeeeecc-CccHH
Confidence 688999999999999999999999999986543 35579999888888888999999999999999999998 88988
Q ss_pred HHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCcEEEec-CCCCCEEEEeecccccccCCC---------
Q psy11767 460 DRIRQKGRCGFTENEASRIMRQLVAAVHFMHSRGVVHRDLKPENLLFSD-PAGDNIKVVDFGFACLKRESL--------- 529 (966)
Q Consensus 460 ~~l~~~~~~~l~e~~~~~i~~Qil~aL~yLHs~~IiHRDLKP~NILl~~-~~~~~iKL~DFGla~~~~~~~--------- 529 (966)
+.+.-..+ .|+..+++.++-|++.-++|+|.++.|||||||+|+|.+- .....+-|+|||||+...+..
T Consensus 99 dLfnfC~R-~ftmkTvLMLaDQml~RiEyvH~r~fiHRDIKPdNFLMGlgrh~~kl~LIDFGLaKky~d~~t~~HIpyre 177 (341)
T KOG1163|consen 99 DLFNFCSR-RFTMKTVLMLADQMLSRIEYVHLRNFIHRDIKPDNFLMGLGRHCNKLYLIDFGLAKKYRDIRTRQHIPYRE 177 (341)
T ss_pred HHHHHHhh-hhhHHhHHHHHHHHHHHHHHHHhhccccccCCccceeeccccccceEEEEeccchhhhccccccccCcccc
Confidence 87754433 6999999999999999999999999999999999999863 234578999999997654321
Q ss_pred -ccccccccccCchhhccCCCCCCCcccchhhhhhhhhhhhcCCCCCCCcCcchhHHHHHHHHhcCCCCCCCCCCchhHH
Q psy11767 530 -HTPCFTLQYAAPEVLRQDKSGYDENCDLWSLGVILVNVLRQDKSGYDENCDLWSLGVILYTMLCGRVPFHARSRDDSAL 608 (966)
Q Consensus 530 -~~~~gT~~Y~APEvl~~~~~~~~~~~Di~SlGvil~el~~~~~~~y~~~~DIWSlGvilyemltG~~Pf~~~~~~~~~~ 608 (966)
....||..|.+--.... .| -+...|+-|+|.+|..+.-|.+||++..... ..
T Consensus 178 ~r~ltGTaRYASinAh~g------------------~e--------qSRRDDmeSvgYvLmYfnrG~LPWQglka~t-k~ 230 (341)
T KOG1163|consen 178 DRNLTGTARYASINAHLG------------------IE--------QSRRDDMESVGYVLMYFNRGSLPWQGLKAAT-KK 230 (341)
T ss_pred CCccceeeeehhhhhhhh------------------hh--------hhhhhhhhhhcceeeeeecCCCcccccchhh-HH
Confidence 12346776665332210 11 1456799999999999999999999876432 23
Q ss_pred HHHHHHHcCCCCCCchhh-ccCCHHHHHHHHHhcccCccccCChHHHHHHh
Q psy11767 609 SIMARIKEGQFNFDAEAW-STVSSEAKELTKSLLTVNPAQRIRMMRVKLTF 658 (966)
Q Consensus 609 ~~~~~i~~~~~~~~~~~~-~~is~e~~~Li~~~L~~dP~~R~t~~~v~~~~ 658 (966)
+-.++|.+.....+.+.. ...+.|+--.+.-|=..-=++-|.-.-+...+
T Consensus 231 QKyEkI~EkK~s~~ie~LC~G~P~EF~myl~Y~R~L~F~E~Pdy~ylrqlF 281 (341)
T KOG1163|consen 231 QKYEKISEKKMSTPIEVLCKGFPAEFAMYLNYCRGLGFEEKPDYMYLRQLF 281 (341)
T ss_pred HHHHHHHHhhcCCCHHHHhCCCcHHHHHHHHHHhhcCCCCCCcHHHHHHHH
Confidence 345667666555444332 34567777777766555555556554343333
|
|
| >cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Probab=99.89 E-value=3.8e-23 Score=227.74 Aligned_cols=211 Identities=24% Similarity=0.359 Sum_probs=160.4
Q ss_pred cceeeeecccccceEEEEEEcCCCCEEEEEeccccc--------hhhHHHHHHHHhhCCCccccccccccc---------
Q psy11767 118 LDKAGILGDGSYSVCRRCVEKSTGQEYAVKIISRKI--------DCSEEINLLRACQGHPNICRRCVEKST--------- 180 (966)
Q Consensus 118 f~~~~~LG~GsFGkV~La~~k~tg~~yAiKvl~K~~--------~~~~E~~il~~~~~~pfi~~~~~~~~~--------- 180 (966)
|+.+++||+|+||+|++|+++.+|+.||+|++++.. ...+|..+|.++ +||+|+.....+..
T Consensus 2 f~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l-~~~~iv~~~~~~~~~~~~~lv~e 80 (285)
T cd05631 2 FRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKV-NSRFVVSLAYAYETKDALCLVLT 80 (285)
T ss_pred ceEEEEEecCCCEEEEEEEEecCCceEEEEEeeHhhhhhhhhHHHHHHHHHHHHhc-CCCcEEEEEEEEccCCeEEEEEE
Confidence 688999999999999999999999999999987642 235688999887 69999762111110
Q ss_pred -----------------------chhHHHHHHHh----------hcccchhhhHhhhccCCceEEecCcccc--------
Q psy11767 181 -----------------------GQEYAVKIISR----------KIDCSEEINLLRACQGHPNIVNLHCVFQ-------- 219 (966)
Q Consensus 181 -----------------------~~~~~~~~v~~----------~~~~~~e~nil~~~~gh~~iv~l~~~~~-------- 219 (966)
...++.+++.+ ..|++++ |||.+.+|.++|+||+.+..
T Consensus 81 ~~~~g~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~iiH~dikp~-Nill~~~~~~kl~Dfg~~~~~~~~~~~~ 159 (285)
T cd05631 81 IMNGGDLKFHIYNMGNPGFDEQRAIFYAAELCCGLEDLQRERIVYRDLKPE-NILLDDRGHIRISDLGLAVQIPEGETVR 159 (285)
T ss_pred ecCCCcHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCCCHH-HEEECCCCCEEEeeCCCcEEcCCCCeec
Confidence 01111222211 0133333 99999899999999986532
Q ss_pred ----------ccccccccCCCcceeeechhhHHHHHHHhhCCCCCCCCcH----HHHHHHHHhCCCCCCCCCCHHHHHHH
Q psy11767 220 ----------DEVIDWDDFSRGIECVFFSSSLIIFFIILSFTLSFIHDYY----HIQYRRILKTEPPIPEDLSPDVADFI 285 (966)
Q Consensus 220 ----------~e~i~~~~y~~~~d~~~~~~~~il~~~m~~g~~pf~~~~~----~~~~~~I~~~~~~~P~~~s~~a~dli 285 (966)
+|++....|+...| .|+.|+++|+|++|.+||...+. ..+...+......+|..+++++++||
T Consensus 160 ~~~g~~~y~aPE~~~~~~~~~~~D---vwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li 236 (285)
T cd05631 160 GRVGTVGYMAPEVINNEKYTFSPD---WWGLGCLIYEMIQGQSPFRKRKERVKREEVDRRVKEDQEEYSEKFSEDAKSIC 236 (285)
T ss_pred CCCCCCCccCHhhhcCCCCCcccC---chhHHHHHHHHHhCCCCCCCCCcchhHHHHHHHhhcccccCCccCCHHHHHHH
Confidence 34555555554444 34567888888999999986543 34556666777889999999999999
Q ss_pred HhhcccCCCcccCCCCCCHHHHhcCCceeeeCccccccCCCCCCCCcc
Q psy11767 286 SRLLVKDPRRRLGGGELDAEELKRHPFFNVIDWDDLATKRIPAPFVPK 333 (966)
Q Consensus 286 ~~LL~kdp~~RLG~~~~g~~~Ik~HpfF~~idW~~l~~k~~~pP~~P~ 333 (966)
+++|++||.+|++....++++|++||||.+++|+.+.++.++|||.|.
T Consensus 237 ~~~l~~~P~~R~~~~~~~~~~~~~h~~~~~~~~~~~~~~~~~~~~~~~ 284 (285)
T cd05631 237 RMLLTKNPKERLGCRGNGAAGVKQHPIFKNINFKRLEANMLEPPFCPD 284 (285)
T ss_pred HHHhhcCHHHhcCCCCCCHHHHhcCHhhcCCCHHHHHhCcCCcCCCCC
Confidence 999999999999876567999999999999999999999999999996
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i |
| >cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Probab=99.89 E-value=2.1e-23 Score=234.38 Aligned_cols=224 Identities=30% Similarity=0.530 Sum_probs=174.4
Q ss_pred eeecccccceEEEEEEcCCCCEEEEEeccccc--------hhhHHHHHHHHhhCCCccccccccccc-------------
Q psy11767 122 GILGDGSYSVCRRCVEKSTGQEYAVKIISRKI--------DCSEEINLLRACQGHPNICRRCVEKST------------- 180 (966)
Q Consensus 122 ~~LG~GsFGkV~La~~k~tg~~yAiKvl~K~~--------~~~~E~~il~~~~~~pfi~~~~~~~~~------------- 180 (966)
++||+|+||+|++|+++.+|+.||+|++++.. ....|..+|... +||+|+.....+..
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~~-~hp~i~~~~~~~~~~~~~~lv~E~~~~ 79 (325)
T cd05594 1 KLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNS-RHPFLTALKYSFQTHDRLCFVMEYANG 79 (325)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhC-CCCCCCceEEEEEcCCEEEEEEeCCCC
Confidence 57999999999999999999999999998752 235577777765 69999762111111
Q ss_pred -----------------chhHHHHHH------Hh--h---cccchhhhHhhhccCCceEEecCcccc-------------
Q psy11767 181 -----------------GQEYAVKII------SR--K---IDCSEEINLLRACQGHPNIVNLHCVFQ------------- 219 (966)
Q Consensus 181 -----------------~~~~~~~~v------~~--~---~~~~~e~nil~~~~gh~~iv~l~~~~~------------- 219 (966)
...++.+++ .. . .|+++ .|||.+.+|.++|+||+.+..
T Consensus 80 ~~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH~~~~ivHrDikp-~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~g 158 (325)
T cd05594 80 GELFFHLSRERVFSEDRARFYGAEIVSALDYLHSEKNVVYRDLKL-ENLMLDKDGHIKITDFGLCKEGIKDGATMKTFCG 158 (325)
T ss_pred CcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCCEEecCCCC-CeEEECCCCCEEEecCCCCeecCCCCcccccccC
Confidence 111111222 11 1 13333 399999999999999986421
Q ss_pred ------ccccccccCCCcceeeechhhHHHHHHHhhCCCCCCCCcHHHHHHHHHhCCCCCCCCCCHHHHHHHHhhcccCC
Q psy11767 220 ------DEVIDWDDFSRGIECVFFSSSLIIFFIILSFTLSFIHDYYHIQYRRILKTEPPIPEDLSPDVADFISRLLVKDP 293 (966)
Q Consensus 220 ------~e~i~~~~y~~~~d~~~~~~~~il~~~m~~g~~pf~~~~~~~~~~~I~~~~~~~P~~~s~~a~dli~~LL~kdp 293 (966)
+|++....|+...| .| +.|+++|+|++|.+||...+...+++.|....+.+|..+++++++||+++|++||
T Consensus 159 t~~y~aPE~~~~~~~~~~~D--iw-slG~il~el~tG~~Pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~li~~~L~~dP 235 (325)
T cd05594 159 TPEYLAPEVLEDNDYGRAVD--WW-GLGVVMYEMMCGRLPFYNQDHEKLFELILMEEIRFPRTLSPEAKSLLSGLLKKDP 235 (325)
T ss_pred CcccCCHHHHccCCCCCccc--cc-cccceeeeeccCCCCCCCCCHHHHHHHHhcCCCCCCCCCCHHHHHHHHHHhhcCH
Confidence 34444445555444 34 5567888889999999999988999999999999999999999999999999999
Q ss_pred CcccCCCCCCHHHHhcCCceeeeCccccccCCCCCCCCccccccccccccccccccC
Q psy11767 294 RRRLGGGELDAEELKRHPFFNVIDWDDLATKRIPAPFVPKISNELDVSNFSDEFTKM 350 (966)
Q Consensus 294 ~~RLG~~~~g~~~Ik~HpfF~~idW~~l~~k~~~pP~~P~i~~~~D~snFd~ef~~~ 350 (966)
.+|++.....+.+|..||||.+++|..+..+.+.||+.|......+..+|++++...
T Consensus 236 ~~R~~~~~~~~~~il~h~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 292 (325)
T cd05594 236 KQRLGGGPDDAKEIMQHKFFAGIVWQDVYEKKLVPPFKPQVTSETDTRYFDEEFTAQ 292 (325)
T ss_pred HHhCCCCCCCHHHHhcCCCcCCCCHHHHHhCCCCCCcCCcCCCcchhhhcCchhhcC
Confidence 999987666799999999999999999999999999999998888999999887654
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien |
| >KOG1024|consensus | Back alignment and domain information |
|---|
Probab=99.89 E-value=4e-23 Score=223.47 Aligned_cols=247 Identities=19% Similarity=0.312 Sum_probs=186.0
Q ss_pred ccccccccccccEEEEEEEcCC-----CcEEEEEEeccccC------hHHHHHHHHHhcCCCCceEEEEEEEeC-CeEEE
Q psy11767 381 DKAGILGDGSYSVCRRCVEKST-----GQEYAVKIISRKID------CSEEINLLRACQGHPNIVNLHCVFQDE-VHTYL 448 (966)
Q Consensus 381 ~~~~~LG~G~fG~Vy~a~~~~t-----g~~vAvK~i~~~~~------~~~Ei~iL~~l~~HpnIV~l~~~~~~~-~~~~l 448 (966)
...-++-+|.||.||+|..+.. .+.|-+|.++.... ...|--+|..+ .|||+....++...+ ...+.
T Consensus 287 ~l~~llqEGtFGri~~gI~~eEdt~n~~q~v~vKTvk~~AS~iQv~~~L~es~lly~~-sH~nll~V~~V~ie~~~~P~V 365 (563)
T KOG1024|consen 287 RLSCLLQEGTFGRIYRGIWREEDTYNDCQEVLVKTVKQHASQIQVNLLLQESMLLYGA-SHPNLLSVLGVSIEDYATPFV 365 (563)
T ss_pred echhhhhcCchhheeeeeecccCCcchHHHHHHHHHHhcccHHHHHHHHHHHHHHhcC-cCCCccceeEEEeeccCcceE
Confidence 3356789999999999976642 34455666644322 12244444444 599999998887654 56788
Q ss_pred EEEccCCCCHHHHHHhc------CCCCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCcEEEecCCCCCEEEEeeccc
Q psy11767 449 VLELLKGGELLDRIRQK------GRCGFTENEASRIMRQLVAAVHFMHSRGVVHRDLKPENLLFSDPAGDNIKVVDFGFA 522 (966)
Q Consensus 449 VmEy~~gg~L~~~l~~~------~~~~l~e~~~~~i~~Qil~aL~yLHs~~IiHRDLKP~NILl~~~~~~~iKL~DFGla 522 (966)
++.++.-|+|..+|... +...++-.+...++.|++.|++|||+.||||.||-..|++|++ .-.+||+|=.|+
T Consensus 366 ~y~~~~~gNLK~FL~~Cr~~~~~~aqtvtt~qlV~masQla~am~hlh~~~ViHkDiAaRNCvIdd--~LqVkltDsaLS 443 (563)
T KOG1024|consen 366 LYPATGVGNLKSFLQICRGDDPSYAQTVTTIQLVLMASQLAMAMEHLHNHGVIHKDIAARNCVIDD--QLQVKLTDSALS 443 (563)
T ss_pred EEeccCcchHHHHHHHhccCCCccccchhHHHHHHHHHHHHHHHHHHHhcCcccchhhhhcceehh--heeEEeccchhc
Confidence 88998889999999732 2335778888899999999999999999999999999999986 458999999998
Q ss_pred ccccCCCcc-----ccccccccCchhhccCCCCCCCcccchhhhhhhhhhhhcCCCCCCCcCcchhHHHHHHHHhc-CCC
Q psy11767 523 CLKRESLHT-----PCFTLQYAAPEVLRQDKSGYDENCDLWSLGVILVNVLRQDKSGYDENCDLWSLGVILYTMLC-GRV 596 (966)
Q Consensus 523 ~~~~~~~~~-----~~gT~~Y~APEvl~~~~~~~~~~~Di~SlGvil~el~~~~~~~y~~~~DIWSlGvilyemlt-G~~ 596 (966)
+........ .-.+..||+||.+.. ..|+..+|+|||||+||||+| |+.
T Consensus 444 RDLFP~DYhcLGDnEnRPvkWMslEal~n--------------------------~~yssasDvWsfGVllWELmtlg~~ 497 (563)
T KOG1024|consen 444 RDLFPGDYHCLGDNENRPVKWMSLEALQN--------------------------SHYSSASDVWSFGVLLWELMTLGKL 497 (563)
T ss_pred cccCcccccccCCCCCCcccccCHHHHhh--------------------------hhhcchhhhHHHHHHHHHHHhcCCC
Confidence 754322111 123667999999863 348889999999999999986 999
Q ss_pred CCCCCCCchhHHHHHHHHHcCCCCCCchhhccCCHHHHHHHHHhcccCccccCChHHHHHHhhhhHH
Q psy11767 597 PFHARSRDDSALSIMARIKEGQFNFDAEAWSTVSSEAKELTKSLLTVNPAQRIRMMRVKLTFHAFHQ 663 (966)
Q Consensus 597 Pf~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~is~e~~~Li~~~L~~dP~~R~t~~~v~~~~~~~~~ 663 (966)
|+-..+..+ +...++.|.- +.. +-+.++++-.++..||+.+|++||+..++...+..|+.
T Consensus 498 PyaeIDPfE----m~~ylkdGyR-laQ--P~NCPDeLf~vMacCWallpeeRPsf~Qlv~cLseF~~ 557 (563)
T KOG1024|consen 498 PYAEIDPFE----MEHYLKDGYR-LAQ--PFNCPDELFTVMACCWALLPEERPSFSQLVICLSEFHT 557 (563)
T ss_pred CccccCHHH----HHHHHhccce-ecC--CCCCcHHHHHHHHHHHhcCcccCCCHHHHHHHHHHHHH
Confidence 998765533 3334555432 221 23678999999999999999999999999888877753
|
|
| >cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=99.89 E-value=1.5e-22 Score=227.37 Aligned_cols=231 Identities=30% Similarity=0.534 Sum_probs=178.2
Q ss_pred eeeecccccceEEEEEE---cCCCCEEEEEeccccc---------hhhHHHHHHHHhhCCCcccccccccccc-------
Q psy11767 121 AGILGDGSYSVCRRCVE---KSTGQEYAVKIISRKI---------DCSEEINLLRACQGHPNICRRCVEKSTG------- 181 (966)
Q Consensus 121 ~~~LG~GsFGkV~La~~---k~tg~~yAiKvl~K~~---------~~~~E~~il~~~~~~pfi~~~~~~~~~~------- 181 (966)
++.||+|+||+|++|+. +.+|+.||||++++.. ...+|..+|+.+ +||+|+.....+...
T Consensus 1 ~~~lg~G~~g~V~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~il~~l-~hp~iv~~~~~~~~~~~~~lv~ 79 (323)
T cd05584 1 LKVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAV-KHPFIVDLIYAFQTGGKLYLIL 79 (323)
T ss_pred CceeeecCCeEEEEEEEcccCCCCCEEEEEEEEHHHHHhhhhhHHHHHHHHHHHHhC-CCCchhceeeEEecCCeEEEEE
Confidence 46899999999999986 4689999999998642 235788999888 599998622111111
Q ss_pred -----------------------hhHHHHHHHh----------hcccchhhhHhhhccCCceEEecCccc----------
Q psy11767 182 -----------------------QEYAVKIISR----------KIDCSEEINLLRACQGHPNIVNLHCVF---------- 218 (966)
Q Consensus 182 -----------------------~~~~~~~v~~----------~~~~~~e~nil~~~~gh~~iv~l~~~~---------- 218 (966)
..+..+++.+ ..|++++ |||.+.+|.++|.||+.+.
T Consensus 80 e~~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~-Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~ 158 (323)
T cd05584 80 EYLSGGELFMHLEREGIFMEDTACFYLSEISLALEHLHQQGIIYRDLKPE-NILLDAQGHVKLTDFGLCKESIHEGTVTH 158 (323)
T ss_pred eCCCCchHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHH-HeEECCCCCEEEeeCcCCeecccCCCccc
Confidence 1111122211 0133434 9999999999999998642
Q ss_pred ---------cccccccccCCCcceeeechhhHHHHHHHhhCCCCCCCCcHHHHHHHHHhCCCCCCCCCCHHHHHHHHhhc
Q psy11767 219 ---------QDEVIDWDDFSRGIECVFFSSSLIIFFIILSFTLSFIHDYYHIQYRRILKTEPPIPEDLSPDVADFISRLL 289 (966)
Q Consensus 219 ---------~~e~i~~~~y~~~~d~~~~~~~~il~~~m~~g~~pf~~~~~~~~~~~I~~~~~~~P~~~s~~a~dli~~LL 289 (966)
.+|++....++...| .| +.|+++|+|++|.+||...+....+++|+.+.+.+|..++++++|||+++|
T Consensus 159 ~~~gt~~y~aPE~~~~~~~~~~~D--iw-slG~il~ell~G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l 235 (323)
T cd05584 159 TFCGTIEYMAPEILMRSGHGKAVD--WW-SLGALMYDMLTGAPPFTAENRKKTIDKILKGKLNLPPYLTPEARDLLKKLL 235 (323)
T ss_pred ccCCCccccChhhccCCCCCCcce--ec-ccHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCCCCCCCHHHHHHHHHHc
Confidence 134444444544444 44 456778889999999999988888999999999999999999999999999
Q ss_pred ccCCCcccCCCCCCHHHHhcCCceeeeCccccccCCCCCCCCccccccccccccccccccCcCCCCC
Q psy11767 290 VKDPRRRLGGGELDAEELKRHPFFNVIDWDDLATKRIPAPFVPKISNELDVSNFSDEFTKMIPADSP 356 (966)
Q Consensus 290 ~kdp~~RLG~~~~g~~~Ik~HpfF~~idW~~l~~k~~~pP~~P~i~~~~D~snFd~ef~~~~p~dSp 356 (966)
++||.+|+++....+++++.||||...+|+.+..+.+.+|+.+......+.+.|+..|+...+.++|
T Consensus 236 ~~~p~~R~~~~~~~~~~l~~h~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 302 (323)
T cd05584 236 KRNPSSRLGAGPGDAAEVQSHPFFRHVNWDDLLARKVEPPFKPLLQSEEDVSQFDSKFTRQTPVDSP 302 (323)
T ss_pred ccCHhHcCCCCCCCHHHHhcCCCcCCCCHHHHhcCCCCCCcCCCCCCcchhhhcCchhcccccccCc
Confidence 9999999987767899999999999999999999999999999998888888898877665554443
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in |
| >cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Probab=99.89 E-value=1e-22 Score=228.27 Aligned_cols=227 Identities=30% Similarity=0.456 Sum_probs=172.4
Q ss_pred eeecccccceEEEEEEcCCCCEEEEEeccccc--------hhhHHHHHHHHhhCCCcccccccccccc------------
Q psy11767 122 GILGDGSYSVCRRCVEKSTGQEYAVKIISRKI--------DCSEEINLLRACQGHPNICRRCVEKSTG------------ 181 (966)
Q Consensus 122 ~~LG~GsFGkV~La~~k~tg~~yAiKvl~K~~--------~~~~E~~il~~~~~~pfi~~~~~~~~~~------------ 181 (966)
++||+|+||+|++|+++.+|+.||+|+++|.. ....|+..+.+.-+||+|++....+...
T Consensus 1 ~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~~~~ 80 (321)
T cd05603 1 KVIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGLHYSFQTAEKLYFVLDYVNG 80 (321)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHHhCCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 47999999999999999999999999998642 2344554444445799998732211111
Q ss_pred ------------------hhHHHHHHHh----------hcccchhhhHhhhccCCceEEecCcccc--------------
Q psy11767 182 ------------------QEYAVKIISR----------KIDCSEEINLLRACQGHPNIVNLHCVFQ-------------- 219 (966)
Q Consensus 182 ------------------~~~~~~~v~~----------~~~~~~e~nil~~~~gh~~iv~l~~~~~-------------- 219 (966)
..++.+++.+ ..|++++ |||.+.+|+++|.||+.+..
T Consensus 81 ~~L~~~l~~~~~~~~~~~~~~~~qi~~~L~~lH~~~ivH~Dlkp~-NIll~~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt 159 (321)
T cd05603 81 GELFFHLQRERCFLEPRARFYAAEVASAIGYLHSLNIIYRDLKPE-NILLDSQGHVVLTDFGLCKEGVEPEETTSTFCGT 159 (321)
T ss_pred CCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHH-HeEECCCCCEEEccCCCCccCCCCCCccccccCC
Confidence 1111122211 0134444 99999999999999986532
Q ss_pred -----ccccccccCCCcceeeechhhHHHHHHHhhCCCCCCCCcHHHHHHHHHhCCCCCCCCCCHHHHHHHHhhcccCCC
Q psy11767 220 -----DEVIDWDDFSRGIECVFFSSSLIIFFIILSFTLSFIHDYYHIQYRRILKTEPPIPEDLSPDVADFISRLLVKDPR 294 (966)
Q Consensus 220 -----~e~i~~~~y~~~~d~~~~~~~~il~~~m~~g~~pf~~~~~~~~~~~I~~~~~~~P~~~s~~a~dli~~LL~kdp~ 294 (966)
+|++....|+...| .| +.|+++|+|++|.+||...+...+++.|+...+.+|...+.++++||.++|++||.
T Consensus 160 ~~y~aPE~~~~~~~~~~~D--iw-slG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~li~~~l~~~p~ 236 (321)
T cd05603 160 PEYLAPEVLRKEPYDRTVD--WW-CLGAVLYEMLYGLPPFYSRDVSQMYDNILHKPLQLPGGKTVAACDLLVGLLHKDQR 236 (321)
T ss_pred cccCCHHHhcCCCCCCcCc--cc-ccchhhhhhhcCCCCCCCCCHHHHHHHHhcCCCCCCCCCCHHHHHHHHHHccCCHh
Confidence 23444444544434 34 56678888899999999999999999999999999999999999999999999999
Q ss_pred cccCCCCCCHHHHhcCCceeeeCccccccCCCCCCCCccccccccccccccccccCcCC
Q psy11767 295 RRLGGGELDAEELKRHPFFNVIDWDDLATKRIPAPFVPKISNELDVSNFSDEFTKMIPA 353 (966)
Q Consensus 295 ~RLG~~~~g~~~Ik~HpfF~~idW~~l~~k~~~pP~~P~i~~~~D~snFd~ef~~~~p~ 353 (966)
+|++.. ..+.+|++|+||..++|+.+..+.+.||+.|......+...|+++++.....
T Consensus 237 ~R~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 294 (321)
T cd05603 237 RRLGAK-ADFLEIKNHVFFSPINWDDLYHKRITPPYNPNVAGPADLRHFDPEFTQEAVS 294 (321)
T ss_pred hcCCCC-CCHHHHhCCCCcCCCCHHHHhcCCCCCCcCCCCCCcchhhhcCCcccccccc
Confidence 999863 3588999999999999999999999999999988888888998877654433
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. |
| >PRK09188 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.89 E-value=7.5e-23 Score=231.55 Aligned_cols=150 Identities=24% Similarity=0.281 Sum_probs=117.7
Q ss_pred ccccccccccEEEEEEEcC-CCcEEEEEEeccc-----c-----ChHHHHHHHHHhcCCCCceE-EEEEEEeCCeEEEEE
Q psy11767 383 AGILGDGSYSVCRRCVEKS-TGQEYAVKIISRK-----I-----DCSEEINLLRACQGHPNIVN-LHCVFQDEVHTYLVL 450 (966)
Q Consensus 383 ~~~LG~G~fG~Vy~a~~~~-tg~~vAvK~i~~~-----~-----~~~~Ei~iL~~l~~HpnIV~-l~~~~~~~~~~~lVm 450 (966)
.+.||+|+||+||+|++.. +++.||||++... . ...+|+++|+.+. |+|||. +++. +..||||
T Consensus 23 ~~~IG~G~fg~Vy~a~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~E~~iL~~L~-h~~iv~~l~~~----~~~~LVm 97 (365)
T PRK09188 23 TAVLKRDVFSTVERGYFAGDPGTARAVRRRVSEVPWWSKPLARHLAAREIRALKTVR-GIGVVPQLLAT----GKDGLVR 97 (365)
T ss_pred ccEEeecCcEEEEEEEEcCCCCeEEEEEEecccccccccHHHHHHHHHHHHHHHhcc-CCCCCcEEEEc----CCcEEEE
Confidence 5789999999999999886 7888999986532 1 1457999999984 999884 5542 4579999
Q ss_pred EccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCceeccC-CCCcEEEecCCCCCEEEEeecccccccC--
Q psy11767 451 ELLKGGELLDRIRQKGRCGFTENEASRIMRQLVAAVHFMHSRGVVHRDL-KPENLLFSDPAGDNIKVVDFGFACLKRE-- 527 (966)
Q Consensus 451 Ey~~gg~L~~~l~~~~~~~l~e~~~~~i~~Qil~aL~yLHs~~IiHRDL-KP~NILl~~~~~~~iKL~DFGla~~~~~-- 527 (966)
|||+|++|.. +.. .. ...++.|++.||+|||++||+|||| ||+|||++. ++.+||+|||+|+....
T Consensus 98 E~~~G~~L~~-~~~-----~~---~~~~~~~i~~aL~~lH~~gIiHrDL~KP~NILv~~--~~~ikLiDFGlA~~~~~~~ 166 (365)
T PRK09188 98 GWTEGVPLHL-ARP-----HG---DPAWFRSAHRALRDLHRAGITHNDLAKPQNWLMGP--DGEAAVIDFQLASVFRRRG 166 (365)
T ss_pred EccCCCCHHH-hCc-----cc---hHHHHHHHHHHHHHHHHCCCeeCCCCCcceEEEcC--CCCEEEEECccceecccCc
Confidence 9999999962 211 11 1468899999999999999999999 999999964 45899999999975432
Q ss_pred ---------CCccccccccccCchhhccCC
Q psy11767 528 ---------SLHTPCFTLQYAAPEVLRQDK 548 (966)
Q Consensus 528 ---------~~~~~~gT~~Y~APEvl~~~~ 548 (966)
...+..+++.|+|||++....
T Consensus 167 ~~~~~~~~~d~~~~~~~~~~~~pe~~~~~~ 196 (365)
T PRK09188 167 ALYRIAAYEDLRHLLKHKRTYAPDALTPRE 196 (365)
T ss_pred chhhhhhhhhhhhhhccCccCCcccCChhh
Confidence 123456788899999986543
|
|
| >cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.89 E-value=1.4e-22 Score=231.03 Aligned_cols=219 Identities=27% Similarity=0.503 Sum_probs=167.1
Q ss_pred CcceeeeecccccceEEEEEEcCCCCEEEEEeccccc--------hhhHHHHHHHHhhCCCccccccccccc--------
Q psy11767 117 DLDKAGILGDGSYSVCRRCVEKSTGQEYAVKIISRKI--------DCSEEINLLRACQGHPNICRRCVEKST-------- 180 (966)
Q Consensus 117 df~~~~~LG~GsFGkV~La~~k~tg~~yAiKvl~K~~--------~~~~E~~il~~~~~~pfi~~~~~~~~~-------- 180 (966)
||+++++||+|+||+|++|+++.+|+.||||++++.. ....|..+|+.+ +||+|+..+..+..
T Consensus 2 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~l-~h~~iv~~~~~~~~~~~~~lv~ 80 (364)
T cd05599 2 DFESIKVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEA-DNPWVVKLYYSFQDENYLYLIM 80 (364)
T ss_pred CceEEEEEEecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhC-CCCCCcceEEEEEcCCeEEEEE
Confidence 7899999999999999999999999999999998742 246799999988 59999873221111
Q ss_pred ----------------------chhHHHHHHHh----------hcccchhhhHhhhccCCceEEecCccc----------
Q psy11767 181 ----------------------GQEYAVKIISR----------KIDCSEEINLLRACQGHPNIVNLHCVF---------- 218 (966)
Q Consensus 181 ----------------------~~~~~~~~v~~----------~~~~~~e~nil~~~~gh~~iv~l~~~~---------- 218 (966)
.+.+..+++.+ ..|++++ |||.+.+|+.+|+||+.+.
T Consensus 81 E~~~~g~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH~~~ivH~Dlkp~-NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~ 159 (364)
T cd05599 81 EYLPGGDMMTLLMKKDTFTEEETRFYIAETILAIDSIHKLGYIHRDIKPD-NLLLDAKGHIKLSDFGLCTGLKKSHRTEF 159 (364)
T ss_pred CCCCCcHHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHH-HeEECCCCCEEEeecccceeccccccccc
Confidence 12222223222 1144444 9999999999999987542
Q ss_pred -----------------------------------------------cccccccccCCCcceeeechhhHHHHHHHhhCC
Q psy11767 219 -----------------------------------------------QDEVIDWDDFSRGIECVFFSSSLIIFFIILSFT 251 (966)
Q Consensus 219 -----------------------------------------------~~e~i~~~~y~~~~d~~~~~~~~il~~~m~~g~ 251 (966)
.+|++...+|+...| .| +.|+++|+|++|.
T Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~D--iw-SlG~il~el~~G~ 236 (364)
T cd05599 160 YRILSHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKECD--WW-SLGVIMYEMLVGY 236 (364)
T ss_pred cccccccccccccccccccccccccccchhhcccccccccccCccccCHHHHcCCCCCCeee--ee-cchhHHHHhhcCC
Confidence 134444445554444 34 4577888899999
Q ss_pred CCCCCCcHHHHHHHHHhCC--CCCCC--CCCHHHHHHHHhhcccCCCcccCCCCCCHHHHhcCCceeeeCccccccCCCC
Q psy11767 252 LSFIHDYYHIQYRRILKTE--PPIPE--DLSPDVADFISRLLVKDPRRRLGGGELDAEELKRHPFFNVIDWDDLATKRIP 327 (966)
Q Consensus 252 ~pf~~~~~~~~~~~I~~~~--~~~P~--~~s~~a~dli~~LL~kdp~~RLG~~~~g~~~Ik~HpfF~~idW~~l~~k~~~ 327 (966)
+||...+....+.+|++.. +.+|. .++++++|||++||. ||.+|++. .++++++.||||++++|+.+. ..+
T Consensus 237 ~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~ll~-~p~~R~~~--~~~~~ll~h~~~~~~~~~~~~--~~~ 311 (364)
T cd05599 237 PPFCSDNPQETYRKIINWKETLQFPDEVPLSPEAKDLIKRLCC-EAERRLGN--NGVNEIKSHPFFKGVDWEHIR--ERP 311 (364)
T ss_pred CCCCCCCHHHHHHHHHcCCCccCCCCCCCCCHHHHHHHHHHcc-CHhhcCCC--CCHHHHhcCCCcCCCCHHHHh--hcC
Confidence 9999998888899998654 45565 479999999999996 99999974 369999999999999999875 457
Q ss_pred CCCCcccccccccccccc
Q psy11767 328 APFVPKISNELDVSNFSD 345 (966)
Q Consensus 328 pP~~P~i~~~~D~snFd~ 345 (966)
+|+.|...+..|.++|++
T Consensus 312 ~~~~~~~~~~~~~~~~~~ 329 (364)
T cd05599 312 APIIPELKSITDTSNFDD 329 (364)
T ss_pred CCCCCCCCCchhhhhccc
Confidence 899999988889999975
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica |
| >KOG0588|consensus | Back alignment and domain information |
|---|
Probab=99.89 E-value=7.4e-23 Score=234.28 Aligned_cols=203 Identities=24% Similarity=0.391 Sum_probs=162.7
Q ss_pred CcceeeeecccccceEEEEEEcCCCCEEEEEeccccc--------hhhHHHHHHHHhhCCCcccc---------------
Q psy11767 117 DLDKAGILGDGSYSVCRRCVEKSTGQEYAVKIISRKI--------DCSEEINLLRACQGHPNICR--------------- 173 (966)
Q Consensus 117 df~~~~~LG~GsFGkV~La~~k~tg~~yAiKvl~K~~--------~~~~E~~il~~~~~~pfi~~--------------- 173 (966)
=+.++++||+|+=|.|+||+|..||+..||||+.|.. .+.+|.-||+.+ .||.+..
T Consensus 13 pwkLgkTLG~Gstg~vrlakh~~TGqlaaiKii~k~~~~s~s~~~~IerEIviMkLi-~HpnVl~LydVwe~~~~lylvl 91 (786)
T KOG0588|consen 13 PWKLGKTLGKGSTGCVRLAKHAETGQLAAIKIIPKRSELSSSQPAGIEREIVIMKLI-EHPNVLRLYDVWENKQHLYLVL 91 (786)
T ss_pred ceeccccccCCCCceehhhhcccccceeEEEeeccccccccccccchhhhhHHHHHh-cCCCeeeeeeeeccCceEEEEE
Confidence 3579999999999999999999999999999999872 457788777666 7999865
Q ss_pred ---------------cccccccchhHHHHHHHh----------hcccchhhhHhhhccCCceEEecCccc----------
Q psy11767 174 ---------------RCVEKSTGQEYAVKIISR----------KIDCSEEINLLRACQGHPNIVNLHCVF---------- 218 (966)
Q Consensus 174 ---------------~~~~~~~~~~~~~~~v~~----------~~~~~~e~nil~~~~gh~~iv~l~~~~---------- 218 (966)
+.+.+..+..|+-+|+.. ..|+++| |+|+|..+.++|.||+-+-
T Consensus 92 Eyv~gGELFdylv~kG~l~e~eaa~ff~QIi~gv~yCH~~~icHRDLKpE-NlLLd~~~nIKIADFGMAsLe~~gklLeT 170 (786)
T KOG0588|consen 92 EYVPGGELFDYLVRKGPLPEREAAHFFRQILDGVSYCHAFNICHRDLKPE-NLLLDVKNNIKIADFGMASLEVPGKLLET 170 (786)
T ss_pred EecCCchhHHHHHhhCCCCCHHHHHHHHHHHHHHHHHhhhcceeccCCch-hhhhhcccCEeeeccceeecccCCccccc
Confidence 334444444455555533 1366777 9999998889999998431
Q ss_pred --------cccccccccCCCcceeeechhhHHHHHHHhhCCCCCCCCcHHHHHHHHHhCCCCCCCCCCHHHHHHHHhhcc
Q psy11767 219 --------QDEVIDWDDFSRGIECVFFSSSLIIFFIILSFTLSFIHDYYHIQYRRILKTEPPIPEDLSPDVADFISRLLV 290 (966)
Q Consensus 219 --------~~e~i~~~~y~~~~d~~~~~~~~il~~~m~~g~~pf~~~~~~~~~~~I~~~~~~~P~~~s~~a~dli~~LL~ 290 (966)
.+|+|....|. |.-.|-| +.|||+|.||+|.+||.+++-..++.|+..|.+.+|..+|++|+|||+++|.
T Consensus 171 SCGSPHYA~PEIV~G~pYd-G~~sDVW-SCGVILfALLtG~LPFdDdNir~LLlKV~~G~f~MPs~Is~eaQdLLr~ml~ 248 (786)
T KOG0588|consen 171 SCGSPHYAAPEIVSGRPYD-GRPSDVW-SCGVILFALLTGKLPFDDDNIRVLLLKVQRGVFEMPSNISSEAQDLLRRMLD 248 (786)
T ss_pred cCCCcccCCchhhcCCCCC-CCccccc-hhHHHHHHHHhCCCCCCCccHHHHHHHHHcCcccCCCcCCHHHHHHHHHHhc
Confidence 36888888886 4444434 5678889999999999999999999999999999999999999999999999
Q ss_pred cCCCcccCCCCCCHHHHhcCCceeeeCccccccCCCCCC
Q psy11767 291 KDPRRRLGGGELDAEELKRHPFFNVIDWDDLATKRIPAP 329 (966)
Q Consensus 291 kdp~~RLG~~~~g~~~Ik~HpfF~~idW~~l~~k~~~pP 329 (966)
.||.+|+. .+||.+|||..+..=.. ..+.+++|
T Consensus 249 VDp~~RiT-----~~eI~kHP~l~g~~~~~-~~~~~~~~ 281 (786)
T KOG0588|consen 249 VDPSTRIT-----TEEILKHPFLSGYTSLP-SSKSLRPP 281 (786)
T ss_pred cCcccccc-----HHHHhhCchhhcCCCCC-hhhhcCCC
Confidence 99999995 79999999998775322 23455555
|
|
| >KOG1165|consensus | Back alignment and domain information |
|---|
Probab=99.88 E-value=5.5e-22 Score=211.43 Aligned_cols=245 Identities=21% Similarity=0.300 Sum_probs=185.3
Q ss_pred ccccccccccccccEEEEEEEcCCCcEEEEEEeccccC---hHHHHHHHHHhcCCCCceEEEEEEEeCCeEEEEEEccCC
Q psy11767 379 DLDKAGILGDGSYSVCRRCVEKSTGQEYAVKIISRKID---CSEEINLLRACQGHPNIVNLHCVFQDEVHTYLVLELLKG 455 (966)
Q Consensus 379 ~~~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~~---~~~Ei~iL~~l~~HpnIV~l~~~~~~~~~~~lVmEy~~g 455 (966)
.|...++||+|+||+.+.|.+.-+++.||||.-.++.+ ...|.+..+.|.+-++|...|.+...+.+..||||++ |
T Consensus 29 hyrVGkKIGeGsFG~lf~G~Nl~nne~VAIKfEPrkS~APQLrdEYr~YKlL~g~~GIP~vYYFGqeG~~NiLVidLL-G 107 (449)
T KOG1165|consen 29 HYRVGKKIGEGSFGVLFLGKNLYNNEPVAIKFEPRKSEAPQLRDEYRTYKLLGGTEGIPQVYYFGQEGKYNILVIDLL-G 107 (449)
T ss_pred cceeccccccCcceeeecccccccCceEEEEeccccCCcchHHHHHHHHHHHcCCCCCCceeeeccccchhhhhhhhh-C
Confidence 34447899999999999999999999999999887765 3458888888888999999999999999999999999 8
Q ss_pred CCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCcEEEecCC---CCCEEEEeecccccccCCC---
Q psy11767 456 GELLDRIRQKGRCGFTENEASRIMRQLVAAVHFMHSRGVVHRDLKPENLLFSDPA---GDNIKVVDFGFACLKRESL--- 529 (966)
Q Consensus 456 g~L~~~l~~~~~~~l~e~~~~~i~~Qil~aL~yLHs~~IiHRDLKP~NILl~~~~---~~~iKL~DFGla~~~~~~~--- 529 (966)
-+|.|.+.-.++ .|+..++..++.|++.-++|+|++.+|.|||||+|+||+.+. ...|-|+|||+|+...+..
T Consensus 108 PSLEDLFD~CgR-~FSvKTV~miA~Qmi~rie~vH~k~LIYRDIKPdNFLIGrp~~k~~n~IhiiDFGmAK~YrDp~Tkq 186 (449)
T KOG1165|consen 108 PSLEDLFDLCGR-RFSVKTVAMIAKQMITRIEYVHEKDLIYRDIKPDNFLIGRPGTKDANVIHIIDFGMAKEYRDPKTKQ 186 (449)
T ss_pred cCHHHHHHHhcC-cccHHhHHHHHHHHHHHHHHHHhcceeecccCccceeecCCCCCCCceEEEEeccchhhhcCccccc
Confidence 899988876665 799999999999999999999999999999999999998643 3468999999998754421
Q ss_pred -------ccccccccccCchhhccCCCCCCCcccchhhhhhhhhhhhcCCCCCCCcCcchhHHHHHHHHhcCCCCCCCCC
Q psy11767 530 -------HTPCFTLQYAAPEVLRQDKSGYDENCDLWSLGVILVNVLRQDKSGYDENCDLWSLGVILYTMLCGRVPFHARS 602 (966)
Q Consensus 530 -------~~~~gT~~Y~APEvl~~~~~~~~~~~Di~SlGvil~el~~~~~~~y~~~~DIWSlGvilyemltG~~Pf~~~~ 602 (966)
.+..||..||+--.-.+ + .=+...|+-|||-|+++.|-|.+||.+.-
T Consensus 187 HIPYrE~KSLsGTARYMSINTHlG-----------------------r---EQSRRDDLEaLGHvFmYFLRGsLPWQGLK 240 (449)
T KOG1165|consen 187 HIPYREHKSLSGTARYMSINTHLG-----------------------R---EQSRRDDLEALGHVFMYFLRGSLPWQGLK 240 (449)
T ss_pred cCccccccccccceeeeEeecccc-----------------------c---hhhhhhhHHHhhhhhhhhccCCCcccccc
Confidence 24568999997543221 1 12556799999999999999999999875
Q ss_pred CchhHHHHHHHHHcCCCCCCc-hhhccCCHHHHHHHHHhcccCccccCChH
Q psy11767 603 RDDSALSIMARIKEGQFNFDA-EAWSTVSSEAKELTKSLLTVNPAQRIRMM 652 (966)
Q Consensus 603 ~~~~~~~~~~~i~~~~~~~~~-~~~~~is~e~~~Li~~~L~~dP~~R~t~~ 652 (966)
.. ...+-.++|.+..-.-+. +....++.++..-+.-.=..+=.+-|.-.
T Consensus 241 A~-tnK~kYeKIGe~Kr~T~i~~Lc~g~P~efa~Yl~yvR~L~F~E~PDYd 290 (449)
T KOG1165|consen 241 AD-TNKEKYEKIGETKRSTPIEVLCEGFPEEFATYLRYVRRLDFFETPDYD 290 (449)
T ss_pred Cc-chHHHHHHhccccccCCHHHHHhcCHHHHHHHHHHHHhcCcccCCCHH
Confidence 43 233445666554332222 22234555555444433233334445443
|
|
| >cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Probab=99.88 E-value=2.6e-22 Score=230.08 Aligned_cols=222 Identities=25% Similarity=0.443 Sum_probs=166.8
Q ss_pred CcceeeeecccccceEEEEEEcCCCCEEEEEeccccc--------hhhHHHHHHHHhhCCCccccccccccc--------
Q psy11767 117 DLDKAGILGDGSYSVCRRCVEKSTGQEYAVKIISRKI--------DCSEEINLLRACQGHPNICRRCVEKST-------- 180 (966)
Q Consensus 117 df~~~~~LG~GsFGkV~La~~k~tg~~yAiKvl~K~~--------~~~~E~~il~~~~~~pfi~~~~~~~~~-------- 180 (966)
+|++.++||+|+||+|++|+++.+++.||+|+++|.. ...+|+.+|+.+ +||+|++....+..
T Consensus 44 ~y~~~~~lG~G~fg~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~-~hp~iv~~~~~~~~~~~~~lv~ 122 (370)
T cd05621 44 DYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFA-NSPWVVQLFCAFQDDKYLYMVM 122 (370)
T ss_pred HCeEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhC-CCCCEeeEEEEEEcCCEEEEEE
Confidence 8899999999999999999999999999999998732 245688888775 79999872211111
Q ss_pred ---------------------chhHHHHHHHh----------hcccchhhhHhhhccCCceEEecCcccc----------
Q psy11767 181 ---------------------GQEYAVKIISR----------KIDCSEEINLLRACQGHPNIVNLHCVFQ---------- 219 (966)
Q Consensus 181 ---------------------~~~~~~~~v~~----------~~~~~~e~nil~~~~gh~~iv~l~~~~~---------- 219 (966)
...++.+++.+ ..|++++ |||.+.+|+++|+||+.+..
T Consensus 123 Ey~~gg~L~~~l~~~~~~~~~~~~~~~qil~aL~~LH~~~IvHrDLKp~-NILl~~~~~~kL~DFG~a~~~~~~~~~~~~ 201 (370)
T cd05621 123 EYMPGGDLVNLMSNYDVPEKWAKFYTAEVVLALDAIHSMGLIHRDVKPD-NMLLDKHGHLKLADFGTCMKMDETGMVRCD 201 (370)
T ss_pred cCCCCCcHHHHHHhcCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHH-HEEECCCCCEEEEecccceecccCCceecc
Confidence 11222223222 1244444 99999999999999986532
Q ss_pred ----------cccccccc----CCCcceeeechhhHHHHHHHhhCCCCCCCCcHHHHHHHHHhC--CCCCCC--CCCHHH
Q psy11767 220 ----------DEVIDWDD----FSRGIECVFFSSSLIIFFIILSFTLSFIHDYYHIQYRRILKT--EPPIPE--DLSPDV 281 (966)
Q Consensus 220 ----------~e~i~~~~----y~~~~d~~~~~~~~il~~~m~~g~~pf~~~~~~~~~~~I~~~--~~~~P~--~~s~~a 281 (966)
+|++.... |+...| .| +.|+++|+|++|.+||...+....+.+|+.. .+.+|. .++..+
T Consensus 202 ~~~gt~~Y~aPE~~~~~~~~~~~~~~~D--iw-SlG~ilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~ 278 (370)
T cd05621 202 TAVGTPDYISPEVLKSQGGDGYYGRECD--WW-SVGVFLFEMLVGDTPFYADSLVGTYSKIMDHKNSLNFPEDVEISKHA 278 (370)
T ss_pred cCCCCcccCCHHHHhccCCCCCCCcccC--EE-eehHHHHHHHhCCCCCCCCCHHHHHHHHHhCCcccCCCCcccCCHHH
Confidence 23333221 333344 34 5567888899999999999988899999874 467787 469999
Q ss_pred HHHHHhhcccCCCcccCCCCCCHHHHhcCCceeeeCccccccCCCCCCCCccccccccccccccc
Q psy11767 282 ADFISRLLVKDPRRRLGGGELDAEELKRHPFFNVIDWDDLATKRIPAPFVPKISNELDVSNFSDE 346 (966)
Q Consensus 282 ~dli~~LL~kdp~~RLG~~~~g~~~Ik~HpfF~~idW~~l~~k~~~pP~~P~i~~~~D~snFd~e 346 (966)
++||.++|+ ++.+|++. .+++++++||||+..+|+....+...+|+.|.+.+..|.++|++.
T Consensus 279 ~~li~~~L~-~~~~r~~R--~~~~e~l~hp~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~ 340 (370)
T cd05621 279 KNLICAFLT-DREVRLGR--NGVEEIKQHPFFKNDQWNWDNIRETAAPVVPELSSDIDSSNFDDI 340 (370)
T ss_pred HHHHHHHcc-CchhccCC--CCHHHHhcCcccCCCCcChHhcCCCCCCcCCCCCCcchhhhcCCc
Confidence 999999998 66677653 379999999999998887777778899999999999999999854
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found |
| >cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=99.88 E-value=1.6e-22 Score=226.47 Aligned_cols=230 Identities=28% Similarity=0.470 Sum_probs=175.0
Q ss_pred eeeecccccceEEEEEE---cCCCCEEEEEeccccc-------hhhHHHHHHHHhhCCCcccccccccccc---------
Q psy11767 121 AGILGDGSYSVCRRCVE---KSTGQEYAVKIISRKI-------DCSEEINLLRACQGHPNICRRCVEKSTG--------- 181 (966)
Q Consensus 121 ~~~LG~GsFGkV~La~~---k~tg~~yAiKvl~K~~-------~~~~E~~il~~~~~~pfi~~~~~~~~~~--------- 181 (966)
+++||+|+||+|++|+. +.+|+.||+|++++.. ....|.++|+++ +||+|++....+...
T Consensus 1 l~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~lv~e~ 79 (318)
T cd05582 1 LKVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKMERDILAEV-NHPFIVKLHYAFQTEGKLYLILDF 79 (318)
T ss_pred CceeeeCCCEEEEEEEEeccCCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhC-CCCCcccEEEEEEcCCEEEEEEcC
Confidence 46899999999999986 5789999999998742 245688899888 599998622211111
Q ss_pred ---------------------hhHHHHHHHh----------hcccchhhhHhhhccCCceEEecCcccc-----------
Q psy11767 182 ---------------------QEYAVKIISR----------KIDCSEEINLLRACQGHPNIVNLHCVFQ----------- 219 (966)
Q Consensus 182 ---------------------~~~~~~~v~~----------~~~~~~e~nil~~~~gh~~iv~l~~~~~----------- 219 (966)
..++.+++.+ ..|+++ .|||.+.+|.++|.||+.+..
T Consensus 80 ~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp-~Nil~~~~~~~kL~Dfg~~~~~~~~~~~~~~~ 158 (318)
T cd05582 80 LRGGDLFTRLSKEVMFTEEDVKFYLAELALALDHLHSLGIIYRDLKP-ENILLDEEGHIKLTDFGLSKESIDHEKKAYSF 158 (318)
T ss_pred CCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCH-HHeEECCCCcEEEeeccCCcccCCCCCceecc
Confidence 1111122211 013333 399999999999999986532
Q ss_pred --------ccccccccCCCcceeeechhhHHHHHHHhhCCCCCCCCcHHHHHHHHHhCCCCCCCCCCHHHHHHHHhhccc
Q psy11767 220 --------DEVIDWDDFSRGIECVFFSSSLIIFFIILSFTLSFIHDYYHIQYRRILKTEPPIPEDLSPDVADFISRLLVK 291 (966)
Q Consensus 220 --------~e~i~~~~y~~~~d~~~~~~~~il~~~m~~g~~pf~~~~~~~~~~~I~~~~~~~P~~~s~~a~dli~~LL~k 291 (966)
+|++....++...| .| +.|+++|+|++|.+||...+...+++.|....+.+|..+++++++||+++|++
T Consensus 159 ~g~~~y~aPE~~~~~~~~~~~D--iw-slG~il~el~tg~~p~~~~~~~~~~~~i~~~~~~~p~~~~~~~~~li~~~l~~ 235 (318)
T cd05582 159 CGTVEYMAPEVVNRRGHTQSAD--WW-SFGVLMFEMLTGSLPFQGKDRKETMTMILKAKLGMPQFLSPEAQSLLRALFKR 235 (318)
T ss_pred cCChhhcCHHHHcCCCCCCccc--ee-ccceEeeeeccCCCCCCCCCHHHHHHHHHcCCCCCCCCCCHHHHHHHHHHhhc
Confidence 23444444544444 34 45678888899999999988888999999999999999999999999999999
Q ss_pred CCCcccCCCCCCHHHHhcCCceeeeCccccccCCCCCCCCccccccccccccccccccCcCCCC
Q psy11767 292 DPRRRLGGGELDAEELKRHPFFNVIDWDDLATKRIPAPFVPKISNELDVSNFSDEFTKMIPADS 355 (966)
Q Consensus 292 dp~~RLG~~~~g~~~Ik~HpfF~~idW~~l~~k~~~pP~~P~i~~~~D~snFd~ef~~~~p~dS 355 (966)
||.+|+.+.....++++.||||..++|..+..+++.||+.|......+..+|++.+....+...
T Consensus 236 ~P~~R~~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 299 (318)
T cd05582 236 NPANRLGAGPDGVEEIKRHPFFSTIDWNKLYRREIKPPFKPAVGRPDDTFYFDPEFTSRTPKDS 299 (318)
T ss_pred CHhHcCCCCCCCHHHHhCCCCcCCCCHHHHHhcCCCCCcCCCCCCcchhhhcCcccccCccccC
Confidence 9999998766668999999999999999999999999999988777777778877655444333
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate |
| >KOG0583|consensus | Back alignment and domain information |
|---|
Probab=99.88 E-value=2.2e-22 Score=229.33 Aligned_cols=192 Identities=30% Similarity=0.457 Sum_probs=160.0
Q ss_pred CcceeeeecccccceEEEEEEcCCCCEEEEEeccccc----------hhhHHHHHHHHhhCCCcccc-------------
Q psy11767 117 DLDKAGILGDGSYSVCRRCVEKSTGQEYAVKIISRKI----------DCSEEINLLRACQGHPNICR------------- 173 (966)
Q Consensus 117 df~~~~~LG~GsFGkV~La~~k~tg~~yAiKvl~K~~----------~~~~E~~il~~~~~~pfi~~------------- 173 (966)
.|.+.++||+|+||+|++|+++.||..+|||++.|+. .+.+|..+|+.+..||.||+
T Consensus 18 ~y~~~~~lG~GsfgkV~~a~~~~t~~~vAiKii~~~~~~~~~~~~~~~i~rEi~~~~~~~~HpnI~~l~ev~~t~~~~~i 97 (370)
T KOG0583|consen 18 KYELGRTLGSGSFGKVKLAKHRLTGEKVAIKIIDRKKVSSKSQKLDELIKREISILRRLRSHPNIIRLLEVFATPTKIYI 97 (370)
T ss_pred ceeeeeeecCCCCeeEEEeeeccCCCeEEEEEechhcccccccccchhhHHHHHHHHHhccCCCEeEEEEEEecCCeEEE
Confidence 4589999999999999999999999999999988751 23579999999988999986
Q ss_pred -----------------cccccccchhHHHHHHHh----------hcccchhhhHhhhcc-CCceEEecCccc-------
Q psy11767 174 -----------------RCVEKSTGQEYAVKIISR----------KIDCSEEINLLRACQ-GHPNIVNLHCVF------- 218 (966)
Q Consensus 174 -----------------~~~~~~~~~~~~~~~v~~----------~~~~~~e~nil~~~~-gh~~iv~l~~~~------- 218 (966)
+.+.+..++.++.+++++ ..|++.| |+|++.+ +..+|.||+++-
T Consensus 98 vmEy~~gGdL~~~i~~~g~l~E~~ar~~F~Qlisav~y~H~~gi~HRDLK~E-Nilld~~~~~~Kl~DFG~s~~~~~~~~ 176 (370)
T KOG0583|consen 98 VMEYCSGGDLFDYIVNKGRLKEDEARKYFRQLISAVAYCHSRGIVHRDLKPE-NILLDGNEGNLKLSDFGLSAISPGEDG 176 (370)
T ss_pred EEEecCCccHHHHHHHcCCCChHHHHHHHHHHHHHHHHHHhCCEeeCCCCHH-HEEecCCCCCEEEeccccccccCCCCC
Confidence 233444456666666655 1367777 9999998 999999998664
Q ss_pred ------------ccccccccc-CCCcceeeechhhHHHHHHHhhCCCCCCCCcHHHHHHHHHhCCCCCCCCC-CHHHHHH
Q psy11767 219 ------------QDEVIDWDD-FSRGIECVFFSSSLIIFFIILSFTLSFIHDYYHIQYRRILKTEPPIPEDL-SPDVADF 284 (966)
Q Consensus 219 ------------~~e~i~~~~-y~~~~d~~~~~~~~il~~~m~~g~~pf~~~~~~~~~~~I~~~~~~~P~~~-s~~a~dl 284 (966)
++|++...+ |. |...| .|+.||++|.|++|..||.+++...+|++|..+.+.+|.++ |+++++|
T Consensus 177 ~l~t~cGsp~Y~aPEvl~~~~~Y~-g~~aD-vWS~GViLy~ml~G~~PF~d~~~~~l~~ki~~~~~~~p~~~~S~~~~~L 254 (370)
T KOG0583|consen 177 LLKTFCGSPAYAAPEVLSGKGTYS-GKAAD-VWSLGVILYVLLCGRLPFDDSNVPNLYRKIRKGEFKIPSYLLSPEARSL 254 (370)
T ss_pred cccCCCCCcccCCHHHhCCCCCcC-Cchhh-hhhhHHHHHHHHhCCCCCCCccHHHHHHHHhcCCccCCCCcCCHHHHHH
Confidence 246777766 75 44444 44678889999999999999999999999999999999999 9999999
Q ss_pred HHhhcccCCCcccCCCCCCHHHHhcCCceeee
Q psy11767 285 ISRLLVKDPRRRLGGGELDAEELKRHPFFNVI 316 (966)
Q Consensus 285 i~~LL~kdp~~RLG~~~~g~~~Ik~HpfF~~i 316 (966)
|+++|+.||.+|+. ..+|+.||||+.-
T Consensus 255 i~~mL~~~P~~R~t-----~~~i~~h~w~~~~ 281 (370)
T KOG0583|consen 255 IEKMLVPDPSTRIT-----LLEILEHPWFQKE 281 (370)
T ss_pred HHHHcCCCcccCCC-----HHHHhhChhhccC
Confidence 99999999999984 8999999999854
|
|
| >cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Probab=99.88 E-value=6.4e-22 Score=226.87 Aligned_cols=224 Identities=25% Similarity=0.418 Sum_probs=167.6
Q ss_pred CcceeeeecccccceEEEEEEcCCCCEEEEEeccccc--------hhhHHHHHHHHhhCCCccccccccccc--------
Q psy11767 117 DLDKAGILGDGSYSVCRRCVEKSTGQEYAVKIISRKI--------DCSEEINLLRACQGHPNICRRCVEKST-------- 180 (966)
Q Consensus 117 df~~~~~LG~GsFGkV~La~~k~tg~~yAiKvl~K~~--------~~~~E~~il~~~~~~pfi~~~~~~~~~-------- 180 (966)
||++.+.||+|+||+|++|+++.+|+.||||+++|.. ...+|..+|+.+ +||+|+.....+..
T Consensus 44 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~-~h~~iv~~~~~~~~~~~~~lv~ 122 (370)
T cd05596 44 DFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEERDIMAHA-NSEWIVQLHYAFQDDKYLYMVM 122 (370)
T ss_pred HcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhC-CCCCcceEEEEEecCCEEEEEE
Confidence 8999999999999999999999999999999998642 235688888876 69999862211111
Q ss_pred ---------------------chhHHHHHHHh----------hcccchhhhHhhhccCCceEEecCcccc----------
Q psy11767 181 ---------------------GQEYAVKIISR----------KIDCSEEINLLRACQGHPNIVNLHCVFQ---------- 219 (966)
Q Consensus 181 ---------------------~~~~~~~~v~~----------~~~~~~e~nil~~~~gh~~iv~l~~~~~---------- 219 (966)
...++.+++.+ ..|++++ |||.+.+|+++|+||+.+..
T Consensus 123 Ey~~gg~L~~~l~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDLkp~-NILl~~~~~~kL~DfG~~~~~~~~~~~~~~ 201 (370)
T cd05596 123 EYMPGGDLVNLMSNYDIPEKWARFYTAEVVLALDAIHSMGFIHRDVKPD-NMLLDKSGHLKLADFGTCMKMDANGMVRCD 201 (370)
T ss_pred cCCCCCcHHHHHHhcCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHH-HEEEcCCCCEEEEeccceeeccCCCcccCC
Confidence 11122222222 1244444 99999999999999986532
Q ss_pred ----------ccccccc----cCCCcceeeechhhHHHHHHHhhCCCCCCCCcHHHHHHHHHhC--CCCCCC--CCCHHH
Q psy11767 220 ----------DEVIDWD----DFSRGIECVFFSSSLIIFFIILSFTLSFIHDYYHIQYRRILKT--EPPIPE--DLSPDV 281 (966)
Q Consensus 220 ----------~e~i~~~----~y~~~~d~~~~~~~~il~~~m~~g~~pf~~~~~~~~~~~I~~~--~~~~P~--~~s~~a 281 (966)
+|++... .|+.. .|.| +.|+++|+|++|.+||...+...+|.+|+.. .+.+|. .+|.++
T Consensus 202 ~~~gt~~y~aPE~~~~~~~~~~~~~~--~Diw-SlGvilyelltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~ 278 (370)
T cd05596 202 TAVGTPDYISPEVLKSQGGDGYYGRE--CDWW-SVGVFLYEMLVGDTPFYADSLVGTYSKIMDHKNSLTFPDDIEISKQA 278 (370)
T ss_pred CCCCCcCeECHHHhccCCCCCCCCCc--eeee-ehhHHHHHHHhCCCCcCCCCHHHHHHHHHcCCCcCCCCCcCCCCHHH
Confidence 2333221 13223 3444 4567888899999999999998999999875 467887 479999
Q ss_pred HHHHHhhcccCCCcccCCCCCCHHHHhcCCceeeeCccccccCCCCCCCCccccccccccccccccc
Q psy11767 282 ADFISRLLVKDPRRRLGGGELDAEELKRHPFFNVIDWDDLATKRIPAPFVPKISNELDVSNFSDEFT 348 (966)
Q Consensus 282 ~dli~~LL~kdp~~RLG~~~~g~~~Ik~HpfF~~idW~~l~~k~~~pP~~P~i~~~~D~snFd~ef~ 348 (966)
+|||+++|+.+|.+ ++. .++++|+.||||++.+|.....+...+|+.|......+.++|++...
T Consensus 279 ~~li~~~L~~~p~r-~~R--~s~~ell~h~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~ 342 (370)
T cd05596 279 KDLICAFLTDREVR-LGR--NGVDEIKSHPFFKNDQWTFDNIRETVAPVVPELSSDIDTSNFDDIED 342 (370)
T ss_pred HHHHHHHccChhhc-cCC--CCHHHHhcCcccCCCChhhHHhcCCCcCccCcCCCcchhhhcCCccc
Confidence 99999999988865 321 25899999999999999887778888999999998888999986543
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in |
| >cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.87 E-value=2.7e-22 Score=225.86 Aligned_cols=223 Identities=30% Similarity=0.466 Sum_probs=170.5
Q ss_pred ecccccceEEEEEEcCCCCEEEEEeccccc--------hhhHHHHHHHHhh--CCCcccccccccccc------------
Q psy11767 124 LGDGSYSVCRRCVEKSTGQEYAVKIISRKI--------DCSEEINLLRACQ--GHPNICRRCVEKSTG------------ 181 (966)
Q Consensus 124 LG~GsFGkV~La~~k~tg~~yAiKvl~K~~--------~~~~E~~il~~~~--~~pfi~~~~~~~~~~------------ 181 (966)
||+|+||+|++|+++.+|+.||||+++|.. ....|.+++.... +||+|+.....+...
T Consensus 1 lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~p~i~~~~~~~~~~~~~~lv~e~~~~ 80 (330)
T cd05586 1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVGLKFSFQTDSDLYLVTDYMSG 80 (330)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEEeHHHHhhhhHHHHHHHHHHHHHHhccCCCCcCcceEEEEecCCeEEEEEcCCCC
Confidence 799999999999999999999999998642 2345777776655 899997622211111
Q ss_pred ------------------hhHHHHHHHh----------hcccchhhhHhhhccCCceEEecCcccc--------------
Q psy11767 182 ------------------QEYAVKIISR----------KIDCSEEINLLRACQGHPNIVNLHCVFQ-------------- 219 (966)
Q Consensus 182 ------------------~~~~~~~v~~----------~~~~~~e~nil~~~~gh~~iv~l~~~~~-------------- 219 (966)
..++.+++.+ ..|++++ |||.+.+|.++|+||+.+..
T Consensus 81 g~L~~~l~~~~~~~~~~~~~~~~qil~al~~LH~~~ivHrDlkp~-Nili~~~~~~kl~Dfg~a~~~~~~~~~~~~~~gt 159 (330)
T cd05586 81 GELFWHLQKEGRFSEDRAKFYIAELVLALEHLHKYDIVYRDLKPE-NILLDATGHIALCDFGLSKANLTDNKTTNTFCGT 159 (330)
T ss_pred ChHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHH-HeEECCCCCEEEecCCcCcCCCCCCCCccCccCC
Confidence 1111222221 1244444 99999999999999986532
Q ss_pred -----cccccc-ccCCCcceeeechhhHHHHHHHhhCCCCCCCCcHHHHHHHHHhCCCCCCCC-CCHHHHHHHHhhcccC
Q psy11767 220 -----DEVIDW-DDFSRGIECVFFSSSLIIFFIILSFTLSFIHDYYHIQYRRILKTEPPIPED-LSPDVADFISRLLVKD 292 (966)
Q Consensus 220 -----~e~i~~-~~y~~~~d~~~~~~~~il~~~m~~g~~pf~~~~~~~~~~~I~~~~~~~P~~-~s~~a~dli~~LL~kd 292 (966)
+|++.. .+|+...| .| +.|+++|+|++|..||...+...++++|..+.+.+|.. +++++++||+++|++|
T Consensus 160 ~~y~aPE~~~~~~~~~~~~D--vw-slGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~li~~~L~~~ 236 (330)
T cd05586 160 TEYLAPEVLLDEKGYTKHVD--FW-SLGVLVFEMCCGWSPFYAEDTQQMYRNIAFGKVRFPKNVLSDEGRQFVKGLLNRN 236 (330)
T ss_pred ccccCHHHHcCCCCCCCccc--ee-ccccEEEEeccCCCCCCCCCHHHHHHHHHcCCCCCCCccCCHHHHHHHHHHcCCC
Confidence 233322 23444444 44 45678888999999999999999999999999999974 7999999999999999
Q ss_pred CCcccCCCCCCHHHHhcCCceeeeCccccccCCCCCCCCccccccccccccccccccCc
Q psy11767 293 PRRRLGGGELDAEELKRHPFFNVIDWDDLATKRIPAPFVPKISNELDVSNFSDEFTKMI 351 (966)
Q Consensus 293 p~~RLG~~~~g~~~Ik~HpfF~~idW~~l~~k~~~pP~~P~i~~~~D~snFd~ef~~~~ 351 (966)
|.+|+++. ..+++++.||||..++|+.+..+.+++|+.|......+.++|+.+|....
T Consensus 237 P~~R~~~~-~~~~~ll~h~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 294 (330)
T cd05586 237 PQHRLGAH-RDAVELKEHPFFADIDWDLLSKKQITPPFKPIVDSDEDVSNFDPEFTNSS 294 (330)
T ss_pred HHHCCCCC-CCHHHHhcCccccCCCHHHHHhCCCCCCccCCCCCCcchhhcCccccccc
Confidence 99999763 36899999999999999999999999999999988899999998876543
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of |
| >cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Probab=99.87 E-value=1.2e-21 Score=224.59 Aligned_cols=222 Identities=25% Similarity=0.429 Sum_probs=167.0
Q ss_pred CcceeeeecccccceEEEEEEcCCCCEEEEEeccccc--------hhhHHHHHHHHhhCCCccccccccccc--------
Q psy11767 117 DLDKAGILGDGSYSVCRRCVEKSTGQEYAVKIISRKI--------DCSEEINLLRACQGHPNICRRCVEKST-------- 180 (966)
Q Consensus 117 df~~~~~LG~GsFGkV~La~~k~tg~~yAiKvl~K~~--------~~~~E~~il~~~~~~pfi~~~~~~~~~-------- 180 (966)
+|++.+.||+|+||+|++|+++.|++.||+|+++|.. ...+|+.+|+.+ +||+|++....+..
T Consensus 44 ~y~i~~~lG~G~fg~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~i~~~~-~hp~iv~~~~~~~~~~~~~lv~ 122 (371)
T cd05622 44 DYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFA-NSPWVVQLFYAFQDDRYLYMVM 122 (371)
T ss_pred hcEEEEEEeecCCeEEEEEEECCCCcEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhC-CCCCCCeEEEEEEcCCEEEEEE
Confidence 8899999999999999999999999999999998642 235678887775 79999872221111
Q ss_pred ---------------------chhHHHHHHHh----------hcccchhhhHhhhccCCceEEecCcccc----------
Q psy11767 181 ---------------------GQEYAVKIISR----------KIDCSEEINLLRACQGHPNIVNLHCVFQ---------- 219 (966)
Q Consensus 181 ---------------------~~~~~~~~v~~----------~~~~~~e~nil~~~~gh~~iv~l~~~~~---------- 219 (966)
...++.+++.+ ..|++++ |||.+.+|+++|+||+.+..
T Consensus 123 Ey~~gg~L~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDLkp~-NIll~~~~~ikL~DfG~a~~~~~~~~~~~~ 201 (371)
T cd05622 123 EYMPGGDLVNLMSNYDVPEKWARFYTAEVVLALDAIHSMGFIHRDVKPD-NMLLDKSGHLKLADFGTCMKMNKEGMVRCD 201 (371)
T ss_pred cCCCCCcHHHHHHhcCCCHHHHHHHHHHHHHHHHHHHHCCEEeCCCCHH-HEEECCCCCEEEEeCCceeEcCcCCccccc
Confidence 11222222222 1244444 99999999999999986531
Q ss_pred ----------cccccccc----CCCcceeeechhhHHHHHHHhhCCCCCCCCcHHHHHHHHHhCC--CCCCC--CCCHHH
Q psy11767 220 ----------DEVIDWDD----FSRGIECVFFSSSLIIFFIILSFTLSFIHDYYHIQYRRILKTE--PPIPE--DLSPDV 281 (966)
Q Consensus 220 ----------~e~i~~~~----y~~~~d~~~~~~~~il~~~m~~g~~pf~~~~~~~~~~~I~~~~--~~~P~--~~s~~a 281 (966)
+|++.... |+...| .| +.|+++|+|++|.+||...+...+|++|++.. +.+|. .+++++
T Consensus 202 ~~~gt~~y~aPE~l~~~~~~~~~~~~~D--iw-SlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~ 278 (371)
T cd05622 202 TAVGTPDYISPEVLKSQGGDGYYGRECD--WW-SVGVFLYEMLVGDTPFYADSLVGTYSKIMNHKNSLTFPDDNDISKEA 278 (371)
T ss_pred CcccCccccCHHHHhccCCCccCCCccc--ee-ehhHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCcccCCCcCCCCHHH
Confidence 34443221 433334 34 55778888999999999999999999999754 56775 589999
Q ss_pred HHHHHhhcccCCCcccCCCCCCHHHHhcCCceeeeCccccccCCCCCCCCccccccccccccccc
Q psy11767 282 ADFISRLLVKDPRRRLGGGELDAEELKRHPFFNVIDWDDLATKRIPAPFVPKISNELDVSNFSDE 346 (966)
Q Consensus 282 ~dli~~LL~kdp~~RLG~~~~g~~~Ik~HpfF~~idW~~l~~k~~~pP~~P~i~~~~D~snFd~e 346 (966)
++||.++|+ +|.+|++. .++++|++||||++.+|+....++..+|+.|......+.++|++.
T Consensus 279 ~~li~~~L~-~~~~r~~r--~~~~ei~~h~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 340 (371)
T cd05622 279 KNLICAFLT-DREVRLGR--NGVEEIKRHLFFKNDQWAWETLRDTVAPVVPDLSSDIDTSNFDDI 340 (371)
T ss_pred HHHHHHHcC-ChhhhcCC--CCHHHHhcCcccCCCChhHHhcCCCCCCCCCCCCCcchhhhcCCC
Confidence 999999998 88888764 479999999999997776666688899999999888888888753
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an |
| >cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Probab=99.87 E-value=3.9e-22 Score=228.70 Aligned_cols=221 Identities=24% Similarity=0.371 Sum_probs=166.2
Q ss_pred CcceeeeecccccceEEEEEEcCCCCEEEEEeccccc--------hhhHHHHHHHHhhCCCcccccccccccc-------
Q psy11767 117 DLDKAGILGDGSYSVCRRCVEKSTGQEYAVKIISRKI--------DCSEEINLLRACQGHPNICRRCVEKSTG------- 181 (966)
Q Consensus 117 df~~~~~LG~GsFGkV~La~~k~tg~~yAiKvl~K~~--------~~~~E~~il~~~~~~pfi~~~~~~~~~~------- 181 (966)
||++++.||+|+||+|++|+++.+|+.||||++.|.. ...+|..+|+++ +||+|+..+..+...
T Consensus 2 ~y~~~~~lG~G~~g~V~~a~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l-~h~~iv~~~~~~~~~~~~~lv~ 80 (376)
T cd05598 2 MFVKIKTIGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAEA-DNEWVVKLYYSFQDKDNLYFVM 80 (376)
T ss_pred CceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEcHHHHHhhhhHHHHHHHHHHHHhC-CCCCcceEEEEEEcCCEEEEEE
Confidence 6899999999999999999999999999999998642 356789999887 699998622221111
Q ss_pred -----------------------hhHHHHHHHh----------hcccchhhhHhhhccCCceEEecCccc----------
Q psy11767 182 -----------------------QEYAVKIISR----------KIDCSEEINLLRACQGHPNIVNLHCVF---------- 218 (966)
Q Consensus 182 -----------------------~~~~~~~v~~----------~~~~~~e~nil~~~~gh~~iv~l~~~~---------- 218 (966)
+.++.+++.+ ..|++++ |||.+.+|+++|+||+.+.
T Consensus 81 E~~~~g~L~~~i~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivHrDlkp~-Nill~~~~~ikL~DFG~a~~~~~~~~~~~ 159 (376)
T cd05598 81 DYIPGGDMMSLLIRLGIFEEDLARFYIAELTCAIESVHKMGFIHRDIKPD-NILIDRDGHIKLTDFGLCTGFRWTHDSKY 159 (376)
T ss_pred eCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCCHH-HEEECCCCCEEEEeCCCCccccccccccc
Confidence 1112222221 1244444 9999999999999998641
Q ss_pred ----------------------------------------------------cccccccccCCCcceeeechhhHHHHHH
Q psy11767 219 ----------------------------------------------------QDEVIDWDDFSRGIECVFFSSSLIIFFI 246 (966)
Q Consensus 219 ----------------------------------------------------~~e~i~~~~y~~~~d~~~~~~~~il~~~ 246 (966)
.+|++...+|+...| .| +.|+++|+
T Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~D--iw-SlGvilye 236 (376)
T cd05598 160 YQKGDHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCD--WW-SVGVILYE 236 (376)
T ss_pred cccccccccccccccccccccccccccchhhhhhhhcccccccccCCCccccCHHHHcCCCCCccee--ee-eccceeee
Confidence 134444445544444 34 45677888
Q ss_pred HhhCCCCCCCCcHHHHHHHHHhCC--CCCCC--CCCHHHHHHHHhhcccCCCcccCCCCCCHHHHhcCCceeeeCccccc
Q psy11767 247 ILSFTLSFIHDYYHIQYRRILKTE--PPIPE--DLSPDVADFISRLLVKDPRRRLGGGELDAEELKRHPFFNVIDWDDLA 322 (966)
Q Consensus 247 m~~g~~pf~~~~~~~~~~~I~~~~--~~~P~--~~s~~a~dli~~LL~kdp~~RLG~~~~g~~~Ik~HpfF~~idW~~l~ 322 (966)
|++|.+||...+....+.+|.... +.+|. .+++++++||.+|+ .||.+|++. ..++++++||||++++|..+.
T Consensus 237 ll~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~l~-~~p~~R~~~--~t~~ell~h~~~~~~~~~~~~ 313 (376)
T cd05598 237 MLVGQPPFLADTPAETQLKVINWETTLHIPSQAKLSREASDLILRLC-CGAEDRLGK--NGADEIKAHPFFKGIDFASLI 313 (376)
T ss_pred hhhCCCCCCCCCHHHHHHHHhccCccccCCCCCCCCHHHHHHHHHHh-cCHhhcCCC--CCHHHHhCCCCcCCCCHHHHh
Confidence 999999999988887777887643 33443 68999999999976 599999974 268999999999999998887
Q ss_pred cCCCCCCCCccccccccccccccc
Q psy11767 323 TKRIPAPFVPKISNELDVSNFSDE 346 (966)
Q Consensus 323 ~k~~~pP~~P~i~~~~D~snFd~e 346 (966)
++.++|+.|.+....+.++|++.
T Consensus 314 -~~~~~~~~~~~~~~~~~~~~~~~ 336 (376)
T cd05598 314 -RRQKAPYIPKITHPTDTSNFDPV 336 (376)
T ss_pred -hcCCCCCCCcCCCcchhhhcCCC
Confidence 77889999999888888888764
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. |
| >KOG0597|consensus | Back alignment and domain information |
|---|
Probab=99.87 E-value=2.1e-22 Score=226.16 Aligned_cols=189 Identities=23% Similarity=0.326 Sum_probs=156.3
Q ss_pred CcceeeeecccccceEEEEEEcCCCCEEEEEeccccc-------hhhHHHHHHHHhhCCCcccccccccccc--------
Q psy11767 117 DLDKAGILGDGSYSVCRRCVEKSTGQEYAVKIISRKI-------DCSEEINLLRACQGHPNICRRCVEKSTG-------- 181 (966)
Q Consensus 117 df~~~~~LG~GsFGkV~La~~k~tg~~yAiKvl~K~~-------~~~~E~~il~~~~~~pfi~~~~~~~~~~-------- 181 (966)
+|.+...||+|+||+||-.|.|.|++++|||++.|.. .+.+|..||+.+ +||.|+.....+++.
T Consensus 3 ~yhv~e~iG~Gsfg~VYKgrrK~t~~~vAik~i~K~gr~~k~l~~l~~ev~i~r~l-kHpniv~m~esfEt~~~~~vVte 81 (808)
T KOG0597|consen 3 QYHVYEMIGEGSFGRVYKGRRKYTIQVVAIKFIDKSGRNEKELKNLRQEVRILRSL-KHPNIVEMLESFETSAHLWVVTE 81 (808)
T ss_pred chhHHHHhcCCccceeeecccccceeEEEEEEehhcCCchHHHHHHHHHHHHHHhc-CCcchhhHHHhhcccceEEEEeh
Confidence 5788889999999999999999999999999999852 367899999998 599999855444443
Q ss_pred ---------------------hhHHHHHHHhh--------c--ccchhhhHhhhccCCceEEecCccc------------
Q psy11767 182 ---------------------QEYAVKIISRK--------I--DCSEEINLLRACQGHPNIVNLHCVF------------ 218 (966)
Q Consensus 182 ---------------------~~~~~~~v~~~--------~--~~~~e~nil~~~~gh~~iv~l~~~~------------ 218 (966)
+..+...|.+. + |. +..|||++..||.++.||+++-
T Consensus 82 ~a~g~L~~il~~d~~lpEe~v~~~a~~LVsaL~yLhs~rilhrd~-kPqniLl~~~~~~KlcdFg~Ar~m~~~t~vltsi 160 (808)
T KOG0597|consen 82 YAVGDLFTILEQDGKLPEEQVRAIAYDLVSALYYLHSNRILHRDM-KPQNILLEKGGTLKLCDFGLARAMSTNTSVLTSI 160 (808)
T ss_pred hhhhhHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhcCcccccC-CcceeeecCCCceeechhhhhhhcccCceeeeec
Confidence 22222333331 1 22 3559999999999999988653
Q ss_pred -------cccccccccCCCcceeeechhhHHHHHHHhhCCCCCCCCcHHHHHHHHHhCCCCCCCCCCHHHHHHHHhhccc
Q psy11767 219 -------QDEVIDWDDFSRGIECVFFSSSLIIFFIILSFTLSFIHDYYHIQYRRILKTEPPIPEDLSPDVADFISRLLVK 291 (966)
Q Consensus 219 -------~~e~i~~~~y~~~~d~~~~~~~~il~~~m~~g~~pf~~~~~~~~~~~I~~~~~~~P~~~s~~a~dli~~LL~k 291 (966)
.+|++...+|+...| -|+.|+|+|||+.|.|||+......+.++|+.+++++|...|.+.++||++||+|
T Consensus 161 kGtPlYmAPElv~e~pyd~~sD---lWslGcilYE~~~G~PPF~a~si~~Lv~~I~~d~v~~p~~~S~~f~nfl~gLL~k 237 (808)
T KOG0597|consen 161 KGTPLYMAPELVEEQPYDHTSD---LWSLGCILYELYVGQPPFYARSITQLVKSILKDPVKPPSTASSSFVNFLQGLLIK 237 (808)
T ss_pred cCcccccCHHHHcCCCccchhh---HHHHHHHHHHHhcCCCCchHHHHHHHHHHHhcCCCCCcccccHHHHHHHHHHhhc
Confidence 467788888888877 3477888999999999999999999999999999999999999999999999999
Q ss_pred CCCcccCCCCCCHHHHhcCCceee
Q psy11767 292 DPRRRLGGGELDAEELKRHPFFNV 315 (966)
Q Consensus 292 dp~~RLG~~~~g~~~Ik~HpfF~~ 315 (966)
||.+||. ..++..|||.++
T Consensus 238 dP~~Rlt-----W~~Ll~HpF~k~ 256 (808)
T KOG0597|consen 238 DPAQRLT-----WTDLLGHPFWKG 256 (808)
T ss_pred Chhhccc-----HHHHhcChHHhh
Confidence 9999995 789999999864
|
|
| >KOG0606|consensus | Back alignment and domain information |
|---|
Probab=99.87 E-value=1.7e-22 Score=241.40 Aligned_cols=218 Identities=32% Similarity=0.585 Sum_probs=157.3
Q ss_pred cccccccccccccccEEEEEEEcCCCcEEEEEEeccccChHHHHHHHHHhcCCCCceEEEEEEEeCCeEEEEEEccCCCC
Q psy11767 378 MDLDKAGILGDGSYSVCRRCVEKSTGQEYAVKIISRKIDCSEEINLLRACQGHPNIVNLHCVFQDEVHTYLVLELLKGGE 457 (966)
Q Consensus 378 i~~~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~~~~~Ei~iL~~l~~HpnIV~l~~~~~~~~~~~lVmEy~~gg~ 457 (966)
.||+.++.|-.|+||-||.++|+.+.+.+|+|+ +++....+- +|... +.|.+| ||
T Consensus 83 ~df~~IklisngAygavylvrh~~trqrfa~ki-Nkq~lilRn--ilt~a-~npfvv---------------------gD 137 (1205)
T KOG0606|consen 83 SDFNTIKLISNGAYGAVYLVRHKETRQRFAMKI-NKQNLILRN--ILTFA-GNPFVV---------------------GD 137 (1205)
T ss_pred cccceeEeeccCCCCceeeeeccccccchhhcc-cccchhhhc--ccccc-CCccee---------------------ch
Confidence 367778999999999999999999999999955 333221111 12111 234333 44
Q ss_pred HHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCcEEEecCCCCCEEEEeecccccccCC---------
Q psy11767 458 LLDRIRQKGRCGFTENEASRIMRQLVAAVHFMHSRGVVHRDLKPENLLFSDPAGDNIKVVDFGFACLKRES--------- 528 (966)
Q Consensus 458 L~~~l~~~~~~~l~e~~~~~i~~Qil~aL~yLHs~~IiHRDLKP~NILl~~~~~~~iKL~DFGla~~~~~~--------- 528 (966)
-...++.-+ .++.. ++.+++|||+.||+|||+||+|.||.. -|++|+.|||+++.....
T Consensus 138 c~tllk~~g--~lPvd--------mvla~Eylh~ygivhrdlkpdnllIT~--mGhiKlTDfgLsk~GLms~atnl~eg~ 205 (1205)
T KOG0606|consen 138 CATLLKNIG--PLPVD--------MVLAVEYLHSYGIVHRDLKPDNLLITS--MGHIKLTDFGLSKKGLMSLATNLKEGH 205 (1205)
T ss_pred hhhhcccCC--CCcch--------hhHHhHhhccCCeecCCCCCCcceeee--cccccccchhhhhhhhhhccchhhhcc
Confidence 444444433 33332 278999999999999999999999984 679999999998643210
Q ss_pred ---------CccccccccccCchhhccCCCCCCCcccchhhhhhhhhhhhcCCCCCCCcCcchhHHHHHHHHhcCCCCCC
Q psy11767 529 ---------LHTPCFTLQYAAPEVLRQDKSGYDENCDLWSLGVILVNVLRQDKSGYDENCDLWSLGVILYTMLCGRVPFH 599 (966)
Q Consensus 529 ---------~~~~~gT~~Y~APEvl~~~~~~~~~~~Di~SlGvil~el~~~~~~~y~~~~DIWSlGvilyemltG~~Pf~ 599 (966)
....||||.|+|||++. ..+|+..+|+|++|+|+||.+.|+.||+
T Consensus 206 I~k~t~Ef~dKqvcgTPeyiaPeVil--------------------------rqgygkpvdwwamGiIlyeFLVgcvpff 259 (1205)
T KOG0606|consen 206 IEKDTHEFQDKQVCGTPEYIAPEVIL--------------------------RQGYGKPVDWWAMGIILYEFLVGCVPFF 259 (1205)
T ss_pred hHHHHHHhhhccccCCccccChhhhh--------------------------hhccCCCccHHHHHHHHHHHheeeeecc
Confidence 12358999999999986 3468999999999999999999999999
Q ss_pred CCCCchhHHHHHHHHHcCCCCCCchhhccCCHHHHHHHHHhcccCccccCCh-HHHHHHhhhhHH
Q psy11767 600 ARSRDDSALSIMARIKEGQFNFDAEAWSTVSSEAKELTKSLLTVNPAQRIRM-MRVKLTFHAFHQ 663 (966)
Q Consensus 600 ~~~~~~~~~~~~~~i~~~~~~~~~~~~~~is~e~~~Li~~~L~~dP~~R~t~-~~v~~~~~~~~~ 663 (966)
+.+..+ ++..+......++.+ -..+.+|++++|.++|+.+|..|... .+.+...|.|++
T Consensus 260 Gdtpee----lfg~visd~i~wpE~-dea~p~Ea~dli~~LL~qnp~~Rlgt~ga~evk~h~ff~ 319 (1205)
T KOG0606|consen 260 GDTPEE----LFGQVISDDIEWPEE-DEALPPEAQDLIEQLLRQNPLCRLGTGGALEVKQHGFFQ 319 (1205)
T ss_pred CCCHHH----HHhhhhhhhcccccc-CcCCCHHHHHHHHHHHHhChHhhcccchhhhhhhcccee
Confidence 987654 333333333333333 23678999999999999999999643 344556666653
|
|
| >cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.86 E-value=4.5e-21 Score=217.09 Aligned_cols=218 Identities=30% Similarity=0.529 Sum_probs=166.1
Q ss_pred CcceeeeecccccceEEEEEEcCCCCEEEEEeccccc--------hhhHHHHHHHHhhCCCccccccccccc--------
Q psy11767 117 DLDKAGILGDGSYSVCRRCVEKSTGQEYAVKIISRKI--------DCSEEINLLRACQGHPNICRRCVEKST-------- 180 (966)
Q Consensus 117 df~~~~~LG~GsFGkV~La~~k~tg~~yAiKvl~K~~--------~~~~E~~il~~~~~~pfi~~~~~~~~~-------- 180 (966)
+|.+++.||+|+||+|++|+++.+|+.||||++++.. ....|..+|..+ +||+|+.....+..
T Consensus 2 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~-~~~~i~~~~~~~~~~~~~~lv~ 80 (350)
T cd05573 2 DFEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADA-DSPWIVKLYYSFQDEEHLYLVM 80 (350)
T ss_pred CceEEEEEEeCCcEEEEEEEECCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhc-CCCCccchhhheecCCeEEEEE
Confidence 6799999999999999999999999999999998742 346788888887 59999862211111
Q ss_pred ----------------------chhHHHHHHHh----------hcccchhhhHhhhccCCceEEecCcccc---------
Q psy11767 181 ----------------------GQEYAVKIISR----------KIDCSEEINLLRACQGHPNIVNLHCVFQ--------- 219 (966)
Q Consensus 181 ----------------------~~~~~~~~v~~----------~~~~~~e~nil~~~~gh~~iv~l~~~~~--------- 219 (966)
...++.+++.+ ..|++++ |||.+.+|+++|+||+.+..
T Consensus 81 e~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~giiH~Dlkp~-NIll~~~~~~kL~Dfg~~~~~~~~~~~~~ 159 (350)
T cd05573 81 EYMPGGDLMNLLIRKDVFPEETARFYIAELVLALDSVHKLGFIHRDIKPD-NILIDADGHIKLADFGLCKKMNKAKDREY 159 (350)
T ss_pred cCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHH-HeEECCCCCEEeecCCCCccCcccCcccc
Confidence 11111222221 0134444 99999999999999886531
Q ss_pred ---------------------------------------ccccccccCCCcceeeechhhHHHHHHHhhCCCCCCCCcHH
Q psy11767 220 ---------------------------------------DEVIDWDDFSRGIECVFFSSSLIIFFIILSFTLSFIHDYYH 260 (966)
Q Consensus 220 ---------------------------------------~e~i~~~~y~~~~d~~~~~~~~il~~~m~~g~~pf~~~~~~ 260 (966)
+|++....|+...| .| +.|+++|+|++|.+||...+..
T Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~D--iw-SlG~il~ell~g~~Pf~~~~~~ 236 (350)
T cd05573 160 YLNDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECD--WW-SLGVILYEMLYGFPPFYSDTLQ 236 (350)
T ss_pred cccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCcee--eE-ecchhhhhhccCCCCCCCCCHH
Confidence 23333344544444 33 5567888899999999998888
Q ss_pred HHHHHHHh--CCCCCCCCC--CHHHHHHHHhhcccCCCcccCCCCCCHHHHhcCCceeeeCccccccCCCCCCCCccccc
Q psy11767 261 IQYRRILK--TEPPIPEDL--SPDVADFISRLLVKDPRRRLGGGELDAEELKRHPFFNVIDWDDLATKRIPAPFVPKISN 336 (966)
Q Consensus 261 ~~~~~I~~--~~~~~P~~~--s~~a~dli~~LL~kdp~~RLG~~~~g~~~Ik~HpfF~~idW~~l~~k~~~pP~~P~i~~ 336 (966)
..+.+|+. ....+|... ++++++||.+||. ||.+|..+ +++|..||||++++|+... +.+||+.|.+.+
T Consensus 237 ~~~~~i~~~~~~~~~p~~~~~~~~~~~li~~ll~-dp~~R~~s----~~~ll~hp~~~~~~~~~~~--~~~~~~~~~~~~ 309 (350)
T cd05573 237 ETYNKIINWKESLRFPPDPPVSPEAIDLICRLLC-DPEDRLGS----FEEIKSHPFFKGIDWENLR--ETKPPFVPELSS 309 (350)
T ss_pred HHHHHHhccCCcccCCCCCCCCHHHHHHHHHHcc-ChhhcCCC----HHHHhcCCCcCCCCHHHHh--hCCCCcCCCCCC
Confidence 88999998 677777665 9999999999997 99999852 8999999999999999886 667899999999
Q ss_pred cccccccccc
Q psy11767 337 ELDVSNFSDE 346 (966)
Q Consensus 337 ~~D~snFd~e 346 (966)
..+..+|++.
T Consensus 310 ~~~~~~~~~~ 319 (350)
T cd05573 310 PLDTSNFDDF 319 (350)
T ss_pred chhhhhcCCC
Confidence 8898888864
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the |
| >cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=99.86 E-value=6e-21 Score=210.53 Aligned_cols=224 Identities=29% Similarity=0.459 Sum_probs=174.0
Q ss_pred CcceeeeecccccceEEEEEEcCCCCEEEEEeccccc--------hhhHHHHHHHHhhCCCcccccccccccc-------
Q psy11767 117 DLDKAGILGDGSYSVCRRCVEKSTGQEYAVKIISRKI--------DCSEEINLLRACQGHPNICRRCVEKSTG------- 181 (966)
Q Consensus 117 df~~~~~LG~GsFGkV~La~~k~tg~~yAiKvl~K~~--------~~~~E~~il~~~~~~pfi~~~~~~~~~~------- 181 (966)
+|.+.++||+|+||+|++|+++.+++.||||++++.. ...+|.++|+.+. ||+|+.-.......
T Consensus 2 ~y~~~~~ig~g~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~~~v~ 80 (290)
T cd05580 2 DFEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIR-HPFLVNLYGSFQDDSNLYLVM 80 (290)
T ss_pred ceEEEEEeecCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCC-CCCccceeeEEEcCCeEEEEE
Confidence 5789999999999999999999999999999998642 3467888998885 99997621111100
Q ss_pred -----------------------hhHHHHHHHhh-------c---ccchhhhHhhhccCCceEEecCcccc---------
Q psy11767 182 -----------------------QEYAVKIISRK-------I---DCSEEINLLRACQGHPNIVNLHCVFQ--------- 219 (966)
Q Consensus 182 -----------------------~~~~~~~v~~~-------~---~~~~e~nil~~~~gh~~iv~l~~~~~--------- 219 (966)
..+..+++.+. + ++. ..|+|.+.+|.++|+|++.+..
T Consensus 81 e~~~~~~L~~~~~~~~~l~~~~~~~~~~qil~~l~~lH~~~i~H~dl~-p~nili~~~~~~kl~dfg~~~~~~~~~~~~~ 159 (290)
T cd05580 81 EYVPGGELFSHLRKSGRFPEPVARFYAAQVVLALEYLHSLDIVYRDLK-PENLLLDSDGYIKITDFGFAKRVKGRTYTLC 159 (290)
T ss_pred ecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCC-HHHEEECCCCCEEEeeCCCccccCCCCCCCC
Confidence 01111222110 1 222 4488998899999999886532
Q ss_pred -------ccccccccCCCcceeeechhhHHHHHHHhhCCCCCCCCcHHHHHHHHHhCCCCCCCCCCHHHHHHHHhhcccC
Q psy11767 220 -------DEVIDWDDFSRGIECVFFSSSLIIFFIILSFTLSFIHDYYHIQYRRILKTEPPIPEDLSPDVADFISRLLVKD 292 (966)
Q Consensus 220 -------~e~i~~~~y~~~~d~~~~~~~~il~~~m~~g~~pf~~~~~~~~~~~I~~~~~~~P~~~s~~a~dli~~LL~kd 292 (966)
+|.+....++.. .|.| +.|+++|+|++|.+||...+...++++|+.+.+.+|..++++.+++|+++|+.|
T Consensus 160 ~~~~y~aPE~~~~~~~~~~--~Di~-slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~ 236 (290)
T cd05580 160 GTPEYLAPEIILSKGYGKA--VDWW-ALGILIYEMLAGYPPFFDDNPIQIYEKILEGKVRFPSFFSPDAKDLIRNLLQVD 236 (290)
T ss_pred CCccccChhhhcCCCCCcc--ccHH-HHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCccCCccCCHHHHHHHHHHccCC
Confidence 233333333333 3344 457778888889999998888888999999999999999999999999999999
Q ss_pred CCcccCCCCCCHHHHhcCCceeeeCccccccCCCCCCCCcccccccccccccc
Q psy11767 293 PRRRLGGGELDAEELKRHPFFNVIDWDDLATKRIPAPFVPKISNELDVSNFSD 345 (966)
Q Consensus 293 p~~RLG~~~~g~~~Ik~HpfF~~idW~~l~~k~~~pP~~P~i~~~~D~snFd~ 345 (966)
|.+|.+.....++|+..||||+.++|..+....+++|+.|......|.+.|++
T Consensus 237 p~~R~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 289 (290)
T cd05580 237 LTKRLGNLKNGVNDIKNHPWFAGIDWIALLQRKIEAPFIPKVKGPGDTSNFDD 289 (290)
T ss_pred HHHccCcccCCHHHHHcCcccccCCHHHHhhccCCCCccCCCCCccccccccC
Confidence 99999876668999999999999999999999999999999998999998886
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi |
| >cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Probab=99.85 E-value=5.4e-21 Score=215.63 Aligned_cols=221 Identities=24% Similarity=0.427 Sum_probs=160.6
Q ss_pred CcceeeeecccccceEEEEEEcCCCCEEEEEeccccc--------hhhHHHHHHHHhhCCCcccccccccc---------
Q psy11767 117 DLDKAGILGDGSYSVCRRCVEKSTGQEYAVKIISRKI--------DCSEEINLLRACQGHPNICRRCVEKS--------- 179 (966)
Q Consensus 117 df~~~~~LG~GsFGkV~La~~k~tg~~yAiKvl~K~~--------~~~~E~~il~~~~~~pfi~~~~~~~~--------- 179 (966)
||++++.||+|+||+|++|+++.+++.||||+++|.. ...+|..++... +||+|+.....+.
T Consensus 2 ~y~i~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~-~~~~i~~l~~~~~~~~~~~lv~ 80 (331)
T cd05624 2 DFEIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVNG-DCQWITTLHYAFQDENYLYLVM 80 (331)
T ss_pred CceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHHHhhHHHHHHHHHHHHHHhC-CCCCEeeEEEEEEcCCEEEEEE
Confidence 6899999999999999999999999999999998732 235577777665 7999875211111
Q ss_pred ----------------------cchhHHHHHHHh----------hcccchhhhHhhhccCCceEEecCcccc--------
Q psy11767 180 ----------------------TGQEYAVKIISR----------KIDCSEEINLLRACQGHPNIVNLHCVFQ-------- 219 (966)
Q Consensus 180 ----------------------~~~~~~~~~v~~----------~~~~~~e~nil~~~~gh~~iv~l~~~~~-------- 219 (966)
....++.+++.+ ..|++++ |||.+.+|+.+|+||+.+..
T Consensus 81 Ey~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~~L~~lH~~~iiHrDlkp~-Nill~~~~~~kl~DfG~a~~~~~~~~~~ 159 (331)
T cd05624 81 DYYVGGDLLTLLSKFEDRLPEDMARFYIAEMVLAIHSIHQLHYVHRDIKPD-NVLLDMNGHIRLADFGSCLKMNQDGTVQ 159 (331)
T ss_pred eCCCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCchH-HEEEcCCCCEEEEeccceeeccCCCcee
Confidence 111222222221 1144444 99999999999999985421
Q ss_pred ------------cccccc-----ccCCCcceeeechhhHHHHHHHhhCCCCCCCCcHHHHHHHHHhCC--CCCCCC---C
Q psy11767 220 ------------DEVIDW-----DDFSRGIECVFFSSSLIIFFIILSFTLSFIHDYYHIQYRRILKTE--PPIPED---L 277 (966)
Q Consensus 220 ------------~e~i~~-----~~y~~~~d~~~~~~~~il~~~m~~g~~pf~~~~~~~~~~~I~~~~--~~~P~~---~ 277 (966)
+|++.. ..|+...| .| +.|+++|+|++|.+||...+....+.+|+... +.+|.. +
T Consensus 160 ~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~D--iw-SlGvil~ell~g~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~~ 236 (331)
T cd05624 160 SSVAVGTPDYISPEILQAMEDGMGKYGPECD--WW-SLGVCMYEMLYGETPFYAESLVETYGKIMNHEERFQFPSHITDV 236 (331)
T ss_pred eccccCCcccCCHHHHhccccCCCCCCCccc--EE-eeehhhhhhhhCCCCccCCCHHHHHHHHHcCCCcccCCCccccC
Confidence 233332 12333333 34 55688888899999999988888899998754 455654 6
Q ss_pred CHHHHHHHHhhcccCCCcccCCCCCCHHHHhcCCceeeeCccccccCCCCCCCCcccccccccccccccc
Q psy11767 278 SPDVADFISRLLVKDPRRRLGGGELDAEELKRHPFFNVIDWDDLATKRIPAPFVPKISNELDVSNFSDEF 347 (966)
Q Consensus 278 s~~a~dli~~LL~kdp~~RLG~~~~g~~~Ik~HpfF~~idW~~l~~k~~~pP~~P~i~~~~D~snFd~ef 347 (966)
+++++|||.+||+. +.+|++. .+++++++||||++++|+.+ +.+.+|+.|......+.++|+...
T Consensus 237 ~~~~~~li~~ll~~-~~~~~~~--~~~~~~~~h~~f~~~~~~~~--~~~~~~~~p~~~~~~~~~~~~~~~ 301 (331)
T cd05624 237 SEEAKDLIQRLICS-RERRLGQ--NGIEDFKKHAFFEGIDWENI--RNLEAPYIPDVSSPSDTSNFDVDD 301 (331)
T ss_pred CHHHHHHHHHHccC-chhhcCC--CCHHHHhcCCCcCCCCHHHH--hhCCCCccCCCCCcchhhhcCCcc
Confidence 89999999999985 4567653 47999999999999999998 567899999988888888887553
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. |
| >KOG4717|consensus | Back alignment and domain information |
|---|
Probab=99.85 E-value=7.3e-22 Score=219.05 Aligned_cols=191 Identities=23% Similarity=0.366 Sum_probs=156.9
Q ss_pred cceeeeecccccceEEEEEEcCCCCEEEEEeccccc-------hhhHHHHHHHHhhCCCccccccccccc----------
Q psy11767 118 LDKAGILGDGSYSVCRRCVEKSTGQEYAVKIISRKI-------DCSEEINLLRACQGHPNICRRCVEKST---------- 180 (966)
Q Consensus 118 f~~~~~LG~GsFGkV~La~~k~tg~~yAiKvl~K~~-------~~~~E~~il~~~~~~pfi~~~~~~~~~---------- 180 (966)
||+-++||+|-|..|.||+|-=||..+|+|||.|.. ++..|..-|+.+ +||+||+.|..-.+
T Consensus 20 YDLekTlG~GHFAVVKLArHVFTGekVAVKviDKTKlD~~st~hlfqEVRCMKLV-QHpNiVRLYEViDTQTKlyLiLEL 98 (864)
T KOG4717|consen 20 YDLEKTLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDTLSTGHLFQEVRCMKLV-QHPNIVRLYEVIDTQTKLYLILEL 98 (864)
T ss_pred ehhhhhhcCCceehhhhhhhhcccceeEEEEecccccchhhhhHHHHHHHHHHHh-cCcCeeeeeehhcccceEEEEEEe
Confidence 477899999999999999999999999999999963 567788888777 59999984433333
Q ss_pred ---------------------chhHHHHHHHh----------hcccchhhhHhhhccCCceEEecCcc--cc--------
Q psy11767 181 ---------------------GQEYAVKIISR----------KIDCSEEINLLRACQGHPNIVNLHCV--FQ-------- 219 (966)
Q Consensus 181 ---------------------~~~~~~~~v~~----------~~~~~~e~nil~~~~gh~~iv~l~~~--~~-------- 219 (966)
++.|+++|+.+ ..|+++|--++....|..+|+||+++ |+
T Consensus 99 GD~GDl~DyImKHe~Gl~E~La~kYF~QI~~AI~YCHqLHVVHRDLKPENVVFFEKlGlVKLTDFGFSNkf~PG~kL~Ts 178 (864)
T KOG4717|consen 99 GDGGDLFDYIMKHEEGLNEDLAKKYFAQIVHAISYCHQLHVVHRDLKPENVVFFEKLGLVKLTDFGFSNKFQPGKKLTTS 178 (864)
T ss_pred cCCchHHHHHHhhhccccHHHHHHHHHHHHHHHHHHhhhhhhcccCCcceeEEeeecCceEeeeccccccCCCcchhhcc
Confidence 35677777655 13677774445556799999999875 33
Q ss_pred --------ccccccccCCC-cceeeechhhHHHHHHHhhCCCCCCCCcHHHHHHHHHhCCCCCCCCCCHHHHHHHHhhcc
Q psy11767 220 --------DEVIDWDDFSR-GIECVFFSSSLIIFFIILSFTLSFIHDYYHIQYRRILKTEPPIPEDLSPDVADFISRLLV 290 (966)
Q Consensus 220 --------~e~i~~~~y~~-~~d~~~~~~~~il~~~m~~g~~pf~~~~~~~~~~~I~~~~~~~P~~~s~~a~dli~~LL~ 290 (966)
+|++.-..|+. ++| .|++|||+|||++|.+||...+..++.-+|+..++..|.++|.+++|||..+|+
T Consensus 179 CGSLAYSAPEILLGDsYDAPAVD---iWSLGVILyMLVCGq~PFqeANDSETLTmImDCKYtvPshvS~eCrdLI~sMLv 255 (864)
T KOG4717|consen 179 CGSLAYSAPEILLGDSYDAPAVD---IWSLGVILYMLVCGQPPFQEANDSETLTMIMDCKYTVPSHVSKECRDLIQSMLV 255 (864)
T ss_pred cchhhccCchhhhcCccCCcchh---hhHHHHHHHHHHhCCCccccccchhhhhhhhcccccCchhhhHHHHHHHHHHHh
Confidence 45666666764 344 447889999999999999988888889999999999999999999999999999
Q ss_pred cCCCcccCCCCCCHHHHhcCCceeeeC
Q psy11767 291 KDPRRRLGGGELDAEELKRHPFFNVID 317 (966)
Q Consensus 291 kdp~~RLG~~~~g~~~Ik~HpfF~~id 317 (966)
+||+||- ..++|-.|+|.+.+|
T Consensus 256 RdPkkRA-----slEeI~s~~Wlq~~D 277 (864)
T KOG4717|consen 256 RDPKKRA-----SLEEIVSTSWLQAGD 277 (864)
T ss_pred cCchhhc-----cHHHHhccccccCCC
Confidence 9999996 489999999999988
|
|
| >cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain | Back alignment and domain information |
|---|
Probab=99.85 E-value=4.1e-21 Score=199.78 Aligned_cols=134 Identities=19% Similarity=0.299 Sum_probs=104.7
Q ss_pred ccccccccccEEEEEEEcCCCcEEEEEEeccccC-------------------------------hHHHHHHHHHhcCCC
Q psy11767 383 AGILGDGSYSVCRRCVEKSTGQEYAVKIISRKID-------------------------------CSEEINLLRACQGHP 431 (966)
Q Consensus 383 ~~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~~-------------------------------~~~Ei~iL~~l~~Hp 431 (966)
.+.||+|+||.||+|.+. +|+.||||+++.... ...|+++|..+. |+
T Consensus 2 ~~~ig~G~~~~Vy~a~~~-~g~~vAvKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-~~ 79 (190)
T cd05147 2 NGCISTGKEANVYHATTA-NGEERAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKSNPRKMVRTWAEKEMRNLKRLV-TA 79 (190)
T ss_pred CCccccccceEEEEEECC-CCCEEEEEEEEecccccccHHHhhcCCchhhccccCCCHHHHHHHHHHHHHHHHHHHH-HC
Confidence 367999999999999997 899999999864310 013888888884 66
Q ss_pred CceEEEEEEEeCCeEEEEEEccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHH-HhcCceeccCCCCcEEEecCC
Q psy11767 432 NIVNLHCVFQDEVHTYLVLELLKGGELLDRIRQKGRCGFTENEASRIMRQLVAAVHFM-HSRGVVHRDLKPENLLFSDPA 510 (966)
Q Consensus 432 nIV~l~~~~~~~~~~~lVmEy~~gg~L~~~l~~~~~~~l~e~~~~~i~~Qil~aL~yL-Hs~~IiHRDLKP~NILl~~~~ 510 (966)
+|......... ..+|||||++|+++...+.... .+++.++..++.|++.+|+|| |+.||+||||||+|||+++
T Consensus 80 ~v~~p~~~~~~--~~~iVmE~i~g~~l~~~~~~~~--~~~~~~~~~i~~qi~~~L~~l~H~~giiHrDlkP~NIli~~-- 153 (190)
T cd05147 80 GIPCPEPILLK--SHVLVMEFIGDDGWAAPRLKDA--PLSESKARELYLQVIQIMRILYQDCRLVHADLSEYNLLYHD-- 153 (190)
T ss_pred CCCCCcEEEec--CCEEEEEEeCCCCCcchhhhcC--CCCHHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEEC--
Confidence 65333222222 2389999999887765533332 589999999999999999999 7999999999999999973
Q ss_pred CCCEEEEeecccccc
Q psy11767 511 GDNIKVVDFGFACLK 525 (966)
Q Consensus 511 ~~~iKL~DFGla~~~ 525 (966)
+.++|+|||+|...
T Consensus 154 -~~v~LiDFG~a~~~ 167 (190)
T cd05147 154 -GKLYIIDVSQSVEH 167 (190)
T ss_pred -CcEEEEEccccccC
Confidence 58999999998653
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c |
| >cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.84 E-value=1.1e-20 Score=213.08 Aligned_cols=217 Identities=22% Similarity=0.373 Sum_probs=162.8
Q ss_pred CcceeeeecccccceEEEEEEcCCCCEEEEEeccccc--------hhhHHHHHHHHhhCCCcccccccccccc-------
Q psy11767 117 DLDKAGILGDGSYSVCRRCVEKSTGQEYAVKIISRKI--------DCSEEINLLRACQGHPNICRRCVEKSTG------- 181 (966)
Q Consensus 117 df~~~~~LG~GsFGkV~La~~k~tg~~yAiKvl~K~~--------~~~~E~~il~~~~~~pfi~~~~~~~~~~------- 181 (966)
+|++++.||+|+||+|++|+++.+|+.||||++++.. ....|..+|.++. ||+|++....+...
T Consensus 2 ~y~~~~~ig~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~-h~~iv~~~~~~~~~~~~~lv~ 80 (333)
T cd05600 2 DFQILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTK-SEWLVKLLYAFQDDEYLYLAM 80 (333)
T ss_pred CcEEEEEEeecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhCC-CCCCccEEEEEEcCCEEEEEE
Confidence 6899999999999999999999999999999998752 3567889998884 99998622111111
Q ss_pred -----------------------hhHHHHHHHh----------hcccchhhhHhhhccCCceEEecCccc----------
Q psy11767 182 -----------------------QEYAVKIISR----------KIDCSEEINLLRACQGHPNIVNLHCVF---------- 218 (966)
Q Consensus 182 -----------------------~~~~~~~v~~----------~~~~~~e~nil~~~~gh~~iv~l~~~~---------- 218 (966)
..+..+++.+ ..|++++ |||.+.+|+++|+||+.+.
T Consensus 81 e~~~g~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~-Nil~~~~~~~kL~Dfg~a~~~~~~~~~~~ 159 (333)
T cd05600 81 EYVPGGDFRTLLNNLGVLSEDHARFYMAEMFEAVDALHELGYIHRDLKPE-NFLIDASGHIKLTDFGLSKGIVTYANSVV 159 (333)
T ss_pred eCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHH-HEEECCCCCEEEEeCcCCcccccccCCcc
Confidence 1111122211 0133334 9999999999999998653
Q ss_pred ------cccccccccCCCcceeeechhhHHHHHHHhhCCCCCCCCcHHHHHHHHHhCC--CCCCC------CCCHHHHHH
Q psy11767 219 ------QDEVIDWDDFSRGIECVFFSSSLIIFFIILSFTLSFIHDYYHIQYRRILKTE--PPIPE------DLSPDVADF 284 (966)
Q Consensus 219 ------~~e~i~~~~y~~~~d~~~~~~~~il~~~m~~g~~pf~~~~~~~~~~~I~~~~--~~~P~------~~s~~a~dl 284 (966)
.+|++....|+...| +|+.|+++|+|++|.+||...+...++..|.... +..|. .+++++.+|
T Consensus 160 gt~~y~aPE~~~~~~~~~~~D---vwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~s~~~~~l 236 (333)
T cd05600 160 GSPDYMAPEVLRGKGYDFTVD---YWSLGCMLYEFLCGFPPFSGSTPNETWENLKYWKETLQRPVYDDPRFNLSDEAWDL 236 (333)
T ss_pred cCccccChhHhcCCCCCCccc---eecchHHHhhhhhCCCCCCCCCHHHHHHHHHhccccccCCCCCccccccCHHHHHH
Confidence 245555555655555 3356788888999999999998888888887533 22333 458999999
Q ss_pred HHhhcccCCCcccCCCCCCHHHHhcCCceeeeCccccccCCCCCCCCcccccccccccccc
Q psy11767 285 ISRLLVKDPRRRLGGGELDAEELKRHPFFNVIDWDDLATKRIPAPFVPKISNELDVSNFSD 345 (966)
Q Consensus 285 i~~LL~kdp~~RLG~~~~g~~~Ik~HpfF~~idW~~l~~k~~~pP~~P~i~~~~D~snFd~ 345 (966)
|.++|..+|.+|. .+++|+.||||.+++|+.+. +..||+.|...+..+..+|++
T Consensus 237 i~~~l~~~~~rr~-----s~~~ll~h~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~ 290 (333)
T cd05600 237 ITKLINDPSRRFG-----SLEDIKNHPFFKEVDWNELR--ELKPPFVPELESEIDTGYFDD 290 (333)
T ss_pred HHHHhhChhhhcC-----CHHHHHhCcccCCCCHHHHh--hCCCCCCCCCCCcchhhhccC
Confidence 9999998888886 48999999999999999886 788899999887777777764
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. |
| >cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.84 E-value=1.3e-20 Score=207.51 Aligned_cols=212 Identities=24% Similarity=0.343 Sum_probs=157.1
Q ss_pred CcceeeeecccccceEEEEEEcCCCCEEEEEeccccc--------hhhHHHHHHHHhhCCCccccccccccc--------
Q psy11767 117 DLDKAGILGDGSYSVCRRCVEKSTGQEYAVKIISRKI--------DCSEEINLLRACQGHPNICRRCVEKST-------- 180 (966)
Q Consensus 117 df~~~~~LG~GsFGkV~La~~k~tg~~yAiKvl~K~~--------~~~~E~~il~~~~~~pfi~~~~~~~~~-------- 180 (966)
.|+..++||+|+||+|++|+.+.+|+.||+|++++.. ...+|..+|+.+ +||+|+.....+..
T Consensus 1 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~ 79 (285)
T cd05605 1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKV-NSRFVVSLAYAYETKDALCLVL 79 (285)
T ss_pred CceEEEEEecCCCeEEEEEEEcCCCceEEEEEEehhhhhhhhhHHHHHHHHHHHHhc-CCCCEeeeeeeecCCCeEEEEE
Confidence 3789999999999999999999999999999997632 235688999888 69999762211111
Q ss_pred ------------------------chhHHHHHHHhh----------cccchhhhHhhhccCCceEEecCcccc-------
Q psy11767 181 ------------------------GQEYAVKIISRK----------IDCSEEINLLRACQGHPNIVNLHCVFQ------- 219 (966)
Q Consensus 181 ------------------------~~~~~~~~v~~~----------~~~~~e~nil~~~~gh~~iv~l~~~~~------- 219 (966)
...++.+++.+. .+++ ..|+|.+..|+++|.||+.+..
T Consensus 80 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlk-p~Nil~~~~~~~~l~Dfg~~~~~~~~~~~ 158 (285)
T cd05605 80 TLMNGGDLKFHIYNMGNPGFDEERAVFYAAEITCGLEDLHRERIVYRDLK-PENILLDDYGHIRISDLGLAVEIPEGETI 158 (285)
T ss_pred eccCCCcHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCC-HHHEEECCCCCEEEeeCCCceecCCCCcc
Confidence 011112222210 1233 3488888889999999886542
Q ss_pred -----------ccccccccCCCcceeeechhhHHHHHHHhhCCCCCCCCcHH----HHHHHHHhCCCCCCCCCCHHHHHH
Q psy11767 220 -----------DEVIDWDDFSRGIECVFFSSSLIIFFIILSFTLSFIHDYYH----IQYRRILKTEPPIPEDLSPDVADF 284 (966)
Q Consensus 220 -----------~e~i~~~~y~~~~d~~~~~~~~il~~~m~~g~~pf~~~~~~----~~~~~I~~~~~~~P~~~s~~a~dl 284 (966)
+|++....|+... |.|+ .|+++|+|++|.+||...+.. .+...|......+|..++..+++|
T Consensus 159 ~~~~~~~~y~aPE~~~~~~~~~~~--Diws-~G~~l~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 235 (285)
T cd05605 159 RGRVGTVGYMAPEVVKNERYTFSP--DWWG-LGCLIYEMIEGKSPFRQRKEKVKREEVERRVKEDQEEYSEKFSEAARSI 235 (285)
T ss_pred ccccCCCCccCcHHhcCCCCCccc--cchh-HHHHHHHHHHCCCCCCCCchhhHHHHHHHHhhhcccccCcccCHHHHHH
Confidence 3344444444333 3444 467777888899999875543 344556677788999999999999
Q ss_pred HHhhcccCCCcccCCCCCCHHHHhcCCceeeeCccccccCCCCCCCCcc
Q psy11767 285 ISRLLVKDPRRRLGGGELDAEELKRHPFFNVIDWDDLATKRIPAPFVPK 333 (966)
Q Consensus 285 i~~LL~kdp~~RLG~~~~g~~~Ik~HpfF~~idW~~l~~k~~~pP~~P~ 333 (966)
|.++|.+||.+|+++....+++++.||||...+|+.+.++.++||+.|.
T Consensus 236 i~~~l~~~P~~R~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~ 284 (285)
T cd05605 236 CRQLLTKDPGFRLGCRGEGAEEVKAHPFFRTANFKRLEAGMLEPPFCPD 284 (285)
T ss_pred HHHHccCCHHHhcCCCCCCHHHHhcCcCccCCCHHHHhhCCCCCCCCCC
Confidence 9999999999999875557999999999999999999999999999984
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, |
| >cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Probab=99.84 E-value=7e-21 Score=214.20 Aligned_cols=218 Identities=28% Similarity=0.461 Sum_probs=161.4
Q ss_pred CcceeeeecccccceEEEEEEcCCCCEEEEEeccccc--------hhhHHHHHHHHhhCCCccccccccccc--------
Q psy11767 117 DLDKAGILGDGSYSVCRRCVEKSTGQEYAVKIISRKI--------DCSEEINLLRACQGHPNICRRCVEKST-------- 180 (966)
Q Consensus 117 df~~~~~LG~GsFGkV~La~~k~tg~~yAiKvl~K~~--------~~~~E~~il~~~~~~pfi~~~~~~~~~-------- 180 (966)
||++.+.||+|+||+|++|+++.+|+.||||++++.. ...+|..+|+.. +||+|+.....+..
T Consensus 2 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~-~~~~i~~~~~~~~~~~~~~lv~ 80 (330)
T cd05601 2 DFDVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSIS-NSPWIPQLQYAFQDKDNLYLVM 80 (330)
T ss_pred CceEEEEEEeccCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhC-CCCCCcceeeEEecCCeEEEEE
Confidence 6899999999999999999999999999999999752 245677887765 79999762111111
Q ss_pred -----------------------chhHHHHHHHh----------hcccchhhhHhhhccCCceEEecCcccc--------
Q psy11767 181 -----------------------GQEYAVKIISR----------KIDCSEEINLLRACQGHPNIVNLHCVFQ-------- 219 (966)
Q Consensus 181 -----------------------~~~~~~~~v~~----------~~~~~~e~nil~~~~gh~~iv~l~~~~~-------- 219 (966)
.+.+..+++.+ ..|++++ |||.+.+|+++|.||+.+..
T Consensus 81 e~~~~~~L~~~l~~~~~~l~~~~~~~~~~qi~~aL~~lH~~~i~H~Dlkp~-NIll~~~~~~kL~Dfg~a~~~~~~~~~~ 159 (330)
T cd05601 81 EYQPGGDLLSLLNRYEDQFDEDMAQFYLAELVLAIHSVHQMGYVHRDIKPE-NVLIDRTGHIKLADFGSAARLTANKMVN 159 (330)
T ss_pred CCCCCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEcccCchH-heEECCCCCEEeccCCCCeECCCCCcee
Confidence 11111222221 0134444 99999999999999986531
Q ss_pred ------------ccccc------cccCCCcceeeechhhHHHHHHHhhCCCCCCCCcHHHHHHHHHhCC--CCCCC--CC
Q psy11767 220 ------------DEVID------WDDFSRGIECVFFSSSLIIFFIILSFTLSFIHDYYHIQYRRILKTE--PPIPE--DL 277 (966)
Q Consensus 220 ------------~e~i~------~~~y~~~~d~~~~~~~~il~~~m~~g~~pf~~~~~~~~~~~I~~~~--~~~P~--~~ 277 (966)
+|++. ...|+.. +|.| +.|+++|+|++|.+||...+....+.+|++.. +.+|. .+
T Consensus 160 ~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~--~Diw-slG~il~el~~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 236 (330)
T cd05601 160 SKLPVGTPDYIAPEVLTTMNGDGKGTYGVE--CDWW-SLGVIAYEMIYGRSPFHEGTSAKTYNNIMNFQRFLKFPEDPKV 236 (330)
T ss_pred eecccCCccccCHHHhccccccccCCCCCc--ceee-cccceeeeeccCCCCCCCCCHHHHHHHHHcCCCccCCCCCCCC
Confidence 23332 1123333 3444 55678888899999999988888899998753 55665 57
Q ss_pred CHHHHHHHHhhcccCCCcccCCCCCCHHHHhcCCceeeeCccccccCCCCCCCCcccccccccccccccc
Q psy11767 278 SPDVADFISRLLVKDPRRRLGGGELDAEELKRHPFFNVIDWDDLATKRIPAPFVPKISNELDVSNFSDEF 347 (966)
Q Consensus 278 s~~a~dli~~LL~kdp~~RLG~~~~g~~~Ik~HpfF~~idW~~l~~k~~~pP~~P~i~~~~D~snFd~ef 347 (966)
++++++||++||+ ||.+|++ +++|+.||||+.++|+.+. ..+||+.|.+....|.++|++..
T Consensus 237 ~~~~~~li~~ll~-~p~~R~t-----~~~l~~h~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~ 298 (330)
T cd05601 237 SSDFLDLIQSLLC-GQKERLG-----YEGLCCHPFFSKIDWNNIR--NSLPPFVPTLKSDDDTSNFDEPE 298 (330)
T ss_pred CHHHHHHHHHHcc-ChhhCCC-----HHHHhCCCCcCCCCHHHHh--hCCCCccCcCCCcchhhhcCCCc
Confidence 9999999999997 9999984 8999999999999999885 46788999998888888887643
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor |
| >cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Probab=99.84 E-value=1.7e-20 Score=211.59 Aligned_cols=218 Identities=24% Similarity=0.433 Sum_probs=158.5
Q ss_pred CcceeeeecccccceEEEEEEcCCCCEEEEEeccccc--------hhhHHHHHHHHhhCCCccccccccccc--------
Q psy11767 117 DLDKAGILGDGSYSVCRRCVEKSTGQEYAVKIISRKI--------DCSEEINLLRACQGHPNICRRCVEKST-------- 180 (966)
Q Consensus 117 df~~~~~LG~GsFGkV~La~~k~tg~~yAiKvl~K~~--------~~~~E~~il~~~~~~pfi~~~~~~~~~-------- 180 (966)
||++.++||+|+||.|++|+++.+++.||+|+++|.. ...+|+.+|... +||+|+.....+..
T Consensus 2 ~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~-~~~~i~~~~~~~~~~~~~~lv~ 80 (332)
T cd05623 2 DFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNG-DNQWITTLHYAFQDENNLYLVM 80 (332)
T ss_pred CceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEeHHHHHHhhHHHHHHHHHHHHhhC-CCCCEeeEEEEEecCCEEEEEE
Confidence 7899999999999999999999999999999998632 235677777665 79998752211111
Q ss_pred -----------------------chhHHHHHHHh----------hcccchhhhHhhhccCCceEEecCcccc--------
Q psy11767 181 -----------------------GQEYAVKIISR----------KIDCSEEINLLRACQGHPNIVNLHCVFQ-------- 219 (966)
Q Consensus 181 -----------------------~~~~~~~~v~~----------~~~~~~e~nil~~~~gh~~iv~l~~~~~-------- 219 (966)
.+.+..+++.+ ..|++++ |+|.+.+|+.+|+||+.+..
T Consensus 81 ey~~~g~L~~~l~~~~~~l~~~~~~~~~~qi~~al~~lH~~~iiHrDlkp~-Nili~~~~~~kL~DfG~a~~~~~~~~~~ 159 (332)
T cd05623 81 DYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVIAIDSVHQLHYVHRDIKPD-NILMDMNGHIRLADFGSCLKLMEDGTVQ 159 (332)
T ss_pred eccCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHH-HEEECCCCCEEEeecchheecccCCcce
Confidence 11122222221 0144444 99999999999999986421
Q ss_pred ------------ccccc-----cccCCCcceeeechhhHHHHHHHhhCCCCCCCCcHHHHHHHHHhCC--CCCCC---CC
Q psy11767 220 ------------DEVID-----WDDFSRGIECVFFSSSLIIFFIILSFTLSFIHDYYHIQYRRILKTE--PPIPE---DL 277 (966)
Q Consensus 220 ------------~e~i~-----~~~y~~~~d~~~~~~~~il~~~m~~g~~pf~~~~~~~~~~~I~~~~--~~~P~---~~ 277 (966)
+|++. ...|+... |.| +.|+++|+|++|.+||...+....+++|+... ..+|. .+
T Consensus 160 ~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~--Dvw-SlGvil~ell~g~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~~ 236 (332)
T cd05623 160 SSVAVGTPDYISPEILQAMEDGKGKYGPEC--DWW-SLGVCMYEMLYGETPFYAESLVETYGKIMNHKERFQFPAQVTDV 236 (332)
T ss_pred ecccccCccccCHHHHhccccCCCCCCCcC--CEE-eeHHHHHHHhcCCCCCCCCCHHHHHHHHhCCCccccCCCccccC
Confidence 23332 11233333 344 45788888999999999999889999998764 34554 57
Q ss_pred CHHHHHHHHhhcccCCCcccCCCCCCHHHHhcCCceeeeCccccccCCCCCCCCccccccccccccc
Q psy11767 278 SPDVADFISRLLVKDPRRRLGGGELDAEELKRHPFFNVIDWDDLATKRIPAPFVPKISNELDVSNFS 344 (966)
Q Consensus 278 s~~a~dli~~LL~kdp~~RLG~~~~g~~~Ik~HpfF~~idW~~l~~k~~~pP~~P~i~~~~D~snFd 344 (966)
+++++|||++||+. +.+|++. .++++++.||||.+++|+.+. ...+|++|...+..+.++++
T Consensus 237 s~~~~~li~~ll~~-~~~r~~r--~~~~~~~~h~~f~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~ 298 (332)
T cd05623 237 SEDAKDLIRRLICS-REHRLGQ--NGIEDFKQHPFFTGIDWDNIR--NCEAPYIPEVSSPTDTSNFD 298 (332)
T ss_pred CHHHHHHHHHHccC-hhhhcCC--CCHHHHhCCCCcCCCCHHHHh--hCCCCccCCCCCCcccccCC
Confidence 99999999999986 5566653 479999999999999999985 46788899888888877765
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw |
| >KOG0033|consensus | Back alignment and domain information |
|---|
Probab=99.84 E-value=5.7e-22 Score=203.45 Aligned_cols=193 Identities=32% Similarity=0.534 Sum_probs=148.6
Q ss_pred ccchhccCCcceeeeecccccceEEEEEEcCCCCEEEEEecccc-------chhhHHHHHHHHhhCCCcccc--------
Q psy11767 109 LFFEQYDMDLDKAGILGDGSYSVCRRCVEKSTGQEYAVKIISRK-------IDCSEEINLLRACQGHPNICR-------- 173 (966)
Q Consensus 109 ~~~~~~~~df~~~~~LG~GsFGkV~La~~k~tg~~yAiKvl~K~-------~~~~~E~~il~~~~~~pfi~~-------- 173 (966)
+|.+.| ++..+||+|.|+.|+.|-|+.||+-||+|++.-. +.+.+|+.|-+.+ +||+||+
T Consensus 8 ~f~d~y----~l~e~igkG~FSvVrRc~~~~tg~~fa~kiin~~k~~~~~~e~l~rEarIC~~L-qHP~IvrL~~ti~~~ 82 (355)
T KOG0033|consen 8 KFSDNY----DVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKL-QHPNIVRLHDSIQEE 82 (355)
T ss_pred ccchhh----hHHHHHccCchHHHHHHHhccchHHHHHHHhhhhhhccccHHHHHHHHHHHHhc-CCCcEeehhhhhccc
Confidence 455555 8999999999999999999999999999999832 3567888888777 5999997
Q ss_pred ----cccccccc---------hhHH---------HHHHHh----------hcccchhhhHhhhcc--CC-ceEEecCccc
Q psy11767 174 ----RCVEKSTG---------QEYA---------VKIISR----------KIDCSEEINLLRACQ--GH-PNIVNLHCVF 218 (966)
Q Consensus 174 ----~~~~~~~~---------~~~~---------~~~v~~----------~~~~~~e~nil~~~~--gh-~~iv~l~~~~ 218 (966)
..|++.++ +|++ -+++.+ ..|+++| |+|+... |- .+|.+|+.+.
T Consensus 83 ~~~ylvFe~m~G~dl~~eIV~R~~ySEa~aSH~~rQiLeal~yCH~n~IvHRDvkP~-nllLASK~~~A~vKL~~FGvAi 161 (355)
T KOG0033|consen 83 SFHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILEALAYCHSNGIVHRDLKPE-NLLLASKAKGAAVKLADFGLAI 161 (355)
T ss_pred ceeEEEEecccchHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHhcCceeccCChh-heeeeeccCCCceeecccceEE
Confidence 23333333 2222 111111 0144445 7777543 22 3677766443
Q ss_pred ------------------cccccccccCCCcceeeechhhHHHHHHHhhCCCCCCCCcHHHHHHHHHhCCCCCCC----C
Q psy11767 219 ------------------QDEVIDWDDFSRGIECVFFSSSLIIFFIILSFTLSFIHDYYHIQYRRILKTEPPIPE----D 276 (966)
Q Consensus 219 ------------------~~e~i~~~~y~~~~d~~~~~~~~il~~~m~~g~~pf~~~~~~~~~~~I~~~~~~~P~----~ 276 (966)
.+|+++...|++.+|. |+.||++|.|+.|.|||++.+.+.+|+.|+.+.+.||. +
T Consensus 162 ~l~~g~~~~G~~GtP~fmaPEvvrkdpy~kpvDi---W~cGViLfiLL~G~~PF~~~~~~rlye~I~~g~yd~~~~~w~~ 238 (355)
T KOG0033|consen 162 EVNDGEAWHGFAGTPGYLSPEVLKKDPYSKPVDI---WACGVILYILLVGYPPFWDEDQHRLYEQIKAGAYDYPSPEWDT 238 (355)
T ss_pred EeCCccccccccCCCcccCHHHhhcCCCCCcchh---hhhhHHHHHHHhCCCCCCCccHHHHHHHHhccccCCCCcccCc
Confidence 3688999999988883 36778899999999999999999999999999998875 6
Q ss_pred CCHHHHHHHHhhcccCCCcccCCCCCCHHHHhcCCceee
Q psy11767 277 LSPDVADFISRLLVKDPRRRLGGGELDAEELKRHPFFNV 315 (966)
Q Consensus 277 ~s~~a~dli~~LL~kdp~~RLG~~~~g~~~Ik~HpfF~~ 315 (966)
+|++|+|||+++|..||.||+. +.|-.+|||...
T Consensus 239 is~~Ak~LvrrML~~dP~kRIt-----a~EAL~HpWi~~ 272 (355)
T KOG0033|consen 239 VTPEAKSLIRRMLTVNPKKRIT-----ADEALKHPWICN 272 (355)
T ss_pred CCHHHHHHHHHHhccChhhhcc-----HHHHhCCchhcc
Confidence 8999999999999999999995 789999999864
|
|
| >cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain | Back alignment and domain information |
|---|
Probab=99.84 E-value=2.8e-20 Score=193.47 Aligned_cols=135 Identities=20% Similarity=0.250 Sum_probs=106.8
Q ss_pred ccccccccccEEEEEEEcCCCcEEEEEEeccccC-------------------------------hHHHHHHHHHhcCCC
Q psy11767 383 AGILGDGSYSVCRRCVEKSTGQEYAVKIISRKID-------------------------------CSEEINLLRACQGHP 431 (966)
Q Consensus 383 ~~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~~-------------------------------~~~Ei~iL~~l~~Hp 431 (966)
.+.||+|+||+||+|.+. +|+.||||++..... ...|...+..+. |+
T Consensus 2 ~~~ig~G~~~~Vy~a~~~-~g~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-~~ 79 (190)
T cd05145 2 NGCISTGKEANVYHARTG-DGEELAVKIYKTSTLSFKDRDKYIEGDPRFRSRYSKSNPRKLVFAWAEKEFRNLKRLY-EA 79 (190)
T ss_pred CceeecCCCcEEEEEEcC-CCCEEEEEEEEcCcceEeeHHHHhcCCcccccccccCCHHHHHHHHHHHHHHHHHHHH-hC
Confidence 468999999999999987 899999999864311 135778888874 88
Q ss_pred CceEEEEEEEeCCeEEEEEEccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHh-cCceeccCCCCcEEEecCC
Q psy11767 432 NIVNLHCVFQDEVHTYLVLELLKGGELLDRIRQKGRCGFTENEASRIMRQLVAAVHFMHS-RGVVHRDLKPENLLFSDPA 510 (966)
Q Consensus 432 nIV~l~~~~~~~~~~~lVmEy~~gg~L~~~l~~~~~~~l~e~~~~~i~~Qil~aL~yLHs-~~IiHRDLKP~NILl~~~~ 510 (966)
+|.....+.... .||||||++|+++........ .+++.++..++.|++.+|.+||+ .||+||||||+|||++
T Consensus 80 ~i~~p~~~~~~~--~~lVmE~~~g~~~~~~~l~~~--~~~~~~~~~i~~~l~~~l~~lH~~~givHrDlkP~NIll~--- 152 (190)
T cd05145 80 GVPVPEPILLKK--NVLVMEFIGDDGSPAPRLKDV--PLEEEEAEELYEQVVEQMRRLYQEAGLVHGDLSEYNILYH--- 152 (190)
T ss_pred CCCCceEEEecC--CEEEEEEecCCCchhhhhhhc--cCCHHHHHHHHHHHHHHHHHHHHhCCEecCCCChhhEEEE---
Confidence 875444433332 489999999886544322222 57899999999999999999999 9999999999999997
Q ss_pred CCCEEEEeeccccccc
Q psy11767 511 GDNIKVVDFGFACLKR 526 (966)
Q Consensus 511 ~~~iKL~DFGla~~~~ 526 (966)
++.++|+|||+|....
T Consensus 153 ~~~~~liDFG~a~~~~ 168 (190)
T cd05145 153 DGKPYIIDVSQAVELD 168 (190)
T ss_pred CCCEEEEEcccceecC
Confidence 4589999999986543
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro |
| >KOG0599|consensus | Back alignment and domain information |
|---|
Probab=99.84 E-value=3.1e-21 Score=200.57 Aligned_cols=194 Identities=32% Similarity=0.474 Sum_probs=153.4
Q ss_pred cchhccCCcceeeeecccccceEEEEEEcCCCCEEEEEecccc-------------chhhHHHHHHHHhhCCCccccccc
Q psy11767 110 FFEQYDMDLDKAGILGDGSYSVCRRCVEKSTGQEYAVKIISRK-------------IDCSEEINLLRACQGHPNICRRCV 176 (966)
Q Consensus 110 ~~~~~~~df~~~~~LG~GsFGkV~La~~k~tg~~yAiKvl~K~-------------~~~~~E~~il~~~~~~pfi~~~~~ 176 (966)
||++| +-.++||+|.-+.|..|-||.||+.||+|+|.-. .....|..||+++..||.|+...-
T Consensus 15 fy~~y----~pkeilgrgvss~vrRci~k~t~~e~a~kii~~~at~~~~e~~~~~~EaT~~Ev~ILRqv~GHP~II~l~D 90 (411)
T KOG0599|consen 15 FYAKY----EPKEILGRGVSSVVRRCIHKETGKEFAVKIIDVTATTESGETPYEMREATRQEISILRQVMGHPYIIDLQD 90 (411)
T ss_pred HHhhc----ChHHHhcccchhhhhhhhhcccccceeEEEEEecccccCCccHHHHHHHHHHHHHHHHHhcCCCcEEEeee
Confidence 66777 6889999999999999999999999999999742 135779999999999999987433
Q ss_pred ccccchhHH------------------------------------HHHHHh-h---cccchhhhHhhhccCCceEEecCc
Q psy11767 177 EKSTGQEYA------------------------------------VKIISR-K---IDCSEEINLLRACQGHPNIVNLHC 216 (966)
Q Consensus 177 ~~~~~~~~~------------------------------------~~~v~~-~---~~~~~e~nil~~~~gh~~iv~l~~ 216 (966)
..++..|.+ ++.+.+ . .|+++| |||+|.+...+|.||++
T Consensus 91 ~yes~sF~FlVFdl~prGELFDyLts~VtlSEK~tR~iMrqlfegVeylHa~~IVHRDLKpE-NILlddn~~i~isDFGF 169 (411)
T KOG0599|consen 91 VYESDAFVFLVFDLMPRGELFDYLTSKVTLSEKETRRIMRQLFEGVEYLHARNIVHRDLKPE-NILLDDNMNIKISDFGF 169 (411)
T ss_pred eccCcchhhhhhhhcccchHHHHhhhheeecHHHHHHHHHHHHHHHHHHHHhhhhhcccChh-heeeccccceEEeccce
Confidence 333332222 111222 1 256666 99999998999999998
Q ss_pred ccc------------------ccccc------cccCCCcceeeechhhHHHHHHHhhCCCCCCCCcHHHHHHHHHhCCCC
Q psy11767 217 VFQ------------------DEVID------WDDFSRGIECVFFSSSLIIFFIILSFTLSFIHDYYHIQYRRILKTEPP 272 (966)
Q Consensus 217 ~~~------------------~e~i~------~~~y~~~~d~~~~~~~~il~~~m~~g~~pf~~~~~~~~~~~I~~~~~~ 272 (966)
+.+ +|.|. .-||++-+| . |+.|||+|-++.|.|||+|.....|.++|+.|++.
T Consensus 170 a~~l~~GekLrelCGTPgYLAPEtikC~m~e~~pGYs~EVD--~-Wa~GVImyTLLaGcpPFwHRkQmlMLR~ImeGkyq 246 (411)
T KOG0599|consen 170 ACQLEPGEKLRELCGTPGYLAPETIKCSMYENHPGYSKEVD--E-WACGVIMYTLLAGCPPFWHRKQMLMLRMIMEGKYQ 246 (411)
T ss_pred eeccCCchhHHHhcCCCcccChhheeeecccCCCCccchhh--H-HHHHHHHHHHHcCCCchhHHHHHHHHHHHHhcccc
Confidence 865 23332 226755555 3 46788899999999999999999999999999998
Q ss_pred CC----CCCCHHHHHHHHhhcccCCCcccCCCCCCHHHHhcCCceeee
Q psy11767 273 IP----EDLSPDVADFISRLLVKDPRRRLGGGELDAEELKRHPFFNVI 316 (966)
Q Consensus 273 ~P----~~~s~~a~dli~~LL~kdp~~RLG~~~~g~~~Ik~HpfF~~i 316 (966)
|- .++|.+++|||.+||+.||++|+. ++|...||||..+
T Consensus 247 F~speWadis~~~KdLIsrlLqVdp~~Rit-----ake~LaHpff~q~ 289 (411)
T KOG0599|consen 247 FRSPEWADISATVKDLISRLLQVDPTKRIT-----AKEALAHPFFIQI 289 (411)
T ss_pred cCCcchhhccccHHHHHHHHHeeCchhccc-----HHHHhcChHHHHH
Confidence 84 358999999999999999999995 7999999999655
|
|
| >KOG0607|consensus | Back alignment and domain information |
|---|
Probab=99.83 E-value=9.5e-21 Score=200.72 Aligned_cols=227 Identities=29% Similarity=0.485 Sum_probs=162.7
Q ss_pred hhhhccCCccchhccCCcceeeeecccccceEEEEEEcCCCCEEEEEeccccc-----hhhHHHHHHHHhhCCCcccccc
Q psy11767 101 IACKFKGSLFFEQYDMDLDKAGILGDGSYSVCRRCVEKSTGQEYAVKIISRKI-----DCSEEINLLRACQGHPNICRRC 175 (966)
Q Consensus 101 ~~~~~~~~~~~~~~~~df~~~~~LG~GsFGkV~La~~k~tg~~yAiKvl~K~~-----~~~~E~~il~~~~~~pfi~~~~ 175 (966)
++-..+++-|++.|.+- ..+||+|+||.|.-|....||+.||+|||.|+. .+.+|.+++.++|.|+.|+...
T Consensus 66 r~~ss~~g~F~d~YkLt---~e~LGeGAyasVqtcv~i~t~~EYAVKiidKq~gHsR~RvfREVe~f~~Cqgh~nilqLi 142 (463)
T KOG0607|consen 66 RATSSLSGKFEDMYKLT---SELLGEGAYASVQTCVSIQTGKEYAVKIIDKQPGHSRSRVFREVETFYQCQGHKNILQLI 142 (463)
T ss_pred cccccccchHHHHHHhH---HHHhcCccceeeeeeeeeccchhhhhhhhhcCCchHHHHHHHHHHHHHHhcCCccHHHHH
Confidence 44566777899999772 345999999999999999999999999999973 4788999999999999998722
Q ss_pred --cccccchhHHH-------------------------HHH----Hh----------hcccchhhhHhhhccCC---ceE
Q psy11767 176 --VEKSTGQEYAV-------------------------KII----SR----------KIDCSEEINLLRACQGH---PNI 211 (966)
Q Consensus 176 --~~~~~~~~~~~-------------------------~~v----~~----------~~~~~~e~nil~~~~gh---~~i 211 (966)
|+.. .+||.+ .++ ++ ..|+++| |||-..-.| .+|
T Consensus 143 efFEdd-~~FYLVfEKm~GGplLshI~~~~~F~E~EAs~vvkdia~aLdFlH~kgIAHRDlKPE-NiLC~~pn~vsPvKi 220 (463)
T KOG0607|consen 143 EFFEDD-TRFYLVFEKMRGGPLLSHIQKRKHFNEREASRVVKDIASALDFLHTKGIAHRDLKPE-NILCESPNKVSPVKI 220 (463)
T ss_pred HHhccc-ceEEEEEecccCchHHHHHHHhhhccHHHHHHHHHHHHHHHHHHhhcCcccccCCcc-ceeecCCCCcCceee
Confidence 2222 222220 111 11 1255666 887543333 488
Q ss_pred EecCccc--------------------------ccccccc-----ccCCCcceeeechhhHHHHHHHhhCCCCCCC----
Q psy11767 212 VNLHCVF--------------------------QDEVIDW-----DDFSRGIECVFFSSSLIIFFIILSFTLSFIH---- 256 (966)
Q Consensus 212 v~l~~~~--------------------------~~e~i~~-----~~y~~~~d~~~~~~~~il~~~m~~g~~pf~~---- 256 (966)
.||.+.. .+|+++. +-|++- || -|++|+++|.||.|.|||..
T Consensus 221 CDfDLgSg~k~~~~~spastP~L~tPvGSAEfMAPEVVd~fv~qA~~YDKr--CD-lwSLGvIlYImLsGYpPFvG~Cg~ 297 (463)
T KOG0607|consen 221 CDFDLGSGIKLNNDCSPASTPELLTPVGSAEFMAPEVVDVFVDQATFYDKR--CD-LWSLGVILYIMLSGYPPFVGHCGA 297 (463)
T ss_pred eccccccccccCCCCCCCCCccccCcccchhhcchhHHhhhcccccccccc--cc-HHHHHHHHHHHHhCCCCccCccCC
Confidence 8876442 2344443 235444 34 34677888999999999974
Q ss_pred -----------CcHHHHHHHHHhCCCCCCC----CCCHHHHHHHHhhcccCCCcccCCCCCCHHHHhcCCceeeeCcccc
Q psy11767 257 -----------DYYHIQYRRILKTEPPIPE----DLSPDVADFISRLLVKDPRRRLGGGELDAEELKRHPFFNVIDWDDL 321 (966)
Q Consensus 257 -----------~~~~~~~~~I~~~~~~~P~----~~s~~a~dli~~LL~kdp~~RLG~~~~g~~~Ik~HpfF~~idW~~l 321 (966)
.....+|+.|..|++.||+ ++|.+|+|||++||.+|+..||. +..+.+||||..+-=+
T Consensus 298 dCGWdrGe~Cr~CQ~~LFesIQEGkYeFPdkdWahIS~eakdlisnLlvrda~~rls-----a~~vlnhPw~~~~~~e-- 370 (463)
T KOG0607|consen 298 DCGWDRGEVCRVCQNKLFESIQEGKYEFPDKDWAHISSEAKDLISNLLVRDAKQRLS-----AAQVLNHPWVQRCAPE-- 370 (463)
T ss_pred cCCccCCCccHHHHHHHHHHHhccCCcCChhhhHHhhHHHHHHHHHHHhccHHhhhh-----hhhccCCccccccchh--
Confidence 2456789999999999997 59999999999999999999995 6889999999987543
Q ss_pred ccCCCCCCC-Cccccccccccccc
Q psy11767 322 ATKRIPAPF-VPKISNELDVSNFS 344 (966)
Q Consensus 322 ~~k~~~pP~-~P~i~~~~D~snFd 344 (966)
+-++.|. +-...+..+.+.|.
T Consensus 371 --kalptp~v~~r~~s~~~lslfa 392 (463)
T KOG0607|consen 371 --KALPTPQVLQRNSSTMDLSLFA 392 (463)
T ss_pred --ccCCCCcccccCccchhhHHHH
Confidence 5555443 33444445666665
|
|
| >cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Probab=99.83 E-value=2.2e-20 Score=205.16 Aligned_cols=205 Identities=26% Similarity=0.450 Sum_probs=152.4
Q ss_pred ecccccceEEEEEEcCCCCEEEEEeccccc--------hhhHHHHHHHHhhCCCccccccccccc---------------
Q psy11767 124 LGDGSYSVCRRCVEKSTGQEYAVKIISRKI--------DCSEEINLLRACQGHPNICRRCVEKST--------------- 180 (966)
Q Consensus 124 LG~GsFGkV~La~~k~tg~~yAiKvl~K~~--------~~~~E~~il~~~~~~pfi~~~~~~~~~--------------- 180 (966)
||+|+||+||+|+++.+|+.||+|++++.. ....|..+|+++ +||+|+.....+..
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l-~~~~i~~~~~~~~~~~~~~lv~e~~~~g~ 79 (280)
T cd05608 1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKV-HSRFIVSLAYAFQTKTDLCLVMTIMNGGD 79 (280)
T ss_pred CCCCCceeEEEEEEccCCcEEEEEeeeHHHHhhhHHHHHHHHHHHHHHhC-CCCcEeeeeEEEcCCCeEEEEEeCCCCCC
Confidence 799999999999999999999999998642 235688899887 79999752111100
Q ss_pred -------------------chhHHHHHHHh----------hcccchhhhHhhhccCCceEEecCcccc------------
Q psy11767 181 -------------------GQEYAVKIISR----------KIDCSEEINLLRACQGHPNIVNLHCVFQ------------ 219 (966)
Q Consensus 181 -------------------~~~~~~~~v~~----------~~~~~~e~nil~~~~gh~~iv~l~~~~~------------ 219 (966)
...++.+++.+ ..|+++ .|+|.+.+|..+|+||+.+..
T Consensus 80 L~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp-~Nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~ 158 (280)
T cd05608 80 LRYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQRRIIYRDLKP-ENVLLDNDGNVRISDLGLAVELKDGQSKTKGYA 158 (280)
T ss_pred HHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCH-HHEEECCCCCEEEeeCccceecCCCCccccccC
Confidence 01111222221 013333 399998889999999986531
Q ss_pred -------ccccccccCCCcceeeechhhHHHHHHHhhCCCCCCCCc----HHHHHHHHHhCCCCCCCCCCHHHHHHHHhh
Q psy11767 220 -------DEVIDWDDFSRGIECVFFSSSLIIFFIILSFTLSFIHDY----YHIQYRRILKTEPPIPEDLSPDVADFISRL 288 (966)
Q Consensus 220 -------~e~i~~~~y~~~~d~~~~~~~~il~~~m~~g~~pf~~~~----~~~~~~~I~~~~~~~P~~~s~~a~dli~~L 288 (966)
+|++....|+...| .| +.|+++|+|++|..||.... ...+.+.++...+.+|..+++++++||.++
T Consensus 159 g~~~y~aPE~~~~~~~~~~~D--vw-slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~ 235 (280)
T cd05608 159 GTPGFMAPELLQGEEYDFSVD--YF-ALGVTLYEMIAARGPFRARGEKVENKELKQRILNDSVTYPDKFSPASKSFCEAL 235 (280)
T ss_pred CCcCccCHHHhcCCCCCcccc--HH-HHHHHHHHHHhCCCCCCCCCcchhHHHHHHhhcccCCCCcccCCHHHHHHHHHH
Confidence 23444444544434 34 45677788888999997543 345677888888899999999999999999
Q ss_pred cccCCCcccCCCCCCHHHHhcCCceeeeCccccccCCCCCCCCcc
Q psy11767 289 LVKDPRRRLGGGELDAEELKRHPFFNVIDWDDLATKRIPAPFVPK 333 (966)
Q Consensus 289 L~kdp~~RLG~~~~g~~~Ik~HpfF~~idW~~l~~k~~~pP~~P~ 333 (966)
|++||.+|++.....++++.+||||++++|+.+..+.+++|+.|.
T Consensus 236 l~~~P~~R~~~~~~~~~~~l~h~~~~~~~~~~~~~~~~~~~~~~~ 280 (280)
T cd05608 236 LAKDPEKRLGFRDGNCDGLRTHPLFRDLNWRQLEAGMLPPPFVPD 280 (280)
T ss_pred hcCCHHHhcCCCCCCHHHHhcChhhhcCCHhHHhhccCCCCCCCC
Confidence 999999999865446899999999999999999999999999873
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g |
| >cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.83 E-value=5.6e-20 Score=207.39 Aligned_cols=220 Identities=26% Similarity=0.457 Sum_probs=158.7
Q ss_pred CcceeeeecccccceEEEEEEcCCCCEEEEEeccccc--------hhhHHHHHHHHhhCCCcccccccccc---------
Q psy11767 117 DLDKAGILGDGSYSVCRRCVEKSTGQEYAVKIISRKI--------DCSEEINLLRACQGHPNICRRCVEKS--------- 179 (966)
Q Consensus 117 df~~~~~LG~GsFGkV~La~~k~tg~~yAiKvl~K~~--------~~~~E~~il~~~~~~pfi~~~~~~~~--------- 179 (966)
||++++.||+|+||+|++|+++.+++.||||+++|.. ...+|+.+|... +||+|+.....+.
T Consensus 2 ~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~-~~~~i~~~~~~~~~~~~~~lv~ 80 (331)
T cd05597 2 DFEILKVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDVLVNG-DRRWITNLHYAFQDENNLYLVM 80 (331)
T ss_pred CceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhC-CCCCCCceEEEEecCCeEEEEE
Confidence 6899999999999999999999999999999998732 235678887775 7999975211111
Q ss_pred ----------------------cchhHHHHHHHhh----------cccchhhhHhhhccCCceEEecCcccc--------
Q psy11767 180 ----------------------TGQEYAVKIISRK----------IDCSEEINLLRACQGHPNIVNLHCVFQ-------- 219 (966)
Q Consensus 180 ----------------------~~~~~~~~~v~~~----------~~~~~e~nil~~~~gh~~iv~l~~~~~-------- 219 (966)
....+..+++.+. .|++++ |||.+.+|+++|+||+.+..
T Consensus 81 e~~~g~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~-Nill~~~~~~kl~Dfg~~~~~~~~~~~~ 159 (331)
T cd05597 81 DYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVLAIDSVHQLGYVHRDIKPD-NVLLDKNGHIRLADFGSCLRLLADGTVQ 159 (331)
T ss_pred ecCCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEECCCCHH-HEEECCCCCEEEEECCceeecCCCCCcc
Confidence 1111222222220 134434 99999999999999986521
Q ss_pred ------------cccccc-----ccCCCcceeeechhhHHHHHHHhhCCCCCCCCcHHHHHHHHHhCC--CCCCC---CC
Q psy11767 220 ------------DEVIDW-----DDFSRGIECVFFSSSLIIFFIILSFTLSFIHDYYHIQYRRILKTE--PPIPE---DL 277 (966)
Q Consensus 220 ------------~e~i~~-----~~y~~~~d~~~~~~~~il~~~m~~g~~pf~~~~~~~~~~~I~~~~--~~~P~---~~ 277 (966)
+|++.. ..|+.. .|.| +.|+++|+|++|.+||...+....+.+|+... +.+|. .+
T Consensus 160 ~~~~~gt~~y~aPE~~~~~~~~~~~~~~~--~Diw-slG~~l~el~~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 236 (331)
T cd05597 160 SNVAVGTPDYISPEILQAMEDGKGRYGPE--CDWW-SLGVCMYEMLYGETPFYAESLVETYGKIMNHKEHFQFPPDVTDV 236 (331)
T ss_pred ccceeccccccCHHHHhhccccccCCCCc--ceee-hhhhHHHHHhhCCCCCCCCCHHHHHHHHHcCCCcccCCCccCCC
Confidence 223321 123323 3334 56778888889999999988888899998654 34443 47
Q ss_pred CHHHHHHHHhhcccCCCcccCCCCCCHHHHhcCCceeeeCccccccCCCCCCCCccccccccccccccc
Q psy11767 278 SPDVADFISRLLVKDPRRRLGGGELDAEELKRHPFFNVIDWDDLATKRIPAPFVPKISNELDVSNFSDE 346 (966)
Q Consensus 278 s~~a~dli~~LL~kdp~~RLG~~~~g~~~Ik~HpfF~~idW~~l~~k~~~pP~~P~i~~~~D~snFd~e 346 (966)
++++++||++||+. |.+|.+. .++++++.||||.+++|+.+.. ..+|+.|......+.++|+..
T Consensus 237 ~~~~~~li~~ll~~-~~~r~~r--~~~~~~l~hp~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~ 300 (331)
T cd05597 237 SEEAKDLIRRLICS-PETRLGR--NGLQDFKDHPFFEGIDWDNIRN--STAPYVPEVSSPTDTSNFDVD 300 (331)
T ss_pred CHHHHHHHHHHccC-cccccCC--CCHHHHhcCCCCCCCCHHHHhh--CCCCccCcCCCcchhhhcCCc
Confidence 99999999999985 6677653 3689999999999999999854 567899998888888888754
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, |
| >PRK10345 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.83 E-value=4.7e-20 Score=194.21 Aligned_cols=135 Identities=19% Similarity=0.264 Sum_probs=107.8
Q ss_pred cccccccccccccEEEEEEEcCCCcEEEEEEeccc-----cChHHHHHHHHHhc----CCCCceEEEEEEEeCC---eEE
Q psy11767 380 LDKAGILGDGSYSVCRRCVEKSTGQEYAVKIISRK-----IDCSEEINLLRACQ----GHPNIVNLHCVFQDEV---HTY 447 (966)
Q Consensus 380 ~~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~-----~~~~~Ei~iL~~l~----~HpnIV~l~~~~~~~~---~~~ 447 (966)
......||+|+||.||. |+.++.. +||++... ....+|+++|+.+. .||||++++++++++. .++
T Consensus 4 L~~~~~LG~G~~~~Vy~--hp~~~~k-~IKv~~~~~~~~~~~~~rEi~~l~~L~~~~~~h~nIvr~yg~~et~~g~g~v~ 80 (210)
T PRK10345 4 LSEQSPLGTGRHRKCYA--HPEDAQR-CIKIVYHRGDGGDKEIRRELKYYAHLSRRLIDWSGIPRYYGTVETDCGTGYVY 80 (210)
T ss_pred cCCcceecCCCceEEEE--CCCCcCe-EEEEEeccccchHHHHHHHHHHHHHhhccCCCCcccceeeEEEEeCCCCeEEE
Confidence 34467899999999995 8888776 69988643 23568999999884 4899999999999874 434
Q ss_pred -EEEEc--cCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHH-HHHHhcCceeccCCCCcEEEecC--CCCCEEEEeecc
Q psy11767 448 -LVLEL--LKGGELLDRIRQKGRCGFTENEASRIMRQLVAAV-HFMHSRGVVHRDLKPENLLFSDP--AGDNIKVVDFGF 521 (966)
Q Consensus 448 -lVmEy--~~gg~L~~~l~~~~~~~l~e~~~~~i~~Qil~aL-~yLHs~~IiHRDLKP~NILl~~~--~~~~iKL~DFGl 521 (966)
+|||| +.+|+|.+++.+. .+++. ..++.|++.++ +|||+++|+||||||+|||++.. .+..++|+|||.
T Consensus 81 ~~I~e~~G~~~~tL~~~l~~~---~~~e~--~~~~~~~L~~l~~yLh~~~IvhrDlKp~NILl~~~~~~~~~~~LiDg~G 155 (210)
T PRK10345 81 DVIADFDGKPSITLTEFAEQC---RYEED--VAQLRQLLKKLKRYLLDNRIVTMELKPQNILCQRISESEVIPVVCDNIG 155 (210)
T ss_pred EEEecCCCCcchhHHHHHHcc---cccHh--HHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEeccCCCCCcEEEEECCC
Confidence 78999 5679999999653 36666 36688888888 99999999999999999999742 234799999554
Q ss_pred c
Q psy11767 522 A 522 (966)
Q Consensus 522 a 522 (966)
+
T Consensus 156 ~ 156 (210)
T PRK10345 156 E 156 (210)
T ss_pred C
Confidence 3
|
|
| >KOG0032|consensus | Back alignment and domain information |
|---|
Probab=99.82 E-value=4.6e-20 Score=210.54 Aligned_cols=193 Identities=28% Similarity=0.424 Sum_probs=151.9
Q ss_pred ccCCcceeeeecccccceEEEEEEcCCCCEEEEEeccccc--------hhhHHHHHHHHhhCCCcccccccccccch---
Q psy11767 114 YDMDLDKAGILGDGSYSVCRRCVEKSTGQEYAVKIISRKI--------DCSEEINLLRACQGHPNICRRCVEKSTGQ--- 182 (966)
Q Consensus 114 ~~~df~~~~~LG~GsFGkV~La~~k~tg~~yAiKvl~K~~--------~~~~E~~il~~~~~~pfi~~~~~~~~~~~--- 182 (966)
..--|++.+.||+|.||.|++|+++.||+.||+|+++|.. .+.+|..||+++..||+||.....+.+..
T Consensus 33 ~~~~Y~l~~~lG~G~Fg~v~~~~~~~tg~~~A~K~i~k~~~~~~~~~~~v~~Ev~il~~l~~hpniv~l~~~~e~~~~~~ 112 (382)
T KOG0032|consen 33 IKEKYELGRELGRGQFGVVYLCREKSTGKEVACKVIPKRKLRGKEDREDVRREVAILQQLSGHPNIVQLKDAFEDPDSVY 112 (382)
T ss_pred ccccEEehhhhCCCCceEEEEEEecCCCceeEEEEeehhhccccccHHHHHHHHHHHHhccCCCCEEEEEEEEEcCCeEE
Confidence 3345688899999999999999999999999999999852 46889999999989999987333322221
Q ss_pred --------------------------hHHHHHHHh----------hcccchhhhHhhhcc----CCceEEecCcccc---
Q psy11767 183 --------------------------EYAVKIISR----------KIDCSEEINLLRACQ----GHPNIVNLHCVFQ--- 219 (966)
Q Consensus 183 --------------------------~~~~~~v~~----------~~~~~~e~nil~~~~----gh~~iv~l~~~~~--- 219 (966)
....+++.+ ..|+++| |+|.... +..+++||+.+..
T Consensus 113 lvmEL~~GGeLfd~i~~~~~sE~da~~~~~~il~av~~lH~~gvvHrDlKpE-N~L~~~~~~~~~~ik~~DFGla~~~~~ 191 (382)
T KOG0032|consen 113 LVMELCEGGELFDRIVKKHYSERDAAGIIRQILEAVKYLHSLGVVHRDLKPE-NLLLASKDEGSGRIKLIDFGLAKFIKP 191 (382)
T ss_pred EEEEecCCchHHHHHHHccCCHHHHHHHHHHHHHHHHHHHhCCceeccCCHH-HeeeccccCCCCcEEEeeCCCceEccC
Confidence 111111111 1255666 8887543 4689999987642
Q ss_pred ---------------ccccccccCCCcceeeechhhHHHHHHHhhCCCCCCCCcHHHHHHHHHhCCCCCCC----CCCHH
Q psy11767 220 ---------------DEVIDWDDFSRGIECVFFSSSLIIFFIILSFTLSFIHDYYHIQYRRILKTEPPIPE----DLSPD 280 (966)
Q Consensus 220 ---------------~e~i~~~~y~~~~d~~~~~~~~il~~~m~~g~~pf~~~~~~~~~~~I~~~~~~~P~----~~s~~ 280 (966)
+|++....|+..+|+| +.|+++|.|++|.+||.......++.+|+.+++.|+. .+|..
T Consensus 192 ~~~~~~~~Gtp~y~APEvl~~~~y~~~~DiW---S~Gvi~yiLL~G~~PF~~~~~~~~~~~i~~~~~~f~~~~w~~is~~ 268 (382)
T KOG0032|consen 192 GERLHTIVGTPEYVAPEVLGGRPYGDEVDVW---SIGVILYILLSGVPPFWGETEFEIFLAILRGDFDFTSEPWDDISES 268 (382)
T ss_pred CceEeeecCCccccCchhhcCCCCCcccchh---HHHHHHHHHhhCCCCCcCCChhHHHHHHHcCCCCCCCCCccccCHH
Confidence 5677778898888754 7788889999999999999999999999999887764 57999
Q ss_pred HHHHHHhhcccCCCcccCCCCCCHHHHhcCCceee
Q psy11767 281 VADFISRLLVKDPRRRLGGGELDAEELKRHPFFNV 315 (966)
Q Consensus 281 a~dli~~LL~kdp~~RLG~~~~g~~~Ik~HpfF~~ 315 (966)
|+|||++||++||.+|+. +.++..|||.++
T Consensus 269 akd~i~~ll~~dp~~R~t-----a~~~L~HpWi~~ 298 (382)
T KOG0032|consen 269 AKDFIRKLLEFDPRKRLT-----AAQALQHPWIKS 298 (382)
T ss_pred HHHHHHHhcccCcccCCC-----HHHHhcCccccC
Confidence 999999999999999995 789999999543
|
|
| >KOG0611|consensus | Back alignment and domain information |
|---|
Probab=99.82 E-value=1.7e-20 Score=203.50 Aligned_cols=190 Identities=22% Similarity=0.381 Sum_probs=156.1
Q ss_pred CcceeeeecccccceEEEEEEcCCCCEEEEEeccccc--------hhhHHHHHHHHhhCCCcccc---------------
Q psy11767 117 DLDKAGILGDGSYSVCRRCVEKSTGQEYAVKIISRKI--------DCSEEINLLRACQGHPNICR--------------- 173 (966)
Q Consensus 117 df~~~~~LG~GsFGkV~La~~k~tg~~yAiKvl~K~~--------~~~~E~~il~~~~~~pfi~~--------------- 173 (966)
.|++.++||+|+||||.+|.+...|+.+|||.|+|.. ++.+|++||..+ +||.|+.
T Consensus 54 RyE~~etLGkGTYGKVk~A~e~~sgR~VAiKsIrKdkIkdeqDlvhIRREIeIMSsL-NHPhII~IyEVFENkdKIvivM 132 (668)
T KOG0611|consen 54 RYEITETLGKGTYGKVKLAYEHKSGREVAIKSIRKDKIKDEQDLVHIRREIEIMSSL-NHPHIIQIYEVFENKDKIVIVM 132 (668)
T ss_pred HHHHHHHhcCCcccceeehhhccCCcEeehhhhhhhhcccHHHHHHHHHHHHHHhhc-CCCceeehhhhhcCCceEEEEE
Confidence 6799999999999999999999999999999999863 678999999988 6999975
Q ss_pred ---------------cccccccchhHHHHHHHh----------hcccchhhhHhhhccCCceEEecCccc----------
Q psy11767 174 ---------------RCVEKSTGQEYAVKIISR----------KIDCSEEINLLRACQGHPNIVNLHCVF---------- 218 (966)
Q Consensus 174 ---------------~~~~~~~~~~~~~~~v~~----------~~~~~~e~nil~~~~gh~~iv~l~~~~---------- 218 (966)
+.+.+..++.++.+|+++ ..|++.| |||+|.++..+|.||+++-
T Consensus 133 EYaS~GeLYDYiSer~~LsErEaRhfFRQIvSAVhYCHknrVvHRDLKLE-NILLD~N~NiKIADFGLSNly~~~kfLqT 211 (668)
T KOG0611|consen 133 EYASGGELYDYISERGSLSEREARHFFRQIVSAVHYCHKNRVVHRDLKLE-NILLDQNNNIKIADFGLSNLYADKKFLQT 211 (668)
T ss_pred EecCCccHHHHHHHhccccHHHHHHHHHHHHHHHHHHhhccceecccchh-heeecCCCCeeeeccchhhhhccccHHHH
Confidence 233333445555566655 1255556 9999999999999998652
Q ss_pred --------cccccccccCCCcceeeechhhHHHHHHHhhCCCCCCCCcHHHHHHHHHhCCCCCCCCCCHHHHHHHHhhcc
Q psy11767 219 --------QDEVIDWDDFSRGIECVFFSSSLIIFFIILSFTLSFIHDYYHIQYRRILKTEPPIPEDLSPDVADFISRLLV 290 (966)
Q Consensus 219 --------~~e~i~~~~y~~~~d~~~~~~~~il~~~m~~g~~pf~~~~~~~~~~~I~~~~~~~P~~~s~~a~dli~~LL~ 290 (966)
-+|++..+.| .|-+.+.| ++|||+|-|+.|..||...|...|.+.|-+|.+.-|+. ..+|.-||+.+|.
T Consensus 212 FCGSPLYASPEIvNG~PY-~GPEVDsW-sLGvLLYtLVyGtMPFDG~Dhk~lvrQIs~GaYrEP~~-PSdA~gLIRwmLm 288 (668)
T KOG0611|consen 212 FCGSPLYASPEIVNGTPY-KGPEVDSW-SLGVLLYTLVYGTMPFDGRDHKRLVRQISRGAYREPET-PSDASGLIRWMLM 288 (668)
T ss_pred hcCCcccCCccccCCCCC-CCCccchh-hHHHHHHHHhhcccccCCchHHHHHHHhhcccccCCCC-CchHHHHHHHHHh
Confidence 2578888888 36565555 57899999999999999999999999999999988876 4589999999999
Q ss_pred cCCCcccCCCCCCHHHHhcCCceeeeCcc
Q psy11767 291 KDPRRRLGGGELDAEELKRHPFFNVIDWD 319 (966)
Q Consensus 291 kdp~~RLG~~~~g~~~Ik~HpfF~~idW~ 319 (966)
.||.+|- ..+||.+|=| +||.
T Consensus 289 VNP~RRA-----TieDiAsHWW---vNwg 309 (668)
T KOG0611|consen 289 VNPERRA-----TIEDIASHWW---VNWG 309 (668)
T ss_pred cCcccch-----hHHHHhhhhe---eecc
Confidence 9999996 4899999966 4674
|
|
| >cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Probab=99.82 E-value=8.5e-20 Score=201.24 Aligned_cols=212 Identities=24% Similarity=0.381 Sum_probs=151.8
Q ss_pred CcceeeeecccccceEEEEEEcCCCCEEEEEeccccc--------hhhHHHHHHHHhhCCCccccccccccc--------
Q psy11767 117 DLDKAGILGDGSYSVCRRCVEKSTGQEYAVKIISRKI--------DCSEEINLLRACQGHPNICRRCVEKST-------- 180 (966)
Q Consensus 117 df~~~~~LG~GsFGkV~La~~k~tg~~yAiKvl~K~~--------~~~~E~~il~~~~~~pfi~~~~~~~~~-------- 180 (966)
.|+..++||+|+||.|++|..+.|++.||+|.+++.. ....|..+|+++ +||+++.....+..
T Consensus 1 ~f~~~~~ig~G~~g~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l-~~~~i~~~~~~~~~~~~~~lv~ 79 (285)
T cd05630 1 TFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKV-NSRFVVSLAYAYETKDALCLVL 79 (285)
T ss_pred CceeeEEeecCCCeEEEEEEEcCCCceEEEEEEehhhccchHHHHHHHHHHHHHHhC-CCCCeeeeeEEEecCCEEEEEE
Confidence 4788999999999999999999999999999987642 235688898887 68998752111100
Q ss_pred ------------------------chhHHHHHHHhh----------cccchhhhHhhhccCCceEEecCcccc-------
Q psy11767 181 ------------------------GQEYAVKIISRK----------IDCSEEINLLRACQGHPNIVNLHCVFQ------- 219 (966)
Q Consensus 181 ------------------------~~~~~~~~v~~~----------~~~~~e~nil~~~~gh~~iv~l~~~~~------- 219 (966)
...++.+++.+. .|++ ..|+|.+..|..+|+||+.+..
T Consensus 80 e~~~g~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~iiH~dik-p~Nil~~~~~~~~l~Dfg~~~~~~~~~~~ 158 (285)
T cd05630 80 TLMNGGDLKFHIYHMGEAGFEEGRAVFYAAEICCGLEDLHQERIVYRDLK-PENILLDDHGHIRISDLGLAVHVPEGQTI 158 (285)
T ss_pred EecCCCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCCC-HHHEEECCCCCEEEeeccceeecCCCccc
Confidence 011111222210 1233 3489998889999999886532
Q ss_pred -----------ccccccccCCCcceeeechhhHHHHHHHhhCCCCCCCCcHH---HHHHHH-HhCCCCCCCCCCHHHHHH
Q psy11767 220 -----------DEVIDWDDFSRGIECVFFSSSLIIFFIILSFTLSFIHDYYH---IQYRRI-LKTEPPIPEDLSPDVADF 284 (966)
Q Consensus 220 -----------~e~i~~~~y~~~~d~~~~~~~~il~~~m~~g~~pf~~~~~~---~~~~~I-~~~~~~~P~~~s~~a~dl 284 (966)
+|++....|+...| .| +.|+++|+|++|.+||...... .....+ ......+|..+++++++|
T Consensus 159 ~~~~g~~~y~aPE~~~~~~~~~~~D--iw-slG~~l~~l~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 235 (285)
T cd05630 159 KGRVGTVGYMAPEVVKNERYTFSPD--WW-ALGCLLYEMIAGQSPFQQRKKKIKREEVERLVKEVQEEYSEKFSPDARSL 235 (285)
T ss_pred cCCCCCccccChHHHcCCCCCCccc--cH-HHHHHHHHHHhCCCCCCCCCccchHHHHHhhhhhhhhhcCccCCHHHHHH
Confidence 34444444544434 44 4567777888899999864321 112222 223456788999999999
Q ss_pred HHhhcccCCCcccCCCCCCHHHHhcCCceeeeCccccccCCCCCCCCcc
Q psy11767 285 ISRLLVKDPRRRLGGGELDAEELKRHPFFNVIDWDDLATKRIPAPFVPK 333 (966)
Q Consensus 285 i~~LL~kdp~~RLG~~~~g~~~Ik~HpfF~~idW~~l~~k~~~pP~~P~ 333 (966)
|+++|+.||.+|++....+++++.+||||+.++|+.+...+.+|||.|.
T Consensus 236 i~~~l~~~p~~R~s~~~~~~~~~~~h~~~~~~~~~~~~~~~~~~~~~~~ 284 (285)
T cd05630 236 CKMLLCKDPKERLGCQGGGAREVKEHPLFKQINFKRLEAGMLEPPFKPD 284 (285)
T ss_pred HHHHhhcCHHHccCCCCCchHHHHcChhhhccCHHHHhcCCCCCCCCCC
Confidence 9999999999999865457999999999999999999999999999986
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as |
| >KOG0581|consensus | Back alignment and domain information |
|---|
Probab=99.82 E-value=4.4e-20 Score=201.03 Aligned_cols=190 Identities=26% Similarity=0.398 Sum_probs=148.7
Q ss_pred CcceeeeecccccceEEEEEEcCCCCEEEEEeccc------cchhhHHHHHHHHhhCCCcccccccccccch-------h
Q psy11767 117 DLDKAGILGDGSYSVCRRCVEKSTGQEYAVKIISR------KIDCSEEINLLRACQGHPNICRRCVEKSTGQ-------E 183 (966)
Q Consensus 117 df~~~~~LG~GsFGkV~La~~k~tg~~yAiKvl~K------~~~~~~E~~il~~~~~~pfi~~~~~~~~~~~-------~ 183 (966)
|++.+++||+|+.|.|++|+||.|+++||+|+|.- +..+.+|..||+.+ +||+||.-+-.|.... +
T Consensus 80 dle~~~~lG~G~gG~V~kv~Hk~t~~i~AlK~I~~~~~~~~~~Qi~rEl~il~~~-~spyIV~~ygaF~~~~~~isI~mE 158 (364)
T KOG0581|consen 80 DLERLGVLGSGNGGTVYKVRHKPTGKIYALKVILLNIDPALQKQILRELEILRSC-QSPYIVGFYGAFYSNGEEISICME 158 (364)
T ss_pred HhhhhhhcccCCCcEEEEEEEcCCCeEEEEEeecccCCHHHHHHHHHHHHHHhhC-CCCCeeeEeEEEEeCCceEEeehh
Confidence 89999999999999999999999999999999932 24679999999999 8999998443333221 1
Q ss_pred HH------------------------HHHH------Hh--h---cccchhhhHhhhccCCceEEecCccc----------
Q psy11767 184 YA------------------------VKII------SR--K---IDCSEEINLLRACQGHPNIVNLHCVF---------- 218 (966)
Q Consensus 184 ~~------------------------~~~v------~~--~---~~~~~e~nil~~~~gh~~iv~l~~~~---------- 218 (966)
|. ..++ .. . .|.+ ..|||....|.+||+||+-+.
T Consensus 159 YMDgGSLd~~~k~~g~i~E~~L~~ia~~VL~GL~YLh~~~~IIHRDIK-PsNlLvNskGeVKicDFGVS~~lvnS~a~tf 237 (364)
T KOG0581|consen 159 YMDGGSLDDILKRVGRIPEPVLGKIARAVLRGLSYLHEERKIIHRDIK-PSNLLVNSKGEVKICDFGVSGILVNSIANTF 237 (364)
T ss_pred hcCCCCHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhccCeeeccCC-HHHeeeccCCCEEeccccccHHhhhhhcccc
Confidence 11 0111 10 0 1333 349999999999999998442
Q ss_pred -------cccccccccCCCcceeeechhhHHHHHHHhhCCCCCCCC-----cHHHHHHHHHh-CCCCCCCC-CCHHHHHH
Q psy11767 219 -------QDEVIDWDDFSRGIECVFFSSSLIIFFIILSFTLSFIHD-----YYHIQYRRILK-TEPPIPED-LSPDVADF 284 (966)
Q Consensus 219 -------~~e~i~~~~y~~~~d~~~~~~~~il~~~m~~g~~pf~~~-----~~~~~~~~I~~-~~~~~P~~-~s~~a~dl 284 (966)
.+|-|+...|+...| .| ++|+.+.||+.|..||... ++.+++..|++ ..|..|.. ||++.++|
T Consensus 238 vGT~~YMsPERi~g~~Ys~~sD--IW-SLGLsllE~a~GrfP~~~~~~~~~~~~~Ll~~Iv~~ppP~lP~~~fS~ef~~F 314 (364)
T KOG0581|consen 238 VGTSAYMSPERISGESYSVKSD--IW-SLGLSLLELAIGRFPYPPPNPPYLDIFELLCAIVDEPPPRLPEGEFSPEFRSF 314 (364)
T ss_pred cccccccChhhhcCCcCCcccc--ee-cccHHHHHHhhCCCCCCCcCCCCCCHHHHHHHHhcCCCCCCCcccCCHHHHHH
Confidence 367788888876655 44 4567777888888888764 77889999998 56789997 99999999
Q ss_pred HHhhcccCCCcccCCCCCCHHHHhcCCceeee
Q psy11767 285 ISRLLVKDPRRRLGGGELDAEELKRHPFFNVI 316 (966)
Q Consensus 285 i~~LL~kdp~~RLG~~~~g~~~Ik~HpfF~~i 316 (966)
|..+|+|||.+|- +++++.+|||++..
T Consensus 315 V~~CL~Kdp~~R~-----s~~qLl~Hpfi~~~ 341 (364)
T KOG0581|consen 315 VSCCLRKDPSERP-----SAKQLLQHPFIKKF 341 (364)
T ss_pred HHHHhcCCcccCC-----CHHHHhcCHHHhhc
Confidence 9999999999996 58999999999743
|
|
| >cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Probab=99.81 E-value=1.3e-19 Score=198.74 Aligned_cols=204 Identities=24% Similarity=0.384 Sum_probs=147.9
Q ss_pred ecccccceEEEEEEcCCCCEEEEEeccccc--------hhhHHHHHHHHhhCCCcccccccccccc--------------
Q psy11767 124 LGDGSYSVCRRCVEKSTGQEYAVKIISRKI--------DCSEEINLLRACQGHPNICRRCVEKSTG-------------- 181 (966)
Q Consensus 124 LG~GsFGkV~La~~k~tg~~yAiKvl~K~~--------~~~~E~~il~~~~~~pfi~~~~~~~~~~-------------- 181 (966)
||+|+||.|++|+.+.+|+.||+|.+++.. ....|.++|+++ +||+|+.....+...
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~il~~l-~hp~i~~~~~~~~~~~~~~lv~e~~~g~~ 79 (277)
T cd05607 1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKV-NSPFIVNLAYAFESKTHLCLVMSLMNGGD 79 (277)
T ss_pred CCCCCceEEEEEEEccCCcEEEEEEEcHHHhhcchhhHHHHHHHHHHHhc-CCCcEEEEEEEEecCCeEEEEEecCCCCC
Confidence 799999999999999999999999997531 234589999998 799998622111111
Q ss_pred ------------------hhHHHHHHHhh----------cccchhhhHhhhccCCceEEecCcccc--------------
Q psy11767 182 ------------------QEYAVKIISRK----------IDCSEEINLLRACQGHPNIVNLHCVFQ-------------- 219 (966)
Q Consensus 182 ------------------~~~~~~~v~~~----------~~~~~e~nil~~~~gh~~iv~l~~~~~-------------- 219 (966)
..++.+++.+. .+++ ..|||.+.++.++|+||+.+..
T Consensus 80 L~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dik-p~Nili~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~ 158 (277)
T cd05607 80 LKYHIYNVGERGLEMERVIHYSAQITCGILHLHSMDIVYRDMK-PENVLLDDQGNCRLSDLGLAVELKDGKTITQRAGTN 158 (277)
T ss_pred HHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHHCCEEEccCC-hHhEEEcCCCCEEEeeceeeeecCCCceeeccCCCC
Confidence 01111222110 1333 3389998889999999886531
Q ss_pred ----ccccccccCCCcceeeechhhHHHHHHHhhCCCCCCCC----cHHHHHHHHHhCCCCCC-CCCCHHHHHHHHhhcc
Q psy11767 220 ----DEVIDWDDFSRGIECVFFSSSLIIFFIILSFTLSFIHD----YYHIQYRRILKTEPPIP-EDLSPDVADFISRLLV 290 (966)
Q Consensus 220 ----~e~i~~~~y~~~~d~~~~~~~~il~~~m~~g~~pf~~~----~~~~~~~~I~~~~~~~P-~~~s~~a~dli~~LL~ 290 (966)
+|++....|+...| .| +.|+++|+|++|.+||... +...+.++++...+.++ ..++++++|||+++|+
T Consensus 159 ~y~aPE~~~~~~~~~~~D--vw-slGv~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~ 235 (277)
T cd05607 159 GYMAPEILKEEPYSYPVD--WF-AMGCSIYEMVAGRTPFKDHKEKVAKEELKRRTLEDEVKFEHQNFTEESKDICRLFLA 235 (277)
T ss_pred CccCHHHHccCCCCCchh--HH-HHHHHHHHHHhCCCCCCCCcchhhHHHHHHHhhccccccccccCCHHHHHHHHHHhc
Confidence 23343344444444 34 5568888888899998653 33456777787777665 4689999999999999
Q ss_pred cCCCcccCCCCCCHHHHhcCCceeeeCccccccCCCCCCCCcc
Q psy11767 291 KDPRRRLGGGELDAEELKRHPFFNVIDWDDLATKRIPAPFVPK 333 (966)
Q Consensus 291 kdp~~RLG~~~~g~~~Ik~HpfF~~idW~~l~~k~~~pP~~P~ 333 (966)
+||.+|.++.. ..++++.||||+++||..+..+.++|||.|.
T Consensus 236 ~~P~~R~~~~~-~~~~~~~h~~f~~~~~~~~~~~~~~~~~~~~ 277 (277)
T cd05607 236 KKPEDRLGSRE-KNDDPRKHEFFKTINFPRLEAGLIPPPFVPD 277 (277)
T ss_pred cCHhhCCCCcc-chhhhhcChhhcCCCHHHHhcCcCCCCCCCC
Confidence 99999998632 2478999999999999999999999999774
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr |
| >cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Probab=99.81 E-value=2.1e-19 Score=198.00 Aligned_cols=211 Identities=26% Similarity=0.386 Sum_probs=156.7
Q ss_pred cceeeeecccccceEEEEEEcCCCCEEEEEeccccc--------hhhHHHHHHHHhhCCCcccccccccccc--------
Q psy11767 118 LDKAGILGDGSYSVCRRCVEKSTGQEYAVKIISRKI--------DCSEEINLLRACQGHPNICRRCVEKSTG-------- 181 (966)
Q Consensus 118 f~~~~~LG~GsFGkV~La~~k~tg~~yAiKvl~K~~--------~~~~E~~il~~~~~~pfi~~~~~~~~~~-------- 181 (966)
|...++||+|+||+|++|+.+.+|+.||+|++++.. ...+|..+|+++ +||+|+.....+...
T Consensus 2 ~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l-~~~~i~~~~~~~~~~~~~~lv~e 80 (285)
T cd05632 2 FRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKV-NSQFVVNLAYAYETKDALCLVLT 80 (285)
T ss_pred ceEEEEEecCCCeEEEEEEECCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHHc-CCcCceeEEEEEecCCEEEEEEE
Confidence 678899999999999999999999999999998642 235688999887 689987521111100
Q ss_pred ------------------------hhHHHHHHHhh----------cccchhhhHhhhccCCceEEecCcccc--------
Q psy11767 182 ------------------------QEYAVKIISRK----------IDCSEEINLLRACQGHPNIVNLHCVFQ-------- 219 (966)
Q Consensus 182 ------------------------~~~~~~~v~~~----------~~~~~e~nil~~~~gh~~iv~l~~~~~-------- 219 (966)
...+.+++.+. .|++ ..|+|.+.++.++|+||+.+..
T Consensus 81 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~iiH~dik-p~Nili~~~~~~kl~Dfg~~~~~~~~~~~~ 159 (285)
T cd05632 81 IMNGGDLKFHIYNMGNPGFEEERALFYAAEILCGLEDLHRENTVYRDLK-PENILLDDYGHIRISDLGLAVKIPEGESIR 159 (285)
T ss_pred eccCccHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCC-HHHEEECCCCCEEEecCCcceecCCCCccc
Confidence 11111222110 1233 3488888889999999886632
Q ss_pred ----------ccccccccCCCcceeeechhhHHHHHHHhhCCCCCCCCcHH----HHHHHHHhCCCCCCCCCCHHHHHHH
Q psy11767 220 ----------DEVIDWDDFSRGIECVFFSSSLIIFFIILSFTLSFIHDYYH----IQYRRILKTEPPIPEDLSPDVADFI 285 (966)
Q Consensus 220 ----------~e~i~~~~y~~~~d~~~~~~~~il~~~m~~g~~pf~~~~~~----~~~~~I~~~~~~~P~~~s~~a~dli 285 (966)
+|++....|+... |.| +.|+++|+|++|.+||...... .+..++......++..+++++.+||
T Consensus 160 ~~~g~~~~~aPE~~~~~~~~~~~--Di~-slG~~l~~l~~g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li 236 (285)
T cd05632 160 GRVGTVGYMAPEVLNNQRYTLSP--DYW-GLGCLIYEMIEGQSPFRGRKEKVKREEVDRRVLETEEVYSAKFSEEAKSIC 236 (285)
T ss_pred CCCCCcCccChHHhcCCCCCccc--chH-HHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhhccccccCccCCHHHHHHH
Confidence 3344444444333 344 4567778888899999875543 3455566677788999999999999
Q ss_pred HhhcccCCCcccCCCCCCHHHHhcCCceeeeCccccccCCCCCCCCcc
Q psy11767 286 SRLLVKDPRRRLGGGELDAEELKRHPFFNVIDWDDLATKRIPAPFVPK 333 (966)
Q Consensus 286 ~~LL~kdp~~RLG~~~~g~~~Ik~HpfF~~idW~~l~~k~~~pP~~P~ 333 (966)
.++|++||.+|.++...++++++.|+||+.++|+.+..+++.|||.|.
T Consensus 237 ~~~l~~~P~~R~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~ 284 (285)
T cd05632 237 KMLLTKDPKQRLGCQEEGAGEVKRHPFFRNMNFKRLEAGMLDPPFVPD 284 (285)
T ss_pred HHHccCCHhHcCCCcccChHHHHcChhhhcCCHHHHhcCcCCCCCCCC
Confidence 999999999999987778999999999999999999999999999986
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with |
| >PRK12274 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.80 E-value=5.8e-19 Score=183.58 Aligned_cols=178 Identities=19% Similarity=0.174 Sum_probs=132.7
Q ss_pred ccccccccccEEEEEEEcCCCcEEEEEEecccc---------ChHHHHHHHHHhcCCCCceEEEEEEEeCCeEEEEEEcc
Q psy11767 383 AGILGDGSYSVCRRCVEKSTGQEYAVKIISRKI---------DCSEEINLLRACQGHPNIVNLHCVFQDEVHTYLVLELL 453 (966)
Q Consensus 383 ~~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~---------~~~~Ei~iL~~l~~HpnIV~l~~~~~~~~~~~lVmEy~ 453 (966)
...||+|+||+|+.+.. .+..++.+.+...- .+.+|+++|+.+.+|++|++++++ ...|++|||+
T Consensus 7 ~~~l~~~~f~~v~~~~~--~~~k~~~~~l~~~~~~~~~~~~~l~~rE~~iL~~L~~~~~vP~ll~~----~~~~lvmeyI 80 (218)
T PRK12274 7 NEPLKSDTFGRILLVRG--GERKFVRRDLSAAPWWLRGVAWWLARREALALRQLDGLPRTPRLLHW----DGRHLDRSYL 80 (218)
T ss_pred ceeecCCCcceEEEeec--CCceeeecccccchhhhhhHHHHHHHHHHHHHHhcCCCCCCCEEEEE----cCEEEEEeee
Confidence 45799999999997765 57788876664321 246799999999878999999886 3469999999
Q ss_pred CCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCceeccC-CCCcEEEecCCCCCEEEEeecccccccCCCc--
Q psy11767 454 KGGELLDRIRQKGRCGFTENEASRIMRQLVAAVHFMHSRGVVHRDL-KPENLLFSDPAGDNIKVVDFGFACLKRESLH-- 530 (966)
Q Consensus 454 ~gg~L~~~l~~~~~~~l~e~~~~~i~~Qil~aL~yLHs~~IiHRDL-KP~NILl~~~~~~~iKL~DFGla~~~~~~~~-- 530 (966)
.|.+|.+.+.. . ...++.|++.+|++||++||+|||| ||+|||++. ++.++|+|||+|........
T Consensus 81 ~G~~L~~~~~~--------~-~~~~~~qi~~~L~~lH~~GIvHrDL~kp~NILv~~--~g~i~LIDFG~A~~~~~~~~~~ 149 (218)
T PRK12274 81 AGAAMYQRPPR--------G-DLAYFRAARRLLQQLHRCGVAHNDLAKEANWLVQE--DGSPAVIDFQLAVRGNPRARWM 149 (218)
T ss_pred cCccHHhhhhh--------h-hHHHHHHHHHHHHHHHHCcCccCCCCCcceEEEcC--CCCEEEEECCCceecCCcchHH
Confidence 99998654311 1 2357899999999999999999999 799999974 56899999999975432210
Q ss_pred --------------cccccccccCchhhccCCCCCCCcccchhhhhhhhhhhhcCCCCCC-CcCcchhHHHHHHHHhcCC
Q psy11767 531 --------------TPCFTLQYAAPEVLRQDKSGYDENCDLWSLGVILVNVLRQDKSGYD-ENCDLWSLGVILYTMLCGR 595 (966)
Q Consensus 531 --------------~~~gT~~Y~APEvl~~~~~~~~~~~Di~SlGvil~el~~~~~~~y~-~~~DIWSlGvilyemltG~ 595 (966)
....++.|++|+--.... .-+ ...++++.|+.+|.|+|+.
T Consensus 150 r~L~~rDl~~llk~~~~y~~~~l~~~~~~~l~-------------------------~~~~~~~~w~~~g~~~~~~~~~~ 204 (218)
T PRK12274 150 RLLAREDLRHLLKHKRMYCPAALTPVERRVLK-------------------------RTSWIRELWFATGKPVYRFVTRR 204 (218)
T ss_pred HHHHHHHHHHHHHHHHhcCCCCCCHHHHhhhc-------------------------cchhHHHHHHHhcchHHHHHhcc
Confidence 012467778877543110 011 2357888899999999999
Q ss_pred CCCCCCC
Q psy11767 596 VPFHARS 602 (966)
Q Consensus 596 ~Pf~~~~ 602 (966)
.|+.+..
T Consensus 205 ~~~~~~~ 211 (218)
T PRK12274 205 VLHWEDN 211 (218)
T ss_pred CCccccC
Confidence 9987543
|
|
| >KOG0595|consensus | Back alignment and domain information |
|---|
Probab=99.78 E-value=3.1e-19 Score=195.94 Aligned_cols=128 Identities=29% Similarity=0.417 Sum_probs=101.9
Q ss_pred cCCCCCCccccccccccCCCchhh-hh-hhhccccccccccCCCCCCCCCchhhHhhHHHHhCCcCCCcceeeeeccccC
Q psy11767 815 RKHKPDTSSQCSKSLPATHSTPAR-KK-KKADRQPAKQEEKQPVPQTTPPTDLVTLFEEQLLGPITRARRRTFVNRSRYN 892 (966)
Q Consensus 815 ~~~~~~~~~~~~~~~~~~~~~~~~-~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~l~e~~il~~l~~~~i~~~~~~~~~~ 892 (966)
.+.+-|.+.++-++.|+.+.+..+ |. .+++- .++.....+.|.++|+.|+|+||+.+++..+.+
T Consensus 16 ~~iG~GsfavVykg~h~~~~~~VAIK~i~~~~l--------------~~k~~e~L~~Ei~iLkel~H~nIV~l~d~~~~~ 81 (429)
T KOG0595|consen 16 REIGSGSFAVVYKGRHKKSGTEVAIKCIAKKKL--------------NKKLVELLLSEIKILKELKHPNIVRLLDCIEDD 81 (429)
T ss_pred hhccCcceEEEEEeEeccCCceEEeeeehhhcc--------------CHHHHHHHHHHHHHHHhcCCcceeeEEEEEecC
Confidence 335566677777776666553322 21 11110 111112225699999999999999999999999
Q ss_pred ceEEEEEeccCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCCeEeecC
Q psy11767 893 VHTYLVLELLKGGELLDRIRQKGRCGFTENEASRIMRQLVAAVHFMHSRGVVHRDLKPENLLLSGI 958 (966)
Q Consensus 893 ~~~yLVmEy~~gg~L~~~i~~~~~~~~~~~~~~~~~~qi~~al~ylH~~gIiHRDlKPeNILl~~~ 958 (966)
+++|||||||.||||.++|++++ .++|..++.++.||+.|+++||+++||||||||+||||+..
T Consensus 82 ~~i~lVMEyC~gGDLs~yi~~~~--~l~e~t~r~Fm~QLA~alq~L~~~~IiHRDLKPQNiLLs~~ 145 (429)
T KOG0595|consen 82 DFIYLVMEYCNGGDLSDYIRRRG--RLPEATARHFMQQLASALQFLHENNIIHRDLKPQNILLSTT 145 (429)
T ss_pred CeEEEEEEeCCCCCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCCeeeccCCcceEEeccC
Confidence 99999999999999999999876 48999999999999999999999999999999999999875
|
|
| >PRK10359 lipopolysaccharide core biosynthesis protein; Provisional | Back alignment and domain information |
|---|
Probab=99.78 E-value=5e-19 Score=187.55 Aligned_cols=128 Identities=15% Similarity=0.228 Sum_probs=102.8
Q ss_pred ccccccccccccEEEEEEEcCCCcEEEEEEecccc----C----------hHHHHHHHHHhcCCCCceEEEEEEEeC---
Q psy11767 381 DKAGILGDGSYSVCRRCVEKSTGQEYAVKIISRKI----D----------CSEEINLLRACQGHPNIVNLHCVFQDE--- 443 (966)
Q Consensus 381 ~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~----~----------~~~Ei~iL~~l~~HpnIV~l~~~~~~~--- 443 (966)
...++||.|+||.||++.. ++..+|||++.... . ..+|+..+..+ .||+|....+++...
T Consensus 34 ~~~~~l~~~~f~~v~l~~~--~~~~~iiKvf~~~~~~~~~~~~~f~~g~~~e~Ea~~l~rL-~~~GI~~~~d~~~~~~~~ 110 (232)
T PRK10359 34 KTIKVFRNIDDTKVSLIDT--DYGKYILKVFAPKVKRTERFLKSFVKGDYYENLIVQTDRV-RSEGLASLNDFYLLAERK 110 (232)
T ss_pred EEEEEecCCCceEEEEEec--CCCcEEEEEechhcCchHHHHHhhhhhHHHHHHHHHHHHH-HHCCCCcceEeeeecccc
Confidence 3478999999999999654 47789999986331 1 35688888888 599999999887643
Q ss_pred -----CeEEEEEEccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCcEEEecCCCCCEEEEe
Q psy11767 444 -----VHTYLVLELLKGGELLDRIRQKGRCGFTENEASRIMRQLVAAVHFMHSRGVVHRDLKPENLLFSDPAGDNIKVVD 518 (966)
Q Consensus 444 -----~~~~lVmEy~~gg~L~~~l~~~~~~~l~e~~~~~i~~Qil~aL~yLHs~~IiHRDLKP~NILl~~~~~~~iKL~D 518 (966)
+..+|||||++|.+|.+.. .+++. ...+++.+|..||+.|++||||||+|||++. ++ ++|+|
T Consensus 111 ~~~~~~~~~lvmEyi~G~tL~~~~------~~~~~----~~~~i~~~l~~lH~~gi~H~Dikp~Nili~~--~g-i~liD 177 (232)
T PRK10359 111 TLRYAHTYIMLIEYIEGVELNDMP------EISED----VKAKIKASIESLHQHGMVSGDPHKGNFIVSK--NG-LRIID 177 (232)
T ss_pred cccccCCeEEEEEEECCccHHHhh------hccHH----HHHHHHHHHHHHHHcCCccCCCChHHEEEeC--CC-EEEEE
Confidence 3579999999999997763 23332 4669999999999999999999999999974 44 99999
Q ss_pred eccccc
Q psy11767 519 FGFACL 524 (966)
Q Consensus 519 FGla~~ 524 (966)
||....
T Consensus 178 fg~~~~ 183 (232)
T PRK10359 178 LSGKRC 183 (232)
T ss_pred CCCccc
Confidence 998744
|
|
Homologous Structure Templates
Structure Templates Detected by BLAST
Original result of BLAST against Protein Data Bank
| ID | Alignment Graph | Length |
Definition |
E-value | |
| Query | 966 | ||||
| 3kn5_A | 325 | Crystal Structure Of The C-Terminal Kinase Domain O | 5e-75 | ||
| 3kn5_A | 325 | Crystal Structure Of The C-Terminal Kinase Domain O | 3e-10 | ||
| 2wnt_A | 330 | Crystal Structure Of The Human Ribosomal Protein S6 | 9e-50 | ||
| 2wnt_A | 330 | Crystal Structure Of The Human Ribosomal Protein S6 | 3e-06 | ||
| 3rny_A | 346 | Crystal Structure Of Human Rsk1 C-Terminal Kinase D | 1e-49 | ||
| 3rny_A | 346 | Crystal Structure Of Human Rsk1 C-Terminal Kinase D | 3e-06 | ||
| 2qr8_A | 342 | 2.0a X-ray Structure Of C-terminal Kinase Domain Of | 1e-49 | ||
| 2qr8_A | 342 | 2.0a X-ray Structure Of C-terminal Kinase Domain Of | 7e-06 | ||
| 2qr7_A | 342 | 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of | 3e-48 | ||
| 2qr7_A | 342 | 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of | 6e-06 | ||
| 3igo_A | 486 | Crystal Structure Of Cryptosporidium Parvum Cdpk1, | 8e-40 | ||
| 3igo_A | 486 | Crystal Structure Of Cryptosporidium Parvum Cdpk1, | 9e-07 | ||
| 2wei_A | 287 | Crystal Structure Of The Kinase Domain Of Cryptospo | 4e-39 | ||
| 2wei_A | 287 | Crystal Structure Of The Kinase Domain Of Cryptospo | 1e-06 | ||
| 3fhr_A | 336 | High Resolution Crystal Structure Of Mitogen-Activa | 4e-39 | ||
| 3fhr_A | 336 | High Resolution Crystal Structure Of Mitogen-Activa | 2e-08 | ||
| 3dfa_A | 286 | Crystal Structure Of Kinase Domain Of Calcium-depen | 4e-39 | ||
| 3dfa_A | 286 | Crystal Structure Of Kinase Domain Of Calcium-depen | 1e-06 | ||
| 3r1n_A | 317 | Mk3 Kinase Bound To Compound 5b Length = 317 | 4e-39 | ||
| 3r1n_A | 317 | Mk3 Kinase Bound To Compound 5b Length = 317 | 2e-08 | ||
| 3i79_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 2e-36 | ||
| 3i79_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 5e-07 | ||
| 3ku2_A | 507 | Crystal Structure Of Inactivated Form Of Cdpk1 From | 3e-36 | ||
| 3ku2_A | 507 | Crystal Structure Of Inactivated Form Of Cdpk1 From | 5e-07 | ||
| 3hx4_A | 508 | Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tg | 3e-36 | ||
| 3hx4_A | 508 | Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tg | 5e-07 | ||
| 3dxn_A | 287 | Crystal Structure Of The Calcium-dependent Kinase F | 3e-36 | ||
| 3dxn_A | 287 | Crystal Structure Of The Calcium-dependent Kinase F | 3e-06 | ||
| 3ma6_A | 298 | Crystal Structure Of Kinase Domain Of Tgcdpk1 In Pr | 4e-36 | ||
| 3ma6_A | 298 | Crystal Structure Of Kinase Domain Of Tgcdpk1 In Pr | 5e-07 | ||
| 2bdw_A | 362 | Crystal Structure Of The Auto-Inhibited Kinase Doma | 6e-36 | ||
| 2bdw_A | 362 | Crystal Structure Of The Auto-Inhibited Kinase Doma | 4e-05 | ||
| 3hzt_A | 467 | Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme4 | 7e-36 | ||
| 3hzt_A | 467 | Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme4 | 2e-06 | ||
| 3kl8_A | 269 | Camkiintide Inhibitor Complex Length = 269 | 1e-35 | ||
| 3kl8_A | 269 | Camkiintide Inhibitor Complex Length = 269 | 3e-05 | ||
| 3kk8_A | 284 | Camkii Substrate Complex A Length = 284 | 2e-35 | ||
| 3kk8_A | 284 | Camkii Substrate Complex A Length = 284 | 3e-05 | ||
| 3kk9_A | 282 | Camkii Substrate Complex B Length = 282 | 2e-35 | ||
| 3kk9_A | 282 | Camkii Substrate Complex B Length = 282 | 3e-05 | ||
| 2onl_C | 406 | Crystal Structure Of The P38a-Mapkap Kinase 2 Heter | 2e-34 | ||
| 2onl_C | 406 | Crystal Structure Of The P38a-Mapkap Kinase 2 Heter | 1e-07 | ||
| 1kwp_A | 400 | Crystal Structure Of Mapkap2 Length = 400 | 2e-34 | ||
| 1kwp_A | 400 | Crystal Structure Of Mapkap2 Length = 400 | 1e-07 | ||
| 2oza_A | 356 | Structure Of P38alpha Complex Length = 356 | 2e-34 | ||
| 2oza_A | 356 | Structure Of P38alpha Complex Length = 356 | 1e-07 | ||
| 3i7c_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 2e-34 | ||
| 3i7c_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 3e-06 | ||
| 2y7j_A | 365 | Structure Of Human Phosphorylase Kinase, Gamma 2 Le | 3e-34 | ||
| 2y7j_A | 365 | Structure Of Human Phosphorylase Kinase, Gamma 2 Le | 5e-06 | ||
| 3fpm_A | 325 | Crystal Structure Of A Squarate Inhibitor Bound To | 3e-34 | ||
| 3fpm_A | 325 | Crystal Structure Of A Squarate Inhibitor Bound To | 1e-07 | ||
| 2jbo_A | 326 | Protein Kinase Mk2 In Complex With An Inhibitor (Cr | 3e-34 | ||
| 2jbo_A | 326 | Protein Kinase Mk2 In Complex With An Inhibitor (Cr | 1e-07 | ||
| 3gok_A | 334 | Binding Site Mapping Of Protein Ligands Length = 33 | 3e-34 | ||
| 3gok_A | 334 | Binding Site Mapping Of Protein Ligands Length = 33 | 2e-07 | ||
| 2pzy_A | 324 | Structure Of Mk2 Complexed With Compound 76 Length | 3e-34 | ||
| 2pzy_A | 324 | Structure Of Mk2 Complexed With Compound 76 Length | 1e-07 | ||
| 3r2b_A | 318 | Mk2 Kinase Bound To Compound 5b Length = 318 | 3e-34 | ||
| 3r2b_A | 318 | Mk2 Kinase Bound To Compound 5b Length = 318 | 2e-07 | ||
| 2p3g_X | 327 | Crystal Structure Of A Pyrrolopyridine Inhibitor Bo | 3e-34 | ||
| 2p3g_X | 327 | Crystal Structure Of A Pyrrolopyridine Inhibitor Bo | 1e-07 | ||
| 3r2y_A | 319 | Mk2 Kinase Bound To Compound 1 Length = 319 | 3e-34 | ||
| 3r2y_A | 319 | Mk2 Kinase Bound To Compound 1 Length = 319 | 2e-07 | ||
| 2hw6_A | 307 | Crystal Structure Of Mnk1 Catalytic Domain Length = | 3e-34 | ||
| 2hw6_A | 307 | Crystal Structure Of Mnk1 Catalytic Domain Length = | 2e-07 | ||
| 2vz6_A | 313 | Structure Of Human Calcium Calmodulin Dependent Pro | 1e-33 | ||
| 2vz6_A | 313 | Structure Of Human Calcium Calmodulin Dependent Pro | 2e-05 | ||
| 3ka0_A | 320 | Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4 | 2e-33 | ||
| 3ka0_A | 320 | Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4 | 1e-07 | ||
| 2wel_A | 327 | Crystal Structure Of Su6656-Bound CalciumCALMODULIN | 8e-33 | ||
| 2wel_A | 327 | Crystal Structure Of Su6656-Bound CalciumCALMODULIN | 7e-05 | ||
| 3lij_A | 494 | Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) | 1e-32 | ||
| 3lij_A | 494 | Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) | 6e-06 | ||
| 2w4o_A | 349 | Crystal Structure Of Human Camk4 In Complex With 4- | 1e-32 | ||
| 2w4o_A | 349 | Crystal Structure Of Human Camk4 In Complex With 4- | 1e-06 | ||
| 2vn9_A | 301 | Crystal Structure Of Human Calcium Calmodulin Depen | 1e-32 | ||
| 2vn9_A | 301 | Crystal Structure Of Human Calcium Calmodulin Depen | 8e-05 | ||
| 1ql6_A | 298 | The Catalytic Mechanism Of Phosphorylase Kinase Pro | 2e-32 | ||
| 1ql6_A | 298 | The Catalytic Mechanism Of Phosphorylase Kinase Pro | 7e-04 | ||
| 3soa_A | 444 | Full-Length Human Camkii Length = 444 | 2e-32 | ||
| 3soa_A | 444 | Full-Length Human Camkii Length = 444 | 9e-05 | ||
| 2phk_A | 277 | The Crystal Structure Of A Phosphorylase Kinase Pep | 2e-32 | ||
| 2phk_A | 277 | The Crystal Structure Of A Phosphorylase Kinase Pep | 6e-04 | ||
| 2jc6_A | 334 | Crystal Structure Of Human Calmodulin-Dependent Pro | 3e-32 | ||
| 2jc6_A | 334 | Crystal Structure Of Human Calmodulin-Dependent Pro | 1e-08 | ||
| 1phk_A | 298 | Two Structures Of The Catalytic Domain Of Phosphory | 3e-32 | ||
| 1phk_A | 298 | Two Structures Of The Catalytic Domain Of Phosphory | 7e-04 | ||
| 3q5i_A | 504 | Crystal Structure Of Pbanka_031420 Length = 504 | 4e-32 | ||
| 3q5i_A | 504 | Crystal Structure Of Pbanka_031420 Length = 504 | 2e-05 | ||
| 1nxk_A | 400 | Crystal Structure Of Staurosporine Bound To Map Kap | 4e-32 | ||
| 1nxk_A | 400 | Crystal Structure Of Staurosporine Bound To Map Kap | 6e-07 | ||
| 2v7o_A | 336 | Crystal Structure Of Human Calcium-Calmodulin-Depen | 1e-31 | ||
| 2v7o_A | 336 | Crystal Structure Of Human Calcium-Calmodulin-Depen | 3e-04 | ||
| 2jam_A | 304 | Crystal Structure Of Human Calmodulin-Dependent Pro | 1e-31 | ||
| 2jam_A | 304 | Crystal Structure Of Human Calmodulin-Dependent Pro | 5e-08 | ||
| 3bhh_A | 295 | Crystal Structure Of Human Calcium/calmodulin-depen | 2e-31 | ||
| 3bhh_A | 295 | Crystal Structure Of Human Calcium/calmodulin-depen | 4e-05 | ||
| 1a06_A | 332 | Calmodulin-Dependent Protein Kinase From Rat Length | 5e-31 | ||
| 1a06_A | 332 | Calmodulin-Dependent Protein Kinase From Rat Length | 6e-08 | ||
| 4fg9_A | 320 | Crystal Structure Of Human Calcium/calmodulin-depen | 2e-30 | ||
| 4fg9_A | 320 | Crystal Structure Of Human Calcium/calmodulin-depen | 5e-08 | ||
| 4fg7_A | 293 | Crystal Structure Of Human Calcium/calmodulin-depen | 2e-30 | ||
| 4fg7_A | 293 | Crystal Structure Of Human Calcium/calmodulin-depen | 4e-08 | ||
| 4fg8_A | 315 | Crystal Structure Of Human Calcium/calmodulin-depen | 2e-30 | ||
| 4fg8_A | 315 | Crystal Structure Of Human Calcium/calmodulin-depen | 5e-08 | ||
| 2ac5_A | 316 | Structure Of Human Mnk2 Kinase Domain Mutant D228g | 1e-29 | ||
| 2ac5_A | 316 | Structure Of Human Mnk2 Kinase Domain Mutant D228g | 6e-05 | ||
| 2j90_A | 304 | Crystal Structure Of Human Zip Kinase In Complex Wi | 3e-29 | ||
| 2j90_A | 304 | Crystal Structure Of Human Zip Kinase In Complex Wi | 2e-05 | ||
| 1yrp_A | 278 | Catalytic Domain Of Human Zip Kinase Phosphorylated | 4e-29 | ||
| 1yrp_A | 278 | Catalytic Domain Of Human Zip Kinase Phosphorylated | 2e-05 | ||
| 3bhy_A | 283 | Crystal Structure Of Human Death Associated Protein | 4e-29 | ||
| 3bhy_A | 283 | Crystal Structure Of Human Death Associated Protein | 2e-05 | ||
| 2ac3_A | 316 | Structure Of Human Mnk2 Kinase Domain Length = 316 | 8e-29 | ||
| 2ac3_A | 316 | Structure Of Human Mnk2 Kinase Domain Length = 316 | 6e-05 | ||
| 2qg5_A | 294 | Cryptosporidium Parvum Calcium Dependent Protein Ki | 1e-28 | ||
| 2qg5_A | 294 | Cryptosporidium Parvum Calcium Dependent Protein Ki | 9e-05 | ||
| 3f3z_A | 277 | Crystal Structure Of Cryptosporidium Parvum Calcium | 1e-28 | ||
| 3f3z_A | 277 | Crystal Structure Of Cryptosporidium Parvum Calcium | 1e-04 | ||
| 1kob_A | 387 | Twitchin Kinase Fragment (Aplysia), Autoregulated P | 1e-28 | ||
| 3lm0_A | 327 | Crystal Structure Of Human SerineTHREONINE KINASE 1 | 4e-28 | ||
| 3lm0_A | 327 | Crystal Structure Of Human SerineTHREONINE KINASE 1 | 4e-05 | ||
| 1koa_A | 491 | Twitchin Kinase Fragment (C.Elegans), Autoregulated | 1e-26 | ||
| 2xuu_A | 334 | Crystal Structure Of A Dap-Kinase 1 Mutant Length = | 1e-26 | ||
| 2xuu_A | 334 | Crystal Structure Of A Dap-Kinase 1 Mutant Length = | 3e-04 | ||
| 3uto_A | 573 | Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin- | 1e-26 | ||
| 2yak_A | 285 | Structure Of Death-Associated Protein Kinase 1 (Dap | 1e-26 | ||
| 2yak_A | 285 | Structure Of Death-Associated Protein Kinase 1 (Dap | 3e-04 | ||
| 2w4k_A | 302 | X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | 1e-26 | ||
| 2w4k_A | 302 | X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | 3e-04 | ||
| 1wvw_A | 278 | Crystal Structures Of Kinase Domain Of Dap Kinase I | 1e-26 | ||
| 1wvw_A | 278 | Crystal Structures Of Kinase Domain Of Dap Kinase I | 3e-04 | ||
| 2w4j_A | 277 | X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | 2e-26 | ||
| 2w4j_A | 277 | X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | 3e-04 | ||
| 1p4f_A | 293 | Death Associated Protein Kinase Catalytic Domain Wi | 2e-26 | ||
| 1p4f_A | 293 | Death Associated Protein Kinase Catalytic Domain Wi | 3e-04 | ||
| 1ig1_A | 294 | 1.8a X-Ray Structure Of Ternary Complex Of A Cataly | 2e-26 | ||
| 1ig1_A | 294 | 1.8a X-Ray Structure Of Ternary Complex Of A Cataly | 3e-04 | ||
| 3f5u_A | 295 | Crystal Structure Of The Death Associated Protein K | 2e-26 | ||
| 3f5u_A | 295 | Crystal Structure Of The Death Associated Protein K | 3e-04 | ||
| 2xzs_A | 312 | Death Associated Protein Kinase 1 Residues 1-312 Le | 2e-26 | ||
| 2xzs_A | 312 | Death Associated Protein Kinase 1 Residues 1-312 Le | 3e-04 | ||
| 3dfc_B | 295 | Crystal Structure Of A Glycine-Rich Loop Mutant Of | 2e-26 | ||
| 3dfc_B | 295 | Crystal Structure Of A Glycine-Rich Loop Mutant Of | 3e-04 | ||
| 3gu8_A | 295 | Crystal Structure Of Dapkl93g With N6-Cyclopentylad | 2e-26 | ||
| 3gu8_A | 295 | Crystal Structure Of Dapkl93g With N6-Cyclopentylad | 3e-04 | ||
| 2y0a_A | 326 | Structure Of Dapk1 Construct Residues 1-304 Length | 2e-26 | ||
| 2y0a_A | 326 | Structure Of Dapk1 Construct Residues 1-304 Length | 3e-04 | ||
| 2x0g_A | 334 | X-ray Structure Of A Dap-kinase Calmodulin Complex | 2e-26 | ||
| 2x0g_A | 334 | X-ray Structure Of A Dap-kinase Calmodulin Complex | 3e-04 | ||
| 3gu4_A | 295 | Crystal Structure Of Dapkq23v-Amppnp Length = 295 | 2e-26 | ||
| 3gu4_A | 295 | Crystal Structure Of Dapkq23v-Amppnp Length = 295 | 3e-04 | ||
| 3mn3_A | 271 | An Inhibited Conformation For The Protein Kinase Do | 3e-26 | ||
| 3mn3_A | 271 | An Inhibited Conformation For The Protein Kinase Do | 2e-05 | ||
| 2fh9_A | 274 | Structure And Dimerization Of The Kinase Domain Fro | 3e-26 | ||
| 2fh9_A | 274 | Structure And Dimerization Of The Kinase Domain Fro | 2e-05 | ||
| 2ya9_A | 361 | Crystal Structure Of The Autoinhibited Form Of Mous | 1e-25 | ||
| 3mfr_A | 351 | Cask-4m Cam Kinase Domain, Native Length = 351 | 2e-25 | ||
| 3mfr_A | 351 | Cask-4m Cam Kinase Domain, Native Length = 351 | 2e-04 | ||
| 3hyh_A | 275 | Crystal Structure Of The Protein Kinase Domain Of Y | 5e-25 | ||
| 3hyh_A | 275 | Crystal Structure Of The Protein Kinase Domain Of Y | 2e-05 | ||
| 3dae_A | 283 | Crystal Structure Of Phosphorylated Snf1 Kinase Dom | 5e-25 | ||
| 3dae_A | 283 | Crystal Structure Of Phosphorylated Snf1 Kinase Dom | 2e-05 | ||
| 2ycr_A | 323 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 6e-25 | ||
| 2ycr_A | 323 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 3e-04 | ||
| 2cn5_A | 329 | Crystal Structure Of Human Chk2 In Complex With Adp | 6e-25 | ||
| 2cn5_A | 329 | Crystal Structure Of Human Chk2 In Complex With Adp | 3e-04 | ||
| 2w0j_A | 323 | Crystal Structure Of Chk2 In Complex With Nsc 10955 | 6e-25 | ||
| 2w0j_A | 323 | Crystal Structure Of Chk2 In Complex With Nsc 10955 | 3e-04 | ||
| 2xk9_A | 322 | Structural Analysis Of Checkpoint Kinase 2 (Chk2) I | 7e-25 | ||
| 2xk9_A | 322 | Structural Analysis Of Checkpoint Kinase 2 (Chk2) I | 3e-04 | ||
| 2ycf_A | 322 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 7e-25 | ||
| 2ycf_A | 322 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 3e-04 | ||
| 3cok_A | 278 | Crystal Structure Of Plk4 Kinase Length = 278 | 1e-24 | ||
| 3cok_A | 278 | Crystal Structure Of Plk4 Kinase Length = 278 | 6e-05 | ||
| 3i6u_A | 419 | Structure And Activation Mechanism Of The Chk2 Dna- | 2e-24 | ||
| 3i6u_A | 419 | Structure And Activation Mechanism Of The Chk2 Dna- | 3e-04 | ||
| 3kga_A | 299 | Crystal Structure Of Mapkap Kinase 2 (Mk2) Complexe | 2e-24 | ||
| 3kga_A | 299 | Crystal Structure Of Mapkap Kinase 2 (Mk2) Complexe | 2e-07 | ||
| 3i6w_A | 443 | Structure And Activation Mechanism Of The Chk2 Dna- | 2e-24 | ||
| 3i6w_A | 443 | Structure And Activation Mechanism Of The Chk2 Dna- | 3e-04 | ||
| 2r0u_A | 323 | Crystal Structure Of Chek1 In Complex With Inhibito | 3e-24 | ||
| 2r0u_A | 323 | Crystal Structure Of Chek1 In Complex With Inhibito | 2e-05 | ||
| 2hog_A | 322 | Crystal Structure Of Chek1 In Complex With Inhibito | 4e-24 | ||
| 2hog_A | 322 | Crystal Structure Of Chek1 In Complex With Inhibito | 2e-05 | ||
| 2br1_A | 297 | Structure-Based Design Of Novel Chk1 Inhibitors: In | 5e-24 | ||
| 2br1_A | 297 | Structure-Based Design Of Novel Chk1 Inhibitors: In | 2e-05 | ||
| 1ia8_A | 289 | The 1.7 A Crystal Structure Of Human Cell Cycle Che | 5e-24 | ||
| 1ia8_A | 289 | The 1.7 A Crystal Structure Of Human Cell Cycle Che | 2e-05 | ||
| 1zlt_A | 295 | Crystal Structure Of Chk1 Complexed With A Hymenald | 5e-24 | ||
| 1zlt_A | 295 | Crystal Structure Of Chk1 Complexed With A Hymenald | 2e-05 | ||
| 1vzo_A | 355 | The Structure Of The N-Terminal Kinase Domain Of Ms | 5e-24 | ||
| 1vzo_A | 355 | The Structure Of The N-Terminal Kinase Domain Of Ms | 2e-21 | ||
| 1zys_A | 273 | Co-Crystal Structure Of Checkpoint Kinase Chk1 With | 1e-23 | ||
| 1zys_A | 273 | Co-Crystal Structure Of Checkpoint Kinase Chk1 With | 3e-05 | ||
| 4fsy_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 1e-23 | ||
| 4fsy_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 2e-05 | ||
| 3zgw_A | 347 | Crystal Structure Of Maternal Embryonic Leucine Zip | 1e-23 | ||
| 3zgw_A | 347 | Crystal Structure Of Maternal Embryonic Leucine Zip | 2e-05 | ||
| 1zws_A | 288 | Crystal Structure Of The Catalytic Domain Of Human | 1e-23 | ||
| 2a27_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 1e-23 | ||
| 1wmk_A | 321 | Human Death-Associated Kinase Drp-1, Mutant S308d D | 1e-23 | ||
| 4fsn_A | 278 | Crystal Structure Of The Chk1 Length = 278 | 1e-23 | ||
| 4fsn_A | 278 | Crystal Structure Of The Chk1 Length = 278 | 2e-05 | ||
| 4fsm_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 1e-23 | ||
| 4fsm_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 2e-05 | ||
| 1z9x_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 2e-23 | ||
| 2a2a_A | 321 | High-resolution Crystallographic Analysis Of The Au | 2e-23 | ||
| 2x8e_A | 276 | Discovery Of A Novel Class Of Triazolones As Checkp | 3e-23 | ||
| 2x8e_A | 276 | Discovery Of A Novel Class Of Triazolones As Checkp | 2e-05 | ||
| 2e9v_A | 268 | Structure Of H-Chk1 Complexed With A859017 Length = | 3e-23 | ||
| 2e9v_A | 268 | Structure Of H-Chk1 Complexed With A859017 Length = | 2e-05 | ||
| 2z7q_A | 321 | Crystal Structure Of The N-Terminal Kinase Domain O | 3e-23 | ||
| 3ot3_A | 273 | X-Ray Crystal Structure Of Compound 22k Bound To Hu | 3e-23 | ||
| 3ot3_A | 273 | X-Ray Crystal Structure Of Compound 22k Bound To Hu | 2e-05 | ||
| 3jvr_A | 271 | Characterization Of The Chk1 Allosteric Inhibitor B | 4e-23 | ||
| 3jvr_A | 271 | Characterization Of The Chk1 Allosteric Inhibitor B | 2e-05 | ||
| 2ghg_A | 269 | H-Chk1 Complexed With A431994 Length = 269 | 4e-23 | ||
| 2ghg_A | 269 | H-Chk1 Complexed With A431994 Length = 269 | 2e-05 | ||
| 2ayp_A | 269 | Crystal Structure Of Chk1 With An Indol Inhibitor L | 4e-23 | ||
| 2ayp_A | 269 | Crystal Structure Of Chk1 With An Indol Inhibitor L | 2e-05 | ||
| 4ft3_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 7e-23 | ||
| 4ft3_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 2e-05 | ||
| 3c0g_A | 351 | Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Len | 9e-23 | ||
| 1zmu_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 1e-22 | ||
| 1zmu_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 5e-04 | ||
| 2r0i_A | 327 | Crystal Structure Of A Kinase Mark2PAR-1 Mutant Len | 1e-22 | ||
| 2r0i_A | 327 | Crystal Structure Of A Kinase Mark2PAR-1 Mutant Len | 4e-04 | ||
| 4fsz_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 1e-22 | ||
| 4fsz_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 2e-05 | ||
| 4fsu_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 2e-22 | ||
| 4fsu_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 2e-05 | ||
| 4dfy_A | 371 | Crystal Structure Of R194a Mutant Of Camp-Dependent | 2e-22 | ||
| 4fsw_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 2e-22 | ||
| 4fsw_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 2e-05 | ||
| 1zmv_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 2e-22 | ||
| 1zmv_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 5e-04 | ||
| 3hko_A | 345 | Crystal Structure Of A Cdpk Kinase Domain From Cryp | 3e-22 | ||
| 3hko_A | 345 | Crystal Structure Of A Cdpk Kinase Domain From Cryp | 7e-06 | ||
| 2ydj_A | 276 | Discovery Of Checkpoint Kinase Inhibitor Azd7762 By | 3e-22 | ||
| 2ydj_A | 276 | Discovery Of Checkpoint Kinase Inhibitor Azd7762 By | 2e-05 | ||
| 3is5_A | 285 | Crystal Structure Of Cdpk Kinase Domain From Toxopl | 3e-22 | ||
| 3is5_A | 285 | Crystal Structure Of Cdpk Kinase Domain From Toxopl | 5e-04 | ||
| 3h4j_B | 336 | Crystal Structure Of Pombe Ampk Kdaid Fragment Leng | 3e-22 | ||
| 3h4j_B | 336 | Crystal Structure Of Pombe Ampk Kdaid Fragment Leng | 2e-05 | ||
| 1zmw_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 5e-22 | ||
| 1zmw_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 5e-04 | ||
| 4fst_A | 269 | Crystal Structure Of The Chk1 Length = 269 | 5e-22 | ||
| 4fst_A | 269 | Crystal Structure Of The Chk1 Length = 269 | 2e-05 | ||
| 3g51_A | 325 | Structural Diversity Of The Active Conformation Of | 5e-22 | ||
| 1mrv_A | 339 | Crystal Structure Of An Inactive Akt2 Kinase Domain | 6e-22 | ||
| 1gzn_A | 335 | Structure Of Pkb Kinase Domain Length = 335 | 6e-22 | ||
| 1gzk_A | 315 | Molecular Mechanism For The Regulation Of Protein K | 7e-22 | ||
| 3ubd_A | 304 | Structure Of N-Terminal Domain Of Rsk2 Kinase In Co | 7e-22 | ||
| 4el9_A | 305 | Structure Of N-Terminal Kinase Domain Of Rsk2 With | 7e-22 | ||
| 1y8g_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 8e-22 | ||
| 1y8g_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 4e-04 | ||
| 3iec_A | 319 | Helicobacter Pylori Caga Inhibits Par1MARK FAMILY K | 9e-22 | ||
| 3iec_A | 319 | Helicobacter Pylori Caga Inhibits Par1MARK FAMILY K | 6e-04 | ||
| 3tac_A | 361 | Crystal Structure Of The Liprin-AlphaCASK COMPLEX L | 1e-21 | ||
| 2wzj_A | 327 | Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82 | 1e-21 | ||
| 2wzj_A | 327 | Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82 | 5e-04 | ||
| 2qnj_A | 328 | Kinase And Ubiquitin-Associated Domains Of Mark3PAR | 1e-21 | ||
| 2qnj_A | 328 | Kinase And Ubiquitin-Associated Domains Of Mark3PAR | 5e-04 | ||
| 2gu8_A | 337 | Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel | 1e-21 | ||
| 2erz_E | 351 | Crystal Structure Of C-amp Dependent Kinase (pka) B | 1e-21 | ||
| 2qur_A | 350 | Crystal Structure Of F327aK285P MUTANT OF CAMP-Depe | 1e-21 | ||
| 1syk_A | 350 | Crystal Structure Of E230q Mutant Of Camp-Dependent | 1e-21 | ||
| 1fmo_E | 350 | Crystal Structure Of A Polyhistidine-Tagged Recombi | 2e-21 | ||
| 1jbp_E | 350 | Crystal Structure Of The Catalytic Subunit Of Camp- | 2e-21 | ||
| 1bkx_A | 350 | A Binary Complex Of The Catalytic Subunit Of Camp-D | 2e-21 | ||
| 3ama_A | 351 | Protein Kinase A Sixfold Mutant Model Of Aurora B W | 2e-21 | ||
| 3l9m_A | 351 | Crystal Structure Of Pkab3 (Pka Triple Mutant V123a | 2e-21 | ||
| 1apm_E | 350 | 2.0 Angstrom Refined Crystal Structure Of The Catal | 2e-21 | ||
| 3pvb_A | 345 | Crystal Structure Of (73-244)ria:c Holoenzyme Of Ca | 2e-21 | ||
| 1l3r_E | 350 | Crystal Structure Of A Transition State Mimic Of Th | 2e-21 | ||
| 3e87_A | 335 | Crystal Structures Of The Kinase Domain Of Akt2 In | 3e-21 | ||
| 2uzt_A | 336 | Pka Structures Of Akt, Indazole-Pyridine Inhibitors | 3e-21 | ||
| 2qcs_A | 350 | A Complex Structure Between The Catalytic And Regul | 3e-21 | ||
| 1o6k_A | 336 | Structure Of Activated Form Of Pkb Kinase Domain S4 | 3e-21 | ||
| 4dg3_E | 371 | Crystal Structure Of R336a Mutant Of Camp-dependent | 3e-21 | ||
| 2jdo_A | 342 | Structure Of Pkb-Beta (Akt2) Complexed With Isoquin | 3e-21 | ||
| 4ae6_A | 343 | Structure And Function Of The Human Sperm-specific | 3e-21 | ||
| 3agl_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 3e-21 | ||
| 3agm_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 3e-21 | ||
| 3nx8_A | 351 | Human Camp Dependent Protein Kinase In Complex With | 3e-21 | ||
| 1o6l_A | 337 | Crystal Structure Of An Activated Akt/protein Kinas | 3e-21 | ||
| 2f7e_E | 351 | Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoqu | 3e-21 | ||
| 4dfx_E | 350 | Crystal Structure Of Myristoylated K7c Catalytic Su | 3e-21 | ||
| 3mvj_A | 371 | Human Cyclic Amp-Dependent Protein Kinase Pka Inhib | 3e-21 | ||
| 3o7l_B | 350 | Crystal Structure Of Phospholamban (1-19):pka C-Sub | 4e-21 | ||
| 4ae9_A | 343 | Structure And Function Of The Human Sperm-specific | 5e-21 | ||
| 3qal_E | 350 | Crystal Structure Of Arg280ala Mutant Of Catalytic | 5e-21 | ||
| 3udb_A | 317 | Crystal Structure Of Snrk2.6 Length = 317 | 7e-21 | ||
| 3udb_A | 317 | Crystal Structure Of Snrk2.6 Length = 317 | 1e-04 | ||
| 1ctp_E | 350 | Structure Of The Mammalian Catalytic Subunit Of Cam | 7e-21 | ||
| 3qam_E | 350 | Crystal Structure Of Glu208ala Mutant Of Catalytic | 7e-21 | ||
| 1cdk_A | 350 | Camp-Dependent Protein Kinase Catalytic Subunit (E. | 7e-21 | ||
| 3fe3_A | 328 | Crystal Structure Of The Kinase Mark3PAR-1: T211a-S | 8e-21 | ||
| 3fe3_A | 328 | Crystal Structure Of The Kinase Mark3PAR-1: T211a-S | 4e-04 | ||
| 1cmk_E | 350 | Crystal Structures Of The Myristylated Catalytic Su | 8e-21 | ||
| 1q61_A | 350 | Pka Triple Mutant Model Of Pkb Length = 350 | 8e-21 | ||
| 1ydt_E | 350 | Structure Of Camp-Dependent Protein Kinase, Alpha-C | 1e-20 | ||
| 2gnj_A | 350 | Pka Three Fold Mutant Model Of Rho-Kinase With Y-27 | 1e-20 | ||
| 3fhi_A | 350 | Crystal Structure Of A Complex Between The Catalyti | 1e-20 | ||
| 2gnf_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 1e-20 | ||
| 2gng_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 1e-20 | ||
| 3dnd_A | 350 | Camp-Dependent Protein Kinase Pka Catalytic Subunit | 1e-20 | ||
| 1svh_A | 350 | Crystal Structure Of Protein Kinase A In Complex Wi | 1e-20 | ||
| 1szm_A | 350 | Dual Binding Mode Of Bisindolylmaleimide 2 To Prote | 1e-20 | ||
| 1stc_E | 350 | Camp-Dependent Protein Kinase, Alpha-Catalytic Subu | 1e-20 | ||
| 2c1a_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 1e-20 | ||
| 1rdq_E | 350 | Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of | 2e-20 | ||
| 1j3h_A | 350 | Crystal Structure Of Apoenzyme Camp-Dependent Prote | 2e-20 | ||
| 1q24_A | 350 | Pka Double Mutant Model Of Pkb In Complex With Mgat | 2e-20 | ||
| 3hrc_A | 311 | Crystal Structure Of A Mutant Of Human Pdk1 Kinase | 2e-20 | ||
| 3hrc_A | 311 | Crystal Structure Of A Mutant Of Human Pdk1 Kinase | 7e-04 | ||
| 2jds_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 2e-20 | ||
| 1q8w_A | 350 | The Catalytic Subunit Of Camp-Dependent Protein Kin | 2e-20 | ||
| 1xh7_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 2e-20 | ||
| 1xh9_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 3e-20 | ||
| 2vo0_A | 351 | Structure Of Pka-Pkb Chimera Complexed With C-(4-(4 | 3e-20 | ||
| 2jdt_A | 351 | Structure Of Pka-Pkb Chimera Complexed With Isoquin | 3e-20 | ||
| 3qc4_A | 314 | Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = | 3e-20 | ||
| 3qc4_A | 314 | Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = | 7e-04 | ||
| 3ujg_A | 361 | Crystal Structure Of Snrk2.6 In Complex With Hab1 L | 3e-20 | ||
| 3ujg_A | 361 | Crystal Structure Of Snrk2.6 In Complex With Hab1 L | 2e-04 | ||
| 3txo_A | 353 | Pkc Eta Kinase In Complex With A Naphthyridine Leng | 3e-20 | ||
| 2hak_A | 328 | Catalytic And Ubiqutin-Associated Domains Of Mark1P | 4e-20 | ||
| 2hak_A | 328 | Catalytic And Ubiqutin-Associated Domains Of Mark1P | 9e-05 | ||
| 4ejn_A | 446 | Crystal Structure Of Autoinhibited Form Of Akt1 In | 4e-20 | ||
| 2uvy_A | 351 | Structure Of Pka-pkb Chimera Complexed With Methyl- | 4e-20 | ||
| 2r7b_A | 312 | Crystal Structure Of The Phosphoinositide-Dependent | 5e-20 | ||
| 2r7b_A | 312 | Crystal Structure Of The Phosphoinositide-Dependent | 7e-04 | ||
| 3o96_A | 446 | Crystal Structure Of Human Akt1 With An Allosteric | 5e-20 | ||
| 3nax_A | 311 | Pdk1 In Complex With Inhibitor Mp7 Length = 311 | 5e-20 | ||
| 3nax_A | 311 | Pdk1 In Complex With Inhibitor Mp7 Length = 311 | 7e-04 | ||
| 2biy_A | 310 | Structure Of Pdk1-S241a Mutant Kinase Domain Length | 6e-20 | ||
| 2biy_A | 310 | Structure Of Pdk1-S241a Mutant Kinase Domain Length | 7e-04 | ||
| 1z5m_A | 286 | Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrr | 6e-20 | ||
| 1z5m_A | 286 | Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrr | 6e-04 | ||
| 3h9o_A | 311 | Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) | 6e-20 | ||
| 3h9o_A | 311 | Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) | 7e-04 | ||
| 1smh_A | 350 | Protein Kinase A Variant Complex With Completely Or | 6e-20 | ||
| 2xch_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 7e-20 | ||
| 2xch_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 7e-04 | ||
| 3uc4_A | 362 | The Crystal Structure Of Snf1-Related Kinase 2.6 Le | 7e-20 | ||
| 3uc4_A | 362 | The Crystal Structure Of Snf1-Related Kinase 2.6 Le | 2e-04 | ||
| 3iop_A | 312 | Pdk-1 In Complex With The Inhibitor Compound-8i Len | 7e-20 | ||
| 3iop_A | 312 | Pdk-1 In Complex With The Inhibitor Compound-8i Len | 7e-04 | ||
| 1uu3_A | 310 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 7e-20 | ||
| 1uu3_A | 310 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 7e-04 | ||
| 3sc1_A | 311 | Novel Isoquinolone Pdk1 Inhibitors Discovered Throu | 7e-20 | ||
| 3sc1_A | 311 | Novel Isoquinolone Pdk1 Inhibitors Discovered Throu | 7e-04 | ||
| 3rwp_A | 311 | Discovery Of A Novel, Potent And Selective Inhibito | 8e-20 | ||
| 3rwp_A | 311 | Discovery Of A Novel, Potent And Selective Inhibito | 7e-04 | ||
| 3nay_A | 311 | Pdk1 In Complex With Inhibitor Mp6 Length = 311 | 8e-20 | ||
| 3nay_A | 311 | Pdk1 In Complex With Inhibitor Mp6 Length = 311 | 7e-04 | ||
| 2xck_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 8e-20 | ||
| 2xck_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 7e-04 | ||
| 3nun_A | 292 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lea | 9e-20 | ||
| 3nun_A | 292 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lea | 7e-04 | ||
| 3uc3_A | 361 | The Crystal Structure Of Snf1-Related Kinase 2.3 Le | 1e-19 | ||
| 3uc3_A | 361 | The Crystal Structure Of Snf1-Related Kinase 2.3 Le | 1e-04 | ||
| 2h6d_A | 276 | Protein Kinase Domain Of The Human 5'-Amp-Activated | 1e-19 | ||
| 2h6d_A | 276 | Protein Kinase Domain Of The Human 5'-Amp-Activated | 1e-04 | ||
| 3orx_A | 316 | Pdk1 Mutant Bound To Allosteric Disulfide Fragment | 1e-19 | ||
| 3orx_A | 316 | Pdk1 Mutant Bound To Allosteric Disulfide Fragment | 7e-04 | ||
| 3zuu_A | 362 | The Structure Of Ost1 (D160a, S175d) Kinase In Comp | 2e-19 | ||
| 3zuu_A | 362 | The Structure Of Ost1 (D160a, S175d) Kinase In Comp | 2e-04 | ||
| 3zut_A | 362 | The Structure Of Ost1 (D160a) Kinase Length = 362 | 2e-19 | ||
| 3zut_A | 362 | The Structure Of Ost1 (D160a) Kinase Length = 362 | 2e-04 | ||
| 2f2u_A | 402 | Crystal Structure Of The Rho-Kinase Kinase Domain L | 2e-19 | ||
| 1tki_A | 321 | Autoinhibited Serine Kinase Domain Of The Giant Mus | 2e-19 | ||
| 3ocb_A | 341 | Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor | 3e-19 | ||
| 3cqu_A | 342 | Crystal Structure Of Akt-1 Complexed With Substrate | 3e-19 | ||
| 4a07_A | 311 | Human Pdk1 Kinase Domain In Complex With Allosteric | 3e-19 | ||
| 4a07_A | 311 | Human Pdk1 Kinase Domain In Complex With Allosteric | 7e-04 | ||
| 4gv1_A | 340 | Pkb Alpha In Complex With Azd5363 Length = 340 | 3e-19 | ||
| 2y94_A | 476 | Structure Of An Active Form Of Mammalian Ampk Lengt | 4e-19 | ||
| 2y94_A | 476 | Structure Of An Active Form Of Mammalian Ampk Lengt | 3e-04 | ||
| 2x4f_A | 373 | The Crystal Structure Of The Human Myosin Light Cha | 5e-19 | ||
| 2yza_A | 276 | Crystal Structure Of Kinase Domain Of Human 5'-Amp- | 6e-19 | ||
| 2yza_A | 276 | Crystal Structure Of Kinase Domain Of Human 5'-Amp- | 1e-04 | ||
| 3pwy_A | 311 | Crystal Structure Of An Extender (Spd28345)-Modifie | 9e-19 | ||
| 3pwy_A | 311 | Crystal Structure Of An Extender (Spd28345)-Modifie | 7e-04 | ||
| 3v8s_A | 410 | Human Rho-Associated Protein Kinase 1 (Rock 1) In C | 1e-18 | ||
| 3a60_A | 327 | Crystal Structure Of Unphosphorylated P70s6k1 (Form | 1e-18 | ||
| 2esm_A | 415 | Crystal Structure Of Rock 1 Bound To Fasudil Length | 1e-18 | ||
| 2v55_A | 406 | Mechanism Of Multi-site Phosphorylation From A Rock | 1e-18 | ||
| 1h1w_A | 289 | High Resolution Crystal Structure Of The Human Pdk1 | 1e-18 | ||
| 1h1w_A | 289 | High Resolution Crystal Structure Of The Human Pdk1 | 7e-04 | ||
| 1uu9_A | 286 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 2e-18 | ||
| 1uu9_A | 286 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 7e-04 | ||
| 3nus_A | 286 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fra | 2e-18 | ||
| 3nus_A | 286 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fra | 7e-04 | ||
| 3coh_A | 268 | Crystal Structure Of Aurora-A In Complex With A Pen | 2e-18 | ||
| 2j4z_A | 306 | Structure Of Aurora-2 In Complex With Pha-680626 Le | 3e-18 | ||
| 3iw4_A | 360 | Crystal Structure Of Pkc Alpha In Complex With Nvp- | 3e-18 | ||
| 2bmc_A | 306 | Aurora-2 T287d T288d Complexed With Pha-680632 Leng | 3e-18 | ||
| 3d5u_A | 317 | Crystal Structure Of A Wildtype Polo-Like Kinase 1 | 4e-18 | ||
| 3a62_A | 327 | Crystal Structure Of Phosphorylated P70s6k1 Length | 4e-18 | ||
| 1muo_A | 297 | Crystal Structure Of Aurora-2, An Oncogenic Serine- | 4e-18 | ||
| 2wtw_A | 285 | Aurora-A Inhibitor Structure (2nd Crystal Form) Len | 5e-18 | ||
| 3qbn_A | 281 | Structure Of Human Aurora A In Complex With A Diami | 5e-18 | ||
| 2v5q_A | 315 | Crystal Structure Of Wild-type Plk-1 Kinase Domain | 5e-18 | ||
| 1fot_A | 318 | Structure Of The Unliganded Camp-Dependent Protein | 5e-18 | ||
| 2vrx_A | 285 | Structure Of Aurora B Kinase In Complex With Zm4474 | 5e-18 | ||
| 2vrx_A | 285 | Structure Of Aurora B Kinase In Complex With Zm4474 | 3e-05 | ||
| 2j50_A | 280 | Structure Of Aurora-2 In Complex With Pha-739358 Le | 5e-18 | ||
| 3kb7_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 5e-18 | ||
| 2bfx_B | 284 | Mechanism Of Aurora-B Activation By Incenp And Inhi | 6e-18 | ||
| 2bfx_B | 284 | Mechanism Of Aurora-B Activation By Incenp And Inhi | 3e-05 | ||
| 2xru_A | 280 | Aurora-A T288e Complexed With Pha-828300 Length = 2 | 6e-18 | ||
| 2yac_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 6e-18 | ||
| 2xng_A | 283 | Structure Of Aurora-A Bound To A Selective Imidazop | 6e-18 | ||
| 2bfy_A | 284 | Complex Of Aurora-B With Incenp And Hesperidin. Len | 6e-18 | ||
| 2bfy_A | 284 | Complex Of Aurora-B With Incenp And Hesperidin. Len | 3e-05 | ||
| 3o50_A | 267 | Crystal Structure Of Benzamide 9 Bound To Auroraa L | 7e-18 | ||
| 2x6d_A | 285 | Aurora-A Bound To An Inhibitor Length = 285 | 7e-18 | ||
| 1ol5_A | 282 | Structure Of Aurora-A 122-403, Phosphorylated On Th | 7e-18 | ||
| 1mq4_A | 272 | Crystal Structure Of Aurora-A Protein Kinase Length | 7e-18 | ||
| 2dwb_A | 285 | Aurora-A Kinase Complexed With Amppnp Length = 285 | 7e-18 | ||
| 3nrm_A | 283 | Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibito | 7e-18 | ||
| 3unz_A | 279 | Aurora A In Complex With Rpm1679 Length = 279 | 7e-18 | ||
| 3fdn_A | 279 | Structure-Based Drug Design Of Novel Aurora Kinase | 7e-18 | ||
| 3h0y_A | 268 | Aurora A In Complex With A Bisanilinopyrimidine Len | 7e-18 | ||
| 2c6e_A | 283 | Aurora A Kinase Activated Mutant (T287d) In Complex | 7e-18 | ||
| 3lau_A | 287 | Crystal Structure Of Aurora2 Kinase In Complex With | 8e-18 | ||
| 2w1d_A | 275 | Structure Determination Of Aurora Kinase In Complex | 8e-18 | ||
| 3ha6_A | 268 | Crystal Structure Of Aurora A In Complex With Tpx2 | 8e-18 | ||
| 2w1c_A | 275 | Structure Determination Of Aurora Kinase In Complex | 8e-18 | ||
| 2c6d_A | 275 | Aurora A Kinase Activated Mutant (T287d) In Complex | 8e-18 | ||
| 3e5a_A | 268 | Crystal Structure Of Aurora A In Complex With Vx-68 | 8e-18 | ||
| 2wqe_A | 262 | Structure Of S155r Aurora-A Somatic Mutant Length = | 9e-18 | ||
| 3r21_A | 271 | Design, Synthesis, And Biological Evaluation Of Pyr | 9e-18 | ||
| 3d5w_A | 317 | Crystal Structure Of A Phosphorylated Polo-Like Kin | 1e-17 | ||
| 3thb_A | 333 | Structure Of Plk1 Kinase Domain In Complex With A B | 2e-17 | ||
| 2ou7_A | 335 | Structure Of The Catalytic Domain Of Human Polo-Lik | 2e-17 | ||
| 3d14_A | 272 | Crystal Structure Of Mouse Aurora A (Asn186->gly, L | 2e-17 | ||
| 3db6_A | 301 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 2e-17 | ||
| 3d5v_A | 317 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 2e-17 | ||
| 1ol6_A | 282 | Structure Of Unphosphorylated D274n Mutant Of Auror | 2e-17 | ||
| 2xne_A | 272 | Structure Of Aurora-A Bound To An Imidazopyrazine I | 2e-17 | ||
| 3daj_A | 272 | Crystal Structure Of Aurora A Complexed With An Inh | 2e-17 | ||
| 2r5t_A | 373 | Crystal Structure Of Inactive Serum And Glucocortic | 2e-17 | ||
| 2jed_A | 352 | The Crystal Structure Of The Kinase Domain Of The P | 3e-17 | ||
| 2rku_A | 294 | Structure Of Plk1 In Complex With Bi2536 Length = 2 | 3e-17 | ||
| 2wtv_A | 285 | Aurora-A Inhibitor Structure Length = 285 | 6e-17 | ||
| 1xjd_A | 345 | Crystal Structure Of Pkc-Theta Complexed With Staur | 6e-17 | ||
| 4fr4_A | 384 | Crystal Structure Of Human SerineTHREONINE-Protein | 7e-17 | ||
| 2i0e_A | 353 | Structure Of Catalytic Domain Of Human Protein Kina | 1e-16 | ||
| 4dc2_A | 396 | Structure Of Pkc In Complex With A Substrate Peptid | 2e-16 | ||
| 3pfq_A | 674 | Crystal Structure And Allosteric Activation Of Prot | 2e-16 | ||
| 3qfv_A | 415 | Mrck Beta In Complex With Tpca-1 Length = 415 | 2e-16 | ||
| 3tku_A | 433 | Mrck Beta In Complex With Fasudil Length = 433 | 2e-16 | ||
| 3zh8_A | 349 | A Novel Small Molecule Apkc Inhibitor Length = 349 | 3e-16 | ||
| 3a8w_A | 345 | Crystal Structure Of Pkciota Kinase Domain Length = | 4e-16 | ||
| 2w9f_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 4e-16 | ||
| 2w9f_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 6e-04 | ||
| 1zrz_A | 364 | Crystal Structure Of The Catalytic Domain Of Atypic | 4e-16 | ||
| 2w96_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 4e-16 | ||
| 2w96_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 6e-04 | ||
| 2w99_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 4e-16 | ||
| 2w99_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 6e-04 | ||
| 3g33_A | 308 | Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | 1e-15 | ||
| 3g33_A | 308 | Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | 6e-04 | ||
| 4agu_A | 311 | Crystal Structure Of The Human Cdkl1 Kinase Domain | 1e-15 | ||
| 2j7t_A | 302 | Crystal Structure Of Human Serine Threonine Kinase- | 3e-15 | ||
| 4bc6_A | 293 | Crystal Structure Of Human Serine Threonine Kinase- | 4e-15 | ||
| 3coi_A | 353 | Crystal Structure Of P38delta Kinase Length = 353 | 9e-15 | ||
| 4af3_A | 292 | Human Aurora B Kinase In Complex With Incenp And Vx | 9e-15 | ||
| 4exu_A | 371 | Mapk13, Inactive Form Length = 371 | 1e-14 | ||
| 4eoi_A | 299 | Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyc | 1e-14 | ||
| 3kvx_A | 364 | Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Le | 2e-14 | ||
| 2j51_A | 325 | Crystal Structure Of Human Ste20-Like Kinase Bound | 2e-14 | ||
| 2r9s_A | 356 | C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Qu | 2e-14 | ||
| 4eoj_A | 302 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 2e-14 | ||
| 2zv2_A | 298 | Crystal Structure Of Human CalciumCALMODULIN-Depend | 2e-14 | ||
| 4eok_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 2e-14 | ||
| 2clq_A | 295 | Structure Of Mitogen-Activated Protein Kinase Kinas | 2e-14 | ||
| 3vw6_A | 269 | Crystal Structure Of Human Apoptosis Signal-Regulat | 2e-14 | ||
| 4erw_A | 306 | Cdk2 In Complex With Staurosporine Length = 306 | 3e-14 | ||
| 1bi8_A | 326 | Mechanism Of G1 Cyclin Dependent Kinase Inhibition | 3e-14 | ||
| 3nup_A | 307 | Cdk6 (Monomeric) In Complex With Inhibitor Length = | 3e-14 | ||
| 2jfm_A | 325 | Crystal Structure Of Human Ste20-Like Kinase (Unlig | 3e-14 | ||
| 4eom_A | 301 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 4e-14 | ||
| 4eon_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 4e-14 | ||
| 1jow_B | 308 | Crystal Structure Of A Complex Of Human Cdk6 And A | 4e-14 | ||
| 1gz8_A | 299 | Human Cyclin Dependent Kinase 2 Complexed With The | 4e-14 | ||
| 4eop_A | 300 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 5e-14 | ||
| 4eoo_A | 299 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 5e-14 | ||
| 2jfl_A | 325 | Crystal Structure Of Human Ste20-Like Kinase ( Diph | 5e-14 | ||
| 3pxf_A | 306 | Cdk2 In Complex With Two Molecules Of 8-Anilino-1-N | 8e-14 | ||
| 3fi3_A | 364 | Crystal Structure Of Jnk3 With Indazole Inhibitor, | 8e-14 | ||
| 4aw2_A | 437 | Crystal Structure Of Cdc42 Binding Protein Kinase A | 9e-14 | ||
| 2iwi_A | 312 | Crystal Structure Of The Human Pim2 In Complex With | 1e-13 | ||
| 2iwi_A | 312 | Crystal Structure Of The Human Pim2 In Complex With | 4e-04 | ||
| 4eos_A | 300 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 1e-13 | ||
| 1oit_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 1e-13 | ||
| 1e9h_A | 297 | Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex | 1e-13 | ||
| 3oxi_A | 362 | Design And Synthesis Of Disubstituted Thiophene And | 1e-13 | ||
| 1w98_A | 298 | The Structural Basis Of Cdk2 Activation By Cyclin E | 1e-13 | ||
| 2exc_X | 356 | Inhibitor Complex Of Jnk3 Length = 356 | 1e-13 | ||
| 1ogu_A | 302 | Structure Of Human Thr160-phospho Cdk2/cyclin A Com | 1e-13 | ||
| 1qmz_A | 299 | Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Com | 1e-13 | ||
| 2o0u_A | 364 | Crystal Structure Of Human Jnk3 Complexed With N-{3 | 1e-13 | ||
| 4eoq_A | 301 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 1e-13 | ||
| 4bcq_A | 301 | Structure Of Cdk2 In Complex With Cyclin A And A 2- | 1e-13 | ||
| 4i3z_A | 296 | Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNES | 1e-13 | ||
| 3bht_A | 300 | Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN | 1e-13 | ||
| 2ok1_A | 365 | Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3 | 1e-13 | ||
| 1pf8_A | 298 | Crystal Structure Of Human Cyclin-dependent Kinase | 1e-13 | ||
| 3ptg_A | 363 | Design And Synthesis Of A Novel, Orally Efficacious | 1e-13 | ||
| 1pmn_A | 364 | Crystal Structure Of Jnk3 In Complex With An Imidaz | 1e-13 | ||
| 1jst_A | 298 | Phosphorylated Cyclin-Dependent Kinase-2 Bound To C | 1e-13 | ||
| 2b1p_A | 355 | Inhibitor Complex Of Jnk3 Length = 355 | 1e-13 | ||
| 1jnk_A | 423 | The C-Jun N-Terminal Kinase (Jnk3s) Complexed With | 1e-13 | ||
| 4h36_A | 356 | Crystal Structure Of Jnk3 In Complex With Atf2 Pept | 1e-13 | ||
| 2w17_A | 299 | Cdk2 In Complex With The Imidazole Pyrimidine Amide | 1e-13 | ||
| 3qhr_A | 298 | Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic | 1e-13 | ||
| 1fin_A | 298 | Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = | 1e-13 | ||
| 1vyw_A | 309 | Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = | 1e-13 | ||
| 3pj8_A | 299 | Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D] | 1e-13 | ||
| 1h1p_A | 303 | Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMP | 1e-13 | ||
| 3ezr_A | 300 | Cdk-2 With Indazole Inhibitor 17 Bound At Its Activ | 1e-13 | ||
| 2iw8_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82 | 1e-13 | ||
| 2jgz_A | 289 | Crystal Structure Of Phospho-Cdk2 In Complex With C | 2e-13 | ||
| 3vum_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M7 | 2e-13 | ||
| 2pk9_A | 317 | Structure Of The Pho85-pho80 Cdk-cyclin Complex Of | 2e-13 | ||
| 2iw6_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A Com | 2e-13 | ||
| 1gii_A | 298 | Human Cyclin Dependent Kinase 2 Complexed With The | 2e-13 | ||
| 3ttj_A | 464 | Crystal Structure Of Jnk3 Complexed With Cc-359, A | 2e-13 | ||
| 3fv8_A | 355 | Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Le | 2e-13 | ||
| 1cm8_A | 367 | Phosphorylated Map Kinase P38-Gamma Length = 367 | 2e-13 | ||
| 4aaa_A | 331 | Crystal Structure Of The Human Cdkl2 Kinase Domain | 3e-13 | ||
| 3com_A | 314 | Crystal Structure Of Mst1 Kinase Length = 314 | 3e-13 | ||
| 2vd5_A | 412 | Structure Of Human Myotonic Dystrophy Protein Kinas | 3e-13 | ||
| 3oz6_A | 388 | Crystal Structure Of Mapk From Cryptosporidium Parv | 3e-13 | ||
| 2jav_A | 279 | Human Kinase With Pyrrole-Indolinone Ligand Length | 4e-13 | ||
| 3vul_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 4e-13 | ||
| 2w5a_A | 279 | Human Nek2 Kinase Adp-Bound Length = 279 | 4e-13 | ||
| 3dls_A | 335 | Crystal Structure Of Human Pas Kinase Bound To Adp | 4e-13 | ||
| 2qkr_A | 313 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 6e-13 | ||
| 1z57_A | 339 | Crystal Structure Of Human Clk1 In Complex With 10z | 6e-13 | ||
| 3niz_A | 311 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 6e-13 | ||
| 1oir_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 6e-13 | ||
| 1h01_A | 298 | Cdk2 In Complex With A Disubstituted 2, 4-Bis Anili | 6e-13 | ||
| 1v0o_A | 288 | Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulpho | 7e-13 | ||
| 2wqm_A | 310 | Structure Of Apo Human Nek7 Length = 310 | 7e-13 | ||
| 2vx3_A | 382 | Crystal Structure Of The Human Dual Specificity Tyr | 7e-13 | ||
| 1v0b_A | 288 | Crystal Structure Of The T198a Mutant Of Pfpk5 Leng | 7e-13 | ||
| 3anq_A | 368 | Human Dyrk1aINHIBITOR COMPLEX Length = 368 | 7e-13 | ||
| 3cik_A | 689 | Human Grk2 In Complex With Gbetagamma Subunits Leng | 8e-13 | ||
| 1ob3_A | 288 | Structure Of P. Falciparum Pfpk5 Length = 288 | 8e-13 | ||
| 3krw_A | 688 | Human Grk2 In Complex With Gbetgamma Subunits And B | 8e-13 | ||
| 4a4x_A | 279 | Nek2-Ede Bound To Cct248662 Length = 279 | 9e-13 | ||
| 4aze_A | 382 | Human Dyrk1a In Complex With Leucettine L41 Length | 9e-13 | ||
| 1omw_A | 689 | Crystal Structure Of The Complex Between G Protein- | 9e-13 | ||
| 3psc_A | 695 | Bovine Grk2 In Complex With Gbetagamma Subunits Len | 9e-13 | ||
| 3vuh_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M3 | 9e-13 | ||
| 3fi2_A | 353 | Crystal Structure Of Jnk3 With Amino-Pyrazole Inhib | 1e-12 | ||
| 4e7w_A | 394 | Structure Of Gsk3 From Ustilago Maydis Length = 394 | 1e-12 | ||
| 2vag_A | 339 | Crystal Structure Of Di-Phosphorylated Human Clk1 I | 2e-12 | ||
| 3zhp_C | 294 | Human Mst3 (stk24) In Complex With Mo25beta Length | 2e-12 | ||
| 2x7f_A | 326 | Crystal Structure Of The Kinase Domain Of Human Tra | 2e-12 | ||
| 3e7o_A | 360 | Crystal Structure Of Jnk2 Length = 360 | 2e-12 | ||
| 3vuk_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M5 | 3e-12 | ||
| 2acx_A | 576 | Crystal Structure Of G Protein Coupled Receptor Kin | 4e-12 | ||
| 3elj_A | 369 | Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine | 4e-12 | ||
| 3nyn_A | 576 | Crystal Structure Of G Protein-Coupled Receptor Kin | 4e-12 | ||
| 3v3v_A | 379 | Structural And Functional Analysis Of Quercetagetin | 4e-12 | ||
| 3pze_A | 358 | Jnk1 In Complex With Inhibitor Length = 358 | 4e-12 | ||
| 3ckw_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 4e-12 | ||
| 3vug_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 5e-12 | ||
| 3vui_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 5e-12 | ||
| 3a7f_A | 303 | Human Mst3 Kinase Length = 303 | 7e-12 | ||
| 2xs0_A | 386 | Linear Binding Motifs For Jnk And For Calcineurin A | 7e-12 | ||
| 3ckx_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 7e-12 | ||
| 2g01_A | 370 | Pyrazoloquinolones As Novel, Selective Jnk1 Inhibit | 8e-12 | ||
| 2uv2_A | 287 | Crystal Structure Of Human Ste20-Like Kinase Bound | 8e-12 | ||
| 1na7_A | 329 | Crystal Structure Of The Catalytic Subunit Of Human | 8e-12 | ||
| 3c4w_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 9e-12 | ||
| 2xrw_A | 371 | Linear Binding Motifs For Jnk And For Calcineurin A | 9e-12 | ||
| 3t8o_A | 543 | Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolu | 9e-12 | ||
| 3c4x_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 9e-12 | ||
| 1ukh_A | 369 | Structural Basis For The Selective Inhibition Of Jn | 9e-12 | ||
| 3gc9_A | 370 | The Structure Of P38beta C119s, C162s In Complex Wi | 1e-11 | ||
| 3mtl_A | 324 | Crystal Structure Of The Pctaire1 Kinase In Complex | 1e-11 | ||
| 3qc9_A | 543 | Crystal Structure Of Cross-Linked Bovine Grk1 T8cN4 | 1e-11 | ||
| 3vud_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 1e-11 | ||
| 3gc8_A | 370 | The Structure Of P38beta C162s In Complex With A Di | 1e-11 | ||
| 3o17_A | 370 | Crystal Structure Of Jnk1-Alpha1 Isoform Length = 3 | 2e-11 | ||
| 2puu_A | 348 | Crystal Structure Of P38 Complex With 1-(5-Tert-But | 2e-11 | ||
| 2xik_A | 294 | Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related K | 2e-11 | ||
| 3py3_A | 380 | Crystal Structure Of Phosphorylated P38alpha Map Ki | 2e-11 | ||
| 3kvw_A | 429 | Crystal Structure Of Dual-Specificity Tyrosine Phos | 2e-11 | ||
| 3ggf_A | 301 | Crystal Structure Of Human SerineTHREONINE-Protein | 2e-11 | ||
| 2y8o_A | 362 | Crystal Structure Of Human P38alpha Complexed With | 2e-11 | ||
| 2vwi_A | 303 | Structure Of The Osr1 Kinase, A Hypertension Drug T | 2e-11 | ||
| 1ove_A | 366 | The Structure Of P38 Alpha In Complex With A Dihydr | 3e-11 | ||
| 3d83_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 3e-11 | ||
| 3gp0_A | 348 | Crystal Structure Of Human Mitogen Activated Protei | 3e-11 | ||
| 4azf_A | 417 | Human Dyrk2 In Complex With Leucettine L41 Length = | 3e-11 | ||
| 3tg1_A | 380 | Crystal Structure Of P38alpha In Complex With A Map | 3e-11 | ||
| 2wtk_C | 305 | Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo2 | 3e-11 | ||
| 1lew_A | 360 | Crystal Structure Of Map Kinase P38 Complexed To Th | 3e-11 | ||
| 1bmk_A | 379 | The Complex Structure Of The Map Kinase P38SB218655 | 3e-11 | ||
| 3p4k_A | 370 | The Third Conformation Of P38a Map Kinase Observed | 3e-11 | ||
| 2gtm_A | 348 | Mutated Mouse P38 Map Kinase Domain In Complex With | 3e-11 | ||
| 2baq_A | 365 | P38alpha Bound To Ro3201195 Length = 365 | 3e-11 | ||
| 3dak_A | 290 | Crystal Structure Of Domain-Swapped Osr1 Kinase Dom | 3e-11 | ||
| 1zy4_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 4e-11 | ||
| 1zy4_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 5e-04 | ||
| 1zyc_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 4e-11 | ||
| 1zyc_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 5e-04 | ||
| 1ywr_A | 360 | Crystal Structure Analysis Of Inactive P38 Kinase D | 4e-11 | ||
| 3d7z_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 4e-11 | ||
| 1yw2_A | 360 | Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | 4e-11 | ||
| 3e92_A | 371 | Crystal Structure Of P38 Kinase In Complex With A B | 4e-11 | ||
| 2ghl_A | 348 | Mutant Mus Musculus P38 Kinase Domain In Complex Wi | 4e-11 | ||
| 3npc_A | 364 | Crystal Structure Of Jnk2 Complexed With Birb796 Le | 4e-11 | ||
| 2oza_B | 366 | Structure Of P38alpha Complex Length = 366 | 4e-11 | ||
| 4gs6_A | 315 | Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxoz | 4e-11 | ||
| 4e5a_X | 360 | The W197a Mutant Of P38a Map Kinase Length = 360 | 4e-11 | ||
| 2bal_A | 365 | P38alpha Map Kinase Bound To Pyrazoloamine Length = | 4e-11 | ||
| 3nr9_A | 368 | Structure Of Human Cdc2-Like Kinase 2 (Clk2) Length | 4e-11 | ||
| 3nnx_A | 354 | Crystal Structure Of Phosphorylated P38 Alpha In Co | 4e-11 | ||
| 4ewq_A | 383 | Human P38 Alpha Mapk In Complex With A Pyridazine B | 4e-11 | ||
| 1f3m_C | 297 | Crystal Structure Of Human SerineTHREONINE KINASE P | 4e-11 | ||
| 2fso_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a) A | 4e-11 | ||
| 2baj_A | 365 | P38alpha Bound To Pyrazolourea Length = 365 | 5e-11 | ||
| 3hrb_A | 359 | P38 Kinase Crystal Structure In Complex With Small | 5e-11 | ||
| 3mpt_A | 371 | Crystal Structure Of P38 Kinase In Complex With A P | 5e-11 | ||
| 2fsl_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a+f3 | 5e-11 | ||
| 2fst_X | 367 | Mitogen Activated Protein Kinase P38alpha (d176a+f3 | 5e-11 | ||
| 3odz_X | 360 | Crystal Structure Of P38alpha Y323r Active Mutant L | 5e-11 | ||
| 3gcu_A | 360 | Human P38 Map Kinase In Complex With Rl48 Length = | 5e-11 | ||
| 3hvc_A | 362 | Crystal Structure Of Human P38alpha Map Kinase Leng | 5e-11 | ||
| 1bl6_A | 379 | The Complex Structure Of The Map Kinase P38SB216995 | 5e-11 | ||
| 1oz1_A | 372 | P38 Mitogen-Activated Kinase In Complex With 4-Azai | 5e-11 | ||
| 3ody_X | 360 | Crystal Structure Of P38alpha Y323q Active Mutant L | 5e-11 | ||
| 2gfs_A | 372 | P38 Kinase Crystal Structure In Complex With Ro3201 | 5e-11 | ||
| 1yhv_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Two Po | 5e-11 | ||
| 3k3j_A | 362 | P38alpha Bound To Novel Dfg-Out Compound Pf-0041612 | 5e-11 | ||
| 2npq_A | 367 | A Novel Lipid Binding Site In The P38 Alpha Map Kin | 5e-11 | ||
| 3dt1_A | 383 | P38 Complexed With A Quinazoline Inhibitor Length = | 5e-11 | ||
| 1zzl_A | 351 | Crystal Structure Of P38 With Triazolopyridine Leng | 5e-11 | ||
| 3oef_X | 360 | Crystal Structure Of Y323f Inactive Mutant Of P38al | 5e-11 | ||
| 1m7q_A | 366 | Crystal Structure Of P38 Map Kinase In Complex With | 5e-11 | ||
| 3s3i_A | 349 | P38 Kinase Crystal Structure In Complex With Small | 6e-11 | ||
| 3od6_X | 360 | Crystal Structure Of P38alpha Y323t Active Mutant L | 6e-11 | ||
| 3kq7_A | 380 | Structure Of Human P38alpha With N-[4-Methyl-3-(6-{ | 6e-11 | ||
| 2lgc_A | 359 | Joint Nmr And X-Ray Refinement Reveals The Structur | 6e-11 | ||
| 3zsg_A | 362 | X-Ray Structure Of P38alpha Bound To Tak-715 Length | 6e-11 | ||
| 3k3i_A | 350 | P38alpha Bound To Novel Dgf-Out Compound Pf-0021595 | 6e-11 | ||
| 3hec_A | 348 | P38 In Complex With Imatinib Length = 348 | 6e-11 | ||
| 1di9_A | 360 | The Structure Of P38 Mitogen-Activated Protein Kina | 6e-11 | ||
| 3nnu_A | 354 | Crystal Structure Of P38 Alpha In Complex With Dp13 | 6e-11 | ||
| 1yxs_A | 293 | Crystal Structure Of Kinase Pim1 With P123m Mutatio | 6e-11 | ||
| 3uix_A | 298 | Crystal Structure Of Pim1 Kinase In Complex With Sm | 6e-11 | ||
| 1xws_A | 313 | Crystal Structure Of The Human Pim1 Kinase Domain L | 6e-11 | ||
| 4alu_A | 328 | Benzofuropyrimidinone Inhibitors Of Pim-1 Length = | 7e-11 | ||
| 3r00_A | 299 | The Discovery Of Novel Benzofuran-2-Carboxylic Acid | 7e-11 | ||
| 4dtk_A | 276 | Novel And Selective Pan-Pim Kinase Inhibitor Length | 7e-11 | ||
| 1ywv_A | 293 | Crystal Structures Of Proto-Oncogene Kinase Pim1: A | 7e-11 | ||
| 2f9g_A | 353 | Crystal Structure Of Fus3 Phosphorylated On Tyr182 | 7e-11 | ||
| 3jxw_A | 294 | Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4- | 7e-11 | ||
| 2xj0_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-4 Fro | 7e-11 | ||
| 4alv_A | 328 | Benzofuropyrimidinone Inhibitors Of Pim-1 Length = | 7e-11 | ||
| 2bil_B | 313 | The Human Protein Kinase Pim1 In Complex With Its C | 7e-11 | ||
| 3c4e_A | 273 | Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7 | 7e-11 | ||
| 1ian_A | 366 | Human P38 Map Kinase Inhibitor Complex Length = 366 | 7e-11 | ||
| 3a99_A | 320 | Structure Of Pim-1 Kinase Crystallized In The Prese | 7e-11 | ||
| 3qa8_A | 676 | Crystal Structure Of Inhibitor Of Kappa B Kinase Be | 8e-11 | ||
| 3cxw_A | 314 | Crystal Structure Of Human Proto-Oncogene Serine Th | 8e-11 | ||
| 1xqz_A | 300 | Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolut | 8e-11 | ||
| 4as0_A | 273 | Cyclometalated Phthalimides As Protein Kinase Inhib | 8e-11 | ||
| 3rzf_A | 677 | Crystal Structure Of Inhibitor Of Kappab Kinase Bet | 8e-11 | ||
| 3jpv_A | 313 | Crystal Structure Of Human Proto-Oncogene Serine Th | 8e-11 | ||
| 4g31_A | 299 | Crystal Structure Of Gsk6414 Bound To Perk (R587-R1 | 8e-11 | ||
| 4g31_A | 299 | Crystal Structure Of Gsk6414 Bound To Perk (R587-R1 | 6e-05 | ||
| 3gcp_A | 360 | Human P38 Map Kinase In Complex With Sb203580 Lengt | 9e-11 | ||
| 2j2i_B | 312 | Crystal Structure Of The Humab Pim1 In Complex With | 9e-11 | ||
| 2b9f_A | 353 | Crystal Structure Of Non-Phosphorylated Fus3 Length | 9e-11 | ||
| 1h4l_A | 292 | Structure And Regulation Of The Cdk5-P25(Nck5a) Com | 1e-10 | ||
| 1yhs_A | 273 | Crystal Structure Of Pim-1 Bound To Staurosporine L | 1e-10 | ||
| 3gbz_A | 329 | Structure Of The Cmgc Cdk Kinase From Giardia Lambl | 1e-10 | ||
| 1o9u_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 1e-10 | ||
| 3fi4_A | 372 | P38 Kinase Crystal Structure In Complex With Ro4499 | 1e-10 | ||
| 3mh2_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 1e-10 | ||
| 2c30_A | 321 | Crystal Structure Of The Human P21-Activated Kinase | 1e-10 | ||
| 2eva_A | 307 | Structural Basis For The Interaction Of Tak1 Kinase | 1e-10 | ||
| 2b9h_A | 353 | Crystal Structure Of Fus3 With A Docking Motif From | 2e-10 | ||
| 3q4z_A | 306 | Structure Of Unphosphorylated Pak1 Kinase Domain Le | 2e-10 | ||
| 4dit_A | 382 | Crystal Structure Of Gsk3beta In Complex With A Imi | 2e-10 | ||
| 3say_A | 430 | Crystal Structure Of Human Glycogen Synthase Kinase | 2e-10 | ||
| 3fxz_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Ruthen | 2e-10 | ||
| 3zrk_A | 371 | Identification Of 2-(4-Pyridyl)thienopyridinones As | 2e-10 | ||
| 1gng_A | 378 | Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With | 2e-10 | ||
| 3q52_A | 306 | Structure Of Phosphorylated Pak1 Kinase Domain Leng | 2e-10 | ||
| 1uv5_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With 6-Br | 2e-10 | ||
| 1h8f_A | 352 | Glycogen Synthase Kinase 3 Beta. Length = 352 | 2e-10 | ||
| 2obj_A | 333 | Crystal Structure Of Human Pim-1 Kinase In Complex | 2e-10 | ||
| 4afj_A | 367 | 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selec | 2e-10 | ||
| 3f2a_A | 300 | Crystal Structure Of Human Pim-1 In Complex With Da | 2e-10 | ||
| 1q5k_A | 414 | Crystal Structure Of Glycogen Synthase Kinase 3 In | 2e-10 | ||
| 2xiy_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-2 Fro | 2e-10 | ||
| 4a7c_A | 308 | Crystal Structure Of Pim1 Kinase With Etp46546 Leng | 2e-10 | ||
| 3cy3_A | 314 | Crystal Structure Of Human Proto-Oncogene Serine Th | 2e-10 | ||
| 1i09_A | 420 | Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Len | 2e-10 | ||
| 3dcv_A | 328 | Crystal Structure Of Human Pim1 Kinase Complexed Wi | 2e-10 | ||
| 2bik_B | 313 | Human Pim1 Phosphorylated On Ser261 Length = 313 | 2e-10 | ||
| 4acc_A | 465 | Gsk3b In Complex With Inhibitor Length = 465 | 3e-10 | ||
| 3zdi_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 3e-10 | ||
| 1q3d_A | 424 | Gsk-3 Beta Complexed With Staurosporine Length = 42 | 3e-10 | ||
| 1pyx_A | 422 | Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | 3e-10 | ||
| 2eu9_A | 355 | Crystal Structure Of Clk3 Length = 355 | 3e-10 | ||
| 3gb2_A | 353 | Gsk3beta Inhibitor Complex Length = 353 | 3e-10 | ||
| 3f7z_A | 350 | X-ray Co-crystal Structure Of Glycogen Synthase Kin | 3e-10 | ||
| 3ma3_A | 313 | Crystal Structure Of Human Proto-Oncogene Serine Th | 3e-10 | ||
| 2ow3_A | 352 | Glycogen Synthase Kinase-3 Beta In Complex With Bis | 3e-10 | ||
| 3oht_A | 389 | Crystal Structure Of Salmo Salar P38alpha Length = | 3e-10 | ||
| 2wu6_A | 381 | Crystal Structure Of The Human Clk3 In Complex With | 3e-10 | ||
| 2exe_A | 357 | Crystal Structure Of The Phosphorylated Clk3 Length | 3e-10 | ||
| 1r0e_A | 391 | Glycogen Synthase Kinase-3 Beta In Complex With 3-I | 3e-10 | ||
| 2o5k_A | 372 | Crystal Structure Of Gsk3beta In Complex With A Ben | 3e-10 | ||
| 3gi3_A | 360 | Crystal Structure Of A N-Phenyl-N'-Naphthylurea Ana | 3e-10 | ||
| 3k2l_A | 429 | Crystal Structure Of Dual-Specificity Tyrosine Phos | 3e-10 | ||
| 2xix_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-1 Fro | 3e-10 | ||
| 3o8p_A | 360 | Conformational Plasticity Of P38 Map Kinase Dfg Mot | 3e-10 | ||
| 3sd0_A | 350 | Identification Of A Glycogen Synthase Kinase-3b Inh | 4e-10 | ||
| 4euu_A | 319 | Structure Of Bx-795 Complexed With Human Tbk1 Kinas | 4e-10 | ||
| 3omv_A | 307 | Crystal Structure Of C-Raf (Raf-1) Length = 307 | 4e-10 | ||
| 1ung_A | 292 | Structural Mechanism For The Inhibition Of Cdk5-P25 | 5e-10 | ||
| 1zxe_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 5e-10 | ||
| 4eut_A | 396 | Structure Of Bx-795 Complexed With Unphosphorylated | 6e-10 | ||
| 3mh0_A | 360 | Mutagenesis Of P38 Map Kinase Eshtablishes Key Role | 6e-10 | ||
| 3ll6_A | 337 | Crystal Structure Of The Human Cyclin G Associated | 7e-10 | ||
| 3mh1_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 7e-10 | ||
| 3mh3_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 8e-10 | ||
| 1ua2_A | 346 | Crystal Structure Of Human Cdk7 Length = 346 | 9e-10 | ||
| 3aln_A | 327 | Crystal Structure Of Human Non-Phosphorylated Mkk4 | 9e-10 | ||
| 2f57_A | 317 | Crystal Structure Of The Human P21-activated Kinase | 1e-09 | ||
| 2buj_A | 317 | Crystal Structure Of The Human Serine-Threonine Kin | 1e-09 | ||
| 3rgf_A | 405 | Crystal Structure Of Human Cdk8CYCC Length = 405 | 1e-09 | ||
| 3f88_A | 349 | Glycogen Synthase Kinase 3beta Inhibitor Complex Le | 2e-09 | ||
| 4h3q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 2e-09 | ||
| 4ec8_A | 373 | Structure Of Full Length Cdk9 In Complex With Cycli | 2e-09 | ||
| 3ii5_A | 306 | The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimi | 2e-09 | ||
| 3d4q_A | 307 | Pyrazole-Based Inhibitors Of B-Raf Kinase Length = | 2e-09 | ||
| 2fb8_A | 281 | Structure Of The B-Raf Kinase Domain Bound To Sb-59 | 2e-09 | ||
| 3c4c_A | 280 | B-Raf Kinase In Complex With Plx4720 Length = 280 | 2e-09 | ||
| 3q96_A | 282 | B-Raf Kinase Domain In Complex With A Tetrahydronap | 2e-09 | ||
| 4bcf_A | 331 | Structure Of Cdk9 In Complex With Cyclin T And A 2- | 2e-09 | ||
| 4dbn_A | 284 | Crystal Structure Of The Kinase Domain Of Human B-R | 2e-09 | ||
| 1uwh_A | 276 | The Complex Of Wild Type B-Raf And Bay439006 Length | 2e-09 | ||
| 3mi9_A | 351 | Crystal Structure Of Hiv-1 Tat Complexed With Human | 2e-09 | ||
| 4h58_A | 275 | Braf In Complex With Compound 3 Length = 275 | 2e-09 | ||
| 3n9x_A | 432 | Crystal Structure Of Map Kinase From Plasmodium Ber | 3e-09 | ||
| 2zoq_A | 382 | Structural Dissection Of Human Mitogen-Activated Ki | 3e-09 | ||
| 3blh_A | 331 | Crystal Structure Of Human Cdk9CYCLINT1 Length = 33 | 3e-09 | ||
| 3tei_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 3e-09 | ||
| 3hmn_A | 342 | Crystal Structure Of Human Mps1 Catalytic Domain In | 3e-09 | ||
| 2x9e_A | 317 | Human Mps1 In Complex With Nms-P715 Length = 317 | 3e-09 | ||
| 2zmc_A | 390 | Crystal Structure Of Human Mitotic Checkpoint Kinas | 3e-09 | ||
| 3dbq_A | 343 | Crystal Structure Of Ttk Kinase Domain Length = 343 | 3e-09 | ||
| 4g3d_A | 371 | Crystal Structure Of Human Nf-kappab Inducing Kinas | 4e-09 | ||
| 3h9f_A | 313 | Crystal Structure Of Human Dual Specificity Protein | 4e-09 | ||
| 3vqu_A | 320 | Crystal Structure Of Human Mps1 Catalytic Domain In | 4e-09 | ||
| 3uib_A | 362 | Map Kinase Lmampk10 From Leishmania Major In Comple | 4e-09 | ||
| 4dn5_A | 356 | Crystal Structure Of Nf-kb-inducing Kinase (nik) Le | 4e-09 | ||
| 3pg1_A | 362 | Map Kinase Lmampk10 From Leishmania Major (1.95 Ang | 4e-09 | ||
| 2rio_A | 434 | Structure Of The Dual Enzyme Ire1 Reveals The Basis | 5e-09 | ||
| 3bys_A | 277 | Co-Crystal Structure Of Lck And Aminopyrimidine Ami | 5e-09 | ||
| 3cek_A | 313 | Crystal Structure Of Human Dual Specificity Protein | 5e-09 | ||
| 3sa0_A | 360 | Complex Of Erk2 With Norathyriol Length = 360 | 5e-09 | ||
| 2ofv_A | 277 | Crystal Structure Of Aminoquinazoline 1 Bound To Lc | 5e-09 | ||
| 3vn9_A | 340 | Rifined Crystal Structure Of Non-Phosphorylated Map | 5e-09 | ||
| 3lj0_A | 434 | Ire1 Complexed With Adp And Quercetin Length = 434 | 5e-09 | ||
| 2pl0_A | 289 | Lck Bound To Imatinib Length = 289 | 5e-09 | ||
| 4fk3_A | 292 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 5e-09 | ||
| 2of2_A | 271 | Crystal Structure Of Furanopyrimidine 8 Bound To Lc | 5e-09 | ||
| 3fpq_A | 290 | Crystal Structure Of The Kinase Domain Of Wnk1 Leng | 6e-09 | ||
| 3idp_A | 300 | B-Raf V600e Kinase Domain In Complex With An Aminoi | 6e-09 | ||
| 2og8_A | 265 | Crystal Structure Of Aminoquinazoline 36 Bound To L | 6e-09 | ||
| 4fv7_A | 360 | Crystal Structure Of The Erk2 Complexed With E94 Le | 6e-09 | ||
| 4gsb_A | 364 | Monoclinic Crystal Form Of The Apo-Erk2 Length = 36 | 6e-09 | ||
| 4fux_A | 360 | Crystal Structure Of The Erk2 Complexed With E75 Le | 6e-09 | ||
| 4g9r_A | 307 | B-Raf V600e Kinase Domain Bound To A Type Ii Dihydr | 6e-09 | ||
| 3og7_A | 289 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 6e-09 | ||
| 3qyw_A | 364 | Crystal Structure Of Erk2 In Complex With An Inhibi | 6e-09 | ||
| 4b99_A | 398 | Crystal Structure Of Mapk7 (Erk5) With Inhibitor Le | 7e-09 | ||
| 1pme_A | 380 | Structure Of Penta Mutant Human Erk2 Map Kinase Com | 7e-09 | ||
| 4apc_A | 350 | Crystal Structure Of Human Nima-Related Kinase 1 (N | 7e-09 | ||
| 1uwj_A | 276 | The Complex Of Mutant V599e B-raf And Bay439006 Len | 7e-09 | ||
| 2ojg_A | 380 | Crystal Structure Of Erk2 In Complex With N,n-dimet | 8e-09 | ||
| 1wzy_A | 368 | Crystal Structure Of Human Erk2 Complexed With A Py | 8e-09 | ||
| 1tvo_A | 368 | The Structure Of Erk2 In Complex With A Small Molec | 8e-09 | ||
| 2y9q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 8e-09 | ||
| 3o71_A | 358 | Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length | 8e-09 | ||
| 1gol_A | 364 | Coordinates Of Rat Map Kinase Erk2 With An Arginine | 8e-09 | ||
| 4fv6_A | 360 | Crystal Structure Of The Erk2 Complexed With E57 Le | 8e-09 | ||
| 3r63_A | 358 | Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | 8e-09 | ||
| 2gph_A | 364 | Docking Motif Interactions In The Map Kinase Erk2 L | 8e-09 | ||
| 3zuv_A | 364 | Crystal Structure Of A Designed Selected Ankyrin Re | 8e-09 | ||
| 3zu7_A | 365 | Crystal Structure Of A Designed Selected Ankyrin Re | 8e-09 | ||
| 2z7l_A | 366 | Unphosphorylated Mitogen Activated Protein Kinase E | 8e-09 | ||
| 3c9w_A | 357 | Crystal Structure Of Erk-2 With Hypothemycin Covale | 8e-09 | ||
| 2fys_B | 364 | Crystal Structure Of Erk2 Complex With Kim Peptide | 8e-09 | ||
| 2erk_A | 365 | Phosphorylated Map Kinase Erk2 Length = 365 | 8e-09 | ||
| 4ic7_A | 442 | Crystal Structure Of The Erk5 Kinase Domain In Comp | 9e-09 | ||
| 1qpd_A | 279 | Structural Analysis Of The Lymphocyte-specific Kina | 9e-09 | ||
| 3ppz_A | 309 | Crystal Structure Of Ctr1 Kinase Domain In Complex | 1e-08 | ||
| 3uiu_A | 306 | Crystal Structure Of Apo-Pkr Kinase Domain Length = | 1e-08 | ||
| 3qd2_B | 332 | Crsytal Structure Of Mouse Perk Kinase Domain Lengt | 1e-08 | ||
| 4g3g_A | 350 | Crystal Structure Of Murine Nf-kappab Inducing Kina | 1e-08 | ||
| 3p86_A | 309 | Crystal Structure Of Ctr1 Kinase Domain Mutant D676 | 1e-08 | ||
| 2zm1_A | 285 | Crystal Structure Of Imidazo Pyrazin 1 Bound To The | 1e-08 | ||
| 3kxz_A | 287 | The Complex Crystal Structure Of Lck With A Probe M | 1e-08 | ||
| 3lck_A | 271 | The Kinase Domain Of Human Lymphocyte Kinase (Lck), | 1e-08 | ||
| 2zmd_A | 390 | Crystal Structure Of Human Mps1 Catalytic Domain T6 | 1e-08 | ||
| 2ofu_A | 273 | X-Ray Crystal Structure Of 2-Aminopyrimidine Carbam | 1e-08 | ||
| 1qpe_A | 279 | Structural Analysis Of The Lymphocyte-Specific Kina | 1e-08 | ||
| 3kmm_A | 288 | Structure Of Human Lck Kinase With A Small Molecule | 1e-08 | ||
| 3bym_A | 272 | X-Ray Co-Crystal Structure Aminobenzimidazole Triaz | 1e-08 | ||
| 3nie_A | 429 | Crystal Structure Of Pf11_0147 Length = 429 | 2e-08 | ||
| 3mpm_A | 267 | Lck Complexed With A Pyrazolopyrimidine Length = 26 | 2e-08 | ||
| 4f99_A | 361 | Human Cdc7 Kinase In Complex With Dbf4 And Nucleoti | 2e-08 | ||
| 4g3f_A | 336 | Crystal Structure Of Murine Nf-kappab Inducing Kina | 2e-08 | ||
| 3sdj_A | 448 | Structure Of Rnase-Inactive Point Mutant Of Oligome | 2e-08 | ||
| 3fbv_A | 448 | Crystal Structure Of The Oligomer Formed By The Kin | 3e-08 | ||
| 1u5q_A | 348 | Crystal Structure Of The Tao2 Kinase Domain: Activa | 3e-08 | ||
| 3e3b_X | 339 | Crystal Structure Of Catalytic Subunit Of Human Pro | 3e-08 | ||
| 3f69_A | 311 | Crystal Structure Of The Mycobacterium Tuberculosis | 3e-08 | ||
| 4g3c_A | 352 | Crystal Structure Of Apo Murine Nf-kappab Inducing | 3e-08 | ||
| 3ofm_A | 350 | Structure Of A Human Ck2alpha Prime, The Paralog Is | 3e-08 | ||
| 3llt_A | 360 | Crystal Structure Of Pf14_0431, Kinase Domain Lengt | 4e-08 | ||
| 4eqm_A | 294 | Structural Analysis Of Staphylococcus Aureus Serine | 4e-08 | ||
| 4dgl_C | 335 | Crystal Structure Of The Ck2 Tetrameric Holoenzyme | 4e-08 | ||
| 3f61_A | 311 | Crystal Structure Of M. Tuberculosis Pknb Leu33aspV | 4e-08 | ||
| 2a19_B | 284 | Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Leng | 5e-08 | ||
| 2gcd_A | 309 | Tao2 Kinase Domain-Staurosporine Structure Length = | 5e-08 | ||
| 1byg_A | 278 | Kinase Domain Of Human C-Terminal Src Kinase (Csk) | 5e-08 | ||
| 1k9a_A | 450 | Crystal Structure Analysis Of Full-Length Carboxyl- | 6e-08 | ||
| 3d7u_A | 263 | Structural Basis For The Recognition Of C-Src By It | 6e-08 | ||
| 1o6y_A | 299 | Catalytic Domain Of Pknb Kinase From Mycobacterium | 6e-08 | ||
| 3orm_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain D76a | 7e-08 | ||
| 3fme_A | 290 | Crystal Structure Of Human Mitogen-Activated Protei | 8e-08 | ||
| 3d7t_A | 269 | Structural Basis For The Recognition Of C-Src By It | 8e-08 | ||
| 4fie_A | 423 | Full-Length Human Pak4 Length = 423 | 9e-08 | ||
| 1mru_A | 311 | Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycob | 9e-08 | ||
| 3ori_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain L33d | 1e-07 | ||
| 3p23_A | 432 | Crystal Structure Of The Human Kinase And Rnase Dom | 1e-07 | ||
| 3juh_A | 335 | Crystal Structure Of A Mutant Of Human Protein Kina | 1e-07 | ||
| 4fif_A | 346 | Catalytic Domain Of Human Pak4 With Rpkplvdp Peptid | 2e-07 | ||
| 2q0n_A | 301 | Structure Of Human P21 Activating Kinase 4 (Pak4) I | 2e-07 | ||
| 2cdz_A | 303 | Crystal Structure Of The Human P21-Activated Kinase | 2e-07 | ||
| 3eb0_A | 383 | Crystal Structure Of Cgd4_240 From Cryptosporidium | 2e-07 | ||
| 2bva_A | 292 | Crystal Structure Of The Human P21-Activated Kinase | 2e-07 | ||
| 3u87_A | 349 | Structure Of A Chimeric Construct Of Human Ck2alpha | 2e-07 | ||
| 3enm_A | 316 | The Structure Of The Map2k Mek6 Reveals An Autoinhi | 2e-07 | ||
| 2x4z_A | 296 | Crystal Structure Of The Human P21-Activated Kinase | 2e-07 | ||
| 1jwh_A | 337 | Crystal Structure Of Human Protein Kinase Ck2 Holoe | 2e-07 | ||
| 3q9w_A | 336 | Crystal Structure Of Human Ck2 Alpha In Complex Wit | 2e-07 | ||
| 2r7i_A | 335 | Crystal Structure Of Catalytic Subunit Of Protein K | 2e-07 | ||
| 2zjw_A | 340 | Crystal Structure Of Human Ck2 Alpha Complexed With | 2e-07 | ||
| 3bqc_A | 335 | High Ph-Value Crystal Structure Of Emodin In Comple | 2e-07 | ||
| 1pjk_A | 334 | Crystal Structure Of A C-terminal Deletion Mutant O | 2e-07 | ||
| 3h30_A | 334 | Crystal Structure Of The Catalytic Subunit Of Human | 2e-07 | ||
| 3nga_A | 333 | Human Ck2 Catalytic Domain In Complex With Cx-4945 | 2e-07 | ||
| 3nsz_A | 330 | Human Ck2 Catalytic Domain In Complex With Amppn Le | 2e-07 | ||
| 3q04_A | 328 | Crystal Structure Of The Apo-Form Of Human Ck2 Alph | 3e-07 | ||
| 3mb6_A | 331 | Human Ck2 Catalytic Domain In Complex With A Difura | 3e-07 | ||
| 2dyl_A | 318 | Crystal Structure Of Human Mitogen-Activated Protei | 4e-07 | ||
| 3sls_A | 304 | Crystal Structure Of Human Mek-1 Kinase In Complex | 5e-07 | ||
| 2wtk_B | 373 | Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo2 | 6e-07 | ||
| 1eh4_A | 298 | Binary Complex Of Casein Kinase-1 From S. Pombe Wit | 6e-07 | ||
| 3gni_B | 389 | Structure Of Strad And Mo25 Length = 389 | 6e-07 | ||
| 2csn_A | 297 | Binary Complex Of Casein Kinase-1 With Cki7 Length | 6e-07 | ||
| 1q8y_A | 373 | The Structure Of The Yeast Sr Protein Kinase, Sky1p | 7e-07 | ||
| 3rp9_A | 458 | Crystal Structure Of The Apo Mapk From Toxoplasma G | 7e-07 | ||
| 3dtc_A | 271 | Crystal Structure Of Mixed-Lineage Kinase Mlk1 Comp | 7e-07 | ||
| 1how_A | 373 | The X-Ray Crystal Structure Of Sky1p, An Sr Protein | 7e-07 | ||
| 3orn_A | 307 | Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In | 9e-07 | ||
| 2i6l_A | 320 | Crystal Structure Of Human Mitogen Activated Protei | 1e-06 | ||
| 3pvg_A | 331 | Crystal Structure Of Z. Mays Ck2 Alpha Subunit In C | 2e-06 | ||
| 1ds5_A | 332 | Dimeric Crystal Structure Of The Alpha Subunit In C | 2e-06 | ||
| 2qc6_A | 332 | Protein Kinase Ck2 In Complex With Dbc Length = 332 | 2e-06 | ||
| 2pvh_A | 352 | Structure-Based Design Of Pyrazolo[1,5-A][1,3,5]tri | 2e-06 | ||
| 4anm_A | 335 | Complex Of Ck2 With A Cdc7 Inhibitor Length = 335 | 2e-06 | ||
| 3gvu_A | 292 | The Crystal Structure Of Human Abl2 In Complex With | 2e-06 | ||
| 3kxg_A | 327 | Crystal Structure Of Z. Mays Ck2 Kinase Alpha Subun | 2e-06 | ||
| 3e3p_A | 360 | Glycogen Synthase Kinase From Leishmania Major Leng | 2e-06 | ||
| 1daw_A | 327 | Crystal Structure Of A Binary Complex Of Protein Ki | 2e-06 | ||
| 4dgn_A | 326 | Crystal Structure Of Maize Ck2 In Complex With The | 2e-06 | ||
| 1m2p_A | 325 | Crystal Structure Of 1,8-Di-Hydroxy-4-Nitro- Anthra | 2e-06 | ||
| 4dgm_A | 326 | Crystal Structure Of Maize Ck2 In Complex With The | 2e-06 | ||
| 3sxr_A | 268 | Crystal Structure Of Bmx Non-Receptor Tyrosine Kina | 2e-06 | ||
| 3s95_A | 310 | Crystal Structure Of The Human Limk1 Kinase Domain | 2e-06 | ||
| 2y4i_B | 319 | Ksr2-Mek1 Heterodimer Length = 319 | 3e-06 | ||
| 2y4i_C | 395 | Ksr2-Mek1 Heterodimer Length = 395 | 4e-06 | ||
| 3a4o_X | 286 | Lyn Kinase Domain Length = 286 | 5e-06 | ||
| 2zv7_A | 279 | Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | 5e-06 | ||
| 2hk5_A | 270 | Hck Kinase In Complex With Lck Targetted Inhibitor | 6e-06 | ||
| 3eqc_A | 360 | X-Ray Structure Of The Human Mitogen-Activated Prot | 6e-06 | ||
| 1qcf_A | 454 | Crystal Structure Of Hck In Complex With A Src Fami | 7e-06 | ||
| 2p55_A | 333 | X-Ray Structure Of The Human Mitogen-Activated Prot | 8e-06 | ||
| 1s9j_A | 341 | X-Ray Structure Of The Human Mitogen-Activated Prot | 8e-06 | ||
| 2qok_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 9e-06 | ||
| 4an2_A | 301 | Crystal Structures Of Human Mek1 With Carboxamide-B | 9e-06 | ||
| 1jpa_A | 312 | Crystal Structure Of Unphosphorylated Ephb2 Recepto | 1e-05 | ||
| 3mbl_A | 328 | Crystal Structure Of The Human Mitogen-Activated Pr | 1e-05 | ||
| 3dv3_A | 322 | Mek1 With Pf-04622664 Bound Length = 322 | 1e-05 | ||
| 3miy_A | 266 | X-Ray Crystal Structure Of Itk Complexed With Sunit | 1e-05 | ||
| 2nru_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 1e-05 | ||
| 2nry_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 1e-05 | ||
| 2rei_A | 318 | Kinase Domain Of Human Ephrin Type-a Receptor 7 (ep | 1e-05 | ||
| 2qon_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 2e-05 | ||
| 3t9t_A | 267 | Crystal Structure Of Btk Mutant (F435t,K596r) Compl | 2e-05 | ||
| 1ad5_A | 438 | Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | 2e-05 | ||
| 2qoo_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 2e-05 | ||
| 3hng_A | 360 | Crystal Structure Of Vegfr1 In Complex With N-(4-ch | 2e-05 | ||
| 4hct_A | 269 | Crystal Structure Of Itk In Complex With Compound 5 | 2e-05 | ||
| 1sm2_A | 264 | Crystal Structure Of The Phosphorylated Interleukin | 2e-05 | ||
| 4hvd_A | 314 | Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h | 2e-05 | ||
| 3v5j_A | 266 | Crystal Structure Of Interleukin-2 Inducible T-Cell | 2e-05 | ||
| 3qgw_A | 286 | Crystal Structure Of Itk Kinase Bound To An Inhibit | 2e-05 | ||
| 4aw5_A | 291 | Complex Of The Ephb4 Kinase Domain With An Oxindole | 2e-05 | ||
| 3dzq_A | 361 | Human Epha3 Kinase Domain In Complex With Inhibitor | 2e-05 | ||
| 2qob_A | 344 | Human Epha3 Kinase Domain, Base Structure Length = | 2e-05 | ||
| 2qoi_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 2e-05 | ||
| 3lxk_A | 327 | Structural And Thermodynamic Characterization Of Th | 2e-05 | ||
| 2qof_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f | 2e-05 | ||
| 2qod_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y602f | 2e-05 | ||
| 3pjc_A | 315 | Crystal Structure Of Jak3 Complexed With A Potent A | 2e-05 | ||
| 2qoc_A | 344 | Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp | 2e-05 | ||
| 2gsf_A | 373 | The Human Epha3 Receptor Tyrosine Kinase And Juxtam | 2e-05 | ||
| 2qo7_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Dephos | 2e-05 | ||
| 2qol_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596:y | 2e-05 | ||
| 1yvj_A | 290 | Crystal Structure Of The Jak3 Kinase Domain In Comp | 2e-05 | ||
| 3fxx_A | 371 | Human Epha3 Kinase And Juxtamembrane Region Bound T | 3e-05 | ||
| 4f0f_A | 287 | Crystal Structure Of The Roco4 Kinase Domain Bound | 3e-05 | ||
| 3zzw_A | 289 | Crystal Structure Of The Kinase Domain Of Ror2 Leng | 4e-05 | ||
| 4gt4_A | 308 | Structure Of Unliganded, Inactive Ror2 Kinase Domai | 4e-05 | ||
| 1rjb_A | 344 | Crystal Structure Of Flt3 Length = 344 | 5e-05 | ||
| 1s9i_A | 354 | X-Ray Structure Of The Human Mitogen-Activated Prot | 5e-05 | ||
| 3gen_A | 283 | The 1.6 A Crystal Structure Of Human Bruton's Tyros | 5e-05 | ||
| 2oib_A | 301 | Crystal Structure Of Irak4 Kinase Domain Apo Form L | 5e-05 | ||
| 3vid_A | 356 | Crystal Structure Of Human Vegfr2 Kinase Domain Wit | 6e-05 | ||
| 3u6j_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 6e-05 | ||
| 1y6a_A | 366 | Crystal Structure Of Vegfr2 In Complex With A 2-Ani | 6e-05 | ||
| 3ewh_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 6e-05 | ||
| 3vhk_A | 368 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 6e-05 | ||
| 3vhe_A | 359 | Crystal Structure Of Human Vegfr2 Kinase Domain Wit | 6e-05 | ||
| 3cjf_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 7e-05 | ||
| 2pzi_A | 681 | Crystal Structure Of Protein Kinase Pkng From Mycob | 7e-05 | ||
| 2h8h_A | 535 | Src Kinase In Complex With A Quinazoline Inhibitor | 7e-05 | ||
| 4agc_A | 353 | Crystal Structure Of Vegfr2 (Juxtamembrane And Kina | 7e-05 | ||
| 4f1o_A | 287 | Crystal Structure Of The L1180t Mutant Roco4 Kinase | 7e-05 | ||
| 2hen_A | 286 | Crystal Structure Of The Ephb2 Receptor Kinase Doma | 7e-05 | ||
| 3vnt_A | 318 | Crystal Structure Of The Kinase Domain Of Human Veg | 7e-05 | ||
| 2xir_A | 316 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 7e-05 | ||
| 3cjg_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 7e-05 | ||
| 3p08_A | 267 | Crystal Structure Of The Human Btk Kinase Domain Le | 7e-05 | ||
| 3oct_A | 265 | Crystal Structure Of Bruton's Tyrosine Kinase Mutan | 8e-05 | ||
| 2r2p_A | 295 | Kinase Domain Of Human Ephrin Type-A Receptor 5 (Ep | 9e-05 | ||
| 1k2p_A | 263 | Crystal Structure Of Bruton's Tyrosine Kinase Domai | 9e-05 | ||
| 3pix_A | 274 | Crystal Structure Of Btk Kinase Domain Complexed Wi | 9e-05 | ||
| 3ocs_A | 271 | Crystal Structure Of Bruton's Tyrosine Kinase In Co | 9e-05 | ||
| 1y57_A | 452 | Structure Of Unphosphorylated C-Src In Complex With | 1e-04 | ||
| 1fmk_A | 452 | Crystal Structure Of Human Tyrosine-Protein Kinase | 1e-04 | ||
| 3k54_A | 283 | Structures Of Human Bruton's Tyrosine Kinase In Act | 1e-04 | ||
| 1ksw_A | 452 | Structure Of Human C-Src Tyrosine Kinase (Thr338gly | 1e-04 | ||
| 1yol_A | 283 | Crystal Structure Of Src Kinase Domain In Complex W | 1e-04 | ||
| 2bdf_A | 279 | Src Kinase In Complex With Inhibitor Ap23451 Length | 1e-04 | ||
| 2p2i_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 1e-04 | ||
| 2p2h_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 1e-04 | ||
| 3d7u_B | 277 | Structural Basis For The Recognition Of C-Src By It | 1e-04 | ||
| 2vwu_A | 302 | Ephb4 Kinase Domain Inhibitor Complex Length = 302 | 1e-04 | ||
| 3sv0_A | 483 | Crystal Structure Of Casein Kinase-1 Like Protein I | 2e-04 | ||
| 3u4w_A | 275 | Src In Complex With Dna-Templated Macrocyclic Inhib | 2e-04 | ||
| 3oez_A | 286 | Crystal Structure Of The L317i Mutant Of The Chicke | 2e-04 | ||
| 2oiq_A | 286 | Crystal Structure Of Chicken C-Src Kinase Domain In | 2e-04 | ||
| 1ywn_A | 316 | Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]p | 2e-04 | ||
| 3g6h_A | 286 | Src Thr338ile Inhibited In The Dfg-Asp-Out Conforma | 2e-04 | ||
| 1u46_A | 291 | Crystal Structure Of The Unphosphorylated Kinase Do | 2e-04 | ||
| 1u54_A | 291 | Crystal Structures Of The Phosphorylated And Unphos | 2e-04 | ||
| 3c7q_A | 316 | Structure Of Vegfr2 Kinase Domain In Complex With B | 2e-04 | ||
| 2oh4_A | 316 | Crystal Structure Of Vegfr2 With A Benzimidazole-Ur | 2e-04 | ||
| 4hzs_A | 341 | Crystal Structure Of Ack1 Kinase Domain With C-term | 2e-04 | ||
| 1vr2_A | 316 | Human Vascular Endothelial Growth Factor Receptor 2 | 2e-04 | ||
| 2hwo_A | 286 | Crystal Structure Of Src Kinase Domain In Complex W | 2e-04 | ||
| 3svv_A | 286 | Crystal Structure Of T338c C-Src Covalently Bound T | 2e-04 | ||
| 2qq7_A | 286 | Crystal Structure Of Drug Resistant Src Kinase Doma | 2e-04 | ||
| 4f1m_A | 287 | Crystal Structure Of The G1179s Roco4 Kinase Domain | 2e-04 | ||
| 3eqp_B | 276 | Crystal Structure Of Ack1 With Compound T95 Length | 2e-04 | ||
| 2o8y_A | 298 | Apo Irak4 Kinase Domain Length = 298 | 2e-04 | ||
| 4ewh_B | 275 | Co-Crystal Structure Of Ack1 With Inhibitor Length | 2e-04 | ||
| 3hgk_A | 327 | Crystal Structure Of Effect Protein Avrptob Complex | 3e-04 | ||
| 2dq7_X | 283 | Crystal Structure Of Fyn Kinase Domain Complexed Wi | 3e-04 | ||
| 4hzr_A | 277 | Crystal Structure Of Ack1 Kinase Domain Length = 27 | 3e-04 | ||
| 2in6_A | 287 | Wee1 Kinase Complex With Inhibitor Pd311839 Length | 3e-04 | ||
| 2z2w_A | 285 | Humand Wee1 Kinase Complexed With Inhibitor Pf03357 | 3e-04 | ||
| 3bi6_A | 287 | Wee1 Kinase Complex With Inhibitor Pd352396 Length | 3e-04 | ||
| 1x8b_A | 289 | Structure Of Human Wee1a Kinase: Kinase Domain Comp | 3e-04 | ||
| 4id7_A | 273 | Ack1 Kinase In Complex With The Inhibitor Cis-3-[8- | 3e-04 | ||
| 1yoj_A | 283 | Crystal Structure Of Src Kinase Domain Length = 283 | 3e-04 | ||
| 2ptk_A | 453 | Chicken Src Tyrosine Kinase Length = 453 | 3e-04 | ||
| 3geq_A | 286 | Structural Basis For The Chemical Rescue Of Src Kin | 3e-04 | ||
| 1yi6_A | 276 | C-Term Tail Segment Of Human Tyrosine Kinase (258-5 | 3e-04 | ||
| 2qkw_B | 321 | Structural Basis For Activation Of Plant Immunity B | 4e-04 | ||
| 3lxn_A | 318 | Structural And Thermodynamic Characterization Of Th | 4e-04 | ||
| 2pml_X | 348 | Crystal Structure Of Pfpk7 In Complex With An Atp A | 4e-04 | ||
| 4hgl_A | 330 | Crystal Structure Of Ck1g3 With Compound 1 Length = | 4e-04 | ||
| 3dqw_A | 286 | C-Src Kinase Domain Thr338ile Mutant In Complex Wit | 4e-04 | ||
| 3nyx_A | 302 | Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-T | 5e-04 | ||
| 2j0k_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 6e-04 | ||
| 2jkk_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 6e-04 | ||
| 3js2_A | 317 | Crystal Structure Of Minimal Kinase Domain Of Fibro | 6e-04 | ||
| 1fgk_A | 310 | Crystal Structure Of The Tyrosine Kinase Domain Of | 6e-04 | ||
| 4f63_A | 309 | Crystal Structure Of Human Fibroblast Growth Factor | 6e-04 | ||
| 3rhx_B | 306 | Crystal Structure Of The Catalytic Domain Of Fgfr1 | 6e-04 | ||
| 3kxx_A | 317 | Structure Of The Mutant Fibroblast Growth Factor Re | 6e-04 | ||
| 3tt0_A | 382 | Co-Structure Of Fibroblast Growth Factor Receptor 1 | 7e-04 | ||
| 3c4f_A | 302 | Fgfr Tyrosine Kinase Domain In Complex With 3-(3- M | 7e-04 | ||
| 3gql_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 7e-04 | ||
| 2c47_A | 313 | Structure Of Casein Kinase 1 Gamma 2 Length = 313 | 8e-04 | ||
| 3uys_A | 296 | Crystal Structure Of Apo Human Ck1d Length = 296 | 8e-04 | ||
| 4asz_A | 299 | Crystal Structure Of Apo Trkb Kinase Domain Length | 8e-04 | ||
| 3lmg_A | 344 | Crystal Structure Of The Erbb3 Kinase Domain In Com | 8e-04 | ||
| 4hni_A | 296 | Crystal Structure Of Ck1e In Complex With Pf4800567 | 8e-04 | ||
| 1ckj_A | 317 | Casein Kinase I Delta Truncation Mutant Containing | 8e-04 | ||
| 2oo8_X | 317 | Synthesis, Structural Analysis, And Sar Studies Of | 8e-04 | ||
| 1fvr_A | 327 | Tie2 Kinase Domain Length = 327 | 8e-04 | ||
| 2r4b_A | 321 | Erbb4 Kinase Domain Complexed With A Thienopyrimidi | 9e-04 |
| >pdb|3KN5|A Chain A, Crystal Structure Of The C-Terminal Kinase Domain Of Msk1 In With Amp-Pnp Length = 325 | Back alignment and structure |
|
| >pdb|3KN5|A Chain A, Crystal Structure Of The C-Terminal Kinase Domain Of Msk1 In With Amp-Pnp Length = 325 | Back alignment and structure |
|
| >pdb|2WNT|A Chain A, Crystal Structure Of The Human Ribosomal Protein S6 Kinase Length = 330 | Back alignment and structure |
|
| >pdb|2WNT|A Chain A, Crystal Structure Of The Human Ribosomal Protein S6 Kinase Length = 330 | Back alignment and structure |
|
| >pdb|3RNY|A Chain A, Crystal Structure Of Human Rsk1 C-Terminal Kinase Domain Length = 346 | Back alignment and structure |
|
| >pdb|3RNY|A Chain A, Crystal Structure Of Human Rsk1 C-Terminal Kinase Domain Length = 346 | Back alignment and structure |
|
| >pdb|2QR8|A Chain A, 2.0a X-ray Structure Of C-terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 (rsk2) Length = 342 | Back alignment and structure |
|
| >pdb|2QR8|A Chain A, 2.0a X-ray Structure Of C-terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 (rsk2) Length = 342 | Back alignment and structure |
|
| >pdb|2QR7|A Chain A, 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2: Se-Met Derivative Length = 342 | Back alignment and structure |
|
| >pdb|2QR7|A Chain A, 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2: Se-Met Derivative Length = 342 | Back alignment and structure |
|
| >pdb|3IGO|A Chain A, Crystal Structure Of Cryptosporidium Parvum Cdpk1, Cgd3_920 Length = 486 | Back alignment and structure |
|
| >pdb|3IGO|A Chain A, Crystal Structure Of Cryptosporidium Parvum Cdpk1, Cgd3_920 Length = 486 | Back alignment and structure |
|
| >pdb|2WEI|A Chain A, Crystal Structure Of The Kinase Domain Of Cryptosporidium Parvum Calcium Dependent Protein Kinase In Complex With 3- Mb-Pp1 Length = 287 | Back alignment and structure |
|
| >pdb|2WEI|A Chain A, Crystal Structure Of The Kinase Domain Of Cryptosporidium Parvum Calcium Dependent Protein Kinase In Complex With 3- Mb-Pp1 Length = 287 | Back alignment and structure |
|
| >pdb|3FHR|A Chain A, High Resolution Crystal Structure Of Mitogen-Activated Protein Kinase-Activated Protein Kinase 3 (Mk3)-Inhibitor Complex Length = 336 | Back alignment and structure |
|
| >pdb|3FHR|A Chain A, High Resolution Crystal Structure Of Mitogen-Activated Protein Kinase-Activated Protein Kinase 3 (Mk3)-Inhibitor Complex Length = 336 | Back alignment and structure |
|
| >pdb|3DFA|A Chain A, Crystal Structure Of Kinase Domain Of Calcium-dependent Protein Kinase Cgd3_920 From Cryptosporidium Parvum Length = 286 | Back alignment and structure |
|
| >pdb|3DFA|A Chain A, Crystal Structure Of Kinase Domain Of Calcium-dependent Protein Kinase Cgd3_920 From Cryptosporidium Parvum Length = 286 | Back alignment and structure |
|
| >pdb|3R1N|A Chain A, Mk3 Kinase Bound To Compound 5b Length = 317 | Back alignment and structure |
|
| >pdb|3R1N|A Chain A, Mk3 Kinase Bound To Compound 5b Length = 317 | Back alignment and structure |
|
| >pdb|3I79|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) Length = 484 | Back alignment and structure |
|
| >pdb|3I79|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) Length = 484 | Back alignment and structure |
|
| >pdb|3KU2|A Chain A, Crystal Structure Of Inactivated Form Of Cdpk1 From Toxoplasma Gondii, Tgme49.101440 Length = 507 | Back alignment and structure |
|
| >pdb|3KU2|A Chain A, Crystal Structure Of Inactivated Form Of Cdpk1 From Toxoplasma Gondii, Tgme49.101440 Length = 507 | Back alignment and structure |
|
| >pdb|3HX4|A Chain A, Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tgme49_101440, In Presence Of Calcium Length = 508 | Back alignment and structure |
|
| >pdb|3HX4|A Chain A, Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tgme49_101440, In Presence Of Calcium Length = 508 | Back alignment and structure |
|
| >pdb|3DXN|A Chain A, Crystal Structure Of The Calcium-dependent Kinase From Toxoplasma Gondii, 541.m00134, Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|3DXN|A Chain A, Crystal Structure Of The Calcium-dependent Kinase From Toxoplasma Gondii, 541.m00134, Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|3MA6|A Chain A, Crystal Structure Of Kinase Domain Of Tgcdpk1 In Presence Of 3brb-Pp1 Length = 298 | Back alignment and structure |
|
| >pdb|3MA6|A Chain A, Crystal Structure Of Kinase Domain Of Tgcdpk1 In Presence Of 3brb-Pp1 Length = 298 | Back alignment and structure |
|
| >pdb|2BDW|A Chain A, Crystal Structure Of The Auto-Inhibited Kinase Domain Of CalciumCALMODULIN ACTIVATED KINASE II Length = 362 | Back alignment and structure |
|
| >pdb|2BDW|A Chain A, Crystal Structure Of The Auto-Inhibited Kinase Domain Of CalciumCALMODULIN ACTIVATED KINASE II Length = 362 | Back alignment and structure |
|
| >pdb|3HZT|A Chain A, Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme49_105860 Length = 467 | Back alignment and structure |
|
| >pdb|3HZT|A Chain A, Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme49_105860 Length = 467 | Back alignment and structure |
|
| >pdb|3KL8|A Chain A, Camkiintide Inhibitor Complex Length = 269 | Back alignment and structure |
|
| >pdb|3KL8|A Chain A, Camkiintide Inhibitor Complex Length = 269 | Back alignment and structure |
|
| >pdb|3KK8|A Chain A, Camkii Substrate Complex A Length = 284 | Back alignment and structure |
|
| >pdb|3KK8|A Chain A, Camkii Substrate Complex A Length = 284 | Back alignment and structure |
|
| >pdb|3KK9|A Chain A, Camkii Substrate Complex B Length = 282 | Back alignment and structure |
|
| >pdb|3KK9|A Chain A, Camkii Substrate Complex B Length = 282 | Back alignment and structure |
|
| >pdb|2ONL|C Chain C, Crystal Structure Of The P38a-Mapkap Kinase 2 Heterodimer Length = 406 | Back alignment and structure |
|
| >pdb|2ONL|C Chain C, Crystal Structure Of The P38a-Mapkap Kinase 2 Heterodimer Length = 406 | Back alignment and structure |
|
| >pdb|1KWP|A Chain A, Crystal Structure Of Mapkap2 Length = 400 | Back alignment and structure |
|
| >pdb|1KWP|A Chain A, Crystal Structure Of Mapkap2 Length = 400 | Back alignment and structure |
|
| >pdb|2OZA|A Chain A, Structure Of P38alpha Complex Length = 356 | Back alignment and structure |
|
| >pdb|2OZA|A Chain A, Structure Of P38alpha Complex Length = 356 | Back alignment and structure |
|
| >pdb|3I7C|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) In Complex With Bumped Kinase Inhibitor Na-Pp2 Length = 484 | Back alignment and structure |
|
| >pdb|3I7C|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) In Complex With Bumped Kinase Inhibitor Na-Pp2 Length = 484 | Back alignment and structure |
|
| >pdb|2Y7J|A Chain A, Structure Of Human Phosphorylase Kinase, Gamma 2 Length = 365 | Back alignment and structure |
|
| >pdb|2Y7J|A Chain A, Structure Of Human Phosphorylase Kinase, Gamma 2 Length = 365 | Back alignment and structure |
|
| >pdb|3FPM|A Chain A, Crystal Structure Of A Squarate Inhibitor Bound To Mapkap Kinase-2 Length = 325 | Back alignment and structure |
|
| >pdb|3FPM|A Chain A, Crystal Structure Of A Squarate Inhibitor Bound To Mapkap Kinase-2 Length = 325 | Back alignment and structure |
|
| >pdb|2JBO|A Chain A, Protein Kinase Mk2 In Complex With An Inhibitor (Crystal Form-1, Soaking) Length = 326 | Back alignment and structure |
|
| >pdb|2JBO|A Chain A, Protein Kinase Mk2 In Complex With An Inhibitor (Crystal Form-1, Soaking) Length = 326 | Back alignment and structure |
|
| >pdb|3GOK|A Chain A, Binding Site Mapping Of Protein Ligands Length = 334 | Back alignment and structure |
|
| >pdb|3GOK|A Chain A, Binding Site Mapping Of Protein Ligands Length = 334 | Back alignment and structure |
|
| >pdb|2PZY|A Chain A, Structure Of Mk2 Complexed With Compound 76 Length = 324 | Back alignment and structure |
|
| >pdb|2PZY|A Chain A, Structure Of Mk2 Complexed With Compound 76 Length = 324 | Back alignment and structure |
|
| >pdb|3R2B|A Chain A, Mk2 Kinase Bound To Compound 5b Length = 318 | Back alignment and structure |
|
| >pdb|3R2B|A Chain A, Mk2 Kinase Bound To Compound 5b Length = 318 | Back alignment and structure |
|
| >pdb|2P3G|X Chain X, Crystal Structure Of A Pyrrolopyridine Inhibitor Bound To Mapkap Kinase-2 Length = 327 | Back alignment and structure |
|
| >pdb|2P3G|X Chain X, Crystal Structure Of A Pyrrolopyridine Inhibitor Bound To Mapkap Kinase-2 Length = 327 | Back alignment and structure |
|
| >pdb|3R2Y|A Chain A, Mk2 Kinase Bound To Compound 1 Length = 319 | Back alignment and structure |
|
| >pdb|3R2Y|A Chain A, Mk2 Kinase Bound To Compound 1 Length = 319 | Back alignment and structure |
|
| >pdb|2HW6|A Chain A, Crystal Structure Of Mnk1 Catalytic Domain Length = 307 | Back alignment and structure |
|
| >pdb|2HW6|A Chain A, Crystal Structure Of Mnk1 Catalytic Domain Length = 307 | Back alignment and structure |
|
| >pdb|2VZ6|A Chain A, Structure Of Human Calcium Calmodulin Dependent Protein Kinase Type Ii Alpha (Camk2a) In Complex With Indirubin E804 Length = 313 | Back alignment and structure |
|
| >pdb|2VZ6|A Chain A, Structure Of Human Calcium Calmodulin Dependent Protein Kinase Type Ii Alpha (Camk2a) In Complex With Indirubin E804 Length = 313 | Back alignment and structure |
|
| >pdb|3KA0|A Chain A, Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4-Ylamino)-2- Hydroxyphenyl)-N-Methylbenzo[b]thiophene-2-Carboxamide Length = 320 | Back alignment and structure |
|
| >pdb|3KA0|A Chain A, Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4-Ylamino)-2- Hydroxyphenyl)-N-Methylbenzo[b]thiophene-2-Carboxamide Length = 320 | Back alignment and structure |
|
| >pdb|2WEL|A Chain A, Crystal Structure Of Su6656-Bound CalciumCALMODULIN- Dependent Protein Kinase Ii Delta In Complex With Calmodulin Length = 327 | Back alignment and structure |
|
| >pdb|2WEL|A Chain A, Crystal Structure Of Su6656-Bound CalciumCALMODULIN- Dependent Protein Kinase Ii Delta In Complex With Calmodulin Length = 327 | Back alignment and structure |
|
| >pdb|3LIJ|A Chain A, Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) In Complex With Ca2+ And Amppnp Length = 494 | Back alignment and structure |
|
| >pdb|3LIJ|A Chain A, Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) In Complex With Ca2+ And Amppnp Length = 494 | Back alignment and structure |
|
| >pdb|2W4O|A Chain A, Crystal Structure Of Human Camk4 In Complex With 4-Amino( Sulfamoyl-Phenylamino)-Triazole-Carbothioic Acid (2,6- Difluoro-Phenyl)-Amide) Length = 349 | Back alignment and structure |
|
| >pdb|2W4O|A Chain A, Crystal Structure Of Human Camk4 In Complex With 4-Amino( Sulfamoyl-Phenylamino)-Triazole-Carbothioic Acid (2,6- Difluoro-Phenyl)-Amide) Length = 349 | Back alignment and structure |
|
| >pdb|2VN9|A Chain A, Crystal Structure Of Human Calcium Calmodulin Dependent Protein Kinase Ii Delta Isoform 1, Camkd Length = 301 | Back alignment and structure |
|
| >pdb|2VN9|A Chain A, Crystal Structure Of Human Calcium Calmodulin Dependent Protein Kinase Ii Delta Isoform 1, Camkd Length = 301 | Back alignment and structure |
|
| >pdb|1QL6|A Chain A, The Catalytic Mechanism Of Phosphorylase Kinase Probed By Mutational Studies Length = 298 | Back alignment and structure |
|
| >pdb|1QL6|A Chain A, The Catalytic Mechanism Of Phosphorylase Kinase Probed By Mutational Studies Length = 298 | Back alignment and structure |
|
| >pdb|3SOA|A Chain A, Full-Length Human Camkii Length = 444 | Back alignment and structure |
|
| >pdb|3SOA|A Chain A, Full-Length Human Camkii Length = 444 | Back alignment and structure |
|
| >pdb|2PHK|A Chain A, The Crystal Structure Of A Phosphorylase Kinase Peptide Substrate Complex: Kinase Substrate Recognition Length = 277 | Back alignment and structure |
|
| >pdb|2PHK|A Chain A, The Crystal Structure Of A Phosphorylase Kinase Peptide Substrate Complex: Kinase Substrate Recognition Length = 277 | Back alignment and structure |
|
| >pdb|2JC6|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase 1d Length = 334 | Back alignment and structure |
|
| >pdb|2JC6|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase 1d Length = 334 | Back alignment and structure |
|
| >pdb|1PHK|A Chain A, Two Structures Of The Catalytic Domain Of Phosphorylase, Kinase: An Active Protein Kinase Complexed With Nucleotide, Substrate-Analogue And Product Length = 298 | Back alignment and structure |
|
| >pdb|1PHK|A Chain A, Two Structures Of The Catalytic Domain Of Phosphorylase, Kinase: An Active Protein Kinase Complexed With Nucleotide, Substrate-Analogue And Product Length = 298 | Back alignment and structure |
|
| >pdb|3Q5I|A Chain A, Crystal Structure Of Pbanka_031420 Length = 504 | Back alignment and structure |
|
| >pdb|3Q5I|A Chain A, Crystal Structure Of Pbanka_031420 Length = 504 | Back alignment and structure |
|
| >pdb|1NXK|A Chain A, Crystal Structure Of Staurosporine Bound To Map Kap Kinase 2 Length = 400 | Back alignment and structure |
|
| >pdb|1NXK|A Chain A, Crystal Structure Of Staurosporine Bound To Map Kap Kinase 2 Length = 400 | Back alignment and structure |
|
| >pdb|2V7O|A Chain A, Crystal Structure Of Human Calcium-Calmodulin-Dependent Protein Kinase Ii Gamma Length = 336 | Back alignment and structure |
|
| >pdb|2V7O|A Chain A, Crystal Structure Of Human Calcium-Calmodulin-Dependent Protein Kinase Ii Gamma Length = 336 | Back alignment and structure |
|
| >pdb|2JAM|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase I G Length = 304 | Back alignment and structure |
|
| >pdb|2JAM|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase I G Length = 304 | Back alignment and structure |
|
| >pdb|3BHH|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase Iib Isoform 1 (camk2b) Length = 295 | Back alignment and structure |
|
| >pdb|3BHH|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase Iib Isoform 1 (camk2b) Length = 295 | Back alignment and structure |
|
| >pdb|1A06|A Chain A, Calmodulin-Dependent Protein Kinase From Rat Length = 332 | Back alignment and structure |
|
| >pdb|1A06|A Chain A, Calmodulin-Dependent Protein Kinase From Rat Length = 332 | Back alignment and structure |
|
| >pdb|4FG9|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-320 In Complex With Atp Length = 320 | Back alignment and structure |
|
| >pdb|4FG9|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-320 In Complex With Atp Length = 320 | Back alignment and structure |
|
| >pdb|4FG7|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-293 In Complex With Atp Length = 293 | Back alignment and structure |
|
| >pdb|4FG7|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-293 In Complex With Atp Length = 293 | Back alignment and structure |
|
| >pdb|4FG8|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-315 In Complex With Atp Length = 315 | Back alignment and structure |
|
| >pdb|4FG8|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-315 In Complex With Atp Length = 315 | Back alignment and structure |
|
| >pdb|2AC5|A Chain A, Structure Of Human Mnk2 Kinase Domain Mutant D228g Length = 316 | Back alignment and structure |
|
| >pdb|2AC5|A Chain A, Structure Of Human Mnk2 Kinase Domain Mutant D228g Length = 316 | Back alignment and structure |
|
| >pdb|2J90|A Chain A, Crystal Structure Of Human Zip Kinase In Complex With A Tetracyclic Pyridone Inhibitor (pyridone 6) Length = 304 | Back alignment and structure |
|
| >pdb|2J90|A Chain A, Crystal Structure Of Human Zip Kinase In Complex With A Tetracyclic Pyridone Inhibitor (pyridone 6) Length = 304 | Back alignment and structure |
|
| >pdb|1YRP|A Chain A, Catalytic Domain Of Human Zip Kinase Phosphorylated At Thr265 Length = 278 | Back alignment and structure |
|
| >pdb|1YRP|A Chain A, Catalytic Domain Of Human Zip Kinase Phosphorylated At Thr265 Length = 278 | Back alignment and structure |
|
| >pdb|3BHY|A Chain A, Crystal Structure Of Human Death Associated Protein Kinase 3 (Dapk3) In Complex With A Beta-Carboline Ligand Length = 283 | Back alignment and structure |
|
| >pdb|3BHY|A Chain A, Crystal Structure Of Human Death Associated Protein Kinase 3 (Dapk3) In Complex With A Beta-Carboline Ligand Length = 283 | Back alignment and structure |
|
| >pdb|2AC3|A Chain A, Structure Of Human Mnk2 Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|2AC3|A Chain A, Structure Of Human Mnk2 Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|2QG5|A Chain A, Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 Length = 294 | Back alignment and structure |
|
| >pdb|2QG5|A Chain A, Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 Length = 294 | Back alignment and structure |
|
| >pdb|3F3Z|A Chain A, Crystal Structure Of Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 In Presence Of Indirubin E804 Length = 277 | Back alignment and structure |
|
| >pdb|3F3Z|A Chain A, Crystal Structure Of Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 In Presence Of Indirubin E804 Length = 277 | Back alignment and structure |
|
| >pdb|1KOB|A Chain A, Twitchin Kinase Fragment (Aplysia), Autoregulated Protein Kinase Domain Length = 387 | Back alignment and structure |
|
| >pdb|3LM0|A Chain A, Crystal Structure Of Human SerineTHREONINE KINASE 17B (STK17B) Length = 327 | Back alignment and structure |
|
| >pdb|3LM0|A Chain A, Crystal Structure Of Human SerineTHREONINE KINASE 17B (STK17B) Length = 327 | Back alignment and structure |
|
| >pdb|1KOA|A Chain A, Twitchin Kinase Fragment (C.Elegans), Autoregulated Protein Kinase And Immunoglobulin Domains Length = 491 | Back alignment and structure |
|
| >pdb|2XUU|A Chain A, Crystal Structure Of A Dap-Kinase 1 Mutant Length = 334 | Back alignment and structure |
|
| >pdb|2XUU|A Chain A, Crystal Structure Of A Dap-Kinase 1 Mutant Length = 334 | Back alignment and structure |
|
| >pdb|3UTO|A Chain A, Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-Crd-Ig26) Length = 573 | Back alignment and structure |
|
| >pdb|2YAK|A Chain A, Structure Of Death-Associated Protein Kinase 1 (Dapk1) In Complex With A Ruthenium Octasporine Ligand (Osv) Length = 285 | Back alignment and structure |
|
| >pdb|2YAK|A Chain A, Structure Of Death-Associated Protein Kinase 1 (Dapk1) In Complex With A Ruthenium Octasporine Ligand (Osv) Length = 285 | Back alignment and structure |
|
| >pdb|2W4K|A Chain A, X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | Back alignment and structure |
|
| >pdb|2W4K|A Chain A, X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | Back alignment and structure |
|
| >pdb|1WVW|A Chain A, Crystal Structures Of Kinase Domain Of Dap Kinase In Complex With Small Molecular Inhibitors Length = 278 | Back alignment and structure |
|
| >pdb|1WVW|A Chain A, Crystal Structures Of Kinase Domain Of Dap Kinase In Complex With Small Molecular Inhibitors Length = 278 | Back alignment and structure |
|
| >pdb|2W4J|A Chain A, X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | Back alignment and structure |
|
| >pdb|2W4J|A Chain A, X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | Back alignment and structure |
|
| >pdb|1P4F|A Chain A, Death Associated Protein Kinase Catalytic Domain With Bound Inhibitor Fragment Length = 293 | Back alignment and structure |
|
| >pdb|1P4F|A Chain A, Death Associated Protein Kinase Catalytic Domain With Bound Inhibitor Fragment Length = 293 | Back alignment and structure |
|
| >pdb|1IG1|A Chain A, 1.8a X-Ray Structure Of Ternary Complex Of A Catalytic Domain Of Death-Associated Protein Kinase With Atp Analogue And Mn. Length = 294 | Back alignment and structure |
|
| >pdb|1IG1|A Chain A, 1.8a X-Ray Structure Of Ternary Complex Of A Catalytic Domain Of Death-Associated Protein Kinase With Atp Analogue And Mn. Length = 294 | Back alignment and structure |
|
| >pdb|3F5U|A Chain A, Crystal Structure Of The Death Associated Protein Kinase In Complex With Amppnp And Mg2+ Length = 295 | Back alignment and structure |
|
| >pdb|3F5U|A Chain A, Crystal Structure Of The Death Associated Protein Kinase In Complex With Amppnp And Mg2+ Length = 295 | Back alignment and structure |
|
| >pdb|2XZS|A Chain A, Death Associated Protein Kinase 1 Residues 1-312 Length = 312 | Back alignment and structure |
|
| >pdb|2XZS|A Chain A, Death Associated Protein Kinase 1 Residues 1-312 Length = 312 | Back alignment and structure |
|
| >pdb|3DFC|B Chain B, Crystal Structure Of A Glycine-Rich Loop Mutant Of The Death Associated Protein Kinase Catalytic Domain With Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|3DFC|B Chain B, Crystal Structure Of A Glycine-Rich Loop Mutant Of The Death Associated Protein Kinase Catalytic Domain With Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|3GU8|A Chain A, Crystal Structure Of Dapkl93g With N6-Cyclopentyladenosine Length = 295 | Back alignment and structure |
|
| >pdb|3GU8|A Chain A, Crystal Structure Of Dapkl93g With N6-Cyclopentyladenosine Length = 295 | Back alignment and structure |
|
| >pdb|2Y0A|A Chain A, Structure Of Dapk1 Construct Residues 1-304 Length = 326 | Back alignment and structure |
|
| >pdb|2Y0A|A Chain A, Structure Of Dapk1 Construct Residues 1-304 Length = 326 | Back alignment and structure |
|
| >pdb|2X0G|A Chain A, X-ray Structure Of A Dap-kinase Calmodulin Complex Length = 334 | Back alignment and structure |
|
| >pdb|2X0G|A Chain A, X-ray Structure Of A Dap-kinase Calmodulin Complex Length = 334 | Back alignment and structure |
|
| >pdb|3GU4|A Chain A, Crystal Structure Of Dapkq23v-Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|3GU4|A Chain A, Crystal Structure Of Dapkq23v-Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|3MN3|A Chain A, An Inhibited Conformation For The Protein Kinase Domain Of The Saccharomyces Cerevisiae Ampk Homolog Snf1 Length = 271 | Back alignment and structure |
|
| >pdb|3MN3|A Chain A, An Inhibited Conformation For The Protein Kinase Domain Of The Saccharomyces Cerevisiae Ampk Homolog Snf1 Length = 271 | Back alignment and structure |
|
| >pdb|2FH9|A Chain A, Structure And Dimerization Of The Kinase Domain From Yeast Snf1 Length = 274 | Back alignment and structure |
|
| >pdb|2FH9|A Chain A, Structure And Dimerization Of The Kinase Domain From Yeast Snf1 Length = 274 | Back alignment and structure |
|
| >pdb|2YA9|A Chain A, Crystal Structure Of The Autoinhibited Form Of Mouse Dapk2 Length = 361 | Back alignment and structure |
|
| >pdb|3MFR|A Chain A, Cask-4m Cam Kinase Domain, Native Length = 351 | Back alignment and structure |
|
| >pdb|3MFR|A Chain A, Cask-4m Cam Kinase Domain, Native Length = 351 | Back alignment and structure |
|
| >pdb|3HYH|A Chain A, Crystal Structure Of The Protein Kinase Domain Of Yeast Amp-Activated Protein Kinase Snf1 Length = 275 | Back alignment and structure |
|
| >pdb|3HYH|A Chain A, Crystal Structure Of The Protein Kinase Domain Of Yeast Amp-Activated Protein Kinase Snf1 Length = 275 | Back alignment and structure |
|
| >pdb|3DAE|A Chain A, Crystal Structure Of Phosphorylated Snf1 Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|3DAE|A Chain A, Crystal Structure Of Phosphorylated Snf1 Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|2YCR|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv976 Length = 323 | Back alignment and structure |
|
| >pdb|2YCR|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv976 Length = 323 | Back alignment and structure |
|
| >pdb|2CN5|A Chain A, Crystal Structure Of Human Chk2 In Complex With Adp Length = 329 | Back alignment and structure |
|
| >pdb|2CN5|A Chain A, Crystal Structure Of Human Chk2 In Complex With Adp Length = 329 | Back alignment and structure |
|
| >pdb|2W0J|A Chain A, Crystal Structure Of Chk2 In Complex With Nsc 109555, A Specific Inhibitor Length = 323 | Back alignment and structure |
|
| >pdb|2W0J|A Chain A, Crystal Structure Of Chk2 In Complex With Nsc 109555, A Specific Inhibitor Length = 323 | Back alignment and structure |
|
| >pdb|2XK9|A Chain A, Structural Analysis Of Checkpoint Kinase 2 (Chk2) In Complex With Inhibitor Pv1533 Length = 322 | Back alignment and structure |
|
| >pdb|2XK9|A Chain A, Structural Analysis Of Checkpoint Kinase 2 (Chk2) In Complex With Inhibitor Pv1533 Length = 322 | Back alignment and structure |
|
| >pdb|2YCF|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv1531 Length = 322 | Back alignment and structure |
|
| >pdb|2YCF|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv1531 Length = 322 | Back alignment and structure |
|
| >pdb|3COK|A Chain A, Crystal Structure Of Plk4 Kinase Length = 278 | Back alignment and structure |
|
| >pdb|3COK|A Chain A, Crystal Structure Of Plk4 Kinase Length = 278 | Back alignment and structure |
|
| >pdb|3I6U|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 419 | Back alignment and structure |
|
| >pdb|3I6U|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 419 | Back alignment and structure |
|
| >pdb|3KGA|A Chain A, Crystal Structure Of Mapkap Kinase 2 (Mk2) Complexed With A Potent 3-Aminopyrazole Atp Site Inhibitor Length = 299 | Back alignment and structure |
|
| >pdb|3KGA|A Chain A, Crystal Structure Of Mapkap Kinase 2 (Mk2) Complexed With A Potent 3-Aminopyrazole Atp Site Inhibitor Length = 299 | Back alignment and structure |
|
| >pdb|3I6W|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 443 | Back alignment and structure |
|
| >pdb|3I6W|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 443 | Back alignment and structure |
|
| >pdb|2R0U|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 54 Length = 323 | Back alignment and structure |
|
| >pdb|2R0U|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 54 Length = 323 | Back alignment and structure |
|
| >pdb|2HOG|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 20 Length = 322 | Back alignment and structure |
|
| >pdb|2HOG|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 20 Length = 322 | Back alignment and structure |
|
| >pdb|2BR1|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights Into Hydrogen Bonding And Protein-Ligand Affinity Length = 297 | Back alignment and structure |
|
| >pdb|2BR1|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights Into Hydrogen Bonding And Protein-Ligand Affinity Length = 297 | Back alignment and structure |
|
| >pdb|1IA8|A Chain A, The 1.7 A Crystal Structure Of Human Cell Cycle Checkpoint Kinase Chk1 Length = 289 | Back alignment and structure |
|
| >pdb|1IA8|A Chain A, The 1.7 A Crystal Structure Of Human Cell Cycle Checkpoint Kinase Chk1 Length = 289 | Back alignment and structure |
|
| >pdb|1ZLT|A Chain A, Crystal Structure Of Chk1 Complexed With A Hymenaldisine Analog Length = 295 | Back alignment and structure |
|
| >pdb|1ZLT|A Chain A, Crystal Structure Of Chk1 Complexed With A Hymenaldisine Analog Length = 295 | Back alignment and structure |
|
| >pdb|1VZO|A Chain A, The Structure Of The N-Terminal Kinase Domain Of Msk1 Reveals A Novel Autoinhibitory Conformation For A Dual Kinase Protein Length = 355 | Back alignment and structure |
|
| >pdb|1VZO|A Chain A, The Structure Of The N-Terminal Kinase Domain Of Msk1 Reveals A Novel Autoinhibitory Conformation For A Dual Kinase Protein Length = 355 | Back alignment and structure |
|
| >pdb|1ZYS|A Chain A, Co-Crystal Structure Of Checkpoint Kinase Chk1 With A Pyrrolo-Pyridine Inhibitor Length = 273 | Back alignment and structure |
|
| >pdb|1ZYS|A Chain A, Co-Crystal Structure Of Checkpoint Kinase Chk1 With A Pyrrolo-Pyridine Inhibitor Length = 273 | Back alignment and structure |
|
| >pdb|4FSY|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4FSY|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|1ZWS|A Chain A, Crystal Structure Of The Catalytic Domain Of Human Drp-1 Kinase Length = 288 | Back alignment and structure |
|
| >pdb|2A27|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 8 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|1WMK|A Chain A, Human Death-Associated Kinase Drp-1, Mutant S308d D40 Length = 321 | Back alignment and structure |
|
| >pdb|4FSN|A Chain A, Crystal Structure Of The Chk1 Length = 278 | Back alignment and structure |
|
| >pdb|4FSN|A Chain A, Crystal Structure Of The Chk1 Length = 278 | Back alignment and structure |
|
| >pdb|4FSM|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4FSM|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|1Z9X|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 3 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|2A2A|A Chain A, High-resolution Crystallographic Analysis Of The Autoinhibited Conformation Of A Human Death-associated Protein Kinase Length = 321 | Back alignment and structure |
|
| >pdb|2X8E|A Chain A, Discovery Of A Novel Class Of Triazolones As Checkpoint Kinase Inhibitors - Hit To Lead Exploration Length = 276 | Back alignment and structure |
|
| >pdb|2X8E|A Chain A, Discovery Of A Novel Class Of Triazolones As Checkpoint Kinase Inhibitors - Hit To Lead Exploration Length = 276 | Back alignment and structure |
|
| >pdb|2E9V|A Chain A, Structure Of H-Chk1 Complexed With A859017 Length = 268 | Back alignment and structure |
|
| >pdb|2E9V|A Chain A, Structure Of H-Chk1 Complexed With A859017 Length = 268 | Back alignment and structure |
|
| >pdb|2Z7Q|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human Rsk-1 Bound To Amp-Pcp Length = 321 | Back alignment and structure |
|
| >pdb|3OT3|A Chain A, X-Ray Crystal Structure Of Compound 22k Bound To Human Chk1 Kinase Domain Length = 273 | Back alignment and structure |
|
| >pdb|3OT3|A Chain A, X-Ray Crystal Structure Of Compound 22k Bound To Human Chk1 Kinase Domain Length = 273 | Back alignment and structure |
|
| >pdb|3JVR|A Chain A, Characterization Of The Chk1 Allosteric Inhibitor Binding Site Length = 271 | Back alignment and structure |
|
| >pdb|3JVR|A Chain A, Characterization Of The Chk1 Allosteric Inhibitor Binding Site Length = 271 | Back alignment and structure |
|
| >pdb|2GHG|A Chain A, H-Chk1 Complexed With A431994 Length = 269 | Back alignment and structure |
|
| >pdb|2GHG|A Chain A, H-Chk1 Complexed With A431994 Length = 269 | Back alignment and structure |
|
| >pdb|2AYP|A Chain A, Crystal Structure Of Chk1 With An Indol Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|2AYP|A Chain A, Crystal Structure Of Chk1 With An Indol Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|4FT3|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4FT3|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3C0G|A Chain A, Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Length = 351 | Back alignment and structure |
|
| >pdb|1ZMU|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Wild Type Length = 327 | Back alignment and structure |
|
| >pdb|1ZMU|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Wild Type Length = 327 | Back alignment and structure |
|
| >pdb|2R0I|A Chain A, Crystal Structure Of A Kinase Mark2PAR-1 Mutant Length = 327 | Back alignment and structure |
|
| >pdb|2R0I|A Chain A, Crystal Structure Of A Kinase Mark2PAR-1 Mutant Length = 327 | Back alignment and structure |
|
| >pdb|4FSZ|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4FSZ|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4FSU|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4FSU|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4DFY|A Chain A, Crystal Structure Of R194a Mutant Of Camp-Dependent Protein Kinase With Unphosphorylated Activation Loop Length = 371 | Back alignment and structure |
|
| >pdb|4FSW|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4FSW|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|1ZMV|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: K82r Mutant Length = 327 | Back alignment and structure |
|
| >pdb|1ZMV|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: K82r Mutant Length = 327 | Back alignment and structure |
|
| >pdb|3HKO|A Chain A, Crystal Structure Of A Cdpk Kinase Domain From Cryptosporidium Parvum, Cgd7_40 Length = 345 | Back alignment and structure |
|
| >pdb|3HKO|A Chain A, Crystal Structure Of A Cdpk Kinase Domain From Cryptosporidium Parvum, Cgd7_40 Length = 345 | Back alignment and structure |
|
| >pdb|2YDJ|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By Structure Based Design And Optimization Of Thiophene Carboxamide Ureas Length = 276 | Back alignment and structure |
|
| >pdb|2YDJ|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By Structure Based Design And Optimization Of Thiophene Carboxamide Ureas Length = 276 | Back alignment and structure |
|
| >pdb|3IS5|A Chain A, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma Gondii, Tgme49_018720 Length = 285 | Back alignment and structure |
|
| >pdb|3IS5|A Chain A, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma Gondii, Tgme49_018720 Length = 285 | Back alignment and structure |
|
| >pdb|3H4J|B Chain B, Crystal Structure Of Pombe Ampk Kdaid Fragment Length = 336 | Back alignment and structure |
|
| >pdb|3H4J|B Chain B, Crystal Structure Of Pombe Ampk Kdaid Fragment Length = 336 | Back alignment and structure |
|
| >pdb|1ZMW|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: T208aS212A INACTIVE DOUBLE MUTANT Length = 327 | Back alignment and structure |
|
| >pdb|1ZMW|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: T208aS212A INACTIVE DOUBLE MUTANT Length = 327 | Back alignment and structure |
|
| >pdb|4FST|A Chain A, Crystal Structure Of The Chk1 Length = 269 | Back alignment and structure |
|
| >pdb|4FST|A Chain A, Crystal Structure Of The Chk1 Length = 269 | Back alignment and structure |
|
| >pdb|3G51|A Chain A, Structural Diversity Of The Active Conformation Of The N- Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 Length = 325 | Back alignment and structure |
|
| >pdb|1MRV|A Chain A, Crystal Structure Of An Inactive Akt2 Kinase Domain Length = 339 | Back alignment and structure |
|
| >pdb|1GZN|A Chain A, Structure Of Pkb Kinase Domain Length = 335 | Back alignment and structure |
|
| >pdb|1GZK|A Chain A, Molecular Mechanism For The Regulation Of Protein Kinase B Akt By Hydrophobic Motif Phosphorylation Length = 315 | Back alignment and structure |
|
| >pdb|3UBD|A Chain A, Structure Of N-Terminal Domain Of Rsk2 Kinase In Complex With Flavonoid Glycoside Sl0101 Length = 304 | Back alignment and structure |
|
| >pdb|4EL9|A Chain A, Structure Of N-Terminal Kinase Domain Of Rsk2 With Afzelin Length = 305 | Back alignment and structure |
|
| >pdb|1Y8G|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Inactive Double Mutant With Selenomethionine Length = 327 | Back alignment and structure |
|
| >pdb|1Y8G|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Inactive Double Mutant With Selenomethionine Length = 327 | Back alignment and structure |
|
| >pdb|3IEC|A Chain A, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES BY Mimicking Host Substrates Length = 319 | Back alignment and structure |
|
| >pdb|3IEC|A Chain A, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES BY Mimicking Host Substrates Length = 319 | Back alignment and structure |
|
| >pdb|3TAC|A Chain A, Crystal Structure Of The Liprin-AlphaCASK COMPLEX Length = 361 | Back alignment and structure |
|
| >pdb|2WZJ|A Chain A, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r, T208e Double Mutant Length = 327 | Back alignment and structure |
|
| >pdb|2WZJ|A Chain A, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r, T208e Double Mutant Length = 327 | Back alignment and structure |
|
| >pdb|2QNJ|A Chain A, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|2QNJ|A Chain A, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|2GU8|A Chain A, Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel And Potent Inhibitors For Akt: Synthesis And Sar Studies Length = 337 | Back alignment and structure |
|
| >pdb|2ERZ|E Chain E, Crystal Structure Of C-amp Dependent Kinase (pka) Bound To Hydroxyfasudil Length = 351 | Back alignment and structure |
|
| >pdb|2QUR|A Chain A, Crystal Structure Of F327aK285P MUTANT OF CAMP-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|1SYK|A Chain A, Crystal Structure Of E230q Mutant Of Camp-Dependent Protein Kinase Reveals Unexpected Apoenzyme Conformation Length = 350 | Back alignment and structure |
|
| >pdb|1FMO|E Chain E, Crystal Structure Of A Polyhistidine-Tagged Recombinant Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With The Peptide Inhibitor Pki(5-24) And Adenosine Length = 350 | Back alignment and structure |
|
| >pdb|1JBP|E Chain E, Crystal Structure Of The Catalytic Subunit Of Camp- Dependent Protein Kinase Complexed With A Substrate Peptide, Adp And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|1BKX|A Chain A, A Binary Complex Of The Catalytic Subunit Of Camp-Dependent Protein Kinase And Adenosine Further Defines Conformational Flexibility Length = 350 | Back alignment and structure |
|
| >pdb|3AMA|A Chain A, Protein Kinase A Sixfold Mutant Model Of Aurora B With Inhibitor Jnj- 7706621 Length = 351 | Back alignment and structure |
|
| >pdb|3L9M|A Chain A, Crystal Structure Of Pkab3 (Pka Triple Mutant V123a, L173m, Q181k) With Compound 18 Length = 351 | Back alignment and structure |
|
| >pdb|1APM|E Chain E, 2.0 Angstrom Refined Crystal Structure Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With A Peptide Inhibitor And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|3PVB|A Chain A, Crystal Structure Of (73-244)ria:c Holoenzyme Of Camp-Dependent Protein Kinase Length = 345 | Back alignment and structure |
|
| >pdb|1L3R|E Chain E, Crystal Structure Of A Transition State Mimic Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3E87|A Chain A, Crystal Structures Of The Kinase Domain Of Akt2 In Complex With Atp- Competitive Inhibitors Length = 335 | Back alignment and structure |
|
| >pdb|2UZT|A Chain A, Pka Structures Of Akt, Indazole-Pyridine Inhibitors Length = 336 | Back alignment and structure |
|
| >pdb|2QCS|A Chain A, A Complex Structure Between The Catalytic And Regulatory Subunit Of Protein Kinase A That Represents The Inhibited State Length = 350 | Back alignment and structure |
|
| >pdb|1O6K|A Chain A, Structure Of Activated Form Of Pkb Kinase Domain S474d With Gsk3 Peptide And Amp-Pnp Length = 336 | Back alignment and structure |
|
| >pdb|4DG3|E Chain E, Crystal Structure Of R336a Mutant Of Camp-dependent Protein Kinase With Unphosphorylated Turn Motif Length = 371 | Back alignment and structure |
|
| >pdb|2JDO|A Chain A, Structure Of Pkb-Beta (Akt2) Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 342 | Back alignment and structure |
|
| >pdb|4AE6|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit Calpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|3AGL|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-1039 Length = 351 | Back alignment and structure |
|
| >pdb|3AGM|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-670 Length = 351 | Back alignment and structure |
|
| >pdb|3NX8|A Chain A, Human Camp Dependent Protein Kinase In Complex With Phenol Length = 351 | Back alignment and structure |
|
| >pdb|1O6L|A Chain A, Crystal Structure Of An Activated Akt/protein Kinase B (pkb-pif Chimera) Ternary Complex With Amp-pnp And Gsk3 Peptide Length = 337 | Back alignment and structure |
|
| >pdb|2F7E|E Chain E, Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoquinolin-6- Yl-Pyridin-3-Yloxymethyl-Etylamine Length = 351 | Back alignment and structure |
|
| >pdb|4DFX|E Chain E, Crystal Structure Of Myristoylated K7c Catalytic Subunit Of Camp- Dependent Protein Kinase In Complex With Sp20 And Amp-Pnp Length = 350 | Back alignment and structure |
|
| >pdb|3MVJ|A Chain A, Human Cyclic Amp-Dependent Protein Kinase Pka Inhibitor Complex Length = 371 | Back alignment and structure |
|
| >pdb|3O7L|B Chain B, Crystal Structure Of Phospholamban (1-19):pka C-Subunit:amp-Pnp:mg2+ Complex Length = 350 | Back alignment and structure |
|
| >pdb|4AE9|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit C Alpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|3QAL|E Chain E, Crystal Structure Of Arg280ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3UDB|A Chain A, Crystal Structure Of Snrk2.6 Length = 317 | Back alignment and structure |
|
| >pdb|3UDB|A Chain A, Crystal Structure Of Snrk2.6 Length = 317 | Back alignment and structure |
|
| >pdb|1CTP|E Chain E, Structure Of The Mammalian Catalytic Subunit Of Camp-Dependent Protein Kinase And An Inhibitor Peptide Displays An Open Conformation Length = 350 | Back alignment and structure |
|
| >pdb|3QAM|E Chain E, Crystal Structure Of Glu208ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|1CDK|A Chain A, Camp-Dependent Protein Kinase Catalytic Subunit (E.C.2.7.1.37) (Protein Kinase A) Complexed With Protein Kinase Inhibitor Peptide Fragment 5-24 (Pki(5-24) Isoelectric Variant Ca) And Mn2+ Adenylyl Imidodiphosphate (Mnamp-Pnp) At Ph 5.6 And 7c And 4c Length = 350 | Back alignment and structure |
|
| >pdb|3FE3|A Chain A, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a Double Mutant Length = 328 | Back alignment and structure |
|
| >pdb|3FE3|A Chain A, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a Double Mutant Length = 328 | Back alignment and structure |
|
| >pdb|1CMK|E Chain E, Crystal Structures Of The Myristylated Catalytic Subunit Of Camp- Dependent Protein Kinase Reveal Open And Closed Conformations Length = 350 | Back alignment and structure |
|
| >pdb|1Q61|A Chain A, Pka Triple Mutant Model Of Pkb Length = 350 | Back alignment and structure |
|
| >pdb|1YDT|E Chain E, Structure Of Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With H89 Protein Kinase Inhibitor N-[2- (4-Bromocinnamylamino)ethyl]-5-Isoquinoline Length = 350 | Back alignment and structure |
|
| >pdb|2GNJ|A Chain A, Pka Three Fold Mutant Model Of Rho-Kinase With Y-27632 Length = 350 | Back alignment and structure |
|
| >pdb|3FHI|A Chain A, Crystal Structure Of A Complex Between The Catalytic And Regulatory (Ri{alpha}) Subunits Of Pka Length = 350 | Back alignment and structure |
|
| >pdb|2GNF|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase With Y- 27632 Length = 350 | Back alignment and structure |
|
| >pdb|2GNG|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3DND|A Chain A, Camp-Dependent Protein Kinase Pka Catalytic Subunit With Pki-5-24 Length = 350 | Back alignment and structure |
|
| >pdb|1SVH|A Chain A, Crystal Structure Of Protein Kinase A In Complex With Azepane Derivative 8 Length = 350 | Back alignment and structure |
|
| >pdb|1SZM|A Chain A, Dual Binding Mode Of Bisindolylmaleimide 2 To Protein Kinase A (Pka) Length = 350 | Back alignment and structure |
|
| >pdb|1STC|E Chain E, Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With Staurosporine Length = 350 | Back alignment and structure |
|
| >pdb|2C1A|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With Isoquinoline-5-Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl)amide Length = 351 | Back alignment and structure |
|
| >pdb|1RDQ|E Chain E, Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|1J3H|A Chain A, Crystal Structure Of Apoenzyme Camp-Dependent Protein Kinase Catalytic Subunit Length = 350 | Back alignment and structure |
|
| >pdb|1Q24|A Chain A, Pka Double Mutant Model Of Pkb In Complex With Mgatp Length = 350 | Back alignment and structure |
|
| >pdb|3HRC|A Chain A, Crystal Structure Of A Mutant Of Human Pdk1 Kinase Domain In Complex With Atp Length = 311 | Back alignment and structure |
|
| >pdb|3HRC|A Chain A, Crystal Structure Of A Mutant Of Human Pdk1 Kinase Domain In Complex With Atp Length = 311 | Back alignment and structure |
|
| >pdb|2JDS|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With A- 443654 Length = 351 | Back alignment and structure |
|
| >pdb|1Q8W|A Chain A, The Catalytic Subunit Of Camp-Dependent Protein Kinase In Complex With Rho-Kinase Inhibitor Fasudil (Ha-1077) Length = 350 | Back alignment and structure |
|
| >pdb|1XH7|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|1XH9|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|2VO0|A Chain A, Structure Of Pka-Pkb Chimera Complexed With C-(4-(4- Chlorophenyl)-1-(7h-Pyrrolo(2, 3-D)pyrimidin-4-Yl)piperidin- 4-Yl)methylamine Length = 351 | Back alignment and structure |
|
| >pdb|2JDT|A Chain A, Structure Of Pka-Pkb Chimera Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 351 | Back alignment and structure |
|
| >pdb|3QC4|A Chain A, Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = 314 | Back alignment and structure |
|
| >pdb|3QC4|A Chain A, Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = 314 | Back alignment and structure |
|
| >pdb|3UJG|A Chain A, Crystal Structure Of Snrk2.6 In Complex With Hab1 Length = 361 | Back alignment and structure |
|
| >pdb|3UJG|A Chain A, Crystal Structure Of Snrk2.6 In Complex With Hab1 Length = 361 | Back alignment and structure |
|
| >pdb|3TXO|A Chain A, Pkc Eta Kinase In Complex With A Naphthyridine Length = 353 | Back alignment and structure |
|
| >pdb|2HAK|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|2HAK|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|4EJN|A Chain A, Crystal Structure Of Autoinhibited Form Of Akt1 In Complex With N-(4- (5-(3-Acetamidophenyl)-2-(2-Aminopyridin-3-Yl)-3h- Imidazo[4,5- B]pyridin-3-Yl)benzyl)-3-Fluorobenzamide Length = 446 | Back alignment and structure |
|
| >pdb|2UVY|A Chain A, Structure Of Pka-pkb Chimera Complexed With Methyl-(4-(9h- Purin-6-yl)-benzyl)-amine Length = 351 | Back alignment and structure |
|
| >pdb|2R7B|A Chain A, Crystal Structure Of The Phosphoinositide-Dependent Kinase- 1 (Pdk-1)catalytic Domain Bound To A Dibenzonaphthyridine Inhibitor Length = 312 | Back alignment and structure |
|
| >pdb|2R7B|A Chain A, Crystal Structure Of The Phosphoinositide-Dependent Kinase- 1 (Pdk-1)catalytic Domain Bound To A Dibenzonaphthyridine Inhibitor Length = 312 | Back alignment and structure |
|
| >pdb|3O96|A Chain A, Crystal Structure Of Human Akt1 With An Allosteric Inhibitor Length = 446 | Back alignment and structure |
|
| >pdb|3NAX|A Chain A, Pdk1 In Complex With Inhibitor Mp7 Length = 311 | Back alignment and structure |
|
| >pdb|3NAX|A Chain A, Pdk1 In Complex With Inhibitor Mp7 Length = 311 | Back alignment and structure |
|
| >pdb|2BIY|A Chain A, Structure Of Pdk1-S241a Mutant Kinase Domain Length = 310 | Back alignment and structure |
|
| >pdb|2BIY|A Chain A, Structure Of Pdk1-S241a Mutant Kinase Domain Length = 310 | Back alignment and structure |
|
| >pdb|1Z5M|A Chain A, Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrrolidinylcarbonyl) Amino]phenyl]amino]-4-pyrimidinyl]amino]propyl]-2,2- Dimethylpropanediamide Complexed With Human Pdk1 Length = 286 | Back alignment and structure |
|
| >pdb|1Z5M|A Chain A, Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrrolidinylcarbonyl) Amino]phenyl]amino]-4-pyrimidinyl]amino]propyl]-2,2- Dimethylpropanediamide Complexed With Human Pdk1 Length = 286 | Back alignment and structure |
|
| >pdb|3H9O|A Chain A, Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) In Complex With Compound 9 Length = 311 | Back alignment and structure |
|
| >pdb|3H9O|A Chain A, Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) In Complex With Compound 9 Length = 311 | Back alignment and structure |
|
| >pdb|1SMH|A Chain A, Protein Kinase A Variant Complex With Completely Ordered N- Terminal Helix Length = 350 | Back alignment and structure |
|
| >pdb|2XCH|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|2XCH|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|3UC4|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.6 Length = 362 | Back alignment and structure |
|
| >pdb|3UC4|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.6 Length = 362 | Back alignment and structure |
|
| >pdb|3IOP|A Chain A, Pdk-1 In Complex With The Inhibitor Compound-8i Length = 312 | Back alignment and structure |
|
| >pdb|3IOP|A Chain A, Pdk-1 In Complex With The Inhibitor Compound-8i Length = 312 | Back alignment and structure |
|
| >pdb|1UU3|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Ly333531 Length = 310 | Back alignment and structure |
|
| >pdb|1UU3|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Ly333531 Length = 310 | Back alignment and structure |
|
| >pdb|3SC1|A Chain A, Novel Isoquinolone Pdk1 Inhibitors Discovered Through Fragment-Based Lead Discovery Length = 311 | Back alignment and structure |
|
| >pdb|3SC1|A Chain A, Novel Isoquinolone Pdk1 Inhibitors Discovered Through Fragment-Based Lead Discovery Length = 311 | Back alignment and structure |
|
| >pdb|3RWP|A Chain A, Discovery Of A Novel, Potent And Selective Inhibitor Of 3- Phosphoinositide Dependent Kinase (Pdk1) Length = 311 | Back alignment and structure |
|
| >pdb|3RWP|A Chain A, Discovery Of A Novel, Potent And Selective Inhibitor Of 3- Phosphoinositide Dependent Kinase (Pdk1) Length = 311 | Back alignment and structure |
|
| >pdb|3NAY|A Chain A, Pdk1 In Complex With Inhibitor Mp6 Length = 311 | Back alignment and structure |
|
| >pdb|3NAY|A Chain A, Pdk1 In Complex With Inhibitor Mp6 Length = 311 | Back alignment and structure |
|
| >pdb|2XCK|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|2XCK|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|3NUN|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lead Compound Length = 292 | Back alignment and structure |
|
| >pdb|3NUN|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lead Compound Length = 292 | Back alignment and structure |
|
| >pdb|3UC3|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.3 Length = 361 | Back alignment and structure |
|
| >pdb|3UC3|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.3 Length = 361 | Back alignment and structure |
|
| >pdb|2H6D|A Chain A, Protein Kinase Domain Of The Human 5'-Amp-Activated Protein Kinase Catalytic Subunit Alpha-2 (Ampk Alpha-2 Chain) Length = 276 | Back alignment and structure |
|
| >pdb|2H6D|A Chain A, Protein Kinase Domain Of The Human 5'-Amp-Activated Protein Kinase Catalytic Subunit Alpha-2 (Ampk Alpha-2 Chain) Length = 276 | Back alignment and structure |
|
| >pdb|3ORX|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment Inhibitor 1f8 Length = 316 | Back alignment and structure |
|
| >pdb|3ORX|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment Inhibitor 1f8 Length = 316 | Back alignment and structure |
|
| >pdb|3ZUU|A Chain A, The Structure Of Ost1 (D160a, S175d) Kinase In Complex With Gold Length = 362 | Back alignment and structure |
|
| >pdb|3ZUU|A Chain A, The Structure Of Ost1 (D160a, S175d) Kinase In Complex With Gold Length = 362 | Back alignment and structure |
|
| >pdb|3ZUT|A Chain A, The Structure Of Ost1 (D160a) Kinase Length = 362 | Back alignment and structure |
|
| >pdb|3ZUT|A Chain A, The Structure Of Ost1 (D160a) Kinase Length = 362 | Back alignment and structure |
|
| >pdb|2F2U|A Chain A, Crystal Structure Of The Rho-Kinase Kinase Domain Length = 402 | Back alignment and structure |
|
| >pdb|1TKI|A Chain A, Autoinhibited Serine Kinase Domain Of The Giant Muscle Protein Titin Length = 321 | Back alignment and structure |
|
| >pdb|3OCB|A Chain A, Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor Length = 341 | Back alignment and structure |
|
| >pdb|3CQU|A Chain A, Crystal Structure Of Akt-1 Complexed With Substrate Peptide And Inhibitor Length = 342 | Back alignment and structure |
|
| >pdb|4A07|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric Activator Ps171 Bound To The Pif-Pocket Length = 311 | Back alignment and structure |
|
| >pdb|4A07|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric Activator Ps171 Bound To The Pif-Pocket Length = 311 | Back alignment and structure |
|
| >pdb|4GV1|A Chain A, Pkb Alpha In Complex With Azd5363 Length = 340 | Back alignment and structure |
|
| >pdb|2Y94|A Chain A, Structure Of An Active Form Of Mammalian Ampk Length = 476 | Back alignment and structure |
|
| >pdb|2Y94|A Chain A, Structure Of An Active Form Of Mammalian Ampk Length = 476 | Back alignment and structure |
|
| >pdb|2X4F|A Chain A, The Crystal Structure Of The Human Myosin Light Chain Kinase Loc340156. Length = 373 | Back alignment and structure |
|
| >pdb|2YZA|A Chain A, Crystal Structure Of Kinase Domain Of Human 5'-Amp-Activated Protein Kinase Alpha-2 Subunit Mutant (T172d) Length = 276 | Back alignment and structure |
|
| >pdb|2YZA|A Chain A, Crystal Structure Of Kinase Domain Of Human 5'-Amp-Activated Protein Kinase Alpha-2 Subunit Mutant (T172d) Length = 276 | Back alignment and structure |
|
| >pdb|3PWY|A Chain A, Crystal Structure Of An Extender (Spd28345)-Modified Human Pdk1 Complex 2 Length = 311 | Back alignment and structure |
|
| >pdb|3PWY|A Chain A, Crystal Structure Of An Extender (Spd28345)-Modified Human Pdk1 Complex 2 Length = 311 | Back alignment and structure |
|
| >pdb|3V8S|A Chain A, Human Rho-Associated Protein Kinase 1 (Rock 1) In Complex With Indazole Derivative (Compound 18) Length = 410 | Back alignment and structure |
|
| >pdb|3A60|A Chain A, Crystal Structure Of Unphosphorylated P70s6k1 (Form I) Length = 327 | Back alignment and structure |
|
| >pdb|2ESM|A Chain A, Crystal Structure Of Rock 1 Bound To Fasudil Length = 415 | Back alignment and structure |
|
| >pdb|2V55|A Chain A, Mechanism Of Multi-site Phosphorylation From A Rock-i:rhoe Complex Structure Length = 406 | Back alignment and structure |
|
| >pdb|1H1W|A Chain A, High Resolution Crystal Structure Of The Human Pdk1 Catalytic Domain Length = 289 | Back alignment and structure |
|
| >pdb|1H1W|A Chain A, High Resolution Crystal Structure Of The Human Pdk1 Catalytic Domain Length = 289 | Back alignment and structure |
|
| >pdb|1UU9|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Bim-3 Length = 286 | Back alignment and structure |
|
| >pdb|1UU9|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Bim-3 Length = 286 | Back alignment and structure |
|
| >pdb|3NUS|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment8 Length = 286 | Back alignment and structure |
|
| >pdb|3NUS|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment8 Length = 286 | Back alignment and structure |
|
| >pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A Pentacyclic Inhibitor Length = 268 | Back alignment and structure |
|
| >pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626 Length = 306 | Back alignment and structure |
|
| >pdb|3IW4|A Chain A, Crystal Structure Of Pkc Alpha In Complex With Nvp-Aeb071 Length = 360 | Back alignment and structure |
|
| >pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632 Length = 306 | Back alignment and structure |
|
| >pdb|3D5U|A Chain A, Crystal Structure Of A Wildtype Polo-Like Kinase 1 (Plk1) Catalytic Domain Length = 317 | Back alignment and structure |
|
| >pdb|3A62|A Chain A, Crystal Structure Of Phosphorylated P70s6k1 Length = 327 | Back alignment and structure |
|
| >pdb|1MUO|A Chain A, Crystal Structure Of Aurora-2, An Oncogenic Serine- Threonine Kinase Length = 297 | Back alignment and structure |
|
| >pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form) Length = 285 | Back alignment and structure |
|
| >pdb|3QBN|A Chain A, Structure Of Human Aurora A In Complex With A Diaminopyrimidine Length = 281 | Back alignment and structure |
|
| >pdb|2V5Q|A Chain A, Crystal Structure Of Wild-type Plk-1 Kinase Domain In Complex With A Selective Darpin Length = 315 | Back alignment and structure |
|
| >pdb|1FOT|A Chain A, Structure Of The Unliganded Camp-Dependent Protein Kinase Catalytic Subunit From Saccharomyces Cerevisiae Length = 318 | Back alignment and structure |
|
| >pdb|2VRX|A Chain A, Structure Of Aurora B Kinase In Complex With Zm447439 Length = 285 | Back alignment and structure |
|
| >pdb|2VRX|A Chain A, Structure Of Aurora B Kinase In Complex With Zm447439 Length = 285 | Back alignment and structure |
|
| >pdb|2J50|A Chain A, Structure Of Aurora-2 In Complex With Pha-739358 Length = 280 | Back alignment and structure |
|
| >pdb|3KB7|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 311 | Back alignment and structure |
|
| >pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300 Length = 280 | Back alignment and structure |
|
| >pdb|2YAC|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With Nms-P937 Length = 311 | Back alignment and structure |
|
| >pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective Imidazopyrazine Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|2BFY|A Chain A, Complex Of Aurora-B With Incenp And Hesperidin. Length = 284 | Back alignment and structure |
|
| >pdb|2BFY|A Chain A, Complex Of Aurora-B With Incenp And Hesperidin. Length = 284 | Back alignment and structure |
|
| >pdb|3O50|A Chain A, Crystal Structure Of Benzamide 9 Bound To Auroraa Length = 267 | Back alignment and structure |
|
| >pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor Length = 285 | Back alignment and structure |
|
| >pdb|1OL5|A Chain A, Structure Of Aurora-A 122-403, Phosphorylated On Thr287, Thr288 And Bound To Tpx2 1-43 Length = 282 | Back alignment and structure |
|
| >pdb|1MQ4|A Chain A, Crystal Structure Of Aurora-A Protein Kinase Length = 272 | Back alignment and structure |
|
| >pdb|2DWB|A Chain A, Aurora-A Kinase Complexed With Amppnp Length = 285 | Back alignment and structure |
|
| >pdb|3NRM|A Chain A, Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibitors Length = 283 | Back alignment and structure |
|
| >pdb|3UNZ|A Chain A, Aurora A In Complex With Rpm1679 Length = 279 | Back alignment and structure |
|
| >pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A Inhibitors: Structure Basis For Potency And Specificity Length = 279 | Back alignment and structure |
|
| >pdb|3H0Y|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine Length = 268 | Back alignment and structure |
|
| >pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A 5-Aminopyrimidinyl Quinazoline Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A Gsk3beta Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|2W1D|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|3HA6|A Chain A, Crystal Structure Of Aurora A In Complex With Tpx2 And Compound 10 Length = 268 | Back alignment and structure |
|
| >pdb|2W1C|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With Adpnp Length = 275 | Back alignment and structure |
|
| >pdb|3E5A|A Chain A, Crystal Structure Of Aurora A In Complex With Vx-680 And Tpx2 Length = 268 | Back alignment and structure |
|
| >pdb|2WQE|A Chain A, Structure Of S155r Aurora-A Somatic Mutant Length = 262 | Back alignment and structure |
|
| >pdb|3R21|A Chain A, Design, Synthesis, And Biological Evaluation Of Pyrazolopyridine- Sulfonamides As Potent Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I) Length = 271 | Back alignment and structure |
|
| >pdb|3D5W|A Chain A, Crystal Structure Of A Phosphorylated Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Adp Length = 317 | Back alignment and structure |
|
| >pdb|3THB|A Chain A, Structure Of Plk1 Kinase Domain In Complex With A Benzolactam-Derived Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|2OU7|A Chain A, Structure Of The Catalytic Domain Of Human Polo-Like Kinase 1 Length = 335 | Back alignment and structure |
|
| >pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240->arg, Met302- >leu) In Complex With 1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]- Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea Length = 272 | Back alignment and structure |
|
| >pdb|3DB6|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Compound 902 Length = 301 | Back alignment and structure |
|
| >pdb|3D5V|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain. Length = 317 | Back alignment and structure |
|
| >pdb|1OL6|A Chain A, Structure Of Unphosphorylated D274n Mutant Of Aurora-a Length = 282 | Back alignment and structure |
|
| >pdb|2XNE|A Chain A, Structure Of Aurora-A Bound To An Imidazopyrazine Inhibitor Length = 272 | Back alignment and structure |
|
| >pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor Discovered Through Site-Directed Dynamic Tethering Length = 272 | Back alignment and structure |
|
| >pdb|2R5T|A Chain A, Crystal Structure Of Inactive Serum And Glucocorticoid- Regulated Kinase 1 In Complex With Amp-Pnp Length = 373 | Back alignment and structure |
|
| >pdb|2JED|A Chain A, The Crystal Structure Of The Kinase Domain Of The Protein Kinase C Theta In Complex With Nvp-Xaa228 At 2.32a Resolution. Length = 352 | Back alignment and structure |
|
| >pdb|2RKU|A Chain A, Structure Of Plk1 In Complex With Bi2536 Length = 294 | Back alignment and structure |
|
| >pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure Length = 285 | Back alignment and structure |
|
| >pdb|1XJD|A Chain A, Crystal Structure Of Pkc-Theta Complexed With Staurosporine At 2a Resolution Length = 345 | Back alignment and structure |
|
| >pdb|4FR4|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase 32a (Yank1) Length = 384 | Back alignment and structure |
|
| >pdb|2I0E|A Chain A, Structure Of Catalytic Domain Of Human Protein Kinase C Beta Ii Complexed With A Bisindolylmaleimide Inhibitor Length = 353 | Back alignment and structure |
|
| >pdb|4DC2|A Chain A, Structure Of Pkc In Complex With A Substrate Peptide From Par-3 Length = 396 | Back alignment and structure |
|
| >pdb|3PFQ|A Chain A, Crystal Structure And Allosteric Activation Of Protein Kinase C Beta Ii Length = 674 | Back alignment and structure |
|
| >pdb|3QFV|A Chain A, Mrck Beta In Complex With Tpca-1 Length = 415 | Back alignment and structure |
|
| >pdb|3TKU|A Chain A, Mrck Beta In Complex With Fasudil Length = 433 | Back alignment and structure |
|
| >pdb|3ZH8|A Chain A, A Novel Small Molecule Apkc Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|3A8W|A Chain A, Crystal Structure Of Pkciota Kinase Domain Length = 345 | Back alignment and structure |
|
| >pdb|2W9F|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|2W9F|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|1ZRZ|A Chain A, Crystal Structure Of The Catalytic Domain Of Atypical Protein Kinase C-Iota Length = 364 | Back alignment and structure |
|
| >pdb|2W96|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|2W96|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|2W99|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|2W99|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|3G33|A Chain A, Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | Back alignment and structure |
|
| >pdb|3G33|A Chain A, Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | Back alignment and structure |
|
| >pdb|4AGU|A Chain A, Crystal Structure Of The Human Cdkl1 Kinase Domain Length = 311 | Back alignment and structure |
|
| >pdb|2J7T|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Su11274 Length = 302 | Back alignment and structure |
|
| >pdb|4BC6|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Novel Bosutinib Isoform 1, Previously Thought To Be Bosutinib Length = 293 | Back alignment and structure |
|
| >pdb|3COI|A Chain A, Crystal Structure Of P38delta Kinase Length = 353 | Back alignment and structure |
|
| >pdb|4AF3|A Chain A, Human Aurora B Kinase In Complex With Incenp And Vx-680 Length = 292 | Back alignment and structure |
|
| >pdb|4EXU|A Chain A, Mapk13, Inactive Form Length = 371 | Back alignment and structure |
|
| >pdb|4EOI|A Chain A, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 299 | Back alignment and structure |
|
| >pdb|3KVX|A Chain A, Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Length = 364 | Back alignment and structure |
|
| >pdb|2J51|A Chain A, Crystal Structure Of Human Ste20-Like Kinase Bound To 5- Amino-3-((4-(Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2,4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|2R9S|A Chain A, C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Quinoline Inhibitor Length = 356 | Back alignment and structure |
|
| >pdb|4EOJ|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With Atp Length = 302 | Back alignment and structure |
|
| >pdb|2ZV2|A Chain A, Crystal Structure Of Human CalciumCALMODULIN-Dependent Protein Kinase Kinase 2, Beta, Camkk2 Kinase Domain In Complex With Sto-609 Length = 298 | Back alignment and structure |
|
| >pdb|4EOK|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With The Inhibitor Nu6102 Length = 300 | Back alignment and structure |
|
| >pdb|2CLQ|A Chain A, Structure Of Mitogen-Activated Protein Kinase Kinase Kinase 5 Length = 295 | Back alignment and structure |
|
| >pdb|3VW6|A Chain A, Crystal Structure Of Human Apoptosis Signal-Regulating Kinase 1 (Ask1) With Imidazopyridine Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|4ERW|A Chain A, Cdk2 In Complex With Staurosporine Length = 306 | Back alignment and structure |
|
| >pdb|1BI8|A Chain A, Mechanism Of G1 Cyclin Dependent Kinase Inhibition From The Structures Cdk6-P19ink4d Inhibitor Complex Length = 326 | Back alignment and structure |
|
| >pdb|3NUP|A Chain A, Cdk6 (Monomeric) In Complex With Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|2JFM|A Chain A, Crystal Structure Of Human Ste20-Like Kinase (Unliganded Form) Length = 325 | Back alignment and structure |
|
| >pdb|4EOM|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|4EON|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|1JOW|B Chain B, Crystal Structure Of A Complex Of Human Cdk6 And A Viral Cyclin Length = 308 | Back alignment and structure |
|
| >pdb|1GZ8|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Inhibitor 2-Amino-6-(3'-Methyl-2'-Oxo)butoxypurine Length = 299 | Back alignment and structure |
|
| >pdb|4EOP|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|4EOO|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With Atp Length = 299 | Back alignment and structure |
|
| >pdb|2JFL|A Chain A, Crystal Structure Of Human Ste20-Like Kinase ( Diphosphorylated Form) Bound To 5- Amino-3-((4-( Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2, 4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|3PXF|A Chain A, Cdk2 In Complex With Two Molecules Of 8-Anilino-1-Naphthalene Sulfonate Length = 306 | Back alignment and structure |
|
| >pdb|3FI3|A Chain A, Crystal Structure Of Jnk3 With Indazole Inhibitor, Sr-3737 Length = 364 | Back alignment and structure |
|
| >pdb|4AW2|A Chain A, Crystal Structure Of Cdc42 Binding Protein Kinase Alpha (Mrck Alpha) Length = 437 | Back alignment and structure |
|
| >pdb|2IWI|A Chain A, Crystal Structure Of The Human Pim2 In Complex With A Ruthenium Organometallic Ligand Ru1 Length = 312 | Back alignment and structure |
|
| >pdb|2IWI|A Chain A, Crystal Structure Of The Human Pim2 In Complex With A Ruthenium Organometallic Ligand Ru1 Length = 312 | Back alignment and structure |
|
| >pdb|4EOS|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|1OIT|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-dependent Kinase Inhibitors Identified Through Structure-based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|1E9H|A Chain A, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With The Inhibitor Indirubin-5-Sulphonate Bound Length = 297 | Back alignment and structure |
|
| >pdb|3OXI|A Chain A, Design And Synthesis Of Disubstituted Thiophene And Thiazole Based Inhibitors Of Jnk For The Treatment Of Neurodegenerative Diseases Length = 362 | Back alignment and structure |
|
| >pdb|1W98|A Chain A, The Structural Basis Of Cdk2 Activation By Cyclin E Length = 298 | Back alignment and structure |
|
| >pdb|2EXC|X Chain X, Inhibitor Complex Of Jnk3 Length = 356 | Back alignment and structure |
|
| >pdb|1OGU|A Chain A, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed With A 2-arylamino-4-cyclohexylmethyl-5-nitroso-6- aminopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|1QMZ|A Chain A, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex Length = 299 | Back alignment and structure |
|
| >pdb|2O0U|A Chain A, Crystal Structure Of Human Jnk3 Complexed With N-{3-Cyano-6-[3-(1- Piperidinyl)propanoyl]-4,5,6,7-Tetrahydrothieno[2, 3-C]pyridin-2-Yl}- 1-Naphthalenecarboxamide Length = 364 | Back alignment and structure |
|
| >pdb|4EOQ|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|4BCQ|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|4I3Z|A Chain A, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM IONS Length = 296 | Back alignment and structure |
|
| >pdb|3BHT|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX WITH THE Inhibitor Meriolin 3 Length = 300 | Back alignment and structure |
|
| >pdb|2OK1|A Chain A, Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3- Chlorophenyl)-1h-Pyrazol-3-Yl)-1h-Pyrrole-2-Carboxamide Length = 365 | Back alignment and structure |
|
| >pdb|1PF8|A Chain A, Crystal Structure Of Human Cyclin-dependent Kinase 2 Complexed With A Nucleoside Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3PTG|A Chain A, Design And Synthesis Of A Novel, Orally Efficacious Tri-Substituted Thiophene Based Jnk Inhibitor Length = 363 | Back alignment and structure |
|
| >pdb|1PMN|A Chain A, Crystal Structure Of Jnk3 In Complex With An Imidazole- Pyrimidine Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|1JST|A Chain A, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A Length = 298 | Back alignment and structure |
|
| >pdb|2B1P|A Chain A, Inhibitor Complex Of Jnk3 Length = 355 | Back alignment and structure |
|
| >pdb|1JNK|A Chain A, The C-Jun N-Terminal Kinase (Jnk3s) Complexed With Mgamp-Pnp Length = 423 | Back alignment and structure |
|
| >pdb|4H36|A Chain A, Crystal Structure Of Jnk3 In Complex With Atf2 Peptide Length = 356 | Back alignment and structure |
|
| >pdb|2W17|A Chain A, Cdk2 In Complex With The Imidazole Pyrimidine Amide, Compound (S)-8b Length = 299 | Back alignment and structure |
|
| >pdb|3QHR|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic Length = 298 | Back alignment and structure |
|
| >pdb|1FIN|A Chain A, Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = 298 | Back alignment and structure |
|
| >pdb|1VYW|A Chain A, Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = 309 | Back alignment and structure |
|
| >pdb|3PJ8|A Chain A, Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]pyrimidine Bioisostere Of Roscovitine Length = 299 | Back alignment and structure |
|
| >pdb|1H1P|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED With The Inhibitor Nu2058 Length = 303 | Back alignment and structure |
|
| >pdb|3EZR|A Chain A, Cdk-2 With Indazole Inhibitor 17 Bound At Its Active Site Length = 300 | Back alignment and structure |
|
| >pdb|2IW8|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v- H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|2JGZ|A Chain A, Crystal Structure Of Phospho-Cdk2 In Complex With Cyclin B Length = 289 | Back alignment and structure |
|
| >pdb|3VUM|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M7 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|2PK9|A Chain A, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The Phosphate-responsive Signal Transduction Pathway Length = 317 | Back alignment and structure |
|
| >pdb|2IW6|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed With A Bisanilinopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|1GII|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3TTJ|A Chain A, Crystal Structure Of Jnk3 Complexed With Cc-359, A Jnk Inhibitor For The Prevention Of Ischemia-Reperfusion Injury Length = 464 | Back alignment and structure |
|
| >pdb|3FV8|A Chain A, Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Length = 355 | Back alignment and structure |
|
| >pdb|1CM8|A Chain A, Phosphorylated Map Kinase P38-Gamma Length = 367 | Back alignment and structure |
|
| >pdb|4AAA|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain Length = 331 | Back alignment and structure |
|
| >pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase Length = 314 | Back alignment and structure |
|
| >pdb|2VD5|A Chain A, Structure Of Human Myotonic Dystrophy Protein Kinase In Complex With The Bisindoylmaleide Inhibitor Bim Viii Length = 412 | Back alignment and structure |
|
| >pdb|3OZ6|A Chain A, Crystal Structure Of Mapk From Cryptosporidium Parvum, Cgd2_1960 Length = 388 | Back alignment and structure |
|
| >pdb|2JAV|A Chain A, Human Kinase With Pyrrole-Indolinone Ligand Length = 279 | Back alignment and structure |
|
| >pdb|3VUL|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|2W5A|A Chain A, Human Nek2 Kinase Adp-Bound Length = 279 | Back alignment and structure |
|
| >pdb|3DLS|A Chain A, Crystal Structure Of Human Pas Kinase Bound To Adp Length = 335 | Back alignment and structure |
|
| >pdb|2QKR|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Indirubin 3'-Monoxime Bound Length = 313 | Back alignment and structure |
|
| >pdb|1Z57|A Chain A, Crystal Structure Of Human Clk1 In Complex With 10z-Hymenialdisine Length = 339 | Back alignment and structure |
|
| >pdb|3NIZ|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Adp Bound Length = 311 | Back alignment and structure |
|
| >pdb|1OIR|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-Dependent Kinase Inhibitors Identified Through Structure-Based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|1H01|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino Pyrimidine Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|1V0O|A Chain A, Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulphonate Ligand Complex Length = 288 | Back alignment and structure |
|
| >pdb|2WQM|A Chain A, Structure Of Apo Human Nek7 Length = 310 | Back alignment and structure |
|
| >pdb|2VX3|A Chain A, Crystal Structure Of The Human Dual Specificity Tyrosine- Phosphorylation-Regulated Kinase 1a Length = 382 | Back alignment and structure |
|
| >pdb|1V0B|A Chain A, Crystal Structure Of The T198a Mutant Of Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|3ANQ|A Chain A, Human Dyrk1aINHIBITOR COMPLEX Length = 368 | Back alignment and structure |
|
| >pdb|3CIK|A Chain A, Human Grk2 In Complex With Gbetagamma Subunits Length = 689 | Back alignment and structure |
|
| >pdb|1OB3|A Chain A, Structure Of P. Falciparum Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|3KRW|A Chain A, Human Grk2 In Complex With Gbetgamma Subunits And Balanol (Soak) Length = 688 | Back alignment and structure |
|
| >pdb|4A4X|A Chain A, Nek2-Ede Bound To Cct248662 Length = 279 | Back alignment and structure |
|
| >pdb|4AZE|A Chain A, Human Dyrk1a In Complex With Leucettine L41 Length = 382 | Back alignment and structure |
|
| >pdb|1OMW|A Chain A, Crystal Structure Of The Complex Between G Protein-Coupled Receptor Kinase 2 And Heterotrimeric G Protein Beta 1 And Gamma 2 Subunits Length = 689 | Back alignment and structure |
|
| >pdb|3PSC|A Chain A, Bovine Grk2 In Complex With Gbetagamma Subunits Length = 695 | Back alignment and structure |
|
| >pdb|3VUH|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M3 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3FI2|A Chain A, Crystal Structure Of Jnk3 With Amino-Pyrazole Inhibitor, Sr- 3451 Length = 353 | Back alignment and structure |
|
| >pdb|4E7W|A Chain A, Structure Of Gsk3 From Ustilago Maydis Length = 394 | Back alignment and structure |
|
| >pdb|2VAG|A Chain A, Crystal Structure Of Di-Phosphorylated Human Clk1 In Complex With A Novel Substituted Indole Inhibitor Length = 339 | Back alignment and structure |
|
| >pdb|3ZHP|C Chain C, Human Mst3 (stk24) In Complex With Mo25beta Length = 294 | Back alignment and structure |
|
| >pdb|2X7F|A Chain A, Crystal Structure Of The Kinase Domain Of Human Traf2- And Nck-Interacting Kinase With Wee1chk1 Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|3E7O|A Chain A, Crystal Structure Of Jnk2 Length = 360 | Back alignment and structure |
|
| >pdb|3VUK|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M5 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|2ACX|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 6 Bound To Amppnp Length = 576 | Back alignment and structure |
|
| >pdb|3ELJ|A Chain A, Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine Inhibitor Length = 369 | Back alignment and structure |
|
| >pdb|3NYN|A Chain A, Crystal Structure Of G Protein-Coupled Receptor Kinase 6 In Complex With Sangivamycin Length = 576 | Back alignment and structure |
|
| >pdb|3V3V|A Chain A, Structural And Functional Analysis Of Quercetagetin, A Natural Jnk1 Inhibitor Length = 379 | Back alignment and structure |
|
| >pdb|3PZE|A Chain A, Jnk1 In Complex With Inhibitor Length = 358 | Back alignment and structure |
|
| >pdb|3CKW|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) Length = 304 | Back alignment and structure |
|
| >pdb|3VUG|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3VUI|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3A7F|A Chain A, Human Mst3 Kinase Length = 303 | Back alignment and structure |
|
| >pdb|2XS0|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 386 | Back alignment and structure |
|
| >pdb|3CKX|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) In Complex With Staurosporine Length = 304 | Back alignment and structure |
|
| >pdb|2G01|A Chain A, Pyrazoloquinolones As Novel, Selective Jnk1 Inhibitors Length = 370 | Back alignment and structure |
|
| >pdb|1NA7|A Chain A, Crystal Structure Of The Catalytic Subunit Of Human Protein Kinase Ck2 Length = 329 | Back alignment and structure |
|
| >pdb|3C4W|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.7a Length = 543 | Back alignment and structure |
|
| >pdb|2XRW|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 371 | Back alignment and structure |
|
| >pdb|3T8O|A Chain A, Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolution Length = 543 | Back alignment and structure |
|
| >pdb|3C4X|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.9a Length = 543 | Back alignment and structure |
|
| >pdb|1UKH|A Chain A, Structural Basis For The Selective Inhibition Of Jnk1 By The Scaffolding Protein Jip1 And Sp600125 Length = 369 | Back alignment and structure |
|
| >pdb|3GC9|A Chain A, The Structure Of P38beta C119s, C162s In Complex With A Dihydroquinazolinone Inhibitor Length = 370 | Back alignment and structure |
|
| >pdb|3MTL|A Chain A, Crystal Structure Of The Pctaire1 Kinase In Complex With Ind E804 Length = 324 | Back alignment and structure |
|
| >pdb|3QC9|A Chain A, Crystal Structure Of Cross-Linked Bovine Grk1 T8cN480C DOUBLE MUTANT Complexed With Adp And Mg Length = 543 | Back alignment and structure |
|
| >pdb|3VUD|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3GC8|A Chain A, The Structure Of P38beta C162s In Complex With A Dihydroquinazolinone Length = 370 | Back alignment and structure |
|
| >pdb|3O17|A Chain A, Crystal Structure Of Jnk1-Alpha1 Isoform Length = 370 | Back alignment and structure |
|
| >pdb|2PUU|A Chain A, Crystal Structure Of P38 Complex With 1-(5-Tert-Butyl-2-P- Tolyl-2h-Pyrazol-3-Yl)-3-[4-(6-Morpholin-4-Ylmethyl- Pyridin-3-Yl)naphthalen-1-Yl]urea Length = 348 | Back alignment and structure |
|
| >pdb|2XIK|A Chain A, Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related Kinase 1) Length = 294 | Back alignment and structure |
|
| >pdb|3PY3|A Chain A, Crystal Structure Of Phosphorylated P38alpha Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|3KVW|A Chain A, Crystal Structure Of Dual-Specificity Tyrosine Phosphorylation Regulated Kinase 2 (Dyrk2) In Complex With An Indirubin Ligand Length = 429 | Back alignment and structure |
|
| >pdb|3GGF|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase Mst4 In Complex With An Quinazolin Length = 301 | Back alignment and structure |
|
| >pdb|2Y8O|A Chain A, Crystal Structure Of Human P38alpha Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|2VWI|A Chain A, Structure Of The Osr1 Kinase, A Hypertension Drug Target Length = 303 | Back alignment and structure |
|
| >pdb|1OVE|A Chain A, The Structure Of P38 Alpha In Complex With A Dihydroquinolinone Length = 366 | Back alignment and structure |
|
| >pdb|3D83|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|3GP0|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 11 (p38 Beta) In Complex With Nilotinib Length = 348 | Back alignment and structure |
|
| >pdb|4AZF|A Chain A, Human Dyrk2 In Complex With Leucettine L41 Length = 417 | Back alignment and structure |
|
| >pdb|3TG1|A Chain A, Crystal Structure Of P38alpha In Complex With A Mapk Docking Partner Length = 380 | Back alignment and structure |
|
| >pdb|2WTK|C Chain C, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha Complex Length = 305 | Back alignment and structure |
|
| >pdb|1LEW|A Chain A, Crystal Structure Of Map Kinase P38 Complexed To The Docking Site On Its Nuclear Substrate Mef2a Length = 360 | Back alignment and structure |
|
| >pdb|1BMK|A Chain A, The Complex Structure Of The Map Kinase P38SB218655 Length = 379 | Back alignment and structure |
|
| >pdb|3P4K|A Chain A, The Third Conformation Of P38a Map Kinase Observed In Phosphorylated P38a And In Solution Length = 370 | Back alignment and structure |
|
| >pdb|2GTM|A Chain A, Mutated Mouse P38 Map Kinase Domain In Complex With Inhibitor Pg-892579 Length = 348 | Back alignment and structure |
|
| >pdb|2BAQ|A Chain A, P38alpha Bound To Ro3201195 Length = 365 | Back alignment and structure |
|
| >pdb|3DAK|A Chain A, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain Length = 290 | Back alignment and structure |
|
| >pdb|1ZY4|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g Hyperactivating Mutant In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|1ZY4|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g Hyperactivating Mutant In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|1ZYC|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild- Type In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|1ZYC|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild- Type In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|1YWR|A Chain A, Crystal Structure Analysis Of Inactive P38 Kinase Domain In Complex With A Monocyclic Pyrazolone Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|3D7Z|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|1YW2|A Chain A, Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | Back alignment and structure |
|
| >pdb|3E92|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biaryl Amide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|2GHL|A Chain A, Mutant Mus Musculus P38 Kinase Domain In Complex With Inhibitor Pg-874743 Length = 348 | Back alignment and structure |
|
| >pdb|3NPC|A Chain A, Crystal Structure Of Jnk2 Complexed With Birb796 Length = 364 | Back alignment and structure |
|
| >pdb|2OZA|B Chain B, Structure Of P38alpha Complex Length = 366 | Back alignment and structure |
|
| >pdb|4GS6|A Chain A, Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxozeaenol Length = 315 | Back alignment and structure |
|
| >pdb|4E5A|X Chain X, The W197a Mutant Of P38a Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|2BAL|A Chain A, P38alpha Map Kinase Bound To Pyrazoloamine Length = 365 | Back alignment and structure |
|
| >pdb|3NR9|A Chain A, Structure Of Human Cdc2-Like Kinase 2 (Clk2) Length = 368 | Back alignment and structure |
|
| >pdb|3NNX|A Chain A, Crystal Structure Of Phosphorylated P38 Alpha In Complex With Dp802 Length = 354 | Back alignment and structure |
|
| >pdb|4EWQ|A Chain A, Human P38 Alpha Mapk In Complex With A Pyridazine Based Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|1F3M|C Chain C, Crystal Structure Of Human SerineTHREONINE KINASE PAK1 Length = 297 | Back alignment and structure |
|
| >pdb|2FSO|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|2BAJ|A Chain A, P38alpha Bound To Pyrazolourea Length = 365 | Back alignment and structure |
|
| >pdb|3HRB|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|3MPT|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Pyrrole-2- Carboxamide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|2FSL|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a+f327s) Activating Mutant Form-A Length = 367 | Back alignment and structure |
|
| >pdb|2FST|X Chain X, Mitogen Activated Protein Kinase P38alpha (d176a+f327l) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|3ODZ|X Chain X, Crystal Structure Of P38alpha Y323r Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3GCU|A Chain A, Human P38 Map Kinase In Complex With Rl48 Length = 360 | Back alignment and structure |
|
| >pdb|3HVC|A Chain A, Crystal Structure Of Human P38alpha Map Kinase Length = 362 | Back alignment and structure |
|
| >pdb|1BL6|A Chain A, The Complex Structure Of The Map Kinase P38SB216995 Length = 379 | Back alignment and structure |
|
| >pdb|1OZ1|A Chain A, P38 Mitogen-Activated Kinase In Complex With 4-Azaindole Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|3ODY|X Chain X, Crystal Structure Of P38alpha Y323q Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|2GFS|A Chain A, P38 Kinase Crystal Structure In Complex With Ro3201195 Length = 372 | Back alignment and structure |
|
| >pdb|1YHV|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Two Point Mutations (K299r, T423e) Length = 297 | Back alignment and structure |
|
| >pdb|3K3J|A Chain A, P38alpha Bound To Novel Dfg-Out Compound Pf-00416121 Length = 362 | Back alignment and structure |
|
| >pdb|2NPQ|A Chain A, A Novel Lipid Binding Site In The P38 Alpha Map Kinase Length = 367 | Back alignment and structure |
|
| >pdb|3DT1|A Chain A, P38 Complexed With A Quinazoline Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|1ZZL|A Chain A, Crystal Structure Of P38 With Triazolopyridine Length = 351 | Back alignment and structure |
|
| >pdb|3OEF|X Chain X, Crystal Structure Of Y323f Inactive Mutant Of P38alpha Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|1M7Q|A Chain A, Crystal Structure Of P38 Map Kinase In Complex With A Dihydroquinazolinone Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|3S3I|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|3OD6|X Chain X, Crystal Structure Of P38alpha Y323t Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3KQ7|A Chain A, Structure Of Human P38alpha With N-[4-Methyl-3-(6-{[2-(1- Methylpyrrolidin-2-Yl)ethyl]amino}pyridine-3- Amido)phenyl]- 2-(Morpholin-4-Yl)pyridine-4-Carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|2LGC|A Chain A, Joint Nmr And X-Ray Refinement Reveals The Structure Of A Novel Dibenzo[a,D]cycloheptenone InhibitorP38 MAP KINASE COMPLEX IN Solution Length = 359 | Back alignment and structure |
|
| >pdb|3ZSG|A Chain A, X-Ray Structure Of P38alpha Bound To Tak-715 Length = 362 | Back alignment and structure |
|
| >pdb|3K3I|A Chain A, P38alpha Bound To Novel Dgf-Out Compound Pf-00215955 Length = 350 | Back alignment and structure |
|
| >pdb|3HEC|A Chain A, P38 In Complex With Imatinib Length = 348 | Back alignment and structure |
|
| >pdb|1DI9|A Chain A, The Structure Of P38 Mitogen-Activated Protein Kinase In Complex With 4-[3-Methylsulfanylanilino]-6,7- Dimethoxyquinazoline Length = 360 | Back alignment and structure |
|
| >pdb|3NNU|A Chain A, Crystal Structure Of P38 Alpha In Complex With Dp1376 Length = 354 | Back alignment and structure |
|
| >pdb|1YXS|A Chain A, Crystal Structure Of Kinase Pim1 With P123m Mutation Length = 293 | Back alignment and structure |
|
| >pdb|3UIX|A Chain A, Crystal Structure Of Pim1 Kinase In Complex With Small Molecule Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|1XWS|A Chain A, Crystal Structure Of The Human Pim1 Kinase Domain Length = 313 | Back alignment and structure |
|
| >pdb|4ALU|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328 | Back alignment and structure |
|
| >pdb|3R00|A Chain A, The Discovery Of Novel Benzofuran-2-Carboxylic Acids As Potent Pim-1 Inhibitors Length = 299 | Back alignment and structure |
|
| >pdb|4DTK|A Chain A, Novel And Selective Pan-Pim Kinase Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|1YWV|A Chain A, Crystal Structures Of Proto-Oncogene Kinase Pim1: A Target Of Aberrant Somatic Hypermutations In Diffuse Large Cell Lymphoma Length = 293 | Back alignment and structure |
|
| >pdb|2F9G|A Chain A, Crystal Structure Of Fus3 Phosphorylated On Tyr182 Length = 353 | Back alignment and structure |
|
| >pdb|3JXW|A Chain A, Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4-Ones As Potent, Highly Selective And Orally Bioavailable Pim Kinases Inhibitors Length = 294 | Back alignment and structure |
|
| >pdb|2XJ0|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-4 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|4ALV|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328 | Back alignment and structure |
|
| >pdb|2BIL|B Chain B, The Human Protein Kinase Pim1 In Complex With Its Consensus Peptide Pimtide Length = 313 | Back alignment and structure |
|
| >pdb|3C4E|A Chain A, Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7- Azaindole Length = 273 | Back alignment and structure |
|
| >pdb|1IAN|A Chain A, Human P38 Map Kinase Inhibitor Complex Length = 366 | Back alignment and structure |
|
| >pdb|3A99|A Chain A, Structure Of Pim-1 Kinase Crystallized In The Presence Of P27kip1 Carboxy-Terminal Peptide Length = 320 | Back alignment and structure |
|
| >pdb|3QA8|A Chain A, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta Length = 676 | Back alignment and structure |
|
| >pdb|3CXW|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Beta Carboline Ligand I Length = 314 | Back alignment and structure |
|
| >pdb|1XQZ|A Chain A, Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolution Length = 300 | Back alignment and structure |
|
| >pdb|4AS0|A Chain A, Cyclometalated Phthalimides As Protein Kinase Inhibitors Length = 273 | Back alignment and structure |
|
| >pdb|3RZF|A Chain A, Crystal Structure Of Inhibitor Of Kappab Kinase Beta (I4122) Length = 677 | Back alignment and structure |
|
| >pdb|3JPV|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Pyrrolo[2,3- A]carbazole Ligand Length = 313 | Back alignment and structure |
|
| >pdb|4G31|A Chain A, Crystal Structure Of Gsk6414 Bound To Perk (R587-R1092, Delete A660- T867) At 2.28 A Resolution Length = 299 | Back alignment and structure |
|
| >pdb|4G31|A Chain A, Crystal Structure Of Gsk6414 Bound To Perk (R587-R1092, Delete A660- T867) At 2.28 A Resolution Length = 299 | Back alignment and structure |
|
| >pdb|3GCP|A Chain A, Human P38 Map Kinase In Complex With Sb203580 Length = 360 | Back alignment and structure |
|
| >pdb|2J2I|B Chain B, Crystal Structure Of The Humab Pim1 In Complex With Ly333531 Length = 312 | Back alignment and structure |
|
| >pdb|2B9F|A Chain A, Crystal Structure Of Non-Phosphorylated Fus3 Length = 353 | Back alignment and structure |
|
| >pdb|1H4L|A Chain A, Structure And Regulation Of The Cdk5-P25(Nck5a) Complex Length = 292 | Back alignment and structure |
|
| >pdb|1YHS|A Chain A, Crystal Structure Of Pim-1 Bound To Staurosporine Length = 273 | Back alignment and structure |
|
| >pdb|3GBZ|A Chain A, Structure Of The Cmgc Cdk Kinase From Giardia Lamblia Length = 329 | Back alignment and structure |
|
| >pdb|1O9U|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide Length = 350 | Back alignment and structure |
|
| >pdb|3FI4|A Chain A, P38 Kinase Crystal Structure In Complex With Ro4499 Length = 372 | Back alignment and structure |
|
| >pdb|3MH2|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|2C30|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 6 Length = 321 | Back alignment and structure |
|
| >pdb|2EVA|A Chain A, Structural Basis For The Interaction Of Tak1 Kinase With Its Activating Protein Tab1 Length = 307 | Back alignment and structure |
|
| >pdb|2B9H|A Chain A, Crystal Structure Of Fus3 With A Docking Motif From Ste7 Length = 353 | Back alignment and structure |
|
| >pdb|3Q4Z|A Chain A, Structure Of Unphosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|4DIT|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Imidazopyridine Inhibitor Length = 382 | Back alignment and structure |
|
| >pdb|3SAY|A Chain A, Crystal Structure Of Human Glycogen Synthase Kinase 3 Beta (Gsk3b) In Complex With Inhibitor 142 Length = 430 | Back alignment and structure |
|
| >pdb|3FXZ|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium Complex Lambda-Fl172 Length = 297 | Back alignment and structure |
|
| >pdb|3ZRK|A Chain A, Identification Of 2-(4-Pyridyl)thienopyridinones As Gsk-3beta Inhibitors Length = 371 | Back alignment and structure |
|
| >pdb|1GNG|A Chain A, Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With Frattide Peptide Length = 378 | Back alignment and structure |
|
| >pdb|3Q52|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|1UV5|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With 6-Bromoindirubin-3'-Oxime Length = 350 | Back alignment and structure |
|
| >pdb|1H8F|A Chain A, Glycogen Synthase Kinase 3 Beta. Length = 352 | Back alignment and structure |
|
| >pdb|2OBJ|A Chain A, Crystal Structure Of Human Pim-1 Kinase In Complex With Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|4AFJ|A Chain A, 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selective Gsk-3 Inhibitors Length = 367 | Back alignment and structure |
|
| >pdb|3F2A|A Chain A, Crystal Structure Of Human Pim-1 In Complex With Dappa Length = 300 | Back alignment and structure |
|
| >pdb|1Q5K|A Chain A, Crystal Structure Of Glycogen Synthase Kinase 3 In Complexed With Inhibitor Length = 414 | Back alignment and structure |
|
| >pdb|2XIY|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-2 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|4A7C|A Chain A, Crystal Structure Of Pim1 Kinase With Etp46546 Length = 308 | Back alignment and structure |
|
| >pdb|3CY3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And The Jnk Inhibitor V Length = 314 | Back alignment and structure |
|
| >pdb|1I09|A Chain A, Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Length = 420 | Back alignment and structure |
|
| >pdb|3DCV|A Chain A, Crystal Structure Of Human Pim1 Kinase Complexed With 4-(4- Hydroxy-3-Methyl-Phenyl)-6-Phenylpyrimidin-2(1h)-One Length = 328 | Back alignment and structure |
|
| >pdb|2BIK|B Chain B, Human Pim1 Phosphorylated On Ser261 Length = 313 | Back alignment and structure |
|
| >pdb|4ACC|A Chain A, Gsk3b In Complex With Inhibitor Length = 465 | Back alignment and structure |
|
| >pdb|3ZDI|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide And Inhibitor 7d Length = 350 | Back alignment and structure |
|
| >pdb|1Q3D|A Chain A, Gsk-3 Beta Complexed With Staurosporine Length = 424 | Back alignment and structure |
|
| >pdb|1PYX|A Chain A, Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | Back alignment and structure |
|
| >pdb|2EU9|A Chain A, Crystal Structure Of Clk3 Length = 355 | Back alignment and structure |
|
| >pdb|3GB2|A Chain A, Gsk3beta Inhibitor Complex Length = 353 | Back alignment and structure |
|
| >pdb|3F7Z|A Chain A, X-ray Co-crystal Structure Of Glycogen Synthase Kinase 3beta In Complex With An Inhibitor Length = 350 | Back alignment and structure |
|
| >pdb|3MA3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Naphtho-Difuran Ligand Length = 313 | Back alignment and structure |
|
| >pdb|2OW3|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With Bis- (Indole)maleimide Pyridinophane Inhibitor Length = 352 | Back alignment and structure |
|
| >pdb|3OHT|A Chain A, Crystal Structure Of Salmo Salar P38alpha Length = 389 | Back alignment and structure |
|
| >pdb|2WU6|A Chain A, Crystal Structure Of The Human Clk3 In Complex With Dki Length = 381 | Back alignment and structure |
|
| >pdb|2EXE|A Chain A, Crystal Structure Of The Phosphorylated Clk3 Length = 357 | Back alignment and structure |
|
| >pdb|1R0E|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With 3-Indolyl-4- Arylmaleimide Inhibitor Length = 391 | Back alignment and structure |
|
| >pdb|2O5K|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Benzoimidazol Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|3GI3|A Chain A, Crystal Structure Of A N-Phenyl-N'-Naphthylurea Analog In Complex With P38 Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|3K2L|A Chain A, Crystal Structure Of Dual-Specificity Tyrosine Phosphorylation Regulated Kinase 2 (Dyrk2) Length = 429 | Back alignment and structure |
|
| >pdb|2XIX|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-1 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|3O8P|A Chain A, Conformational Plasticity Of P38 Map Kinase Dfg Motif Mutants In Response To Inhibitor Binding Length = 360 | Back alignment and structure |
|
| >pdb|3SD0|A Chain A, Identification Of A Glycogen Synthase Kinase-3b Inhibitor That Attenuates Hyperactivity In Clock Mutant Mice Length = 350 | Back alignment and structure |
|
| >pdb|4EUU|A Chain A, Structure Of Bx-795 Complexed With Human Tbk1 Kinase Domain Phosphorylated On Ser172 Length = 319 | Back alignment and structure |
|
| >pdb|3OMV|A Chain A, Crystal Structure Of C-Raf (Raf-1) Length = 307 | Back alignment and structure |
|
| >pdb|1UNG|A Chain A, Structural Mechanism For The Inhibition Of Cdk5-P25 By Roscovitine, Aloisine And Indirubin. Length = 292 | Back alignment and structure |
|
| >pdb|1ZXE|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: D835n Inactivating Mutant In Apo Form Length = 303 | Back alignment and structure |
|
| >pdb|4EUT|A Chain A, Structure Of Bx-795 Complexed With Unphosphorylated Human Tbk1 Kinase- Uld Domain Length = 396 | Back alignment and structure |
|
| >pdb|3MH0|A Chain A, Mutagenesis Of P38 Map Kinase Eshtablishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3LL6|A Chain A, Crystal Structure Of The Human Cyclin G Associated Kinase (gak) Length = 337 | Back alignment and structure |
|
| >pdb|3MH1|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3MH3|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|1UA2|A Chain A, Crystal Structure Of Human Cdk7 Length = 346 | Back alignment and structure |
|
| >pdb|3ALN|A Chain A, Crystal Structure Of Human Non-Phosphorylated Mkk4 Kinase Domain Complexed With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|2F57|A Chain A, Crystal Structure Of The Human P21-activated Kinase 5 Length = 317 | Back alignment and structure |
|
| >pdb|2BUJ|A Chain A, Crystal Structure Of The Human Serine-Threonine Kinase 16 In Complex With Staurosporine Length = 317 | Back alignment and structure |
|
| >pdb|3RGF|A Chain A, Crystal Structure Of Human Cdk8CYCC Length = 405 | Back alignment and structure |
|
| >pdb|3F88|A Chain A, Glycogen Synthase Kinase 3beta Inhibitor Complex Length = 349 | Back alignment and structure |
|
| >pdb|4H3Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|4EC8|A Chain A, Structure Of Full Length Cdk9 In Complex With Cyclint And Drb Length = 373 | Back alignment and structure |
|
| >pdb|3II5|A Chain A, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine Inhibitor Length = 306 | Back alignment and structure |
|
| >pdb|3D4Q|A Chain A, Pyrazole-Based Inhibitors Of B-Raf Kinase Length = 307 | Back alignment and structure |
|
| >pdb|2FB8|A Chain A, Structure Of The B-Raf Kinase Domain Bound To Sb-590885 Length = 281 | Back alignment and structure |
|
| >pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720 Length = 280 | Back alignment and structure |
|
| >pdb|3Q96|A Chain A, B-Raf Kinase Domain In Complex With A Tetrahydronaphthalene Inhibitor Length = 282 | Back alignment and structure |
|
| >pdb|4BCF|A Chain A, Structure Of Cdk9 In Complex With Cyclin T And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 331 | Back alignment and structure |
|
| >pdb|4DBN|A Chain A, Crystal Structure Of The Kinase Domain Of Human B-Raf With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 284 | Back alignment and structure |
|
| >pdb|1UWH|A Chain A, The Complex Of Wild Type B-Raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|3MI9|A Chain A, Crystal Structure Of Hiv-1 Tat Complexed With Human P-Tefb Length = 351 | Back alignment and structure |
|
| >pdb|4H58|A Chain A, Braf In Complex With Compound 3 Length = 275 | Back alignment and structure |
|
| >pdb|3N9X|A Chain A, Crystal Structure Of Map Kinase From Plasmodium Berghei, Pb000659.00.0 Length = 432 | Back alignment and structure |
|
| >pdb|2ZOQ|A Chain A, Structural Dissection Of Human Mitogen-Activated Kinase Erk1 Length = 382 | Back alignment and structure |
|
| >pdb|3BLH|A Chain A, Crystal Structure Of Human Cdk9CYCLINT1 Length = 331 | Back alignment and structure |
|
| >pdb|3TEI|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3HMN|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With Atp Length = 342 | Back alignment and structure |
|
| >pdb|2X9E|A Chain A, Human Mps1 In Complex With Nms-P715 Length = 317 | Back alignment and structure |
|
| >pdb|2ZMC|A Chain A, Crystal Structure Of Human Mitotic Checkpoint Kinase Mps1 Catalytic Domain Apo Form Length = 390 | Back alignment and structure |
|
| >pdb|3DBQ|A Chain A, Crystal Structure Of Ttk Kinase Domain Length = 343 | Back alignment and structure |
|
| >pdb|4G3D|A Chain A, Crystal Structure Of Human Nf-kappab Inducing Kinase (nik) Length = 371 | Back alignment and structure |
|
| >pdb|3H9F|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (Ttk) In Complex With A Pyrimido-Diazepin Ligand Length = 313 | Back alignment and structure |
|
| >pdb|3VQU|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With 4- [(4-Amino-5-Cyano-6-Ethoxypyridin-2- Yl)amino]benzamide Length = 320 | Back alignment and structure |
|
| >pdb|3UIB|A Chain A, Map Kinase Lmampk10 From Leishmania Major In Complex With Sb203580 Length = 362 | Back alignment and structure |
|
| >pdb|4DN5|A Chain A, Crystal Structure Of Nf-kb-inducing Kinase (nik) Length = 356 | Back alignment and structure |
|
| >pdb|3PG1|A Chain A, Map Kinase Lmampk10 From Leishmania Major (1.95 Angs Resolution) Length = 362 | Back alignment and structure |
|
| >pdb|2RIO|A Chain A, Structure Of The Dual Enzyme Ire1 Reveals The Basis For Catalysis And Regulation Of Non-conventional Splicing Length = 434 | Back alignment and structure |
|
| >pdb|3BYS|A Chain A, Co-Crystal Structure Of Lck And Aminopyrimidine Amide 10b Length = 277 | Back alignment and structure |
|
| >pdb|3CEK|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (ttk) Length = 313 | Back alignment and structure |
|
| >pdb|3SA0|A Chain A, Complex Of Erk2 With Norathyriol Length = 360 | Back alignment and structure |
|
| >pdb|2OFV|A Chain A, Crystal Structure Of Aminoquinazoline 1 Bound To Lck Length = 277 | Back alignment and structure |
|
| >pdb|3VN9|A Chain A, Rifined Crystal Structure Of Non-Phosphorylated Map2k6 In A Putative Auto-Inhibition State Length = 340 | Back alignment and structure |
|
| >pdb|3LJ0|A Chain A, Ire1 Complexed With Adp And Quercetin Length = 434 | Back alignment and structure |
|
| >pdb|2PL0|A Chain A, Lck Bound To Imatinib Length = 289 | Back alignment and structure |
|
| >pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx3203 Length = 292 | Back alignment and structure |
|
| >pdb|2OF2|A Chain A, Crystal Structure Of Furanopyrimidine 8 Bound To Lck Length = 271 | Back alignment and structure |
|
| >pdb|3FPQ|A Chain A, Crystal Structure Of The Kinase Domain Of Wnk1 Length = 290 | Back alignment and structure |
|
| >pdb|3IDP|A Chain A, B-Raf V600e Kinase Domain In Complex With An Aminoisoquinoline Inhibitor Length = 300 | Back alignment and structure |
|
| >pdb|2OG8|A Chain A, Crystal Structure Of Aminoquinazoline 36 Bound To Lck Length = 265 | Back alignment and structure |
|
| >pdb|4FV7|A Chain A, Crystal Structure Of The Erk2 Complexed With E94 Length = 360 | Back alignment and structure |
|
| >pdb|4GSB|A Chain A, Monoclinic Crystal Form Of The Apo-Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|4FUX|A Chain A, Crystal Structure Of The Erk2 Complexed With E75 Length = 360 | Back alignment and structure |
|
| >pdb|4G9R|A Chain A, B-Raf V600e Kinase Domain Bound To A Type Ii Dihydroquinazoline Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx4032 Length = 289 | Back alignment and structure |
|
| >pdb|3QYW|A Chain A, Crystal Structure Of Erk2 In Complex With An Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|4B99|A Chain A, Crystal Structure Of Mapk7 (Erk5) With Inhibitor Length = 398 | Back alignment and structure |
|
| >pdb|1PME|A Chain A, Structure Of Penta Mutant Human Erk2 Map Kinase Complexed With A Specific Inhibitor Of Human P38 Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|4APC|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1) Length = 350 | Back alignment and structure |
|
| >pdb|1UWJ|A Chain A, The Complex Of Mutant V599e B-raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|2OJG|A Chain A, Crystal Structure Of Erk2 In Complex With N,n-dimethyl-4-(4- Phenyl-1h-pyrazol-3-yl)-1h-pyrrole-2-carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|1WZY|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Pyrazolopyridazine Derivative Length = 368 | Back alignment and structure |
|
| >pdb|1TVO|A Chain A, The Structure Of Erk2 In Complex With A Small Molecule Inhibitor Length = 368 | Back alignment and structure |
|
| >pdb|2Y9Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3O71|A Chain A, Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length = 358 | Back alignment and structure |
|
| >pdb|1GOL|A Chain A, Coordinates Of Rat Map Kinase Erk2 With An Arginine Mutation At Position 52 Length = 364 | Back alignment and structure |
|
| >pdb|4FV6|A Chain A, Crystal Structure Of The Erk2 Complexed With E57 Length = 360 | Back alignment and structure |
|
| >pdb|3R63|A Chain A, Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | Back alignment and structure |
|
| >pdb|2GPH|A Chain A, Docking Motif Interactions In The Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|3ZUV|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Phosphorylated Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|3ZU7|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|2Z7L|A Chain A, Unphosphorylated Mitogen Activated Protein Kinase Erk2 In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin 2-Yl]amino}phenyl)acetic Acid Length = 366 | Back alignment and structure |
|
| >pdb|3C9W|A Chain A, Crystal Structure Of Erk-2 With Hypothemycin Covalently Bound Length = 357 | Back alignment and structure |
|
| >pdb|2FYS|B Chain B, Crystal Structure Of Erk2 Complex With Kim Peptide Derived From Mkp3 Length = 364 | Back alignment and structure |
|
| >pdb|2ERK|A Chain A, Phosphorylated Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|4IC7|A Chain A, Crystal Structure Of The Erk5 Kinase Domain In Complex With An Mkk5 Binding Fragment Length = 442 | Back alignment and structure |
|
| >pdb|1QPD|A Chain A, Structural Analysis Of The Lymphocyte-specific Kinase Lck In Complex With Non-selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|3PPZ|A Chain A, Crystal Structure Of Ctr1 Kinase Domain In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|3UIU|A Chain A, Crystal Structure Of Apo-Pkr Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3QD2|B Chain B, Crsytal Structure Of Mouse Perk Kinase Domain Length = 332 | Back alignment and structure |
|
| >pdb|4G3G|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) V408l Bound To A 2-(aminothiazolyl)phenol (cmp3) Length = 350 | Back alignment and structure |
|
| >pdb|3P86|A Chain A, Crystal Structure Of Ctr1 Kinase Domain Mutant D676n In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|2ZM1|A Chain A, Crystal Structure Of Imidazo Pyrazin 1 Bound To The Kinase Domain Of Human Lck, (Auto-Phosphorylated On Tyr394) Length = 285 | Back alignment and structure |
|
| >pdb|3KXZ|A Chain A, The Complex Crystal Structure Of Lck With A Probe Molecule W259 Length = 287 | Back alignment and structure |
|
| >pdb|3LCK|A Chain A, The Kinase Domain Of Human Lymphocyte Kinase (Lck), Activated Form (Auto-Phosphorylated On Tyr394) Length = 271 | Back alignment and structure |
|
| >pdb|2ZMD|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain T686a Mutant In Complex With Sp600125 Inhibitor Length = 390 | Back alignment and structure |
|
| >pdb|2OFU|A Chain A, X-Ray Crystal Structure Of 2-Aminopyrimidine Carbamate 43 Bound To Lck Length = 273 | Back alignment and structure |
|
| >pdb|1QPE|A Chain A, Structural Analysis Of The Lymphocyte-Specific Kinase Lck In Complex With Non-Selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|3KMM|A Chain A, Structure Of Human Lck Kinase With A Small Molecule Inhibitor Length = 288 | Back alignment and structure |
|
| >pdb|3BYM|A Chain A, X-Ray Co-Crystal Structure Aminobenzimidazole Triazine 1 Bound To Lck Length = 272 | Back alignment and structure |
|
| >pdb|3NIE|A Chain A, Crystal Structure Of Pf11_0147 Length = 429 | Back alignment and structure |
|
| >pdb|3MPM|A Chain A, Lck Complexed With A Pyrazolopyrimidine Length = 267 | Back alignment and structure |
|
| >pdb|4F99|A Chain A, Human Cdc7 Kinase In Complex With Dbf4 And Nucleotide Length = 361 | Back alignment and structure |
|
| >pdb|4G3F|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) Bound To A 2-(aminothiazoly)phenol (cmp2) Length = 336 | Back alignment and structure |
|
| >pdb|3SDJ|A Chain A, Structure Of Rnase-Inactive Point Mutant Of Oligomeric KinaseRNASE Ire1 Length = 448 | Back alignment and structure |
|
| >pdb|3FBV|A Chain A, Crystal Structure Of The Oligomer Formed By The Kinase-Ribonuclease Domain Of Ire1 Length = 448 | Back alignment and structure |
|
| >pdb|1U5Q|A Chain A, Crystal Structure Of The Tao2 Kinase Domain: Activation And Specifity Of A Ste20p Map3k Length = 348 | Back alignment and structure |
|
| >pdb|3E3B|X Chain X, Crystal Structure Of Catalytic Subunit Of Human Protein Kinase Ck2alpha Prime With A Potent Indazole-Derivative Inhibitor Length = 339 | Back alignment and structure |
|
| >pdb|3F69|A Chain A, Crystal Structure Of The Mycobacterium Tuberculosis Pknb Mutant Kinase Domain In Complex With Kt5720 Length = 311 | Back alignment and structure |
|
| >pdb|4G3C|A Chain A, Crystal Structure Of Apo Murine Nf-kappab Inducing Kinase (nik) Length = 352 | Back alignment and structure |
|
| >pdb|3OFM|A Chain A, Structure Of A Human Ck2alpha Prime, The Paralog Isoform Of The Catalytic Subunit Of Protein Kinase Ck2 From Homo Sapiens Length = 350 | Back alignment and structure |
|
| >pdb|3LLT|A Chain A, Crystal Structure Of Pf14_0431, Kinase Domain Length = 360 | Back alignment and structure |
|
| >pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus SerineTHREONINE KINASE Pknb Length = 294 | Back alignment and structure |
|
| >pdb|4DGL|C Chain C, Crystal Structure Of The Ck2 Tetrameric Holoenzyme Length = 335 | Back alignment and structure |
|
| >pdb|3F61|A Chain A, Crystal Structure Of M. Tuberculosis Pknb Leu33aspVAL222ASP DOUBLE MUTANT IN COMPLEX WITH ADP Length = 311 | Back alignment and structure |
|
| >pdb|2A19|B Chain B, Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Length = 284 | Back alignment and structure |
|
| >pdb|2GCD|A Chain A, Tao2 Kinase Domain-Staurosporine Structure Length = 309 | Back alignment and structure |
|
| >pdb|1BYG|A Chain A, Kinase Domain Of Human C-Terminal Src Kinase (Csk) In Complex With Inhibitor Staurosporine Length = 278 | Back alignment and structure |
|
| >pdb|1K9A|A Chain A, Crystal Structure Analysis Of Full-Length Carboxyl-Terminal Src Kinase At 2.5 A Resolution Length = 450 | Back alignment and structure |
|
| >pdb|3D7U|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 263 | Back alignment and structure |
|
| >pdb|1O6Y|A Chain A, Catalytic Domain Of Pknb Kinase From Mycobacterium Tuberculosis Length = 299 | Back alignment and structure |
|
| >pdb|3ORM|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain D76a Mutant Length = 311 | Back alignment and structure |
|
| >pdb|3FME|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 6 (Mek6) Activated Mutant (S207d, T211d) Length = 290 | Back alignment and structure |
|
| >pdb|3D7T|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 269 | Back alignment and structure |
|
| >pdb|4FIE|A Chain A, Full-Length Human Pak4 Length = 423 | Back alignment and structure |
|
| >pdb|1MRU|A Chain A, Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycobacterium Tuberculosis Pknb. Length = 311 | Back alignment and structure |
|
| >pdb|3ORI|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant (Crystal Form 1) Length = 311 | Back alignment and structure |
|
| >pdb|3P23|A Chain A, Crystal Structure Of The Human Kinase And Rnase Domains In Complex With Adp Length = 432 | Back alignment and structure |
|
| >pdb|3JUH|A Chain A, Crystal Structure Of A Mutant Of Human Protein Kinase Ck2alpha With Altered Cosubstrate Specificity Length = 335 | Back alignment and structure |
|
| >pdb|4FIF|A Chain A, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide Length = 346 | Back alignment and structure |
|
| >pdb|2Q0N|A Chain A, Structure Of Human P21 Activating Kinase 4 (Pak4) In Complex With A Consensus Peptide Length = 301 | Back alignment and structure |
|
| >pdb|2CDZ|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Cgp74514a Length = 303 | Back alignment and structure |
|
| >pdb|3EB0|A Chain A, Crystal Structure Of Cgd4_240 From Cryptosporidium Parvum In Complex With Indirubin E804 Length = 383 | Back alignment and structure |
|
| >pdb|2BVA|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 Length = 292 | Back alignment and structure |
|
| >pdb|3U87|A Chain A, Structure Of A Chimeric Construct Of Human Ck2alpha And Human Ck2alpha' In Complex With A Non-hydrolysable Atp-analogue Length = 349 | Back alignment and structure |
|
| >pdb|3ENM|A Chain A, The Structure Of The Map2k Mek6 Reveals An Autoinhibitory Dimer Length = 316 | Back alignment and structure |
|
| >pdb|2X4Z|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Pf-03758309 Length = 296 | Back alignment and structure |
|
| >pdb|1JWH|A Chain A, Crystal Structure Of Human Protein Kinase Ck2 Holoenzyme Length = 337 | Back alignment and structure |
|
| >pdb|3Q9W|A Chain A, Crystal Structure Of Human Ck2 Alpha In Complex With Emodin At Ph 8.5 Length = 336 | Back alignment and structure |
|
| >pdb|2R7I|A Chain A, Crystal Structure Of Catalytic Subunit Of Protein Kinase Ck2 Length = 335 | Back alignment and structure |
|
| >pdb|2ZJW|A Chain A, Crystal Structure Of Human Ck2 Alpha Complexed With Ellagic Acid Length = 340 | Back alignment and structure |
|
| >pdb|3BQC|A Chain A, High Ph-Value Crystal Structure Of Emodin In Complex With The Catalytic Subunit Of Protein Kinase Ck2 Length = 335 | Back alignment and structure |
|
| >pdb|1PJK|A Chain A, Crystal Structure Of A C-terminal Deletion Mutant Of Human Protein Kinase Ck2 Catalytic Subunit Length = 334 | Back alignment and structure |
|
| >pdb|3H30|A Chain A, Crystal Structure Of The Catalytic Subunit Of Human Protein Kinase Ck2 With 5,6-Dichloro-1-Beta-D- Ribofuranosylbenzimidazole Length = 334 | Back alignment and structure |
|
| >pdb|3NGA|A Chain A, Human Ck2 Catalytic Domain In Complex With Cx-4945 Length = 333 | Back alignment and structure |
|
| >pdb|3NSZ|A Chain A, Human Ck2 Catalytic Domain In Complex With Amppn Length = 330 | Back alignment and structure |
|
| >pdb|3Q04|A Chain A, Crystal Structure Of The Apo-Form Of Human Ck2 Alpha At Ph 8.5 Length = 328 | Back alignment and structure |
|
| >pdb|3MB6|A Chain A, Human Ck2 Catalytic Domain In Complex With A Difurane Derivative Inhibitor (Cpa) Length = 331 | Back alignment and structure |
|
| >pdb|2DYL|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 7 Activated Mutant (S287d, T291d) Length = 318 | Back alignment and structure |
|
| >pdb|3SLS|A Chain A, Crystal Structure Of Human Mek-1 Kinase In Complex With Ucb1353770 And Amppnp Length = 304 | Back alignment and structure |
|
| >pdb|2WTK|B Chain B, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha Complex Length = 373 | Back alignment and structure |
|
| >pdb|1EH4|A Chain A, Binary Complex Of Casein Kinase-1 From S. Pombe With An Atp Competitive Inhibitor, Ic261 Length = 298 | Back alignment and structure |
|
| >pdb|3GNI|B Chain B, Structure Of Strad And Mo25 Length = 389 | Back alignment and structure |
|
| >pdb|2CSN|A Chain A, Binary Complex Of Casein Kinase-1 With Cki7 Length = 297 | Back alignment and structure |
|
| >pdb|1Q8Y|A Chain A, The Structure Of The Yeast Sr Protein Kinase, Sky1p, With Bound Adp Length = 373 | Back alignment and structure |
|
| >pdb|3RP9|A Chain A, Crystal Structure Of The Apo Mapk From Toxoplasma Gondii, 25.M01780 Or Tgme49_007820 Length = 458 | Back alignment and structure |
|
| >pdb|3DTC|A Chain A, Crystal Structure Of Mixed-Lineage Kinase Mlk1 Complexed With Compound 16 Length = 271 | Back alignment and structure |
|
| >pdb|1HOW|A Chain A, The X-Ray Crystal Structure Of Sky1p, An Sr Protein Kinase In Yeast Length = 373 | Back alignment and structure |
|
| >pdb|3ORN|A Chain A, Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In Complex With Ch4987655 And Mgamp-Pnp Length = 307 | Back alignment and structure |
|
| >pdb|2I6L|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 6 (Mapk6) Length = 320 | Back alignment and structure |
|
| >pdb|3PVG|A Chain A, Crystal Structure Of Z. Mays Ck2 Alpha Subunit In Complex With The Inhibitor 4,5,6,7-Tetrabromo-1-Carboxymethylbenzimidazole (K68) Length = 331 | Back alignment and structure |
|
| >pdb|1DS5|A Chain A, Dimeric Crystal Structure Of The Alpha Subunit In Complex With Two Beta Peptides Mimicking The Architecture Of The Tetrameric Protein Kinase Ck2 Holoenzyme. Length = 332 | Back alignment and structure |
|
| >pdb|2QC6|A Chain A, Protein Kinase Ck2 In Complex With Dbc Length = 332 | Back alignment and structure |
|
| >pdb|2PVH|A Chain A, Structure-Based Design Of Pyrazolo[1,5-A][1,3,5]triazine Derivatives As Potent Inhibitors Of Protein Kinase Ck2 Length = 352 | Back alignment and structure |
|
| >pdb|4ANM|A Chain A, Complex Of Ck2 With A Cdc7 Inhibitor Length = 335 | Back alignment and structure |
|
| >pdb|3GVU|A Chain A, The Crystal Structure Of Human Abl2 In Complex With Gleevec Length = 292 | Back alignment and structure |
|
| >pdb|3KXG|A Chain A, Crystal Structure Of Z. Mays Ck2 Kinase Alpha Subunit In Complex With The Inhibitor 3,4,5,6,7-Pentabromo-1h-Indazole (K64) Length = 327 | Back alignment and structure |
|
| >pdb|3E3P|A Chain A, Glycogen Synthase Kinase From Leishmania Major Length = 360 | Back alignment and structure |
|
| >pdb|1DAW|A Chain A, Crystal Structure Of A Binary Complex Of Protein Kinase Ck2 (Alpha-Subunit) And Mg-Amppnp Length = 327 | Back alignment and structure |
|
| >pdb|4DGN|A Chain A, Crystal Structure Of Maize Ck2 In Complex With The Inhibitor Luteolin Length = 326 | Back alignment and structure |
|
| >pdb|1M2P|A Chain A, Crystal Structure Of 1,8-Di-Hydroxy-4-Nitro- AnthraquinoneCK2 KINASE COMPLEX Length = 325 | Back alignment and structure |
|
| >pdb|4DGM|A Chain A, Crystal Structure Of Maize Ck2 In Complex With The Inhibitor Apigenin Length = 326 | Back alignment and structure |
|
| >pdb|3SXR|A Chain A, Crystal Structure Of Bmx Non-Receptor Tyrosine Kinase Complex With Dasatinib Length = 268 | Back alignment and structure |
|
| >pdb|3S95|A Chain A, Crystal Structure Of The Human Limk1 Kinase Domain In Complex With Staurosporine Length = 310 | Back alignment and structure |
|
| >pdb|2Y4I|B Chain B, Ksr2-Mek1 Heterodimer Length = 319 | Back alignment and structure |
|
| >pdb|2Y4I|C Chain C, Ksr2-Mek1 Heterodimer Length = 395 | Back alignment and structure |
|
| >pdb|3A4O|X Chain X, Lyn Kinase Domain Length = 286 | Back alignment and structure |
|
| >pdb|2ZV7|A Chain A, Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | Back alignment and structure |
|
| >pdb|2HK5|A Chain A, Hck Kinase In Complex With Lck Targetted Inhibitor Pg- 1009247 Length = 270 | Back alignment and structure |
|
| >pdb|3EQC|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Ternary Complex With Compound 1, Atp-Gs And Mg2p Length = 360 | Back alignment and structure |
|
| >pdb|1QCF|A Chain A, Crystal Structure Of Hck In Complex With A Src Family- Selective Tyrosine Kinase Inhibitor Length = 454 | Back alignment and structure |
|
| >pdb|2P55|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 333 | Back alignment and structure |
|
| >pdb|1S9J|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 341 | Back alignment and structure |
|
| >pdb|2QOK|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:s768a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|4AN2|A Chain A, Crystal Structures Of Human Mek1 With Carboxamide-Based Allosteric Inhibitor Xl518 (Gdc-0973), Or Related Analogs. Length = 301 | Back alignment and structure |
|
| >pdb|1JPA|A Chain A, Crystal Structure Of Unphosphorylated Ephb2 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 312 | Back alignment and structure |
|
| >pdb|3MBL|A Chain A, Crystal Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek 1) In Complex With Ligand And Mgadp Length = 328 | Back alignment and structure |
|
| >pdb|3DV3|A Chain A, Mek1 With Pf-04622664 Bound Length = 322 | Back alignment and structure |
|
| >pdb|3MIY|A Chain A, X-Ray Crystal Structure Of Itk Complexed With Sunitinib Length = 266 | Back alignment and structure |
|
| >pdb|2NRU|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|2NRY|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|2REI|A Chain A, Kinase Domain Of Human Ephrin Type-a Receptor 7 (epha7) Length = 318 | Back alignment and structure |
|
| >pdb|2QON|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3T9T|A Chain A, Crystal Structure Of Btk Mutant (F435t,K596r) Complexed With Imidazo[1,5-A]quinoxaline Length = 267 | Back alignment and structure |
|
| >pdb|1AD5|A Chain A, Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | Back alignment and structure |
|
| >pdb|2QOO|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742f Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3HNG|A Chain A, Crystal Structure Of Vegfr1 In Complex With N-(4-chlorophenyl)-2- ((pyridin-4-ylmethyl)amino)benzamide Length = 360 | Back alignment and structure |
|
| >pdb|4HCT|A Chain A, Crystal Structure Of Itk In Complex With Compound 52 Length = 269 | Back alignment and structure |
|
| >pdb|1SM2|A Chain A, Crystal Structure Of The Phosphorylated Interleukin-2 Tyrosine Kinase Catalytic Domain Length = 264 | Back alignment and structure |
|
| >pdb|4HVD|A Chain A, Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h-pyrrolo[2,3- B]pyrazine-7-carboxylic Acid ((s)-1,2,2-trimethyl-propyl)-amide Length = 314 | Back alignment and structure |
|
| >pdb|3V5J|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase Itk Catalytic Domain With Thienopyrazolylindole Inhibitor 090 Length = 266 | Back alignment and structure |
|
| >pdb|3QGW|A Chain A, Crystal Structure Of Itk Kinase Bound To An Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|4AW5|A Chain A, Complex Of The Ephb4 Kinase Domain With An Oxindole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|3DZQ|A Chain A, Human Epha3 Kinase Domain In Complex With Inhibitor Awl-Ii- 38.3 Length = 361 | Back alignment and structure |
|
| >pdb|2QOB|A Chain A, Human Epha3 Kinase Domain, Base Structure Length = 344 | Back alignment and structure |
|
| >pdb|2QOI|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f Double Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3LXK|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 327 | Back alignment and structure |
|
| >pdb|2QOF|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOD|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y602f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3PJC|A Chain A, Crystal Structure Of Jak3 Complexed With A Potent Atp Site Inhibitor Showing High Selectivity Within The Janus Kinase Family Length = 315 | Back alignment and structure |
|
| >pdb|2QOC|A Chain A, Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp Bound Structure Length = 344 | Back alignment and structure |
|
| >pdb|2GSF|A Chain A, The Human Epha3 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 373 | Back alignment and structure |
|
| >pdb|2QO7|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Dephosphorylated, Amp-Pnp Bound Length = 373 | Back alignment and structure |
|
| >pdb|2QOL|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596:y602:s768g Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|1YVJ|A Chain A, Crystal Structure Of The Jak3 Kinase Domain In Complex With A Staurosporine Analogue Length = 290 | Back alignment and structure |
|
| >pdb|3FXX|A Chain A, Human Epha3 Kinase And Juxtamembrane Region Bound To Substrate Kqwdnye[ptyr]iw Length = 371 | Back alignment and structure |
|
| >pdb|4F0F|A Chain A, Crystal Structure Of The Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|3ZZW|A Chain A, Crystal Structure Of The Kinase Domain Of Ror2 Length = 289 | Back alignment and structure |
|
| >pdb|4GT4|A Chain A, Structure Of Unliganded, Inactive Ror2 Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|1RJB|A Chain A, Crystal Structure Of Flt3 Length = 344 | Back alignment and structure |
|
| >pdb|1S9I|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 2 (Mek2)in A Complex With Ligand And Mgatp Length = 354 | Back alignment and structure |
|
| >pdb|3GEN|A Chain A, The 1.6 A Crystal Structure Of Human Bruton's Tyrosine Kinase Bound To A Pyrrolopyrimidine-Containing Compound Length = 283 | Back alignment and structure |
|
| >pdb|2OIB|A Chain A, Crystal Structure Of Irak4 Kinase Domain Apo Form Length = 301 | Back alignment and structure |
|
| >pdb|3VID|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With Compound A Length = 356 | Back alignment and structure |
|
| >pdb|3U6J|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyrazolone Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|1Y6A|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 2-Anilino-5-Aryl-Oxazole Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|3EWH|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridyl-Pyrimidine Benzimidazole Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3VHK|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Back Pocket Binder Length = 368 | Back alignment and structure |
|
| >pdb|3VHE|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With A Novel Pyrrolopyrimidine Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|3CJF|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|2PZI|A Chain A, Crystal Structure Of Protein Kinase Pkng From Mycobacterium Tuberculosis In Complex With Tetrahydrobenzothiophene Ax20017 Length = 681 | Back alignment and structure |
|
| >pdb|2H8H|A Chain A, Src Kinase In Complex With A Quinazoline Inhibitor Length = 535 | Back alignment and structure |
|
| >pdb|4AGC|A Chain A, Crystal Structure Of Vegfr2 (Juxtamembrane And Kinase Domains) In Complex With Axitinib (Ag-013736) (N-Methyl-2-( 3-((E)-2-Pyridin-2-Yl-Vinyl)-1h-Indazol-6-Ylsulfanyl)- Benzamide) Length = 353 | Back alignment and structure |
|
| >pdb|4F1O|A Chain A, Crystal Structure Of The L1180t Mutant Roco4 Kinase Domain From D. Discoideum Bound To Appcp Length = 287 | Back alignment and structure |
|
| >pdb|2HEN|A Chain A, Crystal Structure Of The Ephb2 Receptor Kinase Domain In Complex With Adp Length = 286 | Back alignment and structure |
|
| >pdb|3VNT|A Chain A, Crystal Structure Of The Kinase Domain Of Human Vegfr2 With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 318 | Back alignment and structure |
|
| >pdb|2XIR|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With Pf-00337210 (N,2-Dimethyl-6-(7-(2-Morpholinoethoxy) Quinolin-4-Yloxy)benzofuran-3-Carboxamide) Length = 316 | Back alignment and structure |
|
| >pdb|3CJG|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|3P08|A Chain A, Crystal Structure Of The Human Btk Kinase Domain Length = 267 | Back alignment and structure |
|
| >pdb|3OCT|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Mutant V555r In Complex With Dasatinib Length = 265 | Back alignment and structure |
|
| >pdb|2R2P|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 5 (Epha5) Length = 295 | Back alignment and structure |
|
| >pdb|1K2P|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Domain Length = 263 | Back alignment and structure |
|
| >pdb|3PIX|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With 2-Isopropyl-7- (4-Methyl-Piperazin-1-Yl)-4-(5-Methyl-2h-Pyrazol-3- Ylamino)-2h- Phthalazin-1-One Length = 274 | Back alignment and structure |
|
| >pdb|3OCS|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase In Complex With Inhibitor Cgi1746 Length = 271 | Back alignment and structure |
|
| >pdb|1Y57|A Chain A, Structure Of Unphosphorylated C-Src In Complex With An Inhibitor Length = 452 | Back alignment and structure |
|
| >pdb|1FMK|A Chain A, Crystal Structure Of Human Tyrosine-Protein Kinase C-Src Length = 452 | Back alignment and structure |
|
| >pdb|3K54|A Chain A, Structures Of Human Bruton's Tyrosine Kinase In Active And Inactive Conformations Suggests A Mechanism Of Activation For Tec Family Kinases Length = 283 | Back alignment and structure |
|
| >pdb|1KSW|A Chain A, Structure Of Human C-Src Tyrosine Kinase (Thr338gly Mutant) In Complex With N6-Benzyl Adp Length = 452 | Back alignment and structure |
|
| >pdb|1YOL|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Cgp77675 Length = 283 | Back alignment and structure |
|
| >pdb|2BDF|A Chain A, Src Kinase In Complex With Inhibitor Ap23451 Length = 279 | Back alignment and structure |
|
| >pdb|2P2I|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Nicotinamide Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|2P2H|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridinyl-Triazine Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3D7U|B Chain B, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 277 | Back alignment and structure |
|
| >pdb|2VWU|A Chain A, Ephb4 Kinase Domain Inhibitor Complex Length = 302 | Back alignment and structure |
|
| >pdb|3SV0|A Chain A, Crystal Structure Of Casein Kinase-1 Like Protein In Plant Length = 483 | Back alignment and structure |
|
| >pdb|3U4W|A Chain A, Src In Complex With Dna-Templated Macrocyclic Inhibitor Mc4b Length = 275 | Back alignment and structure |
|
| >pdb|3OEZ|A Chain A, Crystal Structure Of The L317i Mutant Of The Chicken C-Src Tyrosine Kinase Domain Complexed With Imatinib Length = 286 | Back alignment and structure |
|
| >pdb|2OIQ|A Chain A, Crystal Structure Of Chicken C-Src Kinase Domain In Complex With The Cancer Drug Imatinib. Length = 286 | Back alignment and structure |
|
| >pdb|1YWN|A Chain A, Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]pyrimidine Length = 316 | Back alignment and structure |
|
| >pdb|3G6H|A Chain A, Src Thr338ile Inhibited In The Dfg-Asp-Out Conformation Length = 286 | Back alignment and structure |
|
| >pdb|1U46|A Chain A, Crystal Structure Of The Unphosphorylated Kinase Domain Of The Tyrosine Kinase Ack1 Length = 291 | Back alignment and structure |
|
| >pdb|1U54|A Chain A, Crystal Structures Of The Phosphorylated And Unphosphorylated Kinase Domains Of The Cdc42-Associated Tyrosine Kinase Ack1 Bound To Amp-Pcp Length = 291 | Back alignment and structure |
|
| >pdb|3C7Q|A Chain A, Structure Of Vegfr2 Kinase Domain In Complex With Bibf1120 Length = 316 | Back alignment and structure |
|
| >pdb|2OH4|A Chain A, Crystal Structure Of Vegfr2 With A Benzimidazole-Urea Inhibitor Length = 316 | Back alignment and structure |
|
| >pdb|4HZS|A Chain A, Crystal Structure Of Ack1 Kinase Domain With C-terminal Sh3 Domain Length = 341 | Back alignment and structure |
|
| >pdb|1VR2|A Chain A, Human Vascular Endothelial Growth Factor Receptor 2 (Kdr) Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|2HWO|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Covalent Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|3SVV|A Chain A, Crystal Structure Of T338c C-Src Covalently Bound To Vinylsulfonamide- Pyrazolopyrimidine 9 Length = 286 | Back alignment and structure |
|
| >pdb|2QQ7|A Chain A, Crystal Structure Of Drug Resistant Src Kinase Domain With Irreversible Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|4F1M|A Chain A, Crystal Structure Of The G1179s Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|3EQP|B Chain B, Crystal Structure Of Ack1 With Compound T95 Length = 276 | Back alignment and structure |
|
| >pdb|2O8Y|A Chain A, Apo Irak4 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|4EWH|B Chain B, Co-Crystal Structure Of Ack1 With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|3HGK|A Chain A, Crystal Structure Of Effect Protein Avrptob Complexed With Kinase Pto Length = 327 | Back alignment and structure |
|
| >pdb|2DQ7|X Chain X, Crystal Structure Of Fyn Kinase Domain Complexed With Staurosporine Length = 283 | Back alignment and structure |
|
| >pdb|4HZR|A Chain A, Crystal Structure Of Ack1 Kinase Domain Length = 277 | Back alignment and structure |
|
| >pdb|2IN6|A Chain A, Wee1 Kinase Complex With Inhibitor Pd311839 Length = 287 | Back alignment and structure |
|
| >pdb|2Z2W|A Chain A, Humand Wee1 Kinase Complexed With Inhibitor Pf0335770 Length = 285 | Back alignment and structure |
|
| >pdb|3BI6|A Chain A, Wee1 Kinase Complex With Inhibitor Pd352396 Length = 287 | Back alignment and structure |
|
| >pdb|1X8B|A Chain A, Structure Of Human Wee1a Kinase: Kinase Domain Complexed With Inhibitor Pd0407824 Length = 289 | Back alignment and structure |
|
| >pdb|4ID7|A Chain A, Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-amino-1-(4- Phenoxyphenyl)imidazo[1,5-a]pyrazin-3-yl]cyclobutanol Length = 273 | Back alignment and structure |
|
| >pdb|1YOJ|A Chain A, Crystal Structure Of Src Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|2PTK|A Chain A, Chicken Src Tyrosine Kinase Length = 453 | Back alignment and structure |
|
| >pdb|3GEQ|A Chain A, Structural Basis For The Chemical Rescue Of Src Kinase Activity Length = 286 | Back alignment and structure |
|
| >pdb|1YI6|A Chain A, C-Term Tail Segment Of Human Tyrosine Kinase (258-533) Length = 276 | Back alignment and structure |
|
| >pdb|2QKW|B Chain B, Structural Basis For Activation Of Plant Immunity By Bacterial Effector Protein Avrpto Length = 321 | Back alignment and structure |
|
| >pdb|3LXN|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 318 | Back alignment and structure |
|
| >pdb|2PML|X Chain X, Crystal Structure Of Pfpk7 In Complex With An Atp Analogue Length = 348 | Back alignment and structure |
|
| >pdb|4HGL|A Chain A, Crystal Structure Of Ck1g3 With Compound 1 Length = 330 | Back alignment and structure |
|
| >pdb|3DQW|A Chain A, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs Length = 286 | Back alignment and structure |
|
| >pdb|3NYX|A Chain A, Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-Thiadiazole- Thiophene Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|2J0K|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains. Length = 656 | Back alignment and structure |
|
| >pdb|2JKK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|3JS2|A Chain A, Crystal Structure Of Minimal Kinase Domain Of Fibroblast Growth Factor Receptor 1 In Complex With 5-(2-Thienyl) Nicotinic Acid Length = 317 | Back alignment and structure |
|
| >pdb|1FGK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of Fibroblast Growth Factor Receptor 1 Length = 310 | Back alignment and structure |
|
| >pdb|4F63|A Chain A, Crystal Structure Of Human Fibroblast Growth Factor Receptor 1 Kinase Domain In Complex With Compound 1 Length = 309 | Back alignment and structure |
|
| >pdb|3RHX|B Chain B, Crystal Structure Of The Catalytic Domain Of Fgfr1 Kinase In Complex With Arq 069 Length = 306 | Back alignment and structure |
|
| >pdb|3KXX|A Chain A, Structure Of The Mutant Fibroblast Growth Factor Receptor 1 Length = 317 | Back alignment and structure |
|
| >pdb|3TT0|A Chain A, Co-Structure Of Fibroblast Growth Factor Receptor 1 Kinase Domain With 3-(2,6-Dichloro-3, 5-Dimethoxy-Phenyl)-1-{6-[4-(4-Ethyl-Piperazin-1- Yl)-Phenylamino]-Pyrimidin-4-Yl}-1-Methyl-Urea (Bgj398) Length = 382 | Back alignment and structure |
|
| >pdb|3C4F|A Chain A, Fgfr Tyrosine Kinase Domain In Complex With 3-(3- Methoxybenzyl)-7-Azaindole Length = 302 | Back alignment and structure |
|
| >pdb|3GQL|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|2C47|A Chain A, Structure Of Casein Kinase 1 Gamma 2 Length = 313 | Back alignment and structure |
|
| >pdb|3UYS|A Chain A, Crystal Structure Of Apo Human Ck1d Length = 296 | Back alignment and structure |
|
| >pdb|4ASZ|A Chain A, Crystal Structure Of Apo Trkb Kinase Domain Length = 299 | Back alignment and structure |
|
| >pdb|3LMG|A Chain A, Crystal Structure Of The Erbb3 Kinase Domain In Complex With Amp-Pnp Length = 344 | Back alignment and structure |
|
| >pdb|4HNI|A Chain A, Crystal Structure Of Ck1e In Complex With Pf4800567 Length = 296 | Back alignment and structure |
|
| >pdb|1CKJ|A Chain A, Casein Kinase I Delta Truncation Mutant Containing Residues 1-317 Complex With Bound Tungstate Length = 317 | Back alignment and structure |
|
| >pdb|2OO8|X Chain X, Synthesis, Structural Analysis, And Sar Studies Of Triazine Derivatives As Potent, Selective Tie-2 Inhibitors Length = 317 | Back alignment and structure |
|
| >pdb|1FVR|A Chain A, Tie2 Kinase Domain Length = 327 | Back alignment and structure |
|
| >pdb|2R4B|A Chain A, Erbb4 Kinase Domain Complexed With A Thienopyrimidine Inhibitor Length = 321 | Back alignment and structure |
|
Structure Templates Detected by RPS-BLAST
Original result of RPS-BLAST against PDB70 database
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325 | Back alignment and structure |
|---|
Score = 381 bits (980), Expect = e-125
Identities = 164/353 (46%), Positives = 216/353 (61%), Gaps = 72/353 (20%)
Query: 368 KGSLFFEQYDMDLDKAGILGDGSYSVCRRCVEKSTGQEYAVKIISRKI--DCSEEINLLR 425
K S F++ YD+DL LG+GS+S+CR+CV K + Q +AVKIIS+++ + +EI L+
Sbjct: 2 KDSPFYQHYDLDLKDK-PLGEGSFSICRKCVHKKSNQAFAVKIISKRMEANTQKEITALK 60
Query: 426 ACQGHPNIVNLHCVFQDEVHTYLVLELLKGGELLDRIRQKGRCGFTENEASRIMRQLVAA 485
C+GHPNIV LH VF D++HT+LV+ELL GGEL +RI++K F+E EAS IMR+LV+A
Sbjct: 61 LCEGHPNIVKLHEVFHDQLHTFLVMELLNGGELFERIKKKKH--FSETEASYIMRKLVSA 118
Query: 486 VHFMHSRGVVHRDLKPENLLFSDPAGD-NIKVVDFGFACLKR---ESLHTPCFTLQYAAP 541
V MH GVVHRDLKPENLLF+D + IK++DFGFA LK + L TPCFTL YAAP
Sbjct: 119 VSHMHDVGVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQPLKTPCFTLHYAAP 178
Query: 542 EVLRQDKSGYDENCDLWSLGVILVNVLRQDKSGYDENCDLWSLGVILYTMLCGRVPFHAR 601
E+L ++GYDE+CDLWSLGVILYTML G+VPF +
Sbjct: 179 ELLN--------------------------QNGYDESCDLWSLGVILYTMLSGQVPFQSH 212
Query: 602 SRDDSALS---IMARIKEGQFNFDAEAWSTVSSEAKELTKSLLTVNPAQRI--------- 649
R + S IM +IK+G F+F+ EAW VS EAK+L + LLTV+P +R+
Sbjct: 213 DRSLTCTSAVEIMKKIKKGDFSFEGEAWKNVSQEAKDLIQGLLTVDPNKRLKMSGLRYNE 272
Query: 650 -------------------------RMMRVKLTFHAFHQAQKEGFRLQDVTSA 677
VK TFHAF++ ++EGF LQ+V A
Sbjct: 273 WLQDGSQLSSNPLMTPDILGSSGAAVHTCVKATFHAFNKYKREGFCLQNVDKA 325
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325 | Back alignment and structure |
|---|
Score = 120 bits (302), Expect = 9e-30
Identities = 45/73 (61%), Positives = 55/73 (75%), Gaps = 3/73 (4%)
Query: 894 HTYLVLELLKGGELLDRIRQKGRCGFTENEASRIMRQLVAAVHFMHSRGVVHRDLKPENL 953
HT+LV+ELL GGEL +RI++K F+E EAS IMR+LV+AV MH GVVHRDLKPENL
Sbjct: 80 HTFLVMELLNGGELFERIKKKKH--FSETEASYIMRKLVSAVSHMHDVGVVHRDLKPENL 137
Query: 954 LLSGISGN-LIKI 965
L + + N IKI
Sbjct: 138 LFTDENDNLEIKI 150
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325 | Back alignment and structure |
|---|
Score = 90.0 bits (224), Expect = 1e-19
Identities = 33/68 (48%), Positives = 49/68 (72%), Gaps = 3/68 (4%)
Query: 106 KGSLFFEQYDMDLDKAGILGDGSYSVCRRCVEKSTGQEYAVKIISRKI--DCSEEINLLR 163
K S F++ YD+DL LG+GS+S+CR+CV K + Q +AVKIIS+++ + +EI L+
Sbjct: 2 KDSPFYQHYDLDLKDK-PLGEGSFSICRKCVHKKSNQAFAVKIISKRMEANTQKEITALK 60
Query: 164 ACQGHPNI 171
C+GHPNI
Sbjct: 61 LCEGHPNI 68
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325 | Back alignment and structure |
|---|
Score = 48.8 bits (117), Expect = 5e-06
Identities = 17/93 (18%), Positives = 31/93 (33%), Gaps = 13/93 (13%)
Query: 263 YRRILK-----TEPPIPEDLSPDVADFISRLLVKDPRRRLGGGELDAEELKRHPFFNVID 317
++I K ++S + D I LL DP +R L L+ + + D
Sbjct: 225 MKKIKKGDFSFEGEAWK-NVSQEAKDLIQGLLTVDPNKR-----LKMSGLRYNEWLQ--D 276
Query: 318 WDDLATKRIPAPFVPKISNELDVSNFSDEFTKM 350
L++ + P + S + F
Sbjct: 277 GSQLSSNPLMTPDILGSSGAAVHTCVKATFHAF 309
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342 | Back alignment and structure |
|---|
Score = 379 bits (976), Expect = e-124
Identities = 129/359 (35%), Positives = 189/359 (52%), Gaps = 71/359 (19%)
Query: 368 KGSLFFEQYDMDLDKAGILGDGSYSVCRRCVEKSTGQEYAVKIIS-RKIDCSEEINLLRA 426
F + Y++ +G GSYSVC+RC+ K+T E+AVKII K D +EEI +L
Sbjct: 16 NSIQFTDGYEVK----EDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKRDPTEEIEILLR 71
Query: 427 CQGHPNIVNLHCVFQDEVHTYLVLELLKGGELLDRIRQKGRCGFTENEASRIMRQLVAAV 486
HPNI+ L V+ D + Y+V EL+KGGELLD+I ++ F+E EAS ++ + V
Sbjct: 72 YGQHPNIITLKDVYDDGKYVYVVTELMKGGELLDKILRQKF--FSEREASAVLFTITKTV 129
Query: 487 HFMHSRGVVHRDLKPENLLFSDPAGD--NIKVVDFGFACLKR---ESLHTPCFTLQYAAP 541
++H++GVVHRDLKP N+L+ D +G+ +I++ DFGFA R L TPC+T + AP
Sbjct: 130 EYLHAQGVVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAENGLLMTPCYTANFVAP 189
Query: 542 EVLRQDKSGYDENCDLWSLGVILVNVLRQDKSGYDENCDLWSLGVILYTMLCGRVPFHAR 601
EVL + GYD CD+WSLGV+LYTML G PF
Sbjct: 190 EVLE--------------------------RQGYDAACDIWSLGVLLYTMLTGYTPFANG 223
Query: 602 SRDDSALSIMARIKEGQFNFDAEAWSTVSSEAKELTKSLLTVNPAQRI------------ 649
DD+ I+ARI G+F+ W++VS AK+L +L V+P QR+
Sbjct: 224 P-DDTPEEILARIGSGKFSLSGGYWNSVSDTAKDLVSKMLHVDPHQRLTAALVLRHPWIV 282
Query: 650 ----------------RMMR--VKLTFHAFHQAQKEGFRLQDVTSAKLAQRRKNKNVSN 690
+++ + T+ A ++ Q L+ V + LAQRR K +++
Sbjct: 283 HWDQLPQYQLNRQDAPHLVKGAMAATYSALNRNQS--PVLEPVGRSTLAQRRGIKKITS 339
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342 | Back alignment and structure |
|---|
Score = 121 bits (305), Expect = 5e-30
Identities = 35/74 (47%), Positives = 51/74 (68%), Gaps = 4/74 (5%)
Query: 894 HTYLVLELLKGGELLDRIRQKGRCGFTENEASRIMRQLVAAVHFMHSRGVVHRDLKPENL 953
+ Y+V EL+KGGELLD+I ++ F+E EAS ++ + V ++H++GVVHRDLKP N+
Sbjct: 90 YVYVVTELMKGGELLDKILRQKF--FSEREASAVLFTITKTVEYLHAQGVVHRDLKPSNI 147
Query: 954 LLSGISGN--LIKI 965
L SGN I+I
Sbjct: 148 LYVDESGNPESIRI 161
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342 | Back alignment and structure |
|---|
Score = 89.7 bits (223), Expect = 3e-19
Identities = 29/67 (43%), Positives = 39/67 (58%), Gaps = 5/67 (7%)
Query: 106 KGSLFFEQYDMDLDKAGILGDGSYSVCRRCVEKSTGQEYAVKIIS-RKIDCSEEINLLRA 164
F + Y++ +G GSYSVC+RC+ K+T E+AVKII K D +EEI +L
Sbjct: 16 NSIQFTDGYEVK----EDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKRDPTEEIEILLR 71
Query: 165 CQGHPNI 171
HPNI
Sbjct: 72 YGQHPNI 78
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336 | Back alignment and structure |
|---|
Score = 363 bits (935), Expect = e-118
Identities = 97/288 (33%), Positives = 152/288 (52%), Gaps = 35/288 (12%)
Query: 368 KGSLFFEQYDMDLDKAGILGDGSYSVCRRCVEKSTGQEYAVKIISRKIDCSEEINLLRAC 427
K + Y + +LG G C + TGQ+ A+K++ +E++
Sbjct: 22 KKYAVTDDYQLSKQ---VLGLGVNGKVLECFHRRTGQKCALKLLYDSPKARQEVDHHWQA 78
Query: 428 QGHPNIVNLHCVFQDEVHT----YLVLELLKGGELLDRIRQKGRCGFTENEASRIMRQLV 483
G P+IV + V+++ H +++E ++GGEL RI+++G FTE EA+ IMR +
Sbjct: 79 SGGPHIVCILDVYENMHHGKRCLLIIMECMEGGELFSRIQERGDQAFTEREAAEIMRDIG 138
Query: 484 AAVHFMHSRGVVHRDLKPENLLFSDPAGD-NIKVVDFGFA-CLKRESLHTPCFTLQYAAP 541
A+ F+HS + HRD+KPENLL++ D +K+ DFGFA + +L TPC+T Y AP
Sbjct: 139 TAIQFLHSHNIAHRDVKPENLLYTSKEKDAVLKLTDFGFAKETTQNALQTPCYTPYYVAP 198
Query: 542 EVLRQDKSGYDENCDLWSLGVILVNVLRQDKSGYDENCDLWSLGVILYTMLCGRVPFHAR 601
EVL YD++CD+WSLGVI+Y +LCG PF++
Sbjct: 199 EVLG--------------------------PEKYDKSCDMWSLGVIMYILLCGFPPFYSN 232
Query: 602 SRDDSALSIMARIKEGQFNFDAEAWSTVSSEAKELTKSLLTVNPAQRI 649
+ + + RI+ GQ+ F WS VS +AK+L + LL +P +R+
Sbjct: 233 TGQAISPGMKRRIRLGQYGFPNPEWSEVSEDAKQLIRLLLKTDPTERL 280
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336 | Back alignment and structure |
|---|
Score = 122 bits (309), Expect = 1e-30
Identities = 31/83 (37%), Positives = 51/83 (61%), Gaps = 1/83 (1%)
Query: 884 TFVNRSRYNVHTYLVLELLKGGELLDRIRQKGRCGFTENEASRIMRQLVAAVHFMHSRGV 943
+ N +++E ++GGEL RI+++G FTE EA+ IMR + A+ F+HS +
Sbjct: 90 VYENMHHGKRCLLIIMECMEGGELFSRIQERGDQAFTEREAAEIMRDIGTAIQFLHSHNI 149
Query: 944 VHRDLKPENLLLSGISGN-LIKI 965
HRD+KPENLL + + ++K+
Sbjct: 150 AHRDVKPENLLYTSKEKDAVLKL 172
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336 | Back alignment and structure |
|---|
Score = 100 bits (250), Expect = 7e-23
Identities = 51/280 (18%), Positives = 85/280 (30%), Gaps = 82/280 (29%)
Query: 104 KFKGSLFFEQYDMDLDKAGILGDGSYSVCRRCVEKSTGQEYAVKIISRKIDCSEEINLLR 163
+ K + Y + +LG G C + TGQ+ A+K++ +E++
Sbjct: 20 EPKKYAVTDDYQLSKQ---VLGLGVNGKVLECFHRRTGQKCALKLLYDSPKARQEVDHHW 76
Query: 164 ACQGHPNI------------CRRCV----EKSTGQEYAVKIISRKIDC-SEE-------- 198
G P+I +RC+ E G E +I R +E
Sbjct: 77 QASGGPHIVCILDVYENMHHGKRCLLIIMECMEGGELFSRIQERGDQAFTEREAAEIMRD 136
Query: 199 -INLLRACQGHPNIV-------NLHCVFQDE-----VIDWDDFSRGIECVFFSS------ 239
++ H NI NL +++ + D+ F++ +
Sbjct: 137 IGTAIQFLHSH-NIAHRDVKPENLLYTSKEKDAVLKLTDF-GFAKETTQNALQTPCYTPY 194
Query: 240 -------------------SL-IIFFIILS----FTLSFIHDYYHIQYRRILKTEPPIPE 275
SL +I +I+L F + RRI + P
Sbjct: 195 YVAPEVLGPEKYDKSCDMWSLGVIMYILLCGFPPFYSNTGQAISPGMKRRIRLGQYGFPN 254
Query: 276 D----LSPDVADFISRLLVKDPRRRLGGGELDAEELKRHP 311
+S D I LL DP R L + HP
Sbjct: 255 PEWSEVSEDAKQLIRLLLKTDPTER-----LTITQFMNHP 289
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400 | Back alignment and structure |
|---|
Score = 364 bits (936), Expect = e-117
Identities = 111/406 (27%), Positives = 172/406 (42%), Gaps = 76/406 (18%)
Query: 327 PAPFVPKISNELDVSNFSDEFTKMIPADSPAIVPPNFDKIFKGSLFFEQYDMDLDKAGIL 386
PAP P + + + P P + +I K + + Y + + +L
Sbjct: 15 PAPAPPPQPPTPALPHPPAQPPPPPPQQFPQFHVKSGLQIKKNA-IIDDYKVT---SQVL 70
Query: 387 GDGSYSVCRRCVEKSTGQEYAVKIISRKIDCSEEINLLRACQGHPNIVNLHCVFQDEV-- 444
G G + K T +++A+K++ E+ L P+IV + V+++
Sbjct: 71 GLGINGKVLQIFNKRTQEKFALKMLQDCPKARREVELHWRASQCPHIVRIVDVYENLYAG 130
Query: 445 --HTYLVLELLKGGELLDRIRQKGRCGFTENEASRIMRQLVAAVHFMHSRGVVHRDLKPE 502
+V+E L GGEL RI+ +G FTE EAS IM+ + A+ ++HS + HRD+KPE
Sbjct: 131 RKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPE 190
Query: 503 NLLFSDPAGD-NIKVVDFGFACLKR--ESLHTPCFTLQYAAPEVLRQDKSGYDENCDLWS 559
NLL++ + +K+ DFGFA SL TPC+T Y APEVL
Sbjct: 191 NLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAPEVLG-------------- 236
Query: 560 LGVILVNVLRQDKSGYDENCDLWSLGVILYTMLCGRVPFHARSRDDSALSIMARIKEGQF 619
YD++CD+WSLGVI+Y +LCG PF++ + + RI+ GQ+
Sbjct: 237 ------------PEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQY 284
Query: 620 NFDAEAWSTVSSEAKELTKSLLTVNPAQRI------------------------------ 649
F WS VS E K L ++LL P QR+
Sbjct: 285 EFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQSTKVPQTPLHTSRVLKE 344
Query: 650 ---------RMMRVKLTFHAFHQAQKEGFRLQDVTSAKLAQRRKNK 686
M L Q + +++D ++ L +RRK
Sbjct: 345 DKERWEDVKEEMTSALATMRVDYEQIKIKKIEDASNPLLLKRRKKA 390
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400 | Back alignment and structure |
|---|
Score = 123 bits (310), Expect = 3e-30
Identities = 33/83 (39%), Positives = 49/83 (59%), Gaps = 1/83 (1%)
Query: 884 TFVNRSRYNVHTYLVLELLKGGELLDRIRQKGRCGFTENEASRIMRQLVAAVHFMHSRGV 943
+ N +V+E L GGEL RI+ +G FTE EAS IM+ + A+ ++HS +
Sbjct: 123 VYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINI 182
Query: 944 VHRDLKPENLLLSGISGN-LIKI 965
HRD+KPENLL + N ++K+
Sbjct: 183 AHRDVKPENLLYTSKRPNAILKL 205
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400 | Back alignment and structure |
|---|
Score = 89.0 bits (221), Expect = 8e-19
Identities = 15/83 (18%), Positives = 31/83 (37%), Gaps = 3/83 (3%)
Query: 89 PSLDKRPNTSNLIACKFKGSLFFEQYDMDLDKAGILGDGSYSVCRRCVEKSTGQEYAVKI 148
P + P + K + + Y + + +LG G + K T +++A+K+
Sbjct: 38 PPPQQFPQFHVKSGLQIKKNAIIDDYKVT---SQVLGLGINGKVLQIFNKRTQEKFALKM 94
Query: 149 ISRKIDCSEEINLLRACQGHPNI 171
+ E+ L P+I
Sbjct: 95 LQDCPKARREVELHWRASQCPHI 117
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400 | Back alignment and structure |
|---|
Score = 83.2 bits (206), Expect = 6e-17
Identities = 10/52 (19%), Positives = 23/52 (44%)
Query: 171 ICRRCVEKSTGQEYAVKIISRKIDCSEEINLLRACQGHPNIVNLHCVFQDEV 222
+ K T +++A+K++ E+ L P+IV + V+++
Sbjct: 77 KVLQIFNKRTQEKFALKMLQDCPKARREVELHWRASQCPHIVRIVDVYENLY 128
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316 | Back alignment and structure |
|---|
Score = 352 bits (905), Expect = e-114
Identities = 97/305 (31%), Positives = 151/305 (49%), Gaps = 53/305 (17%)
Query: 372 FFEQYDMDLDKAGILGDGSYSVCRRCVEKSTGQEYAVKIISR-----KIDCSEEINLLRA 426
F + Y + + +LG+G+++ + C+ T QEYAVKII + + E+ +L
Sbjct: 10 FEDVYQL---QEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQ 66
Query: 427 CQGHPNIVNLHCVFQDEVHTYLVLELLKGGELLDRIRQKGRCGFTENEASRIMRQLVAAV 486
CQGH N++ L F++E YLV E ++GG +L I ++ F E EAS +++ + +A+
Sbjct: 67 CQGHRNVLELIEFFEEEDRFYLVFEKMRGGSILSHIHKRRH--FNELEASVVVQDVASAL 124
Query: 487 HFMHSRGVVHRDLKPENLLFSDPAGD-NIKVVDFGFACLKRE----------SLHTPCFT 535
F+H++G+ HRDLKPEN+L P +K+ DF + L TPC +
Sbjct: 125 DFLHNKGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLTPCGS 184
Query: 536 LQYAAPEVLRQDKSGYDENCDLWSLGVILVNVLRQDKSGYDENCDLWSLGVILYTMLCGR 595
+Y APEV+ ++ S YD+ CDLWSLGVILY +L G
Sbjct: 185 AEYMAPEVVEAFS---------------------EEASIYDKRCDLWSLGVILYILLSGY 223
Query: 596 VPFHARSRDDSALS-----------IMARIKEGQFNFDAEAWSTVSSEAKELTKSLLTVN 644
PF R D + I+EG++ F + W+ +S AK+L LL +
Sbjct: 224 PPFVGRCGSDCGWDRGEACPACQNMLFESIQEGKYEFPDKDWAHISCAAKDLISKLLVRD 283
Query: 645 PAQRI 649
QR+
Sbjct: 284 AKQRL 288
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316 | Back alignment and structure |
|---|
Score = 120 bits (302), Expect = 7e-30
Identities = 28/73 (38%), Positives = 46/73 (63%), Gaps = 3/73 (4%)
Query: 894 HTYLVLELLKGGELLDRIRQKGRCGFTENEASRIMRQLVAAVHFMHSRGVVHRDLKPENL 953
YLV E ++GG +L I ++ F E EAS +++ + +A+ F+H++G+ HRDLKPEN+
Sbjct: 85 RFYLVFEKMRGGSILSHIHKRRH--FNELEASVVVQDVASALDFLHNKGIAHRDLKPENI 142
Query: 954 LLSGISGN-LIKI 965
L + +KI
Sbjct: 143 LCEHPNQVSPVKI 155
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316 | Back alignment and structure |
|---|
Score = 85.4 bits (212), Expect = 4e-18
Identities = 25/112 (22%), Positives = 43/112 (38%), Gaps = 38/112 (33%)
Query: 110 FFEQYDMDLDKAGILGDGSYSVCRRCVEKSTGQEYAVKIISRKIDCSEEINLLRACQGHP 169
F + Y + + +LG+G+++ + C+ T QEYAVKII ++
Sbjct: 10 FEDVYQL---QEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRS----------- 55
Query: 170 NICRRCVEKSTGQEYAVKIISRKIDCSEEINLLRACQGHPNIVNLHCVFQDE 221
E+ +L CQGH N++ L F++E
Sbjct: 56 ------------------------RVFREVEMLYQCQGHRNVLELIEFFEEE 83
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299 | Back alignment and structure |
|---|
Score = 330 bits (848), Expect = e-106
Identities = 85/288 (29%), Positives = 134/288 (46%), Gaps = 53/288 (18%)
Query: 367 FKGSLFFEQYDMDLDKAGILGDGSYSVCRRCVEKSTGQEYAVKIISRKIDCSEEINLLRA 426
K + + Y + + +LG G + K T +++A+K++ E+ L
Sbjct: 10 IKKNAIIDDYKVT---SQVLGLGINGKVLQIFNKRTQEKFALKMLQDCPKARREVELHWR 66
Query: 427 CQGHPNIVNLHCVFQDEV----HTYLVLELLKGGELLDRIRQKGRCGFTENEASRIMRQL 482
P+IV + V+++ +V+E L GGEL RI+ +G FTE EAS IM+ +
Sbjct: 67 ASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSI 126
Query: 483 VAAVHFMHSRGVVHRDLKPENLLFSDPAGD-NIKVVDFGFACLKRESLHTPCFTLQYAAP 541
A+ ++HS + HRD+KPENLL++ + +K+ DFGF A
Sbjct: 127 GEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGF------------------AK 168
Query: 542 EVLRQDKSGYDENCDLWSLGVILVNVLRQDKSGYDENCDLWSLGVILYTMLCGRVPFHAR 601
E + YD++CD+WSLGVI+Y +LCG PF++
Sbjct: 169 ETTGE---------------------------KYDKSCDMWSLGVIMYILLCGYPPFYSN 201
Query: 602 SRDDSALSIMARIKEGQFNFDAEAWSTVSSEAKELTKSLLTVNPAQRI 649
+ + RI+ GQ+ F WS VS E K L ++LL P QR+
Sbjct: 202 HGLAISPGMKTRIRMGQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRM 249
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299 | Back alignment and structure |
|---|
Score = 122 bits (309), Expect = 5e-31
Identities = 33/83 (39%), Positives = 49/83 (59%), Gaps = 1/83 (1%)
Query: 884 TFVNRSRYNVHTYLVLELLKGGELLDRIRQKGRCGFTENEASRIMRQLVAAVHFMHSRGV 943
+ N +V+E L GGEL RI+ +G FTE EAS IM+ + A+ ++HS +
Sbjct: 79 VYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINI 138
Query: 944 VHRDLKPENLLLSGISGN-LIKI 965
HRD+KPENLL + N ++K+
Sbjct: 139 AHRDVKPENLLYTSKRPNAILKL 161
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299 | Back alignment and structure |
|---|
Score = 85.4 bits (212), Expect = 4e-18
Identities = 14/70 (20%), Positives = 29/70 (41%), Gaps = 3/70 (4%)
Query: 104 KFKGSLFFEQYDMDLDKAGILGDGSYSVCRRCVEKSTGQEYAVKIISRKIDCSEEINLLR 163
+ K + + Y + + +LG G + K T +++A+K++ E+ L
Sbjct: 9 QIKKNAIIDDYKVT---SQVLGLGINGKVLQIFNKRTQEKFALKMLQDCPKARREVELHW 65
Query: 164 ACQGHPNICR 173
P+I R
Sbjct: 66 RASQCPHIVR 75
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299 | Back alignment and structure |
|---|
Score = 82.3 bits (204), Expect = 4e-17
Identities = 11/57 (19%), Positives = 24/57 (42%)
Query: 166 QGHPNICRRCVEKSTGQEYAVKIISRKIDCSEEINLLRACQGHPNIVNLHCVFQDEV 222
G + K T +++A+K++ E+ L P+IV + V+++
Sbjct: 28 LGINGKVLQIFNKRTQEKFALKMLQDCPKARREVELHWRASQCPHIVRIVDVYENLY 84
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298 | Back alignment and structure |
|---|
Score = 316 bits (811), Expect = e-100
Identities = 97/294 (32%), Positives = 137/294 (46%), Gaps = 48/294 (16%)
Query: 372 FFEQYDMDLDKAGILGDGSYSVCRRCVEKSTGQEYAVKIISRK--------------IDC 417
F+E Y+ ILG G SV RRC+ K T +EYAVKII
Sbjct: 15 FYENYEPK----EILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREAT 70
Query: 418 SEEINLLRACQGHPNIVNLHCVFQDEVHTYLVLELLKGGELLDRIRQKGRCGFTENEASR 477
+E+++LR GHPNI+ L ++ +LV +L+K GEL D + +K +E E +
Sbjct: 71 LKEVDILRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKVT--LSEKETRK 128
Query: 478 IMRQLVAAVHFMHSRGVVHRDLKPENLLFSDPAGDNIKVVDFGFACLKRES--LHTPCFT 535
IMR L+ + +H +VHRDLKPEN+L D NIK+ DFGF+C L C T
Sbjct: 129 IMRALLEVICALHKLNIVHRDLKPENILLDDDM--NIKLTDFGFSCQLDPGEKLREVCGT 186
Query: 536 LQYAAPEVLRQDKSGYDENCDLWSLGVILVNVLRQDKSGYDENCDLWSLGVILYTMLCGR 595
Y APE++ + + GY + D+WS GVI+YT+L G
Sbjct: 187 PSYLAPEIIE--------------------CSMNDNHPGYGKEVDMWSTGVIMYTLLAGS 226
Query: 596 VPFHARSRDDSALSIMARIKEGQFNFDAEAWSTVSSEAKELTKSLLTVNPAQRI 649
PF + ++ I G + F + W S K+L L V P +R
Sbjct: 227 PPFW----HRKQMLMLRMIMSGNYQFGSPEWDDYSDTVKDLVSRFLVVQPQKRY 276
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298 | Back alignment and structure |
|---|
Score = 113 bits (286), Expect = 7e-28
Identities = 29/72 (40%), Positives = 42/72 (58%), Gaps = 4/72 (5%)
Query: 894 HTYLVLELLKGGELLDRIRQKGRCGFTENEASRIMRQLVAAVHFMHSRGVVHRDLKPENL 953
+LV +L+K GEL D + +K +E E +IMR L+ + +H +VHRDLKPEN+
Sbjct: 98 FFFLVFDLMKKGELFDYLTEKVT--LSEKETRKIMRALLEVICALHKLNIVHRDLKPENI 155
Query: 954 LLSGISGNLIKI 965
LL IK+
Sbjct: 156 LLDDDM--NIKL 165
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298 | Back alignment and structure |
|---|
Score = 80.4 bits (199), Expect = 1e-16
Identities = 32/121 (26%), Positives = 47/121 (38%), Gaps = 30/121 (24%)
Query: 101 IACKFKGSLFFEQYDMDLDKAGILGDGSYSVCRRCVEKSTGQEYAVKIISRKIDCSEEIN 160
+ F+E Y+ ILG G SV RRC+ K T +EYAVKII
Sbjct: 6 LPGSHSTHGFYENYEPK----EILGRGVSSVVRRCIHKPTCKEYAVKIIDV--------- 52
Query: 161 LLRACQGHPNICRRCVEKSTGQEYAVKIISRKIDCSEEINLLRACQGHPNIVNLHCVFQD 220
G A ++ + +E+++LR GHPNI+ L ++
Sbjct: 53 -----------------TGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYET 95
Query: 221 E 221
Sbjct: 96 N 96
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298 | Back alignment and structure |
|---|
Score = 47.6 bits (114), Expect = 9e-06
Identities = 24/85 (28%), Positives = 37/85 (43%), Gaps = 11/85 (12%)
Query: 242 IIFFIILSFTLSFIHDYYHIQYRRILK-----TEPPIPEDLSPDVADFISRLLVKDPRRR 296
+I + +L+ + F H + R I+ P D S V D +SR LV P++R
Sbjct: 217 VIMYTLLAGSPPFWHRKQMLMLRMIMSGNYQFGSPEWD-DYSDTVKDLVSRFLVVQPQKR 275
Query: 297 LGGGELDAEELKRHPFFNVIDWDDL 321
AEE HPFF +++
Sbjct: 276 -----YTAEEALAHPFFQQYVVEEV 295
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365 | Back alignment and structure |
|---|
Score = 316 bits (811), Expect = e-100
Identities = 104/343 (30%), Positives = 153/343 (44%), Gaps = 47/343 (13%)
Query: 322 ATKRIPAPFVPKISNELDVSNFSDEFTKMIPADSPAIVPPNFDKIFKGSLFFEQYDMDLD 381
+ R + E N + F+++YD
Sbjct: 42 RSLRDDPSQSANLLAEAKKLNDAQPKGTENLYFQSMGPEDELPDWAAAKEFYQKYDPK-- 99
Query: 382 KAGILGDGSYSVCRRCVEKSTGQEYAVKIIS-RKIDCSE------------EINLLRACQ 428
++G G SV RRCV ++TG E+AVKI+ S E ++LR
Sbjct: 100 --DVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVA 157
Query: 429 GHPNIVNLHCVFQDEVHTYLVLELLKGGELLDRIRQKGRCGFTENEASRIMRQLVAAVHF 488
GHP+I+ L ++ +LV +L++ GEL D + +K +E E IMR L+ AV F
Sbjct: 158 GHPHIITLIDSYESSSFMFLVFDLMRKGELFDYLTEKVA--LSEKETRSIMRSLLEAVSF 215
Query: 489 MHSRGVVHRDLKPENLLFSDPAGDNIKVVDFGFACLKR--ESLHTPCFTLQYAAPEVLRQ 546
+H+ +VHRDLKPEN+L D I++ DFGF+C E L C T Y APE+L+
Sbjct: 216 LHANNIVHRDLKPENILLDDNM--QIRLSDFGFSCHLEPGEKLRELCGTPGYLAPEILKC 273
Query: 547 DKSGYDENCDLWSLGVILVNVLRQDKSGYDENCDLWSLGVILYTMLCGRVPFHARSRDDS 606
+ + GY + DLW+ GVIL+T+L G PF R +
Sbjct: 274 S--------------------MDETHPGYGKEVDLWACGVILFTLLAGSPPFWHRRQIL- 312
Query: 607 ALSIMARIKEGQFNFDAEAWSTVSSEAKELTKSLLTVNPAQRI 649
++ I EGQ+ F + W SS K+L LL V+P R+
Sbjct: 313 ---MLRMIMEGQYQFSSPEWDDRSSTVKDLISRLLQVDPEARL 352
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365 | Back alignment and structure |
|---|
Score = 113 bits (285), Expect = 3e-27
Identities = 30/72 (41%), Positives = 44/72 (61%), Gaps = 4/72 (5%)
Query: 894 HTYLVLELLKGGELLDRIRQKGRCGFTENEASRIMRQLVAAVHFMHSRGVVHRDLKPENL 953
+LV +L++ GEL D + +K +E E IMR L+ AV F+H+ +VHRDLKPEN+
Sbjct: 174 FMFLVFDLMRKGELFDYLTEKVA--LSEKETRSIMRSLLEAVSFLHANNIVHRDLKPENI 231
Query: 954 LLSGISGNLIKI 965
LL I++
Sbjct: 232 LLDDNM--QIRL 241
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365 | Back alignment and structure |
|---|
Score = 81.3 bits (201), Expect = 2e-16
Identities = 34/171 (19%), Positives = 58/171 (33%), Gaps = 31/171 (18%)
Query: 51 SSNQRSEKRRRTRREGGYSYVSPSVLFSENIISNEIFQPSLDKRPNTSNLIACKFKGSLF 110
+ QR R R + S + N + + + + + F
Sbjct: 33 NREQRRAFIRSLRDDPSQSANLLAEAKKLNDAQPKGTENLYFQSMGPEDELPDWAAAKEF 92
Query: 111 FEQYDMDLDKAGILGDGSYSVCRRCVEKSTGQEYAVKIISRKIDCSEEINLLRACQGHPN 170
+++YD ++G G SV RRCV ++TG E+AVKI+
Sbjct: 93 YQKYDPK----DVIGRGVSSVVRRCVHRATGHEFAVKIMEV------------------- 129
Query: 171 ICRRCVEKSTGQEYAVKIISRKIDCSEEINLLRACQGHPNIVNLHCVFQDE 221
E + R E ++LR GHP+I+ L ++
Sbjct: 130 --TAERLSPEQLEEVREATRR------ETHILRQVAGHPHIITLIDSYESS 172
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365 | Back alignment and structure |
|---|
Score = 45.9 bits (109), Expect = 4e-05
Identities = 27/77 (35%), Positives = 37/77 (48%), Gaps = 11/77 (14%)
Query: 242 IIFFIILSFTLSFIHDYYHIQYRRILK-----TEPPIPEDLSPDVADFISRLLVKDPRRR 296
+I F +L+ + F H + R I++ + P D S V D ISRLL DP R
Sbjct: 293 VILFTLLAGSPPFWHRRQILMLRMIMEGQYQFSSPEWD-DRSSTVKDLISRLLQVDPEAR 351
Query: 297 LGGGELDAEELKRHPFF 313
L AE+ +HPFF
Sbjct: 352 -----LTAEQALQHPFF 363
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284 | Back alignment and structure |
|---|
Score = 309 bits (793), Expect = 4e-98
Identities = 105/288 (36%), Positives = 151/288 (52%), Gaps = 47/288 (16%)
Query: 372 FFEQYDMDLDKAGILGDGSYSVCRRCVEKSTGQEYAVKIISRKIDCSE-------EINLL 424
F + YD+ LG G++SV RRCV K+TG E+A KII+ K + E +
Sbjct: 4 FSDNYDVK----EELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARIC 59
Query: 425 RACQGHPNIVNLHCVFQDEVHTYLVLELLKGGELLDRIRQKGRCGFTENEASRIMRQLVA 484
R Q HPNIV LH Q+E YLV +L+ GGEL + I + ++E +AS ++Q++
Sbjct: 60 RKLQ-HPNIVRLHDSIQEESFHYLVFDLVTGGELFEDIVAREF--YSEADASHCIQQILE 116
Query: 485 AVHFMHSRGVVHRDLKPENLLFSDPAGD-NIKVVDFGFACLKRES--LHTPCFTLQYAAP 541
++ + HS G+VHR+LKPENLL + A +K+ DFG A +S H T Y +P
Sbjct: 117 SIAYCHSNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAWHGFAGTPGYLSP 176
Query: 542 EVLRQDKSGYDENCDLWSLGVILVNVLRQDKSGYDENCDLWSLGVILYTMLCGRVPFHAR 601
EVL+ K Y + D+W+ GVILY +L G PF
Sbjct: 177 EVLK--------------------------KDPYSKPVDIWACGVILYILLVGYPPFWDE 210
Query: 602 SRDDSALSIMARIKEGQFNFDAEAWSTVSSEAKELTKSLLTVNPAQRI 649
+ + A+IK G +++ + W TV+ EAK L S+LTVNP +RI
Sbjct: 211 DQHR----LYAQIKAGAYDYPSPEWDTVTPEAKSLIDSMLTVNPKKRI 254
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284 | Back alignment and structure |
|---|
Score = 111 bits (280), Expect = 3e-27
Identities = 28/73 (38%), Positives = 48/73 (65%), Gaps = 3/73 (4%)
Query: 894 HTYLVLELLKGGELLDRIRQKGRCGFTENEASRIMRQLVAAVHFMHSRGVVHRDLKPENL 953
YLV +L+ GGEL + I + ++E +AS ++Q++ ++ + HS G+VHR+LKPENL
Sbjct: 79 FHYLVFDLVTGGELFEDIVAREF--YSEADASHCIQQILESIAYCHSNGIVHRNLKPENL 136
Query: 954 LLSGISGN-LIKI 965
LL+ + +K+
Sbjct: 137 LLASKAKGAAVKL 149
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284 | Back alignment and structure |
|---|
Score = 73.7 bits (182), Expect = 2e-14
Identities = 34/112 (30%), Positives = 45/112 (40%), Gaps = 38/112 (33%)
Query: 110 FFEQYDMDLDKAGILGDGSYSVCRRCVEKSTGQEYAVKIISRKIDCSEEINLLRACQGHP 169
F + YD+ LG G++SV RRCV K+TG E+A KII+ K + + L
Sbjct: 4 FSDNYDVK----EELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLE------ 53
Query: 170 NICRRCVEKSTGQEYAVKIISRKIDCSEEINLLRACQGHPNIVNLHCVFQDE 221
E + R Q HPNIV LH Q+E
Sbjct: 54 ---------------------------REARICRKLQ-HPNIVRLHDSIQEE 77
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284 | Back alignment and structure |
|---|
Score = 42.2 bits (100), Expect = 5e-04
Identities = 17/76 (22%), Positives = 34/76 (44%), Gaps = 9/76 (11%)
Query: 242 IIFFIILSFTLSFIHDYYHIQYRRILKTEP--PIPE--DLSPDVADFISRLLVKDPRRRL 297
+I +I+L F + H Y +I P PE ++P+ I +L +P++R
Sbjct: 195 VILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKSLIDSMLTVNPKKR- 253
Query: 298 GGGELDAEELKRHPFF 313
+ A++ + P+
Sbjct: 254 ----ITADQALKVPWI 265
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287 | Back alignment and structure |
|---|
Score = 304 bits (782), Expect = 1e-96
Identities = 101/288 (35%), Positives = 157/288 (54%), Gaps = 48/288 (16%)
Query: 372 FFEQYDMDLDKAGILGDGSYSVCRRCVEKSTGQEYAVKIIS-RKIDCSE------EINLL 424
F E+Y++ +LG GS+ +C ++ T QEYAVK+I+ + E+ LL
Sbjct: 20 FAERYNIV----CMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELL 75
Query: 425 RACQGHPNIVNLHCVFQDEVHTYLVLELLKGGELLDRIRQKGRCGFTENEASRIMRQLVA 484
+ HPNI+ L + +D Y+V EL GGEL D I ++ R F+E++A+RI++Q+ +
Sbjct: 76 KKLD-HPNIMKLFEILEDSSSFYIVGELYTGGELFDEIIKRKR--FSEHDAARIIKQVFS 132
Query: 485 AVHFMHSRGVVHRDLKPENLLFSDPAGD-NIKVVDFGFACLKRES--LHTPCFTLQYAAP 541
+ +MH +VHRDLKPEN+L D +IK++DFG + +++ + T Y AP
Sbjct: 133 GITYMHKHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKMKDRIGTAYYIAP 192
Query: 542 EVLRQDKSGYDENCDLWSLGVILVNVLRQDKSGYDENCDLWSLGVILYTMLCGRVPFHAR 601
EVLR YDE CD+WS GVILY +L G PF+ +
Sbjct: 193 EVLRG---------------------------TYDEKCDVWSAGVILYILLSGTPPFYGK 225
Query: 602 SRDDSALSIMARIKEGQFNFDAEAWSTVSSEAKELTKSLLTVNPAQRI 649
+ D I+ R++ G++ FD W T+S +AK+L + +LT +P+ RI
Sbjct: 226 NEYD----ILKRVETGKYAFDLPQWRTISDDAKDLIRKMLTFHPSLRI 269
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287 | Back alignment and structure |
|---|
Score = 113 bits (284), Expect = 9e-28
Identities = 33/73 (45%), Positives = 49/73 (67%), Gaps = 3/73 (4%)
Query: 894 HTYLVLELLKGGELLDRIRQKGRCGFTENEASRIMRQLVAAVHFMHSRGVVHRDLKPENL 953
Y+V EL GGEL D I ++ R F+E++A+RI++Q+ + + +MH +VHRDLKPEN+
Sbjct: 95 SFYIVGELYTGGELFDEIIKRKR--FSEHDAARIIKQVFSGITYMHKHNIVHRDLKPENI 152
Query: 954 LLSGISGN-LIKI 965
LL + IKI
Sbjct: 153 LLESKEKDCDIKI 165
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287 | Back alignment and structure |
|---|
Score = 70.0 bits (172), Expect = 4e-13
Identities = 28/128 (21%), Positives = 53/128 (41%), Gaps = 39/128 (30%)
Query: 94 RPNTSNLIACKFKGSLFFEQYDMDLDKAGILGDGSYSVCRRCVEKSTGQEYAVKIISRKI 153
++S F+G+ F E+Y++ +LG GS+ +C ++ T QEYAVK+I++
Sbjct: 5 HHHSSGRENLYFQGT-FAERYNIV----CMLGKGSFGEVLKCKDRITQQEYAVKVINKAS 59
Query: 154 DCSEEINLLRACQGHPNICRRCVEKSTGQEYAVKIISRKIDCSEEINLLRACQGHPNIVN 213
+++ + + E+ LL+ HPNI+
Sbjct: 60 AKNKDTSTIL---------------------------------REVELLKKLD-HPNIMK 85
Query: 214 LHCVFQDE 221
L + +D
Sbjct: 86 LFEILEDS 93
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A Length = 304 | Back alignment and structure |
|---|
Score = 304 bits (781), Expect = 3e-96
Identities = 90/290 (31%), Positives = 146/290 (50%), Gaps = 44/290 (15%)
Query: 367 FKGSLFFEQYDMDLDKAGILGDGSYSVCRRCVEKSTGQEYAVKIISRKI-----DCSEEI 421
+ + + + +LG G++S ++ TG+ +A+K I + EI
Sbjct: 2 MQTTNIRKTFIFM----EVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLENEI 57
Query: 422 NLLRACQGHPNIVNLHCVFQDEVHTYLVLELLKGGELLDRIRQKGRCGFTENEASRIMRQ 481
+L+ + H NIV L +++ H YLV++L+ GGEL DRI ++G +TE +AS +++Q
Sbjct: 58 AVLKKIK-HENIVTLEDIYESTTHYYLVMQLVSGGELFDRILERGV--YTEKDASLVIQQ 114
Query: 482 LVAAVHFMHSRGVVHRDLKPENLLFSDPAGD-NIKVVDFGFA-CLKRESLHTPCFTLQYA 539
+++AV ++H G+VHRDLKPENLL+ P + I + DFG + + + T C T Y
Sbjct: 115 VLSAVKYLHENGIVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQNGIMSTACGTPGYV 174
Query: 540 APEVLRQDKSGYDENCDLWSLGVILVNVLRQDKSGYDENCDLWSLGVILYTMLCGRVPFH 599
APEVL + Y + D WS+GVI Y +LCG PF+
Sbjct: 175 APEVLA--------------------------QKPYSKAVDCWSIGVITYILLCGYPPFY 208
Query: 600 ARSRDDSALSIMARIKEGQFNFDAEAWSTVSSEAKELTKSLLTVNPAQRI 649
+ + +IKEG + F++ W +S AK+ LL +P +R
Sbjct: 209 EETESK----LFEKIKEGYYEFESPFWDDISESAKDFICHLLEKDPNERY 254
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A Length = 304 | Back alignment and structure |
|---|
Score = 112 bits (282), Expect = 3e-27
Identities = 36/73 (49%), Positives = 52/73 (71%), Gaps = 3/73 (4%)
Query: 894 HTYLVLELLKGGELLDRIRQKGRCGFTENEASRIMRQLVAAVHFMHSRGVVHRDLKPENL 953
H YLV++L+ GGEL DRI ++G +TE +AS +++Q+++AV ++H G+VHRDLKPENL
Sbjct: 80 HYYLVMQLVSGGELFDRILERGV--YTEKDASLVIQQVLSAVKYLHENGIVHRDLKPENL 137
Query: 954 LLSGISGN-LIKI 965
L N I I
Sbjct: 138 LYLTPEENSKIMI 150
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A Length = 304 | Back alignment and structure |
|---|
Score = 64.1 bits (157), Expect = 4e-11
Identities = 17/117 (14%), Positives = 37/117 (31%), Gaps = 40/117 (34%)
Query: 105 FKGSLFFEQYDMDLDKAGILGDGSYSVCRRCVEKSTGQEYAVKIISRKIDCSEEINLLRA 164
+ + + + +LG G++S ++ TG+ +A+K I + +
Sbjct: 2 MQTTNIRKTFIFM----EVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDS------ 51
Query: 165 CQGHPNICRRCVEKSTGQEYAVKIISRKIDCSEEINLLRACQGHPNIVNLHCVFQDE 221
EI +L+ + H NIV L +++
Sbjct: 52 -----------------------------SLENEIAVLKKIK-HENIVTLEDIYEST 78
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362 | Back alignment and structure |
|---|
Score = 305 bits (782), Expect = 2e-95
Identities = 106/311 (34%), Positives = 153/311 (49%), Gaps = 48/311 (15%)
Query: 349 KMIPADSPAIVPPNFDKIFKGSLFFEQYDMDLDKAGILGDGSYSVCRRCVEKSTGQEYAV 408
+ F F + YD+ LG G++SV RRCV K+TG E+A
Sbjct: 5 ASMTGGQQMGRGSEFMMNASTK-FSDNYDVK----EELGKGAFSVVRRCVHKTTGLEFAA 59
Query: 409 KIISRKIDCSE-------EINLLRACQGHPNIVNLHCVFQDEVHTYLVLELLKGGELLDR 461
KII+ K + E + R Q HPNIV LH Q+E YLV +L+ GGEL +
Sbjct: 60 KIINTKKLSARDFQKLEREARICRKLQ-HPNIVRLHDSIQEESFHYLVFDLVTGGELFED 118
Query: 462 IRQKGRCGFTENEASRIMRQLVAAVHFMHSRGVVHRDLKPENLLFSDPAGD-NIKVVDFG 520
I + ++E +AS ++Q++ ++ + HS G+VHR+LKPENLL + A +K+ DFG
Sbjct: 119 IVAREF--YSEADASHCIQQILESIAYCHSNGIVHRNLKPENLLLASKAKGAAVKLADFG 176
Query: 521 FACLKRES--LHTPCFTLQYAAPEVLRQDKSGYDENCDLWSLGVILVNVLRQDKSGYDEN 578
A +S H T Y +PEVL+ K Y +
Sbjct: 177 LAIEVNDSEAWHGFAGTPGYLSPEVLK--------------------------KDPYSKP 210
Query: 579 CDLWSLGVILYTMLCGRVPFHARSRDDSALSIMARIKEGQFNFDAEAWSTVSSEAKELTK 638
D+W+ GVILY +L G PF + + A+IK G +++ + W TV+ EAK L
Sbjct: 211 VDIWACGVILYILLVGYPPFWDEDQHR----LYAQIKAGAYDYPSPEWDTVTPEAKSLID 266
Query: 639 SLLTVNPAQRI 649
S+LTVNP +RI
Sbjct: 267 SMLTVNPKKRI 277
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362 | Back alignment and structure |
|---|
Score = 110 bits (277), Expect = 4e-26
Identities = 28/73 (38%), Positives = 48/73 (65%), Gaps = 3/73 (4%)
Query: 894 HTYLVLELLKGGELLDRIRQKGRCGFTENEASRIMRQLVAAVHFMHSRGVVHRDLKPENL 953
YLV +L+ GGEL + I + ++E +AS ++Q++ ++ + HS G+VHR+LKPENL
Sbjct: 102 FHYLVFDLVTGGELFEDIVAREF--YSEADASHCIQQILESIAYCHSNGIVHRNLKPENL 159
Query: 954 LLSGISGN-LIKI 965
LL+ + +K+
Sbjct: 160 LLASKAKGAAVKL 172
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362 | Back alignment and structure |
|---|
Score = 71.6 bits (176), Expect = 2e-13
Identities = 34/116 (29%), Positives = 46/116 (39%), Gaps = 38/116 (32%)
Query: 106 KGSLFFEQYDMDLDKAGILGDGSYSVCRRCVEKSTGQEYAVKIISRKIDCSEEINLLRAC 165
+ F + YD+ LG G++SV RRCV K+TG E+A KII+ K + + L
Sbjct: 23 ASTKFSDNYDVK----EELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLE-- 76
Query: 166 QGHPNICRRCVEKSTGQEYAVKIISRKIDCSEEINLLRACQGHPNIVNLHCVFQDE 221
E + R Q HPNIV LH Q+E
Sbjct: 77 -------------------------------REARICRKLQ-HPNIVRLHDSIQEE 100
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362 | Back alignment and structure |
|---|
Score = 41.9 bits (99), Expect = 7e-04
Identities = 17/76 (22%), Positives = 34/76 (44%), Gaps = 9/76 (11%)
Query: 242 IIFFIILSFTLSFIHDYYHIQYRRILKTEP--PIPE--DLSPDVADFISRLLVKDPRRRL 297
+I +I+L F + H Y +I P PE ++P+ I +L +P++R
Sbjct: 218 VILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKSLIDSMLTVNPKKR- 276
Query: 298 GGGELDAEELKRHPFF 313
+ A++ + P+
Sbjct: 277 ----ITADQALKVPWI 288
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277 | Back alignment and structure |
|---|
Score = 301 bits (773), Expect = 2e-95
Identities = 93/273 (34%), Positives = 139/273 (50%), Gaps = 42/273 (15%)
Query: 385 ILGDGSYSVCRRCVEKSTGQEYAVKIIS-RKIDCSE----EINLLRACQGHPNIVNLHCV 439
+G GS+ + V+K T A K I ++ + EI ++++ HPNI+ L+
Sbjct: 16 TIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLD-HPNIIRLYET 74
Query: 440 FQDEVHTYLVLELLKGGELLDRIRQKGRCGFTENEASRIMRQLVAAVHFMHSRGVVHRDL 499
F+D YLV+EL GGEL +R+ K F E++A+RIM+ +++AV + H V HRDL
Sbjct: 75 FEDNTDIYLVMELCTGGELFERVVHKRV--FRESDAARIMKDVLSAVAYCHKLNVAHRDL 132
Query: 500 KPENLLFSDPAGD-NIKVVDFGFACLKRES--LHTPCFTLQYAAPEVLRQDKSGYDENCD 556
KPEN LF + D +K++DFG A + + T T Y +P+VL
Sbjct: 133 KPENFLFLTDSPDSPLKLIDFGLAARFKPGKMMRTKVGTPYYVSPQVLEG---------- 182
Query: 557 LWSLGVILVNVLRQDKSGYDENCDLWSLGVILYTMLCGRVPFHARSRDDSALSIMARIKE 616
Y CD WS GV++Y +LCG PF A + + +M +I+E
Sbjct: 183 -----------------LYGPECDEWSAGVMMYVLLCGYPPFSAPTDSE----VMLKIRE 221
Query: 617 GQFNFDAEAWSTVSSEAKELTKSLLTVNPAQRI 649
G F F + W VS +A+ L + LLT +P QRI
Sbjct: 222 GTFTFPEKDWLNVSPQAESLIRRLLTKSPKQRI 254
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277 | Back alignment and structure |
|---|
Score = 113 bits (285), Expect = 6e-28
Identities = 32/73 (43%), Positives = 46/73 (63%), Gaps = 3/73 (4%)
Query: 894 HTYLVLELLKGGELLDRIRQKGRCGFTENEASRIMRQLVAAVHFMHSRGVVHRDLKPENL 953
YLV+EL GGEL +R+ K F E++A+RIM+ +++AV + H V HRDLKPEN
Sbjct: 80 DIYLVMELCTGGELFERVVHKRV--FRESDAARIMKDVLSAVAYCHKLNVAHRDLKPENF 137
Query: 954 LLSGISGN-LIKI 965
L S + +K+
Sbjct: 138 LFLTDSPDSPLKL 150
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277 | Back alignment and structure |
|---|
Score = 59.9 bits (146), Expect = 7e-10
Identities = 16/61 (26%), Positives = 29/61 (47%), Gaps = 6/61 (9%)
Query: 166 QGHPNICRRCVEKSTGQEYAVKIIS-RKIDCSE----EINLLRACQGHPNIVNLHCVFQD 220
+G + V+K T A K I ++ + EI ++++ HPNI+ L+ F+D
Sbjct: 19 RGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLD-HPNIIRLYETFED 77
Query: 221 E 221
Sbjct: 78 N 78
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277 | Back alignment and structure |
|---|
Score = 44.1 bits (105), Expect = 1e-04
Identities = 16/76 (21%), Positives = 30/76 (39%), Gaps = 9/76 (11%)
Query: 242 IIFFIILSFTLSFIHDYYHIQYRRILKTEPPIPED----LSPDVADFISRLLVKDPRRRL 297
++ +++L F +I + PE +SP I RLL K P++R
Sbjct: 195 VMMYVLLCGYPPFSAPTDSEVMLKIREGTFTFPEKDWLNVSPQAESLIRRLLTKSPKQR- 253
Query: 298 GGGELDAEELKRHPFF 313
+ + + H +F
Sbjct: 254 ----ITSLQALEHEWF 265
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322 | Back alignment and structure |
|---|
Score = 299 bits (769), Expect = 3e-94
Identities = 102/349 (29%), Positives = 152/349 (43%), Gaps = 61/349 (17%)
Query: 372 FFEQYDMDLDKAGILGDGSYSVCRRCVEKSTGQEYAVKIIS-RKIDCSE----------- 419
++Y M LG G+ + E+ T ++ A+KIIS RK
Sbjct: 8 LRDEYIMS----KTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVE 63
Query: 420 -EINLLRACQGHPNIVNLHCVFQDEVHTYLVLELLKGGELLDRIRQKGRCGFTENEASRI 478
EI +L+ HP I+ + F E Y+VLEL++GGEL D++ R E
Sbjct: 64 TEIEILKKLN-HPCIIKIKNFFDAE-DYYIVLELMEGGELFDKVVGNKR--LKEATCKLY 119
Query: 479 MRQLVAAVHFMHSRGVVHRDLKPENLLFSDPAGD-NIKVVDFGFACLKRES--LHTPCFT 535
Q++ AV ++H G++HRDLKPEN+L S D IK+ DFG + + E+ + T C T
Sbjct: 120 FYQMLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRTLCGT 179
Query: 536 LQYAAPEVLRQDKSGYDENCDLWSLGVILVNVLRQDKSGYDENCDLWSLGVILYTMLCGR 595
Y APEVL +GY+ D WSLGVIL+ L G
Sbjct: 180 PTYLAPEVLVSVG-----------------------TAGYNRAVDCWSLGVILFICLSGY 216
Query: 596 VPFHARSRDDSALSIMARIKEGQFNFDAEAWSTVSSEAKELTKSLLTVNPAQR------- 648
PF S+ +I G++NF E W+ VS +A +L K LL V+P R
Sbjct: 217 PPFSEHRTQV---SLKDQITSGKYNFIPEVWAEVSEKALDLVKKLLVVDPKARFTTEEAL 273
Query: 649 ----IRMMRVKLTFHAFHQAQKEGFRLQDVTSAKLAQRRKNKNVSNDNS 693
++ +K F + E L V + R++ + + +
Sbjct: 274 RHPWLQDEDMKRKFQDLLSEENESTALPQVLAQPSTSRKRPREGEAEGA 322
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322 | Back alignment and structure |
|---|
Score = 113 bits (285), Expect = 2e-27
Identities = 31/71 (43%), Positives = 44/71 (61%), Gaps = 3/71 (4%)
Query: 896 YLVLELLKGGELLDRIRQKGRCGFTENEASRIMRQLVAAVHFMHSRGVVHRDLKPENLLL 955
Y+VLEL++GGEL D++ R E Q++ AV ++H G++HRDLKPEN+LL
Sbjct: 90 YIVLELMEGGELFDKVVGNKR--LKEATCKLYFYQMLLAVQYLHENGIIHRDLKPENVLL 147
Query: 956 SGISGNL-IKI 965
S + IKI
Sbjct: 148 SSQEEDCLIKI 158
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322 | Back alignment and structure |
|---|
Score = 68.5 bits (168), Expect = 2e-12
Identities = 22/112 (19%), Positives = 38/112 (33%), Gaps = 32/112 (28%)
Query: 110 FFEQYDMDLDKAGILGDGSYSVCRRCVEKSTGQEYAVKIISRKIDCSEEINLLRACQGHP 169
++Y M LG G+ + E+ T ++ A+KIIS+
Sbjct: 8 LRDEYIMS----KTLGSGACGEVKLAFERKTCKKVAIKIISK------------------ 45
Query: 170 NICRRCVEKSTGQEYAVKIISRKIDCSEEINLLRACQGHPNIVNLHCVFQDE 221
R+ S + + EI +L+ HP I+ + F E
Sbjct: 46 ---RKFAIGSAREADPALNVET------EIEILKKLN-HPCIIKIKNFFDAE 87
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322 | Back alignment and structure |
|---|
Score = 43.0 bits (102), Expect = 3e-04
Identities = 26/114 (22%), Positives = 44/114 (38%), Gaps = 14/114 (12%)
Query: 242 IIFFIILSFTLSFIHDYYHIQ-YRRILKTE----PPIPEDLSPDVADFISRLLVKDPRRR 296
+I FI LS F + +I + P + ++S D + +LLV DP+ R
Sbjct: 207 VILFICLSGYPPFSEHRTQVSLKDQITSGKYNFIPEVWAEVSEKALDLVKKLLVVDPKAR 266
Query: 297 LGGGELDAEELKRHPFFNVIDWD----DLATKRIPAPFVPKISNELDVSNFSDE 346
EE RHP+ D DL ++ + +P++ + S
Sbjct: 267 -----FTTEEALRHPWLQDEDMKRKFQDLLSEENESTALPQVLAQPSTSRKRPR 315
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444 | Back alignment and structure |
|---|
Score = 304 bits (780), Expect = 4e-94
Identities = 101/293 (34%), Positives = 147/293 (50%), Gaps = 48/293 (16%)
Query: 368 KGSLFFEQYDMDLDKAGILGDGSYSVCRRCVEKSTGQEYAVKIISRKI-------DCSEE 420
+ F E+Y + LG G++SV RRCV+ GQEYA II+ K E
Sbjct: 5 TCTRFTEEYQLF----EELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLERE 60
Query: 421 INLLRACQGHPNIVNLHCVFQDEVHTYLVLELLKGGELLDRIRQKGRCGFTENEASRIMR 480
+ R + HPNIV LH +E H YL+ +L+ GGEL + I + ++E +AS ++
Sbjct: 61 ARICRLLK-HPNIVRLHDSISEEGHHYLIFDLVTGGELFEDIVAREY--YSEADASHCIQ 117
Query: 481 QLVAAVHFMHSRGVVHRDLKPENLLFSDPAGD-NIKVVDFGFACL---KRESLHTPCFTL 536
Q++ AV H GVVHR+LKPENLL + +K+ DFG A ++++ T
Sbjct: 118 QILEAVLHCHQMGVVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEGEQQAWFGFAGTP 177
Query: 537 QYAAPEVLRQDKSGYDENCDLWSLGVILVNVLRQDKSGYDENCDLWSLGVILYTMLCGRV 596
Y +PEVLR K Y + DLW+ GVILY +L G
Sbjct: 178 GYLSPEVLR--------------------------KDPYGKPVDLWACGVILYILLVGYP 211
Query: 597 PFHARSRDDSALSIMARIKEGQFNFDAEAWSTVSSEAKELTKSLLTVNPAQRI 649
PF + + +IK G ++F + W TV+ EAK+L +LT+NP++RI
Sbjct: 212 PFWDEDQHR----LYQQIKAGAYDFPSPEWDTVTPEAKDLINKMLTINPSKRI 260
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444 | Back alignment and structure |
|---|
Score = 110 bits (277), Expect = 1e-25
Identities = 30/73 (41%), Positives = 46/73 (63%), Gaps = 3/73 (4%)
Query: 894 HTYLVLELLKGGELLDRIRQKGRCGFTENEASRIMRQLVAAVHFMHSRGVVHRDLKPENL 953
H YL+ +L+ GGEL + I + ++E +AS ++Q++ AV H GVVHR+LKPENL
Sbjct: 84 HHYLIFDLVTGGELFEDIVAREY--YSEADASHCIQQILEAVLHCHQMGVVHRNLKPENL 141
Query: 954 LLSGISGN-LIKI 965
LL+ +K+
Sbjct: 142 LLASKLKGAAVKL 154
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444 | Back alignment and structure |
|---|
Score = 69.3 bits (170), Expect = 2e-12
Identities = 31/116 (26%), Positives = 43/116 (37%), Gaps = 38/116 (32%)
Query: 106 KGSLFFEQYDMDLDKAGILGDGSYSVCRRCVEKSTGQEYAVKIISRKIDCSEEINLLRAC 165
+ F E+Y + LG G++SV RRCV+ GQEYA II+ K + + L
Sbjct: 5 TCTRFTEEYQLF----EELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLE-- 58
Query: 166 QGHPNICRRCVEKSTGQEYAVKIISRKIDCSEEINLLRACQGHPNIVNLHCVFQDE 221
E + R + HPNIV LH +E
Sbjct: 59 -------------------------------REARICRLLK-HPNIVRLHDSISEE 82
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327 | Back alignment and structure |
|---|
Score = 299 bits (768), Expect = 6e-94
Identities = 80/292 (27%), Positives = 132/292 (45%), Gaps = 43/292 (14%)
Query: 368 KGSLFFEQYDMDLDKAGILGDGSYSVCRRCVEKSTGQEYAVKIISRKIDCSE-------E 420
F Y + + LG G ++V R+C+ KSTGQEYA K + ++ + E
Sbjct: 22 SMENFNNFYILTSKE---LGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHE 78
Query: 421 INLLRACQGHPNIVNLHCVFQDEVHTYLVLELLKGGELLDRIRQKGRCGFTENEASRIMR 480
I +L + P ++NLH V+++ L+LE GGE+ + +EN+ R+++
Sbjct: 79 IAVLELAKSCPRVINLHEVYENTSEIILILEYAAGGEIFSLCLPELAEMVSENDVIRLIK 138
Query: 481 QLVAAVHFMHSRGVVHRDLKPENLLFSDPAGD-NIKVVDFGFA--CLKRESLHTPCFTLQ 537
Q++ V+++H +VH DLKP+N+L S +IK+VDFG + L T +
Sbjct: 139 QILEGVYYLHQNNIVHLDLKPQNILLSSIYPLGDIKIVDFGMSRKIGHACELREIMGTPE 198
Query: 538 YAAPEVLRQDKSGYDENCDLWSLGVILVNVLRQDKSGYDENCDLWSLGVILYTMLCGRVP 597
Y APE+L D D+W++G+I Y +L P
Sbjct: 199 YLAPEILNYD--------------------------PITTATDMWNIGIIAYMLLTHTSP 232
Query: 598 FHARSRDDSALSIMARIKEGQFNFDAEAWSTVSSEAKELTKSLLTVNPAQRI 649
F + I + ++ E +S+VS A + +SLL NP +R
Sbjct: 233 FVGEDNQE----TYLNISQVNVDYSEETFSSVSQLATDFIQSLLVKNPEKRP 280
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327 | Back alignment and structure |
|---|
Score = 111 bits (281), Expect = 6e-27
Identities = 26/73 (35%), Positives = 42/73 (57%), Gaps = 1/73 (1%)
Query: 894 HTYLVLELLKGGELLDRIRQKGRCGFTENEASRIMRQLVAAVHFMHSRGVVHRDLKPENL 953
L+LE GGE+ + +EN+ R+++Q++ V+++H +VH DLKP+N+
Sbjct: 103 EIILILEYAAGGEIFSLCLPELAEMVSENDVIRLIKQILEGVYYLHQNNIVHLDLKPQNI 162
Query: 954 LLSGISGN-LIKI 965
LLS I IKI
Sbjct: 163 LLSSIYPLGDIKI 175
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327 | Back alignment and structure |
|---|
Score = 73.8 bits (182), Expect = 3e-14
Identities = 25/116 (21%), Positives = 43/116 (37%), Gaps = 36/116 (31%)
Query: 106 KGSLFFEQYDMDLDKAGILGDGSYSVCRRCVEKSTGQEYAVKIISRKIDCSEEINLLRAC 165
F Y + + LG G ++V R+C+ KSTGQEYA K + ++ + +
Sbjct: 22 SMENFNNFYILTSKE---LGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEIL-- 76
Query: 166 QGHPNICRRCVEKSTGQEYAVKIISRKIDCSEEINLLRACQGHPNIVNLHCVFQDE 221
EI +L + P ++NLH V+++
Sbjct: 77 -------------------------------HEIAVLELAKSCPRVINLHEVYENT 101
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351 | Back alignment and structure |
|---|
Score = 298 bits (766), Expect = 2e-93
Identities = 80/302 (26%), Positives = 136/302 (45%), Gaps = 52/302 (17%)
Query: 364 DKIFKGSLFFEQYDMDLDKAGILGDGSYSVCRRCVEKSTGQEYAVKIIS-RKIDCSE--- 419
D LF + Y++ ++G G +SV RRC+ + TGQ++AVKI+ K S
Sbjct: 14 DMADDDVLFEDVYELC----EVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLS 69
Query: 420 ------EINLLRACQGHPNIVNLHCVFQDEVHTYLVLELLKGGELLDRIRQKGRCG--FT 471
E ++ HP+IV L + + Y+V E + G +L I ++ G ++
Sbjct: 70 TEDLKREASICHML-KHPHIVELLETYSSDGMLYMVFEFMDGADLCFEIVKRADAGFVYS 128
Query: 472 ENEASRIMRQLVAAVHFMHSRGVVHRDLKPENLLFSDPAGD-NIKVVDFGFACL---KRE 527
E AS MRQ++ A+ + H ++HRD+KP +L + +K+ FG A
Sbjct: 129 EAVASHYMRQILEALRYCHDNNIIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLGESGL 188
Query: 528 SLHTPCFTLQYAAPEVLRQDKSGYDENCDLWSLGVILVNVLRQDKSGYDENCDLWSLGVI 587
T + APEV++ + Y + D+W GVI
Sbjct: 189 VAGGRVGTPHFMAPEVVK--------------------------REPYGKPVDVWGCGVI 222
Query: 588 LYTMLCGRVPFHARSRDDSALSIMARIKEGQFNFDAEAWSTVSSEAKELTKSLLTVNPAQ 647
L+ +L G +PF+ + I +G++ + WS +S AK+L + +L ++PA+
Sbjct: 223 LFILLSGCLPFYGTKER-----LFEGIIKGKYKMNPRQWSHISESAKDLVRRMLMLDPAE 277
Query: 648 RI 649
RI
Sbjct: 278 RI 279
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351 | Back alignment and structure |
|---|
Score = 110 bits (277), Expect = 3e-26
Identities = 23/73 (31%), Positives = 42/73 (57%), Gaps = 3/73 (4%)
Query: 896 YLVLELLKGGELLDRIRQKGRCG--FTENEASRIMRQLVAAVHFMHSRGVVHRDLKPENL 953
Y+V E + G +L I ++ G ++E AS MRQ++ A+ + H ++HRD+KP +
Sbjct: 102 YMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCHDNNIIHRDVKPHCV 161
Query: 954 LLSGISGN-LIKI 965
LL+ + +K+
Sbjct: 162 LLASKENSAPVKL 174
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351 | Back alignment and structure |
|---|
Score = 70.8 bits (174), Expect = 4e-13
Identities = 24/128 (18%), Positives = 46/128 (35%), Gaps = 35/128 (27%)
Query: 94 RPNTSNLIACKFKGSLFFEQYDMDLDKAGILGDGSYSVCRRCVEKSTGQEYAVKIISRKI 153
++ LF + Y++ ++G G +SV RRC+ + TGQ++AVKI+
Sbjct: 6 SGGGGGILDMADDDVLFEDVYELC----EVIGKGPFSVVRRCINRETGQQFAVKIVDV-- 59
Query: 154 DCSEEINLLRACQGHPNICRRCVEKSTGQEYAVKIISRKIDCSEEINLLRACQGHPNIVN 213
P + +++ E ++ HP+IV
Sbjct: 60 ---------AKFTSSPGLSTEDLKR-------------------EASICHML-KHPHIVE 90
Query: 214 LHCVFQDE 221
L + +
Sbjct: 91 LLETYSSD 98
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349 | Back alignment and structure |
|---|
Score = 298 bits (765), Expect = 3e-93
Identities = 96/304 (31%), Positives = 155/304 (50%), Gaps = 42/304 (13%)
Query: 352 PADSPAIVPPNFDKIFKGSLFFEQYDMDLDKAGILGDGSYSVCRRCVEKSTGQEYAVKII 411
+ ++VP + + ++++ LG G+ S+ RC +K T + YA+K++
Sbjct: 31 APGTASLVPDYWIDGSNRDALSDFFEVE----SELGRGATSIVYRCKQKGTQKPYALKVL 86
Query: 412 SRKID---CSEEINLLRACQGHPNIVNLHCVFQDEVHTYLVLELLKGGELLDRIRQKGRC 468
+ +D EI +L HPNI+ L +F+ LVLEL+ GGEL DRI +KG
Sbjct: 87 KKTVDKKIVRTEIGVLLRLS-HPNIIKLKEIFETPTEISLVLELVTGGELFDRIVEKGY- 144
Query: 469 GFTENEASRIMRQLVAAVHFMHSRGVVHRDLKPENLLFSDPAGD-NIKVVDFGFACLKRE 527
++E +A+ ++Q++ AV ++H G+VHRDLKPENLL++ PA D +K+ DFG + +
Sbjct: 145 -YSERDAADAVKQILEAVAYLHENGIVHRDLKPENLLYATPAPDAPLKIADFGLSKIVEH 203
Query: 528 S--LHTPCFTLQYAAPEVLRQDKSGYDENCDLWSLGVILVNVLRQDKSGYDENCDLWSLG 585
+ T C T Y APE+LR Y D+WS+G
Sbjct: 204 QVLMKTVCGTPGYCAPEILR--------------------------GCAYGPEVDMWSVG 237
Query: 586 VILYTMLCGRVPFHARSRDDSALSIMARIKEGQFNFDAEAWSTVSSEAKELTKSLLTVNP 645
+I Y +LCG PF+ D + RI ++ F + W VS AK+L + L+ ++P
Sbjct: 238 IITYILLCGFEPFYDERGDQ---FMFRRILNCEYYFISPWWDEVSLNAKDLVRKLIVLDP 294
Query: 646 AQRI 649
+R+
Sbjct: 295 KKRL 298
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349 | Back alignment and structure |
|---|
Score = 110 bits (278), Expect = 2e-26
Identities = 34/73 (46%), Positives = 51/73 (69%), Gaps = 3/73 (4%)
Query: 894 HTYLVLELLKGGELLDRIRQKGRCGFTENEASRIMRQLVAAVHFMHSRGVVHRDLKPENL 953
LVLEL+ GGEL DRI +KG ++E +A+ ++Q++ AV ++H G+VHRDLKPENL
Sbjct: 122 EISLVLELVTGGELFDRIVEKGY--YSERDAADAVKQILEAVAYLHENGIVHRDLKPENL 179
Query: 954 LLSGISGN-LIKI 965
L + + + +KI
Sbjct: 180 LYATPAPDAPLKI 192
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349 | Back alignment and structure |
|---|
Score = 59.3 bits (144), Expect = 2e-09
Identities = 19/52 (36%), Positives = 29/52 (55%), Gaps = 4/52 (7%)
Query: 123 ILGDGSYSVCRRCVEKSTGQEYAVKIISRKID---CSEEINLLRACQGHPNI 171
LG G+ S+ RC +K T + YA+K++ + +D EI +L HPNI
Sbjct: 60 ELGRGATSIVYRCKQKGTQKPYALKVLKKTVDKKIVRTEIGVLLRLS-HPNI 110
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349 | Back alignment and structure |
|---|
Score = 58.1 bits (141), Expect = 5e-09
Identities = 19/59 (32%), Positives = 32/59 (54%), Gaps = 4/59 (6%)
Query: 166 QGHPNICRRCVEKSTGQEYAVKIISRKID---CSEEINLLRACQGHPNIVNLHCVFQDE 221
+G +I RC +K T + YA+K++ + +D EI +L HPNI+ L +F+
Sbjct: 63 RGATSIVYRCKQKGTQKPYALKVLKKTVDKKIVRTEIGVLLRLS-HPNIIKLKEIFETP 120
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373 | Back alignment and structure |
|---|
Score = 297 bits (763), Expect = 1e-92
Identities = 87/325 (26%), Positives = 137/325 (42%), Gaps = 42/325 (12%)
Query: 332 PKISNELDVSNFSDEFTKMIPADSPAIVPPNFDKIFKGSLFFEQYDMDLDKAGILGDGSY 391
++ + V + + PA +G+ Y + K ILG G +
Sbjct: 46 ADLTERMPVKSKRTSALAVDIPAPPAPFDHRIVTAKQGA-VNSFYT--VSKTEILGGGRF 102
Query: 392 SVCRRCVEKSTGQEYAVKIIS-RKIDCSE----EINLLRACQGHPNIVNLHCVFQDEVHT 446
+C E +TG + A KII R + E EI+++ H N++ L+ F+ +
Sbjct: 103 GQVHKCEETATGLKLAAKIIKTRGMKDKEEVKNEISVMNQLD-HANLIQLYDAFESKNDI 161
Query: 447 YLVLELLKGGELLDRIRQKGRCGFTENEASRIMRQLVAAVHFMHSRGVVHRDLKPENLLF 506
LV+E + GGEL DRI + TE + M+Q+ + MH ++H DLKPEN+L
Sbjct: 162 VLVMEYVDGGELFDRIIDES-YNLTELDTILFMKQICEGIRHMHQMYILHLDLKPENILC 220
Query: 507 SDPAGDNIKVVDFGFACL--KRESLHTPCFTLQYAAPEVLRQDKSGYDENCDLWSLGVIL 564
+ IK++DFG A RE L T ++ APEV+ D
Sbjct: 221 VNRDAKQIKIIDFGLARRYKPREKLKVNFGTPEFLAPEVVNYD----------------- 263
Query: 565 VNVLRQDKSGYDENCDLWSLGVILYTMLCGRVPFHARSRDDSALSIMARIKEGQFNFDAE 624
D+WS+GVI Y +L G PF + + + I +++ + E
Sbjct: 264 ---------FVSFPTDMWSVGVIAYMLLSGLSPFLGDNDAE----TLNNILACRWDLEDE 310
Query: 625 AWSTVSSEAKELTKSLLTVNPAQRI 649
+ +S EAKE LL + RI
Sbjct: 311 EFQDISEEAKEFISKLLIKEKSWRI 335
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373 | Back alignment and structure |
|---|
Score = 113 bits (285), Expect = 3e-27
Identities = 27/72 (37%), Positives = 37/72 (51%), Gaps = 1/72 (1%)
Query: 894 HTYLVLELLKGGELLDRIRQKGRCGFTENEASRIMRQLVAAVHFMHSRGVVHRDLKPENL 953
LV+E + GGEL DRI + TE + M+Q+ + MH ++H DLKPEN+
Sbjct: 160 DIVLVMEYVDGGELFDRIIDES-YNLTELDTILFMKQICEGIRHMHQMYILHLDLKPENI 218
Query: 954 LLSGISGNLIKI 965
L IKI
Sbjct: 219 LCVNRDAKQIKI 230
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373 | Back alignment and structure |
|---|
Score = 69.0 bits (169), Expect = 2e-12
Identities = 32/188 (17%), Positives = 58/188 (30%), Gaps = 43/188 (22%)
Query: 38 SSTPLMTPDILLGSSNQRSEKRRRTRREGGYSYVSPSVLFSENIISNEIFQPSLDKRPNT 97
S L T ++ S ++ R+ S + L + ++ P
Sbjct: 10 SGVDLGTENLYFQSMKNSGDQDSRSGHNEAKEVWSNADLTERMPVKSKRTSALAVDIPAP 69
Query: 98 SNLIACKF---KGSLFFEQYDMDLDKAGILGDGSYSVCRRCVEKSTGQEYAVKIIS-RKI 153
+ K Y + K ILG G + +C E +TG + A KII R +
Sbjct: 70 PAPFDHRIVTAKQGAVNSFYT--VSKTEILGGGRFGQVHKCEETATGLKLAAKIIKTRGM 127
Query: 154 DCSEEINLLRACQGHPNICRRCVEKSTGQEYAVKIISRKIDCSEEINLLRACQGHPNIVN 213
EE+ + EI+++ H N++
Sbjct: 128 KDKEEV-------------KN-----------------------EISVMNQLD-HANLIQ 150
Query: 214 LHCVFQDE 221
L+ F+ +
Sbjct: 151 LYDAFESK 158
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486 | Back alignment and structure |
|---|
Score = 301 bits (773), Expect = 2e-92
Identities = 101/288 (35%), Positives = 155/288 (53%), Gaps = 48/288 (16%)
Query: 372 FFEQYDMDLDKAGILGDGSYSVCRRCVEKSTGQEYAVKIISRK-------IDCSEEINLL 424
F E+Y++ +LG GS+ +C ++ T QEYAVK+I++ E+ LL
Sbjct: 20 FAERYNIV----CMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELL 75
Query: 425 RACQGHPNIVNLHCVFQDEVHTYLVLELLKGGELLDRIRQKGRCGFTENEASRIMRQLVA 484
+ HPNI+ L + +D Y+V EL GGEL D I ++ R F+E++A+RI++Q+ +
Sbjct: 76 KKL-DHPNIMKLFEILEDSSSFYIVGELYTGGELFDEIIKRKR--FSEHDAARIIKQVFS 132
Query: 485 AVHFMHSRGVVHRDLKPENLLFSDPAGD-NIKVVDFGFACL--KRESLHTPCFTLQYAAP 541
+ +MH +VHRDLKPEN+L D +IK++DFG + + + T Y AP
Sbjct: 133 GITYMHKHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKMKDRIGTAYYIAP 192
Query: 542 EVLRQDKSGYDENCDLWSLGVILVNVLRQDKSGYDENCDLWSLGVILYTMLCGRVPFHAR 601
EVLR YDE CD+WS GVILY +L G PF+ +
Sbjct: 193 EVLRGT---------------------------YDEKCDVWSAGVILYILLSGTPPFYGK 225
Query: 602 SRDDSALSIMARIKEGQFNFDAEAWSTVSSEAKELTKSLLTVNPAQRI 649
+ D I+ R++ G++ FD W T+S +AK+L + +LT +P+ RI
Sbjct: 226 NEYD----ILKRVETGKYAFDLPQWRTISDDAKDLIRKMLTFHPSLRI 269
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486 | Back alignment and structure |
|---|
Score = 111 bits (280), Expect = 7e-26
Identities = 33/73 (45%), Positives = 49/73 (67%), Gaps = 3/73 (4%)
Query: 894 HTYLVLELLKGGELLDRIRQKGRCGFTENEASRIMRQLVAAVHFMHSRGVVHRDLKPENL 953
Y+V EL GGEL D I ++ R F+E++A+RI++Q+ + + +MH +VHRDLKPEN+
Sbjct: 95 SFYIVGELYTGGELFDEIIKRKR--FSEHDAARIIKQVFSGITYMHKHNIVHRDLKPENI 152
Query: 954 LLSGISGN-LIKI 965
LL + IKI
Sbjct: 153 LLESKEKDCDIKI 165
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486 | Back alignment and structure |
|---|
Score = 63.2 bits (154), Expect = 2e-10
Identities = 25/112 (22%), Positives = 46/112 (41%), Gaps = 38/112 (33%)
Query: 110 FFEQYDMDLDKAGILGDGSYSVCRRCVEKSTGQEYAVKIISRKIDCSEEINLLRACQGHP 169
F E+Y++ +LG GS+ +C ++ T QEYAVK+I++ +++ + +
Sbjct: 20 FAERYNIV----CMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTIL------ 69
Query: 170 NICRRCVEKSTGQEYAVKIISRKIDCSEEINLLRACQGHPNIVNLHCVFQDE 221
E+ LL+ HPNI+ L + +D
Sbjct: 70 ---------------------------REVELLKKL-DHPNIMKLFEILEDS 93
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486 | Back alignment and structure |
|---|
Score = 42.4 bits (100), Expect = 6e-04
Identities = 17/76 (22%), Positives = 30/76 (39%), Gaps = 9/76 (11%)
Query: 242 IIFFIILSFTLSFIHDYYHIQYRRILKTEPPIPED----LSPDVADFISRLLVKDPRRRL 297
+I +I+LS T F + +R+ + +S D D I ++L P R
Sbjct: 210 VILYILLSGTPPFYGKNEYDILKRVETGKYAFDLPQWRTISDDAKDLIRKMLTFHPSLR- 268
Query: 298 GGGELDAEELKRHPFF 313
+ A + HP+
Sbjct: 269 ----ITATQCLEHPWI 280
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283 | Back alignment and structure |
|---|
Score = 293 bits (752), Expect = 3e-92
Identities = 90/295 (30%), Positives = 148/295 (50%), Gaps = 52/295 (17%)
Query: 370 SLFFEQYDMDLDKAGILGDGSYSVCRRCVEKSTGQEYAVKIIS-RKIDCSE--------- 419
S+ + Y+M LG G +++ R+C +K TG+EYA K I R++ S
Sbjct: 1 SMVEDHYEMG----EELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIE 56
Query: 420 -EINLLRACQGHPNIVNLHCVFQDEVHTYLVLELLKGGELLDRIRQKGRCGFTENEASRI 478
E+N+LR + HPNI+ LH +F+++ L+LEL+ GGEL D + +K TE+EA++
Sbjct: 57 REVNILREIR-HPNIITLHDIFENKTDVVLILELVSGGELFDFLAEKES--LTEDEATQF 113
Query: 479 MRQLVAAVHFMHSRGVVHRDLKPENLLFSDPAGDN--IKVVDFGFACL--KRESLHTPCF 534
++Q++ VH++HS+ + H DLKPEN++ D N IK++DFG A
Sbjct: 114 LKQILDGVHYLHSKRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGNEFKNIFG 173
Query: 535 TLQYAAPEVLRQDKSGYDENCDLWSLGVILVNVLRQDKSGYDENCDLWSLGVILYTMLCG 594
T ++ APE++ + D+WS+GVI Y +L G
Sbjct: 174 TPEFVAPEIVNYE--------------------------PLGLEADMWSIGVITYILLSG 207
Query: 595 RVPFHARSRDDSALSIMARIKEGQFNFDAEAWSTVSSEAKELTKSLLTVNPAQRI 649
PF ++ + + I ++FD E +S S AK+ + LL +P +R+
Sbjct: 208 ASPFLGETKQE----TLTNISAVNYDFDEEYFSNTSELAKDFIRRLLVKDPKRRM 258
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283 | Back alignment and structure |
|---|
Score = 111 bits (281), Expect = 2e-27
Identities = 29/74 (39%), Positives = 48/74 (64%), Gaps = 4/74 (5%)
Query: 894 HTYLVLELLKGGELLDRIRQKGRCGFTENEASRIMRQLVAAVHFMHSRGVVHRDLKPENL 953
L+LEL+ GGEL D + +K TE+EA++ ++Q++ VH++HS+ + H DLKPEN+
Sbjct: 82 DVVLILELVSGGELFDFLAEKES--LTEDEATQFLKQILDGVHYLHSKRIAHFDLKPENI 139
Query: 954 LLS--GISGNLIKI 965
+L + IK+
Sbjct: 140 MLLDKNVPNPRIKL 153
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283 | Back alignment and structure |
|---|
Score = 69.1 bits (170), Expect = 8e-13
Identities = 30/114 (26%), Positives = 52/114 (45%), Gaps = 34/114 (29%)
Query: 108 SLFFEQYDMDLDKAGILGDGSYSVCRRCVEKSTGQEYAVKIISRKIDCSEEINLLRACQG 167
S+ + Y+M LG G +++ R+C +K TG+EYA K I ++ R
Sbjct: 1 SMVEDHYEMG----EELGSGQFAIVRKCRQKGTGKEYAAKFIKKR----------RLSSS 46
Query: 168 HPNICRRCVEKSTGQEYAVKIISRKIDCSEEINLLRACQGHPNIVNLHCVFQDE 221
+ R +E+ E+N+LR + HPNI+ LH +F+++
Sbjct: 47 RRGVSREEIER-------------------EVNILREIR-HPNIITLHDIFENK 80
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321 | Back alignment and structure |
|---|
Score = 293 bits (751), Expect = 1e-91
Identities = 87/300 (29%), Positives = 140/300 (46%), Gaps = 52/300 (17%)
Query: 365 KIFKGSLFFEQYDMDLDKAGILGDGSYSVCRRCVEKSTGQEYAVKIIS-RKIDCSE---- 419
+ FK + YD+ LG G +++ ++C EKSTG EYA K I R+ S
Sbjct: 3 EPFKQQKVEDFYDIG----EELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVS 58
Query: 420 ------EINLLRACQGHPNIVNLHCVFQDEVHTYLVLELLKGGELLDRIRQKGRCGFTEN 473
E+++LR H N++ LH V+++ L+LEL+ GGEL D + QK +E
Sbjct: 59 REEIEREVSILRQVL-HHNVITLHDVYENRTDVVLILELVSGGELFDFLAQKES--LSEE 115
Query: 474 EASRIMRQLVAAVHFMHSRGVVHRDLKPENLLFSDPAGDN--IKVVDFGFACL--KRESL 529
EA+ ++Q++ V+++H++ + H DLKPEN++ D IK++DFG A
Sbjct: 116 EATSFIKQILDGVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEF 175
Query: 530 HTPCFTLQYAAPEVLRQDKSGYDENCDLWSLGVILVNVLRQDKSGYDENCDLWSLGVILY 589
T ++ APE++ + D+WS+GVI Y
Sbjct: 176 KNIFGTPEFVAPEIVNYE--------------------------PLGLEADMWSIGVITY 209
Query: 590 TMLCGRVPFHARSRDDSALSIMARIKEGQFNFDAEAWSTVSSEAKELTKSLLTVNPAQRI 649
+L G PF D+ +A I ++FD E +S S AK+ + LL +R+
Sbjct: 210 ILLSGASPFL----GDTKQETLANITSVSYDFDEEFFSHTSELAKDFIRKLLVKETRKRL 265
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321 | Back alignment and structure |
|---|
Score = 110 bits (276), Expect = 2e-26
Identities = 27/74 (36%), Positives = 47/74 (63%), Gaps = 4/74 (5%)
Query: 894 HTYLVLELLKGGELLDRIRQKGRCGFTENEASRIMRQLVAAVHFMHSRGVVHRDLKPENL 953
L+LEL+ GGEL D + QK +E EA+ ++Q++ V+++H++ + H DLKPEN+
Sbjct: 89 DVVLILELVSGGELFDFLAQKES--LSEEEATSFIKQILDGVNYLHTKKIAHFDLKPENI 146
Query: 954 LLSGISGNL--IKI 965
+L + + IK+
Sbjct: 147 MLLDKNIPIPHIKL 160
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321 | Back alignment and structure |
|---|
Score = 70.0 bits (172), Expect = 6e-13
Identities = 28/117 (23%), Positives = 50/117 (42%), Gaps = 34/117 (29%)
Query: 105 FKGSLFFEQYDMDLDKAGILGDGSYSVCRRCVEKSTGQEYAVKIISRKIDCSEEINLLRA 164
FK + YD+ LG G +++ ++C EKSTG EYA K I ++ ++
Sbjct: 5 FKQQKVEDFYDIG----EELGSGQFAIVKKCREKSTGLEYAAKFIKKR----------QS 50
Query: 165 CQGHPNICRRCVEKSTGQEYAVKIISRKIDCSEEINLLRACQGHPNIVNLHCVFQDE 221
+ R +E+ E+++LR H N++ LH V+++
Sbjct: 51 RASRRGVSREEIER-------------------EVSILRQVL-HHNVITLHDVYENR 87
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484 | Back alignment and structure |
|---|
Score = 298 bits (764), Expect = 2e-91
Identities = 103/289 (35%), Positives = 153/289 (52%), Gaps = 49/289 (16%)
Query: 372 FFEQYDMDLDKAGILGDGSYSVCRRCVEKSTGQEYAVKIIS-RKIDCSE-------EINL 423
F ++Y +LG GS+ C +K TGQE AVK+IS R++ E+ L
Sbjct: 24 FSDRYKGQ----RVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQL 79
Query: 424 LRACQGHPNIVNLHCVFQDEVHTYLVLELLKGGELLDRIRQKGRCGFTENEASRIMRQLV 483
L+ HPNI+ L+ F+D+ + YLV E+ GGEL D I + R F+E +A+RI+RQ++
Sbjct: 80 LKQL-DHPNIMKLYEFFEDKGYFYLVGEVYTGGELFDEIISRKR--FSEVDAARIIRQVL 136
Query: 484 AAVHFMHSRGVVHRDLKPENLLFSDPAGD-NIKVVDFGFACL--KRESLHTPCFTLQYAA 540
+ + +MH +VHRDLKPENLL + D NI+++DFG + + + T Y A
Sbjct: 137 SGITYMHKNKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKKMKDKIGTAYYIA 196
Query: 541 PEVLRQDKSGYDENCDLWSLGVILVNVLRQDKSGYDENCDLWSLGVILYTMLCGRVPFHA 600
PEVL YDE CD+WS GVILY +L G PF+
Sbjct: 197 PEVLHGT---------------------------YDEKCDVWSTGVILYILLSGCPPFNG 229
Query: 601 RSRDDSALSIMARIKEGQFNFDAEAWSTVSSEAKELTKSLLTVNPAQRI 649
+ D I+ ++++G++ F+ W VS AK+L + +LT P+ RI
Sbjct: 230 ANEYD----ILKKVEKGKYTFELPQWKKVSESAKDLIRKMLTYVPSMRI 274
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484 | Back alignment and structure |
|---|
Score = 109 bits (274), Expect = 4e-25
Identities = 35/73 (47%), Positives = 50/73 (68%), Gaps = 3/73 (4%)
Query: 894 HTYLVLELLKGGELLDRIRQKGRCGFTENEASRIMRQLVAAVHFMHSRGVVHRDLKPENL 953
+ YLV E+ GGEL D I + R F+E +A+RI+RQ+++ + +MH +VHRDLKPENL
Sbjct: 100 YFYLVGEVYTGGELFDEIISRKR--FSEVDAARIIRQVLSGITYMHKNKIVHRDLKPENL 157
Query: 954 LLSGISGN-LIKI 965
LL S + I+I
Sbjct: 158 LLESKSKDANIRI 170
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484 | Back alignment and structure |
|---|
Score = 77.0 bits (190), Expect = 8e-15
Identities = 52/315 (16%), Positives = 101/315 (32%), Gaps = 100/315 (31%)
Query: 90 SLDKRPNTSNLIACKFKGSLFFEQYDMDLDKAGILGDGSYSVCRRCVEKSTGQEYAVKII 149
S+ + + + + ++F ++Y +LG GS+ C +K TGQE AVK+I
Sbjct: 4 SMMDHLHATPGMFVQHSTAIFSDRYKGQ----RVLGKGSFGEVILCKDKITGQECAVKVI 59
Query: 150 S-RKIDCSE-------EINLLRACQGHPNICR-------------------------RCV 176
S R++ E+ LL+ HPNI + +
Sbjct: 60 SKRQVKQKTDKESLLREVQLLKQL-DHPNIMKLYEFFEDKGYFYLVGEVYTGGELFDEII 118
Query: 177 EKSTGQEYAVKIISRKIDCSEEINLLRACQGHPNIV-------NLHCVFQDE-----VID 224
+ E I R++ ++ + + IV NL + + +ID
Sbjct: 119 SRKRFSEVDAARIIRQV-----LSGITYMHKN-KIVHRDLKPENLLLESKSKDANIRIID 172
Query: 225 WDDFSRGIECVFFSSSL------------------------------IIFFIILSFTLSF 254
+ G+ F +S +I +I+LS F
Sbjct: 173 F-----GLSTHFEASKKMKDKIGTAYYIAPEVLHGTYDEKCDVWSTGVILYILLSGCPPF 227
Query: 255 IHDYYHIQYRRILKTEPPIPED----LSPDVADFISRLLVKDPRRRLGGGELDAEELKRH 310
+ +++ K + +S D I ++L P R + A + H
Sbjct: 228 NGANEYDILKKVEKGKYTFELPQWKKVSESAKDLIRKMLTYVPSMR-----ISARDALDH 282
Query: 311 PFFNVIDWDDLATKR 325
+ + ++
Sbjct: 283 EWIQTYTKEQISVDV 297
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 292 bits (749), Expect = 3e-91
Identities = 87/299 (29%), Positives = 143/299 (47%), Gaps = 52/299 (17%)
Query: 366 IFKGSLFFEQYDMDLDKAGILGDGSYSVCRRCVEKSTGQEYAVKIIS-RKIDCSE----- 419
+F+ + YD LG G ++V ++C EKSTG +YA K I R+ S
Sbjct: 3 VFRQENVDDYYDTG----EELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSR 58
Query: 420 -----EINLLRACQGHPNIVNLHCVFQDEVHTYLVLELLKGGELLDRIRQKGRCGFTENE 474
E+++L+ Q HPN++ LH V++++ L+LEL+ GGEL D + +K TE E
Sbjct: 59 EDIEREVSILKEIQ-HPNVITLHEVYENKTDVILILELVAGGELFDFLAEKES--LTEEE 115
Query: 475 ASRIMRQLVAAVHFMHSRGVVHRDLKPENLLFSDPAGDN--IKVVDFGFACL--KRESLH 530
A+ ++Q++ V+++HS + H DLKPEN++ D IK++DFG A
Sbjct: 116 ATEFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFK 175
Query: 531 TPCFTLQYAAPEVLRQDKSGYDENCDLWSLGVILVNVLRQDKSGYDENCDLWSLGVILYT 590
T ++ APE++ + D+WS+GVI Y
Sbjct: 176 NIFGTPEFVAPEIVNYE--------------------------PLGLEADMWSIGVITYI 209
Query: 591 MLCGRVPFHARSRDDSALSIMARIKEGQFNFDAEAWSTVSSEAKELTKSLLTVNPAQRI 649
+L G PF D+ +A + + F+ E +S S+ AK+ + LL +P +R+
Sbjct: 210 LLSGASPFL----GDTKQETLANVSAVNYEFEDEYFSNTSALAKDFIRRLLVKDPKKRM 264
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 110 bits (277), Expect = 2e-26
Identities = 29/74 (39%), Positives = 45/74 (60%), Gaps = 4/74 (5%)
Query: 894 HTYLVLELLKGGELLDRIRQKGRCGFTENEASRIMRQLVAAVHFMHSRGVVHRDLKPENL 953
L+LEL+ GGEL D + +K TE EA+ ++Q++ V+++HS + H DLKPEN+
Sbjct: 88 DVILILELVAGGELFDFLAEKES--LTEEEATEFLKQILNGVYYLHSLQIAHFDLKPENI 145
Query: 954 LLS--GISGNLIKI 965
+L + IKI
Sbjct: 146 MLLDRNVPKPRIKI 159
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 68.0 bits (167), Expect = 2e-12
Identities = 29/117 (24%), Positives = 51/117 (43%), Gaps = 34/117 (29%)
Query: 105 FKGSLFFEQYDMDLDKAGILGDGSYSVCRRCVEKSTGQEYAVKIISRKIDCSEEINLLRA 164
F+ + YD LG G ++V ++C EKSTG +YA K I ++ R
Sbjct: 4 FRQENVDDYYDTG----EELGSGQFAVVKKCREKSTGLQYAAKFIKKR----------RT 49
Query: 165 CQGHPNICRRCVEKSTGQEYAVKIISRKIDCSEEINLLRACQGHPNIVNLHCVFQDE 221
+ R +E+ E+++L+ Q HPN++ LH V++++
Sbjct: 50 KSSRRGVSREDIER-------------------EVSILKEIQ-HPNVITLHEVYENK 86
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321 | Back alignment and structure |
|---|
Score = 291 bits (748), Expect = 4e-91
Identities = 72/284 (25%), Positives = 121/284 (42%), Gaps = 42/284 (14%)
Query: 372 FFEQYDMDLDKAGILGDGSYSVCRRCVEKSTGQEYAVKIISRKI----DCSEEINLLRAC 427
+E+Y + LG G + + RCVE S+ + Y K + K +EI++L
Sbjct: 3 LYEKYMIA----EDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQVLVKKEISILNIA 58
Query: 428 QGHPNIVNLHCVFQDEVHTYLVLELLKGGELLDRIRQKGRCGFTENEASRIMRQLVAAVH 487
H NI++LH F+ ++ E + G ++ +RI E E + Q+ A+
Sbjct: 59 -RHRNILHLHESFESMEELVMIFEFISGLDIFERINTSA-FELNEREIVSYVHQVCEALQ 116
Query: 488 FMHSRGVVHRDLKPENLLFSDPAGDNIKVVDFGFACL--KRESLHTPCFTLQYAAPEVLR 545
F+HS + H D++PEN+++ IK+++FG A ++ +Y APEV +
Sbjct: 117 FLHSHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNFRLLFTAPEYYAPEVHQ 176
Query: 546 QDKSGYDENCDLWSLGVILVNVLRQDKSGYDENCDLWSLGVILYTMLCGRVPFHARSRDD 605
D D+WSLG ++Y +L G PF A +
Sbjct: 177 HD--------------------------VVSTATDMWSLGTLVYVLLSGINPFLAETNQQ 210
Query: 606 SALSIMARIKEGQFNFDAEAWSTVSSEAKELTKSLLTVNPAQRI 649
I+ I ++ FD EA+ +S EA + LL R+
Sbjct: 211 ----IIENIMNAEYTFDEEAFKEISIEAMDFVDRLLVKERKSRM 250
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321 | Back alignment and structure |
|---|
Score = 113 bits (285), Expect = 2e-27
Identities = 19/72 (26%), Positives = 35/72 (48%), Gaps = 1/72 (1%)
Query: 894 HTYLVLELLKGGELLDRIRQKGRCGFTENEASRIMRQLVAAVHFMHSRGVVHRDLKPENL 953
++ E + G ++ +RI E E + Q+ A+ F+HS + H D++PEN+
Sbjct: 75 ELVMIFEFISGLDIFERINTSA-FELNEREIVSYVHQVCEALQFLHSHNIGHFDIRPENI 133
Query: 954 LLSGISGNLIKI 965
+ + IKI
Sbjct: 134 IYQTRRSSTIKI 145
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321 | Back alignment and structure |
|---|
Score = 63.4 bits (155), Expect = 8e-11
Identities = 22/112 (19%), Positives = 38/112 (33%), Gaps = 41/112 (36%)
Query: 110 FFEQYDMDLDKAGILGDGSYSVCRRCVEKSTGQEYAVKIISRKIDCSEEINLLRACQGHP 169
+E+Y + LG G + + RCVE S+ + Y K + K +
Sbjct: 3 LYEKYMIA----EDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQVLV---------- 48
Query: 170 NICRRCVEKSTGQEYAVKIISRKIDCSEEINLLRACQGHPNIVNLHCVFQDE 221
++ EI++L H NI++LH F+
Sbjct: 49 ---KK-----------------------EISILNIA-RHRNILHLHESFESM 73
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361 | Back alignment and structure |
|---|
Score = 292 bits (749), Expect = 9e-91
Identities = 102/400 (25%), Positives = 161/400 (40%), Gaps = 82/400 (20%)
Query: 367 FKGSLFFEQYDMDLDKAGILGDGSYSVCRRCVEKSTGQEYAVKIIS-RKIDCSE------ 419
FK + YD+ LG G +++ ++C EKSTG EYA K I R+ S
Sbjct: 5 FKQQKVEDFYDIG----EELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCRE 60
Query: 420 ----EINLLRACQGHPNIVNLHCVFQDEVHTYLVLELLKGGELLDRIRQKGRCGFTENEA 475
E+++LR HPNI+ LH V+++ L+LEL+ GGEL D + QK +E EA
Sbjct: 61 EIEREVSILRQVL-HPNIITLHDVYENRTDVVLILELVSGGELFDFLAQKES--LSEEEA 117
Query: 476 SRIMRQLVAAVHFMHSRGVVHRDLKPENLLFSDPAGDN--IKVVDFGFA--CLKRESLHT 531
+ ++Q++ V+++H++ + H DLKPEN++ D IK++DFG A
Sbjct: 118 TSFIKQILDGVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKN 177
Query: 532 PCFTLQYAAPEVLRQDKSGYDENCDLWSLGVILVNVLRQDKSGYDENCDLWSLGVILYTM 591
T ++ APE++ + D+WS+GVI Y +
Sbjct: 178 IFGTPEFVAPEIVNYE--------------------------PLGLEADMWSIGVITYIL 211
Query: 592 LCGRVPFHARSRDDSALSIMARIKEGQFNFDAEAWSTVSSEAKELTKSLLTVNPAQRI-- 649
L G PF D+ +A I ++FD E +S S AK+ + LL +R+
Sbjct: 212 LSGASPFL----GDTKQETLANITAVSYDFDEEFFSQTSELAKDFIRKLLVKETRKRLTI 267
Query: 650 ----------RMMRVKLTFHAFHQAQKEGFRLQDVTSAKLAQRRK-----------NKNV 688
+ + E F+ K RR+ N
Sbjct: 268 QEALRHPWITPVDTQQAMVRRESVVNLENFK-------KQYVRRRWKLSFSIVSLCNHLT 320
Query: 689 SNDNSRSFSSTSSSLSSSSSGTSSLKTPCSSTQPSVPSKP 728
+ + TS L + S T + P S
Sbjct: 321 RSLMKKVHLRTSEDLRNCESDTEENIARRKALHPRRRSST 360
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361 | Back alignment and structure |
|---|
Score = 109 bits (274), Expect = 8e-26
Identities = 27/74 (36%), Positives = 47/74 (63%), Gaps = 4/74 (5%)
Query: 894 HTYLVLELLKGGELLDRIRQKGRCGFTENEASRIMRQLVAAVHFMHSRGVVHRDLKPENL 953
L+LEL+ GGEL D + QK +E EA+ ++Q++ V+++H++ + H DLKPEN+
Sbjct: 89 DVVLILELVSGGELFDFLAQKES--LSEEEATSFIKQILDGVNYLHTKKIAHFDLKPENI 146
Query: 954 LLSGISGNL--IKI 965
+L + + IK+
Sbjct: 147 MLLDKNIPIPHIKL 160
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361 | Back alignment and structure |
|---|
Score = 68.1 bits (167), Expect = 4e-12
Identities = 31/117 (26%), Positives = 52/117 (44%), Gaps = 34/117 (29%)
Query: 105 FKGSLFFEQYDMDLDKAGILGDGSYSVCRRCVEKSTGQEYAVKIISRKIDCSEEINLLRA 164
FK + YD+ LG G +++ ++C EKSTG EYA K I ++ ++
Sbjct: 5 FKQQKVEDFYDIG----EELGSGQFAIVKKCREKSTGLEYAAKFIKKR----------QS 50
Query: 165 CQGHPNICRRCVEKSTGQEYAVKIISRKIDCSEEINLLRACQGHPNIVNLHCVFQDE 221
+CR +E+ E+++LR HPNI+ LH V+++
Sbjct: 51 RASRRGVCREEIER-------------------EVSILRQVL-HPNIITLHDVYENR 87
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494 | Back alignment and structure |
|---|
Score = 296 bits (761), Expect = 1e-90
Identities = 102/315 (32%), Positives = 149/315 (47%), Gaps = 47/315 (14%)
Query: 344 SDEFTKMIPADSPAIVPPNFDKIFKGSLFFEQYDMDLDKAGILGDGSYSVCRRCVEKSTG 403
S + P F KG E Y LG G+Y C +K T
Sbjct: 8 SSGRENLYFQGDLQATPGMFITSKKGH-LSEMYQRV----KKLGSGAYGEVLLCRDKVTH 62
Query: 404 QEYAVKIIS-RKIDCSEEINLLRACQ-----GHPNIVNLHCVFQDEVHTYLVLELLKGGE 457
E A+KII + S LL HPNI+ L+ F+D+ + YLV+E KGGE
Sbjct: 63 VERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNIMKLYDFFEDKRNYYLVMECYKGGE 122
Query: 458 LLDRIRQKGRCGFTENEASRIMRQLVAAVHFMHSRGVVHRDLKPENLLFSDPAGD-NIKV 516
L D I + + F E +A+ I++Q+++ V ++H +VHRDLKPENLL D IK+
Sbjct: 123 LFDEIIHRMK--FNEVDAAVIIKQVLSGVTYLHKHNIVHRDLKPENLLLESKEKDALIKI 180
Query: 517 VDFGFACLKRES--LHTPCFTLQYAAPEVLRQDKSGYDENCDLWSLGVILVNVLRQDKSG 574
VDFG + + + T Y APEVLR+
Sbjct: 181 VDFGLSAVFENQKKMKERLGTAYYIAPEVLRKK--------------------------- 213
Query: 575 YDENCDLWSLGVILYTMLCGRVPFHARSRDDSALSIMARIKEGQFNFDAEAWSTVSSEAK 634
YDE CD+WS+GVIL+ +L G PF ++ + I+ ++++G++ FD+ W VS AK
Sbjct: 214 YDEKCDVWSIGVILFILLAGYPPFGGQTDQE----ILRKVEKGKYTFDSPEWKNVSEGAK 269
Query: 635 ELTKSLLTVNPAQRI 649
+L K +L + +RI
Sbjct: 270 DLIKQMLQFDSQRRI 284
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494 | Back alignment and structure |
|---|
Score = 109 bits (273), Expect = 5e-25
Identities = 34/73 (46%), Positives = 49/73 (67%), Gaps = 3/73 (4%)
Query: 894 HTYLVLELLKGGELLDRIRQKGRCGFTENEASRIMRQLVAAVHFMHSRGVVHRDLKPENL 953
+ YLV+E KGGEL D I + + F E +A+ I++Q+++ V ++H +VHRDLKPENL
Sbjct: 110 NYYLVMECYKGGELFDEIIHRMK--FNEVDAAVIIKQVLSGVTYLHKHNIVHRDLKPENL 167
Query: 954 LLSGISGN-LIKI 965
LL + LIKI
Sbjct: 168 LLESKEKDALIKI 180
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494 | Back alignment and structure |
|---|
Score = 77.0 bits (190), Expect = 1e-14
Identities = 50/281 (17%), Positives = 86/281 (30%), Gaps = 97/281 (34%)
Query: 110 FFEQYDMDLDKAGILGDGSYSVCRRCVEKSTGQEYAVKIIS-RKIDCSEEINLLRACQ-- 166
E Y LG G+Y C +K T E A+KII + S LL
Sbjct: 35 LSEMYQRV----KKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVL 90
Query: 167 ---GHPNICR-------------------------RCVEKSTGQEYAVKIISRKIDCSEE 198
HPNI + + + E +I +++
Sbjct: 91 KLLDHPNIMKLYDFFEDKRNYYLVMECYKGGELFDEIIHRMKFNEVDAAVIIKQV----- 145
Query: 199 INLLRACQGHPNIV-------NLHCVFQDE-----VIDWDDFSRGIECVFFSSSL----- 241
++ + H NIV NL +++ ++D+ G+ VF +
Sbjct: 146 LSGVTYLHKH-NIVHRDLKPENLLLESKEKDALIKIVDF-----GLSAVFENQKKMKERL 199
Query: 242 -------------------------IIFFIILSFTLSFIHDYYHIQYRRILKTEPPIPED 276
+I FI+L+ F R++ K +
Sbjct: 200 GTAYYIAPEVLRKKYDEKCDVWSIGVILFILLAGYPPFGGQTDQEILRKVEKGKYTFDSP 259
Query: 277 ----LSPDVADFISRLLVKDPRRRLGGGELDAEELKRHPFF 313
+S D I ++L D +RR + A++ HP+
Sbjct: 260 EWKNVSEGAKDLIKQMLQFDSQRR-----ISAQQALEHPWI 295
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285 | Back alignment and structure |
|---|
Score = 288 bits (740), Expect = 2e-90
Identities = 84/275 (30%), Positives = 136/275 (49%), Gaps = 44/275 (16%)
Query: 386 LGDGSYSVCRRCVEKSTGQEYAVKIIS-RKIDCSE-----EINLLRACQGHPNIVNLHCV 439
LG G++ E+S+G E +K I+ + EI +L++ HPNI+ + V
Sbjct: 30 LGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLD-HPNIIKIFEV 88
Query: 440 FQDEVHTYLVLELLKGGELLDRIRQKGRCG--FTENEASRIMRQLVAAVHFMHSRGVVHR 497
F+D + Y+V+E +GGELL+RI G +E + +M+Q++ A+ + HS+ VVH+
Sbjct: 89 FEDYHNMYIVMETCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFHSQHVVHK 148
Query: 498 DLKPENLLFSDPAGD-NIKVVDFGFACL--KRESLHTPCFTLQYAAPEVLRQDKSGYDEN 554
DLKPEN+LF D + IK++DFG A L E T Y APEV ++D
Sbjct: 149 DLKPENILFQDTSPHSPIKIIDFGLAELFKSDEHSTNAAGTALYMAPEVFKRD------- 201
Query: 555 CDLWSLGVILVNVLRQDKSGYDENCDLWSLGVILYTMLCGRVPFHARSRDDSALSIMARI 614
CD+WS GV++Y +L G +PF S ++ + +
Sbjct: 202 --------------------VTFKCDIWSAGVVMYFLLTGCLPFTGTSLEE----VQQKA 237
Query: 615 KEGQFNFDAEAWSTVSSEAKELTKSLLTVNPAQRI 649
+ N+ E ++ +A +L K +LT +P +R
Sbjct: 238 TYKEPNYAVE-CRPLTPQAVDLLKQMLTKDPERRP 271
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285 | Back alignment and structure |
|---|
Score = 109 bits (274), Expect = 2e-26
Identities = 31/73 (42%), Positives = 47/73 (64%), Gaps = 3/73 (4%)
Query: 896 YLVLELLKGGELLDRIRQKGRCG--FTENEASRIMRQLVAAVHFMHSRGVVHRDLKPENL 953
Y+V+E +GGELL+RI G +E + +M+Q++ A+ + HS+ VVH+DLKPEN+
Sbjct: 96 YIVMETCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFHSQHVVHKDLKPENI 155
Query: 954 LLSGISGN-LIKI 965
L S + IKI
Sbjct: 156 LFQDTSPHSPIKI 168
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285 | Back alignment and structure |
|---|
Score = 61.5 bits (150), Expect = 3e-10
Identities = 20/98 (20%), Positives = 36/98 (36%), Gaps = 35/98 (35%)
Query: 124 LGDGSYSVCRRCVEKSTGQEYAVKIISRKIDCSEEINLLRACQGHPNICRRCVEKSTGQE 183
LG G++ E+S+G E +K I++ +S
Sbjct: 30 LGSGAFGDVHLVEERSSGLERVIKTINKD-------------------------RSQVPM 64
Query: 184 YAVKIISRKIDCSEEINLLRACQGHPNIVNLHCVFQDE 221
++ EI +L++ HPNI+ + VF+D
Sbjct: 65 EQIE---------AEIEVLKSLD-HPNIIKIFEVFEDY 92
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285 | Back alignment and structure |
|---|
Score = 47.6 bits (114), Expect = 8e-06
Identities = 16/75 (21%), Positives = 30/75 (40%), Gaps = 8/75 (10%)
Query: 242 IIFFIILSFTLSFIHDYYHIQYRRILKTE---PPIPEDLSPDVADFISRLLVKDPRRRLG 298
++ + +L+ L F ++ E L+P D + ++L KDP RR
Sbjct: 213 VVMYFLLTGCLPFTGTSLEEVQQKATYKEPNYAVECRPLTPQAVDLLKQMLTKDPERR-- 270
Query: 299 GGELDAEELKRHPFF 313
A ++ H +F
Sbjct: 271 ---PSAAQVLHHEWF 282
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504 | Back alignment and structure |
|---|
Score = 295 bits (756), Expect = 5e-90
Identities = 101/323 (31%), Positives = 158/323 (48%), Gaps = 60/323 (18%)
Query: 348 TKMIPADSPAIVPPNFDKIFKGSLFFEQYDMDLDKAGILGDGSYSVCRRCVEKSTGQEYA 407
+ + AI P + + +G E Y LG G+Y C EK+ E A
Sbjct: 11 RENLYFQGIAINPGMYVRKKEGK-IGESYFKV----RKLGSGAYGEVLLCKEKNGHSEKA 65
Query: 408 VKIISRK------------------IDCSEEINLLRACQGHPNIVNLHCVFQDEVHTYLV 449
+K+I + + EI+LL++ HPNI+ L VF+D+ + YLV
Sbjct: 66 IKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKS-LDHPNIIKLFDVFEDKKYFYLV 124
Query: 450 LELLKGGELLDRIRQKGRCGFTENEASRIMRQLVAAVHFMHSRGVVHRDLKPENLLFSDP 509
E +GGEL ++I + + F E +A+ IM+Q+++ + ++H +VHRD+KPEN+L +
Sbjct: 125 TEFYEGGELFEQIINRHK--FDECDAANIMKQILSGICYLHKHNIVHRDIKPENILLENK 182
Query: 510 AGD-NIKVVDFGFACL--KRESLHTPCFTLQYAAPEVLRQDKSGYDENCDLWSLGVILVN 566
NIK+VDFG + K L T Y APEVL++
Sbjct: 183 NSLLNIKIVDFGLSSFFSKDYKLRDRLGTAYYIAPEVLKKK------------------- 223
Query: 567 VLRQDKSGYDENCDLWSLGVILYTMLCGRVPFHARSRDDSALSIMARIKEGQFNFDAEAW 626
Y+E CD+WS GVI+Y +LCG PF ++ D I+ ++++G++ FD W
Sbjct: 224 --------YNEKCDVWSCGVIMYILLCGYPPFGGQNDQD----IIKKVEKGKYYFDFNDW 271
Query: 627 STVSSEAKELTKSLLTVNPAQRI 649
+S EAKEL K +LT + +R
Sbjct: 272 KNISDEAKELIKLMLTYDYNKRC 294
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504 | Back alignment and structure |
|---|
Score = 110 bits (276), Expect = 2e-25
Identities = 29/73 (39%), Positives = 48/73 (65%), Gaps = 3/73 (4%)
Query: 894 HTYLVLELLKGGELLDRIRQKGRCGFTENEASRIMRQLVAAVHFMHSRGVVHRDLKPENL 953
+ YLV E +GGEL ++I + + F E +A+ IM+Q+++ + ++H +VHRD+KPEN+
Sbjct: 120 YFYLVTEFYEGGELFEQIINRHK--FDECDAANIMKQILSGICYLHKHNIVHRDIKPENI 177
Query: 954 LLSGISGN-LIKI 965
LL + IKI
Sbjct: 178 LLENKNSLLNIKI 190
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504 | Back alignment and structure |
|---|
Score = 70.5 bits (173), Expect = 1e-12
Identities = 48/296 (16%), Positives = 88/296 (29%), Gaps = 116/296 (39%)
Query: 110 FFEQYDMDLDKAGILGDGSYSVCRRCVEKSTGQEYAVKIISRK----------------- 152
E Y LG G+Y C EK+ E A+K+I +
Sbjct: 34 IGESYFKV----RKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKF 89
Query: 153 -IDCSEEINLLRACQGHPNICR-------------------------RCVEKSTGQEYAV 186
+ EI+LL++ HPNI + + + + E
Sbjct: 90 HEEIYNEISLLKS-LDHPNIIKLFDVFEDKKYFYLVTEFYEGGELFEQIINRHKFDECDA 148
Query: 187 KIISRKIDCSEEINLLRACQGHPNIVNLH-------CVFQDE-------VIDWDDFSRGI 232
I ++I ++ + H NIV H + +++ ++D+ G+
Sbjct: 149 ANIMKQI-----LSGICYLHKH-NIV--HRDIKPENILLENKNSLLNIKIVDF-----GL 195
Query: 233 ECVFFSS------------------------------SL-IIFFIILSFTLSFIHDYYHI 261
FFS S +I +I+L F
Sbjct: 196 -SSFFSKDYKLRDRLGTAYYIAPEVLKKKYNEKCDVWSCGVIMYILLCGYPPFGGQNDQD 254
Query: 262 QYRRILKTEPPIPED----LSPDVADFISRLLVKDPRRRLGGGELDAEELKRHPFF 313
+++ K + + +S + + I +L D +R AEE +
Sbjct: 255 IIKKVEKGKYYFDFNDWKNISDEAKELIKLMLTYDYNKR-----CTAEEALNSRWI 305
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419 | Back alignment and structure |
|---|
Score = 291 bits (748), Expect = 7e-90
Identities = 96/302 (31%), Positives = 140/302 (46%), Gaps = 50/302 (16%)
Query: 364 DKIFKGSLFFEQYDMDLDKAGILGDGSYSVCRRCVEKSTGQEYAVKIIS-RKIDCSE--- 419
D+ ++Y M LG G+ + E+ T ++ A++IIS RK
Sbjct: 125 DQSVYPKALRDEYIMS----KTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSARE 180
Query: 420 ---------EINLLRACQGHPNIVNLHCVFQDEVHTYLVLELLKGGELLDRIRQKGRCGF 470
EI +L+ HP I+ + F E Y+VLEL++GGEL D++ R
Sbjct: 181 ADPALNVETEIEILKKLN-HPCIIKIKNFFDAE-DYYIVLELMEGGELFDKVVGNKR--L 236
Query: 471 TENEASRIMRQLVAAVHFMHSRGVVHRDLKPENLLFSDPAGD-NIKVVDFGFACLKRES- 528
E Q++ AV ++H G++HRDLKPEN+L S D IK+ DFG + + E+
Sbjct: 237 KEATCKLYFYQMLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETS 296
Query: 529 -LHTPCFTLQYAAPEVLRQDKSGYDENCDLWSLGVILVNVLRQDKSGYDENCDLWSLGVI 587
+ T C T Y APEVL +GY+ D WSLGVI
Sbjct: 297 LMRTLCGTPTYLAPEVLVSVG-----------------------TAGYNRAVDCWSLGVI 333
Query: 588 LYTMLCGRVPFHARSRDDSALSIMARIKEGQFNFDAEAWSTVSSEAKELTKSLLTVNPAQ 647
L+ L G PF + +S+ +I G++NF E W+ VS +A +L K LL V+P
Sbjct: 334 LFICLSGYPPFSE---HRTQVSLKDQITSGKYNFIPEVWAEVSEKALDLVKKLLVVDPKA 390
Query: 648 RI 649
R
Sbjct: 391 RF 392
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419 | Back alignment and structure |
|---|
Score = 110 bits (276), Expect = 1e-25
Identities = 32/71 (45%), Positives = 45/71 (63%), Gaps = 3/71 (4%)
Query: 896 YLVLELLKGGELLDRIRQKGRCGFTENEASRIMRQLVAAVHFMHSRGVVHRDLKPENLLL 955
Y+VLEL++GGEL D++ R E Q++ AV ++H G++HRDLKPEN+LL
Sbjct: 215 YIVLELMEGGELFDKVVGNKR--LKEATCKLYFYQMLLAVQYLHENGIIHRDLKPENVLL 272
Query: 956 SGISGN-LIKI 965
S + LIKI
Sbjct: 273 SSQEEDCLIKI 283
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419 | Back alignment and structure |
|---|
Score = 68.2 bits (167), Expect = 4e-12
Identities = 21/112 (18%), Positives = 38/112 (33%), Gaps = 32/112 (28%)
Query: 110 FFEQYDMDLDKAGILGDGSYSVCRRCVEKSTGQEYAVKIISRKIDCSEEINLLRACQGHP 169
++Y M LG G+ + E+ T ++ A++IIS+
Sbjct: 133 LRDEYIMS----KTLGSGACGEVKLAFERKTCKKVAIRIISK------------------ 170
Query: 170 NICRRCVEKSTGQEYAVKIISRKIDCSEEINLLRACQGHPNIVNLHCVFQDE 221
R+ S + + EI +L+ HP I+ + F E
Sbjct: 171 ---RKFAIGSAREADPALNVET------EIEILKKLN-HPCIIKIKNFFDAE 212
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419 | Back alignment and structure |
|---|
Score = 44.3 bits (105), Expect = 1e-04
Identities = 21/78 (26%), Positives = 32/78 (41%), Gaps = 10/78 (12%)
Query: 242 IIFFIILSFTLSFIHDYYHIQ-YRRILKTE----PPIPEDLSPDVADFISRLLVKDPRRR 296
+I FI LS F + +I + P + ++S D + +LLV DP+ R
Sbjct: 332 VILFICLSGYPPFSEHRTQVSLKDQITSGKYNFIPEVWAEVSEKALDLVKKLLVVDPKAR 391
Query: 297 LGGGELDAEELKRHPFFN 314
EE RHP+
Sbjct: 392 -----FTTEEALRHPWLQ 404
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387 | Back alignment and structure |
|---|
Score = 289 bits (742), Expect = 2e-89
Identities = 88/318 (27%), Positives = 145/318 (45%), Gaps = 49/318 (15%)
Query: 339 DVSNFSDEFTKMIPADSPAIVPPNFDKIFKGSLFFEQYDMDLDKAGILGDGSYSVCRRCV 398
++++ + + P V K ++ YD+ LG G++ V RCV
Sbjct: 22 KINDYDKFYEDIWKKYVPQPVE------VKQGSVYDYYDIL----EELGSGAFGVVHRCV 71
Query: 399 EKSTGQEYAVKIIS-----RKIDCSEEINLLRACQGHPNIVNLHCVFQDEVHTYLVLELL 453
EK+TG+ + K I+ K EI+++ HP ++NLH F+D+ L+LE L
Sbjct: 72 EKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLH-HPKLINLHDAFEDKYEMVLILEFL 130
Query: 454 KGGELLDRIRQKGRCGFTENEASRIMRQLVAAVHFMHSRGVVHRDLKPENLLFSDPAGDN 513
GGEL DRI + +E E MRQ + MH +VH D+KPEN++ +
Sbjct: 131 SGGELFDRIAAED-YKMSEAEVINYMRQACEGLKHMHEHSIVHLDIKPENIMCETKKASS 189
Query: 514 IKVVDFGFACL--KRESLHTPCFTLQYAAPEVLRQDKSGYDENCDLWSLGVILVNVLRQD 571
+K++DFG A E + T ++AAPE++ ++
Sbjct: 190 VKIIDFGLATKLNPDEIVKVTTATAEFAAPEIVDRE------------------------ 225
Query: 572 KSGYDENCDLWSLGVILYTMLCGRVPFHARSRDDSALSIMARIKEGQFNFDAEAWSTVSS 631
D+W++GV+ Y +L G PF + + +K + FD +A+S+VS
Sbjct: 226 --PVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLE----TLQNVKRCDWEFDEDAFSSVSP 279
Query: 632 EAKELTKSLLTVNPAQRI 649
EAK+ K+LL P +R+
Sbjct: 280 EAKDFIKNLLQKEPRKRL 297
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387 | Back alignment and structure |
|---|
Score = 111 bits (280), Expect = 2e-26
Identities = 27/72 (37%), Positives = 37/72 (51%), Gaps = 1/72 (1%)
Query: 894 HTYLVLELLKGGELLDRIRQKGRCGFTENEASRIMRQLVAAVHFMHSRGVVHRDLKPENL 953
L+LE L GGEL DRI + +E E MRQ + MH +VH D+KPEN+
Sbjct: 122 EMVLILEFLSGGELFDRIAAED-YKMSEAEVINYMRQACEGLKHMHEHSIVHLDIKPENI 180
Query: 954 LLSGISGNLIKI 965
+ + +KI
Sbjct: 181 MCETKKASSVKI 192
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387 | Back alignment and structure |
|---|
Score = 62.4 bits (152), Expect = 2e-10
Identities = 25/120 (20%), Positives = 43/120 (35%), Gaps = 40/120 (33%)
Query: 102 ACKFKGSLFFEQYDMDLDKAGILGDGSYSVCRRCVEKSTGQEYAVKIISRKIDCSEEINL 161
+ K ++ YD+ LG G++ V RCVEK+TG+ + K I+
Sbjct: 41 PVEVKQGSVYDYYDIL----EELGSGAFGVVHRCVEKATGRVFVAKFINTP--------- 87
Query: 162 LRACQGHPNICRRCVEKSTGQEYAVKIISRKIDCSEEINLLRACQGHPNIVNLHCVFQDE 221
+ EI+++ HP ++NLH F+D+
Sbjct: 88 ----------------YPLDKY----------TVKNEISIMNQLH-HPKLINLHDAFEDK 120
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345 | Back alignment and structure |
|---|
Score = 286 bits (733), Expect = 9e-89
Identities = 87/333 (26%), Positives = 137/333 (41%), Gaps = 88/333 (26%)
Query: 372 FFEQYDMDLDKAGILGDGSYSVCRRCVEKSTGQEYAVKIISRKI----------DCSEEI 421
++Y + G +G GSY V R +E T A+KI+++ E+
Sbjct: 24 LQKKYHLK----GAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEV 79
Query: 422 NLLRACQGHPNIVNLHCVFQDEVHTYLVLELLKGGELLDRIRQKGRCG------------ 469
L++ HPNI L+ V++DE + LV+EL GG LLD++
Sbjct: 80 RLMKKLH-HPNIARLYEVYEDEQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQ 138
Query: 470 --------------------------FTENEASRIMRQLVAAVHFMHSRGVVHRDLKPEN 503
E S IMRQ+ +A+H++H++G+ HRD+KPEN
Sbjct: 139 ICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSALHYLHNQGICHRDIKPEN 198
Query: 504 LLFSDPAGDNIKVVDFGFACL-------KRESLHTPCFTLQYAAPEVLRQDKSGYDENCD 556
LFS IK+VDFG + + + T T + APE
Sbjct: 199 FLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPE-------------- 244
Query: 557 LWSLGVILVNVLRQDKSGYDENCDLWSLGVILYTMLCGRVPFHARSRDDSALSIMARIKE 616
VL Y CD WS GV+L+ +L G VPF + D ++++
Sbjct: 245 ----------VLNTTNESYGPKCDAWSAGVLLHLLLMGAVPFPGVNDAD----TISQVLN 290
Query: 617 GQFNFDAEAWSTVSSEAKELTKSLLTVNPAQRI 649
+ F+ ++ +S A++L +LL N +R
Sbjct: 291 KKLCFENPNYNVLSPLARDLLSNLLNRNVDERF 323
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345 | Back alignment and structure |
|---|
Score = 99.1 bits (247), Expect = 2e-22
Identities = 30/110 (27%), Positives = 44/110 (40%), Gaps = 38/110 (34%)
Query: 894 HTYLVLELLKGGELLDRIRQKGRCG----------------------------------- 918
+ LV+EL GG LLD++
Sbjct: 102 YICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESL 161
Query: 919 ---FTENEASRIMRQLVAAVHFMHSRGVVHRDLKPENLLLSGISGNLIKI 965
E S IMRQ+ +A+H++H++G+ HRD+KPEN L S IK+
Sbjct: 162 DFVQREKLISNIMRQIFSALHYLHNQGICHRDIKPENFLFSTNKSFEIKL 211
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345 | Back alignment and structure |
|---|
Score = 61.4 bits (149), Expect = 5e-10
Identities = 23/112 (20%), Positives = 41/112 (36%), Gaps = 35/112 (31%)
Query: 110 FFEQYDMDLDKAGILGDGSYSVCRRCVEKSTGQEYAVKIISRKIDCSEEINLLRACQGHP 169
++Y + G +G GSY V R +E T A+KI+++ + +
Sbjct: 24 LQKKYHLK----GAIGQGSYGVVRVAIENQTRAIRAIKIMNKN-------KIRQINPKDV 72
Query: 170 NICRRCVEKSTGQEYAVKIISRKIDCSEEINLLRACQGHPNIVNLHCVFQDE 221
+ E+ L++ HPNI L+ V++DE
Sbjct: 73 ERIKT-----------------------EVRLMKKLH-HPNIARLYEVYEDE 100
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345 | Back alignment and structure |
|---|
Score = 50.6 bits (121), Expect = 1e-06
Identities = 15/77 (19%), Positives = 29/77 (37%), Gaps = 9/77 (11%)
Query: 242 IIFFIILSFTLSFIHDYYHIQYRRILKTEPPIPED----LSPDVADFISRLLVKDPRRRL 297
++ ++L + F ++L + LSP D +S LL ++ R
Sbjct: 264 VLLHLLLMGAVPFPGVNDADTISQVLNKKLCFENPNYNVLSPLARDLLSNLLNRNVDER- 322
Query: 298 GGGELDAEELKRHPFFN 314
DA +HP+ +
Sbjct: 323 ----FDAMRALQHPWIS 335
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573 | Back alignment and structure |
|---|
Score = 288 bits (738), Expect = 2e-86
Identities = 90/425 (21%), Positives = 160/425 (37%), Gaps = 51/425 (12%)
Query: 324 KRIPAPFVPKISNELDVSNFSDEFTKMIPADSPAIVPPNFDKIFKGSLFFEQYDMDLDKA 383
KR V + + D P +I + YD+
Sbjct: 108 KRRRGYDVDEQGKIVRGKGTVSSNYDNYVFDIWKQYYPQPVEIKHDH-VLDHYDIH---- 162
Query: 384 GILGDGSYSVCRRCVEKSTGQEYAVKIISR-----KIDCSEEINLLRACQGHPNIVNLHC 438
LG G++ V R E++TG +A K + K +EI + + HP +VNLH
Sbjct: 163 EELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLR-HPTLVNLHD 221
Query: 439 VFQDEVHTYLVLELLKGGELLDRIRQKGRCGFTENEASRIMRQLVAAVHFMHSRGVVHRD 498
F+D+ ++ E + GGEL +++ + +E+EA MRQ+ + MH VH D
Sbjct: 222 AFEDDNEMVMIYEFMSGGELFEKVADE-HNKMSEDEAVEYMRQVCKGLCHMHENNYVHLD 280
Query: 499 LKPENLLFSDPAGDNIKVVDFGFACL--KRESLHTPCFTLQYAAPEVLRQDKSGYDENCD 556
LKPEN++F+ + +K++DFG ++S+ T ++AAPEV
Sbjct: 281 LKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVKVTTGTAEFAAPEVAEGK--------- 331
Query: 557 LWSLGVILVNVLRQDKSGYDENCDLWSLGVILYTMLCGRVPFHARSRDDSALSIMARIKE 616
D+WS+GV+ Y +L G PF + D+ + +K
Sbjct: 332 -----------------PVGYYTDMWSVGVLSYILLSGLSPFGGENDDE----TLRNVKS 370
Query: 617 GQFNFDAEAWSTVSSEAKELTKSLLTVNPAQRIRMMRVKLTFHAFHQAQKEGFRLQDVTS 676
+N D A+S +S + K+ + LL +P R+ + + L H + R + S
Sbjct: 371 CDWNMDDSAFSGISEDGKDFIRKLLLADPNTRMTIHQA-LE-HPWLTPGNAPGRDSQIPS 428
Query: 677 AKLAQ-----RRKNKNVSNDNSRSFSSTSSSLSSSSSGTSSLKTPCSSTQPSVPSKPVKR 731
++ + + K ++ S + + + +
Sbjct: 429 SRYTKIRDSIKTKYDAWPEPLPPLGRISNYSSLRKHRPQEYSIRDAFWDRSEAQPRFIVK 488
Query: 732 INKDA 736
Sbjct: 489 PYGTE 493
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573 | Back alignment and structure |
|---|
Score = 108 bits (272), Expect = 1e-24
Identities = 41/242 (16%), Positives = 81/242 (33%), Gaps = 61/242 (25%)
Query: 759 SSSSEHGTSPPSSSTIQLQLSPVRKKKKPDLTLPASNKAESEQLHLAEPSTLAGTKRKHK 818
+ ++HG S P T + + +K++ + K + ++ +
Sbjct: 83 IAENKHGQSKPCEPTAPVLIPGDERKRRRGYDVDEQGKIVRGKGTVSSNYDNYVFDIWKQ 142
Query: 819 PDTSSQCSKSLP-------------------------ATHSTPA----RKKKKADRQPAK 849
K AT + A ++D++ +
Sbjct: 143 YYPQPVEIKHDHVLDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVR 202
Query: 850 QE------EKQPVPQTTPPTDLVTLFEEQLLGPITRARRRTFVNRSRYNVHTYLVLELLK 903
+E + P LV L + F + + ++ E +
Sbjct: 203 KEIQTMSVLRHP--------TLVNLHD-------------AFEDDNEM----VMIYEFMS 237
Query: 904 GGELLDRIRQKGRCGFTENEASRIMRQLVAAVHFMHSRGVVHRDLKPENLLLSGISGNLI 963
GGEL +++ + +E+EA MRQ+ + MH VH DLKPEN++ + N +
Sbjct: 238 GGELFEKVADE-HNKMSEDEAVEYMRQVCKGLCHMHENNYVHLDLKPENIMFTTKRSNEL 296
Query: 964 KI 965
K+
Sbjct: 297 KL 298
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573 | Back alignment and structure |
|---|
Score = 62.2 bits (151), Expect = 5e-10
Identities = 24/118 (20%), Positives = 41/118 (34%), Gaps = 40/118 (33%)
Query: 104 KFKGSLFFEQYDMDLDKAGILGDGSYSVCRRCVEKSTGQEYAVKIISRKIDCSEEINLLR 163
+ K + YD+ LG G++ V R E++TG +A K +
Sbjct: 149 EIKHDHVLDHYDIH----EELGTGAFGVVHRVTERATGNNFAAKFVMTP----------- 193
Query: 164 ACQGHPNICRRCVEKSTGQEYAVKIISRKIDCSEEINLLRACQGHPNIVNLHCVFQDE 221
+ +E +EI + + HP +VNLH F+D+
Sbjct: 194 --------------HESDKE----------TVRKEIQTMSVLR-HPTLVNLHDAFEDD 226
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 258 bits (662), Expect = 6e-79
Identities = 61/299 (20%), Positives = 108/299 (36%), Gaps = 53/299 (17%)
Query: 385 ILGDGSYSVCRRCVEKSTGQEYAVKIISRKIDCSE------EINLLRACQGHPNIVNLHC 438
ILG G+ + R K TG +A+K+ + E +L+ H NIV L
Sbjct: 16 ILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLN-HKNIVKLFA 74
Query: 439 VFQDE--VHTYLVLELLKGGELLDRIRQKGR-CGFTENEASRIMRQLVAAVHFMHSRGVV 495
+ ++ H L++E G L + + G E+E ++R +V ++ + G+V
Sbjct: 75 IEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENGIV 134
Query: 496 HRDLKPENLLFSDPAGD--NIKVVDFGFACLKRES--LHTPCFTLQYAAPEVLRQDKSGY 551
HR++KP N++ K+ DFG A + + T +Y P++ +
Sbjct: 135 HRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQFVSLYGTEEYLHPDMYERAVLRK 194
Query: 552 DENCDLWSLGVILVNVLRQDKSGYDENCDLWSLGVILYTMLCGRVPFHARSRDDSALSIM 611
D Y DLWS+GV Y G +PF +M
Sbjct: 195 DHQ------------------KKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVM 236
Query: 612 ARIKEGQ-----------------FNFDAEAWSTVSSEAKELTKS----LLTVNPAQRI 649
+I G+ ++ D ++S + L +L + +
Sbjct: 237 YKIITGKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCW 295
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 109 bits (274), Expect = 3e-26
Identities = 18/75 (24%), Positives = 36/75 (48%), Gaps = 3/75 (4%)
Query: 894 HTYLVLELLKGGELLDRIRQKGR-CGFTENEASRIMRQLVAAVHFMHSRGVVHRDLKPEN 952
H L++E G L + + G E+E ++R +V ++ + G+VHR++KP N
Sbjct: 83 HKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENGIVHRNIKPGN 142
Query: 953 LLLSGISGN--LIKI 965
++ + K+
Sbjct: 143 IMRVIGEDGQSVYKL 157
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 56.7 bits (137), Expect = 1e-08
Identities = 18/99 (18%), Positives = 30/99 (30%), Gaps = 35/99 (35%)
Query: 123 ILGDGSYSVCRRCVEKSTGQEYAVKIISRKIDCSEEINLLRACQGHPNICRRCVEKSTGQ 182
ILG G+ + R K TG +A+K+ + +R
Sbjct: 16 ILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMR------------------- 56
Query: 183 EYAVKIISRKIDCSEEINLLRACQGHPNIVNLHCVFQDE 221
E +L+ H NIV L + ++
Sbjct: 57 ---------------EFEVLKKLN-HKNIVKLFAIEEET 79
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294 | Back alignment and structure |
|---|
Score = 252 bits (645), Expect = 9e-77
Identities = 75/281 (26%), Positives = 121/281 (43%), Gaps = 50/281 (17%)
Query: 386 LGDGSYSVCRRCVEKSTGQEYAVKIISR----KIDCSE----EINLLRACQGHPNIVNLH 437
LG G ++ C + T + +A KI+ + K E EI++ R+ H ++V H
Sbjct: 23 LGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLA-HQHVVGFH 81
Query: 438 CVFQDEVHTYLVLELLKGGELLDRIRQKGRCGFTENEASRIMRQLVAAVHFMHSRGVVHR 497
F+D ++VLEL + LL+ +++ TE EA +RQ+V ++H V+HR
Sbjct: 82 GFFEDNDFVFVVLELCRRRSLLELHKRRKA--LTEPEARYYLRQIVLGCQYLHRNRVIHR 139
Query: 498 DLKPENLLFSDPAGDNIKVVDFGFACL---KRESLHTPCFTLQYAAPEVLRQDKSGYDEN 554
DLK NL ++ +K+ DFG A E C T Y APEVL
Sbjct: 140 DLKLGNLFLNE--DLEVKIGDFGLATKVEYDGERKKVLCGTPNYIAPEVL---------- 187
Query: 555 CDLWSLGVILVNVLRQDKSGYDENCDLWSLGVILYTMLCGRVPFHARSRDDSALSIMARI 614
K G+ D+WS+G I+YT+L G+ PF RI
Sbjct: 188 ----------------SKKGHSFEVDVWSIGCIMYTLLVGKPPFE----TSCLKETYLRI 227
Query: 615 KEGQFNFDAEAWSTVSSEAKELTKSLLTVNPAQRIRMMRVK 655
K+ +++ ++ A L + +L +P R + +
Sbjct: 228 KKNEYSIP----KHINPVAASLIQKMLQTDPTARPTINELL 264
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294 | Back alignment and structure |
|---|
Score = 105 bits (264), Expect = 5e-25
Identities = 25/72 (34%), Positives = 38/72 (52%), Gaps = 4/72 (5%)
Query: 894 HTYLVLELLKGGELLDRIRQKGRCGFTENEASRIMRQLVAAVHFMHSRGVVHRDLKPENL 953
++VLEL + LL+ +++ TE EA +RQ+V ++H V+HRDLK NL
Sbjct: 89 FVFVVLELCRRRSLLELHKRRKA--LTEPEARYYLRQIVLGCQYLHRNRVIHRDLKLGNL 146
Query: 954 LLSGISGNLIKI 965
L + KI
Sbjct: 147 FL-NEDLEV-KI 156
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294 | Back alignment and structure |
|---|
Score = 58.4 bits (142), Expect = 3e-09
Identities = 21/73 (28%), Positives = 28/73 (38%), Gaps = 5/73 (6%)
Query: 242 IIFFIILSFTLSFIHDYYHIQYRRILKTEPPIPEDLSPDVADFISRLLVKDPRRRLGGGE 301
I + +L F Y RI K E IP+ ++P A I ++L DP R
Sbjct: 203 CIMYTLLVGKPPFETSCLKETYLRIKKNEYSIPKHINPVAASLIQKMLQTDPTAR----- 257
Query: 302 LDAEELKRHPFFN 314
EL FF
Sbjct: 258 PTINELLNDEFFT 270
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294 | Back alignment and structure |
|---|
Score = 46.0 bits (110), Expect = 3e-05
Identities = 15/58 (25%), Positives = 26/58 (44%), Gaps = 9/58 (15%)
Query: 172 CRRCVEKSTGQEYAVKIISR----KIDCSE----EINLLRACQGHPNIVNLHCVFQDE 221
C + T + +A KI+ + K E EI++ R+ H ++V H F+D
Sbjct: 31 CFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLA-HQHVVGFHGFFEDN 87
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335 | Back alignment and structure |
|---|
Score = 251 bits (644), Expect = 4e-76
Identities = 75/281 (26%), Positives = 121/281 (43%), Gaps = 50/281 (17%)
Query: 386 LGDGSYSVCRRCVEKSTGQEYAVKIISR----KIDCSE----EINLLRACQGHPNIVNLH 437
LG G ++ C + T + +A KI+ + K E EI++ R+ H ++V H
Sbjct: 49 LGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLA-HQHVVGFH 107
Query: 438 CVFQDEVHTYLVLELLKGGELLDRIRQKGRCGFTENEASRIMRQLVAAVHFMHSRGVVHR 497
F+D ++VLEL + LL+ +++ TE EA +RQ+V ++H V+HR
Sbjct: 108 GFFEDNDFVFVVLELCRRRSLLELHKRRKA--LTEPEARYYLRQIVLGCQYLHRNRVIHR 165
Query: 498 DLKPENLLFSDPAGDNIKVVDFGFACL---KRESLHTPCFTLQYAAPEVLRQDKSGYDEN 554
DLK NL ++ +K+ DFG A E C T Y APEVL
Sbjct: 166 DLKLGNLFLNE--DLEVKIGDFGLATKVEYDGERKKVLCGTPNYIAPEVL---------- 213
Query: 555 CDLWSLGVILVNVLRQDKSGYDENCDLWSLGVILYTMLCGRVPFHARSRDDSALSIMARI 614
K G+ D+WS+G I+YT+L G+ PF RI
Sbjct: 214 ----------------SKKGHSFEVDVWSIGCIMYTLLVGKPPFE----TSCLKETYLRI 253
Query: 615 KEGQFNFDAEAWSTVSSEAKELTKSLLTVNPAQRIRMMRVK 655
K+ +++ ++ A L + +L +P R + +
Sbjct: 254 KKNEYSIP----KHINPVAASLIQKMLQTDPTARPTINELL 290
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335 | Back alignment and structure |
|---|
Score = 105 bits (263), Expect = 1e-24
Identities = 25/72 (34%), Positives = 38/72 (52%), Gaps = 4/72 (5%)
Query: 894 HTYLVLELLKGGELLDRIRQKGRCGFTENEASRIMRQLVAAVHFMHSRGVVHRDLKPENL 953
++VLEL + LL+ +++ TE EA +RQ+V ++H V+HRDLK NL
Sbjct: 115 FVFVVLELCRRRSLLELHKRRKA--LTEPEARYYLRQIVLGCQYLHRNRVIHRDLKLGNL 172
Query: 954 LLSGISGNLIKI 965
L +KI
Sbjct: 173 FL-NEDLE-VKI 182
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335 | Back alignment and structure |
|---|
Score = 57.7 bits (140), Expect = 6e-09
Identities = 21/73 (28%), Positives = 28/73 (38%), Gaps = 5/73 (6%)
Query: 242 IIFFIILSFTLSFIHDYYHIQYRRILKTEPPIPEDLSPDVADFISRLLVKDPRRRLGGGE 301
I + +L F Y RI K E IP+ ++P A I ++L DP R
Sbjct: 229 CIMYTLLVGKPPFETSCLKETYLRIKKNEYSIPKHINPVAASLIQKMLQTDPTAR----- 283
Query: 302 LDAEELKRHPFFN 314
EL FF
Sbjct: 284 PTINELLNDEFFT 296
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335 | Back alignment and structure |
|---|
Score = 46.5 bits (111), Expect = 3e-05
Identities = 15/58 (25%), Positives = 26/58 (44%), Gaps = 9/58 (15%)
Query: 172 CRRCVEKSTGQEYAVKIISR----KIDCSE----EINLLRACQGHPNIVNLHCVFQDE 221
C + T + +A KI+ + K E EI++ R+ H ++V H F+D
Sbjct: 57 CFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLA-HQHVVGFHGFFEDN 113
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396 | Back alignment and structure |
|---|
Score = 251 bits (643), Expect = 3e-75
Identities = 61/299 (20%), Positives = 108/299 (36%), Gaps = 53/299 (17%)
Query: 385 ILGDGSYSVCRRCVEKSTGQEYAVKIISRKIDCSE------EINLLRACQGHPNIVNLHC 438
ILG G+ + R K TG +A+K+ + E +L+ H NIV L
Sbjct: 16 ILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLN-HKNIVKLFA 74
Query: 439 VFQDE--VHTYLVLELLKGGELLDRIRQKGR-CGFTENEASRIMRQLVAAVHFMHSRGVV 495
+ ++ H L++E G L + + G E+E ++R +V ++ + G+V
Sbjct: 75 IEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENGIV 134
Query: 496 HRDLKPENLLFSDPAGD--NIKVVDFGFACLKRES--LHTPCFTLQYAAPEVLRQDKSGY 551
HR++KP N++ K+ DFG A + + T +Y P++ +
Sbjct: 135 HRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQFVSLYGTEEYLHPDMYERAVLRK 194
Query: 552 DENCDLWSLGVILVNVLRQDKSGYDENCDLWSLGVILYTMLCGRVPFHARSRDDSALSIM 611
D Y DLWS+GV Y G +PF +M
Sbjct: 195 DHQ------------------KKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVM 236
Query: 612 ARIKEGQ-----------------FNFDAEAWSTVSSEAKELTKSL----LTVNPAQRI 649
+I G+ ++ D ++S + L + L + +
Sbjct: 237 YKIITGKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCW 295
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396 | Back alignment and structure |
|---|
Score = 108 bits (270), Expect = 4e-25
Identities = 18/75 (24%), Positives = 36/75 (48%), Gaps = 3/75 (4%)
Query: 894 HTYLVLELLKGGELLDRIRQKGR-CGFTENEASRIMRQLVAAVHFMHSRGVVHRDLKPEN 952
H L++E G L + + G E+E ++R +V ++ + G+VHR++KP N
Sbjct: 83 HKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENGIVHRNIKPGN 142
Query: 953 LLLSGISGN--LIKI 965
++ + K+
Sbjct: 143 IMRVIGEDGQSVYKL 157
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396 | Back alignment and structure |
|---|
Score = 55.2 bits (133), Expect = 6e-08
Identities = 18/99 (18%), Positives = 30/99 (30%), Gaps = 35/99 (35%)
Query: 123 ILGDGSYSVCRRCVEKSTGQEYAVKIISRKIDCSEEINLLRACQGHPNICRRCVEKSTGQ 182
ILG G+ + R K TG +A+K+ + +R
Sbjct: 16 ILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMR------------------- 56
Query: 183 EYAVKIISRKIDCSEEINLLRACQGHPNIVNLHCVFQDE 221
E +L+ H NIV L + ++
Sbjct: 57 ---------------EFEVLKKLN-HKNIVKLFAIEEET 79
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278 | Back alignment and structure |
|---|
Score = 247 bits (632), Expect = 4e-75
Identities = 84/281 (29%), Positives = 132/281 (46%), Gaps = 49/281 (17%)
Query: 386 LGDGSYSVCRRCVEKSTGQEYAVKIISR----KIDCSE----EINLLRACQGHPNIVNLH 437
LG GS++ R TG E A+K+I + K + E+ + + HP+I+ L+
Sbjct: 19 LGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLK-HPSILELY 77
Query: 438 CVFQDEVHTYLVLELLKGGELLDRIRQKGRCGFTENEASRIMRQLVAAVHFMHSRGVVHR 497
F+D + YLVLE+ GE+ ++ + + F+ENEA M Q++ + ++HS G++HR
Sbjct: 78 NYFEDSNYVYLVLEMCHNGEMNRYLKNRVKP-FSENEARHFMHQIITGMLYLHSHGILHR 136
Query: 498 DLKPENLLFSDPAGDNIKVVDFGFACL---KRESLHTPCFTLQYAAPEVLRQDKSGYDEN 554
DL NLL + NIK+ DFG A E +T C T Y +PE+
Sbjct: 137 DLTLSNLLLTR--NMNIKIADFGLATQLKMPHEKHYTLCGTPNYISPEIA---------- 184
Query: 555 CDLWSLGVILVNVLRQDKSGYDENCDLWSLGVILYTMLCGRVPFHARSRDDSALSIMARI 614
+S + D+WSLG + YT+L GR PF D+ + + ++
Sbjct: 185 ----------------TRSAHGLESDVWSLGCMFYTLLIGRPPFD----TDTVKNTLNKV 224
Query: 615 KEGQFNFDAEAWSTVSSEAKELTKSLLTVNPAQRIRMMRVK 655
+ S +S EAK+L LL NPA R+ + V
Sbjct: 225 VLADYEMP----SFLSIEAKDLIHQLLRRNPADRLSLSSVL 261
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278 | Back alignment and structure |
|---|
Score = 106 bits (267), Expect = 2e-25
Identities = 29/70 (41%), Positives = 44/70 (62%), Gaps = 3/70 (4%)
Query: 896 YLVLELLKGGELLDRIRQKGRCGFTENEASRIMRQLVAAVHFMHSRGVVHRDLKPENLLL 955
YLVLE+ GE+ ++ + + F+ENEA M Q++ + ++HS G++HRDL NLLL
Sbjct: 87 YLVLEMCHNGEMNRYLKNRVKP-FSENEARHFMHQIITGMLYLHSHGILHRDLTLSNLLL 145
Query: 956 SGISGNLIKI 965
+ N IKI
Sbjct: 146 -TRNMN-IKI 153
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278 | Back alignment and structure |
|---|
Score = 56.8 bits (138), Expect = 1e-08
Identities = 17/73 (23%), Positives = 31/73 (42%), Gaps = 5/73 (6%)
Query: 242 IIFFIILSFTLSFIHDYYHIQYRRILKTEPPIPEDLSPDVADFISRLLVKDPRRRLGGGE 301
+F+ +L F D +++ + +P LS + D I +LL ++P R
Sbjct: 200 CMFYTLLIGRPPFDTDTVKNTLNKVVLADYEMPSFLSIEAKDLIHQLLRRNPADR----- 254
Query: 302 LDAEELKRHPFFN 314
L + HPF +
Sbjct: 255 LSLSSVLDHPFMS 267
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278 | Back alignment and structure |
|---|
Score = 44.4 bits (106), Expect = 8e-05
Identities = 15/58 (25%), Positives = 26/58 (44%), Gaps = 9/58 (15%)
Query: 172 CRRCVEKSTGQEYAVKIISR----KIDCSE----EINLLRACQGHPNIVNLHCVFQDE 221
R TG E A+K+I + K + E+ + + HP+I+ L+ F+D
Sbjct: 27 VYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLK-HPSILELYNYFEDS 83
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303 | Back alignment and structure |
|---|
Score = 245 bits (628), Expect = 3e-74
Identities = 60/312 (19%), Positives = 117/312 (37%), Gaps = 73/312 (23%)
Query: 372 FFEQYDMDLDKAGILGDGSYSVCRRCVEKSTGQEYAVKIISRKIDCSE----EINLLRAC 427
+ ++ +LG G++ + + YA+K I + E+ LL +
Sbjct: 4 YASDFEEI----AVLGQGAFGQVVKARNALDSRYYAIKKIRHTEEKLSTILSEVMLLASL 59
Query: 428 QGHPNIVNLHCVFQDEVHT-------------YLVLELLKGGELLDRIRQKGRCGFTENE 474
H +V + + + + ++ +E + G L D I + +E
Sbjct: 60 N-HQYVVRYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHSENL-NQQRDE 117
Query: 475 ASRIMRQLVAAVHFMHSRGVVHRDLKPENLLFSDPAGDNIKVVDFGFA------------ 522
R+ RQ++ A+ ++HS+G++HRDLKP N+ + N+K+ DFG A
Sbjct: 118 YWRLFRQILEALSYIHSQGIIHRDLKPMNIFIDE--SRNVKIGDFGLAKNVHRSLDILKL 175
Query: 523 -----CLKRESLHTPCFTLQYAAPEVLRQDKSGYDENCDLWSLGVILVNVLRQDKSGYDE 577
++L + T Y A EVL Y+E
Sbjct: 176 DSQNLPGSSDNLTSAIGTAMYVATEVL-------------------------DGTGHYNE 210
Query: 578 NCDLWSLGVILYTMLCGRVPFHARSRDDSALSIMARIKEGQFNFDAEAWSTVSSEAKELT 637
D++SLG+I + M+ R + I+ +++ F + K++
Sbjct: 211 KIDMYSLGIIFFEMIYP--FSTGMERVN----ILKKLRSVSIEFPPDFDDNKMKVEKKII 264
Query: 638 KSLLTVNPAQRI 649
+ L+ +P +R
Sbjct: 265 RLLIDHDPNKRP 276
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303 | Back alignment and structure |
|---|
Score = 98.2 bits (245), Expect = 2e-22
Identities = 24/70 (34%), Positives = 42/70 (60%), Gaps = 3/70 (4%)
Query: 896 YLVLELLKGGELLDRIRQKGRCGFTENEASRIMRQLVAAVHFMHSRGVVHRDLKPENLLL 955
++ +E + G L D I + +E R+ RQ++ A+ ++HS+G++HRDLKP N+ +
Sbjct: 91 FIQMEYCENGTLYDLIHSENL-NQQRDEYWRLFRQILEALSYIHSQGIIHRDLKPMNIFI 149
Query: 956 SGISGNLIKI 965
S N +KI
Sbjct: 150 DE-SRN-VKI 157
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303 | Back alignment and structure |
|---|
Score = 58.9 bits (143), Expect = 2e-09
Identities = 12/68 (17%), Positives = 25/68 (36%), Gaps = 9/68 (13%)
Query: 110 FFEQYDMDLDKAGILGDGSYSVCRRCVEKSTGQEYAVKIISRKIDCSE----EINLLRAC 165
+ ++ +LG G++ + + YA+K I + E+ LL +
Sbjct: 4 YASDFEEI----AVLGQGAFGQVVKARNALDSRYYAIKKIRHTEEKLSTILSEVMLLASL 59
Query: 166 QGHPNICR 173
H + R
Sbjct: 60 N-HQYVVR 66
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303 | Back alignment and structure |
|---|
Score = 54.3 bits (131), Expect = 7e-08
Identities = 20/92 (21%), Positives = 35/92 (38%), Gaps = 12/92 (13%)
Query: 240 SL-IIFFIILSFTLSFIHDYYHIQYRRILKTEPPIPEDL----SPDVADFISRLLVKDPR 294
SL IIFF ++ + S + +I +++ P D I L+ DP
Sbjct: 216 SLGIIFFEMI-YPFSTGMERVNI-LKKLRSVSIEFPPDFDDNKMKVEKKIIRLLIDHDPN 273
Query: 295 RRLGGGELDAEELKRHPFFNVIDWDDLATKRI 326
+R G A L + V D++ + +
Sbjct: 274 KRPG-----ARTLLNSGWLPVKHQDEVIKEAL 300
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303 | Back alignment and structure |
|---|
Score = 53.5 bits (129), Expect = 1e-07
Identities = 9/54 (16%), Positives = 19/54 (35%), Gaps = 5/54 (9%)
Query: 172 CRRCVEKSTGQEYAVKIISRKIDCSE----EINLLRACQGHPNIVNLHCVFQDE 221
+ + YA+K I + E+ LL + H +V + + +
Sbjct: 22 VVKARNALDSRYYAIKKIRHTEEKLSTILSEVMLLASLN-HQYVVRYYAAWLER 74
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 241 bits (618), Expect = 3e-73
Identities = 76/279 (27%), Positives = 119/279 (42%), Gaps = 48/279 (17%)
Query: 386 LGDGSYSVCRRCVEKSTGQEYAVKIISR----KIDCSE----EINLLRACQGHPNIVNLH 437
LG G + EK + A+K++ + K E+ + + HPNI+ L+
Sbjct: 17 LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLR-HPNILRLY 75
Query: 438 CVFQDEVHTYLVLELLKGGELLDRIRQKGRCGFTENEASRIMRQLVAAVHFMHSRGVVHR 497
F D YL+LE G + +++ + F E + + +L A+ + HS+ V+HR
Sbjct: 76 GYFHDATRVYLILEYAPLGTVYRELQKLSK--FDEQRTATYITELANALSYCHSKRVIHR 133
Query: 498 DLKPENLLFSDPAGDNIKVVDFGFACLKRES-LHTPCFTLQYAAPEVLRQDKSGYDENCD 556
D+KPENLL + +K+ DFG++ S C TL Y PE++
Sbjct: 134 DIKPENLLLG--SAGELKIADFGWSVHAPSSRRTDLCGTLDYLPPEMIE----------- 180
Query: 557 LWSLGVILVNVLRQDKSGYDENCDLWSLGVILYTMLCGRVPFHARSRDDSALSIMARIKE 616
+DE DLWSLGV+ Y L G+ PF ++ RI
Sbjct: 181 ---------------GRMHDEKVDLWSLGVLCYEFLVGKPPFE----ANTYQETYKRISR 221
Query: 617 GQFNFDAEAWSTVSSEAKELTKSLLTVNPAQRIRMMRVK 655
+F F V+ A++L LL NP+QR + V
Sbjct: 222 VEFTFP----DFVTEGARDLISRLLKHNPSQRPMLREVL 256
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 100 bits (252), Expect = 1e-23
Identities = 26/70 (37%), Positives = 42/70 (60%), Gaps = 4/70 (5%)
Query: 896 YLVLELLKGGELLDRIRQKGRCGFTENEASRIMRQLVAAVHFMHSRGVVHRDLKPENLLL 955
YL+LE G + +++ + F E + + +L A+ + HS+ V+HRD+KPENLLL
Sbjct: 85 YLILEYAPLGTVYRELQKLSK--FDEQRTATYITELANALSYCHSKRVIHRDIKPENLLL 142
Query: 956 SGISGNLIKI 965
G +G +KI
Sbjct: 143 -GSAGE-LKI 150
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 60.7 bits (148), Expect = 4e-10
Identities = 19/72 (26%), Positives = 32/72 (44%), Gaps = 5/72 (6%)
Query: 242 IIFFIILSFTLSFIHDYYHIQYRRILKTEPPIPEDLSPDVADFISRLLVKDPRRRLGGGE 301
++ + L F + Y Y+RI + E P+ ++ D ISRLL +P +R
Sbjct: 195 VLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVTEGARDLISRLLKHNPSQRPM--- 251
Query: 302 LDAEELKRHPFF 313
E+ HP+
Sbjct: 252 --LREVLEHPWI 261
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 46.1 bits (110), Expect = 3e-05
Identities = 19/98 (19%), Positives = 32/98 (32%), Gaps = 33/98 (33%)
Query: 124 LGDGSYSVCRRCVEKSTGQEYAVKIISRKIDCSEEINLLRACQGHPNICRRCVEKSTGQE 183
LG G + EK + A+K++ + L +A H + R
Sbjct: 17 LGKGKFGNVYLAREKQSKFILALKVLFKA-------QLEKAGVEH-QLRR---------- 58
Query: 184 YAVKIISRKIDCSEEINLLRACQGHPNIVNLHCVFQDE 221
E+ + + HPNI+ L+ F D
Sbjct: 59 --------------EVEIQSHLR-HPNILRLYGYFHDA 81
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434 | Back alignment and structure |
|---|
Score = 246 bits (629), Expect = 8e-73
Identities = 74/318 (23%), Positives = 121/318 (38%), Gaps = 65/318 (20%)
Query: 361 PNFDKIFKGSLFFEQYDMDLDKAGILGDGSYSVCRRCVEKSTGQEYAVKIISRKI--DCS 418
PNF++ K + ILG GS G+ AVK +
Sbjct: 7 PNFEQSLK-----NLVVSE----KILGYGSSGTVVFQ-GSFQGRPVAVKRMLIDFCDIAL 56
Query: 419 EEINLLRACQGHPNIVNLHCVFQDEVHTYLVLELLKGGELLDRIRQKGR-----CGFTEN 473
EI LL HPN++ +C + Y+ LEL L D + K E
Sbjct: 57 MEIKLLTESDDHPNVIRYYCSETTDRFLYIALELC-NLNLQDLVESKNVSDENLKLQKEY 115
Query: 474 EASRIMRQLVAAVHFMHSRGVVHRDLKPENLLFSDPAGD-----------NIKVVDFGFA 522
++RQ+ + V +HS ++HRDLKP+N+L S + I + DFG
Sbjct: 116 NPISLLRQIASGVAHLHSLKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLC 175
Query: 523 -------CLKRESLHTPCFTLQYAAPEVLRQDKSGYDENCDLWSLGVILVNVLRQDKSGY 575
R +L+ P T + APE+L + + Q K
Sbjct: 176 KKLDSGQSSFRTNLNNPSGTSGWRAPELLEESNNL-------------------QTKRRL 216
Query: 576 DENCDLWSLGVILYTMLC-GRVPFHARSRDDSALSIMARIKEGQFNFDA---EAWSTVSS 631
+ D++S+G + Y +L G+ PF + + + I G F+ D ++ +
Sbjct: 217 TRSIDIFSMGCVFYYILSKGKHPFGDKYSRE------SNIIRGIFSLDEMKCLHDRSLIA 270
Query: 632 EAKELTKSLLTVNPAQRI 649
EA +L ++ +P +R
Sbjct: 271 EATDLISQMIDHDPLKRP 288
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434 | Back alignment and structure |
|---|
Score = 91.0 bits (226), Expect = 2e-19
Identities = 22/68 (32%), Positives = 34/68 (50%), Gaps = 6/68 (8%)
Query: 894 HTYLVLELLKGGELLDRIRQKGR-----CGFTENEASRIMRQLVAAVHFMHSRGVVHRDL 948
Y+ LEL L D + K E ++RQ+ + V +HS ++HRDL
Sbjct: 83 FLYIALELC-NLNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHSLKIIHRDL 141
Query: 949 KPENLLLS 956
KP+N+L+S
Sbjct: 142 KPQNILVS 149
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434 | Back alignment and structure |
|---|
Score = 56.3 bits (136), Expect = 3e-08
Identities = 12/47 (25%), Positives = 18/47 (38%), Gaps = 2/47 (4%)
Query: 177 EKSTGQEYAVKIISRKI--DCSEEINLLRACQGHPNIVNLHCVFQDE 221
G+ AVK + EI LL HPN++ +C +
Sbjct: 35 GSFQGRPVAVKRMLIDFCDIALMEIKLLTESDDHPNVIRYYCSETTD 81
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434 | Back alignment and structure |
|---|
Score = 54.0 bits (130), Expect = 1e-07
Identities = 17/53 (32%), Positives = 20/53 (37%), Gaps = 3/53 (5%)
Query: 123 ILGDGSYSVCRRCVEKSTGQEYAVKIISRKI--DCSEEINLLRACQGHPNICR 173
ILG GS G+ AVK + EI LL HPN+ R
Sbjct: 22 ILGYGSSGTVVFQ-GSFQGRPVAVKRMLIDFCDIALMEIKLLTESDDHPNVIR 73
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434 | Back alignment and structure |
|---|
Score = 50.6 bits (121), Expect = 2e-06
Identities = 26/108 (24%), Positives = 47/108 (43%), Gaps = 21/108 (19%)
Query: 242 IIFFIILSFTLSFIHDYYHIQYRRILK-------TEPPIPEDLSPDVADFISRLLVKDPR 294
+F+ ILS D Y + I++ + L + D IS+++ DP
Sbjct: 227 CVFYYILSKGKHPFGDKYSRESN-IIRGIFSLDEMKCLHDRSLIAEATDLISQMIDHDPL 285
Query: 295 RRLGGGELDAEELKRHPFFNVIDWDDLATKRIPAPFVPKISNELDVSN 342
+R A ++ RHP F W +K++ F+ K+S+ L++ N
Sbjct: 286 KR-----PTAMKVLRHPLF----WP--KSKKL--EFLLKVSDRLEIEN 320
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284 | Back alignment and structure |
|---|
Score = 239 bits (612), Expect = 3e-72
Identities = 79/279 (28%), Positives = 114/279 (40%), Gaps = 48/279 (17%)
Query: 386 LGDGSYSVCRRCVEKSTGQEYAVKIISR----KIDCSE----EINLLRACQGHPNIVNLH 437
LG G + EK A+K++ + K EI + + HPNI+ ++
Sbjct: 22 LGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLR-HPNILRMY 80
Query: 438 CVFQDEVHTYLVLELLKGGELLDRIRQKGRCGFTENEASRIMRQLVAAVHFMHSRGVVHR 497
F D YL+LE GEL +++ GR F E ++ M +L A+H+ H R V+HR
Sbjct: 81 NYFHDRKRIYLMLEFAPRGELYKELQKHGR--FDEQRSATFMEELADALHYCHERKVIHR 138
Query: 498 DLKPENLLFSDPAGDNIKVVDFGFACLKRES-LHTPCFTLQYAAPEVLRQDKSGYDENCD 556
D+KPENLL +K+ DFG++ T C TL Y PE++
Sbjct: 139 DIKPENLLMG--YKGELKIADFGWSVHAPSLRRRTMCGTLDYLPPEMIE----------- 185
Query: 557 LWSLGVILVNVLRQDKSGYDENCDLWSLGVILYTMLCGRVPFHARSRDDSALSIMARIKE 616
+DE DLW GV+ Y L G PF S RI
Sbjct: 186 ---------------GKTHDEKVDLWCAGVLCYEFLVGMPPFD----SPSHTETHRRIVN 226
Query: 617 GQFNFDAEAWSTVSSEAKELTKSLLTVNPAQRIRMMRVK 655
F +S +K+L LL +P QR+ + V
Sbjct: 227 VDLKFP----PFLSDGSKDLISKLLRYHPPQRLPLKGVM 261
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284 | Back alignment and structure |
|---|
Score = 101 bits (253), Expect = 1e-23
Identities = 31/70 (44%), Positives = 44/70 (62%), Gaps = 4/70 (5%)
Query: 896 YLVLELLKGGELLDRIRQKGRCGFTENEASRIMRQLVAAVHFMHSRGVVHRDLKPENLLL 955
YL+LE GEL +++ GR F E ++ M +L A+H+ H R V+HRD+KPENLL+
Sbjct: 90 YLMLEFAPRGELYKELQKHGR--FDEQRSATFMEELADALHYCHERKVIHRDIKPENLLM 147
Query: 956 SGISGNLIKI 965
G G +KI
Sbjct: 148 -GYKGE-LKI 155
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284 | Back alignment and structure |
|---|
Score = 69.2 bits (170), Expect = 8e-13
Identities = 20/96 (20%), Positives = 37/96 (38%), Gaps = 11/96 (11%)
Query: 242 IIFFIILSFTLSFIHDYYHIQYRRILKTEPPIPEDLSPDVADFISRLLVKDPRRRLGGGE 301
++ + L F + +RRI+ + P LS D IS+LL P +RL
Sbjct: 200 VLCYEFLVGMPPFDSPSHTETHRRIVNVDLKFPPFLSDGSKDLISKLLRYHPPQRLP--- 256
Query: 302 LDAEELKRHPFFNVIDWDDLATKRIPAPFVPKISNE 337
+ + HP+ ++R+ P ++
Sbjct: 257 --LKGVMEHPWVK------ANSRRVLPPVYQSTQSK 284
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284 | Back alignment and structure |
|---|
Score = 44.1 bits (105), Expect = 1e-04
Identities = 13/53 (24%), Positives = 22/53 (41%), Gaps = 9/53 (16%)
Query: 177 EKSTGQEYAVKIISR----KIDCSE----EINLLRACQGHPNIVNLHCVFQDE 221
EK A+K++ + K EI + + HPNI+ ++ F D
Sbjct: 35 EKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLR-HPNILRMYNYFHDR 86
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343 | Back alignment and structure |
|---|
Score = 239 bits (611), Expect = 2e-71
Identities = 80/348 (22%), Positives = 135/348 (38%), Gaps = 42/348 (12%)
Query: 386 LGDGSYSVCRRCVEKSTGQEYAVKIISRK-IDCSE------EINLLRACQGH-PNIVNLH 437
+G G S + + + Q YA+K ++ + D EI L Q H I+ L+
Sbjct: 17 IGSGGSSKVFQVLNE-KKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLY 75
Query: 438 CVFQDEVHTYLVLELLKGGELLDRIRQKGRCGFTENEASRIMRQLVAAVHFMHSRGVVHR 497
+ + Y+V+E +L +++K E + ++ AVH +H G+VH
Sbjct: 76 DYEITDQYIYMVMEC-GNIDLNSWLKKKKS--IDPWERKSYWKNMLEAVHTIHQHGIVHS 132
Query: 498 DLKPENLLFSDPAGDNIKVVDFGFA-----CLKRESLHTPCFTLQYAAPEVLRQDKSGYD 552
DLKP N L D +K++DFG A + T+ Y PE ++ S +
Sbjct: 133 DLKPANFLIVD---GMLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRE 189
Query: 553 ENCDLWSLGVILVNVLRQDKSGYDENCDLWSLGVILYTMLCGRVPFHARSRDDSALSIMA 612
+ KS D+WSLG ILY M G+ PF + +S +
Sbjct: 190 NG---------------KSKSKISPKSDVWSLGCILYYMTYGKTPFQQ---IINQISKLH 231
Query: 613 RIKEGQFNFDAEAWSTVSSEAKELTKSLLTVNPAQRIRMMRVKLTFHAFHQAQKEGFRLQ 672
I + E + +++ K L +P QRI + +L H + Q Q
Sbjct: 232 AIIDPNHEI--EFPDIPEKDLQDVLKCCLKRDPKQRISI--PELLAHPYVQIQTHPVNQM 287
Query: 673 DVTSAKLAQRRKNKNVSNDNSRSFSSTSSSLSSSSSGTSSLKTPCSST 720
+ + + + V ++ S + +L SG S + S T
Sbjct: 288 AKGTTEEMKYVLGQLVGLNSPNSILKAAKTLYEHYSGGESHNSSSSKT 335
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343 | Back alignment and structure |
|---|
Score = 92.1 bits (229), Expect = 3e-20
Identities = 20/72 (27%), Positives = 36/72 (50%), Gaps = 6/72 (8%)
Query: 894 HTYLVLELLKGGELLDRIRQKGRCGFTENEASRIMRQLVAAVHFMHSRGVVHRDLKPENL 953
+ Y+V+E +L +++K E + ++ AVH +H G+VH DLKP N
Sbjct: 83 YIYMVMEC-GNIDLNSWLKKKKS--IDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANF 139
Query: 954 LLSGISGNLIKI 965
L+ ++K+
Sbjct: 140 LI---VDGMLKL 148
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343 | Back alignment and structure |
|---|
Score = 55.9 bits (135), Expect = 3e-08
Identities = 18/79 (22%), Positives = 29/79 (36%), Gaps = 9/79 (11%)
Query: 240 SL-IIFFIILSFTLSFIHDYYHIQ-YRRILKT--EPPIPEDLSPDVADFISRLLVKDPRR 295
SL I + + F I I+ E P+ D+ D + L +DP++
Sbjct: 205 SLGCILYYMTYGKTPFQQIINQISKLHAIIDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQ 264
Query: 296 RLGGGELDAEELKRHPFFN 314
R + EL HP+
Sbjct: 265 R-----ISIPELLAHPYVQ 278
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361 | Back alignment and structure |
|---|
Score = 239 bits (611), Expect = 4e-71
Identities = 85/276 (30%), Positives = 120/276 (43%), Gaps = 36/276 (13%)
Query: 386 LGDGSYSVCRRCVEKSTGQEYAVKIISRKIDCSE----EINLLRACQGHPNIVNLHCVFQ 441
+G G++ V R +K T + AVK I R E EI R+ + HPNIV V
Sbjct: 28 IGSGNFGVARLMRDKLTKELVAVKYIERGAAIDENVQREIINHRSLR-HPNIVRFKEVIL 86
Query: 442 DEVHTYLVLELLKGGELLDRIRQKGRCGFTENEASRIMRQLVAAVHFMHSRGVVHRDLKP 501
H +++E GGEL +RI GR F+E+EA +QL++ V + HS + HRDLK
Sbjct: 87 TPTHLAIIMEYASGGELYERICNAGR--FSEDEARFFFQQLLSGVSYCHSMQICHRDLKL 144
Query: 502 ENLLFSDPAGDNIKVVDFGFACLKR--ESLHTPCFTLQYAAPEVLRQDKSGYDENCDLWS 559
EN L +K+ DFG++ + T Y APEVL + YD
Sbjct: 145 ENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLL--RQEYD------- 195
Query: 560 LGVILVNVLRQDKSGYDENCDLWSLGVILYTMLCGRVPFHARSRDDSALSIMARIKEGQF 619
G I D+WS GV LY ML G PF + RI ++
Sbjct: 196 -GKIA---------------DVWSCGVTLYVMLVGAYPFEDPEEPRDYRKTIQRILSVKY 239
Query: 620 NFDAEAWSTVSSEAKELTKSLLTVNPAQRIRMMRVK 655
+ + +S E L + +PA RI + +K
Sbjct: 240 SIPDDIR--ISPECCHLISRIFVADPATRISIPEIK 273
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361 | Back alignment and structure |
|---|
Score = 106 bits (267), Expect = 6e-25
Identities = 31/72 (43%), Positives = 43/72 (59%), Gaps = 2/72 (2%)
Query: 894 HTYLVLELLKGGELLDRIRQKGRCGFTENEASRIMRQLVAAVHFMHSRGVVHRDLKPENL 953
H +++E GGEL +RI GR F+E+EA +QL++ V + HS + HRDLK EN
Sbjct: 90 HLAIIMEYASGGELYERICNAGR--FSEDEARFFFQQLLSGVSYCHSMQICHRDLKLENT 147
Query: 954 LLSGISGNLIKI 965
LL G +KI
Sbjct: 148 LLDGSPAPRLKI 159
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361 | Back alignment and structure |
|---|
Score = 49.7 bits (119), Expect = 2e-06
Identities = 31/152 (20%), Positives = 57/152 (37%), Gaps = 21/152 (13%)
Query: 242 IIFFIILSFTLSF----IHDYYHIQYRRILKTEPPIPED--LSPDVADFISRLLVKDPRR 295
+ +++L F Y +RIL + IP+D +SP+ ISR+ V DP
Sbjct: 206 VTLYVMLVGAYPFEDPEEPRDYRKTIQRILSVKYSIPDDIRISPECCHLISRIFVADPAT 265
Query: 296 RLGGGELDAEELKRHPFFNVIDWDDLATKRIPAPFVPKISNELDVSNFSDEFTKMIPADS 355
R + E+K H +F +L + E + S + I +++
Sbjct: 266 R-----ISIPEIKTHSWFLK----NLPADLMNESNTGSQFQEPEQPMQSLDTIMQIISEA 316
Query: 356 --PAIVPPNFDKIFKGSL----FFEQYDMDLD 381
PA+ D +L + +D + +
Sbjct: 317 TIPAVRNRCLDDFMTDNLDLDDDMDDFDSESE 348
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361 | Back alignment and structure |
|---|
Score = 44.7 bits (106), Expect = 1e-04
Identities = 20/54 (37%), Positives = 27/54 (50%), Gaps = 5/54 (9%)
Query: 124 LGDGSYSVCRRCVEKSTGQEYAVKIISRKIDCSE----EINLLRACQGHPNICR 173
+G G++ V R +K T + AVK I R E EI R+ + HPNI R
Sbjct: 28 IGSGNFGVARLMRDKLTKELVAVKYIERGAAIDENVQREIINHRSLR-HPNIVR 80
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276 | Back alignment and structure |
|---|
Score = 234 bits (598), Expect = 2e-70
Identities = 87/283 (30%), Positives = 127/283 (44%), Gaps = 50/283 (17%)
Query: 386 LGDGSYSVCRRCVEKSTGQEYAVKIISRK--IDCSE----EINLLRACQGHPNIVNLHCV 439
LG+G+Y + V + T + AVKI+ K +DC E EI + + H N+V +
Sbjct: 15 LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLN-HENVVKFYGH 73
Query: 440 FQDEVHTYLVLELLKGGELLDRIRQKGRCGFTENEASRIMRQLVAAVHFMHSRGVVHRDL 499
++ YL LE GGEL DRI E +A R QL+A V ++H G+ HRD+
Sbjct: 74 RREGNIQYLFLEYCSGGELFDRIEPDIG--MPEPDAQRFFHQLMAGVVYLHGIGITHRDI 131
Query: 500 KPENLLFSDPAGDNIKVVDFGFACL-----KRESLHTPCFTLQYAAPEVLRQDKSGYDEN 554
KPENLL D DN+K+ DFG A + + L+ C TL Y APE+L+
Sbjct: 132 KPENLLL-D-ERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLK--------- 180
Query: 555 CDLWSLGVILVNVLRQDKSGYD-ENCDLWSLGVILYTMLCGRVPFHARSRDDSALSIMAR 613
+ + E D+WS G++L ML G +P+ S
Sbjct: 181 -----------------RREFHAEPVDVWSCGIVLTAMLAGELPWD----QPSDSCQEYS 219
Query: 614 -IKEGQFNFDAEAWSTVSSEAKELTKSLLTVNPAQRIRMMRVK 655
KE + + W + S L +L NP+ RI + +K
Sbjct: 220 DWKEKKTYLN--PWKKIDSAPLALLHKILVENPSARITIPDIK 260
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276 | Back alignment and structure |
|---|
Score = 105 bits (264), Expect = 3e-25
Identities = 33/72 (45%), Positives = 40/72 (55%), Gaps = 4/72 (5%)
Query: 894 HTYLVLELLKGGELLDRIRQKGRCGFTENEASRIMRQLVAAVHFMHSRGVVHRDLKPENL 953
YL LE GGEL DRI E +A R QL+A V ++H G+ HRD+KPENL
Sbjct: 79 IQYLFLEYCSGGELFDRIEPDIG--MPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENL 136
Query: 954 LLSGISGNLIKI 965
LL N +KI
Sbjct: 137 LLDE-RDN-LKI 146
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276 | Back alignment and structure |
|---|
Score = 49.1 bits (118), Expect = 3e-06
Identities = 11/76 (14%), Positives = 31/76 (40%), Gaps = 8/76 (10%)
Query: 242 IIFFIILSFTLSFIHDYYHIQ-YRRILKTEPPIP--EDLSPDVADFISRLLVKDPRRRLG 298
I+ +L+ L + Q Y + + + + + + ++LV++P R
Sbjct: 196 IVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPLALLHKILVENPSAR-- 253
Query: 299 GGELDAEELKRHPFFN 314
+ ++K+ ++N
Sbjct: 254 ---ITIPDIKKDRWYN 266
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276 | Back alignment and structure |
|---|
Score = 44.1 bits (105), Expect = 1e-04
Identities = 18/56 (32%), Positives = 29/56 (51%), Gaps = 7/56 (12%)
Query: 124 LGDGSYSVCRRCVEKSTGQEYAVKIISRK--IDCSE----EINLLRACQGHPNICR 173
LG+G+Y + V + T + AVKI+ K +DC E EI + + H N+ +
Sbjct: 15 LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLN-HENVVK 69
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313 | Back alignment and structure |
|---|
Score = 233 bits (597), Expect = 8e-70
Identities = 68/277 (24%), Positives = 111/277 (40%), Gaps = 40/277 (14%)
Query: 386 LGDGSYSVCRRCVEKSTGQEYAVKIISR-KIDCSE------EINLLRACQGH-PNIVNLH 437
+G G S + + + Q YA+K ++ + D EI L Q H I+ L+
Sbjct: 36 IGSGGSSKVFQVLNE-KKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLY 94
Query: 438 CVFQDEVHTYLVLELLKGGELLDRIRQKGRCGFTENEASRIMRQLVAAVHFMHSRGVVHR 497
+ + Y+V+E +L +++K E + ++ AVH +H G+VH
Sbjct: 95 DYEITDQYIYMVMEC-GNIDLNSWLKKKKS--IDPWERKSYWKNMLEAVHTIHQHGIVHS 151
Query: 498 DLKPENLLFSDPAGDNIKVVDFGFA-----CLKRESLHTPCFTLQYAAPEVLRQDKSGYD 552
DLKP N L D +K++DFG A + T+ Y PE ++ S +
Sbjct: 152 DLKPANFLIVD---GMLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRE 208
Query: 553 ENCDLWSLGVILVNVLRQDKSGYDENCDLWSLGVILYTMLCGRVPFHARSRDDSALSIMA 612
+ KS D+WSLG ILY M G+ PF + +S +
Sbjct: 209 NG---------------KSKSKISPKSDVWSLGCILYYMTYGKTPFQQ---IINQISKLH 250
Query: 613 RIKEGQFNFDAEAWSTVSSEAKELTKSLLTVNPAQRI 649
I + E + +++ K L +P QRI
Sbjct: 251 AIIDPNHEI--EFPDIPEKDLQDVLKCCLKRDPKQRI 285
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313 | Back alignment and structure |
|---|
Score = 93.1 bits (232), Expect = 1e-20
Identities = 20/72 (27%), Positives = 36/72 (50%), Gaps = 6/72 (8%)
Query: 894 HTYLVLELLKGGELLDRIRQKGRCGFTENEASRIMRQLVAAVHFMHSRGVVHRDLKPENL 953
+ Y+V+E +L +++K E + ++ AVH +H G+VH DLKP N
Sbjct: 102 YIYMVMEC-GNIDLNSWLKKKKS--IDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANF 158
Query: 954 LLSGISGNLIKI 965
L+ ++K+
Sbjct: 159 LI---VDGMLKL 167
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313 | Back alignment and structure |
|---|
Score = 55.4 bits (134), Expect = 3e-08
Identities = 18/80 (22%), Positives = 30/80 (37%), Gaps = 9/80 (11%)
Query: 240 SL-IIFFIILSFTLSFIHDYYHIQ-YRRILKT--EPPIPEDLSPDVADFISRLLVKDPRR 295
SL I + + F I I+ E P+ D+ D + L +DP++
Sbjct: 224 SLGCILYYMTYGKTPFQQIINQISKLHAIIDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQ 283
Query: 296 RLGGGELDAEELKRHPFFNV 315
R + EL HP+ +
Sbjct: 284 R-----ISIPELLAHPYVQI 298
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313 | Back alignment and structure |
|---|
Score = 41.9 bits (99), Expect = 6e-04
Identities = 15/58 (25%), Positives = 23/58 (39%), Gaps = 9/58 (15%)
Query: 124 LGDGSYSVCRRCVEKSTGQEYAVKIISR-KIDCSE------EINLLRACQGH-PNICR 173
+G G S + + + Q YA+K ++ + D EI L Q H I R
Sbjct: 36 IGSGGSSKVFQVLNE-KKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIR 92
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432 | Back alignment and structure |
|---|
Score = 237 bits (607), Expect = 1e-69
Identities = 64/279 (22%), Positives = 107/279 (38%), Gaps = 47/279 (16%)
Query: 385 ILGDGSY-SVCRRCVEKSTGQEYAVKIISRK-IDCSE-EINLLRACQGHPNIVNLHCVFQ 441
+LG G+ ++ R ++ AVK I + ++ E+ LLR HPN++ C +
Sbjct: 31 VLGHGAEGTIVYRG--MFDNRDVAVKRILPECFSFADREVQLLRESDEHPNVIRYFCTEK 88
Query: 442 DEVHTYLVLELLKGGELLDRIRQKGRCGFTENEASRIMRQLVAAVHFMHSRGVVHRDLKP 501
D Y+ +EL L + + QK E +++Q + + +HS +VHRDLKP
Sbjct: 89 DRQFQYIAIELC-AATLQEYVEQKDF-AHLGLEPITLLQQTTSGLAHLHSLNIVHRDLKP 146
Query: 502 ENLLFSDPAGD---NIKVVDFGFAC------LKRESLHTPCFTLQYAAPEVLRQDKSGYD 552
N+L S P + DFG T + APE+L +D
Sbjct: 147 HNILISMPNAHGKIKAMISDFGLCKKLAVGRHSFSRRSGVPGTEGWIAPEMLSEDC---- 202
Query: 553 ENCDLWSLGVILVNVLRQDKSGYDENCDLWSLGVILYTMLC-GRVPFHARSRDDSALSIM 611
K D++S G + Y ++ G PF +
Sbjct: 203 -------------------KENPTYTVDIFSAGCVFYYVISEGSHPFGKSLQRQ------ 237
Query: 612 ARIKEGQFNFDA-EAWSTVSSEAKELTKSLLTVNPAQRI 649
A I G + D A+EL + ++ ++P +R
Sbjct: 238 ANILLGACSLDCLHPEKHEDVIARELIEKMIAMDPQKRP 276
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432 | Back alignment and structure |
|---|
Score = 90.6 bits (225), Expect = 3e-19
Identities = 20/63 (31%), Positives = 33/63 (52%), Gaps = 2/63 (3%)
Query: 894 HTYLVLELLKGGELLDRIRQKGRCGFTENEASRIMRQLVAAVHFMHSRGVVHRDLKPENL 953
Y+ +EL L + + QK E +++Q + + +HS +VHRDLKP N+
Sbjct: 92 FQYIAIELC-AATLQEYVEQKDF-AHLGLEPITLLQQTTSGLAHLHSLNIVHRDLKPHNI 149
Query: 954 LLS 956
L+S
Sbjct: 150 LIS 152
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432 | Back alignment and structure |
|---|
Score = 59.8 bits (145), Expect = 2e-09
Identities = 13/49 (26%), Positives = 22/49 (44%), Gaps = 2/49 (4%)
Query: 175 CVEKSTGQEYAVKIISRK-IDCSE-EINLLRACQGHPNIVNLHCVFQDE 221
++ AVK I + ++ E+ LLR HPN++ C +D
Sbjct: 42 YRGMFDNRDVAVKRILPECFSFADREVQLLRESDEHPNVIRYFCTEKDR 90
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432 | Back alignment and structure |
|---|
Score = 55.2 bits (133), Expect = 6e-08
Identities = 23/155 (14%), Positives = 54/155 (34%), Gaps = 17/155 (10%)
Query: 221 EVIDWDDFSR-GIECVFFSSSLIIFFIILSFTLSFIHDYYHIQYRRILK---TEPPIPED 276
E++ D FS+ + +++I + F + +
Sbjct: 196 EMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKSLQRQANILLGACSLDCLHPEKH 255
Query: 277 LSPDVADFISRLLVKDPRRRLGGGELDAEELKRHPFFNVIDWDDLATKRIPAPFVPKISN 336
+ I +++ DP++R A+ + +HPFF W K++ F +S+
Sbjct: 256 EDVIARELIEKMIAMDPQKR-----PSAKHVLKHPFF----WS--LEKQL--QFFQDVSD 302
Query: 337 ELDVSNFSDEFTKMIPADSPAIVPPNFDKIFKGSL 371
++ + K + A+V ++ + L
Sbjct: 303 RIEKESLDGPIVKQLERGGRAVVKMDWRENITVPL 337
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432 | Back alignment and structure |
|---|
Score = 54.8 bits (132), Expect = 9e-08
Identities = 20/66 (30%), Positives = 32/66 (48%), Gaps = 6/66 (9%)
Query: 123 ILGDGSY-SVCRRCVEKSTGQEYAVKIISRK-IDCSE-EINLLRACQGHPNICR-RCVEK 178
+LG G+ ++ R ++ AVK I + ++ E+ LLR HPN+ R C EK
Sbjct: 31 VLGHGAEGTIVYRG--MFDNRDVAVKRILPECFSFADREVQLLRESDEHPNVIRYFCTEK 88
Query: 179 STGQEY 184
+Y
Sbjct: 89 DRQFQY 94
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323 | Back alignment and structure |
|---|
Score = 232 bits (595), Expect = 2e-69
Identities = 97/340 (28%), Positives = 152/340 (44%), Gaps = 51/340 (15%)
Query: 386 LGDGSYSVCRRCVEKSTGQEYAVKIISRK--IDCSE----EINLLRACQGHPNIVNLHCV 439
LG+G+Y + V + T + AVKI+ K +DC E EI + + H N+V +
Sbjct: 15 LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLN-HENVVKFYGH 73
Query: 440 FQDEVHTYLVLELLKGGELLDRIRQKGRCGFTENEASRIMRQLVAAVHFMHSRGVVHRDL 499
++ YL LE GGEL DRI E +A R QL+A V ++H G+ HRD+
Sbjct: 74 RREGNIQYLFLEYCSGGELFDRIEPDIG--MPEPDAQRFFHQLMAGVVYLHGIGITHRDI 131
Query: 500 KPENLLFSDPAGDNIKVVDFGFACL-----KRESLHTPCFTLQYAAPEVLRQDKSGYDEN 554
KPENLL D DN+K+ DFG A + + L+ C TL Y APE+L+
Sbjct: 132 KPENLLL-D-ERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLK--------- 180
Query: 555 CDLWSLGVILVNVLRQDKSGYD-ENCDLWSLGVILYTMLCGRVPFHARSRDDSALSIMAR 613
+ + E D+WS G++L ML G +P+ DS
Sbjct: 181 -----------------RREFHAEPVDVWSCGIVLTAMLAGELPWD--QPSDSCQEYSDW 221
Query: 614 IKEGQFNFDAEAWSTVSSEAKELTKSLLTVNPAQRIRMMRVKLTFHA-FHQAQKEGFRLQ 672
++ + W + S L +L NP+ RI + +K +++ K+G +
Sbjct: 222 KEKKTYLNP---WKKIDSAPLALLHKILVENPSARITIPDIKK--DRWYNKPLKKGAKRP 276
Query: 673 DVTSAKLAQRRKNKNVSNDNSRSFSSTSSSLSSSSSGTSS 712
VTS +++ + ++ FS +S+ + SG S
Sbjct: 277 RVTSGGVSESPSGFSKHIQSNLDFSPVNSASRTPGSGWSK 316
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323 | Back alignment and structure |
|---|
Score = 105 bits (264), Expect = 9e-25
Identities = 33/72 (45%), Positives = 40/72 (55%), Gaps = 4/72 (5%)
Query: 894 HTYLVLELLKGGELLDRIRQKGRCGFTENEASRIMRQLVAAVHFMHSRGVVHRDLKPENL 953
YL LE GGEL DRI E +A R QL+A V ++H G+ HRD+KPENL
Sbjct: 79 IQYLFLEYCSGGELFDRIEPDIG--MPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENL 136
Query: 954 LLSGISGNLIKI 965
LL N +KI
Sbjct: 137 LLDE-RDN-LKI 146
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323 | Back alignment and structure |
|---|
Score = 50.0 bits (120), Expect = 2e-06
Identities = 19/139 (13%), Positives = 49/139 (35%), Gaps = 18/139 (12%)
Query: 242 IIFFIILSFTLSFIHDYYHIQ-YRRILKTEPPIP--EDLSPDVADFISRLLVKDPRRRLG 298
I+ +L+ L + Q Y + + + + + + ++LV++P R
Sbjct: 196 IVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPLALLHKILVENPSAR-- 253
Query: 299 GGELDAEELKRHPFFNVIDWDDLATKRIPAPFVPKISNELDVSNFSDEFTKMIPADSPAI 358
+ ++K+ ++N K + VS F+K I ++
Sbjct: 254 ---ITIPDIKKDRWYN---------KPLKKGAKRPRVTSGGVSESPSGFSKHIQSNLDFS 301
Query: 359 VPPNFDKIFKGSLFFEQYD 377
+ + GS + +++
Sbjct: 302 PVNSASRT-PGSGWSKEHH 319
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323 | Back alignment and structure |
|---|
Score = 43.8 bits (104), Expect = 2e-04
Identities = 18/56 (32%), Positives = 29/56 (51%), Gaps = 7/56 (12%)
Query: 124 LGDGSYSVCRRCVEKSTGQEYAVKIISRK--IDCSE----EINLLRACQGHPNICR 173
LG+G+Y + V + T + AVKI+ K +DC E EI + + H N+ +
Sbjct: 15 LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLN-HENVVK 69
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 231 bits (590), Expect = 5e-69
Identities = 73/306 (23%), Positives = 131/306 (42%), Gaps = 71/306 (23%)
Query: 386 LGDGSYSVCRRCVEKSTGQEYAVKIISR-KIDCS-------------------------- 418
+G GSY V + ++ YA+K++S+ K+
Sbjct: 21 IGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPI 80
Query: 419 ----EEINLLRACQGHPNIVNLHCVFQD--EVHTYLVLELLKGGELLDRIRQKGRCGFTE 472
+EI +L+ HPN+V L V D E H Y+V EL+ G +++ + +E
Sbjct: 81 EQVYQEIAILKKLD-HPNVVKLVEVLDDPNEDHLYMVFELVNQGPVME-VPTLKP--LSE 136
Query: 473 NEASRIMRQLVAAVHFMHSRGVVHRDLKPENLLFSDPAGDNIKVVDFGFACLKRES---L 529
++A + L+ + ++H + ++HRD+KP NLL + +IK+ DFG + + S L
Sbjct: 137 DQARFYFQDLIKGIEYLHYQKIIHRDIKPSNLLVGE--DGHIKIADFGVSNEFKGSDALL 194
Query: 530 HTPCFTLQYAAPEVLRQDKSGYDENCDLWSLGVILVNVLRQDKSGYDENCDLWSLGVILY 589
T + APE L + + + G + D+W++GV LY
Sbjct: 195 SNTVGTPAFMAPESLSETRKIFS--------G---------------KALDVWAMGVTLY 231
Query: 590 TMLCGRVPFHARSRDDSALSIMARIKEGQFNFDAEAWSTVSSEAKELTKSLLTVNPAQRI 649
+ G+ PF D+ + + ++IK F ++ + K+L +L NP RI
Sbjct: 232 CFVFGQCPFM----DERIMCLHSKIKSQALEF--PDQPDIAEDLKDLITRMLDKNPESRI 285
Query: 650 RMMRVK 655
+ +K
Sbjct: 286 VVPEIK 291
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 98.5 bits (246), Expect = 1e-22
Identities = 22/72 (30%), Positives = 42/72 (58%), Gaps = 5/72 (6%)
Query: 894 HTYLVLELLKGGELLDRIRQKGRCGFTENEASRIMRQLVAAVHFMHSRGVVHRDLKPENL 953
H Y+V EL+ G +++ + +E++A + L+ + ++H + ++HRD+KP NL
Sbjct: 112 HLYMVFELVNQGPVME-VPTLKP--LSEDQARFYFQDLIKGIEYLHYQKIIHRDIKPSNL 168
Query: 954 LLSGISGNLIKI 965
L+ G+ IKI
Sbjct: 169 LVGE-DGH-IKI 178
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 55.0 bits (133), Expect = 4e-08
Identities = 23/97 (23%), Positives = 37/97 (38%), Gaps = 10/97 (10%)
Query: 124 LGDGSYSVCRRCVEKSTGQEYAVKIISRKIDCSEEINLLRACQGHPNICRRCVEKSTGQE 183
+G GSY V + ++ YA+K++S+K + R + G
Sbjct: 21 IGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPI 80
Query: 184 YAVKIISRKIDCSEEINLLRACQGHPNIVNLHCVFQD 220
V +EI +L+ HPN+V L V D
Sbjct: 81 EQVY---------QEIAILKKLD-HPNVVKLVEVLDD 107
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 53.4 bits (129), Expect = 1e-07
Identities = 16/75 (21%), Positives = 33/75 (44%), Gaps = 7/75 (9%)
Query: 242 IIFFIILSFTLSFIHDYYHIQYRRILKTEPPIPE--DLSPDVADFISRLLVKDPRRRLGG 299
+ + + F+ + + +I P+ D++ D+ D I+R+L K+P R
Sbjct: 228 VTLYCFVFGQCPFMDERIMCLHSKIKSQALEFPDQPDIAEDLKDLITRMLDKNPESR--- 284
Query: 300 GELDAEELKRHPFFN 314
+ E+K HP+
Sbjct: 285 --IVVPEIKLHPWVT 297
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312 | Back alignment and structure |
|---|
Score = 230 bits (589), Expect = 1e-68
Identities = 75/281 (26%), Positives = 111/281 (39%), Gaps = 60/281 (21%)
Query: 386 LGDGSYSVCRRCVEKSTGQEYAVKIISR-KIDCSE----------EIN---LLRACQGHP 431
LG G + + + A+K+I R ++ E+ + A GHP
Sbjct: 39 LGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHP 98
Query: 432 NIVNLHCVFQDEVHTYLVLEL-LKGGELLDRIRQKGRCGFTENEASRIMRQLVAAVHFMH 490
++ L F+ + LVLE L +L D I +KG E + Q+VAA+ H
Sbjct: 99 GVIRLLDWFETQEGFMLVLERPLPAQDLFDYITEKGP--LGEGPSRCFFGQVVAAIQHCH 156
Query: 491 SRGVVHRDLKPENLLFSDPAGDNIKVVDFGF-ACLKRESLHTPCFTLQYAAPEVLRQDKS 549
SRGVVHRD+K EN+L D K++DFG A L E T Y+ PE +
Sbjct: 157 SRGVVHRDIKDENILI-DLRRGCAKLIDFGSGALLHDEPYTDFDGTRVYSPPEWIS---- 211
Query: 550 GYDENCDLWSLGVILVNVLRQDKSGYD-ENCDLWSLGVILYTMLCGRVPFHARSRDDSAL 608
+ Y +WSLG++LY M+CG +PF
Sbjct: 212 ----------------------RHQYHALPATVWSLGILLYDMVCGDIPFERDQ------ 243
Query: 609 SIMARIKEGQFNFDAEAWSTVSSEAKELTKSLLTVNPAQRI 649
I E + +F + VS + L + L P+ R
Sbjct: 244 ----EILEAELHFP----AHVSPDCCALIRRCLAPKPSSRP 276
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312 | Back alignment and structure |
|---|
Score = 104 bits (262), Expect = 1e-24
Identities = 30/73 (41%), Positives = 39/73 (53%), Gaps = 4/73 (5%)
Query: 894 HTYLVLEL-LKGGELLDRIRQKGRCGFTENEASRIMRQLVAAVHFMHSRGVVHRDLKPEN 952
LVLE L +L D I +KG E + Q+VAA+ HSRGVVHRD+K EN
Sbjct: 112 GFMLVLERPLPAQDLFDYITEKGP--LGEGPSRCFFGQVVAAIQHCHSRGVVHRDIKDEN 169
Query: 953 LLLSGISGNLIKI 965
+L+ G K+
Sbjct: 170 ILIDLRRGC-AKL 181
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312 | Back alignment and structure |
|---|
Score = 47.7 bits (114), Expect = 9e-06
Identities = 20/88 (22%), Positives = 30/88 (34%), Gaps = 11/88 (12%)
Query: 242 IIFFIILSFTLSFIHDYYHIQYRRILKTEPPIPEDLSPDVADFISRLLVKDPRRRLGGGE 301
I+ + ++ + F D + IL+ E P +SPD I R L P R
Sbjct: 227 ILLYDMVCGDIPFERD------QEILEAELHFPAHVSPDCCALIRRCLAPKPSSR----- 275
Query: 302 LDAEELKRHPFFNVIDWDDLATKRIPAP 329
EE+ P+ D P
Sbjct: 276 PSLEEILLDPWMQTPAEDVPLNPSKGGP 303
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312 | Back alignment and structure |
|---|
Score = 41.5 bits (98), Expect = 9e-04
Identities = 17/95 (17%), Positives = 30/95 (31%), Gaps = 18/95 (18%)
Query: 93 KRPNTSNLIACKFKGSLFFEQYDMDLDKAGILGDGSYSVCRRCVEKSTGQEYAVKIISR- 151
P T F +Y + +LG G + + + A+K+I R
Sbjct: 12 APPGTPTPPPGGKDREAFEAEYRLG----PLLGKGGFGTVFAGHRLTDRLQVAIKVIPRN 67
Query: 152 KIDCSE----------EIN---LLRACQGHPNICR 173
++ E+ + A GHP + R
Sbjct: 68 RVLGWSPLSDSVTCPLEVALLWKVGAGGGHPGVIR 102
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390 | Back alignment and structure |
|---|
Score = 233 bits (595), Expect = 1e-68
Identities = 80/355 (22%), Positives = 135/355 (38%), Gaps = 42/355 (11%)
Query: 386 LGDGSYSVCRRCVEKSTGQEYAVKIISRK-IDCSE------EINLLRACQGH-PNIVNLH 437
+G G S + + + Q YA+K ++ + D EI L Q H I+ L+
Sbjct: 64 IGSGGSSKVFQVLNE-KKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLY 122
Query: 438 CVFQDEVHTYLVLELLKGGELLDRIRQKGRCGFTENEASRIMRQLVAAVHFMHSRGVVHR 497
+ + Y+V+E +L +++K E + ++ AVH +H G+VH
Sbjct: 123 DYEITDQYIYMVMEC-GNIDLNSWLKKKKS--IDPWERKSYWKNMLEAVHTIHQHGIVHS 179
Query: 498 DLKPENLLFSDPAGDNIKVVDFGFA-----CLKRESLHTPCFTLQYAAPEVLRQDKSGYD 552
DLKP N L D +K++DFG A + + Y PE ++ S +
Sbjct: 180 DLKPANFLIVD---GMLKLIDFGIANQMQPDTTSVVKDSQVGAVNYMPPEAIKDMSSSRE 236
Query: 553 ENCDLWSLGVILVNVLRQDKSGYDENCDLWSLGVILYTMLCGRVPFHARSRDDSALSIMA 612
+ KS D+WSLG ILY M G+ PF + +S +
Sbjct: 237 NG---------------KSKSKISPKSDVWSLGCILYYMTYGKTPFQQ---IINQISKLH 278
Query: 613 RIKEGQFNFDAEAWSTVSSEAKELTKSLLTVNPAQRIRMMRVKLTFHAFHQAQKEGFRLQ 672
I + E + +++ K L +P QRI + +L H + Q Q
Sbjct: 279 AIIDPNHEI--EFPDIPEKDLQDVLKCCLKRDPKQRISIP--ELLAHPYVQIQTHPVNQM 334
Query: 673 DVTSAKLAQRRKNKNVSNDNSRSFSSTSSSLSSSSSGTSSLKTPCSSTQPSVPSK 727
+ + + + V ++ S + +L SG S + S T K
Sbjct: 335 AKGTTEEMKYVLGQLVGLNSPNSILKAAKTLYEHYSGGESHNSSSSKTFEKKRGK 389
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390 | Back alignment and structure |
|---|
Score = 90.6 bits (225), Expect = 2e-19
Identities = 20/72 (27%), Positives = 36/72 (50%), Gaps = 6/72 (8%)
Query: 894 HTYLVLELLKGGELLDRIRQKGRCGFTENEASRIMRQLVAAVHFMHSRGVVHRDLKPENL 953
+ Y+V+E +L +++K E + ++ AVH +H G+VH DLKP N
Sbjct: 130 YIYMVMEC-GNIDLNSWLKKKKS--IDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANF 186
Query: 954 LLSGISGNLIKI 965
L+ ++K+
Sbjct: 187 LI---VDGMLKL 195
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390 | Back alignment and structure |
|---|
Score = 55.2 bits (133), Expect = 5e-08
Identities = 21/116 (18%), Positives = 38/116 (32%), Gaps = 9/116 (7%)
Query: 240 SL-IIFFIILSFTLSFIHDYYHIQ-YRRILKT--EPPIPEDLSPDVADFISRLLVKDPRR 295
SL I + + F I I+ E P+ D+ D + L +DP++
Sbjct: 252 SLGCILYYMTYGKTPFQQIINQISKLHAIIDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQ 311
Query: 296 RLGGGELDAEELKRHPFFNVIDWDDLATKRIPAPFVPKISNELDVSNFSDEFTKMI 351
R + EL HP+ + + + + +L N + K
Sbjct: 312 R-----ISIPELLAHPYVQIQTHPVNQMAKGTTEEMKYVLGQLVGLNSPNSILKAA 362
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328 | Back alignment and structure |
|---|
Score = 230 bits (589), Expect = 2e-68
Identities = 88/281 (31%), Positives = 135/281 (48%), Gaps = 51/281 (18%)
Query: 386 LGDGSYSVCRRCVEKSTGQEYAVKIISR-KIDCSE------EINLLRACQGHPNIVNLHC 438
+G G+++ + TG+E A+KII + +++ + E+ +++ HPNIV L
Sbjct: 23 IGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILN-HPNIVKLFE 81
Query: 439 VFQDEVHTYLVLELLKGGELLDRIRQKGRCGFTENEASRIMRQLVAAVHFMHSRGVVHRD 498
V + E YL++E GGE+ D + GR E EA RQ+V+AV + H + +VHRD
Sbjct: 82 VIETEKTLYLIMEYASGGEVFDYLVAHGR--MKEKEARSKFRQIVSAVQYCHQKRIVHRD 139
Query: 499 LKPENLLFSDPAGDNIKVVDFGFACLKR--ESLHTPCFTLQYAAPEVLRQDKSGYDENCD 556
LK ENLL A NIK+ DFGF+ L C YAAPE+ + K
Sbjct: 140 LKAENLLLD--ADMNIKIADFGFSNEFTVGGKLDAFCGAPPYAAPELFQGKK-------- 189
Query: 557 LWSLGVILVNVLRQDKSGYD-ENCDLWSLGVILYTMLCGRVPFHARSRDDSALSIM-ARI 614
YD D+WSLGVILYT++ G +PF D L + R+
Sbjct: 190 ------------------YDGPEVDVWSLGVILYTLVSGSLPF-----DGQNLKELRERV 226
Query: 615 KEGQFNFDAEAWSTVSSEAKELTKSLLTVNPAQRIRMMRVK 655
G++ +S++ + L K L +NP +R + ++
Sbjct: 227 LRGKYRIP----FYMSTDCENLLKRFLVLNPIKRGTLEQIM 263
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328 | Back alignment and structure |
|---|
Score = 103 bits (260), Expect = 3e-24
Identities = 33/72 (45%), Positives = 42/72 (58%), Gaps = 4/72 (5%)
Query: 894 HTYLVLELLKGGELLDRIRQKGRCGFTENEASRIMRQLVAAVHFMHSRGVVHRDLKPENL 953
YL++E GGE+ D + GR E EA RQ+V+AV + H + +VHRDLK ENL
Sbjct: 88 TLYLIMEYASGGEVFDYLVAHGR--MKEKEARSKFRQIVSAVQYCHQKRIVHRDLKAENL 145
Query: 954 LLSGISGNLIKI 965
LL N IKI
Sbjct: 146 LLDA-DMN-IKI 155
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328 | Back alignment and structure |
|---|
Score = 55.4 bits (134), Expect = 3e-08
Identities = 17/74 (22%), Positives = 34/74 (45%), Gaps = 5/74 (6%)
Query: 242 IIFFIILSFTLSFIHDYYHIQYRRILKTEPPIPEDLSPDVADFISRLLVKDPRRRLGGGE 301
+I + ++S +L F R+L+ + IP +S D + + R LV +P +R
Sbjct: 202 VILYTLVSGSLPFDGQNLKELRERVLRGKYRIPFYMSTDCENLLKRFLVLNPIKR----- 256
Query: 302 LDAEELKRHPFFNV 315
E++ + + N
Sbjct: 257 GTLEQIMKDRWINA 270
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328 | Back alignment and structure |
|---|
Score = 42.7 bits (101), Expect = 4e-04
Identities = 14/57 (24%), Positives = 31/57 (54%), Gaps = 8/57 (14%)
Query: 124 LGDGSYSVCRRCVEKSTGQEYAVKIISR-KIDCSE------EINLLRACQGHPNICR 173
+G G+++ + TG+E A+KII + +++ + E+ +++ HPNI +
Sbjct: 23 IGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILN-HPNIVK 78
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276 | Back alignment and structure |
|---|
Score = 227 bits (580), Expect = 8e-68
Identities = 89/282 (31%), Positives = 134/282 (47%), Gaps = 52/282 (18%)
Query: 386 LGDGSYSVCRRCVEKSTGQEYAVKIISR-KIDCSE-------EINLLRACQGHPNIVNLH 437
LG G++ + + TG + AVKI++R KI + EI L+ + HP+I+ L+
Sbjct: 19 LGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFR-HPHIIKLY 77
Query: 438 CVFQDEVHTYLVLELLKGGELLDRIRQKGRCGFTENEASRIMRQLVAAVHFMHSRGVVHR 497
V ++V+E + GGEL D I + GR E EA R+ +Q+++AV + H VVHR
Sbjct: 78 QVISTPTDFFMVMEYVSGGELFDYICKHGR--VEEMEARRLFQQILSAVDYCHRHMVVHR 135
Query: 498 DLKPENLLFSDPAGDNIKVVDFGFACLKR--ESLHTPCFTLQYAAPEVLRQDKSGYDENC 555
DLKPEN+L D N K+ DFG + + E L T C + YAAPEV+
Sbjct: 136 DLKPENVLL-DAHM-NAKIADFGLSNMMSDGEFLRTSCGSPNYAAPEVIS---------- 183
Query: 556 DLWSLGVILVNVLRQDKSGYD-ENCDLWSLGVILYTMLCGRVPFHARSRDDSALSIM-AR 613
Y D+WS GVILY +LCG +PF DD + + +
Sbjct: 184 ----------------GRLYAGPEVDIWSCGVILYALLCGTLPF-----DDEHVPTLFKK 222
Query: 614 IKEGQFNFDAEAWSTVSSEAKELTKSLLTVNPAQRIRMMRVK 655
I+ G F ++ L +L V+P +R + ++
Sbjct: 223 IRGGVFYIP----EYLNRSVATLLMHMLQVDPLKRATIKDIR 260
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276 | Back alignment and structure |
|---|
Score = 100 bits (251), Expect = 2e-23
Identities = 33/70 (47%), Positives = 45/70 (64%), Gaps = 4/70 (5%)
Query: 896 YLVLELLKGGELLDRIRQKGRCGFTENEASRIMRQLVAAVHFMHSRGVVHRDLKPENLLL 955
++V+E + GGEL D I + GR E EA R+ +Q+++AV + H VVHRDLKPEN+LL
Sbjct: 87 FMVMEYVSGGELFDYICKHGR--VEEMEARRLFQQILSAVDYCHRHMVVHRDLKPENVLL 144
Query: 956 SGISGNLIKI 965
N KI
Sbjct: 145 DA-HMN-AKI 152
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276 | Back alignment and structure |
|---|
Score = 58.4 bits (142), Expect = 2e-09
Identities = 20/92 (21%), Positives = 41/92 (44%), Gaps = 14/92 (15%)
Query: 242 IIFFIILSFTLSFIHDYYHIQYRRILKTEPPIPEDLSPDVADFISRLLVKDPRRRLGGGE 301
+I + +L TL F ++ +++I IPE L+ VA + +L DP +R
Sbjct: 199 VILYALLCGTLPFDDEHVPTLFKKIRGGVFYIPEYLNRSVATLLMHMLQVDPLKR----- 253
Query: 302 LDAEELKRHPFFNVIDWDDLATKRIPAPFVPK 333
++++ H +F + +P+ P+
Sbjct: 254 ATIKDIREHEWFK---------QDLPSYLFPE 276
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320 | Back alignment and structure |
|---|
Score = 226 bits (579), Expect = 4e-67
Identities = 73/279 (26%), Positives = 110/279 (39%), Gaps = 58/279 (20%)
Query: 386 LGDGSYSVCRRCVEKSTGQEYAVKIISR-KIDCSE----------EINLLRACQ-GHPNI 433
LG G + + S A+K + + +I E+ LL+ G +
Sbjct: 51 LGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGV 110
Query: 434 VNLHCVFQDEVHTYLVLELLKG-GELLDRIRQKGRCGFTENEASRIMRQLVAAVHFMHSR 492
+ L F+ L+LE + +L D I ++G E A Q++ AV H+
Sbjct: 111 IRLLDWFERPDSFVLILERPEPVQDLFDFITERGA--LQEELARSFFWQVLEAVRHCHNC 168
Query: 493 GVVHRDLKPENLLFSDPAGDNIKVVDFGF-ACLKRESLHTPCFTLQYAAPEVLRQDKSGY 551
GV+HRD+K EN+L D +K++DFG A LK T Y+ PE +R
Sbjct: 169 GVLHRDIKDENILI-DLNRGELKLIDFGSGALLKDTVYTDFDGTRVYSPPEWIR------ 221
Query: 552 DENCDLWSLGVILVNVLRQDKSGYD-ENCDLWSLGVILYTMLCGRVPFHARSRDDSALSI 610
Y + +WSLG++LY M+CG +PF D
Sbjct: 222 --------------------YHRYHGRSAAVWSLGILLYDMVCGDIPFE----HDE---- 253
Query: 611 MARIKEGQFNFDAEAWSTVSSEAKELTKSLLTVNPAQRI 649
I GQ F VSSE + L + L + P+ R
Sbjct: 254 --EIIRGQVFFR----QRVSSECQHLIRWCLALRPSDRP 286
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320 | Back alignment and structure |
|---|
Score = 103 bits (260), Expect = 3e-24
Identities = 24/73 (32%), Positives = 38/73 (52%), Gaps = 4/73 (5%)
Query: 894 HTYLVLELLKG-GELLDRIRQKGRCGFTENEASRIMRQLVAAVHFMHSRGVVHRDLKPEN 952
L+LE + +L D I ++G E A Q++ AV H+ GV+HRD+K EN
Sbjct: 122 SFVLILERPEPVQDLFDFITERGA--LQEELARSFFWQVLEAVRHCHNCGVLHRDIKDEN 179
Query: 953 LLLSGISGNLIKI 965
+L+ G +K+
Sbjct: 180 ILIDLNRGE-LKL 191
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320 | Back alignment and structure |
|---|
Score = 46.6 bits (111), Expect = 2e-05
Identities = 14/73 (19%), Positives = 28/73 (38%), Gaps = 11/73 (15%)
Query: 242 IIFFIILSFTLSFIHDYYHIQYRRILKTEPPIPEDLSPDVADFISRLLVKDPRRRLGGGE 301
I+ + ++ + F HD I++ + + +S + I L P R
Sbjct: 237 ILLYDMVCGDIPFEHD------EEIIRGQVFFRQRVSSECQHLIRWCLALRPSDR----- 285
Query: 302 LDAEELKRHPFFN 314
EE++ HP+
Sbjct: 286 PTFEEIQNHPWMQ 298
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348 | Back alignment and structure |
|---|
Score = 224 bits (574), Expect = 4e-66
Identities = 51/315 (16%), Positives = 105/315 (33%), Gaps = 77/315 (24%)
Query: 386 LGDGSYSVCRRCVEKSTGQEYAVKIISRKIDCSE----------------------EINL 423
L G ++ C + + YA+K + + + E+ +
Sbjct: 39 LNQGKFNKIILC--EKDNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQI 96
Query: 424 LRACQGHPNIVNLHCVFQDEVHTYLVLELLKGGELLDRIRQKGR------CGFTENEASR 477
+ + + + + + Y++ E ++ +L C
Sbjct: 97 ITDIK-NEYCLTCEGIITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFIPIQVIKC 155
Query: 478 IMRQLVAAVHFMHS-RGVVHRDLKPENLLFSDPAGDNIKVVDFGFACLKRES-LHTPCFT 535
I++ ++ + ++H+ + + HRD+KP N+L +K+ DFG + + + T
Sbjct: 156 IIKSVLNSFSYIHNEKNICHRDVKPSNILMD--KNGRVKLSDFGESEYMVDKKIKGSRGT 213
Query: 536 LQYAAPEVLRQDKSGYDENCDLWSLGVILVNVLRQDKSGYDENCDLWSLGVILYTMLCGR 595
++ PE ++S Y D+WSLG+ LY M
Sbjct: 214 YEFMPPEFF-SNESSY-----------------------NGAKVDIWSLGICLYVMFYNV 249
Query: 596 VPFHARSRDDSALSIMARIKEGQFNF---------------DAEAWSTVSSEAKELTKSL 640
VPF S + + I+ + + + +S+E + K
Sbjct: 250 VPFSL---KISLVELFNNIRTKNIEYPLDRNHFLYPLTNKKSTCSNNFLSNEDIDFLKLF 306
Query: 641 LTVNPAQRIRMMRVK 655
L NPA+RI
Sbjct: 307 LRKNPAERITSEDAL 321
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348 | Back alignment and structure |
|---|
Score = 94.4 bits (235), Expect = 6e-21
Identities = 15/77 (19%), Positives = 36/77 (46%), Gaps = 9/77 (11%)
Query: 896 YLVLELLKGGELLDRIRQKGR------CGFTENEASRIMRQLVAAVHFMHS-RGVVHRDL 948
Y++ E ++ +L C I++ ++ + ++H+ + + HRD+
Sbjct: 119 YIIYEYMENDSILKFDEYFFVLDKNYTCFIPIQVIKCIIKSVLNSFSYIHNEKNICHRDV 178
Query: 949 KPENLLLSGISGNLIKI 965
KP N+L+ +G +K+
Sbjct: 179 KPSNILM-DKNGR-VKL 193
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348 | Back alignment and structure |
|---|
Score = 60.1 bits (146), Expect = 1e-09
Identities = 17/100 (17%), Positives = 34/100 (34%), Gaps = 25/100 (25%)
Query: 242 IIFFIILSFTLSFIHDYYHIQ-YRRILKTEPPIPED-------------------LSPDV 281
I +++ + F ++ + I P D LS +
Sbjct: 240 ICLYVMFYNVVPFSLKISLVELFNNIRTKNIEYPLDRNHFLYPLTNKKSTCSNNFLSNED 299
Query: 282 ADFISRLLVKDPRRRLGGGELDAEELKRHPFFNVIDWDDL 321
DF+ L K+P R+ +E+ +H + + +DL
Sbjct: 300 IDFLKLFLRKNPAERIT-----SEDALKHEWLADTNIEDL 334
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348 | Back alignment and structure |
|---|
Score = 44.3 bits (105), Expect = 1e-04
Identities = 10/98 (10%), Positives = 27/98 (27%), Gaps = 21/98 (21%)
Query: 124 LGDGSYSVCRRCVEKSTGQEYAVKIISRKIDCSEEINLLRACQGHPNICRRCVEKSTGQE 183
L G ++ C + + YA+K + L + + + KS
Sbjct: 39 LNQGKFNKIILC--EKDNKFYALKKYEKS-------LLEKKRDFTKSNNDKISIKS---- 85
Query: 184 YAVKIISRKIDCSEEINLLRACQGHPNIVNLHCVFQDE 221
E+ ++ + + + + +
Sbjct: 86 -KYDDFKN------ELQIITDIK-NEYCLTCEGIITNY 115
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336 | Back alignment and structure |
|---|
Score = 220 bits (564), Expect = 7e-65
Identities = 84/282 (29%), Positives = 132/282 (46%), Gaps = 53/282 (18%)
Query: 386 LGDGSYSVCRRCVEKSTGQEYAVKIISR-KIDCSE-------EINLLRACQGHPNIVNLH 437
LG+GS+ + T Q+ A+K ISR + S+ EI+ L+ + HP+I+ L+
Sbjct: 17 LGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLR-HPHIIKLY 75
Query: 438 CVFQDEVHTYLVLELLKGGELLDRIRQKGRCGFTENEASRIMRQLVAAVHFMHSRGVVHR 497
V +V+E GGEL D I +K R TE+E R +Q++ A+ + H +VHR
Sbjct: 76 DVITTPTDIVMVIEYA-GGELFDYIVEKKR--MTEDEGRRFFQQIICAIEYCHRHKIVHR 132
Query: 498 DLKPENLLFSDPAGDNIKVVDFGFACLKRES--LHTPCFTLQYAAPEVLRQDKSGYDENC 555
DLKPENLL N+K+ DFG + + + L T C + YAAPEV+
Sbjct: 133 DLKPENLLLD--DNLNVKIADFGLSNIMTDGNFLKTSCGSPNYAAPEVIN---------- 180
Query: 556 DLWSLGVILVNVLRQDKSGYD-ENCDLWSLGVILYTMLCGRVPFHARSRDDSALSIM-AR 613
Y D+WS G++LY ML GR+PF DD + + +
Sbjct: 181 ----------------GKLYAGPEVDVWSCGIVLYVMLVGRLPF-----DDEFIPNLFKK 219
Query: 614 IKEGQFNFDAEAWSTVSSEAKELTKSLLTVNPAQRIRMMRVK 655
+ + +S A+ L + ++ +P QRI + ++
Sbjct: 220 VNSCVYVMP----DFLSPGAQSLIRRMIVADPMQRITIQEIR 257
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336 | Back alignment and structure |
|---|
Score = 94.3 bits (235), Expect = 6e-21
Identities = 32/72 (44%), Positives = 44/72 (61%), Gaps = 5/72 (6%)
Query: 894 HTYLVLELLKGGELLDRIRQKGRCGFTENEASRIMRQLVAAVHFMHSRGVVHRDLKPENL 953
+V+E GGEL D I +K R TE+E R +Q++ A+ + H +VHRDLKPENL
Sbjct: 83 DIVMVIEYA-GGELFDYIVEKKR--MTEDEGRRFFQQIICAIEYCHRHKIVHRDLKPENL 139
Query: 954 LLSGISGNLIKI 965
LL + N +KI
Sbjct: 140 LLDD-NLN-VKI 149
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336 | Back alignment and structure |
|---|
Score = 57.7 bits (140), Expect = 7e-09
Identities = 20/74 (27%), Positives = 40/74 (54%), Gaps = 5/74 (6%)
Query: 242 IIFFIILSFTLSFIHDYYHIQYRRILKTEPPIPEDLSPDVADFISRLLVKDPRRRLGGGE 301
I+ +++L L F ++ ++++ +P+ LSP I R++V DP +R
Sbjct: 196 IVLYVMLVGRLPFDDEFIPNLFKKVNSCVYVMPDFLSPGAQSLIRRMIVADPMQR----- 250
Query: 302 LDAEELKRHPFFNV 315
+ +E++R P+FNV
Sbjct: 251 ITIQEIRRDPWFNV 264
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336 | Back alignment and structure |
|---|
Score = 42.3 bits (100), Expect = 6e-04
Identities = 18/58 (31%), Positives = 30/58 (51%), Gaps = 9/58 (15%)
Query: 124 LGDGSYSVCRRCVEKSTGQEYAVKIISR-KIDCSE-------EINLLRACQGHPNICR 173
LG+GS+ + T Q+ A+K ISR + S+ EI+ L+ + HP+I +
Sbjct: 17 LGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLR-HPHIIK 73
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476 | Back alignment and structure |
|---|
Score = 224 bits (573), Expect = 2e-64
Identities = 106/425 (24%), Positives = 167/425 (39%), Gaps = 90/425 (21%)
Query: 386 LGDGSYSVCRRCVEKSTGQEYAVKIISR-KIDCSE-------EINLLRACQGHPNIVNLH 437
LG G++ + + TG + AVKI++R KI + EI L+ + HP+I+ L+
Sbjct: 24 LGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFR-HPHIIKLY 82
Query: 438 CVFQDEVHTYLVLELLKGGELLDRIRQKGRCGFTENEASRIMRQLVAAVHFMHSRGVVHR 497
V ++V+E + GGEL D I + GR E E+ R+ +Q+++ V + H VVHR
Sbjct: 83 QVISTPSDIFMVMEYVSGGELFDYICKNGR--LDEKESRRLFQQILSGVDYCHRHMVVHR 140
Query: 498 DLKPENLLFSDPAGDNIKVVDFGFACLKR--ESLHTPCFTLQYAAPEVLRQDKSGYDENC 555
DLKPEN+L D N K+ DFG + + E L T C + YAAPEV+
Sbjct: 141 DLKPENVLL-DAHM-NAKIADFGLSNMMSDGEFLRTSCGSPNYAAPEVIS---------- 188
Query: 556 DLWSLGVILVNVLRQDKSGYD-ENCDLWSLGVILYTMLCGRVPFHARSRDDSALSIM-AR 613
Y D+WS GVILY +LCG +PF DD + + +
Sbjct: 189 ----------------GRLYAGPEVDIWSSGVILYALLCGTLPF-----DDDHVPTLFKK 227
Query: 614 IKEGQFNFDAEAWSTVSSEAKELTKSLLTVNPAQRIRM--------MRVKLTFHAFHQ-- 663
I +G F ++ L K +L V+P +R + + L + F +
Sbjct: 228 ICDGIFYTP----QYLNPSVISLLKHMLQVDPMKRATIKDIREHEWFKQDLPKYLFPEDP 283
Query: 664 ---------------AQKEGFRLQDVTSAKLAQR------------RKNKNVSNDNSRSF 696
+K ++V S + N+ + N+ +
Sbjct: 284 SYSSTMIDDEALKEVCEKFECSEEEVLSCLYNRNHQDPLAVAYHLIIDNRRIMNEAKDFY 343
Query: 697 SSTSSSLSSSSSGTSSLKTPCSSTQPSVPSKPVKRINKDASSGTVFDFAEARVQEYLSSL 756
+TS S + P V P R D + R ++ +
Sbjct: 344 LATSPPDSFLDDHHLTRPHP-ERVPFLVAETPRARHTLDELNPQKSKHQGVRKAKWHLGI 402
Query: 757 SSSSS 761
S S
Sbjct: 403 RSQSR 407
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476 | Back alignment and structure |
|---|
Score = 99.1 bits (247), Expect = 7e-22
Identities = 31/72 (43%), Positives = 44/72 (61%), Gaps = 4/72 (5%)
Query: 894 HTYLVLELLKGGELLDRIRQKGRCGFTENEASRIMRQLVAAVHFMHSRGVVHRDLKPENL 953
++V+E + GGEL D I + GR E E+ R+ +Q+++ V + H VVHRDLKPEN+
Sbjct: 90 DIFMVMEYVSGGELFDYICKNGR--LDEKESRRLFQQILSGVDYCHRHMVVHRDLKPENV 147
Query: 954 LLSGISGNLIKI 965
LL N KI
Sbjct: 148 LLDA-HMN-AKI 157
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476 | Back alignment and structure |
|---|
Score = 57.5 bits (139), Expect = 1e-08
Identities = 17/73 (23%), Positives = 34/73 (46%), Gaps = 5/73 (6%)
Query: 242 IIFFIILSFTLSFIHDYYHIQYRRILKTEPPIPEDLSPDVADFISRLLVKDPRRRLGGGE 301
+I + +L TL F D+ +++I P+ L+P V + +L DP +R
Sbjct: 204 VILYALLCGTLPFDDDHVPTLFKKICDGIFYTPQYLNPSVISLLKHMLQVDPMKR----- 258
Query: 302 LDAEELKRHPFFN 314
++++ H +F
Sbjct: 259 ATIKDIREHEWFK 271
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676 | Back alignment and structure |
|---|
Score = 229 bits (584), Expect = 3e-64
Identities = 65/338 (19%), Positives = 118/338 (34%), Gaps = 69/338 (20%)
Query: 385 ILGDGSYSVCRRCVEKSTGQEYAVKIISRKIDCSE------EINLLRACQGHPNIVNLHC 438
LG G + R + + TG++ A+K +++ EI +++ HPN+V+
Sbjct: 21 RLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLN-HPNVVSARE 79
Query: 439 VFQDEVH------TYLVLELLKGGELLDRIRQKGR-CGFTENEASRIMRQLVAAVHFMHS 491
V L +E +GG+L + Q CG E ++ + +A+ ++H
Sbjct: 80 VPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALRYLHE 139
Query: 492 RGVVHRDLKPENLLFSDPAGD-NIKVVDFGFACL--KRESLHTPCFTLQYAAPEVLRQDK 548
++HRDLKPEN++ K++D G+A + E TLQY APE+L Q K
Sbjct: 140 NRIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELDQGELCTEFVGTLQYLAPELLEQKK 199
Query: 549 SGYDENCDLWSLGVILVNVLRQDKSGYDENCDLWSLGVILYTMLCGRVPFHARSRDDSAL 608
Y D WS G + + + G PF +
Sbjct: 200 --------------------------YTVTVDYWSFGTLAFECITGFRPFLPNWQPV--- 230
Query: 609 SIMARIKEGQFNFDAEAW--------------------STVSSEAKELTKSLLTVNPAQR 648
+ N + ++ + + + +L + QR
Sbjct: 231 -QWHGKVREKSNEHIVVYDDLTGAVKFSSVLPTPNHLSGILAGKLERWLQCMLMWHQRQR 289
Query: 649 IRMMRVKLTFHAFHQAQKEGFRLQDVTSAKLAQRRKNK 686
+ QA L+ ++ + R +
Sbjct: 290 GTDPQNPN--VGCFQALDSILSLKLLSVMNMVSGRVHT 325
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676 | Back alignment and structure |
|---|
Score = 105 bits (264), Expect = 1e-23
Identities = 24/81 (29%), Positives = 40/81 (49%), Gaps = 2/81 (2%)
Query: 887 NRSRYNVHTYLVLELLKGGELLDRIRQKGR-CGFTENEASRIMRQLVAAVHFMHSRGVVH 945
+ N L +E +GG+L + Q CG E ++ + +A+ ++H ++H
Sbjct: 85 QKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALRYLHENRIIH 144
Query: 946 RDLKPENLLLSGISGNL-IKI 965
RDLKPEN++L L KI
Sbjct: 145 RDLKPENIVLQPGPQRLIHKI 165
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676 | Back alignment and structure |
|---|
Score = 50.8 bits (121), Expect = 2e-06
Identities = 15/99 (15%), Positives = 29/99 (29%), Gaps = 35/99 (35%)
Query: 123 ILGDGSYSVCRRCVEKSTGQEYAVKIISRKIDCSEEINLLRACQGHPNICRRCVEKSTGQ 182
LG G + R + + TG++ A+K +++
Sbjct: 21 RLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCL------------------- 61
Query: 183 EYAVKIISRKIDCSEEINLLRACQGHPNIVNLHCVFQDE 221
EI +++ HPN+V+ V
Sbjct: 62 ---------------EIQIMKKLN-HPNVVSAREVPDGL 84
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305 | Back alignment and structure |
|---|
Score = 218 bits (557), Expect = 3e-64
Identities = 71/288 (24%), Positives = 118/288 (40%), Gaps = 56/288 (19%)
Query: 386 LGDGSYSVCRRCVEKSTGQEYAVKIISR-KIDCSE--------EINLLRACQGHPNIVNL 436
LG+GSY + ++ T AVKI+ + K+ EI LLR + H N++ L
Sbjct: 13 LGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLR-HKNVIQL 71
Query: 437 HCVFQDEVHT--YLVLELLKGG--ELLDRIRQKGRCGFTENEASRIMRQLVAAVHFMHSR 492
V +E Y+V+E G E+LD + +K F +A QL+ + ++HS+
Sbjct: 72 VDVLYNEEKQKMYMVMEYCVCGMQEMLDSVPEKR---FPVCQAHGYFCQLIDGLEYLHSQ 128
Query: 493 GVVHRDLKPENLLFSDPAGDNIKVVDFGFACLKRES-----LHTPCFTLQYAAPEVLRQD 547
G+VH+D+KP NLL + G +K+ G A T + + PE+
Sbjct: 129 GIVHKDIKPGNLLLT--TGGTLKISALGVAEALHPFAADDTCRTSQGSPAFQPPEIANGL 186
Query: 548 KSGYDENCDLWSLGVILVNVLRQDKSGYDENCDLWSLGVILYTMLCGRVPFHARSRDDSA 607
+ G+ D+WS GV LY + G PF D+
Sbjct: 187 D-TFS---------------------GFK--VDIWSAGVTLYNITTGLYPFE----GDNI 218
Query: 608 LSIMARIKEGQFNFDAEAWSTVSSEAKELTKSLLTVNPAQRIRMMRVK 655
+ I +G + + +L K +L PA+R + +++
Sbjct: 219 YKLFENIGKGSYAIPGD----CGPPLSDLLKGMLEYEPAKRFSIRQIR 262
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305 | Back alignment and structure |
|---|
Score = 94.3 bits (235), Expect = 3e-21
Identities = 27/74 (36%), Positives = 43/74 (58%), Gaps = 7/74 (9%)
Query: 894 HTYLVLELLKGG--ELLDRIRQKGRCGFTENEASRIMRQLVAAVHFMHSRGVVHRDLKPE 951
Y+V+E G E+LD + +K F +A QL+ + ++HS+G+VH+D+KP
Sbjct: 82 KMYMVMEYCVCGMQEMLDSVPEKR---FPVCQAHGYFCQLIDGLEYLHSQGIVHKDIKPG 138
Query: 952 NLLLSGISGNLIKI 965
NLLL+ G +KI
Sbjct: 139 NLLLTT-GGT-LKI 150
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305 | Back alignment and structure |
|---|
Score = 59.2 bits (144), Expect = 2e-09
Identities = 16/76 (21%), Positives = 33/76 (43%), Gaps = 5/76 (6%)
Query: 239 SSLIIFFIILSFTLSFIHDYYHIQYRRILKTEPPIPEDLSPDVADFISRLLVKDPRRRLG 298
S+ + + I + F D + + I K IP D P ++D + +L +P +R
Sbjct: 198 SAGVTLYNITTGLYPFEGDNIYKLFENIGKGSYAIPGDCGPPLSDLLKGMLEYEPAKR-- 255
Query: 299 GGELDAEELKRHPFFN 314
++++H +F
Sbjct: 256 ---FSIRQIRQHSWFR 268
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305 | Back alignment and structure |
|---|
Score = 43.0 bits (102), Expect = 3e-04
Identities = 25/98 (25%), Positives = 37/98 (37%), Gaps = 32/98 (32%)
Query: 124 LGDGSYSVCRRCVEKSTGQEYAVKIISRKIDCSEEINLLRACQGHPNICRRCVEKSTGQE 183
LG+GSY + ++ T AVKI+ +K L R G N+ +
Sbjct: 13 LGEGSYGKVKEVLDSETLCRRAVKILKKK-------KLRRIPNGEANVKK---------- 55
Query: 184 YAVKIISRKIDCSEEINLLRACQGHPNIVNLHCVFQDE 221
EI LLR + H N++ L V +E
Sbjct: 56 --------------EIQLLRRLR-HKNVIQLVDVLYNE 78
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335 | Back alignment and structure |
|---|
Score = 216 bits (552), Expect = 3e-63
Identities = 75/287 (26%), Positives = 120/287 (41%), Gaps = 62/287 (21%)
Query: 386 LGDGSYSVCRRCVEKSTGQEYAVKIISR-KIDCSE------------EINLLRACQGHPN 432
LG G++ V+K +E VK I + K+ EI +L + H N
Sbjct: 32 LGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVE-HAN 90
Query: 433 IVNLHCVFQDEVHTYLVLEL-LKGGELLDRIRQKGRCGFTENEASRIMRQLVAAVHFMHS 491
I+ + +F+++ LV+E G +L I + R E AS I RQLV+AV ++
Sbjct: 91 IIKVLDIFENQGFFQLVMEKHGSGLDLFAFIDRHPR--LDEPLASYIFRQLVSAVGYLRL 148
Query: 492 RGVVHRDLKPENLLFSDPAGDNIKVVDFGFACL--KRESLHTPCFTLQYAAPEVLRQDKS 549
+ ++HRD+K EN++ IK++DFG A + + +T C T++Y APEVL
Sbjct: 149 KDIIHRDIKDENIVI-AEDF-TIKLIDFGSAAYLERGKLFYTFCGTIEYCAPEVLM---- 202
Query: 550 GYDENCDLWSLGVILVNVLRQDKSGYD-ENCDLWSLGVILYTMLCGRVPFHARSRDDSAL 608
+ Y ++WSLGV LYT++ PF +
Sbjct: 203 ----------------------GNPYRGPELEMWSLGVTLYTLVFEENPF-----CE--- 232
Query: 609 SIMARIKEGQFNFDAEAWSTVSSEAKELTKSLLTVNPAQRIRMMRVK 655
+ E + VS E L LL P +R + ++
Sbjct: 233 --LEETVEAAIHPP----YLVSKELMSLVSGLLQPVPERRTTLEKLV 273
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335 | Back alignment and structure |
|---|
Score = 95.9 bits (239), Expect = 2e-21
Identities = 25/73 (34%), Positives = 40/73 (54%), Gaps = 5/73 (6%)
Query: 894 HTYLVLEL-LKGGELLDRIRQKGRCGFTENEASRIMRQLVAAVHFMHSRGVVHRDLKPEN 952
LV+E G +L I + R E AS I RQLV+AV ++ + ++HRD+K EN
Sbjct: 103 FFQLVMEKHGSGLDLFAFIDRHPR--LDEPLASYIFRQLVSAVGYLRLKDIIHRDIKDEN 160
Query: 953 LLLSGISGNLIKI 965
++++ IK+
Sbjct: 161 IVIAE-DFT-IKL 171
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335 | Back alignment and structure |
|---|
Score = 49.7 bits (119), Expect = 2e-06
Identities = 12/73 (16%), Positives = 25/73 (34%), Gaps = 11/73 (15%)
Query: 242 IIFFIILSFTLSFIHDYYHIQYRRILKTEPPIPEDLSPDVADFISRLLVKDPRRRLGGGE 301
+ + ++ F + ++ P +S ++ +S LL P RR
Sbjct: 218 VTLYTLVFEENPF-CEL-----EETVEAAIHPPYLVSKELMSLVSGLLQPVPERR----- 266
Query: 302 LDAEELKRHPFFN 314
E+L P+
Sbjct: 267 TTLEKLVTDPWVT 279
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317 | Back alignment and structure |
|---|
Score = 206 bits (527), Expect = 5e-60
Identities = 68/292 (23%), Positives = 111/292 (38%), Gaps = 54/292 (18%)
Query: 386 LGDGSYSVCRRCVEKSTGQEYAVKII-----SRKIDCSEEINLLRACQGHPNIVNLHCVF 440
LG+G +S G YA+K I + + E ++ R HPNI+ L
Sbjct: 37 LGEGGFSYVDLVEGLHDGHFYALKRILCHEQQDREEAQREADMHRLF-NHPNILRLVAYC 95
Query: 441 QDEVHT----YLVLELLKGGELLDRIRQKGRCG--FTENEASRIMRQLVAAVHFMHSRGV 494
E +L+L K G L + I + G TE++ ++ + + +H++G
Sbjct: 96 LRERGAKHEAWLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIHAKGY 155
Query: 495 VHRDLKPENLLFSDPAGDNIKVVDFGFACLKR------------ESLHTPCFTLQYAAPE 542
HRDLKP N+L D ++D G + T+ Y APE
Sbjct: 156 AHRDLKPTNILLGDE--GQPVLMDLGSMNQACIHVEGSRQALTLQDWAAQRCTISYRAPE 213
Query: 543 VLRQDKSGYDENCDLWSLGVILVNVLRQDKSGYDENCDLWSLGVILYTMLCGRVPFHARS 602
+ + S DE D+WSLG +LY M+ G P+
Sbjct: 214 L-----------FSVQS------------HCVIDERTDVWSLGCVLYAMMFGEGPYDMVF 250
Query: 603 RDDSALSIMARIKEGQFNFDAEAWSTVSSEAKELTKSLLTVNPAQRIRMMRV 654
+ ++ A + Q + SS +L S++TV+P QR + +
Sbjct: 251 QKGDSV---ALAVQNQLSI--PQSPRHSSALWQLLNSMMTVDPHQRPHIPLL 297
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317 | Back alignment and structure |
|---|
Score = 90.9 bits (226), Expect = 6e-20
Identities = 20/83 (24%), Positives = 36/83 (43%), Gaps = 4/83 (4%)
Query: 885 FVNRSRYNVHTYLVLELLKGGELLDRIRQKGRCG--FTENEASRIMRQLVAAVHFMHSRG 942
+ +L+L K G L + I + G TE++ ++ + + +H++G
Sbjct: 95 CLRERGAKHEAWLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIHAKG 154
Query: 943 VVHRDLKPENLLLSGISGNLIKI 965
HRDLKP N+LL +
Sbjct: 155 YAHRDLKPTNILLG--DEGQPVL 175
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317 | Back alignment and structure |
|---|
Score = 46.2 bits (110), Expect = 3e-05
Identities = 16/55 (29%), Positives = 23/55 (41%), Gaps = 6/55 (10%)
Query: 124 LGDGSYSVCRRCVEKSTGQEYAVKII-----SRKIDCSEEINLLRACQGHPNICR 173
LG+G +S G YA+K I + + E ++ R HPNI R
Sbjct: 37 LGEGGFSYVDLVEGLHDGHFYALKRILCHEQQDREEAQREADMHRLF-NHPNILR 90
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279 | Back alignment and structure |
|---|
Score = 202 bits (516), Expect = 6e-59
Identities = 79/284 (27%), Positives = 117/284 (41%), Gaps = 55/284 (19%)
Query: 385 ILGDGSYSVCRRCVEKSTGQEYAVKIISR-------KIDCSEEINLLRACQGHPNIVNLH 437
+G GSY C++ KS G+ K + K E+NLLR + HPNIV +
Sbjct: 13 TIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELK-HPNIVRYY 71
Query: 438 CVFQDEVHT--YLVLELLKGGELLDRIRQKGRCG--FTENEASRIMRQLVAAVHFMHSRG 493
D +T Y+V+E +GG+L I + + E R+M QL A+ H R
Sbjct: 72 DRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRS 131
Query: 494 -----VVHRDLKPENLLFSDPAGDNIKVVDFGFA-CLKRES--LHTPCFTLQYAAPEVLR 545
V+HRDLKP N+ N+K+ DFG A L ++ T T Y +PE +
Sbjct: 132 DGGHTVLHRDLKPANVFLD--GKQNVKLGDFGLARILNHDTSFAKTFVGTPYYMSPEQMN 189
Query: 546 QDKSGYDENCDLWSLGVILVNVLRQDKSGYDENCDLWSLGVILYTMLCGRVPFHARSRDD 605
+ Y+E D+WSLG +LY + PF A S+
Sbjct: 190 RMS--------------------------YNEKSDIWSLGCLLYELCALMPPFTAFSQK- 222
Query: 606 SALSIMARIKEGQFNFDAEAWSTVSSEAKELTKSLLTVNPAQRI 649
+ +I+EG+F S E E+ +L + R
Sbjct: 223 ---ELAGKIREGKFRRI---PYRYSDELNEIITRMLNLKDYHRP 260
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279 | Back alignment and structure |
|---|
Score = 78.5 bits (194), Expect = 5e-16
Identities = 25/77 (32%), Positives = 37/77 (48%), Gaps = 9/77 (11%)
Query: 896 YLVLELLKGGELLDRIRQKGRCG--FTENEASRIMRQLVAAVHFMHSRG-----VVHRDL 948
Y+V+E +GG+L I + + E R+M QL A+ H R V+HRDL
Sbjct: 83 YIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDL 142
Query: 949 KPENLLLSGISGNLIKI 965
KP N+ L +K+
Sbjct: 143 KPANVFLD--GKQNVKL 157
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279 | Back alignment and structure |
|---|
Score = 50.0 bits (120), Expect = 1e-06
Identities = 20/58 (34%), Positives = 27/58 (46%), Gaps = 8/58 (13%)
Query: 123 ILGDGSYSVCRRCVEKSTGQEYAVKIISR-------KIDCSEEINLLRACQGHPNICR 173
+G GSY C++ KS G+ K + K E+NLLR + HPNI R
Sbjct: 13 TIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELK-HPNIVR 69
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279 | Back alignment and structure |
|---|
Score = 46.9 bits (112), Expect = 1e-05
Identities = 17/58 (29%), Positives = 24/58 (41%), Gaps = 8/58 (13%)
Query: 171 ICRRCVEKSTGQEYAVKIISR-------KIDCSEEINLLRACQGHPNIVNLHCVFQDE 221
C++ KS G+ K + K E+NLLR + HPNIV + D
Sbjct: 21 RCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELK-HPNIVRYYDRIIDR 77
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279 | Back alignment and structure |
|---|
Score = 46.1 bits (110), Expect = 2e-05
Identities = 11/52 (21%), Positives = 21/52 (40%), Gaps = 6/52 (11%)
Query: 263 YRRILKTE-PPIPEDLSPDVADFISRLLVKDPRRRLGGGELDAEELKRHPFF 313
+I + + IP S ++ + I+R+L R EE+ +P
Sbjct: 225 AGKIREGKFRRIPYRYSDELNEIITRMLNLKDYHR-----PSVEEILENPLI 271
|
| >4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350 | Back alignment and structure |
|---|
Score = 202 bits (516), Expect = 5e-58
Identities = 74/383 (19%), Positives = 141/383 (36%), Gaps = 54/383 (14%)
Query: 355 SPAIVPPNFDKIFKGSLFFEQYDMDLDKAGILGDGSYSVCRRCVEKSTGQEYAVKIISR- 413
+ V + ++ S+ E+Y + +G+GS+ G++Y +K I+
Sbjct: 7 HSSGVDLGTENLYFQSM--EKYV----RLQKIGEGSFGKAILVKSTEDGRQYVIKEINIS 60
Query: 414 ------KIDCSEEINLLRACQGHPNIVNLHCVFQDEVHTYLVLELLKGGELLDRIRQKGR 467
+ + E+ +L + HPNIV F++ Y+V++ +GG+L RI +
Sbjct: 61 RMSSKEREESRREVAVLANMK-HPNIVQYRESFEENGSLYIVMDYCEGGDLFKRINAQKG 119
Query: 468 CGFTENEASRIMRQLVAAVHFMHSRGVVHRDLKPENLLFSDPAGDNIKVVDFGFACL--- 524
F E++ Q+ A+ +H R ++HRD+K +N+ + +++ DFG A +
Sbjct: 120 VLFQEDQILDWFVQICLALKHVHDRKILHRDIKSQNIFLTK--DGTVQLGDFGIARVLNS 177
Query: 525 KRESLHTPCFTLQYAAPEVLRQDKSGYDENCDLWSLGVILVNVLRQDKSGYDENCDLWSL 584
E T Y +PE+ Y+ D+W+L
Sbjct: 178 TVELARACIGTPYYLSPEICEN--------------------------KPYNNKSDIWAL 211
Query: 585 GVILYTMLCGRVPFHARSRDDSALSIMARIKEGQFNFDAEAWSTVSSEAKELTKSLLTVN 644
G +LY + + F A S +++ +I G F S + + L L N
Sbjct: 212 GCVLYELCTLKHAFEAGSM----KNLVLKIISGSF---PPVSLHYSYDLRSLVSQLFKRN 264
Query: 645 PAQRIRMMRVKLTFHAFHQAQKEGFRLQDVTSAKLAQRRKNKNVSNDNSRSFSSTSSSLS 704
P R + + F + E F + + + + +K S ++ +
Sbjct: 265 PRDRPSV--NSILEKGFIAKRIEKFLSPQLIAEEFCLKTFSKFGSQPIPAKRPASGQNSI 322
Query: 705 SSSSGTSSLKTPCSSTQPSVPSK 727
S K P K
Sbjct: 323 SVMPAQKITKPAAKYGIPLAYKK 345
|
| >4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350 | Back alignment and structure |
|---|
Score = 80.5 bits (199), Expect = 3e-16
Identities = 19/70 (27%), Positives = 39/70 (55%), Gaps = 2/70 (2%)
Query: 896 YLVLELLKGGELLDRIRQKGRCGFTENEASRIMRQLVAAVHFMHSRGVVHRDLKPENLLL 955
Y+V++ +GG+L RI + F E++ Q+ A+ +H R ++HRD+K +N+ L
Sbjct: 99 YIVMDYCEGGDLFKRINAQKGVLFQEDQILDWFVQICLALKHVHDRKILHRDIKSQNIFL 158
Query: 956 SGISGNLIKI 965
+ +++
Sbjct: 159 T--KDGTVQL 166
|
| >4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350 | Back alignment and structure |
|---|
Score = 49.3 bits (118), Expect = 3e-06
Identities = 24/97 (24%), Positives = 38/97 (39%), Gaps = 16/97 (16%)
Query: 263 YRRILKTE-PPIPEDLSPDVADFISRLLVKDPRRRLGGGELDAEELKRHPFFNVIDWDDL 321
+I+ PP+ S D+ +S+L ++PR R + F
Sbjct: 234 VLKIISGSFPPVSLHYSYDLRSLVSQLFKRNPRDR-----PSVNSILEKGFI-------- 280
Query: 322 ATKRIPAPFVPK-ISNELDVSNFSDEFTKMIPADSPA 357
KRI P+ I+ E + FS ++ IPA PA
Sbjct: 281 -AKRIEKFLSPQLIAEEFCLKTFSKFGSQPIPAKRPA 316
|
| >4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350 | Back alignment and structure |
|---|
Score = 48.5 bits (116), Expect = 5e-06
Identities = 13/58 (22%), Positives = 26/58 (44%), Gaps = 8/58 (13%)
Query: 123 ILGDGSYSVCRRCVEKSTGQEYAVKIIS-------RKIDCSEEINLLRACQGHPNICR 173
+G+GS+ G++Y +K I+ + + E+ +L + HPNI +
Sbjct: 31 KIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMK-HPNIVQ 87
|
| >4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350 | Back alignment and structure |
|---|
Score = 43.9 bits (104), Expect = 2e-04
Identities = 12/57 (21%), Positives = 23/57 (40%), Gaps = 8/57 (14%)
Query: 172 CRRCVEKSTGQEYAVKIIS-------RKIDCSEEINLLRACQGHPNIVNLHCVFQDE 221
G++Y +K I+ + + E+ +L + HPNIV F++
Sbjct: 40 AILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMK-HPNIVQYRESFEEN 95
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284 | Back alignment and structure |
|---|
Score = 199 bits (509), Expect = 5e-58
Identities = 54/284 (19%), Positives = 100/284 (35%), Gaps = 60/284 (21%)
Query: 385 ILGDGSYSVCRRCVEKSTGQEYAVKIISR-KIDCSEEINLLRACQGHPNIVNLHCVFQDE 443
++G G + + + G+ Y +K + E+ L H NIV+ + +
Sbjct: 18 LIGSGGFGQVFKAKHRIDGKTYVIKRVKYNNEKAEREVKALAKLD-HVNIVHYNGCWDGF 76
Query: 444 VHT----------------YLVLELLKGGELLDRIRQKGRCGFTENEASRIMRQLVAAVH 487
+ ++ +E G L I ++ + A + Q+ V
Sbjct: 77 DYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLALELFEQITKGVD 136
Query: 488 FMHSRGVVHRDLKPENLLFSDPAGDNIKVVDFGFA-CLKRESLH-TPCFTLQYAAPEVLR 545
++HS+ +++RDLKP N+ D +K+ DFG LK + TL+Y +PE +
Sbjct: 137 YIHSKKLINRDLKPSNIFLVD--TKQVKIGDFGLVTSLKNDGKRTRSKGTLRYMSPEQIS 194
Query: 546 QDKSGYDENCDLWSLGVILVNVLRQDKSGYDENCDLWSLGVILYTMLCGRVPFHARSRDD 605
Y + DL++LG+IL +L S
Sbjct: 195 --------------------------SQDYGKEVDLYALGLILAELLHVCDTAFETS--- 225
Query: 606 SALSIMARIKEGQFNFDAEAWSTVSSEAKELTKSLLTVNPAQRI 649
+++G + + K L + LL+ P R
Sbjct: 226 ---KFFTDLRDGIIS------DIFDKKEKTLLQKLLSKKPEDRP 260
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284 | Back alignment and structure |
|---|
Score = 86.2 bits (214), Expect = 1e-18
Identities = 18/70 (25%), Positives = 34/70 (48%), Gaps = 2/70 (2%)
Query: 896 YLVLELLKGGELLDRIRQKGRCGFTENEASRIMRQLVAAVHFMHSRGVVHRDLKPENLLL 955
++ +E G L I ++ + A + Q+ V ++HS+ +++RDLKP N+ L
Sbjct: 96 FIQMEFCDKGTLEQWIEKRRGEKLDKVLALELFEQITKGVDYIHSKKLINRDLKPSNIFL 155
Query: 956 SGISGNLIKI 965
+KI
Sbjct: 156 V--DTKQVKI 163
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284 | Back alignment and structure |
|---|
Score = 54.6 bits (132), Expect = 5e-08
Identities = 10/52 (19%), Positives = 19/52 (36%), Gaps = 2/52 (3%)
Query: 123 ILGDGSYSVCRRCVEKSTGQEYAVKIISR-KIDCSEEINLLRACQGHPNICR 173
++G G + + + G+ Y +K + E+ L H NI
Sbjct: 18 LIGSGGFGQVFKAKHRIDGKTYVIKRVKYNNEKAEREVKALAKLD-HVNIVH 68
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284 | Back alignment and structure |
|---|
Score = 51.5 bits (124), Expect = 5e-07
Identities = 14/80 (17%), Positives = 24/80 (30%), Gaps = 6/80 (7%)
Query: 172 CRRCVEKSTGQEYAVKIISR-KIDCSEEINLLRACQGHPNIVNLHCVFQDEVIDWDDFSR 230
+ + G+ Y +K + E+ L H NIV+ + + D
Sbjct: 27 VFKAKHRIDGKTYVIKRVKYNNEKAEREVKALAKLD-HVNIVHYNGCWDGF----DYDPE 81
Query: 231 GIECVFFSSSLIIFFIILSF 250
S FI + F
Sbjct: 82 TSSKNSSRSKTKCLFIQMEF 101
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284 | Back alignment and structure |
|---|
Score = 45.4 bits (108), Expect = 4e-05
Identities = 8/51 (15%), Positives = 15/51 (29%), Gaps = 7/51 (13%)
Query: 263 YRRILKTEPPIPEDLSPDVADFISRLLVKDPRRRLGGGELDAEELKRHPFF 313
+ + I + + +LL K P R + E+ R
Sbjct: 228 FTDLRD--GIISDIFDKKEKTLLQKLLSKKPEDR-----PNTSEILRTLTV 271
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377 | Back alignment and structure |
|---|
Score = 203 bits (517), Expect = 6e-58
Identities = 48/372 (12%), Positives = 108/372 (29%), Gaps = 82/372 (22%)
Query: 324 KRIPAPFVPKISNELDVSNFSDEFTKMIPADSPAIVPPNFDKIFKGSLFFEQYDMDLDKA 383
RIP V S + + S T + P V + L +
Sbjct: 29 NRIPQANVRTTSEYMQSAADSLVSTSLWNTGQPFRVES----------ELGERPRTLVRG 78
Query: 384 GILGDGSYSVCRRCVEKSTGQEYAVKIISR-KIDCSEEINLLR----------------- 425
+LG ++ TG+ + V + + S I ++
Sbjct: 79 TVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQ 138
Query: 426 --------------ACQGHPNIVNLHCVFQDE--VHTYLVLELLK------GGELLDRIR 463
++ + +D + + + ++ G LL
Sbjct: 139 AKVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSS 198
Query: 464 QKGRCGFTENEASRIMRQLVAAVHFMHSRGVVHRDLKPENLLFSDPAGDNIKVVDFGFAC 523
+ ++ Q++ + +H G+VH L+P +++ D G + + F
Sbjct: 199 THKS--LVHHARLQLTLQVIRLLASLHHYGLVHTYLRPVDIVL-DQRG-GVFLTGFEHLV 254
Query: 524 LKRESLHTPCFTLQYAAPEVLRQDKSGYDENCDLWSLGVILVNVLRQDKSGYDENCDLWS 583
+ + + + PE+ + + R ++ + D W+
Sbjct: 255 -RDGARVVSSVSRGFEPPELEARRATISYH---------------RDRRTLMTFSFDAWA 298
Query: 584 LGVILYTMLCGRVPFHARSRDDSALSIMARIKEGQFNFDAEAWSTVSSEAKELTKSLLTV 643
LG+++Y + C +P D+AL I + + L + L
Sbjct: 299 LGLVIYWIWCADLPIT----KDAALGGSEWIFRS--------CKNIPQPVRALLEGFLRY 346
Query: 644 NPAQRIRMMRVK 655
R+ ++
Sbjct: 347 PKEDRLLPLQAM 358
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377 | Back alignment and structure |
|---|
Score = 78.1 bits (192), Expect = 2e-15
Identities = 19/148 (12%), Positives = 46/148 (31%), Gaps = 13/148 (8%)
Query: 827 KSLPATHSTPARKKKKADRQPAKQEEKQPV--PQTTPPTDLVTLFEEQLLGPITRARRRT 884
T P+ K+ + + + + + + + P + R
Sbjct: 104 HVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDLVKDPQKKKMIRV 163
Query: 885 FVNRSRYNVHTYLVLELL-------KGGELLDRIRQKGRCGFTENEASRIMRQLVAAVHF 937
++ V + L G LL + ++ Q++ +
Sbjct: 164 RLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSSTHKS--LVHHARLQLTLQVIRLLAS 221
Query: 938 MHSRGVVHRDLKPENLLLSGISGNLIKI 965
+H G+VH L+P +++L G + +
Sbjct: 222 LHHYGLVHTYLRPVDIVLDQ-RGG-VFL 247
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377 | Back alignment and structure |
|---|
Score = 58.1 bits (140), Expect = 6e-09
Identities = 9/76 (11%), Positives = 21/76 (27%), Gaps = 9/76 (11%)
Query: 242 IIFFIILSFTLSFIHDYYHIQYRRILKTEPPIPEDLSPDVADFISRLLVKDPRRRLGGGE 301
++ + I L D I ++ +++ V + L RL
Sbjct: 301 LVIYWIWCADLPITKDAALGGSEWIFRS----CKNIPQPVRALLEGFLRYPKEDRLL--- 353
Query: 302 LDAEELKRHPFFNVID 317
+ P + +
Sbjct: 354 --PLQAMETPEYEQLR 367
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377 | Back alignment and structure |
|---|
Score = 47.7 bits (113), Expect = 1e-05
Identities = 11/114 (9%), Positives = 32/114 (28%), Gaps = 10/114 (8%)
Query: 111 FEQYDMDLDKAGILGDGSYSVCRRCVEKSTGQEYAVKIISR-KIDCSEEINLLRACQGHP 169
+ L + +LG ++ TG+ + V + + S I ++
Sbjct: 68 LGERPRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKE----- 122
Query: 170 NICRRCVEKSTGQEYAVKIISRKIDCSEEINLLRACQGHPNIVNLHCVFQDEVI 223
+ K + +L++ ++ + +D +
Sbjct: 123 ---EVLRLRLLRGIKNQKQAKVHLRFIFPFDLVKD-PQKKKMIRVRLDERDMWV 172
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 198 bits (505), Expect = 9e-57
Identities = 77/336 (22%), Positives = 126/336 (37%), Gaps = 71/336 (21%)
Query: 386 LGDGSYSVCRRCVEKSTGQEYAVKIISRKIDCSE-----EINLLRACQGHPNIVNLHCVF 440
L +G ++ + +G+EYA+K + + E+ ++ GHPNIV
Sbjct: 36 LAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRAIIQEVCFMKKLSGHPNIVQFCSAA 95
Query: 441 QDEVHT-------YLVLELLKGGELLD---RIRQKGRCGFTENEASRIMRQLVAAVHFMH 490
+L+L L G+L++ ++ +G + + +I Q AV MH
Sbjct: 96 SIGKEESDTGQAEFLLLTELCKGQLVEFLKKMESRGP--LSCDTVLKIFYQTCRAVQHMH 153
Query: 491 SRG--VVHRDLKPENLLFSDPAGDNIKVVDFGFACLKR---------------ESLHTPC 533
+ ++HRDLK ENLL S+ IK+ DFG A E T
Sbjct: 154 RQKPPIIHRDLKVENLLLSNQ--GTIKLCDFGSATTISHYPDYSWSAQRRALVEEEITRN 211
Query: 534 FTLQYAAPEVLRQDKSGYDENCDLWSLGVILVNVLRQDKSGYDENCDLWSLGVILYTMLC 593
T Y PE+ DL+S E D+W+LG ILY +
Sbjct: 212 TTPMYRTPEI-----------IDLYS------------NFPIGEKQDIWALGCILYLLCF 248
Query: 594 GRVPFHARSRDDSALSIMARIKEGQFNFDAEAWSTVSSEAKELTKSLLTVNPAQRIRMMR 653
+ PF +D A RI G+++ T + L +++L VNP +R+ +
Sbjct: 249 RQHPF-----EDGA---KLRIVNGKYSI--PPHDTQYTVFHSLIRAMLQVNPEERLSIAE 298
Query: 654 VKLTFHAFHQAQKEGFRLQDVTSAKLAQRRKNKNVS 689
V A + + L Q + +
Sbjct: 299 VV--HQLQEIAAARNVNPKSPITELLEQNGGYGSAT 332
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 82.1 bits (203), Expect = 8e-17
Identities = 25/75 (33%), Positives = 41/75 (54%), Gaps = 9/75 (12%)
Query: 896 YLVLELLKGGELLD---RIRQKGRCGFTENEASRIMRQLVAAVHFMHSRG--VVHRDLKP 950
+L+L L G+L++ ++ +G + + +I Q AV MH + ++HRDLK
Sbjct: 109 FLLLTELCKGQLVEFLKKMESRGP--LSCDTVLKIFYQTCRAVQHMHRQKPPIIHRDLKV 166
Query: 951 ENLLLSGISGNLIKI 965
ENLLLS + IK+
Sbjct: 167 ENLLLS--NQGTIKL 179
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 47.8 bits (114), Expect = 1e-05
Identities = 13/55 (23%), Positives = 26/55 (47%), Gaps = 5/55 (9%)
Query: 124 LGDGSYSVCRRCVEKSTGQEYAVKIISRKIDCSE-----EINLLRACQGHPNICR 173
L +G ++ + +G+EYA+K + + E+ ++ GHPNI +
Sbjct: 36 LAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRAIIQEVCFMKKLSGHPNIVQ 90
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 41.7 bits (98), Expect = 8e-04
Identities = 13/55 (23%), Positives = 22/55 (40%), Gaps = 5/55 (9%)
Query: 178 KSTGQEYAVKIISRKIDCSE-----EINLLRACQGHPNIVNLHCVFQDEVIDWDD 227
+G+EYA+K + + E+ ++ GHPNIV + D
Sbjct: 50 VGSGREYALKRLLSNEEEKNRAIIQEVCFMKKLSGHPNIVQFCSAASIGKEESDT 104
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 196 bits (499), Expect = 3e-56
Identities = 67/304 (22%), Positives = 109/304 (35%), Gaps = 55/304 (18%)
Query: 355 SPAIVPPNFDKIFKGSLFFEQYDMDLDKAGILGDGSYSVCRRCVEKSTGQEYAVKIISR- 413
S + P +D S F + + + LG GSY + K G+ YAVK
Sbjct: 38 SETLQSPGYDPSRPESFFQQSFQ----RLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSP 93
Query: 414 ------KIDCSEEINLLRACQGHPNIVNLHCVFQDEVHTYLVLELLKGGELLDRIRQKGR 467
+ E+ HP V L +++ YL EL G L G
Sbjct: 94 FRGPKDRARKLAEVGSHEKVGQHPCCVRLEQAWEEGGILYLQTELC-GPSLQQHCEAWGA 152
Query: 468 CGFTENEASRIMRQLVAAVHFMHSRGVVHRDLKPENLLFSDPAGDNIKVVDFGFACL--K 525
E + +R + A+ +HS+G+VH D+KP N +F P G K+ DFG
Sbjct: 153 S-LPEAQVWGYLRDTLLALAHLHSQGLVHLDVKPAN-IFLGPRG-RCKLGDFGLLVELGT 209
Query: 526 RESLHTPCFTLQYAAPEVLRQDKSGYDENCDLWSLGVILVNVLRQDKSGYDENCDLWSLG 585
+ +Y APE+L+ Y D++SLG
Sbjct: 210 AGAGEVQEGDPRYMAPELLQ---------------------------GSYGTAADVFSLG 242
Query: 586 VILYTMLCGR-VPFHARSRDDSALSIMARIKEGQFNFDAEAWSTVSSEAKELTKSLLTVN 644
+ + + C +P ++++G E + +SSE + + +L +
Sbjct: 243 LTILEVACNMELPHGGEG--------WQQLRQG--YLPPEFTAGLSSELRSVLVMMLEPD 292
Query: 645 PAQR 648
P R
Sbjct: 293 PKLR 296
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 79.7 bits (197), Expect = 4e-16
Identities = 21/72 (29%), Positives = 31/72 (43%), Gaps = 4/72 (5%)
Query: 894 HTYLVLELLKGGELLDRIRQKGRCGFTENEASRIMRQLVAAVHFMHSRGVVHRDLKPENL 953
YL EL G L G E + +R + A+ +HS+G+VH D+KP N+
Sbjct: 131 ILYLQTELC-GPSLQQHCEAWGAS-LPEAQVWGYLRDTLLALAHLHSQGLVHLDVKPANI 188
Query: 954 LLSGISGNLIKI 965
L K+
Sbjct: 189 FLG--PRGRCKL 198
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 53.9 bits (130), Expect = 1e-07
Identities = 12/51 (23%), Positives = 18/51 (35%), Gaps = 7/51 (13%)
Query: 263 YRRILKTEPPIPEDLSPDVADFISRLLVKDPRRRLGGGELDAEELKRHPFF 313
+ L P LS ++ + +L DP+ R AE L P
Sbjct: 265 RQGYLP--PEFTAGLSSELRSVLVMMLEPDPKLRAT-----AEALLALPVL 308
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 51.2 bits (123), Expect = 6e-07
Identities = 17/75 (22%), Positives = 24/75 (32%), Gaps = 11/75 (14%)
Query: 106 KGSLFFEQYDMDLDKAGILGDGSYSVCRRCVEKSTGQEYAVKIISR-------KIDCSEE 158
S F + + + LG GSY + K G+ YAVK + E
Sbjct: 51 PESFFQQSFQ----RLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAE 106
Query: 159 INLLRACQGHPNICR 173
+ HP R
Sbjct: 107 VGSHEKVGQHPCCVR 121
|
| >1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310 | Back alignment and structure |
|---|
Score = 195 bits (499), Expect = 4e-56
Identities = 79/284 (27%), Positives = 133/284 (46%), Gaps = 52/284 (18%)
Query: 379 DLDKAGILGDGSYSVCRRCVEKSTGQEYAVKIIS-------RKIDC-SEEINLLRACQGH 430
D ILG+GS+S E +T +EYA+KI+ K+ + E +++ H
Sbjct: 31 DFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLD-H 89
Query: 431 PNIVNLHCVFQDEVHTYLVLELLKGGELLDRIRQKGRCGFTENEASRIMRQLVAAVHFMH 490
P V L+ FQD+ Y L K GELL IR+ G F E ++V+A+ ++H
Sbjct: 90 PFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGS--FDETCTRFYTAEIVSALEYLH 147
Query: 491 SRGVVHRDLKPENLLFSDPAGDNIKVVDFGFA-----CLKRESLHTPCFTLQYAAPEVLR 545
+G++HRDLKPEN+L + +I++ DFG A K+ ++ T QY +PE+L
Sbjct: 148 GKGIIHRDLKPENILL-NEDM-HIQITDFGTAKVLSPESKQARANSFVGTAQYVSPELLT 205
Query: 546 QDKSGYDENCDLWSLGVILVNVLRQDKSGYDENCDLWSLGVILYTMLCGRVPFHARSRDD 605
+ ++ DLW+LG I+Y ++ G PF A +
Sbjct: 206 --------------------------EKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYL 239
Query: 606 SALSIMARIKEGQFNFDAEAWSTVSSEAKELTKSLLTVNPAQRI 649
I +I + +++F +A++L + LL ++ +R+
Sbjct: 240 ----IFQKIIKLEYDF----PEKFFPKARDLVEKLLVLDATKRL 275
|
| >1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310 | Back alignment and structure |
|---|
Score = 89.6 bits (223), Expect = 1e-19
Identities = 24/66 (36%), Positives = 36/66 (54%), Gaps = 1/66 (1%)
Query: 263 YRRILKTEPPIPEDLSPDVADFISRLLVKDPRRRLGGGEL-DAEELKRHPFFNVIDWDDL 321
+++I+K E PE P D + +LLV D +RLG E+ LK HPFF + W++L
Sbjct: 241 FQKIIKLEYDFPEKFFPKARDLVEKLLVLDATKRLGCEEMEGYGPLKAHPFFESVTWENL 300
Query: 322 ATKRIP 327
+ P
Sbjct: 301 HQQTPP 306
|
| >1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310 | Back alignment and structure |
|---|
Score = 77.3 bits (191), Expect = 2e-15
Identities = 26/60 (43%), Positives = 37/60 (61%), Gaps = 2/60 (3%)
Query: 896 YLVLELLKGGELLDRIRQKGRCGFTENEASRIMRQLVAAVHFMHSRGVVHRDLKPENLLL 955
Y L K GELL IR+ G F E ++V+A+ ++H +G++HRDLKPEN+LL
Sbjct: 106 YFGLSYAKNGELLKYIRKIGS--FDETCTRFYTAEIVSALEYLHGKGIIHRDLKPENILL 163
|
| >1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310 | Back alignment and structure |
|---|
Score = 44.5 bits (106), Expect = 1e-04
Identities = 24/107 (22%), Positives = 39/107 (36%), Gaps = 37/107 (34%)
Query: 117 DLDKAGILGDGSYSVCRRCVEKSTGQEYAVKIISRKIDCSEEINLLRACQGHPNICRRCV 176
D ILG+GS+S E +T +EYA+KI+ ++
Sbjct: 31 DFKFGKILGEGSFSTVVLARELATSREYAIKILEKR------------------------ 66
Query: 177 EKSTGQEYAVKIISRK-IDC-SEEINLLRACQGHPNIVNLHCVFQDE 221
II + + E +++ HP V L+ FQD+
Sbjct: 67 ----------HIIKENKVPYVTRERDVMSRLD-HPFFVKLYFTFQDD 102
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371 | Back alignment and structure |
|---|
Score = 197 bits (502), Expect = 4e-56
Identities = 52/361 (14%), Positives = 99/361 (27%), Gaps = 69/361 (19%)
Query: 346 EFTKMIPADSPAIVPPNFDKIFKGSLFFEQYDMDLDKAGILGDGSYSVCRRCVEKSTGQE 405
E M+ A + + P N + L + + L + L G SV + ++
Sbjct: 32 EPAAMVEAVTATVWPQNAETTVDSLLSQGERKLKLVE--PLRVGDRSVVFLVRDVERLED 89
Query: 406 YAVKIISRKIDCS--------EEINLLRAC-----------------------QGHPNIV 434
+A+K+ + + S E Q P
Sbjct: 90 FALKVFTMGAENSRSELERLHEATFAAARLLGESPEEARDRRRLLLPSDAVAVQSQPPFA 149
Query: 435 NLHCVFQDE--VHTYLVLELLKG-----GELLDRIRQKGRCGFTENEASRIMRQLVAAVH 487
L D + L++ LD + + QL+
Sbjct: 150 QLSPGQDDYAVANYLLLMPAASVDLELLFSTLDFVYVFRGD-EGILALHILTAQLIRLAA 208
Query: 488 FMHSRGVVHRDLKPENLLFSDPAGDNIKVVDFGFACLKRESLHTPCFTLQYAAPEVLRQD 547
+ S+G+VH P+NL + + D + YA E
Sbjct: 209 NLQSKGLVHGHFTPDNLFIMP--DGRLMLGDVSALWKVGTRGPASSVPVTYAPRE----- 261
Query: 548 KSGYDENCDLWSLGVILVNVLRQDKSGYDENCDLWSLGVILYTMLCGRVPFHARSRDDSA 607
L + + + W LG+ +Y + C +PF +
Sbjct: 262 -------------------FLNASTATFTHALNAWQLGLSIYRVWCLFLPFGLVTPGIKG 302
Query: 608 LSIMARIKE-GQFNFDAEAWSTVSSEAKELTKSLLTVNPAQRIRMMRVKLTFHAFHQAQK 666
++ G + + + + K L L + +R+ + + F Q Q
Sbjct: 303 SWKRPSLRVPGTDSLAFGSCTPLPDFVKTLIGRFLNFDRRRRLLPLEA-METPEFLQLQN 361
Query: 667 E 667
E
Sbjct: 362 E 362
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371 | Back alignment and structure |
|---|
Score = 75.1 bits (184), Expect = 2e-14
Identities = 17/134 (12%), Positives = 36/134 (26%), Gaps = 16/134 (11%)
Query: 838 RKKKKADRQPAKQ--EEKQPVPQTTPPTDLVTLFEEQLLGPITRAR--------RRTFVN 887
+ R ++ E + + +LL P + +
Sbjct: 96 TMGAENSRSELERLHEATFAAARLLGESPEEARDRRRLLLPSDAVAVQSQPPFAQLSPGQ 155
Query: 888 RSRYNVHTYLVLELLKG-----GELLDRIRQKGRCGFTENEASRIMRQLVAAVHFMHSRG 942
+ L++ LD + + QL+ + S+G
Sbjct: 156 DDYAVANYLLLMPAASVDLELLFSTLDFVYVFRGD-EGILALHILTAQLIRLAANLQSKG 214
Query: 943 VVHRDLKPENLLLS 956
+VH P+NL +
Sbjct: 215 LVHGHFTPDNLFIM 228
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371 | Back alignment and structure |
|---|
Score = 50.4 bits (120), Expect = 1e-06
Identities = 18/82 (21%), Positives = 24/82 (29%), Gaps = 14/82 (17%)
Query: 242 IIFFIILSFTLSFIHDYYHIQ--YRRILKTEPPIPE-------DLSPDVADFISRLLVKD 292
+ + + L F I+ ++R P L V I R L D
Sbjct: 281 LSIYRVWCLFLPFGLVTPGIKGSWKRPSLRVPGTDSLAFGSCTPLPDFVKTLIGRFLNFD 340
Query: 293 PRRRLGGGELDAEELKRHPFFN 314
RRR L E P F
Sbjct: 341 RRRR-----LLPLEAMETPEFL 357
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371 | Back alignment and structure |
|---|
Score = 47.0 bits (111), Expect = 2e-05
Identities = 11/104 (10%), Positives = 25/104 (24%), Gaps = 13/104 (12%)
Query: 123 ILGDGSYSVCRRCVEKSTGQEYAVKIISRKIDCS--------EEINLLRACQGHPNICRR 174
L G SV + +++A+K+ + + S E +
Sbjct: 69 PLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLL-GESPEEA 127
Query: 175 CVEKSTGQEYAVKIISRKIDCSEEINLLRACQGHPNIVNLHCVF 218
+ + + L Q + N +
Sbjct: 128 RDRRRLLLPSDAVAVQSQ----PPFAQLSPGQDDYAVANYLLLM 167
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384 | Back alignment and structure |
|---|
Score = 191 bits (487), Expect = 9e-54
Identities = 79/275 (28%), Positives = 123/275 (44%), Gaps = 45/275 (16%)
Query: 386 LGDGSYSVCRRCVEKSTGQEYAVKIISRKIDCSE---------EINLLRACQGHPNIVNL 436
+G GS+ + T + YA+K + K C E E+ +++ + HP +VNL
Sbjct: 23 IGKGSFGKVCIVQKNDTKKMYAMKYM-NKQKCVERNEVRNVFKELQIMQGLE-HPFLVNL 80
Query: 437 HCVFQDEVHTYLVLELLKGGELLDRIRQKGRCGFTENEASRIMRQLVAAVHFMHSRGVVH 496
FQDE ++V++LL GG+L ++Q F E + +LV A+ ++ ++ ++H
Sbjct: 81 WYSFQDEEDMFMVVDLLLGGDLRYHLQQNVH--FKEETVKLFICELVMALDYLQNQRIIH 138
Query: 497 RDLKPENLLFSDPAGDNIKVVDFGFA--CLKRESLHTPCFTLQYAAPEVLRQDKSGYDEN 554
RD+KP+N+L D G ++ + DF A + + T T Y APE+
Sbjct: 139 RDMKPDNILL-DEHG-HVHITDFNIAAMLPRETQITTMAGTKPYMAPEMF---------- 186
Query: 555 CDLWSLGVILVNVLRQDKSGYDENCDLWSLGVILYTMLCGRVPFHARSRDDSALSIMARI 614
+ +GY D WSLGV Y +L GR P+H RS S I+
Sbjct: 187 -------------SSRKGAGYSFAVDWWSLGVTAYELLRGRRPYHIRSSTSSK-EIVHTF 232
Query: 615 KEGQFNFDAEAWSTVSSEAKELTKSLLTVNPAQRI 649
+ + S S E L K LL NP QR
Sbjct: 233 ETTVVTYP----SAWSQEMVSLLKKLLEPNPDQRF 263
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384 | Back alignment and structure |
|---|
Score = 115 bits (290), Expect = 1e-27
Identities = 21/96 (21%), Positives = 36/96 (37%), Gaps = 10/96 (10%)
Query: 263 YRRILKTEPPIPEDLSPDVADFISRLLVKDPRRRLGGGELDAEELKRHPFFNVIDWDDLA 322
T P S ++ + +LL +P +R +++ P+ N I+WD +
Sbjct: 229 VHTFETTVVTYPSAWSQEMVSLLKKLLEPNPDQRFSQ----LSDVQNFPYMNDINWDAVF 284
Query: 323 TKRIPAPFVPKISNELDVSNFSDEFT--KMIPADSP 356
KR+ F+P N F +MI P
Sbjct: 285 QKRLIPGFIPNK----GRLNCDPTFELEEMILESKP 316
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384 | Back alignment and structure |
|---|
Score = 73.9 bits (182), Expect = 5e-14
Identities = 20/60 (33%), Positives = 39/60 (65%), Gaps = 2/60 (3%)
Query: 896 YLVLELLKGGELLDRIRQKGRCGFTENEASRIMRQLVAAVHFMHSRGVVHRDLKPENLLL 955
++V++LL GG+L ++Q F E + +LV A+ ++ ++ ++HRD+KP+N+LL
Sbjct: 91 FMVVDLLLGGDLRYHLQQNVH--FKEETVKLFICELVMALDYLQNQRIIHRDMKPDNILL 148
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 Length = 355 | Back alignment and structure |
|---|
Score = 186 bits (474), Expect = 3e-52
Identities = 83/279 (29%), Positives = 137/279 (49%), Gaps = 48/279 (17%)
Query: 386 LGDGSYS---VCRRCVEKSTGQEYAVKI-----ISRKIDCSE----EINLLRACQGHPNI 433
LG G+Y + R+ TG+ YA+K+ I +K +E E +L + P +
Sbjct: 62 LGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFL 121
Query: 434 VNLHCVFQDEVHTYLVLELLKGGELLDRIRQKGRCGFTENEASRIMRQLVAAVHFMHSRG 493
V LH FQ E +L+L+ + GGEL + Q+ R FTE+E + ++V A+ +H G
Sbjct: 122 VTLHYAFQTETKLHLILDYINGGELFTHLSQRER--FTEHEVQIYVGEIVLALEHLHKLG 179
Query: 494 VVHRDLKPENLLFSDPAGDNIKVVDFGFA----CLKRESLHTPCFTLQYAAPEVLRQDKS 549
+++RD+K EN+L D G ++ + DFG + + E + C T++Y AP+++R S
Sbjct: 180 IIYRDIKLENILL-DSNG-HVVLTDFGLSKEFVADETERAYDFCGTIEYMAPDIVRGGDS 237
Query: 550 GYDENCDLWSLGVILVNVLRQDKSGYDENCDLWSLGVILYTMLCGRVPFHARSRDDSALS 609
G+D+ D W WSLGV++Y +L G PF +S
Sbjct: 238 GHDKAVD-W-----------------------WSLGVLMYELLTGASPFTVDGEKNSQAE 273
Query: 610 IMARIKEGQFNFDAEAWSTVSSEAKELTKSLLTVNPAQR 648
I RI + + + +S+ AK+L + LL +P +R
Sbjct: 274 ISRRILKSEPPYP----QEMSALAKDLIQRLLMKDPKKR 308
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 Length = 355 | Back alignment and structure |
|---|
Score = 130 bits (328), Expect = 7e-33
Identities = 49/81 (60%), Positives = 62/81 (76%)
Query: 263 YRRILKTEPPIPEDLSPDVADFISRLLVKDPRRRLGGGELDAEELKRHPFFNVIDWDDLA 322
RRILK+EPP P+++S D I RLL+KDP++RLG G DA+E+K H FF I+WDDLA
Sbjct: 275 SRRILKSEPPYPQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEHLFFQKINWDDLA 334
Query: 323 TKRIPAPFVPKISNELDVSNF 343
K++PAPF P I +ELDVSNF
Sbjct: 335 AKKVPAPFKPVIRDELDVSNF 355
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 Length = 355 | Back alignment and structure |
|---|
Score = 71.6 bits (176), Expect = 2e-13
Identities = 23/60 (38%), Positives = 40/60 (66%), Gaps = 2/60 (3%)
Query: 896 YLVLELLKGGELLDRIRQKGRCGFTENEASRIMRQLVAAVHFMHSRGVVHRDLKPENLLL 955
+L+L+ + GGEL + Q+ R FTE+E + ++V A+ +H G+++RD+K EN+LL
Sbjct: 135 HLILDYINGGELFTHLSQRER--FTEHEVQIYVGEIVLALEHLHKLGIIYRDIKLENILL 192
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310 | Back alignment and structure |
|---|
Score = 183 bits (467), Expect = 8e-52
Identities = 68/276 (24%), Positives = 116/276 (42%), Gaps = 46/276 (16%)
Query: 386 LGDGSYSVCRRCVEKSTGQEYAVKIISR--------KIDCSEEINLLRACQGHPNIVNLH 437
+G G +S R G A+K + + DC +EI+LL+ HPN++ +
Sbjct: 40 IGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLN-HPNVIKYY 98
Query: 438 CVFQDEVHTYLVLELLKGGELLDRIRQKGRCG--FTENEASRIMRQLVAAVHFMHSRGVV 495
F ++ +VLEL G+L I+ + E + QL +A+ MHSR V+
Sbjct: 99 ASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMHSRRVM 158
Query: 496 HRDLKPENLLFSDPAGDNIKVVDFGFACL---KRESLHTPCFTLQYAAPEVLRQDKSGYD 552
HRD+KP N+ + A +K+ D G K + H+ T Y +PE + +
Sbjct: 159 HRDIKPANVFIT--ATGVVKLGDLGLGRFFSSKTTAAHSLVGTPYYMSPERIHE------ 210
Query: 553 ENCDLWSLGVILVNVLRQDKSGYDENCDLWSLGVILYTMLCGRVPFHARSRDDSALSIMA 612
+GY+ D+WSLG +LY M + PF+ + +L
Sbjct: 211 --------------------NGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSL--CK 248
Query: 613 RIKEGQFNFDAEAWSTVSSEAKELTKSLLTVNPAQR 648
+I++ + S E ++L + +P +R
Sbjct: 249 KIEQCD--YPPLPSDHYSEELRQLVNMCINPDPEKR 282
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310 | Back alignment and structure |
|---|
Score = 74.3 bits (183), Expect = 2e-14
Identities = 23/72 (31%), Positives = 39/72 (54%), Gaps = 4/72 (5%)
Query: 896 YLVLELLKGGELLDRIRQKGRCG--FTENEASRIMRQLVAAVHFMHSRGVVHRDLKPENL 953
+VLEL G+L I+ + E + QL +A+ MHSR V+HRD+KP N+
Sbjct: 108 NIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMHSRRVMHRDIKPANV 167
Query: 954 LLSGISGNLIKI 965
++ + ++K+
Sbjct: 168 FIT--ATGVVKL 177
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310 | Back alignment and structure |
|---|
Score = 49.6 bits (119), Expect = 2e-06
Identities = 16/58 (27%), Positives = 26/58 (44%), Gaps = 9/58 (15%)
Query: 124 LGDGSYSVCRRCVEKSTGQEYAVKIISR--------KIDCSEEINLLRACQGHPNICR 173
+G G +S R G A+K + + DC +EI+LL+ HPN+ +
Sbjct: 40 IGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLN-HPNVIK 96
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310 | Back alignment and structure |
|---|
Score = 42.7 bits (101), Expect = 4e-04
Identities = 14/58 (24%), Positives = 25/58 (43%), Gaps = 9/58 (15%)
Query: 172 CRRCVEKSTGQEYAVKIISR--------KIDCSEEINLLRACQGHPNIVNLHCVFQDE 221
R G A+K + + DC +EI+LL+ HPN++ + F ++
Sbjct: 48 VYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLN-HPNVIKYYASFIED 104
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 Length = 318 | Back alignment and structure |
|---|
Score = 183 bits (467), Expect = 8e-52
Identities = 72/271 (26%), Positives = 125/271 (46%), Gaps = 47/271 (17%)
Query: 386 LGDGSYSVCRRCVEKSTGQEYAVK------IISRK-IDCS-EEINLLRACQGHPNIVNLH 437
LG GS+ + G+ YA+K ++ K ++ + +E +L HP I+ +
Sbjct: 14 LGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVT-HPFIIRMW 72
Query: 438 CVFQDEVHTYLVLELLKGGELLDRIRQKGRCGFTENEASRIMRQLVAAVHFMHSRGVVHR 497
FQD +++++ ++GGEL +R+ R F A ++ A+ ++HS+ +++R
Sbjct: 73 GTFQDAQQIFMIMDYIEGGELFSLLRKSQR--FPNPVAKFYAAEVCLALEYLHSKDIIYR 130
Query: 498 DLKPENLLFSDPAGDNIKVVDFGFACLKRESLHTPCFTLQYAAPEVLRQDKSGYDENCDL 557
DLKPEN+L D G +IK+ DFGFA + +T C T Y APEV+
Sbjct: 131 DLKPENILL-DKNG-HIKITDFGFAKYVPDVTYTLCGTPDYIAPEVVS------------ 176
Query: 558 WSLGVILVNVLRQDKSGYDENCDLWSLGVILYTMLCGRVPFHARSRDDSALSIMARIKEG 617
Y+++ D WS G+++Y ML G PF+ + +I
Sbjct: 177 --------------TKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMK----TYEKILNA 218
Query: 618 QFNFDAEAWSTVSSEAKELTKSLLTVNPAQR 648
+ F + + K+L L+T + +QR
Sbjct: 219 ELRF----PPFFNEDVKDLLSRLITRDLSQR 245
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 Length = 318 | Back alignment and structure |
|---|
Score = 128 bits (324), Expect = 1e-32
Identities = 32/108 (29%), Positives = 54/108 (50%), Gaps = 3/108 (2%)
Query: 263 YRRILKTEPPIPEDLSPDVADFISRLLVKDPRRRLGGGELDAEELKRHPFFNVIDWDDLA 322
Y +IL E P + DV D +SRL+ +D +RLG + E++K HP+F + W+ L
Sbjct: 212 YEKILNAELRFPPFFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKNHPWFKEVVWEKLL 271
Query: 323 TKRIPAPFVPKI-SNELDVSNFSDEFTKMIPADSPAIVPPNFDKIFKG 369
++ I P+ P I + D S F D++ + P + +F+
Sbjct: 272 SRNIETPYEPPIQQGQGDTSQF-DKYPEEDINYGVQGEDP-YADLFRD 317
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 Length = 318 | Back alignment and structure |
|---|
Score = 70.3 bits (173), Expect = 4e-13
Identities = 20/60 (33%), Positives = 39/60 (65%), Gaps = 2/60 (3%)
Query: 896 YLVLELLKGGELLDRIRQKGRCGFTENEASRIMRQLVAAVHFMHSRGVVHRDLKPENLLL 955
+++++ ++GGEL +R+ R F A ++ A+ ++HS+ +++RDLKPEN+LL
Sbjct: 82 FMIMDYIEGGELFSLLRKSQR--FPNPVAKFYAAEVCLALEYLHSKDIIYRDLKPENILL 139
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299 | Back alignment and structure |
|---|
Score = 182 bits (464), Expect = 1e-51
Identities = 60/311 (19%), Positives = 108/311 (34%), Gaps = 76/311 (24%)
Query: 372 FFEQYDMDLDKAGILGDGSYSVCRRCVEKSTGQEYAVKIISR------KIDCSEEINLLR 425
+ ++ LG G + V K YA+K I + E+ L
Sbjct: 3 YLTDFE----PIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALA 58
Query: 426 ACQGHPNIVNLHCVFQDEVHT------------YLVLELLKGGELLDRI-RQKGRCGFTE 472
+ HP IV + ++ T Y+ ++L + L D + +
Sbjct: 59 KLE-HPGIVRYFNAWLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERER 117
Query: 473 NEASRIMRQLVAAVHFMHSRGVVHRDLKPENLLFSDPAGDNIKVVDFGFACL-------- 524
+ I Q+ AV F+HS+G++HRDLKP N+ F+ D +KV DFG
Sbjct: 118 SVCLHIFLQIAEAVEFLHSKGLMHRDLKPSNIFFTM--DDVVKVGDFGLVTAMDQDEEEQ 175
Query: 525 -------KRESLHTPCFTLQYAAPEVLRQDKSGYDENCDLWSLGVILVNVLRQDKSGYDE 577
T Y +PE + + Y
Sbjct: 176 TVLTPMPAYARHTGQVGTKLYMSPEQIH--------------------------GNSYSH 209
Query: 578 NCDLWSLGVILYTMLCGRVPFHARSRDDSALSIMARIKEGQFNFDAEAWSTVSSEAKELT 637
D++SLG+IL+ +L PF + + + ++ +F ++ +
Sbjct: 210 KVDIFSLGLILFELLY---PFSTQM---ERVRTLTDVRNLKF---PPLFTQKYPCEYVMV 260
Query: 638 KSLLTVNPAQR 648
+ +L+ +P +R
Sbjct: 261 QDMLSPSPMER 271
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299 | Back alignment and structure |
|---|
Score = 78.9 bits (195), Expect = 5e-16
Identities = 22/80 (27%), Positives = 41/80 (51%), Gaps = 3/80 (3%)
Query: 887 NRSRYNVHTYLVLELLKGGELLDRI-RQKGRCGFTENEASRIMRQLVAAVHFMHSRGVVH 945
S V+ Y+ ++L + L D + + + I Q+ AV F+HS+G++H
Sbjct: 82 QPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQIAEAVEFLHSKGLMH 141
Query: 946 RDLKPENLLLSGISGNLIKI 965
RDLKP N+ + +++K+
Sbjct: 142 RDLKPSNIFFT--MDDVVKV 159
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299 | Back alignment and structure |
|---|
Score = 50.8 bits (122), Expect = 1e-06
Identities = 15/70 (21%), Positives = 23/70 (32%), Gaps = 11/70 (15%)
Query: 110 FFEQYDMDLDKAGILGDGSYSVCRRCVEKSTGQEYAVKIISR------KIDCSEEINLLR 163
+ ++ LG G + V K YA+K I + E+ L
Sbjct: 3 YLTDFE----PIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALA 58
Query: 164 ACQGHPNICR 173
+ HP I R
Sbjct: 59 KLE-HPGIVR 67
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299 | Back alignment and structure |
|---|
Score = 45.8 bits (109), Expect = 3e-05
Identities = 11/66 (16%), Positives = 19/66 (28%), Gaps = 7/66 (10%)
Query: 171 ICRRCVEKSTGQEYAVKIISR------KIDCSEEINLLRACQGHPNIVNLHCVFQDEVID 224
+ K YA+K I + E+ L + HP IV + ++
Sbjct: 20 VVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLE-HPGIVRYFNAWLEKNTT 78
Query: 225 WDDFSR 230
Sbjct: 79 EKLQPS 84
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299 | Back alignment and structure |
|---|
Score = 44.7 bits (106), Expect = 8e-05
Identities = 8/43 (18%), Positives = 14/43 (32%), Gaps = 5/43 (11%)
Query: 271 PPIPEDLSPDVADFISRLLVKDPRRRLGGGELDAEELKRHPFF 313
PP+ P + +L P R +A + + F
Sbjct: 246 PPLFTQKYPCEYVMVQDMLSPSPMER-----PEAINIIENAVF 283
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... Length = 350 | Back alignment and structure |
|---|
Score = 184 bits (468), Expect = 1e-51
Identities = 85/279 (30%), Positives = 130/279 (46%), Gaps = 47/279 (16%)
Query: 379 DLDKAGILGDGSYSVCRRCVEKSTGQEYAVKIISRK--IDCSE------EINLLRACQGH 430
D+ LG GS+ K +G YA+KI+ ++ + + E +L+A
Sbjct: 42 QFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVN-F 100
Query: 431 PNIVNLHCVFQDEVHTYLVLELLKGGELLDRIRQKGRCGFTENEASRIMRQLVAAVHFMH 490
P +V L F+D + Y+V+E + GGE+ +R+ GR F+E A Q+V ++H
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGR--FSEPHARFYAAQIVLTFEYLH 158
Query: 491 SRGVVHRDLKPENLLFSDPAGDNIKVVDFGFACLKRESLHTPCFTLQYAAPEVLRQDKSG 550
S +++RDLKPENLL D G I+V DFGFA + T C T + APE++
Sbjct: 159 SLDLIYRDLKPENLLI-DQQG-YIQVTDFGFAKRVKGRTWTLCGTPEALAPEIILS---- 212
Query: 551 YDENCDLWSLGVILVNVLRQDKSGYDENCDLWSLGVILYTMLCGRVPFHARSRDDSALSI 610
GY++ D W+LGV++Y M G PF A I
Sbjct: 213 ----------------------KGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQ----I 246
Query: 611 MARIKEGQFNFDAEAWSTVSSEAKELTKSLLTVNPAQRI 649
+I G+ F S SS+ K+L ++LL V+ +R
Sbjct: 247 YEKIVSGKVRFP----SHFSSDLKDLLRNLLQVDLTKRF 281
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... Length = 350 | Back alignment and structure |
|---|
Score = 128 bits (323), Expect = 2e-32
Identities = 29/107 (27%), Positives = 47/107 (43%), Gaps = 4/107 (3%)
Query: 263 YRRILKTEPPIPEDLSPDVADFISRLLVKDPRRRLGGGELDAEELKRHPFFNVIDWDDLA 322
Y +I+ + P S D+ D + LL D +R G + ++K H +F DW +
Sbjct: 247 YEKIVSGKVRFPSHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKNHKWFATTDWIAIY 306
Query: 323 TKRIPAPFVPKISNELDVSNFSDEFTKMIPADSPAIVPPNFDKIFKG 369
+++ APF+PK D SNF D++ + S K F
Sbjct: 307 QRKVEAPFIPKFKGPGDTSNF-DDYEEEEIRVSI---NEKCGKEFTE 349
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... Length = 350 | Back alignment and structure |
|---|
Score = 70.8 bits (174), Expect = 4e-13
Identities = 25/60 (41%), Positives = 39/60 (65%), Gaps = 2/60 (3%)
Query: 896 YLVLELLKGGELLDRIRQKGRCGFTENEASRIMRQLVAAVHFMHSRGVVHRDLKPENLLL 955
Y+V+E + GGE+ +R+ GR F+E A Q+V ++HS +++RDLKPENLL+
Sbjct: 117 YMVMEYVAGGEMFSHLRRIGR--FSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLI 174
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412 | Back alignment and structure |
|---|
Score = 183 bits (467), Expect = 8e-51
Identities = 80/284 (28%), Positives = 122/284 (42%), Gaps = 43/284 (15%)
Query: 379 DLDKAGILGDGSYSVCRRCVEKSTGQEYAVKIISRK-------IDCS-EEINLLRACQGH 430
D + ++G G++S K TGQ YA+KI+++ + C EE ++L
Sbjct: 62 DFEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGD-R 120
Query: 431 PNIVNLHCVFQDEVHTYLVLELLKGGELLDRIRQKGRCGFTENEASRIMRQLVAAVHFMH 490
I LH FQDE + YLV+E GG+LL + + G A + ++V A+ +H
Sbjct: 121 RWITQLHFAFQDENYLYLVMEYYVGGDLLTLLSKFGER-IPAEMARFYLAEIVMAIDSVH 179
Query: 491 SRGVVHRDLKPENLLFSDPAGDNIKVVDFGFACLKRESL------HTPCFTLQYAAPEVL 544
G VHRD+KP+N+L D G +I++ DFG + T Y +PE+L
Sbjct: 180 RLGYVHRDIKPDNILL-DRCG-HIRLADFGSC--LKLRADGTVRSLVAVGTPDYLSPEIL 235
Query: 545 RQDKSGYDENCDLWSLGVILVNVLRQDKSGYDENCDLWSLGVILYTMLCGRVPFHARSRD 604
+ G Y CD W+LGV Y M G+ PF+A S
Sbjct: 236 QAVGGGPGTG-------------------SYGPECDWWALGVFAYEMFYGQTPFYADSTA 276
Query: 605 DSALSIMARIKEGQFNFDAEAWSTVSSEAKELTKSLLTVNPAQR 648
++ I+ + E V EA++ + LL P R
Sbjct: 277 ETYGKIVHYKEHLSLPLVDEG---VPEEARDFIQRLLC-PPETR 316
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412 | Back alignment and structure |
|---|
Score = 114 bits (288), Expect = 3e-27
Identities = 32/114 (28%), Positives = 45/114 (39%), Gaps = 12/114 (10%)
Query: 263 YRRILKTE-----PPIPEDLSPDVADFISRLLVKDPRRRLGGGELDAEELKRHPFFNVID 317
Y +I+ + P + E + + DFI RLL P RLG G A + + HPFF +D
Sbjct: 279 YGKIVHYKEHLSLPLVDEGVPEEARDFIQRLL-CPPETRLGRG--GAGDFRTHPFFFGLD 335
Query: 318 WDDLATKRIPAPFVPKISNELDVSNFSDEFTKMIPADSPA--IVPPNFDKIFKG 369
WD L + PF P D NF + S + + G
Sbjct: 336 WDGL--RDSVPPFTPDFEGATDTCNFDLVEDGLTAMVSGGGETLSDIREGAPLG 387
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412 | Back alignment and structure |
|---|
Score = 72.1 bits (177), Expect = 2e-13
Identities = 23/60 (38%), Positives = 35/60 (58%), Gaps = 1/60 (1%)
Query: 896 YLVLELLKGGELLDRIRQKGRCGFTENEASRIMRQLVAAVHFMHSRGVVHRDLKPENLLL 955
YLV+E GG+LL + + G A + ++V A+ +H G VHRD+KP+N+LL
Sbjct: 137 YLVMEYYVGGDLLTLLSKFGER-IPAEMARFYLAEIVMAIDSVHRLGYVHRDIKPDNILL 195
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365 | Back alignment and structure |
|---|
Score = 178 bits (453), Expect = 2e-49
Identities = 43/375 (11%), Positives = 104/375 (27%), Gaps = 89/375 (23%)
Query: 311 PFFNVIDWDDLATKRIPAPFVPKISNEL---------DVSNFSDEFTKMIPADSPAIVPP 361
P + + D + P+ K+ +L N + K+ P
Sbjct: 3 PQMSSLGTVDAPNFIVGNPWDDKLIFKLLSGLSKPVSSYPNTFEWQCKL----------P 52
Query: 362 NFDKIFKGSLFFEQYDMDLDKAGILGDGSYSVCRRCVEKS-----TGQEYAVKIISRKI- 415
+ L + + +LG+G+++ + Q++ +K+
Sbjct: 53 AIKPKTEFQLGSKLVYVH----HLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANP 108
Query: 416 ----DCSEEINLLRACQGHPNIVNLHCVFQDEVHTYLVLELLKGGELLDRIRQKGRC--- 468
++ + L+ + + + + LV EL G LL+ I
Sbjct: 109 WEFYIGTQLMERLKP-SMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEK 167
Query: 469 GFTENEASRIMRQLVAAVHFMHSRGVVHRDLKPENLLFSDPAGD---------NIKVVDF 519
+ +++ + +H ++H D+KP+N + + + + ++D
Sbjct: 168 VMPQGLVISFAMRMLYMIEQVHDCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDL 227
Query: 520 GFACLKR-----ESLHTPCFTLQYAAPEVLRQDKSGYDENCDLWSLGVILVNVLRQDKSG 574
G + + C T + E+L
Sbjct: 228 GQSIDMKLFPKGTIFTAKCETSGFQCVEMLS--------------------------NKP 261
Query: 575 YDENCDLWSLGVILYTMLCGRVPFHARSRDDSALSIMARIKEGQFNFDAEAWSTVSSEAK 634
++ D + + +Y ML G + + + W
Sbjct: 262 WNYQIDYFGVAATVYCMLFGTYMKV--KNEGGECKPEGLFRR---LPHLDMW-------N 309
Query: 635 ELTKSLLTVNPAQRI 649
E +L + +
Sbjct: 310 EFFHVMLNIPDCHHL 324
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365 | Back alignment and structure |
|---|
Score = 81.9 bits (202), Expect = 1e-16
Identities = 15/68 (22%), Positives = 29/68 (42%), Gaps = 3/68 (4%)
Query: 891 YNVHTYLVLELLKGGELLDRIRQKGRC---GFTENEASRIMRQLVAAVHFMHSRGVVHRD 947
+ + LV EL G LL+ I + +++ + +H ++H D
Sbjct: 138 FQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCEIIHGD 197
Query: 948 LKPENLLL 955
+KP+N +L
Sbjct: 198 IKPDNFIL 205
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437 | Back alignment and structure |
|---|
Score = 180 bits (458), Expect = 3e-49
Identities = 77/275 (28%), Positives = 120/275 (43%), Gaps = 44/275 (16%)
Query: 385 ILGDGSYSVCRRCVEKSTGQEYAVKIIS-------RKIDCS-EEINLLRACQGHPNIVNL 436
++G G++ K+ + +A+KI++ + C EE ++L I L
Sbjct: 81 VIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGD-SKWITTL 139
Query: 437 HCVFQDEVHTYLVLELLKGGELLDRIRQKGRCGFTENEASRIMRQLVAAVHFMHSRGVVH 496
H FQD+ + YLV++ GG+LL + K E A + ++V A+ +H VH
Sbjct: 140 HYAFQDDNNLYLVMDYYVGGDLLTLL-SKFEDRLPEEMARFYLAEMVIAIDSVHQLHYVH 198
Query: 497 RDLKPENLLFSDPAGDNIKVVDFGFACLK-----RESLHTPCFTLQYAAPEVLRQDKSGY 551
RD+KP+N+L D G +I++ DFG CLK T Y +PE+L+ + G
Sbjct: 199 RDIKPDNILM-DMNG-HIRLADFGS-CLKLMEDGTVQSSVAVGTPDYISPEILQAMEGG- 254
Query: 552 DENCDLWSLGVILVNVLRQDKSGYDENCDLWSLGVILYTMLCGRVPFHARSRDDSALSIM 611
K Y CD WSLGV +Y ML G PF+A S +
Sbjct: 255 --------------------KGRYGPECDWWSLGVCMYEMLYGETPFYAESLVE----TY 290
Query: 612 ARIKEGQFNFDAEAW-STVSSEAKELTKSLLTVNP 645
+I + F + VS AK+L + L+
Sbjct: 291 GKIMNHKERFQFPTQVTDVSENAKDLIRRLICSRE 325
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437 | Back alignment and structure |
|---|
Score = 111 bits (280), Expect = 3e-26
Identities = 36/120 (30%), Positives = 59/120 (49%), Gaps = 14/120 (11%)
Query: 263 YRRILKTE-----PPIPEDLSPDVADFISRLLVKDPRRRLGGGELDAEELKRHPFFNVID 317
Y +I+ + P D+S + D I RL+ RLG E+ K+HPFF+ ID
Sbjct: 290 YGKIMNHKERFQFPTQVTDVSENAKDLIRRLI-CSREHRLGQN--GIEDFKKHPFFSGID 346
Query: 318 WDDLATKRIPAPFVPKISNELDVSNFSDEFTKMIPADSPAIVPPNFDKIFKGS-LFFEQY 376
WD++ + AP++P++S+ D SNF + + +++ PP F G L F +
Sbjct: 347 WDNI--RNCEAPYIPEVSSPTDTSNFDVDDDCLKNSETM---PPPTHTAFSGHHLPFVGF 401
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437 | Back alignment and structure |
|---|
Score = 69.4 bits (170), Expect = 2e-12
Identities = 21/60 (35%), Positives = 34/60 (56%), Gaps = 1/60 (1%)
Query: 896 YLVLELLKGGELLDRIRQKGRCGFTENEASRIMRQLVAAVHFMHSRGVVHRDLKPENLLL 955
YLV++ GG+LL + K E A + ++V A+ +H VHRD+KP+N+L+
Sbjct: 150 YLVMDYYVGGDLLTLL-SKFEDRLPEEMARFYLAEMVIAIDSVHQLHYVHRDIKPDNILM 208
|
| >3g51_A Ribosomal protein S6 kinase alpha-3; N-terminal kinase domain of P90 ribosomal S6 kinase 2, ATP- binding, nucleotide-binding, phosphoprotein; HET: ANP; 1.80A {Mus musculus} PDB: 2z7q_A* 2z7r_A* 2z7s_A* Length = 325 | Back alignment and structure |
|---|
Score = 175 bits (447), Expect = 5e-49
Identities = 83/279 (29%), Positives = 134/279 (48%), Gaps = 58/279 (20%)
Query: 386 LGDGSYS---VCRRCVEKSTGQEYAVKIISRK-------IDCSEEINLLRACQGHPNIVN 435
LG GS+ + ++ Q YA+K++ + + E ++L HP IV
Sbjct: 32 LGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVN-HPFIVK 90
Query: 436 LHCVFQDEVHTYLVLELLKGGELLDRIRQKGRCGFTENEASRIMRQLVAAVHFMHSRGVV 495
LH FQ E YL+L+ L+GG+L R+ ++ FTE + + +L A+ +HS G++
Sbjct: 91 LHYAFQTEGKLYLILDFLRGGDLFTRLSKEVM--FTEEDVKFYLAELALALDHLHSLGII 148
Query: 496 HRDLKPENLLFSDPAGDNIKVVDFGFACLKRESL------HTPCFTLQYAAPEVLRQDKS 549
+RDLKPEN+L D G +IK+ DFG L +ES+ ++ C T++Y APEV+
Sbjct: 149 YRDLKPENILL-DEEG-HIKLTDFG---LSKESIDHEKKAYSFCGTVEYMAPEVVN---- 199
Query: 550 GYDENCDLWSLGVILVNVLRQDKSGYDENCDLWSLGVILYTMLCGRVPFHARSRDDSALS 609
+ G+ ++ D WS GV+++ ML G +PF + R +
Sbjct: 200 ----------------------RRGHTQSADWWSFGVLMFEMLTGTLPFQGKDRKE---- 233
Query: 610 IMARIKEGQFNFDAEAWSTVSSEAKELTKSLLTVNPAQR 648
M I + + +S EA+ L + L NPA R
Sbjct: 234 TMTMILKAKLGMP----QFLSPEAQSLLRMLFKRNPANR 268
|
| >3g51_A Ribosomal protein S6 kinase alpha-3; N-terminal kinase domain of P90 ribosomal S6 kinase 2, ATP- binding, nucleotide-binding, phosphoprotein; HET: ANP; 1.80A {Mus musculus} PDB: 2z7q_A* 2z7r_A* 2z7s_A* Length = 325 | Back alignment and structure |
|---|
Score = 143 bits (362), Expect = 1e-37
Identities = 34/90 (37%), Positives = 45/90 (50%)
Query: 263 YRRILKTEPPIPEDLSPDVADFISRLLVKDPRRRLGGGELDAEELKRHPFFNVIDWDDLA 322
ILK + +P+ LSP+ + L ++P RLG G EE+KRH FF+ IDW+ L
Sbjct: 235 MTMILKAKLGMPQFLSPEAQSLLRMLFKRNPANRLGAGPDGVEEIKRHSFFSTIDWNKLY 294
Query: 323 TKRIPAPFVPKISNELDVSNFSDEFTKMIP 352
+ I PF P D F EFT P
Sbjct: 295 RREIHPPFKPATGRPEDTFYFDPEFTAKTP 324
|
| >3g51_A Ribosomal protein S6 kinase alpha-3; N-terminal kinase domain of P90 ribosomal S6 kinase 2, ATP- binding, nucleotide-binding, phosphoprotein; HET: ANP; 1.80A {Mus musculus} PDB: 2z7q_A* 2z7r_A* 2z7s_A* Length = 325 | Back alignment and structure |
|---|
Score = 70.7 bits (174), Expect = 4e-13
Identities = 25/60 (41%), Positives = 41/60 (68%), Gaps = 2/60 (3%)
Query: 896 YLVLELLKGGELLDRIRQKGRCGFTENEASRIMRQLVAAVHFMHSRGVVHRDLKPENLLL 955
YL+L+ L+GG+L R+ ++ FTE + + +L A+ +HS G+++RDLKPEN+LL
Sbjct: 102 YLILDFLRGGDLFTRLSKEVM--FTEEDVKFYLAELALALDHLHSLGIIYRDLKPENILL 159
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* Length = 327 | Back alignment and structure |
|---|
Score = 175 bits (445), Expect = 9e-49
Identities = 86/281 (30%), Positives = 136/281 (48%), Gaps = 60/281 (21%)
Query: 386 LGDGSYS---VCRRCVEKSTGQEYAVKI-----ISRKIDCSE----EINLLRACQGHPNI 433
LG G Y R+ +TG+ +A+K+ I R + E N+L + HP I
Sbjct: 25 LGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVK-HPFI 83
Query: 434 VNLHCVFQDEVHTYLVLELLKGGELLDRIRQKGRCGFTENEASRIMRQLVAAVHFMHSRG 493
V+L FQ YL+LE L GGEL ++ ++G F E+ A + ++ A+ +H +G
Sbjct: 84 VDLIYAFQTGGKLYLILEYLSGGELFMQLEREGI--FMEDTACFYLAEISMALGHLHQKG 141
Query: 494 VVHRDLKPENLLFSDPAGDNIKVVDFGFACLKRESL------HTPCFTLQYAAPEVLRQD 547
+++RDLKPEN++ + G ++K+ DFG L +ES+ HT C T++Y APE+L
Sbjct: 142 IIYRDLKPENIML-NHQG-HVKLTDFG---LCKESIHDGTVTHTFCGTIEYMAPEILM-- 194
Query: 548 KSGYDENCDLWSLGVILVNVLRQDKSGYDENCDLWSLGVILYTMLCGRVPFHARSRDDSA 607
+SG++ D WSLG ++Y ML G PF +R
Sbjct: 195 ------------------------RSGHNRAVDWWSLGALMYDMLTGAPPFTGENRKK-- 228
Query: 608 LSIMARIKEGQFNFDAEAWSTVSSEAKELTKSLLTVNPAQR 648
+ +I + + N ++ EA++L K LL N A R
Sbjct: 229 --TIDKILKCKLNLP----PYLTQEARDLLKKLLKRNAASR 263
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* Length = 327 | Back alignment and structure |
|---|
Score = 150 bits (382), Expect = 3e-40
Identities = 36/95 (37%), Positives = 57/95 (60%)
Query: 263 YRRILKTEPPIPEDLSPDVADFISRLLVKDPRRRLGGGELDAEELKRHPFFNVIDWDDLA 322
+ILK + +P L+ + D + +LL ++ RLG G DA E++ HPFF I+W++L
Sbjct: 230 IDKILKCKLNLPPYLTQEARDLLKKLLKRNAASRLGAGPGDAGEVQAHPFFRHINWEELL 289
Query: 323 TKRIPAPFVPKISNELDVSNFSDEFTKMIPADSPA 357
+++ PF P + +E DVS F +FT+ P DSP
Sbjct: 290 ARKVEPPFKPLLQSEEDVSQFDSKFTRQTPVDSPD 324
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* Length = 327 | Back alignment and structure |
|---|
Score = 70.6 bits (174), Expect = 4e-13
Identities = 24/60 (40%), Positives = 41/60 (68%), Gaps = 2/60 (3%)
Query: 896 YLVLELLKGGELLDRIRQKGRCGFTENEASRIMRQLVAAVHFMHSRGVVHRDLKPENLLL 955
YL+LE L GGEL ++ ++G F E+ A + ++ A+ +H +G+++RDLKPEN++L
Sbjct: 97 YLILEYLSGGELFMQLEREGI--FMEDTACFYLAEISMALGHLHQKGIIYRDLKPENIML 154
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410 | Back alignment and structure |
|---|
Score = 177 bits (451), Expect = 1e-48
Identities = 78/283 (27%), Positives = 127/283 (44%), Gaps = 47/283 (16%)
Query: 379 DLDKAGILGDGSYSVCRRCVEKSTGQEYAVKIISRK-------IDCS-EEINLLRACQGH 430
D + ++G G++ + KST + YA+K++S+ EE +++
Sbjct: 70 DYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFAN-S 128
Query: 431 PNIVNLHCVFQDEVHTYLVLELLKGGELLDRIRQKGRCGFTENEASRIMRQLVAAVHFMH 490
P +V L FQD+ + Y+V+E + GG+L+ + E A ++V A+ +H
Sbjct: 129 PWVVQLFYAFQDDRYLYMVMEYMPGGDLV-NLMSNYD--VPEKWARFYTAEVVLALDAIH 185
Query: 491 SRGVVHRDLKPENLLFSDPAGDNIKVVDFGFACLKRESL-----HTPCFTLQYAAPEVLR 545
S G +HRD+KP+N+L D +G ++K+ DFG C+K T T Y +PEVL+
Sbjct: 186 SMGFIHRDVKPDNMLL-DKSG-HLKLADFGT-CMKMNKEGMVRCDTAVGTPDYISPEVLK 242
Query: 546 QDKSGYDENCDLWSLGVILVNVLRQDKSGYDENCDLWSLGVILYTMLCGRVPFHARSRDD 605
+ Y CD WS+GV LY ML G PF+A S
Sbjct: 243 S----------------------QGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVG 280
Query: 606 SALSIMARIKEGQFNFDAEAWSTVSSEAKELTKSLLTVNPAQR 648
++I + + + +S EAK L + LT + R
Sbjct: 281 ----TYSKIMNHKNSLTFPDDNDISKEAKNLICAFLT-DREVR 318
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410 | Back alignment and structure |
|---|
Score = 114 bits (286), Expect = 4e-27
Identities = 32/114 (28%), Positives = 48/114 (42%), Gaps = 11/114 (9%)
Query: 263 YRRILKTEPPIP----EDLSPDVADFISRLLVKDPRRRLGGGELDAEELKRHPFFNVIDW 318
Y +I+ + + D+S + + I L D RLG EE+KRH FF W
Sbjct: 282 YSKIMNHKNSLTFPDDNDISKEAKNLICAFL-TDREVRLGRN--GVEEIKRHLFFKNDQW 338
Query: 319 DDLATKRIPAPFVPKISNELDVSNFSDEFTKMIPADSPAIVPPNF---DKIFKG 369
+ AP VP +S+++D SNF D ++ +P F F G
Sbjct: 339 AWETLRDTVAPVVPDLSSDIDTSNFDDLEEDKGEEETFP-IPKAFVGNQLPFVG 391
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410 | Back alignment and structure |
|---|
Score = 68.2 bits (167), Expect = 4e-12
Identities = 21/60 (35%), Positives = 35/60 (58%), Gaps = 3/60 (5%)
Query: 896 YLVLELLKGGELLDRIRQKGRCGFTENEASRIMRQLVAAVHFMHSRGVVHRDLKPENLLL 955
Y+V+E + GG+L+ + E A ++V A+ +HS G +HRD+KP+N+LL
Sbjct: 145 YMVMEYMPGGDLV-NLMSNYD--VPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLL 201
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576 | Back alignment and structure |
|---|
Score = 180 bits (459), Expect = 2e-48
Identities = 85/376 (22%), Positives = 150/376 (39%), Gaps = 63/376 (16%)
Query: 301 ELDAEELKRHPFFNVIDWDDLATKRIPAPFVPK-----ISNELDVSNFSDEFTKMIPADS 355
E+ ++ ++ N+ T P VP+ + L+ D F ++
Sbjct: 91 EVTPDDKRKACGRNLTQNFLSHTGPDLIPEVPRQLVTNCTQRLEQGPCKDLFQELTRLTH 150
Query: 356 PAIVPPNFDKIFKGSLFFEQY----DMDLDKAGI--------LGDGSYS-VCRRCVEKST 402
+ F + S++F ++ ++ LG G + VC C ++T
Sbjct: 151 EYLSVAPFAD-YLDSIYFNRFLQWKWLERQPVTKNTFRQYRVLGKGGFGEVCA-CQVRAT 208
Query: 403 GQEYAVKIISRK-------IDCS-EEINLLRACQGHPNIVNLHCVFQDEVHTYLVLELLK 454
G+ YA K + +K + E +L +V+L ++ + LVL L+
Sbjct: 209 GKMYACKKLEKKRIKKRKGEAMALNEKQILEKVN-SRFVVSLAYAYETKDALCLVLTLMN 267
Query: 455 GGELLDRIRQKGRCGFTENEASRIMRQLVAAVHFMHSRGVVHRDLKPENLLFSDPAGDNI 514
GG+L I G+ GF E A ++ + +H +V+RDLKPEN+L D G +I
Sbjct: 268 GGDLKFHIYHMGQAGFPEARAVFYAAEICCGLEDLHRERIVYRDLKPENILL-DDHG-HI 325
Query: 515 KVVDFGFAC--LKRESLHTPCFTLQYAAPEVLRQDKSGYDENCDLWSLGVILVNVLRQDK 572
++ D G A + +++ T+ Y APEV++
Sbjct: 326 RISDLGLAVHVPEGQTIKGRVGTVGYMAPEVVK--------------------------N 359
Query: 573 SGYDENCDLWSLGVILYTMLCGRVPFHARSRDDSALSIMARIKEGQFNFDAEAWSTVSSE 632
Y + D W+LG +LY M+ G+ PF R + + +KE + S +
Sbjct: 360 ERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVKEVPEEYS----ERFSPQ 415
Query: 633 AKELTKSLLTVNPAQR 648
A+ L LL +PA+R
Sbjct: 416 ARSLCSQLLCKDPAER 431
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576 | Back alignment and structure |
|---|
Score = 122 bits (308), Expect = 4e-29
Identities = 27/97 (27%), Positives = 36/97 (37%), Gaps = 2/97 (2%)
Query: 263 YRRILKTEPPIPEDLSPDVADFISRLLVKDPRRRLGGGELDAEELKRHPFFNVIDWDDLA 322
R + + E SP S+LL KDP RLG A E+K HP F +++ L
Sbjct: 398 ERLVKEVPEEYSERFSPQARSLCSQLLCKDPAERLGCRGGSAREVKEHPLFKKLNFKRLG 457
Query: 323 TKRIPAPFVPKIS--NELDVSNFSDEFTKMIPADSPA 357
+ PF P DV + T P
Sbjct: 458 AGMLEPPFKPDPQAIYCKDVLDIEQFSTVKGVELEPT 494
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576 | Back alignment and structure |
|---|
Score = 74.1 bits (182), Expect = 1e-13
Identities = 24/62 (38%), Positives = 34/62 (54%)
Query: 894 HTYLVLELLKGGELLDRIRQKGRCGFTENEASRIMRQLVAAVHFMHSRGVVHRDLKPENL 953
LVL L+ GG+L I G+ GF E A ++ + +H +V+RDLKPEN+
Sbjct: 258 ALCLVLTLMNGGDLKFHIYHMGQAGFPEARAVFYAAEICCGLEDLHRERIVYRDLKPENI 317
Query: 954 LL 955
LL
Sbjct: 318 LL 319
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413 | Back alignment and structure |
|---|
Score = 171 bits (435), Expect = 1e-46
Identities = 52/328 (15%), Positives = 99/328 (30%), Gaps = 74/328 (22%)
Query: 380 LDKAGILGDGSYSVCRRCVEKSTGQEYAVKIISRKIDCS--------EEINLLRACQG-- 429
L + +LG ++ TG+ + V + EE+ LR +G
Sbjct: 80 LVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIK 139
Query: 430 -------------------HPNIVNLHCVFQDEVHTYLVLELL-----------KGGELL 459
P + V DE +++ G LL
Sbjct: 140 NQKQAKVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLL 199
Query: 460 DRIRQKGRCGFTENEASRIMRQLVAAVHFMHSRGVVHRDLKPENLLFSDPAGDNIKVVDF 519
+ ++ Q++ + +H G+VH L+P +++ D G + + F
Sbjct: 200 SHSSTHKS--LVHHARLQLTLQVIRLLASLHHYGLVHTYLRPVDIVL-DQRG-GVFLTGF 255
Query: 520 GFACLKRESLHTPCFTLQYAAPEVLRQDKSGYDENCDLWSLGVILVNVLRQDKSGYDENC 579
S +P +A PE ++ + +
Sbjct: 256 EHLVRDGASAVSPI-GRGFAPPET----------------TAERMLPFGQHHPTLMTFAF 298
Query: 580 DLWSLGVILYTMLCGRVPFHARSRDDSALSIMARIKEGQFNFDAEAWSTVSSEAKELTKS 639
D W+LG+ +Y + C +P DD+AL I N + + L +
Sbjct: 299 DTWTLGLAIYWIWCADLPNT----DDAALGGSEWIFRSCKN--------IPQPVRALLEG 346
Query: 640 LLTVNPAQRIRMMRVKLTFHAFHQAQKE 667
L R+ ++ T + Q + E
Sbjct: 347 FLRYPKEDRLLPLQAMET-PEYEQLRTE 373
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413 | Back alignment and structure |
|---|
Score = 72.8 bits (178), Expect = 2e-13
Identities = 12/79 (15%), Positives = 27/79 (34%), Gaps = 5/79 (6%)
Query: 883 RTFVNRSRYNVHTYLVLELLKGGELLDRIRQKGRCG-----FTENEASRIMRQLVAAVHF 937
R ++ V + L L + ++ Q++ +
Sbjct: 167 RVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLAS 226
Query: 938 MHSRGVVHRDLKPENLLLS 956
+H G+VH L+P +++L
Sbjct: 227 LHHYGLVHTYLRPVDIVLD 245
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413 | Back alignment and structure |
|---|
Score = 51.2 bits (122), Expect = 9e-07
Identities = 12/88 (13%), Positives = 22/88 (25%), Gaps = 9/88 (10%)
Query: 242 IIFFIILSFTLSFIHDYYHIQYRRILKTEPPIPEDLSPDVADFISRLLVKDPRRRLGGGE 301
+ + I L D I ++ IP V + L R
Sbjct: 305 LAIYWIWCADLPNTDDAALGGSEWIFRSCKNIP----QPVRALLEGFLRYPKEDR----- 355
Query: 302 LDAEELKRHPFFNVIDWDDLATKRIPAP 329
L + P + + + A +
Sbjct: 356 LLPLQAMETPEYEQLRTELSAALPLYQT 383
|
| >3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695 | Back alignment and structure |
|---|
Score = 177 bits (450), Expect = 2e-46
Identities = 92/442 (20%), Positives = 152/442 (34%), Gaps = 92/442 (20%)
Query: 264 RRILKTEPPIPEDLSPDVADFISRLLVKDPRRRLGG------GELDAEELKRHPFFN--V 315
++IL EP I + + D K ++LG EE K F +
Sbjct: 30 KKILLPEPSIRSVMQKYLEDRGEVTFEKIFSQKLGYLLFRDFCLKHLEEAKPLVEFYEEI 89
Query: 316 IDWDDLATK------------------------RIPAPFVPKISNELDVSNFSDEFTKMI 351
++ L T+ + + L + +
Sbjct: 90 KKYEKLETEEERLVCSREIFDTYIMKELLACSHPFSKSAIEHVQGHLVKKQVPPDLFQPY 149
Query: 352 PADSPAIVPPNFDKIFKGSLFFEQYDM-------------DLDKAGILGDGSY-SVCRRC 397
+ + + + F S F ++ D I+G G + V C
Sbjct: 150 IEEICQNLRGDVFQKFIESDKFTRFCQWKNVELNIHLTMNDFSVHRIIGRGGFGEVYG-C 208
Query: 398 VEKSTGQEYAVK------IISRK-IDCS-EEINLLRACQG--HPNIVNLHCVFQDEVHTY 447
+ TG+ YA+K I ++ + E +L P IV + F
Sbjct: 209 RKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLS 268
Query: 448 LVLELLKGGELLDRIRQKGRCGFTENEASRIMRQLVAAVHFMHSRGVVHRDLKPENLLFS 507
+L+L+ GG+L + Q G F+E + +++ + MH+R VV+RDLKP N+L
Sbjct: 269 FILDLMNGGDLHYHLSQHGV--FSEADMRFYAAEIILGLEHMHNRFVVYRDLKPANILL- 325
Query: 508 DPAGDNIKVVDFGFAC-LKRESLHTPCFTLQYAAPEVLRQDKSGYDENCDLWSLGVILVN 566
D G ++++ D G AC ++ H T Y APEVL
Sbjct: 326 DEHG-HVRISDLGLACDFSKKKPHASVGTHGYMAPEVL---------------------- 362
Query: 567 VLRQDKSGYDENCDLWSLGVILYTMLCGRVPFHARSRDDSALSIMARIKEGQFNFDAEAW 626
Q YD + D +SLG +L+ +L G PF D I
Sbjct: 363 ---QKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKH-EIDRMTLTMAVELP---- 414
Query: 627 STVSSEAKELTKSLLTVNPAQR 648
+ S E + L + LL + +R
Sbjct: 415 DSFSPELRSLLEGLLQRDVNRR 436
|
| >3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695 | Back alignment and structure |
|---|
Score = 151 bits (383), Expect = 4e-38
Identities = 37/261 (14%), Positives = 87/261 (33%), Gaps = 35/261 (13%)
Query: 263 YRRILKTEPPIPEDLSPDVADFISRLLVKDPRRRLGGGELDAEELKRHPFFNVIDWDDLA 322
R L +P+ SP++ + LL +D RRLG A+E+K PFF +DW +
Sbjct: 403 DRMTLTMAVELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKESPFFRSLDWQMVF 462
Query: 323 TKRIPAPFVPKIS-----NELDVSNFSDEFTKMIPADSPA---------IVPPNFDKIFK 368
++ P P +P + D+ +F +E TK I + + +
Sbjct: 463 LQKYPPPLIPPRGEVNAADAFDIGSFDEEDTKGIKLLDSDQELYRNFPLTISERWQQEVA 522
Query: 369 GSLFFE--------QYDMDLDKAGILGDGSYSVCRRCVEKSTGQEYAVKIISR-----KI 415
++F + + + Y++ + C+ + +++
Sbjct: 523 ETVFDTINAETDRLEARKKTKNKQLGHEEDYALGKDCIMHGYMSKMGNPFLTQWQRRYFY 582
Query: 416 DCSEEINLLRACQGHPNIVNLHCVFQDEVHTY-----LVLELLKGGELLDRIRQKGRCGF 470
+ + +++ + + E L+L++ G + + ++
Sbjct: 583 LFPNRLEWRGEGEAPQSLLTMEEIQSVEETQIKERKCLLLKIRGGKQFV--LQCDSDPEL 640
Query: 471 TENEASRIMRQLVAAVHFMHS 491
+ + A +
Sbjct: 641 VQ-WKKELRDAYREAQQLVQR 660
|
| >3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695 | Back alignment and structure |
|---|
Score = 73.4 bits (180), Expect = 2e-13
Identities = 29/93 (31%), Positives = 47/93 (50%), Gaps = 7/93 (7%)
Query: 867 TLFEEQLLGPITRARRRTFVNRSRYNVHT----YLVLELLKGGELLDRIRQKGRCGFTEN 922
L E +L ++ F+ Y HT +L+L+ GG+L + Q G F+E
Sbjct: 236 ALNERIMLSLVSTGDCP-FIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGV--FSEA 292
Query: 923 EASRIMRQLVAAVHFMHSRGVVHRDLKPENLLL 955
+ +++ + MH+R VV+RDLKP N+LL
Sbjct: 293 DMRFYAAEIILGLEHMHNRFVVYRDLKPANILL 325
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* Length = 345 | Back alignment and structure |
|---|
Score = 169 bits (430), Expect = 2e-46
Identities = 75/274 (27%), Positives = 124/274 (45%), Gaps = 49/274 (17%)
Query: 386 LGDGSYSVCRRCVEKSTGQEYAVK------IISRK-IDCSE-EINLLRACQGHPNIVNLH 437
LG GS+ K T Q +A+K ++ ++C+ E +L HP + ++
Sbjct: 25 LGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMF 84
Query: 438 CVFQDEVHTYLVLELLKGGELLDRIRQKGRCGFTENEASRIMRQLVAAVHFMHSRGVVHR 497
C FQ + + + V+E L GG+L+ I+ + F + A+ +++ + F+HS+G+V+R
Sbjct: 85 CTFQTKENLFFVMEYLNGGDLMYHIQSCHK--FDLSRATFYAAEIILGLQFLHSKGIVYR 142
Query: 498 DLKPENLLFSDPAGDNIKVVDFGFA---CLKRESLHTPCFTLQYAAPEVLRQDKSGYDEN 554
DLK +N+L D G +IK+ DFG L +T C T Y APE+L
Sbjct: 143 DLKLDNILL-DKDG-HIKIADFGMCKENMLGDAKTNTFCGTPDYIAPEILL--------- 191
Query: 555 CDLWSLGVILVNVLRQDKSGYDENCDLWSLGVILYTMLCGRVPFHARSRDDSALSIMARI 614
Y+ + D WS GV+LY ML G+ PFH + ++ + I
Sbjct: 192 -----------------GQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEE----LFHSI 230
Query: 615 KEGQFNFDAEAWSTVSSEAKELTKSLLTVNPAQR 648
+ + + EAK+L L P +R
Sbjct: 231 RMDNPFYP----RWLEKEAKDLLVKLFVREPEKR 260
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* Length = 345 | Back alignment and structure |
|---|
Score = 136 bits (346), Expect = 2e-35
Identities = 33/110 (30%), Positives = 53/110 (48%), Gaps = 7/110 (6%)
Query: 263 YRRILKTEPPIPEDLSPDVADFISRLLVKDPRRRLGGGELDAEELKRHPFFNVIDWDDLA 322
+ I P P L + D + +L V++P +RLG ++++HP F I+W++L
Sbjct: 227 FHSIRMDNPFYPRWLEKEAKDLLVKLFVREPEKRLGVRG----DIRQHPLFREINWEELE 282
Query: 323 TKRIPAPFVPKISNELDVSNFSDEFTKMIPADSPA---IVPPNFDKIFKG 369
K I PF PK+ + D SNF EF P S A ++ +F+
Sbjct: 283 RKEIDPPFRPKVKSPFDCSNFDKEFLNEKPRLSFADRALINSMDQNMFRN 332
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* Length = 345 | Back alignment and structure |
|---|
Score = 69.2 bits (170), Expect = 1e-12
Identities = 21/62 (33%), Positives = 40/62 (64%), Gaps = 2/62 (3%)
Query: 894 HTYLVLELLKGGELLDRIRQKGRCGFTENEASRIMRQLVAAVHFMHSRGVVHRDLKPENL 953
+ + V+E L GG+L+ I+ + F + A+ +++ + F+HS+G+V+RDLK +N+
Sbjct: 92 NLFFVMEYLNGGDLMYHIQSCHK--FDLSRATFYAAEIILGLQFLHSKGIVYRDLKLDNI 149
Query: 954 LL 955
LL
Sbjct: 150 LL 151
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 168 bits (429), Expect = 3e-46
Identities = 80/277 (28%), Positives = 127/277 (45%), Gaps = 55/277 (19%)
Query: 386 LGDGSYSVCRRCVEKSTGQEYAVK------IISRK-IDCSE-EINLLRACQGHPNIVNLH 437
LG GS+ K TG YAVK I+ ++C+ E +L + HP + L
Sbjct: 31 LGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLF 90
Query: 438 CVFQDEVHTYLVLELLKGGELLDRIRQKGRCGFTENEASRIMRQLVAAVHFMHSRGVVHR 497
C FQ + V+E + GG+L+ I++ R F E A ++++A+ F+H +G+++R
Sbjct: 91 CCFQTPDRLFFVMEFVNGGDLMFHIQKSRR--FDEARARFYAAEIISALMFLHDKGIIYR 148
Query: 498 DLKPENLLFSDPAGDNIKVVDFGFACLKRESL------HTPCFTLQYAAPEVLRQDKSGY 551
DLK +N+L D G + K+ DFG + +E + T C T Y APE+L+
Sbjct: 149 DLKLDNVLL-DHEG-HCKLADFG---MCKEGICNGVTTATFCGTPDYIAPEILQ------ 197
Query: 552 DENCDLWSLGVILVNVLRQDKSGYDENCDLWSLGVILYTMLCGRVPFHARSRDDSALSIM 611
+ Y D W++GV+LY MLCG PF A + DD +
Sbjct: 198 --------------------EMLYGPAVDWWAMGVLLYEMLCGHAPFEAENEDD----LF 233
Query: 612 ARIKEGQFNFDAEAWSTVSSEAKELTKSLLTVNPAQR 648
I + + + + +A + KS +T NP R
Sbjct: 234 EAILNDEVVYP----TWLHEDATGILKSFMTKNPTMR 266
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 141 bits (358), Expect = 7e-37
Identities = 37/111 (33%), Positives = 50/111 (45%), Gaps = 4/111 (3%)
Query: 263 YRRILKTEPPIPEDLSPDVADFISRLLVKDPRRRLGGGELDAE-ELKRHPFFNVIDWDDL 321
+ IL E P L D + + K+P RLG E + RHPFF IDW L
Sbjct: 233 FEAILNDEVVYPTWLHEDATGILKSFMTKNPTMRLGSLTQGGEHAILRHPFFKEIDWAQL 292
Query: 322 ATKRIPAPFVPKISNELDVSNFSDEFTKMIPADSPA---IVPPNFDKIFKG 369
++I PF P+I + DVSNF +F K P +P +P F+
Sbjct: 293 NHRQIEPPFRPRIKSREDVSNFDPDFIKEEPVLTPIDEGHLPMINQDEFRN 343
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 70.0 bits (172), Expect = 8e-13
Identities = 21/62 (33%), Positives = 40/62 (64%), Gaps = 2/62 (3%)
Query: 894 HTYLVLELLKGGELLDRIRQKGRCGFTENEASRIMRQLVAAVHFMHSRGVVHRDLKPENL 953
+ V+E + GG+L+ I++ R F E A ++++A+ F+H +G+++RDLK +N+
Sbjct: 98 RLFFVMEFVNGGDLMFHIQKSRR--FDEARARFYAAEIISALMFLHDKGIIYRDLKLDNV 155
Query: 954 LL 955
LL
Sbjct: 156 LL 157
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* Length = 373 | Back alignment and structure |
|---|
Score = 169 bits (430), Expect = 4e-46
Identities = 79/277 (28%), Positives = 120/277 (43%), Gaps = 55/277 (19%)
Query: 386 LGDGSYSVCRRCVEKSTGQEYAVK------IISRK-IDCSE-EINLLRACQGHPNIVNLH 437
+G GS+ K+ YAVK I+ +K E N+L HP +V LH
Sbjct: 46 IGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLH 105
Query: 438 CVFQDEVHTYLVLELLKGGELLDRIRQKGRCGFTENEASRIMRQLVAAVHFMHSRGVVHR 497
FQ Y VL+ + GGEL ++++ F E A ++ +A+ ++HS +V+R
Sbjct: 106 FSFQTADKLYFVLDYINGGELFYHLQRERC--FLEPRARFYAAEIASALGYLHSLNIVYR 163
Query: 498 DLKPENLLFSDPAGDNIKVVDFGFACLKRESL------HTPCFTLQYAAPEVLRQDKSGY 551
DLKPEN+L D G +I + DFG +E++ T C T +Y APEVL
Sbjct: 164 DLKPENILL-DSQG-HIVLTDFGLC---KENIEHNSTTSTFCGTPEYLAPEVLH------ 212
Query: 552 DENCDLWSLGVILVNVLRQDKSGYDENCDLWSLGVILYTMLCGRVPFHARSRDDSALSIM 611
K YD D W LG +LY ML G PF++R+ + +
Sbjct: 213 --------------------KQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAE----MY 248
Query: 612 ARIKEGQFNFDAEAWSTVSSEAKELTKSLLTVNPAQR 648
I +++ A+ L + LL + +R
Sbjct: 249 DNILNKPLQLK----PNITNSARHLLEGLLQKDRTKR 281
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* Length = 373 | Back alignment and structure |
|---|
Score = 140 bits (355), Expect = 3e-36
Identities = 33/100 (33%), Positives = 52/100 (52%), Gaps = 1/100 (1%)
Query: 263 YRRILKTEPPIPEDLSPDVADFISRLLVKDPRRRLGGGELDAEELKRHPFFNVIDWDDLA 322
Y IL + +++ + LL KD +RLG + D E+K H FF++I+WDDL
Sbjct: 248 YDNILNKPLQLKPNITNSARHLLEGLLQKDRTKRLGAKD-DFMEIKSHVFFSLINWDDLI 306
Query: 323 TKRIPAPFVPKISNELDVSNFSDEFTKMIPADSPAIVPPN 362
K+I PF P +S D+ +F EFT+ ++ P +
Sbjct: 307 NKKITPPFNPNVSGPNDLRHFDPEFTEEPVPNAIGKAPDS 346
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* Length = 373 | Back alignment and structure |
|---|
Score = 69.6 bits (171), Expect = 1e-12
Identities = 23/62 (37%), Positives = 38/62 (61%), Gaps = 2/62 (3%)
Query: 894 HTYLVLELLKGGELLDRIRQKGRCGFTENEASRIMRQLVAAVHFMHSRGVVHRDLKPENL 953
Y VL+ + GGEL ++++ F E A ++ +A+ ++HS +V+RDLKPEN+
Sbjct: 113 KLYFVLDYINGGELFYHLQRERC--FLEPRARFYAAEIASALGYLHSLNIVYRDLKPENI 170
Query: 954 LL 955
LL
Sbjct: 171 LL 172
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... Length = 337 | Back alignment and structure |
|---|
Score = 167 bits (425), Expect = 7e-46
Identities = 86/277 (31%), Positives = 129/277 (46%), Gaps = 56/277 (20%)
Query: 386 LGDGSYSVCRRCVEKSTGQEYAVK------IISRK-IDCSE-EINLLRACQGHPNIVNLH 437
LG G++ EK+TG+ YA+K II++ + + E +L+ + HP + L
Sbjct: 13 LGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTR-HPFLTALK 71
Query: 438 CVFQDEVHTYLVLELLKGGELLDRIRQKGRCGFTENEASRIMRQLVAAVHFMHSRGVVHR 497
FQ V+E GGEL + ++ FTE A ++V+A+ ++HSR VV+R
Sbjct: 72 YAFQTHDRLCFVMEYANGGELFFHLSRERV--FTEERARFYGAEIVSALEYLHSRDVVYR 129
Query: 498 DLKPENLLFSDPAGDNIKVVDFGFACLKRESL------HTPCFTLQYAAPEVLRQDKSGY 551
D+K ENL+ D G +IK+ DFG L +E + T C T +Y APEVL
Sbjct: 130 DIKLENLML-DKDG-HIKITDFG---LCKEGISDGATMKTFCGTPEYLAPEVLE------ 178
Query: 552 DENCDLWSLGVILVNVLRQDKSGYDENCDLWSLGVILYTMLCGRVPFHARSRDDSALSIM 611
+ Y D W LGV++Y M+CGR+PF+ + + +
Sbjct: 179 --------------------DNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHER----LF 214
Query: 612 ARIKEGQFNFDAEAWSTVSSEAKELTKSLLTVNPAQR 648
I + F T+S EAK L LL +P QR
Sbjct: 215 ELILMEEIRFP----RTLSPEAKSLLAGLLKKDPKQR 247
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... Length = 337 | Back alignment and structure |
|---|
Score = 145 bits (367), Expect = 4e-38
Identities = 38/95 (40%), Positives = 56/95 (58%)
Query: 263 YRRILKTEPPIPEDLSPDVADFISRLLVKDPRRRLGGGELDAEELKRHPFFNVIDWDDLA 322
+ IL E P LSP+ ++ LL KDP++RLGGG DA+E+ H FF I+W D+
Sbjct: 214 FELILMEEIRFPRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEHRFFLSINWQDVV 273
Query: 323 TKRIPAPFVPKISNELDVSNFSDEFTKMIPADSPA 357
K++ PF P++++E+D F DEFT +P
Sbjct: 274 QKKLLPPFKPQVTSEVDTRYFDDEFTAQSITITPP 308
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... Length = 337 | Back alignment and structure |
|---|
Score = 70.7 bits (174), Expect = 4e-13
Identities = 24/62 (38%), Positives = 37/62 (59%), Gaps = 2/62 (3%)
Query: 894 HTYLVLELLKGGELLDRIRQKGRCGFTENEASRIMRQLVAAVHFMHSRGVVHRDLKPENL 953
V+E GGEL + ++ FTE A ++V+A+ ++HSR VV+RD+K ENL
Sbjct: 79 RLCFVMEYANGGELFFHLSRERV--FTEERARFYGAEIVSALEYLHSRDVVYRDIKLENL 136
Query: 954 LL 955
+L
Sbjct: 137 ML 138
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* Length = 353 | Back alignment and structure |
|---|
Score = 167 bits (424), Expect = 1e-45
Identities = 78/277 (28%), Positives = 124/277 (44%), Gaps = 55/277 (19%)
Query: 386 LGDGSYSVCRRCVEKSTGQEYAVK------IISRK-IDCSE-EINLLRACQGHPNIVNLH 437
LG GS+ K T + YAVK +I ++C+ E +L P + LH
Sbjct: 28 LGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLH 87
Query: 438 CVFQDEVHTYLVLELLKGGELLDRIRQKGRCGFTENEASRIMRQLVAAVHFMHSRGVVHR 497
FQ Y V+E + GG+L+ I+Q GR F E A ++ + F+ S+G+++R
Sbjct: 88 SCFQTMDRLYFVMEYVNGGDLMYHIQQVGR--FKEPHAVFYAAEIAIGLFFLQSKGIIYR 145
Query: 498 DLKPENLLFSDPAGDNIKVVDFGFACLKRESL------HTPCFTLQYAAPEVLRQDKSGY 551
DLK +N++ D G +IK+ DFG + +E++ T C T Y APE++
Sbjct: 146 DLKLDNVML-DSEG-HIKIADFG---MCKENIWDGVTTKTFCGTPDYIAPEIIA------ 194
Query: 552 DENCDLWSLGVILVNVLRQDKSGYDENCDLWSLGVILYTMLCGRVPFHARSRDDSALSIM 611
Y ++ D W+ GV+LY ML G+ PF D+ +
Sbjct: 195 --------------------YQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDE----LF 230
Query: 612 ARIKEGQFNFDAEAWSTVSSEAKELTKSLLTVNPAQR 648
I E + ++S EA + K L+T +P +R
Sbjct: 231 QSIMEHNVAYP----KSMSKEAVAICKGLMTKHPGKR 263
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* Length = 353 | Back alignment and structure |
|---|
Score = 141 bits (359), Expect = 5e-37
Identities = 31/110 (28%), Positives = 50/110 (45%), Gaps = 4/110 (3%)
Query: 263 YRRILKTEPPIPEDLSPDVADFISRLLVKDPRRRLGGGELDAEELKRHPFFNVIDWDDLA 322
++ I++ P+ +S + L+ K P +RLG G ++K H FF IDW+ L
Sbjct: 230 FQSIMEHNVAYPKSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKEHAFFRYIDWEKLE 289
Query: 323 TKRIPAPFVPKISNELDVSNFSDEFTKMIPADSP---AIVPPNFDKIFKG 369
K I P+ PK + NF FT+ P +P ++ F+G
Sbjct: 290 RKEIQPPYKPKACGR-NAENFDRFFTRHPPVLTPPDQEVIRNIDQSEFEG 338
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* Length = 353 | Back alignment and structure |
|---|
Score = 70.0 bits (172), Expect = 9e-13
Identities = 22/62 (35%), Positives = 38/62 (61%), Gaps = 2/62 (3%)
Query: 894 HTYLVLELLKGGELLDRIRQKGRCGFTENEASRIMRQLVAAVHFMHSRGVVHRDLKPENL 953
Y V+E + GG+L+ I+Q GR F E A ++ + F+ S+G+++RDLK +N+
Sbjct: 95 RLYFVMEYVNGGDLMYHIQQVGR--FKEPHAVFYAAEIAIGLFFLQSKGIIYRDLKLDNV 152
Query: 954 LL 955
+L
Sbjct: 153 ML 154
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289 | Back alignment and structure |
|---|
Score = 164 bits (418), Expect = 2e-45
Identities = 52/299 (17%), Positives = 101/299 (33%), Gaps = 62/299 (20%)
Query: 376 YDMDLDKAGILGDGSYSVCRRCVEKSTGQEYAVKIISR-------KIDCSEEINLLRACQ 428
Y + + +G G + +CV++ G YA+K + + + E+
Sbjct: 9 YTTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLG 68
Query: 429 GHPNIVNLHCVFQDEVHTYLVLELLKGGELLDRIRQKGRCG--FTENEASRIMRQLVAAV 486
H ++V + ++ H + E GG L D I + R F E E ++ Q+ +
Sbjct: 69 QHSHVVRYFSAWAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGL 128
Query: 487 HFMHSRGVVHRDLKPENLLFS-----------------DPAGDNIKVVDFGFACLKRESL 529
++HS +VH D+KP N+ S K+ D G + S
Sbjct: 129 RYIHSMSLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLGHVT-RISSP 187
Query: 530 HTPCFTLQYAAPEVLRQDKSGYDENCDLWSLGVILVNVLRQDKSGYDENCDLWSLGVILY 589
++ A EVL+++ + D+++L + +
Sbjct: 188 QVEEGDSRFLANEVLQENY-------------------------THLPKADIFALALTVV 222
Query: 590 TMLCGRVPFHARSRDDSALSIMARIKEGQFNFDAEAWSTVSSEAKELTKSLLTVNPAQR 648
I++G+ +S E EL K ++ +P +R
Sbjct: 223 CAAGAEPLPR-------NGDQWHEIRQGRL---PRIPQVLSQEFTELLKVMIHPDPERR 271
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289 | Back alignment and structure |
|---|
Score = 75.4 bits (186), Expect = 6e-15
Identities = 21/65 (32%), Positives = 33/65 (50%), Gaps = 2/65 (3%)
Query: 894 HTYLVLELLKGGELLDRIRQKGRCG--FTENEASRIMRQLVAAVHFMHSRGVVHRDLKPE 951
H + E GG L D I + R F E E ++ Q+ + ++HS +VH D+KP
Sbjct: 85 HMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIHSMSLVHMDIKPS 144
Query: 952 NLLLS 956
N+ +S
Sbjct: 145 NIFIS 149
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289 | Back alignment and structure |
|---|
Score = 49.6 bits (119), Expect = 2e-06
Identities = 12/67 (17%), Positives = 26/67 (38%), Gaps = 7/67 (10%)
Query: 114 YDMDLDKAGILGDGSYSVCRRCVEKSTGQEYAVKIISR-------KIDCSEEINLLRACQ 166
Y + + +G G + +CV++ G YA+K + + + E+
Sbjct: 9 YTTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLG 68
Query: 167 GHPNICR 173
H ++ R
Sbjct: 69 QHSHVVR 75
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289 | Back alignment and structure |
|---|
Score = 48.5 bits (116), Expect = 4e-06
Identities = 14/52 (26%), Positives = 23/52 (44%), Gaps = 6/52 (11%)
Query: 262 QYRRILKTE-PPIPEDLSPDVADFISRLLVKDPRRRLGGGELDAEELKRHPF 312
Q+ I + P IP+ LS + + + ++ DP RR A L +H
Sbjct: 236 QWHEIRQGRLPRIPQVLSQEFTELLKVMIHPDPERR-----PSAMALVKHSV 282
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289 | Back alignment and structure |
|---|
Score = 43.5 bits (103), Expect = 2e-04
Identities = 9/55 (16%), Positives = 22/55 (40%), Gaps = 7/55 (12%)
Query: 174 RCVEKSTGQEYAVKIISR-------KIDCSEEINLLRACQGHPNIVNLHCVFQDE 221
+CV++ G YA+K + + + E+ H ++V + ++
Sbjct: 29 KCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHSHVVRYFSAWAED 83
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* Length = 345 | Back alignment and structure |
|---|
Score = 164 bits (418), Expect = 7e-45
Identities = 76/283 (26%), Positives = 128/283 (45%), Gaps = 56/283 (19%)
Query: 385 ILGDGSYSVCRRCVEKSTGQEYAVK------IISRK-IDCSE-EINLLRACQGHPNIVNL 436
++G GSY+ K T + YA+K + + ID + E ++ HP +V L
Sbjct: 16 VIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGL 75
Query: 437 HCVFQDEVHTYLVLELLKGGELLDRIRQKGRCGFTENEASRIMRQLVAAVHFMHSRGVVH 496
H FQ E + V+E + GG+L+ ++++ + E A ++ A++++H RG+++
Sbjct: 76 HSCFQTESRLFFVIEYVNGGDLMFHMQRQRK--LPEEHARFYSAEISLALNYLHERGIIY 133
Query: 497 RDLKPENLLFSDPAGDNIKVVDFGFACLKRESL------HTPCFTLQYAAPEVLRQDKSG 550
RDLK +N+L D G +IK+ D+G + +E L T C T Y APE+LR
Sbjct: 134 RDLKLDNVLL-DSEG-HIKLTDYG---MCKEGLRPGDTTSTFCGTPNYIAPEILR----- 183
Query: 551 YDENCDLWSLGVILVNVLRQDKSGYDENCDLWSLGVILYTMLCGRVPFHARSRDDSALS- 609
Y + D W+LGV+++ M+ GR PF D+
Sbjct: 184 ---------------------GEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQN 222
Query: 610 ----IMARIKEGQFNFDAEAWSTVSSEAKELTKSLLTVNPAQR 648
+ I E Q ++S +A + KS L +P +R
Sbjct: 223 TEDYLFQVILEKQIRIP----RSLSVKAASVLKSFLNKDPKER 261
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* Length = 345 | Back alignment and structure |
|---|
Score = 142 bits (361), Expect = 2e-37
Identities = 37/111 (33%), Positives = 54/111 (48%), Gaps = 4/111 (3%)
Query: 263 YRRILKTEPPIPEDLSPDVADFISRLLVKDPRRRLGGGELDA-EELKRHPFFNVIDWDDL 321
++ IL+ + IP LS A + L KDP+ RLG +++ HPFF +DWD +
Sbjct: 228 FQVILEKQIRIPRSLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGHPFFRNVDWDMM 287
Query: 322 ATKRIPAPFVPKISNELDVSNFSDEFTKMIPADSP---AIVPPNFDKIFKG 369
K++ PF P IS E + NF +FT +P IV F+G
Sbjct: 288 EQKQVVPPFKPNISGEFGLDNFDSQFTNEPVQLTPDDDDIVRKIDQSEFEG 338
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* Length = 345 | Back alignment and structure |
|---|
Score = 70.3 bits (173), Expect = 6e-13
Identities = 18/62 (29%), Positives = 39/62 (62%), Gaps = 2/62 (3%)
Query: 894 HTYLVLELLKGGELLDRIRQKGRCGFTENEASRIMRQLVAAVHFMHSRGVVHRDLKPENL 953
+ V+E + GG+L+ ++++ + E A ++ A++++H RG+++RDLK +N+
Sbjct: 84 RLFFVIEYVNGGDLMFHMQRQRK--LPEEHARFYSAEISLALNYLHERGIIYRDLKLDNV 141
Query: 954 LL 955
LL
Sbjct: 142 LL 143
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543 | Back alignment and structure |
|---|
Score = 169 bits (430), Expect = 9e-45
Identities = 72/278 (25%), Positives = 116/278 (41%), Gaps = 48/278 (17%)
Query: 385 ILGDGSY-SVCRRCVEKSTGQEYAVKIISRK-------IDCS-EEINLLRACQGHPNIVN 435
+LG G + V C K+TG+ YA K +++K + E +L IV+
Sbjct: 192 VLGRGGFGEVFA-CQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVH-SRFIVS 249
Query: 436 LHCVFQDEVHTYLVLELLKGGELLDRIRQKGRC--GFTENEASRIMRQLVAAVHFMHSRG 493
L F+ + LV+ ++ GG++ I GF E A Q+V+ + +H R
Sbjct: 250 LAYAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQRN 309
Query: 494 VVHRDLKPENLLFSDPAGDNIKVVDFGFACL---KRESLHTPCFTLQYAAPEVLRQDKSG 550
+++RDLKPEN+L D G N+++ D G A + T + APE+L
Sbjct: 310 IIYRDLKPENVLL-DDDG-NVRISDLGLAVELKAGQTKTKGYAGTPGFMAPELLL----- 362
Query: 551 YDENCDLWSLGVILVNVLRQDKSGYDENCDLWSLGVILYTMLCGRVPFHARSRDDSALSI 610
YD + D ++LGV LY M+ R PF AR +
Sbjct: 363 ---------------------GEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKEL 401
Query: 611 MARIKEGQFNFDAEAWSTVSSEAKELTKSLLTVNPAQR 648
R+ E + S +K+ ++LL +P +R
Sbjct: 402 KQRVLEQAVTYP----DKFSPASKDFCEALLQKDPEKR 435
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543 | Back alignment and structure |
|---|
Score = 115 bits (289), Expect = 7e-27
Identities = 34/112 (30%), Positives = 46/112 (41%), Gaps = 16/112 (14%)
Query: 263 YRRILKTEPPIPEDLSPDVADFISRLLVKDPRRRLGGGELDAEELKRHPFFNVIDWDDLA 322
+R+L+ P+ SP DF LL KDP +RLG + + L+ HP F I W L
Sbjct: 402 KQRVLEQAVTYPDKFSPASKDFCEALLQKDPEKRLGFRDGSCDGLRTHPLFRDISWRQLE 461
Query: 323 TKRIPAPFVPKIS-----NELDVSNFS-----------DEFTKMIPADSPAI 358
+ PFVP N DV FS EF + + + I
Sbjct: 462 AGMLTPPFVPDSRTVYAKNIQDVGAFSTVKGVAFEKADTEFFQEFASGTCPI 513
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543 | Back alignment and structure |
|---|
Score = 67.1 bits (164), Expect = 1e-11
Identities = 22/64 (34%), Positives = 35/64 (54%), Gaps = 2/64 (3%)
Query: 894 HTYLVLELLKGGELLDRIRQKGRC--GFTENEASRIMRQLVAAVHFMHSRGVVHRDLKPE 951
LV+ ++ GG++ I GF E A Q+V+ + +H R +++RDLKPE
Sbjct: 259 DLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQRNIIYRDLKPE 318
Query: 952 NLLL 955
N+LL
Sbjct: 319 NVLL 322
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} Length = 396 | Back alignment and structure |
|---|
Score = 163 bits (414), Expect = 7e-44
Identities = 75/283 (26%), Positives = 128/283 (45%), Gaps = 56/283 (19%)
Query: 385 ILGDGSYSVCRRCVEKSTGQEYAVK------IISRK-IDCSE-EINLLRACQGHPNIVNL 436
++G GSY+ K T + YA++ + + ID + E ++ HP +V L
Sbjct: 59 VIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGL 118
Query: 437 HCVFQDEVHTYLVLELLKGGELLDRIRQKGRCGFTENEASRIMRQLVAAVHFMHSRGVVH 496
H FQ E + V+E + GG+L+ ++++ + E A ++ A++++H RG+++
Sbjct: 119 HSCFQTESRLFFVIEYVNGGDLMFHMQRQRK--LPEEHARFYSAEISLALNYLHERGIIY 176
Query: 497 RDLKPENLLFSDPAGDNIKVVDFGFACLKRESL------HTPCFTLQYAAPEVLRQDKSG 550
RDLK +N+L D G +IK+ D+G + +E L T C T Y APE+LR
Sbjct: 177 RDLKLDNVLL-DSEG-HIKLTDYG---MCKEGLRPGDTTSTFCGTPNYIAPEILR----- 226
Query: 551 YDENCDLWSLGVILVNVLRQDKSGYDENCDLWSLGVILYTMLCGRVPFHARSRDDSALS- 609
Y + D W+LGV+++ M+ GR PF D+
Sbjct: 227 ---------------------GEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQN 265
Query: 610 ----IMARIKEGQFNFDAEAWSTVSSEAKELTKSLLTVNPAQR 648
+ I E Q ++S +A + KS L +P +R
Sbjct: 266 TEDYLFQVILEKQIRIP----RSLSVKAASVLKSFLNKDPKER 304
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} Length = 396 | Back alignment and structure |
|---|
Score = 142 bits (360), Expect = 8e-37
Identities = 37/111 (33%), Positives = 54/111 (48%), Gaps = 4/111 (3%)
Query: 263 YRRILKTEPPIPEDLSPDVADFISRLLVKDPRRRLGGGELDA-EELKRHPFFNVIDWDDL 321
++ IL+ + IP LS A + L KDP+ RLG +++ HPFF +DWD +
Sbjct: 271 FQVILEKQIRIPRSLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGHPFFRNVDWDMM 330
Query: 322 ATKRIPAPFVPKISNELDVSNFSDEFTKMIPADSPA---IVPPNFDKIFKG 369
K++ PF P IS E + NF +FT +P IV F+G
Sbjct: 331 EQKQVVPPFKPNISGEFGLDNFDSQFTNEPVQLTPDDDDIVRKIDQSEFEG 381
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} Length = 396 | Back alignment and structure |
|---|
Score = 70.1 bits (172), Expect = 1e-12
Identities = 18/62 (29%), Positives = 39/62 (62%), Gaps = 2/62 (3%)
Query: 894 HTYLVLELLKGGELLDRIRQKGRCGFTENEASRIMRQLVAAVHFMHSRGVVHRDLKPENL 953
+ V+E + GG+L+ ++++ + E A ++ A++++H RG+++RDLK +N+
Sbjct: 127 RLFFVIEYVNGGDLMFHMQRQRK--LPEEHARFYSAEISLALNYLHERGIIYRDLKLDNV 184
Query: 954 LL 955
LL
Sbjct: 185 LL 186
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446 | Back alignment and structure |
|---|
Score = 164 bits (416), Expect = 1e-43
Identities = 89/374 (23%), Positives = 144/374 (38%), Gaps = 80/374 (21%)
Query: 316 IDWDDLATKRIPAPFVPKISNELDVSNFSDEF-----------TKMIPADSPAIVPPNFD 364
+ L P P I + F T I + +
Sbjct: 57 VAQCQLMKTERPRPNTFIIRCLQWTTVIERTFHVETPEEREEWTTAIQTVADGLKKQAAA 116
Query: 365 KIFKGSLFFEQYDMDLD----------KAGI--------LGDGSYSVCRRCVEKSTGQEY 406
++ S + + + LG G++ EK+TG+ Y
Sbjct: 117 EMDFRSGSPSDNSGAEEMEVSLAKPKHRVTMNEFEYLKLLGKGTFGKVILVKEKATGRYY 176
Query: 407 AVK------IISRK-IDCS-EEINLLRACQGHPNIVNLHCVFQDEVHTYLVLELLKGGEL 458
A+K I+++ + + E +L+ + HP + L FQ V+E GGEL
Sbjct: 177 AMKILKKEVIVAKDEVAHTLTENRVLQNSR-HPFLTALKYSFQTHDRLCFVMEYANGGEL 235
Query: 459 LDRIRQKGRCGFTENEASRIMRQLVAAVHFMHS-RGVVHRDLKPENLLFSDPAGDNIKVV 517
+ ++ F+E+ A ++V+A+ ++HS + VV+RDLK ENL+ D G +IK+
Sbjct: 236 FFHLSRERV--FSEDRARFYGAEIVSALDYLHSEKNVVYRDLKLENLML-DKDG-HIKIT 291
Query: 518 DFGFA---CLKRESLHTPCFTLQYAAPEVLRQDKSGYDENCDLWSLGVILVNVLRQDKSG 574
DFG ++ T C T +Y APEVL +
Sbjct: 292 DFGLCKEGIKDGATMKTFCGTPEYLAPEVLE--------------------------DND 325
Query: 575 YDENCDLWSLGVILYTMLCGRVPFHARSRDDSALSIMARIKEGQFNFDAEAWSTVSSEAK 634
Y D W LGV++Y M+CGR+PF+ + + + I + F T+ EAK
Sbjct: 326 YGRAVDWWGLGVVMYEMMCGRLPFYNQDHEK----LFELILMEEIRFP----RTLGPEAK 377
Query: 635 ELTKSLLTVNPAQR 648
L LL +P QR
Sbjct: 378 SLLSGLLKKDPKQR 391
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446 | Back alignment and structure |
|---|
Score = 132 bits (335), Expect = 4e-33
Identities = 35/89 (39%), Positives = 52/89 (58%)
Query: 263 YRRILKTEPPIPEDLSPDVADFISRLLVKDPRRRLGGGELDAEELKRHPFFNVIDWDDLA 322
+ IL E P L P+ +S LL KDP++RLGGG DA+E+ +H FF I W +
Sbjct: 358 FELILMEEIRFPRTLGPEAKSLLSGLLKKDPKQRLGGGSEDAKEIMQHRFFAGIVWQHVY 417
Query: 323 TKRIPAPFVPKISNELDVSNFSDEFTKMI 351
K++ PF P++++E D F +EFT +
Sbjct: 418 EKKLSPPFKPQVTSETDTRYFDEEFTAQM 446
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446 | Back alignment and structure |
|---|
Score = 64.4 bits (157), Expect = 9e-11
Identities = 23/63 (36%), Positives = 38/63 (60%), Gaps = 3/63 (4%)
Query: 894 HTYLVLELLKGGELLDRIRQKGRCGFTENEASRIMRQLVAAVHFMHS-RGVVHRDLKPEN 952
V+E GGEL + ++ F+E+ A ++V+A+ ++HS + VV+RDLK EN
Sbjct: 222 RLCFVMEYANGGELFFHLSRERV--FSEDRARFYGAEIVSALDYLHSEKNVVYRDLKLEN 279
Query: 953 LLL 955
L+L
Sbjct: 280 LML 282
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A Length = 674 | Back alignment and structure |
|---|
Score = 165 bits (419), Expect = 9e-43
Identities = 101/469 (21%), Positives = 169/469 (36%), Gaps = 62/469 (13%)
Query: 197 EEINLLRACQGHPNIVNLHCVFQDEVIDWDDFSRGIECVFFSSSLIIFFIILSFTLSFIH 256
I + IV + +D + S + + T+
Sbjct: 161 GRIYIQAHIDREVLIVVVRDAKNLVPMDPNGLSDPYVKLKLIPDPKSESKQKTKTIKSSL 220
Query: 257 DYYHIQYRRILKTEPPIPEDLSPDVADFISRLLVKDPRRRLGGGELDAEELKRHPFFNVI 316
+ + R E LS ++ D+ + +G EL++
Sbjct: 221 NPEWNETFRFQLKESDKDRRLSVEIWDW----DLTSRNDFMGSLSFGISELQKAGVDGWF 276
Query: 317 DWDDLATKRIPAPFVPKISNELDVSNFSDEFTKMIPADSPAIVPPNFDKIFKGSLFFEQY 376
VP +E + I + A + I K +
Sbjct: 277 KLLSQEEGEYFNVPVPPEGSEGNEELRQKFERAKIGQGTKAPEEKTANTISKFDNNGNRD 336
Query: 377 DMDLDK---AGILGDGSYSVCRRCVEKSTGQEYAVK------IISRK-IDCS-EEINLLR 425
M L +LG GS+ K T + YAVK +I ++C+ E +L
Sbjct: 337 RMKLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLA 396
Query: 426 ACQGHPNIVNLHCVFQDEVHTYLVLELLKGGELLDRIRQKGRCGFTENEASRIMRQLVAA 485
P + LH FQ Y V+E + GG+L+ I+Q GR F E A ++
Sbjct: 397 LPGKPPFLTQLHSCFQTMDRLYFVMEYVNGGDLMYHIQQVGR--FKEPHAVFYAAEIAIG 454
Query: 486 VHFMHSRGVVHRDLKPENLLFSDPAGDNIKVVDFGFACLKRESL------HTPCFTLQYA 539
+ F+ S+G+++RDLK +N++ D G +IK+ DFG + +E++ T C T Y
Sbjct: 455 LFFLQSKGIIYRDLKLDNVML-DSEG-HIKIADFG---MCKENIWDGVTTKTFCGTPDYI 509
Query: 540 APEVLRQDKSGYDENCDLWSLGVILVNVLRQDKSGYDENCDLWSLGVILYTMLCGRVPFH 599
APE++ Y ++ D W+ GV+LY ML G+ PF
Sbjct: 510 APEIIA--------------------------YQPYGKSVDWWAFGVLLYEMLAGQAPFE 543
Query: 600 ARSRDDSALSIMARIKEGQFNFDAEAWSTVSSEAKELTKSLLTVNPAQR 648
D+ + I E + ++S EA + K L+T +P +R
Sbjct: 544 GEDEDE----LFQSIMEHNVAYP----KSMSKEAVAICKGLMTKHPGKR 584
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A Length = 674 | Back alignment and structure |
|---|
Score = 137 bits (345), Expect = 2e-33
Identities = 32/110 (29%), Positives = 51/110 (46%), Gaps = 4/110 (3%)
Query: 263 YRRILKTEPPIPEDLSPDVADFISRLLVKDPRRRLGGGELDAEELKRHPFFNVIDWDDLA 322
++ I++ P+ +S + L+ K P +RLG G ++K H FF IDW+ L
Sbjct: 551 FQSIMEHNVAYPKSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKEHAFFRYIDWEKLE 610
Query: 323 TKRIPAPFVPKISNELDVSNFSDEFTKMIPADSPA---IVPPNFDKIFKG 369
K I P+ PK S + NF FT+ P +P ++ F+G
Sbjct: 611 RKEIQPPYKPKASGR-NAENFDRFFTRHPPVLTPPDQEVIRNIDQSEFEG 659
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A Length = 674 | Back alignment and structure |
|---|
Score = 67.7 bits (165), Expect = 1e-11
Identities = 22/62 (35%), Positives = 38/62 (61%), Gaps = 2/62 (3%)
Query: 894 HTYLVLELLKGGELLDRIRQKGRCGFTENEASRIMRQLVAAVHFMHSRGVVHRDLKPENL 953
Y V+E + GG+L+ I+Q GR F E A ++ + F+ S+G+++RDLK +N+
Sbjct: 416 RLYFVMEYVNGGDLMYHIQQVGR--FKEPHAVFYAAEIAIGLFFLQSKGIIYRDLKLDNV 473
Query: 954 LL 955
+L
Sbjct: 474 ML 475
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336 | Back alignment and structure |
|---|
Score = 155 bits (393), Expect = 1e-41
Identities = 63/297 (21%), Positives = 108/297 (36%), Gaps = 47/297 (15%)
Query: 386 LGDGSYSVCRRCVEKSTGQEYAVKIISRKIDCSEEINLLRACQGHPNIVNLHCVFQDEVH 445
+G GS+ R +K TG + AVK + ++ EE+ P IV L+ ++
Sbjct: 66 VGRGSFGEVHRMKDKQTGFQCAVKKVRLEVFRVEELVACAGLS-SPRIVPLYGAVREGPW 124
Query: 446 TYLVLELLKGGELLDRIRQKGRCGFTENEASRIMRQLVAAVHFMHSRGVVHRDLKPENLL 505
+ +ELL+GG L I+Q G E+ A + Q + + ++H+R ++H D+K +N+L
Sbjct: 125 VNIFMELLEGGSLGQLIKQMGC--LPEDRALYYLGQALEGLEYLHTRRILHGDVKADNVL 182
Query: 506 FSDPAGDNIKVVDFGFA------CLKRESLHTPCF--TLQYAAPEVLRQDKSGYDENCDL 557
G + DFG A L + L T + APEV+
Sbjct: 183 L-SSDGSRAALCDFGHALCLQPDGLGKSLLTGDYIPGTETHMAPEVVMG----------- 230
Query: 558 WSLGVILVNVLRQDKSGYDENCDLWSLGVILYTMLCGRVPFHARSRDDSALSIMARI-KE 616
D D+WS ++ ML G P+ + +I E
Sbjct: 231 ---------------KPCDAKVDIWSSCCMMLHMLNGCHPWT----QYFRGPLCLKIASE 271
Query: 617 GQFNFDAEAWSTVSSEAKELTKSLLTVNPAQRIRMMRVKLTFHAFHQAQKEGFRLQD 673
+ + + + + L P R ++L Q+ G
Sbjct: 272 PPPIREIP--PSCAPLTAQAIQEGLRKEPVHRA--SAMELRRKVGKALQEVGGLKSP 324
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336 | Back alignment and structure |
|---|
Score = 72.1 bits (177), Expect = 1e-13
Identities = 22/70 (31%), Positives = 40/70 (57%), Gaps = 3/70 (4%)
Query: 896 YLVLELLKGGELLDRIRQKGRCGFTENEASRIMRQLVAAVHFMHSRGVVHRDLKPENLLL 955
+ +ELL+GG L I+Q G E+ A + Q + + ++H+R ++H D+K +N+LL
Sbjct: 126 NIFMELLEGGSLGQLIKQMGC--LPEDRALYYLGQALEGLEYLHTRRILHGDVKADNVLL 183
Query: 956 SGISGNLIKI 965
S G+ +
Sbjct: 184 SS-DGSRAAL 192
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336 | Back alignment and structure |
|---|
Score = 52.0 bits (125), Expect = 4e-07
Identities = 14/51 (27%), Positives = 19/51 (37%), Gaps = 5/51 (9%)
Query: 271 PPIPEDLSPDVADFISRLLVKDPRRRLGGGELDAEELKRHPFFNVIDWDDL 321
IP +P A I L K+P R A EL+R + + L
Sbjct: 276 REIPPSCAPLTAQAIQEGLRKEPVHR-----ASAMELRRKVGKALQEVGGL 321
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336 | Back alignment and structure |
|---|
Score = 48.6 bits (116), Expect = 6e-06
Identities = 14/48 (29%), Positives = 22/48 (45%), Gaps = 1/48 (2%)
Query: 124 LGDGSYSVCRRCVEKSTGQEYAVKIISRKIDCSEEINLLRACQGHPNI 171
+G GS+ R +K TG + AVK + ++ EE+ P I
Sbjct: 66 VGRGSFGEVHRMKDKQTGFQCAVKKVRLEVFRVEELVACAGLS-SPRI 112
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336 | Back alignment and structure |
|---|
Score = 46.7 bits (111), Expect = 2e-05
Identities = 13/48 (27%), Positives = 22/48 (45%), Gaps = 1/48 (2%)
Query: 174 RCVEKSTGQEYAVKIISRKIDCSEEINLLRACQGHPNIVNLHCVFQDE 221
R +K TG + AVK + ++ EE+ P IV L+ ++
Sbjct: 76 RMKDKQTGFQCAVKKVRLEVFRVEELVACAGLS-SPRIVPLYGAVREG 122
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 140 bits (356), Expect = 5e-37
Identities = 80/314 (25%), Positives = 124/314 (39%), Gaps = 77/314 (24%)
Query: 374 EQYDMDLDKAGILGDGSYSVCRRCVEKSTGQEYAVKIISRKIDCSE-------EINLLRA 426
E+Y+ K G +G+GSY V +C + TGQ A+K D EI +L+
Sbjct: 3 EKYE----KIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQ 58
Query: 427 CQGHPNIVNLHCVFQDEVHTYLVLELLKG--GELLDRIRQKGRCGFTENEASRIMRQLVA 484
+ HPN+VNL VF+ + +LV E LDR ++ G E+ I Q +
Sbjct: 59 LK-HPNLVNLLEVFRRKRRLHLVFEYCDHTVLHELDRYQR----GVPEHLVKSITWQTLQ 113
Query: 485 AVHFMHSRGVVHRDLKPENLLFSDPAGDNIKVVDFGFACLKRE-SLHTPCF-----TLQY 538
AV+F H +HRD+KPEN+L + IK+ DFGFA R + + + T Y
Sbjct: 114 AVNFCHKHNCIHRDVKPENILITKH--SVIKLCDFGFA---RLLTGPSDYYDDEVATRWY 168
Query: 539 AAPEVLRQDKSGYDENCDLWSLGVILVNVLRQDKSGYDENCDLWSLGVILYTMLCGRVPF 598
+PE+L D Y D+W++G + +L G +
Sbjct: 169 RSPELLVGDTQ-------------------------YGPPVDVWAIGCVFAELLSGVPLW 203
Query: 599 HARSRDDSALSIMA-------RIKEG--------QFNFD--------AEAWSTVSSEAKE 635
+S D I R ++ + +S A
Sbjct: 204 PGKSDVDQLYLIRKTLGDLIPRHQQVFSTNQYFSGVKIPDPEDMEPLELKFPNISYPALG 263
Query: 636 LTKSLLTVNPAQRI 649
L K L ++P +R+
Sbjct: 264 LLKGCLHMDPTERL 277
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 69.1 bits (170), Expect = 9e-13
Identities = 23/72 (31%), Positives = 36/72 (50%), Gaps = 8/72 (11%)
Query: 896 YLVLELLKG--GELLDRIRQKGRCGFTENEASRIMRQLVAAVHFMHSRGVVHRDLKPENL 953
+LV E LDR ++ G E+ I Q + AV+F H +HRD+KPEN+
Sbjct: 78 HLVFEYCDHTVLHELDRYQR----GVPEHLVKSITWQTLQAVNFCHKHNCIHRDVKPENI 133
Query: 954 LLSGISGNLIKI 965
L++ + K+
Sbjct: 134 LITK-HSVI-KL 143
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 44.1 bits (105), Expect = 1e-04
Identities = 28/110 (25%), Positives = 42/110 (38%), Gaps = 38/110 (34%)
Query: 112 EQYDMDLDKAGILGDGSYSVCRRCVEKSTGQEYAVKIISRKIDCSEEINLLRACQGHPNI 171
E+Y+ K G +G+GSY V +C + TGQ A+K + I
Sbjct: 3 EKYE----KIGKIGEGSYGVVFKCRNRDTGQIVAIKKF--LESEDDP--------VIKKI 48
Query: 172 CRRCVEKSTGQEYAVKIISRKIDCSEEINLLRACQGHPNIVNLHCVFQDE 221
R EI +L+ + HPN+VNL VF+ +
Sbjct: 49 ALR-----------------------EIRMLKQLK-HPNLVNLLEVFRRK 74
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331 | Back alignment and structure |
|---|
Score = 140 bits (356), Expect = 7e-37
Identities = 78/334 (23%), Positives = 127/334 (38%), Gaps = 83/334 (24%)
Query: 356 PAIVPPNFDKIFKGSLFFEQYDMDLDKAGILGDGSYSVCRRCVEKSTGQEYAVKIISRKI 415
+ V + ++ S+ E+Y+ G++G+GSY + +C K TG+ A+K
Sbjct: 9 SSGVDLGTENLYFQSM--EKYE----NLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESD 62
Query: 416 DCSE-------EINLLRACQGHPNIVNLHCVFQDEVHTYLVLEL----LKGGELLDRIRQ 464
D EI LL+ + H N+VNL V + + YLV E + + L+
Sbjct: 63 DDKMVKKIAMREIKLLKQLR-HENLVNLLEVCKKKKRWYLVFEFVDHTIL--DDLELFPN 119
Query: 465 KGRCGFTENEASRIMRQLVAAVHFMHSRGVVHRDLKPENLLFSDPAGDNIKVVDFGFACL 524
G + + Q++ + F HS ++HRD+KPEN+L S +K+ DFGFA
Sbjct: 120 ----GLDYQVVQKYLFQIINGIGFCHSHNIIHRDIKPENILVSQS--GVVKLCDFGFA-- 171
Query: 525 KRE-SLHTPCF-----TLQYAAPEVLRQDKSGYDENCDLWSLGVILVNVLRQDKSGYDEN 578
R + + T Y APE+L D Y +
Sbjct: 172 -RTLAAPGEVYDDEVATRWYRAPELLVGDVK-------------------------YGKA 205
Query: 579 CDLWSLGVILYTMLCGRVPFHARSRDDSALSIMA-------RIKEG--------QFNFD- 622
D+W++G ++ M G F S D IM R +E
Sbjct: 206 VDVWAIGCLVTEMFMGEPLFPGDSDIDQLYHIMMCLGNLIPRHQELFNKNPVFAGVRLPE 265
Query: 623 -------AEAWSTVSSEAKELTKSLLTVNPAQRI 649
+ +S +L K L ++P +R
Sbjct: 266 IKEREPLERRYPKLSEVVIDLAKKCLHIDPDKRP 299
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331 | Back alignment and structure |
|---|
Score = 68.4 bits (168), Expect = 2e-12
Identities = 22/74 (29%), Positives = 37/74 (50%), Gaps = 12/74 (16%)
Query: 896 YLVLEL----LKGGELLDRIRQKGRCGFTENEASRIMRQLVAAVHFMHSRGVVHRDLKPE 951
YLV E + + L+ G + + Q++ + F HS ++HRD+KPE
Sbjct: 100 YLVFEFVDHTIL--DDLELFPN----GLDYQVVQKYLFQIINGIGFCHSHNIIHRDIKPE 153
Query: 952 NLLLSGISGNLIKI 965
N+L+S SG + K+
Sbjct: 154 NILVSQ-SGVV-KL 165
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331 | Back alignment and structure |
|---|
Score = 45.3 bits (108), Expect = 7e-05
Identities = 23/103 (22%), Positives = 38/103 (36%), Gaps = 34/103 (33%)
Query: 119 DKAGILGDGSYSVCRRCVEKSTGQEYAVKIISRKIDCSEEINLLRACQGHPNICRRCVEK 178
+ G++G+GSY + +C K TG+ A+K ++ I R
Sbjct: 28 ENLGLVGEGSYGMVMKCRNKDTGRIVAIKKF--LESDDDK--------MVKKIAMR---- 73
Query: 179 STGQEYAVKIISRKIDCSEEINLLRACQGHPNIVNLHCVFQDE 221
EI LL+ + H N+VNL V + +
Sbjct: 74 -------------------EIKLLKQLR-HENLVNLLEVCKKK 96
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332 | Back alignment and structure |
|---|
Score = 140 bits (354), Expect = 1e-36
Identities = 53/270 (19%), Positives = 96/270 (35%), Gaps = 54/270 (20%)
Query: 395 RRCVEKSTGQEYAVKIISRKIDCSEEINLLRACQGHPNIVNLHCVFQDEVHTYLVLELLK 454
K ++ + S S +I + N V +V+ Y+ ++L +
Sbjct: 86 DEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFS-TKNTVGQLQPSSPKVYLYIQMQLCR 144
Query: 455 GGELLDRI-RQKGRCGFTENEASRIMRQLVAAVHFMHSRGVVHRDLKPENLLFSDPAGDN 513
L D + R+ I Q+ AV F+HS+G++HRDLKP N+ F+ D
Sbjct: 145 KENLKDWMNRRCSLEDREHGVCLHIFIQIAEAVEFLHSKGLMHRDLKPSNIFFTM--DDV 202
Query: 514 IKVVDFGFACL---------------KRESLHTPCFTLQYAAPEVLRQDKSGYDENCDLW 558
+KV DFG + T Y +PE +
Sbjct: 203 VKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTKLYMSPEQIH------------- 249
Query: 559 SLGVILVNVLRQDKSGYDENCDLWSLGVILYTMLCGRVPFHARSRDDSALSIMARIKEGQ 618
+ Y D++SLG+IL+ +L R R I+ ++ +
Sbjct: 250 -------------GNNYSHKVDIFSLGLILFELLYSFSTQMERVR------IITDVRNLK 290
Query: 619 FNFDAEAWSTVSSEAKELTKSLLTVNPAQR 648
F ++ + + + +L+ +P +R
Sbjct: 291 FPLL---FTQKYPQEHMMVQDMLSPSPTER 317
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332 | Back alignment and structure |
|---|
Score = 77.6 bits (191), Expect = 2e-15
Identities = 31/140 (22%), Positives = 62/140 (44%), Gaps = 3/140 (2%)
Query: 827 KSLPATHSTPARKKKKADRQPAKQEEKQPVPQTTPPTDLVTLFEEQLLGPITRARRRTFV 886
+ A TP K ++ + ++E P ++P + + + P + +
Sbjct: 68 RYFNAWLETPPEKWQEEMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQL 127
Query: 887 NRSRYNVHTYLVLELLKGGELLDRI-RQKGRCGFTENEASRIMRQLVAAVHFMHSRGVVH 945
S V+ Y+ ++L + L D + R+ I Q+ AV F+HS+G++H
Sbjct: 128 QPSSPKVYLYIQMQLCRKENLKDWMNRRCSLEDREHGVCLHIFIQIAEAVEFLHSKGLMH 187
Query: 946 RDLKPENLLLSGISGNLIKI 965
RDLKP N+ + +++K+
Sbjct: 188 RDLKPSNIFFT--MDDVVKV 205
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332 | Back alignment and structure |
|---|
Score = 45.3 bits (107), Expect = 6e-05
Identities = 16/78 (20%), Positives = 24/78 (30%), Gaps = 7/78 (8%)
Query: 376 YDMDLDKAGILGDGSYSVCRRCVEKSTGQEYAVKIISRKID------CSEEINLLRACQG 429
Y D + +G G + V K YA+K I E+ L +
Sbjct: 4 YLTDFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLE- 62
Query: 430 HPNIVNLHCVFQDEVHTY 447
HP IV + +
Sbjct: 63 HPGIVRYFNAWLETPPEK 80
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332 | Back alignment and structure |
|---|
Score = 43.7 bits (103), Expect = 2e-04
Identities = 7/43 (16%), Positives = 14/43 (32%), Gaps = 5/43 (11%)
Query: 271 PPIPEDLSPDVADFISRLLVKDPRRRLGGGELDAEELKRHPFF 313
P + P + +L P R +A ++ + F
Sbjct: 292 PLLFTQKYPQEHMMVQDMLSPSPTER-----PEATDIIENAIF 329
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332 | Back alignment and structure |
|---|
Score = 41.8 bits (98), Expect = 9e-04
Identities = 20/135 (14%), Positives = 34/135 (25%), Gaps = 12/135 (8%)
Query: 114 YDMDLDKAGILGDGSYSVCRRCVEKSTGQEYAVKIISRKID------CSEEINLLRACQG 167
Y D + +G G + V K YA+K I E+ L +
Sbjct: 4 YLTDFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLE- 62
Query: 168 HPNICRRC-----VEKSTGQEYAVKIISRKIDCSEEINLLRACQGHPNIVNLHCVFQDEV 222
HP I R QE +I + ++ + F +
Sbjct: 63 HPGIVRYFNAWLETPPEKWQEEMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKN 122
Query: 223 IDWDDFSRGIECVFF 237
+ +
Sbjct: 123 TVGQLQPSSPKVYLY 137
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295 | Back alignment and structure |
|---|
Score = 139 bits (352), Expect = 1e-36
Identities = 72/275 (26%), Positives = 117/275 (42%), Gaps = 44/275 (16%)
Query: 385 ILGDGSYSVCRRCVEKSTGQEYAVKIIS-RKIDCSE----EINLLRACQGHPNIVNLHCV 439
+LG G+Y + + S A+K I R S+ EI L + + H NIV
Sbjct: 29 VLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLK-HKNIVQYLGS 87
Query: 440 FQDEVHTYLVLELLKGGELLDRIRQK-GRCGFTENEASRIMRQLVAAVHFMHSRGVVHRD 498
F + + +E + GG L +R K G E +Q++ + ++H +VHRD
Sbjct: 88 FSENGFIKIFMEQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHDNQIVHRD 147
Query: 499 LKPENLLFSDPAGDNIKVVDFGFACLKRESLHTPCF-----TLQYAAPEVLRQDKSGYDE 553
+K +N+L + +G +K+ DFG + KR + PC TLQY APE++ + GY +
Sbjct: 148 IKGDNVLINTYSG-VLKISDFGTS--KRLAGINPCTETFTGTLQYMAPEIIDKGPRGYGK 204
Query: 554 NCDLWSLGVILVNVLRQDKSGYDENCDLWSLGVILYTMLCGRVPFHARSRDDSALSIMAR 613
D +WSLG + M G+ PF+ + M +
Sbjct: 205 AAD------------------------IWSLGCTIIEMATGKPPFY---ELGEPQAAMFK 237
Query: 614 IKEGQFNFDAEAWSTVSSEAKELTKSLLTVNPAQR 648
+ G F E ++S+EAK +P +R
Sbjct: 238 V--GMFKVHPEIPESMSAEAKAFILKCFEPDPDKR 270
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295 | Back alignment and structure |
|---|
Score = 65.4 bits (160), Expect = 1e-11
Identities = 21/71 (29%), Positives = 38/71 (53%), Gaps = 2/71 (2%)
Query: 896 YLVLELLKGGELLDRIRQK-GRCGFTENEASRIMRQLVAAVHFMHSRGVVHRDLKPENLL 954
+ +E + GG L +R K G E +Q++ + ++H +VHRD+K +N+L
Sbjct: 95 KIFMEQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHDNQIVHRDIKGDNVL 154
Query: 955 LSGISGNLIKI 965
++ SG +KI
Sbjct: 155 INTYSGV-LKI 164
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295 | Back alignment and structure |
|---|
Score = 53.8 bits (130), Expect = 1e-07
Identities = 14/45 (31%), Positives = 19/45 (42%), Gaps = 5/45 (11%)
Query: 268 KTEPPIPEDLSPDVADFISRLLVKDPRRRLGGGELDAEELKRHPF 312
K P IPE +S + FI + DP +R A +L F
Sbjct: 242 KVHPEIPESMSAEAKAFILKCFEPDPDKR-----ACANDLLVDEF 281
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295 | Back alignment and structure |
|---|
Score = 41.9 bits (99), Expect = 7e-04
Identities = 16/56 (28%), Positives = 25/56 (44%), Gaps = 6/56 (10%)
Query: 123 ILGDGSYSVCRRCVEKSTGQEYAVKIIS-RKIDCSE----EINLLRACQGHPNICR 173
+LG G+Y + + S A+K I R S+ EI L + + H NI +
Sbjct: 29 VLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLK-HKNIVQ 83
|
| >2r3i_A Cell division protein kinase 2; serine/threonine-protein kinase, cell cycle, inhibition, cyclin-dependent kinase, cancer, ATP-binding; HET: SCF; 1.28A {Homo sapiens} PDB: 2r3j_A* 2r3k_A* 2r3l_A* 2r3m_A* 2r3n_A* 2r3o_A* 2r3p_A* 2r3q_A* 1jvp_P* 1buh_A 1ckp_A* 1di8_A* 1dm2_A* 1f5q_A 1fin_A* 1fq1_B* 1fvt_A* 1fvv_A* 1g5s_A* 1gih_A* ... Length = 299 | Back alignment and structure |
|---|
Score = 66.4 bits (163), Expect = 6e-12
Identities = 25/74 (33%), Positives = 35/74 (47%), Gaps = 11/74 (14%)
Query: 896 YLVLEL----LKGGELLDRIRQKGRCGFTENEASRIMRQLVAAVHFMHSRGVVHRDLKPE 951
YLV E LK +D G + QL+ + F HS V+HRDLKP+
Sbjct: 78 YLVFEFLHQDLKK--FMDASALTG---IPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQ 132
Query: 952 NLLLSGISGNLIKI 965
NLL++ G + K+
Sbjct: 133 NLLINT-EGAI-KL 144
|
| >2r3i_A Cell division protein kinase 2; serine/threonine-protein kinase, cell cycle, inhibition, cyclin-dependent kinase, cancer, ATP-binding; HET: SCF; 1.28A {Homo sapiens} PDB: 2r3j_A* 2r3k_A* 2r3l_A* 2r3m_A* 2r3n_A* 2r3o_A* 2r3p_A* 2r3q_A* 1jvp_P* 1buh_A 1ckp_A* 1di8_A* 1dm2_A* 1f5q_A 1fin_A* 1fq1_B* 1fvt_A* 1fvv_A* 1g5s_A* 1gih_A* ... Length = 299 | Back alignment and structure |
|---|
Score = 41.7 bits (99), Expect = 7e-04
Identities = 19/57 (33%), Positives = 26/57 (45%), Gaps = 12/57 (21%)
Query: 174 RCVEKSTGQEYAVKIISRKIDCSE---------EINLLRACQGHPNIVNLHCVFQDE 221
+ K TG+ A+K I ++D EI+LL+ HPNIV L V E
Sbjct: 21 KARNKLTGEVVALKKI--RLDTETEGVPSTAIREISLLKELN-HPNIVKLLDVIHTE 74
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329 | Back alignment and structure |
|---|
Score = 139 bits (353), Expect = 2e-36
Identities = 74/351 (21%), Positives = 124/351 (35%), Gaps = 81/351 (23%)
Query: 340 VSNFSDEFTKMIPADSPAIVPPNFDKIFKGSLFFEQYDMDLDKAGILGDGSYSVCRRCVE 399
+++ + A + + + ++Y + K LG+G+Y + ++
Sbjct: 1 MAHHHHHHMGTLEAQTQGPGSMSVSAA-PSATSIDRYRR-ITK---LGEGTYGEVYKAID 55
Query: 400 KSTGQEYAVKIISRKIDCSE---------EINLLRACQGHPNIVNLHCVFQDEVHTYLVL 450
T + A+K I +++ E E++LL+ Q H NI+ L V +L+
Sbjct: 56 TVTNETVAIKRI--RLEHEEEGVPGTAIREVSLLKELQ-HRNIIELKSVIHHNHRLHLIF 112
Query: 451 EL----LKGGELLDRIRQKGRCGFTENEASRIMRQLVAAVHFMHSRGVVHRDLKPENLLF 506
E LK +D+ + + QL+ V+F HSR +HRDLKP+NLL
Sbjct: 113 EYAENDLKK--YMDKNP-----DVSMRVIKSFLYQLINGVNFCHSRRCLHRDLKPQNLLL 165
Query: 507 SDPAGDN---IKVVDFGFACLKRESLHT---PCFTLQYAAPEVLRQDKSGYDENCDLWSL 560
S +K+ DFG A + TL Y PE+L L
Sbjct: 166 SVSDASETPVLKIGDFGLARAFGIPIRQFTHEIITLWYRPPEIL---------------L 210
Query: 561 GVILVNVLRQDKSGYDENCDLWSLGVILYTMLCGRVPFHARSRDDSALSI---------- 610
G Y + D+WS+ I ML F S D I
Sbjct: 211 GS----------RHYSTSVDIWSIACIWAEMLMKTPLFPGDSEIDQLFKIFEVLGLPDDT 260
Query: 611 ------------MARIKEGQFNFDAEAWSTVSSEAKELTKSLLTVNPAQRI 649
+ K + + E +L ++L ++P +RI
Sbjct: 261 TWPGVTALPDWKQSFPKFRGKTLKRVLGALLDDEGLDLLTAMLEMDPVKRI 311
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329 | Back alignment and structure |
|---|
Score = 64.6 bits (158), Expect = 4e-11
Identities = 25/77 (32%), Positives = 38/77 (49%), Gaps = 14/77 (18%)
Query: 896 YLVLEL----LKGGELLDRIRQKGRCGFTENEASRIMRQLVAAVHFMHSRGVVHRDLKPE 951
+L+ E LK +D+ + + QL+ V+F HSR +HRDLKP+
Sbjct: 109 HLIFEYAENDLKK--YMDKNP-----DVSMRVIKSFLYQLINGVNFCHSRRCLHRDLKPQ 161
Query: 952 NLLLSGISGN---LIKI 965
NLLLS + ++KI
Sbjct: 162 NLLLSVSDASETPVLKI 178
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329 | Back alignment and structure |
|---|
Score = 43.4 bits (103), Expect = 2e-04
Identities = 22/103 (21%), Positives = 37/103 (35%), Gaps = 34/103 (33%)
Query: 119 DKAGILGDGSYSVCRRCVEKSTGQEYAVKIISRKIDCSEEINLLRACQGHPNICRRCVEK 178
+ LG+G+Y + ++ T + A+K I +++ EE G P R
Sbjct: 37 RRITKLGEGTYGEVYKAIDTVTNETVAIKRI--RLEHEEE--------GVPGTAIR---- 82
Query: 179 STGQEYAVKIISRKIDCSEEINLLRACQGHPNIVNLHCVFQDE 221
E++LL+ Q H NI+ L V
Sbjct: 83 -------------------EVSLLKELQ-HRNIIELKSVIHHN 105
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292 | Back alignment and structure |
|---|
Score = 137 bits (347), Expect = 6e-36
Identities = 75/315 (23%), Positives = 117/315 (37%), Gaps = 80/315 (25%)
Query: 374 EQYDMDLDKAGILGDGSYSVCRRCVEKSTGQEYAVKIISRKIDCSE---------EINLL 424
++Y+ L+K +G+G+Y + + T + A+K + ++D + EI LL
Sbjct: 2 QKYEK-LEK---IGEGTYGTVFKAKNRETHEIVALKRV--RLDDDDEGVPSSALREICLL 55
Query: 425 RACQGHPNIVNLHCVFQDEVHTYLVLEL----LKGGELLDRIRQKGRCGFTENEASRIMR 480
+ + H NIV LH V + LV E LK D +
Sbjct: 56 KELK-HKNIVRLHDVLHSDKKLTLVFEFCDQDLKK--YFDSCNG----DLDPEIVKSFLF 108
Query: 481 QLVAAVHFMHSRGVVHRDLKPENLLFSDPAGDNIKVVDFGFACLKRESLH--TPC-FTLQ 537
QL+ + F HSR V+HRDLKP+NLL + G +K+ +FG A + + TL
Sbjct: 109 QLLKGLGFCHSRNVLHRDLKPQNLLI-NRNG-ELKLANFGLARAFGIPVRCYSAEVVTLW 166
Query: 538 YAAPEVLRQDKSGYDENCDLWSLGVILVNVLRQDKSGYDENCDLWSLGVILYTMLCGRVP 597
Y P+VL G Y + D+WS G I + P
Sbjct: 167 YRPPDVL---------------FG----------AKLYSTSIDMWSAGCIFAELANAGRP 201
Query: 598 -FHARSRDDSALSIMARI----------------------KEGQFNFDAEAWSTVSSEAK 634
F DD L + R+ +++ +
Sbjct: 202 LFPGNDVDDQ-LKRIFRLLGTPTEEQWPSMTKLPDYKPYPMYPATTSLVNVVPKLNATGR 260
Query: 635 ELTKSLLTVNPAQRI 649
+L ++LL NP QRI
Sbjct: 261 DLLQNLLKCNPVQRI 275
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292 | Back alignment and structure |
|---|
Score = 66.0 bits (162), Expect = 1e-11
Identities = 25/74 (33%), Positives = 34/74 (45%), Gaps = 12/74 (16%)
Query: 896 YLVLEL----LKGGELLDRIRQKGRCGFTENEASRIMRQLVAAVHFMHSRGVVHRDLKPE 951
LV E LK D + QL+ + F HSR V+HRDLKP+
Sbjct: 77 TLVFEFCDQDLKK--YFDSCNG----DLDPEIVKSFLFQLLKGLGFCHSRNVLHRDLKPQ 130
Query: 952 NLLLSGISGNLIKI 965
NLL++ +G L K+
Sbjct: 131 NLLINR-NGEL-KL 142
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389 | Back alignment and structure |
|---|
Score = 139 bits (352), Expect = 6e-36
Identities = 43/193 (22%), Positives = 81/193 (41%), Gaps = 20/193 (10%)
Query: 387 GDGSYSVCRRCVEKSTGQEYAVKIISRKIDCSE-------EINLLRACQGHPNIVNLHCV 439
G K TG+ V+ I+ + +E E+++ + HPNIV
Sbjct: 36 GFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLFN-HPNIVPYRAT 94
Query: 440 FQDEVHTYLVLELLKGGELLDRIRQKGRCGFTENEASRIMRQLVAAVHFMHSRGVVHRDL 499
F + ++V + G D I G E + I++ ++ A+ ++H G VHR +
Sbjct: 95 FIADNELWVVTSFMAYGSAKDLICTHFMDGMNELAIAYILQGVLKALDYIHHMGYVHRSV 154
Query: 500 KPENLLFSDPAGDNIKVVDFGF-ACL-----KRESLHTPCF----TLQYAAPEVLRQDKS 549
K ++L S + + + ++ +H L + +PEVL+Q+
Sbjct: 155 KASHILISVDG--KVYLSGLRSNLSMISHGQRQRVVHDFPKYSVKVLPWLSPEVLQQNLQ 212
Query: 550 GYDENCDLWSLGV 562
GYD D++S+G+
Sbjct: 213 GYDAKSDIYSVGI 225
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389 | Back alignment and structure |
|---|
Score = 61.5 bits (149), Expect = 6e-10
Identities = 16/61 (26%), Positives = 31/61 (50%)
Query: 896 YLVLELLKGGELLDRIRQKGRCGFTENEASRIMRQLVAAVHFMHSRGVVHRDLKPENLLL 955
++V + G D I G E + I++ ++ A+ ++H G VHR +K ++L+
Sbjct: 102 WVVTSFMAYGSAKDLICTHFMDGMNELAIAYILQGVLKALDYIHHMGYVHRSVKASHILI 161
Query: 956 S 956
S
Sbjct: 162 S 162
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389 | Back alignment and structure |
|---|
Score = 43.0 bits (101), Expect = 4e-04
Identities = 12/46 (26%), Positives = 16/46 (34%), Gaps = 5/46 (10%)
Query: 268 KTEPPIPEDLSPDVADFISRLLVKDPRRRLGGGELDAEELKRHPFF 313
P SP F+ + L ++P R A L H FF
Sbjct: 297 SPSHPYHRTFSPHFHHFVEQCLQRNPDAR-----PSASTLLNHSFF 337
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303 | Back alignment and structure |
|---|
Score = 137 bits (346), Expect = 9e-36
Identities = 54/190 (28%), Positives = 93/190 (48%), Gaps = 25/190 (13%)
Query: 386 LGDGSYSVCRRCVEKSTGQEYAVKIIS------RKIDCSEEINLLRACQGHPNIVNLHCV 439
+G GS+ + ++ T + A+KII D +EI +L C P + +
Sbjct: 30 IGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCD-SPYVTKYYGS 88
Query: 440 FQDEVHTYLVLELLKGGELLDRIRQKGRCGFTENEASRIMRQLVAAVHFMHSRGVVHRDL 499
+ + ++++E L GG LD + E + + I+R+++ + ++HS +HRD+
Sbjct: 89 YLKDTKLWIIMEYLGGGSALDLLEPGP---LDETQIATILREILKGLDYLHSEKKIHRDI 145
Query: 500 KPENLLFSDPAGDNIKVVDFGF-ACL-----KRESL-HTPCFTLQYAAPEVLRQDKSGYD 552
K N+L S+ +K+ DFG L KR + TP + APEV++Q S YD
Sbjct: 146 KAANVLLSEHG--EVKLADFGVAGQLTDTQIKRNTFVGTPF----WMAPEVIKQ--SAYD 197
Query: 553 ENCDLWSLGV 562
D+WSLG+
Sbjct: 198 SKADIWSLGI 207
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303 | Back alignment and structure |
|---|
Score = 56.6 bits (137), Expect = 1e-08
Identities = 19/60 (31%), Positives = 35/60 (58%), Gaps = 3/60 (5%)
Query: 897 LVLELLKGGELLDRIRQKGRCGFTENEASRIMRQLVAAVHFMHSRGVVHRDLKPENLLLS 956
+++E L GG LD + E + + I+R+++ + ++HS +HRD+K N+LLS
Sbjct: 97 IIMEYLGGGSALDLLEPGP---LDETQIATILREILKGLDYLHSEKKIHRDIKAANVLLS 153
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303 | Back alignment and structure |
|---|
Score = 45.4 bits (108), Expect = 6e-05
Identities = 15/49 (30%), Positives = 23/49 (46%), Gaps = 6/49 (12%)
Query: 266 ILKTEPP-IPEDLSPDVADFISRLLVKDPRRRLGGGELDAEELKRHPFF 313
I K PP + + S + +F+ L K+P R A+EL +H F
Sbjct: 231 IPKNNPPTLEGNYSKPLKEFVEACLNKEPSFR-----PTAKELLKHKFI 274
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303 | Back alignment and structure |
|---|
Score = 42.7 bits (101), Expect = 3e-04
Identities = 12/58 (20%), Positives = 23/58 (39%), Gaps = 7/58 (12%)
Query: 174 RCVEKSTGQEYAVKIIS------RKIDCSEEINLLRACQGHPNIVNLHCVFQDEVIDW 225
+ ++ T + A+KII D +EI +L C P + + + + W
Sbjct: 40 KGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCD-SPYVTKYYGSYLKDTKLW 96
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303 | Back alignment and structure |
|---|
Score = 42.3 bits (100), Expect = 4e-04
Identities = 14/56 (25%), Positives = 25/56 (44%), Gaps = 7/56 (12%)
Query: 124 LGDGSYSVCRRCVEKSTGQEYAVKIIS------RKIDCSEEINLLRACQGHPNICR 173
+G GS+ + ++ T + A+KII D +EI +L C P + +
Sbjct: 30 IGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCD-SPYVTK 84
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324 | Back alignment and structure |
|---|
Score = 136 bits (346), Expect = 2e-35
Identities = 79/314 (25%), Positives = 115/314 (36%), Gaps = 79/314 (25%)
Query: 374 EQYDMDLDKAGILGDGSYSVCRRCVEKSTGQEYAVKIISRKIDCSE--------EINLLR 425
E Y LDK LG+G+Y+ + K T A+K I +++ E E++LL+
Sbjct: 2 ETYIK-LDK---LGEGTYATVYKGKSKLTDNLVALKEI--RLEHEEGAPCTAIREVSLLK 55
Query: 426 ACQGHPNIVNLHCVFQDEVHTYLVLEL----LKGGELLDRIRQKGRCGFTENEASRIMRQ 481
+ H NIV LH + E LV E LK LD + + Q
Sbjct: 56 DLK-HANIVTLHDIIHTEKSLTLVFEYLDKDLKQ--YLDDCGN----IINMHNVKLFLFQ 108
Query: 482 LVAAVHFMHSRGVVHRDLKPENLLFSDPAGDNIKVVDFGFACLKRESLH--TPC-FTLQY 538
L+ + + H + V+HRDLKP+NLL + G +K+ DFG A K TL Y
Sbjct: 109 LLRGLAYCHRQKVLHRDLKPQNLLI-NERG-ELKLADFGLARAKSIPTKTYDNEVVTLWY 166
Query: 539 AAPEVLRQDKSGYDENCDLWSLGVILVNVLRQDKSGYDENCDLWSLGVILYTMLCGRVPF 598
P++L LG + Y D+W +G I Y M GR F
Sbjct: 167 RPPDIL---------------LG----------STDYSTQIDMWGVGCIFYEMATGRPLF 201
Query: 599 HARSRDDSALSIMARI------------------KEGQF-----NFDAEAWSTVSSEAKE 635
+ ++ I RI K + + S+ +
Sbjct: 202 PGSTVEEQLHFIF-RILGTPTEETWPGILSNEEFKTYNYPKYRAEALLSHAPRLDSDGAD 260
Query: 636 LTKSLLTVNPAQRI 649
L LL RI
Sbjct: 261 LLTKLLQFEGRNRI 274
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324 | Back alignment and structure |
|---|
Score = 63.8 bits (156), Expect = 7e-11
Identities = 23/74 (31%), Positives = 34/74 (45%), Gaps = 12/74 (16%)
Query: 896 YLVLEL----LKGGELLDRIRQKGRCGFTENEASRIMRQLVAAVHFMHSRGVVHRDLKPE 951
LV E LK LD + + QL+ + + H + V+HRDLKP+
Sbjct: 76 TLVFEYLDKDLKQ--YLDDCGN----IINMHNVKLFLFQLLRGLAYCHRQKVLHRDLKPQ 129
Query: 952 NLLLSGISGNLIKI 965
NLL++ G L K+
Sbjct: 130 NLLINE-RGEL-KL 141
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324 | Back alignment and structure |
|---|
Score = 41.8 bits (99), Expect = 7e-04
Identities = 16/56 (28%), Positives = 26/56 (46%), Gaps = 11/56 (19%)
Query: 174 RCVEKSTGQEYAVKIISRKIDCSE--------EINLLRACQGHPNIVNLHCVFQDE 221
+ K T A+K I +++ E E++LL+ + H NIV LH + E
Sbjct: 20 KGKSKLTDNLVALKEI--RLEHEEGAPCTAIREVSLLKDLK-HANIVTLHDIIHTE 72
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297 | Back alignment and structure |
|---|
Score = 135 bits (341), Expect = 3e-35
Identities = 55/189 (29%), Positives = 96/189 (50%), Gaps = 24/189 (12%)
Query: 386 LGDGSYSVCRRCVEKSTGQEYAVKIIS-----RKIDCSEEINLLRACQGHPNIVNLHCVF 440
+G G+ ++ +TGQE A++ ++ +K EI ++R + +PNIVN +
Sbjct: 28 IGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENK-NPNIVNYLDSY 86
Query: 441 QDEVHTYLVLELLKGGELLDRIRQKGRCGFTENEASRIMRQLVAAVHFMHSRGVVHRDLK 500
++V+E L GG L D + + E + + + R+ + A+ F+HS V+HRD+K
Sbjct: 87 LVGDELWVVMEYLAGGSLTDVVTETC---MDEGQIAAVCRECLQALEFLHSNQVIHRDIK 143
Query: 501 PENLLFSDPAGDNIKVVDFGFA------CLKRESL-HTPCFTLQYAAPEVLRQDKSGYDE 553
+N+L ++K+ DFGF KR ++ TP + APEV+ + Y
Sbjct: 144 SDNILLGMDG--SVKLTDFGFCAQITPEQSKRSTMVGTPYWM----APEVVTR--KAYGP 195
Query: 554 NCDLWSLGV 562
D+WSLG+
Sbjct: 196 KVDIWSLGI 204
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297 | Back alignment and structure |
|---|
Score = 58.1 bits (141), Expect = 4e-09
Identities = 21/60 (35%), Positives = 36/60 (60%), Gaps = 3/60 (5%)
Query: 897 LVLELLKGGELLDRIRQKGRCGFTENEASRIMRQLVAAVHFMHSRGVVHRDLKPENLLLS 956
+V+E L GG L D + + E + + + R+ + A+ F+HS V+HRD+K +N+LL
Sbjct: 94 VVMEYLAGGSLTDVVTETC---MDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLG 150
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297 | Back alignment and structure |
|---|
Score = 45.8 bits (109), Expect = 4e-05
Identities = 17/52 (32%), Positives = 22/52 (42%), Gaps = 8/52 (15%)
Query: 265 RILKTEPPI---PEDLSPDVADFISRLLVKDPRRRLGGGELDAEELKRHPFF 313
I P PE LS DF++R L D +R A+EL +H F
Sbjct: 227 LIATNGTPELQNPEKLSAIFRDFLNRCLEMDVEKR-----GSAKELLQHQFL 273
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297 | Back alignment and structure |
|---|
Score = 45.0 bits (107), Expect = 6e-05
Identities = 14/53 (26%), Positives = 28/53 (52%), Gaps = 6/53 (11%)
Query: 124 LGDGSYSVCRRCVEKSTGQEYAVKIIS-----RKIDCSEEINLLRACQGHPNI 171
+G G+ ++ +TGQE A++ ++ +K EI ++R + +PNI
Sbjct: 28 IGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENK-NPNI 79
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297 | Back alignment and structure |
|---|
Score = 43.1 bits (102), Expect = 2e-04
Identities = 14/47 (29%), Positives = 26/47 (55%), Gaps = 6/47 (12%)
Query: 174 RCVEKSTGQEYAVKIIS-----RKIDCSEEINLLRACQGHPNIVNLH 215
++ +TGQE A++ ++ +K EI ++R + +PNIVN
Sbjct: 38 TAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENK-NPNIVNYL 83
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303 | Back alignment and structure |
|---|
Score = 134 bits (340), Expect = 5e-35
Identities = 56/201 (27%), Positives = 97/201 (48%), Gaps = 32/201 (15%)
Query: 386 LGDGSYSVCRRCVEKSTGQEYAVKII------SRKIDCSEEINLLRACQGHPNIVNLHCV 439
+G G+ +V + ++ A+K I + + +EI + C HPNIV+ +
Sbjct: 23 IGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCH-HPNIVSYYTS 81
Query: 440 FQDEVHTYLVLELLKGGELLDRIRQKGRCG------FTENEASRIMRQLVAAVHFMHSRG 493
F + +LV++LL GG +LD I+ G E+ + I+R+++ + ++H G
Sbjct: 82 FVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHKNG 141
Query: 494 VVHRDLKPENLLFSDPAGDNIKVVDFGF-ACLKRESLH-----------TPCFTLQYAAP 541
+HRD+K N+L + ++++ DFG A L TPC + AP
Sbjct: 142 QIHRDVKAGNILLGEDG--SVQIADFGVSAFLATGGDITRNKVRKTFVGTPC----WMAP 195
Query: 542 EVLRQDKSGYDENCDLWSLGV 562
EV+ Q + GYD D+WS G+
Sbjct: 196 EVMEQVR-GYDFKADIWSFGI 215
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303 | Back alignment and structure |
|---|
Score = 55.4 bits (134), Expect = 3e-08
Identities = 22/67 (32%), Positives = 39/67 (58%), Gaps = 6/67 (8%)
Query: 896 YLVLELLKGGELLDRIRQKGRCG------FTENEASRIMRQLVAAVHFMHSRGVVHRDLK 949
+LV++LL GG +LD I+ G E+ + I+R+++ + ++H G +HRD+K
Sbjct: 89 WLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHKNGQIHRDVK 148
Query: 950 PENLLLS 956
N+LL
Sbjct: 149 AGNILLG 155
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303 | Back alignment and structure |
|---|
Score = 42.3 bits (100), Expect = 5e-04
Identities = 12/51 (23%), Positives = 21/51 (41%), Gaps = 7/51 (13%)
Query: 174 RCVEKSTGQEYAVKII------SRKIDCSEEINLLRACQGHPNIVNLHCVF 218
++ A+K I + + +EI + C HPNIV+ + F
Sbjct: 33 AAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCH-HPNIVSYYTSF 82
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303 | Back alignment and structure |
|---|
Score = 41.9 bits (99), Expect = 7e-04
Identities = 13/54 (24%), Positives = 24/54 (44%), Gaps = 7/54 (12%)
Query: 124 LGDGSYSVCRRCVEKSTGQEYAVKII------SRKIDCSEEINLLRACQGHPNI 171
+G G+ +V + ++ A+K I + + +EI + C HPNI
Sbjct: 23 IGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCH-HPNI 75
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303 | Back alignment and structure |
|---|
Score = 41.5 bits (98), Expect = 8e-04
Identities = 17/58 (29%), Positives = 22/58 (37%), Gaps = 15/58 (25%)
Query: 266 ILKTEPP----------IPEDLSPDVADFISRLLVKDPRRRLGGGELDAEELKRHPFF 313
L+ +PP + + IS L KDP +R A EL RH FF
Sbjct: 239 TLQNDPPSLETGVQDKEMLKKYGKSFRKMISLCLQKDPEKR-----PTAAELLRHKFF 291
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317 | Back alignment and structure |
|---|
Score = 135 bits (341), Expect = 5e-35
Identities = 78/318 (24%), Positives = 122/318 (38%), Gaps = 78/318 (24%)
Query: 374 EQYDMDLDKAGILGDGSYSVCRRCVEKSTGQEYAVKIISRKIDCSE--------EINLLR 425
Q+ L+K LG+G+Y+ + + K+TG A+K + K+D E EI+L++
Sbjct: 5 SQFKQ-LEK---LGNGTYATVYKGLNKTTGVYVALKEV--KLDSEEGTPSTAIREISLMK 58
Query: 426 ACQGHPNIVNLHCVFQDEVHTYLVLEL----LKGGELLDRIRQKGR-CGFTENEASRIMR 480
+ H NIV L+ V E LV E LK +D G N
Sbjct: 59 ELK-HENIVRLYDVIHTENKLTLVFEFMDNDLKK--YMDSRTVGNTPRGLELNLVKYFQW 115
Query: 481 QLVAAVHFMHSRGVVHRDLKPENLLFSDPAGDNIKVVDFGFACLKRESLHT---PCFTLQ 537
QL+ + F H ++HRDLKP+NLL + G +K+ DFG A ++T TL
Sbjct: 116 QLLQGLAFCHENKILHRDLKPQNLLI-NKRG-QLKLGDFGLARAFGIPVNTFSSEVVTLW 173
Query: 538 YAAPEVLRQDKSGYDENCDLWSLGVILVNVLRQDKSGYDENCDLWSLGVILYTMLCGRVP 597
Y AP+VL +G Y + D+WS G IL M+ G+
Sbjct: 174 YRAPDVL---------------MG----------SRTYSTSIDIWSCGCILAEMITGKPL 208
Query: 598 FHARSRDDSALSI--------------MARIKEGQFNF------------DAEAWSTVSS 631
F + ++ I + ++ + N +
Sbjct: 209 FPGTNDEEQLKLIFDIMGTPNESLWPSVTKLPKYNPNIQQRPPRDLRQVLQPHTKEPLDG 268
Query: 632 EAKELTKSLLTVNPAQRI 649
+ LL +NP R+
Sbjct: 269 NLMDFLHGLLQLNPDMRL 286
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317 | Back alignment and structure |
|---|
Score = 66.1 bits (162), Expect = 1e-11
Identities = 24/75 (32%), Positives = 33/75 (44%), Gaps = 9/75 (12%)
Query: 896 YLVLEL----LKGGELLDRIRQKGR-CGFTENEASRIMRQLVAAVHFMHSRGVVHRDLKP 950
LV E LK +D G N QL+ + F H ++HRDLKP
Sbjct: 79 TLVFEFMDNDLKK--YMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCHENKILHRDLKP 136
Query: 951 ENLLLSGISGNLIKI 965
+NLL++ G L K+
Sbjct: 137 QNLLINK-RGQL-KL 149
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317 | Back alignment and structure |
|---|
Score = 42.6 bits (101), Expect = 4e-04
Identities = 18/56 (32%), Positives = 29/56 (51%), Gaps = 11/56 (19%)
Query: 174 RCVEKSTGQEYAVKIISRKIDCSE--------EINLLRACQGHPNIVNLHCVFQDE 221
+ + K+TG A+K + K+D E EI+L++ + H NIV L+ V E
Sbjct: 23 KGLNKTTGVYVALKEV--KLDSEEGTPSTAIREISLMKELK-HENIVRLYDVIHTE 75
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321 | Back alignment and structure |
|---|
Score = 134 bits (339), Expect = 9e-35
Identities = 57/190 (30%), Positives = 102/190 (53%), Gaps = 26/190 (13%)
Query: 386 LGDGSY-SVCRRCVEKSTGQEYAVKIIS-----RKIDCSEEINLLRACQGHPNIVNLHCV 439
+G+GS VC EK +G++ AVK++ R+ E+ ++R Q H N+V ++
Sbjct: 53 IGEGSTGIVCL-AREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQ-HFNVVEMYKS 110
Query: 440 FQDEVHTYLVLELLKGGELLDRIRQKGRCGFTENEASRIMRQLVAAVHFMHSRGVVHRDL 499
+ ++++E L+GG L D + Q E + + + ++ A+ ++H++GV+HRD+
Sbjct: 111 YLVGEELWVLMEFLQGGALTDIVSQ---VRLNEEQIATVCEAVLQALAYLHAQGVIHRDI 167
Query: 500 KPENLLFSDPAGDNIKVVDFGFA------CLKRESL-HTPCFTLQYAAPEVLRQDKSGYD 552
K +++L + +K+ DFGF KR+SL TP + APEV+ + S Y
Sbjct: 168 KSDSILLTLDG--RVKLSDFGFCAQISKDVPKRKSLVGTPYWM----APEVISR--SLYA 219
Query: 553 ENCDLWSLGV 562
D+WSLG+
Sbjct: 220 TEVDIWSLGI 229
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321 | Back alignment and structure |
|---|
Score = 57.8 bits (140), Expect = 6e-09
Identities = 18/60 (30%), Positives = 39/60 (65%), Gaps = 3/60 (5%)
Query: 897 LVLELLKGGELLDRIRQKGRCGFTENEASRIMRQLVAAVHFMHSRGVVHRDLKPENLLLS 956
+++E L+GG L D + Q E + + + ++ A+ ++H++GV+HRD+K +++LL+
Sbjct: 119 VLMEFLQGGALTDIVSQ---VRLNEEQIATVCEAVLQALAYLHAQGVIHRDIKSDSILLT 175
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321 | Back alignment and structure |
|---|
Score = 45.8 bits (109), Expect = 4e-05
Identities = 19/52 (36%), Positives = 28/52 (53%), Gaps = 8/52 (15%)
Query: 265 RILKTEPPI---PEDLSPDVADFISRLLVKDPRRRLGGGELDAEELKRHPFF 313
R+ + PP +SP + DF+ R+LV+DP+ R A+EL HPF
Sbjct: 252 RLRDSPPPKLKNSHKVSPVLRDFLERMLVRDPQER-----ATAQELLDHPFL 298
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321 | Back alignment and structure |
|---|
Score = 45.1 bits (107), Expect = 7e-05
Identities = 17/54 (31%), Positives = 29/54 (53%), Gaps = 8/54 (14%)
Query: 124 LGDGSY-SVCRRCVEKSTGQEYAVKIIS-----RKIDCSEEINLLRACQGHPNI 171
+G+GS VC EK +G++ AVK++ R+ E+ ++R Q H N+
Sbjct: 53 IGEGSTGIVCL-AREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQ-HFNV 104
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321 | Back alignment and structure |
|---|
Score = 42.7 bits (101), Expect = 4e-04
Identities = 13/47 (27%), Positives = 25/47 (53%), Gaps = 6/47 (12%)
Query: 174 RCVEKSTGQEYAVKIIS-----RKIDCSEEINLLRACQGHPNIVNLH 215
EK +G++ AVK++ R+ E+ ++R Q H N+V ++
Sbjct: 63 LAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQ-HFNVVEMY 108
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314 | Back alignment and structure |
|---|
Score = 134 bits (338), Expect = 1e-34
Identities = 55/187 (29%), Positives = 98/187 (52%), Gaps = 20/187 (10%)
Query: 386 LGDGSYSVCRRCVEKSTGQEYAVKIISRKIDCSE---EINLLRACQGHPNIVNLHCVFQD 442
LG+GSY + + K TGQ A+K + + D E EI++++ C P++V + +
Sbjct: 37 LGEGSYGSVYKAIHKETGQIVAIKQVPVESDLQEIIKEISIMQQCD-SPHVVKYYGSYFK 95
Query: 443 EVHTYLVLELLKGGELLDRIRQKGRCGFTENEASRIMRQLVAAVHFMHSRGVVHRDLKPE 502
++V+E G + D IR + + TE+E + I++ + + ++H +HRD+K
Sbjct: 96 NTDLWIVMEYCGAGSVSDIIRLRNKT-LTEDEIATILQSTLKGLEYLHFMRKIHRDIKAG 154
Query: 503 NLLFSDPAGDNIKVVDFGFAC------LKRESL-HTPCFTLQYAAPEVLRQDKSGYDENC 555
N+L + + K+ DFG A KR ++ TP + APEV+++ GY+
Sbjct: 155 NILLNTEG--HAKLADFGVAGQLTDTMAKRNTVIGTPF----WMAPEVIQE--IGYNCVA 206
Query: 556 DLWSLGV 562
D+WSLG+
Sbjct: 207 DIWSLGI 213
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314 | Back alignment and structure |
|---|
Score = 58.9 bits (143), Expect = 2e-09
Identities = 18/60 (30%), Positives = 35/60 (58%), Gaps = 1/60 (1%)
Query: 897 LVLELLKGGELLDRIRQKGRCGFTENEASRIMRQLVAAVHFMHSRGVVHRDLKPENLLLS 956
+V+E G + D IR + + TE+E + I++ + + ++H +HRD+K N+LL+
Sbjct: 101 IVMEYCGAGSVSDIIRLRNKT-LTEDEIATILQSTLKGLEYLHFMRKIHRDIKAGNILLN 159
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314 | Back alignment and structure |
|---|
Score = 45.0 bits (107), Expect = 7e-05
Identities = 18/51 (35%), Positives = 24/51 (47%), Gaps = 8/51 (15%)
Query: 266 ILKTEPPI---PEDLSPDVADFISRLLVKDPRRRLGGGELDAEELKRHPFF 313
I PP PE S + DF+ + LVK P +R A +L +HPF
Sbjct: 237 IPTNPPPTFRKPELWSDNFTDFVKQCLVKSPEQR-----ATATQLLQHPFV 282
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314 | Back alignment and structure |
|---|
Score = 43.5 bits (103), Expect = 2e-04
Identities = 17/51 (33%), Positives = 29/51 (56%), Gaps = 4/51 (7%)
Query: 124 LGDGSYSVCRRCVEKSTGQEYAVKIISRKIDCSE---EINLLRACQGHPNI 171
LG+GSY + + K TGQ A+K + + D E EI++++ C P++
Sbjct: 37 LGEGSYGSVYKAIHKETGQIVAIKQVPVESDLQEIIKEISIMQQCD-SPHV 86
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314 | Back alignment and structure |
|---|
Score = 42.0 bits (99), Expect = 6e-04
Identities = 13/45 (28%), Positives = 25/45 (55%), Gaps = 4/45 (8%)
Query: 174 RCVEKSTGQEYAVKIISRKIDCSE---EINLLRACQGHPNIVNLH 215
+ + K TGQ A+K + + D E EI++++ C P++V +
Sbjct: 47 KAIHKETGQIVAIKQVPVESDLQEIIKEISIMQQCD-SPHVVKYY 90
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 134 bits (339), Expect = 1e-34
Identities = 51/254 (20%), Positives = 107/254 (42%), Gaps = 51/254 (20%)
Query: 368 KGSLFFEQYDMDLDK---AGILGDGSYS-VCRRCVEKSTG---QEYAVKIISRKIDCSE- 419
+ S+F +++D+ ++ ++G G + V G E A+++I + D +
Sbjct: 20 QTSIFLQEWDIPFEQLEIGELIGKGRFGQVYH-------GRWHGEVAIRLIDIERDNEDQ 72
Query: 420 ------EINLLRACQGHPNIVNLHCVFQDEVHTYLVLELLKGGELLDRIRQKGRCGFTEN 473
E+ R + H N+V H ++ L KG L +R + N
Sbjct: 73 LKAFKREVMAYRQTR-HENVVLFMGACMSPPHLAIITSLCKGRTLYSVVRDA-KIVLDVN 130
Query: 474 EASRIMRQLVAAVHFMHSRGVVHRDLKPENLLFSDPAGDNIKVVDFGFACLKR------- 526
+ +I +++V + ++H++G++H+DLK +N+ + + + + DFG +
Sbjct: 131 KTRQIAQEIVKGMGYLHAKGILHKDLKSKNVFYDN---GKVVITDFGLFSISGVLQAGRR 187
Query: 527 -ESLHTPCFTLQYAAPEVLRQDKSGYDENCDLWSLGVILVNVLRQDKSGYDENCDLWSLG 585
+ L L + APE++RQ + +DK + ++ D+++LG
Sbjct: 188 EDKLRIQNGWLCHLAPEIIRQLSPDTE-----------------EDKLPFSKHSDVFALG 230
Query: 586 VILYTMLCGRVPFH 599
I Y + PF
Sbjct: 231 TIWYELHAREWPFK 244
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 61.2 bits (149), Expect = 4e-10
Identities = 16/62 (25%), Positives = 35/62 (56%), Gaps = 1/62 (1%)
Query: 894 HTYLVLELLKGGELLDRIRQKGRCGFTENEASRIMRQLVAAVHFMHSRGVVHRDLKPENL 953
H ++ L KG L +R + N+ +I +++V + ++H++G++H+DLK +N+
Sbjct: 103 HLAIITSLCKGRTLYSVVRDA-KIVLDVNKTRQIAQEIVKGMGYLHAKGILHKDLKSKNV 161
Query: 954 LL 955
Sbjct: 162 FY 163
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302 | Back alignment and structure |
|---|
Score = 133 bits (337), Expect = 1e-34
Identities = 60/197 (30%), Positives = 97/197 (49%), Gaps = 23/197 (11%)
Query: 381 DKAGILGDGSYSVCRRCVEKSTGQEYAVKIIS-----RKIDCSEEINLLRACQGHPNIVN 435
+ G LGDG++ + K TG A K+I D EI +L C HP IV
Sbjct: 22 EIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCD-HPYIVK 80
Query: 436 LHCVFQDEVHTYLVLELLKGGELLDRIRQKGRCGFTENEASRIMRQLVAAVHFMHSRGVV 495
L + + ++++E GG + + + R TE + + RQ++ A++F+HS+ ++
Sbjct: 81 LLGAYYHDGKLWIMIEFCPGGAVDAIMLELDRG-LTEPQIQVVCRQMLEALNFLHSKRII 139
Query: 496 HRDLKPENLLFSDPAGDNIKVVDFGFA------CLKRESL-HTPCFTLQYAAPEVL---R 545
HRDLK N+L + +I++ DFG + KR+S TP + APEV+
Sbjct: 140 HRDLKAGNVLMTLEG--DIRLADFGVSAKNLKTLQKRDSFIGTPYWM----APEVVMCET 193
Query: 546 QDKSGYDENCDLWSLGV 562
+ YD D+WSLG+
Sbjct: 194 MKDTPYDYKADIWSLGI 210
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302 | Back alignment and structure |
|---|
Score = 59.3 bits (144), Expect = 1e-09
Identities = 19/60 (31%), Positives = 38/60 (63%), Gaps = 1/60 (1%)
Query: 897 LVLELLKGGELLDRIRQKGRCGFTENEASRIMRQLVAAVHFMHSRGVVHRDLKPENLLLS 956
+++E GG + + + R TE + + RQ++ A++F+HS+ ++HRDLK N+L++
Sbjct: 93 IMIEFCPGGAVDAIMLELDRG-LTEPQIQVVCRQMLEALNFLHSKRIIHRDLKAGNVLMT 151
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302 | Back alignment and structure |
|---|
Score = 46.5 bits (111), Expect = 2e-05
Identities = 17/51 (33%), Positives = 23/51 (45%), Gaps = 8/51 (15%)
Query: 266 ILKTEPPI---PEDLSPDVADFISRLLVKDPRRRLGGGELDAEELKRHPFF 313
I K++PP P S + DF+ L K+P R A +L HPF
Sbjct: 234 IAKSDPPTLLTPSKWSVEFRDFLKIALDKNPETR-----PSAAQLLEHPFV 279
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302 | Back alignment and structure |
|---|
Score = 43.8 bits (104), Expect = 1e-04
Identities = 19/58 (32%), Positives = 25/58 (43%), Gaps = 6/58 (10%)
Query: 119 DKAGILGDGSYSVCRRCVEKSTGQEYAVKIIS-----RKIDCSEEINLLRACQGHPNI 171
+ G LGDG++ + K TG A K+I D EI +L C HP I
Sbjct: 22 EIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCD-HPYI 78
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302 | Back alignment and structure |
|---|
Score = 42.3 bits (100), Expect = 5e-04
Identities = 16/47 (34%), Positives = 19/47 (40%), Gaps = 6/47 (12%)
Query: 174 RCVEKSTGQEYAVKIIS-----RKIDCSEEINLLRACQGHPNIVNLH 215
+ K TG A K+I D EI +L C HP IV L
Sbjct: 37 KAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCD-HPYIVKLL 82
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307 | Back alignment and structure |
|---|
Score = 133 bits (337), Expect = 1e-34
Identities = 65/249 (26%), Positives = 104/249 (41%), Gaps = 45/249 (18%)
Query: 379 DLDKAGILGDGSYSVCRRCVEKST--GQEYAVKIISRKIDCSE---EINLLRACQGHPNI 433
+++ ++G G++ V V K+ ++ A+K I + + E+ L HPNI
Sbjct: 9 EIEVEEVVGRGAFGV----VCKAKWRAKDVAIKQIESESERKAFIVELRQLSRVN-HPNI 63
Query: 434 VNLHCVFQDEVHTYLVLELLKGGELLDRIR-QKGRCGFTENEASRIMRQLVAAVHFMHSR 492
V L+ + V LV+E +GG L + + + +T A Q V ++HS
Sbjct: 64 VKLYGACLNPV--CLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSM 121
Query: 493 ---GVVHRDLKPENLLFSDPAGDNIKVVDFGFACLKRESLHTPCFTLQYAAPEVLRQDKS 549
++HRDLKP NLL G +K+ DFG AC + + + + APEV
Sbjct: 122 QPKALIHRDLKPPNLLL-VAGGTVLKICDFGTACDIQTHMTNNKGSAAWMAPEVFE---- 176
Query: 550 GYDENCDLWSLGVILVNVLRQDKSGYDENCDLWSLGVILYTMLCGRVPFHARSRDDSALS 609
S Y E CD++S G+IL+ ++ R PF A
Sbjct: 177 ----------------------GSNYSEKCDVFSWGIILWEVITRRKPFD--EIGGPAFR 212
Query: 610 IMARIKEGQ 618
IM + G
Sbjct: 213 IMWAVHNGT 221
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307 | Back alignment and structure |
|---|
Score = 60.0 bits (146), Expect = 1e-09
Identities = 25/74 (33%), Positives = 37/74 (50%), Gaps = 5/74 (6%)
Query: 896 YLVLELLKGGELLDRIR-QKGRCGFTENEASRIMRQLVAAVHFMHSR---GVVHRDLKPE 951
LV+E +GG L + + + +T A Q V ++HS ++HRDLKP
Sbjct: 75 CLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHRDLKPP 134
Query: 952 NLLLSGISGNLIKI 965
NLLL G ++KI
Sbjct: 135 NLLLVA-GGTVLKI 147
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288 | Back alignment and structure |
|---|
Score = 133 bits (336), Expect = 1e-34
Identities = 78/313 (24%), Positives = 120/313 (38%), Gaps = 78/313 (24%)
Query: 374 EQYDMDLDKAGILGDGSYSVCRRCVEKSTGQEYAVKIISRKIDCSE---------EINLL 424
E+Y +G+G+Y V + G+ +A+K I +++ + EI++L
Sbjct: 2 EKYH----GLEKIGEGTYGVVYKAQNN-YGETFALKKI--RLEKEDEGIPSTTIREISIL 54
Query: 425 RACQGHPNIVNLHCVFQDEVHTYLVLEL----LKGGELLDRIRQKGRCGFTENEASRIMR 480
+ + H NIV L+ V + LV E LK LLD G A +
Sbjct: 55 KELK-HSNIVKLYDVIHTKKRLVLVFEHLDQDLKK--LLDVCEG----GLESVTAKSFLL 107
Query: 481 QLVAAVHFMHSRGVVHRDLKPENLLFSDPAGDNIKVVDFGFACLKRESLH--TPC-FTLQ 537
QL+ + + H R V+HRDLKP+NLL + G +K+ DFG A + T TL
Sbjct: 108 QLLNGIAYCHDRRVLHRDLKPQNLLI-NREG-ELKIADFGLARAFGIPVRKYTHEIVTLW 165
Query: 538 YAAPEVLRQDKSGYDENCDLWSLGVILVNVLRQDKSGYDENCDLWSLGVILYTMLCGRVP 597
Y AP+VL +G Y D+WS+G I M+ G
Sbjct: 166 YRAPDVL---------------MG----------SKKYSTTIDIWSVGCIFAEMVNGTPL 200
Query: 598 FHARSRDDSALSI--------------MARIKEGQFNFD-------AEAWSTVSSEAKEL 636
F S D + I + + + NF + +L
Sbjct: 201 FPGVSEADQLMRIFRILGTPNSKNWPNVTELPKYDPNFTVYEPLPWESFLKGLDESGIDL 260
Query: 637 TKSLLTVNPAQRI 649
+L ++P QRI
Sbjct: 261 LSKMLKLDPNQRI 273
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288 | Back alignment and structure |
|---|
Score = 65.2 bits (160), Expect = 1e-11
Identities = 28/74 (37%), Positives = 36/74 (48%), Gaps = 12/74 (16%)
Query: 896 YLVLEL----LKGGELLDRIRQKGRCGFTENEASRIMRQLVAAVHFMHSRGVVHRDLKPE 951
LV E LK LLD G A + QL+ + + H R V+HRDLKP+
Sbjct: 76 VLVFEHLDQDLKK--LLDVCEG----GLESVTAKSFLLQLLNGIAYCHDRRVLHRDLKPQ 129
Query: 952 NLLLSGISGNLIKI 965
NLL++ G L KI
Sbjct: 130 NLLINR-EGEL-KI 141
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327 | Back alignment and structure |
|---|
Score = 133 bits (338), Expect = 2e-34
Identities = 66/293 (22%), Positives = 110/293 (37%), Gaps = 49/293 (16%)
Query: 373 FEQYDMDLDKAGILGDGSYSVCRRCVEKSTGQEYAVKIISRKIDCSE------EIN-LLR 425
++ DL G +G G+Y + V K +GQ AVK I +D E +++ ++R
Sbjct: 17 WDFTAEDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQKQLLMDLDVVMR 76
Query: 426 ACQGHPNIVNLHCVFQDEVHTYLVLELLKGG--ELLDRIRQKGRCGFTENEASRIMRQLV 483
+ P IV + E ++ +EL+ + + E +I V
Sbjct: 77 SSD-CPYIVQFYGALFREGDCWICMELMSTSFDKFYKYVYSVLDDVIPEEILGKITLATV 135
Query: 484 AAVHFMHS-RGVVHRDLKPENLLFSDPAGDNIKVVDFGF-ACL-----KRESLHTPCFTL 536
A++ + ++HRD+KP N+L +G+ IK+ DFG L K
Sbjct: 136 KALNHLKENLKIIHRDIKPSNILLDR-SGN-IKLCDFGISGQLVDSIAKTRDAGCRP--- 190
Query: 537 QYAAPEVLRQDKSGYDENCDLWSLGVILVNVLRQDKSGYDENCDLWSLGVILYTMLCGRV 596
Y APE + S GYD D+WSLG+ LY + GR
Sbjct: 191 -YMAPERIDPSASR----------------------QGYDVRSDVWSLGITLYELATGRF 227
Query: 597 PFHARSRDDSALSIMARIKEGQ-FNFDAEAWSTVSSEAKELTKSLLTVNPAQR 648
P+ +S + ++ +G S LT + ++R
Sbjct: 228 PYPK---WNSVFDQLTQVVKGDPPQLSNSEEREFSPSFINFVNLCLTKDESKR 277
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327 | Back alignment and structure |
|---|
Score = 56.9 bits (138), Expect = 1e-08
Identities = 19/81 (23%), Positives = 34/81 (41%), Gaps = 13/81 (16%)
Query: 896 YLVLELLKGG--ELLDRIRQKGRCGFTENEASRIMRQLVAAVHFMHS-RGVVHRDLKPEN 952
++ +EL+ + + E +I V A++ + ++HRD+KP N
Sbjct: 97 WICMELMSTSFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLKENLKIIHRDIKPSN 156
Query: 953 LLLS----------GISGNLI 963
+LL GISG L+
Sbjct: 157 ILLDRSGNIKLCDFGISGQLV 177
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327 | Back alignment and structure |
|---|
Score = 47.7 bits (114), Expect = 9e-06
Identities = 20/77 (25%), Positives = 34/77 (44%), Gaps = 8/77 (10%)
Query: 104 KFKGSLFFEQYDMDLDKAGILGDGSYSVCRRCVEKSTGQEYAVKIISRKIDCSE------ 157
K ++ DL G +G G+Y + V K +GQ AVK I +D E
Sbjct: 10 KISPEQHWDFTAEDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQKQLLM 69
Query: 158 EIN-LLRACQGHPNICR 173
+++ ++R+ P I +
Sbjct: 70 DLDVVMRSSD-CPYIVQ 85
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327 | Back alignment and structure |
|---|
Score = 43.1 bits (102), Expect = 3e-04
Identities = 15/54 (27%), Positives = 26/54 (48%), Gaps = 10/54 (18%)
Query: 265 RILKTEPPI-----PEDLSPDVADFISRLLVKDPRRRLGGGELDAEELKRHPFF 313
+++K +PP + SP +F++ L KD +R +EL +HPF
Sbjct: 241 QVVKGDPPQLSNSEEREFSPSFINFVNLCLTKDESKR-----PKYKELLKHPFI 289
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311 | Back alignment and structure |
|---|
Score = 133 bits (337), Expect = 2e-34
Identities = 79/308 (25%), Positives = 122/308 (39%), Gaps = 77/308 (25%)
Query: 381 DKAGILGDGSYSVCRRCVEKSTGQEYAVKIISRKIDCSE---------EINLLRACQGHP 431
K +G+G+Y V + + G+ A+K I ++D + EI+LL+ HP
Sbjct: 24 QKLEKVGEGTYGVVYKAKDS-QGRIVALKRI--RLDAEDEGIPSTAIREISLLKELH-HP 79
Query: 432 NIVNLHCVFQDEVHTYLVLEL----LKGGELLDRIRQKGRCGFTENEASRIMRQLVAAVH 487
NIV+L V E LV E LK +LD + G +++ + QL+ V
Sbjct: 80 NIVSLIDVIHSERCLTLVFEFMEKDLKK--VLDENKT----GLQDSQIKIYLYQLLRGVA 133
Query: 488 FMHSRGVVHRDLKPENLLFSDPAGDNIKVVDFGFACLKRESLH--TPC-FTLQYAAPEVL 544
H ++HRDLKP+NLL + G +K+ DFG A + T TL Y AP+VL
Sbjct: 134 HCHQHRILHRDLKPQNLLINS-DG-ALKLADFGLARAFGIPVRSYTHEVVTLWYRAPDVL 191
Query: 545 RQDKSGYDENCDLWSLGVILVNVLRQDKSGYDENCDLWSLGVILYTMLCGRVPFHARSRD 604
+G Y + D+WS+G I M+ G+ F + D
Sbjct: 192 ---------------MG----------SKKYSTSVDIWSIGCIFAEMITGKPLFPGVTDD 226
Query: 605 DSALSIMARI------------------KEGQF-----NFDAEAWSTVSSEAKELTKSLL 641
D L + I K+ F + E +L ++L
Sbjct: 227 D-QLPKIFSILGTPNPREWPQVQELPLWKQRTFQVFEKKPWSSIIPGFCQEGIDLLSNML 285
Query: 642 TVNPAQRI 649
+P +RI
Sbjct: 286 CFDPNKRI 293
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311 | Back alignment and structure |
|---|
Score = 66.4 bits (163), Expect = 8e-12
Identities = 24/74 (32%), Positives = 37/74 (50%), Gaps = 12/74 (16%)
Query: 896 YLVLEL----LKGGELLDRIRQKGRCGFTENEASRIMRQLVAAVHFMHSRGVVHRDLKPE 951
LV E LK +LD + G +++ + QL+ V H ++HRDLKP+
Sbjct: 95 TLVFEFMEKDLKK--VLDENKT----GLQDSQIKIYLYQLLRGVAHCHQHRILHRDLKPQ 148
Query: 952 NLLLSGISGNLIKI 965
NLL++ G L K+
Sbjct: 149 NLLINS-DGAL-KL 160
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360 | Back alignment and structure |
|---|
Score = 134 bits (339), Expect = 2e-34
Identities = 65/308 (21%), Positives = 119/308 (38%), Gaps = 33/308 (10%)
Query: 364 DKIFKGSLFFEQYDMDLDKAGILGDGSYSVCRRCVEKSTGQEYAVKIISRKIDCSE---- 419
+ + E D D +K LG G+ V + K +G A K+I +I +
Sbjct: 19 AFLTQKQKVGELKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQI 78
Query: 420 --EINLLRACQGHPNIVNLHCVFQDEVHTYLVLELLKGGELLDRIRQKGRCGFTENEASR 477
E+ +L C P IV + F + + +E + GG L +++ GR E +
Sbjct: 79 IRELQVLHECN-SPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGR--IPEQILGK 135
Query: 478 IMRQLVAAVHFMHSRG-VVHRDLKPENLLFSDPAGDNIKVVDFGFACLKRESL-HTPCFT 535
+ ++ + ++ + ++HRD+KP N+L + G+ IK+ DFG + +S+ ++ T
Sbjct: 136 VSIAVIKGLTYLREKHKIMHRDVKPSNILVNS-RGE-IKLCDFGVSGQLIDSMANSFVGT 193
Query: 536 LQYAAPEVLRQDKSGYDENCDLWSLGVILV--------------NVLRQDKSGYDENCDL 581
Y +PE L+ + Y D+WS+G+ LV L E
Sbjct: 194 RSYMSPERLQG--THYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAA 251
Query: 582 WSLGVILYTMLCGRVPFHARSRDDSALSIMARI-KEGQFNFDAEAWSTVSSEAKELTKSL 640
+ + ++ I E + + S E ++
Sbjct: 252 ETPPRPRTPGRPLNKFGMDSRPPMAIFELLDYIVNEPPPKLPSGVF---SLEFQDFVNKC 308
Query: 641 LTVNPAQR 648
L NPA+R
Sbjct: 309 LIKNPAER 316
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360 | Back alignment and structure |
|---|
Score = 58.3 bits (141), Expect = 5e-09
Identities = 19/80 (23%), Positives = 40/80 (50%), Gaps = 13/80 (16%)
Query: 896 YLVLELLKGGELLDRIRQKGRCGFTENEASRIMRQLVAAVHFMHSRG-VVHRDLKPENLL 954
+ +E + GG L +++ GR E ++ ++ + ++ + ++HRD+KP N+L
Sbjct: 107 SICMEHMDGGSLDQVLKKAGR--IPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNIL 164
Query: 955 LS----------GISGNLIK 964
++ G+SG LI
Sbjct: 165 VNSRGEIKLCDFGVSGQLID 184
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360 | Back alignment and structure |
|---|
Score = 50.6 bits (121), Expect = 1e-06
Identities = 23/92 (25%), Positives = 36/92 (39%), Gaps = 8/92 (8%)
Query: 88 QPSLDKRPNTSNLIACKFKGSLFFEQYDMDLDKAGILGDGSYSVCRRCVEKSTGQEYAVK 147
+ LD++ L A + E D D +K LG G+ V + K +G A K
Sbjct: 6 ELELDEQQRKR-LEAFLTQKQKVGELKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARK 64
Query: 148 IISRKIDCSE------EINLLRACQGHPNICR 173
+I +I + E+ +L C P I
Sbjct: 65 LIHLEIKPAIRNQIIRELQVLHECN-SPYIVG 95
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287 | Back alignment and structure |
|---|
Score = 131 bits (331), Expect = 5e-34
Identities = 43/203 (21%), Positives = 82/203 (40%), Gaps = 21/203 (10%)
Query: 379 DLDKAGILGDGSYSVCRRCVEKSTGQEYAVKIISRKIDCSE------------EINLLRA 426
+++ +G G + + + A+K + E E+ ++
Sbjct: 20 EIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSN 79
Query: 427 CQGHPNIVNLHCVFQDEVHTYLVLELLKGGELLDRIRQKGRCGFTENEASRIMRQLVAAV 486
HPNIV L+ + + +V+E + G+L R+ K + R+M + +
Sbjct: 80 LN-HPNIVKLYGLMHNPP--RMVMEFVPCGDLYHRLLDKAHP-IKWSVKLRLMLDIALGI 135
Query: 487 HFMHSRG--VVHRDLKPENLLFSDPAGD---NIKVVDFGFACLKRESLHTPCFTLQYAAP 541
+M ++ +VHRDL+ N+ + KV DFG + S+ Q+ AP
Sbjct: 136 EYMQNQNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGLSQQSVHSVSGLLGNFQWMAP 195
Query: 542 EVLRQDKSGYDENCDLWSLGVIL 564
E + ++ Y E D +S +IL
Sbjct: 196 ETIGAEEESYTEKADTYSFAMIL 218
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287 | Back alignment and structure |
|---|
Score = 59.3 bits (144), Expect = 2e-09
Identities = 18/75 (24%), Positives = 35/75 (46%), Gaps = 6/75 (8%)
Query: 896 YLVLELLKGGELLDRIRQKGRCGFTENEASRIMRQLVAAVHFMHSRG--VVHRDLKPENL 953
+V+E + G+L R+ K + R+M + + +M ++ +VHRDL+ N+
Sbjct: 97 RMVMEFVPCGDLYHRLLDKAHP-IKWSVKLRLMLDIALGIEYMQNQNPPIVHRDLRSPNI 155
Query: 954 LLSGISGNL---IKI 965
L + N K+
Sbjct: 156 FLQSLDENAPVCAKV 170
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290 | Back alignment and structure |
|---|
Score = 130 bits (329), Expect = 1e-33
Identities = 63/282 (22%), Positives = 113/282 (40%), Gaps = 43/282 (15%)
Query: 379 DLDKAGILGDGSYSVCRRCVEKSTGQEYAVKIISRKIDCSE------EIN-LLRACQGHP 431
DL+ LG G+Y V + +GQ AVK I ++ E +++ +R P
Sbjct: 8 DLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVD-CP 66
Query: 432 NIVNLHCVFQDEVHTYLVLELLKGG--ELLDRIRQKGRCGFTENEASRIMRQLVAAVHFM 489
V + E ++ +EL+ + ++ KG+ E+ +I +V A+ +
Sbjct: 67 FTVTFYGALFREGDVWICMELMDTSLDKFYKQVIDKGQT-IPEDILGKIAVSIVKALEHL 125
Query: 490 HS-RGVVHRDLKPENLLFSDPAGDNIKVVDFGFACLKRESLHTPCF--TLQYAAPEVLRQ 546
HS V+HRD+KP N+L + G +K+ DFG + + + Y APE +
Sbjct: 126 HSKLSVIHRDVKPSNVLINA-LGQ-VKMCDFGISGYLVDDVAKDIDAGCKPYMAPERINP 183
Query: 547 DKSGYDENCDLWSLGVILVNVLRQDKSGYDENCDLWSLGVILYTMLCGRVPFHARSRDDS 606
+ + GY D+WSLG+ + + R P+ +
Sbjct: 184 ELNQ----------------------KGYSVKSDIWSLGITMIELAILRFPYDSWGTPFQ 221
Query: 607 ALSIMARIKEGQFNFDAEAWSTVSSEAKELTKSLLTVNPAQR 648
L + ++E A+ + S+E + T L N +R
Sbjct: 222 QLKQV--VEEPSPQLPADKF---SAEFVDFTSQCLKKNSKER 258
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290 | Back alignment and structure |
|---|
Score = 54.6 bits (132), Expect = 5e-08
Identities = 23/81 (28%), Positives = 42/81 (51%), Gaps = 14/81 (17%)
Query: 896 YLVLELLKGG--ELLDRIRQKGRCGFTENEASRIMRQLVAAVHFMHS-RGVVHRDLKPEN 952
++ +EL+ + ++ KG+ E+ +I +V A+ +HS V+HRD+KP N
Sbjct: 82 WICMELMDTSLDKFYKQVIDKGQT-IPEDILGKIAVSIVKALEHLHSKLSVIHRDVKPSN 140
Query: 953 LLLS----------GISGNLI 963
+L++ GISG L+
Sbjct: 141 VLINALGQVKMCDFGISGYLV 161
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290 | Back alignment and structure |
|---|
Score = 48.0 bits (115), Expect = 8e-06
Identities = 16/64 (25%), Positives = 26/64 (40%), Gaps = 8/64 (12%)
Query: 117 DLDKAGILGDGSYSVCRRCVEKSTGQEYAVKIISRKIDCSE------EIN-LLRACQGHP 169
DL+ LG G+Y V + +GQ AVK I ++ E +++ +R P
Sbjct: 8 DLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVD-CP 66
Query: 170 NICR 173
Sbjct: 67 FTVT 70
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290 | Back alignment and structure |
|---|
Score = 44.9 bits (107), Expect = 6e-05
Identities = 14/51 (27%), Positives = 24/51 (47%), Gaps = 7/51 (13%)
Query: 265 RILKTEPPI--PEDLSPDVADFISRLLVKDPRRRLGGGELDAEELKRHPFF 313
++++ P + S + DF S+ L K+ + R EL +HPFF
Sbjct: 225 QVVEEPSPQLPADKFSAEFVDFTSQCLKKNSKER-----PTYPELMQHPFF 270
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308 | Back alignment and structure |
|---|
Score = 130 bits (330), Expect = 1e-33
Identities = 76/313 (24%), Positives = 111/313 (35%), Gaps = 79/313 (25%)
Query: 381 DKAGILGDGSYSVCRRCVEKSTGQEYAVKIISRKIDCSE------------EINLLRACQ 428
+ +G G+Y + + +G A+K + ++ E+ LLR +
Sbjct: 12 EPVAEIGVGAYGTVYKARDPHSGHFVALKSV--RVPNGGGGGGGLPISTVREVALLRRLE 69
Query: 429 G--HPNIVNLHCVFQDEVHT-----YLVLEL----LKGGELLDRIRQKGRCGFTENEASR 477
HPN+V L V LV E L+ LD+ G
Sbjct: 70 AFEHPNVVRLMDVCATSRTDREIKVTLVFEHVDQDLRT--YLDKAPPPG---LPAETIKD 124
Query: 478 IMRQLVAAVHFMHSRGVVHRDLKPENLLFSDPAGDNIKVVDFGFACLKRESLH-TPC-FT 535
+MRQ + + F+H+ +VHRDLKPEN+L + G +K+ DFG A + + TP T
Sbjct: 125 LMRQFLRGLDFLHANCIVHRDLKPENILVTS-GG-TVKLADFGLARIYSYQMALTPVVVT 182
Query: 536 LQYAAPEVLRQDKSGYDENCDLWSLGVILVNVLRQDKSGYDENCDLWSLGVILYTMLCGR 595
L Y APEVL L S Y D+WS+G I M +
Sbjct: 183 LWYRAPEVL---------------LQ-----------STYATPVDMWSVGCIFAEMFRRK 216
Query: 596 VPFHARSRDDSALSI--------------MARIKEGQF-----NFDAEAWSTVSSEAKEL 636
F S D I + G F + +L
Sbjct: 217 PLFCGNSEADQLGKIFDLIGLPPEDDWPRDVSLPRGAFPPRGPRPVQSVVPEMEESGAQL 276
Query: 637 TKSLLTVNPAQRI 649
+LT NP +RI
Sbjct: 277 LLEMLTFNPHKRI 289
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308 | Back alignment and structure |
|---|
Score = 67.6 bits (166), Expect = 3e-12
Identities = 24/74 (32%), Positives = 37/74 (50%), Gaps = 11/74 (14%)
Query: 896 YLVLEL----LKGGELLDRIRQKGRCGFTENEASRIMRQLVAAVHFMHSRGVVHRDLKPE 951
LV E L+ LD+ G +MRQ + + F+H+ +VHRDLKPE
Sbjct: 95 TLVFEHVDQDLRT--YLDKAPPPG---LPAETIKDLMRQFLRGLDFLHANCIVHRDLKPE 149
Query: 952 NLLLSGISGNLIKI 965
N+L++ G + K+
Sbjct: 150 NILVTS-GGTV-KL 161
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* Length = 382 | Back alignment and structure |
|---|
Score = 132 bits (334), Expect = 2e-33
Identities = 62/212 (29%), Positives = 99/212 (46%), Gaps = 18/212 (8%)
Query: 365 KIFKGSLFFEQYDMDLDKAGILGDGSYSVCRRCVEKSTGQEYAVKIISRKIDCSE----E 420
+ G + ++Y++ ++G GS+ + ++ + A+KII K E
Sbjct: 45 IVKNGEKWMDRYEI----DSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNKKAFLNQAQIE 100
Query: 421 INLLRACQGHP-----NIVNLHCVFQDEVHTYLVLELLKGGELLDRIRQKGRCGFTENEA 475
+ LL H IV+L F H LV E+L L D +R G + N
Sbjct: 101 VRLLELMNKHDTEMKYYIVHLKRHFMFRNHLCLVFEML-SYNLYDLLRNTNFRGVSLNLT 159
Query: 476 SRIMRQLVAAVHFMHSR--GVVHRDLKPENLLFSDPAGDNIKVVDFGFACLKRESLHTPC 533
+ +Q+ A+ F+ + ++H DLKPEN+L +P IK+VDFG +C + ++
Sbjct: 160 RKFAQQMCTALLFLATPELSIIHCDLKPENILLCNPKRSAIKIVDFGSSCQLGQRIYQYI 219
Query: 534 FTLQYAAPEVLRQDKSGYDENCDLWSLGVILV 565
+ Y +PEVL YD D+WSLG ILV
Sbjct: 220 QSRFYRSPEVLL--GMPYDLAIDMWSLGCILV 249
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* Length = 382 | Back alignment and structure |
|---|
Score = 60.1 bits (146), Expect = 1e-09
Identities = 28/86 (32%), Positives = 44/86 (51%), Gaps = 7/86 (8%)
Query: 882 RRTFVNRSRYNVHTYLVLELLKGGELLDRIRQKGRCGFTENEASRIMRQLVAAVHFMHSR 941
+R F+ R+ H LV E+L L D +R G + N + +Q+ A+ F+ +
Sbjct: 122 KRHFMFRN----HLCLVFEML-SYNLYDLLRNTNFRGVSLNLTRKFAQQMCTALLFLATP 176
Query: 942 --GVVHRDLKPENLLLSGISGNLIKI 965
++H DLKPEN+LL + IKI
Sbjct: 177 ELSIIHCDLKPENILLCNPKRSAIKI 202
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 130 bits (330), Expect = 2e-33
Identities = 75/330 (22%), Positives = 133/330 (40%), Gaps = 54/330 (16%)
Query: 386 LGDGSYSVCRRCVEKSTGQEYAVKIISRKIDCSE----EINLLRACQGHPNIVNLHCVF- 440
+G+G+Y + TGQ A+K++ D E EIN+L+ H NI + F
Sbjct: 32 VGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEEEEIKQEINMLKKYSHHRNIATYYGAFI 91
Query: 441 -----QDEVHTYLVLELLKGGELLDRIRQKGRCGFTENEASRIMRQLVAAVHFMHSRGVV 495
+ +LV+E G + D I+ E + I R+++ + +H V+
Sbjct: 92 KKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQHKVI 151
Query: 496 HRDLKPENLLFSDPAGDNIKVVDFGFA------CLKRESL-HTPCFTLQYAAPEVLRQDK 548
HRD+K +N+L ++ A +K+VDFG + +R + TP + APEV+ D+
Sbjct: 152 HRDIKGQNVLLTENA--EVKLVDFGVSAQLDRTVGRRNTFIGTPY----WMAPEVIACDE 205
Query: 549 SGYDENCDLWSLGVILVNVLRQDKSGYDENCDLWSLGVILYTMLCGRVPFHARSRDDSAL 608
+ YD DLWSLG+ M G P D +
Sbjct: 206 ---------------------NPDATYDFKSDLWSLGITAIEMAEGAPPLC----DMHPM 240
Query: 609 SIMARI-KEGQFNFDAEAWSTVSSEAKELTKSLLTVNPAQRIRMMRVKLTFHAFHQAQKE 667
+ I + ++ W S + + +S L N +QR +L H F + Q
Sbjct: 241 RALFLIPRNPAPRLKSKKW---SKKFQSFIESCLVKNHSQRPATE--QLMKHPFIRDQPN 295
Query: 668 GFRLQDVTSAKLAQRRKNKNVSNDNSRSFS 697
+++ + + +K + ++ +S
Sbjct: 296 ERQVRIQLKDHIDRTKKKRGEKDETEYEYS 325
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 59.3 bits (144), Expect = 2e-09
Identities = 19/75 (25%), Positives = 37/75 (49%), Gaps = 2/75 (2%)
Query: 884 TFVNRSRYNVHTYL--VLELLKGGELLDRIRQKGRCGFTENEASRIMRQLVAAVHFMHSR 941
F+ ++ + L V+E G + D I+ E + I R+++ + +H
Sbjct: 89 AFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQH 148
Query: 942 GVVHRDLKPENLLLS 956
V+HRD+K +N+LL+
Sbjct: 149 KVIHRDIKGQNVLLT 163
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 45.4 bits (108), Expect = 5e-05
Identities = 14/50 (28%), Positives = 20/50 (40%), Gaps = 7/50 (14%)
Query: 266 ILKTEPPI--PEDLSPDVADFISRLLVKDPRRRLGGGELDAEELKRHPFF 313
I + P + S FI LVK+ +R E+L +HPF
Sbjct: 246 IPRNPAPRLKSKKWSKKFQSFIESCLVKNHSQR-----PATEQLMKHPFI 290
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 42.4 bits (100), Expect = 5e-04
Identities = 17/52 (32%), Positives = 26/52 (50%), Gaps = 4/52 (7%)
Query: 124 LGDGSYSVCRRCVEKSTGQEYAVKIISRKIDCSE----EINLLRACQGHPNI 171
+G+G+Y + TGQ A+K++ D E EIN+L+ H NI
Sbjct: 32 VGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEEEEIKQEINMLKKYSHHRNI 83
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318 | Back alignment and structure |
|---|
Score = 129 bits (325), Expect = 7e-33
Identities = 62/300 (20%), Positives = 113/300 (37%), Gaps = 50/300 (16%)
Query: 364 DKIFKGSLFFEQYDMDLDKAGILGDGSYSVCRRCVEKSTGQEYAVKIISRKIDCSE---- 419
+ G ++ DL+ G +G G+ + + TG AVK + R + E
Sbjct: 11 GYLTIGGQRYQAEINDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRI 70
Query: 420 --EINLLRACQGHPNIVNLHCVFQDEVHTYLVLELLKGGELLDRIRQKGRCGFTENEASR 477
+++++ P IV F ++ +EL+ + R +G E +
Sbjct: 71 LMDLDVVLKSHDCPYIVQCFGTFITNTDVFIAMELMGTCAEKLKKRMQGP--IPERILGK 128
Query: 478 IMRQLVAAVHFMHS-RGVVHRDLKPENLLFSDPAGDNIKVVDFGF-ACL-----KRESLH 530
+ +V A++++ GV+HRD+KP N+L + G IK+ DFG L K S
Sbjct: 129 MTVAIVKALYYLKEKHGVIHRDVKPSNILLDE-RGQ-IKLCDFGISGRLVDDKAKDRSAG 186
Query: 531 TPCFTLQYAAPEVLRQDKSGYDENCDLWSLGVILVNVLRQDKSGYDENCDLWSLGVILYT 590
Y APE + K YD D+WSLG+ L
Sbjct: 187 CAA----YMAPERIDPP---------------------DPTKPDYDIRADVWSLGISLVE 221
Query: 591 MLCGRVPFHARSRDDSALSIMARIKEGQFNF--DAEAWSTVSSEAKELTKSLLTVNPAQR 648
+ G+ P+ + ++ ++ + + + S + + K LT + +R
Sbjct: 222 LATGQFPYKN---CKTDFEVLTKVLQEEPPLLPGHMGF---SGDFQSFVKDCLTKDHRKR 275
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318 | Back alignment and structure |
|---|
Score = 56.2 bits (136), Expect = 2e-08
Identities = 22/80 (27%), Positives = 39/80 (48%), Gaps = 13/80 (16%)
Query: 896 YLVLELLKGGELLDRIRQKGRCGFTENEASRIMRQLVAAVHFMHS-RGVVHRDLKPENLL 954
++ +EL+ + R +G E ++ +V A++++ GV+HRD+KP N+L
Sbjct: 100 FIAMELMGTCAEKLKKRMQGP--IPERILGKMTVAIVKALYYLKEKHGVIHRDVKPSNIL 157
Query: 955 LS----------GISGNLIK 964
L GISG L+
Sbjct: 158 LDERGQIKLCDFGISGRLVD 177
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318 | Back alignment and structure |
|---|
Score = 44.3 bits (105), Expect = 1e-04
Identities = 14/63 (22%), Positives = 27/63 (42%), Gaps = 6/63 (9%)
Query: 117 DLDKAGILGDGSYSVCRRCVEKSTGQEYAVKIISRKIDCSE------EINLLRACQGHPN 170
DL+ G +G G+ + + TG AVK + R + E +++++ P
Sbjct: 26 DLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDVVLKSHDCPY 85
Query: 171 ICR 173
I +
Sbjct: 86 IVQ 88
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318 | Back alignment and structure |
|---|
Score = 43.5 bits (103), Expect = 2e-04
Identities = 15/52 (28%), Positives = 22/52 (42%), Gaps = 8/52 (15%)
Query: 265 RILKTEPPIPED---LSPDVADFISRLLVKDPRRRLGGGELDAEELKRHPFF 313
++L+ EPP+ S D F+ L KD R+R +L H F
Sbjct: 241 KVLQEEPPLLPGHMGFSGDFQSFVKDCLTKDHRKR-----PKYNKLLEHSFI 287
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3mb7_A* 3mb6_A* 3owj_A* 3owk_A* ... Length = 330 | Back alignment and structure |
|---|
Score = 128 bits (325), Expect = 9e-33
Identities = 67/305 (21%), Positives = 118/305 (38%), Gaps = 77/305 (25%)
Query: 386 LGDGSYSVCRRCVEKSTGQEYAVKIISRKIDCSE---EINLLRACQGHPNIVNLHCVFQD 442
LG G YS + + ++ VKI+ + + + EI +L +G PNI+ L + +D
Sbjct: 44 LGRGKYSEVFEAINITNNEKVVVKIL-KPVKKKKIKREIKILENLRGGPNIITLADIVKD 102
Query: 443 EVH--TYLVLELLKGGELLDRIRQKGRCGFTENEASRIMRQLVAAVHFMHSRGVVHRDLK 500
V LV E + + ++ Q T+ + M +++ A+ + HS G++HRD+K
Sbjct: 103 PVSRTPALVFEHVNNTDF-KQLYQT----LTDYDIRFYMYEILKALDYCHSMGIMHRDVK 157
Query: 501 PENLLFSDPAGDNIKVVDFGFACLKRESLHTPCF------TLQYAAPEVLRQDKSGYDEN 554
P N++ D ++++D+G A E H + + PE
Sbjct: 158 PHNVMI-DHEHRKLRLIDWGLA----EFYHPGQEYNVRVASRYFKGPE------------ 200
Query: 555 CDLWSLGVILVNVLRQDKSGYDENCDLWSLGVILYTMLCGRVP-FHARS----------- 602
+LV+ YD + D+WSLG +L +M+ + P FH
Sbjct: 201 --------LLVDY-----QMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKV 247
Query: 603 ----------------RDDSALSIMARIKEGQFN--FDAEAWSTVSSEAKELTKSLLTVN 644
D I+ R ++ +E VS EA + LL +
Sbjct: 248 LGTEDLYDYIDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYD 307
Query: 645 PAQRI 649
R+
Sbjct: 308 HQSRL 312
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3mb7_A* 3mb6_A* 3owj_A* 3owk_A* ... Length = 330 | Back alignment and structure |
|---|
Score = 51.9 bits (125), Expect = 4e-07
Identities = 17/70 (24%), Positives = 36/70 (51%), Gaps = 6/70 (8%)
Query: 896 YLVLELLKGGELLDRIRQKGRCGFTENEASRIMRQLVAAVHFMHSRGVVHRDLKPENLLL 955
LV E + + ++ Q T+ + M +++ A+ + HS G++HRD+KP N+++
Sbjct: 109 ALVFEHVNNTDF-KQLYQT----LTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMI 163
Query: 956 SGISGNLIKI 965
L ++
Sbjct: 164 DHEHRKL-RL 172
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3mb7_A* 3mb6_A* 3owj_A* 3owk_A* ... Length = 330 | Back alignment and structure |
|---|
Score = 43.8 bits (104), Expect = 2e-04
Identities = 21/98 (21%), Positives = 42/98 (42%), Gaps = 19/98 (19%)
Query: 174 RCVEKSTGQEYAVKIISRKIDCSE---EINLLRACQGHPNIVNLHCVFQD---------- 220
+ + ++ VKI+ + + + EI +L +G PNI+ L + +D
Sbjct: 54 EAINITNNEKVVVKIL-KPVKKKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVF 112
Query: 221 EVIDWDDFSRGIECVFFSSSLIIFFI--ILSFTLSFIH 256
E ++ DF + + + I F++ IL L + H
Sbjct: 113 EHVNNTDFKQLYQT--LTDYDIRFYMYEILK-ALDYCH 147
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3mb7_A* 3mb6_A* 3owj_A* 3owk_A* ... Length = 330 | Back alignment and structure |
|---|
Score = 42.6 bits (101), Expect = 4e-04
Identities = 15/51 (29%), Positives = 25/51 (49%), Gaps = 4/51 (7%)
Query: 124 LGDGSYSVCRRCVEKSTGQEYAVKIISRKIDCSE---EINLLRACQGHPNI 171
LG G YS + + ++ VKI+ + + + EI +L +G PNI
Sbjct: 44 LGRGKYSEVFEAINITNNEKVVVKIL-KPVKKKKIKREIKILENLRGGPNI 93
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346 | Back alignment and structure |
|---|
Score = 129 bits (326), Expect = 1e-32
Identities = 72/315 (22%), Positives = 110/315 (34%), Gaps = 79/315 (25%)
Query: 374 EQYDMDLDKAGILGDGSYSVCRRCVEKSTGQEYAVKIISRKIDCSE------------EI 421
++Y+ LD LG+G ++ + +K+T Q A+K I K+ EI
Sbjct: 10 KRYEK-LDF---LGEGQFATVYKARDKNTNQIVAIKKI--KLGHRSEAKDGINRTALREI 63
Query: 422 NLLRACQGHPNIVNLHCVFQDEVHTYLVLEL----LKGGELLDRIRQKGRCGFTENEASR 477
LL+ HPNI+ L F + + LV + L+ ++ T +
Sbjct: 64 KLLQELS-HPNIIGLLDAFGHKSNISLVFDFMETDLEV--IIKDNSLV----LTPSHIKA 116
Query: 478 IMRQLVAAVHFMHSRGVVHRDLKPENLLFSDPAGDNIKVVDFGFACLKRESLH--TPC-F 534
M + + ++H ++HRDLKP NLL D G +K+ DFG A T
Sbjct: 117 YMLMTLQGLEYLHQHWILHRDLKPNNLLL-DENG-VLKLADFGLAKSFGSPNRAYTHQVV 174
Query: 535 TLQYAAPEVLRQDKSGYDENCDLWSLGVILVNVLRQDKSGYDENCDLWSLGVILYTMLCG 594
T Y APE+L G R Y D+W++G IL +L
Sbjct: 175 TRWYRAPELL---------------FG------ARM----YGVGVDMWAVGCILAELLLR 209
Query: 595 RVPFHARSRDD--------------------SALSIMARIKEGQFNFDAEAWSTVSSEAK 634
S D +L K +S +
Sbjct: 210 VPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSLPDYVTFKSFPGIPLHHIFSAAGDDLL 269
Query: 635 ELTKSLLTVNPAQRI 649
+L + L NP RI
Sbjct: 270 DLIQGLFLFNPCARI 284
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346 | Back alignment and structure |
|---|
Score = 65.3 bits (160), Expect = 3e-11
Identities = 19/74 (25%), Positives = 32/74 (43%), Gaps = 12/74 (16%)
Query: 896 YLVLEL----LKGGELLDRIRQKGRCGFTENEASRIMRQLVAAVHFMHSRGVVHRDLKPE 951
LV + L+ ++ T + M + + ++H ++HRDLKP
Sbjct: 88 SLVFDFMETDLEV--IIKDNSLV----LTPSHIKAYMLMTLQGLEYLHQHWILHRDLKPN 141
Query: 952 NLLLSGISGNLIKI 965
NLLL +G L K+
Sbjct: 142 NLLLDE-NGVL-KL 153
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294 | Back alignment and structure |
|---|
Score = 127 bits (322), Expect = 1e-32
Identities = 57/225 (25%), Positives = 96/225 (42%), Gaps = 41/225 (18%)
Query: 430 HPNIVNLHCVFQDEVHTYLVLELLKGGELLDRIRQKGRCGFTENEASRIMRQLVAAVHFM 489
H NIV++ V +++ YLV+E ++G L + I G + + A Q++ +
Sbjct: 70 HQNIVSMIDVDEEDDCYYLVMEYIEGPTLSEYIESHGP--LSVDTAINFTNQILDGIKHA 127
Query: 490 HSRGVVHRDLKPENLLFSDPAGDNIKVVDFGFACLKRESLHTPCF----TLQYAAPEVLR 545
H +VHRD+KP+N+L +K+ DFG A E+ T T+QY +PE
Sbjct: 128 HDMRIVHRDIKPQNILIDS--NKTLKIFDFGIAKALSETSLTQTNHVLGTVQYFSPE--- 182
Query: 546 QDKSGYDENCDLWSLGVILVNVLRQDKSGY-DENCDLWSLGVILYTMLCGRVPFHARSRD 604
Q K DE D++S+G++LY ML G PF+
Sbjct: 183 ------------------------QAKGEATDECTDIYSIGIVLYEMLVGEPPFNG---- 214
Query: 605 DSALSI-MARIKEGQFNFDAEAWSTVSSEAKELTKSLLTVNPAQR 648
++A+SI + I++ N + + + + A R
Sbjct: 215 ETAVSIAIKHIQDSVPNVTTDVRKDIPQSLSNVILRATEKDKANR 259
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294 | Back alignment and structure |
|---|
Score = 73.4 bits (181), Expect = 3e-14
Identities = 19/61 (31%), Positives = 33/61 (54%), Gaps = 2/61 (3%)
Query: 896 YLVLELLKGGELLDRIRQKGRCGFTENEASRIMRQLVAAVHFMHSRGVVHRDLKPENLLL 955
YLV+E ++G L + I G + + A Q++ + H +VHRD+KP+N+L+
Sbjct: 87 YLVMEYIEGPTLSEYIESHGP--LSVDTAINFTNQILDGIKHAHDMRIVHRDIKPQNILI 144
Query: 956 S 956
Sbjct: 145 D 145
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290 | Back alignment and structure |
|---|
Score = 127 bits (321), Expect = 1e-32
Identities = 67/278 (24%), Positives = 114/278 (41%), Gaps = 50/278 (17%)
Query: 385 ILGDGSYSVCRRCVEKSTGQEYAVKIIS-RKIDCSE------EINLLRACQGHPNIVNLH 437
+G GS+ + ++ T E A + RK+ SE E +L+ Q HPNIV +
Sbjct: 33 EIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQ-HPNIVRFY 91
Query: 438 CVFQDEVHT----YLVLELLKGGELLDRIRQKGRCGFTENEASRIMRQLVAAVHFMHSRG 493
++ V LV EL+ G L +++ RQ++ + F+H+R
Sbjct: 92 DSWESTVKGKKCIVLVTELMTSGTLKTYLKRFKV--MKIKVLRSWCRQILKGLQFLHTRT 149
Query: 494 --VVHRDLKPENLLFSDPAGDNIKVVDFGFACLKRESLHTPCF-TLQYAAPEVLRQDKSG 550
++HRDLK +N+ + P G ++K+ D G A LKR S T ++ APE+ +
Sbjct: 150 PPIIHRDLKCDNIFITGPTG-SVKIGDLGLATLKRASFAKAVIGTPEFMAPEMYEE---- 204
Query: 551 YDENCDLWSLGVILVNVLRQDKSGYDENCDLWSLGVILYTMLCGRVPFHARSRDDSALSI 610
YDE+ D+++ G+ + M P+ S +A I
Sbjct: 205 -----------------------KYDESVDVYAFGMCMLEMATSEYPY---SECQNAAQI 238
Query: 611 MARIKEGQFNFDAEAWSTVSSEAKELTKSLLTVNPAQR 648
R+ G + E KE+ + + N +R
Sbjct: 239 YRRVTSGVKPASFD--KVAIPEVKEIIEGCIRQNKDER 274
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290 | Back alignment and structure |
|---|
Score = 62.0 bits (151), Expect = 2e-10
Identities = 21/83 (25%), Positives = 42/83 (50%), Gaps = 5/83 (6%)
Query: 885 FVNRSRYNVHTYLVLELLKGGELLDRIRQKGRCGFTENEASRIMRQLVAAVHFMHSRG-- 942
+ + + LV EL+ G L +++ RQ++ + F+H+R
Sbjct: 94 WESTVKGKKCIVLVTELMTSGTLKTYLKRFKV--MKIKVLRSWCRQILKGLQFLHTRTPP 151
Query: 943 VVHRDLKPENLLLSGISGNLIKI 965
++HRDLK +N+ ++G +G+ +KI
Sbjct: 152 IIHRDLKCDNIFITGPTGS-VKI 173
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290 | Back alignment and structure |
|---|
Score = 49.3 bits (118), Expect = 3e-06
Identities = 12/53 (22%), Positives = 21/53 (39%), Gaps = 7/53 (13%)
Query: 263 YRRILKTEPP--IPEDLSPDVADFISRLLVKDPRRRLGGGELDAEELKRHPFF 313
YRR+ P + P+V + I + ++ R ++L H FF
Sbjct: 239 YRRVTSGVKPASFDKVAIPEVKEIIEGCIRQNKDER-----YSIKDLLNHAFF 286
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* Length = 429 | Back alignment and structure |
|---|
Score = 129 bits (327), Expect = 3e-32
Identities = 50/210 (23%), Positives = 91/210 (43%), Gaps = 16/210 (7%)
Query: 365 KIFKGSLFFEQYDMDLDKAGILGDGSYSVCRRCVEKSTGQEYAVKIISRKIDCSE----E 420
+Y++ ++G GS+ + + Q A+K++ + E
Sbjct: 88 VQVPHDHVAYRYEVL----KVIGKGSFGQVVKAYDHKVHQHVALKMVRNEKRFHRQAAEE 143
Query: 421 INLLRACQGHP-----NIVNLHCVFQDEVHTYLVLELLKGGELLDRIRQKGRCGFTENEA 475
I +L + N++++ F H + ELL L + I++ GF+
Sbjct: 144 IRILEHLRKQDKDNTMNVIHMLENFTFRNHICMTFELL-SMNLYELIKKNKFQGFSLPLV 202
Query: 476 SRIMRQLVAAVHFMHSRGVVHRDLKPENLLFSDPAGDNIKVVDFGFACLKRESLHTPCFT 535
+ ++ + +H ++H DLKPEN+L IKV+DFG +C + + ++T +
Sbjct: 203 RKFAHSILQCLDALHKNRIIHCDLKPENILLKQQGRSGIKVIDFGSSCYEHQRVYTYIQS 262
Query: 536 LQYAAPEVLRQDKSGYDENCDLWSLGVILV 565
Y APEV+ + Y D+WSLG IL
Sbjct: 263 RFYRAPEVILG--ARYGMPIDMWSLGCILA 290
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* Length = 429 | Back alignment and structure |
|---|
Score = 60.9 bits (148), Expect = 1e-09
Identities = 20/72 (27%), Positives = 35/72 (48%), Gaps = 1/72 (1%)
Query: 894 HTYLVLELLKGGELLDRIRQKGRCGFTENEASRIMRQLVAAVHFMHSRGVVHRDLKPENL 953
H + ELL L + I++ GF+ + ++ + +H ++H DLKPEN+
Sbjct: 173 HICMTFELL-SMNLYELIKKNKFQGFSLPLVRKFAHSILQCLDALHKNRIIHCDLKPENI 231
Query: 954 LLSGISGNLIKI 965
LL + IK+
Sbjct: 232 LLKQQGRSGIKV 243
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348 | Back alignment and structure |
|---|
Score = 127 bits (321), Expect = 4e-32
Identities = 66/324 (20%), Positives = 117/324 (36%), Gaps = 55/324 (16%)
Query: 386 LGDGSY-SVCRRCVEKSTGQEYAVKII-----SRKIDCSE---EINLLRACQGHPNIVNL 436
+G GS+ +V + + A+K + + E+ L+ + HPN +
Sbjct: 62 IGHGSFGAVYF-ARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLR-HPNTIQY 119
Query: 437 HCVFQDEVHTYLVLELLKGGELLDRIRQKGRCGFTENEASRIMRQLVAAVHFMHSRGVVH 496
+ E +LV+E G D + + E E + + + + ++HS ++H
Sbjct: 120 RGCYLREHTAWLVMEYCLGS-ASDLLEVHKKP-LQEVEIAAVTHGALQGLAYLHSHNMIH 177
Query: 497 RDLKPENLLFSDPAGDNIKVVDFGFAC--LKRESL-HTPCFTLQYAAPEVLRQDKSGYDE 553
RD+K N+L S+P +K+ DFG A S TP + APEV
Sbjct: 178 RDVKAGNILLSEPG--LVKLGDFGSASIMAPANSFVGTPY----WMAPEV---------- 221
Query: 554 NCDLWSLGVILVNVLRQDKSGYDENCDLWSLGVILYTMLCGRVPFHARSRDDSALSIMAR 613
+L D+ YD D+WSLG+ + + P + +A+S +
Sbjct: 222 -------------ILAMDEGQYDGKVDVWSLGITCIELAERKPPLF----NMNAMSALYH 264
Query: 614 I-KEGQFNFDAEAWSTVSSEAKELTKSLLTVNPAQRIRMMRVKLTFHAFHQAQKEGFRLQ 672
I + + W S + S L P R L H F ++ +
Sbjct: 265 IAQNESPALQSGHW---SEYFRNFVDSCLQKIPQD--RPTSEVLLKHRFVLRERPPTVIM 319
Query: 673 DVTSAKLAQRRKNKNVSNDNSRSF 696
D+ R+ N+ +
Sbjct: 320 DLIQRTKDAVRELDNLQYRKMKKI 343
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348 | Back alignment and structure |
|---|
Score = 52.8 bits (127), Expect = 3e-07
Identities = 18/78 (23%), Positives = 33/78 (42%), Gaps = 12/78 (15%)
Query: 897 LVLELLKGGELLDRIRQKGRCGFTENEASRIMRQLVAAVHFMHSRGVVHRDLKPENLLLS 956
LV+E G D + + E E + + + + ++HS ++HRD+K N+LLS
Sbjct: 131 LVMEYCLGS-ASDLLEVHKKP-LQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLS 188
Query: 957 ----------GISGNLIK 964
G + +
Sbjct: 189 EPGLVKLGDFGSASIMAP 206
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348 | Back alignment and structure |
|---|
Score = 43.2 bits (102), Expect = 3e-04
Identities = 13/50 (26%), Positives = 19/50 (38%), Gaps = 7/50 (14%)
Query: 266 ILKTEPPI--PEDLSPDVADFISRLLVKDPRRRLGGGELDAEELKRHPFF 313
I + E P S +F+ L K P+ R +E L +H F
Sbjct: 265 IAQNESPALQSGHWSEYFRNFVDSCLQKIPQDR-----PTSEVLLKHRFV 309
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326 | Back alignment and structure |
|---|
Score = 126 bits (320), Expect = 4e-32
Identities = 80/311 (25%), Positives = 118/311 (37%), Gaps = 77/311 (24%)
Query: 381 DKAGILGDGSYSVCRRCVE-KSTGQEYAVKIISRKIDCSE---------EINLLRACQG- 429
+ +G+G+Y + + K+ G+ A+K + ++ E E+ +LR +
Sbjct: 14 ECVAEIGEGAYGKVFKARDLKNGGRFVALKRV--RVQTGEEGMPLSTIREVAVLRHLETF 71
Query: 430 -HPNIVNLHCVFQDEVHT-----YLVLEL----LKGGELLDRIRQKGRCGFTENEASRIM 479
HPN+V L V LV E L LD++ + G +M
Sbjct: 72 EHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTT--YLDKVPEPG---VPTETIKDMM 126
Query: 480 RQLVAAVHFMHSRGVVHRDLKPENLLFSDPAGDNIKVVDFGFACLKRESLH-TPC-FTLQ 537
QL+ + F+HS VVHRDLKP+N+L + +G IK+ DFG A + + T TL
Sbjct: 127 FQLLRGLDFLHSHRVVHRDLKPQNILVTS-SG-QIKLADFGLARIYSFQMALTSVVVTLW 184
Query: 538 YAAPEVLRQDKSGYDENCDLWSLGVILVNVLRQDKSGYDENCDLWSLGVILYTMLCGRVP 597
Y APEVL L S Y DLWS+G I M +
Sbjct: 185 YRAPEVL---------------LQ-----------SSYATPVDLWSVGCIFAEMFRRKPL 218
Query: 598 FHARSRDDSALSI--------------MARIKEGQF-----NFDAEAWSTVSSEAKELTK 638
F S D I + F + + + K+L
Sbjct: 219 FRGSSDVDQLGKILDVIGLPGEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLL 278
Query: 639 SLLTVNPAQRI 649
LT NPA+RI
Sbjct: 279 KCLTFNPAKRI 289
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326 | Back alignment and structure |
|---|
Score = 67.6 bits (166), Expect = 3e-12
Identities = 26/74 (35%), Positives = 39/74 (52%), Gaps = 11/74 (14%)
Query: 896 YLVLEL----LKGGELLDRIRQKGRCGFTENEASRIMRQLVAAVHFMHSRGVVHRDLKPE 951
LV E L LD++ + G +M QL+ + F+HS VVHRDLKP+
Sbjct: 95 TLVFEHVDQDLTT--YLDKVPEPG---VPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQ 149
Query: 952 NLLLSGISGNLIKI 965
N+L++ SG + K+
Sbjct: 150 NILVTS-SGQI-KL 161
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309 | Back alignment and structure |
|---|
Score = 125 bits (316), Expect = 9e-32
Identities = 61/257 (23%), Positives = 105/257 (40%), Gaps = 47/257 (18%)
Query: 359 VPPNFDKIFKGSLFFEQYDMDLDK---AGILGDGSYSVCRRCVEKSTGQEYAVKIISRKI 415
+P + F+G++ + D+ +G GS+ R G + AVKI+ +
Sbjct: 15 IPTTENLYFQGAMDGDDMDIPWCDLNIKEKIGAGSFGTVHRAEWH--GSDVAVKILMEQD 72
Query: 416 DCSE-------EINLLRACQGHPNIVNLHCVFQDEVHTYLVLELLKGGELLDRIRQKG-R 467
+E E+ +++ + HPNIV + +V E L G L + + G R
Sbjct: 73 FHAERVNEFLREVAIMKRLR-HPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKSGAR 131
Query: 468 CGFTENEASRIMRQLVAAVHFMHSRG--VVHRDLKPENLLFSDPAGDNIKVVDFGFACLK 525
E + + ++++H+R +VHR+LK NLL +KV DFG + LK
Sbjct: 132 EQLDERRRLSMAYDVAKGMNYLHNRNPPIVHRNLKSPNLLVDK--KYTVKVCDFGLSRLK 189
Query: 526 RE---SLHTPCFTLQYAAPEVLRQDKSGYDENCDLWSLGVILVNVLRQDKSGYDENCDLW 582
S + T ++ APEVLR + +E D++
Sbjct: 190 ASTFLSSKSAAGTPEWMAPEVLRDEP--------------------------SNEKSDVY 223
Query: 583 SLGVILYTMLCGRVPFH 599
S GVIL+ + + P+
Sbjct: 224 SFGVILWELATLQQPWG 240
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309 | Back alignment and structure |
|---|
Score = 53.5 bits (129), Expect = 1e-07
Identities = 19/73 (26%), Positives = 34/73 (46%), Gaps = 5/73 (6%)
Query: 896 YLVLELLKGGELLDRIRQKG-RCGFTENEASRIMRQLVAAVHFMHSRG--VVHRDLKPEN 952
+V E L G L + + G R E + + ++++H+R +VHR+LK N
Sbjct: 110 SIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHNRNPPIVHRNLKSPN 169
Query: 953 LLLSGISGNLIKI 965
LL+ +K+
Sbjct: 170 LLVD--KKYTVKV 180
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289 | Back alignment and structure |
|---|
Score = 124 bits (314), Expect = 1e-31
Identities = 43/204 (21%), Positives = 83/204 (40%), Gaps = 40/204 (19%)
Query: 407 AVKIISRKIDCSE-------EINLLRACQGHPNIVNLHCVFQDEVHTYLVLELLKGGELL 459
AVK+++ + E+ +LR + H NI+ +V + +G L
Sbjct: 50 AVKMLNVTAPTPQQLQAFKNEVGVLRKTR-HVNILLFMGYSTAP-QLAIVTQWCEGSSLY 107
Query: 460 DRIRQKGRCGFTENEASRIMRQLVAAVHFMHSRGVVHRDLKPENLLFSDPAGDNIKVVDF 519
+ F + I RQ + ++H++ ++HRDLK N+ + + +K+ DF
Sbjct: 108 HHLHASET-KFEMKKLIDIARQTARGMDYLHAKSIIHRDLKSNNIFLHE--DNTVKIGDF 164
Query: 520 GFACLKRE-----SLHTPCFTLQYAAPEVLRQDKSGYDENCDLWSLGVILVNVLRQDKSG 574
G A K ++ + APEV+R QD +
Sbjct: 165 GLATEKSRWSGSHQFEQLSGSILWMAPEVIRM-----------------------QDSNP 201
Query: 575 YDENCDLWSLGVILYTMLCGRVPF 598
Y D+++ G++LY ++ G++P+
Sbjct: 202 YSFQSDVYAFGIVLYELMTGQLPY 225
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289 | Back alignment and structure |
|---|
Score = 60.4 bits (147), Expect = 6e-10
Identities = 18/72 (25%), Positives = 32/72 (44%), Gaps = 3/72 (4%)
Query: 894 HTYLVLELLKGGELLDRIRQKGRCGFTENEASRIMRQLVAAVHFMHSRGVVHRDLKPENL 953
+V + +G L + F + I RQ + ++H++ ++HRDLK N+
Sbjct: 93 QLAIVTQWCEGSSLYHHLHASET-KFEMKKLIDIARQTARGMDYLHAKSIIHRDLKSNNI 151
Query: 954 LLSGISGNLIKI 965
L N +KI
Sbjct: 152 FLH--EDNTVKI 161
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271 | Back alignment and structure |
|---|
Score = 123 bits (310), Expect = 2e-31
Identities = 58/239 (24%), Positives = 89/239 (37%), Gaps = 51/239 (21%)
Query: 379 DLDKAGILGDGSYSVCRRCVEKSTGQEYAVKIISRKIDCSE---------EINLLRACQG 429
+L I+G G + R G E AVK D E L +
Sbjct: 8 ELTLEEIIGIGGFGKVYRAFWI--GDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLK- 64
Query: 430 HPNIVNLHCVFQDEVHTYLVLELLKGGELLDRIRQKGRCGFTENEASRIMRQLVAAVHFM 489
HPNI+ L V E + LV+E +GG L + K + Q+ ++++
Sbjct: 65 HPNIIALRGVCLKEPNLCLVMEFARGGPLNRVLSGKR---IPPDILVNWAVQIARGMNYL 121
Query: 490 HSRG---VVHRDLKPENLLFS------DPAGDNIKVVDFGFACLKRESLH-TPCFTLQYA 539
H ++HRDLK N+L D + +K+ DFG A + + +
Sbjct: 122 HDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDFGLAREWHRTTKMSAAGAYAWM 181
Query: 540 APEVLRQDKSGYDENCDLWSLGVILVNVLRQDKSGYDENCDLWSLGVILYTMLCGRVPF 598
APEV+R + + D+WS GV+L+ +L G VPF
Sbjct: 182 APEVIRASM--------------------------FSKGSDVWSYGVLLWELLTGEVPF 214
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271 | Back alignment and structure |
|---|
Score = 54.2 bits (131), Expect = 6e-08
Identities = 19/81 (23%), Positives = 36/81 (44%), Gaps = 12/81 (14%)
Query: 894 HTYLVLELLKGGELLDRIRQKGRCGFTENEASRIMRQLVAAVHFMHSRG---VVHRDLKP 950
+ LV+E +GG L + K + Q+ ++++H ++HRDLK
Sbjct: 80 NLCLVMEFARGGPLNRVLSGKR---IPPDILVNWAVQIARGMNYLHDEAIVPIIHRDLKS 136
Query: 951 ENLLLS------GISGNLIKI 965
N+L+ +S ++KI
Sbjct: 137 SNILILQKVENGDLSNKILKI 157
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309 | Back alignment and structure |
|---|
Score = 123 bits (310), Expect = 5e-31
Identities = 48/191 (25%), Positives = 78/191 (40%), Gaps = 38/191 (19%)
Query: 430 HPNIVNLHCVFQDEVHTYLVLELLKGGELLDRIRQKGRCGFTENEASRIMRQLVAAVHFM 489
P++V +H + + Y+ + L+ G +L +R++G A I+RQ+ +A+
Sbjct: 93 EPHVVPIHDFGEIDGQLYVDMRLINGVDLAAMLRRQGP--LAPPRAVAIVRQIGSALDAA 150
Query: 490 HSRGVVHRDLKPENLLFSDPAGDNIKVVDFGFACLKRESLHTPCF----TLQYAAPEVLR 545
H+ G HRD+KPEN+L S D +VDFG A + T TL Y APE
Sbjct: 151 HAAGATHRDVKPENILVSA--DDFAYLVDFGIASATTDEKLTQLGNTVGTLYYMAPERFS 208
Query: 546 QDKSGYDENCDLWSLGVILVNVLRQDKSGYDENCDLWSLGVILYTMLCGRVPFHARSRDD 605
+ + D+++L +LY L G P+ D
Sbjct: 209 ESHA--------------------------TYRADIYALTCVLYECLTGSPPYQG----D 238
Query: 606 SALSIMARIKE 616
+ A I +
Sbjct: 239 QLSVMGAHINQ 249
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309 | Back alignment and structure |
|---|
Score = 71.5 bits (176), Expect = 2e-13
Identities = 22/61 (36%), Positives = 37/61 (60%), Gaps = 2/61 (3%)
Query: 896 YLVLELLKGGELLDRIRQKGRCGFTENEASRIMRQLVAAVHFMHSRGVVHRDLKPENLLL 955
Y+ + L+ G +L +R++G A I+RQ+ +A+ H+ G HRD+KPEN+L+
Sbjct: 110 YVDMRLINGVDLAAMLRRQGP--LAPPRAVAIVRQIGSALDAAHAAGATHRDVKPENILV 167
Query: 956 S 956
S
Sbjct: 168 S 168
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311 | Back alignment and structure |
|---|
Score = 122 bits (309), Expect = 9e-31
Identities = 53/199 (26%), Positives = 86/199 (43%), Gaps = 47/199 (23%)
Query: 430 HPNIVNLHCVFQDEVHT----YLVLELLKGGELLDRIRQKGRCGFTENEASRIMRQLVAA 485
HP IV ++ + E Y+V+E + G L D + +G T A ++ A
Sbjct: 71 HPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGP--MTPKRAIEVIADACQA 128
Query: 486 VHFMHSRGVVHRDLKPENLLFSDPAGDNIKVVDFGFACLKRESLHTPCF------TLQYA 539
++F H G++HRD+KP N++ S + +KV+DFG A +S ++ T QY
Sbjct: 129 LNFSHQNGIIHRDVKPANIMISA--TNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYL 186
Query: 540 APEVLRQDKSGYDENCDLWSLGVILVNVLRQDKSGY-DENCDLWSLGVILYTMLCGRVPF 598
+PE Q + D D++SLG +LY +L G PF
Sbjct: 187 SPE---------------------------QARGDSVDARSDVYSLGCVLYEVLTGEPPF 219
Query: 599 HARSRDDSALSI-MARIKE 616
DS +S+ ++E
Sbjct: 220 TG----DSPVSVAYQHVRE 234
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311 | Back alignment and structure |
|---|
Score = 72.7 bits (179), Expect = 6e-14
Identities = 20/61 (32%), Positives = 35/61 (57%), Gaps = 2/61 (3%)
Query: 896 YLVLELLKGGELLDRIRQKGRCGFTENEASRIMRQLVAAVHFMHSRGVVHRDLKPENLLL 955
Y+V+E + G L D + +G T A ++ A++F H G++HRD+KP N+++
Sbjct: 92 YIVMEYVDGVTLRDIVHTEGP--MTPKRAIEVIADACQALNFSHQNGIIHRDVKPANIMI 149
Query: 956 S 956
S
Sbjct: 150 S 150
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271 | Back alignment and structure |
|---|
Score = 121 bits (305), Expect = 1e-30
Identities = 33/234 (14%), Positives = 77/234 (32%), Gaps = 45/234 (19%)
Query: 379 DLDKAGILGDGSYSVCRRCVEKST--GQEYAVKIISRKIDCSE-------EINLLRACQG 429
L+ L + + K G + VK++ + + E LR
Sbjct: 11 QLNFLTKLNENHSGE----LWKGRWQGNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFS- 65
Query: 430 HPNIVNLH--CVFQDEVHTYLVLELLKGGELLDRIRQKGRCGFTENEASRIMRQLVAAVH 487
HPN++ + C H L+ + G L + + + +++A + + +
Sbjct: 66 HPNVLPVLGACQSPPAPHPTLITHWMPYGSLYNVLHEGTNFVVDQSQAVKFALDMARGMA 125
Query: 488 FMHSRG--VVHRDLKPENLLFSDPAGDNIKVVDFGFACLKRESLHTPCFTLQYAAPEVLR 545
F+H+ + L +++ + ++ + + + APE L+
Sbjct: 126 FLHTLEPLIPRHALNSRSVMIDE--DMTARISMADVKFSFQSP--GRMYAPAWVAPEALQ 181
Query: 546 QDKSGYDENCDLWSLGVILVNVLRQDKSGYDENCDLWSLGVILYTMLCGRVPFH 599
+ + + + D+WS V+L+ ++ VPF
Sbjct: 182 K-----------------------KPEDTNRRSADMWSFAVLLWELVTREVPFA 212
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271 | Back alignment and structure |
|---|
Score = 53.0 bits (128), Expect = 2e-07
Identities = 8/65 (12%), Positives = 26/65 (40%), Gaps = 2/65 (3%)
Query: 894 HTYLVLELLKGGELLDRIRQKGRCGFTENEASRIMRQLVAAVHFMHSRG--VVHRDLKPE 951
H L+ + G L + + + +++A + + + F+H+ + L
Sbjct: 83 HPTLITHWMPYGSLYNVLHEGTNFVVDQSQAVKFALDMARGMAFLHTLEPLIPRHALNSR 142
Query: 952 NLLLS 956
++++
Sbjct: 143 SVMID 147
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} Length = 360 | Back alignment and structure |
|---|
Score = 122 bits (309), Expect = 2e-30
Identities = 59/214 (27%), Positives = 91/214 (42%), Gaps = 36/214 (16%)
Query: 384 GILGDGSYSVCRRCVEKSTGQEYAVKIISRKIDC-----SEEINLLRACQGHP----NIV 434
+GDG++ C + YAVK++ R I E ++L+ Q NIV
Sbjct: 41 RKMGDGTFGRVLLCQHIDNKKYYAVKVV-RNIKKYTRSAKIEADILKKIQNDDINNNNIV 99
Query: 435 NLHCVFQDEVHTYLVLELLKGGELLDRIRQKGRCGFTENEASRIMRQLVAAVHFMHSRGV 494
H F H L+ E L G L + I + GF + +++ A++++ +
Sbjct: 100 KYHGKFMYYDHMCLIFEPL-GPSLYEIITRNNYNGFHIEDIKLYCIEILKALNYLRKMSL 158
Query: 495 VHRDLKPENLLFSDPAGD-----------------------NIKVVDFGFACLKRESLHT 531
H DLKPEN+L DP + IK++DFG A K + +
Sbjct: 159 THTDLKPENILLDDPYFEKSLITVRRVTDGKKIQIYRTKSTGIKLIDFGCATFKSDYHGS 218
Query: 532 PCFTLQYAAPEVLRQDKSGYDENCDLWSLGVILV 565
T QY APEV+ G+D + D+WS G +L
Sbjct: 219 IINTRQYRAPEVILN--LGWDVSSDMWSFGCVLA 250
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} Length = 360 | Back alignment and structure |
|---|
Score = 61.6 bits (150), Expect = 4e-10
Identities = 20/74 (27%), Positives = 34/74 (45%), Gaps = 5/74 (6%)
Query: 882 RRTFVNRSRYNVHTYLVLELLKGGELLDRIRQKGRCGFTENEASRIMRQLVAAVHFMHSR 941
F+ H L+ E L G L + I + GF + +++ A++++
Sbjct: 102 HGKFMYYD----HMCLIFEPL-GPSLYEIITRNNYNGFHIEDIKLYCIEILKALNYLRKM 156
Query: 942 GVVHRDLKPENLLL 955
+ H DLKPEN+LL
Sbjct: 157 SLTHTDLKPENILL 170
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A Length = 373 | Back alignment and structure |
|---|
Score = 122 bits (308), Expect = 4e-30
Identities = 63/258 (24%), Positives = 97/258 (37%), Gaps = 52/258 (20%)
Query: 384 GILGDGSYSVCRRCVEKSTGQEYAVKIISRKIDCSE----EINLLR----------ACQG 429
LG G +S + A+KI+ +E EI LL+ G
Sbjct: 25 RKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYTEAAEDEIKLLQRVNDADNTKEDSMG 84
Query: 430 HPNIVNLHCVFQ----DEVHTYLVLELLKGGELLDRIRQKGRCGFTENEASRIMRQLVAA 485
+I+ L F + VH +V E+L G LL I++ G +I +QL+
Sbjct: 85 ANHILKLLDHFNHKGPNGVHVVMVFEVL-GENLLALIKKYEHRGIPLIYVKQISKQLLLG 143
Query: 486 VHFMHSR-GVVHRDLKPENLLFSDP----AGDNIKVVDFGFACLKRESLHTPCFTLQYAA 540
+ +MH R G++H D+KPEN+L IK+ D G AC E T +Y +
Sbjct: 144 LDYMHRRCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEHYTNSIQTREYRS 203
Query: 541 PEVLRQDKSGYDENCDLWSLGVILVNVLRQDKSGYDENCDLWSLGVILYTMLCGRVPFHA 600
PEVL LG + D+WS +++ ++ G F
Sbjct: 204 PEVL---------------LGA-----------PWGCGADIWSTACLIFELITGDFLFEP 237
Query: 601 RSRDDSALSI--MARIKE 616
+A+I E
Sbjct: 238 DEGHSYTKDDDHIAQIIE 255
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A Length = 373 | Back alignment and structure |
|---|
Score = 58.2 bits (141), Expect = 6e-09
Identities = 28/89 (31%), Positives = 45/89 (50%), Gaps = 6/89 (6%)
Query: 882 RRTFVNRSRYNVHTYLVLELLKGGELLDRIRQKGRCGFTENEASRIMRQLVAAVHFMHSR 941
F ++ VH +V E+L G LL I++ G +I +QL+ + +MH R
Sbjct: 92 LDHFNHKGPNGVHVVMVFEVL-GENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRR 150
Query: 942 -GVVHRDLKPENLLLSG----ISGNLIKI 965
G++H D+KPEN+L+ + IKI
Sbjct: 151 CGIIHTDIKPENVLMEIVDSPENLIQIKI 179
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A Length = 373 | Back alignment and structure |
|---|
Score = 43.9 bits (104), Expect = 2e-04
Identities = 15/51 (29%), Positives = 26/51 (50%), Gaps = 5/51 (9%)
Query: 264 RRILKTEPPIPEDLSPDVADFISRLLVKDPRRRLGGGELDAEELKRHPFFN 314
+L + +D + +++DF+S +L DPR+R DA L HP+
Sbjct: 293 EDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKR-----ADAGGLVNHPWLK 338
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351 | Back alignment and structure |
|---|
Score = 121 bits (306), Expect = 4e-30
Identities = 71/322 (22%), Positives = 120/322 (37%), Gaps = 90/322 (27%)
Query: 381 DKAGILGDGSYSVCRRCVEKSTGQEYAVKIISRKIDCSE----------EINLLRACQGH 430
+K +G G++ + + TGQ+ A+K + ++ +E EI +L+ + H
Sbjct: 20 EKLAKIGQGTFGEVFKARHRKTGQKVALKKV--LME-NEKEGFPITALREIKILQLLK-H 75
Query: 431 PNIVNLHCVFQDEVHT--------YLVLEL----LKGGELLDRIRQKGRCGFTENEASRI 478
N+VNL + + + YLV + L G LL + K FT +E R+
Sbjct: 76 ENVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAG--LLSNVLVK----FTLSEIKRV 129
Query: 479 MRQLVAAVHFMHSRGVVHRDLKPENLLFSDPAGDNIKVVDFG----FACLKRESLH--TP 532
M+ L+ ++++H ++HRD+K N+L + G +K+ DFG F+ K + T
Sbjct: 130 MQMLLNGLYYIHRNKILHRDMKAANVLITR-DG-VLKLADFGLARAFSLAKNSQPNRYTN 187
Query: 533 C-FTLQYAAPEVLRQDKSGYDENCDLWSLGVILVNVLRQDKSGYDENCDLWSLGVILYTM 591
TL Y PE+L ++ Y DLW G I+ M
Sbjct: 188 RVVTLWYRPPELLLGERD-------------------------YGPPIDLWGAGCIMAEM 222
Query: 592 LCGRVPFHARSRDDSALSI----------------------MARIKEGQFNFDAEA--WS 627
+ I + +GQ +
Sbjct: 223 WTRSPIMQGNTEQHQLALISQLCGSITPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAY 282
Query: 628 TVSSEAKELTKSLLTVNPAQRI 649
A +L LL ++PAQRI
Sbjct: 283 VRDPYALDLIDKLLVLDPAQRI 304
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351 | Back alignment and structure |
|---|
Score = 64.9 bits (159), Expect = 3e-11
Identities = 24/74 (32%), Positives = 41/74 (55%), Gaps = 12/74 (16%)
Query: 896 YLVLEL----LKGGELLDRIRQKGRCGFTENEASRIMRQLVAAVHFMHSRGVVHRDLKPE 951
YLV + L G LL + K FT +E R+M+ L+ ++++H ++HRD+K
Sbjct: 100 YLVFDFCEHDLAG--LLSNVLVK----FTLSEIKRVMQMLLNGLYYIHRNKILHRDMKAA 153
Query: 952 NLLLSGISGNLIKI 965
N+L++ G L K+
Sbjct: 154 NVLITR-DGVL-KL 165
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* Length = 339 | Back alignment and structure |
|---|
Score = 120 bits (302), Expect = 1e-29
Identities = 65/228 (28%), Positives = 97/228 (42%), Gaps = 34/228 (14%)
Query: 365 KIFKGSLFFEQYDMDLDKAGILGDGSYSVCRRCVEKSTGQEY-AVKIISRKIDCSE---- 419
G + +Y++ LG+G++ C++ G + AVKI+ E
Sbjct: 5 ICQSGDVLSARYEIV----DTLGEGAFGKVVECIDHKAGGRHVAVKIVKNVDRYCEAARS 60
Query: 420 EINLLRA-----CQGHPNIVNLHCVFQDEVHTYLVLELLKGGELLDRIRQKGRCGFTENE 474
EI +L V + F+ H +V ELL G D I++ G F +
Sbjct: 61 EIQVLEHLNTTDPNSTFRCVQMLEWFEHHGHICIVFELL-GLSTYDFIKENGFLPFRLDH 119
Query: 475 ASRIMRQLVAAVHFMHSRGVVHRDLKPENLLFSDPAGDN-----------------IKVV 517
++ Q+ +V+F+HS + H DLKPEN+LF IKVV
Sbjct: 120 IRKMAYQICKSVNFLHSNKLTHTDLKPENILFVQSDYTEAYNPKIKRDERTLINPDIKVV 179
Query: 518 DFGFACLKRESLHTPCFTLQYAAPEVLRQDKSGYDENCDLWSLGVILV 565
DFG A E T T Y APEV+ G+ + CD+WS+G IL+
Sbjct: 180 DFGSATYDDEHHSTLVSTRHYRAPEVILA--LGWSQPCDVWSIGCILI 225
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* Length = 339 | Back alignment and structure |
|---|
Score = 62.3 bits (152), Expect = 2e-10
Identities = 24/74 (32%), Positives = 37/74 (50%), Gaps = 5/74 (6%)
Query: 882 RRTFVNRSRYNVHTYLVLELLKGGELLDRIRQKGRCGFTENEASRIMRQLVAAVHFMHSR 941
F + H +V ELL G D I++ G F + ++ Q+ +V+F+HS
Sbjct: 83 LEWFEHHG----HICIVFELL-GLSTYDFIKENGFLPFRLDHIRKMAYQICKSVNFLHSN 137
Query: 942 GVVHRDLKPENLLL 955
+ H DLKPEN+L
Sbjct: 138 KLTHTDLKPENILF 151
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310 | Back alignment and structure |
|---|
Score = 119 bits (300), Expect = 1e-29
Identities = 47/208 (22%), Positives = 89/208 (42%), Gaps = 28/208 (13%)
Query: 379 DLDKAGILGDGSYSVCRRCVEKSTGQEYAVKIISRKIDCSE-----EINLLRACQGHPNI 433
DL +LG G + + + TG+ +K + R + ++ E+ ++R + HPN+
Sbjct: 11 DLIHGEVLGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCLE-HPNV 69
Query: 434 VNLHCVFQDEVHTYLVLELLKGGELLDRIRQKGRCGFTENEASRIMRQLVAAVHFMHSRG 493
+ V + + E +KGG L I+ + ++ + + + + ++HS
Sbjct: 70 LKFIGVLYKDKRLNFITEYIKGGTLRGIIKSMDS-QYPWSQRVSFAKDIASGMAYLHSMN 128
Query: 494 VVHRDLKPENLLFSDPAGDNIKVVDFGFACLKRE-----------------SLHTPCFTL 536
++HRDL N L + N+ V DFG A L + +T
Sbjct: 129 IIHRDLNSHNCLVRE--NKNVVVADFGLARLMVDEKTQPEGLRSLKKPDRKKRYTVVGNP 186
Query: 537 QYAAPEVLRQDKSGYDENCDLWSLGVIL 564
+ APE++ YDE D++S G++L
Sbjct: 187 YWMAPEMINGRS--YDEKVDVFSFGIVL 212
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310 | Back alignment and structure |
|---|
Score = 57.7 bits (140), Expect = 5e-09
Identities = 14/70 (20%), Positives = 31/70 (44%), Gaps = 3/70 (4%)
Query: 896 YLVLELLKGGELLDRIRQKGRCGFTENEASRIMRQLVAAVHFMHSRGVVHRDLKPENLLL 955
+ E +KGG L I+ + ++ + + + + ++HS ++HRDL N L+
Sbjct: 83 NFITEYIKGGTLRGIIKSMDS-QYPWSQRVSFAKDIASGMAYLHSMNIIHRDLNSHNCLV 141
Query: 956 SGISGNLIKI 965
+ +
Sbjct: 142 R--ENKNVVV 149
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405 | Back alignment and structure |
|---|
Score = 119 bits (301), Expect = 4e-29
Identities = 81/412 (19%), Positives = 138/412 (33%), Gaps = 101/412 (24%)
Query: 386 LGDGSYSVCRRCVEKS--TGQEYAVKIISRK-IDCSE--EINLLRACQGHPNIVNLHCVF 440
+G G+Y + K ++YA+K I I S EI LLR + HPN+++L VF
Sbjct: 29 VGRGTYGHVYKAKRKDGKDDKDYALKQIEGTGISMSACREIALLRELK-HPNVISLQKVF 87
Query: 441 QDEVHT--YLVLEL----LKGGELLDRIRQKGR----CGFTENEASRIMRQLVAAVHFMH 490
+L+ + L ++ R ++ Q++ +H++H
Sbjct: 88 LSHADRKVWLLFDYAEHDLWH--IIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLH 145
Query: 491 SRGVVHRDLKPENLLFSDPAGDN--IKVVDFGFAC-----LKRESLHTPC-FTLQYAAPE 542
+ V+HRDLKP N+L + +K+ D GFA LK + P T Y APE
Sbjct: 146 ANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVTFWYRAPE 205
Query: 543 VLRQDKSGYDENCDLWSLGVILVNVLRQDKSGYDENCDLWSLGVILYTMLCGRVPFHARS 602
+L LG R Y + D+W++G I +L FH R
Sbjct: 206 LL---------------LGA------RH----YTKAIDIWAIGCIFAELLTSEPIFHCRQ 240
Query: 603 RDDSALSI-----MARI----------------------------------KEGQFNFDA 623
D + + RI +
Sbjct: 241 EDIKTSNPYHHDQLDRIFNVMGFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYME 300
Query: 624 EAWSTVSSEAKELTKSLLTVNPAQRI---RMMRVKLTFHA-FHQAQKEGFRLQDVTSAKL 679
+ S+A L + LLT++P +RI + M+ F + +
Sbjct: 301 KHKVKPDSKAFHLLQKLLTMDPIKRITSEQAMQ-----DPYFLEDPLPTSDVFAGCQIPY 355
Query: 680 AQRRKNKNVSNDNSRSFSSTSSSLSSSSSGTSSLKTPCSSTQPSVPSKPVKR 731
+R + + ++ T+ P + P+K+
Sbjct: 356 PKREFLT--EEEPDDKGDKKNQQQQQGNNHTNGTGHPGNQDSSHTQGPPLKK 405
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405 | Back alignment and structure |
|---|
Score = 64.8 bits (158), Expect = 5e-11
Identities = 18/80 (22%), Positives = 35/80 (43%), Gaps = 12/80 (15%)
Query: 896 YLVLEL----LKGGELLDRIRQKGR----CGFTENEASRIMRQLVAAVHFMHSRGVVHRD 947
+L+ + L ++ R ++ Q++ +H++H+ V+HRD
Sbjct: 96 WLLFDYAEHDLWH--IIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANWVLHRD 153
Query: 948 LKPENLLLSGISGN--LIKI 965
LKP N+L+ G +KI
Sbjct: 154 LKPANILVMGEGPERGRVKI 173
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* Length = 355 | Back alignment and structure |
|---|
Score = 117 bits (295), Expect = 1e-28
Identities = 60/228 (26%), Positives = 95/228 (41%), Gaps = 34/228 (14%)
Query: 365 KIFKGSLFFEQYDMDLDKAGILGDGSYSVCRRCVEKSTGQEY-AVKIISRKIDCSE---- 419
G E+Y++ G LG+G++ C++ + G+ A+KII E
Sbjct: 10 VCRIGDWLQERYEIV----GNLGEGTFGKVVECLDHARGKSQVALKIIRNVGKYREAARL 65
Query: 420 EINLLRA-----CQGHPNIVNLHCVFQDEVHTYLVLELLKGGELLDRIRQKGRCGFTENE 474
EIN+L+ + V + F H + ELL G + +++ +
Sbjct: 66 EINVLKKIKEKDKENKFLCVLMSDWFNFHGHMCIAFELL-GKNTFEFLKENNFQPYPLPH 124
Query: 475 ASRIMRQLVAAVHFMHSRGVVHRDLKPENLLFSDPAGDN-----------------IKVV 517
+ QL A+ F+H + H DLKPEN+LF + + I+V
Sbjct: 125 VRHMAYQLCHALRFLHENQLTHTDLKPENILFVNSEFETLYNEHKSCEEKSVKNTSIRVA 184
Query: 518 DFGFACLKRESLHTPCFTLQYAAPEVLRQDKSGYDENCDLWSLGVILV 565
DFG A E T T Y PEV+ + G+ + CD+WS+G IL
Sbjct: 185 DFGSATFDHEHHTTIVATRHYRPPEVILE--LGWAQPCDVWSIGCILF 230
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* Length = 355 | Back alignment and structure |
|---|
Score = 59.6 bits (145), Expect = 2e-09
Identities = 19/74 (25%), Positives = 30/74 (40%), Gaps = 5/74 (6%)
Query: 882 RRTFVNRSRYNVHTYLVLELLKGGELLDRIRQKGRCGFTENEASRIMRQLVAAVHFMHSR 941
F H + ELL G + +++ + + QL A+ F+H
Sbjct: 88 SDWFNFHG----HMCIAFELL-GKNTFEFLKENNFQPYPLPHVRHMAYQLCHALRFLHEN 142
Query: 942 GVVHRDLKPENLLL 955
+ H DLKPEN+L
Sbjct: 143 QLTHTDLKPENILF 156
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681 | Back alignment and structure |
|---|
Score = 121 bits (306), Expect = 1e-28
Identities = 37/183 (20%), Positives = 71/183 (38%), Gaps = 44/183 (24%)
Query: 430 HPNIVNLHCVFQDEVHT-----YLVLELLKGGELLDRIRQKGRCGFTENEASRIMRQLVA 484
HP+IV + + Y+V+E + G L QK EA + +++
Sbjct: 138 HPSIVQIFNFVEHTDRHGDPVGYIVMEYVGGQSLKRSKGQK----LPVAEAIAYLLEILP 193
Query: 485 AVHFMHSRGVVHRDLKPENLLFSDPAGDNIKVVDFGFACLKRESLHT--PCFTLQYAAPE 542
A+ ++HS G+V+ DLKPEN++ ++ + +K++D G T + APE
Sbjct: 194 ALSYLHSIGLVYNDLKPENIMLTE---EQLKLIDLGAV---SRINSFGYLYGTPGFQAPE 247
Query: 543 VLRQDKSGYDENCDLWSLGVILVNVLRQDKSGYDENCDLWSLGVILYTMLCGRVPFHARS 602
++R + + D++++G L + + R
Sbjct: 248 IVRTGPT---------------------VAT------DIYTVGRTLAALTLDLPTRNGRY 280
Query: 603 RDD 605
D
Sbjct: 281 VDG 283
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681 | Back alignment and structure |
|---|
Score = 71.0 bits (174), Expect = 1e-12
Identities = 21/62 (33%), Positives = 36/62 (58%), Gaps = 4/62 (6%)
Query: 896 YLVLELLKGGELLDRIRQKGRCGFTENEASRIMRQLVAAVHFMHSRGVVHRDLKPENLLL 955
Y+V+E + G L QK EA + +++ A+ ++HS G+V+ DLKPEN++L
Sbjct: 160 YIVMEYVGGQSLKRSKGQK----LPVAEAIAYLLEILPALSYLHSIGLVYNDLKPENIML 215
Query: 956 SG 957
+
Sbjct: 216 TE 217
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420 | Back alignment and structure |
|---|
Score = 115 bits (291), Expect = 1e-27
Identities = 74/301 (24%), Positives = 122/301 (40%), Gaps = 68/301 (22%)
Query: 385 ILGDGSYSVCRRCVEKSTGQEYAVK-IISRKIDCSEEINLLRACQGHPNIVNLHCVF--- 440
++G+GS+ V + +G+ A+K ++ K + E+ ++R H NIV L F
Sbjct: 61 VIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNRELQIMRKLD-HCNIVRLRYFFYSS 119
Query: 441 ---QDEVHTYLVLELLKGGELLDRI---RQKGRCGFTENEASRIMRQLVAAVHFMHSRGV 494
+DEV+ LVL+ + E + R+ + + M QL ++ ++HS G+
Sbjct: 120 GEKKDEVYLNLVLDYV--PETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGI 177
Query: 495 VHRDLKPENLLFSDPAGDNIKVVDFGFACLKRESLHTPCF-----TLQYAAPEVLRQDKS 549
HRD+KP+NLL DP +K+ DFG A ++ + + Y APE++
Sbjct: 178 CHRDIKPQNLLL-DPDTAVLKLCDFGSA---KQLVRGEPNVSYICSRYYRAPELI----- 228
Query: 550 GYDENCDLWSLGVILVNVLRQDKSGYDENCDLWSLGVILYTMLCGRVPFHARSRDDSALS 609
G + Y + D+WS G +L +L G+ F S D +
Sbjct: 229 ----------FGA----------TDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVE 268
Query: 610 IM---------------ARIKEGQF-NFDAEAWSTV-----SSEAKELTKSLLTVNPAQR 648
I+ E +F A W+ V EA L LL P R
Sbjct: 269 IIKVLGTPTREQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTAR 328
Query: 649 I 649
+
Sbjct: 329 L 329
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420 | Back alignment and structure |
|---|
Score = 58.6 bits (142), Expect = 5e-09
Identities = 23/82 (28%), Positives = 40/82 (48%), Gaps = 6/82 (7%)
Query: 887 NRSRYNVHTYLVLELLKGGELLDRI---RQKGRCGFTENEASRIMRQLVAAVHFMHSRGV 943
+ V+ LVL+ + E + R+ + + M QL ++ ++HS G+
Sbjct: 120 GEKKDEVYLNLVLDYV--PETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGI 177
Query: 944 VHRDLKPENLLLSGISGNLIKI 965
HRD+KP+NLLL + L K+
Sbjct: 178 CHRDIKPQNLLLDPDTAVL-KL 198
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394 | Back alignment and structure |
|---|
Score = 112 bits (283), Expect = 8e-27
Identities = 73/301 (24%), Positives = 124/301 (41%), Gaps = 69/301 (22%)
Query: 385 ILGDGSYSVCRRCVEKSTGQEYAVK-IISRKIDCSEEINLLRACQGHPNIVNLHCVF--- 440
++G+GS+ V + + E A+K ++ K + E+ ++R + HPN+V+L F
Sbjct: 47 VIGNGSFGVVFQAKLVESD-EVAIKKVLQDKRFKNRELQIMRIVK-HPNVVDLKAFFYSN 104
Query: 441 ---QDEVHTYLVLELLKGGELLDRI---RQKGRCGFTENEASRIMRQLVAAVHFMHSRGV 494
+DEV LVLE + E + R K + M QL+ ++ ++HS G+
Sbjct: 105 GDKKDEVFLNLVLEYV--PETVYRASRHYAKLKQTMPMLLIKLYMYQLLRSLAYIHSIGI 162
Query: 495 VHRDLKPENLLFSDPAGDNIKVVDFGFACLKRESLHTPCF-----TLQYAAPEVLRQDKS 549
HRD+KP+NLL DP +K++DFG A + + + Y APE++
Sbjct: 163 CHRDIKPQNLLL-DPPSGVLKLIDFGSA---KILIAGEPNVSYICSRYYRAPELI----- 213
Query: 550 GYDENCDLWSLGVILVNVLRQDKSGYDENCDLWSLGVILYTMLCGRVPFHARSRDDSALS 609
G + Y N D+WS G ++ ++ G+ F S D +
Sbjct: 214 ----------FGA----------TNYTTNIDIWSTGCVMAELMQGQPLFPGESGIDQLVE 253
Query: 610 IM---------------ARIKEGQF-NFDAEAWSTV-----SSEAKELTKSLLTVNPAQR 648
I+ E +F +S V +A +L LL P+ R
Sbjct: 254 IIKVLGTPSREQIKTMNPNYMEHKFPQIRPHPFSKVFRPRTPPDAIDLISRLLEYTPSAR 313
Query: 649 I 649
+
Sbjct: 314 L 314
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394 | Back alignment and structure |
|---|
Score = 59.7 bits (145), Expect = 2e-09
Identities = 26/73 (35%), Positives = 38/73 (52%), Gaps = 6/73 (8%)
Query: 896 YLVLELLKGGELLDRI---RQKGRCGFTENEASRIMRQLVAAVHFMHSRGVVHRDLKPEN 952
LVLE + E + R K + M QL+ ++ ++HS G+ HRD+KP+N
Sbjct: 114 NLVLEYV--PETVYRASRHYAKLKQTMPMLLIKLYMYQLLRSLAYIHSIGICHRDIKPQN 171
Query: 953 LLLSGISGNLIKI 965
LLL SG L K+
Sbjct: 172 LLLDPPSGVL-KL 183
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286 | Back alignment and structure |
|---|
Score = 105 bits (265), Expect = 3e-25
Identities = 35/270 (12%), Positives = 70/270 (25%), Gaps = 64/270 (23%)
Query: 386 LGDGSYSVCRRCVEKSTGQEYAVKIISRKIDCSEEIN--LLRACQ-----GHPNIVNLHC 438
G + ++ + ++ A+ + + +++ L P + +
Sbjct: 39 HGGVPPLQFWQALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVARVLD 98
Query: 439 VFQDEVHTYLVLELLKGGELLDRIRQKGRCGFTENEASRIMRQLVAAVHFMHSRGVVHRD 498
V +V E ++GG L + + A R M+ L AA H GV
Sbjct: 99 VVHTRAGGLVVAEWIRGGSLQEVADT----SPSPVGAIRAMQSLAAAADAAHRAGVALSI 154
Query: 499 LKPENLLFSDPAGDNIKVVDFGFACLKRESLHTPCFTLQYAAPEVLRQDKSGYDENCDLW 558
P + S ++ +
Sbjct: 155 DHPSRVRVSI--DGDVVLAYPA-----------------TMPDA---------------- 179
Query: 559 SLGVILVNVLRQDKSGYDENCDLWSLGVILYTMLCGRVPFHARSRDDSALSIMARIKEGQ 618
+ D+ +G LY +L R P S L+ R GQ
Sbjct: 180 -----------------NPQDDIRGIGASLYALLVNRWPLPEAG-VRSGLAPAERDTAGQ 221
Query: 619 FNFDAEAWSTVSSEAKELTKSLLTVNPAQR 648
A+ + + + + + R
Sbjct: 222 PIEPADIDRDIPFQISAVAARSVQGDGGIR 251
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286 | Back alignment and structure |
|---|
Score = 65.5 bits (160), Expect = 1e-11
Identities = 16/63 (25%), Positives = 24/63 (38%), Gaps = 4/63 (6%)
Query: 894 HTYLVLELLKGGELLDRIRQKGRCGFTENEASRIMRQLVAAVHFMHSRGVVHRDLKPENL 953
+V E ++GG L + + A R M+ L AA H GV P +
Sbjct: 105 GGLVVAEWIRGGSLQEVADT----SPSPVGAIRAMQSLAAAADAAHRAGVALSIDHPSRV 160
Query: 954 LLS 956
+S
Sbjct: 161 RVS 163
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371 | Back alignment and structure |
|---|
Score = 106 bits (267), Expect = 6e-25
Identities = 61/274 (22%), Positives = 107/274 (39%), Gaps = 59/274 (21%)
Query: 385 ILGDGSYSVCRRCVEKSTGQEYAVKIISR----KIDCSE---EINLLRACQGHPNIVNLH 437
+G G+ + + + A+K +SR + E+ L++ H NI+ L
Sbjct: 32 PIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVN-HKNIIGLL 90
Query: 438 CVFQDEVHT------YLVLELLKGGELLDRIRQKGRCGFTENEASRIMRQLVAAVHFMHS 491
VF + Y+V+EL+ L I+ + S ++ Q++ + +HS
Sbjct: 91 NVFTPQKSLEEFQDVYIVMELM-DANLCQVIQME----LDHERMSYLLYQMLCGIKHLHS 145
Query: 492 RGVVHRDLKPENLLFSDPAGDNIKVVDFGFACLKRESLHTPCFTLQ-----YAAPEVLRQ 546
G++HRDLKP N++ +K++DFG A R + + T Y APEV+
Sbjct: 146 AGIIHRDLKPSNIVVKSDC--TLKILDFGLA---RTAGTSFMMTPYVVTRYYRAPEVI-- 198
Query: 547 DKSGYDENCDLWSLGVILVNVLRQDKSGYDENCDLWSLGVILYTMLCGRVPFHARSRDDS 606
LG GY EN D+WS+G I+ M+ G V F D
Sbjct: 199 -------------LG-----------MGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQ 234
Query: 607 ALSIMARIKEGQFNFDAEAWSTVSSEAKELTKSL 640
++ ++ E + + ++
Sbjct: 235 WNKVIEQLGTP----CPEFMKKLQPTVRTYVENR 264
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371 | Back alignment and structure |
|---|
Score = 53.5 bits (129), Expect = 2e-07
Identities = 18/60 (30%), Positives = 34/60 (56%), Gaps = 5/60 (8%)
Query: 896 YLVLELLKGGELLDRIRQKGRCGFTENEASRIMRQLVAAVHFMHSRGVVHRDLKPENLLL 955
Y+V+EL+ L I+ + S ++ Q++ + +HS G++HRDLKP N+++
Sbjct: 106 YIVMELM-DANLCQVIQME----LDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVV 160
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 105 bits (263), Expect = 2e-24
Identities = 71/301 (23%), Positives = 126/301 (41%), Gaps = 71/301 (23%)
Query: 386 LGDGSYSVCRRCVEKSTGQEYAVKIISR----KIDCSE---EINLLRACQGHPNIVNLHC 438
+G G+Y ++K +G++ A+K +SR +I E+ LL+ Q H N++ L
Sbjct: 32 VGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQ-HENVIGLLD 90
Query: 439 VFQDEVHT------YLVLELLKGGELLDRIRQKGRCGFTENEASRIMRQLVAAVHFMHSR 492
VF YLV+ + +L + K F+E + ++ Q++ + ++HS
Sbjct: 91 VFTPASSLRNFYDFYLVMPFM-QTDLQKIMGLK----FSEEKIQYLVYQMLKGLKYIHSA 145
Query: 493 GVVHRDLKPENLLFSDPAGDNIKVVDFGFACLKRESLHTPCFTLQYAAPEVLRQDKSGYD 552
GVVHRDLKP NL + +K++DFG A + T Y APEV+
Sbjct: 146 GVVHRDLKPGNLAVN--EDCELKILDFGLARHADAEMTGYVVTRWYRAPEVI-------- 195
Query: 553 ENCDLWSLGVILVNVLRQDKSGYDENCDLWSLGVILYTMLCGRVPFHARS---------- 602
L Y++ D+WS+G I+ ML G+ F +
Sbjct: 196 -------LSW----------MHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILK 238
Query: 603 -------------RDDSALSIMARIKEGQ-FNFDAEAWSTVSSEAKELTKSLLTVNPAQR 648
D +A S + + + +F + + S +A +L + +L ++ +R
Sbjct: 239 VTGVPGTEFVQKLNDKAAKSYIQSLPQTPRKDF-TQLFPRASPQAADLLEKMLELDVDKR 297
Query: 649 I 649
+
Sbjct: 298 L 298
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 55.4 bits (134), Expect = 4e-08
Identities = 21/60 (35%), Positives = 35/60 (58%), Gaps = 5/60 (8%)
Query: 896 YLVLELLKGGELLDRIRQKGRCGFTENEASRIMRQLVAAVHFMHSRGVVHRDLKPENLLL 955
YLV+ + +L + K F+E + ++ Q++ + ++HS GVVHRDLKP NL +
Sbjct: 105 YLVMPFM-QTDLQKIMGLK----FSEEKIQYLVYQMLKGLKYIHSAGVVHRDLKPGNLAV 159
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301 | Back alignment and structure |
|---|
Score = 102 bits (256), Expect = 6e-24
Identities = 51/269 (18%), Positives = 94/269 (34%), Gaps = 61/269 (22%)
Query: 379 DLDKAGILGDGSYSVCRRCVEKSTGQEYAVKIISRKIDCSE----EINLLRACQGHPNIV 434
D+ +G G Y R + G+ AVKI S + + S E+ + H NI+
Sbjct: 9 DITLLECVGKGRYGEVWRGSWQ--GENVAVKIFSSRDEKSWFRETELYNTVMLR-HENIL 65
Query: 435 NL--HCVFQDEVHT--YLVLELLKGGELLDRIRQKGRCGFTENEASRIMRQLVAAVHFMH 490
+ T +L+ + G L D ++ RI+ + + + +H
Sbjct: 66 GFIASDMTSRHSSTQLWLITHYHEMGSLYDYLQLTT---LDTVSCLRIVLSIASGLAHLH 122
Query: 491 SR--------GVVHRDLKPENLLFSDPAGDNIKVVDFGFACLKRESLHTPCF-------T 535
+ HRDLK +N+L + D G A + +S + T
Sbjct: 123 IEIFGTQGKPAIAHRDLKSKNILVKK--NGQCCIADLGLAVMHSQSTNQLDVGNNPRVGT 180
Query: 536 LQYAAPEVLRQDKSGYDENCDLWSLGVILVNVLRQDKSGYDENCDLWSLGVILYTMLCG- 594
+Y APEVL ++ D + D+W+ G++L+ +
Sbjct: 181 KRYMAPEVLD--------------------ETIQVDCFDSYKRVDIWAFGLVLWEVARRM 220
Query: 595 ---------RVPFHARSRDDSALSIMARI 614
+ PF+ +D + M ++
Sbjct: 221 VSNGIVEDYKPPFYDVVPNDPSFEDMRKV 249
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301 | Back alignment and structure |
|---|
Score = 47.0 bits (112), Expect = 1e-05
Identities = 14/68 (20%), Positives = 28/68 (41%), Gaps = 11/68 (16%)
Query: 896 YLVLELLKGGELLDRIRQKGRCGFTENEASRIMRQLVAAVHFMHSR--------GVVHRD 947
+L+ + G L D ++ RI+ + + + +H + HRD
Sbjct: 82 WLITHYHEMGSLYDYLQLTT---LDTVSCLRIVLSIASGLAHLHIEIFGTQGKPAIAHRD 138
Query: 948 LKPENLLL 955
LK +N+L+
Sbjct: 139 LKSKNILV 146
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... Length = 367 | Back alignment and structure |
|---|
Score = 102 bits (255), Expect = 2e-23
Identities = 68/301 (22%), Positives = 121/301 (40%), Gaps = 70/301 (23%)
Query: 386 LGDGSYSVCRRCVEKSTGQEYAVKIISR----KIDCSE---EINLLRACQGHPNIVNLHC 438
+G G+Y + TG AVK +SR I E+ LL+ + H N++ L
Sbjct: 37 VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMK-HENVIGLLD 95
Query: 439 VFQDEVHT------YLVLELLKGGELLDRIRQKGRCGFTENEASRIMRQLVAAVHFMHSR 492
VF YLV L+ G +L + ++ + T++ ++ Q++ + ++HS
Sbjct: 96 VFTPARSLEEFNDVYLVTHLM-GADLNNIVKCQK---LTDDHVQFLIYQILRGLKYIHSA 151
Query: 493 GVVHRDLKPENLLFSDPAGDNIKVVDFGFACLKRESLHTPCFTLQYAAPEVLRQDKSGYD 552
++HRDLKP NL + +K++DFG A + + T Y APE++
Sbjct: 152 DIIHRDLKPSNLAVN--EDCELKILDFGLARHTADEMTGYVATRWYRAPEIM-------- 201
Query: 553 ENCDLWSLGVILVNVLRQDKSGYDENCDLWSLGVILYTMLCGRVPFHARS---------- 602
L Y++ D+WS+G I+ +L GR F
Sbjct: 202 -------LNW----------MHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILR 244
Query: 603 -------------RDDSALSIMARIKEGQ-FNFDAEAWSTVSSEAKELTKSLLTVNPAQR 648
+SA + + + + NF A + + A +L + +L ++ +R
Sbjct: 245 LVGTPGAELLKKISSESARNYIQSLTQMPKMNF-ANVFIGANPLAVDLLEKMLVLDSDKR 303
Query: 649 I 649
I
Sbjct: 304 I 304
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... Length = 367 | Back alignment and structure |
|---|
Score = 51.6 bits (124), Expect = 8e-07
Identities = 18/60 (30%), Positives = 36/60 (60%), Gaps = 4/60 (6%)
Query: 896 YLVLELLKGGELLDRIRQKGRCGFTENEASRIMRQLVAAVHFMHSRGVVHRDLKPENLLL 955
YLV L+ G +L + ++ + T++ ++ Q++ + ++HS ++HRDLKP NL +
Sbjct: 110 YLVTHLM-GADLNNIVKCQK---LTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAV 165
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 Length = 367 | Back alignment and structure |
|---|
Score = 101 bits (254), Expect = 4e-23
Identities = 67/302 (22%), Positives = 121/302 (40%), Gaps = 72/302 (23%)
Query: 386 LGDGSYSVCRRCVEKSTGQEYAVKIISR----KIDCSE---EINLLRACQGHPNIVNLHC 438
+G G+Y V+ TG + A+K + R ++ E+ LL+ + H N++ L
Sbjct: 33 VGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMR-HENVIGLLD 91
Query: 439 VFQDEVHT------YLVLELLKGGELLDRIRQKGRCGFTENEASRIMRQLVAAVHFMHSR 492
VF + YLV+ + G L ++ + + E+ ++ Q++ + ++H+
Sbjct: 92 VFTPDETLDDFTDFYLVMPFM--GTDLGKLMKHEK--LGEDRIQFLVYQMLKGLRYIHAA 147
Query: 493 GVVHRDLKPENLLFSDPAGDNIKVVDFGFACLKRESLHTPCFTLQYAAPEVLRQDKSGYD 552
G++HRDLKP NL + +K++DFG A + T Y APEV+
Sbjct: 148 GIIHRDLKPGNLAVN--EDCELKILDFGLARQADSEMTGYVVTRWYRAPEVI-------- 197
Query: 553 ENCDLWSLGVILVNVLRQDKSGYDENCDLWSLGVILYTMLCGRVPFHARS---------- 602
L Y + D+WS+G I+ M+ G+ F
Sbjct: 198 -------LNW----------MRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMK 240
Query: 603 -------------RDDSALSIMARI--KEGQFNFDAEAWSTVSSEAKELTKSLLTVNPAQ 647
+ D A + M + E + +F A + S A L + +L ++ Q
Sbjct: 241 VTGTPPAEFVQRLQSDEAKNYMKGLPELEKK-DF-ASILTNASPLAVNLLEKMLVLDAEQ 298
Query: 648 RI 649
R+
Sbjct: 299 RV 300
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 Length = 367 | Back alignment and structure |
|---|
Score = 51.9 bits (125), Expect = 6e-07
Identities = 17/60 (28%), Positives = 35/60 (58%), Gaps = 4/60 (6%)
Query: 896 YLVLELLKGGELLDRIRQKGRCGFTENEASRIMRQLVAAVHFMHSRGVVHRDLKPENLLL 955
YLV+ + G L ++ + + E+ ++ Q++ + ++H+ G++HRDLKP NL +
Sbjct: 106 YLVMPFM--GTDLGKLMKHEK--LGEDRIQFLVYQMLKGLRYIHAAGIIHRDLKPGNLAV 161
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} Length = 320 | Back alignment and structure |
|---|
Score = 100 bits (251), Expect = 4e-23
Identities = 66/315 (20%), Positives = 103/315 (32%), Gaps = 84/315 (26%)
Query: 385 ILGDGSY-SVCRRCVEKSTGQEYAVKIIS--RKIDCSE---EINLLRACQGHPNIVNLHC 438
LG G V V+ + A+K I EI ++R H NIV +
Sbjct: 18 PLGCGGNGLVFS-AVDNDCDKRVAIKKIVLTDPQSVKHALREIKIIRRLD-HDNIVKVFE 75
Query: 439 VFQDEVHT--------------YLVLELLKGGELLDRIRQKGRCGFTENEASRIMRQLVA 484
+ Y+V E + L + ++G E A M QL+
Sbjct: 76 ILGPSGSQLTDDVGSLTELNSVYIVQEYM--ETDLANVLEQGP--LLEEHARLFMYQLLR 131
Query: 485 AVHFMHSRGVVHRDLKPENLLFSDPAGD-NIKVVDFGFA-CLKRESLHTPCF-----TLQ 537
+ ++HS V+HRDLKP NL + D +K+ DFG A + H T
Sbjct: 132 GLKYIHSANVLHRDLKPANLFIN--TEDLVLKIGDFGLARIMDPHYSHKGHLSEGLVTKW 189
Query: 538 YAAPEVLRQDKSGYDENCDLWSLGVILVNVLRQDKSGYDENCDLWSLGVILYTMLCGRVP 597
Y +P +L L + Y + D+W+ G I ML G+
Sbjct: 190 YRSPRLL---------------LSP----------NNYTKAIDMWAAGCIFAEMLTGKTL 224
Query: 598 FHARS-----------------------RDDSALSIMARIKEGQFNFDAEAWSTVSSEAK 634
F + I + E + +S EA
Sbjct: 225 FAGAHELEQMQLILESIPVVHEEDRQELLSVIPVYIRNDMTEPHKPL-TQLLPGISREAV 283
Query: 635 ELTKSLLTVNPAQRI 649
+ + +LT +P R+
Sbjct: 284 DFLEQILTFSPMDRL 298
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} Length = 320 | Back alignment and structure |
|---|
Score = 51.5 bits (124), Expect = 6e-07
Identities = 21/60 (35%), Positives = 32/60 (53%), Gaps = 4/60 (6%)
Query: 896 YLVLELLKGGELLDRIRQKGRCGFTENEASRIMRQLVAAVHFMHSRGVVHRDLKPENLLL 955
Y+V E + L + ++G E A M QL+ + ++HS V+HRDLKP NL +
Sbjct: 98 YIVQEYM--ETDLANVLEQGP--LLEEHARLFMYQLLRGLKYIHSANVLHRDLKPANLFI 153
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464 | Back alignment and structure |
|---|
Score = 102 bits (256), Expect = 5e-23
Identities = 63/270 (23%), Positives = 110/270 (40%), Gaps = 53/270 (19%)
Query: 386 LGDGSYSVCRRCVEKSTGQEYAVKIISR----KIDCSE---EINLLRACQGHPNIVNLHC 438
+G G+ + + + A+K +SR + E+ L++ H NI++L
Sbjct: 70 IGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVN-HKNIISLLN 128
Query: 439 VFQDEVHT------YLVLELLKGGELLDRIRQKGRCGFTENEASRIMRQLVAAVHFMHSR 492
VF + YLV+EL+ L I+ + S ++ Q++ + +HS
Sbjct: 129 VFTPQKTLEEFQDVYLVMELM-DANLCQVIQME----LDHERMSYLLYQMLCGIKHLHSA 183
Query: 493 GVVHRDLKPENLLFSDPAGDNIKVVDFGFACLKRESLH-TP-CFTLQYAAPEVLRQDKSG 550
G++HRDLKP N++ + +K++DFG A S TP T Y APEV+
Sbjct: 184 GIIHRDLKPSNIVVK--SDCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVI------ 235
Query: 551 YDENCDLWSLGVILVNVLRQDKSGYDENCDLWSLGVILYTMLCGRVPFHARSRDDSALSI 610
LG GY EN D+WS+G I+ M+ ++ F R D +
Sbjct: 236 ---------LG-----------MGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKV 275
Query: 611 MARIKEGQFNFDAEAWSTVSSEAKELTKSL 640
+ ++ E + + ++
Sbjct: 276 IEQLGTP----CPEFMKKLQPTVRNYVENR 301
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464 | Back alignment and structure |
|---|
Score = 53.3 bits (128), Expect = 3e-07
Identities = 19/60 (31%), Positives = 34/60 (56%), Gaps = 5/60 (8%)
Query: 896 YLVLELLKGGELLDRIRQKGRCGFTENEASRIMRQLVAAVHFMHSRGVVHRDLKPENLLL 955
YLV+EL+ L I+ + S ++ Q++ + +HS G++HRDLKP N+++
Sbjct: 143 YLVMELM-DANLCQVIQME----LDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVV 197
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} Length = 362 | Back alignment and structure |
|---|
Score = 100 bits (251), Expect = 7e-23
Identities = 72/316 (22%), Positives = 110/316 (34%), Gaps = 86/316 (27%)
Query: 385 ILGDGSY-SVCRRCVEKSTGQEYAVKIISRKIDCSE----------------EINLLRAC 427
+ GSY +VC S G A+K + + EI LL
Sbjct: 29 FISSGSYGAVCA--GVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHF 86
Query: 428 QGHPNIVNLHCVFQDEVHT-----YLVLELLKGGELLDRIRQKGRCGFTENEASRIMRQL 482
HPNI+ L +F YLV EL+ L ++ R + M +
Sbjct: 87 H-HPNILGLRDIFVHFEEPAMHKLYLVTELM--RTDLAQVIHDQRIVISPQHIQYFMYHI 143
Query: 483 VAAVHFMHSRGVVHRDLKPENLLFSDPAGDNIKVVDFGFACLKRESLHTPCFTLQ----- 537
+ +H +H GVVHRDL P N+L + ++I + DF A RE T
Sbjct: 144 LLGLHVLHEAGVVHRDLHPGNILLA--DNNDITICDFNLA---REDTADANKTHYVTHRW 198
Query: 538 YAAPEVLRQDKSGYDENCDLWSLGVILVNVLRQDKSGYDENCDLWSLGVILYTMLCGRVP 597
Y APE++ + G+ + D+WS G ++ M +
Sbjct: 199 YRAPELV---------------MQF----------KGFTKLVDMWSAGCVMAEMFNRKAL 233
Query: 598 FHARSRDDSALSIM------------------AR--IKEGQFNFDAEAWSTV----SSEA 633
F + + I+ AR ++ N A AW+ V A
Sbjct: 234 FRGSTFYNQLNKIVEVVGTPKIEDVVMFSSPSARDYLRNSLSNVPARAWTAVVPTADPVA 293
Query: 634 KELTKSLLTVNPAQRI 649
+L +L NP +RI
Sbjct: 294 LDLIAKMLEFNPQRRI 309
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} Length = 362 | Back alignment and structure |
|---|
Score = 56.9 bits (138), Expect = 1e-08
Identities = 21/60 (35%), Positives = 30/60 (50%), Gaps = 2/60 (3%)
Query: 896 YLVLELLKGGELLDRIRQKGRCGFTENEASRIMRQLVAAVHFMHSRGVVHRDLKPENLLL 955
YLV EL+ L ++ R + M ++ +H +H GVVHRDL P N+LL
Sbjct: 110 YLVTELM--RTDLAQVIHDQRIVISPQHIQYFMYHILLGLHVLHEAGVVHRDLHPGNILL 167
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3o71_A 3r63_A 3c9w_A* 2y9q_A* 3sa0_A* 1wzy_A* 2e14_A* 1tvo_A* 2ojg_A* 2oji_A* ... Length = 364 | Back alignment and structure |
|---|
Score = 98.5 bits (246), Expect = 4e-22
Identities = 66/306 (21%), Positives = 117/306 (38%), Gaps = 76/306 (24%)
Query: 386 LGDGSYSVCRRCVEKSTGQEYAVKIIS---RKIDCSE---EINLLRACQGHPNIVNLHCV 439
+G+G+Y + + A+K IS + C EI +L + H NI+ ++ +
Sbjct: 35 IGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFR-HENIIGINDI 93
Query: 440 FQDEVHT-----YLVLELLKGGELLDRIRQKGRCGFTENEASRIMRQLVAAVHFMHSRGV 494
+ Y+V +L+ L ++ + + + + Q++ + ++HS V
Sbjct: 94 IRAPTIEQMKDVYIVQDLM--ETDLYKLLKTQH--LSNDHICYFLYQILRGLKYIHSANV 149
Query: 495 VHRDLKPENLLFSDPAGDNIKVVDFGFACLKRESLHTPCF------TLQYAAPEVLRQDK 548
+HRDLKP NLL + ++K+ DFG A + F T Y APE++
Sbjct: 150 LHRDLKPSNLLLN--TTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIM---- 203
Query: 549 SGYDENCDLWSLGVILVNVLRQDKSGYDENCDLWSLGVILYTMLCGRVPFHARS------ 602
L GY ++ D+WS+G IL ML R F +
Sbjct: 204 -----------LNS----------KGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLN 242
Query: 603 -----------------RDDSALSIMARI--KEGQFNFDAEAWSTVSSEAKELTKSLLTV 643
+ A + + + K + + S+A +L +LT
Sbjct: 243 HILGILGSPSQEDLNCIINLKARNYLLSLPHKNKV-PW-NRLFPNADSKALDLLDKMLTF 300
Query: 644 NPAQRI 649
NP +RI
Sbjct: 301 NPHKRI 306
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3o71_A 3r63_A 3c9w_A* 2y9q_A* 3sa0_A* 1wzy_A* 2e14_A* 1tvo_A* 2ojg_A* 2oji_A* ... Length = 364 | Back alignment and structure |
|---|
Score = 50.7 bits (122), Expect = 1e-06
Identities = 18/60 (30%), Positives = 33/60 (55%), Gaps = 4/60 (6%)
Query: 896 YLVLELLKGGELLDRIRQKGRCGFTENEASRIMRQLVAAVHFMHSRGVVHRDLKPENLLL 955
Y+V +L+ L ++ + + + + Q++ + ++HS V+HRDLKP NLLL
Sbjct: 106 YIVQDLM--ETDLYKLLKTQH--LSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLL 161
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360 | Back alignment and structure |
|---|
Score = 98.1 bits (245), Expect = 5e-22
Identities = 68/307 (22%), Positives = 116/307 (37%), Gaps = 71/307 (23%)
Query: 385 ILGDGSYSVCRRCVEKSTGQEYAVK-IISRKIDCSEEINLLR--ACQGHPNIVNLHCVF- 440
+ G G++ + EKSTG A+K +I + E+ +++ A HPNIV L F
Sbjct: 30 MAGQGTFGTVQLGKEKSTGMSVAIKKVIQDPRFRNRELQIMQDLAVLHHPNIVQLQSYFY 89
Query: 441 ------QDEVHTYLVLELLKGGELLDRI---RQKGRCGFTENEASRIMRQLVAAVHFMH- 490
+ +++ +V+E + + L R + + + QL+ ++ +H
Sbjct: 90 TLGERDRRDIYLNVVMEYV--PDTLHRCCRNYYRRQVAPPPILIKVFLFQLIRSIGCLHL 147
Query: 491 -SRGVVHRDLKPENLLFSDPAGDNIKVVDFGFA-CLKRESLHTP--CFTLQYAAPEVLRQ 546
S V HRD+KP N+L + A +K+ DFG A L + C + Y APE++
Sbjct: 148 PSVNVCHRDIKPHNVLV-NEADGTLKLCDFGSAKKLSPSEPNVAYIC-SRYYRAPELI-- 203
Query: 547 DKSGYDENCDLWSLGVILVNVLRQDKSGYDENCDLWSLGVILYTMLCGRVPFHARSRDDS 606
G Y D+WS+G I M+ G F +
Sbjct: 204 -------------FGN----------QHYTTAVDIWSVGCIFAEMMLGEPIFRGDNSAGQ 240
Query: 607 ALSIM-----------ARIKEG--QFNF---DAEAWSTV--------SSEAKELTKSLLT 642
I+ ++ + WS V + EA +L +LL
Sbjct: 241 LHEIVRVLGCPSREVLRKLNPSHTDVDLYNSKGIPWSNVFSDHSLKDAKEAYDLLSALLQ 300
Query: 643 VNPAQRI 649
P +R+
Sbjct: 301 YLPEERM 307
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360 | Back alignment and structure |
|---|
Score = 48.4 bits (116), Expect = 7e-06
Identities = 19/78 (24%), Positives = 37/78 (47%), Gaps = 8/78 (10%)
Query: 893 VHTYLVLELLKGGELLDRI---RQKGRCGFTENEASRIMRQLVAAVHFMH--SRGVVHRD 947
++ +V+E + + L R + + + QL+ ++ +H S V HRD
Sbjct: 99 IYLNVVMEYV--PDTLHRCCRNYYRRQVAPPPILIKVFLFQLIRSIGCLHLPSVNVCHRD 156
Query: 948 LKPENLLLSGISGNLIKI 965
+KP N+L++ G L K+
Sbjct: 157 IKPHNVLVNEADGTL-KL 173
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342 | Back alignment and structure |
|---|
Score = 97.5 bits (243), Expect = 5e-22
Identities = 43/213 (20%), Positives = 76/213 (35%), Gaps = 35/213 (16%)
Query: 379 DLDKAGILGDGSYSVCRRCVEKSTGQEYAVKIISRKIDCSE----EINLLRACQGHPNIV 434
+ +G G + R + G+E AVKI S + + S EI + H NI+
Sbjct: 43 TIVLQESIGKGRFGEVWRGKWR--GEEVAVKIFSSREERSWFREAEIYQTVMLR-HENIL 99
Query: 435 NLHCV----FQDEVHTYLVLELLKGGELLDRIRQKGRCGFTENEASRIMRQLVAAVHFMH 490
+LV + + G L D + + T ++ + + +H
Sbjct: 100 GFIAADNKDNGTWTQLWLVSDYHEHGSLFDYLNRYT---VTVEGMIKLALSTASGLAHLH 156
Query: 491 SR--------GVVHRDLKPENLLFSDPAGDNIKVVDFGFACLKRESLHTPCF-------T 535
+ HRDLK +N+L + D G A + T T
Sbjct: 157 MEIVGTQGKPAIAHRDLKSKNILVKK--NGTCCIADLGLAVRHDSATDTIDIAPNHRVGT 214
Query: 536 LQYAAPEVLRQDKSG----YDENCDLWSLGVIL 564
+Y APEVL + + D++++G++
Sbjct: 215 KRYMAPEVLDDSINMKHFESFKRADIYAMGLVF 247
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342 | Back alignment and structure |
|---|
Score = 42.8 bits (101), Expect = 4e-04
Identities = 14/68 (20%), Positives = 28/68 (41%), Gaps = 11/68 (16%)
Query: 896 YLVLELLKGGELLDRIRQKGRCGFTENEASRIMRQLVAAVHFMHSR--------GVVHRD 947
+LV + + G L D + + T ++ + + +H + HRD
Sbjct: 116 WLVSDYHEHGSLFDYLNRYT---VTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRD 172
Query: 948 LKPENLLL 955
LK +N+L+
Sbjct: 173 LKSKNILV 180
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} Length = 388 | Back alignment and structure |
|---|
Score = 97.8 bits (244), Expect = 8e-22
Identities = 59/222 (26%), Positives = 89/222 (40%), Gaps = 58/222 (26%)
Query: 385 ILGDGSY-SVCRRCVEKSTGQEYAVKIISR----KIDCSE---EINLLRACQGHPNIVNL 436
LG G+Y V + +++ TG+ AVK I D EI +L GH NIVNL
Sbjct: 16 KLGKGAYGIVWK-SIDRRTGEVVAVKKIFDAFQNSTDAQRTFREIMILTELSGHENIVNL 74
Query: 437 HCVFQDE--VHTYLVLEL--------LKGGELLDRIRQKGRCGFTENEASRIMRQLVAAV 486
V + + YLV + ++ L +Q ++ QL+ +
Sbjct: 75 LNVLRADNDRDVYLVFDYMETDLHAVIRANILEPVHKQ------------YVVYQLIKVI 122
Query: 487 HFMHSRGVVHRDLKPENLLFSDPAGDNIKVVDFGFACLKRESLHTPCFTLQ--------- 537
++HS G++HRD+KP N+L + A ++KV DFG +
Sbjct: 123 KYLHSGGLLHRDMKPSNILLN--AECHVKVADFGLSRSFVNIRRVTNNIPLSINENTENF 180
Query: 538 ---------------YAAPEVLRQDKSGYDENCDLWSLGVIL 564
Y APE+L Y + D+WSLG IL
Sbjct: 181 DDDQPILTDYVATRWYRAPEILLGST-KYTKGIDMWSLGCIL 221
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} Length = 388 | Back alignment and structure |
|---|
Score = 51.2 bits (123), Expect = 9e-07
Identities = 13/29 (44%), Positives = 23/29 (79%)
Query: 927 IMRQLVAAVHFMHSRGVVHRDLKPENLLL 955
++ QL+ + ++HS G++HRD+KP N+LL
Sbjct: 114 VVYQLIKVIKYLHSGGLLHRDMKPSNILL 142
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* Length = 298 | Back alignment and structure |
|---|
Score = 95.1 bits (237), Expect = 2e-21
Identities = 55/206 (26%), Positives = 90/206 (43%), Gaps = 32/206 (15%)
Query: 386 LGDGSYSVCRRCVEKSTGQEYAVKIISRKIDCS---EEINLLRACQGHPNIVNLHCVFQD 442
+G+GS+ V Q+ A+K R+ D +E + G I N++ Q+
Sbjct: 18 IGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDAPQLRDEYRTYKLLAGCTGIPNVYYFGQE 77
Query: 443 EVHTYLVLELLKGGELLDRIRQKGRCGFTENEASRIMRQLVAAVHFMHSRGVVHRDLKPE 502
+H LV++LL G L D + GR F+ + +Q++A V +H + +V+RD+KP+
Sbjct: 78 GLHNVLVIDLL-GPSLEDLLDLCGRK-FSVKTVAMAAKQMLARVQSIHEKSLVYRDIKPD 135
Query: 503 NLLFSDPAGDNIKVV---DFGFACLKRES---LHTP-------CFTLQYAAP------EV 543
N L P N ++ DFG R+ H P T +Y + E
Sbjct: 136 NFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGTARYMSINTHLGREQ 195
Query: 544 LRQDKSGYDENCDLWSLGVILVNVLR 569
R+D DL +LG + + LR
Sbjct: 196 SRRD--------DLEALGHVFMYFLR 213
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* Length = 298 | Back alignment and structure |
|---|
Score = 56.2 bits (136), Expect = 2e-08
Identities = 22/66 (33%), Positives = 39/66 (59%), Gaps = 2/66 (3%)
Query: 890 RYNVHTYLVLELLKGGELLDRIRQKGRCGFTENEASRIMRQLVAAVHFMHSRGVVHRDLK 949
+ +H LV++LL G L D + GR F+ + +Q++A V +H + +V+RD+K
Sbjct: 76 QEGLHNVLVIDLL-GPSLEDLLDLCGRK-FSVKTVAMAAKQMLARVQSIHEKSLVYRDIK 133
Query: 950 PENLLL 955
P+N L+
Sbjct: 134 PDNFLI 139
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* Length = 397 | Back alignment and structure |
|---|
Score = 96.1 bits (239), Expect = 3e-21
Identities = 63/337 (18%), Positives = 113/337 (33%), Gaps = 100/337 (29%)
Query: 332 PKISNELDVSNFSDEFTKMIPADSPAIVPPNFDKIFKGSLFFEQYDMDLDKAGILGDGSY 391
P+ E+ S+ ++ D + + G LF +Y + LG G +
Sbjct: 1 PEQEEEILGSDDDEQ------EDPNDYCKGGYHLVKIGDLFNGRYHV----IRKLGWGHF 50
Query: 392 SVCRRCVEKSTGQEYAVKIISRKIDCSE----EINLLRA-------CQGHPNIVNLHCVF 440
S + + A+K++ +E EI LL++ +V L F
Sbjct: 51 STVWLSWDIQGKKFVAMKVVKSAEHYTETALDEIRLLKSVRNSDPNDPNREMVVQLLDDF 110
Query: 441 Q----DEVHTYLVLELLKGGELLDRIRQKGRCGFTENEASRIMRQLVAAVHFMHSR-GVV 495
+ + H +V E+L G LL I + G +I++Q++ + ++H++ ++
Sbjct: 111 KISGVNGTHICMVFEVL-GHHLLKWIIKSNYQGLPLPCVKKIIQQVLQGLDYLHTKCRII 169
Query: 496 HRDLKPENLLFSDPAGD------------------------------------------- 512
H D+KPEN+L S
Sbjct: 170 HTDIKPENILLSVNEQYIRRLAAEATEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKN 229
Query: 513 ----NIKVVDFGFACLKRESLHTPCFTLQYAAPEVLRQDKSGYDENCDLWSLGVILVNVL 568
+K+ D G AC + T QY + EVL +G
Sbjct: 230 AEKLKVKIADLGNACWVHKHFTEDIQTRQYRSLEVL---------------IG------- 267
Query: 569 RQDKSGYDENCDLWSLGVILYTMLCGRVPFHARSRDD 605
SGY+ D+WS + + + G F S ++
Sbjct: 268 ----SGYNTPADIWSTACMAFELATGDYLFEPHSGEE 300
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* Length = 397 | Back alignment and structure |
|---|
Score = 54.9 bits (132), Expect = 7e-08
Identities = 21/64 (32%), Positives = 38/64 (59%), Gaps = 2/64 (3%)
Query: 894 HTYLVLELLKGGELLDRIRQKGRCGFTENEASRIMRQLVAAVHFMHSR-GVVHRDLKPEN 952
H +V E+L G LL I + G +I++Q++ + ++H++ ++H D+KPEN
Sbjct: 119 HICMVFEVL-GHHLLKWIIKSNYQGLPLPCVKKIIQQVLQGLDYLHTKCRIIHTDIKPEN 177
Query: 953 LLLS 956
+LLS
Sbjct: 178 ILLS 181
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} Length = 483 | Back alignment and structure |
|---|
Score = 97.4 bits (242), Expect = 3e-21
Identities = 79/435 (18%), Positives = 146/435 (33%), Gaps = 62/435 (14%)
Query: 386 LGDGSYSVCRRCVEKSTGQEYAVKIISRKIDCS---EEINLLRACQGHPNIVNLHCVFQD 442
+G GS+ T +E A+K+ + K E + R QG I N+ +
Sbjct: 15 IGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLLYESKIYRILQGGTGIPNVRWFGVE 74
Query: 443 EVHTYLVLELLKGGELLDRIRQKGRCGFTENEASRIMRQLVAAVHFMHSRGVVHRDLKPE 502
+ LV++LL G L D R + + Q++ V F+HS+ +HRD+KP+
Sbjct: 75 GDYNVLVMDLL-GPSLEDLFNFCSR-KLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPD 132
Query: 503 NLLFSDPAGDN-IKVVDFGFACLKRES---LHTPCF-------TLQYAAP------EVLR 545
N L N + ++DFG A R++ H P T +YA+ E R
Sbjct: 133 NFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYASVNTHLGIEQSR 192
Query: 546 QDKSGYDENCDLWSLGVILVNVLR-----------QDKSGYDENCDL---WSLGVIL--- 588
+D DL SLG +L+ LR K Y++ + S+ +
Sbjct: 193 RD--------DLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVATSIEALCRGY 244
Query: 589 ------YTMLCGRVPFHARSRDDSALSIMARIKEGQ-----FNFDAEAWSTVSSEAKELT 637
Y C + F + + + + + FD W+ + + ++
Sbjct: 245 PTEFASYFHYCRSLRFDDKPDYSYLKRLFRDLFIREGFQFDYVFD---WTILKYQQSQIA 301
Query: 638 KSLLTVNPAQRIRMMRVKLTFHAFHQAQKEGFRLQDVTSAKLAQRRKNKNVSNDNSRSFS 697
+ Q+ + R +S + ++ +
Sbjct: 302 SAPPRAVGHGAGPSGLAPPALQNDRQSGVDEGRTSGWSSMDRRRAPPPIASVGTLAKQKA 361
Query: 698 STSSSLSSSSSGTSSLKTPCSSTQPSVPSKPVKRINKDASSGTVFDFAEARVQEYLSSLS 757
+ S S S + S +P ++D + + R +
Sbjct: 362 PVGNDASFSKEPVISASNFLGRSSGS-SRRPAVSSSRDVMPIDTSEPSRTRATDASPGAF 420
Query: 758 SSSSSEHGTSPPSSS 772
+S +SP +S+
Sbjct: 421 RRTSGPQKSSPVNSA 435
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} Length = 483 | Back alignment and structure |
|---|
Score = 55.0 bits (132), Expect = 7e-08
Identities = 22/77 (28%), Positives = 38/77 (49%), Gaps = 3/77 (3%)
Query: 890 RYNVHTYLVLELLKGGELLDRIRQKGRCGFTENEASRIMRQLVAAVHFMHSRGVVHRDLK 949
+ LV++LL G L D R + + Q++ V F+HS+ +HRD+K
Sbjct: 73 VEGDYNVLVMDLL-GPSLEDLFNFCSR-KLSLKTVLMLADQMINRVEFVHSKSFLHRDIK 130
Query: 950 PENLLLSGISGNLIKIY 966
P+N L+ G+ ++Y
Sbjct: 131 PDNFLM-GLGRRANQVY 146
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* Length = 353 | Back alignment and structure |
|---|
Score = 95.4 bits (238), Expect = 3e-21
Identities = 72/318 (22%), Positives = 118/318 (37%), Gaps = 90/318 (28%)
Query: 385 ILGDGSY-SVCRRCVEKSTGQEYAVKIIS---RKIDCSE---EINLLRACQGHPNIVNLH 437
+LG+G+Y VC K TG+ A+K I + + EI +L+ + H NI+ +
Sbjct: 18 LLGEGAYGVVCS-ATHKPTGEIVAIKKIEPFDKPLFALRTLREIKILKHFK-HENIITIF 75
Query: 438 CVFQ-------DEVHTYLVLELLKGGELLDRIRQKGRCGFTENEASRIMRQLVAAVHFMH 490
+ + +EV Y++ EL+ L R+ +++ + Q + AV +H
Sbjct: 76 NIQRPDSFENFNEV--YIIQELM--QTDLHRVISTQM--LSDDHIQYFIYQTLRAVKVLH 129
Query: 491 SRGVVHRDLKPENLLFSDPAGDNIKVVDFGFACLKRESLHTPCFTLQ------------- 537
V+HRDLKP NLL + + ++KV DFG A + ES
Sbjct: 130 GSNVIHRDLKPSNLLIN--SNCDLKVCDFGLARIIDESAADNSEPTGQQSGMVEFVATRW 187
Query: 538 YAAPEVLRQDKSGYDENCDLWSLGVILVNVLRQDKSGYDENCDLWSLGVILYTMLCGRVP 597
Y APEV+ L S + Y D+WS G IL + R
Sbjct: 188 YRAPEVM------------LTS-------------AKYSRAMDVWSCGCILAELFLRRPI 222
Query: 598 FHARS------------------------RDDSALSIMARI--KEGQFNFDAEAWSTVSS 631
F R A + + + + V+
Sbjct: 223 FPGRDYRHQLLLIFGIIGTPHSDNDLRCIESPRAREYIKSLPMYPAA-PL-EKMFPRVNP 280
Query: 632 EAKELTKSLLTVNPAQRI 649
+ +L + +L +PA+RI
Sbjct: 281 KGIDLLQRMLVFDPAKRI 298
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* Length = 353 | Back alignment and structure |
|---|
Score = 49.9 bits (120), Expect = 2e-06
Identities = 14/29 (48%), Positives = 19/29 (65%)
Query: 927 IMRQLVAAVHFMHSRGVVHRDLKPENLLL 955
+ Q + AV +H V+HRDLKP NLL+
Sbjct: 117 FIYQTLRAVKVLHGSNVIHRDLKPSNLLI 145
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A Length = 296 | Back alignment and structure |
|---|
Score = 94.0 bits (234), Expect = 4e-21
Identities = 51/204 (25%), Positives = 88/204 (43%), Gaps = 30/204 (14%)
Query: 386 LGDGSYSVCRRCVEKSTGQEYAVKIISRKIDCSE---EINLLRACQGHPNIVNLHCVFQD 442
+G GS+ + + G+E A+K+ K + E + + QG I + +
Sbjct: 17 IGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHPQLHIESKIYKMMQGGVGIPTIRWCGAE 76
Query: 443 EVHTYLVLELLKGGELLDRIRQKGRCGFTENEASRIMRQLVAAVHFMHSRGVVHRDLKPE 502
+ +V+ELL G L D R F+ + Q+++ + ++HS+ +HRD+KP+
Sbjct: 77 GDYNVMVMELL-GPSLEDLFNFCSR-KFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPD 134
Query: 503 NLLFSDPAGDN-IKVVDFGFACLKRES---LHTPCF-------TLQYAAP------EVLR 545
N L N + ++DFG A R++ H P T +YA+ E R
Sbjct: 135 NFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSR 194
Query: 546 QDKSGYDENCDLWSLGVILVNVLR 569
+D DL SLG +L+
Sbjct: 195 RD--------DLESLGYVLMYFNL 210
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A Length = 296 | Back alignment and structure |
|---|
Score = 56.2 bits (136), Expect = 1e-08
Identities = 21/77 (27%), Positives = 39/77 (50%), Gaps = 3/77 (3%)
Query: 890 RYNVHTYLVLELLKGGELLDRIRQKGRCGFTENEASRIMRQLVAAVHFMHSRGVVHRDLK 949
+ +V+ELL G L D R F+ + Q+++ + ++HS+ +HRD+K
Sbjct: 75 AEGDYNVMVMELL-GPSLEDLFNFCSR-KFSLKTVLLLADQMISRIEYIHSKNFIHRDVK 132
Query: 950 PENLLLSGISGNLIKIY 966
P+N L+ G+ +Y
Sbjct: 133 PDNFLM-GLGKKGNLVY 148
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* Length = 330 | Back alignment and structure |
|---|
Score = 94.0 bits (234), Expect = 7e-21
Identities = 49/206 (23%), Positives = 79/206 (38%), Gaps = 32/206 (15%)
Query: 386 LGDGSYSVCRRCVEKSTGQEYAVKIISRKIDCS---EEINLLRACQGHPNIVNLHCVFQD 442
+G G++ R T + A+K+ K E + I ++
Sbjct: 17 IGCGNFGELRLGKNLYTNEYVAIKLEPMKSRAPQLHLEYRFYKQLGSGDGIPQVYYFGPC 76
Query: 443 EVHTYLVLELLKGGELLDRIRQKGRCGFTENEASRIMRQLVAAVHFMHSRGVVHRDLKPE 502
+ +VLELL G L D R F+ I QL++ + ++HS+ +++RD+KPE
Sbjct: 77 GKYNAMVLELL-GPSLEDLFDLCDRT-FSLKTVLMIAIQLISRMEYVHSKNLIYRDVKPE 134
Query: 503 NLLFSDPAGDNIKVV---DFGFA---CLKRESLHTP-------CFTLQYAAP------EV 543
N L P +V+ DF A H P T +Y + E
Sbjct: 135 NFLIGRPGNKTQQVIHIIDFALAKEYIDPETKKHIPYREHKSLTGTARYMSINTHLGKEQ 194
Query: 544 LRQDKSGYDENCDLWSLGVILVNVLR 569
R+D DL +LG + + LR
Sbjct: 195 SRRD--------DLEALGHMFMYFLR 212
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* Length = 330 | Back alignment and structure |
|---|
Score = 57.4 bits (139), Expect = 8e-09
Identities = 23/78 (29%), Positives = 39/78 (50%), Gaps = 3/78 (3%)
Query: 890 RYNVHTYLVLELLKGGELLDRIRQKGRCGFTENEASRIMRQLVAAVHFMHSRGVVHRDLK 949
+ +VLELL G L D R F+ I QL++ + ++HS+ +++RD+K
Sbjct: 75 PCGKYNAMVLELL-GPSLEDLFDLCDRT-FSLKTVLMIAIQLISRMEYVHSKNLIYRDVK 132
Query: 950 PENLLLS-GISGNLIKIY 966
PEN L+ + I+
Sbjct: 133 PENFLIGRPGNKTQQVIH 150
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495 | Back alignment and structure |
|---|
Score = 94.8 bits (236), Expect = 2e-20
Identities = 50/188 (26%), Positives = 85/188 (45%), Gaps = 13/188 (6%)
Query: 385 ILGDGSYSVCRRCVEKSTGQEYAVKII----SRKIDCSEEINLLRACQGHPNIVNLHCVF 440
LG G Y V K AVK + + +E +++ + HPN+V L V
Sbjct: 227 KLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIK-HPNLVQLLGVC 285
Query: 441 QDEVHTYLVLELLKGGELLDRIRQKGRCGFTENEASRIMRQLVAAVHFMHSRGVVHRDLK 500
E Y++ E + G LLD +R+ R + + Q+ +A+ ++ + +HR+L
Sbjct: 286 TREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRNLA 345
Query: 501 PENLLFSDPAGDNIKVVDFGFACLKRESLHTP----CFTLQYAAPEVLRQDKSGYDENCD 556
N L + +KV DFG + L +T F +++ APE L +K + D
Sbjct: 346 ARNCLVGE--NHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNK--FSIKSD 401
Query: 557 LWSLGVIL 564
+W+ GV+L
Sbjct: 402 VWAFGVLL 409
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495 | Back alignment and structure |
|---|
Score = 50.2 bits (120), Expect = 2e-06
Identities = 17/70 (24%), Positives = 36/70 (51%), Gaps = 2/70 (2%)
Query: 896 YLVLELLKGGELLDRIRQKGRCGFTENEASRIMRQLVAAVHFMHSRGVVHRDLKPENLLL 955
Y++ E + G LLD +R+ R + + Q+ +A+ ++ + +HR+L N L+
Sbjct: 292 YIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRNLAARNCLV 351
Query: 956 SGISGNLIKI 965
+L+K+
Sbjct: 352 G--ENHLVKV 359
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 91.7 bits (228), Expect = 5e-20
Identities = 42/215 (19%), Positives = 72/215 (33%), Gaps = 39/215 (18%)
Query: 379 DLDKAGILGDGSYSVCRRCVEKST--GQEYAVKIISRKIDCSE----EINLLRACQGHPN 432
+ +G G Y V G++ AVK+ + S EI + H N
Sbjct: 38 QIQMVKQIGKGRYG----EVWMGKWRGEKVAVKVFFTTEEASWFRETEIYQTVLMR-HEN 92
Query: 433 IVNLHCV----FQDEVHTYLVLELLKGGELLDRIRQKGRCGFTENEASRIMRQLVAAVHF 488
I+ YL+ + + G L D ++ ++ V+ +
Sbjct: 93 ILGFIAADIKGTGSWTQLYLITDYHENGSLYDYLKSTT---LDAKSMLKLAYSSVSGLCH 149
Query: 489 MHSR--------GVVHRDLKPENLLFSDPAGDNIKVVDFGFACLKRESLHTPCF------ 534
+H+ + HRDLK +N+L + D G A +
Sbjct: 150 LHTEIFSTQGKPAIAHRDLKSKNILVKK--NGTCCIADLGLAVKFISDTNEVDIPPNTRV 207
Query: 535 -TLQYAAPEVLRQDKSG----YDENCDLWSLGVIL 564
T +Y PEVL + + D++S G+IL
Sbjct: 208 GTKRYMPPEVLDESLNRNHFQSYIMADMYSFGLIL 242
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 43.6 bits (103), Expect = 2e-04
Identities = 14/68 (20%), Positives = 29/68 (42%), Gaps = 11/68 (16%)
Query: 896 YLVLELLKGGELLDRIRQKGRCGFTENEASRIMRQLVAAVHFMHSR--------GVVHRD 947
YL+ + + G L D ++ ++ V+ + +H+ + HRD
Sbjct: 111 YLITDYHENGSLYDYLKSTT---LDAKSMLKLAYSSVSGLCHLHTEIFSTQGKPAIAHRD 167
Query: 948 LKPENLLL 955
LK +N+L+
Sbjct: 168 LKSKNILV 175
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322 | Back alignment and structure |
|---|
Score = 90.5 bits (225), Expect = 9e-20
Identities = 43/222 (19%), Positives = 76/222 (34%), Gaps = 34/222 (15%)
Query: 369 GSLFFEQYDMDLDKAGILGDGSYSVCRRCVEKSTGQEYAVKIISRKIDCSE----EINLL 424
G+ M L + G + + + AVKI + S E+ L
Sbjct: 15 GTENLYFQSMPLQLLEVKARGRFGCVWKAQLL--NEYVAVKIFPIQDKQSWQNEYEVYSL 72
Query: 425 RACQGHPNIVNL--HCVFQDEVHT--YLVLELLKGGELLDRIRQKGRCGFTENEASRIMR 480
+ H NI+ V +L+ + G L D ++ + NE I
Sbjct: 73 PGMK-HENILQFIGAEKRGTSVDVDLWLITAFHEKGSLSDFLKANV---VSWNELCHIAE 128
Query: 481 QLVAAVHFMHSR----------GVVHRDLKPENLLFSDPAGDNIKVVDFGFACLKRESLH 530
+ + ++H + HRD+K +N+L + + DFG A
Sbjct: 129 TMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNL--TACIADFGLALKFEAGKS 186
Query: 531 TPCF-----TLQYAAPEVLR---QDKSGYDENCDLWSLGVIL 564
T +Y APEVL + D++++G++L
Sbjct: 187 AGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVL 228
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} Length = 458 | Back alignment and structure |
|---|
Score = 92.2 bits (229), Expect = 1e-19
Identities = 54/223 (24%), Positives = 89/223 (39%), Gaps = 51/223 (22%)
Query: 385 ILGDGSYSVCRRCVEKSTGQEYAVKIISR----KIDCSE---EINLLRACQGHPNIVNLH 437
++G GSY +K + A+K I R IDC EI +L H ++V +
Sbjct: 60 LIGTGSYGHVCEAYDKLEKRVVAIKKILRVFEDLIDCKRILREIAILNRLN-HDHVVKVL 118
Query: 438 CVFQDEV-----HTYLVLELLKGGEL-LDRIRQKGRCGFTENEASRIMRQLVAAVHFMHS 491
+ + Y+VLE+ + ++ + TE ++ L+ V ++HS
Sbjct: 119 DIVIPKDVEKFDELYVVLEIA---DSDFKKLFRTPV-YLTELHIKTLLYNLLVGVKYVHS 174
Query: 492 RGVVHRDLKPENLLFSDPAGDNIKVVDFGFA------------------------CLKRE 527
G++HRDLKP N L + ++KV DFG A
Sbjct: 175 AGILHRDLKPANCLVN--QDCSVKVCDFGLARTVDYPENGNSQLPISPREDDMNLVTFPH 232
Query: 528 SLHTPCF------TLQYAAPEVLRQDKSGYDENCDLWSLGVIL 564
+ + T Y APE++ ++ Y E D+WS+G I
Sbjct: 233 TKNLKRQLTGHVVTRWYRAPELILLQEN-YTEAIDVWSIGCIF 274
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} Length = 458 | Back alignment and structure |
|---|
Score = 51.4 bits (123), Expect = 1e-06
Identities = 13/29 (44%), Positives = 21/29 (72%)
Query: 927 IMRQLVAAVHFMHSRGVVHRDLKPENLLL 955
++ L+ V ++HS G++HRDLKP N L+
Sbjct: 161 LLYNLLVGVKYVHSAGILHRDLKPANCLV 189
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* Length = 432 | Back alignment and structure |
|---|
Score = 91.0 bits (226), Expect = 2e-19
Identities = 55/245 (22%), Positives = 98/245 (40%), Gaps = 36/245 (14%)
Query: 385 ILGDGSYSVCRRCVEKSTGQEYAVKIISR----KIDCSE---EINLLRACQGHPNIVNLH 437
++G GSY +K+T + A+K ++R IDC EI +L + I+ L+
Sbjct: 33 LIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCKRILREITILNRLK-SDYIIRLY 91
Query: 438 CVFQDEVHT-----YLVLELLKGGELLDRIRQKGRCGFTENEASRIMRQLVAAVHFMHSR 492
+ + Y+VLE+ L ++ + TE I+ L+ +F+H
Sbjct: 92 DLIIPDDLLKFDELYIVLEIA--DSDLKKLFKTPI-FLTEEHIKTILYNLLLGENFIHES 148
Query: 493 GVVHRDLKPENLLFSDPAGDNIKVVDFGFACLKRESLHTPCFTLQYAAPEVLRQDKSGYD 552
G++HRDLKP N L + ++KV DFG A R ++++ T E +
Sbjct: 149 GIIHRDLKPANCLLN--QDCSVKVCDFGLA---R-TINSEKDTNIVNDLEENEEPGPHNK 202
Query: 553 ENCDLWSLGV---------ILVNVLRQDKSGYDENCDLWSLGVILYTMLCGRVPFHARSR 603
+ V +++ + Y ++ D+WS G I +L
Sbjct: 203 NLKKQLTSHVVTRWYRAPELILL-----QENYTKSIDIWSTGCIFAELLNMLQSHINDPT 257
Query: 604 DDSAL 608
+ L
Sbjct: 258 NRFPL 262
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* Length = 432 | Back alignment and structure |
|---|
Score = 50.5 bits (121), Expect = 2e-06
Identities = 14/29 (48%), Positives = 20/29 (68%)
Query: 927 IMRQLVAAVHFMHSRGVVHRDLKPENLLL 955
I+ L+ +F+H G++HRDLKP N LL
Sbjct: 134 ILYNLLLGENFIHESGIIHRDLKPANCLL 162
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} Length = 383 | Back alignment and structure |
|---|
Score = 89.4 bits (222), Expect = 4e-19
Identities = 70/331 (21%), Positives = 121/331 (36%), Gaps = 96/331 (29%)
Query: 385 ILGDGSY-SVCRRCVEKSTGQEYAVK-IISRKIDCSEEINLLRACQGHPNIVNLHCVF-- 440
LG GS+ VC + +G+ +A+K ++ + E+++++ H NI+ L F
Sbjct: 14 TLGTGSFGIVCE-VFDIESGKRFALKKVLQDPRYKNRELDIMKVLD-HVNIIKLVDYFYT 71
Query: 441 ------------------------------------QDEVHTYLVLELLKGGELLDRIRQ 464
+ +++E + L ++
Sbjct: 72 TGDEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYV-PDTLHKVLKS 130
Query: 465 KGRCG--FTENEASRIMRQLVAAVHFMHSRGVVHRDLKPENLLFSDPAGDNIKVVDFGFA 522
R G N S + QL AV F+HS G+ HRD+KP+NLL + + +K+ DFG A
Sbjct: 131 FIRSGRSIPMNLISIYIYQLFRAVGFIHSLGICHRDIKPQNLLV-NSKDNTLKLCDFGSA 189
Query: 523 -CLKRESLHTP--CFTLQYAAPEVLRQDKSGYDENCDLWSLGVILVNVLRQDKSGYDENC 579
L C + Y APE++ LG + Y +
Sbjct: 190 KKLIPSEPSVAYIC-SRFYRAPELM---------------LGA----------TEYTPSI 223
Query: 580 DLWSLGVILYTMLCGRVPFHARSRDDSALSIMARI-------------KEGQFNF---DA 623
DLWS+G + ++ G+ F + D + I+ + + F A
Sbjct: 224 DLWSIGCVFGELILGKPLFSGETSIDQLVRIIQIMGTPTKEQMIRMNPHYTEVRFPTLKA 283
Query: 624 EAWSTV-----SSEAKELTKSLLTVNPAQRI 649
+ W + S A +L + +L P RI
Sbjct: 284 KDWRKILPEGTPSLAIDLLEQILRYEPDLRI 314
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} Length = 383 | Back alignment and structure |
|---|
Score = 54.7 bits (132), Expect = 6e-08
Identities = 24/72 (33%), Positives = 38/72 (52%), Gaps = 4/72 (5%)
Query: 896 YLVLELLKGGELLDRIRQKGRCG--FTENEASRIMRQLVAAVHFMHSRGVVHRDLKPENL 953
+++E + L ++ R G N S + QL AV F+HS G+ HRD+KP+NL
Sbjct: 114 NVIMEYV-PDTLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVGFIHSLGICHRDIKPQNL 172
Query: 954 LLSGISGNLIKI 965
L++ L K+
Sbjct: 173 LVNSKDNTL-KL 183
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336 | Back alignment and structure |
|---|
Score = 88.0 bits (218), Expect = 8e-19
Identities = 40/220 (18%), Positives = 73/220 (33%), Gaps = 42/220 (19%)
Query: 379 DLDKAGILGDGSYSVCRRCVEKSTGQEYAVKIISRKIDCSE----EINLLRACQGHPNIV 434
+L ++G G Y + + AVK+ S + I + + H NI
Sbjct: 14 NLKLLELIGRGRYGAVYKG--SLDERPVAVKVFSFANRQNFINEKNIYRVPLME-HDNIA 70
Query: 435 NL-----HCVFQDEVHTYLVLELLKGGELLDRIRQKGRCGFTENEASRIMRQLVAAVHFM 489
+ LV+E G L + + R+ + + ++
Sbjct: 71 RFIVGDERVTADGRMEYLLVMEYYPNGSLXKYLSLHT---SDWVSSCRLAHSVTRGLAYL 127
Query: 490 HS---------RGVVHRDLKPENLLFSDPAGDNIKVVDFGFACLKRESLHTPCF------ 534
H+ + HRDL N+L + + DFG + +
Sbjct: 128 HTELPRGDHYKPAISHRDLNSRNVLVKNDG--TCVISDFGLSMRLTGNRLVRPGEEDNAA 185
Query: 535 -----TLQYAAPEVLR-----QDKSGYDENCDLWSLGVIL 564
T++Y APEVL +D + D+++LG+I
Sbjct: 186 ISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIY 225
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336 | Back alignment and structure |
|---|
Score = 41.7 bits (98), Expect = 7e-04
Identities = 13/69 (18%), Positives = 25/69 (36%), Gaps = 12/69 (17%)
Query: 896 YLVLELLKGGELLDRIRQKGRCGFTENEASRIMRQLVAAVHFMHS---------RGVVHR 946
LV+E G L + + R+ + + ++H+ + HR
Sbjct: 88 LLVMEYYPNGSLXKYLSLHT---SDWVSSCRLAHSVTRGLAYLHTELPRGDHYKPAISHR 144
Query: 947 DLKPENLLL 955
DL N+L+
Sbjct: 145 DLNSRNVLV 153
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278 | Back alignment and structure |
|---|
Score = 86.1 bits (214), Expect = 1e-18
Identities = 50/189 (26%), Positives = 88/189 (46%), Gaps = 21/189 (11%)
Query: 385 ILGDGSYSVCRRCVEKSTGQEYAVKIISRKIDCSE-----EINLLRACQGHPNIVNLH-C 438
+G G + + G + AVK I K D + E +++ + H N+V L
Sbjct: 28 TIGKGEFGDVMLGDYR--GNKVAVKCI--KNDATAQAFLAEASVMTQLR-HSNLVQLLGV 82
Query: 439 VFQDEVHTYLVLELLKGGELLDRIRQKGRCGFTENEASRIMRQLVAAVHFMHSRGVVHRD 498
+ +++ Y+V E + G L+D +R +GR + + + A+ ++ VHRD
Sbjct: 83 IVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRD 142
Query: 499 LKPENLLFSDPAGDNIKVVDFGFACLKRESLHTPC---FTLQYAAPEVLRQDKSGYDENC 555
L N+L S+ + KV DFG +E+ T +++ APE LR+ K +
Sbjct: 143 LAARNVLVSE--DNVAKVSDFGLT---KEASSTQDTGKLPVKWTAPEALREKK--FSTKS 195
Query: 556 DLWSLGVIL 564
D+WS G++L
Sbjct: 196 DVWSFGILL 204
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278 | Back alignment and structure |
|---|
Score = 49.1 bits (118), Expect = 2e-06
Identities = 20/70 (28%), Positives = 35/70 (50%), Gaps = 2/70 (2%)
Query: 896 YLVLELLKGGELLDRIRQKGRCGFTENEASRIMRQLVAAVHFMHSRGVVHRDLKPENLLL 955
Y+V E + G L+D +R +GR + + + A+ ++ VHRDL N+L+
Sbjct: 91 YIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLV 150
Query: 956 SGISGNLIKI 965
S N+ K+
Sbjct: 151 S--EDNVAKV 158
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450 | Back alignment and structure |
|---|
Score = 88.9 bits (221), Expect = 1e-18
Identities = 47/168 (27%), Positives = 81/168 (48%), Gaps = 13/168 (7%)
Query: 403 GQEYAVKIISRKIDCSE-----EINLLRACQGHPNIVNLH-CVFQDEVHTYLVLELLKGG 456
G + AVK I K D + E +++ + H N+V L + +++ Y+V E + G
Sbjct: 216 GNKVAVKCI--KNDATAQAFLAEASVMTQLR-HSNLVQLLGVIVEEKGGLYIVTEYMAKG 272
Query: 457 ELLDRIRQKGRCGFTENEASRIMRQLVAAVHFMHSRGVVHRDLKPENLLFSDPAGDNIKV 516
L+D +R +GR + + + A+ ++ VHRDL N+L S+ + KV
Sbjct: 273 SLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVSE--DNVAKV 330
Query: 517 VDFGFACLKRESLHTPCFTLQYAAPEVLRQDKSGYDENCDLWSLGVIL 564
DFG + T +++ APE LR+ K + D+WS G++L
Sbjct: 331 SDFGLTKEASSTQDTGKLPVKWTAPEALREKK--FSTKSDVWSFGILL 376
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450 | Back alignment and structure |
|---|
Score = 50.8 bits (122), Expect = 1e-06
Identities = 20/70 (28%), Positives = 35/70 (50%), Gaps = 2/70 (2%)
Query: 896 YLVLELLKGGELLDRIRQKGRCGFTENEASRIMRQLVAAVHFMHSRGVVHRDLKPENLLL 955
Y+V E + G L+D +R +GR + + + A+ ++ VHRDL N+L+
Sbjct: 263 YIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLV 322
Query: 956 SGISGNLIKI 965
S N+ K+
Sbjct: 323 S--EDNVAKV 330
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288 | Back alignment and structure |
|---|
Score = 84.6 bits (210), Expect = 5e-18
Identities = 54/190 (28%), Positives = 86/190 (45%), Gaps = 17/190 (8%)
Query: 385 ILGDGSYSVCRRCVEKSTGQEYAVKIISRKIDCSE------EINLLRACQGHPNIVNLHC 438
LG G Y V K AVK + K D E E +++ + HPN+V L
Sbjct: 20 KLGGGQYGEVYEGVWKKYSLTVAVKTL--KEDTMEVEEFLKEAAVMKEIK-HPNLVQLLG 76
Query: 439 VFQDEVHTYLVLELLKGGELLDRIRQKGRCGFTENEASRIMRQLVAAVHFMHSRGVVHRD 498
V E Y++ E + G LLD +R+ R + + Q+ +A+ ++ + +HRD
Sbjct: 77 VCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRD 136
Query: 499 LKPENLLFSDPAGDNIKVVDFGFACLKRESLHTPC----FTLQYAAPEVLRQDKSGYDEN 554
L N L + +KV DFG + L +T F +++ APE L +K +
Sbjct: 137 LAARNCLVGE--NHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNK--FSIK 192
Query: 555 CDLWSLGVIL 564
D+W+ GV+L
Sbjct: 193 SDVWAFGVLL 202
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288 | Back alignment and structure |
|---|
Score = 48.4 bits (116), Expect = 4e-06
Identities = 18/71 (25%), Positives = 36/71 (50%), Gaps = 2/71 (2%)
Query: 895 TYLVLELLKGGELLDRIRQKGRCGFTENEASRIMRQLVAAVHFMHSRGVVHRDLKPENLL 954
Y++ E + G LLD +R+ R + + Q+ +A+ ++ + +HRDL N L
Sbjct: 84 FYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCL 143
Query: 955 LSGISGNLIKI 965
+ +L+K+
Sbjct: 144 VG--ENHLVKV 152
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377 | Back alignment and structure |
|---|
Score = 85.0 bits (211), Expect = 1e-17
Identities = 46/192 (23%), Positives = 86/192 (44%), Gaps = 21/192 (10%)
Query: 386 LGDGSYSVCRRCVEKSTGQEYAVKIISRKIDCS--------EEINLLRACQGHPNIVNLH 437
+G G++ ++ AVK + +E +L+ HPNIV L
Sbjct: 122 IGRGNFGEVFSGRLRADNTLVAVKSC--RETLPPDLKAKFLQEARILKQYS-HPNIVRLI 178
Query: 438 CVFQDEVHTYLVLELLKGGELLDRIRQKGRCGFTENEASRIMRQLVAAVHFMHSRGVVHR 497
V + Y+V+EL++GG+ L +R +G +++ A + ++ S+ +HR
Sbjct: 179 GVCTQKQPIYIVMELVQGGDFLTFLRTEGA-RLRVKTLLQMVGDAAAGMEYLESKCCIHR 237
Query: 498 DLKPENLLFSDPAGDNIKVVDFGFACLKRESLHTPCFTLQY-----AAPEVLRQDKSGYD 552
DL N L ++ + +K+ DFG + + + ++ L+ APE L + Y
Sbjct: 238 DLAARNCLVTE--KNVLKISDFGMSREEADGVYAASGGLRQVPVKWTAPEALNYGR--YS 293
Query: 553 ENCDLWSLGVIL 564
D+WS G++L
Sbjct: 294 SESDVWSFGILL 305
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377 | Back alignment and structure |
|---|
Score = 49.9 bits (120), Expect = 2e-06
Identities = 20/71 (28%), Positives = 39/71 (54%), Gaps = 3/71 (4%)
Query: 895 TYLVLELLKGGELLDRIRQKGRCGFTENEASRIMRQLVAAVHFMHSRGVVHRDLKPENLL 954
Y+V+EL++GG+ L +R +G +++ A + ++ S+ +HRDL N L
Sbjct: 187 IYIVMELVQGGDFLTFLRTEGA-RLRVKTLLQMVGDAAAGMEYLESKCCIHRDLAARNCL 245
Query: 955 LSGISGNLIKI 965
++ N++KI
Sbjct: 246 VT--EKNVLKI 254
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452 | Back alignment and structure |
|---|
Score = 83.3 bits (206), Expect = 9e-17
Identities = 40/166 (24%), Positives = 76/166 (45%), Gaps = 14/166 (8%)
Query: 407 AVKII----SRKIDCSEEINLLRACQGHPNIVNLHCVFQDEVHTYLVLELLKGGELLDRI 462
A+K + +E +++ + H +V L+ V +E Y+V E + G LLD +
Sbjct: 212 AIKTLKPGTMSPEAFLQEAQVMKKLR-HEKLVQLYAVVSEE-PIYIVTEYMSKGSLLDFL 269
Query: 463 RQKGRCGFTENEASRIMRQLVAAVHFMHSRGVVHRDLKPENLLFSDPAGDNIKVVDFGFA 522
+ + + + Q+ + + ++ VHRDL+ N+L + KV DFG A
Sbjct: 270 KGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGE--NLVCKVADFGLA 327
Query: 523 CLKRESLHTPC----FTLQYAAPEVLRQDKSGYDENCDLWSLGVIL 564
L ++ +T F +++ APE + + D+WS G++L
Sbjct: 328 RLIEDNEYTARQGAKFPIKWTAPEAALYGR--FTIKSDVWSFGILL 371
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452 | Back alignment and structure |
|---|
Score = 48.2 bits (115), Expect = 8e-06
Identities = 16/70 (22%), Positives = 33/70 (47%), Gaps = 2/70 (2%)
Query: 896 YLVLELLKGGELLDRIRQKGRCGFTENEASRIMRQLVAAVHFMHSRGVVHRDLKPENLLL 955
Y+V E + G LLD ++ + + + Q+ + + ++ VHRDL+ N+L+
Sbjct: 254 YIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILV 313
Query: 956 SGISGNLIKI 965
+ K+
Sbjct: 314 G--ENLVCKV 321
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454 | Back alignment and structure |
|---|
Score = 82.8 bits (205), Expect = 1e-16
Identities = 42/167 (25%), Positives = 69/167 (41%), Gaps = 16/167 (9%)
Query: 407 AVKIISRKIDCSEEINLLRACQ-----GHPNIVNLHCVFQDEVHTYLVLELLKGGELLDR 461
AVK + K L H +V LH V E Y++ E + G LLD
Sbjct: 216 AVKTM--KPGSMSVEAFLAEANVMKTLQHDKLVKLHAVVTKE-PIYIITEFMAKGSLLDF 272
Query: 462 IRQKGRCGFTENEASRIMRQLVAAVHFMHSRGVVHRDLKPENLLFSDPAGDNIKVVDFGF 521
++ + Q+ + F+ R +HRDL+ N+L S K+ DFG
Sbjct: 273 LKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRNYIHRDLRAANILVSA--SLVCKIADFGL 330
Query: 522 ACLKRESLHTP----CFTLQYAAPEVLRQDKSGYDENCDLWSLGVIL 564
A + ++ +T F +++ APE + + D+WS G++L
Sbjct: 331 ARVIEDNEYTAREGAKFPIKWTAPEAINFGS--FTIKSDVWSFGILL 375
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454 | Back alignment and structure |
|---|
Score = 47.4 bits (113), Expect = 2e-05
Identities = 18/70 (25%), Positives = 33/70 (47%), Gaps = 2/70 (2%)
Query: 896 YLVLELLKGGELLDRIRQKGRCGFTENEASRIMRQLVAAVHFMHSRGVVHRDLKPENLLL 955
Y++ E + G LLD ++ + Q+ + F+ R +HRDL+ N+L+
Sbjct: 258 YIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRNYIHRDLRAANILV 317
Query: 956 SGISGNLIKI 965
S + + KI
Sbjct: 318 S--ASLVCKI 325
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 79.9 bits (198), Expect = 2e-16
Identities = 47/168 (27%), Positives = 80/168 (47%), Gaps = 18/168 (10%)
Query: 407 AVKIISRKIDCSE------EINLLRACQGHPNIVNLHCVFQDEVHTYLVLELLKGGELLD 460
AVK + K E NL++ Q H +V L+ V E Y++ E ++ G L+D
Sbjct: 41 AVKSL--KQGSMSPDAFLAEANLMKQLQ-HQRLVRLYAVVTQE-PIYIITEYMENGSLVD 96
Query: 461 RIRQKGRCGFTENEASRIMRQLVAAVHFMHSRGVVHRDLKPENLLFSDPAGDNIKVVDFG 520
++ T N+ + Q+ + F+ R +HRDL+ N+L SD + K+ DFG
Sbjct: 97 FLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHRDLRAANILVSD--TLSCKIADFG 154
Query: 521 FACLKRESLHTPC----FTLQYAAPEVLRQDKSGYDENCDLWSLGVIL 564
A L ++ +T F +++ APE + + D+WS G++L
Sbjct: 155 LARLIEDNEYTAREGAKFPIKWTAPEAINYGT--FTIKSDVWSFGILL 200
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 49.1 bits (118), Expect = 3e-06
Identities = 19/71 (26%), Positives = 35/71 (49%), Gaps = 2/71 (2%)
Query: 895 TYLVLELLKGGELLDRIRQKGRCGFTENEASRIMRQLVAAVHFMHSRGVVHRDLKPENLL 954
Y++ E ++ G L+D ++ T N+ + Q+ + F+ R +HRDL+ N+L
Sbjct: 82 IYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHRDLRAANIL 141
Query: 955 LSGISGNLIKI 965
+S KI
Sbjct: 142 VS--DTLSCKI 150
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535 | Back alignment and structure |
|---|
Score = 82.6 bits (204), Expect = 2e-16
Identities = 40/166 (24%), Positives = 76/166 (45%), Gaps = 14/166 (8%)
Query: 407 AVKII----SRKIDCSEEINLLRACQGHPNIVNLHCVFQDEVHTYLVLELLKGGELLDRI 462
A+K + +E +++ + H +V L+ V +E Y+V E + G LLD +
Sbjct: 295 AIKTLKPGTMSPEAFLQEAQVMKKLR-HEKLVQLYAVVSEE-PIYIVTEYMSKGSLLDFL 352
Query: 463 RQKGRCGFTENEASRIMRQLVAAVHFMHSRGVVHRDLKPENLLFSDPAGDNIKVVDFGFA 522
+ + + + Q+ + + ++ VHRDL+ N+L + KV DFG A
Sbjct: 353 KGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGE--NLVCKVADFGLA 410
Query: 523 CLKRESLHTPC----FTLQYAAPEVLRQDKSGYDENCDLWSLGVIL 564
L ++ +T F +++ APE + + D+WS G++L
Sbjct: 411 RLIEDNEYTARQGAKFPIKWTAPEAALYGR--FTIKSDVWSFGILL 454
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535 | Back alignment and structure |
|---|
Score = 47.6 bits (113), Expect = 2e-05
Identities = 16/70 (22%), Positives = 33/70 (47%), Gaps = 2/70 (2%)
Query: 896 YLVLELLKGGELLDRIRQKGRCGFTENEASRIMRQLVAAVHFMHSRGVVHRDLKPENLLL 955
Y+V E + G LLD ++ + + + Q+ + + ++ VHRDL+ N+L+
Sbjct: 337 YIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILV 396
Query: 956 SGISGNLIKI 965
+ K+
Sbjct: 397 G--ENLVCKV 404
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295 | Back alignment and structure |
|---|
Score = 79.3 bits (196), Expect = 3e-16
Identities = 53/206 (25%), Positives = 91/206 (44%), Gaps = 29/206 (14%)
Query: 379 DLDKAGILGDGSY-SVCR---RCVEKSTGQEYAVKII-----SRKIDCSEEINLLRACQG 429
L LG G++ SV ++ +TG+ AVK + D EI +L++ Q
Sbjct: 11 HLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQ- 69
Query: 430 HPNIVNLH--CVFQDEVHTYLVLELLKGGELLDRIRQKGRCGFTENEASRIMRQLVAAVH 487
H NIV C + L++E L G L D ++ K + + + Q+ +
Sbjct: 70 HDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQ-KHKERIDHIKLLQYTSQICKGME 128
Query: 488 FMHSRGVVHRDLKPENLLFSDPAGDNIKVVDFGFACL---------KRESLHTPCFTLQY 538
++ ++ +HRDL N+L + + +K+ DFG + +E +P F +
Sbjct: 129 YLGTKRYIHRDLATRNILVENE--NRVKIGDFGLTKVLPQDKEFFKVKEPGESPIF---W 183
Query: 539 AAPEVLRQDKSGYDENCDLWSLGVIL 564
APE L + K + D+WS GV+L
Sbjct: 184 YAPESLTESK--FSVASDVWSFGVVL 207
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295 | Back alignment and structure |
|---|
Score = 45.7 bits (109), Expect = 4e-05
Identities = 21/94 (22%), Positives = 40/94 (42%), Gaps = 13/94 (13%)
Query: 872 QLLGPITRARRRTFVNRSRYNVHTYLVLELLKGGELLDRIRQKGRCGFTENEASRIMRQL 931
+ G A RR L++E L G L D ++ K + + + Q+
Sbjct: 75 KYKGVCYSAGRRNL----------KLIMEYLPYGSLRDYLQ-KHKERIDHIKLLQYTSQI 123
Query: 932 VAAVHFMHSRGVVHRDLKPENLLLSGISGNLIKI 965
+ ++ ++ +HRDL N+L+ + N +KI
Sbjct: 124 CKGMEYLGTKRYIHRDLATRNILVE--NENRVKI 155
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} Length = 352 | Back alignment and structure |
|---|
Score = 80.2 bits (198), Expect = 4e-16
Identities = 33/212 (15%), Positives = 68/212 (32%), Gaps = 40/212 (18%)
Query: 389 GSYSVCRRCVEKSTGQEYAVKIISRKIDCSEEINLLRACQGHPNIVNL------------ 436
+ + C Q++++K+ ++ E N + +
Sbjct: 61 AAPTSTLTCDSGPQKQKFSLKLDAKDGRLFNEQNFFQRAAKPLQVNKWKKLYSTPLLAIP 120
Query: 437 ---HCVFQDEVHTYLVLELLKGGELLDRIRQKGRCGFTENEASRIMRQLVAAVHFMHSRG 493
+ + +LVL L G L + + +E ++ +L+ A+ F+H
Sbjct: 121 TCMGFGVHQDKYRFLVLPSL-GRSLQSALDVSPKHVLSERSVLQVACRLLDALEFLHENE 179
Query: 494 VVHRDLKPENLLFSDPAGDNIKVVDFGFACLKRES-LHTP-------CF--TLQYAA--- 540
VH ++ EN+ + + +GFA S H L++ +
Sbjct: 180 YVHGNVTAENIFVDPEDQSQVTLAGYGFAFRYCPSGKHVAYVEGSRSPHEGDLEFISMDL 239
Query: 541 ---PEVLRQDKSGYDENCDLWSLGVILVNVLR 569
R+ DL SLG ++ L
Sbjct: 240 HKGCGPSRRS--------DLQSLGYCMLKWLY 263
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} Length = 352 | Back alignment and structure |
|---|
Score = 62.8 bits (153), Expect = 2e-10
Identities = 17/81 (20%), Positives = 37/81 (45%), Gaps = 6/81 (7%)
Query: 886 VNRSRYNVHTYLVLELLKGGELLDRIRQKGRCGFTENEASRIMRQLVAAVHFMHSRGVVH 945
V++ +Y +LVL L G L + + +E ++ +L+ A+ F+H VH
Sbjct: 127 VHQDKYR---FLVLPSL-GRSLQSALDVSPKHVLSERSVLQVACRLLDALEFLHENEYVH 182
Query: 946 RDLKPENLLLSGISGNLIKIY 966
++ EN+ + + ++
Sbjct: 183 GNVTAENIFVD--PEDQSQVT 201
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268 | Back alignment and structure |
|---|
Score = 78.4 bits (194), Expect = 5e-16
Identities = 43/168 (25%), Positives = 71/168 (42%), Gaps = 18/168 (10%)
Query: 407 AVKIISRKIDCSE------EINLLRACQGHPNIVNLHCVFQDEVHTYLVLELLKGGELLD 460
AVK+I K E + HP +V + V E Y+V E + G LL+
Sbjct: 36 AVKMI--KEGSMSEDEFFQEAQTMMKLS-HPKLVKFYGVCSKEYPIYIVTEYISNGCLLN 92
Query: 461 RIRQKGRCGFTENEASRIMRQLVAAVHFMHSRGVVHRDLKPENLLFSDPAGDNIKVVDFG 520
+R G+ G ++ + + + F+ S +HRDL N L +KV DFG
Sbjct: 93 YLRSHGK-GLEPSQLLEMCYDVCEGMAFLESHQFIHRDLAARNCLVDR--DLCVKVSDFG 149
Query: 521 FACLKRESLHTPC----FTLQYAAPEVLRQDKSGYDENCDLWSLGVIL 564
+ + F ++++APEV K Y D+W+ G+++
Sbjct: 150 MTRYVLDDQYVSSVGTKFPVKWSAPEVFHYFK--YSSKSDVWAFGILM 195
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268 | Back alignment and structure |
|---|
Score = 46.4 bits (111), Expect = 2e-05
Identities = 18/71 (25%), Positives = 33/71 (46%), Gaps = 3/71 (4%)
Query: 895 TYLVLELLKGGELLDRIRQKGRCGFTENEASRIMRQLVAAVHFMHSRGVVHRDLKPENLL 954
Y+V E + G LL+ +R G+ G ++ + + + F+ S +HRDL N L
Sbjct: 78 IYIVTEYISNGCLLNYLRSHGK-GLEPSQLLEMCYDVCEGMAFLESHQFIHRDLAARNCL 136
Query: 955 LSGISGNLIKI 965
+ +K+
Sbjct: 137 VD--RDLCVKV 145
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 79.0 bits (195), Expect = 6e-16
Identities = 53/206 (25%), Positives = 91/206 (44%), Gaps = 29/206 (14%)
Query: 379 DLDKAGILGDGSY-SVCR---RCVEKSTGQEYAVKII-----SRKIDCSEEINLLRACQG 429
L LG G++ SV ++ +TG+ AVK + D EI +L++ Q
Sbjct: 42 HLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQ- 100
Query: 430 HPNIVNLH--CVFQDEVHTYLVLELLKGGELLDRIRQKGRCGFTENEASRIMRQLVAAVH 487
H NIV C + L++E L G L D ++ K + + + Q+ +
Sbjct: 101 HDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQ-KHKERIDHIKLLQYTSQICKGME 159
Query: 488 FMHSRGVVHRDLKPENLLFSDPAGDNIKVVDFGFACL---------KRESLHTPCFTLQY 538
++ ++ +HRDL N+L + + +K+ DFG + +E +P F +
Sbjct: 160 YLGTKRYIHRDLATRNILVENE--NRVKIGDFGLTKVLPQDKEYYKVKEPGESPIF---W 214
Query: 539 AAPEVLRQDKSGYDENCDLWSLGVIL 564
APE L + K + D+WS GV+L
Sbjct: 215 YAPESLTESK--FSVASDVWSFGVVL 238
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 45.8 bits (109), Expect = 4e-05
Identities = 21/94 (22%), Positives = 40/94 (42%), Gaps = 13/94 (13%)
Query: 872 QLLGPITRARRRTFVNRSRYNVHTYLVLELLKGGELLDRIRQKGRCGFTENEASRIMRQL 931
+ G A RR L++E L G L D ++ K + + + Q+
Sbjct: 106 KYKGVCYSAGRRNL----------KLIMEYLPYGSLRDYLQ-KHKERIDHIKLLQYTSQI 154
Query: 932 VAAVHFMHSRGVVHRDLKPENLLLSGISGNLIKI 965
+ ++ ++ +HRDL N+L+ + N +KI
Sbjct: 155 CKGMEYLGTKRYIHRDLATRNILVE--NENRVKI 186
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327 | Back alignment and structure |
|---|
Score = 78.8 bits (195), Expect = 8e-16
Identities = 44/204 (21%), Positives = 81/204 (39%), Gaps = 28/204 (13%)
Query: 379 DLDKAGILGDGSY-SVCR---RCVEKSTGQEYAVKIISRKIDCSE--------EINLLRA 426
+ K +LG G++ +V + + A+K + + S E ++ +
Sbjct: 16 EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKEL--REATSPKANKEILDEAYVMAS 73
Query: 427 CQGHPNIVNLH-CVFQDEVHTYLVLELLKGGELLDRIRQKGRCGFTENEASRIMRQLVAA 485
+P++ L V L+ +L+ G LLD +R+ Q+
Sbjct: 74 VD-NPHVCRLLGICLTSTV--QLITQLMPFGCLLDYVREHKD-NIGSQYLLNWCVQIAKG 129
Query: 486 VHFMHSRGVVHRDLKPENLLFSDPAGDNIKVVDFGFA-CLKRESLHTPC----FTLQYAA 540
++++ R +VHRDL N+L P ++K+ DFG A L E +++ A
Sbjct: 130 MNYLEDRRLVHRDLAARNVLVKTP--QHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMA 187
Query: 541 PEVLRQDKSGYDENCDLWSLGVIL 564
E + Y D+WS GV +
Sbjct: 188 LESILHRI--YTHQSDVWSYGVTV 209
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327 | Back alignment and structure |
|---|
Score = 49.2 bits (118), Expect = 4e-06
Identities = 18/70 (25%), Positives = 33/70 (47%), Gaps = 3/70 (4%)
Query: 896 YLVLELLKGGELLDRIRQKGRCGFTENEASRIMRQLVAAVHFMHSRGVVHRDLKPENLLL 955
L+ +L+ G LLD +R+ Q+ ++++ R +VHRDL N+L+
Sbjct: 92 QLITQLMPFGCLLDYVREHKD-NIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLV 150
Query: 956 SGISGNLIKI 965
+ +KI
Sbjct: 151 K--TPQHVKI 158
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327 | Back alignment and structure |
|---|
Score = 76.6 bits (189), Expect = 4e-15
Identities = 55/208 (26%), Positives = 83/208 (39%), Gaps = 33/208 (15%)
Query: 379 DLDKAGILGDGSY-SVCR---RCVEKSTGQEYAVKIISRKIDCSE-------EINLLRAC 427
L LG G++ SV + +TG AVK + + + EI +L+A
Sbjct: 24 HLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQL--QHSGPDQQRDFQREIQILKAL 81
Query: 428 QGHPNIVNLH--CVFQDEVHTYLVLELLKGGELLDRIRQKGRCGFTENEASRIMRQLVAA 485
IV LV+E L G L D ++ + R + Q+
Sbjct: 82 H-SDFIVKYRGVSYGPGRQSLRLVMEYLPSGCLRDFLQ-RHRARLDASRLLLYSSQICKG 139
Query: 486 VHFMHSRGVVHRDLKPENLLFSDPAGDNIKVVDFGFACL---------KRESLHTPCFTL 536
+ ++ SR VHRDL N+L ++K+ DFG A L RE +P F
Sbjct: 140 MEYLGSRRCVHRDLAARNILVESE--AHVKIADFGLAKLLPLDKDYYVVREPGQSPIF-- 195
Query: 537 QYAAPEVLRQDKSGYDENCDLWSLGVIL 564
+ APE L + + D+WS GV+L
Sbjct: 196 -WYAPESLSDNI--FSRQSDVWSFGVVL 220
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327 | Back alignment and structure |
|---|
Score = 45.0 bits (107), Expect = 7e-05
Identities = 21/70 (30%), Positives = 33/70 (47%), Gaps = 3/70 (4%)
Query: 896 YLVLELLKGGELLDRIRQKGRCGFTENEASRIMRQLVAAVHFMHSRGVVHRDLKPENLLL 955
LV+E L G L D ++ + R + Q+ + ++ SR VHRDL N+L+
Sbjct: 102 RLVMEYLPSGCLRDFLQ-RHRARLDASRLLLYSSQICKGMEYLGSRRCVHRDLAARNILV 160
Query: 956 SGISGNLIKI 965
S +KI
Sbjct: 161 E--SEAHVKI 168
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267 | Back alignment and structure |
|---|
Score = 75.3 bits (186), Expect = 5e-15
Identities = 42/168 (25%), Positives = 71/168 (42%), Gaps = 18/168 (10%)
Query: 407 AVKIISRKIDCSE------EINLLRACQGHPNIVNLHCVFQDEVHTYLVLELLKGGELLD 460
A+K I + E ++ HP +V L+ V ++ LV E ++ G L D
Sbjct: 36 AIKTI--REGAMSEEDFIEEAEVMMKLS-HPKLVQLYGVCLEQAPICLVTEFMEHGCLSD 92
Query: 461 RIRQKGRCGFTENEASRIMRQLVAAVHFMHSRGVVHRDLKPENLLFSDPAGDNIKVVDFG 520
+R + F + + + ++ V+HRDL N L + IKV DFG
Sbjct: 93 YLRTQRG-LFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLVGE--NQVIKVSDFG 149
Query: 521 FACLKRESLHTPC----FTLQYAAPEVLRQDKSGYDENCDLWSLGVIL 564
+ +T F +++A+PEV + Y D+WS GV++
Sbjct: 150 MTRFVLDDQYTSSTGTKFPVKWASPEVFSFSR--YSSKSDVWSFGVLM 195
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267 | Back alignment and structure |
|---|
Score = 44.5 bits (106), Expect = 9e-05
Identities = 17/70 (24%), Positives = 30/70 (42%), Gaps = 3/70 (4%)
Query: 896 YLVLELLKGGELLDRIRQKGRCGFTENEASRIMRQLVAAVHFMHSRGVVHRDLKPENLLL 955
LV E ++ G L D +R + F + + + ++ V+HRDL N L+
Sbjct: 79 CLVTEFMEHGCLSDYLRTQRG-LFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLV 137
Query: 956 SGISGNLIKI 965
+IK+
Sbjct: 138 G--ENQVIKV 145
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289 | Back alignment and structure |
|---|
Score = 75.8 bits (187), Expect = 5e-15
Identities = 39/211 (18%), Positives = 79/211 (37%), Gaps = 39/211 (18%)
Query: 407 AVKII-----SRKIDCSEEINLLRACQGHPNIVNLHCVFQDEVHTYLVLELLKGGELLDR 461
+K++ + E +++ H ++V + V LV E +K G L
Sbjct: 44 LLKVLDKAHRNYSESFFEAASMMSKLS-HKHLVLNYGVCVCGDENILVQEFVKFGSLDTY 102
Query: 462 IRQKGRCGFTENEASRIMRQLVAAVHFMHSRGVVHRDLKPENLL----FSDPAGDN--IK 515
+++ C + +QL AA+HF+ ++H ++ +N+L G+ IK
Sbjct: 103 LKKNKNC-INILWKLEVAKQLAAAMHFLEENTLIHGNVCAKNILLIREEDRKTGNPPFIK 161
Query: 516 VVDFGFA--CLKRESLHTPCFTLQYAAPEVLRQDKSGYDENCDLWSLGVIL--------- 564
+ D G + L ++ L + + PE + K+ + D WS G L
Sbjct: 162 LSDPGISITVLPKDILQER---IPWVPPECIENPKN-LNLATDKWSFGTTLWEICSGGDK 217
Query: 565 -------VNVLRQDKSGY----DENCDLWSL 584
L+ + + + +L +L
Sbjct: 218 PLSALDSQRKLQFYEDRHQLPAPKAAELANL 248
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289 | Back alignment and structure |
|---|
Score = 44.6 bits (106), Expect = 8e-05
Identities = 19/76 (25%), Positives = 34/76 (44%), Gaps = 7/76 (9%)
Query: 896 YLVLELLKGGELLDRIRQKGRCGFTENEASRIMRQLVAAVHFMHSRGVVHRDLKPENLLL 955
LV E +K G L +++ C + +QL AA+HF+ ++H ++ +N+LL
Sbjct: 88 ILVQEFVKFGSLDTYLKKNKNC-INILWKLEVAKQLAAAMHFLEENTLIHGNVCAKNILL 146
Query: 956 SGIS------GNLIKI 965
IK+
Sbjct: 147 IREEDRKTGNPPFIKL 162
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298 | Back alignment and structure |
|---|
Score = 75.4 bits (186), Expect = 8e-15
Identities = 49/196 (25%), Positives = 82/196 (41%), Gaps = 21/196 (10%)
Query: 385 ILGDGSY-SVCRRCVEKSTGQEY--AVKIISRKIDCSEEINLLRACQ-----GHPNIVNL 436
++G G + V + + G++ AVK ++R D E L HPN+++L
Sbjct: 32 VIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSL 91
Query: 437 H-CVFQDEVHTYLVLELLKGGELLDRIRQKGRCGFTENEASRIMRQLVAAVHFMHSRGVV 495
+ E +VL +K G+L + IR + T + Q+ + ++ S+ V
Sbjct: 92 LGICLRSEGSPLVVLPYMKHGDLRNFIRNETH-NPTVKDLIGFGLQVAKGMKYLASKKFV 150
Query: 496 HRDLKPENLLFSDPAGDNIKVVDFGFACLKRESLHTPCFTLQYA-------APEVLRQDK 548
HRDL N + + +KV DFG A + + A A E L+ K
Sbjct: 151 HRDLAARNCMLDE--KFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALESLQTQK 208
Query: 549 SGYDENCDLWSLGVIL 564
+ D+WS GV+L
Sbjct: 209 --FTTKSDVWSFGVLL 222
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298 | Back alignment and structure |
|---|
Score = 44.6 bits (106), Expect = 9e-05
Identities = 18/70 (25%), Positives = 32/70 (45%), Gaps = 3/70 (4%)
Query: 896 YLVLELLKGGELLDRIRQKGRCGFTENEASRIMRQLVAAVHFMHSRGVVHRDLKPENLLL 955
+VL +K G+L + IR + T + Q+ + ++ S+ VHRDL N +L
Sbjct: 103 LVVLPYMKHGDLRNFIRNETH-NPTVKDLIGFGLQVAKGMKYLASKKFVHRDLAARNCML 161
Query: 956 SGISGNLIKI 965
+K+
Sbjct: 162 D--EKFTVKV 169
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302 | Back alignment and structure |
|---|
Score = 75.0 bits (185), Expect = 9e-15
Identities = 54/209 (25%), Positives = 83/209 (39%), Gaps = 34/209 (16%)
Query: 379 DLDKAGILGDGSY-SVCR---RCVEKSTGQEYAVKIISRKIDCSE--------EINLLRA 426
L + LG+G + V +TG++ AVK + K + EI +LR
Sbjct: 22 FLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSL--KPESGGNHIADLKKEIEILRN 79
Query: 427 CQGHPNIVNLH--CVFQDEVHTYLVLELLKGGELLDRIRQKGRCGFTENEASRIMRQLVA 484
H NIV C L++E L G L + + K + + + Q+
Sbjct: 80 LY-HENIVKYKGICTEDGGNGIKLIMEFLPSGSLKEYLP-KNKNKINLKQQLKYAVQICK 137
Query: 485 AVHFMHSRGVVHRDLKPENLLFSDPAGDNIKVVDFGFACL---------KRESLHTPCFT 535
+ ++ SR VHRDL N+L +K+ DFG ++ +P F
Sbjct: 138 GMDYLGSRQYVHRDLAARNVLVESE--HQVKIGDFGLTKAIETDKEYYTVKDDRDSPVF- 194
Query: 536 LQYAAPEVLRQDKSGYDENCDLWSLGVIL 564
+ APE L Q K + D+WS GV L
Sbjct: 195 --WYAPECLMQSK--FYIASDVWSFGVTL 219
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302 | Back alignment and structure |
|---|
Score = 45.8 bits (109), Expect = 4e-05
Identities = 21/94 (22%), Positives = 37/94 (39%), Gaps = 13/94 (13%)
Query: 872 QLLGPITRARRRTFVNRSRYNVHTYLVLELLKGGELLDRIRQKGRCGFTENEASRIMRQL 931
+ G T L++E L G L + + K + + + Q+
Sbjct: 87 KYKGICTEDGGNGI----------KLIMEFLPSGSLKEYLP-KNKNKINLKQQLKYAVQI 135
Query: 932 VAAVHFMHSRGVVHRDLKPENLLLSGISGNLIKI 965
+ ++ SR VHRDL N+L+ S + +KI
Sbjct: 136 CKGMDYLGSRQYVHRDLAARNVLVE--SEHQVKI 167
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318 | Back alignment and structure |
|---|
Score = 75.1 bits (185), Expect = 1e-14
Identities = 55/209 (26%), Positives = 85/209 (40%), Gaps = 36/209 (17%)
Query: 379 DLDKAGILGDGSY-SVCR---RCVEKSTGQEYAVKIISRKIDCSE--------EINLLRA 426
L K LG+G + V TG+ AVK + K D EI++LR
Sbjct: 32 YLKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKAL--KADAGPQHRSGWKQEIDILRT 89
Query: 427 CQGHPNIVNLH--CVFQDEVHTYLVLELLKGGELLDRIRQKGRCGFTENEASRIMRQLVA 484
H +I+ C LV+E + G L D + R + +Q+
Sbjct: 90 LY-HEHIIKYKGCCEDAGAASLQLVMEYVPLGSLRDYLP---RHSIGLAQLLLFAQQICE 145
Query: 485 AVHFMHSRGVVHRDLKPENLLFSDPAGDNIKVVDFGFACL---------KRESLHTPCFT 535
+ ++H++ +HRDL N+L + +K+ DFG A RE +P F
Sbjct: 146 GMAYLHAQHYIHRDLAARNVLLDN--DRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVF- 202
Query: 536 LQYAAPEVLRQDKSGYDENCDLWSLGVIL 564
+ APE L++ K + D+WS GV L
Sbjct: 203 --WYAPECLKEYK--FYYASDVWSFGVTL 227
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318 | Back alignment and structure |
|---|
Score = 45.0 bits (107), Expect = 6e-05
Identities = 19/70 (27%), Positives = 34/70 (48%), Gaps = 5/70 (7%)
Query: 896 YLVLELLKGGELLDRIRQKGRCGFTENEASRIMRQLVAAVHFMHSRGVVHRDLKPENLLL 955
LV+E + G L D + R + +Q+ + ++H++ +HRDL N+LL
Sbjct: 111 QLVMEYVPLGSLRDYLP---RHSIGLAQLLLFAQQICEGMAYLHAQHYIHRDLAARNVLL 167
Query: 956 SGISGNLIKI 965
+ L+KI
Sbjct: 168 D--NDRLVKI 175
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373 | Back alignment and structure |
|---|
Score = 75.9 bits (187), Expect = 1e-14
Identities = 45/195 (23%), Positives = 86/195 (44%), Gaps = 21/195 (10%)
Query: 385 ILGDGSY-SVCRRCVEKSTGQEYAVKIISRKIDCSE--------EINLLRACQGHPNIVN 435
++G G + VC ++ + +E +V I + K+ +E E +++ HPNI+
Sbjct: 52 VVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFD-HPNIIR 110
Query: 436 LHCVFQDEVHTYLVLELLKGGELLDRIRQKGRCGFTENEASRIMRQLVAAVHFMHSRGVV 495
L V +V E ++ G L +R+ FT + ++R + + + ++ G V
Sbjct: 111 LEGVVTKSKPVMIVTEYMENGSLDSFLRKHDA-QFTVIQLVGMLRGIASGMKYLSDMGYV 169
Query: 496 HRDLKPENLLFSDPAGDNIKVVDFGFACLKRESLHTPC------FTLQYAAPEVLRQDKS 549
HRDL N+L + KV DFG + + +++ +PE + K
Sbjct: 170 HRDLAARNILINSN--LVCKVSDFGLGRVLEDDPEAAYTTRGGKIPIRWTSPEAIAYRK- 226
Query: 550 GYDENCDLWSLGVIL 564
+ D+WS G++L
Sbjct: 227 -FTSASDVWSYGIVL 240
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373 | Back alignment and structure |
|---|
Score = 44.3 bits (105), Expect = 1e-04
Identities = 18/70 (25%), Positives = 36/70 (51%), Gaps = 3/70 (4%)
Query: 896 YLVLELLKGGELLDRIRQKGRCGFTENEASRIMRQLVAAVHFMHSRGVVHRDLKPENLLL 955
+V E ++ G L +R+ FT + ++R + + + ++ G VHRDL N+L+
Sbjct: 122 MIVTEYMENGSLDSFLRKHDA-QFTVIQLVGMLRGIASGMKYLSDMGYVHRDLAARNILI 180
Query: 956 SGISGNLIKI 965
+ S + K+
Sbjct: 181 N--SNLVCKV 188
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 74.6 bits (184), Expect = 1e-14
Identities = 46/196 (23%), Positives = 79/196 (40%), Gaps = 21/196 (10%)
Query: 385 ILGDGSYSVCRRCVEKSTGQEY---AVKIISRKIDCSEEINLLRACQ-----GHPNIVNL 436
++G G + V Q A+K +SR + + LR HPN++ L
Sbjct: 28 VIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHPNVLAL 87
Query: 437 H-CVFQDEVHTYLVLELLKGGELLDRIRQKGRCGFTENEASRIMRQLVAAVHFMHSRGVV 495
+ E +++L + G+LL IR R T + Q+ + ++ + V
Sbjct: 88 IGIMLPPEGLPHVLLPYMCHGDLLQFIRSPQR-NPTVKDLISFGLQVARGMEYLAEQKFV 146
Query: 496 HRDLKPENLLFSDPAGDNIKVVDFGFACLKRESLHTPCFTLQYA-------APEVLRQDK 548
HRDL N + + +KV DFG A + + ++A A E L+ +
Sbjct: 147 HRDLAARNCMLDE--SFTVKVADFGLARDILDREYYSVQQHRHARLPVKWTALESLQTYR 204
Query: 549 SGYDENCDLWSLGVIL 564
+ D+WS GV+L
Sbjct: 205 --FTTKSDVWSFGVLL 218
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 43.8 bits (104), Expect = 1e-04
Identities = 17/70 (24%), Positives = 31/70 (44%), Gaps = 3/70 (4%)
Query: 896 YLVLELLKGGELLDRIRQKGRCGFTENEASRIMRQLVAAVHFMHSRGVVHRDLKPENLLL 955
+++L + G+LL IR R T + Q+ + ++ + VHRDL N +L
Sbjct: 99 HVLLPYMCHGDLLQFIRSPQR-NPTVKDLISFGLQVARGMEYLAEQKFVHRDLAARNCML 157
Query: 956 SGISGNLIKI 965
+K+
Sbjct: 158 D--ESFTVKV 165
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373 | Back alignment and structure |
|---|
Score = 75.6 bits (186), Expect = 2e-14
Identities = 50/196 (25%), Positives = 81/196 (41%), Gaps = 21/196 (10%)
Query: 385 ILGDGSY-SVCRRCVEKSTGQEY--AVKIISRKIDCSEEINLLRACQ-----GHPNIVNL 436
++G G + V + + G++ AVK ++R D E L HPN+++L
Sbjct: 96 VIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSL 155
Query: 437 H-CVFQDEVHTYLVLELLKGGELLDRIRQKGRCGFTENEASRIMRQLVAAVHFMHSRGVV 495
+ E +VL +K G+L + IR + T + Q+ + F+ S+ V
Sbjct: 156 LGICLRSEGSPLVVLPYMKHGDLRNFIRNETH-NPTVKDLIGFGLQVAKGMKFLASKKFV 214
Query: 496 HRDLKPENLLFSDPAGDNIKVVDFGFACLKRESLHTPCFTLQYA-------APEVLRQDK 548
HRDL N + + +KV DFG A + A A E L+ K
Sbjct: 215 HRDLAARNCMLDE--KFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESLQTQK 272
Query: 549 SGYDENCDLWSLGVIL 564
+ D+WS GV+L
Sbjct: 273 --FTTKSDVWSFGVLL 286
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373 | Back alignment and structure |
|---|
Score = 44.0 bits (104), Expect = 2e-04
Identities = 19/70 (27%), Positives = 32/70 (45%), Gaps = 3/70 (4%)
Query: 896 YLVLELLKGGELLDRIRQKGRCGFTENEASRIMRQLVAAVHFMHSRGVVHRDLKPENLLL 955
+VL +K G+L + IR + T + Q+ + F+ S+ VHRDL N +L
Sbjct: 167 LVVLPYMKHGDLRNFIRNETH-NPTVKDLIGFGLQVAKGMKFLASKKFVHRDLAARNCML 225
Query: 956 SGISGNLIKI 965
+K+
Sbjct: 226 D--EKFTVKV 233
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325 | Back alignment and structure |
|---|
Score = 74.6 bits (184), Expect = 2e-14
Identities = 46/197 (23%), Positives = 80/197 (40%), Gaps = 25/197 (12%)
Query: 385 ILGDGSY-SVCRRCVEKSTGQEY--AVKIISRKIDCSE--------EINLLRACQGHPNI 433
I+G G VC + ++ A+K + K +E E +++ HPNI
Sbjct: 56 IIGSGDSGEVCYGRLRVPGQRDVPVAIKAL--KAGYTERQRRDFLSEASIMGQFD-HPNI 112
Query: 434 VNLHCVFQDEVHTYLVLELLKGGELLDRIRQKGRCGFTENEASRIMRQLVAAVHFMHSRG 493
+ L V +V E ++ G L +R FT + ++R + A + ++ G
Sbjct: 113 IRLEGVVTRGRLAMIVTEYMENGSLDTFLRTHDG-QFTIMQLVGMLRGVGAGMRYLSDLG 171
Query: 494 VVHRDLKPENLLFSDPAGDNIKVVDFGFACLKRESLHTPC------FTLQYAAPEVLRQD 547
VHRDL N+L KV DFG + + + +++ APE +
Sbjct: 172 YVHRDLAARNVLVDSN--LVCKVSDFGLSRVLEDDPDAAYTTTGGKIPIRWTAPEAIAFR 229
Query: 548 KSGYDENCDLWSLGVIL 564
+ D+WS GV++
Sbjct: 230 T--FSSASDVWSFGVVM 244
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325 | Back alignment and structure |
|---|
Score = 45.4 bits (108), Expect = 6e-05
Identities = 19/70 (27%), Positives = 34/70 (48%), Gaps = 3/70 (4%)
Query: 896 YLVLELLKGGELLDRIRQKGRCGFTENEASRIMRQLVAAVHFMHSRGVVHRDLKPENLLL 955
+V E ++ G L +R FT + ++R + A + ++ G VHRDL N+L+
Sbjct: 126 MIVTEYMENGSLDTFLRTHDG-QFTIMQLVGMLRGVGAGMRYLSDLGYVHRDLAARNVLV 184
Query: 956 SGISGNLIKI 965
S + K+
Sbjct: 185 D--SNLVCKV 192
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283 | Back alignment and structure |
|---|
Score = 73.8 bits (182), Expect = 2e-14
Identities = 40/168 (23%), Positives = 77/168 (45%), Gaps = 18/168 (10%)
Query: 407 AVKIISRKIDCSE------EINLLRACQGHPNIVNLHCVFQDEVHTYLVLELLKGGELLD 460
A+K+I K E ++ H +V L+ V + +++ E + G LL+
Sbjct: 52 AIKMI--KEGSMSEDEFIEEAKVMMNLS-HEKLVQLYGVCTKQRPIFIITEYMANGCLLN 108
Query: 461 RIRQKGRCGFTENEASRIMRQLVAAVHFMHSRGVVHRDLKPENLLFSDPAGDNIKVVDFG 520
+R+ F + + + + A+ ++ S+ +HRDL N L +D +KV DFG
Sbjct: 109 YLREMRHR-FQTQQLLEMCKDVCEAMEYLESKQFLHRDLAARNCLVND--QGVVKVSDFG 165
Query: 521 FACLKRESLHTPC----FTLQYAAPEVLRQDKSGYDENCDLWSLGVIL 564
+ + +T F ++++ PEVL K + D+W+ GV++
Sbjct: 166 LSRYVLDDEYTSSVGSKFPVRWSPPEVLMYSK--FSSKSDIWAFGVLM 211
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283 | Back alignment and structure |
|---|
Score = 43.4 bits (103), Expect = 2e-04
Identities = 15/70 (21%), Positives = 36/70 (51%), Gaps = 3/70 (4%)
Query: 896 YLVLELLKGGELLDRIRQKGRCGFTENEASRIMRQLVAAVHFMHSRGVVHRDLKPENLLL 955
+++ E + G LL+ +R+ F + + + + A+ ++ S+ +HRDL N L+
Sbjct: 95 FIITEYMANGCLLNYLREMRHR-FQTQQLLEMCKDVCEAMEYLESKQFLHRDLAARNCLV 153
Query: 956 SGISGNLIKI 965
+ ++K+
Sbjct: 154 N--DQGVVKV 161
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} Length = 345 | Back alignment and structure |
|---|
Score = 74.4 bits (183), Expect = 3e-14
Identities = 34/224 (15%), Positives = 76/224 (33%), Gaps = 53/224 (23%)
Query: 386 LGDGSYSVCRRCVEKSTGQEYAVKIISRKIDCSE------EINLLRACQGHPNIVNLH-- 437
+G G + + + ++ A ++ K++ E E+ + I
Sbjct: 45 IGSGGFGLIYLAFPTNKPEKDARHVV--KVEYQENGPLFSELKFYQRVAKKDCIKKWIER 102
Query: 438 ----------------CVFQDEVHTYLVLELLKGGELLDRIRQKGRCGFTENEASRIMRQ 481
F+ + ++V+E L G +L Q G F ++ ++ +
Sbjct: 103 KQLDYLGIPLFYGSGLTEFKGRSYRFMVMERL-GIDLQKISGQNGT--FKKSTVLQLGIR 159
Query: 482 LVAAVHFMHSRGVVHRDLKPENLLFSDPAGDNIKVVDFGFA---CLKRESLHTP-----C 533
++ + ++H VH D+K NLL D + + D+G + C
Sbjct: 160 MLDVLEYIHENEYVHGDIKAANLLLGYKNPDQVYLADYGLSYRYCPNGNHKQYQENPRKG 219
Query: 534 F--TLQYAA------PEVLRQDKSGYDENCDLWSLGVILVNVLR 569
T+++ + + R+ D+ LG ++ L
Sbjct: 220 HNGTIEFTSLDAHKGVALSRRS--------DVEILGYCMLRWLC 255
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} Length = 345 | Back alignment and structure |
|---|
Score = 57.8 bits (140), Expect = 7e-09
Identities = 17/70 (24%), Positives = 36/70 (51%), Gaps = 3/70 (4%)
Query: 894 HTYLVLELLKGGELLDRIRQKGRCGFTENEASRIMRQLVAAVHFMHSRGVVHRDLKPENL 953
+ ++V+E L G +L Q G F ++ ++ +++ + ++H VH D+K NL
Sbjct: 126 YRFMVMERL-GIDLQKISGQNGT--FKKSTVLQLGIRMLDVLEYIHENEYVHGDIKAANL 182
Query: 954 LLSGISGNLI 963
LL + + +
Sbjct: 183 LLGYKNPDQV 192
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327 | Back alignment and structure |
|---|
Score = 73.9 bits (182), Expect = 3e-14
Identities = 44/204 (21%), Positives = 81/204 (39%), Gaps = 28/204 (13%)
Query: 379 DLDKAGILGDGSY-SVCR---RCVEKSTGQEYAVKIISRKIDCSE--------EINLLRA 426
+ K +LG G++ +V + + A+K + + S E ++ +
Sbjct: 16 EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKEL--REATSPKANKEILDEAYVMAS 73
Query: 427 CQGHPNIVNLH-CVFQDEVHTYLVLELLKGGELLDRIRQKGRCGFTENEASRIMRQLVAA 485
+P++ L V L+ +L+ G LLD +R+ Q+
Sbjct: 74 VD-NPHVCRLLGICLTSTV--QLITQLMPFGCLLDYVREHKD-NIGSQYLLNWCVQIAKG 129
Query: 486 VHFMHSRGVVHRDLKPENLLFSDPAGDNIKVVDFGFA-CLKRESLHTPC----FTLQYAA 540
++++ R +VHRDL N+L P ++K+ DFG A L E +++ A
Sbjct: 130 MNYLEDRRLVHRDLAARNVLVKTP--QHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMA 187
Query: 541 PEVLRQDKSGYDENCDLWSLGVIL 564
E + Y D+WS GV +
Sbjct: 188 LESILHRI--YTHQSDVWSYGVTV 209
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327 | Back alignment and structure |
|---|
Score = 46.6 bits (111), Expect = 2e-05
Identities = 18/70 (25%), Positives = 33/70 (47%), Gaps = 3/70 (4%)
Query: 896 YLVLELLKGGELLDRIRQKGRCGFTENEASRIMRQLVAAVHFMHSRGVVHRDLKPENLLL 955
L+ +L+ G LLD +R+ Q+ ++++ R +VHRDL N+L+
Sbjct: 92 QLITQLMPFGCLLDYVREHKD-NIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLV 150
Query: 956 SGISGNLIKI 965
+ +KI
Sbjct: 151 K--TPQHVKI 158
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281 | Back alignment and structure |
|---|
Score = 72.7 bits (179), Expect = 5e-14
Identities = 44/195 (22%), Positives = 79/195 (40%), Gaps = 24/195 (12%)
Query: 385 ILGDGSY-SVCRRCVEKSTGQEY--AVKIISRKIDCSE--------EINLLRACQGHPNI 433
+G+G + V + A+K K S+ E +R HP+I
Sbjct: 22 CIGEGQFGDVHQGIYMSPENPALAVAIKTC--KNCTSDSVREKFLQEALTMRQFD-HPHI 78
Query: 434 VNLHCVFQDEVHTYLVLELLKGGELLDRIRQKGRCGFTENEASRIMRQLVAAVHFMHSRG 493
V L V + ++++EL GEL ++ + QL A+ ++ S+
Sbjct: 79 VKLIGVITEN-PVWIIMELCTLGELRSFLQVRKY-SLDLASLILYAYQLSTALAYLESKR 136
Query: 494 VVHRDLKPENLLFSDPAGDNIKVVDFGFACLKRESLHTPC----FTLQYAAPEVLRQDKS 549
VHRD+ N+L S D +K+ DFG + +S + +++ APE + +
Sbjct: 137 FVHRDIAARNVLVSSN--DCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESINFRR- 193
Query: 550 GYDENCDLWSLGVIL 564
+ D+W GV +
Sbjct: 194 -FTSASDVWMFGVCM 207
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281 | Back alignment and structure |
|---|
Score = 44.5 bits (106), Expect = 9e-05
Identities = 18/71 (25%), Positives = 35/71 (49%), Gaps = 3/71 (4%)
Query: 895 TYLVLELLKGGELLDRIRQKGRCGFTENEASRIMRQLVAAVHFMHSRGVVHRDLKPENLL 954
++++EL GEL ++ + QL A+ ++ S+ VHRD+ N+L
Sbjct: 90 VWIIMELCTLGELRSFLQVRKY-SLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVL 148
Query: 955 LSGISGNLIKI 965
+S S + +K+
Sbjct: 149 VS--SNDCVKL 157
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333 | Back alignment and structure |
|---|
Score = 73.5 bits (181), Expect = 5e-14
Identities = 43/198 (21%), Positives = 87/198 (43%), Gaps = 26/198 (13%)
Query: 385 ILGDGSY-SVCRRCVEKSTGQEY---AVKIISRKIDCSE--------EINLLRACQGHPN 432
++G G + V + ++ S+G++ A+K + K +E E ++ H N
Sbjct: 51 VIGAGEFGEVYKGMLKTSSGKKEVPVAIKTL--KAGYTEKQRVDFLGEAGIMGQFS-HHN 107
Query: 433 IVNLHCVFQDEVHTYLVLELLKGGELLDRIRQKGRCGFTENEASRIMRQLVAAVHFMHSR 492
I+ L V ++ E ++ G L +R+K F+ + ++R + A + ++ +
Sbjct: 108 IIRLEGVISKYKPMMIITEYMENGALDKFLREKDG-EFSVLQLVGMLRGIAAGMKYLANM 166
Query: 493 GVVHRDLKPENLLFSDPAGDNIKVVDFGFACLKRESLHTPC------FTLQYAAPEVLRQ 546
VHRDL N+L + KV DFG + + + +++ APE +
Sbjct: 167 NYVHRDLAARNILVNSN--LVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWTAPEAISY 224
Query: 547 DKSGYDENCDLWSLGVIL 564
K + D+WS G+++
Sbjct: 225 RK--FTSASDVWSFGIVM 240
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333 | Back alignment and structure |
|---|
Score = 43.5 bits (103), Expect = 2e-04
Identities = 17/71 (23%), Positives = 37/71 (52%), Gaps = 3/71 (4%)
Query: 895 TYLVLELLKGGELLDRIRQKGRCGFTENEASRIMRQLVAAVHFMHSRGVVHRDLKPENLL 954
++ E ++ G L +R+K F+ + ++R + A + ++ + VHRDL N+L
Sbjct: 121 MMIITEYMENGALDKFLREKDG-EFSVLQLVGMLRGIAAGMKYLANMNYVHRDLAARNIL 179
Query: 955 LSGISGNLIKI 965
++ S + K+
Sbjct: 180 VN--SNLVCKV 188
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325 | Back alignment and structure |
|---|
Score = 72.7 bits (179), Expect = 7e-14
Identities = 46/203 (22%), Positives = 80/203 (39%), Gaps = 26/203 (12%)
Query: 379 DLDKAGILGDGSY-SVCR---RCVEKSTGQEYAVKIISRKIDCS--------EEINLLRA 426
+L K +LG G + +V + +S +K+I + + + + +
Sbjct: 14 ELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVI--EDKSGRQSFQAVTDHMLAIGS 71
Query: 427 CQGHPNIVNLHCVFQDEVHTYLVLELLKGGELLDRIRQKGRCGFTENEASRIMRQLVAAV 486
H +IV L + LV + L G LLD +RQ Q+ +
Sbjct: 72 LD-HAHIVRLLGLCPGS-SLQLVTQYLPLGSLLDHVRQHRG-ALGPQLLLNWGVQIAKGM 128
Query: 487 HFMHSRGVVHRDLKPENLLFSDPAGDNIKVVDFGFA-CLKRESLHTPC----FTLQYAAP 541
+++ G+VHR+L N+L P ++V DFG A L + +++ A
Sbjct: 129 YYLEEHGMVHRNLAARNVLLKSP--SQVQVADFGVADLLPPDDKQLLYSEAKTPIKWMAL 186
Query: 542 EVLRQDKSGYDENCDLWSLGVIL 564
E + K Y D+WS GV +
Sbjct: 187 ESIHFGK--YTHQSDVWSYGVTV 207
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325 | Back alignment and structure |
|---|
Score = 46.2 bits (110), Expect = 3e-05
Identities = 19/70 (27%), Positives = 33/70 (47%), Gaps = 3/70 (4%)
Query: 896 YLVLELLKGGELLDRIRQKGRCGFTENEASRIMRQLVAAVHFMHSRGVVHRDLKPENLLL 955
LV + L G LLD +RQ Q+ ++++ G+VHR+L N+LL
Sbjct: 90 QLVTQYLPLGSLLDHVRQHRG-ALGPQLLLNWGVQIAKGMYYLEEHGMVHRNLAARNVLL 148
Query: 956 SGISGNLIKI 965
S + +++
Sbjct: 149 K--SPSQVQV 156
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A Length = 364 | Back alignment and structure |
|---|
Score = 73.3 bits (180), Expect = 7e-14
Identities = 33/224 (14%), Positives = 69/224 (30%), Gaps = 50/224 (22%)
Query: 386 LGDGS----YSVCRRCVEK-STGQEYAVKIISRKID-CSEEINLLRACQGHPNIVNLH-- 437
+G G Y E + VK+ E+ + I
Sbjct: 43 IGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIRT 102
Query: 438 ----------------CVFQDEVHTYLVLELLKGGELLDRIRQKGRCGFTENEASRIMRQ 481
+ + +++++ G +L + F+ ++ +
Sbjct: 103 RKLKYLGVPKYWGSGLHDKNGKSYRFMIMDRF-GSDLQKIYEANAKR-FSRKTVLQLSLR 160
Query: 482 LVAAVHFMHSRGVVHRDLKPENLLFSDPAGDNIKVVDFGFA---CLKRESLHTP-----C 533
++ + ++H VH D+K NLL + D + +VD+G A C + C
Sbjct: 161 ILDILEYIHEHEYVHGDIKASNLLLNYKNPDQVYLVDYGLAYRYCPEGVHKAYAADPKRC 220
Query: 534 F--TLQYAA------PEVLRQDKSGYDENCDLWSLGVILVNVLR 569
T+++ + R+ DL LG ++ L
Sbjct: 221 HDGTIEFTSIDAHNGVAPSRRG--------DLEILGYCMIQWLT 256
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A Length = 364 | Back alignment and structure |
|---|
Score = 57.1 bits (138), Expect = 1e-08
Identities = 14/77 (18%), Positives = 34/77 (44%), Gaps = 5/77 (6%)
Query: 887 NRSRYNVHTYLVLELLKGGELLDRIRQKGRCGFTENEASRIMRQLVAAVHFMHSRGVVHR 946
N Y ++++ G +L + F+ ++ +++ + ++H VH
Sbjct: 122 NGKSYRF---MIMDRF-GSDLQKIYEANAKR-FSRKTVLQLSLRILDILEYIHEHEYVHG 176
Query: 947 DLKPENLLLSGISGNLI 963
D+K NLLL+ + + +
Sbjct: 177 DIKASNLLLNYKNPDQV 193
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287 | Back alignment and structure |
|---|
Score = 71.5 bits (176), Expect = 1e-13
Identities = 48/195 (24%), Positives = 83/195 (42%), Gaps = 25/195 (12%)
Query: 386 LGDGSY-SVCRRCVEKSTGQEY-AVKIISRKIDCSE--------EINLLRACQGHPNIVN 435
LG G++ SV + Q A+K++ K + E ++ +P IV
Sbjct: 18 LGCGNFGSVRQGVYRMRKKQIDVAIKVL--KQGTEKADTEEMMREAQIMHQLD-NPYIVR 74
Query: 436 LHCVFQDEVHTYLVLELLKGGELLDRIRQKGRCGFTENEASRIMRQLVAAVHFMHSRGVV 495
L V Q E LV+E+ GG L + K + + ++ Q+ + ++ + V
Sbjct: 75 LIGVCQAEAL-MLVMEMAGGGPLHKFLVGKRE-EIPVSNVAELLHQVSMGMKYLEEKNFV 132
Query: 496 HRDLKPENLLFSDPAGDNIKVVDFGFA--CLKRESLHTPC----FTLQYAAPEVLRQDKS 549
HRDL N+L + K+ DFG + +S +T + L++ APE + K
Sbjct: 133 HRDLAARNVLLVNR--HYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINFRK- 189
Query: 550 GYDENCDLWSLGVIL 564
+ D+WS GV +
Sbjct: 190 -FSSRSDVWSYGVTM 203
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287 | Back alignment and structure |
|---|
Score = 48.0 bits (115), Expect = 6e-06
Identities = 18/70 (25%), Positives = 33/70 (47%), Gaps = 3/70 (4%)
Query: 896 YLVLELLKGGELLDRIRQKGRCGFTENEASRIMRQLVAAVHFMHSRGVVHRDLKPENLLL 955
LV+E+ GG L + K + + ++ Q+ + ++ + VHRDL N+LL
Sbjct: 85 MLVMEMAGGGPLHKFLVGKRE-EIPVSNVAELLHQVSMGMKYLEEKNFVHRDLAARNVLL 143
Query: 956 SGISGNLIKI 965
+ + KI
Sbjct: 144 V--NRHYAKI 151
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291 | Back alignment and structure |
|---|
Score = 71.5 bits (176), Expect = 1e-13
Identities = 44/195 (22%), Positives = 85/195 (43%), Gaps = 23/195 (11%)
Query: 385 ILGDGSY-SVCR-RCVEKSTGQEYAVKII-------SRKIDCSEEINLLRACQGHPNIVN 435
LG G++ +V + K + AVKI+ + K + E N+++ +P IV
Sbjct: 24 ELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLD-NPYIVR 82
Query: 436 LHCVFQDEVHTYLVLELLKGGELLDRIRQKGRCGFTENEASRIMRQLVAAVHFMHSRGVV 495
+ + + E LV+E+ + G L ++Q + ++ Q+ + ++ V
Sbjct: 83 MIGICEAESW-MLVMEMAELGPLNKYLQQNRH--VKDKNIIELVHQVSMGMKYLEESNFV 139
Query: 496 HRDLKPENLLFSDPAGDNIKVVDFGFA--CLKRESLHTPC----FTLQYAAPEVLRQDKS 549
HRDL N+L K+ DFG + E+ + + +++ APE + K
Sbjct: 140 HRDLAARNVLLVTQ--HYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYYK- 196
Query: 550 GYDENCDLWSLGVIL 564
+ D+WS GV++
Sbjct: 197 -FSSKSDVWSFGVLM 210
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291 | Back alignment and structure |
|---|
Score = 47.6 bits (114), Expect = 8e-06
Identities = 17/70 (24%), Positives = 32/70 (45%), Gaps = 4/70 (5%)
Query: 896 YLVLELLKGGELLDRIRQKGRCGFTENEASRIMRQLVAAVHFMHSRGVVHRDLKPENLLL 955
LV+E+ + G L ++Q + ++ Q+ + ++ VHRDL N+LL
Sbjct: 93 MLVMEMAELGPLNKYLQQNRH--VKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLL 150
Query: 956 SGISGNLIKI 965
+ + KI
Sbjct: 151 V--TQHYAKI 158
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291 | Back alignment and structure |
|---|
Score = 71.5 bits (176), Expect = 1e-13
Identities = 57/203 (28%), Positives = 84/203 (41%), Gaps = 24/203 (11%)
Query: 379 DLDKAGILGDGSY-SVCRRCVEKSTGQEY--AVKII--------SRKIDCSEEINLLRAC 427
DL LGDGS+ V R + +G+ AVK + D E+N + +
Sbjct: 19 DLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSL 78
Query: 428 QGHPNIVNLHCVFQDEVHTYLVLELLKGGELLDRIRQKGRCGFTENEASRIMRQLVAAVH 487
H N++ L+ V +V EL G LLDR+R+ F SR Q+ +
Sbjct: 79 D-HRNLIRLYGVVLTP-PMKMVTELAPLGSLLDRLRKHQG-HFLLGTLSRYAVQVAEGMG 135
Query: 488 FMHSRGVVHRDLKPENLLFSDPAGDNIKVVDFGFA-CLKRESLHTPC-----FTLQYAAP 541
++ S+ +HRDL NLL + D +K+ DFG L + H + AP
Sbjct: 136 YLESKRFIHRDLAARNLLLATR--DLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAP 193
Query: 542 EVLRQDKSGYDENCDLWSLGVIL 564
E L+ + D W GV L
Sbjct: 194 ESLKTRT--FSHASDTWMFGVTL 214
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291 | Back alignment and structure |
|---|
Score = 49.2 bits (118), Expect = 3e-06
Identities = 25/70 (35%), Positives = 38/70 (54%), Gaps = 3/70 (4%)
Query: 896 YLVLELLKGGELLDRIRQKGRCGFTENEASRIMRQLVAAVHFMHSRGVVHRDLKPENLLL 955
+V EL G LLDR+R+ F SR Q+ + ++ S+ +HRDL NLLL
Sbjct: 96 KMVTELAPLGSLLDRLRKHQG-HFLLGTLSRYAVQVAEGMGYLESKRFIHRDLAARNLLL 154
Query: 956 SGISGNLIKI 965
+ + +L+KI
Sbjct: 155 A--TRDLVKI 162
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656 | Back alignment and structure |
|---|
Score = 72.6 bits (178), Expect = 3e-13
Identities = 45/193 (23%), Positives = 80/193 (41%), Gaps = 20/193 (10%)
Query: 385 ILGDGSY-SVCRRCVEKSTGQEYAVKIISRKIDCSE--------EINLLRACQGHPNIVN 435
+G+G + V + AV I + K S+ E +R HP+IV
Sbjct: 397 CIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFD-HPHIVK 455
Query: 436 LHCVFQDEVHTYLVLELLKGGELLDRIRQKGRCGFTENEASRIMRQLVAAVHFMHSRGVV 495
L V + ++++EL GEL ++ + QL A+ ++ S+ V
Sbjct: 456 LIGVITEN-PVWIIMELCTLGELRSFLQVRKF-SLDLASLILYAYQLSTALAYLESKRFV 513
Query: 496 HRDLKPENLLFSDPAGDNIKVVDFGFACLKRESLHTPC----FTLQYAAPEVLRQDKSGY 551
HRD+ N+L S D +K+ DFG + +S + +++ APE + + +
Sbjct: 514 HRDIAARNVLVSSN--DCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESINFRR--F 569
Query: 552 DENCDLWSLGVIL 564
D+W GV +
Sbjct: 570 TSASDVWMFGVCM 582
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656 | Back alignment and structure |
|---|
Score = 44.8 bits (106), Expect = 1e-04
Identities = 18/71 (25%), Positives = 35/71 (49%), Gaps = 3/71 (4%)
Query: 895 TYLVLELLKGGELLDRIRQKGRCGFTENEASRIMRQLVAAVHFMHSRGVVHRDLKPENLL 954
++++EL GEL ++ + QL A+ ++ S+ VHRD+ N+L
Sbjct: 465 VWIIMELCTLGELRSFLQVRKF-SLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVL 523
Query: 955 LSGISGNLIKI 965
+S S + +K+
Sbjct: 524 VS--SNDCVKL 532
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281 | Back alignment and structure |
|---|
Score = 69.5 bits (171), Expect = 5e-13
Identities = 44/195 (22%), Positives = 84/195 (43%), Gaps = 24/195 (12%)
Query: 385 ILGDGSY-SVCRRCVEKSTGQEY--AVKIISRKIDCS--------EEINLLRACQGHPNI 433
ILG+G + V G++ AVK K DC+ E +++ HP+I
Sbjct: 19 ILGEGFFGEVYEGVYTNHKGEKINVAVKTC--KKDCTLDNKEKFMSEAVIMKNLD-HPHI 75
Query: 434 VNLHCVFQDEVHTYLVLELLKGGELLDRIRQKGRCGFTENEASRIMRQLVAAVHFMHSRG 493
V L + ++E T++++EL GEL + + Q+ A+ ++ S
Sbjct: 76 VKLIGIIEEE-PTWIIMELYPYGELGHYLERNKN-SLKVLTLVLYSLQICKAMAYLESIN 133
Query: 494 VVHRDLKPENLLFSDPAGDNIKVVDFGFACLKRESLHTPC----FTLQYAAPEVLRQDKS 549
VHRD+ N+L + P + +K+ DFG + + + +++ +PE + +
Sbjct: 134 CVHRDIAVRNILVASP--ECVKLGDFGLSRYIEDEDYYKASVTRLPIKWMSPESINFRR- 190
Query: 550 GYDENCDLWSLGVIL 564
+ D+W V +
Sbjct: 191 -FTTASDVWMFAVCM 204
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281 | Back alignment and structure |
|---|
Score = 45.7 bits (109), Expect = 4e-05
Identities = 17/71 (23%), Positives = 33/71 (46%), Gaps = 3/71 (4%)
Query: 895 TYLVLELLKGGELLDRIRQKGRCGFTENEASRIMRQLVAAVHFMHSRGVVHRDLKPENLL 954
T++++EL GEL + + Q+ A+ ++ S VHRD+ N+L
Sbjct: 87 TWIIMELYPYGELGHYLERNKN-SLKVLTLVLYSLQICKAMAYLESINCVHRDIAVRNIL 145
Query: 955 LSGISGNLIKI 965
++ S +K+
Sbjct: 146 VA--SPECVKL 154
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613 | Back alignment and structure |
|---|
Score = 70.7 bits (173), Expect = 1e-12
Identities = 66/323 (20%), Positives = 110/323 (34%), Gaps = 31/323 (9%)
Query: 259 YHIQYRRILKTEPPIPEDLSPDVADFISRLLVKDPRRRLGGGELDAEELKRHPFFNVIDW 318
Y I T + E L I L P P
Sbjct: 221 YCIPEGTKFDTLWQLVEYLKLKADGLIYCLKEACPNSSA-----SNASGAAAPTLPAHPS 275
Query: 319 DDLATKRIPAPFVPKISNELDVSNFSDEFTKMIPADSPAIVPPNFD-KIFKGSLFFEQYD 377
+R S + + +P D+ P D + K F + D
Sbjct: 276 TLTHPQRRIDTLNSDGYTPEPARITSPDKPRPMPMDTSVFESPFSDPEELKDKKLFLKRD 335
Query: 378 MDLDKAGILGDGSY-SVCRRCVEKSTGQEY-AVKIISRKIDCSE--------EINLLRAC 427
L LG G++ SV + Q A+K++ K + E ++
Sbjct: 336 NLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVL--KQGTEKADTEEMMREAQIMHQL 393
Query: 428 QGHPNIVNLHCVFQDEVHTYLVLELLKGGELLDRIRQKGRCGFTENEASRIMRQLVAAVH 487
+P IV L V Q E LV+E+ GG L + K + + ++ Q+ +
Sbjct: 394 D-NPYIVRLIGVCQAEAL-MLVMEMAGGGPLHKFLVGKRE-EIPVSNVAELLHQVSMGMK 450
Query: 488 FMHSRGVVHRDLKPENLLFSDPAGDNIKVVDFGFA--CLKRESLHTPC----FTLQYAAP 541
++ + VHR+L N+L + K+ DFG + +S +T + L++ AP
Sbjct: 451 YLEEKNFVHRNLAARNVLLVNR--HYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAP 508
Query: 542 EVLRQDKSGYDENCDLWSLGVIL 564
E + K + D+WS GV +
Sbjct: 509 ECINFRK--FSSRSDVWSYGVTM 529
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613 | Back alignment and structure |
|---|
Score = 46.1 bits (109), Expect = 5e-05
Identities = 17/70 (24%), Positives = 33/70 (47%), Gaps = 3/70 (4%)
Query: 896 YLVLELLKGGELLDRIRQKGRCGFTENEASRIMRQLVAAVHFMHSRGVVHRDLKPENLLL 955
LV+E+ GG L + K + + ++ Q+ + ++ + VHR+L N+LL
Sbjct: 411 MLVMEMAGGGPLHKFLVGKRE-EIPVSNVAELLHQVSMGMKYLEEKNFVHRNLAARNVLL 469
Query: 956 SGISGNLIKI 965
+ + KI
Sbjct: 470 V--NRHYAKI 477
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333 | Back alignment and structure |
|---|
Score = 68.8 bits (169), Expect = 2e-12
Identities = 44/185 (23%), Positives = 76/185 (41%), Gaps = 35/185 (18%)
Query: 407 AVKII------SRKIDCSEEINLLRACQGHPNIVNLH-CVFQDEVHTYLVLELLKGGELL 459
AVK++ K E+ ++ H NIVNL ++ E G+LL
Sbjct: 80 AVKMLKSTAHADEKEALMSELKIMSHLGQHENIVNLLGACTHGG-PVLVITEYCCYGDLL 138
Query: 460 DRIRQKGRCGFTENEASRIMRQL-----------VAA-VHFMHSRGVVHRDLKPENLLFS 507
+ +R+K R T+ + VA + F+ S+ +HRD+ N+L +
Sbjct: 139 NFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLASKNCIHRDVAARNVLLT 198
Query: 508 DPAGDNIKVVDFGFACLKRESLHTPCFTLQYA--------APEVLRQDKSGYDENCDLWS 559
+ G K+ DFG A R+ ++ + ++ APE + Y D+WS
Sbjct: 199 N--GHVAKIGDFGLA---RDIMNDSNYIVKGNARLPVKWMAPESIFDCV--YTVQSDVWS 251
Query: 560 LGVIL 564
G++L
Sbjct: 252 YGILL 256
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333 | Back alignment and structure |
|---|
Score = 42.3 bits (100), Expect = 5e-04
Identities = 21/83 (25%), Positives = 39/83 (46%), Gaps = 14/83 (16%)
Query: 895 TYLVLELLKGGELLDRIRQKGRCGFTENEASRIMRQL-----------VAA-VHFMHSRG 942
++ E G+LL+ +R+K R T+ + VA + F+ S+
Sbjct: 125 VLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLASKN 184
Query: 943 VVHRDLKPENLLLSGISGNLIKI 965
+HRD+ N+LL+ +G++ KI
Sbjct: 185 CIHRDVAARNVLLT--NGHVAKI 205
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316 | Back alignment and structure |
|---|
Score = 67.7 bits (166), Expect = 3e-12
Identities = 46/187 (24%), Positives = 74/187 (39%), Gaps = 36/187 (19%)
Query: 407 AVKII------SRKIDCSEEINLLRACQGHPNIVNLH-CVFQDEVHTYLVLELLKGGELL 459
AVK++ S E+ +L H N+VNL + +++E K G L
Sbjct: 61 AVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLS 120
Query: 460 DRIRQK--------------GRCGFTENEASRIMRQLVAAVHFMHSRGVVHRDLKPENLL 505
+R K + T Q+ + F+ SR +HRDL N+L
Sbjct: 121 TYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNIL 180
Query: 506 FSDPAGDNIKVVDFGFA--------CLKRESLHTPCFTLQYAAPEVLRQDKSGYDENCDL 557
S+ + +K+ DFG A +++ P L++ APE + Y D+
Sbjct: 181 LSE--KNVVKICDFGLARDIYKDPDYVRKGDARLP---LKWMAPETIFDRV--YTIQSDV 233
Query: 558 WSLGVIL 564
WS GV+L
Sbjct: 234 WSFGVLL 240
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322 | Back alignment and structure |
|---|
Score = 67.7 bits (166), Expect = 4e-12
Identities = 42/212 (19%), Positives = 79/212 (37%), Gaps = 45/212 (21%)
Query: 385 ILGDGSY-----SVCRRCVEKSTGQEYAVKIISRKIDCSEEINLLRACQ-----GHPNIV 434
LG GS+ V + V+ A+K ++ E I L ++V
Sbjct: 32 ELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVV 91
Query: 435 NLH-CVFQDEVHTYLVLELLKGGELLDRIRQKGRCGFTENEAS--------RIMRQLVAA 485
L V Q + T +++EL+ G+L +R + ++ ++
Sbjct: 92 RLLGVVSQGQ-PTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADG 150
Query: 486 VHFMHSRGVVHRDLKPENLLFSDPAGDNIKVVDFGFACLKRESLHTPCFTLQYA------ 539
+ ++++ VHRDL N + ++ +K+ DFG R+ + Y
Sbjct: 151 MAYLNANKFVHRDLAARNCMVAE--DFTVKIGDFGMT---RD-----IYETDYYRKGGKG 200
Query: 540 -------APEVLRQDKSGYDENCDLWSLGVIL 564
+PE L+ + D+WS GV+L
Sbjct: 201 LLPVRWMSPESLKDGV--FTTYSDVWSFGVVL 230
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* Length = 327 | Back alignment and structure |
|---|
Score = 67.3 bits (165), Expect = 5e-12
Identities = 42/205 (20%), Positives = 71/205 (34%), Gaps = 31/205 (15%)
Query: 385 ILGDGSY-SVCR----RCVEKSTGQEYAVKIISRKIDCSEEINLLRACQ-----GHPNIV 434
LG G++ V + + AVK + +E++ L H NIV
Sbjct: 37 GLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIV 96
Query: 435 NLH-CVFQDEVHTYLVLELLKGGELLD-----RIRQKGRCGFTENEASRIMRQLVAAVHF 488
Q ++++EL+ GG+L R R + + R + +
Sbjct: 97 RCIGVSLQSL-PRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQY 155
Query: 489 MHSRGVVHRDLKPENLLFSDPAGDNI-KVVDFGFACLKRESLHTPCFTLQYA-------- 539
+ +HRD+ N L + P + K+ DFG A R+ +
Sbjct: 156 LEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMA---RDIYRASYYRKGGCAMLPVKWM 212
Query: 540 APEVLRQDKSGYDENCDLWSLGVIL 564
PE + + D WS GV+L
Sbjct: 213 PPEAFMEGI--FTSKTDTWSFGVLL 235
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313 | Back alignment and structure |
|---|
Score = 66.5 bits (163), Expect = 7e-12
Identities = 44/189 (23%), Positives = 77/189 (40%), Gaps = 39/189 (20%)
Query: 407 AVKII------SRKIDCSEEINLLRACQGHPNIVNLH-CVFQDEVHTYLVLELLKGGELL 459
AVK++ + + E+ +L H NIVNL T ++ E G+LL
Sbjct: 57 AVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTIGG-PTLVITEYCCYGDLL 115
Query: 460 DRIRQK---------GRCGFTENEASRIMRQLV-------AAVHFMHSRGVVHRDLKPEN 503
+ +R+K ++E + + L+ + F+ S+ +HRDL N
Sbjct: 116 NFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAARN 175
Query: 504 LLFSDPAGDNIKVVDFGFA--------CLKRESLHTPCFTLQYAAPEVLRQDKSGYDENC 555
+L + G K+ DFG A + + + P +++ APE + Y
Sbjct: 176 ILLTH--GRITKICDFGLARDIKNDSNYVVKGNARLP---VKWMAPESIFNCV--YTFES 228
Query: 556 DLWSLGVIL 564
D+WS G+ L
Sbjct: 229 DVWSYGIFL 237
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} Length = 367 | Back alignment and structure |
|---|
Score = 67.0 bits (164), Expect = 8e-12
Identities = 43/205 (20%), Positives = 71/205 (34%), Gaps = 31/205 (15%)
Query: 385 ILGDGSY-SVCR----RCVEKSTGQEYAVKIISRKIDCSEEINLLRACQ-----GHPNIV 434
LG G++ V + + AVK + +E++ L H NIV
Sbjct: 78 GLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIV 137
Query: 435 NLH-CVFQDEVHTYLVLELLKGGELLD-----RIRQKGRCGFTENEASRIMRQLVAAVHF 488
Q +++LEL+ GG+L R R + + R + +
Sbjct: 138 RCIGVSLQSL-PRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQY 196
Query: 489 MHSRGVVHRDLKPENLLFSDPAGDNI-KVVDFGFACLKRESLHTPCFTLQYA-------- 539
+ +HRD+ N L + P + K+ DFG A R+ +
Sbjct: 197 LEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMA---RDIYRAGYYRKGGCAMLPVKWM 253
Query: 540 APEVLRQDKSGYDENCDLWSLGVIL 564
PE + + D WS GV+L
Sbjct: 254 PPEAFMEGI--FTSKTDTWSFGVLL 276
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327 | Back alignment and structure |
|---|
Score = 65.4 bits (160), Expect = 2e-11
Identities = 46/215 (21%), Positives = 78/215 (36%), Gaps = 50/215 (23%)
Query: 385 ILGDGSY-SVCR-RCVEKSTGQEYAVKII------SRKIDCSEEINLLRACQGHPNIVNL 436
++G+G++ V + R + + A+K + D + E+ +L HPNI+NL
Sbjct: 32 VIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINL 91
Query: 437 H-CVFQDEVHTYLVLELLKGGELLDRIRQKGRCG--------------FTENEASRIMRQ 481
+ YL +E G LLD +R+ + +
Sbjct: 92 LGACEHRG-YLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAAD 150
Query: 482 LVAAVHFMHSRGVVHRDLKPENLLFSDPAGDNIKVVDFGFACLKRESLHTPCFTLQYA-- 539
+ + ++ + +HRDL N+L + K+ DFG + R Y
Sbjct: 151 VARGMDYLSQKQFIHRDLAARNILVGE--NYVAKIADFGLS---RGQEV-------YVKK 198
Query: 540 ----------APEVLRQDKSGYDENCDLWSLGVIL 564
A E L Y N D+WS GV+L
Sbjct: 199 TMGRLPVRWMAIESLNYSV--YTTNSDVWSYGVLL 231
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382 | Back alignment and structure |
|---|
Score = 64.3 bits (157), Expect = 7e-11
Identities = 45/189 (23%), Positives = 79/189 (41%), Gaps = 41/189 (21%)
Query: 407 AVKIISRKIDCSE--------EINLLRACQGHPNIVNLH-CVFQDEVHTYLVLELLKGGE 457
AVK++ K D +E E+ +++ H NI+NL QD Y+++E G
Sbjct: 105 AVKML--KSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQDG-PLYVIVEYASKGN 161
Query: 458 LLDRIRQKGRCGFTENEAS--------------RIMRQLVAAVHFMHSRGVVHRDLKPEN 503
L + ++ + G + Q+ + ++ S+ +HRDL N
Sbjct: 162 LREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARN 221
Query: 504 LLFSDPAGDNIKVVDFGFA--------CLKRESLHTPCFTLQYAAPEVLRQDKSGYDENC 555
+L ++ + +K+ DFG A K + P +++ APE L Y
Sbjct: 222 VLVTE--DNVMKIADFGLARDIHHIDYYKKTTNGRLP---VKWMAPEALFDRI--YTHQS 274
Query: 556 DLWSLGVIL 564
D+WS GV+L
Sbjct: 275 DVWSFGVLL 283
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334 | Back alignment and structure |
|---|
Score = 63.1 bits (154), Expect = 1e-10
Identities = 44/187 (23%), Positives = 76/187 (40%), Gaps = 37/187 (19%)
Query: 407 AVKII------SRKIDCSEEINLLRACQGHPNIVNLH-CVFQDEVHTYLVLELLKGGELL 459
AVK++ D E+ +++ H NI+NL QD Y+++E G L
Sbjct: 71 AVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDG-PLYVIVEYASKGNLR 129
Query: 460 DRIRQK--------------GRCGFTENEASRIMRQLVAAVHFMHSRGVVHRDLKPENLL 505
+ +R + T + QL + ++ S+ +HRDL N+L
Sbjct: 130 EYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVL 189
Query: 506 FSDPAGDNIKVVDFGFA--------CLKRESLHTPCFTLQYAAPEVLRQDKSGYDENCDL 557
++ + +K+ DFG A K + P +++ APE L Y D+
Sbjct: 190 VTE--NNVMKIADFGLARDINNIDYYKKTTNGRLP---VKWMAPEALFDRV--YTHQSDV 242
Query: 558 WSLGVIL 564
WS GV++
Sbjct: 243 WSFGVLM 249
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313 | Back alignment and structure |
|---|
Score = 62.7 bits (153), Expect = 1e-10
Identities = 42/206 (20%), Positives = 74/206 (35%), Gaps = 33/206 (16%)
Query: 385 ILGDGSY-SVCRRCVEKSTGQEYAVKIISRKIDCS---EEINLLRACQ-----GHPNIVN 435
ILG+G + SV +++ G V + + K+D S E L HPN++
Sbjct: 41 ILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVIR 100
Query: 436 L-HCVFQDEVHT----YLVLELLKGGELLDRIRQK----GRCGFTENEASRIMRQLVAAV 486
L + ++L +K G+L + G + M + +
Sbjct: 101 LLGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGM 160
Query: 487 HFMHSRGVVHRDLKPENLLFSDPAGDNIKVVDFGFACLKRESLHTPCFTLQYA------- 539
++ +R +HRDL N + D + V DFG + ++ +
Sbjct: 161 EYLSNRNFLHRDLAARNCMLRD--DMTVCVADFGLS---KKIYSGDYYRQGRIAKMPVKW 215
Query: 540 -APEVLRQDKSGYDENCDLWSLGVIL 564
A E L Y D+W+ GV +
Sbjct: 216 IAIESLADRV--YTSKSDVWAFGVTM 239
|
| >3v5q_A NT-3 growth factor receptor; kinase domain, kinase, phosphorylation, transferase-transfer inhibitor complex; HET: 0F4; 2.20A {Homo sapiens} Length = 297 | Back alignment and structure |
|---|
Score = 61.9 bits (151), Expect = 2e-10
Identities = 48/212 (22%), Positives = 78/212 (36%), Gaps = 42/212 (19%)
Query: 386 LGDGSY-----SVCRRCVEKSTGQEYAVKII-----SRKIDCSEEINLLRACQGHPNIVN 435
LG+G++ + C AVK + + + D E LL Q H +IV
Sbjct: 23 LGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQ-HEHIVK 81
Query: 436 LH-CVFQDEVHTYLVLELLKGGELLDRIRQKGRCGFTENEAS--------------RIMR 480
+ + +V E +K G+L +R G + I
Sbjct: 82 FYGVCGDGD-PLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIAS 140
Query: 481 QLVAAVHFMHSRGVVHRDLKPENLLFSDPAGDNIKVVDFGFACLKRESLHTPCFTLQYA- 539
Q+ + + ++ S+ VHRDL N L +K+ DFG + R+ T + +
Sbjct: 141 QIASGMVYLASQHFVHRDLATRNCLVGA--NLLVKIGDFGMS---RDVYSTDYYRVGGHT 195
Query: 540 -------APEVLRQDKSGYDENCDLWSLGVIL 564
PE + K + D+WS GVIL
Sbjct: 196 MLPIRWMPPESIMYRK--FTTESDVWSFGVIL 225
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 Length = 344 | Back alignment and structure |
|---|
Score = 61.9 bits (151), Expect = 3e-10
Identities = 49/194 (25%), Positives = 76/194 (39%), Gaps = 44/194 (22%)
Query: 407 AVKII------SRKIDCSEEINLLRACQGHPNIVNLH-CVFQDEVHTYLVLELLKGGELL 459
AVK++ S + E+ ++ H NIVNL YL+ E G+LL
Sbjct: 79 AVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTLSG-PIYLIFEYCCYGDLL 137
Query: 460 D---RIRQKGRCGFTENEASRI-----------MRQL------VAA-VHFMHSRGVVHRD 498
+ R+K E E + L VA + F+ + VHRD
Sbjct: 138 NYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKSCVHRD 197
Query: 499 LKPENLLFSDPAGDNIKVVDFGFACLKRESLHTPCFTLQYA--------APEVLRQDKSG 550
L N+L + G +K+ DFG A R+ + + ++ APE L +
Sbjct: 198 LAARNVLVTH--GKVVKICDFGLA---RDIMSDSNYVVRGNARLPVKWMAPESLFEGI-- 250
Query: 551 YDENCDLWSLGVIL 564
Y D+WS G++L
Sbjct: 251 YTIKSDVWSYGILL 264
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323 | Back alignment and structure |
|---|
Score = 61.6 bits (150), Expect = 4e-10
Identities = 40/208 (19%), Positives = 74/208 (35%), Gaps = 36/208 (17%)
Query: 385 ILGDGSYSVCRRCVEKSTGQEY---AVKII-------SRKIDCSEEINLLRACQGHPNIV 434
+LG G + R K + AVK++ S + E ++ HP++
Sbjct: 30 MLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFD-HPHVA 88
Query: 435 NL-HCVFQDE-----VHTYLVLELLKGGELLDRIRQ----KGRCGFTENEASRIMRQLVA 484
L + ++L +K G+L + + R M +
Sbjct: 89 KLVGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIAC 148
Query: 485 AVHFMHSRGVVHRDLKPENLLFSDPAGDNIKVVDFGFACLKRESLHTPCFTLQYA----- 539
+ ++ SR +HRDL N + ++ + V DFG + R+ + A
Sbjct: 149 GMEYLSSRNFIHRDLAARNCMLAE--DMTVCVADFGLS---RKIYSGDYYRQGCASKLPV 203
Query: 540 ---APEVLRQDKSGYDENCDLWSLGVIL 564
A E L + Y + D+W+ GV +
Sbjct: 204 KWLALESLADNL--YTVHSDVWAFGVTM 229
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370 | Back alignment and structure |
|---|
Score = 61.2 bits (149), Expect = 5e-10
Identities = 46/189 (24%), Positives = 78/189 (41%), Gaps = 41/189 (21%)
Query: 407 AVKIISRKIDCSE--------EINLLRACQGHPNIVNLH-CVFQDEVHTYLVLELLKGGE 457
AVK++ K D +E E+ +++ H NI+NL QD Y+++E G
Sbjct: 117 AVKML--KDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDG-PLYVIVEYASKGN 173
Query: 458 LLD--------------RIRQKGRCGFTENEASRIMRQLVAAVHFMHSRGVVHRDLKPEN 503
L + I + T + QL + ++ S+ +HRDL N
Sbjct: 174 LREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARN 233
Query: 504 LLFSDPAGDNIKVVDFGFA--------CLKRESLHTPCFTLQYAAPEVLRQDKSGYDENC 555
+L ++ + +K+ DFG A K + P +++ APE L Y
Sbjct: 234 VLVTE--NNVMKIADFGLARDINNIDYYKKTTNGRLP---VKWMAPEALFDRV--YTHQS 286
Query: 556 DLWSLGVIL 564
D+WS GV++
Sbjct: 287 DVWSFGVLM 295
|
| >3zzw_A Tyrosine-protein kinase transmembrane receptor RO; transferase, neurotrophic tyrosine kinase, receptor-related NTRKR2; 2.90A {Homo sapiens} Length = 289 | Back alignment and structure |
|---|
Score = 59.1 bits (144), Expect = 1e-09
Identities = 43/189 (22%), Positives = 71/189 (37%), Gaps = 42/189 (22%)
Query: 407 AVKIISRKIDCSE--------EINLLRACQGHPNIVNLH-CVFQDEVHTYLVLELLKGGE 457
A+K + K E L Q HPN+V L V +D+ ++ G+
Sbjct: 43 AIKTL--KDKAEGPLREEFRHEAMLRARLQ-HPNVVCLLGVVTKDQ-PLSMIFSYCSHGD 98
Query: 458 LLDRIRQKGRCGFTENEASR--------------IMRQLVAAVHFMHSRGVVHRDLKPEN 503
L + + + + ++ Q+ A + ++ S VVH+DL N
Sbjct: 99 LHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYLSSHHVVHKDLATRN 158
Query: 504 LLFSDPAGDNIKVVDFGFACLKRESLHTPCFTLQYA--------APEVLRQDKSGYDENC 555
+L D N+K+ D G RE + L APE + K + +
Sbjct: 159 VLVYD--KLNVKISDLGLF---REVYAADYYKLLGNSLLPIRWMAPEAIMYGK--FSIDS 211
Query: 556 DLWSLGVIL 564
D+WS GV+L
Sbjct: 212 DIWSYGVVL 220
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* Length = 314 | Back alignment and structure |
|---|
Score = 58.8 bits (143), Expect = 3e-09
Identities = 48/199 (24%), Positives = 75/199 (37%), Gaps = 54/199 (27%)
Query: 407 AVKII------SRKIDCSEEINLLRACQGHPNIVNLH-CVFQDEVHTYLVLELLKGGELL 459
AVK++ S D E N+L+ HP+++ L+ QD L++E K G L
Sbjct: 57 AVKMLKENASPSELRDLLSEFNVLKQV-NHPHVIKLYGACSQDG-PLLLIVEYAKYGSLR 114
Query: 460 D--RIRQKGRCGFTENEASR--------------------IMRQLVAAVHFMHSRGVVHR 497
R +K G+ + SR Q+ + ++ +VHR
Sbjct: 115 GFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAEMKLVHR 174
Query: 498 DLKPENLLFSDPAGDNIKVVDFGFACLKRESLHTPCFTLQYA------------APEVLR 545
DL N+L ++ G +K+ DFG + R+ Y A E L
Sbjct: 175 DLAARNILVAE--GRKMKISDFGLS---RDVYEED----SYVKRSQGRIPVKWMAIESLF 225
Query: 546 QDKSGYDENCDLWSLGVIL 564
Y D+WS GV+L
Sbjct: 226 DHI--YTTQSDVWSFGVLL 242
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329 | Back alignment and structure |
|---|
Score = 58.1 bits (141), Expect = 4e-09
Identities = 47/216 (21%), Positives = 75/216 (34%), Gaps = 51/216 (23%)
Query: 386 LGDGSY-SVCRRCVEKSTGQEY----AVKII-----SRKIDCSEEINLLRACQGHPNIVN 435
LG+G++ V ++ AVK + S + D E LL Q H +IV
Sbjct: 49 LGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQ-HQHIVR 107
Query: 436 LH-CVFQDEVHTYLVLELLKGGELLDRIR-------------QKGRCGFTENEASRIMRQ 481
+ +V E ++ G+L +R + + Q
Sbjct: 108 FFGVCTEGR-PLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQ 166
Query: 482 LVAAVHFMHSRGVVHRDLKPENLLFSDPAGDNIKVVDFGFACLKRESLHTPCFTLQY--- 538
+ A + ++ VHRDL N L G +K+ DFG + R+ T Y
Sbjct: 167 VAAGMVYLAGLHFVHRDLATRNCLVGQ--GLVVKIGDFGMS---RDIYST-----DYYRV 216
Query: 539 ----------AAPEVLRQDKSGYDENCDLWSLGVIL 564
PE + K + D+WS GV+L
Sbjct: 217 GGRTMLPIRWMPPESILYRK--FTTESDVWSFGVVL 250
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 Length = 343 | Back alignment and structure |
|---|
Score = 57.7 bits (140), Expect = 6e-09
Identities = 43/197 (21%), Positives = 69/197 (35%), Gaps = 50/197 (25%)
Query: 407 AVKIISRKIDCSE--------EINLLRACQGHPNIVNLH-CVFQDEVHTYLVLELLKGGE 457
AVK++ K + S E L+ +PNIV L + L+ E + G+
Sbjct: 81 AVKML--KEEASADMQADFQREAALMAEFD-NPNIVKLLGVCAVGK-PMCLLFEYMAYGD 136
Query: 458 LLDRIRQKGRCGFTENEAS----------------------RIMRQLVAAVHFMHSRGVV 495
L + +R S I RQ+ A + ++ R V
Sbjct: 137 LNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERKFV 196
Query: 496 HRDLKPENLLFSDPAGDNIKVVDFGFACLKRESLHTPCFTLQYA--------APEVLRQD 547
HRDL N L + +K+ DFG + R + PE + +
Sbjct: 197 HRDLATRNCLVGE--NMVVKIADFGLS---RNIYSADYYKADGNDAIPIRWMPPESIFYN 251
Query: 548 KSGYDENCDLWSLGVIL 564
+ Y D+W+ GV+L
Sbjct: 252 R--YTTESDVWAYGVVL 266
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* Length = 321 | Back alignment and structure |
|---|
Score = 56.4 bits (137), Expect = 2e-08
Identities = 60/265 (22%), Positives = 103/265 (38%), Gaps = 67/265 (25%)
Query: 381 DKAGILGDGSYSVCRRCVEK---STGQEYAVKIISRKIDCSE--------EINLLRACQG 429
D ++G G + V K G + A+K + + S EI L C+
Sbjct: 42 DHKFLIGHGVFG----KVYKGVLRDGAKVALKRRTPE---SSQGIEEFETEIETLSFCR- 93
Query: 430 HPNIVNLH--CVFQDEVHTYLVLELLKGGELLDRIRQKGRCGFTENEASRIMRQLVAA-- 485
HP++V+L C + L+ + ++ G L + + + R+ + AA
Sbjct: 94 HPHLVSLIGFCD--ERNEMILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAARG 151
Query: 486 VHFMHSRGVVHRDLKPENLLFSDPAGDNIKVVDFGFACLKRESLHT-----PCFTLQYAA 540
+H++H+R ++HRD+K N+L + K+ DFG + E T TL Y
Sbjct: 152 LHYLHTRAIIHRDVKSINILLDE--NFVPKITDFGISKKGTELDQTHLSTVVKGTLGYID 209
Query: 541 PEVLRQDKSGYDENCDLWSLGVILVNVLRQ---DKSGYDENCDLWSLGVILYTMLCGRVP 597
PE Y ++ +KS D++S GV+L+ +LC R
Sbjct: 210 PE--------Y---------------FIKGRLTEKS------DVYSFGVVLFEVLCARSA 240
Query: 598 F-HARSRDDSALSIMAR--IKEGQF 619
+ R+ L+ A GQ
Sbjct: 241 IVQSLPREMVNLAEWAVESHNNGQL 265
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* Length = 307 | Back alignment and structure |
|---|
Score = 54.1 bits (131), Expect = 8e-08
Identities = 57/236 (24%), Positives = 84/236 (35%), Gaps = 66/236 (27%)
Query: 403 GQEYAVKIISRKIDCS---------EEINLLRACQGHPNIVNLH--CVFQDEVHTYLVLE 451
AVK ++ +D + +EI ++ CQ H N+V L D LV
Sbjct: 54 NTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQ-HENLVELLGFSS--DGDDLCLVYV 110
Query: 452 LLKGGELLDRIRQKGRCGFTENEASRI---MRQLVAA-----VHFMHSRGVVHRDLKPEN 503
+ G LLDR+ + + MR +A ++F+H +HRD+K N
Sbjct: 111 YMPNGSLLDRL-------SCLDGTPPLSWHMRCKIAQGAANGINFLHENHHIHRDIKSAN 163
Query: 504 -LLFSDPAGDNIKVVDFGFACLKRESLHTPCF-----TLQYAAPEVLRQDKSGYDENCDL 557
LL K+ DFG A + T T Y APE LR
Sbjct: 164 ILLDEA---FTAKISDFGLARASEKFAQTVMTSRIVGTTAYMAPEALR------------ 208
Query: 558 WSLGVILVNVLRQDKSGYDENCDLWSLGVILYTMLCGRVPFHARSRDDSALSIMAR 613
G I KS D++S GV+L ++ G R+ L +
Sbjct: 209 ---GEITP------KS------DIYSFGVVLLEIITGLPAVD-EHREPQLLLDIKE 248
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A Length = 336 | Back alignment and structure |
|---|
Score = 53.7 bits (128), Expect = 1e-07
Identities = 37/213 (17%), Positives = 65/213 (30%), Gaps = 65/213 (30%)
Query: 360 PPNFDKIFKGSLFFEQYDMDLDKAGILGDGSYSVCRRCVEKSTGQEYAVKIIS------- 412
P F +K +G+G + + + A+KII+
Sbjct: 10 PVPFSHCLPTEKLQR-----CEK---IGEGVFGEVFQT--IADHTPVAIKIIAIEGPDLV 59
Query: 413 ------------RKIDCSEEINLLRA--CQGHPNIVNLHCVF------------------ 440
+I S+E++LL C + L+ V
Sbjct: 60 NGSHQKTFEEILPEIIISKELSLLSGEVCNRTEGFIGLNSVHCVQGSYPPLLLKAWDHYN 119
Query: 441 ------------QDEVHTYLVLELLKGGELLDRIRQKGRCGFTENEASRIMRQLVAAVHF 488
+ ++VLE GG L+++R K + A I+ QL A++
Sbjct: 120 STKGSANDRPDFFKDDQLFIVLEFEFGGIDLEQMRTKLS---SLATAKSILHQLTASLAV 176
Query: 489 MHSR-GVVHRDLKPENLLFSDPAGDNIKVVDFG 520
+ HRDL N+L + + G
Sbjct: 177 AEASLRFEHRDLHWGNVLLKKTSLKKLHYTLNG 209
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A Length = 336 | Back alignment and structure |
|---|
Score = 49.5 bits (117), Expect = 3e-06
Identities = 20/62 (32%), Positives = 31/62 (50%), Gaps = 4/62 (6%)
Query: 896 YLVLELLKGGELLDRIRQKGRCGFTENEASRIMRQLVAAVHFMHSR-GVVHRDLKPENLL 954
++VLE GG L+++R K + A I+ QL A++ + HRDL N+L
Sbjct: 138 FIVLEFEFGGIDLEQMRTKLS---SLATAKSILHQLTASLAVAEASLRFEHRDLHWGNVL 194
Query: 955 LS 956
L
Sbjct: 195 LK 196
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 50.6 bits (120), Expect = 3e-06
Identities = 59/414 (14%), Positives = 115/414 (27%), Gaps = 122/414 (29%)
Query: 310 HPFFNVIDWD----DLATKRIPAPFVPKISNELDVSNFSDEFTKMIPA---DSPAIVPPN 362
H + +D++ K I + F + D + D ++ D +
Sbjct: 1 HHHHHHMDFETGEHQYQYKDILSVFEDAFVDNFDCKDVQDMPKSILSKEEIDHIIMSKDA 60
Query: 363 ---FDKIF-----KGS----LFFEQ-----YD------MDLDKAGILGDGSYSVCRRCVE 399
++F K F E+ Y + + Y R
Sbjct: 61 VSGTLRLFWTLLSKQEEMVQKFVEEVLRINYKFLMSPIKTEQRQPSMMTRMYIEQRD-RL 119
Query: 400 KSTGQEYAVKIISRKIDCSEEINLLRAC----QGHPNIVNLHCVFQDEVH-------TYL 448
+ Q +A +SR + LR + N++ + T++
Sbjct: 120 YNDNQVFAKYNVSRL----QPYLKLRQALLELRPAKNVL---------IDGVLGSGKTWV 166
Query: 449 VLELLKGGELLDRIRQK------GRCGFTENEASRIMRQLVAAVHFM---------HSRG 493
L++ ++ ++ K C N ++ L ++ + HS
Sbjct: 167 ALDVCLSYKVQCKMDFKIFWLNLKNC----NSPETVLEMLQKLLYQIDPNWTSRSDHSSN 222
Query: 494 VVHR--DLKPE-NLLFSDPAG-------DNI---KVVD-FGFACLKRESLHTPCFTLQYA 539
+ R ++ E L N+ K + F +C K L
Sbjct: 223 IKLRIHSIQAELRRLLKSKPYENCLLVLLNVQNAKAWNAFNLSC-K---------IL--- 269
Query: 540 APEVLRQDKSGYDENCDLWSLGVILVNVLRQDK--SGY--DENCDLWSLGVILYTMLCGR 595
+ + K D L + D DE L +
Sbjct: 270 ---LTTRFKQVTD------FLSAATTTHISLDHHSMTLTPDEVKSLLLKYL---DCRPQD 317
Query: 596 VPFHARSRDDSALS-IMARIKEGQFNFDAEAWSTVSSEAKE--LTKSLLTVNPA 646
+P + + LS I I++G +D W V+ + + SL + PA
Sbjct: 318 LPREVLTTNPRRLSIIAESIRDGLATWD--NWKHVNCDKLTTIIESSLNVLEPA 369
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 48.3 bits (114), Expect = 1e-05
Identities = 60/398 (15%), Positives = 115/398 (28%), Gaps = 119/398 (29%)
Query: 27 LSNPWTNGCDVSSTPLMTPDILLGSSNQRSEKRRRTRREGGYSYVSPSVLFSENIISNEI 86
+ WT+ D SS + + ++E RR + + Y + +L N+ + +
Sbjct: 209 IDPNWTSRSDHSSNIKLRIHSI------QAELRRLLKSK---PYEN-CLLVLLNVQNAKA 258
Query: 87 FQPSLDKRPNTSNLIACKFKGSLFFEQYDMDLDKAGILGDGSYSVCRRCVEKSTG--QEY 144
+ + + ++CK L ++ D L + + S +
Sbjct: 259 WN-AFN--------LSCK---ILLTTRFKQVTD---FLSAATTTH-ISLDHHSMTLTPDE 302
Query: 145 AVKIISRKIDCSEEINL-LRACQGHPNICRRCVE-----KSTGQEYA-------VKIISR 191
++ + +DC + +L +P E +T + II
Sbjct: 303 VKSLLLKYLDCRPQ-DLPREVLTTNPRRLSIIAESIRDGLATWDNWKHVNCDKLTTIIES 361
Query: 192 KIDCSEEINLLRACQGHPNIVNLHCVFQDEV--------IDWDDFS----RGIECVFFSS 239
++ E R L VF + W D +
Sbjct: 362 SLNVLEP-AEYRKM-----FDRL-SVFPPSAHIPTILLSLIWFDVIKSDVMVVVNKLHKY 414
Query: 240 SLI----------IFFIILSFTLSFIHDYY-H---IQYRRILKTEPPIPEDLSPDVAD-- 283
SL+ I I L + ++Y H + + I KT +DL P D
Sbjct: 415 SLVEKQPKESTISIPSIYLELKVKLENEYALHRSIVDHYNIPKTFDS--DDLIPPYLDQY 472
Query: 284 -----------------------------FISRLLVKDPRRRLGGGEL-----DAEELKR 309
F+ + + D G + + K
Sbjct: 473 FYSHIGHHLKNIEHPERMTLFRMVFLDFRFLEQKIRHDSTAWNASGSILNTLQQLKFYKP 532
Query: 310 HPFFNVIDWDDLATKRIPA--PFVPKISNELDVSNFSD 345
+ + D D + + A F+PKI L S ++D
Sbjct: 533 Y----ICDNDPKYERLVNAILDFLPKIEENLICSKYTD 566
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359 | Back alignment and structure |
|---|
Score = 44.5 bits (105), Expect = 1e-04
Identities = 29/103 (28%), Positives = 46/103 (44%), Gaps = 15/103 (14%)
Query: 470 FTENEASRIMRQLVAAVHFMHSRGVVHRDLKPENLLFSDPAGDNIKVVDFGFA------- 522
T Q+ + F+ SR +HRDL N+L S+ + +K+ DFG A
Sbjct: 190 LTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSE--KNVVKICDFGLARDIYKDP 247
Query: 523 -CLKRESLHTPCFTLQYAAPEVLRQDKSGYDENCDLWSLGVIL 564
+++ P L++ APE + Y D+WS GV+L
Sbjct: 248 DYVRKGDARLP---LKWMAPETIFDRV--YTIQSDVWSFGVLL 285
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3tl8_A* Length = 326 | Back alignment and structure |
|---|
Score = 42.6 bits (101), Expect = 4e-04
Identities = 48/211 (22%), Positives = 78/211 (36%), Gaps = 45/211 (21%)
Query: 381 DKAGILGDGSYSVCRRCVEK---STGQEYAVKIISRKI---DCSE---EINLLRACQGHP 431
ILG G + V K + G AVK + + + E+ ++ H
Sbjct: 33 SNKNILGRGGFG----KVYKGRLADGTLVAVKRLKEERTQGGELQFQTEVEMISMAV-HR 87
Query: 432 NIVNLH--CVFQDEVHTYLVLELLKGGELLDRIRQKGRCGFTENEASRIMRQLVAAVHFM 489
N++ L C+ LV + G + +R++ + R L +A
Sbjct: 88 NLLRLRGFCM--TPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIALGSA---- 141
Query: 490 HSRG-----------VVHRDLKPENLLFSDPAGDNIKVVDFGFACL-KRESLHTP---CF 534
RG ++HRD+K N+L + V DFG A L + H
Sbjct: 142 --RGLAYLHDHCDPKIIHRDVKAANILLDE--EFEAVVGDFGLAKLMDYKDTHVTTAVRG 197
Query: 535 TLQYAAPEVLRQDKSGY-DENCDLWSLGVIL 564
T+ + APE L +G E D++ GV+L
Sbjct: 198 TIGHIAPEYLS---TGKSSEKTDVFGYGVML 225
|
Structure Templates Detected by HHsearch
Original result of HHsearch against PDB70 database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 966 | |||
| 4b9d_A | 350 | Serine/threonine-protein kinase NEK1; transferase, | 100.0 | |
| 4aw0_A | 311 | HPDK1, 3-phosphoinositide-dependent protein kinase | 100.0 | |
| 4fih_A | 346 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 4g3f_A | 336 | NF-kappa-beta-inducing kinase; non-RD kinase, prot | 100.0 | |
| 3hyh_A | 275 | Carbon catabolite-derepressing protein kinase; kin | 100.0 | |
| 4fie_A | 423 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 3fpq_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 3ubd_A | 304 | Ribosomal protein S6 kinase alpha-3; kinase-inhibi | 100.0 | |
| 4asz_A | 299 | BDNF/NT-3 growth factors receptor; transferase, TR | 100.0 | |
| 4f9c_A | 361 | Cell division cycle 7-related protein kinase; Ser/ | 100.0 | |
| 4b99_A | 398 | Mitogen-activated protein kinase 7; transferase, i | 100.0 | |
| 3omv_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 4gt4_A | 308 | Tyrosine-protein kinase transmembrane receptor RO; | 100.0 | |
| 4aoj_A | 329 | High affinity nerve growth factor receptor; transf | 100.0 | |
| 4g31_A | 299 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 3v5w_A | 689 | G-protein coupled receptor kinase 2; inhibitor com | 100.0 | |
| 3uto_A | 573 | Twitchin; kinase, muscle sarcomere, transferase; H | 100.0 | |
| 4ase_A | 353 | Vascular endothelial growth factor receptor 2; tra | 100.0 | |
| 3hmm_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 3kn6_A | 325 | Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1 | 100.0 | |
| 1nxk_A | 400 | MAP kinase-activated protein kinase 2; MK2, phosph | 100.0 | |
| 2yab_A | 361 | Death-associated protein kinase 2; apoptosis, tran | 100.0 | |
| 2qr7_A | 342 | Ribosomal protein S6 kinase alpha-3; kinase domain | 100.0 | |
| 3txo_A | 353 | PKC-L, NPKC-ETA, protein kinase C ETA type; phosph | 100.0 | |
| 4dc2_A | 396 | Protein kinase C IOTA type; kinase, substrate, cel | 100.0 | |
| 1tki_A | 321 | Titin; serine kinase, muscle, autoinhibition; 2.00 | 100.0 | |
| 3soa_A | 444 | Calcium/calmodulin-dependent protein kinase type a | 100.0 | |
| 2bdw_A | 362 | Hypothetical protein K11E8.1D; kinase, calmodulin | 100.0 | |
| 3fe3_A | 328 | MAP/microtubule affinity-regulating kinase 3; seri | 100.0 | |
| 1o6l_A | 337 | RAC-beta serine/threonine protein kinase; protein | 100.0 | |
| 1xjd_A | 345 | Protein kinase C, theta type; PKC-theta, ATP, AMP, | 100.0 | |
| 3zgw_A | 347 | Maternal embryonic leucine zipper kinase; transfer | 100.0 | |
| 3c0i_A | 351 | Peripheral plasma membrane protein CASK; neurexin, | 100.0 | |
| 2i0e_A | 353 | Protein kinase C-beta II; serine/threonine protein | 100.0 | |
| 3a8x_A | 345 | Protein kinase C IOTA type; transferase; HET: TPO; | 100.0 | |
| 1fot_A | 318 | TPK1 delta, CAMP-dependent protein kinase type 1; | 100.0 | |
| 2y0a_A | 326 | Death-associated protein kinase 1; transferase, ca | 100.0 | |
| 3uc3_A | 361 | Serine/threonine-protein kinase SRK2I; SNRK2, ABA | 100.0 | |
| 1rdq_E | 350 | PKA C-alpha, CAMP-dependent protein kinase, alpha- | 100.0 | |
| 2ac3_A | 316 | MAP kinase-interacting serine/threonine kinase 2; | 100.0 | |
| 3v8s_A | 410 | RHO-associated protein kinase 1; dimerization, myo | 100.0 | |
| 3fxz_A | 297 | Serine/threonine-protein kinase PAK 1; transferase | 100.0 | |
| 4fr4_A | 384 | YANK1, serine/threonine-protein kinase 32A; struct | 100.0 | |
| 1kob_A | 387 | Twitchin; kinase, intrasteric regulation; 2.30A {A | 100.0 | |
| 2w4o_A | 349 | Calcium/calmodulin-dependent protein kinase type I | 100.0 | |
| 3llt_A | 360 | Serine/threonine kinase-1, pflammer; lammer kinase | 100.0 | |
| 2r5t_A | 373 | Serine/threonine-protein kinase SGK1; AGC protein | 100.0 | |
| 3g33_A | 308 | Cell division protein kinase 4; Ser/Thr protein ki | 100.0 | |
| 3q5i_A | 504 | Protein kinase; CDPK, malaria, phosphotransferase, | 100.0 | |
| 3tki_A | 323 | Serine/threonine-protein kinase CHK1; cell checkpo | 100.0 | |
| 2x4f_A | 373 | Myosin light chain kinase family member 4; LUNG, b | 100.0 | |
| 3lm5_A | 327 | Serine/threonine-protein kinase 17B; STK17B, serin | 100.0 | |
| 4aw2_A | 437 | Serine/threonine-protein kinase MRCK alpha; transf | 100.0 | |
| 3niz_A | 311 | Rhodanese family protein; structural genomics, str | 100.0 | |
| 3mwu_A | 486 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 3oz6_A | 388 | Mitogen-activated protein kinase 1, serine/threon | 100.0 | |
| 3lij_A | 494 | Calcium/calmodulin dependent protein kinase with A | 100.0 | |
| 3nyv_A | 484 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 4eqm_A | 294 | Protein kinase; transferase; HET: ANP; 3.00A {Stap | 100.0 | |
| 2vd5_A | 412 | DMPK protein; serine/threonine-protein kinase, kin | 100.0 | |
| 3p1a_A | 311 | MYT1 kinase, membrane-associated tyrosine- and thr | 100.0 | |
| 3o0g_A | 292 | Cell division protein kinase 5; kinase activator c | 100.0 | |
| 3kk8_A | 284 | Calcium/calmodulin dependent protein kinase II; AT | 100.0 | |
| 2izr_A | 330 | Casein kinase I isoform gamma-3; serine/threonine- | 100.0 | |
| 2pmi_A | 317 | Negative RE, cyclin-dependent protein kinase PHO85 | 100.0 | |
| 2acx_A | 576 | G protein-coupled receptor kinase 6; GRK, G transf | 100.0 | |
| 3c4z_A | 543 | Rhodopsin kinase; Ser/Thr kinase, RGS homology dom | 100.0 | |
| 3fhr_A | 336 | MAP kinase-activated protein kinase 3; kinase-inhi | 100.0 | |
| 3i6u_A | 419 | CDS1, serine/threonine-protein kinase CHK2; Ser/Th | 100.0 | |
| 2a2a_A | 321 | Death-associated protein kinase 2; autoinhibition, | 100.0 | |
| 3h4j_B | 336 | AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin | 100.0 | |
| 2zv2_A | 298 | Calcium/calmodulin-dependent protein kinase kinas; | 100.0 | |
| 3a62_A | 327 | Ribosomal protein S6 kinase beta-1; kinase domain, | 100.0 | |
| 3rp9_A | 458 | Mitogen-activated protein kinase; structural genom | 100.0 | |
| 3f3z_A | 277 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 1csn_A | 298 | Casein kinase-1; phosphotransferase; HET: ATP; 2.0 | 100.0 | |
| 3gni_B | 389 | Strad alpha; kinase fold, pseudokinase, alpha heli | 100.0 | |
| 3pfq_A | 674 | PKC-B, PKC-beta, protein kinase C beta type; phosp | 100.0 | |
| 2y7j_A | 365 | Phosphorylase B kinase gamma catalytic chain, test | 100.0 | |
| 3hko_A | 345 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 3ttj_A | 464 | Mitogen-activated protein kinase 10; JNK3, protein | 100.0 | |
| 1ob3_A | 288 | PFPK5, cell division control protein 2 homolog; tr | 100.0 | |
| 4ejn_A | 446 | RAC-alpha serine/threonine-protein kinase; AKT1, a | 100.0 | |
| 3kvw_A | 429 | DYRK2, dual specificity tyrosine-phosphorylation-r | 100.0 | |
| 4euu_A | 319 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 1wak_A | 397 | Serine/threonine-protein kinase SPRK1; SRPK, trans | 100.0 | |
| 3n9x_A | 432 | Phosphotransferase; malaria kinase, structural gen | 100.0 | |
| 2psq_A | 370 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 2y94_A | 476 | 5'-AMP-activated protein kinase catalytic subunit; | 100.0 | |
| 3gbz_A | 329 | Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide- | 100.0 | |
| 2eue_A | 275 | Carbon catabolite derepressing protein kinase; kin | 100.0 | |
| 3p86_A | 309 | Serine/threonine-protein kinase CTR1; ETR1, ERS1, | 100.0 | |
| 3mtl_A | 324 | Cell division protein kinase 16; pctaire1, indirub | 100.0 | |
| 4agu_A | 311 | Cyclin-dependent kinase-like 1; transferase, phosp | 100.0 | |
| 1phk_A | 298 | Phosphorylase kinase; glycogen metabolism, transfe | 100.0 | |
| 1vzo_A | 355 | Ribosomal protein S6 kinase alpha 5; protein kinas | 100.0 | |
| 1cm8_A | 367 | Phosphorylated MAP kinase P38-gamma; phosphorylati | 100.0 | |
| 2jam_A | 304 | Calcium/calmodulin-dependent protein kinase type 1 | 100.0 | |
| 1j1b_A | 420 | Glycogen synthase kinase-3 beta; complex, TAU, AMP | 100.0 | |
| 3is5_A | 285 | Calcium-dependent protein kinase; CDPK, structural | 100.0 | |
| 2ycf_A | 322 | Serine/threonine-protein kinase CHK2; transferase, | 100.0 | |
| 3ork_A | 311 | Serine/threonine protein kinase; structural genomi | 100.0 | |
| 3vhe_A | 359 | Vascular endothelial growth factor receptor 2; kin | 100.0 | |
| 3s95_A | 310 | LIMK-1, LIM domain kinase 1; structural genomics, | 100.0 | |
| 2c30_A | 321 | Serine/threonine-protein kinase PAK 6; CRIB domain | 100.0 | |
| 3bhy_A | 283 | Death-associated protein kinase 3; death associate | 100.0 | |
| 2vx3_A | 382 | Dual specificity tyrosine-phosphorylation- regula | 100.0 | |
| 3dbq_A | 343 | Dual specificity protein kinase TTK; MPS1 structur | 100.0 | |
| 3qd2_B | 332 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 2zmd_A | 390 | Dual specificity protein kinase TTK; MPS1, T686A, | 100.0 | |
| 3mi9_A | 351 | Cell division protein kinase 9; P-TEFB, HIV-1, pro | 100.0 | |
| 3eb0_A | 383 | Putative uncharacterized protein; kinase cryptospo | 100.0 | |
| 3op5_A | 364 | Serine/threonine-protein kinase VRK1; adenosine tr | 100.0 | |
| 3nsz_A | 330 | CK II alpha, casein kinase II subunit alpha; inhib | 100.0 | |
| 1x8b_A | 289 | WEE1HU, WEE1-like protein kinase; cell cycle, tran | 100.0 | |
| 3kul_A | 325 | Ephrin type-A receptor 8; ATP-binding, kinase, nuc | 100.0 | |
| 4hgt_A | 296 | Casein kinase I isoform delta; CK1D, inhibitor, tr | 100.0 | |
| 3fdn_A | 279 | Serine/threonine-protein kinase 6; aurora kinase i | 100.0 | |
| 1z57_A | 339 | Dual specificity protein kinase CLK1; protein tyro | 100.0 | |
| 1u5q_A | 348 | Serine/threonine protein kinase TAO2; transferase; | 100.0 | |
| 4hcu_A | 269 | Tyrosine-protein kinase ITK/TSK; transferase-trans | 100.0 | |
| 3l9p_A | 367 | Anaplastic lymphoma kinase; kinase domain, ATP-bin | 100.0 | |
| 3cbl_A | 377 | C-FES, proto-oncogene tyrosine-protein kinase FES/ | 100.0 | |
| 4aaa_A | 331 | Cyclin-dependent kinase-like 2; transferase, phosp | 100.0 | |
| 2fst_X | 367 | Mitogen-activated protein kinase 14; active mutant | 100.0 | |
| 3rgf_A | 405 | Cyclin-dependent kinase 8; protein kinase complex, | 100.0 | |
| 3dls_A | 335 | PAS domain-containing serine/threonine-protein KI; | 100.0 | |
| 1t46_A | 313 | HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom | 100.0 | |
| 3sv0_A | 483 | Casein kinase I-like; typical kinase domain fold, | 100.0 | |
| 4f0f_A | 287 | Serine/threonine-protein kinase ROCO4; LRRK2, ATP- | 100.0 | |
| 1rjb_A | 344 | FL cytokine receptor; kinase, structure, autoinhib | 100.0 | |
| 1ua2_A | 346 | CAK, cell division protein kinase 7; cell cycle, p | 100.0 | |
| 2wei_A | 287 | Calmodulin-domain protein kinase 1, putative; nucl | 100.0 | |
| 3q60_A | 371 | ROP5B; pseudokinase, transferase; HET: ATP; 1.72A | 100.0 | |
| 2x7f_A | 326 | TRAF2 and NCK-interacting protein kinase; serine/t | 100.0 | |
| 2vgo_A | 284 | Serine/threonine-protein kinase 12-A; nucleotide-b | 100.0 | |
| 4e7w_A | 394 | Glycogen synthase kinase 3; GSK3, PTyr195, transfe | 100.0 | |
| 3uzp_A | 296 | CKI-delta, CKID, casein kinase I isoform delta; CK | 100.0 | |
| 3tt0_A | 382 | Basic fibroblast growth factor receptor 1; kinase | 100.0 | |
| 3kfa_A | 288 | Tyrosine-protein kinase ABL1; CML, drug resistance | 100.0 | |
| 3qyz_A | 364 | Mitogen-activated protein kinase 1; transferase, s | 100.0 | |
| 3sxs_A | 268 | Cytoplasmic tyrosine-protein kinase BMX; transfera | 100.0 | |
| 1k9a_A | 450 | Carboxyl-terminal SRC kinase; COOH-terminal SRC ki | 100.0 | |
| 1luf_A | 343 | Muscle-specific tyrosine kinase receptor MUSK; pho | 100.0 | |
| 3cok_A | 278 | Serine/threonine-protein kinase PLK4; POLO-like ki | 100.0 | |
| 2r3i_A | 299 | Cell division protein kinase 2; serine/threonine-p | 100.0 | |
| 2jii_A | 352 | Serine/threonine-protein kinase VRK3 molecule: VA | 100.0 | |
| 3eqc_A | 360 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 2ivs_A | 314 | Proto-oncogene tyrosine-protein kinase receptor RE | 100.0 | |
| 3fme_A | 290 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 2xrw_A | 371 | Mitogen-activated protein kinase 8; transcription, | 100.0 | |
| 3byv_A | 377 | Rhoptry kinase; malaria, transferase, structural g | 100.0 | |
| 3gen_A | 283 | Tyrosine-protein kinase BTK; bruton'S tyrosine kin | 100.0 | |
| 1t4h_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 2rku_A | 294 | Serine/threonine-protein kinase PLK1; structure of | 100.0 | |
| 2h6d_A | 276 | 5'-AMP-activated protein kinase catalytic subunit | 100.0 | |
| 3soc_A | 322 | Activin receptor type-2A; structural genomics cons | 100.0 | |
| 3q4u_A | 301 | Activin receptor type-1; structural genomics conso | 100.0 | |
| 2v62_A | 345 | Serine/threonine-protein kinase VRK2; transferase, | 100.0 | |
| 2owb_A | 335 | Serine/threonine-protein kinase PLK1; catalytic do | 100.0 | |
| 2eu9_A | 355 | Dual specificity protein kinase CLK3; kinase domai | 100.0 | |
| 1mp8_A | 281 | Focal adhesion kinase 1; tyrosine protein kinase, | 100.0 | |
| 3lb7_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 2yex_A | 276 | Serine/threonine-protein kinase CHK1; transferase, | 100.0 | |
| 2a19_B | 284 | Interferon-induced, double-stranded RNA-activated | 100.0 | |
| 2i1m_A | 333 | Macrophage colony-stimulating factor 1 receptor; k | 100.0 | |
| 2wqm_A | 310 | Serine/threonine-protein kinase NEK7; ATP-binding, | 100.0 | |
| 3ugc_A | 295 | Tyrosine-protein kinase JAK2; small molecule inhib | 100.0 | |
| 4eut_A | 396 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 1blx_A | 326 | Cyclin-dependent kinase 6; inhibitor protein, cycl | 100.0 | |
| 1opk_A | 495 | P150, C-ABL, proto-oncogene tyrosine-protein kinas | 100.0 | |
| 3an0_A | 340 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 3poz_A | 327 | Epidermal growth factor receptor; kinase domain, a | 100.0 | |
| 2h34_A | 309 | Serine/threonine-protein kinase PKNE; apoenzyme, t | 100.0 | |
| 3m2w_A | 299 | MAP kinase-activated protein kinase 2; small molec | 100.0 | |
| 3kex_A | 325 | Receptor tyrosine-protein kinase ERBB-3; kinase do | 100.0 | |
| 3kmu_A | 271 | ILK, integrin-linked kinase; cell adhesion, ANK re | 100.0 | |
| 2j7t_A | 302 | Serine/threonine-protein kinase 10; transferase, A | 100.0 | |
| 1q8y_A | 373 | SR protein kinase; transferase; HET: ADP ADE; 2.05 | 100.0 | |
| 3com_A | 314 | Serine/threonine-protein kinase 4; MST1, STE20-lik | 100.0 | |
| 4e5w_A | 302 | Tyrosine-protein kinase JAK1; kinase domain, trans | 100.0 | |
| 1fvr_A | 327 | Tyrosine-protein kinase TIE-2; tyrosine kinase, tr | 100.0 | |
| 4exu_A | 371 | Mitogen-activated protein kinase 13; P38 kinase, t | 100.0 | |
| 2xir_A | 316 | Vascular endothelial growth factor receptor 2; ang | 100.0 | |
| 2clq_A | 295 | Mitogen-activated protein kinase kinase kinase 5; | 100.0 | |
| 2i6l_A | 320 | Mitogen-activated protein kinase 6; MAPK6, ERK3, e | 100.0 | |
| 2pvf_A | 334 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 3t9t_A | 267 | Tyrosine-protein kinase ITK/TSK; kinase domain, al | 100.0 | |
| 3dtc_A | 271 | Mitogen-activated protein kinase kinase kinase 9; | 100.0 | |
| 1qcf_A | 454 | Haematopoetic cell kinase (HCK); tyrosine kinase-i | 100.0 | |
| 3pls_A | 298 | Macrophage-stimulating protein receptor; protein k | 100.0 | |
| 4fvq_A | 289 | Tyrosine-protein kinase JAK2; janus protein kinase | 100.0 | |
| 2wtk_C | 305 | Serine/threonine-protein kinase 11; transferase-me | 100.0 | |
| 3qup_A | 323 | Tyrosine-protein kinase receptor TYRO3; protein ki | 100.0 | |
| 3a7i_A | 303 | MST3 kinase, serine/threonine kinase 24 (STE20 hom | 100.0 | |
| 2b9h_A | 353 | MAP kinase FUS3, mitogen-activated protein kinase | 100.0 | |
| 3lzb_A | 327 | Epidermal growth factor receptor; epidermal growth | 100.0 | |
| 3e3p_A | 360 | Protein kinase, putative glycogen synthase kinase; | 100.0 | |
| 3a99_A | 320 | Proto-oncogene serine/threonine-protein kinase PI; | 100.0 | |
| 1zy4_A | 303 | Serine/threonine-protein kinase GCN2; translation | 100.0 | |
| 2qol_A | 373 | Ephrin receptor; receptor tyrosine kinase, juxtame | 100.0 | |
| 2qkw_B | 321 | Protein kinase; three-helix bundle motif, AVRPTO-P | 100.0 | |
| 3mdy_A | 337 | Bone morphogenetic protein receptor type-1B; compl | 100.0 | |
| 2eva_A | 307 | TAK1 kinase - TAB1 chimera fusion protein; transfe | 100.0 | |
| 1u59_A | 287 | Tyrosine-protein kinase ZAP-70; transferase; HET: | 100.0 | |
| 1byg_A | 278 | CSK, protein (C-terminal SRC kinase); protein kina | 100.0 | |
| 3cc6_A | 281 | Protein tyrosine kinase 2 beta; focal adhesion kin | 100.0 | |
| 2w5a_A | 279 | Serine/threonine-protein kinase NEK2; Ser/Thr prot | 100.0 | |
| 1qpc_A | 279 | LCK kinase; alpha beta fold, transferase; HET: PTR | 100.0 | |
| 3coi_A | 353 | Mitogen-activated protein kinase 13; P38D, P38delt | 100.0 | |
| 3ll6_A | 337 | Cyclin G-associated kinase; transferase, protein k | 100.0 | |
| 2vwi_A | 303 | Serine/threonine-protein kinase OSR1; STE kinase, | 100.0 | |
| 3og7_A | 289 | AKAP9-BRAF fusion protein; proto-oncogene, V600E, | 100.0 | |
| 2yfx_A | 327 | Tyrosine-protein kinase receptor; nucleotide-bindi | 100.0 | |
| 1p4o_A | 322 | Insulin-like growth factor I receptor protein; IGF | 100.0 | |
| 3e7e_A | 365 | HBUB1, BUB1A, mitotic checkpoint serine/threonine- | 100.0 | |
| 2pml_X | 348 | PFPK7, Ser/Thr protein kinase; phosphorylati trans | 100.0 | |
| 1mqb_A | 333 | Ephrin type-A receptor 2; tyrosine protein kinase, | 100.0 | |
| 3pg1_A | 362 | Mitogen-activated protein kinase, putative (MAP K | 100.0 | |
| 3p23_A | 432 | Serine/threonine-protein kinase/endoribonuclease; | 100.0 | |
| 1xbb_A | 291 | Tyrosine-protein kinase SYK; gleevec, STI-571, ima | 100.0 | |
| 1fmk_A | 452 | C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros | 100.0 | |
| 3uim_A | 326 | Brassinosteroid insensitive 1-associated receptor; | 100.0 | |
| 3f66_A | 298 | Hepatocyte growth factor receptor; C-Met, protein | 100.0 | |
| 2nru_A | 307 | Interleukin-1 receptor-associated kinase 4; inhibi | 100.0 | |
| 2buj_A | 317 | Serine/threonine-protein kinase 16; transferase, A | 100.0 | |
| 3lxl_A | 327 | Tyrosine-protein kinase JAK3; TYK2, inflammation, | 100.0 | |
| 3v5w_A | 689 | G-protein coupled receptor kinase 2; inhibitor com | 100.0 | |
| 2iwi_A | 312 | Serine/threonine-protein kinase PIM-2; nucleotide- | 100.0 | |
| 3aln_A | 327 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 3brb_A | 313 | Proto-oncogene tyrosine-protein kinase MER; ATP-bi | 100.0 | |
| 3lxp_A | 318 | Non-receptor tyrosine-protein kinase TYK2; JAK3, i | 100.0 | |
| 4fl3_A | 635 | Tyrosine-protein kinase SYK; transferase; HET: ANP | 100.0 | |
| 3c1x_A | 373 | Hepatocyte growth factor receptor; receptor tyrosi | 100.0 | |
| 3cek_A | 313 | Dual specificity protein kinase TTK; HMPS1, PYT, E | 100.0 | |
| 2dyl_A | 318 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| 2ozo_A | 613 | Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t | 100.0 | |
| 2h8h_A | 535 | Proto-oncogene tyrosine-protein kinase SRC; SRC ki | 100.0 | |
| 2w1i_A | 326 | JAK2; chromosomal rearrangement, nucleotide-bindin | 100.0 | |
| 1b6c_B | 342 | TGF-B superfamily receptor type I; complex (isomer | 100.0 | |
| 2rio_A | 434 | Serine/threonine-protein kinase/endoribonuclease I | 100.0 | |
| 3g2f_A | 336 | Bone morphogenetic protein receptor type-2; kinase | 100.0 | |
| 1u46_A | 291 | ACK-1, activated CDC42 kinase 1; tyrosine kinase, | 100.0 | |
| 3gxj_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 2y4i_B | 319 | KSR2, HKSR2, kinase suppressor of RAS 2; transfera | 100.0 | |
| 2j0j_A | 656 | Focal adhesion kinase 1; cell migration, FERM, tra | 100.0 | |
| 3uqc_A | 286 | Probable conserved transmembrane protein; structur | 100.0 | |
| 2vuw_A | 336 | Serine/threonine-protein kinase haspin; cell cycle | 100.0 | |
| 3dzo_A | 413 | Rhoptry kinase domain; parasitic disease, transfer | 100.0 | |
| 2pzi_A | 681 | Probable serine/threonine-protein kinase PKNG; ATP | 100.0 | |
| 4aw0_A | 311 | HPDK1, 3-phosphoinositide-dependent protein kinase | 100.0 | |
| 3ubd_A | 304 | Ribosomal protein S6 kinase alpha-3; kinase-inhibi | 100.0 | |
| 3qa8_A | 676 | MGC80376 protein; kinase ubiquitin-like domain, ph | 100.0 | |
| 4dc2_A | 396 | Protein kinase C IOTA type; kinase, substrate, cel | 100.0 | |
| 3txo_A | 353 | PKC-L, NPKC-ETA, protein kinase C ETA type; phosph | 100.0 | |
| 1o6l_A | 337 | RAC-beta serine/threonine protein kinase; protein | 100.0 | |
| 2i0e_A | 353 | Protein kinase C-beta II; serine/threonine protein | 100.0 | |
| 3pfq_A | 674 | PKC-B, PKC-beta, protein kinase C beta type; phosp | 100.0 | |
| 2r5t_A | 373 | Serine/threonine-protein kinase SGK1; AGC protein | 100.0 | |
| 1xjd_A | 345 | Protein kinase C, theta type; PKC-theta, ATP, AMP, | 99.98 | |
| 3a8x_A | 345 | Protein kinase C IOTA type; transferase; HET: TPO; | 99.98 | |
| 1fot_A | 318 | TPK1 delta, CAMP-dependent protein kinase type 1; | 99.97 | |
| 1rdq_E | 350 | PKA C-alpha, CAMP-dependent protein kinase, alpha- | 99.97 | |
| 3v8s_A | 410 | RHO-associated protein kinase 1; dimerization, myo | 99.97 | |
| 2vd5_A | 412 | DMPK protein; serine/threonine-protein kinase, kin | 99.97 | |
| 4azs_A | 569 | Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15 | 99.97 | |
| 4aw2_A | 437 | Serine/threonine-protein kinase MRCK alpha; transf | 99.96 | |
| 4ejn_A | 446 | RAC-alpha serine/threonine-protein kinase; AKT1, a | 99.96 | |
| 3c4z_A | 543 | Rhodopsin kinase; Ser/Thr kinase, RGS homology dom | 99.96 | |
| 3a62_A | 327 | Ribosomal protein S6 kinase beta-1; kinase domain, | 99.96 | |
| 2acx_A | 576 | G protein-coupled receptor kinase 6; GRK, G transf | 99.95 | |
| 3hyh_A | 275 | Carbon catabolite-derepressing protein kinase; kin | 99.95 | |
| 4fih_A | 346 | Serine/threonine-protein kinase PAK 4; kinase doma | 99.95 | |
| 4fr4_A | 384 | YANK1, serine/threonine-protein kinase 32A; struct | 99.95 | |
| 4fie_A | 423 | Serine/threonine-protein kinase PAK 4; kinase doma | 99.94 | |
| 4b9d_A | 350 | Serine/threonine-protein kinase NEK1; transferase, | 99.94 | |
| 3uto_A | 573 | Twitchin; kinase, muscle sarcomere, transferase; H | 99.93 | |
| 4b99_A | 398 | Mitogen-activated protein kinase 7; transferase, i | 99.93 | |
| 4g3f_A | 336 | NF-kappa-beta-inducing kinase; non-RD kinase, prot | 99.92 | |
| 3en9_A | 540 | Glycoprotease, O-sialoglycoprotein endopeptidase/p | 99.92 | |
| 1vzo_A | 355 | Ribosomal protein S6 kinase alpha 5; protein kinas | 99.91 | |
| 4f9c_A | 361 | Cell division cycle 7-related protein kinase; Ser/ | 99.91 | |
| 3fpq_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 99.9 | |
| 2qr7_A | 342 | Ribosomal protein S6 kinase alpha-3; kinase domain | 99.9 | |
| 4g31_A | 299 | Eukaryotic translation initiation factor 2-alpha; | 99.89 | |
| 2yab_A | 361 | Death-associated protein kinase 2; apoptosis, tran | 99.88 | |
| 3fe3_A | 328 | MAP/microtubule affinity-regulating kinase 3; seri | 99.87 | |
| 3oz6_A | 388 | Mitogen-activated protein kinase 1, serine/threon | 99.86 | |
| 1zar_A | 282 | RIO2 kinase; serine kinase, winged-helix, RIO doma | 99.86 | |
| 3zgw_A | 347 | Maternal embryonic leucine zipper kinase; transfer | 99.85 | |
| 3kn6_A | 325 | Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1 | 99.84 | |
| 3rp9_A | 458 | Mitogen-activated protein kinase; structural genom | 99.83 | |
| 3lm5_A | 327 | Serine/threonine-protein kinase 17B; STK17B, serin | 99.83 | |
| 3ttj_A | 464 | Mitogen-activated protein kinase 10; JNK3, protein | 99.82 | |
| 4asz_A | 299 | BDNF/NT-3 growth factors receptor; transferase, TR | 99.81 | |
| 2y94_A | 476 | 5'-AMP-activated protein kinase catalytic subunit; | 99.81 | |
| 3h4j_B | 336 | AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin | 99.81 | |
| 1nxk_A | 400 | MAP kinase-activated protein kinase 2; MK2, phosph | 99.81 | |
| 3gni_B | 389 | Strad alpha; kinase fold, pseudokinase, alpha heli | 99.8 | |
| 2y0a_A | 326 | Death-associated protein kinase 1; transferase, ca | 99.8 | |
| 3c0i_A | 351 | Peripheral plasma membrane protein CASK; neurexin, | 99.8 | |
| 3soa_A | 444 | Calcium/calmodulin-dependent protein kinase type a | 99.8 | |
| 3n9x_A | 432 | Phosphotransferase; malaria kinase, structural gen | 99.8 | |
| 4aoj_A | 329 | High affinity nerve growth factor receptor; transf | 99.8 | |
| 2bdw_A | 362 | Hypothetical protein K11E8.1D; kinase, calmodulin | 99.8 | |
| 1j1b_A | 420 | Glycogen synthase kinase-3 beta; complex, TAU, AMP | 99.79 | |
| 2vgo_A | 284 | Serine/threonine-protein kinase 12-A; nucleotide-b | 99.79 | |
| 3o0g_A | 292 | Cell division protein kinase 5; kinase activator c | 99.79 | |
| 2ac3_A | 316 | MAP kinase-interacting serine/threonine kinase 2; | 99.79 | |
| 2zv2_A | 298 | Calcium/calmodulin-dependent protein kinase kinas; | 99.79 | |
| 3gbz_A | 329 | Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide- | 99.79 | |
| 2eue_A | 275 | Carbon catabolite derepressing protein kinase; kin | 99.79 | |
| 3niz_A | 311 | Rhodanese family protein; structural genomics, str | 99.79 | |
| 2pmi_A | 317 | Negative RE, cyclin-dependent protein kinase PHO85 | 99.79 | |
| 3nsz_A | 330 | CK II alpha, casein kinase II subunit alpha; inhib | 99.78 | |
| 3uc3_A | 361 | Serine/threonine-protein kinase SRK2I; SNRK2, ABA | 99.78 | |
| 1tki_A | 321 | Titin; serine kinase, muscle, autoinhibition; 2.00 | 99.78 | |
| 1zth_A | 258 | RIO1 serine protein kinase; ribosome biogenesis, r | 99.78 | |
| 2xrw_A | 371 | Mitogen-activated protein kinase 8; transcription, | 99.78 | |
| 2a2a_A | 321 | Death-associated protein kinase 2; autoinhibition, | 99.78 | |
| 4e7w_A | 394 | Glycogen synthase kinase 3; GSK3, PTyr195, transfe | 99.78 | |
| 3g33_A | 308 | Cell division protein kinase 4; Ser/Thr protein ki | 99.78 | |
| 3fdn_A | 279 | Serine/threonine-protein kinase 6; aurora kinase i | 99.78 | |
| 1phk_A | 298 | Phosphorylase kinase; glycogen metabolism, transfe | 99.77 | |
| 3nyv_A | 484 | Calmodulin-domain protein kinase 1; serine/threoni | 99.77 | |
| 3fxz_A | 297 | Serine/threonine-protein kinase PAK 1; transferase | 99.77 | |
| 3mwu_A | 486 | Calmodulin-domain protein kinase 1; serine/threoni | 99.77 | |
| 1kob_A | 387 | Twitchin; kinase, intrasteric regulation; 2.30A {A | 99.77 | |
| 1cm8_A | 367 | Phosphorylated MAP kinase P38-gamma; phosphorylati | 99.77 | |
| 3q5i_A | 504 | Protein kinase; CDPK, malaria, phosphotransferase, | 99.77 | |
| 4agu_A | 311 | Cyclin-dependent kinase-like 1; transferase, phosp | 99.77 | |
| 3kk8_A | 284 | Calcium/calmodulin dependent protein kinase II; AT | 99.77 | |
| 4ase_A | 353 | Vascular endothelial growth factor receptor 2; tra | 99.76 | |
| 2w4o_A | 349 | Calcium/calmodulin-dependent protein kinase type I | 99.76 | |
| 2y7j_A | 365 | Phosphorylase B kinase gamma catalytic chain, test | 99.76 | |
| 3tki_A | 323 | Serine/threonine-protein kinase CHK1; cell checkpo | 99.76 | |
| 4exu_A | 371 | Mitogen-activated protein kinase 13; P38 kinase, t | 99.76 | |
| 3qyz_A | 364 | Mitogen-activated protein kinase 1; transferase, s | 99.76 | |
| 3eb0_A | 383 | Putative uncharacterized protein; kinase cryptospo | 99.76 | |
| 3mi9_A | 351 | Cell division protein kinase 9; P-TEFB, HIV-1, pro | 99.76 | |
| 3mtl_A | 324 | Cell division protein kinase 16; pctaire1, indirub | 99.76 | |
| 3lij_A | 494 | Calcium/calmodulin dependent protein kinase with A | 99.75 | |
| 3dls_A | 335 | PAS domain-containing serine/threonine-protein KI; | 99.75 | |
| 2x4f_A | 373 | Myosin light chain kinase family member 4; LUNG, b | 99.75 | |
| 1ob3_A | 288 | PFPK5, cell division control protein 2 homolog; tr | 99.75 | |
| 4gt4_A | 308 | Tyrosine-protein kinase transmembrane receptor RO; | 99.75 | |
| 3hko_A | 345 | Calcium/calmodulin-dependent protein kinase with d | 99.75 | |
| 2wtk_C | 305 | Serine/threonine-protein kinase 11; transferase-me | 99.75 | |
| 3i6u_A | 419 | CDS1, serine/threonine-protein kinase CHK2; Ser/Th | 99.75 | |
| 3llt_A | 360 | Serine/threonine kinase-1, pflammer; lammer kinase | 99.74 | |
| 3coi_A | 353 | Mitogen-activated protein kinase 13; P38D, P38delt | 99.74 | |
| 2jam_A | 304 | Calcium/calmodulin-dependent protein kinase type 1 | 99.74 | |
| 3cok_A | 278 | Serine/threonine-protein kinase PLK4; POLO-like ki | 99.74 | |
| 2owb_A | 335 | Serine/threonine-protein kinase PLK1; catalytic do | 99.74 | |
| 2rku_A | 294 | Serine/threonine-protein kinase PLK1; structure of | 99.74 | |
| 1blx_A | 326 | Cyclin-dependent kinase 6; inhibitor protein, cycl | 99.74 | |
| 1ua2_A | 346 | CAK, cell division protein kinase 7; cell cycle, p | 99.74 | |
| 3bhy_A | 283 | Death-associated protein kinase 3; death associate | 99.74 | |
| 2fst_X | 367 | Mitogen-activated protein kinase 14; active mutant | 99.74 | |
| 2pml_X | 348 | PFPK7, Ser/Thr protein kinase; phosphorylati trans | 99.73 | |
| 3m2w_A | 299 | MAP kinase-activated protein kinase 2; small molec | 99.73 | |
| 2b9h_A | 353 | MAP kinase FUS3, mitogen-activated protein kinase | 99.73 | |
| 3q60_A | 371 | ROP5B; pseudokinase, transferase; HET: ATP; 1.72A | 99.73 | |
| 3kvw_A | 429 | DYRK2, dual specificity tyrosine-phosphorylation-r | 99.73 | |
| 2vx3_A | 382 | Dual specificity tyrosine-phosphorylation- regula | 99.73 | |
| 3f3z_A | 277 | Calcium/calmodulin-dependent protein kinase with d | 99.72 | |
| 2r3i_A | 299 | Cell division protein kinase 2; serine/threonine-p | 99.72 | |
| 3omv_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 99.72 | |
| 2h6d_A | 276 | 5'-AMP-activated protein kinase catalytic subunit | 99.72 | |
| 2c30_A | 321 | Serine/threonine-protein kinase PAK 6; CRIB domain | 99.72 | |
| 3kex_A | 325 | Receptor tyrosine-protein kinase ERBB-3; kinase do | 99.72 | |
| 3is5_A | 285 | Calcium-dependent protein kinase; CDPK, structural | 99.72 | |
| 2j7t_A | 302 | Serine/threonine-protein kinase 10; transferase, A | 99.71 | |
| 3eqc_A | 360 | Dual specificity mitogen-activated protein kinase; | 99.71 | |
| 4aaa_A | 331 | Cyclin-dependent kinase-like 2; transferase, phosp | 99.71 | |
| 2ycf_A | 322 | Serine/threonine-protein kinase CHK2; transferase, | 99.71 | |
| 3e3p_A | 360 | Protein kinase, putative glycogen synthase kinase; | 99.71 | |
| 3p23_A | 432 | Serine/threonine-protein kinase/endoribonuclease; | 99.71 | |
| 2wei_A | 287 | Calmodulin-domain protein kinase 1, putative; nucl | 99.71 | |
| 2i6l_A | 320 | Mitogen-activated protein kinase 6; MAPK6, ERK3, e | 99.71 | |
| 2izr_A | 330 | Casein kinase I isoform gamma-3; serine/threonine- | 99.71 | |
| 3p1a_A | 311 | MYT1 kinase, membrane-associated tyrosine- and thr | 99.7 | |
| 3fme_A | 290 | Dual specificity mitogen-activated protein kinase; | 99.7 | |
| 3pg1_A | 362 | Mitogen-activated protein kinase, putative (MAP K | 99.7 | |
| 3com_A | 314 | Serine/threonine-protein kinase 4; MST1, STE20-lik | 99.7 | |
| 3byv_A | 377 | Rhoptry kinase; malaria, transferase, structural g | 99.7 | |
| 3a99_A | 320 | Proto-oncogene serine/threonine-protein kinase PI; | 99.7 | |
| 2eu9_A | 355 | Dual specificity protein kinase CLK3; kinase domai | 99.7 | |
| 2zmd_A | 390 | Dual specificity protein kinase TTK; MPS1, T686A, | 99.7 | |
| 1wak_A | 397 | Serine/threonine-protein kinase SPRK1; SRPK, trans | 99.69 | |
| 1q8y_A | 373 | SR protein kinase; transferase; HET: ADP ADE; 2.05 | 99.69 | |
| 3rgf_A | 405 | Cyclin-dependent kinase 8; protein kinase complex, | 99.69 | |
| 3qd2_B | 332 | Eukaryotic translation initiation factor 2-alpha; | 99.69 | |
| 2yex_A | 276 | Serine/threonine-protein kinase CHK1; transferase, | 99.69 | |
| 2x7f_A | 326 | TRAF2 and NCK-interacting protein kinase; serine/t | 99.69 | |
| 1x8b_A | 289 | WEE1HU, WEE1-like protein kinase; cell cycle, tran | 99.69 | |
| 3fhr_A | 336 | MAP kinase-activated protein kinase 3; kinase-inhi | 99.69 | |
| 1u5q_A | 348 | Serine/threonine protein kinase TAO2; transferase; | 99.69 | |
| 3an0_A | 340 | Dual specificity mitogen-activated protein kinase; | 99.68 | |
| 2w5a_A | 279 | Serine/threonine-protein kinase NEK2; Ser/Thr prot | 99.67 | |
| 2dyl_A | 318 | Dual specificity mitogen-activated protein kinase | 99.67 | |
| 3qup_A | 323 | Tyrosine-protein kinase receptor TYRO3; protein ki | 99.67 | |
| 3dbq_A | 343 | Dual specificity protein kinase TTK; MPS1 structur | 99.67 | |
| 3ork_A | 311 | Serine/threonine protein kinase; structural genomi | 99.66 | |
| 3sv0_A | 483 | Casein kinase I-like; typical kinase domain fold, | 99.66 | |
| 3a7i_A | 303 | MST3 kinase, serine/threonine kinase 24 (STE20 hom | 99.66 | |
| 2vwi_A | 303 | Serine/threonine-protein kinase OSR1; STE kinase, | 99.66 | |
| 1zy4_A | 303 | Serine/threonine-protein kinase GCN2; translation | 99.66 | |
| 1t4h_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 99.65 | |
| 3l9p_A | 367 | Anaplastic lymphoma kinase; kinase domain, ATP-bin | 99.65 | |
| 2iwi_A | 312 | Serine/threonine-protein kinase PIM-2; nucleotide- | 99.64 | |
| 3aln_A | 327 | Dual specificity mitogen-activated protein kinase; | 99.64 | |
| 2rio_A | 434 | Serine/threonine-protein kinase/endoribonuclease I | 99.64 | |
| 4gyi_A | 397 | RIO2 kinase; protein kinase, ADP complex, phosphoa | 99.64 | |
| 1z57_A | 339 | Dual specificity protein kinase CLK1; protein tyro | 99.63 | |
| 2clq_A | 295 | Mitogen-activated protein kinase kinase kinase 5; | 99.63 | |
| 3dzo_A | 413 | Rhoptry kinase domain; parasitic disease, transfer | 99.63 | |
| 4euu_A | 319 | Serine/threonine-protein kinase TBK1; ATP binding, | 99.63 | |
| 2psq_A | 370 | Fibroblast growth factor receptor 2; kinase domain | 99.62 | |
| 1p4o_A | 322 | Insulin-like growth factor I receptor protein; IGF | 99.62 | |
| 3kfa_A | 288 | Tyrosine-protein kinase ABL1; CML, drug resistance | 99.62 | |
| 3cek_A | 313 | Dual specificity protein kinase TTK; HMPS1, PYT, E | 99.61 | |
| 4eqm_A | 294 | Protein kinase; transferase; HET: ANP; 3.00A {Stap | 99.6 | |
| 4hcu_A | 269 | Tyrosine-protein kinase ITK/TSK; transferase-trans | 99.6 | |
| 3p86_A | 309 | Serine/threonine-protein kinase CTR1; ETR1, ERS1, | 99.6 | |
| 1csn_A | 298 | Casein kinase-1; phosphotransferase; HET: ATP; 2.0 | 99.59 | |
| 3vhe_A | 359 | Vascular endothelial growth factor receptor 2; kin | 99.59 | |
| 4azs_A | 569 | Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15 | 99.58 | |
| 3kul_A | 325 | Ephrin type-A receptor 8; ATP-binding, kinase, nuc | 99.58 | |
| 3tt0_A | 382 | Basic fibroblast growth factor receptor 1; kinase | 99.58 | |
| 4hgt_A | 296 | Casein kinase I isoform delta; CK1D, inhibitor, tr | 99.58 | |
| 3gen_A | 283 | Tyrosine-protein kinase BTK; bruton'S tyrosine kin | 99.58 | |
| 1fvr_A | 327 | Tyrosine-protein kinase TIE-2; tyrosine kinase, tr | 99.57 | |
| 2h34_A | 309 | Serine/threonine-protein kinase PKNE; apoenzyme, t | 99.57 | |
| 3cbl_A | 377 | C-FES, proto-oncogene tyrosine-protein kinase FES/ | 99.57 | |
| 3hmm_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 99.56 | |
| 1luf_A | 343 | Muscle-specific tyrosine kinase receptor MUSK; pho | 99.56 | |
| 3lzb_A | 327 | Epidermal growth factor receptor; epidermal growth | 99.56 | |
| 1opk_A | 495 | P150, C-ABL, proto-oncogene tyrosine-protein kinas | 99.55 | |
| 3sxs_A | 268 | Cytoplasmic tyrosine-protein kinase BMX; transfera | 99.55 | |
| 1rjb_A | 344 | FL cytokine receptor; kinase, structure, autoinhib | 99.55 | |
| 3poz_A | 327 | Epidermal growth factor receptor; kinase domain, a | 99.54 | |
| 3t9t_A | 267 | Tyrosine-protein kinase ITK/TSK; kinase domain, al | 99.54 | |
| 2pvf_A | 334 | Fibroblast growth factor receptor 2; kinase domain | 99.54 | |
| 3ll6_A | 337 | Cyclin G-associated kinase; transferase, protein k | 99.54 | |
| 2ivs_A | 314 | Proto-oncogene tyrosine-protein kinase receptor RE | 99.54 | |
| 2xir_A | 316 | Vascular endothelial growth factor receptor 2; ang | 99.53 | |
| 1t46_A | 313 | HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom | 99.53 | |
| 1mp8_A | 281 | Focal adhesion kinase 1; tyrosine protein kinase, | 99.53 | |
| 2vuw_A | 336 | Serine/threonine-protein kinase haspin; cell cycle | 99.53 | |
| 1byg_A | 278 | CSK, protein (C-terminal SRC kinase); protein kina | 99.53 | |
| 3pls_A | 298 | Macrophage-stimulating protein receptor; protein k | 99.53 | |
| 1k9a_A | 450 | Carboxyl-terminal SRC kinase; COOH-terminal SRC ki | 99.53 | |
| 1qcf_A | 454 | Haematopoetic cell kinase (HCK); tyrosine kinase-i | 99.52 | |
| 3op5_A | 364 | Serine/threonine-protein kinase VRK1; adenosine tr | 99.52 | |
| 4fvq_A | 289 | Tyrosine-protein kinase JAK2; janus protein kinase | 99.52 | |
| 1u59_A | 287 | Tyrosine-protein kinase ZAP-70; transferase; HET: | 99.52 | |
| 2i1m_A | 333 | Macrophage colony-stimulating factor 1 receptor; k | 99.51 | |
| 3ugc_A | 295 | Tyrosine-protein kinase JAK2; small molecule inhib | 99.51 | |
| 2yfx_A | 327 | Tyrosine-protein kinase receptor; nucleotide-bindi | 99.51 | |
| 2jii_A | 352 | Serine/threonine-protein kinase VRK3 molecule: VA | 99.51 | |
| 3cc6_A | 281 | Protein tyrosine kinase 2 beta; focal adhesion kin | 99.51 | |
| 1qpc_A | 279 | LCK kinase; alpha beta fold, transferase; HET: PTR | 99.51 | |
| 4f0f_A | 287 | Serine/threonine-protein kinase ROCO4; LRRK2, ATP- | 99.51 | |
| 3brb_A | 313 | Proto-oncogene tyrosine-protein kinase MER; ATP-bi | 99.51 | |
| 4fl3_A | 635 | Tyrosine-protein kinase SYK; transferase; HET: ANP | 99.51 | |
| 3qa8_A | 676 | MGC80376 protein; kinase ubiquitin-like domain, ph | 99.51 | |
| 3uzp_A | 296 | CKI-delta, CKID, casein kinase I isoform delta; CK | 99.5 | |
| 4eut_A | 396 | Serine/threonine-protein kinase TBK1; ATP binding, | 99.5 | |
| 1xbb_A | 291 | Tyrosine-protein kinase SYK; gleevec, STI-571, ima | 99.5 | |
| 3dtc_A | 271 | Mitogen-activated protein kinase kinase kinase 9; | 99.5 | |
| 3kmu_A | 271 | ILK, integrin-linked kinase; cell adhesion, ANK re | 99.5 | |
| 1mqb_A | 333 | Ephrin type-A receptor 2; tyrosine protein kinase, | 99.49 | |
| 1u46_A | 291 | ACK-1, activated CDC42 kinase 1; tyrosine kinase, | 99.49 | |
| 2ozo_A | 613 | Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t | 99.48 | |
| 1fmk_A | 452 | C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros | 99.48 | |
| 2qol_A | 373 | Ephrin receptor; receptor tyrosine kinase, juxtame | 99.48 | |
| 3lxp_A | 318 | Non-receptor tyrosine-protein kinase TYK2; JAK3, i | 99.48 | |
| 2buj_A | 317 | Serine/threonine-protein kinase 16; transferase, A | 99.48 | |
| 3lxl_A | 327 | Tyrosine-protein kinase JAK3; TYK2, inflammation, | 99.47 | |
| 2a19_B | 284 | Interferon-induced, double-stranded RNA-activated | 99.47 | |
| 2h8h_A | 535 | Proto-oncogene tyrosine-protein kinase SRC; SRC ki | 99.46 | |
| 2j0j_A | 656 | Focal adhesion kinase 1; cell migration, FERM, tra | 99.45 | |
| 2wqm_A | 310 | Serine/threonine-protein kinase NEK7; ATP-binding, | 99.45 | |
| 3lb7_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 99.45 | |
| 4e5w_A | 302 | Tyrosine-protein kinase JAK1; kinase domain, trans | 99.45 | |
| 2eva_A | 307 | TAK1 kinase - TAB1 chimera fusion protein; transfe | 99.45 | |
| 3f66_A | 298 | Hepatocyte growth factor receptor; C-Met, protein | 99.44 | |
| 2v62_A | 345 | Serine/threonine-protein kinase VRK2; transferase, | 99.42 | |
| 3uqc_A | 286 | Probable conserved transmembrane protein; structur | 99.41 | |
| 3c1x_A | 373 | Hepatocyte growth factor receptor; receptor tyrosi | 99.41 | |
| 3s95_A | 310 | LIMK-1, LIM domain kinase 1; structural genomics, | 99.41 | |
| 2w1i_A | 326 | JAK2; chromosomal rearrangement, nucleotide-bindin | 99.36 | |
| 2y4i_B | 319 | KSR2, HKSR2, kinase suppressor of RAS 2; transfera | 99.36 | |
| 3q4u_A | 301 | Activin receptor type-1; structural genomics conso | 99.36 | |
| 3og7_A | 289 | AKAP9-BRAF fusion protein; proto-oncogene, V600E, | 99.36 | |
| 3e7e_A | 365 | HBUB1, BUB1A, mitotic checkpoint serine/threonine- | 99.36 | |
| 2qkw_B | 321 | Protein kinase; three-helix bundle motif, AVRPTO-P | 99.35 | |
| 3uim_A | 326 | Brassinosteroid insensitive 1-associated receptor; | 99.32 | |
| 3soc_A | 322 | Activin receptor type-2A; structural genomics cons | 99.28 |
| >4b9d_A Serine/threonine-protein kinase NEK1; transferase, inhibitor; HET: CK7; 1.90A {Homo sapiens} PDB: 4apc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-55 Score=492.57 Aligned_cols=246 Identities=25% Similarity=0.453 Sum_probs=207.0
Q ss_pred ccccccccccccEEEEEEEcCCCcEEEEEEecccc-------ChHHHHHHHHHhcCCCCceEEEEEEEeCCeEEEEEEcc
Q psy11767 381 DKAGILGDGSYSVCRRCVEKSTGQEYAVKIISRKI-------DCSEEINLLRACQGHPNIVNLHCVFQDEVHTYLVLELL 453 (966)
Q Consensus 381 ~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~-------~~~~Ei~iL~~l~~HpnIV~l~~~~~~~~~~~lVmEy~ 453 (966)
+.++.||+|+||+||+|+++.+|+.||||++.+.. ...+|+++|+.+ +|||||+++++|++++.+|||||||
T Consensus 27 ~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l-~HpnIV~~~~~~~~~~~~yiVmEy~ 105 (350)
T 4b9d_A 27 VRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANM-KHPNIVQYRESFEENGSLYIVMDYC 105 (350)
T ss_dssp EEEEEC------CEEEEEETTTCCEEEEEEEECTTSCHHHHHHHHHHHHHHHHC-CCTTBCCEEEEEEETTEEEEEEECC
T ss_pred EEeEEEecCCCeEEEEEEECCCCCEEEEEEEehHHCCHHHHHHHHHHHHHHHHC-CCCCCCcEEEEEEECCEEEEEEeCC
Confidence 34789999999999999999999999999997543 245799999998 5999999999999999999999999
Q ss_pred CCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCcEEEecCCCCCEEEEeecccccccCC---Cc
Q psy11767 454 KGGELLDRIRQKGRCGFTENEASRIMRQLVAAVHFMHSRGVVHRDLKPENLLFSDPAGDNIKVVDFGFACLKRES---LH 530 (966)
Q Consensus 454 ~gg~L~~~l~~~~~~~l~e~~~~~i~~Qil~aL~yLHs~~IiHRDLKP~NILl~~~~~~~iKL~DFGla~~~~~~---~~ 530 (966)
+||+|.++|..+....+++.+++.|+.||+.||+|||++|||||||||+||||+. ++.+||+|||+|+..... ..
T Consensus 106 ~gg~L~~~i~~~~~~~~~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~--~g~vKl~DFGla~~~~~~~~~~~ 183 (350)
T 4b9d_A 106 EGGDLFKRINAQKGVLFQEDQILDWFVQICLALKHVHDRKILHRDIKSQNIFLTK--DGTVQLGDFGIARVLNSTVELAR 183 (350)
T ss_dssp TTCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTCEETTCCGGGEEECT--TCCEEECSTTEESCCCHHHHHHH
T ss_pred CCCcHHHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCCHHHEEECC--CCCEEEcccccceeecCCccccc
Confidence 9999999998766557899999999999999999999999999999999999975 569999999999875432 24
Q ss_pred cccccccccCchhhccCCCCCCCcccchhhhhhhhhhhhcCCCCCCCcCcchhHHHHHHHHhcCCCCCCCCCCchhHHHH
Q psy11767 531 TPCFTLQYAAPEVLRQDKSGYDENCDLWSLGVILVNVLRQDKSGYDENCDLWSLGVILYTMLCGRVPFHARSRDDSALSI 610 (966)
Q Consensus 531 ~~~gT~~Y~APEvl~~~~~~~~~~~Di~SlGvil~el~~~~~~~y~~~~DIWSlGvilyemltG~~Pf~~~~~~~~~~~~ 610 (966)
+.+||+.|||||++.. ..|+.++|||||||++|||++|++||.+.+. ..+
T Consensus 184 ~~~GT~~YmAPE~l~~--------------------------~~y~~~~DiwSlGvilyemltG~~PF~~~~~----~~~ 233 (350)
T 4b9d_A 184 ACIGTPYYLSPEICEN--------------------------KPYNNKSDIWALGCVLYELCTLKHAFEAGSM----KNL 233 (350)
T ss_dssp HHHSCCTTCCHHHHTT--------------------------CCCCHHHHHHHHHHHHHHHHHSSCSCCCSSH----HHH
T ss_pred ccCCCccccCHHHHCC--------------------------CCCCcHHHHHHHHHHHHHHHHCCCCCCCcCH----HHH
Confidence 5689999999999852 3488999999999999999999999987643 345
Q ss_pred HHHHHcCCCCCCchhhccCCHHHHHHHHHhcccCccccCChHHHHHHhhhhHHh
Q psy11767 611 MARIKEGQFNFDAEAWSTVSSEAKELTKSLLTVNPAQRIRMMRVKLTFHAFHQA 664 (966)
Q Consensus 611 ~~~i~~~~~~~~~~~~~~is~e~~~Li~~~L~~dP~~R~t~~~v~~~~~~~~~~ 664 (966)
+.+|..+.+.. .+..+|+++++||.+||+.||++|||+.++ ..|+|...
T Consensus 234 ~~~i~~~~~~~---~~~~~s~~~~~li~~~L~~dP~~R~s~~e~--l~hp~~~~ 282 (350)
T 4b9d_A 234 VLKIISGSFPP---VSLHYSYDLRSLVSQLFKRNPRDRPSVNSI--LEKGFIAK 282 (350)
T ss_dssp HHHHHHTCCCC---CCTTSCHHHHHHHHHHTCSSGGGSCCHHHH--HTSHHHHT
T ss_pred HHHHHcCCCCC---CCccCCHHHHHHHHHHccCChhHCcCHHHH--hcCHHhhc
Confidence 66777776542 345689999999999999999999999976 45777653
|
| >4aw0_A HPDK1, 3-phosphoinositide-dependent protein kinase 1; transferase, allosteric regulation, allosteric site, phosphorylation, AGC protein kinase; HET: SEP ATP MJF; 1.43A {Homo sapiens} PDB: 3hrc_A* 3hrf_A* 4a06_A* 4a07_A* 3rcj_A* 4aw1_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* 1uu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-55 Score=484.78 Aligned_cols=245 Identities=33% Similarity=0.580 Sum_probs=213.5
Q ss_pred cccccccccccccEEEEEEEcCCCcEEEEEEecccc--------ChHHHHHHHHHhcCCCCceEEEEEEEeCCeEEEEEE
Q psy11767 380 LDKAGILGDGSYSVCRRCVEKSTGQEYAVKIISRKI--------DCSEEINLLRACQGHPNIVNLHCVFQDEVHTYLVLE 451 (966)
Q Consensus 380 ~~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~--------~~~~Ei~iL~~l~~HpnIV~l~~~~~~~~~~~lVmE 451 (966)
|+.++.||+|+||+||+|+++.+|+.||||++.+.. ...+|+++|+.+ +|||||+++++|++++++|||||
T Consensus 34 y~i~~~lG~G~fg~V~~a~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l-~HpnIv~l~~~~~~~~~~yivmE 112 (311)
T 4aw0_A 34 FKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRL-DHPFFVKLYFTFQDDEKLYFGLS 112 (311)
T ss_dssp EEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTC-CCTTBCCEEEEEECSSEEEEEEC
T ss_pred cEEEEEEecccCeEEEEEEECCCCCEEEEEEEEHHHCCCHHHHHHHHHHHHHHHhC-CCCCCCeEEEEEEeCCEEEEEEe
Confidence 445789999999999999999999999999996431 245799999998 59999999999999999999999
Q ss_pred ccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCcEEEecCCCCCEEEEeecccccccC----
Q psy11767 452 LLKGGELLDRIRQKGRCGFTENEASRIMRQLVAAVHFMHSRGVVHRDLKPENLLFSDPAGDNIKVVDFGFACLKRE---- 527 (966)
Q Consensus 452 y~~gg~L~~~l~~~~~~~l~e~~~~~i~~Qil~aL~yLHs~~IiHRDLKP~NILl~~~~~~~iKL~DFGla~~~~~---- 527 (966)
||+||+|.++|.+.+ .|+|.+++.|+.||+.||+|||++|||||||||+||||+. ++.+||+|||+|+....
T Consensus 113 y~~gG~L~~~i~~~~--~l~e~~~~~~~~qi~~al~ylH~~~IiHRDlKPeNILl~~--~g~vKl~DFGla~~~~~~~~~ 188 (311)
T 4aw0_A 113 YAKNGELLKYIRKIG--SFDETCTRFYTAEIVSALEYLHGKGIIHRDLKPENILLNE--DMHIQITDFGTAKVLSPESKQ 188 (311)
T ss_dssp CCTTEEHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECT--TSCEEECCCTTCEECCTTTTC
T ss_pred cCCCCCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCHHHeEEcC--CCCEEEEEcCCceecCCCCCc
Confidence 999999999998876 5999999999999999999999999999999999999975 56999999999986432
Q ss_pred -CCccccccccccCchhhccCCCCCCCcccchhhhhhhhhhhhcCCCCCCCcCcchhHHHHHHHHhcCCCCCCCCCCchh
Q psy11767 528 -SLHTPCFTLQYAAPEVLRQDKSGYDENCDLWSLGVILVNVLRQDKSGYDENCDLWSLGVILYTMLCGRVPFHARSRDDS 606 (966)
Q Consensus 528 -~~~~~~gT~~Y~APEvl~~~~~~~~~~~Di~SlGvil~el~~~~~~~y~~~~DIWSlGvilyemltG~~Pf~~~~~~~~ 606 (966)
...+.|||+.|||||++.. ..|+.++|||||||++|+|++|++||.+.+.
T Consensus 189 ~~~~~~~GTp~YmAPEvl~~--------------------------~~y~~~~DiWSlGvilyeml~G~~PF~~~~~--- 239 (311)
T 4aw0_A 189 ARANSFVGTAQYVSPELLTE--------------------------KSACKSSDLWALGCIIYQLVAGLPPFRAGNE--- 239 (311)
T ss_dssp CCBCCCCSCGGGCCHHHHHH--------------------------SCBCHHHHHHHHHHHHHHHHHSSCSSCCSSH---
T ss_pred ccccCcccCcccCCHHHHcC--------------------------CCCCcHHHHHHHHHHHHHHHhCCCCCCCCCH---
Confidence 2456799999999999863 3478899999999999999999999987543
Q ss_pred HHHHHHHHHcCCCCCCchhhccCCHHHHHHHHHhcccCccccCChHHH----HHHhhhhHH
Q psy11767 607 ALSIMARIKEGQFNFDAEAWSTVSSEAKELTKSLLTVNPAQRIRMMRV----KLTFHAFHQ 663 (966)
Q Consensus 607 ~~~~~~~i~~~~~~~~~~~~~~is~e~~~Li~~~L~~dP~~R~t~~~v----~~~~~~~~~ 663 (966)
..++.+|..+.+.++ ..+|+++++||.+||+.||++|||+.++ ....|+|++
T Consensus 240 -~~~~~~i~~~~~~~p----~~~s~~~~dli~~lL~~dp~~R~t~~e~~~~~~i~~Hp~F~ 295 (311)
T 4aw0_A 240 -GLIFAKIIKLEYDFP----EKFFPKARDLVEKLLVLDATKRLGCEEMEGYGPLKAHPFFE 295 (311)
T ss_dssp -HHHHHHHHHTCCCCC----TTCCHHHHHHHHHHSCSSGGGSTTSGGGTCHHHHHTSGGGT
T ss_pred -HHHHHHHHcCCCCCC----cccCHHHHHHHHHHccCCHhHCcChHHHcCCHHHHCCCCcC
Confidence 356677888877654 3589999999999999999999999875 245677764
|
| >4fih_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP; 1.97A {Homo sapiens} PDB: 4fig_A* 4fif_A* 4fii_A* 4fij_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7e-54 Score=482.03 Aligned_cols=245 Identities=26% Similarity=0.452 Sum_probs=210.7
Q ss_pred cccccccccccccEEEEEEEcCCCcEEEEEEecccc-----ChHHHHHHHHHhcCCCCceEEEEEEEeCCeEEEEEEccC
Q psy11767 380 LDKAGILGDGSYSVCRRCVEKSTGQEYAVKIISRKI-----DCSEEINLLRACQGHPNIVNLHCVFQDEVHTYLVLELLK 454 (966)
Q Consensus 380 ~~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~-----~~~~Ei~iL~~l~~HpnIV~l~~~~~~~~~~~lVmEy~~ 454 (966)
|+.++.||+|+||+||+|+++.+|+.||||++.... ...+|+++|+.+ +|||||+|+++|++++.+|||||||+
T Consensus 76 y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~Ei~il~~l-~HpnIV~l~~~~~~~~~~~ivmEy~~ 154 (346)
T 4fih_A 76 LDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDY-QHENVVEMYNSYLVGDELWVVMEFLE 154 (346)
T ss_dssp EEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCSSGGGGHHHHHHHHHC-CCTTBCCEEEEEEETTEEEEEECCCT
T ss_pred cEEeEEeecCcCeEEEEEEECCCCCEEEEEEEecCchhHHHHHHHHHHHHHhC-CCCCCCcEEEEEEECCEEEEEEeCCC
Confidence 344678999999999999999999999999996432 356899999998 59999999999999999999999999
Q ss_pred CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCcEEEecCCCCCEEEEeecccccccC---CCcc
Q psy11767 455 GGELLDRIRQKGRCGFTENEASRIMRQLVAAVHFMHSRGVVHRDLKPENLLFSDPAGDNIKVVDFGFACLKRE---SLHT 531 (966)
Q Consensus 455 gg~L~~~l~~~~~~~l~e~~~~~i~~Qil~aL~yLHs~~IiHRDLKP~NILl~~~~~~~iKL~DFGla~~~~~---~~~~ 531 (966)
||+|.+++.+. .+++.+++.|+.||+.||+|||++|||||||||+||||+. ++.+||+|||+|+.... ...+
T Consensus 155 gg~L~~~l~~~---~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~--~g~vKl~DFGla~~~~~~~~~~~~ 229 (346)
T 4fih_A 155 GGALTDIVTHT---RMNEEQIAAVCLAVLQALSVLHAQGVIHRDIKSDSILLTH--DGRVKLSDFGFCAQVSKEVPRRKS 229 (346)
T ss_dssp TEEHHHHHHHS---CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECT--TCCEEECCCTTCEECCSSSCCBCC
T ss_pred CCcHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCCcccccCCHHHEEECC--CCCEEEecCcCceecCCCCCcccc
Confidence 99999998763 5999999999999999999999999999999999999975 56999999999986543 3456
Q ss_pred ccccccccCchhhccCCCCCCCcccchhhhhhhhhhhhcCCCCCCCcCcchhHHHHHHHHhcCCCCCCCCCCchhHHHHH
Q psy11767 532 PCFTLQYAAPEVLRQDKSGYDENCDLWSLGVILVNVLRQDKSGYDENCDLWSLGVILYTMLCGRVPFHARSRDDSALSIM 611 (966)
Q Consensus 532 ~~gT~~Y~APEvl~~~~~~~~~~~Di~SlGvil~el~~~~~~~y~~~~DIWSlGvilyemltG~~Pf~~~~~~~~~~~~~ 611 (966)
.|||+.|||||++.. ..|+.++|||||||++|||++|++||.+.+. ..++
T Consensus 230 ~~GTp~YmAPEvl~~--------------------------~~y~~~~DiWSlGvilyeml~G~~PF~~~~~----~~~~ 279 (346)
T 4fih_A 230 LVGTPYWMAPELISR--------------------------LPYGPEVDIWSLGIMVIEMVDGEPPYFNEPP----LKAM 279 (346)
T ss_dssp CCSCGGGCCHHHHTT--------------------------CCBCTHHHHHHHHHHHHHHHHSSCTTTTSCH----HHHH
T ss_pred cccCcCcCCHHHHCC--------------------------CCCCcHHHHHHHHHHHHHHHHCCCCCCCcCH----HHHH
Confidence 799999999999852 3488999999999999999999999987543 2345
Q ss_pred HHHHcCCCCCCchhhccCCHHHHHHHHHhcccCccccCChHHHHHHhhhhHH
Q psy11767 612 ARIKEGQFNFDAEAWSTVSSEAKELTKSLLTVNPAQRIRMMRVKLTFHAFHQ 663 (966)
Q Consensus 612 ~~i~~~~~~~~~~~~~~is~e~~~Li~~~L~~dP~~R~t~~~v~~~~~~~~~ 663 (966)
..|..+. ......|..+|+++++||.+||+.||++|||+.++ ..|+|+.
T Consensus 280 ~~i~~~~-~~~~~~~~~~s~~~~dli~~~L~~dP~~R~ta~e~--l~Hp~~~ 328 (346)
T 4fih_A 280 KMIRDNL-PPRLKNLHKVSPSLKGFLDRLLVRDPAQRATAAEL--LKHPFLA 328 (346)
T ss_dssp HHHHHSS-CCCCSCGGGSCHHHHHHHHHHSCSSTTTSCCHHHH--TTCGGGG
T ss_pred HHHHcCC-CCCCCccccCCHHHHHHHHHHcCCChhHCcCHHHH--hcCHhhc
Confidence 5565543 23334567899999999999999999999999876 5678764
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-53 Score=475.61 Aligned_cols=242 Identities=25% Similarity=0.347 Sum_probs=207.5
Q ss_pred ccccccccccccEEEEEEEcCCCcEEEEEEeccccChHHHHHHHHHhcCCCCceEEEEEEEeCCeEEEEEEccCCCCHHH
Q psy11767 381 DKAGILGDGSYSVCRRCVEKSTGQEYAVKIISRKIDCSEEINLLRACQGHPNIVNLHCVFQDEVHTYLVLELLKGGELLD 460 (966)
Q Consensus 381 ~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~~~~~Ei~iL~~l~~HpnIV~l~~~~~~~~~~~lVmEy~~gg~L~~ 460 (966)
+..+.||+|+||+||+|+++.+|+.||||+++......+|+.+|+.+ +|||||+++++|+++..+|||||||+||+|.+
T Consensus 61 ~~~~~lG~G~fG~Vy~a~~~~~g~~vAiK~i~~~~~~~~E~~il~~l-~HpnIV~l~~~~~~~~~~~ivmEy~~gg~L~~ 139 (336)
T 4g3f_A 61 THQPRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEVFRVEELVACAGL-SSPRIVPLYGAVREGPWVNIFMELLEGGSLGQ 139 (336)
T ss_dssp EEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCTHHHHTTTTC-CCTTBCCEEEEEEETTEEEEEECCCTTCBHHH
T ss_pred EeCcEeccCCCeEEEEEEECCCCCEEEEEEECHHHhHHHHHHHHHhC-CCCCCCcEEEEEEECCEEEEEEeccCCCcHHH
Confidence 34678999999999999999999999999998777777899999988 59999999999999999999999999999999
Q ss_pred HHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCcEEEecCCCCCEEEEeecccccccCC--------Cccc
Q psy11767 461 RIRQKGRCGFTENEASRIMRQLVAAVHFMHSRGVVHRDLKPENLLFSDPAGDNIKVVDFGFACLKRES--------LHTP 532 (966)
Q Consensus 461 ~l~~~~~~~l~e~~~~~i~~Qil~aL~yLHs~~IiHRDLKP~NILl~~~~~~~iKL~DFGla~~~~~~--------~~~~ 532 (966)
+|.+.+ .|++.+++.|+.||+.||+|||++|||||||||+||||+. .+..+||+|||+|+..... ....
T Consensus 140 ~l~~~~--~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~-~g~~vKl~DFGla~~~~~~~~~~~~~~~~~~ 216 (336)
T 4g3f_A 140 LIKQMG--CLPEDRALYYLGQALEGLEYLHTRRILHGDVKADNVLLSS-DGSRAALCDFGHALCLQPDGLGKSLLTGDYI 216 (336)
T ss_dssp HHHHHS--SCCHHHHHHHHHHHHHHHHHHHTTTEECSCCCGGGEEECT-TSCCEEECCCTTCEEC------------CCC
T ss_pred HHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCCceecccCHHHEEEeC-CCCEEEEeeCCCCeEccCCCcccceecCCcc
Confidence 998876 5999999999999999999999999999999999999974 2337999999999764321 1245
Q ss_pred cccccccCchhhccCCCCCCCcccchhhhhhhhhhhhcCCCCCCCcCcchhHHHHHHHHhcCCCCCCCCCCchhHHHHHH
Q psy11767 533 CFTLQYAAPEVLRQDKSGYDENCDLWSLGVILVNVLRQDKSGYDENCDLWSLGVILYTMLCGRVPFHARSRDDSALSIMA 612 (966)
Q Consensus 533 ~gT~~Y~APEvl~~~~~~~~~~~Di~SlGvil~el~~~~~~~y~~~~DIWSlGvilyemltG~~Pf~~~~~~~~~~~~~~ 612 (966)
+||+.|||||++.. ..|+.++|||||||++|||++|++||.+.+..+. +.
T Consensus 217 ~GT~~YmAPE~~~~--------------------------~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~~~----~~ 266 (336)
T 4g3f_A 217 PGTETHMAPEVVMG--------------------------KPCDAKVDIWSSCCMMLHMLNGCHPWTQYFRGPL----CL 266 (336)
T ss_dssp CCCGGGCCHHHHTT--------------------------CCCCTHHHHHHHHHHHHHHHHSSCSSTTTCCSCC----HH
T ss_pred ccCccccCHHHHCC--------------------------CCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHHHH----HH
Confidence 89999999999853 3488999999999999999999999988765543 34
Q ss_pred HHHcCCCCCCchhhccCCHHHHHHHHHhcccCccccCChHHHHHH
Q psy11767 613 RIKEGQFNFDAEAWSTVSSEAKELTKSLLTVNPAQRIRMMRVKLT 657 (966)
Q Consensus 613 ~i~~~~~~~~~~~~~~is~e~~~Li~~~L~~dP~~R~t~~~v~~~ 657 (966)
+|..+...+ .+.++.+|+++++||.+||+.||++|||+.++...
T Consensus 267 ~i~~~~~~~-~~~~~~~s~~~~~li~~~L~~dP~~R~sa~el~~~ 310 (336)
T 4g3f_A 267 KIASEPPPI-REIPPSCAPLTAQAIQEGLRKEPVHRASAMELRRK 310 (336)
T ss_dssp HHHHSCCGG-GGSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHcCCCCc-hhcCccCCHHHHHHHHHHccCCHhHCcCHHHHHHH
Confidence 455544332 23456799999999999999999999999987543
|
| >3hyh_A Carbon catabolite-derepressing protein kinase; kinase domain, transferase, ATP-binding, carbohydrate metabo kinase, membrane; 2.20A {Saccharomyces cerevisiae} PDB: 3dae_A 2fh9_A 3mn3_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-53 Score=461.48 Aligned_cols=242 Identities=37% Similarity=0.627 Sum_probs=197.8
Q ss_pred cccccccccccEEEEEEEcCCCcEEEEEEecccc--------ChHHHHHHHHHhcCCCCceEEEEEEEeCCeEEEEEEcc
Q psy11767 382 KAGILGDGSYSVCRRCVEKSTGQEYAVKIISRKI--------DCSEEINLLRACQGHPNIVNLHCVFQDEVHTYLVLELL 453 (966)
Q Consensus 382 ~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~--------~~~~Ei~iL~~l~~HpnIV~l~~~~~~~~~~~lVmEy~ 453 (966)
..+.||+|+||+||+|+++.+|+.||||++.+.. ...+|+++|+.+ +|||||+++++|++++.+|||||||
T Consensus 17 i~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l-~HpnIv~~~~~~~~~~~~~ivmEy~ 95 (275)
T 3hyh_A 17 IVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLL-RHPHIIKLYDVIKSKDEIIMVIEYA 95 (275)
T ss_dssp EEEEEEC---CCEEEEECTTTCCEEEEEEEECC------CHHHHHHHHHHHHHC-CCTTBCCEEEEEECSSEEEEEEECC
T ss_pred EEEEEecCcCeEEEEEEECCCCCEEEEEEEeHHHcCCHHHHHHHHHHHHHHHHC-CCCCCCeEEEEEEECCEEEEEEeCC
Confidence 3688999999999999999999999999996542 145799999998 5999999999999999999999999
Q ss_pred CCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCcEEEecCCCCCEEEEeecccccccC--CCcc
Q psy11767 454 KGGELLDRIRQKGRCGFTENEASRIMRQLVAAVHFMHSRGVVHRDLKPENLLFSDPAGDNIKVVDFGFACLKRE--SLHT 531 (966)
Q Consensus 454 ~gg~L~~~l~~~~~~~l~e~~~~~i~~Qil~aL~yLHs~~IiHRDLKP~NILl~~~~~~~iKL~DFGla~~~~~--~~~~ 531 (966)
+|+|.+++.+++ .+++.+++.++.||+.||+|||++||+||||||+|||++. ++.+||+|||+|+.... ...+
T Consensus 96 -~g~L~~~l~~~~--~l~e~~~~~~~~qi~~al~ylH~~~IiHRDiKP~NILl~~--~~~vkl~DFGla~~~~~~~~~~~ 170 (275)
T 3hyh_A 96 -GNELFDYIVQRD--KMSEQEARRFFQQIISAVEYCHRHKIVHRDLKPENLLLDE--HLNVKIADFGLSNIMTDGNFLKT 170 (275)
T ss_dssp -CEEHHHHHHHSC--SCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCTTTEEECT--TCCEEECCSSCC-----------
T ss_pred -CCCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCCcccccCChHHeEECC--CCCEEEeecCCCeecCCCCccCC
Confidence 789999998765 5999999999999999999999999999999999999975 56999999999976543 3456
Q ss_pred ccccccccCchhhccCCCCCCCcccchhhhhhhhhhhhcCCCCCCCcCcchhHHHHHHHHhcCCCCCCCCCCchhHHHHH
Q psy11767 532 PCFTLQYAAPEVLRQDKSGYDENCDLWSLGVILVNVLRQDKSGYDENCDLWSLGVILYTMLCGRVPFHARSRDDSALSIM 611 (966)
Q Consensus 532 ~~gT~~Y~APEvl~~~~~~~~~~~Di~SlGvil~el~~~~~~~y~~~~DIWSlGvilyemltG~~Pf~~~~~~~~~~~~~ 611 (966)
.+||+.|||||++... ..++.++||||+||++|+|++|++||.+.+. ..++
T Consensus 171 ~~GT~~Y~APE~~~~~-------------------------~y~~~~~DiwSlGvily~lltg~~PF~~~~~----~~~~ 221 (275)
T 3hyh_A 171 SCGSPNYAAPEVISGK-------------------------LYAGPEVDVWSCGVILYVMLCRRLPFDDESI----PVLF 221 (275)
T ss_dssp ----CTTSCHHHHSSS-------------------------SCCCTHHHHHHHHHHHHHHHHSSCSSCCSSH----HHHH
T ss_pred eeECcccCChhhhcCC-------------------------CCCCChhhhHHHHHHHHHHHHCCCCCCCCCH----HHHH
Confidence 7899999999998532 2246789999999999999999999987543 3556
Q ss_pred HHHHcCCCCCCchhhccCCHHHHHHHHHhcccCccccCChHHHHHHhhhhHHh
Q psy11767 612 ARIKEGQFNFDAEAWSTVSSEAKELTKSLLTVNPAQRIRMMRVKLTFHAFHQA 664 (966)
Q Consensus 612 ~~i~~~~~~~~~~~~~~is~e~~~Li~~~L~~dP~~R~t~~~v~~~~~~~~~~ 664 (966)
..|..+.+.++ ..+|+++++||.+||+.||++|||+.++ ..|+|++.
T Consensus 222 ~~i~~~~~~~p----~~~s~~~~~li~~~L~~dP~~R~s~~ei--l~hpw~k~ 268 (275)
T 3hyh_A 222 KNISNGVYTLP----KFLSPGAAGLIKRMLIVNPLNRISIHEI--MQDDWFKV 268 (275)
T ss_dssp HHHHHTCCCCC----TTSCHHHHHHHHHHSCSSGGGSCCHHHH--HHCHHHHT
T ss_pred HHHHcCCCCCC----CCCCHHHHHHHHHHccCChhHCcCHHHH--HcCccccc
Confidence 77777776654 3589999999999999999999999976 45788753
|
| >4fie_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP ANP; 3.11A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.1e-53 Score=484.23 Aligned_cols=245 Identities=26% Similarity=0.452 Sum_probs=210.7
Q ss_pred cccccccccccccEEEEEEEcCCCcEEEEEEecccc-----ChHHHHHHHHHhcCCCCceEEEEEEEeCCeEEEEEEccC
Q psy11767 380 LDKAGILGDGSYSVCRRCVEKSTGQEYAVKIISRKI-----DCSEEINLLRACQGHPNIVNLHCVFQDEVHTYLVLELLK 454 (966)
Q Consensus 380 ~~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~-----~~~~Ei~iL~~l~~HpnIV~l~~~~~~~~~~~lVmEy~~ 454 (966)
|+.++.||+|+||+||+|+++.+|+.||||++.... ...+|+.+|+.+ +|||||+|+++|++++.+|||||||+
T Consensus 153 y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~Ei~il~~l-~HpnIV~l~~~~~~~~~~~iVmEy~~ 231 (423)
T 4fie_A 153 LDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDY-QHENVVEMYNSYLVGDELWVVMEFLE 231 (423)
T ss_dssp EEEEEEEEECSSCEEEEEEETTTCCEEEEEEEESTTCSSGGGHHHHHHHHHHC-CCTTBCCEEEEEEETTEEEEEEECCT
T ss_pred cEeeeEeccCcCcEEEEEEECCCCCEEEEEEEeccchhHHHHHHHHHHHHHhC-CCCCCCceEEEEEECCEEEEEEeCCC
Confidence 445788999999999999999999999999996432 256899999998 59999999999999999999999999
Q ss_pred CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCcEEEecCCCCCEEEEeecccccccC---CCcc
Q psy11767 455 GGELLDRIRQKGRCGFTENEASRIMRQLVAAVHFMHSRGVVHRDLKPENLLFSDPAGDNIKVVDFGFACLKRE---SLHT 531 (966)
Q Consensus 455 gg~L~~~l~~~~~~~l~e~~~~~i~~Qil~aL~yLHs~~IiHRDLKP~NILl~~~~~~~iKL~DFGla~~~~~---~~~~ 531 (966)
||+|.+++... .|++.+++.|+.||+.||+|||++|||||||||+||||+. ++.+||+|||+|+.... ...+
T Consensus 232 gG~L~~~i~~~---~l~e~~~~~~~~qil~aL~ylH~~~IiHRDiKp~NILl~~--~g~vKl~DFGla~~~~~~~~~~~~ 306 (423)
T 4fie_A 232 GGALTDIVTHT---RMNEEQIAAVCLAVLQALSVLHAQGVIHRDIKSDSILLTH--DGRVKLSDFGFCAQVSKEVPRRKS 306 (423)
T ss_dssp TEEHHHHHHHS---CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSTTTEEECT--TCCEEECCCTTCEECCSSCCCBCC
T ss_pred CCcHHHHHhcc---CCCHHHHHHHHHHHHHHHHHHHHCCeecccCCHHHEEEcC--CCCEEEecCccceECCCCCccccc
Confidence 99999998754 4999999999999999999999999999999999999975 56999999999986543 3456
Q ss_pred ccccccccCchhhccCCCCCCCcccchhhhhhhhhhhhcCCCCCCCcCcchhHHHHHHHHhcCCCCCCCCCCchhHHHHH
Q psy11767 532 PCFTLQYAAPEVLRQDKSGYDENCDLWSLGVILVNVLRQDKSGYDENCDLWSLGVILYTMLCGRVPFHARSRDDSALSIM 611 (966)
Q Consensus 532 ~~gT~~Y~APEvl~~~~~~~~~~~Di~SlGvil~el~~~~~~~y~~~~DIWSlGvilyemltG~~Pf~~~~~~~~~~~~~ 611 (966)
.|||+.|||||++.. ..|+.++|||||||++|||++|++||.+.+. ..++
T Consensus 307 ~~GTp~YmAPEvl~~--------------------------~~y~~~~DiWSlGvilyeml~G~~PF~~~~~----~~~~ 356 (423)
T 4fie_A 307 LVGTPYWMAPELISR--------------------------LPYGPEVDIWSLGIMVIEMVDGEPPYFNEPP----LKAM 356 (423)
T ss_dssp CEECTTTCCHHHHTT--------------------------CCBCTHHHHHHHHHHHHHHHHSSCTTTTSCH----HHHH
T ss_pred cccCcCcCCHHHHCC--------------------------CCCCcHHHHHHHHHHHHHHHHCCCCCCCcCH----HHHH
Confidence 799999999999852 3488999999999999999999999987543 3445
Q ss_pred HHHHcCCCCCCchhhccCCHHHHHHHHHhcccCccccCChHHHHHHhhhhHH
Q psy11767 612 ARIKEGQFNFDAEAWSTVSSEAKELTKSLLTVNPAQRIRMMRVKLTFHAFHQ 663 (966)
Q Consensus 612 ~~i~~~~~~~~~~~~~~is~e~~~Li~~~L~~dP~~R~t~~~v~~~~~~~~~ 663 (966)
..|..+. ......+..+|+++++||.+||+.||++|||+.++ ..|+|+.
T Consensus 357 ~~i~~~~-~~~~~~~~~~s~~~~dli~~~L~~dP~~R~ta~el--l~Hp~~~ 405 (423)
T 4fie_A 357 KMIRDNL-PPRLKNLHKVSPSLKGFLDRLLVRDPAQRATAAEL--LKHPFLA 405 (423)
T ss_dssp HHHHHSC-CCCCSCTTSSCHHHHHHHHHHSCSSTTTSCCHHHH--TTCGGGG
T ss_pred HHHHcCC-CCCCcccccCCHHHHHHHHHHcCCChhHCcCHHHH--hcCHHhc
Confidence 5565543 22334566899999999999999999999999876 5678765
|
| >3fpq_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase, ATP-BIND kinase, nucleotide-binding, phosphoprotein; 1.80A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-52 Score=458.19 Aligned_cols=242 Identities=26% Similarity=0.402 Sum_probs=204.2
Q ss_pred cccccccccEEEEEEEcCCCcEEEEEEecccc-------ChHHHHHHHHHhcCCCCceEEEEEEEe----CCeEEEEEEc
Q psy11767 384 GILGDGSYSVCRRCVEKSTGQEYAVKIISRKI-------DCSEEINLLRACQGHPNIVNLHCVFQD----EVHTYLVLEL 452 (966)
Q Consensus 384 ~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~-------~~~~Ei~iL~~l~~HpnIV~l~~~~~~----~~~~~lVmEy 452 (966)
++||+|+||+||+|+++.+++.||||++.... ...+|+++|+.+ +|||||+++++|++ +..+||||||
T Consensus 32 ~~iG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l-~HpnIV~~~~~~~~~~~~~~~~~lvmEy 110 (290)
T 3fpq_A 32 IEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGL-QHPNIVRFYDSWESTVKGKKCIVLVTEL 110 (290)
T ss_dssp EEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHTC-CCTTBCCEEEEEEEEETTEEEEEEEEEC
T ss_pred eEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhC-CCCCCCcEEEEEeeccCCCcEEEEEEeC
Confidence 46999999999999999999999999996543 245799999998 59999999999975 3568999999
Q ss_pred cCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcC--ceeccCCCCcEEEecCCCCCEEEEeecccccccC-CC
Q psy11767 453 LKGGELLDRIRQKGRCGFTENEASRIMRQLVAAVHFMHSRG--VVHRDLKPENLLFSDPAGDNIKVVDFGFACLKRE-SL 529 (966)
Q Consensus 453 ~~gg~L~~~l~~~~~~~l~e~~~~~i~~Qil~aL~yLHs~~--IiHRDLKP~NILl~~~~~~~iKL~DFGla~~~~~-~~ 529 (966)
|+||+|.++|.+.+ .+++.+++.|+.||+.||+|||++| ||||||||+||||++ .++.+||+|||+|+.... ..
T Consensus 111 ~~gg~L~~~l~~~~--~l~~~~~~~~~~qi~~aL~ylH~~~~~IiHRDlKp~NILl~~-~~g~vKl~DFGla~~~~~~~~ 187 (290)
T 3fpq_A 111 MTSGTLKTYLKRFK--VMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITG-PTGSVKIGDLGLATLKRASFA 187 (290)
T ss_dssp CCSCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHTSSSCCCCCCCCGGGEEESS-TTSCEEECCTTGGGGCCTTSB
T ss_pred CCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCCCEEecccChhheeEEC-CCCCEEEEeCcCCEeCCCCcc
Confidence 99999999998765 5999999999999999999999998 999999999999964 246899999999986543 34
Q ss_pred ccccccccccCchhhccCCCCCCCcccchhhhhhhhhhhhcCCCCCCCcCcchhHHHHHHHHhcCCCCCCCCCCchhHHH
Q psy11767 530 HTPCFTLQYAAPEVLRQDKSGYDENCDLWSLGVILVNVLRQDKSGYDENCDLWSLGVILYTMLCGRVPFHARSRDDSALS 609 (966)
Q Consensus 530 ~~~~gT~~Y~APEvl~~~~~~~~~~~Di~SlGvil~el~~~~~~~y~~~~DIWSlGvilyemltG~~Pf~~~~~~~~~~~ 609 (966)
.+.+||+.|||||++. ..|+.++|||||||++|||+||++||.+.... ..
T Consensus 188 ~~~~GTp~YmAPE~~~---------------------------~~y~~~~DiwSlGvilyelltg~~Pf~~~~~~---~~ 237 (290)
T 3fpq_A 188 KAVIGTPEFMAPEMYE---------------------------EKYDESVDVYAFGMCMLEMATSEYPYSECQNA---AQ 237 (290)
T ss_dssp EESCSSCCCCCGGGGG---------------------------TCCCTHHHHHHHHHHHHHHHHSSCTTTTCSSH---HH
T ss_pred CCcccCccccCHHHcC---------------------------CCCCcHHHHHHHHHHHHHHHHCCCCCCCCCcH---HH
Confidence 5678999999999874 13789999999999999999999999765432 34
Q ss_pred HHHHHHcCCCCCCchhhccCCHHHHHHHHHhcccCccccCChHHHHHHhhhhHH
Q psy11767 610 IMARIKEGQFNFDAEAWSTVSSEAKELTKSLLTVNPAQRIRMMRVKLTFHAFHQ 663 (966)
Q Consensus 610 ~~~~i~~~~~~~~~~~~~~is~e~~~Li~~~L~~dP~~R~t~~~v~~~~~~~~~ 663 (966)
+...+..+.. +...+..+++++++||.+||+.||++|||+.++ ..|+|++
T Consensus 238 ~~~~i~~~~~--~~~~~~~~~~~~~~li~~~L~~dP~~R~s~~e~--l~Hp~~~ 287 (290)
T 3fpq_A 238 IYRRVTSGVK--PASFDKVAIPEVKEIIEGCIRQNKDERYSIKDL--LNHAFFQ 287 (290)
T ss_dssp HHHHHTTTCC--CGGGGGCCCHHHHHHHHHHSCSSGGGSCCHHHH--HTSGGGC
T ss_pred HHHHHHcCCC--CCCCCccCCHHHHHHHHHHccCChhHCcCHHHH--hcCcccc
Confidence 4556665543 233445688999999999999999999999876 4577764
|
| >3ubd_A Ribosomal protein S6 kinase alpha-3; kinase-inhibitor complex, induced FIT, transferase-transfera inhibitor complex; HET: SL0; 1.53A {Mus musculus} PDB: 4el9_A* 3g51_A* 2z7q_A* 2z7r_A* 2z7s_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-52 Score=465.41 Aligned_cols=245 Identities=33% Similarity=0.603 Sum_probs=203.8
Q ss_pred cccccccccccccEEEEEEEc---CCCcEEEEEEeccc-------cChHHHHHHHHHhcCCCCceEEEEEEEeCCeEEEE
Q psy11767 380 LDKAGILGDGSYSVCRRCVEK---STGQEYAVKIISRK-------IDCSEEINLLRACQGHPNIVNLHCVFQDEVHTYLV 449 (966)
Q Consensus 380 ~~~~~~LG~G~fG~Vy~a~~~---~tg~~vAvK~i~~~-------~~~~~Ei~iL~~l~~HpnIV~l~~~~~~~~~~~lV 449 (966)
|+.++.||+|+||+||+|++. .+++.||||++.+. ....+|+++|+.+ +|||||+++++|++++.+|||
T Consensus 26 Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l-~HpnIv~l~~~~~~~~~~~iv 104 (304)
T 3ubd_A 26 FELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEV-NHPFIVKLHYAFQTEGKLYLI 104 (304)
T ss_dssp EEEEEEEECGGGCEEEEEEECSSTTTTCEEEEEEEESEEEEEEECC------CCCCCC-CCTTEECEEEEEEETTEEEEE
T ss_pred cEEEEEEecCCCeEEEEEEEccCCCCCEEEEEEEEehHHcChHHHHHHHHHHHHHHHC-CCCCCCeEEEEEEECCEEEEE
Confidence 444789999999999999985 46899999999643 2356799999888 599999999999999999999
Q ss_pred EEccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCcEEEecCCCCCEEEEeeccccccc---
Q psy11767 450 LELLKGGELLDRIRQKGRCGFTENEASRIMRQLVAAVHFMHSRGVVHRDLKPENLLFSDPAGDNIKVVDFGFACLKR--- 526 (966)
Q Consensus 450 mEy~~gg~L~~~l~~~~~~~l~e~~~~~i~~Qil~aL~yLHs~~IiHRDLKP~NILl~~~~~~~iKL~DFGla~~~~--- 526 (966)
||||+||+|.++|.+.+ .+++.+++.|+.||+.||+|||++|||||||||+|||++. ++.+||+|||+|+...
T Consensus 105 mEy~~gg~L~~~l~~~~--~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~--~g~vKl~DFGla~~~~~~~ 180 (304)
T 3ubd_A 105 LDFLRGGDLFTRLSKEV--MFTEEDVKFYLAELALALDHLHSLGIIYRDLKPENILLDE--EGHIKLTDFGLSKESIDHE 180 (304)
T ss_dssp ECCCTTCEEHHHHHHHC--CCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCCGGGEEECT--TSCEEEESSEEEEC-----
T ss_pred EEcCCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCCcCCCCCHHHeEEcC--CCCEEecccccceeccCCC
Confidence 99999999999998876 5999999999999999999999999999999999999975 5699999999997643
Q ss_pred CCCccccccccccCchhhccCCCCCCCcccchhhhhhhhhhhhcCCCCCCCcCcchhHHHHHHHHhcCCCCCCCCCCchh
Q psy11767 527 ESLHTPCFTLQYAAPEVLRQDKSGYDENCDLWSLGVILVNVLRQDKSGYDENCDLWSLGVILYTMLCGRVPFHARSRDDS 606 (966)
Q Consensus 527 ~~~~~~~gT~~Y~APEvl~~~~~~~~~~~Di~SlGvil~el~~~~~~~y~~~~DIWSlGvilyemltG~~Pf~~~~~~~~ 606 (966)
....+.+||+.|||||++.. ..|+.++|||||||++|||++|++||.+.+.
T Consensus 181 ~~~~~~~GT~~YmAPE~~~~--------------------------~~y~~~~DiwSlGvilyemltG~~PF~~~~~--- 231 (304)
T 3ubd_A 181 KKAYSFCGTVEYMAPEVVNR--------------------------RGHTQSADWWSFGVLMFEMLTGTLPFQGKDR--- 231 (304)
T ss_dssp CCCCSCCCCGGGCCHHHHHT--------------------------SCCCTHHHHHHHHHHHHHHHHSSCSSCCSSH---
T ss_pred ccccccccCcccCCHHHhcc--------------------------CCCCCCCcccchHHHHHHHHhCCCCCCCcCH---
Confidence 23456789999999999863 3488899999999999999999999987653
Q ss_pred HHHHHHHHHcCCCCCCchhhccCCHHHHHHHHHhcccCccccCChHH--H-HHHhhhhHH
Q psy11767 607 ALSIMARIKEGQFNFDAEAWSTVSSEAKELTKSLLTVNPAQRIRMMR--V-KLTFHAFHQ 663 (966)
Q Consensus 607 ~~~~~~~i~~~~~~~~~~~~~~is~e~~~Li~~~L~~dP~~R~t~~~--v-~~~~~~~~~ 663 (966)
..++.+|.++.+.++ ..+|+++++||.+||+.||++|||+.. + ....|+|++
T Consensus 232 -~~~~~~i~~~~~~~p----~~~s~~~~~li~~~L~~dP~~R~ta~~~~~~eil~Hp~f~ 286 (304)
T 3ubd_A 232 -KETMTMILKAKLGMP----QFLSPEAQSLLRMLFKRNPANRLGAGPDGVEEIKRHSFFS 286 (304)
T ss_dssp -HHHHHHHHHCCCCCC----TTSCHHHHHHHHHHTCSSGGGSTTCSTTTHHHHHTSGGGT
T ss_pred -HHHHHHHHcCCCCCC----CcCCHHHHHHHHHHcccCHHHCCCCCcCCHHHHHcCcccc
Confidence 345667777766543 468999999999999999999999631 1 335677764
|
| >4asz_A BDNF/NT-3 growth factors receptor; transferase, TRKA, TRKB; 1.70A {Homo sapiens} PDB: 4at3_A* 4at4_A* 4at5_A* 3v5q_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-50 Score=446.42 Aligned_cols=242 Identities=24% Similarity=0.347 Sum_probs=200.8
Q ss_pred cccccccccccEEEEEEEc-----CCCcEEEEEEecccc-----ChHHHHHHHHHhcCCCCceEEEEEEEeCCeEEEEEE
Q psy11767 382 KAGILGDGSYSVCRRCVEK-----STGQEYAVKIISRKI-----DCSEEINLLRACQGHPNIVNLHCVFQDEVHTYLVLE 451 (966)
Q Consensus 382 ~~~~LG~G~fG~Vy~a~~~-----~tg~~vAvK~i~~~~-----~~~~Ei~iL~~l~~HpnIV~l~~~~~~~~~~~lVmE 451 (966)
..+.||+|+||+||+|++. .+|+.||||+++... .+.+|+++|+.+ +|||||+++++|.++...|||||
T Consensus 17 l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~il~~l-~HpnIV~l~g~~~~~~~~~lV~E 95 (299)
T 4asz_A 17 LKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNL-QHEHIVKFYGVCVEGDPLIMVFE 95 (299)
T ss_dssp EEEEEEC--CCCEEEEEECSCC----CEEEEEEEECSCCHHHHHHHHHHHHHHTTC-CCTTBCCEEEEECSSSSEEEEEE
T ss_pred EeeEEeeCCCcEEEEEEECCcccCCCCEEEEEEEeCCCChHHHHHHHHHHHHHHhC-CCCCCccEEEEEeeCCEEEEEEE
Confidence 3578999999999999875 368899999997542 255799999998 59999999999999999999999
Q ss_pred ccCCCCHHHHHHhcC-----------CCCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCcEEEecCCCCCEEEEeec
Q psy11767 452 LLKGGELLDRIRQKG-----------RCGFTENEASRIMRQLVAAVHFMHSRGVVHRDLKPENLLFSDPAGDNIKVVDFG 520 (966)
Q Consensus 452 y~~gg~L~~~l~~~~-----------~~~l~e~~~~~i~~Qil~aL~yLHs~~IiHRDLKP~NILl~~~~~~~iKL~DFG 520 (966)
||+||+|.++|.+.+ ...|++.++..|+.||+.||+|||+++||||||||+||||+. ++.+||+|||
T Consensus 96 y~~~G~L~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHRDlKp~NILl~~--~~~~Ki~DFG 173 (299)
T 4asz_A 96 YMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQIAAGMVYLASQHFVHRDLATRNCLVGE--NLLVKIGDFG 173 (299)
T ss_dssp CCTTCBHHHHHHHTSHHHHHC----CCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECG--GGCEEECCCS
T ss_pred cCCCCcHHHHHHhcCcccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCccCHhhEEECC--CCcEEECCcc
Confidence 999999999997643 236999999999999999999999999999999999999985 5689999999
Q ss_pred ccccccCC-----CccccccccccCchhhccCCCCCCCcccchhhhhhhhhhhhcCCCCCCCcCcchhHHHHHHHHhc-C
Q psy11767 521 FACLKRES-----LHTPCFTLQYAAPEVLRQDKSGYDENCDLWSLGVILVNVLRQDKSGYDENCDLWSLGVILYTMLC-G 594 (966)
Q Consensus 521 la~~~~~~-----~~~~~gT~~Y~APEvl~~~~~~~~~~~Di~SlGvil~el~~~~~~~y~~~~DIWSlGvilyemlt-G 594 (966)
+|+..... ....+||+.|||||++.. ..|+.++|||||||+||||+| |
T Consensus 174 la~~~~~~~~~~~~~~~~gt~~ymAPE~~~~--------------------------~~~~~k~DVwS~Gvvl~Ellt~G 227 (299)
T 4asz_A 174 MSRDVYSTDYYRVGGHTMLPIRWMPPESIMY--------------------------RKFTTESDVWSLGVVLWEIFTYG 227 (299)
T ss_dssp CHHHHTGGGCEEETTTEEECGGGCCHHHHHH--------------------------CCCCHHHHHHHHHHHHHHHHTTT
T ss_pred cceecCCCCceeecCceecChhhcCHHHHcC--------------------------CCCCchhhHHHHHHHHHHHHcCC
Confidence 99754321 123468999999999863 248899999999999999998 9
Q ss_pred CCCCCCCCCchhHHHHHHHHHcCCCCCCchhhccCCHHHHHHHHHhcccCccccCChHHHHHHhh
Q psy11767 595 RVPFHARSRDDSALSIMARIKEGQFNFDAEAWSTVSSEAKELTKSLLTVNPAQRIRMMRVKLTFH 659 (966)
Q Consensus 595 ~~Pf~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~is~e~~~Li~~~L~~dP~~R~t~~~v~~~~~ 659 (966)
+.||.+.+. .+++..+..+.... .+..+++++.+||.+||+.||++|||+.++...+.
T Consensus 228 ~~Pf~~~~~----~~~~~~i~~~~~~~---~p~~~~~~~~~li~~cl~~dP~~RPs~~~i~~~L~ 285 (299)
T 4asz_A 228 KQPWYQLSN----NEVIECITQGRVLQ---RPRTCPQEVYELMLGCWQREPHMRKNIKGIHTLLQ 285 (299)
T ss_dssp CCTTTTSCH----HHHHHHHHHTCCCC---CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred CCCCCCCCH----HHHHHHHHcCCCCC---CCccchHHHHHHHHHHcCCChhHCcCHHHHHHHHH
Confidence 999987653 34566677765432 23468999999999999999999999998855443
|
| >4f9c_A Cell division cycle 7-related protein kinase; Ser/Thr protein kinase, transferase, phosphorylation, cell C cell division, mitosis, S phase; HET: 0SX; 2.08A {Homo sapiens} PDB: 4f99_A* 4f9b_A* 4f9a_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.7e-50 Score=454.45 Aligned_cols=249 Identities=28% Similarity=0.474 Sum_probs=199.2
Q ss_pred cccccccccccEEEEEEEc---CCCcEEEEEEeccccC---hHHHHHHHHHhcCCCCceEEEEEEEeCCeEEEEEEccCC
Q psy11767 382 KAGILGDGSYSVCRRCVEK---STGQEYAVKIISRKID---CSEEINLLRACQGHPNIVNLHCVFQDEVHTYLVLELLKG 455 (966)
Q Consensus 382 ~~~~LG~G~fG~Vy~a~~~---~tg~~vAvK~i~~~~~---~~~Ei~iL~~l~~HpnIV~l~~~~~~~~~~~lVmEy~~g 455 (966)
..+.||+|+||+||+|+++ .+++.||||++.+... ..+|+++|+.+.+|||||+++++|++++++|||||||+|
T Consensus 25 i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~~~~~~~E~~~l~~~~~h~nIv~l~~~~~~~~~~~lvmE~~~g 104 (361)
T 4f9c_A 25 IEDKIGEGTFSSVYLATAQLQVGPEEKIALKHLIPTSHPIRIAAELQCLTVAGGQDNVMGVKYCFRKNDHVVIAMPYLEH 104 (361)
T ss_dssp EEEEEEECSSEEEEEEEEEBTTSCEEEEEEEEECTTSCHHHHHHHHHHHHHTCSBTTBCCCSEEEEETTEEEEEEECCCC
T ss_pred EEEEEecccCcEEEEEEEcccCCCCCEEEEEEEccccCHHHHHHHHHHHHHhcCCCCCceEEEEEEECCEEEEEEeCCCc
Confidence 3688999999999999986 4688999999876543 457999999988899999999999999999999999999
Q ss_pred CCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCcEEEecCCCCCEEEEeecccccccC--------
Q psy11767 456 GELLDRIRQKGRCGFTENEASRIMRQLVAAVHFMHSRGVVHRDLKPENLLFSDPAGDNIKVVDFGFACLKRE-------- 527 (966)
Q Consensus 456 g~L~~~l~~~~~~~l~e~~~~~i~~Qil~aL~yLHs~~IiHRDLKP~NILl~~~~~~~iKL~DFGla~~~~~-------- 527 (966)
|+|.+++. .+++.+++.|+.||+.||+|||++|||||||||+|||++. ..+.+||+|||+|+....
T Consensus 105 ~~L~~~~~-----~l~~~~~~~~~~qll~al~ylH~~gIiHRDiKPeNiLl~~-~~~~~kl~DFGla~~~~~~~~~~~~~ 178 (361)
T 4f9c_A 105 ESFLDILN-----SLSFQEVREYMLNLFKALKRIHQFGIVHRDVKPSNFLYNR-RLKKYALVDFGLAQGTHDTKIELLKF 178 (361)
T ss_dssp CCHHHHHT-----TCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEET-TTTEEEECCCTTCEECTTCSCGGGGG
T ss_pred ccHHHHHc-----CCCHHHHHHHHHHHHHHHHHHHHCCeEeCcCCHHHeEEeC-CCCeEEECcCCCCcccCCcccccccc
Confidence 99999983 4899999999999999999999999999999999999975 346899999999964321
Q ss_pred -----------------------CCccccccccccCchhhccCCCCCCCcccchhhhhhhhhhhhcCCCCCCCcCcchhH
Q psy11767 528 -----------------------SLHTPCFTLQYAAPEVLRQDKSGYDENCDLWSLGVILVNVLRQDKSGYDENCDLWSL 584 (966)
Q Consensus 528 -----------------------~~~~~~gT~~Y~APEvl~~~~~~~~~~~Di~SlGvil~el~~~~~~~y~~~~DIWSl 584 (966)
...+.+||+.|||||++.. ...|+.++||||+
T Consensus 179 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~-------------------------~~~y~~~~DiWSl 233 (361)
T 4f9c_A 179 VQSEAQQERCSQNKCSICLSRRQQVAPRAGTPGFRAPEVLTK-------------------------CPNQTTAIDMWSA 233 (361)
T ss_dssp C--------------------------CCCCGGGCCHHHHTT-------------------------CSCCCTHHHHHHH
T ss_pred ccccccccccccccccccccccccccccccCccccCHHHHcC-------------------------CCCCCCccchhhh
Confidence 1234579999999999853 2347889999999
Q ss_pred HHHHHHHhcCCCCCCCCCCchhHHHHHHHHH-----------------------------------cCCC----------
Q psy11767 585 GVILYTMLCGRVPFHARSRDDSALSIMARIK-----------------------------------EGQF---------- 619 (966)
Q Consensus 585 GvilyemltG~~Pf~~~~~~~~~~~~~~~i~-----------------------------------~~~~---------- 619 (966)
||++|||++|++||...+.....+..+..+. ....
T Consensus 234 G~il~ell~G~~Pf~~~~~~~~~l~~I~~~~G~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~p~~~~~~~ 313 (361)
T 4f9c_A 234 GVIFLSLLSGRYPFYKASDDLTALAQIMTIRGSRETIQAAKTFGKSILCSKEVPAQDLRKLCERLRGMDSSTPKLTSDIQ 313 (361)
T ss_dssp HHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHHHHHHHTTEEEEESSCCCCCCHHHHHHHHC--------------
T ss_pred HHHHHHHHHCCCCCCCCCCHHHHHHHHHHhcCCccchhhhhhccccccccccCcchhhhHHHHhhccccccccccccccc
Confidence 9999999999999976554322222111110 0000
Q ss_pred --CCCchhhccCCHHHHHHHHHhcccCccccCChHHHHHHhhhhHH
Q psy11767 620 --NFDAEAWSTVSSEAKELTKSLLTVNPAQRIRMMRVKLTFHAFHQ 663 (966)
Q Consensus 620 --~~~~~~~~~is~e~~~Li~~~L~~dP~~R~t~~~v~~~~~~~~~ 663 (966)
....+.|..+|++++|||.+||++||++|+|+.++ ..|||++
T Consensus 314 ~~~~~~~~~~~is~~a~DLl~~lL~~dP~~R~ta~ea--L~Hp~f~ 357 (361)
T 4f9c_A 314 GHATNLEGWNEVPDEAYDLLDKLLDLNPASRITAEEA--LLHPFFK 357 (361)
T ss_dssp --------CTTCCHHHHHHHHHHTCSCTTTSCCHHHH--HTSGGGT
T ss_pred cccccccccccCCHHHHHHHHHHCcCChhHCcCHHHH--hcCcccC
Confidence 01123466789999999999999999999999876 4688864
|
| >4b99_A Mitogen-activated protein kinase 7; transferase, inhibitor; HET: R4L; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.2e-50 Score=458.55 Aligned_cols=251 Identities=27% Similarity=0.423 Sum_probs=203.0
Q ss_pred cccccccccccccEEEEEEEcCCCcEEEEEEeccccC-------hHHHHHHHHHhcCCCCceEEEEEEEe------CCeE
Q psy11767 380 LDKAGILGDGSYSVCRRCVEKSTGQEYAVKIISRKID-------CSEEINLLRACQGHPNIVNLHCVFQD------EVHT 446 (966)
Q Consensus 380 ~~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~~-------~~~Ei~iL~~l~~HpnIV~l~~~~~~------~~~~ 446 (966)
|+.++.||+|+||+||+|+++.+|+.||||++.+... ..+|+++|+.+ +|||||++++++.. .+++
T Consensus 56 Y~~~~~lG~G~fG~V~~a~~~~t~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l-~HpnIv~l~~~~~~~~~~~~~~~~ 134 (398)
T 4b99_A 56 YEIIETIGNGAYGVVSSARRRLTGQQVAIKKIPNAFDVVTNAKRTLRELKILKHF-KHDNIIAIKDILRPTVPYGEFKSV 134 (398)
T ss_dssp EEEEEEEEECSSCEEEEEEETTTCCEEEEEEETTTTSSHHHHHHHHHHHHHHHHC-CCTTBCCEEEECCCSSCTTTCCCE
T ss_pred eEEEEEEecccCeEEEEEEECCCCCEEEEEEECccccchHHHHHHHHHHHHHHhc-CCCCcceEeeeeecccccccCCEE
Confidence 4447899999999999999999999999999975432 34699999998 59999999999864 3678
Q ss_pred EEEEEccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCcEEEecCCCCCEEEEeeccccccc
Q psy11767 447 YLVLELLKGGELLDRIRQKGRCGFTENEASRIMRQLVAAVHFMHSRGVVHRDLKPENLLFSDPAGDNIKVVDFGFACLKR 526 (966)
Q Consensus 447 ~lVmEy~~gg~L~~~l~~~~~~~l~e~~~~~i~~Qil~aL~yLHs~~IiHRDLKP~NILl~~~~~~~iKL~DFGla~~~~ 526 (966)
|||||||+ |+|.+++.+.+ .|++.+++.|+.||+.||+|||++|||||||||+|||++. .+.+||+|||+|+...
T Consensus 135 ~ivmE~~~-g~L~~~i~~~~--~l~~~~~~~~~~qil~al~ylH~~~iiHRDlKP~NIl~~~--~~~~Ki~DFGla~~~~ 209 (398)
T 4b99_A 135 YVVLDLME-SDLHQIIHSSQ--PLTLEHVRYFLYQLLRGLKYMHSAQVIHRDLKPSNLLVNE--NCELKIGDFGMARGLC 209 (398)
T ss_dssp EEEEECCS-EEHHHHHTSSS--CCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECT--TCCEEECCCTTCBCC-
T ss_pred EEEEeCCC-CCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCcCcCCCcCccccccCC--CCCEEEeecceeeecc
Confidence 99999995 78999997654 6999999999999999999999999999999999999985 5699999999997542
Q ss_pred C-------CCccccccccccCchhhccCCCCCCCcccchhhhhhhhhhhhcCCCCCCCcCcchhHHHHHHHHhcCCCCCC
Q psy11767 527 E-------SLHTPCFTLQYAAPEVLRQDKSGYDENCDLWSLGVILVNVLRQDKSGYDENCDLWSLGVILYTMLCGRVPFH 599 (966)
Q Consensus 527 ~-------~~~~~~gT~~Y~APEvl~~~~~~~~~~~Di~SlGvil~el~~~~~~~y~~~~DIWSlGvilyemltG~~Pf~ 599 (966)
. ...+.+||+.|||||++.. ...|+.++||||+||++|||++|++||.
T Consensus 210 ~~~~~~~~~~~~~~GT~~Y~APEv~~~-------------------------~~~~~~~~DiWSlG~il~ell~G~~pF~ 264 (398)
T 4b99_A 210 TSPAEHQYFMTEYVATRWYRAPELMLS-------------------------LHEYTQAIDLWSVGCIFGEMLARRQLFP 264 (398)
T ss_dssp ------CCCCCSSCCCCTTCCHHHHTT-------------------------CSCCCTHHHHHHHHHHHHHHHHTSCSSC
T ss_pred cCccccccccccceeChHhcCHHHhcC-------------------------CCCCCChhheehhHHHHHHHHHCCCCCC
Confidence 1 2346799999999999853 2347889999999999999999999999
Q ss_pred CCCCchhHHHHHHHHHcCCC-------------------CCC----chhhccCCHHHHHHHHHhcccCccccCChHHHHH
Q psy11767 600 ARSRDDSALSIMARIKEGQF-------------------NFD----AEAWSTVSSEAKELTKSLLTVNPAQRIRMMRVKL 656 (966)
Q Consensus 600 ~~~~~~~~~~~~~~i~~~~~-------------------~~~----~~~~~~is~e~~~Li~~~L~~dP~~R~t~~~v~~ 656 (966)
+.+..+....++........ ... ...++.+|++++|||.+||++||++|||+.++
T Consensus 265 g~~~~~~l~~I~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~-- 342 (398)
T 4b99_A 265 GKNYVHQLQLIMMVLGTPSPAVIQAVGAERVRAYIQSLPPRQPVPWETVYPGADRQALSLLGRMLRFEPSARISAAAA-- 342 (398)
T ss_dssp CSSHHHHHHHHHHHHCCCCGGGTC-----CHHHHHHSSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSTTTSCCHHHH--
T ss_pred CCCHHHHHHHHHHhcCCCChHHhhhhhhhhhhhhhhcCCCcCCCCHHHhCCCCCHHHHHHHHHHCcCChhHCcCHHHH--
Confidence 87654433333222111000 000 11234679999999999999999999999876
Q ss_pred HhhhhHH
Q psy11767 657 TFHAFHQ 663 (966)
Q Consensus 657 ~~~~~~~ 663 (966)
..|+|+.
T Consensus 343 L~Hp~f~ 349 (398)
T 4b99_A 343 LRHPFLA 349 (398)
T ss_dssp TTSGGGT
T ss_pred hcCHhhC
Confidence 5678764
|
| >3omv_A RAF proto-oncogene serine/threonine-protein kinas; serine/threonine-protein kinase, transferase; HET: SM5; 4.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-49 Score=441.31 Aligned_cols=243 Identities=22% Similarity=0.408 Sum_probs=195.1
Q ss_pred cccccccccccEEEEEEEcCCCcEEEEEEecccc-------ChHHHHHHHHHhcCCCCceEEEEEEEeCCeEEEEEEccC
Q psy11767 382 KAGILGDGSYSVCRRCVEKSTGQEYAVKIISRKI-------DCSEEINLLRACQGHPNIVNLHCVFQDEVHTYLVLELLK 454 (966)
Q Consensus 382 ~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~-------~~~~Ei~iL~~l~~HpnIV~l~~~~~~~~~~~lVmEy~~ 454 (966)
..+.||+|+||+||+|++.. .||||+++... .+.+|+.+|+.+ +|||||++++++.+ +.+|||||||+
T Consensus 40 l~~~iG~G~fG~Vy~~~~~~---~vAvK~~~~~~~~~~~~~~f~~E~~il~~l-~HpNIV~l~g~~~~-~~~~iVmEy~~ 114 (307)
T 3omv_A 40 LSTRIGSGSFGTVYKGKWHG---DVAVKILKVVDPTPEQFQAFRNEVAVLRKT-RHVNILLFMGYMTK-DNLAIVTQWCE 114 (307)
T ss_dssp EEEECCCCSSSEEEEEESSS---EEEEEECCCSSCCHHHHHHHHHHHHHHTTC-CCTTBCCEEEEECS-SSCEEEEECCS
T ss_pred EeeEEeeCCCcEEEEEEECC---cEEEEEEEecCCCHHHHHHHHHHHHHHHhC-CCCCEeeEEEEEEC-CeEEEEEEcCC
Confidence 35679999999999998643 59999986432 245799999998 59999999998754 56899999999
Q ss_pred CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCcEEEecCCCCCEEEEeecccccccC-----CC
Q psy11767 455 GGELLDRIRQKGRCGFTENEASRIMRQLVAAVHFMHSRGVVHRDLKPENLLFSDPAGDNIKVVDFGFACLKRE-----SL 529 (966)
Q Consensus 455 gg~L~~~l~~~~~~~l~e~~~~~i~~Qil~aL~yLHs~~IiHRDLKP~NILl~~~~~~~iKL~DFGla~~~~~-----~~ 529 (966)
||+|.++|..... .+++.++..|+.||+.||+|||+++||||||||+||||++ ++.+||+|||+|+.... ..
T Consensus 115 gGsL~~~l~~~~~-~l~~~~~~~i~~qia~gL~yLH~~~IiHRDlKp~NILl~~--~~~~Ki~DFGla~~~~~~~~~~~~ 191 (307)
T 3omv_A 115 GSSLYKHLHVQET-KFQMFQLIDIARQTAQGMDYLHAKNIIHRDMKSNNIFLHE--GLTVKIGDFGLATVKSRWSGSQQV 191 (307)
T ss_dssp SCBHHHHHHTSCC-CCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCCSSSEEEET--TEEEEECCCSSCBC----------
T ss_pred CCCHHHHHhhcCC-CCCHHHHHHHHHHHHHHHHHHHHCCccCCccCHHHEEECC--CCcEEEeeccCceecccCCcceee
Confidence 9999999976543 6999999999999999999999999999999999999985 56899999999976432 23
Q ss_pred ccccccccccCchhhccCCCCCCCcccchhhhhhhhhhhhcCCCCCCCcCcchhHHHHHHHHhcCCCCCCCCCCchhHHH
Q psy11767 530 HTPCFTLQYAAPEVLRQDKSGYDENCDLWSLGVILVNVLRQDKSGYDENCDLWSLGVILYTMLCGRVPFHARSRDDSALS 609 (966)
Q Consensus 530 ~~~~gT~~Y~APEvl~~~~~~~~~~~Di~SlGvil~el~~~~~~~y~~~~DIWSlGvilyemltG~~Pf~~~~~~~~~~~ 609 (966)
.+.+||+.|||||++.... ...|+.++|||||||+||||+||+.||.+.+... .
T Consensus 192 ~~~~GT~~ymAPE~l~~~~-----------------------~~~y~~ksDVwS~Gvvl~Elltg~~Pf~~~~~~~---~ 245 (307)
T 3omv_A 192 EQPTGSVLWMAPEVIRMQD-----------------------NNPFSFQSDVYSYGIVLYELMTGELPYSHINNRD---Q 245 (307)
T ss_dssp --CCCCTTSCCHHHHHCCS-----------------------SCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHH---H
T ss_pred cccccCCCccCHHHhhccC-----------------------CCCCCcHHHhHhHHHHHHHHHHCCCCCCCCChHH---H
Confidence 4568999999999986321 2358899999999999999999999998765432 2
Q ss_pred HHHHHHcCCCCCC-chhhccCCHHHHHHHHHhcccCccccCChHHHHHHh
Q psy11767 610 IMARIKEGQFNFD-AEAWSTVSSEAKELTKSLLTVNPAQRIRMMRVKLTF 658 (966)
Q Consensus 610 ~~~~i~~~~~~~~-~~~~~~is~e~~~Li~~~L~~dP~~R~t~~~v~~~~ 658 (966)
+...+..+..... ...+..+++++.+||.+||+.||++|||+.++...+
T Consensus 246 ~~~~~~~~~~~p~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ei~~~L 295 (307)
T 3omv_A 246 IIFMVGRGYASPDLSKLYKNCPKAMKRLVADCVKKVKEERPLFPQILSSI 295 (307)
T ss_dssp HHHHHHTTCCCCCSTTSCTTSCHHHHHHHHHHTCSSSTTSCCHHHHHHHH
T ss_pred HHHHHhcCCCCCCcccccccchHHHHHHHHHHcCCCHhHCcCHHHHHHHH
Confidence 3334444433222 234567899999999999999999999999875443
|
| >4gt4_A Tyrosine-protein kinase transmembrane receptor RO; ATP binding, phosphorylation, transferase; 2.41A {Homo sapiens} PDB: 3zzw_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-49 Score=442.47 Aligned_cols=243 Identities=21% Similarity=0.337 Sum_probs=202.8
Q ss_pred ccccccccccEEEEEEEc-----CCCcEEEEEEecccc------ChHHHHHHHHHhcCCCCceEEEEEEEeCCeEEEEEE
Q psy11767 383 AGILGDGSYSVCRRCVEK-----STGQEYAVKIISRKI------DCSEEINLLRACQGHPNIVNLHCVFQDEVHTYLVLE 451 (966)
Q Consensus 383 ~~~LG~G~fG~Vy~a~~~-----~tg~~vAvK~i~~~~------~~~~Ei~iL~~l~~HpnIV~l~~~~~~~~~~~lVmE 451 (966)
.+.||+|+||+||+|... .+++.||||+++... .+.+|+.+|..+ +|||||+|++++.++...|||||
T Consensus 31 ~~~lG~G~fG~Vykg~~~~~~~~~~~~~VAvK~l~~~~~~~~~~~f~~E~~il~~l-~HpNIV~l~g~~~~~~~~~lV~E 109 (308)
T 4gt4_A 31 MEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARL-QHPNVVCLLGVVTKDQPLSMIFS 109 (308)
T ss_dssp EEEEEECSSCEEEEEEEC-------CEEEEEEECCC-CCC-CHHHHHHHHHHHHHC-CCTTBCCEEEEECSSSSCEEEEE
T ss_pred eeEeccCCCcEEEEEEEcCCccCCCCeEEEEEEECcccChHHHHHHHHHHHHHHhC-CCCCCCCcceEEEECCEEEEEEE
Confidence 567999999999999853 467899999996542 256799999998 59999999999999999999999
Q ss_pred ccCCCCHHHHHHhcC--------------CCCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCcEEEecCCCCCEEEE
Q psy11767 452 LLKGGELLDRIRQKG--------------RCGFTENEASRIMRQLVAAVHFMHSRGVVHRDLKPENLLFSDPAGDNIKVV 517 (966)
Q Consensus 452 y~~gg~L~~~l~~~~--------------~~~l~e~~~~~i~~Qil~aL~yLHs~~IiHRDLKP~NILl~~~~~~~iKL~ 517 (966)
||++|+|.++|..+. ...|++.++..|+.||+.||+|||+++||||||||+||||++ ++.+||+
T Consensus 110 y~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHRDLK~~NILl~~--~~~~Ki~ 187 (308)
T 4gt4_A 110 YCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYLSSHHVVHKDLATRNVLVYD--KLNVKIS 187 (308)
T ss_dssp CCSSCBHHHHHHTTCSSCCCC-----CCEECCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECG--GGCEEEC
T ss_pred cCCCCcHHHHHHhhCccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCCCccccceEECC--CCCEEEC
Confidence 999999999997542 135899999999999999999999999999999999999985 5689999
Q ss_pred eecccccccC-----CCccccccccccCchhhccCCCCCCCcccchhhhhhhhhhhhcCCCCCCCcCcchhHHHHHHHHh
Q psy11767 518 DFGFACLKRE-----SLHTPCFTLQYAAPEVLRQDKSGYDENCDLWSLGVILVNVLRQDKSGYDENCDLWSLGVILYTML 592 (966)
Q Consensus 518 DFGla~~~~~-----~~~~~~gT~~Y~APEvl~~~~~~~~~~~Di~SlGvil~el~~~~~~~y~~~~DIWSlGvilyeml 592 (966)
|||+|+.... ...+.+||+.|||||++... .|+.++|||||||+||||+
T Consensus 188 DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~--------------------------~~s~ksDVwSfGvvl~El~ 241 (308)
T 4gt4_A 188 DLGLFREVYAADYYKLLGNSLLPIRWMAPEAIMYG--------------------------KFSIDSDIWSYGVVLWEVF 241 (308)
T ss_dssp CSCCBCGGGGGGCBCSSSSSCBCGGGCCHHHHHHC--------------------------CCCHHHHHHHHHHHHHHHH
T ss_pred CcccceeccCCCceeEecccccCCcccCHHHHhCC--------------------------CCCccchhhhHHHHHHHHH
Confidence 9999975432 23456789999999998632 4889999999999999999
Q ss_pred c-CCCCCCCCCCchhHHHHHHHHHcCCCCCCchhhccCCHHHHHHHHHhcccCccccCChHHHHHHhhhh
Q psy11767 593 C-GRVPFHARSRDDSALSIMARIKEGQFNFDAEAWSTVSSEAKELTKSLLTVNPAQRIRMMRVKLTFHAF 661 (966)
Q Consensus 593 t-G~~Pf~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~is~e~~~Li~~~L~~dP~~R~t~~~v~~~~~~~ 661 (966)
| |+.||.+.+. ..++..+..+.... .+..+++++.+||.+||+.||++|||+.++...+.+|
T Consensus 242 t~g~~Pf~~~~~----~~~~~~i~~~~~~~---~p~~~~~~~~~li~~C~~~dP~~RPs~~ei~~~L~a~ 304 (308)
T 4gt4_A 242 SYGLQPYCGYSN----QDVVEMIRNRQVLP---CPDDCPAWVYALMIECWNEFPSRRPRFKDIHSRLRAW 304 (308)
T ss_dssp TTTCCTTTTCCH----HHHHHHHHTTCCCC---CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTS
T ss_pred hCCCCCCCCCCH----HHHHHHHHcCCCCC---CcccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHhc
Confidence 8 8999987653 24556677665432 2346899999999999999999999999986655543
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-49 Score=445.50 Aligned_cols=244 Identities=22% Similarity=0.338 Sum_probs=197.6
Q ss_pred cccccccccccEEEEEEEc-----CCCcEEEEEEecccc-----ChHHHHHHHHHhcCCCCceEEEEEEEeCCeEEEEEE
Q psy11767 382 KAGILGDGSYSVCRRCVEK-----STGQEYAVKIISRKI-----DCSEEINLLRACQGHPNIVNLHCVFQDEVHTYLVLE 451 (966)
Q Consensus 382 ~~~~LG~G~fG~Vy~a~~~-----~tg~~vAvK~i~~~~-----~~~~Ei~iL~~l~~HpnIV~l~~~~~~~~~~~lVmE 451 (966)
..++||+|+||+||+|+++ .+++.||||+++... .+.+|+++|+.+ +|||||+|+++|.++...|||||
T Consensus 45 l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~il~~l-~HpnIV~l~g~~~~~~~~~lV~E 123 (329)
T 4aoj_A 45 LKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTML-QHQHIVRFFGVCTEGRPLLMVFE 123 (329)
T ss_dssp EEEEEEECSSEEEEEEEESSSCC---CEEEEEEEESCCSHHHHHHHHHHHHHHTTC-CCTTBCCEEEEECSSSSEEEEEE
T ss_pred EEEEEccCCCcEEEEEEECCcccCCCCeEEEEEEECcCCHHHHHHHHHHHHHHHhC-CCCCCCcEEEEEEECCEEEEEEE
Confidence 3568999999999999865 468999999997542 255799999998 59999999999999999999999
Q ss_pred ccCCCCHHHHHHhcC-------------CCCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCcEEEecCCCCCEEEEe
Q psy11767 452 LLKGGELLDRIRQKG-------------RCGFTENEASRIMRQLVAAVHFMHSRGVVHRDLKPENLLFSDPAGDNIKVVD 518 (966)
Q Consensus 452 y~~gg~L~~~l~~~~-------------~~~l~e~~~~~i~~Qil~aL~yLHs~~IiHRDLKP~NILl~~~~~~~iKL~D 518 (966)
||+||+|.++|++.. ...|++.++..|+.||+.||+|||+++||||||||+||||++ ++.+||+|
T Consensus 124 y~~~G~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHRDLKp~NILl~~--~~~~Ki~D 201 (329)
T 4aoj_A 124 YMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGLHFVHRDLATRNCLVGQ--GLVVKIGD 201 (329)
T ss_dssp CCTTCBHHHHHHTSSCC-----------CCSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEET--TTEEEECC
T ss_pred cCCCCcHHHHHHhcCcccccccccccccCCCCCHHHHHHHHHHHHHHHHHHhcCCeecccccHhhEEECC--CCcEEEcc
Confidence 999999999997643 135999999999999999999999999999999999999985 56999999
Q ss_pred ecccccccCC-----CccccccccccCchhhccCCCCCCCcccchhhhhhhhhhhhcCCCCCCCcCcchhHHHHHHHHhc
Q psy11767 519 FGFACLKRES-----LHTPCFTLQYAAPEVLRQDKSGYDENCDLWSLGVILVNVLRQDKSGYDENCDLWSLGVILYTMLC 593 (966)
Q Consensus 519 FGla~~~~~~-----~~~~~gT~~Y~APEvl~~~~~~~~~~~Di~SlGvil~el~~~~~~~y~~~~DIWSlGvilyemlt 593 (966)
||+|+..... ....+||+.|||||++.. ..|+.++|||||||+||||+|
T Consensus 202 FGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~--------------------------~~~~~~sDvwS~Gvvl~Ellt 255 (329)
T 4aoj_A 202 FGMSRDIYSTDYYRVGGRTMLPIRWMPPESILY--------------------------RKFTTESDVWSFGVVLWEIFT 255 (329)
T ss_dssp CC----------------CCCCGGGCCHHHHTT--------------------------CCCCHHHHHHHHHHHHHHHHT
T ss_pred cccceeccCCCcceecCcccccccccChhhhcC--------------------------CCCCccccccchHHHHHHHHc
Confidence 9999764321 234578999999999853 348899999999999999998
Q ss_pred -CCCCCCCCCCchhHHHHHHHHHcCCCCCCchhhccCCHHHHHHHHHhcccCccccCChHHHHHHhhhh
Q psy11767 594 -GRVPFHARSRDDSALSIMARIKEGQFNFDAEAWSTVSSEAKELTKSLLTVNPAQRIRMMRVKLTFHAF 661 (966)
Q Consensus 594 -G~~Pf~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~is~e~~~Li~~~L~~dP~~R~t~~~v~~~~~~~ 661 (966)
|+.||.+.+.. .++..+..+... +.+..+++++.+||.+||+.||++|||+.++...+...
T Consensus 256 ~G~~Pf~~~~~~----~~~~~i~~g~~~---~~p~~~~~~~~~li~~cl~~dP~~RPs~~ei~~~L~~l 317 (329)
T 4aoj_A 256 YGKQPWYQLSNT----EAIDCITQGREL---ERPRACPPEVYAIMRGCWQREPQQRHSIKDVHARLQAL 317 (329)
T ss_dssp TSCCTTCSSCHH----HHHHHHHHTCCC---CCCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHHHHHHH
T ss_pred CCCCCCCCCCHH----HHHHHHHcCCCC---CCcccccHHHHHHHHHHcCcChhHCcCHHHHHHHHHHH
Confidence 99999876532 445566665422 22346899999999999999999999999986555443
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-49 Score=440.15 Aligned_cols=247 Identities=25% Similarity=0.427 Sum_probs=193.0
Q ss_pred ccccccccccccccccEEEEEEEcCCCcEEEEEEeccccC------hHHHHHHHHHhcCCCCceEEEEEEEeCC------
Q psy11767 377 DMDLDKAGILGDGSYSVCRRCVEKSTGQEYAVKIISRKID------CSEEINLLRACQGHPNIVNLHCVFQDEV------ 444 (966)
Q Consensus 377 ~i~~~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~~------~~~Ei~iL~~l~~HpnIV~l~~~~~~~~------ 444 (966)
.-||+.++.||+|+||+||+|+++.+|+.||||++..... ..+|+++|+.+ +|||||+++++|.+.+
T Consensus 4 l~dy~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~E~~il~~l-~HpnIV~~~~~~~~~~~~~~~~ 82 (299)
T 4g31_A 4 LTDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKL-EHPGIVRYFNAWLEKNTTEKLQ 82 (299)
T ss_dssp HHHEEEEEEEEECC--EEEEEEETTTCCEEEEEEEEECSSHHHHHHHHHHHHHHTTC-CCTTBCCEEEEEEEEC------
T ss_pred chhCEEeeEEecCCCeEEEEEEECCCCCEEEEEEEeccCCHHHHHHHHHHHHHHHhC-CCCCCCeEEEEEEecCcccccc
Confidence 3356668999999999999999999999999999964332 45799999998 5999999999997544
Q ss_pred ------eEEEEEEccCCCCHHHHHHhcCC-CCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCcEEEecCCCCCEEEE
Q psy11767 445 ------HTYLVLELLKGGELLDRIRQKGR-CGFTENEASRIMRQLVAAVHFMHSRGVVHRDLKPENLLFSDPAGDNIKVV 517 (966)
Q Consensus 445 ------~~~lVmEy~~gg~L~~~l~~~~~-~~l~e~~~~~i~~Qil~aL~yLHs~~IiHRDLKP~NILl~~~~~~~iKL~ 517 (966)
++|||||||+||+|.+++..+.. ...++..++.|+.||+.||+|||++|||||||||+|||++. ++.+||+
T Consensus 83 ~~~~~~~l~ivmE~~~gg~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~ylH~~~IiHRDlKp~NILl~~--~~~vKl~ 160 (299)
T 4g31_A 83 PSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQIAEAVEFLHSKGLMHRDLKPSNIFFTM--DDVVKVG 160 (299)
T ss_dssp ----CEEEEEEEECCCSCCHHHHHHTCCSGGGSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECT--TCCEEEC
T ss_pred ccCCCcEEEEEEecCCCCcHHHHHHhcCCCChhHHHHHHHHHHHHHHHHHHHHHCcCccccCcHHHeEECC--CCcEEEc
Confidence 47999999999999999987542 12456778999999999999999999999999999999975 5699999
Q ss_pred eecccccccCC---------------CccccccccccCchhhccCCCCCCCcccchhhhhhhhhhhhcCCCCCCCcCcch
Q psy11767 518 DFGFACLKRES---------------LHTPCFTLQYAAPEVLRQDKSGYDENCDLWSLGVILVNVLRQDKSGYDENCDLW 582 (966)
Q Consensus 518 DFGla~~~~~~---------------~~~~~gT~~Y~APEvl~~~~~~~~~~~Di~SlGvil~el~~~~~~~y~~~~DIW 582 (966)
|||+|+..... ..+.+||+.|||||++.. ..|+.++|||
T Consensus 161 DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~--------------------------~~y~~~~Diw 214 (299)
T 4g31_A 161 DFGLVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHG--------------------------NSYSHKVDIF 214 (299)
T ss_dssp CCCCC--------------------------CCCTTSCHHHHTT--------------------------CCCCTHHHHH
T ss_pred cCccceecCCCccccccccccccccccCCcccCccccCHHHHcC--------------------------CCCCCHHHHH
Confidence 99999764321 124589999999999852 3488999999
Q ss_pred hHHHHHHHHhcCCCCCCCCCCchhHHHHHHHHHcCCCCCCchhhccCCHHHHHHHHHhcccCccccCChHHHHHHhhhhH
Q psy11767 583 SLGVILYTMLCGRVPFHARSRDDSALSIMARIKEGQFNFDAEAWSTVSSEAKELTKSLLTVNPAQRIRMMRVKLTFHAFH 662 (966)
Q Consensus 583 SlGvilyemltG~~Pf~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~is~e~~~Li~~~L~~dP~~R~t~~~v~~~~~~~~ 662 (966)
||||++|||++ ||.... .....+..+....+. +.+...++++.+||.+||+.||++|||+.++ ..|+|+
T Consensus 215 SlGvilyell~---Pf~~~~---~~~~~~~~~~~~~~p---~~~~~~~~~~~~li~~~L~~dP~~Rps~~ei--l~h~~~ 283 (299)
T 4g31_A 215 SLGLILFELLY---PFSTQM---ERVRTLTDVRNLKFP---PLFTQKYPCEYVMVQDMLSPSPMERPEAINI--IENAVF 283 (299)
T ss_dssp HHHHHHHHHHS---CCSSHH---HHHHHHHHHHTTCCC---HHHHHHCHHHHHHHHHHTCSSGGGSCCHHHH--HTSGGG
T ss_pred HHHHHHHHHcc---CCCCcc---HHHHHHHHHhcCCCC---CCCcccCHHHHHHHHHHcCCChhHCcCHHHH--hcCHhh
Confidence 99999999996 886421 223344455555432 3455678899999999999999999999976 346665
Q ss_pred H
Q psy11767 663 Q 663 (966)
Q Consensus 663 ~ 663 (966)
+
T Consensus 284 ~ 284 (299)
T 4g31_A 284 E 284 (299)
T ss_dssp C
T ss_pred C
Confidence 3
|
| >3v5w_A G-protein coupled receptor kinase 2; inhibitor complex, protein kinase, beta propeller, RGS homol domain; HET: 8PR; 2.07A {Homo sapiens} PDB: 3cik_A* 3krw_A* 3krx_A* 1omw_A 1ym7_A 2bcj_A* 3uzs_A 3uzt_A 3pvu_A* 3psc_A* 3pvw_A* 1bak_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.9e-49 Score=472.13 Aligned_cols=258 Identities=27% Similarity=0.451 Sum_probs=212.0
Q ss_pred cccccccccccccEEEEEEEcCCCcEEEEEEecccc-----C---hHHHHHHHHHh--cCCCCceEEEEEEEeCCeEEEE
Q psy11767 380 LDKAGILGDGSYSVCRRCVEKSTGQEYAVKIISRKI-----D---CSEEINLLRAC--QGHPNIVNLHCVFQDEVHTYLV 449 (966)
Q Consensus 380 ~~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~-----~---~~~Ei~iL~~l--~~HpnIV~l~~~~~~~~~~~lV 449 (966)
|+.+++||+|+||+||+|+++.+|+.||||++.+.. . ..+|..++..+ .+|||||+|+++|+++.++|||
T Consensus 191 f~i~k~LG~G~fG~V~la~~~~tg~~~AiK~i~K~~i~~~~~~~~~~~E~~~l~ll~~~~HP~IV~l~~~f~~~~~lylV 270 (689)
T 3v5w_A 191 FSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFI 270 (689)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSEEEEE
T ss_pred eEEEEEEecccCeEEEEEEECCCCCEEEEEEEeHHHcchhhhHHHHHHHHHHHHHHhhCCCCCEeEEEEEEEECCEEEEE
Confidence 445789999999999999999999999999996431 1 23344444332 2699999999999999999999
Q ss_pred EEccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCcEEEecCCCCCEEEEeecccccccC-C
Q psy11767 450 LELLKGGELLDRIRQKGRCGFTENEASRIMRQLVAAVHFMHSRGVVHRDLKPENLLFSDPAGDNIKVVDFGFACLKRE-S 528 (966)
Q Consensus 450 mEy~~gg~L~~~l~~~~~~~l~e~~~~~i~~Qil~aL~yLHs~~IiHRDLKP~NILl~~~~~~~iKL~DFGla~~~~~-~ 528 (966)
||||+||+|.++|.+.+ .|++..++.|+.||+.||+|||++|||||||||+||||+. ++++||+|||+|+.... .
T Consensus 271 mEy~~GGdL~~~l~~~~--~l~E~~a~~y~~qIl~aL~yLH~~gIiHRDLKPeNILld~--~G~vKL~DFGlA~~~~~~~ 346 (689)
T 3v5w_A 271 LDLMNGGDLHYHLSQHG--VFSEADMRFYAAEIILGLEHMHNRFVVYRDLKPANILLDE--HGHVRISDLGLACDFSKKK 346 (689)
T ss_dssp ECCCCSCBHHHHHHHHC--CCCHHHHHHHHHHHHHHHHHHHTTTEECCCCSGGGEEECT--TSCEEECCCTTCEECSSCC
T ss_pred EecCCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCccccCCchHHeEEeC--CCCEEecccceeeecCCCC
Confidence 99999999999998876 5999999999999999999999999999999999999985 67999999999986543 4
Q ss_pred CccccccccccCchhhccCCCCCCCcccchhhhhhhhhhhhcCCCCCCCcCcchhHHHHHHHHhcCCCCCCCCCCchhHH
Q psy11767 529 LHTPCFTLQYAAPEVLRQDKSGYDENCDLWSLGVILVNVLRQDKSGYDENCDLWSLGVILYTMLCGRVPFHARSRDDSAL 608 (966)
Q Consensus 529 ~~~~~gT~~Y~APEvl~~~~~~~~~~~Di~SlGvil~el~~~~~~~y~~~~DIWSlGvilyemltG~~Pf~~~~~~~~~~ 608 (966)
..+.|||+.|||||++.. +.+|+.++|||||||++|||++|++||.+.+..+ ..
T Consensus 347 ~~t~~GTp~YmAPEvl~~-------------------------~~~y~~~vDiWSLGvilYEmLtG~~PF~~~~~~~-~~ 400 (689)
T 3v5w_A 347 PHASVGTHGYMAPEVLQK-------------------------GVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKD-KH 400 (689)
T ss_dssp CCSCCSCGGGCCHHHHST-------------------------TCCCCTHHHHHHHHHHHHHHHHSSCTTCGGGCCC-HH
T ss_pred CCCccCCcCccCHHHHhC-------------------------CCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHH-HH
Confidence 567899999999999852 2358899999999999999999999998754433 23
Q ss_pred HHHHHHHcCCCCCCchhhccCCHHHHHHHHHhcccCccccCCh-----HHHHHHhhhhHHhhhccccccccchHHHHHh
Q psy11767 609 SIMARIKEGQFNFDAEAWSTVSSEAKELTKSLLTVNPAQRIRM-----MRVKLTFHAFHQAQKEGFRLQDVTSAKLAQR 682 (966)
Q Consensus 609 ~~~~~i~~~~~~~~~~~~~~is~e~~~Li~~~L~~dP~~R~t~-----~~v~~~~~~~~~~~~~~~~~~~~~~~~l~~~ 682 (966)
.+...+....+.+ +..+|+++++||.+||+.||.+|++. .+ ...|+|++ .+.+..+..+
T Consensus 401 ~i~~~i~~~~~~~----p~~~S~~a~dLI~~lL~~dP~~Rl~~~~~ga~e--i~~HpfF~---------~idW~~l~~~ 464 (689)
T 3v5w_A 401 EIDRMTLTMAVEL----PDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQE--VKESPFFR---------SLDWQMVFLQ 464 (689)
T ss_dssp HHHHHHHHCCCCC----CTTSCHHHHHHHHHHTCSCGGGCTTCSSSTHHH--HTTSGGGT---------TCCHHHHHTT
T ss_pred HHHHhhcCCCCCC----CccCCHHHHHHHHHHccCCHhHCCCCCCCCHHH--HhcCcccc---------CCCHHHHHcC
Confidence 4555666665544 34689999999999999999999984 44 46688864 4555555443
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-49 Score=474.44 Aligned_cols=253 Identities=30% Similarity=0.588 Sum_probs=221.3
Q ss_pred ecccccccccccccccccccEEEEEEEcCCCcEEEEEEecccc-----ChHHHHHHHHHhcCCCCceEEEEEEEeCCeEE
Q psy11767 373 FEQYDMDLDKAGILGDGSYSVCRRCVEKSTGQEYAVKIISRKI-----DCSEEINLLRACQGHPNIVNLHCVFQDEVHTY 447 (966)
Q Consensus 373 ~~~~~i~~~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~-----~~~~Ei~iL~~l~~HpnIV~l~~~~~~~~~~~ 447 (966)
.++|++ ++.||+|+||+||+|+++.+|+.||||++.... ...+|+.+|+.+ +|||||+|+++|+++.++|
T Consensus 156 l~~Y~i----~~~lG~G~fg~V~~~~~~~tg~~~AiK~i~~~~~~~~~~~~~Ei~il~~l-~hpnIv~l~~~~~~~~~~~ 230 (573)
T 3uto_A 156 LDHYDI----HEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVL-RHPTLVNLHDAFEDDNEMV 230 (573)
T ss_dssp GGTEEE----EEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHHHT-CCTTBCCEEEEEECSSEEE
T ss_pred ccccEE----EEEEeeccCeEEEEEEECCCCCEEEEEEEeccchhhHHHHHHHHHHHHhC-CCCCCCeEEEEEEECCEEE
Confidence 345554 688999999999999999999999999997543 245799999998 5999999999999999999
Q ss_pred EEEEccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCcEEEecCCCCCEEEEeecccccccC
Q psy11767 448 LVLELLKGGELLDRIRQKGRCGFTENEASRIMRQLVAAVHFMHSRGVVHRDLKPENLLFSDPAGDNIKVVDFGFACLKRE 527 (966)
Q Consensus 448 lVmEy~~gg~L~~~l~~~~~~~l~e~~~~~i~~Qil~aL~yLHs~~IiHRDLKP~NILl~~~~~~~iKL~DFGla~~~~~ 527 (966)
||||||+||+|+++|.... ..|++.+++.|+.||+.||+|||++||+||||||+|||++....+.+||+|||+|+....
T Consensus 231 iv~E~~~gg~L~~~i~~~~-~~l~e~~~~~~~~qi~~al~ylH~~~iiHRDlKp~Nill~~~~~~~vKl~DFG~a~~~~~ 309 (573)
T 3uto_A 231 MIYEFMSGGELFEKVADEH-NKMSEDEAVEYMRQVCKGLCHMHENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDP 309 (573)
T ss_dssp EEEECCCCCBHHHHHTCTT-SCEEHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSSCCCEEECCCSSCEECCT
T ss_pred EEEeecCCCcHHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCChhhccccCCCCCCEEEeeccceeEccC
Confidence 9999999999999996543 269999999999999999999999999999999999999865567999999999987543
Q ss_pred --CCccccccccccCchhhccCCCCCCCcccchhhhhhhhhhhhcCCCCCCCcCcchhHHHHHHHHhcCCCCCCCCCCch
Q psy11767 528 --SLHTPCFTLQYAAPEVLRQDKSGYDENCDLWSLGVILVNVLRQDKSGYDENCDLWSLGVILYTMLCGRVPFHARSRDD 605 (966)
Q Consensus 528 --~~~~~~gT~~Y~APEvl~~~~~~~~~~~Di~SlGvil~el~~~~~~~y~~~~DIWSlGvilyemltG~~Pf~~~~~~~ 605 (966)
...+.|||+.|||||++.. ..|+.++|||||||++|+|++|++||.+.+.
T Consensus 310 ~~~~~~~~GT~~y~APEv~~~--------------------------~~y~~~~DiWSlGvilyeml~G~~Pf~~~~~-- 361 (573)
T 3uto_A 310 KQSVKVTTGTAEFAAPEVAEG--------------------------KPVGYYTDMWSVGVLSYILLSGLSPFGGEND-- 361 (573)
T ss_dssp TSEEEEECSSGGGCCHHHHTT--------------------------CCBCHHHHHHHHHHHHHHHHHSCCSSCCSSH--
T ss_pred CCceeeeEECccccCHHHhCC--------------------------CCCCcHHHHHHHHHHHHHHHHCCCCCCCcCH--
Confidence 2346789999999999853 3478899999999999999999999987653
Q ss_pred hHHHHHHHHHcCCCCCCchhhccCCHHHHHHHHHhcccCccccCChHHHHHHhhhhHH
Q psy11767 606 SALSIMARIKEGQFNFDAEAWSTVSSEAKELTKSLLTVNPAQRIRMMRVKLTFHAFHQ 663 (966)
Q Consensus 606 ~~~~~~~~i~~~~~~~~~~~~~~is~e~~~Li~~~L~~dP~~R~t~~~v~~~~~~~~~ 663 (966)
...+..|..+.+.++...|..+|+++++||.+||+.||.+|||+.++ ..|+|+.
T Consensus 362 --~~~~~~i~~~~~~~~~~~~~~~s~~~~dli~~~L~~dp~~R~t~~e~--l~Hpw~~ 415 (573)
T 3uto_A 362 --DETLRNVKSCDWNMDDSAFSGISEDGKDFIRKLLLADPNTRMTIHQA--LEHPWLT 415 (573)
T ss_dssp --HHHHHHHHTTCCCCCSGGGTTSCHHHHHHHHTTSCSSGGGSCCHHHH--HHSTTTS
T ss_pred --HHHHHHHHhCCCCCCcccccCCCHHHHHHHHHHccCChhHCcCHHHH--hcCcCcC
Confidence 35567888888888888889999999999999999999999999976 4577765
|
| >4ase_A Vascular endothelial growth factor receptor 2; transferase, angiogenesis, signaling protein, phosphorylatio receptor, inhibitor; HET: AV9; 1.83A {Homo sapiens} PDB: 4agd_A* 4asd_A* 4agc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-48 Score=438.81 Aligned_cols=248 Identities=24% Similarity=0.331 Sum_probs=202.9
Q ss_pred ccccccccccccEEEEEEEcCC-----CcEEEEEEeccccC------hHHHHHHHHHhcCCCCceEEEEEEEeC-CeEEE
Q psy11767 381 DKAGILGDGSYSVCRRCVEKST-----GQEYAVKIISRKID------CSEEINLLRACQGHPNIVNLHCVFQDE-VHTYL 448 (966)
Q Consensus 381 ~~~~~LG~G~fG~Vy~a~~~~t-----g~~vAvK~i~~~~~------~~~Ei~iL~~l~~HpnIV~l~~~~~~~-~~~~l 448 (966)
+..+.||+|+||+||+|.+..+ ++.||||++..... ..+|+++|..+.+|||||+|+++|.++ ..+||
T Consensus 67 ~l~~~LG~G~fG~Vy~a~~~~~~~~~~~k~VAvK~l~~~~~~~~~~~~~~E~~il~~l~hhpnIV~l~g~~~~~~~~~~i 146 (353)
T 4ase_A 67 KLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGPLMV 146 (353)
T ss_dssp EEEEEEEECSSEEEEEEEEETSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECCTTSCCEE
T ss_pred EEeeEEecCCCeEEEEEEEcCCCcccCCeEEEEEEEccccChHHHHHHHHHHHHHHHcCCCCcEEEEEEEEEecCCEEEE
Confidence 3467899999999999998754 46899999975432 456999999998779999999998764 57899
Q ss_pred EEEccCCCCHHHHHHhcC--------------CCCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCcEEEecCCCCCE
Q psy11767 449 VLELLKGGELLDRIRQKG--------------RCGFTENEASRIMRQLVAAVHFMHSRGVVHRDLKPENLLFSDPAGDNI 514 (966)
Q Consensus 449 VmEy~~gg~L~~~l~~~~--------------~~~l~e~~~~~i~~Qil~aL~yLHs~~IiHRDLKP~NILl~~~~~~~i 514 (966)
|||||++|+|.++|++.. ...|++.++..|+.||+.||+|||+++||||||||+|||+++ ++.+
T Consensus 147 V~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~yLH~~~iiHRDLK~~NILl~~--~~~v 224 (353)
T 4ase_A 147 IVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSE--KNVV 224 (353)
T ss_dssp EEECCTTEEHHHHHHHTGGGBCCC-------CTTCBCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECG--GGCE
T ss_pred EEEcCCCCCHHHHHHhcccccccccccchhhccccCCHHHHHHHHHHHHHHHHhHhhCCeecCccCccceeeCC--CCCE
Confidence 999999999999997642 235899999999999999999999999999999999999985 5699
Q ss_pred EEEeecccccccCC-----CccccccccccCchhhccCCCCCCCcccchhhhhhhhhhhhcCCCCCCCcCcchhHHHHHH
Q psy11767 515 KVVDFGFACLKRES-----LHTPCFTLQYAAPEVLRQDKSGYDENCDLWSLGVILVNVLRQDKSGYDENCDLWSLGVILY 589 (966)
Q Consensus 515 KL~DFGla~~~~~~-----~~~~~gT~~Y~APEvl~~~~~~~~~~~Di~SlGvil~el~~~~~~~y~~~~DIWSlGvily 589 (966)
||+|||+|+..... ..+.+||+.|||||++.. ..|+.++|||||||+||
T Consensus 225 Ki~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~--------------------------~~y~~ksDVwS~Gv~l~ 278 (353)
T 4ase_A 225 KICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFD--------------------------RVYTIQSDVWSFGVLLW 278 (353)
T ss_dssp EECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHH--------------------------CCCCHHHHHHHHHHHHH
T ss_pred EECcchhhhhcccCCCceeeccccccccccCHHHHhc--------------------------CCCCCcccEeehHHHHH
Confidence 99999999864321 234578999999999863 24889999999999999
Q ss_pred HHhc-CCCCCCCCCCchhHHHHHHHHHcCCCCCCchhhccCCHHHHHHHHHhcccCccccCChHHHHHHhhhhH
Q psy11767 590 TMLC-GRVPFHARSRDDSALSIMARIKEGQFNFDAEAWSTVSSEAKELTKSLLTVNPAQRIRMMRVKLTFHAFH 662 (966)
Q Consensus 590 emlt-G~~Pf~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~is~e~~~Li~~~L~~dP~~R~t~~~v~~~~~~~~ 662 (966)
||+| |+.||.+....+. +...+..+... ..+..+++++.+||.+||+.||++|||+.++...+..+.
T Consensus 279 El~t~G~~Pf~~~~~~~~---~~~~i~~g~~~---~~p~~~~~~~~~li~~c~~~dP~~RPt~~eil~~L~~ll 346 (353)
T 4ase_A 279 EIFSLGASPYPGVKIDEE---FCRRLKEGTRM---RAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLL 346 (353)
T ss_dssp HHTTTSCCSSTTCCCSHH---HHHHHHHTCCC---CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred HHHhCCCCCCCCCCHHHH---HHHHHHcCCCC---CCCccCCHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHH
Confidence 9998 9999988665432 34445555322 122457999999999999999999999999866554443
|
| >3hmm_A TGF-beta receptor type-1; ALK5, kinase, inhibitor, quinazoline, aortic aneurysm, ATP-binding, craniosynostosis, disease mutation, disulfide bond; HET: 855; 1.70A {Homo sapiens} PDB: 1vjy_A* 3gxl_A* 3tzm_A* 2wot_A* 2wou_A* 1py5_A* 1rw8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-46 Score=417.81 Aligned_cols=250 Identities=20% Similarity=0.286 Sum_probs=185.9
Q ss_pred ccccccccccEEEEEEEcCCCcEEEEEEeccccC--hHH--HHHHHHHhcCCCCceEEEEEEEeCC----eEEEEEEccC
Q psy11767 383 AGILGDGSYSVCRRCVEKSTGQEYAVKIISRKID--CSE--EINLLRACQGHPNIVNLHCVFQDEV----HTYLVLELLK 454 (966)
Q Consensus 383 ~~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~~--~~~--Ei~iL~~l~~HpnIV~l~~~~~~~~----~~~lVmEy~~ 454 (966)
.+.||+|+||+||+|++ +|+.||||++..... ..+ |+..+..+ +|||||++++++.+++ .+|||||||+
T Consensus 8 ~~~iG~G~fG~Vy~~~~--~g~~VAvK~l~~~~~~~~~~e~Ei~~~~~l-~HpNIv~l~g~~~~~~~~~~~~~lV~Ey~~ 84 (303)
T 3hmm_A 8 QESIGKGRFGEVWRGKW--RGEEVAVKIFSSREERSWFREAEIYQTVML-RHENILGFIAADNKDNGTWTQLWLVSDYHE 84 (303)
T ss_dssp EEEEEECSSSEEEEEEE--TTEEEEEEEECGGGHHHHHHHHHHHTSTTC-CCTTBCCEEEEEEEECSSSEEEEEEEECCT
T ss_pred EEEEeeCCCeEEEEEEE--CCEEEEEEEECccchhhHHHHHHHHHHhcC-CCCCCCcEEEEEEecCCCceEEEEEecCCC
Confidence 46899999999999987 589999999975432 223 44444445 6999999999998654 5899999999
Q ss_pred CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhc--------CceeccCCCCcEEEecCCCCCEEEEeeccccccc
Q psy11767 455 GGELLDRIRQKGRCGFTENEASRIMRQLVAAVHFMHSR--------GVVHRDLKPENLLFSDPAGDNIKVVDFGFACLKR 526 (966)
Q Consensus 455 gg~L~~~l~~~~~~~l~e~~~~~i~~Qil~aL~yLHs~--------~IiHRDLKP~NILl~~~~~~~iKL~DFGla~~~~ 526 (966)
||+|.++|+.. .+++.++..++.|++.||+|||++ +||||||||+||||+. ++.+||+|||+|+...
T Consensus 85 ~gsL~~~l~~~---~l~~~~~~~i~~~ia~gl~ylH~~~~~~~~~~~IiHRDlKp~NILl~~--~~~~Ki~DFGla~~~~ 159 (303)
T 3hmm_A 85 HGSLFDYLNRY---TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKK--NGTCCIADLGLAVRHD 159 (303)
T ss_dssp TCBHHHHHHHC---CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCCEECSCCCGGGEEECT--TSCEEECCCTTCEEEE
T ss_pred CCcHHHHHHhC---CCCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCEeeccCCcccEEECC--CCCEEEEeCCCCcccc
Confidence 99999999765 489999999999999999999987 9999999999999985 5699999999997643
Q ss_pred CC-------CccccccccccCchhhccCCCCCCCcccchhhhhhhhhhhhcCCCCCCCcCcchhHHHHHHHHhcCCCCCC
Q psy11767 527 ES-------LHTPCFTLQYAAPEVLRQDKSGYDENCDLWSLGVILVNVLRQDKSGYDENCDLWSLGVILYTMLCGRVPFH 599 (966)
Q Consensus 527 ~~-------~~~~~gT~~Y~APEvl~~~~~~~~~~~Di~SlGvil~el~~~~~~~y~~~~DIWSlGvilyemltG~~Pf~ 599 (966)
.. ..+.+||+.|||||++...... ....|+.++|||||||+||||+||.+||.
T Consensus 160 ~~~~~~~~~~~~~~GT~~ymAPE~l~~~~~~--------------------~~~~~~~k~DVwS~Gvvl~El~tg~~~~~ 219 (303)
T 3hmm_A 160 SATDTIDIAPNHRVGTKRYMAPEVLDDSINM--------------------KHFESFKRADIYAMGLVFWEIARRCSIGG 219 (303)
T ss_dssp TTTTEESCC-----CCGGGCCHHHHTTCSCT--------------------TCHHHHHHHHHHHHHHHHHHHHHTBCBTT
T ss_pred CCCCceeeecccccccccccCHHHhcccccc--------------------cCCccChhHhhhhHHHHHHHHHHCCCCCC
Confidence 21 1245799999999999642100 01136778999999999999999987664
Q ss_pred CCC----------Cc-hhHHHHHHHHHcCCCCCCc-hhh--ccCCHHHHHHHHHhcccCccccCChHHHHHHhhh
Q psy11767 600 ARS----------RD-DSALSIMARIKEGQFNFDA-EAW--STVSSEAKELTKSLLTVNPAQRIRMMRVKLTFHA 660 (966)
Q Consensus 600 ~~~----------~~-~~~~~~~~~i~~~~~~~~~-~~~--~~is~e~~~Li~~~L~~dP~~R~t~~~v~~~~~~ 660 (966)
... .. .....+...+..+...+.. ..+ ...+..+.+|+.+||+.||++|||+.++...+..
T Consensus 220 ~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~rp~~p~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~L~~ 294 (303)
T 3hmm_A 220 IHEDYQLPYYDLVPSDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQ 294 (303)
T ss_dssp BCCCCCCTTTTTSCSSCCHHHHHHHHTTSCCCCCCCGGGGSSHHHHHHHHHHHTTCCSSGGGSCCHHHHHHHHHH
T ss_pred ccccccccchhcccccchHHHHHHHHhcccCCCCCCccccchHHHHHHHHHHHHHcccCHhHCcCHHHHHHHHHH
Confidence 322 11 1122333334443332221 111 1234578899999999999999999998655543
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=8.2e-45 Score=406.32 Aligned_cols=263 Identities=58% Similarity=1.047 Sum_probs=208.2
Q ss_pred ccceecccccccccccccccccccEEEEEEEcCCCcEEEEEEecccc--ChHHHHHHHHHhcCCCCceEEEEEEEeCCeE
Q psy11767 369 GSLFFEQYDMDLDKAGILGDGSYSVCRRCVEKSTGQEYAVKIISRKI--DCSEEINLLRACQGHPNIVNLHCVFQDEVHT 446 (966)
Q Consensus 369 G~~~~~~~~i~~~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~--~~~~Ei~iL~~l~~HpnIV~l~~~~~~~~~~ 446 (966)
...|+++|+++.+ .+.||+|+||+||+|.+..+|+.||||++.+.. ...+|+.+|+.+.+|||||+++++|.++...
T Consensus 3 ~~~f~~~y~~~~~-~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~e~~~l~~l~~h~niv~~~~~~~~~~~~ 81 (325)
T 3kn6_A 3 DSPFYQHYDLDLK-DKPLGEGSFSICRKCVHKKSNQAFAVKIISKRMEANTQKEITALKLCEGHPNIVKLHEVFHDQLHT 81 (325)
T ss_dssp CCHHHHHEEECTT-SCCSEEETTEEEEEEEETTTCCEEEEEEEEGGGHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEE
T ss_pred CCcchhccccccC-CCccccCCCeEEEEEEECCCCCEEEEEEEChhhhhhHHHHHHHHHHhcCCCCeeEEEEEEEcCCEE
Confidence 3457788888654 578999999999999999999999999997653 3567999999997899999999999999999
Q ss_pred EEEEEccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCcEEEecCC-CCCEEEEeecccccc
Q psy11767 447 YLVLELLKGGELLDRIRQKGRCGFTENEASRIMRQLVAAVHFMHSRGVVHRDLKPENLLFSDPA-GDNIKVVDFGFACLK 525 (966)
Q Consensus 447 ~lVmEy~~gg~L~~~l~~~~~~~l~e~~~~~i~~Qil~aL~yLHs~~IiHRDLKP~NILl~~~~-~~~iKL~DFGla~~~ 525 (966)
|+|||||+||+|.+++.... .+++.+++.++.||+.||+|||++||+||||||+|||++... ...+||+|||+++..
T Consensus 82 ~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~~kl~Dfg~a~~~ 159 (325)
T 3kn6_A 82 FLVMELLNGGELFERIKKKK--HFSETEASYIMRKLVSAVSHMHDVGVVHRDLKPENLLFTDENDNLEIKIIDFGFARLK 159 (325)
T ss_dssp EEEECCCCSCBHHHHHHHCS--CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEEC----CEEEECCCTTCEEC
T ss_pred EEEEEccCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCHHHEEEecCCCcccEEEeccccceec
Confidence 99999999999999998764 699999999999999999999999999999999999997532 237999999999764
Q ss_pred cC---CCccccccccccCchhhccCCCCCCCcccchhhhhhhhhhhhcCCCCCCCcCcchhHHHHHHHHhcCCCCCCCCC
Q psy11767 526 RE---SLHTPCFTLQYAAPEVLRQDKSGYDENCDLWSLGVILVNVLRQDKSGYDENCDLWSLGVILYTMLCGRVPFHARS 602 (966)
Q Consensus 526 ~~---~~~~~~gT~~Y~APEvl~~~~~~~~~~~Di~SlGvil~el~~~~~~~y~~~~DIWSlGvilyemltG~~Pf~~~~ 602 (966)
.. .....++|+.|+|||++.. ..|+.++|||||||++|+|++|+.||....
T Consensus 160 ~~~~~~~~~~~~t~~y~aPE~~~~--------------------------~~~~~~~DiwslG~il~~ll~g~~pf~~~~ 213 (325)
T 3kn6_A 160 PPDNQPLKTPCFTLHYAAPELLNQ--------------------------NGYDESCDLWSLGVILYTMLSGQVPFQSHD 213 (325)
T ss_dssp CC------------------------------------------------CCCCHHHHHHHHHHHHHHHHHSSCTTC---
T ss_pred CCCCCcccccCCCcCccCHHHhcC--------------------------CCCCCccchHHHHHHHHHHHhCCCCCCCCc
Confidence 32 2345678999999998852 347889999999999999999999998654
Q ss_pred Cc---hhHHHHHHHHHcCCCCCCchhhccCCHHHHHHHHHhcccCccccCChHHHHHHhhhhH
Q psy11767 603 RD---DSALSIMARIKEGQFNFDAEAWSTVSSEAKELTKSLLTVNPAQRIRMMRVKLTFHAFH 662 (966)
Q Consensus 603 ~~---~~~~~~~~~i~~~~~~~~~~~~~~is~e~~~Li~~~L~~dP~~R~t~~~v~~~~~~~~ 662 (966)
.. .....++..+..+.+.+..+.|..+++++++||.+||..||++|||+.++ ..|+|.
T Consensus 214 ~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~el--l~h~w~ 274 (325)
T 3kn6_A 214 RSLTCTSAVEIMKKIKKGDFSFEGEAWKNVSQEAKDLIQGLLTVDPNKRLKMSGL--RYNEWL 274 (325)
T ss_dssp ----CCCHHHHHHHHTTTCCCCCSHHHHTSCHHHHHHHHHHHCCCTTTCCCTTTS--TTCGGG
T ss_pred cccccccHHHHHHHHHcCCCCCCcccccCCCHHHHHHHHHHCCCChhHCCCHHHH--hcChhh
Confidence 31 23346678888999988888899999999999999999999999999876 456665
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-44 Score=416.52 Aligned_cols=252 Identities=38% Similarity=0.676 Sum_probs=208.7
Q ss_pred cccccccccEEEEEEEcCCCcEEEEEEeccccChHHHHHHHHHhcCCCCceEEEEEEEe----CCeEEEEEEccCCCCHH
Q psy11767 384 GILGDGSYSVCRRCVEKSTGQEYAVKIISRKIDCSEEINLLRACQGHPNIVNLHCVFQD----EVHTYLVLELLKGGELL 459 (966)
Q Consensus 384 ~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~~~~~Ei~iL~~l~~HpnIV~l~~~~~~----~~~~~lVmEy~~gg~L~ 459 (966)
++||+|+||+||+|.+..+|+.||||++.......+|+.++..+.+|||||+++++|.. ..++|||||||+||+|.
T Consensus 68 ~~LG~G~~g~V~~~~~~~~~~~vAiK~~~~~~~~~~E~~~~~~~~~hp~iv~l~~~~~~~~~~~~~~~lv~E~~~gg~L~ 147 (400)
T 1nxk_A 68 QVLGLGINGKVLQIFNKRTQEKFALKMLQDCPKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELF 147 (400)
T ss_dssp EEEEEETTEEEEEEEETTTCCEEEEEEEECSHHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEEEEEECCCSEEHH
T ss_pred ceeeeccCeEEEEEEECCCCCEEEEEEeCcchhHHHHHHHHHHhcCCCCcceEeEEEeecccCCcEEEEEEEeCCCCcHH
Confidence 57999999999999999999999999998766677899998777789999999999976 56789999999999999
Q ss_pred HHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCcEEEecCC-CCCEEEEeecccccccC--CCccccccc
Q psy11767 460 DRIRQKGRCGFTENEASRIMRQLVAAVHFMHSRGVVHRDLKPENLLFSDPA-GDNIKVVDFGFACLKRE--SLHTPCFTL 536 (966)
Q Consensus 460 ~~l~~~~~~~l~e~~~~~i~~Qil~aL~yLHs~~IiHRDLKP~NILl~~~~-~~~iKL~DFGla~~~~~--~~~~~~gT~ 536 (966)
+++...+...+++.+++.++.||+.||+|||++||+||||||+|||++... ++.+||+|||+++.... ...+.+||+
T Consensus 148 ~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~~~~~~kl~DFG~a~~~~~~~~~~~~~gt~ 227 (400)
T 1nxk_A 148 SRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTP 227 (400)
T ss_dssp HHHHCC---CCBHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSSTTCCEEECCCTTCEECC-----------C
T ss_pred HHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCcCcceEEEecCCCCccEEEEecccccccCCCCccccCCCCC
Confidence 999876555699999999999999999999999999999999999997532 56899999999976543 235678999
Q ss_pred cccCchhhccCCCCCCCcccchhhhhhhhhhhhcCCCCCCCcCcchhHHHHHHHHhcCCCCCCCCCCchhHHHHHHHHHc
Q psy11767 537 QYAAPEVLRQDKSGYDENCDLWSLGVILVNVLRQDKSGYDENCDLWSLGVILYTMLCGRVPFHARSRDDSALSIMARIKE 616 (966)
Q Consensus 537 ~Y~APEvl~~~~~~~~~~~Di~SlGvil~el~~~~~~~y~~~~DIWSlGvilyemltG~~Pf~~~~~~~~~~~~~~~i~~ 616 (966)
.|+|||++.. ..|+.++|||||||++|+|++|+.||.+.............+..
T Consensus 228 ~y~aPE~~~~--------------------------~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~i~~ 281 (400)
T 1nxk_A 228 YYVAPEVLGP--------------------------EKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRM 281 (400)
T ss_dssp TTCCGGGSCC--------------------------CCSSSHHHHHHHHHHHHHHHHSSCSCCCCTTCSSCCSHHHHHHH
T ss_pred CccCHhhcCC--------------------------CCCCCcccHHHHHHHHHHHHhCCCCCCCCccccccHHHHHHHHc
Confidence 9999999842 34788999999999999999999999876543221224456777
Q ss_pred CCCCCCchhhccCCHHHHHHHHHhcccCccccCChHHHHHHhhhhHH
Q psy11767 617 GQFNFDAEAWSTVSSEAKELTKSLLTVNPAQRIRMMRVKLTFHAFHQ 663 (966)
Q Consensus 617 ~~~~~~~~~~~~is~e~~~Li~~~L~~dP~~R~t~~~v~~~~~~~~~ 663 (966)
+.+.++...|..+++++++||.+||..||++|||+.++ ..|+|..
T Consensus 282 ~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~ei--l~hp~~~ 326 (400)
T 1nxk_A 282 GQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEF--MNHPWIM 326 (400)
T ss_dssp TCCCCCTTTTTTSCHHHHHHHHTTSCSSGGGSCCHHHH--HHSHHHH
T ss_pred CcccCCCcccccCCHHHHHHHHHHCCCChhHCcCHHHH--hcCcccc
Confidence 88877777788899999999999999999999999876 4567654
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-44 Score=407.43 Aligned_cols=253 Identities=34% Similarity=0.635 Sum_probs=217.7
Q ss_pred eecccccccccccccccccccEEEEEEEcCCCcEEEEEEecccc-----------ChHHHHHHHHHhcCCCCceEEEEEE
Q psy11767 372 FFEQYDMDLDKAGILGDGSYSVCRRCVEKSTGQEYAVKIISRKI-----------DCSEEINLLRACQGHPNIVNLHCVF 440 (966)
Q Consensus 372 ~~~~~~i~~~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~-----------~~~~Ei~iL~~l~~HpnIV~l~~~~ 440 (966)
+.+.|.+ .+.||+|+||+||+|+++.+|+.||||++.... ...+|+.+|+.+ .|||||+++++|
T Consensus 10 ~~~~y~~----~~~LG~G~fg~V~~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~~~~E~~il~~l-~hpnIv~l~~~~ 84 (361)
T 2yab_A 10 VEDFYDI----GEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQV-LHPNIITLHDVY 84 (361)
T ss_dssp GGGTEEE----EEEEEEETTEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHTTC-CCTTBCCEEEEE
T ss_pred hhhceEE----eeEEeeCcCEEEEEEEECCCCCEEEEEEEEccccccccchhHHHHHHHHHHHHHhC-CCcCCCcEEEEE
Confidence 3444544 688999999999999999999999999997542 135799999988 499999999999
Q ss_pred EeCCeEEEEEEccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCcEEEecCCC--CCEEEEe
Q psy11767 441 QDEVHTYLVLELLKGGELLDRIRQKGRCGFTENEASRIMRQLVAAVHFMHSRGVVHRDLKPENLLFSDPAG--DNIKVVD 518 (966)
Q Consensus 441 ~~~~~~~lVmEy~~gg~L~~~l~~~~~~~l~e~~~~~i~~Qil~aL~yLHs~~IiHRDLKP~NILl~~~~~--~~iKL~D 518 (966)
++....|+|||||+||+|.+++...+ .+++.+++.++.||+.||+|||++||+||||||+|||+++... ..+||+|
T Consensus 85 ~~~~~~~lv~e~~~gg~L~~~l~~~~--~l~~~~~~~i~~qi~~aL~~LH~~givHrDlkp~NIll~~~~~~~~~vkl~D 162 (361)
T 2yab_A 85 ENRTDVVLILELVSGGELFDFLAQKE--SLSEEEATSFIKQILDGVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLID 162 (361)
T ss_dssp ECSSEEEEEEECCCSCBHHHHHTTCS--CCBHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCTTSSSCCEEECC
T ss_pred EeCCEEEEEEEcCCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEeCCCCCccCEEEEe
Confidence 99999999999999999999997654 6999999999999999999999999999999999999975321 2799999
Q ss_pred ecccccccC--CCccccccccccCchhhccCCCCCCCcccchhhhhhhhhhhhcCCCCCCCcCcchhHHHHHHHHhcCCC
Q psy11767 519 FGFACLKRE--SLHTPCFTLQYAAPEVLRQDKSGYDENCDLWSLGVILVNVLRQDKSGYDENCDLWSLGVILYTMLCGRV 596 (966)
Q Consensus 519 FGla~~~~~--~~~~~~gT~~Y~APEvl~~~~~~~~~~~Di~SlGvil~el~~~~~~~y~~~~DIWSlGvilyemltG~~ 596 (966)
||++..... .....+||+.|+|||++.. ..|+.++|||||||++|+|++|.+
T Consensus 163 FG~a~~~~~~~~~~~~~gt~~y~aPE~~~~--------------------------~~~~~~~DiwslGvil~~ll~g~~ 216 (361)
T 2yab_A 163 FGLAHEIEDGVEFKNIFGTPEFVAPEIVNY--------------------------EPLGLEADMWSIGVITYILLSGAS 216 (361)
T ss_dssp CSSCEECCTTCCCCCCCSCGGGCCHHHHTT--------------------------CCCCTHHHHHHHHHHHHHHHHSCC
T ss_pred cCCceEcCCCCccccCCCCccEECchHHcC--------------------------CCCCccccHHHHHHHHHHHHhCCC
Confidence 999976543 2346689999999999852 347889999999999999999999
Q ss_pred CCCCCCCchhHHHHHHHHHcCCCCCCchhhccCCHHHHHHHHHhcccCccccCChHHHHHHhhhhHH
Q psy11767 597 PFHARSRDDSALSIMARIKEGQFNFDAEAWSTVSSEAKELTKSLLTVNPAQRIRMMRVKLTFHAFHQ 663 (966)
Q Consensus 597 Pf~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~is~e~~~Li~~~L~~dP~~R~t~~~v~~~~~~~~~ 663 (966)
||.+.+. ...+..|..+.+.++.+.|..+|+++++||.+||..||++|||+.++ ..|+|..
T Consensus 217 Pf~~~~~----~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~--l~hp~~~ 277 (361)
T 2yab_A 217 PFLGDTK----QETLANITAVSYDFDEEFFSQTSELAKDFIRKLLVKETRKRLTIQEA--LRHPWIT 277 (361)
T ss_dssp SSCCSSH----HHHHHHHHTTCCCCCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHH--HTSTTTS
T ss_pred CCCCCCH----HHHHHHHHhcCCCCCchhccCCCHHHHHHHHHHCCCChhHCcCHHHH--hcCcCcC
Confidence 9987543 34567788888888888899999999999999999999999999876 4577764
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-44 Score=404.61 Aligned_cols=257 Identities=46% Similarity=0.836 Sum_probs=220.3
Q ss_pred eecccccccccccccccccccEEEEEEEcCCCcEEEEEEecccc-ChHHHHHHHHHhcCCCCceEEEEEEEeCCeEEEEE
Q psy11767 372 FFEQYDMDLDKAGILGDGSYSVCRRCVEKSTGQEYAVKIISRKI-DCSEEINLLRACQGHPNIVNLHCVFQDEVHTYLVL 450 (966)
Q Consensus 372 ~~~~~~i~~~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~-~~~~Ei~iL~~l~~HpnIV~l~~~~~~~~~~~lVm 450 (966)
|.+.|.+ .+.||+|+||+||+|.++.+|+.||||++.+.. ...+|+++|..+.+|||||+++++|.++...|+||
T Consensus 20 ~~~~y~~----~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~ 95 (342)
T 2qr7_A 20 FTDGYEV----KEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKRDPTEEIEILLRYGQHPNIITLKDVYDDGKYVYVVT 95 (342)
T ss_dssp HHHHEEE----EEEEEECSSEEEEEEEETTTTEEEEEEEEETTTCCCHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEEE
T ss_pred ccccEEE----EEEEeeCCCEEEEEEEECCCCCEEEEEEEEcccCChHHHHHHHHHhcCCCCcCeEEEEEEcCCEEEEEE
Confidence 4455555 688999999999999999999999999997643 56789999998878999999999999999999999
Q ss_pred EccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCcEEEecCCC--CCEEEEeecccccccC-
Q psy11767 451 ELLKGGELLDRIRQKGRCGFTENEASRIMRQLVAAVHFMHSRGVVHRDLKPENLLFSDPAG--DNIKVVDFGFACLKRE- 527 (966)
Q Consensus 451 Ey~~gg~L~~~l~~~~~~~l~e~~~~~i~~Qil~aL~yLHs~~IiHRDLKP~NILl~~~~~--~~iKL~DFGla~~~~~- 527 (966)
|||+||+|.+++...+ .+++.+++.++.||+.||+|||++||+||||||+|||+.+..+ +.+||+|||+++....
T Consensus 96 E~~~gg~L~~~i~~~~--~~~~~~~~~~~~qi~~al~~lH~~givHrDlkp~NIl~~~~~~~~~~~kl~Dfg~a~~~~~~ 173 (342)
T 2qr7_A 96 ELMKGGELLDKILRQK--FFSEREASAVLFTITKTVEYLHAQGVVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAE 173 (342)
T ss_dssp CCCCSCBHHHHHHTCT--TCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEESSSSCSGGGEEECCCTTCEECBCT
T ss_pred eCCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCCcEeccCCHHHEEEecCCCCcCeEEEEECCCcccCcCC
Confidence 9999999999997754 5999999999999999999999999999999999999965322 3599999999976432
Q ss_pred --CCccccccccccCchhhccCCCCCCCcccchhhhhhhhhhhhcCCCCCCCcCcchhHHHHHHHHhcCCCCCCCCCCch
Q psy11767 528 --SLHTPCFTLQYAAPEVLRQDKSGYDENCDLWSLGVILVNVLRQDKSGYDENCDLWSLGVILYTMLCGRVPFHARSRDD 605 (966)
Q Consensus 528 --~~~~~~gT~~Y~APEvl~~~~~~~~~~~Di~SlGvil~el~~~~~~~y~~~~DIWSlGvilyemltG~~Pf~~~~~~~ 605 (966)
...+.++|+.|+|||++... .|+.++|||||||++|+|++|..||.+... +
T Consensus 174 ~~~~~~~~gt~~y~aPE~~~~~--------------------------~~~~~~DiwslG~il~ell~g~~Pf~~~~~-~ 226 (342)
T 2qr7_A 174 NGLLMTPCYTANFVAPEVLERQ--------------------------GYDAACDIWSLGVLLYTMLTGYTPFANGPD-D 226 (342)
T ss_dssp TCCBCCSSCCSSCCCHHHHHHH--------------------------HHHHHHHHHHHHHHHHHHHHSSCSSCSSTT-S
T ss_pred CCceeccCCCccccCHHHhcCC--------------------------CCCCccCeeeHhHHHHHHhcCCCCCCCCCc-C
Confidence 23467899999999998531 256789999999999999999999986432 2
Q ss_pred hHHHHHHHHHcCCCCCCchhhccCCHHHHHHHHHhcccCccccCChHHHHHHhhhhHH
Q psy11767 606 SALSIMARIKEGQFNFDAEAWSTVSSEAKELTKSLLTVNPAQRIRMMRVKLTFHAFHQ 663 (966)
Q Consensus 606 ~~~~~~~~i~~~~~~~~~~~~~~is~e~~~Li~~~L~~dP~~R~t~~~v~~~~~~~~~ 663 (966)
....++..+..+.+.+....|..+|+++++||.+||..||++|||+.++ ..|+|..
T Consensus 227 ~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~~i--l~hp~~~ 282 (342)
T 2qr7_A 227 TPEEILARIGSGKFSLSGGYWNSVSDTAKDLVSKMLHVDPHQRLTAALV--LRHPWIV 282 (342)
T ss_dssp CHHHHHHHHHHCCCCCCSTTTTTSCHHHHHHHHHHTCSSTTTSCCHHHH--TTSHHHH
T ss_pred CHHHHHHHHccCCcccCccccccCCHHHHHHHHHHCCCChhHCcCHHHH--hcCCeec
Confidence 3346777888898888888888999999999999999999999999876 4577763
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-44 Score=406.69 Aligned_cols=246 Identities=30% Similarity=0.578 Sum_probs=205.3
Q ss_pred cccccccccccccEEEEEEEcCCCcEEEEEEecccc--------ChHHHHHHHHHhcCCCCceEEEEEEEeCCeEEEEEE
Q psy11767 380 LDKAGILGDGSYSVCRRCVEKSTGQEYAVKIISRKI--------DCSEEINLLRACQGHPNIVNLHCVFQDEVHTYLVLE 451 (966)
Q Consensus 380 ~~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~--------~~~~Ei~iL~~l~~HpnIV~l~~~~~~~~~~~lVmE 451 (966)
|+.++.||+|+||+||+|+++.+|+.||||++.+.. ...+|+.+|+.+.+|||||+++++|.+....|||||
T Consensus 25 y~~~~~lG~G~fg~V~~~~~~~~~~~~AvK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~~lv~E 104 (353)
T 3txo_A 25 FEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLFCCFQTPDRLFFVME 104 (353)
T ss_dssp EEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHHTTHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEEE
T ss_pred eEEEEEEeeCCCEEEEEEEEcCCCCEEEEEEEEHHHhcchhHHHHHHHHHHHHHhccCCCceeeEEEEEEeCCEEEEEEe
Confidence 344789999999999999999999999999997531 134688899888789999999999999999999999
Q ss_pred ccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCcEEEecCCCCCEEEEeeccccccc---CC
Q psy11767 452 LLKGGELLDRIRQKGRCGFTENEASRIMRQLVAAVHFMHSRGVVHRDLKPENLLFSDPAGDNIKVVDFGFACLKR---ES 528 (966)
Q Consensus 452 y~~gg~L~~~l~~~~~~~l~e~~~~~i~~Qil~aL~yLHs~~IiHRDLKP~NILl~~~~~~~iKL~DFGla~~~~---~~ 528 (966)
||+||+|.+++.+.+ .+++.+++.++.||+.||+|||++||+||||||+|||++. ++.+||+|||+|+... ..
T Consensus 105 ~~~gg~L~~~l~~~~--~~~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~--~g~ikL~DFG~a~~~~~~~~~ 180 (353)
T 3txo_A 105 FVNGGDLMFHIQKSR--RFDEARARFYAAEIISALMFLHDKGIIYRDLKLDNVLLDH--EGHCKLADFGMCKEGICNGVT 180 (353)
T ss_dssp CCCSCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECT--TSCEEECCCTTCBCSCC----
T ss_pred CCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCHHHEEECC--CCCEEEccccceeecccCCcc
Confidence 999999999998765 5999999999999999999999999999999999999975 5699999999997532 23
Q ss_pred CccccccccccCchhhccCCCCCCCcccchhhhhhhhhhhhcCCCCCCCcCcchhHHHHHHHHhcCCCCCCCCCCchhHH
Q psy11767 529 LHTPCFTLQYAAPEVLRQDKSGYDENCDLWSLGVILVNVLRQDKSGYDENCDLWSLGVILYTMLCGRVPFHARSRDDSAL 608 (966)
Q Consensus 529 ~~~~~gT~~Y~APEvl~~~~~~~~~~~Di~SlGvil~el~~~~~~~y~~~~DIWSlGvilyemltG~~Pf~~~~~~~~~~ 608 (966)
..+.+||+.|+|||++... .|+.++|||||||++|+|++|++||.+.+..
T Consensus 181 ~~~~~gt~~y~aPE~~~~~--------------------------~~~~~~DiwslG~il~ell~G~~Pf~~~~~~---- 230 (353)
T 3txo_A 181 TATFCGTPDYIAPEILQEM--------------------------LYGPAVDWWAMGVLLYEMLCGHAPFEAENED---- 230 (353)
T ss_dssp -----CCGGGCCHHHHHHH--------------------------HCTTHHHHHHHHHHHHHHHHSSCSSCCSSHH----
T ss_pred ccccCCCcCeEChhhcCCC--------------------------CcCCccCCCcchHHHHHHHhCCCCCCCCCHH----
Confidence 4467899999999998532 3788999999999999999999999876533
Q ss_pred HHHHHHHcCCCCCCchhhccCCHHHHHHHHHhcccCccccCChHH----HHHHhhhhHH
Q psy11767 609 SIMARIKEGQFNFDAEAWSTVSSEAKELTKSLLTVNPAQRIRMMR----VKLTFHAFHQ 663 (966)
Q Consensus 609 ~~~~~i~~~~~~~~~~~~~~is~e~~~Li~~~L~~dP~~R~t~~~----v~~~~~~~~~ 663 (966)
.++..|..+.+.++. .+++++++||.+||+.||++||++.+ -....|+|++
T Consensus 231 ~~~~~i~~~~~~~p~----~~~~~~~~li~~lL~~dP~~R~~~~~~~~~~~il~hp~f~ 285 (353)
T 3txo_A 231 DLFEAILNDEVVYPT----WLHEDATGILKSFMTKNPTMRLGSLTQGGEHAILRHPFFK 285 (353)
T ss_dssp HHHHHHHHCCCCCCT----TSCHHHHHHHHHHTCSSGGGSTTSGGGTCTHHHHTSGGGT
T ss_pred HHHHHHHcCCCCCCC----CCCHHHHHHHHHHhhhCHHHccCCcccCCHHHHhhCCccc
Confidence 456677777665542 47999999999999999999999821 2345677764
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-43 Score=406.46 Aligned_cols=250 Identities=29% Similarity=0.540 Sum_probs=208.5
Q ss_pred cccccccccccccEEEEEEEcCCCcEEEEEEecccc--------ChHHHHHHHHHhcCCCCceEEEEEEEeCCeEEEEEE
Q psy11767 380 LDKAGILGDGSYSVCRRCVEKSTGQEYAVKIISRKI--------DCSEEINLLRACQGHPNIVNLHCVFQDEVHTYLVLE 451 (966)
Q Consensus 380 ~~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~--------~~~~Ei~iL~~l~~HpnIV~l~~~~~~~~~~~lVmE 451 (966)
|+.+++||+|+||+||+|+++.+++.||||++.+.. ....|+.+|+.+.+|||||+++++|.++..+|||||
T Consensus 54 y~~~~~LG~G~fG~V~~~~~~~~~~~~AvK~~~k~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~~lV~E 133 (396)
T 4dc2_A 54 FDLLRVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIE 133 (396)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGTC----CCHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEEEEE
T ss_pred cEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhcCCCCCcCeeEEEEEECCEEEEEEE
Confidence 444789999999999999999999999999997542 145789999888789999999999999999999999
Q ss_pred ccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCcEEEecCCCCCEEEEeeccccccc---CC
Q psy11767 452 LLKGGELLDRIRQKGRCGFTENEASRIMRQLVAAVHFMHSRGVVHRDLKPENLLFSDPAGDNIKVVDFGFACLKR---ES 528 (966)
Q Consensus 452 y~~gg~L~~~l~~~~~~~l~e~~~~~i~~Qil~aL~yLHs~~IiHRDLKP~NILl~~~~~~~iKL~DFGla~~~~---~~ 528 (966)
||+||+|.+++.+.+ .+++..++.++.||+.||+|||++||+||||||+|||++. ++.+||+|||+|+... ..
T Consensus 134 ~~~gg~L~~~l~~~~--~l~~~~~~~~~~qi~~aL~~LH~~givHrDLKp~NILl~~--~g~ikL~DFGla~~~~~~~~~ 209 (396)
T 4dc2_A 134 YVNGGDLMFHMQRQR--KLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLDS--EGHIKLTDYGMCKEGLRPGDT 209 (396)
T ss_dssp CCTTCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECT--TSCEEECCCTTCBCCCCTTCC
T ss_pred cCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCCEEeccCCHHHEEECC--CCCEEEeecceeeecccCCCc
Confidence 999999999998765 5999999999999999999999999999999999999975 5699999999997532 23
Q ss_pred CccccccccccCchhhccCCCCCCCcccchhhhhhhhhhhhcCCCCCCCcCcchhHHHHHHHHhcCCCCCCCCCCch---
Q psy11767 529 LHTPCFTLQYAAPEVLRQDKSGYDENCDLWSLGVILVNVLRQDKSGYDENCDLWSLGVILYTMLCGRVPFHARSRDD--- 605 (966)
Q Consensus 529 ~~~~~gT~~Y~APEvl~~~~~~~~~~~Di~SlGvil~el~~~~~~~y~~~~DIWSlGvilyemltG~~Pf~~~~~~~--- 605 (966)
..+.+||+.|+|||++.. ..|+.++|||||||++|+|++|++||......+
T Consensus 210 ~~~~~gt~~Y~aPE~l~~--------------------------~~~~~~~DiwslGvllyell~G~~Pf~~~~~~~~~~ 263 (396)
T 4dc2_A 210 TSTFCGTPNYIAPEILRG--------------------------EDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPD 263 (396)
T ss_dssp BCCCCBCGGGCCHHHHTT--------------------------CCBCTHHHHHHHHHHHHHHHHSSCSSTTTTC-----
T ss_pred cccccCCcccCCchhhcC--------------------------CCCChHHHHHHHHHHHHHHHhCCCCCcccccccccc
Confidence 456789999999999853 347889999999999999999999997543211
Q ss_pred --hHHHHHHHHHcCCCCCCchhhccCCHHHHHHHHHhcccCccccCChH---H-HHHHhhhhHH
Q psy11767 606 --SALSIMARIKEGQFNFDAEAWSTVSSEAKELTKSLLTVNPAQRIRMM---R-VKLTFHAFHQ 663 (966)
Q Consensus 606 --~~~~~~~~i~~~~~~~~~~~~~~is~e~~~Li~~~L~~dP~~R~t~~---~-v~~~~~~~~~ 663 (966)
....+...+..+.+.++ ..+|+++++||.+||+.||++||++. . .....|+|++
T Consensus 264 ~~~~~~~~~~i~~~~~~~p----~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~ei~~Hpff~ 323 (396)
T 4dc2_A 264 QNTEDYLFQVILEKQIRIP----RSLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGHPFFR 323 (396)
T ss_dssp -CCHHHHHHHHHHCCCCCC----TTSCHHHHHHHHHHTCSCTTTSTTCSTTTHHHHHHHSTTTT
T ss_pred hhhHHHHHHHHhccccCCC----CcCCHHHHHHHHHHhcCCHhHcCCCCCCCCHHHHhcCcccc
Confidence 12234556666665544 35899999999999999999999962 1 2345677763
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=8.5e-44 Score=397.55 Aligned_cols=250 Identities=28% Similarity=0.528 Sum_probs=216.1
Q ss_pred cccccccccccEEEEEEEcCCCcEEEEEEecccc----ChHHHHHHHHHhcCCCCceEEEEEEEeCCeEEEEEEccCCCC
Q psy11767 382 KAGILGDGSYSVCRRCVEKSTGQEYAVKIISRKI----DCSEEINLLRACQGHPNIVNLHCVFQDEVHTYLVLELLKGGE 457 (966)
Q Consensus 382 ~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~----~~~~Ei~iL~~l~~HpnIV~l~~~~~~~~~~~lVmEy~~gg~ 457 (966)
..+.||+|+||+||+|.+..+|+.||+|++.... ...+|+.+|+.+ +|||||++++++.+....|+|||||+||+
T Consensus 9 ~~~~lG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~E~~~l~~l-~hpnIv~~~~~~~~~~~~~lv~e~~~g~~ 87 (321)
T 1tki_A 9 IAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQVLVKKEISILNIA-RHRNILHLHESFESMEELVMIFEFISGLD 87 (321)
T ss_dssp EEEEEEECSSEEEEEEEETTTTEEEEEEEECCCTHHHHHHHHHHHHHHHS-CCTTBCCEEEEEEETTEEEEEECCCCCCB
T ss_pred eeeEEecCCCeEEEEEEECCCCcEEEEEEEecCcccHHHHHHHHHHHHhC-CCCCCCeEeEEEecCCEEEEEEEeCCCCC
Confidence 3688999999999999999999999999986542 245799999988 59999999999999999999999999999
Q ss_pred HHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCcEEEecCCCCCEEEEeecccccccCC--Ccccccc
Q psy11767 458 LLDRIRQKGRCGFTENEASRIMRQLVAAVHFMHSRGVVHRDLKPENLLFSDPAGDNIKVVDFGFACLKRES--LHTPCFT 535 (966)
Q Consensus 458 L~~~l~~~~~~~l~e~~~~~i~~Qil~aL~yLHs~~IiHRDLKP~NILl~~~~~~~iKL~DFGla~~~~~~--~~~~~gT 535 (966)
|.+++.... ..+++.+++.++.||+.||+|||++||+||||||+|||++...++.+||+|||++...... ....++|
T Consensus 88 L~~~l~~~~-~~~~~~~~~~i~~qi~~al~~lH~~givH~Dlkp~NIl~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~gt 166 (321)
T 1tki_A 88 IFERINTSA-FELNEREIVSYVHQVCEALQFLHSHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNFRLLFTA 166 (321)
T ss_dssp HHHHHTSSS-CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSSCCCEEECCCTTCEECCTTCEEEEEESC
T ss_pred HHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHCCCCcCCCCHHHEEEccCCCCCEEEEECCCCeECCCCCccccccCC
Confidence 999997643 2599999999999999999999999999999999999998644679999999999765432 2345689
Q ss_pred ccccCchhhccCCCCCCCcccchhhhhhhhhhhhcCCCCCCCcCcchhHHHHHHHHhcCCCCCCCCCCchhHHHHHHHHH
Q psy11767 536 LQYAAPEVLRQDKSGYDENCDLWSLGVILVNVLRQDKSGYDENCDLWSLGVILYTMLCGRVPFHARSRDDSALSIMARIK 615 (966)
Q Consensus 536 ~~Y~APEvl~~~~~~~~~~~Di~SlGvil~el~~~~~~~y~~~~DIWSlGvilyemltG~~Pf~~~~~~~~~~~~~~~i~ 615 (966)
+.|+|||++.. ..|+.++|||||||++|+|++|..||.+.+. ..++..+.
T Consensus 167 ~~y~aPE~~~~--------------------------~~~~~~~DiwslG~il~~ll~g~~pf~~~~~----~~~~~~i~ 216 (321)
T 1tki_A 167 PEYYAPEVHQH--------------------------DVVSTATDMWSLGTLVYVLLSGINPFLAETN----QQIIENIM 216 (321)
T ss_dssp GGGSCHHHHTT--------------------------CEECHHHHHHHHHHHHHHHHHSSCTTCCSSH----HHHHHHHH
T ss_pred hhhcCcHHhcC--------------------------CCCCchhhHHHHHHHHHHHHhCCCCCcCCCH----HHHHHHHH
Confidence 99999999853 2367889999999999999999999987543 34567778
Q ss_pred cCCCCCCchhhccCCHHHHHHHHHhcccCccccCChHHHHHHhhhhHHhh
Q psy11767 616 EGQFNFDAEAWSTVSSEAKELTKSLLTVNPAQRIRMMRVKLTFHAFHQAQ 665 (966)
Q Consensus 616 ~~~~~~~~~~~~~is~e~~~Li~~~L~~dP~~R~t~~~v~~~~~~~~~~~ 665 (966)
.+.+.++...|..+|+++++||.+||..||.+|||+.++ ..|+|....
T Consensus 217 ~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~e~--l~hp~~~~~ 264 (321)
T 1tki_A 217 NAEYTFDEEAFKEISIEAMDFVDRLLVKERKSRMTASEA--LQHPWLKQK 264 (321)
T ss_dssp HTCCCCCHHHHTTSCHHHHHHHHTTSCSSGGGSCCHHHH--HHSHHHHSC
T ss_pred cCCCCCChhhhccCCHHHHHHHHHHcCCChhHCcCHHHH--hcChhhccC
Confidence 888888888888999999999999999999999999976 457777544
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-43 Score=411.98 Aligned_cols=254 Identities=40% Similarity=0.687 Sum_probs=217.6
Q ss_pred eecccccccccccccccccccEEEEEEEcCCCcEEEEEEeccccC-------hHHHHHHHHHhcCCCCceEEEEEEEeCC
Q psy11767 372 FFEQYDMDLDKAGILGDGSYSVCRRCVEKSTGQEYAVKIISRKID-------CSEEINLLRACQGHPNIVNLHCVFQDEV 444 (966)
Q Consensus 372 ~~~~~~i~~~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~~-------~~~Ei~iL~~l~~HpnIV~l~~~~~~~~ 444 (966)
|.++|.+ .+.||+|+||+||+|.+..+|+.||+|++..... ..+|+.+|+.+ +|||||++++++.+++
T Consensus 9 ~~~~Y~i----~~~LG~G~fg~V~~~~~~~~~~~~a~K~i~~~~~~~~~~~~~~~E~~il~~l-~hpnIv~l~~~~~~~~ 83 (444)
T 3soa_A 9 FTEEYQL----FEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLL-KHPNIVRLHDSISEEG 83 (444)
T ss_dssp HHHHEEE----EEEEEEC--CEEEEEEETTTTEEEEEEEEESCSCHHHHHHHHHHHHHHHHHC-CBTTBCCEEEEEECSS
T ss_pred ccCCeEE----EEEeccCCCeEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhC-CCcCCCeEEEEEEECC
Confidence 4455554 6889999999999999999999999999976432 45799999998 5999999999999999
Q ss_pred eEEEEEEccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCcEEEecC-CCCCEEEEeecccc
Q psy11767 445 HTYLVLELLKGGELLDRIRQKGRCGFTENEASRIMRQLVAAVHFMHSRGVVHRDLKPENLLFSDP-AGDNIKVVDFGFAC 523 (966)
Q Consensus 445 ~~~lVmEy~~gg~L~~~l~~~~~~~l~e~~~~~i~~Qil~aL~yLHs~~IiHRDLKP~NILl~~~-~~~~iKL~DFGla~ 523 (966)
..|+|||||+||+|.+.+.... .+++.++..++.||+.||+|||++||+||||||+|||++.. .++.+||+|||+|.
T Consensus 84 ~~~lv~E~~~gg~L~~~i~~~~--~~~e~~~~~i~~qil~aL~~lH~~givHrDlKp~NIll~~~~~~~~vkL~DFG~a~ 161 (444)
T 3soa_A 84 HHYLIFDLVTGGELFEDIVARE--YYSEADASHCIQQILEAVLHCHQMGVVHRNLKPENLLLASKLKGAAVKLADFGLAI 161 (444)
T ss_dssp EEEEEECCCBCCBHHHHHHHCS--CCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSSTTEEESBSSTTCCEEECCCSSCB
T ss_pred EEEEEEEeCCCCCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEeccCCCCcEEEccCceeE
Confidence 9999999999999999998765 59999999999999999999999999999999999999753 34689999999997
Q ss_pred cccCC---CccccccccccCchhhccCCCCCCCcccchhhhhhhhhhhhcCCCCCCCcCcchhHHHHHHHHhcCCCCCCC
Q psy11767 524 LKRES---LHTPCFTLQYAAPEVLRQDKSGYDENCDLWSLGVILVNVLRQDKSGYDENCDLWSLGVILYTMLCGRVPFHA 600 (966)
Q Consensus 524 ~~~~~---~~~~~gT~~Y~APEvl~~~~~~~~~~~Di~SlGvil~el~~~~~~~y~~~~DIWSlGvilyemltG~~Pf~~ 600 (966)
..... ....+||+.|+|||++.. ..|+.++|||||||++|+|++|.+||.+
T Consensus 162 ~~~~~~~~~~~~~gt~~Y~APE~l~~--------------------------~~~~~~~DIwSlGvilyell~G~~Pf~~ 215 (444)
T 3soa_A 162 EVEGEQQAWFGFAGTPGYLSPEVLRK--------------------------DPYGKPVDLWACGVILYILLVGYPPFWD 215 (444)
T ss_dssp CCCTTCCBCCCSCSCGGGCCHHHHTT--------------------------CCBCTHHHHHHHHHHHHHHHHSSCSCCC
T ss_pred EecCCCceeecccCCcccCCHHHhcC--------------------------CCCCCccccHHHHHHHHHHHhCCCCCCC
Confidence 65432 235689999999999852 2478899999999999999999999987
Q ss_pred CCCchhHHHHHHHHHcCCCCCCchhhccCCHHHHHHHHHhcccCccccCChHHHHHHhhhhHHh
Q psy11767 601 RSRDDSALSIMARIKEGQFNFDAEAWSTVSSEAKELTKSLLTVNPAQRIRMMRVKLTFHAFHQA 664 (966)
Q Consensus 601 ~~~~~~~~~~~~~i~~~~~~~~~~~~~~is~e~~~Li~~~L~~dP~~R~t~~~v~~~~~~~~~~ 664 (966)
.+. ..++..+..+.+.++...|..+++++++||.+||+.||++|||+.++ ..|+|...
T Consensus 216 ~~~----~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~e~--L~hp~~~~ 273 (444)
T 3soa_A 216 EDQ----HRLYQQIKAGAYDFPSPEWDTVTPEAKDLINKMLTINPSKRITAAEA--LKHPWISH 273 (444)
T ss_dssp SSH----HHHHHHHHHTCCCCCTTTTTTSCHHHHHHHHHHSCSSTTTSCCHHHH--HHSCTTHH
T ss_pred ccH----HHHHHHHHhCCCCCCccccccCCHHHHHHHHHHcCCChhHCCCHHHH--hcCccccC
Confidence 543 35567788888888888889999999999999999999999999976 45677643
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-43 Score=400.02 Aligned_cols=253 Identities=41% Similarity=0.710 Sum_probs=217.3
Q ss_pred eecccccccccccccccccccEEEEEEEcCCCcEEEEEEeccccC-------hHHHHHHHHHhcCCCCceEEEEEEEeCC
Q psy11767 372 FFEQYDMDLDKAGILGDGSYSVCRRCVEKSTGQEYAVKIISRKID-------CSEEINLLRACQGHPNIVNLHCVFQDEV 444 (966)
Q Consensus 372 ~~~~~~i~~~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~~-------~~~Ei~iL~~l~~HpnIV~l~~~~~~~~ 444 (966)
+.+.|.+ .+.||+|+||.||+|.+..+|+.||||++..... ..+|+.+|+.+ +|||||++++++.++.
T Consensus 27 ~~~~y~~----~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~il~~l-~hpnIv~~~~~~~~~~ 101 (362)
T 2bdw_A 27 FSDNYDV----KEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKL-QHPNIVRLHDSIQEES 101 (362)
T ss_dssp HHHHEEE----EEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCHHHHHHHHHHHHHHHHC-CCTTBCCEEEEEECSS
T ss_pred cccCeEE----eeEEecCCCeEEEEEEECCCCCEEEEEEEEcccCCHHHHHHHHHHHHHHHhC-CCCCCCeEEEEEEeCC
Confidence 4455554 6889999999999999999999999999975432 34699999998 5999999999999999
Q ss_pred eEEEEEEccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCcEEEecCC-CCCEEEEeecccc
Q psy11767 445 HTYLVLELLKGGELLDRIRQKGRCGFTENEASRIMRQLVAAVHFMHSRGVVHRDLKPENLLFSDPA-GDNIKVVDFGFAC 523 (966)
Q Consensus 445 ~~~lVmEy~~gg~L~~~l~~~~~~~l~e~~~~~i~~Qil~aL~yLHs~~IiHRDLKP~NILl~~~~-~~~iKL~DFGla~ 523 (966)
..|+|||||+||+|.+++.... .+++.++..++.||+.||+|||++||+||||||+|||++... ++.+||+|||++.
T Consensus 102 ~~~lv~e~~~gg~L~~~l~~~~--~~~~~~~~~~~~qi~~al~~lH~~~ivH~Dlkp~NIll~~~~~~~~~kl~DfG~a~ 179 (362)
T 2bdw_A 102 FHYLVFDLVTGGELFEDIVARE--FYSEADASHCIQQILESIAYCHSNGIVHRNLKPENLLLASKAKGAAVKLADFGLAI 179 (362)
T ss_dssp EEEEEECCCCSCBHHHHHTTCS--CCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEESCSSTTCCEEECCCTTCB
T ss_pred EEEEEEecCCCCCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCCeEeccCchHHEEEecCCCCCCEEEeecCcce
Confidence 9999999999999999997654 589999999999999999999999999999999999997532 3469999999997
Q ss_pred cccCC--CccccccccccCchhhccCCCCCCCcccchhhhhhhhhhhhcCCCCCCCcCcchhHHHHHHHHhcCCCCCCCC
Q psy11767 524 LKRES--LHTPCFTLQYAAPEVLRQDKSGYDENCDLWSLGVILVNVLRQDKSGYDENCDLWSLGVILYTMLCGRVPFHAR 601 (966)
Q Consensus 524 ~~~~~--~~~~~gT~~Y~APEvl~~~~~~~~~~~Di~SlGvil~el~~~~~~~y~~~~DIWSlGvilyemltG~~Pf~~~ 601 (966)
..... ....+||+.|+|||++.. ..|+.++|||||||++|+|++|.+||.+.
T Consensus 180 ~~~~~~~~~~~~gt~~y~aPE~~~~--------------------------~~~~~~~DiwslG~il~~ll~g~~Pf~~~ 233 (362)
T 2bdw_A 180 EVNDSEAWHGFAGTPGYLSPEVLKK--------------------------DPYSKPVDIWACGVILYILLVGYPPFWDE 233 (362)
T ss_dssp CCTTCCSCCCSCSCTTTCCHHHHTT--------------------------CCCCTHHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred EecCCcccccCCCCccccCHHHHcc--------------------------CCCCchhhHHHHHHHHHHHHHCCCCCCCC
Confidence 65432 345689999999999852 24788999999999999999999999875
Q ss_pred CCchhHHHHHHHHHcCCCCCCchhhccCCHHHHHHHHHhcccCccccCChHHHHHHhhhhHH
Q psy11767 602 SRDDSALSIMARIKEGQFNFDAEAWSTVSSEAKELTKSLLTVNPAQRIRMMRVKLTFHAFHQ 663 (966)
Q Consensus 602 ~~~~~~~~~~~~i~~~~~~~~~~~~~~is~e~~~Li~~~L~~dP~~R~t~~~v~~~~~~~~~ 663 (966)
+. ..+...+..+.+.++...|..+++++++||.+||..||++|||+.++ ..|+|..
T Consensus 234 ~~----~~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~--l~hp~~~ 289 (362)
T 2bdw_A 234 DQ----HRLYAQIKAGAYDYPSPEWDTVTPEAKSLIDSMLTVNPKKRITADQA--LKVPWIC 289 (362)
T ss_dssp SH----HHHHHHHHHTCCCCCTTGGGGSCHHHHHHHHHHSCSSGGGSCCHHHH--TTSHHHH
T ss_pred CH----HHHHHHHHhCCCCCCcccccCCCHHHHHHHHHHcCCChhhCcCHHHH--hcCcccC
Confidence 43 34567788888888888888999999999999999999999999876 4566664
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-43 Score=394.29 Aligned_cols=241 Identities=34% Similarity=0.586 Sum_probs=206.4
Q ss_pred ccccccccccEEEEEEEcCCCcEEEEEEeccccC-------hHHHHHHHHHhcCCCCceEEEEEEEeCCeEEEEEEccCC
Q psy11767 383 AGILGDGSYSVCRRCVEKSTGQEYAVKIISRKID-------CSEEINLLRACQGHPNIVNLHCVFQDEVHTYLVLELLKG 455 (966)
Q Consensus 383 ~~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~~-------~~~Ei~iL~~l~~HpnIV~l~~~~~~~~~~~lVmEy~~g 455 (966)
.+.||+|+||+||+|.+..+|+.||||++.+... ..+|+++|+.+ +||||+++++++.++...|+|||||+|
T Consensus 20 ~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l-~hpnIv~l~~~~~~~~~~~lv~e~~~~ 98 (328)
T 3fe3_A 20 LKTIGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKIL-NHPNIVKLFEVIETEKTLYLIMEYASG 98 (328)
T ss_dssp EEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHC-CCTTBCCEEEEEECSSEEEEEECCCTT
T ss_pred EEEEeeCCCEEEEEEEECCCCCEEEEEEEEhhcCCHHHHHHHHHHHHHHHhC-CCCCEeeEEEEEEECCEEEEEEECCCC
Confidence 6889999999999999999999999999975432 34699999988 599999999999999999999999999
Q ss_pred CCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCcEEEecCCCCCEEEEeecccccccC--CCcccc
Q psy11767 456 GELLDRIRQKGRCGFTENEASRIMRQLVAAVHFMHSRGVVHRDLKPENLLFSDPAGDNIKVVDFGFACLKRE--SLHTPC 533 (966)
Q Consensus 456 g~L~~~l~~~~~~~l~e~~~~~i~~Qil~aL~yLHs~~IiHRDLKP~NILl~~~~~~~iKL~DFGla~~~~~--~~~~~~ 533 (966)
|+|.+++...+ .+++.+++.++.||+.||+|||++||+||||||+|||++. ++.+||+|||+|..... .....+
T Consensus 99 ~~L~~~l~~~~--~l~~~~~~~~~~qi~~al~~lH~~~ivHrDlkp~NIll~~--~~~~kl~DFG~a~~~~~~~~~~~~~ 174 (328)
T 3fe3_A 99 GEVFDYLVAHG--RMKEKEARSKFRQIVSAVQYCHQKRIVHRDLKAENLLLDA--DMNIKIADFGFSNEFTVGGKLDAFC 174 (328)
T ss_dssp CBHHHHHHHHC--CCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECT--TSCEEECSTTCCGGGSSSCGGGTTS
T ss_pred CcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCCEeccCCCHHHEEEcC--CCCEEEeeccCceecCCCCcccccc
Confidence 99999998765 5999999999999999999999999999999999999974 56899999999975432 345678
Q ss_pred ccccccCchhhccCCCCCCCcccchhhhhhhhhhhhcCCCCCCCcCcchhHHHHHHHHhcCCCCCCCCCCchhHHHHHHH
Q psy11767 534 FTLQYAAPEVLRQDKSGYDENCDLWSLGVILVNVLRQDKSGYDENCDLWSLGVILYTMLCGRVPFHARSRDDSALSIMAR 613 (966)
Q Consensus 534 gT~~Y~APEvl~~~~~~~~~~~Di~SlGvil~el~~~~~~~y~~~~DIWSlGvilyemltG~~Pf~~~~~~~~~~~~~~~ 613 (966)
||+.|+|||++.... .++.++|||||||++|+|++|++||.+.+. ..+...
T Consensus 175 gt~~y~aPE~~~~~~-------------------------~~~~~~DiwslG~il~ell~g~~pf~~~~~----~~~~~~ 225 (328)
T 3fe3_A 175 GAPPYAAPELFQGKK-------------------------YDGPEVDVWSLGVILYTLVSGSLPFDGQNL----KELRER 225 (328)
T ss_dssp SSGGGCCHHHHHTCC-------------------------CCSHHHHHHHHHHHHHHHHHSSCSSCCSSH----HHHHHH
T ss_pred CCcceeCcccccCCC-------------------------cCCchhhhhhhHHHHHHHHhCCCCCCCCCH----HHHHHH
Confidence 999999999986321 134689999999999999999999987653 345566
Q ss_pred HHcCCCCCCchhhccCCHHHHHHHHHhcccCccccCChHHHHHHhhhhHH
Q psy11767 614 IKEGQFNFDAEAWSTVSSEAKELTKSLLTVNPAQRIRMMRVKLTFHAFHQ 663 (966)
Q Consensus 614 i~~~~~~~~~~~~~~is~e~~~Li~~~L~~dP~~R~t~~~v~~~~~~~~~ 663 (966)
+..+.+.++ ..+|+++.+||.+||..||.+|||+.++ ..|+|..
T Consensus 226 i~~~~~~~p----~~~s~~~~~li~~~L~~dP~~R~t~~ei--l~h~~~~ 269 (328)
T 3fe3_A 226 VLRGKYRIP----FYMSTDCENLLKRFLVLNPIKRGTLEQI--MKDRWIN 269 (328)
T ss_dssp HHHCCCCCC----TTSCHHHHHHHHHHCCSSTTTSCCHHHH--TTCTTTT
T ss_pred HHhCCCCCC----CCCCHHHHHHHHHHCCCChhHCcCHHHH--hcCHhhc
Confidence 777766544 2479999999999999999999999976 4466653
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=8.1e-43 Score=392.75 Aligned_cols=243 Identities=35% Similarity=0.591 Sum_probs=206.2
Q ss_pred cccccccccccccEEEEEEEcCCCcEEEEEEecccc--------ChHHHHHHHHHhcCCCCceEEEEEEEeCCeEEEEEE
Q psy11767 380 LDKAGILGDGSYSVCRRCVEKSTGQEYAVKIISRKI--------DCSEEINLLRACQGHPNIVNLHCVFQDEVHTYLVLE 451 (966)
Q Consensus 380 ~~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~--------~~~~Ei~iL~~l~~HpnIV~l~~~~~~~~~~~lVmE 451 (966)
|+.++.||+|+||+||+|+++.+|+.||||++.+.. ...+|+.+|+.+ +||||++++++|.+....|+|||
T Consensus 7 y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l-~hp~iv~l~~~~~~~~~~~lv~E 85 (337)
T 1o6l_A 7 FDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNT-RHPFLTALKYAFQTHDRLCFVME 85 (337)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSC-CCTTBCCEEEEEECSSEEEEEEE
T ss_pred eEEEEEEecCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhC-CCCcCcceEEEEEeCCEEEEEEe
Confidence 445789999999999999999999999999996431 245689999887 59999999999999999999999
Q ss_pred ccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCcEEEecCCCCCEEEEeeccccccc---CC
Q psy11767 452 LLKGGELLDRIRQKGRCGFTENEASRIMRQLVAAVHFMHSRGVVHRDLKPENLLFSDPAGDNIKVVDFGFACLKR---ES 528 (966)
Q Consensus 452 y~~gg~L~~~l~~~~~~~l~e~~~~~i~~Qil~aL~yLHs~~IiHRDLKP~NILl~~~~~~~iKL~DFGla~~~~---~~ 528 (966)
||+||+|.+++.+.+ .+++..++.++.||+.||+|||++||+||||||+|||++. ++.+||+|||+|+... ..
T Consensus 86 ~~~gg~L~~~l~~~~--~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~--~g~vkL~DFG~a~~~~~~~~~ 161 (337)
T 1o6l_A 86 YANGGELFFHLSRER--VFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLDK--DGHIKITDFGLCKEGISDGAT 161 (337)
T ss_dssp CCTTCBHHHHHHHHS--CCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECT--TSCEEECCCTTCBCSCCTTCC
T ss_pred CCCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCeecCcCCHHHEEECC--CCCEEEeeccchhhcccCCCc
Confidence 999999999998765 5999999999999999999999999999999999999974 5699999999997532 23
Q ss_pred CccccccccccCchhhccCCCCCCCcccchhhhhhhhhhhhcCCCCCCCcCcchhHHHHHHHHhcCCCCCCCCCCchhHH
Q psy11767 529 LHTPCFTLQYAAPEVLRQDKSGYDENCDLWSLGVILVNVLRQDKSGYDENCDLWSLGVILYTMLCGRVPFHARSRDDSAL 608 (966)
Q Consensus 529 ~~~~~gT~~Y~APEvl~~~~~~~~~~~Di~SlGvil~el~~~~~~~y~~~~DIWSlGvilyemltG~~Pf~~~~~~~~~~ 608 (966)
..+.+||+.|+|||++.. ..|+.++|||||||++|+|++|++||.+.+. .
T Consensus 162 ~~~~~gt~~y~aPE~~~~--------------------------~~~~~~~DiwslG~il~ell~g~~Pf~~~~~----~ 211 (337)
T 1o6l_A 162 MKTFCGTPEYLAPEVLED--------------------------NDYGRAVDWWGLGVVMYEMMCGRLPFYNQDH----E 211 (337)
T ss_dssp BCCCEECGGGCCGGGGSS--------------------------SCBCTTHHHHHHHHHHHHHHHSSCSSCCSSH----H
T ss_pred ccccccChhhCChhhhcC--------------------------CCCCchhhcccchhHHHHHhcCCCCCCCCCH----H
Confidence 456789999999999852 3478899999999999999999999987543 2
Q ss_pred HHHHHHHcCCCCCCchhhccCCHHHHHHHHHhcccCccccC-----ChHHHHHHhhhhHH
Q psy11767 609 SIMARIKEGQFNFDAEAWSTVSSEAKELTKSLLTVNPAQRI-----RMMRVKLTFHAFHQ 663 (966)
Q Consensus 609 ~~~~~i~~~~~~~~~~~~~~is~e~~~Li~~~L~~dP~~R~-----t~~~v~~~~~~~~~ 663 (966)
.+...+..+...++ ..+++++++||.+||+.||++|| ++.++ ..|+|+.
T Consensus 212 ~~~~~i~~~~~~~p----~~~s~~~~~li~~lL~~dP~~R~g~~~~~~~ei--~~h~~f~ 265 (337)
T 1o6l_A 212 RLFELILMEEIRFP----RTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEV--MEHRFFL 265 (337)
T ss_dssp HHHHHHHHCCCCCC----TTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHH--HTSGGGT
T ss_pred HHHHHHHcCCCCCC----CCCCHHHHHHHHHHhhcCHHHhcCCCCCCHHHH--HcCCCcC
Confidence 34555666655543 35899999999999999999999 67655 4567753
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-43 Score=398.40 Aligned_cols=244 Identities=30% Similarity=0.536 Sum_probs=207.2
Q ss_pred cccccccccccccEEEEEEEcCCCcEEEEEEecccc--------ChHHHHHHHHHhcCCCCceEEEEEEEeCCeEEEEEE
Q psy11767 380 LDKAGILGDGSYSVCRRCVEKSTGQEYAVKIISRKI--------DCSEEINLLRACQGHPNIVNLHCVFQDEVHTYLVLE 451 (966)
Q Consensus 380 ~~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~--------~~~~Ei~iL~~l~~HpnIV~l~~~~~~~~~~~lVmE 451 (966)
|+..+.||+|+||+||+|+++.+|+.||||++.+.. ....|..+|..+.+|||||+++++|++....|+|||
T Consensus 19 y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~iv~l~~~~~~~~~~~lv~E 98 (345)
T 1xjd_A 19 FILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLFFVME 98 (345)
T ss_dssp EEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEEEEE
T ss_pred eEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhHHhhhhhhHHHHHHHHHHHHhcCCCCCCCcEEEEEEeCCEEEEEEe
Confidence 334689999999999999999999999999996531 134688888887689999999999999999999999
Q ss_pred ccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCcEEEecCCCCCEEEEeeccccccc---CC
Q psy11767 452 LLKGGELLDRIRQKGRCGFTENEASRIMRQLVAAVHFMHSRGVVHRDLKPENLLFSDPAGDNIKVVDFGFACLKR---ES 528 (966)
Q Consensus 452 y~~gg~L~~~l~~~~~~~l~e~~~~~i~~Qil~aL~yLHs~~IiHRDLKP~NILl~~~~~~~iKL~DFGla~~~~---~~ 528 (966)
||+||+|.+++.+.+ .+++.+++.++.||+.||+|||++||+||||||+|||++. ++.+||+|||+|+... ..
T Consensus 99 ~~~gg~L~~~l~~~~--~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~--~g~vkL~DFG~a~~~~~~~~~ 174 (345)
T 1xjd_A 99 YLNGGDLMYHIQSCH--KFDLSRATFYAAEIILGLQFLHSKGIVYRDLKLDNILLDK--DGHIKIADFGMCKENMLGDAK 174 (345)
T ss_dssp CCTTCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECT--TSCEEECCCTTCBCCCCTTCC
T ss_pred CCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCChhhEEECC--CCCEEEeEChhhhhcccCCCc
Confidence 999999999998765 5999999999999999999999999999999999999974 5699999999997532 23
Q ss_pred CccccccccccCchhhccCCCCCCCcccchhhhhhhhhhhhcCCCCCCCcCcchhHHHHHHHHhcCCCCCCCCCCchhHH
Q psy11767 529 LHTPCFTLQYAAPEVLRQDKSGYDENCDLWSLGVILVNVLRQDKSGYDENCDLWSLGVILYTMLCGRVPFHARSRDDSAL 608 (966)
Q Consensus 529 ~~~~~gT~~Y~APEvl~~~~~~~~~~~Di~SlGvil~el~~~~~~~y~~~~DIWSlGvilyemltG~~Pf~~~~~~~~~~ 608 (966)
..+.+||+.|+|||++.. ..|+.++|||||||++|+|++|+.||.+.+..
T Consensus 175 ~~~~~gt~~y~aPE~~~~--------------------------~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~---- 224 (345)
T 1xjd_A 175 TNTFCGTPDYIAPEILLG--------------------------QKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEE---- 224 (345)
T ss_dssp BCCCCSCGGGCCHHHHTT--------------------------CCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHH----
T ss_pred ccCCCCCcccCChhhhcC--------------------------CCCCChhhhHHHHHHHHHHhcCCCCCCCCCHH----
Confidence 456789999999999852 24788999999999999999999999875432
Q ss_pred HHHHHHHcCCCCCCchhhccCCHHHHHHHHHhcccCccccCChH-HHHHHhhhhHH
Q psy11767 609 SIMARIKEGQFNFDAEAWSTVSSEAKELTKSLLTVNPAQRIRMM-RVKLTFHAFHQ 663 (966)
Q Consensus 609 ~~~~~i~~~~~~~~~~~~~~is~e~~~Li~~~L~~dP~~R~t~~-~v~~~~~~~~~ 663 (966)
.++..|..+...++ ..+++++++||.+||..||++||++. ++ ..|+|+.
T Consensus 225 ~~~~~i~~~~~~~p----~~~s~~~~~li~~lL~~dp~~R~~~~~~i--~~hp~f~ 274 (345)
T 1xjd_A 225 ELFHSIRMDNPFYP----RWLEKEAKDLLVKLFVREPEKRLGVRGDI--RQHPLFR 274 (345)
T ss_dssp HHHHHHHHCCCCCC----TTSCHHHHHHHHHHSCSSGGGSBTTBSCG--GGSGGGT
T ss_pred HHHHHHHhCCCCCC----cccCHHHHHHHHHHhcCCHhHcCCChHHH--HcCcccc
Confidence 44556666655443 35899999999999999999999987 44 4567753
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-43 Score=396.82 Aligned_cols=255 Identities=31% Similarity=0.612 Sum_probs=215.3
Q ss_pred eecccccccccccccccccccEEEEEEEcCCCcEEEEEEeccc----------cChHHHHHHHHHhcCCCCceEEEEEEE
Q psy11767 372 FFEQYDMDLDKAGILGDGSYSVCRRCVEKSTGQEYAVKIISRK----------IDCSEEINLLRACQGHPNIVNLHCVFQ 441 (966)
Q Consensus 372 ~~~~~~i~~~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~----------~~~~~Ei~iL~~l~~HpnIV~l~~~~~ 441 (966)
+.++|.+ .+.||+|+||+||+|.++.+|+.||||++... ....+|+.+|+.+ +|||||+++++|.
T Consensus 22 ~~~~y~~----~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~hpnIv~~~~~~~ 96 (351)
T 3c0i_A 22 FEDVYEL----CEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHML-KHPHIVELLETYS 96 (351)
T ss_dssp HHHHEEE----EEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHTSSSCCHHHHHHHHHHHHHC-CCTTBCCEEEEEE
T ss_pred cccceEE----eeEEeeCCCEEEEEEEECCCCCEEEEEEEEhhhccccccchHHHHHHHHHHHHhC-CCCCCCcEEEEEE
Confidence 3445555 68899999999999999999999999998532 1245799999998 5999999999999
Q ss_pred eCCeEEEEEEccCCCCHHHHHHhcC--CCCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCcEEEecCC-CCCEEEEe
Q psy11767 442 DEVHTYLVLELLKGGELLDRIRQKG--RCGFTENEASRIMRQLVAAVHFMHSRGVVHRDLKPENLLFSDPA-GDNIKVVD 518 (966)
Q Consensus 442 ~~~~~~lVmEy~~gg~L~~~l~~~~--~~~l~e~~~~~i~~Qil~aL~yLHs~~IiHRDLKP~NILl~~~~-~~~iKL~D 518 (966)
++...|+|||||+||+|.+++.+.. ...+++..++.++.||+.||+|||++||+||||||+|||++... ...+||+|
T Consensus 97 ~~~~~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivHrDlkp~NIl~~~~~~~~~vkl~D 176 (351)
T 3c0i_A 97 SDGMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCHDNNIIHRDVKPHCVLLASKENSAPVKLGG 176 (351)
T ss_dssp ETTEEEEEEECCSSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECSSSTTCCEEECC
T ss_pred eCCEEEEEEeCCCCCCHHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCChHHeEEecCCCCCcEEEec
Confidence 9999999999999999998886532 23589999999999999999999999999999999999997532 34599999
Q ss_pred ecccccccCC---CccccccccccCchhhccCCCCCCCcccchhhhhhhhhhhhcCCCCCCCcCcchhHHHHHHHHhcCC
Q psy11767 519 FGFACLKRES---LHTPCFTLQYAAPEVLRQDKSGYDENCDLWSLGVILVNVLRQDKSGYDENCDLWSLGVILYTMLCGR 595 (966)
Q Consensus 519 FGla~~~~~~---~~~~~gT~~Y~APEvl~~~~~~~~~~~Di~SlGvil~el~~~~~~~y~~~~DIWSlGvilyemltG~ 595 (966)
||++...... ....+||+.|+|||++.. ..|+.++|||||||++|+|++|+
T Consensus 177 fg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~--------------------------~~~~~~~DiwslG~il~~ll~g~ 230 (351)
T 3c0i_A 177 FGVAIQLGESGLVAGGRVGTPHFMAPEVVKR--------------------------EPYGKPVDVWGCGVILFILLSGC 230 (351)
T ss_dssp CTTCEECCTTSCBCCCCCSCGGGCCHHHHTT--------------------------CCBCTHHHHHHHHHHHHHHHHSS
T ss_pred CcceeEecCCCeeecCCcCCcCccCHHHHcC--------------------------CCCCchHhhHHHHHHHHHHHHCC
Confidence 9999765432 335679999999999852 24788999999999999999999
Q ss_pred CCCCCCCCchhHHHHHHHHHcCCCCCCchhhccCCHHHHHHHHHhcccCccccCChHHHHHHhhhhHHh
Q psy11767 596 VPFHARSRDDSALSIMARIKEGQFNFDAEAWSTVSSEAKELTKSLLTVNPAQRIRMMRVKLTFHAFHQA 664 (966)
Q Consensus 596 ~Pf~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~is~e~~~Li~~~L~~dP~~R~t~~~v~~~~~~~~~~ 664 (966)
.||.+.. ..++..+..+.+.+....|..+++++++||.+||..||++|||+.++ ..|+|...
T Consensus 231 ~pf~~~~-----~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~e~--l~hp~~~~ 292 (351)
T 3c0i_A 231 LPFYGTK-----ERLFEGIIKGKYKMNPRQWSHISESAKDLVRRMLMLDPAERITVYEA--LNHPWLKE 292 (351)
T ss_dssp CSSCSSH-----HHHHHHHHHTCCCCCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHH--HTSHHHHT
T ss_pred CCCCCcH-----HHHHHHHHcCCCCCCccccccCCHHHHHHHHHHCCCChhHCcCHHHH--hcChhhcC
Confidence 9998632 24566677788888888888999999999999999999999999876 45777654
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-43 Score=398.85 Aligned_cols=246 Identities=30% Similarity=0.532 Sum_probs=207.2
Q ss_pred cccccccccccccEEEEEEEcCCCcEEEEEEecccc--------ChHHHHHHHHHhcCCCCceEEEEEEEeCCeEEEEEE
Q psy11767 380 LDKAGILGDGSYSVCRRCVEKSTGQEYAVKIISRKI--------DCSEEINLLRACQGHPNIVNLHCVFQDEVHTYLVLE 451 (966)
Q Consensus 380 ~~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~--------~~~~Ei~iL~~l~~HpnIV~l~~~~~~~~~~~lVmE 451 (966)
|+.++.||+|+||+||+|+++.+|+.||||++.+.. ....|..+|..+.+||||++++++|++....|+|||
T Consensus 22 y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~~lv~E 101 (353)
T 2i0e_A 22 FNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVME 101 (353)
T ss_dssp EEEEEEEEEETTEEEEEEEETTEEEEEEEEEEEHHHHHHTTCHHHHHHHHHHHTCTTCCTTBCCEEEEEECSSEEEEEEE
T ss_pred cEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhcchHHHHHHHHHHHHHhcCCCCEEeeEEEEEEcCCEEEEEEe
Confidence 444789999999999999999999999999996531 134688888877689999999999999999999999
Q ss_pred ccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCcEEEecCCCCCEEEEeeccccccc---CC
Q psy11767 452 LLKGGELLDRIRQKGRCGFTENEASRIMRQLVAAVHFMHSRGVVHRDLKPENLLFSDPAGDNIKVVDFGFACLKR---ES 528 (966)
Q Consensus 452 y~~gg~L~~~l~~~~~~~l~e~~~~~i~~Qil~aL~yLHs~~IiHRDLKP~NILl~~~~~~~iKL~DFGla~~~~---~~ 528 (966)
||+||+|.+++.+.+ .+++..++.++.||+.||+|||++||+||||||+|||++. ++.+||+|||+|+... ..
T Consensus 102 ~~~gg~L~~~l~~~~--~~~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIll~~--~g~vkL~DFG~a~~~~~~~~~ 177 (353)
T 2i0e_A 102 YVNGGDLMYHIQQVG--RFKEPHAVFYAAEIAIGLFFLQSKGIIYRDLKLDNVMLDS--EGHIKIADFGMCKENIWDGVT 177 (353)
T ss_dssp CCCSCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECT--TSCEEECCCTTCBCCCCTTCC
T ss_pred CCCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCEEeccCCHHHEEEcC--CCcEEEEeCCcccccccCCcc
Confidence 999999999998765 5999999999999999999999999999999999999974 5699999999997532 23
Q ss_pred CccccccccccCchhhccCCCCCCCcccchhhhhhhhhhhhcCCCCCCCcCcchhHHHHHHHHhcCCCCCCCCCCchhHH
Q psy11767 529 LHTPCFTLQYAAPEVLRQDKSGYDENCDLWSLGVILVNVLRQDKSGYDENCDLWSLGVILYTMLCGRVPFHARSRDDSAL 608 (966)
Q Consensus 529 ~~~~~gT~~Y~APEvl~~~~~~~~~~~Di~SlGvil~el~~~~~~~y~~~~DIWSlGvilyemltG~~Pf~~~~~~~~~~ 608 (966)
..+.+||+.|+|||++.. ..|+.++|||||||++|+|++|++||.+.+. .
T Consensus 178 ~~~~~gt~~y~aPE~~~~--------------------------~~~~~~~DiwslG~il~ell~G~~Pf~~~~~----~ 227 (353)
T 2i0e_A 178 TKTFCGTPDYIAPEIIAY--------------------------QPYGKSVDWWAFGVLLYEMLAGQAPFEGEDE----D 227 (353)
T ss_dssp BCCCCSCGGGCCHHHHTT--------------------------CCBSTHHHHHHHHHHHHHHHHSSCSSCCSSH----H
T ss_pred cccccCCccccChhhhcC--------------------------CCcCCcccccchHHHHHHHHcCCCCCCCCCH----H
Confidence 456789999999999852 3478899999999999999999999987543 2
Q ss_pred HHHHHHHcCCCCCCchhhccCCHHHHHHHHHhcccCccccCChH---HHHHHhhhhHH
Q psy11767 609 SIMARIKEGQFNFDAEAWSTVSSEAKELTKSLLTVNPAQRIRMM---RVKLTFHAFHQ 663 (966)
Q Consensus 609 ~~~~~i~~~~~~~~~~~~~~is~e~~~Li~~~L~~dP~~R~t~~---~v~~~~~~~~~ 663 (966)
.++..|..+.+.++ ..+++++++||.+||..||.+||++. .-....|+|+.
T Consensus 228 ~~~~~i~~~~~~~p----~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~i~~h~~f~ 281 (353)
T 2i0e_A 228 ELFQSIMEHNVAYP----KSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKEHAFFR 281 (353)
T ss_dssp HHHHHHHHCCCCCC----TTSCHHHHHHHHHHTCSCTTSCTTCSTTHHHHHHTSGGGT
T ss_pred HHHHHHHhCCCCCC----CCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhcCcccc
Confidence 45566766666544 35899999999999999999999751 12345677763
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-42 Score=393.01 Aligned_cols=250 Identities=29% Similarity=0.540 Sum_probs=206.9
Q ss_pred cccccccccccccEEEEEEEcCCCcEEEEEEeccccC--------hHHHHHHHHHhcCCCCceEEEEEEEeCCeEEEEEE
Q psy11767 380 LDKAGILGDGSYSVCRRCVEKSTGQEYAVKIISRKID--------CSEEINLLRACQGHPNIVNLHCVFQDEVHTYLVLE 451 (966)
Q Consensus 380 ~~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~~--------~~~Ei~iL~~l~~HpnIV~l~~~~~~~~~~~lVmE 451 (966)
|+..+.||+|+||+||+|+++.+|+.||||++.+... ..+|+.+|+.+.+|||||+++++|.++...|+|||
T Consensus 11 y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~~lv~e 90 (345)
T 3a8x_A 11 FDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIE 90 (345)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGSCSHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEEC
T ss_pred eEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEhHHhcchHHHHHHHHHHHHHHhcCCCCccCeEEEEEEeCCEEEEEEe
Confidence 4447899999999999999999999999999975421 34688899888789999999999999999999999
Q ss_pred ccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCcEEEecCCCCCEEEEeeccccccc---CC
Q psy11767 452 LLKGGELLDRIRQKGRCGFTENEASRIMRQLVAAVHFMHSRGVVHRDLKPENLLFSDPAGDNIKVVDFGFACLKR---ES 528 (966)
Q Consensus 452 y~~gg~L~~~l~~~~~~~l~e~~~~~i~~Qil~aL~yLHs~~IiHRDLKP~NILl~~~~~~~iKL~DFGla~~~~---~~ 528 (966)
||+||+|.+++.+.+ .+++..++.++.||+.||+|||++||+||||||+|||++. ++.+||+|||+|+... ..
T Consensus 91 ~~~gg~L~~~l~~~~--~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~--~g~~kL~DFG~a~~~~~~~~~ 166 (345)
T 3a8x_A 91 YVNGGDLMFHMQRQR--KLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLDS--EGHIKLTDYGMCKEGLRPGDT 166 (345)
T ss_dssp CCCSCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECT--TSCEEECCGGGCBCSCCTTCC
T ss_pred CCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCCceecCCCHHHEEECC--CCCEEEEeccccccccCCCCc
Confidence 999999999998765 5999999999999999999999999999999999999974 5699999999997532 23
Q ss_pred CccccccccccCchhhccCCCCCCCcccchhhhhhhhhhhhcCCCCCCCcCcchhHHHHHHHHhcCCCCCCCCCCc----
Q psy11767 529 LHTPCFTLQYAAPEVLRQDKSGYDENCDLWSLGVILVNVLRQDKSGYDENCDLWSLGVILYTMLCGRVPFHARSRD---- 604 (966)
Q Consensus 529 ~~~~~gT~~Y~APEvl~~~~~~~~~~~Di~SlGvil~el~~~~~~~y~~~~DIWSlGvilyemltG~~Pf~~~~~~---- 604 (966)
..+.+||+.|+|||++.. ..|+.++|||||||++|+|++|+.||......
T Consensus 167 ~~~~~gt~~y~aPE~~~~--------------------------~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~ 220 (345)
T 3a8x_A 167 TSTFCGTPNYIAPEILRG--------------------------EDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPD 220 (345)
T ss_dssp BCCCCSCGGGCCHHHHTT--------------------------CCBCTHHHHHHHHHHHHHHHHSSCTTTTTTC-----
T ss_pred ccccCCCccccCccccCC--------------------------CCCChHHhHHHHHHHHHHHHhCCCCcCCcccccccc
Confidence 456789999999999852 34788999999999999999999999753221
Q ss_pred -hhHHHHHHHHHcCCCCCCchhhccCCHHHHHHHHHhcccCccccCChH---H-HHHHhhhhHH
Q psy11767 605 -DSALSIMARIKEGQFNFDAEAWSTVSSEAKELTKSLLTVNPAQRIRMM---R-VKLTFHAFHQ 663 (966)
Q Consensus 605 -~~~~~~~~~i~~~~~~~~~~~~~~is~e~~~Li~~~L~~dP~~R~t~~---~-v~~~~~~~~~ 663 (966)
.....+...+..+...++ ..+++++++||.+||..||.+||++. . .....|+|+.
T Consensus 221 ~~~~~~~~~~i~~~~~~~p----~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~~i~~hp~f~ 280 (345)
T 3a8x_A 221 QNTEDYLFQVILEKQIRIP----RSLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGHPFFR 280 (345)
T ss_dssp --CHHHHHHHHHHCCCCCC----TTSCHHHHHHHHHHTCSSTTTSTTCCTTTHHHHHHTSGGGT
T ss_pred cccHHHHHHHHHcCCCCCC----CCCCHHHHHHHHHHhcCCHhHCCCCCCcCCHHHHhcCCccC
Confidence 112234455666655543 35899999999999999999999962 1 1345677763
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-43 Score=391.41 Aligned_cols=243 Identities=29% Similarity=0.571 Sum_probs=208.3
Q ss_pred cccccccccccccEEEEEEEcCCCcEEEEEEecccc--------ChHHHHHHHHHhcCCCCceEEEEEEEeCCeEEEEEE
Q psy11767 380 LDKAGILGDGSYSVCRRCVEKSTGQEYAVKIISRKI--------DCSEEINLLRACQGHPNIVNLHCVFQDEVHTYLVLE 451 (966)
Q Consensus 380 ~~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~--------~~~~Ei~iL~~l~~HpnIV~l~~~~~~~~~~~lVmE 451 (966)
|+..+.||+|+||+||+|++..+|+.||||++.+.. ...+|+.+|+.+ +|||||+++++|.+....|+|||
T Consensus 8 y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l-~hp~Iv~~~~~~~~~~~~~lv~e 86 (318)
T 1fot_A 8 FQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIV-THPFIIRMWGTFQDAQQIFMIMD 86 (318)
T ss_dssp EEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSC-CBTTBCCEEEEEECSSEEEEEEC
T ss_pred cEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhhC-CCCCCceEeEEEEeCCEEEEEEe
Confidence 444789999999999999999999999999986431 134688888887 69999999999999999999999
Q ss_pred ccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCcEEEecCCCCCEEEEeecccccccCCCcc
Q psy11767 452 LLKGGELLDRIRQKGRCGFTENEASRIMRQLVAAVHFMHSRGVVHRDLKPENLLFSDPAGDNIKVVDFGFACLKRESLHT 531 (966)
Q Consensus 452 y~~gg~L~~~l~~~~~~~l~e~~~~~i~~Qil~aL~yLHs~~IiHRDLKP~NILl~~~~~~~iKL~DFGla~~~~~~~~~ 531 (966)
||+||+|.+++.+.. .+++..++.++.||+.||+|||++||+||||||+|||++. ++.+||+|||+++.......+
T Consensus 87 ~~~gg~L~~~l~~~~--~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~--~g~~kL~Dfg~a~~~~~~~~~ 162 (318)
T 1fot_A 87 YIEGGELFSLLRKSQ--RFPNPVAKFYAAEVCLALEYLHSKDIIYRDLKPENILLDK--NGHIKITDFGFAKYVPDVTYT 162 (318)
T ss_dssp CCCSCBHHHHHHHTS--SCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECT--TSCEEECCCSSCEECSSCBCC
T ss_pred CCCCCCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCCccccCCChheEEEcC--CCCEEEeecCcceecCCcccc
Confidence 999999999998755 5999999999999999999999999999999999999974 569999999999877666667
Q ss_pred ccccccccCchhhccCCCCCCCcccchhhhhhhhhhhhcCCCCCCCcCcchhHHHHHHHHhcCCCCCCCCCCchhHHHHH
Q psy11767 532 PCFTLQYAAPEVLRQDKSGYDENCDLWSLGVILVNVLRQDKSGYDENCDLWSLGVILYTMLCGRVPFHARSRDDSALSIM 611 (966)
Q Consensus 532 ~~gT~~Y~APEvl~~~~~~~~~~~Di~SlGvil~el~~~~~~~y~~~~DIWSlGvilyemltG~~Pf~~~~~~~~~~~~~ 611 (966)
.+||+.|+|||++.. ..|+.++|||||||++|+|++|+.||.+.+. ....
T Consensus 163 ~~gt~~y~aPE~~~~--------------------------~~~~~~~DiwslG~il~ell~g~~pf~~~~~----~~~~ 212 (318)
T 1fot_A 163 LCGTPDYIAPEVVST--------------------------KPYNKSIDWWSFGILIYEMLAGYTPFYDSNT----MKTY 212 (318)
T ss_dssp CCSCTTTCCHHHHTT--------------------------CCBCTTHHHHHHHHHHHHHHHSSCTTCCSSH----HHHH
T ss_pred ccCCccccCHhHhcC--------------------------CCCCcccchhhhHHHHHHHHhCCCCCCCCCH----HHHH
Confidence 889999999999852 3478899999999999999999999987543 2345
Q ss_pred HHHHcCCCCCCchhhccCCHHHHHHHHHhcccCccccC-----ChHHHHHHhhhhHH
Q psy11767 612 ARIKEGQFNFDAEAWSTVSSEAKELTKSLLTVNPAQRI-----RMMRVKLTFHAFHQ 663 (966)
Q Consensus 612 ~~i~~~~~~~~~~~~~~is~e~~~Li~~~L~~dP~~R~-----t~~~v~~~~~~~~~ 663 (966)
..+..+.+.++ ..+++++++||.+||..||++|+ ++.++ ..|+|+.
T Consensus 213 ~~i~~~~~~~p----~~~~~~~~~li~~lL~~dp~~R~~~~~~~~~~i--~~hp~f~ 263 (318)
T 1fot_A 213 EKILNAELRFP----PFFNEDVKDLLSRLITRDLSQRLGNLQNGTEDV--KNHPWFK 263 (318)
T ss_dssp HHHHHCCCCCC----TTSCHHHHHHHHHHTCSCTTTCTTSSTTTTHHH--HTSGGGS
T ss_pred HHHHhCCCCCC----CCCCHHHHHHHHHHhccCHHHcCCCcCCCHHHH--hcCcccc
Confidence 56666665544 35799999999999999999999 66655 4577753
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.9e-43 Score=390.20 Aligned_cols=246 Identities=33% Similarity=0.633 Sum_probs=211.0
Q ss_pred ccccccccccEEEEEEEcCCCcEEEEEEecccc-----------ChHHHHHHHHHhcCCCCceEEEEEEEeCCeEEEEEE
Q psy11767 383 AGILGDGSYSVCRRCVEKSTGQEYAVKIISRKI-----------DCSEEINLLRACQGHPNIVNLHCVFQDEVHTYLVLE 451 (966)
Q Consensus 383 ~~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~-----------~~~~Ei~iL~~l~~HpnIV~l~~~~~~~~~~~lVmE 451 (966)
.+.||+|+||.||+|.+..+|+.||||++.... ...+|+.+|+.+ +|||||+++++|.+....|+|||
T Consensus 16 ~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~hp~iv~~~~~~~~~~~~~lv~e 94 (326)
T 2y0a_A 16 GEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEI-QHPNVITLHEVYENKTDVILILE 94 (326)
T ss_dssp EEEEECCSSEEEEEEEETTTCCEEEEEEEEBCCSTTCSSSBCHHHHHHHHHHHHHC-CCTTBCCEEEEEECSSEEEEEEE
T ss_pred ceEEeeCCCeEEEEEEECCCCcEEEEEEEEccccccccchhhHHHHHHHHHHHHhC-CCCCCCcEEEEEEeCCEEEEEEE
Confidence 678999999999999999999999999986532 145799999998 59999999999999999999999
Q ss_pred ccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCcEEEecCC--CCCEEEEeecccccccC--
Q psy11767 452 LLKGGELLDRIRQKGRCGFTENEASRIMRQLVAAVHFMHSRGVVHRDLKPENLLFSDPA--GDNIKVVDFGFACLKRE-- 527 (966)
Q Consensus 452 y~~gg~L~~~l~~~~~~~l~e~~~~~i~~Qil~aL~yLHs~~IiHRDLKP~NILl~~~~--~~~iKL~DFGla~~~~~-- 527 (966)
||+||+|.+++.... .+++.+++.++.||+.||+|||++||+||||||+|||+++.. ...+||+|||++.....
T Consensus 95 ~~~~~~L~~~l~~~~--~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~NIll~~~~~~~~~~kl~Dfg~a~~~~~~~ 172 (326)
T 2y0a_A 95 LVAGGELFDFLAEKE--SLTEEEATEFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGN 172 (326)
T ss_dssp CCCSCBHHHHHTTSS--CCBHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESCSSSSSCCEEECCCTTCEECCTTS
T ss_pred cCCCCCHHHHHHhcC--CcCHHHHHHHHHHHHHHHHHHHHCCeEcCCCCHHHEEEecCCCCCCCEEEEECCCCeECCCCC
Confidence 999999999997654 699999999999999999999999999999999999997532 22799999999976532
Q ss_pred CCccccccccccCchhhccCCCCCCCcccchhhhhhhhhhhhcCCCCCCCcCcchhHHHHHHHHhcCCCCCCCCCCchhH
Q psy11767 528 SLHTPCFTLQYAAPEVLRQDKSGYDENCDLWSLGVILVNVLRQDKSGYDENCDLWSLGVILYTMLCGRVPFHARSRDDSA 607 (966)
Q Consensus 528 ~~~~~~gT~~Y~APEvl~~~~~~~~~~~Di~SlGvil~el~~~~~~~y~~~~DIWSlGvilyemltG~~Pf~~~~~~~~~ 607 (966)
.....+||+.|+|||++.. ..|+.++|||||||++|+|++|..||.+...
T Consensus 173 ~~~~~~gt~~y~aPE~~~~--------------------------~~~~~~~DiwslG~il~~ll~g~~pf~~~~~---- 222 (326)
T 2y0a_A 173 EFKNIFGTPEFVAPEIVNY--------------------------EPLGLEADMWSIGVITYILLSGASPFLGDTK---- 222 (326)
T ss_dssp CCCCCCSCTTTCCHHHHTT--------------------------CCCCTHHHHHHHHHHHHHHHHSCCSSCCSSH----
T ss_pred ccccccCCcCcCCceeecC--------------------------CCCCcHHHHHHHHHHHHHHHHCcCCCCCCCH----
Confidence 3345679999999998852 2478899999999999999999999987543
Q ss_pred HHHHHHHHcCCCCCCchhhccCCHHHHHHHHHhcccCccccCChHHHHHHhhhhHH
Q psy11767 608 LSIMARIKEGQFNFDAEAWSTVSSEAKELTKSLLTVNPAQRIRMMRVKLTFHAFHQ 663 (966)
Q Consensus 608 ~~~~~~i~~~~~~~~~~~~~~is~e~~~Li~~~L~~dP~~R~t~~~v~~~~~~~~~ 663 (966)
...+..+....+.+....+..+++++++||.+||..||++|||+.++ ..|+|+.
T Consensus 223 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~--l~hp~~~ 276 (326)
T 2y0a_A 223 QETLANVSAVNYEFEDEYFSNTSALAKDFIRRLLVKDPKKRMTIQDS--LQHPWIK 276 (326)
T ss_dssp HHHHHHHHHTCCCCCHHHHTTSCHHHHHHHHHHSCSSGGGSCCHHHH--HHSTTTS
T ss_pred HHHHHHHHhcCCCcCccccccCCHHHHHHHHHHccCChhhCCCHHHH--hcCCCcc
Confidence 23455666777777777788899999999999999999999999976 3466653
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-42 Score=394.49 Aligned_cols=248 Identities=33% Similarity=0.514 Sum_probs=200.3
Q ss_pred ccccccccccEEEEEEEcCCCcEEEEEEecccc----ChHHHHHHHHHhcCCCCceEEEEEEEeCCeEEEEEEccCCCCH
Q psy11767 383 AGILGDGSYSVCRRCVEKSTGQEYAVKIISRKI----DCSEEINLLRACQGHPNIVNLHCVFQDEVHTYLVLELLKGGEL 458 (966)
Q Consensus 383 ~~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~----~~~~Ei~iL~~l~~HpnIV~l~~~~~~~~~~~lVmEy~~gg~L 458 (966)
.+.||+|+||+||+|++..+|+.||||++.... ...+|+.+++.+ +|||||++++++.+....|+|||||+||+|
T Consensus 25 ~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l-~hpniv~~~~~~~~~~~~~lv~e~~~~~~L 103 (361)
T 3uc3_A 25 VKDIGSGNFGVARLMRDKLTKELVAVKYIERGAAIDENVQREIINHRSL-RHPNIVRFKEVILTPTHLAIIMEYASGGEL 103 (361)
T ss_dssp EEEESSSTTSSEEEEEETTTCCEEEEEEEESSTTSCHHHHHHHHHHHHC-CCTTBCCEEEEEECSSEEEEEEECCCSCBH
T ss_pred EEEeccCCCEEEEEEEECCCCcEEEEEEEecCccccHHHHHHHHHHHhC-CCCCCCcEEEEEeeCCEEEEEEEeCCCCCH
Confidence 688999999999999999999999999997543 255799999998 599999999999999999999999999999
Q ss_pred HHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCcEEEecCCCCCEEEEeeccccccc--CCCccccccc
Q psy11767 459 LDRIRQKGRCGFTENEASRIMRQLVAAVHFMHSRGVVHRDLKPENLLFSDPAGDNIKVVDFGFACLKR--ESLHTPCFTL 536 (966)
Q Consensus 459 ~~~l~~~~~~~l~e~~~~~i~~Qil~aL~yLHs~~IiHRDLKP~NILl~~~~~~~iKL~DFGla~~~~--~~~~~~~gT~ 536 (966)
.+++...+ .+++.+++.++.||+.||+|||++||+||||||+|||++....+.+||+|||+|+... ......+||+
T Consensus 104 ~~~l~~~~--~~~~~~~~~i~~ql~~~L~~LH~~~ivH~Dlkp~Nill~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~gt~ 181 (361)
T 3uc3_A 104 YERICNAG--RFSEDEARFFFQQLLSGVSYCHSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTP 181 (361)
T ss_dssp HHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHHTTCCSCCCCGGGEEECSSSSCCEEECCCCCC---------------C
T ss_pred HHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEcCCCCceEEEeecCccccccccCCCCCCcCCC
Confidence 99998765 5999999999999999999999999999999999999986444569999999997432 2234567999
Q ss_pred cccCchhhccCCCCCCCcccchhhhhhhhhhhhcCCCCCC-CcCcchhHHHHHHHHhcCCCCCCCCCCchhHHHHHHHHH
Q psy11767 537 QYAAPEVLRQDKSGYDENCDLWSLGVILVNVLRQDKSGYD-ENCDLWSLGVILYTMLCGRVPFHARSRDDSALSIMARIK 615 (966)
Q Consensus 537 ~Y~APEvl~~~~~~~~~~~Di~SlGvil~el~~~~~~~y~-~~~DIWSlGvilyemltG~~Pf~~~~~~~~~~~~~~~i~ 615 (966)
.|+|||++... .|+ .++|||||||++|+|++|+.||.+..........+..+.
T Consensus 182 ~y~aPE~~~~~--------------------------~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~~~~ 235 (361)
T 3uc3_A 182 AYIAPEVLLRQ--------------------------EYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPRDYRKTIQRIL 235 (361)
T ss_dssp TTSCHHHHHCS--------------------------SCCHHHHHHHHHHHHHHHHHHSSCSCC----CCCHHHHHHHHH
T ss_pred CcCChhhhcCC--------------------------CCCCCeeeeehhHHHHHHHHhCCCCCCCCccHHHHHHHHHHHh
Confidence 99999998632 233 348999999999999999999987765555556666776
Q ss_pred cCCCCCCchhhccCCHHHHHHHHHhcccCccccCChHHHHHHhhhhHH
Q psy11767 616 EGQFNFDAEAWSTVSSEAKELTKSLLTVNPAQRIRMMRVKLTFHAFHQ 663 (966)
Q Consensus 616 ~~~~~~~~~~~~~is~e~~~Li~~~L~~dP~~R~t~~~v~~~~~~~~~ 663 (966)
...+.++. ...+++++++||.+||..||++|||+.++ ..|+|+.
T Consensus 236 ~~~~~~~~--~~~~s~~~~~li~~~L~~dP~~Rps~~el--l~hp~f~ 279 (361)
T 3uc3_A 236 SVKYSIPD--DIRISPECCHLISRIFVADPATRISIPEI--KTHSWFL 279 (361)
T ss_dssp TTCCCCCT--TSCCCHHHHHHHHHHSCSCTTTSCCHHHH--HTSHHHH
T ss_pred cCCCCCCC--cCCCCHHHHHHHHHHccCChhHCcCHHHH--HhCcchh
Confidence 66655443 23689999999999999999999999876 4577763
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=7e-43 Score=395.24 Aligned_cols=243 Identities=34% Similarity=0.608 Sum_probs=209.5
Q ss_pred cccccccccccccEEEEEEEcCCCcEEEEEEecccc--------ChHHHHHHHHHhcCCCCceEEEEEEEeCCeEEEEEE
Q psy11767 380 LDKAGILGDGSYSVCRRCVEKSTGQEYAVKIISRKI--------DCSEEINLLRACQGHPNIVNLHCVFQDEVHTYLVLE 451 (966)
Q Consensus 380 ~~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~--------~~~~Ei~iL~~l~~HpnIV~l~~~~~~~~~~~lVmE 451 (966)
|+.++.||+|+||.||+|++..+|+.||||++.+.. ...+|+.+|+.+ +||||++++++|.++...|+|||
T Consensus 43 y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l-~hp~iv~~~~~~~~~~~~~lv~e 121 (350)
T 1rdq_E 43 FDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAV-NFPFLVKLEFSFKDNSNLYMVME 121 (350)
T ss_dssp EEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTC-CCTTBCCEEEEEECSSEEEEEEE
T ss_pred CEEEEEeecCcCcEEEEEEECCCCCEEEEEEEEhHHhccHHHHHHHHHHHHHHHhC-CCCCCCeEEEEEEcCCEEEEEEc
Confidence 344789999999999999999999999999986431 244689999888 69999999999999999999999
Q ss_pred ccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCcEEEecCCCCCEEEEeecccccccCCCcc
Q psy11767 452 LLKGGELLDRIRQKGRCGFTENEASRIMRQLVAAVHFMHSRGVVHRDLKPENLLFSDPAGDNIKVVDFGFACLKRESLHT 531 (966)
Q Consensus 452 y~~gg~L~~~l~~~~~~~l~e~~~~~i~~Qil~aL~yLHs~~IiHRDLKP~NILl~~~~~~~iKL~DFGla~~~~~~~~~ 531 (966)
||+||+|.+++.+.+ .+++..++.++.||+.||+|||++||+||||||+|||++. ++.+||+|||+++.......+
T Consensus 122 ~~~gg~L~~~l~~~~--~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~--~g~~kL~DFg~a~~~~~~~~~ 197 (350)
T 1rdq_E 122 YVAGGEMFSHLRRIG--RFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQ--QGYIQVTDFGFAKRVKGRTWT 197 (350)
T ss_dssp CCTTCBHHHHHHHHC--CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECT--TSCEEECCCTTCEECSSCBCC
T ss_pred CCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCCcccccCccceEEECC--CCCEEEcccccceeccCCccc
Confidence 999999999998765 5999999999999999999999999999999999999974 569999999999877666667
Q ss_pred ccccccccCchhhccCCCCCCCcccchhhhhhhhhhhhcCCCCCCCcCcchhHHHHHHHHhcCCCCCCCCCCchhHHHHH
Q psy11767 532 PCFTLQYAAPEVLRQDKSGYDENCDLWSLGVILVNVLRQDKSGYDENCDLWSLGVILYTMLCGRVPFHARSRDDSALSIM 611 (966)
Q Consensus 532 ~~gT~~Y~APEvl~~~~~~~~~~~Di~SlGvil~el~~~~~~~y~~~~DIWSlGvilyemltG~~Pf~~~~~~~~~~~~~ 611 (966)
.+||+.|+|||++.. ..|+.++|||||||++|+|++|++||.+.+. ..+.
T Consensus 198 ~~gt~~y~aPE~~~~--------------------------~~~~~~~DiwslG~il~ell~g~~Pf~~~~~----~~~~ 247 (350)
T 1rdq_E 198 LCGTPEALAPEIILS--------------------------KGYNKAVDWWALGVLIYEMAAGYPPFFADQP----IQIY 247 (350)
T ss_dssp CEECGGGCCHHHHTT--------------------------CCBCTHHHHHHHHHHHHHHHHSSCSSCCSSH----HHHH
T ss_pred ccCCccccCHHHhcC--------------------------CCCCCcCCEecccHhHhHHhhCCCCCCCCCH----HHHH
Confidence 889999999999852 2478899999999999999999999987543 3456
Q ss_pred HHHHcCCCCCCchhhccCCHHHHHHHHHhcccCccccCC-----hHHHHHHhhhhHH
Q psy11767 612 ARIKEGQFNFDAEAWSTVSSEAKELTKSLLTVNPAQRIR-----MMRVKLTFHAFHQ 663 (966)
Q Consensus 612 ~~i~~~~~~~~~~~~~~is~e~~~Li~~~L~~dP~~R~t-----~~~v~~~~~~~~~ 663 (966)
..|..+.+.++ ..+++++++||.+||+.||.+||+ +.++ ..|+|+.
T Consensus 248 ~~i~~~~~~~p----~~~~~~~~~li~~lL~~dp~~R~~~~~~~~~ei--~~h~~f~ 298 (350)
T 1rdq_E 248 EKIVSGKVRFP----SHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDI--KNHKWFA 298 (350)
T ss_dssp HHHHHCCCCCC----TTCCHHHHHHHHHHSCSCTTTCTTSSTTTTHHH--HTSGGGT
T ss_pred HHHHcCCCCCC----CCCCHHHHHHHHHHhhcCHHhccCCccCCHHHH--HhCcCcC
Confidence 67777766554 357999999999999999999998 6654 4567653
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-42 Score=383.65 Aligned_cols=255 Identities=38% Similarity=0.717 Sum_probs=208.5
Q ss_pred cccccccccEEEEEEEcCCCcEEEEEEecccc-----ChHHHHHHHHHhcCCCCceEEEEEEEeCCeEEEEEEccCCCCH
Q psy11767 384 GILGDGSYSVCRRCVEKSTGQEYAVKIISRKI-----DCSEEINLLRACQGHPNIVNLHCVFQDEVHTYLVLELLKGGEL 458 (966)
Q Consensus 384 ~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~-----~~~~Ei~iL~~l~~HpnIV~l~~~~~~~~~~~lVmEy~~gg~L 458 (966)
+.||+|+||.||+|.+..+|+.||||++.... ...+|+.+|+.+.+||||+++++++.++...|+|||||+||+|
T Consensus 19 ~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 98 (316)
T 2ac3_A 19 DVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEFFEEEDRFYLVFEKMRGGSI 98 (316)
T ss_dssp CCCCCCSSEEEEEEECSSSCCEEEEEEEECCSSCCHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEECCTTCBH
T ss_pred ceecCCceEEEEEEEEcCCCcEEEEEEEeeCcchhHHHHHHHHHHHHHhcCCCCeeeEEEEEeeCCEEEEEEEcCCCCcH
Confidence 67999999999999999999999999996542 2457999999877899999999999999999999999999999
Q ss_pred HHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCcEEEecCCC-CCEEEEeecccccccC----------
Q psy11767 459 LDRIRQKGRCGFTENEASRIMRQLVAAVHFMHSRGVVHRDLKPENLLFSDPAG-DNIKVVDFGFACLKRE---------- 527 (966)
Q Consensus 459 ~~~l~~~~~~~l~e~~~~~i~~Qil~aL~yLHs~~IiHRDLKP~NILl~~~~~-~~iKL~DFGla~~~~~---------- 527 (966)
.+++.... .+++.+++.++.||+.||+|||++||+||||||+|||++.... ..+||+|||++.....
T Consensus 99 ~~~l~~~~--~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~ 176 (316)
T 2ac3_A 99 LSHIHKRR--HFNELEASVVVQDVASALDFLHNKGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTP 176 (316)
T ss_dssp HHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEESCSSSSCSEEECCTTCCC--------------
T ss_pred HHHHhccC--CCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCHHHEEEccCCCcCceEEEEccCccccccCCcccccccc
Confidence 99998765 5999999999999999999999999999999999999975321 3499999999865321
Q ss_pred CCccccccccccCchhhccCCCCCCCcccchhhhhhhhhhhhcCCCCCCCcCcchhHHHHHHHHhcCCCCCCCCCCch--
Q psy11767 528 SLHTPCFTLQYAAPEVLRQDKSGYDENCDLWSLGVILVNVLRQDKSGYDENCDLWSLGVILYTMLCGRVPFHARSRDD-- 605 (966)
Q Consensus 528 ~~~~~~gT~~Y~APEvl~~~~~~~~~~~Di~SlGvil~el~~~~~~~y~~~~DIWSlGvilyemltG~~Pf~~~~~~~-- 605 (966)
.....+||+.|+|||++.... .....|+.++|||||||++|+|++|+.||.+....+
T Consensus 177 ~~~~~~gt~~y~aPE~~~~~~---------------------~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~ 235 (316)
T 2ac3_A 177 ELLTPCGSAEYMAPEVVEAFS---------------------EEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCG 235 (316)
T ss_dssp -----CCSGGGCCHHHHHHTS---------------------HHHHHHTTTHHHHHHHHHHHHHHHSSCSCCCCCCSCSC
T ss_pred ccccccCCcCccChHHhhccc---------------------ccccCCCcccccHhHHHHHHHHHHCCCCCccccccccc
Confidence 123456899999999985311 001236788999999999999999999998764321
Q ss_pred ---------hHHHHHHHHHcCCCCCCchhhccCCHHHHHHHHHhcccCccccCChHHHHHHhhhhHH
Q psy11767 606 ---------SALSIMARIKEGQFNFDAEAWSTVSSEAKELTKSLLTVNPAQRIRMMRVKLTFHAFHQ 663 (966)
Q Consensus 606 ---------~~~~~~~~i~~~~~~~~~~~~~~is~e~~~Li~~~L~~dP~~R~t~~~v~~~~~~~~~ 663 (966)
....+...+..+.+.++...+..+++++++||.+||..||++|||+.++ ..|+|.+
T Consensus 236 ~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~--l~hp~~~ 300 (316)
T 2ac3_A 236 WDRGEACPACQNMLFESIQEGKYEFPDKDWAHISCAAKDLISKLLVRDAKQRLSAAQV--LQHPWVQ 300 (316)
T ss_dssp C----CCHHHHHHHHHHHHHCCCCCCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHH--HHSTTCC
T ss_pred ccccccchhHHHHHHHHHhccCcccCchhcccCCHHHHHHHHHHhhCChhhCCCHHHH--hcChhhc
Confidence 1233556777888887777778899999999999999999999999976 3466653
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3twj_A* 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-43 Score=405.26 Aligned_cols=250 Identities=30% Similarity=0.492 Sum_probs=206.7
Q ss_pred cccccccccccccEEEEEEEcCCCcEEEEEEeccc--------cChHHHHHHHHHhcCCCCceEEEEEEEeCCeEEEEEE
Q psy11767 380 LDKAGILGDGSYSVCRRCVEKSTGQEYAVKIISRK--------IDCSEEINLLRACQGHPNIVNLHCVFQDEVHTYLVLE 451 (966)
Q Consensus 380 ~~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~--------~~~~~Ei~iL~~l~~HpnIV~l~~~~~~~~~~~lVmE 451 (966)
|+..++||+|+||+||+|+++.+|+.||||++.+. ....+|+.+|+.+ +|||||+++++|.++..+|||||
T Consensus 71 y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~E~~il~~l-~hp~Iv~l~~~~~~~~~~~lV~E 149 (410)
T 3v8s_A 71 YEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFA-NSPWVVQLFYAFQDDRYLYMVME 149 (410)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTCCCSTHHHHHHHHHHC-CCTTBCCEEEEEECSSEEEEEEC
T ss_pred cEEEEEEEcCCCEEEEEEEECCCCcEEEEEEEehhhhhhhHHHHHHHHHHHHHHhC-CCCCCCeEEEEEEECCEEEEEEe
Confidence 44578999999999999999999999999998642 1256799999887 69999999999999999999999
Q ss_pred ccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCcEEEecCCCCCEEEEeecccccccCC---
Q psy11767 452 LLKGGELLDRIRQKGRCGFTENEASRIMRQLVAAVHFMHSRGVVHRDLKPENLLFSDPAGDNIKVVDFGFACLKRES--- 528 (966)
Q Consensus 452 y~~gg~L~~~l~~~~~~~l~e~~~~~i~~Qil~aL~yLHs~~IiHRDLKP~NILl~~~~~~~iKL~DFGla~~~~~~--- 528 (966)
||+||+|.+++.+. .+++..++.++.||+.||+|||++||+||||||+|||++. .+.+||+|||+|+.....
T Consensus 150 ~~~gg~L~~~l~~~---~~~e~~~~~~~~qi~~aL~~LH~~givHrDLKp~NILl~~--~g~ikL~DFG~a~~~~~~~~~ 224 (410)
T 3v8s_A 150 YMPGGDLVNLMSNY---DVPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLDK--SGHLKLADFGTCMKMNKEGMV 224 (410)
T ss_dssp CCTTEEHHHHHHHC---CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECT--TSCEEECCCTTCEECCTTSEE
T ss_pred CCCCCcHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeeECC--CCCEEEeccceeEeeccCCcc
Confidence 99999999999764 4899999999999999999999999999999999999975 569999999999765432
Q ss_pred -CccccccccccCchhhccCCCCCCCcccchhhhhhhhhhhhcCCCCCCCcCcchhHHHHHHHHhcCCCCCCCCCCchhH
Q psy11767 529 -LHTPCFTLQYAAPEVLRQDKSGYDENCDLWSLGVILVNVLRQDKSGYDENCDLWSLGVILYTMLCGRVPFHARSRDDSA 607 (966)
Q Consensus 529 -~~~~~gT~~Y~APEvl~~~~~~~~~~~Di~SlGvil~el~~~~~~~y~~~~DIWSlGvilyemltG~~Pf~~~~~~~~~ 607 (966)
..+.+||+.|+|||++.... ....|+.++|||||||++|+|++|++||.+.+..
T Consensus 225 ~~~~~~gt~~Y~APE~l~~~~----------------------~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~--- 279 (410)
T 3v8s_A 225 RCDTAVGTPDYISPEVLKSQG----------------------GDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLV--- 279 (410)
T ss_dssp ECCSCCSCGGGCCHHHHHTTT----------------------TTCEEETHHHHHHHHHHHHHHHHSSCTTCCSSHH---
T ss_pred cccCCcCCccccCHHHhhccC----------------------CCcCCCCcceEecchHHHHHHHhCCCCCCCCChh---
Confidence 34678999999999986321 0122678999999999999999999999876543
Q ss_pred HHHHHHHHcCCCCCCchhhccCCHHHHHHHHHhcccCccc--cCChHHHHHHhhhhHH
Q psy11767 608 LSIMARIKEGQFNFDAEAWSTVSSEAKELTKSLLTVNPAQ--RIRMMRVKLTFHAFHQ 663 (966)
Q Consensus 608 ~~~~~~i~~~~~~~~~~~~~~is~e~~~Li~~~L~~dP~~--R~t~~~v~~~~~~~~~ 663 (966)
....+|..+...+..+.+..+|+++++||.+||..+|.+ |+++.++ ..|+|++
T Consensus 280 -~~~~~i~~~~~~~~~p~~~~~s~~~~~li~~lL~~~~~rlgR~~~~ei--~~Hp~f~ 334 (410)
T 3v8s_A 280 -GTYSKIMNHKNSLTFPDDNDISKEAKNLICAFLTDREVRLGRNGVEEI--KRHLFFK 334 (410)
T ss_dssp -HHHHHHHTHHHHCCCCTTCCCCHHHHHHHHHHSSCGGGCTTSSCHHHH--HTSGGGC
T ss_pred -hHHHHHHhccccccCCCcccccHHHHHHHHHHccChhhhCCCCCHHHH--hcCcccc
Confidence 334444433222222233568999999999999999988 9999876 4577764
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} SCOP: d.144.1.7 PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-42 Score=380.42 Aligned_cols=246 Identities=25% Similarity=0.424 Sum_probs=203.4
Q ss_pred ccccccccccccEEEEEEEcCCCcEEEEEEeccccC-----hHHHHHHHHHhcCCCCceEEEEEEEeCCeEEEEEEccCC
Q psy11767 381 DKAGILGDGSYSVCRRCVEKSTGQEYAVKIISRKID-----CSEEINLLRACQGHPNIVNLHCVFQDEVHTYLVLELLKG 455 (966)
Q Consensus 381 ~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~~-----~~~Ei~iL~~l~~HpnIV~l~~~~~~~~~~~lVmEy~~g 455 (966)
+..+.||+|+||+||+|.+..+|+.||||++..... ..+|+.+|+.+ +|||||+++++|.++...|+|||||+|
T Consensus 23 ~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l-~hp~iv~~~~~~~~~~~~~lv~e~~~~ 101 (297)
T 3fxz_A 23 TRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMREN-KNPNIVNYLDSYLVGDELWVVMEYLAG 101 (297)
T ss_dssp CCCEEEEEETTEEEEEEEBTTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHHC-CCTTBCCEEEEEEETTEEEEEEECCTT
T ss_pred eeeeeeccCCCeEEEEEEECCCCcEEEEEEeecccccHHHHHHHHHHHHhcC-CCCCCCeEeEEEEECCEEEEEEECCCC
Confidence 346889999999999999999999999999864322 45799999988 599999999999999999999999999
Q ss_pred CCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCcEEEecCCCCCEEEEeecccccccC---CCccc
Q psy11767 456 GELLDRIRQKGRCGFTENEASRIMRQLVAAVHFMHSRGVVHRDLKPENLLFSDPAGDNIKVVDFGFACLKRE---SLHTP 532 (966)
Q Consensus 456 g~L~~~l~~~~~~~l~e~~~~~i~~Qil~aL~yLHs~~IiHRDLKP~NILl~~~~~~~iKL~DFGla~~~~~---~~~~~ 532 (966)
|+|.+++... .+++.+++.++.||+.||+|||++||+||||||+|||++. ++.+||+|||++..... .....
T Consensus 102 ~~L~~~~~~~---~~~~~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~Nil~~~--~~~~kl~Dfg~~~~~~~~~~~~~~~ 176 (297)
T 3fxz_A 102 GSLTDVVTET---CMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGM--DGSVKLTDFGFCAQITPEQSKRSTM 176 (297)
T ss_dssp CBHHHHHHHS---CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECT--TCCEEECCCTTCEECCSTTCCBCCC
T ss_pred CCHHHHHhhc---CCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCHHHEEECC--CCCEEEeeCCCceecCCcccccCCc
Confidence 9999999765 4899999999999999999999999999999999999974 56899999999876543 23356
Q ss_pred cccccccCchhhccCCCCCCCcccchhhhhhhhhhhhcCCCCCCCcCcchhHHHHHHHHhcCCCCCCCCCCchhHHHHHH
Q psy11767 533 CFTLQYAAPEVLRQDKSGYDENCDLWSLGVILVNVLRQDKSGYDENCDLWSLGVILYTMLCGRVPFHARSRDDSALSIMA 612 (966)
Q Consensus 533 ~gT~~Y~APEvl~~~~~~~~~~~Di~SlGvil~el~~~~~~~y~~~~DIWSlGvilyemltG~~Pf~~~~~~~~~~~~~~ 612 (966)
+||+.|+|||++.. ..|+.++|||||||++|+|++|+.||........ ...
T Consensus 177 ~gt~~y~aPE~~~~--------------------------~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~---~~~ 227 (297)
T 3fxz_A 177 VGTPYWMAPEVVTR--------------------------KAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRA---LYL 227 (297)
T ss_dssp CSCGGGCCHHHHHC--------------------------SCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHH---HHH
T ss_pred cCCcCccChhhhcC--------------------------CCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHH---HHH
Confidence 78999999999853 2478899999999999999999999987653322 111
Q ss_pred HHHcCCCCCCchhhccCCHHHHHHHHHhcccCccccCChHHHHHHhhhhHHhh
Q psy11767 613 RIKEGQFNFDAEAWSTVSSEAKELTKSLLTVNPAQRIRMMRVKLTFHAFHQAQ 665 (966)
Q Consensus 613 ~i~~~~~~~~~~~~~~is~e~~~Li~~~L~~dP~~R~t~~~v~~~~~~~~~~~ 665 (966)
....+...+ .....+++++.+||.+||+.||++|||+.++ ..|+|++..
T Consensus 228 ~~~~~~~~~--~~~~~~~~~~~~li~~~l~~dp~~Rps~~el--l~h~~~~~~ 276 (297)
T 3fxz_A 228 IATNGTPEL--QNPEKLSAIFRDFLNRCLEMDVEKRGSAKEL--LQHQFLKIA 276 (297)
T ss_dssp HHHHCSCCC--SCGGGSCHHHHHHHHHHSCSSTTTSCCHHHH--TTCGGGGGC
T ss_pred HHhCCCCCC--CCccccCHHHHHHHHHHccCChhHCcCHHHH--hhChhhccc
Confidence 222222222 2234689999999999999999999999976 456776543
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-42 Score=394.89 Aligned_cols=246 Identities=30% Similarity=0.545 Sum_probs=206.1
Q ss_pred cccccccccccEEEEEEEcCCCcEEEEEEecccc--------ChHHHHHHHHHhcCCCCceEEEEEEEeCCeEEEEEEcc
Q psy11767 382 KAGILGDGSYSVCRRCVEKSTGQEYAVKIISRKI--------DCSEEINLLRACQGHPNIVNLHCVFQDEVHTYLVLELL 453 (966)
Q Consensus 382 ~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~--------~~~~Ei~iL~~l~~HpnIV~l~~~~~~~~~~~lVmEy~ 453 (966)
.++.||+|+||+||+|.+..+|+.||||++.+.. ...+|+.+|+.+ +|||||+++++|.+....|+|||||
T Consensus 19 i~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~il~~l-~hp~Iv~l~~~~~~~~~~~lv~e~~ 97 (384)
T 4fr4_A 19 ILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGL-EHPFLVNLWYSFQDEEDMFMVVDLL 97 (384)
T ss_dssp EEEEEECCTTCCEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTC-CCTTBCCEEEEEECSSEEEEEECCC
T ss_pred EEEEEeeCCCeEEEEEEECCCCCEEEEEEEehhhcccHHHHHHHHHHHHHHHhC-CCCCCCcEEEEEEeCCEEEEEEecC
Confidence 3789999999999999999999999999986432 245799999988 5999999999999999999999999
Q ss_pred CCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCcEEEecCCCCCEEEEeecccccccC--CCcc
Q psy11767 454 KGGELLDRIRQKGRCGFTENEASRIMRQLVAAVHFMHSRGVVHRDLKPENLLFSDPAGDNIKVVDFGFACLKRE--SLHT 531 (966)
Q Consensus 454 ~gg~L~~~l~~~~~~~l~e~~~~~i~~Qil~aL~yLHs~~IiHRDLKP~NILl~~~~~~~iKL~DFGla~~~~~--~~~~ 531 (966)
.||+|.+++.... .+++..++.++.||+.||+|||++||+||||||+|||++. .+.+||+|||+|+.... ...+
T Consensus 98 ~gg~L~~~l~~~~--~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIll~~--~g~vkL~DFG~a~~~~~~~~~~~ 173 (384)
T 4fr4_A 98 LGGDLRYHLQQNV--HFKEETVKLFICELVMALDYLQNQRIIHRDMKPDNILLDE--HGHVHITDFNIAAMLPRETQITT 173 (384)
T ss_dssp TTEEHHHHHHTTC--CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECT--TSCEEECCCTTCEECCTTCCBCC
T ss_pred CCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCceeccCcHHHeEECC--CCCEEEeccceeeeccCCCceec
Confidence 9999999998754 5999999999999999999999999999999999999975 56999999999976533 3456
Q ss_pred ccccccccCchhhccCCCCCCCcccchhhhhhhhhhhhcCCCCCCCcCcchhHHHHHHHHhcCCCCCCCCCCchhHHHHH
Q psy11767 532 PCFTLQYAAPEVLRQDKSGYDENCDLWSLGVILVNVLRQDKSGYDENCDLWSLGVILYTMLCGRVPFHARSRDDSALSIM 611 (966)
Q Consensus 532 ~~gT~~Y~APEvl~~~~~~~~~~~Di~SlGvil~el~~~~~~~y~~~~DIWSlGvilyemltG~~Pf~~~~~~~~~~~~~ 611 (966)
.+||+.|+|||++.... ..+|+.++|||||||++|+|++|+.||....... ...+.
T Consensus 174 ~~gt~~Y~aPE~~~~~~-----------------------~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~-~~~~~ 229 (384)
T 4fr4_A 174 MAGTKPYMAPEMFSSRK-----------------------GAGYSFAVDWWSLGVTAYELLRGRRPYHIRSSTS-SKEIV 229 (384)
T ss_dssp CCSCGGGCCGGGTCCCS-----------------------SCCBCTTHHHHHHHHHHHHHHHSSCSSCCCTTSC-HHHHH
T ss_pred cCCCccccCCeeeccCC-----------------------CCCCCccceeechHHHHHHHHhCCCCCCCCCCcc-HHHHH
Confidence 78999999999985321 2357889999999999999999999998655432 23444
Q ss_pred HHHHcCCCCCCchhhccCCHHHHHHHHHhcccCccccCC-hHHHHHHhhhhH
Q psy11767 612 ARIKEGQFNFDAEAWSTVSSEAKELTKSLLTVNPAQRIR-MMRVKLTFHAFH 662 (966)
Q Consensus 612 ~~i~~~~~~~~~~~~~~is~e~~~Li~~~L~~dP~~R~t-~~~v~~~~~~~~ 662 (966)
..+......++ ..+++++.+||.+||..||.+||+ +.++ ..|+|+
T Consensus 230 ~~~~~~~~~~p----~~~s~~~~~li~~lL~~dP~~R~s~~~~l--~~hp~f 275 (384)
T 4fr4_A 230 HTFETTVVTYP----SAWSQEMVSLLKKLLEPNPDQRFSQLSDV--QNFPYM 275 (384)
T ss_dssp HHHHHCCCCCC----TTSCHHHHHHHHHHSCSSGGGSCCSHHHH--HTSGGG
T ss_pred HHHhhcccCCC----CcCCHHHHHHHHHHhcCCHhHhcccHHHH--HcChhh
Confidence 55555544433 357999999999999999999999 4443 456665
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-42 Score=398.69 Aligned_cols=253 Identities=34% Similarity=0.647 Sum_probs=215.4
Q ss_pred ecccccccccccccccccccEEEEEEEcCCCcEEEEEEecccc-----ChHHHHHHHHHhcCCCCceEEEEEEEeCCeEE
Q psy11767 373 FEQYDMDLDKAGILGDGSYSVCRRCVEKSTGQEYAVKIISRKI-----DCSEEINLLRACQGHPNIVNLHCVFQDEVHTY 447 (966)
Q Consensus 373 ~~~~~i~~~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~-----~~~~Ei~iL~~l~~HpnIV~l~~~~~~~~~~~ 447 (966)
.+.|.+ .+.||+|+||.||+|.+..+|+.||+|++.... ...+|+.+|+.+ +|||||+++++|.++...|
T Consensus 50 ~~~y~i----~~~LG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~E~~il~~l-~hpnIv~~~~~~~~~~~~~ 124 (387)
T 1kob_A 50 YDYYDI----LEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQL-HHPKLINLHDAFEDKYEMV 124 (387)
T ss_dssp GGTEEE----EEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTC-CSTTBCCEEEEEECSSEEE
T ss_pred ccceEE----EEEEecCCCEEEEEEEECCCCCEEEEEEecccchhhHHHHHHHHHHHHhC-CCcCCCeEEEEEEeCCEEE
Confidence 344554 688999999999999999999999999997542 245799999888 5999999999999999999
Q ss_pred EEEEccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCcEEEecCCCCCEEEEeecccccccC
Q psy11767 448 LVLELLKGGELLDRIRQKGRCGFTENEASRIMRQLVAAVHFMHSRGVVHRDLKPENLLFSDPAGDNIKVVDFGFACLKRE 527 (966)
Q Consensus 448 lVmEy~~gg~L~~~l~~~~~~~l~e~~~~~i~~Qil~aL~yLHs~~IiHRDLKP~NILl~~~~~~~iKL~DFGla~~~~~ 527 (966)
+|||||+||+|.+++.... ..+++.+++.++.||+.||+|||++||+||||||+|||++....+.+||+|||+|+....
T Consensus 125 lv~E~~~gg~L~~~l~~~~-~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlkp~NIll~~~~~~~vkL~DFG~a~~~~~ 203 (387)
T 1kob_A 125 LILEFLSGGELFDRIAAED-YKMSEAEVINYMRQACEGLKHMHEHSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNP 203 (387)
T ss_dssp EEEECCCCCBHHHHTTCTT-CCBCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSTTCCCEEECCCTTCEECCT
T ss_pred EEEEcCCCCcHHHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHHhCCeeecccchHHeEEecCCCCceEEEecccceecCC
Confidence 9999999999999987543 259999999999999999999999999999999999999754556899999999976543
Q ss_pred C--CccccccccccCchhhccCCCCCCCcccchhhhhhhhhhhhcCCCCCCCcCcchhHHHHHHHHhcCCCCCCCCCCch
Q psy11767 528 S--LHTPCFTLQYAAPEVLRQDKSGYDENCDLWSLGVILVNVLRQDKSGYDENCDLWSLGVILYTMLCGRVPFHARSRDD 605 (966)
Q Consensus 528 ~--~~~~~gT~~Y~APEvl~~~~~~~~~~~Di~SlGvil~el~~~~~~~y~~~~DIWSlGvilyemltG~~Pf~~~~~~~ 605 (966)
. ....+||+.|+|||++.. ..|+.++|||||||++|+|++|..||.+.+.
T Consensus 204 ~~~~~~~~gt~~y~aPE~~~~--------------------------~~~~~~~DiwSlG~il~elltg~~Pf~~~~~-- 255 (387)
T 1kob_A 204 DEIVKVTTATAEFAAPEIVDR--------------------------EPVGFYTDMWAIGVLGYVLLSGLSPFAGEDD-- 255 (387)
T ss_dssp TSCEEEECSSGGGCCHHHHTT--------------------------CCBCHHHHHHHHHHHHHHHHHSCCSSCCSSH--
T ss_pred CcceeeeccCCCccCchhccC--------------------------CCCCCcccEeeHhHHHHHHHhCCCCCCCCCH--
Confidence 2 234578999999999852 2367889999999999999999999987543
Q ss_pred hHHHHHHHHHcCCCCCCchhhccCCHHHHHHHHHhcccCccccCChHHHHHHhhhhHH
Q psy11767 606 SALSIMARIKEGQFNFDAEAWSTVSSEAKELTKSLLTVNPAQRIRMMRVKLTFHAFHQ 663 (966)
Q Consensus 606 ~~~~~~~~i~~~~~~~~~~~~~~is~e~~~Li~~~L~~dP~~R~t~~~v~~~~~~~~~ 663 (966)
...+..+..+.+.+....+..+++++++||.+||..||++|||+.++ ..|+|..
T Consensus 256 --~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~el--l~hp~~~ 309 (387)
T 1kob_A 256 --LETLQNVKRCDWEFDEDAFSSVSPEAKDFIKNLLQKEPRKRLTVHDA--LEHPWLK 309 (387)
T ss_dssp --HHHHHHHHHCCCCCCSSTTTTSCHHHHHHHHTTSCSSGGGSCCHHHH--HTSTTTS
T ss_pred --HHHHHHHHhCCCCCCccccccCCHHHHHHHHHHcCCChhHCcCHHHH--hhCcccc
Confidence 34556677777777777778899999999999999999999999976 3466653
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-42 Score=389.02 Aligned_cols=251 Identities=36% Similarity=0.697 Sum_probs=201.9
Q ss_pred cccccccccccEEEEEEEcCCCcEEEEEEecccc---ChHHHHHHHHHhcCCCCceEEEEEEEeCCeEEEEEEccCCCCH
Q psy11767 382 KAGILGDGSYSVCRRCVEKSTGQEYAVKIISRKI---DCSEEINLLRACQGHPNIVNLHCVFQDEVHTYLVLELLKGGEL 458 (966)
Q Consensus 382 ~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~---~~~~Ei~iL~~l~~HpnIV~l~~~~~~~~~~~lVmEy~~gg~L 458 (966)
..+.||+|+||.||+|.+..+++.||||++.... ...+|+.+|+.+ +|||||+++++|.+....|+||||++||+|
T Consensus 57 ~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~lv~e~~~~~~L 135 (349)
T 2w4o_A 57 VESELGRGATSIVYRCKQKGTQKPYALKVLKKTVDKKIVRTEIGVLLRL-SHPNIIKLKEIFETPTEISLVLELVTGGEL 135 (349)
T ss_dssp EEEEEEECSSEEEEEEEETTTCCEEEEEEEEC----------CHHHHHC-CCTTBCCEEEEEECSSEEEEEECCCCSCBH
T ss_pred EeeEEeeCCCEEEEEEEECCCCcEEEEEEeccchhHHHHHHHHHHHHhC-CCCCCcceeeeEecCCeEEEEEEeCCCCCH
Confidence 3688999999999999999999999999997543 345799999998 599999999999999999999999999999
Q ss_pred HHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCcEEEec-CCCCCEEEEeecccccccCC--Ccccccc
Q psy11767 459 LDRIRQKGRCGFTENEASRIMRQLVAAVHFMHSRGVVHRDLKPENLLFSD-PAGDNIKVVDFGFACLKRES--LHTPCFT 535 (966)
Q Consensus 459 ~~~l~~~~~~~l~e~~~~~i~~Qil~aL~yLHs~~IiHRDLKP~NILl~~-~~~~~iKL~DFGla~~~~~~--~~~~~gT 535 (966)
.+++...+ .+++.+++.++.||+.||+|||++||+||||||+|||++. ..++.+||+|||+++..... ....+||
T Consensus 136 ~~~l~~~~--~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dikp~NIll~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~gt 213 (349)
T 2w4o_A 136 FDRIVEKG--YYSERDAADAVKQILEAVAYLHENGIVHRDLKPENLLYATPAPDAPLKIADFGLSKIVEHQVLMKTVCGT 213 (349)
T ss_dssp HHHHTTCS--SCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEESSSSTTCCEEECCCC----------------C
T ss_pred HHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCcccEEEecCCCCCCEEEccCccccccCcccccccccCC
Confidence 99997654 5899999999999999999999999999999999999974 23568999999999765432 3456789
Q ss_pred ccccCchhhccCCCCCCCcccchhhhhhhhhhhhcCCCCCCCcCcchhHHHHHHHHhcCCCCCCCCCCchhHHHHHHHHH
Q psy11767 536 LQYAAPEVLRQDKSGYDENCDLWSLGVILVNVLRQDKSGYDENCDLWSLGVILYTMLCGRVPFHARSRDDSALSIMARIK 615 (966)
Q Consensus 536 ~~Y~APEvl~~~~~~~~~~~Di~SlGvil~el~~~~~~~y~~~~DIWSlGvilyemltG~~Pf~~~~~~~~~~~~~~~i~ 615 (966)
+.|+|||++.. ..|+.++|||||||++|+|++|..||......+ ..+..+.
T Consensus 214 ~~y~aPE~~~~--------------------------~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~---~~~~~i~ 264 (349)
T 2w4o_A 214 PGYCAPEILRG--------------------------CAYGPEVDMWSVGIITYILLCGFEPFYDERGDQ---FMFRRIL 264 (349)
T ss_dssp GGGSCHHHHTT--------------------------CCCCTHHHHHHHHHHHHHHHHSSCTTCCTTCHH---HHHHHHH
T ss_pred CCccCHHHhcC--------------------------CCCCcccchHHHHHHHHHHHhCCCCCCCCcccH---HHHHHHH
Confidence 99999999852 237889999999999999999999998755432 3456677
Q ss_pred cCCCCCCchhhccCCHHHHHHHHHhcccCccccCChHHHHHHhhhhHHhhh
Q psy11767 616 EGQFNFDAEAWSTVSSEAKELTKSLLTVNPAQRIRMMRVKLTFHAFHQAQK 666 (966)
Q Consensus 616 ~~~~~~~~~~~~~is~e~~~Li~~~L~~dP~~R~t~~~v~~~~~~~~~~~~ 666 (966)
.+.+.+....|..++.++++||.+||..||++|||+.++ ..|+|.....
T Consensus 265 ~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~--l~hp~~~~~~ 313 (349)
T 2w4o_A 265 NCEYYFISPWWDEVSLNAKDLVRKLIVLDPKKRLTTFQA--LQHPWVTGKA 313 (349)
T ss_dssp TTCCCCCTTTTTTSCHHHHHHHHTTSCSSGGGSCCHHHH--HHSTTTTSTT
T ss_pred hCCCccCCchhhhCCHHHHHHHHHHccCChhhCcCHHHH--hcCcccCCCc
Confidence 777766666778899999999999999999999999976 4577765443
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-42 Score=390.34 Aligned_cols=257 Identities=26% Similarity=0.434 Sum_probs=207.8
Q ss_pred ccceecccccccccccccccccccEEEEEEEcCCCcEEEEEEecccc----ChHHHHHHHHHhc----CCCCceEEEEEE
Q psy11767 369 GSLFFEQYDMDLDKAGILGDGSYSVCRRCVEKSTGQEYAVKIISRKI----DCSEEINLLRACQ----GHPNIVNLHCVF 440 (966)
Q Consensus 369 G~~~~~~~~i~~~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~----~~~~Ei~iL~~l~----~HpnIV~l~~~~ 440 (966)
|..+.++|.+ .+.||+|+||+||+|++..+|+.||||++.... ....|+.+|+.+. +|||||++++++
T Consensus 30 g~~~~~~y~~----~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~~~~~~h~~iv~~~~~~ 105 (360)
T 3llt_A 30 GMLLNNAFLV----IRKMGDGTFGRVLLCQHIDNKKYYAVKVVRNIKKYTRSAKIEADILKKIQNDDINNNNIVKYHGKF 105 (360)
T ss_dssp TCEETTTEEE----EEEEEECSSEEEEEEEETTTCCEEEEEEECSCHHHHHHHHHHHHHHHHTCCCSTTGGGBCCEEEEE
T ss_pred ceEecCEEEE----EEEEcccCCeEEEEEEECCCCeEEEEEEeccchhhhhhhHHHHHHHHHhcccCCCCCCeeccccee
Confidence 4455566665 688999999999999999999999999997432 2456899999886 599999999999
Q ss_pred EeCCeEEEEEEccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCcEEEec------------
Q psy11767 441 QDEVHTYLVLELLKGGELLDRIRQKGRCGFTENEASRIMRQLVAAVHFMHSRGVVHRDLKPENLLFSD------------ 508 (966)
Q Consensus 441 ~~~~~~~lVmEy~~gg~L~~~l~~~~~~~l~e~~~~~i~~Qil~aL~yLHs~~IiHRDLKP~NILl~~------------ 508 (966)
....+.|+||||+ +++|.+++.......+++.+++.++.||+.||+|||++||+||||||+|||+++
T Consensus 106 ~~~~~~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~~~~~~~~~ 184 (360)
T 3llt_A 106 MYYDHMCLIFEPL-GPSLYEIITRNNYNGFHIEDIKLYCIEILKALNYLRKMSLTHTDLKPENILLDDPYFEKSLITVRR 184 (360)
T ss_dssp EETTEEEEEECCC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCTTCCEEEEEEEC
T ss_pred eECCeeEEEEcCC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCcccEEEccccccccccchhc
Confidence 9999999999999 999999998876557999999999999999999999999999999999999974
Q ss_pred -----------CCCCCEEEEeecccccccCCCccccccccccCchhhccCCCCCCCcccchhhhhhhhhhhhcCCCCCCC
Q psy11767 509 -----------PAGDNIKVVDFGFACLKRESLHTPCFTLQYAAPEVLRQDKSGYDENCDLWSLGVILVNVLRQDKSGYDE 577 (966)
Q Consensus 509 -----------~~~~~iKL~DFGla~~~~~~~~~~~gT~~Y~APEvl~~~~~~~~~~~Di~SlGvil~el~~~~~~~y~~ 577 (966)
...+.+||+|||+|+.........+||+.|+|||++.. ..|+.
T Consensus 185 ~~~~~~~~~~~~~~~~~kl~DFG~a~~~~~~~~~~~gt~~y~aPE~~~~--------------------------~~~~~ 238 (360)
T 3llt_A 185 VTDGKKIQIYRTKSTGIKLIDFGCATFKSDYHGSIINTRQYRAPEVILN--------------------------LGWDV 238 (360)
T ss_dssp TTTCCEEEEEEESCCCEEECCCTTCEETTSCCCSCCSCGGGCCHHHHTT--------------------------CCCCT
T ss_pred ccccccccccccCCCCEEEEeccCceecCCCCcCccCcccccCcHHHcC--------------------------CCCCC
Confidence 12568999999999876666667789999999999852 24788
Q ss_pred cCcchhHHHHHHHHhcCCCCCCCCCCchhHHHHHHHHHcCCCCCCch---------------------------------
Q psy11767 578 NCDLWSLGVILYTMLCGRVPFHARSRDDSALSIMARIKEGQFNFDAE--------------------------------- 624 (966)
Q Consensus 578 ~~DIWSlGvilyemltG~~Pf~~~~~~~~~~~~~~~i~~~~~~~~~~--------------------------------- 624 (966)
++|||||||++|+|++|+.||......+.. ..+..+.. .++..
T Consensus 239 ~~DiwslG~il~ell~g~~pf~~~~~~~~~-~~~~~~~~---~~p~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~ 314 (360)
T 3llt_A 239 SSDMWSFGCVLAELYTGSLLFRTHEHMEHL-AMMESIIQ---PIPKNMLYEATKTNGSKYVNKDELKLAWPENASSINSI 314 (360)
T ss_dssp THHHHHHHHHHHHHHHSSCSCCCSSHHHHH-HHHHHHTC---CCCHHHHHHHTTSGGGGGEETTTTEECTTTTCSCHHHH
T ss_pred ccchHHHHHHHHHHHHCCCCCCCCcHHHHH-HHHHHhcC---CCCHHHHhhhhhccCccccCcccceecCcccccchhhh
Confidence 999999999999999999999876543322 22222111 10000
Q ss_pred ---------hhccCCHHHHHHHHHhcccCccccCChHHHHHHhhhhH
Q psy11767 625 ---------AWSTVSSEAKELTKSLLTVNPAQRIRMMRVKLTFHAFH 662 (966)
Q Consensus 625 ---------~~~~is~e~~~Li~~~L~~dP~~R~t~~~v~~~~~~~~ 662 (966)
.....++++.+||.+||+.||++|||+.++ ..|+|+
T Consensus 315 ~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpta~el--L~hp~f 359 (360)
T 3llt_A 315 KHVKKCLPLYKIIKHELFCDFLYSILQIDPTLRPSPAEL--LKHKFL 359 (360)
T ss_dssp HHHHTCCCHHHHCCCHHHHHHHHHHCCSSGGGSCCHHHH--TTSGGG
T ss_pred hhhhhcccccccchHHHHHHHHHHHhcCChhhCCCHHHH--hcCccc
Confidence 001234778899999999999999999876 446664
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-42 Score=395.33 Aligned_cols=246 Identities=31% Similarity=0.527 Sum_probs=201.3
Q ss_pred cccccccccccccEEEEEEEcCCCcEEEEEEeccccC--------hHHHHHHHHHhcCCCCceEEEEEEEeCCeEEEEEE
Q psy11767 380 LDKAGILGDGSYSVCRRCVEKSTGQEYAVKIISRKID--------CSEEINLLRACQGHPNIVNLHCVFQDEVHTYLVLE 451 (966)
Q Consensus 380 ~~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~~--------~~~Ei~iL~~l~~HpnIV~l~~~~~~~~~~~lVmE 451 (966)
|+.++.||+|+||+||+|+++.+++.||||++.+... ...|..++....+|||||+++++|.+....|+|||
T Consensus 40 y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~e~~~ll~~~~hp~Iv~l~~~~~~~~~~~lv~E 119 (373)
T 2r5t_A 40 FHFLKVIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYFVLD 119 (373)
T ss_dssp EEEEEEEECCTTCEEEEEEETTTCCEEEEEEEEGGGBC-------------CCBCCCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred eEEEEEEeeCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHHhCCCCCCCCEEEEEEeCCEEEEEEe
Confidence 4457899999999999999999999999999975421 22344443333479999999999999999999999
Q ss_pred ccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCcEEEecCCCCCEEEEeeccccccc---CC
Q psy11767 452 LLKGGELLDRIRQKGRCGFTENEASRIMRQLVAAVHFMHSRGVVHRDLKPENLLFSDPAGDNIKVVDFGFACLKR---ES 528 (966)
Q Consensus 452 y~~gg~L~~~l~~~~~~~l~e~~~~~i~~Qil~aL~yLHs~~IiHRDLKP~NILl~~~~~~~iKL~DFGla~~~~---~~ 528 (966)
||+||+|.+++.+.+ .+++..++.++.||+.||+|||++||+||||||+|||++. ++.+||+|||+++... ..
T Consensus 120 ~~~gg~L~~~l~~~~--~~~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIll~~--~g~ikL~DFG~a~~~~~~~~~ 195 (373)
T 2r5t_A 120 YINGGELFYHLQRER--CFLEPRARFYAAEIASALGYLHSLNIVYRDLKPENILLDS--QGHIVLTDFGLCKENIEHNST 195 (373)
T ss_dssp CCCSCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECT--TSCEEECCCCBCGGGBCCCCC
T ss_pred CCCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCceecCCCHHHEEECC--CCCEEEeeCccccccccCCCc
Confidence 999999999998765 5899999999999999999999999999999999999974 5699999999997532 23
Q ss_pred CccccccccccCchhhccCCCCCCCcccchhhhhhhhhhhhcCCCCCCCcCcchhHHHHHHHHhcCCCCCCCCCCchhHH
Q psy11767 529 LHTPCFTLQYAAPEVLRQDKSGYDENCDLWSLGVILVNVLRQDKSGYDENCDLWSLGVILYTMLCGRVPFHARSRDDSAL 608 (966)
Q Consensus 529 ~~~~~gT~~Y~APEvl~~~~~~~~~~~Di~SlGvil~el~~~~~~~y~~~~DIWSlGvilyemltG~~Pf~~~~~~~~~~ 608 (966)
..+.+||+.|+|||++.. ..|+.++|||||||++|||++|.+||.+.+. .
T Consensus 196 ~~~~~gt~~y~aPE~~~~--------------------------~~~~~~~DiwslG~il~ell~G~~Pf~~~~~----~ 245 (373)
T 2r5t_A 196 TSTFCGTPEYLAPEVLHK--------------------------QPYDRTVDWWCLGAVLYEMLYGLPPFYSRNT----A 245 (373)
T ss_dssp CCSBSCCCCCCCHHHHTT--------------------------CCCCTHHHHHHHHHHHHHHHHSSCTTCCSBH----H
T ss_pred cccccCCccccCHHHhCC--------------------------CCCCchhhhHHHHHHHHHHHcCCCCCCCCCH----H
Confidence 456789999999999852 3478899999999999999999999987543 2
Q ss_pred HHHHHHHcCCCCCCchhhccCCHHHHHHHHHhcccCccccCChHH--HHHHhhhhHH
Q psy11767 609 SIMARIKEGQFNFDAEAWSTVSSEAKELTKSLLTVNPAQRIRMMR--VKLTFHAFHQ 663 (966)
Q Consensus 609 ~~~~~i~~~~~~~~~~~~~~is~e~~~Li~~~L~~dP~~R~t~~~--v~~~~~~~~~ 663 (966)
.+...|..+...++ ..++.++++||.+||+.||.+||++.+ .....|+|+.
T Consensus 246 ~~~~~i~~~~~~~~----~~~~~~~~~li~~lL~~dp~~R~~~~~~~~~i~~h~~f~ 298 (373)
T 2r5t_A 246 EMYDNILNKPLQLK----PNITNSARHLLEGLLQKDRTKRLGAKDDFMEIKSHVFFS 298 (373)
T ss_dssp HHHHHHHHSCCCCC----SSSCHHHHHHHHHHTCSSGGGSTTTTTTHHHHHTSGGGT
T ss_pred HHHHHHHhcccCCC----CCCCHHHHHHHHHHcccCHHhCCCCCCCHHHHhCCcccc
Confidence 44556666655543 358999999999999999999999852 1345667653
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-42 Score=379.07 Aligned_cols=259 Identities=29% Similarity=0.469 Sum_probs=203.8
Q ss_pred cceecccccccccccccccccccEEEEEEEcCCCcEEEEEEecccc----------ChHHHHHHHHHhc--CCCCceEEE
Q psy11767 370 SLFFEQYDMDLDKAGILGDGSYSVCRRCVEKSTGQEYAVKIISRKI----------DCSEEINLLRACQ--GHPNIVNLH 437 (966)
Q Consensus 370 ~~~~~~~~i~~~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~----------~~~~Ei~iL~~l~--~HpnIV~l~ 437 (966)
..+.++|.+ .+.||+|+||+||+|++..+|+.||||++.... ...+|+.+++.+. +||||++++
T Consensus 5 ~~~~~~y~~----~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~niv~~~ 80 (308)
T 3g33_A 5 SMATSRYEP----VAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEAFEHPNVVRLM 80 (308)
T ss_dssp -----CCEE----EEEECCSSSCCEEEEECTTTCCEEEEEEEEEECCCTTSSCCCHHHHHHHHHHHHHHHHCCTTBCCEE
T ss_pred cccccceEE----EEEEecCCCeEEEEEEECCCCcEEEEEEEecccccccccccchhHHHHHHHHHHHhhcCCCCeEEee
Confidence 344456655 688999999999999999999999999986322 2457888887765 599999999
Q ss_pred EEEEeCC-----eEEEEEEccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCcEEEecCCCC
Q psy11767 438 CVFQDEV-----HTYLVLELLKGGELLDRIRQKGRCGFTENEASRIMRQLVAAVHFMHSRGVVHRDLKPENLLFSDPAGD 512 (966)
Q Consensus 438 ~~~~~~~-----~~~lVmEy~~gg~L~~~l~~~~~~~l~e~~~~~i~~Qil~aL~yLHs~~IiHRDLKP~NILl~~~~~~ 512 (966)
+++.+.. ..++||||+. |+|.+++.......+++.+++.++.||+.||+|||++||+||||||+|||++. ++
T Consensus 81 ~~~~~~~~~~~~~~~lv~e~~~-~~L~~~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nil~~~--~~ 157 (308)
T 3g33_A 81 DVCATSRTDREIKVTLVFEHVD-QDLRTYLDKAPPPGLPAETIKDLMRQFLRGLDFLHANCIVHRDLKPENILVTS--GG 157 (308)
T ss_dssp EEEEECCSSSEEEEEEEEECCC-CBHHHHHHTCCTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCTTTEEECT--TS
T ss_pred eeeeccCCCCceeEEEEehhhh-cCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEcC--CC
Confidence 9998765 5899999996 69999998876556999999999999999999999999999999999999975 56
Q ss_pred CEEEEeecccccccC--CCccccccccccCchhhccCCCCCCCcccchhhhhhhhhhhhcCCCCCCCcCcchhHHHHHHH
Q psy11767 513 NIKVVDFGFACLKRE--SLHTPCFTLQYAAPEVLRQDKSGYDENCDLWSLGVILVNVLRQDKSGYDENCDLWSLGVILYT 590 (966)
Q Consensus 513 ~iKL~DFGla~~~~~--~~~~~~gT~~Y~APEvl~~~~~~~~~~~Di~SlGvil~el~~~~~~~y~~~~DIWSlGvilye 590 (966)
.+||+|||+|+.... .....++|+.|+|||++.. ..|+.++|||||||++|+
T Consensus 158 ~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~--------------------------~~~~~~~DiwslG~il~~ 211 (308)
T 3g33_A 158 TVKLADFGLARIYSYQMALTPVVVTLWYRAPEVLLQ--------------------------STYATPVDMWSVGCIFAE 211 (308)
T ss_dssp CEEECSCSCTTTSTTCCCSGGGGCCCSSCCHHHHHT--------------------------SCCCSTHHHHHHHHHHHH
T ss_pred CEEEeeCccccccCCCcccCCccccccccCchHHcC--------------------------CCCCchHHHHHHHHHHHH
Confidence 899999999976543 2345678999999999853 237889999999999999
Q ss_pred HhcCCCCCCCCCCchhHHHHHHHHHcCC---C----CC------------CchhhccCCHHHHHHHHHhcccCccccCCh
Q psy11767 591 MLCGRVPFHARSRDDSALSIMARIKEGQ---F----NF------------DAEAWSTVSSEAKELTKSLLTVNPAQRIRM 651 (966)
Q Consensus 591 mltG~~Pf~~~~~~~~~~~~~~~i~~~~---~----~~------------~~~~~~~is~e~~~Li~~~L~~dP~~R~t~ 651 (966)
|++|++||.+.+..+....++..+.... + .. .....+.+++++.+||.+||+.||++|||+
T Consensus 212 l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~ 291 (308)
T 3g33_A 212 MFRRKPLFCGNSEADQLGKIFDLIGLPPEDDWPRDVSLPRGAFPPRGPRPVQSVVPEMEESGAQLLLEMLTFNPHKRISA 291 (308)
T ss_dssp TTTSSCSCCCSSHHHHHHHHHHHHCCCCTTTSCSSCSSCGGGSCCCCCCCHHHHSCSCCHHHHHHHHHHTCSSTTTSCCH
T ss_pred HHhCCCCCCCCCHHHHHHHHHHHhCCCChhhccchhhccccccCCCCCCcHHHhCccccHHHHHHHHHHhcCCCccCCCH
Confidence 9999999988765444333333321110 0 00 011234688999999999999999999999
Q ss_pred HHHHHHhhhhHH
Q psy11767 652 MRVKLTFHAFHQ 663 (966)
Q Consensus 652 ~~v~~~~~~~~~ 663 (966)
.++ ..|+|++
T Consensus 292 ~e~--l~h~~~~ 301 (308)
T 3g33_A 292 FRA--LQHSYLH 301 (308)
T ss_dssp HHH--HTSTTC-
T ss_pred HHH--hcCcccc
Confidence 976 4577754
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-42 Score=406.16 Aligned_cols=254 Identities=37% Similarity=0.674 Sum_probs=216.5
Q ss_pred eecccccccccccccccccccEEEEEEEcCCCcEEEEEEecccc------------------ChHHHHHHHHHhcCCCCc
Q psy11767 372 FFEQYDMDLDKAGILGDGSYSVCRRCVEKSTGQEYAVKIISRKI------------------DCSEEINLLRACQGHPNI 433 (966)
Q Consensus 372 ~~~~~~i~~~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~------------------~~~~Ei~iL~~l~~HpnI 433 (966)
+.++|.+ .+.||+|+||+||+|.++.+++.||||++.... ...+|+.+|+.+ +||||
T Consensus 34 i~~~Y~~----~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~hpni 108 (504)
T 3q5i_A 34 IGESYFK----VRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSL-DHPNI 108 (504)
T ss_dssp GGGTEEE----EEEEEC--CEEEEEEEETTTCCEEEEEEEEC----------------CTHHHHHHHHHHHHTC-CCTTB
T ss_pred cccceEE----EeEecccCCeEEEEEEECCCCcEEEEEEEEhhhcccccccccchhhHHHHHHHHHHHHHHHhC-CCCCC
Confidence 4455555 689999999999999999999999999986432 134699999998 59999
Q ss_pred eEEEEEEEeCCeEEEEEEccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCcEEEecCCC-C
Q psy11767 434 VNLHCVFQDEVHTYLVLELLKGGELLDRIRQKGRCGFTENEASRIMRQLVAAVHFMHSRGVVHRDLKPENLLFSDPAG-D 512 (966)
Q Consensus 434 V~l~~~~~~~~~~~lVmEy~~gg~L~~~l~~~~~~~l~e~~~~~i~~Qil~aL~yLHs~~IiHRDLKP~NILl~~~~~-~ 512 (966)
|+++++|.+....|+|||||+||+|.+++.... .+++..++.++.||+.||+|||++||+||||||+|||++.... .
T Consensus 109 v~~~~~~~~~~~~~lv~e~~~gg~L~~~l~~~~--~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~ 186 (504)
T 3q5i_A 109 IKLFDVFEDKKYFYLVTEFYEGGELFEQIINRH--KFDECDAANIMKQILSGICYLHKHNIVHRDIKPENILLENKNSLL 186 (504)
T ss_dssp CCEEEEEECSSEEEEEEECCTTCBHHHHHHHHS--CCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESSTTCCS
T ss_pred CeEEEEEEcCCEEEEEEecCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCcHHHEEEecCCCCc
Confidence 999999999999999999999999999998765 5999999999999999999999999999999999999975322 3
Q ss_pred CEEEEeecccccccC--CCccccccccccCchhhccCCCCCCCcccchhhhhhhhhhhhcCCCCCCCcCcchhHHHHHHH
Q psy11767 513 NIKVVDFGFACLKRE--SLHTPCFTLQYAAPEVLRQDKSGYDENCDLWSLGVILVNVLRQDKSGYDENCDLWSLGVILYT 590 (966)
Q Consensus 513 ~iKL~DFGla~~~~~--~~~~~~gT~~Y~APEvl~~~~~~~~~~~Di~SlGvil~el~~~~~~~y~~~~DIWSlGvilye 590 (966)
.+||+|||+|..... .....+||+.|+|||++. ..|+.++|||||||++|+
T Consensus 187 ~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~---------------------------~~~~~~~DiwslG~il~~ 239 (504)
T 3q5i_A 187 NIKIVDFGLSSFFSKDYKLRDRLGTAYYIAPEVLK---------------------------KKYNEKCDVWSCGVIMYI 239 (504)
T ss_dssp SEEECCCTTCEECCTTSCBCCCCSCTTTCCHHHHT---------------------------TCBCTHHHHHHHHHHHHH
T ss_pred cEEEEECCCCEEcCCCCccccccCCcCCCCHHHhc---------------------------cCCCchHHHHHHHHHHHH
Confidence 699999999976543 234567999999999874 136789999999999999
Q ss_pred HhcCCCCCCCCCCchhHHHHHHHHHcCCCCCCchhhccCCHHHHHHHHHhcccCccccCChHHHHHHhhhhHHhh
Q psy11767 591 MLCGRVPFHARSRDDSALSIMARIKEGQFNFDAEAWSTVSSEAKELTKSLLTVNPAQRIRMMRVKLTFHAFHQAQ 665 (966)
Q Consensus 591 mltG~~Pf~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~is~e~~~Li~~~L~~dP~~R~t~~~v~~~~~~~~~~~ 665 (966)
|++|.+||.+.+. ..++..+..+.+.++...|..+|+++++||.+||..||.+|||+.++ ..|+|.+..
T Consensus 240 ll~g~~pf~~~~~----~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~R~t~~e~--l~h~~~~~~ 308 (504)
T 3q5i_A 240 LLCGYPPFGGQND----QDIIKKVEKGKYYFDFNDWKNISDEAKELIKLMLTYDYNKRCTAEEA--LNSRWIKKY 308 (504)
T ss_dssp HHHSSCSSCCSSH----HHHHHHHHHCCCCCCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHH--HTSHHHHHT
T ss_pred HHhCCCCCCCCCH----HHHHHHHHcCCCCCCccccCCCCHHHHHHHHHHcCCChhHCCCHHHH--hcCHhhhhc
Confidence 9999999987543 35667788888888888899999999999999999999999999976 457777543
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-42 Score=385.76 Aligned_cols=250 Identities=35% Similarity=0.589 Sum_probs=204.9
Q ss_pred eecccccccccccccccccccEEEEEEEcCCCcEEEEEEeccc------cChHHHHHHHHHhcCCCCceEEEEEEEeCCe
Q psy11767 372 FFEQYDMDLDKAGILGDGSYSVCRRCVEKSTGQEYAVKIISRK------IDCSEEINLLRACQGHPNIVNLHCVFQDEVH 445 (966)
Q Consensus 372 ~~~~~~i~~~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~------~~~~~Ei~iL~~l~~HpnIV~l~~~~~~~~~ 445 (966)
|.++|++ .+.||+|+||+||+|++..+++.||||++... ....+|+.+|+.+ +|||||++++++.++..
T Consensus 5 ~~~~y~i----~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~hpnIv~~~~~~~~~~~ 79 (323)
T 3tki_A 5 FVEDWDL----VQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKML-NHENVVKFYGHRREGNI 79 (323)
T ss_dssp TTTCEEE----EEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHHC-CCTTBCCEEEEEECSSE
T ss_pred Hhhhcee----eeEEecCCCEEEEEEEECCCCcEEEEEEEEcccccchHHHHHHHHHHHHhC-CCCCCCeEEEEEecCCe
Confidence 4455555 68999999999999999999999999998643 2356799999988 59999999999999999
Q ss_pred EEEEEEccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCcEEEecCCCCCEEEEeecccccc
Q psy11767 446 TYLVLELLKGGELLDRIRQKGRCGFTENEASRIMRQLVAAVHFMHSRGVVHRDLKPENLLFSDPAGDNIKVVDFGFACLK 525 (966)
Q Consensus 446 ~~lVmEy~~gg~L~~~l~~~~~~~l~e~~~~~i~~Qil~aL~yLHs~~IiHRDLKP~NILl~~~~~~~iKL~DFGla~~~ 525 (966)
.|+|||||+||+|.+++.... .+++.+++.++.||+.||+|||++||+||||||+|||++. .+.+||+|||+++..
T Consensus 80 ~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~i~~qi~~aL~~LH~~givH~Dlkp~NIll~~--~~~~kl~Dfg~a~~~ 155 (323)
T 3tki_A 80 QYLFLEYCSGGELFDRIEPDI--GMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDE--RDNLKISDFGLATVF 155 (323)
T ss_dssp EEEEEECCTTEEGGGGSBTTT--BCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECT--TCCEEECCCTTCEEC
T ss_pred EEEEEEcCCCCcHHHHHhhcC--CCCHHHHHHHHHHHHHHHHHHHHCCccccccchHHEEEeC--CCCEEEEEeecccee
Confidence 999999999999999986543 5999999999999999999999999999999999999975 568999999999754
Q ss_pred cC-----CCccccccccccCchhhccCCCCCCCcccchhhhhhhhhhhhcCCCCCCCcCcchhHHHHHHHHhcCCCCCCC
Q psy11767 526 RE-----SLHTPCFTLQYAAPEVLRQDKSGYDENCDLWSLGVILVNVLRQDKSGYDENCDLWSLGVILYTMLCGRVPFHA 600 (966)
Q Consensus 526 ~~-----~~~~~~gT~~Y~APEvl~~~~~~~~~~~Di~SlGvil~el~~~~~~~y~~~~DIWSlGvilyemltG~~Pf~~ 600 (966)
.. .....+||+.|+|||++... ..++.++|||||||++|+|++|+.||..
T Consensus 156 ~~~~~~~~~~~~~gt~~y~aPE~~~~~-------------------------~~~~~~~DiwslG~il~~ll~g~~pf~~ 210 (323)
T 3tki_A 156 RYNNRERLLNKMCGTLPYVAPELLKRR-------------------------EFHAEPVDVWSCGIVLTAMLAGELPWDQ 210 (323)
T ss_dssp EETTEECCBCSCCSCGGGSCHHHHHCS-------------------------SBCHHHHHHHHHHHHHHHHHHSSCSCSS
T ss_pred ccCCcccccCCCccCcCccCcHHhccC-------------------------CCCCCcccHHHHHHHHHHHHhCCCCCCC
Confidence 21 23456799999999998532 1236689999999999999999999987
Q ss_pred CCCchhHHHHHHHHHcCCCCCCchhhccCCHHHHHHHHHhcccCccccCChHHHHHHhhhhH
Q psy11767 601 RSRDDSALSIMARIKEGQFNFDAEAWSTVSSEAKELTKSLLTVNPAQRIRMMRVKLTFHAFH 662 (966)
Q Consensus 601 ~~~~~~~~~~~~~i~~~~~~~~~~~~~~is~e~~~Li~~~L~~dP~~R~t~~~v~~~~~~~~ 662 (966)
....... ...+...... ...+..+++++.+||.+||..||++|||+.++ ..|+|+
T Consensus 211 ~~~~~~~---~~~~~~~~~~--~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ei--l~h~~~ 265 (323)
T 3tki_A 211 PSDSCQE---YSDWKEKKTY--LNPWKKIDSAPLALLHKILVENPSARITIPDI--KKDRWY 265 (323)
T ss_dssp SCTTSHH---HHHHHTTCTT--STTGGGSCHHHHHHHHHHSCSSTTTSCCHHHH--TTCTTT
T ss_pred CchHHHH---HHHHhccccc--CCccccCCHHHHHHHHHHccCChhhCcCHHHH--hhChhh
Confidence 6543221 2222222222 22356789999999999999999999999876 345664
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-42 Score=393.63 Aligned_cols=248 Identities=31% Similarity=0.524 Sum_probs=207.6
Q ss_pred ccccccccccEEEEEEEcCCCcEEEEEEecccc-----ChHHHHHHHHHhcCCCCceEEEEEEEeCCeEEEEEEccCCCC
Q psy11767 383 AGILGDGSYSVCRRCVEKSTGQEYAVKIISRKI-----DCSEEINLLRACQGHPNIVNLHCVFQDEVHTYLVLELLKGGE 457 (966)
Q Consensus 383 ~~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~-----~~~~Ei~iL~~l~~HpnIV~l~~~~~~~~~~~lVmEy~~gg~ 457 (966)
.+.||+|+||.||+|.+..+|+.||||++.... ...+|+.+|+.+ +|||||++++++.+....|||||||+||+
T Consensus 94 ~~~lG~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~hpnIv~~~~~~~~~~~~~lv~E~~~~~~ 172 (373)
T 2x4f_A 94 TEILGGGRFGQVHKCEETATGLKLAAKIIKTRGMKDKEEVKNEISVMNQL-DHANLIQLYDAFESKNDIVLVMEYVDGGE 172 (373)
T ss_dssp EEECC-----CEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTC-CCTTBCCEEEEEECSSEEEEEEECCTTCE
T ss_pred ceEEecCcCEEEEEEEEcCCCcEEEEEEEcccccccHHHHHHHHHHHHhC-CCCCCCeEEEEEEECCEEEEEEeCCCCCc
Confidence 467999999999999999999999999997542 245799999988 59999999999999999999999999999
Q ss_pred HHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCcEEEecCCCCCEEEEeecccccccC--CCcccccc
Q psy11767 458 LLDRIRQKGRCGFTENEASRIMRQLVAAVHFMHSRGVVHRDLKPENLLFSDPAGDNIKVVDFGFACLKRE--SLHTPCFT 535 (966)
Q Consensus 458 L~~~l~~~~~~~l~e~~~~~i~~Qil~aL~yLHs~~IiHRDLKP~NILl~~~~~~~iKL~DFGla~~~~~--~~~~~~gT 535 (966)
|.+++..... .+++.+++.++.||+.||+|||++||+||||||+|||+.+...+.+||+|||+++.... .....+||
T Consensus 173 L~~~l~~~~~-~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~~~kl~DFG~a~~~~~~~~~~~~~gt 251 (373)
T 2x4f_A 173 LFDRIIDESY-NLTELDTILFMKQICEGIRHMHQMYILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPREKLKVNFGT 251 (373)
T ss_dssp EHHHHHHTGG-GCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEEETTTTEEEECCCSSCEECCTTCBCCCCCSS
T ss_pred HHHHHHhcCC-CCCHHHHHHHHHHHHHHHHHHHHCCcccccCCHHHEEEecCCCCcEEEEeCCCceecCCccccccccCC
Confidence 9999876432 58999999999999999999999999999999999999654567899999999976543 23445789
Q ss_pred ccccCchhhccCCCCCCCcccchhhhhhhhhhhhcCCCCCCCcCcchhHHHHHHHHhcCCCCCCCCCCchhHHHHHHHHH
Q psy11767 536 LQYAAPEVLRQDKSGYDENCDLWSLGVILVNVLRQDKSGYDENCDLWSLGVILYTMLCGRVPFHARSRDDSALSIMARIK 615 (966)
Q Consensus 536 ~~Y~APEvl~~~~~~~~~~~Di~SlGvil~el~~~~~~~y~~~~DIWSlGvilyemltG~~Pf~~~~~~~~~~~~~~~i~ 615 (966)
+.|+|||++.. ..|+.++|||||||++|+|++|+.||.+.+.. ..+..+.
T Consensus 252 ~~y~aPE~~~~--------------------------~~~~~~~DiwslG~il~elltg~~pf~~~~~~----~~~~~i~ 301 (373)
T 2x4f_A 252 PEFLAPEVVNY--------------------------DFVSFPTDMWSVGVIAYMLLSGLSPFLGDNDA----ETLNNIL 301 (373)
T ss_dssp CTTCCHHHHTT--------------------------CBCCHHHHHHHHHHHHHHHHHSSCTTCCSSHH----HHHHHHH
T ss_pred CcEeChhhccC--------------------------CCCCcHHhHHHHHHHHHHHHhCCCCCCCCCHH----HHHHHHH
Confidence 99999998852 23678899999999999999999999876532 3456667
Q ss_pred cCCCCCCchhhccCCHHHHHHHHHhcccCccccCChHHHHHHhhhhHHh
Q psy11767 616 EGQFNFDAEAWSTVSSEAKELTKSLLTVNPAQRIRMMRVKLTFHAFHQA 664 (966)
Q Consensus 616 ~~~~~~~~~~~~~is~e~~~Li~~~L~~dP~~R~t~~~v~~~~~~~~~~ 664 (966)
.+.+.+....+..+++++++||.+||+.||.+|||+.++ ..|+|+..
T Consensus 302 ~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rps~~e~--l~hp~~~~ 348 (373)
T 2x4f_A 302 ACRWDLEDEEFQDISEEAKEFISKLLIKEKSWRISASEA--LKHPWLSD 348 (373)
T ss_dssp HTCCCSCSGGGTTSCHHHHHHHHTTSCSSGGGSCCHHHH--HHSHHHHC
T ss_pred hccCCCChhhhccCCHHHHHHHHHHcCCChhhCCCHHHH--hcCcCcCC
Confidence 777777777788899999999999999999999999876 45677643
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-42 Score=387.18 Aligned_cols=259 Identities=31% Similarity=0.539 Sum_probs=212.9
Q ss_pred cceecccccccccccccccccccEEEEEEEcCCCcEEEEEEecccc-------ChHHHHHHHHHhcCCCCceEEEEEEEe
Q psy11767 370 SLFFEQYDMDLDKAGILGDGSYSVCRRCVEKSTGQEYAVKIISRKI-------DCSEEINLLRACQGHPNIVNLHCVFQD 442 (966)
Q Consensus 370 ~~~~~~~~i~~~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~-------~~~~Ei~iL~~l~~HpnIV~l~~~~~~ 442 (966)
..|.++|.+. .+.||+|+||+||+|.+..+|+.||||++.... ...+|+.+|+.+.+||||++++++|.+
T Consensus 24 ~~~~~~y~~~---~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~iv~~~~~~~~ 100 (327)
T 3lm5_A 24 ENFNNFYILT---SKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRVINLHEVYEN 100 (327)
T ss_dssp HHHHHHEEEE---EEEEEEETTEEEEEEEETTTCCEEEEEEEESEETTEECHHHHHHHHHHHHHTTTCTTBCCEEEEEEC
T ss_pred HhhhhEEeec---cceeCCCCCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHhccCCCCEEEEEEEEEe
Confidence 3455555552 268999999999999999999999999987532 245799999999889999999999999
Q ss_pred CCeEEEEEEccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCcEEEecCC-CCCEEEEeecc
Q psy11767 443 EVHTYLVLELLKGGELLDRIRQKGRCGFTENEASRIMRQLVAAVHFMHSRGVVHRDLKPENLLFSDPA-GDNIKVVDFGF 521 (966)
Q Consensus 443 ~~~~~lVmEy~~gg~L~~~l~~~~~~~l~e~~~~~i~~Qil~aL~yLHs~~IiHRDLKP~NILl~~~~-~~~iKL~DFGl 521 (966)
....|+|||||+||+|.+++.......+++.+++.++.||+.||+|||++||+||||||+|||++... .+.+||+|||+
T Consensus 101 ~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~ql~~~L~~LH~~givH~Dikp~NIl~~~~~~~~~~kL~Dfg~ 180 (327)
T 3lm5_A 101 TSEIILILEYAAGGEIFSLCLPELAEMVSENDVIRLIKQILEGVYYLHQNNIVHLDLKPQNILLSSIYPLGDIKIVDFGM 180 (327)
T ss_dssp SSEEEEEEECCTTEEGGGGGSSCC-CCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEESCBTTBCCEEECCGGG
T ss_pred CCeEEEEEEecCCCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeecCcCChHHEEEecCCCCCcEEEeeCcc
Confidence 99999999999999999998665445799999999999999999999999999999999999997421 46899999999
Q ss_pred cccccCC--CccccccccccCchhhccCCCCCCCcccchhhhhhhhhhhhcCCCCCCCcCcchhHHHHHHHHhcCCCCCC
Q psy11767 522 ACLKRES--LHTPCFTLQYAAPEVLRQDKSGYDENCDLWSLGVILVNVLRQDKSGYDENCDLWSLGVILYTMLCGRVPFH 599 (966)
Q Consensus 522 a~~~~~~--~~~~~gT~~Y~APEvl~~~~~~~~~~~Di~SlGvil~el~~~~~~~y~~~~DIWSlGvilyemltG~~Pf~ 599 (966)
+...... ....++|+.|+|||++.. ..|+.++|||||||++|+|++|+.||.
T Consensus 181 a~~~~~~~~~~~~~gt~~y~aPE~~~~--------------------------~~~~~~~DiwslG~il~~ll~g~~pf~ 234 (327)
T 3lm5_A 181 SRKIGHACELREIMGTPEYLAPEILNY--------------------------DPITTATDMWNIGIIAYMLLTHTSPFV 234 (327)
T ss_dssp CEEC---------CCCGGGCCHHHHTT--------------------------CCCCTHHHHHHHHHHHHHHHHSSCSSC
T ss_pred ccccCCccccccccCCcCccCCeeecC--------------------------CCCCchhhHHHHHHHHHHHHhCCCCCC
Confidence 9765432 334578999999999852 247889999999999999999999998
Q ss_pred CCCCchhHHHHHHHHHcCCCCCCchhhccCCHHHHHHHHHhcccCccccCChHHHHHHhhhhHH
Q psy11767 600 ARSRDDSALSIMARIKEGQFNFDAEAWSTVSSEAKELTKSLLTVNPAQRIRMMRVKLTFHAFHQ 663 (966)
Q Consensus 600 ~~~~~~~~~~~~~~i~~~~~~~~~~~~~~is~e~~~Li~~~L~~dP~~R~t~~~v~~~~~~~~~ 663 (966)
+.... .....+......+..+.+..+++++.+||.+||+.||++|||+.++ ..|+|++
T Consensus 235 ~~~~~----~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~~l--l~h~~~~ 292 (327)
T 3lm5_A 235 GEDNQ----ETYLNISQVNVDYSEETFSSVSQLATDFIQSLLVKNPEKRPTAEIC--LSHSWLQ 292 (327)
T ss_dssp CSSHH----HHHHHHHHTCCCCCTTTTTTSCHHHHHHHHHHSCSSGGGSCCHHHH--TTCGGGC
T ss_pred CCCch----HHHHHHHhcccccCchhhcccCHHHHHHHHHHcCCChhhCcCHHHH--hCCHhhc
Confidence 75533 3344555666666666777899999999999999999999999876 4566653
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-42 Score=401.21 Aligned_cols=252 Identities=29% Similarity=0.479 Sum_probs=206.4
Q ss_pred cccccccccccccEEEEEEEcCCCcEEEEEEeccc--------cChHHHHHHHHHhcCCCCceEEEEEEEeCCeEEEEEE
Q psy11767 380 LDKAGILGDGSYSVCRRCVEKSTGQEYAVKIISRK--------IDCSEEINLLRACQGHPNIVNLHCVFQDEVHTYLVLE 451 (966)
Q Consensus 380 ~~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~--------~~~~~Ei~iL~~l~~HpnIV~l~~~~~~~~~~~lVmE 451 (966)
|+..++||+|+||+||+|+++.+++.||||++.+. ....+|+.+|..+ +|||||+++++|.++..+|||||
T Consensus 76 y~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~~-~hp~Iv~l~~~~~~~~~~~lV~E 154 (437)
T 4aw2_A 76 FEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNG-DSKWITTLHYAFQDDNNLYLVMD 154 (437)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTTTCCHHHHHHHHHHS-CTTTBCCEEEEEECSSEEEEEEC
T ss_pred eEEEEEEEeCCCEEEEEEEEcCCCcEEEEEEEEHHHhhhHHHHHHHHHHHHHHHhC-CCCCEEEEEEEEeeCCEEEEEEe
Confidence 44478999999999999999999999999998642 1256799999887 69999999999999999999999
Q ss_pred ccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCcEEEecCCCCCEEEEeecccccccCC---
Q psy11767 452 LLKGGELLDRIRQKGRCGFTENEASRIMRQLVAAVHFMHSRGVVHRDLKPENLLFSDPAGDNIKVVDFGFACLKRES--- 528 (966)
Q Consensus 452 y~~gg~L~~~l~~~~~~~l~e~~~~~i~~Qil~aL~yLHs~~IiHRDLKP~NILl~~~~~~~iKL~DFGla~~~~~~--- 528 (966)
||+||+|.+++.+.. ..+++..++.++.||+.||+|||++|||||||||+|||++. ++.+||+|||+|+.....
T Consensus 155 y~~gg~L~~~l~~~~-~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKp~NILl~~--~g~vkL~DFGla~~~~~~~~~ 231 (437)
T 4aw2_A 155 YYVGGDLLTLLSKFE-DRLPEEMARFYLAEMVIAIDSVHQLHYVHRDIKPDNILMDM--NGHIRLADFGSCLKLMEDGTV 231 (437)
T ss_dssp CCTTCBHHHHHHTTT-TCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECT--TSCEEECCCTTCEECCTTSCE
T ss_pred cCCCCcHHHHHHHcc-CCCCHHHHHHHHHHHHHHHHHHHhCCeEecccCHHHeeEcC--CCCEEEcchhhhhhcccCCCc
Confidence 999999999998743 26999999999999999999999999999999999999974 569999999999754332
Q ss_pred -CccccccccccCchhhccCCCCCCCcccchhhhhhhhhhhhcCCCCCCCcCcchhHHHHHHHHhcCCCCCCCCCCchhH
Q psy11767 529 -LHTPCFTLQYAAPEVLRQDKSGYDENCDLWSLGVILVNVLRQDKSGYDENCDLWSLGVILYTMLCGRVPFHARSRDDSA 607 (966)
Q Consensus 529 -~~~~~gT~~Y~APEvl~~~~~~~~~~~Di~SlGvil~el~~~~~~~y~~~~DIWSlGvilyemltG~~Pf~~~~~~~~~ 607 (966)
....+||+.|+|||++.... .+...|+.++|||||||++|||++|++||.+.+..+.
T Consensus 232 ~~~~~~GT~~Y~APE~l~~~~---------------------~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~~~- 289 (437)
T 4aw2_A 232 QSSVAVGTPDYISPEILQAME---------------------GGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVET- 289 (437)
T ss_dssp ECCSCCSCGGGCCHHHHHHHH---------------------TSCCEECTHHHHHHHHHHHHHHHHSSCTTCCSSHHHH-
T ss_pred ccccccCCcCeeChHHHhhcc---------------------cCCCCCCCcCeeHHHHHHHHHHHhCCCCCCCCChhHH-
Confidence 23468999999999985211 1233578899999999999999999999987654433
Q ss_pred HHHHHHHHcC--CCCCCchhhccCCHHHHHHHHHhcccCccc--cCChHHHHHHhhhhHH
Q psy11767 608 LSIMARIKEG--QFNFDAEAWSTVSSEAKELTKSLLTVNPAQ--RIRMMRVKLTFHAFHQ 663 (966)
Q Consensus 608 ~~~~~~i~~~--~~~~~~~~~~~is~e~~~Li~~~L~~dP~~--R~t~~~v~~~~~~~~~ 663 (966)
+.+|... .+.++ ..+..+|+++++||++||..+|++ |+++.++ ..|+|+.
T Consensus 290 ---~~~i~~~~~~~~~p-~~~~~~s~~~~dLi~~lL~~~~~r~~r~~~~ei--l~Hpff~ 343 (437)
T 4aw2_A 290 ---YGKIMNHKERFQFP-TQVTDVSENAKDLIRRLICSREHRLGQNGIEDF--KKHPFFS 343 (437)
T ss_dssp ---HHHHHTHHHHCCCC-SSCCCSCHHHHHHHHTTSSCGGGCTTTTTTHHH--HTSGGGT
T ss_pred ---HHhhhhccccccCC-cccccCCHHHHHHHHHHhcccccccCCCCHHHH--hCCCccC
Confidence 3333321 12222 223468999999999999999888 8998876 4578764
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} SCOP: d.144.1.7 PDB: 2qkr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.8e-42 Score=379.91 Aligned_cols=259 Identities=28% Similarity=0.465 Sum_probs=205.4
Q ss_pred ccceecccccccccccccccccccEEEEEEEcCCCcEEEEEEecccc-------ChHHHHHHHHHhcCCCCceEEEEEEE
Q psy11767 369 GSLFFEQYDMDLDKAGILGDGSYSVCRRCVEKSTGQEYAVKIISRKI-------DCSEEINLLRACQGHPNIVNLHCVFQ 441 (966)
Q Consensus 369 G~~~~~~~~i~~~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~-------~~~~Ei~iL~~l~~HpnIV~l~~~~~ 441 (966)
++.+.++|.+ ++.||+|+||+||+|.+. +|+.||||++.... ...+|+++|+.+ +|||||++++++.
T Consensus 16 ~q~l~~~y~~----~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~hp~iv~~~~~~~ 89 (311)
T 3niz_A 16 FQGLMEKYQK----LEKVGEGTYGVVYKAKDS-QGRIVALKRIRLDAEDEGIPSTAIREISLLKEL-HHPNIVSLIDVIH 89 (311)
T ss_dssp EECSSCEEEE----EEEEEECSSCEEEEEEET-TSCEEEEEEEC------CHHHHHHHHHHHHHHC-CCTTBCCEEEEEC
T ss_pred ecchHhhhHh----hhhccCCCCeEEEEEEEC-CCCEEEEEEEecccccchhhHHHHHHHHHHHHc-CCCCEeeeeeEEc
Confidence 3445566665 688999999999999995 59999999986432 245799999998 5999999999999
Q ss_pred eCCeEEEEEEccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCcEEEecCCCCCEEEEeecc
Q psy11767 442 DEVHTYLVLELLKGGELLDRIRQKGRCGFTENEASRIMRQLVAAVHFMHSRGVVHRDLKPENLLFSDPAGDNIKVVDFGF 521 (966)
Q Consensus 442 ~~~~~~lVmEy~~gg~L~~~l~~~~~~~l~e~~~~~i~~Qil~aL~yLHs~~IiHRDLKP~NILl~~~~~~~iKL~DFGl 521 (966)
++...|+|||||+ |+|.+.+.... ..+++.+++.++.||+.||+|||++||+||||||+|||++. ++.+||+|||+
T Consensus 90 ~~~~~~lv~e~~~-~~l~~~~~~~~-~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~Dikp~NIl~~~--~~~~kl~Dfg~ 165 (311)
T 3niz_A 90 SERCLTLVFEFME-KDLKKVLDENK-TGLQDSQIKIYLYQLLRGVAHCHQHRILHRDLKPQNLLINS--DGALKLADFGL 165 (311)
T ss_dssp CSSCEEEEEECCS-EEHHHHHHTCT-TCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECT--TCCEEECCCTT
T ss_pred cCCEEEEEEcCCC-CCHHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCchHhEEECC--CCCEEEccCcC
Confidence 9999999999997 58888887654 36999999999999999999999999999999999999975 56899999999
Q ss_pred cccccC---CCccccccccccCchhhccCCCCCCCcccchhhhhhhhhhhhcCCCCCCCcCcchhHHHHHHHHhcCCCCC
Q psy11767 522 ACLKRE---SLHTPCFTLQYAAPEVLRQDKSGYDENCDLWSLGVILVNVLRQDKSGYDENCDLWSLGVILYTMLCGRVPF 598 (966)
Q Consensus 522 a~~~~~---~~~~~~gT~~Y~APEvl~~~~~~~~~~~Di~SlGvil~el~~~~~~~y~~~~DIWSlGvilyemltG~~Pf 598 (966)
|+.... .....++|+.|+|||++.. ...|+.++|||||||++|+|++|+.||
T Consensus 166 a~~~~~~~~~~~~~~~t~~y~aPE~~~~-------------------------~~~~~~~~DiwslG~il~~ll~g~~pf 220 (311)
T 3niz_A 166 ARAFGIPVRSYTHEVVTLWYRAPDVLMG-------------------------SKKYSTSVDIWSIGCIFAEMITGKPLF 220 (311)
T ss_dssp CEETTSCCC---CCCCCCTTCCHHHHTT-------------------------CCSCCTHHHHHHHHHHHHHHHHSSCSC
T ss_pred ceecCCCcccccCCcccCCcCCHHHhcC-------------------------CCCCCchHHhHHHHHHHHHHHhCCCCC
Confidence 976542 2334578999999999852 234788999999999999999999999
Q ss_pred CCCCCchhHHHHHHHHHcCCCC------------------CC----chhhccCCHHHHHHHHHhcccCccccCChHHHHH
Q psy11767 599 HARSRDDSALSIMARIKEGQFN------------------FD----AEAWSTVSSEAKELTKSLLTVNPAQRIRMMRVKL 656 (966)
Q Consensus 599 ~~~~~~~~~~~~~~~i~~~~~~------------------~~----~~~~~~is~e~~~Li~~~L~~dP~~R~t~~~v~~ 656 (966)
.+....+....+...+...... +. ....+.+++++++||.+||+.||++|||+.++
T Consensus 221 ~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~el-- 298 (311)
T 3niz_A 221 PGVTDDDQLPKIFSILGTPNPREWPQVQELPLWKQRTFQVFEKKPWSSIIPGFCQEGIDLLSNMLCFDPNKRISARDA-- 298 (311)
T ss_dssp CCSSTTTHHHHHHHHHCCCCTTTSGGGTTSHHHHSCCCCCCCCCCHHHHSTTCCHHHHHHHHHHSCSCTTTSCCHHHH--
T ss_pred CCCChHHHHHHHHHHHCCCChHHhhhhhccchhhhcccccccCCcHHHhCcccCHHHHHHHHHHcCCChhHCCCHHHH--
Confidence 9877665544444332211110 00 01223578899999999999999999999976
Q ss_pred HhhhhHHh
Q psy11767 657 TFHAFHQA 664 (966)
Q Consensus 657 ~~~~~~~~ 664 (966)
..|+|++.
T Consensus 299 l~hp~f~~ 306 (311)
T 3niz_A 299 MNHPYFKD 306 (311)
T ss_dssp HTSGGGTT
T ss_pred hcCccccc
Confidence 45777653
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-42 Score=405.73 Aligned_cols=254 Identities=39% Similarity=0.749 Sum_probs=218.1
Q ss_pred ceecccccccccccccccccccEEEEEEEcCCCcEEEEEEecccc-------ChHHHHHHHHHhcCCCCceEEEEEEEeC
Q psy11767 371 LFFEQYDMDLDKAGILGDGSYSVCRRCVEKSTGQEYAVKIISRKI-------DCSEEINLLRACQGHPNIVNLHCVFQDE 443 (966)
Q Consensus 371 ~~~~~~~i~~~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~-------~~~~Ei~iL~~l~~HpnIV~l~~~~~~~ 443 (966)
.+.++|.+ .+.||+|+||+||+|.+..+|+.||||++.... ...+|+.+|+.+ +|||||++++++.+.
T Consensus 19 ~~~~~y~~----~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~hpniv~~~~~~~~~ 93 (486)
T 3mwu_A 19 TFAERYNI----VCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKL-DHPNIMKLFEILEDS 93 (486)
T ss_dssp HHHHHEEE----EEEEECCSSSEEEEEEETTTCCEEEEEEEEHHHHBCSCHHHHHHHHHHHHHC-CCTTBCCEEEEEECS
T ss_pred ChhcceEE----eEEEeecCCEEEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHHHhC-CCCCcCeEEEEEEcC
Confidence 35566666 688999999999999999999999999985321 245799999998 599999999999999
Q ss_pred CeEEEEEEccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCcEEEecC-CCCCEEEEeeccc
Q psy11767 444 VHTYLVLELLKGGELLDRIRQKGRCGFTENEASRIMRQLVAAVHFMHSRGVVHRDLKPENLLFSDP-AGDNIKVVDFGFA 522 (966)
Q Consensus 444 ~~~~lVmEy~~gg~L~~~l~~~~~~~l~e~~~~~i~~Qil~aL~yLHs~~IiHRDLKP~NILl~~~-~~~~iKL~DFGla 522 (966)
...|+|||||.||+|.+.+.... .+++.+++.++.||+.||+|||++||+||||||+|||++.. ..+.+||+|||+|
T Consensus 94 ~~~~lv~e~~~~~~L~~~~~~~~--~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a 171 (486)
T 3mwu_A 94 SSFYIVGELYTGGELFDEIIKRK--RFSEHDAARIIKQVFSGITYMHKHNIVHRDLKPENILLESKEKDCDIKIIDFGLS 171 (486)
T ss_dssp SEEEEEECCCCSCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEESSSSTTCCEEECSCSCT
T ss_pred CEEEEEEEcCCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCeEeccCchHHEEEecCCCCCCEEEEECCcC
Confidence 99999999999999999998765 59999999999999999999999999999999999999642 2457999999999
Q ss_pred ccccC--CCccccccccccCchhhccCCCCCCCcccchhhhhhhhhhhhcCCCCCCCcCcchhHHHHHHHHhcCCCCCCC
Q psy11767 523 CLKRE--SLHTPCFTLQYAAPEVLRQDKSGYDENCDLWSLGVILVNVLRQDKSGYDENCDLWSLGVILYTMLCGRVPFHA 600 (966)
Q Consensus 523 ~~~~~--~~~~~~gT~~Y~APEvl~~~~~~~~~~~Di~SlGvil~el~~~~~~~y~~~~DIWSlGvilyemltG~~Pf~~ 600 (966)
+.... .....+||+.|+|||++.. .|+.++|||||||++|+|++|.+||.+
T Consensus 172 ~~~~~~~~~~~~~gt~~y~aPE~~~~---------------------------~~~~~~DiwslG~il~~ll~g~~pf~~ 224 (486)
T 3mwu_A 172 TCFQQNTKMKDRIGTAYYIAPEVLRG---------------------------TYDEKCDVWSAGVILYILLSGTPPFYG 224 (486)
T ss_dssp TTBCCC----CCTTGGGGCCGGGGGS---------------------------CCCHHHHHHHHHHHHHHHHHSSCSSCC
T ss_pred eECCCCCccCCCcCCCCCCCHHHhCC---------------------------CCCchhhHHHHHHHHHHHHhCCCCCCC
Confidence 76543 2345679999999998842 277899999999999999999999987
Q ss_pred CCCchhHHHHHHHHHcCCCCCCchhhccCCHHHHHHHHHhcccCccccCChHHHHHHhhhhHHh
Q psy11767 601 RSRDDSALSIMARIKEGQFNFDAEAWSTVSSEAKELTKSLLTVNPAQRIRMMRVKLTFHAFHQA 664 (966)
Q Consensus 601 ~~~~~~~~~~~~~i~~~~~~~~~~~~~~is~e~~~Li~~~L~~dP~~R~t~~~v~~~~~~~~~~ 664 (966)
.+. ..++..+..+.+.+..+.|..+|+++++||.+||..||.+|||+.++ ..|+|.+.
T Consensus 225 ~~~----~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~R~t~~~~--l~hp~~~~ 282 (486)
T 3mwu_A 225 KNE----YDILKRVETGKYAFDLPQWRTISDDAKDLIRKMLTFHPSLRITATQC--LEHPWIQK 282 (486)
T ss_dssp SSH----HHHHHHHHHTCCCSCSGGGGGSCHHHHHHHHHHTCSSTTTSCCHHHH--HHCHHHHH
T ss_pred CCH----HHHHHHHHhCCCCCCCcccCCCCHHHHHHHHHHcCCChhhCcCHHHH--hcCHhhcc
Confidence 543 34567788888888888889999999999999999999999999876 45777654
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-42 Score=392.84 Aligned_cols=254 Identities=31% Similarity=0.501 Sum_probs=192.5
Q ss_pred ecccccccccccccccccccEEEEEEEcCCCcEEEEEEeccccC-------hHHHHHHHHHhcCCCCceEEEEEEEeCC-
Q psy11767 373 FEQYDMDLDKAGILGDGSYSVCRRCVEKSTGQEYAVKIISRKID-------CSEEINLLRACQGHPNIVNLHCVFQDEV- 444 (966)
Q Consensus 373 ~~~~~i~~~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~~-------~~~Ei~iL~~l~~HpnIV~l~~~~~~~~- 444 (966)
.++|.+ .+.||+|+||+||+|.+..+|+.||||++.+... ..+|+.+|+.+.+|||||+++++|..++
T Consensus 8 ~~~y~~----~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~ 83 (388)
T 3oz6_A 8 LRKYEL----VKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTFREIMILTELSGHENIVNLLNVLRADND 83 (388)
T ss_dssp HTTEEE----EEC-------CEEEEEETTTCCEEEEEEECC--CCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECTTS
T ss_pred cCceEE----EEEeeeCCCeEEEEEEECCCCCEEEEEEecccccChHHHHHHHHHHHHHHhccCCCCCCeeeeEEecCCC
Confidence 345544 6899999999999999999999999999865322 3469999999978999999999998654
Q ss_pred -eEEEEEEccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCcEEEecCCCCCEEEEeecccc
Q psy11767 445 -HTYLVLELLKGGELLDRIRQKGRCGFTENEASRIMRQLVAAVHFMHSRGVVHRDLKPENLLFSDPAGDNIKVVDFGFAC 523 (966)
Q Consensus 445 -~~~lVmEy~~gg~L~~~l~~~~~~~l~e~~~~~i~~Qil~aL~yLHs~~IiHRDLKP~NILl~~~~~~~iKL~DFGla~ 523 (966)
..|+|||||+ |+|.+++... .+++..++.++.||+.||+|||++||+||||||+|||++. ++.+||+|||+|+
T Consensus 84 ~~~~lv~e~~~-~~L~~~~~~~---~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~--~~~~kl~DFG~a~ 157 (388)
T 3oz6_A 84 RDVYLVFDYME-TDLHAVIRAN---ILEPVHKQYVVYQLIKVIKYLHSGGLLHRDMKPSNILLNA--ECHVKVADFGLSR 157 (388)
T ss_dssp SCEEEEEECCS-EEHHHHHHHT---CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECT--TCCEEECCCTTCE
T ss_pred CEEEEEecccC-cCHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHhCCEEeCCCCHHHeEEcC--CCCEEecCCcccc
Confidence 7899999996 6899998764 5899999999999999999999999999999999999975 5689999999997
Q ss_pred cccC------------------------CCccccccccccCchhhccCCCCCCCcccchhhhhhhhhhhhcCCCCCCCcC
Q psy11767 524 LKRE------------------------SLHTPCFTLQYAAPEVLRQDKSGYDENCDLWSLGVILVNVLRQDKSGYDENC 579 (966)
Q Consensus 524 ~~~~------------------------~~~~~~gT~~Y~APEvl~~~~~~~~~~~Di~SlGvil~el~~~~~~~y~~~~ 579 (966)
.... .....+||++|+|||++.. ...|+.++
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-------------------------~~~~~~~~ 212 (388)
T 3oz6_A 158 SFVNIRRVTNNIPLSINENTENFDDDQPILTDYVATRWYRAPEILLG-------------------------STKYTKGI 212 (388)
T ss_dssp ESSSCCCCCCCGGGCCC---------------CCCGGGGCCHHHHTT-------------------------CCCCCTHH
T ss_pred cccccccccccccccccccccccccccccccCCcccCCcCCHHHhcC-------------------------CCCCCChh
Confidence 5321 1234578999999999852 23478899
Q ss_pred cchhHHHHHHHHhcCCCCCCCCCCchhHHHHHHHHHcCC---------------------------CCCCc---------
Q psy11767 580 DLWSLGVILYTMLCGRVPFHARSRDDSALSIMARIKEGQ---------------------------FNFDA--------- 623 (966)
Q Consensus 580 DIWSlGvilyemltG~~Pf~~~~~~~~~~~~~~~i~~~~---------------------------~~~~~--------- 623 (966)
|||||||++|+|++|++||.+.+..+....++..+.... .....
T Consensus 213 DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 292 (388)
T 3oz6_A 213 DMWSLGCILGEILCGKPIFPGSSTMNQLERIIGVIDFPSNEDVESIQSPFAKTMIESLKEKVEIRQSNKRDIFTKWKNLL 292 (388)
T ss_dssp HHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCHHHHHTSCCSSHHHHHHHHHHHCC-----CCCCHHHHHHHH
T ss_pred hHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHhccCHHHHHHHHhCcccccccCCCHHHhCcchhhhc
Confidence 999999999999999999998765443333332211000 00000
Q ss_pred ---hhhccCCHHHHHHHHHhcccCccccCChHHHHHHhhhhHH
Q psy11767 624 ---EAWSTVSSEAKELTKSLLTVNPAQRIRMMRVKLTFHAFHQ 663 (966)
Q Consensus 624 ---~~~~~is~e~~~Li~~~L~~dP~~R~t~~~v~~~~~~~~~ 663 (966)
..+..+++++.+||.+||+.||++|||+.++ ..|+|+.
T Consensus 293 ~~~~~~~~~~~~~~dll~~~L~~dP~~R~t~~e~--l~Hp~~~ 333 (388)
T 3oz6_A 293 LKINPKADCNEEALDLLDKLLQFNPNKRISANDA--LKHPFVS 333 (388)
T ss_dssp HHHCTTCCCCHHHHHHHHHHCCSSGGGSCCHHHH--TTSTTTT
T ss_pred ccccccccCCHHHHHHHHHhhccCcccCCCHHHH--hCCHHHH
Confidence 0112678999999999999999999999876 4567653
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.3e-42 Score=404.17 Aligned_cols=252 Identities=38% Similarity=0.690 Sum_probs=214.0
Q ss_pred eecccccccccccccccccccEEEEEEEcCCCcEEEEEEecccc-------ChHHHHHHHHHhcCCCCceEEEEEEEeCC
Q psy11767 372 FFEQYDMDLDKAGILGDGSYSVCRRCVEKSTGQEYAVKIISRKI-------DCSEEINLLRACQGHPNIVNLHCVFQDEV 444 (966)
Q Consensus 372 ~~~~~~i~~~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~-------~~~~Ei~iL~~l~~HpnIV~l~~~~~~~~ 444 (966)
+.++|.+ .+.||+|+||+||+|++..+++.||||++.+.. ...+|+.+|+.+ +|||||+++++|.+..
T Consensus 35 ~~~~y~~----~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l-~hpniv~~~~~~~~~~ 109 (494)
T 3lij_A 35 LSEMYQR----VKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLL-DHPNIMKLYDFFEDKR 109 (494)
T ss_dssp HHHHEEE----EEEEECC---EEEEEEETTTCCEEEEEEEEC-----CTTHHHHHHHHHHTTC-CCTTBCCEEEEEECSS
T ss_pred hhcCeEE----eeEEecCCCEEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHhC-CCCCCCeEEEEEEeCC
Confidence 3445555 689999999999999999999999999986532 245799999888 5999999999999999
Q ss_pred eEEEEEEccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCcEEEecCC-CCCEEEEeecccc
Q psy11767 445 HTYLVLELLKGGELLDRIRQKGRCGFTENEASRIMRQLVAAVHFMHSRGVVHRDLKPENLLFSDPA-GDNIKVVDFGFAC 523 (966)
Q Consensus 445 ~~~lVmEy~~gg~L~~~l~~~~~~~l~e~~~~~i~~Qil~aL~yLHs~~IiHRDLKP~NILl~~~~-~~~iKL~DFGla~ 523 (966)
..|+|||||+||+|.+++.... .+++..++.++.||+.||+|||++||+||||||+|||++... .+.+||+|||+|.
T Consensus 110 ~~~lv~e~~~~g~L~~~~~~~~--~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~kl~DfG~a~ 187 (494)
T 3lij_A 110 NYYLVMECYKGGELFDEIIHRM--KFNEVDAAVIIKQVLSGVTYLHKHNIVHRDLKPENLLLESKEKDALIKIVDFGLSA 187 (494)
T ss_dssp EEEEEEECCCSCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCSSTTCCEEECCCTTCE
T ss_pred EEEEEEecCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCCceeccCChhhEEEeCCCCCCcEEEEECCCCe
Confidence 9999999999999999998765 599999999999999999999999999999999999997532 3569999999997
Q ss_pred cccC--CCccccccccccCchhhccCCCCCCCcccchhhhhhhhhhhhcCCCCCCCcCcchhHHHHHHHHhcCCCCCCCC
Q psy11767 524 LKRE--SLHTPCFTLQYAAPEVLRQDKSGYDENCDLWSLGVILVNVLRQDKSGYDENCDLWSLGVILYTMLCGRVPFHAR 601 (966)
Q Consensus 524 ~~~~--~~~~~~gT~~Y~APEvl~~~~~~~~~~~Di~SlGvil~el~~~~~~~y~~~~DIWSlGvilyemltG~~Pf~~~ 601 (966)
.... .....+||+.|+|||++. ..|+.++|||||||++|+|++|.+||.+.
T Consensus 188 ~~~~~~~~~~~~gt~~y~aPE~l~---------------------------~~~~~~~DiwslG~il~~ll~g~~pf~~~ 240 (494)
T 3lij_A 188 VFENQKKMKERLGTAYYIAPEVLR---------------------------KKYDEKCDVWSIGVILFILLAGYPPFGGQ 240 (494)
T ss_dssp ECBTTBCBCCCCSCTTTCCHHHHT---------------------------TCBCTHHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred ECCCCccccccCCCcCeeCHHHHc---------------------------ccCCCchhHHHHHHHHHHHHhCCCCCCCC
Confidence 6543 234567999999999874 13788999999999999999999999875
Q ss_pred CCchhHHHHHHHHHcCCCCCCchhhccCCHHHHHHHHHhcccCccccCChHHHHHHhhhhHH
Q psy11767 602 SRDDSALSIMARIKEGQFNFDAEAWSTVSSEAKELTKSLLTVNPAQRIRMMRVKLTFHAFHQ 663 (966)
Q Consensus 602 ~~~~~~~~~~~~i~~~~~~~~~~~~~~is~e~~~Li~~~L~~dP~~R~t~~~v~~~~~~~~~ 663 (966)
+. ..++..+..+.+.+....|..+|+++++||.+||+.||.+|||+.++ ..|+|.+
T Consensus 241 ~~----~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~e~--l~hp~~~ 296 (494)
T 3lij_A 241 TD----QEILRKVEKGKYTFDSPEWKNVSEGAKDLIKQMLQFDSQRRISAQQA--LEHPWIK 296 (494)
T ss_dssp SH----HHHHHHHHHTCCCCCSGGGTTSCHHHHHHHHHHTCSSTTTSCCHHHH--HTCHHHH
T ss_pred CH----HHHHHHHHhCCCCCCchhcccCCHHHHHHHHHHCCCChhhCccHHHH--hcCcccc
Confidence 53 34667788888888888899999999999999999999999999976 4567764
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-42 Score=405.09 Aligned_cols=254 Identities=40% Similarity=0.714 Sum_probs=218.5
Q ss_pred ceecccccccccccccccccccEEEEEEEcCCCcEEEEEEecccc--------ChHHHHHHHHHhcCCCCceEEEEEEEe
Q psy11767 371 LFFEQYDMDLDKAGILGDGSYSVCRRCVEKSTGQEYAVKIISRKI--------DCSEEINLLRACQGHPNIVNLHCVFQD 442 (966)
Q Consensus 371 ~~~~~~~i~~~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~--------~~~~Ei~iL~~l~~HpnIV~l~~~~~~ 442 (966)
.+.++|.+ .+.||+|+||.||+|++..+|+.||||++.+.. ...+|+.+|+.+ +|||||+++++|.+
T Consensus 23 ~~~~~y~~----~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l-~hpniv~~~~~~~~ 97 (484)
T 3nyv_A 23 IFSDRYKG----QRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQL-DHPNIMKLYEFFED 97 (484)
T ss_dssp CHHHHEEE----EEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCBSSCHHHHHHHHHHHTTC-CCTTBCCEEEEEEC
T ss_pred cccCceEE----eeEEecCCCEEEEEEEECCCCCEEEEEEEEhhhcccchHHHHHHHHHHHHHhC-CCCCCCcEEEEEEe
Confidence 34556665 688999999999999999999999999986432 145799999988 59999999999999
Q ss_pred CCeEEEEEEccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCcEEEecC-CCCCEEEEeecc
Q psy11767 443 EVHTYLVLELLKGGELLDRIRQKGRCGFTENEASRIMRQLVAAVHFMHSRGVVHRDLKPENLLFSDP-AGDNIKVVDFGF 521 (966)
Q Consensus 443 ~~~~~lVmEy~~gg~L~~~l~~~~~~~l~e~~~~~i~~Qil~aL~yLHs~~IiHRDLKP~NILl~~~-~~~~iKL~DFGl 521 (966)
....|+|||||.||+|.+++.... .+++.+++.++.||+.||+|||++||+||||||+|||++.. ..+.+||+|||+
T Consensus 98 ~~~~~lv~e~~~~~~L~~~~~~~~--~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~ 175 (484)
T 3nyv_A 98 KGYFYLVGEVYTGGELFDEIISRK--RFSEVDAARIIRQVLSGITYMHKNKIVHRDLKPENLLLESKSKDANIRIIDFGL 175 (484)
T ss_dssp SSEEEEEECCCCSCBHHHHHHTCS--CCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESSSSTTCCEEECCTTH
T ss_pred CCEEEEEEecCCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEEecCCCCCcEEEEeeee
Confidence 999999999999999999997765 59999999999999999999999999999999999999532 356899999999
Q ss_pred cccccCC--CccccccccccCchhhccCCCCCCCcccchhhhhhhhhhhhcCCCCCCCcCcchhHHHHHHHHhcCCCCCC
Q psy11767 522 ACLKRES--LHTPCFTLQYAAPEVLRQDKSGYDENCDLWSLGVILVNVLRQDKSGYDENCDLWSLGVILYTMLCGRVPFH 599 (966)
Q Consensus 522 a~~~~~~--~~~~~gT~~Y~APEvl~~~~~~~~~~~Di~SlGvil~el~~~~~~~y~~~~DIWSlGvilyemltG~~Pf~ 599 (966)
|+..... ....+||+.|+|||++.. .|+.++|||||||++|+|++|.+||.
T Consensus 176 a~~~~~~~~~~~~~gt~~y~aPE~~~~---------------------------~~~~~~DiwslG~il~~ll~g~~pf~ 228 (484)
T 3nyv_A 176 STHFEASKKMKDKIGTAYYIAPEVLHG---------------------------TYDEKCDVWSTGVILYILLSGCPPFN 228 (484)
T ss_dssp HHHBCCCCSHHHHTTGGGTCCHHHHHT---------------------------CCCTHHHHHHHHHHHHHHHHSSCSSC
T ss_pred eEEcccccccccCCCCccccCceeecC---------------------------CCCCcceeHHHHHHHHHHHHCCCCCC
Confidence 9765432 234578999999998842 37889999999999999999999998
Q ss_pred CCCCchhHHHHHHHHHcCCCCCCchhhccCCHHHHHHHHHhcccCccccCChHHHHHHhhhhHHh
Q psy11767 600 ARSRDDSALSIMARIKEGQFNFDAEAWSTVSSEAKELTKSLLTVNPAQRIRMMRVKLTFHAFHQA 664 (966)
Q Consensus 600 ~~~~~~~~~~~~~~i~~~~~~~~~~~~~~is~e~~~Li~~~L~~dP~~R~t~~~v~~~~~~~~~~ 664 (966)
+.+. ..++..+..+.+.+..+.|..+|+++++||.+||+.||.+|||+.++ ..|+|.+.
T Consensus 229 ~~~~----~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~e~--l~h~~~~~ 287 (484)
T 3nyv_A 229 GANE----YDILKKVEKGKYTFELPQWKKVSESAKDLIRKMLTYVPSMRISARDA--LDHEWIQT 287 (484)
T ss_dssp CSSH----HHHHHHHHHCCCCCCSGGGGGSCHHHHHHHHHHTCSSGGGSCCHHHH--HTSHHHHH
T ss_pred CCCH----HHHHHHHHcCCCCCCCcccccCCHHHHHHHHHHCCCChhHCcCHHHH--hhChhhcc
Confidence 7543 34667788888888888889999999999999999999999999976 45777653
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.1e-42 Score=375.66 Aligned_cols=252 Identities=25% Similarity=0.403 Sum_probs=201.8
Q ss_pred cccceecccccccccccccccccccEEEEEEEcCCCcEEEEEEecccc--------ChHHHHHHHHHhcCCCCceEEEEE
Q psy11767 368 KGSLFFEQYDMDLDKAGILGDGSYSVCRRCVEKSTGQEYAVKIISRKI--------DCSEEINLLRACQGHPNIVNLHCV 439 (966)
Q Consensus 368 ~G~~~~~~~~i~~~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~--------~~~~Ei~iL~~l~~HpnIV~l~~~ 439 (966)
.|..+.++|.+ .+.||+|+||.||+|.+..+++.||||++.... ...+|+.+++.+ +||||++++++
T Consensus 5 ~g~~~~~~y~i----~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l-~hp~iv~~~~~ 79 (294)
T 4eqm_A 5 IGKIINERYKI----VDKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQL-SHQNIVSMIDV 79 (294)
T ss_dssp CSSCEETTEEE----EEEEEEETTEEEEEEEETTTCSEEEEEEEECCSSCCHHHHHHHHHHHHHHTTC-CBTTBCCEEEE
T ss_pred hhhHhhccEEE----EEEEccCCCEEEEEEEECCCCCeEEEEEeccCccccHHHHHHHHHHHHHHhcC-CCCCCceEEEe
Confidence 35556677766 688999999999999999999999999985422 134688888888 59999999999
Q ss_pred EEeCCeEEEEEEccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCcEEEecCCCCCEEEEee
Q psy11767 440 FQDEVHTYLVLELLKGGELLDRIRQKGRCGFTENEASRIMRQLVAAVHFMHSRGVVHRDLKPENLLFSDPAGDNIKVVDF 519 (966)
Q Consensus 440 ~~~~~~~~lVmEy~~gg~L~~~l~~~~~~~l~e~~~~~i~~Qil~aL~yLHs~~IiHRDLKP~NILl~~~~~~~iKL~DF 519 (966)
+.++...|+||||++|++|.+++...+ .+++.+++.++.||+.||+|||++||+||||||+|||++. ++.+||+||
T Consensus 80 ~~~~~~~~lv~e~~~g~~L~~~l~~~~--~~~~~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~Nil~~~--~~~~kl~Df 155 (294)
T 4eqm_A 80 DEEDDCYYLVMEYIEGPTLSEYIESHG--PLSVDTAINFTNQILDGIKHAHDMRIVHRDIKPQNILIDS--NKTLKIFDF 155 (294)
T ss_dssp EECSSEEEEEEECCCSCBHHHHHHHHC--SCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECT--TSCEEECCC
T ss_pred eeeCCeEEEEEeCCCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECC--CCCEEEEeC
Confidence 999999999999999999999998765 5999999999999999999999999999999999999975 568999999
Q ss_pred cccccccCC----CccccccccccCchhhccCCCCCCCcccchhhhhhhhhhhhcCCCCCCCcCcchhHHHHHHHHhcCC
Q psy11767 520 GFACLKRES----LHTPCFTLQYAAPEVLRQDKSGYDENCDLWSLGVILVNVLRQDKSGYDENCDLWSLGVILYTMLCGR 595 (966)
Q Consensus 520 Gla~~~~~~----~~~~~gT~~Y~APEvl~~~~~~~~~~~Di~SlGvil~el~~~~~~~y~~~~DIWSlGvilyemltG~ 595 (966)
|++...... ....+||+.|+|||++.. ..++.++|||||||++|+|++|+
T Consensus 156 g~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--------------------------~~~~~~~Di~slG~~l~~ll~g~ 209 (294)
T 4eqm_A 156 GIAKALSETSLTQTNHVLGTVQYFSPEQAKG--------------------------EATDECTDIYSIGIVLYEMLVGE 209 (294)
T ss_dssp SSSTTC-------------CCSSCCHHHHHT--------------------------CCCCTTHHHHHHHHHHHHHHHSS
T ss_pred CCccccccccccccCccccCccccCHhHhcC--------------------------CCCCchHhHHHHHHHHHHHHhCC
Confidence 999765432 234568999999999853 23678899999999999999999
Q ss_pred CCCCCCCCchhHHHHHHHHHcCCCCCCchhhccCCHHHHHHHHHhcccCccccC-ChHHHHHH
Q psy11767 596 VPFHARSRDDSALSIMARIKEGQFNFDAEAWSTVSSEAKELTKSLLTVNPAQRI-RMMRVKLT 657 (966)
Q Consensus 596 ~Pf~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~is~e~~~Li~~~L~~dP~~R~-t~~~v~~~ 657 (966)
.||.+....+ .....+..............+++.+.++|.+||+.||++|| ++.++...
T Consensus 210 ~pf~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~R~~~~~~l~~~ 269 (294)
T 4eqm_A 210 PPFNGETAVS---IAIKHIQDSVPNVTTDVRKDIPQSLSNVILRATEKDKANRYKTIQEMKDD 269 (294)
T ss_dssp CSSCSSCHHH---HHHHHHSSCCCCHHHHSCTTSCHHHHHHHHHHSCSSGGGSCSSHHHHHHH
T ss_pred CCCCCCChHH---HHHHHhhccCCCcchhcccCCCHHHHHHHHHHhcCCHhHccccHHHHHHH
Confidence 9998765332 12233333322222334467899999999999999999999 55555433
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.6e-42 Score=395.09 Aligned_cols=253 Identities=30% Similarity=0.488 Sum_probs=203.8
Q ss_pred cccccccccccccEEEEEEEcCCCcEEEEEEeccc--------cChHHHHHHHHHhcCCCCceEEEEEEEeCCeEEEEEE
Q psy11767 380 LDKAGILGDGSYSVCRRCVEKSTGQEYAVKIISRK--------IDCSEEINLLRACQGHPNIVNLHCVFQDEVHTYLVLE 451 (966)
Q Consensus 380 ~~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~--------~~~~~Ei~iL~~l~~HpnIV~l~~~~~~~~~~~lVmE 451 (966)
|+..++||+|+||+||+|+++.+|+.||||++.+. ....+|+.+|..+ +|||||+++++|+++.++|||||
T Consensus 63 f~~~~~lG~G~fG~V~~~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~il~~~-~hp~Iv~l~~~~~~~~~~~lVmE 141 (412)
T 2vd5_A 63 FEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNG-DRRWITQLHFAFQDENYLYLVME 141 (412)
T ss_dssp EEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHGGGCCHHHHHHHHHHS-CTTTBCCEEEEEECSSEEEEEEC
T ss_pred EEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhc-CCCCeeeEEEEEeeCCEEEEEEc
Confidence 44578999999999999999999999999999642 2356799999887 69999999999999999999999
Q ss_pred ccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCcEEEecCCCCCEEEEeecccccccCC---
Q psy11767 452 LLKGGELLDRIRQKGRCGFTENEASRIMRQLVAAVHFMHSRGVVHRDLKPENLLFSDPAGDNIKVVDFGFACLKRES--- 528 (966)
Q Consensus 452 y~~gg~L~~~l~~~~~~~l~e~~~~~i~~Qil~aL~yLHs~~IiHRDLKP~NILl~~~~~~~iKL~DFGla~~~~~~--- 528 (966)
||+||+|.+++.+.+. .+++..++.++.||+.||+|||++||+||||||+|||++. .+++||+|||+|+.....
T Consensus 142 ~~~gg~L~~~l~~~~~-~l~~~~~~~~~~qi~~aL~~LH~~giiHrDLKp~NILld~--~g~vkL~DFGla~~~~~~~~~ 218 (412)
T 2vd5_A 142 YYVGGDLLTLLSKFGE-RIPAEMARFYLAEIVMAIDSVHRLGYVHRDIKPDNILLDR--CGHIRLADFGSCLKLRADGTV 218 (412)
T ss_dssp CCCSCBHHHHHHHHSS-CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECT--TSCEEECCCTTCEECCTTSCE
T ss_pred CCCCCcHHHHHHhcCC-CCCHHHHHHHHHHHHHHHHHHHHCCeeecccCHHHeeecC--CCCEEEeechhheeccCCCcc
Confidence 9999999999987643 5999999999999999999999999999999999999975 569999999999765432
Q ss_pred -CccccccccccCchhhccCCCCCCCcccchhhhhhhhhhhhcCCCCCCCcCcchhHHHHHHHHhcCCCCCCCCCCchhH
Q psy11767 529 -LHTPCFTLQYAAPEVLRQDKSGYDENCDLWSLGVILVNVLRQDKSGYDENCDLWSLGVILYTMLCGRVPFHARSRDDSA 607 (966)
Q Consensus 529 -~~~~~gT~~Y~APEvl~~~~~~~~~~~Di~SlGvil~el~~~~~~~y~~~~DIWSlGvilyemltG~~Pf~~~~~~~~~ 607 (966)
....+||+.|+|||++..... ......|+.++|||||||++|||++|++||.+.+..+
T Consensus 219 ~~~~~~Gt~~Y~APE~l~~~~~-------------------~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~-- 277 (412)
T 2vd5_A 219 RSLVAVGTPDYLSPEILQAVGG-------------------GPGTGSYGPECDWWALGVFAYEMFYGQTPFYADSTAE-- 277 (412)
T ss_dssp ECSSCCSCGGGCCHHHHHHHHT-------------------CTTCSEECTHHHHHHHHHHHHHHHHSSCTTCCSSHHH--
T ss_pred ccceeccccCcCCHHHHhhccc-------------------CcCCCCCChHHhhhHHhHHHHHHHhCCCCCCCCCHHH--
Confidence 234689999999999863110 0012347889999999999999999999998765433
Q ss_pred HHHHHHHHcCC--CCCCchhhccCCHHHHHHHHHhcccCccccC---ChHHHHHHhhhhHH
Q psy11767 608 LSIMARIKEGQ--FNFDAEAWSTVSSEAKELTKSLLTVNPAQRI---RMMRVKLTFHAFHQ 663 (966)
Q Consensus 608 ~~~~~~i~~~~--~~~~~~~~~~is~e~~~Li~~~L~~dP~~R~---t~~~v~~~~~~~~~ 663 (966)
.+.+|.... +.++ .....+|+++++||.+||. +|.+|+ ++.++ ..|+|+.
T Consensus 278 --~~~~i~~~~~~~~~p-~~~~~~s~~~~dli~~lL~-~p~~Rlgr~~~~ei--~~Hpff~ 332 (412)
T 2vd5_A 278 --TYGKIVHYKEHLSLP-LVDEGVPEEARDFIQRLLC-PPETRLGRGGAGDF--RTHPFFF 332 (412)
T ss_dssp --HHHHHHTHHHHCCCC-----CCCHHHHHHHHTTSS-CGGGCTTTTTHHHH--HTSGGGT
T ss_pred --HHHHHHhcccCcCCC-ccccCCCHHHHHHHHHHcC-ChhhcCCCCCHHHH--hcCCCcC
Confidence 333333211 1121 1234689999999999999 999995 67665 5677764
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-41 Score=374.28 Aligned_cols=255 Identities=24% Similarity=0.344 Sum_probs=203.6
Q ss_pred CCcccccccceecccccccccccccccccccEEEEEEEcCCCcEEEEEEeccccC-------hHHHHHHHHHhcCCCCce
Q psy11767 362 NFDKIFKGSLFFEQYDMDLDKAGILGDGSYSVCRRCVEKSTGQEYAVKIISRKID-------CSEEINLLRACQGHPNIV 434 (966)
Q Consensus 362 ~~d~if~G~~~~~~~~i~~~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~~-------~~~Ei~iL~~l~~HpnIV 434 (966)
.++....+..+.++|++ .++||+|+||+||+|++..+|+.||||++..... ...|+..+..+.+|||||
T Consensus 45 ~~~p~~~~~~~~~~y~~----~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~~~~~~~h~~iv 120 (311)
T 3p1a_A 45 GYDPSRPESFFQQSFQR----LSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHPCCV 120 (311)
T ss_dssp TCCTTSSSCHHHHHEEE----EEEEEEETTEEEEEEEETTTSCEEEEEEESSSCCSHHHHHHHHHHHHHHHHHCCCTTBC
T ss_pred CCCCCCccchhhhheee----eheeccCCCeEEEEEEECCCCeEEEEEEecccccChHHHHHHHHHHHHHHHhcCCCcEE
Confidence 33334445555566555 6889999999999999999999999999865432 223555666666799999
Q ss_pred EEEEEEEeCCeEEEEEEccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCcEEEecCCCCCE
Q psy11767 435 NLHCVFQDEVHTYLVLELLKGGELLDRIRQKGRCGFTENEASRIMRQLVAAVHFMHSRGVVHRDLKPENLLFSDPAGDNI 514 (966)
Q Consensus 435 ~l~~~~~~~~~~~lVmEy~~gg~L~~~l~~~~~~~l~e~~~~~i~~Qil~aL~yLHs~~IiHRDLKP~NILl~~~~~~~i 514 (966)
+++++|.++...||||||| +++|.+++...+. .+++..++.++.||+.||+|||++||+||||||+|||++. ++.+
T Consensus 121 ~l~~~~~~~~~~~lv~e~~-~~~L~~~~~~~~~-~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIll~~--~~~~ 196 (311)
T 3p1a_A 121 RLEQAWEEGGILYLQTELC-GPSLQQHCEAWGA-SLPEAQVWGYLRDTLLALAHLHSQGLVHLDVKPANIFLGP--RGRC 196 (311)
T ss_dssp CEEEEEEETTEEEEEEECC-CCBHHHHHHHHCS-CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECG--GGCE
T ss_pred EEEEEEEeCCEEEEEEecc-CCCHHHHHHhcCC-CCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEECC--CCCE
Confidence 9999999999999999999 7899999887653 6999999999999999999999999999999999999975 5689
Q ss_pred EEEeecccccccCC--CccccccccccCchhhccCCCCCCCcccchhhhhhhhhhhhcCCCCCCCcCcchhHHHHHHHHh
Q psy11767 515 KVVDFGFACLKRES--LHTPCFTLQYAAPEVLRQDKSGYDENCDLWSLGVILVNVLRQDKSGYDENCDLWSLGVILYTML 592 (966)
Q Consensus 515 KL~DFGla~~~~~~--~~~~~gT~~Y~APEvl~~~~~~~~~~~Di~SlGvil~el~~~~~~~y~~~~DIWSlGvilyeml 592 (966)
||+|||++...... ....+||+.|+|||++.. .|+.++|||||||++|+|+
T Consensus 197 kl~DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~~---------------------------~~~~~~DiwslG~il~el~ 249 (311)
T 3p1a_A 197 KLGDFGLLVELGTAGAGEVQEGDPRYMAPELLQG---------------------------SYGTAADVFSLGLTILEVA 249 (311)
T ss_dssp EECCCTTCEECC------CCCCCGGGCCGGGGGT---------------------------CCSTHHHHHHHHHHHHHHH
T ss_pred EEccceeeeecccCCCCcccCCCccccCHhHhcC---------------------------CCCchhhHHHHHHHHHHHH
Confidence 99999999765432 234568999999998742 3678999999999999999
Q ss_pred cCCCCCCCCCCchhHHHHHHHHHcCCCCCCchhhccCCHHHHHHHHHhcccCccccCChHHHHHHhhhhH
Q psy11767 593 CGRVPFHARSRDDSALSIMARIKEGQFNFDAEAWSTVSSEAKELTKSLLTVNPAQRIRMMRVKLTFHAFH 662 (966)
Q Consensus 593 tG~~Pf~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~is~e~~~Li~~~L~~dP~~R~t~~~v~~~~~~~~ 662 (966)
+|..||... .....+..+. ...+.+..+++++.+||.+||+.||++|||+.++ ..|+|.
T Consensus 250 ~g~~~~~~~-------~~~~~~~~~~--~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~el--l~hp~~ 308 (311)
T 3p1a_A 250 CNMELPHGG-------EGWQQLRQGY--LPPEFTAGLSSELRSVLVMMLEPDPKLRATAEAL--LALPVL 308 (311)
T ss_dssp HTCCCCSSH-------HHHHHHTTTC--CCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHH--HTSGGG
T ss_pred hCCCCCCCc-------cHHHHHhccC--CCcccccCCCHHHHHHHHHHcCCChhhCcCHHHH--HhCccc
Confidence 997766542 1233344433 2344556789999999999999999999999976 346664
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} SCOP: d.144.1.7 PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-41 Score=369.63 Aligned_cols=251 Identities=27% Similarity=0.411 Sum_probs=197.2
Q ss_pred ccccccccccccEEEEEEEcCCCcEEEEEEeccccC-------hHHHHHHHHHhcCCCCceEEEEEEEeCCeEEEEEEcc
Q psy11767 381 DKAGILGDGSYSVCRRCVEKSTGQEYAVKIISRKID-------CSEEINLLRACQGHPNIVNLHCVFQDEVHTYLVLELL 453 (966)
Q Consensus 381 ~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~~-------~~~Ei~iL~~l~~HpnIV~l~~~~~~~~~~~lVmEy~ 453 (966)
+..+.||+|+||+||+|.+..+|+.||||++..... ..+|+.+|+.+ +|||||++++++.++...|+|||||
T Consensus 5 ~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~e~~ 83 (292)
T 3o0g_A 5 EKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKEL-KHKNIVRLHDVLHSDKKLTLVFEFC 83 (292)
T ss_dssp EEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTC-CCTTBCCEEEEEEETTEEEEEEECC
T ss_pred eeeeEecCCCCeEEEEEEECCCCceEEEEeeeccCCcCCcchHHHHHHHHHhcC-CCCCEeeEEeEEEeCCEEEEEEecC
Confidence 346889999999999999999999999999964321 34699999888 5999999999999999999999999
Q ss_pred CCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCcEEEecCCCCCEEEEeecccccccC---CCc
Q psy11767 454 KGGELLDRIRQKGRCGFTENEASRIMRQLVAAVHFMHSRGVVHRDLKPENLLFSDPAGDNIKVVDFGFACLKRE---SLH 530 (966)
Q Consensus 454 ~gg~L~~~l~~~~~~~l~e~~~~~i~~Qil~aL~yLHs~~IiHRDLKP~NILl~~~~~~~iKL~DFGla~~~~~---~~~ 530 (966)
++ +|.+.+.... ..+++.+++.++.||+.||+|||++||+||||||+|||++. ++.+||+|||++..... ...
T Consensus 84 ~~-~l~~~~~~~~-~~l~~~~~~~~~~ql~~~l~~lH~~~ivH~dikp~Nil~~~--~~~~kl~Dfg~~~~~~~~~~~~~ 159 (292)
T 3o0g_A 84 DQ-DLKKYFDSCN-GDLDPEIVKSFLFQLLKGLGFCHSRNVLHRDLKPQNLLINR--NGELKLANFGLARAFGIPVRCYS 159 (292)
T ss_dssp SE-EHHHHHHHTT-TCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECT--TSCEEECCCTTCEECCSCCSCCC
T ss_pred CC-CHHHHHHhCC-CCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcC--CCCEEEeecccceecCCcccccc
Confidence 64 6777766543 36999999999999999999999999999999999999975 56899999999976542 234
Q ss_pred cccccccccCchhhccCCCCCCCcccchhhhhhhhhhhhcCCCCCCCcCcchhHHHHHHHHhcCCCCCCCCCCchhHHHH
Q psy11767 531 TPCFTLQYAAPEVLRQDKSGYDENCDLWSLGVILVNVLRQDKSGYDENCDLWSLGVILYTMLCGRVPFHARSRDDSALSI 610 (966)
Q Consensus 531 ~~~gT~~Y~APEvl~~~~~~~~~~~Di~SlGvil~el~~~~~~~y~~~~DIWSlGvilyemltG~~Pf~~~~~~~~~~~~ 610 (966)
..++|+.|+|||++.. ...|+.++|||||||++|+|++|..||............
T Consensus 160 ~~~~t~~y~aPE~~~~-------------------------~~~~~~~~DiwslG~il~~l~~~~~p~~~~~~~~~~~~~ 214 (292)
T 3o0g_A 160 AEVVTLWYRPPDVLFG-------------------------AKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKR 214 (292)
T ss_dssp SCCSCGGGCCHHHHTT-------------------------CSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHHHHH
T ss_pred CCccccCCcChHHHcC-------------------------CCCcCchHHHHHHHHHHHHHHHcCCCCcCCCCHHHHHHH
Confidence 4578999999999852 223788999999999999999988886544433222222
Q ss_pred HHHHHcCCCC----------------------CCchhhccCCHHHHHHHHHhcccCccccCChHHHHHHhhhhHH
Q psy11767 611 MARIKEGQFN----------------------FDAEAWSTVSSEAKELTKSLLTVNPAQRIRMMRVKLTFHAFHQ 663 (966)
Q Consensus 611 ~~~i~~~~~~----------------------~~~~~~~~is~e~~~Li~~~L~~dP~~R~t~~~v~~~~~~~~~ 663 (966)
+......... ......+.+++++++||.+||+.||++|||+.++ ..|+|+.
T Consensus 215 i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~--l~hp~f~ 287 (292)
T 3o0g_A 215 IFRLLGTPTEEQWPSMTKLPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEA--LQHPYFS 287 (292)
T ss_dssp HHHHHCCCCTTTCTTGGGSTTCCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHH--HTSGGGT
T ss_pred HHHHhCCCChhhhhhhcccccccccccccCCcchhhcccccChHHHHHHHHHhccChhhCCCHHHH--hcCcccc
Confidence 2111110000 0001223578999999999999999999999976 4577754
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-41 Score=368.24 Aligned_cols=248 Identities=41% Similarity=0.692 Sum_probs=211.9
Q ss_pred cccccccccccEEEEEEEcCCCcEEEEEEeccccC-------hHHHHHHHHHhcCCCCceEEEEEEEeCCeEEEEEEccC
Q psy11767 382 KAGILGDGSYSVCRRCVEKSTGQEYAVKIISRKID-------CSEEINLLRACQGHPNIVNLHCVFQDEVHTYLVLELLK 454 (966)
Q Consensus 382 ~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~~-------~~~Ei~iL~~l~~HpnIV~l~~~~~~~~~~~lVmEy~~ 454 (966)
..+.||+|+||.||+|.+..+|+.||+|++..... ..+|+.+++.+ +||||+++++++.++...|+||||++
T Consensus 10 ~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~~v~e~~~ 88 (284)
T 3kk8_A 10 VKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKL-QHPNIVRLHDSIQEESFHYLVFDLVT 88 (284)
T ss_dssp EEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCHHHHHHHHHHHHHHHHC-CCTTBCCEEEEEECSSEEEEEECCCC
T ss_pred hhhhhcCcCCeEEEEEEEcCCCceEEEEEeecccCCHHHHHHHHHHHHHHHHc-CCCCcCeEEEEEEcCCEEEEEEecCC
Confidence 36889999999999999999999999999965432 34689999998 59999999999999999999999999
Q ss_pred CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCcEEEecCC-CCCEEEEeecccccccCC--Ccc
Q psy11767 455 GGELLDRIRQKGRCGFTENEASRIMRQLVAAVHFMHSRGVVHRDLKPENLLFSDPA-GDNIKVVDFGFACLKRES--LHT 531 (966)
Q Consensus 455 gg~L~~~l~~~~~~~l~e~~~~~i~~Qil~aL~yLHs~~IiHRDLKP~NILl~~~~-~~~iKL~DFGla~~~~~~--~~~ 531 (966)
+++|.+.+.... .+++..+..++.||+.||+|||++||+||||||+|||++... .+.+||+|||++...... ...
T Consensus 89 ~~~l~~~~~~~~--~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~~~~~~~kl~Dfg~~~~~~~~~~~~~ 166 (284)
T 3kk8_A 89 GGELFEDIVARE--FYSEADASHCIQQILESIAYCHSNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAWHG 166 (284)
T ss_dssp SCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEESSSSTTCCEEECCCTTCEECCSSCBCCC
T ss_pred CCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCcCcCCCCHHHEEEecCCCCCcEEEeeceeeEEcccCccccC
Confidence 999999998765 599999999999999999999999999999999999997532 245999999999765432 234
Q ss_pred ccccccccCchhhccCCCCCCCcccchhhhhhhhhhhhcCCCCCCCcCcchhHHHHHHHHhcCCCCCCCCCCchhHHHHH
Q psy11767 532 PCFTLQYAAPEVLRQDKSGYDENCDLWSLGVILVNVLRQDKSGYDENCDLWSLGVILYTMLCGRVPFHARSRDDSALSIM 611 (966)
Q Consensus 532 ~~gT~~Y~APEvl~~~~~~~~~~~Di~SlGvil~el~~~~~~~y~~~~DIWSlGvilyemltG~~Pf~~~~~~~~~~~~~ 611 (966)
..+|+.|+|||++.. ..|+.++|||||||++|+|++|+.||.+... ....
T Consensus 167 ~~~~~~y~aPE~~~~--------------------------~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~----~~~~ 216 (284)
T 3kk8_A 167 FAGTPGYLSPEVLKK--------------------------DPYSKPVDIWACGVILYILLVGYPPFWDEDQ----HRLY 216 (284)
T ss_dssp SCSCGGGCCHHHHTT--------------------------CCBCTHHHHHHHHHHHHHHHHSSCSSCCSSH----HHHH
T ss_pred CCCCcCCcCchhhcC--------------------------CCCCcccchHHHHHHHHHHHHCCCCCCCCch----hHHH
Confidence 578999999999852 2367889999999999999999999987543 2455
Q ss_pred HHHHcCCCCCCchhhccCCHHHHHHHHHhcccCccccCChHHHHHHhhhhHHh
Q psy11767 612 ARIKEGQFNFDAEAWSTVSSEAKELTKSLLTVNPAQRIRMMRVKLTFHAFHQA 664 (966)
Q Consensus 612 ~~i~~~~~~~~~~~~~~is~e~~~Li~~~L~~dP~~R~t~~~v~~~~~~~~~~ 664 (966)
..+..+.+.++...+..+++++.+||.+||+.||++|||+.++ ..|+|...
T Consensus 217 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~--l~h~~~~~ 267 (284)
T 3kk8_A 217 AQIKAGAYDYPSPEWDTVTPEAKSLIDSMLTVNPKKRITADQA--LKVPWICN 267 (284)
T ss_dssp HHHHHTCCCCCTTTTTTSCHHHHHHHHHHSCSSTTTSCCHHHH--TTSHHHHS
T ss_pred HHHHhccccCCchhhcccCHHHHHHHHHHcccChhhCCCHHHH--hcCccccC
Confidence 6677777777777778899999999999999999999999976 45677643
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-41 Score=378.67 Aligned_cols=250 Identities=20% Similarity=0.216 Sum_probs=203.5
Q ss_pred ccccccccccccEEEEEEEcCCCcEEEEEEecccc---ChHHHHHHHHHhcCCCCceEEEEEEEeCCeEEEEEEccCCCC
Q psy11767 381 DKAGILGDGSYSVCRRCVEKSTGQEYAVKIISRKI---DCSEEINLLRACQGHPNIVNLHCVFQDEVHTYLVLELLKGGE 457 (966)
Q Consensus 381 ~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~---~~~~Ei~iL~~l~~HpnIV~l~~~~~~~~~~~lVmEy~~gg~ 457 (966)
+..+.||+|+||.||+|.+..+|+.||||++.... ...+|+.+|+.+.+||||+++++++.++...|+||||+ +++
T Consensus 12 ~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~lv~e~~-~~~ 90 (330)
T 2izr_A 12 RVGKKIGCGNFGELRLGKNLYTNEYVAIKLEPMKSRAPQLHLEYRFYKQLGSGDGIPQVYYFGPCGKYNAMVLELL-GPS 90 (330)
T ss_dssp EEEEECCC-CTTSEEEEEETTTTEEEEEEEEETTCSSCCHHHHHHHHHHHCSCTTSCCEEEEEEETTEEEEEEECC-CCB
T ss_pred EEEEEeeccCCceEEEEEECCCCcEEEEEEeccccchHHHHHHHHHHHHhhCCCCCCEEEEEEecCCccEEEEEeC-CCC
Confidence 34688999999999999999999999999986442 46789999999977999999999999999999999999 999
Q ss_pred HHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCcEEEecCCC---CCEEEEeecccccccCC------
Q psy11767 458 LLDRIRQKGRCGFTENEASRIMRQLVAAVHFMHSRGVVHRDLKPENLLFSDPAG---DNIKVVDFGFACLKRES------ 528 (966)
Q Consensus 458 L~~~l~~~~~~~l~e~~~~~i~~Qil~aL~yLHs~~IiHRDLKP~NILl~~~~~---~~iKL~DFGla~~~~~~------ 528 (966)
|.+++.... ..+++.+++.++.||+.||+|||++||+||||||+|||++.... ..+||+|||+|+.....
T Consensus 91 L~~~~~~~~-~~~~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~Nill~~~~~~~~~~~kl~DFg~a~~~~~~~~~~~~ 169 (330)
T 2izr_A 91 LEDLFDLCD-RTFSLKTVLMIAIQLISRMEYVHSKNLIYRDVKPENFLIGRPGNKTQQVIHIIDFALAKEYIDPETKKHI 169 (330)
T ss_dssp HHHHHHHTT-TCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECCGGGTCTTSEEECCCTTCEESBCTTTCCBC
T ss_pred HHHHHHHcC-CCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeeeccCCCCCCceEEEEEcccceeeecCCCCccc
Confidence 999998653 36999999999999999999999999999999999999975221 12999999999764321
Q ss_pred ----CccccccccccCchhhccCCCCCCCcccchhhhhhhhhhhhcCCCCCCCcCcchhHHHHHHHHhcCCCCCCCCCCc
Q psy11767 529 ----LHTPCFTLQYAAPEVLRQDKSGYDENCDLWSLGVILVNVLRQDKSGYDENCDLWSLGVILYTMLCGRVPFHARSRD 604 (966)
Q Consensus 529 ----~~~~~gT~~Y~APEvl~~~~~~~~~~~Di~SlGvil~el~~~~~~~y~~~~DIWSlGvilyemltG~~Pf~~~~~~ 604 (966)
....+||+.|+|||++.. ..|+.++|||||||++|+|++|+.||.+....
T Consensus 170 ~~~~~~~~~gt~~y~aPE~~~~--------------------------~~~~~~~Di~slG~il~ell~g~~Pf~~~~~~ 223 (330)
T 2izr_A 170 PYREHKSLTGTARYMSINTHLG--------------------------KEQSRRDDLEALGHMFMYFLRGSLPWQGLKAD 223 (330)
T ss_dssp CCCCCCCCCSCTTTCCHHHHTT--------------------------CCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCS
T ss_pred cccccCCcCCCccccChHHHcC--------------------------CCCCchhHHHHHHHHHHHHhcCCCCccccccc
Confidence 135678999999999853 34788999999999999999999999886543
Q ss_pred hhHHHHHHHHHcCCCCCCchhhccCCHHHHHHHHHhcccCccccCChHHHHHHhh
Q psy11767 605 DSALSIMARIKEGQFNFDAEAWSTVSSEAKELTKSLLTVNPAQRIRMMRVKLTFH 659 (966)
Q Consensus 605 ~~~~~~~~~i~~~~~~~~~~~~~~is~e~~~Li~~~L~~dP~~R~t~~~v~~~~~ 659 (966)
+ ....+..+.........+......+++.++|.+||..||.+||++.++...+.
T Consensus 224 ~-~~~~~~~i~~~~~~~~~~~~~~~~p~~~~li~~~l~~~p~~RP~~~~l~~~l~ 277 (330)
T 2izr_A 224 T-LKERYQKIGDTKRATPIEVLCENFPEMATYLRYVRRLDFFEKPDYDYLRKLFT 277 (330)
T ss_dssp S-HHHHHHHHHHHHHHSCHHHHTTTCHHHHHHHHHHHHCCTTCCCCHHHHHHHHH
T ss_pred c-HHHHHHHHHhhhccCCHHHHhccChHHHHHHHHHHhCCCCCCCCHHHHHHHHH
Confidence 3 23344444443333333333333449999999999999999999998865444
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-41 Score=376.54 Aligned_cols=253 Identities=26% Similarity=0.438 Sum_probs=192.5
Q ss_pred cccccccccccccEEEEEEEcCCCcEEEEEEecccc------ChHHHHHHHHHhcCCCCceEEEEEEEeCCeEEEEEEcc
Q psy11767 380 LDKAGILGDGSYSVCRRCVEKSTGQEYAVKIISRKI------DCSEEINLLRACQGHPNIVNLHCVFQDEVHTYLVLELL 453 (966)
Q Consensus 380 ~~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~------~~~~Ei~iL~~l~~HpnIV~l~~~~~~~~~~~lVmEy~ 453 (966)
|+.++.||+|+||.||+|.+..+|+.||||++.... ...+|+.+|+.+ +|||||++++++.+++..|+|||||
T Consensus 7 y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l-~hp~iv~~~~~~~~~~~~~lv~e~~ 85 (317)
T 2pmi_A 7 FKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGTPSTAIREISLMKEL-KHENIVRLYDVIHTENKLTLVFEFM 85 (317)
T ss_dssp ------------CEEEEEECSSSCCEEEEEEEECCSTTCSCHHHHHHHHHHTTC-CBTTBCCEEEEECCTTEEEEEEECC
T ss_pred eeEeeEECCCCCEEEEEEEECCCCcEEEEEEeecccccccHHHHHHHHHHHHhc-CCCCcceEEEEEEECCeEEEEEEec
Confidence 344789999999999999999999999999986432 245799999988 5999999999999999999999999
Q ss_pred CCCCHHHHHHhcC----CCCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCcEEEecCCCCCEEEEeecccccccC--
Q psy11767 454 KGGELLDRIRQKG----RCGFTENEASRIMRQLVAAVHFMHSRGVVHRDLKPENLLFSDPAGDNIKVVDFGFACLKRE-- 527 (966)
Q Consensus 454 ~gg~L~~~l~~~~----~~~l~e~~~~~i~~Qil~aL~yLHs~~IiHRDLKP~NILl~~~~~~~iKL~DFGla~~~~~-- 527 (966)
+ |+|.+++.... ...+++..++.++.||+.||+|||++||+||||||+|||++. ++.+||+|||+++....
T Consensus 86 ~-~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~ivH~Dlkp~NIl~~~--~~~~kl~Dfg~~~~~~~~~ 162 (317)
T 2pmi_A 86 D-NDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCHENKILHRDLKPQNLLINK--RGQLKLGDFGLARAFGIPV 162 (317)
T ss_dssp C-CBHHHHHHHHHSSSCCCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECT--TCCEEECCCSSCEETTSCC
T ss_pred C-CCHHHHHHhccccccccCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCChHHeEEcC--CCCEEECcCccceecCCCc
Confidence 7 69999987642 135899999999999999999999999999999999999975 56899999999976542
Q ss_pred -CCccccccccccCchhhccCCCCCCCcccchhhhhhhhhhhhcCCCCCCCcCcchhHHHHHHHHhcCCCCCCCCCCchh
Q psy11767 528 -SLHTPCFTLQYAAPEVLRQDKSGYDENCDLWSLGVILVNVLRQDKSGYDENCDLWSLGVILYTMLCGRVPFHARSRDDS 606 (966)
Q Consensus 528 -~~~~~~gT~~Y~APEvl~~~~~~~~~~~Di~SlGvil~el~~~~~~~y~~~~DIWSlGvilyemltG~~Pf~~~~~~~~ 606 (966)
.....++|+.|+|||++.. ...|+.++|||||||++|+|++|+.||.+.+..+.
T Consensus 163 ~~~~~~~~t~~y~aPE~~~~-------------------------~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~ 217 (317)
T 2pmi_A 163 NTFSSEVVTLWYRAPDVLMG-------------------------SRTYSTSIDIWSCGCILAEMITGKPLFPGTNDEEQ 217 (317)
T ss_dssp CCCCCCCSCCTTCCHHHHTT-------------------------CCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHH
T ss_pred ccCCCCcccccccCchHhhC-------------------------CCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHH
Confidence 2335578999999999852 22478899999999999999999999987665433
Q ss_pred HHHHHHHHHcCCCC----------C----------------CchhhccCCHHHHHHHHHhcccCccccCChHHHHHHhhh
Q psy11767 607 ALSIMARIKEGQFN----------F----------------DAEAWSTVSSEAKELTKSLLTVNPAQRIRMMRVKLTFHA 660 (966)
Q Consensus 607 ~~~~~~~i~~~~~~----------~----------------~~~~~~~is~e~~~Li~~~L~~dP~~R~t~~~v~~~~~~ 660 (966)
...+...+...... + .......+++++++||.+||+.||++|||+.++ ..|+
T Consensus 218 ~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~e~--l~hp 295 (317)
T 2pmi_A 218 LKLIFDIMGTPNESLWPSVTKLPKYNPNIQQRPPRDLRQVLQPHTKEPLDGNLMDFLHGLLQLNPDMRLSAKQA--LHHP 295 (317)
T ss_dssp HHHHHHHHCSCCTTTCGGGGGCTTCCTTCCCCCCCCSHHHHGGGCSSCCCHHHHHHHHHHSCSSGGGSCCHHHH--TTSG
T ss_pred HHHHHHHhCCCChhHhhhhhhhhhcccccccccchhHHHhhcccccccCCHHHHHHHHHHCCCCcccCCCHHHH--hCCh
Confidence 33332222110000 0 001112578999999999999999999999876 4567
Q ss_pred hHH
Q psy11767 661 FHQ 663 (966)
Q Consensus 661 ~~~ 663 (966)
|+.
T Consensus 296 ~f~ 298 (317)
T 2pmi_A 296 WFA 298 (317)
T ss_dssp GGG
T ss_pred hhh
Confidence 654
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.1e-42 Score=408.44 Aligned_cols=249 Identities=29% Similarity=0.510 Sum_probs=209.7
Q ss_pred cccccccccccccEEEEEEEcCCCcEEEEEEecccc--------ChHHHHHHHHHhcCCCCceEEEEEEEeCCeEEEEEE
Q psy11767 380 LDKAGILGDGSYSVCRRCVEKSTGQEYAVKIISRKI--------DCSEEINLLRACQGHPNIVNLHCVFQDEVHTYLVLE 451 (966)
Q Consensus 380 ~~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~--------~~~~Ei~iL~~l~~HpnIV~l~~~~~~~~~~~lVmE 451 (966)
|+..++||+|+||.||+|+++.+|+.||||++.+.. ...+|+.+|+.+ +|||||+++++|++....|||||
T Consensus 186 f~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~l~k~~~~~~~~~~~~~~E~~iL~~l-~hp~Iv~l~~~~~~~~~l~lVmE 264 (576)
T 2acx_A 186 FRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKV-NSRFVVSLAYAYETKDALCLVLT 264 (576)
T ss_dssp EEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHC-CCTTBCCEEEEEECSSEEEEEEC
T ss_pred eEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhHhhhhhHHHHHHHHHHHHHHHc-CCCCEeeEEEEEeeCCEEEEEEE
Confidence 344688999999999999999999999999986431 145799999998 59999999999999999999999
Q ss_pred ccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCcEEEecCCCCCEEEEeecccccccC--CC
Q psy11767 452 LLKGGELLDRIRQKGRCGFTENEASRIMRQLVAAVHFMHSRGVVHRDLKPENLLFSDPAGDNIKVVDFGFACLKRE--SL 529 (966)
Q Consensus 452 y~~gg~L~~~l~~~~~~~l~e~~~~~i~~Qil~aL~yLHs~~IiHRDLKP~NILl~~~~~~~iKL~DFGla~~~~~--~~ 529 (966)
||+||+|.+++...+...+++..++.++.||+.||+|||++||+||||||+|||++. ++.+||+|||+|+.... ..
T Consensus 265 y~~gg~L~~~l~~~~~~~l~e~~~~~i~~qIl~aL~yLH~~gIvHrDLKPeNILld~--~g~vKL~DFGla~~~~~~~~~ 342 (576)
T 2acx_A 265 LMNGGDLKFHIYHMGQAGFPEARAVFYAAEICCGLEDLHRERIVYRDLKPENILLDD--HGHIRISDLGLAVHVPEGQTI 342 (576)
T ss_dssp CCCSCBHHHHHHSSSSCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECT--TSCEEECCCTTCEECCTTCCE
T ss_pred cCCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeccCCchheEEEeC--CCCeEEEecccceecccCccc
Confidence 999999999998766556999999999999999999999999999999999999974 56999999999976543 23
Q ss_pred ccccccccccCchhhccCCCCCCCcccchhhhhhhhhhhhcCCCCCCCcCcchhHHHHHHHHhcCCCCCCCCCCchhHHH
Q psy11767 530 HTPCFTLQYAAPEVLRQDKSGYDENCDLWSLGVILVNVLRQDKSGYDENCDLWSLGVILYTMLCGRVPFHARSRDDSALS 609 (966)
Q Consensus 530 ~~~~gT~~Y~APEvl~~~~~~~~~~~Di~SlGvil~el~~~~~~~y~~~~DIWSlGvilyemltG~~Pf~~~~~~~~~~~ 609 (966)
...+||+.|+|||++.. ..|+.++|||||||++|+|++|++||.+.........
T Consensus 343 ~~~~GT~~Y~APEvl~~--------------------------~~~~~~~DiwSLGvilyeLltG~~PF~~~~~~~~~~~ 396 (576)
T 2acx_A 343 KGRVGTVGYMAPEVVKN--------------------------ERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREE 396 (576)
T ss_dssp ECCCSCGGGCCHHHHTT--------------------------CEESSHHHHHHHHHHHHHHHHSSCSSSCSSSCCCHHH
T ss_pred cccCCCccccCHHHHcC--------------------------CCCCccchHHHHHHHHHHHHhCCCCCcccccchhHHH
Confidence 45689999999999853 2378899999999999999999999988654433344
Q ss_pred HHHHHHcCCCCCCchhhccCCHHHHHHHHHhcccCccccC-----ChHHHHHHhhhhHH
Q psy11767 610 IMARIKEGQFNFDAEAWSTVSSEAKELTKSLLTVNPAQRI-----RMMRVKLTFHAFHQ 663 (966)
Q Consensus 610 ~~~~i~~~~~~~~~~~~~~is~e~~~Li~~~L~~dP~~R~-----t~~~v~~~~~~~~~ 663 (966)
+...+......++ ..+|+++++||.+||+.||.+|| ++.++ ..|+|++
T Consensus 397 i~~~i~~~~~~~p----~~~s~~~~dLI~~lL~~dP~~R~g~~~~sa~ei--l~HpfF~ 449 (576)
T 2acx_A 397 VERLVKEVPEEYS----ERFSPQARSLCSQLLCKDPAERLGCRGGSAREV--KEHPLFK 449 (576)
T ss_dssp HHHHHHHCCCCCC----TTSCHHHHHHHHHHTCSSGGGSTTCSSSHHHHH--HTSGGGT
T ss_pred HHHHhhcccccCC----ccCCHHHHHHHHHhccCCHHHcCCCCCCCHHHH--HhChhhc
Confidence 5555665544433 46899999999999999999999 45544 5677764
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-41 Score=404.52 Aligned_cols=251 Identities=29% Similarity=0.478 Sum_probs=210.2
Q ss_pred cccccccccccccEEEEEEEcCCCcEEEEEEecccc--------ChHHHHHHHHHhcCCCCceEEEEEEEeCCeEEEEEE
Q psy11767 380 LDKAGILGDGSYSVCRRCVEKSTGQEYAVKIISRKI--------DCSEEINLLRACQGHPNIVNLHCVFQDEVHTYLVLE 451 (966)
Q Consensus 380 ~~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~--------~~~~Ei~iL~~l~~HpnIV~l~~~~~~~~~~~lVmE 451 (966)
|...++||+|+||+||+|+++.+|+.||||++.+.. ...+|+.+|+.+ +|||||+++++|++...+|+|||
T Consensus 187 f~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l-~hp~Iv~l~~~~~~~~~l~lVmE 265 (543)
T 3c4z_A 187 FLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKV-HSRFIVSLAYAFETKTDLCLVMT 265 (543)
T ss_dssp EEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHC-CCTTBCCEEEEEECSSEEEEEEC
T ss_pred eEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEEhHHhhhhHHHHHHHHHHHHHHhc-CCCCEeeEEEEEeeCCEEEEEEE
Confidence 344688999999999999999999999999996431 245699999988 59999999999999999999999
Q ss_pred ccCCCCHHHHHHhcC--CCCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCcEEEecCCCCCEEEEeecccccccCC-
Q psy11767 452 LLKGGELLDRIRQKG--RCGFTENEASRIMRQLVAAVHFMHSRGVVHRDLKPENLLFSDPAGDNIKVVDFGFACLKRES- 528 (966)
Q Consensus 452 y~~gg~L~~~l~~~~--~~~l~e~~~~~i~~Qil~aL~yLHs~~IiHRDLKP~NILl~~~~~~~iKL~DFGla~~~~~~- 528 (966)
||+||+|.+++.... ...+++..++.++.||+.||+|||++||+||||||+|||++. ++.+||+|||+++.....
T Consensus 266 ~~~gg~L~~~l~~~~~~~~~l~e~~~~~~~~qi~~aL~~LH~~gIvHrDLKP~NILl~~--~g~vkL~DFGla~~~~~~~ 343 (543)
T 3c4z_A 266 IMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQRNIIYRDLKPENVLLDD--DGNVRISDLGLAVELKAGQ 343 (543)
T ss_dssp CCTTCBHHHHHHTSSTTSCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECT--TSCEEECCCTTCEECCTTC
T ss_pred eccCCCHHHHHHHhhcccccccHHHHHHHHHHHHHHHHHHHHcCCcccCCChHHEEEeC--CCCEEEeecceeeeccCCC
Confidence 999999999997654 336999999999999999999999999999999999999975 569999999999765432
Q ss_pred --CccccccccccCchhhccCCCCCCCcccchhhhhhhhhhhhcCCCCCCCcCcchhHHHHHHHHhcCCCCCCCCCCchh
Q psy11767 529 --LHTPCFTLQYAAPEVLRQDKSGYDENCDLWSLGVILVNVLRQDKSGYDENCDLWSLGVILYTMLCGRVPFHARSRDDS 606 (966)
Q Consensus 529 --~~~~~gT~~Y~APEvl~~~~~~~~~~~Di~SlGvil~el~~~~~~~y~~~~DIWSlGvilyemltG~~Pf~~~~~~~~ 606 (966)
....+||+.|+|||++.. ..|+.++|||||||++|||++|++||.+......
T Consensus 344 ~~~~~~~GT~~Y~APE~l~~--------------------------~~~~~~~DiwSlGvilyelltG~~PF~~~~~~~~ 397 (543)
T 3c4z_A 344 TKTKGYAGTPGFMAPELLLG--------------------------EEYDFSVDYFALGVTLYEMIAARGPFRARGEKVE 397 (543)
T ss_dssp CCBCCCCSCTTTSCHHHHTT--------------------------CCBCTHHHHHHHHHHHHHHHHSSCSSCCTTCCCC
T ss_pred cccccccCCccccChhhhcC--------------------------CCCChHHhcCcchHHHHHHHhCCCCCCCCccchh
Confidence 234589999999999852 3478899999999999999999999987654333
Q ss_pred HHHHHHHHHcCCCCCCchhhccCCHHHHHHHHHhcccCccccCChHH---HHHHhhhhHH
Q psy11767 607 ALSIMARIKEGQFNFDAEAWSTVSSEAKELTKSLLTVNPAQRIRMMR---VKLTFHAFHQ 663 (966)
Q Consensus 607 ~~~~~~~i~~~~~~~~~~~~~~is~e~~~Li~~~L~~dP~~R~t~~~---v~~~~~~~~~ 663 (966)
...+...+..+...++ ..+++++++||.+||+.||++||++.+ -....|+|++
T Consensus 398 ~~~~~~~i~~~~~~~p----~~~s~~~~~li~~lL~~dP~~R~~~~~~~a~ei~~Hpff~ 453 (543)
T 3c4z_A 398 NKELKQRVLEQAVTYP----DKFSPASKDFCEALLQKDPEKRLGFRDGSCDGLRTHPLFR 453 (543)
T ss_dssp HHHHHHHHHHCCCCCC----TTSCHHHHHHHHHHSCSSGGGSCCCBTTBSHHHHTSGGGT
T ss_pred HHHHHHHHhhcccCCC----cccCHHHHHHHHHhccCCHhHCCCCcccCHHHHHcCcccc
Confidence 4456666666655543 468999999999999999999998632 2345677764
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-42 Score=385.06 Aligned_cols=263 Identities=36% Similarity=0.709 Sum_probs=188.4
Q ss_pred ceecccccccccccccccccccEEEEEEEcCCCcEEEEEEeccccChHHHHHHHHHhcCCCCceEEEEEEEe----CCeE
Q psy11767 371 LFFEQYDMDLDKAGILGDGSYSVCRRCVEKSTGQEYAVKIISRKIDCSEEINLLRACQGHPNIVNLHCVFQD----EVHT 446 (966)
Q Consensus 371 ~~~~~~~i~~~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~~~~~Ei~iL~~l~~HpnIV~l~~~~~~----~~~~ 446 (966)
.+.++|.+. .++||+|+||+||+|.+..+|+.||||++.......+|+..+....+||||+++++++.. +...
T Consensus 25 ~~~~~y~i~---~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~ 101 (336)
T 3fhr_A 25 AVTDDYQLS---KQVLGLGVNGKVLECFHRRTGQKCALKLLYDSPKARQEVDHHWQASGGPHIVCILDVYENMHHGKRCL 101 (336)
T ss_dssp CGGGTEEEE---EEEEEEETTEEEEEEEETTTCCEEEEEEEESSHHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEE
T ss_pred cccceeEec---ceeeeeCCCeEEEEEEECCCCCEEEEEEecCcHHHHHHHHHHHHhcCCCChHHHHHHHhhccCCCceE
Confidence 344556552 246999999999999999999999999997765566677666666689999999999986 4568
Q ss_pred EEEEEccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCcEEEecCC-CCCEEEEeecccccc
Q psy11767 447 YLVLELLKGGELLDRIRQKGRCGFTENEASRIMRQLVAAVHFMHSRGVVHRDLKPENLLFSDPA-GDNIKVVDFGFACLK 525 (966)
Q Consensus 447 ~lVmEy~~gg~L~~~l~~~~~~~l~e~~~~~i~~Qil~aL~yLHs~~IiHRDLKP~NILl~~~~-~~~iKL~DFGla~~~ 525 (966)
|+|||||+||+|.+++.......+++.+++.++.||+.||+|||++||+||||||+|||++... .+.+||+|||++...
T Consensus 102 ~lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~ivH~dlkp~NIll~~~~~~~~~kl~Dfg~~~~~ 181 (336)
T 3fhr_A 102 LIIMECMEGGELFSRIQERGDQAFTEREAAEIMRDIGTAIQFLHSHNIAHRDVKPENLLYTSKEKDAVLKLTDFGFAKET 181 (336)
T ss_dssp EEEEECCTTEEHHHHHHTC-CCCCBHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCSSTTCCEEECCCTTCEEC
T ss_pred EEEEeccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEEecCCCceEEEeccccceec
Confidence 9999999999999999877655799999999999999999999999999999999999997532 456999999999765
Q ss_pred cC-CCccccccccccCchhhccCCCCCCCcccchhhhhhhhhhhhcCCCCCCCcCcchhHHHHHHHHhcCCCCCCCCCCc
Q psy11767 526 RE-SLHTPCFTLQYAAPEVLRQDKSGYDENCDLWSLGVILVNVLRQDKSGYDENCDLWSLGVILYTMLCGRVPFHARSRD 604 (966)
Q Consensus 526 ~~-~~~~~~gT~~Y~APEvl~~~~~~~~~~~Di~SlGvil~el~~~~~~~y~~~~DIWSlGvilyemltG~~Pf~~~~~~ 604 (966)
.. .....++|+.|+|||++.. ..|+.++|||||||++|+|++|+.||......
T Consensus 182 ~~~~~~~~~~t~~y~aPE~~~~--------------------------~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~ 235 (336)
T 3fhr_A 182 TQNALQTPCYTPYYVAPEVLGP--------------------------EKYDKSCDMWSLGVIMYILLCGFPPFYSNTGQ 235 (336)
T ss_dssp ------------------------------------------------CHHHHHHHHHHHHHHHHHHHHSSCCC------
T ss_pred cccccccCCCCcCccChhhhCC--------------------------CCCCchhhHHHHHHHHHHHHHCCCCCCCccch
Confidence 43 2345678999999998842 23567899999999999999999999876544
Q ss_pred hhHHHHHHHHHcCCCCCCchhhccCCHHHHHHHHHhcccCccccCChHHHHHHhhhhHHh
Q psy11767 605 DSALSIMARIKEGQFNFDAEAWSTVSSEAKELTKSLLTVNPAQRIRMMRVKLTFHAFHQA 664 (966)
Q Consensus 605 ~~~~~~~~~i~~~~~~~~~~~~~~is~e~~~Li~~~L~~dP~~R~t~~~v~~~~~~~~~~ 664 (966)
.........+..+.+.++...|..+++++++||.+||..||++|||+.++ ..|+|+..
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~el--l~hp~~~~ 293 (336)
T 3fhr_A 236 AISPGMKRRIRLGQYGFPNPEWSEVSEDAKQLIRLLLKTDPTERLTITQF--MNHPWINQ 293 (336)
T ss_dssp ---------------CCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHH--HHSHHHHT
T ss_pred hhhhhHHHhhhccccccCchhhccCCHHHHHHHHHHCCCChhHCcCHHHH--hcCccccc
Confidence 33223344455556666666677899999999999999999999999976 45777643
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.9e-42 Score=396.26 Aligned_cols=250 Identities=36% Similarity=0.637 Sum_probs=204.8
Q ss_pred cccccccccccEEEEEEEcCCCcEEEEEEecccc-------------ChHHHHHHHHHhcCCCCceEEEEEEEeCCeEEE
Q psy11767 382 KAGILGDGSYSVCRRCVEKSTGQEYAVKIISRKI-------------DCSEEINLLRACQGHPNIVNLHCVFQDEVHTYL 448 (966)
Q Consensus 382 ~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~-------------~~~~Ei~iL~~l~~HpnIV~l~~~~~~~~~~~l 448 (966)
..+.||+|+||+||+|.+..+++.||||++.+.. ...+|+.+|+.+ +|||||++++++.. ...|+
T Consensus 139 ~~~~LG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~hpniv~l~~~~~~-~~~~l 216 (419)
T 3i6u_A 139 MSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKL-NHPCIIKIKNFFDA-EDYYI 216 (419)
T ss_dssp EEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGGTTC--------CCHHHHHHHHHHC-CCTTBCCCCEEEES-SEEEE
T ss_pred EEeEEeeCCCeEEEEEEECCCCcEEEEEEEEechhcccccccchhHHHHHHHHHHHHhC-CCCCEeeEEEEEec-CceEE
Confidence 3688999999999999999999999999986532 256799999998 69999999999865 45899
Q ss_pred EEEccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCcEEEecCC-CCCEEEEeecccccccC
Q psy11767 449 VLELLKGGELLDRIRQKGRCGFTENEASRIMRQLVAAVHFMHSRGVVHRDLKPENLLFSDPA-GDNIKVVDFGFACLKRE 527 (966)
Q Consensus 449 VmEy~~gg~L~~~l~~~~~~~l~e~~~~~i~~Qil~aL~yLHs~~IiHRDLKP~NILl~~~~-~~~iKL~DFGla~~~~~ 527 (966)
|||||++|+|.+++.... .+++.+++.++.||+.||+|||++||+||||||+|||++... ...+||+|||+|+....
T Consensus 217 v~e~~~~g~L~~~l~~~~--~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~NIll~~~~~~~~~kl~DFG~a~~~~~ 294 (419)
T 3i6u_A 217 VLELMEGGELFDKVVGNK--RLKEATCKLYFYQMLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGE 294 (419)
T ss_dssp EEECCTTCBGGGGTSSSC--CCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESSSSSSCCEEECCSSTTTSCC-
T ss_pred EEEcCCCCcHHHHHhccC--CCCHHHHHHHHHHHHHHHHHHHHCCccccCCChHhEEEecCCCcceEEEeecccceecCC
Confidence 999999999999886654 599999999999999999999999999999999999997422 34699999999987543
Q ss_pred C--CccccccccccCchhhccCCCCCCCcccchhhhhhhhhhhhcCCCCCCCcCcchhHHHHHHHHhcCCCCCCCCCCch
Q psy11767 528 S--LHTPCFTLQYAAPEVLRQDKSGYDENCDLWSLGVILVNVLRQDKSGYDENCDLWSLGVILYTMLCGRVPFHARSRDD 605 (966)
Q Consensus 528 ~--~~~~~gT~~Y~APEvl~~~~~~~~~~~Di~SlGvil~el~~~~~~~y~~~~DIWSlGvilyemltG~~Pf~~~~~~~ 605 (966)
. ..+.+||+.|+|||++... ....|+.++|||||||++|+|++|++||.......
T Consensus 295 ~~~~~~~~gt~~y~aPE~~~~~-----------------------~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~ 351 (419)
T 3i6u_A 295 TSLMRTLCGTPTYLAPEVLVSV-----------------------GTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQV 351 (419)
T ss_dssp ----------CTTCCTTTTC---------------------------CTTHHHHHHHHHHHHHHHHHHSSCSSCCCSSSC
T ss_pred CccccccCCCCCccCceeeecC-----------------------CCCCCCchhhhHhHHHHHHHHHHCCCCCCCCcchH
Confidence 2 3456799999999998521 12347789999999999999999999998755433
Q ss_pred hHHHHHHHHHcCCCCCCchhhccCCHHHHHHHHHhcccCccccCChHHHHHHhhhhHH
Q psy11767 606 SALSIMARIKEGQFNFDAEAWSTVSSEAKELTKSLLTVNPAQRIRMMRVKLTFHAFHQ 663 (966)
Q Consensus 606 ~~~~~~~~i~~~~~~~~~~~~~~is~e~~~Li~~~L~~dP~~R~t~~~v~~~~~~~~~ 663 (966)
. +...+..+.+.+.++.|..+++++.+||.+||+.||++|||+.++ ..|+|++
T Consensus 352 ~---~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~--l~hp~~~ 404 (419)
T 3i6u_A 352 S---LKDQITSGKYNFIPEVWAEVSEKALDLVKKLLVVDPKARFTTEEA--LRHPWLQ 404 (419)
T ss_dssp C---HHHHHHTTCCCCCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHH--HHSGGGC
T ss_pred H---HHHHHhcCCCCCCchhhcccCHHHHHHHHHHccCChhHCcCHHHH--hCCcccC
Confidence 2 345677788888888888999999999999999999999999876 4577764
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-41 Score=376.32 Aligned_cols=254 Identities=33% Similarity=0.617 Sum_probs=214.3
Q ss_pred ceecccccccccccccccccccEEEEEEEcCCCcEEEEEEecccc-----------ChHHHHHHHHHhcCCCCceEEEEE
Q psy11767 371 LFFEQYDMDLDKAGILGDGSYSVCRRCVEKSTGQEYAVKIISRKI-----------DCSEEINLLRACQGHPNIVNLHCV 439 (966)
Q Consensus 371 ~~~~~~~i~~~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~-----------~~~~Ei~iL~~l~~HpnIV~l~~~ 439 (966)
.+.++|.+ .+.||+|+||.||+|.+..+|+.||||++.... ...+|+.+|+.+ .||||++++++
T Consensus 9 ~~~~~y~~----~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~ 83 (321)
T 2a2a_A 9 KVEDFYDI----GEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQV-LHHNVITLHDV 83 (321)
T ss_dssp CHHHHEEE----EEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSSSCSSSBCHHHHHHHHHHHHHC-CCTTBCCEEEE
T ss_pred hhhccEEE----eeEeeecCCEEEEEEEECCCCeEEEEEEEecccccccccchhHHHHHHHHHHHHhC-CCCCcceEEEE
Confidence 34455555 688999999999999999999999999986532 145799999998 59999999999
Q ss_pred EEeCCeEEEEEEccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCcEEEecCCC--CCEEEE
Q psy11767 440 FQDEVHTYLVLELLKGGELLDRIRQKGRCGFTENEASRIMRQLVAAVHFMHSRGVVHRDLKPENLLFSDPAG--DNIKVV 517 (966)
Q Consensus 440 ~~~~~~~~lVmEy~~gg~L~~~l~~~~~~~l~e~~~~~i~~Qil~aL~yLHs~~IiHRDLKP~NILl~~~~~--~~iKL~ 517 (966)
+.+....|+||||++|++|.+++.... .+++..++.++.||+.||+|||++||+||||||+|||+++... ..+||+
T Consensus 84 ~~~~~~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~i~~qi~~aL~~lH~~~ivH~dikp~NIl~~~~~~~~~~~kl~ 161 (321)
T 2a2a_A 84 YENRTDVVLILELVSGGELFDFLAQKE--SLSEEEATSFIKQILDGVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLI 161 (321)
T ss_dssp EECSSEEEEEECCCCSCBHHHHHHTCS--CEEHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCTTSSSCCEEEC
T ss_pred EecCCEEEEEEEcCCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCeecCCCChHHEEEecCCCCcCCEEEc
Confidence 999999999999999999999997654 5899999999999999999999999999999999999975321 179999
Q ss_pred eecccccccCC--CccccccccccCchhhccCCCCCCCcccchhhhhhhhhhhhcCCCCCCCcCcchhHHHHHHHHhcCC
Q psy11767 518 DFGFACLKRES--LHTPCFTLQYAAPEVLRQDKSGYDENCDLWSLGVILVNVLRQDKSGYDENCDLWSLGVILYTMLCGR 595 (966)
Q Consensus 518 DFGla~~~~~~--~~~~~gT~~Y~APEvl~~~~~~~~~~~Di~SlGvil~el~~~~~~~y~~~~DIWSlGvilyemltG~ 595 (966)
|||++...... .....||+.|+|||++.. ..|+.++|||||||++|+|++|.
T Consensus 162 Dfg~~~~~~~~~~~~~~~gt~~y~aPE~~~~--------------------------~~~~~~~Di~slG~il~~l~~g~ 215 (321)
T 2a2a_A 162 DFGLAHEIEDGVEFKNIFGTPEFVAPEIVNY--------------------------EPLGLEADMWSIGVITYILLSGA 215 (321)
T ss_dssp CCTTCEECCTTCCCCCCCSCGGGCCHHHHTT--------------------------CCCCTHHHHHHHHHHHHHHHHSC
T ss_pred cCccceecCccccccccCCCCCccCcccccC--------------------------CCCCCccccHHHHHHHHHHHHCC
Confidence 99999765432 345578999999998852 23678999999999999999999
Q ss_pred CCCCCCCCchhHHHHHHHHHcCCCCCCchhhccCCHHHHHHHHHhcccCccccCChHHHHHHhhhhHH
Q psy11767 596 VPFHARSRDDSALSIMARIKEGQFNFDAEAWSTVSSEAKELTKSLLTVNPAQRIRMMRVKLTFHAFHQ 663 (966)
Q Consensus 596 ~Pf~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~is~e~~~Li~~~L~~dP~~R~t~~~v~~~~~~~~~ 663 (966)
.||.+... ...+..+..+.+.++...+..+++++.+||.+||..||++|||+.++ ..|+|..
T Consensus 216 ~pf~~~~~----~~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~e~--l~hp~~~ 277 (321)
T 2a2a_A 216 SPFLGDTK----QETLANITSVSYDFDEEFFSHTSELAKDFIRKLLVKETRKRLTIQEA--LRHPWIT 277 (321)
T ss_dssp CSSCCSSH----HHHHHHHHTTCCCCCHHHHTTCCHHHHHHHHTTSCSSTTTSCCHHHH--HHSTTTS
T ss_pred CCCCCCCH----HHHHHHHHhcccccChhhhcccCHHHHHHHHHHcCCChhhCcCHHHH--hcCcccc
Confidence 99987543 24456677777777777778899999999999999999999999976 3466653
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-42 Score=387.35 Aligned_cols=246 Identities=33% Similarity=0.594 Sum_probs=203.7
Q ss_pred ecccccccccccccccccccEEEEEEEcCCCcEEEEEEecccc--------ChHHHHHHHHHhcCCCCceEEEEEEEeCC
Q psy11767 373 FEQYDMDLDKAGILGDGSYSVCRRCVEKSTGQEYAVKIISRKI--------DCSEEINLLRACQGHPNIVNLHCVFQDEV 444 (966)
Q Consensus 373 ~~~~~i~~~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~--------~~~~Ei~iL~~l~~HpnIV~l~~~~~~~~ 444 (966)
..+|.+ .+.||+|+||+||+|.+..+|+.||||++.+.. ...+|+.+|+.+ +|||||++++++.++.
T Consensus 8 i~~Y~i----~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l-~hpnIv~l~~~~~~~~ 82 (336)
T 3h4j_B 8 IGPYII----RETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLL-RHPHIIKLYDVITTPT 82 (336)
T ss_dssp ETTEEE----EEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCSHHHHHHHHHHTTC-CCTTBCCEEEEEECSS
T ss_pred cCCEEE----EEEEecCCCeEEEEEEECCCCCEEEEEEEehHHccchhHHHHHHHHHHHHHhC-CCCCCCeEEEEEEeCC
Confidence 345555 688999999999999999999999999986431 245799999888 5999999999999999
Q ss_pred eEEEEEEccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCcEEEecCCCCCEEEEeeccccc
Q psy11767 445 HTYLVLELLKGGELLDRIRQKGRCGFTENEASRIMRQLVAAVHFMHSRGVVHRDLKPENLLFSDPAGDNIKVVDFGFACL 524 (966)
Q Consensus 445 ~~~lVmEy~~gg~L~~~l~~~~~~~l~e~~~~~i~~Qil~aL~yLHs~~IiHRDLKP~NILl~~~~~~~iKL~DFGla~~ 524 (966)
..|+||||+ +|+|.+++...+ .+++.+++.++.||+.||+|||++||+||||||+|||+++ ++.+||+|||++..
T Consensus 83 ~~~lv~E~~-~g~l~~~l~~~~--~l~~~~~~~i~~qi~~aL~~LH~~givH~Dlkp~NIll~~--~~~~kl~DFG~s~~ 157 (336)
T 3h4j_B 83 DIVMVIEYA-GGELFDYIVEKK--RMTEDEGRRFFQQIICAIEYCHRHKIVHRDLKPENLLLDD--NLNVKIADFGLSNI 157 (336)
T ss_dssp EEEEEECCC-CEEHHHHHHHHC--SCCHHHHHHHHHHHHHHHHHHHHHTCCCCCCSTTTEEECT--TCCEEECCSSCTBT
T ss_pred EEEEEEECC-CCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCCeEecCCchhhEEEcC--CCCEEEEEecccee
Confidence 999999999 789999998765 5999999999999999999999999999999999999985 56899999999976
Q ss_pred ccC--CCccccccccccCchhhccCCCCCCCcccchhhhhhhhhhhhcCCCCCCCcCcchhHHHHHHHHhcCCCCCCCCC
Q psy11767 525 KRE--SLHTPCFTLQYAAPEVLRQDKSGYDENCDLWSLGVILVNVLRQDKSGYDENCDLWSLGVILYTMLCGRVPFHARS 602 (966)
Q Consensus 525 ~~~--~~~~~~gT~~Y~APEvl~~~~~~~~~~~Di~SlGvil~el~~~~~~~y~~~~DIWSlGvilyemltG~~Pf~~~~ 602 (966)
... ...+.+||+.|+|||++.... .++.++|||||||++|+|++|+.||.+..
T Consensus 158 ~~~~~~~~~~~gt~~y~aPE~~~~~~-------------------------~~~~~~DiwslG~il~~ll~g~~Pf~~~~ 212 (336)
T 3h4j_B 158 MTDGNFLKTSCGSPNYAAPEVINGKL-------------------------YAGPEVDVWSCGIVLYVMLVGRLPFDDEF 212 (336)
T ss_dssp TTTSBTTCCCTTSTTTSCGGGSCCSG-------------------------GGCHHHHHHHHHHHHHHHHHSSCSSBCSS
T ss_pred ccCCcccccccCCcCcCCHHHHcCCC-------------------------CCCCccchhHHHHHHHHHHhCCCCCCCcc
Confidence 543 345678999999999985321 12678999999999999999999998754
Q ss_pred CchhHHHHHHHHHcCCCCCCchhhccCCHHHHHHHHHhcccCccccCChHHHHHHhhhhHH
Q psy11767 603 RDDSALSIMARIKEGQFNFDAEAWSTVSSEAKELTKSLLTVNPAQRIRMMRVKLTFHAFHQ 663 (966)
Q Consensus 603 ~~~~~~~~~~~i~~~~~~~~~~~~~~is~e~~~Li~~~L~~dP~~R~t~~~v~~~~~~~~~ 663 (966)
..+ +...+..+.+.+ ...+|+++++||.+||..||.+|||+.++ ..|+|+.
T Consensus 213 ~~~----~~~~i~~~~~~~----p~~~s~~~~~li~~~L~~dP~~Rpt~~ei--l~hp~~~ 263 (336)
T 3h4j_B 213 IPN----LFKKVNSCVYVM----PDFLSPGAQSLIRRMIVADPMQRITIQEI--RRDPWFN 263 (336)
T ss_dssp STT----CBCCCCSSCCCC----CTTSCHHHHHHHHTTSCSSGGGSCCHHHH--TTCHHHH
T ss_pred HHH----HHHHHHcCCCCC----cccCCHHHHHHHHHHcCCChhHCcCHHHH--HhChhhc
Confidence 332 122233333322 23579999999999999999999999976 4567764
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-41 Score=374.87 Aligned_cols=249 Identities=30% Similarity=0.571 Sum_probs=200.4
Q ss_pred ecccccccccccccccccccEEEEEEEcCCCcEEEEEEecccc-------------------------------ChHHHH
Q psy11767 373 FEQYDMDLDKAGILGDGSYSVCRRCVEKSTGQEYAVKIISRKI-------------------------------DCSEEI 421 (966)
Q Consensus 373 ~~~~~i~~~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~-------------------------------~~~~Ei 421 (966)
.++|.+ .+.||+|+||.||+|++..+|+.||||++.... ...+|+
T Consensus 12 ~~~y~~----~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~ 87 (298)
T 2zv2_A 12 LNQYTL----KDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPIEQVYQEI 87 (298)
T ss_dssp ETTEEE----EEEEEC--CCEEEEEEETTTTEEEEEEEEECC-------------------------------CHHHHHH
T ss_pred ecceEE----EeEEeecCCEEEEEEEECCCCcEEEEEEeehhhhhhhcccccccccccccccccccccccchHHHHHHHH
Confidence 345555 678999999999999999999999999986432 245799
Q ss_pred HHHHHhcCCCCceEEEEEEEe--CCeEEEEEEccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCceeccC
Q psy11767 422 NLLRACQGHPNIVNLHCVFQD--EVHTYLVLELLKGGELLDRIRQKGRCGFTENEASRIMRQLVAAVHFMHSRGVVHRDL 499 (966)
Q Consensus 422 ~iL~~l~~HpnIV~l~~~~~~--~~~~~lVmEy~~gg~L~~~l~~~~~~~l~e~~~~~i~~Qil~aL~yLHs~~IiHRDL 499 (966)
.+|+.+ +||||+++++++.+ ....|+||||+++++|.+++.. ..+++.+++.++.||+.||+|||++||+||||
T Consensus 88 ~~l~~l-~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~---~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dl 163 (298)
T 2zv2_A 88 AILKKL-DHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVPTL---KPLSEDQARFYFQDLIKGIEYLHYQKIIHRDI 163 (298)
T ss_dssp HHHHTC-CCTTBCCEEEEEECSSSSEEEEEEECCTTCBSCCSSCS---SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCC
T ss_pred HHHHhC-CCCCCCeEEEEEEcCCCCEEEEEEecCCCCcHHHHhhc---CCCCHHHHHHHHHHHHHHHHHHHHCCeeccCC
Confidence 999998 59999999999987 5689999999999999876432 25999999999999999999999999999999
Q ss_pred CCCcEEEecCCCCCEEEEeecccccccCC---CccccccccccCchhhccCCCCCCCcccchhhhhhhhhhhhcCCCCCC
Q psy11767 500 KPENLLFSDPAGDNIKVVDFGFACLKRES---LHTPCFTLQYAAPEVLRQDKSGYDENCDLWSLGVILVNVLRQDKSGYD 576 (966)
Q Consensus 500 KP~NILl~~~~~~~iKL~DFGla~~~~~~---~~~~~gT~~Y~APEvl~~~~~~~~~~~Di~SlGvil~el~~~~~~~y~ 576 (966)
||+|||++. ++.+||+|||++...... ....+||+.|+|||++.... ...++
T Consensus 164 kp~Nil~~~--~~~~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-----------------------~~~~~ 218 (298)
T 2zv2_A 164 KPSNLLVGE--DGHIKIADFGVSNEFKGSDALLSNTVGTPAFMAPESLSETR-----------------------KIFSG 218 (298)
T ss_dssp CGGGEEECT--TSCEEECCCTTCEECSSSSCEECCCCSCGGGCCGGGCCTTC-----------------------CCEES
T ss_pred CHHHEEECC--CCCEEEecCCCccccccccccccCCcCCccccChhhhccCC-----------------------CCCCC
Confidence 999999975 568999999999765432 23467899999999985321 11136
Q ss_pred CcCcchhHHHHHHHHhcCCCCCCCCCCchhHHHHHHHHHcCCCCCCchhhccCCHHHHHHHHHhcccCccccCChHHHHH
Q psy11767 577 ENCDLWSLGVILYTMLCGRVPFHARSRDDSALSIMARIKEGQFNFDAEAWSTVSSEAKELTKSLLTVNPAQRIRMMRVKL 656 (966)
Q Consensus 577 ~~~DIWSlGvilyemltG~~Pf~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~is~e~~~Li~~~L~~dP~~R~t~~~v~~ 656 (966)
.++|||||||++|+|++|+.||..... ......+..+...++. ...+++++.+||.+||..||++|||+.++
T Consensus 219 ~~~Di~slG~~l~~l~~g~~pf~~~~~----~~~~~~~~~~~~~~~~--~~~~~~~l~~li~~~l~~dp~~R~s~~e~-- 290 (298)
T 2zv2_A 219 KALDVWAMGVTLYCFVFGQCPFMDERI----MCLHSKIKSQALEFPD--QPDIAEDLKDLITRMLDKNPESRIVVPEI-- 290 (298)
T ss_dssp HHHHHHHHHHHHHHHHHSSCSSCCSSH----HHHHHHHHHCCCCCCS--SSCCCHHHHHHHHHHTCSCTTTSCCHHHH--
T ss_pred chhhhHhHHHHHHHHHHCCCCCCCccH----HHHHHHHhcccCCCCC--ccccCHHHHHHHHHHhhcChhhCCCHHHH--
Confidence 688999999999999999999986542 2344555555544332 34689999999999999999999999876
Q ss_pred HhhhhH
Q psy11767 657 TFHAFH 662 (966)
Q Consensus 657 ~~~~~~ 662 (966)
..|+|+
T Consensus 291 l~hp~~ 296 (298)
T 2zv2_A 291 KLHPWV 296 (298)
T ss_dssp TTCHHH
T ss_pred hcCccc
Confidence 456664
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-41 Score=377.22 Aligned_cols=242 Identities=34% Similarity=0.613 Sum_probs=198.4
Q ss_pred ccccccccccccEEEEEEEc---CCCcEEEEEEecccc---------ChHHHHHHHHHhcCCCCceEEEEEEEeCCeEEE
Q psy11767 381 DKAGILGDGSYSVCRRCVEK---STGQEYAVKIISRKI---------DCSEEINLLRACQGHPNIVNLHCVFQDEVHTYL 448 (966)
Q Consensus 381 ~~~~~LG~G~fG~Vy~a~~~---~tg~~vAvK~i~~~~---------~~~~Ei~iL~~l~~HpnIV~l~~~~~~~~~~~l 448 (966)
+..+.||+|+||.||+|++. .+|+.||||++.+.. ...+|+.+|+.+ +|||||+++++|.++...|+
T Consensus 20 ~~~~~lG~G~~g~V~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~E~~~l~~l-~hp~iv~~~~~~~~~~~~~l 98 (327)
T 3a62_A 20 ELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEV-KHPFIVDLIYAFQTGGKLYL 98 (327)
T ss_dssp EEEEEEEEETTEEEEEEEECSSTTTTCEEEEEEECCC--------------HHHHHHHC-CCTTBCCEEEEEECSSCEEE
T ss_pred EEEEEEEeCCCEEEEEEEEeccCCCCcEEEEEEEEHHHhhhhhhHHHHHHHHHHHHHhC-CCCCccceeEEEEcCCEEEE
Confidence 34688999999999999986 689999999987532 234699999998 59999999999999999999
Q ss_pred EEEccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCcEEEecCCCCCEEEEeecccccccC-
Q psy11767 449 VLELLKGGELLDRIRQKGRCGFTENEASRIMRQLVAAVHFMHSRGVVHRDLKPENLLFSDPAGDNIKVVDFGFACLKRE- 527 (966)
Q Consensus 449 VmEy~~gg~L~~~l~~~~~~~l~e~~~~~i~~Qil~aL~yLHs~~IiHRDLKP~NILl~~~~~~~iKL~DFGla~~~~~- 527 (966)
|||||+||+|.+++...+ .+++..++.++.||+.||+|||++||+||||||+|||++. ++.+||+|||+++....
T Consensus 99 v~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~qi~~al~~lH~~~ivH~Dlkp~Nill~~--~~~~kl~Dfg~~~~~~~~ 174 (327)
T 3a62_A 99 ILEYLSGGELFMQLEREG--IFMEDTACFYLAEISMALGHLHQKGIIYRDLKPENIMLNH--QGHVKLTDFGLCKESIHD 174 (327)
T ss_dssp EEECCTTEEHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCTTTEEECT--TSCEEECCCSCC------
T ss_pred EEeCCCCCcHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHhCCEEcccCCHHHeEECC--CCcEEEEeCCcccccccC
Confidence 999999999999998765 5899999999999999999999999999999999999974 56999999999875322
Q ss_pred --CCccccccccccCchhhccCCCCCCCcccchhhhhhhhhhhhcCCCCCCCcCcchhHHHHHHHHhcCCCCCCCCCCch
Q psy11767 528 --SLHTPCFTLQYAAPEVLRQDKSGYDENCDLWSLGVILVNVLRQDKSGYDENCDLWSLGVILYTMLCGRVPFHARSRDD 605 (966)
Q Consensus 528 --~~~~~~gT~~Y~APEvl~~~~~~~~~~~Di~SlGvil~el~~~~~~~y~~~~DIWSlGvilyemltG~~Pf~~~~~~~ 605 (966)
.....+||+.|+|||++.. ..|+.++|||||||++|+|++|+.||.+.+..
T Consensus 175 ~~~~~~~~gt~~y~aPE~~~~--------------------------~~~~~~~DiwslG~il~el~~g~~pf~~~~~~- 227 (327)
T 3a62_A 175 GTVTHTFCGTIEYMAPEILMR--------------------------SGHNRAVDWWSLGALMYDMLTGAPPFTGENRK- 227 (327)
T ss_dssp ----CTTSSCCTTSCHHHHTT--------------------------SCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHH-
T ss_pred CccccccCCCcCccCHhhCcC--------------------------CCCCCcccchhHHHHHHHHHHCCCCCCCCCHH-
Confidence 2345679999999999852 23678999999999999999999999875532
Q ss_pred hHHHHHHHHHcCCCCCCchhhccCCHHHHHHHHHhcccCccccCC-----hHHHHHHhhhhHH
Q psy11767 606 SALSIMARIKEGQFNFDAEAWSTVSSEAKELTKSLLTVNPAQRIR-----MMRVKLTFHAFHQ 663 (966)
Q Consensus 606 ~~~~~~~~i~~~~~~~~~~~~~~is~e~~~Li~~~L~~dP~~R~t-----~~~v~~~~~~~~~ 663 (966)
..+..+..+.+.++ ..+++++++||.+||..||++||+ +.++ ..|+|+.
T Consensus 228 ---~~~~~i~~~~~~~p----~~~~~~~~~li~~~L~~dp~~R~~~~~~~~~e~--l~hp~f~ 281 (327)
T 3a62_A 228 ---KTIDKILKCKLNLP----PYLTQEARDLLKKLLKRNAASRLGAGPGDAGEV--QAHPFFR 281 (327)
T ss_dssp ---HHHHHHHHTCCCCC----TTSCHHHHHHHHHHSCSCGGGSTTSSTTTHHHH--HHSGGGS
T ss_pred ---HHHHHHHhCCCCCC----CCCCHHHHHHHHHHHhcCHhhccCCCCCCHHHH--HcCCccc
Confidence 34455666655543 357999999999999999999994 4444 5577763
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-41 Score=398.42 Aligned_cols=250 Identities=28% Similarity=0.417 Sum_probs=182.9
Q ss_pred ccccccccccccEEEEEEEcCCCcEEEEEEeccccC-------hHHHHHHHHHhcCCCCceEEEEEEEeC-----CeEEE
Q psy11767 381 DKAGILGDGSYSVCRRCVEKSTGQEYAVKIISRKID-------CSEEINLLRACQGHPNIVNLHCVFQDE-----VHTYL 448 (966)
Q Consensus 381 ~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~~-------~~~Ei~iL~~l~~HpnIV~l~~~~~~~-----~~~~l 448 (966)
+..+.||+|+||+||+|++..+|+.||||++.+... ..+|+.+|+.+ +|||||+++++|... ..+|+
T Consensus 56 ~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~~~~~~l 134 (458)
T 3rp9_A 56 EIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRVFEDLIDCKRILREIAILNRL-NHDHVVKVLDIVIPKDVEKFDELYV 134 (458)
T ss_dssp EECCC-------CEEEEEECC--CEEEEEEECSTTSSHHHHHHHHHHHHHHHHC-CCTTBCCEEEECCCSCTTTCCCEEE
T ss_pred EEeeEeeecCCeEEEEEEECCCCcEEEEEEechhhcCHHHHHHHHHHHHHHHhC-CCCCCCceEEEEecCCcccCceEEE
Confidence 347899999999999999999999999999865422 34799999998 599999999999543 57999
Q ss_pred EEEccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCcEEEecCCCCCEEEEeecccccccC-
Q psy11767 449 VLELLKGGELLDRIRQKGRCGFTENEASRIMRQLVAAVHFMHSRGVVHRDLKPENLLFSDPAGDNIKVVDFGFACLKRE- 527 (966)
Q Consensus 449 VmEy~~gg~L~~~l~~~~~~~l~e~~~~~i~~Qil~aL~yLHs~~IiHRDLKP~NILl~~~~~~~iKL~DFGla~~~~~- 527 (966)
||||+ +|+|.+++.... .+++..++.++.||+.||+|||++|||||||||+|||++. ++.+||+|||+|+....
T Consensus 135 v~e~~-~~~L~~~~~~~~--~l~~~~~~~~~~qi~~aL~~LH~~~iiHrDlKp~NILl~~--~~~~kl~DFGla~~~~~~ 209 (458)
T 3rp9_A 135 VLEIA-DSDFKKLFRTPV--YLTELHIKTLLYNLLVGVKYVHSAGILHRDLKPANCLVNQ--DCSVKVCDFGLARTVDYP 209 (458)
T ss_dssp EECCC-SEEHHHHHHSSC--CCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECT--TCCEEECCCTTCBCTTSC
T ss_pred EEecc-ccchhhhcccCC--CCCHHHHHHHHHHHHHHHHHHHhCCcCCCCCChhhEEECC--CCCEeecccccchhccCc
Confidence 99998 679999987654 5999999999999999999999999999999999999975 56999999999976431
Q ss_pred -----------------------------CCccccccccccCchhhccCCCCCCCcccchhhhhhhhhhhhcCCCCCCCc
Q psy11767 528 -----------------------------SLHTPCFTLQYAAPEVLRQDKSGYDENCDLWSLGVILVNVLRQDKSGYDEN 578 (966)
Q Consensus 528 -----------------------------~~~~~~gT~~Y~APEvl~~~~~~~~~~~Di~SlGvil~el~~~~~~~y~~~ 578 (966)
.....+||++|+|||++.. ...|+.+
T Consensus 210 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~-------------------------~~~~~~~ 264 (458)
T 3rp9_A 210 ENGNSQLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILL-------------------------QENYTEA 264 (458)
T ss_dssp TTCCCCCC---------------------------CCCTTCCHHHHTT-------------------------CCCCCTH
T ss_pred cccccccccCccccccccccccccccccccccCCcccccccChHHhhC-------------------------CCCCCcH
Confidence 1234578999999998742 2347889
Q ss_pred CcchhHHHHHHHHhc-----------CCCCCCCCCC--------------------chhHHHHHHHHHc-----------
Q psy11767 579 CDLWSLGVILYTMLC-----------GRVPFHARSR--------------------DDSALSIMARIKE----------- 616 (966)
Q Consensus 579 ~DIWSlGvilyemlt-----------G~~Pf~~~~~--------------------~~~~~~~~~~i~~----------- 616 (966)
+|||||||++|||++ |++||.+.+. .+....++..+..
T Consensus 265 ~DiwSlG~il~elltg~~~~~~~~~~~~p~f~g~~~~~~~~~~~~~~~~~~~~~~~~~~l~~i~~~~g~p~~~~~~~~~~ 344 (458)
T 3rp9_A 265 IDVWSIGCIFAELLNMIKENVAYHADRGPLFPGSSCFPLSPDQKAGNDFKFHTRGNRDQLNVIFNILGTPSEEDIEALEK 344 (458)
T ss_dssp HHHHHHHHHHHHHHTTSTTTCSSGGGCCCSCC--------------------CHHHHHHHHHHHHHHCCCCHHHHHTSSC
T ss_pred hHHHHHHHHHHHHHHhccccccccccccccCCCCccccccccccccccccccccCCHHHHHHHHHHcCCCCHHHHhhcCC
Confidence 999999999999998 7777766431 0111111111100
Q ss_pred ------------CCCCCCchhhccCCHHHHHHHHHhcccCccccCChHHHHHHhhhhHH
Q psy11767 617 ------------GQFNFDAEAWSTVSSEAKELTKSLLTVNPAQRIRMMRVKLTFHAFHQ 663 (966)
Q Consensus 617 ------------~~~~~~~~~~~~is~e~~~Li~~~L~~dP~~R~t~~~v~~~~~~~~~ 663 (966)
.......+.++.+++++.+||.+||..||++|||+.++ ..|+|+.
T Consensus 345 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~t~~e~--L~Hp~f~ 401 (458)
T 3rp9_A 345 EDAKRYIRIFPKREGTDLAERFPASSADAIHLLKRMLVFNPNKRITINEC--LAHPFFK 401 (458)
T ss_dssp HHHHHHHTTSCCCCCCCGGGGSTTSCHHHHHHHHHHSCSSTTTSCCHHHH--HHSGGGT
T ss_pred HHHHHHHHhcCCCCCCCHHHHCCCCCHHHHHHHHHHhccCccccCCHHHH--hcCHhhh
Confidence 00001122345679999999999999999999999876 4577765
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.3e-41 Score=364.07 Aligned_cols=246 Identities=38% Similarity=0.685 Sum_probs=211.7
Q ss_pred ccccccccccEEEEEEEcCCCcEEEEEEecccc-----ChHHHHHHHHHhcCCCCceEEEEEEEeCCeEEEEEEccCCCC
Q psy11767 383 AGILGDGSYSVCRRCVEKSTGQEYAVKIISRKI-----DCSEEINLLRACQGHPNIVNLHCVFQDEVHTYLVLELLKGGE 457 (966)
Q Consensus 383 ~~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~-----~~~~Ei~iL~~l~~HpnIV~l~~~~~~~~~~~lVmEy~~gg~ 457 (966)
.+.||+|+||.||+|.+..++..||+|++.... ...+|+.+|+.+ +||||+++++++.+....|+||||+++++
T Consensus 14 ~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~~~ 92 (277)
T 3f3z_A 14 ENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSL-DHPNIIRLYETFEDNTDIYLVMELCTGGE 92 (277)
T ss_dssp EEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHTC-CCTTBCCEEEEEECSSEEEEEEECCCSCB
T ss_pred eeEEeecCCEEEEEEEeCCCCcEEEEEeehhhccchHHHHHHHHHHHHhC-CCCCEeeEEEEEecCCeEEEEEeccCCCc
Confidence 678999999999999999999999999986532 245799999998 69999999999999999999999999999
Q ss_pred HHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCcEEEec-CCCCCEEEEeecccccccC--CCccccc
Q psy11767 458 LLDRIRQKGRCGFTENEASRIMRQLVAAVHFMHSRGVVHRDLKPENLLFSD-PAGDNIKVVDFGFACLKRE--SLHTPCF 534 (966)
Q Consensus 458 L~~~l~~~~~~~l~e~~~~~i~~Qil~aL~yLHs~~IiHRDLKP~NILl~~-~~~~~iKL~DFGla~~~~~--~~~~~~g 534 (966)
|.+++.... .+++.+++.++.||+.||+|||++||+||||||+|||+.. ..++.+||+|||++..... ......+
T Consensus 93 L~~~~~~~~--~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~~~~l~Dfg~~~~~~~~~~~~~~~~ 170 (277)
T 3f3z_A 93 LFERVVHKR--VFRESDAARIMKDVLSAVAYCHKLNVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPGKMMRTKVG 170 (277)
T ss_dssp HHHHHHHHC--SCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESSSSTTCCEEECCCTTCEECCTTSCBCCCCS
T ss_pred HHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCCccCCCCCHHHEEEecCCCCCcEEEEecccceeccCccchhccCC
Confidence 999998765 5899999999999999999999999999999999999932 1356899999999976443 2345678
Q ss_pred cccccCchhhccCCCCCCCcccchhhhhhhhhhhhcCCCCCCCcCcchhHHHHHHHHhcCCCCCCCCCCchhHHHHHHHH
Q psy11767 535 TLQYAAPEVLRQDKSGYDENCDLWSLGVILVNVLRQDKSGYDENCDLWSLGVILYTMLCGRVPFHARSRDDSALSIMARI 614 (966)
Q Consensus 535 T~~Y~APEvl~~~~~~~~~~~Di~SlGvil~el~~~~~~~y~~~~DIWSlGvilyemltG~~Pf~~~~~~~~~~~~~~~i 614 (966)
|+.|+|||++.. .++.++|||||||++|+|++|+.||..... ......+
T Consensus 171 t~~y~aPE~~~~---------------------------~~~~~~Di~slG~~l~~l~~g~~p~~~~~~----~~~~~~~ 219 (277)
T 3f3z_A 171 TPYYVSPQVLEG---------------------------LYGPECDEWSAGVMMYVLLCGYPPFSAPTD----SEVMLKI 219 (277)
T ss_dssp CTTTCCHHHHTT---------------------------CBCTTHHHHHHHHHHHHHHHSSCSSCCSSH----HHHHHHH
T ss_pred CCCccChHHhcc---------------------------cCCchhhehhHHHHHHHHHHCCCCCCCCCH----HHHHHHH
Confidence 999999998741 267889999999999999999999987543 2455667
Q ss_pred HcCCCCCCchhhccCCHHHHHHHHHhcccCccccCChHHHHHHhhhhHHh
Q psy11767 615 KEGQFNFDAEAWSTVSSEAKELTKSLLTVNPAQRIRMMRVKLTFHAFHQA 664 (966)
Q Consensus 615 ~~~~~~~~~~~~~~is~e~~~Li~~~L~~dP~~R~t~~~v~~~~~~~~~~ 664 (966)
..+.+.++...+..+++++.+||.+||+.||++|||+.++ ..|+|++.
T Consensus 220 ~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~s~~~~--l~h~~~~~ 267 (277)
T 3f3z_A 220 REGTFTFPEKDWLNVSPQAESLIRRLLTKSPKQRITSLQA--LEHEWFEK 267 (277)
T ss_dssp HHCCCCCCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHH--TTSHHHHH
T ss_pred HhCCCCCCchhhhcCCHHHHHHHHHHccCChhhCcCHHHH--hcCHHHhc
Confidence 7788888877788899999999999999999999999876 45677643
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6e-41 Score=367.42 Aligned_cols=252 Identities=23% Similarity=0.299 Sum_probs=205.3
Q ss_pred cccccccccccEEEEEEEcCCCcEEEEEEeccc---cChHHHHHHHHHhcCCCCceEEEEEEEeCCeEEEEEEccCCCCH
Q psy11767 382 KAGILGDGSYSVCRRCVEKSTGQEYAVKIISRK---IDCSEEINLLRACQGHPNIVNLHCVFQDEVHTYLVLELLKGGEL 458 (966)
Q Consensus 382 ~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~---~~~~~Ei~iL~~l~~HpnIV~l~~~~~~~~~~~lVmEy~~gg~L 458 (966)
..+.||+|+||.||+|.+..+|+.||||++... ....+|+.+++.+.+|+||+++++++.+....|+||||+ +++|
T Consensus 14 ~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv~e~~-~~~L 92 (298)
T 1csn_A 14 VGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDAPQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLVIDLL-GPSL 92 (298)
T ss_dssp EEEEEEECSSCEEEEEEETTTTEEEEEEEEECCTTSCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEEEECC-CCBH
T ss_pred EEEEEeecCCEEEEEEEECCCCcEEEEEEeccCCccHHHHHHHHHHHHHhcCCCCCeEEeecCCCceeEEEEEec-CCCH
Confidence 368899999999999999999999999998654 246789999999988999999999999999999999999 9999
Q ss_pred HHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCcEEEecCC---CCCEEEEeecccccccCC-------
Q psy11767 459 LDRIRQKGRCGFTENEASRIMRQLVAAVHFMHSRGVVHRDLKPENLLFSDPA---GDNIKVVDFGFACLKRES------- 528 (966)
Q Consensus 459 ~~~l~~~~~~~l~e~~~~~i~~Qil~aL~yLHs~~IiHRDLKP~NILl~~~~---~~~iKL~DFGla~~~~~~------- 528 (966)
.+++...+. .+++.+++.++.||+.||+|||++||+||||||+|||++... ...+||+|||+++.....
T Consensus 93 ~~~l~~~~~-~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~NIl~~~~~~~~~~~~kl~Dfg~~~~~~~~~~~~~~~ 171 (298)
T 1csn_A 93 EDLLDLCGR-KFSVKTVAMAAKQMLARVQSIHEKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIP 171 (298)
T ss_dssp HHHHHHTTT-CCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECCSSSTTTTCEEECCCTTCEESBCTTTCCBCC
T ss_pred HHHHHHhcc-CCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEeccCCCCCCCeEEEEECcccccccccccccccc
Confidence 999987543 599999999999999999999999999999999999997522 234999999999764332
Q ss_pred ---CccccccccccCchhhccCCCCCCCcccchhhhhhhhhhhhcCCCCCCCcCcchhHHHHHHHHhcCCCCCCCCCCch
Q psy11767 529 ---LHTPCFTLQYAAPEVLRQDKSGYDENCDLWSLGVILVNVLRQDKSGYDENCDLWSLGVILYTMLCGRVPFHARSRDD 605 (966)
Q Consensus 529 ---~~~~~gT~~Y~APEvl~~~~~~~~~~~Di~SlGvil~el~~~~~~~y~~~~DIWSlGvilyemltG~~Pf~~~~~~~ 605 (966)
....+||+.|+|||++.. ..|+.++|||||||++|+|++|+.||.+.....
T Consensus 172 ~~~~~~~~gt~~y~aPE~~~~--------------------------~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~ 225 (298)
T 1csn_A 172 YREKKNLSGTARYMSINTHLG--------------------------REQSRRDDLEALGHVFMYFLRGSLPWQGLKAAT 225 (298)
T ss_dssp CCCCCCCCSCTTTCCHHHHTT--------------------------CCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCC
T ss_pred ccCccCCCCCcccCCchhhcC--------------------------CCCChHHHHHHHHHHHHHHHcCCCCcchhhccc
Confidence 234568999999999852 236889999999999999999999998765432
Q ss_pred hHHHHHHHHHcCCCCCC-chhhccCCHHHHHHHHHhcccCccccCChHHHHHHhhhhH
Q psy11767 606 SALSIMARIKEGQFNFD-AEAWSTVSSEAKELTKSLLTVNPAQRIRMMRVKLTFHAFH 662 (966)
Q Consensus 606 ~~~~~~~~i~~~~~~~~-~~~~~~is~e~~~Li~~~L~~dP~~R~t~~~v~~~~~~~~ 662 (966)
. ...+..+..+..... ......+++++.+||.+||..||++||++.++...+....
T Consensus 226 ~-~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~RP~~~~l~~~l~~~~ 282 (298)
T 1csn_A 226 N-KQKYERIGEKKQSTPLRELCAGFPEEFYKYMHYARNLAFDATPDYDYLQGLFSKVL 282 (298)
T ss_dssp H-HHHHHHHHHHHHHSCHHHHTTTSCHHHHHHHHHHHHCCTTCCCCHHHHHHHHHHHH
T ss_pred c-HHHHHHHHhhccCccHHHHHhhCcHHHHHHHHHHhcCCcccCCCHHHHHHHHHHHH
Confidence 2 222333332222111 2233468999999999999999999999998866655443
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-41 Score=385.24 Aligned_cols=255 Identities=22% Similarity=0.308 Sum_probs=201.4
Q ss_pred ccccccccc--cccEEEEEEEcCCCcEEEEEEeccccC-------hHHHHHHHHHhcCCCCceEEEEEEEeCCeEEEEEE
Q psy11767 381 DKAGILGDG--SYSVCRRCVEKSTGQEYAVKIISRKID-------CSEEINLLRACQGHPNIVNLHCVFQDEVHTYLVLE 451 (966)
Q Consensus 381 ~~~~~LG~G--~fG~Vy~a~~~~tg~~vAvK~i~~~~~-------~~~Ei~iL~~l~~HpnIV~l~~~~~~~~~~~lVmE 451 (966)
+..+.||+| +||.||+|++..+|+.||||++..... ..+|+.+|+.+ +|||||+++++|.++...|+|||
T Consensus 28 ~~~~~lG~G~~~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~lv~e 106 (389)
T 3gni_B 28 ELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLF-NHPNIVPYRATFIADNELWVVTS 106 (389)
T ss_dssp EEEEEEEEETTTTEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHC-CCTTBCCEEEEEEETTEEEEEEE
T ss_pred EEEecccCCcCCceEEEEEEEcCCCCEEEEEEecccccChHHHHHHHHHHHHHHhC-CCCCCCcEeEEEEECCEEEEEEE
Confidence 336889999 999999999999999999999975432 34599999998 59999999999999999999999
Q ss_pred ccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCcEEEecCCCCCEEEEeecccccccC----
Q psy11767 452 LLKGGELLDRIRQKGRCGFTENEASRIMRQLVAAVHFMHSRGVVHRDLKPENLLFSDPAGDNIKVVDFGFACLKRE---- 527 (966)
Q Consensus 452 y~~gg~L~~~l~~~~~~~l~e~~~~~i~~Qil~aL~yLHs~~IiHRDLKP~NILl~~~~~~~iKL~DFGla~~~~~---- 527 (966)
||++|+|.+++.......+++..++.++.||+.||+|||++||+||||||+|||++. ++.+||+|||++.....
T Consensus 107 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~NIll~~--~~~~kl~dfg~~~~~~~~~~~ 184 (389)
T 3gni_B 107 FMAYGSAKDLICTHFMDGMNELAIAYILQGVLKALDYIHHMGYVHRSVKASHILISV--DGKVYLSGLRSNLSMISHGQR 184 (389)
T ss_dssp CCTTCBHHHHHHHTCTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECT--TCCEEECCGGGCEECEETTEE
T ss_pred ccCCCCHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcC--CCCEEEcccccceeecccccc
Confidence 999999999998765557999999999999999999999999999999999999974 56999999999854211
Q ss_pred ------CCccccccccccCchhhccCCCCCCCcccchhhhhhhhhhhhcCCCCCCCcCcchhHHHHHHHHhcCCCCCCCC
Q psy11767 528 ------SLHTPCFTLQYAAPEVLRQDKSGYDENCDLWSLGVILVNVLRQDKSGYDENCDLWSLGVILYTMLCGRVPFHAR 601 (966)
Q Consensus 528 ------~~~~~~gT~~Y~APEvl~~~~~~~~~~~Di~SlGvil~el~~~~~~~y~~~~DIWSlGvilyemltG~~Pf~~~ 601 (966)
.....+||+.|+|||++... ...|+.++|||||||++|+|++|+.||.+.
T Consensus 185 ~~~~~~~~~~~~gt~~y~aPE~~~~~------------------------~~~~~~~~DiwslG~il~el~~g~~pf~~~ 240 (389)
T 3gni_B 185 QRVVHDFPKYSVKVLPWLSPEVLQQN------------------------LQGYDAKSDIYSVGITACELANGHVPFKDM 240 (389)
T ss_dssp CSCBCCCCTTCTTTGGGSCHHHHSTT------------------------SSCBCTHHHHHHHHHHHHHHHHSSCTTTTC
T ss_pred ccccccccccccccccccCHHHHhcc------------------------CCCCCcHhHHHHHHHHHHHHHHCCCCCCCC
Confidence 12234789999999998532 134788999999999999999999999876
Q ss_pred CCchhHHHHHHHHHcC--------------------------------------CCCCCchhhccCCHHHHHHHHHhccc
Q psy11767 602 SRDDSALSIMARIKEG--------------------------------------QFNFDAEAWSTVSSEAKELTKSLLTV 643 (966)
Q Consensus 602 ~~~~~~~~~~~~i~~~--------------------------------------~~~~~~~~~~~is~e~~~Li~~~L~~ 643 (966)
+..+.....+...... ........+..+++++++||.+||+.
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~ 320 (389)
T 3gni_B 241 PATQMLLEKLNGTVPCLLDTSTIPAEELTMSPSRSVANSGLSDSLTTSTPRPSNGDSPSHPYHRTFSPHFHHFVEQCLQR 320 (389)
T ss_dssp CSTTHHHHC--------------------------------------------------------CCHHHHHHHHHHTCS
T ss_pred CHHHHHHHHhcCCCCccccccccccccccccccccccccccccccccCccccccCCCCCCccccccCHHHHHHHHHHhhc
Confidence 6544332221110000 00001113346789999999999999
Q ss_pred CccccCChHHHHHHhhhhHHh
Q psy11767 644 NPAQRIRMMRVKLTFHAFHQA 664 (966)
Q Consensus 644 dP~~R~t~~~v~~~~~~~~~~ 664 (966)
||++|||+.++ ..|+|++.
T Consensus 321 dP~~Rpta~el--l~hp~f~~ 339 (389)
T 3gni_B 321 NPDARPSASTL--LNHSFFKQ 339 (389)
T ss_dssp CTTTSCCHHHH--TTSGGGGG
T ss_pred CcccCCCHHHH--hcCHHHHH
Confidence 99999999976 45777643
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-41 Score=416.66 Aligned_cols=247 Identities=31% Similarity=0.536 Sum_probs=210.0
Q ss_pred ccccccccccccccEEEEEEEcCCCcEEEEEEecccc--------ChHHHHHHHHHhcCCCCceEEEEEEEeCCeEEEEE
Q psy11767 379 DLDKAGILGDGSYSVCRRCVEKSTGQEYAVKIISRKI--------DCSEEINLLRACQGHPNIVNLHCVFQDEVHTYLVL 450 (966)
Q Consensus 379 ~~~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~--------~~~~Ei~iL~~l~~HpnIV~l~~~~~~~~~~~lVm 450 (966)
+|+.+++||+|+||+||+|+++.+++.||||++.+.. ....|+.+|..+.+||||++++++|++...+||||
T Consensus 342 ~f~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~l~~~~~~~~~~~lV~ 421 (674)
T 3pfq_A 342 DFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVM 421 (674)
T ss_dssp TEEEEEESSBTTTBCEEEEEESSSCCEEEEEEEEHHHHHHTTTTHHHHHHHHHHTCTTCCTTBCCEEEECBCSSEEEEEE
T ss_pred ceEEEEEEccCCCEEEEEEEECCCCcEEEEEEEeccccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEEEeCCEEEEEE
Confidence 3555789999999999999999999999999987431 13468888887778999999999999999999999
Q ss_pred EccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCcEEEecCCCCCEEEEeeccccccc---C
Q psy11767 451 ELLKGGELLDRIRQKGRCGFTENEASRIMRQLVAAVHFMHSRGVVHRDLKPENLLFSDPAGDNIKVVDFGFACLKR---E 527 (966)
Q Consensus 451 Ey~~gg~L~~~l~~~~~~~l~e~~~~~i~~Qil~aL~yLHs~~IiHRDLKP~NILl~~~~~~~iKL~DFGla~~~~---~ 527 (966)
||++||+|.+++...+ .+++..++.|+.||+.||+|||++|||||||||+||||+. ++.+||+|||+|+... .
T Consensus 422 E~~~gg~L~~~l~~~~--~~~~~~~~~~~~qi~~aL~~LH~~gIiHrDLKp~NILl~~--~g~ikL~DFGla~~~~~~~~ 497 (674)
T 3pfq_A 422 EYVNGGDLMYHIQQVG--RFKEPHAVFYAAEIAIGLFFLQSKGIIYRDLKLDNVMLDS--EGHIKIADFGMCKENIWDGV 497 (674)
T ss_dssp ECCCSCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHHTSEECCCCCSTTEEECS--SSCEEECCCTTCEECCCTTC
T ss_pred eCcCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCeEeccCChhhEEEcC--CCcEEEeecceeeccccCCc
Confidence 9999999999998765 5999999999999999999999999999999999999975 5699999999997532 2
Q ss_pred CCccccccccccCchhhccCCCCCCCcccchhhhhhhhhhhhcCCCCCCCcCcchhHHHHHHHHhcCCCCCCCCCCchhH
Q psy11767 528 SLHTPCFTLQYAAPEVLRQDKSGYDENCDLWSLGVILVNVLRQDKSGYDENCDLWSLGVILYTMLCGRVPFHARSRDDSA 607 (966)
Q Consensus 528 ~~~~~~gT~~Y~APEvl~~~~~~~~~~~Di~SlGvil~el~~~~~~~y~~~~DIWSlGvilyemltG~~Pf~~~~~~~~~ 607 (966)
...+.+||+.|+|||++.. ..|+.++|||||||++|||++|++||.+.+.
T Consensus 498 ~~~~~~GT~~Y~APE~l~~--------------------------~~~~~~~DvwSlGvilyelltG~~Pf~~~~~---- 547 (674)
T 3pfq_A 498 TTKTFCGTPDYIAPEIIAY--------------------------QPYGKSVDWWAFGVLLYEMLAGQAPFEGEDE---- 547 (674)
T ss_dssp CBCCCCSCSSSCCHHHHTC--------------------------CCBSTHHHHHHHHHHHHHHHHSSCSSCCSSH----
T ss_pred ccccccCCCcccCHhhhcC--------------------------CCCCccceEechHHHHHHHHcCCCCCCCCCH----
Confidence 3456789999999999852 3478899999999999999999999987543
Q ss_pred HHHHHHHHcCCCCCCchhhccCCHHHHHHHHHhcccCccccCChH---HHHHHhhhhHH
Q psy11767 608 LSIMARIKEGQFNFDAEAWSTVSSEAKELTKSLLTVNPAQRIRMM---RVKLTFHAFHQ 663 (966)
Q Consensus 608 ~~~~~~i~~~~~~~~~~~~~~is~e~~~Li~~~L~~dP~~R~t~~---~v~~~~~~~~~ 663 (966)
..++..|..+.+.++ ..+++++++||.+||+.||++|+++. .-....|+|++
T Consensus 548 ~~~~~~i~~~~~~~p----~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~ei~~h~ff~ 602 (674)
T 3pfq_A 548 DELFQSIMEHNVAYP----KSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKEHAFFR 602 (674)
T ss_dssp HHHHHHHHSSCCCCC----TTSCHHHHHHHHHHSCSSSTTCTTCSTTHHHHHHSSGGGS
T ss_pred HHHHHHHHhCCCCCC----ccCCHHHHHHHHHHccCCHHHCCCCCCCcHHHHhcCcccc
Confidence 345667777776654 35899999999999999999999971 11335677763
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-41 Score=382.48 Aligned_cols=257 Identities=39% Similarity=0.758 Sum_probs=217.0
Q ss_pred eecccccccccccccccccccEEEEEEEcCCCcEEEEEEecccc-------------ChHHHHHHHHHhcCCCCceEEEE
Q psy11767 372 FFEQYDMDLDKAGILGDGSYSVCRRCVEKSTGQEYAVKIISRKI-------------DCSEEINLLRACQGHPNIVNLHC 438 (966)
Q Consensus 372 ~~~~~~i~~~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~-------------~~~~Ei~iL~~l~~HpnIV~l~~ 438 (966)
|.++|.+ .+.||+|+||.||+|.+..+|+.||||++.... ...+|+.+|+.+.+||||+++++
T Consensus 92 ~~~~y~~----~~~lg~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~ 167 (365)
T 2y7j_A 92 FYQKYDP----KDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITLID 167 (365)
T ss_dssp HHHHEEE----EEEEEECSSEEEEEEEETTTCCEEEEEEEETTSSCCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEE
T ss_pred hhhhccc----ceEEecCCCEEEEEEEECCCCcEEEEEEEEccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeEEEE
Confidence 4444544 688999999999999999999999999986432 13468899998877999999999
Q ss_pred EEEeCCeEEEEEEccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCcEEEecCCCCCEEEEe
Q psy11767 439 VFQDEVHTYLVLELLKGGELLDRIRQKGRCGFTENEASRIMRQLVAAVHFMHSRGVVHRDLKPENLLFSDPAGDNIKVVD 518 (966)
Q Consensus 439 ~~~~~~~~~lVmEy~~gg~L~~~l~~~~~~~l~e~~~~~i~~Qil~aL~yLHs~~IiHRDLKP~NILl~~~~~~~iKL~D 518 (966)
++......|+||||++|++|.+++.... .+++..++.++.||+.||+|||+.||+||||||+|||++. ++.+||+|
T Consensus 168 ~~~~~~~~~lv~e~~~g~~L~~~l~~~~--~l~~~~~~~i~~qi~~~L~~LH~~gi~H~Dlkp~NIl~~~--~~~ikl~D 243 (365)
T 2y7j_A 168 SYESSSFMFLVFDLMRKGELFDYLTEKV--ALSEKETRSIMRSLLEAVSFLHANNIVHRDLKPENILLDD--NMQIRLSD 243 (365)
T ss_dssp EEEBSSEEEEEECCCTTCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECT--TCCEEECC
T ss_pred EEeeCCEEEEEEEeCCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECC--CCCEEEEe
Confidence 9999999999999999999999998764 5999999999999999999999999999999999999975 56899999
Q ss_pred ecccccccC--CCccccccccccCchhhccCCCCCCCcccchhhhhhhhhhhhcCCCCCCCcCcchhHHHHHHHHhcCCC
Q psy11767 519 FGFACLKRE--SLHTPCFTLQYAAPEVLRQDKSGYDENCDLWSLGVILVNVLRQDKSGYDENCDLWSLGVILYTMLCGRV 596 (966)
Q Consensus 519 FGla~~~~~--~~~~~~gT~~Y~APEvl~~~~~~~~~~~Di~SlGvil~el~~~~~~~y~~~~DIWSlGvilyemltG~~ 596 (966)
||++..... .....+||+.|+|||++..... .....|+.++|||||||++|+|++|+.
T Consensus 244 fG~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~--------------------~~~~~~~~~~Di~slG~il~ell~g~~ 303 (365)
T 2y7j_A 244 FGFSCHLEPGEKLRELCGTPGYLAPEILKCSMD--------------------ETHPGYGKEVDLWACGVILFTLLAGSP 303 (365)
T ss_dssp CTTCEECCTTCCBCCCCSCGGGCCHHHHHHTTC--------------------TTSCCBCTTHHHHHHHHHHHHHHHSSC
T ss_pred cCcccccCCCcccccCCCCCCccChhhcccccc--------------------ccCcCCCchhhHHhHHHHHHHHHHCCC
Confidence 999976543 2345689999999999863211 113357889999999999999999999
Q ss_pred CCCCCCCchhHHHHHHHHHcCCCCCCchhhccCCHHHHHHHHHhcccCccccCChHHHHHHhhhhH
Q psy11767 597 PFHARSRDDSALSIMARIKEGQFNFDAEAWSTVSSEAKELTKSLLTVNPAQRIRMMRVKLTFHAFH 662 (966)
Q Consensus 597 Pf~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~is~e~~~Li~~~L~~dP~~R~t~~~v~~~~~~~~ 662 (966)
||..... ...+..+..+.+.+....|..+++++.+||.+||..||++|||+.++ ..|+|+
T Consensus 304 pf~~~~~----~~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~el--l~hp~f 363 (365)
T 2y7j_A 304 PFWHRRQ----ILMLRMIMEGQYQFSSPEWDDRSSTVKDLISRLLQVDPEARLTAEQA--LQHPFF 363 (365)
T ss_dssp SSCCSSH----HHHHHHHHHTCCCCCHHHHSSSCHHHHHHHHHHSCSSTTTSCCHHHH--HHSGGG
T ss_pred CCCCCCH----HHHHHHHHhCCCCCCCcccccCCHHHHHHHHHHcCCChhHCcCHHHH--hcCccc
Confidence 9986542 34456677788888777888999999999999999999999999976 346664
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-41 Score=381.35 Aligned_cols=252 Identities=35% Similarity=0.577 Sum_probs=206.2
Q ss_pred cccccccccccEEEEEEEcCCCcEEEEEEecccc----------ChHHHHHHHHHhcCCCCceEEEEEEEeCCeEEEEEE
Q psy11767 382 KAGILGDGSYSVCRRCVEKSTGQEYAVKIISRKI----------DCSEEINLLRACQGHPNIVNLHCVFQDEVHTYLVLE 451 (966)
Q Consensus 382 ~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~----------~~~~Ei~iL~~l~~HpnIV~l~~~~~~~~~~~lVmE 451 (966)
..+.||+|+||+||+|.+..+++.||||++.... ...+|+.+|+.+ +|||||+++++|.+....|+|||
T Consensus 30 ~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~hpniv~~~~~~~~~~~~~lv~e 108 (345)
T 3hko_A 30 LKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKL-HHPNIARLYEVYEDEQYICLVME 108 (345)
T ss_dssp EEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHC---CHHHHHHHHHHHHHHC-CCTTBCCEEEEEECSSEEEEEEE
T ss_pred ecceeeecCCeEEEEEEECCCCceEEEeehhhhhhcccCHHHHHHHHHHHHHHHhC-CCCCcceeehhhccCCeEEEEEe
Confidence 3689999999999999999999999999986431 245699999998 59999999999999999999999
Q ss_pred ccCCCCHHHHHHhcC--------------------------------------CCCCCHHHHHHHHHHHHHHHHHHHhcC
Q psy11767 452 LLKGGELLDRIRQKG--------------------------------------RCGFTENEASRIMRQLVAAVHFMHSRG 493 (966)
Q Consensus 452 y~~gg~L~~~l~~~~--------------------------------------~~~l~e~~~~~i~~Qil~aL~yLHs~~ 493 (966)
||+||+|.+++.... ...+++..++.++.||+.||+|||++|
T Consensus 109 ~~~gg~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ 188 (345)
T 3hko_A 109 LCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSALHYLHNQG 188 (345)
T ss_dssp CCCSCBHHHHEEEEEETTTTEEEEEEECCCCCCSHHHHHHHHHSCC--CEEECCHHHHHHHHHHHHHHHHHHHHHHHHTT
T ss_pred CCCCCcHHHHHHHhhcccccccccccccccccccccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHHHCC
Confidence 999999999885210 112468889999999999999999999
Q ss_pred ceeccCCCCcEEEecCCCCCEEEEeecccccccC-------CCccccccccccCchhhccCCCCCCCcccchhhhhhhhh
Q psy11767 494 VVHRDLKPENLLFSDPAGDNIKVVDFGFACLKRE-------SLHTPCFTLQYAAPEVLRQDKSGYDENCDLWSLGVILVN 566 (966)
Q Consensus 494 IiHRDLKP~NILl~~~~~~~iKL~DFGla~~~~~-------~~~~~~gT~~Y~APEvl~~~~~~~~~~~Di~SlGvil~e 566 (966)
|+||||||+|||++......+||+|||++..... ......||+.|+|||++...
T Consensus 189 ivH~Dlkp~NIll~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~------------------- 249 (345)
T 3hko_A 189 ICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTT------------------- 249 (345)
T ss_dssp EECCCCCGGGEEESCSSSCCEEECCCTTCEEGGGTTCC--------CCCGGGCCHHHHTCS-------------------
T ss_pred ccccCCChhhEEEecCCCceEEEeeccccccccccCccccccccccCCCccccCchhhccC-------------------
Confidence 9999999999999754444899999999975432 12355789999999998532
Q ss_pred hhhcCCCCCCCcCcchhHHHHHHHHhcCCCCCCCCCCchhHHHHHHHHHcCCCCCCchhhccCCHHHHHHHHHhcccCcc
Q psy11767 567 VLRQDKSGYDENCDLWSLGVILYTMLCGRVPFHARSRDDSALSIMARIKEGQFNFDAEAWSTVSSEAKELTKSLLTVNPA 646 (966)
Q Consensus 567 l~~~~~~~y~~~~DIWSlGvilyemltG~~Pf~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~is~e~~~Li~~~L~~dP~ 646 (966)
...|+.++|||||||++|+|++|+.||.+.... .....+..+...+....+..+++++.+||.+||..||.
T Consensus 250 -----~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~----~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~ 320 (345)
T 3hko_A 250 -----NESYGPKCDAWSAGVLLHLLLMGAVPFPGVNDA----DTISQVLNKKLCFENPNYNVLSPLARDLLSNLLNRNVD 320 (345)
T ss_dssp -----SSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHH----HHHHHHHHCCCCTTSGGGGGSCHHHHHHHHHHSCSCTT
T ss_pred -----CCCCCcHHHHHHHHHHHHHHHHCCCCCCCCChH----HHHHHHHhcccccCCcccccCCHHHHHHHHHHcCCChh
Confidence 234788999999999999999999999876543 33455556666666666778999999999999999999
Q ss_pred ccCChHHHHHHhhhhHHh
Q psy11767 647 QRIRMMRVKLTFHAFHQA 664 (966)
Q Consensus 647 ~R~t~~~v~~~~~~~~~~ 664 (966)
+|||+.++ ..|+|+..
T Consensus 321 ~Rps~~~~--l~hp~~~~ 336 (345)
T 3hko_A 321 ERFDAMRA--LQHPWISQ 336 (345)
T ss_dssp TSCCHHHH--HHSHHHHT
T ss_pred HCCCHHHH--hcChhhcc
Confidence 99999876 45777653
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-41 Score=399.36 Aligned_cols=251 Identities=27% Similarity=0.499 Sum_probs=192.5
Q ss_pred ecccccccccccccccccccEEEEEEEcCCCcEEEEEEecccc-------ChHHHHHHHHHhcCCCCceEEEEEEEeC--
Q psy11767 373 FEQYDMDLDKAGILGDGSYSVCRRCVEKSTGQEYAVKIISRKI-------DCSEEINLLRACQGHPNIVNLHCVFQDE-- 443 (966)
Q Consensus 373 ~~~~~i~~~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~-------~~~~Ei~iL~~l~~HpnIV~l~~~~~~~-- 443 (966)
.++|.+ ++.||+|+||+||+|++..+|+.||||++.+.. ...+|+.+|+.+ +|||||+++++|...
T Consensus 61 ~~~y~~----~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l-~hpnIv~l~~~~~~~~~ 135 (464)
T 3ttj_A 61 LKRYQN----LKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCV-NHKNIISLLNVFTPQKT 135 (464)
T ss_dssp ETTEEE----EEEEEECSSCEEEEEEETTTTEEEEEEEEESGGGSHHHHHHHHHHHHHHHHC-CCTTBCCCSEEECSCCS
T ss_pred cCCeEE----EEEeecCCCeEEEEEEECCCCCEEEEEEECccccChHHHHHHHHHHHHHHhC-CCCCCCcEEEEEccCCc
Confidence 345554 789999999999999999999999999997542 244799999988 699999999999755
Q ss_pred ----CeEEEEEEccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCcEEEecCCCCCEEEEee
Q psy11767 444 ----VHTYLVLELLKGGELLDRIRQKGRCGFTENEASRIMRQLVAAVHFMHSRGVVHRDLKPENLLFSDPAGDNIKVVDF 519 (966)
Q Consensus 444 ----~~~~lVmEy~~gg~L~~~l~~~~~~~l~e~~~~~i~~Qil~aL~yLHs~~IiHRDLKP~NILl~~~~~~~iKL~DF 519 (966)
.+.|||||||++ +|.+.+.. .+++.+++.++.||+.||+|||++||+||||||+|||++. ++.+||+||
T Consensus 136 ~~~~~~~~lv~E~~~~-~l~~~~~~----~l~~~~~~~~~~qil~aL~~lH~~~iiHrDlkp~NIll~~--~~~~kl~DF 208 (464)
T 3ttj_A 136 LEEFQDVYLVMELMDA-NLCQVIQM----ELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKS--DCTLKILDF 208 (464)
T ss_dssp TTTCCEEEEEEECCSE-EHHHHHTS----CCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECT--TSCEEECCC
T ss_pred cccCCeEEEEEeCCCC-CHHHHHhh----cCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChHhEEEeC--CCCEEEEEE
Confidence 467999999965 57777643 4899999999999999999999999999999999999985 568999999
Q ss_pred cccccccCC--CccccccccccCchhhccCCCCCCCcccchhhhhhhhhhhhcCCCCCCCcCcchhHHHHHHHHhcCCCC
Q psy11767 520 GFACLKRES--LHTPCFTLQYAAPEVLRQDKSGYDENCDLWSLGVILVNVLRQDKSGYDENCDLWSLGVILYTMLCGRVP 597 (966)
Q Consensus 520 Gla~~~~~~--~~~~~gT~~Y~APEvl~~~~~~~~~~~Di~SlGvil~el~~~~~~~y~~~~DIWSlGvilyemltG~~P 597 (966)
|+|+..... ....+||+.|+|||++.. ..|+.++|||||||++|+|++|++|
T Consensus 209 G~a~~~~~~~~~~~~~gt~~y~aPE~~~~--------------------------~~~~~~~DiwSlG~il~ell~g~~p 262 (464)
T 3ttj_A 209 GLARTAGTSFMMTPYVVTRYYRAPEVILG--------------------------MGYKENVDIWSVGCIMGEMVRHKIL 262 (464)
T ss_dssp CCC-----CCCC----CCCTTCCHHHHTT--------------------------CCCCTTHHHHHHHHHHHHHHHSSCS
T ss_pred EeeeecCCCcccCCCcccccccCHHHHcC--------------------------CCCCHHHHHHHHHHHHHHHHhCCCC
Confidence 999765432 345689999999999853 2478899999999999999999999
Q ss_pred CCCCCCchhHHHHHHHHHcC------------------CCCCC----------------chhhccCCHHHHHHHHHhccc
Q psy11767 598 FHARSRDDSALSIMARIKEG------------------QFNFD----------------AEAWSTVSSEAKELTKSLLTV 643 (966)
Q Consensus 598 f~~~~~~~~~~~~~~~i~~~------------------~~~~~----------------~~~~~~is~e~~~Li~~~L~~ 643 (966)
|.+.+..+....++..+... ...+. .+.....++++++||.+||+.
T Consensus 263 F~g~~~~~~~~~i~~~lg~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~ 342 (464)
T 3ttj_A 263 FPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVI 342 (464)
T ss_dssp SCCSSHHHHHHHHHHHHCSCCHHHHTTSCHHHHHHHTTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCS
T ss_pred CCCCCHHHHHHHHHHhcCCCCHHHHHHcchhhhhHhhcccccCCCChHHhCcccccccccccccccCHHHHHHHHHHcCC
Confidence 99876544433333222110 00000 000111267899999999999
Q ss_pred CccccCChHHHHHHhhhhHH
Q psy11767 644 NPAQRIRMMRVKLTFHAFHQ 663 (966)
Q Consensus 644 dP~~R~t~~~v~~~~~~~~~ 663 (966)
||++|||+.++ ..|+|+.
T Consensus 343 dP~~R~ta~e~--L~Hp~~~ 360 (464)
T 3ttj_A 343 DPAKRISVDDA--LQHPYIN 360 (464)
T ss_dssp STTTSCCHHHH--HTSTTTG
T ss_pred ChhhCCCHHHH--hcChhhh
Confidence 99999999976 4577664
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-41 Score=369.23 Aligned_cols=250 Identities=28% Similarity=0.454 Sum_probs=196.7
Q ss_pred ccccccccccccEEEEEEEcCCCcEEEEEEecccc-------ChHHHHHHHHHhcCCCCceEEEEEEEeCCeEEEEEEcc
Q psy11767 381 DKAGILGDGSYSVCRRCVEKSTGQEYAVKIISRKI-------DCSEEINLLRACQGHPNIVNLHCVFQDEVHTYLVLELL 453 (966)
Q Consensus 381 ~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~-------~~~~Ei~iL~~l~~HpnIV~l~~~~~~~~~~~lVmEy~ 453 (966)
+..+.||+|+||+||+|.+ .+|+.||||++.... ...+|+.+|+.+ +||||+++++++.++...|+||||+
T Consensus 5 ~~~~~lg~G~~g~V~~~~~-~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~e~~ 82 (288)
T 1ob3_A 5 HGLEKIGEGTYGVVYKAQN-NYGETFALKKIRLEKEDEGIPSTTIREISILKEL-KHSNIVKLYDVIHTKKRLVLVFEHL 82 (288)
T ss_dssp EEEEEEEEETTEEEEEEEE-TTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGC-CCTTBCCEEEEEECSSCEEEEEECC
T ss_pred hhhhhcccCCCEEEEEEEc-CCCCEEEEEEEeccccccccchhHHHHHHHHHhc-CCCCEeeeeeEEccCCeEEEEEEec
Confidence 3468899999999999999 679999999986432 235799999988 5999999999999999999999999
Q ss_pred CCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCcEEEecCCCCCEEEEeecccccccC---CCc
Q psy11767 454 KGGELLDRIRQKGRCGFTENEASRIMRQLVAAVHFMHSRGVVHRDLKPENLLFSDPAGDNIKVVDFGFACLKRE---SLH 530 (966)
Q Consensus 454 ~gg~L~~~l~~~~~~~l~e~~~~~i~~Qil~aL~yLHs~~IiHRDLKP~NILl~~~~~~~iKL~DFGla~~~~~---~~~ 530 (966)
++ +|.+++.... ..+++.+++.++.||+.||+|||++||+||||||+|||++. ++.+||+|||++..... ...
T Consensus 83 ~~-~l~~~~~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~--~~~~kl~Dfg~~~~~~~~~~~~~ 158 (288)
T 1ob3_A 83 DQ-DLKKLLDVCE-GGLESVTAKSFLLQLLNGIAYCHDRRVLHRDLKPQNLLINR--EGELKIADFGLARAFGIPVRKYT 158 (288)
T ss_dssp SE-EHHHHHHTST-TCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECT--TSCEEECCTTHHHHHCC------
T ss_pred CC-CHHHHHHhcc-cCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcC--CCCEEEeECccccccCccccccc
Confidence 75 9999887653 36999999999999999999999999999999999999974 56899999999976432 223
Q ss_pred cccccccccCchhhccCCCCCCCcccchhhhhhhhhhhhcCCCCCCCcCcchhHHHHHHHHhcCCCCCCCCCCchhHHHH
Q psy11767 531 TPCFTLQYAAPEVLRQDKSGYDENCDLWSLGVILVNVLRQDKSGYDENCDLWSLGVILYTMLCGRVPFHARSRDDSALSI 610 (966)
Q Consensus 531 ~~~gT~~Y~APEvl~~~~~~~~~~~Di~SlGvil~el~~~~~~~y~~~~DIWSlGvilyemltG~~Pf~~~~~~~~~~~~ 610 (966)
..++|+.|+|||++.. ...|+.++|||||||++|+|++|++||.+.+..+....+
T Consensus 159 ~~~~t~~y~aPE~~~~-------------------------~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~ 213 (288)
T 1ob3_A 159 HEIVTLWYRAPDVLMG-------------------------SKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRI 213 (288)
T ss_dssp ---CCCTTCCHHHHTT-------------------------CCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHH
T ss_pred cccccccccCchheeC-------------------------CCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHH
Confidence 4578999999999852 234788999999999999999999999876544333333
Q ss_pred HHHHHcCCCC----------C-------C----chhhccCCHHHHHHHHHhcccCccccCChHHHHHHhhhhHH
Q psy11767 611 MARIKEGQFN----------F-------D----AEAWSTVSSEAKELTKSLLTVNPAQRIRMMRVKLTFHAFHQ 663 (966)
Q Consensus 611 ~~~i~~~~~~----------~-------~----~~~~~~is~e~~~Li~~~L~~dP~~R~t~~~v~~~~~~~~~ 663 (966)
+..+...... + . ......+++++.+||.+||+.||++|||+.++ ..|+|++
T Consensus 214 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~--l~hp~f~ 285 (288)
T 1ob3_A 214 FRILGTPNSKNWPNVTELPKYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQA--LEHAYFK 285 (288)
T ss_dssp HHHHCCCCTTTSTTGGGSTTCCTTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHH--HTSGGGG
T ss_pred HHHHCCCChhhchhhhcccccccccccccCccHHHHhhhcCHHHHHHHHHHcCCCcccCCCHHHH--hcCcchh
Confidence 3222111000 0 0 01123578999999999999999999999876 4466653
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-41 Score=396.38 Aligned_cols=242 Identities=33% Similarity=0.589 Sum_probs=199.3
Q ss_pred ccccccccccccEEEEEEEcCCCcEEEEEEeccc--------cChHHHHHHHHHhcCCCCceEEEEEEEeCCeEEEEEEc
Q psy11767 381 DKAGILGDGSYSVCRRCVEKSTGQEYAVKIISRK--------IDCSEEINLLRACQGHPNIVNLHCVFQDEVHTYLVLEL 452 (966)
Q Consensus 381 ~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~--------~~~~~Ei~iL~~l~~HpnIV~l~~~~~~~~~~~lVmEy 452 (966)
+..+.||+|+||.||+|.+..+|+.||||++... ....+|+.+|+.+ +|||||+++++|.+....||||||
T Consensus 151 ~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~l~~~~~~~~~~~lv~e~ 229 (446)
T 4ejn_A 151 EYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNS-RHPFLTALKYSFQTHDRLCFVMEY 229 (446)
T ss_dssp EEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHC-------------CCCCC-SCTTSCCEEEEEEETTEEEEEECC
T ss_pred EEeEEEeeCcCEEEEEEEEcCCCCEEEEEEEEhhhhhhhHHHHHHHHHHHHHHhC-CCCeEeeEEEEEeeCCEEEEEEee
Confidence 3468999999999999999999999999998643 1234577888777 599999999999999999999999
Q ss_pred cCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHh-cCceeccCCCCcEEEecCCCCCEEEEeeccccccc---CC
Q psy11767 453 LKGGELLDRIRQKGRCGFTENEASRIMRQLVAAVHFMHS-RGVVHRDLKPENLLFSDPAGDNIKVVDFGFACLKR---ES 528 (966)
Q Consensus 453 ~~gg~L~~~l~~~~~~~l~e~~~~~i~~Qil~aL~yLHs-~~IiHRDLKP~NILl~~~~~~~iKL~DFGla~~~~---~~ 528 (966)
|+||+|.+++.... .+++..++.++.||+.||+|||+ +||+||||||+|||++. ++.+||+|||+|+... ..
T Consensus 230 ~~~~~L~~~l~~~~--~~~~~~~~~~~~qi~~aL~~LH~~~giiHrDlkp~NIll~~--~~~~kl~DFG~a~~~~~~~~~ 305 (446)
T 4ejn_A 230 ANGGELFFHLSRER--VFSEDRARFYGAEIVSALDYLHSEKNVVYRDLKLENLMLDK--DGHIKITDFGLCKEGIKDGAT 305 (446)
T ss_dssp CSSCBHHHHHHHHS--CCCHHHHHHHHHHHHHHHHHHHHHTCCCCCCCCGGGEEECS--SSCEEECCCCCCCTTCC----
T ss_pred CCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHhhcCCEEECCCCHHHEEECC--CCCEEEccCCCceeccCCCcc
Confidence 99999999998765 59999999999999999999998 99999999999999975 5699999999997532 23
Q ss_pred CccccccccccCchhhccCCCCCCCcccchhhhhhhhhhhhcCCCCCCCcCcchhHHHHHHHHhcCCCCCCCCCCchhHH
Q psy11767 529 LHTPCFTLQYAAPEVLRQDKSGYDENCDLWSLGVILVNVLRQDKSGYDENCDLWSLGVILYTMLCGRVPFHARSRDDSAL 608 (966)
Q Consensus 529 ~~~~~gT~~Y~APEvl~~~~~~~~~~~Di~SlGvil~el~~~~~~~y~~~~DIWSlGvilyemltG~~Pf~~~~~~~~~~ 608 (966)
....+||+.|+|||++.. ..|+.++|||||||++|+|++|++||.+.+..
T Consensus 306 ~~~~~gt~~y~aPE~~~~--------------------------~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~---- 355 (446)
T 4ejn_A 306 MKTFCGTPEYLAPEVLED--------------------------NDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHE---- 355 (446)
T ss_dssp -CCSSSCGGGCCHHHHHT--------------------------SCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHH----
T ss_pred cccccCCccccCHhhcCC--------------------------CCCCCccchhhhHHHHHHHhhCCCCCCCCCHH----
Confidence 456789999999999853 24788999999999999999999999875432
Q ss_pred HHHHHHHcCCCCCCchhhccCCHHHHHHHHHhcccCccccC-----ChHHHHHHhhhhHH
Q psy11767 609 SIMARIKEGQFNFDAEAWSTVSSEAKELTKSLLTVNPAQRI-----RMMRVKLTFHAFHQ 663 (966)
Q Consensus 609 ~~~~~i~~~~~~~~~~~~~~is~e~~~Li~~~L~~dP~~R~-----t~~~v~~~~~~~~~ 663 (966)
.+...+..+...++ ..+++++++||.+||+.||.+|| ++.++ ..|+|+.
T Consensus 356 ~~~~~i~~~~~~~p----~~~~~~~~~li~~~L~~dP~~R~~~~~~t~~el--l~hp~f~ 409 (446)
T 4ejn_A 356 KLFELILMEEIRFP----RTLGPEAKSLLSGLLKKDPKQRLGGGSEDAKEI--MQHRFFA 409 (446)
T ss_dssp HHHHHHHHCCCCCC----TTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHH--HTSGGGT
T ss_pred HHHHHHHhCCCCCC----ccCCHHHHHHHHHHcccCHHHhCCCCCCCHHHH--HhCcccc
Confidence 34555555555443 35799999999999999999999 88765 4577764
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* 4azf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.2e-41 Score=389.47 Aligned_cols=253 Identities=24% Similarity=0.416 Sum_probs=204.9
Q ss_pred cccccccccccEEEEEEEcCCCcEEEEEEecccc----ChHHHHHHHHHhc-----CCCCceEEEEEEEeCCeEEEEEEc
Q psy11767 382 KAGILGDGSYSVCRRCVEKSTGQEYAVKIISRKI----DCSEEINLLRACQ-----GHPNIVNLHCVFQDEVHTYLVLEL 452 (966)
Q Consensus 382 ~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~----~~~~Ei~iL~~l~-----~HpnIV~l~~~~~~~~~~~lVmEy 452 (966)
..+.||+|+||+||+|.+..+++.||||++.... ...+|+.+|+.+. +|+||++++++|....+.|+||||
T Consensus 101 ~~~~LG~G~fg~V~~a~~~~~~~~vAvK~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~~iv~~~~~~~~~~~~~lv~e~ 180 (429)
T 3kvw_A 101 VLKVIGKGSFGQVVKAYDHKVHQHVALKMVRNEKRFHRQAAEEIRILEHLRKQDKDNTMNVIHMLENFTFRNHICMTFEL 180 (429)
T ss_dssp EEEEEEESSSEEEEEEEETTTTEEEEEEEECSCHHHHHHHHHHHHHHHHHHTTCTTSCSCBCCEEEEEEETTEEEEEECC
T ss_pred EEEEcccCccEEEEEEEECCCCcEEEEEEECCccchHHHHHHHHHHHHHHhhccccCCcCEEEEEeecccCCeEEEEEec
Confidence 3689999999999999999999999999997543 2446888888764 588999999999999999999999
Q ss_pred cCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCcEEEecCCCCCEEEEeecccccccCCCccc
Q psy11767 453 LKGGELLDRIRQKGRCGFTENEASRIMRQLVAAVHFMHSRGVVHRDLKPENLLFSDPAGDNIKVVDFGFACLKRESLHTP 532 (966)
Q Consensus 453 ~~gg~L~~~l~~~~~~~l~e~~~~~i~~Qil~aL~yLHs~~IiHRDLKP~NILl~~~~~~~iKL~DFGla~~~~~~~~~~ 532 (966)
+. ++|.+++.......+++..++.++.||+.||+|||++||+||||||+|||++......+||+|||+|+.......+.
T Consensus 181 ~~-~~L~~~l~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlKp~NILl~~~~~~~vkL~DFG~a~~~~~~~~~~ 259 (429)
T 3kvw_A 181 LS-MNLYELIKKNKFQGFSLPLVRKFAHSILQCLDALHKNRIIHCDLKPENILLKQQGRSGIKVIDFGSSCYEHQRVYTY 259 (429)
T ss_dssp CC-CBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHHTEECSCCSGGGEEESSTTSCCEEECCCTTCEETTCCCCSS
T ss_pred cC-CCHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEEccCCCcceEEeecccceecCCccccc
Confidence 95 79999998876557999999999999999999999999999999999999986433349999999998777666778
Q ss_pred cccccccCchhhccCCCCCCCcccchhhhhhhhhhhhcCCCCCCCcCcchhHHHHHHHHhcCCCCCCCCCCchhHHHHHH
Q psy11767 533 CFTLQYAAPEVLRQDKSGYDENCDLWSLGVILVNVLRQDKSGYDENCDLWSLGVILYTMLCGRVPFHARSRDDSALSIMA 612 (966)
Q Consensus 533 ~gT~~Y~APEvl~~~~~~~~~~~Di~SlGvil~el~~~~~~~y~~~~DIWSlGvilyemltG~~Pf~~~~~~~~~~~~~~ 612 (966)
++|+.|+|||++.. ..|+.++|||||||++|+|++|++||.+.+..+....++.
T Consensus 260 ~gt~~y~aPE~~~~--------------------------~~~~~~~DiwSlG~il~elltG~~pf~~~~~~~~l~~i~~ 313 (429)
T 3kvw_A 260 IQSRFYRAPEVILG--------------------------ARYGMPIDMWSLGCILAELLTGYPLLPGEDEGDQLACMIE 313 (429)
T ss_dssp CSCGGGCCHHHHHT--------------------------BCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHH
T ss_pred CCCCCccChHHHhC--------------------------CCCCchHHHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHH
Confidence 89999999999863 2378899999999999999999999988765443333332
Q ss_pred HHHcCC------------------CC----------------------------CCchhh-----ccCCHHHHHHHHHhc
Q psy11767 613 RIKEGQ------------------FN----------------------------FDAEAW-----STVSSEAKELTKSLL 641 (966)
Q Consensus 613 ~i~~~~------------------~~----------------------------~~~~~~-----~~is~e~~~Li~~~L 641 (966)
.+.... +. .....| ...++++.+||.+||
T Consensus 314 ~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~dli~~~L 393 (429)
T 3kvw_A 314 LLGMPSQKLLDASKRAKNFVSSKGYPRYCTVTTLSDGSVVLNGGRSRRGKLRGPPESREWGNALKGCDDPLFLDFLKQCL 393 (429)
T ss_dssp HHCCCCHHHHHTBTTHHHHBCTTSCBTTSCEECCCC--CEECCEECTTCCEECSTTCSCHHHHTTTCCCHHHHHHHHHHT
T ss_pred HcCCCCHHHHHhhhhhhhccCCCCCcccccccccccccccccccccchhhccCCccchhhHhhccccchHHHHHHHHHHC
Confidence 211000 00 000001 123788999999999
Q ss_pred ccCccccCChHHHHHHhhhhHH
Q psy11767 642 TVNPAQRIRMMRVKLTFHAFHQ 663 (966)
Q Consensus 642 ~~dP~~R~t~~~v~~~~~~~~~ 663 (966)
+.||++|||+.++ ..|+|++
T Consensus 394 ~~dP~~Rpta~e~--L~Hpw~~ 413 (429)
T 3kvw_A 394 EWDPAVRMTPGQA--LRHPWLR 413 (429)
T ss_dssp CSSTTTSCCHHHH--HTSTTTC
T ss_pred CCChhhCCCHHHH--hCChhhc
Confidence 9999999999976 4577764
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-41 Score=374.41 Aligned_cols=260 Identities=22% Similarity=0.373 Sum_probs=204.0
Q ss_pred eecccccccccccccccccccEEEEEEEcCCCcEEEEEEecccc------ChHHHHHHHHHhcCCCCceEEEEEEEeCC-
Q psy11767 372 FFEQYDMDLDKAGILGDGSYSVCRRCVEKSTGQEYAVKIISRKI------DCSEEINLLRACQGHPNIVNLHCVFQDEV- 444 (966)
Q Consensus 372 ~~~~~~i~~~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~------~~~~Ei~iL~~l~~HpnIV~l~~~~~~~~- 444 (966)
+.++|.+ .+.||+|+||+||+|.+..+|+.||||++.... ...+|+++|+.+. ||||+++++++.+..
T Consensus 7 ~~~~y~~----~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~~~ 81 (319)
T 4euu_A 7 SNHLWLL----SDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLN-HKNIVKLFAIEEETTT 81 (319)
T ss_dssp SSEEEEE----EEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCC-CTTBCCEEEEEECTTT
T ss_pred CCCCEEE----EEEecCCCCeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhcC-CCCcceEEEEeecCCC
Confidence 3345555 688999999999999999999999999986532 2347999999984 999999999998765
Q ss_pred -eEEEEEEccCCCCHHHHHHhcCC-CCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCcEEEec--CCCCCEEEEeec
Q psy11767 445 -HTYLVLELLKGGELLDRIRQKGR-CGFTENEASRIMRQLVAAVHFMHSRGVVHRDLKPENLLFSD--PAGDNIKVVDFG 520 (966)
Q Consensus 445 -~~~lVmEy~~gg~L~~~l~~~~~-~~l~e~~~~~i~~Qil~aL~yLHs~~IiHRDLKP~NILl~~--~~~~~iKL~DFG 520 (966)
..|+||||++||+|.+++..... ..+++.+++.++.||+.||+|||++||+||||||+|||+.. ...+.+||+|||
T Consensus 82 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~kL~Dfg 161 (319)
T 4euu_A 82 RHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFG 161 (319)
T ss_dssp CCEEEEEECCTTCBHHHHHHSGGGTTCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEECTTSCEEEEECCCT
T ss_pred ceEEEEEeCCCCCCHHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEEeccCCCCceEEEccCC
Confidence 78999999999999999976542 23999999999999999999999999999999999999821 134579999999
Q ss_pred ccccccCC--CccccccccccCchhhccCCCCCCCcccchhhhhhhhhhhhcCCCCCCCcCcchhHHHHHHHHhcCCCCC
Q psy11767 521 FACLKRES--LHTPCFTLQYAAPEVLRQDKSGYDENCDLWSLGVILVNVLRQDKSGYDENCDLWSLGVILYTMLCGRVPF 598 (966)
Q Consensus 521 la~~~~~~--~~~~~gT~~Y~APEvl~~~~~~~~~~~Di~SlGvil~el~~~~~~~y~~~~DIWSlGvilyemltG~~Pf 598 (966)
+|+..... ....++|+.|+|||++...... ......|+.++|||||||++|+|++|+.||
T Consensus 162 ~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~------------------~~~~~~~~~~~DiwslG~il~el~~g~~pf 223 (319)
T 4euu_A 162 AARELEDDEQFVSLYGTEEYLHPDMYERAVLR------------------KDHQKKYGATVDLWSIGVTFYHAATGSLPF 223 (319)
T ss_dssp TCEECCTTCCBCCCCSCGGGCCHHHHHHHTSC------------------CCCCCCBCTTHHHHHHHHHHHHHHHSSCSE
T ss_pred CceecCCCCceeecccCCCccCHHHhhhcccc------------------ccccCCCCcHHHHHHHHHHHHHHHhCCCCC
Confidence 99765432 3456789999999998532100 011345788999999999999999999999
Q ss_pred CCCCCchhHHHHHHHHHcCCCC---------------------CCchhhccCCHHHHHHHHHhcccCccccCChHHH
Q psy11767 599 HARSRDDSALSIMARIKEGQFN---------------------FDAEAWSTVSSEAKELTKSLLTVNPAQRIRMMRV 654 (966)
Q Consensus 599 ~~~~~~~~~~~~~~~i~~~~~~---------------------~~~~~~~~is~e~~~Li~~~L~~dP~~R~t~~~v 654 (966)
...........++..+..+... ........++..+.+||.+||+.||++|||+.++
T Consensus 224 ~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~~L~~dP~~R~s~~el 300 (319)
T 4euu_A 224 RPFEGPRRNKEVMYKIITGKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQF 300 (319)
T ss_dssp ECTTCGGGCHHHHHHHHHHCCTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHH
T ss_pred CCCCccchhHHHHHHHhcCCCcccchhhhcccCCccccCccCCcccccchhHHHHhHHHHHHhccCChhhhccHHHh
Confidence 8665544444555555443321 1111123456788999999999999999999976
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-41 Score=384.88 Aligned_cols=270 Identities=23% Similarity=0.410 Sum_probs=208.5
Q ss_pred CCCCcccccccceecccccccccccccccccccEEEEEEEcCCCcEEEEEEecccc----ChHHHHHHHHHhc-------
Q psy11767 360 PPNFDKIFKGSLFFEQYDMDLDKAGILGDGSYSVCRRCVEKSTGQEYAVKIISRKI----DCSEEINLLRACQ------- 428 (966)
Q Consensus 360 p~~~d~if~G~~~~~~~~i~~~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~----~~~~Ei~iL~~l~------- 428 (966)
+.++..+..|..+.++|.+ .+.||+|+||+||+|++..+|+.||||++.... ...+|+.+|+.+.
T Consensus 23 ~~~~~~~~~g~~~~~~y~~----~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~ 98 (397)
T 1wak_A 23 KGGYHLVKIGDLFNGRYHV----IRKLGWGHFSTVWLSWDIQGKKFVAMKVVKSAEHYTETALDEIRLLKSVRNSDPNDP 98 (397)
T ss_dssp C--CCSSCTTCEETTTEEE----EEEEEECSSEEEEEEEETTTTEEEEEEEECSCHHHHHHHHHHHHHHHHHHHSCTTCG
T ss_pred CCCceEEehhhhcCCeEEE----EEEeeecCCeeEEEEEecCCCeEEEEEEEecCCcchHHHHHHHHHHHHHhhcCCCCC
Confidence 3444555566777777766 688999999999999999999999999997542 2457999998875
Q ss_pred CCCCceEEEEEEE----eCCeEEEEEEccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhc-CceeccCCCCc
Q psy11767 429 GHPNIVNLHCVFQ----DEVHTYLVLELLKGGELLDRIRQKGRCGFTENEASRIMRQLVAAVHFMHSR-GVVHRDLKPEN 503 (966)
Q Consensus 429 ~HpnIV~l~~~~~----~~~~~~lVmEy~~gg~L~~~l~~~~~~~l~e~~~~~i~~Qil~aL~yLHs~-~IiHRDLKP~N 503 (966)
+||||++++++|. +..+.||||||+ +++|.+.+.......+++..++.++.||+.||+|||++ ||+||||||+|
T Consensus 99 ~~~~iv~~~~~~~~~~~~~~~~~lv~e~~-~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~givHrDikp~N 177 (397)
T 1wak_A 99 NREMVVQLLDDFKISGVNGTHICMVFEVL-GHHLLKWIIKSNYQGLPLPCVKKIIQQVLQGLDYLHTKCRIIHTDIKPEN 177 (397)
T ss_dssp GGGGBCCEEEEEEEEETTEEEEEEEECCC-CCBHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTCEECCCCSGGG
T ss_pred CcceeeeeecceeecCCCCceEEEEEecc-CccHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHH
Confidence 3889999999998 556899999999 77888888776545799999999999999999999999 99999999999
Q ss_pred EEEecCC-----------------------------------------------CCCEEEEeecccccccCCCccccccc
Q psy11767 504 LLFSDPA-----------------------------------------------GDNIKVVDFGFACLKRESLHTPCFTL 536 (966)
Q Consensus 504 ILl~~~~-----------------------------------------------~~~iKL~DFGla~~~~~~~~~~~gT~ 536 (966)
||++... ...+||+|||+|+.........+||+
T Consensus 178 Ill~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DfG~a~~~~~~~~~~~gt~ 257 (397)
T 1wak_A 178 ILLSVNEQYIRRLAAEATEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKHFTEDIQTR 257 (397)
T ss_dssp EEECCCHHHHHHHHHHHC---------------------CCTTSCCTTSGGGGGGCCEEECCGGGCEETTBCSCSCCSCG
T ss_pred eeEeccchhhhhhhhhhHHHhhcCCCCCCCCccccCCcccccccccccccccccccceEeccccccccccccCccCCCCC
Confidence 9997421 12799999999987766666778999
Q ss_pred cccCchhhccCCCCCCCcccchhhhhhhhhhhhcCCCCCCCcCcchhHHHHHHHHhcCCCCCCCCCCchh-----HHHHH
Q psy11767 537 QYAAPEVLRQDKSGYDENCDLWSLGVILVNVLRQDKSGYDENCDLWSLGVILYTMLCGRVPFHARSRDDS-----ALSIM 611 (966)
Q Consensus 537 ~Y~APEvl~~~~~~~~~~~Di~SlGvil~el~~~~~~~y~~~~DIWSlGvilyemltG~~Pf~~~~~~~~-----~~~~~ 611 (966)
.|+|||++.. ..|+.++|||||||++|+|++|+.||...+..+. ....+
T Consensus 258 ~y~aPE~~~~--------------------------~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~ 311 (397)
T 1wak_A 258 QYRSLEVLIG--------------------------SGYNTPADIWSTACMAFELATGDYLFEPHSGEEYTRDEDHIALI 311 (397)
T ss_dssp GGCCHHHHHT--------------------------SCCCTHHHHHHHHHHHHHHHHSSCSCCCCCCSSSCHHHHHHHHH
T ss_pred cccCChhhcC--------------------------CCCCcHHHHHHHHHHHHHHhhCCCCCCCCcccccCchHHHHHHH
Confidence 9999999863 2378899999999999999999999987653221 11111
Q ss_pred HHHHc---------CCCCC---C-----------------------chhhccCCHHHHHHHHHhcccCccccCChHHHHH
Q psy11767 612 ARIKE---------GQFNF---D-----------------------AEAWSTVSSEAKELTKSLLTVNPAQRIRMMRVKL 656 (966)
Q Consensus 612 ~~i~~---------~~~~~---~-----------------------~~~~~~is~e~~~Li~~~L~~dP~~R~t~~~v~~ 656 (966)
..+.. +.+.. . .......+.++.+||.+||+.||++|||+.++
T Consensus 312 ~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~-- 389 (397)
T 1wak_A 312 IELLGKVPRKLIVAGKYSKEFFTKKGDLKHITKLKPWGLFEVLVEKYEWSQEEAAGFTDFLLPMLELIPEKRATAAEC-- 389 (397)
T ss_dssp HHHHCSCCHHHHHHCTTGGGTBCTTSSBSSCCCCCCCCHHHHHHHTSCCCHHHHHHHHHHHGGGGCSSGGGSCCHHHH--
T ss_pred HHhcCCCChHHhhcccccccccCCccccccccccCCcchhHhhhhhcccchhhHHHHHHHHHHHhccChhhcCCHHHH--
Confidence 11111 11100 0 00012345678999999999999999999976
Q ss_pred HhhhhH
Q psy11767 657 TFHAFH 662 (966)
Q Consensus 657 ~~~~~~ 662 (966)
..|+|+
T Consensus 390 l~hp~~ 395 (397)
T 1wak_A 390 LRHPWL 395 (397)
T ss_dssp HTSGGG
T ss_pred hhCccc
Confidence 346665
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-41 Score=389.97 Aligned_cols=260 Identities=27% Similarity=0.405 Sum_probs=198.1
Q ss_pred ccccceecccccccccccccccccccEEEEEEEcCCCcEEEEEEecccc-------ChHHHHHHHHHhcCCCCceEEEEE
Q psy11767 367 FKGSLFFEQYDMDLDKAGILGDGSYSVCRRCVEKSTGQEYAVKIISRKI-------DCSEEINLLRACQGHPNIVNLHCV 439 (966)
Q Consensus 367 f~G~~~~~~~~i~~~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~-------~~~~Ei~iL~~l~~HpnIV~l~~~ 439 (966)
+....+.++|.+ .+.||+|+||+||+|++..+|+.||||++.+.. ...+|+++|+.+ +|||||+++++
T Consensus 19 ~~~~~i~~~y~~----~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~nIv~l~~~ 93 (432)
T 3n9x_A 19 IKNVHVPDNYII----KHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCKRILREITILNRL-KSDYIIRLYDL 93 (432)
T ss_dssp GGGCCCCTTEEE----EEEEEEETTEEEEEEEETTTTEEEEEEEECSTTTSHHHHHHHHHHHHHHHHC-CCTTBCCEEEE
T ss_pred CCcceecCCEEE----EEEEeecCCEEEEEEEECCCCcEEEEEEeCchhcChHHHHHHHHHHHHHHHc-CCCCcceEEEE
Confidence 444445556655 689999999999999999999999999997542 244799999998 59999999999
Q ss_pred EEeC-----CeEEEEEEccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCcEEEecCCCCCE
Q psy11767 440 FQDE-----VHTYLVLELLKGGELLDRIRQKGRCGFTENEASRIMRQLVAAVHFMHSRGVVHRDLKPENLLFSDPAGDNI 514 (966)
Q Consensus 440 ~~~~-----~~~~lVmEy~~gg~L~~~l~~~~~~~l~e~~~~~i~~Qil~aL~yLHs~~IiHRDLKP~NILl~~~~~~~i 514 (966)
+... ...|+||||+. |+|.+++.... .+++..++.++.||+.||+|||++||+||||||+|||++. ++.+
T Consensus 94 ~~~~~~~~~~~~~lv~e~~~-~~L~~~~~~~~--~l~~~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~--~~~~ 168 (432)
T 3n9x_A 94 IIPDDLLKFDELYIVLEIAD-SDLKKLFKTPI--FLTEEHIKTILYNLLLGENFIHESGIIHRDLKPANCLLNQ--DCSV 168 (432)
T ss_dssp CCCSCTTTCCCEEEEEECCS-EEHHHHHHSSC--CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECT--TCCE
T ss_pred EecCCCCcCCeEEEEEecCC-cCHHHHHhccC--CCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCHHHeEECC--CCCE
Confidence 9876 57999999995 69999997654 5999999999999999999999999999999999999974 5689
Q ss_pred EEEeecccccccCC-------------------------CccccccccccCchhhccCCCCCCCcccchhhhhhhhhhhh
Q psy11767 515 KVVDFGFACLKRES-------------------------LHTPCFTLQYAAPEVLRQDKSGYDENCDLWSLGVILVNVLR 569 (966)
Q Consensus 515 KL~DFGla~~~~~~-------------------------~~~~~gT~~Y~APEvl~~~~~~~~~~~Di~SlGvil~el~~ 569 (966)
||+|||+|+..... ....+||++|+|||++..
T Consensus 169 kL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~----------------------- 225 (432)
T 3n9x_A 169 KVCDFGLARTINSEKDTNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILL----------------------- 225 (432)
T ss_dssp EECCCTTCEEC-------------------------------CCCCCTTCCHHHHTT-----------------------
T ss_pred EEccCCCcccccccccccccccccccccccccccchhccccCCCCCccccCHHHHhc-----------------------
Confidence 99999999764321 245678999999998742
Q ss_pred cCCCCCCCcCcchhHHHHHHHHhcC-----------CCCCCCCCC-----------------chhHHHHHHH--------
Q psy11767 570 QDKSGYDENCDLWSLGVILYTMLCG-----------RVPFHARSR-----------------DDSALSIMAR-------- 613 (966)
Q Consensus 570 ~~~~~y~~~~DIWSlGvilyemltG-----------~~Pf~~~~~-----------------~~~~~~~~~~-------- 613 (966)
...|+.++|||||||++|||++| .++|.+.+. .++...++..
T Consensus 226 --~~~~~~~~DiwSlG~il~ell~g~~p~~~~~~~~~p~f~g~~~~~~~~~~~~~~~~~~~~~~ql~~i~~~~g~p~~~~ 303 (432)
T 3n9x_A 226 --QENYTKSIDIWSTGCIFAELLNMLQSHINDPTNRFPLFPGSSCFPLSPDRNSKKVHEKSNRDQLNIIFNIIGTPTEDD 303 (432)
T ss_dssp --CSCCCTHHHHHHHHHHHHHHHTTCTTTCSSGGGCCCSCCCSCSCC----------CHHHHHHHHHHHHHHHCSCCHHH
T ss_pred --CCCCCcccccchHHHHHHHHHhcccccccccccccccCCCccccccCcccccccccccchHHHHHHHHHhcCCCCHHH
Confidence 23478899999999999999984 444444321 0111111111
Q ss_pred ------------HHcCCCCC---CchhhccCCHHHHHHHHHhcccCccccCChHHHHHHhhhhHH
Q psy11767 614 ------------IKEGQFNF---DAEAWSTVSSEAKELTKSLLTVNPAQRIRMMRVKLTFHAFHQ 663 (966)
Q Consensus 614 ------------i~~~~~~~---~~~~~~~is~e~~~Li~~~L~~dP~~R~t~~~v~~~~~~~~~ 663 (966)
+....... ....++.+++++.+||.+||+.||++|||+.++ ..|+|+.
T Consensus 304 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~--L~Hp~f~ 366 (432)
T 3n9x_A 304 LKNINKPEVIKYIKLFPHRKPINLKQKYPSISDDGINLLESMLKFNPNKRITIDQA--LDHPYLK 366 (432)
T ss_dssp HHTCCCHHHHHHHHTSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSSTTTSCCHHHH--HTCGGGT
T ss_pred HHhccCHHHHHHHHhCCCCCCCCHHHHCCCCCHHHHHHHHHHhcCCcccCCCHHHH--hcChhhh
Confidence 11100000 012335689999999999999999999999876 4577764
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-40 Score=379.09 Aligned_cols=246 Identities=21% Similarity=0.376 Sum_probs=202.0
Q ss_pred ccccccccccccEEEEEEEc-------CCCcEEEEEEeccccC------hHHHHHHHHHhcCCCCceEEEEEEEeCCeEE
Q psy11767 381 DKAGILGDGSYSVCRRCVEK-------STGQEYAVKIISRKID------CSEEINLLRACQGHPNIVNLHCVFQDEVHTY 447 (966)
Q Consensus 381 ~~~~~LG~G~fG~Vy~a~~~-------~tg~~vAvK~i~~~~~------~~~Ei~iL~~l~~HpnIV~l~~~~~~~~~~~ 447 (966)
+..+.||+|+||.||+|.+. .++..||||++..... ..+|+.+|+.+.+|||||+++++|.++...|
T Consensus 84 ~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~~~~~ 163 (370)
T 2psq_A 84 TLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLY 163 (370)
T ss_dssp EEEEEESCCSSSEEEEEEEETCSTTCTTCEEEEEEEECCTTCBHHHHHHHHHHHHHHHHSCCCTTBCCEEEEECSSSSCE
T ss_pred EeeeEEeeCCCeeEEEEEEecccCcCcCcceeEEEEEecCCcCHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEccCCCEE
Confidence 34688999999999999975 3567899999975432 4569999999867999999999999999999
Q ss_pred EEEEccCCCCHHHHHHhcCC--------------CCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCcEEEecCCCCC
Q psy11767 448 LVLELLKGGELLDRIRQKGR--------------CGFTENEASRIMRQLVAAVHFMHSRGVVHRDLKPENLLFSDPAGDN 513 (966)
Q Consensus 448 lVmEy~~gg~L~~~l~~~~~--------------~~l~e~~~~~i~~Qil~aL~yLHs~~IiHRDLKP~NILl~~~~~~~ 513 (966)
+||||++||+|.+++..... ..+++.++..++.||+.||+|||++||+||||||+|||++. ++.
T Consensus 164 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~--~~~ 241 (370)
T 2psq_A 164 VIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVTE--NNV 241 (370)
T ss_dssp EEEECCTTCBHHHHHHHTCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECT--TCC
T ss_pred EEEEcCCCCCHHHHHHhhCCccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCCeeccccchhhEEECC--CCC
Confidence 99999999999999987542 24899999999999999999999999999999999999974 569
Q ss_pred EEEEeecccccccCC-----CccccccccccCchhhccCCCCCCCcccchhhhhhhhhhhhcCCCCCCCcCcchhHHHHH
Q psy11767 514 IKVVDFGFACLKRES-----LHTPCFTLQYAAPEVLRQDKSGYDENCDLWSLGVILVNVLRQDKSGYDENCDLWSLGVIL 588 (966)
Q Consensus 514 iKL~DFGla~~~~~~-----~~~~~gT~~Y~APEvl~~~~~~~~~~~Di~SlGvil~el~~~~~~~y~~~~DIWSlGvil 588 (966)
+||+|||+|+..... .....+|+.|+|||++.. ..|+.++|||||||++
T Consensus 242 ~kl~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~--------------------------~~~~~~~DvwslG~il 295 (370)
T 2psq_A 242 MKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFD--------------------------RVYTHQSDVWSFGVLM 295 (370)
T ss_dssp EEECCCSSCEETTCCCTTCTTTTTTSCGGGCCHHHHHT--------------------------CCCCHHHHHHHHHHHH
T ss_pred EEEccccCCcccCcccceecccCCCcccceECHhHhcC--------------------------CCCCcHHHHHHHHHHH
Confidence 999999999754321 223456889999999853 2478899999999999
Q ss_pred HHHhc-CCCCCCCCCCchhHHHHHHHHHcCCCCCCchhhccCCHHHHHHHHHhcccCccccCChHHHHHHhhhh
Q psy11767 589 YTMLC-GRVPFHARSRDDSALSIMARIKEGQFNFDAEAWSTVSSEAKELTKSLLTVNPAQRIRMMRVKLTFHAF 661 (966)
Q Consensus 589 yemlt-G~~Pf~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~is~e~~~Li~~~L~~dP~~R~t~~~v~~~~~~~ 661 (966)
|||++ |..||.+....+ ++..+..+... .....++.++.+||.+||..||++|||+.++...+...
T Consensus 296 ~ellt~g~~p~~~~~~~~----~~~~~~~~~~~---~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~L~~i 362 (370)
T 2psq_A 296 WEIFTLGGSPYPGIPVEE----LFKLLKEGHRM---DKPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRI 362 (370)
T ss_dssp HHHHTTSCCSSTTCCGGG----HHHHHHTTCCC---CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred HHHHcCCCCCCCCCCHHH----HHHHHhcCCCC---CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence 99999 999998765433 33445544322 12246789999999999999999999999886655443
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-41 Score=395.38 Aligned_cols=252 Identities=33% Similarity=0.595 Sum_probs=211.4
Q ss_pred ccceecccccccccccccccccccEEEEEEEcCCCcEEEEEEecccc--------ChHHHHHHHHHhcCCCCceEEEEEE
Q psy11767 369 GSLFFEQYDMDLDKAGILGDGSYSVCRRCVEKSTGQEYAVKIISRKI--------DCSEEINLLRACQGHPNIVNLHCVF 440 (966)
Q Consensus 369 G~~~~~~~~i~~~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~--------~~~~Ei~iL~~l~~HpnIV~l~~~~ 440 (966)
+....++|.+ .+.||+|+||+||+|++..+|+.||||++.+.. ...+|+.+|+.+ +||||+++++++
T Consensus 11 ~~~~~~~Y~l----~~~LG~G~fg~V~~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l-~HpnIv~l~~~~ 85 (476)
T 2y94_A 11 GRVKIGHYIL----GDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLF-RHPHIIKLYQVI 85 (476)
T ss_dssp SCCEETTEEE----EEEEECCSSSCEEEEEETTTCCEEEEEEEEHHHHHHTTTHHHHHHHHHHHTTC-CCTTBCCEEEEE
T ss_pred CCceecCEEE----EEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhC-CCCCCCcEEEEE
Confidence 3344455655 688999999999999999999999999996431 245799999888 599999999999
Q ss_pred EeCCeEEEEEEccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCcEEEecCCCCCEEEEeec
Q psy11767 441 QDEVHTYLVLELLKGGELLDRIRQKGRCGFTENEASRIMRQLVAAVHFMHSRGVVHRDLKPENLLFSDPAGDNIKVVDFG 520 (966)
Q Consensus 441 ~~~~~~~lVmEy~~gg~L~~~l~~~~~~~l~e~~~~~i~~Qil~aL~yLHs~~IiHRDLKP~NILl~~~~~~~iKL~DFG 520 (966)
.+....|+|||||+||+|.+++.+.+ .+++.+++.++.||+.||+|||++||+||||||+|||++. ++.+||+|||
T Consensus 86 ~~~~~~~lv~E~~~gg~L~~~l~~~~--~l~~~~~~~i~~qi~~aL~~LH~~givHrDLkp~NIll~~--~~~vkL~DFG 161 (476)
T 2y94_A 86 STPSDIFMVMEYVSGGELFDYICKNG--RLDEKESRRLFQQILSGVDYCHRHMVVHRDLKPENVLLDA--HMNAKIADFG 161 (476)
T ss_dssp ECSSEEEEEEECCSSEEHHHHTTSSS--SCCHHHHHHHHHHHHHHHHHHHTTTEECSCCSGGGEEECT--TCCEEECCCS
T ss_pred EECCEEEEEEeCCCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCCCcccccHHHEEEec--CCCeEEEecc
Confidence 99999999999999999999997654 5999999999999999999999999999999999999974 5689999999
Q ss_pred ccccccC--CCccccccccccCchhhccCCCCCCCcccchhhhhhhhhhhhcCCCCCCCcCcchhHHHHHHHHhcCCCCC
Q psy11767 521 FACLKRE--SLHTPCFTLQYAAPEVLRQDKSGYDENCDLWSLGVILVNVLRQDKSGYDENCDLWSLGVILYTMLCGRVPF 598 (966)
Q Consensus 521 la~~~~~--~~~~~~gT~~Y~APEvl~~~~~~~~~~~Di~SlGvil~el~~~~~~~y~~~~DIWSlGvilyemltG~~Pf 598 (966)
++..... ...+.+||+.|+|||++... ..++.++|||||||++|+|++|+.||
T Consensus 162 ~a~~~~~~~~~~~~~gt~~y~aPE~~~~~-------------------------~~~~~~~DiwSlGvil~elltG~~Pf 216 (476)
T 2y94_A 162 LSNMMSDGEFLRTSCGSPNYAAPEVISGR-------------------------LYAGPEVDIWSSGVILYALLCGTLPF 216 (476)
T ss_dssp SCEECCTTCCBCCCCSCSTTCCHHHHTTC-------------------------CBCSHHHHHHHHHHHHHHHHHSSCSS
T ss_pred chhhccccccccccCCCcCeEChhhccCC-------------------------CCCCCcceehhhHHHHHHHhhCCCCC
Confidence 9976543 24567899999999998532 12367899999999999999999999
Q ss_pred CCCCCchhHHHHHHHHHcCCCCCCchhhccCCHHHHHHHHHhcccCccccCChHHHHHHhhhhHHh
Q psy11767 599 HARSRDDSALSIMARIKEGQFNFDAEAWSTVSSEAKELTKSLLTVNPAQRIRMMRVKLTFHAFHQA 664 (966)
Q Consensus 599 ~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~is~e~~~Li~~~L~~dP~~R~t~~~v~~~~~~~~~~ 664 (966)
.+.+.. .+..++..+.+..+ ..+++++.+||.+||..||++|||+.++ ..|+|+..
T Consensus 217 ~~~~~~----~~~~~i~~~~~~~p----~~~s~~~~~Li~~~L~~dP~~Rpt~~ei--l~hp~~~~ 272 (476)
T 2y94_A 217 DDDHVP----TLFKKICDGIFYTP----QYLNPSVISLLKHMLQVDPMKRATIKDI--REHEWFKQ 272 (476)
T ss_dssp CCSSSH----HHHHHHHTTCCCCC----TTCCHHHHHHHHHHTCSSTTTSCCHHHH--HTCHHHHT
T ss_pred CCCCHH----HHHHHHhcCCcCCC----ccCCHHHHHHHHHHcCCCchhCcCHHHH--HhCHHhhh
Confidence 876543 34566777765433 3578999999999999999999999976 45677653
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.8e-41 Score=374.64 Aligned_cols=257 Identities=26% Similarity=0.406 Sum_probs=199.8
Q ss_pred eecccccccccccccccccccEEEEEEEcCCCcEEEEEEecccc-------ChHHHHHHHHHhcCCCCceEEEEEEEeCC
Q psy11767 372 FFEQYDMDLDKAGILGDGSYSVCRRCVEKSTGQEYAVKIISRKI-------DCSEEINLLRACQGHPNIVNLHCVFQDEV 444 (966)
Q Consensus 372 ~~~~~~i~~~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~-------~~~~Ei~iL~~l~~HpnIV~l~~~~~~~~ 444 (966)
..++|.+ .+.||+|+||+||+|++..+|+.||||++.... ...+|+.+|+.+ +|||||++++++.++.
T Consensus 32 ~~~~y~~----~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~ 106 (329)
T 3gbz_A 32 SIDRYRR----ITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEEGVPGTAIREVSLLKEL-QHRNIIELKSVIHHNH 106 (329)
T ss_dssp CGGGEEE----EEEEEECSSSEEEEEEETTTTEEEEEEECCCCC--------CHHHHHHGGGC-CCTTBCCEEEEEEETT
T ss_pred chhhEEE----EEEEEecCCeEEEEEEECCCCceEEEEEEcccccccccchhHHHHHHHHHHc-CCCCcceEEEEEecCC
Confidence 3455555 688999999999999999999999999986432 245799999998 5999999999999999
Q ss_pred eEEEEEEccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCcEEEecC---CCCCEEEEeecc
Q psy11767 445 HTYLVLELLKGGELLDRIRQKGRCGFTENEASRIMRQLVAAVHFMHSRGVVHRDLKPENLLFSDP---AGDNIKVVDFGF 521 (966)
Q Consensus 445 ~~~lVmEy~~gg~L~~~l~~~~~~~l~e~~~~~i~~Qil~aL~yLHs~~IiHRDLKP~NILl~~~---~~~~iKL~DFGl 521 (966)
..||||||++ |+|.+++.... .+++.+++.++.||+.||+|||++||+||||||+|||++.. ..+.+||+|||+
T Consensus 107 ~~~lv~e~~~-~~L~~~~~~~~--~~~~~~~~~i~~ql~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~~kl~Dfg~ 183 (329)
T 3gbz_A 107 RLHLIFEYAE-NDLKKYMDKNP--DVSMRVIKSFLYQLINGVNFCHSRRCLHRDLKPQNLLLSVSDASETPVLKIGDFGL 183 (329)
T ss_dssp EEEEEEECCS-EEHHHHHHHCT--TCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEC-----CCEEEECCTTH
T ss_pred EEEEEEecCC-CCHHHHHhhcC--CCCHHHHHHHHHHHHHHHHHHHhCCEECCCCCHHHEEEecCCCCccceEEECcCCC
Confidence 9999999997 59999998765 59999999999999999999999999999999999999632 234699999999
Q ss_pred cccccC---CCccccccccccCchhhccCCCCCCCcccchhhhhhhhhhhhcCCCCCCCcCcchhHHHHHHHHhcCCCCC
Q psy11767 522 ACLKRE---SLHTPCFTLQYAAPEVLRQDKSGYDENCDLWSLGVILVNVLRQDKSGYDENCDLWSLGVILYTMLCGRVPF 598 (966)
Q Consensus 522 a~~~~~---~~~~~~gT~~Y~APEvl~~~~~~~~~~~Di~SlGvil~el~~~~~~~y~~~~DIWSlGvilyemltG~~Pf 598 (966)
|+.... .....++|+.|+|||++.. ...|+.++|||||||++|+|++|+.||
T Consensus 184 a~~~~~~~~~~~~~~~t~~y~aPE~~~~-------------------------~~~~~~~~DiwslG~il~ell~g~~pf 238 (329)
T 3gbz_A 184 ARAFGIPIRQFTHEIITLWYRPPEILLG-------------------------SRHYSTSVDIWSIACIWAEMLMKTPLF 238 (329)
T ss_dssp HHHHC-----------CCTTCCHHHHTT-------------------------CCCCCTHHHHHHHHHHHHHHHHSSCSS
T ss_pred ccccCCcccccCCCcCCccccCHHHhcC-------------------------CCCCCcHHHHHHHHHHHHHHHHCCCCc
Confidence 976542 2344568999999999852 234788999999999999999999999
Q ss_pred CCCCCchhHHHHHHHHHcCCCC-CC---------------------chhhccCCHHHHHHHHHhcccCccccCChHHHHH
Q psy11767 599 HARSRDDSALSIMARIKEGQFN-FD---------------------AEAWSTVSSEAKELTKSLLTVNPAQRIRMMRVKL 656 (966)
Q Consensus 599 ~~~~~~~~~~~~~~~i~~~~~~-~~---------------------~~~~~~is~e~~~Li~~~L~~dP~~R~t~~~v~~ 656 (966)
.+....+....++..+...... +. ......+++++++||.+||+.||++|||+.++
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~-- 316 (329)
T 3gbz_A 239 PGDSEIDQLFKIFEVLGLPDDTTWPGVTALPDWKQSFPKFRGKTLKRVLGALLDDEGLDLLTAMLEMDPVKRISAKNA-- 316 (329)
T ss_dssp CCSSHHHHHHHHHHHHCCCCTTTSTTGGGSTTCCTTCCCCCCCCHHHHHGGGSCHHHHHHHHHHTCSSGGGSCCHHHH--
T ss_pred CCCCHHHHHHHHHHHhCCCchhhhhhhhhhhhhhhhhhhhccccHhhhcccccCHHHHHHHHHHccCChhhCCCHHHH--
Confidence 8766544333333322111000 00 00112278999999999999999999999976
Q ss_pred HhhhhHH
Q psy11767 657 TFHAFHQ 663 (966)
Q Consensus 657 ~~~~~~~ 663 (966)
..|+|+.
T Consensus 317 l~hp~f~ 323 (329)
T 3gbz_A 317 LEHPYFS 323 (329)
T ss_dssp HTSGGGS
T ss_pred hCCcccC
Confidence 4577754
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.7e-41 Score=371.04 Aligned_cols=245 Identities=24% Similarity=0.377 Sum_probs=192.3
Q ss_pred ccccccccccccEEEEEEEcCCCcEEEEEEeccccC-------hHHHHHHHHHhcCCCCceEEEEEEEeCCeEEEEEEcc
Q psy11767 381 DKAGILGDGSYSVCRRCVEKSTGQEYAVKIISRKID-------CSEEINLLRACQGHPNIVNLHCVFQDEVHTYLVLELL 453 (966)
Q Consensus 381 ~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~~-------~~~Ei~iL~~l~~HpnIV~l~~~~~~~~~~~lVmEy~ 453 (966)
+..+.||+|+||+||+|.+ +|+.||||++..... ..+|+++|+.+ +|||||++++++.+....|+|||||
T Consensus 40 ~i~~~lG~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~hp~iv~~~~~~~~~~~~~lv~e~~ 116 (309)
T 3p86_A 40 NIKEKIGAGSFGTVHRAEW--HGSDVAVKILMEQDFHAERVNEFLREVAIMKRL-RHPNIVLFMGAVTQPPNLSIVTEYL 116 (309)
T ss_dssp EEEEEEEECSSEEEEEEEE--TTEEEEEEEECCCCCSHHHHHHHHHHHHHHHHC-CCTTBCCEEEEECSTTCCEEEEECC
T ss_pred eeeeEeecCCCeEEEEEEE--CCCcEEEEEecCCCCCHHHHHHHHHHHHHHHhC-CCCCEeeEEEEEEECCceEEEEecC
Confidence 3468899999999999987 588999999865432 34699999998 5999999999999999999999999
Q ss_pred CCCCHHHHHHhcCC-CCCCHHHHHHHHHHHHHHHHHHHhcC--ceeccCCCCcEEEecCCCCCEEEEeecccccccCC--
Q psy11767 454 KGGELLDRIRQKGR-CGFTENEASRIMRQLVAAVHFMHSRG--VVHRDLKPENLLFSDPAGDNIKVVDFGFACLKRES-- 528 (966)
Q Consensus 454 ~gg~L~~~l~~~~~-~~l~e~~~~~i~~Qil~aL~yLHs~~--IiHRDLKP~NILl~~~~~~~iKL~DFGla~~~~~~-- 528 (966)
++|+|.+++..... ..+++..++.++.||+.||+|||++| |+||||||+|||++. ++.+||+|||+++.....
T Consensus 117 ~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~ivH~Dikp~NIll~~--~~~~kL~Dfg~a~~~~~~~~ 194 (309)
T 3p86_A 117 SRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHNRNPPIVHRNLKSPNLLVDK--KYTVKVCDFGLSRLKASTFL 194 (309)
T ss_dssp TTCBHHHHHHSTTHHHHSCHHHHHHHHHHHHHHHHHHHTSSSCCCCTTCCGGGEEECT--TCCEEECCCC----------
T ss_pred CCCcHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCEECCCCChhhEEEeC--CCcEEECCCCCCcccccccc
Confidence 99999999976431 13899999999999999999999999 999999999999975 569999999999754432
Q ss_pred -CccccccccccCchhhccCCCCCCCcccchhhhhhhhhhhhcCCCCCCCcCcchhHHHHHHHHhcCCCCCCCCCCchhH
Q psy11767 529 -LHTPCFTLQYAAPEVLRQDKSGYDENCDLWSLGVILVNVLRQDKSGYDENCDLWSLGVILYTMLCGRVPFHARSRDDSA 607 (966)
Q Consensus 529 -~~~~~gT~~Y~APEvl~~~~~~~~~~~Di~SlGvil~el~~~~~~~y~~~~DIWSlGvilyemltG~~Pf~~~~~~~~~ 607 (966)
....+||+.|+|||++.. ..++.++|||||||++|+|++|+.||...+..+
T Consensus 195 ~~~~~~gt~~y~aPE~~~~--------------------------~~~~~~~DiwslG~il~elltg~~Pf~~~~~~~-- 246 (309)
T 3p86_A 195 SSKSAAGTPEWMAPEVLRD--------------------------EPSNEKSDVYSFGVILWELATLQQPWGNLNPAQ-- 246 (309)
T ss_dssp -------CCTTSCHHHHTT--------------------------CCCCTTHHHHHHHHHHHHHHHCCCTTTTSCHHH--
T ss_pred ccccCCCCccccChhhhcC--------------------------CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH--
Confidence 335678999999999853 236789999999999999999999998765432
Q ss_pred HHHHHHHHcCCCCCCchhhccCCHHHHHHHHHhcccCccccCChHHHHHHhhhhH
Q psy11767 608 LSIMARIKEGQFNFDAEAWSTVSSEAKELTKSLLTVNPAQRIRMMRVKLTFHAFH 662 (966)
Q Consensus 608 ~~~~~~i~~~~~~~~~~~~~~is~e~~~Li~~~L~~dP~~R~t~~~v~~~~~~~~ 662 (966)
....+....... .....+++++.+||.+||..||++|||+.++...+..+.
T Consensus 247 --~~~~~~~~~~~~--~~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~~L~~~~ 297 (309)
T 3p86_A 247 --VVAAVGFKCKRL--EIPRNLNPQVAAIIEGCWTNEPWKRPSFATIMDLLRPLI 297 (309)
T ss_dssp --HHHHHHHSCCCC--CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred --HHHHHHhcCCCC--CCCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHH
Confidence 223332221111 123468999999999999999999999999876665543
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.5e-41 Score=374.00 Aligned_cols=252 Identities=27% Similarity=0.433 Sum_probs=198.0
Q ss_pred ccccccccccccEEEEEEEcCCCcEEEEEEecccc------ChHHHHHHHHHhcCCCCceEEEEEEEeCCeEEEEEEccC
Q psy11767 381 DKAGILGDGSYSVCRRCVEKSTGQEYAVKIISRKI------DCSEEINLLRACQGHPNIVNLHCVFQDEVHTYLVLELLK 454 (966)
Q Consensus 381 ~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~------~~~~Ei~iL~~l~~HpnIV~l~~~~~~~~~~~lVmEy~~ 454 (966)
...+.||+|+||+||+|.+..+|+.||||++.... ...+|+.+|+.+ +||||+++++++.++...|+||||++
T Consensus 5 ~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~e~~~ 83 (324)
T 3mtl_A 5 IKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDL-KHANIVTLHDIIHTEKSLTLVFEYLD 83 (324)
T ss_dssp EEEEEEEECSSEEEEEEEETTTCCEEEEEEECC------CCCCCCCHHHHSCC-CCTTBCCEEEEEECSSCEEEEEECCS
T ss_pred EEEEEEcCCCCEEEEEEEECCCCcEEEEEEEecccccccchhHHHHHHHHHhc-CCCCCCeeeeEEeeCCEEEEEecccc
Confidence 34688999999999999999999999999986432 234699999888 59999999999999999999999996
Q ss_pred CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCcEEEecCCCCCEEEEeecccccccC---CCcc
Q psy11767 455 GGELLDRIRQKGRCGFTENEASRIMRQLVAAVHFMHSRGVVHRDLKPENLLFSDPAGDNIKVVDFGFACLKRE---SLHT 531 (966)
Q Consensus 455 gg~L~~~l~~~~~~~l~e~~~~~i~~Qil~aL~yLHs~~IiHRDLKP~NILl~~~~~~~iKL~DFGla~~~~~---~~~~ 531 (966)
|+|.+++...+. .+++..++.++.||+.||+|||++||+||||||+|||++. ++.+||+|||++..... ....
T Consensus 84 -~~l~~~~~~~~~-~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~--~~~~kl~Dfg~a~~~~~~~~~~~~ 159 (324)
T 3mtl_A 84 -KDLKQYLDDCGN-IINMHNVKLFLFQLLRGLAYCHRQKVLHRDLKPQNLLINE--RGELKLADFGLARAKSIPTKTYDN 159 (324)
T ss_dssp -EEHHHHHHHTTT-CCCHHHHHHHHHHHHHHHHHHHHTTEEESSCCGGGEEECT--TCCEEECSSSEEECC---------
T ss_pred -cCHHHHHHhcCC-CCCHHHHHHHHHHHHHHHHHHHHCCccCCCcCHHHEEECC--CCCEEEccCcccccccCCcccccc
Confidence 699999887643 6999999999999999999999999999999999999975 56899999999975432 2234
Q ss_pred ccccccccCchhhccCCCCCCCcccchhhhhhhhhhhhcCCCCCCCcCcchhHHHHHHHHhcCCCCCCCCCCchhHHHHH
Q psy11767 532 PCFTLQYAAPEVLRQDKSGYDENCDLWSLGVILVNVLRQDKSGYDENCDLWSLGVILYTMLCGRVPFHARSRDDSALSIM 611 (966)
Q Consensus 532 ~~gT~~Y~APEvl~~~~~~~~~~~Di~SlGvil~el~~~~~~~y~~~~DIWSlGvilyemltG~~Pf~~~~~~~~~~~~~ 611 (966)
.++|+.|+|||++.. ...|+.++|||||||++|+|++|+.||.+.+..+....+.
T Consensus 160 ~~~t~~y~aPE~~~~-------------------------~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~ 214 (324)
T 3mtl_A 160 EVVTLWYRPPDILLG-------------------------STDYSTQIDMWGVGCIFYEMATGRPLFPGSTVEEQLHFIF 214 (324)
T ss_dssp ---CGGGCCHHHHTT-------------------------CCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHH
T ss_pred ccCcccccChhhhcC-------------------------CCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH
Confidence 578999999999852 2347889999999999999999999998866544333322
Q ss_pred HHHHcCCCC---------------CC-------chhhccCCHHHHHHHHHhcccCccccCChHHHHHHhhhhHHh
Q psy11767 612 ARIKEGQFN---------------FD-------AEAWSTVSSEAKELTKSLLTVNPAQRIRMMRVKLTFHAFHQA 664 (966)
Q Consensus 612 ~~i~~~~~~---------------~~-------~~~~~~is~e~~~Li~~~L~~dP~~R~t~~~v~~~~~~~~~~ 664 (966)
..+...... ++ ...++.+++++.+||.+||+.||++|||+.++ ..|+|+..
T Consensus 215 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~--l~hp~f~~ 287 (324)
T 3mtl_A 215 RILGTPTEETWPGILSNEEFKTYNYPKYRAEALLSHAPRLDSDGADLLTKLLQFEGRNRISAEDA--MKHPFFLS 287 (324)
T ss_dssp HHHCCCCTTTSTTGGGCHHHHHTCCCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSGGGSCCHHHH--TTSGGGGG
T ss_pred HHhCCCChHhchhhhcchhhcccccccccchhhhhhcCCCCHHHHHHHHHHcCcCcccCCCHHHH--hcChhhhh
Confidence 222111000 00 11224578999999999999999999999876 45777653
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.8e-41 Score=368.73 Aligned_cols=251 Identities=30% Similarity=0.483 Sum_probs=198.2
Q ss_pred cccccccccccEEEEEEEcCCCcEEEEEEeccccC-------hHHHHHHHHHhcCCCCceEEEEEEEeCCeEEEEEEccC
Q psy11767 382 KAGILGDGSYSVCRRCVEKSTGQEYAVKIISRKID-------CSEEINLLRACQGHPNIVNLHCVFQDEVHTYLVLELLK 454 (966)
Q Consensus 382 ~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~~-------~~~Ei~iL~~l~~HpnIV~l~~~~~~~~~~~lVmEy~~ 454 (966)
..+.||+|+||+||+|.+..+|+.||||++..... ..+|+.+|+.+ +||||+++++++.+....|+|||||+
T Consensus 7 ~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~ 85 (311)
T 4agu_A 7 KIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQL-KHPNLVNLLEVFRRKRRLHLVFEYCD 85 (311)
T ss_dssp EEEEEEECSSEEEEEEEETTTCCEEEEEEECCCCC-HHHHHHHHHHHHHHHHC-CCTTBCCEEEEEEETTEEEEEEECCS
T ss_pred EeeEEeecCCeEEEEEEeCCCCcEEEEEEeeccccchHHHHHHHHHHHHHHhC-CCCCccchhheeecCCeEEEEEEeCC
Confidence 36899999999999999999999999999865432 34699999998 59999999999999999999999999
Q ss_pred CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCcEEEecCCCCCEEEEeecccccccC---CCcc
Q psy11767 455 GGELLDRIRQKGRCGFTENEASRIMRQLVAAVHFMHSRGVVHRDLKPENLLFSDPAGDNIKVVDFGFACLKRE---SLHT 531 (966)
Q Consensus 455 gg~L~~~l~~~~~~~l~e~~~~~i~~Qil~aL~yLHs~~IiHRDLKP~NILl~~~~~~~iKL~DFGla~~~~~---~~~~ 531 (966)
+++|.+++.... .+++..++.++.||+.||+|||++||+||||||+|||++. ++.+||+|||++..... ....
T Consensus 86 ~~~l~~~~~~~~--~~~~~~~~~i~~~l~~~l~~lH~~~ivH~dlkp~Nil~~~--~~~~kl~Dfg~~~~~~~~~~~~~~ 161 (311)
T 4agu_A 86 HTVLHELDRYQR--GVPEHLVKSITWQTLQAVNFCHKHNCIHRDVKPENILITK--HSVIKLCDFGFARLLTGPSDYYDD 161 (311)
T ss_dssp EEHHHHHHHTSS--CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECT--TSCEEECCCTTCEECC--------
T ss_pred CchHHHHHhhhc--CCCHHHHHHHHHHHHHHHHHHHHCCCcCCCCChhhEEEcC--CCCEEEeeCCCchhccCcccccCC
Confidence 999888876544 5999999999999999999999999999999999999975 56999999999976542 2235
Q ss_pred ccccccccCchhhccCCCCCCCcccchhhhhhhhhhhhcCCCCCCCcCcchhHHHHHHHHhcCCCCCCCCCCchhHHHHH
Q psy11767 532 PCFTLQYAAPEVLRQDKSGYDENCDLWSLGVILVNVLRQDKSGYDENCDLWSLGVILYTMLCGRVPFHARSRDDSALSIM 611 (966)
Q Consensus 532 ~~gT~~Y~APEvl~~~~~~~~~~~Di~SlGvil~el~~~~~~~y~~~~DIWSlGvilyemltG~~Pf~~~~~~~~~~~~~ 611 (966)
.++|+.|+|||++.. ...|+.++|||||||++|+|++|++||.+....+....+.
T Consensus 162 ~~~~~~y~aPE~~~~-------------------------~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~ 216 (311)
T 4agu_A 162 EVATRWYRSPELLVG-------------------------DTQYGPPVDVWAIGCVFAELLSGVPLWPGKSDVDQLYLIR 216 (311)
T ss_dssp ----GGGCCHHHHHT-------------------------CSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHH
T ss_pred CcCCccccChHHHhc-------------------------CCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH
Confidence 578999999999852 2347889999999999999999999998866544332222
Q ss_pred HHHHc-----------C----CCCCC--------chhhccCCHHHHHHHHHhcccCccccCChHHHHHHhhhhHHh
Q psy11767 612 ARIKE-----------G----QFNFD--------AEAWSTVSSEAKELTKSLLTVNPAQRIRMMRVKLTFHAFHQA 664 (966)
Q Consensus 612 ~~i~~-----------~----~~~~~--------~~~~~~is~e~~~Li~~~L~~dP~~R~t~~~v~~~~~~~~~~ 664 (966)
..+.. . ....+ ...++.+++++.+||.+||..||++|||+.++ ..|+|++.
T Consensus 217 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~el--l~hp~f~~ 290 (311)
T 4agu_A 217 KTLGDLIPRHQQVFSTNQYFSGVKIPDPEDMEPLELKFPNISYPALGLLKGCLHMDPTERLTCEQL--LHHPYFEN 290 (311)
T ss_dssp HHHCSCCHHHHHHHHTCGGGTTCCCCCCSSCCCHHHHCTTCCHHHHHHHHHHCCSSTTTSCCHHHH--HTSGGGTT
T ss_pred HHhcccccccccccccccccccCcCCCccccchhhhhcccccHHHHHHHHHHccCChhhcCCHHHH--hcChHHHh
Confidence 21110 0 00000 11235689999999999999999999999976 45777653
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-40 Score=362.95 Aligned_cols=258 Identities=39% Similarity=0.733 Sum_probs=215.8
Q ss_pred eecccccccccccccccccccEEEEEEEcCCCcEEEEEEecccc--------------ChHHHHHHHHHhcCCCCceEEE
Q psy11767 372 FFEQYDMDLDKAGILGDGSYSVCRRCVEKSTGQEYAVKIISRKI--------------DCSEEINLLRACQGHPNIVNLH 437 (966)
Q Consensus 372 ~~~~~~i~~~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~--------------~~~~Ei~iL~~l~~HpnIV~l~ 437 (966)
+.++|.+ .+.||+|+||.||+|.+..+|+.||||++.... ...+|+.+|+.+.+||||++++
T Consensus 15 ~~~~y~~----~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~ 90 (298)
T 1phk_A 15 FYENYEP----KEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLK 90 (298)
T ss_dssp CTTTEEE----EEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEE
T ss_pred hhhccce----eeeecCCCceEEEEEEEcCcCceEEEEEEecccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeeee
Confidence 4455554 688999999999999999999999999986432 1346899999987799999999
Q ss_pred EEEEeCCeEEEEEEccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCcEEEecCCCCCEEEE
Q psy11767 438 CVFQDEVHTYLVLELLKGGELLDRIRQKGRCGFTENEASRIMRQLVAAVHFMHSRGVVHRDLKPENLLFSDPAGDNIKVV 517 (966)
Q Consensus 438 ~~~~~~~~~~lVmEy~~gg~L~~~l~~~~~~~l~e~~~~~i~~Qil~aL~yLHs~~IiHRDLKP~NILl~~~~~~~iKL~ 517 (966)
+++.++...|+||||+++++|.+++.... .+++..++.++.||+.||+|||++||+||||||+|||++. ++.+||+
T Consensus 91 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~--~~~~kl~ 166 (298)
T 1phk_A 91 DTYETNTFFFLVFDLMKKGELFDYLTEKV--TLSEKETRKIMRALLEVICALHKLNIVHRDLKPENILLDD--DMNIKLT 166 (298)
T ss_dssp EEEECSSEEEEEEECCTTCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECT--TCCEEEC
T ss_pred eeeccCCeEEEEEeccCCCcHHHHHhccC--CCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcceEEEcC--CCcEEEe
Confidence 99999999999999999999999998764 5899999999999999999999999999999999999974 5689999
Q ss_pred eecccccccC--CCccccccccccCchhhccCCCCCCCcccchhhhhhhhhhhhcCCCCCCCcCcchhHHHHHHHHhcCC
Q psy11767 518 DFGFACLKRE--SLHTPCFTLQYAAPEVLRQDKSGYDENCDLWSLGVILVNVLRQDKSGYDENCDLWSLGVILYTMLCGR 595 (966)
Q Consensus 518 DFGla~~~~~--~~~~~~gT~~Y~APEvl~~~~~~~~~~~Di~SlGvil~el~~~~~~~y~~~~DIWSlGvilyemltG~ 595 (966)
|||++..... .....++|+.|+|||++.... ......|+.++|||||||++|+|++|+
T Consensus 167 dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~--------------------~~~~~~~~~~~Di~slG~~l~~l~~g~ 226 (298)
T 1phk_A 167 DFGFSCQLDPGEKLREVCGTPSYLAPEIIECSM--------------------NDNHPGYGKEVDMWSTGVIMYTLLAGS 226 (298)
T ss_dssp CCTTCEECCTTCCBCCCCSCGGGCCHHHHHHHH--------------------CTTSCCBCTHHHHHHHHHHHHHHHHSS
T ss_pred cccchhhcCCCcccccccCCccccCHHHhcccc--------------------ccccccCCcccccHhHHHHHHHHHHCC
Confidence 9999976543 234567899999999885311 012345788999999999999999999
Q ss_pred CCCCCCCCchhHHHHHHHHHcCCCCCCchhhccCCHHHHHHHHHhcccCccccCChHHHHHHhhhhHH
Q psy11767 596 VPFHARSRDDSALSIMARIKEGQFNFDAEAWSTVSSEAKELTKSLLTVNPAQRIRMMRVKLTFHAFHQ 663 (966)
Q Consensus 596 ~Pf~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~is~e~~~Li~~~L~~dP~~R~t~~~v~~~~~~~~~ 663 (966)
.||..... ......+..+.+.+....+..++.++.+||.+||..||++|||+.++ ..|+|++
T Consensus 227 ~p~~~~~~----~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l--l~h~~~~ 288 (298)
T 1phk_A 227 PPFWHRKQ----MLMLRMIMSGNYQFGSPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEA--LAHPFFQ 288 (298)
T ss_dssp CSSCCSSH----HHHHHHHHHTCCCCCTTTGGGSCHHHHHHHHHHCCSSGGGSCCHHHH--TTSGGGC
T ss_pred CCCcCccH----HHHHHHHhcCCcccCcccccccCHHHHHHHHHHccCCcccCCCHHHH--HhChHhh
Confidence 99986543 23455666777777766777899999999999999999999999876 3566653
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=9.9e-41 Score=377.79 Aligned_cols=249 Identities=31% Similarity=0.541 Sum_probs=204.5
Q ss_pred cccccccccccccEEEEEEEc---CCCcEEEEEEecccc---------ChHHHHHHHHHhcCCCCceEEEEEEEeCCeEE
Q psy11767 380 LDKAGILGDGSYSVCRRCVEK---STGQEYAVKIISRKI---------DCSEEINLLRACQGHPNIVNLHCVFQDEVHTY 447 (966)
Q Consensus 380 ~~~~~~LG~G~fG~Vy~a~~~---~tg~~vAvK~i~~~~---------~~~~Ei~iL~~l~~HpnIV~l~~~~~~~~~~~ 447 (966)
|+..+.||+|+||+||+|++. .+|+.||||++.... ...+|+.+|+.+.+||||+++++++.++...|
T Consensus 56 y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~ 135 (355)
T 1vzo_A 56 FELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTETKLH 135 (355)
T ss_dssp EEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETTEEE
T ss_pred eEEEEEeccCCCEEEEEEEEcccCCCCeEEEEEEEeHHHhhhhhhHHHHHHHHHHHHHHccCCCceeEEEEEEeeCceEE
Confidence 344688999999999999995 589999999986421 24469999999978999999999999999999
Q ss_pred EEEEccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCcEEEecCCCCCEEEEeecccccccC
Q psy11767 448 LVLELLKGGELLDRIRQKGRCGFTENEASRIMRQLVAAVHFMHSRGVVHRDLKPENLLFSDPAGDNIKVVDFGFACLKRE 527 (966)
Q Consensus 448 lVmEy~~gg~L~~~l~~~~~~~l~e~~~~~i~~Qil~aL~yLHs~~IiHRDLKP~NILl~~~~~~~iKL~DFGla~~~~~ 527 (966)
||||||++|+|.+++.... .+++.+++.++.||+.||+|||++||+||||||+|||++. ++.+||+|||+++....
T Consensus 136 lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~--~~~~kl~DfG~a~~~~~ 211 (355)
T 1vzo_A 136 LILDYINGGELFTHLSQRE--RFTEHEVQIYVGEIVLALEHLHKLGIIYRDIKLENILLDS--NGHVVLTDFGLSKEFVA 211 (355)
T ss_dssp EEECCCCSCBHHHHHHHHS--CCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECT--TSCEEESCSSEEEECCG
T ss_pred EEeecCCCCCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECC--CCcEEEeeCCCCeeccc
Confidence 9999999999999998765 5999999999999999999999999999999999999974 56899999999975432
Q ss_pred ----CCccccccccccCchhhccCCCCCCCcccchhhhhhhhhhhhcCCCCCCCcCcchhHHHHHHHHhcCCCCCCCCCC
Q psy11767 528 ----SLHTPCFTLQYAAPEVLRQDKSGYDENCDLWSLGVILVNVLRQDKSGYDENCDLWSLGVILYTMLCGRVPFHARSR 603 (966)
Q Consensus 528 ----~~~~~~gT~~Y~APEvl~~~~~~~~~~~Di~SlGvil~el~~~~~~~y~~~~DIWSlGvilyemltG~~Pf~~~~~ 603 (966)
.....+||+.|+|||++... ...|+.++|||||||++|+|++|+.||.....
T Consensus 212 ~~~~~~~~~~gt~~y~aPE~~~~~------------------------~~~~~~~~DvwslG~il~ell~g~~pf~~~~~ 267 (355)
T 1vzo_A 212 DETERAYDFCGTIEYMAPDIVRGG------------------------DSGHDKAVDWWSLGVLMYELLTGASPFTVDGE 267 (355)
T ss_dssp GGGGGGCGGGSCCTTCCHHHHTTC------------------------C---CTHHHHHHHHHHHHHHHHSSCTTSCTTS
T ss_pred CCCCcccCcccCcCccChhhhcCC------------------------CCCCCchhhHHHHHHHHHHHHHCCCCCccCCc
Confidence 22345789999999998532 23467889999999999999999999987655
Q ss_pred chhHHHHHHHHHcCCCCCCchhhccCCHHHHHHHHHhcccCccccC-----ChHHHHHHhhhhH
Q psy11767 604 DDSALSIMARIKEGQFNFDAEAWSTVSSEAKELTKSLLTVNPAQRI-----RMMRVKLTFHAFH 662 (966)
Q Consensus 604 ~~~~~~~~~~i~~~~~~~~~~~~~~is~e~~~Li~~~L~~dP~~R~-----t~~~v~~~~~~~~ 662 (966)
......+...+......+ ...++..+++||.+||..||++|| ++.++ ..|+|+
T Consensus 268 ~~~~~~~~~~~~~~~~~~----~~~~~~~~~~li~~~L~~dP~~R~~~~~~s~~el--l~h~~f 325 (355)
T 1vzo_A 268 KNSQAEISRRILKSEPPY----PQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEI--KEHLFF 325 (355)
T ss_dssp CCCHHHHHHHHHHCCCCC----CTTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHH--HTSGGG
T ss_pred cchHHHHHHHHhccCCCC----CcccCHHHHHHHHHHhhhCHHHhcCCCCCCHHHH--HcCcch
Confidence 444445555555544333 246789999999999999999999 77765 446665
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=9.7e-41 Score=379.84 Aligned_cols=250 Identities=26% Similarity=0.459 Sum_probs=196.8
Q ss_pred cccccccccccccEEEEEEEcCCCcEEEEEEeccccC-------hHHHHHHHHHhcCCCCceEEEEEEEeCC------eE
Q psy11767 380 LDKAGILGDGSYSVCRRCVEKSTGQEYAVKIISRKID-------CSEEINLLRACQGHPNIVNLHCVFQDEV------HT 446 (966)
Q Consensus 380 ~~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~~-------~~~Ei~iL~~l~~HpnIV~l~~~~~~~~------~~ 446 (966)
|...+.||+|+||.||+|.+..+|+.||||++..... ..+|+++|+.+. |||||++++++.... ..
T Consensus 27 y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~-hpnIv~l~~~~~~~~~~~~~~~~ 105 (367)
T 1cm8_A 27 YRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMR-HENVIGLLDVFTPDETLDDFTDF 105 (367)
T ss_dssp EEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCC-BTTBCCCSEEECSCSSTTTCCCC
T ss_pred EEEeEEeeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCC-CcCCCCceeeEecCCccccCceE
Confidence 3447889999999999999999999999999865322 347999999985 999999999998763 46
Q ss_pred EEEEEccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCcEEEecCCCCCEEEEeeccccccc
Q psy11767 447 YLVLELLKGGELLDRIRQKGRCGFTENEASRIMRQLVAAVHFMHSRGVVHRDLKPENLLFSDPAGDNIKVVDFGFACLKR 526 (966)
Q Consensus 447 ~lVmEy~~gg~L~~~l~~~~~~~l~e~~~~~i~~Qil~aL~yLHs~~IiHRDLKP~NILl~~~~~~~iKL~DFGla~~~~ 526 (966)
|+||||+ +++|.+++... .+++..++.++.||+.||+|||++||+||||||+|||++. ++.+||+|||+|+...
T Consensus 106 ~lv~e~~-~~~L~~~~~~~---~l~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~--~~~~kl~Dfg~a~~~~ 179 (367)
T 1cm8_A 106 YLVMPFM-GTDLGKLMKHE---KLGEDRIQFLVYQMLKGLRYIHAAGIIHRDLKPGNLAVNE--DCELKILDFGLARQAD 179 (367)
T ss_dssp EEEEECC-SEEHHHHHHHC---CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECT--TCCEEECCCTTCEECC
T ss_pred EEEEecC-CCCHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCCccccCcCHHHEEEcC--CCCEEEEeeecccccc
Confidence 9999999 88999998763 5899999999999999999999999999999999999975 5689999999998776
Q ss_pred CCCccccccccccCchhhccCCCCCCCcccchhhhhhhhhhhhcCCCCCCCcCcchhHHHHHHHHhcCCCCCCCCCCchh
Q psy11767 527 ESLHTPCFTLQYAAPEVLRQDKSGYDENCDLWSLGVILVNVLRQDKSGYDENCDLWSLGVILYTMLCGRVPFHARSRDDS 606 (966)
Q Consensus 527 ~~~~~~~gT~~Y~APEvl~~~~~~~~~~~Di~SlGvil~el~~~~~~~y~~~~DIWSlGvilyemltG~~Pf~~~~~~~~ 606 (966)
......++|+.|+|||++.. ...|+.++||||+||++|+|++|++||.+.+..+.
T Consensus 180 ~~~~~~~~t~~y~aPE~~~~-------------------------~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~ 234 (367)
T 1cm8_A 180 SEMTGYVVTRWYRAPEVILN-------------------------WMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQ 234 (367)
T ss_dssp SSCCSSCSCGGGCCTHHHHT-------------------------TTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHH
T ss_pred cccCcCcCCCCcCCHHHHhC-------------------------CCCCChhhhHHHHHHHHHHHHhCCCCCCCCCHHHH
Confidence 66666789999999999853 13478899999999999999999999988665433
Q ss_pred HHHHHHHHHcC-------------------CCCC----CchhhccCCHHHHHHHHHhcccCccccCChHHHHHHhhhhHH
Q psy11767 607 ALSIMARIKEG-------------------QFNF----DAEAWSTVSSEAKELTKSLLTVNPAQRIRMMRVKLTFHAFHQ 663 (966)
Q Consensus 607 ~~~~~~~i~~~-------------------~~~~----~~~~~~~is~e~~~Li~~~L~~dP~~R~t~~~v~~~~~~~~~ 663 (966)
...++...... .... ....++.+++++.+||.+||..||++|||+.++ ..|+|+.
T Consensus 235 l~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~mL~~dP~~R~t~~e~--l~hp~f~ 312 (367)
T 1cm8_A 235 LKEIMKVTGTPPAEFVQRLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEA--LAHPYFE 312 (367)
T ss_dssp HHHHHHHHCCCCHHHHHTCSCHHHHHHHHHSCCCCCCCGGGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHH--HHSGGGT
T ss_pred HHHHHHhcCCCCHHHHHHhhhHHHHHHHHhCCCCCCCCHHHHCCCCCHHHHHHHHHHccCChhHCCCHHHH--hcChHHH
Confidence 33322211100 0000 012234679999999999999999999999876 4577764
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-40 Score=367.04 Aligned_cols=247 Identities=37% Similarity=0.702 Sum_probs=211.4
Q ss_pred ccccccccccEEEEEEEcCCCcEEEEEEecccc-----ChHHHHHHHHHhcCCCCceEEEEEEEeCCeEEEEEEccCCCC
Q psy11767 383 AGILGDGSYSVCRRCVEKSTGQEYAVKIISRKI-----DCSEEINLLRACQGHPNIVNLHCVFQDEVHTYLVLELLKGGE 457 (966)
Q Consensus 383 ~~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~-----~~~~Ei~iL~~l~~HpnIV~l~~~~~~~~~~~lVmEy~~gg~ 457 (966)
.+.||+|+||.||+|.+..+|+.||||++.... ...+|+.+|+.+ +||||+++++++.+....|+||||++|++
T Consensus 14 ~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~~~ 92 (304)
T 2jam_A 14 MEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLENEIAVLKKI-KHENIVTLEDIYESTTHYYLVMQLVSGGE 92 (304)
T ss_dssp EEEEEECSSEEEEEEEETTTCCEEEEEEEECC------HHHHHHHHHHHC-CCTTBCCEEEEEECSSEEEEEECCCCSCB
T ss_pred eeeccCCCCceEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHhC-CCCCeeehhhhcccCCEEEEEEEcCCCcc
Confidence 688999999999999999999999999997542 245799999998 59999999999999999999999999999
Q ss_pred HHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCcEEEec-CCCCCEEEEeecccccccCC-Ccccccc
Q psy11767 458 LLDRIRQKGRCGFTENEASRIMRQLVAAVHFMHSRGVVHRDLKPENLLFSD-PAGDNIKVVDFGFACLKRES-LHTPCFT 535 (966)
Q Consensus 458 L~~~l~~~~~~~l~e~~~~~i~~Qil~aL~yLHs~~IiHRDLKP~NILl~~-~~~~~iKL~DFGla~~~~~~-~~~~~gT 535 (966)
|.+++...+ .+++.++..++.||+.||+|||++||+||||||+|||+.. ..++.+||+|||++...... ....++|
T Consensus 93 L~~~l~~~~--~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dikp~NIl~~~~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~ 170 (304)
T 2jam_A 93 LFDRILERG--VYTEKDASLVIQQVLSAVKYLHENGIVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQNGIMSTACGT 170 (304)
T ss_dssp HHHHHHHHS--CCCHHHHHHHHHHHHHHHHHHHHTTCCCCSCCGGGCEESSSSTTCCEEBCSCSTTCCCCCBTTHHHHSC
T ss_pred HHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEecCCCCCCEEEccCCcceecCCCccccccCC
Confidence 999998765 5899999999999999999999999999999999999932 13568999999999754432 2345689
Q ss_pred ccccCchhhccCCCCCCCcccchhhhhhhhhhhhcCCCCCCCcCcchhHHHHHHHHhcCCCCCCCCCCchhHHHHHHHHH
Q psy11767 536 LQYAAPEVLRQDKSGYDENCDLWSLGVILVNVLRQDKSGYDENCDLWSLGVILYTMLCGRVPFHARSRDDSALSIMARIK 615 (966)
Q Consensus 536 ~~Y~APEvl~~~~~~~~~~~Di~SlGvil~el~~~~~~~y~~~~DIWSlGvilyemltG~~Pf~~~~~~~~~~~~~~~i~ 615 (966)
+.|+|||++.. ..|+.++|||||||++|+|++|..||..... ..+...+.
T Consensus 171 ~~y~aPE~~~~--------------------------~~~~~~~Di~slG~il~~l~~g~~pf~~~~~----~~~~~~i~ 220 (304)
T 2jam_A 171 PGYVAPEVLAQ--------------------------KPYSKAVDCWSIGVITYILLCGYPPFYEETE----SKLFEKIK 220 (304)
T ss_dssp CCBCCTTTBSS--------------------------CSCCHHHHHHHHHHHHHHHHHSSCTTTTSCH----HHHHHHHH
T ss_pred CCccChHHhcc--------------------------CCCCchhhHHHHHHHHHHHHHCCCCCCCCCH----HHHHHHHH
Confidence 99999998852 2367899999999999999999999987543 24566777
Q ss_pred cCCCCCCchhhccCCHHHHHHHHHhcccCccccCChHHHHHHhhhhHHh
Q psy11767 616 EGQFNFDAEAWSTVSSEAKELTKSLLTVNPAQRIRMMRVKLTFHAFHQA 664 (966)
Q Consensus 616 ~~~~~~~~~~~~~is~e~~~Li~~~L~~dP~~R~t~~~v~~~~~~~~~~ 664 (966)
.+.+.+....+..+++++.+||.+||..||++|||+.++ ..|+|...
T Consensus 221 ~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~--l~h~~~~~ 267 (304)
T 2jam_A 221 EGYYEFESPFWDDISESAKDFICHLLEKDPNERYTCEKA--LSHPWIDG 267 (304)
T ss_dssp HCCCCCCTTTTTTSCHHHHHHHHHHHCSSTTTSCCHHHH--HTSHHHHS
T ss_pred cCCCCCCccccccCCHHHHHHHHHHcCCChhHCcCHHHH--hcCccccC
Confidence 787777777777899999999999999999999999976 45777653
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=9.3e-41 Score=386.89 Aligned_cols=256 Identities=27% Similarity=0.436 Sum_probs=199.5
Q ss_pred ccccccccccccccEEEEEEEcCCCcEEEEEEecccc-ChHHHHHHHHHhcCCCCceEEEEEEEeC------CeEEEEEE
Q psy11767 379 DLDKAGILGDGSYSVCRRCVEKSTGQEYAVKIISRKI-DCSEEINLLRACQGHPNIVNLHCVFQDE------VHTYLVLE 451 (966)
Q Consensus 379 ~~~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~-~~~~Ei~iL~~l~~HpnIV~l~~~~~~~------~~~~lVmE 451 (966)
.|+..+.||+|+||+||+|++..+|+.||||++.... ...+|+++|+.+ +|||||+++++|... .++++|||
T Consensus 55 ~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~~~~~~E~~il~~l-~hpniv~l~~~~~~~~~~~~~~~~~lv~e 133 (420)
T 1j1b_A 55 SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNRELQIMRKL-DHCNIVRLRYFFYSSGEKKDEVYLNLVLD 133 (420)
T ss_dssp EEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECCTTSCCHHHHHHHTC-CCTTBCCEEEEEEEEETTTTEEEEEEEEE
T ss_pred eEEeeeEEeeCCCEEEEEEEECCCCcEEEEEEecccchhHHHHHHHHHHc-CCCCccceeeEEeccCCCCcceeEEeehh
Confidence 3455789999999999999999999999999986543 345799999998 599999999998542 24789999
Q ss_pred ccCCCCHHHHHHh--cCCCCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCcEEEecCCCCCEEEEeecccccccC--
Q psy11767 452 LLKGGELLDRIRQ--KGRCGFTENEASRIMRQLVAAVHFMHSRGVVHRDLKPENLLFSDPAGDNIKVVDFGFACLKRE-- 527 (966)
Q Consensus 452 y~~gg~L~~~l~~--~~~~~l~e~~~~~i~~Qil~aL~yLHs~~IiHRDLKP~NILl~~~~~~~iKL~DFGla~~~~~-- 527 (966)
|+++ +|.+.+.. .....+++..++.++.||+.||+|||++||+||||||+|||++. .++.+||+|||+|+....
T Consensus 134 ~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NILl~~-~~~~~kl~DFG~a~~~~~~~ 211 (420)
T 1j1b_A 134 YVPE-TVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDP-DTAVLKLCDFGSAKQLVRGE 211 (420)
T ss_dssp CCCE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTTEECSCCSGGGEEEET-TTTEEEECCCTTCEECCTTC
T ss_pred cccc-cHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChhhEEEeC-CCCeEEeccchhhhhcccCC
Confidence 9975 66666643 22346999999999999999999999999999999999999974 245789999999976432
Q ss_pred CCccccccccccCchhhccCCCCCCCcccchhhhhhhhhhhhcCCCCCCCcCcchhHHHHHHHHhcCCCCCCCCCCchhH
Q psy11767 528 SLHTPCFTLQYAAPEVLRQDKSGYDENCDLWSLGVILVNVLRQDKSGYDENCDLWSLGVILYTMLCGRVPFHARSRDDSA 607 (966)
Q Consensus 528 ~~~~~~gT~~Y~APEvl~~~~~~~~~~~Di~SlGvil~el~~~~~~~y~~~~DIWSlGvilyemltG~~Pf~~~~~~~~~ 607 (966)
.....++|+.|+|||++.. ...|+.++|||||||++|||++|++||.+.+..+..
T Consensus 212 ~~~~~~~t~~y~aPE~~~~-------------------------~~~~~~~~DiwSlG~il~ell~G~~pf~~~~~~~~l 266 (420)
T 1j1b_A 212 PNVSYICSRYYRAPELIFG-------------------------ATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQL 266 (420)
T ss_dssp CCCSCCSCTTSCCHHHHTT-------------------------CSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHH
T ss_pred CceeeeeCCCcCCHHHHcC-------------------------CCCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHH
Confidence 3345678999999999852 224788999999999999999999999987654443
Q ss_pred HHHHHHHH--------c-----CCCCCC---chhh-----ccCCHHHHHHHHHhcccCccccCChHHHHHHhhhhHHh
Q psy11767 608 LSIMARIK--------E-----GQFNFD---AEAW-----STVSSEAKELTKSLLTVNPAQRIRMMRVKLTFHAFHQA 664 (966)
Q Consensus 608 ~~~~~~i~--------~-----~~~~~~---~~~~-----~~is~e~~~Li~~~L~~dP~~R~t~~~v~~~~~~~~~~ 664 (966)
..++..+. . ..+.++ ...| ..+++++++||.+||..||++|||+.++ ..|+|+..
T Consensus 267 ~~i~~~lg~p~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~R~t~~e~--l~hp~f~~ 342 (420)
T 1j1b_A 267 VEIIKVLGTPTREQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEA--CAHSFFDE 342 (420)
T ss_dssp HHHHHHHCSCCHHHHHHHCSCCCCCCCCCCCCCCHHHHSCTTSCHHHHHHHHHHSCSSGGGSCCHHHH--HTSGGGGG
T ss_pred HHHHHHhCCCCHHHHHhhChhhhhhccCccCCCCHHHhcCCCCCHHHHHHHHHhccCChhHCCCHHHH--hCCHhhcc
Confidence 33333211 1 011111 1111 3568999999999999999999999876 45777654
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-40 Score=363.93 Aligned_cols=251 Identities=33% Similarity=0.596 Sum_probs=200.7
Q ss_pred cccccccccccccccccccEEEEEEEcCCCcEEEEEEecccc------ChHHHHHHHHHhcCCCCceEEEEEEEeCCeEE
Q psy11767 374 EQYDMDLDKAGILGDGSYSVCRRCVEKSTGQEYAVKIISRKI------DCSEEINLLRACQGHPNIVNLHCVFQDEVHTY 447 (966)
Q Consensus 374 ~~~~i~~~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~------~~~~Ei~iL~~l~~HpnIV~l~~~~~~~~~~~ 447 (966)
++|.+ .+.||+|+||.||+|.+..+|+.||+|++.... ...+|+++|+.+ +||||+++++++.+....|
T Consensus 22 ~~y~~----~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l-~hp~iv~~~~~~~~~~~~~ 96 (285)
T 3is5_A 22 DLFIF----KRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSL-DHPNIIKIFEVFEDYHNMY 96 (285)
T ss_dssp HHEEE----EEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCCSCHHHHHHHHHHHHTC-CCTTBCCEEEEEECSSEEE
T ss_pred hheee----cceeccCCCeEEEEEEEccCCceEEEEEeeccccchhHHHHHHHHHHHHhC-CCchHHhHHHheecCCeEE
Confidence 45554 678999999999999999999999999986543 245799999998 5999999999999999999
Q ss_pred EEEEccCCCCHHHHHHhc--CCCCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCcEEEecC-CCCCEEEEeeccccc
Q psy11767 448 LVLELLKGGELLDRIRQK--GRCGFTENEASRIMRQLVAAVHFMHSRGVVHRDLKPENLLFSDP-AGDNIKVVDFGFACL 524 (966)
Q Consensus 448 lVmEy~~gg~L~~~l~~~--~~~~l~e~~~~~i~~Qil~aL~yLHs~~IiHRDLKP~NILl~~~-~~~~iKL~DFGla~~ 524 (966)
+||||+++|+|.+++... ....+++..++.++.||+.||+|||++||+||||||+|||+++. ..+.+||+|||++..
T Consensus 97 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~dikp~NIl~~~~~~~~~~kl~Dfg~a~~ 176 (285)
T 3is5_A 97 IVMETCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFHSQHVVHKDLKPENILFQDTSPHSPIKIIDFGLAEL 176 (285)
T ss_dssp EEECCCSCCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEESSSSTTCCEEECCCCCCCC
T ss_pred EEEEeCCCCcHHHHHHhhhhcccCCCHHHHHHHHHHHHHHHHHHHhCCEEECCCCHHHEEEecCCCCCCEEEEeeeccee
Confidence 999999999999998643 12369999999999999999999999999999999999999642 246899999999976
Q ss_pred ccC--CCccccccccccCchhhccCCCCCCCcccchhhhhhhhhhhhcCCCCCCCcCcchhHHHHHHHHhcCCCCCCCCC
Q psy11767 525 KRE--SLHTPCFTLQYAAPEVLRQDKSGYDENCDLWSLGVILVNVLRQDKSGYDENCDLWSLGVILYTMLCGRVPFHARS 602 (966)
Q Consensus 525 ~~~--~~~~~~gT~~Y~APEvl~~~~~~~~~~~Di~SlGvil~el~~~~~~~y~~~~DIWSlGvilyemltG~~Pf~~~~ 602 (966)
... .....++|+.|+|||++. ..++.++|||||||++|+|++|+.||.+..
T Consensus 177 ~~~~~~~~~~~~t~~y~aPE~~~---------------------------~~~~~~~Di~slG~il~~ll~g~~pf~~~~ 229 (285)
T 3is5_A 177 FKSDEHSTNAAGTALYMAPEVFK---------------------------RDVTFKCDIWSAGVVMYFLLTGCLPFTGTS 229 (285)
T ss_dssp ----------CTTGGGCCHHHHT---------------------------TCCCHHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred cCCcccCcCcccccCcCChHHhc---------------------------cCCCcccCeehHHHHHHHHHhCCCCCCCCC
Confidence 433 234567899999999874 136778999999999999999999998755
Q ss_pred CchhHHHHHHHHHcCCCCCCchhhccCCHHHHHHHHHhcccCccccCChHHHHHHhhhhHH
Q psy11767 603 RDDSALSIMARIKEGQFNFDAEAWSTVSSEAKELTKSLLTVNPAQRIRMMRVKLTFHAFHQ 663 (966)
Q Consensus 603 ~~~~~~~~~~~i~~~~~~~~~~~~~~is~e~~~Li~~~L~~dP~~R~t~~~v~~~~~~~~~ 663 (966)
.. .....+......+... ...+++++.+||.+||+.||++|||+.++ ..|+|++
T Consensus 230 ~~----~~~~~~~~~~~~~~~~-~~~~~~~~~~li~~~L~~dP~~Rps~~e~--l~hp~f~ 283 (285)
T 3is5_A 230 LE----EVQQKATYKEPNYAVE-CRPLTPQAVDLLKQMLTKDPERRPSAAQV--LHHEWFK 283 (285)
T ss_dssp HH----HHHHHHHHCCCCCCC---CCCCHHHHHHHHHHTCSCTTTSCCHHHH--HTSGGGG
T ss_pred HH----HHHhhhccCCcccccc-cCcCCHHHHHHHHHHccCChhhCcCHHHH--hcCHHhh
Confidence 32 2233333333333222 23478999999999999999999999976 3466653
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.6e-41 Score=371.55 Aligned_cols=250 Identities=37% Similarity=0.641 Sum_probs=208.1
Q ss_pred cccccccccccEEEEEEEcCCCcEEEEEEecccc-------------ChHHHHHHHHHhcCCCCceEEEEEEEeCCeEEE
Q psy11767 382 KAGILGDGSYSVCRRCVEKSTGQEYAVKIISRKI-------------DCSEEINLLRACQGHPNIVNLHCVFQDEVHTYL 448 (966)
Q Consensus 382 ~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~-------------~~~~Ei~iL~~l~~HpnIV~l~~~~~~~~~~~l 448 (966)
..+.||+|+||.||+|.+..+|+.||||++.... ...+|+.+|+.+ +||||+++++++..+. .|+
T Consensus 14 ~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~~~-~~l 91 (322)
T 2ycf_A 14 MSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKL-NHPCIIKIKNFFDAED-YYI 91 (322)
T ss_dssp EEEEEEECSSEEEEEEEETTTTEEEEEEEECC---------------CHHHHHHHHHHC-CCTTBCCEEEEEESSS-EEE
T ss_pred EeeEEecCCCEEEEEEEEcCCCcEEEEEEeehhhhhhcccccchhhhhHHHHHHHHHhC-CCCCCceEeeEEcCCc-eEE
Confidence 3688999999999999999999999999986431 256799999998 5999999999998765 899
Q ss_pred EEEccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCcEEEecCC-CCCEEEEeecccccccC
Q psy11767 449 VLELLKGGELLDRIRQKGRCGFTENEASRIMRQLVAAVHFMHSRGVVHRDLKPENLLFSDPA-GDNIKVVDFGFACLKRE 527 (966)
Q Consensus 449 VmEy~~gg~L~~~l~~~~~~~l~e~~~~~i~~Qil~aL~yLHs~~IiHRDLKP~NILl~~~~-~~~iKL~DFGla~~~~~ 527 (966)
||||+++++|.+++.... .+++..++.++.||+.||+|||++||+||||||+|||++... ...+||+|||++.....
T Consensus 92 v~e~~~~~~L~~~~~~~~--~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~~~~~~~ 169 (322)
T 2ycf_A 92 VLELMEGGELFDKVVGNK--RLKEATCKLYFYQMLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGE 169 (322)
T ss_dssp EEECCTTEETHHHHSTTC--CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESSSSSSCCEEECCCTTCEECCC
T ss_pred EEecCCCCcHHHHHhccC--CCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEEecCCCCCeEEEccCccceeccc
Confidence 999999999999987654 699999999999999999999999999999999999997532 23599999999976543
Q ss_pred C--CccccccccccCchhhccCCCCCCCcccchhhhhhhhhhhhcCCCCCCCcCcchhHHHHHHHHhcCCCCCCCCCCch
Q psy11767 528 S--LHTPCFTLQYAAPEVLRQDKSGYDENCDLWSLGVILVNVLRQDKSGYDENCDLWSLGVILYTMLCGRVPFHARSRDD 605 (966)
Q Consensus 528 ~--~~~~~gT~~Y~APEvl~~~~~~~~~~~Di~SlGvil~el~~~~~~~y~~~~DIWSlGvilyemltG~~Pf~~~~~~~ 605 (966)
. ....+||+.|+|||++... ....|+.++|||||||++|+|++|..||.......
T Consensus 170 ~~~~~~~~gt~~y~aPE~~~~~-----------------------~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~ 226 (322)
T 2ycf_A 170 TSLMRTLCGTPTYLAPEVLVSV-----------------------GTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQV 226 (322)
T ss_dssp CHHHHHHHSCCTTCCHHHHHHT-----------------------TTTTCTTHHHHHHHHHHHHHHHHSSCSSCSTTCSS
T ss_pred ccccccccCCcCccCchhhccC-----------------------CCCCCCchhhHHHHHHHHHHHHhCCCCCcccchHH
Confidence 2 1245689999999987421 12347889999999999999999999998765433
Q ss_pred hHHHHHHHHHcCCCCCCchhhccCCHHHHHHHHHhcccCccccCChHHHHHHhhhhHH
Q psy11767 606 SALSIMARIKEGQFNFDAEAWSTVSSEAKELTKSLLTVNPAQRIRMMRVKLTFHAFHQ 663 (966)
Q Consensus 606 ~~~~~~~~i~~~~~~~~~~~~~~is~e~~~Li~~~L~~dP~~R~t~~~v~~~~~~~~~ 663 (966)
. +...+..+.+.+.++.+..+++++.+||.+||..||++|||+.++ ..|+|+.
T Consensus 227 ~---~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~~~--l~h~~~~ 279 (322)
T 2ycf_A 227 S---LKDQITSGKYNFIPEVWAEVSEKALDLVKKLLVVDPKARFTTEEA--LRHPWLQ 279 (322)
T ss_dssp C---HHHHHHHTCCCCCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHH--HTSGGGC
T ss_pred H---HHHHHHhCccccCchhhhhcCHHHHHHHHHHcccCHhhCCCHHHH--hhCcCcC
Confidence 2 344566677777777788899999999999999999999999876 4466653
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-41 Score=373.17 Aligned_cols=244 Identities=27% Similarity=0.423 Sum_probs=193.7
Q ss_pred eecccccccccccccccccccEEEEEEEcCCCcEEEEEEeccccC--------hHHHHHHHHHhcCCCCceEEEEEEEeC
Q psy11767 372 FFEQYDMDLDKAGILGDGSYSVCRRCVEKSTGQEYAVKIISRKID--------CSEEINLLRACQGHPNIVNLHCVFQDE 443 (966)
Q Consensus 372 ~~~~~~i~~~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~~--------~~~Ei~iL~~l~~HpnIV~l~~~~~~~ 443 (966)
+.++|.+ .+.||+|+||.||+|++..+|+.||||++..... ..+|+.+++.+ +|||||++++++...
T Consensus 10 ~~~~y~~----~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~hp~iv~~~~~~~~~ 84 (311)
T 3ork_A 10 LSDRYEL----GEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAAL-NHPAIVAVYDTGEAE 84 (311)
T ss_dssp ETTTEEE----EEEEEECSSEEEEEEEETTTTEEEEEEEECTTTTTSHHHHHHHHHHHTTCCCC-CCTTBCCEEEEEEEE
T ss_pred ecCcEEE----EEEEccCCCEEEEEEEECCCCceEEEEEeCccccCCHHHHHHHHHHHHHHHcC-CCCCcceEEEeeecc
Confidence 4455555 6889999999999999999999999999975421 34677777777 599999999998865
Q ss_pred C----eEEEEEEccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCcEEEecCCCCCEEEEee
Q psy11767 444 V----HTYLVLELLKGGELLDRIRQKGRCGFTENEASRIMRQLVAAVHFMHSRGVVHRDLKPENLLFSDPAGDNIKVVDF 519 (966)
Q Consensus 444 ~----~~~lVmEy~~gg~L~~~l~~~~~~~l~e~~~~~i~~Qil~aL~yLHs~~IiHRDLKP~NILl~~~~~~~iKL~DF 519 (966)
. ..|+||||++||+|.+++...+ .+++.+++.++.||+.||+|||++||+||||||+|||++. ++.+||+||
T Consensus 85 ~~~~~~~~lv~e~~~g~~L~~~l~~~~--~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~--~~~~kl~Df 160 (311)
T 3ork_A 85 TPAGPLPYIVMEYVDGVTLRDIVHTEG--PMTPKRAIEVIADACQALNFSHQNGIIHRDVKPANIMISA--TNAVKVMDF 160 (311)
T ss_dssp ETTEEEEEEEEECCCEEEHHHHHHHHC--SCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEET--TSCEEECCC
T ss_pred CCCCcccEEEEecCCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCCCcCCCCHHHEEEcC--CCCEEEeec
Confidence 4 3499999999999999998765 5999999999999999999999999999999999999985 568999999
Q ss_pred cccccccCC------CccccccccccCchhhccCCCCCCCcccchhhhhhhhhhhhcCCCCCCCcCcchhHHHHHHHHhc
Q psy11767 520 GFACLKRES------LHTPCFTLQYAAPEVLRQDKSGYDENCDLWSLGVILVNVLRQDKSGYDENCDLWSLGVILYTMLC 593 (966)
Q Consensus 520 Gla~~~~~~------~~~~~gT~~Y~APEvl~~~~~~~~~~~Di~SlGvil~el~~~~~~~y~~~~DIWSlGvilyemlt 593 (966)
|++...... ....+||+.|+|||++.. ..|+.++|||||||++|+|++
T Consensus 161 g~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--------------------------~~~~~~~Di~slG~~l~~ll~ 214 (311)
T 3ork_A 161 GIARAIADSGNSVTQTAAVIGTAQYLSPEQARG--------------------------DSVDARSDVYSLGCVLYEVLT 214 (311)
T ss_dssp SCC------------------CCTTCCHHHHHT--------------------------CCCCHHHHHHHHHHHHHHHHH
T ss_pred cCcccccccccccccccccCcCcccCCHHHhcC--------------------------CCCCchHhHHHHHHHHHHHHh
Confidence 999754321 223568999999999853 246789999999999999999
Q ss_pred CCCCCCCCCCchhHHHHHHHHHcCCCCCCchhhccCCHHHHHHHHHhcccCccccCChHHH
Q psy11767 594 GRVPFHARSRDDSALSIMARIKEGQFNFDAEAWSTVSSEAKELTKSLLTVNPAQRIRMMRV 654 (966)
Q Consensus 594 G~~Pf~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~is~e~~~Li~~~L~~dP~~R~t~~~v 654 (966)
|+.||.+.... .....+...........+..+++++.+||.+||+.||++||++.++
T Consensus 215 g~~pf~~~~~~----~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~R~~~~~~ 271 (311)
T 3ork_A 215 GEPPFTGDSPV----SVAYQHVREDPIPPSARHEGLSADLDAVVLKALAKNPENRYQTAAE 271 (311)
T ss_dssp SSCSCCCSSHH----HHHHHHHHCCCCCHHHHSTTCCHHHHHHHHHHTCSSGGGSCSSHHH
T ss_pred CCCCCCCCChH----HHHHHHhcCCCCCcccccCCCCHHHHHHHHHHHhcCHhhChhhHHH
Confidence 99999875532 2223333333333334456789999999999999999999988754
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vhk_A* 3vid_A* 3hng_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.2e-41 Score=376.48 Aligned_cols=248 Identities=25% Similarity=0.342 Sum_probs=200.6
Q ss_pred cccccccccccccEEEEEE-----EcCCCcEEEEEEeccccC------hHHHHHHHHHhcCCCCceEEEEEEEeCC-eEE
Q psy11767 380 LDKAGILGDGSYSVCRRCV-----EKSTGQEYAVKIISRKID------CSEEINLLRACQGHPNIVNLHCVFQDEV-HTY 447 (966)
Q Consensus 380 ~~~~~~LG~G~fG~Vy~a~-----~~~tg~~vAvK~i~~~~~------~~~Ei~iL~~l~~HpnIV~l~~~~~~~~-~~~ 447 (966)
|+..+.||+|+||.||+|. +..+++.||||++..... ..+|+++|..+.+|||||++++++.+.. ..|
T Consensus 24 y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpniv~~~~~~~~~~~~~~ 103 (359)
T 3vhe_A 24 LKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGPLM 103 (359)
T ss_dssp EEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTTSCCE
T ss_pred eeeceeecCCCCceEEEEEeccccccccceEEEEEEecCcCCHHHHHHHHHHHHHHHhhcCCcceeeeeeeeecCCCceE
Confidence 3346889999999999999 556779999999976432 4579999999988999999999998765 489
Q ss_pred EEEEccCCCCHHHHHHhcCC------------------------------------------------------------
Q psy11767 448 LVLELLKGGELLDRIRQKGR------------------------------------------------------------ 467 (966)
Q Consensus 448 lVmEy~~gg~L~~~l~~~~~------------------------------------------------------------ 467 (966)
+|||||+||+|.+++.....
T Consensus 104 iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 183 (359)
T 3vhe_A 104 VIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSGFVEEKSLSDVEEEEAPE 183 (359)
T ss_dssp EEEECCTTEEHHHHHHTTTTSBCSCC------------------------------------------------------
T ss_pred EEEEecCCCcHHHHHHhccccccccccccchhhcccccccccchhhhccccccCccccccccccccccccchhhhccccc
Confidence 99999999999999976532
Q ss_pred ----CCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCcEEEecCCCCCEEEEeecccccccCC-----Cccccccccc
Q psy11767 468 ----CGFTENEASRIMRQLVAAVHFMHSRGVVHRDLKPENLLFSDPAGDNIKVVDFGFACLKRES-----LHTPCFTLQY 538 (966)
Q Consensus 468 ----~~l~e~~~~~i~~Qil~aL~yLHs~~IiHRDLKP~NILl~~~~~~~iKL~DFGla~~~~~~-----~~~~~gT~~Y 538 (966)
..+++..++.++.||+.||+|||++||+||||||+|||++. ++.+||+|||++...... .....+|+.|
T Consensus 184 ~~~~~~l~~~~~~~~~~ql~~aL~~LH~~~ivH~Dikp~NIll~~--~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~t~~y 261 (359)
T 3vhe_A 184 DLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSE--KNVVKICDFGLARDIYKDPDYVRKGDARLPLKW 261 (359)
T ss_dssp CTTTTCBCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECG--GGCEEECCCGGGSCTTSCTTCEEC--CEECGGG
T ss_pred chhccccCHHHHHHHHHHHHHHHHHHHHCCcccCCCChhhEEEcC--CCcEEEEeccceeeecccccchhccccCCCcee
Confidence 12899999999999999999999999999999999999975 568999999999754321 2345678999
Q ss_pred cCchhhccCCCCCCCcccchhhhhhhhhhhhcCCCCCCCcCcchhHHHHHHHHhc-CCCCCCCCCCchhHHHHHHHHHcC
Q psy11767 539 AAPEVLRQDKSGYDENCDLWSLGVILVNVLRQDKSGYDENCDLWSLGVILYTMLC-GRVPFHARSRDDSALSIMARIKEG 617 (966)
Q Consensus 539 ~APEvl~~~~~~~~~~~Di~SlGvil~el~~~~~~~y~~~~DIWSlGvilyemlt-G~~Pf~~~~~~~~~~~~~~~i~~~ 617 (966)
+|||++.. ..|+.++|||||||++|+|++ |..||.+....+. ....+..+
T Consensus 262 ~aPE~~~~--------------------------~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~---~~~~~~~~ 312 (359)
T 3vhe_A 262 MAPETIFD--------------------------RVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEE---FCRRLKEG 312 (359)
T ss_dssp CCHHHHHH--------------------------CCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSHH---HHHHHHHT
T ss_pred EChhhhcC--------------------------CCCCchhhhhhHHHHHHHHHhcCCCCCCccchhHH---HHHHHHcC
Confidence 99999853 237889999999999999998 9999988765433 23333333
Q ss_pred CCCCCchhhccCCHHHHHHHHHhcccCccccCChHHHHHHhhhh
Q psy11767 618 QFNFDAEAWSTVSSEAKELTKSLLTVNPAQRIRMMRVKLTFHAF 661 (966)
Q Consensus 618 ~~~~~~~~~~~is~e~~~Li~~~L~~dP~~R~t~~~v~~~~~~~ 661 (966)
.... ....+++++.++|.+||+.||++|||+.++...+..+
T Consensus 313 ~~~~---~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~ 353 (359)
T 3vhe_A 313 TRMR---APDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNL 353 (359)
T ss_dssp CCCC---CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred CCCC---CCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHH
Confidence 2221 2235789999999999999999999999886655544
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.6e-41 Score=369.26 Aligned_cols=247 Identities=19% Similarity=0.342 Sum_probs=199.3
Q ss_pred ccccccccccccEEEEEEEcCCCcEEEEEEecccc-----ChHHHHHHHHHhcCCCCceEEEEEEEeCCeEEEEEEccCC
Q psy11767 381 DKAGILGDGSYSVCRRCVEKSTGQEYAVKIISRKI-----DCSEEINLLRACQGHPNIVNLHCVFQDEVHTYLVLELLKG 455 (966)
Q Consensus 381 ~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~-----~~~~Ei~iL~~l~~HpnIV~l~~~~~~~~~~~lVmEy~~g 455 (966)
...+.||+|+||+||+|.+..+|+.||+|++.... ...+|+.+|+.+ +||||+++++++.++...|+||||++|
T Consensus 13 ~~~~~lG~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~E~~~l~~l-~hp~iv~~~~~~~~~~~~~lv~e~~~~ 91 (310)
T 3s95_A 13 IHGEVLGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCL-EHPNVLKFIGVLYKDKRLNFITEYIKG 91 (310)
T ss_dssp EEEEEEECCSSEEEEEEEETTTCCEEEEEEESCCCHHHHHHHHHHHHHHTTC-CCTTBCCEEEEEEETTEEEEEEECCTT
T ss_pred eccceecCCCCEEEEEEEECCCCcEEEEEEeccCCHHHHHHHHHHHHHHHhC-CCcCcccEEEEEecCCeeEEEEEecCC
Confidence 33688999999999999999999999999885432 245799999888 599999999999999999999999999
Q ss_pred CCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCcEEEecCCCCCEEEEeecccccccCCC------
Q psy11767 456 GELLDRIRQKGRCGFTENEASRIMRQLVAAVHFMHSRGVVHRDLKPENLLFSDPAGDNIKVVDFGFACLKRESL------ 529 (966)
Q Consensus 456 g~L~~~l~~~~~~~l~e~~~~~i~~Qil~aL~yLHs~~IiHRDLKP~NILl~~~~~~~iKL~DFGla~~~~~~~------ 529 (966)
|+|.+++..... .+++.++..++.||+.||+|||++||+||||||+|||++. ++.+||+|||+++......
T Consensus 92 ~~L~~~l~~~~~-~~~~~~~~~i~~qi~~al~~lH~~~ivH~dlkp~Nil~~~--~~~~kl~Dfg~~~~~~~~~~~~~~~ 168 (310)
T 3s95_A 92 GTLRGIIKSMDS-QYPWSQRVSFAKDIASGMAYLHSMNIIHRDLNSHNCLVRE--NKNVVVADFGLARLMVDEKTQPEGL 168 (310)
T ss_dssp CBHHHHHHHCCT-TSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEECT--TSCEEECCCTTCEECC---------
T ss_pred CcHHHHHHhccC-CCCHHHHHHHHHHHHHHHHHHHhCCccCCCCCcCeEEECC--CCCEEEeecccceeccccccccccc
Confidence 999999987543 6999999999999999999999999999999999999975 5689999999997543211
Q ss_pred -----------ccccccccccCchhhccCCCCCCCcccchhhhhhhhhhhhcCCCCCCCcCcchhHHHHHHHHhcCCCCC
Q psy11767 530 -----------HTPCFTLQYAAPEVLRQDKSGYDENCDLWSLGVILVNVLRQDKSGYDENCDLWSLGVILYTMLCGRVPF 598 (966)
Q Consensus 530 -----------~~~~gT~~Y~APEvl~~~~~~~~~~~Di~SlGvil~el~~~~~~~y~~~~DIWSlGvilyemltG~~Pf 598 (966)
...+||+.|+|||++.. ..|+.++|||||||++|+|++|..||
T Consensus 169 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~--------------------------~~~~~~~Di~slG~~l~el~~g~~~~ 222 (310)
T 3s95_A 169 RSLKKPDRKKRYTVVGNPYWMAPEMING--------------------------RSYDEKVDVFSFGIVLCEIIGRVNAD 222 (310)
T ss_dssp -----------CCCCSCGGGCCHHHHTT--------------------------CCCCTHHHHHHHHHHHHHHHHTCCSS
T ss_pred ccccccccccccccCCCcceeCHHHhcC--------------------------CCCCcHHHHHHHHHHHHHHhcCCCCC
Confidence 14578999999999852 34788999999999999999999999
Q ss_pred CCCCCchhHHH-HHHHHHcCCCCCCchhhccCCHHHHHHHHHhcccCccccCChHHHHHHhhhhHH
Q psy11767 599 HARSRDDSALS-IMARIKEGQFNFDAEAWSTVSSEAKELTKSLLTVNPAQRIRMMRVKLTFHAFHQ 663 (966)
Q Consensus 599 ~~~~~~~~~~~-~~~~i~~~~~~~~~~~~~~is~e~~~Li~~~L~~dP~~R~t~~~v~~~~~~~~~ 663 (966)
........... ........ .....+++++.+||.+||+.||++|||+.++...+..+..
T Consensus 223 ~~~~~~~~~~~~~~~~~~~~------~~~~~~~~~l~~li~~~l~~dP~~Rps~~~l~~~L~~l~~ 282 (310)
T 3s95_A 223 PDYLPRTMDFGLNVRGFLDR------YCPPNCPPSFFPITVRCCDLDPEKRPSFVKLEHWLETLRM 282 (310)
T ss_dssp TTTSCBCTTSSBCHHHHHHH------TCCTTCCTTHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred cchhhhHHHHhhhhhccccc------cCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHH
Confidence 76433211000 00111110 0123578899999999999999999999998766655443
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-40 Score=369.72 Aligned_cols=243 Identities=25% Similarity=0.461 Sum_probs=201.9
Q ss_pred cccccccccccEEEEEEEcCCCcEEEEEEeccccC-----hHHHHHHHHHhcCCCCceEEEEEEEeCCeEEEEEEccCCC
Q psy11767 382 KAGILGDGSYSVCRRCVEKSTGQEYAVKIISRKID-----CSEEINLLRACQGHPNIVNLHCVFQDEVHTYLVLELLKGG 456 (966)
Q Consensus 382 ~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~~-----~~~Ei~iL~~l~~HpnIV~l~~~~~~~~~~~lVmEy~~gg 456 (966)
....||+|+||.||+|++..+|+.||||++..... ..+|+.+|+.+ +|||||++++++......|+||||++||
T Consensus 49 ~~~~lg~G~~g~V~~a~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~lv~e~~~~~ 127 (321)
T 2c30_A 49 SYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDY-QHFNVVEMYKSYLVGEELWVLMEFLQGG 127 (321)
T ss_dssp EEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCSHHHHHHHHHHHTTC-CCTTBCCEEEEEEETTEEEEEECCCCSC
T ss_pred ccEEeccCCCeEEEEEEECCCCcEEEEEEEeccchhHHHHHHHHHHHHHhC-CCCCcceEEEEEEECCEEEEEEecCCCC
Confidence 34579999999999999999999999999864432 45799999888 5999999999999999999999999999
Q ss_pred CHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCcEEEecCCCCCEEEEeecccccccCC---Ccccc
Q psy11767 457 ELLDRIRQKGRCGFTENEASRIMRQLVAAVHFMHSRGVVHRDLKPENLLFSDPAGDNIKVVDFGFACLKRES---LHTPC 533 (966)
Q Consensus 457 ~L~~~l~~~~~~~l~e~~~~~i~~Qil~aL~yLHs~~IiHRDLKP~NILl~~~~~~~iKL~DFGla~~~~~~---~~~~~ 533 (966)
+|.+++.+. .+++..+..++.||+.||+|||++||+||||||+|||++. ++.+||+|||++...... ....+
T Consensus 128 ~L~~~l~~~---~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~--~~~~kl~Dfg~~~~~~~~~~~~~~~~ 202 (321)
T 2c30_A 128 ALTDIVSQV---RLNEEQIATVCEAVLQALAYLHAQGVIHRDIKSDSILLTL--DGRVKLSDFGFCAQISKDVPKRKSLV 202 (321)
T ss_dssp BHHHHHTTC---CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECT--TCCEEECCCTTCEECCSSSCCBCCCC
T ss_pred CHHHHHHhc---CCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECC--CCcEEEeeeeeeeecccCcccccccc
Confidence 999988653 5999999999999999999999999999999999999974 568999999998765432 34557
Q ss_pred ccccccCchhhccCCCCCCCcccchhhhhhhhhhhhcCCCCCCCcCcchhHHHHHHHHhcCCCCCCCCCCchhHHHHHHH
Q psy11767 534 FTLQYAAPEVLRQDKSGYDENCDLWSLGVILVNVLRQDKSGYDENCDLWSLGVILYTMLCGRVPFHARSRDDSALSIMAR 613 (966)
Q Consensus 534 gT~~Y~APEvl~~~~~~~~~~~Di~SlGvil~el~~~~~~~y~~~~DIWSlGvilyemltG~~Pf~~~~~~~~~~~~~~~ 613 (966)
||+.|+|||++.. ..|+.++|||||||++|+|++|+.||...... ..+..
T Consensus 203 gt~~y~aPE~~~~--------------------------~~~~~~~Dv~slG~il~el~~g~~pf~~~~~~----~~~~~ 252 (321)
T 2c30_A 203 GTPYWMAPEVISR--------------------------SLYATEVDIWSLGIMVIEMVDGEPPYFSDSPV----QAMKR 252 (321)
T ss_dssp SCGGGCCHHHHTT--------------------------CCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHH----HHHHH
T ss_pred CCccccCHhhhcC--------------------------CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH----HHHHH
Confidence 8999999999852 23678899999999999999999999875432 23344
Q ss_pred HHcCCCCCCchhhccCCHHHHHHHHHhcccCccccCChHHHHHHhhhhHH
Q psy11767 614 IKEGQFNFDAEAWSTVSSEAKELTKSLLTVNPAQRIRMMRVKLTFHAFHQ 663 (966)
Q Consensus 614 i~~~~~~~~~~~~~~is~e~~~Li~~~L~~dP~~R~t~~~v~~~~~~~~~ 663 (966)
+...... .......+++++.+||.+||+.||++|||+.++ ..|+|+.
T Consensus 253 ~~~~~~~-~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~el--l~hp~~~ 299 (321)
T 2c30_A 253 LRDSPPP-KLKNSHKVSPVLRDFLERMLVRDPQERATAQEL--LDHPFLL 299 (321)
T ss_dssp HHHSSCC-CCTTGGGSCHHHHHHHHHHSCSSTTTSCCHHHH--HTSGGGG
T ss_pred HhcCCCC-CcCccccCCHHHHHHHHHHccCChhhCcCHHHH--hcChhhc
Confidence 4443322 112234689999999999999999999999976 3466654
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-40 Score=358.39 Aligned_cols=248 Identities=35% Similarity=0.672 Sum_probs=208.4
Q ss_pred cccccccccccEEEEEEEcCCCcEEEEEEecccc-----------ChHHHHHHHHHhcCCCCceEEEEEEEeCCeEEEEE
Q psy11767 382 KAGILGDGSYSVCRRCVEKSTGQEYAVKIISRKI-----------DCSEEINLLRACQGHPNIVNLHCVFQDEVHTYLVL 450 (966)
Q Consensus 382 ~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~-----------~~~~Ei~iL~~l~~HpnIV~l~~~~~~~~~~~lVm 450 (966)
..+.||+|+||.||+|.+..+|+.||||++.... ...+|+.+|+.+ +||||+++++++.+....|+||
T Consensus 9 ~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~ 87 (283)
T 3bhy_A 9 MGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREI-RHPNIITLHDIFENKTDVVLIL 87 (283)
T ss_dssp EEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHC-CCTTBCCEEEEEECSSEEEEEE
T ss_pred hHHhhcccCceEEEEEEEcCCCCeeehHHhhhccccccccchHHHHHHHHHHHHHhC-CCCCeeehhheecCCCeEEEEE
Confidence 3688999999999999999999999999986532 145799999998 4999999999999999999999
Q ss_pred EccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCcEEEecCC--CCCEEEEeecccccccC-
Q psy11767 451 ELLKGGELLDRIRQKGRCGFTENEASRIMRQLVAAVHFMHSRGVVHRDLKPENLLFSDPA--GDNIKVVDFGFACLKRE- 527 (966)
Q Consensus 451 Ey~~gg~L~~~l~~~~~~~l~e~~~~~i~~Qil~aL~yLHs~~IiHRDLKP~NILl~~~~--~~~iKL~DFGla~~~~~- 527 (966)
||+++++|.+++.... .+++.+++.++.||+.||+|||++||+||||||+|||++... ...+||+|||++.....
T Consensus 88 e~~~~~~L~~~l~~~~--~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~~~~kl~dfg~~~~~~~~ 165 (283)
T 3bhy_A 88 ELVSGGELFDFLAEKE--SLTEDEATQFLKQILDGVHYLHSKRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAG 165 (283)
T ss_dssp ECCCSCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCSSSSSCCEEECCCTTCEECC--
T ss_pred eecCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCccCCCCChHHEEEecCCCCCCceEEEecccceeccCC
Confidence 9999999999997754 589999999999999999999999999999999999997532 23799999999976543
Q ss_pred -CCccccccccccCchhhccCCCCCCCcccchhhhhhhhhhhhcCCCCCCCcCcchhHHHHHHHHhcCCCCCCCCCCchh
Q psy11767 528 -SLHTPCFTLQYAAPEVLRQDKSGYDENCDLWSLGVILVNVLRQDKSGYDENCDLWSLGVILYTMLCGRVPFHARSRDDS 606 (966)
Q Consensus 528 -~~~~~~gT~~Y~APEvl~~~~~~~~~~~Di~SlGvil~el~~~~~~~y~~~~DIWSlGvilyemltG~~Pf~~~~~~~~ 606 (966)
......+|+.|+|||++.. ..++.++|||||||++|+|++|..||.+...
T Consensus 166 ~~~~~~~~~~~y~aPE~~~~--------------------------~~~~~~~Di~slG~il~~l~~g~~p~~~~~~--- 216 (283)
T 3bhy_A 166 NEFKNIFGTPEFVAPEIVNY--------------------------EPLGLEADMWSIGVITYILLSGASPFLGETK--- 216 (283)
T ss_dssp ------CCCGGGCCHHHHTT--------------------------CCCCTHHHHHHHHHHHHHHHHSSCTTCCSSH---
T ss_pred CcccccCCCcCccCcceecC--------------------------CCCCcchhhhhHHHHHHHHHHCCCCCCCcch---
Confidence 2234568999999998852 2367889999999999999999999987543
Q ss_pred HHHHHHHHHcCCCCCCchhhccCCHHHHHHHHHhcccCccccCChHHHHHHhhhhHHh
Q psy11767 607 ALSIMARIKEGQFNFDAEAWSTVSSEAKELTKSLLTVNPAQRIRMMRVKLTFHAFHQA 664 (966)
Q Consensus 607 ~~~~~~~i~~~~~~~~~~~~~~is~e~~~Li~~~L~~dP~~R~t~~~v~~~~~~~~~~ 664 (966)
...+..+......+....+..+++++.+||.+||..||++|||+.++ ..|+|.+.
T Consensus 217 -~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~--l~h~~~~~ 271 (283)
T 3bhy_A 217 -QETLTNISAVNYDFDEEYFSNTSELAKDFIRRLLVKDPKRRMTIAQS--LEHSWIKA 271 (283)
T ss_dssp -HHHHHHHHTTCCCCCHHHHTTCCHHHHHHHHTTSCSSGGGSCCHHHH--HHCHHHHH
T ss_pred -HHHHHHhHhcccCCcchhcccCCHHHHHHHHHHccCCHhHCcCHHHH--HhCHHHHH
Confidence 23455666777777777778899999999999999999999999876 34666654
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-40 Score=380.50 Aligned_cols=262 Identities=29% Similarity=0.471 Sum_probs=207.2
Q ss_pred ccceecccccccccccccccccccEEEEEEEcCCCcEEEEEEeccccC----hHHHHHHHHHhcCCCC-----ceEEEEE
Q psy11767 369 GSLFFEQYDMDLDKAGILGDGSYSVCRRCVEKSTGQEYAVKIISRKID----CSEEINLLRACQGHPN-----IVNLHCV 439 (966)
Q Consensus 369 G~~~~~~~~i~~~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~~----~~~Ei~iL~~l~~Hpn-----IV~l~~~ 439 (966)
+..+.++|.+ .+.||+|+||+||+|.+..+|+.||||++..... ...|+.+|+.+..|+| |++++++
T Consensus 49 ~~~~~~~y~~----~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~iv~~~~~ 124 (382)
T 2vx3_A 49 GEKWMDRYEI----DSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNKKAFLNQAQIEVRLLELMNKHDTEMKYYIVHLKRH 124 (382)
T ss_dssp TCEETTTEEE----EEEEEEETTEEEEEEEETTTTEEEEEEEECSSHHHHHHHHHHHHHHHHHHHCSSGGGGGBCCEEEE
T ss_pred CCEeeeeEEE----EEEEeecCCEEEEEEEEcCCCcEEEEEEEeccHHHHHHHHHHHHHHHHHHhcccccceeEEEeeee
Confidence 4555666665 6889999999999999999999999999975432 3458888888765664 9999999
Q ss_pred EEeCCeEEEEEEccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHH--hcCceeccCCCCcEEEecCCCCCEEEE
Q psy11767 440 FQDEVHTYLVLELLKGGELLDRIRQKGRCGFTENEASRIMRQLVAAVHFMH--SRGVVHRDLKPENLLFSDPAGDNIKVV 517 (966)
Q Consensus 440 ~~~~~~~~lVmEy~~gg~L~~~l~~~~~~~l~e~~~~~i~~Qil~aL~yLH--s~~IiHRDLKP~NILl~~~~~~~iKL~ 517 (966)
|....+.||||||+. |+|.+++.......+++..++.++.||+.||+||| +.||+||||||+|||+++...+.+||+
T Consensus 125 ~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~~~ivHrDlkp~NIll~~~~~~~~kL~ 203 (382)
T 2vx3_A 125 FMFRNHLCLVFEMLS-YNLYDLLRNTNFRGVSLNLTRKFAQQMCTALLFLATPELSIIHCDLKPENILLCNPKRSAIKIV 203 (382)
T ss_dssp EEETTEEEEEEECCC-CBHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHTSTTTCEECCCCSGGGEEESSTTSCCEEEC
T ss_pred eccCCceEEEEecCC-CCHHHHHhhcCcCCCCHHHHHHHHHHHHHHHHHhccCCCCEEcCCCCcccEEEecCCCCcEEEE
Confidence 999999999999995 69999998876557999999999999999999999 479999999999999975456789999
Q ss_pred eecccccccCCCccccccccccCchhhccCCCCCCCcccchhhhhhhhhhhhcCCCCCCCcCcchhHHHHHHHHhcCCCC
Q psy11767 518 DFGFACLKRESLHTPCFTLQYAAPEVLRQDKSGYDENCDLWSLGVILVNVLRQDKSGYDENCDLWSLGVILYTMLCGRVP 597 (966)
Q Consensus 518 DFGla~~~~~~~~~~~gT~~Y~APEvl~~~~~~~~~~~Di~SlGvil~el~~~~~~~y~~~~DIWSlGvilyemltG~~P 597 (966)
|||+|+.........++|+.|+|||++.. ..|+.++|||||||++|+|++|++|
T Consensus 204 DFG~a~~~~~~~~~~~~t~~y~aPE~~~~--------------------------~~~~~~~DiwSlG~il~elltg~~p 257 (382)
T 2vx3_A 204 DFGSSCQLGQRIYQYIQSRFYRSPEVLLG--------------------------MPYDLAIDMWSLGCILVEMHTGEPL 257 (382)
T ss_dssp CCTTCEETTCCCCSSCSCGGGCCHHHHTT--------------------------CCCCTHHHHHHHHHHHHHHHHSSCS
T ss_pred eccCceecccccccccCCccccChHHHcC--------------------------CCCCcHHHHHHHHHHHHHHHhCCCC
Confidence 99999887666667789999999999852 2478899999999999999999999
Q ss_pred CCCCCCchhHHHHHHHHHc---------------------CCCC----------CCchhhc-------------------
Q psy11767 598 FHARSRDDSALSIMARIKE---------------------GQFN----------FDAEAWS------------------- 627 (966)
Q Consensus 598 f~~~~~~~~~~~~~~~i~~---------------------~~~~----------~~~~~~~------------------- 627 (966)
|.+.+..+....+...... +.+. +....+.
T Consensus 258 f~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 337 (382)
T 2vx3_A 258 FSGANEVDQMNKIVEVLGIPPAHILDQAPKARKFFEKLPDGTWNLKKTKDGKREYKPPGTRKLHNILGVETGGPGGRRAG 337 (382)
T ss_dssp SCCSSHHHHHHHHHHHHCSCCHHHHTTCTTHHHHEEECTTSCEEECCCCTTCCCSCCTTCSCHHHHHTTTTTSGGGTTTT
T ss_pred CCCCCHHHHHHHHHHHhCCCCHHHHHhhHHHHHHHHhccccccccccccccccccCCcchhhHHHHhhccccCCCccccc
Confidence 9986654433333222110 0000 0000000
Q ss_pred ------cCCHHHHHHHHHhcccCccccCChHHHHHHhhhhHH
Q psy11767 628 ------TVSSEAKELTKSLLTVNPAQRIRMMRVKLTFHAFHQ 663 (966)
Q Consensus 628 ------~is~e~~~Li~~~L~~dP~~R~t~~~v~~~~~~~~~ 663 (966)
..++++++||.+||+.||++|||+.++ ..|+|++
T Consensus 338 ~~~~~~~~~~~~~dli~~mL~~dP~~Rpta~e~--L~hp~f~ 377 (382)
T 2vx3_A 338 ESGHTVADYLKFKDLILRMLDYDPKTRIQPYYA--LQHSFFK 377 (382)
T ss_dssp CTTCCHHHHHHHHHHHHHHTCSCTTTSCCHHHH--TTSGGGC
T ss_pred cccccchhhHHHHHHHHHhcCCChhhCCCHHHH--hcCcccc
Confidence 011478999999999999999999976 4577764
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-40 Score=373.02 Aligned_cols=256 Identities=27% Similarity=0.412 Sum_probs=196.1
Q ss_pred ccccccccccccEEEEEEEcCCCcEEEEEEeccccC-------hHHHHHHHHHhcCC-CCceEEEEEEEeCCeEEEEEEc
Q psy11767 381 DKAGILGDGSYSVCRRCVEKSTGQEYAVKIISRKID-------CSEEINLLRACQGH-PNIVNLHCVFQDEVHTYLVLEL 452 (966)
Q Consensus 381 ~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~~-------~~~Ei~iL~~l~~H-pnIV~l~~~~~~~~~~~lVmEy 452 (966)
+..+.||+|+||.||+|.+. +++.||||++..... ..+|+.+|+.+.+| |||+++++++.++...|||||+
T Consensus 12 ~i~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~~~~lv~e~ 90 (343)
T 3dbq_A 12 SILKQIGSGGSSKVFQVLNE-KKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVMEC 90 (343)
T ss_dssp EEEEEESCCSSEEEEEEECT-TSCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEECC
T ss_pred EEEEEEecCCCeEEEEEEeC-CCCEEEEEEeeccccchHHHHHHHHHHHHHHhhhhcCCceEEEeeeEeeCCEEEEEEeC
Confidence 34689999999999999984 689999999865422 35699999998643 9999999999999999999995
Q ss_pred cCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCcEEEecCCCCCEEEEeecccccccCC----
Q psy11767 453 LKGGELLDRIRQKGRCGFTENEASRIMRQLVAAVHFMHSRGVVHRDLKPENLLFSDPAGDNIKVVDFGFACLKRES---- 528 (966)
Q Consensus 453 ~~gg~L~~~l~~~~~~~l~e~~~~~i~~Qil~aL~yLHs~~IiHRDLKP~NILl~~~~~~~iKL~DFGla~~~~~~---- 528 (966)
.+|+|.+++.... .+++.+++.++.||+.||+|||++||+||||||+|||++ ++.+||+|||+|+.....
T Consensus 91 -~~~~L~~~l~~~~--~~~~~~~~~i~~qi~~al~~lH~~~iiHrDikp~NIll~---~~~~kl~DFG~a~~~~~~~~~~ 164 (343)
T 3dbq_A 91 -GNIDLNSWLKKKK--SIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIV---DGMLKLIDFGIANQMQPDTTSV 164 (343)
T ss_dssp -CSEEHHHHHHHSC--CCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEE---TTEEEECCCSSSCCC-------
T ss_pred -CCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCcceEEEE---CCcEEEeecccccccCcccccc
Confidence 5889999998764 699999999999999999999999999999999999997 358999999999765332
Q ss_pred -CccccccccccCchhhccCCCCCCCcccchhhhhhhhhhhhcCCCCCCCcCcchhHHHHHHHHhcCCCCCCCCCCchhH
Q psy11767 529 -LHTPCFTLQYAAPEVLRQDKSGYDENCDLWSLGVILVNVLRQDKSGYDENCDLWSLGVILYTMLCGRVPFHARSRDDSA 607 (966)
Q Consensus 529 -~~~~~gT~~Y~APEvl~~~~~~~~~~~Di~SlGvil~el~~~~~~~y~~~~DIWSlGvilyemltG~~Pf~~~~~~~~~ 607 (966)
....+||+.|+|||++........ .......|+.++|||||||++|+|++|+.||......
T Consensus 165 ~~~~~~gt~~y~aPE~~~~~~~~~~---------------~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~--- 226 (343)
T 3dbq_A 165 VKDSQVGTVNYMPPEAIKDMSSSRE---------------NGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQ--- 226 (343)
T ss_dssp -----CCCCSSCCHHHHHHCC--------------------------CCHHHHHHHHHHHHHHHHHSSCTTTTCCSH---
T ss_pred cCCCCcCCcCcCCHHHHhhcccccc---------------ccccccCCCchhhHHHHHHHHHHHHhCCCcchhhhhH---
Confidence 234578999999999864211000 0011245788999999999999999999999865432
Q ss_pred HHHHHHHHcCCCCCCchhhccCCHHHHHHHHHhcccCccccCChHHHHHHhhhhHHhh
Q psy11767 608 LSIMARIKEGQFNFDAEAWSTVSSEAKELTKSLLTVNPAQRIRMMRVKLTFHAFHQAQ 665 (966)
Q Consensus 608 ~~~~~~i~~~~~~~~~~~~~~is~e~~~Li~~~L~~dP~~R~t~~~v~~~~~~~~~~~ 665 (966)
...+..+....... ......+.++.+||.+||+.||.+|||+.++ ..|+|++..
T Consensus 227 ~~~~~~~~~~~~~~--~~~~~~~~~l~~li~~~L~~dp~~Rpt~~e~--l~hp~~~~~ 280 (343)
T 3dbq_A 227 ISKLHAIIDPNHEI--EFPDIPEKDLQDVLKCCLKRDPKQRISIPEL--LAHPYVQIQ 280 (343)
T ss_dssp HHHHHHHHCTTSCC--CCCCCSCHHHHHHHHHHTCSSTTTSCCHHHH--HTSHHHHSC
T ss_pred HHHHHHHhcCCccc--CCcccCCHHHHHHHHHHcCCChhHCCCHHHH--HhCcccccc
Confidence 12233333322221 1223467899999999999999999999976 457777643
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-40 Score=369.25 Aligned_cols=243 Identities=24% Similarity=0.413 Sum_probs=194.0
Q ss_pred cccccccccccccEEEEEEEcCCCcEEEEEEecccc------ChHHHHHHHHHhcCCCCceEEEEEEEeCC---------
Q psy11767 380 LDKAGILGDGSYSVCRRCVEKSTGQEYAVKIISRKI------DCSEEINLLRACQGHPNIVNLHCVFQDEV--------- 444 (966)
Q Consensus 380 ~~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~------~~~~Ei~iL~~l~~HpnIV~l~~~~~~~~--------- 444 (966)
|+..+.||+|+||+||+|+++.+|+.||||++.... ...+|+++|+.+ +|||||+++++|.+..
T Consensus 8 y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~hpniv~~~~~~~~~~~~~~~~~~~ 86 (332)
T 3qd2_B 8 FEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKL-EHPGIVRYFNAWLETPPEKWQEEMD 86 (332)
T ss_dssp EEEEEEEECC-CSEEEEEEETTTCCEEEEEEEECCSTTTHHHHHHHHHHHHTSC-CCTTBCCEEEEEEECCSCHHHHHHH
T ss_pred CceeeEecCCCCeEEEEEEEcCCCcEEEEEEeecCCchhHHHHHHHHHHHHHhC-CCCCEeeEEEEEEEeccchhhhhhh
Confidence 344789999999999999999999999999986432 245799999988 5999999999986543
Q ss_pred ------------------------------------------------eEEEEEEccCCCCHHHHHHhcCC-CCCCHHHH
Q psy11767 445 ------------------------------------------------HTYLVLELLKGGELLDRIRQKGR-CGFTENEA 475 (966)
Q Consensus 445 ------------------------------------------------~~~lVmEy~~gg~L~~~l~~~~~-~~l~e~~~ 475 (966)
+.|+|||||+||+|.+++..... ...++..+
T Consensus 87 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~ 166 (332)
T 3qd2_B 87 EIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLEDREHGVC 166 (332)
T ss_dssp C--------------------------------------------CCCEEEEEEECCCSSCHHHHHHTCCSGGGSCHHHH
T ss_pred hhhhccccccccccCCCcccccccceeeccccCcccccccccCCCCCceEEEEEEecCCCCHHHHHhcccCccchhhHHH
Confidence 38999999999999999987542 23567779
Q ss_pred HHHHHHHHHHHHHHHhcCceeccCCCCcEEEecCCCCCEEEEeecccccccCC---------------CccccccccccC
Q psy11767 476 SRIMRQLVAAVHFMHSRGVVHRDLKPENLLFSDPAGDNIKVVDFGFACLKRES---------------LHTPCFTLQYAA 540 (966)
Q Consensus 476 ~~i~~Qil~aL~yLHs~~IiHRDLKP~NILl~~~~~~~iKL~DFGla~~~~~~---------------~~~~~gT~~Y~A 540 (966)
+.++.||+.||+|||++||+||||||+|||++. ++.+||+|||+++..... ....+||+.|+|
T Consensus 167 ~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~--~~~~kL~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~a 244 (332)
T 3qd2_B 167 LHIFIQIAEAVEFLHSKGLMHRDLKPSNIFFTM--DDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTKLYMS 244 (332)
T ss_dssp HHHHHHHHHHHHHHHHTTEECCCCCGGGEEECT--TCCEEECCCTTCEECSCC--------------CCCSCC-CGGGSC
T ss_pred HHHHHHHHHHHHHHHhCCeeecCCCcccEEEeC--CCCEEEeecCcccccccchhhccccccccccccccccCCCcCccC
Confidence 999999999999999999999999999999974 569999999999765432 133568999999
Q ss_pred chhhccCCCCCCCcccchhhhhhhhhhhhcCCCCCCCcCcchhHHHHHHHHhcCCCCCCCCCCchhHHHHHHHHHcCCCC
Q psy11767 541 PEVLRQDKSGYDENCDLWSLGVILVNVLRQDKSGYDENCDLWSLGVILYTMLCGRVPFHARSRDDSALSIMARIKEGQFN 620 (966)
Q Consensus 541 PEvl~~~~~~~~~~~Di~SlGvil~el~~~~~~~y~~~~DIWSlGvilyemltG~~Pf~~~~~~~~~~~~~~~i~~~~~~ 620 (966)
||++.. ..|+.++|||||||++|+|++|..|+.. .......+..+.+
T Consensus 245 PE~~~~--------------------------~~~~~~~Di~slG~il~el~~~~~~~~~------~~~~~~~~~~~~~- 291 (332)
T 3qd2_B 245 PEQIHG--------------------------NNYSHKVDIFSLGLILFELLYSFSTQME------RVRIITDVRNLKF- 291 (332)
T ss_dssp HHHHHC--------------------------CCCCTHHHHHHHHHHHHHHHSCCCCHHH------HHHHHHHHHTTCC-
T ss_pred hHHhcC--------------------------CCCcchhhHHHHHHHHHHHHHcCCChhH------HHHHHHHhhccCC-
Confidence 999853 2478899999999999999999877532 2233444444433
Q ss_pred CCchhhccCCHHHHHHHHHhcccCccccCChHHHHHHhhhhH
Q psy11767 621 FDAEAWSTVSSEAKELTKSLLTVNPAQRIRMMRVKLTFHAFH 662 (966)
Q Consensus 621 ~~~~~~~~is~e~~~Li~~~L~~dP~~R~t~~~v~~~~~~~~ 662 (966)
+..+...++++.+||.+||+.||++|||+.++. .|+|+
T Consensus 292 --~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l--~~~~f 329 (332)
T 3qd2_B 292 --PLLFTQKYPQEHMMVQDMLSPSPTERPEATDII--ENAIF 329 (332)
T ss_dssp --CHHHHHHCHHHHHHHHHHHCSSGGGSCCHHHHH--HSTTC
T ss_pred --CcccccCChhHHHHHHHHccCCCCcCCCHHHHh--hchhh
Confidence 223456788999999999999999999999763 35553
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-40 Score=380.42 Aligned_cols=256 Identities=25% Similarity=0.392 Sum_probs=199.6
Q ss_pred cccccccccccccEEEEEEEcCCCcEEEEEEecccc-------ChHHHHHHHHHhcC-CCCceEEEEEEEeCCeEEEEEE
Q psy11767 380 LDKAGILGDGSYSVCRRCVEKSTGQEYAVKIISRKI-------DCSEEINLLRACQG-HPNIVNLHCVFQDEVHTYLVLE 451 (966)
Q Consensus 380 ~~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~-------~~~~Ei~iL~~l~~-HpnIV~l~~~~~~~~~~~lVmE 451 (966)
|...+.||+|+||+||+|.+.. ++.||||++.... ...+|+.+|+.+.. |||||++++++.++...|||||
T Consensus 58 y~~~~~LG~G~fg~Vy~~~~~~-~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~~~~~~iv~~~~~~~~~~~~~lv~E 136 (390)
T 2zmd_A 58 YSILKQIGSGGSSKVFQVLNEK-KQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVME 136 (390)
T ss_dssp EEEEEEEECCSSEEEEEEECTT-CCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEEE
T ss_pred eEEEEEEccCCCeEEEEEEcCC-CCEEEEEEEecccccHHHHHHHHHHHHHHHHcccCCCeEEEEEEEEecCCEEEEEEe
Confidence 4447899999999999999875 9999999996542 24579999999874 7999999999999999999999
Q ss_pred ccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCcEEEecCCCCCEEEEeecccccccCC---
Q psy11767 452 LLKGGELLDRIRQKGRCGFTENEASRIMRQLVAAVHFMHSRGVVHRDLKPENLLFSDPAGDNIKVVDFGFACLKRES--- 528 (966)
Q Consensus 452 y~~gg~L~~~l~~~~~~~l~e~~~~~i~~Qil~aL~yLHs~~IiHRDLKP~NILl~~~~~~~iKL~DFGla~~~~~~--- 528 (966)
+.+++|.+++.... .+++.+++.++.||+.||+|||++||+||||||+|||++ ++.+||+|||+|+.....
T Consensus 137 -~~~~~L~~~l~~~~--~~~~~~~~~i~~qi~~aL~~lH~~~ivHrDlkp~NIll~---~~~~kl~DFG~a~~~~~~~~~ 210 (390)
T 2zmd_A 137 -CGNIDLNSWLKKKK--SIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIV---DGMLKLIDFGIANQMQPDTTS 210 (390)
T ss_dssp -CCSEEHHHHHHHCS--SCCHHHHHHHHHHHHHHHHHHHTTTCCCCCCCGGGEEES---SSCEEECCCSSSCCC------
T ss_pred -cCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHEEEE---CCeEEEEecCccccccCCCcc
Confidence 56899999998765 689999999999999999999999999999999999995 358999999999765322
Q ss_pred --CccccccccccCchhhccCCCCCCCcccchhhhhhhhhhhhcCCCCCCCcCcchhHHHHHHHHhcCCCCCCCCCCchh
Q psy11767 529 --LHTPCFTLQYAAPEVLRQDKSGYDENCDLWSLGVILVNVLRQDKSGYDENCDLWSLGVILYTMLCGRVPFHARSRDDS 606 (966)
Q Consensus 529 --~~~~~gT~~Y~APEvl~~~~~~~~~~~Di~SlGvil~el~~~~~~~y~~~~DIWSlGvilyemltG~~Pf~~~~~~~~ 606 (966)
....+||+.|+|||++....... ........|+.++|||||||++|+|++|+.||......
T Consensus 211 ~~~~~~~gt~~y~aPE~~~~~~~~~---------------~~~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~-- 273 (390)
T 2zmd_A 211 VVKDSQVGAVNYMPPEAIKDMSSSR---------------ENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQ-- 273 (390)
T ss_dssp ---CCSCCCGGGCCHHHHHCC---------------------------CCHHHHHHHHHHHHHHHHHSSCTTTTCCCH--
T ss_pred ccCCCCCcCCCccChHHhhhccccc---------------cccccccCCCChhhHHHHHHHHHHHHHCCCcchhhhHH--
Confidence 23567999999999986421000 00011235889999999999999999999999865432
Q ss_pred HHHHHHHHHcCCCCCCchhhccCCHHHHHHHHHhcccCccccCChHHHHHHhhhhHHh
Q psy11767 607 ALSIMARIKEGQFNFDAEAWSTVSSEAKELTKSLLTVNPAQRIRMMRVKLTFHAFHQA 664 (966)
Q Consensus 607 ~~~~~~~i~~~~~~~~~~~~~~is~e~~~Li~~~L~~dP~~R~t~~~v~~~~~~~~~~ 664 (966)
...+..+..+...+.. ....+.++++||.+||..||++|||+.++ ..|+|.+.
T Consensus 274 -~~~~~~~~~~~~~~~~--~~~~~~~~~~li~~~L~~dP~~Rps~~el--l~hp~~~~ 326 (390)
T 2zmd_A 274 -ISKLHAIIDPNHEIEF--PDIPEKDLQDVLKCCLKRDPKQRISIPEL--LAHPYVQI 326 (390)
T ss_dssp -HHHHHHHHCTTSCCCC--CCCSCHHHHHHHHHHTCSSTTTSCCHHHH--HTSHHHHS
T ss_pred -HHHHHHHhCccccCCC--CccchHHHHHHHHHHcccChhhCCCHHHH--hhCcCccc
Confidence 2233444444333222 22357899999999999999999999976 45777654
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 4ec9_A* 4ec8_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* 4bch_A* 4bci_A* 4bcj_A* 4bcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-40 Score=373.74 Aligned_cols=246 Identities=26% Similarity=0.423 Sum_probs=195.8
Q ss_pred cccccccccccEEEEEEEcCCCcEEEEEEecccc-------ChHHHHHHHHHhcCCCCceEEEEEEEe--------CCeE
Q psy11767 382 KAGILGDGSYSVCRRCVEKSTGQEYAVKIISRKI-------DCSEEINLLRACQGHPNIVNLHCVFQD--------EVHT 446 (966)
Q Consensus 382 ~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~-------~~~~Ei~iL~~l~~HpnIV~l~~~~~~--------~~~~ 446 (966)
..+.||+|+||+||+|++..+|+.||||++.... ...+|+.+|+.+ +||||+++++++.+ .+..
T Consensus 21 ~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~~~~~~~~ 99 (351)
T 3mi9_A 21 KLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLL-KHENVVNLIEICRTKASPYNRCKGSI 99 (351)
T ss_dssp EEEECSSCSTTSEEEEEETTTCCEEEEEECCCSSCSSSSCHHHHHHHHHHHHC-CCTTBCCEEEEEEEC--------CEE
T ss_pred EEEEEecCCCcEEEEEEECCCCCEEEEEEEecccccccchHHHHHHHHHHHhc-cCCCcccHhheeeccccccccCCceE
Confidence 3688999999999999999999999999985432 245799999998 59999999999987 4568
Q ss_pred EEEEEccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCcEEEecCCCCCEEEEeeccccccc
Q psy11767 447 YLVLELLKGGELLDRIRQKGRCGFTENEASRIMRQLVAAVHFMHSRGVVHRDLKPENLLFSDPAGDNIKVVDFGFACLKR 526 (966)
Q Consensus 447 ~lVmEy~~gg~L~~~l~~~~~~~l~e~~~~~i~~Qil~aL~yLHs~~IiHRDLKP~NILl~~~~~~~iKL~DFGla~~~~ 526 (966)
|+|||||+ |+|.+.+..... .+++.+++.++.||+.||+|||++||+||||||+|||++. ++.+||+|||+|+...
T Consensus 100 ~lv~e~~~-~~l~~~l~~~~~-~~~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIl~~~--~~~~kl~Dfg~a~~~~ 175 (351)
T 3mi9_A 100 YLVFDFCE-HDLAGLLSNVLV-KFTLSEIKRVMQMLLNGLYYIHRNKILHRDMKAANVLITR--DGVLKLADFGLARAFS 175 (351)
T ss_dssp EEEEECCS-EEHHHHHHCTTS-CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECT--TSCEEECCCTTCEECC
T ss_pred EEEEeccC-CCHHHHHhhccC-CCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCHHHEEEcC--CCCEEEccchhccccc
Confidence 99999996 588888866543 5999999999999999999999999999999999999975 5699999999997543
Q ss_pred C-------CCccccccccccCchhhccCCCCCCCcccchhhhhhhhhhhhcCCCCCCCcCcchhHHHHHHHHhcCCCCCC
Q psy11767 527 E-------SLHTPCFTLQYAAPEVLRQDKSGYDENCDLWSLGVILVNVLRQDKSGYDENCDLWSLGVILYTMLCGRVPFH 599 (966)
Q Consensus 527 ~-------~~~~~~gT~~Y~APEvl~~~~~~~~~~~Di~SlGvil~el~~~~~~~y~~~~DIWSlGvilyemltG~~Pf~ 599 (966)
. .....+||+.|+|||++.. ...|+.++|||||||++|+|++|++||.
T Consensus 176 ~~~~~~~~~~~~~~gt~~y~aPE~~~~-------------------------~~~~~~~~DiwslG~il~ell~g~~pf~ 230 (351)
T 3mi9_A 176 LAKNSQPNRYTNRVVTLWYRPPELLLG-------------------------ERDYGPPIDLWGAGCIMAEMWTRSPIMQ 230 (351)
T ss_dssp CCSSSSCCCCCSSCSCGGGCCHHHHTT-------------------------CCSCCTHHHHHHHHHHHHHHHHSSCSCC
T ss_pred ccccccccccCCcccccCccCchhhcC-------------------------CCCCCcHhHHHHHHHHHHHHHhCCCCCC
Confidence 1 2234578999999998852 2347889999999999999999999998
Q ss_pred CCCCchhHHHHHHHHHcCCCCCCchhhcc----------------------------CCHHHHHHHHHhcccCccccCCh
Q psy11767 600 ARSRDDSALSIMARIKEGQFNFDAEAWST----------------------------VSSEAKELTKSLLTVNPAQRIRM 651 (966)
Q Consensus 600 ~~~~~~~~~~~~~~i~~~~~~~~~~~~~~----------------------------is~e~~~Li~~~L~~dP~~R~t~ 651 (966)
+....+.... +..+.. . +..+.|+. .++++++||.+||+.||++|||+
T Consensus 231 ~~~~~~~~~~-i~~~~~-~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~ 306 (351)
T 3mi9_A 231 GNTEQHQLAL-ISQLCG-S--ITPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDS 306 (351)
T ss_dssp CSSHHHHHHH-HHHHHC-C--CCTTTSTTGGGCGGGTSSCCCSSCCCCHHHHHHHHHCCHHHHHHHHHHSCSSGGGSCCH
T ss_pred CCChHHHHHH-HHHHhC-C--CChhhccccccchhhcccccccccccCHHHHhhhccCChHHHHHHHHHhcCChhhCCCH
Confidence 8654433222 222211 1 11111111 37889999999999999999999
Q ss_pred HHHHHHhhhhHH
Q psy11767 652 MRVKLTFHAFHQ 663 (966)
Q Consensus 652 ~~v~~~~~~~~~ 663 (966)
.++ ..|+|+.
T Consensus 307 ~e~--l~hp~f~ 316 (351)
T 3mi9_A 307 DDA--LNHDFFW 316 (351)
T ss_dssp HHH--HTSGGGG
T ss_pred HHH--hCCCCcC
Confidence 876 4567763
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-40 Score=379.99 Aligned_cols=256 Identities=25% Similarity=0.395 Sum_probs=200.0
Q ss_pred cccccccccccccEEEEEEEcCCCcEEEEEEecccc-ChHHHHHHHHHhcCCCCceEEEEEEEe----------------
Q psy11767 380 LDKAGILGDGSYSVCRRCVEKSTGQEYAVKIISRKI-DCSEEINLLRACQGHPNIVNLHCVFQD---------------- 442 (966)
Q Consensus 380 ~~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~-~~~~Ei~iL~~l~~HpnIV~l~~~~~~---------------- 442 (966)
|...+.||+|+||+||+|.+..+|+.||||++.... ...+|+.+|+.+ +|||||+++++|..
T Consensus 9 y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~~~~~~~E~~il~~l-~hpnIv~l~~~~~~~~~~~~~~~~~~~~~~ 87 (383)
T 3eb0_A 9 YSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDPRYKNRELDIMKVL-DHVNIIKLVDYFYTTGDEEPKPPQPPDDHN 87 (383)
T ss_dssp EEEEEEEECC-CEEEEEEEETTTCCEEEEEEEECCTTSCCHHHHHHTTC-CCTTBCCEEEEEEEC---------------
T ss_pred EEEEEEEEeccCEEEEEEEECCCCCEEEEEEEecCcchHHHHHHHHHHc-CCCCccchhheeeecCcccccccccccccc
Confidence 344789999999999999999999999999986543 355899999988 59999999999844
Q ss_pred ----------------------CCeEEEEEEccCCCCHHHHHHh--cCCCCCCHHHHHHHHHHHHHHHHHHHhcCceecc
Q psy11767 443 ----------------------EVHTYLVLELLKGGELLDRIRQ--KGRCGFTENEASRIMRQLVAAVHFMHSRGVVHRD 498 (966)
Q Consensus 443 ----------------------~~~~~lVmEy~~gg~L~~~l~~--~~~~~l~e~~~~~i~~Qil~aL~yLHs~~IiHRD 498 (966)
+.+.++|||||+ |+|.+.+.. .....+++..++.++.||+.||+|||++||+|||
T Consensus 88 ~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~gi~H~D 166 (383)
T 3eb0_A 88 KLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVP-DTLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVGFIHSLGICHRD 166 (383)
T ss_dssp ----------------------CCEEEEEECCCS-EEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTTEECSC
T ss_pred cccccccccccccccccccCCCceEEEEEEecCC-ccHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCcCccCc
Confidence 345899999997 587777754 2234699999999999999999999999999999
Q ss_pred CCCCcEEEecCCCCCEEEEeecccccccC--CCccccccccccCchhhccCCCCCCCcccchhhhhhhhhhhhcCCCCCC
Q psy11767 499 LKPENLLFSDPAGDNIKVVDFGFACLKRE--SLHTPCFTLQYAAPEVLRQDKSGYDENCDLWSLGVILVNVLRQDKSGYD 576 (966)
Q Consensus 499 LKP~NILl~~~~~~~iKL~DFGla~~~~~--~~~~~~gT~~Y~APEvl~~~~~~~~~~~Di~SlGvil~el~~~~~~~y~ 576 (966)
|||+|||++. .++.+||+|||+|+.... .....++|+.|+|||++.. ...|+
T Consensus 167 ikp~Nil~~~-~~~~~kl~Dfg~a~~~~~~~~~~~~~~t~~y~aPE~~~~-------------------------~~~~~ 220 (383)
T 3eb0_A 167 IKPQNLLVNS-KDNTLKLCDFGSAKKLIPSEPSVAYICSRFYRAPELMLG-------------------------ATEYT 220 (383)
T ss_dssp CCGGGEEEET-TTTEEEECCCTTCEECCTTSCCCCCCCCSSCCCHHHHTT-------------------------CSSCC
T ss_pred cCHHHEEEcC-CCCcEEEEECCCCcccCCCCCCcCcccCCCccCHHHhcC-------------------------CCCCC
Confidence 9999999973 356899999999976432 3345678999999998852 23478
Q ss_pred CcCcchhHHHHHHHHhcCCCCCCCCCCchhHHHHHHHHHcC-------------CCCCC---ch-----hhccCCHHHHH
Q psy11767 577 ENCDLWSLGVILYTMLCGRVPFHARSRDDSALSIMARIKEG-------------QFNFD---AE-----AWSTVSSEAKE 635 (966)
Q Consensus 577 ~~~DIWSlGvilyemltG~~Pf~~~~~~~~~~~~~~~i~~~-------------~~~~~---~~-----~~~~is~e~~~ 635 (966)
.++||||+||++|+|++|++||.+.+..+....++..+... .+.++ .. ....+++++.+
T Consensus 221 ~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 300 (383)
T 3eb0_A 221 PSIDLWSIGCVFGELILGKPLFSGETSIDQLVRIIQIMGTPTKEQMIRMNPHYTEVRFPTLKAKDWRKILPEGTPSLAID 300 (383)
T ss_dssp THHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHHHCTTC--CCCCCCCCCCHHHHSCTTCCHHHHH
T ss_pred cchhhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHhCcccccccCCccCcccHHhhCCCCCCHHHHH
Confidence 89999999999999999999999876554433333221110 00000 01 12347899999
Q ss_pred HHHHhcccCccccCChHHHHHHhhhhHHhh
Q psy11767 636 LTKSLLTVNPAQRIRMMRVKLTFHAFHQAQ 665 (966)
Q Consensus 636 Li~~~L~~dP~~R~t~~~v~~~~~~~~~~~ 665 (966)
||.+||+.||++|||+.++ ..|+|+...
T Consensus 301 li~~~L~~dP~~R~t~~e~--l~hp~f~~~ 328 (383)
T 3eb0_A 301 LLEQILRYEPDLRINPYEA--MAHPFFDHL 328 (383)
T ss_dssp HHHHHCCSSGGGSCCHHHH--HTSGGGHHH
T ss_pred HHHHHccCChhhCCCHHHH--hcCHHHHHH
Confidence 9999999999999999876 457877543
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-40 Score=376.87 Aligned_cols=254 Identities=13% Similarity=0.176 Sum_probs=193.8
Q ss_pred cccccccccccccEEEEEEEcCC-----CcEEEEEEecccc-ChHHHHHHHHHhc--------------CCCCceEEEEE
Q psy11767 380 LDKAGILGDGSYSVCRRCVEKST-----GQEYAVKIISRKI-DCSEEINLLRACQ--------------GHPNIVNLHCV 439 (966)
Q Consensus 380 ~~~~~~LG~G~fG~Vy~a~~~~t-----g~~vAvK~i~~~~-~~~~Ei~iL~~l~--------------~HpnIV~l~~~ 439 (966)
|...+.||+|+||.||+|.+..+ ++.||||++.... ...+|+++++.+. .|||||+++++
T Consensus 37 y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~ 116 (364)
T 3op5_A 37 WKVGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIRTRKLKYLGVPKYWGS 116 (364)
T ss_dssp EEEEEECCCC-CCEEEEEEECCSSCCCTTCSEEEEEEETTCHHHHHHHHHHHHHCCHHHHHHHHHHTTCSCCCSCCEEEE
T ss_pred EEEEEEEecCCCeEEEEeeecCccccccccceEEEEeeccchhHHHHHHHHHhhhhhHHHHHHHHHhhccCCCCCeEEee
Confidence 34478999999999999999875 5889999987543 2345555555443 49999999999
Q ss_pred EEeC----CeEEEEEEccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCcEEEecCCCCCEE
Q psy11767 440 FQDE----VHTYLVLELLKGGELLDRIRQKGRCGFTENEASRIMRQLVAAVHFMHSRGVVHRDLKPENLLFSDPAGDNIK 515 (966)
Q Consensus 440 ~~~~----~~~~lVmEy~~gg~L~~~l~~~~~~~l~e~~~~~i~~Qil~aL~yLHs~~IiHRDLKP~NILl~~~~~~~iK 515 (966)
+.+. .+.||||||| |++|.+++.... ..+++.+++.++.||+.||+|||++||+||||||+|||++....+.+|
T Consensus 117 ~~~~~~~~~~~~lv~e~~-g~~L~~~~~~~~-~~l~~~~~~~i~~qi~~~l~~lH~~~iiHrDlkp~Nill~~~~~~~~k 194 (364)
T 3op5_A 117 GLHDKNGKSYRFMIMDRF-GSDLQKIYEANA-KRFSRKTVLQLSLRILDILEYIHEHEYVHGDIKASNLLLNYKNPDQVY 194 (364)
T ss_dssp EEEEETTEEEEEEEEECE-EEEHHHHHHHTT-SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEESSCTTCEE
T ss_pred eeeccCCcceEEEEEeCC-CCCHHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHHCCeEEecCCHHHEEEecCCCCeEE
Confidence 8865 5689999999 999999998753 369999999999999999999999999999999999999844467999
Q ss_pred EEeecccccccCC----------CccccccccccCchhhccCCCCCCCcccchhhhhhhhhhhhcCCCCCCCcCcchhHH
Q psy11767 516 VVDFGFACLKRES----------LHTPCFTLQYAAPEVLRQDKSGYDENCDLWSLGVILVNVLRQDKSGYDENCDLWSLG 585 (966)
Q Consensus 516 L~DFGla~~~~~~----------~~~~~gT~~Y~APEvl~~~~~~~~~~~Di~SlGvil~el~~~~~~~y~~~~DIWSlG 585 (966)
|+|||+|+..... ....+||+.|+|||++.. ..|+.++||||||
T Consensus 195 l~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--------------------------~~~~~~~Di~slG 248 (364)
T 3op5_A 195 LVDYGLAYRYCPEGVHKAYAADPKRCHDGTIEFTSIDAHNG--------------------------VAPSRRGDLEILG 248 (364)
T ss_dssp ECCCTTCEESSGGGCCCCSSCCSSCCCCCCTTTCCHHHHTT--------------------------CCCCHHHHHHHHH
T ss_pred EEECCcceecccCCcccccccCcccccCCCCCccCHHHhCC--------------------------CCCCchhhHHHHH
Confidence 9999999654321 123458999999998852 2378899999999
Q ss_pred HHHHHHhcCCCCCCCCCCchhHHHHHHHHHcCCC-CCCchh--hccCCHHHHHHHHHhcccCccccCChHHHHHHhhhh
Q psy11767 586 VILYTMLCGRVPFHARSRDDSALSIMARIKEGQF-NFDAEA--WSTVSSEAKELTKSLLTVNPAQRIRMMRVKLTFHAF 661 (966)
Q Consensus 586 vilyemltG~~Pf~~~~~~~~~~~~~~~i~~~~~-~~~~~~--~~~is~e~~~Li~~~L~~dP~~R~t~~~v~~~~~~~ 661 (966)
|++|+|++|+.||.+................... .+.... ...+++++.++|.+||..||++||++.++...+...
T Consensus 249 ~~l~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~RP~~~~l~~~l~~~ 327 (364)
T 3op5_A 249 YCMIQWLTGHLPWEDNLKDPKYVRDSKIRYRENIASLMDKCFPAANAPGEIAKYMETVKLLDYTEKPLYENLRDILLQG 327 (364)
T ss_dssp HHHHHHHHSCCTTGGGTTCHHHHHHHHHHHHHCHHHHHHHHSCTTCCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHH
T ss_pred HHHHHHHhCCCCccccccCHHHHHHHHHHhhhhHHHHHHHhcccccCHHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHH
Confidence 9999999999999865443322221111111000 000000 135789999999999999999999999886555443
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} SCOP: d.144.1.7 PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3u9c_A* 4fbx_A* 3mb7_A* 3mb6_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-40 Score=367.63 Aligned_cols=251 Identities=24% Similarity=0.424 Sum_probs=201.0
Q ss_pred cccccccccccccEEEEEEEcCCCcEEEEEEecccc--ChHHHHHHHHHhcCCCCceEEEEEEEe--CCeEEEEEEccCC
Q psy11767 380 LDKAGILGDGSYSVCRRCVEKSTGQEYAVKIISRKI--DCSEEINLLRACQGHPNIVNLHCVFQD--EVHTYLVLELLKG 455 (966)
Q Consensus 380 ~~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~--~~~~Ei~iL~~l~~HpnIV~l~~~~~~--~~~~~lVmEy~~g 455 (966)
|+..+.||+|+||.||+|++..+|+.||||++.... ...+|+.+|+.+.+||||+++++++.+ ....++||||+.+
T Consensus 38 y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~lv~e~~~~ 117 (330)
T 3nsz_A 38 YQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVKKKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVFEHVNN 117 (330)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSCCHHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCCEEEEEECCCC
T ss_pred eEEEEEecccCCeEEEEEEECCCCcEEEEEEecccchHHHHHHHHHHHHcCCCCCEEEeeeeeccCCCCceEEEEeccCc
Confidence 334689999999999999999999999999997432 356799999999889999999999998 6789999999999
Q ss_pred CCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCcEEEecCCCCCEEEEeecccccccC--CCcccc
Q psy11767 456 GELLDRIRQKGRCGFTENEASRIMRQLVAAVHFMHSRGVVHRDLKPENLLFSDPAGDNIKVVDFGFACLKRE--SLHTPC 533 (966)
Q Consensus 456 g~L~~~l~~~~~~~l~e~~~~~i~~Qil~aL~yLHs~~IiHRDLKP~NILl~~~~~~~iKL~DFGla~~~~~--~~~~~~ 533 (966)
++|.+++. .+++.+++.++.||+.||+|||++||+||||||+|||++. .+..+||+|||+|+.... .....+
T Consensus 118 ~~l~~~~~-----~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dikp~Nil~~~-~~~~~kl~Dfg~a~~~~~~~~~~~~~ 191 (330)
T 3nsz_A 118 TDFKQLYQ-----TLTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDH-EHRKLRLIDWGLAEFYHPGQEYNVRV 191 (330)
T ss_dssp CCHHHHGG-----GCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEET-TTTEEEECCCTTCEECCTTCCCCSCC
T ss_pred hhHHHHHH-----hCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEEcC-CCCEEEEEeCCCceEcCCCCcccccc
Confidence 99998874 3899999999999999999999999999999999999974 234899999999976432 334567
Q ss_pred ccccccCchhhccCCCCCCCcccchhhhhhhhhhhhcCCCCCCCcCcchhHHHHHHHHhcCCCCCCCCCCchhHHHHH--
Q psy11767 534 FTLQYAAPEVLRQDKSGYDENCDLWSLGVILVNVLRQDKSGYDENCDLWSLGVILYTMLCGRVPFHARSRDDSALSIM-- 611 (966)
Q Consensus 534 gT~~Y~APEvl~~~~~~~~~~~Di~SlGvil~el~~~~~~~y~~~~DIWSlGvilyemltG~~Pf~~~~~~~~~~~~~-- 611 (966)
+|+.|+|||++.. ...|+.++|||||||++|+|++|+.||............+
T Consensus 192 ~~~~y~aPE~~~~-------------------------~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~l~~~~~ 246 (330)
T 3nsz_A 192 ASRYFKGPELLVD-------------------------YQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAK 246 (330)
T ss_dssp SCGGGCCHHHHTT-------------------------CCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHH
T ss_pred ccccccChhhhcC-------------------------CCcCCchhhHHHHHHHHHHHHhCCCCcccCCchHHHHHHHHH
Confidence 8999999999852 2347889999999999999999999996554332211111
Q ss_pred --------HHHHcCCCCCC--------------------chhhccCCHHHHHHHHHhcccCccccCChHHHHHHhhhhHH
Q psy11767 612 --------ARIKEGQFNFD--------------------AEAWSTVSSEAKELTKSLLTVNPAQRIRMMRVKLTFHAFHQ 663 (966)
Q Consensus 612 --------~~i~~~~~~~~--------------------~~~~~~is~e~~~Li~~~L~~dP~~R~t~~~v~~~~~~~~~ 663 (966)
..+........ ......+++++.+||.+||+.||++|||+.++ ..|+|+.
T Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~e~--l~hp~f~ 324 (330)
T 3nsz_A 247 VLGTEDLYDYIDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREA--MEHPYFY 324 (330)
T ss_dssp HHCHHHHHHHHHHTTCCCCTHHHHHHCCCCCCCGGGGCCTTTGGGCCHHHHHHHHTTSCSSGGGSCCHHHH--HTSGGGT
T ss_pred hcCCchhhhHHHHhccccccchhhhhhhccccchhhhccccccccCCHHHHHHHHHHhcCCcccCCCHHHH--hcCccHh
Confidence 11122221111 11223479999999999999999999999976 4577764
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-40 Score=358.20 Aligned_cols=246 Identities=21% Similarity=0.323 Sum_probs=200.0
Q ss_pred ccccccccccccccEEEEEEEcCCCcEEEEEEecccc-------ChHHHHHHHHHhcCCCCceEEEEEEEeCCeEEEEEE
Q psy11767 379 DLDKAGILGDGSYSVCRRCVEKSTGQEYAVKIISRKI-------DCSEEINLLRACQGHPNIVNLHCVFQDEVHTYLVLE 451 (966)
Q Consensus 379 ~~~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~-------~~~~Ei~iL~~l~~HpnIV~l~~~~~~~~~~~lVmE 451 (966)
+|+..+.||+|+||+||+|.+..+++.||||++.... ...+|+..+..+.+||||+++++++.++...|+|||
T Consensus 12 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~~h~~iv~~~~~~~~~~~~~lv~e 91 (289)
T 1x8b_A 12 EFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHSHVVRYFSAWAEDDHMLIQNE 91 (289)
T ss_dssp HEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCCTTSHHHHHHHHHHHHHHHSCSCTTBCCEEEEEEETTEEEEEEE
T ss_pred hhhhhhhhcCCCceEEEEEEEcCCCceEEEEEecccccccHHHHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEEEEE
Confidence 3444789999999999999999999999999987532 234588888887679999999999999999999999
Q ss_pred ccCCCCHHHHHHhcC--CCCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCcEEEecC-----------------CCC
Q psy11767 452 LLKGGELLDRIRQKG--RCGFTENEASRIMRQLVAAVHFMHSRGVVHRDLKPENLLFSDP-----------------AGD 512 (966)
Q Consensus 452 y~~gg~L~~~l~~~~--~~~l~e~~~~~i~~Qil~aL~yLHs~~IiHRDLKP~NILl~~~-----------------~~~ 512 (966)
|++||+|.+++.... ...+++.+++.++.||+.||+|||++||+||||||+|||++.. ...
T Consensus 92 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dikp~NIl~~~~~~~~~~~~~~~~~~~~~~~~ 171 (289)
T 1x8b_A 92 YCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIHSMSLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKV 171 (289)
T ss_dssp CCTTCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEC--------------------CC
T ss_pred ecCCCcHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHHhCCEeecCCCHHHEEEcCCCCCcccccccccccccCCce
Confidence 999999999997642 1358999999999999999999999999999999999999732 234
Q ss_pred CEEEEeecccccccCCCccccccccccCchhhccCCCCCCCcccchhhhhhhhhhhhcCCCCCCCcCcchhHHHHHHHHh
Q psy11767 513 NIKVVDFGFACLKRESLHTPCFTLQYAAPEVLRQDKSGYDENCDLWSLGVILVNVLRQDKSGYDENCDLWSLGVILYTML 592 (966)
Q Consensus 513 ~iKL~DFGla~~~~~~~~~~~gT~~Y~APEvl~~~~~~~~~~~Di~SlGvil~el~~~~~~~y~~~~DIWSlGvilyeml 592 (966)
.+||+|||++...... ....+|+.|+|||++... ..++.++|||||||++|+|+
T Consensus 172 ~~kl~Dfg~~~~~~~~-~~~~gt~~y~aPE~~~~~-------------------------~~~~~~~Di~slG~il~~l~ 225 (289)
T 1x8b_A 172 MFKIGDLGHVTRISSP-QVEEGDSRFLANEVLQEN-------------------------YTHLPKADIFALALTVVCAA 225 (289)
T ss_dssp CEEECCCTTCEETTCS-CCCCCCGGGCCHHHHTTC-------------------------CTTHHHHHHHHHHHHHHHHT
T ss_pred EEEEcccccccccCCc-cccCCCccccChhHhcCC-------------------------CCCCchhhHHHHHHHHHHHh
Confidence 7999999999765543 345689999999998521 23567899999999999999
Q ss_pred cCCCCCCCCCCchhHHHHHHHHHcCCCCCCchhhccCCHHHHHHHHHhcccCccccCChHHHHHHhhhhH
Q psy11767 593 CGRVPFHARSRDDSALSIMARIKEGQFNFDAEAWSTVSSEAKELTKSLLTVNPAQRIRMMRVKLTFHAFH 662 (966)
Q Consensus 593 tG~~Pf~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~is~e~~~Li~~~L~~dP~~R~t~~~v~~~~~~~~ 662 (966)
+|.+|+.... ....+..+.... ....+++++.+||.+||..||++|||+.++ ..|+|+
T Consensus 226 ~~~~~~~~~~-------~~~~~~~~~~~~---~~~~~~~~~~~li~~~l~~dp~~Rps~~~l--l~h~~~ 283 (289)
T 1x8b_A 226 GAEPLPRNGD-------QWHEIRQGRLPR---IPQVLSQEFTELLKVMIHPDPERRPSAMAL--VKHSVL 283 (289)
T ss_dssp TCCCCCSSSH-------HHHHHHTTCCCC---CSSCCCHHHHHHHHHHTCSSGGGSCCHHHH--HTCTTC
T ss_pred cCCCCCcchh-------HHHHHHcCCCCC---CCcccCHHHHHHHHHHhCCCcccCCCHHHH--hhChHh
Confidence 9998875421 233444544322 224689999999999999999999999876 446654
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-40 Score=370.14 Aligned_cols=242 Identities=23% Similarity=0.380 Sum_probs=197.6
Q ss_pred ccccccccccEEEEEEEcCCCc---EEEEEEeccccC------hHHHHHHHHHhcCCCCceEEEEEEEeCCeEEEEEEcc
Q psy11767 383 AGILGDGSYSVCRRCVEKSTGQ---EYAVKIISRKID------CSEEINLLRACQGHPNIVNLHCVFQDEVHTYLVLELL 453 (966)
Q Consensus 383 ~~~LG~G~fG~Vy~a~~~~tg~---~vAvK~i~~~~~------~~~Ei~iL~~l~~HpnIV~l~~~~~~~~~~~lVmEy~ 453 (966)
.+.||+|+||.||+|.+..+|+ .||||++..... ..+|+.+|+.+ +|||||++++++.++...|+||||+
T Consensus 54 ~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~e~~ 132 (325)
T 3kul_A 54 EKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQF-DHPNIIRLEGVVTRGRLAMIVTEYM 132 (325)
T ss_dssp EEEEEETTTEEEEEEEECCTTSCCEEEEEEEECTTCCHHHHHHHHHHHHHHTTC-CCTTBCCEEEEECGGGCCEEEEECC
T ss_pred eeEEEeCCCcEEEEEEEecCCCCCceEEEEecCCCCCHHHHHHHHHHHHHHHhC-CCCCCCcEEEEEEeCCccEEEeeCC
Confidence 6899999999999999986655 599999975432 45699999888 5999999999999999999999999
Q ss_pred CCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCcEEEecCCCCCEEEEeecccccccCC-----
Q psy11767 454 KGGELLDRIRQKGRCGFTENEASRIMRQLVAAVHFMHSRGVVHRDLKPENLLFSDPAGDNIKVVDFGFACLKRES----- 528 (966)
Q Consensus 454 ~gg~L~~~l~~~~~~~l~e~~~~~i~~Qil~aL~yLHs~~IiHRDLKP~NILl~~~~~~~iKL~DFGla~~~~~~----- 528 (966)
+||+|.+++..... .+++.+++.++.||+.||+|||++||+||||||+|||++. ++.+||+|||+++.....
T Consensus 133 ~~~~L~~~l~~~~~-~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~--~~~~kl~Dfg~a~~~~~~~~~~~ 209 (325)
T 3kul_A 133 ENGSLDTFLRTHDG-QFTIMQLVGMLRGVGAGMRYLSDLGYVHRDLAARNVLVDS--NLVCKVSDFGLSRVLEDDPDAAY 209 (325)
T ss_dssp TTCBHHHHHHTTTT-CSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECT--TCCEEECCCSSCEECC----CCE
T ss_pred CCCcHHHHHHhccc-CCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCcceEEECC--CCCEEECCCCcccccccCcccee
Confidence 99999999976533 6999999999999999999999999999999999999974 569999999999765432
Q ss_pred -CccccccccccCchhhccCCCCCCCcccchhhhhhhhhhhhcCCCCCCCcCcchhHHHHHHHHhc-CCCCCCCCCCchh
Q psy11767 529 -LHTPCFTLQYAAPEVLRQDKSGYDENCDLWSLGVILVNVLRQDKSGYDENCDLWSLGVILYTMLC-GRVPFHARSRDDS 606 (966)
Q Consensus 529 -~~~~~gT~~Y~APEvl~~~~~~~~~~~Di~SlGvil~el~~~~~~~y~~~~DIWSlGvilyemlt-G~~Pf~~~~~~~~ 606 (966)
.....+|+.|+|||++... .|+.++|||||||++|+|++ |..||......
T Consensus 210 ~~~~~~~t~~y~aPE~~~~~--------------------------~~~~~~Di~slG~il~ell~~g~~p~~~~~~~-- 261 (325)
T 3kul_A 210 TTTGGKIPIRWTAPEAIAFR--------------------------TFSSASDVWSFGVVMWEVLAYGERPYWNMTNR-- 261 (325)
T ss_dssp ECC---CCGGGSCHHHHHHC--------------------------EECHHHHHHHHHHHHHHHHTTSCCTTTTSCHH--
T ss_pred eccCCCCcccccCHhHhcCC--------------------------CCCcHHHHHHHHHHHHHHHcCCCCCcccCCHH--
Confidence 1223457789999998532 36788999999999999999 99999875533
Q ss_pred HHHHHHHHHcCCCCCCchhhccCCHHHHHHHHHhcccCccccCChHHHHHHhhhh
Q psy11767 607 ALSIMARIKEGQFNFDAEAWSTVSSEAKELTKSLLTVNPAQRIRMMRVKLTFHAF 661 (966)
Q Consensus 607 ~~~~~~~i~~~~~~~~~~~~~~is~e~~~Li~~~L~~dP~~R~t~~~v~~~~~~~ 661 (966)
.+...+..+... .....+++++.+||.+||..||++|||+.++...+..+
T Consensus 262 --~~~~~~~~~~~~---~~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~~L~~l 311 (325)
T 3kul_A 262 --DVISSVEEGYRL---PAPMGCPHALHQLMLDCWHKDRAQRPRFSQIVSVLDAL 311 (325)
T ss_dssp --HHHHHHHTTCCC---CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred --HHHHHHHcCCCC---CCCCCcCHHHHHHHHHHccCChhhCcCHHHHHHHHHHH
Confidence 344455544221 12246889999999999999999999999886555443
|
| >4hgt_A Casein kinase I isoform delta; CK1D, inhibitor, transferase-transferase inhibitor C; HET: 15G; 1.80A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 3uzp_A* 4hnf_A* 1cki_A 1ckj_A 4hni_A* 4hok_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-40 Score=359.18 Aligned_cols=253 Identities=21% Similarity=0.283 Sum_probs=199.2
Q ss_pred cccccccccccEEEEEEEcCCCcEEEEEEeccc---cChHHHHHHHHHhcCCCCceEEEEEEEeCCeEEEEEEccCCCCH
Q psy11767 382 KAGILGDGSYSVCRRCVEKSTGQEYAVKIISRK---IDCSEEINLLRACQGHPNIVNLHCVFQDEVHTYLVLELLKGGEL 458 (966)
Q Consensus 382 ~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~---~~~~~Ei~iL~~l~~HpnIV~l~~~~~~~~~~~lVmEy~~gg~L 458 (966)
..+.||+|+||+||+|.+..+++.||||++... ....+|+.+++.+.+|++|..+..++.+....++||||+ +++|
T Consensus 13 ~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~e~~-~~~L 91 (296)
T 4hgt_A 13 LGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMELL-GPSL 91 (296)
T ss_dssp EEEEEEECSSSEEEEEEETTTTEEEEEEEEEC---CCCHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEEEEECC-CCBH
T ss_pred EeeeecCCCCeEEEEEEEcCCCceEEEEeecccccchHHHHHHHHHHHhcCCCCCCeeeeecCCCCceEEEEEcc-CCCH
Confidence 368899999999999999999999999987543 346789999999975556666667778888999999999 9999
Q ss_pred HHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCcEEEec-CCCCCEEEEeecccccccCC---------
Q psy11767 459 LDRIRQKGRCGFTENEASRIMRQLVAAVHFMHSRGVVHRDLKPENLLFSD-PAGDNIKVVDFGFACLKRES--------- 528 (966)
Q Consensus 459 ~~~l~~~~~~~l~e~~~~~i~~Qil~aL~yLHs~~IiHRDLKP~NILl~~-~~~~~iKL~DFGla~~~~~~--------- 528 (966)
.+++..... .+++.+++.++.||+.||+|||++||+||||||+|||++. ..++.+||+|||+++.....
T Consensus 92 ~~~~~~~~~-~~~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIl~~~~~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~ 170 (296)
T 4hgt_A 92 EDLFNFCSR-KFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYR 170 (296)
T ss_dssp HHHHHHTTS-CCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECCGGGTTCEEECCCTTCEECBCTTTCCBCCCC
T ss_pred HHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeeeeccCCCCeEEEecCccceeccCcccCccCCCC
Confidence 999975443 5999999999999999999999999999999999999931 13568999999999764432
Q ss_pred -CccccccccccCchhhccCCCCCCCcccchhhhhhhhhhhhcCCCCCCCcCcchhHHHHHHHHhcCCCCCCCCCCchhH
Q psy11767 529 -LHTPCFTLQYAAPEVLRQDKSGYDENCDLWSLGVILVNVLRQDKSGYDENCDLWSLGVILYTMLCGRVPFHARSRDDSA 607 (966)
Q Consensus 529 -~~~~~gT~~Y~APEvl~~~~~~~~~~~Di~SlGvil~el~~~~~~~y~~~~DIWSlGvilyemltG~~Pf~~~~~~~~~ 607 (966)
.....+|+.|+|||++.. ..|+.++|||||||++|+|++|+.||.+.......
T Consensus 171 ~~~~~~gt~~y~aPE~~~~--------------------------~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~ 224 (296)
T 4hgt_A 171 ENKNLTGTARYASINTHLG--------------------------IEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKR 224 (296)
T ss_dssp CSCCCCSCGGGCCHHHHTT--------------------------CCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSS
T ss_pred cccccCCCccccchHHhcC--------------------------CCCCchhHHHHHHHHHHHHhcCCCCCcccchhhhh
Confidence 124578999999999853 23678999999999999999999999875432211
Q ss_pred HHHHHHHHcCCCCCCc-hhhccCCHHHHHHHHHhcccCccccCChHHHHHHhhhhHH
Q psy11767 608 LSIMARIKEGQFNFDA-EAWSTVSSEAKELTKSLLTVNPAQRIRMMRVKLTFHAFHQ 663 (966)
Q Consensus 608 ~~~~~~i~~~~~~~~~-~~~~~is~e~~~Li~~~L~~dP~~R~t~~~v~~~~~~~~~ 663 (966)
..+..+.......+. .....+++++.+||.+||+.||++|||+.++...+.....
T Consensus 225 -~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~~l~~~~~ 280 (296)
T 4hgt_A 225 -QKYERISEKKMSTPIEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFH 280 (296)
T ss_dssp -SHHHHHHHHHHHSCHHHHTTTSCHHHHHHHHHHHTSCTTCCCCHHHHHHHHHHHHH
T ss_pred -hhhhhhhcccccchhhhhhccCCHHHHHHHHHHHhcCCCCCCCHHHHHHHHHHHHH
Confidence 112222222222221 2234678999999999999999999999998766655443
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 4dea_A* 4deb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-40 Score=358.49 Aligned_cols=242 Identities=32% Similarity=0.543 Sum_probs=200.9
Q ss_pred cccccccccccEEEEEEEcCCCcEEEEEEecccc--------ChHHHHHHHHHhcCCCCceEEEEEEEeCCeEEEEEEcc
Q psy11767 382 KAGILGDGSYSVCRRCVEKSTGQEYAVKIISRKI--------DCSEEINLLRACQGHPNIVNLHCVFQDEVHTYLVLELL 453 (966)
Q Consensus 382 ~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~--------~~~~Ei~iL~~l~~HpnIV~l~~~~~~~~~~~lVmEy~ 453 (966)
..+.||+|+||.||+|.+..+++.||||++.... ...+|+.+++.+ +||||+++++++.+....|+||||+
T Consensus 13 ~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~ 91 (279)
T 3fdn_A 13 IGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL-RHPNILRLYGYFHDATRVYLILEYA 91 (279)
T ss_dssp EEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHTTC-CCTTBCCEEEEEECSSEEEEEECCC
T ss_pred EeeEEecCCCeEEEEEEEccCCcEEEEEEEeccccchhhHHHHHHHHHHHHHcC-CCCCCcchhheEecCCEEEEEEecC
Confidence 3688999999999999999999999999985421 245688999888 4999999999999999999999999
Q ss_pred CCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCcEEEecCCCCCEEEEeecccccccC-CCccc
Q psy11767 454 KGGELLDRIRQKGRCGFTENEASRIMRQLVAAVHFMHSRGVVHRDLKPENLLFSDPAGDNIKVVDFGFACLKRE-SLHTP 532 (966)
Q Consensus 454 ~gg~L~~~l~~~~~~~l~e~~~~~i~~Qil~aL~yLHs~~IiHRDLKP~NILl~~~~~~~iKL~DFGla~~~~~-~~~~~ 532 (966)
++|+|.+++.... .+++..++.++.||+.||+|||++||+||||||+|||++. ++.+||+|||++..... .....
T Consensus 92 ~~~~l~~~l~~~~--~~~~~~~~~~~~qi~~~l~~LH~~~i~H~dlkp~Nili~~--~~~~~l~Dfg~~~~~~~~~~~~~ 167 (279)
T 3fdn_A 92 PLGTVYRELQKLS--KFDEQRTATYITELANALSYCHSKRVIHRDIKPENLLLGS--AGELKIADFGWSVHAPSSRRTDL 167 (279)
T ss_dssp TTEEHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHTTTCEECCCCGGGEEECT--TSCEEECSCCEESCC--------
T ss_pred CCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCEecccCChHhEEEcC--CCCEEEEeccccccCCccccccc
Confidence 9999999998765 5999999999999999999999999999999999999974 56899999999865433 23456
Q ss_pred cccccccCchhhccCCCCCCCcccchhhhhhhhhhhhcCCCCCCCcCcchhHHHHHHHHhcCCCCCCCCCCchhHHHHHH
Q psy11767 533 CFTLQYAAPEVLRQDKSGYDENCDLWSLGVILVNVLRQDKSGYDENCDLWSLGVILYTMLCGRVPFHARSRDDSALSIMA 612 (966)
Q Consensus 533 ~gT~~Y~APEvl~~~~~~~~~~~Di~SlGvil~el~~~~~~~y~~~~DIWSlGvilyemltG~~Pf~~~~~~~~~~~~~~ 612 (966)
++|+.|+|||++.. ..++.++|||||||++|+|++|..||...... ....
T Consensus 168 ~~~~~y~aPE~~~~--------------------------~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~----~~~~ 217 (279)
T 3fdn_A 168 CGTLDYLPPEMIEG--------------------------RMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQ----ETYK 217 (279)
T ss_dssp CCCCTTCCHHHHTT--------------------------CCCCTTHHHHHHHHHHHHHHHSSCTTCCSSHH----HHHH
T ss_pred CCCCCccCHhHhcc--------------------------CCCCccchhHhHHHHHHHHHHCCCCCCCCcHH----HHHH
Confidence 78999999998852 23677899999999999999999999865432 3445
Q ss_pred HHHcCCCCCCchhhccCCHHHHHHHHHhcccCccccCChHHHHHHhhhhHHh
Q psy11767 613 RIKEGQFNFDAEAWSTVSSEAKELTKSLLTVNPAQRIRMMRVKLTFHAFHQA 664 (966)
Q Consensus 613 ~i~~~~~~~~~~~~~~is~e~~~Li~~~L~~dP~~R~t~~~v~~~~~~~~~~ 664 (966)
.+......++ ..+++++.+||.+||..||++|||+.++ ..|+|...
T Consensus 218 ~~~~~~~~~~----~~~~~~~~~li~~~l~~~p~~Rps~~e~--l~h~~~~~ 263 (279)
T 3fdn_A 218 RISRVEFTFP----DFVTEGARDLISRLLKHNPSQRPMLREV--LEHPWITA 263 (279)
T ss_dssp HHHHTCCCCC----TTSCHHHHHHHHHHCCSSGGGSCCHHHH--HHCHHHHH
T ss_pred HHHhCCCCCC----CcCCHHHHHHHHHHhccChhhCCCHHHH--hhCccccC
Confidence 5555554433 3578999999999999999999999976 34677643
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-40 Score=367.33 Aligned_cols=264 Identities=31% Similarity=0.524 Sum_probs=207.4
Q ss_pred cccceecccccccccccccccccccEEEEEEE-cCCCcEEEEEEecccc----ChHHHHHHHHHhc-----CCCCceEEE
Q psy11767 368 KGSLFFEQYDMDLDKAGILGDGSYSVCRRCVE-KSTGQEYAVKIISRKI----DCSEEINLLRACQ-----GHPNIVNLH 437 (966)
Q Consensus 368 ~G~~~~~~~~i~~~~~~~LG~G~fG~Vy~a~~-~~tg~~vAvK~i~~~~----~~~~Ei~iL~~l~-----~HpnIV~l~ 437 (966)
.|..+.++|.+ .+.||+|+||.||+|.+ ..+|+.||||++.... ...+|+.+|+.+. .|++|++++
T Consensus 8 ~g~~~~~~y~~----~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~i~~~~ 83 (339)
T 1z57_A 8 SGDVLSARYEI----VDTLGEGAFGKVVECIDHKAGGRHVAVKIVKNVDRYCEAARSEIQVLEHLNTTDPNSTFRCVQML 83 (339)
T ss_dssp TTCEETTTEEE----EEEEEEETTEEEEEEEETTTTTEEEEEEEECSSHHHHHHHHHHHHHHHHHHHHCTTCTTCBCCEE
T ss_pred cCCCccCceEE----EEEEecCCCeEEEEEEecCCCCcEEEEEEEecCCchhHHHHHHHHHHHHhhhcCCCCceeeEeee
Confidence 34555566666 68899999999999999 5689999999997532 2456888888774 244699999
Q ss_pred EEEEeCCeEEEEEEccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCcEEEecCC-------
Q psy11767 438 CVFQDEVHTYLVLELLKGGELLDRIRQKGRCGFTENEASRIMRQLVAAVHFMHSRGVVHRDLKPENLLFSDPA------- 510 (966)
Q Consensus 438 ~~~~~~~~~~lVmEy~~gg~L~~~l~~~~~~~l~e~~~~~i~~Qil~aL~yLHs~~IiHRDLKP~NILl~~~~------- 510 (966)
+++.+..+.|+||||+ +++|.+++.......+++.+++.++.||+.||+|||++||+||||||+|||++...
T Consensus 84 ~~~~~~~~~~lv~e~~-~~~l~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~~~ 162 (339)
T 1z57_A 84 EWFEHHGHICIVFELL-GLSTYDFIKENGFLPFRLDHIRKMAYQICKSVNFLHSNKLTHTDLKPENILFVQSDYTEAYNP 162 (339)
T ss_dssp EEEEETTEEEEEEECC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESCCCEEEEEC-
T ss_pred cccccCCcEEEEEcCC-CCCHHHHHHhcCCCCCcHHHHHHHHHHHHHHHHHHHHCCCcCCCCCHHHEEEeccccccccCC
Confidence 9999999999999999 89999999887655799999999999999999999999999999999999997532
Q ss_pred ----------CCCEEEEeecccccccCCCccccccccccCchhhccCCCCCCCcccchhhhhhhhhhhhcCCCCCCCcCc
Q psy11767 511 ----------GDNIKVVDFGFACLKRESLHTPCFTLQYAAPEVLRQDKSGYDENCDLWSLGVILVNVLRQDKSGYDENCD 580 (966)
Q Consensus 511 ----------~~~iKL~DFGla~~~~~~~~~~~gT~~Y~APEvl~~~~~~~~~~~Di~SlGvil~el~~~~~~~y~~~~D 580 (966)
.+.+||+|||++..........++|+.|+|||++.. ..|+.++|
T Consensus 163 ~~~~~~~~~~~~~~kl~Dfg~~~~~~~~~~~~~gt~~y~aPE~~~~--------------------------~~~~~~~D 216 (339)
T 1z57_A 163 KIKRDERTLINPDIKVVDFGSATYDDEHHSTLVSTRHYRAPEVILA--------------------------LGWSQPCD 216 (339)
T ss_dssp ---CEEEEESCCCEEECCCSSCEETTSCCCSSCSCGGGCCHHHHTT--------------------------SCCCTHHH
T ss_pred ccccccccccCCCceEeeCcccccCccccccccCCccccChHHhhC--------------------------CCCCcchh
Confidence 457999999999876666667789999999999852 23788999
Q ss_pred chhHHHHHHHHhcCCCCCCCCCCchhHHHHHHHHHcCCCC-------------CCchhh---------------------
Q psy11767 581 LWSLGVILYTMLCGRVPFHARSRDDSALSIMARIKEGQFN-------------FDAEAW--------------------- 626 (966)
Q Consensus 581 IWSlGvilyemltG~~Pf~~~~~~~~~~~~~~~i~~~~~~-------------~~~~~~--------------------- 626 (966)
||||||++|+|++|..||...+..+. ...+..+...... .....|
T Consensus 217 i~slG~il~el~~g~~pf~~~~~~~~-~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 295 (339)
T 1z57_A 217 VWSIGCILIEYYLGFTVFPTHDSKEH-LAMMERILGPLPKHMIQKTRKRKYFHHDRLDWDEHSSAGRYVSRACKPLKEFM 295 (339)
T ss_dssp HHHHHHHHHHHHHSSCSCCCSCHHHH-HHHHHHHHCSCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGC
T ss_pred hHHHHHHHHHHHhCCCCCCCCChHHH-HHHHHHHhCCCCHHHHhhccchhHHhhccccccccccccchhhhcCcchhhhc
Confidence 99999999999999999987654332 2222222211000 000000
Q ss_pred ---ccCCHHHHHHHHHhcccCccccCChHHHHHHhhhhHHhh
Q psy11767 627 ---STVSSEAKELTKSLLTVNPAQRIRMMRVKLTFHAFHQAQ 665 (966)
Q Consensus 627 ---~~is~e~~~Li~~~L~~dP~~R~t~~~v~~~~~~~~~~~ 665 (966)
...++++.+||.+||..||.+|||+.++ ..|+|++..
T Consensus 296 ~~~~~~~~~l~~li~~~L~~dP~~Rpt~~el--l~hp~f~~~ 335 (339)
T 1z57_A 296 LSQDVEHERLFDLIQKMLEYDPAKRITLREA--LKHPFFDLL 335 (339)
T ss_dssp SCCSHHHHHHHHHHHHHTCSSTTTSCCHHHH--TTSGGGGGG
T ss_pred ccchhhHHHHHHHHHHHhCcCcccccCHHHH--hcCHHHHHH
Confidence 1235678899999999999999999976 457776543
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.7e-40 Score=370.36 Aligned_cols=248 Identities=23% Similarity=0.328 Sum_probs=202.7
Q ss_pred cccccccccccccEEEEEEEcCCCcEEEEEEecccc--------ChHHHHHHHHHhcCCCCceEEEEEEEeCCeEEEEEE
Q psy11767 380 LDKAGILGDGSYSVCRRCVEKSTGQEYAVKIISRKI--------DCSEEINLLRACQGHPNIVNLHCVFQDEVHTYLVLE 451 (966)
Q Consensus 380 ~~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~--------~~~~Ei~iL~~l~~HpnIV~l~~~~~~~~~~~lVmE 451 (966)
|...+.||+|+||+||+|++..+|+.||||++.... ...+|+++|+.+ +|||||++++++.++...|||||
T Consensus 56 y~~~~~lG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l-~hpniv~~~~~~~~~~~~~lv~e 134 (348)
T 1u5q_A 56 FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKL-RHPNTIQYRGCYLREHTAWLVME 134 (348)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTTEEEEEEEEESCSSCHHHHHHHHHHHHHHHHHC-CCTTBCCEEEEEEETTEEEEEEE
T ss_pred eeeeeEEccCCCEEEEEEEEccCCeEEEEEEEccccccchHHHHHHHHHHHHHHhC-CCCCEeeEEEEEEECCeEEEEEe
Confidence 445688999999999999999999999999986432 245799999998 59999999999999999999999
Q ss_pred ccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCcEEEecCCCCCEEEEeecccccccCCCcc
Q psy11767 452 LLKGGELLDRIRQKGRCGFTENEASRIMRQLVAAVHFMHSRGVVHRDLKPENLLFSDPAGDNIKVVDFGFACLKRESLHT 531 (966)
Q Consensus 452 y~~gg~L~~~l~~~~~~~l~e~~~~~i~~Qil~aL~yLHs~~IiHRDLKP~NILl~~~~~~~iKL~DFGla~~~~~~~~~ 531 (966)
||. |+|.+.+..... .+++.+++.++.||+.||+|||++||+||||||+|||++. ++.+||+|||++..... ...
T Consensus 135 ~~~-g~l~~~l~~~~~-~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~--~~~~kL~DfG~a~~~~~-~~~ 209 (348)
T 1u5q_A 135 YCL-GSASDLLEVHKK-PLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLSE--PGLVKLGDFGSASIMAP-ANS 209 (348)
T ss_dssp CCS-EEHHHHHHHHTS-CCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEEET--TTEEEECCCTTCBSSSS-BCC
T ss_pred cCC-CCHHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEECC--CCCEEEeeccCceecCC-CCc
Confidence 996 688888865443 6999999999999999999999999999999999999985 56999999999976543 345
Q ss_pred ccccccccCchhhccCCCCCCCcccchhhhhhhhhhhhcCCCCCCCcCcchhHHHHHHHHhcCCCCCCCCCCchhHHHHH
Q psy11767 532 PCFTLQYAAPEVLRQDKSGYDENCDLWSLGVILVNVLRQDKSGYDENCDLWSLGVILYTMLCGRVPFHARSRDDSALSIM 611 (966)
Q Consensus 532 ~~gT~~Y~APEvl~~~~~~~~~~~Di~SlGvil~el~~~~~~~y~~~~DIWSlGvilyemltG~~Pf~~~~~~~~~~~~~ 611 (966)
.+||+.|+|||++... ....|+.++|||||||++|+|++|+.||...+.. ..+
T Consensus 210 ~~gt~~y~aPE~~~~~-----------------------~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~----~~~ 262 (348)
T 1u5q_A 210 FVGTPYWMAPEVILAM-----------------------DEGQYDGKVDVWSLGITCIELAERKPPLFNMNAM----SAL 262 (348)
T ss_dssp CCSCGGGCCHHHHHTT-----------------------SSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHH----HHH
T ss_pred ccCCcceeCHhhhccc-----------------------cCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChH----HHH
Confidence 6799999999998521 1234788999999999999999999999875432 223
Q ss_pred HHHHcCCCCCCchhhccCCHHHHHHHHHhcccCccccCChHHHHHHhhhhHHh
Q psy11767 612 ARIKEGQFNFDAEAWSTVSSEAKELTKSLLTVNPAQRIRMMRVKLTFHAFHQA 664 (966)
Q Consensus 612 ~~i~~~~~~~~~~~~~~is~e~~~Li~~~L~~dP~~R~t~~~v~~~~~~~~~~ 664 (966)
..+..+..... ....+++++.+||.+||+.||++|||+.++ ..|+|...
T Consensus 263 ~~~~~~~~~~~--~~~~~~~~l~~li~~~l~~dP~~Rps~~~l--l~h~~~~~ 311 (348)
T 1u5q_A 263 YHIAQNESPAL--QSGHWSEYFRNFVDSCLQKIPQDRPTSEVL--LKHRFVLR 311 (348)
T ss_dssp HHHHHSCCCCC--CCTTSCHHHHHHHHHHTCSSGGGSCCHHHH--TTCHHHHS
T ss_pred HHHHhcCCCCC--CCCCCCHHHHHHHHHHcccChhhCcCHHHH--hhChhhhc
Confidence 33333332211 123578999999999999999999999876 44666643
|
| >4hcu_A Tyrosine-protein kinase ITK/TSK; transferase-transferase inhibitor complex; HET: 13L; 1.43A {Homo sapiens} PDB: 4hct_A* 4hcv_A* 3t9t_A* 1sm2_A* 1snu_A* 1snx_A 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.1e-40 Score=353.71 Aligned_cols=242 Identities=24% Similarity=0.418 Sum_probs=199.8
Q ss_pred cccccccccccccEEEEEEEcCCCcEEEEEEecccc----ChHHHHHHHHHhcCCCCceEEEEEEEeCCeEEEEEEccCC
Q psy11767 380 LDKAGILGDGSYSVCRRCVEKSTGQEYAVKIISRKI----DCSEEINLLRACQGHPNIVNLHCVFQDEVHTYLVLELLKG 455 (966)
Q Consensus 380 ~~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~----~~~~Ei~iL~~l~~HpnIV~l~~~~~~~~~~~lVmEy~~g 455 (966)
|+..+.||+|+||.||+|.+. +++.||||++.... ...+|+.+|+.+. ||||+++++++.++...|+||||+++
T Consensus 12 y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~-h~~i~~~~~~~~~~~~~~lv~e~~~~ 89 (269)
T 4hcu_A 12 LTFVQEIGSGQFGLVHLGYWL-NKDKVAIKTIREGAMSEEDFIEEAEVMMKLS-HPKLVQLYGVCLEQAPICLVFEFMEH 89 (269)
T ss_dssp EEEEEEEEECSSCEEEEEEET-TTEEEEEEEECTTSBCHHHHHHHHHHHHTCC-CTTBCCEEEEECSSSSEEEEEECCTT
T ss_pred ceeeheecCCCccEEEEEEec-CCCeEEEEEecccccCHHHHHHHHHHHHhCC-CCCEeeEEEEEecCCceEEEEEeCCC
Confidence 344688999999999999987 47789999997543 2457999999984 99999999999999999999999999
Q ss_pred CCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCcEEEecCCCCCEEEEeecccccccC----CCcc
Q psy11767 456 GELLDRIRQKGRCGFTENEASRIMRQLVAAVHFMHSRGVVHRDLKPENLLFSDPAGDNIKVVDFGFACLKRE----SLHT 531 (966)
Q Consensus 456 g~L~~~l~~~~~~~l~e~~~~~i~~Qil~aL~yLHs~~IiHRDLKP~NILl~~~~~~~iKL~DFGla~~~~~----~~~~ 531 (966)
++|.+++..... .+++..+..++.||+.||+|||++||+||||||+|||++. ++.+||+|||++..... ....
T Consensus 90 ~~L~~~l~~~~~-~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dikp~Nil~~~--~~~~kl~Dfg~~~~~~~~~~~~~~~ 166 (269)
T 4hcu_A 90 GCLSDYLRTQRG-LFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLVGE--NQVIKVSDFGMTRFVLDDQYTSSTG 166 (269)
T ss_dssp CBHHHHHHTTTT-CCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECG--GGCEEECCTTGGGGBCCHHHHSTTS
T ss_pred CcHHHHHHhcCc-ccCHHHHHHHHHHHHHHHHHHHhCCeecCCcchheEEEcC--CCCEEeccccccccccccccccccC
Confidence 999999976543 6899999999999999999999999999999999999975 46899999999976432 2234
Q ss_pred ccccccccCchhhccCCCCCCCcccchhhhhhhhhhhhcCCCCCCCcCcchhHHHHHHHHhc-CCCCCCCCCCchhHHHH
Q psy11767 532 PCFTLQYAAPEVLRQDKSGYDENCDLWSLGVILVNVLRQDKSGYDENCDLWSLGVILYTMLC-GRVPFHARSRDDSALSI 610 (966)
Q Consensus 532 ~~gT~~Y~APEvl~~~~~~~~~~~Di~SlGvil~el~~~~~~~y~~~~DIWSlGvilyemlt-G~~Pf~~~~~~~~~~~~ 610 (966)
..+|+.|+|||++.. ..|+.++|||||||++|+|++ |++||...... ..
T Consensus 167 ~~~~~~y~aPE~~~~--------------------------~~~~~~~Di~slG~~l~~ll~~g~~p~~~~~~~----~~ 216 (269)
T 4hcu_A 167 TKFPVKWASPEVFSF--------------------------SRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNS----EV 216 (269)
T ss_dssp TTCCGGGCCHHHHHH--------------------------CCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHH----HH
T ss_pred cccccccCCHHHhcC--------------------------CCCCchhhhHHHHHHHHHHhcCCCCCCCCCCHH----HH
Confidence 456788999999853 236789999999999999999 99999875533 34
Q ss_pred HHHHHcCCCCCCchhhccCCHHHHHHHHHhcccCccccCChHHHHHHhh
Q psy11767 611 MARIKEGQFNFDAEAWSTVSSEAKELTKSLLTVNPAQRIRMMRVKLTFH 659 (966)
Q Consensus 611 ~~~i~~~~~~~~~~~~~~is~e~~~Li~~~L~~dP~~R~t~~~v~~~~~ 659 (966)
...+..+..... ...+++++.+++.+||+.||++|||+.++...+.
T Consensus 217 ~~~~~~~~~~~~---~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~ 262 (269)
T 4hcu_A 217 VEDISTGFRLYK---PRLASTHVYQIMNHCWRERPEDRPAFSRLLRQLA 262 (269)
T ss_dssp HHHHHTTCCCCC---CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred HHHHhcCccCCC---CCcCCHHHHHHHHHHccCCcccCcCHHHHHHHHH
Confidence 455555432222 2357899999999999999999999998755443
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-40 Score=374.20 Aligned_cols=245 Identities=19% Similarity=0.335 Sum_probs=198.3
Q ss_pred ccccccccccccEEEEEE-----EcCCCcEEEEEEeccccC------hHHHHHHHHHhcCCCCceEEEEEEEeCCeEEEE
Q psy11767 381 DKAGILGDGSYSVCRRCV-----EKSTGQEYAVKIISRKID------CSEEINLLRACQGHPNIVNLHCVFQDEVHTYLV 449 (966)
Q Consensus 381 ~~~~~LG~G~fG~Vy~a~-----~~~tg~~vAvK~i~~~~~------~~~Ei~iL~~l~~HpnIV~l~~~~~~~~~~~lV 449 (966)
...+.||+|+||+||+|. +..+++.||||++..... ..+|+.+|+.+ +|||||++++++.+....|+|
T Consensus 74 ~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~hpnIv~~~~~~~~~~~~~lv 152 (367)
T 3l9p_A 74 TLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKF-NHQNIVRCIGVSLQSLPRFIL 152 (367)
T ss_dssp EEEEECCCCSSSCEEEEEECC-----CCEEEEEEECCSSCCHHHHHHHHHHHHHHHHC-CCTTBCCEEEEECSSSSCEEE
T ss_pred EEeeEeeeCCCEEEEEEEEccCCCCCcceeEEEEecccccChhhHHHHHHHHHHHHhC-CCCCCCeEEEEEecCCCCEEE
Confidence 346889999999999999 556788999999865322 44689999988 599999999999999999999
Q ss_pred EEccCCCCHHHHHHhcCC-----CCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCcEEEecCC-CCCEEEEeecccc
Q psy11767 450 LELLKGGELLDRIRQKGR-----CGFTENEASRIMRQLVAAVHFMHSRGVVHRDLKPENLLFSDPA-GDNIKVVDFGFAC 523 (966)
Q Consensus 450 mEy~~gg~L~~~l~~~~~-----~~l~e~~~~~i~~Qil~aL~yLHs~~IiHRDLKP~NILl~~~~-~~~iKL~DFGla~ 523 (966)
||||+||+|.+++..... ..+++.+++.++.||+.||+|||++||+||||||+|||++... +..+||+|||+|+
T Consensus 153 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~~~~kL~DFG~a~ 232 (367)
T 3l9p_A 153 LELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMAR 232 (367)
T ss_dssp EECCTTEEHHHHHHHHSCCSSSCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESCSSTTCCEEECCCHHHH
T ss_pred EEeCCCCCHHHHHHhhccccCccccccHHHHHHHHHHHHHHHHHHHhCCeeCCCCChhhEEEecCCCCceEEECCCcccc
Confidence 999999999999987542 3589999999999999999999999999999999999997422 3469999999997
Q ss_pred ccc-----CCCccccccccccCchhhccCCCCCCCcccchhhhhhhhhhhhcCCCCCCCcCcchhHHHHHHHHhc-CCCC
Q psy11767 524 LKR-----ESLHTPCFTLQYAAPEVLRQDKSGYDENCDLWSLGVILVNVLRQDKSGYDENCDLWSLGVILYTMLC-GRVP 597 (966)
Q Consensus 524 ~~~-----~~~~~~~gT~~Y~APEvl~~~~~~~~~~~Di~SlGvil~el~~~~~~~y~~~~DIWSlGvilyemlt-G~~P 597 (966)
... .......+|+.|+|||++.. ..|+.++|||||||++|+|++ |..|
T Consensus 233 ~~~~~~~~~~~~~~~~t~~y~aPE~~~~--------------------------~~~~~~~DvwslG~il~ellt~g~~p 286 (367)
T 3l9p_A 233 DIYRAGYYRKGGCAMLPVKWMPPEAFME--------------------------GIFTSKTDTWSFGVLLWEIFSLGYMP 286 (367)
T ss_dssp HHHHHSSCTTCCGGGSCGGGCCHHHHHH--------------------------CCCCHHHHHHHHHHHHHHHHTTSCCS
T ss_pred ccccccccccCCCcCCcccEECHHHhcC--------------------------CCCCcHHHHHHHHHHHHHHHhCCCCC
Confidence 432 12234567999999999853 237889999999999999998 9999
Q ss_pred CCCCCCchhHHHHHHHHHcCCCCCCchhhccCCHHHHHHHHHhcccCccccCChHHHHHHhh
Q psy11767 598 FHARSRDDSALSIMARIKEGQFNFDAEAWSTVSSEAKELTKSLLTVNPAQRIRMMRVKLTFH 659 (966)
Q Consensus 598 f~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~is~e~~~Li~~~L~~dP~~R~t~~~v~~~~~ 659 (966)
|...... .++..+..+.... ....+++++.+||.+||+.||++|||+.++...+.
T Consensus 287 f~~~~~~----~~~~~i~~~~~~~---~~~~~~~~l~~li~~~l~~dP~~Rps~~eil~~l~ 341 (367)
T 3l9p_A 287 YPSKSNQ----EVLEFVTSGGRMD---PPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIE 341 (367)
T ss_dssp STTCCHH----HHHHHHHTTCCCC---CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred CCCCCHH----HHHHHHHcCCCCC---CCccCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHH
Confidence 9876532 3445555544222 22357899999999999999999999998855444
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-40 Score=378.52 Aligned_cols=244 Identities=22% Similarity=0.398 Sum_probs=200.7
Q ss_pred ccccccccccccEEEEEEEcCCCcEEEEEEecccc------ChHHHHHHHHHhcCCCCceEEEEEEEeCCeEEEEEEccC
Q psy11767 381 DKAGILGDGSYSVCRRCVEKSTGQEYAVKIISRKI------DCSEEINLLRACQGHPNIVNLHCVFQDEVHTYLVLELLK 454 (966)
Q Consensus 381 ~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~------~~~~Ei~iL~~l~~HpnIV~l~~~~~~~~~~~lVmEy~~ 454 (966)
...+.||+|+||.||+|.+..+++.||||++.... ...+|+++|+.+ +|||||++++++.++...|+|||||+
T Consensus 117 ~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~hpniv~~~~~~~~~~~~~lv~e~~~ 195 (377)
T 3cbl_A 117 VLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQY-SHPNIVRLIGVCTQKQPIYIVMELVQ 195 (377)
T ss_dssp EEEEEEEEETTEEEEEEEETTTCCEEEEEECCTTSCHHHHTTTTHHHHHHTTC-CCTTBCCEEEEECSSSSCEEEEECCT
T ss_pred EEeeEeccCCCCeEEEEEEecCCeEEEEEEccccCCHHHHHHHHHHHHHHHhC-CCCCEEEEEEEEecCCCcEEEEEcCC
Confidence 34678999999999999999999999999986542 355799999988 59999999999999999999999999
Q ss_pred CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCcEEEecCCCCCEEEEeecccccccCCC-----
Q psy11767 455 GGELLDRIRQKGRCGFTENEASRIMRQLVAAVHFMHSRGVVHRDLKPENLLFSDPAGDNIKVVDFGFACLKRESL----- 529 (966)
Q Consensus 455 gg~L~~~l~~~~~~~l~e~~~~~i~~Qil~aL~yLHs~~IiHRDLKP~NILl~~~~~~~iKL~DFGla~~~~~~~----- 529 (966)
||+|.+++...+. .+++.++..++.||+.||+|||++||+||||||+|||++. ++.+||+|||+|+......
T Consensus 196 ~g~L~~~l~~~~~-~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~Nil~~~--~~~~kl~DfG~s~~~~~~~~~~~~ 272 (377)
T 3cbl_A 196 GGDFLTFLRTEGA-RLRVKTLLQMVGDAAAGMEYLESKCCIHRDLAARNCLVTE--KNVLKISDFGMSREEADGVYAASG 272 (377)
T ss_dssp TCBHHHHHHHHGG-GCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECT--TCCEEECCGGGCEECTTSEEECCS
T ss_pred CCCHHHHHHhcCC-CCCHHHHHHHHHHHHHHHHHHHHCCcCCcccCHHHEEEcC--CCcEEECcCCCceecCCCceeecC
Confidence 9999999987543 5899999999999999999999999999999999999975 5699999999997643321
Q ss_pred ccccccccccCchhhccCCCCCCCcccchhhhhhhhhhhhcCCCCCCCcCcchhHHHHHHHHhc-CCCCCCCCCCchhHH
Q psy11767 530 HTPCFTLQYAAPEVLRQDKSGYDENCDLWSLGVILVNVLRQDKSGYDENCDLWSLGVILYTMLC-GRVPFHARSRDDSAL 608 (966)
Q Consensus 530 ~~~~gT~~Y~APEvl~~~~~~~~~~~Di~SlGvil~el~~~~~~~y~~~~DIWSlGvilyemlt-G~~Pf~~~~~~~~~~ 608 (966)
....+|+.|+|||++... .|+.++|||||||++|||++ |..||.+....
T Consensus 273 ~~~~~~~~y~aPE~~~~~--------------------------~~~~~~DvwslG~il~el~t~g~~p~~~~~~~---- 322 (377)
T 3cbl_A 273 GLRQVPVKWTAPEALNYG--------------------------RYSSESDVWSFGILLWETFSLGASPYPNLSNQ---- 322 (377)
T ss_dssp SCCEEEGGGSCHHHHHHC--------------------------EEEHHHHHHHHHHHHHHHHTTSCCSSTTSCHH----
T ss_pred CCCCCCcCcCCHhHhccC--------------------------CCCchhhHHHHHHHHHHHHhCCCCCCCCCCHH----
Confidence 122357789999998532 36788999999999999998 99999876532
Q ss_pred HHHHHHHcCCCCCCchhhccCCHHHHHHHHHhcccCccccCChHHHHHHhhhh
Q psy11767 609 SIMARIKEGQFNFDAEAWSTVSSEAKELTKSLLTVNPAQRIRMMRVKLTFHAF 661 (966)
Q Consensus 609 ~~~~~i~~~~~~~~~~~~~~is~e~~~Li~~~L~~dP~~R~t~~~v~~~~~~~ 661 (966)
.....+..+.... ....+++++.+||.+||+.||++|||+.++...+..+
T Consensus 323 ~~~~~~~~~~~~~---~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~i 372 (377)
T 3cbl_A 323 QTREFVEKGGRLP---CPELCPDAVFRLMEQCWAYEPGQRPSFSTIYQELQSI 372 (377)
T ss_dssp HHHHHHHTTCCCC---CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred HHHHHHHcCCCCC---CCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHH
Confidence 2334444443211 2235788999999999999999999999886555443
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} PDB: 4bbm_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-40 Score=368.42 Aligned_cols=252 Identities=29% Similarity=0.467 Sum_probs=198.7
Q ss_pred ccccccccccccEEEEEEEcCCCcEEEEEEeccccC-------hHHHHHHHHHhcCCCCceEEEEEEEeCCeEEEEEEcc
Q psy11767 381 DKAGILGDGSYSVCRRCVEKSTGQEYAVKIISRKID-------CSEEINLLRACQGHPNIVNLHCVFQDEVHTYLVLELL 453 (966)
Q Consensus 381 ~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~~-------~~~Ei~iL~~l~~HpnIV~l~~~~~~~~~~~lVmEy~ 453 (966)
+..+.||+|+||.||+|++..+|+.||||++..... ..+|+.+|+.+ +||||+++++++.+....|+||||+
T Consensus 28 ~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~e~~ 106 (331)
T 4aaa_A 28 ENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQL-RHENLVNLLEVCKKKKRWYLVFEFV 106 (331)
T ss_dssp EEEEEGGGGTTSSEEEEEETTTCCEEEEEEEESCSSCHHHHHHHHHHHHHHHHC-CCTTBCCEEEEEEETTEEEEEEECC
T ss_pred eeeeEEeecCCEEEEEEEECCCCceEEEEEEecCCCchHHHHHHHHHHHHHhhC-CCCCEeeEEEEeecCCEEEEEEecC
Confidence 347899999999999999999999999999865432 34699999998 4999999999999999999999999
Q ss_pred CCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCcEEEecCCCCCEEEEeecccccccC---CCc
Q psy11767 454 KGGELLDRIRQKGRCGFTENEASRIMRQLVAAVHFMHSRGVVHRDLKPENLLFSDPAGDNIKVVDFGFACLKRE---SLH 530 (966)
Q Consensus 454 ~gg~L~~~l~~~~~~~l~e~~~~~i~~Qil~aL~yLHs~~IiHRDLKP~NILl~~~~~~~iKL~DFGla~~~~~---~~~ 530 (966)
++++|.+++.... .+++..+..++.||+.||+|||++||+||||||+|||++. ++.+||+|||++..... ...
T Consensus 107 ~~~~l~~~~~~~~--~~~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~Nil~~~--~~~~kl~Dfg~~~~~~~~~~~~~ 182 (331)
T 4aaa_A 107 DHTILDDLELFPN--GLDYQVVQKYLFQIINGIGFCHSHNIIHRDIKPENILVSQ--SGVVKLCDFGFARTLAAPGEVYD 182 (331)
T ss_dssp SEEHHHHHHHSTT--CCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECT--TSCEEECCCTTC-----------
T ss_pred CcchHHHHHhhcc--CCCHHHHHHHHHHHHHHHHHHHHCCEEccCcChheEEEcC--CCcEEEEeCCCceeecCCccccC
Confidence 9888887765443 5999999999999999999999999999999999999975 56999999999975432 234
Q ss_pred cccccccccCchhhccCCCCCCCcccchhhhhhhhhhhhcCCCCCCCcCcchhHHHHHHHHhcCCCCCCCCCCchhHHHH
Q psy11767 531 TPCFTLQYAAPEVLRQDKSGYDENCDLWSLGVILVNVLRQDKSGYDENCDLWSLGVILYTMLCGRVPFHARSRDDSALSI 610 (966)
Q Consensus 531 ~~~gT~~Y~APEvl~~~~~~~~~~~Di~SlGvil~el~~~~~~~y~~~~DIWSlGvilyemltG~~Pf~~~~~~~~~~~~ 610 (966)
..++|+.|+|||++.. ...|+.++|||||||++|+|++|++||.+....+....+
T Consensus 183 ~~~~t~~y~aPE~~~~-------------------------~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~ 237 (331)
T 4aaa_A 183 DEVATRWYRAPELLVG-------------------------DVKYGKAVDVWAIGCLVTEMFMGEPLFPGDSDIDQLYHI 237 (331)
T ss_dssp -CCCCCTTCCHHHHTT-------------------------CTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHH
T ss_pred CCcCCccccCcccccC-------------------------CCCcchHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHH
Confidence 5578999999999852 224688999999999999999999999876654333322
Q ss_pred HHHHHc---------------CCCC--------CCchhhccCCHHHHHHHHHhcccCccccCChHHHHHHhhhhHHh
Q psy11767 611 MARIKE---------------GQFN--------FDAEAWSTVSSEAKELTKSLLTVNPAQRIRMMRVKLTFHAFHQA 664 (966)
Q Consensus 611 ~~~i~~---------------~~~~--------~~~~~~~~is~e~~~Li~~~L~~dP~~R~t~~~v~~~~~~~~~~ 664 (966)
+..... .... .....++.+++++.+||.+||+.||++|||+.++ ..|+|++.
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~el--l~hp~f~~ 312 (331)
T 4aaa_A 238 MMCLGNLIPRHQELFNKNPVFAGVRLPEIKEREPLERRYPKLSEVVIDLAKKCLHIDPDKRPFCAEL--LHHDFFQM 312 (331)
T ss_dssp HHHHCSCCHHHHHHHHHCGGGTTCCCCCCSSCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCGGGG--GGSHHHHG
T ss_pred HHHhCCCChhhhhHhhhccccccccCccccccchhhhcccchhHHHHHHHHHHhccCcccCCCHHHH--hcCchhcc
Confidence 221110 0000 0011234679999999999999999999999976 45777754
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-40 Score=377.43 Aligned_cols=249 Identities=27% Similarity=0.477 Sum_probs=182.2
Q ss_pred ccccccccccccEEEEEEEcCCCcEEEEEEeccccC-------hHHHHHHHHHhcCCCCceEEEEEEEeC------CeEE
Q psy11767 381 DKAGILGDGSYSVCRRCVEKSTGQEYAVKIISRKID-------CSEEINLLRACQGHPNIVNLHCVFQDE------VHTY 447 (966)
Q Consensus 381 ~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~~-------~~~Ei~iL~~l~~HpnIV~l~~~~~~~------~~~~ 447 (966)
+.++.||+|+||.||+|.+..+|+.||||++..... ..+|+.+|+.+. ||||+++++++... ...|
T Consensus 32 ~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~-hpnIv~~~~~~~~~~~~~~~~~~~ 110 (367)
T 2fst_X 32 QNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMK-HENVIGLLDVFTPARSLEEFNDVY 110 (367)
T ss_dssp EEEEECC----CCEEEEEETTTTEEEEEEECSSTTSSHHHHHHHHHHHHHHHHCC-CTTBCCCSEEECSCSSGGGCCCCE
T ss_pred EEeeEEeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCC-CCCCCcEEEEEecCCccccCCeEE
Confidence 347899999999999999999999999999965422 347999999984 99999999999754 5679
Q ss_pred EEEEccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCcEEEecCCCCCEEEEeecccccccC
Q psy11767 448 LVLELLKGGELLDRIRQKGRCGFTENEASRIMRQLVAAVHFMHSRGVVHRDLKPENLLFSDPAGDNIKVVDFGFACLKRE 527 (966)
Q Consensus 448 lVmEy~~gg~L~~~l~~~~~~~l~e~~~~~i~~Qil~aL~yLHs~~IiHRDLKP~NILl~~~~~~~iKL~DFGla~~~~~ 527 (966)
+||||+ +++|.+++... .+++..++.++.||+.||+|||++||+||||||+|||++. ++.+||+|||+|+....
T Consensus 111 lv~e~~-~~~L~~~~~~~---~l~~~~~~~i~~qi~~aL~~LH~~givH~Dlkp~NIll~~--~~~~kL~DFG~a~~~~~ 184 (367)
T 2fst_X 111 LVTHLM-GADLNNIVKCQ---KLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNE--DCELKILDFGLARHTAD 184 (367)
T ss_dssp EEEECC-CEECC-----C---CCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECT--TCCEEECC---------
T ss_pred EEeccc-CCCHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHhhEEECC--CCCEEEeeccccccccc
Confidence 999999 78999888653 5999999999999999999999999999999999999974 56899999999987665
Q ss_pred CCccccccccccCchhhccCCCCCCCcccchhhhhhhhhhhhcCCCCCCCcCcchhHHHHHHHHhcCCCCCCCCCCchhH
Q psy11767 528 SLHTPCFTLQYAAPEVLRQDKSGYDENCDLWSLGVILVNVLRQDKSGYDENCDLWSLGVILYTMLCGRVPFHARSRDDSA 607 (966)
Q Consensus 528 ~~~~~~gT~~Y~APEvl~~~~~~~~~~~Di~SlGvil~el~~~~~~~y~~~~DIWSlGvilyemltG~~Pf~~~~~~~~~ 607 (966)
.....++|+.|+|||++.. ...|+.++|||||||++|+|++|++||.+.+..+..
T Consensus 185 ~~~~~~~t~~y~aPE~~~~-------------------------~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~l 239 (367)
T 2fst_X 185 EMTGYVATRWYRAPEIMLN-------------------------WMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQL 239 (367)
T ss_dssp ------CCCTTCCHHHHTT-------------------------CCSCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHH
T ss_pred cCCCcCcCcCccChHHHcC-------------------------CcCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHH
Confidence 5566789999999999852 134788999999999999999999999886654433
Q ss_pred HHHHHHHHcC-------------------CCCCC----chhhccCCHHHHHHHHHhcccCccccCChHHHHHHhhhhHH
Q psy11767 608 LSIMARIKEG-------------------QFNFD----AEAWSTVSSEAKELTKSLLTVNPAQRIRMMRVKLTFHAFHQ 663 (966)
Q Consensus 608 ~~~~~~i~~~-------------------~~~~~----~~~~~~is~e~~~Li~~~L~~dP~~R~t~~~v~~~~~~~~~ 663 (966)
..++..+... ....+ ...++.+++++.+||.+||..||++|||+.++ ..|+|+.
T Consensus 240 ~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~t~~e~--L~hp~~~ 316 (367)
T 2fst_X 240 KLILRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQA--LAHAYFA 316 (367)
T ss_dssp HHHHHHHCSCCHHHHTTCCCHHHHHHHHTSCCCCCCCHHHHTTTCCHHHHHHHHHHSCSSGGGSCCHHHH--HTSGGGT
T ss_pred HHHHHHhCCCCHHHHHHhhhHHHHHHHhccCCCCCCCHHHHCCCCCHHHHHHHHHhCCCCcccCcCHHHH--hcChhhh
Confidence 3332221110 00000 12234678999999999999999999999876 4567754
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-40 Score=384.03 Aligned_cols=249 Identities=28% Similarity=0.503 Sum_probs=182.9
Q ss_pred ccccccccccEEEEEEEc--CCCcEEEEEEecccc---ChHHHHHHHHHhcCCCCceEEEEEEEe--CCeEEEEEEccCC
Q psy11767 383 AGILGDGSYSVCRRCVEK--STGQEYAVKIISRKI---DCSEEINLLRACQGHPNIVNLHCVFQD--EVHTYLVLELLKG 455 (966)
Q Consensus 383 ~~~LG~G~fG~Vy~a~~~--~tg~~vAvK~i~~~~---~~~~Ei~iL~~l~~HpnIV~l~~~~~~--~~~~~lVmEy~~g 455 (966)
.++||+|+||+||+|+++ .+++.||||++.... ...+|+.+|+.+. |||||+++++|.+ +...||||||+.
T Consensus 26 g~~lG~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~~~~~~~~E~~~l~~l~-hpniv~~~~~~~~~~~~~~~lv~e~~~- 103 (405)
T 3rgf_A 26 GCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGTGISMSACREIALLRELK-HPNVISLQKVFLSHADRKVWLLFDYAE- 103 (405)
T ss_dssp SCCCC-----EEEEEEESSSSCCCCEEEEECSSSSCCHHHHHHHHHHHHCC-CTTBCCCCEEEEETTTTEEEEEEECCS-
T ss_pred CcEeeecCCeEEEEEEEccCCCCeEEEEEEECCCCCCHHHHHHHHHHHhcC-CCCeeeEeeEEecCCCCeEEEEEeCCC-
Confidence 457999999999999976 578999999997543 3567999999994 9999999999964 678999999995
Q ss_pred CCHHHHHHhcC-------CCCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCcEEEec--CCCCCEEEEeeccccccc
Q psy11767 456 GELLDRIRQKG-------RCGFTENEASRIMRQLVAAVHFMHSRGVVHRDLKPENLLFSD--PAGDNIKVVDFGFACLKR 526 (966)
Q Consensus 456 g~L~~~l~~~~-------~~~l~e~~~~~i~~Qil~aL~yLHs~~IiHRDLKP~NILl~~--~~~~~iKL~DFGla~~~~ 526 (966)
|+|.+++.... ...+++..++.++.||+.||+|||++||+||||||+|||+.. ...+.+||+|||+|+...
T Consensus 104 ~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~kl~Dfg~a~~~~ 183 (405)
T 3rgf_A 104 HDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFN 183 (405)
T ss_dssp EEHHHHHHHHHHHC-------CCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECCSSTTTTCEEECCTTCCC---
T ss_pred CCHHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHhCCEeCCCcCHHHeEEecCCCCCCcEEEEECCCceecC
Confidence 58888876321 124999999999999999999999999999999999999942 235689999999997654
Q ss_pred C------CCccccccccccCchhhccCCCCCCCcccchhhhhhhhhhhhcCCCCCCCcCcchhHHHHHHHHhcCCCCCCC
Q psy11767 527 E------SLHTPCFTLQYAAPEVLRQDKSGYDENCDLWSLGVILVNVLRQDKSGYDENCDLWSLGVILYTMLCGRVPFHA 600 (966)
Q Consensus 527 ~------~~~~~~gT~~Y~APEvl~~~~~~~~~~~Di~SlGvil~el~~~~~~~y~~~~DIWSlGvilyemltG~~Pf~~ 600 (966)
. .....+||+.|+|||++.. ...|+.++|||||||++|+|++|++||.+
T Consensus 184 ~~~~~~~~~~~~~gt~~y~aPE~~~~-------------------------~~~~~~~~DiwSlG~il~ell~g~~pf~~ 238 (405)
T 3rgf_A 184 SPLKPLADLDPVVVTFWYRAPELLLG-------------------------ARHYTKAIDIWAIGCIFAELLTSEPIFHC 238 (405)
T ss_dssp -------------CCCTTCCHHHHTT-------------------------CCSCCHHHHHHHHHHHHHHHHHSSCTTCC
T ss_pred CCCcccccCCCceecCcccCchhhcC-------------------------CCcccchhhhHHHHHHHHHHHhCCCCCCC
Confidence 2 2234678999999999853 12378899999999999999999999986
Q ss_pred CCCc---------hhHHHHHHHHHcCCCCCCchhhc----------------------------------cCCHHHHHHH
Q psy11767 601 RSRD---------DSALSIMARIKEGQFNFDAEAWS----------------------------------TVSSEAKELT 637 (966)
Q Consensus 601 ~~~~---------~~~~~~~~~i~~~~~~~~~~~~~----------------------------------~is~e~~~Li 637 (966)
.... +....++..+.. .....|. ..++++.+||
T Consensus 239 ~~~~~~~~~~~~~~~l~~i~~~~g~----p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Ll 314 (405)
T 3rgf_A 239 RQEDIKTSNPYHHDQLDRIFNVMGF----PADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHLL 314 (405)
T ss_dssp CC------CCCCHHHHHHHHHHHCC----CCTTTCGGGGGSTTHHHHHHHCCGGGGTTCCHHHHHHTTTCCTTSHHHHHH
T ss_pred ccccccccccchHHHHHHHHHhhCC----CChhhcchhhcCcchhhhhhhccccCCCcchhhhhHhhcCCCCCHHHHHHH
Confidence 5432 111112211110 0011111 1277899999
Q ss_pred HHhcccCccccCChHHHHHHhhhhHHh
Q psy11767 638 KSLLTVNPAQRIRMMRVKLTFHAFHQA 664 (966)
Q Consensus 638 ~~~L~~dP~~R~t~~~v~~~~~~~~~~ 664 (966)
.+||+.||.+|||+.++ ..|+|+..
T Consensus 315 ~~~L~~dP~~R~ta~e~--L~hp~f~~ 339 (405)
T 3rgf_A 315 QKLLTMDPIKRITSEQA--MQDPYFLE 339 (405)
T ss_dssp HHHSCSSGGGSCCHHHH--HTSGGGTS
T ss_pred HHHccCCcccCCCHHHH--hcChhhcc
Confidence 99999999999999876 45788753
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-40 Score=370.30 Aligned_cols=237 Identities=30% Similarity=0.483 Sum_probs=197.5
Q ss_pred ccccccccccccEEEEEEEcCCCcEEEEEEecccc-------------ChHHHHHHHHHhcCCCCceEEEEEEEeCCeEE
Q psy11767 381 DKAGILGDGSYSVCRRCVEKSTGQEYAVKIISRKI-------------DCSEEINLLRACQGHPNIVNLHCVFQDEVHTY 447 (966)
Q Consensus 381 ~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~-------------~~~~Ei~iL~~l~~HpnIV~l~~~~~~~~~~~ 447 (966)
+..+.||+|+||.||+|++..+|+.||||++.... ...+|+.+|+.+ +||||++++++|.+....+
T Consensus 27 ~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~Iv~~~~~~~~~~~~~ 105 (335)
T 3dls_A 27 STMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRV-EHANIIKVLDIFENQGFFQ 105 (335)
T ss_dssp EEEEECSSSSSCSEEEEEETTTTEEEEEEEEESTTSCTTSEEEETTTEEEEHHHHHHTTC-CCTTBCCEEEEEECSSEEE
T ss_pred EEEeEEEecCCEEEEEEEECCCCcEEEEEEEehhhcccccccchHHHHHHHHHHHHHHhC-CCCCEeeEEEEEeeCCEEE
Confidence 33689999999999999999999999999987542 244699999998 5999999999999999999
Q ss_pred EEEEccCCC-CHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCcEEEecCCCCCEEEEeeccccccc
Q psy11767 448 LVLELLKGG-ELLDRIRQKGRCGFTENEASRIMRQLVAAVHFMHSRGVVHRDLKPENLLFSDPAGDNIKVVDFGFACLKR 526 (966)
Q Consensus 448 lVmEy~~gg-~L~~~l~~~~~~~l~e~~~~~i~~Qil~aL~yLHs~~IiHRDLKP~NILl~~~~~~~iKL~DFGla~~~~ 526 (966)
+||||+.+| +|.+++.... .+++..++.++.||+.||+|||++||+||||||+|||++. ++.+||+|||++....
T Consensus 106 lv~e~~~~g~~l~~~~~~~~--~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~--~~~~kL~Dfg~a~~~~ 181 (335)
T 3dls_A 106 LVMEKHGSGLDLFAFIDRHP--RLDEPLASYIFRQLVSAVGYLRLKDIIHRDIKDENIVIAE--DFTIKLIDFGSAAYLE 181 (335)
T ss_dssp EEEECCTTSCBHHHHHHTCC--CCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECT--TSCEEECCCTTCEECC
T ss_pred EEEEeCCCCccHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCeEEeccCHHHEEEcC--CCcEEEeecccceECC
Confidence 999999776 9999997654 5999999999999999999999999999999999999975 5689999999997654
Q ss_pred CC--CccccccccccCchhhccCCCCCCCcccchhhhhhhhhhhhcCCCCCCCcCcchhHHHHHHHHhcCCCCCCCCCCc
Q psy11767 527 ES--LHTPCFTLQYAAPEVLRQDKSGYDENCDLWSLGVILVNVLRQDKSGYDENCDLWSLGVILYTMLCGRVPFHARSRD 604 (966)
Q Consensus 527 ~~--~~~~~gT~~Y~APEvl~~~~~~~~~~~Di~SlGvil~el~~~~~~~y~~~~DIWSlGvilyemltG~~Pf~~~~~~ 604 (966)
.. ....+||+.|+|||++... ..++.++|||||||++|+|++|+.||.....
T Consensus 182 ~~~~~~~~~gt~~y~aPE~~~~~-------------------------~~~~~~~DiwslG~il~el~~g~~pf~~~~~- 235 (335)
T 3dls_A 182 RGKLFYTFCGTIEYCAPEVLMGN-------------------------PYRGPELEMWSLGVTLYTLVFEENPFCELEE- 235 (335)
T ss_dssp TTCCBCEECSCGGGCCHHHHTTC-------------------------CBCSHHHHHHHHHHHHHHHHHSSCSCSSGGG-
T ss_pred CCCceeccCCCccccChhhhcCC-------------------------CCCCCcccchhHHHHHHHHHhCCCchhhHHH-
Confidence 32 3456789999999998532 1236789999999999999999999975321
Q ss_pred hhHHHHHHHHHcCCCCCCchhhccCCHHHHHHHHHhcccCccccCChHHHHHHhhhhHH
Q psy11767 605 DSALSIMARIKEGQFNFDAEAWSTVSSEAKELTKSLLTVNPAQRIRMMRVKLTFHAFHQ 663 (966)
Q Consensus 605 ~~~~~~~~~i~~~~~~~~~~~~~~is~e~~~Li~~~L~~dP~~R~t~~~v~~~~~~~~~ 663 (966)
....... ....+++++.+||.+||..||++|||+.++ ..|+|..
T Consensus 236 ---------~~~~~~~----~~~~~~~~l~~li~~~L~~dP~~Rps~~el--l~hp~~~ 279 (335)
T 3dls_A 236 ---------TVEAAIH----PPYLVSKELMSLVSGLLQPVPERRTTLEKL--VTDPWVT 279 (335)
T ss_dssp ---------GTTTCCC----CSSCCCHHHHHHHHHHTCSSGGGSCCHHHH--HHCTTTT
T ss_pred ---------HHhhccC----CCcccCHHHHHHHHHHccCChhhCcCHHHH--hcCcccc
Confidence 1111111 123579999999999999999999999976 3466653
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-39 Score=360.10 Aligned_cols=246 Identities=23% Similarity=0.355 Sum_probs=200.8
Q ss_pred ccccccccccccEEEEEEE-----cCCCcEEEEEEeccccC------hHHHHHHHHHhcCCCCceEEEEEEEeCCeEEEE
Q psy11767 381 DKAGILGDGSYSVCRRCVE-----KSTGQEYAVKIISRKID------CSEEINLLRACQGHPNIVNLHCVFQDEVHTYLV 449 (966)
Q Consensus 381 ~~~~~LG~G~fG~Vy~a~~-----~~tg~~vAvK~i~~~~~------~~~Ei~iL~~l~~HpnIV~l~~~~~~~~~~~lV 449 (966)
...+.||+|+||.||+|.+ ..+++.||||++..... ..+|+.+|+.+.+||||+++++++.++...|+|
T Consensus 26 ~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~lv 105 (313)
T 1t46_A 26 SFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTIGGPTLVI 105 (313)
T ss_dssp EEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEE
T ss_pred hHHHhhCccCCcceEEEEEeeccccchhhhhHHHhcCcchhHHHHHHHHHHHHHHhhcccCCCeeeEEEEEecCCCcEEE
Confidence 3368899999999999985 45788999999975432 446999999996799999999999999999999
Q ss_pred EEccCCCCHHHHHHhcCCC----------------CCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCcEEEecCCCCC
Q psy11767 450 LELLKGGELLDRIRQKGRC----------------GFTENEASRIMRQLVAAVHFMHSRGVVHRDLKPENLLFSDPAGDN 513 (966)
Q Consensus 450 mEy~~gg~L~~~l~~~~~~----------------~l~e~~~~~i~~Qil~aL~yLHs~~IiHRDLKP~NILl~~~~~~~ 513 (966)
|||+++|+|.+++...... .+++.+++.++.||+.||+|||++||+||||||+|||++. ++.
T Consensus 106 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~--~~~ 183 (313)
T 1t46_A 106 TEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNILLTH--GRI 183 (313)
T ss_dssp EECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEET--TTE
T ss_pred EecCCCCCHHHHHHhcccccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHHCCeecCCCccceEEEcC--CCC
Confidence 9999999999999875421 4899999999999999999999999999999999999985 568
Q ss_pred EEEEeecccccccCCC-----ccccccccccCchhhccCCCCCCCcccchhhhhhhhhhhhcCCCCCCCcCcchhHHHHH
Q psy11767 514 IKVVDFGFACLKRESL-----HTPCFTLQYAAPEVLRQDKSGYDENCDLWSLGVILVNVLRQDKSGYDENCDLWSLGVIL 588 (966)
Q Consensus 514 iKL~DFGla~~~~~~~-----~~~~gT~~Y~APEvl~~~~~~~~~~~Di~SlGvil~el~~~~~~~y~~~~DIWSlGvil 588 (966)
+||+|||++....... ....+|+.|+|||++.. ..|+.++|||||||++
T Consensus 184 ~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~--------------------------~~~~~~~Di~slG~il 237 (313)
T 1t46_A 184 TKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFN--------------------------CVYTFESDVWSYGIFL 237 (313)
T ss_dssp EEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHH--------------------------CCCCHHHHHHHHHHHH
T ss_pred EEEccccccccccccccceeccCCCCcceeeChHHhcC--------------------------CCCChHHHHHHHHHHH
Confidence 9999999997654321 23456889999998853 2367899999999999
Q ss_pred HHHhc-CCCCCCCCCCchhHHHHHHHHHcCCCCCCchhhccCCHHHHHHHHHhcccCccccCChHHHHHHhhh
Q psy11767 589 YTMLC-GRVPFHARSRDDSALSIMARIKEGQFNFDAEAWSTVSSEAKELTKSLLTVNPAQRIRMMRVKLTFHA 660 (966)
Q Consensus 589 yemlt-G~~Pf~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~is~e~~~Li~~~L~~dP~~R~t~~~v~~~~~~ 660 (966)
|+|++ |+.||.+........ ..+..+... .....++.++.+||.+||..||.+|||+.++...+..
T Consensus 238 ~ellt~g~~p~~~~~~~~~~~---~~~~~~~~~---~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~ 304 (313)
T 1t46_A 238 WELFSLGSSPYPGMPVDSKFY---KMIKEGFRM---LSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEK 304 (313)
T ss_dssp HHHHTTTCCSSTTCCSSHHHH---HHHHHTCCC---CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred HHHHhCCCCCCCcccchhHHH---HHhccCCCC---CCcccCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHH
Confidence 99998 999998776543322 223332211 1224578999999999999999999999988655443
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-39 Score=383.90 Aligned_cols=254 Identities=22% Similarity=0.271 Sum_probs=205.7
Q ss_pred ccccccccccccEEEEEEEcCCCcEEEEEEeccc---cChHHHHHHHHHhcCCCCceEEEEEEEeCCeEEEEEEccCCCC
Q psy11767 381 DKAGILGDGSYSVCRRCVEKSTGQEYAVKIISRK---IDCSEEINLLRACQGHPNIVNLHCVFQDEVHTYLVLELLKGGE 457 (966)
Q Consensus 381 ~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~---~~~~~Ei~iL~~l~~HpnIV~l~~~~~~~~~~~lVmEy~~gg~ 457 (966)
+..++||+|+||.||+|.+..+|+.||||++... ....+|+++|+.+.+|++|+.+..++.+....||||||+ +++
T Consensus 10 ~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~~~~~~E~~il~~L~~~~~i~~i~~~~~~~~~~~lvme~~-g~s 88 (483)
T 3sv0_A 10 RLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLLYESKIYRILQGGTGIPNVRWFGVEGDYNVLVMDLL-GPS 88 (483)
T ss_dssp ECCCCCEECSSCEEEEEEETTTCCEEEEEEEETTCSSCCHHHHHHHHHHTTTSTTCCCEEEEEEETTEEEEEEECC-CCB
T ss_pred EEEEEEeeCCCEEEEEEEECCCCcEEEEEEeccccccHHHHHHHHHHHHhcCCCCCCeEEEEEeeCCEEEEEEECC-CCC
Confidence 3368999999999999999999999999998643 346789999999987788888888889999999999999 999
Q ss_pred HHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCcEEEec-CCCCCEEEEeecccccccCCC-------
Q psy11767 458 LLDRIRQKGRCGFTENEASRIMRQLVAAVHFMHSRGVVHRDLKPENLLFSD-PAGDNIKVVDFGFACLKRESL------- 529 (966)
Q Consensus 458 L~~~l~~~~~~~l~e~~~~~i~~Qil~aL~yLHs~~IiHRDLKP~NILl~~-~~~~~iKL~DFGla~~~~~~~------- 529 (966)
|.+++..... .+++.+++.|+.||+.||+|||++|||||||||+||||+. ...+.+||+|||+|+......
T Consensus 89 L~~ll~~~~~-~l~~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~~~~~~~~~~~ 167 (483)
T 3sv0_A 89 LEDLFNFCSR-KLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPY 167 (483)
T ss_dssp HHHHHHHTTT-CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECCGGGTTCEEECCCTTCEECBCTTTCCBCCC
T ss_pred HHHHHHhhcC-CCCHHHHHHHHHHHHHHHHHHHHCCEeecccCcceEEEecCCCCCeEEEEeCCcceeccCCcccccccc
Confidence 9999976443 6999999999999999999999999999999999999941 135689999999997654321
Q ss_pred ---ccccccccccCchhhccCCCCCCCcccchhhhhhhhhhhhcCCCCCCCcCcchhHHHHHHHHhcCCCCCCCCCCchh
Q psy11767 530 ---HTPCFTLQYAAPEVLRQDKSGYDENCDLWSLGVILVNVLRQDKSGYDENCDLWSLGVILYTMLCGRVPFHARSRDDS 606 (966)
Q Consensus 530 ---~~~~gT~~Y~APEvl~~~~~~~~~~~Di~SlGvil~el~~~~~~~y~~~~DIWSlGvilyemltG~~Pf~~~~~~~~ 606 (966)
...+||+.|+|||++.. ..|+.++|||||||+||+|++|+.||.+......
T Consensus 168 ~~~~~~~gt~~Y~aPE~~~~--------------------------~~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~ 221 (483)
T 3sv0_A 168 RENKNLTGTARYASVNTHLG--------------------------IEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTK 221 (483)
T ss_dssp CCCCCCCSCTTTCCHHHHTT--------------------------CCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSH
T ss_pred ccccccCCCccccCHHHhcC--------------------------CCCChHHHHHHHHHHHHHHHhCCCCCccccchhH
Confidence 25678999999999853 2378899999999999999999999987654322
Q ss_pred HHHHHHHHHcCCCCCC-chhhccCCHHHHHHHHHhcccCccccCChHHHHHHhhhhHH
Q psy11767 607 ALSIMARIKEGQFNFD-AEAWSTVSSEAKELTKSLLTVNPAQRIRMMRVKLTFHAFHQ 663 (966)
Q Consensus 607 ~~~~~~~i~~~~~~~~-~~~~~~is~e~~~Li~~~L~~dP~~R~t~~~v~~~~~~~~~ 663 (966)
...+..+........ ......++.++.+||.+||..||++||++.++...+.....
T Consensus 222 -~~~~~~i~~~~~~~~~~~l~~~~p~~l~~li~~cl~~dP~~RPs~~el~~~L~~l~~ 278 (483)
T 3sv0_A 222 -KQKYEKISEKKVATSIEALCRGYPTEFASYFHYCRSLRFDDKPDYSYLKRLFRDLFI 278 (483)
T ss_dssp -HHHHHHHHHHHHHSCHHHHHTTSCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHHH
T ss_pred -HHHHHHHhhccccccHHHHhcCCcHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHH
Confidence 222333332222111 12235678999999999999999999999998776665544
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9e-40 Score=356.82 Aligned_cols=243 Identities=22% Similarity=0.372 Sum_probs=198.6
Q ss_pred ccccccccccEEEEEEEcCCCcEEEEEEecccc------------ChHHHHHHHHHhcCCCCceEEEEEEEeCCeEEEEE
Q psy11767 383 AGILGDGSYSVCRRCVEKSTGQEYAVKIISRKI------------DCSEEINLLRACQGHPNIVNLHCVFQDEVHTYLVL 450 (966)
Q Consensus 383 ~~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~------------~~~~Ei~iL~~l~~HpnIV~l~~~~~~~~~~~lVm 450 (966)
.+.||+|+||.||+|.+..+++.||||++.... ...+|+.+|+.+ +||||+++++++.+.. ++||
T Consensus 24 ~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~~~--~lv~ 100 (287)
T 4f0f_A 24 EKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNL-NHPNIVKLYGLMHNPP--RMVM 100 (287)
T ss_dssp EEECCCCSSSCEEEEEETTTCCEEEEEECCCCTTTCCHHHHCCSHHHHHHHHHHTTC-CCTTBCCEEEEETTTT--EEEE
T ss_pred hhccccCCceeEEEEEEcCCceEEEEEEeeccccccchhHHHHHHHHHHHHHHHHhC-CCCCchhhheeecCCC--eEEE
Confidence 678999999999999999999999999985321 235699999888 5999999999997765 7999
Q ss_pred EccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcC--ceeccCCCCcEEEecCC---CCCEEEEeecccccc
Q psy11767 451 ELLKGGELLDRIRQKGRCGFTENEASRIMRQLVAAVHFMHSRG--VVHRDLKPENLLFSDPA---GDNIKVVDFGFACLK 525 (966)
Q Consensus 451 Ey~~gg~L~~~l~~~~~~~l~e~~~~~i~~Qil~aL~yLHs~~--IiHRDLKP~NILl~~~~---~~~iKL~DFGla~~~ 525 (966)
||+++|+|.+++..... .+++..++.++.||+.||+|||++| |+||||||+|||++... ...+||+|||+++..
T Consensus 101 e~~~~~~L~~~l~~~~~-~~~~~~~~~~~~~l~~~l~~lH~~~~~ivH~dikp~Nil~~~~~~~~~~~~kl~Dfg~~~~~ 179 (287)
T 4f0f_A 101 EFVPCGDLYHRLLDKAH-PIKWSVKLRLMLDIALGIEYMQNQNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGLSQQS 179 (287)
T ss_dssp ECCTTCBHHHHHHCTTS-CCCHHHHHHHHHHHHHHHHHHHTSSSCCBCSCCSGGGEEESCCCTTCSCCEEECCCTTCBCC
T ss_pred EecCCCCHHHHHhcccC-CccHHHHHHHHHHHHHHHHHHHhCCCCeecCCCCcceEEEeccCCCCceeEEeCCCCccccc
Confidence 99999999999876543 6999999999999999999999999 99999999999997522 113999999999876
Q ss_pred cCCCccccccccccCchhhccCCCCCCCcccchhhhhhhhhhhhcCCCCCCCcCcchhHHHHHHHHhcCCCCCCCCCCch
Q psy11767 526 RESLHTPCFTLQYAAPEVLRQDKSGYDENCDLWSLGVILVNVLRQDKSGYDENCDLWSLGVILYTMLCGRVPFHARSRDD 605 (966)
Q Consensus 526 ~~~~~~~~gT~~Y~APEvl~~~~~~~~~~~Di~SlGvil~el~~~~~~~y~~~~DIWSlGvilyemltG~~Pf~~~~~~~ 605 (966)
........+|+.|+|||++... ...|+.++|||||||++|+|++|+.||.......
T Consensus 180 ~~~~~~~~g~~~y~aPE~~~~~------------------------~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~ 235 (287)
T 4f0f_A 180 VHSVSGLLGNFQWMAPETIGAE------------------------EESYTEKADTYSFAMILYTILTGEGPFDEYSYGK 235 (287)
T ss_dssp SSCEECCCCCCTTSCGGGSSCS------------------------SCEECHHHHHHHHHHHHHHHHHSSCTTTTCCCCH
T ss_pred cccccccCCCccccCchhhccC------------------------CCCcCchhhHHHHHHHHHHHHcCCCCCccccccH
Confidence 6655667899999999988421 2336788999999999999999999998766543
Q ss_pred hHHHHHHHHHcCCCCCCchhhccCCHHHHHHHHHhcccCccccCChHHHHHH
Q psy11767 606 SALSIMARIKEGQFNFDAEAWSTVSSEAKELTKSLLTVNPAQRIRMMRVKLT 657 (966)
Q Consensus 606 ~~~~~~~~i~~~~~~~~~~~~~~is~e~~~Li~~~L~~dP~~R~t~~~v~~~ 657 (966)
. .....+...... ......+++++.+||.+||+.||++|||+.++...
T Consensus 236 ~--~~~~~~~~~~~~--~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~ 283 (287)
T 4f0f_A 236 I--KFINMIREEGLR--PTIPEDCPPRLRNVIELCWSGDPKKRPHFSYIVKE 283 (287)
T ss_dssp H--HHHHHHHHSCCC--CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred H--HHHHHHhccCCC--CCCCcccCHHHHHHHHHHhcCChhhCcCHHHHHHH
Confidence 2 223333333322 22334689999999999999999999999987543
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=8.2e-40 Score=366.82 Aligned_cols=246 Identities=24% Similarity=0.371 Sum_probs=198.7
Q ss_pred ccccccccccccEEEEEEEc-----CCCcEEEEEEecccc------ChHHHHHHHHHhcCCCCceEEEEEEEeCCeEEEE
Q psy11767 381 DKAGILGDGSYSVCRRCVEK-----STGQEYAVKIISRKI------DCSEEINLLRACQGHPNIVNLHCVFQDEVHTYLV 449 (966)
Q Consensus 381 ~~~~~LG~G~fG~Vy~a~~~-----~tg~~vAvK~i~~~~------~~~~Ei~iL~~l~~HpnIV~l~~~~~~~~~~~lV 449 (966)
...+.||+|+||.||+|.+. .+++.||||++.... ...+|+.+|+.+.+||||+++++++.+.+..|+|
T Consensus 48 ~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv 127 (344)
T 1rjb_A 48 EFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTLSGPIYLI 127 (344)
T ss_dssp EEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEE
T ss_pred eeeeeecCCCCceeEEeeeeccccCCcceEEEEEecccccCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEeeCCccEEE
Confidence 34688999999999999983 467789999996532 2457999999996799999999999999999999
Q ss_pred EEccCCCCHHHHHHhcCC---------------------CCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCcEEEec
Q psy11767 450 LELLKGGELLDRIRQKGR---------------------CGFTENEASRIMRQLVAAVHFMHSRGVVHRDLKPENLLFSD 508 (966)
Q Consensus 450 mEy~~gg~L~~~l~~~~~---------------------~~l~e~~~~~i~~Qil~aL~yLHs~~IiHRDLKP~NILl~~ 508 (966)
|||+++|+|.+++..... ..+++.+++.++.||+.||+|||++||+||||||+|||++.
T Consensus 128 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIll~~ 207 (344)
T 1rjb_A 128 FEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKSCVHRDLAARNVLVTH 207 (344)
T ss_dssp EECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHTTEEETTCSGGGEEEET
T ss_pred EecCCCCcHHHHHhhccccccccccchhhhcccccccccccCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChhhEEEcC
Confidence 999999999999976542 23899999999999999999999999999999999999985
Q ss_pred CCCCCEEEEeecccccccCC-----CccccccccccCchhhccCCCCCCCcccchhhhhhhhhhhhcCCCCCCCcCcchh
Q psy11767 509 PAGDNIKVVDFGFACLKRES-----LHTPCFTLQYAAPEVLRQDKSGYDENCDLWSLGVILVNVLRQDKSGYDENCDLWS 583 (966)
Q Consensus 509 ~~~~~iKL~DFGla~~~~~~-----~~~~~gT~~Y~APEvl~~~~~~~~~~~Di~SlGvil~el~~~~~~~y~~~~DIWS 583 (966)
++.+||+|||++...... .....+|+.|+|||++.. ..|+.++||||
T Consensus 208 --~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~--------------------------~~~~~~~Di~s 259 (344)
T 1rjb_A 208 --GKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFE--------------------------GIYTIKSDVWS 259 (344)
T ss_dssp --TTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHH--------------------------CCCCHHHHHHH
T ss_pred --CCcEEeCCCccCcccccCccceeccCccCccCccCHHHhcc--------------------------CCCChhHhHHH
Confidence 568999999999754322 123456889999998853 23678999999
Q ss_pred HHHHHHHHhc-CCCCCCCCCCchhHHHHHHHHHcCCCCCCchhhccCCHHHHHHHHHhcccCccccCChHHHHHHhhh
Q psy11767 584 LGVILYTMLC-GRVPFHARSRDDSALSIMARIKEGQFNFDAEAWSTVSSEAKELTKSLLTVNPAQRIRMMRVKLTFHA 660 (966)
Q Consensus 584 lGvilyemlt-G~~Pf~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~is~e~~~Li~~~L~~dP~~R~t~~~v~~~~~~ 660 (966)
|||++|+|++ |..||.+....... ...+..+ .... ....+++++.+||.+||..||.+|||+.++...+..
T Consensus 260 lG~il~el~t~g~~p~~~~~~~~~~---~~~~~~~-~~~~--~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~ 331 (344)
T 1rjb_A 260 YGILLWEIFSLGVNPYPGIPVDANF---YKLIQNG-FKMD--QPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFLGC 331 (344)
T ss_dssp HHHHHHHHTTTSCCSSTTCCCSHHH---HHHHHTT-CCCC--CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred HHHHHHHHHcCCCCCcccCCcHHHH---HHHHhcC-CCCC--CCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHH
Confidence 9999999998 99999887654322 2223333 2221 223578999999999999999999999988655443
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-40 Score=370.84 Aligned_cols=250 Identities=26% Similarity=0.403 Sum_probs=199.1
Q ss_pred ccccccccccccEEEEEEEcCCCcEEEEEEecccc----------ChHHHHHHHHHhcCCCCceEEEEEEEeCCeEEEEE
Q psy11767 381 DKAGILGDGSYSVCRRCVEKSTGQEYAVKIISRKI----------DCSEEINLLRACQGHPNIVNLHCVFQDEVHTYLVL 450 (966)
Q Consensus 381 ~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~----------~~~~Ei~iL~~l~~HpnIV~l~~~~~~~~~~~lVm 450 (966)
+..+.||+|+||.||+|.+..+|+.||||++.... ...+|+.+|+.+ +||||++++++|.+....|+||
T Consensus 13 ~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~ 91 (346)
T 1ua2_A 13 EKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQEL-SHPNIIGLLDAFGHKSNISLVF 91 (346)
T ss_dssp CEEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHC-CCTTBCCEEEEECCTTCCEEEE
T ss_pred EEEeEEeecCCEEEEEEEECCCCcEEEEEEEecCCcchhhhhhhHHHHHHHHHHhhC-CCCCCCeEEEEEeeCCceEEEE
Confidence 33688999999999999999999999999986421 245799999998 5999999999999999999999
Q ss_pred EccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCcEEEecCCCCCEEEEeecccccccC---
Q psy11767 451 ELLKGGELLDRIRQKGRCGFTENEASRIMRQLVAAVHFMHSRGVVHRDLKPENLLFSDPAGDNIKVVDFGFACLKRE--- 527 (966)
Q Consensus 451 Ey~~gg~L~~~l~~~~~~~l~e~~~~~i~~Qil~aL~yLHs~~IiHRDLKP~NILl~~~~~~~iKL~DFGla~~~~~--- 527 (966)
||+++ +|.+++.... ..+++.+++.++.||+.||+|||++||+||||||+|||++. ++.+||+|||+++....
T Consensus 92 e~~~~-~l~~~~~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~--~~~~kl~Dfg~a~~~~~~~~ 167 (346)
T 1ua2_A 92 DFMET-DLEVIIKDNS-LVLTPSHIKAYMLMTLQGLEYLHQHWILHRDLKPNNLLLDE--NGVLKLADFGLAKSFGSPNR 167 (346)
T ss_dssp ECCSE-EHHHHHTTCC-SSCCSSHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECT--TCCEEECCCGGGSTTTSCCC
T ss_pred EcCCC-CHHHHHHhcC-cCCCHHHHHHHHHHHHHHHHHHHHCCEECCCCCHHHEEEcC--CCCEEEEecccceeccCCcc
Confidence 99975 8888887654 36899999999999999999999999999999999999975 56899999999976532
Q ss_pred CCccccccccccCchhhccCCCCCCCcccchhhhhhhhhhhhcCCCCCCCcCcchhHHHHHHHHhcCCCCCCCCCCchhH
Q psy11767 528 SLHTPCFTLQYAAPEVLRQDKSGYDENCDLWSLGVILVNVLRQDKSGYDENCDLWSLGVILYTMLCGRVPFHARSRDDSA 607 (966)
Q Consensus 528 ~~~~~~gT~~Y~APEvl~~~~~~~~~~~Di~SlGvil~el~~~~~~~y~~~~DIWSlGvilyemltG~~Pf~~~~~~~~~ 607 (966)
.....++|+.|+|||++.. ...|+.++|||||||++|+|++|.+||.+.+..+..
T Consensus 168 ~~~~~~~t~~y~aPE~~~~-------------------------~~~~~~~~DiwslG~il~ell~g~~~~~~~~~~~~~ 222 (346)
T 1ua2_A 168 AYTHQVVTRWYRAPELLFG-------------------------ARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQL 222 (346)
T ss_dssp CCCCSCCCCTTCCHHHHTT-------------------------CSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHH
T ss_pred cCCcccccccccCchHhhC-------------------------CCCCCchhhhHhHHHHHHHHHHCCCCCCCCCHHHHH
Confidence 2345678999999999852 224788899999999999999999999876654333
Q ss_pred HHHHHHHHcCCCC-C---------------C----chhhccCCHHHHHHHHHhcccCccccCChHHHHHHhhhhH
Q psy11767 608 LSIMARIKEGQFN-F---------------D----AEAWSTVSSEAKELTKSLLTVNPAQRIRMMRVKLTFHAFH 662 (966)
Q Consensus 608 ~~~~~~i~~~~~~-~---------------~----~~~~~~is~e~~~Li~~~L~~dP~~R~t~~~v~~~~~~~~ 662 (966)
..++......... + + ...+..+++++++||.+||..||++|||+.++ ..|+|+
T Consensus 223 ~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~el--l~h~~f 295 (346)
T 1ua2_A 223 TRIFETLGTPTEEQWPDMCSLPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQA--LKMKYF 295 (346)
T ss_dssp HHHHHHHCCCCTTTSSSTTSSTTCCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHH--HTSGGG
T ss_pred HHHHHHcCCCChhhhhhhccCcccccccccCCCChHHhhccCCHHHHHHHHHHhccChhhCCCHHHH--hcChhh
Confidence 3333322111000 0 0 01224678999999999999999999999976 346664
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-39 Score=355.63 Aligned_cols=253 Identities=40% Similarity=0.754 Sum_probs=213.6
Q ss_pred ceecccccccccccccccccccEEEEEEEcCCCcEEEEEEecccc-------ChHHHHHHHHHhcCCCCceEEEEEEEeC
Q psy11767 371 LFFEQYDMDLDKAGILGDGSYSVCRRCVEKSTGQEYAVKIISRKI-------DCSEEINLLRACQGHPNIVNLHCVFQDE 443 (966)
Q Consensus 371 ~~~~~~~i~~~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~-------~~~~Ei~iL~~l~~HpnIV~l~~~~~~~ 443 (966)
.+.++|.+ .+.||+|+||.||+|.+..+++.||||++.... ...+|+++|+.+ +||||+++++++.+.
T Consensus 19 ~~~~~y~i----~~~lg~G~~g~V~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~ 93 (287)
T 2wei_A 19 TFAERYNI----VCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKL-DHPNIMKLFEILEDS 93 (287)
T ss_dssp HHHHHEEE----EEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGBSSSCHHHHHHHHHHHHTC-CCTTBCCEEEEEECS
T ss_pred HHhhccee----eEEEcCCCCEEEEEEEEcCCCcEEEEEEecccccchHHHHHHHHHHHHHHhc-cCCCccEEEEEEeCC
Confidence 34456655 688999999999999999999999999986432 245799999998 699999999999999
Q ss_pred CeEEEEEEccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCcEEEecCC-CCCEEEEeeccc
Q psy11767 444 VHTYLVLELLKGGELLDRIRQKGRCGFTENEASRIMRQLVAAVHFMHSRGVVHRDLKPENLLFSDPA-GDNIKVVDFGFA 522 (966)
Q Consensus 444 ~~~~lVmEy~~gg~L~~~l~~~~~~~l~e~~~~~i~~Qil~aL~yLHs~~IiHRDLKP~NILl~~~~-~~~iKL~DFGla 522 (966)
...|+||||+++++|.+++.... .+++.+++.++.||+.||+|||++||+||||||+|||++... ...+||+|||++
T Consensus 94 ~~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~NIlv~~~~~~~~~kL~Dfg~~ 171 (287)
T 2wei_A 94 SSFYIVGELYTGGELFDEIIKRK--RFSEHDAARIIKQVFSGITYMHKHNIVHRDLKPENILLESKEKDCDIKIIDFGLS 171 (287)
T ss_dssp SEEEEEECCCCSCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESCSSTTCCEEECSTTGG
T ss_pred CeEEEEEEccCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCeeccCCChhhEEEecCCCcccEEEeccCcc
Confidence 99999999999999999997765 589999999999999999999999999999999999997532 347999999999
Q ss_pred ccccCC--CccccccccccCchhhccCCCCCCCcccchhhhhhhhhhhhcCCCCCCCcCcchhHHHHHHHHhcCCCCCCC
Q psy11767 523 CLKRES--LHTPCFTLQYAAPEVLRQDKSGYDENCDLWSLGVILVNVLRQDKSGYDENCDLWSLGVILYTMLCGRVPFHA 600 (966)
Q Consensus 523 ~~~~~~--~~~~~gT~~Y~APEvl~~~~~~~~~~~Di~SlGvil~el~~~~~~~y~~~~DIWSlGvilyemltG~~Pf~~ 600 (966)
...... .....+|+.|+|||++.. .++.++|||||||++|+|++|..||.+
T Consensus 172 ~~~~~~~~~~~~~~~~~y~aPE~~~~---------------------------~~~~~~Di~slG~~l~~l~~g~~p~~~ 224 (287)
T 2wei_A 172 TCFQQNTKMKDRIGTAYYIAPEVLRG---------------------------TYDEKCDVWSAGVILYILLSGTPPFYG 224 (287)
T ss_dssp GTBCCCSSCSCHHHHHTTCCHHHHTT---------------------------CCCTHHHHHHHHHHHHHHHHSSCSSCC
T ss_pred eeecCCCccccccCcccccChHHhcC---------------------------CCCCchhhHhHHHHHHHHHhCCCCCCC
Confidence 765432 234468999999998741 267889999999999999999999987
Q ss_pred CCCchhHHHHHHHHHcCCCCCCchhhccCCHHHHHHHHHhcccCccccCChHHHHHHhhhhHH
Q psy11767 601 RSRDDSALSIMARIKEGQFNFDAEAWSTVSSEAKELTKSLLTVNPAQRIRMMRVKLTFHAFHQ 663 (966)
Q Consensus 601 ~~~~~~~~~~~~~i~~~~~~~~~~~~~~is~e~~~Li~~~L~~dP~~R~t~~~v~~~~~~~~~ 663 (966)
.+. ..+...+..+.+.+....+..+++++.+||.+||..||++|||+.++ ..|+|++
T Consensus 225 ~~~----~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~el--l~hp~~~ 281 (287)
T 2wei_A 225 KNE----YDILKRVETGKYAFDLPQWRTISDDAKDLIRKMLTFHPSLRITATQC--LEHPWIQ 281 (287)
T ss_dssp SSH----HHHHHHHHHCCCCCCSGGGTTSCHHHHHHHHHHTCSSGGGSCCHHHH--HHSHHHH
T ss_pred CCH----HHHHHHHHcCCCCCCchhhhhcCHHHHHHHHHHcccChhhCcCHHHH--hcCHHHh
Confidence 543 24556677777777767777899999999999999999999999976 3466654
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.5e-41 Score=381.02 Aligned_cols=256 Identities=14% Similarity=0.153 Sum_probs=186.2
Q ss_pred cccccccccccccEEEEEEEcCCCcEEEEEEeccccC--------hHHHHHHHHHhc-CCCCceEEE-------EEEEeC
Q psy11767 380 LDKAGILGDGSYSVCRRCVEKSTGQEYAVKIISRKID--------CSEEINLLRACQ-GHPNIVNLH-------CVFQDE 443 (966)
Q Consensus 380 ~~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~~--------~~~Ei~iL~~l~-~HpnIV~l~-------~~~~~~ 443 (966)
|...+.||+|+||+||+|.+..+|+.||||++..... ..+|+.+++.+. +|||||+++ +++..+
T Consensus 64 y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~hp~iv~~~~~~~~p~d~~~~~ 143 (371)
T 3q60_A 64 LKLVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGESPEEARDRRRLLLPSDAVAVQ 143 (371)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECCSTTHHHHHHHHHHHHHHHHHHHC----------CBCCCCEEEEET
T ss_pred eeeeeeccCCCCEEEEEEEECCCCceeEEEEEEecccccccHHHHHHHHHHHHHHhcccChhhhhhceeEEeeehheecC
Confidence 4457899999999999999999999999999976432 235655555554 599988865 555543
Q ss_pred -----------------CeEEEEEEccCCCCHHHHHHhcCCCCCCHHHH------HHHHHHHHHHHHHHHhcCceeccCC
Q psy11767 444 -----------------VHTYLVLELLKGGELLDRIRQKGRCGFTENEA------SRIMRQLVAAVHFMHSRGVVHRDLK 500 (966)
Q Consensus 444 -----------------~~~~lVmEy~~gg~L~~~l~~~~~~~l~e~~~------~~i~~Qil~aL~yLHs~~IiHRDLK 500 (966)
...|||||||+ |+|.+++...+. .+++... ..++.||+.||+|||++||+|||||
T Consensus 144 ~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~-~~~~~~~~~~~vk~~i~~qi~~aL~~LH~~~ivHrDik 221 (371)
T 3q60_A 144 SQPPFAQLSPGQDDYAVANYLLLMPAAS-VDLELLFSTLDF-VYVFRGDEGILALHILTAQLIRLAANLQSKGLVHGHFT 221 (371)
T ss_dssp TSCSSSBCSCC---CCEEEEEEEECCCS-EEHHHHHHHHHH-SCCCCHHHHHHHHHHHHHHHHHHHHHHHHTTEEETTCS
T ss_pred CCCCeeeccCCcccceeeeEEEEecCCC-CCHHHHHHHhcc-ccchhhhhhhhhHHHHHHHHHHHHHHHHHCCCccCcCC
Confidence 33899999998 899999987532 3455555 5777999999999999999999999
Q ss_pred CCcEEEecCCCCCEEEEeecccccccCCCccccccccccCchhhccCCCCCCCcccchhhhhhhhhhhhcCCCCCCCcCc
Q psy11767 501 PENLLFSDPAGDNIKVVDFGFACLKRESLHTPCFTLQYAAPEVLRQDKSGYDENCDLWSLGVILVNVLRQDKSGYDENCD 580 (966)
Q Consensus 501 P~NILl~~~~~~~iKL~DFGla~~~~~~~~~~~gT~~Y~APEvl~~~~~~~~~~~Di~SlGvil~el~~~~~~~y~~~~D 580 (966)
|+|||++. ++.+||+|||+|+..........+|+.|+|||++... ...|+.++|
T Consensus 222 p~NIll~~--~~~~kL~DFG~a~~~~~~~~~~~~t~~y~aPE~~~~~------------------------~~~~~~~~D 275 (371)
T 3q60_A 222 PDNLFIMP--DGRLMLGDVSALWKVGTRGPASSVPVTYAPREFLNAS------------------------TATFTHALN 275 (371)
T ss_dssp GGGEEECT--TSCEEECCGGGEEETTCEEEGGGSCGGGCCHHHHTCS------------------------EEECCHHHH
T ss_pred HHHEEECC--CCCEEEEecceeeecCCCccCccCCcCCcChhhccCC------------------------CCCcCcccc
Confidence 99999985 5689999999998766544355677999999998521 134788999
Q ss_pred chhHHHHHHHHhcCCCCCCCCCCchhHH-HHHHHHHcCCCCCCchhhccCCHHHHHHHHHhcccCccccCChHHHHHHhh
Q psy11767 581 LWSLGVILYTMLCGRVPFHARSRDDSAL-SIMARIKEGQFNFDAEAWSTVSSEAKELTKSLLTVNPAQRIRMMRVKLTFH 659 (966)
Q Consensus 581 IWSlGvilyemltG~~Pf~~~~~~~~~~-~~~~~i~~~~~~~~~~~~~~is~e~~~Li~~~L~~dP~~R~t~~~v~~~~~ 659 (966)
||||||++|+|++|+.||.+........ ............+....+..+++++.+||.+||+.||++|||+.++ ..|
T Consensus 276 iwSlG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~--l~h 353 (371)
T 3q60_A 276 AWQLGLSIYRVWCLFLPFGLVTPGIKGSWKRPSLRVPGTDSLAFGSCTPLPDFVKTLIGRFLNFDRRRRLLPLEA--MET 353 (371)
T ss_dssp HHHHHHHHHHHHHSSCSTTBCCTTCTTCCCBCCTTSCCCCSCCCTTSSCCCHHHHHHHHHHTCSSTTTCCCHHHH--TTS
T ss_pred HHHHHHHHHHHHhCCCCCCCcCcccccchhhhhhhhccccccchhhccCCCHHHHHHHHHHcCCChhhCCCHHHH--hcC
Confidence 9999999999999999998764321100 0000011111222223345789999999999999999999999876 457
Q ss_pred hhHHhh
Q psy11767 660 AFHQAQ 665 (966)
Q Consensus 660 ~~~~~~ 665 (966)
+|+...
T Consensus 354 p~f~~~ 359 (371)
T 3q60_A 354 PEFLQL 359 (371)
T ss_dssp HHHHHH
T ss_pred HHHHHH
Confidence 776543
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-39 Score=362.78 Aligned_cols=252 Identities=26% Similarity=0.378 Sum_probs=198.1
Q ss_pred cccccccccccEEEEEEEcCCCcEEEEEEecccc----ChHHHHHHHHHhcCCCCceEEEEEEEe------CCeEEEEEE
Q psy11767 382 KAGILGDGSYSVCRRCVEKSTGQEYAVKIISRKI----DCSEEINLLRACQGHPNIVNLHCVFQD------EVHTYLVLE 451 (966)
Q Consensus 382 ~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~----~~~~Ei~iL~~l~~HpnIV~l~~~~~~------~~~~~lVmE 451 (966)
..+.||+|+||.||+|.+..+|+.||||++.... ...+|+.+|+.+.+||||+++++++.. ....|+|||
T Consensus 28 ~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~~~~~lv~e 107 (326)
T 2x7f_A 28 LVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMDDQLWLVME 107 (326)
T ss_dssp EEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSSTTHHHHHHHHHHHHHCCSTTBCCEEEEEEECC--CCCCEEEEEEE
T ss_pred EEEEeccCCCEEEEEEEECCCCCeEEEEEEecCcccHHHHHHHHHHHHhccCCCCeeeeeeEEeeccCccccceEEEEEE
Confidence 3688999999999999999999999999986442 255799999998779999999999987 468999999
Q ss_pred ccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCcEEEecCCCCCEEEEeecccccccCC---
Q psy11767 452 LLKGGELLDRIRQKGRCGFTENEASRIMRQLVAAVHFMHSRGVVHRDLKPENLLFSDPAGDNIKVVDFGFACLKRES--- 528 (966)
Q Consensus 452 y~~gg~L~~~l~~~~~~~l~e~~~~~i~~Qil~aL~yLHs~~IiHRDLKP~NILl~~~~~~~iKL~DFGla~~~~~~--- 528 (966)
|+++|+|.+++.......+++..++.++.||+.||+|||++||+||||||+|||++. ++.+||+|||++......
T Consensus 108 ~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~NIl~~~--~~~~kl~Dfg~~~~~~~~~~~ 185 (326)
T 2x7f_A 108 FCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQHKVIHRDIKGQNVLLTE--NAEVKLVDFGVSAQLDRTVGR 185 (326)
T ss_dssp CCTTEEHHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEECT--TCCEEECCCTTTC--------
T ss_pred cCCCCcHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCcHHHEEEcC--CCCEEEeeCcCceecCcCccc
Confidence 999999999998754446999999999999999999999999999999999999974 568999999998764322
Q ss_pred CccccccccccCchhhccCCCCCCCcccchhhhhhhhhhhhcCCCCCCCcCcchhHHHHHHHHhcCCCCCCCCCCchhHH
Q psy11767 529 LHTPCFTLQYAAPEVLRQDKSGYDENCDLWSLGVILVNVLRQDKSGYDENCDLWSLGVILYTMLCGRVPFHARSRDDSAL 608 (966)
Q Consensus 529 ~~~~~gT~~Y~APEvl~~~~~~~~~~~Di~SlGvil~el~~~~~~~y~~~~DIWSlGvilyemltG~~Pf~~~~~~~~~~ 608 (966)
.....+|+.|+|||++.... .....|+.++|||||||++|+|++|..||.......
T Consensus 186 ~~~~~~~~~y~aPE~~~~~~---------------------~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~--- 241 (326)
T 2x7f_A 186 RNTFIGTPYWMAPEVIACDE---------------------NPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMR--- 241 (326)
T ss_dssp -----CCGGGCCHHHHC-----------------------------CCTTHHHHHHHHHHHHHHHSSCTTTTSCHHH---
T ss_pred cccccCCccccChhhhcccc---------------------ccCcCCCccchHHHHHHHHHHHHhCCCCCCCCcHHH---
Confidence 23457899999999985321 012347889999999999999999999997654322
Q ss_pred HHHHHHHcCCCCCCchhhccCCHHHHHHHHHhcccCccccCChHHHHHHhhhhHHh
Q psy11767 609 SIMARIKEGQFNFDAEAWSTVSSEAKELTKSLLTVNPAQRIRMMRVKLTFHAFHQA 664 (966)
Q Consensus 609 ~~~~~i~~~~~~~~~~~~~~is~e~~~Li~~~L~~dP~~R~t~~~v~~~~~~~~~~ 664 (966)
....+...... ......++.++.+||.+||..||.+|||+.++ ..|+|+..
T Consensus 242 -~~~~~~~~~~~--~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l--l~hp~~~~ 292 (326)
T 2x7f_A 242 -ALFLIPRNPAP--RLKSKKWSKKFQSFIESCLVKNHSQRPATEQL--MKHPFIRD 292 (326)
T ss_dssp -HHHHHHHSCCC--CCSCSCSCHHHHHHHHHHCCSSGGGSCCHHHH--HTSHHHHC
T ss_pred -HHHHhhcCccc--cCCccccCHHHHHHHHHHhccChhhCCCHHHH--hhChHHhh
Confidence 22333333221 11224578999999999999999999999976 45677653
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-39 Score=354.98 Aligned_cols=242 Identities=33% Similarity=0.558 Sum_probs=204.2
Q ss_pred cccccccccccEEEEEEEcCCCcEEEEEEeccc--------cChHHHHHHHHHhcCCCCceEEEEEEEeCCeEEEEEEcc
Q psy11767 382 KAGILGDGSYSVCRRCVEKSTGQEYAVKIISRK--------IDCSEEINLLRACQGHPNIVNLHCVFQDEVHTYLVLELL 453 (966)
Q Consensus 382 ~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~--------~~~~~Ei~iL~~l~~HpnIV~l~~~~~~~~~~~lVmEy~ 453 (966)
..+.||+|+||.||+|.+..+++.||||++... ....+|+.+++.+ +||||+++++++.++...|+||||+
T Consensus 18 ~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~ 96 (284)
T 2vgo_A 18 IGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHL-RHPNILRMYNYFHDRKRIYLMLEFA 96 (284)
T ss_dssp EEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTC-CCTTBCCEEEEEECSSEEEEEECCC
T ss_pred eeheecCCCCeEEEEEEEcCCCcEEEEEEEcccccchHHHHHHHHHHHHHHhcC-CCCCEeeEEEEEEcCCEEEEEEEeC
Confidence 368899999999999999999999999998542 1245799999988 5999999999999999999999999
Q ss_pred CCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCcEEEecCCCCCEEEEeecccccccC-CCccc
Q psy11767 454 KGGELLDRIRQKGRCGFTENEASRIMRQLVAAVHFMHSRGVVHRDLKPENLLFSDPAGDNIKVVDFGFACLKRE-SLHTP 532 (966)
Q Consensus 454 ~gg~L~~~l~~~~~~~l~e~~~~~i~~Qil~aL~yLHs~~IiHRDLKP~NILl~~~~~~~iKL~DFGla~~~~~-~~~~~ 532 (966)
++|+|.+++...+ .+++..++.++.||+.||+|||++||+||||||+|||++. ++.+||+|||++..... .....
T Consensus 97 ~~~~L~~~l~~~~--~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~--~~~~kl~Dfg~~~~~~~~~~~~~ 172 (284)
T 2vgo_A 97 PRGELYKELQKHG--RFDEQRSATFMEELADALHYCHERKVIHRDIKPENLLMGY--KGELKIADFGWSVHAPSLRRRTM 172 (284)
T ss_dssp TTEEHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHTTTEECCCCSGGGEEECT--TCCEEECCCTTCEECSSSCBCCC
T ss_pred CCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCceecCCCHHHEEEcC--CCCEEEecccccccCcccccccc
Confidence 9999999998765 5899999999999999999999999999999999999974 56899999999865443 23456
Q ss_pred cccccccCchhhccCCCCCCCcccchhhhhhhhhhhhcCCCCCCCcCcchhHHHHHHHHhcCCCCCCCCCCchhHHHHHH
Q psy11767 533 CFTLQYAAPEVLRQDKSGYDENCDLWSLGVILVNVLRQDKSGYDENCDLWSLGVILYTMLCGRVPFHARSRDDSALSIMA 612 (966)
Q Consensus 533 ~gT~~Y~APEvl~~~~~~~~~~~Di~SlGvil~el~~~~~~~y~~~~DIWSlGvilyemltG~~Pf~~~~~~~~~~~~~~ 612 (966)
++|+.|+|||++.. ..++.++|||||||++|+|++|..||...... ....
T Consensus 173 ~~~~~y~aPE~~~~--------------------------~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~----~~~~ 222 (284)
T 2vgo_A 173 CGTLDYLPPEMIEG--------------------------KTHDEKVDLWCAGVLCYEFLVGMPPFDSPSHT----ETHR 222 (284)
T ss_dssp CSCGGGCCHHHHTT--------------------------CCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHH----HHHH
T ss_pred cCCCCcCCHHHhcc--------------------------CCCCcccchhhHHHHHHHHHHCCCCCCCCCHh----HHHH
Confidence 78999999999852 23678899999999999999999999865432 3344
Q ss_pred HHHcCCCCCCchhhccCCHHHHHHHHHhcccCccccCChHHHHHHhhhhHHh
Q psy11767 613 RIKEGQFNFDAEAWSTVSSEAKELTKSLLTVNPAQRIRMMRVKLTFHAFHQA 664 (966)
Q Consensus 613 ~i~~~~~~~~~~~~~~is~e~~~Li~~~L~~dP~~R~t~~~v~~~~~~~~~~ 664 (966)
.+......++ ..++.++++||.+||..||.+|||+.++ ..|+|+..
T Consensus 223 ~~~~~~~~~~----~~~~~~~~~li~~~l~~~p~~Rps~~~l--l~h~~~~~ 268 (284)
T 2vgo_A 223 RIVNVDLKFP----PFLSDGSKDLISKLLRYHPPQRLPLKGV--MEHPWVKA 268 (284)
T ss_dssp HHHTTCCCCC----TTSCHHHHHHHHHHSCSSGGGSCCHHHH--HTCHHHHH
T ss_pred HHhccccCCC----CcCCHHHHHHHHHHhhcCHhhCCCHHHH--hhCHHHHh
Confidence 5555554433 3578999999999999999999999976 45677653
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-40 Score=377.56 Aligned_cols=253 Identities=25% Similarity=0.417 Sum_probs=194.7
Q ss_pred cccccccccccccEEEEEEEcCCCcEEEEEEeccc-cChHHHHHHHHHhcCCCCceEEEEEEEeCC------eEEEEEEc
Q psy11767 380 LDKAGILGDGSYSVCRRCVEKSTGQEYAVKIISRK-IDCSEEINLLRACQGHPNIVNLHCVFQDEV------HTYLVLEL 452 (966)
Q Consensus 380 ~~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~-~~~~~Ei~iL~~l~~HpnIV~l~~~~~~~~------~~~lVmEy 452 (966)
|...++||+|+||+||+|++..+++ ||+|++... ....+|+++|+.+ +|||||+++++|.... ..|+||||
T Consensus 42 Y~~~~~lG~G~~g~V~~a~~~~~~~-~aikk~~~~~~~~~~E~~il~~l-~h~niv~l~~~~~~~~~~~~~~~~~lv~e~ 119 (394)
T 4e7w_A 42 YTNCKVIGNGSFGVVFQAKLVESDE-VAIKKVLQDKRFKNRELQIMRIV-KHPNVVDLKAFFYSNGDKKDEVFLNLVLEY 119 (394)
T ss_dssp EEEEEEEEEETTEEEEEEEETTTEE-EEEEEEECCTTSCCHHHHHHHTC-CCTTBCCEEEEEEEESSSSSCEEEEEEEEC
T ss_pred EEEeEEEeeCCCeEEEEEEECCCCe-EEEEEEecCcchHHHHHHHHHhC-CCCCcceEEEEEEecCCCCCceEEEEEeec
Confidence 3447899999999999999988776 777766543 3455799999998 5999999999996543 38899999
Q ss_pred cCCCCHHHHHHh--cCCCCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCcEEEecCCCCCEEEEeeccccccc--CC
Q psy11767 453 LKGGELLDRIRQ--KGRCGFTENEASRIMRQLVAAVHFMHSRGVVHRDLKPENLLFSDPAGDNIKVVDFGFACLKR--ES 528 (966)
Q Consensus 453 ~~gg~L~~~l~~--~~~~~l~e~~~~~i~~Qil~aL~yLHs~~IiHRDLKP~NILl~~~~~~~iKL~DFGla~~~~--~~ 528 (966)
|+++ +.+.+.. .....+++..++.++.||+.||+|||++||+||||||+|||++. .++.+||+|||+|+... ..
T Consensus 120 ~~~~-l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~Nill~~-~~~~~kL~DFG~a~~~~~~~~ 197 (394)
T 4e7w_A 120 VPET-VYRASRHYAKLKQTMPMLLIKLYMYQLLRSLAYIHSIGICHRDIKPQNLLLDP-PSGVLKLIDFGSAKILIAGEP 197 (394)
T ss_dssp CSEE-HHHHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEET-TTTEEEECCCTTCEECCTTCC
T ss_pred cCcc-HHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCccCCCCCHHHEEEcC-CCCcEEEeeCCCcccccCCCC
Confidence 9764 4444432 12336999999999999999999999999999999999999973 35689999999997643 23
Q ss_pred CccccccccccCchhhccCCCCCCCcccchhhhhhhhhhhhcCCCCCCCcCcchhHHHHHHHHhcCCCCCCCCCCchhHH
Q psy11767 529 LHTPCFTLQYAAPEVLRQDKSGYDENCDLWSLGVILVNVLRQDKSGYDENCDLWSLGVILYTMLCGRVPFHARSRDDSAL 608 (966)
Q Consensus 529 ~~~~~gT~~Y~APEvl~~~~~~~~~~~Di~SlGvil~el~~~~~~~y~~~~DIWSlGvilyemltG~~Pf~~~~~~~~~~ 608 (966)
....++|+.|+|||++.. ...|+.++|||||||++|+|++|++||.+.+..+...
T Consensus 198 ~~~~~~t~~y~aPE~~~~-------------------------~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~l~ 252 (394)
T 4e7w_A 198 NVSYICSRYYRAPELIFG-------------------------ATNYTTNIDIWSTGCVMAELMQGQPLFPGESGIDQLV 252 (394)
T ss_dssp CCSSCSCGGGCCHHHHTT-------------------------CSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHH
T ss_pred CcccccCcCccCHHHHcC-------------------------CCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHH
Confidence 345678999999999852 2347889999999999999999999999876554433
Q ss_pred HHHHHHHcC--------C-----CCCC--------chhhccCCHHHHHHHHHhcccCccccCChHHHHHHhhhhHH
Q psy11767 609 SIMARIKEG--------Q-----FNFD--------AEAWSTVSSEAKELTKSLLTVNPAQRIRMMRVKLTFHAFHQ 663 (966)
Q Consensus 609 ~~~~~i~~~--------~-----~~~~--------~~~~~~is~e~~~Li~~~L~~dP~~R~t~~~v~~~~~~~~~ 663 (966)
.++..+... . ..++ ......+++++.+||.+||+.||.+|||+.++ ..|+|++
T Consensus 253 ~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~--l~hp~f~ 326 (394)
T 4e7w_A 253 EIIKVLGTPSREQIKTMNPNYMEHKFPQIRPHPFSKVFRPRTPPDAIDLISRLLEYTPSARLTAIEA--LCHPFFD 326 (394)
T ss_dssp HHHHHHCCCCHHHHHHHCGGGSSSCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSGGGSCCHHHH--HTSGGGS
T ss_pred HHHHHhCCCCHHHHHhhChhhhhhccccccCCcHHHhccccCCHHHHHHHHHHhCCChhhCCCHHHH--hcChhhh
Confidence 333321100 0 0000 01123488999999999999999999999876 4677764
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-39 Score=355.65 Aligned_cols=253 Identities=21% Similarity=0.285 Sum_probs=198.7
Q ss_pred ccccccccccccEEEEEEEcCCCcEEEEEEecccc---ChHHHHHHHHHhcCCCCceEEEEEEEeCCeEEEEEEccCCCC
Q psy11767 381 DKAGILGDGSYSVCRRCVEKSTGQEYAVKIISRKI---DCSEEINLLRACQGHPNIVNLHCVFQDEVHTYLVLELLKGGE 457 (966)
Q Consensus 381 ~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~---~~~~Ei~iL~~l~~HpnIV~l~~~~~~~~~~~lVmEy~~gg~ 457 (966)
+..+.||+|+||.||+|++..+|+.||||++.... ...+|+.+++.+.+|++|..+..++.+....|+||||+ +++
T Consensus 12 ~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~e~~-~~~ 90 (296)
T 3uzp_A 12 RLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMELL-GPS 90 (296)
T ss_dssp EEEEEEEEETTEEEEEEEETTTTEEEEEEEEESCSSCCHHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEEEEECC-CCB
T ss_pred EEEEEEccCCCeEEEEEEEcCCCcEEEEEEecCCcchhHHHHHHHHHHHhhcCCCCCccccccCCCCceEEEEEec-CCC
Confidence 33688999999999999999999999999986543 35679999999975555666666667888999999999 999
Q ss_pred HHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCcEEEec-CCCCCEEEEeecccccccCC--------
Q psy11767 458 LLDRIRQKGRCGFTENEASRIMRQLVAAVHFMHSRGVVHRDLKPENLLFSD-PAGDNIKVVDFGFACLKRES-------- 528 (966)
Q Consensus 458 L~~~l~~~~~~~l~e~~~~~i~~Qil~aL~yLHs~~IiHRDLKP~NILl~~-~~~~~iKL~DFGla~~~~~~-------- 528 (966)
|.+++..... .+++.+++.++.||+.||+|||++||+||||||+|||++. ..++.+||+|||++......
T Consensus 91 L~~~~~~~~~-~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~ 169 (296)
T 3uzp_A 91 LEDLFNFCSR-KFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPY 169 (296)
T ss_dssp HHHHHHHTTT-CCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECCGGGTTCEEECCCTTCEECBCTTTCCBCCC
T ss_pred HHHHHHhhcc-CCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHeEEecCCCCCeEEEeeCCCccccccccccccccc
Confidence 9999975443 6999999999999999999999999999999999999941 12568999999999764432
Q ss_pred --CccccccccccCchhhccCCCCCCCcccchhhhhhhhhhhhcCCCCCCCcCcchhHHHHHHHHhcCCCCCCCCCCchh
Q psy11767 529 --LHTPCFTLQYAAPEVLRQDKSGYDENCDLWSLGVILVNVLRQDKSGYDENCDLWSLGVILYTMLCGRVPFHARSRDDS 606 (966)
Q Consensus 529 --~~~~~gT~~Y~APEvl~~~~~~~~~~~Di~SlGvil~el~~~~~~~y~~~~DIWSlGvilyemltG~~Pf~~~~~~~~ 606 (966)
.....||+.|+|||++.. ..|+.++|||||||++|+|++|+.||.+......
T Consensus 170 ~~~~~~~gt~~y~aPE~~~~--------------------------~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~ 223 (296)
T 3uzp_A 170 RENKNLTGTARYASINTHLG--------------------------IEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATK 223 (296)
T ss_dssp CCSCCCCSCTTTCCHHHHTT--------------------------CCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSS
T ss_pred ccccccccccccCChhhhcC--------------------------CCCCcchhhHHHHHHHHHHHhCCCCCCCcCchhh
Confidence 234578999999999853 2367899999999999999999999987543211
Q ss_pred HHHHHHHHHcCCCCCC-chhhccCCHHHHHHHHHhcccCccccCChHHHHHHhhhhH
Q psy11767 607 ALSIMARIKEGQFNFD-AEAWSTVSSEAKELTKSLLTVNPAQRIRMMRVKLTFHAFH 662 (966)
Q Consensus 607 ~~~~~~~i~~~~~~~~-~~~~~~is~e~~~Li~~~L~~dP~~R~t~~~v~~~~~~~~ 662 (966)
. ..+..+..+....+ ......+++++.+||.+||+.||++|||+.++...+....
T Consensus 224 ~-~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~~ 279 (296)
T 3uzp_A 224 R-QKYERISEKKMSTPIEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLF 279 (296)
T ss_dssp S-SHHHHHHHHHHHSCHHHHTTTSCHHHHHHHHHHHTSCTTCCCCHHHHHHHHHHHH
T ss_pred h-hhhhhhcccccCCchHHHHhhCCHHHHHHHHHHHhcCcCcCCCHHHHHHHHHHHH
Confidence 0 11222222222222 1223468899999999999999999999999866655443
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-39 Score=370.26 Aligned_cols=244 Identities=20% Similarity=0.364 Sum_probs=201.5
Q ss_pred cccccccccccEEEEEEEcCC-------CcEEEEEEeccccC------hHHHHHHHHHhcCCCCceEEEEEEEeCCeEEE
Q psy11767 382 KAGILGDGSYSVCRRCVEKST-------GQEYAVKIISRKID------CSEEINLLRACQGHPNIVNLHCVFQDEVHTYL 448 (966)
Q Consensus 382 ~~~~LG~G~fG~Vy~a~~~~t-------g~~vAvK~i~~~~~------~~~Ei~iL~~l~~HpnIV~l~~~~~~~~~~~l 448 (966)
..+.||+|+||.||+|.+..+ +..||||++..... ..+|+++|+.+.+|||||++++++.++...|+
T Consensus 73 i~~~LG~G~~g~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~~~~~l 152 (382)
T 3tt0_A 73 LGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQDGPLYV 152 (382)
T ss_dssp EEEEEEECSSEEEEEEEEETSSTTCTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEE
T ss_pred eeeEEecCCCeEEEEEEEccccccccccceEEEEEeeccccCHHHHHHHHHHHHHHHHhcCCchhhhheeeeccCCceEE
Confidence 368899999999999997643 36899999975432 44799999999779999999999999999999
Q ss_pred EEEccCCCCHHHHHHhcCC--------------CCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCcEEEecCCCCCE
Q psy11767 449 VLELLKGGELLDRIRQKGR--------------CGFTENEASRIMRQLVAAVHFMHSRGVVHRDLKPENLLFSDPAGDNI 514 (966)
Q Consensus 449 VmEy~~gg~L~~~l~~~~~--------------~~l~e~~~~~i~~Qil~aL~yLHs~~IiHRDLKP~NILl~~~~~~~i 514 (966)
||||+++|+|.+++..... ..+++.+++.++.||+.||+|||++||+||||||+|||++. ++.+
T Consensus 153 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~--~~~~ 230 (382)
T 3tt0_A 153 IVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTE--DNVM 230 (382)
T ss_dssp EEECCTTCBHHHHHHHTCCSSSSSCCCCCSSCCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECT--TCCE
T ss_pred EEEecCCCcHHHHHHHhcccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCCEecCCCCcceEEEcC--CCcE
Confidence 9999999999999987542 35999999999999999999999999999999999999975 5689
Q ss_pred EEEeecccccccC-----CCccccccccccCchhhccCCCCCCCcccchhhhhhhhhhhhcCCCCCCCcCcchhHHHHHH
Q psy11767 515 KVVDFGFACLKRE-----SLHTPCFTLQYAAPEVLRQDKSGYDENCDLWSLGVILVNVLRQDKSGYDENCDLWSLGVILY 589 (966)
Q Consensus 515 KL~DFGla~~~~~-----~~~~~~gT~~Y~APEvl~~~~~~~~~~~Di~SlGvil~el~~~~~~~y~~~~DIWSlGvily 589 (966)
||+|||+|+.... ......+|+.|+|||++.. ..|+.++|||||||++|
T Consensus 231 kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~--------------------------~~~~~~~DiwslG~il~ 284 (382)
T 3tt0_A 231 KIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFD--------------------------RIYTHQSDVWSFGVLLW 284 (382)
T ss_dssp EECSCSCCCCSSCCCTTCCCTTCCCGGGGSCHHHHHS--------------------------CCCCHHHHHHHHHHHHH
T ss_pred EEcccCcccccccccccccccCCCCCcceeCHHHhcC--------------------------CCCCchhHHHHHHHHHH
Confidence 9999999976532 1233456889999999853 23788999999999999
Q ss_pred HHhc-CCCCCCCCCCchhHHHHHHHHHcCCCCCCchhhccCCHHHHHHHHHhcccCccccCChHHHHHHhhh
Q psy11767 590 TMLC-GRVPFHARSRDDSALSIMARIKEGQFNFDAEAWSTVSSEAKELTKSLLTVNPAQRIRMMRVKLTFHA 660 (966)
Q Consensus 590 emlt-G~~Pf~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~is~e~~~Li~~~L~~dP~~R~t~~~v~~~~~~ 660 (966)
+|++ |..||.+.... .+...+..+.... ....+++++.+||.+||+.||++|||+.++...+..
T Consensus 285 ellt~g~~p~~~~~~~----~~~~~~~~~~~~~---~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~ 349 (382)
T 3tt0_A 285 EIFTLGGSPYPGVPVE----ELFKLLKEGHRMD---KPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDR 349 (382)
T ss_dssp HHHTTSCCSSTTCCHH----HHHHHHHTTCCCC---CCSSCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred HHHhCCCCCCCCCCHH----HHHHHHHcCCCCC---CCccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHH
Confidence 9999 99999876532 3445555543221 224689999999999999999999999988655443
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} SCOP: d.144.1.7 PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-39 Score=355.18 Aligned_cols=246 Identities=24% Similarity=0.399 Sum_probs=204.6
Q ss_pred ccccccccccccEEEEEEEcCCCcEEEEEEeccccC----hHHHHHHHHHhcCCCCceEEEEEEEeCCeEEEEEEccCCC
Q psy11767 381 DKAGILGDGSYSVCRRCVEKSTGQEYAVKIISRKID----CSEEINLLRACQGHPNIVNLHCVFQDEVHTYLVLELLKGG 456 (966)
Q Consensus 381 ~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~~----~~~Ei~iL~~l~~HpnIV~l~~~~~~~~~~~lVmEy~~gg 456 (966)
+..+.||+|+||.||+|.+..+++.||||++..... ..+|+.+|+.+ +||||+++++++.++...|+||||++|+
T Consensus 16 ~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~~~~~~~v~e~~~~~ 94 (288)
T 3kfa_A 16 TMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEI-KHPNLVQLLGVCTREPPFYIITEFMTYG 94 (288)
T ss_dssp EEEEESGGGTTCSEEEEEEGGGTEEEEEEEECSCSTHHHHHHHHHHHHHHC-CCTTBCCEEEEECSSSSEEEEEECCTTE
T ss_pred eEEeecCCCCceeEEEeEecCCCEEEEEEecCcCHHHHHHHHHHHHHHHhC-CCCCEeeEEEEEccCCCEEEEEEcCCCC
Confidence 346789999999999999999999999999976533 45799999998 4999999999999999999999999999
Q ss_pred CHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCcEEEecCCCCCEEEEeecccccccCCC----ccc
Q psy11767 457 ELLDRIRQKGRCGFTENEASRIMRQLVAAVHFMHSRGVVHRDLKPENLLFSDPAGDNIKVVDFGFACLKRESL----HTP 532 (966)
Q Consensus 457 ~L~~~l~~~~~~~l~e~~~~~i~~Qil~aL~yLHs~~IiHRDLKP~NILl~~~~~~~iKL~DFGla~~~~~~~----~~~ 532 (966)
+|.+++.......+++..++.++.||+.||+|||++||+||||||+|||++. ++.+||+|||++....... ...
T Consensus 95 ~L~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dikp~Nil~~~--~~~~~l~Dfg~~~~~~~~~~~~~~~~ 172 (288)
T 3kfa_A 95 NLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGE--NHLVKVADFGLSRLMTGDTYTAHAGA 172 (288)
T ss_dssp EHHHHHHHCCTTTSCHHHHHHHHHHHHHHHHHHHHHTCCCSCCSGGGEEECG--GGCEEECCCCGGGTSCSSSSEEETTE
T ss_pred cHHHHHHhcccCCccHhHHHHHHHHHHHHHHHHHHCCccCCCCCcceEEEcC--CCCEEEccCccceeccCCccccccCC
Confidence 9999998866667999999999999999999999999999999999999975 5689999999997654322 223
Q ss_pred cccccccCchhhccCCCCCCCcccchhhhhhhhhhhhcCCCCCCCcCcchhHHHHHHHHhc-CCCCCCCCCCchhHHHHH
Q psy11767 533 CFTLQYAAPEVLRQDKSGYDENCDLWSLGVILVNVLRQDKSGYDENCDLWSLGVILYTMLC-GRVPFHARSRDDSALSIM 611 (966)
Q Consensus 533 ~gT~~Y~APEvl~~~~~~~~~~~Di~SlGvil~el~~~~~~~y~~~~DIWSlGvilyemlt-G~~Pf~~~~~~~~~~~~~ 611 (966)
.+|+.|+|||++... .|+.++|||||||++|+|++ |..||...+... ..
T Consensus 173 ~~~~~y~aPE~~~~~--------------------------~~~~~~Di~slG~il~~ll~~g~~p~~~~~~~~----~~ 222 (288)
T 3kfa_A 173 KFPIKWTAPESLAYN--------------------------KFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQ----VY 222 (288)
T ss_dssp EECGGGCCHHHHHHC--------------------------CCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGG----HH
T ss_pred ccccCcCChhhhccC--------------------------CCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHH----HH
Confidence 467889999998532 36788999999999999999 999998765443 22
Q ss_pred HHHHcCCCCCCchhhccCCHHHHHHHHHhcccCccccCChHHHHHHhhhhH
Q psy11767 612 ARIKEGQFNFDAEAWSTVSSEAKELTKSLLTVNPAQRIRMMRVKLTFHAFH 662 (966)
Q Consensus 612 ~~i~~~~~~~~~~~~~~is~e~~~Li~~~L~~dP~~R~t~~~v~~~~~~~~ 662 (966)
..+..... ......+++++.+||.+||..||.+|||+.++...+..+.
T Consensus 223 ~~~~~~~~---~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~~~~~l~~~~ 270 (288)
T 3kfa_A 223 ELLEKDYR---MERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMF 270 (288)
T ss_dssp HHHHTTCC---CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred HHHhccCC---CCCCCCCCHHHHHHHHHHhCCChhhCcCHHHHHHHHHHHH
Confidence 33333211 1223468899999999999999999999999866555443
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 4gsb_A* 4gt3_A* 4gva_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3zu7_A 3zuv_A* 3o71_A 3r63_A 3c9w_A* 2y9q_A* 4fmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-39 Score=369.62 Aligned_cols=249 Identities=26% Similarity=0.449 Sum_probs=200.0
Q ss_pred ccccccccccccEEEEEEEcCCCcEEEEEEeccccC------hHHHHHHHHHhcCCCCceEEEEEEEeC-----CeEEEE
Q psy11767 381 DKAGILGDGSYSVCRRCVEKSTGQEYAVKIISRKID------CSEEINLLRACQGHPNIVNLHCVFQDE-----VHTYLV 449 (966)
Q Consensus 381 ~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~~------~~~Ei~iL~~l~~HpnIV~l~~~~~~~-----~~~~lV 449 (966)
+..+.||+|+||.||+|.+..+++.||||++..... ..+|+++|+.+ +||||+++++++... ...|+|
T Consensus 30 ~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~~~~~~iv 108 (364)
T 3qyz_A 30 TNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRF-RHENIIGINDIIRAPTIEQMKDVYIV 108 (364)
T ss_dssp EEEEEEEECSSEEEEEEEETTTTEEEEEEEECCTTCHHHHHHHHHHHHHHHHC-CCTTBCCCCEEECCSSTTTCCCEEEE
T ss_pred EEEEEeecCCCeEEEEEEECCCCeEEEEEEeccccCcHHHHHHHHHHHHHHhc-CCCCCccceeEEecCCccccceEEEE
Confidence 337899999999999999999999999999964322 34799999998 599999999999765 368999
Q ss_pred EEccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCcEEEecCCCCCEEEEeecccccccCC-
Q psy11767 450 LELLKGGELLDRIRQKGRCGFTENEASRIMRQLVAAVHFMHSRGVVHRDLKPENLLFSDPAGDNIKVVDFGFACLKRES- 528 (966)
Q Consensus 450 mEy~~gg~L~~~l~~~~~~~l~e~~~~~i~~Qil~aL~yLHs~~IiHRDLKP~NILl~~~~~~~iKL~DFGla~~~~~~- 528 (966)
|||+. |+|.+++... .+++.+++.++.||+.||+|||++||+||||||+|||++. ++.+||+|||++......
T Consensus 109 ~e~~~-~~L~~~l~~~---~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~--~~~~kl~Dfg~a~~~~~~~ 182 (364)
T 3qyz_A 109 QDLME-TDLYKLLKTQ---HLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNT--TCDLKICDFGLARVADPDH 182 (364)
T ss_dssp EECCS-EEHHHHHHHC---CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECT--TCCEEECCCTTCEECCGGG
T ss_pred EcccC-cCHHHHHHhC---CCCHHHHHHHHHHHHHHHHHHHHCCeecCCCChHhEEECC--CCCEEEEeCcceEecCCCC
Confidence 99996 6999998764 4999999999999999999999999999999999999975 568999999999765422
Q ss_pred -----CccccccccccCchhhccCCCCCCCcccchhhhhhhhhhhhcCCCCCCCcCcchhHHHHHHHHhcCCCCCCCCCC
Q psy11767 529 -----LHTPCFTLQYAAPEVLRQDKSGYDENCDLWSLGVILVNVLRQDKSGYDENCDLWSLGVILYTMLCGRVPFHARSR 603 (966)
Q Consensus 529 -----~~~~~gT~~Y~APEvl~~~~~~~~~~~Di~SlGvil~el~~~~~~~y~~~~DIWSlGvilyemltG~~Pf~~~~~ 603 (966)
....+||+.|+|||++.. ...|+.++|||||||++|+|++|++||.+.+.
T Consensus 183 ~~~~~~~~~~gt~~y~aPE~~~~-------------------------~~~~~~~~DiwslG~il~ell~g~~pf~~~~~ 237 (364)
T 3qyz_A 183 DHTGFLTEYVATRWYRAPEIMLN-------------------------SKGYTKSIDIWSVGCILAEMLSNRPIFPGKHY 237 (364)
T ss_dssp CBCCTTCCCCSCGGGCCHHHHHT-------------------------BCSCSTHHHHHHHHHHHHHHHHSSCSSCCSSG
T ss_pred CccccccccccccCCCCCHHhcC-------------------------CCCCCcchhHHHHHHHHHHHHHCCCCCCCCCh
Confidence 234578999999998752 23478899999999999999999999988766
Q ss_pred chhHHHHHHHHHcCC-----------------------CCCCchhhccCCHHHHHHHHHhcccCccccCChHHHHHHhhh
Q psy11767 604 DDSALSIMARIKEGQ-----------------------FNFDAEAWSTVSSEAKELTKSLLTVNPAQRIRMMRVKLTFHA 660 (966)
Q Consensus 604 ~~~~~~~~~~i~~~~-----------------------~~~~~~~~~~is~e~~~Li~~~L~~dP~~R~t~~~v~~~~~~ 660 (966)
.+....+...+.... .......++.+++++.+||.+||+.||++|||+.++ ..|+
T Consensus 238 ~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~--l~hp 315 (364)
T 3qyz_A 238 LDQLNHILGILGSPSQEDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQA--LAHP 315 (364)
T ss_dssp GGHHHHHHHHHCSCCHHHHHTCCCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHTCSSTTTSCCHHHH--HTSG
T ss_pred HHHHHHHHHHhCCCCHHHHHHhhhhhHHHHHHhcCCccCCCHHHhCCCCCHHHHHHHHHHcCCChhhCCCHHHH--hcCc
Confidence 554433332211100 000011234678999999999999999999999976 4577
Q ss_pred hHH
Q psy11767 661 FHQ 663 (966)
Q Consensus 661 ~~~ 663 (966)
|+.
T Consensus 316 ~~~ 318 (364)
T 3qyz_A 316 YLE 318 (364)
T ss_dssp GGT
T ss_pred chh
Confidence 754
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} SCOP: d.144.1.7 PDB: 3sxr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-39 Score=352.09 Aligned_cols=242 Identities=22% Similarity=0.416 Sum_probs=199.2
Q ss_pred ccccccccccccEEEEEEEcCCCcEEEEEEecccc----ChHHHHHHHHHhcCCCCceEEEEEEEeCCeEEEEEEccCCC
Q psy11767 381 DKAGILGDGSYSVCRRCVEKSTGQEYAVKIISRKI----DCSEEINLLRACQGHPNIVNLHCVFQDEVHTYLVLELLKGG 456 (966)
Q Consensus 381 ~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~----~~~~Ei~iL~~l~~HpnIV~l~~~~~~~~~~~lVmEy~~gg 456 (966)
+..+.||+|+||.||+|.+. ++..||||++.... ...+|+.+|+.+. ||||+++++++.++...|+||||++++
T Consensus 11 ~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~-h~~i~~~~~~~~~~~~~~lv~e~~~~~ 88 (268)
T 3sxs_A 11 TLLKELGSGQFGVVKLGKWK-GQYDVAVKMIKEGSMSEDEFFQEAQTMMKLS-HPKLVKFYGVCSKEYPIYIVTEYISNG 88 (268)
T ss_dssp EEEEEEEEETTEEEEEEEET-TTEEEEEEEECBTTBCHHHHHHHHHHHHHCC-CTTBCCEEEEECSSSSEEEEEECCTTC
T ss_pred eeeeeeccCCCceEEEEEec-CceeEEEEEeccCCCcHHHHHHHHHHHHhCC-CCCEeeEEEEEccCCceEEEEEccCCC
Confidence 34688999999999999876 57789999997543 2457999999984 999999999999999999999999999
Q ss_pred CHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCcEEEecCCCCCEEEEeecccccccCC----Cccc
Q psy11767 457 ELLDRIRQKGRCGFTENEASRIMRQLVAAVHFMHSRGVVHRDLKPENLLFSDPAGDNIKVVDFGFACLKRES----LHTP 532 (966)
Q Consensus 457 ~L~~~l~~~~~~~l~e~~~~~i~~Qil~aL~yLHs~~IiHRDLKP~NILl~~~~~~~iKL~DFGla~~~~~~----~~~~ 532 (966)
+|.+++...+. .+++.+++.++.||+.||+|||++||+||||||+|||++. ++.+||+|||++...... ....
T Consensus 89 ~L~~~l~~~~~-~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~Nil~~~--~~~~~l~Dfg~~~~~~~~~~~~~~~~ 165 (268)
T 3sxs_A 89 CLLNYLRSHGK-GLEPSQLLEMCYDVCEGMAFLESHQFIHRDLAARNCLVDR--DLCVKVSDFGMTRYVLDDQYVSSVGT 165 (268)
T ss_dssp BHHHHHHHHGG-GCCHHHHHHHHHHHHHHHHHHHHTTEEESSCSGGGEEECT--TCCEEECCTTCEEECCTTCEEECCSC
T ss_pred cHHHHHHHcCC-CCCHHHHHHHHHHHHHHHHHHHHCCeecCCcCcceEEECC--CCCEEEccCccceecchhhhhcccCC
Confidence 99999987643 5899999999999999999999999999999999999975 568999999999765432 1233
Q ss_pred cccccccCchhhccCCCCCCCcccchhhhhhhhhhhhcCCCCCCCcCcchhHHHHHHHHhc-CCCCCCCCCCchhHHHHH
Q psy11767 533 CFTLQYAAPEVLRQDKSGYDENCDLWSLGVILVNVLRQDKSGYDENCDLWSLGVILYTMLC-GRVPFHARSRDDSALSIM 611 (966)
Q Consensus 533 ~gT~~Y~APEvl~~~~~~~~~~~Di~SlGvil~el~~~~~~~y~~~~DIWSlGvilyemlt-G~~Pf~~~~~~~~~~~~~ 611 (966)
.+|+.|+|||++... .|+.++|||||||++|+|++ |+.||...... ...
T Consensus 166 ~~~~~y~aPE~~~~~--------------------------~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~----~~~ 215 (268)
T 3sxs_A 166 KFPVKWSAPEVFHYF--------------------------KYSSKSDVWAFGILMWEVFSLGKMPYDLYTNS----EVV 215 (268)
T ss_dssp CCCGGGCCHHHHHHS--------------------------EEETTHHHHHHHHHHHHHHTTTCCTTTTSCHH----HHH
T ss_pred CcCcccCCHHHHhcc--------------------------CCchhhhhHHHHHHHHHHHcCCCCCccccChH----HHH
Confidence 457789999998532 26778999999999999999 99999875533 234
Q ss_pred HHHHcCCCCCCchhhccCCHHHHHHHHHhcccCccccCChHHHHHHhhh
Q psy11767 612 ARIKEGQFNFDAEAWSTVSSEAKELTKSLLTVNPAQRIRMMRVKLTFHA 660 (966)
Q Consensus 612 ~~i~~~~~~~~~~~~~~is~e~~~Li~~~L~~dP~~R~t~~~v~~~~~~ 660 (966)
..+..+.....+ ...++++.++|.+||+.||++|||+.++...+..
T Consensus 216 ~~~~~~~~~~~~---~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~ 261 (268)
T 3sxs_A 216 LKVSQGHRLYRP---HLASDTIYQIMYSCWHELPEKRPTFQQLLSSIEP 261 (268)
T ss_dssp HHHHTTCCCCCC---TTSCHHHHHHHHHTTCSSGGGSCCHHHHHHHHGG
T ss_pred HHHHcCCCCCCC---CcChHHHHHHHHHHcCCChhhCcCHHHHHHHHHH
Confidence 445554433222 3468999999999999999999999988655543
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-39 Score=379.35 Aligned_cols=243 Identities=24% Similarity=0.442 Sum_probs=199.8
Q ss_pred ccccccccccccEEEEEEEcCCCcEEEEEEeccccC---hHHHHHHHHHhcCCCCceEEEEEEEeCC-eEEEEEEccCCC
Q psy11767 381 DKAGILGDGSYSVCRRCVEKSTGQEYAVKIISRKID---CSEEINLLRACQGHPNIVNLHCVFQDEV-HTYLVLELLKGG 456 (966)
Q Consensus 381 ~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~~---~~~Ei~iL~~l~~HpnIV~l~~~~~~~~-~~~lVmEy~~gg 456 (966)
+..+.||+|+||.||+|.+. |+.||||+++.... ..+|+.+|+.+ +|||||++++++.+.. ..|||||||++|
T Consensus 196 ~~~~~lG~G~fg~V~~~~~~--~~~vavK~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~~iv~e~~~~g 272 (450)
T 1k9a_A 196 KLLQTIGKGEFGDVMLGDYR--GNKVAVKCIKNDATAQAFLAEASVMTQL-RHSNLVQLLGVIVEEKGGLYIVTEYMAKG 272 (450)
T ss_dssp EEEEEEEECSSEEEEEEEET--TEEEEEEEESSCTTSHHHHHHHHHHHTC-CCTTBCCEEEEEECTTSCEEEEEECCTTC
T ss_pred EEEeeecCcCCeeEEEEEec--CCeEEEEEeCCchHHHHHHHHHHHHHhc-cCCCEEEEEEEEEcCCCceEEEEEecCCC
Confidence 34678999999999999875 78999999976533 46799999998 5999999999987665 799999999999
Q ss_pred CHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCcEEEecCCCCCEEEEeecccccccCCCccccccc
Q psy11767 457 ELLDRIRQKGRCGFTENEASRIMRQLVAAVHFMHSRGVVHRDLKPENLLFSDPAGDNIKVVDFGFACLKRESLHTPCFTL 536 (966)
Q Consensus 457 ~L~~~l~~~~~~~l~e~~~~~i~~Qil~aL~yLHs~~IiHRDLKP~NILl~~~~~~~iKL~DFGla~~~~~~~~~~~gT~ 536 (966)
+|.+++...+...+++..+..++.||+.||+|||++||+||||||+|||++. ++.+||+|||+++..........+|+
T Consensus 273 ~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~Nill~~--~~~~kl~DfG~a~~~~~~~~~~~~~~ 350 (450)
T 1k9a_A 273 SLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVSE--DNVAKVSDFGLTKEASSTQDTGKLPV 350 (450)
T ss_dssp BHHHHHHHHCTTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECT--TSCEEECCCTTCEECC------CCCT
T ss_pred cHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCHhhEEECC--CCCEEEeeCCCcccccccccCCCCCc
Confidence 9999998876556899999999999999999999999999999999999975 56999999999986554444456789
Q ss_pred cccCchhhccCCCCCCCcccchhhhhhhhhhhhcCCCCCCCcCcchhHHHHHHHHhc-CCCCCCCCCCchhHHHHHHHHH
Q psy11767 537 QYAAPEVLRQDKSGYDENCDLWSLGVILVNVLRQDKSGYDENCDLWSLGVILYTMLC-GRVPFHARSRDDSALSIMARIK 615 (966)
Q Consensus 537 ~Y~APEvl~~~~~~~~~~~Di~SlGvil~el~~~~~~~y~~~~DIWSlGvilyemlt-G~~Pf~~~~~~~~~~~~~~~i~ 615 (966)
.|+|||++.. ..|+.++|||||||++|||++ |+.||......+ +...+.
T Consensus 351 ~y~aPE~~~~--------------------------~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~~----~~~~i~ 400 (450)
T 1k9a_A 351 KWTAPEALRE--------------------------KKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKD----VVPRVE 400 (450)
T ss_dssp TTSCHHHHHS--------------------------SCCCHHHHHHHHHHHHHHHHTTTCCSSTTSCTTT----HHHHHH
T ss_pred ceeCHHHhcC--------------------------CCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHH----HHHHHH
Confidence 9999999853 237889999999999999998 999998766543 334455
Q ss_pred cCCCCCCchhhccCCHHHHHHHHHhcccCccccCChHHHHHHhhhh
Q psy11767 616 EGQFNFDAEAWSTVSSEAKELTKSLLTVNPAQRIRMMRVKLTFHAF 661 (966)
Q Consensus 616 ~~~~~~~~~~~~~is~e~~~Li~~~L~~dP~~R~t~~~v~~~~~~~ 661 (966)
.+... .....+++++.+||.+||..||++|||+.++...+..+
T Consensus 401 ~~~~~---~~p~~~~~~l~~li~~cl~~dp~~Rpt~~~l~~~L~~i 443 (450)
T 1k9a_A 401 KGYKM---DAPDGCPPAVYDVMKNCWHLDAATRPTFLQLREQLEHI 443 (450)
T ss_dssp TTCCC---CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred cCCCC---CCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHH
Confidence 54321 22346899999999999999999999999886555443
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=9.7e-40 Score=365.47 Aligned_cols=244 Identities=21% Similarity=0.346 Sum_probs=200.7
Q ss_pred ccccccccccccEEEEEEEc-----CCCcEEEEEEeccccC------hHHHHHHHHHhcCCCCceEEEEEEEeCCeEEEE
Q psy11767 381 DKAGILGDGSYSVCRRCVEK-----STGQEYAVKIISRKID------CSEEINLLRACQGHPNIVNLHCVFQDEVHTYLV 449 (966)
Q Consensus 381 ~~~~~LG~G~fG~Vy~a~~~-----~tg~~vAvK~i~~~~~------~~~Ei~iL~~l~~HpnIV~l~~~~~~~~~~~lV 449 (966)
+..+.||+|+||.||+|.+. .+++.||||++..... ..+|+.+|+.+ +||||+++++++.++...|+|
T Consensus 50 ~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~hp~iv~~~~~~~~~~~~~lv 128 (343)
T 1luf_A 50 EYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEF-DNPNIVKLLGVCAVGKPMCLL 128 (343)
T ss_dssp EEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTC-CCTTBCCEEEEECSSSSCEEE
T ss_pred eeeeeeeecCCeeEEEEEecCcCCCCCceeEEEEEeccccCHHHHHHHHHHHHHHHhC-CCCCEEEEEEEEccCCceEEE
Confidence 34688999999999999997 4568999999975432 45699999998 599999999999999999999
Q ss_pred EEccCCCCHHHHHHhcCC----------------------CCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCcEEEe
Q psy11767 450 LELLKGGELLDRIRQKGR----------------------CGFTENEASRIMRQLVAAVHFMHSRGVVHRDLKPENLLFS 507 (966)
Q Consensus 450 mEy~~gg~L~~~l~~~~~----------------------~~l~e~~~~~i~~Qil~aL~yLHs~~IiHRDLKP~NILl~ 507 (966)
|||+++|+|.+++..... ..+++.+++.++.||+.||+|||++||+||||||+|||++
T Consensus 129 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIl~~ 208 (343)
T 1luf_A 129 FEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERKFVHRDLATRNCLVG 208 (343)
T ss_dssp EECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEC
T ss_pred EecCCCCcHHHHHHHhCcccccccccccccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCcceEEEC
Confidence 999999999999987421 3699999999999999999999999999999999999997
Q ss_pred cCCCCCEEEEeecccccccC-----CCccccccccccCchhhccCCCCCCCcccchhhhhhhhhhhhcCCCCCCCcCcch
Q psy11767 508 DPAGDNIKVVDFGFACLKRE-----SLHTPCFTLQYAAPEVLRQDKSGYDENCDLWSLGVILVNVLRQDKSGYDENCDLW 582 (966)
Q Consensus 508 ~~~~~~iKL~DFGla~~~~~-----~~~~~~gT~~Y~APEvl~~~~~~~~~~~Di~SlGvil~el~~~~~~~y~~~~DIW 582 (966)
. ++.+||+|||+++.... ......+|+.|+|||++... .|+.++|||
T Consensus 209 ~--~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~--------------------------~~~~~~Di~ 260 (343)
T 1luf_A 209 E--NMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYN--------------------------RYTTESDVW 260 (343)
T ss_dssp G--GGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHC--------------------------CCCHHHHHH
T ss_pred C--CCeEEEeecCCCcccccCccccccCCCcccceecChhhhccC--------------------------CcCcccccH
Confidence 5 56899999999965432 12345678999999988532 368899999
Q ss_pred hHHHHHHHHhc-CCCCCCCCCCchhHHHHHHHHHcCCCCCCchhhccCCHHHHHHHHHhcccCccccCChHHHHHHhhh
Q psy11767 583 SLGVILYTMLC-GRVPFHARSRDDSALSIMARIKEGQFNFDAEAWSTVSSEAKELTKSLLTVNPAQRIRMMRVKLTFHA 660 (966)
Q Consensus 583 SlGvilyemlt-G~~Pf~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~is~e~~~Li~~~L~~dP~~R~t~~~v~~~~~~ 660 (966)
||||++|+|++ |..||.+.... .+...+..+..... ...+++++.+||.+||..||++|||+.++...+..
T Consensus 261 slG~il~el~t~g~~p~~~~~~~----~~~~~~~~~~~~~~---~~~~~~~l~~li~~~l~~~p~~Rps~~~~~~~L~~ 332 (343)
T 1luf_A 261 AYGVVLWEIFSYGLQPYYGMAHE----EVIYYVRDGNILAC---PENCPLELYNLMRLCWSKLPADRPSFCSIHRILQR 332 (343)
T ss_dssp HHHHHHHHHHTTTCCTTTTSCHH----HHHHHHHTTCCCCC---CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred HHHHHHHHHHhcCCCcCCCCChH----HHHHHHhCCCcCCC---CCCCCHHHHHHHHHHcccCcccCCCHHHHHHHHHH
Confidence 99999999999 99999875432 34455666554322 23578999999999999999999999988654443
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.5e-40 Score=356.27 Aligned_cols=242 Identities=35% Similarity=0.579 Sum_probs=182.0
Q ss_pred ccccccccccccEEEEEEEcCCCcEEEEEEecccc--------ChHHHHHHHHHhcCCCCceEEEEEEEeCCeEEEEEEc
Q psy11767 381 DKAGILGDGSYSVCRRCVEKSTGQEYAVKIISRKI--------DCSEEINLLRACQGHPNIVNLHCVFQDEVHTYLVLEL 452 (966)
Q Consensus 381 ~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~--------~~~~Ei~iL~~l~~HpnIV~l~~~~~~~~~~~lVmEy 452 (966)
+..+.||+|+||.||+|.+..+|+.||||++.... ...+|+.+++.+ +||||+++++++.+....|+||||
T Consensus 14 ~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~ 92 (278)
T 3cok_A 14 KVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQL-KHPSILELYNYFEDSNYVYLVLEM 92 (278)
T ss_dssp EEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTB-CCTTBCCEEEEEECSSEEEEEEEC
T ss_pred eeeeeecCCCceEEEEEEEccCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHhC-CCCCeEeEEEEEccCCeEEEEEec
Confidence 34688999999999999999999999999986431 245689999888 599999999999999999999999
Q ss_pred cCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCcEEEecCCCCCEEEEeecccccccC---CC
Q psy11767 453 LKGGELLDRIRQKGRCGFTENEASRIMRQLVAAVHFMHSRGVVHRDLKPENLLFSDPAGDNIKVVDFGFACLKRE---SL 529 (966)
Q Consensus 453 ~~gg~L~~~l~~~~~~~l~e~~~~~i~~Qil~aL~yLHs~~IiHRDLKP~NILl~~~~~~~iKL~DFGla~~~~~---~~ 529 (966)
+++++|.+++.... ..+++.+++.++.||+.||+|||++||+||||||+|||++. ++.+||+|||++..... ..
T Consensus 93 ~~~~~L~~~l~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nili~~--~~~~kl~dfg~~~~~~~~~~~~ 169 (278)
T 3cok_A 93 CHNGEMNRYLKNRV-KPFSENEARHFMHQIITGMLYLHSHGILHRDLTLSNLLLTR--NMNIKIADFGLATQLKMPHEKH 169 (278)
T ss_dssp CTTEEHHHHHHTCS-SCCCHHHHHHHHHHHHHHHHHHHHTTEECSSCCGGGEEECT--TCCEEECCCTTCEECC------
T ss_pred CCCCcHHHHHhhcc-CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcC--CCCEEEEeecceeeccCCCCcc
Confidence 99999999997653 36999999999999999999999999999999999999975 56899999999976432 22
Q ss_pred ccccccccccCchhhccCCCCCCCcccchhhhhhhhhhhhcCCCCCCCcCcchhHHHHHHHHhcCCCCCCCCCCchhHHH
Q psy11767 530 HTPCFTLQYAAPEVLRQDKSGYDENCDLWSLGVILVNVLRQDKSGYDENCDLWSLGVILYTMLCGRVPFHARSRDDSALS 609 (966)
Q Consensus 530 ~~~~gT~~Y~APEvl~~~~~~~~~~~Di~SlGvil~el~~~~~~~y~~~~DIWSlGvilyemltG~~Pf~~~~~~~~~~~ 609 (966)
...++|+.|+|||++.. ..++.++|||||||++|+|++|+.||......+
T Consensus 170 ~~~~~~~~y~aPE~~~~--------------------------~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~---- 219 (278)
T 3cok_A 170 YTLCGTPNYISPEIATR--------------------------SAHGLESDVWSLGCMFYTLLIGRPPFDTDTVKN---- 219 (278)
T ss_dssp ------------------------------------------------CTHHHHHHHHHHHHHHSSCSSCCCSCC-----
T ss_pred eeccCCCCcCCcchhcC--------------------------CCCCchhhHHHHHHHHHHHHhCCCCCCChhHHH----
Confidence 34578999999998852 235778999999999999999999998765432
Q ss_pred HHHHHHcCCCCCCchhhccCCHHHHHHHHHhcccCccccCChHHHHHHhhhhH
Q psy11767 610 IMARIKEGQFNFDAEAWSTVSSEAKELTKSLLTVNPAQRIRMMRVKLTFHAFH 662 (966)
Q Consensus 610 ~~~~i~~~~~~~~~~~~~~is~e~~~Li~~~L~~dP~~R~t~~~v~~~~~~~~ 662 (966)
.+..+....+. ....++.++.+||.+||..||++|||+.++ ..|+|+
T Consensus 220 ~~~~~~~~~~~----~~~~~~~~~~~li~~~l~~dp~~Rps~~~~--l~h~~~ 266 (278)
T 3cok_A 220 TLNKVVLADYE----MPSFLSIEAKDLIHQLLRRNPADRLSLSSV--LDHPFM 266 (278)
T ss_dssp ----CCSSCCC----CCTTSCHHHHHHHHHHSCSSGGGSCCHHHH--TTSTTT
T ss_pred HHHHHhhcccC----CccccCHHHHHHHHHHcccCHhhCCCHHHH--hcCccc
Confidence 12222222222 223578999999999999999999999876 345554
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-40 Score=370.32 Aligned_cols=254 Identities=17% Similarity=0.254 Sum_probs=200.6
Q ss_pred cccccccccccccEEEEEEEcCC--------CcEEEEEEeccccChHHHHHHHHHhcCCCCceE---------------E
Q psy11767 380 LDKAGILGDGSYSVCRRCVEKST--------GQEYAVKIISRKIDCSEEINLLRACQGHPNIVN---------------L 436 (966)
Q Consensus 380 ~~~~~~LG~G~fG~Vy~a~~~~t--------g~~vAvK~i~~~~~~~~Ei~iL~~l~~HpnIV~---------------l 436 (966)
|...+.||+|+||.||+|.+..+ ++.||||++.......+|+++|+.+. |||||+ +
T Consensus 44 y~~~~~lg~G~~g~Vy~~~~~~t~~~~~~~~~~~vavK~~~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~~~i~~~ 122 (352)
T 2jii_A 44 WKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKDGRLFNEQNFFQRAA-KPLQVNKWKKLYSTPLLAIPTC 122 (352)
T ss_dssp EEEEEEEEEETTEEEEEEEECC-----------CEEEEEEETTSTHHHHHHHHHHHC-CHHHHHHHHHHTTCTTCSCCCC
T ss_pred EEEEEEecCCCCeEEEEEeecCCccccccccCceEEEEEecccchHHHHHHHHHHhc-ccchhhhhhhhccCCccCccch
Confidence 34468899999999999999984 88999999988778889999999984 999887 6
Q ss_pred EEEEEe-CCeEEEEEEccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCcEEEecCCCCCEE
Q psy11767 437 HCVFQD-EVHTYLVLELLKGGELLDRIRQKGRCGFTENEASRIMRQLVAAVHFMHSRGVVHRDLKPENLLFSDPAGDNIK 515 (966)
Q Consensus 437 ~~~~~~-~~~~~lVmEy~~gg~L~~~l~~~~~~~l~e~~~~~i~~Qil~aL~yLHs~~IiHRDLKP~NILl~~~~~~~iK 515 (966)
++++.. +...|+||||+ +++|.+++.......+++.+++.++.||+.||+|||++||+||||||+|||++......+|
T Consensus 123 ~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dikp~NIl~~~~~~~~~k 201 (352)
T 2jii_A 123 MGFGVHQDKYRFLVLPSL-GRSLQSALDVSPKHVLSERSVLQVACRLLDALEFLHENEYVHGNVTAENIFVDPEDQSQVT 201 (352)
T ss_dssp CEEEEETTTEEEEEEECC-CEEHHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCCGGGEEEETTEEEEEE
T ss_pred hhccccCCcEEEEEecCC-CcCHHHHHHhCCcCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCCHHHEEEcCCCCceEE
Confidence 777776 77899999999 9999999987533469999999999999999999999999999999999999852222899
Q ss_pred EEeecccccccCC----------CccccccccccCchhhccCCCCCCCcccchhhhhhhhhhhhcCCCCCCCcCcchhHH
Q psy11767 516 VVDFGFACLKRES----------LHTPCFTLQYAAPEVLRQDKSGYDENCDLWSLGVILVNVLRQDKSGYDENCDLWSLG 585 (966)
Q Consensus 516 L~DFGla~~~~~~----------~~~~~gT~~Y~APEvl~~~~~~~~~~~Di~SlGvil~el~~~~~~~y~~~~DIWSlG 585 (966)
|+|||+++..... .....||+.|+|||++.. ..|+.++||||||
T Consensus 202 l~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--------------------------~~~~~~~Di~slG 255 (352)
T 2jii_A 202 LAGYGFAFRYCPSGKHVAYVEGSRSPHEGDLEFISMDLHKG--------------------------CGPSRRSDLQSLG 255 (352)
T ss_dssp ECCGGGCBCSSGGGCCCCCCTTSSCTTCSCTTTCCHHHHTT--------------------------CCCCHHHHHHHHH
T ss_pred EecCcceeeccCCCccccccccccccccCCccccCHHHHcc--------------------------CCCCchhhHHHHH
Confidence 9999999654321 123478999999998852 2378899999999
Q ss_pred HHHHHHhcCCCCCCCCCCc-hhHHHHHHHHHcCCCCC--CchhhccCCHHHHHHHHHhcccCccccCChHHHHHHhhhh
Q psy11767 586 VILYTMLCGRVPFHARSRD-DSALSIMARIKEGQFNF--DAEAWSTVSSEAKELTKSLLTVNPAQRIRMMRVKLTFHAF 661 (966)
Q Consensus 586 vilyemltG~~Pf~~~~~~-~~~~~~~~~i~~~~~~~--~~~~~~~is~e~~~Li~~~L~~dP~~R~t~~~v~~~~~~~ 661 (966)
|++|+|++|+.||...... +........+......+ ....|..+++++.+||.+||..||++|||+.++...+...
T Consensus 256 ~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~ 334 (352)
T 2jii_A 256 YCMLKWLYGFLPWTNCLPNTEDIMKQKQKFVDKPGPFVGPCGHWIRPSETLQKYLKVVMALTYEEKPPYAMLRNNLEAL 334 (352)
T ss_dssp HHHHHHHHSCCTTGGGTTCHHHHHHHHHHHHHSCCCEECTTSCEECCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHH
T ss_pred HHHHHHHhCCCCcccCCcCHHHHHHHHHhccCChhhhhhhccccCCCcHHHHHHHHHHHhCChhhCCCHHHHHHHHHHH
Confidence 9999999999999876522 22222222222222211 1123456799999999999999999999999886655443
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3v01_A* 3v04_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-39 Score=368.22 Aligned_cols=250 Identities=25% Similarity=0.432 Sum_probs=200.9
Q ss_pred ccccccccccccEEEEEEEcCCCcEEEEEEeccccC------hHHHHHHHHHhcCCCCceEEEEEEEeCCeEEEEEEccC
Q psy11767 381 DKAGILGDGSYSVCRRCVEKSTGQEYAVKIISRKID------CSEEINLLRACQGHPNIVNLHCVFQDEVHTYLVLELLK 454 (966)
Q Consensus 381 ~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~~------~~~Ei~iL~~l~~HpnIV~l~~~~~~~~~~~lVmEy~~ 454 (966)
+..+.||+|+||.||+|.+..+|+.||+|++..... ..+|+.+|+.+ +||||+++++++.++...|+||||++
T Consensus 36 ~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~e~~~ 114 (360)
T 3eqc_A 36 EKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHEC-NSPYIVGFYGAFYSDGEISICMEHMD 114 (360)
T ss_dssp EEEEEEEECSSCEEEEEEETTTCCEEEEEEEECCCCHHHHHHHHHHHGGGGGC-CCTTBCCEEEEEEETTEEEEEECCCT
T ss_pred eeeeeecCCCCeEEEEEEECCCCcEEEEEEeccccCHHHHHHHHHHHHHHHHC-CCCCEEEEeEEEEECCEEEEEEECCC
Confidence 346889999999999999999999999999975432 44688888888 59999999999999999999999999
Q ss_pred CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhc-CceeccCCCCcEEEecCCCCCEEEEeecccccccC-CCccc
Q psy11767 455 GGELLDRIRQKGRCGFTENEASRIMRQLVAAVHFMHSR-GVVHRDLKPENLLFSDPAGDNIKVVDFGFACLKRE-SLHTP 532 (966)
Q Consensus 455 gg~L~~~l~~~~~~~l~e~~~~~i~~Qil~aL~yLHs~-~IiHRDLKP~NILl~~~~~~~iKL~DFGla~~~~~-~~~~~ 532 (966)
||+|.+++...+ .+++..+..++.||+.||+|||++ ||+||||||+|||++. ++.+||+|||++..... .....
T Consensus 115 ~~~L~~~l~~~~--~~~~~~~~~i~~~i~~~l~~lh~~~~i~H~dlkp~Nil~~~--~~~~kl~Dfg~~~~~~~~~~~~~ 190 (360)
T 3eqc_A 115 GGSLDQVLKKAG--RIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNS--RGEIKLCDFGVSGQLIDSMANSF 190 (360)
T ss_dssp TCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHHHHCCCCSCCSGGGEEECT--TCCEEECCCCCCHHHHHHC----
T ss_pred CCCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHhCCEEcCCccHHHEEECC--CCCEEEEECCCCcccccccccCC
Confidence 999999998765 589999999999999999999996 9999999999999985 56899999999965432 23456
Q ss_pred cccccccCchhhccCCCCCCCcccchhhhhhhhhhhhcCCCCCCCcCcchhHHHHHHHHhcCCCCCCCCCCchhHH----
Q psy11767 533 CFTLQYAAPEVLRQDKSGYDENCDLWSLGVILVNVLRQDKSGYDENCDLWSLGVILYTMLCGRVPFHARSRDDSAL---- 608 (966)
Q Consensus 533 ~gT~~Y~APEvl~~~~~~~~~~~Di~SlGvil~el~~~~~~~y~~~~DIWSlGvilyemltG~~Pf~~~~~~~~~~---- 608 (966)
+||+.|+|||++.. ..|+.++|||||||++|+|++|+.||...+..+...
T Consensus 191 ~gt~~y~aPE~~~~--------------------------~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~ 244 (360)
T 3eqc_A 191 VGTRSYMSPERLQG--------------------------THYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGC 244 (360)
T ss_dssp CCCCTTCCHHHHTT--------------------------CCCSHHHHHHHHHHHHHHHHHTSCCSSCCCHHHHHHHHC-
T ss_pred CCCCCeECHHHHcC--------------------------CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhcc
Confidence 78999999999852 247889999999999999999999998755332111
Q ss_pred ----------------------------------HHHHHHHcCCCCCCchhhccCCHHHHHHHHHhcccCccccCChHHH
Q psy11767 609 ----------------------------------SIMARIKEGQFNFDAEAWSTVSSEAKELTKSLLTVNPAQRIRMMRV 654 (966)
Q Consensus 609 ----------------------------------~~~~~i~~~~~~~~~~~~~~is~e~~~Li~~~L~~dP~~R~t~~~v 654 (966)
..+..+..+.... .....++.++.+||.+||+.||++|||+.++
T Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~li~~~L~~dP~~Rpt~~el 322 (360)
T 3eqc_A 245 QVEGDAAETPPRPRTPGRPLNKFGMDSRPPMAIFELLDYIVNEPPPK--LPSGVFSLEFQDFVNKCLIKNPAERADLKQL 322 (360)
T ss_dssp -----------------------------CCCHHHHHHHHHHSCCCC--CCTTTSCHHHHHHHHHHHCSSTTTSCCHHHH
T ss_pred cccccCCCCCCCcccCCCcccccccCCCCcccchhhhhHHhccCCCC--CCcccccHHHHHHHHHHhhcChhhCCCHHHH
Confidence 1111122221111 1123478999999999999999999999976
Q ss_pred HHHhhhhHHhh
Q psy11767 655 KLTFHAFHQAQ 665 (966)
Q Consensus 655 ~~~~~~~~~~~ 665 (966)
..|+|++..
T Consensus 323 --l~hp~~~~~ 331 (360)
T 3eqc_A 323 --MVHAFIKRS 331 (360)
T ss_dssp --HTSHHHHHH
T ss_pred --hhChHhhcc
Confidence 467877543
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-39 Score=359.77 Aligned_cols=243 Identities=22% Similarity=0.369 Sum_probs=199.6
Q ss_pred cccccccccccEEEEEEEc-----CCCcEEEEEEeccccC------hHHHHHHHHHhcCCCCceEEEEEEEeCCeEEEEE
Q psy11767 382 KAGILGDGSYSVCRRCVEK-----STGQEYAVKIISRKID------CSEEINLLRACQGHPNIVNLHCVFQDEVHTYLVL 450 (966)
Q Consensus 382 ~~~~LG~G~fG~Vy~a~~~-----~tg~~vAvK~i~~~~~------~~~Ei~iL~~l~~HpnIV~l~~~~~~~~~~~lVm 450 (966)
..+.||+|+||.||+|.+. .+++.||||++..... ..+|+.+|+.+ +|||||++++++.++...|+||
T Consensus 27 ~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~hp~iv~~~~~~~~~~~~~lv~ 105 (314)
T 2ivs_A 27 LGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQV-NHPHVIKLYGACSQDGPLLLIV 105 (314)
T ss_dssp EEEEEEECSSSEEEEEEEETGGGCSSEEEEEEEECCTTCCHHHHHHHHHHHHHHTTC-CCTTBCCEEEEECSSSSCEEEE
T ss_pred eeeeecccCCeeEEEEEEeccCcccCcceEEEEeccCCCCHHHHHHHHHHHHHHhhC-CCCceeeEEEEEecCCceEEEE
Confidence 3678999999999999984 4568999999975432 34689999888 5999999999999999999999
Q ss_pred EccCCCCHHHHHHhcCC----------------------CCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCcEEEec
Q psy11767 451 ELLKGGELLDRIRQKGR----------------------CGFTENEASRIMRQLVAAVHFMHSRGVVHRDLKPENLLFSD 508 (966)
Q Consensus 451 Ey~~gg~L~~~l~~~~~----------------------~~l~e~~~~~i~~Qil~aL~yLHs~~IiHRDLKP~NILl~~ 508 (966)
||+++|+|.+++..... ..+++.+++.++.||+.||+|||++||+||||||+|||++.
T Consensus 106 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dikp~NIli~~ 185 (314)
T 2ivs_A 106 EYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAEMKLVHRDLAARNILVAE 185 (314)
T ss_dssp ECCTTCBHHHHHHHTTTSTTEEC----------------CEECHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEET
T ss_pred eecCCCCHHHHHHHHhhccCCcccccccccccccccccccCcCHHHHHHHHHHHHHHHHHHHHCCCcccccchheEEEcC
Confidence 99999999999987542 23899999999999999999999999999999999999985
Q ss_pred CCCCCEEEEeecccccccCC-----CccccccccccCchhhccCCCCCCCcccchhhhhhhhhhhhcCCCCCCCcCcchh
Q psy11767 509 PAGDNIKVVDFGFACLKRES-----LHTPCFTLQYAAPEVLRQDKSGYDENCDLWSLGVILVNVLRQDKSGYDENCDLWS 583 (966)
Q Consensus 509 ~~~~~iKL~DFGla~~~~~~-----~~~~~gT~~Y~APEvl~~~~~~~~~~~Di~SlGvil~el~~~~~~~y~~~~DIWS 583 (966)
++.+||+|||++...... .....+|+.|+|||++... .|+.++||||
T Consensus 186 --~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~--------------------------~~~~~~Di~s 237 (314)
T 2ivs_A 186 --GRKMKISDFGLSRDVYEEDSYVKRSQGRIPVKWMAIESLFDH--------------------------IYTTQSDVWS 237 (314)
T ss_dssp --TTEEEECCCTTCEECTTTSCEECSSCCCSCGGGCCHHHHHHC--------------------------EECHHHHHHH
T ss_pred --CCCEEEccccccccccccccceeccCCCCcccccChhhhcCC--------------------------CcCchhhHHH
Confidence 568999999999754321 2234568899999988532 3678899999
Q ss_pred HHHHHHHHhc-CCCCCCCCCCchhHHHHHHHHHcCCCCCCchhhccCCHHHHHHHHHhcccCccccCChHHHHHHhhh
Q psy11767 584 LGVILYTMLC-GRVPFHARSRDDSALSIMARIKEGQFNFDAEAWSTVSSEAKELTKSLLTVNPAQRIRMMRVKLTFHA 660 (966)
Q Consensus 584 lGvilyemlt-G~~Pf~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~is~e~~~Li~~~L~~dP~~R~t~~~v~~~~~~ 660 (966)
|||++|+|++ |..||.+..... +...+..+... .....+++++.+||.+||..||++|||+.++...+..
T Consensus 238 lG~il~el~t~g~~p~~~~~~~~----~~~~~~~~~~~---~~~~~~~~~~~~li~~~l~~dp~~Rps~~~l~~~l~~ 308 (314)
T 2ivs_A 238 FGVLLWEIVTLGGNPYPGIPPER----LFNLLKTGHRM---ERPDNCSEEMYRLMLQCWKQEPDKRPVFADISKDLEK 308 (314)
T ss_dssp HHHHHHHHHTTSCCSSTTCCGGG----HHHHHHTTCCC---CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred HHHHHHHHHhCCCCCCCCCCHHH----HHHHhhcCCcC---CCCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHH
Confidence 9999999999 999998766533 23444444322 2234689999999999999999999999988655543
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-39 Score=353.45 Aligned_cols=254 Identities=23% Similarity=0.364 Sum_probs=188.7
Q ss_pred cccccccccccccEEEEEEEcCCCcEEEEEEeccccChH------HHHHHHHHhcCCCCceEEEEEEEeCCeEEEEEEcc
Q psy11767 380 LDKAGILGDGSYSVCRRCVEKSTGQEYAVKIISRKIDCS------EEINLLRACQGHPNIVNLHCVFQDEVHTYLVLELL 453 (966)
Q Consensus 380 ~~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~~~~------~Ei~iL~~l~~HpnIV~l~~~~~~~~~~~lVmEy~ 453 (966)
|+..+.||+|+||+||+|.+..+|+.||||++....... .|+..+....+||||+++++++.++...|+||||+
T Consensus 9 y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~~~~~~~~lv~e~~ 88 (290)
T 3fme_A 9 LEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCPFTVTFYGALFREGDVWICMELM 88 (290)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTTEEEEEEEEC---CHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSSEEEEEECC
T ss_pred hhhHHhcCCCCCeEEEEEEecCCCeEEEEEEeecccCcHHHHHHHHHHHHHHHhCCCCeEEEEeeeeeccCCEEEEEehh
Confidence 344789999999999999999999999999997543322 23333333447999999999999999999999999
Q ss_pred CCCCHHHHHHhc--CCCCCCHHHHHHHHHHHHHHHHHHHhc-CceeccCCCCcEEEecCCCCCEEEEeecccccccCC--
Q psy11767 454 KGGELLDRIRQK--GRCGFTENEASRIMRQLVAAVHFMHSR-GVVHRDLKPENLLFSDPAGDNIKVVDFGFACLKRES-- 528 (966)
Q Consensus 454 ~gg~L~~~l~~~--~~~~l~e~~~~~i~~Qil~aL~yLHs~-~IiHRDLKP~NILl~~~~~~~iKL~DFGla~~~~~~-- 528 (966)
+ |+|.+++... ....+++..++.++.||+.||+|||++ ||+||||||+|||++. .+.+||+|||++......
T Consensus 89 ~-~~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~i~H~dlkp~Nil~~~--~~~~kl~Dfg~~~~~~~~~~ 165 (290)
T 3fme_A 89 D-TSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSKLSVIHRDVKPSNVLINA--LGQVKMCDFGISGYLVDDVA 165 (290)
T ss_dssp S-EEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHSCCCCCCCSGGGCEECT--TCCEEBCCC-----------
T ss_pred c-cchHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhcCCeecCCCCHHHEEECC--CCCEEEeecCCccccccccc
Confidence 6 5887777541 233699999999999999999999998 9999999999999975 569999999999765432
Q ss_pred CccccccccccCchhhccCCCCCCCcccchhhhhhhhhhhhcCCCCCCCcCcchhHHHHHHHHhcCCCCCCCCCCchhHH
Q psy11767 529 LHTPCFTLQYAAPEVLRQDKSGYDENCDLWSLGVILVNVLRQDKSGYDENCDLWSLGVILYTMLCGRVPFHARSRDDSAL 608 (966)
Q Consensus 529 ~~~~~gT~~Y~APEvl~~~~~~~~~~~Di~SlGvil~el~~~~~~~y~~~~DIWSlGvilyemltG~~Pf~~~~~~~~~~ 608 (966)
.....+|+.|+|||++.... ....|+.++|||||||++|+|++|+.||....... .
T Consensus 166 ~~~~~~t~~y~aPE~~~~~~----------------------~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~--~ 221 (290)
T 3fme_A 166 KDIDAGCKPYMAPERINPEL----------------------NQKGYSVKSDIWSLGITMIELAILRFPYDSWGTPF--Q 221 (290)
T ss_dssp ----CCCCCCSCHHHHSCCT----------------------TC--CCHHHHHHHHHHHHHHHHHTSCSSCCCSCHH--H
T ss_pred ccccCCCccccChhhcChhh----------------------cCcCCCcHHHHHHHHHHHHHHHHCCCCccccCchH--H
Confidence 23347899999999974211 12347889999999999999999999998644322 2
Q ss_pred HHHHHHHcCCCCCCchhhccCCHHHHHHHHHhcccCccccCChHHHHHHhhhhHHhh
Q psy11767 609 SIMARIKEGQFNFDAEAWSTVSSEAKELTKSLLTVNPAQRIRMMRVKLTFHAFHQAQ 665 (966)
Q Consensus 609 ~~~~~i~~~~~~~~~~~~~~is~e~~~Li~~~L~~dP~~R~t~~~v~~~~~~~~~~~ 665 (966)
.+...+........ ...+++++.+||.+||+.||++|||+.++ ..|+|+...
T Consensus 222 ~~~~~~~~~~~~~~---~~~~~~~~~~li~~~l~~~p~~Rpt~~e~--l~hp~f~~~ 273 (290)
T 3fme_A 222 QLKQVVEEPSPQLP---ADKFSAEFVDFTSQCLKKNSKERPTYPEL--MQHPFFTLH 273 (290)
T ss_dssp HHHHHHHSCCCCCC---TTTSCHHHHHHHHHHTCSSGGGSCCHHHH--TTSHHHHHH
T ss_pred HHHHHhccCCCCcc---cccCCHHHHHHHHHHhhcChhhCcCHHHH--HhCcccccC
Confidence 22233333332222 23579999999999999999999999976 457777543
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-39 Score=370.03 Aligned_cols=247 Identities=28% Similarity=0.479 Sum_probs=188.3
Q ss_pred ecccccccccccccccccccEEEEEEEcCCCcEEEEEEecccc-------ChHHHHHHHHHhcCCCCceEEEEEEEeCC-
Q psy11767 373 FEQYDMDLDKAGILGDGSYSVCRRCVEKSTGQEYAVKIISRKI-------DCSEEINLLRACQGHPNIVNLHCVFQDEV- 444 (966)
Q Consensus 373 ~~~~~i~~~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~-------~~~~Ei~iL~~l~~HpnIV~l~~~~~~~~- 444 (966)
.++|.+ .+.||+|+||.||+|.+..+|+.||||++.... ...+|+.+|+.+ +||||+++++++....
T Consensus 24 ~~~y~~----~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~hpniv~~~~~~~~~~~ 98 (371)
T 2xrw_A 24 LKRYQN----LKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCV-NHKNIIGLLNVFTPQKS 98 (371)
T ss_dssp ETTEEE----EEEEEECSSEEEEEEEETTTTEEEEEEEEECTTSSHHHHHHHHHHHHHHHHC-CCTTBCCEEEEECSCCS
T ss_pred hhheeE----eeeeEecCCEEEEEEEECCCCceEEEEEeccccCChHHHHHHHHHHHHHHhc-CCCCccceEEeeccccc
Confidence 345544 688999999999999999999999999997532 134699999988 5999999999998765
Q ss_pred -----eEEEEEEccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCcEEEecCCCCCEEEEee
Q psy11767 445 -----HTYLVLELLKGGELLDRIRQKGRCGFTENEASRIMRQLVAAVHFMHSRGVVHRDLKPENLLFSDPAGDNIKVVDF 519 (966)
Q Consensus 445 -----~~~lVmEy~~gg~L~~~l~~~~~~~l~e~~~~~i~~Qil~aL~yLHs~~IiHRDLKP~NILl~~~~~~~iKL~DF 519 (966)
..|+|||||+ |+|.+.+.. .+++..+..++.||+.||+|||++||+||||||+|||++. ++.+||+||
T Consensus 99 ~~~~~~~~lv~e~~~-~~l~~~~~~----~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~NIl~~~--~~~~kl~Df 171 (371)
T 2xrw_A 99 LEEFQDVYIVMELMD-ANLCQVIQM----ELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKS--DCTLKILDF 171 (371)
T ss_dssp TTTCCEEEEEEECCS-EEHHHHHHS----CCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECT--TSCEEECCC
T ss_pred cccccceEEEEEcCC-CCHHHHHhh----ccCHHHHHHHHHHHHHHHHHHHHCCeecccCCHHHEEEcC--CCCEEEEEe
Confidence 7899999996 578888853 4899999999999999999999999999999999999975 568999999
Q ss_pred cccccccCC--CccccccccccCchhhccCCCCCCCcccchhhhhhhhhhhhcCCCCCCCcCcchhHHHHHHHHhcCCCC
Q psy11767 520 GFACLKRES--LHTPCFTLQYAAPEVLRQDKSGYDENCDLWSLGVILVNVLRQDKSGYDENCDLWSLGVILYTMLCGRVP 597 (966)
Q Consensus 520 Gla~~~~~~--~~~~~gT~~Y~APEvl~~~~~~~~~~~Di~SlGvil~el~~~~~~~y~~~~DIWSlGvilyemltG~~P 597 (966)
|+|+..... ....+||+.|+|||++.. ..|+.++|||||||++|+|++|+.|
T Consensus 172 g~a~~~~~~~~~~~~~gt~~y~aPE~~~~--------------------------~~~~~~~DiwslG~il~el~~g~~p 225 (371)
T 2xrw_A 172 GLARTAGTSFMMTPYVVTRYYRAPEVILG--------------------------MGYKENVDIWSVGCIMGEMIKGGVL 225 (371)
T ss_dssp CC----------------CTTCCHHHHTT--------------------------CCCCTTHHHHHHHHHHHHHHHSSCS
T ss_pred ecccccccccccCCceecCCccCHHHhcC--------------------------CCCCchHhHHHHHHHHHHHHhCCCC
Confidence 999765432 334678999999999852 2478899999999999999999999
Q ss_pred CCCCCCchhHHHHHHHHHcCCCCCC--------------------------------------chhhccCCHHHHHHHHH
Q psy11767 598 FHARSRDDSALSIMARIKEGQFNFD--------------------------------------AEAWSTVSSEAKELTKS 639 (966)
Q Consensus 598 f~~~~~~~~~~~~~~~i~~~~~~~~--------------------------------------~~~~~~is~e~~~Li~~ 639 (966)
|.+.+..+. +..+.+...... .+.....++++++||.+
T Consensus 226 f~~~~~~~~----~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ 301 (371)
T 2xrw_A 226 FPGTDHIDQ----WNKVIEQLGTPCPEFMKKLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSK 301 (371)
T ss_dssp SCCSSHHHH----HHHHHC-CCCCCHHHHTTSCHHHHHHHHSSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHH
T ss_pred CCCCCHHHH----HHHHHHHhCCCCHHHHHHhhhHHHHHHhhCccccccchhhhcccccCcccccccccccHHHHHHHHH
Confidence 987654332 222221110000 00111236789999999
Q ss_pred hcccCccccCChHHHHHHhhhhHH
Q psy11767 640 LLTVNPAQRIRMMRVKLTFHAFHQ 663 (966)
Q Consensus 640 ~L~~dP~~R~t~~~v~~~~~~~~~ 663 (966)
||+.||++|||+.++ ..|+|+.
T Consensus 302 mL~~dP~~R~t~~e~--l~hp~~~ 323 (371)
T 2xrw_A 302 MLVIDASKRISVDEA--LQHPYIN 323 (371)
T ss_dssp HSCSSGGGSCCHHHH--HHSHHHH
T ss_pred HCcCChhhCCCHHHH--hCCcchh
Confidence 999999999999976 4577764
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.4e-41 Score=382.11 Aligned_cols=249 Identities=14% Similarity=0.239 Sum_probs=190.1
Q ss_pred ccccccccccccEEEEEEEcCCCcEEEEEEecccc--------ChHHHHHHHHHhc--CCCCceEEE-------EEEEeC
Q psy11767 381 DKAGILGDGSYSVCRRCVEKSTGQEYAVKIISRKI--------DCSEEINLLRACQ--GHPNIVNLH-------CVFQDE 443 (966)
Q Consensus 381 ~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~--------~~~~Ei~iL~~l~--~HpnIV~l~-------~~~~~~ 443 (966)
...+.||+|+||+||+|++..+|+.||||++.... ...+|+.+|+.+. +|||||+++ ++++++
T Consensus 76 ~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~hpniv~~~~~~~~~~~~~~~~ 155 (377)
T 3byv_A 76 VRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDLVKDP 155 (377)
T ss_dssp EEEEEEEEETTEEEEEEEC-CCCCEEEEEEEEECC-CCTTHHHHHHHHHHGGGGSTTCCSHHHHHHHHCBCCCSEEEECT
T ss_pred EEcceeecCCCEEEEEEEECCCCcEEEEEEEeeccccchHHHHHHHHHHHHHHhccccCCHHHHHHHhhhhhhhhhhhcc
Confidence 34688999999999999999999999999986421 1346886555543 699999998 777766
Q ss_pred Ce-----------------EEEEEEccCCCCHHHHHHhcCCCCCCH-------HHHHHHHHHHHHHHHHHHhcCceeccC
Q psy11767 444 VH-----------------TYLVLELLKGGELLDRIRQKGRCGFTE-------NEASRIMRQLVAAVHFMHSRGVVHRDL 499 (966)
Q Consensus 444 ~~-----------------~~lVmEy~~gg~L~~~l~~~~~~~l~e-------~~~~~i~~Qil~aL~yLHs~~IiHRDL 499 (966)
+. .||||||+ +|+|.+++...+ .+++ ..+..|+.||+.||+|||++||+||||
T Consensus 156 ~~~~~~~~~~~~~~~~i~~~~lv~E~~-~g~L~~~l~~~~--~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDi 232 (377)
T 3byv_A 156 QKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLL--SHSSTHKSLVHHARLQLTLQVIRLLASLHHYGLVHTYL 232 (377)
T ss_dssp TSCSEEEC------CEEESEEEEEECC-SEEHHHHHHHHH--HTTTTTHHHHHHHHHHHHHHHHHHHHHHHHTTEECSCC
T ss_pred CCccccccccCCCceEEEEEEEEEecc-CCCHHHHHHhcc--ccccccccccHHHHHHHHHHHHHHHHHHHhCCeecCCC
Confidence 43 89999999 689999998653 2444 888889999999999999999999999
Q ss_pred CCCcEEEecCCCCCEEEEeecccccccCCCccccccccccCchhhccCCCCCCCcccchhhhhhhhhhhhcCCCCCCCcC
Q psy11767 500 KPENLLFSDPAGDNIKVVDFGFACLKRESLHTPCFTLQYAAPEVLRQDKSGYDENCDLWSLGVILVNVLRQDKSGYDENC 579 (966)
Q Consensus 500 KP~NILl~~~~~~~iKL~DFGla~~~~~~~~~~~gT~~Y~APEvl~~~~~~~~~~~Di~SlGvil~el~~~~~~~y~~~~ 579 (966)
||+|||++. ++.+||+|||+|+.........+| +.|+|||++...... .........|+.++
T Consensus 233 kp~NIll~~--~~~~kL~DFG~a~~~~~~~~~~~g-~~y~aPE~~~~~~~~---------------~~~~~~~~~~~~~~ 294 (377)
T 3byv_A 233 RPVDIVLDQ--RGGVFLTGFEHLVRDGARVVSSVS-RGFEPPELEARRATI---------------SYHRDRRTLMTFSF 294 (377)
T ss_dssp CGGGEEECT--TCCEEECCGGGCEETTCEEECCCC-TTCCCHHHHHHHTST---------------HHHHCCEEECCHHH
T ss_pred CHHHEEEcC--CCCEEEEechhheecCCcccCCCC-cCccChhhhcccccc---------------cccccccccCChhh
Confidence 999999985 569999999999876655566678 999999998642000 00011123578999
Q ss_pred cchhHHHHHHHHhcCCCCCCCCCCchhHHHHHHHHHcCCCCCCchhhccCCHHHHHHHHHhcccCccccCChHHHHHHhh
Q psy11767 580 DLWSLGVILYTMLCGRVPFHARSRDDSALSIMARIKEGQFNFDAEAWSTVSSEAKELTKSLLTVNPAQRIRMMRVKLTFH 659 (966)
Q Consensus 580 DIWSlGvilyemltG~~Pf~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~is~e~~~Li~~~L~~dP~~R~t~~~v~~~~~ 659 (966)
|||||||++|+|++|+.||.+....+. ...+. ..+..+++++.+||.+||..||++|||+.++ ..|
T Consensus 295 DvwSlG~il~elltg~~Pf~~~~~~~~----~~~~~--------~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~--l~h 360 (377)
T 3byv_A 295 DAWALGLVIYWIWCADLPITKDAALGG----SEWIF--------RSCKNIPQPVRALLEGFLRYPKEDRLLPLQA--MET 360 (377)
T ss_dssp HHHHHHHHHHHHHHSSCCC------CC----SGGGG--------SSCCCCCHHHHHHHHHHTCSSGGGCCCHHHH--HTS
T ss_pred hHHHHHHHHHHHHHCCCCCcccccccc----hhhhh--------hhccCCCHHHHHHHHHHcCCCchhCCCHHHH--hhC
Confidence 999999999999999999976543211 11111 1235689999999999999999999999976 346
Q ss_pred hhHHh
Q psy11767 660 AFHQA 664 (966)
Q Consensus 660 ~~~~~ 664 (966)
+|+..
T Consensus 361 p~f~~ 365 (377)
T 3byv_A 361 PEYEQ 365 (377)
T ss_dssp HHHHH
T ss_pred hHHHH
Confidence 77654
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-39 Score=351.81 Aligned_cols=242 Identities=21% Similarity=0.380 Sum_probs=196.5
Q ss_pred cccccccccccccEEEEEEEcCCCcEEEEEEecccc----ChHHHHHHHHHhcCCCCceEEEEEEEeCCeEEEEEEccCC
Q psy11767 380 LDKAGILGDGSYSVCRRCVEKSTGQEYAVKIISRKI----DCSEEINLLRACQGHPNIVNLHCVFQDEVHTYLVLELLKG 455 (966)
Q Consensus 380 ~~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~----~~~~Ei~iL~~l~~HpnIV~l~~~~~~~~~~~lVmEy~~g 455 (966)
|+..+.||+|+||.||+|.+. ++..||||++.... ...+|+++|+.+. ||||+++++++.++...|+||||+++
T Consensus 26 y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~-h~~i~~~~~~~~~~~~~~lv~e~~~~ 103 (283)
T 3gen_A 26 LTFLKELGTGQFGVVKYGKWR-GQYDVAIKMIKEGSMSEDEFIEEAKVMMNLS-HEKLVQLYGVCTKQRPIFIITEYMAN 103 (283)
T ss_dssp EEEEEECC---CEEEEEEEET-TTEEEEEEEECTTSBCHHHHHHHHHHHHTCC-CTTBCCEEEEECSSSSEEEEECCCTT
T ss_pred HHhHhhcCCCCCceEEEEEEc-CCCeEEEEEecCCCCCHHHHHHHHHHHhcCC-CCCEeeEEEEEecCCCeEEEEeccCC
Confidence 344689999999999999886 57789999997543 2457999999984 99999999999999999999999999
Q ss_pred CCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCcEEEecCCCCCEEEEeecccccccC----CCcc
Q psy11767 456 GELLDRIRQKGRCGFTENEASRIMRQLVAAVHFMHSRGVVHRDLKPENLLFSDPAGDNIKVVDFGFACLKRE----SLHT 531 (966)
Q Consensus 456 g~L~~~l~~~~~~~l~e~~~~~i~~Qil~aL~yLHs~~IiHRDLKP~NILl~~~~~~~iKL~DFGla~~~~~----~~~~ 531 (966)
++|.+++..... .+++.+++.++.||+.||+|||++||+||||||+|||++. ++.+||+|||+++.... ....
T Consensus 104 ~~L~~~l~~~~~-~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~Nili~~--~~~~kl~Dfg~~~~~~~~~~~~~~~ 180 (283)
T 3gen_A 104 GCLLNYLREMRH-RFQTQQLLEMCKDVCEAMEYLESKQFLHRDLAARNCLVND--QGVVKVSDFGLSRYVLDDEYTSSVG 180 (283)
T ss_dssp CBHHHHHHCGGG-CCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCSGGGEEECT--TSCEEECSTTGGGGBCCHHHHSTTS
T ss_pred CcHHHHHHHhcc-CCCHHHHHHHHHHHHHHHHHHHHCCccCCCCccceEEEcC--CCCEEEccccccccccccccccccC
Confidence 999999976432 5999999999999999999999999999999999999975 56899999999976532 1233
Q ss_pred ccccccccCchhhccCCCCCCCcccchhhhhhhhhhhhcCCCCCCCcCcchhHHHHHHHHhc-CCCCCCCCCCchhHHHH
Q psy11767 532 PCFTLQYAAPEVLRQDKSGYDENCDLWSLGVILVNVLRQDKSGYDENCDLWSLGVILYTMLC-GRVPFHARSRDDSALSI 610 (966)
Q Consensus 532 ~~gT~~Y~APEvl~~~~~~~~~~~Di~SlGvil~el~~~~~~~y~~~~DIWSlGvilyemlt-G~~Pf~~~~~~~~~~~~ 610 (966)
..+|+.|+|||++... .|+.++|||||||++|+|++ |+.||...... ..
T Consensus 181 ~~~~~~y~aPE~~~~~--------------------------~~~~~~Dv~slG~~l~~l~t~g~~p~~~~~~~----~~ 230 (283)
T 3gen_A 181 SKFPVRWSPPEVLMYS--------------------------KFSSKSDIWAFGVLMWEIYSLGKMPYERFTNS----ET 230 (283)
T ss_dssp TTSCGGGCCHHHHHHC--------------------------CCSHHHHHHHHHHHHHHHHTTTCCTTTTSCHH----HH
T ss_pred CccCcccCCHHHhccC--------------------------CCCchhhHHHHHHHHHHHHhCCCCCccccChh----HH
Confidence 4567889999998532 36788999999999999998 99999876533 33
Q ss_pred HHHHHcCCCCCCchhhccCCHHHHHHHHHhcccCccccCChHHHHHHhh
Q psy11767 611 MARIKEGQFNFDAEAWSTVSSEAKELTKSLLTVNPAQRIRMMRVKLTFH 659 (966)
Q Consensus 611 ~~~i~~~~~~~~~~~~~~is~e~~~Li~~~L~~dP~~R~t~~~v~~~~~ 659 (966)
...+..+..... ....++++.+||.+||+.||++|||+.++...+.
T Consensus 231 ~~~~~~~~~~~~---~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~ 276 (283)
T 3gen_A 231 AEHIAQGLRLYR---PHLASEKVYTIMYSCWHEKADERPTFKILLSNIL 276 (283)
T ss_dssp HHHHHTTCCCCC---CTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHH
T ss_pred HHHHhcccCCCC---CCcCCHHHHHHHHHHccCChhHCcCHHHHHHHHH
Confidence 444555433222 2356899999999999999999999998755443
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} PDB: 3fpq_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-39 Score=352.54 Aligned_cols=243 Identities=26% Similarity=0.405 Sum_probs=199.9
Q ss_pred ccccccccccEEEEEEEcCCCcEEEEEEeccccC-------hHHHHHHHHHhcCCCCceEEEEEEEe----CCeEEEEEE
Q psy11767 383 AGILGDGSYSVCRRCVEKSTGQEYAVKIISRKID-------CSEEINLLRACQGHPNIVNLHCVFQD----EVHTYLVLE 451 (966)
Q Consensus 383 ~~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~~-------~~~Ei~iL~~l~~HpnIV~l~~~~~~----~~~~~lVmE 451 (966)
.+.||+|+||.||+|.+..++..||+|++..... ..+|+.+|+.+ +||||++++++|.+ ....|+|||
T Consensus 31 ~~~lg~G~~g~Vy~~~~~~~~~~va~k~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~~~~~lv~e 109 (290)
T 1t4h_A 31 DIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGL-QHPNIVRFYDSWESTVKGKKCIVLVTE 109 (290)
T ss_dssp EEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTC-CCTTBCCEEEEEEEESSSCEEEEEEEE
T ss_pred eeeccCCCCeEEEEeEecCCceEEEEEEecchhhCHHHHHHHHHHHHHHHhC-CCCCeeeeeeeeccccCCCceEEEEEE
Confidence 4679999999999999999999999999865431 34688999888 59999999999876 456899999
Q ss_pred ccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcC--ceeccCCCCcEEEecCCCCCEEEEeecccccccCC-
Q psy11767 452 LLKGGELLDRIRQKGRCGFTENEASRIMRQLVAAVHFMHSRG--VVHRDLKPENLLFSDPAGDNIKVVDFGFACLKRES- 528 (966)
Q Consensus 452 y~~gg~L~~~l~~~~~~~l~e~~~~~i~~Qil~aL~yLHs~~--IiHRDLKP~NILl~~~~~~~iKL~DFGla~~~~~~- 528 (966)
|+++|+|.+++.... .+++..++.++.||+.||+|||++| |+||||||+|||++. ..+.+||+|||++......
T Consensus 110 ~~~~~~L~~~l~~~~--~~~~~~~~~~~~qi~~~l~~lH~~~~~i~H~dikp~Nil~~~-~~~~~kl~Dfg~~~~~~~~~ 186 (290)
T 1t4h_A 110 LMTSGTLKTYLKRFK--VMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITG-PTGSVKIGDLGLATLKRASF 186 (290)
T ss_dssp CCCSCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHTSSSCCCCSCCCGGGEEESS-TTSCEEECCTTGGGGCCTTS
T ss_pred ecCCCCHHHHHHHcc--CCCHHHHHHHHHHHHHHHHHHHcCCCCEEECCCCHHHEEEEC-CCCCEEEeeCCCcccccccc
Confidence 999999999998764 5899999999999999999999999 999999999999963 3568999999999765433
Q ss_pred CccccccccccCchhhccCCCCCCCcccchhhhhhhhhhhhcCCCCCCCcCcchhHHHHHHHHhcCCCCCCCCCCchhHH
Q psy11767 529 LHTPCFTLQYAAPEVLRQDKSGYDENCDLWSLGVILVNVLRQDKSGYDENCDLWSLGVILYTMLCGRVPFHARSRDDSAL 608 (966)
Q Consensus 529 ~~~~~gT~~Y~APEvl~~~~~~~~~~~Di~SlGvil~el~~~~~~~y~~~~DIWSlGvilyemltG~~Pf~~~~~~~~~~ 608 (966)
....++|+.|+|||++.. .|+.++|||||||++|+|++|+.||.......
T Consensus 187 ~~~~~~t~~y~aPE~~~~---------------------------~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~--- 236 (290)
T 1t4h_A 187 AKAVIGTPEFMAPEMYEE---------------------------KYDESVDVYAFGMCMLEMATSEYPYSECQNAA--- 236 (290)
T ss_dssp BEESCSSCCCCCGGGGGT---------------------------CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHH---
T ss_pred cccccCCcCcCCHHHHhc---------------------------cCCCcchHHHHHHHHHHHHhCCCCCCCcCcHH---
Confidence 334578999999998741 26788999999999999999999998754432
Q ss_pred HHHHHHHcCCCCCCchhhccCCHHHHHHHHHhcccCccccCChHHHHHHhhhhHH
Q psy11767 609 SIMARIKEGQFNFDAEAWSTVSSEAKELTKSLLTVNPAQRIRMMRVKLTFHAFHQ 663 (966)
Q Consensus 609 ~~~~~i~~~~~~~~~~~~~~is~e~~~Li~~~L~~dP~~R~t~~~v~~~~~~~~~ 663 (966)
.....+..+.. ........++++.+||.+||+.||.+|||+.++ ..|+|++
T Consensus 237 ~~~~~~~~~~~--~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~el--l~h~~f~ 287 (290)
T 1t4h_A 237 QIYRRVTSGVK--PASFDKVAIPEVKEIIEGCIRQNKDERYSIKDL--LNHAFFQ 287 (290)
T ss_dssp HHHHHHTTTCC--CGGGGGCCCHHHHHHHHHHSCSSGGGSCCHHHH--HTSGGGC
T ss_pred HHHHHHhccCC--ccccCCCCCHHHHHHHHHHccCChhhCCCHHHH--hhCcccc
Confidence 33444444432 222334678999999999999999999999976 4466653
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-39 Score=352.79 Aligned_cols=240 Identities=30% Similarity=0.560 Sum_probs=202.0
Q ss_pred cccccccccccEEEEEEEcCCCcEEEEEEecccc--------ChHHHHHHHHHhcCCCCceEEEEEEEeCCeEEEEEEcc
Q psy11767 382 KAGILGDGSYSVCRRCVEKSTGQEYAVKIISRKI--------DCSEEINLLRACQGHPNIVNLHCVFQDEVHTYLVLELL 453 (966)
Q Consensus 382 ~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~--------~~~~Ei~iL~~l~~HpnIV~l~~~~~~~~~~~lVmEy~ 453 (966)
..+.||+|+||.||+|.+..+++.||+|++.... ...+|+.+|+.+ +||||+++++++.++...|+||||+
T Consensus 19 ~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~e~~ 97 (294)
T 2rku_A 19 RGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSL-AHQHVVGFHGFFEDNDFVFVVLELC 97 (294)
T ss_dssp EEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTC-CCTTBCCEEEEEECSSEEEEEEECC
T ss_pred EEEEEeecCCEEEEEEEECCCCceEEEEEechhhccCHHHHHHHHHHHHHHHhC-CCCCEeeeeeeeccCCEEEEEEecC
Confidence 3688999999999999999999999999986542 134688999888 6999999999999999999999999
Q ss_pred CCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCcEEEecCCCCCEEEEeecccccccC---CCc
Q psy11767 454 KGGELLDRIRQKGRCGFTENEASRIMRQLVAAVHFMHSRGVVHRDLKPENLLFSDPAGDNIKVVDFGFACLKRE---SLH 530 (966)
Q Consensus 454 ~gg~L~~~l~~~~~~~l~e~~~~~i~~Qil~aL~yLHs~~IiHRDLKP~NILl~~~~~~~iKL~DFGla~~~~~---~~~ 530 (966)
++++|.+++.... .+++.+++.++.||+.||+|||++||+||||||+|||++. ++.+||+|||++..... ...
T Consensus 98 ~~~~L~~~~~~~~--~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~--~~~~kl~dfg~~~~~~~~~~~~~ 173 (294)
T 2rku_A 98 RRRSLLELHKRRK--ALTEPEARYYLRQIVLGCQYLHRNRVIHRDLKLGNLFLNE--DLEVKIGDFGLATKVEYDGERKK 173 (294)
T ss_dssp TTCBHHHHHHHHC--SCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECT--TCCEEECCCTTCEECCSTTCCBC
T ss_pred CCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCccccCCChHhEEEcC--CCCEEEEeccCceecccCccccc
Confidence 9999999987765 5999999999999999999999999999999999999975 56899999999976432 233
Q ss_pred cccccccccCchhhccCCCCCCCcccchhhhhhhhhhhhcCCCCCCCcCcchhHHHHHHHHhcCCCCCCCCCCchhHHHH
Q psy11767 531 TPCFTLQYAAPEVLRQDKSGYDENCDLWSLGVILVNVLRQDKSGYDENCDLWSLGVILYTMLCGRVPFHARSRDDSALSI 610 (966)
Q Consensus 531 ~~~gT~~Y~APEvl~~~~~~~~~~~Di~SlGvil~el~~~~~~~y~~~~DIWSlGvilyemltG~~Pf~~~~~~~~~~~~ 610 (966)
..++|+.|+|||++.. ..++.++|||||||++|+|++|+.||...... ..
T Consensus 174 ~~~~~~~y~aPE~~~~--------------------------~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~----~~ 223 (294)
T 2rku_A 174 VLCGTPNYIAPEVLSK--------------------------KGHSFEVDVWSIGCIMYTLLVGKPPFETSCLK----ET 223 (294)
T ss_dssp CCCSCCSSCCHHHHTT--------------------------SCBCTHHHHHHHHHHHHHHHHSSCTTCCSSHH----HH
T ss_pred cccCCCCcCCcchhcc--------------------------CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH----HH
Confidence 4578999999998852 23677899999999999999999999875432 23
Q ss_pred HHHHHcCCCCCCchhhccCCHHHHHHHHHhcccCccccCChHHHHHHhhhhH
Q psy11767 611 MARIKEGQFNFDAEAWSTVSSEAKELTKSLLTVNPAQRIRMMRVKLTFHAFH 662 (966)
Q Consensus 611 ~~~i~~~~~~~~~~~~~~is~e~~~Li~~~L~~dP~~R~t~~~v~~~~~~~~ 662 (966)
...+..+.+.++ ..+++++.+||.+||..||++|||+.++ ..|+|+
T Consensus 224 ~~~~~~~~~~~~----~~~~~~~~~li~~~l~~~p~~Rps~~~l--l~~~~~ 269 (294)
T 2rku_A 224 YLRIKKNEYSIP----KHINPVAASLIQKMLQTDPTARPTINEL--LNDEFF 269 (294)
T ss_dssp HHHHHTTCCCCC----TTSCHHHHHHHHHHTCSSGGGSCCGGGG--GGSHHH
T ss_pred HHHHhhccCCCc----cccCHHHHHHHHHHcccChhhCcCHHHH--hhChhe
Confidence 445555554433 3578999999999999999999999976 345554
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-39 Score=350.68 Aligned_cols=250 Identities=33% Similarity=0.598 Sum_probs=199.9
Q ss_pred cceecccccccccccccccccccEEEEEEEcCCCcEEEEEEecccc--------ChHHHHHHHHHhcCCCCceEEEEEEE
Q psy11767 370 SLFFEQYDMDLDKAGILGDGSYSVCRRCVEKSTGQEYAVKIISRKI--------DCSEEINLLRACQGHPNIVNLHCVFQ 441 (966)
Q Consensus 370 ~~~~~~~~i~~~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~--------~~~~Ei~iL~~l~~HpnIV~l~~~~~ 441 (966)
....++|.+ .+.||+|+||.||+|.+..+|+.||||++.... ...+|+.+|+.+ +||||+++++++.
T Consensus 7 ~~~~~~y~i----~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~ 81 (276)
T 2h6d_A 7 RVKIGHYVL----GDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLF-RHPHIIKLYQVIS 81 (276)
T ss_dssp CCEETTEEE----EEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTC-CCTTBCCEEEEEE
T ss_pred cceeccEEE----EeeecCCCCeEEEEEEECCCCceEEEEEeccccccchhHHHHHHHHHHHHhcC-CCCCEeEEEEEEe
Confidence 344556665 688999999999999999999999999986431 245799999888 5999999999999
Q ss_pred eCCeEEEEEEccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCcEEEecCCCCCEEEEeecc
Q psy11767 442 DEVHTYLVLELLKGGELLDRIRQKGRCGFTENEASRIMRQLVAAVHFMHSRGVVHRDLKPENLLFSDPAGDNIKVVDFGF 521 (966)
Q Consensus 442 ~~~~~~lVmEy~~gg~L~~~l~~~~~~~l~e~~~~~i~~Qil~aL~yLHs~~IiHRDLKP~NILl~~~~~~~iKL~DFGl 521 (966)
+....|+||||+++++|.+++.... .+++.++..++.||+.||+|||++||+||||||+|||++. ++.+||+|||+
T Consensus 82 ~~~~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~--~~~~~l~dfg~ 157 (276)
T 2h6d_A 82 TPTDFFMVMEYVSGGELFDYICKHG--RVEEMEARRLFQQILSAVDYCHRHMVVHRDLKPENVLLDA--HMNAKIADFGL 157 (276)
T ss_dssp CSSEEEEEEECCCSCBHHHHHHHHC--SCCHHHHHHHHHHHHHHHHHHHHHCSSCCCCCGGGEEECT--TSCEEECCCCG
T ss_pred cCCeEEEEEeccCCCcHHHHHhccC--CCCHHHHHHHHHHHHHHHHHHHHCCCccCCCChhhEEECC--CCCEEEeeccc
Confidence 9999999999999999999998765 5899999999999999999999999999999999999974 56899999999
Q ss_pred cccccCC--CccccccccccCchhhccCCCCCCCcccchhhhhhhhhhhhcCCCCCCCcCcchhHHHHHHHHhcCCCCCC
Q psy11767 522 ACLKRES--LHTPCFTLQYAAPEVLRQDKSGYDENCDLWSLGVILVNVLRQDKSGYDENCDLWSLGVILYTMLCGRVPFH 599 (966)
Q Consensus 522 a~~~~~~--~~~~~gT~~Y~APEvl~~~~~~~~~~~Di~SlGvil~el~~~~~~~y~~~~DIWSlGvilyemltG~~Pf~ 599 (966)
+...... ....++|+.|+|||++... ..++.++|||||||++|+|++|+.||.
T Consensus 158 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~-------------------------~~~~~~~Di~slG~~l~~l~~g~~p~~ 212 (276)
T 2h6d_A 158 SNMMSDGEFLRTSCGSPNYAAPEVISGR-------------------------LYAGPEVDIWSCGVILYALLCGTLPFD 212 (276)
T ss_dssp GGCCCC-------------CCTGGGTTS-------------------------CCCHHHHHHHHHHHHHHHHHHSSCSSC
T ss_pred ccccCCCcceecccCCccccCHHHHcCC-------------------------CCCCccchHHHHHHHHHHHHhCCCCCC
Confidence 9765432 2345789999999998532 123568999999999999999999997
Q ss_pred CCCCchhHHHHHHHHHcCCCCCCchhhccCCHHHHHHHHHhcccCccccCChHHHHHHhhhhHH
Q psy11767 600 ARSRDDSALSIMARIKEGQFNFDAEAWSTVSSEAKELTKSLLTVNPAQRIRMMRVKLTFHAFHQ 663 (966)
Q Consensus 600 ~~~~~~~~~~~~~~i~~~~~~~~~~~~~~is~e~~~Li~~~L~~dP~~R~t~~~v~~~~~~~~~ 663 (966)
.... ......+..+.+.++ ..++.++.+||.+||..||++|||+.++. .|+|++
T Consensus 213 ~~~~----~~~~~~~~~~~~~~~----~~~~~~l~~li~~~l~~~p~~Rps~~~~l--~h~~~~ 266 (276)
T 2h6d_A 213 DEHV----PTLFKKIRGGVFYIP----EYLNRSVATLLMHMLQVDPLKRATIKDIR--EHEWFK 266 (276)
T ss_dssp CSSH----HHHHHHHHHCCCCCC----TTSCHHHHHHHHHHTCSSGGGSCCHHHHH--HSHHHH
T ss_pred CCcH----HHHHHHhhcCcccCc----hhcCHHHHHHHHHHccCChhhCCCHHHHH--hChhhc
Confidence 6543 234555666554433 34789999999999999999999999773 467664
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 4asx_A* 2qlu_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.7e-40 Score=365.48 Aligned_cols=253 Identities=18% Similarity=0.227 Sum_probs=192.9
Q ss_pred cccccccccccccEEEEEEEcCCCcEEEEEEeccccC----hHHHHHHHHHhcCCCCceEEEEEEEeCC----eEEEEEE
Q psy11767 380 LDKAGILGDGSYSVCRRCVEKSTGQEYAVKIISRKID----CSEEINLLRACQGHPNIVNLHCVFQDEV----HTYLVLE 451 (966)
Q Consensus 380 ~~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~~----~~~Ei~iL~~l~~HpnIV~l~~~~~~~~----~~~lVmE 451 (966)
|+..+.||+|+||+||+|++. ++.||||++..... ..+|+.+|+.+ +|||||++++++.+.. ..|+|||
T Consensus 26 y~~~~~lg~G~~g~Vy~~~~~--~~~vavK~~~~~~~~~~~~~~E~~~l~~l-~hpniv~~~~~~~~~~~~~~~~~lv~e 102 (322)
T 3soc_A 26 LQLLEVKARGRFGCVWKAQLL--NEYVAVKIFPIQDKQSWQNEYEVYSLPGM-KHENILQFIGAEKRGTSVDVDLWLITA 102 (322)
T ss_dssp EEEEEEEECSTTCEEEEEEET--TEEEEEEEECGGGHHHHHHHHHHHTSTTC-CCTTBCCEEEEEEEECSSSEEEEEEEE
T ss_pred chhhheecccCceEEEEEEEC--CCEEEEEEeecCchHHHHHHHHHHHHhcC-CCCCchhhcceeccCCCCCceEEEEEe
Confidence 344789999999999999875 79999999965432 33577778777 5999999999998744 4799999
Q ss_pred ccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhc----------CceeccCCCCcEEEecCCCCCEEEEeecc
Q psy11767 452 LLKGGELLDRIRQKGRCGFTENEASRIMRQLVAAVHFMHSR----------GVVHRDLKPENLLFSDPAGDNIKVVDFGF 521 (966)
Q Consensus 452 y~~gg~L~~~l~~~~~~~l~e~~~~~i~~Qil~aL~yLHs~----------~IiHRDLKP~NILl~~~~~~~iKL~DFGl 521 (966)
||++|+|.+++... .+++..++.++.||+.||+|||+. ||+||||||+|||++. .+.+||+|||+
T Consensus 103 ~~~~g~L~~~l~~~---~~~~~~~~~i~~qi~~al~~LH~~~~~l~~~~~~~ivH~Dlkp~Nill~~--~~~~kL~DFg~ 177 (322)
T 3soc_A 103 FHEKGSLSDFLKAN---VVSWNELCHIAETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKN--NLTACIADFGL 177 (322)
T ss_dssp CCTTCBHHHHHHHC---CBCHHHHHHHHHHHHHHHHHHTCCEEEETTEEECEEECSCCSGGGEEECT--TCCEEECCCTT
T ss_pred cCCCCCHHHHHHhc---CCCHHHHHHHHHHHHHHHHHHHhhccccccccCCCEEeCCCChHhEEECC--CCeEEEccCCc
Confidence 99999999999764 489999999999999999999999 9999999999999975 56899999999
Q ss_pred cccccCC-----CccccccccccCchhhccCCCCCCCcccchhhhhhhhhhhhcCCCCCCCcCcchhHHHHHHHHhcCCC
Q psy11767 522 ACLKRES-----LHTPCFTLQYAAPEVLRQDKSGYDENCDLWSLGVILVNVLRQDKSGYDENCDLWSLGVILYTMLCGRV 596 (966)
Q Consensus 522 a~~~~~~-----~~~~~gT~~Y~APEvl~~~~~~~~~~~Di~SlGvil~el~~~~~~~y~~~~DIWSlGvilyemltG~~ 596 (966)
|+..... ....+||+.|+|||++..... ....|+.++|||||||++|+|++|+.
T Consensus 178 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~---------------------~~~~~~~~~DiwslG~il~el~tg~~ 236 (322)
T 3soc_A 178 ALKFEAGKSAGDTHGQVGTRRYMAPEVLEGAIN---------------------FQRDAFLRIDMYAMGLVLWELASRCT 236 (322)
T ss_dssp CEEECTTSCCCCCTTCCCCGGGCCHHHHTTCCC---------------------CCHHHHHHHHHHHHHHHHHHHHTTBT
T ss_pred ccccccccCccccccCccCccccCHhhcccccc---------------------cCcCCCccchhHHHHHHHHHHHhCCC
Confidence 9754321 233578999999999863210 01234568899999999999999999
Q ss_pred CCCCCCCch------------hHHHHHHHHHcCCCCCC-chhhc--cCCHHHHHHHHHhcccCccccCChHHHHHHhhhh
Q psy11767 597 PFHARSRDD------------SALSIMARIKEGQFNFD-AEAWS--TVSSEAKELTKSLLTVNPAQRIRMMRVKLTFHAF 661 (966)
Q Consensus 597 Pf~~~~~~~------------~~~~~~~~i~~~~~~~~-~~~~~--~is~e~~~Li~~~L~~dP~~R~t~~~v~~~~~~~ 661 (966)
||.+..... ....+...+........ ...|. ..++++.+||.+||+.||++|||+.++...+..+
T Consensus 237 pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~l 316 (322)
T 3soc_A 237 AADGPVDEYMLPFEEEIGQHPSLEDMQEVVVHKKKRPVLRDYWQKHAGMAMLCETIEECWDHDAEARLSAGCVGERITQM 316 (322)
T ss_dssp TSSSCCCCCCCTTHHHHCSSCCHHHHHHHHTTSCCCCCCCGGGGSSHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred CCCCCcchhccchhhhhccCCchhhhhhhhhcccCCCCccccccccchHHHHHHHHHHHccCChhhCcCHHHHHHHHHHH
Confidence 998654311 11122222222222111 11121 2345699999999999999999999886555443
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.8e-40 Score=359.09 Aligned_cols=251 Identities=24% Similarity=0.357 Sum_probs=190.6
Q ss_pred ccccccccccccEEEEEEEcCCCcEEEEEEeccccC--hHHHHHHHHHh-cCCCCceEEEEEEEeC----CeEEEEEEcc
Q psy11767 381 DKAGILGDGSYSVCRRCVEKSTGQEYAVKIISRKID--CSEEINLLRAC-QGHPNIVNLHCVFQDE----VHTYLVLELL 453 (966)
Q Consensus 381 ~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~~--~~~Ei~iL~~l-~~HpnIV~l~~~~~~~----~~~~lVmEy~ 453 (966)
+..+.||+|+||+||+|.+ +|+.||||++..... ..+|.+++... .+||||+++++++.+. ...|+||||+
T Consensus 11 ~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~e~~~~~~~~l~h~niv~~~~~~~~~~~~~~~~~lv~e~~ 88 (301)
T 3q4u_A 11 TLLECVGKGRYGEVWRGSW--QGENVAVKIFSSRDEKSWFRETELYNTVMLRHENILGFIASDMTSRHSSTQLWLITHYH 88 (301)
T ss_dssp EEEEEEEECSSEEEEEEEE--TTEEEEEEEECGGGHHHHHHHHHHHHHTCCCCTTBCCEEEEEEEEETTEEEEEEEECCC
T ss_pred EEEEeeccCCCcEEEEEEE--CCEEEEEEEeccccchhhHHHHHHHHHhhccCcCeeeEEEeeccccCCCceeEEehhhc
Confidence 3468999999999999987 689999999965432 34577777663 3799999999987543 4689999999
Q ss_pred CCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHH--------hcCceeccCCCCcEEEecCCCCCEEEEeecccccc
Q psy11767 454 KGGELLDRIRQKGRCGFTENEASRIMRQLVAAVHFMH--------SRGVVHRDLKPENLLFSDPAGDNIKVVDFGFACLK 525 (966)
Q Consensus 454 ~gg~L~~~l~~~~~~~l~e~~~~~i~~Qil~aL~yLH--------s~~IiHRDLKP~NILl~~~~~~~iKL~DFGla~~~ 525 (966)
++|+|.+++... .+++..+..++.||+.||+||| ++||+||||||+|||++. ++.+||+|||+|+..
T Consensus 89 ~~g~L~~~l~~~---~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dlkp~Nill~~--~~~~kl~Dfg~a~~~ 163 (301)
T 3q4u_A 89 EMGSLYDYLQLT---TLDTVSCLRIVLSIASGLAHLHIEIFGTQGKPAIAHRDLKSKNILVKK--NGQCCIADLGLAVMH 163 (301)
T ss_dssp TTCBHHHHHTTC---CBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCEEECSCCCGGGEEECT--TSCEEECCCTTCEEE
T ss_pred cCCCHHHHHhhc---ccCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCeecCCCChHhEEEcC--CCCEEEeeCCCeeec
Confidence 999999999543 5999999999999999999999 999999999999999984 569999999999654
Q ss_pred cCC-------CccccccccccCchhhccCCCCCCCcccchhhhhhhhhhhhcCCCCCCCcCcchhHHHHHHHHhcC----
Q psy11767 526 RES-------LHTPCFTLQYAAPEVLRQDKSGYDENCDLWSLGVILVNVLRQDKSGYDENCDLWSLGVILYTMLCG---- 594 (966)
Q Consensus 526 ~~~-------~~~~~gT~~Y~APEvl~~~~~~~~~~~Di~SlGvil~el~~~~~~~y~~~~DIWSlGvilyemltG---- 594 (966)
... ....+||+.|+|||++...... ....++.++|||||||++|+|++|
T Consensus 164 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~--------------------~~~~~~~~~DvwslG~il~el~tg~~~~ 223 (301)
T 3q4u_A 164 SQSTNQLDVGNNPRVGTKRYMAPEVLDETIQV--------------------DCFDSYKRVDIWAFGLVLWEVARRMVSN 223 (301)
T ss_dssp ETTTTEEECCCCCCCCCGGGCCHHHHTTCCCT--------------------TCHHHHHHHHHHHHHHHHHHHHTTBCBT
T ss_pred ccccccccccccccccccceeChhhhcCcCCC--------------------CcccCCchhhHHHHHHHHHHHHhhhcCc
Confidence 322 2234789999999998642110 000245689999999999999999
Q ss_pred ------CCCCCCCCCchhHHHHHHHHH-cCC--CCCCch-hhccCCHHHHHHHHHhcccCccccCChHHHHHHh
Q psy11767 595 ------RVPFHARSRDDSALSIMARIK-EGQ--FNFDAE-AWSTVSSEAKELTKSLLTVNPAQRIRMMRVKLTF 658 (966)
Q Consensus 595 ------~~Pf~~~~~~~~~~~~~~~i~-~~~--~~~~~~-~~~~is~e~~~Li~~~L~~dP~~R~t~~~v~~~~ 658 (966)
..||............+..+. ... ...+.. .....++++.+||.+||+.||++|||+.++...+
T Consensus 224 ~~~~~~~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L 297 (301)
T 3q4u_A 224 GIVEDYKPPFYDVVPNDPSFEDMRKVVCVDQQRPNIPNRWFSDPTLTSLAKLMKECWYQNPSARLTALRIKKTL 297 (301)
T ss_dssp TBCCCCCCTTTTTSCSSCCHHHHHHHHTTSCCCCCCCGGGGGSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHHH
T ss_pred cccccccccccccCCCCcchhhhhHHHhccCCCCCCChhhccCccHHHHHHHHHHHhhcChhhCCCHHHHHHHH
Confidence 899976544332222233222 111 111111 1123567899999999999999999999885544
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.7e-40 Score=368.05 Aligned_cols=249 Identities=14% Similarity=0.195 Sum_probs=187.4
Q ss_pred cccccccccccccEEEEEEEcC---CCcEEEEEEeccccC-hH---------------HHHHHHHHhcCCCCceEEEEEE
Q psy11767 380 LDKAGILGDGSYSVCRRCVEKS---TGQEYAVKIISRKID-CS---------------EEINLLRACQGHPNIVNLHCVF 440 (966)
Q Consensus 380 ~~~~~~LG~G~fG~Vy~a~~~~---tg~~vAvK~i~~~~~-~~---------------~Ei~iL~~l~~HpnIV~l~~~~ 440 (966)
|...+.||+|+||.||+|.+.. ++..||||++..... .. +|+.+++.+ +||||+++++++
T Consensus 39 y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l-~h~ni~~~~~~~ 117 (345)
T 2v62_A 39 WVLGKKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERKQL-DYLGIPLFYGSG 117 (345)
T ss_dssp EEEEEEC------CEEEEEESSSCGGGCCEEEEEEECC-CHHHHHHHHHHHHCCHHHHHHHHHHHTC-SCCCCCCEEEEE
T ss_pred EEEEeeEeecCCeEEEEEEecCCCCccceEEEEeeecCCcchHHHHHHHHHHhhhHHHHHHHhhccc-cccCcceeeccc
Confidence 3446899999999999999987 889999999875432 22 344455555 699999999999
Q ss_pred Ee----CCeEEEEEEccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCcEEEecCCCCCEEE
Q psy11767 441 QD----EVHTYLVLELLKGGELLDRIRQKGRCGFTENEASRIMRQLVAAVHFMHSRGVVHRDLKPENLLFSDPAGDNIKV 516 (966)
Q Consensus 441 ~~----~~~~~lVmEy~~gg~L~~~l~~~~~~~l~e~~~~~i~~Qil~aL~yLHs~~IiHRDLKP~NILl~~~~~~~iKL 516 (966)
.+ ....|+||||| |++|.+++...+ .+++.+++.++.||+.||+|||++||+||||||+|||++....+.+||
T Consensus 118 ~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~--~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~~~kL 194 (345)
T 2v62_A 118 LTEFKGRSYRFMVMERL-GIDLQKISGQNG--TFKKSTVLQLGIRMLDVLEYIHENEYVHGDIKAANLLLGYKNPDQVYL 194 (345)
T ss_dssp EEESSSCEEEEEEEECE-EEEHHHHCBGGG--BCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEESSSTTSEEE
T ss_pred ccccCCCcEEEEEEecc-CCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCeeCCCcCHHHEEEccCCCCcEEE
Confidence 88 78899999999 999999997665 699999999999999999999999999999999999998644459999
Q ss_pred EeecccccccCC----------CccccccccccCchhhccCCCCCCCcccchhhhhhhhhhhhcCCCCCCCcCcchhHHH
Q psy11767 517 VDFGFACLKRES----------LHTPCFTLQYAAPEVLRQDKSGYDENCDLWSLGVILVNVLRQDKSGYDENCDLWSLGV 586 (966)
Q Consensus 517 ~DFGla~~~~~~----------~~~~~gT~~Y~APEvl~~~~~~~~~~~Di~SlGvil~el~~~~~~~y~~~~DIWSlGv 586 (966)
+|||+|+..... ....+||+.|+|||++.. ..|+.++|||||||
T Consensus 195 ~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--------------------------~~~~~~~Di~slG~ 248 (345)
T 2v62_A 195 ADYGLSYRYCPNGNHKQYQENPRKGHNGTIEFTSLDAHKG--------------------------VALSRRSDVEILGY 248 (345)
T ss_dssp CCCTTCEESSGGGCCCCCCCCGGGCSCSCTTTCCHHHHHT--------------------------CCCCHHHHHHHHHH
T ss_pred EeCCCceecccccccccchhccccccCCCccccCHHHhcC--------------------------CCCCchhhHHHHHH
Confidence 999999654221 134578999999999853 23688999999999
Q ss_pred HHHHHhcCCCCCCCCCCchhHHHHH-HHHHcCCCCCCchhh--ccCCHHHHHHHHHhcccCccccCChHHHHHHh
Q psy11767 587 ILYTMLCGRVPFHARSRDDSALSIM-ARIKEGQFNFDAEAW--STVSSEAKELTKSLLTVNPAQRIRMMRVKLTF 658 (966)
Q Consensus 587 ilyemltG~~Pf~~~~~~~~~~~~~-~~i~~~~~~~~~~~~--~~is~e~~~Li~~~L~~dP~~R~t~~~v~~~~ 658 (966)
++|+|++|+.||............. ............... ..+++++.+||.+||..||++||++.++...+
T Consensus 249 il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L 323 (345)
T 2v62_A 249 CMLRWLCGKLPWEQNLKDPVAVQTAKTNLLDELPQSVLKWAPSGSSCCEIAQFLVCAHSLAYDEKPNYQALKKIL 323 (345)
T ss_dssp HHHHHHHSSCTTGGGTTCHHHHHHHHHHHHHTTTHHHHHHSCTTSCCHHHHHHHHHHHTCCTTCCCCHHHHHHHH
T ss_pred HHHHHHhCCCCccccccccHHHHHHHHhhcccccHHHHhhccccccHHHHHHHHHHHhhcCcccCCCHHHHHHHH
Confidence 9999999999997543332222111 111111110000011 16889999999999999999999999885443
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-39 Score=362.96 Aligned_cols=242 Identities=30% Similarity=0.551 Sum_probs=203.5
Q ss_pred ccccccccccccEEEEEEEcCCCcEEEEEEecccc--------ChHHHHHHHHHhcCCCCceEEEEEEEeCCeEEEEEEc
Q psy11767 381 DKAGILGDGSYSVCRRCVEKSTGQEYAVKIISRKI--------DCSEEINLLRACQGHPNIVNLHCVFQDEVHTYLVLEL 452 (966)
Q Consensus 381 ~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~--------~~~~Ei~iL~~l~~HpnIV~l~~~~~~~~~~~lVmEy 452 (966)
...+.||+|+||.||+|.+..+++.||+|++.... ...+|+.+|+.+ +||||+++++++.+....|+||||
T Consensus 44 ~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~e~ 122 (335)
T 2owb_A 44 VRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSL-AHQHVVGFHGFFEDNDFVFVVLEL 122 (335)
T ss_dssp EEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTC-CCTTBCCEEEEEECSSEEEEEECC
T ss_pred EEEEEEeeCCCeEEEEEEECCCCCEEEEEEechhhhcCHHHHHHHHHHHHHHHhC-CCCCCCeEEEEEecCCeEEEEEec
Confidence 34688999999999999999999999999986542 234688999888 599999999999999999999999
Q ss_pred cCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCcEEEecCCCCCEEEEeecccccccC---CC
Q psy11767 453 LKGGELLDRIRQKGRCGFTENEASRIMRQLVAAVHFMHSRGVVHRDLKPENLLFSDPAGDNIKVVDFGFACLKRE---SL 529 (966)
Q Consensus 453 ~~gg~L~~~l~~~~~~~l~e~~~~~i~~Qil~aL~yLHs~~IiHRDLKP~NILl~~~~~~~iKL~DFGla~~~~~---~~ 529 (966)
+++++|.+++.... .+++.+++.++.||+.||+|||++||+||||||+|||++. ++.+||+|||++..... ..
T Consensus 123 ~~~~~L~~~~~~~~--~l~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIl~~~--~~~~kl~Dfg~~~~~~~~~~~~ 198 (335)
T 2owb_A 123 CRRRSLLELHKRRK--ALTEPEARYYLRQIVLGCQYLHRNRVIHRDLKLGNLFLNE--DLEVKIGDFGLATKVEYDGERK 198 (335)
T ss_dssp CTTCBHHHHHHHHC--SCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECT--TCCEEECCCTTCEECCSTTCCB
T ss_pred CCCCCHHHHHhccC--CCCHHHHHHHHHHHHHHHHHHHHCCCEecCCCchhEEEcC--CCCEEEeeccCceecccCcccc
Confidence 99999999987764 5999999999999999999999999999999999999975 56899999999976432 23
Q ss_pred ccccccccccCchhhccCCCCCCCcccchhhhhhhhhhhhcCCCCCCCcCcchhHHHHHHHHhcCCCCCCCCCCchhHHH
Q psy11767 530 HTPCFTLQYAAPEVLRQDKSGYDENCDLWSLGVILVNVLRQDKSGYDENCDLWSLGVILYTMLCGRVPFHARSRDDSALS 609 (966)
Q Consensus 530 ~~~~gT~~Y~APEvl~~~~~~~~~~~Di~SlGvil~el~~~~~~~y~~~~DIWSlGvilyemltG~~Pf~~~~~~~~~~~ 609 (966)
...++|+.|+|||++.. ..++.++|||||||++|+|++|+.||...... .
T Consensus 199 ~~~~gt~~y~aPE~~~~--------------------------~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~----~ 248 (335)
T 2owb_A 199 KVLCGTPNYIAPEVLSK--------------------------KGHSFEVDVWSIGCIMYTLLVGKPPFETSCLK----E 248 (335)
T ss_dssp CCCCSCCSSCCHHHHHT--------------------------SCBCTHHHHHHHHHHHHHHHHSSCTTCCSSHH----H
T ss_pred cccCCCccccCHHHhcc--------------------------CCCCchhhHHHHHHHHHHHHHCcCCCCCCCHH----H
Confidence 34578999999999853 23677899999999999999999999865432 2
Q ss_pred HHHHHHcCCCCCCchhhccCCHHHHHHHHHhcccCccccCChHHHHHHhhhhHH
Q psy11767 610 IMARIKEGQFNFDAEAWSTVSSEAKELTKSLLTVNPAQRIRMMRVKLTFHAFHQ 663 (966)
Q Consensus 610 ~~~~i~~~~~~~~~~~~~~is~e~~~Li~~~L~~dP~~R~t~~~v~~~~~~~~~ 663 (966)
....+..+.+.++ ..+++++.+||.+||..||++|||+.++ ..|+|+.
T Consensus 249 ~~~~~~~~~~~~~----~~~~~~~~~li~~~l~~dp~~Rps~~el--l~~~~~~ 296 (335)
T 2owb_A 249 TYLRIKKNEYSIP----KHINPVAASLIQKMLQTDPTARPTINEL--LNDEFFT 296 (335)
T ss_dssp HHHHHHHTCCCCC----TTSCHHHHHHHHHHTCSSGGGSCCGGGG--GGSHHHH
T ss_pred HHHHHhcCCCCCC----ccCCHHHHHHHHHHccCChhHCcCHHHH--hcCcccc
Confidence 3445555555433 3578999999999999999999999876 3456653
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-39 Score=363.17 Aligned_cols=261 Identities=29% Similarity=0.529 Sum_probs=204.8
Q ss_pred cccceecccccccccccccccccccEEEEEEEcCCC-cEEEEEEecccc----ChHHHHHHHHHhcCCCC------ceEE
Q psy11767 368 KGSLFFEQYDMDLDKAGILGDGSYSVCRRCVEKSTG-QEYAVKIISRKI----DCSEEINLLRACQGHPN------IVNL 436 (966)
Q Consensus 368 ~G~~~~~~~~i~~~~~~~LG~G~fG~Vy~a~~~~tg-~~vAvK~i~~~~----~~~~Ei~iL~~l~~Hpn------IV~l 436 (966)
.|..+.++|.+ .+.||+|+||+||+|.+..++ +.||||++.... ...+|+.+|+.+. |+| |+.+
T Consensus 13 ~g~~~~~~y~~----~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~-~~~~~~~~~~~~~ 87 (355)
T 2eu9_A 13 IGDWLQERYEI----VGNLGEGTFGKVVECLDHARGKSQVALKIIRNVGKYREAARLEINVLKKIK-EKDKENKFLCVLM 87 (355)
T ss_dssp TTCEETTTEEE----EEEEEEETTEEEEEEEETTTTTEEEEEEEECSCHHHHHHHHHHHHHHHHHH-HHCTTSCSCBCCE
T ss_pred cCceecccEEE----EEEeeccCCeEEEEEEecCCCceEEEEEEEcccccchhHHHHHHHHHHHHh-hcCCCCceeEEEe
Confidence 45556666666 688999999999999998887 799999997532 2456888888875 444 9999
Q ss_pred EEEEEeCCeEEEEEEccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCcEEEecC-------
Q psy11767 437 HCVFQDEVHTYLVLELLKGGELLDRIRQKGRCGFTENEASRIMRQLVAAVHFMHSRGVVHRDLKPENLLFSDP------- 509 (966)
Q Consensus 437 ~~~~~~~~~~~lVmEy~~gg~L~~~l~~~~~~~l~e~~~~~i~~Qil~aL~yLHs~~IiHRDLKP~NILl~~~------- 509 (966)
++++....+.|+||||+ +++|.+++.......+++.+++.++.||+.||+|||++||+||||||+|||+...
T Consensus 88 ~~~~~~~~~~~lv~e~~-~~~l~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~ivH~Dlkp~NIll~~~~~~~~~~ 166 (355)
T 2eu9_A 88 SDWFNFHGHMCIAFELL-GKNTFEFLKENNFQPYPLPHVRHMAYQLCHALRFLHENQLTHTDLKPENILFVNSEFETLYN 166 (355)
T ss_dssp EEEEEETTEEEEEEECC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEESCCCEEEEEC
T ss_pred eeeeeeCCeEEEEEecc-CCChHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEeccccccccc
Confidence 99999999999999999 7888888887665579999999999999999999999999999999999999421
Q ss_pred ----------CCCCEEEEeecccccccCCCccccccccccCchhhccCCCCCCCcccchhhhhhhhhhhhcCCCCCCCcC
Q psy11767 510 ----------AGDNIKVVDFGFACLKRESLHTPCFTLQYAAPEVLRQDKSGYDENCDLWSLGVILVNVLRQDKSGYDENC 579 (966)
Q Consensus 510 ----------~~~~iKL~DFGla~~~~~~~~~~~gT~~Y~APEvl~~~~~~~~~~~Di~SlGvil~el~~~~~~~y~~~~ 579 (966)
..+.+||+|||+++.........+||+.|+|||++.. ..|+.++
T Consensus 167 ~~~~~~~~~~~~~~~kl~Dfg~~~~~~~~~~~~~gt~~y~aPE~~~~--------------------------~~~~~~~ 220 (355)
T 2eu9_A 167 EHKSCEEKSVKNTSIRVADFGSATFDHEHHTTIVATRHYRPPEVILE--------------------------LGWAQPC 220 (355)
T ss_dssp CC-CCCEEEESCCCEEECCCTTCEETTSCCCSSCSCGGGCCHHHHTT--------------------------CCCCTHH
T ss_pred ccccccccccCCCcEEEeecCccccccccccCCcCCCcccCCeeeec--------------------------CCCCCcc
Confidence 3568999999999876666667789999999999852 2478899
Q ss_pred cchhHHHHHHHHhcCCCCCCCCCCchhHHHHHHHHHcCCCC------------C-Cchhh--------------------
Q psy11767 580 DLWSLGVILYTMLCGRVPFHARSRDDSALSIMARIKEGQFN------------F-DAEAW-------------------- 626 (966)
Q Consensus 580 DIWSlGvilyemltG~~Pf~~~~~~~~~~~~~~~i~~~~~~------------~-~~~~~-------------------- 626 (966)
|||||||++|+|++|+.||......+. ...+..+...... + ....|
T Consensus 221 Di~slG~il~el~~g~~pf~~~~~~~~-~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 299 (355)
T 2eu9_A 221 DVWSIGCILFEYYRGFTLFQTHENREH-LVMMEKILGPIPSHMIHRTRKQKYFYKGGLVWDENSSDGRYVKENCKPLKSY 299 (355)
T ss_dssp HHHHHHHHHHHHHHSSCSCCCSSHHHH-HHHHHHHHCCCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGG
T ss_pred chHHHHHHHHHHHhCCCCCCCCCHHHH-HHHHHHHcCCCcHHHhhhccchhhhcccccccccccchhccccccCCccccc
Confidence 999999999999999999987654332 2222222211000 0 00000
Q ss_pred ----ccCCHHHHHHHHHhcccCccccCChHHHHHHhhhhHH
Q psy11767 627 ----STVSSEAKELTKSLLTVNPAQRIRMMRVKLTFHAFHQ 663 (966)
Q Consensus 627 ----~~is~e~~~Li~~~L~~dP~~R~t~~~v~~~~~~~~~ 663 (966)
...+.++.+||.+||+.||++|||+.++ ..|+|+.
T Consensus 300 ~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~e~--l~hp~f~ 338 (355)
T 2eu9_A 300 MLQDSLEHVQLFDLMRRMLEFDPAQRITLAEA--LLHPFFA 338 (355)
T ss_dssp CSCCSHHHHHHHHHHHHHTCSSTTTSCCHHHH--TTSGGGG
T ss_pred ccccchhHHHHHHHHHHHhcCChhhCcCHHHH--hcChhhc
Confidence 1124578899999999999999999876 4577764
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-39 Score=352.49 Aligned_cols=242 Identities=23% Similarity=0.393 Sum_probs=188.4
Q ss_pred cccccccccccEEEEEEEcCC---CcEEEEEEeccccC------hHHHHHHHHHhcCCCCceEEEEEEEeCCeEEEEEEc
Q psy11767 382 KAGILGDGSYSVCRRCVEKST---GQEYAVKIISRKID------CSEEINLLRACQGHPNIVNLHCVFQDEVHTYLVLEL 452 (966)
Q Consensus 382 ~~~~LG~G~fG~Vy~a~~~~t---g~~vAvK~i~~~~~------~~~Ei~iL~~l~~HpnIV~l~~~~~~~~~~~lVmEy 452 (966)
..+.||+|+||.||+|.+..+ +..||||++..... ..+|+.+|+.+ +||||+++++++. ++..|+||||
T Consensus 19 ~~~~lg~G~~g~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~-~~~~~lv~e~ 96 (281)
T 1mp8_A 19 LGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQF-DHPHIVKLIGVIT-ENPVWIIMEL 96 (281)
T ss_dssp EEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTC-CCTTBCCEEEEEC-SSSCEEEEEC
T ss_pred EEeEeeecCCeeEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHHhC-CCCccceEEEEEc-cCccEEEEec
Confidence 368899999999999999764 56799999865322 44688999888 5999999999984 5678999999
Q ss_pred cCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCcEEEecCCCCCEEEEeecccccccCC----
Q psy11767 453 LKGGELLDRIRQKGRCGFTENEASRIMRQLVAAVHFMHSRGVVHRDLKPENLLFSDPAGDNIKVVDFGFACLKRES---- 528 (966)
Q Consensus 453 ~~gg~L~~~l~~~~~~~l~e~~~~~i~~Qil~aL~yLHs~~IiHRDLKP~NILl~~~~~~~iKL~DFGla~~~~~~---- 528 (966)
+++|+|.+++.... ..+++..+..++.||+.||+|||++||+||||||+|||++. ++.+||+|||+++.....
T Consensus 97 ~~~~~L~~~l~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~--~~~~kl~Dfg~~~~~~~~~~~~ 173 (281)
T 1mp8_A 97 CTLGELRSFLQVRK-YSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSS--NDCVKLGDFGLSRYMEDSTYYK 173 (281)
T ss_dssp CTTEEHHHHHHHTT-TTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEE--TTEEEECC--------------
T ss_pred CCCCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHhCCeecccccHHHEEECC--CCCEEECccccccccCcccccc
Confidence 99999999997654 35899999999999999999999999999999999999985 568999999999765432
Q ss_pred CccccccccccCchhhccCCCCCCCcccchhhhhhhhhhhhcCCCCCCCcCcchhHHHHHHHHhc-CCCCCCCCCCchhH
Q psy11767 529 LHTPCFTLQYAAPEVLRQDKSGYDENCDLWSLGVILVNVLRQDKSGYDENCDLWSLGVILYTMLC-GRVPFHARSRDDSA 607 (966)
Q Consensus 529 ~~~~~gT~~Y~APEvl~~~~~~~~~~~Di~SlGvil~el~~~~~~~y~~~~DIWSlGvilyemlt-G~~Pf~~~~~~~~~ 607 (966)
.....+|+.|+|||++.. ..|+.++|||||||++|+|++ |..||.+....+
T Consensus 174 ~~~~~~~~~y~aPE~~~~--------------------------~~~~~~~Di~slG~~l~ell~~g~~pf~~~~~~~-- 225 (281)
T 1mp8_A 174 ASKGKLPIKWMAPESINF--------------------------RRFTSASDVWMFGVCMWEILMHGVKPFQGVKNND-- 225 (281)
T ss_dssp -----CCGGGCCHHHHHH--------------------------CCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGGG--
T ss_pred cccCCCcccccChhhccc--------------------------CCCCCccCchHHHHHHHHHHhcCCCCCCcCCHHH--
Confidence 123456789999999853 236788999999999999996 999998766543
Q ss_pred HHHHHHHHcCCCCCCchhhccCCHHHHHHHHHhcccCccccCChHHHHHHhhhh
Q psy11767 608 LSIMARIKEGQFNFDAEAWSTVSSEAKELTKSLLTVNPAQRIRMMRVKLTFHAF 661 (966)
Q Consensus 608 ~~~~~~i~~~~~~~~~~~~~~is~e~~~Li~~~L~~dP~~R~t~~~v~~~~~~~ 661 (966)
....+..+.... ....+++++.++|.+||..||++|||+.++...+..+
T Consensus 226 --~~~~i~~~~~~~---~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~ 274 (281)
T 1mp8_A 226 --VIGRIENGERLP---MPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTI 274 (281)
T ss_dssp --HHHHHHTTCCCC---CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred --HHHHHHcCCCCC---CCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHH
Confidence 334455443221 2346899999999999999999999999886655543
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-39 Score=351.62 Aligned_cols=250 Identities=35% Similarity=0.594 Sum_probs=203.0
Q ss_pred eecccccccccccccccccccEEEEEEEcCCCcEEEEEEecccc------ChHHHHHHHHHhcCCCCceEEEEEEEeCCe
Q psy11767 372 FFEQYDMDLDKAGILGDGSYSVCRRCVEKSTGQEYAVKIISRKI------DCSEEINLLRACQGHPNIVNLHCVFQDEVH 445 (966)
Q Consensus 372 ~~~~~~i~~~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~------~~~~Ei~iL~~l~~HpnIV~l~~~~~~~~~ 445 (966)
|.++|.+ .+.||+|+||.||+|.+..+|+.||||++.... ...+|+.+++.+ +||||+++++++.++..
T Consensus 5 ~~~~y~~----~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~ 79 (276)
T 2yex_A 5 FVEDWDL----VQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKML-NHENVVKFYGHRREGNI 79 (276)
T ss_dssp HHHHEEE----EEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGCTTHHHHHHHHHHHHHTC-CCTTBCCEEEEEEETTE
T ss_pred eecceEE----EEEeecCCCcEEEEEEECCCCcEEEEEEeeeccchhhhHHHHHHHHHHHhc-CCCCceeeeeEEEcCCE
Confidence 3445554 688999999999999999999999999986432 245689999888 59999999999999999
Q ss_pred EEEEEEccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCcEEEecCCCCCEEEEeecccccc
Q psy11767 446 TYLVLELLKGGELLDRIRQKGRCGFTENEASRIMRQLVAAVHFMHSRGVVHRDLKPENLLFSDPAGDNIKVVDFGFACLK 525 (966)
Q Consensus 446 ~~lVmEy~~gg~L~~~l~~~~~~~l~e~~~~~i~~Qil~aL~yLHs~~IiHRDLKP~NILl~~~~~~~iKL~DFGla~~~ 525 (966)
.|+||||+++++|.+++.... .+++.+++.++.||+.||+|||++||+||||||+|||++. ++.+||+|||++...
T Consensus 80 ~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~--~~~~kl~dfg~~~~~ 155 (276)
T 2yex_A 80 QYLFLEYCSGGELFDRIEPDI--GMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDE--RDNLKISDFGLATVF 155 (276)
T ss_dssp EEEEEECCTTEEGGGGSBTTT--BCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECT--TCCEEECCCTTCEEC
T ss_pred EEEEEEecCCCcHHHHHhhcc--CCCHHHHHHHHHHHHHHHHHHHhCCeeccCCChHHEEEcc--CCCEEEeeCCCcccc
Confidence 999999999999999886543 5999999999999999999999999999999999999974 568999999999754
Q ss_pred cC-----CCccccccccccCchhhccCCCCCCCcccchhhhhhhhhhhhcCCCCCCCcCcchhHHHHHHHHhcCCCCCCC
Q psy11767 526 RE-----SLHTPCFTLQYAAPEVLRQDKSGYDENCDLWSLGVILVNVLRQDKSGYDENCDLWSLGVILYTMLCGRVPFHA 600 (966)
Q Consensus 526 ~~-----~~~~~~gT~~Y~APEvl~~~~~~~~~~~Di~SlGvil~el~~~~~~~y~~~~DIWSlGvilyemltG~~Pf~~ 600 (966)
.. .....++|+.|+|||++... ..++.++|||||||++|+|++|+.||..
T Consensus 156 ~~~~~~~~~~~~~~~~~y~aPE~~~~~-------------------------~~~~~~~Di~slG~il~~l~~g~~p~~~ 210 (276)
T 2yex_A 156 RYNNRERLLNKMCGTLPYVAPELLKRR-------------------------EFHAEPVDVWSCGIVLTAMLAGELPWDQ 210 (276)
T ss_dssp EETTEECCBCCCCSCGGGCCGGGGTCS-------------------------SBCHHHHHHHHHHHHHHHHHHSSCCCSC
T ss_pred CCCcchhcccCCccccCccChHHHhcC-------------------------CCCCCcchHHHHHHHHHHHHhCCCCCCC
Confidence 21 23456789999999998532 1135679999999999999999999987
Q ss_pred CCCchhHHHHHHHHHcCCCCCCchhhccCCHHHHHHHHHhcccCccccCChHHHHHHhhhhH
Q psy11767 601 RSRDDSALSIMARIKEGQFNFDAEAWSTVSSEAKELTKSLLTVNPAQRIRMMRVKLTFHAFH 662 (966)
Q Consensus 601 ~~~~~~~~~~~~~i~~~~~~~~~~~~~~is~e~~~Li~~~L~~dP~~R~t~~~v~~~~~~~~ 662 (966)
....... ...+....... ..+..+++++.+||.+||..||++|||+.++ ..|+|+
T Consensus 211 ~~~~~~~---~~~~~~~~~~~--~~~~~~~~~~~~li~~~l~~~p~~Rps~~~i--l~~~~~ 265 (276)
T 2yex_A 211 PSDSCQE---YSDWKEKKTYL--NPWKKIDSAPLALLHKILVENPSARITIPDI--KKDRWY 265 (276)
T ss_dssp SCTTSHH---HHHHHTTCTTS--TTGGGSCHHHHHHHHHHSCSSTTTSCCHHHH--TTCTTT
T ss_pred CchHHHH---HHHhhhccccc--CchhhcCHHHHHHHHHHCCCCchhCCCHHHH--hcCccc
Confidence 6543322 22233322222 2345789999999999999999999999876 335554
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-39 Score=349.42 Aligned_cols=242 Identities=22% Similarity=0.419 Sum_probs=200.7
Q ss_pred ccccccccccccccEEEEEEEcCCCcEEEEEEeccc-cChHHHHHHHHHhcCCCCceEEEEEEEe---------------
Q psy11767 379 DLDKAGILGDGSYSVCRRCVEKSTGQEYAVKIISRK-IDCSEEINLLRACQGHPNIVNLHCVFQD--------------- 442 (966)
Q Consensus 379 ~~~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~-~~~~~Ei~iL~~l~~HpnIV~l~~~~~~--------------- 442 (966)
+|+..+.||+|+||.||+|.+..+|+.||||++... ....+|+++|+.+ .||||+++++++..
T Consensus 12 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~~~~~~~~~~~ 90 (284)
T 2a19_B 12 DFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNNEKAEREVKALAKL-DHVNIVHYNGCWDGFDYDPETSSKNSSRS 90 (284)
T ss_dssp HEEEEEEEECSSSCCEEEEEETTTCCEEEEEEEECCSGGGHHHHHHHHHC-CCTTBCCEEEEEEEEEEC---------CC
T ss_pred ccceeeeeccCCceEEEEEEEcCCCeEEEEEEeccccHHHHHHHHHHHhC-CCCCEEEEeeeEeccccCccccccccccc
Confidence 344578999999999999999999999999999754 3467899999998 59999999999865
Q ss_pred -CCeEEEEEEccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCcEEEecCCCCCEEEEeecc
Q psy11767 443 -EVHTYLVLELLKGGELLDRIRQKGRCGFTENEASRIMRQLVAAVHFMHSRGVVHRDLKPENLLFSDPAGDNIKVVDFGF 521 (966)
Q Consensus 443 -~~~~~lVmEy~~gg~L~~~l~~~~~~~l~e~~~~~i~~Qil~aL~yLHs~~IiHRDLKP~NILl~~~~~~~iKL~DFGl 521 (966)
....|+||||+++|+|.+++.......+++..++.++.||+.||+|||++||+||||||+|||+++ ++.+||+|||+
T Consensus 91 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~--~~~~kl~Dfg~ 168 (284)
T 2a19_B 91 KTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLALELFEQITKGVDYIHSKKLINRDLKPSNIFLVD--TKQVKIGDFGL 168 (284)
T ss_dssp EEEEEEEEECCCCSCBHHHHHHHGGGSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEE--TTEEEECCCTT
T ss_pred CcceEEEEEeccCCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCHHHEEEcC--CCCEEECcchh
Confidence 445899999999999999998764446999999999999999999999999999999999999985 56899999999
Q ss_pred cccccCC--CccccccccccCchhhccCCCCCCCcccchhhhhhhhhhhhcCCCCCCCcCcchhHHHHHHHHhcCCCCCC
Q psy11767 522 ACLKRES--LHTPCFTLQYAAPEVLRQDKSGYDENCDLWSLGVILVNVLRQDKSGYDENCDLWSLGVILYTMLCGRVPFH 599 (966)
Q Consensus 522 a~~~~~~--~~~~~gT~~Y~APEvl~~~~~~~~~~~Di~SlGvil~el~~~~~~~y~~~~DIWSlGvilyemltG~~Pf~ 599 (966)
+...... .....+|+.|+|||++.. ..|+.++|||||||++|+|++|..||.
T Consensus 169 ~~~~~~~~~~~~~~~~~~y~aPE~~~~--------------------------~~~~~~~Di~slG~il~~l~~~~~~~~ 222 (284)
T 2a19_B 169 VTSLKNDGKRTRSKGTLRYMSPEQISS--------------------------QDYGKEVDLYALGLILAELLHVCDTAF 222 (284)
T ss_dssp CEESSCCSCCCCCCSCCTTSCHHHHHC--------------------------SCCCTHHHHHHHHHHHHHHHSCCSSHH
T ss_pred heeccccccccccCCcccccChhhhcc--------------------------CCCcchhhhHHHHHHHHHHHhcCCcch
Confidence 9765432 334578999999999853 236789999999999999999999885
Q ss_pred CCCCchhHHHHHHHHHcCCCCCCchhhccCCHHHHHHHHHhcccCccccCChHHHHHHhhhh
Q psy11767 600 ARSRDDSALSIMARIKEGQFNFDAEAWSTVSSEAKELTKSLLTVNPAQRIRMMRVKLTFHAF 661 (966)
Q Consensus 600 ~~~~~~~~~~~~~~i~~~~~~~~~~~~~~is~e~~~Li~~~L~~dP~~R~t~~~v~~~~~~~ 661 (966)
.. ......+..+.+. ..++.++++||.+||..||++|||+.++...+..+
T Consensus 223 ~~------~~~~~~~~~~~~~------~~~~~~~~~li~~~l~~dp~~Rps~~e~l~~l~~~ 272 (284)
T 2a19_B 223 ET------SKFFTDLRDGIIS------DIFDKKEKTLLQKLLSKKPEDRPNTSEILRTLTVW 272 (284)
T ss_dssp HH------HHHHHHHHTTCCC------TTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred hH------HHHHHHhhccccc------ccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHH
Confidence 31 1233344444321 35788999999999999999999999886554443
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-39 Score=361.07 Aligned_cols=245 Identities=20% Similarity=0.364 Sum_probs=198.7
Q ss_pred ccccccccccccEEEEEEEcCCCc-----EEEEEEeccccC------hHHHHHHHHHhcCCCCceEEEEEEEeCCeEEEE
Q psy11767 381 DKAGILGDGSYSVCRRCVEKSTGQ-----EYAVKIISRKID------CSEEINLLRACQGHPNIVNLHCVFQDEVHTYLV 449 (966)
Q Consensus 381 ~~~~~LG~G~fG~Vy~a~~~~tg~-----~vAvK~i~~~~~------~~~Ei~iL~~l~~HpnIV~l~~~~~~~~~~~lV 449 (966)
...+.||+|+||.||+|.+..+++ .||||++..... ..+|+.+|+.+.+||||+++++++.++...|+|
T Consensus 49 ~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv 128 (333)
T 2i1m_A 49 QFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHENIVNLLGACTHGGPVLVI 128 (333)
T ss_dssp EEEEEEEECSSEEEEEEEETTCSSSCCCCEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEE
T ss_pred eeeeEeccCCCcceEEEEecCCCcccchhHHHHHhcccccChHHHHHHHHHHHHHHhhcCCCCeeeEEEEEecCCceEEE
Confidence 346889999999999999987765 799999975432 457999999986799999999999999999999
Q ss_pred EEccCCCCHHHHHHhcC------------CCCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCcEEEecCCCCCEEEE
Q psy11767 450 LELLKGGELLDRIRQKG------------RCGFTENEASRIMRQLVAAVHFMHSRGVVHRDLKPENLLFSDPAGDNIKVV 517 (966)
Q Consensus 450 mEy~~gg~L~~~l~~~~------------~~~l~e~~~~~i~~Qil~aL~yLHs~~IiHRDLKP~NILl~~~~~~~iKL~ 517 (966)
|||+++|+|.+++.... ...+++..++.++.||+.||+|||++||+||||||+|||++. ++.+||+
T Consensus 129 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~NIl~~~--~~~~kl~ 206 (333)
T 2i1m_A 129 TEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLASKNCIHRDVAARNVLLTN--GHVAKIG 206 (333)
T ss_dssp EECCTTEEHHHHHHHHHHHHSCC-------CCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGCEEEG--GGEEEBC
T ss_pred EecCCCCcHHHHHHHhcccccccccccccccccCHHHHHHHHHHHHHHHHHHhcCCcccCCcccceEEECC--CCeEEEC
Confidence 99999999999997642 235899999999999999999999999999999999999985 5689999
Q ss_pred eecccccccCC-----CccccccccccCchhhccCCCCCCCcccchhhhhhhhhhhhcCCCCCCCcCcchhHHHHHHHHh
Q psy11767 518 DFGFACLKRES-----LHTPCFTLQYAAPEVLRQDKSGYDENCDLWSLGVILVNVLRQDKSGYDENCDLWSLGVILYTML 592 (966)
Q Consensus 518 DFGla~~~~~~-----~~~~~gT~~Y~APEvl~~~~~~~~~~~Di~SlGvil~el~~~~~~~y~~~~DIWSlGvilyeml 592 (966)
|||++...... .....+|+.|+|||++.. ..|+.++|||||||++|+|+
T Consensus 207 Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~--------------------------~~~~~~~Di~slG~il~el~ 260 (333)
T 2i1m_A 207 DFGLARDIMNDSNYIVKGNARLPVKWMAPESIFD--------------------------CVYTVQSDVWSYGILLWEIF 260 (333)
T ss_dssp CCGGGCCGGGCTTSEECSSCEECGGGSCHHHHHH--------------------------CCCCHHHHHHHHHHHHHHHT
T ss_pred ccccccccccccceeecCCCCCCccccCHHHhcc--------------------------CCCChHHHHHHHHHHHHHHH
Confidence 99999754322 123456889999998853 23678899999999999999
Q ss_pred c-CCCCCCCCCCchhHHHHHHHHHcCCCCCCchhhccCCHHHHHHHHHhcccCccccCChHHHHHHhh
Q psy11767 593 C-GRVPFHARSRDDSALSIMARIKEGQFNFDAEAWSTVSSEAKELTKSLLTVNPAQRIRMMRVKLTFH 659 (966)
Q Consensus 593 t-G~~Pf~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~is~e~~~Li~~~L~~dP~~R~t~~~v~~~~~ 659 (966)
+ |..||.+........ ..+..+ .... .....++++.+||.+||..||.+|||+.++...+.
T Consensus 261 t~g~~p~~~~~~~~~~~---~~~~~~-~~~~--~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~ 322 (333)
T 2i1m_A 261 SLGLNPYPGILVNSKFY---KLVKDG-YQMA--QPAFAPKNIYSIMQACWALEPTHRPTFQQICSFLQ 322 (333)
T ss_dssp TTSCCSSTTCCSSHHHH---HHHHHT-CCCC--CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred cCCCCCCcccchhHHHH---HHHhcC-CCCC--CCCCCCHHHHHHHHHHhccChhhCcCHHHHHHHHH
Confidence 8 999998766543322 222222 1111 12346889999999999999999999998855444
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-38 Score=352.11 Aligned_cols=253 Identities=26% Similarity=0.425 Sum_probs=194.4
Q ss_pred eecccccccccccccccccccEEEEEEEcCCCcEEEEEEecccc--------ChHHHHHHHHHhcCCCCceEEEEEEEeC
Q psy11767 372 FFEQYDMDLDKAGILGDGSYSVCRRCVEKSTGQEYAVKIISRKI--------DCSEEINLLRACQGHPNIVNLHCVFQDE 443 (966)
Q Consensus 372 ~~~~~~i~~~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~--------~~~~Ei~iL~~l~~HpnIV~l~~~~~~~ 443 (966)
..++|.+ .+.||+|+||.||+|.+..+|+.||||++.... ...+|+.+|+.+ +||||+++++++.++
T Consensus 30 ~~~~y~~----~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~~ 104 (310)
T 2wqm_A 30 TLANFRI----EKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQL-NHPNVIKYYASFIED 104 (310)
T ss_dssp SGGGEEE----EEEEECC--CEEEEEEETTTCCEEEEEEECTTSSCCHHHHHHHHHHHHHHHTC-CCTTBCCEEEEEEET
T ss_pred cccceEE----EEeecCCCCceEEEEEEcCCCceEEEEeeehhhccCHHHHHHHHHHHHHHHhC-CCCCEeeEEEEEEcC
Confidence 3344554 688999999999999999999999999986421 244699999988 599999999999999
Q ss_pred CeEEEEEEccCCCCHHHHHHhc--CCCCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCcEEEecCCCCCEEEEeecc
Q psy11767 444 VHTYLVLELLKGGELLDRIRQK--GRCGFTENEASRIMRQLVAAVHFMHSRGVVHRDLKPENLLFSDPAGDNIKVVDFGF 521 (966)
Q Consensus 444 ~~~~lVmEy~~gg~L~~~l~~~--~~~~l~e~~~~~i~~Qil~aL~yLHs~~IiHRDLKP~NILl~~~~~~~iKL~DFGl 521 (966)
...++||||+++++|.+++... ....+++..++.++.||+.||+|||++||+||||||+|||++. ++.+||+|||+
T Consensus 105 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~NIl~~~--~~~~kl~Dfg~ 182 (310)
T 2wqm_A 105 NELNIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMHSRRVMHRDIKPANVFITA--TGVVKLGDLGL 182 (310)
T ss_dssp TEEEEEEECCCSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECT--TSCEEECCC--
T ss_pred CcEEEEEecCCCCCHHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHhhCCeeCCCCcHHHEEEcC--CCCEEEEeccc
Confidence 9999999999999999998652 2346899999999999999999999999999999999999974 56899999999
Q ss_pred cccccCC---CccccccccccCchhhccCCCCCCCcccchhhhhhhhhhhhcCCCCCCCcCcchhHHHHHHHHhcCCCCC
Q psy11767 522 ACLKRES---LHTPCFTLQYAAPEVLRQDKSGYDENCDLWSLGVILVNVLRQDKSGYDENCDLWSLGVILYTMLCGRVPF 598 (966)
Q Consensus 522 a~~~~~~---~~~~~gT~~Y~APEvl~~~~~~~~~~~Di~SlGvil~el~~~~~~~y~~~~DIWSlGvilyemltG~~Pf 598 (966)
+...... .....+|+.|+|||++.. ..++.++|||||||++|+|++|+.||
T Consensus 183 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~--------------------------~~~~~~~Dv~slG~il~~l~~g~~p~ 236 (310)
T 2wqm_A 183 GRFFSSKTTAAHSLVGTPYYMSPERIHE--------------------------NGYNFKSDIWSLGCLLYEMAALQSPF 236 (310)
T ss_dssp ----------------CCSSCCHHHHTT--------------------------CCCCHHHHHHHHHHHHHHHHHSSCTT
T ss_pred eeeecCCCccccccCCCeeEeChHHhCC--------------------------CCCCchhhHHHHHHHHHHHHhCCCCC
Confidence 8754332 234568999999998852 23678899999999999999999999
Q ss_pred CCCCCchhHHHHHHHHHcCCCCCCchhhccCCHHHHHHHHHhcccCccccCChHHHHHHhhhh
Q psy11767 599 HARSRDDSALSIMARIKEGQFNFDAEAWSTVSSEAKELTKSLLTVNPAQRIRMMRVKLTFHAF 661 (966)
Q Consensus 599 ~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~is~e~~~Li~~~L~~dP~~R~t~~~v~~~~~~~ 661 (966)
.+..... ......+..+.+... ....+++++.+||.+||..||++|||+.++...+..+
T Consensus 237 ~~~~~~~--~~~~~~~~~~~~~~~--~~~~~~~~l~~li~~~l~~dp~~Rps~~~il~~l~~l 295 (310)
T 2wqm_A 237 YGDKMNL--YSLCKKIEQCDYPPL--PSDHYSEELRQLVNMCINPDPEKRPDVTYVYDVAKRM 295 (310)
T ss_dssp C---CCH--HHHHHHHHTTCSCCC--CTTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred cccchhH--HHHHHHhhcccCCCC--cccccCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHH
Confidence 8654332 234455555544322 2346899999999999999999999999886555443
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 4e4m_A* 4f08_A* 4f09_A* 3q32_A* 3rvg_A* 4hge_A* 3tjc_A* 3tjd_A* 4bbe_A* 4bbf_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-39 Score=357.07 Aligned_cols=247 Identities=21% Similarity=0.338 Sum_probs=193.7
Q ss_pred cccccccccccEEEEEE----EcCCCcEEEEEEecccc-----ChHHHHHHHHHhcCCCCceEEEEEEEeC--CeEEEEE
Q psy11767 382 KAGILGDGSYSVCRRCV----EKSTGQEYAVKIISRKI-----DCSEEINLLRACQGHPNIVNLHCVFQDE--VHTYLVL 450 (966)
Q Consensus 382 ~~~~LG~G~fG~Vy~a~----~~~tg~~vAvK~i~~~~-----~~~~Ei~iL~~l~~HpnIV~l~~~~~~~--~~~~lVm 450 (966)
..+.||+|+||+||+|+ +..+|+.||||++.... ...+|+.+|+.+ +||||+++++++... ...|+||
T Consensus 14 ~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~~~lv~ 92 (295)
T 3ugc_A 14 FLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSL-QHDNIVKYKGVCYSAGRRNLKLIM 92 (295)
T ss_dssp EEEEEEECSSEEEEEEEECTTCSSCCEEEEEEEESCCCHHHHHHHHHHHHHHHTC-CCTTBCCEEEEECHHHHTSCEEEE
T ss_pred hhheeeccCCEEEEEEEEecccCCCCcEEEEEEcccCCHHHHHHHHHHHHHHHhC-CCCCEeeEEEEEecCCCCceEEEE
Confidence 36899999999999998 66789999999987543 245799999998 599999999998653 5689999
Q ss_pred EccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCcEEEecCCCCCEEEEeecccccccCC--
Q psy11767 451 ELLKGGELLDRIRQKGRCGFTENEASRIMRQLVAAVHFMHSRGVVHRDLKPENLLFSDPAGDNIKVVDFGFACLKRES-- 528 (966)
Q Consensus 451 Ey~~gg~L~~~l~~~~~~~l~e~~~~~i~~Qil~aL~yLHs~~IiHRDLKP~NILl~~~~~~~iKL~DFGla~~~~~~-- 528 (966)
|||++|+|.+++..... .+++.++..++.||+.||+|||++||+||||||+|||++. ++.+||+|||++......
T Consensus 93 e~~~~~~L~~~l~~~~~-~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dikp~Nil~~~--~~~~kl~Dfg~~~~~~~~~~ 169 (295)
T 3ugc_A 93 EYLPYGSLRDYLQKHKE-RIDHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILVEN--ENRVKIGDFGLTKVLPQDKE 169 (295)
T ss_dssp ECCTTCBHHHHHHHCGG-GCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEE--TTEEEECCCCSCC-------
T ss_pred EeCCCCCHHHHHHhccc-ccCHHHHHHHHHHHHHHHHHHhcCCcccCCCCHhhEEEcC--CCeEEEccCcccccccCCcc
Confidence 99999999999977543 5899999999999999999999999999999999999985 568999999999765322
Q ss_pred ----CccccccccccCchhhccCCCCCCCcccchhhhhhhhhhhhcCCCCCCCcCcchhHHHHHHHHhcCCCCCCCCCCc
Q psy11767 529 ----LHTPCFTLQYAAPEVLRQDKSGYDENCDLWSLGVILVNVLRQDKSGYDENCDLWSLGVILYTMLCGRVPFHARSRD 604 (966)
Q Consensus 529 ----~~~~~gT~~Y~APEvl~~~~~~~~~~~Di~SlGvil~el~~~~~~~y~~~~DIWSlGvilyemltG~~Pf~~~~~~ 604 (966)
.....+|+.|+|||++.. ..|+.++|||||||++|+|++|..||......
T Consensus 170 ~~~~~~~~~~~~~y~aPE~~~~--------------------------~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~ 223 (295)
T 3ugc_A 170 FFKVKEPGESPIFWYAPESLTE--------------------------SKFSVASDVWSFGVVLYELFTYIEKSKSPPAE 223 (295)
T ss_dssp ------CTTCGGGGCCHHHHHH--------------------------CCCCHHHHHHHHHHHHHHHHHTTCTTCSHHHH
T ss_pred eeeeccCCCCccceeCcHHhcC--------------------------CCCChHHHHHHHHHHHHHHHhcccccCCChHH
Confidence 123346788999999853 23788999999999999999999998643110
Q ss_pred ------------hhHHHHHHHHHcCCCCCCchhhccCCHHHHHHHHHhcccCccccCChHHHHHHhhhh
Q psy11767 605 ------------DSALSIMARIKEGQFNFDAEAWSTVSSEAKELTKSLLTVNPAQRIRMMRVKLTFHAF 661 (966)
Q Consensus 605 ------------~~~~~~~~~i~~~~~~~~~~~~~~is~e~~~Li~~~L~~dP~~R~t~~~v~~~~~~~ 661 (966)
.........+..+... .....+++++.+||.+||..||++|||+.++...+..+
T Consensus 224 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~l~~li~~~l~~dp~~Rps~~el~~~L~~l 289 (295)
T 3ugc_A 224 FMRMIGNDKQGQMIVFHLIELLKNNGRL---PRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQI 289 (295)
T ss_dssp HHHHHCTTCCTHHHHHHHHHHHHTTCCC---CCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHH
T ss_pred HHhhhcCccccchhHHHHHHHHhccCcC---CCCcCcCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHH
Confidence 0011222233332211 12346789999999999999999999999886555443
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-40 Score=377.30 Aligned_cols=264 Identities=22% Similarity=0.345 Sum_probs=203.4
Q ss_pred eecccccccccccccccccccEEEEEEEcCCCcEEEEEEecccc------ChHHHHHHHHHhcCCCCceEEEEEEEeCC-
Q psy11767 372 FFEQYDMDLDKAGILGDGSYSVCRRCVEKSTGQEYAVKIISRKI------DCSEEINLLRACQGHPNIVNLHCVFQDEV- 444 (966)
Q Consensus 372 ~~~~~~i~~~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~------~~~~Ei~iL~~l~~HpnIV~l~~~~~~~~- 444 (966)
+.++|.+ .+.||+|+||+||+|++..+|+.||||++.... ...+|+++|+.+ +|||||++++++.+..
T Consensus 7 ~~~~y~i----~~~LG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l-~hpnIv~~~~~~~~~~~ 81 (396)
T 4eut_A 7 SNHLWLL----SDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKL-NHKNIVKLFAIEEETTT 81 (396)
T ss_dssp SSEEEEE----EEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHC-CCTTBCCEEEEEECTTT
T ss_pred CCCceEE----EEEEEcCCCeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhc-CCCCCCeEEEeeccCCC
Confidence 3345555 688999999999999999999999999987532 234799999998 5999999999998765
Q ss_pred -eEEEEEEccCCCCHHHHHHhcCC-CCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCcEEEec--CCCCCEEEEeec
Q psy11767 445 -HTYLVLELLKGGELLDRIRQKGR-CGFTENEASRIMRQLVAAVHFMHSRGVVHRDLKPENLLFSD--PAGDNIKVVDFG 520 (966)
Q Consensus 445 -~~~lVmEy~~gg~L~~~l~~~~~-~~l~e~~~~~i~~Qil~aL~yLHs~~IiHRDLKP~NILl~~--~~~~~iKL~DFG 520 (966)
..|+|||||+||+|.+++..... ..+++.+++.++.||+.||+|||++||+||||||+|||+.. ...+.+||+|||
T Consensus 82 ~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~kL~DFG 161 (396)
T 4eut_A 82 RHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFG 161 (396)
T ss_dssp CCEEEEECCCTTEEHHHHTTSGGGTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEEECTTSCEEEEECCGG
T ss_pred CeeEEEEecCCCCCHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHHCCEEECCcCHHHEEEeecCCCceeEEEecCC
Confidence 78999999999999999976432 23999999999999999999999999999999999999821 134569999999
Q ss_pred ccccccC--CCccccccccccCchhhccCCCCCCCcccchhhhhhhhhhhhcCCCCCCCcCcchhHHHHHHHHhcCCCCC
Q psy11767 521 FACLKRE--SLHTPCFTLQYAAPEVLRQDKSGYDENCDLWSLGVILVNVLRQDKSGYDENCDLWSLGVILYTMLCGRVPF 598 (966)
Q Consensus 521 la~~~~~--~~~~~~gT~~Y~APEvl~~~~~~~~~~~Di~SlGvil~el~~~~~~~y~~~~DIWSlGvilyemltG~~Pf 598 (966)
+|+.... .....+||+.|+|||++......- .....|+.++|||||||++|+|++|+.||
T Consensus 162 ~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~------------------~~~~~~~~~~DiwSlG~il~el~tg~~Pf 223 (396)
T 4eut_A 162 AARELEDDEQFVSLYGTEEYLHPDMYERAVLRK------------------DHQKKYGATVDLWSIGVTFYHAATGSLPF 223 (396)
T ss_dssp GCEECCCGGGSSCSSSCCTTCCHHHHHHHCC--------------------CHHHHHHHHHHHHHHHHHHHHHHHSSCSE
T ss_pred CceEccCCCccccccCCccccCHHHhhcccccc------------------ccccCCCcHHHHHHHHHHHHHHHHCCCCC
Confidence 9976543 234567899999999985311000 00123567899999999999999999999
Q ss_pred CCCCCchhHHHHHHHHHcCCCCC---------------------CchhhccCCHHHHHHHHHhcccCccccCChHHHHHH
Q psy11767 599 HARSRDDSALSIMARIKEGQFNF---------------------DAEAWSTVSSEAKELTKSLLTVNPAQRIRMMRVKLT 657 (966)
Q Consensus 599 ~~~~~~~~~~~~~~~i~~~~~~~---------------------~~~~~~~is~e~~~Li~~~L~~dP~~R~t~~~v~~~ 657 (966)
...........++..+..+.... .......++..+.++|.+||+.||++|+++.++...
T Consensus 224 ~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~ll~~~L~~dP~~R~s~~e~l~~ 303 (396)
T 4eut_A 224 RPFEGPRRNKEVMYKIITGKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAE 303 (396)
T ss_dssp ECTTCTTTCHHHHHHHHHSCCTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHH
T ss_pred CCCCcccchHHHHHHHhcCCCcccchhheeccCCCcccCccCCcccccchHHHhhchHHHHHhhccChhhhccHHHHHHH
Confidence 76544333345555555543211 001112356678899999999999999999987443
Q ss_pred h
Q psy11767 658 F 658 (966)
Q Consensus 658 ~ 658 (966)
.
T Consensus 304 l 304 (396)
T 4eut_A 304 T 304 (396)
T ss_dssp H
T ss_pred H
Confidence 3
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-39 Score=357.02 Aligned_cols=252 Identities=31% Similarity=0.457 Sum_probs=201.1
Q ss_pred ccccccccccccEEEEEEEc-CCCcEEEEEEeccc-------cChHHHHHHHHHhc--CCCCceEEEEEEE-----eCCe
Q psy11767 381 DKAGILGDGSYSVCRRCVEK-STGQEYAVKIISRK-------IDCSEEINLLRACQ--GHPNIVNLHCVFQ-----DEVH 445 (966)
Q Consensus 381 ~~~~~LG~G~fG~Vy~a~~~-~tg~~vAvK~i~~~-------~~~~~Ei~iL~~l~--~HpnIV~l~~~~~-----~~~~ 445 (966)
+..+.||+|+||.||+|.+. .+|+.||||++... ....+|+.+++.+. +||||+++++++. ....
T Consensus 14 ~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~~~~~ 93 (326)
T 1blx_A 14 ECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDRETK 93 (326)
T ss_dssp EEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEECSSEEE
T ss_pred eeeeeecccccEEEEEEEecCCCCEEEEEEEeccCcccccCCchhhHHHHHHHhhhccCCCCeEeeeeeeeecccCCCce
Confidence 34688999999999999996 67899999998642 23567888888774 6999999999987 5567
Q ss_pred EEEEEEccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCcEEEecCCCCCEEEEeecccccc
Q psy11767 446 TYLVLELLKGGELLDRIRQKGRCGFTENEASRIMRQLVAAVHFMHSRGVVHRDLKPENLLFSDPAGDNIKVVDFGFACLK 525 (966)
Q Consensus 446 ~~lVmEy~~gg~L~~~l~~~~~~~l~e~~~~~i~~Qil~aL~yLHs~~IiHRDLKP~NILl~~~~~~~iKL~DFGla~~~ 525 (966)
.++||||+. |+|.+++.......+++..++.++.||+.||+|||++||+||||||+|||++. ++.+||+|||++...
T Consensus 94 ~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~gi~H~dlkp~Nili~~--~~~~kl~Dfg~~~~~ 170 (326)
T 1blx_A 94 LTLVFEHVD-QDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTS--SGQIKLADFGLARIY 170 (326)
T ss_dssp EEEEEECCS-CBHHHHHHHSCTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECT--TCCEEECSCCSCCCC
T ss_pred EEEEEecCC-CCHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCHHHeEEcC--CCCEEEecCcccccc
Confidence 899999997 69999998766556999999999999999999999999999999999999975 568999999999764
Q ss_pred cC--CCccccccccccCchhhccCCCCCCCcccchhhhhhhhhhhhcCCCCCCCcCcchhHHHHHHHHhcCCCCCCCCCC
Q psy11767 526 RE--SLHTPCFTLQYAAPEVLRQDKSGYDENCDLWSLGVILVNVLRQDKSGYDENCDLWSLGVILYTMLCGRVPFHARSR 603 (966)
Q Consensus 526 ~~--~~~~~~gT~~Y~APEvl~~~~~~~~~~~Di~SlGvil~el~~~~~~~y~~~~DIWSlGvilyemltG~~Pf~~~~~ 603 (966)
.. ......+|+.|+|||++.. ..|+.++|||||||++|+|++|+.||.+...
T Consensus 171 ~~~~~~~~~~~~~~y~aPE~~~~--------------------------~~~~~~~Di~slG~il~~l~~g~~pf~~~~~ 224 (326)
T 1blx_A 171 SFQMALTSVVVTLWYRAPEVLLQ--------------------------SSYATPVDLWSVGCIFAEMFRRKPLFRGSSD 224 (326)
T ss_dssp CGGGGGCCCCCCCTTCCHHHHTT--------------------------CCCCTHHHHHHHHHHHHHHHHSSCSCCCSSH
T ss_pred cCCCCccccccccceeCHHHHhc--------------------------CCCCcchhHHHHHHHHHHHHcCCCCCCCCCH
Confidence 42 2345678999999999852 2368899999999999999999999987654
Q ss_pred chhHHHHHHHHHcC---CC----------------CCCchhhccCCHHHHHHHHHhcccCccccCChHHHHHHhhhhHH
Q psy11767 604 DDSALSIMARIKEG---QF----------------NFDAEAWSTVSSEAKELTKSLLTVNPAQRIRMMRVKLTFHAFHQ 663 (966)
Q Consensus 604 ~~~~~~~~~~i~~~---~~----------------~~~~~~~~~is~e~~~Li~~~L~~dP~~R~t~~~v~~~~~~~~~ 663 (966)
.+....++..+... .+ ......+..+++++++||.+||..||++|||+.++ ..|+|+.
T Consensus 225 ~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~--l~hp~~~ 301 (326)
T 1blx_A 225 VDQLGKILDVIGLPGEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSA--LSHPYFQ 301 (326)
T ss_dssp HHHHHHHHHHHCCCCGGGSCTTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHH--HTSGGGT
T ss_pred HHHHHHHHHHcCCCCcccCccccccchhhhcccCcchhhhccccCCHHHHHHHHHHcCCCcccCCCHHHH--hcCcccc
Confidence 43333333222110 00 00012235689999999999999999999999976 3567754
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-39 Score=384.36 Aligned_cols=246 Identities=23% Similarity=0.414 Sum_probs=204.4
Q ss_pred cccccccccccccEEEEEEEcCCCcEEEEEEecccc----ChHHHHHHHHHhcCCCCceEEEEEEEeCCeEEEEEEccCC
Q psy11767 380 LDKAGILGDGSYSVCRRCVEKSTGQEYAVKIISRKI----DCSEEINLLRACQGHPNIVNLHCVFQDEVHTYLVLELLKG 455 (966)
Q Consensus 380 ~~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~----~~~~Ei~iL~~l~~HpnIV~l~~~~~~~~~~~lVmEy~~g 455 (966)
|+..+.||+|+||.||+|.+..++..||||++.... ...+|+.+|+.+ +|||||++++++.++...|||||||++
T Consensus 222 ~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l-~hpniv~l~~~~~~~~~~~lv~E~~~~ 300 (495)
T 1opk_A 222 ITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEI-KHPNLVQLLGVCTREPPFYIITEFMTY 300 (495)
T ss_dssp EEEEEESGGGTTSSEEEEEEGGGTEEEEEEECCSSSSCHHHHHHHHHHHHHC-CCTTBCCEEEEECSSSSCEEEEECCTT
T ss_pred ceeeeEecCCCCeEEEEEEEcCCCeEEEEEEecCcccchHHHHHHHHHHHhc-CCCCEeeEEEEEecCCcEEEEEEccCC
Confidence 344678999999999999999999999999997543 245799999998 599999999999999999999999999
Q ss_pred CCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCcEEEecCCCCCEEEEeecccccccCC----Ccc
Q psy11767 456 GELLDRIRQKGRCGFTENEASRIMRQLVAAVHFMHSRGVVHRDLKPENLLFSDPAGDNIKVVDFGFACLKRES----LHT 531 (966)
Q Consensus 456 g~L~~~l~~~~~~~l~e~~~~~i~~Qil~aL~yLHs~~IiHRDLKP~NILl~~~~~~~iKL~DFGla~~~~~~----~~~ 531 (966)
|+|.+++.......+++..+..++.||+.||+|||++||+||||||+|||++. ++.+||+|||+++..... ...
T Consensus 301 g~L~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~--~~~~kl~DFG~a~~~~~~~~~~~~~ 378 (495)
T 1opk_A 301 GNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRNLAARNCLVGE--NHLVKVADFGLSRLMTGDTYTAHAG 378 (495)
T ss_dssp CBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECG--GGCEEECCTTCEECCTTCCEECCTT
T ss_pred CCHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChhhEEECC--CCcEEEeecccceeccCCceeecCC
Confidence 99999998766557999999999999999999999999999999999999975 568999999999765432 123
Q ss_pred ccccccccCchhhccCCCCCCCcccchhhhhhhhhhhhcCCCCCCCcCcchhHHHHHHHHhc-CCCCCCCCCCchhHHHH
Q psy11767 532 PCFTLQYAAPEVLRQDKSGYDENCDLWSLGVILVNVLRQDKSGYDENCDLWSLGVILYTMLC-GRVPFHARSRDDSALSI 610 (966)
Q Consensus 532 ~~gT~~Y~APEvl~~~~~~~~~~~Di~SlGvil~el~~~~~~~y~~~~DIWSlGvilyemlt-G~~Pf~~~~~~~~~~~~ 610 (966)
..+|+.|+|||++... .|+.++|||||||++|||++ |..||.+.+..+ +
T Consensus 379 ~~~~~~y~aPE~~~~~--------------------------~~~~~sDvwSlG~~l~el~t~g~~p~~~~~~~~----~ 428 (495)
T 1opk_A 379 AKFPIKWTAPESLAYN--------------------------KFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQ----V 428 (495)
T ss_dssp CCCCGGGCCHHHHHHC--------------------------EECHHHHHHHHHHHHHHHHTTSCCSSTTCCGGG----H
T ss_pred CcCCcceeCHhHHhcC--------------------------CCCcHHhHHhHHHHHHHHHhCCCCCCCCCCHHH----H
Confidence 3457889999998532 36789999999999999999 999998766433 2
Q ss_pred HHHHHcCCCCCCchhhccCCHHHHHHHHHhcccCccccCChHHHHHHhhhh
Q psy11767 611 MARIKEGQFNFDAEAWSTVSSEAKELTKSLLTVNPAQRIRMMRVKLTFHAF 661 (966)
Q Consensus 611 ~~~i~~~~~~~~~~~~~~is~e~~~Li~~~L~~dP~~R~t~~~v~~~~~~~ 661 (966)
...+..+. .. ..+..+++++.+||.+||+.||++|||+.++...+..+
T Consensus 429 ~~~~~~~~-~~--~~~~~~~~~l~~li~~cl~~dP~~RPs~~el~~~L~~~ 476 (495)
T 1opk_A 429 YELLEKDY-RM--ERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETM 476 (495)
T ss_dssp HHHHHTTC-CC--CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTS
T ss_pred HHHHHcCC-CC--CCCCCCCHHHHHHHHHHcCcChhHCcCHHHHHHHHHHH
Confidence 33343332 21 22346889999999999999999999999986655443
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 4g5j_A* 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-39 Score=360.62 Aligned_cols=241 Identities=19% Similarity=0.362 Sum_probs=190.1
Q ss_pred cccccccccccccEEEEEEEcCCCcEE----EEEEecccc------ChHHHHHHHHHhcCCCCceEEEEEEEeCCeEEEE
Q psy11767 380 LDKAGILGDGSYSVCRRCVEKSTGQEY----AVKIISRKI------DCSEEINLLRACQGHPNIVNLHCVFQDEVHTYLV 449 (966)
Q Consensus 380 ~~~~~~LG~G~fG~Vy~a~~~~tg~~v----AvK~i~~~~------~~~~Ei~iL~~l~~HpnIV~l~~~~~~~~~~~lV 449 (966)
|+..+.||+|+||+||+|++..+|+.+ |+|.+.... ...+|+.+|+.+ +|||||++++++.++. .++|
T Consensus 17 y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~-~~~v 94 (327)
T 3poz_A 17 FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV-DNPHVCRLLGICLTST-VQLI 94 (327)
T ss_dssp EEEEEEEEEETTEEEEEEEECC----CCEEEEEEEC-------CHHHHHHHHHHHHHC-CBTTBCCEEEEEESSS-EEEE
T ss_pred cccceEEeeCCCeEEEEEEEcCCCceEEEEEEEeecccccCHHHHHHHHHHHHHHHhC-CCCCEeEEEEEEecCC-eEEE
Confidence 344789999999999999998888765 777764322 245699999998 5999999999998765 7899
Q ss_pred EEccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCcEEEecCCCCCEEEEeecccccccCC-
Q psy11767 450 LELLKGGELLDRIRQKGRCGFTENEASRIMRQLVAAVHFMHSRGVVHRDLKPENLLFSDPAGDNIKVVDFGFACLKRES- 528 (966)
Q Consensus 450 mEy~~gg~L~~~l~~~~~~~l~e~~~~~i~~Qil~aL~yLHs~~IiHRDLKP~NILl~~~~~~~iKL~DFGla~~~~~~- 528 (966)
|||+.+|+|.+++..... .+++..++.++.||+.||+|||++||+||||||+|||++. ++.+||+|||+|+.....
T Consensus 95 ~e~~~~g~L~~~l~~~~~-~~~~~~~~~~~~qi~~~l~~LH~~~ivH~Dikp~NIll~~--~~~~kl~Dfg~a~~~~~~~ 171 (327)
T 3poz_A 95 TQLMPFGCLLDYVREHKD-NIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKT--PQHVKITDFGLAKLLGAEE 171 (327)
T ss_dssp EECCTTCBHHHHHHHSTT-SCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEE--TTEEEECCTTHHHHHTTTC
T ss_pred EEecCCCcHHHHHHhcCC-CCCHHHHHHHHHHHHHHHHHHhhCCeeCCCCChheEEECC--CCCEEEccCcceeEccCCc
Confidence 999999999999987543 6999999999999999999999999999999999999985 568999999999764322
Q ss_pred ----CccccccccccCchhhccCCCCCCCcccchhhhhhhhhhhhcCCCCCCCcCcchhHHHHHHHHhc-CCCCCCCCCC
Q psy11767 529 ----LHTPCFTLQYAAPEVLRQDKSGYDENCDLWSLGVILVNVLRQDKSGYDENCDLWSLGVILYTMLC-GRVPFHARSR 603 (966)
Q Consensus 529 ----~~~~~gT~~Y~APEvl~~~~~~~~~~~Di~SlGvil~el~~~~~~~y~~~~DIWSlGvilyemlt-G~~Pf~~~~~ 603 (966)
.....+|+.|+|||++.. ..|+.++|||||||++|+|++ |+.||.+...
T Consensus 172 ~~~~~~~~~~t~~y~aPE~~~~--------------------------~~~~~~~Di~slG~il~ellt~g~~p~~~~~~ 225 (327)
T 3poz_A 172 KEYHAEGGKVPIKWMALESILH--------------------------RIYTHQSDVWSYGVTVWELMTFGSKPYDGIPA 225 (327)
T ss_dssp C-------CCCGGGSCHHHHHH--------------------------CCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCG
T ss_pred ccccccCCCccccccChHHhcc--------------------------CCCCchhhhhhhHHHHHHHHhcCCCCccCCCH
Confidence 123346889999999863 237889999999999999999 9999987654
Q ss_pred chhHHHHHHHHHcCCCCCCchhhccCCHHHHHHHHHhcccCccccCChHHHHHHh
Q psy11767 604 DDSALSIMARIKEGQFNFDAEAWSTVSSEAKELTKSLLTVNPAQRIRMMRVKLTF 658 (966)
Q Consensus 604 ~~~~~~~~~~i~~~~~~~~~~~~~~is~e~~~Li~~~L~~dP~~R~t~~~v~~~~ 658 (966)
.+ +...+..+.... .....+.++.+++.+||+.||++||++.++...+
T Consensus 226 ~~----~~~~~~~~~~~~---~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~l 273 (327)
T 3poz_A 226 SE----ISSILEKGERLP---QPPICTIDVYMIMVKCWMIDADSRPKFRELIIEF 273 (327)
T ss_dssp GG----HHHHHHTTCCCC---CCTTBCHHHHHHHHHHTCSCGGGSCCHHHHHHHH
T ss_pred HH----HHHHHHcCCCCC---CCccCCHHHHHHHHHHcCCChhhCCCHHHHHHHH
Confidence 43 233343333211 2235789999999999999999999999875443
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-39 Score=356.93 Aligned_cols=246 Identities=24% Similarity=0.372 Sum_probs=194.5
Q ss_pred cccccccccccccccccccEEEEEEEcCCCcEEEEEEecccc--------ChHHHHHHHHHhcCCCCceEEEEEEEeCCe
Q psy11767 374 EQYDMDLDKAGILGDGSYSVCRRCVEKSTGQEYAVKIISRKI--------DCSEEINLLRACQGHPNIVNLHCVFQDEVH 445 (966)
Q Consensus 374 ~~~~i~~~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~--------~~~~Ei~iL~~l~~HpnIV~l~~~~~~~~~ 445 (966)
++|.+ .+.||+|+||.||+|.+..+++.||||++.... ...+|+.+++.+ +||||+++++++.++..
T Consensus 34 ~~y~~----~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l-~hp~iv~~~~~~~~~~~ 108 (309)
T 2h34_A 34 GPYRL----RRLVGRGGMGDVYEAEDTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRL-QEPHVVPIHDFGEIDGQ 108 (309)
T ss_dssp CCEEE----EEEEEECSSSEEEEEEETTTTEEEEEEECGGGGGGSHHHHHHHHHHHHHHTTC-CCTTBCCEEEEEEETTE
T ss_pred ccEEE----EEEEcCCCCeeEEEEEEcCCCeEEEEEecCcccccCHHHHHHHHHHHHHHhhc-CCCCeeEEEEEEeeCCe
Confidence 45554 688999999999999999999999999986542 234688999888 59999999999999999
Q ss_pred EEEEEEccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCcEEEecCCCCCEEEEeecccccc
Q psy11767 446 TYLVLELLKGGELLDRIRQKGRCGFTENEASRIMRQLVAAVHFMHSRGVVHRDLKPENLLFSDPAGDNIKVVDFGFACLK 525 (966)
Q Consensus 446 ~~lVmEy~~gg~L~~~l~~~~~~~l~e~~~~~i~~Qil~aL~yLHs~~IiHRDLKP~NILl~~~~~~~iKL~DFGla~~~ 525 (966)
.|+||||++|++|.+++.... .+++.+++.++.||+.||+|||++||+||||||+|||++. ++.+||+|||++...
T Consensus 109 ~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~NIl~~~--~~~~kl~Dfg~~~~~ 184 (309)
T 2h34_A 109 LYVDMRLINGVDLAAMLRRQG--PLAPPRAVAIVRQIGSALDAAHAAGATHRDVKPENILVSA--DDFAYLVDFGIASAT 184 (309)
T ss_dssp EEEEEECCCCEEHHHHHHHHC--SCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECT--TSCEEECSCCC----
T ss_pred EEEEEEecCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCcCCcCCCChHHEEEcC--CCCEEEecCccCccc
Confidence 999999999999999998765 5999999999999999999999999999999999999975 568999999998764
Q ss_pred cCC----CccccccccccCchhhccCCCCCCCcccchhhhhhhhhhhhcCCCCCCCcCcchhHHHHHHHHhcCCCCCCCC
Q psy11767 526 RES----LHTPCFTLQYAAPEVLRQDKSGYDENCDLWSLGVILVNVLRQDKSGYDENCDLWSLGVILYTMLCGRVPFHAR 601 (966)
Q Consensus 526 ~~~----~~~~~gT~~Y~APEvl~~~~~~~~~~~Di~SlGvil~el~~~~~~~y~~~~DIWSlGvilyemltG~~Pf~~~ 601 (966)
... .....+|+.|+|||++.. ..++.++|||||||++|+|++|+.||.+.
T Consensus 185 ~~~~~~~~~~~~~~~~y~aPE~~~~--------------------------~~~~~~~Di~slG~il~~l~~g~~pf~~~ 238 (309)
T 2h34_A 185 TDEKLTQLGNTVGTLYYMAPERFSE--------------------------SHATYRADIYALTCVLYECLTGSPPYQGD 238 (309)
T ss_dssp ------------CCGGGCCGGGTCC------------------------------CCCHHHHHHHHHHHHHHSSCSSCSC
T ss_pred cccccccccccCCCcCccCHHHHcC--------------------------CCCCchHhHHHHHHHHHHHHHCCCCCCCc
Confidence 432 234568999999998852 23678899999999999999999999864
Q ss_pred CCchhHHHHHHHHHcCCCCCCchhhccCCHHHHHHHHHhcccCccccC-ChHHHHHHhh
Q psy11767 602 SRDDSALSIMARIKEGQFNFDAEAWSTVSSEAKELTKSLLTVNPAQRI-RMMRVKLTFH 659 (966)
Q Consensus 602 ~~~~~~~~~~~~i~~~~~~~~~~~~~~is~e~~~Li~~~L~~dP~~R~-t~~~v~~~~~ 659 (966)
... .+...+. .........++.+++++.++|.+||..||++|| ++.++...+.
T Consensus 239 ~~~----~~~~~~~-~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rp~s~~~l~~~l~ 292 (309)
T 2h34_A 239 QLS----VMGAHIN-QAIPRPSTVRPGIPVAFDAVIARGMAKNPEDRYVTCGDLSAAAH 292 (309)
T ss_dssp HHH----HHHHHHH-SCCCCGGGTSTTCCTHHHHHHHHHTCSSGGGSCSSHHHHHHHHH
T ss_pred hHH----HHHHHhc-cCCCCccccCCCCCHHHHHHHHHhccCCHHHHHHhHHHHHHHHH
Confidence 321 2222333 222223334467899999999999999999999 7877755444
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-39 Score=357.99 Aligned_cols=235 Identities=35% Similarity=0.640 Sum_probs=193.1
Q ss_pred cccccccccEEEEEEEcCCCcEEEEEEeccccChHHHHHHHHHhcCCCCceEEEEEEEe----CCeEEEEEEccCCCCHH
Q psy11767 384 GILGDGSYSVCRRCVEKSTGQEYAVKIISRKIDCSEEINLLRACQGHPNIVNLHCVFQD----EVHTYLVLELLKGGELL 459 (966)
Q Consensus 384 ~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~~~~~Ei~iL~~l~~HpnIV~l~~~~~~----~~~~~lVmEy~~gg~L~ 459 (966)
++||+|+||.||+|.+..+|+.||||++.......+|+.++..+.+||||+++++++.+ ....|+||||++||+|.
T Consensus 24 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~ 103 (299)
T 3m2w_A 24 QVLGLGINGKVLQIFNKRTQEKFALKMLQDCPKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELF 103 (299)
T ss_dssp EEEEEETTEEEEEEEETTTCCEEEEEEEECSHHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEEEEECCCCSCBHH
T ss_pred cccccCCCeEEEEEEEcCCCcEEEEEEecccHHHHHHHHHHHHhccCCCchhHHhhhhhhcCCCceEEEEEeecCCCcHH
Confidence 67999999999999999999999999998776778899999777789999999999987 67899999999999999
Q ss_pred HHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCcEEEecCC-CCCEEEEeecccccccCCCccccccccc
Q psy11767 460 DRIRQKGRCGFTENEASRIMRQLVAAVHFMHSRGVVHRDLKPENLLFSDPA-GDNIKVVDFGFACLKRESLHTPCFTLQY 538 (966)
Q Consensus 460 ~~l~~~~~~~l~e~~~~~i~~Qil~aL~yLHs~~IiHRDLKP~NILl~~~~-~~~iKL~DFGla~~~~~~~~~~~gT~~Y 538 (966)
+++.......+++.+++.++.||+.||+|||++||+||||||+|||++... ++.+||+|||++.....
T Consensus 104 ~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~~----------- 172 (299)
T 3m2w_A 104 SRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTG----------- 172 (299)
T ss_dssp HHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESSSSTTCCEEECCCTTCEECTT-----------
T ss_pred HHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEecCCCCCcEEEecccccccccc-----------
Confidence 999887655799999999999999999999999999999999999998532 46899999998854221
Q ss_pred cCchhhccCCCCCCCcccchhhhhhhhhhhhcCCCCCCCcCcchhHHHHHHHHhcCCCCCCCCCCchhHHHHHHHHHcCC
Q psy11767 539 AAPEVLRQDKSGYDENCDLWSLGVILVNVLRQDKSGYDENCDLWSLGVILYTMLCGRVPFHARSRDDSALSIMARIKEGQ 618 (966)
Q Consensus 539 ~APEvl~~~~~~~~~~~Di~SlGvil~el~~~~~~~y~~~~DIWSlGvilyemltG~~Pf~~~~~~~~~~~~~~~i~~~~ 618 (966)
..|+.++|||||||++|+|++|+.||...............+..+.
T Consensus 173 ----------------------------------~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~ 218 (299)
T 3m2w_A 173 ----------------------------------EKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQ 218 (299)
T ss_dssp ----------------------------------CGGGGHHHHHHHHHHHHHHHHSSCSCCC-------CCSCCSSCTTC
T ss_pred ----------------------------------ccCCchhhHHHHHHHHHHHHHCCCCCCCCcchhhhHHHHHHHhhcc
Confidence 1256789999999999999999999976543211111112233444
Q ss_pred CCCCchhhccCCHHHHHHHHHhcccCccccCChHHHHHHhhhhHHhh
Q psy11767 619 FNFDAEAWSTVSSEAKELTKSLLTVNPAQRIRMMRVKLTFHAFHQAQ 665 (966)
Q Consensus 619 ~~~~~~~~~~is~e~~~Li~~~L~~dP~~R~t~~~v~~~~~~~~~~~ 665 (966)
+.++...+..+++++.+||.+||..||++|||+.++ ..|+|+...
T Consensus 219 ~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~e~--l~hp~~~~~ 263 (299)
T 3m2w_A 219 YEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEF--MNHPWIMQS 263 (299)
T ss_dssp CSSCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHH--HTSHHHHTG
T ss_pred ccCCchhcccCCHHHHHHHHHHcccChhhCCCHHHH--hcChhhccc
Confidence 555555667899999999999999999999999976 457776543
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-39 Score=362.24 Aligned_cols=241 Identities=21% Similarity=0.352 Sum_probs=193.3
Q ss_pred cccccccccccccEEEEEEEcCCCcE----EEEEEecccc------ChHHHHHHHHHhcCCCCceEEEEEEEeCCeEEEE
Q psy11767 380 LDKAGILGDGSYSVCRRCVEKSTGQE----YAVKIISRKI------DCSEEINLLRACQGHPNIVNLHCVFQDEVHTYLV 449 (966)
Q Consensus 380 ~~~~~~LG~G~fG~Vy~a~~~~tg~~----vAvK~i~~~~------~~~~Ei~iL~~l~~HpnIV~l~~~~~~~~~~~lV 449 (966)
|+..+.||+|+||+||+|.+..+|+. ||+|.+.... ...+|+.+++.+ +|||||++++++.+ ...++|
T Consensus 15 y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~~K~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~-~~~~~v 92 (325)
T 3kex_A 15 LRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSL-DHAHIVRLLGLCPG-SSLQLV 92 (325)
T ss_dssp EEEEEEEECCSSCEEEEEEECCTTCSCCEEEEEEEECCTTSCSCBCSCCHHHHHHHTC-CCTTBCCEEEEECB-SSEEEE
T ss_pred ceeeeeeeecCCceEEEEEEcCCCceEEEEEEEEeccccccHHHHHHHHHHHHHHhcC-CCCCcCeEEEEEcC-CccEEE
Confidence 34478999999999999999988876 7777764321 345799999888 59999999999864 568999
Q ss_pred EEccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCcEEEecCCCCCEEEEeecccccccCC-
Q psy11767 450 LELLKGGELLDRIRQKGRCGFTENEASRIMRQLVAAVHFMHSRGVVHRDLKPENLLFSDPAGDNIKVVDFGFACLKRES- 528 (966)
Q Consensus 450 mEy~~gg~L~~~l~~~~~~~l~e~~~~~i~~Qil~aL~yLHs~~IiHRDLKP~NILl~~~~~~~iKL~DFGla~~~~~~- 528 (966)
|||+.+|+|.+++.... ..+++..++.++.||+.||+|||++||+||||||+|||++. .+.+||+|||+|+.....
T Consensus 93 ~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dikp~Nil~~~--~~~~kl~Dfg~a~~~~~~~ 169 (325)
T 3kex_A 93 TQYLPLGSLLDHVRQHR-GALGPQLLLNWGVQIAKGMYYLEEHGMVHRNLAARNVLLKS--PSQVQVADFGVADLLPPDD 169 (325)
T ss_dssp EECCTTCBSHHHHHSSG-GGSCTTHHHHHHHHHHHHHHHHHHTTCCCSCCSSTTEEESS--SSCEEECSCSGGGGSCCCT
T ss_pred EEeCCCCCHHHHHHHcc-ccCCHHHHHHHHHHHHHHHHHHHhCCCCCCccchheEEECC--CCeEEECCCCcccccCccc
Confidence 99999999999997653 25899999999999999999999999999999999999974 568999999999765322
Q ss_pred ----CccccccccccCchhhccCCCCCCCcccchhhhhhhhhhhhcCCCCCCCcCcchhHHHHHHHHhc-CCCCCCCCCC
Q psy11767 529 ----LHTPCFTLQYAAPEVLRQDKSGYDENCDLWSLGVILVNVLRQDKSGYDENCDLWSLGVILYTMLC-GRVPFHARSR 603 (966)
Q Consensus 529 ----~~~~~gT~~Y~APEvl~~~~~~~~~~~Di~SlGvil~el~~~~~~~y~~~~DIWSlGvilyemlt-G~~Pf~~~~~ 603 (966)
.....+|+.|+|||++... .|+.++|||||||++|+|++ |+.||.+...
T Consensus 170 ~~~~~~~~~~~~~y~aPE~~~~~--------------------------~~~~~~Di~slG~~l~el~~~g~~p~~~~~~ 223 (325)
T 3kex_A 170 KQLLYSEAKTPIKWMALESIHFG--------------------------KYTHQSDVWSYGVTVWELMTFGAEPYAGLRL 223 (325)
T ss_dssp TCCC-----CCTTTSCHHHHHHC--------------------------CCCHHHHHHHHHHHHHHHHTTSCCTTTTSCT
T ss_pred ccccccCCCCcccccChHHhccC--------------------------CCChhhHhHHhHHHHHHHHhCCCCCccccCH
Confidence 2234578899999998532 37889999999999999999 9999987654
Q ss_pred chhHHHHHHHHHcCCCCCCchhhccCCHHHHHHHHHhcccCccccCChHHHHHHh
Q psy11767 604 DDSALSIMARIKEGQFNFDAEAWSTVSSEAKELTKSLLTVNPAQRIRMMRVKLTF 658 (966)
Q Consensus 604 ~~~~~~~~~~i~~~~~~~~~~~~~~is~e~~~Li~~~L~~dP~~R~t~~~v~~~~ 658 (966)
.+ +...+..+.....+ ..++.++.+||.+||..||.+|||+.++...+
T Consensus 224 ~~----~~~~~~~~~~~~~~---~~~~~~~~~li~~~l~~dp~~Rps~~el~~~l 271 (325)
T 3kex_A 224 AE----VPDLLEKGERLAQP---QICTIDVYMVMVKCWMIDENIRPTFKELANEF 271 (325)
T ss_dssp TH----HHHHHHTTCBCCCC---TTBCTTTTHHHHHHTCSCTTTSCCHHHHHHHH
T ss_pred HH----HHHHHHcCCCCCCC---CcCcHHHHHHHHHHcCCChhhCcCHHHHHHHH
Confidence 32 33444444322221 24677899999999999999999999885544
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} SCOP: d.144.1.0 PDB: 3kmw_A* 3rep_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-39 Score=350.59 Aligned_cols=242 Identities=17% Similarity=0.277 Sum_probs=195.3
Q ss_pred cccccccccccEEEEEEEcCCCcEEEEEEecccc-------ChHHHHHHHHHhcCCCCceEEEEEEEeC--CeEEEEEEc
Q psy11767 382 KAGILGDGSYSVCRRCVEKSTGQEYAVKIISRKI-------DCSEEINLLRACQGHPNIVNLHCVFQDE--VHTYLVLEL 452 (966)
Q Consensus 382 ~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~-------~~~~Ei~iL~~l~~HpnIV~l~~~~~~~--~~~~lVmEy 452 (966)
..+.||+|+||.||+|.+. |+.||||++.... ...+|+.+|+.+ +||||+++++++.+. ...++||||
T Consensus 14 ~~~~lg~G~~g~V~~~~~~--~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~~~lv~e~ 90 (271)
T 3kmu_A 14 FLTKLNENHSGELWKGRWQ--GNDIVVKVLKVRDWSTRKSRDFNEECPRLRIF-SHPNVLPVLGACQSPPAPHPTLITHW 90 (271)
T ss_dssp EEEEEEEETTEEEEEEEET--TEEEEEEEECCTTCCHHHHHHHHHHGGGGCCC-SCTTEECEEEEECTTTSSSCEEEEEC
T ss_pred HHHHhcCCCcceEEEEEEC--CeeEEEEEecccccCHHHHHHHHHHHHHHHhc-CCCchhheEEEEccCCCCCeEeeecc
Confidence 3678999999999999985 8899999997543 134678888777 599999999999887 788999999
Q ss_pred cCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcC--ceeccCCCCcEEEecCCCCCEEEEeecccccccCCCc
Q psy11767 453 LKGGELLDRIRQKGRCGFTENEASRIMRQLVAAVHFMHSRG--VVHRDLKPENLLFSDPAGDNIKVVDFGFACLKRESLH 530 (966)
Q Consensus 453 ~~gg~L~~~l~~~~~~~l~e~~~~~i~~Qil~aL~yLHs~~--IiHRDLKP~NILl~~~~~~~iKL~DFGla~~~~~~~~ 530 (966)
+++|+|.+++.......+++.+++.++.||+.||+|||++| |+||||||+|||++. ++.++|+|||++.... ..
T Consensus 91 ~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~i~H~dikp~Nil~~~--~~~~~l~~~~~~~~~~--~~ 166 (271)
T 3kmu_A 91 MPYGSLYNVLHEGTNFVVDQSQAVKFALDMARGMAFLHTLEPLIPRHALNSRSVMIDE--DMTARISMADVKFSFQ--SP 166 (271)
T ss_dssp CTTCBHHHHHHSCSSCCCCHHHHHHHHHHHHHHHHHHTTSSSCCTTCCCSGGGEEECT--TSCEEEEGGGSCCTTS--CT
T ss_pred cCCCcHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHhcCCCceecCCCccceEEEcC--CcceeEEeccceeeec--cc
Confidence 99999999998766556999999999999999999999999 999999999999974 5689999999875432 23
Q ss_pred cccccccccCchhhccCCCCCCCcccchhhhhhhhhhhhcCCCCCCCcCcchhHHHHHHHHhcCCCCCCCCCCchhHHHH
Q psy11767 531 TPCFTLQYAAPEVLRQDKSGYDENCDLWSLGVILVNVLRQDKSGYDENCDLWSLGVILYTMLCGRVPFHARSRDDSALSI 610 (966)
Q Consensus 531 ~~~gT~~Y~APEvl~~~~~~~~~~~Di~SlGvil~el~~~~~~~y~~~~DIWSlGvilyemltG~~Pf~~~~~~~~~~~~ 610 (966)
...+|+.|+|||++.... ...++.++|||||||++|+|++|+.||......+ .
T Consensus 167 ~~~~t~~y~aPE~~~~~~-----------------------~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~----~ 219 (271)
T 3kmu_A 167 GRMYAPAWVAPEALQKKP-----------------------EDTNRRSADMWSFAVLLWELVTREVPFADLSNME----I 219 (271)
T ss_dssp TCBSCGGGSCHHHHHSCG-----------------------GGSCHHHHHHHHHHHHHHHHHHCSCTTTTSCHHH----H
T ss_pred CccCCccccChhhhccCC-----------------------CCCCCchhhHHHHHHHHHHHHhCCCCccccChHH----H
Confidence 457899999999986422 1123457999999999999999999998765432 2
Q ss_pred HHHHHcCCCCCCchhhccCCHHHHHHHHHhcccCccccCChHHHHHHhh
Q psy11767 611 MARIKEGQFNFDAEAWSTVSSEAKELTKSLLTVNPAQRIRMMRVKLTFH 659 (966)
Q Consensus 611 ~~~i~~~~~~~~~~~~~~is~e~~~Li~~~L~~dP~~R~t~~~v~~~~~ 659 (966)
...+....... ..+..+++++.++|.+||+.||++|||+.++...+.
T Consensus 220 ~~~~~~~~~~~--~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~L~ 266 (271)
T 3kmu_A 220 GMKVALEGLRP--TIPPGISPHVSKLMKICMNEDPAKRPKFDMIVPILE 266 (271)
T ss_dssp HHHHHHSCCCC--CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred HHHHHhcCCCC--CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHH
Confidence 22333222221 223468999999999999999999999998755443
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-39 Score=354.70 Aligned_cols=257 Identities=29% Similarity=0.449 Sum_probs=201.4
Q ss_pred eecccccccccccccccccccEEEEEEEcCCCcEEEEEEecccc-----ChHHHHHHHHHhcCCCCceEEEEEEEeCCeE
Q psy11767 372 FFEQYDMDLDKAGILGDGSYSVCRRCVEKSTGQEYAVKIISRKI-----DCSEEINLLRACQGHPNIVNLHCVFQDEVHT 446 (966)
Q Consensus 372 ~~~~~~i~~~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~-----~~~~Ei~iL~~l~~HpnIV~l~~~~~~~~~~ 446 (966)
+.++|.+ .+.||+|+||.||+|.+..+|+.||+|++.... ...+|+.+|+.+ +||||+++++++.++...
T Consensus 17 ~~~~y~i----~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~ 91 (302)
T 2j7t_A 17 PNEVWEI----VGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATC-DHPYIVKLLGAYYHDGKL 91 (302)
T ss_dssp GGGTEEE----EEEEECSTTCCEEEEEETTTCCEEEEEEEC----CCHHHHHHHHHHHHHC-CCTTBCCEEEEEECC-CE
T ss_pred Cccceee----cceeccCCCeEEEEEEEcCCCcEEEEEEecCCCHHHHHHHHHHHHHHhcC-CCCCEeeeeeeeeeCCeE
Confidence 3345555 688999999999999999999999999986542 245699999988 599999999999999999
Q ss_pred EEEEEccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCcEEEecCCCCCEEEEeeccccccc
Q psy11767 447 YLVLELLKGGELLDRIRQKGRCGFTENEASRIMRQLVAAVHFMHSRGVVHRDLKPENLLFSDPAGDNIKVVDFGFACLKR 526 (966)
Q Consensus 447 ~lVmEy~~gg~L~~~l~~~~~~~l~e~~~~~i~~Qil~aL~yLHs~~IiHRDLKP~NILl~~~~~~~iKL~DFGla~~~~ 526 (966)
|+||||+++++|.+++..... .+++..++.++.||+.||+|||++||+||||||+|||++. ++.+||+|||++....
T Consensus 92 ~lv~e~~~~~~l~~~~~~~~~-~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~--~~~~kl~Dfg~~~~~~ 168 (302)
T 2j7t_A 92 WIMIEFCPGGAVDAIMLELDR-GLTEPQIQVVCRQMLEALNFLHSKRIIHRDLKAGNVLMTL--EGDIRLADFGVSAKNL 168 (302)
T ss_dssp EEEEECCTTEEHHHHHHHHTS-CCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEECT--TSCEEECCCHHHHHHH
T ss_pred EEEEEeCCCCcHHHHHHhhcc-CCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCHHHEEECC--CCCEEEEECCCCcccc
Confidence 999999999999999876543 5999999999999999999999999999999999999974 5689999999985432
Q ss_pred ---CCCccccccccccCchhhccCCCCCCCcccchhhhhhhhhhhhcCCCCCCCcCcchhHHHHHHHHhcCCCCCCCCCC
Q psy11767 527 ---ESLHTPCFTLQYAAPEVLRQDKSGYDENCDLWSLGVILVNVLRQDKSGYDENCDLWSLGVILYTMLCGRVPFHARSR 603 (966)
Q Consensus 527 ---~~~~~~~gT~~Y~APEvl~~~~~~~~~~~Di~SlGvil~el~~~~~~~y~~~~DIWSlGvilyemltG~~Pf~~~~~ 603 (966)
.......+|+.|+|||++.... .....|+.++|||||||++|+|++|..||...+.
T Consensus 169 ~~~~~~~~~~~~~~y~aPE~~~~~~---------------------~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~ 227 (302)
T 2j7t_A 169 KTLQKRDSFIGTPYWMAPEVVMCET---------------------MKDTPYDYKADIWSLGITLIEMAQIEPPHHELNP 227 (302)
T ss_dssp HHHHC-----CCGGGCCHHHHHHHH---------------------TTSTTTTTHHHHHHHHHHHHHHHHSSCTTTTSCH
T ss_pred ccccccccccCChhhcCCeeecccc---------------------CCCCCCchhhhHHHHHHHHHHHhcCCCCCccCCH
Confidence 1233457899999999984211 1133578899999999999999999999987553
Q ss_pred chhHHHHHHHHHcCCCCCCchhhccCCHHHHHHHHHhcccCccccCChHHHHHHhhhhHHh
Q psy11767 604 DDSALSIMARIKEGQFNFDAEAWSTVSSEAKELTKSLLTVNPAQRIRMMRVKLTFHAFHQA 664 (966)
Q Consensus 604 ~~~~~~~~~~i~~~~~~~~~~~~~~is~e~~~Li~~~L~~dP~~R~t~~~v~~~~~~~~~~ 664 (966)
. .....+..+..... .....++.++.+||.+||..||++|||+.++ ..|+|...
T Consensus 228 ~----~~~~~~~~~~~~~~-~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l--l~h~~~~~ 281 (302)
T 2j7t_A 228 M----RVLLKIAKSDPPTL-LTPSKWSVEFRDFLKIALDKNPETRPSAAQL--LEHPFVSS 281 (302)
T ss_dssp H----HHHHHHHHSCCCCC-SSGGGSCHHHHHHHHHHSCSCTTTSCCHHHH--TTSTTTTT
T ss_pred H----HHHHHHhccCCccc-CCccccCHHHHHHHHHHcccChhhCCCHHHH--hcChHHhh
Confidence 2 22333333332211 1234678999999999999999999999876 44676643
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-39 Score=369.17 Aligned_cols=269 Identities=26% Similarity=0.453 Sum_probs=202.3
Q ss_pred CCccccccccee-cccccccccccccccccccEEEEEEEcCCCcEEEEEEecccc----ChHHHHHHHHHhc--------
Q psy11767 362 NFDKIFKGSLFF-EQYDMDLDKAGILGDGSYSVCRRCVEKSTGQEYAVKIISRKI----DCSEEINLLRACQ-------- 428 (966)
Q Consensus 362 ~~d~if~G~~~~-~~~~i~~~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~----~~~~Ei~iL~~l~-------- 428 (966)
++...+.+..+. .+|.+ .+.||+|+||+||+|.+..+|+.||||++.... ...+|+.+|+.+.
T Consensus 6 ~~~p~~~~~~~~~~~y~~----~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~ 81 (373)
T 1q8y_A 6 GYHPAFKGEPYKDARYIL----VRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYTEAAEDEIKLLQRVNDADNTKED 81 (373)
T ss_dssp -CCCCCTTCEETTTTEEE----EEEEEECSSEEEEEEEETTTTEEEEEEEECSCHHHHHHHHHHHHHHHHHHHTCCSHHH
T ss_pred CceeeecCCcccCCeEEE----EEeeeecCCeEEEEEEecCCCcEEEEEEecCCccchhhhhHHHHHHHHhhcccccchh
Confidence 333444444442 34444 688999999999999999999999999997542 2456888888764
Q ss_pred --CCCCceEEEEEEEeCC----eEEEEEEccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhc-CceeccCCC
Q psy11767 429 --GHPNIVNLHCVFQDEV----HTYLVLELLKGGELLDRIRQKGRCGFTENEASRIMRQLVAAVHFMHSR-GVVHRDLKP 501 (966)
Q Consensus 429 --~HpnIV~l~~~~~~~~----~~~lVmEy~~gg~L~~~l~~~~~~~l~e~~~~~i~~Qil~aL~yLHs~-~IiHRDLKP 501 (966)
+||||+++++++...+ ..++||||+ +++|.+++.......+++..++.++.||+.||+|||++ ||+||||||
T Consensus 82 ~~~~~~i~~~~~~~~~~~~~~~~~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~~ivH~Dikp 160 (373)
T 1q8y_A 82 SMGANHILKLLDHFNHKGPNGVHVVMVFEVL-GENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRCGIIHTDIKP 160 (373)
T ss_dssp HHHHTTBCCCCEEEEEEETTEEEEEEEECCC-CEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTCEECSCCSG
T ss_pred ccccchHHHHHHHhhccCCCCceEEEEEecC-CCCHHHHHHHhhccCCcHHHHHHHHHHHHHHHHHHHhcCCEEecCCCh
Confidence 3899999999998654 789999999 99999999876555699999999999999999999998 999999999
Q ss_pred CcEEEecC----CCCCEEEEeecccccccCCCccccccccccCchhhccCCCCCCCcccchhhhhhhhhhhhcCCCCCCC
Q psy11767 502 ENLLFSDP----AGDNIKVVDFGFACLKRESLHTPCFTLQYAAPEVLRQDKSGYDENCDLWSLGVILVNVLRQDKSGYDE 577 (966)
Q Consensus 502 ~NILl~~~----~~~~iKL~DFGla~~~~~~~~~~~gT~~Y~APEvl~~~~~~~~~~~Di~SlGvil~el~~~~~~~y~~ 577 (966)
+|||++.. ..+.+||+|||+|+.........++|+.|+|||++.. ..|+.
T Consensus 161 ~NIll~~~~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~t~~y~aPE~~~~--------------------------~~~~~ 214 (373)
T 1q8y_A 161 ENVLMEIVDSPENLIQIKIADLGNACWYDEHYTNSIQTREYRSPEVLLG--------------------------APWGC 214 (373)
T ss_dssp GGEEEEEEETTTTEEEEEECCCTTCEETTBCCCSCCSCGGGCCHHHHHT--------------------------CCCCT
T ss_pred HHeEEeccCCCcCcceEEEcccccccccCCCCCCCCCCccccCcHHHhC--------------------------CCCCc
Confidence 99999531 2337999999999877666666789999999999853 23788
Q ss_pred cCcchhHHHHHHHHhcCCCCCCCCCCc------hhHHHHHHHHHc--------CCC-----------------CCC----
Q psy11767 578 NCDLWSLGVILYTMLCGRVPFHARSRD------DSALSIMARIKE--------GQF-----------------NFD---- 622 (966)
Q Consensus 578 ~~DIWSlGvilyemltG~~Pf~~~~~~------~~~~~~~~~i~~--------~~~-----------------~~~---- 622 (966)
++|||||||++|+|++|+.||...... +....+...+.. +.+ ...
T Consensus 215 ~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 294 (373)
T 1q8y_A 215 GADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLED 294 (373)
T ss_dssp HHHHHHHHHHHHHHHHSSCCC---------CHHHHHHHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHH
T ss_pred hHhHHHHHHHHHHHHhCCCCCCCCcccccCChHHHHHHHHHhcCCCCHHHHhccchhhhhcCCcchhcccccccccchhh
Confidence 999999999999999999999865421 111111111100 000 000
Q ss_pred -----chhhccCCHHHHHHHHHhcccCccccCChHHHHHHhhhhHH
Q psy11767 623 -----AEAWSTVSSEAKELTKSLLTVNPAQRIRMMRVKLTFHAFHQ 663 (966)
Q Consensus 623 -----~~~~~~is~e~~~Li~~~L~~dP~~R~t~~~v~~~~~~~~~ 663 (966)
......++.++.+||.+||+.||++|||+.++ ..|+|+.
T Consensus 295 ~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~el--l~hp~f~ 338 (373)
T 1q8y_A 295 VLTEKYKFSKDEAKEISDFLSPMLQLDPRKRADAGGL--VNHPWLK 338 (373)
T ss_dssp HHHHTTCCCHHHHHHHHHHHGGGGCSSTTTCBCHHHH--HTCGGGT
T ss_pred hhhhcccCCcchHHHHHHHHHHHhccCccccCCHHHH--hhChhhh
Confidence 00112356789999999999999999999976 4567654
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9e-39 Score=353.49 Aligned_cols=249 Identities=26% Similarity=0.435 Sum_probs=199.8
Q ss_pred cccccccccccccEEEEEEEcCCCcEEEEEEeccccC---hHHHHHHHHHhcCCCCceEEEEEEEeCCeEEEEEEccCCC
Q psy11767 380 LDKAGILGDGSYSVCRRCVEKSTGQEYAVKIISRKID---CSEEINLLRACQGHPNIVNLHCVFQDEVHTYLVLELLKGG 456 (966)
Q Consensus 380 ~~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~~---~~~Ei~iL~~l~~HpnIV~l~~~~~~~~~~~lVmEy~~gg 456 (966)
|+..+.||+|+||.||+|.+..+|+.||||++..... ..+|+.+|+.+ +||||+++++++.++...|+||||++++
T Consensus 31 y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~~ 109 (314)
T 3com_A 31 FDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVESDLQEIIKEISIMQQC-DSPHVVKYYGSYFKNTDLWIVMEYCGAG 109 (314)
T ss_dssp EEEEEECC----CEEEEEEETTTCCEEEEEEEETTSCCHHHHHHHHHHHTC-CCTTBCCEEEEEEETTEEEEEEECCTTE
T ss_pred hhhheeeccCCCeEEEEEEECCCCCEEEEEecCchHHHHHHHHHHHHHHhC-CCCCCccEEEEEEeCCEEEEEeecCCCC
Confidence 3346889999999999999999999999999976543 45799999988 5999999999999999999999999999
Q ss_pred CHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCcEEEecCCCCCEEEEeecccccccCC---Ccccc
Q psy11767 457 ELLDRIRQKGRCGFTENEASRIMRQLVAAVHFMHSRGVVHRDLKPENLLFSDPAGDNIKVVDFGFACLKRES---LHTPC 533 (966)
Q Consensus 457 ~L~~~l~~~~~~~l~e~~~~~i~~Qil~aL~yLHs~~IiHRDLKP~NILl~~~~~~~iKL~DFGla~~~~~~---~~~~~ 533 (966)
+|.+++..... .+++.+++.++.||+.||+|||++||+||||||+|||++. ++.+||+|||++...... .....
T Consensus 110 ~L~~~~~~~~~-~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~--~~~~kl~dfg~~~~~~~~~~~~~~~~ 186 (314)
T 3com_A 110 SVSDIIRLRNK-TLTEDEIATILQSTLKGLEYLHFMRKIHRDIKAGNILLNT--EGHAKLADFGVAGQLTDTMAKRNTVI 186 (314)
T ss_dssp EHHHHHHHHTC-CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECT--TCCEEECCCTTCEECBTTBSCBCCCC
T ss_pred CHHHHHHhcCC-CCCHHHHHHHHHHHHHHHHHHHhCCCcCCCcCHHHEEECC--CCCEEEeecccchhhhhhccccCccC
Confidence 99999975433 6999999999999999999999999999999999999975 568999999999765432 23457
Q ss_pred ccccccCchhhccCCCCCCCcccchhhhhhhhhhhhcCCCCCCCcCcchhHHHHHHHHhcCCCCCCCCCCchhHHHHHHH
Q psy11767 534 FTLQYAAPEVLRQDKSGYDENCDLWSLGVILVNVLRQDKSGYDENCDLWSLGVILYTMLCGRVPFHARSRDDSALSIMAR 613 (966)
Q Consensus 534 gT~~Y~APEvl~~~~~~~~~~~Di~SlGvil~el~~~~~~~y~~~~DIWSlGvilyemltG~~Pf~~~~~~~~~~~~~~~ 613 (966)
+|+.|+|||++.. ..|+.++|||||||++|+|++|+.||....... ....
T Consensus 187 ~~~~y~aPE~~~~--------------------------~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~----~~~~ 236 (314)
T 3com_A 187 GTPFWMAPEVIQE--------------------------IGYNCVADIWSLGITAIEMAEGKPPYADIHPMR----AIFM 236 (314)
T ss_dssp SCGGGCCHHHHSS--------------------------SCBCTTHHHHHHHHHHHHHHHSSCTTTTSCHHH----HHHH
T ss_pred CCCCccChhhcCC--------------------------CCCCccccHHHHHHHHHHHHhCCCCCCCCChHH----HHHH
Confidence 8999999999852 236788999999999999999999998654322 1222
Q ss_pred HHcCCCCCCchhhccCCHHHHHHHHHhcccCccccCChHHHHHHhhhhHHhh
Q psy11767 614 IKEGQFNFDAEAWSTVSSEAKELTKSLLTVNPAQRIRMMRVKLTFHAFHQAQ 665 (966)
Q Consensus 614 i~~~~~~~~~~~~~~is~e~~~Li~~~L~~dP~~R~t~~~v~~~~~~~~~~~ 665 (966)
+...... .......++.++.+||.+||..||.+|||+.++ ..|+|....
T Consensus 237 ~~~~~~~-~~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~~l--l~~~~~~~~ 285 (314)
T 3com_A 237 IPTNPPP-TFRKPELWSDNFTDFVKQCLVKSPEQRATATQL--LQHPFVRSA 285 (314)
T ss_dssp HHHSCCC-CCSSGGGSCHHHHHHHHHHTCSCTTTSCCHHHH--TTSHHHHTC
T ss_pred HhcCCCc-ccCCcccCCHHHHHHHHHHccCChhhCcCHHHH--HhCHHHhcC
Confidence 2222211 111234578999999999999999999999976 456776543
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 4ehz_A* 4ei4_A* 4fk6_A* 3eyg_A* 3eyh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-39 Score=353.55 Aligned_cols=246 Identities=23% Similarity=0.356 Sum_probs=195.4
Q ss_pred ccccccccccccEEEEEE----EcCCCcEEEEEEecccc------ChHHHHHHHHHhcCCCCceEEEEEEEeC--CeEEE
Q psy11767 381 DKAGILGDGSYSVCRRCV----EKSTGQEYAVKIISRKI------DCSEEINLLRACQGHPNIVNLHCVFQDE--VHTYL 448 (966)
Q Consensus 381 ~~~~~LG~G~fG~Vy~a~----~~~tg~~vAvK~i~~~~------~~~~Ei~iL~~l~~HpnIV~l~~~~~~~--~~~~l 448 (966)
+..+.||+|+||.||+|+ +..+++.||||++.... ...+|+.+|+.+ +||||+++++++.++ ...|+
T Consensus 24 ~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~~~~~~~~l 102 (302)
T 4e5w_A 24 KRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNL-YHENIVKYKGICTEDGGNGIKL 102 (302)
T ss_dssp EEEEEEEECSSEEEEEEEECTTSSSCSEEEEEEEEC-----CCHHHHHHHHHHHHTC-CCTTBCCEEEEEEC---CCEEE
T ss_pred hhhhccCCCCceEEEEEEEccccCccCeEEEEEEecccccchhHHHHHHHHHHHHhC-CCCCeeeeeeEEecCCCceEEE
Confidence 346889999999999999 67789999999987442 245799999998 599999999999877 67899
Q ss_pred EEEccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCcEEEecCCCCCEEEEeecccccccCC
Q psy11767 449 VLELLKGGELLDRIRQKGRCGFTENEASRIMRQLVAAVHFMHSRGVVHRDLKPENLLFSDPAGDNIKVVDFGFACLKRES 528 (966)
Q Consensus 449 VmEy~~gg~L~~~l~~~~~~~l~e~~~~~i~~Qil~aL~yLHs~~IiHRDLKP~NILl~~~~~~~iKL~DFGla~~~~~~ 528 (966)
||||+++|+|.+++..... .+++.+++.++.||+.||+|||++||+||||||+|||++. ++.+||+|||++......
T Consensus 103 v~e~~~~~~L~~~l~~~~~-~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~Nil~~~--~~~~kl~Dfg~~~~~~~~ 179 (302)
T 4e5w_A 103 IMEFLPSGSLKEYLPKNKN-KINLKQQLKYAVQICKGMDYLGSRQYVHRDLAARNVLVES--EHQVKIGDFGLTKAIETD 179 (302)
T ss_dssp EEECCTTCBHHHHHHHHTT-TCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEE--TTEEEECCCTTCEECCTT
T ss_pred EEEeCCCCcHHHHHHhccc-cCCHHHHHHHHHHHHHHHHHhhcCCcccCCCchheEEEcC--CCCEEECcccccccccCC
Confidence 9999999999999966543 5999999999999999999999999999999999999985 568999999999765432
Q ss_pred ------CccccccccccCchhhccCCCCCCCcccchhhhhhhhhhhhcCCCCCCCcCcchhHHHHHHHHhcCCCCCCCCC
Q psy11767 529 ------LHTPCFTLQYAAPEVLRQDKSGYDENCDLWSLGVILVNVLRQDKSGYDENCDLWSLGVILYTMLCGRVPFHARS 602 (966)
Q Consensus 529 ------~~~~~gT~~Y~APEvl~~~~~~~~~~~Di~SlGvil~el~~~~~~~y~~~~DIWSlGvilyemltG~~Pf~~~~ 602 (966)
.....+|+.|+|||++... .|+.++|||||||++|+|++|..|+....
T Consensus 180 ~~~~~~~~~~~~~~~y~aPE~~~~~--------------------------~~~~~~Di~slG~il~~l~~g~~p~~~~~ 233 (302)
T 4e5w_A 180 KEYYTVKDDRDSPVFWYAPECLMQS--------------------------KFYIASDVWSFGVTLHELLTYCDSDSSPM 233 (302)
T ss_dssp CCEEECCCCTTCCGGGCCHHHHHHC--------------------------EEEHHHHHHHHHHHHHHHHTTTCGGGSHH
T ss_pred CcceeccCCCCCCccccCCeeecCC--------------------------CCCcchhHHHHHHHHHHHHHccCCCcchh
Confidence 2345678889999998532 25678999999999999999999874321
Q ss_pred -----------CchhHHHHHHHHHcCCCCCCchhhccCCHHHHHHHHHhcccCccccCChHHHHHHhh
Q psy11767 603 -----------RDDSALSIMARIKEGQFNFDAEAWSTVSSEAKELTKSLLTVNPAQRIRMMRVKLTFH 659 (966)
Q Consensus 603 -----------~~~~~~~~~~~i~~~~~~~~~~~~~~is~e~~~Li~~~L~~dP~~R~t~~~v~~~~~ 659 (966)
.......+...+..+... .....+++++.+||.+||+.||.+|||+.++...+.
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~ 298 (302)
T 4e5w_A 234 ALFLKMIGPTHGQMTVTRLVNTLKEGKRL---PCPPNCPDEVYQLMRKCWEFQPSNRTSFQNLIEGFE 298 (302)
T ss_dssp HHHHHHHCSCCGGGHHHHHHHHHHTTCCC---CCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHH
T ss_pred hHHhhccCCcccccCHHHHHHHHhccCCC---CCCCCCCHHHHHHHHHHcCCCCCCCCCHHHHHHHHH
Confidence 111112233333333221 123468999999999999999999999998865544
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-39 Score=358.93 Aligned_cols=244 Identities=21% Similarity=0.395 Sum_probs=198.4
Q ss_pred ccccccccccccEEEEEEEcCCCcEE--EEEEecccc------ChHHHHHHHHHhcCCCCceEEEEEEEeCCeEEEEEEc
Q psy11767 381 DKAGILGDGSYSVCRRCVEKSTGQEY--AVKIISRKI------DCSEEINLLRACQGHPNIVNLHCVFQDEVHTYLVLEL 452 (966)
Q Consensus 381 ~~~~~LG~G~fG~Vy~a~~~~tg~~v--AvK~i~~~~------~~~~Ei~iL~~l~~HpnIV~l~~~~~~~~~~~lVmEy 452 (966)
+..+.||+|+||.||+|++..+|..+ |||++.... ...+|+.+|+.+.+||||+++++++.++...|+||||
T Consensus 28 ~~~~~lg~G~~g~Vy~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv~e~ 107 (327)
T 1fvr_A 28 KFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEY 107 (327)
T ss_dssp EEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEEEEEECC
T ss_pred cceeeeecCCCceEEEEEEccCCcccceeeeeeccccchHHHHHHHHHHHHHHhccCCCchhhhceeeeeCCceEEEEec
Confidence 33688999999999999999999866 999886422 2457999999986799999999999999999999999
Q ss_pred cCCCCHHHHHHhcC--------------CCCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCcEEEecCCCCCEEEEe
Q psy11767 453 LKGGELLDRIRQKG--------------RCGFTENEASRIMRQLVAAVHFMHSRGVVHRDLKPENLLFSDPAGDNIKVVD 518 (966)
Q Consensus 453 ~~gg~L~~~l~~~~--------------~~~l~e~~~~~i~~Qil~aL~yLHs~~IiHRDLKP~NILl~~~~~~~iKL~D 518 (966)
+++|+|.+++.... ...+++.+++.++.||+.||+|||++||+||||||+|||++. ++.+||+|
T Consensus 108 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIl~~~--~~~~kL~D 185 (327)
T 1fvr_A 108 APHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGE--NYVAKIAD 185 (327)
T ss_dssp CTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECG--GGCEEECC
T ss_pred CCCCCHHHHHHhcccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCCccCCCCccceEEEcC--CCeEEEcc
Confidence 99999999997643 236899999999999999999999999999999999999975 55899999
Q ss_pred ecccccccC--CCccccccccccCchhhccCCCCCCCcccchhhhhhhhhhhhcCCCCCCCcCcchhHHHHHHHHhc-CC
Q psy11767 519 FGFACLKRE--SLHTPCFTLQYAAPEVLRQDKSGYDENCDLWSLGVILVNVLRQDKSGYDENCDLWSLGVILYTMLC-GR 595 (966)
Q Consensus 519 FGla~~~~~--~~~~~~gT~~Y~APEvl~~~~~~~~~~~Di~SlGvil~el~~~~~~~y~~~~DIWSlGvilyemlt-G~ 595 (966)
||+++.... ......+|+.|+|||++... .|+.++|||||||++|+|++ |+
T Consensus 186 fg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~--------------------------~~~~~~Di~slG~il~ellt~g~ 239 (327)
T 1fvr_A 186 FGLSRGQEVYVKKTMGRLPVRWMAIESLNYS--------------------------VYTTNSDVWSYGVLLWEIVSLGG 239 (327)
T ss_dssp TTCEESSCEECCC----CCTTTCCHHHHHHC--------------------------EECHHHHHHHHHHHHHHHHTTSC
T ss_pred cCcCccccccccccCCCCCccccChhhhccc--------------------------cCCchhcchHHHHHHHHHHcCCC
Confidence 999975332 12234568899999988532 36788999999999999998 99
Q ss_pred CCCCCCCCchhHHHHHHHHHcCCCCCCchhhccCCHHHHHHHHHhcccCccccCChHHHHHHhh
Q psy11767 596 VPFHARSRDDSALSIMARIKEGQFNFDAEAWSTVSSEAKELTKSLLTVNPAQRIRMMRVKLTFH 659 (966)
Q Consensus 596 ~Pf~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~is~e~~~Li~~~L~~dP~~R~t~~~v~~~~~ 659 (966)
.||.+.... .+...+..+... .....+++++.+||.+||..||.+|||+.++...+.
T Consensus 240 ~pf~~~~~~----~~~~~~~~~~~~---~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~ 296 (327)
T 1fvr_A 240 TPYCGMTCA----ELYEKLPQGYRL---EKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLN 296 (327)
T ss_dssp CTTTTCCHH----HHHHHGGGTCCC---CCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred CCCCCCcHH----HHHHHhhcCCCC---CCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHH
Confidence 999876532 334455444221 122467899999999999999999999998855444
|
| >4exu_A Mitogen-activated protein kinase 13; P38 kinase, transferase; 1.70A {Homo sapiens} PDB: 4eyj_A* 4eym_A* 3coi_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-39 Score=369.33 Aligned_cols=247 Identities=27% Similarity=0.477 Sum_probs=194.2
Q ss_pred cccccccccccEEEEEEEcCCCcEEEEEEecccc-------ChHHHHHHHHHhcCCCCceEEEEEEEeCCeE------EE
Q psy11767 382 KAGILGDGSYSVCRRCVEKSTGQEYAVKIISRKI-------DCSEEINLLRACQGHPNIVNLHCVFQDEVHT------YL 448 (966)
Q Consensus 382 ~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~-------~~~~Ei~iL~~l~~HpnIV~l~~~~~~~~~~------~l 448 (966)
..+.||+|+||.||+|.+..+|+.||||++.... ...+|+.+|+.+ +||||++++++|...... |+
T Consensus 46 ~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~~~~~~~l 124 (371)
T 4exu_A 46 SPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHM-QHENVIGLLDVFTPASSLRNFYDFYL 124 (371)
T ss_dssp EEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTSSHHHHHHHHHHHHHHHHC-CCTTBCCCSEEECSCSSSTTCCCCEE
T ss_pred EEeEEecCCCeEEEEEEECCCCCEEEEEEecccccchhHHHHHHHHHHHHHhc-CCCCchhhhhheeccCCcccceeEEE
Confidence 3688999999999999999999999999997542 234699999998 499999999999877654 99
Q ss_pred EEEccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCcEEEecCCCCCEEEEeecccccccCC
Q psy11767 449 VLELLKGGELLDRIRQKGRCGFTENEASRIMRQLVAAVHFMHSRGVVHRDLKPENLLFSDPAGDNIKVVDFGFACLKRES 528 (966)
Q Consensus 449 VmEy~~gg~L~~~l~~~~~~~l~e~~~~~i~~Qil~aL~yLHs~~IiHRDLKP~NILl~~~~~~~iKL~DFGla~~~~~~ 528 (966)
||||+. ++|.+.+.. .+++..++.++.||+.||+|||++||+||||||+|||++. ++.+||+|||+++.....
T Consensus 125 v~e~~~-~~l~~~~~~----~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIll~~--~~~~kL~Dfg~a~~~~~~ 197 (371)
T 4exu_A 125 VMPFMQ-TDLQKIMGM----EFSEEKIQYLVYQMLKGLKYIHSAGVVHRDLKPGNLAVNE--DCELKILDFGLARHADAE 197 (371)
T ss_dssp EEECCC-EEHHHHTTS----CCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECT--TCCEEECSTTCC------
T ss_pred EEcccc-ccHHHHhhc----CCCHHHHHHHHHHHHHHHHHHHHCCCcCCCcCHHHeEECC--CCCEEEEecCcccccccC
Confidence 999996 688877632 4899999999999999999999999999999999999975 568999999999877666
Q ss_pred CccccccccccCchhhccCCCCCCCcccchhhhhhhhhhhhcCCCCCCCcCcchhHHHHHHHHhcCCCCCCCCCCchhHH
Q psy11767 529 LHTPCFTLQYAAPEVLRQDKSGYDENCDLWSLGVILVNVLRQDKSGYDENCDLWSLGVILYTMLCGRVPFHARSRDDSAL 608 (966)
Q Consensus 529 ~~~~~gT~~Y~APEvl~~~~~~~~~~~Di~SlGvil~el~~~~~~~y~~~~DIWSlGvilyemltG~~Pf~~~~~~~~~~ 608 (966)
....++|+.|+|||++.. ...|+.++|||||||++|+|++|+.||.+.+..+...
T Consensus 198 ~~~~~~t~~y~aPE~~~~-------------------------~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~ 252 (371)
T 4exu_A 198 MTGYVVTRWYRAPEVILS-------------------------WMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLT 252 (371)
T ss_dssp --CTTCCCTTSCHHHHSC-------------------------CSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHH
T ss_pred cCCcccCccccCHHHhcC-------------------------CCCCCcHHhHHHHHHHHHHHHhCCCCCCCCChHHHHH
Confidence 666788999999999853 1347889999999999999999999998766443333
Q ss_pred HHHHHHHcC-----------------------CCCCCchhhccCCHHHHHHHHHhcccCccccCChHHHHHHhhhhHH
Q psy11767 609 SIMARIKEG-----------------------QFNFDAEAWSTVSSEAKELTKSLLTVNPAQRIRMMRVKLTFHAFHQ 663 (966)
Q Consensus 609 ~~~~~i~~~-----------------------~~~~~~~~~~~is~e~~~Li~~~L~~dP~~R~t~~~v~~~~~~~~~ 663 (966)
.++...... ........++.+++++.+||.+||+.||++|||+.++ ..|+|+.
T Consensus 253 ~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~el--l~hp~f~ 328 (371)
T 4exu_A 253 QILKVTGVPGTEFVQKLNDKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQA--LTHPFFE 328 (371)
T ss_dssp HHHHHHCCCCHHHHTTCSCHHHHHHHHHSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSCTTTSCCHHHH--HTSGGGT
T ss_pred HHHHHhCCCcHHHHHHhhhhhhhhhhhccCCCcchhHHHhccccChHHHHHHHHHCCCChhhcCCHHHH--hcCcccc
Confidence 222211100 0000011234679999999999999999999999876 4577764
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-39 Score=356.11 Aligned_cols=247 Identities=24% Similarity=0.337 Sum_probs=199.5
Q ss_pred ccccccccccccEEEEEEE-----cCCCcEEEEEEeccccC------hHHHHHHHHHhcCCCCceEEEEEEEeCC-eEEE
Q psy11767 381 DKAGILGDGSYSVCRRCVE-----KSTGQEYAVKIISRKID------CSEEINLLRACQGHPNIVNLHCVFQDEV-HTYL 448 (966)
Q Consensus 381 ~~~~~LG~G~fG~Vy~a~~-----~~tg~~vAvK~i~~~~~------~~~Ei~iL~~l~~HpnIV~l~~~~~~~~-~~~l 448 (966)
...+.||+|+||.||+|.+ ..+++.||||++..... ..+|+.+|+.+.+||||+++++++.+.+ ..|+
T Consensus 30 ~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~~l 109 (316)
T 2xir_A 30 KLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGPLMV 109 (316)
T ss_dssp EEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECCTTSCCEE
T ss_pred eeeeEEcCCCceeEEEEEEecCCccccceEEEEEecccCCCcHHHHHHHHHHHHHHhcccCCCeeeEEEEEecCCCceEE
Confidence 3468899999999999985 45789999999976433 3469999999978999999999988754 5899
Q ss_pred EEEccCCCCHHHHHHhcCC--------------CCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCcEEEecCCCCCE
Q psy11767 449 VLELLKGGELLDRIRQKGR--------------CGFTENEASRIMRQLVAAVHFMHSRGVVHRDLKPENLLFSDPAGDNI 514 (966)
Q Consensus 449 VmEy~~gg~L~~~l~~~~~--------------~~l~e~~~~~i~~Qil~aL~yLHs~~IiHRDLKP~NILl~~~~~~~i 514 (966)
||||+++|+|.+++..... ..+++..++.++.||+.||+|||++||+||||||+|||++. .+.+
T Consensus 110 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dikp~Nil~~~--~~~~ 187 (316)
T 2xir_A 110 IVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSE--KNVV 187 (316)
T ss_dssp EEECCTTEEHHHHHHTCTTSEECC-------CTTCEEHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECG--GGCE
T ss_pred EEEcCCCCcHHHHHHhcccccccccccchhhhccccCHHHHHHHHHHHHHHHHHHHhCCcccccCccceEEECC--CCCE
Confidence 9999999999999987542 12899999999999999999999999999999999999975 5689
Q ss_pred EEEeecccccccCC-----CccccccccccCchhhccCCCCCCCcccchhhhhhhhhhhhcCCCCCCCcCcchhHHHHHH
Q psy11767 515 KVVDFGFACLKRES-----LHTPCFTLQYAAPEVLRQDKSGYDENCDLWSLGVILVNVLRQDKSGYDENCDLWSLGVILY 589 (966)
Q Consensus 515 KL~DFGla~~~~~~-----~~~~~gT~~Y~APEvl~~~~~~~~~~~Di~SlGvil~el~~~~~~~y~~~~DIWSlGvily 589 (966)
||+|||+++..... .....+|+.|+|||++.. ..|+.++|||||||++|
T Consensus 188 kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~--------------------------~~~~~~~Di~slG~il~ 241 (316)
T 2xir_A 188 KICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFD--------------------------RVYTIQSDVWSFGVLLW 241 (316)
T ss_dssp EECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHH--------------------------CCCCHHHHHHHHHHHHH
T ss_pred EECCCccccccccCccceeccCCCcceeecCchhhcc--------------------------ccccchhHHHHHHHHHH
Confidence 99999999754322 123457889999999853 23678999999999999
Q ss_pred HHhc-CCCCCCCCCCchhHHHHHHHHHcCCCCCCchhhccCCHHHHHHHHHhcccCccccCChHHHHHHhhhh
Q psy11767 590 TMLC-GRVPFHARSRDDSALSIMARIKEGQFNFDAEAWSTVSSEAKELTKSLLTVNPAQRIRMMRVKLTFHAF 661 (966)
Q Consensus 590 emlt-G~~Pf~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~is~e~~~Li~~~L~~dP~~R~t~~~v~~~~~~~ 661 (966)
+|++ |..||.+....+. ....+..+.... ....+++++.++|.+||..||.+|||+.++...+...
T Consensus 242 ~l~t~g~~p~~~~~~~~~---~~~~~~~~~~~~---~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~ 308 (316)
T 2xir_A 242 EIFSLGASPYPGVKIDEE---FCRRLKEGTRMR---APDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNL 308 (316)
T ss_dssp HHHTTSCCSSTTCCCSHH---HHHHHHHTCCCC---CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred HHHhCCCCCCcccchhHH---HHHHhccCccCC---CCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence 9998 9999987665432 233344433211 1235789999999999999999999999886655443
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.9e-39 Score=350.05 Aligned_cols=249 Identities=26% Similarity=0.388 Sum_probs=199.9
Q ss_pred cccccccccccEEEEEEEcCCCcEEEEEEeccccC-----hHHHHHHHHHhcCCCCceEEEEEEEeCCeEEEEEEccCCC
Q psy11767 382 KAGILGDGSYSVCRRCVEKSTGQEYAVKIISRKID-----CSEEINLLRACQGHPNIVNLHCVFQDEVHTYLVLELLKGG 456 (966)
Q Consensus 382 ~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~~-----~~~Ei~iL~~l~~HpnIV~l~~~~~~~~~~~lVmEy~~gg 456 (966)
...+||+|+||.||+|.+..+++.||||++..... ..+|+.+++.+ +||||+++++++.+....++||||++++
T Consensus 26 ~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~e~~~~~ 104 (295)
T 2clq_A 26 DRVVLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHL-KHKNIVQYLGSFSENGFIKIFMEQVPGG 104 (295)
T ss_dssp SBCEEEECSSSEEEEEEETTTCCEEEEEEEECCCC---HHHHHHHHHHHTC-CCTTBCCEEEEEEETTEEEEEEECCSEE
T ss_pred CcEEEeecCcEEEEEEEECCCCeEEEEEEccCCchHHHHHHHHHHHHHHhC-CCCCEeeEeeEEEeCCcEEEEEEeCCCC
Confidence 35689999999999999999999999999865432 45789999888 5999999999999999999999999999
Q ss_pred CHHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCcEEEecCCCCCEEEEeecccccccC---CCccc
Q psy11767 457 ELLDRIRQKG-RCGFTENEASRIMRQLVAAVHFMHSRGVVHRDLKPENLLFSDPAGDNIKVVDFGFACLKRE---SLHTP 532 (966)
Q Consensus 457 ~L~~~l~~~~-~~~l~e~~~~~i~~Qil~aL~yLHs~~IiHRDLKP~NILl~~~~~~~iKL~DFGla~~~~~---~~~~~ 532 (966)
+|.+++.... ...+++..++.++.||+.||+|||++||+||||||+|||++. .++.+||+|||++..... .....
T Consensus 105 ~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~-~~~~~kl~Dfg~~~~~~~~~~~~~~~ 183 (295)
T 2clq_A 105 SLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHDNQIVHRDIKGDNVLINT-YSGVLKISDFGTSKRLAGINPCTETF 183 (295)
T ss_dssp EHHHHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEET-TTCCEEECCTTTCEESCC-----CCC
T ss_pred CHHHHHHhhccCCCccHHHHHHHHHHHHHHHHHHHhCCEEccCCChhhEEEEC-CCCCEEEeecccccccCCCCCccccc
Confidence 9999998653 235779999999999999999999999999999999999974 256899999999976532 23355
Q ss_pred cccccccCchhhccCCCCCCCcccchhhhhhhhhhhhcCCCCCCCcCcchhHHHHHHHHhcCCCCCCCCCCchhHHHHHH
Q psy11767 533 CFTLQYAAPEVLRQDKSGYDENCDLWSLGVILVNVLRQDKSGYDENCDLWSLGVILYTMLCGRVPFHARSRDDSALSIMA 612 (966)
Q Consensus 533 ~gT~~Y~APEvl~~~~~~~~~~~Di~SlGvil~el~~~~~~~y~~~~DIWSlGvilyemltG~~Pf~~~~~~~~~~~~~~ 612 (966)
.+|+.|+|||++.... ..|+.++|||||||++|+|++|+.||........ ....
T Consensus 184 ~~~~~y~aPE~~~~~~------------------------~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~--~~~~ 237 (295)
T 2clq_A 184 TGTLQYMAPEIIDKGP------------------------RGYGKAADIWSLGCTIIEMATGKPPFYELGEPQA--AMFK 237 (295)
T ss_dssp CCCGGGCCHHHHHHGG------------------------GGCSHHHHHHHHHHHHHHHHHTSCTTGGGSSHHH--HHHH
T ss_pred CCCccccChhhhcCCC------------------------CCCCcHHHHHHHHHHHHHHHHCCCCccCCCchhH--HHHh
Confidence 7899999999985321 2367889999999999999999999976443221 1111
Q ss_pred HHHcCCCCCCchhhccCCHHHHHHHHHhcccCccccCChHHHHHHhhhhHH
Q psy11767 613 RIKEGQFNFDAEAWSTVSSEAKELTKSLLTVNPAQRIRMMRVKLTFHAFHQ 663 (966)
Q Consensus 613 ~i~~~~~~~~~~~~~~is~e~~~Li~~~L~~dP~~R~t~~~v~~~~~~~~~ 663 (966)
.... .........+++++.+||.+||..||++|||+.++ ..|+|+.
T Consensus 238 ~~~~---~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~l--l~~~~~~ 283 (295)
T 2clq_A 238 VGMF---KVHPEIPESMSAEAKAFILKCFEPDPDKRACANDL--LVDEFLK 283 (295)
T ss_dssp HHHH---CCCCCCCTTSCHHHHHHHHHTTCSSTTTSCCHHHH--HTSGGGC
T ss_pred hccc---cccccccccCCHHHHHHHHHHccCChhhCCCHHHH--hcChhhh
Confidence 1111 11122334689999999999999999999999876 3466653
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-39 Score=355.61 Aligned_cols=258 Identities=26% Similarity=0.393 Sum_probs=195.4
Q ss_pred ccceecccccccccccccccccccEEEEEEEcCCCcEEEEEEecccc-----ChHHHHHHHHHhcCCCCceEEEEEEE--
Q psy11767 369 GSLFFEQYDMDLDKAGILGDGSYSVCRRCVEKSTGQEYAVKIISRKI-----DCSEEINLLRACQGHPNIVNLHCVFQ-- 441 (966)
Q Consensus 369 G~~~~~~~~i~~~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~-----~~~~Ei~iL~~l~~HpnIV~l~~~~~-- 441 (966)
|..+.++|.+ .+.||+|+||.||+|.+..+|+.||||++.... ...+|+.+|+.+ +||||+++++++.
T Consensus 6 ~~~~~~~y~~----~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~ 80 (320)
T 2i6l_A 6 GFDLGSRYMD----LKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLTDPQSVKHALREIKIIRRL-DHDNIVKVFEILGPS 80 (320)
T ss_dssp CEEETTTEEE----EEECC-----CEEEEEETTTTEEEEEEEEECCSHHHHHHHHHHHHHHHTC-CCTTBCCEEEEECTT
T ss_pred cCccCCceeE----EEEeccCCCeEEEEEEECCCCeEEEEEEEecCChHHHHHHHHHHHHHHhc-CCCCeeEEEEecccc
Confidence 4445556655 688999999999999999999999999986442 245799999988 5999999999884
Q ss_pred ------------eCCeEEEEEEccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCcEEEecC
Q psy11767 442 ------------DEVHTYLVLELLKGGELLDRIRQKGRCGFTENEASRIMRQLVAAVHFMHSRGVVHRDLKPENLLFSDP 509 (966)
Q Consensus 442 ------------~~~~~~lVmEy~~gg~L~~~l~~~~~~~l~e~~~~~i~~Qil~aL~yLHs~~IiHRDLKP~NILl~~~ 509 (966)
+....|+||||+. |+|.+++.+. .+++..++.++.||+.||+|||++||+||||||+|||++.
T Consensus 81 ~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~~~~~---~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~- 155 (320)
T 2i6l_A 81 GSQLTDDVGSLTELNSVYIVQEYME-TDLANVLEQG---PLLEEHARLFMYQLLRGLKYIHSANVLHRDLKPANLFINT- 155 (320)
T ss_dssp SCBCCC----CCSCSEEEEEEECCS-EEHHHHHTTC---CCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEEET-
T ss_pred ccccccccccccccCceeEEeeccC-CCHHHHhhcC---CccHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcC-
Confidence 4467899999997 6999998643 5899999999999999999999999999999999999974
Q ss_pred CCCCEEEEeecccccccC------CCccccccccccCchhhccCCCCCCCcccchhhhhhhhhhhhcCCCCCCCcCcchh
Q psy11767 510 AGDNIKVVDFGFACLKRE------SLHTPCFTLQYAAPEVLRQDKSGYDENCDLWSLGVILVNVLRQDKSGYDENCDLWS 583 (966)
Q Consensus 510 ~~~~iKL~DFGla~~~~~------~~~~~~gT~~Y~APEvl~~~~~~~~~~~Di~SlGvil~el~~~~~~~y~~~~DIWS 583 (966)
.++.+||+|||++..... ......+|+.|+|||++.. ...|+.++||||
T Consensus 156 ~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-------------------------~~~~~~~~Di~s 210 (320)
T 2i6l_A 156 EDLVLKIGDFGLARIMDPHYSHKGHLSEGLVTKWYRSPRLLLS-------------------------PNNYTKAIDMWA 210 (320)
T ss_dssp TTTEEEECCCTTCBCC--------CCCGGGSCCTTCCHHHHHC-------------------------TTCCCHHHHHHH
T ss_pred CCCeEEEccCccccccCCCcccccccccccccccccCcHHhcC-------------------------cccCCchhhhHh
Confidence 346899999999976432 1233457999999998853 124788999999
Q ss_pred HHHHHHHHhcCCCCCCCCCCchhHHHHHHHHH-----------c-----------CCCCCCchhhccCCHHHHHHHHHhc
Q psy11767 584 LGVILYTMLCGRVPFHARSRDDSALSIMARIK-----------E-----------GQFNFDAEAWSTVSSEAKELTKSLL 641 (966)
Q Consensus 584 lGvilyemltG~~Pf~~~~~~~~~~~~~~~i~-----------~-----------~~~~~~~~~~~~is~e~~~Li~~~L 641 (966)
|||++|+|++|+.||.+.+..+....+...+. . .........++.++.++++||.+||
T Consensus 211 lG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L 290 (320)
T 2i6l_A 211 AGCIFAEMLTGKTLFAGAHELEQMQLILESIPVVHEEDRQELLSVIPVYIRNDMTEPHKPLTQLLPGISREAVDFLEQIL 290 (320)
T ss_dssp HHHHHHHHHHSSCSSCCSSHHHHHHHHHHHSCCCCHHHHHHHHTTSCHHHHHHTTSCCCCHHHHSTTCCHHHHHHHHTTS
T ss_pred HHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCchhhhhhhhhcCcccccccccCCCCChhHhcchhhHHHHHHHHHHc
Confidence 99999999999999987654332222211100 0 0000001223468999999999999
Q ss_pred ccCccccCChHHHHHHhhhhHH
Q psy11767 642 TVNPAQRIRMMRVKLTFHAFHQ 663 (966)
Q Consensus 642 ~~dP~~R~t~~~v~~~~~~~~~ 663 (966)
+.||++|||+.++ ..|+|+.
T Consensus 291 ~~dP~~Rpt~~el--l~hp~~~ 310 (320)
T 2i6l_A 291 TFSPMDRLTAEEA--LSHPYMS 310 (320)
T ss_dssp CSSGGGSCCHHHH--HTSHHHH
T ss_pred CCCccccCCHHHH--hCCcccc
Confidence 9999999999976 4577764
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-38 Score=357.19 Aligned_cols=246 Identities=21% Similarity=0.362 Sum_probs=199.5
Q ss_pred cccccccccccEEEEEEEc-------CCCcEEEEEEeccccC------hHHHHHHHHHhcCCCCceEEEEEEEeCCeEEE
Q psy11767 382 KAGILGDGSYSVCRRCVEK-------STGQEYAVKIISRKID------CSEEINLLRACQGHPNIVNLHCVFQDEVHTYL 448 (966)
Q Consensus 382 ~~~~LG~G~fG~Vy~a~~~-------~tg~~vAvK~i~~~~~------~~~Ei~iL~~l~~HpnIV~l~~~~~~~~~~~l 448 (966)
..+.||+|+||.||+|.+. .+++.||||++..... ..+|+.+|+.+.+||||+++++++.++...|+
T Consensus 39 ~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~l 118 (334)
T 2pvf_A 39 LGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYV 118 (334)
T ss_dssp EEEEEEECSSCEEEEEEETTCSTTCC---CEEEEEECCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSCCEE
T ss_pred EeeEEeecCceeEEEeEeccccccccccceEEEEeeeccCCcHHHHHHHHHHHHHHHHhhcCCCEeeEEEEEccCCceEE
Confidence 3688999999999999986 4678999999975432 34699999998779999999999999999999
Q ss_pred EEEccCCCCHHHHHHhcCC--------------CCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCcEEEecCCCCCE
Q psy11767 449 VLELLKGGELLDRIRQKGR--------------CGFTENEASRIMRQLVAAVHFMHSRGVVHRDLKPENLLFSDPAGDNI 514 (966)
Q Consensus 449 VmEy~~gg~L~~~l~~~~~--------------~~l~e~~~~~i~~Qil~aL~yLHs~~IiHRDLKP~NILl~~~~~~~i 514 (966)
||||+++|+|.+++..... ..+++.+++.++.||+.||+|||++||+||||||+|||++. ++.+
T Consensus 119 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~--~~~~ 196 (334)
T 2pvf_A 119 IVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVTE--NNVM 196 (334)
T ss_dssp EEECCTTCBHHHHHHTTSCTTCCSCC--------CCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECT--TCCE
T ss_pred EEECCCCCcHHHHHHHhccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCccceEEEcC--CCCE
Confidence 9999999999999986542 24899999999999999999999999999999999999974 5689
Q ss_pred EEEeecccccccCC-----CccccccccccCchhhccCCCCCCCcccchhhhhhhhhhhhcCCCCCCCcCcchhHHHHHH
Q psy11767 515 KVVDFGFACLKRES-----LHTPCFTLQYAAPEVLRQDKSGYDENCDLWSLGVILVNVLRQDKSGYDENCDLWSLGVILY 589 (966)
Q Consensus 515 KL~DFGla~~~~~~-----~~~~~gT~~Y~APEvl~~~~~~~~~~~Di~SlGvil~el~~~~~~~y~~~~DIWSlGvily 589 (966)
||+|||+++..... .....+|+.|+|||++... .|+.++|||||||++|
T Consensus 197 kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~--------------------------~~~~~~Di~slG~il~ 250 (334)
T 2pvf_A 197 KIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDR--------------------------VYTHQSDVWSFGVLMW 250 (334)
T ss_dssp EECCCTTCEECTTTSSEECCSCCCCCGGGCCHHHHHHC--------------------------EECHHHHHHHHHHHHH
T ss_pred EEccccccccccccccccccCCCCcccceeChHHhcCC--------------------------CcChHHHHHHHHHHHH
Confidence 99999999765432 2234568899999988532 3678899999999999
Q ss_pred HHhc-CCCCCCCCCCchhHHHHHHHHHcCCCCCCchhhccCCHHHHHHHHHhcccCccccCChHHHHHHhhhhH
Q psy11767 590 TMLC-GRVPFHARSRDDSALSIMARIKEGQFNFDAEAWSTVSSEAKELTKSLLTVNPAQRIRMMRVKLTFHAFH 662 (966)
Q Consensus 590 emlt-G~~Pf~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~is~e~~~Li~~~L~~dP~~R~t~~~v~~~~~~~~ 662 (966)
+|++ |..||.+.... .+...+..+.... ....++.++.+||.+||..||.+|||+.++...+....
T Consensus 251 ellt~g~~p~~~~~~~----~~~~~~~~~~~~~---~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~l~ 317 (334)
T 2pvf_A 251 EIFTLGGSPYPGIPVE----ELFKLLKEGHRMD---KPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIL 317 (334)
T ss_dssp HHHTTSCCSSTTCCHH----HHHHHHHHTCCCC---CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred HHHhCCCCCcCcCCHH----HHHHHHhcCCCCC---CCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHH
Confidence 9999 99999876532 3344444443221 22467899999999999999999999998866555443
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-38 Score=343.57 Aligned_cols=242 Identities=24% Similarity=0.408 Sum_probs=200.1
Q ss_pred ccccccccccccEEEEEEEcCCCcEEEEEEecccc----ChHHHHHHHHHhcCCCCceEEEEEEEeCCeEEEEEEccCCC
Q psy11767 381 DKAGILGDGSYSVCRRCVEKSTGQEYAVKIISRKI----DCSEEINLLRACQGHPNIVNLHCVFQDEVHTYLVLELLKGG 456 (966)
Q Consensus 381 ~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~----~~~~Ei~iL~~l~~HpnIV~l~~~~~~~~~~~lVmEy~~gg 456 (966)
+..+.||+|+||.||+|.+. +++.||||++.... ...+|+.+|+.+ +||||+++++++.++...|+||||++++
T Consensus 11 ~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~~ 88 (267)
T 3t9t_A 11 TFVQEIGSGQFGLVHLGYWL-NKDKVAIKTIREGAMSEEDFIEEAEVMMKL-SHPKLVQLYGVCLEQAPICLVTEFMEHG 88 (267)
T ss_dssp EEEEEEEEETTEEEEEEEET-TTEEEEEEEECTTTBCHHHHHHHHHHHHTC-CCTTBCCEEEEECSSSSCEEEECCCTTC
T ss_pred eeeeEecCCCceeEEEEEec-CCCeEEEEEccccCCCHHHHHHHHHHHHhC-CCCCEeeEEEEEccCCCeEEEEeCCCCC
Confidence 34678999999999999987 57899999997543 245799999988 5999999999999999999999999999
Q ss_pred CHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCcEEEecCCCCCEEEEeecccccccC----CCccc
Q psy11767 457 ELLDRIRQKGRCGFTENEASRIMRQLVAAVHFMHSRGVVHRDLKPENLLFSDPAGDNIKVVDFGFACLKRE----SLHTP 532 (966)
Q Consensus 457 ~L~~~l~~~~~~~l~e~~~~~i~~Qil~aL~yLHs~~IiHRDLKP~NILl~~~~~~~iKL~DFGla~~~~~----~~~~~ 532 (966)
+|.+++..... .+++..+..++.||+.||+|||++||+||||||+|||++. ++.+||+|||++..... .....
T Consensus 89 ~L~~~~~~~~~-~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nili~~--~~~~kl~dfg~~~~~~~~~~~~~~~~ 165 (267)
T 3t9t_A 89 CLSDYLRTQRG-LFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLVGE--NQVIKVSDFGMTRFVLDDQYTSSTGT 165 (267)
T ss_dssp BHHHHHHHTTT-CCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCCGGGEEECG--GGCEEECCTTGGGGBCCHHHHSTTST
T ss_pred cHHHHHhhCcc-cCCHHHHHHHHHHHHHHHHHHHhCCcccCCCchheEEECC--CCCEEEcccccccccccccccccccc
Confidence 99999977543 5899999999999999999999999999999999999975 56899999999976432 12334
Q ss_pred cccccccCchhhccCCCCCCCcccchhhhhhhhhhhhcCCCCCCCcCcchhHHHHHHHHhc-CCCCCCCCCCchhHHHHH
Q psy11767 533 CFTLQYAAPEVLRQDKSGYDENCDLWSLGVILVNVLRQDKSGYDENCDLWSLGVILYTMLC-GRVPFHARSRDDSALSIM 611 (966)
Q Consensus 533 ~gT~~Y~APEvl~~~~~~~~~~~Di~SlGvil~el~~~~~~~y~~~~DIWSlGvilyemlt-G~~Pf~~~~~~~~~~~~~ 611 (966)
.+|+.|+|||++.. ..++.++|||||||++|+|++ |+.||...... ...
T Consensus 166 ~~~~~y~aPE~~~~--------------------------~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~----~~~ 215 (267)
T 3t9t_A 166 KFPVKWASPEVFSF--------------------------SRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNS----EVV 215 (267)
T ss_dssp TCCGGGCCHHHHHH--------------------------CCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHH----HHH
T ss_pred cccccccChhhhcC--------------------------CCccchhchhhhHHHHHHHhccCCCCCCCCCHH----HHH
Confidence 56889999999853 236788999999999999999 89999875432 344
Q ss_pred HHHHcCCCCCCchhhccCCHHHHHHHHHhcccCccccCChHHHHHHhhh
Q psy11767 612 ARIKEGQFNFDAEAWSTVSSEAKELTKSLLTVNPAQRIRMMRVKLTFHA 660 (966)
Q Consensus 612 ~~i~~~~~~~~~~~~~~is~e~~~Li~~~L~~dP~~R~t~~~v~~~~~~ 660 (966)
..+..+..... ...+++++.+++.+||..||++|||+.++...+..
T Consensus 216 ~~i~~~~~~~~---~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~ 261 (267)
T 3t9t_A 216 EDISTGFRLYK---PRLASTHVYQIMNHCWRERPEDRPAFSRLLRQLAE 261 (267)
T ss_dssp HHHHTTCCCCC---CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred HHHhcCCcCCC---CccCcHHHHHHHHHHccCChhhCcCHHHHHHHHHH
Confidence 55555532222 23578999999999999999999999988655443
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} SCOP: d.144.1.0 | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-39 Score=348.03 Aligned_cols=239 Identities=26% Similarity=0.412 Sum_probs=185.6
Q ss_pred ccccccccccccEEEEEEEcCCCcEEEEEEecccc---------ChHHHHHHHHHhcCCCCceEEEEEEEeCCeEEEEEE
Q psy11767 381 DKAGILGDGSYSVCRRCVEKSTGQEYAVKIISRKI---------DCSEEINLLRACQGHPNIVNLHCVFQDEVHTYLVLE 451 (966)
Q Consensus 381 ~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~---------~~~~Ei~iL~~l~~HpnIV~l~~~~~~~~~~~lVmE 451 (966)
+..+.||+|+||.||+|.+. |+.||||++.... ...+|+++++.+ +||||+++++++.++...|+|||
T Consensus 10 ~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e 86 (271)
T 3dtc_A 10 TLEEIIGIGGFGKVYRAFWI--GDEVAVKAARHDPDEDISQTIENVRQEAKLFAML-KHPNIIALRGVCLKEPNLCLVME 86 (271)
T ss_dssp EEEEEEEEETTEEEEEEEET--TEEEEEEEC----------CHHHHHHHHHHHHHC-CCTTBCCEEEEECCC--CEEEEE
T ss_pred eeeeeeccCCCeEEEEEEEc--CCeEEEEEEecCCcccHHHHHHHHHHHHHHHHhc-CCCCEeeEEEEEecCCceEEEEE
Confidence 34678999999999999975 8899999986432 134689999888 59999999999999999999999
Q ss_pred ccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcC---ceeccCCCCcEEEecC------CCCCEEEEeeccc
Q psy11767 452 LLKGGELLDRIRQKGRCGFTENEASRIMRQLVAAVHFMHSRG---VVHRDLKPENLLFSDP------AGDNIKVVDFGFA 522 (966)
Q Consensus 452 y~~gg~L~~~l~~~~~~~l~e~~~~~i~~Qil~aL~yLHs~~---IiHRDLKP~NILl~~~------~~~~iKL~DFGla 522 (966)
|++|++|.+++... .+++..++.++.||+.||+|||++| |+||||||+|||++.. ..+.+||+|||++
T Consensus 87 ~~~~~~L~~~~~~~---~~~~~~~~~i~~~l~~~l~~lH~~~~~~i~H~dikp~Nil~~~~~~~~~~~~~~~kl~Dfg~~ 163 (271)
T 3dtc_A 87 FARGGPLNRVLSGK---RIPPDILVNWAVQIARGMNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDFGLA 163 (271)
T ss_dssp CCTTEEHHHHHTSS---CCCHHHHHHHHHHHHHHHHHHHHSSSSCCCCSCCSGGGEEESSCCSSSCCSSCCEEECCCCC-
T ss_pred cCCCCCHHHHhhcC---CCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCchHHEEEecccccccccCcceEEccCCcc
Confidence 99999999988543 5999999999999999999999999 9999999999999742 2467999999999
Q ss_pred ccccCC-CccccccccccCchhhccCCCCCCCcccchhhhhhhhhhhhcCCCCCCCcCcchhHHHHHHHHhcCCCCCCCC
Q psy11767 523 CLKRES-LHTPCFTLQYAAPEVLRQDKSGYDENCDLWSLGVILVNVLRQDKSGYDENCDLWSLGVILYTMLCGRVPFHAR 601 (966)
Q Consensus 523 ~~~~~~-~~~~~gT~~Y~APEvl~~~~~~~~~~~Di~SlGvil~el~~~~~~~y~~~~DIWSlGvilyemltG~~Pf~~~ 601 (966)
...... .....+|+.|+|||++.. ..|+.++|||||||++|+|++|+.||.+.
T Consensus 164 ~~~~~~~~~~~~~~~~y~aPE~~~~--------------------------~~~~~~~Di~slG~~l~~l~~g~~p~~~~ 217 (271)
T 3dtc_A 164 REWHRTTKMSAAGAYAWMAPEVIRA--------------------------SMFSKGSDVWSYGVLLWELLTGEVPFRGI 217 (271)
T ss_dssp ------------CCGGGSCHHHHHH--------------------------CCCSHHHHHHHHHHHHHHHHHCCCTTTTS
T ss_pred cccccccccCCCCccceeCHHHhcc--------------------------CCCCchhhHHHHHHHHHHHHhCCCCCCCC
Confidence 764432 234578999999998853 23678899999999999999999999875
Q ss_pred CCchhHHHHHHHHHcCCCCCCchhhccCCHHHHHHHHHhcccCccccCChHHHHHH
Q psy11767 602 SRDDSALSIMARIKEGQFNFDAEAWSTVSSEAKELTKSLLTVNPAQRIRMMRVKLT 657 (966)
Q Consensus 602 ~~~~~~~~~~~~i~~~~~~~~~~~~~~is~e~~~Li~~~L~~dP~~R~t~~~v~~~ 657 (966)
... .....+........ ....+++++.++|.+||..||++|||+.++...
T Consensus 218 ~~~----~~~~~~~~~~~~~~--~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~ 267 (271)
T 3dtc_A 218 DGL----AVAYGVAMNKLALP--IPSTCPEPFAKLMEDCWNPDPHSRPSFTNILDQ 267 (271)
T ss_dssp CHH----HHHHHHHTSCCCCC--CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred CHH----HHHHhhhcCCCCCC--CCcccCHHHHHHHHHHhcCCcccCcCHHHHHHH
Confidence 432 22233333333222 224678999999999999999999999987543
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-39 Score=378.22 Aligned_cols=243 Identities=21% Similarity=0.393 Sum_probs=198.3
Q ss_pred ccccccccccccEEEEEEEcCCCcEEEEEEecccc----ChHHHHHHHHHhcCCCCceEEEEEEEeCCeEEEEEEccCCC
Q psy11767 381 DKAGILGDGSYSVCRRCVEKSTGQEYAVKIISRKI----DCSEEINLLRACQGHPNIVNLHCVFQDEVHTYLVLELLKGG 456 (966)
Q Consensus 381 ~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~----~~~~Ei~iL~~l~~HpnIV~l~~~~~~~~~~~lVmEy~~gg 456 (966)
+..+.||+|+||+||+|.+.. +..||||++.... ...+|+.+|+.+ +|||||++++++. ....|||||||++|
T Consensus 191 ~~~~~lG~G~fg~V~~~~~~~-~~~vavK~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~l~~~~~-~~~~~lv~e~~~~g 267 (454)
T 1qcf_A 191 KLEKKLGAGQFGEVWMATYNK-HTKVAVKTMKPGSMSVEAFLAEANVMKTL-QHDKLVKLHAVVT-KEPIYIITEFMAKG 267 (454)
T ss_dssp EEEEEEECCSSEEEEEEEETT-TEEEEEEEECTTSBCHHHHHHHHHHHTTC-CCTTBCCEEEEEC-SSSCEEEECCCTTC
T ss_pred EEEEEcccCCceEEEEEEECC-ccEEEEEEecCCCccHHHHHHHHHHHhhC-CCCCEeeEEEEEe-CCccEEEEeecCCC
Confidence 336789999999999999864 6789999997543 245799999988 5999999999986 56789999999999
Q ss_pred CHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCcEEEecCCCCCEEEEeecccccccCC----Cccc
Q psy11767 457 ELLDRIRQKGRCGFTENEASRIMRQLVAAVHFMHSRGVVHRDLKPENLLFSDPAGDNIKVVDFGFACLKRES----LHTP 532 (966)
Q Consensus 457 ~L~~~l~~~~~~~l~e~~~~~i~~Qil~aL~yLHs~~IiHRDLKP~NILl~~~~~~~iKL~DFGla~~~~~~----~~~~ 532 (966)
+|.+++.......+++.++..++.||+.||+|||++||+||||||+|||++. ++.+||+|||+|+..... ....
T Consensus 268 ~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~Nill~~--~~~~kl~DFG~a~~~~~~~~~~~~~~ 345 (454)
T 1qcf_A 268 SLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRNYIHRDLRAANILVSA--SLVCKIADFGLARVIEDNEYTAREGA 345 (454)
T ss_dssp BHHHHHHSHHHHTCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCSGGGEEECT--TCCEEECSTTGGGGBCCHHHHTTCSS
T ss_pred cHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCCHHHEEECC--CCcEEEeeCCCceEcCCCceeccCCC
Confidence 9999997654335899999999999999999999999999999999999985 569999999999765431 2233
Q ss_pred cccccccCchhhccCCCCCCCcccchhhhhhhhhhhhcCCCCCCCcCcchhHHHHHHHHhc-CCCCCCCCCCchhHHHHH
Q psy11767 533 CFTLQYAAPEVLRQDKSGYDENCDLWSLGVILVNVLRQDKSGYDENCDLWSLGVILYTMLC-GRVPFHARSRDDSALSIM 611 (966)
Q Consensus 533 ~gT~~Y~APEvl~~~~~~~~~~~Di~SlGvil~el~~~~~~~y~~~~DIWSlGvilyemlt-G~~Pf~~~~~~~~~~~~~ 611 (966)
.+|+.|+|||++... .|+.++|||||||++|||++ |+.||.+.+.. .+.
T Consensus 346 ~~~~~y~aPE~~~~~--------------------------~~~~~~DvwslG~~l~el~t~g~~P~~~~~~~----~~~ 395 (454)
T 1qcf_A 346 KFPIKWTAPEAINFG--------------------------SFTIKSDVWSFGILLMEIVTYGRIPYPGMSNP----EVI 395 (454)
T ss_dssp SSCGGGSCHHHHHHC--------------------------CCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHH----HHH
T ss_pred cccccccCHHHhccC--------------------------CCCcHHHHHhHHHHHHHHHhCCCCCCCCCCHH----HHH
Confidence 467889999998532 37889999999999999999 99999876533 334
Q ss_pred HHHHcCCCCCCchhhccCCHHHHHHHHHhcccCccccCChHHHHHHhhhh
Q psy11767 612 ARIKEGQFNFDAEAWSTVSSEAKELTKSLLTVNPAQRIRMMRVKLTFHAF 661 (966)
Q Consensus 612 ~~i~~~~~~~~~~~~~~is~e~~~Li~~~L~~dP~~R~t~~~v~~~~~~~ 661 (966)
..+..+... + ....+++++.+||.+||..||++|||+.++...+..+
T Consensus 396 ~~i~~~~~~-~--~~~~~~~~l~~li~~cl~~dp~~RPt~~~i~~~L~~~ 442 (454)
T 1qcf_A 396 RALERGYRM-P--RPENCPEELYNIMMRCWKNRPEERPTFEYIQSVLDDF 442 (454)
T ss_dssp HHHHHTCCC-C--CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTS
T ss_pred HHHHcCCCC-C--CCCCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHH
Confidence 445444221 1 2246889999999999999999999999886655544
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-38 Score=348.83 Aligned_cols=253 Identities=20% Similarity=0.298 Sum_probs=199.2
Q ss_pred eecccccccccccccccccccEEEEEEEcCCCc---EEEEEEeccccC------hHHHHHHHHHhcCCCCceEEEEEEEe
Q psy11767 372 FFEQYDMDLDKAGILGDGSYSVCRRCVEKSTGQ---EYAVKIISRKID------CSEEINLLRACQGHPNIVNLHCVFQD 442 (966)
Q Consensus 372 ~~~~~~i~~~~~~~LG~G~fG~Vy~a~~~~tg~---~vAvK~i~~~~~------~~~Ei~iL~~l~~HpnIV~l~~~~~~ 442 (966)
+...+.+.+...+.||+|+||+||+|.+..+++ .||+|++..... ..+|+.+|+.+ +||||+++++++.+
T Consensus 15 ~i~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~ 93 (298)
T 3pls_A 15 LIPHERVVTHSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGL-NHPNVLALIGIMLP 93 (298)
T ss_dssp BCCGGGEEEEEEEEEEEETTEEEEEEEEECSSSCEEEEEEEEETTCCSHHHHHHHHHHHHHHHTC-CCTTBCCCCEEECC
T ss_pred EccccceEEccCceeccCCCceEEEEEEecCCCceeeeeeeeccccccHHHHHHHHHHHHHHHhC-CCCCeeeEEEEEec
Confidence 344455556667899999999999999876555 899999975433 34689999988 59999999999987
Q ss_pred CCeE-EEEEEccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCcEEEecCCCCCEEEEeecc
Q psy11767 443 EVHT-YLVLELLKGGELLDRIRQKGRCGFTENEASRIMRQLVAAVHFMHSRGVVHRDLKPENLLFSDPAGDNIKVVDFGF 521 (966)
Q Consensus 443 ~~~~-~lVmEy~~gg~L~~~l~~~~~~~l~e~~~~~i~~Qil~aL~yLHs~~IiHRDLKP~NILl~~~~~~~iKL~DFGl 521 (966)
.... ++||||+.+|+|.+++.... ..+++.++..++.||+.||+|||++||+||||||+|||+++ ++.+||+|||+
T Consensus 94 ~~~~~~~v~e~~~~~~L~~~~~~~~-~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dikp~Nili~~--~~~~kl~Dfg~ 170 (298)
T 3pls_A 94 PEGLPHVLLPYMCHGDLLQFIRSPQ-RNPTVKDLISFGLQVARGMEYLAEQKFVHRDLAARNCMLDE--SFTVKVADFGL 170 (298)
T ss_dssp SSSCCEEEECCCTTCBHHHHHHCTT-CCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECT--TCCEEECCTTS
T ss_pred CCCCcEEEEecccCCCHHHHHhccc-cCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCcceEEEcC--CCcEEeCcCCC
Confidence 6655 99999999999999997643 36899999999999999999999999999999999999975 56899999999
Q ss_pred cccccC-------CCccccccccccCchhhccCCCCCCCcccchhhhhhhhhhhhcCCCCCCCcCcchhHHHHHHHHhcC
Q psy11767 522 ACLKRE-------SLHTPCFTLQYAAPEVLRQDKSGYDENCDLWSLGVILVNVLRQDKSGYDENCDLWSLGVILYTMLCG 594 (966)
Q Consensus 522 a~~~~~-------~~~~~~gT~~Y~APEvl~~~~~~~~~~~Di~SlGvil~el~~~~~~~y~~~~DIWSlGvilyemltG 594 (966)
++.... ......+|+.|+|||++.. ..|+.++|||||||++|+|++|
T Consensus 171 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~--------------------------~~~~~~~Di~slG~il~~l~~g 224 (298)
T 3pls_A 171 ARDILDREYYSVQQHRHARLPVKWTALESLQT--------------------------YRFTTKSDVWSFGVLLWELLTR 224 (298)
T ss_dssp SCTTTTGGGGCSCCSSCTTCGGGGSCHHHHTT--------------------------CCCCHHHHHHHHHHHHHHHHHT
T ss_pred cccccCCcccccccCcCCCCCccccChhhhcc--------------------------CCCChhhchhhHHHHHHHHhhC
Confidence 965322 1234467899999999852 2367899999999999999995
Q ss_pred CCC-CCCCCCchhHHHHHHHHHcCCCCCCchhhccCCHHHHHHHHHhcccCccccCChHHHHHHhhhh
Q psy11767 595 RVP-FHARSRDDSALSIMARIKEGQFNFDAEAWSTVSSEAKELTKSLLTVNPAQRIRMMRVKLTFHAF 661 (966)
Q Consensus 595 ~~P-f~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~is~e~~~Li~~~L~~dP~~R~t~~~v~~~~~~~ 661 (966)
..| |...+..+ ....+..+.... ....+++++.+||.+||..||.+|||+.++...+..+
T Consensus 225 ~~~~~~~~~~~~----~~~~~~~~~~~~---~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~l~~~ 285 (298)
T 3pls_A 225 GAPPYRHIDPFD----LTHFLAQGRRLP---QPEYCPDSLYQVMQQCWEADPAVRPTFRVLVGEVEQI 285 (298)
T ss_dssp SCCTTTTSCGGG----HHHHHHTTCCCC---CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred CCCCCccCCHHH----HHHHhhcCCCCC---CCccchHHHHHHHHHHccCChhhCcCHHHHHHHHHHH
Confidence 555 54433322 233344433221 1235789999999999999999999999886555444
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-39 Score=353.60 Aligned_cols=243 Identities=18% Similarity=0.254 Sum_probs=191.5
Q ss_pred cccccccccccccEEEEEEEcCCC-------cEEEEEEecccc-----ChHHHHHHHHHhcCCCCceEEEEEEEeCCeEE
Q psy11767 380 LDKAGILGDGSYSVCRRCVEKSTG-------QEYAVKIISRKI-----DCSEEINLLRACQGHPNIVNLHCVFQDEVHTY 447 (966)
Q Consensus 380 ~~~~~~LG~G~fG~Vy~a~~~~tg-------~~vAvK~i~~~~-----~~~~Ei~iL~~l~~HpnIV~l~~~~~~~~~~~ 447 (966)
|...+.||+|+||+||+|.+..++ ..||+|++.... ...+|+.+|+.+ +||||+++++++.++...|
T Consensus 10 y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~ 88 (289)
T 4fvq_A 10 LIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKL-SHKHLVLNYGVCVCGDENI 88 (289)
T ss_dssp EEEEEEEEEETTEEEEEEEEEEECGGGCEEEEEEEEEEECGGGGGGHHHHHHHHHHHHTS-CCTTBCCEEEEECCTTCCE
T ss_pred eeeeeeeccCCCceEEEEEEecccccccccchhhhhhhcccccHHHHHHHHHHHHHHHhC-CCCCEeEEEEEEEeCCCCE
Confidence 344688999999999999999887 479999986532 245789999988 5999999999999999999
Q ss_pred EEEEccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCcEEEecCCC------CCEEEEeecc
Q psy11767 448 LVLELLKGGELLDRIRQKGRCGFTENEASRIMRQLVAAVHFMHSRGVVHRDLKPENLLFSDPAG------DNIKVVDFGF 521 (966)
Q Consensus 448 lVmEy~~gg~L~~~l~~~~~~~l~e~~~~~i~~Qil~aL~yLHs~~IiHRDLKP~NILl~~~~~------~~iKL~DFGl 521 (966)
+||||++||+|.+++..... .+++..++.++.||+.||+|||++||+||||||+|||++.... +.+||+|||+
T Consensus 89 lv~e~~~~~~L~~~l~~~~~-~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~~~~~kl~Dfg~ 167 (289)
T 4fvq_A 89 LVQEFVKFGSLDTYLKKNKN-CINILWKLEVAKQLAAAMHFLEENTLIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGI 167 (289)
T ss_dssp EEEECCTTCBHHHHHHHTGG-GCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEEECCBGGGTBCCEEEECCCCS
T ss_pred EEEECCCCCCHHHHHHhCCC-CCCHHHHHHHHHHHHHHHHHHhhCCeECCCcCcceEEEecCCcccccccceeeeccCcc
Confidence 99999999999999987542 4899999999999999999999999999999999999985321 1199999999
Q ss_pred cccccCCCccccccccccCchhhccCCCCCCCcccchhhhhhhhhhhhcCCCCCCCcCcchhHHHHHHHHhcCCCCCCCC
Q psy11767 522 ACLKRESLHTPCFTLQYAAPEVLRQDKSGYDENCDLWSLGVILVNVLRQDKSGYDENCDLWSLGVILYTMLCGRVPFHAR 601 (966)
Q Consensus 522 a~~~~~~~~~~~gT~~Y~APEvl~~~~~~~~~~~Di~SlGvil~el~~~~~~~y~~~~DIWSlGvilyemltG~~Pf~~~ 601 (966)
+...... ....+|+.|+|||++... ..|+.++|||||||++|+|++|..|+...
T Consensus 168 ~~~~~~~-~~~~~~~~y~aPE~~~~~-------------------------~~~~~~~DiwslG~il~el~~g~~~~~~~ 221 (289)
T 4fvq_A 168 SITVLPK-DILQERIPWVPPECIENP-------------------------KNLNLATDKWSFGTTLWEICSGGDKPLSA 221 (289)
T ss_dssp CTTTSCH-HHHHHTTTTSCHHHHHCG-------------------------GGCCHHHHHHHHHHHHHHHHTTTCCTTTT
T ss_pred cccccCc-cccCCcCcccCHHHhCCC-------------------------CCCCchhHHHHHHHHHHHHHcCCCCCccc
Confidence 8654322 234578999999998531 23678999999999999999965444433
Q ss_pred CCchhHHHHHHHHHcCCCCCCchhhccCCHHHHHHHHHhcccCccccCChHHHHHHh
Q psy11767 602 SRDDSALSIMARIKEGQFNFDAEAWSTVSSEAKELTKSLLTVNPAQRIRMMRVKLTF 658 (966)
Q Consensus 602 ~~~~~~~~~~~~i~~~~~~~~~~~~~~is~e~~~Li~~~L~~dP~~R~t~~~v~~~~ 658 (966)
..... ... +......+ ....++++.+||.+||+.||++|||+.++...+
T Consensus 222 ~~~~~---~~~-~~~~~~~~----~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l 270 (289)
T 4fvq_A 222 LDSQR---KLQ-FYEDRHQL----PAPKAAELANLINNCMDYEPDHRPSFRAIIRDL 270 (289)
T ss_dssp SCHHH---HHH-HHHTTCCC----CCCSSCTTHHHHHHHSCSSGGGSCCHHHHHHHH
T ss_pred cchHH---HHH-HhhccCCC----CCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHH
Confidence 32221 111 11222222 234577899999999999999999999875444
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-39 Score=353.60 Aligned_cols=248 Identities=27% Similarity=0.491 Sum_probs=200.5
Q ss_pred cccccccccccccccccccEEEEEEEcCCCcEEEEEEecccc---------ChHHHHHHHHHhcCCCCceEEEEEEE--e
Q psy11767 374 EQYDMDLDKAGILGDGSYSVCRRCVEKSTGQEYAVKIISRKI---------DCSEEINLLRACQGHPNIVNLHCVFQ--D 442 (966)
Q Consensus 374 ~~~~i~~~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~---------~~~~Ei~iL~~l~~HpnIV~l~~~~~--~ 442 (966)
++|.+ .+.||+|+||.||+|.+..+++.||||++.... ...+|+.+|+.+ +||||+++++++. +
T Consensus 5 ~~y~i----~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~~~ 79 (305)
T 2wtk_C 5 GKYLM----GDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRL-RHKNVIQLVDVLYNEE 79 (305)
T ss_dssp CCBCC----CCEEEECSSCEEEEEEBTTTCCEEEEEEECHHHHHHSTTHHHHHHHHHHHHTTC-CCTTBCCEEEEEECC-
T ss_pred cceeE----eeEEecCCCeEEEEEEECCCCcEEEEEEeccccccccchhHHHHHHHHHHHHhc-CCCCeeEEEEEEEcCC
Confidence 44554 689999999999999999999999999996431 245799999888 5999999999984 4
Q ss_pred CCeEEEEEEccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCcEEEecCCCCCEEEEeeccc
Q psy11767 443 EVHTYLVLELLKGGELLDRIRQKGRCGFTENEASRIMRQLVAAVHFMHSRGVVHRDLKPENLLFSDPAGDNIKVVDFGFA 522 (966)
Q Consensus 443 ~~~~~lVmEy~~gg~L~~~l~~~~~~~l~e~~~~~i~~Qil~aL~yLHs~~IiHRDLKP~NILl~~~~~~~iKL~DFGla 522 (966)
....|+||||++++ |.+++.......+++..+..++.||+.||+|||++||+||||||+|||++. ++.+||+|||++
T Consensus 80 ~~~~~lv~e~~~~~-l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~i~H~dlkp~NIl~~~--~~~~kl~dfg~~ 156 (305)
T 2wtk_C 80 KQKMYMVMEYCVCG-MQEMLDSVPEKRFPVCQAHGYFCQLIDGLEYLHSQGIVHKDIKPGNLLLTT--GGTLKISALGVA 156 (305)
T ss_dssp --CEEEEEECCSEE-HHHHHHHSTTCSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECT--TCCEEECCCTTC
T ss_pred CCeEEEEehhccCC-HHHHHHhCcccccCHHHHHHHHHHHHHHHHHHHHCCeeecCCCcccEEEcC--CCcEEeeccccc
Confidence 56789999999876 788887655557999999999999999999999999999999999999975 568999999999
Q ss_pred ccccC-----CCccccccccccCchhhccCCCCCCCcccchhhhhhhhhhhhcCCCCCCCcCcchhHHHHHHHHhcCCCC
Q psy11767 523 CLKRE-----SLHTPCFTLQYAAPEVLRQDKSGYDENCDLWSLGVILVNVLRQDKSGYDENCDLWSLGVILYTMLCGRVP 597 (966)
Q Consensus 523 ~~~~~-----~~~~~~gT~~Y~APEvl~~~~~~~~~~~Di~SlGvil~el~~~~~~~y~~~~DIWSlGvilyemltG~~P 597 (966)
..... ......+|+.|+|||++... ...++.++|||||||++|+|++|+.|
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~------------------------~~~~~~~~Di~slG~il~~l~~g~~p 212 (305)
T 2wtk_C 157 EALHPFAADDTCRTSQGSPAFQPPEIANGL------------------------DTFSGFKVDIWSAGVTLYNITTGLYP 212 (305)
T ss_dssp EECCTTCSSCEECCCCSCGGGCCHHHHTCC------------------------SCEESHHHHHHHHHHHHHHHHHSSCS
T ss_pred cccCccccccccccCCCCCCCcChhhccCc------------------------ccCCcchhhHHHHHHHHHHHHhCCCC
Confidence 76432 12345689999999988532 11236689999999999999999999
Q ss_pred CCCCCCchhHHHHHHHHHcCCCCCCchhhccCCHHHHHHHHHhcccCccccCChHHHHHHhhhhHH
Q psy11767 598 FHARSRDDSALSIMARIKEGQFNFDAEAWSTVSSEAKELTKSLLTVNPAQRIRMMRVKLTFHAFHQ 663 (966)
Q Consensus 598 f~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~is~e~~~Li~~~L~~dP~~R~t~~~v~~~~~~~~~ 663 (966)
|.+.+. ......+..+.+.++ ..+++++.+||.+||..||++|||+.++ ..|+|+.
T Consensus 213 ~~~~~~----~~~~~~i~~~~~~~~----~~~~~~l~~li~~~l~~dp~~Rps~~~l--l~~~~~~ 268 (305)
T 2wtk_C 213 FEGDNI----YKLFENIGKGSYAIP----GDCGPPLSDLLKGMLEYEPAKRFSIRQI--RQHSWFR 268 (305)
T ss_dssp CCCSSH----HHHHHHHHHCCCCCC----SSSCHHHHHHHHHHTCSSTTTSCCHHHH--HHSHHHH
T ss_pred CCCchH----HHHHHHHhcCCCCCC----CccCHHHHHHHHHHccCChhhCCCHHHH--hcCcccc
Confidence 986543 344556666655443 3578999999999999999999999976 3456653
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=6e-39 Score=356.63 Aligned_cols=242 Identities=20% Similarity=0.359 Sum_probs=184.0
Q ss_pred cccccccccccEEEEEEEcCCCc---EEEEEEecccc-------ChHHHHHHHHHhcCCCCceEEEEEEEeCCeE-----
Q psy11767 382 KAGILGDGSYSVCRRCVEKSTGQ---EYAVKIISRKI-------DCSEEINLLRACQGHPNIVNLHCVFQDEVHT----- 446 (966)
Q Consensus 382 ~~~~LG~G~fG~Vy~a~~~~tg~---~vAvK~i~~~~-------~~~~Ei~iL~~l~~HpnIV~l~~~~~~~~~~----- 446 (966)
..+.||+|+||.||+|.+..++. .||||++.... ...+|+.+|+.+ +||||+++++++.+....
T Consensus 27 ~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~~~~~ 105 (323)
T 3qup_A 27 LGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEF-DHPHVAKLVGVSLRSRAKGRLPI 105 (323)
T ss_dssp EEEEEEEETTEEEEEEEC-------CEEEEEEC------CHHHHHHHHHHHHHTTC-CCTTBCCCCEEEECC-------C
T ss_pred EeceecccCCeEEEEEEEcccCCcceeEEEEEecccccCHHHHHHHHHHHHHHHHC-CCCceehhhceeeccccccCCCc
Confidence 36889999999999999988775 89999986542 245799999888 699999999999887655
Q ss_pred -EEEEEccCCCCHHHHHHhcCC----CCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCcEEEecCCCCCEEEEeecc
Q psy11767 447 -YLVLELLKGGELLDRIRQKGR----CGFTENEASRIMRQLVAAVHFMHSRGVVHRDLKPENLLFSDPAGDNIKVVDFGF 521 (966)
Q Consensus 447 -~lVmEy~~gg~L~~~l~~~~~----~~l~e~~~~~i~~Qil~aL~yLHs~~IiHRDLKP~NILl~~~~~~~iKL~DFGl 521 (966)
++||||+++|+|.+++..... ..+++.+++.++.||+.||+|||++||+||||||+|||++. ++.+||+|||+
T Consensus 106 ~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~ivH~Dikp~NIli~~--~~~~kl~Dfg~ 183 (323)
T 3qup_A 106 PMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGMEYLSSRNFIHRDLAARNCMLAE--DMTVCVADFGL 183 (323)
T ss_dssp EEEEEECCTTCBHHHHHHHHHC---CCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECT--TSCEEECCCCC
T ss_pred cEEEEEeccCCcHHHHHHhhhccccccccCHHHHHHHHHHHHHHHHHHHcCCcccCCCCcceEEEcC--CCCEEEeeccc
Confidence 999999999999999965431 24899999999999999999999999999999999999975 56999999999
Q ss_pred cccccCC-----CccccccccccCchhhccCCCCCCCcccchhhhhhhhhhhhcCCCCCCCcCcchhHHHHHHHHhc-CC
Q psy11767 522 ACLKRES-----LHTPCFTLQYAAPEVLRQDKSGYDENCDLWSLGVILVNVLRQDKSGYDENCDLWSLGVILYTMLC-GR 595 (966)
Q Consensus 522 a~~~~~~-----~~~~~gT~~Y~APEvl~~~~~~~~~~~Di~SlGvil~el~~~~~~~y~~~~DIWSlGvilyemlt-G~ 595 (966)
|+..... .....+|+.|+|||++.. ..|+.++|||||||++|+|++ |.
T Consensus 184 a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~--------------------------~~~~~~~Di~slG~il~ell~~g~ 237 (323)
T 3qup_A 184 SRKIYSGDYYRQGCASKLPVKWLALESLAD--------------------------NLYTVHSDVWAFGVTMWEIMTRGQ 237 (323)
T ss_dssp -----------------CCGGGCCHHHHHH--------------------------CCCCHHHHHHHHHHHHHHHHTTSC
T ss_pred cccccccccccccccccCcccccCchhhcC--------------------------CCCCCccchhhHHHHHHHHHhCCC
Confidence 9764321 122345788999999853 236889999999999999999 99
Q ss_pred CCCCCCCCchhHHHHHHHHHcCCCCCCchhhccCCHHHHHHHHHhcccCccccCChHHHHHHhh
Q psy11767 596 VPFHARSRDDSALSIMARIKEGQFNFDAEAWSTVSSEAKELTKSLLTVNPAQRIRMMRVKLTFH 659 (966)
Q Consensus 596 ~Pf~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~is~e~~~Li~~~L~~dP~~R~t~~~v~~~~~ 659 (966)
+||.+....+ +...+..+.... ....+++++.+||.+||+.||++|||+.++...+.
T Consensus 238 ~p~~~~~~~~----~~~~~~~~~~~~---~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~ 294 (323)
T 3qup_A 238 TPYAGIENAE----IYNYLIGGNRLK---QPPECMEEVYDLMYQCWSADPKQRPSFTCLRMELE 294 (323)
T ss_dssp CTTTTCCGGG----HHHHHHTTCCCC---CCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHH
T ss_pred CCccccChHH----HHHHHhcCCCCC---CCCccCHHHHHHHHHHccCChhhCcCHHHHHHHHH
Confidence 9998766543 233444433211 22467899999999999999999999988755444
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-38 Score=349.36 Aligned_cols=243 Identities=26% Similarity=0.449 Sum_probs=201.4
Q ss_pred ccccccccccccEEEEEEEcCCCcEEEEEEecccc------ChHHHHHHHHHhcCCCCceEEEEEEEeCCeEEEEEEccC
Q psy11767 381 DKAGILGDGSYSVCRRCVEKSTGQEYAVKIISRKI------DCSEEINLLRACQGHPNIVNLHCVFQDEVHTYLVLELLK 454 (966)
Q Consensus 381 ~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~------~~~~Ei~iL~~l~~HpnIV~l~~~~~~~~~~~lVmEy~~ 454 (966)
+..+.||+|+||.||+|.+..+|+.||||++.... ...+|+.+|+.+ +||||+++++++.++...|+||||++
T Consensus 25 ~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~ 103 (303)
T 3a7i_A 25 TKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQC-DSPYVTKYYGSYLKDTKLWIIMEYLG 103 (303)
T ss_dssp EEEEEEEECSSSEEEEEEETTTCCEEEEEEEETTTCSTTHHHHHHHHHHHHHC-CCTTBCCEEEEEEETTEEEEEEECCT
T ss_pred HHhhhhcccCCeEEEEEEECCCCcEEEEEEecccccHHHHHHHHHHHHHHHhC-CCCCEeEEEEEEecCCeEEEEEEeCC
Confidence 34688999999999999999999999999986432 245799999988 69999999999999999999999999
Q ss_pred CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCcEEEecCCCCCEEEEeecccccccCC---Ccc
Q psy11767 455 GGELLDRIRQKGRCGFTENEASRIMRQLVAAVHFMHSRGVVHRDLKPENLLFSDPAGDNIKVVDFGFACLKRES---LHT 531 (966)
Q Consensus 455 gg~L~~~l~~~~~~~l~e~~~~~i~~Qil~aL~yLHs~~IiHRDLKP~NILl~~~~~~~iKL~DFGla~~~~~~---~~~ 531 (966)
+++|.+++... .+++..+..++.||+.||+|||++||+||||||+|||++. ++.+||+|||++...... ...
T Consensus 104 ~~~L~~~~~~~---~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~--~~~~kl~Dfg~~~~~~~~~~~~~~ 178 (303)
T 3a7i_A 104 GGSALDLLEPG---PLDETQIATILREILKGLDYLHSEKKIHRDIKAANVLLSE--HGEVKLADFGVAGQLTDTQIKRNT 178 (303)
T ss_dssp TEEHHHHHTTS---CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECT--TSCEEECCCTTCEECBTTBCCBCC
T ss_pred CCcHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCCCccCCCChheEEECC--CCCEEEeecccceecCccccccCc
Confidence 99999998653 5899999999999999999999999999999999999974 568999999999765432 234
Q ss_pred ccccccccCchhhccCCCCCCCcccchhhhhhhhhhhhcCCCCCCCcCcchhHHHHHHHHhcCCCCCCCCCCchhHHHHH
Q psy11767 532 PCFTLQYAAPEVLRQDKSGYDENCDLWSLGVILVNVLRQDKSGYDENCDLWSLGVILYTMLCGRVPFHARSRDDSALSIM 611 (966)
Q Consensus 532 ~~gT~~Y~APEvl~~~~~~~~~~~Di~SlGvil~el~~~~~~~y~~~~DIWSlGvilyemltG~~Pf~~~~~~~~~~~~~ 611 (966)
..+|+.|+|||++.. ..|+.++|||||||++|+|++|+.||...... ...
T Consensus 179 ~~~~~~y~aPE~~~~--------------------------~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~----~~~ 228 (303)
T 3a7i_A 179 FVGTPFWMAPEVIKQ--------------------------SAYDSKADIWSLGITAIELARGEPPHSELHPM----KVL 228 (303)
T ss_dssp CCSCGGGCCHHHHTT--------------------------CCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHH----HHH
T ss_pred cCCCcCccCHHHHhc--------------------------CCCCchhhhHHHHHHHHHHccCCCCCCCcCHH----HHH
Confidence 578999999999852 23678899999999999999999999865432 223
Q ss_pred HHHHcCCCCCCchhhccCCHHHHHHHHHhcccCccccCChHHHHHHhhhhHHh
Q psy11767 612 ARIKEGQFNFDAEAWSTVSSEAKELTKSLLTVNPAQRIRMMRVKLTFHAFHQA 664 (966)
Q Consensus 612 ~~i~~~~~~~~~~~~~~is~e~~~Li~~~L~~dP~~R~t~~~v~~~~~~~~~~ 664 (966)
..+..+... .....++.++.+||.+||..||++|||+.++ ..|+|...
T Consensus 229 ~~~~~~~~~---~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l--l~~~~~~~ 276 (303)
T 3a7i_A 229 FLIPKNNPP---TLEGNYSKPLKEFVEACLNKEPSFRPTAKEL--LKHKFILR 276 (303)
T ss_dssp HHHHHSCCC---CCCSSCCHHHHHHHHHHCCSSGGGSCCHHHH--TTCHHHHH
T ss_pred HHhhcCCCC---CCccccCHHHHHHHHHHcCCChhhCcCHHHH--hhChhhhc
Confidence 334433321 1234678999999999999999999999976 34666543
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.6e-39 Score=359.52 Aligned_cols=249 Identities=29% Similarity=0.462 Sum_probs=196.7
Q ss_pred ccccccccccccEEEEEEEcCCCcEEEEEEeccccC------hHHHHHHHHHhcCCCCceEEEEEEEeC-----CeEEEE
Q psy11767 381 DKAGILGDGSYSVCRRCVEKSTGQEYAVKIISRKID------CSEEINLLRACQGHPNIVNLHCVFQDE-----VHTYLV 449 (966)
Q Consensus 381 ~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~~------~~~Ei~iL~~l~~HpnIV~l~~~~~~~-----~~~~lV 449 (966)
+..+.||+|+||.||+|.+..+|+.||||++..... ..+|+.+|+.+ +||||+++++++..+ ...|+|
T Consensus 14 ~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~~~~~~lv 92 (353)
T 2b9h_A 14 QLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLREIKILKHF-KHENIITIFNIQRPDSFENFNEVYII 92 (353)
T ss_dssp EEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCSSHHHHHHHHHHHHHHHHC-CCTTBCCEEEECCCSCSTTCCCEEEE
T ss_pred EEeeEEcCCCCeEEEEEEECCCCcEEEEEeecccccchHHHHHHHHHHHHHhC-cCCCcCCeeeeecccccCccceEEEE
Confidence 336889999999999999999999999999964322 34799999998 599999999988764 678999
Q ss_pred EEccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCcEEEecCCCCCEEEEeecccccccCC-
Q psy11767 450 LELLKGGELLDRIRQKGRCGFTENEASRIMRQLVAAVHFMHSRGVVHRDLKPENLLFSDPAGDNIKVVDFGFACLKRES- 528 (966)
Q Consensus 450 mEy~~gg~L~~~l~~~~~~~l~e~~~~~i~~Qil~aL~yLHs~~IiHRDLKP~NILl~~~~~~~iKL~DFGla~~~~~~- 528 (966)
|||+. |+|.+++... .+++..++.++.||+.||+|||++||+||||||+|||++. ++.+||+|||++......
T Consensus 93 ~e~~~-~~L~~~~~~~---~~~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlkp~Nil~~~--~~~~kl~Dfg~a~~~~~~~ 166 (353)
T 2b9h_A 93 QELMQ-TDLHRVISTQ---MLSDDHIQYFIYQTLRAVKVLHGSNVIHRDLKPSNLLINS--NCDLKVCDFGLARIIDESA 166 (353)
T ss_dssp ECCCS-EEHHHHHHHC---CCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECT--TCCEEECCCTTCEECC---
T ss_pred EeccC-ccHHHHHhhc---CCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEEcC--CCcEEEEeccccccccccc
Confidence 99996 6899988764 5899999999999999999999999999999999999974 568999999999754321
Q ss_pred ------------CccccccccccCchhhccCCCCCCCcccchhhhhhhhhhhhcCCCCCCCcCcchhHHHHHHHHhcCCC
Q psy11767 529 ------------LHTPCFTLQYAAPEVLRQDKSGYDENCDLWSLGVILVNVLRQDKSGYDENCDLWSLGVILYTMLCGRV 596 (966)
Q Consensus 529 ------------~~~~~gT~~Y~APEvl~~~~~~~~~~~Di~SlGvil~el~~~~~~~y~~~~DIWSlGvilyemltG~~ 596 (966)
....+||+.|+|||++.. ...|+.++|||||||++|+|++|++
T Consensus 167 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-------------------------~~~~~~~~Di~slG~il~~l~~g~~ 221 (353)
T 2b9h_A 167 ADNSEPTGQQSGMVEFVATRWYRAPEVMLT-------------------------SAKYSRAMDVWSCGCILAELFLRRP 221 (353)
T ss_dssp -------------CCCCCCGGGCCHHHHHS-------------------------CCCCCHHHHHHHHHHHHHHHHHSSC
T ss_pred ccccCccccccchhhccccccccCCeeecc-------------------------CCCccchhhHHHHHHHHHHHHhCCC
Confidence 123468999999998752 2346889999999999999999999
Q ss_pred CCCCCCCchhHHHHHHHHHcCC----------------------C--CCCchhhccCCHHHHHHHHHhcccCccccCChH
Q psy11767 597 PFHARSRDDSALSIMARIKEGQ----------------------F--NFDAEAWSTVSSEAKELTKSLLTVNPAQRIRMM 652 (966)
Q Consensus 597 Pf~~~~~~~~~~~~~~~i~~~~----------------------~--~~~~~~~~~is~e~~~Li~~~L~~dP~~R~t~~ 652 (966)
||.+.+..+....+...+.... + ......++.+++++.+||.+||..||++|||+.
T Consensus 222 pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ 301 (353)
T 2b9h_A 222 IFPGRDYRHQLLLIFGIIGTPHSDNDLRCIESPRAREYIKSLPMYPAAPLEKMFPRVNPKGIDLLQRMLVFDPAKRITAK 301 (353)
T ss_dssp SCCCSSHHHHHHHHHHHHCCCCSTTTTTTCCCHHHHHHHHTSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSSGGGSCCHH
T ss_pred CCCCCCcHHHHHHHHHHhCCCchhccccccccchhhHHhhcccCCCCcchhhhcccCCHHHHHHHHHhcCcCcccCCCHH
Confidence 9987654333222222111100 0 000122357899999999999999999999999
Q ss_pred HHHHHhhhhHH
Q psy11767 653 RVKLTFHAFHQ 663 (966)
Q Consensus 653 ~v~~~~~~~~~ 663 (966)
++ ..|+|++
T Consensus 302 el--l~hp~~~ 310 (353)
T 2b9h_A 302 EA--LEHPYLQ 310 (353)
T ss_dssp HH--HTSGGGT
T ss_pred HH--hcCcccc
Confidence 76 3466653
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.3e-39 Score=357.78 Aligned_cols=242 Identities=19% Similarity=0.366 Sum_probs=190.9
Q ss_pred cccccccccccccEEEEEEEcCCCcEE----EEEEecccc------ChHHHHHHHHHhcCCCCceEEEEEEEeCCeEEEE
Q psy11767 380 LDKAGILGDGSYSVCRRCVEKSTGQEY----AVKIISRKI------DCSEEINLLRACQGHPNIVNLHCVFQDEVHTYLV 449 (966)
Q Consensus 380 ~~~~~~LG~G~fG~Vy~a~~~~tg~~v----AvK~i~~~~------~~~~Ei~iL~~l~~HpnIV~l~~~~~~~~~~~lV 449 (966)
|+..+.||+|+||.||+|.+..+++.| |+|.+.... ...+|+.+|+.+ +||||+++++++.++. .++|
T Consensus 17 y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~iK~~~~~~~~~~~~~~~~E~~~l~~l-~hp~iv~~~~~~~~~~-~~~v 94 (327)
T 3lzb_A 17 FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV-DNPHVCRLLGICLTST-VQLI 94 (327)
T ss_dssp EEEEEEEEECSSEEEEEEEECCTTCSCCEEEEEEEECCCSSCCCHHHHHHHHHHHTTC-CBTTBCCCCEEEESSS-EEEE
T ss_pred ceEEEEeeeCCCeEEEEEEEcCCCceEEEEEEEEeeccccCHHHHHHHHHHHHHHHhC-CCCCeeEEEEEEecCC-ceEE
Confidence 344789999999999999999888765 666654321 245699999888 5999999999998765 8899
Q ss_pred EEccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCcEEEecCCCCCEEEEeecccccccCC-
Q psy11767 450 LELLKGGELLDRIRQKGRCGFTENEASRIMRQLVAAVHFMHSRGVVHRDLKPENLLFSDPAGDNIKVVDFGFACLKRES- 528 (966)
Q Consensus 450 mEy~~gg~L~~~l~~~~~~~l~e~~~~~i~~Qil~aL~yLHs~~IiHRDLKP~NILl~~~~~~~iKL~DFGla~~~~~~- 528 (966)
|||+.+|+|.+++..... .+++..++.++.||+.||+|||++||+||||||+|||++. .+.+||+|||+++.....
T Consensus 95 ~~~~~~g~L~~~l~~~~~-~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~--~~~~kL~DfG~a~~~~~~~ 171 (327)
T 3lzb_A 95 TQLMPFGCLLDYVREHKD-NIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKT--PQHVKITDFGLAKLLGAEE 171 (327)
T ss_dssp ECCCSSCBHHHHHHHTTT-CCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEE--TTEEEECCTTC--------
T ss_pred EEecCCCcHHHHHHhcCC-CCCHHHHHHHHHHHHHHHHHHhhCCCcCCCCCHHHEEEcC--CCCEEEccCcceeEccCcc
Confidence 999999999999987543 6999999999999999999999999999999999999985 568999999999764321
Q ss_pred ----CccccccccccCchhhccCCCCCCCcccchhhhhhhhhhhhcCCCCCCCcCcchhHHHHHHHHhc-CCCCCCCCCC
Q psy11767 529 ----LHTPCFTLQYAAPEVLRQDKSGYDENCDLWSLGVILVNVLRQDKSGYDENCDLWSLGVILYTMLC-GRVPFHARSR 603 (966)
Q Consensus 529 ----~~~~~gT~~Y~APEvl~~~~~~~~~~~Di~SlGvil~el~~~~~~~y~~~~DIWSlGvilyemlt-G~~Pf~~~~~ 603 (966)
.....+|+.|+|||++.. ..|+.++|||||||++|+|++ |.+||.+...
T Consensus 172 ~~~~~~~~~~t~~y~aPE~~~~--------------------------~~~~~~~Di~slG~il~ell~~g~~p~~~~~~ 225 (327)
T 3lzb_A 172 KEYHAEGGKVPIKWMALESILH--------------------------RIYTHQSDVWSYGVTVWELMTFGSKPYDGIPA 225 (327)
T ss_dssp --------CCCGGGSCHHHHHH--------------------------CCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCG
T ss_pred ccccccCCCccccccCHHHHcC--------------------------CCCChHHHHHHHHHHHHHHHHCCCCCCCCCCH
Confidence 123346788999999853 237889999999999999999 9999987665
Q ss_pred chhHHHHHHHHHcCCCCCCchhhccCCHHHHHHHHHhcccCccccCChHHHHHHhh
Q psy11767 604 DDSALSIMARIKEGQFNFDAEAWSTVSSEAKELTKSLLTVNPAQRIRMMRVKLTFH 659 (966)
Q Consensus 604 ~~~~~~~~~~i~~~~~~~~~~~~~~is~e~~~Li~~~L~~dP~~R~t~~~v~~~~~ 659 (966)
.+ +...+..+.... ....++.++.+||.+||..||.+||++.++...+.
T Consensus 226 ~~----~~~~~~~~~~~~---~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~ 274 (327)
T 3lzb_A 226 SE----ISSILEKGERLP---QPPICTIDVYMIMRKCWMIDADSRPKFRELIIEFS 274 (327)
T ss_dssp GG----HHHHHHTTCCCC---CCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred HH----HHHHHHcCCCCC---CCccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHH
Confidence 43 233343333221 22357899999999999999999999998865444
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-38 Score=359.64 Aligned_cols=253 Identities=25% Similarity=0.347 Sum_probs=182.3
Q ss_pred cccccccccccEEEEEEEcCCCcEEEEEEeccccC----hHHHHHHHHHhcCCCCceEEEEEEEeCCe-------EEEEE
Q psy11767 382 KAGILGDGSYSVCRRCVEKSTGQEYAVKIISRKID----CSEEINLLRACQGHPNIVNLHCVFQDEVH-------TYLVL 450 (966)
Q Consensus 382 ~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~~----~~~Ei~iL~~l~~HpnIV~l~~~~~~~~~-------~~lVm 450 (966)
..+.||+|+||+||+|.+..+|+.||||++..... ..+|+..|..+ +|||||+++++|.+... .|+||
T Consensus 27 ~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~l~~l-~h~niv~~~~~~~~~~~~~~~~~~~~lv~ 105 (360)
T 3e3p_A 27 VERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDPRFRNRELQIMQDLAVL-HHPNIVQLQSYFYTLGERDRRDIYLNVVM 105 (360)
T ss_dssp EC----------CEEEEETTTCCEEEEEEEECCTTCCCHHHHHHHHHHHH-CCTTBCCEEEEEEEECSSCTTCEEEEEEE
T ss_pred EEEEEecCCCeEEEEEEECCCCCEEEEEEEecCccccHHHHHHHHHHHhc-CCCCcccHHHhhhccccccccceeEEEEe
Confidence 36889999999999999999999999998865422 33455666666 69999999999976433 89999
Q ss_pred EccCCCCHHHHHHh--cCCCCCCHHHHHHHHHHHHHHHHHHH--hcCceeccCCCCcEEEecCCCCCEEEEeeccccccc
Q psy11767 451 ELLKGGELLDRIRQ--KGRCGFTENEASRIMRQLVAAVHFMH--SRGVVHRDLKPENLLFSDPAGDNIKVVDFGFACLKR 526 (966)
Q Consensus 451 Ey~~gg~L~~~l~~--~~~~~l~e~~~~~i~~Qil~aL~yLH--s~~IiHRDLKP~NILl~~~~~~~iKL~DFGla~~~~ 526 (966)
||+++ +|.+.+.. .....+++..++.++.||+.||.||| ++||+||||||+|||++. .++.+||+|||+++...
T Consensus 106 e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~~~ivH~Dlkp~NIll~~-~~~~~kl~Dfg~a~~~~ 183 (360)
T 3e3p_A 106 EYVPD-TLHRCCRNYYRRQVAPPPILIKVFLFQLIRSIGCLHLPSVNVCHRDIKPHNVLVNE-ADGTLKLCDFGSAKKLS 183 (360)
T ss_dssp ECCSC-BHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHTSTTTCCBCSCCCGGGEEEET-TTTEEEECCCTTCBCCC
T ss_pred ecccc-cHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhCCCCCeecCcCCHHHEEEeC-CCCcEEEeeCCCceecC
Confidence 99975 55555443 22336899999999999999999999 999999999999999974 25689999999997654
Q ss_pred CC--CccccccccccCchhhccCCCCCCCcccchhhhhhhhhhhhcCCCCCCCcCcchhHHHHHHHHhcCCCCCCCCCCc
Q psy11767 527 ES--LHTPCFTLQYAAPEVLRQDKSGYDENCDLWSLGVILVNVLRQDKSGYDENCDLWSLGVILYTMLCGRVPFHARSRD 604 (966)
Q Consensus 527 ~~--~~~~~gT~~Y~APEvl~~~~~~~~~~~Di~SlGvil~el~~~~~~~y~~~~DIWSlGvilyemltG~~Pf~~~~~~ 604 (966)
.. ....++|+.|+|||++.. ...|+.++|||||||++|+|++|+.||.+.+..
T Consensus 184 ~~~~~~~~~gt~~y~aPE~~~~-------------------------~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~ 238 (360)
T 3e3p_A 184 PSEPNVAYICSRYYRAPELIFG-------------------------NQHYTTAVDIWSVGCIFAEMMLGEPIFRGDNSA 238 (360)
T ss_dssp TTSCCCSTTSCGGGCCHHHHTT-------------------------CSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHH
T ss_pred CCCCcccccCCcceeCHHHHcC-------------------------CCCCCcHHHHHHHHHHHHHHHhCCCCcCCCChH
Confidence 32 335578999999999842 233788999999999999999999999886654
Q ss_pred hhHHHHHHHHHcC-----------CCCC-----Cc--------hhhccCCHHHHHHHHHhcccCccccCChHHHHHHhhh
Q psy11767 605 DSALSIMARIKEG-----------QFNF-----DA--------EAWSTVSSEAKELTKSLLTVNPAQRIRMMRVKLTFHA 660 (966)
Q Consensus 605 ~~~~~~~~~i~~~-----------~~~~-----~~--------~~~~~is~e~~~Li~~~L~~dP~~R~t~~~v~~~~~~ 660 (966)
+....+...+... .... .. ......++++.+||.+||+.||.+|||+.++ ..|+
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~--l~hp 316 (360)
T 3e3p_A 239 GQLHEIVRVLGCPSREVLRKLNPSHTDVDLYNSKGIPWSNVFSDHSLKDAKEAYDLLSALLQYLPEERMKPYEA--LCHP 316 (360)
T ss_dssp HHHHHHHHHHCCCCHHHHHHHCTTCCCGGGGCCCCCCHHHHTTTCCCTTHHHHHHHHHHHTCSSGGGSCCHHHH--TTSG
T ss_pred HHHHHHHHHcCCCCHHHHHhcccchhhccccccccCCcccccchhhccccHHHHHHHHHHhccCccccCCHHHH--hcCc
Confidence 3333332211100 0000 00 0111257899999999999999999999876 4577
Q ss_pred hHHh
Q psy11767 661 FHQA 664 (966)
Q Consensus 661 ~~~~ 664 (966)
|+..
T Consensus 317 ~f~~ 320 (360)
T 3e3p_A 317 YFDE 320 (360)
T ss_dssp GGGG
T ss_pred cccc
Confidence 7643
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-38 Score=355.15 Aligned_cols=245 Identities=29% Similarity=0.487 Sum_probs=201.3
Q ss_pred cceecccccccccccccccccccEEEEEEEcCCCcEEEEEEecccc-----------ChHHHHHHHHHhc-CCCCceEEE
Q psy11767 370 SLFFEQYDMDLDKAGILGDGSYSVCRRCVEKSTGQEYAVKIISRKI-----------DCSEEINLLRACQ-GHPNIVNLH 437 (966)
Q Consensus 370 ~~~~~~~~i~~~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~-----------~~~~Ei~iL~~l~-~HpnIV~l~ 437 (966)
..+.++|.+ .+.||+|+||.||+|.+..+|+.||||++.... ...+|+.+|+.+. +||||++++
T Consensus 39 ~~~~~~y~~----~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~i~~~~ 114 (320)
T 3a99_A 39 EPLESQYQV----GPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLL 114 (320)
T ss_dssp -CCTTTEEE----EEECSSSSSCEEEEEEETTTTEEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEE
T ss_pred CCccCceEE----EEEEeeCCCeEEEEEEECCCCcEEEEEEEecccchhhhhhhhhhHHHHHHHHHHhhccCCCCceEEE
Confidence 344455555 688999999999999999999999999986432 2457999999986 479999999
Q ss_pred EEEEeCCeEEEEEEccCC-CCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCcEEEecCCCCCEEE
Q psy11767 438 CVFQDEVHTYLVLELLKG-GELLDRIRQKGRCGFTENEASRIMRQLVAAVHFMHSRGVVHRDLKPENLLFSDPAGDNIKV 516 (966)
Q Consensus 438 ~~~~~~~~~~lVmEy~~g-g~L~~~l~~~~~~~l~e~~~~~i~~Qil~aL~yLHs~~IiHRDLKP~NILl~~~~~~~iKL 516 (966)
+++.++...++|||++.+ ++|.+++...+ .+++..++.++.||+.||+|||++||+||||||+|||++. ..+.+||
T Consensus 115 ~~~~~~~~~~lv~e~~~~~~~L~~~l~~~~--~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~-~~~~~kL 191 (320)
T 3a99_A 115 DWFERPDSFVLILERPEPVQDLFDFITERG--ALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDL-NRGELKL 191 (320)
T ss_dssp EEEECSSEEEEEEECCSSEEEHHHHHHHHC--SCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEET-TTTEEEE
T ss_pred EEEecCCcEEEEEEcCCCCccHHHHHhccC--CCCHHHHHHHHHHHHHHHHHHHHCCcEeCCCCHHHEEEeC-CCCCEEE
Confidence 999999999999999976 89999998765 5899999999999999999999999999999999999973 2468999
Q ss_pred EeecccccccCC-CccccccccccCchhhccCCCCCCCcccchhhhhhhhhhhhcCCCCCCCcCcchhHHHHHHHHhcCC
Q psy11767 517 VDFGFACLKRES-LHTPCFTLQYAAPEVLRQDKSGYDENCDLWSLGVILVNVLRQDKSGYDENCDLWSLGVILYTMLCGR 595 (966)
Q Consensus 517 ~DFGla~~~~~~-~~~~~gT~~Y~APEvl~~~~~~~~~~~Di~SlGvil~el~~~~~~~y~~~~DIWSlGvilyemltG~ 595 (966)
+|||++...... .....+|+.|+|||++.... .++.++|||||||++|+|++|+
T Consensus 192 ~Dfg~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-------------------------~~~~~~Di~slG~il~el~~g~ 246 (320)
T 3a99_A 192 IDFGSGALLKDTVYTDFDGTRVYSPPEWIRYHR-------------------------YHGRSAAVWSLGILLYDMVCGD 246 (320)
T ss_dssp CCCTTCEECCSSCBCCCCSCGGGSCHHHHHHSC-------------------------BCHHHHHHHHHHHHHHHHHHSS
T ss_pred eeCccccccccccccCCCCCccCCChHHhccCC-------------------------CCCccchHHhHHHHHHHHHHCC
Confidence 999999765433 34567899999999885321 2356789999999999999999
Q ss_pred CCCCCCCCchhHHHHHHHHHcCCCCCCchhhccCCHHHHHHHHHhcccCccccCChHHHHHHhhhhH
Q psy11767 596 VPFHARSRDDSALSIMARIKEGQFNFDAEAWSTVSSEAKELTKSLLTVNPAQRIRMMRVKLTFHAFH 662 (966)
Q Consensus 596 ~Pf~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~is~e~~~Li~~~L~~dP~~R~t~~~v~~~~~~~~ 662 (966)
.||.... .+..+...+. ..+++++.+||.+||..||++|||+.++ ..|+|+
T Consensus 247 ~pf~~~~----------~~~~~~~~~~----~~~~~~~~~li~~~l~~dp~~Rps~~~l--l~hp~~ 297 (320)
T 3a99_A 247 IPFEHDE----------EIIRGQVFFR----QRVSSECQHLIRWCLALRPSDRPTFEEI--QNHPWM 297 (320)
T ss_dssp CSCCSHH----------HHHHCCCCCS----SCCCHHHHHHHHHHTCSSGGGSCCHHHH--HTSGGG
T ss_pred CCCCChh----------hhhccccccc----ccCCHHHHHHHHHHccCChhhCcCHHHH--hcCHhh
Confidence 9997521 1222332222 3578999999999999999999999977 345664
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-38 Score=349.34 Aligned_cols=246 Identities=25% Similarity=0.463 Sum_probs=196.2
Q ss_pred cccccccccccccEEEEEEEcCCCcEEEEEEecccc----ChHHHHHHHHHhcCCCCceEEEEEEEe-------------
Q psy11767 380 LDKAGILGDGSYSVCRRCVEKSTGQEYAVKIISRKI----DCSEEINLLRACQGHPNIVNLHCVFQD------------- 442 (966)
Q Consensus 380 ~~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~----~~~~Ei~iL~~l~~HpnIV~l~~~~~~------------- 442 (966)
|+..+.||+|+||.||+|++..+|+.||||++.... ...+|+.+|+.+ +||||+++++++.+
T Consensus 8 y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~~~~~~~~~~~~~~ 86 (303)
T 1zy4_A 8 FEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHTEEKLSTILSEVMLLASL-NHQYVVRYYAAWLERRNFVKPMTAVKK 86 (303)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEEEHHHHHHHHHHHHHHTTC-CCTTBCCEEEEEEECCCCCC------C
T ss_pred chhhheeccCCcEEEEEEEEcCCCeEEEEEEEeccHHHHHHHHHHHHHHHhc-CchHHHHHHHHHHhhcchhhhhccccc
Confidence 444789999999999999999999999999986432 245699999888 59999999998865
Q ss_pred CCeEEEEEEccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCcEEEecCCCCCEEEEeeccc
Q psy11767 443 EVHTYLVLELLKGGELLDRIRQKGRCGFTENEASRIMRQLVAAVHFMHSRGVVHRDLKPENLLFSDPAGDNIKVVDFGFA 522 (966)
Q Consensus 443 ~~~~~lVmEy~~gg~L~~~l~~~~~~~l~e~~~~~i~~Qil~aL~yLHs~~IiHRDLKP~NILl~~~~~~~iKL~DFGla 522 (966)
....|+||||++||+|.+++.... ..+++..++.++.||+.||+|||++||+||||||+|||++. ++.+||+|||++
T Consensus 87 ~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dlkp~Nil~~~--~~~~kl~dfg~~ 163 (303)
T 1zy4_A 87 KSTLFIQMEYCENGTLYDLIHSEN-LNQQRDEYWRLFRQILEALSYIHSQGIIHRDLKPMNIFIDE--SRNVKIGDFGLA 163 (303)
T ss_dssp EEEEEEEEECCCSCBHHHHHHHSC-GGGCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECT--TSCEEECCCCCC
T ss_pred CCceEEEEecCCCCCHHHhhhccc-cccchHHHHHHHHHHHHHHHHHHhCCeecccCCHHhEEEcC--CCCEEEeeCcch
Confidence 356899999999999999998654 35889999999999999999999999999999999999974 568999999999
Q ss_pred ccccC-----------------CCccccccccccCchhhccCCCCCCCcccchhhhhhhhhhhhcCCCCCCCcCcchhHH
Q psy11767 523 CLKRE-----------------SLHTPCFTLQYAAPEVLRQDKSGYDENCDLWSLGVILVNVLRQDKSGYDENCDLWSLG 585 (966)
Q Consensus 523 ~~~~~-----------------~~~~~~gT~~Y~APEvl~~~~~~~~~~~Di~SlGvil~el~~~~~~~y~~~~DIWSlG 585 (966)
..... .....++|+.|+|||++.. ...|+.++||||||
T Consensus 164 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-------------------------~~~~~~~~Di~slG 218 (303)
T 1zy4_A 164 KNVHRSLDILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDG-------------------------TGHYNEKIDMYSLG 218 (303)
T ss_dssp SCTTC-------------------------CTTSCHHHHTS-------------------------CSCCCTHHHHHHHH
T ss_pred hhcccccchhccccccccccccccccCCCcccccCcccccC-------------------------CCCCcchhhHHHHH
Confidence 75431 1234568999999999852 12468899999999
Q ss_pred HHHHHHhcCCCCCCCCCCchhHHHHHHHHHcCCCCCCchhhccCCHHHHHHHHHhcccCccccCChHHHHHHhhhhH
Q psy11767 586 VILYTMLCGRVPFHARSRDDSALSIMARIKEGQFNFDAEAWSTVSSEAKELTKSLLTVNPAQRIRMMRVKLTFHAFH 662 (966)
Q Consensus 586 vilyemltG~~Pf~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~is~e~~~Li~~~L~~dP~~R~t~~~v~~~~~~~~ 662 (966)
|++|+|++ ||... .........+......++.......+.++++||.+||..||.+|||+.++. .|+|+
T Consensus 219 ~il~~l~~---p~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll--~h~~~ 287 (303)
T 1zy4_A 219 IIFFEMIY---PFSTG---MERVNILKKLRSVSIEFPPDFDDNKMKVEKKIIRLLIDHDPNKRPGARTLL--NSGWL 287 (303)
T ss_dssp HHHHHHHS---CCSSH---HHHHHHHHHHHSTTCCCCTTCCTTTSHHHHHHHHHHTCSSGGGSCCHHHHH--HSSCS
T ss_pred HHHHHHHh---ccCCc---hhHHHHHHhccccccccCccccccchHHHHHHHHHHHhcCcccCcCHHHHh--CCCCc
Confidence 99999998 66432 122344556666666665555567788999999999999999999999763 46665
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=6.6e-39 Score=365.62 Aligned_cols=244 Identities=20% Similarity=0.370 Sum_probs=188.9
Q ss_pred ccccccccccccEEEEEEEc---CCCcEEEEEEecccc------ChHHHHHHHHHhcCCCCceEEEEEEEeCCeEEEEEE
Q psy11767 381 DKAGILGDGSYSVCRRCVEK---STGQEYAVKIISRKI------DCSEEINLLRACQGHPNIVNLHCVFQDEVHTYLVLE 451 (966)
Q Consensus 381 ~~~~~LG~G~fG~Vy~a~~~---~tg~~vAvK~i~~~~------~~~~Ei~iL~~l~~HpnIV~l~~~~~~~~~~~lVmE 451 (966)
+..+.||+|+||.||+|++. .++..||||++.... ...+|+.+|+.+ +|||||++++++.+....|+|||
T Consensus 48 ~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~lv~e 126 (373)
T 2qol_A 48 SIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQF-DHPNIIRLEGVVTKSKPVMIVTE 126 (373)
T ss_dssp CCCEEEEECSSSEEEEC-CBCTTSCBCCEEEEECCTTCCHHHHHHHHHHHHHHTTC-CCTTBCCEEEEECSSSSCEEEEE
T ss_pred eeeeEEeeCCCeEEEEEEEecCCCCceeEEEEEecCccCHHHHHHHHHHHHHHHhC-CCCCCCeEEEEEeeCCceEEEEe
Confidence 34688999999999999987 567889999987542 245699999888 59999999999999999999999
Q ss_pred ccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCcEEEecCCCCCEEEEeecccccccCCC--
Q psy11767 452 LLKGGELLDRIRQKGRCGFTENEASRIMRQLVAAVHFMHSRGVVHRDLKPENLLFSDPAGDNIKVVDFGFACLKRESL-- 529 (966)
Q Consensus 452 y~~gg~L~~~l~~~~~~~l~e~~~~~i~~Qil~aL~yLHs~~IiHRDLKP~NILl~~~~~~~iKL~DFGla~~~~~~~-- 529 (966)
||+||+|.+++.+... .+++.++..++.||+.||+|||++||+||||||+|||++. ++.+||+|||+++......
T Consensus 127 ~~~~~sL~~~l~~~~~-~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~--~~~~kl~Dfg~a~~~~~~~~~ 203 (373)
T 2qol_A 127 YMENGSLDSFLRKHDA-QFTVIQLVGMLRGIASGMKYLSDMGYVHRDLAARNILINS--NLVCKVSDFGLGRVLEDDPEA 203 (373)
T ss_dssp CCTTCBHHHHHHTTTT-CSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECT--TCCEEECCC------------
T ss_pred CCCCCcHHHHHHhCCC-CCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCcceEEEcC--CCCEEECcCccccccccCCcc
Confidence 9999999999976543 5999999999999999999999999999999999999975 5689999999997654321
Q ss_pred ----ccccccccccCchhhccCCCCCCCcccchhhhhhhhhhhhcCCCCCCCcCcchhHHHHHHHHhc-CCCCCCCCCCc
Q psy11767 530 ----HTPCFTLQYAAPEVLRQDKSGYDENCDLWSLGVILVNVLRQDKSGYDENCDLWSLGVILYTMLC-GRVPFHARSRD 604 (966)
Q Consensus 530 ----~~~~gT~~Y~APEvl~~~~~~~~~~~Di~SlGvil~el~~~~~~~y~~~~DIWSlGvilyemlt-G~~Pf~~~~~~ 604 (966)
....+|+.|+|||++.. ..|+.++|||||||++|||++ |+.||......
T Consensus 204 ~~~~~~~~~~~~y~aPE~~~~--------------------------~~~~~~~Dv~SlG~il~ellt~g~~P~~~~~~~ 257 (373)
T 2qol_A 204 AYTTRGGKIPIRWTSPEAIAY--------------------------RKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQ 257 (373)
T ss_dssp ----------CTTSCHHHHHH--------------------------CCCCHHHHHHHHHHHHHHHHTTC-CTTTTCCHH
T ss_pred ceeccCCCcCCCccChhhhcc--------------------------CCcCchhcHHHHHHHHHHHHhCCCCCCCCCCHH
Confidence 12234778999999853 237889999999999999997 99999876432
Q ss_pred hhHHHHHHHHHcCCCCCCchhhccCCHHHHHHHHHhcccCccccCChHHHHHHhhhh
Q psy11767 605 DSALSIMARIKEGQFNFDAEAWSTVSSEAKELTKSLLTVNPAQRIRMMRVKLTFHAF 661 (966)
Q Consensus 605 ~~~~~~~~~i~~~~~~~~~~~~~~is~e~~~Li~~~L~~dP~~R~t~~~v~~~~~~~ 661 (966)
.+...+..+.. .+ ....++.++.+||.+||+.||++||++.++...+..+
T Consensus 258 ----~~~~~i~~~~~-~~--~~~~~~~~l~~li~~cl~~dp~~RPs~~~i~~~L~~~ 307 (373)
T 2qol_A 258 ----DVIKAVDEGYR-LP--PPMDCPAALYQLMLDCWQKDRNNRPKFEQIVSILDKL 307 (373)
T ss_dssp ----HHHHHHHTTEE-CC--CCTTCBHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred ----HHHHHHHcCCC-CC--CCccccHHHHHHHHHHhCcChhhCcCHHHHHHHHHHH
Confidence 33444444321 11 1235789999999999999999999999886555443
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-39 Score=358.57 Aligned_cols=250 Identities=21% Similarity=0.348 Sum_probs=195.7
Q ss_pred ccccccccccccEEEEEEEcCCCcEEEEEEeccccC-----hHHHHHHHHHhcCCCCceEEEEEEEeCCeEEEEEEccCC
Q psy11767 381 DKAGILGDGSYSVCRRCVEKSTGQEYAVKIISRKID-----CSEEINLLRACQGHPNIVNLHCVFQDEVHTYLVLELLKG 455 (966)
Q Consensus 381 ~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~~-----~~~Ei~iL~~l~~HpnIV~l~~~~~~~~~~~lVmEy~~g 455 (966)
+..+.||+|+||.||+|.+. +|+.||||++..... ..+|+.+|+.+ +||||+++++++.++...|+||||+++
T Consensus 42 ~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~e~~~~ 119 (321)
T 2qkw_B 42 DHKFLIGHGVFGKVYKGVLR-DGAKVALKRRTPESSQGIEEFETEIETLSFC-RHPHLVSLIGFCDERNEMILIYKYMEN 119 (321)
T ss_dssp SCCCCSCBCSSSEEEEEECT-TCCEEEEEECCSCCSSHHHHHHHHHHGGGSC-CCTTBCCEEEECCCTTCCEEEEECCTT
T ss_pred CccceeecCCCeeEEEEEEC-CCCEEEEEEecccChHHHHHHHHHHHHHHhC-CCCCEeeEEEEEcCCCeEEEEEEcCCC
Confidence 34678999999999999964 689999999865432 45688888887 599999999999999999999999999
Q ss_pred CCHHHHHHhcCC--CCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCcEEEecCCCCCEEEEeecccccccCC-----
Q psy11767 456 GELLDRIRQKGR--CGFTENEASRIMRQLVAAVHFMHSRGVVHRDLKPENLLFSDPAGDNIKVVDFGFACLKRES----- 528 (966)
Q Consensus 456 g~L~~~l~~~~~--~~l~e~~~~~i~~Qil~aL~yLHs~~IiHRDLKP~NILl~~~~~~~iKL~DFGla~~~~~~----- 528 (966)
|+|.+++..... ..+++.+++.++.||+.||+|||++||+||||||+|||++. ++.+||+|||+++.....
T Consensus 120 ~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~~~--~~~~kl~Dfg~~~~~~~~~~~~~ 197 (321)
T 2qkw_B 120 GNLKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLHTRAIIHRDVKSINILLDE--NFVPKITDFGISKKGTELDQTHL 197 (321)
T ss_dssp CBTGGGSSSSCCCSCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCSTTEEECT--TCCEEECCCTTCEECSSSSCCCC
T ss_pred CcHHHHHhccCCCccccCHHHHHHHHHHHHHHHHHhcCCCeecCCCCHHHEEECC--CCCEEEeeccccccccccccccc
Confidence 999999865432 24899999999999999999999999999999999999974 569999999999754321
Q ss_pred CccccccccccCchhhccCCCCCCCcccchhhhhhhhhhhhcCCCCCCCcCcchhHHHHHHHHhcCCCCCCCCCCchhH-
Q psy11767 529 LHTPCFTLQYAAPEVLRQDKSGYDENCDLWSLGVILVNVLRQDKSGYDENCDLWSLGVILYTMLCGRVPFHARSRDDSA- 607 (966)
Q Consensus 529 ~~~~~gT~~Y~APEvl~~~~~~~~~~~Di~SlGvil~el~~~~~~~y~~~~DIWSlGvilyemltG~~Pf~~~~~~~~~- 607 (966)
.....||+.|+|||++... .|+.++|||||||++|+|++|+.||......+..
T Consensus 198 ~~~~~gt~~y~aPE~~~~~--------------------------~~~~~~Di~slG~il~ell~g~~p~~~~~~~~~~~ 251 (321)
T 2qkw_B 198 STVVKGTLGYIDPEYFIKG--------------------------RLTEKSDVYSFGVVLFEVLCARSAIVQSLPREMVN 251 (321)
T ss_dssp BCCCEEETTTCCHHHHHHC--------------------------BCCTHHHHHHHHHHHHHHHHCCTTCSCSSSSSCCC
T ss_pred ccccCCCccccCHHHhcCC--------------------------CCCcccchHhHHHHHHHHHhCCCcccccCcHHHHH
Confidence 2234589999999998532 3678999999999999999999999865443211
Q ss_pred -HH-HHHHHHcCCCC------CCchhhccCCHHHHHHHHHhcccCccccCChHHHHHHhhh
Q psy11767 608 -LS-IMARIKEGQFN------FDAEAWSTVSSEAKELTKSLLTVNPAQRIRMMRVKLTFHA 660 (966)
Q Consensus 608 -~~-~~~~i~~~~~~------~~~~~~~~is~e~~~Li~~~L~~dP~~R~t~~~v~~~~~~ 660 (966)
.. .......+.+. ......+..+.++.+++.+||+.||++|||+.++...+..
T Consensus 252 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~ 312 (321)
T 2qkw_B 252 LAEWAVESHNNGQLEQIVDPNLADKIRPESLRKFGDTAVKCLALSSEDRPSMGDVLWKLEY 312 (321)
T ss_dssp HHHHTHHHHTTTCCCSSSSSSCTTCSCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred HHHHhhhccccccHHHhcChhhccccCHHHHHHHHHHHHHHcCCCcccCcCHHHHHHHHHH
Confidence 11 11111222111 1111123456788999999999999999999988655443
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-38 Score=353.93 Aligned_cols=261 Identities=21% Similarity=0.331 Sum_probs=194.4
Q ss_pred cceecccccccccccccccccccEEEEEEEcCCCcEEEEEEeccccC--hHHHHHHHHHh-cCCCCceEEEEEEEeC---
Q psy11767 370 SLFFEQYDMDLDKAGILGDGSYSVCRRCVEKSTGQEYAVKIISRKID--CSEEINLLRAC-QGHPNIVNLHCVFQDE--- 443 (966)
Q Consensus 370 ~~~~~~~~i~~~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~~--~~~Ei~iL~~l-~~HpnIV~l~~~~~~~--- 443 (966)
..+.++|.+ .+.||+|+||.||+|.+. |+.||||++..... ..+|.+++..+ .+||||+++++++.+.
T Consensus 33 ~~~~~~y~~----~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~~~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~ 106 (337)
T 3mdy_A 33 RTIAKQIQM----VKQIGKGRYGEVWMGKWR--GEKVAVKVFFTTEEASWFRETEIYQTVLMRHENILGFIAADIKGTGS 106 (337)
T ss_dssp TTHHHHCEE----EEEEEEETTEEEEEEEET--TEEEEEEEEEGGGHHHHHHHHHHHTSTTCCCTTBCCEEEEEEESCGG
T ss_pred cccccceEE----EeEeecCCCeEEEEEEEC--CceEEEEEEeccccchhhhHHHHHHHHhhcCCCeeeEEEEEccCCCC
Confidence 344455555 689999999999999875 89999999865432 23455555543 3799999999999987
Q ss_pred -CeEEEEEEccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhc--------CceeccCCCCcEEEecCCCCCE
Q psy11767 444 -VHTYLVLELLKGGELLDRIRQKGRCGFTENEASRIMRQLVAAVHFMHSR--------GVVHRDLKPENLLFSDPAGDNI 514 (966)
Q Consensus 444 -~~~~lVmEy~~gg~L~~~l~~~~~~~l~e~~~~~i~~Qil~aL~yLHs~--------~IiHRDLKP~NILl~~~~~~~i 514 (966)
...|+|||||++|+|.+++... .+++..++.++.|++.||+|||++ ||+||||||+|||++. ++.+
T Consensus 107 ~~~~~lv~e~~~~g~L~~~l~~~---~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dikp~Nill~~--~~~~ 181 (337)
T 3mdy_A 107 WTQLYLITDYHENGSLYDYLKST---TLDAKSMLKLAYSSVSGLCHLHTEIFSTQGKPAIAHRDLKSKNILVKK--NGTC 181 (337)
T ss_dssp GCEEEEEECCCTTCBHHHHHHHC---CBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCCEECSCCCGGGEEECT--TSCE
T ss_pred CCceEEEEeccCCCcHHHHhhcc---CCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCEEecccchHHEEECC--CCCE
Confidence 7899999999999999999765 489999999999999999999999 9999999999999975 5699
Q ss_pred EEEeecccccccCC-------CccccccccccCchhhccCCCCCCCcccchhhhhhhhhhhhcCCCCCCCcCcchhHHHH
Q psy11767 515 KVVDFGFACLKRES-------LHTPCFTLQYAAPEVLRQDKSGYDENCDLWSLGVILVNVLRQDKSGYDENCDLWSLGVI 587 (966)
Q Consensus 515 KL~DFGla~~~~~~-------~~~~~gT~~Y~APEvl~~~~~~~~~~~Di~SlGvil~el~~~~~~~y~~~~DIWSlGvi 587 (966)
||+|||+|...... ....+||+.|+|||++...... . ...++.++|||||||+
T Consensus 182 kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~--~------------------~~~~~~~~DiwslG~i 241 (337)
T 3mdy_A 182 CIADLGLAVKFISDTNEVDIPPNTRVGTKRYMPPEVLDESLNR--N------------------HFQSYIMADMYSFGLI 241 (337)
T ss_dssp EECCCTTCEECC---------CCSSCSCGGGCCHHHHTTCCCT--T------------------CTHHHHHHHHHHHHHH
T ss_pred EEEeCCCceeeccccccccCCCCCCccCcceeChhhcccccCC--c------------------cccCccccchHHHHHH
Confidence 99999999654321 1245789999999998632210 0 0011124899999999
Q ss_pred HHHHhcC----------CCCCCCCCCchhHHHHHH-HHHcCCCC--CCch-hhccCCHHHHHHHHHhcccCccccCChHH
Q psy11767 588 LYTMLCG----------RVPFHARSRDDSALSIMA-RIKEGQFN--FDAE-AWSTVSSEAKELTKSLLTVNPAQRIRMMR 653 (966)
Q Consensus 588 lyemltG----------~~Pf~~~~~~~~~~~~~~-~i~~~~~~--~~~~-~~~~is~e~~~Li~~~L~~dP~~R~t~~~ 653 (966)
+|+|++| ..||............+. .+...... ++.. ....+++++.+||.+||+.||++|||+.+
T Consensus 242 l~el~tg~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~e 321 (337)
T 3mdy_A 242 LWEVARRCVSGGIVEEYQLPYHDLVPSDPSYEDMREIVCIKKLRPSFPNRWSSDECLRQMGKLMTECWAHNPASRLTALR 321 (337)
T ss_dssp HHHHHTTBCBTTBCCCCCCTTTTTSCSSCCHHHHHHHHTTSCCCCCCCGGGGGSHHHHHHHHHHHHHSCSSGGGSCCHHH
T ss_pred HHHHHhccCcccccccccccHhhhcCCCCchhhhHHHHhhhccCccccccchhhHHHHHHHHHHHHhhhhChhhCCCHHH
Confidence 9999999 788876543322222222 22222211 1111 11245778999999999999999999998
Q ss_pred HHHHhhhh
Q psy11767 654 VKLTFHAF 661 (966)
Q Consensus 654 v~~~~~~~ 661 (966)
+...+..+
T Consensus 322 ll~~L~~l 329 (337)
T 3mdy_A 322 VKKTLAKM 329 (337)
T ss_dssp HHHHHHHH
T ss_pred HHHHHHHH
Confidence 86655544
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-38 Score=351.89 Aligned_cols=242 Identities=27% Similarity=0.453 Sum_probs=188.4
Q ss_pred ccccccccccccEEEEEEEcCCCcEEEEEEecccc---ChHHHHHHHHHhcCCCCceEEEEEEEeCCeEEEEEEccCCCC
Q psy11767 381 DKAGILGDGSYSVCRRCVEKSTGQEYAVKIISRKI---DCSEEINLLRACQGHPNIVNLHCVFQDEVHTYLVLELLKGGE 457 (966)
Q Consensus 381 ~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~---~~~~Ei~iL~~l~~HpnIV~l~~~~~~~~~~~lVmEy~~gg~ 457 (966)
+..+.||+|+||+||+|.+. ++.||||++.... ...+|+.+|+.+ +||||+++++++.+ ..|+||||++||+
T Consensus 11 ~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~~~~~~~~~E~~~l~~l-~hp~iv~~~~~~~~--~~~lv~e~~~~~~ 85 (307)
T 2eva_A 11 EVEEVVGRGAFGVVCKAKWR--AKDVAIKQIESESERKAFIVELRQLSRV-NHPNIVKLYGACLN--PVCLVMEYAEGGS 85 (307)
T ss_dssp EEEEEEECCSSSEEEEEEET--TEEEEEEECSSTTHHHHHHHHHHHHHHC-CCTTBCCEEEBCTT--TTEEEEECCTTCB
T ss_pred eeeeEeecCCCceEEEEEEC--CeeEEEEEecChhHHHHHHHHHHHHhcC-CCCCcCeEEEEEcC--CcEEEEEcCCCCC
Confidence 34678999999999999875 7899999996543 245799999998 59999999998874 3799999999999
Q ss_pred HHHHHHhcCC-CCCCHHHHHHHHHHHHHHHHHHHh---cCceeccCCCCcEEEecCCCCCEEEEeecccccccCCCcccc
Q psy11767 458 LLDRIRQKGR-CGFTENEASRIMRQLVAAVHFMHS---RGVVHRDLKPENLLFSDPAGDNIKVVDFGFACLKRESLHTPC 533 (966)
Q Consensus 458 L~~~l~~~~~-~~l~e~~~~~i~~Qil~aL~yLHs---~~IiHRDLKP~NILl~~~~~~~iKL~DFGla~~~~~~~~~~~ 533 (966)
|.+++..... ..+++..+..++.||+.||+|||+ +||+||||||+|||++. .+..+||+|||+++..........
T Consensus 86 L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~~~ivH~dlkp~NIll~~-~~~~~kl~Dfg~~~~~~~~~~~~~ 164 (307)
T 2eva_A 86 LYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHRDLKPPNLLLVA-GGTVLKICDFGTACDIQTHMTNNK 164 (307)
T ss_dssp HHHHHHCSSSEECCCHHHHHHHHHHHHHHHHHHHTCSSSCCCCCCCSGGGEEEET-TTTEEEECCCCC------------
T ss_pred HHHHHhccCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeecCCCChhHEEEeC-CCCEEEEcccccccccccccccCC
Confidence 9999976542 247899999999999999999999 89999999999999975 233489999999976655555567
Q ss_pred ccccccCchhhccCCCCCCCcccchhhhhhhhhhhhcCCCCCCCcCcchhHHHHHHHHhcCCCCCCCCCCchhHHHHHHH
Q psy11767 534 FTLQYAAPEVLRQDKSGYDENCDLWSLGVILVNVLRQDKSGYDENCDLWSLGVILYTMLCGRVPFHARSRDDSALSIMAR 613 (966)
Q Consensus 534 gT~~Y~APEvl~~~~~~~~~~~Di~SlGvil~el~~~~~~~y~~~~DIWSlGvilyemltG~~Pf~~~~~~~~~~~~~~~ 613 (966)
||+.|+|||++.. ..|+.++|||||||++|+|++|+.||....... ..+...
T Consensus 165 gt~~y~aPE~~~~--------------------------~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~--~~~~~~ 216 (307)
T 2eva_A 165 GSAAWMAPEVFEG--------------------------SNYSEKCDVFSWGIILWEVITRRKPFDEIGGPA--FRIMWA 216 (307)
T ss_dssp CCTTSSCHHHHTC--------------------------CCCCTHHHHHHHHHHHHHHHHTCCTTTTTCSSH--HHHHHH
T ss_pred CCCceEChhhhCC--------------------------CCCCcHHHHHHHHHHHHHHHHCCCCchhhCccH--HHHHHH
Confidence 8999999999852 247889999999999999999999998654332 223333
Q ss_pred HHcCCCCCCchhhccCCHHHHHHHHHhcccCccccCChHHHHHHhh
Q psy11767 614 IKEGQFNFDAEAWSTVSSEAKELTKSLLTVNPAQRIRMMRVKLTFH 659 (966)
Q Consensus 614 i~~~~~~~~~~~~~~is~e~~~Li~~~L~~dP~~R~t~~~v~~~~~ 659 (966)
+..+... .....+++++.+||.+||..||++|||+.++...+.
T Consensus 217 ~~~~~~~---~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~ 259 (307)
T 2eva_A 217 VHNGTRP---PLIKNLPKPIESLMTRCWSKDPSQRPSMEEIVKIMT 259 (307)
T ss_dssp HHTTCCC---CCBTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred HhcCCCC---CcccccCHHHHHHHHHHhcCChhhCcCHHHHHHHHH
Confidence 4443322 223468999999999999999999999998855443
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-38 Score=343.97 Aligned_cols=240 Identities=23% Similarity=0.380 Sum_probs=195.9
Q ss_pred ccccccccEEEEEEEc--CCCcEEEEEEeccccC------hHHHHHHHHHhcCCCCceEEEEEEEeCCeEEEEEEccCCC
Q psy11767 385 ILGDGSYSVCRRCVEK--STGQEYAVKIISRKID------CSEEINLLRACQGHPNIVNLHCVFQDEVHTYLVLELLKGG 456 (966)
Q Consensus 385 ~LG~G~fG~Vy~a~~~--~tg~~vAvK~i~~~~~------~~~Ei~iL~~l~~HpnIV~l~~~~~~~~~~~lVmEy~~gg 456 (966)
.||+|+||.||+|.+. .+++.||||++..... ..+|+.+|+.+ +||||+++++++. ....|+||||++++
T Consensus 17 ~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~-~~~~~lv~e~~~~~ 94 (287)
T 1u59_A 17 ELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQL-DNPYIVRLIGVCQ-AEALMLVMEMAGGG 94 (287)
T ss_dssp EEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHC-CCTTBCCEEEEEE-SSSEEEEEECCTTE
T ss_pred cccccCceeEEEeEeccCCCcceEEEEecCCccchhHHHHHHHHHHHHHhC-CCCCEeEEEEEec-CCCcEEEEEeCCCC
Confidence 7999999999999864 4688999999976432 34699999998 5999999999994 45699999999999
Q ss_pred CHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCcEEEecCCCCCEEEEeecccccccCC------Cc
Q psy11767 457 ELLDRIRQKGRCGFTENEASRIMRQLVAAVHFMHSRGVVHRDLKPENLLFSDPAGDNIKVVDFGFACLKRES------LH 530 (966)
Q Consensus 457 ~L~~~l~~~~~~~l~e~~~~~i~~Qil~aL~yLHs~~IiHRDLKP~NILl~~~~~~~iKL~DFGla~~~~~~------~~ 530 (966)
+|.+++.... ..+++..++.++.||+.||+|||++||+||||||+|||++. ++.+||+|||++...... ..
T Consensus 95 ~L~~~l~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nili~~--~~~~kl~Dfg~~~~~~~~~~~~~~~~ 171 (287)
T 1u59_A 95 PLHKFLVGKR-EEIPVSNVAELLHQVSMGMKYLEEKNFVHRDLAARNVLLVN--RHYAKISDFGLSKALGADDSYYTARS 171 (287)
T ss_dssp EHHHHHTTCT-TTSCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEEE--TTEEEECCCTTCEECTTCSCEECCCC
T ss_pred CHHHHHHhCC-ccCCHHHHHHHHHHHHHHHHHHHHCCEeeCCCchheEEEcC--CCCEEECcccceeeeccCcceeeccc
Confidence 9999997543 35999999999999999999999999999999999999985 568999999999765321 12
Q ss_pred cccccccccCchhhccCCCCCCCcccchhhhhhhhhhhhcCCCCCCCcCcchhHHHHHHHHhc-CCCCCCCCCCchhHHH
Q psy11767 531 TPCFTLQYAAPEVLRQDKSGYDENCDLWSLGVILVNVLRQDKSGYDENCDLWSLGVILYTMLC-GRVPFHARSRDDSALS 609 (966)
Q Consensus 531 ~~~gT~~Y~APEvl~~~~~~~~~~~Di~SlGvil~el~~~~~~~y~~~~DIWSlGvilyemlt-G~~Pf~~~~~~~~~~~ 609 (966)
...+|+.|+|||++... .++.++|||||||++|+|++ |+.||...... .
T Consensus 172 ~~~~~~~y~aPE~~~~~--------------------------~~~~~~Di~slG~il~ellt~g~~p~~~~~~~----~ 221 (287)
T 1u59_A 172 AGKWPLKWYAPECINFR--------------------------KFSSRSDVWSYGVTMWEALSYGQKPYKKMKGP----E 221 (287)
T ss_dssp SSCCCGGGCCHHHHHHC--------------------------EECHHHHHHHHHHHHHHHHTTSCCTTTTCCTH----H
T ss_pred cccccccccCHHHhccC--------------------------CCCchhhHHHHHHHHHHHHcCCCCCcccCCHH----H
Confidence 33568899999998532 36778999999999999998 99999876543 2
Q ss_pred HHHHHHcCCCCCCchhhccCCHHHHHHHHHhcccCccccCChHHHHHHhhhhH
Q psy11767 610 IMARIKEGQFNFDAEAWSTVSSEAKELTKSLLTVNPAQRIRMMRVKLTFHAFH 662 (966)
Q Consensus 610 ~~~~i~~~~~~~~~~~~~~is~e~~~Li~~~L~~dP~~R~t~~~v~~~~~~~~ 662 (966)
+...+..+... .....+++++.+||.+||..||++||++.++...+..+.
T Consensus 222 ~~~~i~~~~~~---~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~ 271 (287)
T 1u59_A 222 VMAFIEQGKRM---ECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACY 271 (287)
T ss_dssp HHHHHHTTCCC---CCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHH
T ss_pred HHHHHhcCCcC---CCCCCcCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHH
Confidence 34455554322 123468999999999999999999999999866555443
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.9e-39 Score=349.01 Aligned_cols=242 Identities=25% Similarity=0.443 Sum_probs=190.6
Q ss_pred ccccccccccccEEEEEEEcCCCcEEEEEEeccccC---hHHHHHHHHHhcCCCCceEEEEEEEeC-CeEEEEEEccCCC
Q psy11767 381 DKAGILGDGSYSVCRRCVEKSTGQEYAVKIISRKID---CSEEINLLRACQGHPNIVNLHCVFQDE-VHTYLVLELLKGG 456 (966)
Q Consensus 381 ~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~~---~~~Ei~iL~~l~~HpnIV~l~~~~~~~-~~~~lVmEy~~gg 456 (966)
+..+.||+|+||.||+|.+. |+.||||++..... ..+|+.+|+.+ +||||+++++++.+. ...|+||||++++
T Consensus 24 ~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~~lv~e~~~~~ 100 (278)
T 1byg_A 24 KLLQTIGKGEFGDVMLGDYR--GNKVAVKCIKNDATAQAFLAEASVMTQL-RHSNLVQLLGVIVEEKGGLYIVTEYMAKG 100 (278)
T ss_dssp EEEEEEEECSSCEEEEEEET--TEEEEEEECCCCC--HHHHHTHHHHTTC-CCTTBCCEEEEECCC--CCEEEECCCTTE
T ss_pred eEEeEEecCCCceEEEEEEc--CCEEEEEEecchhHHHHHHHHHHHHHhC-CCCCEeeEEEEEEcCCCceEEEEecCCCC
Confidence 34688999999999999874 88999999975533 45699999888 599999999987554 4789999999999
Q ss_pred CHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCcEEEecCCCCCEEEEeecccccccCCCccccccc
Q psy11767 457 ELLDRIRQKGRCGFTENEASRIMRQLVAAVHFMHSRGVVHRDLKPENLLFSDPAGDNIKVVDFGFACLKRESLHTPCFTL 536 (966)
Q Consensus 457 ~L~~~l~~~~~~~l~e~~~~~i~~Qil~aL~yLHs~~IiHRDLKP~NILl~~~~~~~iKL~DFGla~~~~~~~~~~~gT~ 536 (966)
+|.+++.......+++..+..++.||+.||+|||++||+||||||+|||++. ++.+||+|||++...........+|+
T Consensus 101 ~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~--~~~~~l~Dfg~~~~~~~~~~~~~~~~ 178 (278)
T 1byg_A 101 SLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVSE--DNVAKVSDFGLTKEASSTQDTGKLPV 178 (278)
T ss_dssp EHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECT--TSCEEECCCCC------------CCT
T ss_pred CHHHHHHhcccccCCHHHHHHHHHHHHHHHHHHHhCCccccCCCcceEEEeC--CCcEEEeeccccccccccccCCCccc
Confidence 9999998764334899999999999999999999999999999999999974 56899999999976655445556789
Q ss_pred cccCchhhccCCCCCCCcccchhhhhhhhhhhhcCCCCCCCcCcchhHHHHHHHHhc-CCCCCCCCCCchhHHHHHHHHH
Q psy11767 537 QYAAPEVLRQDKSGYDENCDLWSLGVILVNVLRQDKSGYDENCDLWSLGVILYTMLC-GRVPFHARSRDDSALSIMARIK 615 (966)
Q Consensus 537 ~Y~APEvl~~~~~~~~~~~Di~SlGvil~el~~~~~~~y~~~~DIWSlGvilyemlt-G~~Pf~~~~~~~~~~~~~~~i~ 615 (966)
.|+|||++.. ..|+.++|||||||++|+|++ |+.||......+ ....+.
T Consensus 179 ~y~aPE~~~~--------------------------~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~----~~~~~~ 228 (278)
T 1byg_A 179 KWTAPEALRE--------------------------KKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKD----VVPRVE 228 (278)
T ss_dssp TTSCHHHHHH--------------------------CCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGGG----HHHHHT
T ss_pred cccCHHHhCC--------------------------CCCCchhcHHHHHHHHHHHHhCCCCCCCCCCHHH----HHHHHh
Confidence 9999999853 236788999999999999998 999998765432 233444
Q ss_pred cCCCCCCchhhccCCHHHHHHHHHhcccCccccCChHHHHHHhhh
Q psy11767 616 EGQFNFDAEAWSTVSSEAKELTKSLLTVNPAQRIRMMRVKLTFHA 660 (966)
Q Consensus 616 ~~~~~~~~~~~~~is~e~~~Li~~~L~~dP~~R~t~~~v~~~~~~ 660 (966)
.+.. ......+++++.++|.+||..||++|||+.++...+..
T Consensus 229 ~~~~---~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~ 270 (278)
T 1byg_A 229 KGYK---MDAPDGCPPAVYEVMKNCWHLDAAMRPSFLQLREQLEH 270 (278)
T ss_dssp TTCC---CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred cCCC---CCCcccCCHHHHHHHHHHhcCChhhCCCHHHHHHHHHH
Confidence 4321 12234689999999999999999999999988655543
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-38 Score=343.90 Aligned_cols=244 Identities=20% Similarity=0.341 Sum_probs=194.6
Q ss_pred ccccccccccccEEEEEEEcC---CCcEEEEEEeccccC------hHHHHHHHHHhcCCCCceEEEEEEEeCCeEEEEEE
Q psy11767 381 DKAGILGDGSYSVCRRCVEKS---TGQEYAVKIISRKID------CSEEINLLRACQGHPNIVNLHCVFQDEVHTYLVLE 451 (966)
Q Consensus 381 ~~~~~LG~G~fG~Vy~a~~~~---tg~~vAvK~i~~~~~------~~~Ei~iL~~l~~HpnIV~l~~~~~~~~~~~lVmE 451 (966)
...+.||+|+||+||+|.+.. ++..||||++..... ..+|+.+|+.+ +||||+++++++.++ ..|+|||
T Consensus 15 ~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~~-~~~~v~e 92 (281)
T 3cc6_A 15 VLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNL-DHPHIVKLIGIIEEE-PTWIIME 92 (281)
T ss_dssp EEEEEEEECSSSEEEEEEEECTTCCEEEEEEEECCTTSCHHHHHHHHHHHHHHHHH-CCTTBCCEEEEECSS-SCEEEEE
T ss_pred EEEEEEEecCCeeEEEeEEcCCCCCcceEEEEecccccCchHHHHHHHHHHHHHhC-CCCCcceEEEEEcCC-CCEEEEe
Confidence 346789999999999998764 345699999875432 44699999998 599999999998764 5689999
Q ss_pred ccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCcEEEecCCCCCEEEEeecccccccCC---
Q psy11767 452 LLKGGELLDRIRQKGRCGFTENEASRIMRQLVAAVHFMHSRGVVHRDLKPENLLFSDPAGDNIKVVDFGFACLKRES--- 528 (966)
Q Consensus 452 y~~gg~L~~~l~~~~~~~l~e~~~~~i~~Qil~aL~yLHs~~IiHRDLKP~NILl~~~~~~~iKL~DFGla~~~~~~--- 528 (966)
|+++++|.+++..... .+++..+..++.||+.||+|||++||+||||||+|||++. ++.+||+|||++......
T Consensus 93 ~~~~~~L~~~l~~~~~-~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~--~~~~kl~Dfg~~~~~~~~~~~ 169 (281)
T 3cc6_A 93 LYPYGELGHYLERNKN-SLKVLTLVLYSLQICKAMAYLESINCVHRDIAVRNILVAS--PECVKLGDFGLSRYIEDEDYY 169 (281)
T ss_dssp CCTTCBHHHHHHHHTT-TCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEEEE--TTEEEECCCCGGGCC------
T ss_pred cCCCCCHHHHHHhccc-cCCHHHHHHHHHHHHHHHHHHHHCCcccCCCccceEEECC--CCcEEeCccCCCccccccccc
Confidence 9999999999977543 5899999999999999999999999999999999999985 568999999999765432
Q ss_pred -CccccccccccCchhhccCCCCCCCcccchhhhhhhhhhhhcCCCCCCCcCcchhHHHHHHHHhc-CCCCCCCCCCchh
Q psy11767 529 -LHTPCFTLQYAAPEVLRQDKSGYDENCDLWSLGVILVNVLRQDKSGYDENCDLWSLGVILYTMLC-GRVPFHARSRDDS 606 (966)
Q Consensus 529 -~~~~~gT~~Y~APEvl~~~~~~~~~~~Di~SlGvil~el~~~~~~~y~~~~DIWSlGvilyemlt-G~~Pf~~~~~~~~ 606 (966)
.....+|+.|+|||++.. ..|+.++|||||||++|+|++ |+.||......+.
T Consensus 170 ~~~~~~~~~~y~aPE~~~~--------------------------~~~~~~~Di~slG~il~~llt~g~~p~~~~~~~~~ 223 (281)
T 3cc6_A 170 KASVTRLPIKWMSPESINF--------------------------RRFTTASDVWMFAVCMWEILSFGKQPFFWLENKDV 223 (281)
T ss_dssp ---CCCCCGGGCCHHHHHH--------------------------CCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCGGGH
T ss_pred ccccCCCCcceeCchhhcc--------------------------CCCCchhccHHHHHHHHHHHhCCCCCcccCChHHH
Confidence 123456889999998853 236788999999999999998 9999987654432
Q ss_pred HHHHHHHHHcCCCCCCchhhccCCHHHHHHHHHhcccCccccCChHHHHHHhhhhH
Q psy11767 607 ALSIMARIKEGQFNFDAEAWSTVSSEAKELTKSLLTVNPAQRIRMMRVKLTFHAFH 662 (966)
Q Consensus 607 ~~~~~~~i~~~~~~~~~~~~~~is~e~~~Li~~~L~~dP~~R~t~~~v~~~~~~~~ 662 (966)
...+..+.... ....+++++.+||.+||..||++|||+.++...+....
T Consensus 224 ----~~~~~~~~~~~---~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~~ 272 (281)
T 3cc6_A 224 ----IGVLEKGDRLP---KPDLCPPVLYTLMTRCWDYDPSDRPRFTELVCSLSDVY 272 (281)
T ss_dssp ----HHHHHHTCCCC---CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred ----HHHHhcCCCCC---CCCCCCHHHHHHHHHHccCCchhCcCHHHHHHHHHHHH
Confidence 23333332211 12357899999999999999999999998866555443
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-38 Score=346.22 Aligned_cols=239 Identities=32% Similarity=0.481 Sum_probs=196.3
Q ss_pred ccccccccccccEEEEEEEcCCCcEEEEEEecccc-------ChHHHHHHHHHhcCCCCceEEEEEEEe--CCeEEEEEE
Q psy11767 381 DKAGILGDGSYSVCRRCVEKSTGQEYAVKIISRKI-------DCSEEINLLRACQGHPNIVNLHCVFQD--EVHTYLVLE 451 (966)
Q Consensus 381 ~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~-------~~~~Ei~iL~~l~~HpnIV~l~~~~~~--~~~~~lVmE 451 (966)
+..+.||+|+||.||+|.+..+|+.||+|++.... ...+|+.+|+.+ +||||+++++++.+ +...|+|||
T Consensus 9 ~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~~~lv~e 87 (279)
T 2w5a_A 9 EVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLREL-KHPNIVRYYDRIIDRTNTTLYIVME 87 (279)
T ss_dssp EEEEEEEECSSSEEEEEEETTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHC-CCTTBCCEEEEEEEGGGTEEEEEEE
T ss_pred eeehhccCCCCcEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhc-CCCCCCeEEEEEecCCCceEEEEEe
Confidence 34688999999999999999999999999996542 134689999998 59999999998854 568999999
Q ss_pred ccCCCCHHHHHHhcC--CCCCCHHHHHHHHHHHHHHHHHHHhcC-----ceeccCCCCcEEEecCCCCCEEEEeeccccc
Q psy11767 452 LLKGGELLDRIRQKG--RCGFTENEASRIMRQLVAAVHFMHSRG-----VVHRDLKPENLLFSDPAGDNIKVVDFGFACL 524 (966)
Q Consensus 452 y~~gg~L~~~l~~~~--~~~l~e~~~~~i~~Qil~aL~yLHs~~-----IiHRDLKP~NILl~~~~~~~iKL~DFGla~~ 524 (966)
|+++++|.+++.... ...+++..++.++.||+.||+|||++| |+||||||+|||++. ++.+||+|||++..
T Consensus 88 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~ivH~dl~p~NIl~~~--~~~~kl~dfg~~~~ 165 (279)
T 2w5a_A 88 YCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDG--KQNVKLGDFGLARI 165 (279)
T ss_dssp CCTTEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHC------CCCCCSGGGEEECS--SSCEEECCCCHHHH
T ss_pred CCCCCCHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcccCCCCeeEEeccchhhEEEcC--CCCEEEecCchhee
Confidence 999999999997532 235999999999999999999999999 999999999999974 56899999999976
Q ss_pred ccCCC---ccccccccccCchhhccCCCCCCCcccchhhhhhhhhhhhcCCCCCCCcCcchhHHHHHHHHhcCCCCCCCC
Q psy11767 525 KRESL---HTPCFTLQYAAPEVLRQDKSGYDENCDLWSLGVILVNVLRQDKSGYDENCDLWSLGVILYTMLCGRVPFHAR 601 (966)
Q Consensus 525 ~~~~~---~~~~gT~~Y~APEvl~~~~~~~~~~~Di~SlGvil~el~~~~~~~y~~~~DIWSlGvilyemltG~~Pf~~~ 601 (966)
..... ....+|+.|+|||++.. ..|+.++|||||||++|+|++|+.||...
T Consensus 166 ~~~~~~~~~~~~~~~~y~aPE~~~~--------------------------~~~~~~~Di~slG~il~~l~~g~~p~~~~ 219 (279)
T 2w5a_A 166 LNHDTSFAKTFVGTPYYMSPEQMNR--------------------------MSYNEKSDIWSLGCLLYELCALMPPFTAF 219 (279)
T ss_dssp C---CHHHHHHHSCCTTCCHHHHHC--------------------------C-CCHHHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred eccccccccccCCCccccChHHhcc--------------------------CCCCchhhHHHHHHHHHHHHHCCCCCccc
Confidence 54321 23468999999999852 23678899999999999999999999875
Q ss_pred CCchhHHHHHHHHHcCCCCCCchhhccCCHHHHHHHHHhcccCccccCChHHHH
Q psy11767 602 SRDDSALSIMARIKEGQFNFDAEAWSTVSSEAKELTKSLLTVNPAQRIRMMRVK 655 (966)
Q Consensus 602 ~~~~~~~~~~~~i~~~~~~~~~~~~~~is~e~~~Li~~~L~~dP~~R~t~~~v~ 655 (966)
.. ..+...+..+.+... ...+++++.++|.+||..||++|||+.++.
T Consensus 220 ~~----~~~~~~i~~~~~~~~---~~~~~~~l~~li~~~l~~~p~~Rps~~~ll 266 (279)
T 2w5a_A 220 SQ----KELAGKIREGKFRRI---PYRYSDELNEIITRMLNLKDYHRPSVEEIL 266 (279)
T ss_dssp SH----HHHHHHHHHTCCCCC---CTTSCHHHHHHHHHHTCSSGGGSCCHHHHH
T ss_pred CH----HHHHHHHhhcccccC---CcccCHHHHHHHHHHcCCCcccCCCHHHHH
Confidence 43 234455666654322 235789999999999999999999999874
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-38 Score=345.34 Aligned_cols=245 Identities=22% Similarity=0.401 Sum_probs=198.5
Q ss_pred ccccccccccccEEEEEEEcCCCcEEEEEEeccccC----hHHHHHHHHHhcCCCCceEEEEEEEeCCeEEEEEEccCCC
Q psy11767 381 DKAGILGDGSYSVCRRCVEKSTGQEYAVKIISRKID----CSEEINLLRACQGHPNIVNLHCVFQDEVHTYLVLELLKGG 456 (966)
Q Consensus 381 ~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~~----~~~Ei~iL~~l~~HpnIV~l~~~~~~~~~~~lVmEy~~gg 456 (966)
+..+.||+|+||.||+|.+. +++.||||++..... ..+|+++|+.+ +||||+++++++.+ ...|+||||++++
T Consensus 16 ~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~-~~~~~v~e~~~~~ 92 (279)
T 1qpc_A 16 KLVERLGAGQFGEVWMGYYN-GHTKVAVKSLKQGSMSPDAFLAEANLMKQL-QHQRLVRLYAVVTQ-EPIYIITEYMENG 92 (279)
T ss_dssp EEEEEEEEETTEEEEEEEET-TTEEEEEEEECTTSSCHHHHHHHHHHHHHC-CCTTBCCEEEEECS-SSCEEEEECCTTC
T ss_pred hheeeecCCCCeEEEEEEEc-CCcEEEEEEecCCcccHHHHHHHHHHHHhC-CCcCcceEEEEEcC-CCcEEEEecCCCC
Confidence 34688999999999999975 577899999975432 45799999998 59999999999864 4689999999999
Q ss_pred CHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCcEEEecCCCCCEEEEeecccccccCC----Cccc
Q psy11767 457 ELLDRIRQKGRCGFTENEASRIMRQLVAAVHFMHSRGVVHRDLKPENLLFSDPAGDNIKVVDFGFACLKRES----LHTP 532 (966)
Q Consensus 457 ~L~~~l~~~~~~~l~e~~~~~i~~Qil~aL~yLHs~~IiHRDLKP~NILl~~~~~~~iKL~DFGla~~~~~~----~~~~ 532 (966)
+|.+++.......+++.++..++.||+.||+|||++||+||||||+|||+++ ++.+||+|||++...... ....
T Consensus 93 ~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~Nil~~~--~~~~kl~Dfg~~~~~~~~~~~~~~~~ 170 (279)
T 1qpc_A 93 SLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHRDLRAANILVSD--TLSCKIADFGLARLIEDNEYTAREGA 170 (279)
T ss_dssp BHHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECT--TSCEEECCCTTCEECSSSCEECCTTC
T ss_pred CHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHhhEEEcC--CCCEEECCCcccccccCcccccccCC
Confidence 9999997543235899999999999999999999999999999999999974 568999999999765432 1233
Q ss_pred cccccccCchhhccCCCCCCCcccchhhhhhhhhhhhcCCCCCCCcCcchhHHHHHHHHhc-CCCCCCCCCCchhHHHHH
Q psy11767 533 CFTLQYAAPEVLRQDKSGYDENCDLWSLGVILVNVLRQDKSGYDENCDLWSLGVILYTMLC-GRVPFHARSRDDSALSIM 611 (966)
Q Consensus 533 ~gT~~Y~APEvl~~~~~~~~~~~Di~SlGvil~el~~~~~~~y~~~~DIWSlGvilyemlt-G~~Pf~~~~~~~~~~~~~ 611 (966)
.+|+.|+|||++... .|+.++|||||||++|+|++ |+.||.+.... ...
T Consensus 171 ~~~~~y~aPE~~~~~--------------------------~~~~~~Di~slG~il~el~~~g~~p~~~~~~~----~~~ 220 (279)
T 1qpc_A 171 KFPIKWTAPEAINYG--------------------------TFTIKSDVWSFGILLTEIVTHGRIPYPGMTNP----EVI 220 (279)
T ss_dssp CCCTTTSCHHHHHHC--------------------------EECHHHHHHHHHHHHHHHHTTTCCSSTTCCHH----HHH
T ss_pred CCccCccChhhhccC--------------------------CCCchhhhHHHHHHHHHHHhCCCCCCcccCHH----HHH
Confidence 467889999998532 36778999999999999999 99999875432 334
Q ss_pred HHHHcCCCCCCchhhccCCHHHHHHHHHhcccCccccCChHHHHHHhhhhHH
Q psy11767 612 ARIKEGQFNFDAEAWSTVSSEAKELTKSLLTVNPAQRIRMMRVKLTFHAFHQ 663 (966)
Q Consensus 612 ~~i~~~~~~~~~~~~~~is~e~~~Li~~~L~~dP~~R~t~~~v~~~~~~~~~ 663 (966)
..+..+.... ....+++++.+||.+||..||++|||+.++...+..+..
T Consensus 221 ~~~~~~~~~~---~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~ 269 (279)
T 1qpc_A 221 QNLERGYRMV---RPDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDFFT 269 (279)
T ss_dssp HHHHTTCCCC---CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred HHHhcccCCC---CcccccHHHHHHHHHHhccChhhCCCHHHHHHHHHHHHH
Confidence 4455442221 224678999999999999999999999998766665543
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9e-39 Score=360.47 Aligned_cols=247 Identities=27% Similarity=0.476 Sum_probs=192.8
Q ss_pred cccccccccccEEEEEEEcCCCcEEEEEEeccccC-------hHHHHHHHHHhcCCCCceEEEEEEEeCCe------EEE
Q psy11767 382 KAGILGDGSYSVCRRCVEKSTGQEYAVKIISRKID-------CSEEINLLRACQGHPNIVNLHCVFQDEVH------TYL 448 (966)
Q Consensus 382 ~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~~-------~~~Ei~iL~~l~~HpnIV~l~~~~~~~~~------~~l 448 (966)
..+.||+|+||.||+|.+..+|+.||||++..... ..+|+.+|+.+ +||||+++++++.+... .|+
T Consensus 28 ~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~~~~~~~l 106 (353)
T 3coi_A 28 SPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHM-QHENVIGLLDVFTPASSLRNFYDFYL 106 (353)
T ss_dssp EEEEEEECSSEEEEEEEETTTTEEEEEEEESSTTSSHHHHHHHHHHHHHHHHC-CCTTBCCCSEEECSCSSGGGCCCCEE
T ss_pred EeeeEecCCCeEEEEEEECCCCCEEEEEEecccccchHHHHHHHHHHHHHHhc-CCCCcccHhheEecccccccceeEEE
Confidence 36789999999999999999999999999965422 34699999988 59999999999987654 499
Q ss_pred EEEccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCcEEEecCCCCCEEEEeecccccccCC
Q psy11767 449 VLELLKGGELLDRIRQKGRCGFTENEASRIMRQLVAAVHFMHSRGVVHRDLKPENLLFSDPAGDNIKVVDFGFACLKRES 528 (966)
Q Consensus 449 VmEy~~gg~L~~~l~~~~~~~l~e~~~~~i~~Qil~aL~yLHs~~IiHRDLKP~NILl~~~~~~~iKL~DFGla~~~~~~ 528 (966)
||||+. ++|.+++.. .+++.+++.++.||+.||+|||++||+||||||+|||++. ++.+||+|||++......
T Consensus 107 v~e~~~-~~l~~~~~~----~~~~~~~~~i~~qi~~al~~LH~~~ivH~dlkp~NIl~~~--~~~~kl~Dfg~~~~~~~~ 179 (353)
T 3coi_A 107 VMPFMQ-TDLQKIMGL----KFSEEKIQYLVYQMLKGLKYIHSAGVVHRDLKPGNLAVNE--DCELKILDFGLARHADAE 179 (353)
T ss_dssp EEECCS-EEGGGTTTS----CCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCCGGGEEECT--TCCEEECSTTCTTC----
T ss_pred Eecccc-CCHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEeECC--CCcEEEeecccccCCCCC
Confidence 999996 688776632 4899999999999999999999999999999999999975 568999999999876655
Q ss_pred CccccccccccCchhhccCCCCCCCcccchhhhhhhhhhhhcCCCCCCCcCcchhHHHHHHHHhcCCCCCCCCCCchhHH
Q psy11767 529 LHTPCFTLQYAAPEVLRQDKSGYDENCDLWSLGVILVNVLRQDKSGYDENCDLWSLGVILYTMLCGRVPFHARSRDDSAL 608 (966)
Q Consensus 529 ~~~~~gT~~Y~APEvl~~~~~~~~~~~Di~SlGvil~el~~~~~~~y~~~~DIWSlGvilyemltG~~Pf~~~~~~~~~~ 608 (966)
....++|+.|+|||++.. ...|+.++|||||||++|+|++|+.||.+.+..+...
T Consensus 180 ~~~~~~t~~y~aPE~~~~-------------------------~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~ 234 (353)
T 3coi_A 180 MTGYVVTRWYRAPEVILS-------------------------WMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLT 234 (353)
T ss_dssp ----CCSBCCSCHHHHSC-------------------------CSCCCTTHHHHHHHHHHHHHHHSSCSSBSSCHHHHHH
T ss_pred ccccccCcCcCCHHHHhC-------------------------cCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHH
Confidence 556678999999998852 1347889999999999999999999998866433322
Q ss_pred HHHHHHHcC-----------------------CCCCCchhhccCCHHHHHHHHHhcccCccccCChHHHHHHhhhhHH
Q psy11767 609 SIMARIKEG-----------------------QFNFDAEAWSTVSSEAKELTKSLLTVNPAQRIRMMRVKLTFHAFHQ 663 (966)
Q Consensus 609 ~~~~~i~~~-----------------------~~~~~~~~~~~is~e~~~Li~~~L~~dP~~R~t~~~v~~~~~~~~~ 663 (966)
.+....... ........++.+++++.+||.+||..||++|||+.++ ..|+|+.
T Consensus 235 ~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~--l~hp~f~ 310 (353)
T 3coi_A 235 QILKVTGVPGTEFVQKLNDKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQA--LTHPFFE 310 (353)
T ss_dssp HHHHHHCBCCHHHHTTCSCHHHHHHHHTSCBCSSCCTTTTCTTSCHHHHHHHHHHSCSCTTTSCCHHHH--HTSGGGT
T ss_pred HHHHHhCCCCHHHHHHHhhHHHHHHHHhCcCCCCccHHHhcCCcCHHHHHHHHHHcCCCcccCCCHHHH--hcCcchh
Confidence 222211000 0000012234679999999999999999999999876 4567653
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-38 Score=354.92 Aligned_cols=246 Identities=28% Similarity=0.478 Sum_probs=179.1
Q ss_pred cccccccccccccEEEEEEEcCCCcEEEEEEecccc-----ChHHHHHHHHHhcCCCCceEEEEEEE--------eCCeE
Q psy11767 380 LDKAGILGDGSYSVCRRCVEKSTGQEYAVKIISRKI-----DCSEEINLLRACQGHPNIVNLHCVFQ--------DEVHT 446 (966)
Q Consensus 380 ~~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~-----~~~~Ei~iL~~l~~HpnIV~l~~~~~--------~~~~~ 446 (966)
|...+.||+|+||.||+|.+..+|+.||||++.... ...+|+.+|+.+.+||||+++++++. .....
T Consensus 30 y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~~~~~~~~ 109 (337)
T 3ll6_A 30 LRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRAIIQEVCFMKKLSGHPNIVQFCSAASIGKEESDTGQAEF 109 (337)
T ss_dssp EEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEESSHHHHHHHHHHHHHHHHHTTSTTBCCEEEEEEECTTTSTTSSEEE
T ss_pred EEEEEEEccCCceEEEEEEECCCCcEEEEEEecCCchHHHHHHHHHHHHHHHhccCCChhhccccccccccccccCCceE
Confidence 444789999999999999999999999999885432 24568999999877999999999994 34458
Q ss_pred EEEEEccCCCCHHHHHHhc-CCCCCCHHHHHHHHHHHHHHHHHHHhcC--ceeccCCCCcEEEecCCCCCEEEEeecccc
Q psy11767 447 YLVLELLKGGELLDRIRQK-GRCGFTENEASRIMRQLVAAVHFMHSRG--VVHRDLKPENLLFSDPAGDNIKVVDFGFAC 523 (966)
Q Consensus 447 ~lVmEy~~gg~L~~~l~~~-~~~~l~e~~~~~i~~Qil~aL~yLHs~~--IiHRDLKP~NILl~~~~~~~iKL~DFGla~ 523 (966)
++||||+. |+|.+++... ....+++.+++.++.||+.||+|||++| |+||||||+|||++. ++.+||+|||+++
T Consensus 110 ~lv~e~~~-g~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~ivH~Dikp~NIl~~~--~~~~kl~Dfg~~~ 186 (337)
T 3ll6_A 110 LLLTELCK-GQLVEFLKKMESRGPLSCDTVLKIFYQTCRAVQHMHRQKPPIIHRDLKVENLLLSN--QGTIKLCDFGSAT 186 (337)
T ss_dssp EEEEECCS-EEHHHHHHHHHTTCSCCHHHHHHHHHHHHHHHHHHHTSSSCCBCCCCCGGGCEECT--TSCEEBCCCTTCB
T ss_pred EEEEEecC-CCHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEEccCCcccEEECC--CCCEEEecCccce
Confidence 99999995 7999988652 2335999999999999999999999999 999999999999985 5689999999997
Q ss_pred cccCCC---------------ccccccccccCchhhccCCCCCCCcccchhhhhhhhhhhhcCCCCCCCcCcchhHHHHH
Q psy11767 524 LKRESL---------------HTPCFTLQYAAPEVLRQDKSGYDENCDLWSLGVILVNVLRQDKSGYDENCDLWSLGVIL 588 (966)
Q Consensus 524 ~~~~~~---------------~~~~gT~~Y~APEvl~~~~~~~~~~~Di~SlGvil~el~~~~~~~y~~~~DIWSlGvil 588 (966)
...... ...++|+.|+|||++... ....|+.++|||||||++
T Consensus 187 ~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~-----------------------~~~~~~~~~Dv~slG~il 243 (337)
T 3ll6_A 187 TISHYPDYSWSAQRRALVEEEITRNTTPMYRTPEIIDLY-----------------------SNFPIGEKQDIWALGCIL 243 (337)
T ss_dssp CCSSCC-------------------------------CC-----------------------TTSCSSHHHHHHHHHHHH
T ss_pred eccccCcccccccccccchhhccccCCCCcCChhhhhcc-----------------------ccCCCChHHhHHHHHHHH
Confidence 653211 144689999999988421 123468899999999999
Q ss_pred HHHhcCCCCCCCCCCchhHHHHHHHHHcCCCCCCchhhccCCHHHHHHHHHhcccCccccCChHHHHHHhhhh
Q psy11767 589 YTMLCGRVPFHARSRDDSALSIMARIKEGQFNFDAEAWSTVSSEAKELTKSLLTVNPAQRIRMMRVKLTFHAF 661 (966)
Q Consensus 589 yemltG~~Pf~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~is~e~~~Li~~~L~~dP~~R~t~~~v~~~~~~~ 661 (966)
|+|++|+.||...... .+..+.+... .....+.++.+||.+||+.||++|||+.++...+..+
T Consensus 244 ~el~~g~~p~~~~~~~--------~~~~~~~~~~--~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~l~~~ 306 (337)
T 3ll6_A 244 YLLCFRQHPFEDGAKL--------RIVNGKYSIP--PHDTQYTVFHSLIRAMLQVNPEERLSIAEVVHQLQEI 306 (337)
T ss_dssp HHHHHSSCCC--------------------CCCC--TTCCSSGGGHHHHHHHSCSSGGGSCCHHHHHHHHHHH
T ss_pred HHHHhCCCCCcchhHH--------HhhcCcccCC--cccccchHHHHHHHHHccCChhhCcCHHHHHHHHHHH
Confidence 9999999999754321 1222222222 2235677899999999999999999999886554433
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-39 Score=354.02 Aligned_cols=250 Identities=26% Similarity=0.463 Sum_probs=184.0
Q ss_pred cccccccccccEEEEEEEcCCCcEEEEEEecccc------ChHHHHHHHHHhcCCCCceEEEEEEEeCCeEEEEEEccCC
Q psy11767 382 KAGILGDGSYSVCRRCVEKSTGQEYAVKIISRKI------DCSEEINLLRACQGHPNIVNLHCVFQDEVHTYLVLELLKG 455 (966)
Q Consensus 382 ~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~------~~~~Ei~iL~~l~~HpnIV~l~~~~~~~~~~~lVmEy~~g 455 (966)
..+.||+|+||.||+|.+..+++.||||++.... ...+|+.+|+.+ .||||+++++++.++...|+||||++|
T Consensus 19 ~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~ 97 (303)
T 2vwi_A 19 LQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQC-HHPNIVSYYTSFVVKDELWLVMKLLSG 97 (303)
T ss_dssp EEEECC---CCCEEEEEC----CEEEEECCC----------------CCCCC-CCTTBCCEEEEEESSSCEEEEEECCTT
T ss_pred hhheeccccceEEEEEEECCCCcEEEEEEEEhhhcchhHHHHHHHHHHHhhc-CCCCEeeEEEEEeecCCcEEEehhccC
Confidence 3688999999999999999999999999986432 244688888777 599999999999999999999999999
Q ss_pred CCHHHHHHhc------CCCCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCcEEEecCCCCCEEEEeecccccccCC-
Q psy11767 456 GELLDRIRQK------GRCGFTENEASRIMRQLVAAVHFMHSRGVVHRDLKPENLLFSDPAGDNIKVVDFGFACLKRES- 528 (966)
Q Consensus 456 g~L~~~l~~~------~~~~l~e~~~~~i~~Qil~aL~yLHs~~IiHRDLKP~NILl~~~~~~~iKL~DFGla~~~~~~- 528 (966)
++|.+++... ....+++..++.++.||+.||+|||++||+||||||+|||++. ++.+||+|||++......
T Consensus 98 ~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~--~~~~kl~dfg~~~~~~~~~ 175 (303)
T 2vwi_A 98 GSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHKNGQIHRDVKAGNILLGE--DGSVQIADFGVSAFLATGG 175 (303)
T ss_dssp CBHHHHHHHHHHTTTTTTCSSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEECT--TCCEEECCCHHHHHCC---
T ss_pred CchHHHHHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCCCCChhhEEEcC--CCCEEEEeccchheeccCC
Confidence 9999998741 2235899999999999999999999999999999999999974 568999999998654321
Q ss_pred -------CccccccccccCchhhccCCCCCCCcccchhhhhhhhhhhhcCCCCCCCcCcchhHHHHHHHHhcCCCCCCCC
Q psy11767 529 -------LHTPCFTLQYAAPEVLRQDKSGYDENCDLWSLGVILVNVLRQDKSGYDENCDLWSLGVILYTMLCGRVPFHAR 601 (966)
Q Consensus 529 -------~~~~~gT~~Y~APEvl~~~~~~~~~~~Di~SlGvil~el~~~~~~~y~~~~DIWSlGvilyemltG~~Pf~~~ 601 (966)
.....+|+.|+|||++... ..++.++|||||||++|+|++|+.||...
T Consensus 176 ~~~~~~~~~~~~~~~~y~aPE~~~~~-------------------------~~~~~~~Di~slG~il~~l~~g~~pf~~~ 230 (303)
T 2vwi_A 176 DITRNKVRKTFVGTPCWMAPEVMEQV-------------------------RGYDFKADIWSFGITAIELATGAAPYHKY 230 (303)
T ss_dssp ------------CCCTTCCHHHHHHH-------------------------HCCCTHHHHHHHHHHHHHHHHSSCTTTTS
T ss_pred CccchhhhcccCCCccccCHHHhccc-------------------------cCCCchhhHHHHHHHHHHHHhCCCCCccC
Confidence 2345689999999988521 13678899999999999999999999876
Q ss_pred CCchhHHHHHHHHHcCCCCC-----CchhhccCCHHHHHHHHHhcccCccccCChHHHHHHhhhhHHh
Q psy11767 602 SRDDSALSIMARIKEGQFNF-----DAEAWSTVSSEAKELTKSLLTVNPAQRIRMMRVKLTFHAFHQA 664 (966)
Q Consensus 602 ~~~~~~~~~~~~i~~~~~~~-----~~~~~~~is~e~~~Li~~~L~~dP~~R~t~~~v~~~~~~~~~~ 664 (966)
...... ...+....... ..+....++.++.+||.+||..||.+|||+.++ ..|+|+..
T Consensus 231 ~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~l--l~h~~~~~ 293 (303)
T 2vwi_A 231 PPMKVL---MLTLQNDPPSLETGVQDKEMLKKYGKSFRKMISLCLQKDPEKRPTAAEL--LRHKFFQK 293 (303)
T ss_dssp CGGGHH---HHHHTSSCCCTTC-----CCCCCCCHHHHHHHHHHCCSSGGGSCCHHHH--HTSTTC--
T ss_pred chhhHH---HHHhccCCCccccccccchhhhhhhHHHHHHHHHHccCChhhCcCHHHH--hhChhhhc
Confidence 544322 12222211111 112234678999999999999999999999976 34666543
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} SCOP: d.144.1.7 PDB: 4fk3_A* 3c4c_A* 3c4d_A* 3idp_A* 4g9r_A* 3ii5_A* 4e26_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 3d4q_A* 4e4x_A* 4g9c_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-38 Score=348.33 Aligned_cols=243 Identities=23% Similarity=0.429 Sum_probs=186.1
Q ss_pred ccccccccccEEEEEEEcCCCcEEEEEEeccccC-------hHHHHHHHHHhcCCCCceEEEEEEEeCCeEEEEEEccCC
Q psy11767 383 AGILGDGSYSVCRRCVEKSTGQEYAVKIISRKID-------CSEEINLLRACQGHPNIVNLHCVFQDEVHTYLVLELLKG 455 (966)
Q Consensus 383 ~~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~~-------~~~Ei~iL~~l~~HpnIV~l~~~~~~~~~~~lVmEy~~g 455 (966)
.+.||+|+||.||+|.+.. .||||++..... ..+|+.+|+.+ +||||+++++++ .....++|||||++
T Consensus 29 ~~~lG~G~~g~Vy~~~~~~---~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~-~~~~~~lv~e~~~~ 103 (289)
T 3og7_A 29 GQRIGSGSFGTVYKGKWHG---DVAVKMLNVTAPTPQQLQAFKNEVGVLRKT-RHVNILLFMGYS-TAPQLAIVTQWCEG 103 (289)
T ss_dssp EEEEEECSSEEEEEEESSS---EEEEEEESCSSCCHHHHHHHHHHHHHHTTC-CCTTBCCEEEEE-CSSSCEEEEECCCE
T ss_pred eeEecCCCCeEEEEEEEcC---ceEEEEEeccCCCHHHHHHHHHHHHHHHhC-CCCcEEEEEeec-cCCccEEEEEecCC
Confidence 6789999999999998643 599999865432 35689999888 599999999955 55678999999999
Q ss_pred CCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCcEEEecCCCCCEEEEeecccccccC-----CCc
Q psy11767 456 GELLDRIRQKGRCGFTENEASRIMRQLVAAVHFMHSRGVVHRDLKPENLLFSDPAGDNIKVVDFGFACLKRE-----SLH 530 (966)
Q Consensus 456 g~L~~~l~~~~~~~l~e~~~~~i~~Qil~aL~yLHs~~IiHRDLKP~NILl~~~~~~~iKL~DFGla~~~~~-----~~~ 530 (966)
++|.+++.... ..+++.++..++.||+.||+|||++||+||||||+|||++. ++.+||+|||++..... ...
T Consensus 104 ~~L~~~l~~~~-~~~~~~~~~~i~~qi~~~L~~lH~~~i~H~Dlkp~Nil~~~--~~~~kl~Dfg~~~~~~~~~~~~~~~ 180 (289)
T 3og7_A 104 SSLYHHLHASE-TKFEMKKLIDIARQTARGMDYLHAKSIIHRDLKSNNIFLHE--DNTVKIGDFGLATEKSRWSGSHQFE 180 (289)
T ss_dssp EEHHHHHTTC----CCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEET--TTEEEECCCC---------------
T ss_pred CcHHHHHhhcc-CCCCHHHHHHHHHHHHHHHHHHHhCCcccccCccceEEECC--CCCEEEccceecccccccccccccc
Confidence 99999996544 36999999999999999999999999999999999999985 56899999999975432 223
Q ss_pred cccccccccCchhhccCCCCCCCcccchhhhhhhhhhhhcCCCCCCCcCcchhHHHHHHHHhcCCCCCCCCCCchhHHHH
Q psy11767 531 TPCFTLQYAAPEVLRQDKSGYDENCDLWSLGVILVNVLRQDKSGYDENCDLWSLGVILYTMLCGRVPFHARSRDDSALSI 610 (966)
Q Consensus 531 ~~~gT~~Y~APEvl~~~~~~~~~~~Di~SlGvil~el~~~~~~~y~~~~DIWSlGvilyemltG~~Pf~~~~~~~~~~~~ 610 (966)
...||+.|+|||++... ....|+.++|||||||++|+|++|+.||......+. +
T Consensus 181 ~~~gt~~y~aPE~~~~~-----------------------~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~---~ 234 (289)
T 3og7_A 181 QLSGSILWMAPEVIRMQ-----------------------DSNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQ---I 234 (289)
T ss_dssp ---CCCTTCCHHHHC---------------------------CCSCHHHHHHHHHHHHHHHHHSSCTTSSCCCHHH---H
T ss_pred ccCCCccccCchhhccc-----------------------CCCCCCcccchHHHHHHHHHHHHCCCCccccchHHH---H
Confidence 45689999999998521 123477899999999999999999999987655432 3
Q ss_pred HHHHHcCCCCCCc-hhhccCCHHHHHHHHHhcccCccccCChHHHHHHhh
Q psy11767 611 MARIKEGQFNFDA-EAWSTVSSEAKELTKSLLTVNPAQRIRMMRVKLTFH 659 (966)
Q Consensus 611 ~~~i~~~~~~~~~-~~~~~is~e~~~Li~~~L~~dP~~R~t~~~v~~~~~ 659 (966)
...+..+...... .....+++++.+||.+||..||++|||+.++...+.
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~ 284 (289)
T 3og7_A 235 IEMVGRGSLSPDLSKVRSNCPKRMKRLMAECLKKKRDERPSFPRILAEIE 284 (289)
T ss_dssp HHHHHHTSCCCCTTSSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred HHHhcccccCcchhhccccCCHHHHHHHHHHccCChhhCCCHHHHHHHHH
Confidence 3444444443322 223468899999999999999999999998755443
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-38 Score=352.43 Aligned_cols=244 Identities=19% Similarity=0.340 Sum_probs=194.1
Q ss_pred cccccccccccEEEEEE-----EcCCCcEEEEEEecccc------ChHHHHHHHHHhcCCCCceEEEEEEEeCCeEEEEE
Q psy11767 382 KAGILGDGSYSVCRRCV-----EKSTGQEYAVKIISRKI------DCSEEINLLRACQGHPNIVNLHCVFQDEVHTYLVL 450 (966)
Q Consensus 382 ~~~~LG~G~fG~Vy~a~-----~~~tg~~vAvK~i~~~~------~~~~Ei~iL~~l~~HpnIV~l~~~~~~~~~~~lVm 450 (966)
..+.||+|+||.||+|. +..+++.||||++.... ...+|+.+|+.+ +||||+++++++.+....|+||
T Consensus 34 ~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~ 112 (327)
T 2yfx_A 34 LIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKF-NHQNIVRCIGVSLQSLPRFILM 112 (327)
T ss_dssp EEEECC--CSSCEEEEEC--------CCEEEEEECCSSCCHHHHHHHHHHHHHHHHC-CCTTBCCEEEEECSSSSCEEEE
T ss_pred EEEEEcCCCCeeEEEEEEcCCCCCCccceEEEEEeccccchhhHHHHHHHHHHHhhC-CCCCCCeEEEEEcCCCCcEEEE
Confidence 36889999999999999 66788999999996442 244688999988 6999999999999999999999
Q ss_pred EccCCCCHHHHHHhcCC-----CCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCcEEEecCC-CCCEEEEeeccccc
Q psy11767 451 ELLKGGELLDRIRQKGR-----CGFTENEASRIMRQLVAAVHFMHSRGVVHRDLKPENLLFSDPA-GDNIKVVDFGFACL 524 (966)
Q Consensus 451 Ey~~gg~L~~~l~~~~~-----~~l~e~~~~~i~~Qil~aL~yLHs~~IiHRDLKP~NILl~~~~-~~~iKL~DFGla~~ 524 (966)
||++||+|.+++..... ..+++.+++.++.||+.||+|||++||+||||||+|||++... +..+||+|||++..
T Consensus 113 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~i~H~dlkp~NIli~~~~~~~~~kl~Dfg~~~~ 192 (327)
T 2yfx_A 113 ELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARD 192 (327)
T ss_dssp ECCTTEEHHHHHHHTSCCSSSTTSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESCSSTTCCEEECCCHHHHH
T ss_pred ecCCCCcHHHHHHhhcccccccccccHHHHHHHHHHHHHHHHHHhhCCeecCcCCHhHEEEecCCCcceEEECccccccc
Confidence 99999999999987542 3489999999999999999999999999999999999997422 34699999999964
Q ss_pred ccC-----CCccccccccccCchhhccCCCCCCCcccchhhhhhhhhhhhcCCCCCCCcCcchhHHHHHHHHhc-CCCCC
Q psy11767 525 KRE-----SLHTPCFTLQYAAPEVLRQDKSGYDENCDLWSLGVILVNVLRQDKSGYDENCDLWSLGVILYTMLC-GRVPF 598 (966)
Q Consensus 525 ~~~-----~~~~~~gT~~Y~APEvl~~~~~~~~~~~Di~SlGvil~el~~~~~~~y~~~~DIWSlGvilyemlt-G~~Pf 598 (966)
... ......+|+.|+|||++.. ..|+.++|||||||++|+|++ |..||
T Consensus 193 ~~~~~~~~~~~~~~~~~~y~aPE~~~~--------------------------~~~~~~~Di~slG~il~ellt~g~~p~ 246 (327)
T 2yfx_A 193 IYRASYYRKGGCAMLPVKWMPPEAFME--------------------------GIFTSKTDTWSFGVLLWEIFSLGYMPY 246 (327)
T ss_dssp HHC------CCGGGSCGGGCCHHHHHH--------------------------CCCCHHHHHHHHHHHHHHHHTTSCCSS
T ss_pred cccccccccCCCcCCCcceeCHhHhcC--------------------------CCCCchhhHHHHHHHHHHHHcCCCCCC
Confidence 322 1223457899999998853 236789999999999999998 99999
Q ss_pred CCCCCchhHHHHHHHHHcCCCCCCchhhccCCHHHHHHHHHhcccCccccCChHHHHHHhh
Q psy11767 599 HARSRDDSALSIMARIKEGQFNFDAEAWSTVSSEAKELTKSLLTVNPAQRIRMMRVKLTFH 659 (966)
Q Consensus 599 ~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~is~e~~~Li~~~L~~dP~~R~t~~~v~~~~~ 659 (966)
...... .+...+..+.... ....+++++.+||.+||..||.+||++.++...+.
T Consensus 247 ~~~~~~----~~~~~~~~~~~~~---~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~ 300 (327)
T 2yfx_A 247 PSKSNQ----EVLEFVTSGGRMD---PPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIE 300 (327)
T ss_dssp TTCCHH----HHHHHHHTTCCCC---CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred CCcCHH----HHHHHHhcCCCCC---CCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHH
Confidence 875432 3444555543221 22467899999999999999999999998855443
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-38 Score=353.10 Aligned_cols=241 Identities=20% Similarity=0.346 Sum_probs=197.7
Q ss_pred cccccccccccEEEEEEEc-----CCCcEEEEEEeccccC------hHHHHHHHHHhcCCCCceEEEEEEEeCCeEEEEE
Q psy11767 382 KAGILGDGSYSVCRRCVEK-----STGQEYAVKIISRKID------CSEEINLLRACQGHPNIVNLHCVFQDEVHTYLVL 450 (966)
Q Consensus 382 ~~~~LG~G~fG~Vy~a~~~-----~tg~~vAvK~i~~~~~------~~~Ei~iL~~l~~HpnIV~l~~~~~~~~~~~lVm 450 (966)
..+.||+|+||.||+|.+. .+++.||||++..... ..+|+.+|+.+ +||||+++++++.+....|+||
T Consensus 29 ~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~ 107 (322)
T 1p4o_A 29 MSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEF-NCHHVVRLLGVVSQGQPTLVIM 107 (322)
T ss_dssp EEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGC-CCTTBCCEEEEECSSSSCEEEE
T ss_pred eeeEeccCCceEEEeeeecCccCCCCceEEEEEecccccCHHHHHHHHHHHHHHHhc-CCCCEeeeEEEEccCCccEEEE
Confidence 3688999999999999987 4688999999975433 34688888888 5999999999999999999999
Q ss_pred EccCCCCHHHHHHhcC--------CCCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCcEEEecCCCCCEEEEeeccc
Q psy11767 451 ELLKGGELLDRIRQKG--------RCGFTENEASRIMRQLVAAVHFMHSRGVVHRDLKPENLLFSDPAGDNIKVVDFGFA 522 (966)
Q Consensus 451 Ey~~gg~L~~~l~~~~--------~~~l~e~~~~~i~~Qil~aL~yLHs~~IiHRDLKP~NILl~~~~~~~iKL~DFGla 522 (966)
||+++|+|.+++.... ...+++..+..++.||+.||+|||++||+||||||+|||++. ++.+||+|||++
T Consensus 108 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~NIli~~--~~~~kl~Dfg~~ 185 (322)
T 1p4o_A 108 ELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAE--DFTVKIGDFGMT 185 (322)
T ss_dssp ECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCSGGGEEECT--TCCEEECCTTCC
T ss_pred EeCCCCcHHHHHHHhchhhccCCCCCCcCHHHHHHHHHHHHHHHHHHHHCCCccCCCccceEEEcC--CCeEEECcCccc
Confidence 9999999999997632 135799999999999999999999999999999999999985 568999999999
Q ss_pred ccccCC-----CccccccccccCchhhccCCCCCCCcccchhhhhhhhhhhhcCCCCCCCcCcchhHHHHHHHHhc-CCC
Q psy11767 523 CLKRES-----LHTPCFTLQYAAPEVLRQDKSGYDENCDLWSLGVILVNVLRQDKSGYDENCDLWSLGVILYTMLC-GRV 596 (966)
Q Consensus 523 ~~~~~~-----~~~~~gT~~Y~APEvl~~~~~~~~~~~Di~SlGvil~el~~~~~~~y~~~~DIWSlGvilyemlt-G~~ 596 (966)
...... .....+|+.|+|||++.. ..|+.++|||||||++|+|++ |..
T Consensus 186 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~--------------------------~~~~~~~Di~slG~il~el~~~g~~ 239 (322)
T 1p4o_A 186 RDIYETDYYRKGGKGLLPVRWMSPESLKD--------------------------GVFTTYSDVWSFGVVLWEIATLAEQ 239 (322)
T ss_dssp CGGGGGGCEEGGGSSEECGGGCCHHHHHH--------------------------CCCCHHHHHHHHHHHHHHHHHTSCC
T ss_pred cccccccccccccCCCCCCCccChhhhcc--------------------------CCCCchhhHHHHHHHHHHHHhcCCC
Confidence 754321 123456889999999853 236788999999999999999 899
Q ss_pred CCCCCCCchhHHHHHHHHHcCCCCCCchhhccCCHHHHHHHHHhcccCccccCChHHHHHHh
Q psy11767 597 PFHARSRDDSALSIMARIKEGQFNFDAEAWSTVSSEAKELTKSLLTVNPAQRIRMMRVKLTF 658 (966)
Q Consensus 597 Pf~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~is~e~~~Li~~~L~~dP~~R~t~~~v~~~~ 658 (966)
||.+.... .....+..+.... ....++.++.+||.+||..||.+|||+.++...+
T Consensus 240 p~~~~~~~----~~~~~~~~~~~~~---~~~~~~~~l~~li~~~l~~dp~~Rps~~e~l~~L 294 (322)
T 1p4o_A 240 PYQGLSNE----QVLRFVMEGGLLD---KPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSI 294 (322)
T ss_dssp TTTTSCHH----HHHHHHHTTCCCC---CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred ccccCCHH----HHHHHHHcCCcCC---CCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHH
Confidence 99875432 3344555544322 2246789999999999999999999999875443
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.9e-39 Score=362.84 Aligned_cols=246 Identities=15% Similarity=0.250 Sum_probs=190.4
Q ss_pred cccccccccccccEEEEE-----EEcCCCcEEEEEEecccc--ChHHHHHHHHHhc--CCCCceEEEEEEEeCCeEEEEE
Q psy11767 380 LDKAGILGDGSYSVCRRC-----VEKSTGQEYAVKIISRKI--DCSEEINLLRACQ--GHPNIVNLHCVFQDEVHTYLVL 450 (966)
Q Consensus 380 ~~~~~~LG~G~fG~Vy~a-----~~~~tg~~vAvK~i~~~~--~~~~Ei~iL~~l~--~HpnIV~l~~~~~~~~~~~lVm 450 (966)
|...+.||+|+||+||+| .+..+++.||||++.... ....|+.+++.+. .|+||+++++++.+++..||||
T Consensus 67 y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~e~~~~~~l~~~~~~~iv~~~~~~~~~~~~~lv~ 146 (365)
T 3e7e_A 67 VYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQNGSVLVG 146 (365)
T ss_dssp EEEEEEEEECSSEEEEEEEC-------CCCCEEEEEESSCCHHHHHHHHHHHHHSCGGGGGGBCCEEEEEECSSCEEEEE
T ss_pred EEEEEEeeccCCEEEEEEEecCCcccccCcEEEEEEeCCCChhHHHHHHHHHHHhhhhhhhhhhhhheeeecCCCcEEEE
Confidence 334688999999999999 477889999999997543 2456778887764 2899999999999999999999
Q ss_pred EccCCCCHHHHHHhc---CCCCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCcEEEec---------CCCCCEEEEe
Q psy11767 451 ELLKGGELLDRIRQK---GRCGFTENEASRIMRQLVAAVHFMHSRGVVHRDLKPENLLFSD---------PAGDNIKVVD 518 (966)
Q Consensus 451 Ey~~gg~L~~~l~~~---~~~~l~e~~~~~i~~Qil~aL~yLHs~~IiHRDLKP~NILl~~---------~~~~~iKL~D 518 (966)
|||+||+|.+++... ....+++.+++.|+.||+.||+|||++|||||||||+|||++. ...+.+||+|
T Consensus 147 e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~ivHrDiKp~NIll~~~~~~~~~~~~~~~~~kl~D 226 (365)
T 3e7e_A 147 ELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALID 226 (365)
T ss_dssp CCCCSCBHHHHHHHHHTSTTCSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCSGGGEEECGGGTCC------CTTEEECC
T ss_pred eccCCCcHHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHhhCCeecCCCCHHHEEecccccCccccccccCCEEEee
Confidence 999999999999752 2336999999999999999999999999999999999999974 1146899999
Q ss_pred eccccccc-----CCCccccccccccCchhhccCCCCCCCcccchhhhhhhhhhhhcCCCCCCCcCcchhHHHHHHHHhc
Q psy11767 519 FGFACLKR-----ESLHTPCFTLQYAAPEVLRQDKSGYDENCDLWSLGVILVNVLRQDKSGYDENCDLWSLGVILYTMLC 593 (966)
Q Consensus 519 FGla~~~~-----~~~~~~~gT~~Y~APEvl~~~~~~~~~~~Di~SlGvil~el~~~~~~~y~~~~DIWSlGvilyemlt 593 (966)
||+|+... ......+||+.|+|||++.. ..|+.++|||||||++|+|++
T Consensus 227 FG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--------------------------~~~~~~~DiwslG~il~ellt 280 (365)
T 3e7e_A 227 LGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSN--------------------------KPWNYQIDYFGVAATVYCMLF 280 (365)
T ss_dssp CTTCEEGGGSCTTEEECCSSCTTSCCCHHHHTT--------------------------CCBSTHHHHHHHHHHHHHHHH
T ss_pred CchhhhhhccCCCceeeeecCCCCCCChHHhcC--------------------------CCCCccccHHHHHHHHHHHHh
Confidence 99996532 12345679999999999853 237889999999999999999
Q ss_pred CCCCCCCCCCchhHHHHHHHHHcCCCCCCchhhccCCHHHHHHHHHhcccCccccCC-hHHHHHHhhhhHH
Q psy11767 594 GRVPFHARSRDDSALSIMARIKEGQFNFDAEAWSTVSSEAKELTKSLLTVNPAQRIR-MMRVKLTFHAFHQ 663 (966)
Q Consensus 594 G~~Pf~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~is~e~~~Li~~~L~~dP~~R~t-~~~v~~~~~~~~~ 663 (966)
|+.||......... ....+ .. . ..++...+++.+||..+|.+|++ +.++...+..+..
T Consensus 281 g~~pf~~~~~~~~~-------~~~~~--~~-~--~~~~~~~~~~~~~l~~~p~~r~~~~~~l~~~l~~~l~ 339 (365)
T 3e7e_A 281 GTYMKVKNEGGECK-------PEGLF--RR-L--PHLDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKKVFQ 339 (365)
T ss_dssp SSCCCEEEETTEEE-------ECSCC--TT-C--SSHHHHHHHHHHHHCCCCTTCCCCHHHHHHHHHHHHH
T ss_pred CCCccccCCCCcee-------echhc--cc-c--CcHHHHHHHHHHHcCCCCCCcchHHHHHHHHHHHHHH
Confidence 99999654321100 00111 10 1 23567889999999999999964 5555555555543
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.8e-39 Score=359.65 Aligned_cols=255 Identities=21% Similarity=0.439 Sum_probs=207.2
Q ss_pred cceecccccccccccccccccccEEEEEEEcCCCcEEEEEEeccc----------------------cChHHHHHHHHHh
Q psy11767 370 SLFFEQYDMDLDKAGILGDGSYSVCRRCVEKSTGQEYAVKIISRK----------------------IDCSEEINLLRAC 427 (966)
Q Consensus 370 ~~~~~~~~i~~~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~----------------------~~~~~Ei~iL~~l 427 (966)
..+.++|.+ .+.||+|+||.||+|.+ +|+.||||++... ....+|+.+|+.+
T Consensus 27 ~~~~~~y~~----~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l 100 (348)
T 2pml_X 27 DKYINDYRI----IRTLNQGKFNKIILCEK--DNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIITDI 100 (348)
T ss_dssp CEEETTEEE----EEEEECCSSCCEEEEEE--TTEEEEEEEEEHHHHSSCEEECCCSSSSCCEEEHHHHHHHHHHHHTTC
T ss_pred ccccCceEE----EEEEcCCCCeEEEEEEc--CCceEEEEEeecccccchhhhccccchhhhHHhHHHHHHHHHHHHHhC
Confidence 344555555 68899999999999999 8999999998642 2345799999988
Q ss_pred cCCCCceEEEEEEEeCCeEEEEEEccCCCCHHHH------HHhcCCCCCCHHHHHHHHHHHHHHHHHHHh-cCceeccCC
Q psy11767 428 QGHPNIVNLHCVFQDEVHTYLVLELLKGGELLDR------IRQKGRCGFTENEASRIMRQLVAAVHFMHS-RGVVHRDLK 500 (966)
Q Consensus 428 ~~HpnIV~l~~~~~~~~~~~lVmEy~~gg~L~~~------l~~~~~~~l~e~~~~~i~~Qil~aL~yLHs-~~IiHRDLK 500 (966)
+||||+++++++.++...|+||||+++|+|.++ +.......+++..++.++.||+.||+|||+ +||+|||||
T Consensus 101 -~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~i~H~dl~ 179 (348)
T 2pml_X 101 -KNEYCLTCEGIITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFIPIQVIKCIIKSVLNSFSYIHNEKNICHRDVK 179 (348)
T ss_dssp -CCTTBCCCSEEEESSSEEEEEEECCTTCBSSEESSSEESSCSSSCCCCCHHHHHHHHHHHHHHHHHHHHTSCEECCCCC
T ss_pred -CCCCcceEEEEEeeCCeEEEEEeccCCCcHHHHHHHhhhhhhccccCCCHHHHHHHHHHHHHHHHHHhccCCEeecCCC
Confidence 599999999999999999999999999999988 655334579999999999999999999999 999999999
Q ss_pred CCcEEEecCCCCCEEEEeecccccccC-CCccccccccccCchhhccCCCCCCCcccchhhhhhhhhhhhcCCCCCCC-c
Q psy11767 501 PENLLFSDPAGDNIKVVDFGFACLKRE-SLHTPCFTLQYAAPEVLRQDKSGYDENCDLWSLGVILVNVLRQDKSGYDE-N 578 (966)
Q Consensus 501 P~NILl~~~~~~~iKL~DFGla~~~~~-~~~~~~gT~~Y~APEvl~~~~~~~~~~~Di~SlGvil~el~~~~~~~y~~-~ 578 (966)
|+|||++. ++.+||+|||++..... ......+|+.|+|||++... ..|+. +
T Consensus 180 p~Nil~~~--~~~~kl~dfg~~~~~~~~~~~~~~~~~~y~aPE~~~~~-------------------------~~~~~~~ 232 (348)
T 2pml_X 180 PSNILMDK--NGRVKLSDFGESEYMVDKKIKGSRGTYEFMPPEFFSNE-------------------------SSYNGAK 232 (348)
T ss_dssp GGGEEECT--TSCEEECCCTTCEECBTTEECSSCSCGGGCCGGGGSSC-------------------------CCEEHHH
T ss_pred hHhEEEcC--CCcEEEeccccccccccccccCCCCCcCccCchhhcCC-------------------------CCCCcch
Confidence 99999974 56899999999976433 33456789999999998532 13444 8
Q ss_pred CcchhHHHHHHHHhcCCCCCCCCCCchhHHHHHHHHHcCCCCCCch---------------hhccCCHHHHHHHHHhccc
Q psy11767 579 CDLWSLGVILYTMLCGRVPFHARSRDDSALSIMARIKEGQFNFDAE---------------AWSTVSSEAKELTKSLLTV 643 (966)
Q Consensus 579 ~DIWSlGvilyemltG~~Pf~~~~~~~~~~~~~~~i~~~~~~~~~~---------------~~~~is~e~~~Li~~~L~~ 643 (966)
+|||||||++|+|++|+.||...... ......+..+...++.. ....+++++.+||.+||..
T Consensus 233 ~Di~slG~il~~l~~g~~pf~~~~~~---~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~ 309 (348)
T 2pml_X 233 VDIWSLGICLYVMFYNVVPFSLKISL---VELFNNIRTKNIEYPLDRNHFLYPLTNKKSTCSNNFLSNEDIDFLKLFLRK 309 (348)
T ss_dssp HHHHHHHHHHHHHHHSSCSSCCSSCS---HHHHHHHTSCCCCCCCSSSSSTTTTCC--------CCCHHHHHHHHHHCCS
T ss_pred hhHHHHHHHHHHHHhCCCCCCCCCcH---HHHHHHHhccCcCCccchhhhhccccccccccchhhcCHHHHHHHHHHccC
Confidence 99999999999999999999876542 23455666665544321 1146899999999999999
Q ss_pred CccccCChHHHHHHhhhhHH
Q psy11767 644 NPAQRIRMMRVKLTFHAFHQ 663 (966)
Q Consensus 644 dP~~R~t~~~v~~~~~~~~~ 663 (966)
||.+|||+.++ ..|+|+.
T Consensus 310 dP~~Rps~~e~--l~hp~f~ 327 (348)
T 2pml_X 310 NPAERITSEDA--LKHEWLA 327 (348)
T ss_dssp SGGGSCCHHHH--HTSGGGT
T ss_pred ChhhCCCHHHH--hcCcccc
Confidence 99999999976 3467754
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-38 Score=352.72 Aligned_cols=244 Identities=20% Similarity=0.361 Sum_probs=193.3
Q ss_pred ccccccccccccEEEEEEEcCCC----cEEEEEEeccccC------hHHHHHHHHHhcCCCCceEEEEEEEeCCeEEEEE
Q psy11767 381 DKAGILGDGSYSVCRRCVEKSTG----QEYAVKIISRKID------CSEEINLLRACQGHPNIVNLHCVFQDEVHTYLVL 450 (966)
Q Consensus 381 ~~~~~LG~G~fG~Vy~a~~~~tg----~~vAvK~i~~~~~------~~~Ei~iL~~l~~HpnIV~l~~~~~~~~~~~lVm 450 (966)
...+.||+|+||.||+|.+..++ ..||||++..... ..+|+.+|+.+ +||||+++++++.+....|+||
T Consensus 47 ~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~ 125 (333)
T 1mqb_A 47 TRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQF-SHHNIIRLEGVISKYKPMMIIT 125 (333)
T ss_dssp EEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTC-CCTTBCCEEEEECSSSSEEEEE
T ss_pred hcccEEecCCCeEEEEEEEecCCCCccccEEEEEcCCCCCHHHHHHHHHHHHHHHhC-CCCCCCcEEEEEecCCCcEEEE
Confidence 34678999999999999987654 4699999975432 34688999888 5999999999999999999999
Q ss_pred EccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCcEEEecCCCCCEEEEeecccccccCCC-
Q psy11767 451 ELLKGGELLDRIRQKGRCGFTENEASRIMRQLVAAVHFMHSRGVVHRDLKPENLLFSDPAGDNIKVVDFGFACLKRESL- 529 (966)
Q Consensus 451 Ey~~gg~L~~~l~~~~~~~l~e~~~~~i~~Qil~aL~yLHs~~IiHRDLKP~NILl~~~~~~~iKL~DFGla~~~~~~~- 529 (966)
||+++|+|.+++..... .+++.+++.++.||+.||+|||++||+||||||+|||++. ++.+||+|||++.......
T Consensus 126 e~~~~~~L~~~l~~~~~-~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~--~~~~kl~Dfg~~~~~~~~~~ 202 (333)
T 1mqb_A 126 EYMENGALDKFLREKDG-EFSVLQLVGMLRGIAAGMKYLANMNYVHRDLAARNILVNS--NLVCKVSDFGLSRVLEDDPE 202 (333)
T ss_dssp ECCTTEEHHHHHHHTTT-CSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECT--TCCEEECCCCC---------
T ss_pred eCCCCCcHHHHHHhCCC-CCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChheEEECC--CCcEEECCCCcchhhccccc
Confidence 99999999999976533 6999999999999999999999999999999999999974 5699999999997653221
Q ss_pred -----ccccccccccCchhhccCCCCCCCcccchhhhhhhhhhhhcCCCCCCCcCcchhHHHHHHHHhc-CCCCCCCCCC
Q psy11767 530 -----HTPCFTLQYAAPEVLRQDKSGYDENCDLWSLGVILVNVLRQDKSGYDENCDLWSLGVILYTMLC-GRVPFHARSR 603 (966)
Q Consensus 530 -----~~~~gT~~Y~APEvl~~~~~~~~~~~Di~SlGvil~el~~~~~~~y~~~~DIWSlGvilyemlt-G~~Pf~~~~~ 603 (966)
....+|+.|+|||++.. ..|+.++|||||||++|+|++ |+.||.....
T Consensus 203 ~~~~~~~~~~~~~y~aPE~~~~--------------------------~~~~~~~Di~slG~il~ellt~g~~pf~~~~~ 256 (333)
T 1mqb_A 203 ATYTTSGGKIPIRWTAPEAISY--------------------------RKFTSASDVWSFGIVMWEVMTYGERPYWELSN 256 (333)
T ss_dssp --------CCCGGGSCHHHHHS--------------------------CCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCH
T ss_pred cccccCCCCccccccCchhccc--------------------------CCCCchhhhHHHHHHHHHHHcCCCCCcccCCH
Confidence 12345788999999852 236788999999999999998 9999986543
Q ss_pred chhHHHHHHHHHcCCCCCCchhhccCCHHHHHHHHHhcccCccccCChHHHHHHhhhh
Q psy11767 604 DDSALSIMARIKEGQFNFDAEAWSTVSSEAKELTKSLLTVNPAQRIRMMRVKLTFHAF 661 (966)
Q Consensus 604 ~~~~~~~~~~i~~~~~~~~~~~~~~is~e~~~Li~~~L~~dP~~R~t~~~v~~~~~~~ 661 (966)
. .++..+..+.... ....+++++.+||.+||..||++||++.++...+...
T Consensus 257 ~----~~~~~~~~~~~~~---~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~~ 307 (333)
T 1mqb_A 257 H----EVMKAINDGFRLP---TPMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKL 307 (333)
T ss_dssp H----HHHHHHHTTCCCC---CCTTCBHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHH
T ss_pred H----HHHHHHHCCCcCC---CcccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence 2 3445555543211 2236789999999999999999999999886555443
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} PDB: 3uib_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.8e-39 Score=361.30 Aligned_cols=250 Identities=26% Similarity=0.427 Sum_probs=189.7
Q ss_pred cccccccccccEEEEEEEcCCCcEEEEEEecccc----------------ChHHHHHHHHHhcCCCCceEEEEEEEe---
Q psy11767 382 KAGILGDGSYSVCRRCVEKSTGQEYAVKIISRKI----------------DCSEEINLLRACQGHPNIVNLHCVFQD--- 442 (966)
Q Consensus 382 ~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~----------------~~~~Ei~iL~~l~~HpnIV~l~~~~~~--- 442 (966)
..+.||+|+||.||+|.+.. |+.||||++.... ...+|+.+|+.+ +||||++++++|..
T Consensus 26 ~~~~lg~G~~g~V~~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~ 103 (362)
T 3pg1_A 26 VQRFISSGSYGAVCAGVDSE-GIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHF-HHPNILGLRDIFVHFEE 103 (362)
T ss_dssp EEEEEEEETTEEEEEEECTT-SCEEEEEEECEECCTTSCEEGGGSHHHHHHHHHHHHHHHHC-CCTTBCCCSEEEEECCT
T ss_pred EeEEeccCCCEEEEEEECCC-CCeEEEEeccccCCccchhhhhhhhhHHHHHHHHHHHHHhC-CCcCccceeeeEEeccC
Confidence 36899999999999999865 9999999985421 245799999998 59999999999854
Q ss_pred --CCeEEEEEEccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCcEEEecCCCCCEEEEeec
Q psy11767 443 --EVHTYLVLELLKGGELLDRIRQKGRCGFTENEASRIMRQLVAAVHFMHSRGVVHRDLKPENLLFSDPAGDNIKVVDFG 520 (966)
Q Consensus 443 --~~~~~lVmEy~~gg~L~~~l~~~~~~~l~e~~~~~i~~Qil~aL~yLHs~~IiHRDLKP~NILl~~~~~~~iKL~DFG 520 (966)
....|+||||+. |+|.+.+.... ..+++..++.++.||+.||+|||++||+||||||+|||++. ++.+||+|||
T Consensus 104 ~~~~~~~lv~e~~~-~~l~~~~~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~NIl~~~--~~~~kl~Dfg 179 (362)
T 3pg1_A 104 PAMHKLYLVTELMR-TDLAQVIHDQR-IVISPQHIQYFMYHILLGLHVLHEAGVVHRDLHPGNILLAD--NNDITICDFN 179 (362)
T ss_dssp TTCCEEEEEEECCS-EEHHHHHHCTT-SCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECT--TCCEEECCTT
T ss_pred CCcceEEEEEccCC-CCHHHHHHhcc-cCCCHHHHHHHHHHHHHHHHHHHHCcCEecCCChHHEEEcC--CCCEEEEecC
Confidence 346899999997 68988887653 36999999999999999999999999999999999999974 5689999999
Q ss_pred ccccccC--CCccccccccccCchhhccCCCCCCCcccchhhhhhhhhhhhcCCCCCCCcCcchhHHHHHHHHhcCCCCC
Q psy11767 521 FACLKRE--SLHTPCFTLQYAAPEVLRQDKSGYDENCDLWSLGVILVNVLRQDKSGYDENCDLWSLGVILYTMLCGRVPF 598 (966)
Q Consensus 521 la~~~~~--~~~~~~gT~~Y~APEvl~~~~~~~~~~~Di~SlGvil~el~~~~~~~y~~~~DIWSlGvilyemltG~~Pf 598 (966)
++..... .....++|+.|+|||++.. ...|+.++|||||||++|+|++|+.||
T Consensus 180 ~~~~~~~~~~~~~~~~t~~y~aPE~~~~-------------------------~~~~~~~~DiwslG~il~~l~~g~~pf 234 (362)
T 3pg1_A 180 LAREDTADANKTHYVTHRWYRAPELVMQ-------------------------FKGFTKLVDMWSAGCVMAEMFNRKALF 234 (362)
T ss_dssp C---------------CGGGCCHHHHTT-------------------------CTTCCTHHHHHHHHHHHHHHHHSSCSC
T ss_pred cccccccccccceecccceecCcHHhcC-------------------------CCCCCcHhHHHhHHHHHHHHHhCCCCC
Confidence 9975432 2334578999999998852 134788999999999999999999999
Q ss_pred CCCCCchhHHHHHHHHHcC--------------------CCCCCc----hhhccCCHHHHHHHHHhcccCccccCChHHH
Q psy11767 599 HARSRDDSALSIMARIKEG--------------------QFNFDA----EAWSTVSSEAKELTKSLLTVNPAQRIRMMRV 654 (966)
Q Consensus 599 ~~~~~~~~~~~~~~~i~~~--------------------~~~~~~----~~~~~is~e~~~Li~~~L~~dP~~R~t~~~v 654 (966)
.+....+....+....... ...... ...+.+++++.+||.+||+.||++|||+.++
T Consensus 235 ~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~el 314 (362)
T 3pg1_A 235 RGSTFYNQLNKIVEVVGTPKIEDVVMFSSPSARDYLRNSLSNVPARAWTAVVPTADPVALDLIAKMLEFNPQRRISTEQA 314 (362)
T ss_dssp CCSSHHHHHHHHHHHHCCCCHHHHHHTSCHHHHHHTTTCCCCCCCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCHHHH
T ss_pred CCCCHHHHHHHHHHHcCCCChHHhhhccchhhhHHHHhhcccCChhhHHhhCCCCCHHHHHHHHHHhcCChhhCCCHHHH
Confidence 8765443333222211110 001111 1224568899999999999999999999976
Q ss_pred HHHhhhhHHh
Q psy11767 655 KLTFHAFHQA 664 (966)
Q Consensus 655 ~~~~~~~~~~ 664 (966)
..|+|++.
T Consensus 315 --l~hp~f~~ 322 (362)
T 3pg1_A 315 --LRHPYFES 322 (362)
T ss_dssp --HTSGGGTT
T ss_pred --HcCchhhh
Confidence 45777654
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-38 Score=369.68 Aligned_cols=251 Identities=26% Similarity=0.381 Sum_probs=191.2
Q ss_pred ccccccccccccccEEEEEEEcCCCcEEEEEEecccc--ChHHHHHHHHHhcCCCCceEEEEEEEeCCeEEEEEEccCCC
Q psy11767 379 DLDKAGILGDGSYSVCRRCVEKSTGQEYAVKIISRKI--DCSEEINLLRACQGHPNIVNLHCVFQDEVHTYLVLELLKGG 456 (966)
Q Consensus 379 ~~~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~--~~~~Ei~iL~~l~~HpnIV~l~~~~~~~~~~~lVmEy~~gg 456 (966)
.|...++||+|+||+||. ....+|+.||||++.... ...+|+.+|+.+.+|||||++++++.+....|||||||. |
T Consensus 25 ~y~~~~~LG~G~~G~V~~-~~~~~~~~vAvK~~~~~~~~~~~~E~~~l~~l~~HpnIv~l~~~~~~~~~~~lv~E~~~-g 102 (432)
T 3p23_A 25 SFCPKDVLGHGAEGTIVY-RGMFDNRDVAVKRILPECFSFADREVQLLRESDEHPNVIRYFCTEKDRQFQYIAIELCA-A 102 (432)
T ss_dssp EEEEEEEEEECGGGCEEE-EEESSSSEEEEEEECTTTEEECHHHHHHHHHSCCCTTBCCEEEEEEETTEEEEEEECCS-E
T ss_pred EEecCCeeecCcCEEEEE-EEEeCCeEEEEEEECHHHHHHHHHHHHHHHhccCCCCcCeEEEEEecCCEEEEEEECCC-C
Confidence 345568899999999764 455789999999986542 367899999998779999999999999999999999995 6
Q ss_pred CHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCcEEEecC---CCCCEEEEeecccccccC------
Q psy11767 457 ELLDRIRQKGRCGFTENEASRIMRQLVAAVHFMHSRGVVHRDLKPENLLFSDP---AGDNIKVVDFGFACLKRE------ 527 (966)
Q Consensus 457 ~L~~~l~~~~~~~l~e~~~~~i~~Qil~aL~yLHs~~IiHRDLKP~NILl~~~---~~~~iKL~DFGla~~~~~------ 527 (966)
+|.+++..... .+++.++..++.||+.||+|||++||+||||||+|||++.. ....+||+|||+|+....
T Consensus 103 ~L~~~l~~~~~-~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlKp~NIll~~~~~~~~~~~kL~DFG~a~~~~~~~~~~~ 181 (432)
T 3p23_A 103 TLQEYVEQKDF-AHLGLEPITLLQQTTSGLAHLHSLNIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGRHSFS 181 (432)
T ss_dssp EHHHHHHSSSC-CCCSSCHHHHHHHHHHHHHHHHHTTCCCCCCSTTSEEECCCBTTTBCCEEECCTTEEECC--------
T ss_pred CHHHHHHhcCC-CccchhHHHHHHHHHHHHHHHHHCcCEeCCCCHHHEEEecCCCCCceeEEEecccceeeccCCCccee
Confidence 99999976543 46666788999999999999999999999999999999532 233688999999976542
Q ss_pred CCccccccccccCchhhccCCCCCCCcccchhhhhhhhhhhhcCCCCCCCcCcchhHHHHHHHHhc-CCCCCCCCCCchh
Q psy11767 528 SLHTPCFTLQYAAPEVLRQDKSGYDENCDLWSLGVILVNVLRQDKSGYDENCDLWSLGVILYTMLC-GRVPFHARSRDDS 606 (966)
Q Consensus 528 ~~~~~~gT~~Y~APEvl~~~~~~~~~~~Di~SlGvil~el~~~~~~~y~~~~DIWSlGvilyemlt-G~~Pf~~~~~~~~ 606 (966)
.....+||+.|+|||++.... ...++.++|||||||++|+|++ |..||.......
T Consensus 182 ~~~~~~gt~~y~APE~l~~~~-----------------------~~~~t~~~DiwSlG~il~ellt~g~~pf~~~~~~~- 237 (432)
T 3p23_A 182 RRSGVPGTEGWIAPEMLSEDC-----------------------KENPTYTVDIFSAGCVFYYVISEGSHPFGKSLQRQ- 237 (432)
T ss_dssp ----CCSCTTSCCGGGTSCC--------------------------CCCTHHHHHHHHHHHHHHHTTSCBTTBSTTTHH-
T ss_pred eccccCCCcCccChhhhhccc-----------------------ccCCCcHHHHHHHHHHHHHHHcCCCCCcchhhHHH-
Confidence 223467899999999985321 2346778999999999999999 999996543321
Q ss_pred HHHHHHHHHcCCCCCCc-hhhccCCHHHHHHHHHhcccCccccCChHHHHHHhhhhHH
Q psy11767 607 ALSIMARIKEGQFNFDA-EAWSTVSSEAKELTKSLLTVNPAQRIRMMRVKLTFHAFHQ 663 (966)
Q Consensus 607 ~~~~~~~i~~~~~~~~~-~~~~~is~e~~~Li~~~L~~dP~~R~t~~~v~~~~~~~~~ 663 (966)
.. +..+...... ......+..+++||.+||+.||++|||+.++ ..|+|+.
T Consensus 238 ----~~-~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~ev--l~hp~f~ 288 (432)
T 3p23_A 238 ----AN-ILLGACSLDCLHPEKHEDVIARELIEKMIAMDPQKRPSAKHV--LKHPFFW 288 (432)
T ss_dssp ----HH-HHTTCCCCTTSCTTCHHHHHHHHHHHHHSCSSGGGSCCHHHH--HTSTTTC
T ss_pred ----HH-HHhccCCccccCccccccHHHHHHHHHHHhCCHhhCCCHHHH--HhCcccc
Confidence 11 1112111111 1112346678999999999999999999976 4566653
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-38 Score=346.02 Aligned_cols=239 Identities=21% Similarity=0.385 Sum_probs=193.8
Q ss_pred ccccccccEEEEEE--EcCCCcEEEEEEecccc-------ChHHHHHHHHHhcCCCCceEEEEEEEeCCeEEEEEEccCC
Q psy11767 385 ILGDGSYSVCRRCV--EKSTGQEYAVKIISRKI-------DCSEEINLLRACQGHPNIVNLHCVFQDEVHTYLVLELLKG 455 (966)
Q Consensus 385 ~LG~G~fG~Vy~a~--~~~tg~~vAvK~i~~~~-------~~~~Ei~iL~~l~~HpnIV~l~~~~~~~~~~~lVmEy~~g 455 (966)
.||+|+||.||+|. +..+++.||||++.... ...+|+.+|+.+ +||||+++++++ .....|+||||+++
T Consensus 24 ~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~-~~~~~~lv~e~~~~ 101 (291)
T 1xbb_A 24 ELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQL-DNPYIVRMIGIC-EAESWMLVMEMAEL 101 (291)
T ss_dssp EEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTC-CCTTBCCEEEEE-ESSSEEEEEECCTT
T ss_pred ccccccCeeeEeeeecCCCceeeEEEEeecccccCHHHHHHHHHHHHHHHhC-CCCCEEEEEEEE-CCCCcEEEEEeCCC
Confidence 89999999999995 45678999999997542 244699999988 599999999999 55678999999999
Q ss_pred CCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCcEEEecCCCCCEEEEeecccccccCC------C
Q psy11767 456 GELLDRIRQKGRCGFTENEASRIMRQLVAAVHFMHSRGVVHRDLKPENLLFSDPAGDNIKVVDFGFACLKRES------L 529 (966)
Q Consensus 456 g~L~~~l~~~~~~~l~e~~~~~i~~Qil~aL~yLHs~~IiHRDLKP~NILl~~~~~~~iKL~DFGla~~~~~~------~ 529 (966)
++|.+++.... .+++.+++.++.||+.||+|||++||+||||||+|||++. ++.+||+|||++...... .
T Consensus 102 ~~L~~~l~~~~--~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dikp~Nil~~~--~~~~kl~Dfg~~~~~~~~~~~~~~~ 177 (291)
T 1xbb_A 102 GPLNKYLQQNR--HVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVT--QHYAKISDFGLSKALRADENYYKAQ 177 (291)
T ss_dssp EEHHHHHHHCT--TCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEE--TTEEEECCCTTCEECCTTCSEEEC-
T ss_pred CCHHHHHHhCc--CCCHHHHHHHHHHHHHHHHHHHhCCeEcCCCCcceEEEeC--CCcEEEccCCcceeeccCCCccccc
Confidence 99999998754 5999999999999999999999999999999999999985 568999999999765322 1
Q ss_pred ccccccccccCchhhccCCCCCCCcccchhhhhhhhhhhhcCCCCCCCcCcchhHHHHHHHHhc-CCCCCCCCCCchhHH
Q psy11767 530 HTPCFTLQYAAPEVLRQDKSGYDENCDLWSLGVILVNVLRQDKSGYDENCDLWSLGVILYTMLC-GRVPFHARSRDDSAL 608 (966)
Q Consensus 530 ~~~~gT~~Y~APEvl~~~~~~~~~~~Di~SlGvil~el~~~~~~~y~~~~DIWSlGvilyemlt-G~~Pf~~~~~~~~~~ 608 (966)
....+|+.|+|||++... .++.++|||||||++|+|++ |+.||.+....
T Consensus 178 ~~~~~~~~y~aPE~~~~~--------------------------~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~---- 227 (291)
T 1xbb_A 178 THGKWPVKWYAPECINYY--------------------------KFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGS---- 227 (291)
T ss_dssp ---CCCGGGCCHHHHHHC--------------------------EEEHHHHHHHHHHHHHHHHTTTCCSSTTCCHH----
T ss_pred ccCCCCceeeChHHhccC--------------------------CCChhhhHHHHHHHHHHHHhcCCCCCCCCCHH----
Confidence 223457889999998532 25678999999999999999 99999875532
Q ss_pred HHHHHHHcCCCCCCchhhccCCHHHHHHHHHhcccCccccCChHHHHHHhhhhH
Q psy11767 609 SIMARIKEGQFNFDAEAWSTVSSEAKELTKSLLTVNPAQRIRMMRVKLTFHAFH 662 (966)
Q Consensus 609 ~~~~~i~~~~~~~~~~~~~~is~e~~~Li~~~L~~dP~~R~t~~~v~~~~~~~~ 662 (966)
.+...+..+... .....+++++.++|.+||..||++||++.++...+..++
T Consensus 228 ~~~~~~~~~~~~---~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~ 278 (291)
T 1xbb_A 228 EVTAMLEKGERM---GCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYY 278 (291)
T ss_dssp HHHHHHHTTCCC---CCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHH
T ss_pred HHHHHHHcCCCC---CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHH
Confidence 334445544322 122467999999999999999999999999876666554
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-38 Score=372.27 Aligned_cols=243 Identities=20% Similarity=0.352 Sum_probs=195.0
Q ss_pred cccccccccccEEEEEEEcCCCcEEEEEEecccc----ChHHHHHHHHHhcCCCCceEEEEEEEeCCeEEEEEEccCCCC
Q psy11767 382 KAGILGDGSYSVCRRCVEKSTGQEYAVKIISRKI----DCSEEINLLRACQGHPNIVNLHCVFQDEVHTYLVLELLKGGE 457 (966)
Q Consensus 382 ~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~----~~~~Ei~iL~~l~~HpnIV~l~~~~~~~~~~~lVmEy~~gg~ 457 (966)
..+.||+|+||.||+|.+.. +..||||++.... ...+|+.+|+.+ +|||||++++++.+ ...|||||||++|+
T Consensus 188 ~~~~lG~G~fg~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~E~~~l~~l-~hp~iv~~~~~~~~-~~~~iv~e~~~~gs 264 (452)
T 1fmk_A 188 LEVKLGQGCFGEVWMGTWNG-TTRVAIKTLKPGTMSPEAFLQEAQVMKKL-RHEKLVQLYAVVSE-EPIYIVTEYMSKGS 264 (452)
T ss_dssp EEEEEEECSSCEEEEEEETT-TEEEEEEECCTTSSCHHHHHHHHHHHHHC-CCTTBCCEEEEECS-SSCEEEECCCTTCB
T ss_pred eeeeecCCCCeEEEEEEECC-CceEEEEEeccCCCCHHHHHHHHHHHHhC-CCCCEeeEEEEEcC-CceEEEehhhcCCC
Confidence 35789999999999999875 4679999997543 246799999998 59999999999876 67899999999999
Q ss_pred HHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCcEEEecCCCCCEEEEeecccccccCC----Ccccc
Q psy11767 458 LLDRIRQKGRCGFTENEASRIMRQLVAAVHFMHSRGVVHRDLKPENLLFSDPAGDNIKVVDFGFACLKRES----LHTPC 533 (966)
Q Consensus 458 L~~~l~~~~~~~l~e~~~~~i~~Qil~aL~yLHs~~IiHRDLKP~NILl~~~~~~~iKL~DFGla~~~~~~----~~~~~ 533 (966)
|.+++.......+++.++..++.||+.||+|||++||+||||||+|||++. ++.+||+|||+++..... .....
T Consensus 265 L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~Nill~~--~~~~kl~DfG~a~~~~~~~~~~~~~~~ 342 (452)
T 1fmk_A 265 LLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGE--NLVCKVADFGLARLIEDNEYTARQGAK 342 (452)
T ss_dssp HHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECG--GGCEEECCCCTTC--------------
T ss_pred HHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChhhEEECC--CCCEEECCCccceecCCCceecccCCc
Confidence 999997643335899999999999999999999999999999999999975 568999999999765432 12334
Q ss_pred ccccccCchhhccCCCCCCCcccchhhhhhhhhhhhcCCCCCCCcCcchhHHHHHHHHhc-CCCCCCCCCCchhHHHHHH
Q psy11767 534 FTLQYAAPEVLRQDKSGYDENCDLWSLGVILVNVLRQDKSGYDENCDLWSLGVILYTMLC-GRVPFHARSRDDSALSIMA 612 (966)
Q Consensus 534 gT~~Y~APEvl~~~~~~~~~~~Di~SlGvil~el~~~~~~~y~~~~DIWSlGvilyemlt-G~~Pf~~~~~~~~~~~~~~ 612 (966)
+|+.|+|||++... .|+.++|||||||++|||++ |+.||.+.... .++.
T Consensus 343 ~~~~y~aPE~~~~~--------------------------~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~----~~~~ 392 (452)
T 1fmk_A 343 FPIKWTAPEAALYG--------------------------RFTIKSDVWSFGILLTELTTKGRVPYPGMVNR----EVLD 392 (452)
T ss_dssp CCGGGSCHHHHHHC--------------------------CCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHH----HHHH
T ss_pred ccccccCHhHHhcC--------------------------CCCccccHHhHHHHHHHHHhCCCCCCCCCCHH----HHHH
Confidence 67889999988532 37889999999999999999 99999876532 3445
Q ss_pred HHHcCCCCCCchhhccCCHHHHHHHHHhcccCccccCChHHHHHHhhhhH
Q psy11767 613 RIKEGQFNFDAEAWSTVSSEAKELTKSLLTVNPAQRIRMMRVKLTFHAFH 662 (966)
Q Consensus 613 ~i~~~~~~~~~~~~~~is~e~~~Li~~~L~~dP~~R~t~~~v~~~~~~~~ 662 (966)
.+..+... .....+++++.+||.+||..||++|||+.++...+..+.
T Consensus 393 ~i~~~~~~---~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~l~~~L~~~~ 439 (452)
T 1fmk_A 393 QVERGYRM---PCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYF 439 (452)
T ss_dssp HHHTTCCC---CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTTT
T ss_pred HHHcCCCC---CCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHh
Confidence 55554321 122467899999999999999999999998866655443
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3ulz_A* 3tl8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.2e-39 Score=356.47 Aligned_cols=249 Identities=20% Similarity=0.300 Sum_probs=192.3
Q ss_pred cccccccccccccEEEEEEEcCCCcEEEEEEecccc------ChHHHHHHHHHhcCCCCceEEEEEEEeCCeEEEEEEcc
Q psy11767 380 LDKAGILGDGSYSVCRRCVEKSTGQEYAVKIISRKI------DCSEEINLLRACQGHPNIVNLHCVFQDEVHTYLVLELL 453 (966)
Q Consensus 380 ~~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~------~~~~Ei~iL~~l~~HpnIV~l~~~~~~~~~~~lVmEy~ 453 (966)
|...+.||+|+||.||+|.+. +|+.||||++.... ...+|+++|+.+ .||||+++++++.+....++||||+
T Consensus 32 y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~e~~ 109 (326)
T 3uim_A 32 FSNKNILGRGGFGKVYKGRLA-DGTLVAVKRLKEERTQGGELQFQTEVEMISMA-VHRNLLRLRGFCMTPTERLLVYPYM 109 (326)
T ss_dssp SCSTTEEECCSSSEEEEECCS-SSCCEEEEECCC-----CCCHHHHHHHGGGTC-CCTTBCCCCEEECCSSCCEEEEECC
T ss_pred cccceeEecCCCcEEEEEEec-CCCEEEEEEeccccCchHHHHHHHHHHHHHhc-cCCCccceEEEEecCCceEEEEEec
Confidence 344689999999999999854 68999999986532 246799999887 5999999999999999999999999
Q ss_pred CCCCHHHHHHhcCC--CCCCHHHHHHHHHHHHHHHHHHHhc---CceeccCCCCcEEEecCCCCCEEEEeecccccccCC
Q psy11767 454 KGGELLDRIRQKGR--CGFTENEASRIMRQLVAAVHFMHSR---GVVHRDLKPENLLFSDPAGDNIKVVDFGFACLKRES 528 (966)
Q Consensus 454 ~gg~L~~~l~~~~~--~~l~e~~~~~i~~Qil~aL~yLHs~---~IiHRDLKP~NILl~~~~~~~iKL~DFGla~~~~~~ 528 (966)
++|+|.+++..... ..+++..+..++.||+.||+|||++ ||+||||||+|||+++ ++.+||+|||++......
T Consensus 110 ~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nil~~~--~~~~kl~Dfg~~~~~~~~ 187 (326)
T 3uim_A 110 ANGSVASCLRERPESQPPLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDE--EFEAVVGDFGLAKLMDYK 187 (326)
T ss_dssp TTCBHHHHHHCCSTTCCCCCHHHHHHHHHHHHHHHHHHHHSSSSCEECCCCSGGGEEECT--TCCEEECCCSSCEECCSS
T ss_pred cCCCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCchhhEEECC--CCCEEeccCccccccCcc
Confidence 99999999986542 2499999999999999999999999 9999999999999985 568999999999765322
Q ss_pred ----CccccccccccCchhhccCCCCCCCcccchhhhhhhhhhhhcCCCCCCCcCcchhHHHHHHHHhcCCCCCCCC---
Q psy11767 529 ----LHTPCFTLQYAAPEVLRQDKSGYDENCDLWSLGVILVNVLRQDKSGYDENCDLWSLGVILYTMLCGRVPFHAR--- 601 (966)
Q Consensus 529 ----~~~~~gT~~Y~APEvl~~~~~~~~~~~Di~SlGvil~el~~~~~~~y~~~~DIWSlGvilyemltG~~Pf~~~--- 601 (966)
.....||+.|+|||++... .|+.++|||||||++|+|++|+.||...
T Consensus 188 ~~~~~~~~~gt~~y~aPE~~~~~--------------------------~~~~~~Di~slG~il~~l~~g~~pf~~~~~~ 241 (326)
T 3uim_A 188 DTHVTTAVRGTIGHIAPEYLSTG--------------------------KSSEKTDVFGYGVMLLELITGQRAFDLARLA 241 (326)
T ss_dssp SSCEECCCCSCGGGCCHHHHHHS--------------------------EECHHHHHHHHHHHHHHHHHCCCSBCHHHHT
T ss_pred cccccccccCCcCccCHHHhccC--------------------------CCCccccchhHHHHHHHHHhCCCcccccccc
Confidence 2334589999999998532 2678899999999999999999999621
Q ss_pred -CCchhHHHHHHHHH-cCCC------CCCchhhccCCHHHHHHHHHhcccCccccCChHHHHHHh
Q psy11767 602 -SRDDSALSIMARIK-EGQF------NFDAEAWSTVSSEAKELTKSLLTVNPAQRIRMMRVKLTF 658 (966)
Q Consensus 602 -~~~~~~~~~~~~i~-~~~~------~~~~~~~~~is~e~~~Li~~~L~~dP~~R~t~~~v~~~~ 658 (966)
.............. .... ..........+.++.+++.+||+.||.+|||+.++...+
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L 306 (326)
T 3uim_A 242 NDDDVMLLDWVKGLLKEKKLEALVDVDLQGNYKDEEVEQLIQVALLCTQSSPMERPKMSEVVRML 306 (326)
T ss_dssp TTSCSBHHHHHTTTTSSCCSTTSSCTTCTTSCCHHHHHHHHHHHHHHTCSCGGGSCCHHHHHHHH
T ss_pred cccchhHHHHHHHHhhchhhhhhcChhhccccCHHHHHHHHHHHHHHhCcCCccCCCHHHHHHHh
Confidence 11111111111110 1100 001111223457899999999999999999999885444
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 4deg_A* 4deh_A* 4dei_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 4aoi_A* 4ap7_A* 3q6w_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-38 Score=344.79 Aligned_cols=245 Identities=21% Similarity=0.331 Sum_probs=193.3
Q ss_pred cccccccccccccEEEEEEEcCC---CcEEEEEEeccccC------hHHHHHHHHHhcCCCCceEEEEEE-EeCCeEEEE
Q psy11767 380 LDKAGILGDGSYSVCRRCVEKST---GQEYAVKIISRKID------CSEEINLLRACQGHPNIVNLHCVF-QDEVHTYLV 449 (966)
Q Consensus 380 ~~~~~~LG~G~fG~Vy~a~~~~t---g~~vAvK~i~~~~~------~~~Ei~iL~~l~~HpnIV~l~~~~-~~~~~~~lV 449 (966)
|+..+.||+|+||.||+|.+..+ +..||+|.+..... ..+|+.+|+.+ +||||+++++++ ..+...|+|
T Consensus 27 y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~~~v 105 (298)
T 3f66_A 27 VHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDF-SHPNVLSLLGICLRSEGSPLVV 105 (298)
T ss_dssp EEEEEEEEEETTEEEEEEEEC-----CEEEEEEEETTCCSHHHHHHHHHHHHHHHTC-CCTTBCCCCEEECCSSSCCEEE
T ss_pred hhhcceeeecCCceEEEEEEecCCCceeEEEEEecccCCCHHHHHHHHHHHHHHHhC-CCCCEeeeeeEEEcCCCceEEE
Confidence 44468899999999999997654 34689999875433 34689999988 599999999985 456688999
Q ss_pred EEccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCcEEEecCCCCCEEEEeecccccccCC-
Q psy11767 450 LELLKGGELLDRIRQKGRCGFTENEASRIMRQLVAAVHFMHSRGVVHRDLKPENLLFSDPAGDNIKVVDFGFACLKRES- 528 (966)
Q Consensus 450 mEy~~gg~L~~~l~~~~~~~l~e~~~~~i~~Qil~aL~yLHs~~IiHRDLKP~NILl~~~~~~~iKL~DFGla~~~~~~- 528 (966)
|||+++|+|.+++.... ..+++.++..++.||+.||+|||++||+||||||+|||+++ ++.+||+|||+++.....
T Consensus 106 ~e~~~~~~L~~~l~~~~-~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~dikp~Nil~~~--~~~~kl~Dfg~a~~~~~~~ 182 (298)
T 3f66_A 106 LPYMKHGDLRNFIRNET-HNPTVKDLIGFGLQVAKGMKYLASKKFVHRDLAARNCMLDE--KFTVKVADFGLARDMYDKE 182 (298)
T ss_dssp EECCTTCBHHHHHHCTT-CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECT--TCCEEECSCGGGCCCSCGG
T ss_pred EeCCCCCCHHHHHHhcc-cCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCchheEEECC--CCCEEECcccccccccccc
Confidence 99999999999997644 36899999999999999999999999999999999999974 569999999999754321
Q ss_pred ------CccccccccccCchhhccCCCCCCCcccchhhhhhhhhhhhcCCCCCCCcCcchhHHHHHHHHhc-CCCCCCCC
Q psy11767 529 ------LHTPCFTLQYAAPEVLRQDKSGYDENCDLWSLGVILVNVLRQDKSGYDENCDLWSLGVILYTMLC-GRVPFHAR 601 (966)
Q Consensus 529 ------~~~~~gT~~Y~APEvl~~~~~~~~~~~Di~SlGvil~el~~~~~~~y~~~~DIWSlGvilyemlt-G~~Pf~~~ 601 (966)
.....+|+.|+|||++.. ..|+.++|||||||++|+|++ |.+||...
T Consensus 183 ~~~~~~~~~~~~~~~y~aPE~~~~--------------------------~~~~~~~Di~slG~il~~l~~~~~~~~~~~ 236 (298)
T 3f66_A 183 YYSVHNKTGAKLPVKWMALESLQT--------------------------QKFTTKSDVWSFGVLLWELMTRGAPPYPDV 236 (298)
T ss_dssp GCBC-----CCBCGGGSCHHHHHH--------------------------CCCCHHHHHHHHHHHHHHHHTTSCCSSTTS
T ss_pred hhccccccCCCCCccccChHHhcC--------------------------CCCChHHHHHHHHHHHHHHHhCCCCCCccC
Confidence 223456889999999853 236788999999999999999 66777665
Q ss_pred CCchhHHHHHHHHHcCCCCCCchhhccCCHHHHHHHHHhcccCccccCChHHHHHHhhhh
Q psy11767 602 SRDDSALSIMARIKEGQFNFDAEAWSTVSSEAKELTKSLLTVNPAQRIRMMRVKLTFHAF 661 (966)
Q Consensus 602 ~~~~~~~~~~~~i~~~~~~~~~~~~~~is~e~~~Li~~~L~~dP~~R~t~~~v~~~~~~~ 661 (966)
...+ ....+..+.....+ ..+++++.++|.+||..||++|||+.++...+..+
T Consensus 237 ~~~~----~~~~~~~~~~~~~~---~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~ 289 (298)
T 3f66_A 237 NTFD----ITVYLLQGRRLLQP---EYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAI 289 (298)
T ss_dssp CTTT----HHHHHHTTCCCCCC---TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred CHHH----HHHHHhcCCCCCCC---ccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence 5433 23334444433222 35788999999999999999999999886655544
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-38 Score=346.44 Aligned_cols=245 Identities=23% Similarity=0.367 Sum_probs=195.1
Q ss_pred ccccccccccEEEEEEEcCCCcEEEEEEecccc---------ChHHHHHHHHHhcCCCCceEEEEEEEeCCeEEEEEEcc
Q psy11767 383 AGILGDGSYSVCRRCVEKSTGQEYAVKIISRKI---------DCSEEINLLRACQGHPNIVNLHCVFQDEVHTYLVLELL 453 (966)
Q Consensus 383 ~~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~---------~~~~Ei~iL~~l~~HpnIV~l~~~~~~~~~~~lVmEy~ 453 (966)
.+.||+|+||.||+|.+ +++.||||++.... ...+|+.+|+.+ +||||+++++++.+....|+||||+
T Consensus 36 ~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~ 112 (307)
T 2nru_A 36 GNKMGEGGFGVVYKGYV--NNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKC-QHENLVELLGFSSDGDDLCLVYVYM 112 (307)
T ss_dssp CCEEEECSSEEEEEEES--SSCEEEEEEECCCTTSCTTTHHHHHHHHHHHHHHC-CCTTBCCEEEEECSSSSCEEEEECC
T ss_pred CCccccCCCeEEEEEEE--CCceEEEEEEecccCcchHHHHHHHHHHHHHHHhc-CCCCeEEEEEEEecCCceEEEEEec
Confidence 46899999999999986 68899999986432 144699999998 5999999999999999999999999
Q ss_pred CCCCHHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCcEEEecCCCCCEEEEeecccccccCC----
Q psy11767 454 KGGELLDRIRQKG-RCGFTENEASRIMRQLVAAVHFMHSRGVVHRDLKPENLLFSDPAGDNIKVVDFGFACLKRES---- 528 (966)
Q Consensus 454 ~gg~L~~~l~~~~-~~~l~e~~~~~i~~Qil~aL~yLHs~~IiHRDLKP~NILl~~~~~~~iKL~DFGla~~~~~~---- 528 (966)
++|+|.+++.... ...+++..++.++.||+.||+|||++||+||||||+|||++. ++.+||+|||++......
T Consensus 113 ~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dlkp~Nili~~--~~~~kl~Dfg~~~~~~~~~~~~ 190 (307)
T 2nru_A 113 PNGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFLHENHHIHRDIKSANILLDE--AFTAKISDFGLARASEKFAQTV 190 (307)
T ss_dssp TTCBHHHHHHTGGGCCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECT--TCCEEECCCTTCEECCSCSSCE
T ss_pred CCCcHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhcCCeecCCCCHHHEEEcC--CCcEEEeecccccccccccccc
Confidence 9999999997532 235999999999999999999999999999999999999974 569999999999764432
Q ss_pred -CccccccccccCchhhccCCCCCCCcccchhhhhhhhhhhhcCCCCCCCcCcchhHHHHHHHHhcCCCCCCCCCCchhH
Q psy11767 529 -LHTPCFTLQYAAPEVLRQDKSGYDENCDLWSLGVILVNVLRQDKSGYDENCDLWSLGVILYTMLCGRVPFHARSRDDSA 607 (966)
Q Consensus 529 -~~~~~gT~~Y~APEvl~~~~~~~~~~~Di~SlGvil~el~~~~~~~y~~~~DIWSlGvilyemltG~~Pf~~~~~~~~~ 607 (966)
.....||+.|+|||++.. .++.++|||||||++|+|++|.+||.........
T Consensus 191 ~~~~~~g~~~y~aPE~~~~---------------------------~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~ 243 (307)
T 2nru_A 191 MTSRIVGTTAYMAPEALRG---------------------------EITPKSDIYSFGVVLLEIITGLPAVDEHREPQLL 243 (307)
T ss_dssp ECSSCCSCGGGCCHHHHTT---------------------------EECTHHHHHHHHHHHHHHHHCCCSBCTTBSSSBT
T ss_pred cccccCCCcCcCChHHhcC---------------------------CCCccchhHHHHHHHHHHHHCCCCcccCcchHHH
Confidence 223568999999998742 2577899999999999999999999876544333
Q ss_pred HHHHHHHHcCCCCCC-------chhhccCCHHHHHHHHHhcccCccccCChHHHHHHhh
Q psy11767 608 LSIMARIKEGQFNFD-------AEAWSTVSSEAKELTKSLLTVNPAQRIRMMRVKLTFH 659 (966)
Q Consensus 608 ~~~~~~i~~~~~~~~-------~~~~~~is~e~~~Li~~~L~~dP~~R~t~~~v~~~~~ 659 (966)
..+...+......+. .......+.++.+++.+||..||.+|||+.++...+.
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~l~~~L~ 302 (307)
T 2nru_A 244 LDIKEEIEDEEKTIEDYIDKKMNDADSTSVEAMYSVASQCLHEKKNKRPDIKKVQQLLQ 302 (307)
T ss_dssp THHHHHHHTTSCCHHHHSCSSCSCCCHHHHHHHHHHHHHHTCSSTTTSCCHHHHHHHHH
T ss_pred HHHHHHhhhhhhhhhhhccccccccchHHHHHHHHHHHHHcCCCcccCcCHHHHHHHHH
Confidence 333333333221110 1111234678899999999999999999998855443
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-38 Score=353.32 Aligned_cols=249 Identities=26% Similarity=0.408 Sum_probs=191.9
Q ss_pred cccccccccccccEEEEEEEcCCCcEEEEEEecccc-----ChHHHHHHHHHhcCCCCceEEEEEEEe----CCeEEEEE
Q psy11767 380 LDKAGILGDGSYSVCRRCVEKSTGQEYAVKIISRKI-----DCSEEINLLRACQGHPNIVNLHCVFQD----EVHTYLVL 450 (966)
Q Consensus 380 ~~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~-----~~~~Ei~iL~~l~~HpnIV~l~~~~~~----~~~~~lVm 450 (966)
|+..+.||+|+||.||+|.+..+|+.||||++.... ...+|+.+++.+ +||||+++++++.. ....|+||
T Consensus 31 y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~~~~~lv~ 109 (317)
T 2buj_A 31 YLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCHEQQDREEAQREADMHRLF-NHPNILRLVAYCLRERGAKHEAWLLL 109 (317)
T ss_dssp EEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEESSHHHHHHHHHHHHHHHTC-CCTTBCCCCEEEEEEETTEEEEEEEE
T ss_pred EEEEEEecCCCCeEEEEEEecCCCcEEEEEEEecCCHHHHHHHHHHHHHHhhc-CCCCeeeEEEEEEeccCCCceeEEEE
Confidence 344789999999999999999999999999985432 245799999888 69999999999873 34789999
Q ss_pred EccCCCCHHHHHHhc--CCCCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCcEEEecCCCCCEEEEeecccccccCC
Q psy11767 451 ELLKGGELLDRIRQK--GRCGFTENEASRIMRQLVAAVHFMHSRGVVHRDLKPENLLFSDPAGDNIKVVDFGFACLKRES 528 (966)
Q Consensus 451 Ey~~gg~L~~~l~~~--~~~~l~e~~~~~i~~Qil~aL~yLHs~~IiHRDLKP~NILl~~~~~~~iKL~DFGla~~~~~~ 528 (966)
||+++|+|.+++... ....+++.+++.++.||+.||+|||++||+||||||+|||++. .+.+||+|||++......
T Consensus 110 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~dlkp~NIl~~~--~~~~kl~dfg~~~~~~~~ 187 (317)
T 2buj_A 110 PFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIHAKGYAHRDLKPTNILLGD--EGQPVLMDLGSMNQACIH 187 (317)
T ss_dssp ECCTTCBHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECT--TSCEEECCCSSCEESCEE
T ss_pred EeCCCCcHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEcC--CCCEEEEecCcchhcccc
Confidence 999999999999763 2236999999999999999999999999999999999999974 568999999998654311
Q ss_pred C------------ccccccccccCchhhccCCCCCCCcccchhhhhhhhhhhhcCCCCCCCcCcchhHHHHHHHHhcCCC
Q psy11767 529 L------------HTPCFTLQYAAPEVLRQDKSGYDENCDLWSLGVILVNVLRQDKSGYDENCDLWSLGVILYTMLCGRV 596 (966)
Q Consensus 529 ~------------~~~~gT~~Y~APEvl~~~~~~~~~~~Di~SlGvil~el~~~~~~~y~~~~DIWSlGvilyemltG~~ 596 (966)
. ....||+.|+|||++.... ...|+.++|||||||++|+|++|+.
T Consensus 188 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-----------------------~~~~~~~~Di~slG~il~el~~g~~ 244 (317)
T 2buj_A 188 VEGSRQALTLQDWAAQRCTISYRAPELFSVQS-----------------------HCVIDERTDVWSLGCVLYAMMFGEG 244 (317)
T ss_dssp EESHHHHHHHHHHHHHHSCGGGCCGGGSSCCS-----------------------EEEECTHHHHHHHHHHHHHHHHSSC
T ss_pred cccccccccccccccccCCcccCCHhHhccCC-----------------------CcCCCchhhHHHHHHHHHHHHhCCC
Confidence 0 1234699999999885321 1125788999999999999999999
Q ss_pred CCCCCCCchhHHHHHHHHHcCCCCCCchhhccCCHHHHHHHHHhcccCccccCChHHHHHHhh
Q psy11767 597 PFHARSRDDSALSIMARIKEGQFNFDAEAWSTVSSEAKELTKSLLTVNPAQRIRMMRVKLTFH 659 (966)
Q Consensus 597 Pf~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~is~e~~~Li~~~L~~dP~~R~t~~~v~~~~~ 659 (966)
||........ .....+.. ...++ ....+++++.+||.+||..||.+|||+.++...+.
T Consensus 245 p~~~~~~~~~--~~~~~~~~-~~~~~--~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~ 302 (317)
T 2buj_A 245 PYDMVFQKGD--SVALAVQN-QLSIP--QSPRHSSALWQLLNSMMTVDPHQRPHIPLLLSQLE 302 (317)
T ss_dssp TTHHHHHTTS--CHHHHHHC-C--CC--CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred Chhhhhcccc--hhhHHhhc-cCCCC--ccccCCHHHHHHHHHHhhcChhhCCCHHHHHHHhh
Confidence 9964211100 01112222 22222 22467899999999999999999999998855443
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 4hvd_A* 4hvg_A* 4hvh_A* 4hvi_A* 3pjc_A* 1yvj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-38 Score=352.25 Aligned_cols=246 Identities=25% Similarity=0.348 Sum_probs=196.6
Q ss_pred ccccccccccccEEEEEE----EcCCCcEEEEEEecccc-----ChHHHHHHHHHhcCCCCceEEEEEEE--eCCeEEEE
Q psy11767 381 DKAGILGDGSYSVCRRCV----EKSTGQEYAVKIISRKI-----DCSEEINLLRACQGHPNIVNLHCVFQ--DEVHTYLV 449 (966)
Q Consensus 381 ~~~~~LG~G~fG~Vy~a~----~~~tg~~vAvK~i~~~~-----~~~~Ei~iL~~l~~HpnIV~l~~~~~--~~~~~~lV 449 (966)
+..+.||+|+||.||+|+ +..+++.||||++.... ...+|+++|+.+ +||||+++++++. +....|+|
T Consensus 26 ~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~~~~~~~~lv 104 (327)
T 3lxl_A 26 KYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKAL-HSDFIVKYRGVSYGPGRQSLRLV 104 (327)
T ss_dssp EEEEEEEEETTEEEEEEEECTTSSSCSEEEEEEEESSCCHHHHHHHHHHHHHHHTC-CCTTBCCEEEEEECSSSCEEEEE
T ss_pred hhhhhccCCCCeEEEEEEeccCCCCcceEEEEEEeccCCHHHHHHHHHHHHHHHhc-CCCceeEEEEEEecCCCceEEEE
Confidence 346899999999999999 56789999999997543 245799999998 6999999999987 45678999
Q ss_pred EEccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCcEEEecCCCCCEEEEeecccccccCC-
Q psy11767 450 LELLKGGELLDRIRQKGRCGFTENEASRIMRQLVAAVHFMHSRGVVHRDLKPENLLFSDPAGDNIKVVDFGFACLKRES- 528 (966)
Q Consensus 450 mEy~~gg~L~~~l~~~~~~~l~e~~~~~i~~Qil~aL~yLHs~~IiHRDLKP~NILl~~~~~~~iKL~DFGla~~~~~~- 528 (966)
|||+++++|.+++..... .+++..++.++.||+.||+|||++||+||||||+|||++. ++.+||+|||++......
T Consensus 105 ~e~~~~~~L~~~l~~~~~-~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dikp~NIl~~~--~~~~kl~Dfg~~~~~~~~~ 181 (327)
T 3lxl_A 105 MEYLPSGCLRDFLQRHRA-RLDASRLLLYSSQICKGMEYLGSRRCVHRDLAARNILVES--EAHVKIADFGLAKLLPLDK 181 (327)
T ss_dssp EECCTTCBHHHHHHHHGG-GCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEE--TTEEEECCGGGCEECCTTC
T ss_pred EeecCCCCHHHHHHhccc-CCCHHHHHHHHHHHHHHHHHHHhCCccCCCCChhhEEECC--CCCEEEcccccceecccCC
Confidence 999999999999987433 5899999999999999999999999999999999999985 568999999999765322
Q ss_pred -----CccccccccccCchhhccCCCCCCCcccchhhhhhhhhhhhcCCCCCCCcCcchhHHHHHHHHhcCCCCCCCCCC
Q psy11767 529 -----LHTPCFTLQYAAPEVLRQDKSGYDENCDLWSLGVILVNVLRQDKSGYDENCDLWSLGVILYTMLCGRVPFHARSR 603 (966)
Q Consensus 529 -----~~~~~gT~~Y~APEvl~~~~~~~~~~~Di~SlGvil~el~~~~~~~y~~~~DIWSlGvilyemltG~~Pf~~~~~ 603 (966)
.....+|+.|+|||++... .|+.++|||||||++|+|++|+.||.....
T Consensus 182 ~~~~~~~~~~~~~~y~aPE~~~~~--------------------------~~~~~~Di~slG~il~~ll~g~~p~~~~~~ 235 (327)
T 3lxl_A 182 DYYVVREPGQSPIFWYAPESLSDN--------------------------IFSRQSDVWSFGVVLYELFTYCDKSCSPSA 235 (327)
T ss_dssp SEEECSSCCCSCGGGSCHHHHHHC--------------------------EEEHHHHHHHHHHHHHHHHTTTCGGGSHHH
T ss_pred ccceeeccCCccccccCHHHhccC--------------------------CCChHHhHHHHHHHHHHHHhCCCCCccccc
Confidence 1234578889999998532 257789999999999999999999975321
Q ss_pred c-----------hhHHHHHHHHHcCCCCCCchhhccCCHHHHHHHHHhcccCccccCChHHHHHHhh
Q psy11767 604 D-----------DSALSIMARIKEGQFNFDAEAWSTVSSEAKELTKSLLTVNPAQRIRMMRVKLTFH 659 (966)
Q Consensus 604 ~-----------~~~~~~~~~i~~~~~~~~~~~~~~is~e~~~Li~~~L~~dP~~R~t~~~v~~~~~ 659 (966)
. .....+...+..+... .....+++++.+||.+||+.||++|||+.++...+.
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~ 299 (327)
T 3lxl_A 236 EFLRMMGCERDVPALSRLLELLEEGQRL---PAPPACPAEVHELMKLCWAPSPQDRPSFSALGPQLD 299 (327)
T ss_dssp HHHHHCC----CCHHHHHHHHHHTTCCC---CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred hhhhhcccccccccHHHHHHHhhcccCC---CCCCcccHHHHHHHHHHcCCChhhCcCHHHHHHHHH
Confidence 1 0111222333333211 123468999999999999999999999998854443
|
| >3v5w_A G-protein coupled receptor kinase 2; inhibitor complex, protein kinase, beta propeller, RGS homol domain; HET: 8PR; 2.07A {Homo sapiens} PDB: 3cik_A* 3krw_A* 3krx_A* 1omw_A 1ym7_A 2bcj_A* 3uzs_A 3uzt_A 3pvu_A* 3psc_A* 3pvw_A* 1bak_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-38 Score=382.69 Aligned_cols=224 Identities=25% Similarity=0.390 Sum_probs=188.2
Q ss_pred CcceeeeecccccceEEEEEEcCCCCEEEEEeccccc--------hhhHHHHHHHHhh--CCCcccccc-----------
Q psy11767 117 DLDKAGILGDGSYSVCRRCVEKSTGQEYAVKIISRKI--------DCSEEINLLRACQ--GHPNICRRC----------- 175 (966)
Q Consensus 117 df~~~~~LG~GsFGkV~La~~k~tg~~yAiKvl~K~~--------~~~~E~~il~~~~--~~pfi~~~~----------- 175 (966)
||+++++||+|+||+|++|+++.||+.||||+|+|.. ...+|+.+|..+. +|||||+.+
T Consensus 190 df~i~k~LG~G~fG~V~la~~~~tg~~~AiK~i~K~~i~~~~~~~~~~~E~~~l~ll~~~~HP~IV~l~~~f~~~~~lyl 269 (689)
T 3v5w_A 190 DFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSF 269 (689)
T ss_dssp GEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSEEEE
T ss_pred HeEEEEEEecccCeEEEEEEECCCCCEEEEEEEeHHHcchhhhHHHHHHHHHHHHHHhhCCCCCEeEEEEEEEECCEEEE
Confidence 9999999999999999999999999999999998752 3567777776543 799998733
Q ss_pred -------------------cccccchhHHHHHHHh----------hcccchhhhHhhhccCCceEEecCccc--------
Q psy11767 176 -------------------VEKSTGQEYAVKIISR----------KIDCSEEINLLRACQGHPNIVNLHCVF-------- 218 (966)
Q Consensus 176 -------------------~~~~~~~~~~~~~v~~----------~~~~~~e~nil~~~~gh~~iv~l~~~~-------- 218 (966)
+.+..+++|+++++.+ ..|+++| |||++.+||++|+||+++.
T Consensus 270 VmEy~~GGdL~~~l~~~~~l~E~~a~~y~~qIl~aL~yLH~~gIiHRDLKPe-NILld~~G~vKL~DFGlA~~~~~~~~~ 348 (689)
T 3v5w_A 270 ILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGLEHMHNRFVVYRDLKPA-NILLDEHGHVRISDLGLACDFSKKKPH 348 (689)
T ss_dssp EECCCCSCBHHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCSGG-GEEECTTSCEEECCCTTCEECSSCCCC
T ss_pred EEecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCchH-HeEEeCCCCEEecccceeeecCCCCCC
Confidence 3444446666666654 2367777 9999999999999999763
Q ss_pred ---------ccccccc-ccCCCcceeeechhhHHHHHHHhhCCCCCCCC---cHHHHHHHHHhCCCCCCCCCCHHHHHHH
Q psy11767 219 ---------QDEVIDW-DDFSRGIECVFFSSSLIIFFIILSFTLSFIHD---YYHIQYRRILKTEPPIPEDLSPDVADFI 285 (966)
Q Consensus 219 ---------~~e~i~~-~~y~~~~d~~~~~~~~il~~~m~~g~~pf~~~---~~~~~~~~I~~~~~~~P~~~s~~a~dli 285 (966)
.+|++.. .+|+..+| ||+.||++|||++|.+||... +...++++|+...+.+|..+|++++|||
T Consensus 349 t~~GTp~YmAPEvl~~~~~y~~~vD---iWSLGvilYEmLtG~~PF~~~~~~~~~~i~~~i~~~~~~~p~~~S~~a~dLI 425 (689)
T 3v5w_A 349 ASVGTHGYMAPEVLQKGVAYDSSAD---WFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVELPDSFSPELRSLL 425 (689)
T ss_dssp SCCSCGGGCCHHHHSTTCCCCTHHH---HHHHHHHHHHHHHSSCTTCGGGCCCHHHHHHHHHHCCCCCCTTSCHHHHHHH
T ss_pred CccCCcCccCHHHHhCCCCCCcHHH---HHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhhcCCCCCCCccCCHHHHHHH
Confidence 3577754 57888877 678899999999999999753 4567899999999999999999999999
Q ss_pred HhhcccCCCcccCCCCCCHHHHhcCCceeeeCccccccCCCCCCCCccccccccccccc
Q psy11767 286 SRLLVKDPRRRLGGGELDAEELKRHPFFNVIDWDDLATKRIPAPFVPKISNELDVSNFS 344 (966)
Q Consensus 286 ~~LL~kdp~~RLG~~~~g~~~Ik~HpfF~~idW~~l~~k~~~pP~~P~i~~~~D~snFd 344 (966)
++||++||.+|+|+...|++||++||||++|||+.|..++++|||+|.+....+.++||
T Consensus 426 ~~lL~~dP~~Rl~~~~~ga~ei~~HpfF~~idW~~l~~~~~~pP~~P~~~~~~~~~~fD 484 (689)
T 3v5w_A 426 EGLLQRDVNRRLGCLGRGAQEVKESPFFRSLDWQMVFLQKYPPPLIPPRGEVNAADAFD 484 (689)
T ss_dssp HHHTCSCGGGCTTCSSSTHHHHTTSGGGTTCCHHHHHTTCSCCSCCCCTTCSSTTBCCC
T ss_pred HHHccCCHhHCCCCCCCCHHHHhcCccccCCCHHHHHcCCCCcCccCCCCCCCcCCCCC
Confidence 99999999999998778999999999999999999999999999999876655444444
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-38 Score=350.18 Aligned_cols=246 Identities=31% Similarity=0.523 Sum_probs=194.0
Q ss_pred cceecccccccccccccccccccEEEEEEEcCCCcEEEEEEecccc-----------ChHHHHHHHHHhc---CCCCceE
Q psy11767 370 SLFFEQYDMDLDKAGILGDGSYSVCRRCVEKSTGQEYAVKIISRKI-----------DCSEEINLLRACQ---GHPNIVN 435 (966)
Q Consensus 370 ~~~~~~~~i~~~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~-----------~~~~Ei~iL~~l~---~HpnIV~ 435 (966)
..+.++|.+ .+.||+|+||.||+|.+..+|+.||||++.... ...+|+.+|+.+. +||||++
T Consensus 27 ~~~~~~y~~----~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~h~~i~~ 102 (312)
T 2iwi_A 27 EAFEAEYRL----GPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHPGVIR 102 (312)
T ss_dssp ------CEE----EEEEEEETTEEEEEEECTTTCCEEEEEECCSTTTC--------CCCCHHHHHHHHHHSSCCCSSBCC
T ss_pred hhhhhceEE----eeEEEcCCCEEEEEEEEccCCeEEEEEEEecccccccccchhhHHHHHHHHHHHhhcccCCCCCeee
Confidence 344455555 688999999999999999999999999986432 2346999998884 6999999
Q ss_pred EEEEEEeCCeEEEEEEc-cCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCcEEEecCCCCCE
Q psy11767 436 LHCVFQDEVHTYLVLEL-LKGGELLDRIRQKGRCGFTENEASRIMRQLVAAVHFMHSRGVVHRDLKPENLLFSDPAGDNI 514 (966)
Q Consensus 436 l~~~~~~~~~~~lVmEy-~~gg~L~~~l~~~~~~~l~e~~~~~i~~Qil~aL~yLHs~~IiHRDLKP~NILl~~~~~~~i 514 (966)
+++++.+....++|||| +.+++|.+++.... .+++..++.++.||+.||+|||++||+||||||+|||++. .++.+
T Consensus 103 ~~~~~~~~~~~~~v~e~~~~~~~L~~~l~~~~--~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~-~~~~~ 179 (312)
T 2iwi_A 103 LLDWFETQEGFMLVLERPLPAQDLFDYITEKG--PLGEGPSRCFFGQVVAAIQHCHSRGVVHRDIKDENILIDL-RRGCA 179 (312)
T ss_dssp EEEEC-----CEEEEECCSSEEEHHHHHHHHC--SCCHHHHHHHHHHHHHHHHHHHHHTEECCCCSGGGEEEET-TTTEE
T ss_pred EEEEEecCCeEEEEEEecCCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCeeecCCChhhEEEeC-CCCeE
Confidence 99999999999999999 78999999998765 5999999999999999999999999999999999999973 25689
Q ss_pred EEEeecccccccC-CCccccccccccCchhhccCCCCCCCcccchhhhhhhhhhhhcCCCCCCCcCcchhHHHHHHHHhc
Q psy11767 515 KVVDFGFACLKRE-SLHTPCFTLQYAAPEVLRQDKSGYDENCDLWSLGVILVNVLRQDKSGYDENCDLWSLGVILYTMLC 593 (966)
Q Consensus 515 KL~DFGla~~~~~-~~~~~~gT~~Y~APEvl~~~~~~~~~~~Di~SlGvil~el~~~~~~~y~~~~DIWSlGvilyemlt 593 (966)
||+|||++..... ......+|+.|+|||++.... .++.++|||||||++|+|++
T Consensus 180 kl~dfg~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-------------------------~~~~~~Di~slG~il~~l~~ 234 (312)
T 2iwi_A 180 KLIDFGSGALLHDEPYTDFDGTRVYSPPEWISRHQ-------------------------YHALPATVWSLGILLYDMVC 234 (312)
T ss_dssp EECCCSSCEECCSSCBCCCCSCTTTSCHHHHHHSC-------------------------BCHHHHHHHHHHHHHHHHHH
T ss_pred EEEEcchhhhcccCcccccCCcccccCceeeecCC-------------------------CCCccchHHHHHHHHHHHHH
Confidence 9999999976543 334567899999999885321 12457999999999999999
Q ss_pred CCCCCCCCCCchhHHHHHHHHHcCCCCCCchhhccCCHHHHHHHHHhcccCccccCChHHHHHHhhhhHH
Q psy11767 594 GRVPFHARSRDDSALSIMARIKEGQFNFDAEAWSTVSSEAKELTKSLLTVNPAQRIRMMRVKLTFHAFHQ 663 (966)
Q Consensus 594 G~~Pf~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~is~e~~~Li~~~L~~dP~~R~t~~~v~~~~~~~~~ 663 (966)
|+.||.... .+......+. ..++.++.+||.+||..||++|||+.++. .|+|++
T Consensus 235 g~~pf~~~~----------~~~~~~~~~~----~~~~~~~~~li~~~l~~~p~~Rps~~e~l--~~~~~~ 288 (312)
T 2iwi_A 235 GDIPFERDQ----------EILEAELHFP----AHVSPDCCALIRRCLAPKPSSRPSLEEIL--LDPWMQ 288 (312)
T ss_dssp SSCSCCSHH----------HHHHTCCCCC----TTSCHHHHHHHHHHTCSSTTTSCCHHHHH--HSTTTC
T ss_pred CCCCCCChH----------HHhhhccCCc----ccCCHHHHHHHHHHccCChhhCcCHHHHh--cChhhc
Confidence 999997421 1222333322 35789999999999999999999999773 456653
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-38 Score=350.86 Aligned_cols=256 Identities=24% Similarity=0.387 Sum_probs=179.7
Q ss_pred cccccccccccccEEEEEEEcCCCcEEEEEEeccccC------hHHHHHHHHHhcCCCCceEEEEEEEeCCeEEEEEEcc
Q psy11767 380 LDKAGILGDGSYSVCRRCVEKSTGQEYAVKIISRKID------CSEEINLLRACQGHPNIVNLHCVFQDEVHTYLVLELL 453 (966)
Q Consensus 380 ~~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~~------~~~Ei~iL~~l~~HpnIV~l~~~~~~~~~~~lVmEy~ 453 (966)
|+..+.||+|+||.||+|.+..+|+.||||++..... ...|+..+....+||||+++++++.+++..|+||||+
T Consensus 24 y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~h~niv~~~~~~~~~~~~~lv~e~~ 103 (327)
T 3aln_A 24 LKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQKQLLMDLDVVMRSSDCPYIVQFYGALFREGDCWICMELM 103 (327)
T ss_dssp EEC-CEEEECSSEEEEEEEETTTTEEEEEEEEECCCCHHHHHHHHHHHHHHHSSCCCTTBCCEEEEEECSSEEEEEECCC
T ss_pred hhehheeccCCCEEEEEEEEcCCCCEEEEEEeecccCchHHHHHHHHHHHHHHcCCCCcEeeeeeEEEeCCceEEEEeec
Confidence 3446889999999999999999999999999976533 2235553444447999999999999999999999999
Q ss_pred CCCCHHHHHHh---cCCCCCCHHHHHHHHHHHHHHHHHHHhc-CceeccCCCCcEEEecCCCCCEEEEeecccccccCC-
Q psy11767 454 KGGELLDRIRQ---KGRCGFTENEASRIMRQLVAAVHFMHSR-GVVHRDLKPENLLFSDPAGDNIKVVDFGFACLKRES- 528 (966)
Q Consensus 454 ~gg~L~~~l~~---~~~~~l~e~~~~~i~~Qil~aL~yLHs~-~IiHRDLKP~NILl~~~~~~~iKL~DFGla~~~~~~- 528 (966)
.+ +|.+++.. .....+++..+..++.|++.||.|||++ ||+||||||+|||++. ++.+||+|||+++.....
T Consensus 104 ~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~NIll~~--~~~~kl~Dfg~~~~~~~~~ 180 (327)
T 3aln_A 104 ST-SFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLKENLKIIHRDIKPSNILLDR--SGNIKLCDFGISGQLVDSI 180 (327)
T ss_dssp SE-EHHHHHHHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHHHSCCCSCCCGGGEEEET--TTEEEECCCSSSCC-----
T ss_pred CC-ChHHHHHHHHhhhcccCcHHHHHHHHHHHHHHHHHHhccCCEeECCCCHHHEEEcC--CCCEEEccCCCceeccccc
Confidence 75 77777653 2234699999999999999999999999 9999999999999985 568999999999765432
Q ss_pred -CccccccccccCchhhccCCCCCCCcccchhhhhhhhhhhhcCCCCCCCcCcchhHHHHHHHHhcCCCCCCCCCCchhH
Q psy11767 529 -LHTPCFTLQYAAPEVLRQDKSGYDENCDLWSLGVILVNVLRQDKSGYDENCDLWSLGVILYTMLCGRVPFHARSRDDSA 607 (966)
Q Consensus 529 -~~~~~gT~~Y~APEvl~~~~~~~~~~~Di~SlGvil~el~~~~~~~y~~~~DIWSlGvilyemltG~~Pf~~~~~~~~~ 607 (966)
.....||+.|+|||++.... ....|+.++|||||||++|+|++|+.||.......
T Consensus 181 ~~~~~~gt~~y~aPE~~~~~~----------------------~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~-- 236 (327)
T 3aln_A 181 AKTRDAGCRPYMAPERIDPSA----------------------SRQGYDVRSDVWSLGITLYELATGRFPYPKWNSVF-- 236 (327)
T ss_dssp -----------------------------------------------CCSHHHHHHHHHHHHHHHHSCCCSSCC------
T ss_pred ccccCCCCccccCceeecccc----------------------CcCCCCchhhHHHHHHHHHHHHHCCCCCCCcchHH--
Confidence 23347899999999984211 12347889999999999999999999998643211
Q ss_pred HHHHHHHHcCCC-CCCchhhccCCHHHHHHHHHhcccCccccCChHHHHHHhhhhHHhh
Q psy11767 608 LSIMARIKEGQF-NFDAEAWSTVSSEAKELTKSLLTVNPAQRIRMMRVKLTFHAFHQAQ 665 (966)
Q Consensus 608 ~~~~~~i~~~~~-~~~~~~~~~is~e~~~Li~~~L~~dP~~R~t~~~v~~~~~~~~~~~ 665 (966)
..+..+..+.. .+....+..+++++.+||.+||..||++|||+.++ ..|+|....
T Consensus 237 -~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~el--l~hp~~~~~ 292 (327)
T 3aln_A 237 -DQLTQVVKGDPPQLSNSEEREFSPSFINFVNLCLTKDESKRPKYKEL--LKHPFILMY 292 (327)
T ss_dssp ----CCCCCSCCCCCCCCSSCCCCHHHHHHHHHHTCSSGGGSCCHHHH--TTSHHHHHH
T ss_pred -HHHHHHhcCCCCCCCCcccccCCHHHHHHHHHHhhCChhhCcCHHHH--HhChHHHHh
Confidence 11122222221 22223335689999999999999999999999976 456776543
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-37 Score=344.95 Aligned_cols=244 Identities=20% Similarity=0.335 Sum_probs=188.4
Q ss_pred cccccccccccEEEEEEEcC---CCcEEEEEEeccccC-------hHHHHHHHHHhcCCCCceEEEEEEEeCC-----eE
Q psy11767 382 KAGILGDGSYSVCRRCVEKS---TGQEYAVKIISRKID-------CSEEINLLRACQGHPNIVNLHCVFQDEV-----HT 446 (966)
Q Consensus 382 ~~~~LG~G~fG~Vy~a~~~~---tg~~vAvK~i~~~~~-------~~~Ei~iL~~l~~HpnIV~l~~~~~~~~-----~~ 446 (966)
..+.||+|+||.||+|.+.. +++.||||++..... ..+|+.+|+.+ +||||+++++++.+.. ..
T Consensus 38 ~~~~lg~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~~~~~ 116 (313)
T 3brb_A 38 LGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDF-SHPNVIRLLGVCIEMSSQGIPKP 116 (313)
T ss_dssp EEEEEEC-CCCCEEEEEEECTTSCEEEEEEEEC---CCCHHHHHHHHHHHHHHHTC-CCTTBCCCCEEEEC-------CE
T ss_pred eccceeecCCeEEEEEEEeccCCceeEEEEEEEeccccchhHHHHHHHHHHHHhcC-CCCCeeeeeEEEeeccccCCccc
Confidence 36789999999999998875 566899999865422 44688999888 5999999999998765 35
Q ss_pred EEEEEccCCCCHHHHHHhc----CCCCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCcEEEecCCCCCEEEEeeccc
Q psy11767 447 YLVLELLKGGELLDRIRQK----GRCGFTENEASRIMRQLVAAVHFMHSRGVVHRDLKPENLLFSDPAGDNIKVVDFGFA 522 (966)
Q Consensus 447 ~lVmEy~~gg~L~~~l~~~----~~~~l~e~~~~~i~~Qil~aL~yLHs~~IiHRDLKP~NILl~~~~~~~iKL~DFGla 522 (966)
|+||||+++|+|.+++... ....+++.+++.++.||+.||+|||++||+||||||+|||++. ++.+||+|||++
T Consensus 117 ~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dikp~NIli~~--~~~~kl~Dfg~~ 194 (313)
T 3brb_A 117 MVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGMEYLSNRNFLHRDLAARNCMLRD--DMTVCVADFGLS 194 (313)
T ss_dssp EEEEECCTTCBHHHHHHHTTBTTSCCCCCHHHHHHHHHHHHHHHHHHHTTTCCCCCCSGGGEEECT--TSCEEECSCSCC
T ss_pred EEEEecccCCCHHHHHHHhhhhcCCccCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCcceEEEcC--CCcEEEeecCcc
Confidence 9999999999999998542 2346999999999999999999999999999999999999975 568999999999
Q ss_pred ccccCC-----CccccccccccCchhhccCCCCCCCcccchhhhhhhhhhhhcCCCCCCCcCcchhHHHHHHHHhc-CCC
Q psy11767 523 CLKRES-----LHTPCFTLQYAAPEVLRQDKSGYDENCDLWSLGVILVNVLRQDKSGYDENCDLWSLGVILYTMLC-GRV 596 (966)
Q Consensus 523 ~~~~~~-----~~~~~gT~~Y~APEvl~~~~~~~~~~~Di~SlGvil~el~~~~~~~y~~~~DIWSlGvilyemlt-G~~ 596 (966)
...... .....+|+.|+|||++.. ..|+.++|||||||++|+|++ |.+
T Consensus 195 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~--------------------------~~~~~~~Di~slG~il~el~~~g~~ 248 (313)
T 3brb_A 195 KKIYSGDYYRQGRIAKMPVKWIAIESLAD--------------------------RVYTSKSDVWAFGVTMWEIATRGMT 248 (313)
T ss_dssp ----------------CCGGGSCHHHHHS--------------------------SCCCHHHHHHHHHHHHHHHHTTSCC
T ss_pred eecccccccCcccccCCCccccCchhhcC--------------------------CCccchhhhHHHHHHHHHHHhcCCC
Confidence 754321 123356889999999852 236789999999999999999 899
Q ss_pred CCCCCCCchhHHHHHHHHHcCCCCCCchhhccCCHHHHHHHHHhcccCccccCChHHHHHHhhhh
Q psy11767 597 PFHARSRDDSALSIMARIKEGQFNFDAEAWSTVSSEAKELTKSLLTVNPAQRIRMMRVKLTFHAF 661 (966)
Q Consensus 597 Pf~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~is~e~~~Li~~~L~~dP~~R~t~~~v~~~~~~~ 661 (966)
||.+....+ ....+..+... .....+++++.+||.+||..||.+|||+.++...+..+
T Consensus 249 p~~~~~~~~----~~~~~~~~~~~---~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~l 306 (313)
T 3brb_A 249 PYPGVQNHE----MYDYLLHGHRL---KQPEDCLDELYEIMYSCWRTDPLDRPTFSVLRLQLEKL 306 (313)
T ss_dssp SSTTCCGGG----HHHHHHTTCCC---CCBTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHH
T ss_pred CCccCCHHH----HHHHHHcCCCC---CCCccccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence 998765543 23344444322 12346889999999999999999999999886655443
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* 4e20_A* 4e1z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-38 Score=349.93 Aligned_cols=245 Identities=22% Similarity=0.333 Sum_probs=193.5
Q ss_pred cccccccccccEEEEEE----EcCCCcEEEEEEeccccC------hHHHHHHHHHhcCCCCceEEEEEEEeC--CeEEEE
Q psy11767 382 KAGILGDGSYSVCRRCV----EKSTGQEYAVKIISRKID------CSEEINLLRACQGHPNIVNLHCVFQDE--VHTYLV 449 (966)
Q Consensus 382 ~~~~LG~G~fG~Vy~a~----~~~tg~~vAvK~i~~~~~------~~~Ei~iL~~l~~HpnIV~l~~~~~~~--~~~~lV 449 (966)
.++.||+|+||+||+|. +..+|+.||||++..... ..+|+++|+.+. ||||+++++++.+. ...|+|
T Consensus 35 ~~~~lG~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~~~~~~~lv 113 (318)
T 3lxp_A 35 KIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLY-HEHIIKYKGCCEDAGAASLQLV 113 (318)
T ss_dssp EEEEEEECSSEEEEEEEECSCC--CCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCC-CTTBCCEEEEEEETTTTEEEEE
T ss_pred hhheecCCCCeEEEEEEEccCCCCCCcEEEEEEeccccChHHHHHHHHHHHHHHhCC-CcchhhEEEEEecCCCceEEEE
Confidence 36889999999998775 445899999999976532 457999999985 99999999999984 678999
Q ss_pred EEccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCcEEEecCCCCCEEEEeecccccccCC-
Q psy11767 450 LELLKGGELLDRIRQKGRCGFTENEASRIMRQLVAAVHFMHSRGVVHRDLKPENLLFSDPAGDNIKVVDFGFACLKRES- 528 (966)
Q Consensus 450 mEy~~gg~L~~~l~~~~~~~l~e~~~~~i~~Qil~aL~yLHs~~IiHRDLKP~NILl~~~~~~~iKL~DFGla~~~~~~- 528 (966)
|||+++|+|.+++... .+++.+++.++.||+.||+|||++||+||||||+|||++. ++.+||+|||++......
T Consensus 114 ~e~~~~~~L~~~l~~~---~~~~~~~~~i~~~l~~~l~~LH~~~ivH~Dikp~Nil~~~--~~~~kl~Dfg~a~~~~~~~ 188 (318)
T 3lxp_A 114 MEYVPLGSLRDYLPRH---SIGLAQLLLFAQQICEGMAYLHAQHYIHRDLAARNVLLDN--DRLVKIGDFGLAKAVPEGH 188 (318)
T ss_dssp ECCCTTCBHHHHGGGS---CCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECT--TCCEEECCGGGCEECCTTC
T ss_pred EecccCCcHHHHHhhC---CCCHHHHHHHHHHHHHHHHHHHhCCccCCCCchheEEEcC--CCCEEECCccccccccccc
Confidence 9999999999999765 3899999999999999999999999999999999999975 568999999999765432
Q ss_pred -----CccccccccccCchhhccCCCCCCCcccchhhhhhhhhhhhcCCCCCCCcCcchhHHHHHHHHhcCCCCCCCCCC
Q psy11767 529 -----LHTPCFTLQYAAPEVLRQDKSGYDENCDLWSLGVILVNVLRQDKSGYDENCDLWSLGVILYTMLCGRVPFHARSR 603 (966)
Q Consensus 529 -----~~~~~gT~~Y~APEvl~~~~~~~~~~~Di~SlGvil~el~~~~~~~y~~~~DIWSlGvilyemltG~~Pf~~~~~ 603 (966)
.....+|+.|+|||++... .|+.++|||||||++|+|++|+.||.....
T Consensus 189 ~~~~~~~~~~~~~~y~aPE~~~~~--------------------------~~~~~~Di~slG~il~~ll~g~~p~~~~~~ 242 (318)
T 3lxp_A 189 EYYRVREDGDSPVFWYAPECLKEY--------------------------KFYYASDVWSFGVTLYELLTHCDSSQSPPT 242 (318)
T ss_dssp SEEEC---CCCCGGGCCHHHHHHC--------------------------EEEHHHHHHHHHHHHHHHHTTTCGGGSHHH
T ss_pred cccccccCCCCCceeeChHHhcCC--------------------------CCCcHHHHHHHHHHHHHHHhCCCcccccch
Confidence 2234578889999998532 256789999999999999999999975321
Q ss_pred c-----------hhHHHHHHHHHcCCCCCCchhhccCCHHHHHHHHHhcccCccccCChHHHHHHhhhh
Q psy11767 604 D-----------DSALSIMARIKEGQFNFDAEAWSTVSSEAKELTKSLLTVNPAQRIRMMRVKLTFHAF 661 (966)
Q Consensus 604 ~-----------~~~~~~~~~i~~~~~~~~~~~~~~is~e~~~Li~~~L~~dP~~R~t~~~v~~~~~~~ 661 (966)
. .....+...+..+... .....+++++.+||.+||+.||++|||+.++...+..+
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~l 308 (318)
T 3lxp_A 243 KFLELIGIAQGQMTVLRLTELLERGERL---PRPDKCPAEVYHLMKNCWETEASFRPTFENLIPILKTV 308 (318)
T ss_dssp HHHHHHCSCCHHHHHHHHHHHHHTTCCC---CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred hhhhhhcccccchhHHHHHHHHhcccCC---CCCccccHHHHHHHHHHcCCCcccCcCHHHHHHHHHHH
Confidence 1 0111122233333221 12346889999999999999999999999886555443
|
| >4fl3_A Tyrosine-protein kinase SYK; transferase; HET: ANP; 1.90A {Homo sapiens} PDB: 4fl2_A* 1a81_A* 1csy_A* 1csz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-38 Score=382.99 Aligned_cols=240 Identities=21% Similarity=0.382 Sum_probs=195.2
Q ss_pred cccccccccEEEEEEE--cCCCcEEEEEEecccc-------ChHHHHHHHHHhcCCCCceEEEEEEEeCCeEEEEEEccC
Q psy11767 384 GILGDGSYSVCRRCVE--KSTGQEYAVKIISRKI-------DCSEEINLLRACQGHPNIVNLHCVFQDEVHTYLVLELLK 454 (966)
Q Consensus 384 ~~LG~G~fG~Vy~a~~--~~tg~~vAvK~i~~~~-------~~~~Ei~iL~~l~~HpnIV~l~~~~~~~~~~~lVmEy~~ 454 (966)
+.||+|+||+||+|.+ ..+++.||||+++... ...+|+++|+.+ +|||||++++++.++ ..+||||||+
T Consensus 375 ~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l-~hpnIv~l~~~~~~~-~~~lv~E~~~ 452 (635)
T 4fl3_A 375 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQL-DNPYIVRMIGICEAE-SWMLVMEMAE 452 (635)
T ss_dssp EEEEECSSEEEEEEEEECSSCEEEEEEEEECGGGGCGGGHHHHHHHHHHHHHC-CCTTBCCEEEEEESS-SEEEEEECCT
T ss_pred CEeccCCCEEEEEEEEcCCCcceEEEEEEeccccCCHHHHHHHHHHHHHHHhC-CCCCEeeEEEEEecC-CEEEEEEccC
Confidence 5799999999999955 4677899999997532 245799999998 599999999999754 5899999999
Q ss_pred CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCcEEEecCCCCCEEEEeecccccccCC------
Q psy11767 455 GGELLDRIRQKGRCGFTENEASRIMRQLVAAVHFMHSRGVVHRDLKPENLLFSDPAGDNIKVVDFGFACLKRES------ 528 (966)
Q Consensus 455 gg~L~~~l~~~~~~~l~e~~~~~i~~Qil~aL~yLHs~~IiHRDLKP~NILl~~~~~~~iKL~DFGla~~~~~~------ 528 (966)
+|+|.+++.... .+++.+++.|+.||+.||+|||++|||||||||+|||++. ++.+||+|||+|+.....
T Consensus 453 ~g~L~~~l~~~~--~l~~~~~~~i~~qi~~~L~yLH~~~iiHrDLkp~NILl~~--~~~~kL~DFGla~~~~~~~~~~~~ 528 (635)
T 4fl3_A 453 LGPLNKYLQQNR--HVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVT--QHYAKISDFGLSKALRADENYYKA 528 (635)
T ss_dssp TEEHHHHHHHCT--TCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEE--TTEEEECCTTHHHHTTC-------
T ss_pred CCCHHHHHhhCC--CCCHHHHHHHHHHHHHHHHHHHHCCEeCCCCChHhEEEeC--CCCEEEEEcCCccccccCcccccc
Confidence 999999997654 5999999999999999999999999999999999999985 568999999999765321
Q ss_pred CccccccccccCchhhccCCCCCCCcccchhhhhhhhhhhhcCCCCCCCcCcchhHHHHHHHHhc-CCCCCCCCCCchhH
Q psy11767 529 LHTPCFTLQYAAPEVLRQDKSGYDENCDLWSLGVILVNVLRQDKSGYDENCDLWSLGVILYTMLC-GRVPFHARSRDDSA 607 (966)
Q Consensus 529 ~~~~~gT~~Y~APEvl~~~~~~~~~~~Di~SlGvil~el~~~~~~~y~~~~DIWSlGvilyemlt-G~~Pf~~~~~~~~~ 607 (966)
.....+|+.|+|||++.. ..|+.++|||||||++|||++ |+.||.+....
T Consensus 529 ~~~~~~t~~y~APE~~~~--------------------------~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~--- 579 (635)
T 4fl3_A 529 QTHGKWPVKWYAPECINY--------------------------YKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGS--- 579 (635)
T ss_dssp ------CGGGSCHHHHHH--------------------------CCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHH---
T ss_pred ccCCCCceeeeChhhhcC--------------------------CCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHH---
Confidence 123346788999999853 237889999999999999998 99999876543
Q ss_pred HHHHHHHHcCCCCCCchhhccCCHHHHHHHHHhcccCccccCChHHHHHHhhhhH
Q psy11767 608 LSIMARIKEGQFNFDAEAWSTVSSEAKELTKSLLTVNPAQRIRMMRVKLTFHAFH 662 (966)
Q Consensus 608 ~~~~~~i~~~~~~~~~~~~~~is~e~~~Li~~~L~~dP~~R~t~~~v~~~~~~~~ 662 (966)
.+...+..+.... ....+++++.+||.+||..||++||++.++...+..++
T Consensus 580 -~~~~~i~~~~~~~---~p~~~~~~l~~li~~cl~~dP~~RPs~~~l~~~L~~~~ 630 (635)
T 4fl3_A 580 -EVTAMLEKGERMG---CPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYY 630 (635)
T ss_dssp -HHHHHHHTTCCCC---CCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHH
T ss_pred -HHHHHHHcCCCCC---CCCCCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHH
Confidence 3445555554321 22368899999999999999999999999876665543
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-38 Score=358.97 Aligned_cols=244 Identities=21% Similarity=0.325 Sum_probs=187.6
Q ss_pred ccccccccccccEEEEEEEcCCC---cEEEEEEeccccC------hHHHHHHHHHhcCCCCceEEEEEEE-eCCeEEEEE
Q psy11767 381 DKAGILGDGSYSVCRRCVEKSTG---QEYAVKIISRKID------CSEEINLLRACQGHPNIVNLHCVFQ-DEVHTYLVL 450 (966)
Q Consensus 381 ~~~~~LG~G~fG~Vy~a~~~~tg---~~vAvK~i~~~~~------~~~Ei~iL~~l~~HpnIV~l~~~~~-~~~~~~lVm 450 (966)
+..+.||+|+||+||+|.+..++ ..||||.+..... ..+|+.+|+.+ +|||||++++++. .++..|+||
T Consensus 92 ~~~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l-~hpnIv~~~~~~~~~~~~~~lv~ 170 (373)
T 3c1x_A 92 HFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDF-SHPNVLSLLGICLRSEGSPLVVL 170 (373)
T ss_dssp EEEEEEECCSSSEEEEEEEEETTTEEEEEEEEECCSCSCSHHHHHHHHHHTTSTTC-CCTTBCCCCEEECCCSSCCEEEE
T ss_pred ecCcEeeeCCCeEEEEEEEECCCCcEEEEEEEEcCCCCCHHHHHHHHHHHHHHHhC-CCCCcceEEEEEEcCCCCeEEEE
Confidence 34578999999999999986543 4689999865432 34688888888 5999999999865 456789999
Q ss_pred EccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCcEEEecCCCCCEEEEeecccccccCC--
Q psy11767 451 ELLKGGELLDRIRQKGRCGFTENEASRIMRQLVAAVHFMHSRGVVHRDLKPENLLFSDPAGDNIKVVDFGFACLKRES-- 528 (966)
Q Consensus 451 Ey~~gg~L~~~l~~~~~~~l~e~~~~~i~~Qil~aL~yLHs~~IiHRDLKP~NILl~~~~~~~iKL~DFGla~~~~~~-- 528 (966)
||+++|+|.+++..... .+++.++..++.||+.||+|||++||+||||||+|||++. ++.+||+|||+++.....
T Consensus 171 e~~~~g~L~~~l~~~~~-~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~--~~~~kL~DFG~a~~~~~~~~ 247 (373)
T 3c1x_A 171 PYMKHGDLRNFIRNETH-NPTVKDLIGFGLQVAKGMKFLASKKFVHRDLAARNCMLDE--KFTVKVADFGLARDMYDKEF 247 (373)
T ss_dssp ECCTTCBHHHHHHCTTC-CCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECT--TCCEEECCC-----------
T ss_pred ECCCCCCHHHHHhhccc-CCCHHHHHHHHHHHHHHHHHHHHCCEecCccchheEEECC--CCCEEEeecccccccccccc
Confidence 99999999999976543 5899999999999999999999999999999999999975 568999999999754321
Q ss_pred -----CccccccccccCchhhccCCCCCCCcccchhhhhhhhhhhhcCCCCCCCcCcchhHHHHHHHHhc-CCCCCCCCC
Q psy11767 529 -----LHTPCFTLQYAAPEVLRQDKSGYDENCDLWSLGVILVNVLRQDKSGYDENCDLWSLGVILYTMLC-GRVPFHARS 602 (966)
Q Consensus 529 -----~~~~~gT~~Y~APEvl~~~~~~~~~~~Di~SlGvil~el~~~~~~~y~~~~DIWSlGvilyemlt-G~~Pf~~~~ 602 (966)
.....+|+.|+|||++.. ..|+.++|||||||++|+|++ |.+||....
T Consensus 248 ~~~~~~~~~~~~~~y~aPE~~~~--------------------------~~~~~~~DvwSlG~il~ellt~~~~p~~~~~ 301 (373)
T 3c1x_A 248 DSVHNKTGAKLPVKWMALESLQT--------------------------QKFTTKSDVWSFGVLLWELMTRGAPPYPDVN 301 (373)
T ss_dssp ----------CCGGGSCHHHHHH--------------------------CCCCHHHHHHHHHHHHHHHHTTSCCSCTTSC
T ss_pred ccccccCCCCCcccccChHHhcC--------------------------CCCCcHHHHHHHHHHHHHHHhCcCCCCCCCC
Confidence 123356788999999853 237889999999999999999 788887765
Q ss_pred CchhHHHHHHHHHcCCCCCCchhhccCCHHHHHHHHHhcccCccccCChHHHHHHhhhh
Q psy11767 603 RDDSALSIMARIKEGQFNFDAEAWSTVSSEAKELTKSLLTVNPAQRIRMMRVKLTFHAF 661 (966)
Q Consensus 603 ~~~~~~~~~~~i~~~~~~~~~~~~~~is~e~~~Li~~~L~~dP~~R~t~~~v~~~~~~~ 661 (966)
..+. ...+..+.....+ ..+++++.++|.+||..||++|||+.++...+..+
T Consensus 302 ~~~~----~~~~~~~~~~~~p---~~~~~~l~~li~~cl~~dp~~RPs~~ell~~L~~i 353 (373)
T 3c1x_A 302 TFDI----TVYLLQGRRLLQP---EYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAI 353 (373)
T ss_dssp SSCH----HHHHHTTCCCCCC---TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred HHHH----HHHHHcCCCCCCC---CCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence 4432 3344444433222 35789999999999999999999999886555443
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-37 Score=343.42 Aligned_cols=256 Identities=26% Similarity=0.386 Sum_probs=195.0
Q ss_pred cccccccccccccEEEEEEEcCCCcEEEEEEecccc-------ChHHHHHHHHHhcC-CCCceEEEEEEEeCCeEEEEEE
Q psy11767 380 LDKAGILGDGSYSVCRRCVEKSTGQEYAVKIISRKI-------DCSEEINLLRACQG-HPNIVNLHCVFQDEVHTYLVLE 451 (966)
Q Consensus 380 ~~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~-------~~~~Ei~iL~~l~~-HpnIV~l~~~~~~~~~~~lVmE 451 (966)
|...+.||+|+||.||+|.+. +++.||||++.... ...+|+.+|+.+.. ||||+++++++.++...|+|||
T Consensus 30 y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~~~~lv~e 108 (313)
T 3cek_A 30 YSILKQIGSGGSSKVFQVLNE-KKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVME 108 (313)
T ss_dssp EEEEEEEECCSSEEEEEEECT-TCCEEEEEEEECSSCCHHHHHHHHHHHHHHHHHGGGCTTBCCEEEEEECSSEEEEEEC
T ss_pred EEEEEEecCCCCEEEEEEEcC-CCcEEEEEEeccccccccchHHHHHHHHHHHhccccCCceEEEEEEeecCCEEEEEEe
Confidence 344789999999999999986 48999999986542 23569999999874 7999999999999999999999
Q ss_pred ccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCcEEEecCCCCCEEEEeecccccccCC---
Q psy11767 452 LLKGGELLDRIRQKGRCGFTENEASRIMRQLVAAVHFMHSRGVVHRDLKPENLLFSDPAGDNIKVVDFGFACLKRES--- 528 (966)
Q Consensus 452 y~~gg~L~~~l~~~~~~~l~e~~~~~i~~Qil~aL~yLHs~~IiHRDLKP~NILl~~~~~~~iKL~DFGla~~~~~~--- 528 (966)
+.+++|.+++.... .+++.+++.++.||+.||+|||++||+||||||+|||++ ++.+||+|||++......
T Consensus 109 -~~~~~L~~~l~~~~--~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIl~~---~~~~kL~Dfg~~~~~~~~~~~ 182 (313)
T 3cek_A 109 -CGNIDLNSWLKKKK--SIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIV---DGMLKLIDFGIANQMQPDTTS 182 (313)
T ss_dssp -CCSEEHHHHHHHCS--SCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEE---TTEEEECCCSSSCC-------
T ss_pred -cCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCceecCCCcccEEEE---CCeEEEeeccccccccCcccc
Confidence 55889999998764 589999999999999999999999999999999999996 368999999999764322
Q ss_pred --CccccccccccCchhhccCCCCCCCcccchhhhhhhhhhhhcCCCCCCCcCcchhHHHHHHHHhcCCCCCCCCCCchh
Q psy11767 529 --LHTPCFTLQYAAPEVLRQDKSGYDENCDLWSLGVILVNVLRQDKSGYDENCDLWSLGVILYTMLCGRVPFHARSRDDS 606 (966)
Q Consensus 529 --~~~~~gT~~Y~APEvl~~~~~~~~~~~Di~SlGvil~el~~~~~~~y~~~~DIWSlGvilyemltG~~Pf~~~~~~~~ 606 (966)
....++|+.|+|||++....... ........++.++|||||||++|+|++|+.||.......
T Consensus 183 ~~~~~~~gt~~y~aPE~~~~~~~~~---------------~~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~- 246 (313)
T 3cek_A 183 VVKDSQVGTVNYMPPEAIKDMSSSR---------------ENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQI- 246 (313)
T ss_dssp -------CCGGGCCHHHHTTCC-------------------------CCCHHHHHHHHHHHHHHHHHSSCTTTTCCSHH-
T ss_pred ccccCCCCCCCcCCHHHHhhccccc---------------ccccccccCCchHHHHHHHHHHHHHHhCCCchhhHHHHH-
Confidence 12456899999999986321000 000112357889999999999999999999998654322
Q ss_pred HHHHHHHHHcCCCCCCchhhccCCHHHHHHHHHhcccCccccCChHHHHHHhhhhHHh
Q psy11767 607 ALSIMARIKEGQFNFDAEAWSTVSSEAKELTKSLLTVNPAQRIRMMRVKLTFHAFHQA 664 (966)
Q Consensus 607 ~~~~~~~i~~~~~~~~~~~~~~is~e~~~Li~~~L~~dP~~R~t~~~v~~~~~~~~~~ 664 (966)
..+..+........ .....+.++.+||.+||..||++||++.++ ..|+|+..
T Consensus 247 --~~~~~~~~~~~~~~--~~~~~~~~l~~li~~~l~~dp~~Rps~~el--l~h~~~~~ 298 (313)
T 3cek_A 247 --SKLHAIIDPNHEIE--FPDIPEKDLQDVLKCCLKRDPKQRISIPEL--LAHPYVQI 298 (313)
T ss_dssp --HHHHHHHCTTSCCC--CCCCSCHHHHHHHHHHTCSSTTTSCCHHHH--HTSHHHHC
T ss_pred --HHHHHHHhcccccC--CcccchHHHHHHHHHHccCCcccCcCHHHH--hcCccccC
Confidence 22233333322211 223468899999999999999999999876 45677643
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-37 Score=343.32 Aligned_cols=255 Identities=23% Similarity=0.411 Sum_probs=182.9
Q ss_pred ccccccccccccccEEEEEEEcCCCcEEEEEEeccccCh------HHHHHHHHHhcCCCCceEEEEEEEeCCeEEEEEEc
Q psy11767 379 DLDKAGILGDGSYSVCRRCVEKSTGQEYAVKIISRKIDC------SEEINLLRACQGHPNIVNLHCVFQDEVHTYLVLEL 452 (966)
Q Consensus 379 ~~~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~~~------~~Ei~iL~~l~~HpnIV~l~~~~~~~~~~~lVmEy 452 (966)
+|+..+.||+|+||.||+|.+..+|+.||||++...... ..|+..+....+||||+++++++.++...|+||||
T Consensus 26 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~~~~~lv~e~ 105 (318)
T 2dyl_A 26 DLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDVVLKSHDCPYIVQCFGTFITNTDVFIAMEL 105 (318)
T ss_dssp GEEEEEEC------CEEEEEETTTCCEEEEEEEETTSCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEECC
T ss_pred cccccceeeecCCeeEEEEEEecCCeEEEEEEecccccchHHHHHHHHHHHHHHhcCCCceeeEEEEEecCCcEEEEEec
Confidence 345578999999999999999999999999999765332 12333333334799999999999999999999999
Q ss_pred cCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhc-CceeccCCCCcEEEecCCCCCEEEEeecccccccC--CC
Q psy11767 453 LKGGELLDRIRQKGRCGFTENEASRIMRQLVAAVHFMHSR-GVVHRDLKPENLLFSDPAGDNIKVVDFGFACLKRE--SL 529 (966)
Q Consensus 453 ~~gg~L~~~l~~~~~~~l~e~~~~~i~~Qil~aL~yLHs~-~IiHRDLKP~NILl~~~~~~~iKL~DFGla~~~~~--~~ 529 (966)
+ ++.+....... ...+++..++.++.||+.||+|||++ ||+||||||+|||++. ++.+||+|||++..... ..
T Consensus 106 ~-~~~~~~l~~~~-~~~~~~~~~~~~~~~i~~~l~~lH~~~~i~H~dlkp~Nil~~~--~~~~kl~dfg~~~~~~~~~~~ 181 (318)
T 2dyl_A 106 M-GTCAEKLKKRM-QGPIPERILGKMTVAIVKALYYLKEKHGVIHRDVKPSNILLDE--RGQIKLCDFGISGRLVDDKAK 181 (318)
T ss_dssp C-SEEHHHHHHHH-TSCCCHHHHHHHHHHHHHHHHHHHHHHCCCCCCCCGGGEEECT--TSCEEECCCTTC---------
T ss_pred c-CCcHHHHHHHh-ccCCCHHHHHHHHHHHHHHHHHHHhhCCEEeCCCCHHHEEECC--CCCEEEEECCCchhccCCccc
Confidence 9 55555554433 33699999999999999999999996 9999999999999975 56899999999965432 22
Q ss_pred ccccccccccCchhhccCCCCCCCcccchhhhhhhhhhhhcCCCCCCCcCcchhHHHHHHHHhcCCCCCCCCCCchhHHH
Q psy11767 530 HTPCFTLQYAAPEVLRQDKSGYDENCDLWSLGVILVNVLRQDKSGYDENCDLWSLGVILYTMLCGRVPFHARSRDDSALS 609 (966)
Q Consensus 530 ~~~~gT~~Y~APEvl~~~~~~~~~~~Di~SlGvil~el~~~~~~~y~~~~DIWSlGvilyemltG~~Pf~~~~~~~~~~~ 609 (966)
....+|+.|+|||++.... .....|+.++|||||||++|+|++|+.||...... ..
T Consensus 182 ~~~~~~~~y~aPE~~~~~~---------------------~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~---~~ 237 (318)
T 2dyl_A 182 DRSAGCAAYMAPERIDPPD---------------------PTKPDYDIRADVWSLGISLVELATGQFPYKNCKTD---FE 237 (318)
T ss_dssp -----CCTTCCHHHHC-----------------------------CCTHHHHHHHHHHHHHHHHSSCTTTTCCSH---HH
T ss_pred cccCCCccccChhhccccc---------------------ccccCCccccchhhHHHHHHHHHhCCCCCCCCCcc---HH
Confidence 3457899999999985321 01234788999999999999999999999864432 23
Q ss_pred HHHHHHcCCCCCCchhhccCCHHHHHHHHHhcccCccccCChHHHHHHhhhhHHh
Q psy11767 610 IMARIKEGQFNFDAEAWSTVSSEAKELTKSLLTVNPAQRIRMMRVKLTFHAFHQA 664 (966)
Q Consensus 610 ~~~~i~~~~~~~~~~~~~~is~e~~~Li~~~L~~dP~~R~t~~~v~~~~~~~~~~ 664 (966)
.+..+..+.....+ ....+++++.+||.+||..||.+|||+.++ ..|+|++.
T Consensus 238 ~~~~~~~~~~~~~~-~~~~~~~~l~~li~~~l~~dp~~Rps~~~l--l~h~~~~~ 289 (318)
T 2dyl_A 238 VLTKVLQEEPPLLP-GHMGFSGDFQSFVKDCLTKDHRKRPKYNKL--LEHSFIKR 289 (318)
T ss_dssp HHHHHHHSCCCCCC-SSSCCCHHHHHHHHHHTCSCTTTSCCHHHH--TTSHHHHH
T ss_pred HHHHHhccCCCCCC-ccCCCCHHHHHHHHHHccCChhHCcCHHHH--hhCHHHHh
Confidence 34444444332221 223589999999999999999999999976 44677654
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-37 Score=377.32 Aligned_cols=240 Identities=23% Similarity=0.372 Sum_probs=195.0
Q ss_pred ccccccccEEEEEEEcC--CCcEEEEEEecccc------ChHHHHHHHHHhcCCCCceEEEEEEEeCCeEEEEEEccCCC
Q psy11767 385 ILGDGSYSVCRRCVEKS--TGQEYAVKIISRKI------DCSEEINLLRACQGHPNIVNLHCVFQDEVHTYLVLELLKGG 456 (966)
Q Consensus 385 ~LG~G~fG~Vy~a~~~~--tg~~vAvK~i~~~~------~~~~Ei~iL~~l~~HpnIV~l~~~~~~~~~~~lVmEy~~gg 456 (966)
.||+|+||.||+|.++. ++..||||++.... ...+|+++|+.+ +|||||++++++.+ ...|||||||++|
T Consensus 343 ~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l-~hpniv~l~~~~~~-~~~~lv~E~~~~g 420 (613)
T 2ozo_A 343 ELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQL-DNPYIVRLIGVCQA-EALMLVMEMAGGG 420 (613)
T ss_dssp EEEECSSSEEEEEEEECSSCEEEEEEEECCCCCSSTTHHHHHHHHHHHTTC-CCTTBCCEEEEEES-SSEEEEEECCTTC
T ss_pred EEecCCCcEEEEEEEecCCCcEEEEEEEcCCCCChHHHHHHHHHHHHHHhC-CCCCEeeEEEEecc-CCeEEEEEeCCCC
Confidence 69999999999998763 56789999997532 245799999988 59999999999987 4699999999999
Q ss_pred CHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCcEEEecCCCCCEEEEeecccccccCCC------c
Q psy11767 457 ELLDRIRQKGRCGFTENEASRIMRQLVAAVHFMHSRGVVHRDLKPENLLFSDPAGDNIKVVDFGFACLKRESL------H 530 (966)
Q Consensus 457 ~L~~~l~~~~~~~l~e~~~~~i~~Qil~aL~yLHs~~IiHRDLKP~NILl~~~~~~~iKL~DFGla~~~~~~~------~ 530 (966)
+|.+++.... ..+++.++..++.||+.||+|||++||+||||||+|||+++ ++.+||+|||+|+...... .
T Consensus 421 ~L~~~l~~~~-~~l~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~--~~~vkL~DFGla~~~~~~~~~~~~~~ 497 (613)
T 2ozo_A 421 PLHKFLVGKR-EEIPVSNVAELLHQVSMGMKYLEEKNFVHRNLAARNVLLVN--RHYAKISDFGLSKALGADDSYYTARS 497 (613)
T ss_dssp BHHHHHTTCT-TTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEE--TTEEEECCCSTTTTCC----------
T ss_pred cHHHHHhhcc-CCCCHHHHHHHHHHHHHHHHHHHHCCEEcCcCCHHHEEEcC--CCcEEEeeccCcccccCCCceeeecc
Confidence 9999997653 36999999999999999999999999999999999999985 5689999999997653211 1
Q ss_pred cccccccccCchhhccCCCCCCCcccchhhhhhhhhhhhcCCCCCCCcCcchhHHHHHHHHhc-CCCCCCCCCCchhHHH
Q psy11767 531 TPCFTLQYAAPEVLRQDKSGYDENCDLWSLGVILVNVLRQDKSGYDENCDLWSLGVILYTMLC-GRVPFHARSRDDSALS 609 (966)
Q Consensus 531 ~~~gT~~Y~APEvl~~~~~~~~~~~Di~SlGvil~el~~~~~~~y~~~~DIWSlGvilyemlt-G~~Pf~~~~~~~~~~~ 609 (966)
...+|+.|+|||++.. ..|+.++|||||||++|||++ |+.||.+.... .
T Consensus 498 ~~~~~~~y~APE~~~~--------------------------~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~----~ 547 (613)
T 2ozo_A 498 AGKWPLKWYAPECINF--------------------------RKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGP----E 547 (613)
T ss_dssp ----CCTTSCHHHHHH--------------------------CCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCSH----H
T ss_pred CCCCccceeCHhhhcC--------------------------CCCCcHHHHHHHHHHHHHHHHCCCCCCCCCCHH----H
Confidence 2345689999999853 237889999999999999998 99999876543 3
Q ss_pred HHHHHHcCCCCCCchhhccCCHHHHHHHHHhcccCccccCChHHHHHHhhhhH
Q psy11767 610 IMARIKEGQFNFDAEAWSTVSSEAKELTKSLLTVNPAQRIRMMRVKLTFHAFH 662 (966)
Q Consensus 610 ~~~~i~~~~~~~~~~~~~~is~e~~~Li~~~L~~dP~~R~t~~~v~~~~~~~~ 662 (966)
++..+..+... .....+++++.+||.+||..||++||++.++...+..+.
T Consensus 548 ~~~~i~~~~~~---~~p~~~~~~l~~li~~cl~~dP~~RPs~~~l~~~L~~~~ 597 (613)
T 2ozo_A 548 VMAFIEQGKRM---ECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACY 597 (613)
T ss_dssp HHHHHHTTCCC---CCCTTCCHHHHHHHHHTTCSSTTTSCCHHHHHHHHHHHH
T ss_pred HHHHHHcCCCC---CCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHH
Confidence 45556655422 122468899999999999999999999999866655443
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-38 Score=375.90 Aligned_cols=243 Identities=20% Similarity=0.352 Sum_probs=198.8
Q ss_pred cccccccccccEEEEEEEcCCCcEEEEEEecccc----ChHHHHHHHHHhcCCCCceEEEEEEEeCCeEEEEEEccCCCC
Q psy11767 382 KAGILGDGSYSVCRRCVEKSTGQEYAVKIISRKI----DCSEEINLLRACQGHPNIVNLHCVFQDEVHTYLVLELLKGGE 457 (966)
Q Consensus 382 ~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~----~~~~Ei~iL~~l~~HpnIV~l~~~~~~~~~~~lVmEy~~gg~ 457 (966)
..+.||+|+||.||+|.+.. +..||||++.... ...+|+.+|+.+ +|||||++++++.+ ...|||||||++|+
T Consensus 271 ~~~~lG~G~fg~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~E~~~l~~l-~hpniv~~~~~~~~-~~~~lv~e~~~~gs 347 (535)
T 2h8h_A 271 LEVKLGQGCFGEVWMGTWNG-TTRVAIKTLKPGTMSPEAFLQEAQVMKKL-RHEKLVQLYAVVSE-EPIYIVTEYMSKGS 347 (535)
T ss_dssp EEEEEEECSSEEEEEEEETT-TEEEEEEEECTTSSCHHHHHHHHHHHHHC-CCTTBCCEEEEECS-SSCEEEECCCTTEE
T ss_pred hheecccCCCeEEEEEEECC-CceEEEEEeCCCCCCHHHHHHHHHHHHhC-CCCCEeeEEEEEee-ccceEeeehhcCCc
Confidence 35789999999999999875 4679999997543 256799999998 59999999999876 67899999999999
Q ss_pred HHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCcEEEecCCCCCEEEEeecccccccCC----Ccccc
Q psy11767 458 LLDRIRQKGRCGFTENEASRIMRQLVAAVHFMHSRGVVHRDLKPENLLFSDPAGDNIKVVDFGFACLKRES----LHTPC 533 (966)
Q Consensus 458 L~~~l~~~~~~~l~e~~~~~i~~Qil~aL~yLHs~~IiHRDLKP~NILl~~~~~~~iKL~DFGla~~~~~~----~~~~~ 533 (966)
|.+++.......+++.++..++.||+.||+|||++||+||||||+|||++. ++.+||+|||+++..... .....
T Consensus 348 L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~--~~~~kl~DFG~a~~~~~~~~~~~~~~~ 425 (535)
T 2h8h_A 348 LLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGE--NLVCKVADFGLARLIEDNEYTARQGAK 425 (535)
T ss_dssp HHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECG--GGCEEECCTTSTTTCCCHHHHTTCSTT
T ss_pred HHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCHhhEEEcC--CCcEEEcccccceecCCCceecccCCc
Confidence 999997643335899999999999999999999999999999999999975 568999999999765421 22345
Q ss_pred ccccccCchhhccCCCCCCCcccchhhhhhhhhhhhcCCCCCCCcCcchhHHHHHHHHhc-CCCCCCCCCCchhHHHHHH
Q psy11767 534 FTLQYAAPEVLRQDKSGYDENCDLWSLGVILVNVLRQDKSGYDENCDLWSLGVILYTMLC-GRVPFHARSRDDSALSIMA 612 (966)
Q Consensus 534 gT~~Y~APEvl~~~~~~~~~~~Di~SlGvil~el~~~~~~~y~~~~DIWSlGvilyemlt-G~~Pf~~~~~~~~~~~~~~ 612 (966)
+|+.|+|||++... .|+.++|||||||++|||++ |+.||.+.... .++.
T Consensus 426 ~~~~y~aPE~~~~~--------------------------~~~~~sDvwSlGv~l~el~t~g~~P~~~~~~~----~~~~ 475 (535)
T 2h8h_A 426 FPIKWTAPEAALYG--------------------------RFTIKSDVWSFGILLTELTTKGRVPYPGMVNR----EVLD 475 (535)
T ss_dssp SCGGGSCHHHHHHC--------------------------CCCHHHHHHHHHHHHHHHTTTTCCSSTTCCHH----HHHH
T ss_pred CcccccCHHHhccC--------------------------CCCchhhHHHHHHHHHHHHhCCCCCCCCCCHH----HHHH
Confidence 67889999988532 37889999999999999999 99999876532 3445
Q ss_pred HHHcCCCCCCchhhccCCHHHHHHHHHhcccCccccCChHHHHHHhhhhH
Q psy11767 613 RIKEGQFNFDAEAWSTVSSEAKELTKSLLTVNPAQRIRMMRVKLTFHAFH 662 (966)
Q Consensus 613 ~i~~~~~~~~~~~~~~is~e~~~Li~~~L~~dP~~R~t~~~v~~~~~~~~ 662 (966)
.+..+... .....+++++.+||.+||..||++|||+.++...+..+.
T Consensus 476 ~i~~~~~~---~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~L~~~~ 522 (535)
T 2h8h_A 476 QVERGYRM---PCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYF 522 (535)
T ss_dssp HHHTTCCC---CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSS
T ss_pred HHHcCCCC---CCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHh
Confidence 55554321 122467899999999999999999999998866655443
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-37 Score=346.80 Aligned_cols=247 Identities=21% Similarity=0.334 Sum_probs=194.6
Q ss_pred ccccccccccccEEEEEE----EcCCCcEEEEEEeccccC-----hHHHHHHHHHhcCCCCceEEEEEEEeCC--eEEEE
Q psy11767 381 DKAGILGDGSYSVCRRCV----EKSTGQEYAVKIISRKID-----CSEEINLLRACQGHPNIVNLHCVFQDEV--HTYLV 449 (966)
Q Consensus 381 ~~~~~LG~G~fG~Vy~a~----~~~tg~~vAvK~i~~~~~-----~~~Ei~iL~~l~~HpnIV~l~~~~~~~~--~~~lV 449 (966)
+..+.||+|+||.||+|+ +..+|+.||||++..... ..+|+.+|+.+ +||||+++++++.... ..++|
T Consensus 44 ~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~~~lv 122 (326)
T 2w1i_A 44 KFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSL-QHDNIVKYKGVCYSAGRRNLKLI 122 (326)
T ss_dssp EEEEEEECCSSEEEEEEEECTTSSSCCEEEEEEEESSCCSHHHHHHHHHHHHHHTC-CCTTBCCEEEEECC----CCEEE
T ss_pred eeeeeeccCCCeEEEEEEeccccCCCceEEEEEEeccCCHHHHHHHHHHHHHHHhC-CCCCeeeEEEEEEecCCCceEEE
Confidence 346889999999999998 467899999999975432 45799999998 5999999999987654 78999
Q ss_pred EEccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCcEEEecCCCCCEEEEeecccccccCC-
Q psy11767 450 LELLKGGELLDRIRQKGRCGFTENEASRIMRQLVAAVHFMHSRGVVHRDLKPENLLFSDPAGDNIKVVDFGFACLKRES- 528 (966)
Q Consensus 450 mEy~~gg~L~~~l~~~~~~~l~e~~~~~i~~Qil~aL~yLHs~~IiHRDLKP~NILl~~~~~~~iKL~DFGla~~~~~~- 528 (966)
|||+++++|.+++..... .+++.+++.++.||+.||+|||++||+||||||+|||++. ++.+||+|||++......
T Consensus 123 ~e~~~~~~L~~~l~~~~~-~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dikp~NIli~~--~~~~kL~Dfg~~~~~~~~~ 199 (326)
T 2w1i_A 123 MEYLPYGSLRDYLQKHKE-RIDHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILVEN--ENRVKIGDFGLTKVLPQDK 199 (326)
T ss_dssp ECCCTTCBHHHHHHHSTT-SSCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEEEE--TTEEEECCCTTCEECCSSC
T ss_pred EECCCCCCHHHHHHhccc-CCCHHHHHHHHHHHHHHHHHHHhCCEeccCCCcceEEEcC--CCcEEEecCcchhhccccc
Confidence 999999999999987543 5899999999999999999999999999999999999985 568999999999765432
Q ss_pred -----CccccccccccCchhhccCCCCCCCcccchhhhhhhhhhhhcCCCCCCCcCcchhHHHHHHHHhcCCCCCCCCCC
Q psy11767 529 -----LHTPCFTLQYAAPEVLRQDKSGYDENCDLWSLGVILVNVLRQDKSGYDENCDLWSLGVILYTMLCGRVPFHARSR 603 (966)
Q Consensus 529 -----~~~~~gT~~Y~APEvl~~~~~~~~~~~Di~SlGvil~el~~~~~~~y~~~~DIWSlGvilyemltG~~Pf~~~~~ 603 (966)
.....+|+.|+|||++... .++.++|||||||++|+|++|..||.....
T Consensus 200 ~~~~~~~~~~~~~~y~aPE~~~~~--------------------------~~~~~~Di~slG~il~el~tg~~~~~~~~~ 253 (326)
T 2w1i_A 200 EYYKVKEPGESPIFWYAPESLTES--------------------------KFSVASDVWSFGVVLYELFTYIEKSKSPPA 253 (326)
T ss_dssp SEEECSSCCSCCGGGCCHHHHHHC--------------------------EEEHHHHHHHHHHHHHHHHHTTCGGGSHHH
T ss_pred cccccccCCCCceeEECchhhcCC--------------------------CCCchhhHHHHHHHHHHHHhcCCCCCCCHH
Confidence 1234567889999998532 257789999999999999999999864210
Q ss_pred ----------c-hh-HHHHHHHHHcCCCCCCchhhccCCHHHHHHHHHhcccCccccCChHHHHHHhhh
Q psy11767 604 ----------D-DS-ALSIMARIKEGQFNFDAEAWSTVSSEAKELTKSLLTVNPAQRIRMMRVKLTFHA 660 (966)
Q Consensus 604 ----------~-~~-~~~~~~~i~~~~~~~~~~~~~~is~e~~~Li~~~L~~dP~~R~t~~~v~~~~~~ 660 (966)
. .. ...+...+..+... .....+++++.+||.+||..||++|||+.++...+..
T Consensus 254 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~l~~li~~cl~~dP~~Rps~~el~~~L~~ 319 (326)
T 2w1i_A 254 EFMRMIGNDKQGQMIVFHLIELLKNNGRL---PRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQ 319 (326)
T ss_dssp HHHHHHCTTCCTHHHHHHHHHHHHTTCCC---CCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHHHHH
T ss_pred HHHHhhccccchhhhHHHHHHHhhcCCCC---CCCCcccHHHHHHHHHHcCCChhhCcCHHHHHHHHHH
Confidence 0 00 11122233332211 1224678999999999999999999999988655543
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-37 Score=348.57 Aligned_cols=264 Identities=19% Similarity=0.312 Sum_probs=201.7
Q ss_pred ccccceecccccccccccccccccccEEEEEEEcCCCcEEEEEEecccc--ChHHHHHHHHHh-cCCCCceEEEEEEEeC
Q psy11767 367 FKGSLFFEQYDMDLDKAGILGDGSYSVCRRCVEKSTGQEYAVKIISRKI--DCSEEINLLRAC-QGHPNIVNLHCVFQDE 443 (966)
Q Consensus 367 f~G~~~~~~~~i~~~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~--~~~~Ei~iL~~l-~~HpnIV~l~~~~~~~ 443 (966)
..+..+.++|.+ .+.||+|+||.||+|.+ +|+.||||++.... ...+|+++++.+ .+||||+++++++.+.
T Consensus 35 ~~~~~~~~~y~~----~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~e~~~~~~~~l~h~ni~~~~~~~~~~ 108 (342)
T 1b6c_B 35 LVQRTIARTIVL----QESIGKGRFGEVWRGKW--RGEEVAVKIFSSREERSWFREAEIYQTVMLRHENILGFIAADNKD 108 (342)
T ss_dssp HHHHHHHHHCEE----EEEEEEETTEEEEEEEE--TTEEEEEEEECGGGHHHHHHHHHHHHHSCCCCTTBCCEEEEEECC
T ss_pred eecccccccEEE----EeeecCCCCcEEEEEEE--cCccEEEEEeCchhHHHHHHHHHHHHHhhcCCCcEEEEEeeeccc
Confidence 334445566655 68899999999999998 58999999996543 245688888774 3799999999999987
Q ss_pred C----eEEEEEEccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHH--------hcCceeccCCCCcEEEecCCC
Q psy11767 444 V----HTYLVLELLKGGELLDRIRQKGRCGFTENEASRIMRQLVAAVHFMH--------SRGVVHRDLKPENLLFSDPAG 511 (966)
Q Consensus 444 ~----~~~lVmEy~~gg~L~~~l~~~~~~~l~e~~~~~i~~Qil~aL~yLH--------s~~IiHRDLKP~NILl~~~~~ 511 (966)
. ..|+||||+++|+|.+++.+. .+++.+++.++.||+.||+||| +.||+||||||+|||++. +
T Consensus 109 ~~~~~~~~lv~e~~~~g~L~~~l~~~---~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dlkp~NIll~~--~ 183 (342)
T 1b6c_B 109 NGTWTQLWLVSDYHEHGSLFDYLNRY---TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKK--N 183 (342)
T ss_dssp CSSCCCEEEEECCCTTCBHHHHHHHC---CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCSGGGEEECT--T
T ss_pred CCccceeEEEEeecCCCcHHHHHhcc---CccHHHHHHHHHHHHHHHHHHHHHHhhhcccCCeeeCCCCHHHEEECC--C
Confidence 6 899999999999999999764 4899999999999999999999 899999999999999975 5
Q ss_pred CCEEEEeecccccccCC-------CccccccccccCchhhccCCCCCCCcccchhhhhhhhhhhhcCCCCCCCcCcchhH
Q psy11767 512 DNIKVVDFGFACLKRES-------LHTPCFTLQYAAPEVLRQDKSGYDENCDLWSLGVILVNVLRQDKSGYDENCDLWSL 584 (966)
Q Consensus 512 ~~iKL~DFGla~~~~~~-------~~~~~gT~~Y~APEvl~~~~~~~~~~~Di~SlGvil~el~~~~~~~y~~~~DIWSl 584 (966)
+.+||+|||++...... ....++|+.|+|||++...... ....++.++|||||
T Consensus 184 ~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~--------------------~~~~~~~~~Di~sl 243 (342)
T 1b6c_B 184 GTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINM--------------------KHFESFKRADIYAM 243 (342)
T ss_dssp SCEEECCCTTCEEEETTTTEEEECCCSCCCCGGGCCHHHHTSCCCT--------------------TCHHHHHHHHHHHH
T ss_pred CCEEEEECCCceeccccccccccccccCCcCcccCCHhhhcccccc--------------------cccccCCcccHHHH
Confidence 68999999999764432 2345789999999998632100 00013467999999
Q ss_pred HHHHHHHhcC----------CCCCCCCCCch-hHHHHHHHHHcCCCCCCc-hhh--ccCCHHHHHHHHHhcccCccccCC
Q psy11767 585 GVILYTMLCG----------RVPFHARSRDD-SALSIMARIKEGQFNFDA-EAW--STVSSEAKELTKSLLTVNPAQRIR 650 (966)
Q Consensus 585 GvilyemltG----------~~Pf~~~~~~~-~~~~~~~~i~~~~~~~~~-~~~--~~is~e~~~Li~~~L~~dP~~R~t 650 (966)
||++|+|++| ..||......+ ....+...+......... ..+ ...+..+.+||.+||..||++|||
T Consensus 244 G~il~el~tg~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps 323 (342)
T 1b6c_B 244 GLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLT 323 (342)
T ss_dssp HHHHHHHHTTBCBTTBCCCCCCTTTTTSCSSCCHHHHHHHHTTSCCCCCCCGGGGTSHHHHHHHHHHHHHCCSSGGGSCC
T ss_pred HHHHHHHHhccCcCCcccccccCccccCcCcccHHHHHHHHHHHHhCCCCcccccchhHHHHHHHHHHHHhccChhhCCC
Confidence 9999999999 88997654322 222333334333322211 111 134567899999999999999999
Q ss_pred hHHHHHHhhhh
Q psy11767 651 MMRVKLTFHAF 661 (966)
Q Consensus 651 ~~~v~~~~~~~ 661 (966)
+.++...+..+
T Consensus 324 ~~~i~~~L~~i 334 (342)
T 1b6c_B 324 ALRIKKTLSQL 334 (342)
T ss_dssp HHHHHHHHHHH
T ss_pred HHHHHHHHHHH
Confidence 99986655543
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.5e-38 Score=364.59 Aligned_cols=251 Identities=29% Similarity=0.447 Sum_probs=188.7
Q ss_pred ccccccccccEEEEEEEcCCCcEEEEEEecccc--ChHHHHHHHHHhcCCCCceEEEEEEEeCCeEEEEEEccCCCCHHH
Q psy11767 383 AGILGDGSYSVCRRCVEKSTGQEYAVKIISRKI--DCSEEINLLRACQGHPNIVNLHCVFQDEVHTYLVLELLKGGELLD 460 (966)
Q Consensus 383 ~~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~--~~~~Ei~iL~~l~~HpnIV~l~~~~~~~~~~~lVmEy~~gg~L~~ 460 (966)
.++||+|+||+||.+ ...+|+.||||++.... ...+|+.+|+.+.+|||||++++++.++...|||||||. |+|.+
T Consensus 20 ~~~LG~G~~g~V~~~-~~~~g~~vAvK~~~~~~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~lv~E~~~-gsL~~ 97 (434)
T 2rio_A 20 EKILGYGSSGTVVFQ-GSFQGRPVAVKRMLIDFCDIALMEIKLLTESDDHPNVIRYYCSETTDRFLYIALELCN-LNLQD 97 (434)
T ss_dssp EEEEEECSTTCEEEE-EESSSSEEEEEEEEGGGHHHHHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEEECCCS-EEHHH
T ss_pred cCeEeeCCCeEEEEE-EEECCeEEEEEEEcHHHHHHHHHHHHHHHhccCCCCcCeEEEEEecCCeEEEEEecCC-CCHHH
Confidence 467999999999875 45679999999986543 246799999887789999999999999999999999995 69999
Q ss_pred HHHhcCCCC-----CCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCcEEEecC-----------CCCCEEEEeeccccc
Q psy11767 461 RIRQKGRCG-----FTENEASRIMRQLVAAVHFMHSRGVVHRDLKPENLLFSDP-----------AGDNIKVVDFGFACL 524 (966)
Q Consensus 461 ~l~~~~~~~-----l~e~~~~~i~~Qil~aL~yLHs~~IiHRDLKP~NILl~~~-----------~~~~iKL~DFGla~~ 524 (966)
++....... .++..+..++.||+.||+|||++||+||||||+|||++.. ....+||+|||+|+.
T Consensus 98 ~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDLkp~NILl~~~~~~~~~~~~~~~~~~~kL~DFG~a~~ 177 (434)
T 2rio_A 98 LVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHSLKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKK 177 (434)
T ss_dssp HHHTC------------CCHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEECCHHHHSCCTTCCCSCEEEECCCTTCEE
T ss_pred HHhccCCCchhhhhccchhHHHHHHHHHHHHHHHHHCCccccCCChHhEEEecCcccccccccCCCceEEEEccccccee
Confidence 997654211 1333567899999999999999999999999999999742 234799999999976
Q ss_pred ccCC-------CccccccccccCchhhccCCCCCCCcccchhhhhhhhhhhhcCCCCCCCcCcchhHHHHHHHHhc-CCC
Q psy11767 525 KRES-------LHTPCFTLQYAAPEVLRQDKSGYDENCDLWSLGVILVNVLRQDKSGYDENCDLWSLGVILYTMLC-GRV 596 (966)
Q Consensus 525 ~~~~-------~~~~~gT~~Y~APEvl~~~~~~~~~~~Di~SlGvil~el~~~~~~~y~~~~DIWSlGvilyemlt-G~~ 596 (966)
.... ....+||+.|+|||++...... .....|+.++|||||||++|+|++ |+.
T Consensus 178 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~-------------------~~~~~~~~~~DiwSlG~il~ellt~g~~ 238 (434)
T 2rio_A 178 LDSGQSSFRTNLNNPSGTSGWRAPELLEESNNL-------------------QTKRRLTRSIDIFSMGCVFYYILSKGKH 238 (434)
T ss_dssp CCC--------------CCTTSCHHHHSCCCTT-------------------SCCCCCCTHHHHHHHHHHHHHHHTTSCC
T ss_pred cCCCCccceeeecCCCCCCCccCHHHhcccccc-------------------ccccCcchhhhhHhHHHHHHHHHhCCCC
Confidence 5432 2245789999999998642110 113457899999999999999999 999
Q ss_pred CCCCCCCchhHHHHHHHHHcCCCCCCch---hhccCCHHHHHHHHHhcccCccccCChHHHHHHhhhhH
Q psy11767 597 PFHARSRDDSALSIMARIKEGQFNFDAE---AWSTVSSEAKELTKSLLTVNPAQRIRMMRVKLTFHAFH 662 (966)
Q Consensus 597 Pf~~~~~~~~~~~~~~~i~~~~~~~~~~---~~~~is~e~~~Li~~~L~~dP~~R~t~~~v~~~~~~~~ 662 (966)
||......+ ..+..+.+..... ....+++++.+||.+||+.||.+|||+.++ ..|+|+
T Consensus 239 Pf~~~~~~~------~~i~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~ei--l~hp~f 299 (434)
T 2rio_A 239 PFGDKYSRE------SNIIRGIFSLDEMKCLHDRSLIAEATDLISQMIDHDPLKRPTAMKV--LRHPLF 299 (434)
T ss_dssp TTCSTTTHH------HHHHHTCCCCCCCTTCCCHHHHHHHHHHHHHHTCSSGGGSCCHHHH--HTSGGG
T ss_pred CCCCchhhH------HHHhcCCCCcccccccccccchHHHHHHHHHHhhCChhhCCCHHHH--HhCCcc
Confidence 997654322 2233333332221 122457899999999999999999999976 456665
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-38 Score=351.83 Aligned_cols=255 Identities=19% Similarity=0.273 Sum_probs=183.5
Q ss_pred ccccccccccccEEEEEEEcCCCcEEEEEEeccccC--hHHHHHHHHH-hcCCCCceEEEEEEEe-----CCeEEEEEEc
Q psy11767 381 DKAGILGDGSYSVCRRCVEKSTGQEYAVKIISRKID--CSEEINLLRA-CQGHPNIVNLHCVFQD-----EVHTYLVLEL 452 (966)
Q Consensus 381 ~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~~--~~~Ei~iL~~-l~~HpnIV~l~~~~~~-----~~~~~lVmEy 452 (966)
+..+.||+|+||.||+|.+ +++.||||++..... ...|.+++.. ..+||||+++++.+.. ....|+||||
T Consensus 16 ~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~~lv~e~ 93 (336)
T 3g2f_A 16 KLLELIGRGRYGAVYKGSL--DERPVAVKVFSFANRQNFINEKNIYRVPLMEHDNIARFIVGDERVTADGRMEYLLVMEY 93 (336)
T ss_dssp EEEEEEEECSSEEEEEEEE--TTEEEEEEEEEGGGHHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECTTSCEEEEEEECC
T ss_pred heeeecccCCCeEEEEEEE--CCeEEEEEEeeccchhhHHHHHHHHHHHhccCcchhhheecccccccCCCceEEEEEec
Confidence 3368899999999999976 689999999965432 2334444332 2379999999986643 2367999999
Q ss_pred cCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhc---------CceeccCCCCcEEEecCCCCCEEEEeecccc
Q psy11767 453 LKGGELLDRIRQKGRCGFTENEASRIMRQLVAAVHFMHSR---------GVVHRDLKPENLLFSDPAGDNIKVVDFGFAC 523 (966)
Q Consensus 453 ~~gg~L~~~l~~~~~~~l~e~~~~~i~~Qil~aL~yLHs~---------~IiHRDLKP~NILl~~~~~~~iKL~DFGla~ 523 (966)
|++|+|.+++.... +++..+..++.||+.||+|||++ ||+||||||+|||++. .+.+||+|||+|+
T Consensus 94 ~~~g~L~~~l~~~~---~~~~~~~~i~~qi~~~L~~LH~~~~~~~~~~~~ivH~Dikp~Nill~~--~~~~kL~DFG~a~ 168 (336)
T 3g2f_A 94 YPNGSLXKYLSLHT---SDWVSSCRLAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKN--DGTCVISDFGLSM 168 (336)
T ss_dssp CTTCBHHHHHHHCC---BCHHHHHHHHHHHHHHHHHHHCCBCCGGGCBCCEECSSCSGGGEEECT--TSCEEECCCTTCE
T ss_pred CCCCcHHHHHhhcc---cchhHHHHHHHHHHHHHHHHHhhhccccccccceeecccccceEEEcC--CCcEEEeecccee
Confidence 99999999997653 68999999999999999999999 9999999999999975 5699999999997
Q ss_pred cccC-----------CCccccccccccCchhhccCCCCCCCcccchhhhhhhhhhhhcCCCCCCCcCcchhHHHHHHHHh
Q psy11767 524 LKRE-----------SLHTPCFTLQYAAPEVLRQDKSGYDENCDLWSLGVILVNVLRQDKSGYDENCDLWSLGVILYTML 592 (966)
Q Consensus 524 ~~~~-----------~~~~~~gT~~Y~APEvl~~~~~~~~~~~Di~SlGvil~el~~~~~~~y~~~~DIWSlGvilyeml 592 (966)
.... .....+||+.|+|||++...... .....|+.++|||||||++|+|+
T Consensus 169 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~-------------------~~~~~~~~~~DiwslG~il~ell 229 (336)
T 3g2f_A 169 RLTGNRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNL-------------------RDXESALKQVDMYALGLIYWEIF 229 (336)
T ss_dssp ECSSSSCC---------CCTTSCGGGCCHHHHTTCCCG-------------------GGHHHHHHHHHHHHHHHHHHHHH
T ss_pred ecccccccCccccccccccCCCccceeCchhhcCCccc-------------------ccccccccccchHHHHHHHHHHH
Confidence 5432 12245689999999998632100 00123567899999999999999
Q ss_pred cCCCCCCCCCCchh--------------HHHHHHHHHcCCCC-CCchhh---ccCCHHHHHHHHHhcccCccccCChHHH
Q psy11767 593 CGRVPFHARSRDDS--------------ALSIMARIKEGQFN-FDAEAW---STVSSEAKELTKSLLTVNPAQRIRMMRV 654 (966)
Q Consensus 593 tG~~Pf~~~~~~~~--------------~~~~~~~i~~~~~~-~~~~~~---~~is~e~~~Li~~~L~~dP~~R~t~~~v 654 (966)
+|..||........ .......+...... ..++.| ..+++++.+||.+||..||++|||+.++
T Consensus 230 ~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~e~ 309 (336)
T 3g2f_A 230 MRCTDLFPGESVPEYQMAFQTEVGNHPTFEDMQVLVSREKQRPKFPEAWKENSLAVRSLKETIEDCWDQDAEARLTAQXA 309 (336)
T ss_dssp TTBGGGSTTSCCCCCCCTTHHHHCSSCCHHHHHHHHTTSCCCCCCCTTCCCCSHHHHHHHHHHHHHSCSSGGGSCCHHHH
T ss_pred hcCCcCCCccchhHHHHhhhcccCCCchHHHHHhhhcccccCCCCCcccccccchHHHHHHHHHHHhcCChhhCcchHHH
Confidence 99777654322110 00111111111111 111111 2255689999999999999999999988
Q ss_pred HHHhhhh
Q psy11767 655 KLTFHAF 661 (966)
Q Consensus 655 ~~~~~~~ 661 (966)
...+..+
T Consensus 310 l~~L~~l 316 (336)
T 3g2f_A 310 EERMAEL 316 (336)
T ss_dssp HHHHHHH
T ss_pred HHHHHHH
Confidence 6555443
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-37 Score=339.33 Aligned_cols=240 Identities=25% Similarity=0.409 Sum_probs=185.7
Q ss_pred ccccccccccccEEEEEEEcC-CCc--EEEEEEecccc--------ChHHHHHHHHHhcCCCCceEEEEEEEeCCeEEEE
Q psy11767 381 DKAGILGDGSYSVCRRCVEKS-TGQ--EYAVKIISRKI--------DCSEEINLLRACQGHPNIVNLHCVFQDEVHTYLV 449 (966)
Q Consensus 381 ~~~~~LG~G~fG~Vy~a~~~~-tg~--~vAvK~i~~~~--------~~~~Ei~iL~~l~~HpnIV~l~~~~~~~~~~~lV 449 (966)
+..+.||+|+||.||+|.+.. +++ .||||++.... ...+|+++|+.+ +||||+++++++.++. .++|
T Consensus 21 ~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~-~~~v 98 (291)
T 1u46_A 21 RLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSL-DHRNLIRLYGVVLTPP-MKMV 98 (291)
T ss_dssp EEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHC-CCTTBCCEEEEECSSS-CEEE
T ss_pred eeeeeecCCCceeEEEEEeccCCCceeEEEEEEEccCccCCHHHHHHHHHHHHHHHhC-CCCCcccEEEEEccCC-ceee
Confidence 346889999999999998653 333 68999986432 234699999998 5999999999998765 8999
Q ss_pred EEccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCcEEEecCCCCCEEEEeecccccccCC-
Q psy11767 450 LELLKGGELLDRIRQKGRCGFTENEASRIMRQLVAAVHFMHSRGVVHRDLKPENLLFSDPAGDNIKVVDFGFACLKRES- 528 (966)
Q Consensus 450 mEy~~gg~L~~~l~~~~~~~l~e~~~~~i~~Qil~aL~yLHs~~IiHRDLKP~NILl~~~~~~~iKL~DFGla~~~~~~- 528 (966)
|||+++++|.+++..... .+++.++..++.||+.||+|||++||+||||||+|||++. ++.+||+|||++......
T Consensus 99 ~e~~~~~~L~~~l~~~~~-~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~Nili~~--~~~~kl~Dfg~~~~~~~~~ 175 (291)
T 1u46_A 99 TELAPLGSLLDRLRKHQG-HFLLGTLSRYAVQVAEGMGYLESKRFIHRDLAARNLLLAT--RDLVKIGDFGLMRALPQND 175 (291)
T ss_dssp EECCTTCBHHHHHHHHGG-GSCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEEEE--TTEEEECCCTTCEECCC-C
T ss_pred EecccCCCHHHHHHhccC-CcCHHHHHHHHHHHHHHHHHHHhCCcccCCCchheEEEcC--CCCEEEccccccccccccc
Confidence 999999999999987532 5899999999999999999999999999999999999985 568999999999765332
Q ss_pred -----CccccccccccCchhhccCCCCCCCcccchhhhhhhhhhhhcCCCCCCCcCcchhHHHHHHHHhc-CCCCCCCCC
Q psy11767 529 -----LHTPCFTLQYAAPEVLRQDKSGYDENCDLWSLGVILVNVLRQDKSGYDENCDLWSLGVILYTMLC-GRVPFHARS 602 (966)
Q Consensus 529 -----~~~~~gT~~Y~APEvl~~~~~~~~~~~Di~SlGvil~el~~~~~~~y~~~~DIWSlGvilyemlt-G~~Pf~~~~ 602 (966)
.....+|+.|+|||++... .|+.++|||||||++|+|++ |+.||.+.+
T Consensus 176 ~~~~~~~~~~~~~~y~aPE~~~~~--------------------------~~~~~~Di~slG~il~~l~~~g~~p~~~~~ 229 (291)
T 1u46_A 176 DHYVMQEHRKVPFAWCAPESLKTR--------------------------TFSHASDTWMFGVTLWEMFTYGQEPWIGLN 229 (291)
T ss_dssp CEEEC-----CCGGGCCHHHHHHC--------------------------EEEHHHHHHHHHHHHHHHHTTSCCTTTTCC
T ss_pred cchhhhccCCCCceeeCchhhcCC--------------------------CCCchhhHHHHHHHHHHHHhCCCCCcccCC
Confidence 1234568889999998532 25778999999999999999 999998765
Q ss_pred CchhHHHHHHHHHcCCCCCCchhhccCCHHHHHHHHHhcccCccccCChHHHHHH
Q psy11767 603 RDDSALSIMARIKEGQFNFDAEAWSTVSSEAKELTKSLLTVNPAQRIRMMRVKLT 657 (966)
Q Consensus 603 ~~~~~~~~~~~i~~~~~~~~~~~~~~is~e~~~Li~~~L~~dP~~R~t~~~v~~~ 657 (966)
.. ..+..+......+. ....+++++.++|.+||..||++|||+.++...
T Consensus 230 ~~----~~~~~~~~~~~~~~--~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~ 278 (291)
T 1u46_A 230 GS----QILHKIDKEGERLP--RPEDCPQDIYNVMVQCWAHKPEDRPTFVALRDF 278 (291)
T ss_dssp HH----HHHHHHHTSCCCCC--CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HH----HHHHHHHccCCCCC--CCcCcCHHHHHHHHHHccCCcccCcCHHHHHHH
Confidence 32 33445544433322 234689999999999999999999999987543
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-37 Score=343.77 Aligned_cols=248 Identities=20% Similarity=0.356 Sum_probs=195.0
Q ss_pred ccccccccccccEEEEEEEcCCCcEEEEEEecccc-------ChHHHHHHHHHhcCCCCceEEEEEEEeCCeEEEEEEcc
Q psy11767 381 DKAGILGDGSYSVCRRCVEKSTGQEYAVKIISRKI-------DCSEEINLLRACQGHPNIVNLHCVFQDEVHTYLVLELL 453 (966)
Q Consensus 381 ~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~-------~~~~Ei~iL~~l~~HpnIV~l~~~~~~~~~~~lVmEy~ 453 (966)
+..+.||+|+||.||+|.+.. .||+|++.... ...+|+.+|+.+ +||||+++++++.+....++||||+
T Consensus 36 ~~~~~lg~G~~g~V~~~~~~~---~~avk~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~iv~e~~ 111 (319)
T 2y4i_B 36 EIGELIGKGRFGQVYHGRWHG---EVAIRLIDIERDNEDQLKAFKREVMAYRQT-RHENVVLFMGACMSPPHLAIITSLC 111 (319)
T ss_dssp ECCCBCCCSSSSEEEEEEESS---SEEEEECCCCSCCCCCCCCCCTTGGGGTTC-CCTTBCCCCEEEECSSCEEEECBCC
T ss_pred EEeeEeccCCceEEEEEEEcC---eEEEEEeecCCCCHHHHHHHHHHHHHHhcC-CCCCEeEEEEEEecCCceEEEeecc
Confidence 346899999999999999864 49999986431 245789999888 5999999999999999999999999
Q ss_pred CCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCcEEEecCCCCCEEEEeeccccccc-------
Q psy11767 454 KGGELLDRIRQKGRCGFTENEASRIMRQLVAAVHFMHSRGVVHRDLKPENLLFSDPAGDNIKVVDFGFACLKR------- 526 (966)
Q Consensus 454 ~gg~L~~~l~~~~~~~l~e~~~~~i~~Qil~aL~yLHs~~IiHRDLKP~NILl~~~~~~~iKL~DFGla~~~~------- 526 (966)
+|++|.+++.... ..+++.+++.++.||+.||+|||++||+||||||+|||++ ++.+||+|||+++...
T Consensus 112 ~~~~L~~~l~~~~-~~~~~~~~~~i~~qi~~al~~lH~~~i~H~dlkp~NIl~~---~~~~~l~Dfg~~~~~~~~~~~~~ 187 (319)
T 2y4i_B 112 KGRTLYSVVRDAK-IVLDVNKTRQIAQEIVKGMGYLHAKGILHKDLKSKNVFYD---NGKVVITDFGLFSISGVLQAGRR 187 (319)
T ss_dssp CSEEHHHHTTSSC-CCCCSHHHHHHHHHHHHHHHHHHHTTCCCCCCCSTTEEEC-----CCEECCCSCCC----------
T ss_pred cCCcHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCChhhEEEe---CCCEEEeecCCcccccccccccc
Confidence 9999999997644 3689999999999999999999999999999999999997 4589999999986532
Q ss_pred -CCCccccccccccCchhhccCCCCCCCcccchhhhhhhhhhhhcCCCCCCCcCcchhHHHHHHHHhcCCCCCCCCCCch
Q psy11767 527 -ESLHTPCFTLQYAAPEVLRQDKSGYDENCDLWSLGVILVNVLRQDKSGYDENCDLWSLGVILYTMLCGRVPFHARSRDD 605 (966)
Q Consensus 527 -~~~~~~~gT~~Y~APEvl~~~~~~~~~~~Di~SlGvil~el~~~~~~~y~~~~DIWSlGvilyemltG~~Pf~~~~~~~ 605 (966)
.......||+.|+|||++....... ......|+.++|||||||++|+|++|+.||......
T Consensus 188 ~~~~~~~~g~~~y~aPE~~~~~~~~~-----------------~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~- 249 (319)
T 2y4i_B 188 EDKLRIQNGWLCHLAPEIIRQLSPDT-----------------EEDKLPFSKHSDVFALGTIWYELHAREWPFKTQPAE- 249 (319)
T ss_dssp CCSCBCCSGGGGTSCHHHHSCBSCC-------------------CCCSCCCHHHHHHHHHHHHHHHHHSSCSSSSCCHH-
T ss_pred ccccccCCCcccccChHHhhhccccc-----------------cccccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH-
Confidence 1223446899999999986422100 012345788999999999999999999999875532
Q ss_pred hHHHHHHHHHcCCCCCCchhhccCCHHHHHHHHHhcccCccccCChHHHHHHhh
Q psy11767 606 SALSIMARIKEGQFNFDAEAWSTVSSEAKELTKSLLTVNPAQRIRMMRVKLTFH 659 (966)
Q Consensus 606 ~~~~~~~~i~~~~~~~~~~~~~~is~e~~~Li~~~L~~dP~~R~t~~~v~~~~~ 659 (966)
.....+..+..... ....++.++.+||.+||..||++|||+.++...+.
T Consensus 250 ---~~~~~~~~~~~~~~--~~~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~~l~ 298 (319)
T 2y4i_B 250 ---AIIWQMGTGMKPNL--SQIGMGKEISDILLFCWAFEQEERPTFTKLMDMLE 298 (319)
T ss_dssp ---HHHHHHHTTCCCCC--CCSSCCTTHHHHHHHHHCSSTTTSCCHHHHHHHHT
T ss_pred ---HHHHHhccCCCCCC--CcCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHH
Confidence 23344444433221 12357889999999999999999999998865444
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-36 Score=369.22 Aligned_cols=244 Identities=23% Similarity=0.392 Sum_probs=196.1
Q ss_pred cccccccccccccEEEEEEEcCC---CcEEEEEEecccc------ChHHHHHHHHHhcCCCCceEEEEEEEeCCeEEEEE
Q psy11767 380 LDKAGILGDGSYSVCRRCVEKST---GQEYAVKIISRKI------DCSEEINLLRACQGHPNIVNLHCVFQDEVHTYLVL 450 (966)
Q Consensus 380 ~~~~~~LG~G~fG~Vy~a~~~~t---g~~vAvK~i~~~~------~~~~Ei~iL~~l~~HpnIV~l~~~~~~~~~~~lVm 450 (966)
|+..+.||+|+||.||+|.+..+ +..||||++.... ...+|+.+|+.+ +|||||++++++. ++..|+||
T Consensus 392 y~i~~~LG~G~fG~Vy~a~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l-~HpnIv~l~~~~~-~~~~~lv~ 469 (656)
T 2j0j_A 392 IELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQF-DHPHIVKLIGVIT-ENPVWIIM 469 (656)
T ss_dssp EEEEEEEECCSSCCEEEEEECCSSSCCEEEEEEECSSTTCHHHHHHHHHHHHHHHHC-CCTTBCCEEEEEC-SSSCEEEE
T ss_pred EEEeeEEeeCCCEEEEEEEEecCCCccEEEEEEEecccCCHHHHHHHHHHHHHHHhC-CCCCCCeEEEEEe-cCceEEEE
Confidence 34468899999999999998754 5679999986532 245689999988 5999999999985 46689999
Q ss_pred EccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCcEEEecCCCCCEEEEeecccccccCCC-
Q psy11767 451 ELLKGGELLDRIRQKGRCGFTENEASRIMRQLVAAVHFMHSRGVVHRDLKPENLLFSDPAGDNIKVVDFGFACLKRESL- 529 (966)
Q Consensus 451 Ey~~gg~L~~~l~~~~~~~l~e~~~~~i~~Qil~aL~yLHs~~IiHRDLKP~NILl~~~~~~~iKL~DFGla~~~~~~~- 529 (966)
|||++|+|.+++.... ..+++..+..++.||+.||+|||++||+||||||+|||++. ++.+||+|||+|+......
T Consensus 470 E~~~~g~L~~~l~~~~-~~l~~~~~~~i~~qi~~aL~~LH~~givHrDikp~NILl~~--~~~vkL~DFG~a~~~~~~~~ 546 (656)
T 2j0j_A 470 ELCTLGELRSFLQVRK-FSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSS--NDCVKLGDFGLSRYMEDSTY 546 (656)
T ss_dssp ECCTTCBHHHHHHHTT-TTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEE--TTEEEECCCCCCCSCCC---
T ss_pred EcCCCCcHHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHhCCccccccchHhEEEeC--CCCEEEEecCCCeecCCCcc
Confidence 9999999999997654 35899999999999999999999999999999999999985 5689999999997654321
Q ss_pred ---ccccccccccCchhhccCCCCCCCcccchhhhhhhhhhhhcCCCCCCCcCcchhHHHHHHHHhc-CCCCCCCCCCch
Q psy11767 530 ---HTPCFTLQYAAPEVLRQDKSGYDENCDLWSLGVILVNVLRQDKSGYDENCDLWSLGVILYTMLC-GRVPFHARSRDD 605 (966)
Q Consensus 530 ---~~~~gT~~Y~APEvl~~~~~~~~~~~Di~SlGvil~el~~~~~~~y~~~~DIWSlGvilyemlt-G~~Pf~~~~~~~ 605 (966)
....+|+.|+|||++.. ..|+.++|||||||++|||++ |..||.+....
T Consensus 547 ~~~~~~~~t~~y~aPE~~~~--------------------------~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~~- 599 (656)
T 2j0j_A 547 YKASKGKLPIKWMAPESINF--------------------------RRFTSASDVWMFGVCMWEILMHGVKPFQGVKNN- 599 (656)
T ss_dssp -------CCGGGCCHHHHHH--------------------------CCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHH-
T ss_pred eeccCCCCCcceeCHHHhcC--------------------------CCCCchhhHHHHHHHHHHHHHcCCCCCCCCCHH-
Confidence 23456789999999853 237889999999999999997 99999876543
Q ss_pred hHHHHHHHHHcCCCCCCchhhccCCHHHHHHHHHhcccCccccCChHHHHHHhhhh
Q psy11767 606 SALSIMARIKEGQFNFDAEAWSTVSSEAKELTKSLLTVNPAQRIRMMRVKLTFHAF 661 (966)
Q Consensus 606 ~~~~~~~~i~~~~~~~~~~~~~~is~e~~~Li~~~L~~dP~~R~t~~~v~~~~~~~ 661 (966)
..+..+..+.... ....+++++.+||.+||..||++|||+.++...+..+
T Consensus 600 ---~~~~~i~~~~~~~---~~~~~~~~l~~li~~~l~~dP~~RPs~~el~~~L~~i 649 (656)
T 2j0j_A 600 ---DVIGRIENGERLP---MPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTI 649 (656)
T ss_dssp ---HHHHHHHHTCCCC---CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred ---HHHHHHHcCCCCC---CCccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHHH
Confidence 3344555543221 2246789999999999999999999999886655443
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-37 Score=337.83 Aligned_cols=229 Identities=15% Similarity=0.158 Sum_probs=181.2
Q ss_pred cccc-ceecccccccccccccccccccEEEEEEEcCCCcEEEEEEecccc--------ChHHHHHHHHHhcCCCCceEEE
Q psy11767 367 FKGS-LFFEQYDMDLDKAGILGDGSYSVCRRCVEKSTGQEYAVKIISRKI--------DCSEEINLLRACQGHPNIVNLH 437 (966)
Q Consensus 367 f~G~-~~~~~~~i~~~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~--------~~~~Ei~iL~~l~~HpnIV~l~ 437 (966)
..|. .+.++|.+ .+.||+|+||.||+|++..+|+.||||++.... ...+|+.++..+ +||||++++
T Consensus 23 ~~g~~~~~~~y~i----~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l-~hp~iv~~~ 97 (286)
T 3uqc_A 23 VPGARIANGRYRL----LIFHGGVPPLQFWQALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRI-DKPGVARVL 97 (286)
T ss_dssp CTTCEETTTTEEE----EEEEEBSTTCEEEEEEETTTTEEEEEEESCTTCCSCHHHHHHHHHHHHHHHTC-CCTTBCCEE
T ss_pred CCCCEEecCcEEE----EEEEcccCCeEEEEEEecCCCceEEEEEECcccccCHHHHHHHHHHHHHHhcC-CCCCcceee
Confidence 3444 44456666 578999999999999999999999999997542 245688888887 699999999
Q ss_pred EEEEeCCeEEEEEEccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCcEEEecCCCCCEEEE
Q psy11767 438 CVFQDEVHTYLVLELLKGGELLDRIRQKGRCGFTENEASRIMRQLVAAVHFMHSRGVVHRDLKPENLLFSDPAGDNIKVV 517 (966)
Q Consensus 438 ~~~~~~~~~~lVmEy~~gg~L~~~l~~~~~~~l~e~~~~~i~~Qil~aL~yLHs~~IiHRDLKP~NILl~~~~~~~iKL~ 517 (966)
+++.+++..|+||||++|++|.+++.. .....++..++.||+.||+|||++||+||||||+|||+++ ++.+||+
T Consensus 98 ~~~~~~~~~~lv~e~~~g~~L~~~l~~----~~~~~~~~~i~~ql~~aL~~lH~~givH~Dikp~NIll~~--~g~~kl~ 171 (286)
T 3uqc_A 98 DVVHTRAGGLVVAEWIRGGSLQEVADT----SPSPVGAIRAMQSLAAAADAAHRAGVALSIDHPSRVRVSI--DGDVVLA 171 (286)
T ss_dssp EEEEETTEEEEEEECCCEEEHHHHHTT----CCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEEET--TSCEEEC
T ss_pred EEEEECCcEEEEEEecCCCCHHHHHhc----CCChHHHHHHHHHHHHHHHHHHHCCCccCCCCcccEEEcC--CCCEEEE
Confidence 999999999999999999999999853 2466788999999999999999999999999999999985 5688887
Q ss_pred eecccccccCCCccccccccccCchhhccCCCCCCCcccchhhhhhhhhhhhcCCCCCCCcCcchhHHHHHHHHhcCCCC
Q psy11767 518 DFGFACLKRESLHTPCFTLQYAAPEVLRQDKSGYDENCDLWSLGVILVNVLRQDKSGYDENCDLWSLGVILYTMLCGRVP 597 (966)
Q Consensus 518 DFGla~~~~~~~~~~~gT~~Y~APEvl~~~~~~~~~~~Di~SlGvil~el~~~~~~~y~~~~DIWSlGvilyemltG~~P 597 (966)
++| |++| ++.++|||||||++|+|++|+.|
T Consensus 172 ~~~-----------------~~~~---------------------------------~~~~~Di~slG~il~elltg~~P 201 (286)
T 3uqc_A 172 YPA-----------------TMPD---------------------------------ANPQDDIRGIGASLYALLVNRWP 201 (286)
T ss_dssp SCC-----------------CCTT---------------------------------CCHHHHHHHHHHHHHHHHHSEEC
T ss_pred ecc-----------------ccCC---------------------------------CCchhHHHHHHHHHHHHHHCCCC
Confidence 543 3333 46788999999999999999999
Q ss_pred CCCCCCchhHHHHHHHHHcCCCCCCchhhccCCHHHHHHHHHhcccCccccCChHHHHHHh
Q psy11767 598 FHARSRDDSALSIMARIKEGQFNFDAEAWSTVSSEAKELTKSLLTVNPAQRIRMMRVKLTF 658 (966)
Q Consensus 598 f~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~is~e~~~Li~~~L~~dP~~R~t~~~v~~~~ 658 (966)
|.+.+..+.... ..+...+...........+++++.+||.+||+.||++| |+.++...+
T Consensus 202 f~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~R-s~~el~~~L 260 (286)
T 3uqc_A 202 LPEAGVRSGLAP-AERDTAGQPIEPADIDRDIPFQISAVAARSVQGDGGIR-SASTLLNLM 260 (286)
T ss_dssp SCCCSBCCCSEE-CCBCTTSCBCCHHHHCTTSCHHHHHHHHHHHCTTSSCC-CHHHHHHHH
T ss_pred CCcCCcchhhHH-HHHHhccCCCChhhcccCCCHHHHHHHHHHcccCCccC-CHHHHHHHH
Confidence 987654321000 00111222222223446789999999999999999999 998875443
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-37 Score=347.17 Aligned_cols=237 Identities=18% Similarity=0.257 Sum_probs=183.0
Q ss_pred cccccccccccEEEEEEEcCCCcEEEEEEecccc-------------ChHHHHHHHHHhc--------CCCCceEEEEEE
Q psy11767 382 KAGILGDGSYSVCRRCVEKSTGQEYAVKIISRKI-------------DCSEEINLLRACQ--------GHPNIVNLHCVF 440 (966)
Q Consensus 382 ~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~-------------~~~~Ei~iL~~l~--------~HpnIV~l~~~~ 440 (966)
..+.||+|+||+||+|++ +|+.||||++.... ...+|+.+|+.+. +|||||++++++
T Consensus 24 ~~~~lG~G~~g~V~~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~~~~~~~h~niv~l~~~~ 101 (336)
T 2vuw_A 24 RCEKIGEGVFGEVFQTIA--DHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISKELSLLSGEVCNRTEGFIGLNSVH 101 (336)
T ss_dssp TCEEEEEETTEEEEEEEE--TTEEEEEEEEEESCSSCBTTBCCBCHHHHHHHHHHHHHHHHGGGCSSSBCCCBCCEEEEE
T ss_pred heeeecccCceEEEEEEe--CCceEEEEEEecCCccccccccchhHHHHHHHHHHHHHHHHhhccccccCCchhhhccee
Confidence 368899999999999998 78999999997542 2467999999886 588888888775
Q ss_pred E------------------------------eCCeEEEEEEccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHH
Q psy11767 441 Q------------------------------DEVHTYLVLELLKGGELLDRIRQKGRCGFTENEASRIMRQLVAAVHFMH 490 (966)
Q Consensus 441 ~------------------------------~~~~~~lVmEy~~gg~L~~~l~~~~~~~l~e~~~~~i~~Qil~aL~yLH 490 (966)
. ++...|||||||++|++.+.+.+ ..+++.+++.++.||+.||+|||
T Consensus 102 ~~~~~~hp~iv~~~~~~~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~ll~~~~~---~~~~~~~~~~i~~qi~~aL~~lH 178 (336)
T 2vuw_A 102 CVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEFEFGGIDLEQMRT---KLSSLATAKSILHQLTASLAVAE 178 (336)
T ss_dssp EEESSCCHHHHHHHHHHHHHTCCSSCCSCCCCTTCEEEEEEEECCCEETGGGTT---TCCCHHHHHHHHHHHHHHHHHHH
T ss_pred EecCCCcHHHHHHHHHHhhhccccccCccccccCeEEEEEEecCCCccHHHHHh---cCCCHHHHHHHHHHHHHHHHHHH
Confidence 3 26789999999999987777744 25899999999999999999999
Q ss_pred -hcCceeccCCCCcEEEecCC------------------CCCEEEEeecccccccCCCccccccccccCchhhccCCCCC
Q psy11767 491 -SRGVVHRDLKPENLLFSDPA------------------GDNIKVVDFGFACLKRESLHTPCFTLQYAAPEVLRQDKSGY 551 (966)
Q Consensus 491 -s~~IiHRDLKP~NILl~~~~------------------~~~iKL~DFGla~~~~~~~~~~~gT~~Y~APEvl~~~~~~~ 551 (966)
++||+||||||+|||++... ...+||+|||+|+.... ...+||+.|+|||++...
T Consensus 179 ~~~~ivHrDlKp~NILl~~~~~~~~~~~~~~~~~~~~~~~~~vkL~DFG~a~~~~~--~~~~gt~~y~aPE~~~g~---- 252 (336)
T 2vuw_A 179 ASLRFEHRDLHWGNVLLKKTSLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLERD--GIVVFCDVSMDEDLFTGD---- 252 (336)
T ss_dssp HHHCCBCSCCCGGGEEEEECSCSEEEEEETTEEEEEECTTEEEEECCCTTCBEEET--TEEECCCCTTCSGGGCCC----
T ss_pred HhCCEeECCCCHHHEEEeccCCcceeeeccCccccccCCCceEEEeeccccEecCC--CcEEEeecccChhhhcCC----
Confidence 99999999999999998632 12899999999987653 245799999999998521
Q ss_pred CCcccchhhhhhhhhhhhcCCCCCCCcCcchhHHHH-HHHHhcCCCCCCCCCCchhHHHHHHHHH-c--CCCCCCchhhc
Q psy11767 552 DENCDLWSLGVILVNVLRQDKSGYDENCDLWSLGVI-LYTMLCGRVPFHARSRDDSALSIMARIK-E--GQFNFDAEAWS 627 (966)
Q Consensus 552 ~~~~Di~SlGvil~el~~~~~~~y~~~~DIWSlGvi-lyemltG~~Pf~~~~~~~~~~~~~~~i~-~--~~~~~~~~~~~ 627 (966)
.+.++||||+|++ .++++.|..||.... ........+. . .........+.
T Consensus 253 -----------------------~~~~~Diwsl~~~~~~~~~~g~~p~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~ 306 (336)
T 2vuw_A 253 -----------------------GDYQFDIYRLMKKENNNRWGEYHPYSNVL---WLHYLTDKMLKQMTFKTKCNTPAMK 306 (336)
T ss_dssp -----------------------SSHHHHHHHHHHHHHTTCTTSCCTHHHHH---HHHHHHHHHHHTCCCSSCCCSHHHH
T ss_pred -----------------------CccceehhhhhCCCCcccccccCCCcchh---hhhHHHHhhhhhhccCcccchhhhh
Confidence 2567999998777 778899999995311 0011222222 1 11122334566
Q ss_pred cCCHHHHHHHHHhcccCccccCChHHHHHH-hhhhH
Q psy11767 628 TVSSEAKELTKSLLTVNPAQRIRMMRVKLT-FHAFH 662 (966)
Q Consensus 628 ~is~e~~~Li~~~L~~dP~~R~t~~~v~~~-~~~~~ 662 (966)
.+|+++++||.+||+.| |+.++ . .|+|+
T Consensus 307 ~~s~~~~dli~~~L~~d-----sa~e~--l~~Hp~f 335 (336)
T 2vuw_A 307 QIKRKIQEFHRTMLNFS-----SATDL--LCQHSLF 335 (336)
T ss_dssp HHHHHHHHHHHHGGGSS-----SHHHH--HHHCGGG
T ss_pred hcCHHHHHHHHHHhccC-----CHHHH--HhcCCCc
Confidence 78999999999999987 77654 3 46664
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-36 Score=351.22 Aligned_cols=250 Identities=15% Similarity=0.232 Sum_probs=182.5
Q ss_pred ccccccccccccEEEEEEEcCCCcEEEEEEeccccC--------hHHHHHHHHHhcCCCCc-------------------
Q psy11767 381 DKAGILGDGSYSVCRRCVEKSTGQEYAVKIISRKID--------CSEEINLLRACQGHPNI------------------- 433 (966)
Q Consensus 381 ~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~~--------~~~Ei~iL~~l~~HpnI------------------- 433 (966)
...++||+|+||+||+|.+..+|+.||||++..... ..+|+.+++.+.+++|+
T Consensus 81 ~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~ 160 (413)
T 3dzo_A 81 VRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDLVKDP 160 (413)
T ss_dssp EEEEEEEEETTEEEEEEEETTTCCEEEEEEECCSCC----CCHHHHHHHHGGGGSTTCCSHHHHHHHTCBCCCCEEEECC
T ss_pred EEecccccCCCEEEEEEEecCCCCceEEEEEecCCCccHHHHHHHHHHHHHHHhhccCCCHHHHHHhcccccchhhcccC
Confidence 345789999999999999999999999999873322 34688877766421321
Q ss_pred --eEEEEEEEe-----CCeEEEEEEccCCCCHHHHHHh-----cCCCCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCC
Q psy11767 434 --VNLHCVFQD-----EVHTYLVLELLKGGELLDRIRQ-----KGRCGFTENEASRIMRQLVAAVHFMHSRGVVHRDLKP 501 (966)
Q Consensus 434 --V~l~~~~~~-----~~~~~lVmEy~~gg~L~~~l~~-----~~~~~l~e~~~~~i~~Qil~aL~yLHs~~IiHRDLKP 501 (966)
..+..++.. ....+++|+++ +++|.+++.. .....+++..+..++.||+.||+|||++|||||||||
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~L~~ll~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~iiHrDiKp 239 (413)
T 3dzo_A 161 QKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYGLVHTYLRP 239 (413)
T ss_dssp C---------------CCSEEEEEECC-SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHTTEECSCCCG
T ss_pred CCCccccccCCCccccccceEEEeehh-cCCHHHHHHHhhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCccc
Confidence 112122222 22467888876 6899988852 2223478889999999999999999999999999999
Q ss_pred CcEEEecCCCCCEEEEeecccccccCCCccccccccccCchhhccCCCCCCCcccchhhhhhhhhhhhcCCCCCCCcCcc
Q psy11767 502 ENLLFSDPAGDNIKVVDFGFACLKRESLHTPCFTLQYAAPEVLRQDKSGYDENCDLWSLGVILVNVLRQDKSGYDENCDL 581 (966)
Q Consensus 502 ~NILl~~~~~~~iKL~DFGla~~~~~~~~~~~gT~~Y~APEvl~~~~~~~~~~~Di~SlGvil~el~~~~~~~y~~~~DI 581 (966)
+|||++. ++.+||+|||+++.........+| +.|+|||++......+.. .....|+.++||
T Consensus 240 ~NILl~~--~~~~kL~DFG~a~~~~~~~~~~~g-~~y~aPE~~~~~~~~~~~----------------~~~~~~~~~~Dv 300 (413)
T 3dzo_A 240 VDIVLDQ--RGGVFLTGFEHLVRDGASAVSPIG-RGFAPPETTAERMLPFGQ----------------HHPTLMTFAFDT 300 (413)
T ss_dssp GGEEECT--TCCEEECCGGGCEETTEEECCCCC-TTTCCHHHHHHHTSTTGG----------------GCCEEECHHHHH
T ss_pred ceEEEec--CCeEEEEeccceeecCCccccCCC-CceeCchhhhcccccccc----------------ccCcCCCchhhH
Confidence 9999985 557999999999876665666788 999999998532100000 023347889999
Q ss_pred hhHHHHHHHHhcCCCCCCCCCCchhHHHHHHHHHcCCCCCCchhhccCCHHHHHHHHHhcccCccccCChHHHHHHhhhh
Q psy11767 582 WSLGVILYTMLCGRVPFHARSRDDSALSIMARIKEGQFNFDAEAWSTVSSEAKELTKSLLTVNPAQRIRMMRVKLTFHAF 661 (966)
Q Consensus 582 WSlGvilyemltG~~Pf~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~is~e~~~Li~~~L~~dP~~R~t~~~v~~~~~~~ 661 (966)
|||||++|+|++|+.||......+. ...+ ...+..+++++.+||.+||+.||++|||+.++. .|+|
T Consensus 301 wSlGvil~elltg~~Pf~~~~~~~~----~~~~--------~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~~~l--~~~~ 366 (413)
T 3dzo_A 301 WTLGLAIYWIWCADLPNTDDAALGG----SEWI--------FRSCKNIPQPVRALLEGFLRYPKEDRLLPLQAM--ETPE 366 (413)
T ss_dssp HHHHHHHHHHHHSSCCCCTTGGGSC----SGGG--------GSSCCCCCHHHHHHHHHHTCSSGGGSCCHHHHT--TSHH
T ss_pred HHHHHHHHHHHHCCCCCCCcchhhh----HHHH--------HhhcccCCHHHHHHHHHHccCChhhCcCHHHHH--hCHH
Confidence 9999999999999999986543221 1111 112346789999999999999999999998763 3666
Q ss_pred HHh
Q psy11767 662 HQA 664 (966)
Q Consensus 662 ~~~ 664 (966)
++.
T Consensus 367 ~~~ 369 (413)
T 3dzo_A 367 YEQ 369 (413)
T ss_dssp HHH
T ss_pred HHH
Confidence 643
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-36 Score=368.43 Aligned_cols=232 Identities=22% Similarity=0.364 Sum_probs=187.0
Q ss_pred ccceecccccccccccccccccccEEEEEEEcC-CCcEEEEEEeccccC------hHHHHHHHHHhcCCCCceEEEEEEE
Q psy11767 369 GSLFFEQYDMDLDKAGILGDGSYSVCRRCVEKS-TGQEYAVKIISRKID------CSEEINLLRACQGHPNIVNLHCVFQ 441 (966)
Q Consensus 369 G~~~~~~~~i~~~~~~~LG~G~fG~Vy~a~~~~-tg~~vAvK~i~~~~~------~~~Ei~iL~~l~~HpnIV~l~~~~~ 441 (966)
|..+.++|.+ .+.||+|+||+||+|.+.. +|+.||||++..... ..+|+.+|+.+ +|||||+++++|.
T Consensus 75 g~~~~~~y~i----~~~lg~G~~g~Vy~a~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l-~hp~iv~~~~~~~ 149 (681)
T 2pzi_A 75 GDIVAGQYEV----KGCIAHGGLGWIYLALDRNVNGRPVVLKGLVHSGDAEAQAMAMAERQFLAEV-VHPSIVQIFNFVE 149 (681)
T ss_dssp TCEETTTEEE----EEEEEEETTEEEEEEEEGGGTTEEEEEEESCSSCCHHHHHHHHHHHGGGGGC-CCTTBCCEEEEEE
T ss_pred CCEeCCceEE----EEEEeeCCCeEEEEEEEcCCCCcEEEEEEeCccCCHHHHHHHHHHHHHHHhc-CCCCcCeEeeeEe
Confidence 4445566666 6889999999999999986 799999999865432 34688888888 5999999999998
Q ss_pred eCCe-----EEEEEEccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCcEEEecCCCCCEEE
Q psy11767 442 DEVH-----TYLVLELLKGGELLDRIRQKGRCGFTENEASRIMRQLVAAVHFMHSRGVVHRDLKPENLLFSDPAGDNIKV 516 (966)
Q Consensus 442 ~~~~-----~~lVmEy~~gg~L~~~l~~~~~~~l~e~~~~~i~~Qil~aL~yLHs~~IiHRDLKP~NILl~~~~~~~iKL 516 (966)
+... .|||||||+|++|.+++.. .+++.+++.++.||+.||+|||++|||||||||+|||++. +.+||
T Consensus 150 ~~~~~~~~~~~lv~E~~~g~~L~~~~~~----~l~~~~~~~~~~qi~~aL~~lH~~giiHrDlkp~NIll~~---~~~kl 222 (681)
T 2pzi_A 150 HTDRHGDPVGYIVMEYVGGQSLKRSKGQ----KLPVAEAIAYLLEILPALSYLHSIGLVYNDLKPENIMLTE---EQLKL 222 (681)
T ss_dssp EECTTSCEEEEEEEECCCCEECC----C----CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECS---SCEEE
T ss_pred ecCCCCCceeEEEEEeCCCCcHHHHHhC----CCCHHHHHHHHHHHHHHHHHHHHCCCeecccChHHeEEeC---CcEEE
Confidence 7665 7999999999999887644 5899999999999999999999999999999999999974 38999
Q ss_pred EeecccccccCCCccccccccccCchhhccCCCCCCCcccchhhhhhhhhhhhcCCCCCCCcCcchhHHHHHHHHhcCCC
Q psy11767 517 VDFGFACLKRESLHTPCFTLQYAAPEVLRQDKSGYDENCDLWSLGVILVNVLRQDKSGYDENCDLWSLGVILYTMLCGRV 596 (966)
Q Consensus 517 ~DFGla~~~~~~~~~~~gT~~Y~APEvl~~~~~~~~~~~Di~SlGvil~el~~~~~~~y~~~~DIWSlGvilyemltG~~ 596 (966)
+|||+++..... ...+||+.|+|||++.. .++.++|||||||++|+|++|.+
T Consensus 223 ~DFG~a~~~~~~-~~~~gt~~y~aPE~~~~---------------------------~~~~~sDi~slG~~l~~l~~g~~ 274 (681)
T 2pzi_A 223 IDLGAVSRINSF-GYLYGTPGFQAPEIVRT---------------------------GPTVATDIYTVGRTLAALTLDLP 274 (681)
T ss_dssp CCCTTCEETTCC-SCCCCCTTTSCTTHHHH---------------------------CSCHHHHHHHHHHHHHHHHSCCC
T ss_pred EecccchhcccC-CccCCCccccCHHHHcC---------------------------CCCCceehhhhHHHHHHHHhCCC
Confidence 999999776543 45679999999998852 13678999999999999999999
Q ss_pred CCCCCCCchhHHHHHHHHHcCCCCCCchhhccCCHHHHHHHHHhcccCccccCChHHH
Q psy11767 597 PFHARSRDDSALSIMARIKEGQFNFDAEAWSTVSSEAKELTKSLLTVNPAQRIRMMRV 654 (966)
Q Consensus 597 Pf~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~is~e~~~Li~~~L~~dP~~R~t~~~v 654 (966)
||.+..... .. ........++.+.+||.+||..||++||+..+.
T Consensus 275 ~~~~~~~~~-------------~~-~~~~~~~~~~~l~~li~~~l~~dP~~R~~~~~~ 318 (681)
T 2pzi_A 275 TRNGRYVDG-------------LP-EDDPVLKTYDSYGRLLRRAIDPDPRQRFTTAEE 318 (681)
T ss_dssp EETTEECSS-------------CC-TTCHHHHHCHHHHHHHHHHTCSSGGGSCSSHHH
T ss_pred CCccccccc-------------cc-ccccccccCHHHHHHHhhhccCChhhCCCHHHH
Confidence 987532211 00 111122457889999999999999999976643
|
| >4aw0_A HPDK1, 3-phosphoinositide-dependent protein kinase 1; transferase, allosteric regulation, allosteric site, phosphorylation, AGC protein kinase; HET: SEP ATP MJF; 1.43A {Homo sapiens} PDB: 3hrc_A* 3hrf_A* 4a06_A* 4a07_A* 3rcj_A* 4aw1_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* 1uu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=9e-36 Score=330.18 Aligned_cols=204 Identities=25% Similarity=0.410 Sum_probs=171.5
Q ss_pred CcceeeeecccccceEEEEEEcCCCCEEEEEeccccc--------hhhHHHHHHHHhhCCCccccccccc----------
Q psy11767 117 DLDKAGILGDGSYSVCRRCVEKSTGQEYAVKIISRKI--------DCSEEINLLRACQGHPNICRRCVEK---------- 178 (966)
Q Consensus 117 df~~~~~LG~GsFGkV~La~~k~tg~~yAiKvl~K~~--------~~~~E~~il~~~~~~pfi~~~~~~~---------- 178 (966)
||+++++||+|+||+|++|+++.||+.||||+|+|.. .+.+|++||+++ +|||||+.+..+
T Consensus 33 dy~i~~~lG~G~fg~V~~a~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l-~HpnIv~l~~~~~~~~~~yivm 111 (311)
T 4aw0_A 33 DFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRL-DHPFFVKLYFTFQDDEKLYFGL 111 (311)
T ss_dssp GEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTC-CCTTBCCEEEEEECSSEEEEEE
T ss_pred ccEEEEEEecccCeEEEEEEECCCCCEEEEEEEEHHHCCCHHHHHHHHHHHHHHHhC-CCCCCCeEEEEEEeCCEEEEEE
Confidence 7899999999999999999999999999999998752 357899999998 699999733332
Q ss_pred --------------------ccchhHHHHHHHh----------hcccchhhhHhhhccCCceEEecCccc----------
Q psy11767 179 --------------------STGQEYAVKIISR----------KIDCSEEINLLRACQGHPNIVNLHCVF---------- 218 (966)
Q Consensus 179 --------------------~~~~~~~~~~v~~----------~~~~~~e~nil~~~~gh~~iv~l~~~~---------- 218 (966)
..+++++.+++.+ ..|+++| |||++.+|+++|+||+.+.
T Consensus 112 Ey~~gG~L~~~i~~~~~l~e~~~~~~~~qi~~al~ylH~~~IiHRDlKPe-NILl~~~g~vKl~DFGla~~~~~~~~~~~ 190 (311)
T 4aw0_A 112 SYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKGIIHRDLKPE-NILLNEDMHIQITDFGTAKVLSPESKQAR 190 (311)
T ss_dssp CCCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGG-GEEECTTSCEEECCCTTCEECCTTTTCCC
T ss_pred ecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCHH-HeEEcCCCCEEEEEcCCceecCCCCCccc
Confidence 3334444444433 1366777 9999999999999999763
Q ss_pred -----------cccccccccCCCcceeeechhhHHHHHHHhhCCCCCCCCcHHHHHHHHHhCCCCCCCCCCHHHHHHHHh
Q psy11767 219 -----------QDEVIDWDDFSRGIECVFFSSSLIIFFIILSFTLSFIHDYYHIQYRRILKTEPPIPEDLSPDVADFISR 287 (966)
Q Consensus 219 -----------~~e~i~~~~y~~~~d~~~~~~~~il~~~m~~g~~pf~~~~~~~~~~~I~~~~~~~P~~~s~~a~dli~~ 287 (966)
.+|++....|+..+| ||+.||++|+|++|.+||..++...++++|+++++.||+.+|++++|||++
T Consensus 191 ~~~~~GTp~YmAPEvl~~~~y~~~~D---iWSlGvilyeml~G~~PF~~~~~~~~~~~i~~~~~~~p~~~s~~~~dli~~ 267 (311)
T 4aw0_A 191 ANSFVGTAQYVSPELLTEKSACKSSD---LWALGCIIYQLVAGLPPFRAGNEGLIFAKIIKLEYDFPEKFFPKARDLVEK 267 (311)
T ss_dssp BCCCCSCGGGCCHHHHHHSCBCHHHH---HHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCTTCCHHHHHHHHH
T ss_pred ccCcccCcccCCHHHHcCCCCCcHHH---HHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCcccCHHHHHHHHH
Confidence 246677777876666 567889999999999999999999999999999999999999999999999
Q ss_pred hcccCCCcccCCCC-CCHHHHhcCCceeeeCccccccCC
Q psy11767 288 LLVKDPRRRLGGGE-LDAEELKRHPFFNVIDWDDLATKR 325 (966)
Q Consensus 288 LL~kdp~~RLG~~~-~g~~~Ik~HpfF~~idW~~l~~k~ 325 (966)
||++||.+|+++.+ .+..+|++||||++|||+.|.+++
T Consensus 268 lL~~dp~~R~t~~e~~~~~~i~~Hp~F~~idw~~l~~~~ 306 (311)
T 4aw0_A 268 LLVLDATKRLGCEEMEGYGPLKAHPFFESVTWENLHQQT 306 (311)
T ss_dssp HSCSSGGGSTTSGGGTCHHHHHTSGGGTTCCCTTGGGSC
T ss_pred HccCCHhHCcChHHHcCCHHHHCCCCcCCCCHHHhcCCC
Confidence 99999999998754 367889999999999999997664
|
| >3ubd_A Ribosomal protein S6 kinase alpha-3; kinase-inhibitor complex, induced FIT, transferase-transfera inhibitor complex; HET: SL0; 1.53A {Mus musculus} PDB: 4el9_A* 3g51_A* 2z7q_A* 2z7r_A* 2z7s_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.2e-36 Score=331.01 Aligned_cols=211 Identities=27% Similarity=0.432 Sum_probs=174.2
Q ss_pred CcceeeeecccccceEEEEEE---cCCCCEEEEEeccccc-------hhhHHHHHHHHhhCCCccccccccc--------
Q psy11767 117 DLDKAGILGDGSYSVCRRCVE---KSTGQEYAVKIISRKI-------DCSEEINLLRACQGHPNICRRCVEK-------- 178 (966)
Q Consensus 117 df~~~~~LG~GsFGkV~La~~---k~tg~~yAiKvl~K~~-------~~~~E~~il~~~~~~pfi~~~~~~~-------- 178 (966)
||+++++||+|+||+|++|++ +.|++.||||+++|.. ...+|+.+|+++ +||+||+.+..+
T Consensus 25 ~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l-~HpnIv~l~~~~~~~~~~~i 103 (304)
T 3ubd_A 25 QFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEV-NHPFIVKLHYAFQTEGKLYL 103 (304)
T ss_dssp GEEEEEEEECGGGCEEEEEEECSSTTTTCEEEEEEEESEEEEEEECC------CCCCCC-CCTTEECEEEEEEETTEEEE
T ss_pred ccEEEEEEecCCCeEEEEEEEccCCCCCEEEEEEEEehHHcChHHHHHHHHHHHHHHHC-CCCCCCeEEEEEEECCEEEE
Confidence 789999999999999999998 4578999999998752 356799999887 699998733222
Q ss_pred ----------------------ccchhHHHHHHHh----------hcccchhhhHhhhccCCceEEecCccc--------
Q psy11767 179 ----------------------STGQEYAVKIISR----------KIDCSEEINLLRACQGHPNIVNLHCVF-------- 218 (966)
Q Consensus 179 ----------------------~~~~~~~~~~v~~----------~~~~~~e~nil~~~~gh~~iv~l~~~~-------- 218 (966)
..++.++.+++.+ ..|++++ |||++.+|+++|+||+.+.
T Consensus 104 vmEy~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~-NILl~~~g~vKl~DFGla~~~~~~~~~ 182 (304)
T 3ubd_A 104 ILDFLRGGDLFTRLSKEVMFTEEDVKFYLAELALALDHLHSLGIIYRDLKPE-NILLDEEGHIKLTDFGLSKESIDHEKK 182 (304)
T ss_dssp EECCCTTCEEHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCCGG-GEEECTTSCEEEESSEEEEC-----CC
T ss_pred EEEcCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCcCCCCCHH-HeEEcCCCCEEecccccceeccCCCcc
Confidence 2223333344333 1366666 9999999999999999663
Q ss_pred -----------cccccccccCCCcceeeechhhHHHHHHHhhCCCCCCCCcHHHHHHHHHhCCCCCCCCCCHHHHHHHHh
Q psy11767 219 -----------QDEVIDWDDFSRGIECVFFSSSLIIFFIILSFTLSFIHDYYHIQYRRILKTEPPIPEDLSPDVADFISR 287 (966)
Q Consensus 219 -----------~~e~i~~~~y~~~~d~~~~~~~~il~~~m~~g~~pf~~~~~~~~~~~I~~~~~~~P~~~s~~a~dli~~ 287 (966)
.+|++....|+..+| +|+.||++|||++|.+||...+...++++|+++.+.+|..+|++++|||++
T Consensus 183 ~~~~~GT~~YmAPE~~~~~~y~~~~D---iwSlGvilyemltG~~PF~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li~~ 259 (304)
T 3ubd_A 183 AYSFCGTVEYMAPEVVNRRGHTQSAD---WWSFGVLMFEMLTGTLPFQGKDRKETMTMILKAKLGMPQFLSPEAQSLLRM 259 (304)
T ss_dssp CCSCCCCGGGCCHHHHHTSCCCTHHH---HHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCTTSCHHHHHHHHH
T ss_pred ccccccCcccCCHHHhccCCCCCCCc---ccchHHHHHHHHhCCCCCCCcCHHHHHHHHHcCCCCCCCcCCHHHHHHHHH
Confidence 246777778887766 567889999999999999999999999999999999999999999999999
Q ss_pred hcccCCCcccCCCCCCHHHHhcCCceeeeCccccccCCCCCCCCc
Q psy11767 288 LLVKDPRRRLGGGELDAEELKRHPFFNVIDWDDLATKRIPAPFVP 332 (966)
Q Consensus 288 LL~kdp~~RLG~~~~g~~~Ik~HpfF~~idW~~l~~k~~~pP~~P 332 (966)
||++||.+|+++...+++||++||||++|||++|.+++++|||+|
T Consensus 260 ~L~~dP~~R~ta~~~~~~eil~Hp~f~~idw~~l~~~~~~pP~~P 304 (304)
T 3ubd_A 260 LFKRNPANRLGAGPDGVEEIKRHSFFSTIDWNKLYRREIHPPFKP 304 (304)
T ss_dssp HTCSSGGGSTTCSTTTHHHHHTSGGGTTCCHHHHHTTCSCCSSCC
T ss_pred HcccCHHHCCCCCcCCHHHHHcCccccCCCHHHHHhCCCCcCcCC
Confidence 999999999998767899999999999999999999999999998
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-36 Score=363.66 Aligned_cols=258 Identities=24% Similarity=0.397 Sum_probs=194.4
Q ss_pred cccccccccccccccccccEEEEEEEcCCCcEEEEEEeccccC------hHHHHHHHHHhcCCCCceEEEEEEEe-----
Q psy11767 374 EQYDMDLDKAGILGDGSYSVCRRCVEKSTGQEYAVKIISRKID------CSEEINLLRACQGHPNIVNLHCVFQD----- 442 (966)
Q Consensus 374 ~~~~i~~~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~~------~~~Ei~iL~~l~~HpnIV~l~~~~~~----- 442 (966)
++|.+ .+.||+|+||.||+|.+..+|+.||||++..... ..+|+.+|+.+ +|||||++++++..
T Consensus 14 grY~i----~~~LG~G~fG~Vyla~~~~tg~~VAVKvi~~~~~~~~~~~~~~Ei~iL~~L-~HpnIV~l~~v~~~~~~~~ 88 (676)
T 3qa8_A 14 GPWEM----KERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKL-NHPNVVSAREVPDGLQKLA 88 (676)
T ss_dssp ---CC----CCCCCBCSSSBCCCCCCTTTTCCEEECCCCSCCCHHHHHHHHHHHHHHHHC-CBTTBCCEEECCTTTCCCC
T ss_pred CCeEE----EEEEeeCCCeEEEEEEECCCCcEEEEEEecccCCHHHHHHHHHHHHHHHhC-CCCCCCceeeeeccccccc
Confidence 45555 6889999999999999999999999999865432 44699999998 59999999999765
Q ss_pred -CCeEEEEEEccCCCCHHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCcEEEecCCC-CCEEEEee
Q psy11767 443 -EVHTYLVLELLKGGELLDRIRQKG-RCGFTENEASRIMRQLVAAVHFMHSRGVVHRDLKPENLLFSDPAG-DNIKVVDF 519 (966)
Q Consensus 443 -~~~~~lVmEy~~gg~L~~~l~~~~-~~~l~e~~~~~i~~Qil~aL~yLHs~~IiHRDLKP~NILl~~~~~-~~iKL~DF 519 (966)
+...|+|||||+||+|.+++.... ...+++..++.++.||+.||+|||++||+||||||+|||++.... ..+||+||
T Consensus 89 ~~~~~~LVmEy~~ggsL~~~L~~~~~~~~lse~~i~~I~~QLl~aL~yLHs~gIVHrDLKP~NILl~~~g~~~~vKL~DF 168 (676)
T 3qa8_A 89 PNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALRYLHENRIIHRDLKPENIVLQPGPQRLIHKIIDL 168 (676)
T ss_dssp TTSSCCCEEECCSSCBHHHHHHSSSCTTCCCSSHHHHHHHHHHHHHHHHHHTTBCCCCCCSTTEEEECCSSSCEEEECSC
T ss_pred CCCeEEEEEEeCCCCCHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCHHHeEeecCCCceeEEEccc
Confidence 677899999999999999998643 235899999999999999999999999999999999999985321 24899999
Q ss_pred cccccccCC--CccccccccccCchhhccCCCCCCCcccchhhhhhhhhhhhcCCCCCCCcCcchhHHHHHHHHhcCCCC
Q psy11767 520 GFACLKRES--LHTPCFTLQYAAPEVLRQDKSGYDENCDLWSLGVILVNVLRQDKSGYDENCDLWSLGVILYTMLCGRVP 597 (966)
Q Consensus 520 Gla~~~~~~--~~~~~gT~~Y~APEvl~~~~~~~~~~~Di~SlGvil~el~~~~~~~y~~~~DIWSlGvilyemltG~~P 597 (966)
|++...... ....++|+.|+|||++.. ..|+.++|||||||++|+|++|..|
T Consensus 169 G~a~~~~~~~~~~~~~gt~~Y~APE~l~~--------------------------~~~s~ksDIwSLGviLyeLltG~~P 222 (676)
T 3qa8_A 169 GYAKELDQGELCTEFVGTLQYLAPELLEQ--------------------------KKYTVTVDYWSFGTLAFECITGFRP 222 (676)
T ss_dssp CCCCBTTSCCCCCCCCSCCTTCSSCSSCC--------------------------SCCSTTHHHHHHHHHHHHHHSSCSS
T ss_pred ccccccccccccccccCCcccCChHHhcc--------------------------CCCCchhHHHHHHHHHHHHHHCCCC
Confidence 999765432 344578999999998852 2478899999999999999999999
Q ss_pred CCCCCCchhHH-----HHHH-----HHHcCCCCCC------chhhccCCHHHHHHHHHhcccCccccCChHHHHHHhhhh
Q psy11767 598 FHARSRDDSAL-----SIMA-----RIKEGQFNFD------AEAWSTVSSEAKELTKSLLTVNPAQRIRMMRVKLTFHAF 661 (966)
Q Consensus 598 f~~~~~~~~~~-----~~~~-----~i~~~~~~~~------~~~~~~is~e~~~Li~~~L~~dP~~R~t~~~v~~~~~~~ 661 (966)
|.......... .... ....+.+.+. ......+++++.+||.+||..||++|||+.++ ..|+|
T Consensus 223 f~~~~~~~~~~~~i~~~~~~~~~~~~~l~g~~~~~~~lp~p~~l~~~ls~~L~dLI~~mL~~DP~kRPTa~el--L~hp~ 300 (676)
T 3qa8_A 223 FLPNWQPVQWHGKVREKSNEHIVVYDDLTGAVKFSSVLPTPNHLSGILAGKLERWLQCMLMWHQRQRGTDPQN--PNVGC 300 (676)
T ss_dssp CCSSCHHHHSSTTCC------CCSCCCCSSSCCCCSSSCCSCCCCGGGHHHHHHHHHHHSCSSCC---CCTTC--CCCTT
T ss_pred CCcccchhhhhhhhhcccchhhhhhhhhccccccccccCCchhhchhhhHHHHHHHHHHccCCHhhCcCHHHH--hcCHH
Confidence 97642110000 0000 0011111111 11233467899999999999999999999864 34555
Q ss_pred HHh
Q psy11767 662 HQA 664 (966)
Q Consensus 662 ~~~ 664 (966)
+..
T Consensus 301 F~~ 303 (676)
T 3qa8_A 301 FQA 303 (676)
T ss_dssp HHH
T ss_pred HHH
Confidence 543
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.9e-35 Score=334.19 Aligned_cols=236 Identities=25% Similarity=0.430 Sum_probs=195.2
Q ss_pred CcceeeeecccccceEEEEEEcCCCCEEEEEeccccc--------hhhHHHHHHHHhhCCCccccccccccc--------
Q psy11767 117 DLDKAGILGDGSYSVCRRCVEKSTGQEYAVKIISRKI--------DCSEEINLLRACQGHPNICRRCVEKST-------- 180 (966)
Q Consensus 117 df~~~~~LG~GsFGkV~La~~k~tg~~yAiKvl~K~~--------~~~~E~~il~~~~~~pfi~~~~~~~~~-------- 180 (966)
||+++++||+|+||+|++|+++.||+.||||+++|.. ....|+.+|.++.+||||++....+++
T Consensus 53 ~y~~~~~LG~G~fG~V~~~~~~~~~~~~AvK~~~k~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~~lV~ 132 (396)
T 4dc2_A 53 DFDLLRVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVI 132 (396)
T ss_dssp GEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGTC----CCHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEEEE
T ss_pred HcEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhcCCCCCcCeeEEEEEECCEEEEEE
Confidence 8999999999999999999999999999999999752 357899999998899999873322222
Q ss_pred ----------------------chhHHHHHHHh----------hcccchhhhHhhhccCCceEEecCcccc---------
Q psy11767 181 ----------------------GQEYAVKIISR----------KIDCSEEINLLRACQGHPNIVNLHCVFQ--------- 219 (966)
Q Consensus 181 ----------------------~~~~~~~~v~~----------~~~~~~e~nil~~~~gh~~iv~l~~~~~--------- 219 (966)
.++++.+++.+ ..|++++ |||++.+||++|+||+.+..
T Consensus 133 E~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDLKp~-NILl~~~g~ikL~DFGla~~~~~~~~~~~ 211 (396)
T 4dc2_A 133 EYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHERGIIYRDLKLD-NVLLDSEGHIKLTDYGMCKEGLRPGDTTS 211 (396)
T ss_dssp ECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGG-GEEECTTSCEEECCCTTCBCCCCTTCCBC
T ss_pred EcCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEEeccCCHH-HEEECCCCCEEEeecceeeecccCCCccc
Confidence 23333344333 1255555 99999999999999987632
Q ss_pred ----------ccccccccCCCcceeeechhhHHHHHHHhhCCCCCCC---------CcHHHHHHHHHhCCCCCCCCCCHH
Q psy11767 220 ----------DEVIDWDDFSRGIECVFFSSSLIIFFIILSFTLSFIH---------DYYHIQYRRILKTEPPIPEDLSPD 280 (966)
Q Consensus 220 ----------~e~i~~~~y~~~~d~~~~~~~~il~~~m~~g~~pf~~---------~~~~~~~~~I~~~~~~~P~~~s~~ 280 (966)
+|++....|+..+| ||+.|+++|+|++|.+||.. .....+++.|+...+.+|..+|++
T Consensus 212 ~~~gt~~Y~aPE~l~~~~~~~~~D---iwslGvllyell~G~~Pf~~~~~~~~~~~~~~~~~~~~i~~~~~~~p~~~s~~ 288 (396)
T 4dc2_A 212 TFCGTPNYIAPEILRGEDYGFSVD---WWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIRIPRSLSVK 288 (396)
T ss_dssp CCCBCGGGCCHHHHTTCCBCTHHH---HHHHHHHHHHHHHSSCSSTTTTC------CCHHHHHHHHHHCCCCCCTTSCHH
T ss_pred cccCCcccCCchhhcCCCCChHHH---HHHHHHHHHHHHhCCCCCcccccccccchhhHHHHHHHHhccccCCCCcCCHH
Confidence 35666667776666 66788999999999999963 344568999999999999999999
Q ss_pred HHHHHHhhcccCCCcccCCCC-CCHHHHhcCCceeeeCccccccCCCCCCCCccccccccccccccccccCcCCCCC
Q psy11767 281 VADFISRLLVKDPRRRLGGGE-LDAEELKRHPFFNVIDWDDLATKRIPAPFVPKISNELDVSNFSDEFTKMIPADSP 356 (966)
Q Consensus 281 a~dli~~LL~kdp~~RLG~~~-~g~~~Ik~HpfF~~idW~~l~~k~~~pP~~P~i~~~~D~snFd~ef~~~~p~dSp 356 (966)
++|||++||++||.+|+|+.. .|++||++||||++|||+.|..++++|||+|.+.+..|++|||++|+......+|
T Consensus 289 ~~~li~~lL~~dP~~R~~~~~~~~~~ei~~Hpff~~i~w~~l~~~~~~pp~~p~~~~~~d~~~fd~~~~~~~~~~~~ 365 (396)
T 4dc2_A 289 AASVLKSFLNKDPKERLGCHPQTGFADIQGHPFFRNVDWDMMEQKQVVPPFKPNISGEFGLDNFDSQFTNEPVQLTP 365 (396)
T ss_dssp HHHHHHHHTCSCTTTSTTCSTTTHHHHHHHSTTTTTCCHHHHHTTCSCCSCCCCCCSSTTGGGSCHHHHTSCCCCCC
T ss_pred HHHHHHHHhcCCHhHcCCCCCCCCHHHHhcCccccCCCHHHHHcCCCCCCCcCCCCCccchhhcChhhccCCCccCC
Confidence 999999999999999999743 4789999999999999999999999999999999999999999999876554443
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-34 Score=326.78 Aligned_cols=236 Identities=27% Similarity=0.445 Sum_probs=197.3
Q ss_pred CcceeeeecccccceEEEEEEcCCCCEEEEEeccccc--------hhhHHHHHHHHhhCCCccccccccccc--------
Q psy11767 117 DLDKAGILGDGSYSVCRRCVEKSTGQEYAVKIISRKI--------DCSEEINLLRACQGHPNICRRCVEKST-------- 180 (966)
Q Consensus 117 df~~~~~LG~GsFGkV~La~~k~tg~~yAiKvl~K~~--------~~~~E~~il~~~~~~pfi~~~~~~~~~-------- 180 (966)
||+++++||+|+||+|++|+++.||+.||||+++|.. ...+|+.+|..+.+||||++.+..++.
T Consensus 24 ~y~~~~~lG~G~fg~V~~~~~~~~~~~~AvK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~~lv~ 103 (353)
T 3txo_A 24 NFEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLFCCFQTPDRLFFVM 103 (353)
T ss_dssp CEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHHTTHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEE
T ss_pred heEEEEEEeeCCCEEEEEEEEcCCCCEEEEEEEEHHHhcchhHHHHHHHHHHHHHhccCCCceeeEEEEEEeCCEEEEEE
Confidence 8999999999999999999999999999999999752 357899999998899999873222221
Q ss_pred ----------------------chhHHHHHHHh----------hcccchhhhHhhhccCCceEEecCcccc---------
Q psy11767 181 ----------------------GQEYAVKIISR----------KIDCSEEINLLRACQGHPNIVNLHCVFQ--------- 219 (966)
Q Consensus 181 ----------------------~~~~~~~~v~~----------~~~~~~e~nil~~~~gh~~iv~l~~~~~--------- 219 (966)
..+++.+++.+ ..|++++ |||++.+||++|+||+.+..
T Consensus 104 E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~-NILl~~~g~ikL~DFG~a~~~~~~~~~~~ 182 (353)
T 3txo_A 104 EFVNGGDLMFHIQKSRRFDEARARFYAAEIISALMFLHDKGIIYRDLKLD-NVLLDHEGHCKLADFGMCKEGICNGVTTA 182 (353)
T ss_dssp ECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGG-GEEECTTSCEEECCCTTCBCSCC------
T ss_pred eCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCHH-HEEECCCCCEEEccccceeecccCCcccc
Confidence 12333333332 1255555 99999999999999987642
Q ss_pred ----------ccccccccCCCcceeeechhhHHHHHHHhhCCCCCCCCcHHHHHHHHHhCCCCCCCCCCHHHHHHHHhhc
Q psy11767 220 ----------DEVIDWDDFSRGIECVFFSSSLIIFFIILSFTLSFIHDYYHIQYRRILKTEPPIPEDLSPDVADFISRLL 289 (966)
Q Consensus 220 ----------~e~i~~~~y~~~~d~~~~~~~~il~~~m~~g~~pf~~~~~~~~~~~I~~~~~~~P~~~s~~a~dli~~LL 289 (966)
+|++....|+...| ||+.|+++|+|++|.+||...+...++++|+++.+.||..+++++++||++||
T Consensus 183 ~~~gt~~y~aPE~~~~~~~~~~~D---iwslG~il~ell~G~~Pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~li~~lL 259 (353)
T 3txo_A 183 TFCGTPDYIAPEILQEMLYGPAVD---WWAMGVLLYEMLCGHAPFEAENEDDLFEAILNDEVVYPTWLHEDATGILKSFM 259 (353)
T ss_dssp ---CCGGGCCHHHHHHHHCTTHHH---HHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCTTSCHHHHHHHHHHT
T ss_pred ccCCCcCeEChhhcCCCCcCCccC---CCcchHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCCCCCHHHHHHHHHHh
Confidence 34555556766665 66788889999999999999999999999999999999999999999999999
Q ss_pred ccCCCcccCC-CCCCHHHHhcCCceeeeCccccccCCCCCCCCccccccccccccccccccCcCCCCC
Q psy11767 290 VKDPRRRLGG-GELDAEELKRHPFFNVIDWDDLATKRIPAPFVPKISNELDVSNFSDEFTKMIPADSP 356 (966)
Q Consensus 290 ~kdp~~RLG~-~~~g~~~Ik~HpfF~~idW~~l~~k~~~pP~~P~i~~~~D~snFd~ef~~~~p~dSp 356 (966)
++||.+|+++ ...|+++|++||||+++||+.+..++++|||+|.+.+..|++|||++|+...+..+|
T Consensus 260 ~~dP~~R~~~~~~~~~~~il~hp~f~~~~w~~l~~~~~~~p~~p~~~~~~~~~~f~~~~~~~~~~~~~ 327 (353)
T 3txo_A 260 TKNPTMRLGSLTQGGEHAILRHPFFKEIDWAQLNHRQIEPPFRPRIKSREDVSNFDPDFIKEEPVLTP 327 (353)
T ss_dssp CSSGGGSTTSGGGTCTHHHHTSGGGTTCCHHHHHTTCSCCSCCCCCCSTTCCTTSCHHHHTSCCCCCC
T ss_pred hhCHHHccCCcccCCHHHHhhCCcccCCCHHHHhcCcCCCCccCCCCCcccccccCcccccCCCcCCC
Confidence 9999999997 345789999999999999999999999999999999999999999999876655544
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=7.9e-34 Score=319.44 Aligned_cols=233 Identities=30% Similarity=0.521 Sum_probs=194.9
Q ss_pred CcceeeeecccccceEEEEEEcCCCCEEEEEeccccc--------hhhHHHHHHHHhhCCCccccccccccc--------
Q psy11767 117 DLDKAGILGDGSYSVCRRCVEKSTGQEYAVKIISRKI--------DCSEEINLLRACQGHPNICRRCVEKST-------- 180 (966)
Q Consensus 117 df~~~~~LG~GsFGkV~La~~k~tg~~yAiKvl~K~~--------~~~~E~~il~~~~~~pfi~~~~~~~~~-------- 180 (966)
||+++++||+|+||+|++|+++.||+.||||+++|.. ...+|..+|+++ +||+|+.....++.
T Consensus 6 ~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l-~hp~iv~l~~~~~~~~~~~lv~ 84 (337)
T 1o6l_A 6 DFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNT-RHPFLTALKYAFQTHDRLCFVM 84 (337)
T ss_dssp GEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSC-CCTTBCCEEEEEECSSEEEEEE
T ss_pred HeEEEEEEecCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhC-CCCcCcceEEEEEeCCEEEEEE
Confidence 7899999999999999999999999999999998752 357899999887 69999873222221
Q ss_pred ----------------------chhHHHHHHHh----------hcccchhhhHhhhccCCceEEecCccc----------
Q psy11767 181 ----------------------GQEYAVKIISR----------KIDCSEEINLLRACQGHPNIVNLHCVF---------- 218 (966)
Q Consensus 181 ----------------------~~~~~~~~v~~----------~~~~~~e~nil~~~~gh~~iv~l~~~~---------- 218 (966)
...++.+++.+ ..|++++ |||.+.+|+++|+||+.+.
T Consensus 85 E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~-NIll~~~g~vkL~DFG~a~~~~~~~~~~~ 163 (337)
T 1o6l_A 85 EYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSRDVVYRDIKLE-NLMLDKDGHIKITDFGLCKEGISDGATMK 163 (337)
T ss_dssp ECCTTCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGG-GEEECTTSCEEECCCTTCBCSCCTTCCBC
T ss_pred eCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCcCCHH-HEEECCCCCEEEeeccchhhcccCCCccc
Confidence 12233333322 1245555 9999999999999998653
Q ss_pred ---------cccccccccCCCcceeeechhhHHHHHHHhhCCCCCCCCcHHHHHHHHHhCCCCCCCCCCHHHHHHHHhhc
Q psy11767 219 ---------QDEVIDWDDFSRGIECVFFSSSLIIFFIILSFTLSFIHDYYHIQYRRILKTEPPIPEDLSPDVADFISRLL 289 (966)
Q Consensus 219 ---------~~e~i~~~~y~~~~d~~~~~~~~il~~~m~~g~~pf~~~~~~~~~~~I~~~~~~~P~~~s~~a~dli~~LL 289 (966)
.+|++....|+...| ||+.|+++|+|++|.+||...+...++++|+.+.+.+|..+++++++||++||
T Consensus 164 ~~~gt~~y~aPE~~~~~~~~~~~D---iwslG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li~~lL 240 (337)
T 1o6l_A 164 TFCGTPEYLAPEVLEDNDYGRAVD---WWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEIRFPRTLSPEAKSLLAGLL 240 (337)
T ss_dssp CCEECGGGCCGGGGSSSCBCTTHH---HHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCTTSCHHHHHHHHHHT
T ss_pred ccccChhhCChhhhcCCCCCchhh---cccchhHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCCCCCCCHHHHHHHHHHh
Confidence 245666667776666 56778899999999999999999999999999999999999999999999999
Q ss_pred ccCCCcccCCCCCCHHHHhcCCceeeeCccccccCCCCCCCCccccccccccccccccccCcCCC
Q psy11767 290 VKDPRRRLGGGELDAEELKRHPFFNVIDWDDLATKRIPAPFVPKISNELDVSNFSDEFTKMIPAD 354 (966)
Q Consensus 290 ~kdp~~RLG~~~~g~~~Ik~HpfF~~idW~~l~~k~~~pP~~P~i~~~~D~snFd~ef~~~~p~d 354 (966)
++||.+|+|++..++++|++||||+++||+.+..+++.|||+|.+.+..|++|||++|+......
T Consensus 241 ~~dP~~R~g~~~~~~~ei~~h~~f~~~~~~~~~~~~~~pp~~p~~~~~~d~~~f~~~~~~~~~~~ 305 (337)
T 1o6l_A 241 KKDPKQRLGGGPSDAKEVMEHRFFLSINWQDVVQKKLLPPFKPQVTSEVDTRYFDDEFTAQSITI 305 (337)
T ss_dssp CSSTTTSTTCSTTTHHHHHTSGGGTTCCHHHHHTTCSCCSCCCCCSSTTCCTTSCHHHHTSCCC-
T ss_pred hcCHHHhcCCCCCCHHHHHcCCCcCCCCHHHHHhCCCCCCCCCCCCCcchhhcccchhccCccCc
Confidence 99999999988778999999999999999999999999999999999999999999997654433
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-34 Score=327.24 Aligned_cols=234 Identities=24% Similarity=0.408 Sum_probs=193.4
Q ss_pred CcceeeeecccccceEEEEEEcCCCCEEEEEeccccc--------hhhHHHHHHHHhhCCCccccccccccc--------
Q psy11767 117 DLDKAGILGDGSYSVCRRCVEKSTGQEYAVKIISRKI--------DCSEEINLLRACQGHPNICRRCVEKST-------- 180 (966)
Q Consensus 117 df~~~~~LG~GsFGkV~La~~k~tg~~yAiKvl~K~~--------~~~~E~~il~~~~~~pfi~~~~~~~~~-------- 180 (966)
||+++++||+|+||+|++|+++.||+.||||+++|.. ....|+.+|.+..+||||+.....++.
T Consensus 21 ~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~~lv~ 100 (353)
T 2i0e_A 21 DFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVM 100 (353)
T ss_dssp TEEEEEEEEEETTEEEEEEEETTEEEEEEEEEEEHHHHHHTTCHHHHHHHHHHHTCTTCCTTBCCEEEEEECSSEEEEEE
T ss_pred HcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhcchHHHHHHHHHHHHHhcCCCCEEeeEEEEEEcCCEEEEEE
Confidence 8999999999999999999999999999999999752 357899999888899999863222221
Q ss_pred ----------------------chhHHHHHHHh----------hcccchhhhHhhhccCCceEEecCcccc---------
Q psy11767 181 ----------------------GQEYAVKIISR----------KIDCSEEINLLRACQGHPNIVNLHCVFQ--------- 219 (966)
Q Consensus 181 ----------------------~~~~~~~~v~~----------~~~~~~e~nil~~~~gh~~iv~l~~~~~--------- 219 (966)
..+++.+++.+ ..|++++ |||++.+||++|+||+.+..
T Consensus 101 E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~-NIll~~~g~vkL~DFG~a~~~~~~~~~~~ 179 (353)
T 2i0e_A 101 EYVNGGDLMYHIQQVGRFKEPHAVFYAAEIAIGLFFLQSKGIIYRDLKLD-NVMLDSEGHIKIADFGMCKENIWDGVTTK 179 (353)
T ss_dssp ECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGG-GEEECTTSCEEECCCTTCBCCCCTTCCBC
T ss_pred eCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCEEeccCCHH-HEEEcCCCcEEEEeCCcccccccCCcccc
Confidence 12233333332 1255555 99999999999999986642
Q ss_pred ----------ccccccccCCCcceeeechhhHHHHHHHhhCCCCCCCCcHHHHHHHHHhCCCCCCCCCCHHHHHHHHhhc
Q psy11767 220 ----------DEVIDWDDFSRGIECVFFSSSLIIFFIILSFTLSFIHDYYHIQYRRILKTEPPIPEDLSPDVADFISRLL 289 (966)
Q Consensus 220 ----------~e~i~~~~y~~~~d~~~~~~~~il~~~m~~g~~pf~~~~~~~~~~~I~~~~~~~P~~~s~~a~dli~~LL 289 (966)
+|++....|+...| ||+.|+++|+|++|.+||...+...++++|+.+.+.||..+|+++++||++||
T Consensus 180 ~~~gt~~y~aPE~~~~~~~~~~~D---iwslG~il~ell~G~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li~~lL 256 (353)
T 2i0e_A 180 TFCGTPDYIAPEIIAYQPYGKSVD---WWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEHNVAYPKSMSKEAVAICKGLM 256 (353)
T ss_dssp CCCSCGGGCCHHHHTTCCBSTHHH---HHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCTTSCHHHHHHHHHHT
T ss_pred cccCCccccChhhhcCCCcCCccc---ccchHHHHHHHHcCCCCCCCCCHHHHHHHHHhCCCCCCCCCCHHHHHHHHHHh
Confidence 34555566766655 56788889999999999999999999999999999999999999999999999
Q ss_pred ccCCCcccCCCCCCHHHHhcCCceeeeCccccccCCCCCCCCccccccccccccccccccCcCCCC
Q psy11767 290 VKDPRRRLGGGELDAEELKRHPFFNVIDWDDLATKRIPAPFVPKISNELDVSNFSDEFTKMIPADS 355 (966)
Q Consensus 290 ~kdp~~RLG~~~~g~~~Ik~HpfF~~idW~~l~~k~~~pP~~P~i~~~~D~snFd~ef~~~~p~dS 355 (966)
++||.+|+|++..++++|+.||||+++||+.+.+++++|||+|.+.+. |++|||.+|+...+..+
T Consensus 257 ~~dP~~R~~~~~~~~~~i~~h~~f~~~~w~~l~~~~~~~p~~p~~~~~-~~~~f~~~~~~~~~~~~ 321 (353)
T 2i0e_A 257 TKHPGKRLGCGPEGERDIKEHAFFRYIDWEKLERKEIQPPYKPKACGR-NAENFDRFFTRHPPVLT 321 (353)
T ss_dssp CSCTTSCTTCSTTHHHHHHTSGGGTTCCHHHHHTTCSCCSCCCCCCCC---CHHHHHHHHSCCCCC
T ss_pred hcCHHHcCCCCCCCHHHHhcCccccCCCHHHHHhCCCCCCcCCCCCCc-chhhccchhccCCcccC
Confidence 999999999887789999999999999999999999999999999888 99999998876554433
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-34 Score=348.81 Aligned_cols=235 Identities=25% Similarity=0.416 Sum_probs=199.4
Q ss_pred CcceeeeecccccceEEEEEEcCCCCEEEEEeccccc--------hhhHHHHHHHHhhCCCccccccccccc--------
Q psy11767 117 DLDKAGILGDGSYSVCRRCVEKSTGQEYAVKIISRKI--------DCSEEINLLRACQGHPNICRRCVEKST-------- 180 (966)
Q Consensus 117 df~~~~~LG~GsFGkV~La~~k~tg~~yAiKvl~K~~--------~~~~E~~il~~~~~~pfi~~~~~~~~~-------- 180 (966)
||+++++||+|+||+|++|+++.||+.||||+++|.. ....|+.+|....+||||+.....+++
T Consensus 342 ~f~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~l~~~~~~~~~~~lV~ 421 (674)
T 3pfq_A 342 DFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVM 421 (674)
T ss_dssp TEEEEEESSBTTTBCEEEEEESSSCCEEEEEEEEHHHHHHTTTTHHHHHHHHHHTCTTCCTTBCCEEEECBCSSEEEEEE
T ss_pred ceEEEEEEccCCCEEEEEEEECCCCcEEEEEEEeccccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEEEeCCEEEEEE
Confidence 9999999999999999999999999999999999752 357899999988899999863222222
Q ss_pred ----------------------chhHHHHHHHh----------hcccchhhhHhhhccCCceEEecCcccc---------
Q psy11767 181 ----------------------GQEYAVKIISR----------KIDCSEEINLLRACQGHPNIVNLHCVFQ--------- 219 (966)
Q Consensus 181 ----------------------~~~~~~~~v~~----------~~~~~~e~nil~~~~gh~~iv~l~~~~~--------- 219 (966)
..+++.+++.+ ..|++++ |||++.+||++|+||+.+..
T Consensus 422 E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~gIiHrDLKp~-NILl~~~g~ikL~DFGla~~~~~~~~~~~ 500 (674)
T 3pfq_A 422 EYVNGGDLMYHIQQVGRFKEPHAVFYAAEIAIGLFFLQSKGIIYRDLKLD-NVMLDSEGHIKIADFGMCKENIWDGVTTK 500 (674)
T ss_dssp ECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTSEECCCCCST-TEEECSSSCEEECCCTTCEECCCTTCCBC
T ss_pred eCcCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEeccCChh-hEEEcCCCcEEEeecceeeccccCCcccc
Confidence 23333444333 1255556 99999999999999986532
Q ss_pred ----------ccccccccCCCcceeeechhhHHHHHHHhhCCCCCCCCcHHHHHHHHHhCCCCCCCCCCHHHHHHHHhhc
Q psy11767 220 ----------DEVIDWDDFSRGIECVFFSSSLIIFFIILSFTLSFIHDYYHIQYRRILKTEPPIPEDLSPDVADFISRLL 289 (966)
Q Consensus 220 ----------~e~i~~~~y~~~~d~~~~~~~~il~~~m~~g~~pf~~~~~~~~~~~I~~~~~~~P~~~s~~a~dli~~LL 289 (966)
+|++....|+..+| ||+.|+++|||++|.+||...+...++++|+.+.+.||..+|++++|||++||
T Consensus 501 ~~~GT~~Y~APE~l~~~~~~~~~D---vwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li~~lL 577 (674)
T 3pfq_A 501 TFCGTPDYIAPEIIAYQPYGKSVD---WWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEHNVAYPKSMSKEAVAICKGLM 577 (674)
T ss_dssp CCCSCSSSCCHHHHTCCCBSTHHH---HHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHSSCCCCCTTSCHHHHHHHHHHS
T ss_pred cccCCCcccCHhhhcCCCCCccce---EechHHHHHHHHcCCCCCCCCCHHHHHHHHHhCCCCCCccCCHHHHHHHHHHc
Confidence 35666677877666 66788999999999999999999999999999999999999999999999999
Q ss_pred ccCCCcccCCCCCCHHHHhcCCceeeeCccccccCCCCCCCCccccccccccccccccccCcCCCCC
Q psy11767 290 VKDPRRRLGGGELDAEELKRHPFFNVIDWDDLATKRIPAPFVPKISNELDVSNFSDEFTKMIPADSP 356 (966)
Q Consensus 290 ~kdp~~RLG~~~~g~~~Ik~HpfF~~idW~~l~~k~~~pP~~P~i~~~~D~snFd~ef~~~~p~dSp 356 (966)
++||.+|+|++..|++||++||||++|||++|.+++++|||+|.+.+ .|++|||.+|+...+..+|
T Consensus 578 ~~dP~~R~~~~~~~~~ei~~h~ff~~i~w~~l~~~~~~pp~~p~~~~-~~~~~f~~~~~~~~~~~~~ 643 (674)
T 3pfq_A 578 TKHPGKRLGCGPEGERDIKEHAFFRYIDWEKLERKEIQPPYKPKASG-RNAENFDRFFTRHPPVLTP 643 (674)
T ss_dssp CSSSTTCTTCSTTHHHHHHSSGGGSSCCHHHHTTTCSCCSCCCBCCG-GGHHHHTTTTTSSCSSCCC
T ss_pred cCCHHHCCCCCCCcHHHHhcCccccCCCHHHHHhCCCCCCCCCcCCC-CchhhcCchhccCCCccCC
Confidence 99999999987778999999999999999999999999999999988 8999999999877655444
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.2e-34 Score=324.76 Aligned_cols=231 Identities=28% Similarity=0.410 Sum_probs=173.3
Q ss_pred CcceeeeecccccceEEEEEEcCCCCEEEEEeccccc--------hhhHHHHHHHHhhCCCccccccccccc--------
Q psy11767 117 DLDKAGILGDGSYSVCRRCVEKSTGQEYAVKIISRKI--------DCSEEINLLRACQGHPNICRRCVEKST-------- 180 (966)
Q Consensus 117 df~~~~~LG~GsFGkV~La~~k~tg~~yAiKvl~K~~--------~~~~E~~il~~~~~~pfi~~~~~~~~~-------- 180 (966)
||+++++||+|+||+|++|+++.+++.||||+++|.. ....|+.+|.+..+||||++.+..++.
T Consensus 39 ~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~e~~~ll~~~~hp~Iv~l~~~~~~~~~~~lv~ 118 (373)
T 2r5t_A 39 DFHFLKVIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYFVL 118 (373)
T ss_dssp GEEEEEEEECCTTCEEEEEEETTTCCEEEEEEEEGGGBC-------------CCBCCCCCTTBCCEEEEEECSSEEEEEE
T ss_pred heEEEEEEeeCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHHhCCCCCCCCEEEEEEeCCEEEEEE
Confidence 8899999999999999999999999999999998753 345667765555689999873322222
Q ss_pred ----------------------chhHHHHHHHh----------hcccchhhhHhhhccCCceEEecCcccc---------
Q psy11767 181 ----------------------GQEYAVKIISR----------KIDCSEEINLLRACQGHPNIVNLHCVFQ--------- 219 (966)
Q Consensus 181 ----------------------~~~~~~~~v~~----------~~~~~~e~nil~~~~gh~~iv~l~~~~~--------- 219 (966)
.++++.+++.+ ..|++++ |||.+.+||++|+||+.+..
T Consensus 119 E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~-NIll~~~g~ikL~DFG~a~~~~~~~~~~~ 197 (373)
T 2r5t_A 119 DYINGGELFYHLQRERCFLEPRARFYAAEIASALGYLHSLNIVYRDLKPE-NILLDSQGHIVLTDFGLCKENIEHNSTTS 197 (373)
T ss_dssp ECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGG-GEEECTTSCEEECCCCBCGGGBCCCCCCC
T ss_pred eCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCHH-HEEECCCCCEEEeeCccccccccCCCccc
Confidence 12233333322 1255555 99999999999999986642
Q ss_pred ----------ccccccccCCCcceeeechhhHHHHHHHhhCCCCCCCCcHHHHHHHHHhCCCCCCCCCCHHHHHHHHhhc
Q psy11767 220 ----------DEVIDWDDFSRGIECVFFSSSLIIFFIILSFTLSFIHDYYHIQYRRILKTEPPIPEDLSPDVADFISRLL 289 (966)
Q Consensus 220 ----------~e~i~~~~y~~~~d~~~~~~~~il~~~m~~g~~pf~~~~~~~~~~~I~~~~~~~P~~~s~~a~dli~~LL 289 (966)
+|++....|+...| ||+.|+++|+|++|.+||...+...++++|+++.+.+|..+++++++||++||
T Consensus 198 ~~~gt~~y~aPE~~~~~~~~~~~D---iwslG~il~ell~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~li~~lL 274 (373)
T 2r5t_A 198 TFCGTPEYLAPEVLHKQPYDRTVD---WWCLGAVLYEMLYGLPPFYSRNTAEMYDNILNKPLQLKPNITNSARHLLEGLL 274 (373)
T ss_dssp SBSCCCCCCCHHHHTTCCCCTHHH---HHHHHHHHHHHHHSSCTTCCSBHHHHHHHHHHSCCCCCSSSCHHHHHHHHHHT
T ss_pred cccCCccccCHHHhCCCCCCchhh---hHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHHHHHHc
Confidence 34555556666655 56788889999999999999999999999999999999999999999999999
Q ss_pred ccCCCcccCCCCCCHHHHhcCCceeeeCccccccCCCCCCCCccccccccccccccccccCcC
Q psy11767 290 VKDPRRRLGGGELDAEELKRHPFFNVIDWDDLATKRIPAPFVPKISNELDVSNFSDEFTKMIP 352 (966)
Q Consensus 290 ~kdp~~RLG~~~~g~~~Ik~HpfF~~idW~~l~~k~~~pP~~P~i~~~~D~snFd~ef~~~~p 352 (966)
++||.+|+|+. .++++|++||||+++||++|.+++++|||.|.+.+..|++|||++|+....
T Consensus 275 ~~dp~~R~~~~-~~~~~i~~h~~f~~~~w~~l~~~~~~pp~~p~~~~~~d~~~f~~~~~~~~~ 336 (373)
T 2r5t_A 275 QKDRTKRLGAK-DDFMEIKSHVFFSLINWDDLINKKITPPFNPNVSGPNDLRHFDPEFTEEPV 336 (373)
T ss_dssp CSSGGGSTTTT-TTHHHHHTSGGGTTCCHHHHHTTCSCCSCCCSCCC----------------
T ss_pred ccCHHhCCCCC-CCHHHHhCCccccCCCHHHHHhCCCCCCCCCCCCCcchhhhcCcccccccc
Confidence 99999999975 578999999999999999999999999999999999999999999877543
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* | Back alignment and structure |
|---|
Probab=99.98 E-value=5.9e-33 Score=313.38 Aligned_cols=231 Identities=26% Similarity=0.414 Sum_probs=168.0
Q ss_pred CcceeeeecccccceEEEEEEcCCCCEEEEEeccccc--------hhhHHHHHHHHhhCCCccccccccccc--------
Q psy11767 117 DLDKAGILGDGSYSVCRRCVEKSTGQEYAVKIISRKI--------DCSEEINLLRACQGHPNICRRCVEKST-------- 180 (966)
Q Consensus 117 df~~~~~LG~GsFGkV~La~~k~tg~~yAiKvl~K~~--------~~~~E~~il~~~~~~pfi~~~~~~~~~-------- 180 (966)
||.++++||+|+||+|++|+++.||+.||||+++|.. ....|+.+|.+..+||||++.+..++.
T Consensus 18 ~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~iv~l~~~~~~~~~~~lv~ 97 (345)
T 1xjd_A 18 DFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLFFVM 97 (345)
T ss_dssp TEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEEEE
T ss_pred HeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhHHhhhhhhHHHHHHHHHHHHhcCCCCCCCcEEEEEEeCCEEEEEE
Confidence 8899999999999999999999999999999998752 357899999988899999873322222
Q ss_pred ----------------------chhHHHHHHHh----------hcccchhhhHhhhccCCceEEecCcccc---------
Q psy11767 181 ----------------------GQEYAVKIISR----------KIDCSEEINLLRACQGHPNIVNLHCVFQ--------- 219 (966)
Q Consensus 181 ----------------------~~~~~~~~v~~----------~~~~~~e~nil~~~~gh~~iv~l~~~~~--------- 219 (966)
...++.+++.+ ..|++++ |||.+.+|+++|+||+.+..
T Consensus 98 E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~-NIll~~~g~vkL~DFG~a~~~~~~~~~~~ 176 (345)
T 1xjd_A 98 EYLNGGDLMYHIQSCHKFDLSRATFYAAEIILGLQFLHSKGIVYRDLKLD-NILLDKDGHIKIADFGMCKENMLGDAKTN 176 (345)
T ss_dssp ECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGG-GEEECTTSCEEECCCTTCBCCCCTTCCBC
T ss_pred eCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCChh-hEEECCCCCEEEeEChhhhhcccCCCccc
Confidence 12233333322 1245555 99999999999999986642
Q ss_pred ----------ccccccccCCCcceeeechhhHHHHHHHhhCCCCCCCCcHHHHHHHHHhCCCCCCCCCCHHHHHHHHhhc
Q psy11767 220 ----------DEVIDWDDFSRGIECVFFSSSLIIFFIILSFTLSFIHDYYHIQYRRILKTEPPIPEDLSPDVADFISRLL 289 (966)
Q Consensus 220 ----------~e~i~~~~y~~~~d~~~~~~~~il~~~m~~g~~pf~~~~~~~~~~~I~~~~~~~P~~~s~~a~dli~~LL 289 (966)
+|++....|+...| ||+.|+++|+|++|.+||...+...++++|..+.+.+|..+++++++||++||
T Consensus 177 ~~~gt~~y~aPE~~~~~~~~~~~D---iwslG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li~~lL 253 (345)
T 1xjd_A 177 TFCGTPDYIAPEILLGQKYNHSVD---WWSFGVLLYEMLIGQSPFHGQDEEELFHSIRMDNPFYPRWLEKEAKDLLVKLF 253 (345)
T ss_dssp CCCSCGGGCCHHHHTTCCBCTHHH---HHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCTTSCHHHHHHHHHHS
T ss_pred CCCCCcccCChhhhcCCCCCChhh---hHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHhCCCCCCcccCHHHHHHHHHHh
Confidence 24455556665555 56778889999999999999999999999999999999999999999999999
Q ss_pred ccCCCcccCCCCCCHHHHhcCCceeeeCccccccCCCCCCCCccccccccccccccccccCcCCCC
Q psy11767 290 VKDPRRRLGGGELDAEELKRHPFFNVIDWDDLATKRIPAPFVPKISNELDVSNFSDEFTKMIPADS 355 (966)
Q Consensus 290 ~kdp~~RLG~~~~g~~~Ik~HpfF~~idW~~l~~k~~~pP~~P~i~~~~D~snFd~ef~~~~p~dS 355 (966)
++||.+|+|.. ++|++||||+++||+.+..++++|||.|.+.+..|++|||.+|+...+..+
T Consensus 254 ~~dp~~R~~~~----~~i~~hp~f~~~~w~~l~~~~~~~p~~p~~~~~~d~~~f~~~~~~~~~~~~ 315 (345)
T 1xjd_A 254 VREPEKRLGVR----GDIRQHPLFREINWEELERKEIDPPFRPKVKSPFDCSNFDKEFLNEKPRLS 315 (345)
T ss_dssp CSSGGGSBTTB----SCGGGSGGGTTCCHHHHHTTCSCC---------------------------
T ss_pred cCCHhHcCCCh----HHHHcCccccCCCHHHHhhCCCCCCcCCCCCCcchhhhcchhhcccCccCC
Confidence 99999999752 389999999999999999999999999999999999999998877654433
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* | Back alignment and structure |
|---|
Probab=99.98 E-value=3.4e-32 Score=306.99 Aligned_cols=233 Identities=25% Similarity=0.432 Sum_probs=189.5
Q ss_pred CcceeeeecccccceEEEEEEcCCCCEEEEEeccccc--------hhhHHHHHHHHhhCCCccccccccccc--------
Q psy11767 117 DLDKAGILGDGSYSVCRRCVEKSTGQEYAVKIISRKI--------DCSEEINLLRACQGHPNICRRCVEKST-------- 180 (966)
Q Consensus 117 df~~~~~LG~GsFGkV~La~~k~tg~~yAiKvl~K~~--------~~~~E~~il~~~~~~pfi~~~~~~~~~-------- 180 (966)
||+++++||+|+||+|++|+++.||+.||||+++|.. ...+|+.+|+++.+||+|++....+..
T Consensus 10 ~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~~lv~ 89 (345)
T 3a8x_A 10 DFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVI 89 (345)
T ss_dssp GEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGSCSHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEE
T ss_pred heEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEhHHhcchHHHHHHHHHHHHHHhcCCCCccCeEEEEEEeCCEEEEEE
Confidence 7899999999999999999999999999999999752 357799999998889999873222211
Q ss_pred ----------------------chhHHHHHHHh----------hcccchhhhHhhhccCCceEEecCcccc---------
Q psy11767 181 ----------------------GQEYAVKIISR----------KIDCSEEINLLRACQGHPNIVNLHCVFQ--------- 219 (966)
Q Consensus 181 ----------------------~~~~~~~~v~~----------~~~~~~e~nil~~~~gh~~iv~l~~~~~--------- 219 (966)
...++.+++.+ ..|++++ |||.+.+|+++|+||+.+..
T Consensus 90 e~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~-NIll~~~g~~kL~DFG~a~~~~~~~~~~~ 168 (345)
T 3a8x_A 90 EYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHERGIIYRDLKLD-NVLLDSEGHIKLTDYGMCKEGLRPGDTTS 168 (345)
T ss_dssp CCCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGG-GEEECTTSCEEECCGGGCBCSCCTTCCBC
T ss_pred eCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCHH-HEEECCCCCEEEEeccccccccCCCCccc
Confidence 12233333322 1245555 99999999999999986642
Q ss_pred ----------ccccccccCCCcceeeechhhHHHHHHHhhCCCCCCC---------CcHHHHHHHHHhCCCCCCCCCCHH
Q psy11767 220 ----------DEVIDWDDFSRGIECVFFSSSLIIFFIILSFTLSFIH---------DYYHIQYRRILKTEPPIPEDLSPD 280 (966)
Q Consensus 220 ----------~e~i~~~~y~~~~d~~~~~~~~il~~~m~~g~~pf~~---------~~~~~~~~~I~~~~~~~P~~~s~~ 280 (966)
+|++....|+...| ||+.|+++|+|++|.+||.. .....+++.|+...+.+|..++++
T Consensus 169 ~~~gt~~y~aPE~~~~~~~~~~~D---iwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~i~~~~~~~p~~~s~~ 245 (345)
T 3a8x_A 169 TFCGTPNYIAPEILRGEDYGFSVD---WWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIRIPRSLSVK 245 (345)
T ss_dssp CCCSCGGGCCHHHHTTCCBCTHHH---HHHHHHHHHHHHHSSCTTTTTTC-------CHHHHHHHHHHCCCCCCTTSCHH
T ss_pred ccCCCccccCccccCCCCCChHHh---HHHHHHHHHHHHhCCCCcCCcccccccccccHHHHHHHHHcCCCCCCCCCCHH
Confidence 34555556766555 56778889999999999975 455678999999999999999999
Q ss_pred HHHHHHhhcccCCCcccCCC-CCCHHHHhcCCceeeeCccccccCCCCCCCCccccccccccccccccccCcCC
Q psy11767 281 VADFISRLLVKDPRRRLGGG-ELDAEELKRHPFFNVIDWDDLATKRIPAPFVPKISNELDVSNFSDEFTKMIPA 353 (966)
Q Consensus 281 a~dli~~LL~kdp~~RLG~~-~~g~~~Ik~HpfF~~idW~~l~~k~~~pP~~P~i~~~~D~snFd~ef~~~~p~ 353 (966)
+++||++||++||.+|+|+. ..|+++|++||||+++||+.+.+++++|||.|.+.+..|++||+.+|+.....
T Consensus 246 ~~~li~~lL~~dP~~R~~~~~~~~~~~i~~hp~f~~~~w~~~~~~~~~~p~~p~~~~~~~~~~~~~~~~~~~~~ 319 (345)
T 3a8x_A 246 AASVLKSFLNKDPKERLGCHPQTGFADIQGHPFFRNVDWDMMEQKQVVPPFKPNISGEFGLDNFDSQFTNEPVQ 319 (345)
T ss_dssp HHHHHHHHTCSSTTTSTTCCTTTHHHHHHTSGGGTTCCHHHHHTTCSCCSCCCCCCTTTCGGGSCHHHHTSCSS
T ss_pred HHHHHHHHhcCCHhHCCCCCCcCCHHHHhcCCccCCCCHHHHHhCCCCCCcCCCCCCcchhhhcCcccccCccc
Confidence 99999999999999999974 24689999999999999999999999999999999999999999988765443
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=99.97 E-value=7e-32 Score=301.04 Aligned_cols=225 Identities=27% Similarity=0.449 Sum_probs=177.6
Q ss_pred CcceeeeecccccceEEEEEEcCCCCEEEEEeccccc--------hhhHHHHHHHHhhCCCccccccccccc--------
Q psy11767 117 DLDKAGILGDGSYSVCRRCVEKSTGQEYAVKIISRKI--------DCSEEINLLRACQGHPNICRRCVEKST-------- 180 (966)
Q Consensus 117 df~~~~~LG~GsFGkV~La~~k~tg~~yAiKvl~K~~--------~~~~E~~il~~~~~~pfi~~~~~~~~~-------- 180 (966)
||+++++||+|+||+|++|+++.+|+.||||+++|.. ...+|+.+|+.+ +||+|++.+..+..
T Consensus 7 ~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l-~hp~Iv~~~~~~~~~~~~~lv~ 85 (318)
T 1fot_A 7 DFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIV-THPFIIRMWGTFQDAQQIFMIM 85 (318)
T ss_dssp GEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSC-CBTTBCCEEEEEECSSEEEEEE
T ss_pred HcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhhC-CCCCCceEeEEEEeCCEEEEEE
Confidence 7899999999999999999999999999999998752 346789998887 79999873222211
Q ss_pred ----------------------chhHHHHHHHh----------hcccchhhhHhhhccCCceEEecCccc----------
Q psy11767 181 ----------------------GQEYAVKIISR----------KIDCSEEINLLRACQGHPNIVNLHCVF---------- 218 (966)
Q Consensus 181 ----------------------~~~~~~~~v~~----------~~~~~~e~nil~~~~gh~~iv~l~~~~---------- 218 (966)
...++.+++.+ ..|++++ |||.+.+|+++|+||+.+.
T Consensus 86 e~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~-NIll~~~g~~kL~Dfg~a~~~~~~~~~~~ 164 (318)
T 1fot_A 86 DYIEGGELFSLLRKSQRFPNPVAKFYAAEVCLALEYLHSKDIIYRDLKPE-NILLDKNGHIKITDFGFAKYVPDVTYTLC 164 (318)
T ss_dssp CCCCSCBHHHHHHHTSSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGG-GEEECTTSCEEECCCSSCEECSSCBCCCC
T ss_pred eCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChh-eEEEcCCCCEEEeecCcceecCCcccccc
Confidence 12222333322 1244555 9999999999999998663
Q ss_pred ------cccccccccCCCcceeeechhhHHHHHHHhhCCCCCCCCcHHHHHHHHHhCCCCCCCCCCHHHHHHHHhhcccC
Q psy11767 219 ------QDEVIDWDDFSRGIECVFFSSSLIIFFIILSFTLSFIHDYYHIQYRRILKTEPPIPEDLSPDVADFISRLLVKD 292 (966)
Q Consensus 219 ------~~e~i~~~~y~~~~d~~~~~~~~il~~~m~~g~~pf~~~~~~~~~~~I~~~~~~~P~~~s~~a~dli~~LL~kd 292 (966)
.+|++....|+...| ||+.|+++|+|++|.+||...+...++++|+++.+.||..+++++++||++||++|
T Consensus 165 gt~~y~aPE~~~~~~~~~~~D---iwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~li~~lL~~d 241 (318)
T 1fot_A 165 GTPDYIAPEVVSTKPYNKSID---WWSFGILIYEMLAGYTPFYDSNTMKTYEKILNAELRFPPFFNEDVKDLLSRLITRD 241 (318)
T ss_dssp SCTTTCCHHHHTTCCBCTTHH---HHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHCCCCCCTTSCHHHHHHHHHHTCSC
T ss_pred CCccccCHhHhcCCCCCcccc---hhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCCCCCHHHHHHHHHHhccC
Confidence 245666666766666 56788899999999999999999999999999999999999999999999999999
Q ss_pred CCcccCCCCCCHHHHhcCCceeeeCccccccCCCCCCCCcccc-ccccccccccc
Q psy11767 293 PRRRLGGGELDAEELKRHPFFNVIDWDDLATKRIPAPFVPKIS-NELDVSNFSDE 346 (966)
Q Consensus 293 p~~RLG~~~~g~~~Ik~HpfF~~idW~~l~~k~~~pP~~P~i~-~~~D~snFd~e 346 (966)
|.+|+|+...++++|++||||++++|+.+..++++|||.|.+. +..|++|||..
T Consensus 242 p~~R~~~~~~~~~~i~~hp~f~~~~~~~~~~~~~~~p~~p~~~~~~~d~~~f~~~ 296 (318)
T 1fot_A 242 LSQRLGNLQNGTEDVKNHPWFKEVVWEKLLSRNIETPYEPPIQQGQGDTSQFDKY 296 (318)
T ss_dssp TTTCTTSSTTTTHHHHTSGGGSSCCHHHHHTTCSCCSCCCCC-------------
T ss_pred HHHcCCCcCCCHHHHhcCccccCCCHHHHHhCCCCCCCCCCcCCCccchhhcCCC
Confidence 9999998777899999999999999999999999999999998 48899999863
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... | Back alignment and structure |
|---|
Probab=99.97 E-value=1.3e-31 Score=302.95 Aligned_cols=228 Identities=24% Similarity=0.418 Sum_probs=189.8
Q ss_pred CcceeeeecccccceEEEEEEcCCCCEEEEEeccccc--------hhhHHHHHHHHhhCCCccccccccccc--------
Q psy11767 117 DLDKAGILGDGSYSVCRRCVEKSTGQEYAVKIISRKI--------DCSEEINLLRACQGHPNICRRCVEKST-------- 180 (966)
Q Consensus 117 df~~~~~LG~GsFGkV~La~~k~tg~~yAiKvl~K~~--------~~~~E~~il~~~~~~pfi~~~~~~~~~-------- 180 (966)
||+++++||+|+||+|++|+++.||+.||||+++|.. ...+|..+|+++ +||+|++....+..
T Consensus 42 ~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l-~hp~iv~~~~~~~~~~~~~lv~ 120 (350)
T 1rdq_E 42 QFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAV-NFPFLVKLEFSFKDNSNLYMVM 120 (350)
T ss_dssp GEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTC-CCTTBCCEEEEEECSSEEEEEE
T ss_pred HCEEEEEeecCcCcEEEEEEECCCCCEEEEEEEEhHHhccHHHHHHHHHHHHHHHhC-CCCCCCeEEEEEEcCCEEEEEE
Confidence 8899999999999999999999999999999998752 356799999887 79999873222221
Q ss_pred ----------------------chhHHHHHHHh----------hcccchhhhHhhhccCCceEEecCccc----------
Q psy11767 181 ----------------------GQEYAVKIISR----------KIDCSEEINLLRACQGHPNIVNLHCVF---------- 218 (966)
Q Consensus 181 ----------------------~~~~~~~~v~~----------~~~~~~e~nil~~~~gh~~iv~l~~~~---------- 218 (966)
...++.+++.+ ..|++++ |||.+.+|+++|+||+.+.
T Consensus 121 e~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~-NIll~~~g~~kL~DFg~a~~~~~~~~~~~ 199 (350)
T 1rdq_E 121 EYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPE-NLLIDQQGYIQVTDFGFAKRVKGRTWTLC 199 (350)
T ss_dssp ECCTTCBHHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGG-GEEECTTSCEEECCCTTCEECSSCBCCCE
T ss_pred cCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCccc-eEEECCCCCEEEcccccceeccCCccccc
Confidence 12222333322 1245555 9999999999999998763
Q ss_pred ------cccccccccCCCcceeeechhhHHHHHHHhhCCCCCCCCcHHHHHHHHHhCCCCCCCCCCHHHHHHHHhhcccC
Q psy11767 219 ------QDEVIDWDDFSRGIECVFFSSSLIIFFIILSFTLSFIHDYYHIQYRRILKTEPPIPEDLSPDVADFISRLLVKD 292 (966)
Q Consensus 219 ------~~e~i~~~~y~~~~d~~~~~~~~il~~~m~~g~~pf~~~~~~~~~~~I~~~~~~~P~~~s~~a~dli~~LL~kd 292 (966)
.+|++....|+...| ||+.|+++|+|++|.+||...+...++++|+.+.+.+|..+++++++||++||++|
T Consensus 200 gt~~y~aPE~~~~~~~~~~~D---iwslG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~li~~lL~~d 276 (350)
T 1rdq_E 200 GTPEALAPEIILSKGYNKAVD---WWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHFSSDLKDLLRNLLQVD 276 (350)
T ss_dssp ECGGGCCHHHHTTCCBCTHHH---HHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCTTCCHHHHHHHHHHSCSC
T ss_pred CCccccCHHHhcCCCCCCcCC---EecccHhHhHHhhCCCCCCCCCHHHHHHHHHcCCCCCCCCCCHHHHHHHHHHhhcC
Confidence 245666666766655 55778889999999999999999999999999999999999999999999999999
Q ss_pred CCcccCCCCCCHHHHhcCCceeeeCccccccCCCCCCCCccccccccccccccccccC
Q psy11767 293 PRRRLGGGELDAEELKRHPFFNVIDWDDLATKRIPAPFVPKISNELDVSNFSDEFTKM 350 (966)
Q Consensus 293 p~~RLG~~~~g~~~Ik~HpfF~~idW~~l~~k~~~pP~~P~i~~~~D~snFd~ef~~~ 350 (966)
|.+|+++...++++|++||||+++||+.+..++++|||+|.+.+..|++||| +|+..
T Consensus 277 p~~R~~~~~~~~~ei~~h~~f~~~~w~~~~~~~~~~p~~p~~~~~~~~~~f~-~~~~~ 333 (350)
T 1rdq_E 277 LTKRFGNLKNGVNDIKNHKWFATTDWIAIYQRKVEAPFIPKFKGPGDTSNFD-DYEEE 333 (350)
T ss_dssp TTTCTTSSTTTTHHHHTSGGGTTCCHHHHHTTCSCCSCCCCCCSTTCCTTSC-CCCCC
T ss_pred HHhccCCccCCHHHHHhCcCcCCCCHHHHhhccCCCCCCCCCCCcccccccc-ccccc
Confidence 9999998777899999999999999999999999999999999999999999 45543
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3twj_A* 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=3.1e-31 Score=306.12 Aligned_cols=227 Identities=24% Similarity=0.394 Sum_probs=182.1
Q ss_pred CcceeeeecccccceEEEEEEcCCCCEEEEEeccccc--------hhhHHHHHHHHhhCCCccccccccccc--------
Q psy11767 117 DLDKAGILGDGSYSVCRRCVEKSTGQEYAVKIISRKI--------DCSEEINLLRACQGHPNICRRCVEKST-------- 180 (966)
Q Consensus 117 df~~~~~LG~GsFGkV~La~~k~tg~~yAiKvl~K~~--------~~~~E~~il~~~~~~pfi~~~~~~~~~-------- 180 (966)
||+++++||+|+||+|++|+++.||+.||||+++|.. ...+|+.+|..+ +||+|++.+..++.
T Consensus 70 ~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~E~~il~~l-~hp~Iv~l~~~~~~~~~~~lV~ 148 (410)
T 3v8s_A 70 DYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFA-NSPWVVQLFYAFQDDRYLYMVM 148 (410)
T ss_dssp GEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTCCCSTHHHHHHHHHHC-CCTTBCCEEEEEECSSEEEEEE
T ss_pred ccEEEEEEEcCCCEEEEEEEECCCCcEEEEEEEehhhhhhhHHHHHHHHHHHHHHhC-CCCCCCeEEEEEEECCEEEEEE
Confidence 8999999999999999999999999999999998742 357899999887 69999873222221
Q ss_pred ---------------------chhHHHHHHHh----------hcccchhhhHhhhccCCceEEecCcccc----------
Q psy11767 181 ---------------------GQEYAVKIISR----------KIDCSEEINLLRACQGHPNIVNLHCVFQ---------- 219 (966)
Q Consensus 181 ---------------------~~~~~~~~v~~----------~~~~~~e~nil~~~~gh~~iv~l~~~~~---------- 219 (966)
.++++.+++.+ ..|++++ |||++.+||++|+||+.+..
T Consensus 149 E~~~gg~L~~~l~~~~~~e~~~~~~~~qi~~aL~~LH~~givHrDLKp~-NILl~~~g~ikL~DFG~a~~~~~~~~~~~~ 227 (410)
T 3v8s_A 149 EYMPGGDLVNLMSNYDVPEKWARFYTAEVVLALDAIHSMGFIHRDVKPD-NMLLDKSGHLKLADFGTCMKMNKEGMVRCD 227 (410)
T ss_dssp CCCTTEEHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGG-GEEECTTSCEEECCCTTCEECCTTSEEECC
T ss_pred eCCCCCcHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHH-HeeECCCCCEEEeccceeEeeccCCccccc
Confidence 23333344332 1255555 99999999999999987631
Q ss_pred ----------cccccccc----CCCcceeeechhhHHHHHHHhhCCCCCCCCcHHHHHHHHHhC--CCCCCC--CCCHHH
Q psy11767 220 ----------DEVIDWDD----FSRGIECVFFSSSLIIFFIILSFTLSFIHDYYHIQYRRILKT--EPPIPE--DLSPDV 281 (966)
Q Consensus 220 ----------~e~i~~~~----y~~~~d~~~~~~~~il~~~m~~g~~pf~~~~~~~~~~~I~~~--~~~~P~--~~s~~a 281 (966)
+|++...+ |+...| ||+.|+++|+|++|.+||..++...++++|+++ .+.||. .+|+++
T Consensus 228 ~~~gt~~Y~APE~l~~~~~~~~~~~~~D---iwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~ 304 (410)
T 3v8s_A 228 TAVGTPDYISPEVLKSQGGDGYYGRECD---WWSVGVFLYEMLVGDTPFYADSLVGTYSKIMNHKNSLTFPDDNDISKEA 304 (410)
T ss_dssp SCCSCGGGCCHHHHHTTTTTCEEETHHH---HHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTHHHHCCCCTTCCCCHHH
T ss_pred CCcCCccccCHHHhhccCCCcCCCCcce---EecchHHHHHHHhCCCCCCCCChhhHHHHHHhccccccCCCcccccHHH
Confidence 24444332 444444 667888999999999999999999999999975 467775 699999
Q ss_pred HHHHHhhcccCCCcccCCCCCCHHHHhcCCceeeeCccccccCCCCCCCCccccccccccccccccccCc
Q psy11767 282 ADFISRLLVKDPRRRLGGGELDAEELKRHPFFNVIDWDDLATKRIPAPFVPKISNELDVSNFSDEFTKMI 351 (966)
Q Consensus 282 ~dli~~LL~kdp~~RLG~~~~g~~~Ik~HpfF~~idW~~l~~k~~~pP~~P~i~~~~D~snFd~ef~~~~ 351 (966)
+|||++||+ ++.+|||. .+++||++||||+++||+.+..++++|||+|.+.+..|++|||+.+....
T Consensus 305 ~~li~~lL~-~~~~rlgR--~~~~ei~~Hp~f~~~~w~~~~~~~~~~p~~p~~~~~~d~~~fd~~~~~~~ 371 (410)
T 3v8s_A 305 KNLICAFLT-DREVRLGR--NGVEEIKRHLFFKNDQWAWETLRDTVAPVVPDLSSDIDTSNFDDLEEDKG 371 (410)
T ss_dssp HHHHHHHSS-CGGGCTTS--SCHHHHHTSGGGCCSSCCSTTGGGSCCSCCCCCSSTTCCTTSCCCCSCCS
T ss_pred HHHHHHHcc-ChhhhCCC--CCHHHHhcCccccCCCHHHHhhcccCCCCCCcCCCccchhhcCCcccccc
Confidence 999999999 55667763 48999999999999999999999999999999999999999998765543
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.97 E-value=6.5e-31 Score=303.65 Aligned_cols=221 Identities=25% Similarity=0.400 Sum_probs=169.9
Q ss_pred CcceeeeecccccceEEEEEEcCCCCEEEEEeccccc--------hhhHHHHHHHHhhCCCcccccccccc---------
Q psy11767 117 DLDKAGILGDGSYSVCRRCVEKSTGQEYAVKIISRKI--------DCSEEINLLRACQGHPNICRRCVEKS--------- 179 (966)
Q Consensus 117 df~~~~~LG~GsFGkV~La~~k~tg~~yAiKvl~K~~--------~~~~E~~il~~~~~~pfi~~~~~~~~--------- 179 (966)
||+++++||+|+||+|++|+++.||+.||||+++|.. ...+|+.+|.+. +||||++....++
T Consensus 62 ~f~~~~~lG~G~fG~V~~~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~il~~~-~hp~Iv~l~~~~~~~~~~~lVm 140 (412)
T 2vd5_A 62 DFEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNG-DRRWITQLHFAFQDENYLYLVM 140 (412)
T ss_dssp GEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHGGGCCHHHHHHHHHHS-CTTTBCCEEEEEECSSEEEEEE
T ss_pred hEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhc-CCCCeeeEEEEEeeCCEEEEEE
Confidence 8999999999999999999999999999999998742 357899999887 7999986222221
Q ss_pred ----------------------cchhHHHHHHHh----------hcccchhhhHhhhccCCceEEecCcccc--------
Q psy11767 180 ----------------------TGQEYAVKIISR----------KIDCSEEINLLRACQGHPNIVNLHCVFQ-------- 219 (966)
Q Consensus 180 ----------------------~~~~~~~~~v~~----------~~~~~~e~nil~~~~gh~~iv~l~~~~~-------- 219 (966)
..++++.+++.+ ..|++++ |||++.+||++|+||+.+..
T Consensus 141 E~~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~aL~~LH~~giiHrDLKp~-NILld~~g~vkL~DFGla~~~~~~~~~~ 219 (412)
T 2vd5_A 141 EYYVGGDLLTLLSKFGERIPAEMARFYLAEIVMAIDSVHRLGYVHRDIKPD-NILLDRCGHIRLADFGSCLKLRADGTVR 219 (412)
T ss_dssp CCCCSCBHHHHHHHHSSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGG-GEEECTTSCEEECCCTTCEECCTTSCEE
T ss_pred cCCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecccCHH-HeeecCCCCEEEeechhheeccCCCccc
Confidence 123333444333 1255555 99999999999999986631
Q ss_pred ------------cccccc-------ccCCCcceeeechhhHHHHHHHhhCCCCCCCCcHHHHHHHHHhC--CCCCC---C
Q psy11767 220 ------------DEVIDW-------DDFSRGIECVFFSSSLIIFFIILSFTLSFIHDYYHIQYRRILKT--EPPIP---E 275 (966)
Q Consensus 220 ------------~e~i~~-------~~y~~~~d~~~~~~~~il~~~m~~g~~pf~~~~~~~~~~~I~~~--~~~~P---~ 275 (966)
+|++.. ..|+...| ||+.|+++|||++|.+||...+...+|++|++. .+.+| .
T Consensus 220 ~~~~~Gt~~Y~APE~l~~~~~~~~~~~~~~~~D---iwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~ 296 (412)
T 2vd5_A 220 SLVAVGTPDYLSPEILQAVGGGPGTGSYGPECD---WWALGVFAYEMFYGQTPFYADSTAETYGKIVHYKEHLSLPLVDE 296 (412)
T ss_dssp CSSCCSCGGGCCHHHHHHHHTCTTCSEECTHHH---HHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTHHHHCCCC----
T ss_pred cceeccccCcCCHHHHhhcccCcCCCCCChHHh---hhHHhHHHHHHHhCCCCCCCCCHHHHHHHHHhcccCcCCCcccc
Confidence 233431 23544444 667888999999999999999999999999974 35555 6
Q ss_pred CCCHHHHHHHHhhcccCCCcccCCCCCCHHHHhcCCceeeeCccccccCCCCCCCCcccccccccccccccc
Q psy11767 276 DLSPDVADFISRLLVKDPRRRLGGGELDAEELKRHPFFNVIDWDDLATKRIPAPFVPKISNELDVSNFSDEF 347 (966)
Q Consensus 276 ~~s~~a~dli~~LL~kdp~~RLG~~~~g~~~Ik~HpfF~~idW~~l~~k~~~pP~~P~i~~~~D~snFd~ef 347 (966)
.+|++++|||++||+ ||.+|+|. .+++||++||||++|||+.|. +.+|||+|.+.+..|++|||..+
T Consensus 297 ~~s~~~~dli~~lL~-~p~~Rlgr--~~~~ei~~Hpff~~i~w~~l~--~~~~p~~p~~~~~~d~~~f~~~~ 363 (412)
T 2vd5_A 297 GVPEEARDFIQRLLC-PPETRLGR--GGAGDFRTHPFFFGLDWDGLR--DSVPPFTPDFEGATDTCNFDLVE 363 (412)
T ss_dssp CCCHHHHHHHHTTSS-CGGGCTTT--TTHHHHHTSGGGTTCCSTTST--TSCCSCCCC-----CCSSCC--C
T ss_pred CCCHHHHHHHHHHcC-ChhhcCCC--CCHHHHhcCCCcCCCCHHHHh--hcCCCCCCcCCCcccccccCccc
Confidence 899999999999999 99999985 489999999999999999994 57899999999999999999753
|
| >4azs_A Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15A {Escherichia coli} PDB: 4azt_A* 4azv_A* 4azw_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=7.3e-32 Score=323.80 Aligned_cols=155 Identities=17% Similarity=0.240 Sum_probs=125.7
Q ss_pred ccccccccEEEEEEEcCCCcEEEEEEecccc---------------ChHHHHHHHHHhcCCCCceEEEEEEEeCCeEEEE
Q psy11767 385 ILGDGSYSVCRRCVEKSTGQEYAVKIISRKI---------------DCSEEINLLRACQGHPNIVNLHCVFQDEVHTYLV 449 (966)
Q Consensus 385 ~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~---------------~~~~Ei~iL~~l~~HpnIV~l~~~~~~~~~~~lV 449 (966)
.++.|++|.+..++...+|+.||+|++.+.. ...+|+++|+++..|+||++++++++++...|||
T Consensus 241 ~~~~~~~~~h~~~rr~~fg~~~~~K~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~ed~~~~yLV 320 (569)
T 4azs_A 241 QPYAGAGLAHKRSRRYFFGEDYVCKFFYYDMPHGILTAEESQRNKYELHNEIKFLTQPPAGFDAPAVLAHGENAQSGWLV 320 (569)
T ss_dssp C-C--------CCEEEEECSSEEEEEEESSCSTTCSCHHHHHHHHHHHHHHHHHHHSCCTTCCCCCEEEEEECSSEEEEE
T ss_pred ccccCCcccccccccccccceeEEEEEecccccccchhhhhHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEECCEEEEE
Confidence 5788888888888888899999999996531 1456999999998899999999999999999999
Q ss_pred EEccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCcEEEecCCCCCEEEEeecccccccC--
Q psy11767 450 LELLKGGELLDRIRQKGRCGFTENEASRIMRQLVAAVHFMHSRGVVHRDLKPENLLFSDPAGDNIKVVDFGFACLKRE-- 527 (966)
Q Consensus 450 mEy~~gg~L~~~l~~~~~~~l~e~~~~~i~~Qil~aL~yLHs~~IiHRDLKP~NILl~~~~~~~iKL~DFGla~~~~~-- 527 (966)
||||+|++|.++|...+ .+++. .|+.||+.||+|||++|||||||||+||||++ ++.+||+|||+|+....
T Consensus 321 MEyv~G~~L~d~i~~~~--~l~~~---~I~~QIl~AL~ylH~~GIIHRDIKPeNILL~~--dg~vKL~DFGlAr~~~~~~ 393 (569)
T 4azs_A 321 MEKLPGRLLSDMLAAGE--EIDRE---KILGSLLRSLAALEKQGFWHDDVRPWNVMVDA--RQHARLIDFGSIVTTPQDC 393 (569)
T ss_dssp EECCCSEEHHHHHHTTC--CCCHH---HHHHHHHHHHHHHHHTTCEESCCCGGGEEECT--TSCEEECCCTTEESCC---
T ss_pred EecCCCCcHHHHHHhCC--CCCHH---HHHHHHHHHHHHHHHCCceeccCchHhEEECC--CCCEEEeecccCeeCCCCC
Confidence 99999999999998765 47664 58999999999999999999999999999975 56999999999976543
Q ss_pred -CCccccccccccCchhhcc
Q psy11767 528 -SLHTPCFTLQYAAPEVLRQ 546 (966)
Q Consensus 528 -~~~~~~gT~~Y~APEvl~~ 546 (966)
...+.+||+.|||||++..
T Consensus 394 ~~~~t~vGTp~YmAPE~l~g 413 (569)
T 4azs_A 394 SWPTNLVQSFFVFVNELFAE 413 (569)
T ss_dssp CCSHHHHHHHHHHHHHHC--
T ss_pred ccccCceechhhccHHHhCC
Confidence 2345689999999999853
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=8.3e-30 Score=296.53 Aligned_cols=225 Identities=22% Similarity=0.399 Sum_probs=175.1
Q ss_pred CcceeeeecccccceEEEEEEcCCCCEEEEEeccccc--------hhhHHHHHHHHhhCCCcccccccccc---------
Q psy11767 117 DLDKAGILGDGSYSVCRRCVEKSTGQEYAVKIISRKI--------DCSEEINLLRACQGHPNICRRCVEKS--------- 179 (966)
Q Consensus 117 df~~~~~LG~GsFGkV~La~~k~tg~~yAiKvl~K~~--------~~~~E~~il~~~~~~pfi~~~~~~~~--------- 179 (966)
||+++++||+|+||+|++|+++.+|+.||||+++|.. ...+|+.+|.++ +||+|+.....+.
T Consensus 75 ~y~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~~-~hp~Iv~l~~~~~~~~~~~lV~ 153 (437)
T 4aw2_A 75 DFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNG-DSKWITTLHYAFQDDNNLYLVM 153 (437)
T ss_dssp GEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTTTCCHHHHHHHHHHS-CTTTBCCEEEEEECSSEEEEEE
T ss_pred heEEEEEEEeCCCEEEEEEEEcCCCcEEEEEEEEHHHhhhHHHHHHHHHHHHHHHhC-CCCCEEEEEEEEeeCCEEEEEE
Confidence 8999999999999999999999999999999998742 357899999887 7999986222111
Q ss_pred ----------------------cchhHHHHHHHh----------hcccchhhhHhhhccCCceEEecCcccc--------
Q psy11767 180 ----------------------TGQEYAVKIISR----------KIDCSEEINLLRACQGHPNIVNLHCVFQ-------- 219 (966)
Q Consensus 180 ----------------------~~~~~~~~~v~~----------~~~~~~e~nil~~~~gh~~iv~l~~~~~-------- 219 (966)
..++++.+++.+ ..|++++ |||++.+|+++|+||+.+..
T Consensus 154 Ey~~gg~L~~~l~~~~~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKp~-NILl~~~g~vkL~DFGla~~~~~~~~~~ 232 (437)
T 4aw2_A 154 DYYVGGDLLTLLSKFEDRLPEEMARFYLAEMVIAIDSVHQLHYVHRDIKPD-NILMDMNGHIRLADFGSCLKLMEDGTVQ 232 (437)
T ss_dssp CCCTTCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGG-GEEECTTSCEEECCCTTCEECCTTSCEE
T ss_pred ecCCCCcHHHHHHHccCCCCHHHHHHHHHHHHHHHHHHHhCCeEecccCHH-HeeEcCCCCEEEcchhhhhhcccCCCcc
Confidence 122333333322 1255555 99999999999999996621
Q ss_pred ------------ccccc-----cccCCCcceeeechhhHHHHHHHhhCCCCCCCCcHHHHHHHHHhC--CCCCCCC---C
Q psy11767 220 ------------DEVID-----WDDFSRGIECVFFSSSLIIFFIILSFTLSFIHDYYHIQYRRILKT--EPPIPED---L 277 (966)
Q Consensus 220 ------------~e~i~-----~~~y~~~~d~~~~~~~~il~~~m~~g~~pf~~~~~~~~~~~I~~~--~~~~P~~---~ 277 (966)
+|++. ...|+...| ||+.|+++|||++|.+||...+...++++|++. .+.||.. +
T Consensus 233 ~~~~~GT~~Y~APE~l~~~~~~~~~~~~~~D---vwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~~ 309 (437)
T 4aw2_A 233 SSVAVGTPDYISPEILQAMEGGKGRYGPECD---WWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKERFQFPTQVTDV 309 (437)
T ss_dssp CCSCCSCGGGCCHHHHHHHHTSCCEECTHHH---HHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTHHHHCCCCSSCCCS
T ss_pred cccccCCcCeeChHHHhhcccCCCCCCCcCe---eHHHHHHHHHHHhCCCCCCCCChhHHHHhhhhccccccCCcccccC
Confidence 24443 234555555 667888999999999999999999999999864 4677765 8
Q ss_pred CHHHHHHHHhhcccCCCcccCCCCCCHHHHhcCCceeeeCccccccCCCCCCCCccccccccccccccccccCc
Q psy11767 278 SPDVADFISRLLVKDPRRRLGGGELDAEELKRHPFFNVIDWDDLATKRIPAPFVPKISNELDVSNFSDEFTKMI 351 (966)
Q Consensus 278 s~~a~dli~~LL~kdp~~RLG~~~~g~~~Ik~HpfF~~idW~~l~~k~~~pP~~P~i~~~~D~snFd~ef~~~~ 351 (966)
|++++|||++||+.+| +|+|. .+++||++||||+++||+.+ ++++|||+|.+.+..|++|||.++....
T Consensus 310 s~~~~dLi~~lL~~~~-~r~~r--~~~~eil~Hpff~~i~w~~l--~~~~~p~~P~~~~~~d~~~fd~~~~~~~ 378 (437)
T 4aw2_A 310 SENAKDLIRRLICSRE-HRLGQ--NGIEDFKKHPFFSGIDWDNI--RNCEAPYIPEVSSPTDTSNFDVDDDCLK 378 (437)
T ss_dssp CHHHHHHHHTTSSCGG-GCTTT--TTTHHHHTSGGGTTCCTTTG--GGSCCSCCCCCSSTTCCTTSCCC-----
T ss_pred CHHHHHHHHHHhcccc-cccCC--CCHHHHhCCCccCCCCHHHH--hhCCCCCCCcCCCccchhhcCCcccccc
Confidence 9999999999999765 56653 47899999999999999999 5789999999999999999998875543
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=2e-29 Score=293.78 Aligned_cols=229 Identities=29% Similarity=0.523 Sum_probs=177.4
Q ss_pred CcceeeeecccccceEEEEEEcCCCCEEEEEeccccc--------hhhHHHHHHHHhhCCCccccccccccc--------
Q psy11767 117 DLDKAGILGDGSYSVCRRCVEKSTGQEYAVKIISRKI--------DCSEEINLLRACQGHPNICRRCVEKST-------- 180 (966)
Q Consensus 117 df~~~~~LG~GsFGkV~La~~k~tg~~yAiKvl~K~~--------~~~~E~~il~~~~~~pfi~~~~~~~~~-------- 180 (966)
+|+++++||+|+||+|++|+++.+|+.||||++++.. ...+|..+|+++ +||+|+.....+..
T Consensus 149 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~l~~~~~~~~~~~lv~ 227 (446)
T 4ejn_A 149 EFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNS-RHPFLTALKYSFQTHDRLCFVM 227 (446)
T ss_dssp GEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHC-------------CCCCC-SCTTSCCEEEEEEETTEEEEEE
T ss_pred HcEEeEEEeeCcCEEEEEEEEcCCCCEEEEEEEEhhhhhhhHHHHHHHHHHHHHHhC-CCCeEeeEEEEEeeCCEEEEEE
Confidence 7999999999999999999999999999999998752 345677888776 59999862211111
Q ss_pred ----------------------chhHHHHH------HHh-h----cccchhhhHhhhccCCceEEecCcccc--------
Q psy11767 181 ----------------------GQEYAVKI------ISR-K----IDCSEEINLLRACQGHPNIVNLHCVFQ-------- 219 (966)
Q Consensus 181 ----------------------~~~~~~~~------v~~-~----~~~~~e~nil~~~~gh~~iv~l~~~~~-------- 219 (966)
...++.++ ++. . .|++++ |||++.+|+++|+||+.+..
T Consensus 228 e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~giiHrDlkp~-NIll~~~~~~kl~DFG~a~~~~~~~~~~ 306 (446)
T 4ejn_A 228 EYANGGELFFHLSRERVFSEDRARFYGAEIVSALDYLHSEKNVVYRDLKLE-NLMLDKDGHIKITDFGLCKEGIKDGATM 306 (446)
T ss_dssp CCCSSCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHHTCCCCCCCCGG-GEEECSSSCEEECCCCCCCTTCC-----
T ss_pred eeCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhcCCEEECCCCHH-HEEECCCCCEEEccCCCceeccCCCccc
Confidence 11111222 221 1 144445 99999999999999987632
Q ss_pred -----------ccccccccCCCcceeeechhhHHHHHHHhhCCCCCCCCcHHHHHHHHHhCCCCCCCCCCHHHHHHHHhh
Q psy11767 220 -----------DEVIDWDDFSRGIECVFFSSSLIIFFIILSFTLSFIHDYYHIQYRRILKTEPPIPEDLSPDVADFISRL 288 (966)
Q Consensus 220 -----------~e~i~~~~y~~~~d~~~~~~~~il~~~m~~g~~pf~~~~~~~~~~~I~~~~~~~P~~~s~~a~dli~~L 288 (966)
+|++....|+...| +|+.|+++|+|++|.+||...+...+++.|+...+.+|..+++++++||.+|
T Consensus 307 ~~~~gt~~y~aPE~~~~~~~~~~~D---iwslG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~li~~~ 383 (446)
T 4ejn_A 307 KTFCGTPEYLAPEVLEDNDYGRAVD---WWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEIRFPRTLGPEAKSLLSGL 383 (446)
T ss_dssp CCSSSCGGGCCHHHHHTSCCCTHHH---HHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCTTSCHHHHHHHHHH
T ss_pred ccccCCccccCHhhcCCCCCCCccc---hhhhHHHHHHHhhCCCCCCCCCHHHHHHHHHhCCCCCCccCCHHHHHHHHHH
Confidence 34555556665555 4567788899999999999999999999999999999999999999999999
Q ss_pred cccCCCcccCCCCCCHHHHhcCCceeeeCccccccCCCCCCCCccccccccccccccccccC
Q psy11767 289 LVKDPRRRLGGGELDAEELKRHPFFNVIDWDDLATKRIPAPFVPKISNELDVSNFSDEFTKM 350 (966)
Q Consensus 289 L~kdp~~RLG~~~~g~~~Ik~HpfF~~idW~~l~~k~~~pP~~P~i~~~~D~snFd~ef~~~ 350 (966)
|++||.+|+|+....+++|++||||++++|+.+..++++|||.|.+.+..|.++||++|+.+
T Consensus 384 L~~dP~~R~~~~~~t~~ell~hp~f~~~~~~~~~~~~~~pp~~p~~~~~~~~~~~~~~~~~~ 445 (446)
T 4ejn_A 384 LKKDPKQRLGGGSEDAKEIMQHRFFAGIVWQHVYEKKLSPPFKPQVTSETDTRYFDEEFTAQ 445 (446)
T ss_dssp TCSSTTTSTTCSTTTHHHHHTSGGGTTCCHHHHHTTCSCCSCCCSCSSTTCCTTC-------
T ss_pred cccCHHHhCCCCCCCHHHHHhCccccCCCHHHHhhCcCCCCccCCCCCccchhhcchhhhcC
Confidence 99999999988767899999999999999999999999999999999999999999999753
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B | Back alignment and structure |
|---|
Probab=99.96 E-value=3.7e-29 Score=297.96 Aligned_cols=223 Identities=25% Similarity=0.385 Sum_probs=178.0
Q ss_pred CcceeeeecccccceEEEEEEcCCCCEEEEEeccccc--------hhhHHHHHHHHhhCCCccccccccc----------
Q psy11767 117 DLDKAGILGDGSYSVCRRCVEKSTGQEYAVKIISRKI--------DCSEEINLLRACQGHPNICRRCVEK---------- 178 (966)
Q Consensus 117 df~~~~~LG~GsFGkV~La~~k~tg~~yAiKvl~K~~--------~~~~E~~il~~~~~~pfi~~~~~~~---------- 178 (966)
||.++++||+|+||+|++|+++.||+.||||+++|.. ...+|+++|+++ +||||+.....+
T Consensus 186 ~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l-~hp~Iv~l~~~~~~~~~l~lVm 264 (543)
T 3c4z_A 186 WFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKV-HSRFIVSLAYAFETKTDLCLVM 264 (543)
T ss_dssp GEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHC-CCTTBCCEEEEEECSSEEEEEE
T ss_pred heEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEEhHHhhhhHHHHHHHHHHHHHHhc-CCCCEeeEEEEEeeCCEEEEEE
Confidence 8999999999999999999999999999999998752 356799999988 699998622111
Q ss_pred ------------------------ccchhHHHHHHHh----------hcccchhhhHhhhccCCceEEecCccc------
Q psy11767 179 ------------------------STGQEYAVKIISR----------KIDCSEEINLLRACQGHPNIVNLHCVF------ 218 (966)
Q Consensus 179 ------------------------~~~~~~~~~~v~~----------~~~~~~e~nil~~~~gh~~iv~l~~~~------ 218 (966)
....+++.+++.+ ..|++++ |||++.+|+++|+||+.+.
T Consensus 265 E~~~gg~L~~~l~~~~~~~~~l~e~~~~~~~~qi~~aL~~LH~~gIvHrDLKP~-NILl~~~g~vkL~DFGla~~~~~~~ 343 (543)
T 3c4z_A 265 TIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQRNIIYRDLKPE-NVLLDDDGNVRISDLGLAVELKAGQ 343 (543)
T ss_dssp CCCTTCBHHHHHHTSSTTSCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGG-GEEECTTSCEEECCCTTCEECCTTC
T ss_pred EeccCCCHHHHHHHhhcccccccHHHHHHHHHHHHHHHHHHHHcCCcccCCChH-HEEEeCCCCEEEeecceeeeccCCC
Confidence 1122333344332 1255555 9999999999999998663
Q ss_pred -------------cccccccccCCCcceeeechhhHHHHHHHhhCCCCCCCC----cHHHHHHHHHhCCCCCCCCCCHHH
Q psy11767 219 -------------QDEVIDWDDFSRGIECVFFSSSLIIFFIILSFTLSFIHD----YYHIQYRRILKTEPPIPEDLSPDV 281 (966)
Q Consensus 219 -------------~~e~i~~~~y~~~~d~~~~~~~~il~~~m~~g~~pf~~~----~~~~~~~~I~~~~~~~P~~~s~~a 281 (966)
.+|++....|+...| ||+.|+++|+|++|.+||... ....++++|+...+.||..+++++
T Consensus 344 ~~~~~~~GT~~Y~APE~l~~~~~~~~~D---iwSlGvilyelltG~~PF~~~~~~~~~~~~~~~i~~~~~~~p~~~s~~~ 420 (543)
T 3c4z_A 344 TKTKGYAGTPGFMAPELLLGEEYDFSVD---YFALGVTLYEMIAARGPFRARGEKVENKELKQRVLEQAVTYPDKFSPAS 420 (543)
T ss_dssp CCBCCCCSCTTTSCHHHHTTCCBCTHHH---HHHHHHHHHHHHHSSCSSCCTTCCCCHHHHHHHHHHCCCCCCTTSCHHH
T ss_pred cccccccCCccccChhhhcCCCCChHHh---cCcchHHHHHHHhCCCCCCCCccchhHHHHHHHHhhcccCCCcccCHHH
Confidence 134555556766655 567788999999999999865 457889999999999999999999
Q ss_pred HHHHHhhcccCCCcccCCCCCCHHHHhcCCceeeeCccccccCCCCCCCCccccc-----cccccccc
Q psy11767 282 ADFISRLLVKDPRRRLGGGELDAEELKRHPFFNVIDWDDLATKRIPAPFVPKISN-----ELDVSNFS 344 (966)
Q Consensus 282 ~dli~~LL~kdp~~RLG~~~~g~~~Ik~HpfF~~idW~~l~~k~~~pP~~P~i~~-----~~D~snFd 344 (966)
++||++||++||.+|+|....++++|+.||||+++||+.|..++++|||+|.... ..|..+|+
T Consensus 421 ~~li~~lL~~dP~~R~~~~~~~a~ei~~Hpff~~i~w~~l~~~~~~pp~~P~~~~~~~~~~~d~~~f~ 488 (543)
T 3c4z_A 421 KDFCEALLQKDPEKRLGFRDGSCDGLRTHPLFRDISWRQLEAGMLTPPFVPDSRTVYAKNIQDVGAFS 488 (543)
T ss_dssp HHHHHHHSCSSGGGSCCCBTTBSHHHHTSGGGTTCCHHHHHTTCSCCSCCCCSSSCCSCC----CCCC
T ss_pred HHHHHHhccCCHhHCCCCcccCHHHHHcCccccCCCHHHHHcCCCCCCCCCCccccccCCchhhhhcc
Confidence 9999999999999999987668999999999999999999999999999998743 33445554
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=1e-28 Score=275.99 Aligned_cols=235 Identities=28% Similarity=0.490 Sum_probs=168.1
Q ss_pred CcceeeeecccccceEEEEEEc---CCCCEEEEEeccccc---------hhhHHHHHHHHhhCCCcccccccccccc---
Q psy11767 117 DLDKAGILGDGSYSVCRRCVEK---STGQEYAVKIISRKI---------DCSEEINLLRACQGHPNICRRCVEKSTG--- 181 (966)
Q Consensus 117 df~~~~~LG~GsFGkV~La~~k---~tg~~yAiKvl~K~~---------~~~~E~~il~~~~~~pfi~~~~~~~~~~--- 181 (966)
+|+++++||+|+||+|++|++. .+|+.||||+++|.. ...+|..+|+++ +||+|++....+...
T Consensus 18 ~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~E~~~l~~l-~hp~iv~~~~~~~~~~~~ 96 (327)
T 3a62_A 18 CFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEV-KHPFIVDLIYAFQTGGKL 96 (327)
T ss_dssp GEEEEEEEEEETTEEEEEEEECSSTTTTCEEEEEEECCC--------------HHHHHHHC-CCTTBCCEEEEEECSSCE
T ss_pred HeEEEEEEEeCCCEEEEEEEEeccCCCCcEEEEEEEEHHHhhhhhhHHHHHHHHHHHHHhC-CCCCccceeEEEEcCCEE
Confidence 6799999999999999999985 799999999998742 346799999988 599998722211111
Q ss_pred ---------------------------hhHHHHHHHh----------hcccchhhhHhhhccCCceEEecCcccc-----
Q psy11767 182 ---------------------------QEYAVKIISR----------KIDCSEEINLLRACQGHPNIVNLHCVFQ----- 219 (966)
Q Consensus 182 ---------------------------~~~~~~~v~~----------~~~~~~e~nil~~~~gh~~iv~l~~~~~----- 219 (966)
..++.+++.+ ..|++++ |||.+.+|+++|+||+.+..
T Consensus 97 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~Dlkp~-Nill~~~~~~kl~Dfg~~~~~~~~~ 175 (327)
T 3a62_A 97 YLILEYLSGGELFMQLEREGIFMEDTACFYLAEISMALGHLHQKGIIYRDLKPE-NIMLNHQGHVKLTDFGLCKESIHDG 175 (327)
T ss_dssp EEEEECCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCTT-TEEECTTSCEEECCCSCC-------
T ss_pred EEEEeCCCCCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCEEcccCCHH-HeEECCCCcEEEEeCCcccccccCC
Confidence 1112222222 1244444 99999999999999986532
Q ss_pred --------------ccccccccCCCcceeeechhhHHHHHHHhhCCCCCCCCcHHHHHHHHHhCCCCCCCCCCHHHHHHH
Q psy11767 220 --------------DEVIDWDDFSRGIECVFFSSSLIIFFIILSFTLSFIHDYYHIQYRRILKTEPPIPEDLSPDVADFI 285 (966)
Q Consensus 220 --------------~e~i~~~~y~~~~d~~~~~~~~il~~~m~~g~~pf~~~~~~~~~~~I~~~~~~~P~~~s~~a~dli 285 (966)
+|++....|+...| +|+.|+++|+|++|.+||...+...++++|+...+.+|..+++++++||
T Consensus 176 ~~~~~~~gt~~y~aPE~~~~~~~~~~~D---iwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~li 252 (327)
T 3a62_A 176 TVTHTFCGTIEYMAPEILMRSGHNRAVD---WWSLGALMYDMLTGAPPFTGENRKKTIDKILKCKLNLPPYLTQEARDLL 252 (327)
T ss_dssp ---CTTSSCCTTSCHHHHTTSCCCTHHH---HHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHTCCCCCTTSCHHHHHHH
T ss_pred ccccccCCCcCccCHhhCcCCCCCCccc---chhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCCCCCCCCCHHHHHHH
Confidence 24444445555444 5567788899999999999999999999999999999999999999999
Q ss_pred HhhcccCCCcccCCCCCCHHHHhcCCceeeeCccccccCCCCCCCCccccccccccccccccccCcCCCCC
Q psy11767 286 SRLLVKDPRRRLGGGELDAEELKRHPFFNVIDWDDLATKRIPAPFVPKISNELDVSNFSDEFTKMIPADSP 356 (966)
Q Consensus 286 ~~LL~kdp~~RLG~~~~g~~~Ik~HpfF~~idW~~l~~k~~~pP~~P~i~~~~D~snFd~ef~~~~p~dSp 356 (966)
++||++||.+|+++...++++|+.||||++++|+.+..++++|||.|.+.+..|.++|+.+|+...+.++|
T Consensus 253 ~~~L~~dp~~R~~~~~~~~~e~l~hp~f~~~~~~~~~~~~~~~p~~p~~~~~~~~~~~~~~~~~~~~~~~~ 323 (327)
T 3a62_A 253 KKLLKRNAASRLGAGPGDAGEVQAHPFFRHINWEELLARKVEPPFKPLLQSEEDVSQFDSKFTRQTPVDSP 323 (327)
T ss_dssp HHHSCSCGGGSTTSSTTTHHHHHHSGGGSSCCHHHHHTTCSCCSCCCC-----------------------
T ss_pred HHHHhcCHhhccCCCCCCHHHHHcCCcccCCCHHHHhhccCCCCCCCCcCChhhhhhcchhhhccccCCCC
Confidence 99999999999998766899999999999999999999999999999999999999999988776555554
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* | Back alignment and structure |
|---|
Probab=99.95 E-value=6.8e-29 Score=296.83 Aligned_cols=214 Identities=23% Similarity=0.351 Sum_probs=175.2
Q ss_pred CcceeeeecccccceEEEEEEcCCCCEEEEEeccccc--------hhhHHHHHHHHhhCCCccccccccc----------
Q psy11767 117 DLDKAGILGDGSYSVCRRCVEKSTGQEYAVKIISRKI--------DCSEEINLLRACQGHPNICRRCVEK---------- 178 (966)
Q Consensus 117 df~~~~~LG~GsFGkV~La~~k~tg~~yAiKvl~K~~--------~~~~E~~il~~~~~~pfi~~~~~~~---------- 178 (966)
||+++++||+|+||+|++|+++.||+.||||+++|.. ...+|+++|+++ +||||+.....+
T Consensus 185 ~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~l~k~~~~~~~~~~~~~~E~~iL~~l-~hp~Iv~l~~~~~~~~~l~lVm 263 (576)
T 2acx_A 185 TFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKV-NSRFVVSLAYAYETKDALCLVL 263 (576)
T ss_dssp GEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHC-CCTTBCCEEEEEECSSEEEEEE
T ss_pred ceEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhHhhhhhHHHHHHHHHHHHHHHc-CCCCEeeEEEEEeeCCEEEEEE
Confidence 7999999999999999999999999999999998742 357899999988 699998622111
Q ss_pred ----------------------ccchhHHHHHHHh----------hcccchhhhHhhhccCCceEEecCcccc-------
Q psy11767 179 ----------------------STGQEYAVKIISR----------KIDCSEEINLLRACQGHPNIVNLHCVFQ------- 219 (966)
Q Consensus 179 ----------------------~~~~~~~~~~v~~----------~~~~~~e~nil~~~~gh~~iv~l~~~~~------- 219 (966)
....+++.+++.+ ..|++++ |||++.+||++|+||+.+..
T Consensus 264 Ey~~gg~L~~~l~~~~~~~l~e~~~~~i~~qIl~aL~yLH~~gIvHrDLKPe-NILld~~g~vKL~DFGla~~~~~~~~~ 342 (576)
T 2acx_A 264 TLMNGGDLKFHIYHMGQAGFPEARAVFYAAEICCGLEDLHRERIVYRDLKPE-NILLDDHGHIRISDLGLAVHVPEGQTI 342 (576)
T ss_dssp CCCCSCBHHHHHHSSSSCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGG-GEEECTTSCEEECCCTTCEECCTTCCE
T ss_pred EcCCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeccCCchh-eEEEeCCCCeEEEecccceecccCccc
Confidence 1122333344332 1255555 99999999999999987632
Q ss_pred -----------ccccccccCCCcceeeechhhHHHHHHHhhCCCCCCCC----cHHHHHHHHHhCCCCCCCCCCHHHHHH
Q psy11767 220 -----------DEVIDWDDFSRGIECVFFSSSLIIFFIILSFTLSFIHD----YYHIQYRRILKTEPPIPEDLSPDVADF 284 (966)
Q Consensus 220 -----------~e~i~~~~y~~~~d~~~~~~~~il~~~m~~g~~pf~~~----~~~~~~~~I~~~~~~~P~~~s~~a~dl 284 (966)
+|++....|+...| ||+.|+++|+|++|.+||... ....+++.|....+.||..+|++++||
T Consensus 343 ~~~~GT~~Y~APEvl~~~~~~~~~D---iwSLGvilyeLltG~~PF~~~~~~~~~~~i~~~i~~~~~~~p~~~s~~~~dL 419 (576)
T 2acx_A 343 KGRVGTVGYMAPEVVKNERYTFSPD---WWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVKEVPEEYSERFSPQARSL 419 (576)
T ss_dssp ECCCSCGGGCCHHHHTTCEESSHHH---HHHHHHHHHHHHHSSCSSSCSSSCCCHHHHHHHHHHCCCCCCTTSCHHHHHH
T ss_pred cccCCCccccCHHHHcCCCCCccch---HHHHHHHHHHHHhCCCCCcccccchhHHHHHHHhhcccccCCccCCHHHHHH
Confidence 34555556666555 567888999999999999875 457789999999999999999999999
Q ss_pred HHhhcccCCCcccCCCCCCHHHHhcCCceeeeCccccccCCCCCCCCcccc
Q psy11767 285 ISRLLVKDPRRRLGGGELDAEELKRHPFFNVIDWDDLATKRIPAPFVPKIS 335 (966)
Q Consensus 285 i~~LL~kdp~~RLG~~~~g~~~Ik~HpfF~~idW~~l~~k~~~pP~~P~i~ 335 (966)
|++||++||.+|+|+...+++||++||||+++||+.|..++++|||+|...
T Consensus 420 I~~lL~~dP~~R~g~~~~sa~eil~HpfF~~i~w~~l~~~~~~pp~~p~~~ 470 (576)
T 2acx_A 420 CSQLLCKDPAERLGCRGGSAREVKEHPLFKKLNFKRLGAGMLEPPFKPDPQ 470 (576)
T ss_dssp HHHHTCSSGGGSTTCSSSHHHHHHTSGGGTTCCHHHHHTTCSCCSCCCCCC
T ss_pred HHHhccCCHHHcCCCCCCCHHHHHhChhhccCCHHHHhcCCCCCCCCCCcc
Confidence 999999999999998766899999999999999999999999999999864
|
| >3hyh_A Carbon catabolite-derepressing protein kinase; kinase domain, transferase, ATP-binding, carbohydrate metabo kinase, membrane; 2.20A {Saccharomyces cerevisiae} PDB: 3dae_A 2fh9_A 3mn3_A | Back alignment and structure |
|---|
Probab=99.95 E-value=1.9e-28 Score=267.47 Aligned_cols=188 Identities=26% Similarity=0.409 Sum_probs=151.4
Q ss_pred CcceeeeecccccceEEEEEEcCCCCEEEEEeccccc--------hhhHHHHHHHHhhCCCccccccccccc--------
Q psy11767 117 DLDKAGILGDGSYSVCRRCVEKSTGQEYAVKIISRKI--------DCSEEINLLRACQGHPNICRRCVEKST-------- 180 (966)
Q Consensus 117 df~~~~~LG~GsFGkV~La~~k~tg~~yAiKvl~K~~--------~~~~E~~il~~~~~~pfi~~~~~~~~~-------- 180 (966)
||++++.||+|+||+|++|+++.||+.||||+++|.. ...+|..+|+++ +||+||+.+-.+.+
T Consensus 14 ~Y~i~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l-~HpnIv~~~~~~~~~~~~~ivm 92 (275)
T 3hyh_A 14 NYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLL-RHPHIIKLYDVIKSKDEIIMVI 92 (275)
T ss_dssp CCEEEEEEEC---CCEEEEECTTTCCEEEEEEEECC------CHHHHHHHHHHHHHC-CCTTBCCEEEEEECSSEEEEEE
T ss_pred CeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEeHHHcCCHHHHHHHHHHHHHHHHC-CCCCCCeEEEEEEECCEEEEEE
Confidence 7899999999999999999999999999999998752 357899999998 59999873222222
Q ss_pred ---------------------chhHHHHHHHh----------hcccchhhhHhhhccCCceEEecCccc-----------
Q psy11767 181 ---------------------GQEYAVKIISR----------KIDCSEEINLLRACQGHPNIVNLHCVF----------- 218 (966)
Q Consensus 181 ---------------------~~~~~~~~v~~----------~~~~~~e~nil~~~~gh~~iv~l~~~~----------- 218 (966)
++.++.+++.+ ..|+++| |||++.+|+++|+||+.+.
T Consensus 93 Ey~~g~L~~~l~~~~~l~e~~~~~~~~qi~~al~ylH~~~IiHRDiKP~-NILl~~~~~vkl~DFGla~~~~~~~~~~~~ 171 (275)
T 3hyh_A 93 EYAGNELFDYIVQRDKMSEQEARRFFQQIISAVEYCHRHKIVHRDLKPE-NLLLDEHLNVKIADFGLSNIMTDGNFLKTS 171 (275)
T ss_dssp ECCCEEHHHHHHHSCSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCTT-TEEECTTCCEEECCSSCC------------
T ss_pred eCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCChH-HeEECCCCCEEEeecCCCeecCCCCccCCe
Confidence 22333333322 1366666 9999999999999999763
Q ss_pred -------cccccccccC-CCcceeeechhhHHHHHHHhhCCCCCCCCcHHHHHHHHHhCCCCCCCCCCHHHHHHHHhhcc
Q psy11767 219 -------QDEVIDWDDF-SRGIECVFFSSSLIIFFIILSFTLSFIHDYYHIQYRRILKTEPPIPEDLSPDVADFISRLLV 290 (966)
Q Consensus 219 -------~~e~i~~~~y-~~~~d~~~~~~~~il~~~m~~g~~pf~~~~~~~~~~~I~~~~~~~P~~~s~~a~dli~~LL~ 290 (966)
.+|++....| +..+| +|+.||++|+|++|.+||..++...++++|.++.+.+|..+|++++|||+++|+
T Consensus 172 ~GT~~Y~APE~~~~~~y~~~~~D---iwSlGvily~lltg~~PF~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li~~~L~ 248 (275)
T 3hyh_A 172 CGSPNYAAPEVISGKLYAGPEVD---VWSCGVILYVMLCRRLPFDDESIPVLFKNISNGVYTLPKFLSPGAAGLIKRMLI 248 (275)
T ss_dssp ---CTTSCHHHHSSSSCCCTHHH---HHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCTTSCHHHHHHHHHHSC
T ss_pred eECcccCChhhhcCCCCCCChhh---hHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHcCCCCCCCCCCHHHHHHHHHHcc
Confidence 2467766665 34555 567889999999999999999999999999999999999999999999999999
Q ss_pred cCCCcccCCCCCCHHHHhcCCcee
Q psy11767 291 KDPRRRLGGGELDAEELKRHPFFN 314 (966)
Q Consensus 291 kdp~~RLG~~~~g~~~Ik~HpfF~ 314 (966)
+||.+|++ ++||++||||+
T Consensus 249 ~dP~~R~s-----~~eil~hpw~k 267 (275)
T 3hyh_A 249 VNPLNRIS-----IHEIMQDDWFK 267 (275)
T ss_dssp SSGGGSCC-----HHHHHHCHHHH
T ss_pred CChhHCcC-----HHHHHcCcccc
Confidence 99999984 89999999996
|
| >4fih_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP; 1.97A {Homo sapiens} PDB: 4fig_A* 4fif_A* 4fii_A* 4fij_A* | Back alignment and structure |
|---|
Probab=99.95 E-value=5.7e-28 Score=271.48 Aligned_cols=189 Identities=20% Similarity=0.272 Sum_probs=154.0
Q ss_pred CcceeeeecccccceEEEEEEcCCCCEEEEEecccc-----chhhHHHHHHHHhhCCCccccccccccc-----------
Q psy11767 117 DLDKAGILGDGSYSVCRRCVEKSTGQEYAVKIISRK-----IDCSEEINLLRACQGHPNICRRCVEKST----------- 180 (966)
Q Consensus 117 df~~~~~LG~GsFGkV~La~~k~tg~~yAiKvl~K~-----~~~~~E~~il~~~~~~pfi~~~~~~~~~----------- 180 (966)
+|++++.||+|+||+|++|+++.||+.||||++++. ..+.+|..||+++ +||+||+.+-.+.+
T Consensus 75 ~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~Ei~il~~l-~HpnIV~l~~~~~~~~~~~ivmEy~ 153 (346)
T 4fih_A 75 YLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDY-QHENVVEMYNSYLVGDELWVVMEFL 153 (346)
T ss_dssp TEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCSSGGGGHHHHHHHHHC-CCTTBCCEEEEEEETTEEEEEECCC
T ss_pred hcEEeEEeecCcCeEEEEEEECCCCCEEEEEEEecCchhHHHHHHHHHHHHHhC-CCCCCCcEEEEEEECCEEEEEEeCC
Confidence 579999999999999999999999999999999864 2467899999998 69999973322222
Q ss_pred ------------------chhHHHHHHHh----------hcccchhhhHhhhccCCceEEecCccc--------------
Q psy11767 181 ------------------GQEYAVKIISR----------KIDCSEEINLLRACQGHPNIVNLHCVF-------------- 218 (966)
Q Consensus 181 ------------------~~~~~~~~v~~----------~~~~~~e~nil~~~~gh~~iv~l~~~~-------------- 218 (966)
...++.+++.+ ..|++++ |||++.+|+++|+||+.+.
T Consensus 154 ~gg~L~~~l~~~~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~-NILl~~~g~vKl~DFGla~~~~~~~~~~~~~~G 232 (346)
T 4fih_A 154 EGGALTDIVTHTRMNEEQIAAVCLAVLQALSVLHAQGVIHRDIKSD-SILLTHDGRVKLSDFGFCAQVSKEVPRRKSLVG 232 (346)
T ss_dssp TTEEHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGG-GEEECTTCCEEECCCTTCEECCSSSCCBCCCCS
T ss_pred CCCcHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCHH-HEEECCCCCEEEecCcCceecCCCCCccccccc
Confidence 22333333322 1366667 9999999999999999752
Q ss_pred -----cccccccccCCCcceeeechhhHHHHHHHhhCCCCCCCCcHHHHHHHHHhCC---CCCCCCCCHHHHHHHHhhcc
Q psy11767 219 -----QDEVIDWDDFSRGIECVFFSSSLIIFFIILSFTLSFIHDYYHIQYRRILKTE---PPIPEDLSPDVADFISRLLV 290 (966)
Q Consensus 219 -----~~e~i~~~~y~~~~d~~~~~~~~il~~~m~~g~~pf~~~~~~~~~~~I~~~~---~~~P~~~s~~a~dli~~LL~ 290 (966)
.+|++....|+..+| +|+.||++|||++|.+||.+.+...++++|..+. +..+..+|++++|||++||+
T Consensus 233 Tp~YmAPEvl~~~~y~~~~D---iWSlGvilyeml~G~~PF~~~~~~~~~~~i~~~~~~~~~~~~~~s~~~~dli~~~L~ 309 (346)
T 4fih_A 233 TPYWMAPELISRLPYGPEVD---IWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRDNLPPRLKNLHKVSPSLKGFLDRLLV 309 (346)
T ss_dssp CGGGCCHHHHTTCCBCTHHH---HHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSSCCCCSCGGGSCHHHHHHHHHHSC
T ss_pred CcCcCCHHHHCCCCCCcHHH---HHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHcCCCCCCCccccCCHHHHHHHHHHcC
Confidence 246777778887776 5688899999999999999999999999998763 34456799999999999999
Q ss_pred cCCCcccCCCCCCHHHHhcCCceee
Q psy11767 291 KDPRRRLGGGELDAEELKRHPFFNV 315 (966)
Q Consensus 291 kdp~~RLG~~~~g~~~Ik~HpfF~~ 315 (966)
+||.+|++ ++||++||||+.
T Consensus 310 ~dP~~R~t-----a~e~l~Hp~~~~ 329 (346)
T 4fih_A 310 RDPAQRAT-----AAELLKHPFLAK 329 (346)
T ss_dssp SSTTTSCC-----HHHHTTCGGGGG
T ss_pred CChhHCcC-----HHHHhcCHhhcC
Confidence 99999984 899999999974
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.95 E-value=1.2e-27 Score=273.82 Aligned_cols=219 Identities=17% Similarity=0.326 Sum_probs=175.1
Q ss_pred CcceeeeecccccceEEEEEEcCCCCEEEEEeccccc--------hhhHHHHHHHHhhCCCccccccccccc--------
Q psy11767 117 DLDKAGILGDGSYSVCRRCVEKSTGQEYAVKIISRKI--------DCSEEINLLRACQGHPNICRRCVEKST-------- 180 (966)
Q Consensus 117 df~~~~~LG~GsFGkV~La~~k~tg~~yAiKvl~K~~--------~~~~E~~il~~~~~~pfi~~~~~~~~~-------- 180 (966)
||+++++||+|+||+|++|+++.||+.||||+++|.. ...+|..+|+++ +|||||..+..+..
T Consensus 16 ~y~i~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~il~~l-~hp~Iv~l~~~~~~~~~~~lv~ 94 (384)
T 4fr4_A 16 HFEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGL-EHPFLVNLWYSFQDEEDMFMVV 94 (384)
T ss_dssp GEEEEEEEECCTTCCEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTC-CCTTBCCEEEEEECSSEEEEEE
T ss_pred HeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehhhcccHHHHHHHHHHHHHHHhC-CCCCCCcEEEEEEeCCEEEEEE
Confidence 6799999999999999999999999999999998752 356899999988 69999873322221
Q ss_pred ----------------------chhHHHHHHHh----------hcccchhhhHhhhccCCceEEecCccc----------
Q psy11767 181 ----------------------GQEYAVKIISR----------KIDCSEEINLLRACQGHPNIVNLHCVF---------- 218 (966)
Q Consensus 181 ----------------------~~~~~~~~v~~----------~~~~~~e~nil~~~~gh~~iv~l~~~~---------- 218 (966)
...++.+++.+ ..|++++ |||.+.+|+++|+||+.+.
T Consensus 95 e~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~-NIll~~~g~vkL~DFG~a~~~~~~~~~~~ 173 (384)
T 4fr4_A 95 DLLLGGDLRYHLQQNVHFKEETVKLFICELVMALDYLQNQRIIHRDMKPD-NILLDEHGHVHITDFNIAAMLPRETQITT 173 (384)
T ss_dssp CCCTTEEHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGG-GEEECTTSCEEECCCTTCEECCTTCCBCC
T ss_pred ecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCcHH-HeEECCCCCEEEeccceeeeccCCCceec
Confidence 12233333322 1245555 9999999999999998663
Q ss_pred --------ccccccc---ccCCCcceeeechhhHHHHHHHhhCCCCCC---CCcHHHHHHHHHhCCCCCCCCCCHHHHHH
Q psy11767 219 --------QDEVIDW---DDFSRGIECVFFSSSLIIFFIILSFTLSFI---HDYYHIQYRRILKTEPPIPEDLSPDVADF 284 (966)
Q Consensus 219 --------~~e~i~~---~~y~~~~d~~~~~~~~il~~~m~~g~~pf~---~~~~~~~~~~I~~~~~~~P~~~s~~a~dl 284 (966)
.+|++.. .+|+...| ||+.|+++|+|++|.+||. ......+++.|....+.+|..+++++++|
T Consensus 174 ~~gt~~Y~aPE~~~~~~~~~~~~~~D---iwSlG~il~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~p~~~s~~~~~l 250 (384)
T 4fr4_A 174 MAGTKPYMAPEMFSSRKGAGYSFAVD---WWSLGVTAYELLRGRRPYHIRSSTSSKEIVHTFETTVVTYPSAWSQEMVSL 250 (384)
T ss_dssp CCSCGGGCCGGGTCCCSSCCBCTTHH---HHHHHHHHHHHHHSSCSSCCCTTSCHHHHHHHHHHCCCCCCTTSCHHHHHH
T ss_pred cCCCccccCCeeeccCCCCCCCccce---eechHHHHHHHHhCCCCCCCCCCccHHHHHHHHhhcccCCCCcCCHHHHHH
Confidence 2455542 34655555 5678888999999999997 45567788999999999999999999999
Q ss_pred HHhhcccCCCcccCCCCCCHHHHhcCCceeeeCccccccCCCCCCCCccccccccccccccccc
Q psy11767 285 ISRLLVKDPRRRLGGGELDAEELKRHPFFNVIDWDDLATKRIPAPFVPKISNELDVSNFSDEFT 348 (966)
Q Consensus 285 i~~LL~kdp~~RLG~~~~g~~~Ik~HpfF~~idW~~l~~k~~~pP~~P~i~~~~D~snFd~ef~ 348 (966)
|++||++||.+|++ .+++|++||||+++||+++..+++.|||+|... ..|||+.|+
T Consensus 251 i~~lL~~dP~~R~s----~~~~l~~hp~f~~~~w~~~~~~~~~p~~~p~~~----~~~~~~~~~ 306 (384)
T 4fr4_A 251 LKKLLEPNPDQRFS----QLSDVQNFPYMNDINWDAVFQKRLIPGFIPNKG----RLNCDPTFE 306 (384)
T ss_dssp HHHHSCSSGGGSCC----SHHHHHTSGGGTTCCHHHHHTTCSCCCCCCSCC----SSCCCCCCC
T ss_pred HHHHhcCCHhHhcc----cHHHHHcChhhhcCCHHHHHhCCCCCCCCCCCC----CCCCCCccC
Confidence 99999999999997 389999999999999999999999999999863 456776654
|
| >4fie_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP ANP; 3.11A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.94 E-value=4.9e-27 Score=270.26 Aligned_cols=189 Identities=21% Similarity=0.292 Sum_probs=154.2
Q ss_pred CcceeeeecccccceEEEEEEcCCCCEEEEEecccc-----chhhHHHHHHHHhhCCCcccccccccccc----------
Q psy11767 117 DLDKAGILGDGSYSVCRRCVEKSTGQEYAVKIISRK-----IDCSEEINLLRACQGHPNICRRCVEKSTG---------- 181 (966)
Q Consensus 117 df~~~~~LG~GsFGkV~La~~k~tg~~yAiKvl~K~-----~~~~~E~~il~~~~~~pfi~~~~~~~~~~---------- 181 (966)
+|++++.||+|+||+|++|+++.||+.||||+|++. ..+.+|..||+++ +||+||+.+-.+...
T Consensus 152 ~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~Ei~il~~l-~HpnIV~l~~~~~~~~~~~iVmEy~ 230 (423)
T 4fie_A 152 YLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDY-QHENVVEMYNSYLVGDELWVVMEFL 230 (423)
T ss_dssp TEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEESTTCSSGGGHHHHHHHHHHC-CCTTBCCEEEEEEETTEEEEEEECC
T ss_pred hcEeeeEeccCcCcEEEEEEECCCCCEEEEEEEeccchhHHHHHHHHHHHHHhC-CCCCCCceEEEEEECCEEEEEEeCC
Confidence 589999999999999999999999999999999864 2467899999998 699999733222221
Q ss_pred -------------------hhHHHHHHHh----------hcccchhhhHhhhccCCceEEecCccc--------------
Q psy11767 182 -------------------QEYAVKIISR----------KIDCSEEINLLRACQGHPNIVNLHCVF-------------- 218 (966)
Q Consensus 182 -------------------~~~~~~~v~~----------~~~~~~e~nil~~~~gh~~iv~l~~~~-------------- 218 (966)
..++.+++.+ ..|++++ |||++.+|+++|+||+++.
T Consensus 231 ~gG~L~~~i~~~~l~e~~~~~~~~qil~aL~ylH~~~IiHRDiKp~-NILl~~~g~vKl~DFGla~~~~~~~~~~~~~~G 309 (423)
T 4fie_A 231 EGGALTDIVTHTRMNEEQIAAVCLAVLQALSVLHAQGVIHRDIKSD-SILLTHDGRVKLSDFGFCAQVSKEVPRRKSLVG 309 (423)
T ss_dssp TTEEHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSTT-TEEECTTCCEEECCCTTCEECCSSCCCBCCCEE
T ss_pred CCCcHHHHHhccCCCHHHHHHHHHHHHHHHHHHHHCCeecccCCHH-HEEEcCCCCEEEecCccceECCCCCcccccccc
Confidence 2222333322 1266666 9999999999999999763
Q ss_pred -----cccccccccCCCcceeeechhhHHHHHHHhhCCCCCCCCcHHHHHHHHHhCC---CCCCCCCCHHHHHHHHhhcc
Q psy11767 219 -----QDEVIDWDDFSRGIECVFFSSSLIIFFIILSFTLSFIHDYYHIQYRRILKTE---PPIPEDLSPDVADFISRLLV 290 (966)
Q Consensus 219 -----~~e~i~~~~y~~~~d~~~~~~~~il~~~m~~g~~pf~~~~~~~~~~~I~~~~---~~~P~~~s~~a~dli~~LL~ 290 (966)
.+|++....|+..+| +|+.||++|||++|.+||.+.+...++++|..+. +..+..+|++++|||++||+
T Consensus 310 Tp~YmAPEvl~~~~y~~~~D---iWSlGvilyeml~G~~PF~~~~~~~~~~~i~~~~~~~~~~~~~~s~~~~dli~~~L~ 386 (423)
T 4fie_A 310 TPYWMAPELISRLPYGPEVD---IWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRDNLPPRLKNLHKVSPSLKGFLDRLLV 386 (423)
T ss_dssp CTTTCCHHHHTTCCBCTHHH---HHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCCCSCTTSSCHHHHHHHHHHSC
T ss_pred CcCcCCHHHHCCCCCCcHHH---HHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHcCCCCCCcccccCCHHHHHHHHHHcC
Confidence 246777788887776 5678899999999999999999999999998763 45567899999999999999
Q ss_pred cCCCcccCCCCCCHHHHhcCCceee
Q psy11767 291 KDPRRRLGGGELDAEELKRHPFFNV 315 (966)
Q Consensus 291 kdp~~RLG~~~~g~~~Ik~HpfF~~ 315 (966)
+||.+|++ ++||++||||+.
T Consensus 387 ~dP~~R~t-----a~ell~Hp~~~~ 406 (423)
T 4fie_A 387 RDPAQRAT-----AAELLKHPFLAK 406 (423)
T ss_dssp SSTTTSCC-----HHHHTTCGGGGG
T ss_pred CChhHCcC-----HHHHhcCHHhcC
Confidence 99999984 899999999974
|
| >4b9d_A Serine/threonine-protein kinase NEK1; transferase, inhibitor; HET: CK7; 1.90A {Homo sapiens} PDB: 4apc_A* | Back alignment and structure |
|---|
Probab=99.94 E-value=3.2e-27 Score=265.82 Aligned_cols=188 Identities=16% Similarity=0.263 Sum_probs=148.5
Q ss_pred CcceeeeecccccceEEEEEEcCCCCEEEEEeccccc-------hhhHHHHHHHHhhCCCcccccccccc----------
Q psy11767 117 DLDKAGILGDGSYSVCRRCVEKSTGQEYAVKIISRKI-------DCSEEINLLRACQGHPNICRRCVEKS---------- 179 (966)
Q Consensus 117 df~~~~~LG~GsFGkV~La~~k~tg~~yAiKvl~K~~-------~~~~E~~il~~~~~~pfi~~~~~~~~---------- 179 (966)
+|++++.||+|+||+|++|+++.||+.||||+|+|.. ...+|..||+++ +||+||+.+-.+.
T Consensus 25 ~Y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l-~HpnIV~~~~~~~~~~~~yiVmE 103 (350)
T 4b9d_A 25 KYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANM-KHPNIVQYRESFEENGSLYIVMD 103 (350)
T ss_dssp CEEEEEEC------CEEEEEETTTCCEEEEEEEECTTSCHHHHHHHHHHHHHHHHC-CCTTBCCEEEEEEETTEEEEEEE
T ss_pred ceEEeEEEecCCCeEEEEEEECCCCCEEEEEEEehHHCCHHHHHHHHHHHHHHHHC-CCCCCCcEEEEEEECCEEEEEEe
Confidence 7899999999999999999999999999999998752 357899999998 6999987221111
Q ss_pred ----------------------cchhHHHHHHHh----------hcccchhhhHhhhccCCceEEecCccc---------
Q psy11767 180 ----------------------TGQEYAVKIISR----------KIDCSEEINLLRACQGHPNIVNLHCVF--------- 218 (966)
Q Consensus 180 ----------------------~~~~~~~~~v~~----------~~~~~~e~nil~~~~gh~~iv~l~~~~--------- 218 (966)
....++.+++.+ ..|++++ |||++.+|+++|+||+.+.
T Consensus 104 y~~gg~L~~~i~~~~~~~~~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~-NILl~~~g~vKl~DFGla~~~~~~~~~~ 182 (350)
T 4b9d_A 104 YCEGGDLFKRINAQKGVLFQEDQILDWFVQICLALKHVHDRKILHRDIKSQ-NIFLTKDGTVQLGDFGIARVLNSTVELA 182 (350)
T ss_dssp CCTTCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTCEETTCCGG-GEEECTTCCEEECSTTEESCCCHHHHHH
T ss_pred CCCCCcHHHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCCHH-HEEECCCCCEEEcccccceeecCCcccc
Confidence 112233333322 1266666 9999999999999999763
Q ss_pred ----------cccccccccCCCcceeeechhhHHHHHHHhhCCCCCCCCcHHHHHHHHHhCCC-CCCCCCCHHHHHHHHh
Q psy11767 219 ----------QDEVIDWDDFSRGIECVFFSSSLIIFFIILSFTLSFIHDYYHIQYRRILKTEP-PIPEDLSPDVADFISR 287 (966)
Q Consensus 219 ----------~~e~i~~~~y~~~~d~~~~~~~~il~~~m~~g~~pf~~~~~~~~~~~I~~~~~-~~P~~~s~~a~dli~~ 287 (966)
.+|++....|+..+| +|+.||++|||++|.+||...+...++.+|+++.+ .+|..+|++++|||.+
T Consensus 183 ~~~~GT~~YmAPE~l~~~~y~~~~D---iwSlGvilyemltG~~PF~~~~~~~~~~~i~~~~~~~~~~~~s~~~~~li~~ 259 (350)
T 4b9d_A 183 RACIGTPYYLSPEICENKPYNNKSD---IWALGCVLYELCTLKHAFEAGSMKNLVLKIISGSFPPVSLHYSYDLRSLVSQ 259 (350)
T ss_dssp HHHHSCCTTCCHHHHTTCCCCHHHH---HHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHTCCCCCCTTSCHHHHHHHHH
T ss_pred cccCCCccccCHHHHCCCCCCcHHH---HHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHcCCCCCCCccCCHHHHHHHHH
Confidence 257787778877666 56788999999999999999999999999999875 5788999999999999
Q ss_pred hcccCCCcccCCCCCCHHHHhcCCcee
Q psy11767 288 LLVKDPRRRLGGGELDAEELKRHPFFN 314 (966)
Q Consensus 288 LL~kdp~~RLG~~~~g~~~Ik~HpfF~ 314 (966)
||++||.+|+ .++||.+||||+
T Consensus 260 ~L~~dP~~R~-----s~~e~l~hp~~~ 281 (350)
T 4b9d_A 260 LFKRNPRDRP-----SVNSILEKGFIA 281 (350)
T ss_dssp HTCSSGGGSC-----CHHHHHTSHHHH
T ss_pred HccCChhHCc-----CHHHHhcCHHhh
Confidence 9999999998 489999999996
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A | Back alignment and structure |
|---|
Probab=99.93 E-value=4.9e-26 Score=273.30 Aligned_cols=207 Identities=21% Similarity=0.316 Sum_probs=164.6
Q ss_pred CcceeeeecccccceEEEEEEcCCCCEEEEEeccccc-----hhhHHHHHHHHhhCCCccccccccc-------------
Q psy11767 117 DLDKAGILGDGSYSVCRRCVEKSTGQEYAVKIISRKI-----DCSEEINLLRACQGHPNICRRCVEK------------- 178 (966)
Q Consensus 117 df~~~~~LG~GsFGkV~La~~k~tg~~yAiKvl~K~~-----~~~~E~~il~~~~~~pfi~~~~~~~------------- 178 (966)
||+++++||+|+||+|++|+++.||+.||||+|++.. .+.+|.+||+++ +||+||+.+-.+
T Consensus 158 ~Y~i~~~lG~G~fg~V~~~~~~~tg~~~AiK~i~~~~~~~~~~~~~Ei~il~~l-~hpnIv~l~~~~~~~~~~~iv~E~~ 236 (573)
T 3uto_A 158 HYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVL-RHPTLVNLHDAFEDDNEMVMIYEFM 236 (573)
T ss_dssp TEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHHHT-CCTTBCCEEEEEECSSEEEEEEECC
T ss_pred ccEEEEEEeeccCeEEEEEEECCCCCEEEEEEEeccchhhHHHHHHHHHHHHhC-CCCCCCeEEEEEEECCEEEEEEeec
Confidence 7899999999999999999999999999999998742 467899999998 699998622211
Q ss_pred ------------------ccchhHHHHHHHh----------hcccchhhhHhhhcc--CCceEEecCccc----------
Q psy11767 179 ------------------STGQEYAVKIISR----------KIDCSEEINLLRACQ--GHPNIVNLHCVF---------- 218 (966)
Q Consensus 179 ------------------~~~~~~~~~~v~~----------~~~~~~e~nil~~~~--gh~~iv~l~~~~---------- 218 (966)
.....++.+++.+ ..|++++ |||++.+ |+.+|+||+++.
T Consensus 237 ~gg~L~~~i~~~~~~l~e~~~~~~~~qi~~al~ylH~~~iiHRDlKp~-Nill~~~~~~~vKl~DFG~a~~~~~~~~~~~ 315 (573)
T 3uto_A 237 SGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHENNYVHLDLKPE-NIMFTTKRSNELKLIDFGLTAHLDPKQSVKV 315 (573)
T ss_dssp CCCBHHHHHTCTTSCEEHHHHHHHHHHHHHHHHHHHHTTEECCCCCGG-GEEESSSSCCCEEECCCSSCEECCTTSEEEE
T ss_pred CCCcHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCChh-hccccCCCCCCEEEeeccceeEccCCCceee
Confidence 1123333344332 1356666 9999754 899999999763
Q ss_pred --------cccccccccCCCcceeeechhhHHHHHHHhhCCCCCCCCcHHHHHHHHHhCCCCCC----CCCCHHHHHHHH
Q psy11767 219 --------QDEVIDWDDFSRGIECVFFSSSLIIFFIILSFTLSFIHDYYHIQYRRILKTEPPIP----EDLSPDVADFIS 286 (966)
Q Consensus 219 --------~~e~i~~~~y~~~~d~~~~~~~~il~~~m~~g~~pf~~~~~~~~~~~I~~~~~~~P----~~~s~~a~dli~ 286 (966)
.+|++....|+..+| +|+.||++|+|++|.+||.+.+...++++|....+.+| ..+|++++|||+
T Consensus 316 ~~GT~~y~APEv~~~~~y~~~~D---iWSlGvilyeml~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~dli~ 392 (573)
T 3uto_A 316 TTGTAEFAAPEVAEGKPVGYYTD---MWSVGVLSYILLSGLSPFGGENDDETLRNVKSCDWNMDDSAFSGISEDGKDFIR 392 (573)
T ss_dssp ECSSGGGCCHHHHTTCCBCHHHH---HHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHTTCCCCCSGGGTTSCHHHHHHHH
T ss_pred eEECccccCHHHhCCCCCCcHHH---HHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHhCCCCCCcccccCCCHHHHHHHH
Confidence 246777778877666 55778899999999999999999999999999988877 468999999999
Q ss_pred hhcccCCCcccCCCCCCHHHHhcCCceeeeCccccccCCCCCCCCccc
Q psy11767 287 RLLVKDPRRRLGGGELDAEELKRHPFFNVIDWDDLATKRIPAPFVPKI 334 (966)
Q Consensus 287 ~LL~kdp~~RLG~~~~g~~~Ik~HpfF~~idW~~l~~k~~~pP~~P~i 334 (966)
+||++||.+|++ ++|+++||||+..+|.... .+++++..+..
T Consensus 393 ~~L~~dp~~R~t-----~~e~l~Hpw~~~~~~~~~~-~~~p~~~~~~~ 434 (573)
T 3uto_A 393 KLLLADPNTRMT-----IHQALEHPWLTPGNAPGRD-SQIPSSRYTKI 434 (573)
T ss_dssp TTSCSSGGGSCC-----HHHHHHSTTTSCCCCTTTT-CEECGGGGHHH
T ss_pred HHccCChhHCcC-----HHHHhcCcCcCCCCCCCch-hhCCCcccccc
Confidence 999999999984 8999999999999997643 44555554443
|
| >4b99_A Mitogen-activated protein kinase 7; transferase, inhibitor; HET: R4L; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.93 E-value=1.2e-25 Score=258.18 Aligned_cols=192 Identities=20% Similarity=0.236 Sum_probs=148.1
Q ss_pred CcceeeeecccccceEEEEEEcCCCCEEEEEeccccc-------hhhHHHHHHHHhhCCCcccccccccc----------
Q psy11767 117 DLDKAGILGDGSYSVCRRCVEKSTGQEYAVKIISRKI-------DCSEEINLLRACQGHPNICRRCVEKS---------- 179 (966)
Q Consensus 117 df~~~~~LG~GsFGkV~La~~k~tg~~yAiKvl~K~~-------~~~~E~~il~~~~~~pfi~~~~~~~~---------- 179 (966)
+|+++++||+|+||+|++|+++.||+.||||+|+|.. ...+|..||+++ +||+||+.+-.+.
T Consensus 55 ~Y~~~~~lG~G~fG~V~~a~~~~t~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l-~HpnIv~l~~~~~~~~~~~~~~~ 133 (398)
T 4b99_A 55 EYEIIETIGNGAYGVVSSARRRLTGQQVAIKKIPNAFDVVTNAKRTLRELKILKHF-KHDNIIAIKDILRPTVPYGEFKS 133 (398)
T ss_dssp SEEEEEEEEECSSCEEEEEEETTTCCEEEEEEETTTTSSHHHHHHHHHHHHHHHHC-CCTTBCCEEEECCCSSCTTTCCC
T ss_pred CeEEEEEEecccCeEEEEEEECCCCCEEEEEEECccccchHHHHHHHHHHHHHHhc-CCCCcceEeeeeecccccccCCE
Confidence 6899999999999999999999999999999998752 356899999998 6999987332111
Q ss_pred -------------------------cchhHHHHHHHh----------hcccchhhhHhhhccCCceEEecCccc------
Q psy11767 180 -------------------------TGQEYAVKIISR----------KIDCSEEINLLRACQGHPNIVNLHCVF------ 218 (966)
Q Consensus 180 -------------------------~~~~~~~~~v~~----------~~~~~~e~nil~~~~gh~~iv~l~~~~------ 218 (966)
..+.++.+++.+ ..|++++ |||++.+|+.+|+||+.+.
T Consensus 134 ~~ivmE~~~g~L~~~i~~~~~l~~~~~~~~~~qil~al~ylH~~~iiHRDlKP~-NIl~~~~~~~Ki~DFGla~~~~~~~ 212 (398)
T 4b99_A 134 VYVVLDLMESDLHQIIHSSQPLTLEHVRYFLYQLLRGLKYMHSAQVIHRDLKPS-NLLVNENCELKIGDFGMARGLCTSP 212 (398)
T ss_dssp EEEEEECCSEEHHHHHTSSSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGG-GEEECTTCCEEECCCTTCBCC----
T ss_pred EEEEEeCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCcCcCCCcCcc-ccccCCCCCEEEeecceeeecccCc
Confidence 112222333322 1366666 9999999999999999763
Q ss_pred -----------------cccccccc-cCCCcceeeechhhHHHHHHHhhCCCCCCCCcHHHHHHHHHhCCCCC-------
Q psy11767 219 -----------------QDEVIDWD-DFSRGIECVFFSSSLIIFFIILSFTLSFIHDYYHIQYRRILKTEPPI------- 273 (966)
Q Consensus 219 -----------------~~e~i~~~-~y~~~~d~~~~~~~~il~~~m~~g~~pf~~~~~~~~~~~I~~~~~~~------- 273 (966)
.+|++... .|+..+| +|+.|+++|||++|.+||...+...++++|+.....+
T Consensus 213 ~~~~~~~~~~~GT~~Y~APEv~~~~~~~~~~~D---iWSlG~il~ell~G~~pF~g~~~~~~l~~I~~~~g~p~~~~~~~ 289 (398)
T 4b99_A 213 AEHQYFMTEYVATRWYRAPELMLSLHEYTQAID---LWSVGCIFGEMLARRQLFPGKNYVHQLQLIMMVLGTPSPAVIQA 289 (398)
T ss_dssp ---CCCCCSSCCCCTTCCHHHHTTCSCCCTHHH---HHHHHHHHHHHHHTSCSSCCSSHHHHHHHHHHHHCCCCGGGTC-
T ss_pred cccccccccceeChHhcCHHHhcCCCCCCChhh---eehhHHHHHHHHHCCCCCCCCCHHHHHHHHHHhcCCCChHHhhh
Confidence 13555443 4566666 5578899999999999999999988899887532111
Q ss_pred ------------------------CCCCCHHHHHHHHhhcccCCCcccCCCCCCHHHHhcCCceeeeCc
Q psy11767 274 ------------------------PEDLSPDVADFISRLLVKDPRRRLGGGELDAEELKRHPFFNVIDW 318 (966)
Q Consensus 274 ------------------------P~~~s~~a~dli~~LL~kdp~~RLG~~~~g~~~Ik~HpfF~~idW 318 (966)
.+.+|++++|||++||++||.+|++ ++|+.+||||+.+.+
T Consensus 290 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~t-----a~e~L~Hp~f~~~~~ 353 (398)
T 4b99_A 290 VGAERVRAYIQSLPPRQPVPWETVYPGADRQALSLLGRMLRFEPSARIS-----AAAALRHPFLAKYHD 353 (398)
T ss_dssp ----CHHHHHHSSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSTTTSCC-----HHHHTTSGGGTTTCC
T ss_pred hhhhhhhhhhhcCCCcCCCCHHHhCCCCCHHHHHHHHHHCcCChhHCcC-----HHHHhcCHhhCcCCC
Confidence 1357999999999999999999984 899999999987654
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* | Back alignment and structure |
|---|
Probab=99.92 E-value=6.5e-26 Score=253.96 Aligned_cols=183 Identities=21% Similarity=0.253 Sum_probs=147.9
Q ss_pred CcceeeeecccccceEEEEEEcCCCCEEEEEeccccchhhHHHHHHHHhhCCCccccccccccc----------------
Q psy11767 117 DLDKAGILGDGSYSVCRRCVEKSTGQEYAVKIISRKIDCSEEINLLRACQGHPNICRRCVEKST---------------- 180 (966)
Q Consensus 117 df~~~~~LG~GsFGkV~La~~k~tg~~yAiKvl~K~~~~~~E~~il~~~~~~pfi~~~~~~~~~---------------- 180 (966)
+|.+.+.||+|+||+|++|+++.||+.||||+|+++....+|..+|+++ +||+||+.+-.+.+
T Consensus 59 ~~~~~~~lG~G~fG~Vy~a~~~~~g~~vAiK~i~~~~~~~~E~~il~~l-~HpnIV~l~~~~~~~~~~~ivmEy~~gg~L 137 (336)
T 4g3f_A 59 WMTHQPRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEVFRVEELVACAGL-SSPRIVPLYGAVREGPWVNIFMELLEGGSL 137 (336)
T ss_dssp EEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCTHHHHTTTTC-CCTTBCCEEEEEEETTEEEEEECCCTTCBH
T ss_pred heEeCcEeccCCCeEEEEEEECCCCCEEEEEEECHHHhHHHHHHHHHhC-CCCCCCcEEEEEEECCEEEEEEeccCCCcH
Confidence 6789999999999999999999999999999999887778899999988 69999973322222
Q ss_pred --------------chhHHHHHHHh----------hcccchhhhHhhhccC-CceEEecCccc-----------------
Q psy11767 181 --------------GQEYAVKIISR----------KIDCSEEINLLRACQG-HPNIVNLHCVF----------------- 218 (966)
Q Consensus 181 --------------~~~~~~~~v~~----------~~~~~~e~nil~~~~g-h~~iv~l~~~~----------------- 218 (966)
+..++.+++.+ ..|++++ |||++.+| +++|+||+.+.
T Consensus 138 ~~~l~~~~~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~-NILl~~~g~~vKl~DFGla~~~~~~~~~~~~~~~~~~ 216 (336)
T 4g3f_A 138 GQLIKQMGCLPEDRALYYLGQALEGLEYLHTRRILHGDVKAD-NVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGDYI 216 (336)
T ss_dssp HHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTTTEECSCCCGG-GEEECTTSCCEEECCCTTCEEC------------CCC
T ss_pred HHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceecccCHH-HEEEeCCCCEEEEeeCCCCeEccCCCcccceecCCcc
Confidence 22333333322 1266666 99999987 79999998652
Q ss_pred -------cccccccccCCCcceeeechhhHHHHHHHhhCCCCCCCCcHHHHHHHHHhCCC---CCCCCCCHHHHHHHHhh
Q psy11767 219 -------QDEVIDWDDFSRGIECVFFSSSLIIFFIILSFTLSFIHDYYHIQYRRILKTEP---PIPEDLSPDVADFISRL 288 (966)
Q Consensus 219 -------~~e~i~~~~y~~~~d~~~~~~~~il~~~m~~g~~pf~~~~~~~~~~~I~~~~~---~~P~~~s~~a~dli~~L 288 (966)
.+|++....|+..+| +|+.||++|||++|.+||...+...++.+|..+.+ .+|+.+|++++|||.++
T Consensus 217 ~GT~~YmAPE~~~~~~y~~~~D---iwSlGvilyemltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~s~~~~~li~~~ 293 (336)
T 4g3f_A 217 PGTETHMAPEVVMGKPCDAKVD---IWSSCCMMLHMLNGCHPWTQYFRGPLCLKIASEPPPIREIPPSCAPLTAQAIQEG 293 (336)
T ss_dssp CCCGGGCCHHHHTTCCCCTHHH---HHHHHHHHHHHHHSSCSSTTTCCSCCHHHHHHSCCGGGGSCTTSCHHHHHHHHHH
T ss_pred ccCccccCHHHHCCCCCCcHHH---HHHHHHHHHHHHHCcCCCCCCCHHHHHHHHHcCCCCchhcCccCCHHHHHHHHHH
Confidence 246677777877666 56788999999999999998888888999999876 46889999999999999
Q ss_pred cccCCCcccCCCCCCHHHHhc
Q psy11767 289 LVKDPRRRLGGGELDAEELKR 309 (966)
Q Consensus 289 L~kdp~~RLG~~~~g~~~Ik~ 309 (966)
|++||.+|+. +.||.+
T Consensus 294 L~~dP~~R~s-----a~el~~ 309 (336)
T 4g3f_A 294 LRKEPVHRAS-----AMELRR 309 (336)
T ss_dssp TCSSGGGSCC-----HHHHHH
T ss_pred ccCCHhHCcC-----HHHHHH
Confidence 9999999984 788754
|
| >3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A* | Back alignment and structure |
|---|
Probab=99.92 E-value=3.4e-26 Score=273.07 Aligned_cols=175 Identities=18% Similarity=0.229 Sum_probs=135.5
Q ss_pred ccccccccccEEEEEEEcCCCcEEEEEEeccccC-------------hHHHHHHHHHhcCCCCceEEEEEEEeCCeEEEE
Q psy11767 383 AGILGDGSYSVCRRCVEKSTGQEYAVKIISRKID-------------CSEEINLLRACQGHPNIVNLHCVFQDEVHTYLV 449 (966)
Q Consensus 383 ~~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~~-------------~~~Ei~iL~~l~~HpnIV~l~~~~~~~~~~~lV 449 (966)
.++||+|+||+||+| ...++.+|+|+...+.. ..+|+++|+.+ +|||||++..++.++...|||
T Consensus 341 ~~~LG~G~fg~Vy~~--~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l-~h~nIv~~~~~~~~~~~~~lV 417 (540)
T 3en9_A 341 EHLIGKGAEADIKRD--SYLDFDVIIKERVKKGYRDERLDENIRKSRTAREARYLALV-KDFGIPAPYIFDVDLDNKRIM 417 (540)
T ss_dssp -------CCEEEEEE--ECSSCEEEEEEECCCTTSCHHHHHHHHHHHHHHHHHHHHHG-GGGTCCCCCEEEEETTTTEEE
T ss_pred CCEEeeCCCEEEEEE--EECCCeEEEEEEecccccchhhhhHHHHHHHHHHHHHHHhc-CCCCcCceEEEEEeCCccEEE
Confidence 458999999999999 45578999998643221 35799999999 599999555555566777999
Q ss_pred EEccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCcEEEecCCCCCEEEEeecccccccCC-
Q psy11767 450 LELLKGGELLDRIRQKGRCGFTENEASRIMRQLVAAVHFMHSRGVVHRDLKPENLLFSDPAGDNIKVVDFGFACLKRES- 528 (966)
Q Consensus 450 mEy~~gg~L~~~l~~~~~~~l~e~~~~~i~~Qil~aL~yLHs~~IiHRDLKP~NILl~~~~~~~iKL~DFGla~~~~~~- 528 (966)
||||+|++|.+++.. +..++.||+.||+|||++||+||||||+|||+++ .+||+|||+|+.....
T Consensus 418 mE~~~ggsL~~~l~~----------~~~i~~qi~~aL~~LH~~gIiHrDiKp~NILl~~----~~kL~DFGla~~~~~~~ 483 (540)
T 3en9_A 418 MSYINGKLAKDVIED----------NLDIAYKIGEIVGKLHKNDVIHNDLTTSNFIFDK----DLYIIDFGLGKISNLDE 483 (540)
T ss_dssp EECCCSEEHHHHSTT----------CTHHHHHHHHHHHHHHHTTEECTTCCTTSEEESS----SEEECCCTTCEECCCHH
T ss_pred EECCCCCCHHHHHHH----------HHHHHHHHHHHHHHHHHCcCccCCCCHHHEEECC----eEEEEECccCEECCCcc
Confidence 999999999998854 5689999999999999999999999999999974 8999999999876542
Q ss_pred ---------CccccccccccCchhhccCCCCCCCcccchhhhhhhhhhhhcCCCCCCCcCcchhHHHHHHHHhcCCCCC
Q psy11767 529 ---------LHTPCFTLQYAAPEVLRQDKSGYDENCDLWSLGVILVNVLRQDKSGYDENCDLWSLGVILYTMLCGRVPF 598 (966)
Q Consensus 529 ---------~~~~~gT~~Y~APEvl~~~~~~~~~~~Di~SlGvil~el~~~~~~~y~~~~DIWSlGvilyemltG~~Pf 598 (966)
..+.+||+.|||||++.... .+|+..+|+||.++-..+.+.++-+|
T Consensus 484 ~~~~~~~~~~~~~~GT~~y~APEv~~~~~------------------------~~Y~~~~d~ws~vl~~l~~v~~r~rY 538 (540)
T 3en9_A 484 DKAVDLIVFKKAVLSTHHEKFDEIWERFL------------------------EGYKSVYDRWEIILELMKDVERRARY 538 (540)
T ss_dssp HHHHHHHHHHHHHHHHCGGGHHHHHHHHH------------------------HHHHHHCTTHHHHHHHHHHHHTCSCC
T ss_pred ccccchhhhhhhhcCCCCcCCHHHHHHHH------------------------HHHHHHHhHHHHHHHHHHHHHhcccc
Confidence 12567899999999986311 23566789999888777777666665
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=99.91 E-value=1.7e-24 Score=244.64 Aligned_cols=223 Identities=33% Similarity=0.553 Sum_probs=169.4
Q ss_pred CcceeeeecccccceEEEEEEc---CCCCEEEEEeccccc---------hhhHHHHHHHHhhCCCcccccccccccc---
Q psy11767 117 DLDKAGILGDGSYSVCRRCVEK---STGQEYAVKIISRKI---------DCSEEINLLRACQGHPNICRRCVEKSTG--- 181 (966)
Q Consensus 117 df~~~~~LG~GsFGkV~La~~k---~tg~~yAiKvl~K~~---------~~~~E~~il~~~~~~pfi~~~~~~~~~~--- 181 (966)
+|+++++||+|+||+||+|++. .+|+.||||++++.. ...+|..+|+++.+||+|+.....+...
T Consensus 55 ~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~ 134 (355)
T 1vzo_A 55 NFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTETKL 134 (355)
T ss_dssp GEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETTEE
T ss_pred ceEEEEEeccCCCEEEEEEEEcccCCCCeEEEEEEEeHHHhhhhhhHHHHHHHHHHHHHHccCCCceeEEEEEEeeCceE
Confidence 7899999999999999999994 699999999998642 3567999999998999998622111110
Q ss_pred ---------------------------hhHHHHHHHh----------hcccchhhhHhhhccCCceEEecCcccc-----
Q psy11767 182 ---------------------------QEYAVKIISR----------KIDCSEEINLLRACQGHPNIVNLHCVFQ----- 219 (966)
Q Consensus 182 ---------------------------~~~~~~~v~~----------~~~~~~e~nil~~~~gh~~iv~l~~~~~----- 219 (966)
..++.+++.+ ..|++++ |||++.+|+++|+||+.+..
T Consensus 135 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dlkp~-NIll~~~~~~kl~DfG~a~~~~~~~ 213 (355)
T 1vzo_A 135 HLILDYINGGELFTHLSQRERFTEHEVQIYVGEIVLALEHLHKLGIIYRDIKLE-NILLDSNGHVVLTDFGLSKEFVADE 213 (355)
T ss_dssp EEEECCCCSCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGG-GEEECTTSCEEESCSSEEEECCGGG
T ss_pred EEEeecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHH-HEEECCCCcEEEeeCCCCeecccCC
Confidence 0111122211 1244444 99999999999999986531
Q ss_pred ---------------cccccc--ccCCCcceeeechhhHHHHHHHhhCCCCCCC----CcHHHHHHHHHhCCCCCCCCCC
Q psy11767 220 ---------------DEVIDW--DDFSRGIECVFFSSSLIIFFIILSFTLSFIH----DYYHIQYRRILKTEPPIPEDLS 278 (966)
Q Consensus 220 ---------------~e~i~~--~~y~~~~d~~~~~~~~il~~~m~~g~~pf~~----~~~~~~~~~I~~~~~~~P~~~s 278 (966)
+|++.. ..|+...| .|+.|+++|+|++|.+||.. .....+.+.++...+.+|..++
T Consensus 214 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~D---vwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 290 (355)
T 1vzo_A 214 TERAYDFCGTIEYMAPDIVRGGDSGHDKAVD---WWSLGVLMYELLTGASPFTVDGEKNSQAEISRRILKSEPPYPQEMS 290 (355)
T ss_dssp GGGGCGGGSCCTTCCHHHHTTCC---CTHHH---HHHHHHHHHHHHHSSCTTSCTTSCCCHHHHHHHHHHCCCCCCTTSC
T ss_pred CCcccCcccCcCccChhhhcCCCCCCCchhh---HHHHHHHHHHHHHCCCCCccCCccchHHHHHHHHhccCCCCCcccC
Confidence 233322 12333333 44667888889999999964 3456778899999999999999
Q ss_pred HHHHHHHHhhcccCCCcccCCCCCCHHHHhcCCceeeeCccccccCCCCCCCCcccccccccccc
Q psy11767 279 PDVADFISRLLVKDPRRRLGGGELDAEELKRHPFFNVIDWDDLATKRIPAPFVPKISNELDVSNF 343 (966)
Q Consensus 279 ~~a~dli~~LL~kdp~~RLG~~~~g~~~Ik~HpfF~~idW~~l~~k~~~pP~~P~i~~~~D~snF 343 (966)
+.+++||+++|.+||.+|+++....+++|++||||..++|+.+..+++++||.|.+.+..|.+||
T Consensus 291 ~~~~~li~~~L~~dP~~R~~~~~~s~~ell~h~~f~~~~~~~l~~~~~~~p~~p~~~~~~d~~~~ 355 (355)
T 1vzo_A 291 ALAKDLIQRLLMKDPKKRLGCGPRDADEIKEHLFFQKINWDDLAAKKVPAPFKPVIRDELDVSNF 355 (355)
T ss_dssp HHHHHHHHHHTCSSGGGSTTSSTTTHHHHHTSGGGTTCCHHHHHTTCSCCSCCCCCCC-CCC---
T ss_pred HHHHHHHHHHhhhCHHHhcCCCCCCHHHHHcCcchhcCChhHhhhccCCCCCCCccccccccccC
Confidence 99999999999999999998766689999999999999999999999999999999998888887
|
| >4f9c_A Cell division cycle 7-related protein kinase; Ser/Thr protein kinase, transferase, phosphorylation, cell C cell division, mitosis, S phase; HET: 0SX; 2.08A {Homo sapiens} PDB: 4f99_A* 4f9b_A* 4f9a_A* | Back alignment and structure |
|---|
Probab=99.91 E-value=1.5e-24 Score=245.99 Aligned_cols=192 Identities=19% Similarity=0.270 Sum_probs=139.5
Q ss_pred CcceeeeecccccceEEEEEEc---CCCCEEEEEeccccc---hhhHHHHHHHHhhCCCccccccccc------------
Q psy11767 117 DLDKAGILGDGSYSVCRRCVEK---STGQEYAVKIISRKI---DCSEEINLLRACQGHPNICRRCVEK------------ 178 (966)
Q Consensus 117 df~~~~~LG~GsFGkV~La~~k---~tg~~yAiKvl~K~~---~~~~E~~il~~~~~~pfi~~~~~~~------------ 178 (966)
+|++.+.||+|+||+|++|+++ .|++.||||++.+.. .+.+|.++|+++.+||+||+.+..+
T Consensus 22 ~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~~~~~~~E~~~l~~~~~h~nIv~l~~~~~~~~~~~lvmE~ 101 (361)
T 4f9c_A 22 VFKIEDKIGEGTFSSVYLATAQLQVGPEEKIALKHLIPTSHPIRIAAELQCLTVAGGQDNVMGVKYCFRKNDHVVIAMPY 101 (361)
T ss_dssp TCEEEEEEEECSSEEEEEEEEEBTTSCEEEEEEEEECTTSCHHHHHHHHHHHHHTCSBTTBCCCSEEEEETTEEEEEEEC
T ss_pred cEEEEEEEecccCcEEEEEEEcccCCCCCEEEEEEEccccCHHHHHHHHHHHHHhcCCCCCceEEEEEEECCEEEEEEeC
Confidence 5899999999999999999986 578899999988653 4678999999998999998732222
Q ss_pred ---------------ccchhHHHHHHHh----------hcccchhhhHhhhcc-CCceEEecCccc--------------
Q psy11767 179 ---------------STGQEYAVKIISR----------KIDCSEEINLLRACQ-GHPNIVNLHCVF-------------- 218 (966)
Q Consensus 179 ---------------~~~~~~~~~~v~~----------~~~~~~e~nil~~~~-gh~~iv~l~~~~-------------- 218 (966)
...+.+..+++.+ ..|+++| |||++.+ |+.+|+||+.+.
T Consensus 102 ~~g~~L~~~~~~l~~~~~~~~~~qll~al~ylH~~gIiHRDiKPe-NiLl~~~~~~~kl~DFGla~~~~~~~~~~~~~~~ 180 (361)
T 4f9c_A 102 LEHESFLDILNSLSFQEVREYMLNLFKALKRIHQFGIVHRDVKPS-NFLYNRRLKKYALVDFGLAQGTHDTKIELLKFVQ 180 (361)
T ss_dssp CCCCCHHHHHTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGG-GEEEETTTTEEEECCCTTCEECTTCSCGGGGGC-
T ss_pred CCcccHHHHHcCCCHHHHHHHHHHHHHHHHHHHHCCeEeCcCCHH-HeEEeCCCCeEEECcCCCCcccCCcccccccccc
Confidence 2223333344333 1366777 9999876 899999999762
Q ss_pred ---------------------------------cccccccc-cCCCcceeeechhhHHHHHHHhhCCCCCCC-CcHHHHH
Q psy11767 219 ---------------------------------QDEVIDWD-DFSRGIECVFFSSSLIIFFIILSFTLSFIH-DYYHIQY 263 (966)
Q Consensus 219 ---------------------------------~~e~i~~~-~y~~~~d~~~~~~~~il~~~m~~g~~pf~~-~~~~~~~ 263 (966)
.+|++... .|+..+| +|+.|+++|||++|.+||.. ++...+.
T Consensus 181 ~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~y~~~~D---iWSlG~il~ell~G~~Pf~~~~~~~~~l 257 (361)
T 4f9c_A 181 SEAQQERCSQNKCSICLSRRQQVAPRAGTPGFRAPEVLTKCPNQTTAID---MWSAGVIFLSLLSGRYPFYKASDDLTAL 257 (361)
T ss_dssp -------------------------CCCCGGGCCHHHHTTCSCCCTHHH---HHHHHHHHHHHHHTCSSSSCCSSHHHHH
T ss_pred ccccccccccccccccccccccccccccCccccCHHHHcCCCCCCCccc---hhhhHHHHHHHHHCCCCCCCCCCHHHHH
Confidence 23455443 4666666 55778888999999988853 4444444
Q ss_pred HHHHh--------------------------------------CCC----------------CCCCCCCHHHHHHHHhhc
Q psy11767 264 RRILK--------------------------------------TEP----------------PIPEDLSPDVADFISRLL 289 (966)
Q Consensus 264 ~~I~~--------------------------------------~~~----------------~~P~~~s~~a~dli~~LL 289 (966)
.+|.. ... .....+|++|+|||++||
T Consensus 258 ~~I~~~~G~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~is~~a~DLl~~lL 337 (361)
T 4f9c_A 258 AQIMTIRGSRETIQAAKTFGKSILCSKEVPAQDLRKLCERLRGMDSSTPKLTSDIQGHATNLEGWNEVPDEAYDLLDKLL 337 (361)
T ss_dssp HHHHHHHCHHHHHHHHHHTTEEEEESSCCCCCCHHHHHHHHC----------------------CTTCCHHHHHHHHHHT
T ss_pred HHHHHhcCCccchhhhhhccccccccccCcchhhhHHHHhhccccccccccccccccccccccccccCCHHHHHHHHHHC
Confidence 44432 111 123468999999999999
Q ss_pred ccCCCcccCCCCCCHHHHhcCCceeeeC
Q psy11767 290 VKDPRRRLGGGELDAEELKRHPFFNVID 317 (966)
Q Consensus 290 ~kdp~~RLG~~~~g~~~Ik~HpfF~~id 317 (966)
+.||.+|++ ++|+.+||||++|+
T Consensus 338 ~~dP~~R~t-----a~eaL~Hp~f~~i~ 360 (361)
T 4f9c_A 338 DLNPASRIT-----AEEALLHPFFKDMS 360 (361)
T ss_dssp CSCTTTSCC-----HHHHHTSGGGTTC-
T ss_pred cCChhHCcC-----HHHHhcCcccCCCC
Confidence 999999994 89999999999875
|
| >3fpq_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase, ATP-BIND kinase, nucleotide-binding, phosphoprotein; 1.80A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=99.90 E-value=1.5e-23 Score=230.45 Aligned_cols=186 Identities=17% Similarity=0.261 Sum_probs=142.1
Q ss_pred ceeeeecccccceEEEEEEcCCCCEEEEEeccccc-------hhhHHHHHHHHhhCCCccccccccccc-----------
Q psy11767 119 DKAGILGDGSYSVCRRCVEKSTGQEYAVKIISRKI-------DCSEEINLLRACQGHPNICRRCVEKST----------- 180 (966)
Q Consensus 119 ~~~~~LG~GsFGkV~La~~k~tg~~yAiKvl~K~~-------~~~~E~~il~~~~~~pfi~~~~~~~~~----------- 180 (966)
.+.+.||+|+||+||+|+++.||+.||||++.+.. ...+|..+|+++ +||+||+.+-.+..
T Consensus 29 ~~~~~iG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l-~HpnIV~~~~~~~~~~~~~~~~~lv 107 (290)
T 3fpq_A 29 KFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGL-QHPNIVRFYDSWESTVKGKKCIVLV 107 (290)
T ss_dssp EEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHTC-CCTTBCCEEEEEEEEETTEEEEEEE
T ss_pred EeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhC-CCCCCCcEEEEEeeccCCCcEEEEE
Confidence 56678999999999999999999999999998642 357899999998 69999974322111
Q ss_pred -----------------------chhHHHHHHHh-------h-----cccchhhhHhhhc-cCCceEEecCccc------
Q psy11767 181 -----------------------GQEYAVKIISR-------K-----IDCSEEINLLRAC-QGHPNIVNLHCVF------ 218 (966)
Q Consensus 181 -----------------------~~~~~~~~v~~-------~-----~~~~~e~nil~~~-~gh~~iv~l~~~~------ 218 (966)
...++.+++.+ . .|++++ |||++. +|+++|.||+.+.
T Consensus 108 mEy~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~ylH~~~~~IiHRDlKp~-NILl~~~~g~vKl~DFGla~~~~~~~ 186 (290)
T 3fpq_A 108 TELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCD-NIFITGPTGSVKIGDLGLATLKRASF 186 (290)
T ss_dssp EECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTSSSCCCCCCCCGG-GEEESSTTSCEEECCTTGGGGCCTTS
T ss_pred EeCCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCCEEecccChh-heeEECCCCCEEEEeCcCCEeCCCCc
Confidence 01111122211 1 255566 999974 7999999999763
Q ss_pred -----------cccccccccCCCcceeeechhhHHHHHHHhhCCCCCCC-CcHHHHHHHHHhCCC--CCCCCCCHHHHHH
Q psy11767 219 -----------QDEVIDWDDFSRGIECVFFSSSLIIFFIILSFTLSFIH-DYYHIQYRRILKTEP--PIPEDLSPDVADF 284 (966)
Q Consensus 219 -----------~~e~i~~~~y~~~~d~~~~~~~~il~~~m~~g~~pf~~-~~~~~~~~~I~~~~~--~~P~~~s~~a~dl 284 (966)
.||++. ..|+..+| +|+.||++|||++|.+||.. ++...+++.|..+.. .+|..++++++||
T Consensus 187 ~~~~~GTp~YmAPE~~~-~~y~~~~D---iwSlGvilyelltg~~Pf~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~l 262 (290)
T 3fpq_A 187 AKAVIGTPEFMAPEMYE-EKYDESVD---VYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVKPASFDKVAIPEVKEI 262 (290)
T ss_dssp BEESCSSCCCCCGGGGG-TCCCTHHH---HHHHHHHHHHHHHSSCTTTTCSSHHHHHHHHTTTCCCGGGGGCCCHHHHHH
T ss_pred cCCcccCccccCHHHcC-CCCCcHHH---HHHHHHHHHHHHHCCCCCCCCCcHHHHHHHHHcCCCCCCCCccCCHHHHHH
Confidence 356665 35876666 45777899999999999965 566778888887643 4678899999999
Q ss_pred HHhhcccCCCcccCCCCCCHHHHhcCCceee
Q psy11767 285 ISRLLVKDPRRRLGGGELDAEELKRHPFFNV 315 (966)
Q Consensus 285 i~~LL~kdp~~RLG~~~~g~~~Ik~HpfF~~ 315 (966)
|.++|++||.+|+. ++||.+||||+.
T Consensus 263 i~~~L~~dP~~R~s-----~~e~l~Hp~~~~ 288 (290)
T 3fpq_A 263 IEGCIRQNKDERYS-----IKDLLNHAFFQE 288 (290)
T ss_dssp HHHHSCSSGGGSCC-----HHHHHTSGGGC-
T ss_pred HHHHccCChhHCcC-----HHHHhcCccccC
Confidence 99999999999984 899999999973
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A | Back alignment and structure |
|---|
Probab=99.90 E-value=4.1e-24 Score=240.60 Aligned_cols=231 Identities=26% Similarity=0.403 Sum_probs=167.5
Q ss_pred hhccCCccchhccCCcceeeeecccccceEEEEEEcCCCCEEEEEeccccc-hhhHHHHHHHHhhCCCcccccccccccc
Q psy11767 103 CKFKGSLFFEQYDMDLDKAGILGDGSYSVCRRCVEKSTGQEYAVKIISRKI-DCSEEINLLRACQGHPNICRRCVEKSTG 181 (966)
Q Consensus 103 ~~~~~~~~~~~~~~df~~~~~LG~GsFGkV~La~~k~tg~~yAiKvl~K~~-~~~~E~~il~~~~~~pfi~~~~~~~~~~ 181 (966)
+..++..|.+.| +++++||+|+||+|++|+++.||+.||||+++|.. ...+|..+|.++.+||+|+..+-.+...
T Consensus 13 ~~~~~~~~~~~y----~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~E~~~l~~~~~hp~iv~~~~~~~~~ 88 (342)
T 2qr7_A 13 LHRNSIQFTDGY----EVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKRDPTEEIEILLRYGQHPNIITLKDVYDDG 88 (342)
T ss_dssp ------CHHHHE----EEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTTCCCHHHHHHHHHHTTSTTBCCEEEEEECS
T ss_pred hcccccCccccE----EEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEcccCChHHHHHHHHHhcCCCCcCeEEEEEEcC
Confidence 344455555555 89999999999999999999999999999999753 5678999999988999998722111111
Q ss_pred ------------------------------hhHHHHHHHh----------hcccchhhhHhh-hccC---CceEEecCcc
Q psy11767 182 ------------------------------QEYAVKIISR----------KIDCSEEINLLR-ACQG---HPNIVNLHCV 217 (966)
Q Consensus 182 ------------------------------~~~~~~~v~~----------~~~~~~e~nil~-~~~g---h~~iv~l~~~ 217 (966)
..++.+++.+ ..|++++ |||. +.+| +++|+||+.+
T Consensus 89 ~~~~lv~E~~~gg~L~~~i~~~~~~~~~~~~~~~~qi~~al~~lH~~givHrDlkp~-NIl~~~~~~~~~~~kl~Dfg~a 167 (342)
T 2qr7_A 89 KYVYVVTELMKGGELLDKILRQKFFSEREASAVLFTITKTVEYLHAQGVVHRDLKPS-NILYVDESGNPESIRICDFGFA 167 (342)
T ss_dssp SEEEEEECCCCSCBHHHHHHTCTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGG-GEEESSSSCSGGGEEECCCTTC
T ss_pred CEEEEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCcEeccCCHH-HEEEecCCCCcCeEEEEECCCc
Confidence 1112222222 1244555 8886 3333 4899999876
Q ss_pred cc-------------------ccccccccCCCcceeeechhhHHHHHHHhhCCCCCCC---CcHHHHHHHHHhCCCCCC-
Q psy11767 218 FQ-------------------DEVIDWDDFSRGIECVFFSSSLIIFFIILSFTLSFIH---DYYHIQYRRILKTEPPIP- 274 (966)
Q Consensus 218 ~~-------------------~e~i~~~~y~~~~d~~~~~~~~il~~~m~~g~~pf~~---~~~~~~~~~I~~~~~~~P- 274 (966)
.. +|++....|+...| +|+.|+++|+|++|.+||.. ++...++++|..+.+.+|
T Consensus 168 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~D---iwslG~il~ell~g~~Pf~~~~~~~~~~~~~~i~~~~~~~~~ 244 (342)
T 2qr7_A 168 KQLRAENGLLMTPCYTANFVAPEVLERQGYDAACD---IWSLGVLLYTMLTGYTPFANGPDDTPEEILARIGSGKFSLSG 244 (342)
T ss_dssp EECBCTTCCBCCSSCCSSCCCHHHHHHHHHHHHHH---HHHHHHHHHHHHHSSCSSCSSTTSCHHHHHHHHHHCCCCCCS
T ss_pred ccCcCCCCceeccCCCccccCHHHhcCCCCCCccC---eeeHhHHHHHHhcCCCCCCCCCcCCHHHHHHHHccCCcccCc
Confidence 42 22333333433333 55677888999999999975 567788999999988766
Q ss_pred ---CCCCHHHHHHHHhhcccCCCcccCCCCCCHHHHhcCCceeeeCccccccCCCCCCCCccccccccccccccccc
Q psy11767 275 ---EDLSPDVADFISRLLVKDPRRRLGGGELDAEELKRHPFFNVIDWDDLATKRIPAPFVPKISNELDVSNFSDEFT 348 (966)
Q Consensus 275 ---~~~s~~a~dli~~LL~kdp~~RLG~~~~g~~~Ik~HpfF~~idW~~l~~k~~~pP~~P~i~~~~D~snFd~ef~ 348 (966)
..+|+++++||+++|.+||.+|++ +.+|.+|||| .+|+.+..+++.+|+.|.........+|+..+.
T Consensus 245 ~~~~~~s~~~~~li~~~L~~dP~~R~t-----~~~il~hp~~--~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~ 314 (342)
T 2qr7_A 245 GYWNSVSDTAKDLVSKMLHVDPHQRLT-----AALVLRHPWI--VHWDQLPQYQLNRQDAPHLVKGAMAATYSALNR 314 (342)
T ss_dssp TTTTTSCHHHHHHHHHHTCSSTTTSCC-----HHHHTTSHHH--HTGGGSCCSCCCCCCCHHHHHHHHHHHHHHHTT
T ss_pred cccccCCHHHHHHHHHHCCCChhHCcC-----HHHHhcCCee--cCccccccccCCCccchhhhhhHHHHHHhhhcc
Confidence 578999999999999999999985 8999999999 689999999999999987655555566766543
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* | Back alignment and structure |
|---|
Probab=99.89 E-value=4.7e-24 Score=235.89 Aligned_cols=190 Identities=19% Similarity=0.244 Sum_probs=134.8
Q ss_pred CCcceeeeecccccceEEEEEEcCCCCEEEEEeccccc------hhhHHHHHHHHhhCCCccccccccccc---------
Q psy11767 116 MDLDKAGILGDGSYSVCRRCVEKSTGQEYAVKIISRKI------DCSEEINLLRACQGHPNICRRCVEKST--------- 180 (966)
Q Consensus 116 ~df~~~~~LG~GsFGkV~La~~k~tg~~yAiKvl~K~~------~~~~E~~il~~~~~~pfi~~~~~~~~~--------- 180 (966)
-||+++++||+|+||+|++|+++.||+.||||++++.. ...+|..+|+++ +||+||+.+-.+..
T Consensus 5 ~dy~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~E~~il~~l-~HpnIV~~~~~~~~~~~~~~~~~ 83 (299)
T 4g31_A 5 TDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKL-EHPGIVRYFNAWLEKNTTEKLQP 83 (299)
T ss_dssp HHEEEEEEEEECC--EEEEEEETTTCCEEEEEEEEECSSHHHHHHHHHHHHHHTTC-CCTTBCCEEEEEEEEC-------
T ss_pred hhCEEeeEEecCCCeEEEEEEECCCCCEEEEEEEeccCCHHHHHHHHHHHHHHHhC-CCCCCCeEEEEEEecCccccccc
Confidence 38999999999999999999999999999999998632 357899999998 69999873321110
Q ss_pred ------------------------------------chhHHHHHHHh----------hcccchhhhHhhhccCCceEEec
Q psy11767 181 ------------------------------------GQEYAVKIISR----------KIDCSEEINLLRACQGHPNIVNL 214 (966)
Q Consensus 181 ------------------------------------~~~~~~~~v~~----------~~~~~~e~nil~~~~gh~~iv~l 214 (966)
...++.+++.+ ..|++++ |||++.+|+++|.||
T Consensus 84 ~~~~~~l~ivmE~~~gg~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~ylH~~~IiHRDlKp~-NILl~~~~~vKl~DF 162 (299)
T 4g31_A 84 SSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQIAEAVEFLHSKGLMHRDLKPS-NIFFTMDDVVKVGDF 162 (299)
T ss_dssp ---CEEEEEEEECCCSCCHHHHHHTCCSGGGSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGG-GEEECTTCCEEECCC
T ss_pred cCCCcEEEEEEecCCCCcHHHHHHhcCCCChhHHHHHHHHHHHHHHHHHHHHHCcCccccCcHH-HeEECCCCcEEEccC
Confidence 01122222222 1266666 999999999999999
Q ss_pred Cccc-------------------------------cccccccccCCCcceeeechhhHHHHHHHhhCCCCCCCCc-HHHH
Q psy11767 215 HCVF-------------------------------QDEVIDWDDFSRGIECVFFSSSLIIFFIILSFTLSFIHDY-YHIQ 262 (966)
Q Consensus 215 ~~~~-------------------------------~~e~i~~~~y~~~~d~~~~~~~~il~~~m~~g~~pf~~~~-~~~~ 262 (966)
+.+. .||++....|+..+| +|+.||++|||++ ||.... ....
T Consensus 163 Gla~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~D---iwSlGvilyell~---Pf~~~~~~~~~ 236 (299)
T 4g31_A 163 GLVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVD---IFSLGLILFELLY---PFSTQMERVRT 236 (299)
T ss_dssp CCC--------------------------CCCTTSCHHHHTTCCCCTHHH---HHHHHHHHHHHHS---CCSSHHHHHHH
T ss_pred ccceecCCCccccccccccccccccCCcccCccccCHHHHcCCCCCCHHH---HHHHHHHHHHHcc---CCCCccHHHHH
Confidence 9652 246677677877666 4466677777774 776543 2233
Q ss_pred HHHHHhCCCCCCC---CCCHHHHHHHHhhcccCCCcccCCCCCCHHHHhcCCceeeeCccc
Q psy11767 263 YRRILKTEPPIPE---DLSPDVADFISRLLVKDPRRRLGGGELDAEELKRHPFFNVIDWDD 320 (966)
Q Consensus 263 ~~~I~~~~~~~P~---~~s~~a~dli~~LL~kdp~~RLG~~~~g~~~Ik~HpfF~~idW~~ 320 (966)
...+.+. .+|+ ..++++++||+++|++||.+|. .+.||.+||||+++||..
T Consensus 237 ~~~~~~~--~~p~~~~~~~~~~~~li~~~L~~dP~~Rp-----s~~eil~h~~~~~~~~p~ 290 (299)
T 4g31_A 237 LTDVRNL--KFPPLFTQKYPCEYVMVQDMLSPSPMERP-----EAINIIENAVFEDLDFPG 290 (299)
T ss_dssp HHHHHTT--CCCHHHHHHCHHHHHHHHHHTCSSGGGSC-----CHHHHHTSGGGCCC----
T ss_pred HHHHhcC--CCCCCCcccCHHHHHHHHHHcCCChhHCc-----CHHHHhcCHhhCCCCCCC
Confidence 4455543 3453 4578899999999999999998 489999999999999943
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* | Back alignment and structure |
|---|
Probab=99.88 E-value=4e-23 Score=234.37 Aligned_cols=213 Identities=26% Similarity=0.439 Sum_probs=161.8
Q ss_pred CCcceeeeecccccceEEEEEEcCCCCEEEEEeccccc-----------hhhHHHHHHHHhhCCCccccccccccc----
Q psy11767 116 MDLDKAGILGDGSYSVCRRCVEKSTGQEYAVKIISRKI-----------DCSEEINLLRACQGHPNICRRCVEKST---- 180 (966)
Q Consensus 116 ~df~~~~~LG~GsFGkV~La~~k~tg~~yAiKvl~K~~-----------~~~~E~~il~~~~~~pfi~~~~~~~~~---- 180 (966)
-+|+++++||+|+||+|++|+++.||+.||||+++|.. ...+|..+|+++ +||+|++.+..+..
T Consensus 12 ~~y~~~~~LG~G~fg~V~~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~~~~E~~il~~l-~hpnIv~l~~~~~~~~~~ 90 (361)
T 2yab_A 12 DFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQV-LHPNIITLHDVYENRTDV 90 (361)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHTTC-CCTTBCCEEEEEECSSEE
T ss_pred hceEEeeEEeeCcCEEEEEEEECCCCCEEEEEEEEccccccccchhHHHHHHHHHHHHHhC-CCcCCCcEEEEEEeCCEE
Confidence 35699999999999999999999999999999999752 246899999988 59999872221111
Q ss_pred --------------------------chhHHHHHHHh----------hcccchhhhHhhhccC----CceEEecCccc--
Q psy11767 181 --------------------------GQEYAVKIISR----------KIDCSEEINLLRACQG----HPNIVNLHCVF-- 218 (966)
Q Consensus 181 --------------------------~~~~~~~~v~~----------~~~~~~e~nil~~~~g----h~~iv~l~~~~-- 218 (966)
...++.+++.+ ..|++++ |||.+.+| +.+|+||+.+.
T Consensus 91 ~lv~e~~~gg~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlkp~-NIll~~~~~~~~~vkl~DFG~a~~~ 169 (361)
T 2yab_A 91 VLILELVSGGELFDFLAQKESLSEEEATSFIKQILDGVNYLHTKKIAHFDLKPE-NIMLLDKNIPIPHIKLIDFGLAHEI 169 (361)
T ss_dssp EEEEECCCSCBHHHHHTTCSCCBHHHHHHHHHHHHHHHHHHHHTTEECCCCSGG-GEEESCTTSSSCCEEECCCSSCEEC
T ss_pred EEEEEcCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHH-HEEEeCCCCCccCEEEEecCCceEc
Confidence 11112222222 1245555 99887766 78999998653
Q ss_pred ----------------cccccccccCCCcceeeechhhHHHHHHHhhCCCCCCCCcHHHHHHHHHhCCCCCC----CCCC
Q psy11767 219 ----------------QDEVIDWDDFSRGIECVFFSSSLIIFFIILSFTLSFIHDYYHIQYRRILKTEPPIP----EDLS 278 (966)
Q Consensus 219 ----------------~~e~i~~~~y~~~~d~~~~~~~~il~~~m~~g~~pf~~~~~~~~~~~I~~~~~~~P----~~~s 278 (966)
.+|++....|+...| +|+.|+++|+|++|.+||...+...++++|..+.+.|| ..+|
T Consensus 170 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~D---iwslGvil~~ll~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s 246 (361)
T 2yab_A 170 EDGVEFKNIFGTPEFVAPEIVNYEPLGLEAD---MWSIGVITYILLSGASPFLGDTKQETLANITAVSYDFDEEFFSQTS 246 (361)
T ss_dssp CTTCCCCCCCSCGGGCCHHHHTTCCCCTHHH---HHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHTTCCCCCHHHHTTSC
T ss_pred CCCCccccCCCCccEECchHHcCCCCCcccc---HHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCchhccCCC
Confidence 235555556765555 45677888899999999999999999999999998887 5789
Q ss_pred HHHHHHHHhhcccCCCcccCCCCCCHHHHhcCCceeeeCccccccCCCCCCCCcccccccccccccccc
Q psy11767 279 PDVADFISRLLVKDPRRRLGGGELDAEELKRHPFFNVIDWDDLATKRIPAPFVPKISNELDVSNFSDEF 347 (966)
Q Consensus 279 ~~a~dli~~LL~kdp~~RLG~~~~g~~~Ik~HpfF~~idW~~l~~k~~~pP~~P~i~~~~D~snFd~ef 347 (966)
++++|||++||++||.+|++ ++++.+||||.+++|.....++ ....+..+|+.++
T Consensus 247 ~~~~~li~~~L~~dP~~R~t-----~~e~l~hp~~~~~~~~~~~~~~---------~~~~~~~~~~~~~ 301 (361)
T 2yab_A 247 ELAKDFIRKLLVKETRKRLT-----IQEALRHPWITPVDTQQAMVRR---------ESVVNLENFKKQY 301 (361)
T ss_dssp HHHHHHHHHHSCSSTTTSCC-----HHHHHTSTTTSCSSHHHHHHHH---------TCBCCHHHHHHHT
T ss_pred HHHHHHHHHHCCCChhHCcC-----HHHHhcCcCcCCCchhhhhhcc---------cchhhHHHHHHHH
Confidence 99999999999999999984 8999999999999998765443 2234556666544
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A | Back alignment and structure |
|---|
Probab=99.87 E-value=9.9e-22 Score=219.89 Aligned_cols=193 Identities=23% Similarity=0.311 Sum_probs=149.1
Q ss_pred CcceeeeecccccceEEEEEEcCCCCEEEEEeccccc-------hhhHHHHHHHHhhCCCcccccccccccc--------
Q psy11767 117 DLDKAGILGDGSYSVCRRCVEKSTGQEYAVKIISRKI-------DCSEEINLLRACQGHPNICRRCVEKSTG-------- 181 (966)
Q Consensus 117 df~~~~~LG~GsFGkV~La~~k~tg~~yAiKvl~K~~-------~~~~E~~il~~~~~~pfi~~~~~~~~~~-------- 181 (966)
+|.++++||+|+||+|++|+++.||+.||||++++.. ...+|..+|+++ +||+|++.+-...+.
T Consensus 16 ~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l-~hpnIv~l~~~~~~~~~~~lv~e 94 (328)
T 3fe3_A 16 NYRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKIL-NHPNIVKLFEVIETEKTLYLIME 94 (328)
T ss_dssp TEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHC-CCTTBCCEEEEEECSSEEEEEEC
T ss_pred CEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhhcCCHHHHHHHHHHHHHHHhC-CCCCEeeEEEEEEECCEEEEEEE
Confidence 6799999999999999999999999999999998752 346799999888 599998722111110
Q ss_pred ----------------------hhHHHHHHHh----------hcccchhhhHhhhccCCceEEecCcccc----------
Q psy11767 182 ----------------------QEYAVKIISR----------KIDCSEEINLLRACQGHPNIVNLHCVFQ---------- 219 (966)
Q Consensus 182 ----------------------~~~~~~~v~~----------~~~~~~e~nil~~~~gh~~iv~l~~~~~---------- 219 (966)
...+.+++.+ ..|++++ |||.+.+|+++|+||+.+..
T Consensus 95 ~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~al~~lH~~~ivHrDlkp~-NIll~~~~~~kl~DFG~a~~~~~~~~~~~~ 173 (328)
T 3fe3_A 95 YASGGEVFDYLVAHGRMKEKEARSKFRQIVSAVQYCHQKRIVHRDLKAE-NLLLDADMNIKIADFGFSNEFTVGGKLDAF 173 (328)
T ss_dssp CCTTCBHHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGG-GEEECTTSCEEECSTTCCGGGSSSCGGGTT
T ss_pred CCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEeccCCCHH-HEEEcCCCCEEEeeccCceecCCCCccccc
Confidence 1111222222 1244555 99999999999999987632
Q ss_pred --------ccccccccCCCcceeeechhhHHHHHHHhhCCCCCCCCcHHHHHHHHHhCCCCCCCCCCHHHHHHHHhhccc
Q psy11767 220 --------DEVIDWDDFSRGIECVFFSSSLIIFFIILSFTLSFIHDYYHIQYRRILKTEPPIPEDLSPDVADFISRLLVK 291 (966)
Q Consensus 220 --------~e~i~~~~y~~~~d~~~~~~~~il~~~m~~g~~pf~~~~~~~~~~~I~~~~~~~P~~~s~~a~dli~~LL~k 291 (966)
+|++....|. +...| .|+.|+++|+|++|.+||...+...+.++|+.+.+.+|..+++++.+||+++|+.
T Consensus 174 ~gt~~y~aPE~~~~~~~~-~~~~D-iwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li~~~L~~ 251 (328)
T 3fe3_A 174 CGAPPYAAPELFQGKKYD-GPEVD-VWSLGVILYTLVSGSLPFDGQNLKELRERVLRGKYRIPFYMSTDCENLLKRFLVL 251 (328)
T ss_dssp SSSGGGCCHHHHHTCCCC-SHHHH-HHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCTTSCHHHHHHHHHHCCS
T ss_pred cCCcceeCcccccCCCcC-Cchhh-hhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCCCCCHHHHHHHHHHCCC
Confidence 2444443332 22233 4456788899999999999999999999999999999999999999999999999
Q ss_pred CCCcccCCCCCCHHHHhcCCceeeeCc
Q psy11767 292 DPRRRLGGGELDAEELKRHPFFNVIDW 318 (966)
Q Consensus 292 dp~~RLG~~~~g~~~Ik~HpfF~~idW 318 (966)
||.+|. .+++|.+||||+...+
T Consensus 252 dP~~R~-----t~~eil~h~~~~~~~~ 273 (328)
T 3fe3_A 252 NPIKRG-----TLEQIMKDRWINAGHE 273 (328)
T ss_dssp STTTSC-----CHHHHTTCTTTTTTCT
T ss_pred ChhHCc-----CHHHHhcCHhhcCCCc
Confidence 999997 4899999999986554
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=99.86 E-value=5.9e-22 Score=226.19 Aligned_cols=210 Identities=22% Similarity=0.288 Sum_probs=145.4
Q ss_pred CcceeeeecccccceEEEEEEcCCCCEEEEEecccc-------chhhHHHHHHHHhhCCCcccccccccc--cc------
Q psy11767 117 DLDKAGILGDGSYSVCRRCVEKSTGQEYAVKIISRK-------IDCSEEINLLRACQGHPNICRRCVEKS--TG------ 181 (966)
Q Consensus 117 df~~~~~LG~GsFGkV~La~~k~tg~~yAiKvl~K~-------~~~~~E~~il~~~~~~pfi~~~~~~~~--~~------ 181 (966)
+|++++.||+|+||+|++|+++.||+.||||++.+. ....+|..+|+++..||+|++..-.+. ..
T Consensus 10 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~lv 89 (388)
T 3oz6_A 10 KYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTFREIMILTELSGHENIVNLLNVLRADNDRDVYLV 89 (388)
T ss_dssp TEEEEEC-------CEEEEEETTTCCEEEEEEECC--CCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECTTSSCEEEE
T ss_pred ceEEEEEeeeCCCeEEEEEEECCCCCEEEEEEecccccChHHHHHHHHHHHHHHhccCCCCCCeeeeEEecCCCCEEEEE
Confidence 679999999999999999999999999999999753 235689999999988999987322211 10
Q ss_pred ----------------------hhHHHHHHHh----------hcccchhhhHhhhccCCceEEecCccc-----------
Q psy11767 182 ----------------------QEYAVKIISR----------KIDCSEEINLLRACQGHPNIVNLHCVF----------- 218 (966)
Q Consensus 182 ----------------------~~~~~~~v~~----------~~~~~~e~nil~~~~gh~~iv~l~~~~----------- 218 (966)
..++.+++.+ ..|++++ |||.+.+|+++|+||+.+.
T Consensus 90 ~e~~~~~L~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~-NIll~~~~~~kl~DFG~a~~~~~~~~~~~~ 168 (388)
T 3oz6_A 90 FDYMETDLHAVIRANILEPVHKQYVVYQLIKVIKYLHSGGLLHRDMKPS-NILLNAECHVKVADFGLSRSFVNIRRVTNN 168 (388)
T ss_dssp EECCSEEHHHHHHHTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGG-GEEECTTCCEEECCCTTCEESSSCCCCCCC
T ss_pred ecccCcCHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCCCHH-HeEEcCCCCEEecCCccccccccccccccc
Confidence 1111122222 1245555 9999999999999998762
Q ss_pred -----------------------------ccccccc-ccCCCcceeeechhhHHHHHHHhhCCCCCCCCcHHHHHHHHHh
Q psy11767 219 -----------------------------QDEVIDW-DDFSRGIECVFFSSSLIIFFIILSFTLSFIHDYYHIQYRRILK 268 (966)
Q Consensus 219 -----------------------------~~e~i~~-~~y~~~~d~~~~~~~~il~~~m~~g~~pf~~~~~~~~~~~I~~ 268 (966)
.+|++.. ..|+...| +|+.|+++|+|++|.+||...+...++++|+.
T Consensus 169 ~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~D---iwSlG~il~ell~g~~pf~~~~~~~~~~~i~~ 245 (388)
T 3oz6_A 169 IPLSINENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGID---MWSLGCILGEILCGKPIFPGSSTMNQLERIIG 245 (388)
T ss_dssp GGGCCC---------------CCCGGGGCCHHHHTTCCCCCTHHH---HHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHH
T ss_pred ccccccccccccccccccccCCcccCCcCCHHHhcCCCCCCChhh---HHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHH
Confidence 1344432 35655555 55777888999999999999888888888763
Q ss_pred CCCCC------------------------------------------------CCCCCHHHHHHHHhhcccCCCcccCCC
Q psy11767 269 TEPPI------------------------------------------------PEDLSPDVADFISRLLVKDPRRRLGGG 300 (966)
Q Consensus 269 ~~~~~------------------------------------------------P~~~s~~a~dli~~LL~kdp~~RLG~~ 300 (966)
.+.+ +..++++++|||++||+.||.+|++
T Consensus 246 -~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~~L~~dP~~R~t-- 322 (388)
T 3oz6_A 246 -VIDFPSNEDVESIQSPFAKTMIESLKEKVEIRQSNKRDIFTKWKNLLLKINPKADCNEEALDLLDKLLQFNPNKRIS-- 322 (388)
T ss_dssp -HHCCCCHHHHHTSCCSSHHHHHHHHHHHCC-----CCCCHHHHHHHHHHHCTTCCCCHHHHHHHHHHCCSSGGGSCC--
T ss_pred -hcCCCCHHHHHhccCHHHHHHHHhCcccccccCCCHHHhCcchhhhcccccccccCCHHHHHHHHHhhccCcccCCC--
Confidence 1111 2367999999999999999999984
Q ss_pred CCCHHHHhcCCcee---eeCccccccCCCCCCCCccccc
Q psy11767 301 ELDAEELKRHPFFN---VIDWDDLATKRIPAPFVPKISN 336 (966)
Q Consensus 301 ~~g~~~Ik~HpfF~---~idW~~l~~k~~~pP~~P~i~~ 336 (966)
++|+.+||||+ +.+|+....+.+.+|+.+....
T Consensus 323 ---~~e~l~Hp~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 358 (388)
T 3oz6_A 323 ---ANDALKHPFVSIFHNPNEEPNCDHIITIPINDNVKH 358 (388)
T ss_dssp ---HHHHTTSTTTTTTCCGGGCCCCSSCCCCC------C
T ss_pred ---HHHHhCCHHHHHhcCCccCCCCCCCCCCCccccccC
Confidence 89999999965 5678888778888888776543
|
| >1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A* | Back alignment and structure |
|---|
Probab=99.86 E-value=2.2e-22 Score=220.59 Aligned_cols=136 Identities=23% Similarity=0.323 Sum_probs=110.6
Q ss_pred cccccccccccEEEEEEEcCCCcEEEEEEecccc-----------------------ChHHHHHHHHHhcCCCCceEEEE
Q psy11767 382 KAGILGDGSYSVCRRCVEKSTGQEYAVKIISRKI-----------------------DCSEEINLLRACQGHPNIVNLHC 438 (966)
Q Consensus 382 ~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~-----------------------~~~~Ei~iL~~l~~HpnIV~l~~ 438 (966)
..+.||+|+||.||+|.+ .+|+.||||++.... ...+|+.+|+.+. |++++.
T Consensus 94 ~~~~iG~G~~g~Vy~~~~-~~g~~valK~~~~~~~~~~~~~~~~~~~~~~w~~~~~~~~~~E~~~l~~l~-~~~v~~--- 168 (282)
T 1zar_A 94 IGKLMGEGKESAVFNCYS-EKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQ-GLAVPK--- 168 (282)
T ss_dssp EEEEEEECSSEEEEEEEE-TTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTT-TSSSCC---
T ss_pred ecCEeccCCCceEEEEEe-CCCCEEEEEEEECCCCchhhhhhhhhhcchhhHHHHHHHHHHHHHHHHhcc-CCCcCe---
Confidence 357899999999999999 889999999985321 1457999999986 455544
Q ss_pred EEEeCCeEEEEEEccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCcEEEecCCCCCEEEEe
Q psy11767 439 VFQDEVHTYLVLELLKGGELLDRIRQKGRCGFTENEASRIMRQLVAAVHFMHSRGVVHRDLKPENLLFSDPAGDNIKVVD 518 (966)
Q Consensus 439 ~~~~~~~~~lVmEy~~gg~L~~~l~~~~~~~l~e~~~~~i~~Qil~aL~yLHs~~IiHRDLKP~NILl~~~~~~~iKL~D 518 (966)
++.. +..|+|||||+||+|.+ +. . .++..++.||+.||+|||++||+||||||+|||++ ++.+||+|
T Consensus 169 ~~~~-~~~~lvmE~~~g~~L~~-l~------~--~~~~~i~~qi~~~l~~lH~~giiHrDlkp~NILl~---~~~vkl~D 235 (282)
T 1zar_A 169 VYAW-EGNAVLMELIDAKELYR-VR------V--ENPDEVLDMILEEVAKFYHRGIVHGDLSQYNVLVS---EEGIWIID 235 (282)
T ss_dssp EEEE-ETTEEEEECCCCEEGGG-CC------C--SCHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEEE---TTEEEECC
T ss_pred EEec-cceEEEEEecCCCcHHH-cc------h--hhHHHHHHHHHHHHHHHHHCCCEeCCCCHHHEEEE---CCcEEEEE
Confidence 4433 45699999999999987 41 1 23557999999999999999999999999999998 46899999
Q ss_pred ecccccccCCCccccccccccCchhhc
Q psy11767 519 FGFACLKRESLHTPCFTLQYAAPEVLR 545 (966)
Q Consensus 519 FGla~~~~~~~~~~~gT~~Y~APEvl~ 545 (966)
||+|+. +..|+|||++.
T Consensus 236 FG~a~~----------~~~~~a~e~l~ 252 (282)
T 1zar_A 236 FPQSVE----------VGEEGWREILE 252 (282)
T ss_dssp CTTCEE----------TTSTTHHHHHH
T ss_pred CCCCeE----------CCCCCHHHHHH
Confidence 999853 45689999985
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A | Back alignment and structure |
|---|
Probab=99.84 E-value=2.8e-21 Score=215.54 Aligned_cols=201 Identities=29% Similarity=0.506 Sum_probs=145.7
Q ss_pred ccCCccchhccCCcceeeeecccccceEEEEEEcCCCCEEEEEeccccc--hhhHHHHHHHHhhCCCcccccccccccc-
Q psy11767 105 FKGSLFFEQYDMDLDKAGILGDGSYSVCRRCVEKSTGQEYAVKIISRKI--DCSEEINLLRACQGHPNICRRCVEKSTG- 181 (966)
Q Consensus 105 ~~~~~~~~~~~~df~~~~~LG~GsFGkV~La~~k~tg~~yAiKvl~K~~--~~~~E~~il~~~~~~pfi~~~~~~~~~~- 181 (966)
+++++|++.|++++. .+.||+|+||+|++|+++.+|+.||||++++.. ...+|..+|+++..||+|++.+-.+...
T Consensus 1 m~~~~f~~~y~~~~~-~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~e~~~l~~l~~h~niv~~~~~~~~~~ 79 (325)
T 3kn6_A 1 MKDSPFYQHYDLDLK-DKPLGEGSFSICRKCVHKKSNQAFAVKIISKRMEANTQKEITALKLCEGHPNIVKLHEVFHDQL 79 (325)
T ss_dssp -CCCHHHHHEEECTT-SCCSEEETTEEEEEEEETTTCCEEEEEEEEGGGHHHHHHHHHHHHHTTTCTTBCCEEEEEECSS
T ss_pred CCCCcchhccccccC-CCccccCCCeEEEEEEECCCCCEEEEEEEChhhhhhHHHHHHHHHHhcCCCCeeEEEEEEEcCC
Confidence 578999999988775 789999999999999999999999999999763 4678999999998899998722111111
Q ss_pred -----------------------------hhHHHHHHHh----------hcccchhhhHhhhccC---CceEEecCccc-
Q psy11767 182 -----------------------------QEYAVKIISR----------KIDCSEEINLLRACQG---HPNIVNLHCVF- 218 (966)
Q Consensus 182 -----------------------------~~~~~~~v~~----------~~~~~~e~nil~~~~g---h~~iv~l~~~~- 218 (966)
..+..+++.+ ..|++++ |||.+.+| .++|+||+.+.
T Consensus 80 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~-NIll~~~~~~~~~kl~Dfg~a~~ 158 (325)
T 3kn6_A 80 HTFLVMELLNGGELFERIKKKKHFSETEASYIMRKLVSAVSHMHDVGVVHRDLKPE-NLLFTDENDNLEIKIIDFGFARL 158 (325)
T ss_dssp EEEEEECCCCSCBHHHHHHHCSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGG-GEEEEC----CEEEECCCTTCEE
T ss_pred EEEEEEEccCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCHH-HEEEecCCCcccEEEecccccee
Confidence 1111122211 1244444 99987665 78999998763
Q ss_pred ------------------cccccccccCCCcceeeechhhHHHHHHHhhCCCCCCCCc-------HHHHHHHHHhCCCCC
Q psy11767 219 ------------------QDEVIDWDDFSRGIECVFFSSSLIIFFIILSFTLSFIHDY-------YHIQYRRILKTEPPI 273 (966)
Q Consensus 219 ------------------~~e~i~~~~y~~~~d~~~~~~~~il~~~m~~g~~pf~~~~-------~~~~~~~I~~~~~~~ 273 (966)
.+|++....|+...| .|+.|+++|+|++|.+||...+ ...++++|..+.+.+
T Consensus 159 ~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~D---iwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~i~~~~~~~ 235 (325)
T 3kn6_A 159 KPPDNQPLKTPCFTLHYAAPELLNQNGYDESCD---LWSLGVILYTMLSGQVPFQSHDRSLTCTSAVEIMKKIKKGDFSF 235 (325)
T ss_dssp CCC----------------------CCCCHHHH---HHHHHHHHHHHHHSSCTTC-------CCCHHHHHHHHTTTCCCC
T ss_pred cCCCCCcccccCCCcCccCHHHhcCCCCCCccc---hHHHHHHHHHHHhCCCCCCCCccccccccHHHHHHHHHcCCCCC
Confidence 134555555554444 4467788888999999997643 356789999999888
Q ss_pred CC----CCCHHHHHHHHhhcccCCCcccCCCCCCHHHHhcCCceee
Q psy11767 274 PE----DLSPDVADFISRLLVKDPRRRLGGGELDAEELKRHPFFNV 315 (966)
Q Consensus 274 P~----~~s~~a~dli~~LL~kdp~~RLG~~~~g~~~Ik~HpfF~~ 315 (966)
+. .+++++++||+++|+.||.+|+. +.+|..||||++
T Consensus 236 ~~~~~~~~s~~~~~li~~~L~~dP~~Rpt-----~~ell~h~w~~~ 276 (325)
T 3kn6_A 236 EGEAWKNVSQEAKDLIQGLLTVDPNKRLK-----MSGLRYNEWLQD 276 (325)
T ss_dssp CSHHHHTSCHHHHHHHHHHHCCCTTTCCC-----TTTSTTCGGGCT
T ss_pred CcccccCCCHHHHHHHHHHCCCChhHCCC-----HHHHhcChhhcc
Confidence 74 68999999999999999999985 689999999974
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=99.83 E-value=1.2e-20 Score=220.35 Aligned_cols=206 Identities=20% Similarity=0.232 Sum_probs=134.2
Q ss_pred CcceeeeecccccceEEEEEEcCCCCEEEEEecccc-------chhhHHHHHHHHhhCCCccccccccc-----------
Q psy11767 117 DLDKAGILGDGSYSVCRRCVEKSTGQEYAVKIISRK-------IDCSEEINLLRACQGHPNICRRCVEK----------- 178 (966)
Q Consensus 117 df~~~~~LG~GsFGkV~La~~k~tg~~yAiKvl~K~-------~~~~~E~~il~~~~~~pfi~~~~~~~----------- 178 (966)
+|+++++||+|+||+|++|+++.+|+.||||++.+. ....+|..+|+++ +||+|++.+-.+
T Consensus 54 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~~~~~ 132 (458)
T 3rp9_A 54 RYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRVFEDLIDCKRILREIAILNRL-NHDHVVKVLDIVIPKDVEKFDEL 132 (458)
T ss_dssp TEEECCC-------CEEEEEECC--CEEEEEEECSTTSSHHHHHHHHHHHHHHHHC-CCTTBCCEEEECCCSCTTTCCCE
T ss_pred CeEEeeEeeecCCeEEEEEEECCCCcEEEEEEechhhcCHHHHHHHHHHHHHHHhC-CCCCCCceEEEEecCCcccCceE
Confidence 679999999999999999999999999999999763 2356899999998 699998733211
Q ss_pred -----------------------ccchhHHHHHHHh----------hcccchhhhHhhhccCCceEEecCcccc------
Q psy11767 179 -----------------------STGQEYAVKIISR----------KIDCSEEINLLRACQGHPNIVNLHCVFQ------ 219 (966)
Q Consensus 179 -----------------------~~~~~~~~~~v~~----------~~~~~~e~nil~~~~gh~~iv~l~~~~~------ 219 (966)
...+.++.+++.+ ..|++++ |||++.+|+++|+||+.+..
T Consensus 133 ~lv~e~~~~~L~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~iiHrDlKp~-NILl~~~~~~kl~DFGla~~~~~~~~ 211 (458)
T 3rp9_A 133 YVVLEIADSDFKKLFRTPVYLTELHIKTLLYNLLVGVKYVHSAGILHRDLKPA-NCLVNQDCSVKVCDFGLARTVDYPEN 211 (458)
T ss_dssp EEEECCCSEEHHHHHHSSCCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGG-GEEECTTCCEEECCCTTCBCTTSCTT
T ss_pred EEEEeccccchhhhcccCCCCCHHHHHHHHHHHHHHHHHHHhCCcCCCCCChh-hEEECCCCCEeecccccchhccCccc
Confidence 0011222233222 1255555 99999999999999987631
Q ss_pred ----------------------------------------cccc-ccccCCCcceeeechhhHHHHHHHhh---------
Q psy11767 220 ----------------------------------------DEVI-DWDDFSRGIECVFFSSSLIIFFIILS--------- 249 (966)
Q Consensus 220 ----------------------------------------~e~i-~~~~y~~~~d~~~~~~~~il~~~m~~--------- 249 (966)
+|++ ....|+...| +|+.|+++|||++
T Consensus 212 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~D---iwSlG~il~elltg~~~~~~~~ 288 (458)
T 3rp9_A 212 GNSQLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAID---VWSIGCIFAELLNMIKENVAYH 288 (458)
T ss_dssp CCCCCC---------------------------CCCTTCCHHHHTTCCCCCTHHH---HHHHHHHHHHHHTTSTTTCSSG
T ss_pred cccccccCccccccccccccccccccccccCCcccccccChHHhhCCCCCCcHhH---HHHHHHHHHHHHHhcccccccc
Confidence 3433 3345665555 4566777778876
Q ss_pred --CCCCCCCCcH--------------------HHHHHHHHh--CCC-----------------------------CCCCC
Q psy11767 250 --FTLSFIHDYY--------------------HIQYRRILK--TEP-----------------------------PIPED 276 (966)
Q Consensus 250 --g~~pf~~~~~--------------------~~~~~~I~~--~~~-----------------------------~~P~~ 276 (966)
|.|+|...+. ......|++ +.+ ...+.
T Consensus 289 ~~~~p~f~g~~~~~~~~~~~~~~~~~~~~~~~~~~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 368 (458)
T 3rp9_A 289 ADRGPLFPGSSCFPLSPDQKAGNDFKFHTRGNRDQLNVIFNILGTPSEEDIEALEKEDAKRYIRIFPKREGTDLAERFPA 368 (458)
T ss_dssp GGCCCSCC--------------------CHHHHHHHHHHHHHHCCCCHHHHHTSSCHHHHHHHTTSCCCCCCCGGGGSTT
T ss_pred ccccccCCCCccccccccccccccccccccCCHHHHHHHHHHcCCCCHHHHhhcCCHHHHHHHHhcCCCCCCCHHHHCCC
Confidence 6777755331 122222221 111 01235
Q ss_pred CCHHHHHHHHhhcccCCCcccCCCCCCHHHHhcCCceeeeCccccccCCCCCCCCc
Q psy11767 277 LSPDVADFISRLLVKDPRRRLGGGELDAEELKRHPFFNVIDWDDLATKRIPAPFVP 332 (966)
Q Consensus 277 ~s~~a~dli~~LL~kdp~~RLG~~~~g~~~Ik~HpfF~~idW~~l~~k~~~pP~~P 332 (966)
++++++|||++||+.||.+|++ ++|+.+||||++++|..++.....++..|
T Consensus 369 ~s~~~~dLl~~mL~~dP~~R~t-----~~e~L~Hp~f~~~~~~~~e~~~~~~~~~~ 419 (458)
T 3rp9_A 369 SSADAIHLLKRMLVFNPNKRIT-----INECLAHPFFKEVRIAEVETNATEKVRLP 419 (458)
T ss_dssp SCHHHHHHHHHHSCSSTTTSCC-----HHHHHHSGGGTTTCCGGGCCCCSSCCCCS
T ss_pred CCHHHHHHHHHHhccCccccCC-----HHHHhcCHhhhhcCCCccCCCCCCCCCCC
Confidence 6999999999999999999984 89999999999999999877665555544
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* | Back alignment and structure |
|---|
Probab=99.83 E-value=2.9e-20 Score=207.14 Aligned_cols=207 Identities=25% Similarity=0.384 Sum_probs=149.8
Q ss_pred Cccee-eeecccccceEEEEEEcCCCCEEEEEeccccc-------hhhHHHHHHHHhhCCCccccccccccc--------
Q psy11767 117 DLDKA-GILGDGSYSVCRRCVEKSTGQEYAVKIISRKI-------DCSEEINLLRACQGHPNICRRCVEKST-------- 180 (966)
Q Consensus 117 df~~~-~~LG~GsFGkV~La~~k~tg~~yAiKvl~K~~-------~~~~E~~il~~~~~~pfi~~~~~~~~~-------- 180 (966)
.|.+. +.||+|+||+|++|+++.+|+.||||++++.. ...+|..+|+++..||+|+.....+..
T Consensus 29 ~y~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~iv~~~~~~~~~~~~~lv~ 108 (327)
T 3lm5_A 29 FYILTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRVINLHEVYENTSEIILIL 108 (327)
T ss_dssp HEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESEETTEECHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEE
T ss_pred EEeeccceeCCCCCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHhccCCCCEEEEEEEEEeCCeEEEEE
Confidence 45666 89999999999999999999999999998742 457899999999999999762111110
Q ss_pred ------------------------chhHHHHHHHh----------hcccchhhhHhhhc---cCCceEEecCcccc----
Q psy11767 181 ------------------------GQEYAVKIISR----------KIDCSEEINLLRAC---QGHPNIVNLHCVFQ---- 219 (966)
Q Consensus 181 ------------------------~~~~~~~~v~~----------~~~~~~e~nil~~~---~gh~~iv~l~~~~~---- 219 (966)
...++.+++.+ ..|++++ |||.+. .|.++|+||+.+..
T Consensus 109 e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~ql~~~L~~LH~~givH~Dikp~-NIl~~~~~~~~~~kL~Dfg~a~~~~~~ 187 (327)
T 3lm5_A 109 EYAAGGEIFSLCLPELAEMVSENDVIRLIKQILEGVYYLHQNNIVHLDLKPQ-NILLSSIYPLGDIKIVDFGMSRKIGHA 187 (327)
T ss_dssp ECCTTEEGGGGGSSCC-CCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGG-GEEESCBTTBCCEEECCGGGCEEC---
T ss_pred EecCCCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeecCcCChH-HEEEecCCCCCcEEEeeCccccccCCc
Confidence 01111222221 1144444 999877 78999999986632
Q ss_pred --------------ccccccccCCCcceeeechhhHHHHHHHhhCCCCCCCCcHHHHHHHHHhCCCCCCC----CCCHHH
Q psy11767 220 --------------DEVIDWDDFSRGIECVFFSSSLIIFFIILSFTLSFIHDYYHIQYRRILKTEPPIPE----DLSPDV 281 (966)
Q Consensus 220 --------------~e~i~~~~y~~~~d~~~~~~~~il~~~m~~g~~pf~~~~~~~~~~~I~~~~~~~P~----~~s~~a 281 (966)
+|++....|+...| .|+.|+++|+|++|.+||...+....+..|......+|. .+++++
T Consensus 188 ~~~~~~~gt~~y~aPE~~~~~~~~~~~D---iwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 264 (327)
T 3lm5_A 188 CELREIMGTPEYLAPEILNYDPITTATD---MWNIGIIAYMLLTHTSPFVGEDNQETYLNISQVNVDYSEETFSSVSQLA 264 (327)
T ss_dssp ------CCCGGGCCHHHHTTCCCCTHHH---HHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCTTTTTTSCHHH
T ss_pred cccccccCCcCccCCeeecCCCCCchhh---HHHHHHHHHHHHhCCCCCCCCCchHHHHHHHhcccccCchhhcccCHHH
Confidence 34555555555444 456778889999999999999988889999887776654 589999
Q ss_pred HHHHHhhcccCCCcccCCCCCCHHHHhcCCceeeeCccccccCCCCCCCCc
Q psy11767 282 ADFISRLLVKDPRRRLGGGELDAEELKRHPFFNVIDWDDLATKRIPAPFVP 332 (966)
Q Consensus 282 ~dli~~LL~kdp~~RLG~~~~g~~~Ik~HpfF~~idW~~l~~k~~~pP~~P 332 (966)
++||+++|+.||.+|.. +++|.+||||+.++|+.+......++..+
T Consensus 265 ~~li~~~L~~dP~~Rpt-----~~~ll~h~~~~~~~~~~~~~~~~~~~~~~ 310 (327)
T 3lm5_A 265 TDFIQSLLVKNPEKRPT-----AEICLSHSWLQQWDFENLFHPEETSSSSQ 310 (327)
T ss_dssp HHHHHHHSCSSGGGSCC-----HHHHTTCGGGCCCCTTCC-----------
T ss_pred HHHHHHHcCCChhhCcC-----HHHHhCCHhhcccccccccCccCCCCcCc
Confidence 99999999999999984 89999999999999999876655554433
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* | Back alignment and structure |
|---|
Probab=99.82 E-value=2.1e-20 Score=219.03 Aligned_cols=189 Identities=19% Similarity=0.312 Sum_probs=141.1
Q ss_pred CcceeeeecccccceEEEEEEcCCCCEEEEEecccc-------chhhHHHHHHHHhhCCCcccccccccccc--------
Q psy11767 117 DLDKAGILGDGSYSVCRRCVEKSTGQEYAVKIISRK-------IDCSEEINLLRACQGHPNICRRCVEKSTG-------- 181 (966)
Q Consensus 117 df~~~~~LG~GsFGkV~La~~k~tg~~yAiKvl~K~-------~~~~~E~~il~~~~~~pfi~~~~~~~~~~-------- 181 (966)
+|++++.||+|+||+|++|+++.||+.||||++++. ....+|..+|+.+ +||+|++..-.+...
T Consensus 63 ~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l-~hpnIv~l~~~~~~~~~~~~~~~ 141 (464)
T 3ttj_A 63 RYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCV-NHKNIISLLNVFTPQKTLEEFQD 141 (464)
T ss_dssp TEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEESGGGSHHHHHHHHHHHHHHHHC-CCTTBCCCSEEECSCCSTTTCCE
T ss_pred CeEEEEEeecCCCeEEEEEEECCCCCEEEEEEECccccChHHHHHHHHHHHHHHhC-CCCCCCcEEEEEccCCccccCCe
Confidence 679999999999999999999999999999999864 2356789999888 699998733222110
Q ss_pred -------------------------hhHHHHHHHh----------hcccchhhhHhhhccCCceEEecCccc--------
Q psy11767 182 -------------------------QEYAVKIISR----------KIDCSEEINLLRACQGHPNIVNLHCVF-------- 218 (966)
Q Consensus 182 -------------------------~~~~~~~v~~----------~~~~~~e~nil~~~~gh~~iv~l~~~~-------- 218 (966)
..++.+++.+ ..|++++ |||++.+|+++|+||+.+.
T Consensus 142 ~~lv~E~~~~~l~~~~~~~l~~~~~~~~~~qil~aL~~lH~~~iiHrDlkp~-NIll~~~~~~kl~DFG~a~~~~~~~~~ 220 (464)
T 3ttj_A 142 VYLVMELMDANLCQVIQMELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPS-NIVVKSDCTLKILDFGLARTAGTSFMM 220 (464)
T ss_dssp EEEEEECCSEEHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGG-GEEECTTSCEEECCCCCC-----CCCC
T ss_pred EEEEEeCCCCCHHHHHhhcCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChH-hEEEeCCCCEEEEEEEeeeecCCCccc
Confidence 1112222222 1255555 9999999999999998653
Q ss_pred ----------cccccccccCCCcceeeechhhHHHHHHHhhCCCCCCCCcHHHHHHHHHhC-------------------
Q psy11767 219 ----------QDEVIDWDDFSRGIECVFFSSSLIIFFIILSFTLSFIHDYYHIQYRRILKT------------------- 269 (966)
Q Consensus 219 ----------~~e~i~~~~y~~~~d~~~~~~~~il~~~m~~g~~pf~~~~~~~~~~~I~~~------------------- 269 (966)
.+|++....|+...| +|+.|+++|+|++|.+||...+...++.+|+..
T Consensus 221 ~~~~gt~~y~aPE~~~~~~~~~~~D---iwSlG~il~ell~g~~pF~g~~~~~~~~~i~~~lg~p~~~~~~~~~~~~~~~ 297 (464)
T 3ttj_A 221 TPYVVTRYYRAPEVILGMGYKENVD---IWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRNY 297 (464)
T ss_dssp ----CCCTTCCHHHHTTCCCCTTHH---HHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCSCCHHHHTTSCHHHHHH
T ss_pred CCCcccccccCHHHHcCCCCCHHHH---HHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHcchhhhhH
Confidence 245666667776666 457778889999999999998888777777641
Q ss_pred ---CCCC---------CCCC-----------CHHHHHHHHhhcccCCCcccCCCCCCHHHHhcCCceee
Q psy11767 270 ---EPPI---------PEDL-----------SPDVADFISRLLVKDPRRRLGGGELDAEELKRHPFFNV 315 (966)
Q Consensus 270 ---~~~~---------P~~~-----------s~~a~dli~~LL~kdp~~RLG~~~~g~~~Ik~HpfF~~ 315 (966)
.+.+ |..+ +++++|||+++|+.||.+|+. ++|+.+||||+.
T Consensus 298 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~t-----a~e~L~Hp~~~~ 361 (464)
T 3ttj_A 298 VENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRIS-----VDDALQHPYINV 361 (464)
T ss_dssp HTTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCC-----HHHHHTSTTTGG
T ss_pred hhcccccCCCChHHhCcccccccccccccccCHHHHHHHHHHcCCChhhCCC-----HHHHhcChhhhh
Confidence 1111 1111 678999999999999999984 899999999983
|
| >4asz_A BDNF/NT-3 growth factors receptor; transferase, TRKA, TRKB; 1.70A {Homo sapiens} PDB: 4at3_A* 4at4_A* 4at5_A* 3v5q_A* | Back alignment and structure |
|---|
Probab=99.81 E-value=2.1e-20 Score=206.52 Aligned_cols=187 Identities=16% Similarity=0.123 Sum_probs=138.3
Q ss_pred CcceeeeecccccceEEEEEEc-----CCCCEEEEEeccccc-----hhhHHHHHHHHhhCCCccccccccccc------
Q psy11767 117 DLDKAGILGDGSYSVCRRCVEK-----STGQEYAVKIISRKI-----DCSEEINLLRACQGHPNICRRCVEKST------ 180 (966)
Q Consensus 117 df~~~~~LG~GsFGkV~La~~k-----~tg~~yAiKvl~K~~-----~~~~E~~il~~~~~~pfi~~~~~~~~~------ 180 (966)
||.+.+.||+|+||+||+|+++ .+|+.||||+|++.. ...+|.++|+++ +||+||+.+-....
T Consensus 14 ~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~il~~l-~HpnIV~l~g~~~~~~~~~l 92 (299)
T 4asz_A 14 NIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNL-QHEHIVKFYGVCVEGDPLIM 92 (299)
T ss_dssp GEEEEEEEEC--CCCEEEEEECSCC----CEEEEEEEECSCCHHHHHHHHHHHHHHTTC-CCTTBCCEEEEECSSSSEEE
T ss_pred HeEEeeEEeeCCCcEEEEEEECCcccCCCCEEEEEEEeCCCChHHHHHHHHHHHHHHhC-CCCCCccEEEEEeeCCEEEE
Confidence 7899999999999999999975 468899999998642 357899999998 69999872111111
Q ss_pred -------------------------------------chhHHHHHHHh----------hcccchhhhHhhhccCCceEEe
Q psy11767 181 -------------------------------------GQEYAVKIISR----------KIDCSEEINLLRACQGHPNIVN 213 (966)
Q Consensus 181 -------------------------------------~~~~~~~~v~~----------~~~~~~e~nil~~~~gh~~iv~ 213 (966)
...++.++..+ ..|++++ |||++.+++++|.|
T Consensus 93 V~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHRDlKp~-NILl~~~~~~Ki~D 171 (299)
T 4asz_A 93 VFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQIAAGMVYLASQHFVHRDLATR-NCLVGENLLVKIGD 171 (299)
T ss_dssp EEECCTTCBHHHHHHHTSHHHHHC----CCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGG-GEEECGGGCEEECC
T ss_pred EEEcCCCCcHHHHHHhcCcccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCccCHh-hEEECCCCcEEECC
Confidence 11122222221 1255555 99999999999999
Q ss_pred cCccc---------------------cccccccccCCCcceeeechhhHHHHHHHhh-CCCCCCCCcHHHHHHHHHhCC-
Q psy11767 214 LHCVF---------------------QDEVIDWDDFSRGIECVFFSSSLIIFFIILS-FTLSFIHDYYHIQYRRILKTE- 270 (966)
Q Consensus 214 l~~~~---------------------~~e~i~~~~y~~~~d~~~~~~~~il~~~m~~-g~~pf~~~~~~~~~~~I~~~~- 270 (966)
|+.+. .+|++....|+...| .|+.||++|||++ |.+||...+...+++.|..+.
T Consensus 172 FGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~k~D---VwS~Gvvl~Ellt~G~~Pf~~~~~~~~~~~i~~~~~ 248 (299)
T 4asz_A 172 FGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESD---VWSLGVVLWEIFTYGKQPWYQLSNNEVIECITQGRV 248 (299)
T ss_dssp CSCHHHHTGGGCEEETTTEEECGGGCCHHHHHHCCCCHHHH---HHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHHHTCC
T ss_pred cccceecCCCCceeecCceecChhhcCHHHHcCCCCCchhh---HHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcCCC
Confidence 99762 235565566765555 3466677788876 899999988889999999875
Q ss_pred CCCCCCCCHHHHHHHHhhcccCCCcccCCCCCCHHHHhcCCceee
Q psy11767 271 PPIPEDLSPDVADFISRLLVKDPRRRLGGGELDAEELKRHPFFNV 315 (966)
Q Consensus 271 ~~~P~~~s~~a~dli~~LL~kdp~~RLG~~~~g~~~Ik~HpfF~~ 315 (966)
+.+|..+++++.+||.++|++||.+|. .+.+| |+|++.
T Consensus 249 ~~~p~~~~~~~~~li~~cl~~dP~~RP-----s~~~i--~~~L~~ 286 (299)
T 4asz_A 249 LQRPRTCPQEVYELMLGCWQREPHMRK-----NIKGI--HTLLQN 286 (299)
T ss_dssp CCCCTTCCHHHHHHHHHHTCSSGGGSC-----CHHHH--HHHHHH
T ss_pred CCCCccchHHHHHHHHHHcCCChhHCc-----CHHHH--HHHHHH
Confidence 678999999999999999999999997 37888 566654
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=99.81 E-value=4.8e-20 Score=216.53 Aligned_cols=190 Identities=26% Similarity=0.348 Sum_probs=145.9
Q ss_pred CcceeeeecccccceEEEEEEcCCCCEEEEEeccccc--------hhhHHHHHHHHhhCCCccccccccccc--------
Q psy11767 117 DLDKAGILGDGSYSVCRRCVEKSTGQEYAVKIISRKI--------DCSEEINLLRACQGHPNICRRCVEKST-------- 180 (966)
Q Consensus 117 df~~~~~LG~GsFGkV~La~~k~tg~~yAiKvl~K~~--------~~~~E~~il~~~~~~pfi~~~~~~~~~-------- 180 (966)
+|.++++||+|+||+|++|+++.||+.||||++++.. ...+|..+|+++ +||+|++.+-...+
T Consensus 17 ~Y~l~~~LG~G~fg~V~~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l-~HpnIv~l~~~~~~~~~~~lv~ 95 (476)
T 2y94_A 17 HYILGDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLF-RHPHIIKLYQVISTPSDIFMVM 95 (476)
T ss_dssp TEEEEEEEECCSSSCEEEEEETTTCCEEEEEEEEHHHHHHTTTHHHHHHHHHHHTTC-CCTTBCCEEEEEECSSEEEEEE
T ss_pred CEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhC-CCCCCCcEEEEEEECCEEEEEE
Confidence 6799999999999999999999999999999998642 356799999887 59999872211111
Q ss_pred ----------------------chhHHHHHHHh----------hcccchhhhHhhhccCCceEEecCcccc---------
Q psy11767 181 ----------------------GQEYAVKIISR----------KIDCSEEINLLRACQGHPNIVNLHCVFQ--------- 219 (966)
Q Consensus 181 ----------------------~~~~~~~~v~~----------~~~~~~e~nil~~~~gh~~iv~l~~~~~--------- 219 (966)
...++.+++.+ ..|++++ |||.+.+|+++|+||+.+..
T Consensus 96 E~~~gg~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDLkp~-NIll~~~~~vkL~DFG~a~~~~~~~~~~~ 174 (476)
T 2y94_A 96 EYVSGGELFDYICKNGRLDEKESRRLFQQILSGVDYCHRHMVVHRDLKPE-NVLLDAHMNAKIADFGLSNMMSDGEFLRT 174 (476)
T ss_dssp ECCSSEEHHHHTTSSSSCCHHHHHHHHHHHHHHHHHHHTTTEECSCCSGG-GEEECTTCCEEECCCSSCEECCTTCCBCC
T ss_pred eCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCCcccccHH-HEEEecCCCeEEEeccchhhccccccccc
Confidence 11122222222 1244555 99999999999999987632
Q ss_pred ---------ccccccccCCCcceeeechhhHHHHHHHhhCCCCCCCCcHHHHHHHHHhCCCCCCCCCCHHHHHHHHhhcc
Q psy11767 220 ---------DEVIDWDDFSRGIECVFFSSSLIIFFIILSFTLSFIHDYYHIQYRRILKTEPPIPEDLSPDVADFISRLLV 290 (966)
Q Consensus 220 ---------~e~i~~~~y~~~~d~~~~~~~~il~~~m~~g~~pf~~~~~~~~~~~I~~~~~~~P~~~s~~a~dli~~LL~ 290 (966)
+|++....|. +...| .|+.|+++|+|++|.+||...+...++++|..+.+.+|..+++++++||+++|+
T Consensus 175 ~~gt~~y~aPE~~~~~~~~-~~~~D-iwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~Li~~~L~ 252 (476)
T 2y94_A 175 SCGSPNYAAPEVISGRLYA-GPEVD-IWSSGVILYALLCGTLPFDDDHVPTLFKKICDGIFYTPQYLNPSVISLLKHMLQ 252 (476)
T ss_dssp CCSCSTTCCHHHHTTCCBC-SHHHH-HHHHHHHHHHHHHSSCSSCCSSSHHHHHHHHTTCCCCCTTCCHHHHHHHHHHTC
T ss_pred cCCCcCeEChhhccCCCCC-CCcce-ehhhHHHHHHHhhCCCCCCCCCHHHHHHHHhcCCcCCCccCCHHHHHHHHHHcC
Confidence 2333333331 22233 446678888999999999999888999999999999999999999999999999
Q ss_pred cCCCcccCCCCCCHHHHhcCCceee
Q psy11767 291 KDPRRRLGGGELDAEELKRHPFFNV 315 (966)
Q Consensus 291 kdp~~RLG~~~~g~~~Ik~HpfF~~ 315 (966)
.||.+|. .+++|.+||||+.
T Consensus 253 ~dP~~Rp-----t~~eil~hp~~~~ 272 (476)
T 2y94_A 253 VDPMKRA-----TIKDIREHEWFKQ 272 (476)
T ss_dssp SSTTTSC-----CHHHHHTCHHHHT
T ss_pred CCchhCc-----CHHHHHhCHHhhh
Confidence 9999998 4899999999973
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} | Back alignment and structure |
|---|
Probab=99.81 E-value=1e-20 Score=212.44 Aligned_cols=189 Identities=26% Similarity=0.408 Sum_probs=144.6
Q ss_pred CcceeeeecccccceEEEEEEcCCCCEEEEEeccccc--------hhhHHHHHHHHhhCCCcccccccccccc-------
Q psy11767 117 DLDKAGILGDGSYSVCRRCVEKSTGQEYAVKIISRKI--------DCSEEINLLRACQGHPNICRRCVEKSTG------- 181 (966)
Q Consensus 117 df~~~~~LG~GsFGkV~La~~k~tg~~yAiKvl~K~~--------~~~~E~~il~~~~~~pfi~~~~~~~~~~------- 181 (966)
+|.+.++||+|+||+|++|+++.||+.||||++++.. ...+|..+|+.+ +||+|++.+....+.
T Consensus 10 ~Y~i~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l-~hpnIv~l~~~~~~~~~~~lv~ 88 (336)
T 3h4j_B 10 PYIIRETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLL-RHPHIIKLYDVITTPTDIVMVI 88 (336)
T ss_dssp TEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCSHHHHHHHHHHTTC-CCTTBCCEEEEEECSSEEEEEE
T ss_pred CEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEehHHccchhHHHHHHHHHHHHHhC-CCCCCCeEEEEEEeCCEEEEEE
Confidence 6799999999999999999999999999999998642 356789999887 599998722211111
Q ss_pred ----------------------hhHHHHHHHh----------hcccchhhhHhhhccCCceEEecCccc-----------
Q psy11767 182 ----------------------QEYAVKIISR----------KIDCSEEINLLRACQGHPNIVNLHCVF----------- 218 (966)
Q Consensus 182 ----------------------~~~~~~~v~~----------~~~~~~e~nil~~~~gh~~iv~l~~~~----------- 218 (966)
..++.+++.+ ..|++++ |||.+.+|+++|+||+.+.
T Consensus 89 E~~~g~l~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~givH~Dlkp~-NIll~~~~~~kl~DFG~s~~~~~~~~~~~~ 167 (336)
T 3h4j_B 89 EYAGGELFDYIVEKKRMTEDEGRRFFQQIICAIEYCHRHKIVHRDLKPE-NLLLDDNLNVKIADFGLSNIMTDGNFLKTS 167 (336)
T ss_dssp CCCCEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHHTCCCCCCSTT-TEEECTTCCEEECCSSCTBTTTTSBTTCCC
T ss_pred ECCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCchh-hEEEcCCCCEEEEEeccceeccCCcccccc
Confidence 1111222222 1244555 9999999999999998653
Q ss_pred -------cccccccccC-CCcceeeechhhHHHHHHHhhCCCCCCCCcHHHHHHHHHhCCCCCCCCCCHHHHHHHHhhcc
Q psy11767 219 -------QDEVIDWDDF-SRGIECVFFSSSLIIFFIILSFTLSFIHDYYHIQYRRILKTEPPIPEDLSPDVADFISRLLV 290 (966)
Q Consensus 219 -------~~e~i~~~~y-~~~~d~~~~~~~~il~~~m~~g~~pf~~~~~~~~~~~I~~~~~~~P~~~s~~a~dli~~LL~ 290 (966)
.+|++....| +...| .|+.|+++|+|++|.+||...+...++++|..+.+.+|..+|+++++||+++|+
T Consensus 168 ~gt~~y~aPE~~~~~~~~~~~~D---iwslG~il~~ll~g~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li~~~L~ 244 (336)
T 3h4j_B 168 CGSPNYAAPEVINGKLYAGPEVD---VWSCGIVLYVMLVGRLPFDDEFIPNLFKKVNSCVYVMPDFLSPGAQSLIRRMIV 244 (336)
T ss_dssp TTSTTTSCGGGSCCSGGGCHHHH---HHHHHHHHHHHHHSSCSSBCSSSTTCBCCCCSSCCCCCTTSCHHHHHHHHTTSC
T ss_pred cCCcCcCCHHHHcCCCCCCCccc---hhHHHHHHHHHHhCCCCCCCccHHHHHHHHHcCCCCCcccCCHHHHHHHHHHcC
Confidence 1344443333 22233 446778888999999999988877778888888999999999999999999999
Q ss_pred cCCCcccCCCCCCHHHHhcCCceee
Q psy11767 291 KDPRRRLGGGELDAEELKRHPFFNV 315 (966)
Q Consensus 291 kdp~~RLG~~~~g~~~Ik~HpfF~~ 315 (966)
.||.+|+. +++|.+||||+.
T Consensus 245 ~dP~~Rpt-----~~eil~hp~~~~ 264 (336)
T 3h4j_B 245 ADPMQRIT-----IQEIRRDPWFNV 264 (336)
T ss_dssp SSGGGSCC-----HHHHTTCHHHHT
T ss_pred CChhHCcC-----HHHHHhChhhcc
Confidence 99999984 899999999963
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C | Back alignment and structure |
|---|
Probab=99.81 E-value=6.4e-20 Score=210.78 Aligned_cols=190 Identities=21% Similarity=0.272 Sum_probs=144.4
Q ss_pred Cccee-eeecccccceEEEEEEcCCCCEEEEEeccccchhhHHHHHHHHhhCCCccccccccccc---------------
Q psy11767 117 DLDKA-GILGDGSYSVCRRCVEKSTGQEYAVKIISRKIDCSEEINLLRACQGHPNICRRCVEKST--------------- 180 (966)
Q Consensus 117 df~~~-~~LG~GsFGkV~La~~k~tg~~yAiKvl~K~~~~~~E~~il~~~~~~pfi~~~~~~~~~--------------- 180 (966)
||.+. ++||+|+||+|++|+++.||+.||||++++.....+|..++.+..+||+|++.+-.+..
T Consensus 62 ~y~~~~~~LG~G~~g~V~~~~~~~~~~~vAiK~~~~~~~~~~E~~~~~~~~~hp~iv~l~~~~~~~~~~~~~~~lv~E~~ 141 (400)
T 1nxk_A 62 DYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDCPKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECL 141 (400)
T ss_dssp TEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECSHHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEEEEEECC
T ss_pred cceeccceeeeccCeEEEEEEECCCCCEEEEEEeCcchhHHHHHHHHHHhcCCCCcceEeEEEeecccCCcEEEEEEEeC
Confidence 66776 79999999999999999999999999999877778899999888899999862211110
Q ss_pred ---------------------chhHHHHHHHh----------hcccchhhhHhhhc---cCCceEEecCccc--------
Q psy11767 181 ---------------------GQEYAVKIISR----------KIDCSEEINLLRAC---QGHPNIVNLHCVF-------- 218 (966)
Q Consensus 181 ---------------------~~~~~~~~v~~----------~~~~~~e~nil~~~---~gh~~iv~l~~~~-------- 218 (966)
...++.+++.+ ..|++++ |||++. +|+++|+||+.+.
T Consensus 142 ~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~-Nill~~~~~~~~~kl~DFG~a~~~~~~~~~ 220 (400)
T 1nxk_A 142 DGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPE-NLLYTSKRPNAILKLTDFGFAKETTSHNSL 220 (400)
T ss_dssp CSEEHHHHHHCC---CCBHHHHHHHHHHHHHHHHHHHHTTEECCCCCGG-GEEESSSSTTCCEEECCCTTCEECC-----
T ss_pred CCCcHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCcCcc-eEEEecCCCCccEEEEecccccccCCCCcc
Confidence 01111122211 1244555 999987 6899999998653
Q ss_pred ----------cccccccccCCCcceeeechhhHHHHHHHhhCCCCCCCCcHH----HHHHHHHhCCCCCC----CCCCHH
Q psy11767 219 ----------QDEVIDWDDFSRGIECVFFSSSLIIFFIILSFTLSFIHDYYH----IQYRRILKTEPPIP----EDLSPD 280 (966)
Q Consensus 219 ----------~~e~i~~~~y~~~~d~~~~~~~~il~~~m~~g~~pf~~~~~~----~~~~~I~~~~~~~P----~~~s~~ 280 (966)
.+|++....|+...| +|+.|+++|+|++|.+||...+.. .+.++|..+.+.+| ..++++
T Consensus 221 ~~~~gt~~y~aPE~~~~~~~~~~~D---iwslG~il~ell~g~~pf~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~ 297 (400)
T 1nxk_A 221 TTPCYTPYYVAPEVLGPEKYDKSCD---MWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWSEVSEE 297 (400)
T ss_dssp ------CTTCCGGGSCCCCSSSHHH---HHHHHHHHHHHHHSSCSCCCCTTCSSCCSHHHHHHHTCCCCCTTTTTTSCHH
T ss_pred ccCCCCCCccCHhhcCCCCCCCccc---HHHHHHHHHHHHhCCCCCCCCccccccHHHHHHHHcCcccCCCcccccCCHH
Confidence 245666666766555 456778888999999999865432 25788888888887 468999
Q ss_pred HHHHHHhhcccCCCcccCCCCCCHHHHhcCCceee
Q psy11767 281 VADFISRLLVKDPRRRLGGGELDAEELKRHPFFNV 315 (966)
Q Consensus 281 a~dli~~LL~kdp~~RLG~~~~g~~~Ik~HpfF~~ 315 (966)
+++||+++|++||.+|++ +++|.+||||..
T Consensus 298 ~~~li~~~L~~dP~~Rpt-----~~eil~hp~~~~ 327 (400)
T 1nxk_A 298 VKMLIRNLLKTEPTQRMT-----ITEFMNHPWIMQ 327 (400)
T ss_dssp HHHHHHTTSCSSGGGSCC-----HHHHHHSHHHHT
T ss_pred HHHHHHHHCCCChhHCcC-----HHHHhcCccccC
Confidence 999999999999999984 899999999963
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* | Back alignment and structure |
|---|
Probab=99.80 E-value=5e-20 Score=210.12 Aligned_cols=195 Identities=17% Similarity=0.211 Sum_probs=135.2
Q ss_pred Ccceeeeeccc--ccceEEEEEEcCCCCEEEEEeccccc-------hhhHHHHHHHHhhCCCcccccccccccc------
Q psy11767 117 DLDKAGILGDG--SYSVCRRCVEKSTGQEYAVKIISRKI-------DCSEEINLLRACQGHPNICRRCVEKSTG------ 181 (966)
Q Consensus 117 df~~~~~LG~G--sFGkV~La~~k~tg~~yAiKvl~K~~-------~~~~E~~il~~~~~~pfi~~~~~~~~~~------ 181 (966)
+|+++++||+| +||+|++|+++.+|+.||||++++.. ...+|..+|+++ +||+|++..-.+...
T Consensus 26 ~y~~~~~lG~G~~~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~lv 104 (389)
T 3gni_B 26 CYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLF-NHPNIVPYRATFIADNELWVV 104 (389)
T ss_dssp GEEEEEEEEEETTTTEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHC-CCTTBCCEEEEEEETTEEEEE
T ss_pred cEEEEecccCCcCCceEEEEEEEcCCCCEEEEEEecccccChHHHHHHHHHHHHHHhC-CCCCCCcEeEEEEECCEEEEE
Confidence 67999999999 99999999999999999999998652 346699999988 599998722111110
Q ss_pred --------------------------hhHHHHHHHh----------hcccchhhhHhhhccCCceEEecCccc-------
Q psy11767 182 --------------------------QEYAVKIISR----------KIDCSEEINLLRACQGHPNIVNLHCVF------- 218 (966)
Q Consensus 182 --------------------------~~~~~~~v~~----------~~~~~~e~nil~~~~gh~~iv~l~~~~------- 218 (966)
..++.+++.+ ..|++++ |||.+.+|+++|.||+.+.
T Consensus 105 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~-NIll~~~~~~kl~dfg~~~~~~~~~~ 183 (389)
T 3gni_B 105 TSFMAYGSAKDLICTHFMDGMNELAIAYILQGVLKALDYIHHMGYVHRSVKAS-HILISVDGKVYLSGLRSNLSMISHGQ 183 (389)
T ss_dssp EECCTTCBHHHHHHHTCTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGG-GEEECTTCCEEECCGGGCEECEETTE
T ss_pred EEccCCCCHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHH-HEEEcCCCCEEEcccccceeeccccc
Confidence 1111122221 1245555 9999999999999996542
Q ss_pred -------------------ccccccc--ccCCCcceeeechhhHHHHHHHhhCCCCCCCCcHHHHHHHHHhCCC------
Q psy11767 219 -------------------QDEVIDW--DDFSRGIECVFFSSSLIIFFIILSFTLSFIHDYYHIQYRRILKTEP------ 271 (966)
Q Consensus 219 -------------------~~e~i~~--~~y~~~~d~~~~~~~~il~~~m~~g~~pf~~~~~~~~~~~I~~~~~------ 271 (966)
.+|++.. ..|+...| .|+.|+++|+|++|.+||...+...++..++.+.+
T Consensus 184 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~D---iwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 260 (389)
T 3gni_B 184 RQRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSD---IYSVGITACELANGHVPFKDMPATQMLLEKLNGTVPCLLDT 260 (389)
T ss_dssp ECSCBCCCCTTCTTTGGGSCHHHHSTTSSCBCTHHH---HHHHHHHHHHHHHSSCTTTTCCSTTHHHHC-----------
T ss_pred cccccccccccccccccccCHHHHhccCCCCCcHhH---HHHHHHHHHHHHHCCCCCCCCCHHHHHHHHhcCCCCccccc
Confidence 2455544 34655555 44677888889999999987555444444443322
Q ss_pred ----------------------------------------CCCCCCCHHHHHHHHhhcccCCCcccCCCCCCHHHHhcCC
Q psy11767 272 ----------------------------------------PIPEDLSPDVADFISRLLVKDPRRRLGGGELDAEELKRHP 311 (966)
Q Consensus 272 ----------------------------------------~~P~~~s~~a~dli~~LL~kdp~~RLG~~~~g~~~Ik~Hp 311 (966)
.+|..++++++|||+++|+.||.+|+. ++++.+||
T Consensus 261 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt-----a~ell~hp 335 (389)
T 3gni_B 261 STIPAEELTMSPSRSVANSGLSDSLTTSTPRPSNGDSPSHPYHRTFSPHFHHFVEQCLQRNPDARPS-----ASTLLNHS 335 (389)
T ss_dssp ---------------------------------------------CCHHHHHHHHHHTCSCTTTSCC-----HHHHTTSG
T ss_pred cccccccccccccccccccccccccccCccccccCCCCCCccccccCHHHHHHHHHHhhcCcccCCC-----HHHHhcCH
Confidence 256779999999999999999999984 89999999
Q ss_pred ceeeeCcccc
Q psy11767 312 FFNVIDWDDL 321 (966)
Q Consensus 312 fF~~idW~~l 321 (966)
||+.+.|...
T Consensus 336 ~f~~~~~~~~ 345 (389)
T 3gni_B 336 FFKQIKRRAS 345 (389)
T ss_dssp GGGGC---CC
T ss_pred HHHHHhhcch
Confidence 9999988553
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.80 E-value=9.8e-20 Score=203.06 Aligned_cols=198 Identities=25% Similarity=0.435 Sum_probs=150.4
Q ss_pred CcceeeeecccccceEEEEEEcCCCCEEEEEeccccc-----------hhhHHHHHHHHhhCCCcccccccccccc----
Q psy11767 117 DLDKAGILGDGSYSVCRRCVEKSTGQEYAVKIISRKI-----------DCSEEINLLRACQGHPNICRRCVEKSTG---- 181 (966)
Q Consensus 117 df~~~~~LG~GsFGkV~La~~k~tg~~yAiKvl~K~~-----------~~~~E~~il~~~~~~pfi~~~~~~~~~~---- 181 (966)
+|++.+.||+|+||+|++|+++.||+.||+|++++.. ...+|..+|+++ +||+|+...-.+...
T Consensus 12 ~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~hp~iv~~~~~~~~~~~~~ 90 (326)
T 2y0a_A 12 YYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEI-QHPNVITLHEVYENKTDVI 90 (326)
T ss_dssp HEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEBCCSTTCSSSBCHHHHHHHHHHHHHC-CCTTBCCEEEEEECSSEEE
T ss_pred ceEeceEEeeCCCeEEEEEEECCCCcEEEEEEEEccccccccchhhHHHHHHHHHHHHhC-CCCCCCcEEEEEEeCCEEE
Confidence 4589999999999999999999999999999998742 256899999998 599998622111110
Q ss_pred --------------------------hhHHHHHHHh----------hcccchhhhHhhhccC----CceEEecCccc---
Q psy11767 182 --------------------------QEYAVKIISR----------KIDCSEEINLLRACQG----HPNIVNLHCVF--- 218 (966)
Q Consensus 182 --------------------------~~~~~~~v~~----------~~~~~~e~nil~~~~g----h~~iv~l~~~~--- 218 (966)
..++.+++.+ ..|++++ |||.+.+| +++|.||+.+.
T Consensus 91 lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~-NIll~~~~~~~~~~kl~Dfg~a~~~~ 169 (326)
T 2y0a_A 91 LILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLHSLQIAHFDLKPE-NIMLLDRNVPKPRIKIIDFGLAHKID 169 (326)
T ss_dssp EEEECCCSCBHHHHHTTSSCCBHHHHHHHHHHHHHHHHHHHHTTEECCCCCGG-GEEESCSSSSSCCEEECCCTTCEECC
T ss_pred EEEEcCCCCCHHHHHHhcCCcCHHHHHHHHHHHHHHHHHHHHCCeEcCCCCHH-HEEEecCCCCCCCEEEEECCCCeECC
Confidence 1111122211 1244444 99998777 78999998652
Q ss_pred ---------------cccccccccCCCcceeeechhhHHHHHHHhhCCCCCCCCcHHHHHHHHHhCCCCCC----CCCCH
Q psy11767 219 ---------------QDEVIDWDDFSRGIECVFFSSSLIIFFIILSFTLSFIHDYYHIQYRRILKTEPPIP----EDLSP 279 (966)
Q Consensus 219 ---------------~~e~i~~~~y~~~~d~~~~~~~~il~~~m~~g~~pf~~~~~~~~~~~I~~~~~~~P----~~~s~ 279 (966)
.+|++....|+...| .|+.|+++|+|++|.+||...+...++..|....+.+| ..+++
T Consensus 170 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~D---iwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 246 (326)
T 2y0a_A 170 FGNEFKNIFGTPEFVAPEIVNYEPLGLEAD---MWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDEYFSNTSA 246 (326)
T ss_dssp TTSCCCCCCSCTTTCCHHHHTTCCCCTHHH---HHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHHTCCCCCHHHHTTSCH
T ss_pred CCCccccccCCcCcCCceeecCCCCCcHHH---HHHHHHHHHHHHHCcCCCCCCCHHHHHHHHHhcCCCcCccccccCCH
Confidence 134555555655554 44667888899999999999998888999998888776 57899
Q ss_pred HHHHHHHhhcccCCCcccCCCCCCHHHHhcCCceeeeCccccccC
Q psy11767 280 DVADFISRLLVKDPRRRLGGGELDAEELKRHPFFNVIDWDDLATK 324 (966)
Q Consensus 280 ~a~dli~~LL~kdp~~RLG~~~~g~~~Ik~HpfF~~idW~~l~~k 324 (966)
++++||+++|++||.+|.. +++|..||||+..+|.....+
T Consensus 247 ~~~~li~~~L~~dP~~Rpt-----~~e~l~hp~~~~~~~~~~~~~ 286 (326)
T 2y0a_A 247 LAKDFIRRLLVKDPKKRMT-----IQDSLQHPWIKPKDTQQALSR 286 (326)
T ss_dssp HHHHHHHHHSCSSGGGSCC-----HHHHHHSTTTSCCSHHHHHHH
T ss_pred HHHHHHHHHccCChhhCCC-----HHHHhcCCCccCCcchhhhhh
Confidence 9999999999999999984 899999999999998765443
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A | Back alignment and structure |
|---|
Probab=99.80 E-value=8.4e-20 Score=205.83 Aligned_cols=204 Identities=25% Similarity=0.430 Sum_probs=146.1
Q ss_pred hhhhccCCccchhccCCcceeeeecccccceEEEEEEcCCCCEEEEEecccc----------chhhHHHHHHHHhhCCCc
Q psy11767 101 IACKFKGSLFFEQYDMDLDKAGILGDGSYSVCRRCVEKSTGQEYAVKIISRK----------IDCSEEINLLRACQGHPN 170 (966)
Q Consensus 101 ~~~~~~~~~~~~~~~~df~~~~~LG~GsFGkV~La~~k~tg~~yAiKvl~K~----------~~~~~E~~il~~~~~~pf 170 (966)
..+...+..|.+.| ++.++||+|+||+|++|+++.||+.||||++++. ....+|..+|+++ +||+
T Consensus 13 ~~~~~~~~~~~~~y----~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~hpn 87 (351)
T 3c0i_A 13 LDMADDDVLFEDVY----ELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHML-KHPH 87 (351)
T ss_dssp -------CCHHHHE----EEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHTSSSCCHHHHHHHHHHHHHC-CCTT
T ss_pred ccccCCCCccccce----EEeeEEeeCCCEEEEEEEECCCCCEEEEEEEEhhhccccccchHHHHHHHHHHHHhC-CCCC
Confidence 44455555666666 8999999999999999999999999999999753 1357899999988 6999
Q ss_pred cccccccccc----------------------------------chhHHHHHHHh----------hcccchhhhHhhhcc
Q psy11767 171 ICRRCVEKST----------------------------------GQEYAVKIISR----------KIDCSEEINLLRACQ 206 (966)
Q Consensus 171 i~~~~~~~~~----------------------------------~~~~~~~~v~~----------~~~~~~e~nil~~~~ 206 (966)
|++.+-.+.. ...+..+++.+ ..|++++ |||.+.+
T Consensus 88 Iv~~~~~~~~~~~~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivHrDlkp~-NIl~~~~ 166 (351)
T 3c0i_A 88 IVELLETYSSDGMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCHDNNIIHRDVKPH-CVLLASK 166 (351)
T ss_dssp BCCEEEEEEETTEEEEEEECCSSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGG-GEEECSS
T ss_pred CCcEEEEEEeCCEEEEEEeCCCCCCHHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCChH-HeEEecC
Confidence 9862211111 01111122211 1244555 9998765
Q ss_pred CC---ceEEecCcccc-------------------ccccccccCCCcceeeechhhHHHHHHHhhCCCCCCCCcHHHHHH
Q psy11767 207 GH---PNIVNLHCVFQ-------------------DEVIDWDDFSRGIECVFFSSSLIIFFIILSFTLSFIHDYYHIQYR 264 (966)
Q Consensus 207 gh---~~iv~l~~~~~-------------------~e~i~~~~y~~~~d~~~~~~~~il~~~m~~g~~pf~~~~~~~~~~ 264 (966)
+. ++|.||+.+.. +|++....|+...| .|+.|+++|+|++|.+||.... ..+++
T Consensus 167 ~~~~~vkl~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~D---iwslG~il~~ll~g~~pf~~~~-~~~~~ 242 (351)
T 3c0i_A 167 ENSAPVKLGGFGVAIQLGESGLVAGGRVGTPHFMAPEVVKREPYGKPVD---VWGCGVILFILLSGCLPFYGTK-ERLFE 242 (351)
T ss_dssp STTCCEEECCCTTCEECCTTSCBCCCCCSCGGGCCHHHHTTCCBCTHHH---HHHHHHHHHHHHHSSCSSCSSH-HHHHH
T ss_pred CCCCcEEEecCcceeEecCCCeeecCCcCCcCccCHHHHcCCCCCchHh---hHHHHHHHHHHHHCCCCCCCcH-HHHHH
Confidence 54 89999886532 34444445555444 4466788889999999998865 46789
Q ss_pred HHHhCCCCCC----CCCCHHHHHHHHhhcccCCCcccCCCCCCHHHHhcCCceeeeCcc
Q psy11767 265 RILKTEPPIP----EDLSPDVADFISRLLVKDPRRRLGGGELDAEELKRHPFFNVIDWD 319 (966)
Q Consensus 265 ~I~~~~~~~P----~~~s~~a~dli~~LL~kdp~~RLG~~~~g~~~Ik~HpfF~~idW~ 319 (966)
.|+.+.+.++ ..+++++++||+++|++||.+|.. +.++.+||||+..+|.
T Consensus 243 ~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s-----~~e~l~hp~~~~~~~~ 296 (351)
T 3c0i_A 243 GIIKGKYKMNPRQWSHISESAKDLVRRMLMLDPAERIT-----VYEALNHPWLKERDRY 296 (351)
T ss_dssp HHHHTCCCCCHHHHTTSCHHHHHHHHHHTCSSTTTSCC-----HHHHHTSHHHHTHHHH
T ss_pred HHHcCCCCCCccccccCCHHHHHHHHHHCCCChhHCcC-----HHHHhcChhhcCCccc
Confidence 9999988776 578999999999999999999984 8999999999987763
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.80 E-value=1.4e-19 Score=211.00 Aligned_cols=189 Identities=28% Similarity=0.451 Sum_probs=143.8
Q ss_pred CcceeeeecccccceEEEEEEcCCCCEEEEEeccccc-------hhhHHHHHHHHhhCCCcccccccccccc--------
Q psy11767 117 DLDKAGILGDGSYSVCRRCVEKSTGQEYAVKIISRKI-------DCSEEINLLRACQGHPNICRRCVEKSTG-------- 181 (966)
Q Consensus 117 df~~~~~LG~GsFGkV~La~~k~tg~~yAiKvl~K~~-------~~~~E~~il~~~~~~pfi~~~~~~~~~~-------- 181 (966)
+|++++.||+|+||.|++|+++.+|+.||+|++++.. ...+|..+|+++ +||+|++.+..+...
T Consensus 12 ~Y~i~~~LG~G~fg~V~~~~~~~~~~~~a~K~i~~~~~~~~~~~~~~~E~~il~~l-~hpnIv~l~~~~~~~~~~~lv~E 90 (444)
T 3soa_A 12 EYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLL-KHPNIVRLHDSISEEGHHYLIFD 90 (444)
T ss_dssp HEEEEEEEEEC--CEEEEEEETTTTEEEEEEEEESCSCHHHHHHHHHHHHHHHHHC-CBTTBCCEEEEEECSSEEEEEEC
T ss_pred CeEEEEEeccCCCeEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhC-CCcCCCeEEEEEEECCEEEEEEE
Confidence 4589999999999999999999999999999998642 357899999998 699998722111111
Q ss_pred ----------------------hhHHHHHHHh----------hcccchhhhHhhhc---cCCceEEecCcccc-------
Q psy11767 182 ----------------------QEYAVKIISR----------KIDCSEEINLLRAC---QGHPNIVNLHCVFQ------- 219 (966)
Q Consensus 182 ----------------------~~~~~~~v~~----------~~~~~~e~nil~~~---~gh~~iv~l~~~~~------- 219 (966)
..+..+++.+ ..|++++ |||.+. +|.++|+||+.+..
T Consensus 91 ~~~gg~L~~~i~~~~~~~e~~~~~i~~qil~aL~~lH~~givHrDlKp~-NIll~~~~~~~~vkL~DFG~a~~~~~~~~~ 169 (444)
T 3soa_A 91 LVTGGELFEDIVAREYYSEADASHCIQQILEAVLHCHQMGVVHRNLKPE-NLLLASKLKGAAVKLADFGLAIEVEGEQQA 169 (444)
T ss_dssp CCBCCBHHHHHHHCSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSST-TEEESBSSTTCCEEECCCSSCBCCCTTCCB
T ss_pred eCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHH-HEEEeccCCCCcEEEccCceeEEecCCCce
Confidence 1111122211 1245555 999874 57899999987632
Q ss_pred ------------ccccccccCCCcceeeechhhHHHHHHHhhCCCCCCCCcHHHHHHHHHhCCCCCCC----CCCHHHHH
Q psy11767 220 ------------DEVIDWDDFSRGIECVFFSSSLIIFFIILSFTLSFIHDYYHIQYRRILKTEPPIPE----DLSPDVAD 283 (966)
Q Consensus 220 ------------~e~i~~~~y~~~~d~~~~~~~~il~~~m~~g~~pf~~~~~~~~~~~I~~~~~~~P~----~~s~~a~d 283 (966)
+|++....|+...| .|+.|+++|+|++|.+||...+...+++.|..+.+.+|. .+++++++
T Consensus 170 ~~~~~gt~~Y~APE~l~~~~~~~~~D---IwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~ 246 (444)
T 3soa_A 170 WFGFAGTPGYLSPEVLRKDPYGKPVD---LWACGVILYILLVGYPPFWDEDQHRLYQQIKAGAYDFPSPEWDTVTPEAKD 246 (444)
T ss_dssp CCCSCSCGGGCCHHHHTTCCBCTHHH---HHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHTCCCCCTTTTTTSCHHHHH
T ss_pred eecccCCcccCCHHHhcCCCCCCccc---cHHHHHHHHHHHhCCCCCCCccHHHHHHHHHhCCCCCCccccccCCHHHHH
Confidence 34555556665555 446778888999999999999999999999999988875 68999999
Q ss_pred HHHhhcccCCCcccCCCCCCHHHHhcCCceee
Q psy11767 284 FISRLLVKDPRRRLGGGELDAEELKRHPFFNV 315 (966)
Q Consensus 284 li~~LL~kdp~~RLG~~~~g~~~Ik~HpfF~~ 315 (966)
||+++|++||.+|+. +.++.+||||..
T Consensus 247 li~~~L~~dP~~Rpt-----a~e~L~hp~~~~ 273 (444)
T 3soa_A 247 LINKMLTINPSKRIT-----AAEALKHPWISH 273 (444)
T ss_dssp HHHHHSCSSTTTSCC-----HHHHHHSCTTHH
T ss_pred HHHHHcCCChhHCCC-----HHHHhcCccccC
Confidence 999999999999984 899999999974
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* | Back alignment and structure |
|---|
Probab=99.80 E-value=2.1e-19 Score=208.49 Aligned_cols=197 Identities=18% Similarity=0.201 Sum_probs=135.8
Q ss_pred CcceeeeecccccceEEEEEEcCCCCEEEEEecccc-------chhhHHHHHHHHhhCCCccccccccccc---------
Q psy11767 117 DLDKAGILGDGSYSVCRRCVEKSTGQEYAVKIISRK-------IDCSEEINLLRACQGHPNICRRCVEKST--------- 180 (966)
Q Consensus 117 df~~~~~LG~GsFGkV~La~~k~tg~~yAiKvl~K~-------~~~~~E~~il~~~~~~pfi~~~~~~~~~--------- 180 (966)
+|.++++||+|+||+|++|+++.||+.||||++++. ....+|..+|+++ +||+|++.+-....
T Consensus 27 ~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~nIv~l~~~~~~~~~~~~~~~ 105 (432)
T 3n9x_A 27 NYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCKRILREITILNRL-KSDYIIRLYDLIIPDDLLKFDEL 105 (432)
T ss_dssp TEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSTTTSHHHHHHHHHHHHHHHHC-CCTTBCCEEEECCCSCTTTCCCE
T ss_pred CEEEEEEEeecCCEEEEEEEECCCCcEEEEEEeCchhcChHHHHHHHHHHHHHHHc-CCCCcceEEEEEecCCCCcCCeE
Confidence 789999999999999999999999999999999863 2457899999998 59999873211111
Q ss_pred -------------------------chhHHHHHHHh----------hcccchhhhHhhhccCCceEEecCcccc------
Q psy11767 181 -------------------------GQEYAVKIISR----------KIDCSEEINLLRACQGHPNIVNLHCVFQ------ 219 (966)
Q Consensus 181 -------------------------~~~~~~~~v~~----------~~~~~~e~nil~~~~gh~~iv~l~~~~~------ 219 (966)
...++.+++.+ ..|++++ |||.+.+|+++|+||+.+..
T Consensus 106 ~lv~e~~~~~L~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDlkp~-NILl~~~~~~kL~DFGla~~~~~~~~ 184 (432)
T 3n9x_A 106 YIVLEIADSDLKKLFKTPIFLTEEHIKTILYNLLLGENFIHESGIIHRDLKPA-NCLLNQDCSVKVCDFGLARTINSEKD 184 (432)
T ss_dssp EEEEECCSEEHHHHHHSSCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGG-GEEECTTCCEEECCCTTCEEC-----
T ss_pred EEEEecCCcCHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCHH-HeEECCCCCEEEccCCCccccccccc
Confidence 11122222222 1245555 99999999999999986631
Q ss_pred -----------------------------------cccc-ccccCCCcceeeechhhHHHHHHHhh-----------CCC
Q psy11767 220 -----------------------------------DEVI-DWDDFSRGIECVFFSSSLIIFFIILS-----------FTL 252 (966)
Q Consensus 220 -----------------------------------~e~i-~~~~y~~~~d~~~~~~~~il~~~m~~-----------g~~ 252 (966)
+|++ ....|+...| +|+.|+++|||++ |.|
T Consensus 185 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~~D---iwSlG~il~ell~g~~p~~~~~~~~~p 261 (432)
T 3n9x_A 185 TNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSID---IWSTGCIFAELLNMLQSHINDPTNRFP 261 (432)
T ss_dssp --------------------------CCCCCTTCCHHHHTTCSCCCTHHH---HHHHHHHHHHHHTTCTTTCSSGGGCCC
T ss_pred ccccccccccccccccccchhccccCCCCCccccCHHHHhcCCCCCcccc---cchHHHHHHHHHhcccccccccccccc
Confidence 2333 3334655555 4456677777775 555
Q ss_pred CCCCCc-----------------HHHHHHHH------------------------HhCCCCCC-------CCCCHHHHHH
Q psy11767 253 SFIHDY-----------------YHIQYRRI------------------------LKTEPPIP-------EDLSPDVADF 284 (966)
Q Consensus 253 pf~~~~-----------------~~~~~~~I------------------------~~~~~~~P-------~~~s~~a~dl 284 (966)
+|...+ .......| .......| +.++++++||
T Consensus 262 ~f~g~~~~~~~~~~~~~~~~~~~~~~ql~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dL 341 (432)
T 3n9x_A 262 LFPGSSCFPLSPDRNSKKVHEKSNRDQLNIIFNIIGTPTEDDLKNINKPEVIKYIKLFPHRKPINLKQKYPSISDDGINL 341 (432)
T ss_dssp SCCCSCSCC----------CHHHHHHHHHHHHHHHCSCCHHHHHTCCCHHHHHHHHTSCCCCCCCHHHHSTTSCHHHHHH
T ss_pred cCCCccccccCcccccccccccchHHHHHHHHHhcCCCCHHHHHhccCHHHHHHHHhCCCCCCCCHHHHCCCCCHHHHHH
Confidence 554432 11112222 11111222 4589999999
Q ss_pred HHhhcccCCCcccCCCCCCHHHHhcCCceeeeCcccccc
Q psy11767 285 ISRLLVKDPRRRLGGGELDAEELKRHPFFNVIDWDDLAT 323 (966)
Q Consensus 285 i~~LL~kdp~~RLG~~~~g~~~Ik~HpfF~~idW~~l~~ 323 (966)
|++||+.||.+|++ ++|+.+||||++++|..++.
T Consensus 342 l~~mL~~dP~~R~t-----a~e~L~Hp~f~~~~~~~~e~ 375 (432)
T 3n9x_A 342 LESMLKFNPNKRIT-----IDQALDHPYLKDVRKKKLEN 375 (432)
T ss_dssp HHHHSCSSTTTSCC-----HHHHHTCGGGTTTCCTTTC-
T ss_pred HHHHhcCCcccCCC-----HHHHhcChhhhhccCcccCc
Confidence 99999999999984 89999999999999988765
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.80 E-value=1.4e-19 Score=202.57 Aligned_cols=184 Identities=17% Similarity=0.138 Sum_probs=136.4
Q ss_pred CcceeeeecccccceEEEEEEc-----CCCCEEEEEeccccc-----hhhHHHHHHHHhhCCCccccccccccc------
Q psy11767 117 DLDKAGILGDGSYSVCRRCVEK-----STGQEYAVKIISRKI-----DCSEEINLLRACQGHPNICRRCVEKST------ 180 (966)
Q Consensus 117 df~~~~~LG~GsFGkV~La~~k-----~tg~~yAiKvl~K~~-----~~~~E~~il~~~~~~pfi~~~~~~~~~------ 180 (966)
||.+.+.||+|+||+||+|+++ .+|+.||||+|++.. ...+|..||.++ +||+||+.+-....
T Consensus 42 d~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~il~~l-~HpnIV~l~g~~~~~~~~~l 120 (329)
T 4aoj_A 42 DIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTML-QHQHIVRFFGVCTEGRPLLM 120 (329)
T ss_dssp GEEEEEEEEECSSEEEEEEEESSSCC---CEEEEEEEESCCSHHHHHHHHHHHHHHTTC-CCTTBCCEEEEECSSSSEEE
T ss_pred HeEEEEEEccCCCcEEEEEEECCcccCCCCeEEEEEEECcCCHHHHHHHHHHHHHHHhC-CCCCCCcEEEEEEECCEEEE
Confidence 7889999999999999999975 478999999998642 357899999998 69999872111110
Q ss_pred ---------------------------------------chhHHHHHHHh----------hcccchhhhHhhhccCCceE
Q psy11767 181 ---------------------------------------GQEYAVKIISR----------KIDCSEEINLLRACQGHPNI 211 (966)
Q Consensus 181 ---------------------------------------~~~~~~~~v~~----------~~~~~~e~nil~~~~gh~~i 211 (966)
...++.++..+ ..|++++ |||++.+++++|
T Consensus 121 V~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHRDLKp~-NILl~~~~~~Ki 199 (329)
T 4aoj_A 121 VFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGLHFVHRDLATR-NCLVGQGLVVKI 199 (329)
T ss_dssp EEECCTTCBHHHHHHTSSCC-----------CCSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGG-GEEEETTTEEEE
T ss_pred EEEcCCCCcHHHHHHhcCcccccccccccccCCCCCHHHHHHHHHHHHHHHHHHhcCCeecccccHh-hEEECCCCcEEE
Confidence 01112222211 1255555 999999999999
Q ss_pred EecCccc---------------------cccccccccCCCcceeeechhhHHHHHHHhh-CCCCCCCCcHHHHHHHHHhC
Q psy11767 212 VNLHCVF---------------------QDEVIDWDDFSRGIECVFFSSSLIIFFIILS-FTLSFIHDYYHIQYRRILKT 269 (966)
Q Consensus 212 v~l~~~~---------------------~~e~i~~~~y~~~~d~~~~~~~~il~~~m~~-g~~pf~~~~~~~~~~~I~~~ 269 (966)
.||+.+. .+|++....|+...| .|+.||++|||++ |.+||...+...+++.|..+
T Consensus 200 ~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~~sD---vwS~Gvvl~Ellt~G~~Pf~~~~~~~~~~~i~~g 276 (329)
T 4aoj_A 200 GDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESD---VWSFGVVLWEIFTYGKQPWYQLSNTEAIDCITQG 276 (329)
T ss_dssp CCCC----------------CCCCGGGCCHHHHTTCCCCHHHH---HHHHHHHHHHHHTTSCCTTCSSCHHHHHHHHHHT
T ss_pred cccccceeccCCCcceecCcccccccccChhhhcCCCCCcccc---ccchHHHHHHHHcCCCCCCCCCCHHHHHHHHHcC
Confidence 9999763 235555556755555 3466677788876 89999998888889999886
Q ss_pred -CCCCCCCCCHHHHHHHHhhcccCCCcccCCCCCCHHHHhcC
Q psy11767 270 -EPPIPEDLSPDVADFISRLLVKDPRRRLGGGELDAEELKRH 310 (966)
Q Consensus 270 -~~~~P~~~s~~a~dli~~LL~kdp~~RLG~~~~g~~~Ik~H 310 (966)
.+.+|..+++++.+||.++|++||.+|.. ++||..|
T Consensus 277 ~~~~~p~~~~~~~~~li~~cl~~dP~~RPs-----~~ei~~~ 313 (329)
T 4aoj_A 277 RELERPRACPPEVYAIMRGCWQREPQQRHS-----IKDVHAR 313 (329)
T ss_dssp CCCCCCTTCCHHHHHHHHHHCCSSTTTSCC-----HHHHHHH
T ss_pred CCCCCcccccHHHHHHHHHHcCcChhHCcC-----HHHHHHH
Confidence 57899999999999999999999999973 7888654
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B | Back alignment and structure |
|---|
Probab=99.80 E-value=1.7e-19 Score=204.51 Aligned_cols=190 Identities=27% Similarity=0.442 Sum_probs=145.2
Q ss_pred CcceeeeecccccceEEEEEEcCCCCEEEEEeccccc-------hhhHHHHHHHHhhCCCcccccccccccc--------
Q psy11767 117 DLDKAGILGDGSYSVCRRCVEKSTGQEYAVKIISRKI-------DCSEEINLLRACQGHPNICRRCVEKSTG-------- 181 (966)
Q Consensus 117 df~~~~~LG~GsFGkV~La~~k~tg~~yAiKvl~K~~-------~~~~E~~il~~~~~~pfi~~~~~~~~~~-------- 181 (966)
+|++.+.||+|+||.|++|+++.+|+.||+|++++.. ...+|..+|+++ +||+|++.+-.+...
T Consensus 30 ~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~il~~l-~hpnIv~~~~~~~~~~~~~lv~e 108 (362)
T 2bdw_A 30 NYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKL-QHPNIVRLHDSIQEESFHYLVFD 108 (362)
T ss_dssp HEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCHHHHHHHHHHHHHHHHC-CCTTBCCEEEEEECSSEEEEEEC
T ss_pred CeEEeeEEecCCCeEEEEEEECCCCCEEEEEEEEcccCCHHHHHHHHHHHHHHHhC-CCCCCCeEEEEEEeCCEEEEEEe
Confidence 5699999999999999999999999999999998642 356799999998 699998622111110
Q ss_pred ----------------------hhHHHHHHHh----------hcccchhhhHhhhcc---CCceEEecCcccc-------
Q psy11767 182 ----------------------QEYAVKIISR----------KIDCSEEINLLRACQ---GHPNIVNLHCVFQ------- 219 (966)
Q Consensus 182 ----------------------~~~~~~~v~~----------~~~~~~e~nil~~~~---gh~~iv~l~~~~~------- 219 (966)
..+..+++.+ ..|++++ |||.+.+ +.++|+||+.+..
T Consensus 109 ~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~Dlkp~-NIll~~~~~~~~~kl~DfG~a~~~~~~~~~ 187 (362)
T 2bdw_A 109 LVTGGELFEDIVAREFYSEADASHCIQQILESIAYCHSNGIVHRNLKPE-NLLLASKAKGAAVKLADFGLAIEVNDSEAW 187 (362)
T ss_dssp CCCSCBHHHHHTTCSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGG-GEEESCSSTTCCEEECCCTTCBCCTTCCSC
T ss_pred cCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCchH-HEEEecCCCCCCEEEeecCcceEecCCccc
Confidence 1111122211 1244555 9998764 4589999987632
Q ss_pred -----------ccccccccCCCcceeeechhhHHHHHHHhhCCCCCCCCcHHHHHHHHHhCCCCCCC----CCCHHHHHH
Q psy11767 220 -----------DEVIDWDDFSRGIECVFFSSSLIIFFIILSFTLSFIHDYYHIQYRRILKTEPPIPE----DLSPDVADF 284 (966)
Q Consensus 220 -----------~e~i~~~~y~~~~d~~~~~~~~il~~~m~~g~~pf~~~~~~~~~~~I~~~~~~~P~----~~s~~a~dl 284 (966)
+|++....|+...| .|+.|+++|+|++|.+||...+...+++.|..+.+.+|. .+++++++|
T Consensus 188 ~~~~gt~~y~aPE~~~~~~~~~~~D---iwslG~il~~ll~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~l 264 (362)
T 2bdw_A 188 HGFAGTPGYLSPEVLKKDPYSKPVD---IWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKSL 264 (362)
T ss_dssp CCSCSCTTTCCHHHHTTCCCCTHHH---HHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCTTGGGGSCHHHHHH
T ss_pred ccCCCCccccCHHHHccCCCCchhh---HHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCCCCCcccccCCCHHHHHH
Confidence 34555555655555 446778889999999999999999999999999998885 579999999
Q ss_pred HHhhcccCCCcccCCCCCCHHHHhcCCceeee
Q psy11767 285 ISRLLVKDPRRRLGGGELDAEELKRHPFFNVI 316 (966)
Q Consensus 285 i~~LL~kdp~~RLG~~~~g~~~Ik~HpfF~~i 316 (966)
|.++|++||.+|+. +.++.+||||...
T Consensus 265 i~~~L~~dP~~R~t-----~~e~l~hp~~~~~ 291 (362)
T 2bdw_A 265 IDSMLTVNPKKRIT-----ADQALKVPWICNR 291 (362)
T ss_dssp HHHHSCSSGGGSCC-----HHHHTTSHHHHTH
T ss_pred HHHHcCCChhhCcC-----HHHHhcCcccCCC
Confidence 99999999999984 8999999999753
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... | Back alignment and structure |
|---|
Probab=99.79 E-value=2.9e-19 Score=206.62 Aligned_cols=197 Identities=22% Similarity=0.243 Sum_probs=142.5
Q ss_pred cCCcceeeeecccccceEEEEEEcCCCCEEEEEeccccc-hhhHHHHHHHHhhCCCccccccccc---------------
Q psy11767 115 DMDLDKAGILGDGSYSVCRRCVEKSTGQEYAVKIISRKI-DCSEEINLLRACQGHPNICRRCVEK--------------- 178 (966)
Q Consensus 115 ~~df~~~~~LG~GsFGkV~La~~k~tg~~yAiKvl~K~~-~~~~E~~il~~~~~~pfi~~~~~~~--------------- 178 (966)
+.+|+++++||+|+||+||+|+++.+|+.||||++.+.. ...+|.++|+++ +||+|++....+
T Consensus 53 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~~~~~~E~~il~~l-~hpniv~l~~~~~~~~~~~~~~~~~lv 131 (420)
T 1j1b_A 53 EVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNRELQIMRKL-DHCNIVRLRYFFYSSGEKKDEVYLNLV 131 (420)
T ss_dssp EEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECCTTSCCHHHHHHHTC-CCTTBCCEEEEEEEEETTTTEEEEEEE
T ss_pred cceEEeeeEEeeCCCEEEEEEEECCCCcEEEEEEecccchhHHHHHHHHHHc-CCCCccceeeEEeccCCCCcceeEEee
Confidence 346799999999999999999999999999999998653 456799999988 699998732111
Q ss_pred -cc-----------------------chhHHHHHHHh----------hcccchhhhHhhhcc-CCceEEecCcccc----
Q psy11767 179 -ST-----------------------GQEYAVKIISR----------KIDCSEEINLLRACQ-GHPNIVNLHCVFQ---- 219 (966)
Q Consensus 179 -~~-----------------------~~~~~~~~v~~----------~~~~~~e~nil~~~~-gh~~iv~l~~~~~---- 219 (966)
.. ...++.+++.+ ..|++++ |||.+.+ +.++|+||+.+..
T Consensus 132 ~e~~~~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~-NILl~~~~~~~kl~DFG~a~~~~~~ 210 (420)
T 1j1b_A 132 LDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQ-NLLLDPDTAVLKLCDFGSAKQLVRG 210 (420)
T ss_dssp EECCCEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTTEECSCCSGG-GEEEETTTTEEEECCCTTCEECCTT
T ss_pred hhcccccHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChh-hEEEeCCCCeEEeccchhhhhcccC
Confidence 00 00111122211 1244555 9999865 4579999987632
Q ss_pred --------------cccccc-ccCCCcceeeechhhHHHHHHHhhCCCCCCCCcHHHHHHHHHh----------------
Q psy11767 220 --------------DEVIDW-DDFSRGIECVFFSSSLIIFFIILSFTLSFIHDYYHIQYRRILK---------------- 268 (966)
Q Consensus 220 --------------~e~i~~-~~y~~~~d~~~~~~~~il~~~m~~g~~pf~~~~~~~~~~~I~~---------------- 268 (966)
+|++.. ..|+...| +|+.|+++|||++|.+||...+....+.+|+.
T Consensus 211 ~~~~~~~~t~~y~aPE~~~~~~~~~~~~D---iwSlG~il~ell~G~~pf~~~~~~~~l~~i~~~lg~p~~~~~~~~~~~ 287 (420)
T 1j1b_A 211 EPNVSYICSRYYRAPELIFGATDYTSSID---VWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMNPN 287 (420)
T ss_dssp CCCCSCCSCTTSCCHHHHTTCSSCCTHHH---HHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCSCCHHHHHHHCSC
T ss_pred CCceeeeeCCCcCCHHHHcCCCCCCchhh---hHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhhChh
Confidence 244432 25655555 45677888999999999998877666666654
Q ss_pred -CCCC------------CCCCCCHHHHHHHHhhcccCCCcccCCCCCCHHHHhcCCceeeeCcccc
Q psy11767 269 -TEPP------------IPEDLSPDVADFISRLLVKDPRRRLGGGELDAEELKRHPFFNVIDWDDL 321 (966)
Q Consensus 269 -~~~~------------~P~~~s~~a~dli~~LL~kdp~~RLG~~~~g~~~Ik~HpfF~~idW~~l 321 (966)
..+. |+..++++++|||++||+.||.+|+. +.|+..||||..+.|...
T Consensus 288 ~~~~~~p~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~R~t-----~~e~l~hp~f~~~~~~~~ 348 (420)
T 1j1b_A 288 YTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLT-----PLEACAHSFFDELRDPNV 348 (420)
T ss_dssp CCCCCCCCCCCCCHHHHSCTTSCHHHHHHHHHHSCSSGGGSCC-----HHHHHTSGGGGGGGCTTC
T ss_pred hhhhccCccCCCCHHHhcCCCCCHHHHHHHHHhccCChhHCCC-----HHHHhCCHhhcccccccc
Confidence 1223 34567999999999999999999984 899999999998877553
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... | Back alignment and structure |
|---|
Probab=99.79 E-value=3e-19 Score=194.10 Aligned_cols=201 Identities=22% Similarity=0.304 Sum_probs=149.7
Q ss_pred CcceeeeecccccceEEEEEEcCCCCEEEEEecccc--------chhhHHHHHHHHhhCCCcccccccccccc-------
Q psy11767 117 DLDKAGILGDGSYSVCRRCVEKSTGQEYAVKIISRK--------IDCSEEINLLRACQGHPNICRRCVEKSTG------- 181 (966)
Q Consensus 117 df~~~~~LG~GsFGkV~La~~k~tg~~yAiKvl~K~--------~~~~~E~~il~~~~~~pfi~~~~~~~~~~------- 181 (966)
+|++.+.||+|+||.|++|+++.+++.||||++.+. ....+|..+|+++ +||+|++.+......
T Consensus 15 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~ 93 (284)
T 2vgo_A 15 DFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHL-RHPNILRMYNYFHDRKRIYLML 93 (284)
T ss_dssp GEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTC-CCTTBCCEEEEEECSSEEEEEE
T ss_pred hceeeheecCCCCeEEEEEEEcCCCcEEEEEEEcccccchHHHHHHHHHHHHHHhcC-CCCCEeeEEEEEEcCCEEEEEE
Confidence 789999999999999999999999999999999764 1356789999888 599998622111110
Q ss_pred -----------------------hhHHHHHHHh----------hcccchhhhHhhhccCCceEEecCcccc---------
Q psy11767 182 -----------------------QEYAVKIISR----------KIDCSEEINLLRACQGHPNIVNLHCVFQ--------- 219 (966)
Q Consensus 182 -----------------------~~~~~~~v~~----------~~~~~~e~nil~~~~gh~~iv~l~~~~~--------- 219 (966)
...+.+++.+ ..|++++ |||.+.+|+++|+||+.+..
T Consensus 94 e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~-Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~ 172 (284)
T 2vgo_A 94 EFAPRGELYKELQKHGRFDEQRSATFMEELADALHYCHERKVIHRDIKPE-NLLMGYKGELKIADFGWSVHAPSLRRRTM 172 (284)
T ss_dssp CCCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCSGG-GEEECTTCCEEECCCTTCEECSSSCBCCC
T ss_pred EeCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCHH-HEEEcCCCCEEEecccccccCcccccccc
Confidence 0011122211 0133334 99999999999999986532
Q ss_pred --------ccccccccCCCcceeeechhhHHHHHHHhhCCCCCCCCcHHHHHHHHHhCCCCCCCCCCHHHHHHHHhhccc
Q psy11767 220 --------DEVIDWDDFSRGIECVFFSSSLIIFFIILSFTLSFIHDYYHIQYRRILKTEPPIPEDLSPDVADFISRLLVK 291 (966)
Q Consensus 220 --------~e~i~~~~y~~~~d~~~~~~~~il~~~m~~g~~pf~~~~~~~~~~~I~~~~~~~P~~~s~~a~dli~~LL~k 291 (966)
+|++....|+...| .|+.|+++|+|++|.+||...+....++.|....+.+|..+++++++||+++|..
T Consensus 173 ~~~~~y~aPE~~~~~~~~~~~D---i~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~ 249 (284)
T 2vgo_A 173 CGTLDYLPPEMIEGKTHDEKVD---LWCAGVLCYEFLVGMPPFDSPSHTETHRRIVNVDLKFPPFLSDGSKDLISKLLRY 249 (284)
T ss_dssp CSCGGGCCHHHHTTCCBCTTHH---HHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTTCCCCCTTSCHHHHHHHHHHSCS
T ss_pred cCCCCcCCHHHhccCCCCcccc---hhhHHHHHHHHHHCCCCCCCCCHhHHHHHHhccccCCCCcCCHHHHHHHHHHhhc
Confidence 23444444544444 3456788888999999999988888899999999999999999999999999999
Q ss_pred CCCcccCCCCCCHHHHhcCCceeeeCccccccCCCCCCCCcc
Q psy11767 292 DPRRRLGGGELDAEELKRHPFFNVIDWDDLATKRIPAPFVPK 333 (966)
Q Consensus 292 dp~~RLG~~~~g~~~Ik~HpfF~~idW~~l~~k~~~pP~~P~ 333 (966)
||.+|. .+++|.+||||+... +++.||..+.
T Consensus 250 ~p~~Rp-----s~~~ll~h~~~~~~~------~~~~p~~~~~ 280 (284)
T 2vgo_A 250 HPPQRL-----PLKGVMEHPWVKANS------RRVLPPVYQS 280 (284)
T ss_dssp SGGGSC-----CHHHHHTCHHHHHHC------CCCCCCCC--
T ss_pred CHhhCC-----CHHHHhhCHHHHhhc------cccCCCcccc
Confidence 999998 489999999997543 4445555443
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} SCOP: d.144.1.7 PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A | Back alignment and structure |
|---|
Probab=99.79 E-value=2.9e-19 Score=195.29 Aligned_cols=190 Identities=23% Similarity=0.313 Sum_probs=134.0
Q ss_pred CcceeeeecccccceEEEEEEcCCCCEEEEEeccccc-------hhhHHHHHHHHhhCCCccccccccccc---------
Q psy11767 117 DLDKAGILGDGSYSVCRRCVEKSTGQEYAVKIISRKI-------DCSEEINLLRACQGHPNICRRCVEKST--------- 180 (966)
Q Consensus 117 df~~~~~LG~GsFGkV~La~~k~tg~~yAiKvl~K~~-------~~~~E~~il~~~~~~pfi~~~~~~~~~--------- 180 (966)
+|++++.||+|+||+|++|+++.+|+.||||++++.. ...+|..+|+++ +||+|++..-.+..
T Consensus 3 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~e 81 (292)
T 3o0g_A 3 KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKEL-KHKNIVRLHDVLHSDKKLTLVFE 81 (292)
T ss_dssp SEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTC-CCTTBCCEEEEEEETTEEEEEEE
T ss_pred CceeeeEecCCCCeEEEEEEECCCCceEEEEeeeccCCcCCcchHHHHHHHHHhcC-CCCCEeeEEeEEEeCCEEEEEEe
Confidence 5799999999999999999999999999999998642 346789999888 59999872211111
Q ss_pred ---------------------chhHHHHHHHh----------hcccchhhhHhhhccCCceEEecCcccc----------
Q psy11767 181 ---------------------GQEYAVKIISR----------KIDCSEEINLLRACQGHPNIVNLHCVFQ---------- 219 (966)
Q Consensus 181 ---------------------~~~~~~~~v~~----------~~~~~~e~nil~~~~gh~~iv~l~~~~~---------- 219 (966)
...++.+++.+ ..|++++ |||.+.+|+++|+||+.+..
T Consensus 82 ~~~~~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~~ivH~dikp~-Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~ 160 (292)
T 3o0g_A 82 FCDQDLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHSRNVLHRDLKPQ-NLLINRNGELKLANFGLARAFGIPVRCYSA 160 (292)
T ss_dssp CCSEEHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGG-GEEECTTSCEEECCCTTCEECCSCCSCCCS
T ss_pred cCCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHH-HEEEcCCCCEEEeecccceecCCccccccC
Confidence 11111222221 1244445 99999999999999987632
Q ss_pred ---------cccccccc-CCCcceeeechhhHHHHHHHh-hCCCCCCCCcHHHHHHHHHhC--C----------------
Q psy11767 220 ---------DEVIDWDD-FSRGIECVFFSSSLIIFFIIL-SFTLSFIHDYYHIQYRRILKT--E---------------- 270 (966)
Q Consensus 220 ---------~e~i~~~~-y~~~~d~~~~~~~~il~~~m~-~g~~pf~~~~~~~~~~~I~~~--~---------------- 270 (966)
+|++.... |+...| .| +.|+++|+|+ ++.|||...+.....++|... .
T Consensus 161 ~~~t~~y~aPE~~~~~~~~~~~~D--iw-slG~il~~l~~~~~p~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~ 237 (292)
T 3o0g_A 161 EVVTLWYRPPDVLFGAKLYSTSID--MW-SAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLPDYK 237 (292)
T ss_dssp CCSCGGGCCHHHHTTCSCCCTHHH--HH-HHHHHHHHHTTTSCCSCCCSSHHHHHHHHHHHHCCCCTTTCTTGGGSTTCC
T ss_pred CccccCCcChHHHcCCCCcCchHH--HH-HHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHHhCCCChhhhhhhccccccc
Confidence 23333222 444444 44 4556666666 566778888877777777541 1
Q ss_pred -----------CCCCCCCCHHHHHHHHhhcccCCCcccCCCCCCHHHHhcCCceeee
Q psy11767 271 -----------PPIPEDLSPDVADFISRLLVKDPRRRLGGGELDAEELKRHPFFNVI 316 (966)
Q Consensus 271 -----------~~~P~~~s~~a~dli~~LL~kdp~~RLG~~~~g~~~Ik~HpfF~~i 316 (966)
...+..++++++|||+++|+.||.+|+. ++|+.+||||+++
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t-----~~e~l~hp~f~~~ 289 (292)
T 3o0g_A 238 PYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRIS-----AEEALQHPYFSDF 289 (292)
T ss_dssp CCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCC-----HHHHHTSGGGTTC
T ss_pred ccccccCCcchhhcccccChHHHHHHHHHhccChhhCCC-----HHHHhcCcccccC
Confidence 1123458899999999999999999984 8999999999754
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A | Back alignment and structure |
|---|
Probab=99.79 E-value=3.5e-19 Score=196.52 Aligned_cols=198 Identities=25% Similarity=0.385 Sum_probs=139.0
Q ss_pred ccCCccee-eeecccccceEEEEEEcCCCCEEEEEeccccc-----hhhHHHHHHHHhhCCCcccccccccccc------
Q psy11767 114 YDMDLDKA-GILGDGSYSVCRRCVEKSTGQEYAVKIISRKI-----DCSEEINLLRACQGHPNICRRCVEKSTG------ 181 (966)
Q Consensus 114 ~~~df~~~-~~LG~GsFGkV~La~~k~tg~~yAiKvl~K~~-----~~~~E~~il~~~~~~pfi~~~~~~~~~~------ 181 (966)
+.-.|++. ++||+|+||+|++|+++.+|+.||||++++.. ...+|..+|.++.+||+|++..-.+...
T Consensus 10 ~~~~y~i~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~~~~h~~i~~~~~~~~~~~~~~lv 89 (316)
T 2ac3_A 10 FEDVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEFFEEEDRFYLV 89 (316)
T ss_dssp TTTSCEECCCCCCCCSSEEEEEEECSSSCCEEEEEEEECCSSCCHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEE
T ss_pred cceeEEecCceecCCceEEEEEEEEcCCCcEEEEEEEeeCcchhHHHHHHHHHHHHHhcCCCCeeeEEEEEeeCCEEEEE
Confidence 33445775 78999999999999999999999999998642 4578999999988999998722111110
Q ss_pred ------------------------hhHHHHHHHh----------hcccchhhhHhhhccCC---ceEEecCcccc-----
Q psy11767 182 ------------------------QEYAVKIISR----------KIDCSEEINLLRACQGH---PNIVNLHCVFQ----- 219 (966)
Q Consensus 182 ------------------------~~~~~~~v~~----------~~~~~~e~nil~~~~gh---~~iv~l~~~~~----- 219 (966)
...+.+++.+ ..|++++ |||.+.+|. ++|.||+.+..
T Consensus 90 ~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~-Nil~~~~~~~~~~kl~Dfg~~~~~~~~~ 168 (316)
T 2ac3_A 90 FEKMRGGSILSHIHKRRHFNELEASVVVQDVASALDFLHNKGIAHRDLKPE-NILCEHPNQVSPVKICDFDLGSGIKLNG 168 (316)
T ss_dssp EECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGG-GEEESCSSSSCSEEECCTTCCC------
T ss_pred EEcCCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCHH-HEEEccCCCcCceEEEEccCccccccCC
Confidence 0111122211 0144444 999887665 89999876531
Q ss_pred ---------------------cccccc-----ccCCCcceeeechhhHHHHHHHhhCCCCCCCCc---------------
Q psy11767 220 ---------------------DEVIDW-----DDFSRGIECVFFSSSLIIFFIILSFTLSFIHDY--------------- 258 (966)
Q Consensus 220 ---------------------~e~i~~-----~~y~~~~d~~~~~~~~il~~~m~~g~~pf~~~~--------------- 258 (966)
+|++.. ..|+...| .|+.|+++|+|++|.+||....
T Consensus 169 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~D---iwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~ 245 (316)
T 2ac3_A 169 DCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCD---LWSLGVILYILLSGYPPFVGRCGSDCGWDRGEACPAC 245 (316)
T ss_dssp -------------CCSGGGCCHHHHHHTSHHHHHHTTTHH---HHHHHHHHHHHHHSSCSCCCCCCSCSCC----CCHHH
T ss_pred ccccccccccccccCCcCccChHHhhcccccccCCCcccc---cHhHHHHHHHHHHCCCCCcccccccccccccccchhH
Confidence 223321 22444444 4466788889999999997643
Q ss_pred HHHHHHHHHhCCCCCC----CCCCHHHHHHHHhhcccCCCcccCCCCCCHHHHhcCCceeeeCccc
Q psy11767 259 YHIQYRRILKTEPPIP----EDLSPDVADFISRLLVKDPRRRLGGGELDAEELKRHPFFNVIDWDD 320 (966)
Q Consensus 259 ~~~~~~~I~~~~~~~P----~~~s~~a~dli~~LL~kdp~~RLG~~~~g~~~Ik~HpfF~~idW~~ 320 (966)
...+++.|..+.+.+| ..+++++++||+++|+.||.+|.. +++|.+||||++..|+.
T Consensus 246 ~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps-----~~e~l~hp~~~~~~~~~ 306 (316)
T 2ac3_A 246 QNMLFESIQEGKYEFPDKDWAHISCAAKDLISKLLVRDAKQRLS-----AAQVLQHPWVQGCAPEN 306 (316)
T ss_dssp HHHHHHHHHHCCCCCCHHHHTTSCHHHHHHHHHHSCSSTTTSCC-----HHHHHHSTTCC------
T ss_pred HHHHHHHHhccCcccCchhcccCCHHHHHHHHHHhhCChhhCCC-----HHHHhcChhhcCCCCcc
Confidence 3567899999999998 468999999999999999999984 89999999999988764
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.79 E-value=3.5e-19 Score=195.15 Aligned_cols=190 Identities=23% Similarity=0.354 Sum_probs=138.7
Q ss_pred CcceeeeecccccceEEEEEEcCCCCEEEEEeccccc-------------------------------hhhHHHHHHHHh
Q psy11767 117 DLDKAGILGDGSYSVCRRCVEKSTGQEYAVKIISRKI-------------------------------DCSEEINLLRAC 165 (966)
Q Consensus 117 df~~~~~LG~GsFGkV~La~~k~tg~~yAiKvl~K~~-------------------------------~~~~E~~il~~~ 165 (966)
+|.+.+.||+|+||+|++|+++.+|+.||||++++.. ...+|..+|+++
T Consensus 14 ~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l 93 (298)
T 2zv2_A 14 QYTLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPIEQVYQEIAILKKL 93 (298)
T ss_dssp TEEEEEEEEC--CCEEEEEEETTTTEEEEEEEEECC-------------------------------CHHHHHHHHHHTC
T ss_pred ceEEEeEEeecCCEEEEEEEECCCCcEEEEEEeehhhhhhhcccccccccccccccccccccccchHHHHHHHHHHHHhC
Confidence 6799999999999999999999999999999998642 246799999988
Q ss_pred hCCCccccccccccc--c-----------------------------hhHHHHHHHh----------hcccchhhhHhhh
Q psy11767 166 QGHPNICRRCVEKST--G-----------------------------QEYAVKIISR----------KIDCSEEINLLRA 204 (966)
Q Consensus 166 ~~~pfi~~~~~~~~~--~-----------------------------~~~~~~~v~~----------~~~~~~e~nil~~ 204 (966)
+||+|++..-.... . ..++.+++.+ ..|++++ |||.+
T Consensus 94 -~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~-Nil~~ 171 (298)
T 2zv2_A 94 -DHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVPTLKPLSEDQARFYFQDLIKGIEYLHYQKIIHRDIKPS-NLLVG 171 (298)
T ss_dssp -CCTTBCCEEEEEECSSSSEEEEEEECCTTCBSCCSSCSSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGG-GEEEC
T ss_pred -CCCCCCeEEEEEEcCCCCEEEEEEecCCCCcHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHH-HEEEC
Confidence 69999862211110 0 1111122221 1244444 99999
Q ss_pred ccCCceEEecCcccc-------------------ccccccccCC-CcceeeechhhHHHHHHHhhCCCCCCCCcHHHHHH
Q psy11767 205 CQGHPNIVNLHCVFQ-------------------DEVIDWDDFS-RGIECVFFSSSLIIFFIILSFTLSFIHDYYHIQYR 264 (966)
Q Consensus 205 ~~gh~~iv~l~~~~~-------------------~e~i~~~~y~-~~~d~~~~~~~~il~~~m~~g~~pf~~~~~~~~~~ 264 (966)
.+|+++|+||+.+.. +|++...... .+...| .|+.|+++|+|++|.+||...+...+..
T Consensus 172 ~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~D-i~slG~~l~~l~~g~~pf~~~~~~~~~~ 250 (298)
T 2zv2_A 172 EDGHIKIADFGVSNEFKGSDALLSNTVGTPAFMAPESLSETRKIFSGKALD-VWAMGVTLYCFVFGQCPFMDERIMCLHS 250 (298)
T ss_dssp TTSCEEECCCTTCEECSSSSCEECCCCSCGGGCCGGGCCTTCCCEESHHHH-HHHHHHHHHHHHHSSCSSCCSSHHHHHH
T ss_pred CCCCEEEecCCCccccccccccccCCcCCccccChhhhccCCCCCCCchhh-hHhHHHHHHHHHHCCCCCCCccHHHHHH
Confidence 999999999986532 2333222110 011123 4456788888999999999998888899
Q ss_pred HHHhCCCCCCC--CCCHHHHHHHHhhcccCCCcccCCCCCCHHHHhcCCcee
Q psy11767 265 RILKTEPPIPE--DLSPDVADFISRLLVKDPRRRLGGGELDAEELKRHPFFN 314 (966)
Q Consensus 265 ~I~~~~~~~P~--~~s~~a~dli~~LL~kdp~~RLG~~~~g~~~Ik~HpfF~ 314 (966)
.|....+.+|. .+++++++||.++|.+||.+|.. +.+|.+||||.
T Consensus 251 ~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~R~s-----~~e~l~hp~~~ 297 (298)
T 2zv2_A 251 KIKSQALEFPDQPDIAEDLKDLITRMLDKNPESRIV-----VPEIKLHPWVT 297 (298)
T ss_dssp HHHHCCCCCCSSSCCCHHHHHHHHHHTCSCTTTSCC-----HHHHTTCHHHH
T ss_pred HHhcccCCCCCccccCHHHHHHHHHHhhcChhhCCC-----HHHHhcCcccc
Confidence 99998888874 68999999999999999999984 89999999995
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* | Back alignment and structure |
|---|
Probab=99.79 E-value=2.1e-19 Score=200.40 Aligned_cols=193 Identities=23% Similarity=0.315 Sum_probs=138.0
Q ss_pred CcceeeeecccccceEEEEEEcCCCCEEEEEeccccc-------hhhHHHHHHHHhhCCCcccccccccccc--------
Q psy11767 117 DLDKAGILGDGSYSVCRRCVEKSTGQEYAVKIISRKI-------DCSEEINLLRACQGHPNICRRCVEKSTG-------- 181 (966)
Q Consensus 117 df~~~~~LG~GsFGkV~La~~k~tg~~yAiKvl~K~~-------~~~~E~~il~~~~~~pfi~~~~~~~~~~-------- 181 (966)
+|.+++.||+|+||+|++|+++.+|+.||||++++.. ...+|..+|+++ +||+|++..-.....
T Consensus 35 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~e 113 (329)
T 3gbz_A 35 RYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEEGVPGTAIREVSLLKEL-QHRNIIELKSVIHHNHRLHLIFE 113 (329)
T ss_dssp GEEEEEEEEECSSSEEEEEEETTTTEEEEEEECCCCC--------CHHHHHHGGGC-CCTTBCCEEEEEEETTEEEEEEE
T ss_pred hEEEEEEEEecCCeEEEEEEECCCCceEEEEEEcccccccccchhHHHHHHHHHHc-CCCCcceEEEEEecCCEEEEEEe
Confidence 5699999999999999999999999999999998642 346899999988 699998622111110
Q ss_pred ---------------------hhHHHHHHHh----------hcccchhhhHhhhc-----cCCceEEecCccc-------
Q psy11767 182 ---------------------QEYAVKIISR----------KIDCSEEINLLRAC-----QGHPNIVNLHCVF------- 218 (966)
Q Consensus 182 ---------------------~~~~~~~v~~----------~~~~~~e~nil~~~-----~gh~~iv~l~~~~------- 218 (966)
..++.+++.+ ..|++++ |||.+. .+.++|+||+.+.
T Consensus 114 ~~~~~L~~~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~ivH~Dlkp~-NIll~~~~~~~~~~~kl~Dfg~a~~~~~~~~ 192 (329)
T 3gbz_A 114 YAENDLKKYMDKNPDVSMRVIKSFLYQLINGVNFCHSRRCLHRDLKPQ-NLLLSVSDASETPVLKIGDFGLARAFGIPIR 192 (329)
T ss_dssp CCSEEHHHHHHHCTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGG-GEEEEC-----CCEEEECCTTHHHHHC----
T ss_pred cCCCCHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCEECCCCCHH-HEEEecCCCCccceEEECcCCCccccCCccc
Confidence 1111222221 1244444 999844 3458999998552
Q ss_pred ------------cccccccc-cCCCcceeeechhhHHHHHHHhhCCCCCCCCcHHHHHHHHHhC--CC---C--------
Q psy11767 219 ------------QDEVIDWD-DFSRGIECVFFSSSLIIFFIILSFTLSFIHDYYHIQYRRILKT--EP---P-------- 272 (966)
Q Consensus 219 ------------~~e~i~~~-~y~~~~d~~~~~~~~il~~~m~~g~~pf~~~~~~~~~~~I~~~--~~---~-------- 272 (966)
.+|++... .|+...| .|+.|+++|+|++|.+||...+......+|+.. .+ .
T Consensus 193 ~~~~~~~t~~y~aPE~~~~~~~~~~~~D---iwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 269 (329)
T 3gbz_A 193 QFTHEIITLWYRPPEILLGSRHYSTSVD---IWSIACIWAEMLMKTPLFPGDSEIDQLFKIFEVLGLPDDTTWPGVTALP 269 (329)
T ss_dssp -------CCTTCCHHHHTTCCCCCTHHH---HHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTTTSTTGGGST
T ss_pred ccCCCcCCccccCHHHhcCCCCCCcHHH---HHHHHHHHHHHHHCCCCcCCCCHHHHHHHHHHHhCCCchhhhhhhhhhh
Confidence 23444332 3555545 446678899999999999988877777777642 11 1
Q ss_pred -----CC------------CCCCHHHHHHHHhhcccCCCcccCCCCCCHHHHhcCCceeeeCcc
Q psy11767 273 -----IP------------EDLSPDVADFISRLLVKDPRRRLGGGELDAEELKRHPFFNVIDWD 319 (966)
Q Consensus 273 -----~P------------~~~s~~a~dli~~LL~kdp~~RLG~~~~g~~~Ik~HpfF~~idW~ 319 (966)
+| ..++++++|||+++|+.||.+|+. ++|+.+||||+++||+
T Consensus 270 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t-----~~e~l~hp~f~~~~~~ 328 (329)
T 3gbz_A 270 DWKQSFPKFRGKTLKRVLGALLDDEGLDLLTAMLEMDPVKRIS-----AKNALEHPYFSHNDFD 328 (329)
T ss_dssp TCCTTCCCCCCCCHHHHHGGGSCHHHHHHHHHHTCSSGGGSCC-----HHHHHTSGGGSSSCSC
T ss_pred hhhhhhhhhccccHhhhcccccCHHHHHHHHHHccCChhhCCC-----HHHHhCCcccCCCCCC
Confidence 11 127899999999999999999984 8999999999999997
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} SCOP: d.144.1.7 PDB: 2qkr_A* | Back alignment and structure |
|---|
Probab=99.79 E-value=2.6e-19 Score=198.17 Aligned_cols=195 Identities=23% Similarity=0.317 Sum_probs=137.3
Q ss_pred ccCCcceeeeecccccceEEEEEEcCCCCEEEEEeccccc-------hhhHHHHHHHHhhCCCcccccccccccc-----
Q psy11767 114 YDMDLDKAGILGDGSYSVCRRCVEKSTGQEYAVKIISRKI-------DCSEEINLLRACQGHPNICRRCVEKSTG----- 181 (966)
Q Consensus 114 ~~~df~~~~~LG~GsFGkV~La~~k~tg~~yAiKvl~K~~-------~~~~E~~il~~~~~~pfi~~~~~~~~~~----- 181 (966)
.--+|++++.||+|+||+|++|+++ +|+.||+|++++.. ...+|..+|+++ +||+|++..-.+...
T Consensus 19 l~~~y~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~hp~iv~~~~~~~~~~~~~l 96 (311)
T 3niz_A 19 LMEKYQKLEKVGEGTYGVVYKAKDS-QGRIVALKRIRLDAEDEGIPSTAIREISLLKEL-HHPNIVSLIDVIHSERCLTL 96 (311)
T ss_dssp SSCEEEEEEEEEECSSCEEEEEEET-TSCEEEEEEEC------CHHHHHHHHHHHHHHC-CCTTBCCEEEEECCSSCEEE
T ss_pred hHhhhHhhhhccCCCCeEEEEEEEC-CCCEEEEEEEecccccchhhHHHHHHHHHHHHc-CCCCEeeeeeEEccCCEEEE
Confidence 3346799999999999999999996 59999999998542 356899999998 699998722111111
Q ss_pred -------------------------hhHHHHHHHh----------hcccchhhhHhhhccCCceEEecCcccc-------
Q psy11767 182 -------------------------QEYAVKIISR----------KIDCSEEINLLRACQGHPNIVNLHCVFQ------- 219 (966)
Q Consensus 182 -------------------------~~~~~~~v~~----------~~~~~~e~nil~~~~gh~~iv~l~~~~~------- 219 (966)
..++.+++.+ ..|++++ |||.+.+|+++|+||+.+..
T Consensus 97 v~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~Dikp~-NIl~~~~~~~kl~Dfg~a~~~~~~~~~ 175 (311)
T 3niz_A 97 VFEFMEKDLKKVLDENKTGLQDSQIKIYLYQLLRGVAHCHQHRILHRDLKPQ-NLLINSDGALKLADFGLARAFGIPVRS 175 (311)
T ss_dssp EEECCSEEHHHHHHTCTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGG-GEEECTTCCEEECCCTTCEETTSCCC-
T ss_pred EEcCCCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCchH-hEEECCCCCEEEccCcCceecCCCccc
Confidence 1111222221 1244555 99999999999999986632
Q ss_pred ------------cccccc-ccCCCcceeeechhhHHHHHHHhhCCCCCCCCcHHHHHHHHHh--CCCC------------
Q psy11767 220 ------------DEVIDW-DDFSRGIECVFFSSSLIIFFIILSFTLSFIHDYYHIQYRRILK--TEPP------------ 272 (966)
Q Consensus 220 ------------~e~i~~-~~y~~~~d~~~~~~~~il~~~m~~g~~pf~~~~~~~~~~~I~~--~~~~------------ 272 (966)
+|++.. ..|+...| .|+.|+++|+|++|.+||...+......+|.. +.+.
T Consensus 176 ~~~~~~t~~y~aPE~~~~~~~~~~~~D---iwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~ 252 (311)
T 3niz_A 176 YTHEVVTLWYRAPDVLMGSKKYSTSVD---IWSIGCIFAEMITGKPLFPGVTDDDQLPKIFSILGTPNPREWPQVQELPL 252 (311)
T ss_dssp --CCCCCCTTCCHHHHTTCCSCCTHHH---HHHHHHHHHHHHHSSCSCCCSSTTTHHHHHHHHHCCCCTTTSGGGTTSHH
T ss_pred ccCCcccCCcCCHHHhcCCCCCCchHH---hHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHHCCCChHHhhhhhccch
Confidence 233332 23544444 44677888999999999987655555555543 1110
Q ss_pred ----------------CCCCCCHHHHHHHHhhcccCCCcccCCCCCCHHHHhcCCceeeeCcc
Q psy11767 273 ----------------IPEDLSPDVADFISRLLVKDPRRRLGGGELDAEELKRHPFFNVIDWD 319 (966)
Q Consensus 273 ----------------~P~~~s~~a~dli~~LL~kdp~~RLG~~~~g~~~Ik~HpfF~~idW~ 319 (966)
+++.++++++|||+++|+.||.+|+. ++|+.+||||++++|+
T Consensus 253 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt-----~~ell~hp~f~~~~~~ 310 (311)
T 3niz_A 253 WKQRTFQVFEKKPWSSIIPGFCQEGIDLLSNMLCFDPNKRIS-----ARDAMNHPYFKDLDPQ 310 (311)
T ss_dssp HHSCCCCCCCCCCHHHHSTTCCHHHHHHHHHHSCSCTTTSCC-----HHHHHTSGGGTTSCTT
T ss_pred hhhcccccccCCcHHHhCcccCHHHHHHHHHHcCCChhHCCC-----HHHHhcCcccccCCcc
Confidence 12357899999999999999999984 8999999999999875
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* | Back alignment and structure |
|---|
Probab=99.79 E-value=1.9e-19 Score=199.61 Aligned_cols=195 Identities=23% Similarity=0.295 Sum_probs=129.2
Q ss_pred CcceeeeecccccceEEEEEEcCCCCEEEEEeccccc------hhhHHHHHHHHhhCCCcccccccccccc---------
Q psy11767 117 DLDKAGILGDGSYSVCRRCVEKSTGQEYAVKIISRKI------DCSEEINLLRACQGHPNICRRCVEKSTG--------- 181 (966)
Q Consensus 117 df~~~~~LG~GsFGkV~La~~k~tg~~yAiKvl~K~~------~~~~E~~il~~~~~~pfi~~~~~~~~~~--------- 181 (966)
+|++++.||+|+||+|++|+++.+|+.||||++++.. ...+|..+|+++ +||+|++.+-.+...
T Consensus 6 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l-~hp~iv~~~~~~~~~~~~~lv~e~ 84 (317)
T 2pmi_A 6 QFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGTPSTAIREISLMKEL-KHENIVRLYDVIHTENKLTLVFEF 84 (317)
T ss_dssp -------------CEEEEEECSSSCCEEEEEEEECCSTTCSCHHHHHHHHHHTTC-CBTTBCCEEEEECCTTEEEEEEEC
T ss_pred ceeEeeEECCCCCEEEEEEEECCCCcEEEEEEeecccccccHHHHHHHHHHHHhc-CCCCcceEEEEEEECCeEEEEEEe
Confidence 6799999999999999999999999999999998542 357899999988 699998722111110
Q ss_pred --------------------------hhHHHHHHHh----------hcccchhhhHhhhccCCceEEecCcccc------
Q psy11767 182 --------------------------QEYAVKIISR----------KIDCSEEINLLRACQGHPNIVNLHCVFQ------ 219 (966)
Q Consensus 182 --------------------------~~~~~~~v~~----------~~~~~~e~nil~~~~gh~~iv~l~~~~~------ 219 (966)
..++.+++.+ ..|++++ |||.+.+|.++|+||+.+..
T Consensus 85 ~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~ivH~Dlkp~-NIl~~~~~~~kl~Dfg~~~~~~~~~~ 163 (317)
T 2pmi_A 85 MDNDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCHENKILHRDLKPQ-NLLINKRGQLKLGDFGLARAFGIPVN 163 (317)
T ss_dssp CCCBHHHHHHHHHSSSCCCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGG-GEEECTTCCEEECCCSSCEETTSCCC
T ss_pred cCCCHHHHHHhccccccccCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCChH-HeEEcCCCCEEECcCccceecCCCcc
Confidence 1111122222 1244555 99999999999999987632
Q ss_pred -------------cccccc-ccCCCcceeeechhhHHHHHHHhhCCCCCCCCcHHHHHHHHHhC--C-------------
Q psy11767 220 -------------DEVIDW-DDFSRGIECVFFSSSLIIFFIILSFTLSFIHDYYHIQYRRILKT--E------------- 270 (966)
Q Consensus 220 -------------~e~i~~-~~y~~~~d~~~~~~~~il~~~m~~g~~pf~~~~~~~~~~~I~~~--~------------- 270 (966)
+|++.. ..|+...| .|+.|+++|+|++|.+||...+.......|... .
T Consensus 164 ~~~~~~~t~~y~aPE~~~~~~~~~~~~D---iwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 240 (317)
T 2pmi_A 164 TFSSEVVTLWYRAPDVLMGSRTYSTSID---IWSCGCILAEMITGKPLFPGTNDEEQLKLIFDIMGTPNESLWPSVTKLP 240 (317)
T ss_dssp CCCCCCSCCTTCCHHHHTTCCCCCTHHH---HHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCTTTCGGGGGCT
T ss_pred cCCCCcccccccCchHhhCCCCCCcHHH---HHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhHhhhhhhhh
Confidence 233332 23544444 446678889999999999988887777777541 1
Q ss_pred -------------------CCCCCCCCHHHHHHHHhhcccCCCcccCCCCCCHHHHhcCCceeeeCcccc
Q psy11767 271 -------------------PPIPEDLSPDVADFISRLLVKDPRRRLGGGELDAEELKRHPFFNVIDWDDL 321 (966)
Q Consensus 271 -------------------~~~P~~~s~~a~dli~~LL~kdp~~RLG~~~~g~~~Ik~HpfF~~idW~~l 321 (966)
+..+..++++++|||+++|+.||.+|+. ++++.+||||+.+.|.+.
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt-----~~e~l~hp~f~~~~~~~~ 305 (317)
T 2pmi_A 241 KYNPNIQQRPPRDLRQVLQPHTKEPLDGNLMDFLHGLLQLNPDMRLS-----AKQALHHPWFAEYYHHAS 305 (317)
T ss_dssp TCCTTCCCCCCCCSHHHHGGGCSSCCCHHHHHHHHHHSCSSGGGSCC-----HHHHTTSGGGGGGCC---
T ss_pred hcccccccccchhHHHhhcccccccCCHHHHHHHHHHCCCCcccCCC-----HHHHhCChhhhcccchhh
Confidence 1123367899999999999999999984 899999999999988654
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} SCOP: d.144.1.7 PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3u9c_A* 4fbx_A* 3mb7_A* 3mb6_A* ... | Back alignment and structure |
|---|
Probab=99.78 E-value=5.1e-19 Score=196.38 Aligned_cols=195 Identities=22% Similarity=0.276 Sum_probs=134.2
Q ss_pred CcceeeeecccccceEEEEEEcCCCCEEEEEecccc--chhhHHHHHHHHhhCCCccccccccccc--c-----------
Q psy11767 117 DLDKAGILGDGSYSVCRRCVEKSTGQEYAVKIISRK--IDCSEEINLLRACQGHPNICRRCVEKST--G----------- 181 (966)
Q Consensus 117 df~~~~~LG~GsFGkV~La~~k~tg~~yAiKvl~K~--~~~~~E~~il~~~~~~pfi~~~~~~~~~--~----------- 181 (966)
+|++++.||+|+||+|++|+++.+|+.||||++++. ....+|..+|++++.||+|+........ .
T Consensus 37 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~lv~e~~~ 116 (330)
T 3nsz_A 37 DYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVKKKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVFEHVN 116 (330)
T ss_dssp GEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSCCHHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCCEEEEEECCC
T ss_pred ceEEEEEecccCCeEEEEEEECCCCcEEEEEEecccchHHHHHHHHHHHHcCCCCCEEEeeeeeccCCCCceEEEEeccC
Confidence 789999999999999999999999999999999854 3568899999999889999862211111 0
Q ss_pred ----------------hhHHHHHHHh----------hcccchhhhHhhhccC-CceEEecCcccc---------------
Q psy11767 182 ----------------QEYAVKIISR----------KIDCSEEINLLRACQG-HPNIVNLHCVFQ--------------- 219 (966)
Q Consensus 182 ----------------~~~~~~~v~~----------~~~~~~e~nil~~~~g-h~~iv~l~~~~~--------------- 219 (966)
..++.+++.+ ..|++++ |||.+.+| .++|+||+.+..
T Consensus 117 ~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dikp~-Nil~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~ 195 (330)
T 3nsz_A 117 NTDFKQLYQTLTDYDIRFYMYEILKALDYCHSMGIMHRDVKPH-NVMIDHEHRKLRLIDWGLAEFYHPGQEYNVRVASRY 195 (330)
T ss_dssp CCCHHHHGGGCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGG-GEEEETTTTEEEECCCTTCEECCTTCCCCSCCSCGG
T ss_pred chhHHHHHHhCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHH-HEEEcCCCCEEEEEeCCCceEcCCCCcccccccccc
Confidence 1111122211 1244444 99998776 799999987631
Q ss_pred ---cccccc-ccCCCcceeeechhhHHHHHHHhhCCCCCCCC-cHH-------------HHHHHHHhCCCCCC-------
Q psy11767 220 ---DEVIDW-DDFSRGIECVFFSSSLIIFFIILSFTLSFIHD-YYH-------------IQYRRILKTEPPIP------- 274 (966)
Q Consensus 220 ---~e~i~~-~~y~~~~d~~~~~~~~il~~~m~~g~~pf~~~-~~~-------------~~~~~I~~~~~~~P------- 274 (966)
+|++.. ..|+...| .|+.|+++|+|++|..||... +.. .+++.+......++
T Consensus 196 y~aPE~~~~~~~~~~~~D---iwslG~il~~ll~g~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 272 (330)
T 3nsz_A 196 FKGPELLVDYQMYDYSLD---MWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIELDPRFNDIL 272 (330)
T ss_dssp GCCHHHHTTCCCCCTHHH---HHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHHHHHHHTTCCCCTHHHHHH
T ss_pred ccChhhhcCCCcCCchhh---HHHHHHHHHHHHhCCCCcccCCchHHHHHHHHHhcCCchhhhHHHHhccccccchhhhh
Confidence 233322 33444444 345677788888888888542 221 12233333333332
Q ss_pred -----------------CCCCHHHHHHHHhhcccCCCcccCCCCCCHHHHhcCCceeeeCccc
Q psy11767 275 -----------------EDLSPDVADFISRLLVKDPRRRLGGGELDAEELKRHPFFNVIDWDD 320 (966)
Q Consensus 275 -----------------~~~s~~a~dli~~LL~kdp~~RLG~~~~g~~~Ik~HpfF~~idW~~ 320 (966)
..+++++++||+++|+.||.+|+. +++|.+||||+++.|+.
T Consensus 273 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt-----a~e~l~hp~f~~~~~~~ 330 (330)
T 3nsz_A 273 GRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLT-----AREAMEHPYFYTVVKDQ 330 (330)
T ss_dssp CCCCCCCGGGGCCTTTGGGCCHHHHHHHHTTSCSSGGGSCC-----HHHHHTSGGGTTCC---
T ss_pred hhccccchhhhccccccccCCHHHHHHHHHHhcCCcccCCC-----HHHHhcCccHhhhccCC
Confidence 237999999999999999999984 89999999999999873
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A | Back alignment and structure |
|---|
Probab=99.78 E-value=4.8e-19 Score=200.56 Aligned_cols=195 Identities=27% Similarity=0.343 Sum_probs=138.4
Q ss_pred CcceeeeecccccceEEEEEEcCCCCEEEEEeccccc----hhhHHHHHHHHhhCCCcccccccccccc-----------
Q psy11767 117 DLDKAGILGDGSYSVCRRCVEKSTGQEYAVKIISRKI----DCSEEINLLRACQGHPNICRRCVEKSTG----------- 181 (966)
Q Consensus 117 df~~~~~LG~GsFGkV~La~~k~tg~~yAiKvl~K~~----~~~~E~~il~~~~~~pfi~~~~~~~~~~----------- 181 (966)
+|++++.||+|+||+|++|+++.||+.||||++++.. ...+|..+|+++ +||+|++....+...
T Consensus 21 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l-~hpniv~~~~~~~~~~~~~lv~e~~~ 99 (361)
T 3uc3_A 21 RYDFVKDIGSGNFGVARLMRDKLTKELVAVKYIERGAAIDENVQREIINHRSL-RHPNIVRFKEVILTPTHLAIIMEYAS 99 (361)
T ss_dssp TEEEEEEESSSTTSSEEEEEETTTCCEEEEEEEESSTTSCHHHHHHHHHHHHC-CCTTBCCEEEEEECSSEEEEEEECCC
T ss_pred cEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEecCccccHHHHHHHHHHHhC-CCCCCCcEEEEEeeCCEEEEEEEeCC
Confidence 5699999999999999999999999999999998742 457889999887 599998722111110
Q ss_pred -------------------hhHHHHHHHh----------hcccchhhhHhhhccCC--ceEEecCcccc-----------
Q psy11767 182 -------------------QEYAVKIISR----------KIDCSEEINLLRACQGH--PNIVNLHCVFQ----------- 219 (966)
Q Consensus 182 -------------------~~~~~~~v~~----------~~~~~~e~nil~~~~gh--~~iv~l~~~~~----------- 219 (966)
..++.+++.+ ..|++++ |||.+.++. .+|+||+.+..
T Consensus 100 ~~~L~~~l~~~~~~~~~~~~~i~~ql~~~L~~LH~~~ivH~Dlkp~-Nill~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~ 178 (361)
T 3uc3_A 100 GGELYERICNAGRFSEDEARFFFQQLLSGVSYCHSMQICHRDLKLE-NTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTV 178 (361)
T ss_dssp SCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCSCCCCGG-GEEECSSSSCCEEECCCCCC-------------
T ss_pred CCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHH-HEEEcCCCCceEEEeecCccccccccCCCCCCc
Confidence 1111122211 1244444 999976654 89999986641
Q ss_pred -------ccccccccCCCcceeeechhhHHHHHHHhhCCCCCCCC----cHHHHHHHHHhCCCCCCC--CCCHHHHHHHH
Q psy11767 220 -------DEVIDWDDFSRGIECVFFSSSLIIFFIILSFTLSFIHD----YYHIQYRRILKTEPPIPE--DLSPDVADFIS 286 (966)
Q Consensus 220 -------~e~i~~~~y~~~~d~~~~~~~~il~~~m~~g~~pf~~~----~~~~~~~~I~~~~~~~P~--~~s~~a~dli~ 286 (966)
+|++....|. +...| .|+.|+++|+|++|.+||... ....+.+.|+.....+|. .+++++++||+
T Consensus 179 gt~~y~aPE~~~~~~~~-~~~~D-iwslG~il~ell~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~ 256 (361)
T 3uc3_A 179 GTPAYIAPEVLLRQEYD-GKIAD-VWSCGVTLYVMLVGAYPFEDPEEPRDYRKTIQRILSVKYSIPDDIRISPECCHLIS 256 (361)
T ss_dssp --CTTSCHHHHHCSSCC-HHHHH-HHHHHHHHHHHHHSSCSCC----CCCHHHHHHHHHTTCCCCCTTSCCCHHHHHHHH
T ss_pred CCCCcCChhhhcCCCCC-CCeee-eehhHHHHHHHHhCCCCCCCCccHHHHHHHHHHHhcCCCCCCCcCCCCHHHHHHHH
Confidence 2344333332 11123 446678888999999999763 445677888888888887 57999999999
Q ss_pred hhcccCCCcccCCCCCCHHHHhcCCcee-eeCccc
Q psy11767 287 RLLVKDPRRRLGGGELDAEELKRHPFFN-VIDWDD 320 (966)
Q Consensus 287 ~LL~kdp~~RLG~~~~g~~~Ik~HpfF~-~idW~~ 320 (966)
++|++||.+|+. +.+|.+||||. .++++.
T Consensus 257 ~~L~~dP~~Rps-----~~ell~hp~f~~~~~~~~ 286 (361)
T 3uc3_A 257 RIFVADPATRIS-----IPEIKTHSWFLKNLPADL 286 (361)
T ss_dssp HHSCSCTTTSCC-----HHHHHTSHHHHTTCCCC-
T ss_pred HHccCChhHCcC-----HHHHHhCcchhcCCchhh
Confidence 999999999984 89999999995 444443
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=99.78 E-value=3e-19 Score=198.92 Aligned_cols=189 Identities=25% Similarity=0.367 Sum_probs=143.7
Q ss_pred CcceeeeecccccceEEEEEEcCCCCEEEEEeccccc----hhhHHHHHHHHhhCCCccccccccccc------------
Q psy11767 117 DLDKAGILGDGSYSVCRRCVEKSTGQEYAVKIISRKI----DCSEEINLLRACQGHPNICRRCVEKST------------ 180 (966)
Q Consensus 117 df~~~~~LG~GsFGkV~La~~k~tg~~yAiKvl~K~~----~~~~E~~il~~~~~~pfi~~~~~~~~~------------ 180 (966)
+|.+.+.||+|+||+|++|+++.||+.||+|+++... ...+|..+|+++ +||+|++.+-.+..
T Consensus 6 ~y~~~~~lG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~E~~~l~~l-~hpnIv~~~~~~~~~~~~~lv~e~~~ 84 (321)
T 1tki_A 6 KYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQVLVKKEISILNIA-RHRNILHLHESFESMEELVMIFEFIS 84 (321)
T ss_dssp TEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCTHHHHHHHHHHHHHHHS-CCTTBCCEEEEEEETTEEEEEECCCC
T ss_pred ceEeeeEEecCCCeEEEEEEECCCCcEEEEEEEecCcccHHHHHHHHHHHHhC-CCCCCCeEeEEEecCCEEEEEEEeCC
Confidence 5689999999999999999999999999999998542 357899999887 69999862211111
Q ss_pred -------------------chhHHHHHHHh----------hcccchhhhHhhhc--cCCceEEecCcccc----------
Q psy11767 181 -------------------GQEYAVKIISR----------KIDCSEEINLLRAC--QGHPNIVNLHCVFQ---------- 219 (966)
Q Consensus 181 -------------------~~~~~~~~v~~----------~~~~~~e~nil~~~--~gh~~iv~l~~~~~---------- 219 (966)
...++.+++.+ ..|++++ |||.+. ++.++|.||+.+..
T Consensus 85 g~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~givH~Dlkp~-NIl~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~ 163 (321)
T 1tki_A 85 GLDIFERINTSAFELNEREIVSYVHQVCEALQFLHSHNIGHFDIRPE-NIIYQTRRSSTIKIIEFGQARQLKPGDNFRLL 163 (321)
T ss_dssp CCBHHHHHTSSSCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGG-GEEESSSSCCCEEECCCTTCEECCTTCEEEEE
T ss_pred CCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCCcCCCCHH-HEEEccCCCCCEEEEECCCCeECCCCCccccc
Confidence 01111122211 1245555 999876 68999999987632
Q ss_pred --------ccccccccCCCcceeeechhhHHHHHHHhhCCCCCCCCcHHHHHHHHHhCCCCCCC----CCCHHHHHHHHh
Q psy11767 220 --------DEVIDWDDFSRGIECVFFSSSLIIFFIILSFTLSFIHDYYHIQYRRILKTEPPIPE----DLSPDVADFISR 287 (966)
Q Consensus 220 --------~e~i~~~~y~~~~d~~~~~~~~il~~~m~~g~~pf~~~~~~~~~~~I~~~~~~~P~----~~s~~a~dli~~ 287 (966)
+|++....|+...| .|+.|+++|+|++|.+||...+...++++|+.+.+.+|. .+++++++||++
T Consensus 164 ~gt~~y~aPE~~~~~~~~~~~D---iwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~ 240 (321)
T 1tki_A 164 FTAPEYYAPEVHQHDVVSTATD---MWSLGTLVYVLLSGINPFLAETNQQIIENIMNAEYTFDEEAFKEISIEAMDFVDR 240 (321)
T ss_dssp ESCGGGSCHHHHTTCEECHHHH---HHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCCCCCHHHHTTSCHHHHHHHHT
T ss_pred cCChhhcCcHHhcCCCCCchhh---HHHHHHHHHHHHhCCCCCcCCCHHHHHHHHHcCCCCCChhhhccCCHHHHHHHHH
Confidence 23343333443333 446678889999999999999999999999999998874 789999999999
Q ss_pred hcccCCCcccCCCCCCHHHHhcCCceee
Q psy11767 288 LLVKDPRRRLGGGELDAEELKRHPFFNV 315 (966)
Q Consensus 288 LL~kdp~~RLG~~~~g~~~Ik~HpfF~~ 315 (966)
+|.+||.+|+. +.++.+||||+.
T Consensus 241 ~L~~dp~~Rpt-----~~e~l~hp~~~~ 263 (321)
T 1tki_A 241 LLVKERKSRMT-----ASEALQHPWLKQ 263 (321)
T ss_dssp TSCSSGGGSCC-----HHHHHHSHHHHS
T ss_pred HcCCChhHCcC-----HHHHhcChhhcc
Confidence 99999999984 899999999974
|
| >1zth_A RIO1 serine protein kinase; ribosome biogenesis, rRNA, ADP, manganese, transferase; HET: ADP; 1.89A {Archaeoglobus fulgidus} PDB: 1zp9_A* 1ztf_A* | Back alignment and structure |
|---|
Probab=99.78 E-value=1.4e-19 Score=195.49 Aligned_cols=130 Identities=20% Similarity=0.281 Sum_probs=101.9
Q ss_pred cccccccccccEEEEEEEcCCCcE--EEEEEecccc-----------------------------ChHHHHHHHHHhcCC
Q psy11767 382 KAGILGDGSYSVCRRCVEKSTGQE--YAVKIISRKI-----------------------------DCSEEINLLRACQGH 430 (966)
Q Consensus 382 ~~~~LG~G~fG~Vy~a~~~~tg~~--vAvK~i~~~~-----------------------------~~~~Ei~iL~~l~~H 430 (966)
..+.||+|+||.||+|.+..+|+. ||||++.... ...+|+.+|..+. |
T Consensus 51 i~~~ig~G~~g~Vy~a~~~~~g~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-~ 129 (258)
T 1zth_A 51 MGGVISTGKEANVFYADGVFDGKPVAMAVKIYRIETSEFDKMDEYLYGDERFDMRRISPKEKVFIWTEKEFRNLERAK-E 129 (258)
T ss_dssp EEEEEEECSSEEEEEEEEEETTEEEEEEEEEECCC-------GGGTTTCTTSCC----CHHHHHHHHHHHHHHHHHHH-H
T ss_pred hCCEEeecceEEEEEEEEcCCCcEeeEEEEEEECCccchhhHHHhhcccchhhhhccChHHHHHHHHHHHHHHHHHHH-h
Confidence 357899999999999999888999 9999864321 2456899998885 5
Q ss_pred CC--ceEEEEEEEeCCeEEEEEEccCC-C----CHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHH-hcCceeccCCCC
Q psy11767 431 PN--IVNLHCVFQDEVHTYLVLELLKG-G----ELLDRIRQKGRCGFTENEASRIMRQLVAAVHFMH-SRGVVHRDLKPE 502 (966)
Q Consensus 431 pn--IV~l~~~~~~~~~~~lVmEy~~g-g----~L~~~l~~~~~~~l~e~~~~~i~~Qil~aL~yLH-s~~IiHRDLKP~ 502 (966)
+| ++..++. ...+|||||+.+ | +|.+.... +++..+..++.||+.||.||| +.||+||||||+
T Consensus 130 ~~i~~p~~~~~----~~~~lVmE~~g~~g~~~~~L~~~~~~-----~~~~~~~~i~~qi~~~l~~lH~~~givHrDlkp~ 200 (258)
T 1zth_A 130 AGVSVPQPYTY----MKNVLLMEFIGEDELPAPTLVELGRE-----LKELDVEGIFNDVVENVKRLYQEAELVHADLSEY 200 (258)
T ss_dssp TTCCCCCEEEE----ETTEEEEECCEETTEECCBHHHHGGG-----GGGSCHHHHHHHHHHHHHHHHHTSCEECSSCSTT
T ss_pred CCCCCCeEEEc----CCCEEEEEecCCCCCccccHHHHhhc-----cChHHHHHHHHHHHHHHHHHHHHCCEEeCCCCHH
Confidence 54 3444442 246899999942 4 66655422 245678899999999999999 999999999999
Q ss_pred cEEEecCCCCCEEEEeecccccc
Q psy11767 503 NLLFSDPAGDNIKVVDFGFACLK 525 (966)
Q Consensus 503 NILl~~~~~~~iKL~DFGla~~~ 525 (966)
|||+++ .++|+|||+|...
T Consensus 201 NILl~~----~~~liDFG~a~~~ 219 (258)
T 1zth_A 201 NIMYID----KVYFIDMGQAVTL 219 (258)
T ss_dssp SEEESS----SEEECCCTTCEET
T ss_pred HEEEcC----cEEEEECcccccC
Confidence 999973 8999999999653
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... | Back alignment and structure |
|---|
Probab=99.78 E-value=5.6e-19 Score=200.49 Aligned_cols=206 Identities=18% Similarity=0.275 Sum_probs=147.1
Q ss_pred CcceeeeecccccceEEEEEEcCCCCEEEEEecccc-------chhhHHHHHHHHhhCCCcccccccccccc--------
Q psy11767 117 DLDKAGILGDGSYSVCRRCVEKSTGQEYAVKIISRK-------IDCSEEINLLRACQGHPNICRRCVEKSTG-------- 181 (966)
Q Consensus 117 df~~~~~LG~GsFGkV~La~~k~tg~~yAiKvl~K~-------~~~~~E~~il~~~~~~pfi~~~~~~~~~~-------- 181 (966)
+|.+++.||+|+||+|++|+++.+|+.||||++++. ....+|..+|+++ +||+|++..-.+...
T Consensus 26 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~hpniv~~~~~~~~~~~~~~~~~ 104 (371)
T 2xrw_A 26 RYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCV-NHKNIIGLLNVFTPQKSLEEFQD 104 (371)
T ss_dssp TEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECTTSSHHHHHHHHHHHHHHHHC-CCTTBCCEEEEECSCCSTTTCCE
T ss_pred heeEeeeeEecCCEEEEEEEECCCCceEEEEEeccccCChHHHHHHHHHHHHHHhc-CCCCccceEEeeccccccccccc
Confidence 679999999999999999999999999999999863 1356789999887 699998732211110
Q ss_pred -------------------------hhHHHHHHHh----------hcccchhhhHhhhccCCceEEecCccc--------
Q psy11767 182 -------------------------QEYAVKIISR----------KIDCSEEINLLRACQGHPNIVNLHCVF-------- 218 (966)
Q Consensus 182 -------------------------~~~~~~~v~~----------~~~~~~e~nil~~~~gh~~iv~l~~~~-------- 218 (966)
..++.+++.+ ..|++++ |||.+.+|.++|+||+.+.
T Consensus 105 ~~lv~e~~~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~-NIl~~~~~~~kl~Dfg~a~~~~~~~~~ 183 (371)
T 2xrw_A 105 VYIVMELMDANLCQVIQMELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPS-NIVVKSDCTLKILDFGLARTAGTSFMM 183 (371)
T ss_dssp EEEEEECCSEEHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGG-GEEECTTSCEEECCCCC----------
T ss_pred eEEEEEcCCCCHHHHHhhccCHHHHHHHHHHHHHHHHHHHHCCeecccCCHH-HEEEcCCCCEEEEEeeccccccccccc
Confidence 0111122211 1244445 9999999999999998653
Q ss_pred ----------cccccccccCCCcceeeechhhHHHHHHHhhCCCCCCCCcHHHHHHHHHhC-------------------
Q psy11767 219 ----------QDEVIDWDDFSRGIECVFFSSSLIIFFIILSFTLSFIHDYYHIQYRRILKT------------------- 269 (966)
Q Consensus 219 ----------~~e~i~~~~y~~~~d~~~~~~~~il~~~m~~g~~pf~~~~~~~~~~~I~~~------------------- 269 (966)
.+|++....|+...| .|+.|+++|+|++|.+||...+....+.+|+..
T Consensus 184 ~~~~gt~~y~aPE~~~~~~~~~~~D---iwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~ 260 (371)
T 2xrw_A 184 TPYVVTRYYRAPEVILGMGYKENVD---IWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMKKLQPTVRTY 260 (371)
T ss_dssp ------CTTCCHHHHTTCCCCTTHH---HHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHC-CCCCCHHHHTTSCHHHHHH
T ss_pred CCceecCCccCHHHhcCCCCCchHh---HHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHHhhhHHHHH
Confidence 235555556665555 446778888999999999998887778877653
Q ss_pred ---CCCCC--------------CC------CCHHHHHHHHhhcccCCCcccCCCCCCHHHHhcCCceeeeCccccccCCC
Q psy11767 270 ---EPPIP--------------ED------LSPDVADFISRLLVKDPRRRLGGGELDAEELKRHPFFNVIDWDDLATKRI 326 (966)
Q Consensus 270 ---~~~~P--------------~~------~s~~a~dli~~LL~kdp~~RLG~~~~g~~~Ik~HpfF~~idW~~l~~k~~ 326 (966)
.+.|+ .. .+++++|||+++|+.||.+|+. ++++.+||||+ +|........
T Consensus 261 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t-----~~e~l~hp~~~--~~~~~~~~~~ 333 (371)
T 2xrw_A 261 VENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRIS-----VDEALQHPYIN--VWYDPSEAEA 333 (371)
T ss_dssp HHSSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSGGGSCC-----HHHHHHSHHHH--TTCCHHHHTC
T ss_pred HhhCccccccchhhhcccccCcccccccccccHHHHHHHHHHCcCChhhCCC-----HHHHhCCcchh--hhcCccccCC
Confidence 12221 11 1578999999999999999984 89999999997 4555555566
Q ss_pred CCCCCccc
Q psy11767 327 PAPFVPKI 334 (966)
Q Consensus 327 ~pP~~P~i 334 (966)
+||..|..
T Consensus 334 ~~~~~~~~ 341 (371)
T 2xrw_A 334 PPPKIPDK 341 (371)
T ss_dssp CCCCCCTT
T ss_pred CCCCCCCh
Confidence 66666653
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A | Back alignment and structure |
|---|
Probab=99.78 E-value=5.8e-19 Score=195.85 Aligned_cols=198 Identities=25% Similarity=0.415 Sum_probs=149.7
Q ss_pred CcceeeeecccccceEEEEEEcCCCCEEEEEeccccc-----------hhhHHHHHHHHhhCCCcccccccccccc----
Q psy11767 117 DLDKAGILGDGSYSVCRRCVEKSTGQEYAVKIISRKI-----------DCSEEINLLRACQGHPNICRRCVEKSTG---- 181 (966)
Q Consensus 117 df~~~~~LG~GsFGkV~La~~k~tg~~yAiKvl~K~~-----------~~~~E~~il~~~~~~pfi~~~~~~~~~~---- 181 (966)
+|++.+.||+|+||.|++|+++.+|+.||+|++++.. ...+|..+|+++ +||+|+...-.+...
T Consensus 13 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~ 91 (321)
T 2a2a_A 13 FYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQV-LHHNVITLHDVYENRTDVV 91 (321)
T ss_dssp HEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSSSCSSSBCHHHHHHHHHHHHHC-CCTTBCCEEEEEECSSEEE
T ss_pred cEEEeeEeeecCCEEEEEEEECCCCeEEEEEEEecccccccccchhHHHHHHHHHHHHhC-CCCCcceEEEEEecCCEEE
Confidence 5689999999999999999999999999999998742 256899999998 599998622111110
Q ss_pred --------------------------hhHHHHHHHh----------hcccchhhhHhhhccC----CceEEecCcccc--
Q psy11767 182 --------------------------QEYAVKIISR----------KIDCSEEINLLRACQG----HPNIVNLHCVFQ-- 219 (966)
Q Consensus 182 --------------------------~~~~~~~v~~----------~~~~~~e~nil~~~~g----h~~iv~l~~~~~-- 219 (966)
...+.+++.+ ..|++++ |||.+.+| +++|+||+.+..
T Consensus 92 lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~lH~~~ivH~dikp~-NIl~~~~~~~~~~~kl~Dfg~~~~~~ 170 (321)
T 2a2a_A 92 LILELVSGGELFDFLAQKESLSEEEATSFIKQILDGVNYLHTKKIAHFDLKPE-NIMLLDKNIPIPHIKLIDFGLAHEIE 170 (321)
T ss_dssp EEECCCCSCBHHHHHHTCSCEEHHHHHHHHHHHHHHHHHHHHTTEECCCCSGG-GEEESCTTSSSCCEEECCCTTCEECC
T ss_pred EEEEcCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCChH-HEEEecCCCCcCCEEEccCccceecC
Confidence 0111122211 0134444 99988877 789999986531
Q ss_pred ----------------ccccccccCCCcceeeechhhHHHHHHHhhCCCCCCCCcHHHHHHHHHhCCCCCC----CCCCH
Q psy11767 220 ----------------DEVIDWDDFSRGIECVFFSSSLIIFFIILSFTLSFIHDYYHIQYRRILKTEPPIP----EDLSP 279 (966)
Q Consensus 220 ----------------~e~i~~~~y~~~~d~~~~~~~~il~~~m~~g~~pf~~~~~~~~~~~I~~~~~~~P----~~~s~ 279 (966)
+|++....|+...| .|+.|+++|+|++|.+||...+...+...|......+| ..+++
T Consensus 171 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~D---i~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 247 (321)
T 2a2a_A 171 DGVEFKNIFGTPEFVAPEIVNYEPLGLEAD---MWSIGVITYILLSGASPFLGDTKQETLANITSVSYDFDEEFFSHTSE 247 (321)
T ss_dssp TTCCCCCCCSCGGGCCHHHHTTCCCCTHHH---HHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHTTCCCCCHHHHTTCCH
T ss_pred ccccccccCCCCCccCcccccCCCCCCccc---cHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhcccccChhhhcccCH
Confidence 34444445554444 34567788899999999999988888999999888776 57899
Q ss_pred HHHHHHHhhcccCCCcccCCCCCCHHHHhcCCceeeeCccccccC
Q psy11767 280 DVADFISRLLVKDPRRRLGGGELDAEELKRHPFFNVIDWDDLATK 324 (966)
Q Consensus 280 ~a~dli~~LL~kdp~~RLG~~~~g~~~Ik~HpfF~~idW~~l~~k 324 (966)
++++||+++|..||.+|.. +++|.+||||.+++|.....+
T Consensus 248 ~~~~li~~~l~~dp~~Rps-----~~e~l~hp~~~~~~~~~~~~~ 287 (321)
T 2a2a_A 248 LAKDFIRKLLVKETRKRLT-----IQEALRHPWITPVDNQQAMVR 287 (321)
T ss_dssp HHHHHHHTTSCSSTTTSCC-----HHHHHHSTTTSCSSHHHHHHH
T ss_pred HHHHHHHHHcCCChhhCcC-----HHHHhcCccccCCCccccccc
Confidence 9999999999999999984 899999999999999876543
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} | Back alignment and structure |
|---|
Probab=99.78 E-value=3e-19 Score=204.70 Aligned_cols=197 Identities=22% Similarity=0.277 Sum_probs=141.7
Q ss_pred ccCCcceeeeecccccceEEEEEEcCCCCEEEEEeccc-cchhhHHHHHHHHhhCCCccccccccccc------------
Q psy11767 114 YDMDLDKAGILGDGSYSVCRRCVEKSTGQEYAVKIISR-KIDCSEEINLLRACQGHPNICRRCVEKST------------ 180 (966)
Q Consensus 114 ~~~df~~~~~LG~GsFGkV~La~~k~tg~~yAiKvl~K-~~~~~~E~~il~~~~~~pfi~~~~~~~~~------------ 180 (966)
.+.+|.+.++||+|+||+|++|+++.+++ +|+|.+.+ .....+|..+|+++ +||+|++....+..
T Consensus 38 ~~~~Y~~~~~lG~G~~g~V~~a~~~~~~~-~aikk~~~~~~~~~~E~~il~~l-~h~niv~l~~~~~~~~~~~~~~~~~l 115 (394)
T 4e7w_A 38 REIAYTNCKVIGNGSFGVVFQAKLVESDE-VAIKKVLQDKRFKNRELQIMRIV-KHPNVVDLKAFFYSNGDKKDEVFLNL 115 (394)
T ss_dssp EEEEEEEEEEEEEETTEEEEEEEETTTEE-EEEEEEECCTTSCCHHHHHHHTC-CCTTBCCEEEEEEEESSSSSCEEEEE
T ss_pred ccceEEEeEEEeeCCCeEEEEEEECCCCe-EEEEEEecCcchHHHHHHHHHhC-CCCCcceEEEEEEecCCCCCceEEEE
Confidence 34467999999999999999999998888 66665554 44556899999988 69999873211100
Q ss_pred ---------------------------chhHHHHHHHh----------hcccchhhhHhhh-ccCCceEEecCcccc---
Q psy11767 181 ---------------------------GQEYAVKIISR----------KIDCSEEINLLRA-CQGHPNIVNLHCVFQ--- 219 (966)
Q Consensus 181 ---------------------------~~~~~~~~v~~----------~~~~~~e~nil~~-~~gh~~iv~l~~~~~--- 219 (966)
...++.+++.+ ..|++++ |||.+ .+|+++|+||+.+..
T Consensus 116 v~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~-Nill~~~~~~~kL~DFG~a~~~~~ 194 (394)
T 4e7w_A 116 VLEYVPETVYRASRHYAKLKQTMPMLLIKLYMYQLLRSLAYIHSIGICHRDIKPQ-NLLLDPPSGVLKLIDFGSAKILIA 194 (394)
T ss_dssp EEECCSEEHHHHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGG-GEEEETTTTEEEECCCTTCEECCT
T ss_pred EeeccCccHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCccCCCCCHH-HEEEcCCCCcEEEeeCCCcccccC
Confidence 00111122221 1244455 99998 689999999987631
Q ss_pred ---------------cccccc-ccCCCcceeeechhhHHHHHHHhhCCCCCCCCcHHHHHHHHHhC--C-----------
Q psy11767 220 ---------------DEVIDW-DDFSRGIECVFFSSSLIIFFIILSFTLSFIHDYYHIQYRRILKT--E----------- 270 (966)
Q Consensus 220 ---------------~e~i~~-~~y~~~~d~~~~~~~~il~~~m~~g~~pf~~~~~~~~~~~I~~~--~----------- 270 (966)
+|++.. ..|+...| +|+.|+++|+|++|.+||...+.......|+.. .
T Consensus 195 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~~D---iwSlG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~p~~~~~~~~~~ 271 (394)
T 4e7w_A 195 GEPNVSYICSRYYRAPELIFGATNYTTNID---IWSTGCVMAELMQGQPLFPGESGIDQLVEIIKVLGTPSREQIKTMNP 271 (394)
T ss_dssp TCCCCSSCSCGGGCCHHHHTTCSSCCTHHH---HHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHHHCG
T ss_pred CCCCcccccCcCccCHHHHcCCCCCCcHHH---HHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhhCh
Confidence 344432 24655555 456778889999999999988877766666541 1
Q ss_pred ----C------------CCCCCCCHHHHHHHHhhcccCCCcccCCCCCCHHHHhcCCceeeeCcccc
Q psy11767 271 ----P------------PIPEDLSPDVADFISRLLVKDPRRRLGGGELDAEELKRHPFFNVIDWDDL 321 (966)
Q Consensus 271 ----~------------~~P~~~s~~a~dli~~LL~kdp~~RLG~~~~g~~~Ik~HpfF~~idW~~l 321 (966)
. .|+..++++++|||+++|+.||.+|+. +.++..||||+.+.|...
T Consensus 272 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t-----~~e~l~hp~f~~~~~~~~ 333 (394)
T 4e7w_A 272 NYMEHKFPQIRPHPFSKVFRPRTPPDAIDLISRLLEYTPSARLT-----AIEALCHPFFDELRTGEA 333 (394)
T ss_dssp GGSSSCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSGGGSCC-----HHHHHTSGGGSTTTSSCC
T ss_pred hhhhhccccccCCcHHHhccccCCHHHHHHHHHHhCCChhhCCC-----HHHHhcChhhhhhccccc
Confidence 1 145568999999999999999999984 899999999999988664
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.78 E-value=7.5e-19 Score=193.48 Aligned_cols=191 Identities=18% Similarity=0.237 Sum_probs=138.2
Q ss_pred CcceeeeecccccceEEEEEEcCCCCEEEEEeccccc----------hhhHHHHHHHHhh--CCCccccccccccc----
Q psy11767 117 DLDKAGILGDGSYSVCRRCVEKSTGQEYAVKIISRKI----------DCSEEINLLRACQ--GHPNICRRCVEKST---- 180 (966)
Q Consensus 117 df~~~~~LG~GsFGkV~La~~k~tg~~yAiKvl~K~~----------~~~~E~~il~~~~--~~pfi~~~~~~~~~---- 180 (966)
+|++++.||+|+||+||+|+++.+|+.||||++++.. ...+|..+|+.++ +||+|++..-....
T Consensus 10 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~niv~~~~~~~~~~~~ 89 (308)
T 3g33_A 10 RYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEAFEHPNVVRLMDVCATSRTD 89 (308)
T ss_dssp CCEEEEEECCSSSCCEEEEECTTTCCEEEEEEEEEECCCTTSSCCCHHHHHHHHHHHHHHHHCCTTBCCEEEEEEECCSS
T ss_pred ceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEecccccccccccchhHHHHHHHHHHHhhcCCCCeEEeeeeeeccCCC
Confidence 5699999999999999999999999999999998532 4567888888776 59999862211100
Q ss_pred --------------------------------chhHHHHHHHh----------hcccchhhhHhhhccCCceEEecCccc
Q psy11767 181 --------------------------------GQEYAVKIISR----------KIDCSEEINLLRACQGHPNIVNLHCVF 218 (966)
Q Consensus 181 --------------------------------~~~~~~~~v~~----------~~~~~~e~nil~~~~gh~~iv~l~~~~ 218 (966)
...++.+++.+ ..|++++ |||.+.+|.++|+||+.+.
T Consensus 90 ~~~~~~lv~e~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~-Nil~~~~~~~kl~Dfg~a~ 168 (308)
T 3g33_A 90 REIKVTLVFEHVDQDLRTYLDKAPPPGLPAETIKDLMRQFLRGLDFLHANCIVHRDLKPE-NILVTSGGTVKLADFGLAR 168 (308)
T ss_dssp SEEEEEEEEECCCCBHHHHHHTCCTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCTT-TEEECTTSCEEECSCSCTT
T ss_pred CceeEEEEehhhhcCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHH-HEEEcCCCCEEEeeCcccc
Confidence 01111122211 1244444 9999999999999998763
Q ss_pred ------------------cccccccccCCCcceeeechhhHHHHHHHhhCCCCCCCCcHHHHHHHHHhCC-----CCC--
Q psy11767 219 ------------------QDEVIDWDDFSRGIECVFFSSSLIIFFIILSFTLSFIHDYYHIQYRRILKTE-----PPI-- 273 (966)
Q Consensus 219 ------------------~~e~i~~~~y~~~~d~~~~~~~~il~~~m~~g~~pf~~~~~~~~~~~I~~~~-----~~~-- 273 (966)
.+|++....|+...| .|+.|+++|+|++|.+||...+......+|+..- ..+
T Consensus 169 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~D---iwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~ 245 (308)
T 3g33_A 169 IYSYQMALTPVVVTLWYRAPEVLLQSTYATPVD---MWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPEDDWPR 245 (308)
T ss_dssp TSTTCCCSGGGGCCCSSCCHHHHHTSCCCSTHH---HHHHHHHHHHTTTSSCSCCCSSHHHHHHHHHHHHCCCCTTTSCS
T ss_pred ccCCCcccCCccccccccCchHHcCCCCCchHH---HHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhccc
Confidence 134555555655555 4466788899999999999988888888876421 111
Q ss_pred --------------------CCCCCHHHHHHHHhhcccCCCcccCCCCCCHHHHhcCCceeee
Q psy11767 274 --------------------PEDLSPDVADFISRLLVKDPRRRLGGGELDAEELKRHPFFNVI 316 (966)
Q Consensus 274 --------------------P~~~s~~a~dli~~LL~kdp~~RLG~~~~g~~~Ik~HpfF~~i 316 (966)
+..+++++++||.++|+.||.+|+. +.++.+||||+..
T Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t-----~~e~l~h~~~~~~ 303 (308)
T 3g33_A 246 DVSLPRGAFPPRGPRPVQSVVPEMEESGAQLLLEMLTFNPHKRIS-----AFRALQHSYLHKD 303 (308)
T ss_dssp SCSSCGGGSCCCCCCCHHHHSCSCCHHHHHHHHHHTCSSTTTSCC-----HHHHHTSTTC---
T ss_pred hhhccccccCCCCCCcHHHhCccccHHHHHHHHHHhcCCCccCCC-----HHHHhcCccccCC
Confidence 1357899999999999999999984 8999999999854
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 4dea_A* 4deb_A* ... | Back alignment and structure |
|---|
Probab=99.78 E-value=6.1e-19 Score=191.20 Aligned_cols=191 Identities=23% Similarity=0.336 Sum_probs=146.2
Q ss_pred CcceeeeecccccceEEEEEEcCCCCEEEEEeccccc--------hhhHHHHHHHHhhCCCcccccccccccc-------
Q psy11767 117 DLDKAGILGDGSYSVCRRCVEKSTGQEYAVKIISRKI--------DCSEEINLLRACQGHPNICRRCVEKSTG------- 181 (966)
Q Consensus 117 df~~~~~LG~GsFGkV~La~~k~tg~~yAiKvl~K~~--------~~~~E~~il~~~~~~pfi~~~~~~~~~~------- 181 (966)
+|++.+.||+|+||.|++|+++.+++.||+|++.+.. ...+|..+|++++ ||+|+...-.+...
T Consensus 10 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~~lv~ 88 (279)
T 3fdn_A 10 DFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLR-HPNILRLYGYFHDATRVYLIL 88 (279)
T ss_dssp GEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHTTCC-CTTBCCEEEEEECSSEEEEEE
T ss_pred cEEEeeEEecCCCeEEEEEEEccCCcEEEEEEEeccccchhhHHHHHHHHHHHHHcCC-CCCCcchhheEecCCEEEEEE
Confidence 7899999999999999999999999999999997642 3567888888874 99998622111110
Q ss_pred -----------------------hhHHHHHHHh----------hcccchhhhHhhhccCCceEEecCcccc---------
Q psy11767 182 -----------------------QEYAVKIISR----------KIDCSEEINLLRACQGHPNIVNLHCVFQ--------- 219 (966)
Q Consensus 182 -----------------------~~~~~~~v~~----------~~~~~~e~nil~~~~gh~~iv~l~~~~~--------- 219 (966)
...+.+++.+ ..|++++ |||.+.+|.++|+||+.+..
T Consensus 89 e~~~~~~l~~~l~~~~~~~~~~~~~~~~qi~~~l~~LH~~~i~H~dlkp~-Nili~~~~~~~l~Dfg~~~~~~~~~~~~~ 167 (279)
T 3fdn_A 89 EYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKRVIHRDIKPE-NLLLGSAGELKIADFGWSVHAPSSRRTDL 167 (279)
T ss_dssp CCCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTTTCEECCCCGG-GEEECTTSCEEECSCCEESCC--------
T ss_pred ecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCEecccCChH-hEEEcCCCCEEEEeccccccCCccccccc
Confidence 0111122111 0133444 99999999999999986532
Q ss_pred --------ccccccccCCCcceeeechhhHHHHHHHhhCCCCCCCCcHHHHHHHHHhCCCCCCCCCCHHHHHHHHhhccc
Q psy11767 220 --------DEVIDWDDFSRGIECVFFSSSLIIFFIILSFTLSFIHDYYHIQYRRILKTEPPIPEDLSPDVADFISRLLVK 291 (966)
Q Consensus 220 --------~e~i~~~~y~~~~d~~~~~~~~il~~~m~~g~~pf~~~~~~~~~~~I~~~~~~~P~~~s~~a~dli~~LL~k 291 (966)
+|++....++...| .|+.|+++|+|++|.+||...+...+++.|....+.+|..+++++++||+++|..
T Consensus 168 ~~~~~y~aPE~~~~~~~~~~~D---i~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~ 244 (279)
T 3fdn_A 168 CGTLDYLPPEMIEGRMHDEKVD---LWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVTEGARDLISRLLKH 244 (279)
T ss_dssp CCCCTTCCHHHHTTCCCCTTHH---HHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCCCCCTTSCHHHHHHHHHHCCS
T ss_pred CCCCCccCHhHhccCCCCccch---hHhHHHHHHHHHHCCCCCCCCcHHHHHHHHHhCCCCCCCcCCHHHHHHHHHHhcc
Confidence 24444444444444 3466788888999999999999999999999999999999999999999999999
Q ss_pred CCCcccCCCCCCHHHHhcCCceeeeC
Q psy11767 292 DPRRRLGGGELDAEELKRHPFFNVID 317 (966)
Q Consensus 292 dp~~RLG~~~~g~~~Ik~HpfF~~id 317 (966)
||.+|. .+++|.+||||+...
T Consensus 245 ~p~~Rp-----s~~e~l~h~~~~~~~ 265 (279)
T 3fdn_A 245 NPSQRP-----MLREVLEHPWITANS 265 (279)
T ss_dssp SGGGSC-----CHHHHHHCHHHHHHC
T ss_pred ChhhCC-----CHHHHhhCccccCCc
Confidence 999997 489999999998654
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* | Back alignment and structure |
|---|
Probab=99.77 E-value=9.5e-19 Score=191.18 Aligned_cols=197 Identities=29% Similarity=0.459 Sum_probs=143.7
Q ss_pred CcceeeeecccccceEEEEEEcCCCCEEEEEecccc--------------chhhHHHHHHHHhhCCCcccccccccccc-
Q psy11767 117 DLDKAGILGDGSYSVCRRCVEKSTGQEYAVKIISRK--------------IDCSEEINLLRACQGHPNICRRCVEKSTG- 181 (966)
Q Consensus 117 df~~~~~LG~GsFGkV~La~~k~tg~~yAiKvl~K~--------------~~~~~E~~il~~~~~~pfi~~~~~~~~~~- 181 (966)
+|++.+.||+|+||.|++|+++.+|+.||||++++. ....+|..+|+++.+||+|++..-.+...
T Consensus 18 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~ 97 (298)
T 1phk_A 18 NYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYETNT 97 (298)
T ss_dssp TEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEECSS
T ss_pred ccceeeeecCCCceEEEEEEEcCcCceEEEEEEecccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeeeeeeeccCC
Confidence 569999999999999999999999999999999743 13467899999998899998622111110
Q ss_pred -----------------------------hhHHHHHHHh----------hcccchhhhHhhhccCCceEEecCcccc---
Q psy11767 182 -----------------------------QEYAVKIISR----------KIDCSEEINLLRACQGHPNIVNLHCVFQ--- 219 (966)
Q Consensus 182 -----------------------------~~~~~~~v~~----------~~~~~~e~nil~~~~gh~~iv~l~~~~~--- 219 (966)
...+.+++.+ ..|++++ |||.+.+|.++|+||+.+..
T Consensus 98 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~-Nil~~~~~~~kl~dfg~~~~~~~ 176 (298)
T 1phk_A 98 FFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRALLEVICALHKLNIVHRDLKPE-NILLDDDMNIKLTDFGFSCQLDP 176 (298)
T ss_dssp EEEEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGG-GEEECTTCCEEECCCTTCEECCT
T ss_pred eEEEEEeccCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcc-eEEEcCCCcEEEecccchhhcCC
Confidence 0011112111 0133334 99999999999999986632
Q ss_pred ---------------ccccc------cccCCCcceeeechhhHHHHHHHhhCCCCCCCCcHHHHHHHHHhCCCCCCC---
Q psy11767 220 ---------------DEVID------WDDFSRGIECVFFSSSLIIFFIILSFTLSFIHDYYHIQYRRILKTEPPIPE--- 275 (966)
Q Consensus 220 ---------------~e~i~------~~~y~~~~d~~~~~~~~il~~~m~~g~~pf~~~~~~~~~~~I~~~~~~~P~--- 275 (966)
+|++. ...|+...| .|+.|+++|+|++|.+||...+...+.+.|..+.+.+|.
T Consensus 177 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~D---i~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 253 (298)
T 1phk_A 177 GEKLREVCGTPSYLAPEIIECSMNDNHPGYGKEVD---MWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMSGNYQFGSPEW 253 (298)
T ss_dssp TCCBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHH---HHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCTTTG
T ss_pred CcccccccCCccccCHHHhccccccccccCCcccc---cHhHHHHHHHHHHCCCCCcCccHHHHHHHHhcCCcccCcccc
Confidence 22222 122333333 345678888899999999998888889999998877763
Q ss_pred -CCCHHHHHHHHhhcccCCCcccCCCCCCHHHHhcCCceeeeCccccc
Q psy11767 276 -DLSPDVADFISRLLVKDPRRRLGGGELDAEELKRHPFFNVIDWDDLA 322 (966)
Q Consensus 276 -~~s~~a~dli~~LL~kdp~~RLG~~~~g~~~Ik~HpfF~~idW~~l~ 322 (966)
.+++++++||.++|..||.+|. .+++|.+||||+..+|+.+.
T Consensus 254 ~~~~~~l~~li~~~l~~dp~~Rp-----s~~~ll~h~~~~~~~~~~~~ 296 (298)
T 1phk_A 254 DDYSDTVKDLVSRFLVVQPQKRY-----TAEEALAHPFFQQYVVEEVR 296 (298)
T ss_dssp GGSCHHHHHHHHHHCCSSGGGSC-----CHHHHTTSGGGCTTC-----
T ss_pred cccCHHHHHHHHHHccCCcccCC-----CHHHHHhChHhhhccchhhc
Confidence 5799999999999999999998 48999999999999998774
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* | Back alignment and structure |
|---|
Probab=99.77 E-value=4.9e-19 Score=208.09 Aligned_cols=198 Identities=24% Similarity=0.353 Sum_probs=147.7
Q ss_pred CccchhccCCcceeeeecccccceEEEEEEcCCCCEEEEEeccccc--------hhhHHHHHHHHhhCCCcccccccccc
Q psy11767 108 SLFFEQYDMDLDKAGILGDGSYSVCRRCVEKSTGQEYAVKIISRKI--------DCSEEINLLRACQGHPNICRRCVEKS 179 (966)
Q Consensus 108 ~~~~~~~~~df~~~~~LG~GsFGkV~La~~k~tg~~yAiKvl~K~~--------~~~~E~~il~~~~~~pfi~~~~~~~~ 179 (966)
..|.+.| .+.++||+|+||+|++|+++.+|+.||||++++.. ...+|..+|+++ +||+|++.+-.+.
T Consensus 22 ~~~~~~y----~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l-~hpniv~~~~~~~ 96 (484)
T 3nyv_A 22 AIFSDRY----KGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQL-DHPNIMKLYEFFE 96 (484)
T ss_dssp CCHHHHE----EEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCBSSCHHHHHHHHHHHTTC-CCTTBCCEEEEEE
T ss_pred CcccCce----EEeeEEecCCCEEEEEEEECCCCCEEEEEEEEhhhcccchHHHHHHHHHHHHHhC-CCCCCCcEEEEEE
Confidence 3455555 89999999999999999999999999999997642 357899999988 6999987221111
Q ss_pred cc------------------------------hhHHHHHHHh----------hcccchhhhHhh---hccCCceEEecCc
Q psy11767 180 TG------------------------------QEYAVKIISR----------KIDCSEEINLLR---ACQGHPNIVNLHC 216 (966)
Q Consensus 180 ~~------------------------------~~~~~~~v~~----------~~~~~~e~nil~---~~~gh~~iv~l~~ 216 (966)
.. ...+.+++.+ ..|++++ |||. +.+|+++|+||+.
T Consensus 97 ~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~-Nil~~~~~~~~~~kl~Dfg~ 175 (484)
T 3nyv_A 97 DKGYFYLVGEVYTGGELFDEIISRKRFSEVDAARIIRQVLSGITYMHKNKIVHRDLKPE-NLLLESKSKDANIRIIDFGL 175 (484)
T ss_dssp CSSEEEEEECCCCSCBHHHHHHTCSCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGG-GEEESSSSTTCCEEECCTTH
T ss_pred eCCEEEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHH-HEEEecCCCCCcEEEEeeee
Confidence 10 1111122211 1244455 9998 4568999999985
Q ss_pred cc------------------cccccccccCCCcceeeechhhHHHHHHHhhCCCCCCCCcHHHHHHHHHhCCCCCC----
Q psy11767 217 VF------------------QDEVIDWDDFSRGIECVFFSSSLIIFFIILSFTLSFIHDYYHIQYRRILKTEPPIP---- 274 (966)
Q Consensus 217 ~~------------------~~e~i~~~~y~~~~d~~~~~~~~il~~~m~~g~~pf~~~~~~~~~~~I~~~~~~~P---- 274 (966)
+. .+|++.. .|+...| .|+.|+++|+|++|.+||...+...++++|..+.+.++
T Consensus 176 a~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~D---iwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~ 251 (484)
T 3nyv_A 176 STHFEASKKMKDKIGTAYYIAPEVLHG-TYDEKCD---VWSTGVILYILLSGCPPFNGANEYDILKKVEKGKYTFELPQW 251 (484)
T ss_dssp HHHBCCCCSHHHHTTGGGTCCHHHHHT-CCCTHHH---HHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCSGGG
T ss_pred eEEcccccccccCCCCccccCceeecC-CCCCcce---eHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHcCCCCCCCccc
Confidence 52 2344432 4555444 44677888999999999999999999999999987775
Q ss_pred CCCCHHHHHHHHhhcccCCCcccCCCCCCHHHHhcCCceeeeCccc
Q psy11767 275 EDLSPDVADFISRLLVKDPRRRLGGGELDAEELKRHPFFNVIDWDD 320 (966)
Q Consensus 275 ~~~s~~a~dli~~LL~kdp~~RLG~~~~g~~~Ik~HpfF~~idW~~ 320 (966)
..+|+++++||+++|++||.+|+. +.++.+||||+...|+.
T Consensus 252 ~~~s~~~~~li~~~L~~dp~~R~s-----~~e~l~h~~~~~~~~~~ 292 (484)
T 3nyv_A 252 KKVSESAKDLIRKMLTYVPSMRIS-----ARDALDHEWIQTYTKEQ 292 (484)
T ss_dssp GGSCHHHHHHHHHHTCSSGGGSCC-----HHHHHTSHHHHHHTC--
T ss_pred ccCCHHHHHHHHHHCCCChhHCcC-----HHHHhhChhhccccccc
Confidence 468999999999999999999984 89999999999877643
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} SCOP: d.144.1.7 PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* | Back alignment and structure |
|---|
Probab=99.77 E-value=9.1e-19 Score=192.51 Aligned_cols=190 Identities=21% Similarity=0.276 Sum_probs=140.7
Q ss_pred CcceeeeecccccceEEEEEEcCCCCEEEEEeccccc-----hhhHHHHHHHHhhCCCcccccccccccc----------
Q psy11767 117 DLDKAGILGDGSYSVCRRCVEKSTGQEYAVKIISRKI-----DCSEEINLLRACQGHPNICRRCVEKSTG---------- 181 (966)
Q Consensus 117 df~~~~~LG~GsFGkV~La~~k~tg~~yAiKvl~K~~-----~~~~E~~il~~~~~~pfi~~~~~~~~~~---------- 181 (966)
+|.+++.||+|+||+||+|+++.+|+.||||++.... ...+|..+|+++ +||+|++.+-.+...
T Consensus 21 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l-~hp~iv~~~~~~~~~~~~~lv~e~~ 99 (297)
T 3fxz_A 21 KYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMREN-KNPNIVNYLDSYLVGDELWVVMEYL 99 (297)
T ss_dssp TBCCCEEEEEETTEEEEEEEBTTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHHC-CCTTBCCEEEEEEETTEEEEEEECC
T ss_pred ceeeeeeeccCCCeEEEEEEECCCCcEEEEEEeecccccHHHHHHHHHHHHhcC-CCCCCCeEeEEEEECCEEEEEEECC
Confidence 5699999999999999999999999999999997542 357788999887 699998722111110
Q ss_pred -------------------hhHHHHHHHh----------hcccchhhhHhhhccCCceEEecCccc--------------
Q psy11767 182 -------------------QEYAVKIISR----------KIDCSEEINLLRACQGHPNIVNLHCVF-------------- 218 (966)
Q Consensus 182 -------------------~~~~~~~v~~----------~~~~~~e~nil~~~~gh~~iv~l~~~~-------------- 218 (966)
...+.+++.+ ..|++++ |||.+.+|+++|+||+.+.
T Consensus 100 ~~~~L~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~-Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~g 178 (297)
T 3fxz_A 100 AGGSLTDVVTETCMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSD-NILLGMDGSVKLTDFGFCAQITPEQSKRSTMVG 178 (297)
T ss_dssp TTCBHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGG-GEEECTTCCEEECCCTTCEECCSTTCCBCCCCS
T ss_pred CCCCHHHHHhhcCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCHH-HEEECCCCCEEEeeCCCceecCCcccccCCccC
Confidence 1111122211 1244444 9999999999999998653
Q ss_pred -----cccccccccCCCcceeeechhhHHHHHHHhhCCCCCCCCcHHHHHHHHHh-C--CCCCCCCCCHHHHHHHHhhcc
Q psy11767 219 -----QDEVIDWDDFSRGIECVFFSSSLIIFFIILSFTLSFIHDYYHIQYRRILK-T--EPPIPEDLSPDVADFISRLLV 290 (966)
Q Consensus 219 -----~~e~i~~~~y~~~~d~~~~~~~~il~~~m~~g~~pf~~~~~~~~~~~I~~-~--~~~~P~~~s~~a~dli~~LL~ 290 (966)
.+|++....|+...| .|+.|+++|+|++|.+||...+.......+.. . .+..|..+++++++||.++|+
T Consensus 179 t~~y~aPE~~~~~~~~~~~D---iwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~ 255 (297)
T 3fxz_A 179 TPYWMAPEVVTRKAYGPKVD---IWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPELQNPEKLSAIFRDFLNRCLE 255 (297)
T ss_dssp CGGGCCHHHHHCSCBCTHHH---HHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHHCSCCCSCGGGSCHHHHHHHHHHSC
T ss_pred CcCccChhhhcCCCCCcHHH---HHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCCCccccCHHHHHHHHHHcc
Confidence 134455555655555 44677888999999999988877665555553 3 345678899999999999999
Q ss_pred cCCCcccCCCCCCHHHHhcCCceeee
Q psy11767 291 KDPRRRLGGGELDAEELKRHPFFNVI 316 (966)
Q Consensus 291 kdp~~RLG~~~~g~~~Ik~HpfF~~i 316 (966)
.||.+|. .+++|.+||||+..
T Consensus 256 ~dp~~Rp-----s~~ell~h~~~~~~ 276 (297)
T 3fxz_A 256 MDVEKRG-----SAKELLQHQFLKIA 276 (297)
T ss_dssp SSTTTSC-----CHHHHTTCGGGGGC
T ss_pred CChhHCc-----CHHHHhhChhhccc
Confidence 9999997 48999999999743
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* | Back alignment and structure |
|---|
Probab=99.77 E-value=8.6e-19 Score=206.26 Aligned_cols=193 Identities=25% Similarity=0.376 Sum_probs=144.4
Q ss_pred cchhccCCcceeeeecccccceEEEEEEcCCCCEEEEEeccccc-------hhhHHHHHHHHhhCCCcccccccccccc-
Q psy11767 110 FFEQYDMDLDKAGILGDGSYSVCRRCVEKSTGQEYAVKIISRKI-------DCSEEINLLRACQGHPNICRRCVEKSTG- 181 (966)
Q Consensus 110 ~~~~~~~df~~~~~LG~GsFGkV~La~~k~tg~~yAiKvl~K~~-------~~~~E~~il~~~~~~pfi~~~~~~~~~~- 181 (966)
|.+.| +++++||+|+||+|++|+++.+|+.||||++++.. ...+|..+|+++ +||+|++.+-.....
T Consensus 20 ~~~~y----~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~hpniv~~~~~~~~~~ 94 (486)
T 3mwu_A 20 FAERY----NIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKL-DHPNIMKLFEILEDSS 94 (486)
T ss_dssp HHHHE----EEEEEEECCSSSEEEEEEETTTCCEEEEEEEEHHHHBCSCHHHHHHHHHHHHHC-CCTTBCCEEEEEECSS
T ss_pred hhcce----EEeEEEeecCCEEEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHHHhC-CCCCcCeEEEEEEcCC
Confidence 55555 89999999999999999999999999999997642 357899999998 699998722111110
Q ss_pred -----------------------------hhHHHHHHHh----------hcccchhhhHhhh---ccCCceEEecCccc-
Q psy11767 182 -----------------------------QEYAVKIISR----------KIDCSEEINLLRA---CQGHPNIVNLHCVF- 218 (966)
Q Consensus 182 -----------------------------~~~~~~~v~~----------~~~~~~e~nil~~---~~gh~~iv~l~~~~- 218 (966)
..++.+++.+ ..|++++ |||.+ .+++++|+||+.+.
T Consensus 95 ~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~-Nil~~~~~~~~~~kl~Dfg~a~~ 173 (486)
T 3mwu_A 95 SFYIVGELYTGGELFDEIIKRKRFSEHDAARIIKQVFSGITYMHKHNIVHRDLKPE-NILLESKEKDCDIKIIDFGLSTC 173 (486)
T ss_dssp EEEEEECCCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGG-GEEESSSSTTCCEEECSCSCTTT
T ss_pred EEEEEEEcCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCchH-HEEEecCCCCCCEEEEECCcCeE
Confidence 1111122211 1244555 99984 34679999998663
Q ss_pred -----------------cccccccccCCCcceeeechhhHHHHHHHhhCCCCCCCCcHHHHHHHHHhCCCCCC----CCC
Q psy11767 219 -----------------QDEVIDWDDFSRGIECVFFSSSLIIFFIILSFTLSFIHDYYHIQYRRILKTEPPIP----EDL 277 (966)
Q Consensus 219 -----------------~~e~i~~~~y~~~~d~~~~~~~~il~~~m~~g~~pf~~~~~~~~~~~I~~~~~~~P----~~~ 277 (966)
.+|++.. .|+...| .|+.|+++|+|++|.+||...+...++++|..+.+.++ ..+
T Consensus 174 ~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~D---iwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 249 (486)
T 3mwu_A 174 FQQNTKMKDRIGTAYYIAPEVLRG-TYDEKCD---VWSAGVILYILLSGTPPFYGKNEYDILKRVETGKYAFDLPQWRTI 249 (486)
T ss_dssp BCCC----CCTTGGGGCCGGGGGS-CCCHHHH---HHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCSCSGGGGGS
T ss_pred CCCCCccCCCcCCCCCCCHHHhCC-CCCchhh---HHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCCcccCCC
Confidence 1344432 3544333 44667888899999999999999999999999887765 468
Q ss_pred CHHHHHHHHhhcccCCCcccCCCCCCHHHHhcCCceeeeC
Q psy11767 278 SPDVADFISRLLVKDPRRRLGGGELDAEELKRHPFFNVID 317 (966)
Q Consensus 278 s~~a~dli~~LL~kdp~~RLG~~~~g~~~Ik~HpfF~~id 317 (966)
|+++++||+++|+.||.+|+. +.++..||||+...
T Consensus 250 s~~~~~li~~~L~~dp~~R~t-----~~~~l~hp~~~~~~ 284 (486)
T 3mwu_A 250 SDDAKDLIRKMLTFHPSLRIT-----ATQCLEHPWIQKYS 284 (486)
T ss_dssp CHHHHHHHHHHTCSSTTTSCC-----HHHHHHCHHHHHTC
T ss_pred CHHHHHHHHHHcCCChhhCcC-----HHHHhcCHhhccCc
Confidence 999999999999999999984 89999999998654
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=99.77 E-value=1.2e-18 Score=199.31 Aligned_cols=192 Identities=22% Similarity=0.354 Sum_probs=144.8
Q ss_pred CcceeeeecccccceEEEEEEcCCCCEEEEEeccccc-----hhhHHHHHHHHhhCCCccccccccccc-----------
Q psy11767 117 DLDKAGILGDGSYSVCRRCVEKSTGQEYAVKIISRKI-----DCSEEINLLRACQGHPNICRRCVEKST----------- 180 (966)
Q Consensus 117 df~~~~~LG~GsFGkV~La~~k~tg~~yAiKvl~K~~-----~~~~E~~il~~~~~~pfi~~~~~~~~~----------- 180 (966)
+|++++.||+|+||+|++|+++.||+.||+|++++.. ...+|..+|+++ +||+|++....+..
T Consensus 52 ~y~i~~~LG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~E~~il~~l-~hpnIv~~~~~~~~~~~~~lv~E~~ 130 (387)
T 1kob_A 52 YYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQL-HHPKLINLHDAFEDKYEMVLILEFL 130 (387)
T ss_dssp TEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTC-CSTTBCCEEEEEECSSEEEEEEECC
T ss_pred ceEEEEEEecCCCEEEEEEEECCCCCEEEEEEecccchhhHHHHHHHHHHHHhC-CCcCCCeEEEEEEeCCEEEEEEEcC
Confidence 4699999999999999999999999999999998642 457899999888 69999862111111
Q ss_pred --------------------chhHHHHHHHh----------hcccchhhhHhhhc--cCCceEEecCcccc---------
Q psy11767 181 --------------------GQEYAVKIISR----------KIDCSEEINLLRAC--QGHPNIVNLHCVFQ--------- 219 (966)
Q Consensus 181 --------------------~~~~~~~~v~~----------~~~~~~e~nil~~~--~gh~~iv~l~~~~~--------- 219 (966)
...++.+++.+ ..|++++ |||.+. .|+++|+||+.+..
T Consensus 131 ~gg~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlkp~-NIll~~~~~~~vkL~DFG~a~~~~~~~~~~~ 209 (387)
T 1kob_A 131 SGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHEHSIVHLDIKPE-NIMCETKKASSVKIIDFGLATKLNPDEIVKV 209 (387)
T ss_dssp CCCBHHHHTTCTTCCBCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGG-GEEESSTTCCCEEECCCTTCEECCTTSCEEE
T ss_pred CCCcHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccchH-HeEEecCCCCceEEEecccceecCCCcceee
Confidence 01111222221 1244445 999864 47899999986632
Q ss_pred ---------ccccccccCCCcceeeechhhHHHHHHHhhCCCCCCCCcHHHHHHHHHhCCCCCC----CCCCHHHHHHHH
Q psy11767 220 ---------DEVIDWDDFSRGIECVFFSSSLIIFFIILSFTLSFIHDYYHIQYRRILKTEPPIP----EDLSPDVADFIS 286 (966)
Q Consensus 220 ---------~e~i~~~~y~~~~d~~~~~~~~il~~~m~~g~~pf~~~~~~~~~~~I~~~~~~~P----~~~s~~a~dli~ 286 (966)
+|++....|+...| .|+.|+++|+|++|.+||...+...++++|......++ ..+++++++||+
T Consensus 210 ~~gt~~y~aPE~~~~~~~~~~~D---iwSlG~il~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~ 286 (387)
T 1kob_A 210 TTATAEFAAPEIVDREPVGFYTD---MWAIGVLGYVLLSGLSPFAGEDDLETLQNVKRCDWEFDEDAFSSVSPEAKDFIK 286 (387)
T ss_dssp ECSSGGGCCHHHHTTCCBCHHHH---HHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHHCCCCCCSSTTTTSCHHHHHHHH
T ss_pred eccCCCccCchhccCCCCCCccc---EeeHhHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCccccccCCHHHHHHHH
Confidence 34454445544444 44677888999999999999988888999998877766 468999999999
Q ss_pred hhcccCCCcccCCCCCCHHHHhcCCceeeeCc
Q psy11767 287 RLLVKDPRRRLGGGELDAEELKRHPFFNVIDW 318 (966)
Q Consensus 287 ~LL~kdp~~RLG~~~~g~~~Ik~HpfF~~idW 318 (966)
++|++||.+|.. +++|.+||||++..+
T Consensus 287 ~~L~~dP~~Rpt-----~~ell~hp~~~~~~~ 313 (387)
T 1kob_A 287 NLLQKEPRKRLT-----VHDALEHPWLKGDHS 313 (387)
T ss_dssp TTSCSSGGGSCC-----HHHHHTSTTTSSCCT
T ss_pred HHcCCChhHCcC-----HHHHhhCccccCCcc
Confidence 999999999984 899999999987655
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=99.77 E-value=1.2e-18 Score=197.81 Aligned_cols=193 Identities=21% Similarity=0.256 Sum_probs=135.9
Q ss_pred CcceeeeecccccceEEEEEEcCCCCEEEEEecccc-------chhhHHHHHHHHhhCCCcccccccccccc--------
Q psy11767 117 DLDKAGILGDGSYSVCRRCVEKSTGQEYAVKIISRK-------IDCSEEINLLRACQGHPNICRRCVEKSTG-------- 181 (966)
Q Consensus 117 df~~~~~LG~GsFGkV~La~~k~tg~~yAiKvl~K~-------~~~~~E~~il~~~~~~pfi~~~~~~~~~~-------- 181 (966)
+|.+++.||+|+||+|++|+++.||+.||||++.+. ....+|..+|++++ ||+|++..-.+...
T Consensus 26 ~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~-hpnIv~l~~~~~~~~~~~~~~~ 104 (367)
T 1cm8_A 26 VYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMR-HENVIGLLDVFTPDETLDDFTD 104 (367)
T ss_dssp SEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCC-BTTBCCCSEEECSCSSTTTCCC
T ss_pred eEEEeEEeeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCC-CcCCCCceeeEecCCccccCce
Confidence 689999999999999999999999999999999653 23568999999984 99998732211110
Q ss_pred --------------------------hhHHHHHHHh----------hcccchhhhHhhhccCCceEEecCccc-------
Q psy11767 182 --------------------------QEYAVKIISR----------KIDCSEEINLLRACQGHPNIVNLHCVF------- 218 (966)
Q Consensus 182 --------------------------~~~~~~~v~~----------~~~~~~e~nil~~~~gh~~iv~l~~~~------- 218 (966)
..++.+++.+ ..|++++ |||.+.+|+++|+||+.+.
T Consensus 105 ~~lv~e~~~~~L~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlkp~-NIll~~~~~~kl~Dfg~a~~~~~~~~ 183 (367)
T 1cm8_A 105 FYLVMPFMGTDLGKLMKHEKLGEDRIQFLVYQMLKGLRYIHAAGIIHRDLKPG-NLAVNEDCELKILDFGLARQADSEMT 183 (367)
T ss_dssp CEEEEECCSEEHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGG-GEEECTTCCEEECCCTTCEECCSSCC
T ss_pred EEEEEecCCCCHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCcCHH-HEEEcCCCCEEEEeeecccccccccC
Confidence 0111122211 1244444 9999999999999998663
Q ss_pred ---------ccccccc-ccCCCcceeeechhhHHHHHHHhhCCCCCCCCcHHHHHHHHHhC--CC---------------
Q psy11767 219 ---------QDEVIDW-DDFSRGIECVFFSSSLIIFFIILSFTLSFIHDYYHIQYRRILKT--EP--------------- 271 (966)
Q Consensus 219 ---------~~e~i~~-~~y~~~~d~~~~~~~~il~~~m~~g~~pf~~~~~~~~~~~I~~~--~~--------------- 271 (966)
.+|++.. ..|+...| .|+.|+++|+|++|.+||...+...++.+|+.. .+
T Consensus 184 ~~~~t~~y~aPE~~~~~~~~~~~~D---iwslG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~~~~~~~~~~~~~~~~~ 260 (367)
T 1cm8_A 184 GYVVTRWYRAPEVILNWMRYTQTVD---IWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQRLQSDEAKN 260 (367)
T ss_dssp SSCSCGGGCCTHHHHTTTCCCTTHH---HHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHTCSCHHHHH
T ss_pred cCcCCCCcCCHHHHhCCCCCChhhh---HHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHhhhHHHHH
Confidence 2344443 45666666 446778889999999999988887777777641 11
Q ss_pred --------------CCCCCCCHHHHHHHHhhcccCCCcccCCCCCCHHHHhcCCceeeeCcc
Q psy11767 272 --------------PIPEDLSPDVADFISRLLVKDPRRRLGGGELDAEELKRHPFFNVIDWD 319 (966)
Q Consensus 272 --------------~~P~~~s~~a~dli~~LL~kdp~~RLG~~~~g~~~Ik~HpfF~~idW~ 319 (966)
.++..++++++|||++||+.||.+|+. ++++.+||||+.+.+.
T Consensus 261 ~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~mL~~dP~~R~t-----~~e~l~hp~f~~~~~~ 317 (367)
T 1cm8_A 261 YMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVT-----AGEALAHPYFESLHDT 317 (367)
T ss_dssp HHHHSCCCCCCCGGGTCTTCCHHHHHHHHHHSCSSTTTSCC-----HHHHHHSGGGTTTC--
T ss_pred HHHhCCCCCCCCHHHHCCCCCHHHHHHHHHHccCChhHCCC-----HHHHhcChHHHhhcCC
Confidence 123467999999999999999999984 8999999999877654
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} | Back alignment and structure |
|---|
Probab=99.77 E-value=2.4e-18 Score=203.40 Aligned_cols=189 Identities=23% Similarity=0.290 Sum_probs=140.7
Q ss_pred CcceeeeecccccceEEEEEEcCCCCEEEEEeccccc------------------hhhHHHHHHHHhhCCCccccccccc
Q psy11767 117 DLDKAGILGDGSYSVCRRCVEKSTGQEYAVKIISRKI------------------DCSEEINLLRACQGHPNICRRCVEK 178 (966)
Q Consensus 117 df~~~~~LG~GsFGkV~La~~k~tg~~yAiKvl~K~~------------------~~~~E~~il~~~~~~pfi~~~~~~~ 178 (966)
+|.+++.||+|+||+|++|+++.+|+.||||++++.. ...+|..+|+++ +||+|++.+-..
T Consensus 37 ~Y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~hpniv~~~~~~ 115 (504)
T 3q5i_A 37 SYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSL-DHPNIIKLFDVF 115 (504)
T ss_dssp TEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEC----------------CTHHHHHHHHHHHHTC-CCTTBCCEEEEE
T ss_pred ceEEEeEecccCCeEEEEEEECCCCcEEEEEEEEhhhcccccccccchhhHHHHHHHHHHHHHHHhC-CCCCCCeEEEEE
Confidence 4589999999999999999999999999999998642 346799999988 699998722111
Q ss_pred ccc------------------------------hhHHHHHHHh----------hcccchhhhHhhhccC---CceEEecC
Q psy11767 179 STG------------------------------QEYAVKIISR----------KIDCSEEINLLRACQG---HPNIVNLH 215 (966)
Q Consensus 179 ~~~------------------------------~~~~~~~v~~----------~~~~~~e~nil~~~~g---h~~iv~l~ 215 (966)
... ..++.+++.+ ..|++++ |||.+..| +++|+||+
T Consensus 116 ~~~~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~-Nil~~~~~~~~~~kl~Dfg 194 (504)
T 3q5i_A 116 EDKKYFYLVTEFYEGGELFEQIINRHKFDECDAANIMKQILSGICYLHKHNIVHRDIKPE-NILLENKNSLLNIKIVDFG 194 (504)
T ss_dssp ECSSEEEEEEECCTTCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGG-GEEESSTTCCSSEEECCCT
T ss_pred EcCCEEEEEEecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCcHH-HEEEecCCCCccEEEEECC
Confidence 111 1111122211 1244455 99988765 58999998
Q ss_pred cccc------------------ccccccccCCCcceeeechhhHHHHHHHhhCCCCCCCCcHHHHHHHHHhCCCCCC---
Q psy11767 216 CVFQ------------------DEVIDWDDFSRGIECVFFSSSLIIFFIILSFTLSFIHDYYHIQYRRILKTEPPIP--- 274 (966)
Q Consensus 216 ~~~~------------------~e~i~~~~y~~~~d~~~~~~~~il~~~m~~g~~pf~~~~~~~~~~~I~~~~~~~P--- 274 (966)
.+.. +|++. ..|+...| .|+.|+++|+|++|.+||...+...++++|..+.+.+|
T Consensus 195 ~a~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~D---iwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~ 270 (504)
T 3q5i_A 195 LSSFFSKDYKLRDRLGTAYYIAPEVLK-KKYNEKCD---VWSCGVIMYILLCGYPPFGGQNDQDIIKKVEKGKYYFDFND 270 (504)
T ss_dssp TCEECCTTSCBCCCCSCTTTCCHHHHT-TCBCTHHH---HHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCHHH
T ss_pred CCEEcCCCCccccccCCcCCCCHHHhc-cCCCchHH---HHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCccc
Confidence 6631 23433 24544444 34567788899999999999999999999999998887
Q ss_pred -CCCCHHHHHHHHhhcccCCCcccCCCCCCHHHHhcCCceeee
Q psy11767 275 -EDLSPDVADFISRLLVKDPRRRLGGGELDAEELKRHPFFNVI 316 (966)
Q Consensus 275 -~~~s~~a~dli~~LL~kdp~~RLG~~~~g~~~Ik~HpfF~~i 316 (966)
..+|+++++||+++|+.||.+|+. ++++.+||||+..
T Consensus 271 ~~~~s~~~~~li~~~L~~dp~~R~t-----~~e~l~h~~~~~~ 308 (504)
T 3q5i_A 271 WKNISDEAKELIKLMLTYDYNKRCT-----AEEALNSRWIKKY 308 (504)
T ss_dssp HTTSCHHHHHHHHHHTCSSTTTSCC-----HHHHHTSHHHHHT
T ss_pred cCCCCHHHHHHHHHHcCCChhHCCC-----HHHHhcCHhhhhc
Confidence 689999999999999999999984 8999999999754
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.77 E-value=1.8e-18 Score=190.40 Aligned_cols=203 Identities=23% Similarity=0.274 Sum_probs=135.6
Q ss_pred CcceeeeecccccceEEEEEEcCCCCEEEEEeccccc-------hhhHHHHHHHHhhCCCcccccccccccc--------
Q psy11767 117 DLDKAGILGDGSYSVCRRCVEKSTGQEYAVKIISRKI-------DCSEEINLLRACQGHPNICRRCVEKSTG-------- 181 (966)
Q Consensus 117 df~~~~~LG~GsFGkV~La~~k~tg~~yAiKvl~K~~-------~~~~E~~il~~~~~~pfi~~~~~~~~~~-------- 181 (966)
+|++++.||+|+||+|++|+++.||+.||||++.+.. ...+|..+|+++ +||+|++..-.....
T Consensus 4 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e 82 (311)
T 4agu_A 4 KYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQL-KHPNLVNLLEVFRRKRRLHLVFE 82 (311)
T ss_dssp CEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCCCC-HHHHHHHHHHHHHHHHC-CCTTBCCEEEEEEETTEEEEEEE
T ss_pred cceEeeEEeecCCeEEEEEEeCCCCcEEEEEEeeccccchHHHHHHHHHHHHHHhC-CCCCccchhheeecCCeEEEEEE
Confidence 5689999999999999999999999999999987642 246789999988 599998622111110
Q ss_pred ----------------------hhHHHHHHHh----------hcccchhhhHhhhccCCceEEecCcccc----------
Q psy11767 182 ----------------------QEYAVKIISR----------KIDCSEEINLLRACQGHPNIVNLHCVFQ---------- 219 (966)
Q Consensus 182 ----------------------~~~~~~~v~~----------~~~~~~e~nil~~~~gh~~iv~l~~~~~---------- 219 (966)
...+.+++.+ ..|++++ |||.+.+|.++|+||+.+..
T Consensus 83 ~~~~~~l~~~~~~~~~~~~~~~~~i~~~l~~~l~~lH~~~ivH~dlkp~-Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~ 161 (311)
T 4agu_A 83 YCDHTVLHELDRYQRGVPEHLVKSITWQTLQAVNFCHKHNCIHRDVKPE-NILITKHSVIKLCDFGFARLLTGPSDYYDD 161 (311)
T ss_dssp CCSEEHHHHHHHTSSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGG-GEEECTTSCEEECCCTTCEECC--------
T ss_pred eCCCchHHHHHhhhcCCCHHHHHHHHHHHHHHHHHHHHCCCcCCCCChh-hEEEcCCCCEEEeeCCCchhccCcccccCC
Confidence 1111122211 1134444 99999999999999986631
Q ss_pred ---------cccccc-ccCCCcceeeechhhHHHHHHHhhCCCCCCCCcHHHHHHHHHhC-------------------C
Q psy11767 220 ---------DEVIDW-DDFSRGIECVFFSSSLIIFFIILSFTLSFIHDYYHIQYRRILKT-------------------E 270 (966)
Q Consensus 220 ---------~e~i~~-~~y~~~~d~~~~~~~~il~~~m~~g~~pf~~~~~~~~~~~I~~~-------------------~ 270 (966)
+|++.. ..|+...| .|+.|+++|+|++|.+||...+.......+... .
T Consensus 162 ~~~~~~y~aPE~~~~~~~~~~~~D---i~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (311)
T 4agu_A 162 EVATRWYRSPELLVGDTQYGPPVD---VWAIGCVFAELLSGVPLWPGKSDVDQLYLIRKTLGDLIPRHQQVFSTNQYFSG 238 (311)
T ss_dssp ----GGGCCHHHHHTCSCCCTHHH---HHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHHHHTCGGGTT
T ss_pred CcCCccccChHHHhcCCCCCcchh---hHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhccccccccccccccccccc
Confidence 233322 34444444 345678888999999999887766555444321 1
Q ss_pred CCCC------------CCCCHHHHHHHHhhcccCCCcccCCCCCCHHHHhcCCceeeeCccccccCCCCCC
Q psy11767 271 PPIP------------EDLSPDVADFISRLLVKDPRRRLGGGELDAEELKRHPFFNVIDWDDLATKRIPAP 329 (966)
Q Consensus 271 ~~~P------------~~~s~~a~dli~~LL~kdp~~RLG~~~~g~~~Ik~HpfF~~idW~~l~~k~~~pP 329 (966)
...| ..+++++.+||+++|..||.+|.. +++|.+||||+++.|..-..+....|
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt-----~~ell~hp~f~~~~~~~~~~~~~~~~ 304 (311)
T 4agu_A 239 VKIPDPEDMEPLELKFPNISYPALGLLKGCLHMDPTERLT-----CEQLLHHPYFENIREIEDLAKEHDKP 304 (311)
T ss_dssp CCCCCCSSCCCHHHHCTTCCHHHHHHHHHHCCSSTTTSCC-----HHHHHTSGGGTTCC------------
T ss_pred CcCCCccccchhhhhcccccHHHHHHHHHHccCChhhcCC-----HHHHhcChHHHhccCHHHHHHhhccH
Confidence 1111 357899999999999999999984 89999999999999987777766655
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* | Back alignment and structure |
|---|
Probab=99.77 E-value=3.6e-18 Score=185.20 Aligned_cols=196 Identities=27% Similarity=0.425 Sum_probs=146.6
Q ss_pred CcceeeeecccccceEEEEEEcCCCCEEEEEeccccc-------hhhHHHHHHHHhhCCCcccccccccccc--------
Q psy11767 117 DLDKAGILGDGSYSVCRRCVEKSTGQEYAVKIISRKI-------DCSEEINLLRACQGHPNICRRCVEKSTG-------- 181 (966)
Q Consensus 117 df~~~~~LG~GsFGkV~La~~k~tg~~yAiKvl~K~~-------~~~~E~~il~~~~~~pfi~~~~~~~~~~-------- 181 (966)
+|++.+.||+|+||.|++|+++.+|+.||+|++++.. ...+|..+|+++ +||+|++..-.....
T Consensus 7 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~~v~e 85 (284)
T 3kk8_A 7 NYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKL-QHPNIVRLHDSIQEESFHYLVFD 85 (284)
T ss_dssp TEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCHHHHHHHHHHHHHHHHC-CCTTBCCEEEEEECSSEEEEEEC
T ss_pred hhhhhhhhcCcCCeEEEEEEEcCCCceEEEEEeecccCCHHHHHHHHHHHHHHHHc-CCCCcCeEEEEEEcCCEEEEEEe
Confidence 5699999999999999999999999999999998642 346799999998 699998622111110
Q ss_pred ----------------------hhHHHHHHHh-------h---cccchhhhHhhhccCC---ceEEecCcccc-------
Q psy11767 182 ----------------------QEYAVKIISR-------K---IDCSEEINLLRACQGH---PNIVNLHCVFQ------- 219 (966)
Q Consensus 182 ----------------------~~~~~~~v~~-------~---~~~~~e~nil~~~~gh---~~iv~l~~~~~------- 219 (966)
...+.+++.+ . .|++++ |||.+.++. ++|+||+.+..
T Consensus 86 ~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~-Nil~~~~~~~~~~kl~Dfg~~~~~~~~~~~ 164 (284)
T 3kk8_A 86 LVTGGELFEDIVAREFYSEADASHCIQQILESIAYCHSNGIVHRNLKPE-NLLLASKAKGAAVKLADFGLAIEVNDSEAW 164 (284)
T ss_dssp CCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGG-GEEESSSSTTCCEEECCCTTCEECCSSCBC
T ss_pred cCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcCcCCCCHH-HEEEecCCCCCcEEEeeceeeEEcccCccc
Confidence 0011111111 0 133444 999876655 89999987632
Q ss_pred -----------ccccccccCCCcceeeechhhHHHHHHHhhCCCCCCCCcHHHHHHHHHhCCCCCCC----CCCHHHHHH
Q psy11767 220 -----------DEVIDWDDFSRGIECVFFSSSLIIFFIILSFTLSFIHDYYHIQYRRILKTEPPIPE----DLSPDVADF 284 (966)
Q Consensus 220 -----------~e~i~~~~y~~~~d~~~~~~~~il~~~m~~g~~pf~~~~~~~~~~~I~~~~~~~P~----~~s~~a~dl 284 (966)
+|++....|+...| .|+.|+++|+|++|.+||...+...++..|..+...+|. .+++++++|
T Consensus 165 ~~~~~~~~y~aPE~~~~~~~~~~~D---i~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 241 (284)
T 3kk8_A 165 HGFAGTPGYLSPEVLKKDPYSKPVD---IWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKSL 241 (284)
T ss_dssp CCSCSCGGGCCHHHHTTCCBCTHHH---HHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCTTTTTTSCHHHHHH
T ss_pred cCCCCCcCCcCchhhcCCCCCcccc---hHHHHHHHHHHHHCCCCCCCCchhHHHHHHHhccccCCchhhcccCHHHHHH
Confidence 34444444544444 446678888999999999999999999999999888874 689999999
Q ss_pred HHhhcccCCCcccCCCCCCHHHHhcCCceeeeCccccc
Q psy11767 285 ISRLLVKDPRRRLGGGELDAEELKRHPFFNVIDWDDLA 322 (966)
Q Consensus 285 i~~LL~kdp~~RLG~~~~g~~~Ik~HpfF~~idW~~l~ 322 (966)
|+++|+.||.+|.. ++++.+||||.+..+..-.
T Consensus 242 i~~~l~~dp~~Rps-----~~~~l~h~~~~~~~~~~~~ 274 (284)
T 3kk8_A 242 IDSMLTVNPKKRIT-----ADQALKVPWICNRERVASA 274 (284)
T ss_dssp HHHHSCSSTTTSCC-----HHHHTTSHHHHSCCCGGGS
T ss_pred HHHHcccChhhCCC-----HHHHhcCccccCChhHHhH
Confidence 99999999999984 8999999999988775543
|
| >4ase_A Vascular endothelial growth factor receptor 2; transferase, angiogenesis, signaling protein, phosphorylatio receptor, inhibitor; HET: AV9; 1.83A {Homo sapiens} PDB: 4agd_A* 4asd_A* 4agc_A* | Back alignment and structure |
|---|
Probab=99.76 E-value=7.6e-19 Score=198.39 Aligned_cols=185 Identities=17% Similarity=0.166 Sum_probs=135.9
Q ss_pred CcceeeeecccccceEEEEEEcCCC-----CEEEEEeccccc------hhhHHHHHHHHhhCCCcccccccc--cccc--
Q psy11767 117 DLDKAGILGDGSYSVCRRCVEKSTG-----QEYAVKIISRKI------DCSEEINLLRACQGHPNICRRCVE--KSTG-- 181 (966)
Q Consensus 117 df~~~~~LG~GsFGkV~La~~k~tg-----~~yAiKvl~K~~------~~~~E~~il~~~~~~pfi~~~~~~--~~~~-- 181 (966)
||++++.||+|+||+|++|+++.++ +.+|||++++.. ...+|.++|.++.+||+||+.+-. ....
T Consensus 65 ~~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~k~VAvK~l~~~~~~~~~~~~~~E~~il~~l~hhpnIV~l~g~~~~~~~~~ 144 (353)
T 4ase_A 65 RLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGPL 144 (353)
T ss_dssp GEEEEEEEEECSSEEEEEEEEETSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECCTTSCC
T ss_pred HeEEeeEEecCCCeEEEEEEEcCCCcccCCeEEEEEEEccccChHHHHHHHHHHHHHHHcCCCCcEEEEEEEEEecCCEE
Confidence 7899999999999999999987654 689999998642 357799999999888999872211 1100
Q ss_pred -------------------------------------------hhHHHHHHHh----------hcccchhhhHhhhccCC
Q psy11767 182 -------------------------------------------QEYAVKIISR----------KIDCSEEINLLRACQGH 208 (966)
Q Consensus 182 -------------------------------------------~~~~~~~v~~----------~~~~~~e~nil~~~~gh 208 (966)
..++.++..+ ..|++++ |||++.+|+
T Consensus 145 ~iV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~yLH~~~iiHRDLK~~-NILl~~~~~ 223 (353)
T 4ase_A 145 MVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAAR-NILLSEKNV 223 (353)
T ss_dssp EEEEECCTTEEHHHHHHHTGGGBCCC-------CTTCBCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGG-GEEECGGGC
T ss_pred EEEEEcCCCCCHHHHHHhcccccccccccchhhccccCCHHHHHHHHHHHHHHHHhHhhCCeecCccCcc-ceeeCCCCC
Confidence 0111122211 1255555 999999999
Q ss_pred ceEEecCccc---------------------cccccccccCCCcceeeechhhHHHHHHHhh-CCCCCCCCc-HHHHHHH
Q psy11767 209 PNIVNLHCVF---------------------QDEVIDWDDFSRGIECVFFSSSLIIFFIILS-FTLSFIHDY-YHIQYRR 265 (966)
Q Consensus 209 ~~iv~l~~~~---------------------~~e~i~~~~y~~~~d~~~~~~~~il~~~m~~-g~~pf~~~~-~~~~~~~ 265 (966)
+||.||+.+. .+|++....|+...| .|+.||++|||++ |.+||.+.+ ...+.+.
T Consensus 224 vKi~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~y~~ksD---VwS~Gv~l~El~t~G~~Pf~~~~~~~~~~~~ 300 (353)
T 4ase_A 224 VKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSD---VWSFGVLLWEIFSLGASPYPGVKIDEEFCRR 300 (353)
T ss_dssp EEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHH---HHHHHHHHHHHTTTSCCSSTTCCCSHHHHHH
T ss_pred EEECcchhhhhcccCCCceeeccccccccccCHHHHhcCCCCCccc---EeehHHHHHHHHhCCCCCCCCCCHHHHHHHH
Confidence 9999999763 134555556765555 4466788888876 899998754 3445556
Q ss_pred HHhC-CCCCCCCCCHHHHHHHHhhcccCCCcccCCCCCCHHHHhcC
Q psy11767 266 ILKT-EPPIPEDLSPDVADFISRLLVKDPRRRLGGGELDAEELKRH 310 (966)
Q Consensus 266 I~~~-~~~~P~~~s~~a~dli~~LL~kdp~~RLG~~~~g~~~Ik~H 310 (966)
|..+ .+.+|..+++++.+||.++|++||.+|. .+.+|.+|
T Consensus 301 i~~g~~~~~p~~~~~~~~~li~~c~~~dP~~RP-----t~~eil~~ 341 (353)
T 4ase_A 301 LKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRP-----TFSELVEH 341 (353)
T ss_dssp HHHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSC-----CHHHHHHH
T ss_pred HHcCCCCCCCccCCHHHHHHHHHHcCcChhHCc-----CHHHHHHH
Confidence 6554 5789999999999999999999999997 48899887
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.76 E-value=1.9e-18 Score=194.62 Aligned_cols=193 Identities=25% Similarity=0.356 Sum_probs=135.2
Q ss_pred CcceeeeecccccceEEEEEEcCCCCEEEEEeccccc---hhhHHHHHHHHhhCCCcccccccccccc------------
Q psy11767 117 DLDKAGILGDGSYSVCRRCVEKSTGQEYAVKIISRKI---DCSEEINLLRACQGHPNICRRCVEKSTG------------ 181 (966)
Q Consensus 117 df~~~~~LG~GsFGkV~La~~k~tg~~yAiKvl~K~~---~~~~E~~il~~~~~~pfi~~~~~~~~~~------------ 181 (966)
+|++.+.||+|+||+|++|+++.+++.||||++++.. ...+|..+|+++ +||+|++..-.+...
T Consensus 54 ~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~lv~e~~~~ 132 (349)
T 2w4o_A 54 FFEVESELGRGATSIVYRCKQKGTQKPYALKVLKKTVDKKIVRTEIGVLLRL-SHPNIIKLKEIFETPTEISLVLELVTG 132 (349)
T ss_dssp TEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEC----------CHHHHHC-CCTTBCCEEEEEECSSEEEEEECCCCS
T ss_pred cEEEeeEEeeCCCEEEEEEEECCCCcEEEEEEeccchhHHHHHHHHHHHHhC-CCCCCcceeeeEecCCeEEEEEEeCCC
Confidence 5799999999999999999999999999999998752 456799999988 599998622111110
Q ss_pred ------------------hhHHHHHHHh----------hcccchhhhHhhhc---cCCceEEecCcccc-----------
Q psy11767 182 ------------------QEYAVKIISR----------KIDCSEEINLLRAC---QGHPNIVNLHCVFQ----------- 219 (966)
Q Consensus 182 ------------------~~~~~~~v~~----------~~~~~~e~nil~~~---~gh~~iv~l~~~~~----------- 219 (966)
...+.+++.+ ..|++++ |||.+. +|.++|.||+.+..
T Consensus 133 ~~L~~~l~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dikp~-NIll~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~ 211 (349)
T 2w4o_A 133 GELFDRIVEKGYYSERDAADAVKQILEAVAYLHENGIVHRDLKPE-NLLYATPAPDAPLKIADFGLSKIVEHQVLMKTVC 211 (349)
T ss_dssp CBHHHHHTTCSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGG-GEEESSSSTTCCEEECCCC---------------
T ss_pred CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCcc-cEEEecCCCCCCEEEccCccccccCccccccccc
Confidence 0111122211 1144444 999865 78999999986532
Q ss_pred -------ccccccccCCCcceeeechhhHHHHHHHhhCCCCCCCC-cHHHHHHHHHhCCCCCC----CCCCHHHHHHHHh
Q psy11767 220 -------DEVIDWDDFSRGIECVFFSSSLIIFFIILSFTLSFIHD-YYHIQYRRILKTEPPIP----EDLSPDVADFISR 287 (966)
Q Consensus 220 -------~e~i~~~~y~~~~d~~~~~~~~il~~~m~~g~~pf~~~-~~~~~~~~I~~~~~~~P----~~~s~~a~dli~~ 287 (966)
+|++....|+...| .|+.|+++|+|++|..||... ....+++.|++..+.++ ..++.++++||++
T Consensus 212 gt~~y~aPE~~~~~~~~~~~D---iwslG~il~ell~g~~pf~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~ 288 (349)
T 2w4o_A 212 GTPGYCAPEILRGCAYGPEVD---MWSVGIITYILLCGFEPFYDERGDQFMFRRILNCEYYFISPWWDEVSLNAKDLVRK 288 (349)
T ss_dssp -CGGGSCHHHHTTCCCCTHHH---HHHHHHHHHHHHHSSCTTCCTTCHHHHHHHHHTTCCCCCTTTTTTSCHHHHHHHHT
T ss_pred CCCCccCHHHhcCCCCCcccc---hHHHHHHHHHHHhCCCCCCCCcccHHHHHHHHhCCCccCCchhhhCCHHHHHHHHH
Confidence 34444445555444 345667788888888888654 44558999998877665 4689999999999
Q ss_pred hcccCCCcccCCCCCCHHHHhcCCceeeeCcc
Q psy11767 288 LLVKDPRRRLGGGELDAEELKRHPFFNVIDWD 319 (966)
Q Consensus 288 LL~kdp~~RLG~~~~g~~~Ik~HpfF~~idW~ 319 (966)
+|+.||.+|.. +.++.+||||.+..+.
T Consensus 289 ~L~~dP~~Rpt-----~~e~l~hp~~~~~~~~ 315 (349)
T 2w4o_A 289 LIVLDPKKRLT-----TFQALQHPWVTGKAAN 315 (349)
T ss_dssp TSCSSGGGSCC-----HHHHHHSTTTTSTTCC
T ss_pred HccCChhhCcC-----HHHHhcCcccCCCccc
Confidence 99999999984 8999999999876653
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A | Back alignment and structure |
|---|
Probab=99.76 E-value=3e-18 Score=194.30 Aligned_cols=189 Identities=29% Similarity=0.479 Sum_probs=143.0
Q ss_pred CcceeeeecccccceEEEEEEcCCCCEEEEEeccccc-------------hhhHHHHHHHHhhCCCcccccccccccc--
Q psy11767 117 DLDKAGILGDGSYSVCRRCVEKSTGQEYAVKIISRKI-------------DCSEEINLLRACQGHPNICRRCVEKSTG-- 181 (966)
Q Consensus 117 df~~~~~LG~GsFGkV~La~~k~tg~~yAiKvl~K~~-------------~~~~E~~il~~~~~~pfi~~~~~~~~~~-- 181 (966)
+|++.++||+|+||.||+|+++.+|+.||||++++.. ...+|..+|+++.+||+|+.........
T Consensus 95 ~y~~~~~lg~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~ 174 (365)
T 2y7j_A 95 KYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITLIDSYESSSF 174 (365)
T ss_dssp HEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEETTSSCCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEEBSSE
T ss_pred hcccceEEecCCCEEEEEEEECCCCcEEEEEEEEccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeEEEEEEeeCCE
Confidence 6799999999999999999999999999999997532 2467899999988899998622111110
Q ss_pred ----------------------------hhHHHHHHHh-------h---cccchhhhHhhhccCCceEEecCcccc----
Q psy11767 182 ----------------------------QEYAVKIISR-------K---IDCSEEINLLRACQGHPNIVNLHCVFQ---- 219 (966)
Q Consensus 182 ----------------------------~~~~~~~v~~-------~---~~~~~e~nil~~~~gh~~iv~l~~~~~---- 219 (966)
..++.+++.+ . .|++++ |||.+.+|.++|+||+.+..
T Consensus 175 ~~lv~e~~~g~~L~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~gi~H~Dlkp~-NIl~~~~~~ikl~DfG~~~~~~~~ 253 (365)
T 2y7j_A 175 MFLVFDLMRKGELFDYLTEKVALSEKETRSIMRSLLEAVSFLHANNIVHRDLKPE-NILLDDNMQIRLSDFGFSCHLEPG 253 (365)
T ss_dssp EEEEECCCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGG-GEEECTTCCEEECCCTTCEECCTT
T ss_pred EEEEEEeCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHH-HEEECCCCCEEEEecCcccccCCC
Confidence 1111122221 1 144444 99999999999999986531
Q ss_pred --------------cccccc------ccCCCcceeeechhhHHHHHHHhhCCCCCCCCcHHHHHHHHHhCCCCCC----C
Q psy11767 220 --------------DEVIDW------DDFSRGIECVFFSSSLIIFFIILSFTLSFIHDYYHIQYRRILKTEPPIP----E 275 (966)
Q Consensus 220 --------------~e~i~~------~~y~~~~d~~~~~~~~il~~~m~~g~~pf~~~~~~~~~~~I~~~~~~~P----~ 275 (966)
+|++.. ..|+...| .|+.|+++|+|++|.+||...+...+++.|..+.+.++ .
T Consensus 254 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~D---i~slG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~ 330 (365)
T 2y7j_A 254 EKLRELCGTPGYLAPEILKCSMDETHPGYGKEVD---LWACGVILFTLLAGSPPFWHRRQILMLRMIMEGQYQFSSPEWD 330 (365)
T ss_dssp CCBCCCCSCGGGCCHHHHHHTTCTTSCCBCTTHH---HHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCHHHHS
T ss_pred cccccCCCCCCccChhhccccccccCcCCCchhh---HHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCCCCCCcccc
Confidence 233321 13444444 44677888999999999999888889999999988876 4
Q ss_pred CCCHHHHHHHHhhcccCCCcccCCCCCCHHHHhcCCcee
Q psy11767 276 DLSPDVADFISRLLVKDPRRRLGGGELDAEELKRHPFFN 314 (966)
Q Consensus 276 ~~s~~a~dli~~LL~kdp~~RLG~~~~g~~~Ik~HpfF~ 314 (966)
.+++++++||+++|..||.+|. .+++|.+||||+
T Consensus 331 ~~~~~~~~li~~~L~~dP~~Rp-----s~~ell~hp~f~ 364 (365)
T 2y7j_A 331 DRSSTVKDLISRLLQVDPEARL-----TAEQALQHPFFE 364 (365)
T ss_dssp SSCHHHHHHHHHHSCSSTTTSC-----CHHHHHHSGGGC
T ss_pred cCCHHHHHHHHHHcCCChhHCc-----CHHHHhcCcccC
Confidence 7899999999999999999998 489999999996
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* | Back alignment and structure |
|---|
Probab=99.76 E-value=2.1e-18 Score=192.11 Aligned_cols=191 Identities=19% Similarity=0.314 Sum_probs=134.8
Q ss_pred CcceeeeecccccceEEEEEEcCCCCEEEEEecccc------chhhHHHHHHHHhhCCCccccccccccc----------
Q psy11767 117 DLDKAGILGDGSYSVCRRCVEKSTGQEYAVKIISRK------IDCSEEINLLRACQGHPNICRRCVEKST---------- 180 (966)
Q Consensus 117 df~~~~~LG~GsFGkV~La~~k~tg~~yAiKvl~K~------~~~~~E~~il~~~~~~pfi~~~~~~~~~---------- 180 (966)
+|++++.||+|+||+|++|+++.+|+.||||++++. ....+|..+|+++ +||+|++.+.....
T Consensus 8 ~y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~hpnIv~~~~~~~~~~~~~lv~e~ 86 (323)
T 3tki_A 8 DWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKML-NHENVVKFYGHRREGNIQYLFLEY 86 (323)
T ss_dssp CEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHHC-CCTTBCCEEEEEECSSEEEEEEEC
T ss_pred hceeeeEEecCCCEEEEEEEECCCCcEEEEEEEEcccccchHHHHHHHHHHHHhC-CCCCCCeEEEEEecCCeEEEEEEc
Confidence 559999999999999999999999999999999753 2457899999887 69999862111111
Q ss_pred --------------------chhHHHHHHHh----------hcccchhhhHhhhccCCceEEecCcccc-----------
Q psy11767 181 --------------------GQEYAVKIISR----------KIDCSEEINLLRACQGHPNIVNLHCVFQ----------- 219 (966)
Q Consensus 181 --------------------~~~~~~~~v~~----------~~~~~~e~nil~~~~gh~~iv~l~~~~~----------- 219 (966)
...++.+++.+ ..|++++ |||.+.+|+++|+||+.+..
T Consensus 87 ~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~givH~Dlkp~-NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~ 165 (323)
T 3tki_A 87 CSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPE-NLLLDERDNLKISDFGLATVFRYNNRERLLN 165 (323)
T ss_dssp CTTEEGGGGSBTTTBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGG-GEEECTTCCEEECCCTTCEECEETTEECCBC
T ss_pred CCCCcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccccchH-HEEEeCCCCEEEEEeeccceeccCCcccccC
Confidence 11112222222 1244444 99999999999999987631
Q ss_pred ----------ccccccccC-CCcceeeechhhHHHHHHHhhCCCCCCCCcHH-HHHHHHHhCCCCCC--CCCCHHHHHHH
Q psy11767 220 ----------DEVIDWDDF-SRGIECVFFSSSLIIFFIILSFTLSFIHDYYH-IQYRRILKTEPPIP--EDLSPDVADFI 285 (966)
Q Consensus 220 ----------~e~i~~~~y-~~~~d~~~~~~~~il~~~m~~g~~pf~~~~~~-~~~~~I~~~~~~~P--~~~s~~a~dli 285 (966)
+|++....+ +...| .|+.|+++|+|++|.+||...+.. ..+..+.......+ ..+++++++||
T Consensus 166 ~~~gt~~y~aPE~~~~~~~~~~~~D---iwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li 242 (323)
T 3tki_A 166 KMCGTLPYVAPELLKRREFHAEPVD---VWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPLALL 242 (323)
T ss_dssp SCCSCGGGSCHHHHHCSSBCHHHHH---HHHHHHHHHHHHHSSCSCSSSCTTSHHHHHHHTTCTTSTTGGGSCHHHHHHH
T ss_pred CCccCcCccCcHHhccCCCCCCccc---HHHHHHHHHHHHhCCCCCCCCchHHHHHHHHhcccccCCccccCCHHHHHHH
Confidence 233332222 22223 456778888899999999765442 34555555444443 46899999999
Q ss_pred HhhcccCCCcccCCCCCCHHHHhcCCceeeeC
Q psy11767 286 SRLLVKDPRRRLGGGELDAEELKRHPFFNVID 317 (966)
Q Consensus 286 ~~LL~kdp~~RLG~~~~g~~~Ik~HpfF~~id 317 (966)
+++|+.||.+|+. ++||++||||+..-
T Consensus 243 ~~~L~~dP~~R~t-----~~eil~h~~~~~~~ 269 (323)
T 3tki_A 243 HKILVENPSARIT-----IPDIKKDRWYNKPL 269 (323)
T ss_dssp HHHSCSSTTTSCC-----HHHHTTCTTTTCCC
T ss_pred HHHccCChhhCcC-----HHHHhhChhhcccc
Confidence 9999999999984 89999999997543
|
| >4exu_A Mitogen-activated protein kinase 13; P38 kinase, transferase; 1.70A {Homo sapiens} PDB: 4eyj_A* 4eym_A* 3coi_A | Back alignment and structure |
|---|
Probab=99.76 E-value=2.4e-18 Score=195.24 Aligned_cols=194 Identities=23% Similarity=0.277 Sum_probs=141.9
Q ss_pred CcceeeeecccccceEEEEEEcCCCCEEEEEecccc-------chhhHHHHHHHHhhCCCcccccccccccc--------
Q psy11767 117 DLDKAGILGDGSYSVCRRCVEKSTGQEYAVKIISRK-------IDCSEEINLLRACQGHPNICRRCVEKSTG-------- 181 (966)
Q Consensus 117 df~~~~~LG~GsFGkV~La~~k~tg~~yAiKvl~K~-------~~~~~E~~il~~~~~~pfi~~~~~~~~~~-------- 181 (966)
+|.+.+.||+|+||+|++|+++.+|+.||||++++. ....+|..+|+++ +||+|+...-.+...
T Consensus 43 ~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~~~~~ 121 (371)
T 4exu_A 43 TYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHM-QHENVIGLLDVFTPASSLRNFYD 121 (371)
T ss_dssp TEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTSSHHHHHHHHHHHHHHHHC-CCTTBCCCSEEECSCSSSTTCCC
T ss_pred cEEEEeEEecCCCeEEEEEEECCCCCEEEEEEecccccchhHHHHHHHHHHHHHhc-CCCCchhhhhheeccCCccccee
Confidence 789999999999999999999999999999999863 2356789999888 499998622111110
Q ss_pred -------------------------hhHHHHHHHh----------hcccchhhhHhhhccCCceEEecCccc--------
Q psy11767 182 -------------------------QEYAVKIISR----------KIDCSEEINLLRACQGHPNIVNLHCVF-------- 218 (966)
Q Consensus 182 -------------------------~~~~~~~v~~----------~~~~~~e~nil~~~~gh~~iv~l~~~~-------- 218 (966)
...+.+++.+ ..|++++ |||.+.+|+++|+||+.+.
T Consensus 122 ~~lv~e~~~~~l~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~-NIll~~~~~~kL~Dfg~a~~~~~~~~~ 200 (371)
T 4exu_A 122 FYLVMPFMQTDLQKIMGMEFSEEKIQYLVYQMLKGLKYIHSAGVVHRDLKPG-NLAVNEDCELKILDFGLARHADAEMTG 200 (371)
T ss_dssp CEEEEECCCEEHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGG-GEEECTTCCEEECSTTCC--------C
T ss_pred EEEEEccccccHHHHhhcCCCHHHHHHHHHHHHHHHHHHHHCCCcCCCcCHH-HeEECCCCCEEEEecCcccccccCcCC
Confidence 1111122221 1144444 9999999999999998763
Q ss_pred --------ccccccc-ccCCCcceeeechhhHHHHHHHhhCCCCCCCCcHHHHHHHHHhC--CC----------------
Q psy11767 219 --------QDEVIDW-DDFSRGIECVFFSSSLIIFFIILSFTLSFIHDYYHIQYRRILKT--EP---------------- 271 (966)
Q Consensus 219 --------~~e~i~~-~~y~~~~d~~~~~~~~il~~~m~~g~~pf~~~~~~~~~~~I~~~--~~---------------- 271 (966)
.+|++.. ..|+...| .|+.|+++|+|++|.+||...+....+..|+.. .+
T Consensus 201 ~~~t~~y~aPE~~~~~~~~~~~~D---iwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~ 277 (371)
T 4exu_A 201 YVVTRWYRAPEVILSWMHYNQTVD---IWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGTEFVQKLNDKAAKSY 277 (371)
T ss_dssp TTCCCTTSCHHHHSCCSCCCTTHH---HHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCHHHHTTCSCHHHHHH
T ss_pred cccCccccCHHHhcCCCCCCcHHh---HHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCcHHHHHHhhhhhhhhh
Confidence 2344443 34555555 446778888999999999988887777777541 10
Q ss_pred -------------CCCCCCCHHHHHHHHhhcccCCCcccCCCCCCHHHHhcCCceeeeCccc
Q psy11767 272 -------------PIPEDLSPDVADFISRLLVKDPRRRLGGGELDAEELKRHPFFNVIDWDD 320 (966)
Q Consensus 272 -------------~~P~~~s~~a~dli~~LL~kdp~~RLG~~~~g~~~Ik~HpfF~~idW~~ 320 (966)
.++..+++++++||+++|+.||.+|+. +.++.+||||+.+.+..
T Consensus 278 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt-----~~ell~hp~f~~~~~~~ 334 (371)
T 4exu_A 278 IQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLT-----AAQALTHPFFEPFRDPE 334 (371)
T ss_dssp HHHSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSCTTTSCC-----HHHHHTSGGGTTTCCGG
T ss_pred hhccCCCcchhHHHhccccChHHHHHHHHHCCCChhhcCC-----HHHHhcCcccccCCCcc
Confidence 123467999999999999999999984 89999999999776544
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 4gsb_A* 4gt3_A* 4gva_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3zu7_A 3zuv_A* 3o71_A 3r63_A 3c9w_A* 2y9q_A* 4fmq_A* ... | Back alignment and structure |
|---|
Probab=99.76 E-value=2.2e-18 Score=194.80 Aligned_cols=206 Identities=20% Similarity=0.249 Sum_probs=144.7
Q ss_pred CcceeeeecccccceEEEEEEcCCCCEEEEEecccc------chhhHHHHHHHHhhCCCcccccccccccc---------
Q psy11767 117 DLDKAGILGDGSYSVCRRCVEKSTGQEYAVKIISRK------IDCSEEINLLRACQGHPNICRRCVEKSTG--------- 181 (966)
Q Consensus 117 df~~~~~LG~GsFGkV~La~~k~tg~~yAiKvl~K~------~~~~~E~~il~~~~~~pfi~~~~~~~~~~--------- 181 (966)
+|.++++||+|+||+|++|+++.+|+.||||++++. ....+|..+|+++ +||+|+...-.....
T Consensus 28 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~~~~~~ 106 (364)
T 3qyz_A 28 RYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRF-RHENIIGINDIIRAPTIEQMKDVY 106 (364)
T ss_dssp TEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCTTCHHHHHHHHHHHHHHHHC-CCTTBCCCCEEECCSSTTTCCCEE
T ss_pred cEEEEEEeecCCCeEEEEEEECCCCeEEEEEEeccccCcHHHHHHHHHHHHHHhc-CCCCCccceeEEecCCccccceEE
Confidence 679999999999999999999999999999999853 2356899999998 599998632111100
Q ss_pred ------------------------hhHHHHHHHh----------hcccchhhhHhhhccCCceEEecCcccc--------
Q psy11767 182 ------------------------QEYAVKIISR----------KIDCSEEINLLRACQGHPNIVNLHCVFQ-------- 219 (966)
Q Consensus 182 ------------------------~~~~~~~v~~----------~~~~~~e~nil~~~~gh~~iv~l~~~~~-------- 219 (966)
..++.+++.+ ..|++++ |||.+.+|.++|+||+.+..
T Consensus 107 iv~e~~~~~L~~~l~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~-NIl~~~~~~~kl~Dfg~a~~~~~~~~~~ 185 (364)
T 3qyz_A 107 IVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIHSANVLHRDLKPS-NLLLNTTCDLKICDFGLARVADPDHDHT 185 (364)
T ss_dssp EEEECCSEEHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGG-GEEECTTCCEEECCCTTCEECCGGGCBC
T ss_pred EEEcccCcCHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCChH-hEEECCCCCEEEEeCcceEecCCCCCcc
Confidence 0111122211 1244445 99999999999999986631
Q ss_pred --------------ccccc-cccCCCcceeeechhhHHHHHHHhhCCCCCCCCcHHHHHHHHHh--CCC-----------
Q psy11767 220 --------------DEVID-WDDFSRGIECVFFSSSLIIFFIILSFTLSFIHDYYHIQYRRILK--TEP----------- 271 (966)
Q Consensus 220 --------------~e~i~-~~~y~~~~d~~~~~~~~il~~~m~~g~~pf~~~~~~~~~~~I~~--~~~----------- 271 (966)
+|++. ...|+...| .|+.|+++|+|++|.+||...+....++.|+. +.+
T Consensus 186 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~D---iwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 262 (364)
T 3qyz_A 186 GFLTEYVATRWYRAPEIMLNSKGYTKSID---IWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINL 262 (364)
T ss_dssp CTTCCCCSCGGGCCHHHHHTBCSCSTHHH---HHHHHHHHHHHHHSSCSSCCSSGGGHHHHHHHHHCSCCHHHHHTCCCH
T ss_pred ccccccccccCCCCCHHhcCCCCCCcchh---HHHHHHHHHHHHHCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHhhhh
Confidence 22222 223444444 44677888899999999988776666666652 111
Q ss_pred ------------------CCCCCCCHHHHHHHHhhcccCCCcccCCCCCCHHHHhcCCceeeeCccccccCCCCCCCCcc
Q psy11767 272 ------------------PIPEDLSPDVADFISRLLVKDPRRRLGGGELDAEELKRHPFFNVIDWDDLATKRIPAPFVPK 333 (966)
Q Consensus 272 ------------------~~P~~~s~~a~dli~~LL~kdp~~RLG~~~~g~~~Ik~HpfF~~idW~~l~~k~~~pP~~P~ 333 (966)
.++..+++++++||+++|+.||.+|+. +.+|.+||||+.+ |+.......++||.+.
T Consensus 263 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t-----~~e~l~hp~~~~~-~~~~~~~~~~~~~~~~ 336 (364)
T 3qyz_A 263 KARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIE-----VEQALAHPYLEQY-YDPSDEPIAEAPFKFD 336 (364)
T ss_dssp HHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHTCSSTTTSCC-----HHHHHTSGGGTTT-CCGGGSCCCSSCCCCC
T ss_pred hHHHHHHhcCCccCCCHHHhCCCCCHHHHHHHHHHcCCChhhCCC-----HHHHhcCcchhhc-cCcccccCCCCcCCcc
Confidence 122567999999999999999999984 8999999999876 5555444445555443
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=99.76 E-value=1.1e-18 Score=198.88 Aligned_cols=193 Identities=19% Similarity=0.272 Sum_probs=139.6
Q ss_pred CCcceeeeecccccceEEEEEEcCCCCEEEEEecccc-chhhHHHHHHHHhhCCCcccccccccccc-------------
Q psy11767 116 MDLDKAGILGDGSYSVCRRCVEKSTGQEYAVKIISRK-IDCSEEINLLRACQGHPNICRRCVEKSTG------------- 181 (966)
Q Consensus 116 ~df~~~~~LG~GsFGkV~La~~k~tg~~yAiKvl~K~-~~~~~E~~il~~~~~~pfi~~~~~~~~~~------------- 181 (966)
-+|.++++||+|+||+|++|+++.||+.||||++.+. ....+|..+|+++ +||+|++....+...
T Consensus 7 ~~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~~~~~~~E~~il~~l-~hpnIv~l~~~~~~~~~~~~~~~~~~~~ 85 (383)
T 3eb0_A 7 KKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDPRYKNRELDIMKVL-DHVNIIKLVDYFYTTGDEEPKPPQPPDD 85 (383)
T ss_dssp TTEEEEEEEECC-CEEEEEEEETTTCCEEEEEEEECCTTSCCHHHHHHTTC-CCTTBCCEEEEEEEC-------------
T ss_pred ceEEEEEEEEeccCEEEEEEEECCCCCEEEEEEEecCcchHHHHHHHHHHc-CCCCccchhheeeecCcccccccccccc
Confidence 3679999999999999999999999999999998865 3456899999888 699998732211000
Q ss_pred ----------------------------------------------------------hhHHHHHHHh----------hc
Q psy11767 182 ----------------------------------------------------------QEYAVKIISR----------KI 193 (966)
Q Consensus 182 ----------------------------------------------------------~~~~~~~v~~----------~~ 193 (966)
..++.+++.+ ..
T Consensus 86 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~gi~H~ 165 (383)
T 3eb0_A 86 HNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVPDTLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVGFIHSLGICHR 165 (383)
T ss_dssp ------------------------CCEEEEEECCCSEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTTEECS
T ss_pred cccccccccccccccccccccCCCceEEEEEEecCCccHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCcCccC
Confidence 0011122211 01
Q ss_pred ccchhhhHhhh-ccCCceEEecCcccc------------------cccccc-ccCCCcceeeechhhHHHHHHHhhCCCC
Q psy11767 194 DCSEEINLLRA-CQGHPNIVNLHCVFQ------------------DEVIDW-DDFSRGIECVFFSSSLIIFFIILSFTLS 253 (966)
Q Consensus 194 ~~~~e~nil~~-~~gh~~iv~l~~~~~------------------~e~i~~-~~y~~~~d~~~~~~~~il~~~m~~g~~p 253 (966)
|++++ |||.+ .+|.++|+||+.+.. +|++.. ..|+...| .|+.|+++|+|++|.+|
T Consensus 166 Dikp~-Nil~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~D---iwslG~il~ell~g~~p 241 (383)
T 3eb0_A 166 DIKPQ-NLLVNSKDNTLKLCDFGSAKKLIPSEPSVAYICSRFYRAPELMLGATEYTPSID---LWSIGCVFGELILGKPL 241 (383)
T ss_dssp CCCGG-GEEEETTTTEEEECCCTTCEECCTTSCCCCCCCCSSCCCHHHHTTCSSCCTHHH---HHHHHHHHHHHHHSSCS
T ss_pred ccCHH-HEEEcCCCCcEEEEECCCCcccCCCCCCcCcccCCCccCHHHhcCCCCCCcchh---hhhHHHHHHHHHhCCCC
Confidence 44444 99997 578999999987631 233332 23555555 44667888899999999
Q ss_pred CCCCcHHHHHHHHHh--C---------------CCC------------CCCCCCHHHHHHHHhhcccCCCcccCCCCCCH
Q psy11767 254 FIHDYYHIQYRRILK--T---------------EPP------------IPEDLSPDVADFISRLLVKDPRRRLGGGELDA 304 (966)
Q Consensus 254 f~~~~~~~~~~~I~~--~---------------~~~------------~P~~~s~~a~dli~~LL~kdp~~RLG~~~~g~ 304 (966)
|...+.......|+. + ... +|..++++++|||+++|+.||.+|+. +
T Consensus 242 f~~~~~~~~~~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t-----~ 316 (383)
T 3eb0_A 242 FSGETSIDQLVRIIQIMGTPTKEQMIRMNPHYTEVRFPTLKAKDWRKILPEGTPSLAIDLLEQILRYEPDLRIN-----P 316 (383)
T ss_dssp SCCSSHHHHHHHHHHHHCCCCHHHHHHHCTTC--CCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSGGGSCC-----H
T ss_pred CCCCChHHHHHHHHHHhCCCCHHHHHHhCcccccccCCccCcccHHhhCCCCCCHHHHHHHHHHccCChhhCCC-----H
Confidence 998887777777763 1 111 56678999999999999999999984 8
Q ss_pred HHHhcCCceeeeCc
Q psy11767 305 EELKRHPFFNVIDW 318 (966)
Q Consensus 305 ~~Ik~HpfF~~idW 318 (966)
.|+.+||||+.+.+
T Consensus 317 ~e~l~hp~f~~~~~ 330 (383)
T 3eb0_A 317 YEAMAHPFFDHLRN 330 (383)
T ss_dssp HHHHTSGGGHHHHH
T ss_pred HHHhcCHHHHHHHh
Confidence 99999999998754
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 4ec9_A* 4ec8_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* 4bch_A* 4bci_A* 4bcj_A* 4bcf_A* | Back alignment and structure |
|---|
Probab=99.76 E-value=1.7e-18 Score=194.40 Aligned_cols=192 Identities=19% Similarity=0.238 Sum_probs=138.0
Q ss_pred CcceeeeecccccceEEEEEEcCCCCEEEEEeccccc-------hhhHHHHHHHHhhCCCcccccccccccc--------
Q psy11767 117 DLDKAGILGDGSYSVCRRCVEKSTGQEYAVKIISRKI-------DCSEEINLLRACQGHPNICRRCVEKSTG-------- 181 (966)
Q Consensus 117 df~~~~~LG~GsFGkV~La~~k~tg~~yAiKvl~K~~-------~~~~E~~il~~~~~~pfi~~~~~~~~~~-------- 181 (966)
+|++++.||+|+||+|++|+++.+|+.||||++.+.. ...+|..+|+++ +||+|++..-.....
T Consensus 18 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~~~~~ 96 (351)
T 3mi9_A 18 KYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLL-KHENVVNLIEICRTKASPYNRCK 96 (351)
T ss_dssp GEEEEEECSSCSTTSEEEEEETTTCCEEEEEECCCSSCSSSSCHHHHHHHHHHHHC-CCTTBCCEEEEEEEC--------
T ss_pred ceeEEEEEecCCCcEEEEEEECCCCCEEEEEEEecccccccchHHHHHHHHHHHhc-cCCCcccHhheeeccccccccCC
Confidence 6799999999999999999999999999999997542 346899999998 599998632111100
Q ss_pred ------------------------------hhHHHHHHHh----------hcccchhhhHhhhccCCceEEecCcccc--
Q psy11767 182 ------------------------------QEYAVKIISR----------KIDCSEEINLLRACQGHPNIVNLHCVFQ-- 219 (966)
Q Consensus 182 ------------------------------~~~~~~~v~~----------~~~~~~e~nil~~~~gh~~iv~l~~~~~-- 219 (966)
...+.+++.+ ..|++++ |||.+.+|+++|+||+.+..
T Consensus 97 ~~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~-NIl~~~~~~~kl~Dfg~a~~~~ 175 (351)
T 3mi9_A 97 GSIYLVFDFCEHDLAGLLSNVLVKFTLSEIKRVMQMLLNGLYYIHRNKILHRDMKAA-NVLITRDGVLKLADFGLARAFS 175 (351)
T ss_dssp CEEEEEEECCSEEHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGG-GEEECTTSCEEECCCTTCEECC
T ss_pred ceEEEEEeccCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCHH-HEEEcCCCCEEEccchhccccc
Confidence 0111122211 1244455 99999999999999986521
Q ss_pred ---------------------cccccc-ccCCCcceeeechhhHHHHHHHhhCCCCCCCCcHHHHHHHHHhCCCCCCCC-
Q psy11767 220 ---------------------DEVIDW-DDFSRGIECVFFSSSLIIFFIILSFTLSFIHDYYHIQYRRILKTEPPIPED- 276 (966)
Q Consensus 220 ---------------------~e~i~~-~~y~~~~d~~~~~~~~il~~~m~~g~~pf~~~~~~~~~~~I~~~~~~~P~~- 276 (966)
+|++.. ..|+...| .|+.|+++|+|++|.+||...+...+...|......+|..
T Consensus 176 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~D---iwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~ 252 (351)
T 3mi9_A 176 LAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPID---LWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITPEV 252 (351)
T ss_dssp CCSSSSCCCCCSSCSCGGGCCHHHHTTCCSCCTHHH---HHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTT
T ss_pred ccccccccccCCcccccCccCchhhcCCCCCCcHhH---HHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhh
Confidence 233332 23544444 4466788899999999999988887777776532222221
Q ss_pred -------------------------------CCHHHHHHHHhhcccCCCcccCCCCCCHHHHhcCCceeeeCc
Q psy11767 277 -------------------------------LSPDVADFISRLLVKDPRRRLGGGELDAEELKRHPFFNVIDW 318 (966)
Q Consensus 277 -------------------------------~s~~a~dli~~LL~kdp~~RLG~~~~g~~~Ik~HpfF~~idW 318 (966)
.+++++|||+++|+.||.+|+. ++|+.+||||.+..+
T Consensus 253 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t-----~~e~l~hp~f~~~~~ 320 (351)
T 3mi9_A 253 WPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRID-----SDDALNHDFFWSDPM 320 (351)
T ss_dssp STTGGGCGGGTSSCCCSSCCCCHHHHHHHHHCCHHHHHHHHHHSCSSGGGSCC-----HHHHHTSGGGGSSSC
T ss_pred ccccccchhhcccccccccccCHHHHhhhccCChHHHHHHHHHhcCChhhCCC-----HHHHhCCCCcCCCCC
Confidence 2788999999999999999984 899999999976544
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.76 E-value=1.3e-18 Score=193.46 Aligned_cols=193 Identities=23% Similarity=0.297 Sum_probs=138.6
Q ss_pred CcceeeeecccccceEEEEEEcCCCCEEEEEeccccc------hhhHHHHHHHHhhCCCcccccccccccc---------
Q psy11767 117 DLDKAGILGDGSYSVCRRCVEKSTGQEYAVKIISRKI------DCSEEINLLRACQGHPNICRRCVEKSTG--------- 181 (966)
Q Consensus 117 df~~~~~LG~GsFGkV~La~~k~tg~~yAiKvl~K~~------~~~~E~~il~~~~~~pfi~~~~~~~~~~--------- 181 (966)
+|.+++.||+|+||+|++|+++.+|+.||||++++.. ...+|..+|+++ +||+|+...-.....
T Consensus 3 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~e~ 81 (324)
T 3mtl_A 3 TYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDL-KHANIVTLHDIIHTEKSLTLVFEY 81 (324)
T ss_dssp SEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECC------CCCCCCCHHHHSCC-CCTTBCCEEEEEECSSCEEEEEEC
T ss_pred ceEEEEEEcCCCCEEEEEEEECCCCcEEEEEEEecccccccchhHHHHHHHHHhc-CCCCCCeeeeEEeeCCEEEEEecc
Confidence 5789999999999999999999999999999998642 345799999888 599998622111110
Q ss_pred ---------------------hhHHHHHHHh----------hcccchhhhHhhhccCCceEEecCcccc-----------
Q psy11767 182 ---------------------QEYAVKIISR----------KIDCSEEINLLRACQGHPNIVNLHCVFQ----------- 219 (966)
Q Consensus 182 ---------------------~~~~~~~v~~----------~~~~~~e~nil~~~~gh~~iv~l~~~~~----------- 219 (966)
..++.+++.+ ..|++++ |||.+.+|.++|+||+.+..
T Consensus 82 ~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dikp~-NIl~~~~~~~kl~Dfg~a~~~~~~~~~~~~~ 160 (324)
T 3mtl_A 82 LDKDLKQYLDDCGNIINMHNVKLFLFQLLRGLAYCHRQKVLHRDLKPQ-NLLINERGELKLADFGLARAKSIPTKTYDNE 160 (324)
T ss_dssp CSEEHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEEESSCCGG-GEEECTTCCEEECSSSEEECC----------
T ss_pred cccCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccCCCcCHH-HEEECCCCCEEEccCcccccccCCccccccc
Confidence 1111122221 0144444 99999999999999986532
Q ss_pred --------cccccc-ccCCCcceeeechhhHHHHHHHhhCCCCCCCCcHHHHHHHHHh--CCC-----------------
Q psy11767 220 --------DEVIDW-DDFSRGIECVFFSSSLIIFFIILSFTLSFIHDYYHIQYRRILK--TEP----------------- 271 (966)
Q Consensus 220 --------~e~i~~-~~y~~~~d~~~~~~~~il~~~m~~g~~pf~~~~~~~~~~~I~~--~~~----------------- 271 (966)
+|++.. ..|+...| .|+.|+++|+|++|.+||...+...+...|.. +.+
T Consensus 161 ~~t~~y~aPE~~~~~~~~~~~~D---iwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~ 237 (324)
T 3mtl_A 161 VVTLWYRPPDILLGSTDYSTQID---MWGVGCIFYEMATGRPLFPGSTVEEQLHFIFRILGTPTEETWPGILSNEEFKTY 237 (324)
T ss_dssp --CGGGCCHHHHTTCCCCCTHHH---HHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGCHHHHHT
T ss_pred cCcccccChhhhcCCCCCCcHHH---HHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHhchhhhcchhhccc
Confidence 233332 34544444 44677888889999999998888777776654 111
Q ss_pred CC-----------CCCCCHHHHHHHHhhcccCCCcccCCCCCCHHHHhcCCceeeeCcc
Q psy11767 272 PI-----------PEDLSPDVADFISRLLVKDPRRRLGGGELDAEELKRHPFFNVIDWD 319 (966)
Q Consensus 272 ~~-----------P~~~s~~a~dli~~LL~kdp~~RLG~~~~g~~~Ik~HpfF~~idW~ 319 (966)
.+ +..++++++|||+++|+.||.+|+. ++|+.+||||.++.+.
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t-----~~e~l~hp~f~~~~~~ 291 (324)
T 3mtl_A 238 NYPKYRAEALLSHAPRLDSDGADLLTKLLQFEGRNRIS-----AEDAMKHPFFLSLGER 291 (324)
T ss_dssp CCCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSGGGSCC-----HHHHTTSGGGGGGCST
T ss_pred ccccccchhhhhhcCCCCHHHHHHHHHHcCcCcccCCC-----HHHHhcChhhhhcccc
Confidence 11 2357899999999999999999984 8999999999987753
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* | Back alignment and structure |
|---|
Probab=99.75 E-value=2e-18 Score=203.57 Aligned_cols=192 Identities=24% Similarity=0.317 Sum_probs=140.4
Q ss_pred CcceeeeecccccceEEEEEEcCCCCEEEEEeccccc-------hhhHHHHHHHHhhCCCcccccccccccc--------
Q psy11767 117 DLDKAGILGDGSYSVCRRCVEKSTGQEYAVKIISRKI-------DCSEEINLLRACQGHPNICRRCVEKSTG-------- 181 (966)
Q Consensus 117 df~~~~~LG~GsFGkV~La~~k~tg~~yAiKvl~K~~-------~~~~E~~il~~~~~~pfi~~~~~~~~~~-------- 181 (966)
+|++++.||+|+||+|++|+++.+|+.||||++++.. ...+|..+|+.+ +||+|++.+-.+...
T Consensus 38 ~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l-~hpniv~~~~~~~~~~~~~lv~e 116 (494)
T 3lij_A 38 MYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLL-DHPNIMKLYDFFEDKRNYYLVME 116 (494)
T ss_dssp HEEEEEEEECC---EEEEEEETTTCCEEEEEEEEC-----CTTHHHHHHHHHHTTC-CCTTBCCEEEEEECSSEEEEEEE
T ss_pred CeEEeeEEecCCCEEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHhC-CCCCCCeEEEEEEeCCEEEEEEe
Confidence 3489999999999999999999999999999998752 357899999887 699998722111111
Q ss_pred ----------------------hhHHHHHHHh----------hcccchhhhHhhhcc---CCceEEecCccc--------
Q psy11767 182 ----------------------QEYAVKIISR----------KIDCSEEINLLRACQ---GHPNIVNLHCVF-------- 218 (966)
Q Consensus 182 ----------------------~~~~~~~v~~----------~~~~~~e~nil~~~~---gh~~iv~l~~~~-------- 218 (966)
..+..+++.+ ..|++++ |||.+.. +.++|+||+.+.
T Consensus 117 ~~~~g~L~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~-Nil~~~~~~~~~~kl~DfG~a~~~~~~~~~ 195 (494)
T 3lij_A 117 CYKGGELFDEIIHRMKFNEVDAAVIIKQVLSGVTYLHKHNIVHRDLKPE-NLLLESKEKDALIKIVDFGLSAVFENQKKM 195 (494)
T ss_dssp CCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGG-GEEESCSSTTCCEEECCCTTCEECBTTBCB
T ss_pred cCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCChh-hEEEeCCCCCCcEEEEECCCCeECCCCccc
Confidence 0111122211 1244445 9998653 558999998653
Q ss_pred ----------cccccccccCCCcceeeechhhHHHHHHHhhCCCCCCCCcHHHHHHHHHhCCCCCC----CCCCHHHHHH
Q psy11767 219 ----------QDEVIDWDDFSRGIECVFFSSSLIIFFIILSFTLSFIHDYYHIQYRRILKTEPPIP----EDLSPDVADF 284 (966)
Q Consensus 219 ----------~~e~i~~~~y~~~~d~~~~~~~~il~~~m~~g~~pf~~~~~~~~~~~I~~~~~~~P----~~~s~~a~dl 284 (966)
.+|++. ..|+...| .|+.|+++|+|++|.+||...+...++++|..+.+.++ ..+|+++++|
T Consensus 196 ~~~~gt~~y~aPE~l~-~~~~~~~D---iwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~l 271 (494)
T 3lij_A 196 KERLGTAYYIAPEVLR-KKYDEKCD---VWSIGVILFILLAGYPPFGGQTDQEILRKVEKGKYTFDSPEWKNVSEGAKDL 271 (494)
T ss_dssp CCCCSCTTTCCHHHHT-TCBCTHHH---HHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCSGGGTTSCHHHHHH
T ss_pred cccCCCcCeeCHHHHc-ccCCCchh---HHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCchhcccCCHHHHHH
Confidence 134443 34554444 44667888899999999999999999999999988876 3689999999
Q ss_pred HHhhcccCCCcccCCCCCCHHHHhcCCceeeeCcc
Q psy11767 285 ISRLLVKDPRRRLGGGELDAEELKRHPFFNVIDWD 319 (966)
Q Consensus 285 i~~LL~kdp~~RLG~~~~g~~~Ik~HpfF~~idW~ 319 (966)
|+++|+.||.+|+. +.++.+||||+.+.+.
T Consensus 272 i~~~L~~dp~~R~s-----~~e~l~hp~~~~~~~~ 301 (494)
T 3lij_A 272 IKQMLQFDSQRRIS-----AQQALEHPWIKEMCSK 301 (494)
T ss_dssp HHHHTCSSTTTSCC-----HHHHHTCHHHHHHHHH
T ss_pred HHHHCCCChhhCcc-----HHHHhcCcccccCccc
Confidence 99999999999984 8999999999876543
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.75 E-value=7.1e-19 Score=197.06 Aligned_cols=195 Identities=19% Similarity=0.276 Sum_probs=139.6
Q ss_pred CcceeeeecccccceEEEEEEcCCCCEEEEEeccccc-------------hhhHHHHHHHHhhCCCcccccccccccc--
Q psy11767 117 DLDKAGILGDGSYSVCRRCVEKSTGQEYAVKIISRKI-------------DCSEEINLLRACQGHPNICRRCVEKSTG-- 181 (966)
Q Consensus 117 df~~~~~LG~GsFGkV~La~~k~tg~~yAiKvl~K~~-------------~~~~E~~il~~~~~~pfi~~~~~~~~~~-- 181 (966)
+|.+++.||+|+||+||+|+++.+|+.||||++++.. ...+|..+|+++ +||+|++..-.+...
T Consensus 25 ~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~Iv~~~~~~~~~~~ 103 (335)
T 3dls_A 25 KYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRV-EHANIIKVLDIFENQGF 103 (335)
T ss_dssp HEEEEEECSSSSSCSEEEEEETTTTEEEEEEEEESTTSCTTSEEEETTTEEEEHHHHHHTTC-CCTTBCCEEEEEECSSE
T ss_pred ceEEEeEEEecCCEEEEEEEECCCCcEEEEEEEehhhcccccccchHHHHHHHHHHHHHHhC-CCCCEeeEEEEEeeCCE
Confidence 5599999999999999999999999999999998752 346799999998 699998722111110
Q ss_pred -----------------------------hhHHHHHHHh----------hcccchhhhHhhhccCCceEEecCcccc---
Q psy11767 182 -----------------------------QEYAVKIISR----------KIDCSEEINLLRACQGHPNIVNLHCVFQ--- 219 (966)
Q Consensus 182 -----------------------------~~~~~~~v~~----------~~~~~~e~nil~~~~gh~~iv~l~~~~~--- 219 (966)
..++.+++.+ ..|++++ |||.+.+|.++|+||+.+..
T Consensus 104 ~~lv~e~~~~g~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~-NIll~~~~~~kL~Dfg~a~~~~~ 182 (335)
T 3dls_A 104 FQLVMEKHGSGLDLFAFIDRHPRLDEPLASYIFRQLVSAVGYLRLKDIIHRDIKDE-NIVIAEDFTIKLIDFGSAAYLER 182 (335)
T ss_dssp EEEEEECCTTSCBHHHHHHTCCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGG-GEEECTTSCEEECCCTTCEECCT
T ss_pred EEEEEEeCCCCccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEEeccCHH-HEEEcCCCcEEEeecccceECCC
Confidence 0111122211 1244444 99999999999999987632
Q ss_pred ---------------ccccccccC-CCcceeeechhhHHHHHHHhhCCCCCCCCcHHHHHHHHHhCCCCCCCCCCHHHHH
Q psy11767 220 ---------------DEVIDWDDF-SRGIECVFFSSSLIIFFIILSFTLSFIHDYYHIQYRRILKTEPPIPEDLSPDVAD 283 (966)
Q Consensus 220 ---------------~e~i~~~~y-~~~~d~~~~~~~~il~~~m~~g~~pf~~~~~~~~~~~I~~~~~~~P~~~s~~a~d 283 (966)
+|++....| +...| .|+.|+++|+|++|.+||... ..++......|..+++++++
T Consensus 183 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~D---iwslG~il~el~~g~~pf~~~------~~~~~~~~~~~~~~~~~l~~ 253 (335)
T 3dls_A 183 GKLFYTFCGTIEYCAPEVLMGNPYRGPELE---MWSLGVTLYTLVFEENPFCEL------EETVEAAIHPPYLVSKELMS 253 (335)
T ss_dssp TCCBCEECSCGGGCCHHHHTTCCBCSHHHH---HHHHHHHHHHHHHSSCSCSSG------GGGTTTCCCCSSCCCHHHHH
T ss_pred CCceeccCCCccccChhhhcCCCCCCCccc---chhHHHHHHHHHhCCCchhhH------HHHHhhccCCCcccCHHHHH
Confidence 233333333 22233 446778888899999999763 33556677788899999999
Q ss_pred HHHhhcccCCCcccCCCCCCHHHHhcCCcee------eeCccccccCCCC
Q psy11767 284 FISRLLVKDPRRRLGGGELDAEELKRHPFFN------VIDWDDLATKRIP 327 (966)
Q Consensus 284 li~~LL~kdp~~RLG~~~~g~~~Ik~HpfF~------~idW~~l~~k~~~ 327 (966)
||+++|.+||.+|. .+++|.+||||+ .++|+.+.....+
T Consensus 254 li~~~L~~dP~~Rp-----s~~ell~hp~~~~~~~~~~~~~~~~~~~~~~ 298 (335)
T 3dls_A 254 LVSGLLQPVPERRT-----TLEKLVTDPWVTQPVNLADYTWEEVFRVNKP 298 (335)
T ss_dssp HHHHHTCSSGGGSC-----CHHHHHHCTTTTCCCCGGGCCHHHHC-----
T ss_pred HHHHHccCChhhCc-----CHHHHhcCccccCCccccccCHHHHhhhcCC
Confidence 99999999999998 489999999995 4677777655433
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.75 E-value=1.2e-18 Score=198.37 Aligned_cols=194 Identities=25% Similarity=0.378 Sum_probs=139.0
Q ss_pred cceeeeecccccceEEEEEEcCCCCEEEEEecccc-----chhhHHHHHHHHhhCCCcccccccccccc-----------
Q psy11767 118 LDKAGILGDGSYSVCRRCVEKSTGQEYAVKIISRK-----IDCSEEINLLRACQGHPNICRRCVEKSTG----------- 181 (966)
Q Consensus 118 f~~~~~LG~GsFGkV~La~~k~tg~~yAiKvl~K~-----~~~~~E~~il~~~~~~pfi~~~~~~~~~~----------- 181 (966)
+...++||+|+||+|++|+++.+|+.||+|++++. ....+|..+|+++ +||+|++.+-.+...
T Consensus 91 ~~~~~~lG~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~hpnIv~~~~~~~~~~~~~lv~E~~~ 169 (373)
T 2x4f_A 91 VSKTEILGGGRFGQVHKCEETATGLKLAAKIIKTRGMKDKEEVKNEISVMNQL-DHANLIQLYDAFESKNDIVLVMEYVD 169 (373)
T ss_dssp EEEEEECC-----CEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTC-CCTTBCCEEEEEECSSEEEEEEECCT
T ss_pred eecceEEecCcCEEEEEEEEcCCCcEEEEEEEcccccccHHHHHHHHHHHHhC-CCCCCCeEEEEEEECCEEEEEEeCCC
Confidence 34577899999999999999999999999999864 2457899999988 699998622111110
Q ss_pred --------------------hhHHHHHHHh----------hcccchhhhHhh--hccCCceEEecCcccc----------
Q psy11767 182 --------------------QEYAVKIISR----------KIDCSEEINLLR--ACQGHPNIVNLHCVFQ---------- 219 (966)
Q Consensus 182 --------------------~~~~~~~v~~----------~~~~~~e~nil~--~~~gh~~iv~l~~~~~---------- 219 (966)
..++.+++.+ ..|++++ |||. +..+.++|+||+.+..
T Consensus 170 ~~~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~-NIll~~~~~~~~kl~DFG~a~~~~~~~~~~~~ 248 (373)
T 2x4f_A 170 GGELFDRIIDESYNLTELDTILFMKQICEGIRHMHQMYILHLDLKPE-NILCVNRDAKQIKIIDFGLARRYKPREKLKVN 248 (373)
T ss_dssp TCEEHHHHHHTGGGCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGG-GEEEEETTTTEEEECCCSSCEECCTTCBCCCC
T ss_pred CCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCHH-HEEEecCCCCcEEEEeCCCceecCCccccccc
Confidence 0111122211 1144444 9887 4557899999986532
Q ss_pred --------ccccccccCCCcceeeechhhHHHHHHHhhCCCCCCCCcHHHHHHHHHhCCCCCC----CCCCHHHHHHHHh
Q psy11767 220 --------DEVIDWDDFSRGIECVFFSSSLIIFFIILSFTLSFIHDYYHIQYRRILKTEPPIP----EDLSPDVADFISR 287 (966)
Q Consensus 220 --------~e~i~~~~y~~~~d~~~~~~~~il~~~m~~g~~pf~~~~~~~~~~~I~~~~~~~P----~~~s~~a~dli~~ 287 (966)
+|++....|+...| .|+.|+++|+|++|.+||...+...++++|+.....+| ..+++++++||++
T Consensus 249 ~gt~~y~aPE~~~~~~~~~~~D---iwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~ 325 (373)
T 2x4f_A 249 FGTPEFLAPEVVNYDFVSFPTD---MWSVGVIAYMLLSGLSPFLGDNDAETLNNILACRWDLEDEEFQDISEEAKEFISK 325 (373)
T ss_dssp CSSCTTCCHHHHTTCBCCHHHH---HHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCCCSCSGGGTTSCHHHHHHHHT
T ss_pred cCCCcEeChhhccCCCCCcHHh---HHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCCCChhhhccCCHHHHHHHHH
Confidence 24444444443344 44667888999999999999998889999999887776 4689999999999
Q ss_pred hcccCCCcccCCCCCCHHHHhcCCceeeeCcccc
Q psy11767 288 LLVKDPRRRLGGGELDAEELKRHPFFNVIDWDDL 321 (966)
Q Consensus 288 LL~kdp~~RLG~~~~g~~~Ik~HpfF~~idW~~l 321 (966)
||+.||.+|+. ++++.+||||.+..|...
T Consensus 326 ~L~~dp~~Rps-----~~e~l~hp~~~~~~~~~~ 354 (373)
T 2x4f_A 326 LLIKEKSWRIS-----ASEALKHPWLSDHKLHSR 354 (373)
T ss_dssp TSCSSGGGSCC-----HHHHHHSHHHHCHHHHHH
T ss_pred HcCCChhhCCC-----HHHHhcCcCcCCCchhhh
Confidence 99999999984 899999999998877543
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A | Back alignment and structure |
|---|
Probab=99.75 E-value=2.9e-18 Score=187.05 Aligned_cols=190 Identities=23% Similarity=0.324 Sum_probs=135.2
Q ss_pred CcceeeeecccccceEEEEEEcCCCCEEEEEeccccc-------hhhHHHHHHHHhhCCCcccccccccccc--------
Q psy11767 117 DLDKAGILGDGSYSVCRRCVEKSTGQEYAVKIISRKI-------DCSEEINLLRACQGHPNICRRCVEKSTG-------- 181 (966)
Q Consensus 117 df~~~~~LG~GsFGkV~La~~k~tg~~yAiKvl~K~~-------~~~~E~~il~~~~~~pfi~~~~~~~~~~-------- 181 (966)
+|.+++.||+|+||+|++|++ .+|+.||||++++.. ...+|..+|+++ +||+|++.+-.+...
T Consensus 3 ~y~~~~~lg~G~~g~V~~~~~-~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~e 80 (288)
T 1ob3_A 3 KYHGLEKIGEGTYGVVYKAQN-NYGETFALKKIRLEKEDEGIPSTTIREISILKEL-KHSNIVKLYDVIHTKKRLVLVFE 80 (288)
T ss_dssp SEEEEEEEEEETTEEEEEEEE-TTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGC-CCTTBCCEEEEEECSSCEEEEEE
T ss_pred cchhhhhcccCCCEEEEEEEc-CCCCEEEEEEEeccccccccchhHHHHHHHHHhc-CCCCEeeeeeEEccCCeEEEEEE
Confidence 578999999999999999999 689999999997532 346799999888 599998722111110
Q ss_pred ----------------------hhHHHHHHHh----------hcccchhhhHhhhccCCceEEecCccc-----------
Q psy11767 182 ----------------------QEYAVKIISR----------KIDCSEEINLLRACQGHPNIVNLHCVF----------- 218 (966)
Q Consensus 182 ----------------------~~~~~~~v~~----------~~~~~~e~nil~~~~gh~~iv~l~~~~----------- 218 (966)
..++.+++.+ ..|++++ |||.+.+|.++|+||+.+.
T Consensus 81 ~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~-Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~ 159 (288)
T 1ob3_A 81 HLDQDLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHDRRVLHRDLKPQ-NLLINREGELKIADFGLARAFGIPVRKYTH 159 (288)
T ss_dssp CCSEEHHHHHHTSTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGG-GEEECTTSCEEECCTTHHHHHCC-------
T ss_pred ecCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHH-HEEEcCCCCEEEeECccccccCcccccccc
Confidence 1111122221 1244445 9999999999999998652
Q ss_pred --------ccccccc-ccCCCcceeeechhhHHHHHHHhhCCCCCCCCcHHHHHHHHHh--CCC----------------
Q psy11767 219 --------QDEVIDW-DDFSRGIECVFFSSSLIIFFIILSFTLSFIHDYYHIQYRRILK--TEP---------------- 271 (966)
Q Consensus 219 --------~~e~i~~-~~y~~~~d~~~~~~~~il~~~m~~g~~pf~~~~~~~~~~~I~~--~~~---------------- 271 (966)
.+|++.. ..|+...| .|+.|+++|+|++|.+||...+......+|+. +.+
T Consensus 160 ~~~t~~y~aPE~~~~~~~~~~~~D---iwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (288)
T 1ob3_A 160 EIVTLWYRAPDVLMGSKKYSTTID---IWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKYDP 236 (288)
T ss_dssp --CCCTTCCHHHHTTCCSCCTHHH---HHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGSTTCCT
T ss_pred ccccccccCchheeCCCCCCcHHH---HHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHHCCCChhhchhhhccccccc
Confidence 2344432 23554444 44677888899999999998777766666653 111
Q ss_pred -----------CCCCCCCHHHHHHHHhhcccCCCcccCCCCCCHHHHhcCCceeeeC
Q psy11767 272 -----------PIPEDLSPDVADFISRLLVKDPRRRLGGGELDAEELKRHPFFNVID 317 (966)
Q Consensus 272 -----------~~P~~~s~~a~dli~~LL~kdp~~RLG~~~~g~~~Ik~HpfF~~id 317 (966)
.++..+++++++||+++|+.||.+|.. ++++.+||||++.|
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt-----~~e~l~hp~f~~~n 288 (288)
T 1ob3_A 237 NFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRIT-----AKQALEHAYFKENN 288 (288)
T ss_dssp TCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCC-----HHHHHTSGGGGC--
T ss_pred ccccccCccHHHHhhhcCHHHHHHHHHHcCCCcccCCC-----HHHHhcCcchhhcC
Confidence 123458999999999999999999984 89999999998754
|
| >4gt4_A Tyrosine-protein kinase transmembrane receptor RO; ATP binding, phosphorylation, transferase; 2.41A {Homo sapiens} PDB: 3zzw_A | Back alignment and structure |
|---|
Probab=99.75 E-value=3e-18 Score=190.07 Aligned_cols=184 Identities=17% Similarity=0.145 Sum_probs=134.4
Q ss_pred CcceeeeecccccceEEEEEEc-----CCCCEEEEEeccccc------hhhHHHHHHHHhhCCCcccccccccccc----
Q psy11767 117 DLDKAGILGDGSYSVCRRCVEK-----STGQEYAVKIISRKI------DCSEEINLLRACQGHPNICRRCVEKSTG---- 181 (966)
Q Consensus 117 df~~~~~LG~GsFGkV~La~~k-----~tg~~yAiKvl~K~~------~~~~E~~il~~~~~~pfi~~~~~~~~~~---- 181 (966)
|+.+++.||+|+||+||+++.+ .+++.||||+|+... ...+|..+|.++ +||+||+.+-.....
T Consensus 27 ~~~~~~~lG~G~fG~Vykg~~~~~~~~~~~~~VAvK~l~~~~~~~~~~~f~~E~~il~~l-~HpNIV~l~g~~~~~~~~~ 105 (308)
T 4gt4_A 27 AVRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARL-QHPNVVCLLGVVTKDQPLS 105 (308)
T ss_dssp GEEEEEEEEECSSCEEEEEEEC-------CEEEEEEECCC-CCC-CHHHHHHHHHHHHHC-CCTTBCCEEEEECSSSSCE
T ss_pred HCeEeeEeccCCCcEEEEEEEcCCccCCCCeEEEEEEECcccChHHHHHHHHHHHHHHhC-CCCCCCCcceEEEECCEEE
Confidence 6789999999999999999864 578899999998542 357899999998 699998711110000
Q ss_pred ------------------------------------------hhHHHHHHHh----------hcccchhhhHhhhccCCc
Q psy11767 182 ------------------------------------------QEYAVKIISR----------KIDCSEEINLLRACQGHP 209 (966)
Q Consensus 182 ------------------------------------------~~~~~~~v~~----------~~~~~~e~nil~~~~gh~ 209 (966)
..++.++..+ -.|++++ |||++.++++
T Consensus 106 lV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHRDLK~~-NILl~~~~~~ 184 (308)
T 4gt4_A 106 MIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYLSSHHVVHKDLATR-NVLVYDKLNV 184 (308)
T ss_dssp EEEECCSSCBHHHHHHTTCSSCCCC-----CCEECCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGG-GEEECGGGCE
T ss_pred EEEEcCCCCcHHHHHHhhCccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCCCcccc-ceEECCCCCE
Confidence 0111222211 1255555 9999999999
Q ss_pred eEEecCcccc---------------------ccccccccCCCcceeeechhhHHHHHHHhh-CCCCCCCCcHHHHHHHHH
Q psy11767 210 NIVNLHCVFQ---------------------DEVIDWDDFSRGIECVFFSSSLIIFFIILS-FTLSFIHDYYHIQYRRIL 267 (966)
Q Consensus 210 ~iv~l~~~~~---------------------~e~i~~~~y~~~~d~~~~~~~~il~~~m~~-g~~pf~~~~~~~~~~~I~ 267 (966)
+|.||+.+.. +|++....|+...| .|+.||++|||++ |.+||...+...+.+.|.
T Consensus 185 Ki~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~~s~ksD---VwSfGvvl~El~t~g~~Pf~~~~~~~~~~~i~ 261 (308)
T 4gt4_A 185 KISDLGLFREVYAADYYKLLGNSLLPIRWMAPEAIMYGKFSIDSD---IWSYGVVLWEVFSYGLQPYCGYSNQDVVEMIR 261 (308)
T ss_dssp EECCSCCBCGGGGGGCBCSSSSSCBCGGGCCHHHHHHCCCCHHHH---HHHHHHHHHHHHTTTCCTTTTCCHHHHHHHHH
T ss_pred EECCcccceeccCCCceeEecccccCCcccCHHHHhCCCCCccch---hhhHHHHHHHHHhCCCCCCCCCCHHHHHHHHH
Confidence 9999997631 34455555654444 3456677777776 899999988888999998
Q ss_pred hCC-CCCCCCCCHHHHHHHHhhcccCCCcccCCCCCCHHHHhcC
Q psy11767 268 KTE-PPIPEDLSPDVADFISRLLVKDPRRRLGGGELDAEELKRH 310 (966)
Q Consensus 268 ~~~-~~~P~~~s~~a~dli~~LL~kdp~~RLG~~~~g~~~Ik~H 310 (966)
++. +..|..+++++.+|+.+++.+||.+|. .+.||..+
T Consensus 262 ~~~~~~~p~~~~~~~~~li~~C~~~dP~~RP-----s~~ei~~~ 300 (308)
T 4gt4_A 262 NRQVLPCPDDCPAWVYALMIECWNEFPSRRP-----RFKDIHSR 300 (308)
T ss_dssp TTCCCCCCTTCCHHHHHHHHHHTCSSGGGSC-----CHHHHHHH
T ss_pred cCCCCCCcccchHHHHHHHHHHcCCChhHCc-----CHHHHHHH
Confidence 865 578999999999999999999999997 47888654
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=99.75 E-value=4.1e-18 Score=190.34 Aligned_cols=193 Identities=23% Similarity=0.317 Sum_probs=144.1
Q ss_pred CcceeeeecccccceEEEEEEcCCCCEEEEEeccccc----------hhhHHHHHHHHhhCCCcccccccccccc-----
Q psy11767 117 DLDKAGILGDGSYSVCRRCVEKSTGQEYAVKIISRKI----------DCSEEINLLRACQGHPNICRRCVEKSTG----- 181 (966)
Q Consensus 117 df~~~~~LG~GsFGkV~La~~k~tg~~yAiKvl~K~~----------~~~~E~~il~~~~~~pfi~~~~~~~~~~----- 181 (966)
+|.+++.||+|+||.|++|+++.+++.||||++++.. ...+|..+|+++ +||+|++..-.+...
T Consensus 27 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~hpniv~~~~~~~~~~~~~l 105 (345)
T 3hko_A 27 KYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKL-HHPNIARLYEVYEDEQYICL 105 (345)
T ss_dssp HEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHC---CHHHHHHHHHHHHHHC-CCTTBCCEEEEEECSSEEEE
T ss_pred heeecceeeecCCeEEEEEEECCCCceEEEeehhhhhhcccCHHHHHHHHHHHHHHHhC-CCCCcceeehhhccCCeEEE
Confidence 5699999999999999999999999999999998642 357799999998 599998621111100
Q ss_pred -----------------------------------------------------------------hhHHHHHHHh-----
Q psy11767 182 -----------------------------------------------------------------QEYAVKIISR----- 191 (966)
Q Consensus 182 -----------------------------------------------------------------~~~~~~~v~~----- 191 (966)
...+.+++.+
T Consensus 106 v~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH 185 (345)
T 3hko_A 106 VMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSALHYLH 185 (345)
T ss_dssp EEECCCSCBHHHHEEEEEETTTTEEEEEEECCCCCCSHHHHHHHHHSCC--CEEECCHHHHHHHHHHHHHHHHHHHHHHH
T ss_pred EEeCCCCCcHHHHHHHhhcccccccccccccccccccccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHH
Confidence 0011122221
Q ss_pred -----hcccchhhhHhhhccC--CceEEecCcccc-----------------------cccccc--ccCCCcceeeechh
Q psy11767 192 -----KIDCSEEINLLRACQG--HPNIVNLHCVFQ-----------------------DEVIDW--DDFSRGIECVFFSS 239 (966)
Q Consensus 192 -----~~~~~~e~nil~~~~g--h~~iv~l~~~~~-----------------------~e~i~~--~~y~~~~d~~~~~~ 239 (966)
..|++++ |||.+.++ .++|+||+.+.. +|++.. ..|+...| .|+
T Consensus 186 ~~~ivH~Dlkp~-NIll~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~D---iws 261 (345)
T 3hko_A 186 NQGICHRDIKPE-NFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPKCD---AWS 261 (345)
T ss_dssp HTTEECCCCCGG-GEEESCSSSCCEEECCCTTCEEGGGTTCC--------CCCGGGCCHHHHTCSSSCCCTHHH---HHH
T ss_pred HCCccccCCChh-hEEEecCCCceEEEeeccccccccccCccccccccccCCCccccCchhhccCCCCCCcHHH---HHH
Confidence 0144444 99998766 899999986631 234432 23444444 345
Q ss_pred hHHHHHHHhhCCCCCCCCcHHHHHHHHHhCCCCCCC----CCCHHHHHHHHhhcccCCCcccCCCCCCHHHHhcCCceee
Q psy11767 240 SLIIFFIILSFTLSFIHDYYHIQYRRILKTEPPIPE----DLSPDVADFISRLLVKDPRRRLGGGELDAEELKRHPFFNV 315 (966)
Q Consensus 240 ~~il~~~m~~g~~pf~~~~~~~~~~~I~~~~~~~P~----~~s~~a~dli~~LL~kdp~~RLG~~~~g~~~Ik~HpfF~~ 315 (966)
.|+++|+|++|.+||...+.......++.....++. .+++++++||+++|..||.+|+ .+.++.+||||+.
T Consensus 262 lG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp-----s~~~~l~hp~~~~ 336 (345)
T 3hko_A 262 AGVLLHLLLMGAVPFPGVNDADTISQVLNKKLCFENPNYNVLSPLARDLLSNLLNRNVDERF-----DAMRALQHPWISQ 336 (345)
T ss_dssp HHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCTTSGGGGGSCHHHHHHHHHHSCSCTTTSC-----CHHHHHHSHHHHT
T ss_pred HHHHHHHHHHCCCCCCCCChHHHHHHHHhcccccCCcccccCCHHHHHHHHHHcCCChhHCC-----CHHHHhcChhhcc
Confidence 668888999999999998888889999998877764 4799999999999999999998 4899999999998
Q ss_pred eCcc
Q psy11767 316 IDWD 319 (966)
Q Consensus 316 idW~ 319 (966)
+.|.
T Consensus 337 ~~~~ 340 (345)
T 3hko_A 337 FSDK 340 (345)
T ss_dssp TSSC
T ss_pred ChHh
Confidence 8764
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.75 E-value=3.9e-18 Score=186.97 Aligned_cols=196 Identities=23% Similarity=0.315 Sum_probs=144.7
Q ss_pred CcceeeeecccccceEEEEEEcCCCCEEEEEeccccc---------hhhHHHHHHHHhhCCCccccccccc--ccc----
Q psy11767 117 DLDKAGILGDGSYSVCRRCVEKSTGQEYAVKIISRKI---------DCSEEINLLRACQGHPNICRRCVEK--STG---- 181 (966)
Q Consensus 117 df~~~~~LG~GsFGkV~La~~k~tg~~yAiKvl~K~~---------~~~~E~~il~~~~~~pfi~~~~~~~--~~~---- 181 (966)
+|.+.++||+|+||.|++|+++.+|+.||||++++.. ...+|..+|+++ +||+|++..-.. ...
T Consensus 6 ~y~i~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~~~~~~~~ 84 (305)
T 2wtk_C 6 KYLMGDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRL-RHKNVIQLVDVLYNEEKQKMY 84 (305)
T ss_dssp CBCCCCEEEECSSCEEEEEEBTTTCCEEEEEEECHHHHHHSTTHHHHHHHHHHHHTTC-CCTTBCCEEEEEECC---CEE
T ss_pred ceeEeeEEecCCCeEEEEEEECCCCcEEEEEEeccccccccchhHHHHHHHHHHHHhc-CCCCeeEEEEEEEcCCCCeEE
Confidence 5689999999999999999999999999999998642 356789999888 599998722211 100
Q ss_pred ---------------------------hhHHHHHHHh----------hcccchhhhHhhhccCCceEEecCcccc-----
Q psy11767 182 ---------------------------QEYAVKIISR----------KIDCSEEINLLRACQGHPNIVNLHCVFQ----- 219 (966)
Q Consensus 182 ---------------------------~~~~~~~v~~----------~~~~~~e~nil~~~~gh~~iv~l~~~~~----- 219 (966)
..++.+++.+ ..|++++ |||.+.+|.++|.||+.+..
T Consensus 85 lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~i~H~dlkp~-NIl~~~~~~~kl~dfg~~~~~~~~~ 163 (305)
T 2wtk_C 85 MVMEYCVCGMQEMLDSVPEKRFPVCQAHGYFCQLIDGLEYLHSQGIVHKDIKPG-NLLLTTGGTLKISALGVAEALHPFA 163 (305)
T ss_dssp EEEECCSEEHHHHHHHSTTCSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGG-GEEECTTCCEEECCCTTCEECCTTC
T ss_pred EEehhccCCHHHHHHhCcccccCHHHHHHHHHHHHHHHHHHHHCCeeecCCCcc-cEEEcCCCcEEeeccccccccCccc
Confidence 0011112111 0133334 99999999999999987632
Q ss_pred ----------------ccccccccCCCcceeeechhhHHHHHHHhhCCCCCCCCcHHHHHHHHHhCCCCCCCCCCHHHHH
Q psy11767 220 ----------------DEVIDWDDFSRGIECVFFSSSLIIFFIILSFTLSFIHDYYHIQYRRILKTEPPIPEDLSPDVAD 283 (966)
Q Consensus 220 ----------------~e~i~~~~y~~~~d~~~~~~~~il~~~m~~g~~pf~~~~~~~~~~~I~~~~~~~P~~~s~~a~d 283 (966)
+|++.......+...| .|+.|+++|+|++|.+||...+...+++.|..+.+.+|..+++++.+
T Consensus 164 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~D-i~slG~il~~l~~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~l~~ 242 (305)
T 2wtk_C 164 ADDTCRTSQGSPAFQPPEIANGLDTFSGFKVD-IWSAGVTLYNITTGLYPFEGDNIYKLFENIGKGSYAIPGDCGPPLSD 242 (305)
T ss_dssp SSCEECCCCSCGGGCCHHHHTCCSCEESHHHH-HHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHCCCCCCSSSCHHHHH
T ss_pred cccccccCCCCCCCcChhhccCcccCCcchhh-HHHHHHHHHHHHhCCCCCCCchHHHHHHHHhcCCCCCCCccCHHHHH
Confidence 1222211111122233 44567888899999999999999999999999999999999999999
Q ss_pred HHHhhcccCCCcccCCCCCCHHHHhcCCceeeeCccc
Q psy11767 284 FISRLLVKDPRRRLGGGELDAEELKRHPFFNVIDWDD 320 (966)
Q Consensus 284 li~~LL~kdp~~RLG~~~~g~~~Ik~HpfF~~idW~~ 320 (966)
||+++|..||.+|. .+++|.+||||+...+..
T Consensus 243 li~~~l~~dp~~Rp-----s~~~ll~~~~~~~~~~~~ 274 (305)
T 2wtk_C 243 LLKGMLEYEPAKRF-----SIRQIRQHSWFRKKHPPA 274 (305)
T ss_dssp HHHHHTCSSTTTSC-----CHHHHHHSHHHHSCCCC-
T ss_pred HHHHHccCChhhCC-----CHHHHhcCcccccCCCCc
Confidence 99999999999998 489999999998766543
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A | Back alignment and structure |
|---|
Probab=99.75 E-value=2.6e-18 Score=198.56 Aligned_cols=197 Identities=24% Similarity=0.295 Sum_probs=141.9
Q ss_pred CCcceeeeecccccceEEEEEEcCCCCEEEEEeccccc-------------hhhHHHHHHHHhhCCCcccccccccccc-
Q psy11767 116 MDLDKAGILGDGSYSVCRRCVEKSTGQEYAVKIISRKI-------------DCSEEINLLRACQGHPNICRRCVEKSTG- 181 (966)
Q Consensus 116 ~df~~~~~LG~GsFGkV~La~~k~tg~~yAiKvl~K~~-------------~~~~E~~il~~~~~~pfi~~~~~~~~~~- 181 (966)
-+|.+.+.||+|+||+|++|+++.||+.||||++++.. ...+|..+|+++ +||+|++..-.+...
T Consensus 135 ~~y~~~~~LG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~hpniv~l~~~~~~~~ 213 (419)
T 3i6u_A 135 DEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKL-NHPCIIKIKNFFDAED 213 (419)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGGTTC--------CCHHHHHHHHHHC-CCTTBCCCCEEEESSE
T ss_pred ccEEEEeEEeeCCCeEEEEEEECCCCcEEEEEEEEechhcccccccchhHHHHHHHHHHHHhC-CCCCEeeEEEEEecCc
Confidence 37899999999999999999999999999999998742 246899999998 799998621111110
Q ss_pred ----------------------------hhHHHHHHHh----------hcccchhhhHhhhccC---CceEEecCcccc-
Q psy11767 182 ----------------------------QEYAVKIISR----------KIDCSEEINLLRACQG---HPNIVNLHCVFQ- 219 (966)
Q Consensus 182 ----------------------------~~~~~~~v~~----------~~~~~~e~nil~~~~g---h~~iv~l~~~~~- 219 (966)
..++.+++.+ ..|++++ |||.+..+ .++|+||+.+..
T Consensus 214 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~-NIll~~~~~~~~~kl~DFG~a~~~ 292 (419)
T 3i6u_A 214 YYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQYLHENGIIHRDLKPE-NVLLSSQEEDCLIKITDFGHSKIL 292 (419)
T ss_dssp EEEEEECCTTCBGGGGTSSSCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGG-GEEESSSSSSCCEEECCSSTTTSC
T ss_pred eEEEEEcCCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChH-hEEEecCCCcceEEEeecccceec
Confidence 1111122211 1244444 99986544 489999987632
Q ss_pred -----------------ccccc---cccCCCcceeeechhhHHHHHHHhhCCCCCCCC-cHHHHHHHHHhCCCCCC----
Q psy11767 220 -----------------DEVID---WDDFSRGIECVFFSSSLIIFFIILSFTLSFIHD-YYHIQYRRILKTEPPIP---- 274 (966)
Q Consensus 220 -----------------~e~i~---~~~y~~~~d~~~~~~~~il~~~m~~g~~pf~~~-~~~~~~~~I~~~~~~~P---- 274 (966)
+|++. ...|+...| .|+.|+++|+|++|.+||... ....+.+.|..+...++
T Consensus 293 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~D---iwslG~il~~lltg~~pf~~~~~~~~~~~~i~~~~~~~~~~~~ 369 (419)
T 3i6u_A 293 GETSLMRTLCGTPTYLAPEVLVSVGTAGYNRAVD---CWSLGVILFICLSGYPPFSEHRTQVSLKDQITSGKYNFIPEVW 369 (419)
T ss_dssp C-----------CTTCCTTTTC----CTTHHHHH---HHHHHHHHHHHHHSSCSSCCCSSSCCHHHHHHTTCCCCCHHHH
T ss_pred CCCccccccCCCCCccCceeeecCCCCCCCchhh---hHhHHHHHHHHHHCCCCCCCCcchHHHHHHHhcCCCCCCchhh
Confidence 34432 123333333 446677888999999999754 33345677888877765
Q ss_pred CCCCHHHHHHHHhhcccCCCcccCCCCCCHHHHhcCCceeeeCccccc
Q psy11767 275 EDLSPDVADFISRLLVKDPRRRLGGGELDAEELKRHPFFNVIDWDDLA 322 (966)
Q Consensus 275 ~~~s~~a~dli~~LL~kdp~~RLG~~~~g~~~Ik~HpfF~~idW~~l~ 322 (966)
..+++++++||+++|+.||.+|+. ++++.+||||++.+|....
T Consensus 370 ~~~~~~~~~li~~~L~~dP~~Rps-----~~e~l~hp~~~~~~~~~~~ 412 (419)
T 3i6u_A 370 AEVSEKALDLVKKLLVVDPKARFT-----TEEALRHPWLQDEDMKRKF 412 (419)
T ss_dssp TTSCHHHHHHHHHHSCSSTTTSCC-----HHHHHHSGGGCCHHHHHHH
T ss_pred cccCHHHHHHHHHHccCChhHCcC-----HHHHhCCcccCChhHHHHH
Confidence 468999999999999999999984 8999999999999986643
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} | Back alignment and structure |
|---|
Probab=99.74 E-value=3.8e-18 Score=192.05 Aligned_cols=189 Identities=21% Similarity=0.265 Sum_probs=136.9
Q ss_pred CcceeeeecccccceEEEEEEcCCCCEEEEEecccc----chhhHHHHHHHHhh----CCCccccccccccc--------
Q psy11767 117 DLDKAGILGDGSYSVCRRCVEKSTGQEYAVKIISRK----IDCSEEINLLRACQ----GHPNICRRCVEKST-------- 180 (966)
Q Consensus 117 df~~~~~LG~GsFGkV~La~~k~tg~~yAiKvl~K~----~~~~~E~~il~~~~----~~pfi~~~~~~~~~-------- 180 (966)
+|.+++.||+|+||+||+|+++.+|+.||||++++. .....|..+|++++ .||+|++..-.+..
T Consensus 36 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~~~~~~h~~iv~~~~~~~~~~~~~lv~ 115 (360)
T 3llt_A 36 AFLVIRKMGDGTFGRVLLCQHIDNKKYYAVKVVRNIKKYTRSAKIEADILKKIQNDDINNNNIVKYHGKFMYYDHMCLIF 115 (360)
T ss_dssp TEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSCHHHHHHHHHHHHHHHHTCCCSTTGGGBCCEEEEEEETTEEEEEE
T ss_pred EEEEEEEEcccCCeEEEEEEECCCCeEEEEEEeccchhhhhhhHHHHHHHHHhcccCCCCCCeecccceeeECCeeEEEE
Confidence 679999999999999999999999999999999853 23567999999887 59999862211110
Q ss_pred -----------------------chhHHHHHHHh----------hcccchhhhHhhhc----------------------
Q psy11767 181 -----------------------GQEYAVKIISR----------KIDCSEEINLLRAC---------------------- 205 (966)
Q Consensus 181 -----------------------~~~~~~~~v~~----------~~~~~~e~nil~~~---------------------- 205 (966)
...++.+++.+ ..|++++ |||.+.
T Consensus 116 e~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~-NIll~~~~~~~~~~~~~~~~~~~~~~~~ 194 (360)
T 3llt_A 116 EPLGPSLYEIITRNNYNGFHIEDIKLYCIEILKALNYLRKMSLTHTDLKPE-NILLDDPYFEKSLITVRRVTDGKKIQIY 194 (360)
T ss_dssp CCCCCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGG-GEEESCTTCCEEEEEEECTTTCCEEEEE
T ss_pred cCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCcc-cEEEccccccccccchhccccccccccc
Confidence 01111222222 1244555 999864
Q ss_pred ---cCCceEEecCccc----------------cccccccccCCCcceeeechhhHHHHHHHhhCCCCCCCCcHHHHHHHH
Q psy11767 206 ---QGHPNIVNLHCVF----------------QDEVIDWDDFSRGIECVFFSSSLIIFFIILSFTLSFIHDYYHIQYRRI 266 (966)
Q Consensus 206 ---~gh~~iv~l~~~~----------------~~e~i~~~~y~~~~d~~~~~~~~il~~~m~~g~~pf~~~~~~~~~~~I 266 (966)
.+.++|+||+.+. .+|++....|+...| .|+.|+++|+|++|.+||...+.......|
T Consensus 195 ~~~~~~~kl~DFG~a~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~D---iwslG~il~ell~g~~pf~~~~~~~~~~~~ 271 (360)
T 3llt_A 195 RTKSTGIKLIDFGCATFKSDYHGSIINTRQYRAPEVILNLGWDVSSD---MWSFGCVLAELYTGSLLFRTHEHMEHLAMM 271 (360)
T ss_dssp EESCCCEEECCCTTCEETTSCCCSCCSCGGGCCHHHHTTCCCCTTHH---HHHHHHHHHHHHHSSCSCCCSSHHHHHHHH
T ss_pred ccCCCCEEEEeccCceecCCCCcCccCcccccCcHHHcCCCCCCccc---hHHHHHHHHHHHHCCCCCCCCcHHHHHHHH
Confidence 6889999998763 245565556666555 446778889999999999988777766666
Q ss_pred HhCCCCCC--------------------------CC--------------------CCHHHHHHHHhhcccCCCcccCCC
Q psy11767 267 LKTEPPIP--------------------------ED--------------------LSPDVADFISRLLVKDPRRRLGGG 300 (966)
Q Consensus 267 ~~~~~~~P--------------------------~~--------------------~s~~a~dli~~LL~kdp~~RLG~~ 300 (966)
......+| .. .++++++||+++|+.||.+|+.
T Consensus 272 ~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt-- 349 (360)
T 3llt_A 272 ESIIQPIPKNMLYEATKTNGSKYVNKDELKLAWPENASSINSIKHVKKCLPLYKIIKHELFCDFLYSILQIDPTLRPS-- 349 (360)
T ss_dssp HHHTCCCCHHHHHHHTTSGGGGGEETTTTEECTTTTCSCHHHHHHHHTCCCHHHHCCCHHHHHHHHHHCCSSGGGSCC--
T ss_pred HHhcCCCCHHHHhhhhhccCccccCcccceecCcccccchhhhhhhhhcccccccchHHHHHHHHHHHhcCChhhCCC--
Confidence 54333333 21 2377889999999999999984
Q ss_pred CCCHHHHhcCCcee
Q psy11767 301 ELDAEELKRHPFFN 314 (966)
Q Consensus 301 ~~g~~~Ik~HpfF~ 314 (966)
++|+.+||||+
T Consensus 350 ---a~elL~hp~f~ 360 (360)
T 3llt_A 350 ---PAELLKHKFLE 360 (360)
T ss_dssp ---HHHHTTSGGGC
T ss_pred ---HHHHhcCcccC
Confidence 89999999995
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.74 E-value=1.5e-17 Score=186.92 Aligned_cols=194 Identities=23% Similarity=0.276 Sum_probs=140.5
Q ss_pred CcceeeeecccccceEEEEEEcCCCCEEEEEeccccc-------hhhHHHHHHHHhhCCCcccccccccccc--------
Q psy11767 117 DLDKAGILGDGSYSVCRRCVEKSTGQEYAVKIISRKI-------DCSEEINLLRACQGHPNICRRCVEKSTG-------- 181 (966)
Q Consensus 117 df~~~~~LG~GsFGkV~La~~k~tg~~yAiKvl~K~~-------~~~~E~~il~~~~~~pfi~~~~~~~~~~-------- 181 (966)
+|.+.+.||+|+||+|++|+++.+|+.||||++++.. ...+|..+|+++ +||+|++..-.+...
T Consensus 25 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~~~~~ 103 (353)
T 3coi_A 25 TYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHM-QHENVIGLLDVFTPASSLRNFYD 103 (353)
T ss_dssp TEEEEEEEEECSSEEEEEEEETTTTEEEEEEEESSTTSSHHHHHHHHHHHHHHHHC-CCTTBCCCSEEECSCSSGGGCCC
T ss_pred eEEEeeeEecCCCeEEEEEEECCCCCEEEEEEecccccchHHHHHHHHHHHHHHhc-CCCCcccHhheEeccccccccee
Confidence 6799999999999999999999999999999997631 346789999988 599998622111110
Q ss_pred -------------------------hhHHHHHHHh----------hcccchhhhHhhhccCCceEEecCcccc-------
Q psy11767 182 -------------------------QEYAVKIISR----------KIDCSEEINLLRACQGHPNIVNLHCVFQ------- 219 (966)
Q Consensus 182 -------------------------~~~~~~~v~~----------~~~~~~e~nil~~~~gh~~iv~l~~~~~------- 219 (966)
...+.+++.+ ..|++++ |||.+.+|+++|+||+.+..
T Consensus 104 ~~lv~e~~~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~ivH~dlkp~-NIl~~~~~~~kl~Dfg~~~~~~~~~~~ 182 (353)
T 3coi_A 104 FYLVMPFMQTDLQKIMGLKFSEEKIQYLVYQMLKGLKYIHSAGVVHRDLKPG-NLAVNEDCELKILDFGLARHADAEMTG 182 (353)
T ss_dssp CEEEEECCSEEGGGTTTSCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCCGG-GEEECTTCCEEECSTTCTTC-------
T ss_pred EEEEeccccCCHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHH-HEeECCCCcEEEeecccccCCCCCccc
Confidence 0111122211 0134444 99999999999999987632
Q ss_pred ---------cccccc-ccCCCcceeeechhhHHHHHHHhhCCCCCCCCcHHHHHHHHHhC--------------------
Q psy11767 220 ---------DEVIDW-DDFSRGIECVFFSSSLIIFFIILSFTLSFIHDYYHIQYRRILKT-------------------- 269 (966)
Q Consensus 220 ---------~e~i~~-~~y~~~~d~~~~~~~~il~~~m~~g~~pf~~~~~~~~~~~I~~~-------------------- 269 (966)
+|++.. ..|+...| .|+.|+++|+|++|.+||...+....+..|+..
T Consensus 183 ~~~t~~y~aPE~~~~~~~~~~~~D---i~slG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~ 259 (353)
T 3coi_A 183 YVVTRWYRAPEVILSWMHYNQTVD---IWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGTEFVQKLNDKAAKSY 259 (353)
T ss_dssp -CCSBCCSCHHHHSCCSCCCTTHH---HHHHHHHHHHHHHSSCSSBSSCHHHHHHHHHHHHCBCCHHHHTTCSCHHHHHH
T ss_pred cccCcCcCCHHHHhCcCCCCchhh---HHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHHHhhHHHHHH
Confidence 233333 34544444 446778888999999999988877766666531
Q ss_pred --------C---CCCCCCCCHHHHHHHHhhcccCCCcccCCCCCCHHHHhcCCceeeeCccc
Q psy11767 270 --------E---PPIPEDLSPDVADFISRLLVKDPRRRLGGGELDAEELKRHPFFNVIDWDD 320 (966)
Q Consensus 270 --------~---~~~P~~~s~~a~dli~~LL~kdp~~RLG~~~~g~~~Ik~HpfF~~idW~~ 320 (966)
. ...+..+++++++||+++|+.||.+|+. ++++..||||+.+.+..
T Consensus 260 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt-----~~e~l~hp~f~~~~~~~ 316 (353)
T 3coi_A 260 IQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLT-----AAQALTHPFFEPFRDPE 316 (353)
T ss_dssp HHTSCBCSSCCTTTTCTTSCHHHHHHHHHHSCSCTTTSCC-----HHHHHTSGGGTTTCCGG
T ss_pred HHhCcCCCCccHHHhcCCcCHHHHHHHHHHcCCCcccCCC-----HHHHhcCcchhhccCcc
Confidence 1 1233567999999999999999999984 89999999998776543
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A | Back alignment and structure |
|---|
Probab=99.74 E-value=7.5e-18 Score=185.08 Aligned_cols=190 Identities=24% Similarity=0.296 Sum_probs=141.0
Q ss_pred CcceeeeecccccceEEEEEEcCCCCEEEEEeccccc-----hhhHHHHHHHHhhCCCcccccccccccc----------
Q psy11767 117 DLDKAGILGDGSYSVCRRCVEKSTGQEYAVKIISRKI-----DCSEEINLLRACQGHPNICRRCVEKSTG---------- 181 (966)
Q Consensus 117 df~~~~~LG~GsFGkV~La~~k~tg~~yAiKvl~K~~-----~~~~E~~il~~~~~~pfi~~~~~~~~~~---------- 181 (966)
+|.+.++||+|+||+|++|+++.+|+.||||++++.. ...+|..+|+++ +||+|+...-.....
T Consensus 10 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~ 88 (304)
T 2jam_A 10 TFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLENEIAVLKKI-KHENIVTLEDIYESTTHYYLVMQLV 88 (304)
T ss_dssp HEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECC------HHHHHHHHHHHC-CCTTBCCEEEEEECSSEEEEEECCC
T ss_pred cceeeeeccCCCCceEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHhC-CCCCeeehhhhcccCCEEEEEEEcC
Confidence 4589999999999999999999999999999998642 357899999998 699998621111100
Q ss_pred --------------------hhHHHHHHHh----------hcccchhhhHhh---hccCCceEEecCccc----------
Q psy11767 182 --------------------QEYAVKIISR----------KIDCSEEINLLR---ACQGHPNIVNLHCVF---------- 218 (966)
Q Consensus 182 --------------------~~~~~~~v~~----------~~~~~~e~nil~---~~~gh~~iv~l~~~~---------- 218 (966)
...+.+++.+ ..|++++ |||. +.++.++|.||+.+.
T Consensus 89 ~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dikp~-NIl~~~~~~~~~~kl~Dfg~~~~~~~~~~~~~ 167 (304)
T 2jam_A 89 SGGELFDRILERGVYTEKDASLVIQQVLSAVKYLHENGIVHRDLKPE-NLLYLTPEENSKIMITDFGLSKMEQNGIMSTA 167 (304)
T ss_dssp CSCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCSCCGG-GCEESSSSTTCCEEBCSCSTTCCCCCBTTHHH
T ss_pred CCccHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHH-HEEEecCCCCCCEEEccCCcceecCCCccccc
Confidence 0011111111 0134444 8887 667899999998653
Q ss_pred -------cccccccccCCCcceeeechhhHHHHHHHhhCCCCCCCCcHHHHHHHHHhCCCCCC----CCCCHHHHHHHHh
Q psy11767 219 -------QDEVIDWDDFSRGIECVFFSSSLIIFFIILSFTLSFIHDYYHIQYRRILKTEPPIP----EDLSPDVADFISR 287 (966)
Q Consensus 219 -------~~e~i~~~~y~~~~d~~~~~~~~il~~~m~~g~~pf~~~~~~~~~~~I~~~~~~~P----~~~s~~a~dli~~ 287 (966)
.+|++....|+...| .|+.|+++|+|++|.+||...+...++++|..+.+.+| ..+++++++||.+
T Consensus 168 ~~~~~y~aPE~~~~~~~~~~~D---i~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~ 244 (304)
T 2jam_A 168 CGTPGYVAPEVLAQKPYSKAVD---CWSIGVITYILLCGYPPFYEETESKLFEKIKEGYYEFESPFWDDISESAKDFICH 244 (304)
T ss_dssp HSCCCBCCTTTBSSCSCCHHHH---HHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHCCCCCCTTTTTTSCHHHHHHHHH
T ss_pred cCCCCccChHHhccCCCCchhh---HHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHcCCCCCCccccccCCHHHHHHHHH
Confidence 234444444544444 34567888899999999999998899999999876655 5689999999999
Q ss_pred hcccCCCcccCCCCCCHHHHhcCCceeee
Q psy11767 288 LLVKDPRRRLGGGELDAEELKRHPFFNVI 316 (966)
Q Consensus 288 LL~kdp~~RLG~~~~g~~~Ik~HpfF~~i 316 (966)
+|..||.+|.. ++++.+||||.+.
T Consensus 245 ~l~~dp~~Rps-----~~~~l~h~~~~~~ 268 (304)
T 2jam_A 245 LLEKDPNERYT-----CEKALSHPWIDGN 268 (304)
T ss_dssp HHCSSTTTSCC-----HHHHHTSHHHHSS
T ss_pred HcCCChhHCcC-----HHHHhcCccccCC
Confidence 99999999984 8999999999753
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.74 E-value=3.1e-18 Score=185.34 Aligned_cols=190 Identities=23% Similarity=0.313 Sum_probs=132.7
Q ss_pred CcceeeeecccccceEEEEEEcCCCCEEEEEeccccc--------hhhHHHHHHHHhhCCCcccccccccccc-------
Q psy11767 117 DLDKAGILGDGSYSVCRRCVEKSTGQEYAVKIISRKI--------DCSEEINLLRACQGHPNICRRCVEKSTG------- 181 (966)
Q Consensus 117 df~~~~~LG~GsFGkV~La~~k~tg~~yAiKvl~K~~--------~~~~E~~il~~~~~~pfi~~~~~~~~~~------- 181 (966)
+|.+.+.||+|+||+|++|+++.+|+.||||++++.. ...+|..+|+++ +||+|++..-.+...
T Consensus 12 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~ 90 (278)
T 3cok_A 12 DFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQL-KHPSILELYNYFEDSNYVYLVL 90 (278)
T ss_dssp GEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTB-CCTTBCCEEEEEECSSEEEEEE
T ss_pred cceeeeeecCCCceEEEEEEEccCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHhC-CCCCeEeEEEEEccCCeEEEEE
Confidence 6799999999999999999999999999999998642 356788888887 699997621111110
Q ss_pred ------------------------hhHHHHHHHh-------h---cccchhhhHhhhccCCceEEecCcccc--------
Q psy11767 182 ------------------------QEYAVKIISR-------K---IDCSEEINLLRACQGHPNIVNLHCVFQ-------- 219 (966)
Q Consensus 182 ------------------------~~~~~~~v~~-------~---~~~~~e~nil~~~~gh~~iv~l~~~~~-------- 219 (966)
...+.+++.+ . .|++++ |||.+.+|.++|.||+.+..
T Consensus 91 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~-Nili~~~~~~kl~dfg~~~~~~~~~~~~ 169 (278)
T 3cok_A 91 EMCHNGEMNRYLKNRVKPFSENEARHFMHQIITGMLYLHSHGILHRDLTLS-NLLLTRNMNIKIADFGLATQLKMPHEKH 169 (278)
T ss_dssp ECCTTEEHHHHHHTCSSCCCHHHHHHHHHHHHHHHHHHHHTTEECSSCCGG-GEEECTTCCEEECCCTTCEECC------
T ss_pred ecCCCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHH-HEEEcCCCCEEEEeecceeeccCCCCcc
Confidence 0111122211 0 134444 99999999999999986532
Q ss_pred -----------ccccccccCCCcceeeechhhHHHHHHHhhCCCCCCCCcHHHHHHHHHhCCCCCCCCCCHHHHHHHHhh
Q psy11767 220 -----------DEVIDWDDFSRGIECVFFSSSLIIFFIILSFTLSFIHDYYHIQYRRILKTEPPIPEDLSPDVADFISRL 288 (966)
Q Consensus 220 -----------~e~i~~~~y~~~~d~~~~~~~~il~~~m~~g~~pf~~~~~~~~~~~I~~~~~~~P~~~s~~a~dli~~L 288 (966)
+|++....++...| .|+.|+++|+|++|.+||...+.....+++....+.+|..++.++++||.++
T Consensus 170 ~~~~~~~~y~aPE~~~~~~~~~~~D---i~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~ 246 (278)
T 3cok_A 170 YTLCGTPNYISPEIATRSAHGLESD---VWSLGCMFYTLLIGRPPFDTDTVKNTLNKVVLADYEMPSFLSIEAKDLIHQL 246 (278)
T ss_dssp ----------------------CTH---HHHHHHHHHHHHHSSCSSCCCSCC-----CCSSCCCCCTTSCHHHHHHHHHH
T ss_pred eeccCCCCcCCcchhcCCCCCchhh---HHHHHHHHHHHHhCCCCCCChhHHHHHHHHhhcccCCccccCHHHHHHHHHH
Confidence 23343334443334 3456788888999999998877667778888888899999999999999999
Q ss_pred cccCCCcccCCCCCCHHHHhcCCceeee
Q psy11767 289 LVKDPRRRLGGGELDAEELKRHPFFNVI 316 (966)
Q Consensus 289 L~kdp~~RLG~~~~g~~~Ik~HpfF~~i 316 (966)
|+.||.+|. .+++|.+||||..-
T Consensus 247 l~~dp~~Rp-----s~~~~l~h~~~~~~ 269 (278)
T 3cok_A 247 LRRNPADRL-----SLSSVLDHPFMSRN 269 (278)
T ss_dssp SCSSGGGSC-----CHHHHTTSTTTC--
T ss_pred cccCHhhCC-----CHHHHhcCccccCC
Confidence 999999998 48999999999753
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* | Back alignment and structure |
|---|
Probab=99.74 E-value=6.9e-18 Score=188.57 Aligned_cols=190 Identities=23% Similarity=0.295 Sum_probs=144.2
Q ss_pred CcceeeeecccccceEEEEEEcCCCCEEEEEeccccc--------hhhHHHHHHHHhhCCCcccccccccccc-------
Q psy11767 117 DLDKAGILGDGSYSVCRRCVEKSTGQEYAVKIISRKI--------DCSEEINLLRACQGHPNICRRCVEKSTG------- 181 (966)
Q Consensus 117 df~~~~~LG~GsFGkV~La~~k~tg~~yAiKvl~K~~--------~~~~E~~il~~~~~~pfi~~~~~~~~~~------- 181 (966)
+|.+.+.||+|+||+||+|+++.+++.||+|++.+.. ...+|..+|+++ +||+|++.+-.+...
T Consensus 42 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~ 120 (335)
T 2owb_A 42 RYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSL-AHQHVVGFHGFFEDNDFVFVVL 120 (335)
T ss_dssp EEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTC-CCTTBCCEEEEEECSSEEEEEE
T ss_pred ceEEEEEEeeCCCeEEEEEEECCCCCEEEEEEechhhhcCHHHHHHHHHHHHHHHhC-CCCCCCeEEEEEecCCeEEEEE
Confidence 6799999999999999999999999999999998652 346788888887 699998722111110
Q ss_pred -----------------------hhHHHHHHHh----------hcccchhhhHhhhccCCceEEecCcccc---------
Q psy11767 182 -----------------------QEYAVKIISR----------KIDCSEEINLLRACQGHPNIVNLHCVFQ--------- 219 (966)
Q Consensus 182 -----------------------~~~~~~~v~~----------~~~~~~e~nil~~~~gh~~iv~l~~~~~--------- 219 (966)
...+.+++.+ ..|++++ |||.+.+|.++|+||+.+..
T Consensus 121 e~~~~~~L~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~-NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~ 199 (335)
T 2owb_A 121 ELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHRNRVIHRDLKLG-NLFLNEDLEVKIGDFGLATKVEYDGERKK 199 (335)
T ss_dssp CCCTTCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGG-GEEECTTCCEEECCCTTCEECCSTTCCBC
T ss_pred ecCCCCCHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCEecCCCch-hEEEcCCCCEEEeeccCceecccCccccc
Confidence 0011111111 0133444 99999999999999987632
Q ss_pred ----------ccccccccCCCcceeeechhhHHHHHHHhhCCCCCCCCcHHHHHHHHHhCCCCCCCCCCHHHHHHHHhhc
Q psy11767 220 ----------DEVIDWDDFSRGIECVFFSSSLIIFFIILSFTLSFIHDYYHIQYRRILKTEPPIPEDLSPDVADFISRLL 289 (966)
Q Consensus 220 ----------~e~i~~~~y~~~~d~~~~~~~~il~~~m~~g~~pf~~~~~~~~~~~I~~~~~~~P~~~s~~a~dli~~LL 289 (966)
+|++....|+...| .|+.|+++|+|++|.+||...+....+..|....+.+|..+++++++||+++|
T Consensus 200 ~~~gt~~y~aPE~~~~~~~~~~~D---i~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l 276 (335)
T 2owb_A 200 VLCGTPNYIAPEVLSKKGHSFEVD---VWSIGCIMYTLLVGKPPFETSCLKETYLRIKKNEYSIPKHINPVAASLIQKML 276 (335)
T ss_dssp CCCSCCSSCCHHHHHTSCBCTHHH---HHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCCCCCTTSCHHHHHHHHHHT
T ss_pred ccCCCccccCHHHhccCCCCchhh---HHHHHHHHHHHHHCcCCCCCCCHHHHHHHHhcCCCCCCccCCHHHHHHHHHHc
Confidence 23333333443334 34567888889999999999888888999999999999999999999999999
Q ss_pred ccCCCcccCCCCCCHHHHhcCCceeee
Q psy11767 290 VKDPRRRLGGGELDAEELKRHPFFNVI 316 (966)
Q Consensus 290 ~kdp~~RLG~~~~g~~~Ik~HpfF~~i 316 (966)
+.||.+|.. +++|.+||||...
T Consensus 277 ~~dp~~Rps-----~~ell~~~~~~~~ 298 (335)
T 2owb_A 277 QTDPTARPT-----INELLNDEFFTSG 298 (335)
T ss_dssp CSSGGGSCC-----GGGGGGSHHHHTS
T ss_pred cCChhHCcC-----HHHHhcCccccCC
Confidence 999999984 7899999999754
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* | Back alignment and structure |
|---|
Probab=99.74 E-value=9.8e-18 Score=183.11 Aligned_cols=190 Identities=23% Similarity=0.295 Sum_probs=143.3
Q ss_pred CcceeeeecccccceEEEEEEcCCCCEEEEEeccccc--------hhhHHHHHHHHhhCCCcccccccccccc-------
Q psy11767 117 DLDKAGILGDGSYSVCRRCVEKSTGQEYAVKIISRKI--------DCSEEINLLRACQGHPNICRRCVEKSTG------- 181 (966)
Q Consensus 117 df~~~~~LG~GsFGkV~La~~k~tg~~yAiKvl~K~~--------~~~~E~~il~~~~~~pfi~~~~~~~~~~------- 181 (966)
+|.+.+.||+|+||+|++|+++.+|+.||+|++.+.. ...+|..+|+++ +||+|++..-.....
T Consensus 16 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~ 94 (294)
T 2rku_A 16 RYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSL-AHQHVVGFHGFFEDNDFVFVVL 94 (294)
T ss_dssp EEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTC-CCTTBCCEEEEEECSSEEEEEE
T ss_pred ceEEEEEEeecCCEEEEEEEECCCCceEEEEEechhhccCHHHHHHHHHHHHHHHhC-CCCCEeeeeeeeccCCEEEEEE
Confidence 5689999999999999999999999999999998652 346788889887 799998722111110
Q ss_pred -----------------------hhHHHHHHHh----------hcccchhhhHhhhccCCceEEecCcccc---------
Q psy11767 182 -----------------------QEYAVKIISR----------KIDCSEEINLLRACQGHPNIVNLHCVFQ--------- 219 (966)
Q Consensus 182 -----------------------~~~~~~~v~~----------~~~~~~e~nil~~~~gh~~iv~l~~~~~--------- 219 (966)
...+.+++.+ ..|++++ |||.+.+|.++|.||+.+..
T Consensus 95 e~~~~~~L~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dl~p~-Nil~~~~~~~kl~dfg~~~~~~~~~~~~~ 173 (294)
T 2rku_A 95 ELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHRNRVIHRDLKLG-NLFLNEDLEVKIGDFGLATKVEYDGERKK 173 (294)
T ss_dssp ECCTTCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGG-GEEECTTCCEEECCCTTCEECCSTTCCBC
T ss_pred ecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChH-hEEEcCCCCEEEEeccCceecccCccccc
Confidence 0011122111 0133334 99999999999999987632
Q ss_pred ----------ccccccccCCCcceeeechhhHHHHHHHhhCCCCCCCCcHHHHHHHHHhCCCCCCCCCCHHHHHHHHhhc
Q psy11767 220 ----------DEVIDWDDFSRGIECVFFSSSLIIFFIILSFTLSFIHDYYHIQYRRILKTEPPIPEDLSPDVADFISRLL 289 (966)
Q Consensus 220 ----------~e~i~~~~y~~~~d~~~~~~~~il~~~m~~g~~pf~~~~~~~~~~~I~~~~~~~P~~~s~~a~dli~~LL 289 (966)
+|++....++...| .|+.|+++|+|++|.+||...+....+..+....+.+|..+++++.+||+++|
T Consensus 174 ~~~~~~~y~aPE~~~~~~~~~~~D---i~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l 250 (294)
T 2rku_A 174 VLCGTPNYIAPEVLSKKGHSFEVD---VWSIGCIMYTLLVGKPPFETSCLKETYLRIKKNEYSIPKHINPVAASLIQKML 250 (294)
T ss_dssp CCCSCCSSCCHHHHTTSCBCTHHH---HHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTTCCCCCTTSCHHHHHHHHHHT
T ss_pred cccCCCCcCCcchhccCCCCchhh---HHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhhccCCCccccCHHHHHHHHHHc
Confidence 23333333433333 34567788889999999999988888999999999999999999999999999
Q ss_pred ccCCCcccCCCCCCHHHHhcCCceeee
Q psy11767 290 VKDPRRRLGGGELDAEELKRHPFFNVI 316 (966)
Q Consensus 290 ~kdp~~RLG~~~~g~~~Ik~HpfF~~i 316 (966)
+.||.+|.. +++|.+||||...
T Consensus 251 ~~~p~~Rps-----~~~ll~~~~~~~~ 272 (294)
T 2rku_A 251 QTDPTARPT-----INELLNDEFFTSG 272 (294)
T ss_dssp CSSGGGSCC-----GGGGGGSHHHHTS
T ss_pred ccChhhCcC-----HHHHhhChheecC
Confidence 999999984 7899999999743
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B | Back alignment and structure |
|---|
Probab=99.74 E-value=9.6e-18 Score=185.60 Aligned_cols=196 Identities=18% Similarity=0.254 Sum_probs=141.9
Q ss_pred CcceeeeecccccceEEEEEEc-CCCCEEEEEeccccc-------hhhHHHHHHHHhh--CCCcccccccccc-----c-
Q psy11767 117 DLDKAGILGDGSYSVCRRCVEK-STGQEYAVKIISRKI-------DCSEEINLLRACQ--GHPNICRRCVEKS-----T- 180 (966)
Q Consensus 117 df~~~~~LG~GsFGkV~La~~k-~tg~~yAiKvl~K~~-------~~~~E~~il~~~~--~~pfi~~~~~~~~-----~- 180 (966)
+|.+++.||+|+||+|++|+++ .+|+.||||++++.. ...+|..+|+++. +||+|++..-... .
T Consensus 12 ~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~~~ 91 (326)
T 1blx_A 12 QYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDRE 91 (326)
T ss_dssp TEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEECSSE
T ss_pred ceeeeeeecccccEEEEEEEecCCCCEEEEEEEeccCcccccCCchhhHHHHHHHhhhccCCCCeEeeeeeeeecccCCC
Confidence 6799999999999999999995 789999999998642 3467888888876 8999987321111 0
Q ss_pred c------------------------------hhHHHHHHHh----------hcccchhhhHhhhccCCceEEecCcccc-
Q psy11767 181 G------------------------------QEYAVKIISR----------KIDCSEEINLLRACQGHPNIVNLHCVFQ- 219 (966)
Q Consensus 181 ~------------------------------~~~~~~~v~~----------~~~~~~e~nil~~~~gh~~iv~l~~~~~- 219 (966)
. ...+.+++.+ ..|++++ |||.+.+|.++|+||+.+..
T Consensus 92 ~~~~lv~e~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~gi~H~dlkp~-Nili~~~~~~kl~Dfg~~~~~ 170 (326)
T 1blx_A 92 TKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQ-NILVTSSGQIKLADFGLARIY 170 (326)
T ss_dssp EEEEEEEECCSCBHHHHHHHSCTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGG-GEEECTTCCEEECSCCSCCCC
T ss_pred ceEEEEEecCCCCHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCHH-HeEEcCCCCEEEecCcccccc
Confidence 0 0011111111 0133444 99999999999999986632
Q ss_pred -----------------ccccccccCCCcceeeechhhHHHHHHHhhCCCCCCCCcHHHHHHHHHhC--C----------
Q psy11767 220 -----------------DEVIDWDDFSRGIECVFFSSSLIIFFIILSFTLSFIHDYYHIQYRRILKT--E---------- 270 (966)
Q Consensus 220 -----------------~e~i~~~~y~~~~d~~~~~~~~il~~~m~~g~~pf~~~~~~~~~~~I~~~--~---------- 270 (966)
+|++....|+...| .|+.|+++|+|++|.+||...+......+|+.. .
T Consensus 171 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~D---i~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 247 (326)
T 1blx_A 171 SFQMALTSVVVTLWYRAPEVLLQSSYATPVD---LWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPRDV 247 (326)
T ss_dssp CGGGGGCCCCCCCTTCCHHHHTTCCCCTHHH---HHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCGGGSCTTC
T ss_pred cCCCCccccccccceeCHHHHhcCCCCcchh---HHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHcCCCCcccCcccc
Confidence 23343344544444 345677888899999999988887777777641 0
Q ss_pred ---------------CCCCCCCCHHHHHHHHhhcccCCCcccCCCCCCHHHHhcCCceeeeCcccc
Q psy11767 271 ---------------PPIPEDLSPDVADFISRLLVKDPRRRLGGGELDAEELKRHPFFNVIDWDDL 321 (966)
Q Consensus 271 ---------------~~~P~~~s~~a~dli~~LL~kdp~~RLG~~~~g~~~Ik~HpfF~~idW~~l 321 (966)
..++..+++++++||+++|..||.+|.. +.++..||||+.++|..-
T Consensus 248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt-----~~e~l~hp~~~~~~~~~~ 308 (326)
T 1blx_A 248 ALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRIS-----AYSALSHPYFQDLERCKE 308 (326)
T ss_dssp SSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCC-----HHHHHTSGGGTTCCCCCC
T ss_pred ccchhhhcccCcchhhhccccCCHHHHHHHHHHcCCCcccCCC-----HHHHhcCccccccchhhh
Confidence 1244678999999999999999999984 899999999999988653
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=99.74 E-value=8.5e-18 Score=188.72 Aligned_cols=195 Identities=22% Similarity=0.253 Sum_probs=136.7
Q ss_pred CcceeeeecccccceEEEEEEcCCCCEEEEEecccc----------chhhHHHHHHHHhhCCCccccccccccc------
Q psy11767 117 DLDKAGILGDGSYSVCRRCVEKSTGQEYAVKIISRK----------IDCSEEINLLRACQGHPNICRRCVEKST------ 180 (966)
Q Consensus 117 df~~~~~LG~GsFGkV~La~~k~tg~~yAiKvl~K~----------~~~~~E~~il~~~~~~pfi~~~~~~~~~------ 180 (966)
+|+++++||+|+||+|++|+++.+|+.||||++++. ....+|..+|+++ +||+|++..-.+..
T Consensus 11 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~l 89 (346)
T 1ua2_A 11 RYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQEL-SHPNIIGLLDAFGHKSNISL 89 (346)
T ss_dssp --CEEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHC-CCTTBCCEEEEECCTTCCEE
T ss_pred ccEEEeEEeecCCEEEEEEEECCCCcEEEEEEEecCCcchhhhhhhHHHHHHHHHHhhC-CCCCCCeEEEEEeeCCceEE
Confidence 579999999999999999999999999999999853 1346799999988 59999862211111
Q ss_pred ------------------------chhHHHHHHHh----------hcccchhhhHhhhccCCceEEecCcccc-------
Q psy11767 181 ------------------------GQEYAVKIISR----------KIDCSEEINLLRACQGHPNIVNLHCVFQ------- 219 (966)
Q Consensus 181 ------------------------~~~~~~~~v~~----------~~~~~~e~nil~~~~gh~~iv~l~~~~~------- 219 (966)
...++.+++.+ ..|++++ |||.+.+|+++|+||+.+..
T Consensus 90 v~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~-Nil~~~~~~~kl~Dfg~a~~~~~~~~~ 168 (346)
T 1ua2_A 90 VFDFMETDLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQHWILHRDLKPN-NLLLDENGVLKLADFGLAKSFGSPNRA 168 (346)
T ss_dssp EEECCSEEHHHHHTTCCSSCCSSHHHHHHHHHHHHHHHHHHTTCCCCCCCGG-GEEECTTCCEEECCCGGGSTTTSCCCC
T ss_pred EEEcCCCCHHHHHHhcCcCCCHHHHHHHHHHHHHHHHHHHHCCEECCCCCHH-HEEEcCCCCEEEEecccceeccCCccc
Confidence 01111122211 1244445 99999999999999986632
Q ss_pred ------------cccccc-ccCCCcceeeechhhHHHHHHHhhCCCCCCCCcHHHHHHHHHhC--CC---CCC-------
Q psy11767 220 ------------DEVIDW-DDFSRGIECVFFSSSLIIFFIILSFTLSFIHDYYHIQYRRILKT--EP---PIP------- 274 (966)
Q Consensus 220 ------------~e~i~~-~~y~~~~d~~~~~~~~il~~~m~~g~~pf~~~~~~~~~~~I~~~--~~---~~P------- 274 (966)
+|++.. ..|+...| .|+.|+++|+|++|.+||...+....+.+|+.. .+ .+|
T Consensus 169 ~~~~~~t~~y~aPE~~~~~~~~~~~~D---iwslG~il~ell~g~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~ 245 (346)
T 1ua2_A 169 YTHQVVTRWYRAPELLFGARMYGVGVD---MWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSLPD 245 (346)
T ss_dssp CCCSCCCCTTCCHHHHTTCSCCCHHHH---HHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTTTSSSTTSSTT
T ss_pred CCcccccccccCchHhhCCCCCCchhh---hHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHcCCCChhhhhhhccCcc
Confidence 233322 22433333 345667888888899999998888888888752 11 111
Q ss_pred ----------------CCCCHHHHHHHHhhcccCCCcccCCCCCCHHHHhcCCceeeeCcccc
Q psy11767 275 ----------------EDLSPDVADFISRLLVKDPRRRLGGGELDAEELKRHPFFNVIDWDDL 321 (966)
Q Consensus 275 ----------------~~~s~~a~dli~~LL~kdp~~RLG~~~~g~~~Ik~HpfF~~idW~~l 321 (966)
..+++++++||+++|+.||.+|.. ++|+.+||||.+..|...
T Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt-----~~ell~h~~f~~~~~~~~ 303 (346)
T 1ua2_A 246 YVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARIT-----ATQALKMKYFSNRPGPTP 303 (346)
T ss_dssp CCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCC-----HHHHHTSGGGTSSSCCCC
T ss_pred cccccccCCCChHHhhccCCHHHHHHHHHHhccChhhCCC-----HHHHhcChhhhcCCCCCC
Confidence 456799999999999999999984 899999999988766443
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... | Back alignment and structure |
|---|
Probab=99.74 E-value=6e-18 Score=183.38 Aligned_cols=195 Identities=25% Similarity=0.439 Sum_probs=144.7
Q ss_pred CcceeeeecccccceEEEEEEcCCCCEEEEEeccccc-----------hhhHHHHHHHHhhCCCcccccccccccc----
Q psy11767 117 DLDKAGILGDGSYSVCRRCVEKSTGQEYAVKIISRKI-----------DCSEEINLLRACQGHPNICRRCVEKSTG---- 181 (966)
Q Consensus 117 df~~~~~LG~GsFGkV~La~~k~tg~~yAiKvl~K~~-----------~~~~E~~il~~~~~~pfi~~~~~~~~~~---- 181 (966)
+|.+.+.||+|+||+|++|+++.+|+.||+|++++.. ...+|..+|+++ +||+|+...-.....
T Consensus 6 ~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~~~~~~ 84 (283)
T 3bhy_A 6 HYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREI-RHPNIITLHDIFENKTDVV 84 (283)
T ss_dssp HEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHC-CCTTBCCEEEEEECSSEEE
T ss_pred hhhhHHhhcccCceEEEEEEEcCCCCeeehHHhhhccccccccchHHHHHHHHHHHHHhC-CCCCeeehhheecCCCeEE
Confidence 3589999999999999999999999999999998642 346799999998 599998621111110
Q ss_pred --------------------------hhHHHHHHHh-------h---cccchhhhHhhhccC----CceEEecCcccc--
Q psy11767 182 --------------------------QEYAVKIISR-------K---IDCSEEINLLRACQG----HPNIVNLHCVFQ-- 219 (966)
Q Consensus 182 --------------------------~~~~~~~v~~-------~---~~~~~e~nil~~~~g----h~~iv~l~~~~~-- 219 (966)
...+.+++.+ . .|++++ |||.+.+| .++|.||+.+..
T Consensus 85 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~-Nil~~~~~~~~~~~kl~dfg~~~~~~ 163 (283)
T 3bhy_A 85 LILELVSGGELFDFLAEKESLTEDEATQFLKQILDGVHYLHSKRIAHFDLKPE-NIMLLDKNVPNPRIKLIDFGIAHKIE 163 (283)
T ss_dssp EEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGG-GEEESCSSSSSCCEEECCCTTCEECC
T ss_pred EEEeecCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCChH-HEEEecCCCCCCceEEEecccceecc
Confidence 0011111111 0 133334 88887776 789999886532
Q ss_pred ----------------ccccccccCCCcceeeechhhHHHHHHHhhCCCCCCCCcHHHHHHHHHhCCCCCC----CCCCH
Q psy11767 220 ----------------DEVIDWDDFSRGIECVFFSSSLIIFFIILSFTLSFIHDYYHIQYRRILKTEPPIP----EDLSP 279 (966)
Q Consensus 220 ----------------~e~i~~~~y~~~~d~~~~~~~~il~~~m~~g~~pf~~~~~~~~~~~I~~~~~~~P----~~~s~ 279 (966)
+|++....|+...| .|+.|+++|+|++|.+||...+.......|......+| ..+++
T Consensus 164 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~D---i~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (283)
T 3bhy_A 164 AGNEFKNIFGTPEFVAPEIVNYEPLGLEAD---MWSIGVITYILLSGASPFLGETKQETLTNISAVNYDFDEEYFSNTSE 240 (283)
T ss_dssp --------CCCGGGCCHHHHTTCCCCTHHH---HHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTTCCCCCHHHHTTCCH
T ss_pred CCCcccccCCCcCccCcceecCCCCCcchh---hhhHHHHHHHHHHCCCCCCCcchHHHHHHhHhcccCCcchhcccCCH
Confidence 34444444544444 34567788889999999999888888999988877776 57899
Q ss_pred HHHHHHHhhcccCCCcccCCCCCCHHHHhcCCceeeeCcccc
Q psy11767 280 DVADFISRLLVKDPRRRLGGGELDAEELKRHPFFNVIDWDDL 321 (966)
Q Consensus 280 ~a~dli~~LL~kdp~~RLG~~~~g~~~Ik~HpfF~~idW~~l 321 (966)
++++||+++|..||.+|.. +.++.+||||+.+.|..+
T Consensus 241 ~~~~li~~~l~~dp~~Rps-----~~~~l~h~~~~~~~~~~~ 277 (283)
T 3bhy_A 241 LAKDFIRRLLVKDPKRRMT-----IAQSLEHSWIKAIRRRNV 277 (283)
T ss_dssp HHHHHHHTTSCSSGGGSCC-----HHHHHHCHHHHHHHHCCC
T ss_pred HHHHHHHHHccCCHhHCcC-----HHHHHhCHHHHHHHHHhh
Confidence 9999999999999999984 899999999999887654
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... | Back alignment and structure |
|---|
Probab=99.74 E-value=9.8e-18 Score=190.35 Aligned_cols=193 Identities=20% Similarity=0.222 Sum_probs=133.5
Q ss_pred CcceeeeecccccceEEEEEEcCCCCEEEEEecccc-------chhhHHHHHHHHhhCCCccccccccccc---------
Q psy11767 117 DLDKAGILGDGSYSVCRRCVEKSTGQEYAVKIISRK-------IDCSEEINLLRACQGHPNICRRCVEKST--------- 180 (966)
Q Consensus 117 df~~~~~LG~GsFGkV~La~~k~tg~~yAiKvl~K~-------~~~~~E~~il~~~~~~pfi~~~~~~~~~--------- 180 (966)
+|.+++.||+|+||.|++|+++.+|+.||||++++. ....+|..+|++++ ||+|++..-.+..
T Consensus 30 ~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~-hpnIv~~~~~~~~~~~~~~~~~ 108 (367)
T 2fst_X 30 RYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMK-HENVIGLLDVFTPARSLEEFND 108 (367)
T ss_dssp TEEEEEECC----CCEEEEEETTTTEEEEEEECSSTTSSHHHHHHHHHHHHHHHHCC-CTTBCCCSEEECSCSSGGGCCC
T ss_pred ceEEeeEEeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCC-CCCCCcEEEEEecCCccccCCe
Confidence 679999999999999999999999999999999763 13467999999884 9999873221110
Q ss_pred -------------------------chhHHHHHHHh----------hcccchhhhHhhhccCCceEEecCccc-------
Q psy11767 181 -------------------------GQEYAVKIISR----------KIDCSEEINLLRACQGHPNIVNLHCVF------- 218 (966)
Q Consensus 181 -------------------------~~~~~~~~v~~----------~~~~~~e~nil~~~~gh~~iv~l~~~~------- 218 (966)
....+.+++.+ ..|++++ |||.+.+|.++|+||+.+.
T Consensus 109 ~~lv~e~~~~~L~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givH~Dlkp~-NIll~~~~~~kL~DFG~a~~~~~~~~ 187 (367)
T 2fst_X 109 VYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPS-NLAVNEDCELKILDFGLARHTADEMT 187 (367)
T ss_dssp CEEEEECCCEECC-----CCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGG-GEEECTTCCEEECC------------
T ss_pred EEEEecccCCCHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHh-hEEECCCCCEEEeeccccccccccCC
Confidence 01111122221 1244444 9999999999999998663
Q ss_pred ---------ccccccc-ccCCCcceeeechhhHHHHHHHhhCCCCCCCCcHHHHHHHHHh--CC----------------
Q psy11767 219 ---------QDEVIDW-DDFSRGIECVFFSSSLIIFFIILSFTLSFIHDYYHIQYRRILK--TE---------------- 270 (966)
Q Consensus 219 ---------~~e~i~~-~~y~~~~d~~~~~~~~il~~~m~~g~~pf~~~~~~~~~~~I~~--~~---------------- 270 (966)
.+|++.. ..|+...| .|+.|+++|+|++|.+||...+.......|+. +.
T Consensus 188 ~~~~t~~y~aPE~~~~~~~~~~~~D---iwslG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~p~~~~~~~~~~~~~~~ 264 (367)
T 2fst_X 188 GYVATRWYRAPEIMLNWMHYNQTVD---IWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARN 264 (367)
T ss_dssp ---CCCTTCCHHHHTTCCSCCTTHH---HHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHTTCCCHHHHH
T ss_pred CcCcCcCccChHHHcCCcCCCchhh---HHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHHhhhHHHHH
Confidence 2344443 45655555 44677888999999999998887777776654 11
Q ss_pred -----CCCC--------CCCCHHHHHHHHhhcccCCCcccCCCCCCHHHHhcCCceeeeCcc
Q psy11767 271 -----PPIP--------EDLSPDVADFISRLLVKDPRRRLGGGELDAEELKRHPFFNVIDWD 319 (966)
Q Consensus 271 -----~~~P--------~~~s~~a~dli~~LL~kdp~~RLG~~~~g~~~Ik~HpfF~~idW~ 319 (966)
...| ...+++++|||+++|+.||.+|+. ++++..||||+.+.+.
T Consensus 265 ~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~t-----~~e~L~hp~~~~~~~~ 321 (367)
T 2fst_X 265 YIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRIT-----AAQALAHAYFAQYHDP 321 (367)
T ss_dssp HHHTSCCCCCCCHHHHTTTCCHHHHHHHHHHSCSSGGGSCC-----HHHHHTSGGGTTTCCG
T ss_pred HHhccCCCCCCCHHHHCCCCCHHHHHHHHHhCCCCcccCcC-----HHHHhcChhhhhccCC
Confidence 1111 356899999999999999999984 8999999999876543
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* | Back alignment and structure |
|---|
Probab=99.73 E-value=4.6e-18 Score=190.11 Aligned_cols=195 Identities=16% Similarity=0.228 Sum_probs=144.4
Q ss_pred CcceeeeecccccceEEEEEEcCCCCEEEEEecccc----------------------chhhHHHHHHHHhhCCCccccc
Q psy11767 117 DLDKAGILGDGSYSVCRRCVEKSTGQEYAVKIISRK----------------------IDCSEEINLLRACQGHPNICRR 174 (966)
Q Consensus 117 df~~~~~LG~GsFGkV~La~~k~tg~~yAiKvl~K~----------------------~~~~~E~~il~~~~~~pfi~~~ 174 (966)
+|.+++.||+|+||+|++|++ +|+.||||++.+. ....+|..+|+++ +||+|+..
T Consensus 32 ~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~i~~~ 108 (348)
T 2pml_X 32 DYRIIRTLNQGKFNKIILCEK--DNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIITDI-KNEYCLTC 108 (348)
T ss_dssp TEEEEEEEECCSSCCEEEEEE--TTEEEEEEEEEHHHHSSCEEECCCSSSSCCEEEHHHHHHHHHHHHTTC-CCTTBCCC
T ss_pred ceEEEEEEcCCCCeEEEEEEc--CCceEEEEEeecccccchhhhccccchhhhHHhHHHHHHHHHHHHHhC-CCCCcceE
Confidence 779999999999999999999 9999999999864 3357799999888 59999751
Q ss_pred c--------------------cccc------c----c--------hhHHHHHH------Hh--h---cccchhhhHhhhc
Q psy11767 175 C--------------------VEKS------T----G--------QEYAVKII------SR--K---IDCSEEINLLRAC 205 (966)
Q Consensus 175 ~--------------------~~~~------~----~--------~~~~~~~v------~~--~---~~~~~e~nil~~~ 205 (966)
. +..- . . ...+.+++ +. . .|++++ |||.+.
T Consensus 109 ~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~i~H~dl~p~-Nil~~~ 187 (348)
T 2pml_X 109 EGIITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFIPIQVIKCIIKSVLNSFSYIHNEKNICHRDVKPS-NILMDK 187 (348)
T ss_dssp SEEEESSSEEEEEEECCTTCBSSEESSSEESSCSSSCCCCCHHHHHHHHHHHHHHHHHHHHTSCEECCCCCGG-GEEECT
T ss_pred EEEEeeCCeEEEEEeccCCCcHHHHHHHhhhhhhccccCCCHHHHHHHHHHHHHHHHHHhccCCEeecCCChH-hEEEcC
Confidence 1 0000 0 0 01111222 21 1 133334 999999
Q ss_pred cCCceEEecCcccc-----------------ccccccc-cCCCcceeeechhhHHHHHHHhhCCCCCCCCcH-HHHHHHH
Q psy11767 206 QGHPNIVNLHCVFQ-----------------DEVIDWD-DFSRGIECVFFSSSLIIFFIILSFTLSFIHDYY-HIQYRRI 266 (966)
Q Consensus 206 ~gh~~iv~l~~~~~-----------------~e~i~~~-~y~~~~d~~~~~~~~il~~~m~~g~~pf~~~~~-~~~~~~I 266 (966)
+|+++|+||+.+.. +|++... .|.. ...| .|+.|+++|+|++|.+||...+. ..+++.|
T Consensus 188 ~~~~kl~dfg~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~-~~~D-i~slG~il~~l~~g~~pf~~~~~~~~~~~~i 265 (348)
T 2pml_X 188 NGRVKLSDFGESEYMVDKKIKGSRGTYEFMPPEFFSNESSYNG-AKVD-IWSLGICLYVMFYNVVPFSLKISLVELFNNI 265 (348)
T ss_dssp TSCEEECCCTTCEECBTTEECSSCSCGGGCCGGGGSSCCCEEH-HHHH-HHHHHHHHHHHHHSSCSSCCSSCSHHHHHHH
T ss_pred CCcEEEeccccccccccccccCCCCCcCccCchhhcCCCCCCc-chhh-HHHHHHHHHHHHhCCCCCCCCCcHHHHHHHH
Confidence 99999999986632 3444332 2221 0223 44667788889999999987665 7889999
Q ss_pred HhCCCCCC-------------------CCCCHHHHHHHHhhcccCCCcccCCCCCCHHHHhcCCceeeeCccccc
Q psy11767 267 LKTEPPIP-------------------EDLSPDVADFISRLLVKDPRRRLGGGELDAEELKRHPFFNVIDWDDLA 322 (966)
Q Consensus 267 ~~~~~~~P-------------------~~~s~~a~dli~~LL~kdp~~RLG~~~~g~~~Ik~HpfF~~idW~~l~ 322 (966)
..+.+.+| ..+++++++||+++|+.||.+|. .+++|.+||||.+++|+.+.
T Consensus 266 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rp-----s~~e~l~hp~f~~~~~~~~~ 335 (348)
T 2pml_X 266 RTKNIEYPLDRNHFLYPLTNKKSTCSNNFLSNEDIDFLKLFLRKNPAERI-----TSEDALKHEWLADTNIEDLR 335 (348)
T ss_dssp TSCCCCCCCSSSSSTTTTCC--------CCCHHHHHHHHHHCCSSGGGSC-----CHHHHHTSGGGTTCCHHHHH
T ss_pred hccCcCCccchhhhhccccccccccchhhcCHHHHHHHHHHccCChhhCC-----CHHHHhcCccccCCCHHHHH
Confidence 99999999 67999999999999999999998 48999999999999998764
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* | Back alignment and structure |
|---|
Probab=99.73 E-value=4.8e-18 Score=186.53 Aligned_cols=188 Identities=20% Similarity=0.264 Sum_probs=132.3
Q ss_pred Cccee-eeecccccceEEEEEEcCCCCEEEEEeccccchhhHHHHHHHHhhCCCccccccccccc----c----------
Q psy11767 117 DLDKA-GILGDGSYSVCRRCVEKSTGQEYAVKIISRKIDCSEEINLLRACQGHPNICRRCVEKST----G---------- 181 (966)
Q Consensus 117 df~~~-~~LG~GsFGkV~La~~k~tg~~yAiKvl~K~~~~~~E~~il~~~~~~pfi~~~~~~~~~----~---------- 181 (966)
+|.++ ++||+|+||+|++|+++.+|+.||||++++.....+|..++.+..+||+|++..-.+.. .
T Consensus 18 ~y~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~lv~e~~ 97 (299)
T 3m2w_A 18 DYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDCPKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECL 97 (299)
T ss_dssp TEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECSHHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEEEEECCC
T ss_pred chhhcCcccccCCCeEEEEEEEcCCCcEEEEEEecccHHHHHHHHHHHHhccCCCchhHHhhhhhhcCCCceEEEEEeec
Confidence 45677 88999999999999999999999999999877788899999888899999862211111 0
Q ss_pred ----------------------hhHHHHHHHh----------hcccchhhhHhhhc---cCCceEEecCccccccccccc
Q psy11767 182 ----------------------QEYAVKIISR----------KIDCSEEINLLRAC---QGHPNIVNLHCVFQDEVIDWD 226 (966)
Q Consensus 182 ----------------------~~~~~~~v~~----------~~~~~~e~nil~~~---~gh~~iv~l~~~~~~e~i~~~ 226 (966)
...+.+++.+ ..|++++ |||.+. ++.++|.||+.+.. +...
T Consensus 98 ~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~-Nil~~~~~~~~~~kl~Dfg~a~~---~~~~ 173 (299)
T 3m2w_A 98 DGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPE-NLLYTSKRPNAILKLTDFGFAKE---TTGE 173 (299)
T ss_dssp CSCBHHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTTEECCCCSGG-GEEESSSSTTCCEEECCCTTCEE---CTTC
T ss_pred CCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHH-HEEEecCCCCCcEEEeccccccc---cccc
Confidence 0011111111 0133334 888877 67788888887743 2223
Q ss_pred cCCCcceeeechhhHHHHHHHhhCCCCCCCCcHHHH----HHHHHhCCCCCC----CCCCHHHHHHHHhhcccCCCcccC
Q psy11767 227 DFSRGIECVFFSSSLIIFFIILSFTLSFIHDYYHIQ----YRRILKTEPPIP----EDLSPDVADFISRLLVKDPRRRLG 298 (966)
Q Consensus 227 ~y~~~~d~~~~~~~~il~~~m~~g~~pf~~~~~~~~----~~~I~~~~~~~P----~~~s~~a~dli~~LL~kdp~~RLG 298 (966)
.|+...| .|+.|+++|+|++|.+||...+...+ ...+..+...+| ..+++++++||+++|..||.+|.
T Consensus 174 ~~~~~~D---iwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rp- 249 (299)
T 3m2w_A 174 KYDKSCD---MWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRM- 249 (299)
T ss_dssp GGGGHHH---HHHHHHHHHHHHHSSCSCCC-------CCSCCSSCTTCCSSCHHHHTTSCHHHHHHHHHHTCSSTTTSC-
T ss_pred cCCchhh---HHHHHHHHHHHHHCCCCCCCCcchhhhHHHHHHHhhccccCCchhcccCCHHHHHHHHHHcccChhhCC-
Confidence 4444444 44667788889999999987655443 234445566666 67899999999999999999998
Q ss_pred CCCCCHHHHhcCCceeee
Q psy11767 299 GGELDAEELKRHPFFNVI 316 (966)
Q Consensus 299 ~~~~g~~~Ik~HpfF~~i 316 (966)
.+.+|.+||||...
T Consensus 250 ----s~~e~l~hp~~~~~ 263 (299)
T 3m2w_A 250 ----TITEFMNHPWIMQS 263 (299)
T ss_dssp ----CHHHHHTSHHHHTG
T ss_pred ----CHHHHhcChhhccc
Confidence 48999999999753
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* | Back alignment and structure |
|---|
Probab=99.73 E-value=1.1e-17 Score=187.48 Aligned_cols=194 Identities=24% Similarity=0.284 Sum_probs=137.1
Q ss_pred CcceeeeecccccceEEEEEEcCCCCEEEEEeccccc------hhhHHHHHHHHhhCCCccccccccccc----------
Q psy11767 117 DLDKAGILGDGSYSVCRRCVEKSTGQEYAVKIISRKI------DCSEEINLLRACQGHPNICRRCVEKST---------- 180 (966)
Q Consensus 117 df~~~~~LG~GsFGkV~La~~k~tg~~yAiKvl~K~~------~~~~E~~il~~~~~~pfi~~~~~~~~~---------- 180 (966)
+|.+.+.||+|+||+|++|+++.+|+.||||++++.. ...+|..+|+++ +||+|++.+-....
T Consensus 12 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~~~~~~ 90 (353)
T 2b9h_A 12 DFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLREIKILKHF-KHENIITIFNIQRPDSFENFNEVY 90 (353)
T ss_dssp TEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCSSHHHHHHHHHHHHHHHHC-CCTTBCCEEEECCCSCSTTCCCEE
T ss_pred ceEEeeEEcCCCCeEEEEEEECCCCcEEEEEeecccccchHHHHHHHHHHHHHhC-cCCCcCCeeeeecccccCccceEE
Confidence 7899999999999999999999999999999997532 346899999988 59999863211100
Q ss_pred -----------------------chhHHHHHHHh----------hcccchhhhHhhhccCCceEEecCcccc--------
Q psy11767 181 -----------------------GQEYAVKIISR----------KIDCSEEINLLRACQGHPNIVNLHCVFQ-------- 219 (966)
Q Consensus 181 -----------------------~~~~~~~~v~~----------~~~~~~e~nil~~~~gh~~iv~l~~~~~-------- 219 (966)
....+.+++.+ ..|++++ |||.+.+|.++|+||+.+..
T Consensus 91 lv~e~~~~~L~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlkp~-Nil~~~~~~~kl~Dfg~a~~~~~~~~~~ 169 (353)
T 2b9h_A 91 IIQELMQTDLHRVISTQMLSDDHIQYFIYQTLRAVKVLHGSNVIHRDLKPS-NLLINSNCDLKVCDFGLARIIDESAADN 169 (353)
T ss_dssp EEECCCSEEHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGG-GEEECTTCCEEECCCTTCEECC------
T ss_pred EEEeccCccHHHHHhhcCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHH-HeEEcCCCcEEEEecccccccccccccc
Confidence 00111122211 1144444 99999999999999986532
Q ss_pred ---------------------cccccc-ccCCCcceeeechhhHHHHHHHhhCCCCCCCCcHHHHHHHHHh--C------
Q psy11767 220 ---------------------DEVIDW-DDFSRGIECVFFSSSLIIFFIILSFTLSFIHDYYHIQYRRILK--T------ 269 (966)
Q Consensus 220 ---------------------~e~i~~-~~y~~~~d~~~~~~~~il~~~m~~g~~pf~~~~~~~~~~~I~~--~------ 269 (966)
+|++.. ..|+...| .|+.|+++|+|++|.+||...+.......|.. +
T Consensus 170 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~D---i~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 246 (353)
T 2b9h_A 170 SEPTGQQSGMVEFVATRWYRAPEVMLTSAKYSRAMD---VWSCGCILAELFLRRPIFPGRDYRHQLLLIFGIIGTPHSDN 246 (353)
T ss_dssp ----------CCCCCCGGGCCHHHHHSCCCCCHHHH---HHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCSTT
T ss_pred cCccccccchhhccccccccCCeeeccCCCccchhh---HHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCchhc
Confidence 222221 23333333 34566788889999999998877655554432 1
Q ss_pred ----------------CCCC--------CCCCCHHHHHHHHhhcccCCCcccCCCCCCHHHHhcCCceeeeCccc
Q psy11767 270 ----------------EPPI--------PEDLSPDVADFISRLLVKDPRRRLGGGELDAEELKRHPFFNVIDWDD 320 (966)
Q Consensus 270 ----------------~~~~--------P~~~s~~a~dli~~LL~kdp~~RLG~~~~g~~~Ik~HpfF~~idW~~ 320 (966)
-+.+ +..+++++++||+++|..||.+|.. +.+|.+||||+.+.|..
T Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt-----~~ell~hp~~~~~~~~~ 316 (353)
T 2b9h_A 247 DLRCIESPRAREYIKSLPMYPAAPLEKMFPRVNPKGIDLLQRMLVFDPAKRIT-----AKEALEHPYLQTYHDPN 316 (353)
T ss_dssp TTTTCCCHHHHHHHHTSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSSGGGSCC-----HHHHHTSGGGTTTCCTT
T ss_pred cccccccchhhHHhhcccCCCCcchhhhcccCCHHHHHHHHHhcCcCcccCCC-----HHHHhcCccccccCCcc
Confidence 1112 2468999999999999999999984 89999999999888754
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* | Back alignment and structure |
|---|
Probab=99.73 E-value=8e-19 Score=198.99 Aligned_cols=195 Identities=17% Similarity=0.156 Sum_probs=131.4
Q ss_pred CcceeeeecccccceEEEEEEcCCCCEEEEEeccccc--------hhhHHHHHHHHhh-CCCcccccccccc--------
Q psy11767 117 DLDKAGILGDGSYSVCRRCVEKSTGQEYAVKIISRKI--------DCSEEINLLRACQ-GHPNICRRCVEKS-------- 179 (966)
Q Consensus 117 df~~~~~LG~GsFGkV~La~~k~tg~~yAiKvl~K~~--------~~~~E~~il~~~~-~~pfi~~~~~~~~-------- 179 (966)
+|.+++.||+|+||+|++|+++.+|+.||||++++.. ...+|..+++.++ +||+|++.+..+.
T Consensus 63 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~hp~iv~~~~~~~~p~d~~~~ 142 (371)
T 3q60_A 63 KLKLVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGESPEEARDRRRLLLPSDAVAV 142 (371)
T ss_dssp EEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECCSTTHHHHHHHHHHHHHHHHHHHC----------CBCCCCEEEEE
T ss_pred eeeeeeeccCCCCEEEEEEEECCCCceeEEEEEEecccccccHHHHHHHHHHHHHHhcccChhhhhhceeEEeeehheec
Confidence 5799999999999999999999999999999999842 2456766666555 6999765221110
Q ss_pred ---------------------------------------------cch------hHH-HHHHHh----------hcccch
Q psy11767 180 ---------------------------------------------TGQ------EYA-VKIISR----------KIDCSE 197 (966)
Q Consensus 180 ---------------------------------------------~~~------~~~-~~~v~~----------~~~~~~ 197 (966)
..+ .+. .+++.+ ..|+++
T Consensus 143 ~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~L~~~l~~~~~~~~~~~~~~~~vk~~i~~qi~~aL~~LH~~~ivHrDikp 222 (371)
T 3q60_A 143 QSQPPFAQLSPGQDDYAVANYLLLMPAASVDLELLFSTLDFVYVFRGDEGILALHILTAQLIRLAANLQSKGLVHGHFTP 222 (371)
T ss_dssp TTSCSSSBCSCC---CCEEEEEEEECCCSEEHHHHHHHHHHSCCCCHHHHHHHHHHHHHHHHHHHHHHHHTTEEETTCSG
T ss_pred CCCCCeeeccCCcccceeeeEEEEecCCCCCHHHHHHHhccccchhhhhhhhhHHHHHHHHHHHHHHHHHCCCccCcCCH
Confidence 001 121 222222 124555
Q ss_pred hhhHhhhccCCceEEecCcccc----------------cccccc--ccCCCcceeeechhhHHHHHHHhhCCCCCCCCcH
Q psy11767 198 EINLLRACQGHPNIVNLHCVFQ----------------DEVIDW--DDFSRGIECVFFSSSLIIFFIILSFTLSFIHDYY 259 (966)
Q Consensus 198 e~nil~~~~gh~~iv~l~~~~~----------------~e~i~~--~~y~~~~d~~~~~~~~il~~~m~~g~~pf~~~~~ 259 (966)
+ |||.+.+|+++|+||+.+.. +|++.. ..|+...| .|+.|+++|+|++|.+||...+.
T Consensus 223 ~-NIll~~~~~~kL~DFG~a~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~D---iwSlG~il~elltg~~Pf~~~~~ 298 (371)
T 3q60_A 223 D-NLFIMPDGRLMLGDVSALWKVGTRGPASSVPVTYAPREFLNASTATFTHALN---AWQLGLSIYRVWCLFLPFGLVTP 298 (371)
T ss_dssp G-GEEECTTSCEEECCGGGEEETTCEEEGGGSCGGGCCHHHHTCSEEECCHHHH---HHHHHHHHHHHHHSSCSTTBCCT
T ss_pred H-HEEECCCCCEEEEecceeeecCCCccCccCCcCCcChhhccCCCCCcCcccc---HHHHHHHHHHHHhCCCCCCCcCc
Confidence 5 99999999999999987632 344543 34544444 44677888888899999987643
Q ss_pred HH--HHHH-----HHhCCCCCC--CCCCHHHHHHHHhhcccCCCcccCCCCCCHHHHhcCCceeeeCccc
Q psy11767 260 HI--QYRR-----ILKTEPPIP--EDLSPDVADFISRLLVKDPRRRLGGGELDAEELKRHPFFNVIDWDD 320 (966)
Q Consensus 260 ~~--~~~~-----I~~~~~~~P--~~~s~~a~dli~~LL~kdp~~RLG~~~~g~~~Ik~HpfF~~idW~~ 320 (966)
.. .+.+ +....+.+| ..+++++++||.++|+.||.+|+. +.++.+||||+.++|..
T Consensus 299 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt-----~~e~l~hp~f~~~~~~~ 363 (371)
T 3q60_A 299 GIKGSWKRPSLRVPGTDSLAFGSCTPLPDFVKTLIGRFLNFDRRRRLL-----PLEAMETPEFLQLQNEI 363 (371)
T ss_dssp TCTTCCCBCCTTSCCCCSCCCTTSSCCCHHHHHHHHHHTCSSTTTCCC-----HHHHTTSHHHHHHHHHH
T ss_pred ccccchhhhhhhhccccccchhhccCCCHHHHHHHHHHcCCChhhCCC-----HHHHhcCHHHHHHHHHH
Confidence 21 1211 122344555 588999999999999999999984 89999999999998863
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* 4azf_A* | Back alignment and structure |
|---|
Probab=99.73 E-value=6.4e-18 Score=195.90 Aligned_cols=190 Identities=19% Similarity=0.235 Sum_probs=136.9
Q ss_pred CcceeeeecccccceEEEEEEcCCCCEEEEEeccccc----hhhHHHHHHHHhh-----CCCcccccccccc--------
Q psy11767 117 DLDKAGILGDGSYSVCRRCVEKSTGQEYAVKIISRKI----DCSEEINLLRACQ-----GHPNICRRCVEKS-------- 179 (966)
Q Consensus 117 df~~~~~LG~GsFGkV~La~~k~tg~~yAiKvl~K~~----~~~~E~~il~~~~-----~~pfi~~~~~~~~-------- 179 (966)
+|+++++||+|+||+|++|+++.+|+.||||++++.. ...+|..+|+.++ .||+|+.....+.
T Consensus 98 ry~~~~~LG~G~fg~V~~a~~~~~~~~vAvK~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~~iv~~~~~~~~~~~~~lv 177 (429)
T 3kvw_A 98 RYEVLKVIGKGSFGQVVKAYDHKVHQHVALKMVRNEKRFHRQAAEEIRILEHLRKQDKDNTMNVIHMLENFTFRNHICMT 177 (429)
T ss_dssp TEEEEEEEEESSSEEEEEEEETTTTEEEEEEEECSCHHHHHHHHHHHHHHHHHHTTCTTSCSCBCCEEEEEEETTEEEEE
T ss_pred cEEEEEEcccCccEEEEEEEECCCCcEEEEEEECCccchHHHHHHHHHHHHHHhhccccCCcCEEEEEeecccCCeEEEE
Confidence 6799999999999999999999999999999998652 4567888888764 5678875211111
Q ss_pred -----------------------cchhHHHHHHHh----------hcccchhhhHhhhccCC--ceEEecCccc------
Q psy11767 180 -----------------------TGQEYAVKIISR----------KIDCSEEINLLRACQGH--PNIVNLHCVF------ 218 (966)
Q Consensus 180 -----------------------~~~~~~~~~v~~----------~~~~~~e~nil~~~~gh--~~iv~l~~~~------ 218 (966)
....++.+++.+ ..|++++ |||.+.+|. ++|+||+.+.
T Consensus 178 ~e~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlKp~-NILl~~~~~~~vkL~DFG~a~~~~~~~ 256 (429)
T 3kvw_A 178 FELLSMNLYELIKKNKFQGFSLPLVRKFAHSILQCLDALHKNRIIHCDLKPE-NILLKQQGRSGIKVIDFGSSCYEHQRV 256 (429)
T ss_dssp ECCCCCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHHTEECSCCSGG-GEEESSTTSCCEEECCCTTCEETTCCC
T ss_pred EeccCCCHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHH-HeEEccCCCcceEEeecccceecCCcc
Confidence 011112222222 1245555 999998887 8999998763
Q ss_pred ----------cccccccccCCCcceeeechhhHHHHHHHhhCCCCCCCCcHHHHHHHHHhC--C----------------
Q psy11767 219 ----------QDEVIDWDDFSRGIECVFFSSSLIIFFIILSFTLSFIHDYYHIQYRRILKT--E---------------- 270 (966)
Q Consensus 219 ----------~~e~i~~~~y~~~~d~~~~~~~~il~~~m~~g~~pf~~~~~~~~~~~I~~~--~---------------- 270 (966)
.+|++....|+...| .|+.|+++|+|++|.+||...+...+...|+.. .
T Consensus 257 ~~~~gt~~y~aPE~~~~~~~~~~~D---iwSlG~il~elltG~~pf~~~~~~~~l~~i~~~~~~p~~~~~~~~~~~~~~~ 333 (429)
T 3kvw_A 257 YTYIQSRFYRAPEVILGARYGMPID---MWSLGCILAELLTGYPLLPGEDEGDQLACMIELLGMPSQKLLDASKRAKNFV 333 (429)
T ss_dssp CSSCSCGGGCCHHHHHTBCCCTHHH---HHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHTBTTHHHHB
T ss_pred cccCCCCCccChHHHhCCCCCchHH---HHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCCHHHHHhhhhhhhcc
Confidence 245565556766555 446778888999999999988877766666531 0
Q ss_pred --CC---------------------------------------CCCCCCHHHHHHHHhhcccCCCcccCCCCCCHHHHhc
Q psy11767 271 --PP---------------------------------------IPEDLSPDVADFISRLLVKDPRRRLGGGELDAEELKR 309 (966)
Q Consensus 271 --~~---------------------------------------~P~~~s~~a~dli~~LL~kdp~~RLG~~~~g~~~Ik~ 309 (966)
-. ++...+++++|||+++|+.||.+|+. ++|+.+
T Consensus 334 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~dli~~~L~~dP~~Rpt-----a~e~L~ 408 (429)
T 3kvw_A 334 SSKGYPRYCTVTTLSDGSVVLNGGRSRRGKLRGPPESREWGNALKGCDDPLFLDFLKQCLEWDPAVRMT-----PGQALR 408 (429)
T ss_dssp CTTSCBTTSCEECCCC--CEECCEECTTCCEECSTTCSCHHHHTTTCCCHHHHHHHHHHTCSSTTTSCC-----HHHHHT
T ss_pred CCCCCcccccccccccccccccccccchhhccCCccchhhHhhccccchHHHHHHHHHHCCCChhhCCC-----HHHHhC
Confidence 01 12234788999999999999999984 899999
Q ss_pred CCceee
Q psy11767 310 HPFFNV 315 (966)
Q Consensus 310 HpfF~~ 315 (966)
||||+.
T Consensus 409 Hpw~~~ 414 (429)
T 3kvw_A 409 HPWLRR 414 (429)
T ss_dssp STTTC-
T ss_pred Chhhcc
Confidence 999974
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* | Back alignment and structure |
|---|
Probab=99.73 E-value=5.2e-18 Score=193.19 Aligned_cols=194 Identities=20% Similarity=0.223 Sum_probs=133.8
Q ss_pred CcceeeeecccccceEEEEEEcCCCCEEEEEeccccc----hhhHHHHHHHHhhCCCc-----cccccc-----------
Q psy11767 117 DLDKAGILGDGSYSVCRRCVEKSTGQEYAVKIISRKI----DCSEEINLLRACQGHPN-----ICRRCV----------- 176 (966)
Q Consensus 117 df~~~~~LG~GsFGkV~La~~k~tg~~yAiKvl~K~~----~~~~E~~il~~~~~~pf-----i~~~~~----------- 176 (966)
+|.+.++||+|+||+|++|+++.+|+.||||++++.. ....|..+|+.+..|+. |+...-
T Consensus 55 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~iv~~~~~~~~~~~~~lv 134 (382)
T 2vx3_A 55 RYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNKKAFLNQAQIEVRLLELMNKHDTEMKYYIVHLKRHFMFRNHLCLV 134 (382)
T ss_dssp TEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSSHHHHHHHHHHHHHHHHHHHCSSGGGGGBCCEEEEEEETTEEEEE
T ss_pred eEEEEEEEeecCCEEEEEEEEcCCCcEEEEEEEeccHHHHHHHHHHHHHHHHHHhcccccceeEEEeeeeeccCCceEEE
Confidence 6799999999999999999999999999999998652 34668889988877774 443110
Q ss_pred --------------------ccccchhHHHHHHHh---------h---cccchhhhHhhh--ccCCceEEecCccc----
Q psy11767 177 --------------------EKSTGQEYAVKIISR---------K---IDCSEEINLLRA--CQGHPNIVNLHCVF---- 218 (966)
Q Consensus 177 --------------------~~~~~~~~~~~~v~~---------~---~~~~~e~nil~~--~~gh~~iv~l~~~~---- 218 (966)
.......++.+++.+ . .|++++ |||.+ ..+.++|+||+.+.
T Consensus 135 ~e~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~~~ivHrDlkp~-NIll~~~~~~~~kL~DFG~a~~~~~ 213 (382)
T 2vx3_A 135 FEMLSYNLYDLLRNTNFRGVSLNLTRKFAQQMCTALLFLATPELSIIHCDLKPE-NILLCNPKRSAIKIVDFGSSCQLGQ 213 (382)
T ss_dssp EECCCCBHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHTSTTTCEECCCCSGG-GEEESSTTSCCEEECCCTTCEETTC
T ss_pred EecCCCCHHHHHhhcCcCCCCHHHHHHHHHHHHHHHHHhccCCCCEEcCCCCcc-cEEEecCCCCcEEEEeccCceeccc
Confidence 000011111222211 0 144444 99984 46889999998763
Q ss_pred ------------cccccccccCCCcceeeechhhHHHHHHHhhCCCCCCCCcHHHHHHHHHhCCCCCC------------
Q psy11767 219 ------------QDEVIDWDDFSRGIECVFFSSSLIIFFIILSFTLSFIHDYYHIQYRRILKTEPPIP------------ 274 (966)
Q Consensus 219 ------------~~e~i~~~~y~~~~d~~~~~~~~il~~~m~~g~~pf~~~~~~~~~~~I~~~~~~~P------------ 274 (966)
.+|++....|+...| .|+.|+++|+|++|.+||...+...+..+|+......|
T Consensus 214 ~~~~~~~t~~y~aPE~~~~~~~~~~~D---iwSlG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~ 290 (382)
T 2vx3_A 214 RIYQYIQSRFYRSPEVLLGMPYDLAID---MWSLGCILVEMHTGEPLFSGANEVDQMNKIVEVLGIPPAHILDQAPKARK 290 (382)
T ss_dssp CCCSSCSCGGGCCHHHHTTCCCCTHHH---HHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCSCCHHHHTTCTTHHH
T ss_pred ccccccCCccccChHHHcCCCCCcHHH---HHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhhHHHHH
Confidence 245555556665555 44677888899999999998888777777764211000
Q ss_pred ------C------------------C----------------------------CCHHHHHHHHhhcccCCCcccCCCCC
Q psy11767 275 ------E------------------D----------------------------LSPDVADFISRLLVKDPRRRLGGGEL 302 (966)
Q Consensus 275 ------~------------------~----------------------------~s~~a~dli~~LL~kdp~~RLG~~~~ 302 (966)
. . -+++++|||+++|+.||.+|+.
T Consensus 291 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~~Rpt---- 366 (382)
T 2vx3_A 291 FFEKLPDGTWNLKKTKDGKREYKPPGTRKLHNILGVETGGPGGRRAGESGHTVADYLKFKDLILRMLDYDPKTRIQ---- 366 (382)
T ss_dssp HEEECTTSCEEECCCCTTCCCSCCTTCSCHHHHHTTTTTSGGGTTTTCTTCCHHHHHHHHHHHHHHTCSCTTTSCC----
T ss_pred HHHhccccccccccccccccccCCcchhhHHHHhhccccCCCccccccccccchhhHHHHHHHHHhcCCChhhCCC----
Confidence 0 0 0137899999999999999984
Q ss_pred CHHHHhcCCceeeeCcc
Q psy11767 303 DAEELKRHPFFNVIDWD 319 (966)
Q Consensus 303 g~~~Ik~HpfF~~idW~ 319 (966)
++++.+||||+...|+
T Consensus 367 -a~e~L~hp~f~~~~~e 382 (382)
T 2vx3_A 367 -PYYALQHSFFKKTADE 382 (382)
T ss_dssp -HHHHTTSGGGCC----
T ss_pred -HHHHhcCcccccCCCC
Confidence 8999999999987664
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* | Back alignment and structure |
|---|
Probab=99.72 E-value=1.5e-17 Score=179.78 Aligned_cols=189 Identities=21% Similarity=0.303 Sum_probs=142.3
Q ss_pred CcceeeeecccccceEEEEEEcCCCCEEEEEeccccc-----hhhHHHHHHHHhhCCCcccccccccccc----------
Q psy11767 117 DLDKAGILGDGSYSVCRRCVEKSTGQEYAVKIISRKI-----DCSEEINLLRACQGHPNICRRCVEKSTG---------- 181 (966)
Q Consensus 117 df~~~~~LG~GsFGkV~La~~k~tg~~yAiKvl~K~~-----~~~~E~~il~~~~~~pfi~~~~~~~~~~---------- 181 (966)
+|.+.+.||+|+||.|++|+++.+++.+|+|++.+.. ...+|..+|+++ +||+|+...-.+...
T Consensus 10 ~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~ 88 (277)
T 3f3z_A 10 YYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSL-DHPNIIRLYETFEDNTDIYLVMELC 88 (277)
T ss_dssp HEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHTC-CCTTBCCEEEEEECSSEEEEEEECC
T ss_pred hEEeeeEEeecCCEEEEEEEeCCCCcEEEEEeehhhccchHHHHHHHHHHHHhC-CCCCEeeEEEEEecCCeEEEEEecc
Confidence 4589999999999999999999999999999998742 457899999998 699998622111110
Q ss_pred --------------------hhHHHHHHHh----------hcccchhhhHhh---hccCCceEEecCcccc---------
Q psy11767 182 --------------------QEYAVKIISR----------KIDCSEEINLLR---ACQGHPNIVNLHCVFQ--------- 219 (966)
Q Consensus 182 --------------------~~~~~~~v~~----------~~~~~~e~nil~---~~~gh~~iv~l~~~~~--------- 219 (966)
...+.+++.+ ..|++++ |||. +.++.++|+||+.+..
T Consensus 89 ~~~~L~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dlkp~-Nil~~~~~~~~~~~l~Dfg~~~~~~~~~~~~~ 167 (277)
T 3f3z_A 89 TGGELFERVVHKRVFRESDAARIMKDVLSAVAYCHKLNVAHRDLKPE-NFLFLTDSPDSPLKLIDFGLAARFKPGKMMRT 167 (277)
T ss_dssp CSCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGG-GEEESSSSTTCCEEECCCTTCEECCTTSCBCC
T ss_pred CCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccCCCCCHH-HEEEecCCCCCcEEEEecccceeccCccchhc
Confidence 0111122211 1133444 9988 6778999999986631
Q ss_pred ---------ccccccccCCCcceeeechhhHHHHHHHhhCCCCCCCCcHHHHHHHHHhCCCCCCC----CCCHHHHHHHH
Q psy11767 220 ---------DEVIDWDDFSRGIECVFFSSSLIIFFIILSFTLSFIHDYYHIQYRRILKTEPPIPE----DLSPDVADFIS 286 (966)
Q Consensus 220 ---------~e~i~~~~y~~~~d~~~~~~~~il~~~m~~g~~pf~~~~~~~~~~~I~~~~~~~P~----~~s~~a~dli~ 286 (966)
+|++.. .|+...| .|+.|+++|+|++|.+||...+...+..+|..+...+|. .+++++++||+
T Consensus 168 ~~~t~~y~aPE~~~~-~~~~~~D---i~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~ 243 (277)
T 3f3z_A 168 KVGTPYYVSPQVLEG-LYGPECD---EWSAGVMMYVLLCGYPPFSAPTDSEVMLKIREGTFTFPEKDWLNVSPQAESLIR 243 (277)
T ss_dssp CCSCTTTCCHHHHTT-CBCTTHH---HHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCHHHHTTSCHHHHHHHH
T ss_pred cCCCCCccChHHhcc-cCCchhh---ehhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCCCCCchhhhcCCHHHHHHHH
Confidence 233322 2444444 345678888999999999999988999999999999986 78999999999
Q ss_pred hhcccCCCcccCCCCCCHHHHhcCCceeee
Q psy11767 287 RLLVKDPRRRLGGGELDAEELKRHPFFNVI 316 (966)
Q Consensus 287 ~LL~kdp~~RLG~~~~g~~~Ik~HpfF~~i 316 (966)
++|..||.+|.. +.++.+||||+..
T Consensus 244 ~~l~~dp~~R~s-----~~~~l~h~~~~~~ 268 (277)
T 3f3z_A 244 RLLTKSPKQRIT-----SLQALEHEWFEKQ 268 (277)
T ss_dssp HHTCSSTTTSCC-----HHHHTTSHHHHHH
T ss_pred HHccCChhhCcC-----HHHHhcCHHHhcc
Confidence 999999999984 8999999999754
|
| >3omv_A RAF proto-oncogene serine/threonine-protein kinas; serine/threonine-protein kinase, transferase; HET: SM5; 4.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.72 E-value=6.8e-18 Score=186.90 Aligned_cols=180 Identities=16% Similarity=0.109 Sum_probs=124.4
Q ss_pred CcceeeeecccccceEEEEEEcCCCCEEEEEeccccc-------hhhHHHHHHHHhhCCCcccccccccccc--------
Q psy11767 117 DLDKAGILGDGSYSVCRRCVEKSTGQEYAVKIISRKI-------DCSEEINLLRACQGHPNICRRCVEKSTG-------- 181 (966)
Q Consensus 117 df~~~~~LG~GsFGkV~La~~k~tg~~yAiKvl~K~~-------~~~~E~~il~~~~~~pfi~~~~~~~~~~-------- 181 (966)
||.+.+.||+|+||+||+|+++. -+|||+++... ...+|..+|+++ +||+||+.+-.....
T Consensus 37 ~l~l~~~iG~G~fG~Vy~~~~~~---~vAvK~~~~~~~~~~~~~~f~~E~~il~~l-~HpNIV~l~g~~~~~~~~iVmEy 112 (307)
T 3omv_A 37 EVMLSTRIGSGSFGTVYKGKWHG---DVAVKILKVVDPTPEQFQAFRNEVAVLRKT-RHVNILLFMGYMTKDNLAIVTQW 112 (307)
T ss_dssp SCCEEEECCCCSSSEEEEEESSS---EEEEEECCCSSCCHHHHHHHHHHHHHHTTC-CCTTBCCEEEEECSSSCEEEEEC
T ss_pred HeEEeeEEeeCCCcEEEEEEECC---cEEEEEEEecCCCHHHHHHHHHHHHHHHhC-CCCCEeeEEEEEECCeEEEEEEc
Confidence 77899999999999999999764 38999998531 357899999998 699998722111000
Q ss_pred ----------------------hhHHHHHHHh----------hcccchhhhHhhhccCCceEEecCcccc----------
Q psy11767 182 ----------------------QEYAVKIISR----------KIDCSEEINLLRACQGHPNIVNLHCVFQ---------- 219 (966)
Q Consensus 182 ----------------------~~~~~~~v~~----------~~~~~~e~nil~~~~gh~~iv~l~~~~~---------- 219 (966)
..++.++..+ ..|++++ |||++.+|+++|.||+.+..
T Consensus 113 ~~gGsL~~~l~~~~~~l~~~~~~~i~~qia~gL~yLH~~~IiHRDlKp~-NILl~~~~~~Ki~DFGla~~~~~~~~~~~~ 191 (307)
T 3omv_A 113 CEGSSLYKHLHVQETKFQMFQLIDIARQTAQGMDYLHAKNIIHRDMKSN-NIFLHEGLTVKIGDFGLATVKSRWSGSQQV 191 (307)
T ss_dssp CSSCBHHHHHHTSCCCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCCSS-SEEEETTEEEEECCCSSCBC----------
T ss_pred CCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccCCccCHH-HEEECCCCcEEEeeccCceecccCCcceee
Confidence 1111122211 1255555 99999999999999997631
Q ss_pred -----------ccccccc---cCCCcceeeechhhHHHHHHHhhCCCCCCCCc-HHHHHHHHHhCC-----CCCCCCCCH
Q psy11767 220 -----------DEVIDWD---DFSRGIECVFFSSSLIIFFIILSFTLSFIHDY-YHIQYRRILKTE-----PPIPEDLSP 279 (966)
Q Consensus 220 -----------~e~i~~~---~y~~~~d~~~~~~~~il~~~m~~g~~pf~~~~-~~~~~~~I~~~~-----~~~P~~~s~ 279 (966)
+|++... .|+...| .|+.||++|||++|.+||.+.+ ...+...+..+. ...|..+++
T Consensus 192 ~~~~GT~~ymAPE~l~~~~~~~y~~ksD---VwS~Gvvl~Elltg~~Pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~ 268 (307)
T 3omv_A 192 EQPTGSVLWMAPEVIRMQDNNPFSFQSD---VYSYGIVLYELMTGELPYSHINNRDQIIFMVGRGYASPDLSKLYKNCPK 268 (307)
T ss_dssp --CCCCTTSCCHHHHHCCSSCCCCHHHH---HHHHHHHHHHHHHSSCTTTTCCCHHHHHHHHHTTCCCCCSTTSCTTSCH
T ss_pred cccccCCCccCHHHhhccCCCCCCcHHH---hHhHHHHHHHHHHCCCCCCCCChHHHHHHHHhcCCCCCCcccccccchH
Confidence 3455432 2544444 4467788899999999998754 344444444432 235677899
Q ss_pred HHHHHHHhhcccCCCcccCCCCCCHHHHhc
Q psy11767 280 DVADFISRLLVKDPRRRLGGGELDAEELKR 309 (966)
Q Consensus 280 ~a~dli~~LL~kdp~~RLG~~~~g~~~Ik~ 309 (966)
++++||.++|++||.+|.. +.+|..
T Consensus 269 ~l~~li~~cl~~dP~~RPs-----~~ei~~ 293 (307)
T 3omv_A 269 AMKRLVADCVKKVKEERPL-----FPQILS 293 (307)
T ss_dssp HHHHHHHHHTCSSSTTSCC-----HHHHHH
T ss_pred HHHHHHHHHcCCCHhHCcC-----HHHHHH
Confidence 9999999999999999974 666644
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* | Back alignment and structure |
|---|
Probab=99.72 E-value=2.1e-17 Score=178.43 Aligned_cols=189 Identities=26% Similarity=0.351 Sum_probs=141.1
Q ss_pred CcceeeeecccccceEEEEEEcCCCCEEEEEeccccc--------hhhHHHHHHHHhhCCCcccccccccccc-------
Q psy11767 117 DLDKAGILGDGSYSVCRRCVEKSTGQEYAVKIISRKI--------DCSEEINLLRACQGHPNICRRCVEKSTG------- 181 (966)
Q Consensus 117 df~~~~~LG~GsFGkV~La~~k~tg~~yAiKvl~K~~--------~~~~E~~il~~~~~~pfi~~~~~~~~~~------- 181 (966)
+|.+.+.||+|+||.|++|+++.+|+.||||++++.. ...+|..+|+++ +||+|+...-.....
T Consensus 12 ~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~ 90 (276)
T 2h6d_A 12 HYVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLF-RHPHIIKLYQVISTPTDFFMVM 90 (276)
T ss_dssp TEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTC-CCTTBCCEEEEEECSSEEEEEE
T ss_pred cEEEEeeecCCCCeEEEEEEECCCCceEEEEEeccccccchhHHHHHHHHHHHHhcC-CCCCEeEEEEEEecCCeEEEEE
Confidence 5689999999999999999999999999999997642 346788899887 599998621111110
Q ss_pred -----------------------hhHHHHHHHh----------hcccchhhhHhhhccCCceEEecCcccc---------
Q psy11767 182 -----------------------QEYAVKIISR----------KIDCSEEINLLRACQGHPNIVNLHCVFQ--------- 219 (966)
Q Consensus 182 -----------------------~~~~~~~v~~----------~~~~~~e~nil~~~~gh~~iv~l~~~~~--------- 219 (966)
...+.+++.+ ..|++++ |||.+.+|.++|.||+.+..
T Consensus 91 e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~-Nil~~~~~~~~l~dfg~~~~~~~~~~~~~ 169 (276)
T 2h6d_A 91 EYVSGGELFDYICKHGRVEEMEARRLFQQILSAVDYCHRHMVVHRDLKPE-NVLLDAHMNAKIADFGLSNMMSDGEFLRT 169 (276)
T ss_dssp ECCCSCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHHCSSCCCCCGG-GEEECTTSCEEECCCCGGGCCCC------
T ss_pred eccCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCChh-hEEECCCCCEEEeecccccccCCCcceec
Confidence 0011111111 0133334 99999999999999986532
Q ss_pred ---------ccccccccCCCcceeeechhhHHHHHHHhhCCCCCCCCcHHHHHHHHHhCCCCCCCCCCHHHHHHHHhhcc
Q psy11767 220 ---------DEVIDWDDFSRGIECVFFSSSLIIFFIILSFTLSFIHDYYHIQYRRILKTEPPIPEDLSPDVADFISRLLV 290 (966)
Q Consensus 220 ---------~e~i~~~~y~~~~d~~~~~~~~il~~~m~~g~~pf~~~~~~~~~~~I~~~~~~~P~~~s~~a~dli~~LL~ 290 (966)
+|++....+. +...|.| +.|+++|+|++|.+||...+...+++.|..+.+.+|..+++++.+||.++|.
T Consensus 170 ~~~~~~y~aPE~~~~~~~~-~~~~Di~-slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~ 247 (276)
T 2h6d_A 170 SCGSPNYAAPEVISGRLYA-GPEVDIW-SCGVILYALLCGTLPFDDEHVPTLFKKIRGGVFYIPEYLNRSVATLLMHMLQ 247 (276)
T ss_dssp -------CCTGGGTTSCCC-HHHHHHH-HHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCTTSCHHHHHHHHHHTC
T ss_pred ccCCccccCHHHHcCCCCC-CccchHH-HHHHHHHHHHhCCCCCCCCcHHHHHHHhhcCcccCchhcCHHHHHHHHHHcc
Confidence 2333322221 1223334 5667788888999999999888999999999999999999999999999999
Q ss_pred cCCCcccCCCCCCHHHHhcCCcee
Q psy11767 291 KDPRRRLGGGELDAEELKRHPFFN 314 (966)
Q Consensus 291 kdp~~RLG~~~~g~~~Ik~HpfF~ 314 (966)
.||.+|. .+++|.+||||+
T Consensus 248 ~~p~~Rp-----s~~~~l~h~~~~ 266 (276)
T 2h6d_A 248 VDPLKRA-----TIKDIREHEWFK 266 (276)
T ss_dssp SSGGGSC-----CHHHHHHSHHHH
T ss_pred CChhhCC-----CHHHHHhChhhc
Confidence 9999997 489999999996
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* | Back alignment and structure |
|---|
Probab=99.72 E-value=2.3e-17 Score=183.47 Aligned_cols=190 Identities=23% Similarity=0.342 Sum_probs=139.5
Q ss_pred CcceeeeecccccceEEEEEEcCCCCEEEEEeccccc-----hhhHHHHHHHHhhCCCcccccccccccc----------
Q psy11767 117 DLDKAGILGDGSYSVCRRCVEKSTGQEYAVKIISRKI-----DCSEEINLLRACQGHPNICRRCVEKSTG---------- 181 (966)
Q Consensus 117 df~~~~~LG~GsFGkV~La~~k~tg~~yAiKvl~K~~-----~~~~E~~il~~~~~~pfi~~~~~~~~~~---------- 181 (966)
.|+..+.||+|+||+|++|+++.+|+.||||++++.. ...+|..+|+++ +||+|+..+-.....
T Consensus 46 ~~~~~~~lg~G~~g~V~~a~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~lv~e~~ 124 (321)
T 2c30_A 46 LLDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDY-QHFNVVEMYKSYLVGEELWVLMEFL 124 (321)
T ss_dssp HEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCSHHHHHHHHHHHTTC-CCTTBCCEEEEEEETTEEEEEECCC
T ss_pred hhhccEEeccCCCeEEEEEEECCCCcEEEEEEEeccchhHHHHHHHHHHHHHhC-CCCCcceEEEEEEECCEEEEEEecC
Confidence 4788889999999999999999999999999998542 356899999887 699998622111110
Q ss_pred -------------------hhHHHHHHHh-------h---cccchhhhHhhhccCCceEEecCcccc-------------
Q psy11767 182 -------------------QEYAVKIISR-------K---IDCSEEINLLRACQGHPNIVNLHCVFQ------------- 219 (966)
Q Consensus 182 -------------------~~~~~~~v~~-------~---~~~~~e~nil~~~~gh~~iv~l~~~~~------------- 219 (966)
...+.+++.+ . .|++++ |||.+.+|.++|+||+.+..
T Consensus 125 ~~~~L~~~l~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~-NIll~~~~~~kl~Dfg~~~~~~~~~~~~~~~~g 203 (321)
T 2c30_A 125 QGGALTDIVSQVRLNEEQIATVCEAVLQALAYLHAQGVIHRDIKSD-SILLTLDGRVKLSDFGFCAQISKDVPKRKSLVG 203 (321)
T ss_dssp CSCBHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGG-GEEECTTCCEEECCCTTCEECCSSSCCBCCCCS
T ss_pred CCCCHHHHHHhcCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHH-HEEECCCCcEEEeeeeeeeecccCccccccccC
Confidence 0111122211 0 144444 99999999999999986421
Q ss_pred ------ccccccccCCCcceeeechhhHHHHHHHhhCCCCCCCCcHHHHHHHHHhCCC---CCCCCCCHHHHHHHHhhcc
Q psy11767 220 ------DEVIDWDDFSRGIECVFFSSSLIIFFIILSFTLSFIHDYYHIQYRRILKTEP---PIPEDLSPDVADFISRLLV 290 (966)
Q Consensus 220 ------~e~i~~~~y~~~~d~~~~~~~~il~~~m~~g~~pf~~~~~~~~~~~I~~~~~---~~P~~~s~~a~dli~~LL~ 290 (966)
+|++....|+...| .|+.|+++|+|++|.+||...+....+..|..... ..+..+++++++||.++|+
T Consensus 204 t~~y~aPE~~~~~~~~~~~D---v~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~ 280 (321)
T 2c30_A 204 TPYWMAPEVISRSLYATEVD---IWSLGIMVIEMVDGEPPYFSDSPVQAMKRLRDSPPPKLKNSHKVSPVLRDFLERMLV 280 (321)
T ss_dssp CGGGCCHHHHTTCCBCTHHH---HHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSSCCCCTTGGGSCHHHHHHHHHHSC
T ss_pred CccccCHhhhcCCCCCchhh---HHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCCCCcCccccCCHHHHHHHHHHcc
Confidence 23444444544444 44677888889999999999888888888877643 3345689999999999999
Q ss_pred cCCCcccCCCCCCHHHHhcCCceeee
Q psy11767 291 KDPRRRLGGGELDAEELKRHPFFNVI 316 (966)
Q Consensus 291 kdp~~RLG~~~~g~~~Ik~HpfF~~i 316 (966)
.||.+|. .+++|.+||||...
T Consensus 281 ~dp~~Rp-----s~~ell~hp~~~~~ 301 (321)
T 2c30_A 281 RDPQERA-----TAQELLDHPFLLQT 301 (321)
T ss_dssp SSTTTSC-----CHHHHHTSGGGGGC
T ss_pred CChhhCc-----CHHHHhcChhhccC
Confidence 9999997 48999999999643
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* | Back alignment and structure |
|---|
Probab=99.72 E-value=6.9e-18 Score=187.63 Aligned_cols=210 Identities=14% Similarity=0.146 Sum_probs=132.5
Q ss_pred CcceeeeecccccceEEEEEEcCCCCE----EEEEecccc------chhhHHHHHHHHhhCCCcccccccccccc-----
Q psy11767 117 DLDKAGILGDGSYSVCRRCVEKSTGQE----YAVKIISRK------IDCSEEINLLRACQGHPNICRRCVEKSTG----- 181 (966)
Q Consensus 117 df~~~~~LG~GsFGkV~La~~k~tg~~----yAiKvl~K~------~~~~~E~~il~~~~~~pfi~~~~~~~~~~----- 181 (966)
+|.++++||+|+||+||+|+++.+|+. +|+|++.+. ....+|..+|.++ +||+|++.+-.....
T Consensus 14 ~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~~K~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~v 92 (325)
T 3kex_A 14 ELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSL-DHAHIVRLLGLCPGSSLQLV 92 (325)
T ss_dssp TEEEEEEEECCSSCEEEEEEECCTTCSCCEEEEEEEECCTTSCSCBCSCCHHHHHHHTC-CCTTBCCEEEEECBSSEEEE
T ss_pred HceeeeeeeecCCceEEEEEEcCCCceEEEEEEEEeccccccHHHHHHHHHHHHHHhcC-CCCCcCeEEEEEcCCccEEE
Confidence 789999999999999999999999998 455554422 2356788888887 699998622111110
Q ss_pred -------------------------hhHHHHHHHh----------hcccchhhhHhhhccCCceEEecCcccc-------
Q psy11767 182 -------------------------QEYAVKIISR----------KIDCSEEINLLRACQGHPNIVNLHCVFQ------- 219 (966)
Q Consensus 182 -------------------------~~~~~~~v~~----------~~~~~~e~nil~~~~gh~~iv~l~~~~~------- 219 (966)
..++.+++.+ ..|++++ |||.+.+|+++|+||+.+..
T Consensus 93 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dikp~-Nil~~~~~~~kl~Dfg~a~~~~~~~~~ 171 (325)
T 3kex_A 93 TQYLPLGSLLDHVRQHRGALGPQLLLNWGVQIAKGMYYLEEHGMVHRNLAAR-NVLLKSPSQVQVADFGVADLLPPDDKQ 171 (325)
T ss_dssp EECCTTCBSHHHHHSSGGGSCTTHHHHHHHHHHHHHHHHHHTTCCCSCCSST-TEEESSSSCEEECSCSGGGGSCCCTTC
T ss_pred EEeCCCCCHHHHHHHccccCCHHHHHHHHHHHHHHHHHHHhCCCCCCccchh-eEEECCCCeEEECCCCcccccCccccc
Confidence 1111122221 1244444 99999999999999987642
Q ss_pred --------------ccccccccCCCcceeeechhhHHHHHHHhh-CCCCCCCCcHHHHHHHHHhC-CCCCCCCCCHHHHH
Q psy11767 220 --------------DEVIDWDDFSRGIECVFFSSSLIIFFIILS-FTLSFIHDYYHIQYRRILKT-EPPIPEDLSPDVAD 283 (966)
Q Consensus 220 --------------~e~i~~~~y~~~~d~~~~~~~~il~~~m~~-g~~pf~~~~~~~~~~~I~~~-~~~~P~~~s~~a~d 283 (966)
+|++....|+...| +|+.|+++|+|++ |.+||.......+.+.+..+ .+..|..+++++.+
T Consensus 172 ~~~~~~~~~~~y~aPE~~~~~~~~~~~D---i~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 248 (325)
T 3kex_A 172 LLYSEAKTPIKWMALESIHFGKYTHQSD---VWSYGVTVWELMTFGAEPYAGLRLAEVPDLLEKGERLAQPQICTIDVYM 248 (325)
T ss_dssp CC-----CCTTTSCHHHHHHCCCCHHHH---HHHHHHHHHHHHTTSCCTTTTSCTTHHHHHHHTTCBCCCCTTBCTTTTH
T ss_pred ccccCCCCcccccChHHhccCCCChhhH---hHHhHHHHHHHHhCCCCCccccCHHHHHHHHHcCCCCCCCCcCcHHHHH
Confidence 12333333433333 4456667777776 99999988877777888765 57788889999999
Q ss_pred HHHhhcccCCCcccCCCCCCHHHH-------------------------hcCCceeeeCccccccCCCCCCCCccccc
Q psy11767 284 FISRLLVKDPRRRLGGGELDAEEL-------------------------KRHPFFNVIDWDDLATKRIPAPFVPKISN 336 (966)
Q Consensus 284 li~~LL~kdp~~RLG~~~~g~~~I-------------------------k~HpfF~~idW~~l~~k~~~pP~~P~i~~ 336 (966)
||.++|..||.+|.. +.+| ..||++.+++|+.+..++++||+.|....
T Consensus 249 li~~~l~~dp~~Rps-----~~el~~~l~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~d~ 321 (325)
T 3kex_A 249 VMVKCWMIDENIRPT-----FKELANEFTRMARDPPRYLVIKRESGPGIAPGPEPHGLTNKKLEEVELEPELDLDLDL 321 (325)
T ss_dssp HHHHHTCSCTTTSCC-----HHHHHHHHHHHTTSHHHHBCCCSSSSCCCBCCCCCCC---------------------
T ss_pred HHHHHcCCChhhCcC-----HHHHHHHHHHHHhcchhhhccccCCCCCCCCCCccccchhhcccccccchhccCCccc
Confidence 999999999999964 4444 45789999999999999999988776543
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=99.72 E-value=3.6e-17 Score=178.29 Aligned_cols=189 Identities=23% Similarity=0.328 Sum_probs=138.7
Q ss_pred CCcceeeeecccccceEEEEEEcCCCCEEEEEeccccc------hhhHHHHHHHHhhCCCcccccccccccc--------
Q psy11767 116 MDLDKAGILGDGSYSVCRRCVEKSTGQEYAVKIISRKI------DCSEEINLLRACQGHPNICRRCVEKSTG-------- 181 (966)
Q Consensus 116 ~df~~~~~LG~GsFGkV~La~~k~tg~~yAiKvl~K~~------~~~~E~~il~~~~~~pfi~~~~~~~~~~-------- 181 (966)
-+|.+.+.||+|+||+|++|+++.+|+.+|+|++.+.. ...+|..+|+++ +||+|++.+-.....
T Consensus 22 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l-~hp~iv~~~~~~~~~~~~~lv~e 100 (285)
T 3is5_A 22 DLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSL-DHPNIIKIFEVFEDYHNMYIVME 100 (285)
T ss_dssp HHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCCSCHHHHHHHHHHHHTC-CCTTBCCEEEEEECSSEEEEEEC
T ss_pred hheeecceeccCCCeEEEEEEEccCCceEEEEEeeccccchhHHHHHHHHHHHHhC-CCchHHhHHHheecCCeEEEEEE
Confidence 35689999999999999999999999999999998752 357899999988 699998621111110
Q ss_pred --------------------------hhHHHHHHHh-------h---cccchhhhHhh---hccCCceEEecCcccc---
Q psy11767 182 --------------------------QEYAVKIISR-------K---IDCSEEINLLR---ACQGHPNIVNLHCVFQ--- 219 (966)
Q Consensus 182 --------------------------~~~~~~~v~~-------~---~~~~~e~nil~---~~~gh~~iv~l~~~~~--- 219 (966)
...+.+++.+ . .|++++ |||. +..+.++|+||+.+..
T Consensus 101 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~dikp~-NIl~~~~~~~~~~kl~Dfg~a~~~~~ 179 (285)
T 3is5_A 101 TCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFHSQHVVHKDLKPE-NILFQDTSPHSPIKIIDFGLAELFKS 179 (285)
T ss_dssp CCSCCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGG-GEEESSSSTTCCEEECCCCCCCC---
T ss_pred eCCCCcHHHHHHhhhhcccCCCHHHHHHHHHHHHHHHHHHHhCCEEECCCCHH-HEEEecCCCCCCEEEEeeecceecCC
Confidence 0111122211 0 134444 8888 4457899999987632
Q ss_pred ---------------ccccccccCCCcceeeechhhHHHHHHHhhCCCCCCCCcHHHHHHHHHhCCCCCCC---CCCHHH
Q psy11767 220 ---------------DEVIDWDDFSRGIECVFFSSSLIIFFIILSFTLSFIHDYYHIQYRRILKTEPPIPE---DLSPDV 281 (966)
Q Consensus 220 ---------------~e~i~~~~y~~~~d~~~~~~~~il~~~m~~g~~pf~~~~~~~~~~~I~~~~~~~P~---~~s~~a 281 (966)
+|++. ..++...| .|+.|+++|+|++|.+||...+...+.+++....+.++. .+++++
T Consensus 180 ~~~~~~~~~t~~y~aPE~~~-~~~~~~~D---i~slG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 255 (285)
T 3is5_A 180 DEHSTNAAGTALYMAPEVFK-RDVTFKCD---IWSAGVVMYFLLTGCLPFTGTSLEEVQQKATYKEPNYAVECRPLTPQA 255 (285)
T ss_dssp -------CTTGGGCCHHHHT-TCCCHHHH---HHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCC--CCCCHHH
T ss_pred cccCcCcccccCcCChHHhc-cCCCcccC---eehHHHHHHHHHhCCCCCCCCCHHHHHhhhccCCcccccccCcCCHHH
Confidence 23332 23333333 446778888899999999999988888888888777764 379999
Q ss_pred HHHHHhhcccCCCcccCCCCCCHHHHhcCCceee
Q psy11767 282 ADFISRLLVKDPRRRLGGGELDAEELKRHPFFNV 315 (966)
Q Consensus 282 ~dli~~LL~kdp~~RLG~~~~g~~~Ik~HpfF~~ 315 (966)
++||+++|+.||.+|. .+.||.+||||+.
T Consensus 256 ~~li~~~L~~dP~~Rp-----s~~e~l~hp~f~~ 284 (285)
T 3is5_A 256 VDLLKQMLTKDPERRP-----SAAQVLHHEWFKQ 284 (285)
T ss_dssp HHHHHHHTCSCTTTSC-----CHHHHHTSGGGGC
T ss_pred HHHHHHHccCChhhCc-----CHHHHhcCHHhhc
Confidence 9999999999999998 4899999999974
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* | Back alignment and structure |
|---|
Probab=99.71 E-value=2.8e-17 Score=179.85 Aligned_cols=196 Identities=24% Similarity=0.316 Sum_probs=142.7
Q ss_pred CcceeeeecccccceEEEEEEcCCCCEEEEEeccccc-----hhhHHHHHHHHhhCCCcccccccccccc----------
Q psy11767 117 DLDKAGILGDGSYSVCRRCVEKSTGQEYAVKIISRKI-----DCSEEINLLRACQGHPNICRRCVEKSTG---------- 181 (966)
Q Consensus 117 df~~~~~LG~GsFGkV~La~~k~tg~~yAiKvl~K~~-----~~~~E~~il~~~~~~pfi~~~~~~~~~~---------- 181 (966)
+|++++.||+|+||+|++|+++.+|+.||+|+++... ...+|..+|.++ +||+|+...-.....
T Consensus 20 ~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~ 98 (302)
T 2j7t_A 20 VWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATC-DHPYIVKLLGAYYHDGKLWIMIEFC 98 (302)
T ss_dssp TEEEEEEEECSTTCCEEEEEETTTCCEEEEEEEC----CCHHHHHHHHHHHHHC-CCTTBCCEEEEEECC-CEEEEEECC
T ss_pred ceeecceeccCCCeEEEEEEEcCCCcEEEEEEecCCCHHHHHHHHHHHHHHhcC-CCCCEeeeeeeeeeCCeEEEEEEeC
Confidence 5799999999999999999999999999999997542 356789999888 699998722111110
Q ss_pred ---------------------hhHHHHHHHh----------hcccchhhhHhhhccCCceEEecCccc------------
Q psy11767 182 ---------------------QEYAVKIISR----------KIDCSEEINLLRACQGHPNIVNLHCVF------------ 218 (966)
Q Consensus 182 ---------------------~~~~~~~v~~----------~~~~~~e~nil~~~~gh~~iv~l~~~~------------ 218 (966)
...+.+++.+ ..|++++ |||.+.+|.++|.||+.+.
T Consensus 99 ~~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~-Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~ 177 (302)
T 2j7t_A 99 PGGAVDAIMLELDRGLTEPQIQVVCRQMLEALNFLHSKRIIHRDLKAG-NVLMTLEGDIRLADFGVSAKNLKTLQKRDSF 177 (302)
T ss_dssp TTEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGG-GEEECTTSCEEECCCHHHHHHHHHHHC----
T ss_pred CCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCHH-HEEECCCCCEEEEECCCCccccccccccccc
Confidence 0011111111 0133334 9999999999999998542
Q ss_pred -------cccccc-----cccCCCcceeeechhhHHHHHHHhhCCCCCCCCcHHHHHHHHHhCCCC---CCCCCCHHHHH
Q psy11767 219 -------QDEVID-----WDDFSRGIECVFFSSSLIIFFIILSFTLSFIHDYYHIQYRRILKTEPP---IPEDLSPDVAD 283 (966)
Q Consensus 219 -------~~e~i~-----~~~y~~~~d~~~~~~~~il~~~m~~g~~pf~~~~~~~~~~~I~~~~~~---~P~~~s~~a~d 283 (966)
.+|++. ...|+...| .|+.|+++|+|++|.+||...+....+..+...... .|..++.++++
T Consensus 178 ~~~~~y~aPE~~~~~~~~~~~~~~~~D---i~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 254 (302)
T 2j7t_A 178 IGTPYWMAPEVVMCETMKDTPYDYKAD---IWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSDPPTLLTPSKWSVEFRD 254 (302)
T ss_dssp -CCGGGCCHHHHHHHHTTSTTTTTHHH---HHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCCCSSGGGSCHHHHH
T ss_pred cCChhhcCCeeeccccCCCCCCchhhh---HHHHHHHHHHHhcCCCCCccCCHHHHHHHHhccCCcccCCccccCHHHHH
Confidence 234432 233444444 446677888899999999988887778888776543 46778999999
Q ss_pred HHHhhcccCCCcccCCCCCCHHHHhcCCceeeeCccccc
Q psy11767 284 FISRLLVKDPRRRLGGGELDAEELKRHPFFNVIDWDDLA 322 (966)
Q Consensus 284 li~~LL~kdp~~RLG~~~~g~~~Ik~HpfF~~idW~~l~ 322 (966)
||+++|..||.+|. .+.+|.+||||..+.|....
T Consensus 255 li~~~l~~dp~~Rp-----s~~~ll~h~~~~~~~~~~~~ 288 (302)
T 2j7t_A 255 FLKIALDKNPETRP-----SAAQLLEHPFVSSITSNKAL 288 (302)
T ss_dssp HHHHHSCSCTTTSC-----CHHHHTTSTTTTTCCCCHHH
T ss_pred HHHHHcccChhhCC-----CHHHHhcChHHhhhccchhH
Confidence 99999999999998 48999999999999987643
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3v01_A* 3v04_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* ... | Back alignment and structure |
|---|
Probab=99.71 E-value=1.2e-17 Score=188.12 Aligned_cols=196 Identities=21% Similarity=0.294 Sum_probs=140.3
Q ss_pred CcceeeeecccccceEEEEEEcCCCCEEEEEecccc------chhhHHHHHHHHhhCCCcccccccccccc---------
Q psy11767 117 DLDKAGILGDGSYSVCRRCVEKSTGQEYAVKIISRK------IDCSEEINLLRACQGHPNICRRCVEKSTG--------- 181 (966)
Q Consensus 117 df~~~~~LG~GsFGkV~La~~k~tg~~yAiKvl~K~------~~~~~E~~il~~~~~~pfi~~~~~~~~~~--------- 181 (966)
+|++++.||+|+||.|++|+++.+|+.||+|++++. ....+|..+|+++ +||+|+..+-.+...
T Consensus 34 ~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~e~ 112 (360)
T 3eqc_A 34 DFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHEC-NSPYIVGFYGAFYSDGEISICMEH 112 (360)
T ss_dssp GEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECCCCHHHHHHHHHHHGGGGGC-CCTTBCCEEEEEEETTEEEEEECC
T ss_pred cceeeeeecCCCCeEEEEEEECCCCcEEEEEEeccccCHHHHHHHHHHHHHHHHC-CCCCEEEEeEEEEECCEEEEEEEC
Confidence 789999999999999999999999999999999864 2357788888887 699998622111110
Q ss_pred ---------------------hhHHHHHH------Hh--hc---ccchhhhHhhhccCCceEEecCccc-----------
Q psy11767 182 ---------------------QEYAVKII------SR--KI---DCSEEINLLRACQGHPNIVNLHCVF----------- 218 (966)
Q Consensus 182 ---------------------~~~~~~~v------~~--~~---~~~~e~nil~~~~gh~~iv~l~~~~----------- 218 (966)
...+.+++ .. .+ |++++ |||.+.+|+++|+||+.+.
T Consensus 113 ~~~~~L~~~l~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~i~H~dlkp~-Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~ 191 (360)
T 3eqc_A 113 MDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPS-NILVNSRGEIKLCDFGVSGQLIDSMANSFV 191 (360)
T ss_dssp CTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHHHCCCCSCCSGG-GEEECTTCCEEECCCCCCHHHHHHC----C
T ss_pred CCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHhCCEEcCCccHH-HEEECCCCCEEEEECCCCcccccccccCCC
Confidence 00111111 11 11 33344 9999999999999998652
Q ss_pred ------cccccccccCCCcceeeechhhHHHHHHHhhCCCCCCCCcHHHH------------------------------
Q psy11767 219 ------QDEVIDWDDFSRGIECVFFSSSLIIFFIILSFTLSFIHDYYHIQ------------------------------ 262 (966)
Q Consensus 219 ------~~e~i~~~~y~~~~d~~~~~~~~il~~~m~~g~~pf~~~~~~~~------------------------------ 262 (966)
.+|++....|+...| .|+.|+++|+|++|.+||...+...+
T Consensus 192 gt~~y~aPE~~~~~~~~~~~D---i~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 268 (360)
T 3eqc_A 192 GTRSYMSPERLQGTHYSVQSD---IWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRPLNKFG 268 (360)
T ss_dssp CCCTTCCHHHHTTCCCSHHHH---HHHHHHHHHHHHHTSCCSSCCCHHHHHHHHC-------------------------
T ss_pred CCCCeECHHHHcCCCCCchhh---HHHHHHHHHHHHhCCCCCCCCCHHHHHHHhcccccccCCCCCCCcccCCCcccccc
Confidence 234555555554444 44667888889999999986654432
Q ss_pred ------------HHHHHhCC-CCCC-CCCCHHHHHHHHhhcccCCCcccCCCCCCHHHHhcCCceeeeCccccc
Q psy11767 263 ------------YRRILKTE-PPIP-EDLSPDVADFISRLLVKDPRRRLGGGELDAEELKRHPFFNVIDWDDLA 322 (966)
Q Consensus 263 ------------~~~I~~~~-~~~P-~~~s~~a~dli~~LL~kdp~~RLG~~~~g~~~Ik~HpfF~~idW~~l~ 322 (966)
.+.+.+.. +..| ..+++++++||+++|+.||.+|. .++++.+||||+..+|+.+.
T Consensus 269 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rp-----t~~ell~hp~~~~~~~~~~~ 337 (360)
T 3eqc_A 269 MDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERA-----DLKQLMVHAFIKRSDAEEVD 337 (360)
T ss_dssp -----CCCHHHHHHHHHHSCCCCCCTTTSCHHHHHHHHHHHCSSTTTSC-----CHHHHHTSHHHHHHHHSCCC
T ss_pred cCCCCcccchhhhhHHhccCCCCCCcccccHHHHHHHHHHhhcChhhCC-----CHHHHhhChHhhcchHhhhh
Confidence 23344433 2333 35799999999999999999998 48999999999999987764
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} PDB: 4bbm_A* | Back alignment and structure |
|---|
Probab=99.71 E-value=6.6e-18 Score=188.17 Aligned_cols=199 Identities=23% Similarity=0.309 Sum_probs=139.9
Q ss_pred CcceeeeecccccceEEEEEEcCCCCEEEEEeccccc-------hhhHHHHHHHHhhCCCcccccccccccc--------
Q psy11767 117 DLDKAGILGDGSYSVCRRCVEKSTGQEYAVKIISRKI-------DCSEEINLLRACQGHPNICRRCVEKSTG-------- 181 (966)
Q Consensus 117 df~~~~~LG~GsFGkV~La~~k~tg~~yAiKvl~K~~-------~~~~E~~il~~~~~~pfi~~~~~~~~~~-------- 181 (966)
+|+++++||+|+||.|++|+++.+|+.||||++.+.. ...+|..+|+++ +||+|+.........
T Consensus 26 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~e 104 (331)
T 4aaa_A 26 KYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQL-RHENLVNLLEVCKKKKRWYLVFE 104 (331)
T ss_dssp GEEEEEEGGGGTTSSEEEEEETTTCCEEEEEEEESCSSCHHHHHHHHHHHHHHHHC-CCTTBCCEEEEEEETTEEEEEEE
T ss_pred hheeeeEEeecCCEEEEEEEECCCCceEEEEEEecCCCchHHHHHHHHHHHHHhhC-CCCCEeeEEEEeecCCEEEEEEe
Confidence 7899999999999999999999999999999987542 245799999988 499998722111110
Q ss_pred ----------------------hhHHHHHHHh----------hcccchhhhHhhhccCCceEEecCcccc----------
Q psy11767 182 ----------------------QEYAVKIISR----------KIDCSEEINLLRACQGHPNIVNLHCVFQ---------- 219 (966)
Q Consensus 182 ----------------------~~~~~~~v~~----------~~~~~~e~nil~~~~gh~~iv~l~~~~~---------- 219 (966)
..++.+++.+ ..|++++ |||.+.+|+++|+||+.+..
T Consensus 105 ~~~~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~-Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~ 183 (331)
T 4aaa_A 105 FVDHTILDDLELFPNGLDYQVVQKYLFQIINGIGFCHSHNIIHRDIKPE-NILVSQSGVVKLCDFGFARTLAAPGEVYDD 183 (331)
T ss_dssp CCSEEHHHHHHHSTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGG-GEEECTTSCEEECCCTTC------------
T ss_pred cCCcchHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHHCCEEccCcChh-eEEEcCCCcEEEEeCCCceeecCCccccCC
Confidence 1111122211 1144444 99999999999999987632
Q ss_pred ---------ccccccc-cCCCcceeeechhhHHHHHHHhhCCCCCCCCcHHHHHHHHHhC-------------------C
Q psy11767 220 ---------DEVIDWD-DFSRGIECVFFSSSLIIFFIILSFTLSFIHDYYHIQYRRILKT-------------------E 270 (966)
Q Consensus 220 ---------~e~i~~~-~y~~~~d~~~~~~~~il~~~m~~g~~pf~~~~~~~~~~~I~~~-------------------~ 270 (966)
+|++... .|+...| .|+.|+++|+|++|.+||...+.......|+.. .
T Consensus 184 ~~~t~~y~aPE~~~~~~~~~~~~D---i~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 260 (331)
T 4aaa_A 184 EVATRWYRAPELLVGDVKYGKAVD---VWAIGCLVTEMFMGEPLFPGDSDIDQLYHIMMCLGNLIPRHQELFNKNPVFAG 260 (331)
T ss_dssp CCCCCTTCCHHHHTTCTTCCTHHH---HHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHHHHHCGGGTT
T ss_pred CcCCccccCcccccCCCCcchHHH---HHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhhhHhhhcccccc
Confidence 2333222 3444444 446678889999999999887766555555421 1
Q ss_pred CCCC------------CCCCHHHHHHHHhhcccCCCcccCCCCCCHHHHhcCCceeeeCccccccCC
Q psy11767 271 PPIP------------EDLSPDVADFISRLLVKDPRRRLGGGELDAEELKRHPFFNVIDWDDLATKR 325 (966)
Q Consensus 271 ~~~P------------~~~s~~a~dli~~LL~kdp~~RLG~~~~g~~~Ik~HpfF~~idW~~l~~k~ 325 (966)
..+| +.+++++++||+++|+.||.+|.. +.||.+||||+..+|.....++
T Consensus 261 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt-----~~ell~hp~f~~~~~~~~~~~~ 322 (331)
T 4aaa_A 261 VRLPEIKEREPLERRYPKLSEVVIDLAKKCLHIDPDKRPF-----CAELLHHDFFQMDGFAERFSQE 322 (331)
T ss_dssp CCCCCCSSCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCC-----GGGGGGSHHHHGGGHHHHHHHH
T ss_pred ccCccccccchhhhcccchhHHHHHHHHHHhccCcccCCC-----HHHHhcCchhccCChhhhhhHH
Confidence 1111 257899999999999999999984 7899999999988886655443
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* | Back alignment and structure |
|---|
Probab=99.71 E-value=1.8e-17 Score=183.81 Aligned_cols=197 Identities=24% Similarity=0.306 Sum_probs=139.0
Q ss_pred ccCCcceeeeecccccceEEEEEEcCCCCEEEEEeccccc-------------hhhHHHHHHHHhhCCCccccccccccc
Q psy11767 114 YDMDLDKAGILGDGSYSVCRRCVEKSTGQEYAVKIISRKI-------------DCSEEINLLRACQGHPNICRRCVEKST 180 (966)
Q Consensus 114 ~~~df~~~~~LG~GsFGkV~La~~k~tg~~yAiKvl~K~~-------------~~~~E~~il~~~~~~pfi~~~~~~~~~ 180 (966)
..-+|.+.+.||+|+||.|++|+++.+|+.||||++++.. ...+|..+|+++ +||+|+...-....
T Consensus 8 l~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~ 86 (322)
T 2ycf_A 8 LRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKL-NHPCIIKIKNFFDA 86 (322)
T ss_dssp HHHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECC---------------CHHHHHHHHHHC-CCTTBCCEEEEEES
T ss_pred hhhceeEeeEEecCCCEEEEEEEEcCCCcEEEEEEeehhhhhhcccccchhhhhHHHHHHHHHhC-CCCCCceEeeEEcC
Confidence 3346799999999999999999999999999999998642 246799999998 69999862111111
Q ss_pred c-----------------------------hhHHHHHHHh----------hcccchhhhHhhhccCC---ceEEecCccc
Q psy11767 181 G-----------------------------QEYAVKIISR----------KIDCSEEINLLRACQGH---PNIVNLHCVF 218 (966)
Q Consensus 181 ~-----------------------------~~~~~~~v~~----------~~~~~~e~nil~~~~gh---~~iv~l~~~~ 218 (966)
. ...+.+++.+ ..|++++ |||.+.+|. ++|+||+.+.
T Consensus 87 ~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~-NIl~~~~~~~~~~kl~Dfg~~~ 165 (322)
T 2ycf_A 87 EDYYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQYLHENGIIHRDLKPE-NVLLSSQEEDCLIKITDFGHSK 165 (322)
T ss_dssp SSEEEEEECCTTEETHHHHSTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGG-GEEESSSSSSCCEEECCCTTCE
T ss_pred CceEEEEecCCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHH-HEEEecCCCCCeEEEccCccce
Confidence 0 0111122211 0134444 999876654 8999998663
Q ss_pred c------------------ccccc---cccCCCcceeeechhhHHHHHHHhhCCCCCCCCcH-HHHHHHHHhCCCCCC--
Q psy11767 219 Q------------------DEVID---WDDFSRGIECVFFSSSLIIFFIILSFTLSFIHDYY-HIQYRRILKTEPPIP-- 274 (966)
Q Consensus 219 ~------------------~e~i~---~~~y~~~~d~~~~~~~~il~~~m~~g~~pf~~~~~-~~~~~~I~~~~~~~P-- 274 (966)
. +|++. ...|+...| .|+.|+++|+|++|.+||..... ..+.+.|..+...++
T Consensus 166 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~D---i~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 242 (322)
T 2ycf_A 166 ILGETSLMRTLCGTPTYLAPEVLVSVGTAGYNRAVD---CWSLGVILFICLSGYPPFSEHRTQVSLKDQITSGKYNFIPE 242 (322)
T ss_dssp ECCCCHHHHHHHSCCTTCCHHHHHHTTTTTCTTHHH---HHHHHHHHHHHHHSSCSSCSTTCSSCHHHHHHHTCCCCCHH
T ss_pred ecccccccccccCCcCccCchhhccCCCCCCCchhh---HHHHHHHHHHHHhCCCCCcccchHHHHHHHHHhCccccCch
Confidence 2 23332 234444444 34566788889999999975432 345667777776654
Q ss_pred --CCCCHHHHHHHHhhcccCCCcccCCCCCCHHHHhcCCceeeeCccc
Q psy11767 275 --EDLSPDVADFISRLLVKDPRRRLGGGELDAEELKRHPFFNVIDWDD 320 (966)
Q Consensus 275 --~~~s~~a~dli~~LL~kdp~~RLG~~~~g~~~Ik~HpfF~~idW~~ 320 (966)
..+++++++||+++|..||.+|.. +++|.+||||++.+|..
T Consensus 243 ~~~~~~~~~~~li~~~l~~dP~~Rps-----~~~~l~h~~~~~~~~~~ 285 (322)
T 2ycf_A 243 VWAEVSEKALDLVKKLLVVDPKARFT-----TEEALRHPWLQDEDMKR 285 (322)
T ss_dssp HHTTSCHHHHHHHHHHSCSSTTTSCC-----HHHHHTSGGGCCHHHHH
T ss_pred hhhhcCHHHHHHHHHHcccCHhhCCC-----HHHHhhCcCcCCHHHHH
Confidence 568999999999999999999984 89999999999988753
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} | Back alignment and structure |
|---|
Probab=99.71 E-value=2.2e-17 Score=185.56 Aligned_cols=194 Identities=20% Similarity=0.224 Sum_probs=124.3
Q ss_pred CcceeeeecccccceEEEEEEcCCCCEEEEEeccccc----hhhHHHHHHHHhhCCCccccccccccc------------
Q psy11767 117 DLDKAGILGDGSYSVCRRCVEKSTGQEYAVKIISRKI----DCSEEINLLRACQGHPNICRRCVEKST------------ 180 (966)
Q Consensus 117 df~~~~~LG~GsFGkV~La~~k~tg~~yAiKvl~K~~----~~~~E~~il~~~~~~pfi~~~~~~~~~------------ 180 (966)
+|.+.++||+|+||+|++|+++.+|+.||||++.+.. ....|...|.++ +||+|++..-.+..
T Consensus 24 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~l~~l-~h~niv~~~~~~~~~~~~~~~~~~~~ 102 (360)
T 3e3p_A 24 RFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDPRFRNRELQIMQDLAVL-HHPNIVQLQSYFYTLGERDRRDIYLN 102 (360)
T ss_dssp TEEEC----------CEEEEETTTCCEEEEEEEECCTTCCCHHHHHHHHHHHH-CCTTBCCEEEEEEEECSSCTTCEEEE
T ss_pred ceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEecCccccHHHHHHHHHHHhc-CCCCcccHHHhhhccccccccceeEE
Confidence 7899999999999999999999999999999987642 223344444444 79999873211100
Q ss_pred -------c---------------------hhHHHHHH------H--h-h---cccchhhhHhhhc-cCCceEEecCcccc
Q psy11767 181 -------G---------------------QEYAVKII------S--R-K---IDCSEEINLLRAC-QGHPNIVNLHCVFQ 219 (966)
Q Consensus 181 -------~---------------------~~~~~~~v------~--~-~---~~~~~e~nil~~~-~gh~~iv~l~~~~~ 219 (966)
. ...+.+++ + . . .|++++ |||.+. +|+++|+||+.+..
T Consensus 103 lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~~~ivH~Dlkp~-NIll~~~~~~~kl~Dfg~a~~ 181 (360)
T 3e3p_A 103 VVMEYVPDTLHRCCRNYYRRQVAPPPILIKVFLFQLIRSIGCLHLPSVNVCHRDIKPH-NVLVNEADGTLKLCDFGSAKK 181 (360)
T ss_dssp EEEECCSCBHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHTSTTTCCBCSCCCGG-GEEEETTTTEEEECCCTTCBC
T ss_pred EEeecccccHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhCCCCCeecCcCCHH-HEEEeCCCCcEEEeeCCCcee
Confidence 0 00011111 1 1 0 134444 999986 79999999987642
Q ss_pred ------------------ccccccc-cCCCcceeeechhhHHHHHHHhhCCCCCCCCcHHHHHHHHHhC--C--------
Q psy11767 220 ------------------DEVIDWD-DFSRGIECVFFSSSLIIFFIILSFTLSFIHDYYHIQYRRILKT--E-------- 270 (966)
Q Consensus 220 ------------------~e~i~~~-~y~~~~d~~~~~~~~il~~~m~~g~~pf~~~~~~~~~~~I~~~--~-------- 270 (966)
+|++... .|+...| .|+.|+++|+|++|.+||...+...++..|+.. .
T Consensus 182 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~D---i~slG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 258 (360)
T 3e3p_A 182 LSPSEPNVAYICSRYYRAPELIFGNQHYTTAVD---IWSVGCIFAEMMLGEPIFRGDNSAGQLHEIVRVLGCPSREVLRK 258 (360)
T ss_dssp CCTTSCCCSTTSCGGGCCHHHHTTCSSCCTHHH---HHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHH
T ss_pred cCCCCCcccccCCcceeCHHHHcCCCCCCcHHH---HHHHHHHHHHHHhCCCCcCCCChHHHHHHHHHHcCCCCHHHHHh
Confidence 2333222 2444444 446778889999999999998888777777641 0
Q ss_pred ----------------------CCCCCCCCHHHHHHHHhhcccCCCcccCCCCCCHHHHhcCCceeeeCccc
Q psy11767 271 ----------------------PPIPEDLSPDVADFISRLLVKDPRRRLGGGELDAEELKRHPFFNVIDWDD 320 (966)
Q Consensus 271 ----------------------~~~P~~~s~~a~dli~~LL~kdp~~RLG~~~~g~~~Ik~HpfF~~idW~~ 320 (966)
..++...++++++||.++|+.||.+|+. +.+|.+||||+.+.+..
T Consensus 259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt-----~~e~l~hp~f~~~~~~~ 325 (360)
T 3e3p_A 259 LNPSHTDVDLYNSKGIPWSNVFSDHSLKDAKEAYDLLSALLQYLPEERMK-----PYEALCHPYFDELHDPA 325 (360)
T ss_dssp HCTTCCCGGGGCCCCCCHHHHTTTCCCTTHHHHHHHHHHHTCSSGGGSCC-----HHHHTTSGGGGGGGCTT
T ss_pred cccchhhccccccccCCcccccchhhccccHHHHHHHHHHhccCccccCC-----HHHHhcCccccccCCcc
Confidence 1223336789999999999999999984 89999999999887643
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.71 E-value=9.5e-18 Score=194.75 Aligned_cols=208 Identities=20% Similarity=0.303 Sum_probs=138.2
Q ss_pred CcceeeeecccccceEEEEEEcCCCCEEEEEecccc--chhhHHHHHHHHhhCCCcccccccccccc-------------
Q psy11767 117 DLDKAGILGDGSYSVCRRCVEKSTGQEYAVKIISRK--IDCSEEINLLRACQGHPNICRRCVEKSTG------------- 181 (966)
Q Consensus 117 df~~~~~LG~GsFGkV~La~~k~tg~~yAiKvl~K~--~~~~~E~~il~~~~~~pfi~~~~~~~~~~------------- 181 (966)
+|++.++||+|+||+|+. +...+|+.||||++.+. ....+|..+|+++.+||+|++.+..+...
T Consensus 25 ~y~~~~~LG~G~~G~V~~-~~~~~~~~vAvK~~~~~~~~~~~~E~~~l~~l~~HpnIv~l~~~~~~~~~~~lv~E~~~g~ 103 (432)
T 3p23_A 25 SFCPKDVLGHGAEGTIVY-RGMFDNRDVAVKRILPECFSFADREVQLLRESDEHPNVIRYFCTEKDRQFQYIAIELCAAT 103 (432)
T ss_dssp EEEEEEEEEECGGGCEEE-EEESSSSEEEEEEECTTTEEECHHHHHHHHHSCCCTTBCCEEEEEEETTEEEEEEECCSEE
T ss_pred EEecCCeeecCcCEEEEE-EEEeCCeEEEEEEECHHHHHHHHHHHHHHHhccCCCCcCeEEEEEecCCEEEEEEECCCCC
Confidence 789999999999999874 55678999999999865 34678999999998999998732211111
Q ss_pred -----------------hhHHHHHHHh----------hcccchhhhHhhhc---cC--CceEEecCccc-----------
Q psy11767 182 -----------------QEYAVKIISR----------KIDCSEEINLLRAC---QG--HPNIVNLHCVF----------- 218 (966)
Q Consensus 182 -----------------~~~~~~~v~~----------~~~~~~e~nil~~~---~g--h~~iv~l~~~~----------- 218 (966)
...+.+++.+ ..|++++ |||.+. +| .++|+||+.+.
T Consensus 104 L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlKp~-NIll~~~~~~~~~~~kL~DFG~a~~~~~~~~~~~~ 182 (432)
T 3p23_A 104 LQEYVEQKDFAHLGLEPITLLQQTTSGLAHLHSLNIVHRDLKPH-NILISMPNAHGKIKAMISDFGLCKKLAVGRHSFSR 182 (432)
T ss_dssp HHHHHHSSSCCCCSSCHHHHHHHHHHHHHHHHHTTCCCCCCSTT-SEEECCCBTTTBCCEEECCTTEEECC---------
T ss_pred HHHHHHhcCCCccchhHHHHHHHHHHHHHHHHHCcCEeCCCCHH-HEEEecCCCCCceeEEEecccceeeccCCCcceee
Confidence 1112222222 1244444 898843 23 45699988652
Q ss_pred -----------ccccccc---ccCCCcceeeechhhHHHHHHHhh-CCCCCCCCcHHHHHHHHHhCCCCC-----CCCCC
Q psy11767 219 -----------QDEVIDW---DDFSRGIECVFFSSSLIIFFIILS-FTLSFIHDYYHIQYRRILKTEPPI-----PEDLS 278 (966)
Q Consensus 219 -----------~~e~i~~---~~y~~~~d~~~~~~~~il~~~m~~-g~~pf~~~~~~~~~~~I~~~~~~~-----P~~~s 278 (966)
.+|++.. ..++... |.|+ .|+++|+|++ |.+||........ .++.+.... +...+
T Consensus 183 ~~~~~gt~~y~APE~l~~~~~~~~t~~~--DiwS-lG~il~ellt~g~~pf~~~~~~~~--~~~~~~~~~~~~~~~~~~~ 257 (432)
T 3p23_A 183 RSGVPGTEGWIAPEMLSEDCKENPTYTV--DIFS-AGCVFYYVISEGSHPFGKSLQRQA--NILLGACSLDCLHPEKHED 257 (432)
T ss_dssp ---CCSCTTSCCGGGTSCC---CCCTHH--HHHH-HHHHHHHHHTTSCBTTBSTTTHHH--HHHTTCCCCTTSCTTCHHH
T ss_pred ccccCCCcCccChhhhhcccccCCCcHH--HHHH-HHHHHHHHHcCCCCCcchhhHHHH--HHHhccCCccccCcccccc
Confidence 2455542 2333333 4455 5555556655 9999976654442 222222221 23356
Q ss_pred HHHHHHHHhhcccCCCcccCCCCCCHHHHhcCCceeeeCc---------cccccCCCCCCCCccccc
Q psy11767 279 PDVADFISRLLVKDPRRRLGGGELDAEELKRHPFFNVIDW---------DDLATKRIPAPFVPKISN 336 (966)
Q Consensus 279 ~~a~dli~~LL~kdp~~RLG~~~~g~~~Ik~HpfF~~idW---------~~l~~k~~~pP~~P~i~~ 336 (966)
..+++||+++|+.||.+|. ++++|.+||||.+++| +.+......+|+.+.+..
T Consensus 258 ~~~~~li~~~L~~dP~~Rp-----s~~evl~hp~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 319 (432)
T 3p23_A 258 VIARELIEKMIAMDPQKRP-----SAKHVLKHPFFWSLEKQLQFFQDVSDRIEKESLDGPIVKQLER 319 (432)
T ss_dssp HHHHHHHHHHSCSSGGGSC-----CHHHHHTSTTTCCHHHHHHHHHHHHHHCSCSCSSCHHHHHHHH
T ss_pred HHHHHHHHHHHhCCHhhCC-----CHHHHHhCccccChHHHHHHHHHHHHHhhcccccchHHHHHHH
Confidence 7789999999999999998 4899999999999999 566667777777766543
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* | Back alignment and structure |
|---|
Probab=99.71 E-value=3.3e-17 Score=178.43 Aligned_cols=192 Identities=24% Similarity=0.363 Sum_probs=140.7
Q ss_pred CcceeeeecccccceEEEEEEcCCCCEEEEEeccccc-------hhhHHHHHHHHhhCCCcccccccccccc--------
Q psy11767 117 DLDKAGILGDGSYSVCRRCVEKSTGQEYAVKIISRKI-------DCSEEINLLRACQGHPNICRRCVEKSTG-------- 181 (966)
Q Consensus 117 df~~~~~LG~GsFGkV~La~~k~tg~~yAiKvl~K~~-------~~~~E~~il~~~~~~pfi~~~~~~~~~~-------- 181 (966)
+|.+++.||+|+||+|++|+++.+|+.||||++++.. ...+|.++|+++ +||+|++..-.....
T Consensus 23 ~y~i~~~lg~G~~g~V~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e 101 (287)
T 2wei_A 23 RYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKL-DHPNIMKLFEILEDSSSFYIVGE 101 (287)
T ss_dssp HEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGBSSSCHHHHHHHHHHHHTC-CCTTBCCEEEEEECSSEEEEEEC
T ss_pred cceeeEEEcCCCCEEEEEEEEcCCCcEEEEEEecccccchHHHHHHHHHHHHHHhc-cCCCccEEEEEEeCCCeEEEEEE
Confidence 5599999999999999999999999999999997642 356799999988 699998622111110
Q ss_pred ----------------------hhHHHHHHHh-------h---cccchhhhHhhhcc---CCceEEecCcccc-------
Q psy11767 182 ----------------------QEYAVKIISR-------K---IDCSEEINLLRACQ---GHPNIVNLHCVFQ------- 219 (966)
Q Consensus 182 ----------------------~~~~~~~v~~-------~---~~~~~e~nil~~~~---gh~~iv~l~~~~~------- 219 (966)
...+.+++.+ . .|++++ |||.+.. +.++|+||+.+..
T Consensus 102 ~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~-NIlv~~~~~~~~~kL~Dfg~~~~~~~~~~~ 180 (287)
T 2wei_A 102 LYTGGELFDEIIKRKRFSEHDAARIIKQVFSGITYMHKHNIVHRDLKPE-NILLESKEKDCDIKIIDFGLSTCFQQNTKM 180 (287)
T ss_dssp CCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGG-GEEESCSSTTCCEEECSTTGGGTBCCCSSC
T ss_pred ccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCChh-hEEEecCCCcccEEEeccCcceeecCCCcc
Confidence 0011111111 0 133333 8888654 4689999986532
Q ss_pred -----------ccccccccCCCcceeeechhhHHHHHHHhhCCCCCCCCcHHHHHHHHHhCCCCCC----CCCCHHHHHH
Q psy11767 220 -----------DEVIDWDDFSRGIECVFFSSSLIIFFIILSFTLSFIHDYYHIQYRRILKTEPPIP----EDLSPDVADF 284 (966)
Q Consensus 220 -----------~e~i~~~~y~~~~d~~~~~~~~il~~~m~~g~~pf~~~~~~~~~~~I~~~~~~~P----~~~s~~a~dl 284 (966)
+|++.. .|+...| .| +.|+++|+|++|.+||...+...+.+.|..+...++ ..+++++++|
T Consensus 181 ~~~~~~~~y~aPE~~~~-~~~~~~D--i~-slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 256 (287)
T 2wei_A 181 KDRIGTAYYIAPEVLRG-TYDEKCD--VW-SAGVILYILLSGTPPFYGKNEYDILKRVETGKYAFDLPQWRTISDDAKDL 256 (287)
T ss_dssp SCHHHHHTTCCHHHHTT-CCCTHHH--HH-HHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCSGGGTTSCHHHHHH
T ss_pred ccccCcccccChHHhcC-CCCCchh--hH-hHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCchhhhhcCHHHHHH
Confidence 233222 2433333 34 566888889999999999888888999998887665 5689999999
Q ss_pred HHhhcccCCCcccCCCCCCHHHHhcCCceeeeCcc
Q psy11767 285 ISRLLVKDPRRRLGGGELDAEELKRHPFFNVIDWD 319 (966)
Q Consensus 285 i~~LL~kdp~~RLG~~~~g~~~Ik~HpfF~~idW~ 319 (966)
|+++|..||.+|. .+.+|..||||+..+|+
T Consensus 257 i~~~l~~dp~~Rp-----s~~ell~hp~~~~~~~~ 286 (287)
T 2wei_A 257 IRKMLTFHPSLRI-----TATQCLEHPWIQKYSSE 286 (287)
T ss_dssp HHHHTCSSGGGSC-----CHHHHHHSHHHHHHCCC
T ss_pred HHHHcccChhhCc-----CHHHHhcCHHHhccccC
Confidence 9999999999998 48999999999998886
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.71 E-value=1.8e-17 Score=182.35 Aligned_cols=194 Identities=20% Similarity=0.252 Sum_probs=132.9
Q ss_pred CcceeeeecccccceEEEEEEcCCCCEEEEEeccccc-----hhhHHHHHHHHhhCCCcccccccccc------------
Q psy11767 117 DLDKAGILGDGSYSVCRRCVEKSTGQEYAVKIISRKI-----DCSEEINLLRACQGHPNICRRCVEKS------------ 179 (966)
Q Consensus 117 df~~~~~LG~GsFGkV~La~~k~tg~~yAiKvl~K~~-----~~~~E~~il~~~~~~pfi~~~~~~~~------------ 179 (966)
+|.+++.||+|+||.|++|+++.+|+.||||++++.. ...+|..+|+++ +||+|++.+-...
T Consensus 12 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~~~~~~~ 90 (320)
T 2i6l_A 12 RYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLTDPQSVKHALREIKIIRRL-DHDNIVKVFEILGPSGSQLTDDVGS 90 (320)
T ss_dssp TEEEEEECC-----CEEEEEETTTTEEEEEEEEECCSHHHHHHHHHHHHHHHTC-CCTTBCCEEEEECTTSCBCCC----
T ss_pred ceeEEEEeccCCCeEEEEEEECCCCeEEEEEEEecCChHHHHHHHHHHHHHHhc-CCCCeeEEEEecccccccccccccc
Confidence 5699999999999999999999999999999987542 357899999988 6999987321100
Q ss_pred ----c--------------------------chhHHHHHHHh----------hcccchhhhHhhhc-cCCceEEecCccc
Q psy11767 180 ----T--------------------------GQEYAVKIISR----------KIDCSEEINLLRAC-QGHPNIVNLHCVF 218 (966)
Q Consensus 180 ----~--------------------------~~~~~~~~v~~----------~~~~~~e~nil~~~-~gh~~iv~l~~~~ 218 (966)
. ....+.+++.+ ..|++++ |||.+. ++.++|+||+.+.
T Consensus 91 ~~~~~~~~lv~e~~~~~L~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~-Nil~~~~~~~~kl~Dfg~~~ 169 (320)
T 2i6l_A 91 LTELNSVYIVQEYMETDLANVLEQGPLLEEHARLFMYQLLRGLKYIHSANVLHRDLKPA-NLFINTEDLVLKIGDFGLAR 169 (320)
T ss_dssp CCSCSEEEEEEECCSEEHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGG-GEEEETTTTEEEECCCTTCB
T ss_pred ccccCceeEEeeccCCCHHHHhhcCCccHHHHHHHHHHHHHHHHHHHhCCEecCCCCHH-HEEEcCCCCeEEEccCcccc
Confidence 0 00111122211 0134444 999874 5689999998664
Q ss_pred c----------------------cccccc-ccCCCcceeeechhhHHHHHHHhhCCCCCCCCcHHHHHHHHHhCCCC---
Q psy11767 219 Q----------------------DEVIDW-DDFSRGIECVFFSSSLIIFFIILSFTLSFIHDYYHIQYRRILKTEPP--- 272 (966)
Q Consensus 219 ~----------------------~e~i~~-~~y~~~~d~~~~~~~~il~~~m~~g~~pf~~~~~~~~~~~I~~~~~~--- 272 (966)
. +|++.. ..|+...| .|+.|+++|+|++|.+||...+....+++|+...+.
T Consensus 170 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~D---i~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~ 246 (320)
T 2i6l_A 170 IMDPHYSHKGHLSEGLVTKWYRSPRLLLSPNNYTKAID---MWAAGCIFAEMLTGKTLFAGAHELEQMQLILESIPVVHE 246 (320)
T ss_dssp CC--------CCCGGGSCCTTCCHHHHHCTTCCCHHHH---HHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHSCCCCH
T ss_pred ccCCCcccccccccccccccccCcHHhcCcccCCchhh---hHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCch
Confidence 2 122211 23333333 446678888999999999988887777777754321
Q ss_pred ---------------------------CCCCCCHHHHHHHHhhcccCCCcccCCCCCCHHHHhcCCceeeeCccc
Q psy11767 273 ---------------------------IPEDLSPDVADFISRLLVKDPRRRLGGGELDAEELKRHPFFNVIDWDD 320 (966)
Q Consensus 273 ---------------------------~P~~~s~~a~dli~~LL~kdp~~RLG~~~~g~~~Ik~HpfF~~idW~~ 320 (966)
++..+++++++||+++|+.||.+|. .+++|.+||||+.++|..
T Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rp-----t~~ell~hp~~~~~~~p~ 316 (320)
T 2i6l_A 247 EDRQELLSVIPVYIRNDMTEPHKPLTQLLPGISREAVDFLEQILTFSPMDRL-----TAEEALSHPYMSIYSFPM 316 (320)
T ss_dssp HHHHHHHTTSCHHHHHHTTSCCCCHHHHSTTCCHHHHHHHHTTSCSSGGGSC-----CHHHHHTSHHHHTTCC--
T ss_pred hhhhhhhhcCcccccccccCCCCChhHhcchhhHHHHHHHHHHcCCCccccC-----CHHHHhCCcccccccCcc
Confidence 2356899999999999999999998 489999999999888854
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* | Back alignment and structure |
|---|
Probab=99.71 E-value=1.2e-17 Score=185.87 Aligned_cols=203 Identities=19% Similarity=0.202 Sum_probs=141.9
Q ss_pred CcceeeeecccccceEEEEEEcCCCCEEEEEeccccc---hhhHHHHHHHHhhCCCccccccccccc-------------
Q psy11767 117 DLDKAGILGDGSYSVCRRCVEKSTGQEYAVKIISRKI---DCSEEINLLRACQGHPNICRRCVEKST------------- 180 (966)
Q Consensus 117 df~~~~~LG~GsFGkV~La~~k~tg~~yAiKvl~K~~---~~~~E~~il~~~~~~pfi~~~~~~~~~------------- 180 (966)
+|.+.+.||+|+||+|++|+++.+|+.||||++++.. ....|..+|+++.+||+|+..+.....
T Consensus 10 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~lv~e~~~~ 89 (330)
T 2izr_A 10 NFRVGKKIGCGNFGELRLGKNLYTNEYVAIKLEPMKSRAPQLHLEYRFYKQLGSGDGIPQVYYFGPCGKYNAMVLELLGP 89 (330)
T ss_dssp TEEEEEECCC-CTTSEEEEEETTTTEEEEEEEEETTCSSCCHHHHHHHHHHHCSCTTSCCEEEEEEETTEEEEEEECCCC
T ss_pred CeEEEEEeeccCCceEEEEEECCCCcEEEEEEeccccchHHHHHHHHHHHHhhCCCCCCEEEEEEecCCccEEEEEeCCC
Confidence 6799999999999999999999999999999998542 467899999999899999762111111
Q ss_pred -----------------chhHHHHHHHh----------hcccchhhhHhhhccCC-----ceEEecCcccc---------
Q psy11767 181 -----------------GQEYAVKIISR----------KIDCSEEINLLRACQGH-----PNIVNLHCVFQ--------- 219 (966)
Q Consensus 181 -----------------~~~~~~~~v~~----------~~~~~~e~nil~~~~gh-----~~iv~l~~~~~--------- 219 (966)
...++.+++.+ ..|++++ |||.+.+|+ ++|+||+.+..
T Consensus 90 ~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~-Nill~~~~~~~~~~~kl~DFg~a~~~~~~~~~~~ 168 (330)
T 2izr_A 90 SLEDLFDLCDRTFSLKTVLMIAIQLISRMEYVHSKNLIYRDVKPE-NFLIGRPGNKTQQVIHIIDFALAKEYIDPETKKH 168 (330)
T ss_dssp BHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGG-GEEECCGGGTCTTSEEECCCTTCEESBCTTTCCB
T ss_pred CHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHH-HeeeccCCCCCCceEEEEEcccceeeecCCCCcc
Confidence 01111222221 1244555 999988887 99999987632
Q ss_pred -----------------ccccccccCCCcceeeechhhHHHHHHHhhCCCCCCC---CcHHHHHHHHHhCCCCCCCC---
Q psy11767 220 -----------------DEVIDWDDFSRGIECVFFSSSLIIFFIILSFTLSFIH---DYYHIQYRRILKTEPPIPED--- 276 (966)
Q Consensus 220 -----------------~e~i~~~~y~~~~d~~~~~~~~il~~~m~~g~~pf~~---~~~~~~~~~I~~~~~~~P~~--- 276 (966)
+|++....|+...| +|+.|+++|+|++|.+||.. ++....+++|...+...|..
T Consensus 169 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~D---i~slG~il~ell~g~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~~~ 245 (330)
T 2izr_A 169 IPYREHKSLTGTARYMSINTHLGKEQSRRDD---LEALGHMFMYFLRGSLPWQGLKADTLKERYQKIGDTKRATPIEVLC 245 (330)
T ss_dssp CCCCCCCCCCSCTTTCCHHHHTTCCCCHHHH---HHHHHHHHHHHHHSSCTTTTCCCSSHHHHHHHHHHHHHHSCHHHHT
T ss_pred ccccccCCcCCCccccChHHHcCCCCCchhH---HHHHHHHHHHHhcCCCCccccccccHHHHHHHHHhhhccCCHHHHh
Confidence 12233333433333 45667888889999999986 56667788887766555522
Q ss_pred -CCHHHHHHHHhhcccCCCcccCCCCCCHHHHhc----------CCceeeeCccccccCCCCCCCC
Q psy11767 277 -LSPDVADFISRLLVKDPRRRLGGGELDAEELKR----------HPFFNVIDWDDLATKRIPAPFV 331 (966)
Q Consensus 277 -~s~~a~dli~~LL~kdp~~RLG~~~~g~~~Ik~----------HpfF~~idW~~l~~k~~~pP~~ 331 (966)
-.+++++||+++|..||.+|.. +++|.. ..+...+||+ .+.+++|+.
T Consensus 246 ~~~p~~~~li~~~l~~~p~~RP~-----~~~l~~~l~~~~~~~~~~~~~~~dw~---~~~~~~p~~ 303 (330)
T 2izr_A 246 ENFPEMATYLRYVRRLDFFEKPD-----YDYLRKLFTDLFDRKGYMFDYEYDWI---GKQLPTPVG 303 (330)
T ss_dssp TTCHHHHHHHHHHHHCCTTCCCC-----HHHHHHHHHHHHHHTTCCCSCCCTTT---TSCCCCCC-
T ss_pred ccChHHHHHHHHHHhCCCCCCCC-----HHHHHHHHHHHHHHcCCCCCCCccCC---CCCcCCCCC
Confidence 2349999999999999999974 454433 4556678998 467777763
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.70 E-value=9.9e-18 Score=185.32 Aligned_cols=184 Identities=18% Similarity=0.257 Sum_probs=126.7
Q ss_pred CcceeeeecccccceEEEEEEcCCCCEEEEEeccccc-------hhhHHHHHHHHhhCCCccccccccccc---------
Q psy11767 117 DLDKAGILGDGSYSVCRRCVEKSTGQEYAVKIISRKI-------DCSEEINLLRACQGHPNICRRCVEKST--------- 180 (966)
Q Consensus 117 df~~~~~LG~GsFGkV~La~~k~tg~~yAiKvl~K~~-------~~~~E~~il~~~~~~pfi~~~~~~~~~--------- 180 (966)
+|++++.||+|+||+||+|+++.+|+.||||++.+.. ....|...+.+..+||+|+...-....
T Consensus 58 ~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~~~~~~~h~~iv~l~~~~~~~~~~~lv~e 137 (311)
T 3p1a_A 58 SFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHPCCVRLEQAWEEGGILYLQTE 137 (311)
T ss_dssp HEEEEEEEEEETTEEEEEEEETTTSCEEEEEEESSSCCSHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred heeeeheeccCCCeEEEEEEECCCCeEEEEEEecccccChHHHHHHHHHHHHHHHhcCCCcEEEEEEEEEeCCEEEEEEe
Confidence 4599999999999999999999999999999987531 234566666667789999862211110
Q ss_pred ---------------------chhHHHHHHHh----------hcccchhhhHhhhccCCceEEecCccc-----------
Q psy11767 181 ---------------------GQEYAVKIISR----------KIDCSEEINLLRACQGHPNIVNLHCVF----------- 218 (966)
Q Consensus 181 ---------------------~~~~~~~~v~~----------~~~~~~e~nil~~~~gh~~iv~l~~~~----------- 218 (966)
...++.+++.+ ..|++++ |||.+.+|.++|+||+.+.
T Consensus 138 ~~~~~L~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~-NIll~~~~~~kl~DFG~a~~~~~~~~~~~~ 216 (311)
T 3p1a_A 138 LCGPSLQQHCEAWGASLPEAQVWGYLRDTLLALAHLHSQGLVHLDVKPA-NIFLGPRGRCKLGDFGLLVELGTAGAGEVQ 216 (311)
T ss_dssp CCCCBHHHHHHHHCSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGG-GEEECGGGCEEECCCTTCEECC------CC
T ss_pred ccCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHH-HEEECCCCCEEEccceeeeecccCCCCccc
Confidence 11111222221 1244445 9999999999999998653
Q ss_pred -------cccccccccCCCcceeeechhhHHHHHHHhhC-CCCCCCCcHHHHHHHHHhCC--CCCCCCCCHHHHHHHHhh
Q psy11767 219 -------QDEVIDWDDFSRGIECVFFSSSLIIFFIILSF-TLSFIHDYYHIQYRRILKTE--PPIPEDLSPDVADFISRL 288 (966)
Q Consensus 219 -------~~e~i~~~~y~~~~d~~~~~~~~il~~~m~~g-~~pf~~~~~~~~~~~I~~~~--~~~P~~~s~~a~dli~~L 288 (966)
.+|++.. .|+...| .| +.|+++|+|++| .+||..+. ++.+..+. +.+|..+++++++||.++
T Consensus 217 ~gt~~y~aPE~~~~-~~~~~~D--iw-slG~il~el~~g~~~~~~~~~----~~~~~~~~~~~~~~~~~~~~l~~li~~~ 288 (311)
T 3p1a_A 217 EGDPRYMAPELLQG-SYGTAAD--VF-SLGLTILEVACNMELPHGGEG----WQQLRQGYLPPEFTAGLSSELRSVLVMM 288 (311)
T ss_dssp CCCGGGCCGGGGGT-CCSTHHH--HH-HHHHHHHHHHHTCCCCSSHHH----HHHHTTTCCCHHHHTTSCHHHHHHHHHH
T ss_pred CCCccccCHhHhcC-CCCchhh--HH-HHHHHHHHHHhCCCCCCCccH----HHHHhccCCCcccccCCCHHHHHHHHHH
Confidence 2454443 4544444 34 455666666666 55554433 34444443 235678999999999999
Q ss_pred cccCCCcccCCCCCCHHHHhcCCcee
Q psy11767 289 LVKDPRRRLGGGELDAEELKRHPFFN 314 (966)
Q Consensus 289 L~kdp~~RLG~~~~g~~~Ik~HpfF~ 314 (966)
|+.||.+|. .+++|.+||||+
T Consensus 289 L~~dP~~Rp-----t~~ell~hp~~~ 309 (311)
T 3p1a_A 289 LEPDPKLRA-----TAEALLALPVLR 309 (311)
T ss_dssp SCSSTTTSC-----CHHHHHTSGGGS
T ss_pred cCCChhhCc-----CHHHHHhCcccc
Confidence 999999997 489999999996
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A | Back alignment and structure |
|---|
Probab=99.70 E-value=3.3e-17 Score=177.99 Aligned_cols=192 Identities=21% Similarity=0.290 Sum_probs=127.1
Q ss_pred CcceeeeecccccceEEEEEEcCCCCEEEEEeccccc------hhhHHHHHHHHhhCCCcccccccccccc---------
Q psy11767 117 DLDKAGILGDGSYSVCRRCVEKSTGQEYAVKIISRKI------DCSEEINLLRACQGHPNICRRCVEKSTG--------- 181 (966)
Q Consensus 117 df~~~~~LG~GsFGkV~La~~k~tg~~yAiKvl~K~~------~~~~E~~il~~~~~~pfi~~~~~~~~~~--------- 181 (966)
+|++++.||+|+||+|++|+++.+|+.||||++++.. ....|..++.+..+||+|+.........
T Consensus 8 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~~~~~~~~lv~e~ 87 (290)
T 3fme_A 8 DLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCPFTVTFYGALFREGDVWICMEL 87 (290)
T ss_dssp GEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEC---CHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSSEEEEEEC
T ss_pred hhhhHHhcCCCCCeEEEEEEecCCCeEEEEEEeecccCcHHHHHHHHHHHHHHHhCCCCeEEEEeeeeeccCCEEEEEeh
Confidence 7899999999999999999999999999999998642 2233444545556899998621111000
Q ss_pred ------------------------hhHHHHHH------Hh--h---cccchhhhHhhhccCCceEEecCcccc-------
Q psy11767 182 ------------------------QEYAVKII------SR--K---IDCSEEINLLRACQGHPNIVNLHCVFQ------- 219 (966)
Q Consensus 182 ------------------------~~~~~~~v------~~--~---~~~~~e~nil~~~~gh~~iv~l~~~~~------- 219 (966)
...+.+++ .. . .|++++ |||.+.+|.++|+||+.+..
T Consensus 88 ~~~~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~i~H~dlkp~-Nil~~~~~~~kl~Dfg~~~~~~~~~~~ 166 (290)
T 3fme_A 88 MDTSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSKLSVIHRDVKPS-NVLINALGQVKMCDFGISGYLVDDVAK 166 (290)
T ss_dssp CSEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHSCCCCCCCSGG-GCEECTTCCEEBCCC------------
T ss_pred hccchHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhcCCeecCCCCHH-HEEECCCCCEEEeecCCcccccccccc
Confidence 01111111 11 1 133444 99999999999999986531
Q ss_pred -----------cccc----ccccCCCcceeeechhhHHHHHHHhhCCCCCCC--CcHHHHHHHHHhCCCCCC-CCCCHHH
Q psy11767 220 -----------DEVI----DWDDFSRGIECVFFSSSLIIFFIILSFTLSFIH--DYYHIQYRRILKTEPPIP-EDLSPDV 281 (966)
Q Consensus 220 -----------~e~i----~~~~y~~~~d~~~~~~~~il~~~m~~g~~pf~~--~~~~~~~~~I~~~~~~~P-~~~s~~a 281 (966)
+|++ ....|+...| .|+.|+++|+|++|.+||.. .....+.+.+....+..| ..+++++
T Consensus 167 ~~~~~t~~y~aPE~~~~~~~~~~~~~~~D---i~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 243 (290)
T 3fme_A 167 DIDAGCKPYMAPERINPELNQKGYSVKSD---IWSLGITMIELAILRFPYDSWGTPFQQLKQVVEEPSPQLPADKFSAEF 243 (290)
T ss_dssp ---CCCCCCSCHHHHSCCTTC--CCHHHH---HHHHHHHHHHHHHTSCSSCCCSCHHHHHHHHHHSCCCCCCTTTSCHHH
T ss_pred cccCCCccccChhhcChhhcCcCCCcHHH---HHHHHHHHHHHHHCCCCccccCchHHHHHHHhccCCCCcccccCCHHH
Confidence 2343 2223333333 44667788888999999974 344444555555555555 4689999
Q ss_pred HHHHHhhcccCCCcccCCCCCCHHHHhcCCceeeeC
Q psy11767 282 ADFISRLLVKDPRRRLGGGELDAEELKRHPFFNVID 317 (966)
Q Consensus 282 ~dli~~LL~kdp~~RLG~~~~g~~~Ik~HpfF~~id 317 (966)
++||.++|+.||.+|. .+.+|.+||||+...
T Consensus 244 ~~li~~~l~~~p~~Rp-----t~~e~l~hp~f~~~~ 274 (290)
T 3fme_A 244 VDFTSQCLKKNSKERP-----TYPELMQHPFFTLHE 274 (290)
T ss_dssp HHHHHHHTCSSGGGSC-----CHHHHTTSHHHHHHH
T ss_pred HHHHHHHhhcChhhCc-----CHHHHHhCcccccCc
Confidence 9999999999999998 489999999997543
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} PDB: 3uib_A* | Back alignment and structure |
|---|
Probab=99.70 E-value=3.4e-17 Score=184.44 Aligned_cols=189 Identities=22% Similarity=0.306 Sum_probs=135.1
Q ss_pred CcceeeeecccccceEEEEEEcCCCCEEEEEecccc----------------chhhHHHHHHHHhhCCCccccccccc--
Q psy11767 117 DLDKAGILGDGSYSVCRRCVEKSTGQEYAVKIISRK----------------IDCSEEINLLRACQGHPNICRRCVEK-- 178 (966)
Q Consensus 117 df~~~~~LG~GsFGkV~La~~k~tg~~yAiKvl~K~----------------~~~~~E~~il~~~~~~pfi~~~~~~~-- 178 (966)
+|.+.+.||+|+||.|++|+++. |+.||||++.+. ....+|..+|+++ +||+|++..-.+
T Consensus 23 ~y~~~~~lg~G~~g~V~~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~ 100 (362)
T 3pg1_A 23 PYTVQRFISSGSYGAVCAGVDSE-GIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHF-HHPNILGLRDIFVH 100 (362)
T ss_dssp SCEEEEEEEEETTEEEEEEECTT-SCEEEEEEECEECCTTSCEEGGGSHHHHHHHHHHHHHHHHC-CCTTBCCCSEEEEE
T ss_pred ceEEeEEeccCCCEEEEEEECCC-CCeEEEEeccccCCccchhhhhhhhhHHHHHHHHHHHHHhC-CCcCccceeeeEEe
Confidence 78999999999999999999865 999999999763 2346899999998 599998632211
Q ss_pred ---cc------------------------------chhHHHHHHHh----------hcccchhhhHhhhccCCceEEecC
Q psy11767 179 ---ST------------------------------GQEYAVKIISR----------KIDCSEEINLLRACQGHPNIVNLH 215 (966)
Q Consensus 179 ---~~------------------------------~~~~~~~~v~~----------~~~~~~e~nil~~~~gh~~iv~l~ 215 (966)
.. ...++.+++.+ ..|++++ |||.+.+|+++|+||+
T Consensus 101 ~~~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~-NIl~~~~~~~kl~Dfg 179 (362)
T 3pg1_A 101 FEEPAMHKLYLVTELMRTDLAQVIHDQRIVISPQHIQYFMYHILLGLHVLHEAGVVHRDLHPG-NILLADNNDITICDFN 179 (362)
T ss_dssp CCTTTCCEEEEEEECCSEEHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGG-GEEECTTCCEEECCTT
T ss_pred ccCCCcceEEEEEccCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCcCEecCCChH-HEEEcCCCCEEEEecC
Confidence 00 00111122211 1144444 9999999999999998
Q ss_pred cccc------------------cccccc-ccCCCcceeeechhhHHHHHHHhhCCCCCCCCcHHHHHHHHHh--CCC---
Q psy11767 216 CVFQ------------------DEVIDW-DDFSRGIECVFFSSSLIIFFIILSFTLSFIHDYYHIQYRRILK--TEP--- 271 (966)
Q Consensus 216 ~~~~------------------~e~i~~-~~y~~~~d~~~~~~~~il~~~m~~g~~pf~~~~~~~~~~~I~~--~~~--- 271 (966)
.+.. +|++.. ..|+...| .|+.|+++|+|++|.+||...+.....++|+. +.+
T Consensus 180 ~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~D---iwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~ 256 (362)
T 3pg1_A 180 LAREDTADANKTHYVTHRWYRAPELVMQFKGFTKLVD---MWSAGCVMAEMFNRKALFRGSTFYNQLNKIVEVVGTPKIE 256 (362)
T ss_dssp C---------------CGGGCCHHHHTTCTTCCTHHH---HHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCHH
T ss_pred cccccccccccceecccceecCcHHhcCCCCCCcHhH---HHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCChH
Confidence 7632 344433 34544444 44677888899999999998887777777653 111
Q ss_pred ---------------------------CCCCCCCHHHHHHHHhhcccCCCcccCCCCCCHHHHhcCCceeee
Q psy11767 272 ---------------------------PIPEDLSPDVADFISRLLVKDPRRRLGGGELDAEELKRHPFFNVI 316 (966)
Q Consensus 272 ---------------------------~~P~~~s~~a~dli~~LL~kdp~~RLG~~~~g~~~Ik~HpfF~~i 316 (966)
.++...++++++||.++|+.||.+|.. +.+|.+||||+.+
T Consensus 257 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt-----~~ell~hp~f~~~ 323 (362)
T 3pg1_A 257 DVVMFSSPSARDYLRNSLSNVPARAWTAVVPTADPVALDLIAKMLEFNPQRRIS-----TEQALRHPYFESL 323 (362)
T ss_dssp HHHHTSCHHHHHHTTTCCCCCCCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCC-----HHHHHTSGGGTTT
T ss_pred HhhhccchhhhHHHHhhcccCChhhHHhhCCCCCHHHHHHHHHHhcCChhhCCC-----HHHHHcCchhhhc
Confidence 123467899999999999999999984 8999999999876
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.70 E-value=5.6e-17 Score=178.60 Aligned_cols=208 Identities=21% Similarity=0.244 Sum_probs=139.8
Q ss_pred CccchhccCCcceeeeecccccceEEEEEEcCCCCEEEEEeccccc---hhhHHHHHHHHhhCCCcccccccccccc---
Q psy11767 108 SLFFEQYDMDLDKAGILGDGSYSVCRRCVEKSTGQEYAVKIISRKI---DCSEEINLLRACQGHPNICRRCVEKSTG--- 181 (966)
Q Consensus 108 ~~~~~~~~~df~~~~~LG~GsFGkV~La~~k~tg~~yAiKvl~K~~---~~~~E~~il~~~~~~pfi~~~~~~~~~~--- 181 (966)
..+.+..+-+|++++.||+|+||.|++|+++.+|+.||||++++.. ...+|..+|+++ +||+|+..+-.....
T Consensus 21 ~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~ 99 (314)
T 3com_A 21 DSLTKQPEEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVESDLQEIIKEISIMQQC-DSPHVVKYYGSYFKNTDL 99 (314)
T ss_dssp ---------CEEEEEECC----CEEEEEEETTTCCEEEEEEEETTSCCHHHHHHHHHHHTC-CCTTBCCEEEEEEETTEE
T ss_pred hhhhhcchhhhhhheeeccCCCeEEEEEEECCCCCEEEEEecCchHHHHHHHHHHHHHHhC-CCCCCccEEEEEEeCCEE
Confidence 3344455558899999999999999999999999999999998653 457899999988 699998622111100
Q ss_pred ----------------------------hhHHHHHHHh------h----cccchhhhHhhhccCCceEEecCcccc----
Q psy11767 182 ----------------------------QEYAVKIISR------K----IDCSEEINLLRACQGHPNIVNLHCVFQ---- 219 (966)
Q Consensus 182 ----------------------------~~~~~~~v~~------~----~~~~~e~nil~~~~gh~~iv~l~~~~~---- 219 (966)
...+.+++.+ . .|++++ |||.+.+|+++|+||+.+..
T Consensus 100 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dl~p~-Nil~~~~~~~kl~dfg~~~~~~~~ 178 (314)
T 3com_A 100 WIVMEYCGAGSVSDIIRLRNKTLTEDEIATILQSTLKGLEYLHFMRKIHRDIKAG-NILLNTEGHAKLADFGVAGQLTDT 178 (314)
T ss_dssp EEEEECCTTEEHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGG-GEEECTTCCEEECCCTTCEECBTT
T ss_pred EEEeecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcCCCcCHH-HEEECCCCCEEEeecccchhhhhh
Confidence 0011111111 0 133334 99999999999999986621
Q ss_pred ---------------ccccccccCCCcceeeechhhHHHHHHHhhCCCCCCCCcHHHHHHHHHhCC---CCCCCCCCHHH
Q psy11767 220 ---------------DEVIDWDDFSRGIECVFFSSSLIIFFIILSFTLSFIHDYYHIQYRRILKTE---PPIPEDLSPDV 281 (966)
Q Consensus 220 ---------------~e~i~~~~y~~~~d~~~~~~~~il~~~m~~g~~pf~~~~~~~~~~~I~~~~---~~~P~~~s~~a 281 (966)
+|++....|+...| .|+.|+++|+|++|.+||...+.......+.... ...|..+++++
T Consensus 179 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~D---i~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 255 (314)
T 3com_A 179 MAKRNTVIGTPFWMAPEVIQEIGYNCVAD---IWSLGITAIEMAEGKPPYADIHPMRAIFMIPTNPPPTFRKPELWSDNF 255 (314)
T ss_dssp BSCBCCCCSCGGGCCHHHHSSSCBCTTHH---HHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCCCSSGGGSCHHH
T ss_pred ccccCccCCCCCccChhhcCCCCCCcccc---HHHHHHHHHHHHhCCCCCCCCChHHHHHHHhcCCCcccCCcccCCHHH
Confidence 23333334444444 3456788888999999998877665555555442 33467789999
Q ss_pred HHHHHhhcccCCCcccCCCCCCHHHHhcCCceeeeCccccccCC
Q psy11767 282 ADFISRLLVKDPRRRLGGGELDAEELKRHPFFNVIDWDDLATKR 325 (966)
Q Consensus 282 ~dli~~LL~kdp~~RLG~~~~g~~~Ik~HpfF~~idW~~l~~k~ 325 (966)
++||.++|..||.+|. .+.+|..||||+...|....+..
T Consensus 256 ~~li~~~l~~dp~~Rp-----t~~~ll~~~~~~~~~~~~~~~~~ 294 (314)
T 3com_A 256 TDFVKQCLVKSPEQRA-----TATQLLQHPFVRSAKGVSILRDL 294 (314)
T ss_dssp HHHHHHHTCSCTTTSC-----CHHHHTTSHHHHTCCCGGGGHHH
T ss_pred HHHHHHHccCChhhCc-----CHHHHHhCHHHhcCCcchHHHHH
Confidence 9999999999999998 48999999999988877665443
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A | Back alignment and structure |
|---|
Probab=99.70 E-value=2.6e-18 Score=195.32 Aligned_cols=188 Identities=12% Similarity=0.138 Sum_probs=130.4
Q ss_pred CcceeeeecccccceEEEEEEcCCCCEEEEEecccc--------chhhHHHHHHHHhh--CCCcccccc-----------
Q psy11767 117 DLDKAGILGDGSYSVCRRCVEKSTGQEYAVKIISRK--------IDCSEEINLLRACQ--GHPNICRRC----------- 175 (966)
Q Consensus 117 df~~~~~LG~GsFGkV~La~~k~tg~~yAiKvl~K~--------~~~~~E~~il~~~~--~~pfi~~~~----------- 175 (966)
+|.+.+.||+|+||+|++|+++.+|+.||||++++. ....+|..+|+.+. +||+|++.+
T Consensus 74 ~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~hpniv~~~~~~~~~~~~~~ 153 (377)
T 3byv_A 74 TLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDLVK 153 (377)
T ss_dssp EEEEEEEEEEETTEEEEEEEC-CCCCEEEEEEEEECC-CCTTHHHHHHHHHHGGGGSTTCCSHHHHHHHHCBCCCSEEEE
T ss_pred eEEEcceeecCCCEEEEEEEECCCCcEEEEEEEeeccccchHHHHHHHHHHHHHHhccccCCHHHHHHHhhhhhhhhhhh
Confidence 679999999999999999999999999999999853 13467886666554 799997632
Q ss_pred -----------------------cccc--cc------------------------hhHHHHHHHh----------hcccc
Q psy11767 176 -----------------------VEKS--TG------------------------QEYAVKIISR----------KIDCS 196 (966)
Q Consensus 176 -----------------------~~~~--~~------------------------~~~~~~~v~~----------~~~~~ 196 (966)
+..+ .+ ..++.+++.+ ..|++
T Consensus 154 ~~~~~~~~~~~~~~~~~~i~~~~lv~E~~~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDik 233 (377)
T 3byv_A 154 DPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYGLVHTYLR 233 (377)
T ss_dssp CTTSCSEEEC------CEEESEEEEEECCSEEHHHHHHHHHHTTTTTHHHHHHHHHHHHHHHHHHHHHHHHTTEECSCCC
T ss_pred ccCCccccccccCCCceEEEEEEEEEeccCCCHHHHHHhccccccccccccHHHHHHHHHHHHHHHHHHHhCCeecCCCC
Confidence 0000 00 0011122211 12445
Q ss_pred hhhhHhhhccCCceEEecCcccc---------------ccccccc-----------cCCCcceeeechhhHHHHHHHhhC
Q psy11767 197 EEINLLRACQGHPNIVNLHCVFQ---------------DEVIDWD-----------DFSRGIECVFFSSSLIIFFIILSF 250 (966)
Q Consensus 197 ~e~nil~~~~gh~~iv~l~~~~~---------------~e~i~~~-----------~y~~~~d~~~~~~~~il~~~m~~g 250 (966)
++ |||.+.+|.++|+||+.+.. +|++... .|+...| .|+.|+++|+|++|
T Consensus 234 p~-NIll~~~~~~kL~DFG~a~~~~~~~~~~~g~~y~aPE~~~~~~~~~~~~~~~~~~~~~~D---vwSlG~il~elltg 309 (377)
T 3byv_A 234 PV-DIVLDQRGGVFLTGFEHLVRDGARVVSSVSRGFEPPELEARRATISYHRDRRTLMTFSFD---AWALGLVIYWIWCA 309 (377)
T ss_dssp GG-GEEECTTCCEEECCGGGCEETTCEEECCCCTTCCCHHHHHHHTSTHHHHCCEEECCHHHH---HHHHHHHHHHHHHS
T ss_pred HH-HEEEcCCCCEEEEechhheecCCcccCCCCcCccChhhhcccccccccccccccCChhhh---HHHHHHHHHHHHHC
Confidence 55 99999999999999987642 3444443 4554444 45677888889999
Q ss_pred CCCCCCCcHHHHHHHHHhCCCCCCCCCCHHHHHHHHhhcccCCCcccCCCCCCHHHHhcCCceeeeC
Q psy11767 251 TLSFIHDYYHIQYRRILKTEPPIPEDLSPDVADFISRLLVKDPRRRLGGGELDAEELKRHPFFNVID 317 (966)
Q Consensus 251 ~~pf~~~~~~~~~~~I~~~~~~~P~~~s~~a~dli~~LL~kdp~~RLG~~~~g~~~Ik~HpfF~~id 317 (966)
.+||...+...+++.|... +..+++++++||.++|+.||.+|. .+.+|.+||||+.+.
T Consensus 310 ~~Pf~~~~~~~~~~~~~~~----~~~~~~~~~~li~~~L~~dp~~Rp-----t~~e~l~hp~f~~~~ 367 (377)
T 3byv_A 310 DLPITKDAALGGSEWIFRS----CKNIPQPVRALLEGFLRYPKEDRL-----LPLQAMETPEYEQLR 367 (377)
T ss_dssp SCCC------CCSGGGGSS----CCCCCHHHHHHHHHHTCSSGGGCC-----CHHHHHTSHHHHHHH
T ss_pred CCCCcccccccchhhhhhh----ccCCCHHHHHHHHHHcCCCchhCC-----CHHHHhhChHHHHHH
Confidence 9999877665555555443 467889999999999999999998 489999999998763
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... | Back alignment and structure |
|---|
Probab=99.70 E-value=1.8e-17 Score=184.02 Aligned_cols=189 Identities=18% Similarity=0.289 Sum_probs=137.2
Q ss_pred CcceeeeecccccceEEEEEEcCCCCEEEEEeccccc-----------hhhHHHHHHHHhh-CCCcccccccccccc---
Q psy11767 117 DLDKAGILGDGSYSVCRRCVEKSTGQEYAVKIISRKI-----------DCSEEINLLRACQ-GHPNICRRCVEKSTG--- 181 (966)
Q Consensus 117 df~~~~~LG~GsFGkV~La~~k~tg~~yAiKvl~K~~-----------~~~~E~~il~~~~-~~pfi~~~~~~~~~~--- 181 (966)
+|++.++||+|+||+||+|+++.+|+.||||++++.. ...+|..+|+++. .||.|+...-.+...
T Consensus 44 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~i~~~~~~~~~~~~~ 123 (320)
T 3a99_A 44 QYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDSF 123 (320)
T ss_dssp TEEEEEECSSSSSCEEEEEEETTTTEEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEECSSEE
T ss_pred ceEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEecccchhhhhhhhhhHHHHHHHHHHhhccCCCCceEEEEEEecCCcE
Confidence 5699999999999999999999999999999998752 3467999999987 489997611111100
Q ss_pred ----------------------------hhHHHHHHHh----------hcccchhhhHhhh-ccCCceEEecCcccc---
Q psy11767 182 ----------------------------QEYAVKIISR----------KIDCSEEINLLRA-CQGHPNIVNLHCVFQ--- 219 (966)
Q Consensus 182 ----------------------------~~~~~~~v~~----------~~~~~~e~nil~~-~~gh~~iv~l~~~~~--- 219 (966)
...+.+++.+ ..|++++ |||.+ .+|.++|+||+.+..
T Consensus 124 ~lv~e~~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~-NIll~~~~~~~kL~Dfg~~~~~~~ 202 (320)
T 3a99_A 124 VLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDE-NILIDLNRGELKLIDFGSGALLKD 202 (320)
T ss_dssp EEEEECCSSEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGG-GEEEETTTTEEEECCCTTCEECCS
T ss_pred EEEEEcCCCCccHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCcEeCCCCHH-HEEEeCCCCCEEEeeCcccccccc
Confidence 0011122211 0144444 99998 568999999986532
Q ss_pred --------------ccccccccC-CCcceeeechhhHHHHHHHhhCCCCCCCCcHHHHHHHHHhCCCCCCCCCCHHHHHH
Q psy11767 220 --------------DEVIDWDDF-SRGIECVFFSSSLIIFFIILSFTLSFIHDYYHIQYRRILKTEPPIPEDLSPDVADF 284 (966)
Q Consensus 220 --------------~e~i~~~~y-~~~~d~~~~~~~~il~~~m~~g~~pf~~~~~~~~~~~I~~~~~~~P~~~s~~a~dl 284 (966)
+|++....+ +...| .|+.|+++|+|++|.+||...+ .+..+...+|..+++++++|
T Consensus 203 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~D---i~slG~il~el~~g~~pf~~~~------~~~~~~~~~~~~~~~~~~~l 273 (320)
T 3a99_A 203 TVYTDFDGTRVYSPPEWIRYHRYHGRSAA---VWSLGILLYDMVCGDIPFEHDE------EIIRGQVFFRQRVSSECQHL 273 (320)
T ss_dssp SCBCCCCSCGGGSCHHHHHHSCBCHHHHH---HHHHHHHHHHHHHSSCSCCSHH------HHHHCCCCCSSCCCHHHHHH
T ss_pred ccccCCCCCccCCChHHhccCCCCCccch---HHhHHHHHHHHHHCCCCCCChh------hhhcccccccccCCHHHHHH
Confidence 233332222 22223 4466788888999999997643 46678888999999999999
Q ss_pred HHhhcccCCCcccCCCCCCHHHHhcCCceeeeCccc
Q psy11767 285 ISRLLVKDPRRRLGGGELDAEELKRHPFFNVIDWDD 320 (966)
Q Consensus 285 i~~LL~kdp~~RLG~~~~g~~~Ik~HpfF~~idW~~ 320 (966)
|+++|..||.+|. .+++|.+||||+++.+..
T Consensus 274 i~~~l~~dp~~Rp-----s~~~ll~hp~~~~~~~~~ 304 (320)
T 3a99_A 274 IRWCLALRPSDRP-----TFEEIQNHPWMQDVLLPQ 304 (320)
T ss_dssp HHHHTCSSGGGSC-----CHHHHHTSGGGSSCCCHH
T ss_pred HHHHccCChhhCc-----CHHHHhcCHhhcCccCcc
Confidence 9999999999998 489999999999876643
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* | Back alignment and structure |
|---|
Probab=99.70 E-value=1.4e-17 Score=185.98 Aligned_cols=204 Identities=21% Similarity=0.236 Sum_probs=133.5
Q ss_pred CcceeeeecccccceEEEEEEcCCC-CEEEEEecccc----chhhHHHHHHHHhhCCC-----cccccc-----------
Q psy11767 117 DLDKAGILGDGSYSVCRRCVEKSTG-QEYAVKIISRK----IDCSEEINLLRACQGHP-----NICRRC----------- 175 (966)
Q Consensus 117 df~~~~~LG~GsFGkV~La~~k~tg-~~yAiKvl~K~----~~~~~E~~il~~~~~~p-----fi~~~~----------- 175 (966)
+|++.+.||+|+||+|++|+++.++ +.||||++++. ....+|..+|++++.+. .++...
T Consensus 20 ~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~l 99 (355)
T 2eu9_A 20 RYEIVGNLGEGTFGKVVECLDHARGKSQVALKIIRNVGKYREAARLEINVLKKIKEKDKENKFLCVLMSDWFNFHGHMCI 99 (355)
T ss_dssp TEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSCHHHHHHHHHHHHHHHHHHHHCTTSCSCBCCEEEEEEETTEEEE
T ss_pred cEEEEEEeeccCCeEEEEEEecCCCceEEEEEEEcccccchhHHHHHHHHHHHHhhcCCCCceeEEEeeeeeeeCCeEEE
Confidence 5699999999999999999998887 69999999864 24567888888765322 233200
Q ss_pred --------------------cccccchhHHHHHHHh----------hcccchhhhHhh-------------------hcc
Q psy11767 176 --------------------VEKSTGQEYAVKIISR----------KIDCSEEINLLR-------------------ACQ 206 (966)
Q Consensus 176 --------------------~~~~~~~~~~~~~v~~----------~~~~~~e~nil~-------------------~~~ 206 (966)
+.......++.+++.+ ..|++++ |||. +..
T Consensus 100 v~e~~~~~l~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~ivH~Dlkp~-NIll~~~~~~~~~~~~~~~~~~~~~~ 178 (355)
T 2eu9_A 100 AFELLGKNTFEFLKENNFQPYPLPHVRHMAYQLCHALRFLHENQLTHTDLKPE-NILFVNSEFETLYNEHKSCEEKSVKN 178 (355)
T ss_dssp EEECCCCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGG-GEEESCCCEEEEECCC-CCCEEEESC
T ss_pred EEeccCCChHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHH-HEEEecccccccccccccccccccCC
Confidence 0000011112222222 1244444 9988 556
Q ss_pred CCceEEecCccc----------------cccccccccCCCcceeeechhhHHHHHHHhhCCCCCCCCcHHHHHHHHHhCC
Q psy11767 207 GHPNIVNLHCVF----------------QDEVIDWDDFSRGIECVFFSSSLIIFFIILSFTLSFIHDYYHIQYRRILKTE 270 (966)
Q Consensus 207 gh~~iv~l~~~~----------------~~e~i~~~~y~~~~d~~~~~~~~il~~~m~~g~~pf~~~~~~~~~~~I~~~~ 270 (966)
+.++|+||+.+. .+|++....|+...| .|+.|+++|+|++|.+||...+.......+....
T Consensus 179 ~~~kl~Dfg~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~D---i~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~ 255 (355)
T 2eu9_A 179 TSIRVADFGSATFDHEHHTTIVATRHYRPPEVILELGWAQPCD---VWSIGCILFEYYRGFTLFQTHENREHLVMMEKIL 255 (355)
T ss_dssp CCEEECCCTTCEETTSCCCSSCSCGGGCCHHHHTTCCCCTHHH---HHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHH
T ss_pred CcEEEeecCccccccccccCCcCCCcccCCeeeecCCCCCccc---hHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHc
Confidence 889999998663 235555555655555 4466788889999999998876655444433211
Q ss_pred CCCCC--------------------------------------------CCCHHHHHHHHhhcccCCCcccCCCCCCHHH
Q psy11767 271 PPIPE--------------------------------------------DLSPDVADFISRLLVKDPRRRLGGGELDAEE 306 (966)
Q Consensus 271 ~~~P~--------------------------------------------~~s~~a~dli~~LL~kdp~~RLG~~~~g~~~ 306 (966)
-.+|. ..++++++||+++|..||.+|.. +.+
T Consensus 256 ~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt-----~~e 330 (355)
T 2eu9_A 256 GPIPSHMIHRTRKQKYFYKGGLVWDENSSDGRYVKENCKPLKSYMLQDSLEHVQLFDLMRRMLEFDPAQRIT-----LAE 330 (355)
T ss_dssp CCCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCSSTTTSCC-----HHH
T ss_pred CCCcHHHhhhccchhhhcccccccccccchhccccccCCcccccccccchhHHHHHHHHHHHhcCChhhCcC-----HHH
Confidence 11121 12457889999999999999984 899
Q ss_pred HhcCCceeeeCccccccCCCCCC
Q psy11767 307 LKRHPFFNVIDWDDLATKRIPAP 329 (966)
Q Consensus 307 Ik~HpfF~~idW~~l~~k~~~pP 329 (966)
|.+||||.+++|+....+...+|
T Consensus 331 ~l~hp~f~~~~~~~~~~~~~~~p 353 (355)
T 2eu9_A 331 ALLHPFFAGLTPEERSFHTSRNP 353 (355)
T ss_dssp HTTSGGGGGCCHHHHC-------
T ss_pred HhcChhhcCCChhhccccccCCC
Confidence 99999999999988766555544
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* | Back alignment and structure |
|---|
Probab=99.70 E-value=4.9e-17 Score=186.09 Aligned_cols=188 Identities=21% Similarity=0.254 Sum_probs=133.8
Q ss_pred CcceeeeecccccceEEEEEEcCCCCEEEEEeccccc-------hhhHHHHHHHHhhC-CCccccccccccc--------
Q psy11767 117 DLDKAGILGDGSYSVCRRCVEKSTGQEYAVKIISRKI-------DCSEEINLLRACQG-HPNICRRCVEKST-------- 180 (966)
Q Consensus 117 df~~~~~LG~GsFGkV~La~~k~tg~~yAiKvl~K~~-------~~~~E~~il~~~~~-~pfi~~~~~~~~~-------- 180 (966)
+|.+++.||+|+||+|++|+++. |+.||||++++.. ...+|..+|.+++. ||+|+..+-.+..
T Consensus 57 ~y~~~~~LG~G~fg~Vy~~~~~~-~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~~~~~~iv~~~~~~~~~~~~~lv~ 135 (390)
T 2zmd_A 57 IYSILKQIGSGGSSKVFQVLNEK-KQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVM 135 (390)
T ss_dssp EEEEEEEEECCSSEEEEEEECTT-CCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEE
T ss_pred ceEEEEEEccCCCeEEEEEEcCC-CCEEEEEEEecccccHHHHHHHHHHHHHHHHcccCCCeEEEEEEEEecCCEEEEEE
Confidence 58999999999999999999875 9999999997642 35789999999875 7999873211111
Q ss_pred ---------------------chhHHHHHHHh----------hcccchhhhHhhhccCCceEEecCcccc----------
Q psy11767 181 ---------------------GQEYAVKIISR----------KIDCSEEINLLRACQGHPNIVNLHCVFQ---------- 219 (966)
Q Consensus 181 ---------------------~~~~~~~~v~~----------~~~~~~e~nil~~~~gh~~iv~l~~~~~---------- 219 (966)
...++.+++.+ ..|++++ |||.+ +|.++|+||+.+..
T Consensus 136 E~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~lH~~~ivHrDlkp~-NIll~-~~~~kl~DFG~a~~~~~~~~~~~~ 213 (390)
T 2zmd_A 136 ECGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPA-NFLIV-DGMLKLIDFGIANQMQPDTTSVVK 213 (390)
T ss_dssp ECCSEEHHHHHHHCSSCCHHHHHHHHHHHHHHHHHHHTTTCCCCCCCGG-GEEES-SSCEEECCCSSSCCC---------
T ss_pred ecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHH-HEEEE-CCeEEEEecCccccccCCCccccC
Confidence 01111122221 1245555 99885 58999999987632
Q ss_pred -----------cccccc-----------ccCCCcceeeechhhHHHHHHHhhCCCCCCCC-cHHHHHHHHHhC--CCCCC
Q psy11767 220 -----------DEVIDW-----------DDFSRGIECVFFSSSLIIFFIILSFTLSFIHD-YYHIQYRRILKT--EPPIP 274 (966)
Q Consensus 220 -----------~e~i~~-----------~~y~~~~d~~~~~~~~il~~~m~~g~~pf~~~-~~~~~~~~I~~~--~~~~P 274 (966)
+|++.. ..|+...| .|+.|+++|+|++|.+||... +....+..|+.. .+.+|
T Consensus 214 ~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~D---iwSlGvil~ell~G~~Pf~~~~~~~~~~~~~~~~~~~~~~~ 290 (390)
T 2zmd_A 214 DSQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSD---VWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPNHEIEFP 290 (390)
T ss_dssp CCSCCCGGGCCHHHHHCC------------CCHHHH---HHHHHHHHHHHHHSSCTTTTCCCHHHHHHHHHCTTSCCCCC
T ss_pred CCCCcCCCccChHHhhhccccccccccccCCCChhh---HHHHHHHHHHHHHCCCcchhhhHHHHHHHHHhCccccCCCC
Confidence 233322 12333333 446678888899999999763 334456677754 45678
Q ss_pred CCCCHHHHHHHHhhcccCCCcccCCCCCCHHHHhcCCceee
Q psy11767 275 EDLSPDVADFISRLLVKDPRRRLGGGELDAEELKRHPFFNV 315 (966)
Q Consensus 275 ~~~s~~a~dli~~LL~kdp~~RLG~~~~g~~~Ik~HpfF~~ 315 (966)
...++++++||+++|++||.+|. .+.+|.+||||..
T Consensus 291 ~~~~~~~~~li~~~L~~dP~~Rp-----s~~ell~hp~~~~ 326 (390)
T 2zmd_A 291 DIPEKDLQDVLKCCLKRDPKQRI-----SIPELLAHPYVQI 326 (390)
T ss_dssp CCSCHHHHHHHHHHTCSSTTTSC-----CHHHHHTSHHHHS
T ss_pred ccchHHHHHHHHHHcccChhhCC-----CHHHHhhCcCccc
Confidence 88999999999999999999998 4899999999974
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* | Back alignment and structure |
|---|
Probab=99.69 E-value=1.8e-17 Score=188.20 Aligned_cols=190 Identities=18% Similarity=0.201 Sum_probs=131.3
Q ss_pred CcceeeeecccccceEEEEEEcCCCCEEEEEeccccc----hhhHHHHHHHHhhC-------CCcccccccccc------
Q psy11767 117 DLDKAGILGDGSYSVCRRCVEKSTGQEYAVKIISRKI----DCSEEINLLRACQG-------HPNICRRCVEKS------ 179 (966)
Q Consensus 117 df~~~~~LG~GsFGkV~La~~k~tg~~yAiKvl~K~~----~~~~E~~il~~~~~-------~pfi~~~~~~~~------ 179 (966)
+|.+++.||+|+||+||+|+++.+|+.||||++++.. ...+|..+|++++. ||+|+...-.+.
T Consensus 38 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~~~~iv~~~~~~~~~~~~~ 117 (397)
T 1wak_A 38 RYHVIRKLGWGHFSTVWLSWDIQGKKFVAMKVVKSAEHYTETALDEIRLLKSVRNSDPNDPNREMVVQLLDDFKISGVNG 117 (397)
T ss_dssp TEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCHHHHHHHHHHHHHHHHHHHSCTTCGGGGGBCCEEEEEEEEETTE
T ss_pred eEEEEEEeeecCCeeEEEEEecCCCeEEEEEEEecCCcchHHHHHHHHHHHHHhhcCCCCCCcceeeeeecceeecCCCC
Confidence 5699999999999999999999999999999998742 45789999998763 788876222111
Q ss_pred -----------------------------cchhHHHHHH------Hhh-----cccchhhhHhhhccC------------
Q psy11767 180 -----------------------------TGQEYAVKII------SRK-----IDCSEEINLLRACQG------------ 207 (966)
Q Consensus 180 -----------------------------~~~~~~~~~v------~~~-----~~~~~e~nil~~~~g------------ 207 (966)
....++.+++ +.. .|++++ |||.+.+|
T Consensus 118 ~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~givHrDikp~-NIll~~~~~~~~~~~~~~~~ 196 (397)
T 1wak_A 118 THICMVFEVLGHHLLKWIIKSNYQGLPLPCVKKIIQQVLQGLDYLHTKCRIIHTDIKPE-NILLSVNEQYIRRLAAEATE 196 (397)
T ss_dssp EEEEEEECCCCCBHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTCEECCCCSGG-GEEECCCHHHHHHHHHHHC-
T ss_pred ceEEEEEeccCccHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHhCCEecCCCCHH-HeeEeccchhhhhhhhhhHH
Confidence 0011111222 111 144444 99987665
Q ss_pred -------------------------------------CceEEecCccc----------------cccccccccCCCccee
Q psy11767 208 -------------------------------------HPNIVNLHCVF----------------QDEVIDWDDFSRGIEC 234 (966)
Q Consensus 208 -------------------------------------h~~iv~l~~~~----------------~~e~i~~~~y~~~~d~ 234 (966)
.++|+||+.+. .+|++....|+...|
T Consensus 197 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DfG~a~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~D- 275 (397)
T 1wak_A 197 WQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKHFTEDIQTRQYRSLEVLIGSGYNTPAD- 275 (397)
T ss_dssp --------------------CCTTSCCTTSGGGGGGCCEEECCGGGCEETTBCSCSCCSCGGGCCHHHHHTSCCCTHHH-
T ss_pred HhhcCCCCCCCCccccCCcccccccccccccccccccceEeccccccccccccCccCCCCCcccCChhhcCCCCCcHHH-
Confidence 78999988653 245555556666555
Q ss_pred eechhhHHHHHHHhhCCCCCCCCc------HHHHHHHHH-----------------------------------------
Q psy11767 235 VFFSSSLIIFFIILSFTLSFIHDY------YHIQYRRIL----------------------------------------- 267 (966)
Q Consensus 235 ~~~~~~~il~~~m~~g~~pf~~~~------~~~~~~~I~----------------------------------------- 267 (966)
.|+.|+++|+|++|.+||...+ .......|.
T Consensus 276 --iwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 353 (397)
T 1wak_A 276 --IWSTACMAFELATGDYLFEPHSGEEYTRDEDHIALIIELLGKVPRKLIVAGKYSKEFFTKKGDLKHITKLKPWGLFEV 353 (397)
T ss_dssp --HHHHHHHHHHHHHSSCSCCCCCCSSSCHHHHHHHHHHHHHCSCCHHHHHHCTTGGGTBCTTSSBSSCCCCCCCCHHHH
T ss_pred --HHHHHHHHHHHhhCCCCCCCCcccccCchHHHHHHHHHhcCCCChHHhhcccccccccCCccccccccccCCcchhHh
Confidence 4467788889999999997532 112222221
Q ss_pred -hCCCCCCCCCCHHHHHHHHhhcccCCCcccCCCCCCHHHHhcCCceee
Q psy11767 268 -KTEPPIPEDLSPDVADFISRLLVKDPRRRLGGGELDAEELKRHPFFNV 315 (966)
Q Consensus 268 -~~~~~~P~~~s~~a~dli~~LL~kdp~~RLG~~~~g~~~Ik~HpfF~~ 315 (966)
...+.+|...++++++||+++|+.||.+|+. +++|.+||||++
T Consensus 354 ~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt-----~~e~l~hp~~~~ 397 (397)
T 1wak_A 354 LVEKYEWSQEEAAGFTDFLLPMLELIPEKRAT-----AAECLRHPWLNS 397 (397)
T ss_dssp HHHTSCCCHHHHHHHHHHHGGGGCSSGGGSCC-----HHHHHTSGGGGC
T ss_pred hhhhcccchhhHHHHHHHHHHHhccChhhcCC-----HHHHhhCccccC
Confidence 1222345556678899999999999999984 899999999963
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A | Back alignment and structure |
|---|
Probab=99.69 E-value=3e-17 Score=185.08 Aligned_cols=216 Identities=21% Similarity=0.272 Sum_probs=139.8
Q ss_pred CcceeeeecccccceEEEEEEcCCCCEEEEEeccccc----hhhHHHHHHHHhhC----------CCccccccccccc--
Q psy11767 117 DLDKAGILGDGSYSVCRRCVEKSTGQEYAVKIISRKI----DCSEEINLLRACQG----------HPNICRRCVEKST-- 180 (966)
Q Consensus 117 df~~~~~LG~GsFGkV~La~~k~tg~~yAiKvl~K~~----~~~~E~~il~~~~~----------~pfi~~~~~~~~~-- 180 (966)
+|.+++.||+|+||+|++|+++.+|+.||||++++.. ...+|..+|+++.+ ||+|++..-.+..
T Consensus 20 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~i~~~~~~~~~~~ 99 (373)
T 1q8y_A 20 RYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFNHKG 99 (373)
T ss_dssp TEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCHHHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEEEEE
T ss_pred eEEEEEeeeecCCeEEEEEEecCCCcEEEEEEecCCccchhhhhHHHHHHHHhhcccccchhccccchHHHHHHHhhccC
Confidence 6799999999999999999999999999999998642 45678888887653 7888652111100
Q ss_pred ---------------------------------chhHHHHHH------Hh--h---cccchhhhHhhhcc------CCce
Q psy11767 181 ---------------------------------GQEYAVKII------SR--K---IDCSEEINLLRACQ------GHPN 210 (966)
Q Consensus 181 ---------------------------------~~~~~~~~v------~~--~---~~~~~e~nil~~~~------gh~~ 210 (966)
....+.+++ .. . .|++++ |||.+.+ +.++
T Consensus 100 ~~~~~~~lv~e~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~~ivH~Dikp~-NIll~~~~~~~~~~~~k 178 (373)
T 1q8y_A 100 PNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRCGIIHTDIKPE-NVLMEIVDSPENLIQIK 178 (373)
T ss_dssp TTEEEEEEEECCCCEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTCEECSCCSGG-GEEEEEEETTTTEEEEE
T ss_pred CCCceEEEEEecCCCCHHHHHHHhhccCCcHHHHHHHHHHHHHHHHHHHhcCCEEecCCChH-HeEEeccCCCcCcceEE
Confidence 000111111 11 1 134444 8888543 3689
Q ss_pred EEecCccc----------------cccccccccCCCcceeeechhhHHHHHHHhhCCCCCCCCcHH------HHH-----
Q psy11767 211 IVNLHCVF----------------QDEVIDWDDFSRGIECVFFSSSLIIFFIILSFTLSFIHDYYH------IQY----- 263 (966)
Q Consensus 211 iv~l~~~~----------------~~e~i~~~~y~~~~d~~~~~~~~il~~~m~~g~~pf~~~~~~------~~~----- 263 (966)
|+||+.+. .+|++....|+...| .|+.|+++|+|++|.+||...+.. ...
T Consensus 179 l~Dfg~a~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~D---i~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~ 255 (373)
T 1q8y_A 179 IADLGNACWYDEHYTNSIQTREYRSPEVLLGAPWGCGAD---IWSTACLIFELITGDFLFEPDEGHSYTKDDDHIAQIIE 255 (373)
T ss_dssp ECCCTTCEETTBCCCSCCSCGGGCCHHHHHTCCCCTHHH---HHHHHHHHHHHHHSSCCC---------CHHHHHHHHHH
T ss_pred EcccccccccCCCCCCCCCCccccCcHHHhCCCCCchHh---HHHHHHHHHHHHhCCCCCCCCcccccCChHHHHHHHHH
Confidence 99988653 235555555655555 446778889999999999854311 111
Q ss_pred -------------------------------------HHHHhCCCCCCCCCCHHHHHHHHhhcccCCCcccCCCCCCHHH
Q psy11767 264 -------------------------------------RRILKTEPPIPEDLSPDVADFISRLLVKDPRRRLGGGELDAEE 306 (966)
Q Consensus 264 -------------------------------------~~I~~~~~~~P~~~s~~a~dli~~LL~kdp~~RLG~~~~g~~~ 306 (966)
..++...+.+|...++++++||+++|+.||.+|.. +++
T Consensus 256 ~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt-----~~e 330 (373)
T 1q8y_A 256 LLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRAD-----AGG 330 (373)
T ss_dssp HHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTTCBC-----HHH
T ss_pred hcCCCCHHHHhccchhhhhcCCcchhcccccccccchhhhhhhcccCCcchHHHHHHHHHHHhccCccccCC-----HHH
Confidence 12334455677778899999999999999999984 899
Q ss_pred HhcCCceeeeCccccccCCCCCCCCcccccccccccccc
Q psy11767 307 LKRHPFFNVIDWDDLATKRIPAPFVPKISNELDVSNFSD 345 (966)
Q Consensus 307 Ik~HpfF~~idW~~l~~k~~~pP~~P~i~~~~D~snFd~ 345 (966)
|.+||||++. +....+..|-.+...+..|...|..
T Consensus 331 ll~hp~f~~~----~~~~~~~~~~~~~~~~~~~~~~~~~ 365 (373)
T 1q8y_A 331 LVNHPWLKDT----LGMEEIRVPDRELYGSGSDIPGWFE 365 (373)
T ss_dssp HHTCGGGTTC----TTCTTCCCTTSCTTCBSTTSTTSSS
T ss_pred HhhChhhhcc----cCcccccCcchhcCCCcccCchHHH
Confidence 9999999753 2223334443444444444444443
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.69 E-value=3.7e-17 Score=187.65 Aligned_cols=193 Identities=21% Similarity=0.270 Sum_probs=125.1
Q ss_pred cce-eeeecccccceEEEEEEc--CCCCEEEEEeccccc---hhhHHHHHHHHhhCCCccccccccc--cc---------
Q psy11767 118 LDK-AGILGDGSYSVCRRCVEK--STGQEYAVKIISRKI---DCSEEINLLRACQGHPNICRRCVEK--ST--------- 180 (966)
Q Consensus 118 f~~-~~~LG~GsFGkV~La~~k--~tg~~yAiKvl~K~~---~~~~E~~il~~~~~~pfi~~~~~~~--~~--------- 180 (966)
|++ .++||+|+||+||+|+++ .+++.||||++++.. ...+|..+|+++ +||+|+.....+ ..
T Consensus 22 y~~~g~~lG~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~~~~~~~~E~~~l~~l-~hpniv~~~~~~~~~~~~~~~lv~e 100 (405)
T 3rgf_A 22 FEYEGCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGTGISMSACREIALLREL-KHPNVISLQKVFLSHADRKVWLLFD 100 (405)
T ss_dssp EECSSCCCC-----EEEEEEESSSSCCCCEEEEECSSSSCCHHHHHHHHHHHHC-CCTTBCCCCEEEEETTTTEEEEEEE
T ss_pred hhhcCcEeeecCCeEEEEEEEccCCCCeEEEEEEECCCCCCHHHHHHHHHHHhc-CCCCeeeEeeEEecCCCCeEEEEEe
Confidence 344 568999999999999987 578999999998753 467899999998 499998732221 10
Q ss_pred -----------------------------chhHHHHHHHh----------hcccchhhhHhh----hccCCceEEecCcc
Q psy11767 181 -----------------------------GQEYAVKIISR----------KIDCSEEINLLR----ACQGHPNIVNLHCV 217 (966)
Q Consensus 181 -----------------------------~~~~~~~~v~~----------~~~~~~e~nil~----~~~gh~~iv~l~~~ 217 (966)
...++.+++.+ ..|++++ |||. +..|+++|+||+.+
T Consensus 101 ~~~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~ivH~Dlkp~-NIll~~~~~~~~~~kl~Dfg~a 179 (405)
T 3rgf_A 101 YAEHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANWVLHRDLKPA-NILVMGEGPERGRVKIADMGFA 179 (405)
T ss_dssp CCSEEHHHHHHHHHHHC-------CCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGG-GEEECCSSTTTTCEEECCTTCC
T ss_pred CCCCCHHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHhCCEeCCCcCHH-HeEEecCCCCCCcEEEEECCCc
Confidence 01111122221 1244445 9998 67789999999876
Q ss_pred cc----------------------ccccccc-cCCCcceeeechhhHHHHHHHhhCCCCCCCCcHH---------HHHHH
Q psy11767 218 FQ----------------------DEVIDWD-DFSRGIECVFFSSSLIIFFIILSFTLSFIHDYYH---------IQYRR 265 (966)
Q Consensus 218 ~~----------------------~e~i~~~-~y~~~~d~~~~~~~~il~~~m~~g~~pf~~~~~~---------~~~~~ 265 (966)
.. +|++... .|+...| .|+.|+++|+|++|.+||...+.. ....+
T Consensus 180 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~D---iwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~l~~ 256 (405)
T 3rgf_A 180 RLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAID---IWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQLDR 256 (405)
T ss_dssp C----------------CCCTTCCHHHHTTCCSCCHHHH---HHHHHHHHHHHHHSSCTTCCCC------CCCCHHHHHH
T ss_pred eecCCCCcccccCCCceecCcccCchhhcCCCcccchhh---hHHHHHHHHHHHhCCCCCCCccccccccccchHHHHHH
Confidence 32 2334332 2544444 446778889999999999755432 33444
Q ss_pred HHh--CCCCC------------------------------------CCCCCHHHHHHHHhhcccCCCcccCCCCCCHHHH
Q psy11767 266 ILK--TEPPI------------------------------------PEDLSPDVADFISRLLVKDPRRRLGGGELDAEEL 307 (966)
Q Consensus 266 I~~--~~~~~------------------------------------P~~~s~~a~dli~~LL~kdp~~RLG~~~~g~~~I 307 (966)
|+. +.+.- ....++++.|||++||+.||.+|+. ++|+
T Consensus 257 i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Ll~~~L~~dP~~R~t-----a~e~ 331 (405)
T 3rgf_A 257 IFNVMGFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHLLQKLLTMDPIKRIT-----SEQA 331 (405)
T ss_dssp HHHHHCCCCTTTCGGGGGSTTHHHHHHHCCGGGGTTCCHHHHHHTTTCCTTSHHHHHHHHHSCSSGGGSCC-----HHHH
T ss_pred HHHhhCCCChhhcchhhcCcchhhhhhhccccCCCcchhhhhHhhcCCCCCHHHHHHHHHHccCCcccCCC-----HHHH
Confidence 432 11110 1122789999999999999999984 8999
Q ss_pred hcCCceeeeCccc
Q psy11767 308 KRHPFFNVIDWDD 320 (966)
Q Consensus 308 k~HpfF~~idW~~ 320 (966)
.+||||.+..|..
T Consensus 332 L~hp~f~~~~~~~ 344 (405)
T 3rgf_A 332 MQDPYFLEDPLPT 344 (405)
T ss_dssp HTSGGGTSSSCCC
T ss_pred hcChhhccCCCCc
Confidence 9999998776643
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} | Back alignment and structure |
|---|
Probab=99.69 E-value=1.4e-17 Score=184.10 Aligned_cols=188 Identities=18% Similarity=0.228 Sum_probs=129.6
Q ss_pred CcceeeeecccccceEEEEEEcCCCCEEEEEecccc------chhhHHHHHHHHhhCCCccccccccccc----------
Q psy11767 117 DLDKAGILGDGSYSVCRRCVEKSTGQEYAVKIISRK------IDCSEEINLLRACQGHPNICRRCVEKST---------- 180 (966)
Q Consensus 117 df~~~~~LG~GsFGkV~La~~k~tg~~yAiKvl~K~------~~~~~E~~il~~~~~~pfi~~~~~~~~~---------- 180 (966)
+|++++.||+|+||+|++|+++.+|+.||||++++. ....+|..+|+++ +||+|++.+-.+..
T Consensus 7 ~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~hpniv~~~~~~~~~~~~~~~~~~ 85 (332)
T 3qd2_B 7 DFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKL-EHPGIVRYFNAWLETPPEKWQEEM 85 (332)
T ss_dssp HEEEEEEEECC-CSEEEEEEETTTCCEEEEEEEECCSTTTHHHHHHHHHHHHTSC-CCTTBCCEEEEEEECCSCHHHHHH
T ss_pred cCceeeEecCCCCeEEEEEEEcCCCcEEEEEEeecCCchhHHHHHHHHHHHHHhC-CCCCEeeEEEEEEEeccchhhhhh
Confidence 569999999999999999999999999999999853 2457899999988 69999873321100
Q ss_pred --------------------------------------------------------------------------------
Q psy11767 181 -------------------------------------------------------------------------------- 180 (966)
Q Consensus 181 -------------------------------------------------------------------------------- 180 (966)
T Consensus 86 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~ 165 (332)
T 3qd2_B 86 DEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLEDREHGV 165 (332)
T ss_dssp HC--------------------------------------------CCCEEEEEEECCCSSCHHHHHHTCCSGGGSCHHH
T ss_pred hhhhhccccccccccCCCcccccccceeeccccCcccccccccCCCCCceEEEEEEecCCCCHHHHHhcccCccchhhHH
Confidence
Q ss_pred chhHHHHHHHh----------hcccchhhhHhhhccCCceEEecCcccc-------------------------------
Q psy11767 181 GQEYAVKIISR----------KIDCSEEINLLRACQGHPNIVNLHCVFQ------------------------------- 219 (966)
Q Consensus 181 ~~~~~~~~v~~----------~~~~~~e~nil~~~~gh~~iv~l~~~~~------------------------------- 219 (966)
....+.+++.+ ..|++++ |||.+.+|.++|+||+.+..
T Consensus 166 ~~~i~~qi~~aL~~LH~~~ivH~Dlkp~-NIll~~~~~~kL~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~a 244 (332)
T 3qd2_B 166 CLHIFIQIAEAVEFLHSKGLMHRDLKPS-NIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTKLYMS 244 (332)
T ss_dssp HHHHHHHHHHHHHHHHHTTEECCCCCGG-GEEECTTCCEEECCCTTCEECSCC--------------CCCSCC-CGGGSC
T ss_pred HHHHHHHHHHHHHHHHhCCeeecCCCcc-cEEEeCCCCEEEeecCcccccccchhhccccccccccccccccCCCcCccC
Confidence 00111122221 1244444 99999999999999986531
Q ss_pred ccccccccCCCcceeeechhhHHHHHHHhhCCCCCCCCcHHHHHHHHHhCCCC-CCCCCCHHHHHHHHhhcccCCCcccC
Q psy11767 220 DEVIDWDDFSRGIECVFFSSSLIIFFIILSFTLSFIHDYYHIQYRRILKTEPP-IPEDLSPDVADFISRLLVKDPRRRLG 298 (966)
Q Consensus 220 ~e~i~~~~y~~~~d~~~~~~~~il~~~m~~g~~pf~~~~~~~~~~~I~~~~~~-~P~~~s~~a~dli~~LL~kdp~~RLG 298 (966)
+|++....|+...| .|+.|+++|+|++|.+|+.. ...+...+...... .+...++++++||+++|..||.+|.
T Consensus 245 PE~~~~~~~~~~~D---i~slG~il~el~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp- 318 (332)
T 3qd2_B 245 PEQIHGNNYSHKVD---IFSLGLILFELLYSFSTQME--RVRIITDVRNLKFPLLFTQKYPQEHMMVQDMLSPSPTERP- 318 (332)
T ss_dssp HHHHHCCCCCTHHH---HHHHHHHHHHHHSCCCCHHH--HHHHHHHHHTTCCCHHHHHHCHHHHHHHHHHHCSSGGGSC-
T ss_pred hHHhcCCCCcchhh---HHHHHHHHHHHHHcCCChhH--HHHHHHHhhccCCCcccccCChhHHHHHHHHccCCCCcCC-
Confidence 23444445554444 44667777888887666532 22334444444322 1234678999999999999999998
Q ss_pred CCCCCHHHHhcCCceeee
Q psy11767 299 GGELDAEELKRHPFFNVI 316 (966)
Q Consensus 299 ~~~~g~~~Ik~HpfF~~i 316 (966)
.+++|.+||||++|
T Consensus 319 ----s~~~~l~~~~f~~~ 332 (332)
T 3qd2_B 319 ----EATDIIENAIFENL 332 (332)
T ss_dssp ----CHHHHHHSTTCCCC
T ss_pred ----CHHHHhhchhhhcC
Confidence 48999999999875
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... | Back alignment and structure |
|---|
Probab=99.69 E-value=1e-16 Score=172.79 Aligned_cols=191 Identities=19% Similarity=0.301 Sum_probs=132.1
Q ss_pred CcceeeeecccccceEEEEEEcCCCCEEEEEeccccc------hhhHHHHHHHHhhCCCccccccccccc----------
Q psy11767 117 DLDKAGILGDGSYSVCRRCVEKSTGQEYAVKIISRKI------DCSEEINLLRACQGHPNICRRCVEKST---------- 180 (966)
Q Consensus 117 df~~~~~LG~GsFGkV~La~~k~tg~~yAiKvl~K~~------~~~~E~~il~~~~~~pfi~~~~~~~~~---------- 180 (966)
+|++++.||+|+||+|++|+++.+|+.||+|++++.. ...+|..+|+++ +||+|++.+-....
T Consensus 8 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~ 86 (276)
T 2yex_A 8 DWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKML-NHENVVKFYGHRREGNIQYLFLEY 86 (276)
T ss_dssp HEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGCTTHHHHHHHHHHHHHTC-CCTTBCCEEEEEEETTEEEEEEEC
T ss_pred ceEEEEEeecCCCcEEEEEEECCCCcEEEEEEeeeccchhhhHHHHHHHHHHHhc-CCCCceeeeeEEEcCCEEEEEEEe
Confidence 4589999999999999999999999999999997542 356788888887 69999761111100
Q ss_pred --------------------chhHHHHHHHh----------hcccchhhhHhhhccCCceEEecCcccc-----------
Q psy11767 181 --------------------GQEYAVKIISR----------KIDCSEEINLLRACQGHPNIVNLHCVFQ----------- 219 (966)
Q Consensus 181 --------------------~~~~~~~~v~~----------~~~~~~e~nil~~~~gh~~iv~l~~~~~----------- 219 (966)
....+.+++.+ ..|++++ |||.+.+|.++|+||+.+..
T Consensus 87 ~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~-Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~ 165 (276)
T 2yex_A 87 CSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPE-NLLLDERDNLKISDFGLATVFRYNNRERLLN 165 (276)
T ss_dssp CTTEEGGGGSBTTTBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGG-GEEECTTCCEEECCCTTCEECEETTEECCBC
T ss_pred cCCCcHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCChH-HEEEccCCCEEEeeCCCccccCCCcchhccc
Confidence 00111122211 0133334 99999999999999986631
Q ss_pred ----------ccccccccCCCcceeeechhhHHHHHHHhhCCCCCCCCcHH-HHHHHHHhCCCCCC--CCCCHHHHHHHH
Q psy11767 220 ----------DEVIDWDDFSRGIECVFFSSSLIIFFIILSFTLSFIHDYYH-IQYRRILKTEPPIP--EDLSPDVADFIS 286 (966)
Q Consensus 220 ----------~e~i~~~~y~~~~d~~~~~~~~il~~~m~~g~~pf~~~~~~-~~~~~I~~~~~~~P--~~~s~~a~dli~ 286 (966)
+|++....+. +...| .|+.|+++|+|++|.+||...+.. ..+..+.......+ ..+++++++||+
T Consensus 166 ~~~~~~~y~aPE~~~~~~~~-~~~~D-i~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~ 243 (276)
T 2yex_A 166 KMCGTLPYVAPELLKRREFH-AEPVD-VWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPLALLH 243 (276)
T ss_dssp CCCSCGGGCCGGGGTCSSBC-HHHHH-HHHHHHHHHHHHHSSCCCSCSCTTSHHHHHHHTTCTTSTTGGGSCHHHHHHHH
T ss_pred CCccccCccChHHHhcCCCC-CCcch-HHHHHHHHHHHHhCCCCCCCCchHHHHHHHhhhcccccCchhhcCHHHHHHHH
Confidence 2333322221 11123 446678888899999999765432 34556655544443 468999999999
Q ss_pred hhcccCCCcccCCCCCCHHHHhcCCceeee
Q psy11767 287 RLLVKDPRRRLGGGELDAEELKRHPFFNVI 316 (966)
Q Consensus 287 ~LL~kdp~~RLG~~~~g~~~Ik~HpfF~~i 316 (966)
++|..||.+|.. +++|.+||||+..
T Consensus 244 ~~l~~~p~~Rps-----~~~il~~~~~~~~ 268 (276)
T 2yex_A 244 KILVENPSARIT-----IPDIKKDRWYNKP 268 (276)
T ss_dssp HHSCSSTTTSCC-----HHHHTTCTTTTCC
T ss_pred HHCCCCchhCCC-----HHHHhcCccccCh
Confidence 999999999984 8999999999744
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.69 E-value=1.2e-16 Score=176.93 Aligned_cols=196 Identities=20% Similarity=0.215 Sum_probs=140.8
Q ss_pred CcceeeeecccccceEEEEEEcCCCCEEEEEecccc----chhhHHHHHHHHhhCCCccccccccccc------------
Q psy11767 117 DLDKAGILGDGSYSVCRRCVEKSTGQEYAVKIISRK----IDCSEEINLLRACQGHPNICRRCVEKST------------ 180 (966)
Q Consensus 117 df~~~~~LG~GsFGkV~La~~k~tg~~yAiKvl~K~----~~~~~E~~il~~~~~~pfi~~~~~~~~~------------ 180 (966)
+|++++.||+|+||+|++|+++.+|+.||||++++. ....+|..+|+++.+||+|+..+-.+..
T Consensus 25 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~~~~~l 104 (326)
T 2x7f_A 25 IFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMDDQLWL 104 (326)
T ss_dssp TEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSSTTHHHHHHHHHHHHHCCSTTBCCEEEEEEECC--CCCCEEEE
T ss_pred cEEEEEEeccCCCEEEEEEEECCCCCeEEEEEEecCcccHHHHHHHHHHHHhccCCCCeeeeeeEEeeccCccccceEEE
Confidence 679999999999999999999999999999999754 2467899999999889999862211110
Q ss_pred ------c--------------------hhHHHHHHHh----------hcccchhhhHhhhccCCceEEecCcccc-----
Q psy11767 181 ------G--------------------QEYAVKIISR----------KIDCSEEINLLRACQGHPNIVNLHCVFQ----- 219 (966)
Q Consensus 181 ------~--------------------~~~~~~~v~~----------~~~~~~e~nil~~~~gh~~iv~l~~~~~----- 219 (966)
. ...+.+++.+ ..|++++ |||.+.+|.++|+||+.+..
T Consensus 105 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~-NIl~~~~~~~kl~Dfg~~~~~~~~~ 183 (326)
T 2x7f_A 105 VMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQHKVIHRDIKGQ-NVLLTENAEVKLVDFGVSAQLDRTV 183 (326)
T ss_dssp EEECCTTEEHHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGG-GEEECTTCCEEECCCTTTC------
T ss_pred EEEcCCCCcHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCcHH-HEEEcCCCCEEEeeCcCceecCcCc
Confidence 0 0000111111 0133333 99999899999999986532
Q ss_pred --------------ccccc-----cccCCCcceeeechhhHHHHHHHhhCCCCCCCCcHHHHHHHHHhCCCC--CCCCCC
Q psy11767 220 --------------DEVID-----WDDFSRGIECVFFSSSLIIFFIILSFTLSFIHDYYHIQYRRILKTEPP--IPEDLS 278 (966)
Q Consensus 220 --------------~e~i~-----~~~y~~~~d~~~~~~~~il~~~m~~g~~pf~~~~~~~~~~~I~~~~~~--~P~~~s 278 (966)
+|++. ...|+...| .|+.|+++|+|++|.+||...+.......|...... .+..++
T Consensus 184 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~D---i~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 260 (326)
T 2x7f_A 184 GRRNTFIGTPYWMAPEVIACDENPDATYDFKSD---LWSLGITAIEMAEGAPPLCDMHPMRALFLIPRNPAPRLKSKKWS 260 (326)
T ss_dssp -------CCGGGCCHHHHC--------CCTTHH---HHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCCCSCSCSC
T ss_pred cccccccCCccccChhhhccccccCcCCCccch---HHHHHHHHHHHHhCCCCCCCCcHHHHHHHhhcCccccCCccccC
Confidence 23332 123433444 446678888899999999887777666666654332 356789
Q ss_pred HHHHHHHHhhcccCCCcccCCCCCCHHHHhcCCceeeeCcccc
Q psy11767 279 PDVADFISRLLVKDPRRRLGGGELDAEELKRHPFFNVIDWDDL 321 (966)
Q Consensus 279 ~~a~dli~~LL~kdp~~RLG~~~~g~~~Ik~HpfF~~idW~~l 321 (966)
+++++||+++|..||.+|. .+++|.+||||+...|+.-
T Consensus 261 ~~l~~li~~~l~~dp~~Rp-----s~~~ll~hp~~~~~~~~~~ 298 (326)
T 2x7f_A 261 KKFQSFIESCLVKNHSQRP-----ATEQLMKHPFIRDQPNERQ 298 (326)
T ss_dssp HHHHHHHHHHCCSSGGGSC-----CHHHHHTSHHHHCCTTHHH
T ss_pred HHHHHHHHHHhccChhhCC-----CHHHHhhChHHhhCccccc
Confidence 9999999999999999998 4899999999998776543
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* | Back alignment and structure |
|---|
Probab=99.69 E-value=6.8e-17 Score=174.59 Aligned_cols=191 Identities=17% Similarity=0.266 Sum_probs=128.8
Q ss_pred ccCCcceeeeecccccceEEEEEEcCCCCEEEEEecccc-------chhhHHHHHHHHhhCCCccccccccccc------
Q psy11767 114 YDMDLDKAGILGDGSYSVCRRCVEKSTGQEYAVKIISRK-------IDCSEEINLLRACQGHPNICRRCVEKST------ 180 (966)
Q Consensus 114 ~~~df~~~~~LG~GsFGkV~La~~k~tg~~yAiKvl~K~-------~~~~~E~~il~~~~~~pfi~~~~~~~~~------ 180 (966)
+.-+|++++.||+|+||+|++|+++.+|+.||||++++. ....+|..++.++.+||+|++..-.+..
T Consensus 9 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~~h~~iv~~~~~~~~~~~~~l 88 (289)
T 1x8b_A 9 YTTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHSHVVRYFSAWAEDDHMLI 88 (289)
T ss_dssp HHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCCTTSHHHHHHHHHHHHHHHSCSCTTBCCEEEEEEETTEEEE
T ss_pred ccchhhhhhhhcCCCceEEEEEEEcCCCceEEEEEecccccccHHHHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEE
Confidence 444679999999999999999999999999999999864 1346678888888789999862111110
Q ss_pred ----------------------------chhHHHHHHHh----------hcccchhhhHhhhccC---------------
Q psy11767 181 ----------------------------GQEYAVKIISR----------KIDCSEEINLLRACQG--------------- 207 (966)
Q Consensus 181 ----------------------------~~~~~~~~v~~----------~~~~~~e~nil~~~~g--------------- 207 (966)
....+.+++.+ ..|++++ |||.+.+|
T Consensus 89 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dikp~-NIl~~~~~~~~~~~~~~~~~~~~ 167 (289)
T 1x8b_A 89 QNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIHSMSLVHMDIKPS-NIFISRTSIPNAASEEGDEDDWA 167 (289)
T ss_dssp EEECCTTCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGG-GEEEC------------------
T ss_pred EEEecCCCcHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHHhCCEeecCCCHH-HEEEcCCCCCccccccccccccc
Confidence 00111122211 1144444 88887544
Q ss_pred ----CceEEecCcccc---------------ccccccc-cCCCcceeeechhhHHHHHHHhhCCCCCCCCcHHHHHHHHH
Q psy11767 208 ----HPNIVNLHCVFQ---------------DEVIDWD-DFSRGIECVFFSSSLIIFFIILSFTLSFIHDYYHIQYRRIL 267 (966)
Q Consensus 208 ----h~~iv~l~~~~~---------------~e~i~~~-~y~~~~d~~~~~~~~il~~~m~~g~~pf~~~~~~~~~~~I~ 267 (966)
..+|.||+.+.. +|++... .++. ..|.| +.|+++|+|++|.+|+...+. +..+.
T Consensus 168 ~~~~~~kl~Dfg~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~--~~Di~-slG~il~~l~~~~~~~~~~~~---~~~~~ 241 (289)
T 1x8b_A 168 SNKVMFKIGDLGHVTRISSPQVEEGDSRFLANEVLQENYTHLP--KADIF-ALALTVVCAAGAEPLPRNGDQ---WHEIR 241 (289)
T ss_dssp --CCCEEECCCTTCEETTCSCCCCCCGGGCCHHHHTTCCTTHH--HHHHH-HHHHHHHHHTTCCCCCSSSHH---HHHHH
T ss_pred CCceEEEEcccccccccCCccccCCCccccChhHhcCCCCCCc--hhhHH-HHHHHHHHHhcCCCCCcchhH---HHHHH
Confidence 568888875431 2333321 2222 23344 556777889999887766543 45566
Q ss_pred hCC-CCCCCCCCHHHHHHHHhhcccCCCcccCCCCCCHHHHhcCCceeee
Q psy11767 268 KTE-PPIPEDLSPDVADFISRLLVKDPRRRLGGGELDAEELKRHPFFNVI 316 (966)
Q Consensus 268 ~~~-~~~P~~~s~~a~dli~~LL~kdp~~RLG~~~~g~~~Ik~HpfF~~i 316 (966)
.+. +.+|..+++++++||+++|..||.+|. .+.+|.+||||.+.
T Consensus 242 ~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp-----s~~~ll~h~~~~~~ 286 (289)
T 1x8b_A 242 QGRLPRIPQVLSQEFTELLKVMIHPDPERRP-----SAMALVKHSVLLSA 286 (289)
T ss_dssp TTCCCCCSSCCCHHHHHHHHHHTCSSGGGSC-----CHHHHHTCTTC---
T ss_pred cCCCCCCCcccCHHHHHHHHHHhCCCcccCC-----CHHHHhhChHhhhh
Confidence 544 568889999999999999999999998 48999999999854
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* | Back alignment and structure |
|---|
Probab=99.69 E-value=3.1e-17 Score=183.55 Aligned_cols=190 Identities=23% Similarity=0.325 Sum_probs=120.1
Q ss_pred Ccceee-eecccccceEEEEEEcCCCCEEEEEeccccchhhHHHHHHHHhhCCCccccccccccc---------------
Q psy11767 117 DLDKAG-ILGDGSYSVCRRCVEKSTGQEYAVKIISRKIDCSEEINLLRACQGHPNICRRCVEKST--------------- 180 (966)
Q Consensus 117 df~~~~-~LG~GsFGkV~La~~k~tg~~yAiKvl~K~~~~~~E~~il~~~~~~pfi~~~~~~~~~--------------- 180 (966)
+|.+++ +||+|+||+|++|+++.+|+.||||++.+......|...+.+...||+|+...-.+..
T Consensus 29 ~y~i~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~lv~e~~ 108 (336)
T 3fhr_A 29 DYQLSKQVLGLGVNGKVLECFHRRTGQKCALKLLYDSPKARQEVDHHWQASGGPHIVCILDVYENMHHGKRCLLIIMECM 108 (336)
T ss_dssp TEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESSHHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEEEEEECC
T ss_pred eeEecceeeeeCCCeEEEEEEECCCCCEEEEEEecCcHHHHHHHHHHHHhcCCCChHHHHHHHhhccCCCceEEEEEecc
Confidence 678854 7999999999999999999999999998876566666666677789999762111110
Q ss_pred ---------------------chhHHHHHHHh----------hcccchhhhHhhhc---cCCceEEecCcccc-------
Q psy11767 181 ---------------------GQEYAVKIISR----------KIDCSEEINLLRAC---QGHPNIVNLHCVFQ------- 219 (966)
Q Consensus 181 ---------------------~~~~~~~~v~~----------~~~~~~e~nil~~~---~gh~~iv~l~~~~~------- 219 (966)
...++.+++.+ ..|++++ |||.+. .+.++|+||+.+..
T Consensus 109 ~gg~L~~~l~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~ivH~dlkp~-NIll~~~~~~~~~kl~Dfg~~~~~~~~~~~ 187 (336)
T 3fhr_A 109 EGGELFSRIQERGDQAFTEREAAEIMRDIGTAIQFLHSHNIAHRDVKPE-NLLYTSKEKDAVLKLTDFGFAKETTQNALQ 187 (336)
T ss_dssp TTEEHHHHHHTC-CCCCBHHHHHHHHHHHHHHHHHHHHTTEECSCCSGG-GEEESCSSTTCCEEECCCTTCEEC------
T ss_pred CCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHH-HEEEEecCCCceEEEeccccceeccccccc
Confidence 00111122111 0133444 888865 35589999987632
Q ss_pred ----------ccccccccCCCcceeeechhhHHHHHHHhhCCCCCCCCcHHHH----HHHHHhCCCCCC----CCCCHHH
Q psy11767 220 ----------DEVIDWDDFSRGIECVFFSSSLIIFFIILSFTLSFIHDYYHIQ----YRRILKTEPPIP----EDLSPDV 281 (966)
Q Consensus 220 ----------~e~i~~~~y~~~~d~~~~~~~~il~~~m~~g~~pf~~~~~~~~----~~~I~~~~~~~P----~~~s~~a 281 (966)
+|++....|+...| .|+.|+++|+|++|.+||.......+ .+.+..+...+| ..+++++
T Consensus 188 ~~~~t~~y~aPE~~~~~~~~~~~D---i~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 264 (336)
T 3fhr_A 188 TPCYTPYYVAPEVLGPEKYDKSCD---MWSLGVIMYILLCGFPPFYSNTGQAISPGMKRRIRLGQYGFPNPEWSEVSEDA 264 (336)
T ss_dssp ----------------CHHHHHHH---HHHHHHHHHHHHHSSCCC---------------------CCCTTTSTTCCHHH
T ss_pred cCCCCcCccChhhhCCCCCCchhh---HHHHHHHHHHHHHCCCCCCCccchhhhhhHHHhhhccccccCchhhccCCHHH
Confidence 23333333333333 44667788889999999987654432 455555555555 4789999
Q ss_pred HHHHHhhcccCCCcccCCCCCCHHHHhcCCceee
Q psy11767 282 ADFISRLLVKDPRRRLGGGELDAEELKRHPFFNV 315 (966)
Q Consensus 282 ~dli~~LL~kdp~~RLG~~~~g~~~Ik~HpfF~~ 315 (966)
++||+++|..||.+|.. +++|.+||||+.
T Consensus 265 ~~li~~~L~~dP~~Rpt-----~~ell~hp~~~~ 293 (336)
T 3fhr_A 265 KQLIRLLLKTDPTERLT-----ITQFMNHPWINQ 293 (336)
T ss_dssp HHHHHHHSCSSGGGSCC-----HHHHHHSHHHHT
T ss_pred HHHHHHHCCCChhHCcC-----HHHHhcCccccc
Confidence 99999999999999984 899999999974
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* | Back alignment and structure |
|---|
Probab=99.69 E-value=9.3e-17 Score=180.94 Aligned_cols=189 Identities=17% Similarity=0.146 Sum_probs=137.3
Q ss_pred CcceeeeecccccceEEEEEEcCCCCEEEEEecccc--------chhhHHHHHHHHhhCCCcccccccccccc-------
Q psy11767 117 DLDKAGILGDGSYSVCRRCVEKSTGQEYAVKIISRK--------IDCSEEINLLRACQGHPNICRRCVEKSTG------- 181 (966)
Q Consensus 117 df~~~~~LG~GsFGkV~La~~k~tg~~yAiKvl~K~--------~~~~~E~~il~~~~~~pfi~~~~~~~~~~------- 181 (966)
.|..++.||+|+||+|++|+++.+|+.||||++++. ....+|..+|+++ +||+|++..-.....
T Consensus 55 ~y~~~~~lG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l-~hpniv~~~~~~~~~~~~~lv~ 133 (348)
T 1u5q_A 55 LFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKL-RHPNTIQYRGCYLREHTAWLVM 133 (348)
T ss_dssp HEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEESCSSCHHHHHHHHHHHHHHHHHC-CCTTBCCEEEEEEETTEEEEEE
T ss_pred heeeeeEEccCCCEEEEEEEEccCCeEEEEEEEccccccchHHHHHHHHHHHHHHhC-CCCCEeeEEEEEEECCeEEEEE
Confidence 478999999999999999999999999999999753 1356899999988 699998622111100
Q ss_pred -----------------------hhHHHHHHHh----------hcccchhhhHhhhccCCceEEecCcccc---------
Q psy11767 182 -----------------------QEYAVKIISR----------KIDCSEEINLLRACQGHPNIVNLHCVFQ--------- 219 (966)
Q Consensus 182 -----------------------~~~~~~~v~~----------~~~~~~e~nil~~~~gh~~iv~l~~~~~--------- 219 (966)
...+.+++.+ ..|++++ |||.+.+|+++|.||+.+..
T Consensus 134 e~~~g~l~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~-NIll~~~~~~kL~DfG~a~~~~~~~~~~g 212 (348)
T 1u5q_A 134 EYCLGSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAG-NILLSEPGLVKLGDFGSASIMAPANSFVG 212 (348)
T ss_dssp ECCSEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGG-GEEEETTTEEEECCCTTCBSSSSBCCCCS
T ss_pred ecCCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHH-HEEECCCCCEEEeeccCceecCCCCcccC
Confidence 0111112111 0144444 99999999999999987632
Q ss_pred ------ccccc---cccCCCcceeeechhhHHHHHHHhhCCCCCCCCcHHHHHHHHHhCCC-C-CCCCCCHHHHHHHHhh
Q psy11767 220 ------DEVID---WDDFSRGIECVFFSSSLIIFFIILSFTLSFIHDYYHIQYRRILKTEP-P-IPEDLSPDVADFISRL 288 (966)
Q Consensus 220 ------~e~i~---~~~y~~~~d~~~~~~~~il~~~m~~g~~pf~~~~~~~~~~~I~~~~~-~-~P~~~s~~a~dli~~L 288 (966)
+|++. ...|+...| .|+.|+++|+|++|.+||...+.......+..+.. . .+..+++++++||.++
T Consensus 213 t~~y~aPE~~~~~~~~~~~~~~D---iwslG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~ 289 (348)
T 1u5q_A 213 TPYWMAPEVILAMDEGQYDGKVD---VWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPALQSGHWSEYFRNFVDSC 289 (348)
T ss_dssp CGGGCCHHHHHTTSSCCBCTHHH---HHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCCCCCTTSCHHHHHHHHHH
T ss_pred CcceeCHhhhccccCCCCCcHHH---HHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCCCCCCHHHHHHHHHH
Confidence 34442 234544444 44677888899999999988776666666665433 2 3567899999999999
Q ss_pred cccCCCcccCCCCCCHHHHhcCCceee
Q psy11767 289 LVKDPRRRLGGGELDAEELKRHPFFNV 315 (966)
Q Consensus 289 L~kdp~~RLG~~~~g~~~Ik~HpfF~~ 315 (966)
|++||.+|.. +++|.+||||..
T Consensus 290 l~~dP~~Rps-----~~~ll~h~~~~~ 311 (348)
T 1u5q_A 290 LQKIPQDRPT-----SEVLLKHRFVLR 311 (348)
T ss_dssp TCSSGGGSCC-----HHHHTTCHHHHS
T ss_pred cccChhhCcC-----HHHHhhChhhhc
Confidence 9999999984 899999999953
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* | Back alignment and structure |
|---|
Probab=99.67 E-value=2.5e-16 Score=170.22 Aligned_cols=188 Identities=20% Similarity=0.245 Sum_probs=139.8
Q ss_pred CcceeeeecccccceEEEEEEcCCCCEEEEEeccccc-------hhhHHHHHHHHhhCCCccccccccc--ccc------
Q psy11767 117 DLDKAGILGDGSYSVCRRCVEKSTGQEYAVKIISRKI-------DCSEEINLLRACQGHPNICRRCVEK--STG------ 181 (966)
Q Consensus 117 df~~~~~LG~GsFGkV~La~~k~tg~~yAiKvl~K~~-------~~~~E~~il~~~~~~pfi~~~~~~~--~~~------ 181 (966)
+|++++.||+|+||+|++|+++.+|+.||+|++++.. ...+|..+|+++ +||+|++.+-.. ...
T Consensus 7 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~~~lv 85 (279)
T 2w5a_A 7 DYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLREL-KHPNIVRYYDRIIDRTNTTLYIV 85 (279)
T ss_dssp GEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHC-CCTTBCCEEEEEEEGGGTEEEEE
T ss_pred heeeehhccCCCCcEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhc-CCCCCCeEEEEEecCCCceEEEE
Confidence 6799999999999999999999999999999998532 356789999988 699998732111 100
Q ss_pred ----------------------------hhHHHHHHHh-------h-----c---ccchhhhHhhhccCCceEEecCccc
Q psy11767 182 ----------------------------QEYAVKIISR-------K-----I---DCSEEINLLRACQGHPNIVNLHCVF 218 (966)
Q Consensus 182 ----------------------------~~~~~~~v~~-------~-----~---~~~~e~nil~~~~gh~~iv~l~~~~ 218 (966)
...+.+++.+ . + |++ ..|||.+.+|+++|+||+.+.
T Consensus 86 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~ivH~dl~-p~NIl~~~~~~~kl~dfg~~~ 164 (279)
T 2w5a_A 86 MEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLK-PANVFLDGKQNVKLGDFGLAR 164 (279)
T ss_dssp EECCTTEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHC------CCCCCS-GGGEEECSSSCEEECCCCHHH
T ss_pred EeCCCCCCHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcccCCCCeeEEeccc-hhhEEEcCCCCEEEecCchhe
Confidence 0000111111 0 1 233 339999988999999988652
Q ss_pred -------------------cccccccccCCCcceeeechhhHHHHHHHhhCCCCCCCCcHHHHHHHHHhCCC-CCCCCCC
Q psy11767 219 -------------------QDEVIDWDDFSRGIECVFFSSSLIIFFIILSFTLSFIHDYYHIQYRRILKTEP-PIPEDLS 278 (966)
Q Consensus 219 -------------------~~e~i~~~~y~~~~d~~~~~~~~il~~~m~~g~~pf~~~~~~~~~~~I~~~~~-~~P~~~s 278 (966)
.+|++....|+...| .|+.|+++|+|++|.+||...+...+.+.|..+.. .+|..++
T Consensus 165 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~D---i~slG~il~~l~~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~ 241 (279)
T 2w5a_A 165 ILNHDTSFAKTFVGTPYYMSPEQMNRMSYNEKSD---IWSLGCLLYELCALMPPFTAFSQKELAGKIREGKFRRIPYRYS 241 (279)
T ss_dssp HC---CHHHHHHHSCCTTCCHHHHHCC-CCHHHH---HHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCCTTSC
T ss_pred eeccccccccccCCCccccChHHhccCCCCchhh---HHHHHHHHHHHHHCCCCCcccCHHHHHHHHhhcccccCCcccC
Confidence 134444444443334 44667888889999999999888888899988765 6888999
Q ss_pred HHHHHHHHhhcccCCCcccCCCCCCHHHHhcCCcee
Q psy11767 279 PDVADFISRLLVKDPRRRLGGGELDAEELKRHPFFN 314 (966)
Q Consensus 279 ~~a~dli~~LL~kdp~~RLG~~~~g~~~Ik~HpfF~ 314 (966)
+++++||.++|..||.+|. .+++|..|+||.
T Consensus 242 ~~l~~li~~~l~~~p~~Rp-----s~~~ll~~~~~~ 272 (279)
T 2w5a_A 242 DELNEIITRMLNLKDYHRP-----SVEEILENPLIL 272 (279)
T ss_dssp HHHHHHHHHHTCSSGGGSC-----CHHHHHTSTTCC
T ss_pred HHHHHHHHHHcCCCcccCC-----CHHHHHhChhhh
Confidence 9999999999999999997 489999999996
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.67 E-value=1.8e-16 Score=174.49 Aligned_cols=193 Identities=21% Similarity=0.288 Sum_probs=125.8
Q ss_pred CcceeeeecccccceEEEEEEcCCCCEEEEEeccccc------hhhHHHHHHHHhhCCCcccccccccccc---------
Q psy11767 117 DLDKAGILGDGSYSVCRRCVEKSTGQEYAVKIISRKI------DCSEEINLLRACQGHPNICRRCVEKSTG--------- 181 (966)
Q Consensus 117 df~~~~~LG~GsFGkV~La~~k~tg~~yAiKvl~K~~------~~~~E~~il~~~~~~pfi~~~~~~~~~~--------- 181 (966)
+|++++.||+|+||+|++|+++.+|+.||||++++.. ....|...+.+..+||+|++..-.....
T Consensus 26 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~~~~~lv~e~ 105 (318)
T 2dyl_A 26 DLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDVVLKSHDCPYIVQCFGTFITNTDVFIAMEL 105 (318)
T ss_dssp GEEEEEEC------CEEEEEETTTCCEEEEEEEETTSCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEECC
T ss_pred cccccceeeecCCeeEEEEEEecCCeEEEEEEecccccchHHHHHHHHHHHHHHhcCCCceeeEEEEEecCCcEEEEEec
Confidence 8899999999999999999999999999999998642 1233444444555899998621111100
Q ss_pred ---------------------hhHHHHH------HHh--hc---ccchhhhHhhhccCCceEEecCcccc----------
Q psy11767 182 ---------------------QEYAVKI------ISR--KI---DCSEEINLLRACQGHPNIVNLHCVFQ---------- 219 (966)
Q Consensus 182 ---------------------~~~~~~~------v~~--~~---~~~~e~nil~~~~gh~~iv~l~~~~~---------- 219 (966)
...+.++ +.. .+ |++++ |||.+.+|+++|+||+.+..
T Consensus 106 ~~~~~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~i~H~dlkp~-Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~ 184 (318)
T 2dyl_A 106 MGTCAEKLKKRMQGPIPERILGKMTVAIVKALYYLKEKHGVIHRDVKPS-NILLDERGQIKLCDFGISGRLVDDKAKDRS 184 (318)
T ss_dssp CSEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHHHCCCCCCCCGG-GEEECTTSCEEECCCTTC------------
T ss_pred cCCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhhCCEEeCCCCHH-HEEECCCCCEEEEECCCchhccCCcccccc
Confidence 0111111 111 11 33334 99999999999999986631
Q ss_pred --------ccccc-----cccCCCcceeeechhhHHHHHHHhhCCCCCCC-CcHHHHHHHHHhCCC-CCC--CCCCHHHH
Q psy11767 220 --------DEVID-----WDDFSRGIECVFFSSSLIIFFIILSFTLSFIH-DYYHIQYRRILKTEP-PIP--EDLSPDVA 282 (966)
Q Consensus 220 --------~e~i~-----~~~y~~~~d~~~~~~~~il~~~m~~g~~pf~~-~~~~~~~~~I~~~~~-~~P--~~~s~~a~ 282 (966)
+|++. ...|+...| .|+.|+++|+|++|.+||.. .........++.+.. .+| ..++++++
T Consensus 185 ~~~~~y~aPE~~~~~~~~~~~~~~~~D---i~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 261 (318)
T 2dyl_A 185 AGCAAYMAPERIDPPDPTKPDYDIRAD---VWSLGISLVELATGQFPYKNCKTDFEVLTKVLQEEPPLLPGHMGFSGDFQ 261 (318)
T ss_dssp --CCTTCCHHHHC--------CCTHHH---HHHHHHHHHHHHHSSCTTTTCCSHHHHHHHHHHSCCCCCCSSSCCCHHHH
T ss_pred CCCccccChhhcccccccccCCccccc---hhhHHHHHHHHHhCCCCCCCCCccHHHHHHHhccCCCCCCccCCCCHHHH
Confidence 23332 223433344 34567788888899999976 445556677776543 344 35899999
Q ss_pred HHHHhhcccCCCcccCCCCCCHHHHhcCCceeeeCc
Q psy11767 283 DFISRLLVKDPRRRLGGGELDAEELKRHPFFNVIDW 318 (966)
Q Consensus 283 dli~~LL~kdp~~RLG~~~~g~~~Ik~HpfF~~idW 318 (966)
+||.++|..||.+|. .+++|.+||||+..+.
T Consensus 262 ~li~~~l~~dp~~Rp-----s~~~ll~h~~~~~~~~ 292 (318)
T 2dyl_A 262 SFVKDCLTKDHRKRP-----KYNKLLEHSFIKRYET 292 (318)
T ss_dssp HHHHHHTCSCTTTSC-----CHHHHTTSHHHHHHHH
T ss_pred HHHHHHccCChhHCc-----CHHHHhhCHHHHhccc
Confidence 999999999999998 4899999999986643
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} | Back alignment and structure |
|---|
Probab=99.67 E-value=1e-16 Score=177.47 Aligned_cols=207 Identities=15% Similarity=0.169 Sum_probs=125.5
Q ss_pred CcceeeeecccccceEEEEEEcCCCC---EEEEEeccccc-------hhhHHHHHHHHhhCCCcccccccccccc-----
Q psy11767 117 DLDKAGILGDGSYSVCRRCVEKSTGQ---EYAVKIISRKI-------DCSEEINLLRACQGHPNICRRCVEKSTG----- 181 (966)
Q Consensus 117 df~~~~~LG~GsFGkV~La~~k~tg~---~yAiKvl~K~~-------~~~~E~~il~~~~~~pfi~~~~~~~~~~----- 181 (966)
+|.+.+.||+|+||+||+|+++.+++ .||||++++.. ...+|..+|+++ +||+|++.+-.....
T Consensus 24 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~~ 102 (323)
T 3qup_A 24 QFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEF-DHPHVAKLVGVSLRSRAKGR 102 (323)
T ss_dssp -CEEEEEEEEETTEEEEEEEC-------CEEEEEEC------CHHHHHHHHHHHHHTTC-CCTTBCCCCEEEECC-----
T ss_pred HeEEeceecccCCeEEEEEEEcccCCcceeEEEEEecccccCHHHHHHHHHHHHHHHHC-CCCceehhhceeeccccccC
Confidence 78999999999999999999988876 89999998642 357899999888 799998622111000
Q ss_pred -------------------------------------hhHHHHHHHh----------hcccchhhhHhhhccCCceEEec
Q psy11767 182 -------------------------------------QEYAVKIISR----------KIDCSEEINLLRACQGHPNIVNL 214 (966)
Q Consensus 182 -------------------------------------~~~~~~~v~~----------~~~~~~e~nil~~~~gh~~iv~l 214 (966)
...+.+++.+ ..|++++ |||.+.+|.++|+||
T Consensus 103 ~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~ivH~Dikp~-NIli~~~~~~kl~Df 181 (323)
T 3qup_A 103 LPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGMEYLSSRNFIHRDLAAR-NCMLAEDMTVCVADF 181 (323)
T ss_dssp --CEEEEEECCTTCBHHHHHHHHHC---CCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGG-GEEECTTSCEEECCC
T ss_pred CCccEEEEEeccCCcHHHHHHhhhccccccccCHHHHHHHHHHHHHHHHHHHcCCcccCCCCcc-eEEEcCCCCEEEeec
Confidence 0011112111 1144444 999999999999999
Q ss_pred Ccccc---------------------ccccccccCCCcceeeechhhHHHHHHHhh-CCCCCCCCcHHHHHHHHHhC-CC
Q psy11767 215 HCVFQ---------------------DEVIDWDDFSRGIECVFFSSSLIIFFIILS-FTLSFIHDYYHIQYRRILKT-EP 271 (966)
Q Consensus 215 ~~~~~---------------------~e~i~~~~y~~~~d~~~~~~~~il~~~m~~-g~~pf~~~~~~~~~~~I~~~-~~ 271 (966)
+.+.. +|++....|+...| .| +.|+++|+|++ |.+||...+...+++.+..+ .+
T Consensus 182 g~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~D--i~-slG~il~ell~~g~~p~~~~~~~~~~~~~~~~~~~ 258 (323)
T 3qup_A 182 GLSRKIYSGDYYRQGCASKLPVKWLALESLADNLYTVHSD--VW-AFGVTMWEIMTRGQTPYAGIENAEIYNYLIGGNRL 258 (323)
T ss_dssp CC-----------------CCGGGCCHHHHHHCCCCHHHH--HH-HHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTTCCC
T ss_pred cccccccccccccccccccCcccccCchhhcCCCCCCccc--hh-hHHHHHHHHHhCCCCCccccChHHHHHHHhcCCCC
Confidence 87632 22333333433333 44 45566666666 99999988888888888875 46
Q ss_pred CCCCCCCHHHHHHHHhhcccCCCcccCCCC--CCHHHHhcCCceeeeCccccccCCCCC
Q psy11767 272 PIPEDLSPDVADFISRLLVKDPRRRLGGGE--LDAEELKRHPFFNVIDWDDLATKRIPA 328 (966)
Q Consensus 272 ~~P~~~s~~a~dli~~LL~kdp~~RLG~~~--~g~~~Ik~HpfF~~idW~~l~~k~~~p 328 (966)
.+|..+++++.+||+++|..||.+|..... .-.+++..|||+.+..++.|....-++
T Consensus 259 ~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~l~~~~~~~~~~~pl~~~~~~~ 317 (323)
T 3qup_A 259 KQPPECMEEVYDLMYQCWSADPKQRPSFTCLRMELENILGHLSVLSTSQDPLYINIERA 317 (323)
T ss_dssp CCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHC------------------
T ss_pred CCCCccCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHHhhhcCCCCCCCCCCCCcC
Confidence 788999999999999999999999974210 126789999999998888877665444
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.67 E-value=1.6e-16 Score=178.15 Aligned_cols=187 Identities=21% Similarity=0.262 Sum_probs=130.8
Q ss_pred CcceeeeecccccceEEEEEEcCCCCEEEEEeccccc-------hhhHHHHHHHHhhCC-Ccccccccccccc-------
Q psy11767 117 DLDKAGILGDGSYSVCRRCVEKSTGQEYAVKIISRKI-------DCSEEINLLRACQGH-PNICRRCVEKSTG------- 181 (966)
Q Consensus 117 df~~~~~LG~GsFGkV~La~~k~tg~~yAiKvl~K~~-------~~~~E~~il~~~~~~-pfi~~~~~~~~~~------- 181 (966)
.|.+++.||+|+||+|++|+++ +++.||||++++.. ...+|..+|.+++.| |+|+..+..+...
T Consensus 10 ~y~i~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~~~~lv~ 88 (343)
T 3dbq_A 10 IYSILKQIGSGGSSKVFQVLNE-KKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVM 88 (343)
T ss_dssp EEEEEEEESCCSSEEEEEEECT-TSCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEE
T ss_pred EEEEEEEEecCCCeEEEEEEeC-CCCEEEEEEeeccccchHHHHHHHHHHHHHHhhhhcCCceEEEeeeEeeCCEEEEEE
Confidence 4689999999999999999985 68999999998542 346799999998754 8887622211110
Q ss_pred ----------------------hhHHHHHHHh----------hcccchhhhHhhhccCCceEEecCcccc----------
Q psy11767 182 ----------------------QEYAVKIISR----------KIDCSEEINLLRACQGHPNIVNLHCVFQ---------- 219 (966)
Q Consensus 182 ----------------------~~~~~~~v~~----------~~~~~~e~nil~~~~gh~~iv~l~~~~~---------- 219 (966)
..++.+++.+ ..|++++ |||.+ +|.++|+||+.+..
T Consensus 89 e~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~lH~~~iiHrDikp~-NIll~-~~~~kl~DFG~a~~~~~~~~~~~~ 166 (343)
T 3dbq_A 89 ECGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPA-NFLIV-DGMLKLIDFGIANQMQPDTTSVVK 166 (343)
T ss_dssp CCCSEEHHHHHHHSCCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGG-GEEEE-TTEEEECCCSSSCCC---------
T ss_pred eCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCcc-eEEEE-CCcEEEeecccccccCcccccccC
Confidence 1111222221 1244455 99886 58999999987632
Q ss_pred -----------cccccc-----------ccCCCcceeeechhhHHHHHHHhhCCCCCCCC-cHHHHHHHHHh--CCCCCC
Q psy11767 220 -----------DEVIDW-----------DDFSRGIECVFFSSSLIIFFIILSFTLSFIHD-YYHIQYRRILK--TEPPIP 274 (966)
Q Consensus 220 -----------~e~i~~-----------~~y~~~~d~~~~~~~~il~~~m~~g~~pf~~~-~~~~~~~~I~~--~~~~~P 274 (966)
+|++.. ..|+...| .|+.|+++|+|++|.+||... +....+..++. ....+|
T Consensus 167 ~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~D---iwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 243 (343)
T 3dbq_A 167 DSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSD---VWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPNHEIEFP 243 (343)
T ss_dssp ---CCCCSSCCHHHHHHCC-----------CCHHHH---HHHHHHHHHHHHHSSCTTTTCCSHHHHHHHHHCTTSCCCCC
T ss_pred CCCcCCcCcCCHHHHhhccccccccccccCCCchhh---HHHHHHHHHHHHhCCCcchhhhhHHHHHHHHhcCCcccCCc
Confidence 233321 22322233 446677888899999999763 33344555553 456789
Q ss_pred CCCCHHHHHHHHhhcccCCCcccCCCCCCHHHHhcCCcee
Q psy11767 275 EDLSPDVADFISRLLVKDPRRRLGGGELDAEELKRHPFFN 314 (966)
Q Consensus 275 ~~~s~~a~dli~~LL~kdp~~RLG~~~~g~~~Ik~HpfF~ 314 (966)
...++++++||.++|+.||.+|. .+.+|.+||||+
T Consensus 244 ~~~~~~l~~li~~~L~~dp~~Rp-----t~~e~l~hp~~~ 278 (343)
T 3dbq_A 244 DIPEKDLQDVLKCCLKRDPKQRI-----SIPELLAHPYVQ 278 (343)
T ss_dssp CCSCHHHHHHHHHHTCSSTTTSC-----CHHHHHTSHHHH
T ss_pred ccCCHHHHHHHHHHcCCChhHCC-----CHHHHHhCcccc
Confidence 99999999999999999999998 489999999996
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* | Back alignment and structure |
|---|
Probab=99.66 E-value=8e-17 Score=177.76 Aligned_cols=191 Identities=18% Similarity=0.192 Sum_probs=137.6
Q ss_pred CcceeeeecccccceEEEEEEcCCCCEEEEEeccccc--------hhhHHHHHHHHhhCCCccccccccc----------
Q psy11767 117 DLDKAGILGDGSYSVCRRCVEKSTGQEYAVKIISRKI--------DCSEEINLLRACQGHPNICRRCVEK---------- 178 (966)
Q Consensus 117 df~~~~~LG~GsFGkV~La~~k~tg~~yAiKvl~K~~--------~~~~E~~il~~~~~~pfi~~~~~~~---------- 178 (966)
+|++.+.||+|+||+|++|+++.+|+.||||++++.. ...+|..+|.++ +||+|++.+-..
T Consensus 13 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~hp~iv~~~~~~~~~~~~~~~~ 91 (311)
T 3ork_A 13 RYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAAL-NHPAIVAVYDTGEAETPAGPLP 91 (311)
T ss_dssp TEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECTTTTTSHHHHHHHHHHHTTCCCC-CCTTBCCEEEEEEEEETTEEEE
T ss_pred cEEEEEEEccCCCEEEEEEEECCCCceEEEEEeCccccCCHHHHHHHHHHHHHHHcC-CCCCcceEEEeeeccCCCCccc
Confidence 5699999999999999999999999999999998642 245677777777 699998722111
Q ss_pred ----ccc--------------------hhHHHHHHHh----------hcccchhhhHhhhccCCceEEecCcccc-----
Q psy11767 179 ----STG--------------------QEYAVKIISR----------KIDCSEEINLLRACQGHPNIVNLHCVFQ----- 219 (966)
Q Consensus 179 ----~~~--------------------~~~~~~~v~~----------~~~~~~e~nil~~~~gh~~iv~l~~~~~----- 219 (966)
+.. ...+.+++.+ ..|++++ |||.+.+|+++|+||+.+..
T Consensus 92 ~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~-Nil~~~~~~~kl~Dfg~a~~~~~~~ 170 (311)
T 3ork_A 92 YIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQALNFSHQNGIIHRDVKPA-NIMISATNAVKVMDFGIARAIADSG 170 (311)
T ss_dssp EEEEECCCEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGG-GEEEETTSCEEECCCSCC-------
T ss_pred EEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCCcCCCCHH-HEEEcCCCCEEEeeccCcccccccc
Confidence 100 0001111111 0134444 99999999999999987632
Q ss_pred -----------------ccccccccCCCcceeeechhhHHHHHHHhhCCCCCCCCcHHHHHHHHHhCCCCCC----CCCC
Q psy11767 220 -----------------DEVIDWDDFSRGIECVFFSSSLIIFFIILSFTLSFIHDYYHIQYRRILKTEPPIP----EDLS 278 (966)
Q Consensus 220 -----------------~e~i~~~~y~~~~d~~~~~~~~il~~~m~~g~~pf~~~~~~~~~~~I~~~~~~~P----~~~s 278 (966)
+|++....|+...| .|+.|+++|+|++|.+||...+...+...++...+..| ..++
T Consensus 171 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~D---i~slG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 247 (311)
T 3ork_A 171 NSVTQTAAVIGTAQYLSPEQARGDSVDARSD---VYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVREDPIPPSARHEGLS 247 (311)
T ss_dssp -----------CCTTCCHHHHHTCCCCHHHH---HHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHCCCCCHHHHSTTCC
T ss_pred cccccccccCcCcccCCHHHhcCCCCCchHh---HHHHHHHHHHHHhCCCCCCCCChHHHHHHHhcCCCCCcccccCCCC
Confidence 23333334443333 44677888889999999999888887777777766554 4689
Q ss_pred HHHHHHHHhhcccCCCcccCCCCCCHHHHhcCCceeeeC
Q psy11767 279 PDVADFISRLLVKDPRRRLGGGELDAEELKRHPFFNVID 317 (966)
Q Consensus 279 ~~a~dli~~LL~kdp~~RLG~~~~g~~~Ik~HpfF~~id 317 (966)
+++.+||.++|.+||.+|.. ..++..|+|++..+
T Consensus 248 ~~l~~li~~~l~~dP~~R~~-----~~~~l~~~l~~~~~ 281 (311)
T 3ork_A 248 ADLDAVVLKALAKNPENRYQ-----TAAEMRADLVRVHN 281 (311)
T ss_dssp HHHHHHHHHHTCSSGGGSCS-----SHHHHHHHHHHHHT
T ss_pred HHHHHHHHHHHhcCHhhChh-----hHHHHHHHHHHHhc
Confidence 99999999999999999985 56888899887543
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} | Back alignment and structure |
|---|
Probab=99.66 E-value=1.3e-16 Score=187.79 Aligned_cols=213 Identities=17% Similarity=0.125 Sum_probs=139.1
Q ss_pred CcceeeeecccccceEEEEEEcCCCCEEEEEecccc---chhhHHHHHHHHhhCCCcccccc------------------
Q psy11767 117 DLDKAGILGDGSYSVCRRCVEKSTGQEYAVKIISRK---IDCSEEINLLRACQGHPNICRRC------------------ 175 (966)
Q Consensus 117 df~~~~~LG~GsFGkV~La~~k~tg~~yAiKvl~K~---~~~~~E~~il~~~~~~pfi~~~~------------------ 175 (966)
+|.++++||+|+||.||+|+++.+|+.||||++++. .....|.++|+.++.++.+....
T Consensus 8 ~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~~~~~~E~~il~~L~~~~~i~~i~~~~~~~~~~~lvme~~g~ 87 (483)
T 3sv0_A 8 KFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLLYESKIYRILQGGTGIPNVRWFGVEGDYNVLVMDLLGP 87 (483)
T ss_dssp TEECCCCCEECSSCEEEEEEETTTCCEEEEEEEETTCSSCCHHHHHHHHHHTTTSTTCCCEEEEEEETTEEEEEEECCCC
T ss_pred cEEEEEEEeeCCCEEEEEEEECCCCcEEEEEEeccccccHHHHHHHHHHHHhcCCCCCCeEEEEEeeCCEEEEEEECCCC
Confidence 679999999999999999999999999999998854 35688999999998777664310
Q ss_pred ------------cccccchhHHHHHHHh----------hcccchhhhHhh---hccCCceEEecCcccc-----------
Q psy11767 176 ------------VEKSTGQEYAVKIISR----------KIDCSEEINLLR---ACQGHPNIVNLHCVFQ----------- 219 (966)
Q Consensus 176 ------------~~~~~~~~~~~~~v~~----------~~~~~~e~nil~---~~~gh~~iv~l~~~~~----------- 219 (966)
+.......++.+++.+ ..|++++ |||+ +.+|+++|+||+.+..
T Consensus 88 sL~~ll~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~-NILl~~~~~~~~vkL~DFGla~~~~~~~~~~~~~ 166 (483)
T 3sv0_A 88 SLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPD-NFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIP 166 (483)
T ss_dssp BHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGG-GEEECCGGGTTCEEECCCTTCEECBCTTTCCBCC
T ss_pred CHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccCcc-eEEEecCCCCCeEEEEeCCcceeccCCccccccc
Confidence 0111111122222222 1245555 9998 6789999999997632
Q ss_pred ---------------ccccccccCCCcceeeechhhHHHHHHHhhCCCCCCC---CcHHHHHHHHHhCCC-----CCCCC
Q psy11767 220 ---------------DEVIDWDDFSRGIECVFFSSSLIIFFIILSFTLSFIH---DYYHIQYRRILKTEP-----PIPED 276 (966)
Q Consensus 220 ---------------~e~i~~~~y~~~~d~~~~~~~~il~~~m~~g~~pf~~---~~~~~~~~~I~~~~~-----~~P~~ 276 (966)
+|++....|+...| +|+.|+++|+|++|.+||.. ......+++|....+ .++..
T Consensus 167 ~~~~~~~~gt~~Y~aPE~~~~~~~s~~sD---vwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~~~ 243 (483)
T 3sv0_A 167 YRENKNLTGTARYASVNTHLGIEQSRRDD---LESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVATSIEALCRG 243 (483)
T ss_dssp CCCCCCCCSCTTTCCHHHHTTCCCCHHHH---HHHHHHHHHHHHHSSCTTSSCCCSSHHHHHHHHHHHHHHSCHHHHHTT
T ss_pred cccccccCCCccccCHHHhcCCCCChHHH---HHHHHHHHHHHHhCCCCCccccchhHHHHHHHHhhccccccHHHHhcC
Confidence 12222223332233 45667788888999999975 344455666665433 23367
Q ss_pred CCHHHHHHHHhhcccCCCcccCCCC-----CCHHHHhcCCceeeeCccccccCCCCCCCCcc
Q psy11767 277 LSPDVADFISRLLVKDPRRRLGGGE-----LDAEELKRHPFFNVIDWDDLATKRIPAPFVPK 333 (966)
Q Consensus 277 ~s~~a~dli~~LL~kdp~~RLG~~~-----~g~~~Ik~HpfF~~idW~~l~~k~~~pP~~P~ 333 (966)
+++++.+||.++|..||.+|..... ...-..+.|+||..+||+.+..++..+|..|.
T Consensus 244 ~p~~l~~li~~cl~~dP~~RPs~~el~~~L~~l~~~~~~~~~~~~dW~~~~~~~~~~~~~p~ 305 (483)
T 3sv0_A 244 YPTEFASYFHYCRSLRFDDKPDYSYLKRLFRDLFIREGFQFDYVFDWTILKYQQSQIASAPP 305 (483)
T ss_dssp SCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHHHHTTCCCSSCCHHHHHTC----------
T ss_pred CcHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHHHcCCCccCCcCchhhccccccccCCCC
Confidence 8899999999999999999985210 01112356999999999999888877776654
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* | Back alignment and structure |
|---|
Probab=99.66 E-value=4.4e-16 Score=170.72 Aligned_cols=189 Identities=22% Similarity=0.243 Sum_probs=138.8
Q ss_pred CcceeeeecccccceEEEEEEcCCCCEEEEEecccc------chhhHHHHHHHHhhCCCcccccccccccc---------
Q psy11767 117 DLDKAGILGDGSYSVCRRCVEKSTGQEYAVKIISRK------IDCSEEINLLRACQGHPNICRRCVEKSTG--------- 181 (966)
Q Consensus 117 df~~~~~LG~GsFGkV~La~~k~tg~~yAiKvl~K~------~~~~~E~~il~~~~~~pfi~~~~~~~~~~--------- 181 (966)
.|.+++.||+|+||+|++|+++.+|+.||||++++. ....+|..+|+++ +||+|+..+-.....
T Consensus 23 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~ 101 (303)
T 3a7i_A 23 LFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQC-DSPYVTKYYGSYLKDTKLWIIMEY 101 (303)
T ss_dssp TEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEETTTCSTTHHHHHHHHHHHHHC-CCTTBCCEEEEEEETTEEEEEEEC
T ss_pred HHHHhhhhcccCCeEEEEEEECCCCcEEEEEEecccccHHHHHHHHHHHHHHHhC-CCCCEeEEEEEEecCCeEEEEEEe
Confidence 468999999999999999999999999999999754 2357788999887 799998622111110
Q ss_pred --------------------hhHHHHHHHh-------h---cccchhhhHhhhccCCceEEecCcccc------------
Q psy11767 182 --------------------QEYAVKIISR-------K---IDCSEEINLLRACQGHPNIVNLHCVFQ------------ 219 (966)
Q Consensus 182 --------------------~~~~~~~v~~-------~---~~~~~e~nil~~~~gh~~iv~l~~~~~------------ 219 (966)
...+.+++.+ . .|++++ |||.+.+|.++|+||+.+..
T Consensus 102 ~~~~~L~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~-Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~ 180 (303)
T 3a7i_A 102 LGGGSALDLLEPGPLDETQIATILREILKGLDYLHSEKKIHRDIKAA-NVLLSEHGEVKLADFGVAGQLTDTQIKRNTFV 180 (303)
T ss_dssp CTTEEHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGG-GEEECTTSCEEECCCTTCEECBTTBCCBCCCC
T ss_pred CCCCcHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCChh-eEEECCCCCEEEeecccceecCccccccCccC
Confidence 0111122111 0 133334 99999999999999986632
Q ss_pred -------ccccccccCCCcceeeechhhHHHHHHHhhCCCCCCCCcHHHHHHHHHhC-CCCCCCCCCHHHHHHHHhhccc
Q psy11767 220 -------DEVIDWDDFSRGIECVFFSSSLIIFFIILSFTLSFIHDYYHIQYRRILKT-EPPIPEDLSPDVADFISRLLVK 291 (966)
Q Consensus 220 -------~e~i~~~~y~~~~d~~~~~~~~il~~~m~~g~~pf~~~~~~~~~~~I~~~-~~~~P~~~s~~a~dli~~LL~k 291 (966)
+|++....|+...| .|+.|+++|+|++|.+||...+.......|..+ .+.++..+++++++||.++|..
T Consensus 181 ~~~~y~aPE~~~~~~~~~~~D---i~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~ 257 (303)
T 3a7i_A 181 GTPFWMAPEVIKQSAYDSKAD---IWSLGITAIELARGEPPHSELHPMKVLFLIPKNNPPTLEGNYSKPLKEFVEACLNK 257 (303)
T ss_dssp SCGGGCCHHHHTTCCBCTHHH---HHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCCCCSSCCHHHHHHHHHHCCS
T ss_pred CCcCccCHHHHhcCCCCchhh---hHHHHHHHHHHccCCCCCCCcCHHHHHHHhhcCCCCCCccccCHHHHHHHHHHcCC
Confidence 23333334444444 346678888899999999988777777777654 4567888999999999999999
Q ss_pred CCCcccCCCCCCHHHHhcCCceee
Q psy11767 292 DPRRRLGGGELDAEELKRHPFFNV 315 (966)
Q Consensus 292 dp~~RLG~~~~g~~~Ik~HpfF~~ 315 (966)
||.+|. .+++|.+||||..
T Consensus 258 dp~~Rp-----s~~~ll~~~~~~~ 276 (303)
T 3a7i_A 258 EPSFRP-----TAKELLKHKFILR 276 (303)
T ss_dssp SGGGSC-----CHHHHTTCHHHHH
T ss_pred ChhhCc-----CHHHHhhChhhhc
Confidence 999998 4899999999964
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* | Back alignment and structure |
|---|
Probab=99.66 E-value=7.9e-17 Score=175.96 Aligned_cols=198 Identities=20% Similarity=0.254 Sum_probs=117.5
Q ss_pred CcceeeeecccccceEEEEEEcCCCCEEEEEeccccc------hhhHHHHHHHHhhCCCcccccccccccc---------
Q psy11767 117 DLDKAGILGDGSYSVCRRCVEKSTGQEYAVKIISRKI------DCSEEINLLRACQGHPNICRRCVEKSTG--------- 181 (966)
Q Consensus 117 df~~~~~LG~GsFGkV~La~~k~tg~~yAiKvl~K~~------~~~~E~~il~~~~~~pfi~~~~~~~~~~--------- 181 (966)
+|.+.++||+|+||.|++|+++.+|+.||||+++... ...+|..+|+++ +||+|++.+..+...
T Consensus 16 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~ 94 (303)
T 2vwi_A 16 DYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQC-HHPNIVSYYTSFVVKDELWLVMKL 94 (303)
T ss_dssp CCEEEEECC---CCCEEEEEC----CEEEEECCC----------------CCCCC-CCTTBCCEEEEEESSSCEEEEEEC
T ss_pred hhhhhheeccccceEEEEEEECCCCcEEEEEEEEhhhcchhHHHHHHHHHHHhhc-CCCCEeeEEEEEeecCCcEEEehh
Confidence 7899999999999999999999999999999997542 345677777777 699998622111100
Q ss_pred -----------------------------hhHHHHHHHh-------h---cccchhhhHhhhccCCceEEecCccc----
Q psy11767 182 -----------------------------QEYAVKIISR-------K---IDCSEEINLLRACQGHPNIVNLHCVF---- 218 (966)
Q Consensus 182 -----------------------------~~~~~~~v~~-------~---~~~~~e~nil~~~~gh~~iv~l~~~~---- 218 (966)
...+.+++.+ . .|++++ |||.+.+|.++|.||+.+.
T Consensus 95 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dl~p~-Nil~~~~~~~kl~dfg~~~~~~~ 173 (303)
T 2vwi_A 95 LSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHKNGQIHRDVKAG-NILLGEDGSVQIADFGVSAFLAT 173 (303)
T ss_dssp CTTCBHHHHHHHHHHTTTTTTCSSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGG-GEEECTTCCEEECCCHHHHHCC-
T ss_pred ccCCchHHHHHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCCCCChh-hEEEcCCCCEEEEeccchheecc
Confidence 0011111111 0 133334 9999999999999987542
Q ss_pred --------------------ccccccc-ccCCCcceeeechhhHHHHHHHhhCCCCCCCCcHHHHHHHHHhCCC------
Q psy11767 219 --------------------QDEVIDW-DDFSRGIECVFFSSSLIIFFIILSFTLSFIHDYYHIQYRRILKTEP------ 271 (966)
Q Consensus 219 --------------------~~e~i~~-~~y~~~~d~~~~~~~~il~~~m~~g~~pf~~~~~~~~~~~I~~~~~------ 271 (966)
.+|++.. ..|+...| .|+.|+++|+|++|.+||...+....+..++.+.+
T Consensus 174 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~D---i~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 250 (303)
T 2vwi_A 174 GGDITRNKVRKTFVGTPCWMAPEVMEQVRGYDFKAD---IWSFGITAIELATGAAPYHKYPPMKVLMLTLQNDPPSLETG 250 (303)
T ss_dssp --------------CCCTTCCHHHHHHHHCCCTHHH---HHHHHHHHHHHHHSSCTTTTSCGGGHHHHHHTSSCCCTTC-
T ss_pred CCCccchhhhcccCCCccccCHHHhccccCCCchhh---HHHHHHHHHHHHhCCCCCccCchhhHHHHHhccCCCccccc
Confidence 1233322 23444444 34567888889999999987665554455544322
Q ss_pred ----CCCCCCCHHHHHHHHhhcccCCCcccCCCCCCHHHHhcCCceeeeCccccccC
Q psy11767 272 ----PIPEDLSPDVADFISRLLVKDPRRRLGGGELDAEELKRHPFFNVIDWDDLATK 324 (966)
Q Consensus 272 ----~~P~~~s~~a~dli~~LL~kdp~~RLG~~~~g~~~Ik~HpfF~~idW~~l~~k 324 (966)
.++..++++.++||.++|..||.+|. .+.+|.+||||+...+..+.++
T Consensus 251 ~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp-----s~~~ll~h~~~~~~~~~~~~q~ 302 (303)
T 2vwi_A 251 VQDKEMLKKYGKSFRKMISLCLQKDPEKRP-----TAAELLRHKFFQKAKNKEFLQE 302 (303)
T ss_dssp ----CCCCCCCHHHHHHHHHHCCSSGGGSC-----CHHHHHTSTTC-----------
T ss_pred cccchhhhhhhHHHHHHHHHHccCChhhCc-----CHHHHhhChhhhcCCCCccccc
Confidence 23456789999999999999999998 4899999999999988776554
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A | Back alignment and structure |
|---|
Probab=99.66 E-value=1.6e-16 Score=173.12 Aligned_cols=195 Identities=19% Similarity=0.257 Sum_probs=135.4
Q ss_pred CcceeeeecccccceEEEEEEcCCCCEEEEEeccccc----hhhHHHHHHHHhhCCCcccccccccc-------------
Q psy11767 117 DLDKAGILGDGSYSVCRRCVEKSTGQEYAVKIISRKI----DCSEEINLLRACQGHPNICRRCVEKS------------- 179 (966)
Q Consensus 117 df~~~~~LG~GsFGkV~La~~k~tg~~yAiKvl~K~~----~~~~E~~il~~~~~~pfi~~~~~~~~------------- 179 (966)
+|++++.||+|+||.|++|+++.+|+.||||++++.. ...+|..+|+++ +||+|++.+....
T Consensus 7 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~~~~~~~~~~~~~ 85 (303)
T 1zy4_A 7 DFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHTEEKLSTILSEVMLLASL-NHQYVVRYYAAWLERRNFVKPMTAVK 85 (303)
T ss_dssp HEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEEEHHHHHHHHHHHHHHTTC-CCTTBCCEEEEEEECCCCCC------
T ss_pred cchhhheeccCCcEEEEEEEEcCCCeEEEEEEEeccHHHHHHHHHHHHHHHhc-CchHHHHHHHHHHhhcchhhhhcccc
Confidence 5699999999999999999999999999999998642 356799999888 6999976321100
Q ss_pred ----------c--c---h----------------hHHHHHHHh-------h---cccchhhhHhhhccCCceEEecCccc
Q psy11767 180 ----------T--G---Q----------------EYAVKIISR-------K---IDCSEEINLLRACQGHPNIVNLHCVF 218 (966)
Q Consensus 180 ----------~--~---~----------------~~~~~~v~~-------~---~~~~~e~nil~~~~gh~~iv~l~~~~ 218 (966)
. . . ..+.+++.+ . .|++++ |||.+.+|.++|.||+.+.
T Consensus 86 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dlkp~-Nil~~~~~~~kl~dfg~~~ 164 (303)
T 1zy4_A 86 KKSTLFIQMEYCENGTLYDLIHSENLNQQRDEYWRLFRQILEALSYIHSQGIIHRDLKPM-NIFIDESRNVKIGDFGLAK 164 (303)
T ss_dssp CEEEEEEEEECCCSCBHHHHHHHSCGGGCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGG-GEEECTTSCEEECCCCCCS
T ss_pred cCCceEEEEecCCCCCHHHhhhccccccchHHHHHHHHHHHHHHHHHHhCCeecccCCHH-hEEEcCCCCEEEeeCcchh
Confidence 0 0 0 001111111 0 133334 9999999999999998653
Q ss_pred c---------------------------------ccccccc-cCCCcceeeechhhHHHHHHHhhCCCCCC-CCcHHHHH
Q psy11767 219 Q---------------------------------DEVIDWD-DFSRGIECVFFSSSLIIFFIILSFTLSFI-HDYYHIQY 263 (966)
Q Consensus 219 ~---------------------------------~e~i~~~-~y~~~~d~~~~~~~~il~~~m~~g~~pf~-~~~~~~~~ 263 (966)
. +|++... .|+...| .| +.|+++|+|++ ||. ..+...++
T Consensus 165 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~D--i~-slG~il~~l~~---p~~~~~~~~~~~ 238 (303)
T 1zy4_A 165 NVHRSLDILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKID--MY-SLGIIFFEMIY---PFSTGMERVNIL 238 (303)
T ss_dssp CTTC-------------------------CTTSCHHHHTSCSCCCTHHH--HH-HHHHHHHHHHS---CCSSHHHHHHHH
T ss_pred hcccccchhccccccccccccccccCCCcccccCcccccCCCCCcchhh--HH-HHHHHHHHHHh---ccCCchhHHHHH
Confidence 2 2333222 2433333 34 45566677766 444 44555667
Q ss_pred HHHHhCCCCCCCC----CCHHHHHHHHhhcccCCCcccCCCCCCHHHHhcCCceeeeCccccccC
Q psy11767 264 RRILKTEPPIPED----LSPDVADFISRLLVKDPRRRLGGGELDAEELKRHPFFNVIDWDDLATK 324 (966)
Q Consensus 264 ~~I~~~~~~~P~~----~s~~a~dli~~LL~kdp~~RLG~~~~g~~~Ik~HpfF~~idW~~l~~k 324 (966)
+++......+|.. .++.+++||+++|..||.+|. .+.+|.+||||....|+...++
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp-----s~~~ll~h~~~~~~~~~~~~~~ 298 (303)
T 1zy4_A 239 KKLRSVSIEFPPDFDDNKMKVEKKIIRLLIDHDPNKRP-----GARTLLNSGWLPVKHQDEVIKE 298 (303)
T ss_dssp HHHHSTTCCCCTTCCTTTSHHHHHHHHHHTCSSGGGSC-----CHHHHHHSSCSCCCCHHHHHHH
T ss_pred HhccccccccCccccccchHHHHHHHHHHHhcCcccCc-----CHHHHhCCCCcCCCChHHHHHH
Confidence 8888777766654 456789999999999999998 4899999999998888765543
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} PDB: 3fpq_A | Back alignment and structure |
|---|
Probab=99.65 E-value=6.6e-16 Score=168.22 Aligned_cols=187 Identities=18% Similarity=0.275 Sum_probs=133.5
Q ss_pred cceeeeecccccceEEEEEEcCCCCEEEEEeccccc-------hhhHHHHHHHHhhCCCccccccccccc----------
Q psy11767 118 LDKAGILGDGSYSVCRRCVEKSTGQEYAVKIISRKI-------DCSEEINLLRACQGHPNICRRCVEKST---------- 180 (966)
Q Consensus 118 f~~~~~LG~GsFGkV~La~~k~tg~~yAiKvl~K~~-------~~~~E~~il~~~~~~pfi~~~~~~~~~---------- 180 (966)
|.+.+.||+|+||.|++|+++.++..||+|++++.. ...+|..+|+++ +||+|++.+-.+..
T Consensus 28 ~~~~~~lg~G~~g~Vy~~~~~~~~~~va~k~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~~~~~l 106 (290)
T 1t4h_A 28 LKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGL-QHPNIVRFYDSWESTVKGKKCIVL 106 (290)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTC-CCTTBCCEEEEEEEESSSCEEEEE
T ss_pred EEeeeeccCCCCeEEEEeEecCCceEEEEEEecchhhCHHHHHHHHHHHHHHHhC-CCCCeeeeeeeeccccCCCceEEE
Confidence 578889999999999999999999999999998642 346788999888 69999863211100
Q ss_pred ------c------------------hhHHHHHHHh-------h--c---ccchhhhHhhh-ccCCceEEecCccc-----
Q psy11767 181 ------G------------------QEYAVKIISR-------K--I---DCSEEINLLRA-CQGHPNIVNLHCVF----- 218 (966)
Q Consensus 181 ------~------------------~~~~~~~v~~-------~--~---~~~~e~nil~~-~~gh~~iv~l~~~~----- 218 (966)
. ...+.+++.+ . + |+++ .|||.+ .+|.++|.||+.+.
T Consensus 107 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~i~H~dikp-~Nil~~~~~~~~kl~Dfg~~~~~~~~ 185 (290)
T 1t4h_A 107 VTELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKC-DNIFITGPTGSVKIGDLGLATLKRAS 185 (290)
T ss_dssp EEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTSSSCCCCSCCCG-GGEEESSTTSCEEECCTTGGGGCCTT
T ss_pred EEEecCCCCHHHHHHHccCCCHHHHHHHHHHHHHHHHHHHcCCCCEEECCCCH-HHEEEECCCCCEEEeeCCCccccccc
Confidence 0 0001111111 1 1 3333 399887 67899999998663
Q ss_pred ------------cccccccccCCCcceeeechhhHHHHHHHhhCCCCCCC-CcHHHHHHHHHhCC--CCCCCCCCHHHHH
Q psy11767 219 ------------QDEVIDWDDFSRGIECVFFSSSLIIFFIILSFTLSFIH-DYYHIQYRRILKTE--PPIPEDLSPDVAD 283 (966)
Q Consensus 219 ------------~~e~i~~~~y~~~~d~~~~~~~~il~~~m~~g~~pf~~-~~~~~~~~~I~~~~--~~~P~~~s~~a~d 283 (966)
.+|++. ..|+...| .|+.|+++|+|++|.+||.. .+...+++.+..+. ..+|...++++++
T Consensus 186 ~~~~~~~t~~y~aPE~~~-~~~~~~~D---i~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 261 (290)
T 1t4h_A 186 FAKAVIGTPEFMAPEMYE-EKYDESVD---VYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVKPASFDKVAIPEVKE 261 (290)
T ss_dssp SBEESCSSCCCCCGGGGG-TCCCTHHH---HHHHHHHHHHHHHSSCTTTTCSSHHHHHHHHTTTCCCGGGGGCCCHHHHH
T ss_pred ccccccCCcCcCCHHHHh-ccCCCcch---HHHHHHHHHHHHhCCCCCCCcCcHHHHHHHHhccCCccccCCCCCHHHHH
Confidence 234443 23444444 44667888888889989876 56666677777653 3467788899999
Q ss_pred HHHhhcccCCCcccCCCCCCHHHHhcCCceee
Q psy11767 284 FISRLLVKDPRRRLGGGELDAEELKRHPFFNV 315 (966)
Q Consensus 284 li~~LL~kdp~~RLG~~~~g~~~Ik~HpfF~~ 315 (966)
||+++|..||.+|. .+.+|.+||||++
T Consensus 262 li~~~l~~dp~~Rp-----s~~ell~h~~f~~ 288 (290)
T 1t4h_A 262 IIEGCIRQNKDERY-----SIKDLLNHAFFQE 288 (290)
T ss_dssp HHHHHSCSSGGGSC-----CHHHHHTSGGGC-
T ss_pred HHHHHccCChhhCC-----CHHHHhhCccccc
Confidence 99999999999998 4899999999975
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.65 E-value=1.7e-16 Score=179.91 Aligned_cols=207 Identities=16% Similarity=0.151 Sum_probs=142.2
Q ss_pred CcceeeeecccccceEEEEE-----EcCCCCEEEEEeccccc------hhhHHHHHHHHhhCCCcccccccccccc----
Q psy11767 117 DLDKAGILGDGSYSVCRRCV-----EKSTGQEYAVKIISRKI------DCSEEINLLRACQGHPNICRRCVEKSTG---- 181 (966)
Q Consensus 117 df~~~~~LG~GsFGkV~La~-----~k~tg~~yAiKvl~K~~------~~~~E~~il~~~~~~pfi~~~~~~~~~~---- 181 (966)
+|.+++.||+|+||+|++|+ +..+++.||||++++.. ...+|..+|+++ +||+|++..-.+...
T Consensus 72 ~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~hpnIv~~~~~~~~~~~~~ 150 (367)
T 3l9p_A 72 NITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKF-NHQNIVRCIGVSLQSLPRF 150 (367)
T ss_dssp GEEEEEECCCCSSSCEEEEEECC-----CCEEEEEEECCSSCCHHHHHHHHHHHHHHHHC-CCTTBCCEEEEECSSSSCE
T ss_pred HeEEeeEeeeCCCEEEEEEEEccCCCCCcceeEEEEecccccChhhHHHHHHHHHHHHhC-CCCCCCeEEEEEecCCCCE
Confidence 67999999999999999999 56688899999997531 356789999888 699998621111110
Q ss_pred ---------------------------------hhHHHHHHHh----------hcccchhhhHhhhccCC---ceEEecC
Q psy11767 182 ---------------------------------QEYAVKIISR----------KIDCSEEINLLRACQGH---PNIVNLH 215 (966)
Q Consensus 182 ---------------------------------~~~~~~~v~~----------~~~~~~e~nil~~~~gh---~~iv~l~ 215 (966)
..++.+++.+ ..|++++ |||.+.+|. ++|+||+
T Consensus 151 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~-NIll~~~~~~~~~kL~DFG 229 (367)
T 3l9p_A 151 ILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENHFIHRDIAAR-NCLLTCPGPGRVAKIGDFG 229 (367)
T ss_dssp EEEECCTTEEHHHHHHHHSCCSSSCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGG-GEEESCSSTTCCEEECCCH
T ss_pred EEEEeCCCCCHHHHHHhhccccCccccccHHHHHHHHHHHHHHHHHHHhCCeeCCCCChh-hEEEecCCCCceEEECCCc
Confidence 0111122211 1245555 999986665 8999988
Q ss_pred ccc---------------------cccccccccCCCcceeeechhhHHHHHHHhh-CCCCCCCCcHHHHHHHHHhCC-CC
Q psy11767 216 CVF---------------------QDEVIDWDDFSRGIECVFFSSSLIIFFIILS-FTLSFIHDYYHIQYRRILKTE-PP 272 (966)
Q Consensus 216 ~~~---------------------~~e~i~~~~y~~~~d~~~~~~~~il~~~m~~-g~~pf~~~~~~~~~~~I~~~~-~~ 272 (966)
.+. .+|++....|+...| +|+.|+++|+|++ |.+||...+...+++.|..+. +.
T Consensus 230 ~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~D---vwslG~il~ellt~g~~pf~~~~~~~~~~~i~~~~~~~ 306 (367)
T 3l9p_A 230 MARDIYRAGYYRKGGCAMLPVKWMPPEAFMEGIFTSKTD---TWSFGVLLWEIFSLGYMPYPSKSNQEVLEFVTSGGRMD 306 (367)
T ss_dssp HHHHHHHHSSCTTCCGGGSCGGGCCHHHHHHCCCCHHHH---HHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHTTCCCC
T ss_pred cccccccccccccCCCcCCcccEECHHHhcCCCCCcHHH---HHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCC
Confidence 652 234444445554444 4456677777775 999999999988899988764 66
Q ss_pred CCCCCCHHHHHHHHhhcccCCCcccCCCCCCHHHHhcCCceeeeCccccccCCCCCCCCccc
Q psy11767 273 IPEDLSPDVADFISRLLVKDPRRRLGGGELDAEELKRHPFFNVIDWDDLATKRIPAPFVPKI 334 (966)
Q Consensus 273 ~P~~~s~~a~dli~~LL~kdp~~RLG~~~~g~~~Ik~HpfF~~idW~~l~~k~~~pP~~P~i 334 (966)
.|..+++++.+||+++|+.||.+|. .+.+|.+|.++-.-+.+. ....+++.+.|..
T Consensus 307 ~~~~~~~~l~~li~~~l~~dP~~Rp-----s~~eil~~l~~~~~~~~~-~~~~~p~~~~~~~ 362 (367)
T 3l9p_A 307 PPKNCPGPVYRIMTQCWQHQPEDRP-----NFAIILERIEYCTQDPDV-INTALPIEYGPLV 362 (367)
T ss_dssp CCTTCCHHHHHHHHHHTCSSGGGSC-----CHHHHHHHHHHHHHCHHH-HTCCCCCC-----
T ss_pred CCccCCHHHHHHHHHHcCCCHhHCc-----CHHHHHHHHHHHhhChhh-ccCCCccccCCch
Confidence 7889999999999999999999997 489999998886555433 3334444454443
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.64 E-value=5.7e-16 Score=170.54 Aligned_cols=188 Identities=22% Similarity=0.360 Sum_probs=132.3
Q ss_pred CCcceeeeecccccceEEEEEEcCCCCEEEEEeccccc-----------hhhHHHHHHHHhh---CCCcccccccccccc
Q psy11767 116 MDLDKAGILGDGSYSVCRRCVEKSTGQEYAVKIISRKI-----------DCSEEINLLRACQ---GHPNICRRCVEKSTG 181 (966)
Q Consensus 116 ~df~~~~~LG~GsFGkV~La~~k~tg~~yAiKvl~K~~-----------~~~~E~~il~~~~---~~pfi~~~~~~~~~~ 181 (966)
-+|.+.+.||+|+||.||+|+++.+|+.||||++++.. ....|..+|.++. +||+|+...-.+...
T Consensus 31 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~h~~i~~~~~~~~~~ 110 (312)
T 2iwi_A 31 AEYRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHPGVIRLLDWFETQ 110 (312)
T ss_dssp --CEEEEEEEEETTEEEEEEECTTTCCEEEEEECCSTTTC--------CCCCHHHHHHHHHHSSCCCSSBCCEEEEC---
T ss_pred hceEEeeEEEcCCCEEEEEEEEccCCeEEEEEEEecccccccccchhhHHHHHHHHHHHhhcccCCCCCeeeEEEEEecC
Confidence 36799999999999999999999999999999997642 3456899998876 799998621111100
Q ss_pred -------------------------------hhHHHHHHHh----------hcccchhhhHhhh-ccCCceEEecCcccc
Q psy11767 182 -------------------------------QEYAVKIISR----------KIDCSEEINLLRA-CQGHPNIVNLHCVFQ 219 (966)
Q Consensus 182 -------------------------------~~~~~~~v~~----------~~~~~~e~nil~~-~~gh~~iv~l~~~~~ 219 (966)
...+.+++.+ ..|++.+ |||.+ .+|.++|+||+.+..
T Consensus 111 ~~~~~v~e~~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~-Nil~~~~~~~~kl~dfg~~~~ 189 (312)
T 2iwi_A 111 EGFMLVLERPLPAQDLFDYITEKGPLGEGPSRCFFGQVVAAIQHCHSRGVVHRDIKDE-NILIDLRRGCAKLIDFGSGAL 189 (312)
T ss_dssp --CEEEEECCSSEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHHTEECCCCSGG-GEEEETTTTEEEECCCSSCEE
T ss_pred CeEEEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCChh-hEEEeCCCCeEEEEEcchhhh
Confidence 0011111111 0133334 89988 678999999986532
Q ss_pred -----------------ccccccccCCCcceeeechhhHHHHHHHhhCCCCCCCCcHHHHHHHHHhCCCCCCCCCCHHHH
Q psy11767 220 -----------------DEVIDWDDFSRGIECVFFSSSLIIFFIILSFTLSFIHDYYHIQYRRILKTEPPIPEDLSPDVA 282 (966)
Q Consensus 220 -----------------~e~i~~~~y~~~~d~~~~~~~~il~~~m~~g~~pf~~~~~~~~~~~I~~~~~~~P~~~s~~a~ 282 (966)
+|++....+. +...| .|+.|+++|+|++|.+||... +.+....+.+|..++++++
T Consensus 190 ~~~~~~~~~~~~~~y~aPE~~~~~~~~-~~~~D-i~slG~il~~l~~g~~pf~~~------~~~~~~~~~~~~~~~~~~~ 261 (312)
T 2iwi_A 190 LHDEPYTDFDGTRVYSPPEWISRHQYH-ALPAT-VWSLGILLYDMVCGDIPFERD------QEILEAELHFPAHVSPDCC 261 (312)
T ss_dssp CCSSCBCCCCSCTTTSCHHHHHHSCBC-HHHHH-HHHHHHHHHHHHHSSCSCCSH------HHHHHTCCCCCTTSCHHHH
T ss_pred cccCcccccCCcccccCceeeecCCCC-Cccch-HHHHHHHHHHHHHCCCCCCCh------HHHhhhccCCcccCCHHHH
Confidence 2223222221 11123 446678888899999999763 3567788999999999999
Q ss_pred HHHHhhcccCCCcccCCCCCCHHHHhcCCceeeeC
Q psy11767 283 DFISRLLVKDPRRRLGGGELDAEELKRHPFFNVID 317 (966)
Q Consensus 283 dli~~LL~kdp~~RLG~~~~g~~~Ik~HpfF~~id 317 (966)
+||+++|..||.+|. .+++|..||||+...
T Consensus 262 ~li~~~l~~~p~~Rp-----s~~e~l~~~~~~~~~ 291 (312)
T 2iwi_A 262 ALIRRCLAPKPSSRP-----SLEEILLDPWMQTPA 291 (312)
T ss_dssp HHHHHHTCSSTTTSC-----CHHHHHHSTTTCC--
T ss_pred HHHHHHccCChhhCc-----CHHHHhcChhhcCch
Confidence 999999999999997 489999999998654
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* | Back alignment and structure |
|---|
Probab=99.64 E-value=2e-16 Score=175.55 Aligned_cols=196 Identities=21% Similarity=0.311 Sum_probs=128.1
Q ss_pred CcceeeeecccccceEEEEEEcCCCCEEEEEeccccc------hhhHHHHHHHHhhCCCcccccccccccc---------
Q psy11767 117 DLDKAGILGDGSYSVCRRCVEKSTGQEYAVKIISRKI------DCSEEINLLRACQGHPNICRRCVEKSTG--------- 181 (966)
Q Consensus 117 df~~~~~LG~GsFGkV~La~~k~tg~~yAiKvl~K~~------~~~~E~~il~~~~~~pfi~~~~~~~~~~--------- 181 (966)
+|.+++.||+|+||.|++|+++.+|+.||||++++.. ....|..++.+..+||+|++..-.....
T Consensus 23 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~h~niv~~~~~~~~~~~~~lv~e~ 102 (327)
T 3aln_A 23 DLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQKQLLMDLDVVMRSSDCPYIVQFYGALFREGDCWICMEL 102 (327)
T ss_dssp SEEC-CEEEECSSEEEEEEEETTTTEEEEEEEEECCCCHHHHHHHHHHHHHHHSSCCCTTBCCEEEEEECSSEEEEEECC
T ss_pred HhhehheeccCCCEEEEEEEEcCCCCEEEEEEeecccCchHHHHHHHHHHHHHHcCCCCcEeeeeeEEEeCCceEEEEee
Confidence 7899999999999999999999999999999998642 2344555455556899998722111000
Q ss_pred -------------------------hhHHHHHHH------h--h---cccchhhhHhhhccCCceEEecCcccc------
Q psy11767 182 -------------------------QEYAVKIIS------R--K---IDCSEEINLLRACQGHPNIVNLHCVFQ------ 219 (966)
Q Consensus 182 -------------------------~~~~~~~v~------~--~---~~~~~e~nil~~~~gh~~iv~l~~~~~------ 219 (966)
...+.+++. . . .|++++ |||.+.+|.++|+||+.+..
T Consensus 103 ~~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~-NIll~~~~~~kl~Dfg~~~~~~~~~~ 181 (327)
T 3aln_A 103 MSTSFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLKENLKIIHRDIKPS-NILLDRSGNIKLCDFGISGQLVDSIA 181 (327)
T ss_dssp CSEEHHHHHHHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHHHSCCCSCCCGG-GEEEETTTEEEECCCSSSCC------
T ss_pred cCCChHHHHHHHHhhhcccCcHHHHHHHHHHHHHHHHHHhccCCEeECCCCHH-HEEEcCCCCEEEccCCCceecccccc
Confidence 001111111 1 1 133334 99999999999999986632
Q ss_pred ------------cccc----ccccCCCcceeeechhhHHHHHHHhhCCCCCCCCcH-HHHHHHHHhCC-CCCC----CCC
Q psy11767 220 ------------DEVI----DWDDFSRGIECVFFSSSLIIFFIILSFTLSFIHDYY-HIQYRRILKTE-PPIP----EDL 277 (966)
Q Consensus 220 ------------~e~i----~~~~y~~~~d~~~~~~~~il~~~m~~g~~pf~~~~~-~~~~~~I~~~~-~~~P----~~~ 277 (966)
+|++ ....|+...| .|+.|+++|+|++|.+||...+. ......++.+. +.++ ..+
T Consensus 182 ~~~~~gt~~y~aPE~~~~~~~~~~~~~~~D---i~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 258 (327)
T 3aln_A 182 KTRDAGCRPYMAPERIDPSASRQGYDVRSD---VWSLGITLYELATGRFPYPKWNSVFDQLTQVVKGDPPQLSNSEEREF 258 (327)
T ss_dssp ------------------------CCSHHH---HHHHHHHHHHHHHSCCCSSCC-------CCCCCSCCCCCCCCSSCCC
T ss_pred cccCCCCccccCceeeccccCcCCCCchhh---HHHHHHHHHHHHHCCCCCCCcchHHHHHHHHhcCCCCCCCCcccccC
Confidence 3444 2223444444 34567888888889999976432 22333444433 3333 368
Q ss_pred CHHHHHHHHhhcccCCCcccCCCCCCHHHHhcCCceeeeCcccc
Q psy11767 278 SPDVADFISRLLVKDPRRRLGGGELDAEELKRHPFFNVIDWDDL 321 (966)
Q Consensus 278 s~~a~dli~~LL~kdp~~RLG~~~~g~~~Ik~HpfF~~idW~~l 321 (966)
++++++||+++|..||.+|. .+.+|.+||||...++..+
T Consensus 259 ~~~l~~li~~~l~~dp~~Rp-----s~~ell~hp~~~~~~~~~~ 297 (327)
T 3aln_A 259 SPSFINFVNLCLTKDESKRP-----KYKELLKHPFILMYEERAV 297 (327)
T ss_dssp CHHHHHHHHHHTCSSGGGSC-----CHHHHTTSHHHHHHHHSCC
T ss_pred CHHHHHHHHHHhhCChhhCc-----CHHHHHhChHHHHhHhhHH
Confidence 99999999999999999998 4899999999998877654
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* | Back alignment and structure |
|---|
Probab=99.64 E-value=3.4e-16 Score=181.64 Aligned_cols=186 Identities=26% Similarity=0.324 Sum_probs=125.9
Q ss_pred ceeeeecccccceEEEEEEcCCCCEEEEEeccccc--hhhHHHHHHHHhhCCCcccccccccccch--------------
Q psy11767 119 DKAGILGDGSYSVCRRCVEKSTGQEYAVKIISRKI--DCSEEINLLRACQGHPNICRRCVEKSTGQ-------------- 182 (966)
Q Consensus 119 ~~~~~LG~GsFGkV~La~~k~tg~~yAiKvl~K~~--~~~~E~~il~~~~~~pfi~~~~~~~~~~~-------------- 182 (966)
...++||+|+||+|+++ .+.+|+.||||++.+.. ...+|..+|+++.+||+|++.+..+....
T Consensus 18 ~~~~~LG~G~~g~V~~~-~~~~g~~vAvK~~~~~~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~lv~E~~~gsL~ 96 (434)
T 2rio_A 18 VSEKILGYGSSGTVVFQ-GSFQGRPVAVKRMLIDFCDIALMEIKLLTESDDHPNVIRYYCSETTDRFLYIALELCNLNLQ 96 (434)
T ss_dssp EEEEEEEECSTTCEEEE-EESSSSEEEEEEEEGGGHHHHHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEEECCCSEEHH
T ss_pred eccCeEeeCCCeEEEEE-EEECCeEEEEEEEcHHHHHHHHHHHHHHHhccCCCCcCeEEEEEecCCeEEEEEecCCCCHH
Confidence 45688999999999986 55789999999998652 45789999998889999987322111110
Q ss_pred ----------------------hHHHHHHHh----------hcccchhhhHhhhcc-------------CCceEEecCcc
Q psy11767 183 ----------------------EYAVKIISR----------KIDCSEEINLLRACQ-------------GHPNIVNLHCV 217 (966)
Q Consensus 183 ----------------------~~~~~~v~~----------~~~~~~e~nil~~~~-------------gh~~iv~l~~~ 217 (966)
..+.+++.+ ..|++++ |||.+.. ++++|.||+.+
T Consensus 97 ~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDLkp~-NILl~~~~~~~~~~~~~~~~~~~kL~DFG~a 175 (434)
T 2rio_A 97 DLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHSLKIIHRDLKPQ-NILVSTSSRFTADQQTGAENLRILISDFGLC 175 (434)
T ss_dssp HHHHTC------------CCHHHHHHHHHHHHHHHHHTTEECCCCSGG-GEEEECCHHHHSCCTTCCCSCEEEECCCTTC
T ss_pred HHHhccCCCchhhhhccchhHHHHHHHHHHHHHHHHHCCccccCCChH-hEEEecCcccccccccCCCceEEEEcccccc
Confidence 112222222 1244444 9998653 47899999865
Q ss_pred cc-----------------------cccccc-------ccCCCcceeeechhhHHHHHHHhh-CCCCCCCCcHHHHHHHH
Q psy11767 218 FQ-----------------------DEVIDW-------DDFSRGIECVFFSSSLIIFFIILS-FTLSFIHDYYHIQYRRI 266 (966)
Q Consensus 218 ~~-----------------------~e~i~~-------~~y~~~~d~~~~~~~~il~~~m~~-g~~pf~~~~~~~~~~~I 266 (966)
.. +|++.. ..|+...| .| +.|+++|+|++ |.+||....... ..|
T Consensus 176 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~D--iw-SlG~il~ellt~g~~Pf~~~~~~~--~~i 250 (434)
T 2rio_A 176 KKLDSGQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSID--IF-SMGCVFYYILSKGKHPFGDKYSRE--SNI 250 (434)
T ss_dssp EECCC--------------CCTTSCHHHHSCCCTTSCCCCCCTHHH--HH-HHHHHHHHHHTTSCCTTCSTTTHH--HHH
T ss_pred eecCCCCccceeeecCCCCCCCccCHHHhccccccccccCcchhhh--hH-hHHHHHHHHHhCCCCCCCCchhhH--HHH
Confidence 31 233332 23433334 44 55666666665 999997654433 567
Q ss_pred HhCCCCCCC-------CCCHHHHHHHHhhcccCCCcccCCCCCCHHHHhcCCceeee
Q psy11767 267 LKTEPPIPE-------DLSPDVADFISRLLVKDPRRRLGGGELDAEELKRHPFFNVI 316 (966)
Q Consensus 267 ~~~~~~~P~-------~~s~~a~dli~~LL~kdp~~RLG~~~~g~~~Ik~HpfF~~i 316 (966)
+.+...++. .+++++++||+++|+.||.+|.+ +.+|.+||||.+.
T Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps-----~~eil~hp~f~~~ 302 (434)
T 2rio_A 251 IRGIFSLDEMKCLHDRSLIAEATDLISQMIDHDPLKRPT-----AMKVLRHPLFWPK 302 (434)
T ss_dssp HHTCCCCCCCTTCCCHHHHHHHHHHHHHHTCSSGGGSCC-----HHHHHTSGGGSCH
T ss_pred hcCCCCcccccccccccchHHHHHHHHHHhhCChhhCCC-----HHHHHhCCccCCc
Confidence 766655543 24588999999999999999984 8999999999643
|
| >4gyi_A RIO2 kinase; protein kinase, ADP complex, phosphoaspartate, acyl-phosphat ribosome biogenesis, Ser/Thr protein kinase; HET: PHD ADP; 2.20A {Chaetomium thermophilum} PDB: 4gyg_A | Back alignment and structure |
|---|
Probab=99.64 E-value=1e-16 Score=181.81 Aligned_cols=131 Identities=14% Similarity=0.201 Sum_probs=92.7
Q ss_pred cccccccccccccEEEEEEEcCCCcEEEEEEecccc----------------C-----------hHHHHHHHHHhcCCCC
Q psy11767 380 LDKAGILGDGSYSVCRRCVEKSTGQEYAVKIISRKI----------------D-----------CSEEINLLRACQGHPN 432 (966)
Q Consensus 380 ~~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~----------------~-----------~~~Ei~iL~~l~~Hpn 432 (966)
+...+.||.|+||.||+|.+. +|+.||||+++... . +.+|...|..+. +.+
T Consensus 97 Y~I~~~IG~Gk~a~VY~a~d~-~G~~vAvKi~r~~~~sfr~v~~~r~~~~~~~~~~~~~~~rl~A~kE~~nL~rL~-~~g 174 (397)
T 4gyi_A 97 YSVGSRIGVGKESDIMIVADE-KGKQKVLKIHRLGRISFRTVKANRDYLRNRSTGSWMYLSRLAAIKEFAFMKALY-EEG 174 (397)
T ss_dssp SEEEEEEEECSSEEEEEEECT-TCCEEEEEEECTTEECCCCCC--CEECTTSCHHHHHHHHHHHHHHHHHHHHHHH-HTT
T ss_pred EEecCEeeeCCceEEEEEECC-CCCEEEEEEEecccccHHHHHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHH-hcC
Confidence 344689999999999999985 69999999874210 0 123555555552 222
Q ss_pred c--eEEEEEEEeCCeEEEEEEccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCcEEEecCC
Q psy11767 433 I--VNLHCVFQDEVHTYLVLELLKGGELLDRIRQKGRCGFTENEASRIMRQLVAAVHFMHSRGVVHRDLKPENLLFSDPA 510 (966)
Q Consensus 433 I--V~l~~~~~~~~~~~lVmEy~~gg~L~~~l~~~~~~~l~e~~~~~i~~Qil~aL~yLHs~~IiHRDLKP~NILl~~~~ 510 (966)
+ ...+++ . ..+|||||++|+.|.+.. ....+..++.||+.+|.|||+.|||||||||.|||+++..
T Consensus 175 v~vp~p~~~--~--~~~LVME~i~G~~L~~l~--------~~~~~~~l~~qll~~l~~lH~~gIVHrDLKp~NILl~~dg 242 (397)
T 4gyi_A 175 FPVPEPIAQ--S--RHTIVMSLVDALPMRQVS--------SVPDPASLYADLIALILRLAKHGLIHGDFNEFNILIREEK 242 (397)
T ss_dssp CSCCCEEEE--E--TTEEEEECCSCEEGGGCC--------CCSCHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEEEEEE
T ss_pred CCCCeeeec--c--CceEEEEecCCccHhhhc--------ccHHHHHHHHHHHHHHHHHHHCCCcCCCCCHHHEEEeCCC
Confidence 2 222221 1 237999999988875431 2234677899999999999999999999999999998532
Q ss_pred CC--------CEEEEeeccccc
Q psy11767 511 GD--------NIKVVDFGFACL 524 (966)
Q Consensus 511 ~~--------~iKL~DFGla~~ 524 (966)
.+ .+.|+||+-+..
T Consensus 243 d~~d~~~~~~~~~iID~~Q~V~ 264 (397)
T 4gyi_A 243 DAEDPSSITLTPIIIXFPQMVS 264 (397)
T ss_dssp CSSCTTSEEEEEEECCCTTCEE
T ss_pred CcccccccccceEEEEeCCccc
Confidence 21 388999997643
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* | Back alignment and structure |
|---|
Probab=99.63 E-value=2.7e-16 Score=174.11 Aligned_cols=192 Identities=21% Similarity=0.262 Sum_probs=128.1
Q ss_pred CcceeeeecccccceEEEEEE-cCCCCEEEEEecccc----chhhHHHHHHHHhhC-----CCcccccccc---------
Q psy11767 117 DLDKAGILGDGSYSVCRRCVE-KSTGQEYAVKIISRK----IDCSEEINLLRACQG-----HPNICRRCVE--------- 177 (966)
Q Consensus 117 df~~~~~LG~GsFGkV~La~~-k~tg~~yAiKvl~K~----~~~~~E~~il~~~~~-----~pfi~~~~~~--------- 177 (966)
+|++++.||+|+||+|++|++ +.+|+.||||++++. ....+|..+|++++. |++++.....
T Consensus 15 ~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~i~~~~~~~~~~~~~~l 94 (339)
T 1z57_A 15 RYEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKNVDRYCEAARSEIQVLEHLNTTDPNSTFRCVQMLEWFEHHGHICI 94 (339)
T ss_dssp TEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSSHHHHHHHHHHHHHHHHHHHHCTTCTTCBCCEEEEEEETTEEEE
T ss_pred ceEEEEEEecCCCeEEEEEEecCCCCcEEEEEEEecCCchhHHHHHHHHHHHHhhhcCCCCceeeEeeecccccCCcEEE
Confidence 569999999999999999998 678999999999864 245778888887642 2345431100
Q ss_pred ----------------------cccchhHHHHHHHh----------hcccchhhhHhhhc-------------------c
Q psy11767 178 ----------------------KSTGQEYAVKIISR----------KIDCSEEINLLRAC-------------------Q 206 (966)
Q Consensus 178 ----------------------~~~~~~~~~~~v~~----------~~~~~~e~nil~~~-------------------~ 206 (966)
.......+.+++.+ ..|++++ |||.+. +
T Consensus 95 v~e~~~~~l~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~-Nil~~~~~~~~~~~~~~~~~~~~~~~ 173 (339)
T 1z57_A 95 VFELLGLSTYDFIKENGFLPFRLDHIRKMAYQICKSVNFLHSNKLTHTDLKPE-NILFVQSDYTEAYNPKIKRDERTLIN 173 (339)
T ss_dssp EEECCCCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGG-GEEESCCCEEEEEC----CEEEEESC
T ss_pred EEcCCCCCHHHHHHhcCCCCCcHHHHHHHHHHHHHHHHHHHHCCCcCCCCCHH-HEEEeccccccccCCccccccccccC
Confidence 00001111222221 1244444 998876 5
Q ss_pred CCceEEecCcccc----------------ccccccccCCCcceeeechhhHHHHHHHhhCCCCCCCCcHHHHHHHHHhCC
Q psy11767 207 GHPNIVNLHCVFQ----------------DEVIDWDDFSRGIECVFFSSSLIIFFIILSFTLSFIHDYYHIQYRRILKTE 270 (966)
Q Consensus 207 gh~~iv~l~~~~~----------------~e~i~~~~y~~~~d~~~~~~~~il~~~m~~g~~pf~~~~~~~~~~~I~~~~ 270 (966)
+.++|.||+.+.. +|++....|+...| .|+.|+++|+|++|.+||...+.......+....
T Consensus 174 ~~~kl~Dfg~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~D---i~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~ 250 (339)
T 1z57_A 174 PDIKVVDFGSATYDDEHHSTLVSTRHYRAPEVILALGWSQPCD---VWSIGCILIEYYLGFTVFPTHDSKEHLAMMERIL 250 (339)
T ss_dssp CCEEECCCSSCEETTSCCCSSCSCGGGCCHHHHTTSCCCTHHH---HHHHHHHHHHHHHSSCSCCCSCHHHHHHHHHHHH
T ss_pred CCceEeeCcccccCccccccccCCccccChHHhhCCCCCcchh---hHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHh
Confidence 6789999986532 34555555655555 3466788888999999998877655444333211
Q ss_pred CCCC--------------------------------------------CCCCHHHHHHHHhhcccCCCcccCCCCCCHHH
Q psy11767 271 PPIP--------------------------------------------EDLSPDVADFISRLLVKDPRRRLGGGELDAEE 306 (966)
Q Consensus 271 ~~~P--------------------------------------------~~~s~~a~dli~~LL~kdp~~RLG~~~~g~~~ 306 (966)
..+| ...++++.+||+++|+.||.+|.. +.|
T Consensus 251 ~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt-----~~e 325 (339)
T 1z57_A 251 GPLPKHMIQKTRKRKYFHHDRLDWDEHSSAGRYVSRACKPLKEFMLSQDVEHERLFDLIQKMLEYDPAKRIT-----LRE 325 (339)
T ss_dssp CSCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCSSTTTSCC-----HHH
T ss_pred CCCCHHHHhhccchhHHhhccccccccccccchhhhcCcchhhhcccchhhHHHHHHHHHHHhCcCcccccC-----HHH
Confidence 1111 123567889999999999999984 899
Q ss_pred HhcCCceeeeC
Q psy11767 307 LKRHPFFNVID 317 (966)
Q Consensus 307 Ik~HpfF~~id 317 (966)
|.+||||+.+.
T Consensus 326 ll~hp~f~~~~ 336 (339)
T 1z57_A 326 ALKHPFFDLLK 336 (339)
T ss_dssp HTTSGGGGGGG
T ss_pred HhcCHHHHHHh
Confidence 99999998654
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.63 E-value=1e-15 Score=166.68 Aligned_cols=191 Identities=23% Similarity=0.290 Sum_probs=131.0
Q ss_pred CcceeeeecccccceEEEEEEcCCCCEEEEEeccccc-----hhhHHHHHHHHhhCCCcccccccccccc----------
Q psy11767 117 DLDKAGILGDGSYSVCRRCVEKSTGQEYAVKIISRKI-----DCSEEINLLRACQGHPNICRRCVEKSTG---------- 181 (966)
Q Consensus 117 df~~~~~LG~GsFGkV~La~~k~tg~~yAiKvl~K~~-----~~~~E~~il~~~~~~pfi~~~~~~~~~~---------- 181 (966)
+|....+||+|+||.||+|+++.+++.||||++++.. ...+|..+|+++ +||+|++..-.+...
T Consensus 23 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~e~~ 101 (295)
T 2clq_A 23 ENGDRVVLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHL-KHKNIVQYLGSFSENGFIKIFMEQV 101 (295)
T ss_dssp TTSSBCEEEECSSSEEEEEEETTTCCEEEEEEEECCCC---HHHHHHHHHHHTC-CCTTBCCEEEEEEETTEEEEEEECC
T ss_pred CCCCcEEEeecCcEEEEEEEECCCCeEEEEEEccCCchHHHHHHHHHHHHHHhC-CCCCEeeEeeEEEeCCcEEEEEEeC
Confidence 5667779999999999999999999999999998642 356788999887 699998621111000
Q ss_pred -----------------------hhHHHHHHHhh----------cccchhhhHhhhc-cCCceEEecCcccc--------
Q psy11767 182 -----------------------QEYAVKIISRK----------IDCSEEINLLRAC-QGHPNIVNLHCVFQ-------- 219 (966)
Q Consensus 182 -----------------------~~~~~~~v~~~----------~~~~~e~nil~~~-~gh~~iv~l~~~~~-------- 219 (966)
...+.+++.+. .|++++ |||.+. +|.++|.||+.+..
T Consensus 102 ~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~-Nil~~~~~~~~kl~Dfg~~~~~~~~~~~~ 180 (295)
T 2clq_A 102 PGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHDNQIVHRDIKGD-NVLINTYSGVLKISDFGTSKRLAGINPCT 180 (295)
T ss_dssp SEEEHHHHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGG-GEEEETTTCCEEECCTTTCEESCC-----
T ss_pred CCCCHHHHHHhhccCCCccHHHHHHHHHHHHHHHHHHHhCCEEccCCChh-hEEEECCCCCEEEeecccccccCCCCCcc
Confidence 00111222110 133333 899877 78999999986532
Q ss_pred -----------ccccccc--cCCCcceeeechhhHHHHHHHhhCCCCCCCC--cHHHHHHH-HHhCCCCCCCCCCHHHHH
Q psy11767 220 -----------DEVIDWD--DFSRGIECVFFSSSLIIFFIILSFTLSFIHD--YYHIQYRR-ILKTEPPIPEDLSPDVAD 283 (966)
Q Consensus 220 -----------~e~i~~~--~y~~~~d~~~~~~~~il~~~m~~g~~pf~~~--~~~~~~~~-I~~~~~~~P~~~s~~a~d 283 (966)
+|++... .|+...| .|+.|+++|+|++|.+||... ....+++. .....+.+|..+++++++
T Consensus 181 ~~~~~~~~y~aPE~~~~~~~~~~~~~D---i~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 257 (295)
T 2clq_A 181 ETFTGTLQYMAPEIIDKGPRGYGKAAD---IWSLGCTIIEMATGKPPFYELGEPQAAMFKVGMFKVHPEIPESMSAEAKA 257 (295)
T ss_dssp CCCCCCGGGCCHHHHHHGGGGCSHHHH---HHHHHHHHHHHHHTSCTTGGGSSHHHHHHHHHHHCCCCCCCTTSCHHHHH
T ss_pred cccCCCccccChhhhcCCCCCCCcHHH---HHHHHHHHHHHHHCCCCccCCCchhHHHHhhccccccccccccCCHHHHH
Confidence 1233221 1333333 345677788888899999643 22233332 345667889999999999
Q ss_pred HHHhhcccCCCcccCCCCCCHHHHhcCCceeeeC
Q psy11767 284 FISRLLVKDPRRRLGGGELDAEELKRHPFFNVID 317 (966)
Q Consensus 284 li~~LL~kdp~~RLG~~~~g~~~Ik~HpfF~~id 317 (966)
||.++|..||.+|.. +++|..||||+...
T Consensus 258 li~~~l~~dp~~Rps-----~~~ll~~~~~~~~~ 286 (295)
T 2clq_A 258 FILKCFEPDPDKRAC-----ANDLLVDEFLKVSS 286 (295)
T ss_dssp HHHHTTCSSTTTSCC-----HHHHHTSGGGCC--
T ss_pred HHHHHccCChhhCCC-----HHHHhcChhhhhcc
Confidence 999999999999984 89999999997543
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=99.63 E-value=6.3e-17 Score=186.60 Aligned_cols=188 Identities=12% Similarity=0.122 Sum_probs=129.9
Q ss_pred CcceeeeecccccceEEEEEEcCCCCEEEEEeccccc--------hhhHHHHHHHHhhCCC--cccccc-----------
Q psy11767 117 DLDKAGILGDGSYSVCRRCVEKSTGQEYAVKIISRKI--------DCSEEINLLRACQGHP--NICRRC----------- 175 (966)
Q Consensus 117 df~~~~~LG~GsFGkV~La~~k~tg~~yAiKvl~K~~--------~~~~E~~il~~~~~~p--fi~~~~----------- 175 (966)
+|...++||+|+||+||+|+++.+|+.||||+++... ...+|..+++.+..++ ..+..+
T Consensus 79 ~~~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ 158 (413)
T 3dzo_A 79 TLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDLVK 158 (413)
T ss_dssp EEEEEEEEEEETTEEEEEEEETTTCCEEEEEEECCSCC----CCHHHHHHHHGGGGSTTCCSHHHHHHHTCBCCCCEEEE
T ss_pred eEEEecccccCCCEEEEEEEecCCCCceEEEEEecCCCccHHHHHHHHHHHHHHHhhccCCCHHHHHHhcccccchhhcc
Confidence 5788999999999999999999999999999998431 2356777776664311 110000
Q ss_pred -----------------------cc--------------------------cccchhHHHHHHHh----------hcccc
Q psy11767 176 -----------------------VE--------------------------KSTGQEYAVKIISR----------KIDCS 196 (966)
Q Consensus 176 -----------------------~~--------------------------~~~~~~~~~~~v~~----------~~~~~ 196 (966)
+. .......+.+++.+ ..|++
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~~ll~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~iiHrDiK 238 (413)
T 3dzo_A 159 DPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYGLVHTYLR 238 (413)
T ss_dssp CCC---------------CCSEEEEEECCSEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHTTEECSCCC
T ss_pred cCCCCccccccCCCccccccceEEEeehhcCCHHHHHHHhhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCcc
Confidence 00 00000111222221 12555
Q ss_pred hhhhHhhhccCCceEEecCccc---------------ccccc----------ccccCCCcceeeechhhHHHHHHHhhCC
Q psy11767 197 EEINLLRACQGHPNIVNLHCVF---------------QDEVI----------DWDDFSRGIECVFFSSSLIIFFIILSFT 251 (966)
Q Consensus 197 ~e~nil~~~~gh~~iv~l~~~~---------------~~e~i----------~~~~y~~~~d~~~~~~~~il~~~m~~g~ 251 (966)
++ |||.+.+|+++|+||+.+. .+|++ ....|+...| .|+.|+++|+|++|.
T Consensus 239 p~-NILl~~~~~~kL~DFG~a~~~~~~~~~~~g~~y~aPE~~~~~~~~~~~~~~~~~~~~~D---vwSlGvil~elltg~ 314 (413)
T 3dzo_A 239 PV-DIVLDQRGGVFLTGFEHLVRDGASAVSPIGRGFAPPETTAERMLPFGQHHPTLMTFAFD---TWTLGLAIYWIWCAD 314 (413)
T ss_dssp GG-GEEECTTCCEEECCGGGCEETTEEECCCCCTTTCCHHHHHHHTSTTGGGCCEEECHHHH---HHHHHHHHHHHHHSS
T ss_pred cc-eEEEecCCeEEEEeccceeecCCccccCCCCceeCchhhhccccccccccCcCCCchhh---HHHHHHHHHHHHHCC
Confidence 55 9999999999999999753 23444 2222332333 456778888999999
Q ss_pred CCCCCCcHHHHHHHHHhCCCCCCCCCCHHHHHHHHhhcccCCCcccCCCCCCHHHHhcCCceeeeC
Q psy11767 252 LSFIHDYYHIQYRRILKTEPPIPEDLSPDVADFISRLLVKDPRRRLGGGELDAEELKRHPFFNVID 317 (966)
Q Consensus 252 ~pf~~~~~~~~~~~I~~~~~~~P~~~s~~a~dli~~LL~kdp~~RLG~~~~g~~~Ik~HpfF~~id 317 (966)
+||...+....++.|+.... .+++++++||.++|++||.+|+. +.++.+||||+.+.
T Consensus 315 ~Pf~~~~~~~~~~~~~~~~~----~~~~~~~~li~~~l~~dP~~Rpt-----~~~~l~~~~~~~~~ 371 (413)
T 3dzo_A 315 LPNTDDAALGGSEWIFRSCK----NIPQPVRALLEGFLRYPKEDRLL-----PLQAMETPEYEQLR 371 (413)
T ss_dssp CCCCTTGGGSCSGGGGSSCC----CCCHHHHHHHHHHTCSSGGGSCC-----HHHHTTSHHHHHHH
T ss_pred CCCCCcchhhhHHHHHhhcc----cCCHHHHHHHHHHccCChhhCcC-----HHHHHhCHHHHHHH
Confidence 99998877666677766544 45689999999999999999984 89999999998774
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.63 E-value=2.2e-16 Score=174.68 Aligned_cols=185 Identities=16% Similarity=0.222 Sum_probs=127.6
Q ss_pred CcceeeeecccccceEEEEEEcCCCCEEEEEeccccc------hhhHHHHHHHHhhCCCccccccccc--ccc-------
Q psy11767 117 DLDKAGILGDGSYSVCRRCVEKSTGQEYAVKIISRKI------DCSEEINLLRACQGHPNICRRCVEK--STG------- 181 (966)
Q Consensus 117 df~~~~~LG~GsFGkV~La~~k~tg~~yAiKvl~K~~------~~~~E~~il~~~~~~pfi~~~~~~~--~~~------- 181 (966)
.|.+.++||+|+||+|++|+++.+|+.||||++++.. ...+|..+|++++ ||+|++..-.+ ...
T Consensus 10 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~~~~~~~lv~ 88 (319)
T 4euu_A 10 LWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLN-HKNIVKLFAIEEETTTRHKVLIM 88 (319)
T ss_dssp EEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCC-CTTBCCEEEEEECTTTCCEEEEE
T ss_pred CEEEEEEecCCCCeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhcC-CCCcceEEEEeecCCCceEEEEE
Confidence 4589999999999999999999999999999998642 3468999999984 99998732111 100
Q ss_pred --------------------------hhHHHHHHHh----------hcccchhhhHhh----hccCCceEEecCcccc--
Q psy11767 182 --------------------------QEYAVKIISR----------KIDCSEEINLLR----ACQGHPNIVNLHCVFQ-- 219 (966)
Q Consensus 182 --------------------------~~~~~~~v~~----------~~~~~~e~nil~----~~~gh~~iv~l~~~~~-- 219 (966)
...+.+++.+ ..|++++ |||. +..+.++|+||+.+..
T Consensus 89 e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~-NIll~~~~~~~~~~kL~Dfg~a~~~~ 167 (319)
T 4euu_A 89 EFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENGIVHRNIKPG-NIMRVIGEDGQSVYKLTDFGAARELE 167 (319)
T ss_dssp ECCTTCBHHHHHHSGGGTTCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGG-GEEEEECTTSCEEEEECCCTTCEECC
T ss_pred eCCCCCCHHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHH-HEEEeccCCCCceEEEccCCCceecC
Confidence 0011122211 0144444 9987 6667789999987632
Q ss_pred ----------------ccccc--------cccCCCcceeeechhhHHHHHHHhhCCCCCCC----CcHHHHHHHHHhCCC
Q psy11767 220 ----------------DEVID--------WDDFSRGIECVFFSSSLIIFFIILSFTLSFIH----DYYHIQYRRILKTEP 271 (966)
Q Consensus 220 ----------------~e~i~--------~~~y~~~~d~~~~~~~~il~~~m~~g~~pf~~----~~~~~~~~~I~~~~~ 271 (966)
+|++. ...|+...| .|+.|+++|+|++|.+||.. .....+..+|+.+.+
T Consensus 168 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~D---iwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~p 244 (319)
T 4euu_A 168 DDEQFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVD---LWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIITGKP 244 (319)
T ss_dssp TTCCBCCCCSCGGGCCHHHHHHHTSCCCCCCCBCTTHH---HHHHHHHHHHHHHSSCSEECTTCGGGCHHHHHHHHHHCC
T ss_pred CCCceeecccCCCccCHHHhhhccccccccCCCCcHHH---HHHHHHHHHHHHhCCCCCCCCCccchhHHHHHHHhcCCC
Confidence 23332 234444444 45677888889999999963 233455666766554
Q ss_pred -------------------C------CCCCCCHHHHHHHHhhcccCCCcccCCCCCCHHHHhcCC
Q psy11767 272 -------------------P------IPEDLSPDVADFISRLLVKDPRRRLGGGELDAEELKRHP 311 (966)
Q Consensus 272 -------------------~------~P~~~s~~a~dli~~LL~kdp~~RLG~~~~g~~~Ik~Hp 311 (966)
. ++..+++.+++||+++|+.||.+|++ ++|+.+||
T Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~~L~~dP~~R~s-----~~ell~h~ 304 (319)
T 4euu_A 245 SGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWG-----FDQFFAET 304 (319)
T ss_dssp TTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCC-----HHHHHHHH
T ss_pred cccchhhhcccCCccccCccCCcccccchhHHHHhHHHHHHhccCChhhhcc-----HHHhhhcc
Confidence 2 22345678899999999999999984 89999987
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A | Back alignment and structure |
|---|
Probab=99.62 E-value=7.6e-16 Score=174.85 Aligned_cols=185 Identities=12% Similarity=0.119 Sum_probs=133.5
Q ss_pred CcceeeeecccccceEEEEEEc-------CCCCEEEEEeccccc------hhhHHHHHHHHhhCCCcccccccccccc--
Q psy11767 117 DLDKAGILGDGSYSVCRRCVEK-------STGQEYAVKIISRKI------DCSEEINLLRACQGHPNICRRCVEKSTG-- 181 (966)
Q Consensus 117 df~~~~~LG~GsFGkV~La~~k-------~tg~~yAiKvl~K~~------~~~~E~~il~~~~~~pfi~~~~~~~~~~-- 181 (966)
+|.+.++||+|+||+||+|+++ .++..||||++++.. ...+|..+|+++.+||+|++.+-.+...
T Consensus 82 ~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~~~ 161 (370)
T 2psq_A 82 KLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDGP 161 (370)
T ss_dssp GEEEEEEESCCSSSEEEEEEEETCSTTCTTCEEEEEEEECCTTCBHHHHHHHHHHHHHHHHSCCCTTBCCEEEEECSSSS
T ss_pred HCEeeeEEeeCCCeeEEEEEEecccCcCcCcceeEEEEEecCCcCHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEccCCC
Confidence 7899999999999999999975 355689999998642 3578999999998899998722111110
Q ss_pred --------------------------------------------hhHHHHHHHh----------hcccchhhhHhhhccC
Q psy11767 182 --------------------------------------------QEYAVKIISR----------KIDCSEEINLLRACQG 207 (966)
Q Consensus 182 --------------------------------------------~~~~~~~v~~----------~~~~~~e~nil~~~~g 207 (966)
..++.+++.+ ..|++++ |||.+.+|
T Consensus 162 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~-NIll~~~~ 240 (370)
T 2psq_A 162 LYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAAR-NVLVTENN 240 (370)
T ss_dssp CEEEEECCTTCBHHHHHHHTCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGG-GEEECTTC
T ss_pred EEEEEEcCCCCCHHHHHHhhCCccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCCeeccccchh-hEEECCCC
Confidence 0011122221 1244555 99999999
Q ss_pred CceEEecCcccc---------------------ccccccccCCCcceeeechhhHHHHHHHhh-CCCCCCCCcHHHHHHH
Q psy11767 208 HPNIVNLHCVFQ---------------------DEVIDWDDFSRGIECVFFSSSLIIFFIILS-FTLSFIHDYYHIQYRR 265 (966)
Q Consensus 208 h~~iv~l~~~~~---------------------~e~i~~~~y~~~~d~~~~~~~~il~~~m~~-g~~pf~~~~~~~~~~~ 265 (966)
+++|+||+.+.. +|++....|+...| +|+.|+++|+|++ |.+||...+...+++.
T Consensus 241 ~~kl~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~D---vwslG~il~ellt~g~~p~~~~~~~~~~~~ 317 (370)
T 2psq_A 241 VMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSD---VWSFGVLMWEIFTLGGSPYPGIPVEELFKL 317 (370)
T ss_dssp CEEECCCSSCEETTCCCTTCTTTTTTSCGGGCCHHHHHTCCCCHHHH---HHHHHHHHHHHHTTSCCSSTTCCGGGHHHH
T ss_pred CEEEccccCCcccCcccceecccCCCcccceECHhHhcCCCCCcHHH---HHHHHHHHHHHHcCCCCCCCCCCHHHHHHH
Confidence 999999987631 23333334443333 4456677777776 9999998888888888
Q ss_pred HHhC-CCCCCCCCCHHHHHHHHhhcccCCCcccCCCCCCHHHHhcC
Q psy11767 266 ILKT-EPPIPEDLSPDVADFISRLLVKDPRRRLGGGELDAEELKRH 310 (966)
Q Consensus 266 I~~~-~~~~P~~~s~~a~dli~~LL~kdp~~RLG~~~~g~~~Ik~H 310 (966)
+..+ .+..|..+++++.+||+++|..||.+|. .+.+|..+
T Consensus 318 ~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rp-----t~~ell~~ 358 (370)
T 2psq_A 318 LKEGHRMDKPANCTNELYMMMRDCWHAVPSQRP-----TFKQLVED 358 (370)
T ss_dssp HHTTCCCCCCTTSCHHHHHHHHHHTCSSGGGSC-----CHHHHHHH
T ss_pred HhcCCCCCCCCCCCHHHHHHHHHHcCCChhhCc-----CHHHHHHH
Confidence 8776 4678889999999999999999999997 37777654
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... | Back alignment and structure |
|---|
Probab=99.62 E-value=7.4e-16 Score=170.24 Aligned_cols=203 Identities=15% Similarity=0.177 Sum_probs=141.6
Q ss_pred CcceeeeecccccceEEEEEEc-----CCCCEEEEEeccccc------hhhHHHHHHHHhhCCCcccccccccccc----
Q psy11767 117 DLDKAGILGDGSYSVCRRCVEK-----STGQEYAVKIISRKI------DCSEEINLLRACQGHPNICRRCVEKSTG---- 181 (966)
Q Consensus 117 df~~~~~LG~GsFGkV~La~~k-----~tg~~yAiKvl~K~~------~~~~E~~il~~~~~~pfi~~~~~~~~~~---- 181 (966)
+|.+.+.||+|+||+|++|+++ .+++.||||++++.. ...+|..+|+++ +||+|++..-.....
T Consensus 26 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~~~~~~ 104 (322)
T 1p4o_A 26 KITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEF-NCHHVVRLLGVVSQGQPTL 104 (322)
T ss_dssp GEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGC-CCTTBCCEEEEECSSSSCE
T ss_pred heeeeeEeccCCceEEEeeeecCccCCCCceEEEEEecccccCHHHHHHHHHHHHHHHhc-CCCCEeeeEEEEccCCccE
Confidence 6799999999999999999987 578899999998642 346788888887 699997611111100
Q ss_pred ------------------------------------hhHHHHHHHh----------hcccchhhhHhhhccCCceEEecC
Q psy11767 182 ------------------------------------QEYAVKIISR----------KIDCSEEINLLRACQGHPNIVNLH 215 (966)
Q Consensus 182 ------------------------------------~~~~~~~v~~----------~~~~~~e~nil~~~~gh~~iv~l~ 215 (966)
...+.+++.+ ..|++++ |||.+.+|.++|+||+
T Consensus 105 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~-NIli~~~~~~kl~Dfg 183 (322)
T 1p4o_A 105 VIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANKFVHRDLAAR-NCMVAEDFTVKIGDFG 183 (322)
T ss_dssp EEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCSGG-GEEECTTCCEEECCTT
T ss_pred EEEEeCCCCcHHHHHHHhchhhccCCCCCCcCHHHHHHHHHHHHHHHHHHHHCCCccCCCccc-eEEEcCCCeEEECcCc
Confidence 0001111111 0134444 9999999999999998
Q ss_pred cccc---------------------ccccccccCCCcceeeechhhHHHHHHHhh-CCCCCCCCcHHHHHHHHHhCC-CC
Q psy11767 216 CVFQ---------------------DEVIDWDDFSRGIECVFFSSSLIIFFIILS-FTLSFIHDYYHIQYRRILKTE-PP 272 (966)
Q Consensus 216 ~~~~---------------------~e~i~~~~y~~~~d~~~~~~~~il~~~m~~-g~~pf~~~~~~~~~~~I~~~~-~~ 272 (966)
.+.. +|++....|+.. .|.|+ .|+++|+|++ |.+||...+...+.+.+..+. +.
T Consensus 184 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~--~Di~s-lG~il~el~~~g~~p~~~~~~~~~~~~~~~~~~~~ 260 (322)
T 1p4o_A 184 MTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTY--SDVWS-FGVVLWEIATLAEQPYQGLSNEQVLRFVMEGGLLD 260 (322)
T ss_dssp CCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHH--HHHHH-HHHHHHHHHHTSCCTTTTSCHHHHHHHHHTTCCCC
T ss_pred cccccccccccccccCCCCCCCccChhhhccCCCCch--hhHHH-HHHHHHHHHhcCCCccccCCHHHHHHHHHcCCcCC
Confidence 7642 222322333333 33455 4555666665 899999988888888888765 46
Q ss_pred CCCCCCHHHHHHHHhhcccCCCcccCCCCCCHHHHhcC------CceeeeCccccccCCCCCC
Q psy11767 273 IPEDLSPDVADFISRLLVKDPRRRLGGGELDAEELKRH------PFFNVIDWDDLATKRIPAP 329 (966)
Q Consensus 273 ~P~~~s~~a~dli~~LL~kdp~~RLG~~~~g~~~Ik~H------pfF~~idW~~l~~k~~~pP 329 (966)
.|..+++++++||+++|..||.+|.. +.+|.+| ++|..++|......++++|
T Consensus 261 ~~~~~~~~l~~li~~~l~~dp~~Rps-----~~e~l~~L~~~~~~~~~~~~~~~~~~~~~~~~ 318 (322)
T 1p4o_A 261 KPDNCPDMLFELMRMCWQYNPKMRPS-----FLEIISSIKEEMEPGFREVSFYYSEENKLPEP 318 (322)
T ss_dssp CCTTCCHHHHHHHHHHTCSSGGGSCC-----HHHHHHHHGGGSCTTHHHHCSTTSTTC-----
T ss_pred CCCCCCHHHHHHHHHHcCCCcccCcC-----HHHHHHHHHHhhccCCcccccccccccCCCCh
Confidence 78899999999999999999999974 6777665 9999999988877777665
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} SCOP: d.144.1.7 PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... | Back alignment and structure |
|---|
Probab=99.62 E-value=1.1e-15 Score=166.07 Aligned_cols=192 Identities=18% Similarity=0.204 Sum_probs=137.2
Q ss_pred CccchhccC---CcceeeeecccccceEEEEEEcCCCCEEEEEeccccc----hhhHHHHHHHHhhCCCccccccccccc
Q psy11767 108 SLFFEQYDM---DLDKAGILGDGSYSVCRRCVEKSTGQEYAVKIISRKI----DCSEEINLLRACQGHPNICRRCVEKST 180 (966)
Q Consensus 108 ~~~~~~~~~---df~~~~~LG~GsFGkV~La~~k~tg~~yAiKvl~K~~----~~~~E~~il~~~~~~pfi~~~~~~~~~ 180 (966)
+|-++.+++ +|++.+.||+|+||.|++|+++.+++.||+|++++.. ...+|..+|+++ +||+|+...-....
T Consensus 2 ~~~~~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~ 80 (288)
T 3kfa_A 2 SPNYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEI-KHPNLVQLLGVCTR 80 (288)
T ss_dssp CTTCCTTBCCGGGEEEEEESGGGTTCSEEEEEEGGGTEEEEEEEECSCSTHHHHHHHHHHHHHHC-CCTTBCCEEEEECS
T ss_pred CCchhcccccccceeEEeecCCCCceeEEEeEecCCCEEEEEEecCcCHHHHHHHHHHHHHHHhC-CCCCEeeEEEEEcc
Confidence 455666777 8999999999999999999999999999999998652 457899999998 59999862111111
Q ss_pred c--------------------------------hhHHHHHHHh----------hcccchhhhHhhhccCCceEEecCccc
Q psy11767 181 G--------------------------------QEYAVKIISR----------KIDCSEEINLLRACQGHPNIVNLHCVF 218 (966)
Q Consensus 181 ~--------------------------------~~~~~~~v~~----------~~~~~~e~nil~~~~gh~~iv~l~~~~ 218 (966)
. ...+.+++.+ ..|++++ |||.+.+|.++|+||+.+.
T Consensus 81 ~~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dikp~-Nil~~~~~~~~l~Dfg~~~ 159 (288)
T 3kfa_A 81 EPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRDLAAR-NCLVGENHLVKVADFGLSR 159 (288)
T ss_dssp SSSEEEEEECCTTEEHHHHHHHCCTTTSCHHHHHHHHHHHHHHHHHHHHHTCCCSCCSGG-GEEECGGGCEEECCCCGGG
T ss_pred CCCEEEEEEcCCCCcHHHHHHhcccCCccHhHHHHHHHHHHHHHHHHHHCCccCCCCCcc-eEEEcCCCCEEEccCccce
Confidence 0 0011122211 1134444 9999999999999998663
Q ss_pred c--------------------ccccccccCCCcceeeechhhHHHHHHHhh-CCCCCCCCcHHHHHHHHHhC-CCCCCCC
Q psy11767 219 Q--------------------DEVIDWDDFSRGIECVFFSSSLIIFFIILS-FTLSFIHDYYHIQYRRILKT-EPPIPED 276 (966)
Q Consensus 219 ~--------------------~e~i~~~~y~~~~d~~~~~~~~il~~~m~~-g~~pf~~~~~~~~~~~I~~~-~~~~P~~ 276 (966)
. +|++....|+...| .| +.|+++|+|++ |.+||...+...+++.+... .+..|..
T Consensus 160 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~D--i~-slG~il~~ll~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 236 (288)
T 3kfa_A 160 LMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSD--VW-AFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMERPEG 236 (288)
T ss_dssp TSCSSSSEEETTEEECGGGCCHHHHHHCCCCHHHH--HH-HHHHHHHHHHTTSCCSSTTCCGGGHHHHHHTTCCCCCCTT
T ss_pred eccCCccccccCCccccCcCChhhhccCCCCchhh--HH-HHHHHHHHHHhCCCCCCCCCCHHHHHHHHhccCCCCCCCC
Confidence 2 23333334433333 34 45566666666 99999988877777777665 6678899
Q ss_pred CCHHHHHHHHhhcccCCCcccCCCCCCHHHHhc
Q psy11767 277 LSPDVADFISRLLVKDPRRRLGGGELDAEELKR 309 (966)
Q Consensus 277 ~s~~a~dli~~LL~kdp~~RLG~~~~g~~~Ik~ 309 (966)
+++++.+||+++|..||.+|.. +++|.+
T Consensus 237 ~~~~l~~li~~~l~~dp~~Rps-----~~~~~~ 264 (288)
T 3kfa_A 237 CPEKVYELMRACWQWNPSDRPS-----FAEIHQ 264 (288)
T ss_dssp CCHHHHHHHHHHTCSSGGGSCC-----HHHHHH
T ss_pred CCHHHHHHHHHHhCCChhhCcC-----HHHHHH
Confidence 9999999999999999999974 677754
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* | Back alignment and structure |
|---|
Probab=99.61 E-value=2.2e-15 Score=166.10 Aligned_cols=197 Identities=21% Similarity=0.279 Sum_probs=132.8
Q ss_pred CccchhccC---CcceeeeecccccceEEEEEEcCCCCEEEEEeccccc-------hhhHHHHHHHHhhC-CCccccccc
Q psy11767 108 SLFFEQYDM---DLDKAGILGDGSYSVCRRCVEKSTGQEYAVKIISRKI-------DCSEEINLLRACQG-HPNICRRCV 176 (966)
Q Consensus 108 ~~~~~~~~~---df~~~~~LG~GsFGkV~La~~k~tg~~yAiKvl~K~~-------~~~~E~~il~~~~~-~pfi~~~~~ 176 (966)
.++++..+. +|.+++.||+|+||+|++|+++ +|+.||||++++.. ...+|..+|++++. ||+|+..+.
T Consensus 17 ~~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~ 95 (313)
T 3cek_A 17 NLYFQSMSVKGRIYSILKQIGSGGSSKVFQVLNE-KKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYD 95 (313)
T ss_dssp ---CCEEEETTEEEEEEEEEECCSSEEEEEEECT-TCCEEEEEEEECSSCCHHHHHHHHHHHHHHHHHGGGCTTBCCEEE
T ss_pred CCCeeeeeeccceEEEEEEecCCCCEEEEEEEcC-CCcEEEEEEeccccccccchHHHHHHHHHHHhccccCCceEEEEE
Confidence 344444544 6899999999999999999986 58999999997532 34779999999875 799976221
Q ss_pred ccccc-----------------------------hhHHHHHHHh----------hcccchhhhHhhhccCCceEEecCcc
Q psy11767 177 EKSTG-----------------------------QEYAVKIISR----------KIDCSEEINLLRACQGHPNIVNLHCV 217 (966)
Q Consensus 177 ~~~~~-----------------------------~~~~~~~v~~----------~~~~~~e~nil~~~~gh~~iv~l~~~ 217 (966)
..... ...+.+++.+ ..|++++ |||.+ +|.++|+||+.+
T Consensus 96 ~~~~~~~~~lv~e~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~-NIl~~-~~~~kL~Dfg~~ 173 (313)
T 3cek_A 96 YEITDQYIYMVMECGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPA-NFLIV-DGMLKLIDFGIA 173 (313)
T ss_dssp EEECSSEEEEEECCCSEEHHHHHHHCSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGG-GEEEE-TTEEEECCCSSS
T ss_pred EeecCCEEEEEEecCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCcc-cEEEE-CCeEEEeecccc
Confidence 11110 0111122211 0134444 88885 488999999876
Q ss_pred cc---------------------cccccc-----------ccCCCcceeeechhhHHHHHHHhhCCCCCCCC-cHHHHHH
Q psy11767 218 FQ---------------------DEVIDW-----------DDFSRGIECVFFSSSLIIFFIILSFTLSFIHD-YYHIQYR 264 (966)
Q Consensus 218 ~~---------------------~e~i~~-----------~~y~~~~d~~~~~~~~il~~~m~~g~~pf~~~-~~~~~~~ 264 (966)
.. +|++.. ..|+...| .|+.|+++|+|++|.+||... +....+.
T Consensus 174 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~D---i~slG~il~el~~g~~pf~~~~~~~~~~~ 250 (313)
T 3cek_A 174 NQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSD---VWSLGCILYYMTYGKTPFQQIINQISKLH 250 (313)
T ss_dssp CC--------------CCGGGCCHHHHTTCC----------CCCHHHH---HHHHHHHHHHHHHSSCTTTTCCSHHHHHH
T ss_pred ccccCccccccccCCCCCCCcCCHHHHhhcccccccccccccCCchHH---HHHHHHHHHHHHhCCCchhhHHHHHHHHH
Confidence 32 222221 12222233 445677888899999999753 3334455
Q ss_pred HHHh--CCCCCCCCCCHHHHHHHHhhcccCCCcccCCCCCCHHHHhcCCceee
Q psy11767 265 RILK--TEPPIPEDLSPDVADFISRLLVKDPRRRLGGGELDAEELKRHPFFNV 315 (966)
Q Consensus 265 ~I~~--~~~~~P~~~s~~a~dli~~LL~kdp~~RLG~~~~g~~~Ik~HpfF~~ 315 (966)
.++. ....+|...++++++||+++|..||.+|. .+.+|.+||||+.
T Consensus 251 ~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rp-----s~~ell~h~~~~~ 298 (313)
T 3cek_A 251 AIIDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRI-----SIPELLAHPYVQI 298 (313)
T ss_dssp HHHCTTSCCCCCCCSCHHHHHHHHHHTCSSTTTSC-----CHHHHHTSHHHHC
T ss_pred HHHhcccccCCcccchHHHHHHHHHHccCCcccCc-----CHHHHhcCccccC
Confidence 5554 34568888999999999999999999998 4899999999964
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} | Back alignment and structure |
|---|
Probab=99.60 E-value=3e-15 Score=163.97 Aligned_cols=183 Identities=16% Similarity=0.158 Sum_probs=130.1
Q ss_pred CcceeeeecccccceEEEEEEcCCCCEEEEEecccc--------chhhHHHHHHHHhhCCCcccccccccccc-------
Q psy11767 117 DLDKAGILGDGSYSVCRRCVEKSTGQEYAVKIISRK--------IDCSEEINLLRACQGHPNICRRCVEKSTG------- 181 (966)
Q Consensus 117 df~~~~~LG~GsFGkV~La~~k~tg~~yAiKvl~K~--------~~~~~E~~il~~~~~~pfi~~~~~~~~~~------- 181 (966)
+|.+++.||+|+||.|++|+++.+|+.||||++.+. ....+|..+|.++ +||+|+...-.....
T Consensus 12 ~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l-~hp~iv~~~~~~~~~~~~~lv~ 90 (294)
T 4eqm_A 12 RYKIVDKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQL-SHQNIVSMIDVDEEDDCYYLVM 90 (294)
T ss_dssp TEEEEEEEEEETTEEEEEEEETTTCSEEEEEEEECCSSCCHHHHHHHHHHHHHHTTC-CBTTBCCEEEEEECSSEEEEEE
T ss_pred cEEEEEEEccCCCEEEEEEEECCCCCeEEEEEeccCccccHHHHHHHHHHHHHHhcC-CCCCCceEEEeeeeCCeEEEEE
Confidence 458999999999999999999999999999998653 1346788888887 699998622111110
Q ss_pred -----------------------hhHHHHHHHh----------hcccchhhhHhhhccCCceEEecCcccc---------
Q psy11767 182 -----------------------QEYAVKIISR----------KIDCSEEINLLRACQGHPNIVNLHCVFQ--------- 219 (966)
Q Consensus 182 -----------------------~~~~~~~v~~----------~~~~~~e~nil~~~~gh~~iv~l~~~~~--------- 219 (966)
..++.+++.+ ..|++++ |||.+.+|+++|+||+.+..
T Consensus 91 e~~~g~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~-Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~ 169 (294)
T 4eqm_A 91 EYIEGPTLSEYIESHGPLSVDTAINFTNQILDGIKHAHDMRIVHRDIKPQ-NILIDSNKTLKIFDFGIAKALSETSLTQT 169 (294)
T ss_dssp ECCCSCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGG-GEEECTTSCEEECCCSSSTTC--------
T ss_pred eCCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHH-HEEECCCCCEEEEeCCCcccccccccccc
Confidence 1111122211 1244444 99999999999999987632
Q ss_pred -----------ccccccccCCCcceeeechhhHHHHHHHhhCCCCCCCCcHHHHHHHHHhCCCC-----CCCCCCHHHHH
Q psy11767 220 -----------DEVIDWDDFSRGIECVFFSSSLIIFFIILSFTLSFIHDYYHIQYRRILKTEPP-----IPEDLSPDVAD 283 (966)
Q Consensus 220 -----------~e~i~~~~y~~~~d~~~~~~~~il~~~m~~g~~pf~~~~~~~~~~~I~~~~~~-----~P~~~s~~a~d 283 (966)
+|++....|+...| .|+.|+++|+|++|.+||...+......+++..... ++..+++++.+
T Consensus 170 ~~~~gt~~y~aPE~~~~~~~~~~~D---i~slG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 246 (294)
T 4eqm_A 170 NHVLGTVQYFSPEQAKGEATDECTD---IYSIGIVLYEMLVGEPPFNGETAVSIAIKHIQDSVPNVTTDVRKDIPQSLSN 246 (294)
T ss_dssp -----CCSSCCHHHHHTCCCCTTHH---HHHHHHHHHHHHHSSCSSCSSCHHHHHHHHHSSCCCCHHHHSCTTSCHHHHH
T ss_pred CccccCccccCHhHhcCCCCCchHh---HHHHHHHHHHHHhCCCCCCCCChHHHHHHHhhccCCCcchhcccCCCHHHHH
Confidence 23444444544444 456778888999999999988877666666655432 45678999999
Q ss_pred HHHhhcccCCCcccCCCCCCHHHHh
Q psy11767 284 FISRLLVKDPRRRLGGGELDAEELK 308 (966)
Q Consensus 284 li~~LL~kdp~~RLG~~~~g~~~Ik 308 (966)
+|.++|.+||.+|..+ +++++
T Consensus 247 li~~~l~~dp~~R~~~----~~~l~ 267 (294)
T 4eqm_A 247 VILRATEKDKANRYKT----IQEMK 267 (294)
T ss_dssp HHHHHSCSSGGGSCSS----HHHHH
T ss_pred HHHHHhcCCHhHcccc----HHHHH
Confidence 9999999999999853 55554
|
| >4hcu_A Tyrosine-protein kinase ITK/TSK; transferase-transferase inhibitor complex; HET: 13L; 1.43A {Homo sapiens} PDB: 4hct_A* 4hcv_A* 3t9t_A* 1sm2_A* 1snu_A* 1snx_A 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=99.60 E-value=2.5e-15 Score=161.79 Aligned_cols=183 Identities=15% Similarity=0.156 Sum_probs=132.2
Q ss_pred CcceeeeecccccceEEEEEEcCCCCEEEEEeccccc----hhhHHHHHHHHhhCCCcccccccccccc-----------
Q psy11767 117 DLDKAGILGDGSYSVCRRCVEKSTGQEYAVKIISRKI----DCSEEINLLRACQGHPNICRRCVEKSTG----------- 181 (966)
Q Consensus 117 df~~~~~LG~GsFGkV~La~~k~tg~~yAiKvl~K~~----~~~~E~~il~~~~~~pfi~~~~~~~~~~----------- 181 (966)
+|++++.||+|+||+|++|+++ +++.||||++++.. ...+|..+|++++ ||+|++.+-.....
T Consensus 11 ~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~-h~~i~~~~~~~~~~~~~~lv~e~~~ 88 (269)
T 4hcu_A 11 ELTFVQEIGSGQFGLVHLGYWL-NKDKVAIKTIREGAMSEEDFIEEAEVMMKLS-HPKLVQLYGVCLEQAPICLVFEFME 88 (269)
T ss_dssp GEEEEEEEEECSSCEEEEEEET-TTEEEEEEEECTTSBCHHHHHHHHHHHHTCC-CTTBCCEEEEECSSSSEEEEEECCT
T ss_pred hceeeheecCCCccEEEEEEec-CCCeEEEEEecccccCHHHHHHHHHHHHhCC-CCCEeeEEEEEecCCceEEEEEeCC
Confidence 6899999999999999999997 46779999998752 4578999999984 99998622111110
Q ss_pred --------------------hhHHHHHHHh----------hcccchhhhHhhhccCCceEEecCcccc------------
Q psy11767 182 --------------------QEYAVKIISR----------KIDCSEEINLLRACQGHPNIVNLHCVFQ------------ 219 (966)
Q Consensus 182 --------------------~~~~~~~v~~----------~~~~~~e~nil~~~~gh~~iv~l~~~~~------------ 219 (966)
...+.+++.+ ..|++++ |||.+.+|.++|+||+.+..
T Consensus 89 ~~~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dikp~-Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~ 167 (269)
T 4hcu_A 89 HGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAAR-NCLVGENQVIKVSDFGMTRFVLDDQYTSSTGT 167 (269)
T ss_dssp TCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGG-GEEECGGGCEEECCTTGGGGBCCHHHHSTTST
T ss_pred CCcHHHHHHhcCcccCHHHHHHHHHHHHHHHHHHHhCCeecCCcchh-eEEEcCCCCEEeccccccccccccccccccCc
Confidence 0011112111 0134444 99999899999999986631
Q ss_pred --------ccccccccCCCcceeeechhhHHHHHHHhh-CCCCCCCCcHHHHHHHHHhC-CCCCCCCCCHHHHHHHHhhc
Q psy11767 220 --------DEVIDWDDFSRGIECVFFSSSLIIFFIILS-FTLSFIHDYYHIQYRRILKT-EPPIPEDLSPDVADFISRLL 289 (966)
Q Consensus 220 --------~e~i~~~~y~~~~d~~~~~~~~il~~~m~~-g~~pf~~~~~~~~~~~I~~~-~~~~P~~~s~~a~dli~~LL 289 (966)
+|++....|+...| .| +.|+++|+|++ |.+||...+...+.+.|..+ .+..|...++++.+||+++|
T Consensus 168 ~~~~~y~aPE~~~~~~~~~~~D--i~-slG~~l~~ll~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l 244 (269)
T 4hcu_A 168 KFPVKWASPEVFSFSRYSSKSD--VW-SFGVLMWEVFSEGKIPYENRSNSEVVEDISTGFRLYKPRLASTHVYQIMNHCW 244 (269)
T ss_dssp TCCGGGCCHHHHHHCCCCHHHH--HH-HHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTTCCCCCCTTSCHHHHHHHHHHT
T ss_pred ccccccCCHHHhcCCCCCchhh--hH-HHHHHHHHHhcCCCCCCCCCCHHHHHHHHhcCccCCCCCcCCHHHHHHHHHHc
Confidence 23444344444333 34 55566666666 99999999988889998876 56678889999999999999
Q ss_pred ccCCCcccCCCCCCHHHHhcC
Q psy11767 290 VKDPRRRLGGGELDAEELKRH 310 (966)
Q Consensus 290 ~kdp~~RLG~~~~g~~~Ik~H 310 (966)
..||.+|.. +.+|.+|
T Consensus 245 ~~~p~~Rps-----~~~ll~~ 260 (269)
T 4hcu_A 245 RERPEDRPA-----FSRLLRQ 260 (269)
T ss_dssp CSSGGGSCC-----HHHHHHH
T ss_pred cCCcccCcC-----HHHHHHH
Confidence 999999974 7777765
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* | Back alignment and structure |
|---|
Probab=99.60 E-value=2.5e-15 Score=166.13 Aligned_cols=181 Identities=19% Similarity=0.222 Sum_probs=132.0
Q ss_pred CcceeeeecccccceEEEEEEcCCCCEEEEEeccccc-------hhhHHHHHHHHhhCCCcccccccccccc--------
Q psy11767 117 DLDKAGILGDGSYSVCRRCVEKSTGQEYAVKIISRKI-------DCSEEINLLRACQGHPNICRRCVEKSTG-------- 181 (966)
Q Consensus 117 df~~~~~LG~GsFGkV~La~~k~tg~~yAiKvl~K~~-------~~~~E~~il~~~~~~pfi~~~~~~~~~~-------- 181 (966)
||++.+.||+|+||+|++|++ +|+.||||++++.. ...+|..+|+++ +||+|+...-.....
T Consensus 38 ~y~i~~~lG~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~hp~iv~~~~~~~~~~~~~lv~e 114 (309)
T 3p86_A 38 DLNIKEKIGAGSFGTVHRAEW--HGSDVAVKILMEQDFHAERVNEFLREVAIMKRL-RHPNIVLFMGAVTQPPNLSIVTE 114 (309)
T ss_dssp GEEEEEEEEECSSEEEEEEEE--TTEEEEEEEECCCCCSHHHHHHHHHHHHHHHHC-CCTTBCCEEEEECSTTCCEEEEE
T ss_pred HceeeeEeecCCCeEEEEEEE--CCCcEEEEEecCCCCCHHHHHHHHHHHHHHHhC-CCCCEeeEEEEEEECCceEEEEe
Confidence 889999999999999999987 58899999998642 346799999998 599998621111110
Q ss_pred -------------------------hhHHHHHHHh-------h--c---ccchhhhHhhhccCCceEEecCccc------
Q psy11767 182 -------------------------QEYAVKIISR-------K--I---DCSEEINLLRACQGHPNIVNLHCVF------ 218 (966)
Q Consensus 182 -------------------------~~~~~~~v~~-------~--~---~~~~e~nil~~~~gh~~iv~l~~~~------ 218 (966)
...+.+++.+ . + |++++ |||.+.+|.++|+||+.+.
T Consensus 115 ~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~ivH~Dikp~-NIll~~~~~~kL~Dfg~a~~~~~~~ 193 (309)
T 3p86_A 115 YLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHNRNPPIVHRNLKSP-NLLVDKKYTVKVCDFGLSRLKASTF 193 (309)
T ss_dssp CCTTCBHHHHHHSTTHHHHSCHHHHHHHHHHHHHHHHHHHTSSSCCCCTTCCGG-GEEECTTCCEEECCCC---------
T ss_pred cCCCCcHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCEECCCCChh-hEEEeCCCcEEECCCCCCccccccc
Confidence 0011122111 1 1 33344 9999999999999998653
Q ss_pred -------------cccccccccCCCcceeeechhhHHHHHHHhhCCCCCCCCcHHHHHHHHH--hCCCCCCCCCCHHHHH
Q psy11767 219 -------------QDEVIDWDDFSRGIECVFFSSSLIIFFIILSFTLSFIHDYYHIQYRRIL--KTEPPIPEDLSPDVAD 283 (966)
Q Consensus 219 -------------~~e~i~~~~y~~~~d~~~~~~~~il~~~m~~g~~pf~~~~~~~~~~~I~--~~~~~~P~~~s~~a~d 283 (966)
.+|++....++...| .|+.|+++|+|++|.+||...+...+...+. ...+.+|..+++++.+
T Consensus 194 ~~~~~~~gt~~y~aPE~~~~~~~~~~~D---iwslG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 270 (309)
T 3p86_A 194 LSSKSAAGTPEWMAPEVLRDEPSNEKSD---VYSFGVILWELATLQQPWGNLNPAQVVAAVGFKCKRLEIPRNLNPQVAA 270 (309)
T ss_dssp --------CCTTSCHHHHTTCCCCTTHH---HHHHHHHHHHHHHCCCTTTTSCHHHHHHHHHHSCCCCCCCTTSCHHHHH
T ss_pred cccccCCCCccccChhhhcCCCCCchhh---HHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCCCccCCHHHHH
Confidence 134555555555555 4567788899999999999888887777774 4567889999999999
Q ss_pred HHHhhcccCCCcccCCCCCCHHHHhc
Q psy11767 284 FISRLLVKDPRRRLGGGELDAEELKR 309 (966)
Q Consensus 284 li~~LL~kdp~~RLG~~~~g~~~Ik~ 309 (966)
||+++|..||.+|.. +.+|.+
T Consensus 271 li~~~l~~dP~~Rps-----~~~ll~ 291 (309)
T 3p86_A 271 IIEGCWTNEPWKRPS-----FATIMD 291 (309)
T ss_dssp HHHHHTCSSGGGSCC-----HHHHHH
T ss_pred HHHHHccCChhhCcC-----HHHHHH
Confidence 999999999999974 778765
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* | Back alignment and structure |
|---|
Probab=99.59 E-value=3e-15 Score=163.20 Aligned_cols=196 Identities=15% Similarity=0.128 Sum_probs=133.8
Q ss_pred CcceeeeecccccceEEEEEEcCCCCEEEEEecccc---chhhHHHHHHHHhhCCCccccccccccc-------------
Q psy11767 117 DLDKAGILGDGSYSVCRRCVEKSTGQEYAVKIISRK---IDCSEEINLLRACQGHPNICRRCVEKST------------- 180 (966)
Q Consensus 117 df~~~~~LG~GsFGkV~La~~k~tg~~yAiKvl~K~---~~~~~E~~il~~~~~~pfi~~~~~~~~~------------- 180 (966)
+|.+.+.||+|+||+|++|+++.+|+.||||++++. ....+|..+++++.+||.++........
T Consensus 11 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 90 (298)
T 1csn_A 11 HYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDAPQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLVIDLLGP 90 (298)
T ss_dssp TEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCTTSCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEEEECCCC
T ss_pred ceEEEEEEeecCCEEEEEEEECCCCcEEEEEEeccCCccHHHHHHHHHHHHHhcCCCCCeEEeecCCCceeEEEEEecCC
Confidence 569999999999999999999999999999999864 2467899999999889988651111000
Q ss_pred -----------------chhHHHHHHHh----------hcccchhhhHhhhccCC-----ceEEecCcccc---------
Q psy11767 181 -----------------GQEYAVKIISR----------KIDCSEEINLLRACQGH-----PNIVNLHCVFQ--------- 219 (966)
Q Consensus 181 -----------------~~~~~~~~v~~----------~~~~~~e~nil~~~~gh-----~~iv~l~~~~~--------- 219 (966)
....+.+++.+ ..|++++ |||.+.+|+ ++|+||+.+..
T Consensus 91 ~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~-NIl~~~~~~~~~~~~kl~Dfg~~~~~~~~~~~~~ 169 (298)
T 1csn_A 91 SLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHEKSLVYRDIKPD-NFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQH 169 (298)
T ss_dssp BHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGG-GEEECCSSSTTTTCEEECCCTTCEESBCTTTCCB
T ss_pred CHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHH-HEEeccCCCCCCCeEEEEECcccccccccccccc
Confidence 01111122211 0144444 999987776 99999986531
Q ss_pred -----------------ccccccccCCCcceeeechhhHHHHHHHhhCCCCCCC---CcHHHHHHHHHhCCCC-----CC
Q psy11767 220 -----------------DEVIDWDDFSRGIECVFFSSSLIIFFIILSFTLSFIH---DYYHIQYRRILKTEPP-----IP 274 (966)
Q Consensus 220 -----------------~e~i~~~~y~~~~d~~~~~~~~il~~~m~~g~~pf~~---~~~~~~~~~I~~~~~~-----~P 274 (966)
+|++....|+...| .|+.|+++|+|++|.+||.. ......+..|...... ++
T Consensus 170 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~D---i~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 246 (298)
T 1csn_A 170 IPYREKKNLSGTARYMSINTHLGREQSRRDD---LEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQSTPLRELC 246 (298)
T ss_dssp CCCCCCCCCCSCTTTCCHHHHTTCCCCHHHH---HHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHHHHHHHHSCHHHHT
T ss_pred ccccCccCCCCCcccCCchhhcCCCCChHHH---HHHHHHHHHHHHcCCCCcchhhccccHHHHHHHHhhccCccHHHHH
Confidence 23333333433333 44567888888899999986 3445556666654322 33
Q ss_pred CCCCHHHHHHHHhhcccCCCcccCCCCCCHHHHh----------cCCceeeeCcccc
Q psy11767 275 EDLSPDVADFISRLLVKDPRRRLGGGELDAEELK----------RHPFFNVIDWDDL 321 (966)
Q Consensus 275 ~~~s~~a~dli~~LL~kdp~~RLG~~~~g~~~Ik----------~HpfF~~idW~~l 321 (966)
..++++.++||.++|..||.+|.. +++|. .......+||+.|
T Consensus 247 ~~~~~~l~~li~~~l~~dp~~RP~-----~~~l~~~l~~~~~~~~~~~~~~~dw~~l 298 (298)
T 1csn_A 247 AGFPEEFYKYMHYARNLAFDATPD-----YDYLQGLFSKVLERLNTTEDENFDWNLL 298 (298)
T ss_dssp TTSCHHHHHHHHHHHHCCTTCCCC-----HHHHHHHHHHHHHHTTCCSCSCCGGGCC
T ss_pred hhCcHHHHHHHHHHhcCCcccCCC-----HHHHHHHHHHHHHhcCCCCCCccccCCC
Confidence 578999999999999999999974 45443 3455667788754
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vhk_A* 3vid_A* 3hng_A* | Back alignment and structure |
|---|
Probab=99.59 E-value=1.5e-15 Score=170.36 Aligned_cols=185 Identities=18% Similarity=0.181 Sum_probs=131.1
Q ss_pred CcceeeeecccccceEEEEE-----EcCCCCEEEEEeccccc------hhhHHHHHHHHhhCCCccccccccccc--c--
Q psy11767 117 DLDKAGILGDGSYSVCRRCV-----EKSTGQEYAVKIISRKI------DCSEEINLLRACQGHPNICRRCVEKST--G-- 181 (966)
Q Consensus 117 df~~~~~LG~GsFGkV~La~-----~k~tg~~yAiKvl~K~~------~~~~E~~il~~~~~~pfi~~~~~~~~~--~-- 181 (966)
+|.+.+.||+|+||.||+|+ ++.+++.||||++++.. ...+|..+|.++.+||+|++..-.... .
T Consensus 23 ~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpniv~~~~~~~~~~~~~ 102 (359)
T 3vhe_A 23 RLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGPL 102 (359)
T ss_dssp GEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTTSCC
T ss_pred ceeeceeecCCCCceEEEEEeccccccccceEEEEEEecCcCCHHHHHHHHHHHHHHHhhcCCcceeeeeeeeecCCCce
Confidence 78999999999999999999 66788999999998742 357899999999899999872211100 0
Q ss_pred --------------------------------------------------------------------------------
Q psy11767 182 -------------------------------------------------------------------------------- 181 (966)
Q Consensus 182 -------------------------------------------------------------------------------- 181 (966)
T Consensus 103 ~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 182 (359)
T 3vhe_A 103 MVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSGFVEEKSLSDVEEEEAP 182 (359)
T ss_dssp EEEEECCTTEEHHHHHHTTTTSBCSCC-----------------------------------------------------
T ss_pred EEEEEecCCCcHHHHHHhccccccccccccchhhcccccccccchhhhccccccCccccccccccccccccchhhhcccc
Confidence
Q ss_pred -------------hhHHHHHHHh----------hcccchhhhHhhhccCCceEEecCcccc-------------------
Q psy11767 182 -------------QEYAVKIISR----------KIDCSEEINLLRACQGHPNIVNLHCVFQ------------------- 219 (966)
Q Consensus 182 -------------~~~~~~~v~~----------~~~~~~e~nil~~~~gh~~iv~l~~~~~------------------- 219 (966)
..++.+++.+ ..|++++ |||.+.+|+++|.||+.+..
T Consensus 183 ~~~~~~~l~~~~~~~~~~ql~~aL~~LH~~~ivH~Dikp~-NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~t~~y 261 (359)
T 3vhe_A 183 EDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAAR-NILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKW 261 (359)
T ss_dssp -CTTTTCBCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGG-GEEECGGGCEEECCCGGGSCTTSCTTCEEC--CEECGGG
T ss_pred cchhccccCHHHHHHHHHHHHHHHHHHHHCCcccCCCChh-hEEEcCCCcEEEEeccceeeecccccchhccccCCCcee
Confidence 0011122111 0144444 99999999999999987631
Q ss_pred --ccccccccCCCcceeeechhhHHHHHHHhh-CCCCCCCCcH-HHHHHHHHh-CCCCCCCCCCHHHHHHHHhhcccCCC
Q psy11767 220 --DEVIDWDDFSRGIECVFFSSSLIIFFIILS-FTLSFIHDYY-HIQYRRILK-TEPPIPEDLSPDVADFISRLLVKDPR 294 (966)
Q Consensus 220 --~e~i~~~~y~~~~d~~~~~~~~il~~~m~~-g~~pf~~~~~-~~~~~~I~~-~~~~~P~~~s~~a~dli~~LL~kdp~ 294 (966)
+|++....|+...| .|+.|+++|+|++ |.+||..... ..+.+.+.. ..+..|..+++++.+||.++|.+||.
T Consensus 262 ~aPE~~~~~~~~~~~D---i~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~ 338 (359)
T 3vhe_A 262 MAPETIFDRVYTIQSD---VWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPS 338 (359)
T ss_dssp CCHHHHHHCCCCHHHH---HHHHHHHHHHHTTTSCCSSTTCCCSHHHHHHHHHTCCCCCCTTCCHHHHHHHHHHTCSSGG
T ss_pred EChhhhcCCCCCchhh---hhhHHHHHHHHHhcCCCCCCccchhHHHHHHHHcCCCCCCCCCCCHHHHHHHHHHccCChh
Confidence 23333334443444 3456677777876 9999976543 333444444 36678899999999999999999999
Q ss_pred cccCCCCCCHHHHhcC
Q psy11767 295 RRLGGGELDAEELKRH 310 (966)
Q Consensus 295 ~RLG~~~~g~~~Ik~H 310 (966)
+|.. +.+|.+|
T Consensus 339 ~Rps-----~~ell~~ 349 (359)
T 3vhe_A 339 QRPT-----FSELVEH 349 (359)
T ss_dssp GSCC-----HHHHHHH
T ss_pred hCCC-----HHHHHHH
Confidence 9984 7888766
|
| >4azs_A Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15A {Escherichia coli} PDB: 4azt_A* 4azv_A* 4azw_A* | Back alignment and structure |
|---|
Probab=99.58 E-value=1.7e-15 Score=181.64 Aligned_cols=91 Identities=18% Similarity=0.285 Sum_probs=80.6
Q ss_pred hhHHHHhCCc-CCCcceeeeeccccCceEEEEEeccCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccc
Q psy11767 868 LFEEQLLGPI-TRARRRTFVNRSRYNVHTYLVLELLKGGELLDRIRQKGRCGFTENEASRIMRQLVAAVHFMHSRGVVHR 946 (966)
Q Consensus 868 l~e~~il~~l-~~~~i~~~~~~~~~~~~~yLVmEy~~gg~L~~~i~~~~~~~~~~~~~~~~~~qi~~al~ylH~~gIiHR 946 (966)
..|..+|+++ .|++++++++.++.+..+|||||||+|++|.++|.+.+. +++. .|+.||+.||.|||++|||||
T Consensus 289 ~~E~~~l~~~~~~~~i~~~~~~~ed~~~~yLVMEyv~G~~L~d~i~~~~~--l~~~---~I~~QIl~AL~ylH~~GIIHR 363 (569)
T 4azs_A 289 HNEIKFLTQPPAGFDAPAVLAHGENAQSGWLVMEKLPGRLLSDMLAAGEE--IDRE---KILGSLLRSLAALEKQGFWHD 363 (569)
T ss_dssp HHHHHHHHSCCTTCCCCCEEEEEECSSEEEEEEECCCSEEHHHHHHTTCC--CCHH---HHHHHHHHHHHHHHHTTCEES
T ss_pred HHHHHHHHhcCCCCCeeEEEEEEEECCEEEEEEecCCCCcHHHHHHhCCC--CCHH---HHHHHHHHHHHHHHHCCceec
Confidence 4588999998 899999999999999999999999999999999987653 6654 478999999999999999999
Q ss_pred CCCCCCeEeecCCCCeeee
Q psy11767 947 DLKPENLLLSGISGNLIKI 965 (966)
Q Consensus 947 DlKPeNILl~~~~~~~iki 965 (966)
||||+||||+. +| .|||
T Consensus 364 DIKPeNILL~~-dg-~vKL 380 (569)
T 4azs_A 364 DVRPWNVMVDA-RQ-HARL 380 (569)
T ss_dssp CCCGGGEEECT-TS-CEEE
T ss_pred cCchHhEEECC-CC-CEEE
Confidence 99999999975 34 3665
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.58 E-value=5e-15 Score=164.85 Aligned_cols=183 Identities=16% Similarity=0.157 Sum_probs=130.2
Q ss_pred CcceeeeecccccceEEEEEEcCCCCE---EEEEecccc------chhhHHHHHHHHhhCCCcccccccccccc------
Q psy11767 117 DLDKAGILGDGSYSVCRRCVEKSTGQE---YAVKIISRK------IDCSEEINLLRACQGHPNICRRCVEKSTG------ 181 (966)
Q Consensus 117 df~~~~~LG~GsFGkV~La~~k~tg~~---yAiKvl~K~------~~~~~E~~il~~~~~~pfi~~~~~~~~~~------ 181 (966)
+|.+.++||+|+||+|++|+++.+|+. ||||++++. ....+|..+|+++ +||+|++..-.....
T Consensus 50 ~y~i~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~lv 128 (325)
T 3kul_A 50 RIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQF-DHPNIIRLEGVVTRGRLAMIV 128 (325)
T ss_dssp GEEEEEEEEETTTEEEEEEEECCTTSCCEEEEEEEECTTCCHHHHHHHHHHHHHHTTC-CCTTBCCEEEEECGGGCCEEE
T ss_pred HeEEeeEEEeCCCcEEEEEEEecCCCCCceEEEEecCCCCCHHHHHHHHHHHHHHHhC-CCCCCCcEEEEEEeCCccEEE
Confidence 679999999999999999999977765 999999864 2357799999888 599998622111110
Q ss_pred -------------------------hhHHHHHHHh----------hcccchhhhHhhhccCCceEEecCcccc-------
Q psy11767 182 -------------------------QEYAVKIISR----------KIDCSEEINLLRACQGHPNIVNLHCVFQ------- 219 (966)
Q Consensus 182 -------------------------~~~~~~~v~~----------~~~~~~e~nil~~~~gh~~iv~l~~~~~------- 219 (966)
...+.+++.+ ..|++++ |||.+.+|.++|+||+.+..
T Consensus 129 ~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~-NIll~~~~~~kl~Dfg~a~~~~~~~~~ 207 (325)
T 3kul_A 129 TEYMENGSLDTFLRTHDGQFTIMQLVGMLRGVGAGMRYLSDLGYVHRDLAAR-NVLVDSNLVCKVSDFGLSRVLEDDPDA 207 (325)
T ss_dssp EECCTTCBHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGG-GEEECTTCCEEECCCSSCEECC----C
T ss_pred eeCCCCCcHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCcc-eEEECCCCCEEECCCCcccccccCccc
Confidence 0011111111 1244444 99999999999999987642
Q ss_pred ---------------ccccccccCCCcceeeechhhHHHHHHHhh-CCCCCCCCcHHHHHHHHHhC-CCCCCCCCCHHHH
Q psy11767 220 ---------------DEVIDWDDFSRGIECVFFSSSLIIFFIILS-FTLSFIHDYYHIQYRRILKT-EPPIPEDLSPDVA 282 (966)
Q Consensus 220 ---------------~e~i~~~~y~~~~d~~~~~~~~il~~~m~~-g~~pf~~~~~~~~~~~I~~~-~~~~P~~~s~~a~ 282 (966)
+|++....|+...| .| +.|+++|+|++ |.+||...+...+.+.+..+ .+..|..+++++.
T Consensus 208 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~D--i~-slG~il~ell~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 284 (325)
T 3kul_A 208 AYTTTGGKIPIRWTAPEAIAFRTFSSASD--VW-SFGVVMWEVLAYGERPYWNMTNRDVISSVEEGYRLPAPMGCPHALH 284 (325)
T ss_dssp CEECC---CCGGGSCHHHHHHCEECHHHH--HH-HHHHHHHHHHTTSCCTTTTSCHHHHHHHHHTTCCCCCCTTCCHHHH
T ss_pred eeeccCCCCcccccCHhHhcCCCCCcHHH--HH-HHHHHHHHHHcCCCCCcccCCHHHHHHHHHcCCCCCCCCCcCHHHH
Confidence 22232233333333 34 55566666665 99999998888888888875 6678889999999
Q ss_pred HHHHhhcccCCCcccCCCCCCHHHHhc
Q psy11767 283 DFISRLLVKDPRRRLGGGELDAEELKR 309 (966)
Q Consensus 283 dli~~LL~kdp~~RLG~~~~g~~~Ik~ 309 (966)
+||.++|..||.+|.. +.+|..
T Consensus 285 ~li~~~l~~dp~~Rps-----~~eil~ 306 (325)
T 3kul_A 285 QLMLDCWHKDRAQRPR-----FSQIVS 306 (325)
T ss_dssp HHHHHHTCSSGGGSCC-----HHHHHH
T ss_pred HHHHHHccCChhhCcC-----HHHHHH
Confidence 9999999999999974 666654
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.58 E-value=7.1e-15 Score=167.35 Aligned_cols=185 Identities=13% Similarity=0.121 Sum_probs=133.7
Q ss_pred CcceeeeecccccceEEEEEEcCCC-------CEEEEEecccc------chhhHHHHHHHHhhCCCccccccccccc---
Q psy11767 117 DLDKAGILGDGSYSVCRRCVEKSTG-------QEYAVKIISRK------IDCSEEINLLRACQGHPNICRRCVEKST--- 180 (966)
Q Consensus 117 df~~~~~LG~GsFGkV~La~~k~tg-------~~yAiKvl~K~------~~~~~E~~il~~~~~~pfi~~~~~~~~~--- 180 (966)
+|.+.+.||+|+||+|++|++..++ +.||||++++. ....+|..+|+++.+||+|++..-....
T Consensus 70 ~y~i~~~LG~G~~g~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~~~ 149 (382)
T 3tt0_A 70 RLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQDGP 149 (382)
T ss_dssp GEEEEEEEEECSSEEEEEEEEETSSTTCTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSS
T ss_pred heEeeeEEecCCCeEEEEEEEccccccccccceEEEEEeeccccCHHHHHHHHHHHHHHHHhcCCchhhhheeeeccCCc
Confidence 6799999999999999999986544 57999999864 2357899999999889999862111110
Q ss_pred -------------------------------------------chhHHHHHHHh----------hcccchhhhHhhhccC
Q psy11767 181 -------------------------------------------GQEYAVKIISR----------KIDCSEEINLLRACQG 207 (966)
Q Consensus 181 -------------------------------------------~~~~~~~~v~~----------~~~~~~e~nil~~~~g 207 (966)
...++.+++.+ ..|++++ |||.+.+|
T Consensus 150 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~-NIll~~~~ 228 (382)
T 3tt0_A 150 LYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAAR-NVLVTEDN 228 (382)
T ss_dssp CEEEEECCTTCBHHHHHHHTCCSSSSSCCCCCSSCCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGG-GEEECTTC
T ss_pred eEEEEEecCCCcHHHHHHHhcccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCCEecCCCCcc-eEEEcCCC
Confidence 01111222221 1244445 99999999
Q ss_pred CceEEecCcccc---------------------ccccccccCCCcceeeechhhHHHHHHHhh-CCCCCCCCcHHHHHHH
Q psy11767 208 HPNIVNLHCVFQ---------------------DEVIDWDDFSRGIECVFFSSSLIIFFIILS-FTLSFIHDYYHIQYRR 265 (966)
Q Consensus 208 h~~iv~l~~~~~---------------------~e~i~~~~y~~~~d~~~~~~~~il~~~m~~-g~~pf~~~~~~~~~~~ 265 (966)
.++|+||+.+.. +|++....|+...| .| +.|+++|+|++ |.+||...+...+++.
T Consensus 229 ~~kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~D--iw-slG~il~ellt~g~~p~~~~~~~~~~~~ 305 (382)
T 3tt0_A 229 VMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSD--VW-SFGVLLWEIFTLGGSPYPGVPVEELFKL 305 (382)
T ss_dssp CEEECSCSCCCCSSCCCTTCCCTTCCCGGGGSCHHHHHSCCCCHHHH--HH-HHHHHHHHHHTTSCCSSTTCCHHHHHHH
T ss_pred cEEEcccCcccccccccccccccCCCCCcceeCHHHhcCCCCCchhH--HH-HHHHHHHHHHhCCCCCCCCCCHHHHHHH
Confidence 999999987642 12233223333333 34 55666666766 9999999988888888
Q ss_pred HHhC-CCCCCCCCCHHHHHHHHhhcccCCCcccCCCCCCHHHHhcC
Q psy11767 266 ILKT-EPPIPEDLSPDVADFISRLLVKDPRRRLGGGELDAEELKRH 310 (966)
Q Consensus 266 I~~~-~~~~P~~~s~~a~dli~~LL~kdp~~RLG~~~~g~~~Ik~H 310 (966)
|..+ .+..|..+++++.+||+++|..||.+|. .+.+|.+|
T Consensus 306 ~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rp-----s~~ell~~ 346 (382)
T 3tt0_A 306 LKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRP-----TFKQLVED 346 (382)
T ss_dssp HHTTCCCCCCSSCCHHHHHHHHHHTCSSGGGSC-----CHHHHHHH
T ss_pred HHcCCCCCCCccCCHHHHHHHHHHcCCChhhCc-----CHHHHHHH
Confidence 8876 6678889999999999999999999997 47888876
|
| >4hgt_A Casein kinase I isoform delta; CK1D, inhibitor, transferase-transferase inhibitor C; HET: 15G; 1.80A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 3uzp_A* 4hnf_A* 1cki_A 1ckj_A 4hni_A* 4hok_A | Back alignment and structure |
|---|
Probab=99.58 E-value=3.2e-15 Score=162.57 Aligned_cols=196 Identities=18% Similarity=0.141 Sum_probs=131.5
Q ss_pred CcceeeeecccccceEEEEEEcCCCCEEEEEecccc---chhhHHHHHHHHhhCCCcccccccc----------------
Q psy11767 117 DLDKAGILGDGSYSVCRRCVEKSTGQEYAVKIISRK---IDCSEEINLLRACQGHPNICRRCVE---------------- 177 (966)
Q Consensus 117 df~~~~~LG~GsFGkV~La~~k~tg~~yAiKvl~K~---~~~~~E~~il~~~~~~pfi~~~~~~---------------- 177 (966)
+|.+.++||+|+||+|++|+++.+|+.||||++... .....|..++++++.++.+......
T Consensus 10 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 89 (296)
T 4hgt_A 10 RYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMELLGP 89 (296)
T ss_dssp -CEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEC---CCCHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEEEEECCCC
T ss_pred ceEEeeeecCCCCeEEEEEEEcCCCceEEEEeecccccchHHHHHHHHHHHhcCCCCCCeeeeecCCCCceEEEEEccCC
Confidence 679999999999999999999999999999997754 3568899999998766655331000
Q ss_pred --------------cccchhHHHHHHHh----------hcccchhhhHhh---hccCCceEEecCcccc-----------
Q psy11767 178 --------------KSTGQEYAVKIISR----------KIDCSEEINLLR---ACQGHPNIVNLHCVFQ----------- 219 (966)
Q Consensus 178 --------------~~~~~~~~~~~v~~----------~~~~~~e~nil~---~~~gh~~iv~l~~~~~----------- 219 (966)
......++.+++.+ ..|++++ |||. +..|.++|+||+.+..
T Consensus 90 ~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~-NIl~~~~~~~~~~kL~Dfg~a~~~~~~~~~~~~~ 168 (296)
T 4hgt_A 90 SLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPD-NFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIP 168 (296)
T ss_dssp BHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGG-GEEECCGGGTTCEEECCCTTCEECBCTTTCCBCC
T ss_pred CHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHH-HeeeeccCCCCeEEEecCccceeccCcccCccCC
Confidence 00001111122211 1244444 9998 7789999999987631
Q ss_pred ---------------ccccccccCCCcceeeechhhHHHHHHHhhCCCCCCCCc---HHHHHHHHHhCCCCCC-----CC
Q psy11767 220 ---------------DEVIDWDDFSRGIECVFFSSSLIIFFIILSFTLSFIHDY---YHIQYRRILKTEPPIP-----ED 276 (966)
Q Consensus 220 ---------------~e~i~~~~y~~~~d~~~~~~~~il~~~m~~g~~pf~~~~---~~~~~~~I~~~~~~~P-----~~ 276 (966)
+|++....|+...| .|+.|+++|+|++|.+||...+ ....+.++.......| ..
T Consensus 169 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~D---i~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 245 (296)
T 4hgt_A 169 YRENKNLTGTARYASINTHLGIEQSRRDD---LESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIEVLCKG 245 (296)
T ss_dssp CCCSCCCCSCGGGCCHHHHTTCCCCHHHH---HHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHHHHHSCHHHHTTT
T ss_pred CCcccccCCCccccchHHhcCCCCCchhH---HHHHHHHHHHHhcCCCCCcccchhhhhhhhhhhhcccccchhhhhhcc
Confidence 12233333333333 3456677779999999997532 2234555555555455 77
Q ss_pred CCHHHHHHHHhhcccCCCcccCCCCCCHHHHhc----------CCceeeeCcccc
Q psy11767 277 LSPDVADFISRLLVKDPRRRLGGGELDAEELKR----------HPFFNVIDWDDL 321 (966)
Q Consensus 277 ~s~~a~dli~~LL~kdp~~RLG~~~~g~~~Ik~----------HpfF~~idW~~l 321 (966)
+++++.+||+++|..||.+|.. +++|.+ ..|-..+||+.|
T Consensus 246 ~~~~l~~li~~~l~~~p~~Rpt-----~~~l~~~l~~~~~~~~~~~~~~~dw~~~ 295 (296)
T 4hgt_A 246 YPSEFATYLNFCRSLRFDDKPD-----YSYLRQLFRNLFHRQGFSYDYVFDWNML 295 (296)
T ss_dssp SCHHHHHHHHHHHTSCTTCCCC-----HHHHHHHHHHHHHHHTCCTTCCCGGGGC
T ss_pred CCHHHHHHHHHHHhcCCCCCCC-----HHHHHHHHHHHHHHhCCCccCccchhhc
Confidence 8999999999999999999984 555543 566677889876
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A | Back alignment and structure |
|---|
Probab=99.58 E-value=6.4e-15 Score=159.64 Aligned_cols=183 Identities=16% Similarity=0.128 Sum_probs=129.2
Q ss_pred CcceeeeecccccceEEEEEEcCCCCEEEEEeccccc----hhhHHHHHHHHhhCCCcccccccccccc-----------
Q psy11767 117 DLDKAGILGDGSYSVCRRCVEKSTGQEYAVKIISRKI----DCSEEINLLRACQGHPNICRRCVEKSTG----------- 181 (966)
Q Consensus 117 df~~~~~LG~GsFGkV~La~~k~tg~~yAiKvl~K~~----~~~~E~~il~~~~~~pfi~~~~~~~~~~----------- 181 (966)
+|.+++.||+|+||.|++|+++ +++.||||++++.. ...+|..+|++++ ||+|++.+......
T Consensus 25 ~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~-h~~i~~~~~~~~~~~~~~lv~e~~~ 102 (283)
T 3gen_A 25 DLTFLKELGTGQFGVVKYGKWR-GQYDVAIKMIKEGSMSEDEFIEEAKVMMNLS-HEKLVQLYGVCTKQRPIFIITEYMA 102 (283)
T ss_dssp GEEEEEECC---CEEEEEEEET-TTEEEEEEEECTTSBCHHHHHHHHHHHHTCC-CTTBCCEEEEECSSSSEEEEECCCT
T ss_pred HHHhHhhcCCCCCceEEEEEEc-CCCeEEEEEecCCCCCHHHHHHHHHHHhcCC-CCCEeeEEEEEecCCCeEEEEeccC
Confidence 7899999999999999999887 67789999998642 4578999999984 99998622111110
Q ss_pred --------------------hhHHHHHHHh----------hcccchhhhHhhhccCCceEEecCcccc------------
Q psy11767 182 --------------------QEYAVKIISR----------KIDCSEEINLLRACQGHPNIVNLHCVFQ------------ 219 (966)
Q Consensus 182 --------------------~~~~~~~v~~----------~~~~~~e~nil~~~~gh~~iv~l~~~~~------------ 219 (966)
...+.+++.+ ..|++++ |||.+.+|+++|+||+.+..
T Consensus 103 ~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~-Nili~~~~~~kl~Dfg~~~~~~~~~~~~~~~~ 181 (283)
T 3gen_A 103 NGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQFLHRDLAAR-NCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGS 181 (283)
T ss_dssp TCBHHHHHHCGGGCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCSGG-GEEECTTSCEEECSTTGGGGBCCHHHHSTTST
T ss_pred CCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHHCCccCCCCccc-eEEEcCCCCEEEccccccccccccccccccCC
Confidence 0011112111 0134444 99999999999999987632
Q ss_pred --------ccccccccCCCcceeeechhhHHHHHHHhh-CCCCCCCCcHHHHHHHHHhC-CCCCCCCCCHHHHHHHHhhc
Q psy11767 220 --------DEVIDWDDFSRGIECVFFSSSLIIFFIILS-FTLSFIHDYYHIQYRRILKT-EPPIPEDLSPDVADFISRLL 289 (966)
Q Consensus 220 --------~e~i~~~~y~~~~d~~~~~~~~il~~~m~~-g~~pf~~~~~~~~~~~I~~~-~~~~P~~~s~~a~dli~~LL 289 (966)
+|++....|+...| .|+.|+++|+|++ |.+||...+...+.+.|..+ ....|...++++.+||.++|
T Consensus 182 ~~~~~y~aPE~~~~~~~~~~~D---v~slG~~l~~l~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l 258 (283)
T 3gen_A 182 KFPVRWSPPEVLMYSKFSSKSD---IWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQGLRLYRPHLASEKVYTIMYSCW 258 (283)
T ss_dssp TSCGGGCCHHHHHHCCCSHHHH---HHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHHTTCCCCCCTTCCHHHHHHHHHTT
T ss_pred ccCcccCCHHHhccCCCCchhh---HHHHHHHHHHHHhCCCCCccccChhHHHHHHhcccCCCCCCcCCHHHHHHHHHHc
Confidence 23344344443333 3456677777775 99999998888888888876 45567788999999999999
Q ss_pred ccCCCcccCCCCCCHHHHhcC
Q psy11767 290 VKDPRRRLGGGELDAEELKRH 310 (966)
Q Consensus 290 ~kdp~~RLG~~~~g~~~Ik~H 310 (966)
..||.+|.. +.+|.+|
T Consensus 259 ~~~p~~Rps-----~~~ll~~ 274 (283)
T 3gen_A 259 HEKADERPT-----FKILLSN 274 (283)
T ss_dssp CSSGGGSCC-----HHHHHHH
T ss_pred cCChhHCcC-----HHHHHHH
Confidence 999999974 7777765
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* | Back alignment and structure |
|---|
Probab=99.57 E-value=3.6e-15 Score=165.59 Aligned_cols=185 Identities=16% Similarity=0.206 Sum_probs=135.0
Q ss_pred CcceeeeecccccceEEEEEEcCCCCEE--EEEecccc------chhhHHHHHHHHhhCCCcccccccccccc-------
Q psy11767 117 DLDKAGILGDGSYSVCRRCVEKSTGQEY--AVKIISRK------IDCSEEINLLRACQGHPNICRRCVEKSTG------- 181 (966)
Q Consensus 117 df~~~~~LG~GsFGkV~La~~k~tg~~y--AiKvl~K~------~~~~~E~~il~~~~~~pfi~~~~~~~~~~------- 181 (966)
||.+.++||+|+||+|++|+++.+|..+ |+|++++. ....+|..+|+++.+||+|++..-.....
T Consensus 26 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv~ 105 (327)
T 1fvr_A 26 DIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAI 105 (327)
T ss_dssp GCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEEEEEE
T ss_pred HccceeeeecCCCceEEEEEEccCCcccceeeeeeccccchHHHHHHHHHHHHHHhccCCCchhhhceeeeeCCceEEEE
Confidence 7899999999999999999999999876 99999863 24577999999998899998621111000
Q ss_pred ---------------------------------------hhHHHHHHHh----------hcccchhhhHhhhccCCceEE
Q psy11767 182 ---------------------------------------QEYAVKIISR----------KIDCSEEINLLRACQGHPNIV 212 (966)
Q Consensus 182 ---------------------------------------~~~~~~~v~~----------~~~~~~e~nil~~~~gh~~iv 212 (966)
..++.+++.+ ..|++++ |||.+.+|.++|+
T Consensus 106 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~-NIl~~~~~~~kL~ 184 (327)
T 1fvr_A 106 EYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAAR-NILVGENYVAKIA 184 (327)
T ss_dssp CCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGG-GEEECGGGCEEEC
T ss_pred ecCCCCCHHHHHHhcccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCCccCCCCccc-eEEEcCCCeEEEc
Confidence 0011112111 0144444 9999999999999
Q ss_pred ecCcccc------------------ccccccccCCCcceeeechhhHHHHHHHhh-CCCCCCCCcHHHHHHHHHhC-CCC
Q psy11767 213 NLHCVFQ------------------DEVIDWDDFSRGIECVFFSSSLIIFFIILS-FTLSFIHDYYHIQYRRILKT-EPP 272 (966)
Q Consensus 213 ~l~~~~~------------------~e~i~~~~y~~~~d~~~~~~~~il~~~m~~-g~~pf~~~~~~~~~~~I~~~-~~~ 272 (966)
||+.+.. +|++....|+...| .|+.|+++|+|++ |.+||...+...+++.+..+ .+.
T Consensus 185 Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~D---i~slG~il~ellt~g~~pf~~~~~~~~~~~~~~~~~~~ 261 (327)
T 1fvr_A 185 DFGLSRGQEVYVKKTMGRLPVRWMAIESLNYSVYTTNSD---VWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQGYRLE 261 (327)
T ss_dssp CTTCEESSCEECCC----CCTTTCCHHHHHHCEECHHHH---HHHHHHHHHHHHTTSCCTTTTCCHHHHHHHGGGTCCCC
T ss_pred ccCcCccccccccccCCCCCccccChhhhccccCCchhc---chHHHHHHHHHHcCCCCCCCCCcHHHHHHHhhcCCCCC
Confidence 9987642 23333333333333 3455677777776 99999999988889988876 567
Q ss_pred CCCCCCHHHHHHHHhhcccCCCcccCCCCCCHHHHhcC
Q psy11767 273 IPEDLSPDVADFISRLLVKDPRRRLGGGELDAEELKRH 310 (966)
Q Consensus 273 ~P~~~s~~a~dli~~LL~kdp~~RLG~~~~g~~~Ik~H 310 (966)
.|..+++++++||.++|..||.+|.. +++|..|
T Consensus 262 ~~~~~~~~l~~li~~~l~~dp~~Rps-----~~ell~~ 294 (327)
T 1fvr_A 262 KPLNCDDEVYDLMRQCWREKPYERPS-----FAQILVS 294 (327)
T ss_dssp CCTTBCHHHHHHHHHHTCSSGGGSCC-----HHHHHHH
T ss_pred CCCCCCHHHHHHHHHHccCChhhCcC-----HHHHHHH
Confidence 88899999999999999999999974 7888776
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=99.57 E-value=1.2e-14 Score=160.40 Aligned_cols=184 Identities=14% Similarity=0.145 Sum_probs=127.3
Q ss_pred CcceeeeecccccceEEEEEEcCCCCEEEEEeccccc--------hhhHHHHHHHHhhCCCcccccccccccc-------
Q psy11767 117 DLDKAGILGDGSYSVCRRCVEKSTGQEYAVKIISRKI--------DCSEEINLLRACQGHPNICRRCVEKSTG------- 181 (966)
Q Consensus 117 df~~~~~LG~GsFGkV~La~~k~tg~~yAiKvl~K~~--------~~~~E~~il~~~~~~pfi~~~~~~~~~~------- 181 (966)
+|.+.+.||+|+||+||+|+++.+|+.||||++++.. ...+|..+|+++ +||+|+...-.+...
T Consensus 35 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l-~hp~iv~~~~~~~~~~~~~lv~ 113 (309)
T 2h34_A 35 PYRLRRLVGRGGMGDVYEAEDTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRL-QEPHVVPIHDFGEIDGQLYVDM 113 (309)
T ss_dssp CEEEEEEEEECSSSEEEEEEETTTTEEEEEEECGGGGGGSHHHHHHHHHHHHHHTTC-CCTTBCCEEEEEEETTEEEEEE
T ss_pred cEEEEEEEcCCCCeeEEEEEEcCCCeEEEEEecCcccccCHHHHHHHHHHHHHHhhc-CCCCeeEEEEEEeeCCeEEEEE
Confidence 7799999999999999999999999999999998642 346788888887 699998621111100
Q ss_pred -----------------------hhHHHHHHHh-------h---cccchhhhHhhhccCCceEEecCcccc---------
Q psy11767 182 -----------------------QEYAVKIISR-------K---IDCSEEINLLRACQGHPNIVNLHCVFQ--------- 219 (966)
Q Consensus 182 -----------------------~~~~~~~v~~-------~---~~~~~e~nil~~~~gh~~iv~l~~~~~--------- 219 (966)
...+.+++.+ . .|++++ |||.+.+|.++|+||+.+..
T Consensus 114 e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~-NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~ 192 (309)
T 2h34_A 114 RLINGVDLAAMLRRQGPLAPPRAVAIVRQIGSALDAAHAAGATHRDVKPE-NILVSADDFAYLVDFGIASATTDEKLTQL 192 (309)
T ss_dssp ECCCCEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGG-GEEECTTSCEEECSCCC------------
T ss_pred EecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCcCCcCCCChH-HEEEcCCCCEEEecCccCccccccccccc
Confidence 0111122111 0 133444 99999999999999986531
Q ss_pred -----------ccccccccCCCcceeeechhhHHHHHHHhhCCCCCCCCcHHHHHHHHHhCCC---CCCCCCCHHHHHHH
Q psy11767 220 -----------DEVIDWDDFSRGIECVFFSSSLIIFFIILSFTLSFIHDYYHIQYRRILKTEP---PIPEDLSPDVADFI 285 (966)
Q Consensus 220 -----------~e~i~~~~y~~~~d~~~~~~~~il~~~m~~g~~pf~~~~~~~~~~~I~~~~~---~~P~~~s~~a~dli 285 (966)
+|++....|+...| .|+.|+++|+|++|.+||...+...+...+....+ .+|..+++++++||
T Consensus 193 ~~~~~~~~y~aPE~~~~~~~~~~~D---i~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li 269 (309)
T 2h34_A 193 GNTVGTLYYMAPERFSESHATYRAD---IYALTCVLYECLTGSPPYQGDQLSVMGAHINQAIPRPSTVRPGIPVAFDAVI 269 (309)
T ss_dssp ----CCGGGCCGGGTCC----CCCH---HHHHHHHHHHHHHSSCSSCSCHHHHHHHHHHSCCCCGGGTSTTCCTHHHHHH
T ss_pred cccCCCcCccCHHHHcCCCCCchHh---HHHHHHHHHHHHHCCCCCCCchHHHHHHHhccCCCCccccCCCCCHHHHHHH
Confidence 34444334443334 44667888889999999999887766555554332 35678999999999
Q ss_pred HhhcccCCCcccCCCCCCHHHHhc
Q psy11767 286 SRLLVKDPRRRLGGGELDAEELKR 309 (966)
Q Consensus 286 ~~LL~kdp~~RLG~~~~g~~~Ik~ 309 (966)
.++|.+||.+|.. .++++..
T Consensus 270 ~~~l~~dP~~Rp~----s~~~l~~ 289 (309)
T 2h34_A 270 ARGMAKNPEDRYV----TCGDLSA 289 (309)
T ss_dssp HHHTCSSGGGSCS----SHHHHHH
T ss_pred HHhccCCHHHHHH----hHHHHHH
Confidence 9999999999985 3666653
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* | Back alignment and structure |
|---|
Probab=99.57 E-value=6e-15 Score=167.71 Aligned_cols=182 Identities=16% Similarity=0.151 Sum_probs=130.3
Q ss_pred CcceeeeecccccceEEEEEEcCCCCEEEEEecccc------chhhHHHHHHHHhhCCCcccccccccccc---------
Q psy11767 117 DLDKAGILGDGSYSVCRRCVEKSTGQEYAVKIISRK------IDCSEEINLLRACQGHPNICRRCVEKSTG--------- 181 (966)
Q Consensus 117 df~~~~~LG~GsFGkV~La~~k~tg~~yAiKvl~K~------~~~~~E~~il~~~~~~pfi~~~~~~~~~~--------- 181 (966)
||.+.+.||+|+||+|++|+++.+|+.||||++++. ....+|..+|+++ +||+|++.+-.....
T Consensus 115 ~~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~hpniv~~~~~~~~~~~~~lv~e~ 193 (377)
T 3cbl_A 115 DLVLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQY-SHPNIVRLIGVCTQKQPIYIVMEL 193 (377)
T ss_dssp GEEEEEEEEEETTEEEEEEEETTTCCEEEEEECCTTSCHHHHTTTTHHHHHHTTC-CCTTBCCEEEEECSSSSCEEEEEC
T ss_pred HeEEeeEeccCCCCeEEEEEEecCCeEEEEEEccccCCHHHHHHHHHHHHHHHhC-CCCCEEEEEEEEecCCCcEEEEEc
Confidence 789999999999999999999999999999999864 2457899999988 699998722111110
Q ss_pred ----------------------hhHHHHHHHh----------hcccchhhhHhhhccCCceEEecCcccc----------
Q psy11767 182 ----------------------QEYAVKIISR----------KIDCSEEINLLRACQGHPNIVNLHCVFQ---------- 219 (966)
Q Consensus 182 ----------------------~~~~~~~v~~----------~~~~~~e~nil~~~~gh~~iv~l~~~~~---------- 219 (966)
...+.+++.+ ..|++++ |||.+.+|+++|.||+.+..
T Consensus 194 ~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~-Nil~~~~~~~kl~DfG~s~~~~~~~~~~~~ 272 (377)
T 3cbl_A 194 VQGGDFLTFLRTEGARLRVKTLLQMVGDAAAGMEYLESKCCIHRDLAAR-NCLVTEKNVLKISDFGMSREEADGVYAASG 272 (377)
T ss_dssp CTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGG-GEEECTTCCEEECCGGGCEECTTSEEECCS
T ss_pred CCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcCCcccCHH-HEEEcCCCcEEECcCCCceecCCCceeecC
Confidence 0011111111 0144444 99999999999999987632
Q ss_pred -----------ccccccccCCCcceeeechhhHHHHHHHhh-CCCCCCCCcHHHHHHHHHhC-CCCCCCCCCHHHHHHHH
Q psy11767 220 -----------DEVIDWDDFSRGIECVFFSSSLIIFFIILS-FTLSFIHDYYHIQYRRILKT-EPPIPEDLSPDVADFIS 286 (966)
Q Consensus 220 -----------~e~i~~~~y~~~~d~~~~~~~~il~~~m~~-g~~pf~~~~~~~~~~~I~~~-~~~~P~~~s~~a~dli~ 286 (966)
+|++....|+...| .|+.|+++|||++ |.+||...+...+.+.+..+ .+.+|..+++++.+||.
T Consensus 273 ~~~~~~~~y~aPE~~~~~~~~~~~D---vwslG~il~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~ 349 (377)
T 3cbl_A 273 GLRQVPVKWTAPEALNYGRYSSESD---VWSFGILLWETFSLGASPYPNLSNQQTREFVEKGGRLPCPELCPDAVFRLME 349 (377)
T ss_dssp SCCEEEGGGSCHHHHHHCEEEHHHH---HHHHHHHHHHHHTTSCCSSTTSCHHHHHHHHHTTCCCCCCTTCCHHHHHHHH
T ss_pred CCCCCCcCcCCHhHhccCCCCchhh---HHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCHHHHHHHH
Confidence 12222223332223 3455667777775 99999988877777777654 56788899999999999
Q ss_pred hhcccCCCcccCCCCCCHHHHh
Q psy11767 287 RLLVKDPRRRLGGGELDAEELK 308 (966)
Q Consensus 287 ~LL~kdp~~RLG~~~~g~~~Ik 308 (966)
++|..||.+|.. +.+|.
T Consensus 350 ~cl~~dP~~Rps-----~~~i~ 366 (377)
T 3cbl_A 350 QCWAYEPGQRPS-----FSTIY 366 (377)
T ss_dssp HHTCSSGGGSCC-----HHHHH
T ss_pred HHcCCCchhCcC-----HHHHH
Confidence 999999999974 66664
|
| >3hmm_A TGF-beta receptor type-1; ALK5, kinase, inhibitor, quinazoline, aortic aneurysm, ATP-binding, craniosynostosis, disease mutation, disulfide bond; HET: 855; 1.70A {Homo sapiens} PDB: 1vjy_A* 3gxl_A* 3tzm_A* 2wot_A* 2wou_A* 1py5_A* 1rw8_A* | Back alignment and structure |
|---|
Probab=99.56 E-value=2.1e-15 Score=166.74 Aligned_cols=92 Identities=20% Similarity=0.274 Sum_probs=78.6
Q ss_pred hHHHHhCCcCCCcceeeeeccccC----ceEEEEEeccCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhC---
Q psy11767 869 FEEQLLGPITRARRRTFVNRSRYN----VHTYLVLELLKGGELLDRIRQKGRCGFTENEASRIMRQLVAAVHFMHSR--- 941 (966)
Q Consensus 869 ~e~~il~~l~~~~i~~~~~~~~~~----~~~yLVmEy~~gg~L~~~i~~~~~~~~~~~~~~~~~~qi~~al~ylH~~--- 941 (966)
.|..++.+++||||+++++.+..+ ..+|||||||+||+|.+++... .+++.++..++.|++.||.|||++
T Consensus 46 ~Ei~~~~~l~HpNIv~l~g~~~~~~~~~~~~~lV~Ey~~~gsL~~~l~~~---~l~~~~~~~i~~~ia~gl~ylH~~~~~ 122 (303)
T 3hmm_A 46 AEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYLNRY---TVTVEGMIKLALSTASGLAHLHMEIVG 122 (303)
T ss_dssp HHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEEEECCTTCBHHHHHHHC---CBCHHHHHHHHHHHHHHHHHHHCCBCS
T ss_pred HHHHHHhcCCCCCCCcEEEEEEecCCCceEEEEEecCCCCCcHHHHHHhC---CCCHHHHHHHHHHHHHHHHHHHHhhhh
Confidence 455667789999999999887654 3689999999999999999765 389999999999999999999987
Q ss_pred -----CCcccCCCCCCeEeecCCCCeeee
Q psy11767 942 -----GVVHRDLKPENLLLSGISGNLIKI 965 (966)
Q Consensus 942 -----gIiHRDlKPeNILl~~~~~~~iki 965 (966)
+||||||||+||||+.+ + .+||
T Consensus 123 ~~~~~~IiHRDlKp~NILl~~~-~-~~Ki 149 (303)
T 3hmm_A 123 TQGKPAIAHRDLKSKNILVKKN-G-TCCI 149 (303)
T ss_dssp TTCBCCEECSCCCGGGEEECTT-S-CEEE
T ss_pred ccCCCCEeeccCCcccEEECCC-C-CEEE
Confidence 99999999999999753 3 4565
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=99.56 E-value=1.1e-14 Score=162.08 Aligned_cols=184 Identities=15% Similarity=0.157 Sum_probs=132.8
Q ss_pred CcceeeeecccccceEEEEEEc-----CCCCEEEEEeccccc------hhhHHHHHHHHhhCCCcccccccccccc----
Q psy11767 117 DLDKAGILGDGSYSVCRRCVEK-----STGQEYAVKIISRKI------DCSEEINLLRACQGHPNICRRCVEKSTG---- 181 (966)
Q Consensus 117 df~~~~~LG~GsFGkV~La~~k-----~tg~~yAiKvl~K~~------~~~~E~~il~~~~~~pfi~~~~~~~~~~---- 181 (966)
+|.+++.||+|+||+||+|+++ .+++.||||++++.. ...+|..+|+++ +||+|++..-.....
T Consensus 48 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~hp~iv~~~~~~~~~~~~~ 126 (343)
T 1luf_A 48 NIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEF-DNPNIVKLLGVCAVGKPMC 126 (343)
T ss_dssp GCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTC-CCTTBCCEEEEECSSSSCE
T ss_pred HCeeeeeeeecCCeeEEEEEecCcCCCCCceeEEEEEeccccCHHHHHHHHHHHHHHHhC-CCCCEEEEEEEEccCCceE
Confidence 7899999999999999999998 466899999998742 357799999998 699998621111100
Q ss_pred --------------------------------------------------hhHHHHHHHh----------hcccchhhhH
Q psy11767 182 --------------------------------------------------QEYAVKIISR----------KIDCSEEINL 201 (966)
Q Consensus 182 --------------------------------------------------~~~~~~~v~~----------~~~~~~e~ni 201 (966)
..++.+++.+ ..|++++ ||
T Consensus 127 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~-NI 205 (343)
T 1luf_A 127 LLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERKFVHRDLATR-NC 205 (343)
T ss_dssp EEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGG-GE
T ss_pred EEEecCCCCcHHHHHHHhCcccccccccccccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCcc-eE
Confidence 0011122211 0144444 99
Q ss_pred hhhccCCceEEecCcccc---------------------ccccccccCCCcceeeechhhHHHHHHHhh-CCCCCCCCcH
Q psy11767 202 LRACQGHPNIVNLHCVFQ---------------------DEVIDWDDFSRGIECVFFSSSLIIFFIILS-FTLSFIHDYY 259 (966)
Q Consensus 202 l~~~~gh~~iv~l~~~~~---------------------~e~i~~~~y~~~~d~~~~~~~~il~~~m~~-g~~pf~~~~~ 259 (966)
|.+.+|.++|+||+.+.. +|++....|+...| .| +.|+++|+|++ |.+||...+.
T Consensus 206 l~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~D--i~-slG~il~el~t~g~~p~~~~~~ 282 (343)
T 1luf_A 206 LVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESD--VW-AYGVVLWEIFSYGLQPYYGMAH 282 (343)
T ss_dssp EECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHH--HH-HHHHHHHHHHTTTCCTTTTSCH
T ss_pred EECCCCeEEEeecCCCcccccCccccccCCCcccceecChhhhccCCcCcccc--cH-HHHHHHHHHHhcCCCcCCCCCh
Confidence 999999999999986531 23333334443333 34 55677777776 9999999888
Q ss_pred HHHHHHHHhCCC-CCCCCCCHHHHHHHHhhcccCCCcccCCCCCCHHHHhcC
Q psy11767 260 HIQYRRILKTEP-PIPEDLSPDVADFISRLLVKDPRRRLGGGELDAEELKRH 310 (966)
Q Consensus 260 ~~~~~~I~~~~~-~~P~~~s~~a~dli~~LL~kdp~~RLG~~~~g~~~Ik~H 310 (966)
..+...|..+.. .+|..+++++.+||+++|..||.+|. .+.+|.++
T Consensus 283 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rp-----s~~~~~~~ 329 (343)
T 1luf_A 283 EEVIYYVRDGNILACPENCPLELYNLMRLCWSKLPADRP-----SFCSIHRI 329 (343)
T ss_dssp HHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSC-----CHHHHHHH
T ss_pred HHHHHHHhCCCcCCCCCCCCHHHHHHHHHHcccCcccCC-----CHHHHHHH
Confidence 888888887654 67889999999999999999999997 37777654
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.56 E-value=4.2e-15 Score=165.57 Aligned_cols=184 Identities=16% Similarity=0.183 Sum_probs=128.1
Q ss_pred CcceeeeecccccceEEEEEEcCCCCEEEEEecccc----------chhhHHHHHHHHhhCCCcccccccccccc-----
Q psy11767 117 DLDKAGILGDGSYSVCRRCVEKSTGQEYAVKIISRK----------IDCSEEINLLRACQGHPNICRRCVEKSTG----- 181 (966)
Q Consensus 117 df~~~~~LG~GsFGkV~La~~k~tg~~yAiKvl~K~----------~~~~~E~~il~~~~~~pfi~~~~~~~~~~----- 181 (966)
+|.++++||+|+||+||+|+++.+|+.+|+|+.-|. ....+|..+|+++ +||+|+..+-.....
T Consensus 16 ~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~iK~~~~~~~~~~~~~~~~E~~~l~~l-~hp~iv~~~~~~~~~~~~~v 94 (327)
T 3lzb_A 16 EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV-DNPHVCRLLGICLTSTVQLI 94 (327)
T ss_dssp TEEEEEEEEECSSEEEEEEEECCTTCSCCEEEEEEEECCCSSCCCHHHHHHHHHHHTTC-CBTTBCCCCEEEESSSEEEE
T ss_pred HceEEEEeeeCCCeEEEEEEEcCCCceEEEEEEEEeeccccCHHHHHHHHHHHHHHHhC-CCCCeeEEEEEEecCCceEE
Confidence 789999999999999999999999998766554332 1357799999888 599998622111110
Q ss_pred -------------------------hhHHHHHHHh----------hcccchhhhHhhhccCCceEEecCcccc-------
Q psy11767 182 -------------------------QEYAVKIISR----------KIDCSEEINLLRACQGHPNIVNLHCVFQ------- 219 (966)
Q Consensus 182 -------------------------~~~~~~~v~~----------~~~~~~e~nil~~~~gh~~iv~l~~~~~------- 219 (966)
..++.+++.+ ..|++++ |||.+.+|+++|+||+.+..
T Consensus 95 ~~~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~-NIl~~~~~~~kL~DfG~a~~~~~~~~~ 173 (327)
T 3lzb_A 95 TQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAAR-NVLVKTPQHVKITDFGLAKLLGAEEKE 173 (327)
T ss_dssp ECCCSSCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGG-GEEEEETTEEEECCTTC----------
T ss_pred EEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhCCCcCCCCCHH-HEEEcCCCCEEEccCcceeEccCcccc
Confidence 1111122211 1244445 99999999999999987632
Q ss_pred --------------ccccccccCCCcceeeechhhHHHHHHHhh-CCCCCCCCcHHHHHHHHHhC-CCCCCCCCCHHHHH
Q psy11767 220 --------------DEVIDWDDFSRGIECVFFSSSLIIFFIILS-FTLSFIHDYYHIQYRRILKT-EPPIPEDLSPDVAD 283 (966)
Q Consensus 220 --------------~e~i~~~~y~~~~d~~~~~~~~il~~~m~~-g~~pf~~~~~~~~~~~I~~~-~~~~P~~~s~~a~d 283 (966)
+|++....|+...| .| +.|+++|+|++ |.+||...+...+.+.+..+ .+..|..+++++.+
T Consensus 174 ~~~~~~~~t~~y~aPE~~~~~~~~~~~D--i~-slG~il~ell~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 250 (327)
T 3lzb_A 174 YHAEGGKVPIKWMALESILHRIYTHQSD--VW-SYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPICTIDVYM 250 (327)
T ss_dssp ------CCCGGGSCHHHHHHCCCCHHHH--HH-HHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTTCCCCCCTTBCHHHHH
T ss_pred ccccCCCccccccCHHHHcCCCCChHHH--HH-HHHHHHHHHHHCCCCCCCCCCHHHHHHHHHcCCCCCCCccCCHHHHH
Confidence 23333334443333 34 55666677766 99999988777777777654 46778899999999
Q ss_pred HHHhhcccCCCcccCCCCCCHHHHhcC
Q psy11767 284 FISRLLVKDPRRRLGGGELDAEELKRH 310 (966)
Q Consensus 284 li~~LL~kdp~~RLG~~~~g~~~Ik~H 310 (966)
||+++|..||.+|.. +.+|...
T Consensus 251 li~~~l~~dp~~Rps-----~~ell~~ 272 (327)
T 3lzb_A 251 IMRKCWMIDADSRPK-----FRELIIE 272 (327)
T ss_dssp HHHHHTCSSGGGSCC-----HHHHHHH
T ss_pred HHHHHcCCChhHCcC-----HHHHHHH
Confidence 999999999999974 7777653
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A | Back alignment and structure |
|---|
Probab=99.55 E-value=7.7e-15 Score=173.19 Aligned_cols=189 Identities=17% Similarity=0.209 Sum_probs=134.9
Q ss_pred chhccC---CcceeeeecccccceEEEEEEcCCCCEEEEEeccccc----hhhHHHHHHHHhhCCCcccccccccccc--
Q psy11767 111 FEQYDM---DLDKAGILGDGSYSVCRRCVEKSTGQEYAVKIISRKI----DCSEEINLLRACQGHPNICRRCVEKSTG-- 181 (966)
Q Consensus 111 ~~~~~~---df~~~~~LG~GsFGkV~La~~k~tg~~yAiKvl~K~~----~~~~E~~il~~~~~~pfi~~~~~~~~~~-- 181 (966)
++.+++ ||.+.+.||+|+||+|++|+++.++..||||++++.. ...+|..+|+++ +||+|++.+-.....
T Consensus 212 ~~~~~~~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l-~hpniv~l~~~~~~~~~ 290 (495)
T 1opk_A 212 YDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEI-KHPNLVQLLGVCTREPP 290 (495)
T ss_dssp SSCCBCCGGGEEEEEESGGGTTSSEEEEEEGGGTEEEEEEECCSSSSCHHHHHHHHHHHHHC-CCTTBCCEEEEECSSSS
T ss_pred ccccccCHHHceeeeEecCCCCeEEEEEEEcCCCeEEEEEEecCcccchHHHHHHHHHHHhc-CCCCEeeEEEEEecCCc
Confidence 344565 8999999999999999999999999999999998642 457899999998 699998621111100
Q ss_pred ------------------------------hhHHHHHHHh----------hcccchhhhHhhhccCCceEEecCcccc--
Q psy11767 182 ------------------------------QEYAVKIISR----------KIDCSEEINLLRACQGHPNIVNLHCVFQ-- 219 (966)
Q Consensus 182 ------------------------------~~~~~~~v~~----------~~~~~~e~nil~~~~gh~~iv~l~~~~~-- 219 (966)
..++.+++.+ ..|++++ |||.+.+|+++|+||+.+..
T Consensus 291 ~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~-NIll~~~~~~kl~DFG~a~~~~ 369 (495)
T 1opk_A 291 FYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRNLAAR-NCLVGENHLVKVADFGLSRLMT 369 (495)
T ss_dssp CEEEEECCTTCBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGG-GEEECGGGCEEECCTTCEECCT
T ss_pred EEEEEEccCCCCHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChh-hEEECCCCcEEEeecccceecc
Confidence 0111122211 0144444 99999999999999986632
Q ss_pred ------------------ccccccccCCCcceeeechhhHHHHHHHhh-CCCCCCCCcHHHHHHHHHhC-CCCCCCCCCH
Q psy11767 220 ------------------DEVIDWDDFSRGIECVFFSSSLIIFFIILS-FTLSFIHDYYHIQYRRILKT-EPPIPEDLSP 279 (966)
Q Consensus 220 ------------------~e~i~~~~y~~~~d~~~~~~~~il~~~m~~-g~~pf~~~~~~~~~~~I~~~-~~~~P~~~s~ 279 (966)
+|++....|+...| .| +.|+++|||++ |.+||...+...+++.+..+ .+..|..+++
T Consensus 370 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sD--vw-SlG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 446 (495)
T 1opk_A 370 GDTYTAHAGAKFPIKWTAPESLAYNKFSIKSD--VW-AFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMERPEGCPE 446 (495)
T ss_dssp TCCEECCTTCCCCGGGCCHHHHHHCEECHHHH--HH-HHHHHHHHHHTTSCCSSTTCCGGGHHHHHHTTCCCCCCTTCCH
T ss_pred CCceeecCCCcCCcceeCHhHHhcCCCCcHHh--HH-hHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCH
Confidence 22333333333333 34 55667777776 99999988777777777654 5677889999
Q ss_pred HHHHHHHhhcccCCCcccCCCCCCHHHHhc
Q psy11767 280 DVADFISRLLVKDPRRRLGGGELDAEELKR 309 (966)
Q Consensus 280 ~a~dli~~LL~kdp~~RLG~~~~g~~~Ik~ 309 (966)
++.+||.++|+.||.+|.. +.+|..
T Consensus 447 ~l~~li~~cl~~dP~~RPs-----~~el~~ 471 (495)
T 1opk_A 447 KVYELMRACWQWNPSDRPS-----FAEIHQ 471 (495)
T ss_dssp HHHHHHHHHTCSSGGGSCC-----HHHHHH
T ss_pred HHHHHHHHHcCcChhHCcC-----HHHHHH
Confidence 9999999999999999974 677754
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} SCOP: d.144.1.7 PDB: 3sxr_A* | Back alignment and structure |
|---|
Probab=99.55 E-value=1.7e-14 Score=155.09 Aligned_cols=183 Identities=15% Similarity=0.131 Sum_probs=129.6
Q ss_pred CcceeeeecccccceEEEEEEcCCCCEEEEEeccccc----hhhHHHHHHHHhhCCCcccccccccccc-----------
Q psy11767 117 DLDKAGILGDGSYSVCRRCVEKSTGQEYAVKIISRKI----DCSEEINLLRACQGHPNICRRCVEKSTG----------- 181 (966)
Q Consensus 117 df~~~~~LG~GsFGkV~La~~k~tg~~yAiKvl~K~~----~~~~E~~il~~~~~~pfi~~~~~~~~~~----------- 181 (966)
+|.+++.||+|+||.|++|+.+ ++..||+|++++.. ...+|..+|+++ +||+|++........
T Consensus 9 ~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~ 86 (268)
T 3sxs_A 9 EITLLKELGSGQFGVVKLGKWK-GQYDVAVKMIKEGSMSEDEFFQEAQTMMKL-SHPKLVKFYGVCSKEYPIYIVTEYIS 86 (268)
T ss_dssp GEEEEEEEEEETTEEEEEEEET-TTEEEEEEEECBTTBCHHHHHHHHHHHHHC-CCTTBCCEEEEECSSSSEEEEEECCT
T ss_pred heeeeeeeccCCCceEEEEEec-CceeEEEEEeccCCCcHHHHHHHHHHHHhC-CCCCEeeEEEEEccCCceEEEEEccC
Confidence 6799999999999999999887 56779999998742 457899999998 499998622111110
Q ss_pred --------------------hhHHHHHHHh----------hcccchhhhHhhhccCCceEEecCcccc------------
Q psy11767 182 --------------------QEYAVKIISR----------KIDCSEEINLLRACQGHPNIVNLHCVFQ------------ 219 (966)
Q Consensus 182 --------------------~~~~~~~v~~----------~~~~~~e~nil~~~~gh~~iv~l~~~~~------------ 219 (966)
...+.+++.+ ..|++++ |||.+.+|.++|+||+.+..
T Consensus 87 ~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~-Nil~~~~~~~~l~Dfg~~~~~~~~~~~~~~~~ 165 (268)
T 3sxs_A 87 NGCLLNYLRSHGKGLEPSQLLEMCYDVCEGMAFLESHQFIHRDLAAR-NCLVDRDLCVKVSDFGMTRYVLDDQYVSSVGT 165 (268)
T ss_dssp TCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHHHTTEEESSCSGG-GEEECTTCCEEECCTTCEEECCTTCEEECCSC
T ss_pred CCcHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCcCcc-eEEECCCCCEEEccCccceecchhhhhcccCC
Confidence 0011122111 0133444 99999999999999986531
Q ss_pred --------ccccccccCCCcceeeechhhHHHHHHHhh-CCCCCCCCcHHHHHHHHHhCC-CCCCCCCCHHHHHHHHhhc
Q psy11767 220 --------DEVIDWDDFSRGIECVFFSSSLIIFFIILS-FTLSFIHDYYHIQYRRILKTE-PPIPEDLSPDVADFISRLL 289 (966)
Q Consensus 220 --------~e~i~~~~y~~~~d~~~~~~~~il~~~m~~-g~~pf~~~~~~~~~~~I~~~~-~~~P~~~s~~a~dli~~LL 289 (966)
+|++....|+...| .| +.|+++|+|++ |.+||...+......++..+. +..|...++++.+||+++|
T Consensus 166 ~~~~~y~aPE~~~~~~~~~~~D--i~-slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l 242 (268)
T 3sxs_A 166 KFPVKWSAPEVFHYFKYSSKSD--VW-AFGILMWEVFSLGKMPYDLYTNSEVVLKVSQGHRLYRPHLASDTIYQIMYSCW 242 (268)
T ss_dssp CCCGGGCCHHHHHHSEEETTHH--HH-HHHHHHHHHHTTTCCTTTTSCHHHHHHHHHTTCCCCCCTTSCHHHHHHHHHTT
T ss_pred CcCcccCCHHHHhccCCchhhh--hH-HHHHHHHHHHcCCCCCccccChHHHHHHHHcCCCCCCCCcChHHHHHHHHHHc
Confidence 23333333443333 34 55666677776 999999888888888887765 4557778999999999999
Q ss_pred ccCCCcccCCCCCCHHHHhcC
Q psy11767 290 VKDPRRRLGGGELDAEELKRH 310 (966)
Q Consensus 290 ~kdp~~RLG~~~~g~~~Ik~H 310 (966)
..||.+|. .+.+|.+|
T Consensus 243 ~~~p~~Rp-----s~~~ll~~ 258 (268)
T 3sxs_A 243 HELPEKRP-----TFQQLLSS 258 (268)
T ss_dssp CSSGGGSC-----CHHHHHHH
T ss_pred CCChhhCc-----CHHHHHHH
Confidence 99999997 47788766
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=99.55 E-value=1.1e-14 Score=162.41 Aligned_cols=186 Identities=15% Similarity=0.153 Sum_probs=129.5
Q ss_pred CcceeeeecccccceEEEEEEc-----CCCCEEEEEeccccc------hhhHHHHHHHHhhCCCcccccccccccc----
Q psy11767 117 DLDKAGILGDGSYSVCRRCVEK-----STGQEYAVKIISRKI------DCSEEINLLRACQGHPNICRRCVEKSTG---- 181 (966)
Q Consensus 117 df~~~~~LG~GsFGkV~La~~k-----~tg~~yAiKvl~K~~------~~~~E~~il~~~~~~pfi~~~~~~~~~~---- 181 (966)
+|++.+.||+|+||+|++|++. .+++.||||++++.. ...+|..+|.++.+||+|++..-.....
T Consensus 46 ~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~ 125 (344)
T 1rjb_A 46 NLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTLSGPIY 125 (344)
T ss_dssp GEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCE
T ss_pred HceeeeeecCCCCceeEEeeeeccccCCcceEEEEEecccccCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEeeCCccE
Confidence 8899999999999999999973 467789999998642 4578999999998899998621111000
Q ss_pred -------------------------------------------------hhHHHHHHHh----------hcccchhhhHh
Q psy11767 182 -------------------------------------------------QEYAVKIISR----------KIDCSEEINLL 202 (966)
Q Consensus 182 -------------------------------------------------~~~~~~~v~~----------~~~~~~e~nil 202 (966)
...+.+++.+ ..|++++ |||
T Consensus 126 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~-NIl 204 (344)
T 1rjb_A 126 LIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKSCVHRDLAAR-NVL 204 (344)
T ss_dssp EEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHTTEEETTCSGG-GEE
T ss_pred EEEecCCCCcHHHHHhhccccccccccchhhhcccccccccccCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChh-hEE
Confidence 0011122211 0144444 999
Q ss_pred hhccCCceEEecCcccc---------------------ccccccccCCCcceeeechhhHHHHHHHhh-CCCCCCCCcHH
Q psy11767 203 RACQGHPNIVNLHCVFQ---------------------DEVIDWDDFSRGIECVFFSSSLIIFFIILS-FTLSFIHDYYH 260 (966)
Q Consensus 203 ~~~~gh~~iv~l~~~~~---------------------~e~i~~~~y~~~~d~~~~~~~~il~~~m~~-g~~pf~~~~~~ 260 (966)
.+.+|+++|.||+.+.. +|++....|+...| .|+.|+++|+|++ |.+||......
T Consensus 205 l~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~D---i~slG~il~el~t~g~~p~~~~~~~ 281 (344)
T 1rjb_A 205 VTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSD---VWSYGILLWEIFSLGVNPYPGIPVD 281 (344)
T ss_dssp EETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHH---HHHHHHHHHHHTTTSCCSSTTCCCS
T ss_pred EcCCCcEEeCCCccCcccccCccceeccCccCccCccCHHHhccCCCChhHh---HHHHHHHHHHHHcCCCCCcccCCcH
Confidence 99999999999987632 23333333433333 4456677777776 99999876544
Q ss_pred HHHHHHHhC--CCCCCCCCCHHHHHHHHhhcccCCCcccCCCCCCHHHHhcCC
Q psy11767 261 IQYRRILKT--EPPIPEDLSPDVADFISRLLVKDPRRRLGGGELDAEELKRHP 311 (966)
Q Consensus 261 ~~~~~I~~~--~~~~P~~~s~~a~dli~~LL~kdp~~RLG~~~~g~~~Ik~Hp 311 (966)
..+..++.. .+..|..+++++.+||.++|..||.+|.. +.+|..|-
T Consensus 282 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps-----~~~l~~~l 329 (344)
T 1rjb_A 282 ANFYKLIQNGFKMDQPFYATEEIYIIMQSCWAFDSRKRPS-----FPNLTSFL 329 (344)
T ss_dssp HHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCC-----HHHHHHHH
T ss_pred HHHHHHHhcCCCCCCCCCCCHHHHHHHHHHcCCCchhCcC-----HHHHHHHH
Confidence 444555543 45678889999999999999999999984 78888764
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 4g5j_A* 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* ... | Back alignment and structure |
|---|
Probab=99.54 E-value=7.9e-15 Score=163.16 Aligned_cols=184 Identities=17% Similarity=0.175 Sum_probs=124.7
Q ss_pred CcceeeeecccccceEEEEEEcCCCCEE----EEEecccc------chhhHHHHHHHHhhCCCcccccccccccc-----
Q psy11767 117 DLDKAGILGDGSYSVCRRCVEKSTGQEY----AVKIISRK------IDCSEEINLLRACQGHPNICRRCVEKSTG----- 181 (966)
Q Consensus 117 df~~~~~LG~GsFGkV~La~~k~tg~~y----AiKvl~K~------~~~~~E~~il~~~~~~pfi~~~~~~~~~~----- 181 (966)
+|.++++||+|+||+||+|+++.+|+.+ |+|.+++. ....+|..+|+++ +||+|++.+-.....
T Consensus 16 ~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~v 94 (327)
T 3poz_A 16 EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV-DNPHVCRLLGICLTSTVQLI 94 (327)
T ss_dssp GEEEEEEEEEETTEEEEEEEECC----CCEEEEEEEC-------CHHHHHHHHHHHHHC-CBTTBCCEEEEEESSSEEEE
T ss_pred HcccceEEeeCCCeEEEEEEEcCCCceEEEEEEEeecccccCHHHHHHHHHHHHHHHhC-CCCCEeEEEEEEecCCeEEE
Confidence 7899999999999999999999999876 66666432 1357799999988 599998622111110
Q ss_pred -------------------------hhHHHHHHHh----------hcccchhhhHhhhccCCceEEecCccc--------
Q psy11767 182 -------------------------QEYAVKIISR----------KIDCSEEINLLRACQGHPNIVNLHCVF-------- 218 (966)
Q Consensus 182 -------------------------~~~~~~~v~~----------~~~~~~e~nil~~~~gh~~iv~l~~~~-------- 218 (966)
..++.+++.+ ..|++++ |||.+.+|+++|+||+.+.
T Consensus 95 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~Dikp~-NIll~~~~~~kl~Dfg~a~~~~~~~~~ 173 (327)
T 3poz_A 95 TQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAAR-NVLVKTPQHVKITDFGLAKLLGAEEKE 173 (327)
T ss_dssp EECCTTCBHHHHHHHSTTSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGG-GEEEEETTEEEECCTTHHHHHTTTCC-
T ss_pred EEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhCCeeCCCCChh-eEEECCCCCEEEccCcceeEccCCccc
Confidence 1111122211 1244444 9999999999999998652
Q ss_pred -------------cccccccccCCCcceeeechhhHHHHHHHhh-CCCCCCCCcHHHHHHHHHhC-CCCCCCCCCHHHHH
Q psy11767 219 -------------QDEVIDWDDFSRGIECVFFSSSLIIFFIILS-FTLSFIHDYYHIQYRRILKT-EPPIPEDLSPDVAD 283 (966)
Q Consensus 219 -------------~~e~i~~~~y~~~~d~~~~~~~~il~~~m~~-g~~pf~~~~~~~~~~~I~~~-~~~~P~~~s~~a~d 283 (966)
.+|++....|+...| +|+.|+++|+|++ |.+||...+...+.+.+..+ .+..|...+.++.+
T Consensus 174 ~~~~~~~~t~~y~aPE~~~~~~~~~~~D---i~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 250 (327)
T 3poz_A 174 YHAEGGKVPIKWMALESILHRIYTHQSD---VWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPICTIDVYM 250 (327)
T ss_dssp ------CCCGGGSCHHHHHHCCCCHHHH---HHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTTCCCCCCTTBCHHHHH
T ss_pred ccccCCCccccccChHHhccCCCCchhh---hhhhHHHHHHHHhcCCCCccCCCHHHHHHHHHcCCCCCCCccCCHHHHH
Confidence 123343344443333 3456666777776 99999987777766666654 46778889999999
Q ss_pred HHHhhcccCCCcccCCCCCCHHHHhcC
Q psy11767 284 FISRLLVKDPRRRLGGGELDAEELKRH 310 (966)
Q Consensus 284 li~~LL~kdp~~RLG~~~~g~~~Ik~H 310 (966)
||.++|+.||.+|.. +.+|..|
T Consensus 251 li~~~l~~~p~~Rps-----~~ell~~ 272 (327)
T 3poz_A 251 IMVKCWMIDADSRPK-----FRELIIE 272 (327)
T ss_dssp HHHHHTCSCGGGSCC-----HHHHHHH
T ss_pred HHHHHcCCChhhCCC-----HHHHHHH
Confidence 999999999999974 7777665
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=99.54 E-value=1.9e-14 Score=154.13 Aligned_cols=183 Identities=15% Similarity=0.146 Sum_probs=130.2
Q ss_pred CcceeeeecccccceEEEEEEcCCCCEEEEEeccccc----hhhHHHHHHHHhhCCCcccccccccccc-----------
Q psy11767 117 DLDKAGILGDGSYSVCRRCVEKSTGQEYAVKIISRKI----DCSEEINLLRACQGHPNICRRCVEKSTG----------- 181 (966)
Q Consensus 117 df~~~~~LG~GsFGkV~La~~k~tg~~yAiKvl~K~~----~~~~E~~il~~~~~~pfi~~~~~~~~~~----------- 181 (966)
+|.+.+.||+|+||+|++|+++ +++.||+|++++.. ...+|..+|+++ +||+|++..-.....
T Consensus 9 ~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~ 86 (267)
T 3t9t_A 9 ELTFVQEIGSGQFGLVHLGYWL-NKDKVAIKTIREGAMSEEDFIEEAEVMMKL-SHPKLVQLYGVCLEQAPICLVTEFME 86 (267)
T ss_dssp GEEEEEEEEEETTEEEEEEEET-TTEEEEEEEECTTTBCHHHHHHHHHHHHTC-CCTTBCCEEEEECSSSSCEEEECCCT
T ss_pred heeeeeEecCCCceeEEEEEec-CCCeEEEEEccccCCCHHHHHHHHHHHHhC-CCCCEeeEEEEEccCCCeEEEEeCCC
Confidence 6789999999999999999997 67889999998752 457899999988 699998621111110
Q ss_pred --------------------hhHHHHHHHh----------hcccchhhhHhhhccCCceEEecCcccc------------
Q psy11767 182 --------------------QEYAVKIISR----------KIDCSEEINLLRACQGHPNIVNLHCVFQ------------ 219 (966)
Q Consensus 182 --------------------~~~~~~~v~~----------~~~~~~e~nil~~~~gh~~iv~l~~~~~------------ 219 (966)
...+.+++.+ ..|++++ |||.+.+|.++|.||+.+..
T Consensus 87 ~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~-Nili~~~~~~kl~dfg~~~~~~~~~~~~~~~~ 165 (267)
T 3t9t_A 87 HGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAAR-NCLVGENQVIKVSDFGMTRFVLDDQYTSSTGT 165 (267)
T ss_dssp TCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCCGG-GEEECGGGCEEECCTTGGGGBCCHHHHSTTST
T ss_pred CCcHHHHHhhCcccCCHHHHHHHHHHHHHHHHHHHhCCcccCCCchh-eEEECCCCCEEEcccccccccccccccccccc
Confidence 0011111111 0133444 99998889999999986532
Q ss_pred --------ccccccccCCCcceeeechhhHHHHHHHhh-CCCCCCCCcHHHHHHHHHhC-CCCCCCCCCHHHHHHHHhhc
Q psy11767 220 --------DEVIDWDDFSRGIECVFFSSSLIIFFIILS-FTLSFIHDYYHIQYRRILKT-EPPIPEDLSPDVADFISRLL 289 (966)
Q Consensus 220 --------~e~i~~~~y~~~~d~~~~~~~~il~~~m~~-g~~pf~~~~~~~~~~~I~~~-~~~~P~~~s~~a~dli~~LL 289 (966)
+|++....|+... |.|+ .|+++|+|++ |.+||...+...+.+.|..+ .+..|...++++.+||+++|
T Consensus 166 ~~~~~y~aPE~~~~~~~~~~~--Di~s-lG~il~~l~~~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~l~~li~~~l 242 (267)
T 3t9t_A 166 KFPVKWASPEVFSFSRYSSKS--DVWS-FGVLMWEVFSEGKIPYENRSNSEVVEDISTGFRLYKPRLASTHVYQIMNHCW 242 (267)
T ss_dssp TCCGGGCCHHHHHHCCCCHHH--HHHH-HHHHHHHHHTTSCCTTTTCCHHHHHHHHHTTCCCCCCTTSCHHHHHHHHHHT
T ss_pred cccccccChhhhcCCCccchh--chhh-hHHHHHHHhccCCCCCCCCCHHHHHHHHhcCCcCCCCccCcHHHHHHHHHHc
Confidence 2333333343333 3444 5566667766 89999998888888888876 45667889999999999999
Q ss_pred ccCCCcccCCCCCCHHHHhcC
Q psy11767 290 VKDPRRRLGGGELDAEELKRH 310 (966)
Q Consensus 290 ~kdp~~RLG~~~~g~~~Ik~H 310 (966)
..||.+|.. +.+|.++
T Consensus 243 ~~~p~~Rps-----~~~ll~~ 258 (267)
T 3t9t_A 243 RERPEDRPA-----FSRLLRQ 258 (267)
T ss_dssp CSSGGGSCC-----HHHHHHH
T ss_pred cCChhhCcC-----HHHHHHH
Confidence 999999974 6777654
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... | Back alignment and structure |
|---|
Probab=99.54 E-value=2.4e-14 Score=159.49 Aligned_cols=185 Identities=12% Similarity=0.123 Sum_probs=130.0
Q ss_pred CcceeeeecccccceEEEEEEc-------CCCCEEEEEeccccc------hhhHHHHHHHHhhCCCcccccccccccc--
Q psy11767 117 DLDKAGILGDGSYSVCRRCVEK-------STGQEYAVKIISRKI------DCSEEINLLRACQGHPNICRRCVEKSTG-- 181 (966)
Q Consensus 117 df~~~~~LG~GsFGkV~La~~k-------~tg~~yAiKvl~K~~------~~~~E~~il~~~~~~pfi~~~~~~~~~~-- 181 (966)
+|.+.+.||+|+||+|++|++. .+++.||||++++.. ...+|..+|+++.+||+|++..-.....
T Consensus 36 ~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~ 115 (334)
T 2pvf_A 36 KLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDGP 115 (334)
T ss_dssp GEEEEEEEEECSSCEEEEEEETTCSTTCC---CEEEEEECCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSC
T ss_pred HeEEeeEEeecCceeEEEeEeccccccccccceEEEEeeeccCCcHHHHHHHHHHHHHHHHhhcCCCEeeEEEEEccCCc
Confidence 7899999999999999999986 577899999998642 3578999999998899998621111000
Q ss_pred --------------------------------------------hhHHHHHHHh----------hcccchhhhHhhhccC
Q psy11767 182 --------------------------------------------QEYAVKIISR----------KIDCSEEINLLRACQG 207 (966)
Q Consensus 182 --------------------------------------------~~~~~~~v~~----------~~~~~~e~nil~~~~g 207 (966)
...+.+++.+ ..|++++ |||.+.+|
T Consensus 116 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~-NIll~~~~ 194 (334)
T 2pvf_A 116 LYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAAR-NVLVTENN 194 (334)
T ss_dssp CEEEEECCTTCBHHHHHHTTSCTTCCSCC--------CCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGG-GEEECTTC
T ss_pred eEEEEECCCCCcHHHHHHHhccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCccc-eEEEcCCC
Confidence 0011122211 0134444 99999999
Q ss_pred CceEEecCcccc---------------------ccccccccCCCcceeeechhhHHHHHHHhh-CCCCCCCCcHHHHHHH
Q psy11767 208 HPNIVNLHCVFQ---------------------DEVIDWDDFSRGIECVFFSSSLIIFFIILS-FTLSFIHDYYHIQYRR 265 (966)
Q Consensus 208 h~~iv~l~~~~~---------------------~e~i~~~~y~~~~d~~~~~~~~il~~~m~~-g~~pf~~~~~~~~~~~ 265 (966)
+++|+||+.+.. +|++....|+... |.| +.|+++|+|++ |.+||...+...+++.
T Consensus 195 ~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~--Di~-slG~il~ellt~g~~p~~~~~~~~~~~~ 271 (334)
T 2pvf_A 195 VMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQS--DVW-SFGVLMWEIFTLGGSPYPGIPVEELFKL 271 (334)
T ss_dssp CEEECCCTTCEECTTTSSEECCSCCCCCGGGCCHHHHHHCEECHHH--HHH-HHHHHHHHHHTTSCCSSTTCCHHHHHHH
T ss_pred CEEEccccccccccccccccccCCCCcccceeChHHhcCCCcChHH--HHH-HHHHHHHHHHhCCCCCcCcCCHHHHHHH
Confidence 999999987632 1222222232222 334 45666666766 9999999888888888
Q ss_pred HHhC-CCCCCCCCCHHHHHHHHhhcccCCCcccCCCCCCHHHHhcC
Q psy11767 266 ILKT-EPPIPEDLSPDVADFISRLLVKDPRRRLGGGELDAEELKRH 310 (966)
Q Consensus 266 I~~~-~~~~P~~~s~~a~dli~~LL~kdp~~RLG~~~~g~~~Ik~H 310 (966)
+..+ .+..|..++++..+||+++|..||.+|. .+.+|..+
T Consensus 272 ~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rp-----s~~ell~~ 312 (334)
T 2pvf_A 272 LKEGHRMDKPANCTNELYMMMRDCWHAVPSQRP-----TFKQLVED 312 (334)
T ss_dssp HHHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSC-----CHHHHHHH
T ss_pred HhcCCCCCCCccCCHHHHHHHHHHccCChhhCc-----CHHHHHHH
Confidence 8776 4678889999999999999999999997 37777765
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.54 E-value=1.3e-14 Score=160.51 Aligned_cols=182 Identities=20% Similarity=0.270 Sum_probs=119.4
Q ss_pred CcceeeeecccccceEEEEEEcCCCCEEEEEeccccc-----hhhHHHHHHHHhhCCCccccccccc--------cc---
Q psy11767 117 DLDKAGILGDGSYSVCRRCVEKSTGQEYAVKIISRKI-----DCSEEINLLRACQGHPNICRRCVEK--------ST--- 180 (966)
Q Consensus 117 df~~~~~LG~GsFGkV~La~~k~tg~~yAiKvl~K~~-----~~~~E~~il~~~~~~pfi~~~~~~~--------~~--- 180 (966)
+|.+.++||+|+||+|++|+++.+|+.||||++.+.. ...+|..+|+++.+||+|++.+-.. ..
T Consensus 29 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~~~~~~~ 108 (337)
T 3ll6_A 29 RLRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRAIIQEVCFMKKLSGHPNIVQFCSAASIGKEESDTGQAE 108 (337)
T ss_dssp EEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEESSHHHHHHHHHHHHHHHHHTTSTTBCCEEEEEEECTTTSTTSSEE
T ss_pred eEEEEEEEccCCceEEEEEEECCCCcEEEEEEecCCchHHHHHHHHHHHHHHHhccCCChhhccccccccccccccCCce
Confidence 7899999999999999999999999999999986542 4578899999998899998632111 00
Q ss_pred -----------------------------chhHHHHHHHh-------h--c---ccchhhhHhhhccCCceEEecCcccc
Q psy11767 181 -----------------------------GQEYAVKIISR-------K--I---DCSEEINLLRACQGHPNIVNLHCVFQ 219 (966)
Q Consensus 181 -----------------------------~~~~~~~~v~~-------~--~---~~~~e~nil~~~~gh~~iv~l~~~~~ 219 (966)
...++.+++.+ . + |++++ |||.+.+|+++|+||+.+..
T Consensus 109 ~~lv~e~~~g~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~ivH~Dikp~-NIl~~~~~~~kl~Dfg~~~~ 187 (337)
T 3ll6_A 109 FLLLTELCKGQLVEFLKKMESRGPLSCDTVLKIFYQTCRAVQHMHRQKPPIIHRDLKVE-NLLLSNQGTIKLCDFGSATT 187 (337)
T ss_dssp EEEEEECCSEEHHHHHHHHHTTCSCCHHHHHHHHHHHHHHHHHHHTSSSCCBCCCCCGG-GCEECTTSCEEBCCCTTCBC
T ss_pred EEEEEEecCCCHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEEccCCcc-cEEECCCCCEEEecCcccee
Confidence 00011111111 1 1 33333 99999999999999987632
Q ss_pred -------------------------------ccccc---cccCCCcceeeechhhHHHHHHHhhCCCCCCCCcHHHHHHH
Q psy11767 220 -------------------------------DEVID---WDDFSRGIECVFFSSSLIIFFIILSFTLSFIHDYYHIQYRR 265 (966)
Q Consensus 220 -------------------------------~e~i~---~~~y~~~~d~~~~~~~~il~~~m~~g~~pf~~~~~~~~~~~ 265 (966)
+|++. ...|+...| .|+.|+++|+|++|.+||.......
T Consensus 188 ~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~D---v~slG~il~el~~g~~p~~~~~~~~---- 260 (337)
T 3ll6_A 188 ISHYPDYSWSAQRRALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQD---IWALGCILYLLCFRQHPFEDGAKLR---- 260 (337)
T ss_dssp CSSCC-------------------------------CCTTSCSSHHHH---HHHHHHHHHHHHHSSCCC-----------
T ss_pred ccccCcccccccccccchhhccccCCCCcCChhhhhccccCCCChHHh---HHHHHHHHHHHHhCCCCCcchhHHH----
Confidence 23331 222322333 4456778888999999997655433
Q ss_pred HHhCCCC--CCCCCCHHHHHHHHhhcccCCCcccCCCCCCHHHHhcCC
Q psy11767 266 ILKTEPP--IPEDLSPDVADFISRLLVKDPRRRLGGGELDAEELKRHP 311 (966)
Q Consensus 266 I~~~~~~--~P~~~s~~a~dli~~LL~kdp~~RLG~~~~g~~~Ik~Hp 311 (966)
++.+... .+...+.+..+||+++|+.||.+|. .+.+|..|-
T Consensus 261 ~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp-----s~~e~l~~l 303 (337)
T 3ll6_A 261 IVNGKYSIPPHDTQYTVFHSLIRAMLQVNPEERL-----SIAEVVHQL 303 (337)
T ss_dssp -----CCCCTTCCSSGGGHHHHHHHSCSSGGGSC-----CHHHHHHHH
T ss_pred hhcCcccCCcccccchHHHHHHHHHccCChhhCc-----CHHHHHHHH
Confidence 3443333 3456788999999999999999998 488898874
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* | Back alignment and structure |
|---|
Probab=99.54 E-value=1e-14 Score=160.09 Aligned_cols=184 Identities=15% Similarity=0.181 Sum_probs=130.3
Q ss_pred CcceeeeecccccceEEEEEE-----cCCCCEEEEEeccccc------hhhHHHHHHHHhhCCCcccccccccccc----
Q psy11767 117 DLDKAGILGDGSYSVCRRCVE-----KSTGQEYAVKIISRKI------DCSEEINLLRACQGHPNICRRCVEKSTG---- 181 (966)
Q Consensus 117 df~~~~~LG~GsFGkV~La~~-----k~tg~~yAiKvl~K~~------~~~~E~~il~~~~~~pfi~~~~~~~~~~---- 181 (966)
+|.+.+.||+|+||.|++|++ +.+++.||||++++.. ...+|..+|+++ +||+|++.+-.....
T Consensus 24 ~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~hp~iv~~~~~~~~~~~~~ 102 (314)
T 2ivs_A 24 NLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQV-NHPHVIKLYGACSQDGPLL 102 (314)
T ss_dssp GEEEEEEEEECSSSEEEEEEEETGGGCSSEEEEEEEECCTTCCHHHHHHHHHHHHHHTTC-CCTTBCCEEEEECSSSSCE
T ss_pred heeeeeeecccCCeeEEEEEEeccCcccCcceEEEEeccCCCCHHHHHHHHHHHHHHhhC-CCCceeeEEEEEecCCceE
Confidence 789999999999999999998 4667899999998642 356799999888 699998621111000
Q ss_pred --------------------------------------------------hhHHHHHHHh----------hcccchhhhH
Q psy11767 182 --------------------------------------------------QEYAVKIISR----------KIDCSEEINL 201 (966)
Q Consensus 182 --------------------------------------------------~~~~~~~v~~----------~~~~~~e~ni 201 (966)
..++.+++.+ ..|++++ ||
T Consensus 103 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dikp~-NI 181 (314)
T 2ivs_A 103 LIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAEMKLVHRDLAAR-NI 181 (314)
T ss_dssp EEEECCTTCBHHHHHHHTTTSTTEEC----------------CEECHHHHHHHHHHHHHHHHHHHHTTEECCCCSGG-GE
T ss_pred EEEeecCCCCHHHHHHHHhhccCCcccccccccccccccccccCcCHHHHHHHHHHHHHHHHHHHHCCCcccccchh-eE
Confidence 0111122211 0144444 99
Q ss_pred hhhccCCceEEecCcccc---------------------ccccccccCCCcceeeechhhHHHHHHHhh-CCCCCCCCcH
Q psy11767 202 LRACQGHPNIVNLHCVFQ---------------------DEVIDWDDFSRGIECVFFSSSLIIFFIILS-FTLSFIHDYY 259 (966)
Q Consensus 202 l~~~~gh~~iv~l~~~~~---------------------~e~i~~~~y~~~~d~~~~~~~~il~~~m~~-g~~pf~~~~~ 259 (966)
|.+.+|+++|.||+.+.. +|++....|+... |.| +.|+++|+|++ |.+||...+.
T Consensus 182 li~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~--Di~-slG~il~el~t~g~~p~~~~~~ 258 (314)
T 2ivs_A 182 LVAEGRKMKISDFGLSRDVYEEDSYVKRSQGRIPVKWMAIESLFDHIYTTQS--DVW-SFGVLLWEIVTLGGNPYPGIPP 258 (314)
T ss_dssp EEETTTEEEECCCTTCEECTTTSCEECSSCCCSCGGGCCHHHHHHCEECHHH--HHH-HHHHHHHHHHTTSCCSSTTCCG
T ss_pred EEcCCCCEEEccccccccccccccceeccCCCCcccccChhhhcCCCcCchh--hHH-HHHHHHHHHHhCCCCCCCCCCH
Confidence 999899999999987632 1222222232222 334 55677777776 9999998888
Q ss_pred HHHHHHHHhC-CCCCCCCCCHHHHHHHHhhcccCCCcccCCCCCCHHHHhcC
Q psy11767 260 HIQYRRILKT-EPPIPEDLSPDVADFISRLLVKDPRRRLGGGELDAEELKRH 310 (966)
Q Consensus 260 ~~~~~~I~~~-~~~~P~~~s~~a~dli~~LL~kdp~~RLG~~~~g~~~Ik~H 310 (966)
..+++.+..+ .+.+|..+++++.+||.++|..||.+|. .+.+|..|
T Consensus 259 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp-----s~~~l~~~ 305 (314)
T 2ivs_A 259 ERLFNLLKTGHRMERPDNCSEEMYRLMLQCWKQEPDKRP-----VFADISKD 305 (314)
T ss_dssp GGHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSC-----CHHHHHHH
T ss_pred HHHHHHhhcCCcCCCCccCCHHHHHHHHHHccCChhhCc-----CHHHHHHH
Confidence 8888888765 4678889999999999999999999997 47788765
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... | Back alignment and structure |
|---|
Probab=99.53 E-value=1.3e-14 Score=159.55 Aligned_cols=185 Identities=17% Similarity=0.187 Sum_probs=127.9
Q ss_pred CcceeeeecccccceEEEEEE-----cCCCCEEEEEeccccc------hhhHHHHHHHHhhCCCccccccccccc--c--
Q psy11767 117 DLDKAGILGDGSYSVCRRCVE-----KSTGQEYAVKIISRKI------DCSEEINLLRACQGHPNICRRCVEKST--G-- 181 (966)
Q Consensus 117 df~~~~~LG~GsFGkV~La~~-----k~tg~~yAiKvl~K~~------~~~~E~~il~~~~~~pfi~~~~~~~~~--~-- 181 (966)
+|.+.+.||+|+||+||+|++ +.+++.||||++++.. ...+|..+|.++.+||+|+...-.... .
T Consensus 28 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~ 107 (316)
T 2xir_A 28 RLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGPL 107 (316)
T ss_dssp GEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECCTTSCC
T ss_pred heeeeeEEcCCCceeEEEEEEecCCccccceEEEEEecccCCCcHHHHHHHHHHHHHHhcccCCCeeeEEEEEecCCCce
Confidence 789999999999999999995 4688999999998742 356899999999889999862211100 0
Q ss_pred -------------------------------------------hhHHHHHHHh----------hcccchhhhHhhhccCC
Q psy11767 182 -------------------------------------------QEYAVKIISR----------KIDCSEEINLLRACQGH 208 (966)
Q Consensus 182 -------------------------------------------~~~~~~~v~~----------~~~~~~e~nil~~~~gh 208 (966)
..++.+++.+ ..|++++ |||.+.+|+
T Consensus 108 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dikp~-Nil~~~~~~ 186 (316)
T 2xir_A 108 MVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAAR-NILLSEKNV 186 (316)
T ss_dssp EEEEECCTTEEHHHHHHTCTTSEECC-------CTTCEEHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGG-GEEECGGGC
T ss_pred EEEEEcCCCCcHHHHHHhcccccccccccchhhhccccCHHHHHHHHHHHHHHHHHHHhCCcccccCccc-eEEECCCCC
Confidence 0011122211 0134444 999998999
Q ss_pred ceEEecCcccc---------------------ccccccccCCCcceeeechhhHHHHHHHhh-CCCCCCCCcH-HHHHHH
Q psy11767 209 PNIVNLHCVFQ---------------------DEVIDWDDFSRGIECVFFSSSLIIFFIILS-FTLSFIHDYY-HIQYRR 265 (966)
Q Consensus 209 ~~iv~l~~~~~---------------------~e~i~~~~y~~~~d~~~~~~~~il~~~m~~-g~~pf~~~~~-~~~~~~ 265 (966)
++|+||+.+.. +|++....|+...| .| +.|+++|+|++ |.+||..... ..+.+.
T Consensus 187 ~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~D--i~-slG~il~~l~t~g~~p~~~~~~~~~~~~~ 263 (316)
T 2xir_A 187 VKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSD--VW-SFGVLLWEIFSLGASPYPGVKIDEEFCRR 263 (316)
T ss_dssp EEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHH--HH-HHHHHHHHHHTTSCCSSTTCCCSHHHHHH
T ss_pred EEECCCccccccccCccceeccCCCcceeecCchhhccccccchhH--HH-HHHHHHHHHHhCCCCCCcccchhHHHHHH
Confidence 99999986632 22233333433333 34 55666677775 9999976543 344455
Q ss_pred HHhC-CCCCCCCCCHHHHHHHHhhcccCCCcccCCCCCCHHHHhcC
Q psy11767 266 ILKT-EPPIPEDLSPDVADFISRLLVKDPRRRLGGGELDAEELKRH 310 (966)
Q Consensus 266 I~~~-~~~~P~~~s~~a~dli~~LL~kdp~~RLG~~~~g~~~Ik~H 310 (966)
+..+ .+..|..+++++.+||.++|..||.+|. .+.+|..|
T Consensus 264 ~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rp-----s~~ell~~ 304 (316)
T 2xir_A 264 LKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRP-----TFSELVEH 304 (316)
T ss_dssp HHHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSC-----CHHHHHHH
T ss_pred hccCccCCCCCCCCHHHHHHHHHHcCCChhhCc-----CHHHHHHH
Confidence 5544 4678889999999999999999999997 47888776
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* | Back alignment and structure |
|---|
Probab=99.53 E-value=1.2e-14 Score=159.44 Aligned_cols=191 Identities=15% Similarity=0.191 Sum_probs=128.3
Q ss_pred chhccC---CcceeeeecccccceEEEEEE-----cCCCCEEEEEeccccc------hhhHHHHHHHHhhCCCccccccc
Q psy11767 111 FEQYDM---DLDKAGILGDGSYSVCRRCVE-----KSTGQEYAVKIISRKI------DCSEEINLLRACQGHPNICRRCV 176 (966)
Q Consensus 111 ~~~~~~---df~~~~~LG~GsFGkV~La~~-----k~tg~~yAiKvl~K~~------~~~~E~~il~~~~~~pfi~~~~~ 176 (966)
...+++ +|.+.+.||+|+||+|++|+. +.+++.||||++++.. ...+|..+|+++.+||+|++..-
T Consensus 15 ~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~ 94 (313)
T 1t46_A 15 DHKWEFPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLG 94 (313)
T ss_dssp CGGGBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEE
T ss_pred ccccccChhhhhHHHhhCccCCcceEEEEEeeccccchhhhhHHHhcCcchhHHHHHHHHHHHHHHhhcccCCCeeeEEE
Confidence 344454 789999999999999999995 5688999999998642 35789999999988999986211
Q ss_pred ccccc------------------------------------------------hhHHHHHHHh----------hcccchh
Q psy11767 177 EKSTG------------------------------------------------QEYAVKIISR----------KIDCSEE 198 (966)
Q Consensus 177 ~~~~~------------------------------------------------~~~~~~~v~~----------~~~~~~e 198 (966)
..... ...+.+++.+ ..|++++
T Consensus 95 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~ 174 (313)
T 1t46_A 95 ACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAAR 174 (313)
T ss_dssp EECSSSSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGG
T ss_pred EEecCCCcEEEEecCCCCCHHHHHHhcccccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHHCCeecCCCccc
Confidence 11000 0011122211 0134444
Q ss_pred hhHhhhccCCceEEecCcccc---------------------ccccccccCCCcceeeechhhHHHHHHHhh-CCCCCCC
Q psy11767 199 INLLRACQGHPNIVNLHCVFQ---------------------DEVIDWDDFSRGIECVFFSSSLIIFFIILS-FTLSFIH 256 (966)
Q Consensus 199 ~nil~~~~gh~~iv~l~~~~~---------------------~e~i~~~~y~~~~d~~~~~~~~il~~~m~~-g~~pf~~ 256 (966)
|||.+.+|.++|.||+.+.. +|++....|+...| .| +.|+++|+|++ |.+||..
T Consensus 175 -Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~D--i~-slG~il~ellt~g~~p~~~ 250 (313)
T 1t46_A 175 -NILLTHGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESD--VW-SYGIFLWELFSLGSSPYPG 250 (313)
T ss_dssp -GEEEETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHH--HH-HHHHHHHHHHTTTCCSSTT
T ss_pred -eEEEcCCCCEEEccccccccccccccceeccCCCCcceeeChHHhcCCCCChHHH--HH-HHHHHHHHHHhCCCCCCCc
Confidence 99999899999999986632 12232233333333 34 45566666765 9999987
Q ss_pred CcHHHHHHHHHhC--CCCCCCCCCHHHHHHHHhhcccCCCcccCCCCCCHHHHhcC
Q psy11767 257 DYYHIQYRRILKT--EPPIPEDLSPDVADFISRLLVKDPRRRLGGGELDAEELKRH 310 (966)
Q Consensus 257 ~~~~~~~~~I~~~--~~~~P~~~s~~a~dli~~LL~kdp~~RLG~~~~g~~~Ik~H 310 (966)
......+..++.. ....|..+++++.+||+++|..||.+|.. +.+|.++
T Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps-----~~ell~~ 301 (313)
T 1t46_A 251 MPVDSKFYKMIKEGFRMLSPEHAPAEMYDIMKTCWDADPLKRPT-----FKQIVQL 301 (313)
T ss_dssp CCSSHHHHHHHHHTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCC-----HHHHHHH
T ss_pred ccchhHHHHHhccCCCCCCcccCCHHHHHHHHHHcCCCchhCcC-----HHHHHHH
Confidence 6544334444432 44557889999999999999999999974 7777654
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* | Back alignment and structure |
|---|
Probab=99.53 E-value=1.7e-14 Score=156.50 Aligned_cols=184 Identities=18% Similarity=0.235 Sum_probs=125.3
Q ss_pred CcceeeeecccccceEEEEEEcCC---CCEEEEEecccc------chhhHHHHHHHHhhCCCcccccccccccc------
Q psy11767 117 DLDKAGILGDGSYSVCRRCVEKST---GQEYAVKIISRK------IDCSEEINLLRACQGHPNICRRCVEKSTG------ 181 (966)
Q Consensus 117 df~~~~~LG~GsFGkV~La~~k~t---g~~yAiKvl~K~------~~~~~E~~il~~~~~~pfi~~~~~~~~~~------ 181 (966)
+|++.+.||+|+||.||+|+++.+ +..+|||++++. ....+|..+|+++ +||+|++.+-.....
T Consensus 16 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~lv~ 94 (281)
T 1mp8_A 16 RIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQF-DHPHIVKLIGVITENPVWIIM 94 (281)
T ss_dssp GEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTC-CCTTBCCEEEEECSSSCEEEE
T ss_pred HeEEEeEeeecCCeeEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHHhC-CCCccceEEEEEccCccEEEE
Confidence 779999999999999999999764 457999998863 2356788899887 699998622111110
Q ss_pred ------------------------hhHHHHHHHh----------hcccchhhhHhhhccCCceEEecCcccc--------
Q psy11767 182 ------------------------QEYAVKIISR----------KIDCSEEINLLRACQGHPNIVNLHCVFQ-------- 219 (966)
Q Consensus 182 ------------------------~~~~~~~v~~----------~~~~~~e~nil~~~~gh~~iv~l~~~~~-------- 219 (966)
..++.+++.+ ..|++++ |||.+.+|+++|+||+.+..
T Consensus 95 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~-Nil~~~~~~~kl~Dfg~~~~~~~~~~~~ 173 (281)
T 1mp8_A 95 ELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLESKRFVHRDIAAR-NVLVSSNDCVKLGDFGLSRYMEDSTYYK 173 (281)
T ss_dssp ECCTTEEHHHHHHHTTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGG-GEEEEETTEEEECC--------------
T ss_pred ecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeecccccHH-HEEECCCCCEEECccccccccCcccccc
Confidence 0011112111 1144444 99999999999999986532
Q ss_pred ------------ccccccccCCCcceeeechhhHHHHHHHh-hCCCCCCCCcHHHHHHHHHhC-CCCCCCCCCHHHHHHH
Q psy11767 220 ------------DEVIDWDDFSRGIECVFFSSSLIIFFIIL-SFTLSFIHDYYHIQYRRILKT-EPPIPEDLSPDVADFI 285 (966)
Q Consensus 220 ------------~e~i~~~~y~~~~d~~~~~~~~il~~~m~-~g~~pf~~~~~~~~~~~I~~~-~~~~P~~~s~~a~dli 285 (966)
+|++....|+...| .|+ .|+++|+|+ +|.+||...+...+...|..+ .+.+|..+++++.+||
T Consensus 174 ~~~~~~~~~y~aPE~~~~~~~~~~~D--i~s-lG~~l~ell~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~l~~li 250 (281)
T 1mp8_A 174 ASKGKLPIKWMAPESINFRRFTSASD--VWM-FGVCMWEILMHGVKPFQGVKNNDVIGRIENGERLPMPPNCPPTLYSLM 250 (281)
T ss_dssp -----CCGGGCCHHHHHHCCCSHHHH--HHH-HHHHHHHHHTTSCCTTTTCCGGGHHHHHHTTCCCCCCTTCCHHHHHHH
T ss_pred cccCCCcccccChhhcccCCCCCccC--chH-HHHHHHHHHhcCCCCCCcCCHHHHHHHHHcCCCCCCCCCCCHHHHHHH
Confidence 23343334443333 454 455666665 599999887777778888775 4678899999999999
Q ss_pred HhhcccCCCcccCCCCCCHHHHhcC
Q psy11767 286 SRLLVKDPRRRLGGGELDAEELKRH 310 (966)
Q Consensus 286 ~~LL~kdp~~RLG~~~~g~~~Ik~H 310 (966)
+++|..||.+|.. +.+|.++
T Consensus 251 ~~~l~~~p~~Rps-----~~~l~~~ 270 (281)
T 1mp8_A 251 TKCWAYDPSRRPR-----FTELKAQ 270 (281)
T ss_dssp HHHTCSSGGGSCC-----HHHHHHH
T ss_pred HHHccCChhhCcC-----HHHHHHH
Confidence 9999999999974 6777654
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A | Back alignment and structure |
|---|
Probab=99.53 E-value=1.8e-15 Score=168.77 Aligned_cols=189 Identities=14% Similarity=0.178 Sum_probs=128.0
Q ss_pred cchhccC-CcceeeeecccccceEEEEEEcCCCCEEEEEecccc-------------chhhHHHHHHHHhh--------C
Q psy11767 110 FFEQYDM-DLDKAGILGDGSYSVCRRCVEKSTGQEYAVKIISRK-------------IDCSEEINLLRACQ--------G 167 (966)
Q Consensus 110 ~~~~~~~-df~~~~~LG~GsFGkV~La~~k~tg~~yAiKvl~K~-------------~~~~~E~~il~~~~--------~ 167 (966)
|.....+ +|.+++.||+|+||+|++|++ +|+.||||++++. ....+|..+|+.++ .
T Consensus 13 ~~~~~~~~~y~~~~~lG~G~~g~V~~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~~~~~~~ 90 (336)
T 2vuw_A 13 FSHCLPTEKLQRCEKIGEGVFGEVFQTIA--DHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISKELSLLSGEVCNR 90 (336)
T ss_dssp HHHHSCHHHHHTCEEEEEETTEEEEEEEE--TTEEEEEEEEEESCSSCBTTBCCBCHHHHHHHHHHHHHHHHGGGCSSSB
T ss_pred hhhhcccccchheeeecccCceEEEEEEe--CCceEEEEEEecCCccccccccchhHHHHHHHHHHHHHHHHhhcccccc
Confidence 3333334 679999999999999999998 7899999999975 34578999998876 3
Q ss_pred -----------------CCcccccccccc------------------------------------------cchhHHHHH
Q psy11767 168 -----------------HPNICRRCVEKS------------------------------------------TGQEYAVKI 188 (966)
Q Consensus 168 -----------------~pfi~~~~~~~~------------------------------------------~~~~~~~~~ 188 (966)
||+|++.+-.+. ....++.++
T Consensus 91 h~niv~l~~~~~~~~~~hp~iv~~~~~~~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~ll~~~~~~~~~~~~~~~i~~qi 170 (336)
T 2vuw_A 91 TEGFIGLNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEFEFGGIDLEQMRTKLSSLATAKSILHQL 170 (336)
T ss_dssp CCCBCCEEEEEEEESSCCHHHHHHHHHHHHHTCCSSCCSCCCCTTCEEEEEEEECCCEETGGGTTTCCCHHHHHHHHHHH
T ss_pred CCchhhhcceeEecCCCcHHHHHHHHHHhhhccccccCccccccCeEEEEEEecCCCccHHHHHhcCCCHHHHHHHHHHH
Confidence 444433111100 001111122
Q ss_pred ------HH-h-h---cccchhhhHhhhccC--------------------CceEEecCccc--------------ccccc
Q psy11767 189 ------IS-R-K---IDCSEEINLLRACQG--------------------HPNIVNLHCVF--------------QDEVI 223 (966)
Q Consensus 189 ------v~-~-~---~~~~~e~nil~~~~g--------------------h~~iv~l~~~~--------------~~e~i 223 (966)
+. . . .|++++ |||.+.+| +++|+||+.+. .+|++
T Consensus 171 ~~aL~~lH~~~~ivHrDlKp~-NILl~~~~~~~~~~~~~~~~~~~~~~~~~vkL~DFG~a~~~~~~~~~gt~~y~aPE~~ 249 (336)
T 2vuw_A 171 TASLAVAEASLRFEHRDLHWG-NVLLKKTSLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLERDGIVVFCDVSMDEDLF 249 (336)
T ss_dssp HHHHHHHHHHHCCBCSCCCGG-GEEEEECSCSEEEEEETTEEEEEECTTEEEEECCCTTCBEEETTEEECCCCTTCSGGG
T ss_pred HHHHHHHHHhCCEeECCCCHH-HEEEeccCCcceeeeccCccccccCCCceEEEeeccccEecCCCcEEEeecccChhhh
Confidence 22 1 1 255555 99999887 89999999763 24555
Q ss_pred ccccCCCcceeeechhhHHHHHHHhhCCCCCCCCcH-HHHHHHHHhC---CCC----CCCCCCHHHHHHHHhhcccCCCc
Q psy11767 224 DWDDFSRGIECVFFSSSLIIFFIILSFTLSFIHDYY-HIQYRRILKT---EPP----IPEDLSPDVADFISRLLVKDPRR 295 (966)
Q Consensus 224 ~~~~y~~~~d~~~~~~~~il~~~m~~g~~pf~~~~~-~~~~~~I~~~---~~~----~P~~~s~~a~dli~~LL~kdp~~ 295 (966)
.... +..+|.|++++.+.++++.|.+||....+ ..+.++++.. ... ++..+|++++|||+++|++|
T Consensus 250 ~g~~---~~~~Diwsl~~~~~~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~d--- 323 (336)
T 2vuw_A 250 TGDG---DYQFDIYRLMKKENNNRWGEYHPYSNVLWLHYLTDKMLKQMTFKTKCNTPAMKQIKRKIQEFHRTMLNFS--- 323 (336)
T ss_dssp CCCS---SHHHHHHHHHHHHHTTCTTSCCTHHHHHHHHHHHHHHHHTCCCSSCCCSHHHHHHHHHHHHHHHHGGGSS---
T ss_pred cCCC---ccceehhhhhCCCCcccccccCCCcchhhhhHHHHhhhhhhccCcccchhhhhhcCHHHHHHHHHHhccC---
Confidence 4322 33456788888889999999999965433 3345555532 111 12357899999999999987
Q ss_pred ccCCCCCCHHHHh-cCCcee
Q psy11767 296 RLGGGELDAEELK-RHPFFN 314 (966)
Q Consensus 296 RLG~~~~g~~~Ik-~HpfF~ 314 (966)
.++++. +||||+
T Consensus 324 -------sa~e~l~~Hp~f~ 336 (336)
T 2vuw_A 324 -------SATDLLCQHSLFK 336 (336)
T ss_dssp -------SHHHHHHHCGGGC
T ss_pred -------CHHHHHhcCCCcC
Confidence 388999 999995
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* | Back alignment and structure |
|---|
Probab=99.53 E-value=1.6e-14 Score=156.14 Aligned_cols=181 Identities=17% Similarity=0.207 Sum_probs=127.1
Q ss_pred CcceeeeecccccceEEEEEEcCCCCEEEEEeccccc---hhhHHHHHHHHhhCCCcccccccc--cccc----------
Q psy11767 117 DLDKAGILGDGSYSVCRRCVEKSTGQEYAVKIISRKI---DCSEEINLLRACQGHPNICRRCVE--KSTG---------- 181 (966)
Q Consensus 117 df~~~~~LG~GsFGkV~La~~k~tg~~yAiKvl~K~~---~~~~E~~il~~~~~~pfi~~~~~~--~~~~---------- 181 (966)
+|++++.||+|+||+|++|+++ |+.||||++++.. ...+|..+|+++ +||+|++..-. ....
T Consensus 22 ~y~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~~lv~e~~~ 98 (278)
T 1byg_A 22 ELKLLQTIGKGEFGDVMLGDYR--GNKVAVKCIKNDATAQAFLAEASVMTQL-RHSNLVQLLGVIVEEKGGLYIVTEYMA 98 (278)
T ss_dssp GEEEEEEEEECSSCEEEEEEET--TEEEEEEECCCCC--HHHHHTHHHHTTC-CCTTBCCEEEEECCC--CCEEEECCCT
T ss_pred hceEEeEEecCCCceEEEEEEc--CCEEEEEEecchhHHHHHHHHHHHHHhC-CCCCEeeEEEEEEcCCCceEEEEecCC
Confidence 7899999999999999999874 8899999998653 356789999888 59999862211 0000
Q ss_pred ---------------------hhHHHHHHHh----------hcccchhhhHhhhccCCceEEecCcccc-----------
Q psy11767 182 ---------------------QEYAVKIISR----------KIDCSEEINLLRACQGHPNIVNLHCVFQ----------- 219 (966)
Q Consensus 182 ---------------------~~~~~~~v~~----------~~~~~~e~nil~~~~gh~~iv~l~~~~~----------- 219 (966)
...+.+++.+ ..|++++ |||.+.+|.++|+||+.+..
T Consensus 99 ~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~-Nil~~~~~~~~l~Dfg~~~~~~~~~~~~~~~ 177 (278)
T 1byg_A 99 KGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAAR-NVLVSEDNVAKVSDFGLTKEASSTQDTGKLP 177 (278)
T ss_dssp TEEHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGG-GEEECTTSCEEECCCCC------------CC
T ss_pred CCCHHHHHHhcccccCCHHHHHHHHHHHHHHHHHHHhCCccccCCCcc-eEEEeCCCcEEEeeccccccccccccCCCcc
Confidence 0000111111 0133444 99999899999999986532
Q ss_pred -----ccccccccCCCcceeeechhhHHHHHHHhh-CCCCCCCCcHHHHHHHHHhC-CCCCCCCCCHHHHHHHHhhcccC
Q psy11767 220 -----DEVIDWDDFSRGIECVFFSSSLIIFFIILS-FTLSFIHDYYHIQYRRILKT-EPPIPEDLSPDVADFISRLLVKD 292 (966)
Q Consensus 220 -----~e~i~~~~y~~~~d~~~~~~~~il~~~m~~-g~~pf~~~~~~~~~~~I~~~-~~~~P~~~s~~a~dli~~LL~kd 292 (966)
+|++....|+...| .| +.|+++|+|++ |.+||...+...+...+..+ .+.+|..++++..+||+++|..|
T Consensus 178 ~~y~aPE~~~~~~~~~~~D--i~-slG~il~~l~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~ 254 (278)
T 1byg_A 178 VKWTAPEALREKKFSTKSD--VW-SFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGYKMDAPDGCPPAVYEVMKNCWHLD 254 (278)
T ss_dssp TTTSCHHHHHHCCCCHHHH--HH-HHHHHHHHHHTTSCCSCTTSCGGGHHHHHTTTCCCCCCTTCCHHHHHHHHHHTCSS
T ss_pred ccccCHHHhCCCCCCchhc--HH-HHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcCCCCCCcccCCHHHHHHHHHHhcCC
Confidence 34444344444344 34 55667777775 99999988777778888765 56788899999999999999999
Q ss_pred CCcccCCCCCCHHHHhc
Q psy11767 293 PRRRLGGGELDAEELKR 309 (966)
Q Consensus 293 p~~RLG~~~~g~~~Ik~ 309 (966)
|.+|.. +.+|..
T Consensus 255 p~~Rps-----~~~l~~ 266 (278)
T 1byg_A 255 AAMRPS-----FLQLRE 266 (278)
T ss_dssp GGGSCC-----HHHHHH
T ss_pred hhhCCC-----HHHHHH
Confidence 999974 566543
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=99.53 E-value=3.2e-14 Score=155.01 Aligned_cols=191 Identities=14% Similarity=0.122 Sum_probs=129.8
Q ss_pred cchhccCCcceeeeecccccceEEEEEEcCCCC---EEEEEeccccc------hhhHHHHHHHHhhCCCccccccccccc
Q psy11767 110 FFEQYDMDLDKAGILGDGSYSVCRRCVEKSTGQ---EYAVKIISRKI------DCSEEINLLRACQGHPNICRRCVEKST 180 (966)
Q Consensus 110 ~~~~~~~df~~~~~LG~GsFGkV~La~~k~tg~---~yAiKvl~K~~------~~~~E~~il~~~~~~pfi~~~~~~~~~ 180 (966)
+...+.+.|+..++||+|+||.||+|++..+++ .||+|++++.. ...+|..+|+++ +||+|+...-....
T Consensus 15 ~i~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~ 93 (298)
T 3pls_A 15 LIPHERVVTHSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGL-NHPNVLALIGIMLP 93 (298)
T ss_dssp BCCGGGEEEEEEEEEEEETTEEEEEEEEECSSSCEEEEEEEEETTCCSHHHHHHHHHHHHHHHTC-CCTTBCCCCEEECC
T ss_pred EccccceEEccCceeccCCCceEEEEEEecCCCceeeeeeeeccccccHHHHHHHHHHHHHHHhC-CCCCeeeEEEEEec
Confidence 344556678888999999999999999877666 89999998642 346789999888 69999862211110
Q ss_pred c--------------------------------hhHHHHHHHh----------hcccchhhhHhhhccCCceEEecCccc
Q psy11767 181 G--------------------------------QEYAVKIISR----------KIDCSEEINLLRACQGHPNIVNLHCVF 218 (966)
Q Consensus 181 ~--------------------------------~~~~~~~v~~----------~~~~~~e~nil~~~~gh~~iv~l~~~~ 218 (966)
. ..++.+++.+ ..|++++ |||.+.+|+++|+||+.+.
T Consensus 94 ~~~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dikp~-Nili~~~~~~kl~Dfg~~~ 172 (298)
T 3pls_A 94 PEGLPHVLLPYMCHGDLLQFIRSPQRNPTVKDLISFGLQVARGMEYLAEQKFVHRDLAAR-NCMLDESFTVKVADFGLAR 172 (298)
T ss_dssp SSSCCEEEECCCTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGG-GEEECTTCCEEECCTTSSC
T ss_pred CCCCcEEEEecccCCCHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCcc-eEEEcCCCcEEeCcCCCcc
Confidence 0 0011122211 1134444 9999999999999999763
Q ss_pred c-----------------------ccccccccCCCcceeeechhhHHHHHHHhhCCCCCCCCcHHHHHHHHHhC-CCCCC
Q psy11767 219 Q-----------------------DEVIDWDDFSRGIECVFFSSSLIIFFIILSFTLSFIHDYYHIQYRRILKT-EPPIP 274 (966)
Q Consensus 219 ~-----------------------~e~i~~~~y~~~~d~~~~~~~~il~~~m~~g~~pf~~~~~~~~~~~I~~~-~~~~P 274 (966)
. +|++....|+.. .|.|++|+++++++.++.|||...+...+.+.+..+ .+..|
T Consensus 173 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~--~Di~slG~il~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~ 250 (298)
T 3pls_A 173 DILDREYYSVQQHRHARLPVKWTALESLQTYRFTTK--SDVWSFGVLLWELLTRGAPPYRHIDPFDLTHFLAQGRRLPQP 250 (298)
T ss_dssp TTTTGGGGCSCCSSCTTCGGGGSCHHHHTTCCCCHH--HHHHHHHHHHHHHHHTSCCTTTTSCGGGHHHHHHTTCCCCCC
T ss_pred cccCCcccccccCcCCCCCccccChhhhccCCCChh--hchhhHHHHHHHHhhCCCCCCccCCHHHHHHHhhcCCCCCCC
Confidence 1 122332233332 344555544444444478888887777777777665 46678
Q ss_pred CCCCHHHHHHHHhhcccCCCcccCCCCCCHHHHhc
Q psy11767 275 EDLSPDVADFISRLLVKDPRRRLGGGELDAEELKR 309 (966)
Q Consensus 275 ~~~s~~a~dli~~LL~kdp~~RLG~~~~g~~~Ik~ 309 (966)
..+++++.+||+++|..||.+|.. +.+|.+
T Consensus 251 ~~~~~~l~~li~~~l~~~p~~Rps-----~~~ll~ 280 (298)
T 3pls_A 251 EYCPDSLYQVMQQCWEADPAVRPT-----FRVLVG 280 (298)
T ss_dssp TTCCHHHHHHHHHHTCSSGGGSCC-----HHHHHH
T ss_pred ccchHHHHHHHHHHccCChhhCcC-----HHHHHH
Confidence 899999999999999999999974 666654
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A | Back alignment and structure |
|---|
Probab=99.53 E-value=2.2e-14 Score=167.11 Aligned_cols=180 Identities=17% Similarity=0.198 Sum_probs=130.5
Q ss_pred CcceeeeecccccceEEEEEEcCCCCEEEEEeccccc---hhhHHHHHHHHhhCCCcccccccc--cccc----------
Q psy11767 117 DLDKAGILGDGSYSVCRRCVEKSTGQEYAVKIISRKI---DCSEEINLLRACQGHPNICRRCVE--KSTG---------- 181 (966)
Q Consensus 117 df~~~~~LG~GsFGkV~La~~k~tg~~yAiKvl~K~~---~~~~E~~il~~~~~~pfi~~~~~~--~~~~---------- 181 (966)
+|++++.||+|+||+|++++.+ |+.||||++++.. ...+|..+|+++ +||+|++.+-. ....
T Consensus 194 ~~~~~~~lG~G~fg~V~~~~~~--~~~vavK~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~~iv~e~~~ 270 (450)
T 1k9a_A 194 ELKLLQTIGKGEFGDVMLGDYR--GNKVAVKCIKNDATAQAFLAEASVMTQL-RHSNLVQLLGVIVEEKGGLYIVTEYMA 270 (450)
T ss_dssp GEEEEEEEEECSSEEEEEEEET--TEEEEEEEESSCTTSHHHHHHHHHHHTC-CCTTBCCEEEEEECTTSCEEEEEECCT
T ss_pred HeEEEeeecCcCCeeEEEEEec--CCeEEEEEeCCchHHHHHHHHHHHHHhc-cCCCEEEEEEEEEcCCCceEEEEEecC
Confidence 8899999999999999999986 7799999998753 457899999998 69999872211 0000
Q ss_pred ---------------------hhHHHHHHHh----------hcccchhhhHhhhccCCceEEecCcccc-----------
Q psy11767 182 ---------------------QEYAVKIISR----------KIDCSEEINLLRACQGHPNIVNLHCVFQ----------- 219 (966)
Q Consensus 182 ---------------------~~~~~~~v~~----------~~~~~~e~nil~~~~gh~~iv~l~~~~~----------- 219 (966)
..++.+++.+ ..|++++ |||.+.+|+++|.||+.+..
T Consensus 271 ~g~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~-Nill~~~~~~kl~DfG~a~~~~~~~~~~~~~ 349 (450)
T 1k9a_A 271 KGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAAR-NVLVSEDNVAKVSDFGLTKEASSTQDTGKLP 349 (450)
T ss_dssp TCBHHHHHHHHCTTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGG-GEEECTTSCEEECCCTTCEECC------CCC
T ss_pred CCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCHh-hEEECCCCCEEEeeCCCcccccccccCCCCC
Confidence 0011112111 0144444 99999999999999987632
Q ss_pred -----ccccccccCCCcceeeechhhHHHHHHHhh-CCCCCCCCcHHHHHHHHHhC-CCCCCCCCCHHHHHHHHhhcccC
Q psy11767 220 -----DEVIDWDDFSRGIECVFFSSSLIIFFIILS-FTLSFIHDYYHIQYRRILKT-EPPIPEDLSPDVADFISRLLVKD 292 (966)
Q Consensus 220 -----~e~i~~~~y~~~~d~~~~~~~~il~~~m~~-g~~pf~~~~~~~~~~~I~~~-~~~~P~~~s~~a~dli~~LL~kd 292 (966)
+|++....|+...| .|+.|+++|||++ |.+||...+...+.+.|..+ .+..|..+++++.+||+++|..|
T Consensus 350 ~~y~aPE~~~~~~~~~~sD---vwslG~~l~el~t~g~~P~~~~~~~~~~~~i~~~~~~~~p~~~~~~l~~li~~cl~~d 426 (450)
T 1k9a_A 350 VKWTAPEALREKKFSTKSD---VWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGYKMDAPDGCPPAVYDVMKNCWHLD 426 (450)
T ss_dssp TTTSCHHHHHSSCCCHHHH---HHHHHHHHHHHHTTTCCSSTTSCTTTHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSS
T ss_pred cceeCHHHhcCCCCCcHHH---HHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCCcCCHHHHHHHHHHcCCC
Confidence 34444445544444 3456677777776 99999887777777888765 57789999999999999999999
Q ss_pred CCcccCCCCCCHHHHh
Q psy11767 293 PRRRLGGGELDAEELK 308 (966)
Q Consensus 293 p~~RLG~~~~g~~~Ik 308 (966)
|.+|.. +.+|.
T Consensus 427 p~~Rpt-----~~~l~ 437 (450)
T 1k9a_A 427 AATRPT-----FLQLR 437 (450)
T ss_dssp GGGSCC-----HHHHH
T ss_pred hhHCcC-----HHHHH
Confidence 999974 55554
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B | Back alignment and structure |
|---|
Probab=99.52 E-value=2.9e-14 Score=166.31 Aligned_cols=182 Identities=16% Similarity=0.193 Sum_probs=131.4
Q ss_pred CcceeeeecccccceEEEEEEcCCCCEEEEEeccccc----hhhHHHHHHHHhhCCCcccccccccccc-----------
Q psy11767 117 DLDKAGILGDGSYSVCRRCVEKSTGQEYAVKIISRKI----DCSEEINLLRACQGHPNICRRCVEKSTG----------- 181 (966)
Q Consensus 117 df~~~~~LG~GsFGkV~La~~k~tg~~yAiKvl~K~~----~~~~E~~il~~~~~~pfi~~~~~~~~~~----------- 181 (966)
+|++.+.||+|+||+|++|+++. +..||||++++.. ...+|..+|+++ +||+|++........
T Consensus 189 ~~~~~~~lG~G~fg~V~~~~~~~-~~~vavK~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~l~~~~~~~~~~lv~e~~~~ 266 (454)
T 1qcf_A 189 SLKLEKKLGAGQFGEVWMATYNK-HTKVAVKTMKPGSMSVEAFLAEANVMKTL-QHDKLVKLHAVVTKEPIYIITEFMAK 266 (454)
T ss_dssp GEEEEEEEECCSSEEEEEEEETT-TEEEEEEEECTTSBCHHHHHHHHHHHTTC-CCTTBCCEEEEECSSSCEEEECCCTT
T ss_pred HeEEEEEcccCCceEEEEEEECC-ccEEEEEEecCCCccHHHHHHHHHHHhhC-CCCCEeeEEEEEeCCccEEEEeecCC
Confidence 78999999999999999999964 6779999998642 457899999988 699998722111110
Q ss_pred --------------------hhHHHHHHHh----------hcccchhhhHhhhccCCceEEecCcccc------------
Q psy11767 182 --------------------QEYAVKIISR----------KIDCSEEINLLRACQGHPNIVNLHCVFQ------------ 219 (966)
Q Consensus 182 --------------------~~~~~~~v~~----------~~~~~~e~nil~~~~gh~~iv~l~~~~~------------ 219 (966)
..++.+++.+ ..|++++ |||.+.+|+++|+||+.+..
T Consensus 267 g~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~-Nill~~~~~~kl~DFG~a~~~~~~~~~~~~~~ 345 (454)
T 1qcf_A 267 GSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRNYIHRDLRAA-NILVSASLVCKIADFGLARVIEDNEYTAREGA 345 (454)
T ss_dssp CBHHHHHHSHHHHTCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCSGG-GEEECTTCCEEECSTTGGGGBCCHHHHTTCSS
T ss_pred CcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCCHH-HEEECCCCcEEEeeCCCceEcCCCceeccCCC
Confidence 0011122211 1144444 99999999999999987642
Q ss_pred --------ccccccccCCCcceeeechhhHHHHHHHhh-CCCCCCCCcHHHHHHHHHhC-CCCCCCCCCHHHHHHHHhhc
Q psy11767 220 --------DEVIDWDDFSRGIECVFFSSSLIIFFIILS-FTLSFIHDYYHIQYRRILKT-EPPIPEDLSPDVADFISRLL 289 (966)
Q Consensus 220 --------~e~i~~~~y~~~~d~~~~~~~~il~~~m~~-g~~pf~~~~~~~~~~~I~~~-~~~~P~~~s~~a~dli~~LL 289 (966)
+|++....|+...| .|+.|+++|||++ |.+||...+...+.+.|..+ .+..|..+++++.+||.++|
T Consensus 346 ~~~~~y~aPE~~~~~~~~~~~D---vwslG~~l~el~t~g~~P~~~~~~~~~~~~i~~~~~~~~~~~~~~~l~~li~~cl 422 (454)
T 1qcf_A 346 KFPIKWTAPEAINFGSFTIKSD---VWSFGILLMEIVTYGRIPYPGMSNPEVIRALERGYRMPRPENCPEELYNIMMRCW 422 (454)
T ss_dssp SSCGGGSCHHHHHHCCCCHHHH---HHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHHTCCCCCCTTSCHHHHHHHHHHT
T ss_pred cccccccCHHHhccCCCCcHHH---HHhHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCHHHHHHHHHHc
Confidence 23333334443334 4456677777776 99999988888888888765 56678899999999999999
Q ss_pred ccCCCcccCCCCCCHHHHhc
Q psy11767 290 VKDPRRRLGGGELDAEELKR 309 (966)
Q Consensus 290 ~kdp~~RLG~~~~g~~~Ik~ 309 (966)
..||.+|.. +++|..
T Consensus 423 ~~dp~~RPt-----~~~i~~ 437 (454)
T 1qcf_A 423 KNRPEERPT-----FEYIQS 437 (454)
T ss_dssp CSSGGGSCC-----HHHHHH
T ss_pred cCChhHCcC-----HHHHHH
Confidence 999999974 677754
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A | Back alignment and structure |
|---|
Probab=99.52 E-value=1.2e-14 Score=164.20 Aligned_cols=207 Identities=11% Similarity=0.054 Sum_probs=122.7
Q ss_pred CcceeeeecccccceEEEEEEcCC-----CCEEEEEeccccc-hhhHHHHHHHHhhC--------------CCccccccc
Q psy11767 117 DLDKAGILGDGSYSVCRRCVEKST-----GQEYAVKIISRKI-DCSEEINLLRACQG--------------HPNICRRCV 176 (966)
Q Consensus 117 df~~~~~LG~GsFGkV~La~~k~t-----g~~yAiKvl~K~~-~~~~E~~il~~~~~--------------~pfi~~~~~ 176 (966)
+|.+.+.||+|+||.||+|+++.+ ++.||||++++.. ....|.+++++... ||+|++.+-
T Consensus 36 ~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~ 115 (364)
T 3op5_A 36 AWKVGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIRTRKLKYLGVPKYWG 115 (364)
T ss_dssp EEEEEEECCCC-CCEEEEEEECCSSCCCTTCSEEEEEEETTCHHHHHHHHHHHHHCCHHHHHHHHHHTTCSCCCSCCEEE
T ss_pred eEEEEEEEecCCCeEEEEeeecCccccccccceEEEEeeccchhHHHHHHHHHhhhhhHHHHHHHHHhhccCCCCCeEEe
Confidence 679999999999999999999876 5889999998653 34556666655444 898876221
Q ss_pred cccc----------------------------------chhHHHHHHHh----------hcccchhhhHhhh--ccCCce
Q psy11767 177 EKST----------------------------------GQEYAVKIISR----------KIDCSEEINLLRA--CQGHPN 210 (966)
Q Consensus 177 ~~~~----------------------------------~~~~~~~~v~~----------~~~~~~e~nil~~--~~gh~~ 210 (966)
.... ...++.+++.+ ..|++++ |||.+ .+|+++
T Consensus 116 ~~~~~~~~~~~~~lv~e~~g~~L~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~iiHrDlkp~-Nill~~~~~~~~k 194 (364)
T 3op5_A 116 SGLHDKNGKSYRFMIMDRFGSDLQKIYEANAKRFSRKTVLQLSLRILDILEYIHEHEYVHGDIKAS-NLLLNYKNPDQVY 194 (364)
T ss_dssp EEEEEETTEEEEEEEEECEEEEHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGG-GEEEESSCTTCEE
T ss_pred eeeeccCCcceEEEEEeCCCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeEEecCCHH-HEEEecCCCCeEE
Confidence 1100 01111122211 1244555 99998 789999
Q ss_pred EEecCcccc--------------------------ccccccccCCCcceeeechhhHHHHHHHhhCCCCCCCC--cHHHH
Q psy11767 211 IVNLHCVFQ--------------------------DEVIDWDDFSRGIECVFFSSSLIIFFIILSFTLSFIHD--YYHIQ 262 (966)
Q Consensus 211 iv~l~~~~~--------------------------~e~i~~~~y~~~~d~~~~~~~~il~~~m~~g~~pf~~~--~~~~~ 262 (966)
|+||+.+.. +|++....|+...| .|+.|+++|+|++|.+||... +....
T Consensus 195 l~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~D---i~slG~~l~el~~g~~Pf~~~~~~~~~~ 271 (364)
T 3op5_A 195 LVDYGLAYRYCPEGVHKAYAADPKRCHDGTIEFTSIDAHNGVAPSRRGD---LEILGYCMIQWLTGHLPWEDNLKDPKYV 271 (364)
T ss_dssp ECCCTTCEESSGGGCCCCSSCCSSCCCCCCTTTCCHHHHTTCCCCHHHH---HHHHHHHHHHHHHSCCTTGGGTTCHHHH
T ss_pred EEECCcceecccCCcccccccCcccccCCCCCccCHHHhCCCCCCchhh---HHHHHHHHHHHHhCCCCccccccCHHHH
Confidence 999997621 23333333433333 446778888888999999853 22211
Q ss_pred H----------HHHHhCCCCCCCCCCHHHHHHHHhhcccCCCcccCCCCCCHHHHh----------cCCceeeeCccccc
Q psy11767 263 Y----------RRILKTEPPIPEDLSPDVADFISRLLVKDPRRRLGGGELDAEELK----------RHPFFNVIDWDDLA 322 (966)
Q Consensus 263 ~----------~~I~~~~~~~P~~~s~~a~dli~~LL~kdp~~RLG~~~~g~~~Ik----------~HpfF~~idW~~l~ 322 (966)
. ..++...+ -+..++++..+||+.+|..||.+|.. +++|. ..++...+||+.+.
T Consensus 272 ~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~li~~cl~~~p~~RP~-----~~~l~~~l~~~~~~~~~~~~~~~dw~~~~ 345 (364)
T 3op5_A 272 RDSKIRYRENIASLMDKCF-PAANAPGEIAKYMETVKLLDYTEKPL-----YENLRDILLQGLKAIGSKDDGKLDLSVVE 345 (364)
T ss_dssp HHHHHHHHHCHHHHHHHHS-CTTCCCHHHHHHHHHHHTCCTTCCCC-----HHHHHHHHHHHHHHTTCCCCCCCCC----
T ss_pred HHHHHHhhhhHHHHHHHhc-ccccCHHHHHHHHHHHhcCCCCCCCC-----HHHHHHHHHHHHHHcCCCcCCccceEecc
Confidence 1 01111111 12567899999999999999999974 55544 35677788999888
Q ss_pred cCCCCCCCCcc
Q psy11767 323 TKRIPAPFVPK 333 (966)
Q Consensus 323 ~k~~~pP~~P~ 333 (966)
+...++|..+.
T Consensus 346 ~~~~~~~~~~~ 356 (364)
T 3op5_A 346 NGGLKAKTITK 356 (364)
T ss_dssp -----------
T ss_pred CCccchhhhhh
Confidence 88777775443
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* | Back alignment and structure |
|---|
Probab=99.52 E-value=2.2e-14 Score=155.79 Aligned_cols=183 Identities=15% Similarity=0.181 Sum_probs=127.9
Q ss_pred CcceeeeecccccceEEEEEEcCCCC-------EEEEEeccccc-----hhhHHHHHHHHhhCCCcccccccccccc---
Q psy11767 117 DLDKAGILGDGSYSVCRRCVEKSTGQ-------EYAVKIISRKI-----DCSEEINLLRACQGHPNICRRCVEKSTG--- 181 (966)
Q Consensus 117 df~~~~~LG~GsFGkV~La~~k~tg~-------~yAiKvl~K~~-----~~~~E~~il~~~~~~pfi~~~~~~~~~~--- 181 (966)
+|.+.+.||+|+||+|++|+++.+|+ .||+|++++.. ...+|..+|+++ +||+|++.+-.....
T Consensus 9 ~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~ 87 (289)
T 4fvq_A 9 DLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKL-SHKHLVLNYGVCVCGDEN 87 (289)
T ss_dssp GEEEEEEEEEETTEEEEEEEEEEECGGGCEEEEEEEEEEECGGGGGGHHHHHHHHHHHHTS-CCTTBCCEEEEECCTTCC
T ss_pred HeeeeeeeccCCCceEEEEEEecccccccccchhhhhhhcccccHHHHHHHHHHHHHHHhC-CCCCEeEEEEEEEeCCCC
Confidence 78999999999999999999999884 69999997642 356789999988 599998621111100
Q ss_pred ----------------------------hhHHHHHHHh----------hcccchhhhHhhhccCC--------ceEEecC
Q psy11767 182 ----------------------------QEYAVKIISR----------KIDCSEEINLLRACQGH--------PNIVNLH 215 (966)
Q Consensus 182 ----------------------------~~~~~~~v~~----------~~~~~~e~nil~~~~gh--------~~iv~l~ 215 (966)
...+.+++.+ ..|++++ |||.+.+|. ++|.||+
T Consensus 88 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~-NIll~~~~~~~~~~~~~~kl~Dfg 166 (289)
T 4fvq_A 88 ILVQEFVKFGSLDTYLKKNKNCINILWKLEVAKQLAAAMHFLEENTLIHGNVCAK-NILLIREEDRKTGNPPFIKLSDPG 166 (289)
T ss_dssp EEEEECCTTCBHHHHHHHTGGGCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGG-GEEEEECCBGGGTBCCEEEECCCC
T ss_pred EEEEECCCCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHhhCCeECCCcCcc-eEEEecCCcccccccceeeeccCc
Confidence 0111122211 0144444 999988877 8999998
Q ss_pred cccc---------------cccccc-ccCCCcceeeechhhHHHHHHHhh-CCCCCCCCcHHHHHHHHHhCCCCCCCCCC
Q psy11767 216 CVFQ---------------DEVIDW-DDFSRGIECVFFSSSLIIFFIILS-FTLSFIHDYYHIQYRRILKTEPPIPEDLS 278 (966)
Q Consensus 216 ~~~~---------------~e~i~~-~~y~~~~d~~~~~~~~il~~~m~~-g~~pf~~~~~~~~~~~I~~~~~~~P~~~s 278 (966)
.+.. +|++.. ..|+...| .|+ .|+++|+|++ +.+||...+... ...+......+|...+
T Consensus 167 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~D--iws-lG~il~el~~g~~~~~~~~~~~~-~~~~~~~~~~~~~~~~ 242 (289)
T 4fvq_A 167 ISITVLPKDILQERIPWVPPECIENPKNLNLATD--KWS-FGTTLWEICSGGDKPLSALDSQR-KLQFYEDRHQLPAPKA 242 (289)
T ss_dssp SCTTTSCHHHHHHTTTTSCHHHHHCGGGCCHHHH--HHH-HHHHHHHHHTTTCCTTTTSCHHH-HHHHHHTTCCCCCCSS
T ss_pred ccccccCccccCCcCcccCHHHhCCCCCCCchhH--HHH-HHHHHHHHHcCCCCCccccchHH-HHHHhhccCCCCCCCC
Confidence 7632 344443 34444334 454 4555566665 677777666544 4566677888999999
Q ss_pred HHHHHHHHhhcccCCCcccCCCCCCHHHHhcC
Q psy11767 279 PDVADFISRLLVKDPRRRLGGGELDAEELKRH 310 (966)
Q Consensus 279 ~~a~dli~~LL~kdp~~RLG~~~~g~~~Ik~H 310 (966)
+++++||+++|+.||.+|. .+.+|.+|
T Consensus 243 ~~l~~li~~~l~~dp~~Rp-----s~~~ll~~ 269 (289)
T 4fvq_A 243 AELANLINNCMDYEPDHRP-----SFRAIIRD 269 (289)
T ss_dssp CTTHHHHHHHSCSSGGGSC-----CHHHHHHH
T ss_pred HHHHHHHHHHcCCChhHCc-----CHHHHHHH
Confidence 9999999999999999997 47888876
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=99.52 E-value=3e-14 Score=155.02 Aligned_cols=185 Identities=17% Similarity=0.155 Sum_probs=129.5
Q ss_pred Ccceee-eecccccceEEEEEEc--CCCCEEEEEecccc------chhhHHHHHHHHhhCCCcccccccccccc------
Q psy11767 117 DLDKAG-ILGDGSYSVCRRCVEK--STGQEYAVKIISRK------IDCSEEINLLRACQGHPNICRRCVEKSTG------ 181 (966)
Q Consensus 117 df~~~~-~LG~GsFGkV~La~~k--~tg~~yAiKvl~K~------~~~~~E~~il~~~~~~pfi~~~~~~~~~~------ 181 (966)
+|.+.. .||+|+||.|++|.++ .+++.||||++++. ....+|..+|+++ +||+|++..-.....
T Consensus 10 ~~~i~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~~~~~lv~ 88 (287)
T 1u59_A 10 NLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQL-DNPYIVRLIGVCQAEALMLVM 88 (287)
T ss_dssp GEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHC-CCTTBCCEEEEEESSSEEEEE
T ss_pred HhhhhhccccccCceeEEEeEeccCCCcceEEEEecCCccchhHHHHHHHHHHHHHhC-CCCCEeEEEEEecCCCcEEEE
Confidence 456776 8999999999999864 57889999999873 2356899999998 699998622111110
Q ss_pred ------------------------hhHHHHHHHh----------hcccchhhhHhhhccCCceEEecCcccc--------
Q psy11767 182 ------------------------QEYAVKIISR----------KIDCSEEINLLRACQGHPNIVNLHCVFQ-------- 219 (966)
Q Consensus 182 ------------------------~~~~~~~v~~----------~~~~~~e~nil~~~~gh~~iv~l~~~~~-------- 219 (966)
...+.+++.+ ..|++++ |||.+.+|.++|+||+.+..
T Consensus 89 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~-Nili~~~~~~kl~Dfg~~~~~~~~~~~~ 167 (287)
T 1u59_A 89 EMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNFVHRDLAAR-NVLLVNRHYAKISDFGLSKALGADDSYY 167 (287)
T ss_dssp ECCTTEEHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGG-GEEEEETTEEEECCCTTCEECTTCSCEE
T ss_pred EeCCCCCHHHHHHhCCccCCHHHHHHHHHHHHHHHHHHHHCCEeeCCCchh-eEEEcCCCCEEECcccceeeeccCccee
Confidence 0011122211 0133444 99999999999999986532
Q ss_pred --------------ccccccccCCCcceeeechhhHHHHHHHhh-CCCCCCCCcHHHHHHHHHhC-CCCCCCCCCHHHHH
Q psy11767 220 --------------DEVIDWDDFSRGIECVFFSSSLIIFFIILS-FTLSFIHDYYHIQYRRILKT-EPPIPEDLSPDVAD 283 (966)
Q Consensus 220 --------------~e~i~~~~y~~~~d~~~~~~~~il~~~m~~-g~~pf~~~~~~~~~~~I~~~-~~~~P~~~s~~a~d 283 (966)
+|++....|+...| .|+.|+++|+|++ |.+||...+...+.+.|..+ .+.+|..+++++.+
T Consensus 168 ~~~~~~~~~~~y~aPE~~~~~~~~~~~D---i~slG~il~ellt~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~l~~ 244 (287)
T 1u59_A 168 TARSAGKWPLKWYAPECINFRKFSSRSD---VWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQGKRMECPPECPPELYA 244 (287)
T ss_dssp CCCCSSCCCGGGCCHHHHHHCEECHHHH---HHHHHHHHHHHHTTSCCTTTTCCTHHHHHHHHTTCCCCCCTTCCHHHHH
T ss_pred eccccccccccccCHHHhccCCCCchhh---HHHHHHHHHHHHcCCCCCcccCCHHHHHHHHhcCCcCCCCCCcCHHHHH
Confidence 12222223332223 3456677777776 99999987777778888776 47789999999999
Q ss_pred HHHhhcccCCCcccCCCCCCHHHHhcCC
Q psy11767 284 FISRLLVKDPRRRLGGGELDAEELKRHP 311 (966)
Q Consensus 284 li~~LL~kdp~~RLG~~~~g~~~Ik~Hp 311 (966)
||+++|..||.+|. .+.+|..|.
T Consensus 245 li~~~l~~~p~~Rp-----s~~~l~~~l 267 (287)
T 1u59_A 245 LMSDCWIYKWEDRP-----DFLTVEQRM 267 (287)
T ss_dssp HHHHTTCSSGGGSC-----CHHHHHHHH
T ss_pred HHHHHcCCChhhCc-----CHHHHHHHH
Confidence 99999999999997 478888774
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* | Back alignment and structure |
|---|
Probab=99.51 E-value=2.9e-14 Score=158.41 Aligned_cols=190 Identities=15% Similarity=0.196 Sum_probs=129.7
Q ss_pred chhccC---CcceeeeecccccceEEEEEEcCCCC-----EEEEEeccccc------hhhHHHHHHHHhhCCCccccccc
Q psy11767 111 FEQYDM---DLDKAGILGDGSYSVCRRCVEKSTGQ-----EYAVKIISRKI------DCSEEINLLRACQGHPNICRRCV 176 (966)
Q Consensus 111 ~~~~~~---df~~~~~LG~GsFGkV~La~~k~tg~-----~yAiKvl~K~~------~~~~E~~il~~~~~~pfi~~~~~ 176 (966)
.+.+++ +|.+.++||+|+||+|++|+++.+|+ .+|+|++++.. ...+|..+|+++.+||+|++..-
T Consensus 38 ~~~~~~~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~ 117 (333)
T 2i1m_A 38 NEKWEFPRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHENIVNLLG 117 (333)
T ss_dssp CGGGBCCTTSEEEEEEEEECSSEEEEEEEETTCSSSCCCCEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEE
T ss_pred cccccCCHHHceeeeEeccCCCcceEEEEecCCCcccchhHHHHHhcccccChHHHHHHHHHHHHHHhhcCCCCeeeEEE
Confidence 344554 78999999999999999999988776 79999998642 35789999999988999987221
Q ss_pred ccccc--------------------------------------------hhHHHHHHHh----------hcccchhhhHh
Q psy11767 177 EKSTG--------------------------------------------QEYAVKIISR----------KIDCSEEINLL 202 (966)
Q Consensus 177 ~~~~~--------------------------------------------~~~~~~~v~~----------~~~~~~e~nil 202 (966)
..... ...+.+++.+ ..|++++ |||
T Consensus 118 ~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~-NIl 196 (333)
T 2i1m_A 118 ACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLASKNCIHRDVAAR-NVL 196 (333)
T ss_dssp EECSSSSCEEEEECCTTEEHHHHHHHHHHHHSCC-------CCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGG-GCE
T ss_pred EEecCCceEEEEecCCCCcHHHHHHHhcccccccccccccccccCHHHHHHHHHHHHHHHHHHhcCCcccCCcccc-eEE
Confidence 11110 0001111111 0144444 999
Q ss_pred hhccCCceEEecCcccc---------------------ccccccccCCCcceeeechhhHHHHHHHhh-CCCCCCCCcHH
Q psy11767 203 RACQGHPNIVNLHCVFQ---------------------DEVIDWDDFSRGIECVFFSSSLIIFFIILS-FTLSFIHDYYH 260 (966)
Q Consensus 203 ~~~~gh~~iv~l~~~~~---------------------~e~i~~~~y~~~~d~~~~~~~~il~~~m~~-g~~pf~~~~~~ 260 (966)
.+.+|+++|+||+.+.. +|++....|+...| .| +.|+++|+|++ |.+||......
T Consensus 197 ~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~D--i~-slG~il~el~t~g~~p~~~~~~~ 273 (333)
T 2i1m_A 197 LTNGHVAKIGDFGLARDIMNDSNYIVKGNARLPVKWMAPESIFDCVYTVQSD--VW-SYGILLWEIFSLGLNPYPGILVN 273 (333)
T ss_dssp EEGGGEEEBCCCGGGCCGGGCTTSEECSSCEECGGGSCHHHHHHCCCCHHHH--HH-HHHHHHHHHTTTSCCSSTTCCSS
T ss_pred ECCCCeEEECccccccccccccceeecCCCCCCccccCHHHhccCCCChHHH--HH-HHHHHHHHHHcCCCCCCcccchh
Confidence 99999999999987642 12222223333333 34 55667777775 99999876544
Q ss_pred HHHHHHHhC--CCCCCCCCCHHHHHHHHhhcccCCCcccCCCCCCHHHHhc
Q psy11767 261 IQYRRILKT--EPPIPEDLSPDVADFISRLLVKDPRRRLGGGELDAEELKR 309 (966)
Q Consensus 261 ~~~~~I~~~--~~~~P~~~s~~a~dli~~LL~kdp~~RLG~~~~g~~~Ik~ 309 (966)
..+..++.. .+..|...++++.+||.++|..||.+|.. +.+|.+
T Consensus 274 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps-----~~~l~~ 319 (333)
T 2i1m_A 274 SKFYKLVKDGYQMAQPAFAPKNIYSIMQACWALEPTHRPT-----FQQICS 319 (333)
T ss_dssp HHHHHHHHHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCC-----HHHHHH
T ss_pred HHHHHHHhcCCCCCCCCCCCHHHHHHHHHHhccChhhCcC-----HHHHHH
Confidence 444555543 44567888999999999999999999974 777765
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 4e4m_A* 4f08_A* 4f09_A* 3q32_A* 3rvg_A* 4hge_A* 3tjc_A* 3tjd_A* 4bbe_A* 4bbf_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* ... | Back alignment and structure |
|---|
Probab=99.51 E-value=3.8e-14 Score=154.68 Aligned_cols=183 Identities=17% Similarity=0.210 Sum_probs=125.1
Q ss_pred CcceeeeecccccceEEEEE----EcCCCCEEEEEeccccc-----hhhHHHHHHHHhhCCCccccccccccc-------
Q psy11767 117 DLDKAGILGDGSYSVCRRCV----EKSTGQEYAVKIISRKI-----DCSEEINLLRACQGHPNICRRCVEKST------- 180 (966)
Q Consensus 117 df~~~~~LG~GsFGkV~La~----~k~tg~~yAiKvl~K~~-----~~~~E~~il~~~~~~pfi~~~~~~~~~------- 180 (966)
+|++++.||+|+||+|++|+ ++.+|+.||||++++.. ...+|..+|+++ +||+|++..-....
T Consensus 11 ~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~~~ 89 (295)
T 3ugc_A 11 HLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSL-QHDNIVKYKGVCYSAGRRNLK 89 (295)
T ss_dssp GEEEEEEEEECSSEEEEEEEECTTCSSCCEEEEEEEESCCCHHHHHHHHHHHHHHHTC-CCTTBCCEEEEECHHHHTSCE
T ss_pred HhhhhheeeccCCEEEEEEEEecccCCCCcEEEEEEcccCCHHHHHHHHHHHHHHHhC-CCCCEeeEEEEEecCCCCceE
Confidence 67999999999999999999 57799999999998642 356899999998 59999862111000
Q ss_pred -------c-------------------hhHHHHHHHh----------hcccchhhhHhhhccCCceEEecCcccc-----
Q psy11767 181 -------G-------------------QEYAVKIISR----------KIDCSEEINLLRACQGHPNIVNLHCVFQ----- 219 (966)
Q Consensus 181 -------~-------------------~~~~~~~v~~----------~~~~~~e~nil~~~~gh~~iv~l~~~~~----- 219 (966)
. ...+.+++.+ ..|++++ |||.+.+|+++|+||+.+..
T Consensus 90 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dikp~-Nil~~~~~~~kl~Dfg~~~~~~~~~ 168 (295)
T 3ugc_A 90 LIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKRYIHRDLATR-NILVENENRVKIGDFGLTKVLPQDK 168 (295)
T ss_dssp EEEECCTTCBHHHHHHHCGGGCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGG-GEEEEETTEEEECCCCSCC------
T ss_pred EEEEeCCCCCHHHHHHhcccccCHHHHHHHHHHHHHHHHHHhcCCcccCCCCHh-hEEEcCCCeEEEccCcccccccCCc
Confidence 0 0001112111 0134444 99999999999999987632
Q ss_pred -----------------ccccccccCCCcceeeechhhHHHHHHHhhCCCCCCCCcHH----------------HHHHHH
Q psy11767 220 -----------------DEVIDWDDFSRGIECVFFSSSLIIFFIILSFTLSFIHDYYH----------------IQYRRI 266 (966)
Q Consensus 220 -----------------~e~i~~~~y~~~~d~~~~~~~~il~~~m~~g~~pf~~~~~~----------------~~~~~I 266 (966)
+|++....|+...| .|+.|+++|+|++|..||...... .+.+.+
T Consensus 169 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~D---i~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 245 (295)
T 3ugc_A 169 EFFKVKEPGESPIFWYAPESLTESKFSVASD---VWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIELL 245 (295)
T ss_dssp -------CTTCGGGGCCHHHHHHCCCCHHHH---HHHHHHHHHHHHHTTCTTCSHHHHHHHHHCTTCCTHHHHHHHHHHH
T ss_pred ceeeeccCCCCccceeCcHHhcCCCCChHHH---HHHHHHHHHHHHhcccccCCChHHHHhhhcCccccchhHHHHHHHH
Confidence 23333334443333 446678888888888888654322 122333
Q ss_pred H-hCCCCCCCCCCHHHHHHHHhhcccCCCcccCCCCCCHHHHhc
Q psy11767 267 L-KTEPPIPEDLSPDVADFISRLLVKDPRRRLGGGELDAEELKR 309 (966)
Q Consensus 267 ~-~~~~~~P~~~s~~a~dli~~LL~kdp~~RLG~~~~g~~~Ik~ 309 (966)
. ...+..|..+++++.+||+++|..||.+|.. +.+|..
T Consensus 246 ~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps-----~~el~~ 284 (295)
T 3ugc_A 246 KNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPS-----FRDLAL 284 (295)
T ss_dssp HTTCCCCCCTTCCHHHHHHHHHHSCSSGGGSCC-----HHHHHH
T ss_pred hccCcCCCCcCcCHHHHHHHHHHcCCChhhCCC-----HHHHHH
Confidence 3 2466778899999999999999999999974 666653
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* | Back alignment and structure |
|---|
Probab=99.51 E-value=3.3e-14 Score=157.73 Aligned_cols=188 Identities=15% Similarity=0.153 Sum_probs=128.2
Q ss_pred CcceeeeecccccceEEEEE-----EcCCCCEEEEEecccc------chhhHHHHHHHHhhCCCcccccccccccc----
Q psy11767 117 DLDKAGILGDGSYSVCRRCV-----EKSTGQEYAVKIISRK------IDCSEEINLLRACQGHPNICRRCVEKSTG---- 181 (966)
Q Consensus 117 df~~~~~LG~GsFGkV~La~-----~k~tg~~yAiKvl~K~------~~~~~E~~il~~~~~~pfi~~~~~~~~~~---- 181 (966)
+|.+++.||+|+||+||+|+ ...+++.||||++++. ....+|..+|+++ +||+|++..-.....
T Consensus 31 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~ 109 (327)
T 2yfx_A 31 NITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKF-NHQNIVRCIGVSLQSLPRF 109 (327)
T ss_dssp GCEEEEECC--CSSCEEEEEC--------CCEEEEEECCSSCCHHHHHHHHHHHHHHHHC-CCTTBCCEEEEECSSSSCE
T ss_pred heEEEEEEcCCCCeeEEEEEEcCCCCCCccceEEEEEeccccchhhHHHHHHHHHHHhhC-CCCCCCeEEEEEcCCCCcE
Confidence 78999999999999999999 6678999999999753 2356788899888 799998621111100
Q ss_pred ---------------------------------hhHHHHHHHh-------h---cccchhhhHhhhccC---CceEEecC
Q psy11767 182 ---------------------------------QEYAVKIISR-------K---IDCSEEINLLRACQG---HPNIVNLH 215 (966)
Q Consensus 182 ---------------------------------~~~~~~~v~~-------~---~~~~~e~nil~~~~g---h~~iv~l~ 215 (966)
...+.+++.+ . .|++++ |||.+.+| .++|+||+
T Consensus 110 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~i~H~dlkp~-NIli~~~~~~~~~kl~Dfg 188 (327)
T 2yfx_A 110 ILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENHFIHRDIAAR-NCLLTCPGPGRVAKIGDFG 188 (327)
T ss_dssp EEEECCTTEEHHHHHHHTSCCSSSTTSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGG-GEEESCSSTTCCEEECCCH
T ss_pred EEEecCCCCcHHHHHHhhcccccccccccHHHHHHHHHHHHHHHHHHhhCCeecCcCCHh-HEEEecCCCcceEEECccc
Confidence 0011111111 0 134444 89888544 58899987
Q ss_pred ccc---------------------cccccccccCCCcceeeechhhHHHHHHHhh-CCCCCCCCcHHHHHHHHHhC-CCC
Q psy11767 216 CVF---------------------QDEVIDWDDFSRGIECVFFSSSLIIFFIILS-FTLSFIHDYYHIQYRRILKT-EPP 272 (966)
Q Consensus 216 ~~~---------------------~~e~i~~~~y~~~~d~~~~~~~~il~~~m~~-g~~pf~~~~~~~~~~~I~~~-~~~ 272 (966)
.+. .+|++....|+...| .| +.|+++|+|++ |.+||...+...+.+.|..+ .+.
T Consensus 189 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~D--i~-slG~il~ellt~g~~p~~~~~~~~~~~~~~~~~~~~ 265 (327)
T 2yfx_A 189 MARDIYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTD--TW-SFGVLLWEIFSLGYMPYPSKSNQEVLEFVTSGGRMD 265 (327)
T ss_dssp HHHHHHC------CCGGGSCGGGCCHHHHHHCCCCHHHH--HH-HHHHHHHHHHTTSCCSSTTCCHHHHHHHHHTTCCCC
T ss_pred cccccccccccccCCCcCCCcceeCHhHhcCCCCCchhh--HH-HHHHHHHHHHcCCCCCCCCcCHHHHHHHHhcCCCCC
Confidence 542 123343334443333 34 55666777765 99999988888888888765 566
Q ss_pred CCCCCCHHHHHHHHhhcccCCCcccCCCCCCHHHHhcCCcee
Q psy11767 273 IPEDLSPDVADFISRLLVKDPRRRLGGGELDAEELKRHPFFN 314 (966)
Q Consensus 273 ~P~~~s~~a~dli~~LL~kdp~~RLG~~~~g~~~Ik~HpfF~ 314 (966)
.|..+++++.+||.++|..||.+|. .+.+|.+|.|+-
T Consensus 266 ~~~~~~~~l~~li~~~l~~dp~~Rp-----s~~~ll~~l~~~ 302 (327)
T 2yfx_A 266 PPKNCPGPVYRIMTQCWQHQPEDRP-----NFAIILERIEYC 302 (327)
T ss_dssp CCTTCCHHHHHHHHHHTCSSGGGSC-----CHHHHHHHHHHH
T ss_pred CCCCCCHHHHHHHHHHhcCChhhCc-----CHHHHHHHHHHH
Confidence 7889999999999999999999997 489999998774
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.51 E-value=2.6e-14 Score=160.54 Aligned_cols=183 Identities=10% Similarity=0.095 Sum_probs=122.0
Q ss_pred CCcceeeeecccccceEEEEEEcCC--------CCEEEEEeccccchhhHHHHHHHHhhCCCcccccc------------
Q psy11767 116 MDLDKAGILGDGSYSVCRRCVEKST--------GQEYAVKIISRKIDCSEEINLLRACQGHPNICRRC------------ 175 (966)
Q Consensus 116 ~df~~~~~LG~GsFGkV~La~~k~t--------g~~yAiKvl~K~~~~~~E~~il~~~~~~pfi~~~~------------ 175 (966)
-+|.+.+.||+|+||.||+|+++.| ++.||||++++.....+|..+|+++ +||+|++.+
T Consensus 42 ~~y~~~~~lg~G~~g~Vy~~~~~~t~~~~~~~~~~~vavK~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~i~ 120 (352)
T 2jii_A 42 RQWKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKDGRLFNEQNFFQRA-AKPLQVNKWKKLYSTPLLAIP 120 (352)
T ss_dssp CEEEEEEEEEEETTEEEEEEEECC-----------CEEEEEEETTSTHHHHHHHHHHH-CCHHHHHHHHHHTTCTTCSCC
T ss_pred CeEEEEEEecCCCCeEEEEEeecCCccccccccCceEEEEEecccchHHHHHHHHHHh-cccchhhhhhhhccCCccCcc
Confidence 3789999999999999999999985 8999999999887788999999988 588886410
Q ss_pred -----ccc------------------------------ccchhHHHHHHHh----------hcccchhhhHhhhccC--C
Q psy11767 176 -----VEK------------------------------STGQEYAVKIISR----------KIDCSEEINLLRACQG--H 208 (966)
Q Consensus 176 -----~~~------------------------------~~~~~~~~~~v~~----------~~~~~~e~nil~~~~g--h 208 (966)
... .....++.+++.+ ..|++++ |||.+.+| .
T Consensus 121 ~~~~~~~~~~~~~~lv~e~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dikp~-NIl~~~~~~~~ 199 (352)
T 2jii_A 121 TCMGFGVHQDKYRFLVLPSLGRSLQSALDVSPKHVLSERSVLQVACRLLDALEFLHENEYVHGNVTAE-NIFVDPEDQSQ 199 (352)
T ss_dssp CCCEEEEETTTEEEEEEECCCEEHHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCCGG-GEEEETTEEEE
T ss_pred chhhccccCCcEEEEEecCCCcCHHHHHHhCCcCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCCHH-HEEEcCCCCce
Confidence 000 0000111122211 0144444 99998887 8
Q ss_pred ceEEecCcccc--------------------------ccccccccCCCcceeeechhhHHHHHHHhhCCCCCCCC--cHH
Q psy11767 209 PNIVNLHCVFQ--------------------------DEVIDWDDFSRGIECVFFSSSLIIFFIILSFTLSFIHD--YYH 260 (966)
Q Consensus 209 ~~iv~l~~~~~--------------------------~e~i~~~~y~~~~d~~~~~~~~il~~~m~~g~~pf~~~--~~~ 260 (966)
++|+||+.+.. +|++....|+...| .|+.|+++|+|++|.+||... +..
T Consensus 200 ~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~D---i~slG~il~el~~g~~pf~~~~~~~~ 276 (352)
T 2jii_A 200 VTLAGYGFAFRYCPSGKHVAYVEGSRSPHEGDLEFISMDLHKGCGPSRRSD---LQSLGYCMLKWLYGFLPWTNCLPNTE 276 (352)
T ss_dssp EEECCGGGCBCSSGGGCCCCCCTTSSCTTCSCTTTCCHHHHTTCCCCHHHH---HHHHHHHHHHHHHSCCTTGGGTTCHH
T ss_pred EEEecCcceeeccCCCccccccccccccccCCccccCHHHHccCCCCchhh---HHHHHHHHHHHHhCCCCcccCCcCHH
Confidence 99999987632 12233333433333 446677788888999999764 333
Q ss_pred HHHH---HHHhCCCCCCC------CCCHHHHHHHHhhcccCCCcccCCCCCCHHHHh
Q psy11767 261 IQYR---RILKTEPPIPE------DLSPDVADFISRLLVKDPRRRLGGGELDAEELK 308 (966)
Q Consensus 261 ~~~~---~I~~~~~~~P~------~~s~~a~dli~~LL~kdp~~RLG~~~~g~~~Ik 308 (966)
.+.+ .+......++. .+++++++||+++|..||.+|.. +++|.
T Consensus 277 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps-----~~~l~ 328 (352)
T 2jii_A 277 DIMKQKQKFVDKPGPFVGPCGHWIRPSETLQKYLKVVMALTYEEKPP-----YAMLR 328 (352)
T ss_dssp HHHHHHHHHHHSCCCEECTTSCEECCCHHHHHHHHHHHTCCTTCCCC-----HHHHH
T ss_pred HHHHHHHhccCChhhhhhhccccCCCcHHHHHHHHHHHhCChhhCCC-----HHHHH
Confidence 3333 33344444443 56999999999999999999974 56554
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* | Back alignment and structure |
|---|
Probab=99.51 E-value=2.6e-14 Score=154.75 Aligned_cols=184 Identities=20% Similarity=0.198 Sum_probs=126.8
Q ss_pred CcceeeeecccccceEEEEEEcC---CCCEEEEEecccc------chhhHHHHHHHHhhCCCcccccccccccc------
Q psy11767 117 DLDKAGILGDGSYSVCRRCVEKS---TGQEYAVKIISRK------IDCSEEINLLRACQGHPNICRRCVEKSTG------ 181 (966)
Q Consensus 117 df~~~~~LG~GsFGkV~La~~k~---tg~~yAiKvl~K~------~~~~~E~~il~~~~~~pfi~~~~~~~~~~------ 181 (966)
+|.+.++||+|+||+|++|+.+. ++..||+|++++. ....+|..+|+++ +||+|++..-.....
T Consensus 13 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~~~~~~v~ 91 (281)
T 3cc6_A 13 DVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNL-DHPHIVKLIGIIEEEPTWIIM 91 (281)
T ss_dssp GEEEEEEEEECSSSEEEEEEEECTTCCEEEEEEEECCTTSCHHHHHHHHHHHHHHHHH-CCTTBCCEEEEECSSSCEEEE
T ss_pred ceEEEEEEEecCCeeEEEeEEcCCCCCcceEEEEecccccCchHHHHHHHHHHHHHhC-CCCCcceEEEEEcCCCCEEEE
Confidence 78999999999999999999653 4557999999875 2356799999988 699998722111110
Q ss_pred ------------------------hhHHHHHHHh----------hcccchhhhHhhhccCCceEEecCcccc--------
Q psy11767 182 ------------------------QEYAVKIISR----------KIDCSEEINLLRACQGHPNIVNLHCVFQ-------- 219 (966)
Q Consensus 182 ------------------------~~~~~~~v~~----------~~~~~~e~nil~~~~gh~~iv~l~~~~~-------- 219 (966)
..++.+++.+ ..|++++ |||.+.+|.++|+||+.+..
T Consensus 92 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~-Nil~~~~~~~kl~Dfg~~~~~~~~~~~~ 170 (281)
T 3cc6_A 92 ELYPYGELGHYLERNKNSLKVLTLVLYSLQICKAMAYLESINCVHRDIAVR-NILVASPECVKLGDFGLSRYIEDEDYYK 170 (281)
T ss_dssp ECCTTCBHHHHHHHHTTTCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGG-GEEEEETTEEEECCCCGGGCC-------
T ss_pred ecCCCCCHHHHHHhccccCCHHHHHHHHHHHHHHHHHHHHCCcccCCCccc-eEEECCCCcEEeCccCCCcccccccccc
Confidence 0011122211 0134444 99999999999999986532
Q ss_pred ------------ccccccccCCCcceeeechhhHHHHHHHhh-CCCCCCCCcHHHHHHHHHhC-CCCCCCCCCHHHHHHH
Q psy11767 220 ------------DEVIDWDDFSRGIECVFFSSSLIIFFIILS-FTLSFIHDYYHIQYRRILKT-EPPIPEDLSPDVADFI 285 (966)
Q Consensus 220 ------------~e~i~~~~y~~~~d~~~~~~~~il~~~m~~-g~~pf~~~~~~~~~~~I~~~-~~~~P~~~s~~a~dli 285 (966)
+|++....|+...| .| +.|+++|+|++ |.+||...+...+.+.+..+ .+..|..+++++.+||
T Consensus 171 ~~~~~~~~~y~aPE~~~~~~~~~~~D--i~-slG~il~~llt~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li 247 (281)
T 3cc6_A 171 ASVTRLPIKWMSPESINFRRFTTASD--VW-MFAVCMWEILSFGKQPFFWLENKDVIGVLEKGDRLPKPDLCPPVLYTLM 247 (281)
T ss_dssp --CCCCCGGGCCHHHHHHCCCCHHHH--HH-HHHHHHHHHHTTTCCTTTTSCGGGHHHHHHHTCCCCCCTTCCHHHHHHH
T ss_pred cccCCCCcceeCchhhccCCCCchhc--cH-HHHHHHHHHHhCCCCCcccCChHHHHHHHhcCCCCCCCCCCCHHHHHHH
Confidence 23333333433333 34 55667777775 99999866655666666654 5677889999999999
Q ss_pred HhhcccCCCcccCCCCCCHHHHhcC
Q psy11767 286 SRLLVKDPRRRLGGGELDAEELKRH 310 (966)
Q Consensus 286 ~~LL~kdp~~RLG~~~~g~~~Ik~H 310 (966)
.++|..||.+|.. +.+|..|
T Consensus 248 ~~~l~~~p~~Rps-----~~ell~~ 267 (281)
T 3cc6_A 248 TRCWDYDPSDRPR-----FTELVCS 267 (281)
T ss_dssp HHHTCSSGGGSCC-----HHHHHHH
T ss_pred HHHccCCchhCcC-----HHHHHHH
Confidence 9999999999974 7777654
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... | Back alignment and structure |
|---|
Probab=99.51 E-value=6.7e-14 Score=151.25 Aligned_cols=182 Identities=15% Similarity=0.150 Sum_probs=127.6
Q ss_pred CcceeeeecccccceEEEEEEcCCCCEEEEEeccccc----hhhHHHHHHHHhhCCCcccccccccccc-----------
Q psy11767 117 DLDKAGILGDGSYSVCRRCVEKSTGQEYAVKIISRKI----DCSEEINLLRACQGHPNICRRCVEKSTG----------- 181 (966)
Q Consensus 117 df~~~~~LG~GsFGkV~La~~k~tg~~yAiKvl~K~~----~~~~E~~il~~~~~~pfi~~~~~~~~~~----------- 181 (966)
+|++++.||+|+||.|++|+++ +++.||+|++++.. ...+|.++|+++ +||+|++.+......
T Consensus 14 ~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~~~~~~v~e~~~~ 91 (279)
T 1qpc_A 14 TLKLVERLGAGQFGEVWMGYYN-GHTKVAVKSLKQGSMSPDAFLAEANLMKQL-QHQRLVRLYAVVTQEPIYIITEYMEN 91 (279)
T ss_dssp GEEEEEEEEEETTEEEEEEEET-TTEEEEEEEECTTSSCHHHHHHHHHHHHHC-CCTTBCCEEEEECSSSCEEEEECCTT
T ss_pred hhhheeeecCCCCeEEEEEEEc-CCcEEEEEEecCCcccHHHHHHHHHHHHhC-CCcCcceEEEEEcCCCcEEEEecCCC
Confidence 7799999999999999999986 56789999998642 457899999998 699998622111100
Q ss_pred --------------------hhHHHHHHHh-------h---cccchhhhHhhhccCCceEEecCcccc------------
Q psy11767 182 --------------------QEYAVKIISR-------K---IDCSEEINLLRACQGHPNIVNLHCVFQ------------ 219 (966)
Q Consensus 182 --------------------~~~~~~~v~~-------~---~~~~~e~nil~~~~gh~~iv~l~~~~~------------ 219 (966)
...+.+++.+ . .|++++ |||.+.+|.++|+||+.+..
T Consensus 92 ~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~-Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~ 170 (279)
T 1qpc_A 92 GSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHRDLRAA-NILVSDTLSCKIADFGLARLIEDNEYTAREGA 170 (279)
T ss_dssp CBHHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGG-GEEECTTSCEEECCCTTCEECSSSCEECCTTC
T ss_pred CCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHh-hEEEcCCCCEEECCCcccccccCcccccccCC
Confidence 0011112111 0 133444 99999899999999987632
Q ss_pred --------ccccccccCCCcceeeechhhHHHHHHHhh-CCCCCCCCcHHHHHHHHHhC-CCCCCCCCCHHHHHHHHhhc
Q psy11767 220 --------DEVIDWDDFSRGIECVFFSSSLIIFFIILS-FTLSFIHDYYHIQYRRILKT-EPPIPEDLSPDVADFISRLL 289 (966)
Q Consensus 220 --------~e~i~~~~y~~~~d~~~~~~~~il~~~m~~-g~~pf~~~~~~~~~~~I~~~-~~~~P~~~s~~a~dli~~LL 289 (966)
+|++....|+.. .|.| +.|+++|+|++ |.+||...+...+++.+..+ .+..|..+++++.+||+++|
T Consensus 171 ~~~~~y~aPE~~~~~~~~~~--~Di~-slG~il~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l 247 (279)
T 1qpc_A 171 KFPIKWTAPEAINYGTFTIK--SDVW-SFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYRMVRPDNCPEELYQLMRLCW 247 (279)
T ss_dssp CCCTTTSCHHHHHHCEECHH--HHHH-HHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHT
T ss_pred CCccCccChhhhccCCCCch--hhhH-HHHHHHHHHHhCCCCCCcccCHHHHHHHHhcccCCCCcccccHHHHHHHHHHh
Confidence 122222223222 2334 55666677776 99999988888888888765 45678899999999999999
Q ss_pred ccCCCcccCCCCCCHHHHhc
Q psy11767 290 VKDPRRRLGGGELDAEELKR 309 (966)
Q Consensus 290 ~kdp~~RLG~~~~g~~~Ik~ 309 (966)
..||.+|.. +++|..
T Consensus 248 ~~~p~~Rps-----~~~l~~ 262 (279)
T 1qpc_A 248 KERPEDRPT-----FDYLRS 262 (279)
T ss_dssp CSSGGGSCC-----HHHHHH
T ss_pred ccChhhCCC-----HHHHHH
Confidence 999999974 677754
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* | Back alignment and structure |
|---|
Probab=99.51 E-value=5e-14 Score=152.89 Aligned_cols=183 Identities=18% Similarity=0.248 Sum_probs=125.4
Q ss_pred CcceeeeecccccceEEEEEEcCCCCEEEEEecccc------------chhhHHHHHHHHhhCCCcccccccccccc---
Q psy11767 117 DLDKAGILGDGSYSVCRRCVEKSTGQEYAVKIISRK------------IDCSEEINLLRACQGHPNICRRCVEKSTG--- 181 (966)
Q Consensus 117 df~~~~~LG~GsFGkV~La~~k~tg~~yAiKvl~K~------------~~~~~E~~il~~~~~~pfi~~~~~~~~~~--- 181 (966)
+|++.+.||+|+||+|++|+++.+++.||||++.+. ....+|..+|+++ +||+|++.+-.+...
T Consensus 20 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~~~~l 98 (287)
T 4f0f_A 20 EIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNL-NHPNIVKLYGLMHNPPRM 98 (287)
T ss_dssp TEEEEEECCCCSSSCEEEEEETTTCCEEEEEECCCCTTTCCHHHHCCSHHHHHHHHHHTTC-CCTTBCCEEEEETTTTEE
T ss_pred cceehhccccCCceeEEEEEEcCCceEEEEEEeeccccccchhHHHHHHHHHHHHHHHHhC-CCCCchhhheeecCCCeE
Confidence 679999999999999999999999999999999653 1346789999888 599998622111110
Q ss_pred --------------------------hhHHHHHHHh-------h--c---ccchhhhHhhhccCC-----ceEEecCccc
Q psy11767 182 --------------------------QEYAVKIISR-------K--I---DCSEEINLLRACQGH-----PNIVNLHCVF 218 (966)
Q Consensus 182 --------------------------~~~~~~~v~~-------~--~---~~~~e~nil~~~~gh-----~~iv~l~~~~ 218 (966)
...+.+++.+ . + |++++ |||.+.+|. ++|+||+.+.
T Consensus 99 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~ivH~dikp~-Nil~~~~~~~~~~~~kl~Dfg~~~ 177 (287)
T 4f0f_A 99 VMEFVPCGDLYHRLLDKAHPIKWSVKLRLMLDIALGIEYMQNQNPPIVHRDLRSP-NIFLQSLDENAPVCAKVADFGLSQ 177 (287)
T ss_dssp EEECCTTCBHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHHTSSSCCBCSCCSGG-GEEESCCCTTCSCCEEECCCTTCB
T ss_pred EEEecCCCCHHHHHhcccCCccHHHHHHHHHHHHHHHHHHHhCCCCeecCCCCcc-eEEEeccCCCCceeEEeCCCCccc
Confidence 0111122111 1 1 33333 999987776 8999998664
Q ss_pred c----------------ccccc--cccCCCcceeeechhhHHHHHHHhhCCCCCCCCcH--HHHHHHHHh--CCCCCCCC
Q psy11767 219 Q----------------DEVID--WDDFSRGIECVFFSSSLIIFFIILSFTLSFIHDYY--HIQYRRILK--TEPPIPED 276 (966)
Q Consensus 219 ~----------------~e~i~--~~~y~~~~d~~~~~~~~il~~~m~~g~~pf~~~~~--~~~~~~I~~--~~~~~P~~ 276 (966)
. +|++. ...|+...| .|+.|+++|+|++|.+||..... ......+.. ..+.+|..
T Consensus 178 ~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~D---i~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 254 (287)
T 4f0f_A 178 QSVHSVSGLLGNFQWMAPETIGAEEESYTEKAD---TYSFAMILYTILTGEGPFDEYSYGKIKFINMIREEGLRPTIPED 254 (287)
T ss_dssp CCSSCEECCCCCCTTSCGGGSSCSSCEECHHHH---HHHHHHHHHHHHHSSCTTTTCCCCHHHHHHHHHHSCCCCCCCTT
T ss_pred cccccccccCCCccccCchhhccCCCCcCchhh---HHHHHHHHHHHHcCCCCCccccccHHHHHHHHhccCCCCCCCcc
Confidence 2 34442 122322233 44677888889999999975432 233444444 35578899
Q ss_pred CCHHHHHHHHhhcccCCCcccCCCCCCHHHHhc
Q psy11767 277 LSPDVADFISRLLVKDPRRRLGGGELDAEELKR 309 (966)
Q Consensus 277 ~s~~a~dli~~LL~kdp~~RLG~~~~g~~~Ik~ 309 (966)
+++++++||+++|..||.+|.. +++|.+
T Consensus 255 ~~~~l~~li~~~l~~dp~~Rps-----~~~ll~ 282 (287)
T 4f0f_A 255 CPPRLRNVIELCWSGDPKKRPH-----FSYIVK 282 (287)
T ss_dssp SCHHHHHHHHHHTCSSGGGSCC-----HHHHHH
T ss_pred cCHHHHHHHHHHhcCChhhCcC-----HHHHHH
Confidence 9999999999999999999974 666653
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* | Back alignment and structure |
|---|
Probab=99.51 E-value=3.2e-14 Score=156.60 Aligned_cols=184 Identities=17% Similarity=0.128 Sum_probs=125.8
Q ss_pred CcceeeeecccccceEEEEEEcC---CCCEEEEEeccccc-------hhhHHHHHHHHhhCCCcccccccccccc-----
Q psy11767 117 DLDKAGILGDGSYSVCRRCVEKS---TGQEYAVKIISRKI-------DCSEEINLLRACQGHPNICRRCVEKSTG----- 181 (966)
Q Consensus 117 df~~~~~LG~GsFGkV~La~~k~---tg~~yAiKvl~K~~-------~~~~E~~il~~~~~~pfi~~~~~~~~~~----- 181 (966)
+|.+.++||+|+||+|++|+.+. +++.||+|++++.. ...+|..+|+++ +||+|++.+-.....
T Consensus 35 ~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~~ 113 (313)
T 3brb_A 35 LLILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDF-SHPNVIRLLGVCIEMSSQGI 113 (313)
T ss_dssp GEEEEEEEEC-CCCCEEEEEEECTTSCEEEEEEEEC---CCCHHHHHHHHHHHHHHHTC-CCTTBCCCCEEEEC------
T ss_pred HeeeccceeecCCeEEEEEEEeccCCceeEEEEEEEeccccchhHHHHHHHHHHHHhcC-CCCCeeeeeEEEeeccccCC
Confidence 67999999999999999998765 66789999998541 356789999888 599998622111000
Q ss_pred ------------------------------------hhHHHHHHHh----------hcccchhhhHhhhccCCceEEecC
Q psy11767 182 ------------------------------------QEYAVKIISR----------KIDCSEEINLLRACQGHPNIVNLH 215 (966)
Q Consensus 182 ------------------------------------~~~~~~~v~~----------~~~~~~e~nil~~~~gh~~iv~l~ 215 (966)
...+.+++.+ ..|++++ |||.+.+|+++|+||+
T Consensus 114 ~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dikp~-NIli~~~~~~kl~Dfg 192 (313)
T 3brb_A 114 PKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGMEYLSNRNFLHRDLAAR-NCMLRDDMTVCVADFG 192 (313)
T ss_dssp -CEEEEEECCTTCBHHHHHHHTTBTTSCCCCCHHHHHHHHHHHHHHHHHHHTTTCCCCCCSGG-GEEECTTSCEEECSCS
T ss_pred cccEEEEecccCCCHHHHHHHhhhhcCCccCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCcc-eEEEcCCCcEEEeecC
Confidence 0011112111 0133444 9999999999999998
Q ss_pred cccc---------------------ccccccccCCCcceeeechhhHHHHHHHhh-CCCCCCCCcHHHHHHHHHhC-CCC
Q psy11767 216 CVFQ---------------------DEVIDWDDFSRGIECVFFSSSLIIFFIILS-FTLSFIHDYYHIQYRRILKT-EPP 272 (966)
Q Consensus 216 ~~~~---------------------~e~i~~~~y~~~~d~~~~~~~~il~~~m~~-g~~pf~~~~~~~~~~~I~~~-~~~ 272 (966)
.+.. +|++....|+... |.|+ .|+++|+|++ |.+||...+...+++.+..+ .+.
T Consensus 193 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~--Di~s-lG~il~el~~~g~~p~~~~~~~~~~~~~~~~~~~~ 269 (313)
T 3brb_A 193 LSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKS--DVWA-FGVTMWEIATRGMTPYPGVQNHEMYDYLLHGHRLK 269 (313)
T ss_dssp CC----------------CCGGGSCHHHHHSSCCCHHH--HHHH-HHHHHHHHHTTSCCSSTTCCGGGHHHHHHTTCCCC
T ss_pred cceecccccccCcccccCCCccccCchhhcCCCccchh--hhHH-HHHHHHHHHhcCCCCCccCCHHHHHHHHHcCCCCC
Confidence 7632 1222222333333 3454 5566666666 99999988887888888876 577
Q ss_pred CCCCCCHHHHHHHHhhcccCCCcccCCCCCCHHHHhcC
Q psy11767 273 IPEDLSPDVADFISRLLVKDPRRRLGGGELDAEELKRH 310 (966)
Q Consensus 273 ~P~~~s~~a~dli~~LL~kdp~~RLG~~~~g~~~Ik~H 310 (966)
+|..++++..+||.++|..||.+|. .+.+|..|
T Consensus 270 ~~~~~~~~l~~li~~~l~~dp~~Rp-----s~~~l~~~ 302 (313)
T 3brb_A 270 QPEDCLDELYEIMYSCWRTDPLDRP-----TFSVLRLQ 302 (313)
T ss_dssp CBTTCCHHHHHHHHHTTCSSGGGSC-----CHHHHHHH
T ss_pred CCccccHHHHHHHHHHcCCChhhCc-----CHHHHHHH
Confidence 8899999999999999999999997 47777765
|
| >4fl3_A Tyrosine-protein kinase SYK; transferase; HET: ANP; 1.90A {Homo sapiens} PDB: 4fl2_A* 1a81_A* 1csy_A* 1csz_A* | Back alignment and structure |
|---|
Probab=99.51 E-value=3.1e-14 Score=172.97 Aligned_cols=178 Identities=17% Similarity=0.150 Sum_probs=129.6
Q ss_pred eeecccccceEEEE--EEcCCCCEEEEEecccc-------chhhHHHHHHHHhhCCCcccccccccccc-----------
Q psy11767 122 GILGDGSYSVCRRC--VEKSTGQEYAVKIISRK-------IDCSEEINLLRACQGHPNICRRCVEKSTG----------- 181 (966)
Q Consensus 122 ~~LG~GsFGkV~La--~~k~tg~~yAiKvl~K~-------~~~~~E~~il~~~~~~pfi~~~~~~~~~~----------- 181 (966)
+.||+|+||+|++| +.+.+++.||||++++. ....+|..+|+++ +||+||+.+-.....
T Consensus 375 ~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l-~hpnIv~l~~~~~~~~~~lv~E~~~~ 453 (635)
T 4fl3_A 375 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQL-DNPYIVRMIGICEAESWMLVMEMAEL 453 (635)
T ss_dssp EEEEECSSEEEEEEEEECSSCEEEEEEEEECGGGGCGGGHHHHHHHHHHHHHC-CCTTBCCEEEEEESSSEEEEEECCTT
T ss_pred CEeccCCCEEEEEEEEcCCCcceEEEEEEeccccCCHHHHHHHHHHHHHHHhC-CCCCEeeEEEEEecCCEEEEEEccCC
Confidence 47999999999999 45678899999999864 2457899999998 599998722111111
Q ss_pred ------------------hhHHHHHHHh----------hcccchhhhHhhhccCCceEEecCccc---------------
Q psy11767 182 ------------------QEYAVKIISR----------KIDCSEEINLLRACQGHPNIVNLHCVF--------------- 218 (966)
Q Consensus 182 ------------------~~~~~~~v~~----------~~~~~~e~nil~~~~gh~~iv~l~~~~--------------- 218 (966)
..++.+++.+ ..|++++ |||++.+|+++|+||+.+.
T Consensus 454 g~L~~~l~~~~~l~~~~~~~i~~qi~~~L~yLH~~~iiHrDLkp~-NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~ 532 (635)
T 4fl3_A 454 GPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAAR-NVLLVTQHYAKISDFGLSKALRADENYYKAQTHG 532 (635)
T ss_dssp EEHHHHHHHCTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGG-GEEEEETTEEEECCTTHHHHTTC-----------
T ss_pred CCHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHHHCCEeCCCCChH-hEEEeCCCCEEEEEcCCccccccCccccccccCC
Confidence 1111122211 1244555 9999999999999998652
Q ss_pred -------cccccccccCCCcceeeechhhHHHHHHHhh-CCCCCCCCcHHHHHHHHHhC-CCCCCCCCCHHHHHHHHhhc
Q psy11767 219 -------QDEVIDWDDFSRGIECVFFSSSLIIFFIILS-FTLSFIHDYYHIQYRRILKT-EPPIPEDLSPDVADFISRLL 289 (966)
Q Consensus 219 -------~~e~i~~~~y~~~~d~~~~~~~~il~~~m~~-g~~pf~~~~~~~~~~~I~~~-~~~~P~~~s~~a~dli~~LL 289 (966)
.+|++....|+...| +|+.|+++|||++ |.+||...+...+.+.|..+ .+.+|..+++++.+||+++|
T Consensus 533 ~~t~~y~APE~~~~~~~~~~sD---vwSlGv~l~ellt~G~~Pf~~~~~~~~~~~i~~~~~~~~p~~~~~~l~~li~~cl 609 (635)
T 4fl3_A 533 KWPVKWYAPECINYYKFSSKSD---VWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGERMGCPAGCPREMYDLMNLCW 609 (635)
T ss_dssp --CGGGSCHHHHHHCCCCHHHH---HHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHT
T ss_pred CCceeeeChhhhcCCCCCcHHH---HHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCHHHHHHHHHHc
Confidence 234444445554444 4456677777776 99999998888888888876 46789999999999999999
Q ss_pred ccCCCcccCCCCCCHHHHhc
Q psy11767 290 VKDPRRRLGGGELDAEELKR 309 (966)
Q Consensus 290 ~kdp~~RLG~~~~g~~~Ik~ 309 (966)
..||.+|.. +++|..
T Consensus 610 ~~dP~~RPs-----~~~l~~ 624 (635)
T 4fl3_A 610 TYDVENRPG-----FAAVEL 624 (635)
T ss_dssp CSSTTTSCC-----HHHHHH
T ss_pred CCCHhHCcC-----HHHHHH
Confidence 999999984 666643
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* | Back alignment and structure |
|---|
Probab=99.51 E-value=2.9e-15 Score=181.34 Aligned_cols=205 Identities=16% Similarity=0.218 Sum_probs=135.7
Q ss_pred CcceeeeecccccceEEEEEEcCCCCEEEEEeccccc------hhhHHHHHHHHhhCCCccccccccccc----------
Q psy11767 117 DLDKAGILGDGSYSVCRRCVEKSTGQEYAVKIISRKI------DCSEEINLLRACQGHPNICRRCVEKST---------- 180 (966)
Q Consensus 117 df~~~~~LG~GsFGkV~La~~k~tg~~yAiKvl~K~~------~~~~E~~il~~~~~~pfi~~~~~~~~~---------- 180 (966)
+|.+.+.||+|+||.|++|+++.+|+.||||++++.. ...+|..+|+++ +||+|+........
T Consensus 15 rY~i~~~LG~G~fG~Vyla~~~~tg~~VAVKvi~~~~~~~~~~~~~~Ei~iL~~L-~HpnIV~l~~v~~~~~~~~~~~~~ 93 (676)
T 3qa8_A 15 PWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKL-NHPNVVSAREVPDGLQKLAPNDLP 93 (676)
T ss_dssp --CCCCCCCBCSSSBCCCCCCTTTTCCEEECCCCSCCCHHHHHHHHHHHHHHHHC-CBTTBCCEEECCTTTCCCCTTSSC
T ss_pred CeEEEEEEeeCCCeEEEEEEECCCCcEEEEEEecccCCHHHHHHHHHHHHHHHhC-CCCCCCceeeeecccccccCCCeE
Confidence 5689999999999999999999999999999998642 356799999998 69999762111000
Q ss_pred -----------------------------chhHHHHHHHh-------h---cccchhhhHhhhccCC---ceEEecCccc
Q psy11767 181 -----------------------------GQEYAVKIISR-------K---IDCSEEINLLRACQGH---PNIVNLHCVF 218 (966)
Q Consensus 181 -----------------------------~~~~~~~~v~~-------~---~~~~~e~nil~~~~gh---~~iv~l~~~~ 218 (966)
....+.+++.+ . .|++++ |||.+.+|. ++|+||+.+.
T Consensus 94 ~LVmEy~~ggsL~~~L~~~~~~~~lse~~i~~I~~QLl~aL~yLHs~gIVHrDLKP~-NILl~~~g~~~~vKL~DFG~a~ 172 (676)
T 3qa8_A 94 LLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALRYLHENRIIHRDLKPE-NIVLQPGPQRLIHKIIDLGYAK 172 (676)
T ss_dssp CCEEECCSSCBHHHHHHSSSCTTCCCSSHHHHHHHHHHHHHHHHHHTTBCCCCCCST-TEEEECCSSSCEEEECSCCCCC
T ss_pred EEEEEeCCCCCHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCHH-HeEeecCCCceeEEEccccccc
Confidence 00011111111 0 133334 888887665 6788887653
Q ss_pred ------------------cccccccccCCCcceeeechhhHHHHHHHhhCCCCCCCCcHHHH--------------HHHH
Q psy11767 219 ------------------QDEVIDWDDFSRGIECVFFSSSLIIFFIILSFTLSFIHDYYHIQ--------------YRRI 266 (966)
Q Consensus 219 ------------------~~e~i~~~~y~~~~d~~~~~~~~il~~~m~~g~~pf~~~~~~~~--------------~~~I 266 (966)
.+|++....|+...| .|+.|+++|+|++|.+||...+.... +..+
T Consensus 173 ~~~~~~~~~~~~gt~~Y~APE~l~~~~~s~ksD---IwSLGviLyeLltG~~Pf~~~~~~~~~~~~i~~~~~~~~~~~~~ 249 (676)
T 3qa8_A 173 ELDQGELCTEFVGTLQYLAPELLEQKKYTVTVD---YWSFGTLAFECITGFRPFLPNWQPVQWHGKVREKSNEHIVVYDD 249 (676)
T ss_dssp BTTSCCCCCCCCSCCTTCSSCSSCCSCCSTTHH---HHHHHHHHHHHHSSCSSCCSSCHHHHSSTTCC------CCSCCC
T ss_pred ccccccccccccCCcccCChHHhccCCCCchhH---HHHHHHHHHHHHHCCCCCCcccchhhhhhhhhcccchhhhhhhh
Confidence 245555555655555 44677888999999999976533221 1122
Q ss_pred HhCCCCCCC----------CCCHHHHHHHHhhcccCCCcccCCCCCCHHHHhcCCceeeeCccccccCCCCCCCCcc
Q psy11767 267 LKTEPPIPE----------DLSPDVADFISRLLVKDPRRRLGGGELDAEELKRHPFFNVIDWDDLATKRIPAPFVPK 333 (966)
Q Consensus 267 ~~~~~~~P~----------~~s~~a~dli~~LL~kdp~~RLG~~~~g~~~Ik~HpfF~~idW~~l~~k~~~pP~~P~ 333 (966)
+.+.+.|+. .+++++.+||+++|..||.+|.. +.++..||||+. ++.+..+++-++|...
T Consensus 250 l~g~~~~~~~lp~p~~l~~~ls~~L~dLI~~mL~~DP~kRPT-----a~elL~hp~F~~--l~~iL~~kil~~f~~~ 319 (676)
T 3qa8_A 250 LTGAVKFSSVLPTPNHLSGILAGKLERWLQCMLMWHQRQRGT-----DPQNPNVGCFQA--LDSILSLKLLSVMNMV 319 (676)
T ss_dssp CSSSCCCCSSSCCSCCCCGGGHHHHHHHHHHHSCSSCC---C-----CTTCCCCTTHHH--HHHHHCCCEEECCCSS
T ss_pred hccccccccccCCchhhchhhhHHHHHHHHHHccCCHhhCcC-----HHHHhcCHHHHH--HHHHHhcccccccccc
Confidence 233333322 35688999999999999999975 578999999987 4678888876666543
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A | Back alignment and structure |
|---|
Probab=99.50 E-value=2.8e-14 Score=155.31 Aligned_cols=178 Identities=17% Similarity=0.116 Sum_probs=121.3
Q ss_pred CcceeeeecccccceEEEEEEcCCCCEEEEEecccc---chhhHHHHHHHHhhCCCccccc---------------cc--
Q psy11767 117 DLDKAGILGDGSYSVCRRCVEKSTGQEYAVKIISRK---IDCSEEINLLRACQGHPNICRR---------------CV-- 176 (966)
Q Consensus 117 df~~~~~LG~GsFGkV~La~~k~tg~~yAiKvl~K~---~~~~~E~~il~~~~~~pfi~~~---------------~~-- 176 (966)
+|++.+.||+|+||+|++|+++.+|+.||||++... ....+|..+|+.++.++.+... +.
T Consensus 10 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 89 (296)
T 3uzp_A 10 RYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMELLGP 89 (296)
T ss_dssp TEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEESCSSCCHHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEEEEECCCC
T ss_pred EEEEEEEEccCCCeEEEEEEEcCCCcEEEEEEecCCcchhHHHHHHHHHHHhhcCCCCCccccccCCCCceEEEEEecCC
Confidence 679999999999999999999999999999998854 3567899999998765544320 00
Q ss_pred -------------ccccchhHHHHHHHh----------hcccchhhhHhh---hccCCceEEecCcccc-----------
Q psy11767 177 -------------EKSTGQEYAVKIISR----------KIDCSEEINLLR---ACQGHPNIVNLHCVFQ----------- 219 (966)
Q Consensus 177 -------------~~~~~~~~~~~~v~~----------~~~~~~e~nil~---~~~gh~~iv~l~~~~~----------- 219 (966)
........+.+++.+ ..|++++ |||. +.++.++|.||+.+..
T Consensus 90 ~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~-NIl~~~~~~~~~~kl~Dfg~~~~~~~~~~~~~~~ 168 (296)
T 3uzp_A 90 SLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPD-NFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIP 168 (296)
T ss_dssp BHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGG-GEEECCGGGTTCEEECCCTTCEECBCTTTCCBCC
T ss_pred CHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHH-HeEEecCCCCCeEEEeeCCCcccccccccccccc
Confidence 000001111122211 1144444 9998 4778999999986532
Q ss_pred ---------------ccccccccCCCcceeeechhhHHHHHHHhhCCCCCCCC---cHHHHHHHHHhCCCCCC-----CC
Q psy11767 220 ---------------DEVIDWDDFSRGIECVFFSSSLIIFFIILSFTLSFIHD---YYHIQYRRILKTEPPIP-----ED 276 (966)
Q Consensus 220 ---------------~e~i~~~~y~~~~d~~~~~~~~il~~~m~~g~~pf~~~---~~~~~~~~I~~~~~~~P-----~~ 276 (966)
+|++....|+...| .|+.|+++|+|++|.+||... +....+++|......+| ..
T Consensus 169 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~D---i~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 245 (296)
T 3uzp_A 169 YRENKNLTGTARYASINTHLGIEQSRRDD---LESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIEVLCKG 245 (296)
T ss_dssp CCCSCCCCSCTTTCCHHHHTTCCCCHHHH---HHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHHHHHSCHHHHTTT
T ss_pred cccccccccccccCChhhhcCCCCCcchh---hHHHHHHHHHHHhCCCCCCCcCchhhhhhhhhhcccccCCchHHHHhh
Confidence 12233223333333 345678888899999999762 23345666666555555 78
Q ss_pred CCHHHHHHHHhhcccCCCcccC
Q psy11767 277 LSPDVADFISRLLVKDPRRRLG 298 (966)
Q Consensus 277 ~s~~a~dli~~LL~kdp~~RLG 298 (966)
++++..+||+++|..||.+|..
T Consensus 246 ~~~~l~~li~~~l~~dp~~Rps 267 (296)
T 3uzp_A 246 YPSEFATYLNFCRSLRFDDKPD 267 (296)
T ss_dssp SCHHHHHHHHHHHTSCTTCCCC
T ss_pred CCHHHHHHHHHHHhcCcCcCCC
Confidence 8999999999999999999974
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.50 E-value=9.7e-15 Score=167.12 Aligned_cols=198 Identities=16% Similarity=0.240 Sum_probs=127.7
Q ss_pred CcceeeeecccccceEEEEEEcCCCCEEEEEeccccc------hhhHHHHHHHHhhCCCcccccccccc--cc-------
Q psy11767 117 DLDKAGILGDGSYSVCRRCVEKSTGQEYAVKIISRKI------DCSEEINLLRACQGHPNICRRCVEKS--TG------- 181 (966)
Q Consensus 117 df~~~~~LG~GsFGkV~La~~k~tg~~yAiKvl~K~~------~~~~E~~il~~~~~~pfi~~~~~~~~--~~------- 181 (966)
.|.+.++||+|+||+||+|+++.+|+.||||++++.. ...+|..+|+++ +||+|++.+..+. ..
T Consensus 10 ~y~i~~~LG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l-~hpnIv~~~~~~~~~~~~~~~lv~ 88 (396)
T 4eut_A 10 LWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKL-NHKNIVKLFAIEEETTTRHKVLIM 88 (396)
T ss_dssp EEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHC-CCTTBCCEEEEEECTTTCCEEEEE
T ss_pred ceEEEEEEEcCCCeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhc-CCCCCCeEEEeeccCCCCeeEEEE
Confidence 4589999999999999999999999999999998642 346899999998 5999986221110 00
Q ss_pred --------------------------hhHHHHHHHh----------hcccchhhhHhh----hccCCceEEecCcccc--
Q psy11767 182 --------------------------QEYAVKIISR----------KIDCSEEINLLR----ACQGHPNIVNLHCVFQ-- 219 (966)
Q Consensus 182 --------------------------~~~~~~~v~~----------~~~~~~e~nil~----~~~gh~~iv~l~~~~~-- 219 (966)
..++.+++.+ ..|++++ |||. +..+.++|+||+.+..
T Consensus 89 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~-NIll~~~~~~~~~~kL~DFG~a~~~~ 167 (396)
T 4eut_A 89 EFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENGIVHRNIKPG-NIMRVIGEDGQSVYKLTDFGAARELE 167 (396)
T ss_dssp CCCTTEEHHHHTTSGGGTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGG-GEEEEECTTSCEEEEECCGGGCEECC
T ss_pred ecCCCCCHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHHCCEEECCcCHH-HEEEeecCCCceeEEEecCCCceEcc
Confidence 0011122211 0144444 9987 6667789999987632
Q ss_pred ----------------cccccc--------ccCCCcceeeechhhHHHHHHHhhCCCCCCC----CcHHHHHHHHHhCCC
Q psy11767 220 ----------------DEVIDW--------DDFSRGIECVFFSSSLIIFFIILSFTLSFIH----DYYHIQYRRILKTEP 271 (966)
Q Consensus 220 ----------------~e~i~~--------~~y~~~~d~~~~~~~~il~~~m~~g~~pf~~----~~~~~~~~~I~~~~~ 271 (966)
+|++.. ..|+...| .|+.|+++|+|++|.+||.. .....+..+|+.+.+
T Consensus 168 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~D---iwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~p 244 (396)
T 4eut_A 168 DDEQFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVD---LWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIITGKP 244 (396)
T ss_dssp CGGGSSCSSSCCTTCCHHHHHHHCC--CHHHHHHHHHH---HHHHHHHHHHHHHSSCSEECTTCTTTCHHHHHHHHHSCC
T ss_pred CCCccccccCCccccCHHHhhccccccccccCCCcHHH---HHHHHHHHHHHHHCCCCCCCCCcccchHHHHHHHhcCCC
Confidence 122211 12222223 45677888889999999963 223345666766554
Q ss_pred C-------------------CC------CCCCHHHHHHHHhhcccCCCcccCCCCCCHHHHhcCCceeeeCccccccCCC
Q psy11767 272 P-------------------IP------EDLSPDVADFISRLLVKDPRRRLGGGELDAEELKRHPFFNVIDWDDLATKRI 326 (966)
Q Consensus 272 ~-------------------~P------~~~s~~a~dli~~LL~kdp~~RLG~~~~g~~~Ik~HpfF~~idW~~l~~k~~ 326 (966)
. +| ..+++..++||+++|+.||.+|.+ ++++.++- +.++.+++
T Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~ll~~~L~~dP~~R~s-----~~e~l~~l-------~~il~~~~ 312 (396)
T 4eut_A 245 SGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWG-----FDQFFAET-------SDILHRMV 312 (396)
T ss_dssp TTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCC-----HHHHHHHH-------HHHHTCEE
T ss_pred cccchhheeccCCCcccCccCCcccccchHHHhhchHHHHHhhccChhhhcc-----HHHHHHHH-------HHHhhceE
Confidence 2 12 234567899999999999999985 66664432 34455555
Q ss_pred CCCCC
Q psy11767 327 PAPFV 331 (966)
Q Consensus 327 ~pP~~ 331 (966)
..++.
T Consensus 313 ~~~~~ 317 (396)
T 4eut_A 313 IHVFS 317 (396)
T ss_dssp EEEEE
T ss_pred EEEEE
Confidence 44443
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* | Back alignment and structure |
|---|
Probab=99.50 E-value=4.7e-14 Score=153.73 Aligned_cols=183 Identities=17% Similarity=0.155 Sum_probs=126.8
Q ss_pred Ccceee-eecccccceEEEE--EEcCCCCEEEEEeccccc-------hhhHHHHHHHHhhCCCcccccccccccc-----
Q psy11767 117 DLDKAG-ILGDGSYSVCRRC--VEKSTGQEYAVKIISRKI-------DCSEEINLLRACQGHPNICRRCVEKSTG----- 181 (966)
Q Consensus 117 df~~~~-~LG~GsFGkV~La--~~k~tg~~yAiKvl~K~~-------~~~~E~~il~~~~~~pfi~~~~~~~~~~----- 181 (966)
+|.+.+ .||+|+||.|++| +.+.+++.||||++++.. ...+|..+|+++ +||+|++..-.....
T Consensus 17 ~y~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~lv 95 (291)
T 1xbb_A 17 LLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQL-DNPYIVRMIGICEAESWMLV 95 (291)
T ss_dssp GEEEEEEEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTC-CCTTBCCEEEEEESSSEEEE
T ss_pred hhhhccCccccccCeeeEeeeecCCCceeeEEEEeecccccCHHHHHHHHHHHHHHHhC-CCCCEEEEEEEECCCCcEEE
Confidence 567887 9999999999999 457788999999998642 356799999988 699998722111111
Q ss_pred ------------------------hhHHHHHHHh----------hcccchhhhHhhhccCCceEEecCcccc--------
Q psy11767 182 ------------------------QEYAVKIISR----------KIDCSEEINLLRACQGHPNIVNLHCVFQ-------- 219 (966)
Q Consensus 182 ------------------------~~~~~~~v~~----------~~~~~~e~nil~~~~gh~~iv~l~~~~~-------- 219 (966)
...+.+++.+ ..|++++ |||.+.+|.++|+||+.+..
T Consensus 96 ~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dikp~-Nil~~~~~~~kl~Dfg~~~~~~~~~~~~ 174 (291)
T 1xbb_A 96 MEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAAR-NVLLVTQHYAKISDFGLSKALRADENYY 174 (291)
T ss_dssp EECCTTEEHHHHHHHCTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGG-GEEEEETTEEEECCCTTCEECCTTCSEE
T ss_pred EEeCCCCCHHHHHHhCcCCCHHHHHHHHHHHHHHHHHHHhCCeEcCCCCcc-eEEEeCCCcEEEccCCcceeeccCCCcc
Confidence 0111122111 0134444 99999999999999987632
Q ss_pred --------------ccccccccCCCcceeeechhhHHHHHHHhh-CCCCCCCCcHHHHHHHHHhC-CCCCCCCCCHHHHH
Q psy11767 220 --------------DEVIDWDDFSRGIECVFFSSSLIIFFIILS-FTLSFIHDYYHIQYRRILKT-EPPIPEDLSPDVAD 283 (966)
Q Consensus 220 --------------~e~i~~~~y~~~~d~~~~~~~~il~~~m~~-g~~pf~~~~~~~~~~~I~~~-~~~~P~~~s~~a~d 283 (966)
+|++....|+.. .|.| +.|+++|+|++ |.+||...+...+.+.+..+ .+.+|..++++..+
T Consensus 175 ~~~~~~~~~~~y~aPE~~~~~~~~~~--~Di~-slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 251 (291)
T 1xbb_A 175 KAQTHGKWPVKWYAPECINYYKFSSK--SDVW-SFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGERMGCPAGCPREMYD 251 (291)
T ss_dssp EC----CCCGGGCCHHHHHHCEEEHH--HHHH-HHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCCCCCCTTCCHHHHH
T ss_pred cccccCCCCceeeChHHhccCCCChh--hhHH-HHHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCHHHHH
Confidence 122222222222 2334 55667777776 99999998888888888765 46788999999999
Q ss_pred HHHhhcccCCCcccCCCCCCHHHHhc
Q psy11767 284 FISRLLVKDPRRRLGGGELDAEELKR 309 (966)
Q Consensus 284 li~~LL~kdp~~RLG~~~~g~~~Ik~ 309 (966)
||+++|..||.+|.. +.+|..
T Consensus 252 li~~~l~~dp~~Rps-----~~~l~~ 272 (291)
T 1xbb_A 252 LMNLCWTYDVENRPG-----FAAVEL 272 (291)
T ss_dssp HHHHHTCSSTTTSCC-----HHHHHH
T ss_pred HHHHHcCCChhhCcC-----HHHHHH
Confidence 999999999999974 666653
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} SCOP: d.144.1.0 | Back alignment and structure |
|---|
Probab=99.50 E-value=8.2e-14 Score=149.75 Aligned_cols=182 Identities=21% Similarity=0.220 Sum_probs=124.9
Q ss_pred CcceeeeecccccceEEEEEEcCCCCEEEEEeccccc---------hhhHHHHHHHHhhCCCcccccccccccc------
Q psy11767 117 DLDKAGILGDGSYSVCRRCVEKSTGQEYAVKIISRKI---------DCSEEINLLRACQGHPNICRRCVEKSTG------ 181 (966)
Q Consensus 117 df~~~~~LG~GsFGkV~La~~k~tg~~yAiKvl~K~~---------~~~~E~~il~~~~~~pfi~~~~~~~~~~------ 181 (966)
+|.+.++||+|+||.||+|++. |+.||+|++++.. ...+|..+|+++ +||+|++..-.....
T Consensus 8 ~~~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv 84 (271)
T 3dtc_A 8 ELTLEEIIGIGGFGKVYRAFWI--GDEVAVKAARHDPDEDISQTIENVRQEAKLFAML-KHPNIIALRGVCLKEPNLCLV 84 (271)
T ss_dssp SEEEEEEEEEETTEEEEEEEET--TEEEEEEEC----------CHHHHHHHHHHHHHC-CCTTBCCEEEEECCC--CEEE
T ss_pred heeeeeeeccCCCeEEEEEEEc--CCeEEEEEEecCCcccHHHHHHHHHHHHHHHHhc-CCCCEeeEEEEEecCCceEEE
Confidence 7799999999999999999975 8899999998641 346788999888 599998621111110
Q ss_pred -----------------------hhHHHHHHH------h-------hcccchhhhHhhhc--------cCCceEEecCcc
Q psy11767 182 -----------------------QEYAVKIIS------R-------KIDCSEEINLLRAC--------QGHPNIVNLHCV 217 (966)
Q Consensus 182 -----------------------~~~~~~~v~------~-------~~~~~~e~nil~~~--------~gh~~iv~l~~~ 217 (966)
...+.+++. . ..|++++ |||.+. .+.++|.||+.+
T Consensus 85 ~e~~~~~~L~~~~~~~~~~~~~~~~i~~~l~~~l~~lH~~~~~~i~H~dikp~-Nil~~~~~~~~~~~~~~~kl~Dfg~~ 163 (271)
T 3dtc_A 85 MEFARGGPLNRVLSGKRIPPDILVNWAVQIARGMNYLHDEAIVPIIHRDLKSS-NILILQKVENGDLSNKILKITDFGLA 163 (271)
T ss_dssp EECCTTEEHHHHHTSSCCCHHHHHHHHHHHHHHHHHHHHSSSSCCCCSCCSGG-GEEESSCCSSSCCSSCCEEECCCCC-
T ss_pred EEcCCCCCHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCchH-HEEEecccccccccCcceEEccCCcc
Confidence 001111111 1 1133334 888874 678999999876
Q ss_pred cc-----------------ccccccccCCCcceeeechhhHHHHHHHhhCCCCCCCCcHHHHHHHHHhCC--CCCCCCCC
Q psy11767 218 FQ-----------------DEVIDWDDFSRGIECVFFSSSLIIFFIILSFTLSFIHDYYHIQYRRILKTE--PPIPEDLS 278 (966)
Q Consensus 218 ~~-----------------~e~i~~~~y~~~~d~~~~~~~~il~~~m~~g~~pf~~~~~~~~~~~I~~~~--~~~P~~~s 278 (966)
.. +|++....|+...| .|+.|+++|+|++|.+||...+.......+.... +.+|..++
T Consensus 164 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~D---i~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (271)
T 3dtc_A 164 REWHRTTKMSAAGAYAWMAPEVIRASMFSKGSD---VWSYGVLLWELLTGEVPFRGIDGLAVAYGVAMNKLALPIPSTCP 240 (271)
T ss_dssp ------------CCGGGSCHHHHHHCCCSHHHH---HHHHHHHHHHHHHCCCTTTTSCHHHHHHHHHTSCCCCCCCTTCC
T ss_pred cccccccccCCCCccceeCHHHhccCCCCchhh---HHHHHHHHHHHHhCCCCCCCCCHHHHHHhhhcCCCCCCCCcccC
Confidence 32 24444444444444 4466788888999999999887777667776554 45678899
Q ss_pred HHHHHHHHhhcccCCCcccCCCCCCHHHHhcC
Q psy11767 279 PDVADFISRLLVKDPRRRLGGGELDAEELKRH 310 (966)
Q Consensus 279 ~~a~dli~~LL~kdp~~RLG~~~~g~~~Ik~H 310 (966)
++..+||.++|..||.+|.. +.+|.+|
T Consensus 241 ~~~~~li~~~l~~~p~~Rps-----~~e~l~~ 267 (271)
T 3dtc_A 241 EPFAKLMEDCWNPDPHSRPS-----FTNILDQ 267 (271)
T ss_dssp HHHHHHHHHHTCSSGGGSCC-----HHHHHHH
T ss_pred HHHHHHHHHHhcCCcccCcC-----HHHHHHH
Confidence 99999999999999999974 7777654
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} SCOP: d.144.1.0 PDB: 3kmw_A* 3rep_A* | Back alignment and structure |
|---|
Probab=99.50 E-value=4.9e-14 Score=150.98 Aligned_cols=183 Identities=16% Similarity=0.191 Sum_probs=127.5
Q ss_pred CcceeeeecccccceEEEEEEcCCCCEEEEEeccccc-------hhhHHHHHHHHhhCCCcccccccccccc--------
Q psy11767 117 DLDKAGILGDGSYSVCRRCVEKSTGQEYAVKIISRKI-------DCSEEINLLRACQGHPNICRRCVEKSTG-------- 181 (966)
Q Consensus 117 df~~~~~LG~GsFGkV~La~~k~tg~~yAiKvl~K~~-------~~~~E~~il~~~~~~pfi~~~~~~~~~~-------- 181 (966)
+|.+.+.||+|+||.|++|+++ |+.||+|++++.. ...+|..+|+++ +||+|++..-.....
T Consensus 11 ~y~~~~~lg~G~~g~V~~~~~~--~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~~~lv 87 (271)
T 3kmu_A 11 QLNFLTKLNENHSGELWKGRWQ--GNDIVVKVLKVRDWSTRKSRDFNEECPRLRIF-SHPNVLPVLGACQSPPAPHPTLI 87 (271)
T ss_dssp GCEEEEEEEEETTEEEEEEEET--TEEEEEEEECCTTCCHHHHHHHHHHGGGGCCC-SCTTEECEEEEECTTTSSSCEEE
T ss_pred HhHHHHHhcCCCcceEEEEEEC--CeeEEEEEecccccCHHHHHHHHHHHHHHHhc-CCCchhheEEEEccCCCCCeEee
Confidence 7799999999999999999985 8899999998642 346788888777 699998622111100
Q ss_pred --------------------------hhHHHHHHHh-------h--c---ccchhhhHhhhccCCceEEecCcccc----
Q psy11767 182 --------------------------QEYAVKIISR-------K--I---DCSEEINLLRACQGHPNIVNLHCVFQ---- 219 (966)
Q Consensus 182 --------------------------~~~~~~~v~~-------~--~---~~~~e~nil~~~~gh~~iv~l~~~~~---- 219 (966)
..++.+++.+ . + |++ ..|||.+.+|.++|.++++...
T Consensus 88 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~i~H~dik-p~Nil~~~~~~~~l~~~~~~~~~~~~ 166 (271)
T 3kmu_A 88 THWMPYGSLYNVLHEGTNFVVDQSQAVKFALDMARGMAFLHTLEPLIPRHALN-SRSVMIDEDMTARISMADVKFSFQSP 166 (271)
T ss_dssp EECCTTCBHHHHHHSCSSCCCCHHHHHHHHHHHHHHHHHHTTSSSCCTTCCCS-GGGEEECTTSCEEEEGGGSCCTTSCT
T ss_pred ecccCCCcHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHhcCCCceecCCCc-cceEEEcCCcceeEEeccceeeeccc
Confidence 0111111111 1 1 233 3499998889999988775532
Q ss_pred ----------ccccccccCCCc-ceeeechhhHHHHHHHhhCCCCCCCCcHHHHHHHHHhC--CCCCCCCCCHHHHHHHH
Q psy11767 220 ----------DEVIDWDDFSRG-IECVFFSSSLIIFFIILSFTLSFIHDYYHIQYRRILKT--EPPIPEDLSPDVADFIS 286 (966)
Q Consensus 220 ----------~e~i~~~~y~~~-~d~~~~~~~~il~~~m~~g~~pf~~~~~~~~~~~I~~~--~~~~P~~~s~~a~dli~ 286 (966)
+|++....++.. ...| .|+.|+++|+|++|.+||...+...+...+... .+.+|..+++++.+||.
T Consensus 167 ~~~~t~~y~aPE~~~~~~~~~~~~~~D-i~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~ 245 (271)
T 3kmu_A 167 GRMYAPAWVAPEALQKKPEDTNRRSAD-MWSFAVLLWELVTREVPFADLSNMEIGMKVALEGLRPTIPPGISPHVSKLMK 245 (271)
T ss_dssp TCBSCGGGSCHHHHHSCGGGSCHHHHH-HHHHHHHHHHHHHCSCTTTTSCHHHHHHHHHHSCCCCCCCTTCCHHHHHHHH
T ss_pred CccCCccccChhhhccCCCCCCCchhh-HHHHHHHHHHHHhCCCCccccChHHHHHHHHhcCCCCCCCCCCCHHHHHHHH
Confidence 344443333221 0123 446678888888999999988877777777654 56788999999999999
Q ss_pred hhcccCCCcccCCCCCCHHHHhc
Q psy11767 287 RLLVKDPRRRLGGGELDAEELKR 309 (966)
Q Consensus 287 ~LL~kdp~~RLG~~~~g~~~Ik~ 309 (966)
++|..||.+|.. +++|.+
T Consensus 246 ~~l~~~p~~Rps-----~~~il~ 263 (271)
T 3kmu_A 246 ICMNEDPAKRPK-----FDMIVP 263 (271)
T ss_dssp HHTCSSGGGSCC-----HHHHHH
T ss_pred HHcCCChhhCcC-----HHHHHH
Confidence 999999999974 666653
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=99.49 E-value=1.1e-13 Score=154.45 Aligned_cols=184 Identities=15% Similarity=0.177 Sum_probs=126.4
Q ss_pred CcceeeeecccccceEEEEEEcCCCC----EEEEEeccccc------hhhHHHHHHHHhhCCCcccccccccccc-----
Q psy11767 117 DLDKAGILGDGSYSVCRRCVEKSTGQ----EYAVKIISRKI------DCSEEINLLRACQGHPNICRRCVEKSTG----- 181 (966)
Q Consensus 117 df~~~~~LG~GsFGkV~La~~k~tg~----~yAiKvl~K~~------~~~~E~~il~~~~~~pfi~~~~~~~~~~----- 181 (966)
+|.+.++||+|+||+|++|+.+.++. .||||++++.. ...+|..+|+++ +||+|++..-.....
T Consensus 45 ~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~l 123 (333)
T 1mqb_A 45 CVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQF-SHHNIIRLEGVISKYKPMMI 123 (333)
T ss_dssp TEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTC-CCTTBCCEEEEECSSSSEEE
T ss_pred HhhcccEEecCCCeEEEEEEEecCCCCccccEEEEEcCCCCCHHHHHHHHHHHHHHHhC-CCCCCCcEEEEEecCCCcEE
Confidence 67899999999999999999886643 59999998642 346789999888 699998621111110
Q ss_pred --------------------------hhHHHHHHHh-------h---cccchhhhHhhhccCCceEEecCcccc------
Q psy11767 182 --------------------------QEYAVKIISR-------K---IDCSEEINLLRACQGHPNIVNLHCVFQ------ 219 (966)
Q Consensus 182 --------------------------~~~~~~~v~~-------~---~~~~~e~nil~~~~gh~~iv~l~~~~~------ 219 (966)
...+.+++.+ . .|++++ |||.+.+|.++|+||+.+..
T Consensus 124 v~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~-NIl~~~~~~~kl~Dfg~~~~~~~~~~ 202 (333)
T 1mqb_A 124 ITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLANMNYVHRDLAAR-NILVNSNLVCKVSDFGLSRVLEDDPE 202 (333)
T ss_dssp EEECCTTEEHHHHHHHTTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGG-GEEECTTCCEEECCCCC---------
T ss_pred EEeCCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChh-eEEECCCCcEEECCCCcchhhccccc
Confidence 0011112111 0 134444 99999999999999986532
Q ss_pred ----------------ccccccccCCCcceeeechhhHHHHHHHhh-CCCCCCCCcHHHHHHHHHhC-CCCCCCCCCHHH
Q psy11767 220 ----------------DEVIDWDDFSRGIECVFFSSSLIIFFIILS-FTLSFIHDYYHIQYRRILKT-EPPIPEDLSPDV 281 (966)
Q Consensus 220 ----------------~e~i~~~~y~~~~d~~~~~~~~il~~~m~~-g~~pf~~~~~~~~~~~I~~~-~~~~P~~~s~~a 281 (966)
+|++....|+...| .| +.|+++|+|++ |.+||...+...+.+.|..+ .+..|..++++.
T Consensus 203 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~D--i~-slG~il~ellt~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~l 279 (333)
T 1mqb_A 203 ATYTTSGGKIPIRWTAPEAISYRKFTSASD--VW-SFGIVMWEVMTYGERPYWELSNHEVMKAINDGFRLPTPMDCPSAI 279 (333)
T ss_dssp --------CCCGGGSCHHHHHSCCCCHHHH--HH-HHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTTCCCCCCTTCBHHH
T ss_pred cccccCCCCccccccCchhcccCCCCchhh--hH-HHHHHHHHHHcCCCCCcccCCHHHHHHHHHCCCcCCCcccCCHHH
Confidence 23333333433333 44 45566666665 99999988888888888876 566788899999
Q ss_pred HHHHHhhcccCCCcccCCCCCCHHHHhcC
Q psy11767 282 ADFISRLLVKDPRRRLGGGELDAEELKRH 310 (966)
Q Consensus 282 ~dli~~LL~kdp~~RLG~~~~g~~~Ik~H 310 (966)
.+||.++|..||.+|.. +.+|.++
T Consensus 280 ~~li~~~l~~~p~~Rps-----~~~l~~~ 303 (333)
T 1mqb_A 280 YQLMMQCWQQERARRPK-----FADIVSI 303 (333)
T ss_dssp HHHHHHHTCSSTTTSCC-----HHHHHHH
T ss_pred HHHHHHHcCCChhhCcC-----HHHHHHH
Confidence 99999999999999974 6777654
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* | Back alignment and structure |
|---|
Probab=99.49 E-value=5.8e-14 Score=152.40 Aligned_cols=184 Identities=24% Similarity=0.274 Sum_probs=120.0
Q ss_pred CcceeeeecccccceEEEEEEcC-CCC--EEEEEeccccc--------hhhHHHHHHHHhhCCCcccccccccccc----
Q psy11767 117 DLDKAGILGDGSYSVCRRCVEKS-TGQ--EYAVKIISRKI--------DCSEEINLLRACQGHPNICRRCVEKSTG---- 181 (966)
Q Consensus 117 df~~~~~LG~GsFGkV~La~~k~-tg~--~yAiKvl~K~~--------~~~~E~~il~~~~~~pfi~~~~~~~~~~---- 181 (966)
+|++.+.||+|+||.||+|+++. +++ .||||++++.. ...+|..+|+++ +||+|++.+-.....
T Consensus 19 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~ 97 (291)
T 1u46_A 19 DLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSL-DHRNLIRLYGVVLTPPMKM 97 (291)
T ss_dssp GEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHC-CCTTBCCEEEEECSSSCEE
T ss_pred HeeeeeeecCCCceeEEEEEeccCCCceeEEEEEEEccCccCCHHHHHHHHHHHHHHHhC-CCCCcccEEEEEccCCcee
Confidence 67999999999999999999754 444 69999998641 346789999888 699998622111110
Q ss_pred --------------------------hhHHHHHHHh----------hcccchhhhHhhhccCCceEEecCcccc------
Q psy11767 182 --------------------------QEYAVKIISR----------KIDCSEEINLLRACQGHPNIVNLHCVFQ------ 219 (966)
Q Consensus 182 --------------------------~~~~~~~v~~----------~~~~~~e~nil~~~~gh~~iv~l~~~~~------ 219 (966)
..++.+++.+ ..|++++ |||.+.+|.++|+||+.+..
T Consensus 98 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~-Nili~~~~~~kl~Dfg~~~~~~~~~~ 176 (291)
T 1u46_A 98 VTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLESKRFIHRDLAAR-NLLLATRDLVKIGDFGLMRALPQNDD 176 (291)
T ss_dssp EEECCTTCBHHHHHHHHGGGSCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGG-GEEEEETTEEEECCCTTCEECCC-CC
T ss_pred eEecccCCCHHHHHHhccCCcCHHHHHHHHHHHHHHHHHHHhCCcccCCCchh-eEEEcCCCCEEEcccccccccccccc
Confidence 0011122111 0134444 99999999999999986532
Q ss_pred ----------------ccccccccCCCcceeeechhhHHHHHHHhh-CCCCCCCCcHHHHHHHHHhCC--CCCCCCCCHH
Q psy11767 220 ----------------DEVIDWDDFSRGIECVFFSSSLIIFFIILS-FTLSFIHDYYHIQYRRILKTE--PPIPEDLSPD 280 (966)
Q Consensus 220 ----------------~e~i~~~~y~~~~d~~~~~~~~il~~~m~~-g~~pf~~~~~~~~~~~I~~~~--~~~P~~~s~~ 280 (966)
+|++....|+... |.| +.|+++|+|++ |.+||...+...+.+.|.... +..|..++++
T Consensus 177 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~--Di~-slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 253 (291)
T 1u46_A 177 HYVMQEHRKVPFAWCAPESLKTRTFSHAS--DTW-MFGVTLWEMFTYGQEPWIGLNGSQILHKIDKEGERLPRPEDCPQD 253 (291)
T ss_dssp EEEC-----CCGGGCCHHHHHHCEEEHHH--HHH-HHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTSCCCCCCCTTCCHH
T ss_pred chhhhccCCCCceeeCchhhcCCCCCchh--hHH-HHHHHHHHHHhCCCCCcccCCHHHHHHHHHccCCCCCCCcCcCHH
Confidence 1222222232222 334 55667777776 999999988888888888764 4456789999
Q ss_pred HHHHHHhhcccCCCcccCCCCCCHHHHhcC
Q psy11767 281 VADFISRLLVKDPRRRLGGGELDAEELKRH 310 (966)
Q Consensus 281 a~dli~~LL~kdp~~RLG~~~~g~~~Ik~H 310 (966)
+++||.++|..||.+|.. +.+|.++
T Consensus 254 l~~li~~~l~~~p~~Rps-----~~~l~~~ 278 (291)
T 1u46_A 254 IYNVMVQCWAHKPEDRPT-----FVALRDF 278 (291)
T ss_dssp HHHHHHHHTCSSGGGSCC-----HHHHHHH
T ss_pred HHHHHHHHccCCcccCcC-----HHHHHHH
Confidence 999999999999999974 7777753
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.48 E-value=6.3e-14 Score=169.67 Aligned_cols=182 Identities=16% Similarity=0.145 Sum_probs=129.3
Q ss_pred Ccceee-eecccccceEEEEEEc--CCCCEEEEEecccc------chhhHHHHHHHHhhCCCcccccccccccc------
Q psy11767 117 DLDKAG-ILGDGSYSVCRRCVEK--STGQEYAVKIISRK------IDCSEEINLLRACQGHPNICRRCVEKSTG------ 181 (966)
Q Consensus 117 df~~~~-~LG~GsFGkV~La~~k--~tg~~yAiKvl~K~------~~~~~E~~il~~~~~~pfi~~~~~~~~~~------ 181 (966)
++.+.. .||+|+||+|++|..+ .++..||||++++. ....+|.++|+++ +||+|++.+-.....
T Consensus 336 ~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l-~hpniv~l~~~~~~~~~~lv~ 414 (613)
T 2ozo_A 336 NLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQL-DNPYIVRLIGVCQAEALMLVM 414 (613)
T ss_dssp SEEEEEEEEEECSSSEEEEEEEECSSCEEEEEEEECCCCCSSTTHHHHHHHHHHHTTC-CCTTBCCEEEEEESSSEEEEE
T ss_pred ceeEcCcEEecCCCcEEEEEEEecCCCcEEEEEEEcCCCCChHHHHHHHHHHHHHHhC-CCCCEeeEEEEeccCCeEEEE
Confidence 344555 7999999999999876 45678999999864 2457899999988 699998722111110
Q ss_pred ------------------------hhHHHHHHHh----------hcccchhhhHhhhccCCceEEecCcccc--------
Q psy11767 182 ------------------------QEYAVKIISR----------KIDCSEEINLLRACQGHPNIVNLHCVFQ-------- 219 (966)
Q Consensus 182 ------------------------~~~~~~~v~~----------~~~~~~e~nil~~~~gh~~iv~l~~~~~-------- 219 (966)
..++.+++.+ ..|++++ |||.+.+|+++|+||+.+..
T Consensus 415 E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~-NILl~~~~~vkL~DFGla~~~~~~~~~~ 493 (613)
T 2ozo_A 415 EMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNFVHRNLAAR-NVLLVNRHYAKISDFGLSKALGADDSYY 493 (613)
T ss_dssp ECCTTCBHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGG-GEEEEETTEEEECCCSTTTTCC------
T ss_pred EeCCCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCEEcCcCCHH-HEEEcCCCcEEEeeccCcccccCCCcee
Confidence 1111122211 1244444 99999999999999987642
Q ss_pred --------------ccccccccCCCcceeeechhhHHHHHHHhh-CCCCCCCCcHHHHHHHHHhC-CCCCCCCCCHHHHH
Q psy11767 220 --------------DEVIDWDDFSRGIECVFFSSSLIIFFIILS-FTLSFIHDYYHIQYRRILKT-EPPIPEDLSPDVAD 283 (966)
Q Consensus 220 --------------~e~i~~~~y~~~~d~~~~~~~~il~~~m~~-g~~pf~~~~~~~~~~~I~~~-~~~~P~~~s~~a~d 283 (966)
+|++....|+...| +|+.|+++|||++ |.+||...+...+++.|..+ .+.+|..+++++.+
T Consensus 494 ~~~~~~~~~~~y~APE~~~~~~~~~~sD---vwSlGv~l~ellt~G~~Pf~~~~~~~~~~~i~~~~~~~~p~~~~~~l~~ 570 (613)
T 2ozo_A 494 TARSAGKWPLKWYAPECINFRKFSSRSD---VWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQGKRMECPPECPPELYA 570 (613)
T ss_dssp --------CCTTSCHHHHHHCCCCHHHH---HHHHHHHHHHHHTTSCCTTTTCCSHHHHHHHHTTCCCCCCTTCCHHHHH
T ss_pred eeccCCCCccceeCHhhhcCCCCCcHHH---HHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHcCCCCCCCCcCCHHHHH
Confidence 23333334444333 4456677777775 99999988777888888876 46789999999999
Q ss_pred HHHhhcccCCCcccCCCCCCHHHHh
Q psy11767 284 FISRLLVKDPRRRLGGGELDAEELK 308 (966)
Q Consensus 284 li~~LL~kdp~~RLG~~~~g~~~Ik 308 (966)
||.++|..||.+|.. +.+|.
T Consensus 571 li~~cl~~dP~~RPs-----~~~l~ 590 (613)
T 2ozo_A 571 LMSDCWIYKWEDRPD-----FLTVE 590 (613)
T ss_dssp HHHHTTCSSTTTSCC-----HHHHH
T ss_pred HHHHHcCCChhHCcC-----HHHHH
Confidence 999999999999974 66663
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... | Back alignment and structure |
|---|
Probab=99.48 E-value=9.5e-14 Score=161.87 Aligned_cols=182 Identities=15% Similarity=0.147 Sum_probs=130.3
Q ss_pred CcceeeeecccccceEEEEEEcCCCCEEEEEeccccc----hhhHHHHHHHHhhCCCcccccccccccc-----------
Q psy11767 117 DLDKAGILGDGSYSVCRRCVEKSTGQEYAVKIISRKI----DCSEEINLLRACQGHPNICRRCVEKSTG----------- 181 (966)
Q Consensus 117 df~~~~~LG~GsFGkV~La~~k~tg~~yAiKvl~K~~----~~~~E~~il~~~~~~pfi~~~~~~~~~~----------- 181 (966)
+|.+.+.||+|+||+|++|+++.+ ..||||++++.. ...+|..+|+++ +||+|++.+-.....
T Consensus 185 ~~~~~~~lG~G~fg~Vy~~~~~~~-~~vavK~~~~~~~~~~~~~~E~~~l~~l-~hp~iv~~~~~~~~~~~~iv~e~~~~ 262 (452)
T 1fmk_A 185 SLRLEVKLGQGCFGEVWMGTWNGT-TRVAIKTLKPGTMSPEAFLQEAQVMKKL-RHEKLVQLYAVVSEEPIYIVTEYMSK 262 (452)
T ss_dssp GEEEEEEEEECSSCEEEEEEETTT-EEEEEEECCTTSSCHHHHHHHHHHHHHC-CCTTBCCEEEEECSSSCEEEECCCTT
T ss_pred HceeeeeecCCCCeEEEEEEECCC-ceEEEEEeccCCCCHHHHHHHHHHHHhC-CCCCEeeEEEEEcCCceEEEehhhcC
Confidence 789999999999999999999865 569999998642 457899999998 699998722111100
Q ss_pred --------------------hhHHHHHHHh----------hcccchhhhHhhhccCCceEEecCcccc------------
Q psy11767 182 --------------------QEYAVKIISR----------KIDCSEEINLLRACQGHPNIVNLHCVFQ------------ 219 (966)
Q Consensus 182 --------------------~~~~~~~v~~----------~~~~~~e~nil~~~~gh~~iv~l~~~~~------------ 219 (966)
...+.+++.+ ..|++++ |||.+.+|.++|.||+.+..
T Consensus 263 gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~-Nill~~~~~~kl~DfG~a~~~~~~~~~~~~~~ 341 (452)
T 1fmk_A 263 GSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAA-NILVGENLVCKVADFGLARLIEDNEYTARQGA 341 (452)
T ss_dssp CBHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGG-GEEECGGGCEEECCCCTTC-------------
T ss_pred CCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChh-hEEECCCCCEEECCCccceecCCCceecccCC
Confidence 0011112111 0134444 99999999999999987642
Q ss_pred --------ccccccccCCCcceeeechhhHHHHHHHhh-CCCCCCCCcHHHHHHHHHhC-CCCCCCCCCHHHHHHHHhhc
Q psy11767 220 --------DEVIDWDDFSRGIECVFFSSSLIIFFIILS-FTLSFIHDYYHIQYRRILKT-EPPIPEDLSPDVADFISRLL 289 (966)
Q Consensus 220 --------~e~i~~~~y~~~~d~~~~~~~~il~~~m~~-g~~pf~~~~~~~~~~~I~~~-~~~~P~~~s~~a~dli~~LL 289 (966)
+|++....|+...| .|+.|+++|+|++ |.+||.......+.+.|..+ .+..|..+++++.+||.++|
T Consensus 342 ~~~~~y~aPE~~~~~~~~~~sD---vwslG~~l~el~t~g~~P~~~~~~~~~~~~i~~~~~~~~~~~~~~~l~~li~~cl 418 (452)
T 1fmk_A 342 KFPIKWTAPEAALYGRFTIKSD---VWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPPECPESLHDLMCQCW 418 (452)
T ss_dssp -CCGGGSCHHHHHHCCCCHHHH---HHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCCCCCCTTSCHHHHHHHHHHT
T ss_pred cccccccCHhHHhcCCCCcccc---HHhHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCHHHHHHHHHHc
Confidence 23333334433333 3456677777776 99999988888888888765 56778899999999999999
Q ss_pred ccCCCcccCCCCCCHHHHhc
Q psy11767 290 VKDPRRRLGGGELDAEELKR 309 (966)
Q Consensus 290 ~kdp~~RLG~~~~g~~~Ik~ 309 (966)
..||.+|.. +++|..
T Consensus 419 ~~dP~~Rpt-----~~~l~~ 433 (452)
T 1fmk_A 419 RKEPEERPT-----FEYLQA 433 (452)
T ss_dssp CSSGGGSCC-----HHHHHH
T ss_pred cCChhhCcC-----HHHHHH
Confidence 999999974 777765
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... | Back alignment and structure |
|---|
Probab=99.48 E-value=5.5e-14 Score=159.73 Aligned_cols=183 Identities=16% Similarity=0.155 Sum_probs=123.8
Q ss_pred CcceeeeecccccceEEEEEEc---CCCCEEEEEecccc------chhhHHHHHHHHhhCCCcccccccccccc------
Q psy11767 117 DLDKAGILGDGSYSVCRRCVEK---STGQEYAVKIISRK------IDCSEEINLLRACQGHPNICRRCVEKSTG------ 181 (966)
Q Consensus 117 df~~~~~LG~GsFGkV~La~~k---~tg~~yAiKvl~K~------~~~~~E~~il~~~~~~pfi~~~~~~~~~~------ 181 (966)
+|++.++||+|+||+||+|+++ .++..||||++++. ....+|..+|.++ +||+|++..-.....
T Consensus 46 ~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~lv 124 (373)
T 2qol_A 46 NISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQF-DHPNIIRLEGVVTKSKPVMIV 124 (373)
T ss_dssp GCCCCEEEEECSSSEEEEC-CBCTTSCBCCEEEEECCTTCCHHHHHHHHHHHHHHTTC-CCTTBCCEEEEECSSSSCEEE
T ss_pred hceeeeEEeeCCCeEEEEEEEecCCCCceeEEEEEecCccCHHHHHHHHHHHHHHHhC-CCCCCCeEEEEEeeCCceEEE
Confidence 7899999999999999999987 57788999999864 2357799999888 699998621111100
Q ss_pred -------------------------hhHHHHHHHh----------hcccchhhhHhhhccCCceEEecCcccc-------
Q psy11767 182 -------------------------QEYAVKIISR----------KIDCSEEINLLRACQGHPNIVNLHCVFQ------- 219 (966)
Q Consensus 182 -------------------------~~~~~~~v~~----------~~~~~~e~nil~~~~gh~~iv~l~~~~~------- 219 (966)
...+.+++.+ ..|++++ |||.+.+|+++|.||+.+..
T Consensus 125 ~e~~~~~sL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~-NIll~~~~~~kl~Dfg~a~~~~~~~~~ 203 (373)
T 2qol_A 125 TEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYLSDMGYVHRDLAAR-NILINSNLVCKVSDFGLGRVLEDDPEA 203 (373)
T ss_dssp EECCTTCBHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGG-GEEECTTCCEEECCC------------
T ss_pred EeCCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCcc-eEEEcCCCCEEECcCccccccccCCcc
Confidence 0011112111 0144444 99999999999999986532
Q ss_pred ---------------ccccccccCCCcceeeechhhHHHHHHHh-hCCCCCCCCcHHHHHHHHHhC-CCCCCCCCCHHHH
Q psy11767 220 ---------------DEVIDWDDFSRGIECVFFSSSLIIFFIIL-SFTLSFIHDYYHIQYRRILKT-EPPIPEDLSPDVA 282 (966)
Q Consensus 220 ---------------~e~i~~~~y~~~~d~~~~~~~~il~~~m~-~g~~pf~~~~~~~~~~~I~~~-~~~~P~~~s~~a~ 282 (966)
+|++....|+...| .|+ .|+++|+|+ .|.+||...+...+.+.|..+ .+..|..++.+..
T Consensus 204 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~D--v~S-lG~il~ellt~g~~P~~~~~~~~~~~~i~~~~~~~~~~~~~~~l~ 280 (373)
T 2qol_A 204 AYTTRGGKIPIRWTSPEAIAYRKFTSASD--VWS-YGIVLWEVMSYGERPYWEMSNQDVIKAVDEGYRLPPPMDCPAALY 280 (373)
T ss_dssp ----------CTTSCHHHHHHCCCCHHHH--HHH-HHHHHHHHHTTC-CTTTTCCHHHHHHHHHTTEECCCCTTCBHHHH
T ss_pred ceeccCCCcCCCccChhhhccCCcCchhc--HHH-HHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCccccHHHH
Confidence 23333334433333 454 455555555 599999988888888888765 4556778899999
Q ss_pred HHHHhhcccCCCcccCCCCCCHHHHhc
Q psy11767 283 DFISRLLVKDPRRRLGGGELDAEELKR 309 (966)
Q Consensus 283 dli~~LL~kdp~~RLG~~~~g~~~Ik~ 309 (966)
+||.++|.+||.+|.. +.+|..
T Consensus 281 ~li~~cl~~dp~~RPs-----~~~i~~ 302 (373)
T 2qol_A 281 QLMLDCWQKDRNNRPK-----FEQIVS 302 (373)
T ss_dssp HHHHHHTCSSGGGSCC-----HHHHHH
T ss_pred HHHHHHhCcChhhCcC-----HHHHHH
Confidence 9999999999999974 666654
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* 4e20_A* 4e1z_A* | Back alignment and structure |
|---|
Probab=99.48 E-value=1.1e-13 Score=153.21 Aligned_cols=190 Identities=18% Similarity=0.184 Sum_probs=125.6
Q ss_pred cCCccchhccCCcceeeeecccccceEEEEEE----cCCCCEEEEEeccccc------hhhHHHHHHHHhhCCCcccccc
Q psy11767 106 KGSLFFEQYDMDLDKAGILGDGSYSVCRRCVE----KSTGQEYAVKIISRKI------DCSEEINLLRACQGHPNICRRC 175 (966)
Q Consensus 106 ~~~~~~~~~~~df~~~~~LG~GsFGkV~La~~----k~tg~~yAiKvl~K~~------~~~~E~~il~~~~~~pfi~~~~ 175 (966)
....|.++| |.+++.||+|+||+|++|+. +.+|+.||||++++.. ...+|..+|++++ ||+|+...
T Consensus 24 ~~~~~~~r~---~~~~~~lG~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~-h~~iv~~~ 99 (318)
T 3lxp_A 24 DPTVFHKRY---LKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLY-HEHIIKYK 99 (318)
T ss_dssp CCCBCCGGG---EEEEEEEEECSSEEEEEEEECSCC--CCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCC-CTTBCCEE
T ss_pred CCceecHHH---HhhhheecCCCCeEEEEEEEccCCCCCCcEEEEEEeccccChHHHHHHHHHHHHHHhCC-CcchhhEE
Confidence 334455555 68999999999999988865 4588999999998752 3578999999985 99998722
Q ss_pred ccccc--c-----------------------------hhHHHHHHHh----------hcccchhhhHhhhccCCceEEec
Q psy11767 176 VEKST--G-----------------------------QEYAVKIISR----------KIDCSEEINLLRACQGHPNIVNL 214 (966)
Q Consensus 176 ~~~~~--~-----------------------------~~~~~~~v~~----------~~~~~~e~nil~~~~gh~~iv~l 214 (966)
-.... . ...+.+++.+ ..|++++ |||.+.+|.++|+||
T Consensus 100 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~i~~~l~~~l~~LH~~~ivH~Dikp~-Nil~~~~~~~kl~Df 178 (318)
T 3lxp_A 100 GCCEDAGAASLQLVMEYVPLGSLRDYLPRHSIGLAQLLLFAQQICEGMAYLHAQHYIHRDLAAR-NVLLDNDRLVKIGDF 178 (318)
T ss_dssp EEEEETTTTEEEEEECCCTTCBHHHHGGGSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGG-GEEECTTCCEEECCG
T ss_pred EEEecCCCceEEEEEecccCCcHHHHHhhCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCchh-eEEEcCCCCEEECCc
Confidence 11110 0 0001111111 0144444 999999999999999
Q ss_pred Ccccc----------------------ccccccccCCCcceeeechhhHHHHHHHhhCCCCCCCCcHH------------
Q psy11767 215 HCVFQ----------------------DEVIDWDDFSRGIECVFFSSSLIIFFIILSFTLSFIHDYYH------------ 260 (966)
Q Consensus 215 ~~~~~----------------------~e~i~~~~y~~~~d~~~~~~~~il~~~m~~g~~pf~~~~~~------------ 260 (966)
+.+.. +|++....|+...| .|+.|+++|+|++|..||......
T Consensus 179 g~a~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~D---i~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~ 255 (318)
T 3lxp_A 179 GLAKAVPEGHEYYRVREDGDSPVFWYAPECLKEYKFYYASD---VWSFGVTLYELLTHCDSSQSPPTKFLELIGIAQGQM 255 (318)
T ss_dssp GGCEECCTTCSEEEC---CCCCGGGCCHHHHHHCEEEHHHH---HHHHHHHHHHHHTTTCGGGSHHHHHHHHHCSCCHHH
T ss_pred cccccccccccccccccCCCCCceeeChHHhcCCCCCcHHH---HHHHHHHHHHHHhCCCcccccchhhhhhhcccccch
Confidence 86632 12222222322223 456778888999999898764322
Q ss_pred ---HHHHHHHh-CCCCCCCCCCHHHHHHHHhhcccCCCcccCCCCCCHHHHh
Q psy11767 261 ---IQYRRILK-TEPPIPEDLSPDVADFISRLLVKDPRRRLGGGELDAEELK 308 (966)
Q Consensus 261 ---~~~~~I~~-~~~~~P~~~s~~a~dli~~LL~kdp~~RLG~~~~g~~~Ik 308 (966)
.+.+.+.. ..+.+|..+++++.+||+++|..||.+|.. +++|.
T Consensus 256 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps-----~~ell 302 (318)
T 3lxp_A 256 TVLRLTELLERGERLPRPDKCPAEVYHLMKNCWETEASFRPT-----FENLI 302 (318)
T ss_dssp HHHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCC-----HHHHH
T ss_pred hHHHHHHHHhcccCCCCCccccHHHHHHHHHHcCCCcccCcC-----HHHHH
Confidence 12222322 356678899999999999999999999974 66765
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.48 E-value=8.1e-14 Score=153.48 Aligned_cols=183 Identities=16% Similarity=0.166 Sum_probs=120.9
Q ss_pred CcceeeeecccccceEEEEEEcCCCCEEEEEecccc-----chhhHHHHHHHHhhCCCcccccccccc----c-------
Q psy11767 117 DLDKAGILGDGSYSVCRRCVEKSTGQEYAVKIISRK-----IDCSEEINLLRACQGHPNICRRCVEKS----T------- 180 (966)
Q Consensus 117 df~~~~~LG~GsFGkV~La~~k~tg~~yAiKvl~K~-----~~~~~E~~il~~~~~~pfi~~~~~~~~----~------- 180 (966)
+|.+++.||+|+||.|++|+++.+|+.||||++.+. ....+|..+|+++ +||+|++..-... .
T Consensus 30 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~~~~~lv 108 (317)
T 2buj_A 30 HYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCHEQQDREEAQREADMHRLF-NHPNILRLVAYCLRERGAKHEAWLL 108 (317)
T ss_dssp EEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEESSHHHHHHHHHHHHHHHTC-CCTTBCCCCEEEEEEETTEEEEEEE
T ss_pred EEEEEEEecCCCCeEEEEEEecCCCcEEEEEEEecCCHHHHHHHHHHHHHHhhc-CCCCeeeEEEEEEeccCCCceeEEE
Confidence 689999999999999999999999999999998653 2457899999888 6999986221110 0
Q ss_pred -----c----------------------hhHHHHHHHh-------h---cccchhhhHhhhccCCceEEecCccc-----
Q psy11767 181 -----G----------------------QEYAVKIISR-------K---IDCSEEINLLRACQGHPNIVNLHCVF----- 218 (966)
Q Consensus 181 -----~----------------------~~~~~~~v~~-------~---~~~~~e~nil~~~~gh~~iv~l~~~~----- 218 (966)
. ...+.+++.+ . .|++++ |||.+.+|.++|.||+.+.
T Consensus 109 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~dlkp~-NIl~~~~~~~kl~dfg~~~~~~~~ 187 (317)
T 2buj_A 109 LPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIHAKGYAHRDLKPT-NILLGDEGQPVLMDLGSMNQACIH 187 (317)
T ss_dssp EECCTTCBHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGG-GEEECTTSCEEECCCSSCEESCEE
T ss_pred EEeCCCCcHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHH-HEEEcCCCCEEEEecCcchhcccc
Confidence 0 0001111111 0 134444 9999999999999998532
Q ss_pred -----------------------cccccccc---cCCCcceeeechhhHHHHHHHhhCCCCCCCCcH--HHHHHHHHhCC
Q psy11767 219 -----------------------QDEVIDWD---DFSRGIECVFFSSSLIIFFIILSFTLSFIHDYY--HIQYRRILKTE 270 (966)
Q Consensus 219 -----------------------~~e~i~~~---~y~~~~d~~~~~~~~il~~~m~~g~~pf~~~~~--~~~~~~I~~~~ 270 (966)
.+|++... .|+...| .|+.|+++|+|++|.+||..... ..+... +...
T Consensus 188 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~D---i~slG~il~el~~g~~p~~~~~~~~~~~~~~-~~~~ 263 (317)
T 2buj_A 188 VEGSRQALTLQDWAAQRCTISYRAPELFSVQSHCVIDERTD---VWSLGCVLYAMMFGEGPYDMVFQKGDSVALA-VQNQ 263 (317)
T ss_dssp EESHHHHHHHHHHHHHHSCGGGCCGGGSSCCSEEEECTHHH---HHHHHHHHHHHHHSSCTTHHHHHTTSCHHHH-HHCC
T ss_pred cccccccccccccccccCCcccCCHhHhccCCCcCCCchhh---HHHHHHHHHHHHhCCCChhhhhcccchhhHH-hhcc
Confidence 23444322 1333334 44667888889999999853111 111222 2233
Q ss_pred CC--CCCCCCHHHHHHHHhhcccCCCcccCCCCCCHHHHhcC
Q psy11767 271 PP--IPEDLSPDVADFISRLLVKDPRRRLGGGELDAEELKRH 310 (966)
Q Consensus 271 ~~--~P~~~s~~a~dli~~LL~kdp~~RLG~~~~g~~~Ik~H 310 (966)
.. .+..+++++.+||.++|..||.+|. .+.+|.+|
T Consensus 264 ~~~~~~~~~~~~l~~li~~~l~~dp~~Rp-----s~~~ll~~ 300 (317)
T 2buj_A 264 LSIPQSPRHSSALWQLLNSMMTVDPHQRP-----HIPLLLSQ 300 (317)
T ss_dssp --CCCCTTSCHHHHHHHHHHTCSSGGGSC-----CHHHHHHH
T ss_pred CCCCccccCCHHHHHHHHHHhhcChhhCC-----CHHHHHHH
Confidence 33 3457899999999999999999997 47888876
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 4hvd_A* 4hvg_A* 4hvh_A* 4hvi_A* 3pjc_A* 1yvj_A* | Back alignment and structure |
|---|
Probab=99.47 E-value=5.1e-14 Score=156.23 Aligned_cols=184 Identities=18% Similarity=0.227 Sum_probs=125.7
Q ss_pred CcceeeeecccccceEEEEE----EcCCCCEEEEEeccccc-----hhhHHHHHHHHhhCCCccccccccc---ccc---
Q psy11767 117 DLDKAGILGDGSYSVCRRCV----EKSTGQEYAVKIISRKI-----DCSEEINLLRACQGHPNICRRCVEK---STG--- 181 (966)
Q Consensus 117 df~~~~~LG~GsFGkV~La~----~k~tg~~yAiKvl~K~~-----~~~~E~~il~~~~~~pfi~~~~~~~---~~~--- 181 (966)
+|++++.||+|+||+|++|+ .+.+|+.||||++++.. ...+|..+|+++ +||+|+...... ...
T Consensus 24 ~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~~~~~~~~ 102 (327)
T 3lxl_A 24 HLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKAL-HSDFIVKYRGVSYGPGRQSLR 102 (327)
T ss_dssp GEEEEEEEEEETTEEEEEEEECTTSSSCSEEEEEEEESSCCHHHHHHHHHHHHHHHTC-CCTTBCCEEEEEECSSSCEEE
T ss_pred hhhhhhhccCCCCeEEEEEEeccCCCCcceEEEEEEeccCCHHHHHHHHHHHHHHHhc-CCCceeEEEEEEecCCCceEE
Confidence 67999999999999999999 57899999999998652 357899999998 799998622111 000
Q ss_pred ---------------------------hhHHHHHHHh----------hcccchhhhHhhhccCCceEEecCcccc-----
Q psy11767 182 ---------------------------QEYAVKIISR----------KIDCSEEINLLRACQGHPNIVNLHCVFQ----- 219 (966)
Q Consensus 182 ---------------------------~~~~~~~v~~----------~~~~~~e~nil~~~~gh~~iv~l~~~~~----- 219 (966)
...+.+++.+ ..|++++ |||.+.+|.++|+||+.+..
T Consensus 103 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dikp~-NIl~~~~~~~kl~Dfg~~~~~~~~~ 181 (327)
T 3lxl_A 103 LVMEYLPSGCLRDFLQRHRARLDASRLLLYSSQICKGMEYLGSRRCVHRDLAAR-NILVESEAHVKIADFGLAKLLPLDK 181 (327)
T ss_dssp EEEECCTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGG-GEEEEETTEEEECCGGGCEECCTTC
T ss_pred EEEeecCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCChh-hEEECCCCCEEEcccccceecccCC
Confidence 0000111111 0144444 99999999999999987632
Q ss_pred -----------------ccccccccCCCcceeeechhhHHHHHHHhhCCCCCCCCcHH---------------HHHHHHH
Q psy11767 220 -----------------DEVIDWDDFSRGIECVFFSSSLIIFFIILSFTLSFIHDYYH---------------IQYRRIL 267 (966)
Q Consensus 220 -----------------~e~i~~~~y~~~~d~~~~~~~~il~~~m~~g~~pf~~~~~~---------------~~~~~I~ 267 (966)
+|++....|+...| .|+.|+++|+|++|..||...... .+.+.+.
T Consensus 182 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~D---i~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 258 (327)
T 3lxl_A 182 DYYVVREPGQSPIFWYAPESLSDNIFSRQSD---VWSFGVVLYELFTYCDKSCSPSAEFLRMMGCERDVPALSRLLELLE 258 (327)
T ss_dssp SEEECSSCCCSCGGGSCHHHHHHCEEEHHHH---HHHHHHHHHHHHTTTCGGGSHHHHHHHHCC----CCHHHHHHHHHH
T ss_pred ccceeeccCCccccccCHHHhccCCCChHHh---HHHHHHHHHHHHhCCCCCccccchhhhhcccccccccHHHHHHHhh
Confidence 12222222222222 446678888888888888764432 2333333
Q ss_pred h-CCCCCCCCCCHHHHHHHHhhcccCCCcccCCCCCCHHHHhcC
Q psy11767 268 K-TEPPIPEDLSPDVADFISRLLVKDPRRRLGGGELDAEELKRH 310 (966)
Q Consensus 268 ~-~~~~~P~~~s~~a~dli~~LL~kdp~~RLG~~~~g~~~Ik~H 310 (966)
. ..+..|..+++++.+||+++|..||.+|.. +.+|..|
T Consensus 259 ~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps-----~~ell~~ 297 (327)
T 3lxl_A 259 EGQRLPAPPACPAEVHELMKLCWAPSPQDRPS-----FSALGPQ 297 (327)
T ss_dssp TTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCC-----HHHHHHH
T ss_pred cccCCCCCCcccHHHHHHHHHHcCCChhhCcC-----HHHHHHH
Confidence 3 356778899999999999999999999974 7777544
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* | Back alignment and structure |
|---|
Probab=99.47 E-value=7.7e-14 Score=150.66 Aligned_cols=188 Identities=16% Similarity=0.248 Sum_probs=131.8
Q ss_pred hhccCCcceeeeecccccceEEEEEEcCCCCEEEEEecccc-chhhHHHHHHHHhhCCCcccccccccc-----------
Q psy11767 112 EQYDMDLDKAGILGDGSYSVCRRCVEKSTGQEYAVKIISRK-IDCSEEINLLRACQGHPNICRRCVEKS----------- 179 (966)
Q Consensus 112 ~~~~~df~~~~~LG~GsFGkV~La~~k~tg~~yAiKvl~K~-~~~~~E~~il~~~~~~pfi~~~~~~~~----------- 179 (966)
+.+..+|+++++||+|+||.|++|+++.+|+.||||++++. ....+|..+|+++ +||.|++......
T Consensus 7 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~~~~~~ 85 (284)
T 2a19_B 7 KRFGMDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNNEKAEREVKALAKL-DHVNIVHYNGCWDGFDYDPETSSK 85 (284)
T ss_dssp HHHHHHEEEEEEEECSSSCCEEEEEETTTCCEEEEEEEECCSGGGHHHHHHHHHC-CCTTBCCEEEEEEEEEEC------
T ss_pred chhccccceeeeeccCCceEEEEEEEcCCCeEEEEEEeccccHHHHHHHHHHHhC-CCCCEEEEeeeEeccccCcccccc
Confidence 33455779999999999999999999999999999999864 4567899999988 6999986321110
Q ss_pred ---------------c--c---h-----------------hHHHHHHHh----------hcccchhhhHhhhccCCceEE
Q psy11767 180 ---------------T--G---Q-----------------EYAVKIISR----------KIDCSEEINLLRACQGHPNIV 212 (966)
Q Consensus 180 ---------------~--~---~-----------------~~~~~~v~~----------~~~~~~e~nil~~~~gh~~iv 212 (966)
. . . ..+.+++.+ ..|++++ |||.+.+|.++|+
T Consensus 86 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~-Nil~~~~~~~kl~ 164 (284)
T 2a19_B 86 NSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLALELFEQITKGVDYIHSKKLINRDLKPS-NIFLVDTKQVKIG 164 (284)
T ss_dssp ---CCEEEEEEEEECCCCSCBHHHHHHHGGGSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGG-GEEEEETTEEEEC
T ss_pred cccccCcceEEEEEeccCCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCHH-HEEEcCCCCEEEC
Confidence 0 0 0 000111111 0133334 9999988999999
Q ss_pred ecCcccc------------------ccccccccCCCcceeeechhhHHHHHHHhhCCCCCCCCcHHHHHHHHHhCCCCCC
Q psy11767 213 NLHCVFQ------------------DEVIDWDDFSRGIECVFFSSSLIIFFIILSFTLSFIHDYYHIQYRRILKTEPPIP 274 (966)
Q Consensus 213 ~l~~~~~------------------~e~i~~~~y~~~~d~~~~~~~~il~~~m~~g~~pf~~~~~~~~~~~I~~~~~~~P 274 (966)
||+.+.. +|++....|+...| .|+.|+++|+|++|..||... ...++.+..+ .+|
T Consensus 165 Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~D---i~slG~il~~l~~~~~~~~~~--~~~~~~~~~~--~~~ 237 (284)
T 2a19_B 165 DFGLVTSLKNDGKRTRSKGTLRYMSPEQISSQDYGKEVD---LYALGLILAELLHVCDTAFET--SKFFTDLRDG--IIS 237 (284)
T ss_dssp CCTTCEESSCCSCCCCCCSCCTTSCHHHHHCSCCCTHHH---HHHHHHHHHHHHSCCSSHHHH--HHHHHHHHTT--CCC
T ss_pred cchhheeccccccccccCCcccccChhhhccCCCcchhh---hHHHHHHHHHHHhcCCcchhH--HHHHHHhhcc--ccc
Confidence 9986531 23344344544444 345667788888888777542 2345555544 367
Q ss_pred CCCCHHHHHHHHhhcccCCCcccCCCCCCHHHHhcCCce
Q psy11767 275 EDLSPDVADFISRLLVKDPRRRLGGGELDAEELKRHPFF 313 (966)
Q Consensus 275 ~~~s~~a~dli~~LL~kdp~~RLG~~~~g~~~Ik~HpfF 313 (966)
..++++.++||+++|..||.+|. .+.+|.+|.++
T Consensus 238 ~~~~~~~~~li~~~l~~dp~~Rp-----s~~e~l~~l~~ 271 (284)
T 2a19_B 238 DIFDKKEKTLLQKLLSKKPEDRP-----NTSEILRTLTV 271 (284)
T ss_dssp TTSCHHHHHHHHHHTCSSGGGSC-----CHHHHHHHHHH
T ss_pred ccCCHHHHHHHHHHccCChhhCc-----CHHHHHHHHHH
Confidence 88999999999999999999997 48999999765
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 | Back alignment and structure |
|---|
Probab=99.46 E-value=1.6e-13 Score=163.45 Aligned_cols=182 Identities=15% Similarity=0.147 Sum_probs=130.7
Q ss_pred CcceeeeecccccceEEEEEEcCCCCEEEEEeccccc----hhhHHHHHHHHhhCCCcccccccccccc-----------
Q psy11767 117 DLDKAGILGDGSYSVCRRCVEKSTGQEYAVKIISRKI----DCSEEINLLRACQGHPNICRRCVEKSTG----------- 181 (966)
Q Consensus 117 df~~~~~LG~GsFGkV~La~~k~tg~~yAiKvl~K~~----~~~~E~~il~~~~~~pfi~~~~~~~~~~----------- 181 (966)
+|.+.+.||+|+||+||+++++.+ ..||||++++.. ...+|..+|+++ +||+|++.+......
T Consensus 268 ~~~~~~~lG~G~fg~Vy~~~~~~~-~~vavK~~~~~~~~~~~~~~E~~~l~~l-~hpniv~~~~~~~~~~~~lv~e~~~~ 345 (535)
T 2h8h_A 268 SLRLEVKLGQGCFGEVWMGTWNGT-TRVAIKTLKPGTMSPEAFLQEAQVMKKL-RHEKLVQLYAVVSEEPIYIVTEYMSK 345 (535)
T ss_dssp GEEEEEEEEECSSEEEEEEEETTT-EEEEEEEECTTSSCHHHHHHHHHHHHHC-CCTTBCCEEEEECSSSCEEEECCCTT
T ss_pred hhhhheecccCCCeEEEEEEECCC-ceEEEEEeCCCCCCHHHHHHHHHHHHhC-CCCCEeeEEEEEeeccceEeeehhcC
Confidence 789999999999999999999865 569999998642 457899999998 599998722111100
Q ss_pred --------------------hhHHHHHHHh----------hcccchhhhHhhhccCCceEEecCcccc------------
Q psy11767 182 --------------------QEYAVKIISR----------KIDCSEEINLLRACQGHPNIVNLHCVFQ------------ 219 (966)
Q Consensus 182 --------------------~~~~~~~v~~----------~~~~~~e~nil~~~~gh~~iv~l~~~~~------------ 219 (966)
...+.+++.+ ..|++.+ |||.+.++.++|.||+.+..
T Consensus 346 gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~-NIll~~~~~~kl~DFG~a~~~~~~~~~~~~~~ 424 (535)
T 2h8h_A 346 GSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAA-NILVGENLVCKVADFGLARLIEDNEYTARQGA 424 (535)
T ss_dssp EEHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGG-GEEECGGGCEEECCTTSTTTCCCHHHHTTCST
T ss_pred CcHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCHh-hEEEcCCCcEEEcccccceecCCCceecccCC
Confidence 0011111111 0134444 99999999999999987642
Q ss_pred --------ccccccccCCCcceeeechhhHHHHHHHhh-CCCCCCCCcHHHHHHHHHhC-CCCCCCCCCHHHHHHHHhhc
Q psy11767 220 --------DEVIDWDDFSRGIECVFFSSSLIIFFIILS-FTLSFIHDYYHIQYRRILKT-EPPIPEDLSPDVADFISRLL 289 (966)
Q Consensus 220 --------~e~i~~~~y~~~~d~~~~~~~~il~~~m~~-g~~pf~~~~~~~~~~~I~~~-~~~~P~~~s~~a~dli~~LL 289 (966)
+|++....|+...| .|+.|+++|||++ |.+||......++.+.|..+ .+..|..+++++.+||.++|
T Consensus 425 ~~~~~y~aPE~~~~~~~~~~sD---vwSlGv~l~el~t~g~~P~~~~~~~~~~~~i~~~~~~~~~~~~~~~l~~li~~cl 501 (535)
T 2h8h_A 425 KFPIKWTAPEAALYGRFTIKSD---VWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPPECPESLHDLMCQCW 501 (535)
T ss_dssp TSCGGGSCHHHHHHCCCCHHHH---HHHHHHHHHHHTTTTCCSSTTCCHHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHT
T ss_pred cCcccccCHHHhccCCCCchhh---HHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCHHHHHHHHHHc
Confidence 12333333433333 3456677777777 99999988888888888765 56678899999999999999
Q ss_pred ccCCCcccCCCCCCHHHHhc
Q psy11767 290 VKDPRRRLGGGELDAEELKR 309 (966)
Q Consensus 290 ~kdp~~RLG~~~~g~~~Ik~ 309 (966)
..||.+|.. +++|..
T Consensus 502 ~~dP~~RPt-----~~~l~~ 516 (535)
T 2h8h_A 502 RKEPEERPT-----FEYLQA 516 (535)
T ss_dssp CSSGGGSCC-----HHHHHH
T ss_pred CCChhHCcC-----HHHHHH
Confidence 999999974 777765
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* | Back alignment and structure |
|---|
Probab=99.45 E-value=1.9e-13 Score=166.71 Aligned_cols=183 Identities=18% Similarity=0.235 Sum_probs=130.5
Q ss_pred CcceeeeecccccceEEEEEEcCC---CCEEEEEecccc------chhhHHHHHHHHhhCCCcccccccccccc------
Q psy11767 117 DLDKAGILGDGSYSVCRRCVEKST---GQEYAVKIISRK------IDCSEEINLLRACQGHPNICRRCVEKSTG------ 181 (966)
Q Consensus 117 df~~~~~LG~GsFGkV~La~~k~t---g~~yAiKvl~K~------~~~~~E~~il~~~~~~pfi~~~~~~~~~~------ 181 (966)
+|++.+.||+|+||+||+|+++.+ +..+|||++++. ....+|..+|+++ +||+|++.+-.....
T Consensus 391 ~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l-~HpnIv~l~~~~~~~~~~lv~ 469 (656)
T 2j0j_A 391 RIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQF-DHPHIVKLIGVITENPVWIIM 469 (656)
T ss_dssp GEEEEEEEECCSSCCEEEEEECCSSSCCEEEEEEECSSTTCHHHHHHHHHHHHHHHHC-CCTTBCCEEEEECSSSCEEEE
T ss_pred cEEEeeEEeeCCCEEEEEEEEecCCCccEEEEEEEecccCCHHHHHHHHHHHHHHHhC-CCCCCCeEEEEEecCceEEEE
Confidence 789999999999999999999764 457999998763 2356789999888 699998722111110
Q ss_pred ------------------------hhHHHHHHHh----------hcccchhhhHhhhccCCceEEecCcccc--------
Q psy11767 182 ------------------------QEYAVKIISR----------KIDCSEEINLLRACQGHPNIVNLHCVFQ-------- 219 (966)
Q Consensus 182 ------------------------~~~~~~~v~~----------~~~~~~e~nil~~~~gh~~iv~l~~~~~-------- 219 (966)
..++.+++.+ ..|++++ |||.+.+|+++|+||+.+..
T Consensus 470 E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDikp~-NILl~~~~~vkL~DFG~a~~~~~~~~~~ 548 (656)
T 2j0j_A 470 ELCTLGELRSFLQVRKFSLDLASLILYAYQLSTALAYLESKRFVHRDIAAR-NVLVSSNDCVKLGDFGLSRYMEDSTYYK 548 (656)
T ss_dssp ECCTTCBHHHHHHHTTTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGG-GEEEEETTEEEECCCCCCCSCCC-----
T ss_pred EcCCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCccccccchH-hEEEeCCCCEEEEecCCCeecCCCccee
Confidence 0111122211 1244445 99999999999999987642
Q ss_pred ------------ccccccccCCCcceeeechhhHHHHHHHh-hCCCCCCCCcHHHHHHHHHhC-CCCCCCCCCHHHHHHH
Q psy11767 220 ------------DEVIDWDDFSRGIECVFFSSSLIIFFIIL-SFTLSFIHDYYHIQYRRILKT-EPPIPEDLSPDVADFI 285 (966)
Q Consensus 220 ------------~e~i~~~~y~~~~d~~~~~~~~il~~~m~-~g~~pf~~~~~~~~~~~I~~~-~~~~P~~~s~~a~dli 285 (966)
+|++....|+...| .|+ .|+++|+|+ .|.+||...+...+...|..+ .+.+|..+++++.+||
T Consensus 549 ~~~~~~t~~y~aPE~~~~~~~~~~~D--iwS-lG~il~ellt~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~l~~li 625 (656)
T 2j0j_A 549 ASKGKLPIKWMAPESINFRRFTSASD--VWM-FGVCMWEILMHGVKPFQGVKNNDVIGRIENGERLPMPPNCPPTLYSLM 625 (656)
T ss_dssp -----CCGGGCCHHHHHHCCCCHHHH--HHH-HHHHHHHHHTTSCCTTTTCCHHHHHHHHHHTCCCCCCTTCCHHHHHHH
T ss_pred ccCCCCCcceeCHHHhcCCCCCchhh--HHH-HHHHHHHHHHcCCCCCCCCCHHHHHHHHHcCCCCCCCccccHHHHHHH
Confidence 23343344544333 444 555666665 599999988888888888875 4678999999999999
Q ss_pred HhhcccCCCcccCCCCCCHHHHhc
Q psy11767 286 SRLLVKDPRRRLGGGELDAEELKR 309 (966)
Q Consensus 286 ~~LL~kdp~~RLG~~~~g~~~Ik~ 309 (966)
.++|..||.+|.. +.+|..
T Consensus 626 ~~~l~~dP~~RPs-----~~el~~ 644 (656)
T 2j0j_A 626 TKCWAYDPSRRPR-----FTELKA 644 (656)
T ss_dssp HHHTCSSGGGSCC-----HHHHHH
T ss_pred HHHcCCChhHCcC-----HHHHHH
Confidence 9999999999974 677754
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* | Back alignment and structure |
|---|
Probab=99.45 E-value=3.3e-13 Score=148.21 Aligned_cols=184 Identities=18% Similarity=0.263 Sum_probs=120.8
Q ss_pred CcceeeeecccccceEEEEEEcCCCCEEEEEecccc--------chhhHHHHHHHHhhCCCcccccccccccc-------
Q psy11767 117 DLDKAGILGDGSYSVCRRCVEKSTGQEYAVKIISRK--------IDCSEEINLLRACQGHPNICRRCVEKSTG------- 181 (966)
Q Consensus 117 df~~~~~LG~GsFGkV~La~~k~tg~~yAiKvl~K~--------~~~~~E~~il~~~~~~pfi~~~~~~~~~~------- 181 (966)
+|.+.+.||+|+||+|++|+++.+|+.||||++++. ....+|..+|+++ +||+|++.+......
T Consensus 33 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~ 111 (310)
T 2wqm_A 33 NFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQL-NHPNVIKYYASFIEDNELNIVL 111 (310)
T ss_dssp GEEEEEEEECC--CEEEEEEETTTCCEEEEEEECTTSSCCHHHHHHHHHHHHHHHTC-CCTTBCCEEEEEEETTEEEEEE
T ss_pred ceEEEEeecCCCCceEEEEEEcCCCceEEEEeeehhhccCHHHHHHHHHHHHHHHhC-CCCCEeeEEEEEEcCCcEEEEE
Confidence 679999999999999999999999999999999853 1356789999888 699998621111100
Q ss_pred ---------------------------hhHHHHHHHh-------h---cccchhhhHhhhccCCceEEecCcccc-----
Q psy11767 182 ---------------------------QEYAVKIISR-------K---IDCSEEINLLRACQGHPNIVNLHCVFQ----- 219 (966)
Q Consensus 182 ---------------------------~~~~~~~v~~-------~---~~~~~e~nil~~~~gh~~iv~l~~~~~----- 219 (966)
...+.+++.+ . .|++++ |||.+.+|.++|+||+.+..
T Consensus 112 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~-NIl~~~~~~~kl~Dfg~~~~~~~~~ 190 (310)
T 2wqm_A 112 ELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMHSRRVMHRDIKPA-NVFITATGVVKLGDLGLGRFFSSKT 190 (310)
T ss_dssp ECCCSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGG-GEEECTTSCEEECCC----------
T ss_pred ecCCCCCHHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHhhCCeeCCCCcHH-HEEEcCCCCEEEEeccceeeecCCC
Confidence 0011111111 0 133334 99999899999999986531
Q ss_pred --------------ccccccccCCCcceeeechhhHHHHHHHhhCCCCCCCC--cHHHHHHHHHhCCCC-C-CCCCCHHH
Q psy11767 220 --------------DEVIDWDDFSRGIECVFFSSSLIIFFIILSFTLSFIHD--YYHIQYRRILKTEPP-I-PEDLSPDV 281 (966)
Q Consensus 220 --------------~e~i~~~~y~~~~d~~~~~~~~il~~~m~~g~~pf~~~--~~~~~~~~I~~~~~~-~-P~~~s~~a 281 (966)
+|++....|+...| .|+.|+++|+|++|..||... +...+.+.+...... . +..+++++
T Consensus 191 ~~~~~~~~~~~y~aPE~~~~~~~~~~~D---v~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 267 (310)
T 2wqm_A 191 TAAHSLVGTPYYMSPERIHENGYNFKSD---IWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEQCDYPPLPSDHYSEEL 267 (310)
T ss_dssp --------CCSSCCHHHHTTCCCCHHHH---HHHHHHHHHHHHHSSCTTC---CCHHHHHHHHHTTCSCCCCTTTSCHHH
T ss_pred ccccccCCCeeEeChHHhCCCCCCchhh---HHHHHHHHHHHHhCCCCCcccchhHHHHHHHhhcccCCCCcccccCHHH
Confidence 23333333433333 345667888888888898754 334556666654432 2 36789999
Q ss_pred HHHHHhhcccCCCcccCCCCCCHHHHhcC
Q psy11767 282 ADFISRLLVKDPRRRLGGGELDAEELKRH 310 (966)
Q Consensus 282 ~dli~~LL~kdp~~RLG~~~~g~~~Ik~H 310 (966)
++||.++|..||.+|.. +.+|..+
T Consensus 268 ~~li~~~l~~dp~~Rps-----~~~il~~ 291 (310)
T 2wqm_A 268 RQLVNMCINPDPEKRPD-----VTYVYDV 291 (310)
T ss_dssp HHHHHHHTCSSGGGSCC-----HHHHHHH
T ss_pred HHHHHHHcCCChhhCCC-----HHHHHHH
Confidence 99999999999999974 6777654
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 4ehz_A* 4ei4_A* 4fk6_A* 3eyg_A* 3eyh_A* | Back alignment and structure |
|---|
Probab=99.45 E-value=1.3e-13 Score=150.55 Aligned_cols=182 Identities=20% Similarity=0.233 Sum_probs=120.3
Q ss_pred CcceeeeecccccceEEEEE----EcCCCCEEEEEecccc------chhhHHHHHHHHhhCCCcccccccccccc-----
Q psy11767 117 DLDKAGILGDGSYSVCRRCV----EKSTGQEYAVKIISRK------IDCSEEINLLRACQGHPNICRRCVEKSTG----- 181 (966)
Q Consensus 117 df~~~~~LG~GsFGkV~La~----~k~tg~~yAiKvl~K~------~~~~~E~~il~~~~~~pfi~~~~~~~~~~----- 181 (966)
.|++++.||+|+||+|++|+ ++.+|+.||||++++. ....+|..+|+++ +||+|+...-.....
T Consensus 22 ~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~~~~~~~ 100 (302)
T 4e5w_A 22 FLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNL-YHENIVKYKGICTEDGGNGI 100 (302)
T ss_dssp GEEEEEEEEECSSEEEEEEEECTTSSSCSEEEEEEEEC-----CCHHHHHHHHHHHHTC-CCTTBCCEEEEEEC---CCE
T ss_pred hhhhhhccCCCCceEEEEEEEccccCccCeEEEEEEecccccchhHHHHHHHHHHHHhC-CCCCeeeeeeEEecCCCceE
Confidence 46999999999999999999 5789999999999864 2457899999988 599998622111000
Q ss_pred ----------------------------hhHHHHHHHh----------hcccchhhhHhhhccCCceEEecCcccc----
Q psy11767 182 ----------------------------QEYAVKIISR----------KIDCSEEINLLRACQGHPNIVNLHCVFQ---- 219 (966)
Q Consensus 182 ----------------------------~~~~~~~v~~----------~~~~~~e~nil~~~~gh~~iv~l~~~~~---- 219 (966)
...+.+++.+ ..|++++ |||.+.+|+++|+||+.+..
T Consensus 101 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~-Nil~~~~~~~kl~Dfg~~~~~~~~ 179 (302)
T 4e5w_A 101 KLIMEFLPSGSLKEYLPKNKNKINLKQQLKYAVQICKGMDYLGSRQYVHRDLAAR-NVLVESEHQVKIGDFGLTKAIETD 179 (302)
T ss_dssp EEEEECCTTCBHHHHHHHHTTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGG-GEEEEETTEEEECCCTTCEECCTT
T ss_pred EEEEEeCCCCcHHHHHHhccccCCHHHHHHHHHHHHHHHHHhhcCCcccCCCchh-eEEEcCCCCEEECcccccccccCC
Confidence 0001111111 0134444 99999999999999987632
Q ss_pred ------------------ccccccccCCCcceeeechhhHHHHHHHhhCCCCCCCC---------------cHHHHHHHH
Q psy11767 220 ------------------DEVIDWDDFSRGIECVFFSSSLIIFFIILSFTLSFIHD---------------YYHIQYRRI 266 (966)
Q Consensus 220 ------------------~e~i~~~~y~~~~d~~~~~~~~il~~~m~~g~~pf~~~---------------~~~~~~~~I 266 (966)
+|++....|+...| .|+.|+++|+|++|.+|+... ....+.+.+
T Consensus 180 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~D---i~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 256 (302)
T 4e5w_A 180 KEYYTVKDDRDSPVFWYAPECLMQSKFYIASD---VWSFGVTLHELLTYCDSDSSPMALFLKMIGPTHGQMTVTRLVNTL 256 (302)
T ss_dssp CCEEECCCCTTCCGGGCCHHHHHHCEEEHHHH---HHHHHHHHHHHHTTTCGGGSHHHHHHHHHCSCCGGGHHHHHHHHH
T ss_pred CcceeccCCCCCCccccCCeeecCCCCCcchh---HHHHHHHHHHHHHccCCCcchhhHHhhccCCcccccCHHHHHHHH
Confidence 12222222222222 446777788888887765432 122233333
Q ss_pred Hh-CCCCCCCCCCHHHHHHHHhhcccCCCcccCCCCCCHHHHh
Q psy11767 267 LK-TEPPIPEDLSPDVADFISRLLVKDPRRRLGGGELDAEELK 308 (966)
Q Consensus 267 ~~-~~~~~P~~~s~~a~dli~~LL~kdp~~RLG~~~~g~~~Ik 308 (966)
.. ..+.+|..+++++.+||+++|..||.+|.. +.+|.
T Consensus 257 ~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps-----~~~ll 294 (302)
T 4e5w_A 257 KEGKRLPCPPNCPDEVYQLMRKCWEFQPSNRTS-----FQNLI 294 (302)
T ss_dssp HTTCCCCCCTTCCHHHHHHHHHTTCSSGGGSCC-----HHHHH
T ss_pred hccCCCCCCCCCCHHHHHHHHHHcCCCCCCCCC-----HHHHH
Confidence 33 356788899999999999999999999974 66664
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.45 E-value=5.5e-13 Score=146.89 Aligned_cols=182 Identities=20% Similarity=0.322 Sum_probs=124.9
Q ss_pred CcceeeeecccccceEEEEEEcCCCCEEEEEeccccc---hhhHHHHHHHHhhCCCccccccccccc----------c--
Q psy11767 117 DLDKAGILGDGSYSVCRRCVEKSTGQEYAVKIISRKI---DCSEEINLLRACQGHPNICRRCVEKST----------G-- 181 (966)
Q Consensus 117 df~~~~~LG~GsFGkV~La~~k~tg~~yAiKvl~K~~---~~~~E~~il~~~~~~pfi~~~~~~~~~----------~-- 181 (966)
+|++.++||+|+||+|++|+++ ++.||||++++.. ...+|..+|+++ +||+|++.+-.... .
T Consensus 9 ~~~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~~~~~~~~~E~~~l~~l-~hp~iv~~~~~~~~~~~lv~e~~~~~~ 85 (307)
T 2eva_A 9 EIEVEEVVGRGAFGVVCKAKWR--AKDVAIKQIESESERKAFIVELRQLSRV-NHPNIVKLYGACLNPVCLVMEYAEGGS 85 (307)
T ss_dssp GEEEEEEEECCSSSEEEEEEET--TEEEEEEECSSTTHHHHHHHHHHHHHHC-CCTTBCCEEEBCTTTTEEEEECCTTCB
T ss_pred HeeeeeEeecCCCceEEEEEEC--CeeEEEEEecChhHHHHHHHHHHHHhcC-CCCCcCeEEEEEcCCcEEEEEcCCCCC
Confidence 6789999999999999999985 7889999998643 457799999888 69999862211100 0
Q ss_pred -------------------hhHHHHH------HHh----hc---ccchhhhHhhhccCC-ceEEecCccc----------
Q psy11767 182 -------------------QEYAVKI------ISR----KI---DCSEEINLLRACQGH-PNIVNLHCVF---------- 218 (966)
Q Consensus 182 -------------------~~~~~~~------v~~----~~---~~~~e~nil~~~~gh-~~iv~l~~~~---------- 218 (966)
...+.++ +.. .+ |++++ |||.+.+|. ++|+||+.+.
T Consensus 86 L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~~~ivH~dlkp~-NIll~~~~~~~kl~Dfg~~~~~~~~~~~~~ 164 (307)
T 2eva_A 86 LYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHRDLKPP-NLLLVAGGTVLKICDFGTACDIQTHMTNNK 164 (307)
T ss_dssp HHHHHHCSSSEECCCHHHHHHHHHHHHHHHHHHHTCSSSCCCCCCCSGG-GEEEETTTTEEEECCCCC------------
T ss_pred HHHHHhccCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeecCCCChh-HEEEeCCCCEEEEcccccccccccccccCC
Confidence 0000111 111 11 33334 999888777 7999998653
Q ss_pred ------cccccccccCCCcceeeechhhHHHHHHHhhCCCCCCCC--cHHHHHHHHH-hCCCCCCCCCCHHHHHHHHhhc
Q psy11767 219 ------QDEVIDWDDFSRGIECVFFSSSLIIFFIILSFTLSFIHD--YYHIQYRRIL-KTEPPIPEDLSPDVADFISRLL 289 (966)
Q Consensus 219 ------~~e~i~~~~y~~~~d~~~~~~~~il~~~m~~g~~pf~~~--~~~~~~~~I~-~~~~~~P~~~s~~a~dli~~LL 289 (966)
.+|++....|+...| .|+.|+++|+|++|.+||... ....+...+. ...+.++..+++++++||.++|
T Consensus 165 gt~~y~aPE~~~~~~~~~~~D---i~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l 241 (307)
T 2eva_A 165 GSAAWMAPEVFEGSNYSEKCD---VFSWGIILWEVITRRKPFDEIGGPAFRIMWAVHNGTRPPLIKNLPKPIESLMTRCW 241 (307)
T ss_dssp CCTTSSCHHHHTCCCCCTHHH---HHHHHHHHHHHHHTCCTTTTTCSSHHHHHHHHHTTCCCCCBTTCCHHHHHHHHHHT
T ss_pred CCCceEChhhhCCCCCCcHHH---HHHHHHHHHHHHHCCCCchhhCccHHHHHHHHhcCCCCCcccccCHHHHHHHHHHh
Confidence 234555445555555 446678889999999999742 3333334444 3466778899999999999999
Q ss_pred ccCCCcccCCCCCCHHHHhcC
Q psy11767 290 VKDPRRRLGGGELDAEELKRH 310 (966)
Q Consensus 290 ~kdp~~RLG~~~~g~~~Ik~H 310 (966)
..||.+|.. +++|.++
T Consensus 242 ~~dp~~Rps-----~~ell~~ 257 (307)
T 2eva_A 242 SKDPSQRPS-----MEEIVKI 257 (307)
T ss_dssp CSSGGGSCC-----HHHHHHH
T ss_pred cCChhhCcC-----HHHHHHH
Confidence 999999974 7777653
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 4deg_A* 4deh_A* 4dei_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 4aoi_A* 4ap7_A* 3q6w_A* ... | Back alignment and structure |
|---|
Probab=99.44 E-value=2.1e-13 Score=148.89 Aligned_cols=187 Identities=12% Similarity=0.107 Sum_probs=123.9
Q ss_pred ccCCcceeeeecccccceEEEEEEcCCC---CEEEEEeccccc------hhhHHHHHHHHhhCCCcccccccc-ccc-c-
Q psy11767 114 YDMDLDKAGILGDGSYSVCRRCVEKSTG---QEYAVKIISRKI------DCSEEINLLRACQGHPNICRRCVE-KST-G- 181 (966)
Q Consensus 114 ~~~df~~~~~LG~GsFGkV~La~~k~tg---~~yAiKvl~K~~------~~~~E~~il~~~~~~pfi~~~~~~-~~~-~- 181 (966)
....|++.++||+|+||.||+|+++.++ ..||+|++++.. ...+|..+|+++ +||+|+..... ... .
T Consensus 23 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~ 101 (298)
T 3f66_A 23 SSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDF-SHPNVLSLLGICLRSEGS 101 (298)
T ss_dssp GGEEEEEEEEEEEETTEEEEEEEEC-----CEEEEEEEETTCCSHHHHHHHHHHHHHHHTC-CCTTBCCCCEEECCSSSC
T ss_pred cceehhhcceeeecCCceEEEEEEecCCCceeEEEEEecccCCCHHHHHHHHHHHHHHHhC-CCCCEeeeeeEEEcCCCc
Confidence 3457899999999999999999975443 469999998632 346789999988 59999872211 000 0
Q ss_pred -----------------------------hhHHHHHHHh----------hcccchhhhHhhhccCCceEEecCcccc---
Q psy11767 182 -----------------------------QEYAVKIISR----------KIDCSEEINLLRACQGHPNIVNLHCVFQ--- 219 (966)
Q Consensus 182 -----------------------------~~~~~~~v~~----------~~~~~~e~nil~~~~gh~~iv~l~~~~~--- 219 (966)
...+.+++.+ ..|++++ |||.+.+|+++|+||+.+..
T Consensus 102 ~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~dikp~-Nil~~~~~~~kl~Dfg~a~~~~~ 180 (298)
T 3f66_A 102 PLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYLASKKFVHRDLAAR-NCMLDEKFTVKVADFGLARDMYD 180 (298)
T ss_dssp CEEEEECCTTCBHHHHHHCTTCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGG-GEEECTTCCEEECSCGGGCCCSC
T ss_pred eEEEEeCCCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCchh-eEEECCCCCEEECcccccccccc
Confidence 0001122211 0134444 99999999999999987642
Q ss_pred --------------------ccccccccCCCcceeeechhhHHHHHHHhhCCCCCCCCcHHHHHHHHHhCC-CCCCCCCC
Q psy11767 220 --------------------DEVIDWDDFSRGIECVFFSSSLIIFFIILSFTLSFIHDYYHIQYRRILKTE-PPIPEDLS 278 (966)
Q Consensus 220 --------------------~e~i~~~~y~~~~d~~~~~~~~il~~~m~~g~~pf~~~~~~~~~~~I~~~~-~~~P~~~s 278 (966)
+|++....|+.. .|.|++|+++++++.++.+||...+...+...+..+. ...|..++
T Consensus 181 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~--~Di~slG~il~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 258 (298)
T 3f66_A 181 KEYYSVHNKTGAKLPVKWMALESLQTQKFTTK--SDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRRLLQPEYCP 258 (298)
T ss_dssp GGGCBC-----CCBCGGGSCHHHHHHCCCCHH--HHHHHHHHHHHHHHTTSCCSSTTSCTTTHHHHHHTTCCCCCCTTCC
T ss_pred cchhccccccCCCCCccccChHHhcCCCCChH--HHHHHHHHHHHHHHhCCCCCCccCCHHHHHHHHhcCCCCCCCccCC
Confidence 122222233332 3345555444444445888998777766677777654 44578899
Q ss_pred HHHHHHHHhhcccCCCcccCCCCCCHHHHhc
Q psy11767 279 PDVADFISRLLVKDPRRRLGGGELDAEELKR 309 (966)
Q Consensus 279 ~~a~dli~~LL~kdp~~RLG~~~~g~~~Ik~ 309 (966)
+++.+||.++|..||.+|.. +.+|.+
T Consensus 259 ~~l~~li~~~l~~~p~~Rps-----~~ell~ 284 (298)
T 3f66_A 259 DPLYEVMLKCWHPKAEMRPS-----FSELVS 284 (298)
T ss_dssp HHHHHHHHHHTCSSGGGSCC-----HHHHHH
T ss_pred HHHHHHHHHHcCCChhhCcC-----HHHHHH
Confidence 99999999999999999974 666654
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.42 E-value=2.6e-13 Score=152.04 Aligned_cols=183 Identities=10% Similarity=0.027 Sum_probs=111.8
Q ss_pred CcceeeeecccccceEEEEEEcC---CCCEEEEEeccccc-hhh---------------HHHHHHHHhhCCCcccccccc
Q psy11767 117 DLDKAGILGDGSYSVCRRCVEKS---TGQEYAVKIISRKI-DCS---------------EEINLLRACQGHPNICRRCVE 177 (966)
Q Consensus 117 df~~~~~LG~GsFGkV~La~~k~---tg~~yAiKvl~K~~-~~~---------------~E~~il~~~~~~pfi~~~~~~ 177 (966)
+|.+.+.||+|+||+||+|+++. ++..+|||++.+.. ... +|..++..+ +||+|+..+-.
T Consensus 38 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l-~h~ni~~~~~~ 116 (345)
T 2v62_A 38 QWVLGKKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERKQL-DYLGIPLFYGS 116 (345)
T ss_dssp EEEEEEEC------CEEEEEESSSCGGGCCEEEEEEECC-CHHHHHHHHHHHHCCHHHHHHHHHHHTC-SCCCCCCEEEE
T ss_pred eEEEEeeEeecCCeEEEEEEecCCCCccceEEEEeeecCCcchHHHHHHHHHHhhhHHHHHHHhhccc-cccCcceeecc
Confidence 68999999999999999999988 89999999998642 222 333444443 79998762211
Q ss_pred ccc---------------------------------chhHHHHHHHh----------hcccchhhhHhhhccC--CceEE
Q psy11767 178 KST---------------------------------GQEYAVKIISR----------KIDCSEEINLLRACQG--HPNIV 212 (966)
Q Consensus 178 ~~~---------------------------------~~~~~~~~v~~----------~~~~~~e~nil~~~~g--h~~iv 212 (966)
... ...++.+++.+ ..|++++ |||.+.++ .++|+
T Consensus 117 ~~~~~~~~~~~~lv~e~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~-NIll~~~~~~~~kL~ 195 (345)
T 2v62_A 117 GLTEFKGRSYRFMVMERLGIDLQKISGQNGTFKKSTVLQLGIRMLDVLEYIHENEYVHGDIKAA-NLLLGYKNPDQVYLA 195 (345)
T ss_dssp EEEESSSCEEEEEEEECEEEEHHHHCBGGGBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGG-GEEEESSSTTSEEEC
T ss_pred cccccCCCcEEEEEEeccCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCcCHH-HEEEccCCCCcEEEE
Confidence 110 01111222221 0244444 99998877 99999
Q ss_pred ecCcccc--------------------------ccccccccCCCcceeeechhhHHHHHHHhhCCCCCCC--CcHHHHHH
Q psy11767 213 NLHCVFQ--------------------------DEVIDWDDFSRGIECVFFSSSLIIFFIILSFTLSFIH--DYYHIQYR 264 (966)
Q Consensus 213 ~l~~~~~--------------------------~e~i~~~~y~~~~d~~~~~~~~il~~~m~~g~~pf~~--~~~~~~~~ 264 (966)
||+.+.. +|++....|+...| .|+.|+++|+|++|.+||.. .+...+..
T Consensus 196 Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~D---i~slG~il~ell~g~~pf~~~~~~~~~~~~ 272 (345)
T 2v62_A 196 DYGLSYRYCPNGNHKQYQENPRKGHNGTIEFTSLDAHKGVALSRRSD---VEILGYCMLRWLCGKLPWEQNLKDPVAVQT 272 (345)
T ss_dssp CCTTCEESSGGGCCCCCCCCGGGCSCSCTTTCCHHHHHTCCCCHHHH---HHHHHHHHHHHHHSSCTTGGGTTCHHHHHH
T ss_pred eCCCceecccccccccchhccccccCCCccccCHHHhcCCCCCchhh---HHHHHHHHHHHHhCCCCccccccccHHHHH
Confidence 9987621 12333333433334 44667888889999999965 34333332
Q ss_pred HHHhCCCCCCC---------CCCHHHHHHHHhhcccCCCcccCCCCCCHHHHhc
Q psy11767 265 RILKTEPPIPE---------DLSPDVADFISRLLVKDPRRRLGGGELDAEELKR 309 (966)
Q Consensus 265 ~I~~~~~~~P~---------~~s~~a~dli~~LL~kdp~~RLG~~~~g~~~Ik~ 309 (966)
........+|. .+++++++||.++|..||.+|.. +++|.+
T Consensus 273 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps-----~~~l~~ 321 (345)
T 2v62_A 273 AKTNLLDELPQSVLKWAPSGSSCCEIAQFLVCAHSLAYDEKPN-----YQALKK 321 (345)
T ss_dssp HHHHHHHTTTHHHHHHSCTTSCCHHHHHHHHHHHTCCTTCCCC-----HHHHHH
T ss_pred HHHhhcccccHHHHhhccccccHHHHHHHHHHHhhcCcccCCC-----HHHHHH
Confidence 22222223333 78899999999999999999974 677754
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A | Back alignment and structure |
|---|
Probab=99.41 E-value=2.6e-13 Score=148.46 Aligned_cols=86 Identities=22% Similarity=0.213 Sum_probs=78.6
Q ss_pred hhHHHHhCCcCCCcceeeeeccccCceEEEEEeccCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccC
Q psy11767 868 LFEEQLLGPITRARRRTFVNRSRYNVHTYLVLELLKGGELLDRIRQKGRCGFTENEASRIMRQLVAAVHFMHSRGVVHRD 947 (966)
Q Consensus 868 l~e~~il~~l~~~~i~~~~~~~~~~~~~yLVmEy~~gg~L~~~i~~~~~~~~~~~~~~~~~~qi~~al~ylH~~gIiHRD 947 (966)
+.|..++.++.||+++++++.+..+...||||||++|++|.+++.. + ....++..++.||+.||.|||++||+|||
T Consensus 79 ~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~g~~L~~~l~~-~---~~~~~~~~i~~ql~~aL~~lH~~givH~D 154 (286)
T 3uqc_A 79 LSRTLRLSRIDKPGVARVLDVVHTRAGGLVVAEWIRGGSLQEVADT-S---PSPVGAIRAMQSLAAAADAAHRAGVALSI 154 (286)
T ss_dssp HHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEECCCEEEHHHHHTT-C---CCHHHHHHHHHHHHHHHHHHHHTTCCCCC
T ss_pred HHHHHHHhcCCCCCcceeeEEEEECCcEEEEEEecCCCCHHHHHhc-C---CChHHHHHHHHHHHHHHHHHHHCCCccCC
Confidence 5678889999999999999999999999999999999999999843 2 46778899999999999999999999999
Q ss_pred CCCCCeEeec
Q psy11767 948 LKPENLLLSG 957 (966)
Q Consensus 948 lKPeNILl~~ 957 (966)
|||+|||++.
T Consensus 155 ikp~NIll~~ 164 (286)
T 3uqc_A 155 DHPSRVRVSI 164 (286)
T ss_dssp CSGGGEEEET
T ss_pred CCcccEEEcC
Confidence 9999999985
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=99.41 E-value=1.8e-13 Score=155.58 Aligned_cols=185 Identities=12% Similarity=0.123 Sum_probs=122.7
Q ss_pred CCcceeeeecccccceEEEEEEcCCC---CEEEEEeccccc------hhhHHHHHHHHhhCCCcccccccc--cccch--
Q psy11767 116 MDLDKAGILGDGSYSVCRRCVEKSTG---QEYAVKIISRKI------DCSEEINLLRACQGHPNICRRCVE--KSTGQ-- 182 (966)
Q Consensus 116 ~df~~~~~LG~GsFGkV~La~~k~tg---~~yAiKvl~K~~------~~~~E~~il~~~~~~pfi~~~~~~--~~~~~-- 182 (966)
..|++.++||+|+||+||+|+.+.++ ..+|+|++++.. ...+|..+|+++ +||+|++.+-. .....
T Consensus 89 ~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l-~hpnIv~~~~~~~~~~~~~~ 167 (373)
T 3c1x_A 89 LIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDF-SHPNVLSLLGICLRSEGSPL 167 (373)
T ss_dssp EEEEEEEEEECCSSSEEEEEEEEETTTEEEEEEEEECCSCSCSHHHHHHHHHHTTSTTC-CCTTBCCCCEEECCCSSCCE
T ss_pred ceeecCcEeeeCCCeEEEEEEEECCCCcEEEEEEEEcCCCCCHHHHHHHHHHHHHHHhC-CCCCcceEEEEEEcCCCCeE
Confidence 46789999999999999999986543 469999998632 346788888888 69999873211 00000
Q ss_pred ----------------------------hHHHHHHHh----------hcccchhhhHhhhccCCceEEecCcccc-----
Q psy11767 183 ----------------------------EYAVKIISR----------KIDCSEEINLLRACQGHPNIVNLHCVFQ----- 219 (966)
Q Consensus 183 ----------------------------~~~~~~v~~----------~~~~~~e~nil~~~~gh~~iv~l~~~~~----- 219 (966)
.++.+++.+ ..|++++ |||.+.+|+++|+||+.+..
T Consensus 168 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~-NIll~~~~~~kL~DFG~a~~~~~~~ 246 (373)
T 3c1x_A 168 VVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASKKFVHRDLAAR-NCMLDEKFTVKVADFGLARDMYDKE 246 (373)
T ss_dssp EEEECCTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGG-GEEECTTCCEEECCC----------
T ss_pred EEEECCCCCCHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHHCCEecCccchh-eEEECCCCCEEEeeccccccccccc
Confidence 001122211 1144444 99999999999999986631
Q ss_pred ------------------ccccccccCCCcceeeechhhHHHHHHHhh-CCCCCCCCcHHHHHHHHHhC-CCCCCCCCCH
Q psy11767 220 ------------------DEVIDWDDFSRGIECVFFSSSLIIFFIILS-FTLSFIHDYYHIQYRRILKT-EPPIPEDLSP 279 (966)
Q Consensus 220 ------------------~e~i~~~~y~~~~d~~~~~~~~il~~~m~~-g~~pf~~~~~~~~~~~I~~~-~~~~P~~~s~ 279 (966)
+|++....|+... |.|+ .|+++|+|++ |.+||...+...+...+..+ .+..|..+++
T Consensus 247 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~--DvwS-lG~il~ellt~~~~p~~~~~~~~~~~~~~~~~~~~~p~~~~~ 323 (373)
T 3c1x_A 247 FDSVHNKTGAKLPVKWMALESLQTQKFTTKS--DVWS-FGVLLWELMTRGAPPYPDVNTFDITVYLLQGRRLLQPEYCPD 323 (373)
T ss_dssp -----------CCGGGSCHHHHHHCCCCHHH--HHHH-HHHHHHHHHTTSCCSCTTSCSSCHHHHHHTTCCCCCCTTCCH
T ss_pred cccccccCCCCCcccccChHHhcCCCCCcHH--HHHH-HHHHHHHHHhCcCCCCCCCCHHHHHHHHHcCCCCCCCCCCCH
Confidence 2233333443333 3455 4555555555 88999876665666677765 4556788999
Q ss_pred HHHHHHHhhcccCCCcccCCCCCCHHHHhcC
Q psy11767 280 DVADFISRLLVKDPRRRLGGGELDAEELKRH 310 (966)
Q Consensus 280 ~a~dli~~LL~kdp~~RLG~~~~g~~~Ik~H 310 (966)
+..+||.++|..||.+|. .+.+|.++
T Consensus 324 ~l~~li~~cl~~dp~~RP-----s~~ell~~ 349 (373)
T 3c1x_A 324 PLYEVMLKCWHPKAEMRP-----SFSELVSR 349 (373)
T ss_dssp HHHHHHHHHTCSSGGGSC-----CHHHHHHH
T ss_pred HHHHHHHHHcCCChhhCc-----CHHHHHHH
Confidence 999999999999999997 37777654
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.41 E-value=6e-13 Score=146.32 Aligned_cols=89 Identities=19% Similarity=0.359 Sum_probs=82.6
Q ss_pred hhHHHHhCCcCCCcceeeeeccccCceEEEEEeccCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccC
Q psy11767 868 LFEEQLLGPITRARRRTFVNRSRYNVHTYLVLELLKGGELLDRIRQKGRCGFTENEASRIMRQLVAAVHFMHSRGVVHRD 947 (966)
Q Consensus 868 l~e~~il~~l~~~~i~~~~~~~~~~~~~yLVmEy~~gg~L~~~i~~~~~~~~~~~~~~~~~~qi~~al~ylH~~gIiHRD 947 (966)
..|..++.++.||+++++++.+..+...|+||||++|++|.+++..... .+++.++..++.|++.||.|||++||+|||
T Consensus 55 ~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~-~~~~~~~~~i~~qi~~al~~lH~~~ivH~d 133 (310)
T 3s95_A 55 LKEVKVMRCLEHPNVLKFIGVLYKDKRLNFITEYIKGGTLRGIIKSMDS-QYPWSQRVSFAKDIASGMAYLHSMNIIHRD 133 (310)
T ss_dssp HHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEECCTTCBHHHHHHHCCT-TSCHHHHHHHHHHHHHHHHHHHHTTEECSC
T ss_pred HHHHHHHHhCCCcCcccEEEEEecCCeeEEEEEecCCCcHHHHHHhccC-CCCHHHHHHHHHHHHHHHHHHHhCCccCCC
Confidence 5688999999999999999999999999999999999999999976432 589999999999999999999999999999
Q ss_pred CCCCCeEeec
Q psy11767 948 LKPENLLLSG 957 (966)
Q Consensus 948 lKPeNILl~~ 957 (966)
|||+|||++.
T Consensus 134 lkp~Nil~~~ 143 (310)
T 3s95_A 134 LNSHNCLVRE 143 (310)
T ss_dssp CSTTSEEECT
T ss_pred CCcCeEEECC
Confidence 9999999975
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.36 E-value=9.8e-13 Score=145.92 Aligned_cols=183 Identities=17% Similarity=0.211 Sum_probs=121.3
Q ss_pred CcceeeeecccccceEEEEE----EcCCCCEEEEEeccccc-----hhhHHHHHHHHhhCCCccccccccc--cc-----
Q psy11767 117 DLDKAGILGDGSYSVCRRCV----EKSTGQEYAVKIISRKI-----DCSEEINLLRACQGHPNICRRCVEK--ST----- 180 (966)
Q Consensus 117 df~~~~~LG~GsFGkV~La~----~k~tg~~yAiKvl~K~~-----~~~~E~~il~~~~~~pfi~~~~~~~--~~----- 180 (966)
+|.+++.||+|+||+|++|+ +..+|+.||||++++.. ...+|..+|+++ +||+|++..-.. ..
T Consensus 42 ~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~~~ 120 (326)
T 2w1i_A 42 HLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSL-QHDNIVKYKGVCYSAGRRNLK 120 (326)
T ss_dssp GEEEEEEEECCSSEEEEEEEECTTSSSCCEEEEEEEESSCCSHHHHHHHHHHHHHHTC-CCTTBCCEEEEECC----CCE
T ss_pred HceeeeeeccCCCeEEEEEEeccccCCCceEEEEEEeccCCHHHHHHHHHHHHHHHhC-CCCCeeeEEEEEEecCCCceE
Confidence 67999999999999999999 46799999999998642 357899999988 699998621110 00
Q ss_pred -------c-------------------hhHHHHHHHh----------hcccchhhhHhhhccCCceEEecCcccc-----
Q psy11767 181 -------G-------------------QEYAVKIISR----------KIDCSEEINLLRACQGHPNIVNLHCVFQ----- 219 (966)
Q Consensus 181 -------~-------------------~~~~~~~v~~----------~~~~~~e~nil~~~~gh~~iv~l~~~~~----- 219 (966)
. ...+.+++.+ ..|++++ |||.+.+|.++|+||+.+..
T Consensus 121 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dikp~-NIli~~~~~~kL~Dfg~~~~~~~~~ 199 (326)
T 2w1i_A 121 LIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKRYIHRDLATR-NILVENENRVKIGDFGLTKVLPQDK 199 (326)
T ss_dssp EEECCCTTCBHHHHHHHSTTSSCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGG-GEEEEETTEEEECCCTTCEECCSSC
T ss_pred EEEECCCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCEeccCCCcc-eEEEcCCCcEEEecCcchhhccccc
Confidence 0 0001111111 0134444 99999899999999987632
Q ss_pred -----------------ccccccccCCCcceeeechhhHHHHHHHhhCCCCCCCCcHH----------------HHHHHH
Q psy11767 220 -----------------DEVIDWDDFSRGIECVFFSSSLIIFFIILSFTLSFIHDYYH----------------IQYRRI 266 (966)
Q Consensus 220 -----------------~e~i~~~~y~~~~d~~~~~~~~il~~~m~~g~~pf~~~~~~----------------~~~~~I 266 (966)
+|++....|+...| .|+.|+++|+|++|..||...... .+.+.+
T Consensus 200 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~D---i~slG~il~el~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 276 (326)
T 2w1i_A 200 EYYKVKEPGESPIFWYAPESLTESKFSVASD---VWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIELL 276 (326)
T ss_dssp SEEECSSCCSCCGGGCCHHHHHHCEEEHHHH---HHHHHHHHHHHHHTTCGGGSHHHHHHHHHCTTCCTHHHHHHHHHHH
T ss_pred cccccccCCCCceeEECchhhcCCCCCchhh---HHHHHHHHHHHHhcCCCCCCCHHHHHHhhccccchhhhHHHHHHHh
Confidence 11221112222222 446678888888888887653211 112223
Q ss_pred Hh-CCCCCCCCCCHHHHHHHHhhcccCCCcccCCCCCCHHHHhc
Q psy11767 267 LK-TEPPIPEDLSPDVADFISRLLVKDPRRRLGGGELDAEELKR 309 (966)
Q Consensus 267 ~~-~~~~~P~~~s~~a~dli~~LL~kdp~~RLG~~~~g~~~Ik~ 309 (966)
.. ..+..|..+++++.+||+++|..||.+|.. +.+|..
T Consensus 277 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps-----~~el~~ 315 (326)
T 2w1i_A 277 KNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPS-----FRDLAL 315 (326)
T ss_dssp HTTCCCCCCTTCCHHHHHHHHHHSCSSGGGSCC-----HHHHHH
T ss_pred hcCCCCCCCCcccHHHHHHHHHHcCCChhhCcC-----HHHHHH
Confidence 22 356678899999999999999999999984 666653
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.36 E-value=1.2e-12 Score=144.16 Aligned_cols=190 Identities=16% Similarity=0.207 Sum_probs=126.5
Q ss_pred cCCccchhccC---CcceeeeecccccceEEEEEEcCCCCEEEEEecccc-------chhhHHHHHHHHhhCCCcccccc
Q psy11767 106 KGSLFFEQYDM---DLDKAGILGDGSYSVCRRCVEKSTGQEYAVKIISRK-------IDCSEEINLLRACQGHPNICRRC 175 (966)
Q Consensus 106 ~~~~~~~~~~~---df~~~~~LG~GsFGkV~La~~k~tg~~yAiKvl~K~-------~~~~~E~~il~~~~~~pfi~~~~ 175 (966)
..+.+.+.+++ +|++.++||+|+||.|++|+++. .+|+|++++. ....+|..+|+++ +||+|++..
T Consensus 20 ~~~~~~~~~~i~~~~~~~~~~lg~G~~g~V~~~~~~~---~~avk~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~ 95 (319)
T 2y4i_B 20 QTSIFLQEWDIPFEQLEIGELIGKGRFGQVYHGRWHG---EVAIRLIDIERDNEDQLKAFKREVMAYRQT-RHENVVLFM 95 (319)
T ss_dssp --CCCGGGSSSCCSCEECCCBCCCSSSSEEEEEEESS---SEEEEECCCCSCCCCCCCCCCTTGGGGTTC-CCTTBCCCC
T ss_pred ccccccccccCCHHHeEEeeEeccCCceEEEEEEEcC---eEEEEEeecCCCCHHHHHHHHHHHHHHhcC-CCCCEeEEE
Confidence 44556666776 78999999999999999999874 3999999864 1346788888887 699997611
Q ss_pred ccccc-------------------------------chhHHHHHHHh-------h---cccchhhhHhhhccCCceEEec
Q psy11767 176 VEKST-------------------------------GQEYAVKIISR-------K---IDCSEEINLLRACQGHPNIVNL 214 (966)
Q Consensus 176 ~~~~~-------------------------------~~~~~~~~v~~-------~---~~~~~e~nil~~~~gh~~iv~l 214 (966)
..... ....+.+++.+ . .|++++ |||.+ +|.++|.||
T Consensus 96 ~~~~~~~~~~iv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~i~H~dlkp~-NIl~~-~~~~~l~Df 173 (319)
T 2y4i_B 96 GACMSPPHLAIITSLCKGRTLYSVVRDAKIVLDVNKTRQIAQEIVKGMGYLHAKGILHKDLKSK-NVFYD-NGKVVITDF 173 (319)
T ss_dssp EEEECSSCEEEECBCCCSEEHHHHTTSSCCCCCSHHHHHHHHHHHHHHHHHHHTTCCCCCCCST-TEEEC---CCEECCC
T ss_pred EEEecCCceEEEeecccCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCChh-hEEEe-CCCEEEeec
Confidence 11100 01111122211 0 133444 88887 689999999
Q ss_pred Ccccc------------------------cccccc---------ccCCCcceeeechhhHHHHHHHhhCCCCCCCCcHHH
Q psy11767 215 HCVFQ------------------------DEVIDW---------DDFSRGIECVFFSSSLIIFFIILSFTLSFIHDYYHI 261 (966)
Q Consensus 215 ~~~~~------------------------~e~i~~---------~~y~~~~d~~~~~~~~il~~~m~~g~~pf~~~~~~~ 261 (966)
+.+.. +|++.. ..|+.. .|.| +.|+++|+|++|..||...+...
T Consensus 174 g~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~--~Di~-slG~il~el~~g~~p~~~~~~~~ 250 (319)
T 2y4i_B 174 GLFSISGVLQAGRREDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKH--SDVF-ALGTIWYELHAREWPFKTQPAEA 250 (319)
T ss_dssp SCCC----------CCSCBCCSGGGGTSCHHHHSCBSCC--CCCSCCCHH--HHHH-HHHHHHHHHHHSSCSSSSCCHHH
T ss_pred CCccccccccccccccccccCCCcccccChHHhhhccccccccccCCCch--hhHH-HHHHHHHHHHhCCCCCCCCCHHH
Confidence 86421 233322 112222 3334 55688888999999999988888
Q ss_pred HHHHHHhCCCCC--CCCCCHHHHHHHHhhcccCCCcccCCCCCCHHHHhc
Q psy11767 262 QYRRILKTEPPI--PEDLSPDVADFISRLLVKDPRRRLGGGELDAEELKR 309 (966)
Q Consensus 262 ~~~~I~~~~~~~--P~~~s~~a~dli~~LL~kdp~~RLG~~~~g~~~Ik~ 309 (966)
+...+..+.... +..++++..+||.++|..||.+|.. +.+|..
T Consensus 251 ~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt-----~~~l~~ 295 (319)
T 2y4i_B 251 IIWQMGTGMKPNLSQIGMGKEISDILLFCWAFEQEERPT-----FTKLMD 295 (319)
T ss_dssp HHHHHHTTCCCCCCCSSCCTTHHHHHHHHHCSSTTTSCC-----HHHHHH
T ss_pred HHHHhccCCCCCCCcCCCCHHHHHHHHHHhcCChhhCcC-----HHHHHH
Confidence 888887764432 2368899999999999999999973 777765
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* | Back alignment and structure |
|---|
Probab=99.36 E-value=1.4e-12 Score=142.10 Aligned_cols=183 Identities=20% Similarity=0.238 Sum_probs=116.5
Q ss_pred CcceeeeecccccceEEEEEEcCCCCEEEEEeccccc--hhhHHHHHHHHh-hCCCcccccccc----cc----------
Q psy11767 117 DLDKAGILGDGSYSVCRRCVEKSTGQEYAVKIISRKI--DCSEEINLLRAC-QGHPNICRRCVE----KS---------- 179 (966)
Q Consensus 117 df~~~~~LG~GsFGkV~La~~k~tg~~yAiKvl~K~~--~~~~E~~il~~~-~~~pfi~~~~~~----~~---------- 179 (966)
+|.+++.||+|+||+|++|++ +|+.||||++++.. ....|.+++... -+||+|++.... ..
T Consensus 9 ~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~e~~~~~~~~l~h~niv~~~~~~~~~~~~~~~~~lv~e 86 (301)
T 3q4u_A 9 DITLLECVGKGRYGEVWRGSW--QGENVAVKIFSSRDEKSWFRETELYNTVMLRHENILGFIASDMTSRHSSTQLWLITH 86 (301)
T ss_dssp GCEEEEEEEECSSEEEEEEEE--TTEEEEEEEECGGGHHHHHHHHHHHHHTCCCCTTBCCEEEEEEEEETTEEEEEEEEC
T ss_pred cEEEEEeeccCCCcEEEEEEE--CCEEEEEEEeccccchhhHHHHHHHHHhhccCcCeeeEEEeeccccCCCceeEEehh
Confidence 679999999999999999987 69999999998753 346688888774 489999873211 00
Q ss_pred c--c-----------------hhHHHHH------HH--------hh----cccchhhhHhhhccCCceEEecCcccc---
Q psy11767 180 T--G-----------------QEYAVKI------IS--------RK----IDCSEEINLLRACQGHPNIVNLHCVFQ--- 219 (966)
Q Consensus 180 ~--~-----------------~~~~~~~------v~--------~~----~~~~~e~nil~~~~gh~~iv~l~~~~~--- 219 (966)
. . ...+.++ +. .. .|++++ |||.+.+|+++|+||+.+..
T Consensus 87 ~~~~g~L~~~l~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dlkp~-Nill~~~~~~kl~Dfg~a~~~~~ 165 (301)
T 3q4u_A 87 YHEMGSLYDYLQLTTLDTVSCLRIVLSIASGLAHLHIEIFGTQGKPAIAHRDLKSK-NILVKKNGQCCIADLGLAVMHSQ 165 (301)
T ss_dssp CCTTCBHHHHHTTCCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCEEECSCCCGG-GEEECTTSCEEECCCTTCEEEET
T ss_pred hccCCCHHHHHhhcccCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCeecCCCChH-hEEEcCCCCEEEeeCCCeeeccc
Confidence 0 0 0011111 22 10 134444 99999999999999997621
Q ss_pred --------------------ccccccccCCC----cceeeechhhHHHHHHHhhC----------CCCCCCC-----cHH
Q psy11767 220 --------------------DEVIDWDDFSR----GIECVFFSSSLIIFFIILSF----------TLSFIHD-----YYH 260 (966)
Q Consensus 220 --------------------~e~i~~~~y~~----~~d~~~~~~~~il~~~m~~g----------~~pf~~~-----~~~ 260 (966)
+|++....... +...| .|+.|+++|+|++| .+||... ...
T Consensus 166 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~D-vwslG~il~el~tg~~~~~~~~~~~~pf~~~~~~~~~~~ 244 (301)
T 3q4u_A 166 STNQLDVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVD-IWAFGLVLWEVARRMVSNGIVEDYKPPFYDVVPNDPSFE 244 (301)
T ss_dssp TTTEEECCCCCCCCCGGGCCHHHHTTCCCTTCHHHHHHHH-HHHHHHHHHHHHTTBCBTTBCCCCCCTTTTTSCSSCCHH
T ss_pred ccccccccccccccccceeChhhhcCcCCCCcccCCchhh-HHHHHHHHHHHHhhhcCccccccccccccccCCCCcchh
Confidence 23332221100 01123 44667888888888 7888642 223
Q ss_pred HHHHHHHh---CCCCCCCC-----CCHHHHHHHHhhcccCCCcccCCCCCCHHHHhc
Q psy11767 261 IQYRRILK---TEPPIPED-----LSPDVADFISRLLVKDPRRRLGGGELDAEELKR 309 (966)
Q Consensus 261 ~~~~~I~~---~~~~~P~~-----~s~~a~dli~~LL~kdp~~RLG~~~~g~~~Ik~ 309 (966)
. ..+++. ..+.+|.. .++++.+||+++|..||.+|.. +.+|.+
T Consensus 245 ~-~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps-----~~~i~~ 295 (301)
T 3q4u_A 245 D-MRKVVCVDQQRPNIPNRWFSDPTLTSLAKLMKECWYQNPSARLT-----ALRIKK 295 (301)
T ss_dssp H-HHHHHTTSCCCCCCCGGGGGSHHHHHHHHHHHHHCCSSGGGSCC-----HHHHHH
T ss_pred h-hhHHHhccCCCCCCChhhccCccHHHHHHHHHHHhhcChhhCCC-----HHHHHH
Confidence 3 334332 23344432 4578999999999999999984 677654
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} SCOP: d.144.1.7 PDB: 4fk3_A* 3c4c_A* 3c4d_A* 3idp_A* 4g9r_A* 3ii5_A* 4e26_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 3d4q_A* 4e4x_A* 4g9c_A* ... | Back alignment and structure |
|---|
Probab=99.36 E-value=1.1e-12 Score=142.92 Aligned_cols=180 Identities=14% Similarity=0.158 Sum_probs=117.8
Q ss_pred CcceeeeecccccceEEEEEEcCCCCEEEEEeccccc-------hhhHHHHHHHHhhCCCcccccccccccc--------
Q psy11767 117 DLDKAGILGDGSYSVCRRCVEKSTGQEYAVKIISRKI-------DCSEEINLLRACQGHPNICRRCVEKSTG-------- 181 (966)
Q Consensus 117 df~~~~~LG~GsFGkV~La~~k~tg~~yAiKvl~K~~-------~~~~E~~il~~~~~~pfi~~~~~~~~~~-------- 181 (966)
+|.+.+.||+|+||.||+|+.+. .+|+|+++... ...+|..+|+++ +||+|+...-.....
T Consensus 25 ~y~~~~~lG~G~~g~Vy~~~~~~---~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~lv~e~ 100 (289)
T 3og7_A 25 QITVGQRIGSGSFGTVYKGKWHG---DVAVKMLNVTAPTPQQLQAFKNEVGVLRKT-RHVNILLFMGYSTAPQLAIVTQW 100 (289)
T ss_dssp SCEEEEEEEECSSEEEEEEESSS---EEEEEEESCSSCCHHHHHHHHHHHHHHTTC-CCTTBCCEEEEECSSSCEEEEEC
T ss_pred ceeeeeEecCCCCeEEEEEEEcC---ceEEEEEeccCCCHHHHHHHHHHHHHHHhC-CCCcEEEEEeeccCCccEEEEEe
Confidence 67999999999999999998754 49999997532 346789999887 599997621110000
Q ss_pred ----------------------hhHHHHHHHh----------hcccchhhhHhhhccCCceEEecCcccc----------
Q psy11767 182 ----------------------QEYAVKIISR----------KIDCSEEINLLRACQGHPNIVNLHCVFQ---------- 219 (966)
Q Consensus 182 ----------------------~~~~~~~v~~----------~~~~~~e~nil~~~~gh~~iv~l~~~~~---------- 219 (966)
...+.+++.+ ..|++++ |||.+.+|.++|+||+.+..
T Consensus 101 ~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~i~H~Dlkp~-Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~ 179 (289)
T 3og7_A 101 CEGSSLYHHLHASETKFEMKKLIDIARQTARGMDYLHAKSIIHRDLKSN-NIFLHEDNTVKIGDFGLATEKSRWSGSHQF 179 (289)
T ss_dssp CCEEEHHHHHTTC---CCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGG-GEEEETTTEEEECCCC--------------
T ss_pred cCCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCccc-eEEECCCCCEEEccceeccccccccccccc
Confidence 0111122211 0134444 99999999999999986531
Q ss_pred -----------ccccc---cccCCCcceeeechhhHHHHHHHhhCCCCCCC-CcHHHHHHHHHhCCCC-----CCCCCCH
Q psy11767 220 -----------DEVID---WDDFSRGIECVFFSSSLIIFFIILSFTLSFIH-DYYHIQYRRILKTEPP-----IPEDLSP 279 (966)
Q Consensus 220 -----------~e~i~---~~~y~~~~d~~~~~~~~il~~~m~~g~~pf~~-~~~~~~~~~I~~~~~~-----~P~~~s~ 279 (966)
+|++. ...|+...| .|+.|+++|+|++|.+||.. .+...+.+.+..+... ++..+++
T Consensus 180 ~~~~gt~~y~aPE~~~~~~~~~~~~~~D---i~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 256 (289)
T 3og7_A 180 EQLSGSILWMAPEVIRMQDSNPYSFQSD---VYAFGIVLYELMTGQLPYSNINNRDQIIEMVGRGSLSPDLSKVRSNCPK 256 (289)
T ss_dssp ----CCCTTCCHHHHC----CCSCHHHH---HHHHHHHHHHHHHSSCTTSSCCCHHHHHHHHHHTSCCCCTTSSCTTSCH
T ss_pred cccCCCccccCchhhcccCCCCCCcccc---hHHHHHHHHHHHHCCCCccccchHHHHHHHhcccccCcchhhccccCCH
Confidence 23332 222322333 44667888888889999976 4445555555554432 3457889
Q ss_pred HHHHHHHhhcccCCCcccCCCCCCHHHHhc
Q psy11767 280 DVADFISRLLVKDPRRRLGGGELDAEELKR 309 (966)
Q Consensus 280 ~a~dli~~LL~kdp~~RLG~~~~g~~~Ik~ 309 (966)
+.++||.++|..||.+|.. +.+|.+
T Consensus 257 ~l~~li~~~l~~~p~~Rps-----~~ell~ 281 (289)
T 3og7_A 257 RMKRLMAECLKKKRDERPS-----FPRILA 281 (289)
T ss_dssp HHHHHHHHHTCSSGGGSCC-----HHHHHH
T ss_pred HHHHHHHHHccCChhhCCC-----HHHHHH
Confidence 9999999999999999974 666653
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.36 E-value=8.1e-13 Score=149.05 Aligned_cols=89 Identities=20% Similarity=0.299 Sum_probs=76.9
Q ss_pred hHHHHhCCc---CCCcceeeeeccccCceEEEEEeccCCCCHHHHHHhh---CCCCCCHHHHHHHHHHHHHHHHHHHhCC
Q psy11767 869 FEEQLLGPI---TRARRRTFVNRSRYNVHTYLVLELLKGGELLDRIRQK---GRCGFTENEASRIMRQLVAAVHFMHSRG 942 (966)
Q Consensus 869 ~e~~il~~l---~~~~i~~~~~~~~~~~~~yLVmEy~~gg~L~~~i~~~---~~~~~~~~~~~~~~~qi~~al~ylH~~g 942 (966)
.|.+++.++ .|++++.+++.+..+...|||||||+||+|.+++... ....+++..+..++.||+.||.|||++|
T Consensus 113 ~e~~~~~~l~~~~~~~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~ 192 (365)
T 3e7e_A 113 IGTQLMERLKPSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCE 192 (365)
T ss_dssp HHHHHHHHSCGGGGGGBCCEEEEEECSSCEEEEECCCCSCBHHHHHHHHHTSTTCSCCHHHHHHHHHHHHHHHHHHHTTT
T ss_pred HHHHHHHHhhhhhhhhhhhhheeeecCCCcEEEEeccCCCcHHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHhhCC
Confidence 344444444 4999999999999999999999999999999999742 1235899999999999999999999999
Q ss_pred CcccCCCCCCeEeec
Q psy11767 943 VVHRDLKPENLLLSG 957 (966)
Q Consensus 943 IiHRDlKPeNILl~~ 957 (966)
||||||||+||||+.
T Consensus 193 ivHrDiKp~NIll~~ 207 (365)
T 3e7e_A 193 IIHGDIKPDNFILGN 207 (365)
T ss_dssp EECCCCSGGGEEECG
T ss_pred eecCCCCHHHEEecc
Confidence 999999999999975
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* | Back alignment and structure |
|---|
Probab=99.35 E-value=1.3e-12 Score=144.52 Aligned_cols=90 Identities=18% Similarity=0.289 Sum_probs=81.4
Q ss_pred hhHHHHhCCcCCCcceeeeeccccCceEEEEEeccCCCCHHHHHHhhC--CCCCCHHHHHHHHHHHHHHHHHHHhCCCcc
Q psy11767 868 LFEEQLLGPITRARRRTFVNRSRYNVHTYLVLELLKGGELLDRIRQKG--RCGFTENEASRIMRQLVAAVHFMHSRGVVH 945 (966)
Q Consensus 868 l~e~~il~~l~~~~i~~~~~~~~~~~~~yLVmEy~~gg~L~~~i~~~~--~~~~~~~~~~~~~~qi~~al~ylH~~gIiH 945 (966)
..|..++..+.||+++++++.+..+...|+||||++||+|.+++.... ...+++.++..++.|++.||.|||++||+|
T Consensus 83 ~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~ivH 162 (321)
T 2qkw_B 83 ETEIETLSFCRHPHLVSLIGFCDERNEMILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLHTRAIIH 162 (321)
T ss_dssp HHHHHGGGSCCCTTBCCEEEECCCTTCCEEEEECCTTCBTGGGSSSSCCCSCCCCHHHHHHHHHHHHHHHHHHHHTTEEC
T ss_pred HHHHHHHHhCCCCCEeeEEEEEcCCCeEEEEEEcCCCCcHHHHHhccCCCccccCHHHHHHHHHHHHHHHHHhcCCCeec
Confidence 568889999999999999999999999999999999999999886432 124899999999999999999999999999
Q ss_pred cCCCCCCeEeec
Q psy11767 946 RDLKPENLLLSG 957 (966)
Q Consensus 946 RDlKPeNILl~~ 957 (966)
|||||+|||++.
T Consensus 163 ~dlkp~Nil~~~ 174 (321)
T 2qkw_B 163 RDVKSINILLDE 174 (321)
T ss_dssp SCCCSTTEEECT
T ss_pred CCCCHHHEEECC
Confidence 999999999974
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3ulz_A* 3tl8_A* | Back alignment and structure |
|---|
Probab=99.32 E-value=2.2e-12 Score=142.65 Aligned_cols=91 Identities=16% Similarity=0.246 Sum_probs=82.3
Q ss_pred HhhHHHHhCCcCCCcceeeeeccccCceEEEEEeccCCCCHHHHHHhhCC--CCCCHHHHHHHHHHHHHHHHHHHhC---
Q psy11767 867 TLFEEQLLGPITRARRRTFVNRSRYNVHTYLVLELLKGGELLDRIRQKGR--CGFTENEASRIMRQLVAAVHFMHSR--- 941 (966)
Q Consensus 867 ~l~e~~il~~l~~~~i~~~~~~~~~~~~~yLVmEy~~gg~L~~~i~~~~~--~~~~~~~~~~~~~qi~~al~ylH~~--- 941 (966)
-..|..++..+.||+++++++.+......|+||||+.||+|.+++..... ..+++..+..++.|++.||.|||++
T Consensus 74 ~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~ 153 (326)
T 3uim_A 74 FQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIALGSARGLAYLHDHCDP 153 (326)
T ss_dssp HHHHHHGGGTCCCTTBCCCCEEECCSSCCEEEEECCTTCBHHHHHHCCSTTCCCCCHHHHHHHHHHHHHHHHHHHHSSSS
T ss_pred HHHHHHHHHhccCCCccceEEEEecCCceEEEEEeccCCCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCC
Confidence 35688899999999999999999989999999999999999999975432 2389999999999999999999999
Q ss_pred CCcccCCCCCCeEeec
Q psy11767 942 GVVHRDLKPENLLLSG 957 (966)
Q Consensus 942 gIiHRDlKPeNILl~~ 957 (966)
||+||||||+|||++.
T Consensus 154 ~ivH~Dlkp~Nil~~~ 169 (326)
T 3uim_A 154 KIIHRDVKAANILLDE 169 (326)
T ss_dssp CEECCCCSGGGEEECT
T ss_pred CeEeCCCchhhEEECC
Confidence 9999999999999975
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 4asx_A* 2qlu_A* | Back alignment and structure |
|---|
Probab=99.28 E-value=4.3e-12 Score=140.67 Aligned_cols=93 Identities=22% Similarity=0.345 Sum_probs=80.6
Q ss_pred hhHHHHhCCcCCCcceeeeecccc----CceEEEEEeccCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhC--
Q psy11767 868 LFEEQLLGPITRARRRTFVNRSRY----NVHTYLVLELLKGGELLDRIRQKGRCGFTENEASRIMRQLVAAVHFMHSR-- 941 (966)
Q Consensus 868 l~e~~il~~l~~~~i~~~~~~~~~----~~~~yLVmEy~~gg~L~~~i~~~~~~~~~~~~~~~~~~qi~~al~ylH~~-- 941 (966)
..|..++.++.||+++++++.+.. ..++||||||+++|+|.+++... .+++..+..++.|++.||.|||++
T Consensus 66 ~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~---~~~~~~~~~i~~qi~~al~~LH~~~~ 142 (322)
T 3soc_A 66 EYEVYSLPGMKHENILQFIGAEKRGTSVDVDLWLITAFHEKGSLSDFLKAN---VVSWNELCHIAETMARGLAYLHEDIP 142 (322)
T ss_dssp HHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEEEECCTTCBHHHHHHHC---CBCHHHHHHHHHHHHHHHHHHTCCEE
T ss_pred HHHHHHHhcCCCCCchhhcceeccCCCCCceEEEEEecCCCCCHHHHHHhc---CCCHHHHHHHHHHHHHHHHHHHhhcc
Confidence 457788999999999999988765 34589999999999999999764 389999999999999999999999
Q ss_pred --------CCcccCCCCCCeEeecCCCCeeee
Q psy11767 942 --------GVVHRDLKPENLLLSGISGNLIKI 965 (966)
Q Consensus 942 --------gIiHRDlKPeNILl~~~~~~~iki 965 (966)
||+||||||+|||++.. + .+||
T Consensus 143 ~l~~~~~~~ivH~Dlkp~Nill~~~-~-~~kL 172 (322)
T 3soc_A 143 GLKDGHKPAISHRDIKSKNVLLKNN-L-TACI 172 (322)
T ss_dssp EETTEEECEEECSCCSGGGEEECTT-C-CEEE
T ss_pred ccccccCCCEEeCCCChHhEEECCC-C-eEEE
Confidence 99999999999999753 2 3454
|
Homologous Structure Domains
Structure Domains Detected by RPS-BLAST
Original result of RPS-BLAST against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
E-value |
| 966 | ||||
| d1phka_ | 277 | d.144.1.7 (A:) gamma-subunit of glycogen phosphory | 4e-65 | |
| d1phka_ | 277 | d.144.1.7 (A:) gamma-subunit of glycogen phosphory | 3e-17 | |
| d1phka_ | 277 | d.144.1.7 (A:) gamma-subunit of glycogen phosphory | 2e-10 | |
| d1phka_ | 277 | d.144.1.7 (A:) gamma-subunit of glycogen phosphory | 8e-09 | |
| d1koaa2 | 350 | d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C | 2e-64 | |
| d1koaa2 | 350 | d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C | 9e-16 | |
| d1koaa2 | 350 | d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C | 2e-12 | |
| d1koaa2 | 350 | d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C | 1e-06 | |
| d1koba_ | 352 | d.144.1.7 (A:) Twitchin, kinase domain {California | 2e-63 | |
| d1koba_ | 352 | d.144.1.7 (A:) Twitchin, kinase domain {California | 2e-16 | |
| d1koba_ | 352 | d.144.1.7 (A:) Twitchin, kinase domain {California | 8e-16 | |
| d2ozaa1 | 335 | d.144.1.7 (A:51-385) MAP kinase activated protein | 6e-63 | |
| d2ozaa1 | 335 | d.144.1.7 (A:51-385) MAP kinase activated protein | 1e-18 | |
| d2ozaa1 | 335 | d.144.1.7 (A:51-385) MAP kinase activated protein | 3e-10 | |
| d1tkia_ | 321 | d.144.1.7 (A:) Titin, kinase domain {Human (Homo s | 2e-61 | |
| d1tkia_ | 321 | d.144.1.7 (A:) Titin, kinase domain {Human (Homo s | 9e-19 | |
| d1tkia_ | 321 | d.144.1.7 (A:) Titin, kinase domain {Human (Homo s | 7e-14 | |
| d2j4za1 | 263 | d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur | 1e-58 | |
| d2j4za1 | 263 | d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur | 2e-15 | |
| d2j4za1 | 263 | d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur | 7e-15 | |
| d2j4za1 | 263 | d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur | 4e-06 | |
| d1a06a_ | 307 | d.144.1.7 (A:) Calmodulin-dependent protein kinase | 2e-58 | |
| d1a06a_ | 307 | d.144.1.7 (A:) Calmodulin-dependent protein kinase | 3e-20 | |
| d1a06a_ | 307 | d.144.1.7 (A:) Calmodulin-dependent protein kinase | 2e-12 | |
| d1uu3a_ | 288 | d.144.1.7 (A:) 3-phosphoinositide dependent protei | 3e-58 | |
| d1uu3a_ | 288 | d.144.1.7 (A:) 3-phosphoinositide dependent protei | 2e-23 | |
| d1uu3a_ | 288 | d.144.1.7 (A:) 3-phosphoinositide dependent protei | 2e-14 | |
| d2jfla1 | 288 | d.144.1.7 (A:21-308) STE20-like serine/threonine-p | 7e-58 | |
| d2jfla1 | 288 | d.144.1.7 (A:21-308) STE20-like serine/threonine-p | 1e-15 | |
| d2jfla1 | 288 | d.144.1.7 (A:21-308) STE20-like serine/threonine-p | 2e-10 | |
| d2jfla1 | 288 | d.144.1.7 (A:21-308) STE20-like serine/threonine-p | 1e-06 | |
| d1nvra_ | 271 | d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 { | 1e-57 | |
| d1nvra_ | 271 | d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 { | 2e-15 | |
| d1nvra_ | 271 | d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 { | 5e-13 | |
| d2java1 | 269 | d.144.1.7 (A:3-271) Serine/threonine-protein kinas | 4e-56 | |
| d2java1 | 269 | d.144.1.7 (A:3-271) Serine/threonine-protein kinas | 1e-13 | |
| d2java1 | 269 | d.144.1.7 (A:3-271) Serine/threonine-protein kinas | 4e-08 | |
| d2java1 | 269 | d.144.1.7 (A:3-271) Serine/threonine-protein kinas | 2e-07 | |
| d1s9ja_ | 322 | d.144.1.7 (A:) Dual specificity mitogen-activated | 1e-55 | |
| d1s9ja_ | 322 | d.144.1.7 (A:) Dual specificity mitogen-activated | 3e-14 | |
| d1s9ja_ | 322 | d.144.1.7 (A:) Dual specificity mitogen-activated | 3e-10 | |
| d1s9ja_ | 322 | d.144.1.7 (A:) Dual specificity mitogen-activated | 7e-08 | |
| d1u5ra_ | 309 | d.144.1.7 (A:) Serine/threonine protein kinase TAO | 6e-55 | |
| d1u5ra_ | 309 | d.144.1.7 (A:) Serine/threonine protein kinase TAO | 9e-14 | |
| d1u5ra_ | 309 | d.144.1.7 (A:) Serine/threonine protein kinase TAO | 2e-08 | |
| d1u5ra_ | 309 | d.144.1.7 (A:) Serine/threonine protein kinase TAO | 3e-06 | |
| d1t4ha_ | 270 | d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa | 3e-54 | |
| d1t4ha_ | 270 | d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa | 3e-14 | |
| d1t4ha_ | 270 | d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa | 1e-08 | |
| d1t4ha_ | 270 | d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa | 2e-05 | |
| d1yhwa1 | 293 | d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [ | 5e-54 | |
| d1yhwa1 | 293 | d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [ | 2e-13 | |
| d1yhwa1 | 293 | d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [ | 4e-13 | |
| d1jksa_ | 293 | d.144.1.7 (A:) Death-associated protein kinase, Da | 2e-53 | |
| d1jksa_ | 293 | d.144.1.7 (A:) Death-associated protein kinase, Da | 4e-20 | |
| d1jksa_ | 293 | d.144.1.7 (A:) Death-associated protein kinase, Da | 4e-08 | |
| d1xjda_ | 320 | d.144.1.7 (A:) Protein kinase C, theta type {Human | 7e-53 | |
| d1xjda_ | 320 | d.144.1.7 (A:) Protein kinase C, theta type {Human | 9e-37 | |
| d1xjda_ | 320 | d.144.1.7 (A:) Protein kinase C, theta type {Human | 1e-11 | |
| d1omwa3 | 364 | d.144.1.7 (A:186-549) G-protein coupled receptor k | 3e-52 | |
| d1omwa3 | 364 | d.144.1.7 (A:186-549) G-protein coupled receptor k | 1e-31 | |
| d1omwa3 | 364 | d.144.1.7 (A:186-549) G-protein coupled receptor k | 2e-13 | |
| d1o6ya_ | 277 | d.144.1.7 (A:) Mycobacterial protein kinase PknB, | 9e-52 | |
| d1o6ya_ | 277 | d.144.1.7 (A:) Mycobacterial protein kinase PknB, | 3e-13 | |
| d1o6ya_ | 277 | d.144.1.7 (A:) Mycobacterial protein kinase PknB, | 1e-06 | |
| d1o6ya_ | 277 | d.144.1.7 (A:) Mycobacterial protein kinase PknB, | 1e-05 | |
| d1byga_ | 262 | d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) | 5e-51 | |
| d1byga_ | 262 | d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) | 2e-14 | |
| d1byga_ | 262 | d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) | 3e-09 | |
| d1uwha_ | 276 | d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) | 3e-50 | |
| d1uwha_ | 276 | d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) | 1e-14 | |
| d1fota_ | 316 | d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni | 5e-50 | |
| d1fota_ | 316 | d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni | 3e-38 | |
| d1fota_ | 316 | d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni | 4e-09 | |
| d1xwsa_ | 273 | d.144.1.7 (A:) Proto-oncogene serine/threonine-pro | 3e-48 | |
| d1xwsa_ | 273 | d.144.1.7 (A:) Proto-oncogene serine/threonine-pro | 5e-15 | |
| d1xwsa_ | 273 | d.144.1.7 (A:) Proto-oncogene serine/threonine-pro | 1e-10 | |
| d1o6la_ | 337 | d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap | 1e-47 | |
| d1o6la_ | 337 | d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap | 1e-41 | |
| d1o6la_ | 337 | d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap | 1e-09 | |
| d1ua2a_ | 299 | d.144.1.7 (A:) Cell division protein kinase 7, CDK | 1e-46 | |
| d1ua2a_ | 299 | d.144.1.7 (A:) Cell division protein kinase 7, CDK | 1e-08 | |
| d1ua2a_ | 299 | d.144.1.7 (A:) Cell division protein kinase 7, CDK | 6e-08 | |
| d1ua2a_ | 299 | d.144.1.7 (A:) Cell division protein kinase 7, CDK | 2e-06 | |
| d1ckia_ | 299 | d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n | 2e-46 | |
| d1ckia_ | 299 | d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n | 9e-10 | |
| d1ckia_ | 299 | d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n | 9e-08 | |
| d1csna_ | 293 | d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast | 3e-46 | |
| d1csna_ | 293 | d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast | 5e-10 | |
| d1csna_ | 293 | d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast | 6e-09 | |
| d1vzoa_ | 322 | d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5 | 7e-46 | |
| d1vzoa_ | 322 | d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5 | 2e-33 | |
| d1vzoa_ | 322 | d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5 | 3e-09 | |
| d1qpca_ | 272 | d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom | 2e-45 | |
| d1qpca_ | 272 | d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom | 5e-14 | |
| d1qpca_ | 272 | d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom | 5e-05 | |
| d1opja_ | 287 | d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou | 4e-45 | |
| d1opja_ | 287 | d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou | 1e-11 | |
| d1opja_ | 287 | d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou | 1e-06 | |
| d1xbba_ | 277 | d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human | 6e-45 | |
| d1xbba_ | 277 | d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human | 1e-10 | |
| d1xbba_ | 277 | d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human | 3e-08 | |
| d1xbba_ | 277 | d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human | 7e-06 | |
| d1q5ka_ | 350 | d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs | 7e-45 | |
| d1q5ka_ | 350 | d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs | 1e-10 | |
| d1q5ka_ | 350 | d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs | 1e-10 | |
| d1q5ka_ | 350 | d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs | 3e-07 | |
| d1q5ka_ | 350 | d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs | 3e-06 | |
| d3bqca1 | 328 | d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu | 1e-44 | |
| d3bqca1 | 328 | d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu | 1e-09 | |
| d3bqca1 | 328 | d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu | 1e-08 | |
| d3bqca1 | 328 | d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu | 1e-07 | |
| d3bqca1 | 328 | d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu | 4e-07 | |
| d1rjba_ | 325 | d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s | 3e-44 | |
| d1rjba_ | 325 | d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s | 6e-12 | |
| d1rjba_ | 325 | d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s | 2e-05 | |
| d1rjba_ | 325 | d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s | 4e-04 | |
| d1u59a_ | 285 | d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum | 5e-44 | |
| d1u59a_ | 285 | d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum | 3e-13 | |
| d1u59a_ | 285 | d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum | 3e-06 | |
| d1u59a_ | 285 | d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum | 1e-04 | |
| d1rdqe_ | 350 | d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni | 1e-43 | |
| d1rdqe_ | 350 | d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni | 2e-33 | |
| d1rdqe_ | 350 | d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni | 4e-11 | |
| d1k2pa_ | 258 | d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum | 7e-43 | |
| d1k2pa_ | 258 | d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum | 2e-09 | |
| d1k2pa_ | 258 | d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum | 2e-05 | |
| d1k2pa_ | 258 | d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum | 0.001 | |
| d3blha1 | 318 | d.144.1.7 (A:8-325) Cell division protein kinase 9 | 3e-42 | |
| d3blha1 | 318 | d.144.1.7 (A:8-325) Cell division protein kinase 9 | 4e-10 | |
| d3blha1 | 318 | d.144.1.7 (A:8-325) Cell division protein kinase 9 | 6e-06 | |
| d3blha1 | 318 | d.144.1.7 (A:8-325) Cell division protein kinase 9 | 1e-05 | |
| d1pmea_ | 345 | d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien | 3e-42 | |
| d1pmea_ | 345 | d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien | 1e-09 | |
| d1pmea_ | 345 | d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien | 1e-06 | |
| d1pmea_ | 345 | d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien | 3e-06 | |
| d1fmka3 | 285 | d.144.1.7 (A:249-533) c-src tyrosine kinase {Human | 4e-42 | |
| d1fmka3 | 285 | d.144.1.7 (A:249-533) c-src tyrosine kinase {Human | 1e-10 | |
| d1fmka3 | 285 | d.144.1.7 (A:249-533) c-src tyrosine kinase {Human | 1e-04 | |
| d1fmka3 | 285 | d.144.1.7 (A:249-533) c-src tyrosine kinase {Human | 7e-04 | |
| d1fvra_ | 309 | d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [ | 4e-42 | |
| d1fvra_ | 309 | d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [ | 1e-09 | |
| d1fvra_ | 309 | d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [ | 2e-05 | |
| d1fvra_ | 309 | d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [ | 0.002 | |
| d1ob3a_ | 286 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod | 5e-42 | |
| d1ob3a_ | 286 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod | 4e-08 | |
| d1ob3a_ | 286 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod | 5e-06 | |
| d1ob3a_ | 286 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod | 6e-04 | |
| d1ob3a_ | 286 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod | 0.001 | |
| d1sm2a_ | 263 | d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu | 1e-41 | |
| d1sm2a_ | 263 | d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu | 8e-09 | |
| d1sm2a_ | 263 | d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu | 2e-05 | |
| d1gz8a_ | 298 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H | 1e-41 | |
| d1gz8a_ | 298 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H | 4e-10 | |
| d1gz8a_ | 298 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H | 2e-07 | |
| d1blxa_ | 305 | d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H | 2e-41 | |
| d1blxa_ | 305 | d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H | 2e-11 | |
| d1blxa_ | 305 | d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H | 9e-07 | |
| d1blxa_ | 305 | d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H | 9e-04 | |
| d1blxa_ | 305 | d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H | 0.001 | |
| d1unla_ | 292 | d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H | 2e-41 | |
| d1unla_ | 292 | d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H | 2e-07 | |
| d1unla_ | 292 | d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H | 5e-07 | |
| d1unla_ | 292 | d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H | 3e-06 | |
| d1unla_ | 292 | d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H | 3e-05 | |
| d1cm8a_ | 346 | d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s | 2e-41 | |
| d1cm8a_ | 346 | d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s | 1e-08 | |
| d1cm8a_ | 346 | d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s | 6e-08 | |
| d1cm8a_ | 346 | d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s | 3e-06 | |
| d1cm8a_ | 346 | d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s | 1e-05 | |
| d1jpaa_ | 299 | d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou | 3e-41 | |
| d1jpaa_ | 299 | d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou | 2e-10 | |
| d1jpaa_ | 299 | d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou | 5e-05 | |
| d1jpaa_ | 299 | d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou | 0.001 | |
| d1u46a_ | 273 | d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum | 5e-41 | |
| d1u46a_ | 273 | d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum | 5e-11 | |
| d1u46a_ | 273 | d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum | 3e-04 | |
| d1u46a_ | 273 | d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum | 9e-04 | |
| d2gfsa1 | 348 | d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa | 8e-40 | |
| d2gfsa1 | 348 | d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa | 7e-09 | |
| d2gfsa1 | 348 | d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa | 2e-06 | |
| d2gfsa1 | 348 | d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa | 2e-06 | |
| d1t46a_ | 311 | d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens | 1e-39 | |
| d1t46a_ | 311 | d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens | 4e-12 | |
| d1t46a_ | 311 | d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens | 2e-06 | |
| d1t46a_ | 311 | d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens | 7e-04 | |
| d1mp8a_ | 273 | d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma | 1e-39 | |
| d1mp8a_ | 273 | d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma | 7e-11 | |
| d1mp8a_ | 273 | d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma | 4e-05 | |
| d1mp8a_ | 273 | d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma | 2e-04 | |
| d1fgka_ | 299 | d.144.1.7 (A:) Fibroblast growth factor receptor 1 | 5e-39 | |
| d1fgka_ | 299 | d.144.1.7 (A:) Fibroblast growth factor receptor 1 | 3e-11 | |
| d1fgka_ | 299 | d.144.1.7 (A:) Fibroblast growth factor receptor 1 | 0.003 | |
| d1fgka_ | 299 | d.144.1.7 (A:) Fibroblast growth factor receptor 1 | 0.003 | |
| d1xkka_ | 317 | d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb- | 7e-39 | |
| d1xkka_ | 317 | d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb- | 2e-10 | |
| d1xkka_ | 317 | d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb- | 4e-09 | |
| d1r0pa_ | 311 | d.144.1.7 (A:) Hepatocyte growth factor receptor, | 2e-37 | |
| d1r0pa_ | 311 | d.144.1.7 (A:) Hepatocyte growth factor receptor, | 3e-08 | |
| d1r0pa_ | 311 | d.144.1.7 (A:) Hepatocyte growth factor receptor, | 0.002 | |
| d1lufa_ | 301 | d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n | 3e-37 | |
| d1lufa_ | 301 | d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n | 4e-09 | |
| d1lufa_ | 301 | d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n | 0.001 | |
| d1mqba_ | 283 | d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum | 6e-37 | |
| d1mqba_ | 283 | d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum | 2e-08 | |
| d1mqba_ | 283 | d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum | 2e-04 | |
| d1vjya_ | 303 | d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human | 1e-35 | |
| d1vjya_ | 303 | d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human | 2e-09 | |
| d1vjya_ | 303 | d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human | 7e-04 | |
| d1vjya_ | 303 | d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human | 0.002 | |
| d2b1pa1 | 355 | d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3 | 3e-34 | |
| d2b1pa1 | 355 | d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3 | 2e-08 | |
| d2b1pa1 | 355 | d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3 | 6e-07 | |
| d2b1pa1 | 355 | d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3 | 1e-05 | |
| d1p4oa_ | 308 | d.144.1.7 (A:) Insulin-like growth factor 1 recept | 3e-34 | |
| d1p4oa_ | 308 | d.144.1.7 (A:) Insulin-like growth factor 1 recept | 2e-08 | |
| d1p4oa_ | 308 | d.144.1.7 (A:) Insulin-like growth factor 1 recept | 6e-04 | |
| d1ywna1 | 299 | d.144.1.7 (A:818-1166) Vascular endothelial growth | 9e-33 | |
| d1ywna1 | 299 | d.144.1.7 (A:818-1166) Vascular endothelial growth | 7e-09 | |
| d1ywna1 | 299 | d.144.1.7 (A:818-1166) Vascular endothelial growth | 7e-05 | |
| d1q8ya_ | 362 | d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces | 6e-30 | |
| d1q8ya_ | 362 | d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces | 6e-13 | |
| d1q8ya_ | 362 | d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces | 3e-05 | |
| d1q8ya_ | 362 | d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces | 7e-05 | |
| d1zara2 | 191 | d.144.1.9 (A:91-281) Rio2 serine protein kinase C- | 1e-17 | |
| d1zara2 | 191 | d.144.1.9 (A:91-281) Rio2 serine protein kinase C- | 7e-07 |
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Score = 218 bits (556), Expect = 4e-65
Identities = 100/294 (34%), Positives = 139/294 (47%), Gaps = 48/294 (16%)
Query: 372 FFEQYDMDLDKAGILGDGSYSVCRRCVEKSTGQEYAVKIISRKIDCSE------------ 419
F+E Y+ ILG G SV RRC+ K T +EYAVKII S
Sbjct: 1 FYENYEPK----EILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREAT 56
Query: 420 --EINLLRACQGHPNIVNLHCVFQDEVHTYLVLELLKGGELLDRIRQKGRCGFTENEASR 477
E+++LR GHPNI+ L ++ +LV +L+K GEL D + +K +E E +
Sbjct: 57 LKEVDILRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKVT--LSEKETRK 114
Query: 478 IMRQLVAAVHFMHSRGVVHRDLKPENLLFSDPAGDNIKVVDFGFACL--KRESLHTPCFT 535
IMR L+ + +H +VHRDLKPEN+L D NIK+ DFGF+C E L C T
Sbjct: 115 IMRALLEVICALHKLNIVHRDLKPENILLDDD--MNIKLTDFGFSCQLDPGEKLREVCGT 172
Query: 536 LQYAAPEVLRQDKSGYDENCDLWSLGVILVNVLRQDKSGYDENCDLWSLGVILYTMLCGR 595
Y APE++ + + GY + D+WS GVI+YT+L G
Sbjct: 173 PSYLAPEIIECSMN--------------------DNHPGYGKEVDMWSTGVIMYTLLAGS 212
Query: 596 VPFHARSRDDSALSIMARIKEGQFNFDAEAWSTVSSEAKELTKSLLTVNPAQRI 649
PF R + ++ I G + F + W S K+L L V P +R
Sbjct: 213 PPFWHRKQML----MLRMIMSGNYQFGSPEWDDYSDTVKDLVSRFLVVQPQKRY 262
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Score = 80.9 bits (199), Expect = 3e-17
Identities = 30/81 (37%), Positives = 44/81 (54%), Gaps = 4/81 (4%)
Query: 885 FVNRSRYNVHTYLVLELLKGGELLDRIRQKGRCGFTENEASRIMRQLVAAVHFMHSRGVV 944
+ N +LV +L+K GEL D + +K +E E +IMR L+ + +H +V
Sbjct: 75 LKDTYETNTFFFLVFDLMKKGELFDYLTEKVT--LSEKETRKIMRALLEVICALHKLNIV 132
Query: 945 HRDLKPENLLLSGISGNLIKI 965
HRDLKPEN+LL IK+
Sbjct: 133 HRDLKPENILLD--DDMNIKL 151
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Score = 60.5 bits (146), Expect = 2e-10
Identities = 25/79 (31%), Positives = 37/79 (46%), Gaps = 9/79 (11%)
Query: 239 SSLIIFFIILSFTLSFIHDYYHIQYRRILKTE----PPIPEDLSPDVADFISRLLVKDPR 294
S+ +I + +L+ + F H + R I+ P +D S V D +SR LV P+
Sbjct: 200 STGVIMYTLLAGSPPFWHRKQMLMLRMIMSGNYQFGSPEWDDYSDTVKDLVSRFLVVQPQ 259
Query: 295 RRLGGGELDAEELKRHPFF 313
+R AEE HPFF
Sbjct: 260 KRYT-----AEEALAHPFF 273
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Score = 55.5 bits (133), Expect = 8e-09
Identities = 32/112 (28%), Positives = 46/112 (41%), Gaps = 30/112 (26%)
Query: 110 FFEQYDMDLDKAGILGDGSYSVCRRCVEKSTGQEYAVKIISRKIDCSEEINLLRACQGHP 169
F+E Y+ ILG G SV RRC+ K T +EYAVKII
Sbjct: 1 FYENYEPK----EILGRGVSSVVRRCIHKPTCKEYAVKIIDV------------------ 38
Query: 170 NICRRCVEKSTGQEYAVKIISRKIDCSEEINLLRACQGHPNIVNLHCVFQDE 221
G A ++ + +E+++LR GHPNI+ L ++
Sbjct: 39 --------TGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYETN 82
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Score = 219 bits (558), Expect = 2e-64
Identities = 83/331 (25%), Positives = 145/331 (43%), Gaps = 41/331 (12%)
Query: 385 ILGDGSYSVCRRCVEKSTGQEYAVKIISRKIDCSE-----EINLLRACQGHPNIVNLHCV 439
LG G++ V R E++TG +A K + + + EI + + HP +VNLH
Sbjct: 33 ELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLR-HPTLVNLHDA 91
Query: 440 FQDEVHTYLVLELLKGGELLDRIRQKGRCGFTENEASRIMRQLVAAVHFMHSRGVVHRDL 499
F+D+ ++ E + GGEL +++ + +E+EA MRQ+ + MH VH DL
Sbjct: 92 FEDDNEMVMIYEFMSGGELFEKVADEHN-KMSEDEAVEYMRQVCKGLCHMHENNYVHLDL 150
Query: 500 KPENLLFSDPAGDNIKVVDFGFACL--KRESLHTPCFTLQYAAPEVLRQDKSGYDENCDL 557
KPEN++F+ + +K++DFG ++S+ T ++AAPEV
Sbjct: 151 KPENIMFTTKRSNELKLIDFGLTAHLDPKQSVKVTTGTAEFAAPEVAEGKP--------- 201
Query: 558 WSLGVILVNVLRQDKSGYDENCDLWSLGVILYTMLCGRVPFHARSRDDSALSIMARIKEG 617
D+WS+GV+ Y +L G PF + D+ + +K
Sbjct: 202 -----------------VGYYTDMWSVGVLSYILLSGLSPFGGENDDE----TLRNVKSC 240
Query: 618 QFNFDAEAWSTVSSEAKELTKSLLTVNPAQRIRMMRVKLTFHAFHQAQKEGFRLQDVTSA 677
+N D A+S +S + K+ + LL +P R+ + + H + R + S+
Sbjct: 241 DWNMDDSAFSGISEDGKDFIRKLLLADPNTRMTIHQALE--HPWLTPGNAPGRDSQIPSS 298
Query: 678 KLAQRRKNKNVSNDNSRSFSSTSSSLSSSSS 708
+ + R + D +S+ SS
Sbjct: 299 RYTKIRDSIKTKYDAWPEPLPPLGRISNYSS 329
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Score = 77.8 bits (191), Expect = 9e-16
Identities = 23/72 (31%), Positives = 39/72 (54%), Gaps = 1/72 (1%)
Query: 894 HTYLVLELLKGGELLDRIRQKGRCGFTENEASRIMRQLVAAVHFMHSRGVVHRDLKPENL 953
++ E + GGEL +++ + +E+EA MRQ+ + MH VH DLKPEN+
Sbjct: 97 EMVMIYEFMSGGELFEKVADEHN-KMSEDEAVEYMRQVCKGLCHMHENNYVHLDLKPENI 155
Query: 954 LLSGISGNLIKI 965
+ + N +K+
Sbjct: 156 MFTTKRSNELKL 167
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Score = 67.8 bits (165), Expect = 2e-12
Identities = 24/131 (18%), Positives = 48/131 (36%), Gaps = 15/131 (11%)
Query: 242 IIFFIILSFTLSFIHDYYHIQYRRILKTEPPIPE----DLSPDVADFISRLLVKDPRRRL 297
++ +I+LS F + R + + + + +S D DFI +LL+ DP R+
Sbjct: 213 VLSYILLSGLSPFGGENDDETLRNVKSCDWNMDDSAFSGISEDGKDFIRKLLLADPNTRM 272
Query: 298 GGGELDAEELKRHPFFNVIDWDDLATKRIPAPFVPKISNELDVSNFSDEFTKMIPADSPA 357
+ HP+ + ++ IP+ KI + + + P
Sbjct: 273 T-----IHQALEHPWLTPGNAPGRDSQ-IPSSRYTKIRDSIKTK-----YDAWPEPLPPL 321
Query: 358 IVPPNFDKIFK 368
N+ + K
Sbjct: 322 GRISNYSSLRK 332
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Score = 49.3 bits (117), Expect = 1e-06
Identities = 16/53 (30%), Positives = 27/53 (50%), Gaps = 6/53 (11%)
Query: 174 RCVEKSTGQEYAVKIISRKIDCSE-----EINLLRACQGHPNIVNLHCVFQDE 221
R E++TG +A K + + + EI + + HP +VNLH F+D+
Sbjct: 44 RVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLR-HPTLVNLHDAFEDD 95
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Score = 216 bits (551), Expect = 2e-63
Identities = 90/329 (27%), Positives = 147/329 (44%), Gaps = 41/329 (12%)
Query: 386 LGDGSYSVCRRCVEKSTGQEYAVKIISRKIDCSE-----EINLLRACQGHPNIVNLHCVF 440
LG G++ V RCVEK+TG+ + K I+ + EI+++ HP ++NLH F
Sbjct: 37 LGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLH-HPKLINLHDAF 95
Query: 441 QDEVHTYLVLELLKGGELLDRIRQKGRCGFTENEASRIMRQLVAAVHFMHSRGVVHRDLK 500
+D+ L+LE L GGEL DRI + +E E MRQ + MH +VH D+K
Sbjct: 96 EDKYEMVLILEFLSGGELFDRIAAEDY-KMSEAEVINYMRQACEGLKHMHEHSIVHLDIK 154
Query: 501 PENLLFSDPAGDNIKVVDFGFACL--KRESLHTPCFTLQYAAPEVLRQDKSGYDENCDLW 558
PEN++ ++K++DFG A E + T ++AAPE++ ++
Sbjct: 155 PENIMCETKKASSVKIIDFGLATKLNPDEIVKVTTATAEFAAPEIVDREP---------- 204
Query: 559 SLGVILVNVLRQDKSGYDENCDLWSLGVILYTMLCGRVPFHARSRDDSALSIMARIKEGQ 618
D+W++GV+ Y +L G PF + + +K
Sbjct: 205 ----------------VGFYTDMWAIGVLGYVLLSGLSPFAGEDDLE----TLQNVKRCD 244
Query: 619 FNFDAEAWSTVSSEAKELTKSLLTVNPAQRIRMMRVKLTFHAFHQAQKEGFRLQDVTSAK 678
+ FD +A+S+VS EAK+ K+LL P +R+ + H + + + +S
Sbjct: 245 WEFDEDAFSSVSPEAKDFIKNLLQKEPRKRLTVHDALE--HPWLKGDHSNLTSRIPSSRY 302
Query: 679 LAQRRKNKNVSNDNSRSFSSTSSSLSSSS 707
R+K K D + + SS
Sbjct: 303 NKIRQKIKEKYADWPAPQPAIGRIANFSS 331
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Score = 79.7 bits (196), Expect = 2e-16
Identities = 64/313 (20%), Positives = 108/313 (34%), Gaps = 83/313 (26%)
Query: 124 LGDGSYSVCRRCVEKSTGQEYAVKIISRKIDCSE-----EINLLRACQGHPNICR-RCVE 177
LG G++ V RCVEK+TG+ + K I+ + EI+++ HP +
Sbjct: 37 LGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLH-HPKLINLHDAF 95
Query: 178 KSTGQEYAV-----------KIISRKIDCSEE---------INLLRACQGHPNIVNLHCV 217
+ + + +I + SE L+ H +IV+L
Sbjct: 96 EDKYEMVLILEFLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHEH-SIVHLDIK 154
Query: 218 FQDEVIDWDDFSR------GIECVFFSSSLIIFF----------IILSFTLSFIHDYYHI 261
++ + + S G+ ++ I+ + F D + I
Sbjct: 155 PENIMCETKKASSVKIIDFGLATKLNPDEIVKVTTATAEFAAPEIVDREPVGFYTDMWAI 214
Query: 262 ---------------------QYRRILKTEPPIPED----LSPDVADFISRLLVKDPRRR 296
+ + + + ED +SP+ DFI LL K+PR+R
Sbjct: 215 GVLGYVLLSGLSPFAGEDDLETLQNVKRCDWEFDEDAFSSVSPEAKDFIKNLLQKEPRKR 274
Query: 297 LGGGELDAEELKRHPFFNVIDWDDLATKRIPAPFVPKISNELDVSNFSDEFTKMIPADSP 356
L + HP+ D +L T RIP+ KI ++ E PA P
Sbjct: 275 LT-----VHDALEHPWLKG-DHSNL-TSRIPSSRYNKIRQKI------KEKYADWPAPQP 321
Query: 357 AIVP-PNFDKIFK 368
AI NF + K
Sbjct: 322 AIGRIANFSSLRK 334
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Score = 77.8 bits (191), Expect = 8e-16
Identities = 27/72 (37%), Positives = 37/72 (51%), Gaps = 1/72 (1%)
Query: 894 HTYLVLELLKGGELLDRIRQKGRCGFTENEASRIMRQLVAAVHFMHSRGVVHRDLKPENL 953
L+LE L GGEL DRI + +E E MRQ + MH +VH D+KPEN+
Sbjct: 100 EMVLILEFLSGGELFDRIAAEDY-KMSEAEVINYMRQACEGLKHMHEHSIVHLDIKPENI 158
Query: 954 LLSGISGNLIKI 965
+ + +KI
Sbjct: 159 MCETKKASSVKI 170
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 214 bits (546), Expect = 6e-63
Identities = 95/272 (34%), Positives = 141/272 (51%), Gaps = 33/272 (12%)
Query: 385 ILGDGSYSVCRRCVEKSTGQEYAVKIISRKIDCSEEINLLRACQGHPNIVNLHCVFQD-- 442
+LG G + K T +++A+K++ E+ L P+IV + V+++
Sbjct: 19 VLGLGINGKVLQIFNKRTQEKFALKMLQDCPKARREVELHWRASQCPHIVRIVDVYENLY 78
Query: 443 --EVHTYLVLELLKGGELLDRIRQKGRCGFTENEASRIMRQLVAAVHFMHSRGVVHRDLK 500
+V+E L GGEL RI+ +G FTE EAS IM+ + A+ ++HS + HRD+K
Sbjct: 79 AGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVK 138
Query: 501 PENLLFSDPAGD-NIKVVDFGFACL--KRESLHTPCFTLQYAAPEVLRQDKSGYDENCDL 557
PENLL++ + +K+ DFGFA SL TPC+T Y APEVL +K
Sbjct: 139 PENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAPEVLGPEK--------- 189
Query: 558 WSLGVILVNVLRQDKSGYDENCDLWSLGVILYTMLCGRVPFHARSRDDSALSIMARIKEG 617
YD++CD+WSLGVI+Y +LCG PF++ + + RI+ G
Sbjct: 190 -----------------YDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMG 232
Query: 618 QFNFDAEAWSTVSSEAKELTKSLLTVNPAQRI 649
Q+ F WS VS E K L ++LL P QR+
Sbjct: 233 QYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRM 264
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 85.9 bits (212), Expect = 1e-18
Identities = 33/80 (41%), Positives = 46/80 (57%)
Query: 884 TFVNRSRYNVHTYLVLELLKGGELLDRIRQKGRCGFTENEASRIMRQLVAAVHFMHSRGV 943
+ N +V+E L GGEL RI+ +G FTE EAS IM+ + A+ ++HS +
Sbjct: 73 VYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINI 132
Query: 944 VHRDLKPENLLLSGISGNLI 963
HRD+KPENLL + N I
Sbjct: 133 AHRDVKPENLLYTSKRPNAI 152
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 60.5 bits (146), Expect = 3e-10
Identities = 39/328 (11%), Positives = 88/328 (26%), Gaps = 94/328 (28%)
Query: 104 KFKGSLFFEQYDMDLDKAGILGDGSYSVCRRCVEKSTGQEYAVKIISRKIDCSEE----- 158
+ K + + Y + + +LG G + K T +++A+K++ E
Sbjct: 3 QIKKNAIIDDYKV-TSQ--VLGLGINGKVLQIFNKRTQEKFALKMLQDCPKARREVELHW 59
Query: 159 --------INLLRACQ------GHPNICRRCVEKSTGQEYAVKIISRKIDCSEEINLLRA 204
+ ++ + I C++ + E ++++
Sbjct: 60 RASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKS 119
Query: 205 -CQG--------------HPNIVNLHCVFQDEVIDWDDFSRGIEC--------------- 234
+ P + + ++ DF E
Sbjct: 120 IGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYY 179
Query: 235 --------------VFFSSSLIIFFIILSFTLSFIHDY----YHIQYRRILKTEPPIPE- 275
S +I +I+L F ++ RI + P
Sbjct: 180 VAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNP 239
Query: 276 ---DLSPDVADFISRLLVKDPRRRLGGGELDAEELKRHPFFNVIDWDDLATKRIPAPFVP 332
++S +V I LL +P +R+ E HP+ + P P
Sbjct: 240 EWSEVSEEVKMLIRNLLKTEPTQRMT-----ITEFMNHPWI---------MQSTKVPQTP 285
Query: 333 KISNEL------DVSNFSDEFTKMIPAD 354
++ + + +E T +
Sbjct: 286 LHTSRVLKEDKERWEDVKEEMTSALATM 313
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Score = 209 bits (534), Expect = 2e-61
Identities = 83/362 (22%), Positives = 148/362 (40%), Gaps = 51/362 (14%)
Query: 372 FFEQYDMDLDKAGILGDGSYSVCRRCVEKSTGQEYAVKIISRK----IDCSEEINLLRAC 427
+E+Y + LG G + + RCVE S+ + Y K + K + +EI++L
Sbjct: 3 LYEKYMIA----EDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQVLVKKEISILNIA 58
Query: 428 QGHPNIVNLHCVFQDEVHTYLVLELLKGGELLDRIRQKGRCGFTENEASRIMRQLVAAVH 487
+ H NI++LH F+ ++ E + G ++ +RI E E + Q+ A+
Sbjct: 59 R-HRNILHLHESFESMEELVMIFEFISGLDIFERINTSAF-ELNEREIVSYVHQVCEALQ 116
Query: 488 FMHSRGVVHRDLKPENLLFSDPAGDNIKVVDFGFACLKR--ESLHTPCFTLQYAAPEVLR 545
F+HS + H D++PEN+++ IK+++FG A + ++ +Y APEV +
Sbjct: 117 FLHSHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNFRLLFTAPEYYAPEVHQ 176
Query: 546 QDKSGYDENCDLWSLGVILVNVLRQDKSGYDENCDLWSLGVILYTMLCGRVPFHARSRDD 605
D D+WSL G ++Y +L G PF A +
Sbjct: 177 HDV--VSTATDMWSL------------------------GTLVYVLLSGINPFLAETNQQ 210
Query: 606 SALSIMARIKEGQFNFDAEAWSTVSSEAKELTKSLLTVNPAQRIRMMRVKLTFHAFHQAQ 665
I+ I ++ FD EA+ +S EA + LL R+ H + + +
Sbjct: 211 ----IIENIMNAEYTFDEEAFKEISIEAMDFVDRLLVKERKSRMTASEALQ--HPWLKQK 264
Query: 666 KEGFRLQDVTSAKLAQRRKNKNVSND-NSRSFSSTSSSLSSSSSGTSSLKTPCSSTQPSV 724
E S K+ + K++ + + + S+ S G + S + V
Sbjct: 265 IER------VSTKVIRTLKHRRYYHTLIKKDLNMVVSAARISCGGAIRSQKGVSVAKVKV 318
Query: 725 PS 726
S
Sbjct: 319 AS 320
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Score = 86.2 bits (213), Expect = 9e-19
Identities = 53/300 (17%), Positives = 104/300 (34%), Gaps = 76/300 (25%)
Query: 110 FFEQYDMDLDKAGILGDGSYSVCRRCVEKSTGQEYAVKIISRK----IDCSEEINLLRAC 165
+E+Y + LG G + + RCVE S+ + Y K + K + +EI++L
Sbjct: 3 LYEKYMIA----EDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQVLVKKEISILNIA 58
Query: 166 QGHPNICR------------RCVEKSTGQEYAVKIISRKIDCSEE------INLLRACQ- 206
+ H NI E +G + +I + + +E + A Q
Sbjct: 59 R-HRNILHLHESFESMEELVMIFEFISGLDIFERINTSAFELNEREIVSYVHQVCEALQF 117
Query: 207 -GHPNIVNLHCVFQDEVIDWD--------DF--SRGIECVFFSSSL-------------- 241
NI + ++ + +F +R ++ L
Sbjct: 118 LHSHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNFRLLFTAPEYYAPEVHQH 177
Query: 242 -------------IIFFIILSFTLSFIHDYYHIQYRRILKTEPPIPE----DLSPDVADF 284
+ +++LS F+ + I+ E E ++S + DF
Sbjct: 178 DVVSTATDMWSLGTLVYVLLSGINPFLAETNQQIIENIMNAEYTFDEEAFKEISIEAMDF 237
Query: 285 ISRLLVKDPRRRLGGGELDAEELKRHPFFNVIDWDDLATKRIPAPFVPKISNELDVSNFS 344
+ RLLVK+ + R+ A E +HP+ + ++TK I + + L + +
Sbjct: 238 VDRLLVKERKSRMT-----ASEALQHPWLK-QKIERVSTKVIRTLKHRRYYHTLIKKDLN 291
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Score = 71.6 bits (175), Expect = 7e-14
Identities = 19/72 (26%), Positives = 35/72 (48%), Gaps = 1/72 (1%)
Query: 894 HTYLVLELLKGGELLDRIRQKGRCGFTENEASRIMRQLVAAVHFMHSRGVVHRDLKPENL 953
++ E + G ++ +RI E E + Q+ A+ F+HS + H D++PEN+
Sbjct: 75 ELVMIFEFISGLDIFERINTSAF-ELNEREIVSYVHQVCEALQFLHSHNIGHFDIRPENI 133
Query: 954 LLSGISGNLIKI 965
+ + IKI
Sbjct: 134 IYQTRRSSTIKI 145
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 199 bits (508), Expect = 1e-58
Identities = 78/291 (26%), Positives = 123/291 (42%), Gaps = 49/291 (16%)
Query: 375 QYDM-DLDKAGILGDGSYSVCRRCVEKSTGQEYAVKIISRKIDCSE--------EINLLR 425
Q+ + D + LG G + EK + A+K++ + E+ +
Sbjct: 2 QWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQS 61
Query: 426 ACQGHPNIVNLHCVFQDEVHTYLVLELLKGGELLDRIRQKGRCGFTENEASRIMRQLVAA 485
+ HPNI+ L+ F D YL+LE G + +++ + F E + + +L A
Sbjct: 62 HLR-HPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSK--FDEQRTATYITELANA 118
Query: 486 VHFMHSRGVVHRDLKPENLLFSDPAGDNIKVVDFGFAC-LKRESLHTPCFTLQYAAPEVL 544
+ + HS+ V+HRD+KPENLL +K+ DFG++ T C TL Y PE++
Sbjct: 119 LSYCHSKRVIHRDIKPENLLLGSA--GELKIADFGWSVHAPSSRRTTLCGTLDYLPPEMI 176
Query: 545 RQDKSGYDENCDLWSLGVILVNVLRQDKSGYDENCDLWSLGVILYTMLCGRVPFHARSRD 604
+DE DLWSLGV+ Y L G+ PF A +
Sbjct: 177 EGRM--------------------------HDEKVDLWSLGVLCYEFLVGKPPFEANTYQ 210
Query: 605 DSALSIMARIKEGQFNFDAEAWSTVSSEAKELTKSLLTVNPAQRIRMMRVK 655
+ RI +F F V+ A++L LL NP+QR + V
Sbjct: 211 E----TYKRISRVEFTF----PDFVTEGARDLISRLLKHNPSQRPMLREVL 253
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 75.0 bits (184), Expect = 2e-15
Identities = 41/268 (15%), Positives = 73/268 (27%), Gaps = 78/268 (29%)
Query: 113 QYDM-DLDKAGILGDGSYSVCRRCVEKSTGQEYAVKIISRKIDCSE--------EINLLR 163
Q+ + D + LG G + EK + A+K++ + E+ +
Sbjct: 2 QWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQS 61
Query: 164 ACQ--------------GHPNICRRCVEKSTGQEYAVK---------------------- 187
+ + T K
Sbjct: 62 HLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSY 121
Query: 188 -----IISRKIDCSEEINLLRACQGHPNIVNLHCVFQD-----------------EVIDW 225
+I R I NLL G I + E+I+
Sbjct: 122 CHSKRVIHRDIKPE---NLLLGSAGELKIADFGWSVHAPSSRRTTLCGTLDYLPPEMIEG 178
Query: 226 DDFSRGIECVFFSSSLIIFFIILSFTLSFIHDYYHIQYRRILKTEPPIPEDLSPDVADFI 285
++ ++ + L F + Y Y+RI + E P+ ++ D I
Sbjct: 179 RMHDEKVDLWSLG---VLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVTEGARDLI 235
Query: 286 SRLLVKDPRRRLGGGELDAEELKRHPFF 313
SRLL +P +R E+ HP+
Sbjct: 236 SRLLKHNPSQRPM-----LREVLEHPWI 258
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 73.5 bits (180), Expect = 7e-15
Identities = 25/72 (34%), Positives = 40/72 (55%), Gaps = 4/72 (5%)
Query: 894 HTYLVLELLKGGELLDRIRQKGRCGFTENEASRIMRQLVAAVHFMHSRGVVHRDLKPENL 953
YL+LE G + +++ + F E + + +L A+ + HS+ V+HRD+KPENL
Sbjct: 80 RVYLILEYAPLGTVYRELQKLSK--FDEQRTATYITELANALSYCHSKRVIHRDIKPENL 137
Query: 954 LLSGISGNLIKI 965
LL S +KI
Sbjct: 138 LLG--SAGELKI 147
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 46.9 bits (111), Expect = 4e-06
Identities = 32/170 (18%), Positives = 55/170 (32%), Gaps = 31/170 (18%)
Query: 174 RCVEKSTGQEYAVKIISRKIDCSE--------EINLLRACQGHPNIVNLHCVFQD----- 220
EK + A+K++ + E+ + + HPNI+ L+ F D
Sbjct: 24 LAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLR-HPNILRLYGYFHDATRVY 82
Query: 221 ---EVIDWDDFSRGI-ECVFFSSSLIIFFII-LSFTLSFIHD----YYHIQYRRILKTEP 271
E R + + F +I L+ LS+ H + I+ +L
Sbjct: 83 LILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKRVIHRDIKPENLL---- 138
Query: 272 PIPEDLSPDVADF-ISRLLVKDPRRRLGG--GELDAEELKRHPFFNVIDW 318
+ +ADF S R L G L E ++ +D
Sbjct: 139 -LGSAGELKIADFGWSVHAPSSRRTTLCGTLDYLPPEMIEGRMHDEKVDL 187
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 201 bits (511), Expect = 2e-58
Identities = 97/325 (29%), Positives = 158/325 (48%), Gaps = 47/325 (14%)
Query: 385 ILGDGSYSVCRRCVEKSTGQEYAVKIISRKIDCSE------EINLLRACQGHPNIVNLHC 438
+LG G++S +K T + A+K I++K + EI +L + HPNIV L
Sbjct: 16 VLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKIK-HPNIVALDD 74
Query: 439 VFQDEVHTYLVLELLKGGELLDRIRQKGRCGFTENEASRIMRQLVAAVHFMHSRGVVHRD 498
+++ H YL+++L+ GGEL DRI +KG +TE +ASR++ Q++ AV ++H G+VHRD
Sbjct: 75 IYESGGHLYLIMQLVSGGELFDRIVEKGF--YTERDASRLIFQVLDAVKYLHDLGIVHRD 132
Query: 499 LKPENLLFSDPAGD-NIKVVDFGFACL--KRESLHTPCFTLQYAAPEVLRQDKSGYDENC 555
LKPENLL+ D I + DFG + + L T C T Y APEVL Q
Sbjct: 133 LKPENLLYYSLDEDSKIMISDFGLSKMEDPGSVLSTACGTPGYVAPEVLAQ--------- 183
Query: 556 DLWSLGVILVNVLRQDKSGYDENCDLWSLGVILYTMLCGRVPFHARSRDDSALSIMARIK 615
Y + D WS+GVI Y +LCG PF+ + + +I
Sbjct: 184 -----------------KPYSKAVDCWSIGVIAYILLCGYPPFYDENDAK----LFEQIL 222
Query: 616 EGQFNFDAEAWSTVSSEAKELTKSLLTVNPAQRIRMMRVKLTFHAFHQAQKEGFRLQDVT 675
+ ++ FD+ W +S AK+ + L+ +P +R + H + L
Sbjct: 223 KAEYEFDSPYWDDISDSAKDFIRHLMEKDPEKRFTCEQALQ--HPWIAGDTA---LDKNI 277
Query: 676 SAKLAQRRKNKNVSNDNSRSFSSTS 700
++++ K + ++F++T+
Sbjct: 278 HQSVSEQIKKNFAKSKWKQAFNATA 302
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 90.1 bits (223), Expect = 3e-20
Identities = 57/293 (19%), Positives = 98/293 (33%), Gaps = 76/293 (25%)
Query: 123 ILGDGSYSVCRRCVEKSTGQEYAVKIISRKIDCSE------EINLLRACQGHPNICR-RC 175
+LG G++S +K T + A+K I++K + EI +L + HPNI
Sbjct: 16 VLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKIK-HPNIVALDD 74
Query: 176 VEKSTGQEYAV----------KIISRKIDCSEE------INLLRACQGHPNIVNLHCVFQ 219
+ +S G Y + I K +E +L A + ++ +H +
Sbjct: 75 IYESGGHLYLIMQLVSGGELFDRIVEKGFYTERDASRLIFQVLDAVKYLHDLGIVHRDLK 134
Query: 220 DEVIDWDDFSR---------GIECVFFSSSL----------------------------- 241
E + + G+ + S+
Sbjct: 135 PENLLYYSLDEDSKIMISDFGLSKMEDPGSVLSTACGTPGYVAPEVLAQKPYSKAVDCWS 194
Query: 242 --IIFFIILSFTLSFIHDYYHIQYRRILKTE----PPIPEDLSPDVADFISRLLVKDPRR 295
+I +I+L F + + +ILK E P +D+S DFI L+ KDP +
Sbjct: 195 IGVIAYILLCGYPPFYDENDAKLFEQILKAEYEFDSPYWDDISDSAKDFIRHLMEKDPEK 254
Query: 296 RLGGGELDAEELKRHPFFNVIDWDDLATKRIPAPFVPKISNELDVSNFSDEFT 348
R E+ +HP+ D K I +I S + F
Sbjct: 255 RFT-----CEQALQHPWIA---GDTALDKNIHQSVSEQIKKNFAKSKWKQAFN 299
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 66.6 bits (162), Expect = 2e-12
Identities = 34/68 (50%), Positives = 50/68 (73%), Gaps = 2/68 (2%)
Query: 894 HTYLVLELLKGGELLDRIRQKGRCGFTENEASRIMRQLVAAVHFMHSRGVVHRDLKPENL 953
H YL+++L+ GGEL DRI +KG +TE +ASR++ Q++ AV ++H G+VHRDLKPENL
Sbjct: 81 HLYLIMQLVSGGELFDRIVEKGF--YTERDASRLIFQVLDAVKYLHDLGIVHRDLKPENL 138
Query: 954 LLSGISGN 961
L + +
Sbjct: 139 LYYSLDED 146
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 199 bits (508), Expect = 3e-58
Identities = 78/278 (28%), Positives = 134/278 (48%), Gaps = 52/278 (18%)
Query: 385 ILGDGSYSVCRRCVEKSTGQEYAVKIISRKIDCSE--------EINLLRACQGHPNIVNL 436
ILG+GS+S E +T +EYA+KI+ ++ E E +++ HP V L
Sbjct: 15 ILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLD-HPFFVKL 73
Query: 437 HCVFQDEVHTYLVLELLKGGELLDRIRQKGRCGFTENEASRIMRQLVAAVHFMHSRGVVH 496
+ FQD+ Y L K GELL IR+ G F E ++V+A+ ++H +G++H
Sbjct: 74 YFTFQDDEKLYFGLSYAKNGELLKYIRKIGS--FDETCTRFYTAEIVSALEYLHGKGIIH 131
Query: 497 RDLKPENLLFSDPAGDNIKVVDFGFACL-----KRESLHTPCFTLQYAAPEVLRQDKSGY 551
RDLKPEN+L ++ +I++ DFG A + K+ ++ T QY +PE+L +
Sbjct: 132 RDLKPENILLNE--DMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPELLTE----- 184
Query: 552 DENCDLWSLGVILVNVLRQDKSGYDENCDLWSLGVILYTMLCGRVPFHARSRDDSALSIM 611
++ DLW+LG I+Y ++ G PF A + I
Sbjct: 185 ---------------------KSACKSSDLWALGCIIYQLVAGLPPFRAGNEYL----IF 219
Query: 612 ARIKEGQFNFDAEAWSTVSSEAKELTKSLLTVNPAQRI 649
+I + +++F +A++L + LL ++ +R+
Sbjct: 220 QKIIKLEYDF----PEKFFPKARDLVEKLLVLDATKRL 253
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 98.9 bits (246), Expect = 2e-23
Identities = 51/270 (18%), Positives = 91/270 (33%), Gaps = 65/270 (24%)
Query: 123 ILGDGSYSVCRRCVEKSTGQEYAVKIISRKIDCSEE--------------------INLL 162
ILG+GS+S E +T +EYA+KI+ ++ E + L
Sbjct: 15 ILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLY 74
Query: 163 RACQGHPNIC------------RRCVEKSTGQEYAVKIISRKI------DCSEEI----- 199
Q + + + + E + + +I + I
Sbjct: 75 FTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKGIIHRDL 134
Query: 200 ---NLLRACQGHPNIVNL-HCVFQDEVIDWDDFSRGIECVFFSS---------------- 239
N+L H I + + + + S
Sbjct: 135 KPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPELLTEKSACKSSDLW 194
Query: 240 SL-IIFFIILSFTLSFIHDYYHIQYRRILKTEPPIPEDLSPDVADFISRLLVKDPRRRLG 298
+L I + +++ F ++ +++I+K E PE P D + +LLV D +RLG
Sbjct: 195 ALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDFPEKFFPKARDLVEKLLVLDATKRLG 254
Query: 299 GGE-LDAEELKRHPFFNVIDWDDLATKRIP 327
E LK HPFF + W++L + P
Sbjct: 255 CEEMEGYGPLKAHPFFESVTWENLHQQTPP 284
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 72.4 bits (177), Expect = 2e-14
Identities = 26/63 (41%), Positives = 38/63 (60%), Gaps = 2/63 (3%)
Query: 894 HTYLVLELLKGGELLDRIRQKGRCGFTENEASRIMRQLVAAVHFMHSRGVVHRDLKPENL 953
Y L K GELL IR+ G F E ++V+A+ ++H +G++HRDLKPEN+
Sbjct: 82 KLYFGLSYAKNGELLKYIRKIGS--FDETCTRFYTAEIVSALEYLHGKGIIHRDLKPENI 139
Query: 954 LLS 956
LL+
Sbjct: 140 LLN 142
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Score = 198 bits (505), Expect = 7e-58
Identities = 72/276 (26%), Positives = 121/276 (43%), Gaps = 38/276 (13%)
Query: 384 GILGDGSYSVCRRCVEKSTGQEYAVKIISRKIDCS-----EEINLLRACQGHPNIVNLHC 438
G LGDG++ + K T A K+I K + EI++L +C HPNIV L
Sbjct: 18 GELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCD-HPNIVKLLD 76
Query: 439 VFQDEVHTYLVLELLKGGELLDRIRQKGRCGFTENEASRIMRQLVAAVHFMHSRGVVHRD 498
F E + ++++E GG + + + R TE++ + +Q + A++++H ++HRD
Sbjct: 77 AFYYENNLWILIEFCAGGAVDAVMLELER-PLTESQIQVVCKQTLDALNYLHDNKIIHRD 135
Query: 499 LKPENLLFSDPAGDNIKVVDFGFACL---KRESLHTPCFTLQYAAPEVLRQDKSGYDENC 555
LK N+LF+ +IK+ DFG + + + T + APEV+ + S
Sbjct: 136 LKAGNILFTLD--GDIKLADFGVSAKNTRTIQRRDSFIGTPYWMAPEVVMCETS------ 187
Query: 556 DLWSLGVILVNVLRQDKSGYDENCDLWSLGVILYTMLCGRVPFHARSRDDSALSIMARIK 615
YD D+WSLG+ L M P H + + + ++ +I
Sbjct: 188 ---------------KDRPYDYKADVWSLGITLIEMAEIEPPHH----ELNPMRVLLKIA 228
Query: 616 EGQFNFDAEAWSTVSSEAKELTKSLLTVNPAQRIRM 651
+ + A+ S SS K+ K L N R
Sbjct: 229 KSEPPTLAQ-PSRWSSNFKDFLKKCLEKNVDARWTT 263
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Score = 76.6 bits (188), Expect = 1e-15
Identities = 18/72 (25%), Positives = 40/72 (55%), Gaps = 3/72 (4%)
Query: 894 HTYLVLELLKGGELLDRIRQKGRCGFTENEASRIMRQLVAAVHFMHSRGVVHRDLKPENL 953
+ ++++E GG + + + R TE++ + +Q + A++++H ++HRDLK N+
Sbjct: 83 NLWILIEFCAGGAVDAVMLELER-PLTESQIQVVCKQTLDALNYLHDNKIIHRDLKAGNI 141
Query: 954 LLSGISGNLIKI 965
L + IK+
Sbjct: 142 LFT--LDGDIKL 151
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Score = 60.8 bits (147), Expect = 2e-10
Identities = 19/80 (23%), Positives = 28/80 (35%), Gaps = 8/80 (10%)
Query: 239 SSLIIFFIILSFTLSFIHDYYHIQYRRILKTEPP---IPEDLSPDVADFISRLLVKDPRR 295
S I + +I K+EPP P S + DF+ + L K+
Sbjct: 200 SLGITLIEMAEIEPPHHELNPMRVLLKIAKSEPPTLAQPSRWSSNFKDFLKKCLEKNVDA 259
Query: 296 RLGGGELDAEELKRHPFFNV 315
R +L +HPF V
Sbjct: 260 RWT-----TSQLLQHPFVTV 274
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Score = 48.8 bits (116), Expect = 1e-06
Identities = 37/167 (22%), Positives = 60/167 (35%), Gaps = 22/167 (13%)
Query: 149 ISRKIDCSEEINLLRAC-QGHPNICRRCVEKSTGQEYAVKIISRKIDCS-----EEINLL 202
++R ++ + ++ G + K T A K+I K + EI++L
Sbjct: 4 VTRDLNPEDFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDIL 63
Query: 203 RACQGHPNIVNLHCVFQDE-----------VIDWDDFSRGIECVFFSSSLIIFFIILSFT 251
+C HPNIV L F E D +E S + +
Sbjct: 64 ASCD-HPNIVKLLDAFYYENNLWILIEFCAGGAVDAVMLELERPLTESQIQVVCKQTLDA 122
Query: 252 LSFIHDYYHIQYRRILKTEP-PIPEDLSPDVADF-ISRLLVKDPRRR 296
L+++HD I R LK D +ADF +S + +RR
Sbjct: 123 LNYLHDNKIIH--RDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRR 167
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 197 bits (501), Expect = 1e-57
Identities = 92/309 (29%), Positives = 139/309 (44%), Gaps = 53/309 (17%)
Query: 372 FFEQYDMDLDKAGILGDGSYSVCRRCVEKSTGQEYAVKIISRK--IDCSE----EINLLR 425
F E +D+ LG+G+Y + V + T + AVKI+ K +DC E EI + +
Sbjct: 3 FVEDWDLV----QTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINK 58
Query: 426 ACQGHPNIVNLHCVFQDEVHTYLVLELLKGGELLDRIRQKGRCGFTENEASRIMRQLVAA 485
H N+V + ++ YL LE GGEL DRI E +A R QL+A
Sbjct: 59 MLN-HENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIG--MPEPDAQRFFHQLMAG 115
Query: 486 VHFMHSRGVVHRDLKPENLLFSDPAGDNIKVVDFGFACL-----KRESLHTPCFTLQYAA 540
V ++H G+ HRD+KPENLL + DN+K+ DFG A + + L+ C TL Y A
Sbjct: 116 VVYLHGIGITHRDIKPENLLLDE--RDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVA 173
Query: 541 PEVLRQDKSGYDENCDLWSLGVILVNVLRQDKSGYDENCDLWSLGVILYTMLCGRVPFHA 600
PE+L + + + E D+WS G++L ML G +P+
Sbjct: 174 PELL-------------------------KRREFHAEPVDVWSCGIVLTAMLAGELPWDQ 208
Query: 601 RSRDDSALSIMARIKEGQFNFDAEAWSTVSSEAKELTKSLLTVNPAQRIRMMRVKLTFHA 660
S S KE + + W + S L +L NP+ RI + +K
Sbjct: 209 PSDSCQEYSD---WKEKKTYLN--PWKKIDSAPLALLHKILVENPSARITIPDIKK--DR 261
Query: 661 -FHQAQKEG 668
+++ K+G
Sbjct: 262 WYNKPLKKG 270
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 75.4 bits (185), Expect = 2e-15
Identities = 33/76 (43%), Positives = 41/76 (53%), Gaps = 4/76 (5%)
Query: 890 RYNVHTYLVLELLKGGELLDRIRQKGRCGFTENEASRIMRQLVAAVHFMHSRGVVHRDLK 949
R YL LE GGEL DRI E +A R QL+A V ++H G+ HRD+K
Sbjct: 73 REGNIQYLFLEYCSGGELFDRIEPDIG--MPEPDAQRFFHQLMAGVVYLHGIGITHRDIK 130
Query: 950 PENLLLSGISGNLIKI 965
PENLLL + +KI
Sbjct: 131 PENLLLD--ERDNLKI 144
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 68.1 bits (166), Expect = 5e-13
Identities = 43/274 (15%), Positives = 80/274 (29%), Gaps = 81/274 (29%)
Query: 110 FFEQYDMDLDKAGILGDGSYSVCRRCVEKSTGQEYAVKIISRK--IDCSEEI-------- 159
F E +D+ LG+G+Y + V + T + AVKI+ K +DC E I
Sbjct: 3 FVEDWDLV----QTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINK 58
Query: 160 ---------------------------------NLLRACQGHPNICRRCVEKST--GQEY 184
+ + G P + G Y
Sbjct: 59 MLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVY 118
Query: 185 A--VKIISRKIDCSEEINLLRACQGHPNIVNLHCVFQDEVIDWDDFSRGI---------E 233
+ I R I NLL + + I + + + + E
Sbjct: 119 LHGIGITHRDIKPE---NLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPE 175
Query: 234 CVFFS----------SSLIIFFIILSFTLSFIHDYYHIQYRRILK---TEPPIPEDLSPD 280
+ S I+ +L+ L + Q K T + +
Sbjct: 176 LLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSA 235
Query: 281 VADFISRLLVKDPRRRLGGGELDAEELKRHPFFN 314
+ ++LV++P R+ ++K+ ++N
Sbjct: 236 PLALLHKILVENPSARIT-----IPDIKKDRWYN 264
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 192 bits (490), Expect = 4e-56
Identities = 80/296 (27%), Positives = 120/296 (40%), Gaps = 55/296 (18%)
Query: 379 DLDKAGILGDGSYSVCRRCVEKSTGQEYAVKIISR-------KIDCSEEINLLRACQGHP 431
D + +G GSY C++ KS G+ K + K E+NLLR + HP
Sbjct: 5 DYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELK-HP 63
Query: 432 NIVNLHCVFQDEVHT--YLVLELLKGGELLDRIRQ--KGRCGFTENEASRIMRQLVAAVH 487
NIV + D +T Y+V+E +GG+L I + K R E R+M QL A+
Sbjct: 64 NIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALK 123
Query: 488 FMHSRG-----VVHRDLKPENLLFSDPAGDNIKVVDFGFACLKRES---LHTPCFTLQYA 539
H R V+HRDLKP N+ N+K+ DFG A + T Y
Sbjct: 124 ECHRRSDGGHTVLHRDLKPANVFLDGK--QNVKLGDFGLARILNHDTSFAKAFVGTPYYM 181
Query: 540 APEVLRQDKSGYDENCDLWSLGVILVNVLRQDKSGYDENCDLWSLGVILYTMLCGRVPFH 599
+PE + + Y+E D+WSLG +LY + PF
Sbjct: 182 SPEQMNRMS--------------------------YNEKSDIWSLGCLLYELCALMPPFT 215
Query: 600 ARSRDDSALSIMARIKEGQFNFDAEAWSTVSSEAKELTKSLLTVNPAQRIRMMRVK 655
A S+ + + +I+EG+F S E E+ +L + R + +
Sbjct: 216 AFSQKE----LAGKIREGKFR---RIPYRYSDELNEIITRMLNLKDYHRPSVEEIL 264
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 70.0 bits (171), Expect = 1e-13
Identities = 29/75 (38%), Positives = 38/75 (50%), Gaps = 7/75 (9%)
Query: 890 RYNVHTYLVLELLKGGELLDRIRQ--KGRCGFTENEASRIMRQLVAAVHFMHSRG----- 942
R N Y+V+E +GG+L I + K R E R+M QL A+ H R
Sbjct: 75 RTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHT 134
Query: 943 VVHRDLKPENLLLSG 957
V+HRDLKP N+ L G
Sbjct: 135 VLHRDLKPANVFLDG 149
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 53.5 bits (128), Expect = 4e-08
Identities = 12/72 (16%), Positives = 26/72 (36%), Gaps = 6/72 (8%)
Query: 242 IIFFIILSFTLSFIHDYYHIQYRRILKTE-PPIPEDLSPDVADFISRLLVKDPRRRLGGG 300
+ + + + F +I + + IP S ++ + I+R+L R
Sbjct: 202 CLLYELCALMPPFTAFSQKELAGKIREGKFRRIPYRYSDELNEIITRMLNLKDYHR---- 257
Query: 301 ELDAEELKRHPF 312
EE+ +P
Sbjct: 258 -PSVEEILENPL 268
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 51.1 bits (122), Expect = 2e-07
Identities = 23/105 (21%), Positives = 33/105 (31%), Gaps = 34/105 (32%)
Query: 117 DLDKAGILGDGSYSVCRRCVEKSTGQEYAVKIISRKIDCSEEINLLRACQGHPNICRRCV 176
D + +G GSY C++ KS G+ K + E +L
Sbjct: 5 DYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLV------------- 51
Query: 177 EKSTGQEYAVKIISRKIDCSEEINLLRACQGHPNIVNLHCVFQDE 221
E+NLLR + HPNIV + D
Sbjct: 52 --------------------SEVNLLRELK-HPNIVRYYDRIIDR 75
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 193 bits (491), Expect = 1e-55
Identities = 65/327 (19%), Positives = 115/327 (35%), Gaps = 77/327 (23%)
Query: 379 DLDKAGILGDGSYSVCRRCVEKSTGQEYAVKIISRKIDCSE------EINLLRACQGHPN 432
D +K LG G+ V + K +G A K+I +I + E+ +L C P
Sbjct: 7 DFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECN-SPY 65
Query: 433 IVNLHCVFQDEVHTYLVLELLKGGELLDRIRQKGRCGFTENEASRIMRQLVAAVHFMHSR 492
IV + F + + +E + GG L +++ GR E ++ ++ + ++ +
Sbjct: 66 IVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGR--IPEQILGKVSIAVIKGLTYLREK 123
Query: 493 -GVVHRDLKPENLLFSDPAGDNIKVVDFGFAC-LKRESLHTPCFTLQYAAPEVLRQDKSG 550
++HRD+KP N+L + IK+ DFG + L ++ T Y +PE L+
Sbjct: 124 HKIMHRDVKPSNILVNS--RGEIKLCDFGVSGQLIDSMANSFVGTRSYMSPERLQGTH-- 179
Query: 551 YDENCDLWSLGVILVNVLRQDKSGYDENCDLWSLGVILYTMLCGRVPFHARSRDDSALSI 610
Y D+WS+G+ L M GR P + L
Sbjct: 180 ------------------------YSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMF 215
Query: 611 MARIKEGQFNFDAEA------------------------------------WSTVSSEAK 634
+++ S E +
Sbjct: 216 GCQVEGDAAETPPRPRTPGRPLSSYGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQ 275
Query: 635 ELTKSLLTVNPAQRIRMMRVKLTFHAF 661
+ L NPA+R + ++ + HAF
Sbjct: 276 DFVNKCLIKNPAERADLKQLMV--HAF 300
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 72.8 bits (178), Expect = 3e-14
Identities = 17/73 (23%), Positives = 38/73 (52%), Gaps = 5/73 (6%)
Query: 894 HTYLVLELLKGGELLDRIRQKGRCGFTENEASRIMRQLVAAVHFMHSR-GVVHRDLKPEN 952
+ +E + GG L +++ GR E ++ ++ + ++ + ++HRD+KP N
Sbjct: 78 EISICMEHMDGGSLDQVLKKAGR--IPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSN 135
Query: 953 LLLSGISGNLIKI 965
+L++ S IK+
Sbjct: 136 ILVN--SRGEIKL 146
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 60.5 bits (146), Expect = 3e-10
Identities = 34/215 (15%), Positives = 68/215 (31%), Gaps = 48/215 (22%)
Query: 117 DLDKAGILGDGSYSVCRRCVEKSTGQEYAVKIISRKIDCSEEINLLRACQGHPNICRRCV 176
D +K LG G+ V + K +G A K+I +I + ++R
Sbjct: 7 DFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIR------------- 53
Query: 177 EKSTGQEYAVKIISRKIDCSEEINLLRACQGHPNIVNLHCVFQD--------EVIDWDDF 228
E+ +L C P IV + F E +D
Sbjct: 54 ---------------------ELQVLHECN-SPYIVGFYGAFYSDGEISICMEHMDGGSL 91
Query: 229 SRGI-ECVFFSSSLIIFFII-LSFTLSFIHDYYHIQYRRILKTEPPIPEDLSPDVADF-I 285
+ + + ++ I + L+++ + + I +R + + + + DF +
Sbjct: 92 DQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGV 151
Query: 286 SRLLVKDPRRRLGG--GELDAEELKRHPFFNVIDW 318
S L+ G + E L+ + D
Sbjct: 152 SGQLIDSMANSFVGTRSYMSPERLQGTHYSVQSDI 186
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 53.1 bits (127), Expect = 7e-08
Identities = 14/64 (21%), Positives = 29/64 (45%), Gaps = 6/64 (9%)
Query: 258 YYHIQYRRILKTEPPIPED-LSPDVADFISRLLVKDPRRRLGGGELDAEELKRHPFFNVI 316
+ + + + P +P S + DF+++ L+K+P R D ++L H F
Sbjct: 250 IFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAER-----ADLKQLMVHAFIKRS 304
Query: 317 DWDD 320
D ++
Sbjct: 305 DAEE 308
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 190 bits (485), Expect = 6e-55
Identities = 72/340 (21%), Positives = 127/340 (37%), Gaps = 54/340 (15%)
Query: 361 PNFDKIFKGSLFFEQYDMDLDKAGILGDGSYSVCRRCVEKSTGQEYAVKIISRKIDCSE- 419
P+ ++F + + DL + +G GS+ + + A+K +S S
Sbjct: 2 PDVAELFFKDDPEKLFS-DLRE---IGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNE 57
Query: 420 -------EINLLRACQGHPNIVNLHCVFQDEVHTYLVLELLKGGELLDRIRQKGRCGFTE 472
E+ L+ + HPN + + E +LV+E G K E
Sbjct: 58 KWQDIIKEVRFLQKLR-HPNTIQYRGCYLREHTAWLVMEYCLGSASDLLEVHKKP--LQE 114
Query: 473 NEASRIMRQLVAAVHFMHSRGVVHRDLKPENLLFSDPAGDNIKVVDFGFACLKRESLHTP 532
E + + + + ++HS ++HRD+K N+L S+P +K+ DFG A + + ++
Sbjct: 115 VEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLSEP--GLVKLGDFGSASIMAPA-NSF 171
Query: 533 CFTLQYAAPEVLRQDKSGYDENCDLWSLGVILVNVLRQDKSGYDENCDLWSLGVILYTML 592
T + APEV+ L D+ YD D+WSLG+ +
Sbjct: 172 VGTPYWMAPEVI-----------------------LAMDEGQYDGKVDVWSLGITCIELA 208
Query: 593 CGRVPFHARSRDDSALSIMARIKEGQFNFDAEAWSTVSSEAKELTKSLLTVNPAQRIRMM 652
+ P + +A+S + I + + A S + S L P R
Sbjct: 209 ERKPPLF----NMNAMSALYHIAQNE--SPALQSGHWSEYFRNFVDSCLQKIPQDRPTSE 262
Query: 653 RVKLTFHAFHQAQKEGFRLQDVTSAKLAQRRKNKNVSNDN 692
+ H F ++ + D L QR K+ DN
Sbjct: 263 VLLK--HRFVLRERPPTVIMD-----LIQRTKDAVRELDN 295
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 70.8 bits (173), Expect = 9e-14
Identities = 19/72 (26%), Positives = 33/72 (45%), Gaps = 4/72 (5%)
Query: 894 HTYLVLELLKGGELLDRIRQKGRCGFTENEASRIMRQLVAAVHFMHSRGVVHRDLKPENL 953
+LV+E G K E E + + + + ++HS ++HRD+K N+
Sbjct: 89 TAWLVMEYCLGSASDLLEVHKKP--LQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNI 146
Query: 954 LLSGISGNLIKI 965
LLS L+K+
Sbjct: 147 LLS--EPGLVKL 156
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 54.6 bits (131), Expect = 2e-08
Identities = 14/74 (18%), Positives = 22/74 (29%), Gaps = 7/74 (9%)
Query: 242 IIFFIILSFTLSFIHDYYHIQYRRILKTEPP--IPEDLSPDVADFISRLLVKDPRRRLGG 299
I + + I + E P S +F+ L K P+ R
Sbjct: 202 ITCIELAERKPPLFNMNAMSALYHIAQNESPALQSGHWSEYFRNFVDSCLQKIPQDR--- 258
Query: 300 GELDAEELKRHPFF 313
+E L +H F
Sbjct: 259 --PTSEVLLKHRFV 270
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 47.7 bits (113), Expect = 3e-06
Identities = 15/98 (15%), Positives = 28/98 (28%), Gaps = 33/98 (33%)
Query: 124 LGDGSYSVCRRCVEKSTGQEYAVKIISRKIDCSEEINLLRACQGHPNICRRCVEKSTGQE 183
+G GS+ + + A+K +S S E
Sbjct: 23 IGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNE------------------------- 57
Query: 184 YAVKIISRKIDCSEEINLLRACQGHPNIVNLHCVFQDE 221
+ D +E+ L+ + HPN + + E
Sbjct: 58 -------KWQDIIKEVRFLQKLR-HPNTIQYRGCYLRE 87
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 187 bits (476), Expect = 3e-54
Identities = 64/285 (22%), Positives = 112/285 (39%), Gaps = 50/285 (17%)
Query: 385 ILGDGSYSVCRRCVEKSTGQEYAVKIISRKIDCSE-------EINLLRACQGHPNIVNLH 437
+G GS+ + ++ T E A + + E +L+ Q HPNIV +
Sbjct: 16 EIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQ-HPNIVRFY 74
Query: 438 CVFQDEV----HTYLVLELLKGGELLDRIRQKGRCGFTENEASRIMRQLVAAVHFMHSRG 493
++ V LV EL+ G L +++ RQ++ + F+H+R
Sbjct: 75 DSWESTVKGKKCIVLVTELMTSGTLKTYLKRFKV--MKIKVLRSWCRQILKGLQFLHTRT 132
Query: 494 --VVHRDLKPENLLFSDPAGDNIKVVDFGFACLKRESL-HTPCFTLQYAAPEVLRQDKSG 550
++HRDLK +N+ + P G ++K+ D G A LKR S T ++ APE+ +
Sbjct: 133 PPIIHRDLKCDNIFITGPTG-SVKIGDLGLATLKRASFAKAVIGTPEFMAPEMYEE---- 187
Query: 551 YDENCDLWSLGVILVNVLRQDKSGYDENCDLWSLGVILYTMLCGRVPFHARSRDDSALSI 610
YDE+ D+++ G+ + M P+ S +A I
Sbjct: 188 -----------------------KYDESVDVYAFGMCMLEMATSEYPY---SECQNAAQI 221
Query: 611 MARIKEGQFNFDAEAWSTVSSEAKELTKSLLTVNPAQRIRMMRVK 655
R+ G A E KE+ + + N +R + +
Sbjct: 222 YRRVTSG--VKPASFDKVAIPEVKEIIEGCIRQNKDERYSIKDLL 264
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 71.9 bits (176), Expect = 3e-14
Identities = 21/83 (25%), Positives = 42/83 (50%), Gaps = 5/83 (6%)
Query: 885 FVNRSRYNVHTYLVLELLKGGELLDRIRQKGRCGFTENEASRIMRQLVAAVHFMHSRG-- 942
+ + + LV EL+ G L +++ RQ++ + F+H+R
Sbjct: 77 WESTVKGKKCIVLVTELMTSGTLKTYLKRFKV--MKIKVLRSWCRQILKGLQFLHTRTPP 134
Query: 943 VVHRDLKPENLLLSGISGNLIKI 965
++HRDLK +N+ ++G +G+ +KI
Sbjct: 135 IIHRDLKCDNIFITGPTGS-VKI 156
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 55.0 bits (132), Expect = 1e-08
Identities = 13/75 (17%), Positives = 26/75 (34%), Gaps = 8/75 (10%)
Query: 242 IIFFIILSFTLSFIHDYYHIQ-YRRILKTEPP--IPEDLSPDVADFISRLLVKDPRRRLG 298
+ + + + Q YRR+ P + P+V + I + ++ R
Sbjct: 200 MCMLEMATSEYPYSECQNAAQIYRRVTSGVKPASFDKVAIPEVKEIIEGCIRQNKDERYS 259
Query: 299 GGELDAEELKRHPFF 313
++L H FF
Sbjct: 260 -----IKDLLNHAFF 269
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 45.0 bits (106), Expect = 2e-05
Identities = 17/106 (16%), Positives = 30/106 (28%), Gaps = 34/106 (32%)
Query: 123 ILGDGSYSVCRRCVEKSTGQEYAVKIISRKIDCSEEINLLRACQGHPNICRRCVEKSTGQ 182
+G GS+ + ++ T E A + + E +
Sbjct: 16 EIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFK------------------- 56
Query: 183 EYAVKIISRKIDCSEEINLLRACQGHPNIVNLHCVFQDEVIDWDDF 228
EE +L+ Q HPNIV + ++ V
Sbjct: 57 --------------EEAEMLKGLQ-HPNIVRFYDSWESTVKGKKCI 87
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 187 bits (477), Expect = 5e-54
Identities = 60/274 (21%), Positives = 115/274 (41%), Gaps = 45/274 (16%)
Query: 386 LGDGSYSVCRRCVEKSTGQEYAVKIISRKIDCSE-----EINLLRACQGHPNIVNLHCVF 440
+G G+ ++ +TGQE A++ ++ + + EI ++R + +PNIVN +
Sbjct: 28 IGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENK-NPNIVNYLDSY 86
Query: 441 QDEVHTYLVLELLKGGELLDRIRQKGRCGFTENEASRIMRQLVAAVHFMHSRGVVHRDLK 500
++V+E L GG L D + + E + + + R+ + A+ F+HS V+HRD+K
Sbjct: 87 LVGDELWVVMEYLAGGSLTDVVTETC---MDEGQIAAVCRECLQALEFLHSNQVIHRDIK 143
Query: 501 PENLLFSDPAGDNIKVVDFGFACL---KRESLHTPCFTLQYAAPEVLRQDKSGYDENCDL 557
+N+L ++K+ DFGF ++ T T + APEV+ +
Sbjct: 144 SDNILLGMD--GSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTR----------- 190
Query: 558 WSLGVILVNVLRQDKSGYDENCDLWSLGVILYTMLCGRVPFHARSRDDSALSIMARIKEG 617
Y D+WSLG++ M+ G P+ + + I G
Sbjct: 191 ---------------KAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLI---ATNG 232
Query: 618 QFNFDAEAWSTVSSEAKELTKSLLTVNPAQRIRM 651
+ +S+ ++ L ++ +R
Sbjct: 233 TPEL--QNPEKLSAIFRDFLNRCLDMDVEKRGSA 264
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 70.0 bits (171), Expect = 2e-13
Identities = 39/273 (14%), Positives = 79/273 (28%), Gaps = 78/273 (28%)
Query: 124 LGDGSYSVCRRCVEKSTGQEYAVKIISRKIDCSEE-----------------INLLRACQ 166
+G G+ ++ +TGQE A++ ++ + +E +N L +
Sbjct: 28 IGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYL 87
Query: 167 GHPNIC-----------RRCVEKSTGQEYAVKIISRKIDCSEEINLLRACQGHPNIVNLH 215
+ V ++ E + + R+ + L + +++
Sbjct: 88 VGDELWVVMEYLAGGSLTDVVTETCMDEGQIAAVCREC-----LQALEFLHSN-QVIHRD 141
Query: 216 C------VFQDEVIDWDDFSRGIECVFFSSSL---------------------------- 241
+ D + DF + S
Sbjct: 142 IKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWS 201
Query: 242 --IIFFIILSFTLSFIHDYYHIQYRRILKTEPP---IPEDLSPDVADFISRLLVKDPRRR 296
I+ ++ ++++ I P PE LS DF++R L D +R
Sbjct: 202 LGIMAIEMIEGEPPYLNENPLRALYLIATNGTPELQNPEKLSAIFRDFLNRCLDMDVEKR 261
Query: 297 LGGGELDAEELKRHPFFNVIDWDDLATKRIPAP 329
A+EL +H F + T I A
Sbjct: 262 GS-----AKELLQHQFLKIAKPLSSLTPLIAAA 289
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 68.9 bits (168), Expect = 4e-13
Identities = 21/63 (33%), Positives = 37/63 (58%), Gaps = 3/63 (4%)
Query: 894 HTYLVLELLKGGELLDRIRQKGRCGFTENEASRIMRQLVAAVHFMHSRGVVHRDLKPENL 953
++V+E L GG L D + + E + + + R+ + A+ F+HS V+HRD+K +N+
Sbjct: 91 ELWVVMEYLAGGSLTDVVTETC---MDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNI 147
Query: 954 LLS 956
LL
Sbjct: 148 LLG 150
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Score = 186 bits (473), Expect = 2e-53
Identities = 85/305 (27%), Positives = 145/305 (47%), Gaps = 52/305 (17%)
Query: 366 IFKGSLFFEQYDMDLDKAGILGDGSYSVCRRCVEKSTGQEYAVKIISRKIDCSE------ 419
+F+ + YD LG G ++V ++C EKSTG +YA K I ++ S
Sbjct: 2 VFRQENVDDYYDTG----EELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSR 57
Query: 420 -----EINLLRACQGHPNIVNLHCVFQDEVHTYLVLELLKGGELLDRIRQKGRCGFTENE 474
E+++L+ Q HPN++ LH V++++ L+LEL+ GGEL D + +K TE E
Sbjct: 58 EDIEREVSILKEIQ-HPNVITLHEVYENKTDVILILELVAGGELFDFLAEKES--LTEEE 114
Query: 475 ASRIMRQLVAAVHFMHSRGVVHRDLKPENLLFSD--PAGDNIKVVDFGFACLKRES--LH 530
A+ ++Q++ V+++HS + H DLKPEN++ D IK++DFG A
Sbjct: 115 ATEFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFK 174
Query: 531 TPCFTLQYAAPEVLRQDKSGYDENCDLWSLGVILVNVLRQDKSGYDENCDLWSLGVILYT 590
T ++ APE++ + D+WS+GVI Y
Sbjct: 175 NIFGTPEFVAPEIVNYEP--------------------------LGLEADMWSIGVITYI 208
Query: 591 MLCGRVPFHARSRDDSALSIMARIKEGQFNFDAEAWSTVSSEAKELTKSLLTVNPAQRIR 650
+L G PF ++ + +A + + F+ E +S S+ AK+ + LL +P +R+
Sbjct: 209 LLSGASPFLGDTKQE----TLANVSAVNYEFEDEYFSNTSALAKDFIRRLLVKDPKKRMT 264
Query: 651 MMRVK 655
+
Sbjct: 265 IQDSL 269
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Score = 89.8 bits (222), Expect = 4e-20
Identities = 54/282 (19%), Positives = 93/282 (32%), Gaps = 85/282 (30%)
Query: 124 LGDGSYSVCRRCVEKSTGQEYAVKIISRKIDCSE-----------EINLLRACQGHPNIC 172
LG G ++V ++C EKSTG +YA K I ++ S E+++L+ Q HPN+
Sbjct: 18 LGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQ-HPNVI 76
Query: 173 R-------------------------RCVEKSTGQEYAVKIISRKI------DCSEEI-- 199
EK + E ++I S +I
Sbjct: 77 TLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLHSLQIAH 136
Query: 200 ------NLLRACQGHPNIVNLHCVFQD----------------------EVIDWDDFSRG 231
N++ + P F E+++++
Sbjct: 137 FDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEFVAPEIVNYEPLGLE 196
Query: 232 IECVFFSSSLIIFFIILSFTLSFIHDYYHIQYRRILKT----EPPIPEDLSPDVADFISR 287
+ +I +I+LS F+ D + E + S DFI R
Sbjct: 197 ADMWSIG---VITYILLSGASPFLGDTKQETLANVSAVNYEFEDEYFSNTSALAKDFIRR 253
Query: 288 LLVKDPRRRLGGGELDAEELKRHPFFNVIDWDDLATKRIPAP 329
LLVKDP++R+ ++ +HP+ D + P
Sbjct: 254 LLVKDPKKRMT-----IQDSLQHPWIKPKDTQQALSSAWSHP 290
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Score = 53.6 bits (128), Expect = 4e-08
Identities = 26/63 (41%), Positives = 41/63 (65%), Gaps = 2/63 (3%)
Query: 894 HTYLVLELLKGGELLDRIRQKGRCGFTENEASRIMRQLVAAVHFMHSRGVVHRDLKPENL 953
L+LEL+ GGEL D + +K TE EA+ ++Q++ V+++HS + H DLKPEN+
Sbjct: 87 DVILILELVAGGELFDFLAEKES--LTEEEATEFLKQILNGVYYLHSLQIAHFDLKPENI 144
Query: 954 LLS 956
+L
Sbjct: 145 MLL 147
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Score = 185 bits (471), Expect = 7e-53
Identities = 73/276 (26%), Positives = 123/276 (44%), Gaps = 49/276 (17%)
Query: 385 ILGDGSYSVCRRCVEKSTGQEYAVKIISRKIDCSE--------EINLLRACQGHPNIVNL 436
+LG GS+ K T Q +A+K + + + + E +L HP + ++
Sbjct: 9 MLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHM 68
Query: 437 HCVFQDEVHTYLVLELLKGGELLDRIRQKGRCGFTENEASRIMRQLVAAVHFMHSRGVVH 496
C FQ + + + V+E L GG+L+ I+ + F + A+ +++ + F+HS+G+V+
Sbjct: 69 FCTFQTKENLFFVMEYLNGGDLMYHIQSCHK--FDLSRATFYAAEIILGLQFLHSKGIVY 126
Query: 497 RDLKPENLLFSDPAGDNIKVVDFGFA---CLKRESLHTPCFTLQYAAPEVLRQDKSGYDE 553
RDLK +N+L +IK+ DFG L +T C T Y APE+L K
Sbjct: 127 RDLKLDNILLDKD--GHIKIADFGMCKENMLGDAKTNTFCGTPDYIAPEILLGQK----- 179
Query: 554 NCDLWSLGVILVNVLRQDKSGYDENCDLWSLGVILYTMLCGRVPFHARSRDDSALSIMAR 613
Y+ + D WS GV+LY ML G+ PFH + ++ +
Sbjct: 180 ---------------------YNHSVDWWSFGVLLYEMLIGQSPFHGQDEEE----LFHS 214
Query: 614 IKEGQFNFDAEAWSTVSSEAKELTKSLLTVNPAQRI 649
I+ + + EAK+L L P +R+
Sbjct: 215 IRMDNPFY----PRWLEKEAKDLLVKLFVREPEKRL 246
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Score = 139 bits (350), Expect = 9e-37
Identities = 56/313 (17%), Positives = 99/313 (31%), Gaps = 70/313 (22%)
Query: 123 ILGDGSYSVCRRCVEKSTGQEYAVKIISRKIDCSE--------EINLLRACQGHPNICR- 173
+LG GS+ K T Q +A+K + + + + E +L HP +
Sbjct: 9 MLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHM 68
Query: 174 -----------RCVEKSTGQEYAVKIISRKIDCSEEI-----NLLRACQGHPNIVNLHCV 217
+E G + I S ++ Q + ++
Sbjct: 69 FCTFQTKENLFFVMEYLNGGDLMYHIQSCHKFDLSRATFYAAEIILGLQFLHSKGIVYRD 128
Query: 218 FQDEVIDWDDFSRGIECVFFSSSL------------------------------------ 241
+ + I D F
Sbjct: 129 LKLDNILLDKDGHIKIADFGMCKENMLGDAKTNTFCGTPDYIAPEILLGQKYNHSVDWWS 188
Query: 242 --IIFFIILSFTLSFIHDYYHIQYRRILKTEPPIPEDLSPDVADFISRLLVKDPRRRLGG 299
++ + +L F + I P P L + D + +L V++P +RLG
Sbjct: 189 FGVLLYEMLIGQSPFHGQDEEELFHSIRMDNPFYPRWLEKEAKDLLVKLFVREPEKRLGV 248
Query: 300 GELDAEELKRHPFFNVIDWDDLATKRIPAPFVPKISNELDVSNFSDEFTKMIPADSPA-- 357
++++HP F I+W++L K I PF PK+ + D SNF EF P S A
Sbjct: 249 ----RGDIRQHPLFREINWEELERKEIDPPFRPKVKSPFDCSNFDKEFLNEKPRLSFADR 304
Query: 358 -IVPPNFDKIFKG 369
++ +F+
Sbjct: 305 ALINSMDQNMFRN 317
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Score = 64.8 bits (157), Expect = 1e-11
Identities = 20/61 (32%), Positives = 39/61 (63%), Gaps = 2/61 (3%)
Query: 894 HTYLVLELLKGGELLDRIRQKGRCGFTENEASRIMRQLVAAVHFMHSRGVVHRDLKPENL 953
+ + V+E L GG+L+ I+ + F + A+ +++ + F+HS+G+V+RDLK +N+
Sbjct: 77 NLFFVMEYLNGGDLMYHIQSCHK--FDLSRATFYAAEIILGLQFLHSKGIVYRDLKLDNI 134
Query: 954 L 954
L
Sbjct: 135 L 135
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Score = 185 bits (470), Expect = 3e-52
Identities = 67/281 (23%), Positives = 114/281 (40%), Gaps = 47/281 (16%)
Query: 385 ILGDGSYSVCRRCVEKSTGQEYAVKIISRKIDCSE-----------EINLLRACQGHPNI 433
I+G G + C + TG+ YA+K + +K + ++L+ P I
Sbjct: 11 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGD-CPFI 69
Query: 434 VNLHCVFQDEVHTYLVLELLKGGELLDRIRQKGRCGFTENEASRIMRQLVAAVHFMHSRG 493
V + F +L+L+ GG+L + Q G +E + +++ + MH+R
Sbjct: 70 VCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVF--SEADMRFYAAEIILGLEHMHNRF 127
Query: 494 VVHRDLKPENLLFSDPAGDNIKVVDFGFAC-LKRESLHTPCFTLQYAAPEVLRQDKSGYD 552
VV+RDLKP N+L + ++++ D G AC ++ H T Y APEVL++
Sbjct: 128 VVYRDLKPANILLDEH--GHVRISDLGLACDFSKKKPHASVGTHGYMAPEVLQKGV---- 181
Query: 553 ENCDLWSLGVILVNVLRQDKSGYDENCDLWSLGVILYTMLCGRVPFHARSRDDSALSIMA 612
YD + D +SLG +L+ +L G PF D
Sbjct: 182 ---------------------AYDSSADWFSLGCMLFKLLRGHSPFRQHKTKD-----KH 215
Query: 613 RIKEGQFNFDAEAWSTVSSEAKELTKSLLTVNPAQRIRMMR 653
I E + S E + L + LL + +R+ +
Sbjct: 216 EIDRMTLTMAVELPDSFSPELRSLLEGLLQRDVNRRLGCLG 256
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Score = 125 bits (315), Expect = 1e-31
Identities = 56/307 (18%), Positives = 97/307 (31%), Gaps = 74/307 (24%)
Query: 123 ILGDGSYSVCRRCVEKSTGQEYAVKIISRKIDCSE-----------EINLLRACQGHPNI 171
I+G G + C + TG+ YA+K + +K + ++L+ P I
Sbjct: 11 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGD-CPFI 69
Query: 172 CRR------------CVEKSTGQEYAVKIISRKIDCSEEI-------------------- 199
++ G + + + ++
Sbjct: 70 VCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGLEHMHNRFVV 129
Query: 200 -------NLLRACQGHPNIVN--LHCVFQDEVIDWDDFSRGIEC---------VFFSSSL 241
N+L GH I + L C F + + G S+
Sbjct: 130 YRDLKPANILLDEHGHVRISDLGLACDFSKKKPHASVGTHGYMAPEVLQKGVAYDSSADW 189
Query: 242 IIFFIILSFTLSFIHDYY-------HIQYRRILKTEPPIPEDLSPDVADFISRLLVKDPR 294
+L L + H R L +P+ SP++ + LL +D
Sbjct: 190 FSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVELPDSFSPELRSLLEGLLQRDVN 249
Query: 295 RRLGGGELDAEELKRHPFFNVIDWDDLATKRIPAPFVPKISNE-----LDVSNFSDEFTK 349
RRLG A+E+K PFF +DW + ++ P P +P D+ +F +E TK
Sbjct: 250 RRLGCLGRGAQEVKESPFFRSLDWQMVFLQKYPPPLIPPRGEVNAADAFDIGSFDEEDTK 309
Query: 350 MIPADSP 356
I
Sbjct: 310 GIKLLDS 316
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Score = 70.5 bits (172), Expect = 2e-13
Identities = 21/63 (33%), Positives = 35/63 (55%), Gaps = 2/63 (3%)
Query: 894 HTYLVLELLKGGELLDRIRQKGRCGFTENEASRIMRQLVAAVHFMHSRGVVHRDLKPENL 953
+L+L+ GG+L + Q G +E + +++ + MH+R VV+RDLKP N+
Sbjct: 81 KLSFILDLMNGGDLHYHLSQHGVF--SEADMRFYAAEIILGLEHMHNRFVVYRDLKPANI 138
Query: 954 LLS 956
LL
Sbjct: 139 LLD 141
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Score = 181 bits (459), Expect = 9e-52
Identities = 62/285 (21%), Positives = 100/285 (35%), Gaps = 49/285 (17%)
Query: 385 ILGDGSYSVCRRCVEKSTGQEYAVKIISRKIDCSE--------EINLLRACQGHPNIVNL 436
ILG G S + ++ AVK++ + E A HP IV +
Sbjct: 14 ILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALN-HPAIVAV 72
Query: 437 HCVFQDEVHT----YLVLELLKGGELLDRIRQKGRCGFTENEASRIMRQLVAAVHFMHSR 492
+ + E Y+V+E + G L D + +G T A ++ A++F H
Sbjct: 73 YDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGP--MTPKRAIEVIADACQALNFSHQN 130
Query: 493 GVVHRDLKPENLLFSDPAGDNIKVVDFGFACLK----RESLHTPCFTLQYAAPEVLRQDK 548
G++HRD+KP N++ S + A T QY +PE R D
Sbjct: 131 GIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQARGDS 190
Query: 549 SGYDENCDLWSLGVILVNVLRQDKSGYDENCDLWSLGVILYTMLCGRVPFHARSRDDSAL 608
D D++SLG +LY +L G PF DS +
Sbjct: 191 --------------------------VDARSDVYSLGCVLYEVLTGEPPFT----GDSPV 220
Query: 609 SIMARIKEGQFNFDAEAWSTVSSEAKELTKSLLTVNPAQRIRMMR 653
S+ + + +S++ + L NP R +
Sbjct: 221 SVAYQHVREDPIPPSARHEGLSADLDAVVLKALAKNPENRYQTAA 265
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Score = 69.0 bits (168), Expect = 3e-13
Identities = 21/83 (25%), Positives = 40/83 (48%), Gaps = 2/83 (2%)
Query: 884 TFVNRSRYNVHTYLVLELLKGGELLDRIRQKGRCGFTENEASRIMRQLVAAVHFMHSRGV 943
T + Y+V+E + G L D + +G T A ++ A++F H G+
Sbjct: 75 TGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGP--MTPKRAIEVIADACQALNFSHQNGI 132
Query: 944 VHRDLKPENLLLSGISGNLIKIY 966
+HRD+KP N+++S + + +
Sbjct: 133 IHRDVKPANIMISATNAVKVMDF 155
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Score = 48.6 bits (115), Expect = 1e-06
Identities = 15/99 (15%), Positives = 28/99 (28%), Gaps = 33/99 (33%)
Query: 123 ILGDGSYSVCRRCVEKSTGQEYAVKIISRKIDCSEEINLLRACQGHPNICRRCVEKSTGQ 182
ILG G S + ++ AVK++ + +
Sbjct: 14 ILGFGGMSEVHLARDLRLHRDVAVKVLRA-------------------------DLARDP 48
Query: 183 EYAVKIISRKIDCSEEINLLRACQGHPNIVNLHCVFQDE 221
+ ++ E A HP IV ++ + E
Sbjct: 49 SFYLRFR-------REAQNAAALN-HPAIVAVYDTGEAE 79
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Score = 45.5 bits (107), Expect = 1e-05
Identities = 15/72 (20%), Positives = 28/72 (38%), Gaps = 4/72 (5%)
Query: 242 IIFFIILSFTLSFIHDYYHIQYRRILKTEPPIP----EDLSPDVADFISRLLVKDPRRRL 297
+ + +L+ F D + ++ +P P E LS D+ + + L K+P R
Sbjct: 202 CVLYEVLTGEPPFTGDSPVSVAYQHVREDPIPPSARHEGLSADLDAVVLKALAKNPENRY 261
Query: 298 GGGELDAEELKR 309
+L R
Sbjct: 262 QTAAEMRADLVR 273
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 178 bits (452), Expect = 5e-51
Identities = 60/282 (21%), Positives = 115/282 (40%), Gaps = 43/282 (15%)
Query: 379 DLDKAGILGDGSYSVCRRCVEKSTGQEYAVKIISRKIDCSE---EINLLRACQGHPNIVN 435
+L +G G + + G + AVK I E +++ + H N+V
Sbjct: 8 ELKLLQTIGKGEFGDVMLGDYR--GNKVAVKCIKNDATAQAFLAEASVMTQLR-HSNLVQ 64
Query: 436 LH-CVFQDEVHTYLVLELLKGGELLDRIRQKGRCGFTENEASRIMRQLVAAVHFMHSRGV 494
L + +++ Y+V E + G L+D +R +GR + + + A+ ++
Sbjct: 65 LLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNF 124
Query: 495 VHRDLKPENLLFSDPAGDNIKVVDFGFACLKRESLHTPCFTLQYAAPEVLRQDKSGYDEN 554
VHRDL N+L S+ + KV DFG + T +++ APE LR+ K
Sbjct: 125 VHRDLAARNVLVSE--DNVAKVSDFGLTKEASSTQDTGKLPVKWTAPEALREKK------ 176
Query: 555 CDLWSLGVILVNVLRQDKSGYDENCDLWSLGVILYTML-CGRVPFHARSRDDSALSIMAR 613
+ D+WS G++L+ + GRVP+ D ++ R
Sbjct: 177 --------------------FSTKSDVWSFGILLWEIYSFGRVPYPRIPLKD----VVPR 212
Query: 614 IKEGQFNFDAEAWSTVSSEAKELTKSLLTVNPAQRIRMMRVK 655
+++G + +A E+ K+ ++ A R ++++
Sbjct: 213 VEKG---YKMDAPDGCPPAVYEVMKNCWHLDAAMRPSFLQLR 251
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 72.3 bits (177), Expect = 2e-14
Identities = 18/64 (28%), Positives = 31/64 (48%)
Query: 894 HTYLVLELLKGGELLDRIRQKGRCGFTENEASRIMRQLVAAVHFMHSRGVVHRDLKPENL 953
Y+V E + G L+D +R +GR + + + A+ ++ VHRDL N+
Sbjct: 75 GLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNV 134
Query: 954 LLSG 957
L+S
Sbjct: 135 LVSE 138
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 56.9 bits (137), Expect = 3e-09
Identities = 38/256 (14%), Positives = 70/256 (27%), Gaps = 65/256 (25%)
Query: 117 DLDKAGILGDGSYSVCRRCVEKSTGQEYAVKIISRKIDCSE---EINLLRACQGHPNICR 173
+L +G G + + G + AVK I E +++ + H N+ +
Sbjct: 8 ELKLLQTIGKGEFGDVMLGDYR--GNKVAVKCIKNDATAQAFLAEASVMTQLR-HSNLVQ 64
Query: 174 --RCVEKSTGQEYAV-----------KIISRKIDCSEEINLLRACQG---------HPNI 211
+ + G Y V + SR LL+ N
Sbjct: 65 LLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNF 124
Query: 212 VNLHC------VFQDEVIDWDDFSR----------------------------GIECVFF 237
V+ V +D V DF + +
Sbjct: 125 VHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGKLPVKWTAPEALREKKFSTKSDVW 184
Query: 238 SSSLIIFFIILSFTLSFIHDYYHIQYRRILK-TEPPIPEDLSPDVADFISRLLVKDPRRR 296
S ++++ I + + R+ K + P+ P V + + D R
Sbjct: 185 SFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGYKMDAPDGCPPAVYEVMKNCWHLDAAMR 244
Query: 297 LGGGELDA--EELKRH 310
+L E +K H
Sbjct: 245 PSFLQLREQLEHIKTH 260
|
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 176 bits (448), Expect = 3e-50
Identities = 54/278 (19%), Positives = 106/278 (38%), Gaps = 45/278 (16%)
Query: 386 LGDGSYSVCRRCVEKSTGQEYAVKIISRKIDCSE-------EINLLRACQGHPNIVNLHC 438
+G GS+ + + AVK+++ + E+ +LR + H NI+
Sbjct: 16 IGSGSFGTVYKGKWH---GDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTR-HVNILLFMG 71
Query: 439 VFQDEVHTYLVLELLKGGELLDRIRQKGRCGFTENEASRIMRQLVAAVHFMHSRGVVHRD 498
+ +V + +G L + F + I RQ + ++H++ ++HRD
Sbjct: 72 -YSTAPQLAIVTQWCEGSSLYHHLHII-ETKFEMIKLIDIARQTAQGMDYLHAKSIIHRD 129
Query: 499 LKPENLLFSDPAGDNIKVVDFGFACLKRE-----SLHTPCFTLQYAAPEVLRQDKSGYDE 553
LK N+ + +K+ DFG A +K ++ + APEV+R
Sbjct: 130 LKSNNIFLHED--LTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRM------- 180
Query: 554 NCDLWSLGVILVNVLRQDKSGYDENCDLWSLGVILYTMLCGRVPFHARSRDDSALSIMAR 613
QDK+ Y D+++ G++LY ++ G++P+ + D + ++ R
Sbjct: 181 ----------------QDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGR 224
Query: 614 IKEGQFNFDAEAWSTVSSEAKELTKSLLTVNPAQRIRM 651
++ S K L L +R
Sbjct: 225 GYL--SPDLSKVRSNCPKAMKRLMAECLKKKRDERPLF 260
|
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 73.1 bits (179), Expect = 1e-14
Identities = 15/61 (24%), Positives = 28/61 (45%), Gaps = 1/61 (1%)
Query: 896 YLVLELLKGGELLDRIRQKGRCGFTENEASRIMRQLVAAVHFMHSRGVVHRDLKPENLLL 955
+V + +G L + F + I RQ + ++H++ ++HRDLK N+ L
Sbjct: 79 AIVTQWCEGSSLYHHLHII-ETKFEMIKLIDIARQTAQGMDYLHAKSIIHRDLKSNNIFL 137
Query: 956 S 956
Sbjct: 138 H 138
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 177 bits (449), Expect = 5e-50
Identities = 71/283 (25%), Positives = 127/283 (44%), Gaps = 47/283 (16%)
Query: 379 DLDKAGILGDGSYSVCRRCVEKSTGQEYAVKIISRKIDCS--------EEINLLRACQGH 430
D LG GS+ + G+ YA+K++ ++I +E +L H
Sbjct: 5 DFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVT-H 63
Query: 431 PNIVNLHCVFQDEVHTYLVLELLKGGELLDRIRQKGRCGFTENEASRIMRQLVAAVHFMH 490
P I+ + FQD +++++ ++GGEL +R+ R A ++ A+ ++H
Sbjct: 64 PFIIRMWGTFQDAQQIFMIMDYIEGGELFSLLRKSQRF--PNPVAKFYAAEVCLALEYLH 121
Query: 491 SRGVVHRDLKPENLLFSDPAGDNIKVVDFGFACLKRESLHTPCFTLQYAAPEVLRQDKSG 550
S+ +++RDLKPEN+L +IK+ DFGFA + +T C T Y APEV+
Sbjct: 122 SKDIIYRDLKPENILLDK--NGHIKITDFGFAKYVPDVTYTLCGTPDYIAPEVVSTKP-- 177
Query: 551 YDENCDLWSLGVILVNVLRQDKSGYDENCDLWSLGVILYTMLCGRVPFHARSRDDSALSI 610
Y+++ D WS G+++Y ML G PF+ D + +
Sbjct: 178 ------------------------YNKSIDWWSFGILIYEMLAGYTPFY----DSNTMKT 209
Query: 611 MARIKEGQFNFDAEAWSTVSSEAKELTKSLLTVNPAQRIRMMR 653
+I + F + + K+L L+T + +QR+ ++
Sbjct: 210 YEKILNAELRF----PPFFNEDVKDLLSRLITRDLSQRLGNLQ 248
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 143 bits (361), Expect = 3e-38
Identities = 63/317 (19%), Positives = 112/317 (35%), Gaps = 70/317 (22%)
Query: 117 DLDKAGILGDGSYSVCRRCVEKSTGQEYAVKIISRKIDCS--------EEINLLRACQGH 168
D LG GS+ + G+ YA+K++ ++I +E +L H
Sbjct: 5 DFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVT-H 63
Query: 169 PNICR-------------------------RCVEKSTGQEYAVKIISRKI------DCSE 197
P I R + K + ++ S+
Sbjct: 64 PFIIRMWGTFQDAQQIFMIMDYIEGGELFSLLRKSQRFPNPVAKFYAAEVCLALEYLHSK 123
Query: 198 EI--------NLLRACQGHPNIVNLHCVFQ----------------DEVIDWDDFSRGIE 233
+I N+L GH I + EV+ +++ I+
Sbjct: 124 DIIYRDLKPENILLDKNGHIKITDFGFAKYVPDVTYTLCGTPDYIAPEVVSTKPYNKSID 183
Query: 234 CVFFSSSLIIFFIILSFTLSFIHDYYHIQYRRILKTEPPIPEDLSPDVADFISRLLVKDP 293
S I+ + +L+ F Y +IL E P + DV D +SRL+ +D
Sbjct: 184 W---WSFGILIYEMLAGYTPFYDSNTMKTYEKILNAELRFPPFFNEDVKDLLSRLITRDL 240
Query: 294 RRRLGGGELDAEELKRHPFFNVIDWDDLATKRIPAPFVPKI-SNELDVSNFSDEFTKMIP 352
+RLG + E++K HP+F + W+ L ++ I P+ P I + D S F D++ +
Sbjct: 241 SQRLGNLQNGTEDVKNHPWFKEVVWEKLLSRNIETPYEPPIQQGQGDTSQF-DKYPEEDI 299
Query: 353 ADSPAIVPPNFDKIFKG 369
P + +F+
Sbjct: 300 NYGVQGEDP-YADLFRD 315
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 57.0 bits (137), Expect = 4e-09
Identities = 19/63 (30%), Positives = 38/63 (60%), Gaps = 2/63 (3%)
Query: 894 HTYLVLELLKGGELLDRIRQKGRCGFTENEASRIMRQLVAAVHFMHSRGVVHRDLKPENL 953
+++++ ++GGEL +R+ R A ++ A+ ++HS+ +++RDLKPEN+
Sbjct: 78 QIFMIMDYIEGGELFSLLRKSQRF--PNPVAKFYAAEVCLALEYLHSKDIIYRDLKPENI 135
Query: 954 LLS 956
LL
Sbjct: 136 LLD 138
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 171 bits (433), Expect = 3e-48
Identities = 66/284 (23%), Positives = 109/284 (38%), Gaps = 54/284 (19%)
Query: 385 ILGDGSYSVCRRCVEKSTGQEYAVKIISRKIDCSE-----------EINLLRACQ-GHPN 432
+LG G + + S A+K + + E+ LL+ G
Sbjct: 11 LLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSG 70
Query: 433 IVNLHCVFQDEVHTYLVLELLKGGELLDRIRQKGRCGFTENEASRIMRQLVAAVHFMHSR 492
++ L F+ L+LE + + L + R E A Q++ AV H+
Sbjct: 71 VIRLLDWFERPDSFVLILERPEPVQDLFDFITE-RGALQEELARSFFWQVLEAVRHCHNC 129
Query: 493 GVVHRDLKPENLLFSDPAGDNIKVVDFGFACLKRES-LHTPCFTLQYAAPEVLRQDKSGY 551
GV+HRD+K EN+L G +K++DFG L +++ T Y+ PE +R +
Sbjct: 130 GVLHRDIKDENILIDLNRG-ELKLIDFGSGALLKDTVYTDFDGTRVYSPPEWIRYHR--- 185
Query: 552 DENCDLWSLGVILVNVLRQDKSGYDENCDLWSLGVILYTMLCGRVPFHARSRDDSALSIM 611
+ + +WSLG++LY M+CG +PF
Sbjct: 186 ----------------------YHGRSAAVWSLGILLYDMVCGDIPFEHDE--------- 214
Query: 612 ARIKEGQFNFDAEAWSTVSSEAKELTKSLLTVNPAQRIRMMRVK 655
I GQ F VSSE + L + L + P+ R ++
Sbjct: 215 -EIIRGQVFFR----QRVSSECQHLIRWCLALRPSDRPTFEEIQ 253
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 74.0 bits (181), Expect = 5e-15
Identities = 40/259 (15%), Positives = 75/259 (28%), Gaps = 79/259 (30%)
Query: 123 ILGDGSYSVCRRCVEKSTGQEYAVKIISRKIDCSE-----------EINLLRACQ-GHPN 170
+LG G + + S A+K + + E+ LL+ G
Sbjct: 11 LLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSG 70
Query: 171 ICR------------RCVEKSTGQEYAVKIISRKIDCSEEI------NLLRACQGHPNIV 212
+ R +E+ + I+ + EE+ +L A + N
Sbjct: 71 VIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCHNCG 130
Query: 213 NLHCVFQDEVIDWDDFSRGIECVFFSSSL------------------------------- 241
LH +DE I D ++ + F S
Sbjct: 131 VLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVYTDFDGTRVYSPPEWIRYHRYHGRS 190
Query: 242 -------IIFFIILSFTLSFIHDYYHIQYRRILKTEPPIPEDLSPDVADFISRLLVKDPR 294
I+ + ++ + F HD I++ + + +S + I L P
Sbjct: 191 AAVWSLGILLYDMVCGDIPFEHD------EEIIRGQVFFRQRVSSECQHLIRWCLALRPS 244
Query: 295 RRLGGGELDAEELKRHPFF 313
R EE++ HP+
Sbjct: 245 DRPT-----FEEIQNHPWM 258
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 61.3 bits (148), Expect = 1e-10
Identities = 22/69 (31%), Positives = 33/69 (47%), Gaps = 1/69 (1%)
Query: 894 HTYLVLELLKGGELLDRIRQKGRCGFTENEASRIMRQLVAAVHFMHSRGVVHRDLKPENL 953
L+LE + + L + R E A Q++ AV H+ GV+HRD+K EN+
Sbjct: 83 SFVLILERPEPVQDLFDFITE-RGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENI 141
Query: 954 LLSGISGNL 962
L+ G L
Sbjct: 142 LIDLNRGEL 150
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 171 bits (433), Expect = 1e-47
Identities = 83/286 (29%), Positives = 130/286 (45%), Gaps = 50/286 (17%)
Query: 379 DLDKAGILGDGSYSVCRRCVEKSTGQEYAVKIISRKIDCSE--------EINLLRACQGH 430
D D +LG G++ EK+TG+ YA+KI+ +++ ++ E +L+ + H
Sbjct: 6 DFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTR-H 64
Query: 431 PNIVNLHCVFQDEVHTYLVLELLKGGELLDRIRQKGRCGFTENEASRIMRQLVAAVHFMH 490
P + L FQ V+E GGEL + ++ FTE A ++V+A+ ++H
Sbjct: 65 PFLTALKYAFQTHDRLCFVMEYANGGELFFHLSRE--RVFTEERARFYGAEIVSALEYLH 122
Query: 491 SRGVVHRDLKPENLLFSDPAGDNIKVVDFGFACL---KRESLHTPCFTLQYAAPEVLRQD 547
SR VV+RD+K ENL+ +IK+ DFG ++ T C T +Y APEVL +
Sbjct: 123 SRDVVYRDIKLENLMLDK--DGHIKITDFGLCKEGISDGATMKTFCGTPEYLAPEVLEDN 180
Query: 548 KSGYDENCDLWSLGVILVNVLRQDKSGYDENCDLWSLGVILYTMLCGRVPFHARSRDDSA 607
Y D W LGV++Y M+CGR+PF+ + +
Sbjct: 181 --------------------------DYGRAVDWWGLGVVMYEMMCGRLPFYNQDHER-- 212
Query: 608 LSIMARIKEGQFNFDAEAWSTVSSEAKELTKSLLTVNPAQRIRMMR 653
+ I + F T+S EAK L LL +P QR+
Sbjct: 213 --LFELILMEEIRF----PRTLSPEAKSLLAGLLKKDPKQRLGGGP 252
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 153 bits (388), Expect = 1e-41
Identities = 71/318 (22%), Positives = 129/318 (40%), Gaps = 67/318 (21%)
Query: 117 DLDKAGILGDGSYSVCRRCVEKSTGQEYAVKIISRKIDCSE--------EINLLRACQGH 168
D D +LG G++ EK+TG+ YA+KI+ +++ ++ E +L+ + H
Sbjct: 6 DFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTR-H 64
Query: 169 PNICRRCVEKSTGQEYAV-----------KIISRKIDCSEE------INLLRACQGHPNI 211
P + T +SR+ +EE ++ A + +
Sbjct: 65 PFLTALKYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSR 124
Query: 212 VNLHC--------VFQDEVIDWDDFSRGIECVFFSSSL---------------------- 241
++ + +D I DF E + +++
Sbjct: 125 DVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFCGTPEYLAPEVLEDNDYGR 184
Query: 242 --------IIFFIILSFTLSFIHDYYHIQYRRILKTEPPIPEDLSPDVADFISRLLVKDP 293
++ + ++ L F + + + IL E P LSP+ ++ LL KDP
Sbjct: 185 AVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEIRFPRTLSPEAKSLLAGLLKKDP 244
Query: 294 RRRLGGGELDAEELKRHPFFNVIDWDDLATKRIPAPFVPKISNELDVSNFSDEFTKMIPA 353
++RLGGG DA+E+ H FF I+W D+ K++ PF P++++E+D F DEFT
Sbjct: 245 KQRLGGGPSDAKEVMEHRFFLSINWQDVVQKKLLPPFKPQVTSEVDTRYFDDEFTAQSIT 304
Query: 354 DSPAIVPPNFDKIFKGSL 371
+P P +D + L
Sbjct: 305 ITP---PDRYDSLGLLEL 319
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 58.6 bits (141), Expect = 1e-09
Identities = 27/73 (36%), Positives = 40/73 (54%), Gaps = 4/73 (5%)
Query: 894 HTYLVLELLKGGELLDRIRQKGRCGFTENEASRIMRQLVAAVHFMHSRGVVHRDLKPENL 953
V+E GGEL + ++ FTE A ++V+A+ ++HSR VV+RD+K ENL
Sbjct: 79 RLCFVMEYANGGELFFHLSRE--RVFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENL 136
Query: 954 LLSGISGNLIKIY 966
+L IKI
Sbjct: 137 MLD--KDGHIKIT 147
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Score = 166 bits (422), Expect = 1e-46
Identities = 65/302 (21%), Positives = 100/302 (33%), Gaps = 71/302 (23%)
Query: 385 ILGDGSYSVCRRCVEKSTGQEYAVKIISRKIDCSE----------EINLLRACQGHPNIV 434
LG+G ++ + +K+T Q A+K I EI LL+ HPNI+
Sbjct: 5 FLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELS-HPNII 63
Query: 435 NLHCVFQDEVHTYLVLELLKGGELLDRIRQKGRCGFTENEASRIMRQLVAAVHFMHSRGV 494
L F + + LV + ++ + T + M + + ++H +
Sbjct: 64 GLLDAFGHKSNISLVFDFMETDLEVIIKDNSLV--LTPSHIKAYMLMTLQGLEYLHQHWI 121
Query: 495 VHRDLKPENLLFSDPAGDNIKVVDFGFACLKRESLHTP---CFTLQYAAPEVLRQDKSGY 551
+HRDLKP NLL + +K+ DFG A T Y APE+L +
Sbjct: 122 LHRDLKPNNLLLDEN--GVLKLADFGLAKSFGSPNRAYTHQVVTRWYRAPELLFGAR--- 176
Query: 552 DENCDLWSLGVILVNVLRQDKSGYDENCDLWSLGVILYTMLCGRVPFHARSRDDSALSIM 611
Y D+W++G IL +L S D +
Sbjct: 177 ----------------------MYGVGVDMWAVGCILAELLLRVPFLPGDSDLD----QL 210
Query: 612 ARIKEGQFNFDAEAW------------------------STVSSEAKELTKSLLTVNPAQ 647
RI E E W S + +L + L NP
Sbjct: 211 TRIFETLGTPTEEQWPDMCSLPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCA 270
Query: 648 RI 649
RI
Sbjct: 271 RI 272
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Score = 55.2 bits (132), Expect = 1e-08
Identities = 15/63 (23%), Positives = 27/63 (42%), Gaps = 2/63 (3%)
Query: 894 HTYLVLELLKGGELLDRIRQKGRCGFTENEASRIMRQLVAAVHFMHSRGVVHRDLKPENL 953
+ LV + ++ + T + M + + ++H ++HRDLKP NL
Sbjct: 74 NISLVFDFMETDLEVIIKDNSLV--LTPSHIKAYMLMTLQGLEYLHQHWILHRDLKPNNL 131
Query: 954 LLS 956
LL
Sbjct: 132 LLD 134
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Score = 52.9 bits (126), Expect = 6e-08
Identities = 16/77 (20%), Positives = 28/77 (36%), Gaps = 10/77 (12%)
Query: 243 IFFIILSFTLSFIHDYYHIQYRRILKTEPPIP-----EDLSPDVADFISRLLVKDPRRRL 297
IF + + T D + K+ P IP D+ D I L + +P R
Sbjct: 213 IFETLGTPTEEQWPDMCSLPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCAR- 271
Query: 298 GGGELDAEELKRHPFFN 314
+ A + + +F+
Sbjct: 272 ----ITATQALKMKYFS 284
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Score = 48.7 bits (115), Expect = 2e-06
Identities = 20/99 (20%), Positives = 32/99 (32%), Gaps = 31/99 (31%)
Query: 123 ILGDGSYSVCRRCVEKSTGQEYAVKIISRKIDCSEEINLLRACQGHPNICRRCVEKSTGQ 182
LG+G ++ + +K+T Q A+K I + + R
Sbjct: 5 FLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTAL---------------- 48
Query: 183 EYAVKIISRKIDCSEEINLLRACQGHPNIVNLHCVFQDE 221
EI LL+ HPNI+ L F +
Sbjct: 49 --------------REIKLLQELS-HPNIIGLLDAFGHK 72
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 166 bits (421), Expect = 2e-46
Identities = 50/303 (16%), Positives = 99/303 (32%), Gaps = 44/303 (14%)
Query: 386 LGDGSYSVCRRCVEKSTGQEYAVKIISRKIDCSE---EINLLRACQGHPNIVNLHCVFQD 442
+G GS+ + + G+E A+K+ K + E + + QG I + +
Sbjct: 15 IGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHPQLHIESKIYKMMQGGVGIPTIRWCGAE 74
Query: 443 EVHTYLVLELLKGGELLDRIRQKGRCGFTENEASRIMRQLVAAVHFMHSRGVVHRDLKPE 502
+ +V+ELL + F+ + Q+++ + ++HS+ +HRD+KP+
Sbjct: 75 GDYNVMVMELLGPSLEDLFNFCSRK--FSLKTVLLLADQMISRIEYIHSKNFIHRDVKPD 132
Query: 503 NLLF-SDPAGDNIKVVDFGFACLKRES----------LHTPCFTLQYAAPEVLRQDKSGY 551
N L G+ + ++DFG A R++ T +YA+
Sbjct: 133 NFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASINTHL------ 186
Query: 552 DENCDLWSLGVILVNVLRQDKSGYDENCDLWSLGVILYTMLCGRVPFHARSRDDSALSIM 611
DL SLG +L G +P+
Sbjct: 187 --------------------GIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYE 226
Query: 612 ARIKEGQFNFDAEAWSTVSSEAKELTKSLLTVNPAQRIRMMRVKLTFHAFHQAQKEGFRL 671
++ SE ++ + ++ F + ++GF
Sbjct: 227 RISEKKMSTPIEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFR--NLFHRQGFSY 284
Query: 672 QDV 674
V
Sbjct: 285 DYV 287
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 58.7 bits (141), Expect = 9e-10
Identities = 15/61 (24%), Positives = 31/61 (50%), Gaps = 2/61 (3%)
Query: 894 HTYLVLELLKGGELLDRIRQKGRCGFTENEASRIMRQLVAAVHFMHSRGVVHRDLKPENL 953
+ +V+ELL + F+ + Q+++ + ++HS+ +HRD+KP+N
Sbjct: 77 YNVMVMELLGPSLEDLFNFCSRK--FSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNF 134
Query: 954 L 954
L
Sbjct: 135 L 135
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 52.5 bits (125), Expect = 9e-08
Identities = 29/282 (10%), Positives = 68/282 (24%), Gaps = 87/282 (30%)
Query: 124 LGDGSYSVCRRCVEKSTGQEYAVKIIS---------------RKIDCSEEINLLRACQGH 168
+G GS+ + + G+E A+K+ + + I +R C
Sbjct: 15 IGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHPQLHIESKIYKMMQGGVGIPTIRWCGAE 74
Query: 169 PNICRRCVEKSTGQEYAVKIISRKIDCSEEINLLRACQG-----------------HPNI 211
+ +E + + S + LL A Q P+
Sbjct: 75 GDYNVMVMELLGPSLEDLFNFCSRK-FSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDN 133
Query: 212 VNLHCVFQDEVIDWDDFSRGIECVFFSSSL------------------------------ 241
+ + ++ DF + +
Sbjct: 134 FLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRR 193
Query: 242 -------IIFFIILSFTLSFIHDYYHIQYRRILKTE--------PPIPEDLSPDVADFIS 286
+ +L + + ++ + + + + A +++
Sbjct: 194 DDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIEVLCKGYPSEFATYLN 253
Query: 287 RLLVKDPRRRLGGGELDAEELKRHPFFN-------VIDWDDL 321
+ L +L R+ F V DW+ L
Sbjct: 254 FCRSLRFDDKPDYSYL--RQLFRNLFHRQGFSYDYVFDWNML 293
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 165 bits (419), Expect = 3e-46
Identities = 57/305 (18%), Positives = 103/305 (33%), Gaps = 46/305 (15%)
Query: 386 LGDGSYSVCRRCVEKSTGQEYAVKIISRKIDCSE---EINLLRACQGHPNIVNLHCVFQD 442
+G+GS+ V Q+ A+K R+ D + E + G I N++ Q+
Sbjct: 13 IGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDAPQLRDEYRTYKLLAGCTGIPNVYYFGQE 72
Query: 443 EVHTYLVLELLKGGELLDRIRQKGRCGFTENEASRIMRQLVAAVHFMHSRGVVHRDLKPE 502
+H LV++LL G L D + GR F+ + +Q++A V +H + +V+RD+KP+
Sbjct: 73 GLHNVLVIDLL-GPSLEDLLDLCGRK-FSVKTVAMAAKQMLARVQSIHEKSLVYRDIKPD 130
Query: 503 NLLFSDPA---GDNIKVVDFGFACLKRESL----------HTPCFTLQYAAPEVLRQDKS 549
N L P + I VVDFG R+ + T +Y +
Sbjct: 131 NFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGTARYMSINTHLGR-- 188
Query: 550 GYDENCDLWSLGVILVNVLRQDKSGYDENCDLWSLGVILYTMLCGRVPFHARSRDDSALS 609
DL +LG + L G +P+ +
Sbjct: 189 ------------------------EQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQK 224
Query: 610 IMARIKEGQFNFDAEAWSTVSSEAKELTKSLLTVNPAQRIRMMRVKLTFHAFHQAQKEGF 669
++ Q E + E + + ++ F ++
Sbjct: 225 YERIGEKKQSTPLRELCAGFPEEFYKYMHYARNLAFDATPDYDYLQGLFS--KVLERLNT 282
Query: 670 RLQDV 674
+
Sbjct: 283 TEDEN 287
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 59.4 bits (143), Expect = 5e-10
Identities = 22/65 (33%), Positives = 38/65 (58%), Gaps = 2/65 (3%)
Query: 892 NVHTYLVLELLKGGELLDRIRQKGRCGFTENEASRIMRQLVAAVHFMHSRGVVHRDLKPE 951
+H LV++LL G L D + GR F+ + +Q++A V +H + +V+RD+KP+
Sbjct: 73 GLHNVLVIDLL-GPSLEDLLDLCGRK-FSVKTVAMAAKQMLARVQSIHEKSLVYRDIKPD 130
Query: 952 NLLLS 956
N L+
Sbjct: 131 NFLIG 135
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 56.0 bits (134), Expect = 6e-09
Identities = 23/137 (16%), Positives = 41/137 (29%), Gaps = 17/137 (12%)
Query: 174 RCVEKSTGQEYAVKIISRKIDCSE---EINLLRACQGHPNIVNLHCVFQDEV-------- 222
Q+ A+K R+ D + E + G I N++ Q+ +
Sbjct: 23 EGTNLLNNQQVAIKFEPRRSDAPQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLVIDL 82
Query: 223 --IDWDDFSRGIECVFFSSSLIIFFIILSFTLSFIHD----YYHIQYRRILKTEPPIPED 276
+D F ++ + + + IH+ Y I+ L P
Sbjct: 83 LGPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHEKSLVYRDIKPDNFLIGRPNSKNA 142
Query: 277 LSPDVADFISRLLVKDP 293
V DF +DP
Sbjct: 143 NMIYVVDFGMVKFYRDP 159
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 165 bits (419), Expect = 7e-46
Identities = 70/281 (24%), Positives = 123/281 (43%), Gaps = 40/281 (14%)
Query: 385 ILGDGSYSV---CRRCVEKSTGQEYAVKIISRKIDCSE---------EINLLRACQGHPN 432
+LG G+Y R+ TG+ YA+K++ + + E +L + P
Sbjct: 31 VLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPF 90
Query: 433 IVNLHCVFQDEVHTYLVLELLKGGELLDRIRQKGRCGFTENEASRIMRQLVAAVHFMHSR 492
+V LH FQ E +L+L+ + GGEL + Q R FTE+E + ++V A+ +H
Sbjct: 91 LVTLHYAFQTETKLHLILDYINGGELFTHLSQ--RERFTEHEVQIYVGEIVLALEHLHKL 148
Query: 493 GVVHRDLKPENLLFSDPAGDNIKVVDFGFACLKRESLHTPCFTLQYAAPEVLRQDKSGYD 552
G+++RD+K EN+L ++ + DFG + +
Sbjct: 149 GIIYRDIKLENILLDS--NGHVVLTDFGLSKEFVADETERAY------------------ 188
Query: 553 ENCDLWSLGVILVNVLRQDKSGYDENCDLWSLGVILYTMLCGRVPFHARSRDDSALSIMA 612
++ + +++R SG+D+ D WSLGV++Y +L G PF +S A
Sbjct: 189 --DFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNS----QA 242
Query: 613 RIKEGQFNFDAEAWSTVSSEAKELTKSLLTVNPAQRIRMMR 653
I + +S+ AK+L + LL +P +R+
Sbjct: 243 EISRRILKSEPPYPQEMSALAKDLIQRLLMKDPKKRLGCGP 283
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 129 bits (325), Expect = 2e-33
Identities = 70/292 (23%), Positives = 114/292 (39%), Gaps = 74/292 (25%)
Query: 123 ILGDGSYSV---CRRCVEKSTGQEYAVKIISRKIDCSE---------EINLLRACQGHPN 170
+LG G+Y R+ TG+ YA+K++ + + E +L + P
Sbjct: 31 VLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPF 90
Query: 171 ICR------------RCVEKSTGQEYAVKIISRKIDCSEEI------------------- 199
+ ++ G E + R+ E+
Sbjct: 91 LVTLHYAFQTETKLHLILDYINGGELFTHLSQRERFTEHEVQIYVGEIVLALEHLHKLGI 150
Query: 200 --------NLLRACQGHPNIVNLHCVFQDEVIDWDDFSRGIECVFFSSSL---------- 241
N+L GH + + + + + + + +
Sbjct: 151 IYRDIKLENILLDSNGHVVLTDFGLSKEFVADETERAYDFCGTIEYMAPDIVRGGDSGHD 210
Query: 242 ---------IIFFIILSFTLSFIHDYYHIQ----YRRILKTEPPIPEDLSPDVADFISRL 288
++ + +L+ F D RRILK+EPP P+++S D I RL
Sbjct: 211 KAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRILKSEPPYPQEMSALAKDLIQRL 270
Query: 289 LVKDPRRRLGGGELDAEELKRHPFFNVIDWDDLATKRIPAPFVPKISNELDV 340
L+KDP++RLG G DA+E+K H FF I+WDDLA K++PAPF P I +ELDV
Sbjct: 271 LMKDPKKRLGCGPRDADEIKEHLFFQKINWDDLAAKKVPAPFKPVIRDELDV 322
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 57.2 bits (137), Expect = 3e-09
Identities = 23/64 (35%), Positives = 39/64 (60%), Gaps = 2/64 (3%)
Query: 894 HTYLVLELLKGGELLDRIRQKGRCGFTENEASRIMRQLVAAVHFMHSRGVVHRDLKPENL 953
+L+L+ + GGEL + Q R FTE+E + ++V A+ +H G+++RD+K EN+
Sbjct: 103 KLHLILDYINGGELFTHLSQ--RERFTEHEVQIYVGEIVLALEHLHKLGIIYRDIKLENI 160
Query: 954 LLSG 957
LL
Sbjct: 161 LLDS 164
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Score = 162 bits (411), Expect = 2e-45
Identities = 55/304 (18%), Positives = 111/304 (36%), Gaps = 48/304 (15%)
Query: 372 FFEQYDMDLDK---AGILGDGSYSVCRRCVEKSTGQEYAVKIISRKIDCSE----EINLL 424
+ +++++ + LG G + + AVK + + + E NL+
Sbjct: 4 WEDEWEVPRETLKLVERLGAGQFGEVWMGYYN-GHTKVAVKSLKQGSMSPDAFLAEANLM 62
Query: 425 RACQGHPNIVNLHCVFQDEVHTYLVLELLKGGELLDRIRQKGRCGFTENEASRIMRQLVA 484
+ Q H +V L+ V E Y++ E ++ G L+D ++ T N+ + Q+
Sbjct: 63 KQLQ-HQRLVRLYAVVTQE-PIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAE 120
Query: 485 AVHFMHSRGVVHRDLKPENLLFSDPAGDNIKVVDFGFACLKRES----LHTPCFTLQYAA 540
+ F+ R +HRDL+ N+L SD + K+ DFG A L ++ F +++ A
Sbjct: 121 GMAFIEERNYIHRDLRAANILVSDT--LSCKIADFGLARLIEDNEYTAREGAKFPIKWTA 178
Query: 541 PEVLRQDKSGYDENCDLWSLGVILVNVLRQDKSGYDENCDLWSLGVILYTMLCGRVPFHA 600
PE + + D+WS G++L ++ +
Sbjct: 179 PEAINYGT--------------------------FTIKSDVWSFGILLTEIVTHGRIPY- 211
Query: 601 RSRDDSALSIMARIKEGQFNFDAEAWSTVSSEAKELTKSLLTVNPAQRIRMMRVKLTFHA 660
+ ++ ++ G + E +L + P R ++
Sbjct: 212 --PGMTNPEVIQNLERG---YRMVRPDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLED 266
Query: 661 FHQA 664
F A
Sbjct: 267 FFTA 270
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Score = 71.2 bits (174), Expect = 5e-14
Identities = 16/62 (25%), Positives = 32/62 (51%)
Query: 894 HTYLVLELLKGGELLDRIRQKGRCGFTENEASRIMRQLVAAVHFMHSRGVVHRDLKPENL 953
Y++ E ++ G L+D ++ T N+ + Q+ + F+ R +HRDL+ N+
Sbjct: 81 PIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHRDLRAANI 140
Query: 954 LL 955
L+
Sbjct: 141 LV 142
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Score = 43.9 bits (103), Expect = 5e-05
Identities = 25/271 (9%), Positives = 78/271 (28%), Gaps = 73/271 (26%)
Query: 110 FFEQYDMDLDK---AGILGDGSYSVCRRCVEKSTGQEYAVKIISRKIDCSE----EINLL 162
+ +++++ + LG G + + AVK + + + E NL+
Sbjct: 4 WEDEWEVPRETLKLVERLGAGQFGEVWMGYYN-GHTKVAVKSLKQGSMSPDAFLAEANLM 62
Query: 163 RAC-------------QGHPNICRRCVEKSTGQEYAVKIISRKIDCSEEINLLR-ACQG- 207
+ Q I +E + ++ K+ ++ +++ +G
Sbjct: 63 KQLQHQRLVRLYAVVTQEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGM 122
Query: 208 ---------HPNI----VNLHCVFQDEVIDW----------------------------- 225
H ++ + + ++ D+
Sbjct: 123 AFIEERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAI 182
Query: 226 DDFSRGIECVFFSSSLIIFFIILSFTLSFIHDYYHIQYRRILK-TEPPIPEDLSPDVADF 284
+ + I+ +S +++ I+ + + + + + P++ ++
Sbjct: 183 NYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYRMVRPDNCPEELYQL 242
Query: 285 ISRLLVKDPRRRLGGGELDAEELKR--HPFF 313
+ + P R + L+ FF
Sbjct: 243 MRLCWKERPEDR-----PTFDYLRSVLEDFF 268
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Score = 162 bits (410), Expect = 4e-45
Identities = 65/312 (20%), Positives = 113/312 (36%), Gaps = 50/312 (16%)
Query: 360 PPNFDKIFKGSLFFEQYDMDLDKAGILGDGSYSVCRRCVEKSTGQEYAVKIISRKIDCSE 419
PN+DK + M LG G Y V K AVK + E
Sbjct: 6 SPNYDKW---EMERTDITMK----HKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVE 58
Query: 420 ----EINLLRACQGHPNIVNLHCVFQDEVHTYLVLELLKGGELLDRIRQKGRCGFTENEA 475
E +++ + HPN+V L V E Y++ E + G LLD +R+ R +
Sbjct: 59 EFLKEAAVMKEIK-HPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVL 117
Query: 476 SRIMRQLVAAVHFMHSRGVVHRDLKPENLLFSDPAGDNIKVVDFGFACLKRESLHT---- 531
+ Q+ +A+ ++ + +HRDL N L + +KV DFG + L +T
Sbjct: 118 LYMATQISSAMEYLEKKNFIHRDLAARNCLVGE--NHLVKVADFGLSRLMTGDTYTAHAG 175
Query: 532 PCFTLQYAAPEVLRQDKSGYDENCDLWSLGVILVNVLRQDKSGYDENCDLWSLGVILYTM 591
F +++ APE L +K + D+W+ GV+L+ +
Sbjct: 176 AKFPIKWTAPESLAYNK--------------------------FSIKSDVWAFGVLLWEI 209
Query: 592 LCGRVPFHARSRDDSALSIMARIKEGQFNFDAEAWSTVSSEAKELTKSLLTVNPAQRIRM 651
+ + ++ + ++ E + EL ++ NP+ R
Sbjct: 210 ATYGMSPYPGIDLSQVYELLEK------DYRMERPEGCPEKVYELMRACWQWNPSDRPSF 263
Query: 652 MRVKLTFHAFHQ 663
+ F Q
Sbjct: 264 AEIHQAFETMFQ 275
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Score = 64.0 bits (155), Expect = 1e-11
Identities = 18/72 (25%), Positives = 36/72 (50%), Gaps = 2/72 (2%)
Query: 894 HTYLVLELLKGGELLDRIRQKGRCGFTENEASRIMRQLVAAVHFMHSRGVVHRDLKPENL 953
Y++ E + G LLD +R+ R + + Q+ +A+ ++ + +HRDL N
Sbjct: 87 PFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRDLAARNC 146
Query: 954 LLSGISGNLIKI 965
L+ +L+K+
Sbjct: 147 LVG--ENHLVKV 156
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Score = 49.0 bits (116), Expect = 1e-06
Identities = 32/252 (12%), Positives = 62/252 (24%), Gaps = 66/252 (26%)
Query: 111 FEQYDMDLDKAGI---LGDGSYSVCRRCVEKSTGQEYAVKIISRKIDCSEE--------- 158
+++++M+ + LG G Y V K AVK + EE
Sbjct: 9 YDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMK 68
Query: 159 -------INLLRACQGHPNICRRCVEKSTGQEYAVKIISRKIDCSEEINLLRACQGHPNI 211
+ LL C P + G + + S + L A Q +
Sbjct: 69 EIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAM 128
Query: 212 VNLH-------------------------------------------CVFQDEVIDWDDF 228
L F + +
Sbjct: 129 EYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESL 188
Query: 229 SRGI--ECVFFSSSLIIFFIILSFTLSFIHDYYHIQYRRILKTE--PPIPEDLSPDVADF 284
+ + ++ + I ++ +S Q +L+ + PE V +
Sbjct: 189 AYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMERPEGCPEKVYEL 248
Query: 285 ISRLLVKDPRRR 296
+ +P R
Sbjct: 249 MRACWQWNPSDR 260
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Score = 161 bits (408), Expect = 6e-45
Identities = 55/315 (17%), Positives = 117/315 (37%), Gaps = 57/315 (18%)
Query: 371 LFFEQYDMDLDKAGILGDGSYSVCRRCV--EKSTGQEYAVKIISRKIDCSE-------EI 421
++ ++ + L+ LG G++ ++ K + AVKI+ + + E
Sbjct: 1 VYLDRKLLTLED-KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEA 59
Query: 422 NLLRACQGHPNIVNLHCVFQDEVHTYLVLELLKGGELLDRIRQKGRCGFTENEASRIMRQ 481
N+++ +P IV + + + E LV+E+ + G L ++Q + ++ Q
Sbjct: 60 NVMQQLD-NPYIVRMIGICEAE-SWMLVMEMAELGPLNKYLQQNRH--VKDKNIIELVHQ 115
Query: 482 LVAAVHFMHSRGVVHRDLKPENLLFSDPAGDNIKVVDFGFACLKRE------SLHTPCFT 535
+ + ++ VHRDL N+L K+ DFG + R + +
Sbjct: 116 VSMGMKYLEESNFVHRDLAARNVLLVT--QHYAKISDFGLSKALRADENYYKAQTHGKWP 173
Query: 536 LQYAAPEVLRQDKSGYDENCDLWSLGVILVNVLRQDKSGYDENCDLWSLGVILYTMLC-G 594
+++ APE + K + D+WS GV+++ G
Sbjct: 174 VKWYAPECINYYK--------------------------FSSKSDVWSFGVLMWEAFSYG 207
Query: 595 RVPFHARSRDDSALSIMARIKEGQFNFDAEAWSTVSSEAKELTKSLLTVNPAQRIRMMRV 654
+ P+ + + A +++G+ + E +L T + R V
Sbjct: 208 QKPYRGMKGSE----VTAMLEKGERM---GCPAGCPREMYDLMNLCWTYDVENRPGFAAV 260
Query: 655 KLTF-HAFHQAQKEG 668
+L + ++ EG
Sbjct: 261 ELRLRNYYYDVVNEG 275
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Score = 60.9 bits (147), Expect = 1e-10
Identities = 15/61 (24%), Positives = 28/61 (45%), Gaps = 2/61 (3%)
Query: 896 YLVLELLKGGELLDRIRQKGRCGFTENEASRIMRQLVAAVHFMHSRGVVHRDLKPENLLL 955
LV+E+ + G L ++Q + ++ Q+ + ++ VHRDL N+LL
Sbjct: 83 MLVMEMAELGPLNKYLQQNRH--VKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLL 140
Query: 956 S 956
Sbjct: 141 V 141
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Score = 53.6 bits (128), Expect = 3e-08
Identities = 11/84 (13%), Positives = 29/84 (34%), Gaps = 3/84 (3%)
Query: 237 FSSSLIIFFIILSFTLSFIHDYYHIQYRRILKTE-PPIPEDLSPDVADFISRLLVKDPRR 295
+S ++++ + + K E P ++ D ++ D
Sbjct: 194 WSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGERMGCPAGCPREMYDLMNLCWTYDVEN 253
Query: 296 RLGGGELDAEELKRHPFFNVIDWD 319
R G + E R+ +++V++
Sbjct: 254 RPGFAAV--ELRLRNYYYDVVNEG 275
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Score = 46.3 bits (109), Expect = 7e-06
Identities = 32/246 (13%), Positives = 76/246 (30%), Gaps = 63/246 (25%)
Query: 109 LFFEQYDMDLDKAGILGDGSYSVCRRCV--EKSTGQEYAVKIISRKIDCSEEINLLRACQ 166
++ ++ + L+ LG G++ ++ K + AVKI+ + + + L A
Sbjct: 1 VYLDRKLLTLED-KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLA-- 57
Query: 167 GHPNICRRCVEKSTGQEYAVKIISRKIDCSEEINLLRACQGHPNIVNLHCVFQD------ 220
E N+++ +P IV + + +
Sbjct: 58 -------------------------------EANVMQQLD-NPYIVRMIGICEAESWMLV 85
Query: 221 -EVIDWDD-FSRGIECVFFSSSLIIFFII-LSFTLSFIHDYYHIQYRRILKTEPPIPEDL 277
E+ + + II + +S + ++ + +R + +
Sbjct: 86 MEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLE-ESNFVHRDLAARNVLLVTQH 144
Query: 278 SPDVADF-ISRLLVKDPRRRLGG-------GELDAEELKRHPF--------FNVIDWDDL 321
++DF +S+ L D E + + F F V+ W+
Sbjct: 145 YAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAF 204
Query: 322 ATKRIP 327
+ + P
Sbjct: 205 SYGQKP 210
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Score = 163 bits (413), Expect = 7e-45
Identities = 68/296 (22%), Positives = 114/296 (38%), Gaps = 58/296 (19%)
Query: 385 ILGDGSYSVCRRCVEKSTGQEYAVKIISR-KIDCSEEINLLRACQGHPNIVNLHCVF--- 440
++G+GS+ V + +G+ A+K + + K + E+ ++R H NIV L F
Sbjct: 27 VIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNRELQIMRKLD-HCNIVRLRYFFYSS 85
Query: 441 ---QDEVHTYLVLELLKGGELLD-RIRQKGRCGFTENEASRIMRQLVAAVHFMHSRGVVH 496
+DEV+ LVL+ + R + + M QL ++ ++HS G+ H
Sbjct: 86 GEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGICH 145
Query: 497 RDLKPENLLFSDPAGDNIKVVDFGFACL--KRESLHTPCFTLQYAAPEVLRQDKSGYDEN 554
RD+KP+NLL DP +K+ DFG A + E + + Y APE++
Sbjct: 146 RDIKPQNLLL-DPDTAVLKLCDFGSAKQLVRGEPNVSYICSRYYRAPELIFG-------- 196
Query: 555 CDLWSLGVILVNVLRQDKSGYDENCDLWSLGVILYTMLCGRVPFHARSRDDSALSIMARI 614
+ Y + D+WS G +L +L G+ F S D + I+ +
Sbjct: 197 -----------------ATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVL 239
Query: 615 ---------------------KEGQFNFDAEAWSTVSSEAKELTKSLLTVNPAQRI 649
+ + EA L LL P R+
Sbjct: 240 GTPTREQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARL 295
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Score = 62.1 bits (150), Expect = 1e-10
Identities = 23/126 (18%), Positives = 39/126 (30%), Gaps = 19/126 (15%)
Query: 243 IFFIILSFTLSFIHDYYHIQYRRILKTEPPIP------EDLSPDVADFISRLLVKDPRRR 296
I ++ + T I + P P+ SRLL P R
Sbjct: 235 IIKVLGTPTREQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTAR 294
Query: 297 LGGGELDAEELKRHPFFNVIDWDDLATKRIPAPFVPKISNELDVSNFSDEFTKMIPADSP 356
L E H FF+ + P +P + + NF+ + P +
Sbjct: 295 -----LTPLEACAHSFFDELRD--------PNVKLPNGRDTPALFNFTTQELSSNPPLAT 341
Query: 357 AIVPPN 362
++PP+
Sbjct: 342 ILIPPH 347
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Score = 61.7 bits (149), Expect = 1e-10
Identities = 20/71 (28%), Positives = 33/71 (46%), Gaps = 1/71 (1%)
Query: 887 NRSRYNVHTYLVLELLKGGELLD-RIRQKGRCGFTENEASRIMRQLVAAVHFMHSRGVVH 945
+ V+ LVL+ + R + + M QL ++ ++HS G+ H
Sbjct: 86 GEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGICH 145
Query: 946 RDLKPENLLLS 956
RD+KP+NLLL
Sbjct: 146 RDIKPQNLLLD 156
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Score = 51.3 bits (122), Expect = 3e-07
Identities = 14/52 (26%), Positives = 28/52 (53%), Gaps = 2/52 (3%)
Query: 123 ILGDGSYSVCRRCVEKSTGQEYAVKIISR-KIDCSEEINLLRACQGHPNICR 173
++G+GS+ V + +G+ A+K + + K + E+ ++R H NI R
Sbjct: 27 VIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNRELQIMRKLD-HCNIVR 77
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Score = 47.9 bits (113), Expect = 3e-06
Identities = 13/64 (20%), Positives = 26/64 (40%), Gaps = 2/64 (3%)
Query: 174 RCVEKSTGQEYAVKIISR-KIDCSEEINLLRACQGHPNIVNLHCVFQDEVIDWDDFSRGI 232
+ +G+ A+K + + K + E+ ++R H NIV L F D+ +
Sbjct: 38 QAKLCDSGELVAIKKVLQDKRFKNRELQIMRKLD-HCNIVRLRYFFYSSGEKKDEVYLNL 96
Query: 233 ECVF 236
+
Sbjct: 97 VLDY 100
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Score = 162 bits (410), Expect = 1e-44
Identities = 63/301 (20%), Positives = 115/301 (38%), Gaps = 67/301 (22%)
Query: 385 ILGDGSYSVCRRCVEKSTGQEYAVKIIS--RKIDCSEEINLLRACQGHPNIVNLHCVFQD 442
LG G YS + + ++ VKI+ +K EI +L +G PNI+ L + +D
Sbjct: 42 KLGRGKYSEVFEAINITNNEKVVVKILKPVKKKKIKREIKILENLRGGPNIITLADIVKD 101
Query: 443 EVHT--YLVLELLKGGELLDRIRQKGRCGFTENEASRIMRQLVAAVHFMHSRGVVHRDLK 500
V LV E + + + T+ + M +++ A+ + HS G++HRD+K
Sbjct: 102 PVSRTPALVFEHVNNTDFKQLYQT-----LTDYDIRFYMYEILKALDYCHSMGIMHRDVK 156
Query: 501 PENLLFSDPAGDNIKVVDFGFACLKR--ESLHTPCFTLQYAAPEVLRQDKSGYDENCDLW 558
P N++ D ++++D+G A + + + + PE+
Sbjct: 157 PHNVMI-DHEHRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPEL--------------- 200
Query: 559 SLGVILVNVLRQDKSGYDENCDLWSLGVILYTMLCGRVPFHARSRDDSALSIMARIKEGQ 618
D YD + D+WSLG +L +M+ + PF + L +A++ +
Sbjct: 201 ----------LVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTE 250
Query: 619 FNFD------------------------------AEAWSTVSSEAKELTKSLLTVNPAQR 648
+D +E VS EA + LL + R
Sbjct: 251 DLYDYIDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSR 310
Query: 649 I 649
+
Sbjct: 311 L 311
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Score = 58.7 bits (141), Expect = 1e-09
Identities = 16/78 (20%), Positives = 35/78 (44%), Gaps = 5/78 (6%)
Query: 886 VNRSRYNVHTYLVLELLKGGELLDRIRQKGRCGFTENEASRIMRQLVAAVHFMHSRGVVH 945
+ + + LV E + + + T+ + M +++ A+ + HS G++H
Sbjct: 98 IVKDPVSRTPALVFEHVNNTDFKQLYQT-----LTDYDIRFYMYEILKALDYCHSMGIMH 152
Query: 946 RDLKPENLLLSGISGNLI 963
RD+KP N+++ L
Sbjct: 153 RDVKPHNVMIDHEHRKLR 170
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Score = 55.2 bits (132), Expect = 1e-08
Identities = 15/50 (30%), Positives = 22/50 (44%), Gaps = 5/50 (10%)
Query: 270 EPPIPEDLSPDVADFISRLLVKDPRRRLGGGELDAEELKRHPFFNVIDWD 319
+SP+ DF+ +LL D + RL A E HP+F + D
Sbjct: 284 HSENQHLVSPEALDFLDKLLRYDHQSRLT-----AREAMEHPYFYTVVKD 328
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Score = 52.5 bits (125), Expect = 1e-07
Identities = 16/53 (30%), Positives = 24/53 (45%), Gaps = 2/53 (3%)
Query: 123 ILGDGSYSVCRRCVEKSTGQEYAVKIIS--RKIDCSEEINLLRACQGHPNICR 173
LG G YS + + ++ VKI+ +K EI +L +G PNI
Sbjct: 42 KLGRGKYSEVFEAINITNNEKVVVKILKPVKKKKIKREIKILENLRGGPNIIT 94
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Score = 50.6 bits (120), Expect = 4e-07
Identities = 14/51 (27%), Positives = 25/51 (49%), Gaps = 2/51 (3%)
Query: 174 RCVEKSTGQEYAVKIIS--RKIDCSEEINLLRACQGHPNIVNLHCVFQDEV 222
+ + ++ VKI+ +K EI +L +G PNI+ L + +D V
Sbjct: 53 EAINITNNEKVVVKILKPVKKKKIKREIKILENLRGGPNIITLADIVKDPV 103
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 160 bits (406), Expect = 3e-44
Identities = 58/305 (19%), Positives = 100/305 (32%), Gaps = 72/305 (23%)
Query: 385 ILGDGSYSVCRRCVEKSTGQ-----EYAVKIISRKIDCSE------EINLLRACQGHPNI 433
+LG G++ + + AVK++ K D SE E+ ++ H NI
Sbjct: 44 VLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENI 103
Query: 434 VNLHCVFQDEVHTYLVLELLKGGELLDRIRQKGR---------------------CGFTE 472
VNL YL+ E G+LL+ +R K T
Sbjct: 104 VNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTF 163
Query: 473 NEASRIMRQLVAAVHFMHSRGVVHRDLKPENLLFSDPAGDNIKVVDFGFACLKRES---- 528
+ Q+ + F+ + VHRDL N+L + G +K+ DFG A
Sbjct: 164 EDLLCFAYQVAKGMEFLEFKSCVHRDLAARNVLVTH--GKVVKICDFGLARDIMSDSNYV 221
Query: 529 -LHTPCFTLQYAAPEVLRQDKSGYDENCDLWSLGVILVNVLRQDKSGYDENCDLWSLGVI 587
+++ APE L + Y D+WS G++
Sbjct: 222 VRGNARLPVKWMAPESLFEGI--------------------------YTIKSDVWSYGIL 255
Query: 588 LYTML-CGRVPFHARSRDDSALSIMARIKEGQFNFDAEAWSTVSSEAKELTKSLLTVNPA 646
L+ + G P+ D + ++ F + + E + +S +
Sbjct: 256 LWEIFSLGVNPYPGIPVDANFYKLIQN------GFKMDQPFYATEEIYIIMQSCWAFDSR 309
Query: 647 QRIRM 651
+R
Sbjct: 310 KRPSF 314
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 65.6 bits (159), Expect = 6e-12
Identities = 18/84 (21%), Positives = 30/84 (35%), Gaps = 21/84 (25%)
Query: 894 HTYLVLELLKGGELLDRIRQKGR---------------------CGFTENEASRIMRQLV 932
YL+ E G+LL+ +R K T + Q+
Sbjct: 115 PIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVA 174
Query: 933 AAVHFMHSRGVVHRDLKPENLLLS 956
+ F+ + VHRDL N+L++
Sbjct: 175 KGMEFLEFKSCVHRDLAARNVLVT 198
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 45.2 bits (106), Expect = 2e-05
Identities = 43/276 (15%), Positives = 89/276 (32%), Gaps = 42/276 (15%)
Query: 123 ILGDGSYSVCRRCVEKSTGQ-----EYAVKIISRKIDCSE------EINLLRACQGHPNI 171
+LG G++ + + AVK++ K D SE E+ ++ H NI
Sbjct: 44 VLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENI 103
Query: 172 CR-RCVEKSTGQEYAVKIISRKIDCSEEINLLRACQGHPNIVNLHCVFQDEVIDWDDFSR 230
+G Y +I + +N LR+ + + + Q + + +D +
Sbjct: 104 VNLLGACTLSGPIY---LIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLN- 159
Query: 231 GIECVFFSSSLIIFFIILSFTLSFIHDYYHIQYRRILKTEPPIPEDLSPDVADF-ISRLL 289
V L+ F ++ + F+ +R + + + DF ++R +
Sbjct: 160 ----VLTFEDLLCFAYQVAKGMEFLEF-KSCVHRDLAARNVLVTHGKVVKICDFGLARDI 214
Query: 290 VKDPRRRLGG------GELDAEELKRHPF--------FNVIDWDDLATKRIPAPFVPKIS 335
+ D + G + E L + + ++ W+ + P P +P
Sbjct: 215 MSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGIP--- 271
Query: 336 NELDVSNFSDEFTKMIPADSPAIVPPNFDKIFKGSL 371
+NF D P I +
Sbjct: 272 ---VDANFYKLIQNGFKMDQPFYATEEIYIIMQSCW 304
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 41.3 bits (96), Expect = 4e-04
Identities = 8/82 (9%), Positives = 26/82 (31%), Gaps = 7/82 (8%)
Query: 231 GIECVFFSSSLIIFFIILSFTLSFIHDYYHIQYRRILK--TEPPIPEDLSPDVADFISRL 288
I+ +S ++++ I + + ++++ + P + ++ +
Sbjct: 244 TIKSDVWSYGILLWEIFSLGVNPYPGIPVDANFYKLIQNGFKMDQPFYATEEIYIIMQSC 303
Query: 289 LVKDPRRRLGGGELDAEELKRH 310
D R+R L
Sbjct: 304 WAFDSRKR-----PSFPNLTSF 320
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Score = 159 bits (402), Expect = 5e-44
Identities = 58/299 (19%), Positives = 112/299 (37%), Gaps = 54/299 (18%)
Query: 371 LFFEQYDMDLDKAGILGDGSYSVCRRCVEKST--GQEYAVKIISRKIDCSE------EIN 422
LF ++ ++ + + G G++ R+ V + + A+K++ + + ++ E
Sbjct: 3 LFLKRDNLLIADIEL-GCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQ 61
Query: 423 LLRACQGHPNIVNLHCVFQDEVHTYLVLELLKGGELLDRIRQKGRCGFTENEASRIMRQL 482
++ +P IV L V Q E LV+E+ GG L + K R + + ++ Q+
Sbjct: 62 IMHQLD-NPYIVRLIGVCQAE-ALMLVMEMAGGGPLHKFLVGK-REEIPVSNVAELLHQV 118
Query: 483 VAAVHFMHSRGVVHRDLKPENLLFSDPAGDNIKVVDFGFACL------KRESLHTPCFTL 536
+ ++ + VHRDL N+L + K+ DFG + + + L
Sbjct: 119 SMGMKYLEEKNFVHRDLAARNVLLVN--RHYAKISDFGLSKALGADDSYYTARSAGKWPL 176
Query: 537 QYAAPEVLRQDKSGYDENCDLWSLGVILVNVLRQDKSGYDENCDLWSLGVILYTML-CGR 595
++ APE + K + D+WS GV ++ L G+
Sbjct: 177 KWYAPECINFRK--------------------------FSSRSDVWSYGVTMWEALSYGQ 210
Query: 596 VPFHARSRDDSALSIMARIKEGQFNFDAEAWSTVSSEAKELTKSLLTVNPAQRIRMMRV 654
P+ + +MA I++G+ E E L R + V
Sbjct: 211 KPYKKMKGPE----VMAFIEQGKR---MECPPECPPELYALMSDCWIYKWEDRPDFLTV 262
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Score = 69.0 bits (168), Expect = 3e-13
Identities = 17/64 (26%), Positives = 30/64 (46%), Gaps = 1/64 (1%)
Query: 894 HTYLVLELLKGGELLDRIRQKGRCGFTENEASRIMRQLVAAVHFMHSRGVVHRDLKPENL 953
LV+E+ GG L + K R + + ++ Q+ + ++ + VHRDL N+
Sbjct: 82 ALMLVMEMAGGGPLHKFLVGK-REEIPVSNVAELLHQVSMGMKYLEEKNFVHRDLAARNV 140
Query: 954 LLSG 957
LL
Sbjct: 141 LLVN 144
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Score = 47.8 bits (113), Expect = 3e-06
Identities = 27/197 (13%), Positives = 65/197 (32%), Gaps = 50/197 (25%)
Query: 109 LFFEQYDMDLDKAGILGDGSYSVCRRCVEKST--GQEYAVKIISRKIDCSEEINLLRACQ 166
LF ++ ++ + + G G++ R+ V + + A+K++ + + ++ ++R
Sbjct: 3 LFLKRDNLLIADIEL-GCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMR--- 58
Query: 167 GHPNICRRCVEKSTGQEYAVKIISRKIDCSEEINLLRACQGHPNIVNLHCVFQDEVI--- 223
E ++ +P IV L V Q E +
Sbjct: 59 -------------------------------EAQIMHQLD-NPYIVRLIGVCQAEALMLV 86
Query: 224 -------DWDDFSRGIECVFFSSSLIIFFIILSFTLSFIHDYYHIQYRRILKTEPPIPED 276
F G S++ +S + ++ + +R + +
Sbjct: 87 MEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLE-EKNFVHRDLAARNVLLVNR 145
Query: 277 LSPDVADF-ISRLLVKD 292
++DF +S+ L D
Sbjct: 146 HYAKISDFGLSKALGAD 162
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Score = 42.8 bits (100), Expect = 1e-04
Identities = 8/82 (9%), Positives = 27/82 (32%), Gaps = 3/82 (3%)
Query: 237 FSSSLIIFFIILSFTLSFIHDYYHIQYRRILKTE-PPIPEDLSPDVADFISRLLVKDPRR 295
+S + ++ + + I + + P + P++ +S +
Sbjct: 196 WSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQGKRMECPPECPPELYALMSDCWIYKWED 255
Query: 296 RLGGGELDAEELKRHPFFNVID 317
R + E+ R ++++
Sbjct: 256 RPDFLTV--EQRMRACYYSLAS 275
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Score = 160 bits (405), Expect = 1e-43
Identities = 87/318 (27%), Positives = 139/318 (43%), Gaps = 51/318 (16%)
Query: 344 SDEFTKMIPADSPAIVPPNFDKIFKGSLFFEQYDMDLDKAGILGDGSYSVCRRCVEKSTG 403
E K A + ++ + + +Q+D + LG GS+ K +G
Sbjct: 11 EQESVKEFLAKAKEDFLKKWETPSQNTAQLDQFD----RIKTLGTGSFGRVMLVKHKESG 66
Query: 404 QEYAVKIISRKIDCSE--------EINLLRACQGHPNIVNLHCVFQDEVHTYLVLELLKG 455
YA+KI+ ++ E +L+A P +V L F+D + Y+V+E + G
Sbjct: 67 NHYAMKILDKQKVVKLKQIEHTLNEKRILQAVN-FPFLVKLEFSFKDNSNLYMVMEYVAG 125
Query: 456 GELLDRIRQKGRCGFTENEASRIMRQLVAAVHFMHSRGVVHRDLKPENLLFSDPAGDNIK 515
GE+ +R+ GR F+E A Q+V ++HS +++RDLKPENLL I+
Sbjct: 126 GEMFSHLRRIGR--FSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQ--QGYIQ 181
Query: 516 VVDFGFACLKRESLHTPCFTLQYAAPEVLRQDKSGYDENCDLWSLGVILVNVLRQDKSGY 575
V DFGFA + T C T + APE++ GY
Sbjct: 182 VTDFGFAKRVKGRTWTLCGTPEALAPEIILSK--------------------------GY 215
Query: 576 DENCDLWSLGVILYTMLCGRVPFHARSRDDSALSIMARIKEGQFNFDAEAWSTVSSEAKE 635
++ D W+LGV++Y M G PF A I +I G+ F S SS+ K+
Sbjct: 216 NKAVDWWALGVLIYEMAAGYPPFFADQPIQ----IYEKIVSGKVRF----PSHFSSDLKD 267
Query: 636 LTKSLLTVNPAQRIRMMR 653
L ++LL V+ +R ++
Sbjct: 268 LLRNLLQVDLTKRFGNLK 285
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Score = 129 bits (326), Expect = 2e-33
Identities = 55/307 (17%), Positives = 99/307 (32%), Gaps = 65/307 (21%)
Query: 123 ILGDGSYSVCRRCVEKSTGQEYAVKIISRKIDCSE--------EINLLRACQGHPNICR- 173
LG GS+ K +G YA+KI+ ++ E +L+A P + +
Sbjct: 48 TLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVN-FPFLVKL 106
Query: 174 ----------RCVEKSTGQEYAVKIISRKIDCSEEI------------------------ 199
V + + R SE
Sbjct: 107 EFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRD 166
Query: 200 ----NLLRACQGHPNIVNL----HCVFQDEVIDWDDFSRGIECVF---------FSSSLI 242
NLL QG+ + + + + + E + + + +
Sbjct: 167 LKPENLLIDQQGYIQVTDFGFAKRVKGRTWTLCGTPEALAPEIILSKGYNKAVDWWALGV 226
Query: 243 IFFIILSFTLSFIHDYYHIQYRRILKTEPPIPEDLSPDVADFISRLLVKDPRRRLGGGEL 302
+ + + + F D Y +I+ + P S D+ D + LL D +R G +
Sbjct: 227 LIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHFSSDLKDLLRNLLQVDLTKRFGNLKN 286
Query: 303 DAEELKRHPFFNVIDWDDLATKRIPAPFVPKISNELDVSNFSDEFTKMIPADSPAIVPPN 362
++K H +F DW + +++ APF+PK D SNF D++ + S
Sbjct: 287 GVNDIKNHKWFATTDWIAIYQRKVEAPFIPKFKGPGDTSNF-DDYEEEEIRVSI---NEK 342
Query: 363 FDKIFKG 369
K F
Sbjct: 343 CGKEFTE 349
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Score = 63.3 bits (153), Expect = 4e-11
Identities = 28/87 (32%), Positives = 48/87 (55%), Gaps = 2/87 (2%)
Query: 870 EEQLLGPITRARRRTFVNRSRYNVHTYLVLELLKGGELLDRIRQKGRCGFTENEASRIMR 929
E+++L + + N + Y+V+E + GGE+ +R+ GR F+E A
Sbjct: 91 EKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGR--FSEPHARFYAA 148
Query: 930 QLVAAVHFMHSRGVVHRDLKPENLLLS 956
Q+V ++HS +++RDLKPENLL+
Sbjct: 149 QIVLTFEYLHSLDLIYRDLKPENLLID 175
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 154 bits (391), Expect = 7e-43
Identities = 54/282 (19%), Positives = 109/282 (38%), Gaps = 47/282 (16%)
Query: 379 DLDKAGILGDGSYSVCRRCVEKSTGQEYAVKIISR----KIDCSEEINLLRACQGHPNIV 434
DL LG G + V + + + A+K+I + + EE ++ H +V
Sbjct: 5 DLTFLKELGTGQFGVVKYGKWR-GQYDVAIKMIKEGSMSEDEFIEEAKVMMNLS-HEKLV 62
Query: 435 NLHCVFQDEVHTYLVLELLKGGELLDRIRQKGRCGFTENEASRIMRQLVAAVHFMHSRGV 494
L+ V + +++ E + G LL+ +R+ R F + + + + A+ ++ S+
Sbjct: 63 QLYGVCTKQRPIFIITEYMANGCLLNYLREM-RHRFQTQQLLEMCKDVCEAMEYLESKQF 121
Query: 495 VHRDLKPENLLFSDPAGDNIKVVDFGFACLKRESLHT----PCFTLQYAAPEVLRQDKSG 550
+HRDL N L +D +KV DFG + + +T F ++++ PEVL K
Sbjct: 122 LHRDLAARNCLVNDQ--GVVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLMYSK-- 177
Query: 551 YDENCDLWSLGVILVNVLRQDKSGYDENCDLWSLGVILYTML-CGRVPFHARSRDDSALS 609
+ D+W+ GV+++ + G++P+ + +
Sbjct: 178 ------------------------FSSKSDIWAFGVLMWEIYSLGKMPYERFTNSE---- 209
Query: 610 IMARIKEGQFNFDAEAWSTVSSEAKELTKSLLTVNPAQRIRM 651
I +G + S + + S +R
Sbjct: 210 TAEHIAQGLRLYR---PHLASEKVYTIMYSCWHEKADERPTF 248
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 57.0 bits (137), Expect = 2e-09
Identities = 15/64 (23%), Positives = 33/64 (51%), Gaps = 1/64 (1%)
Query: 894 HTYLVLELLKGGELLDRIRQKGRCGFTENEASRIMRQLVAAVHFMHSRGVVHRDLKPENL 953
+++ E + G LL+ +R+ R F + + + + A+ ++ S+ +HRDL N
Sbjct: 73 PIFIITEYMANGCLLNYLREM-RHRFQTQQLLEMCKDVCEAMEYLESKQFLHRDLAARNC 131
Query: 954 LLSG 957
L++
Sbjct: 132 LVND 135
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 44.7 bits (105), Expect = 2e-05
Identities = 20/140 (14%), Positives = 48/140 (34%), Gaps = 18/140 (12%)
Query: 176 VEKSTGQEYAVKIISR----KIDCSEEINLLRACQGHPNIVNLHCVFQDEVI-------- 223
+ + A+K+I + + EE ++ H +V L+ V +
Sbjct: 23 GKWRGQYDVAIKMIKEGSMSEDEFIEEAKVMMNLS-HEKLVQLYGVCTKQRPIFIITEYM 81
Query: 224 ---DWDDFSRGIECVFFSSSLIIFFIILSFTLSFIHDYYHIQYRRILKTEPPIPEDLSPD 280
++ R + F + L+ + + ++ +R + + +
Sbjct: 82 ANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLE-SKQFLHRDLAARNCLVNDQGVVK 140
Query: 281 VADF-ISRLLVKDPRRRLGG 299
V+DF +SR ++ D G
Sbjct: 141 VSDFGLSRYVLDDEYTSSVG 160
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 39.3 bits (91), Expect = 0.001
Identities = 7/79 (8%), Positives = 21/79 (26%), Gaps = 6/79 (7%)
Query: 233 ECVFFSSSLIIFFIILSFTLSFIHDYYHIQYRRILKT-EPPIPEDLSPDVADFISRLLVK 291
+ ++ ++++ I + + I + P S V + +
Sbjct: 181 KSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQGLRLYRPHLASEKVYTIMYSCWHE 240
Query: 292 DPRRRLGGGELDAEELKRH 310
R + L +
Sbjct: 241 KADER-----PTFKILLSN 254
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Score = 155 bits (391), Expect = 3e-42
Identities = 64/314 (20%), Positives = 110/314 (35%), Gaps = 84/314 (26%)
Query: 386 LGDGSYSVCRRCVEKSTGQEYAVKIISRK-------IDCSEEINLLRACQGHPNIVNLHC 438
+G G++ + + TGQ+ A+K + + I EI +L+ + H N+VNL
Sbjct: 18 IGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLK-HENVVNLIE 76
Query: 439 VFQD--------EVHTYLVLELLKGGELLDRIRQKGRCGFTENEASRIMRQLVAAVHFMH 490
+ + + YLV + + + FT +E R+M+ L+ ++++H
Sbjct: 77 ICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVK--FTLSEIKRVMQMLLNGLYYIH 134
Query: 491 SRGVVHRDLKPENLLFSDPAGDNIKVVDFGFA-------CLKRESLHTPCFTLQYAAPEV 543
++HRD+K N+L + +K+ DFG A + TL Y PE+
Sbjct: 135 RNKILHRDMKAANVLITR--DGVLKLADFGLARAFSLAKNSQPNRYTNRVVTLWYRPPEL 192
Query: 544 LRQDKSGYDENCDLWSLGVILVNVLRQDKSGYDENCDLWSLGVILYTMLCGRVPFHARSR 603
L ++ Y DLW G I+ M +
Sbjct: 193 LLGER-------------------------DYGPPIDLWGAGCIMAEMWTRSPIMQGNTE 227
Query: 604 DDSALSIMARIKEGQFNFDAEAWSTV----------------------------SSEAKE 635
+A I + + E W V A +
Sbjct: 228 QH----QLALISQLCGSITPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALD 283
Query: 636 LTKSLLTVNPAQRI 649
L LL ++PAQRI
Sbjct: 284 LIDKLLVLDPAQRI 297
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Score = 60.3 bits (145), Expect = 4e-10
Identities = 18/76 (23%), Positives = 38/76 (50%), Gaps = 4/76 (5%)
Query: 890 RYNVHTYLVLELLKGGELLDRIRQKGRCGFTENEASRIMRQLVAAVHFMHSRGVVHRDLK 949
R YLV + + + FT +E R+M+ L+ ++++H ++HRD+K
Sbjct: 87 RCKGSIYLVFDFCEHDLAGLLSNVLVK--FTLSEIKRVMQMLLNGLYYIHRNKILHRDMK 144
Query: 950 PENLLLSGISGNLIKI 965
N+L++ ++K+
Sbjct: 145 AANVLIT--RDGVLKL 158
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Score = 46.8 bits (110), Expect = 6e-06
Identities = 32/184 (17%), Positives = 60/184 (32%), Gaps = 52/184 (28%)
Query: 124 LGDGSYSVCRRCVEKSTGQEYAVKIISRKIDCSEEINLLRACQGHPNICRRCVEKSTGQE 183
+G G++ + + TGQ+ A+K + + +G P R
Sbjct: 18 IGQGTFGEVFKARHRKTGQKVALKKVLME----------NEKEGFPITALR--------- 58
Query: 184 YAVKIISRKIDCSEEINLLRACQGHPNIVNLHCVFQDEVIDWDDFSRGIECVF------- 236
EI +L+ + H N+VNL + + + ++ I VF
Sbjct: 59 --------------EIKILQLLK-HENVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDL 103
Query: 237 ----------FSSSLIIFFIILSFTLSFIHDYYHIQYRRILKTEPPIPEDLSPDVADF-I 285
F+ S I + + + I +R + I D +ADF +
Sbjct: 104 AGLLSNVLVKFTLSEIKRVMQMLLNGLYYIHRNKILHRDMKAANVLITRDGVLKLADFGL 163
Query: 286 SRLL 289
+R
Sbjct: 164 ARAF 167
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Score = 46.4 bits (109), Expect = 1e-05
Identities = 17/77 (22%), Positives = 31/77 (40%), Gaps = 11/77 (14%)
Query: 243 IFFIILSFTLSFIHDYYHIQYRRILKTEPPIPED------LSPDVADFISRLLVKDPRRR 296
+ I + +Y + ++K + +D P D I +LLV DP +R
Sbjct: 237 LCGSITPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQR 296
Query: 297 LGGGELDAEELKRHPFF 313
+D+++ H FF
Sbjct: 297 -----IDSDDALNHDFF 308
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 155 bits (393), Expect = 3e-42
Identities = 67/305 (21%), Positives = 115/305 (37%), Gaps = 72/305 (23%)
Query: 385 ILGDGSYSVCRRCVEKSTGQEYAVKIISRKIDCSE------EINLLRACQGHPNIVNLHC 438
+G+G+Y + + A+K IS + EI +L + H NI+ ++
Sbjct: 15 YIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFR-HENIIGIND 73
Query: 439 VFQDE-----VHTYLVLELLKGGELLDRIRQKGRCGFTENEASRIMRQLVAAVHFMHSRG 493
+ + YLV L+ G +L ++ + + + + Q++ + ++HS
Sbjct: 74 IIRAPTIEQMKDVYLVTHLM-GADLYKLLKTQH---LSNDHICYFLYQILRGLKYIHSAN 129
Query: 494 VVHRDLKPENLLFSDPAGDNIKVVDFGFACL------KRESLHTPCFTLQYAAPEVLRQD 547
V+HRDLKP NLL + ++K+ DFG A + L T Y APE++
Sbjct: 130 VLHRDLKPSNLLLNT--TCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLN- 186
Query: 548 KSGYDENCDLWSLGVILVNVLRQDKSGYDENCDLWSLGVILYTMLCGRVPFHARSRDDSA 607
GY ++ D+WS+G IL ML R F + D
Sbjct: 187 ------------------------SKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQL 222
Query: 608 LSIMA--------------RIKEGQFNFD---------AEAWSTVSSEAKELTKSLLTVN 644
I+ +K + + S+A +L +LT N
Sbjct: 223 NHILGILGSPSQEDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFN 282
Query: 645 PAQRI 649
P +RI
Sbjct: 283 PHKRI 287
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 58.7 bits (141), Expect = 1e-09
Identities = 22/76 (28%), Positives = 39/76 (51%), Gaps = 6/76 (7%)
Query: 890 RYNVHTYLVLELLKGGELLDRIRQKGRCGFTENEASRIMRQLVAAVHFMHSRGVVHRDLK 949
YLV L+ G +L ++ + + + + Q++ + ++HS V+HRDLK
Sbjct: 81 EQMKDVYLVTHLM-GADLYKLLKTQH---LSNDHICYFLYQILRGLKYIHSANVLHRDLK 136
Query: 950 PENLLLSGISGNLIKI 965
P NLLL+ + +KI
Sbjct: 137 PSNLLLN--TTCDLKI 150
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 49.4 bits (117), Expect = 1e-06
Identities = 25/187 (13%), Positives = 56/187 (29%), Gaps = 50/187 (26%)
Query: 123 ILGDGSYSVCRRCVEKSTGQEYAVKIISRKIDCSEEINLLRACQGHPNICRRCVEKSTGQ 182
+G+G+Y + + A+K IS + LR
Sbjct: 15 YIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLR------------------- 55
Query: 183 EYAVKIISRKIDCSEEINLLRACQGHPNIVNLHCVFQD-------------EVIDWDDFS 229
EI +L + H NI+ ++ + + ++ D +
Sbjct: 56 ---------------EIKILLRFR-HENIIGINDIIRAPTIEQMKDVYLVTHLMGADLYK 99
Query: 230 RGIECVFFSSSLIIFFIILSFTLSFIHDYYHIQYRRILKTEPPIPEDLSPDVADF-ISRL 288
+ + F + L +IH ++ +R + + + + DF ++R+
Sbjct: 100 LLKTQHLSNDHICYFLYQILRGLKYIHS-ANVLHRDLKPSNLLLNTTCDLKICDFGLARV 158
Query: 289 LVKDPRR 295
D
Sbjct: 159 ADPDHDH 165
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 47.9 bits (113), Expect = 3e-06
Identities = 16/129 (12%), Positives = 37/129 (28%), Gaps = 8/129 (6%)
Query: 211 IVNLHCVFQDEVIDWDDFSRGIECVFFSSSLIIFFIILSFTLSFIHDYYHIQYRRILKTE 270
+ + + + + + + +Y +
Sbjct: 201 CILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLKARNYLLSLPHKNKVPW 260
Query: 271 PPIPEDLSPDVADFISRLLVKDPRRRLGGGELDAEELKRHPFFNVIDWDDLATKRIPAPF 330
+ + D + ++L +P +R ++ E+ HP+ +D APF
Sbjct: 261 NRLFPNADSKALDLLDKMLTFNPHKR-----IEVEQALAHPYLEQ-YYDPSDEPIAEAPF 314
Query: 331 VPKISNELD 339
K ELD
Sbjct: 315 --KFDMELD 321
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 153 bits (388), Expect = 4e-42
Identities = 48/287 (16%), Positives = 97/287 (33%), Gaps = 45/287 (15%)
Query: 386 LGDGSYSVCRRCVEKSTGQEYAVKIISRKIDCSE----EINLLRACQGHPNIVNLHCVFQ 441
LG G + T A+K + E E +++ + H +V L+ V
Sbjct: 25 LGQGCFGEVWMGTWNGT-TRVAIKTLKPGTMSPEAFLQEAQVMKKLR-HEKLVQLYAVVS 82
Query: 442 DEVHTYLVLELLKGGELLDRIRQKGRCGFTENEASRIMRQLVAAVHFMHSRGVVHRDLKP 501
+E Y+V E + G LLD ++ + + + Q+ + + ++ VHRDL+
Sbjct: 83 EE-PIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRA 141
Query: 502 ENLLFSDPAGDNIKVVDFGFACLKRES----LHTPCFTLQYAAPEVLRQDKSGYDENCDL 557
N+L + KV DFG A L ++ F +++ APE +
Sbjct: 142 ANILVGE--NLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGR--------- 190
Query: 558 WSLGVILVNVLRQDKSGYDENCDLWSLGVILYTMLCGRVPFHARSRDDSALSIMARIKEG 617
+ D+WS G++L + + ++ +++ G
Sbjct: 191 -----------------FTIKSDVWSFGILLTELTTKGRVPYP---GMVNREVLDQVERG 230
Query: 618 QFNFDAEAWSTVSSEAKELTKSLLTVNPAQRIRMMRVKLTFHAFHQA 664
+ +L P +R ++ + +
Sbjct: 231 ---YRMPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTS 274
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 61.3 bits (148), Expect = 1e-10
Identities = 16/70 (22%), Positives = 33/70 (47%), Gaps = 2/70 (2%)
Query: 896 YLVLELLKGGELLDRIRQKGRCGFTENEASRIMRQLVAAVHFMHSRGVVHRDLKPENLLL 955
Y+V E + G LLD ++ + + + Q+ + + ++ VHRDL+ N+L+
Sbjct: 87 YIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILV 146
Query: 956 SGISGNLIKI 965
+ K+
Sbjct: 147 G--ENLVCKV 154
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 42.8 bits (100), Expect = 1e-04
Identities = 10/81 (12%), Positives = 27/81 (33%), Gaps = 8/81 (9%)
Query: 237 FSSSLIIFFIILSFTLSFIHDYYHIQYRRILK-TEPPIPEDLSPDVADFISRLLVKDPRR 295
+S +++ + + + ++ + P P + + D + + K+P
Sbjct: 198 WSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPPECPESLHDLMCQCWRKEPEE 257
Query: 296 RLGGGELDAEELKR--HPFFN 314
R E L+ +F
Sbjct: 258 R-----PTFEYLQAFLEDYFT 273
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 40.5 bits (94), Expect = 7e-04
Identities = 23/135 (17%), Positives = 51/135 (37%), Gaps = 18/135 (13%)
Query: 181 GQEYAVKIISRKIDCSE----EINLLRACQGHPNIVNLHCVFQDEVI----------DWD 226
A+K + E E +++ + H +V L+ V +E I
Sbjct: 41 TTRVAIKTLKPGTMSPEAFLQEAQVMKKLR-HEKLVQLYAVVSEEPIYIVTEYMSKGSLL 99
Query: 227 DFSRGIECVFFSSSLIIFFII-LSFTLSFIHDYYHIQYRRILKTEPPIPEDLSPDVADF- 284
DF +G + ++ ++ ++++ + +R + + E+L VADF
Sbjct: 100 DFLKGETGKYLRLPQLVDMAAQIASGMAYVE-RMNYVHRDLRAANILVGENLVCKVADFG 158
Query: 285 ISRLLVKDPRRRLGG 299
++RL+ + G
Sbjct: 159 LARLIEDNEYTARQG 173
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 154 bits (389), Expect = 4e-42
Identities = 53/308 (17%), Positives = 106/308 (34%), Gaps = 60/308 (19%)
Query: 385 ILGDGSYSVCRRCVEKSTGQEYAVKIISRKIDCSE--------EINLLRACQGHPNIVNL 436
++G+G++ + K G I K S+ E+ +L HPNI+NL
Sbjct: 17 VIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINL 76
Query: 437 HCVFQDEVHTYLVLELLKGGELLDRIRQKGRC--------------GFTENEASRIMRQL 482
+ + YL +E G LLD +R+ + + +
Sbjct: 77 LGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADV 136
Query: 483 VAAVHFMHSRGVVHRDLKPENLLFSDPAGDNIKVVDFGFA--CLKRESLHTPCFTLQYAA 540
+ ++ + +HRDL N+L + K+ DFG + +++ A
Sbjct: 137 ARGMDYLSQKQFIHRDLAARNILVGE--NYVAKIADFGLSRGQEVYVKKTMGRLPVRWMA 194
Query: 541 PEVLRQDKSGYDENCDLWSLGVILVNVLRQDKSGYDENCDLWSLGVILYTML-CGRVPFH 599
E L Y N D+WS GV+L+ ++ G P+
Sbjct: 195 IESLNYSV--------------------------YTTNSDVWSYGVLLWEIVSLGGTPYC 228
Query: 600 ARSRDDSALSIMARIKEGQFNFDAEAWSTVSSEAKELTKSLLTVNPAQRIRMMRVKLTFH 659
+ + + ++ +G + E E +L + P +R ++ ++ +
Sbjct: 229 GMTCAE----LYEKLPQG---YRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLN 281
Query: 660 AFHQAQKE 667
+ +K
Sbjct: 282 RMLEERKT 289
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 58.3 bits (140), Expect = 1e-09
Identities = 16/86 (18%), Positives = 31/86 (36%), Gaps = 16/86 (18%)
Query: 894 HTYLVLELLKGGELLDRIRQKGRC--------------GFTENEASRIMRQLVAAVHFMH 939
+ YL +E G LLD +R+ + + + + ++
Sbjct: 85 YLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLS 144
Query: 940 SRGVVHRDLKPENLLLSGISGNLIKI 965
+ +HRDL N+L+ + KI
Sbjct: 145 QKQFIHRDLAARNILVG--ENYVAKI 168
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 45.2 bits (106), Expect = 2e-05
Identities = 13/59 (22%), Positives = 22/59 (37%), Gaps = 8/59 (13%)
Query: 123 ILGDGSYSVCRRCVEKSTGQEYAVKIISRKIDCSE--------EINLLRACQGHPNICR 173
++G+G++ + K G I K S+ E+ +L HPNI
Sbjct: 17 VIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIIN 75
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 38.6 bits (89), Expect = 0.002
Identities = 8/61 (13%), Positives = 23/61 (37%), Gaps = 1/61 (1%)
Query: 237 FSSSLIIFFIILSFTLSFIHDYYHIQYRRILKTE-PPIPEDLSPDVADFISRLLVKDPRR 295
+S ++++ I+ + Y ++ + P + +V D + + + P
Sbjct: 210 WSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQGYRLEKPLNCDDEVYDLMRQCWREKPYE 269
Query: 296 R 296
R
Sbjct: 270 R 270
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Score = 153 bits (386), Expect = 5e-42
Identities = 71/301 (23%), Positives = 111/301 (36%), Gaps = 70/301 (23%)
Query: 386 LGDGSYSVCRRCVEKSTGQEYAVKIISRKIDCSE-------EINLLRACQGHPNIVNLHC 438
+G+G+Y V + + + G+ +A+K I + + EI++L+ + H NIV L+
Sbjct: 10 IGEGTYGVVYKA-QNNYGETFALKKIRLEKEDEGIPSTTIREISILKELK-HSNIVKLYD 67
Query: 439 VFQDEVHTYLVLELLKGGELLDRIRQKGRCGFTENEASRIMRQLVAAVHFMHSRGVVHRD 498
V + LV E L +G G A + QL+ + + H R V+HRD
Sbjct: 68 VIHTKKRLVLVFEHLDQDLKKLLDVCEG--GLESVTAKSFLLQLLNGIAYCHDRRVLHRD 125
Query: 499 LKPENLLFSDPAGDNIKVVDFGFACL---KRESLHTPCFTLQYAAPEVLRQDKSGYDENC 555
LKP+NLL + +K+ DFG A TL Y AP+VL K
Sbjct: 126 LKPQNLLINR--EGELKIADFGLARAFGIPVRKYTHEIVTLWYRAPDVLMGSK------- 176
Query: 556 DLWSLGVILVNVLRQDKSGYDENCDLWSLGVILYTMLCGRVPFHARSRDDSALSIMARIK 615
Y D+WS+G I M+ G F S D + RI
Sbjct: 177 ------------------KYSTTIDIWSVGCIFAEMVNGTPLFPGVSEAD----QLMRIF 214
Query: 616 EGQFNFDAEAW-------------------------STVSSEAKELTKSLLTVNPAQRIR 650
+++ W + +L +L ++P QRI
Sbjct: 215 RILGTPNSKNWPNVTELPKYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRIT 274
Query: 651 M 651
Sbjct: 275 A 275
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Score = 53.4 bits (127), Expect = 4e-08
Identities = 21/63 (33%), Positives = 30/63 (47%), Gaps = 2/63 (3%)
Query: 894 HTYLVLELLKGGELLDRIRQKGRCGFTENEASRIMRQLVAAVHFMHSRGVVHRDLKPENL 953
LV E L +G G A + QL+ + + H R V+HRDLKP+NL
Sbjct: 74 RLVLVFEHLDQDLKKLLDVCEG--GLESVTAKSFLLQLLNGIAYCHDRRVLHRDLKPQNL 131
Query: 954 LLS 956
L++
Sbjct: 132 LIN 134
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Score = 47.2 bits (111), Expect = 5e-06
Identities = 16/77 (20%), Positives = 31/77 (40%), Gaps = 11/77 (14%)
Query: 243 IFFIILSFTLSFIHDYYHI-QYRRILKTEPPIP-----EDLSPDVADFISRLLVKDPRRR 296
IF I+ + + + +Y P+P + L D +S++L DP +R
Sbjct: 213 IFRILGTPNSKNWPNVTELPKYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQR 272
Query: 297 LGGGELDAEELKRHPFF 313
+ A++ H +F
Sbjct: 273 -----ITAKQALEHAYF 284
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Score = 40.6 bits (94), Expect = 6e-04
Identities = 14/57 (24%), Positives = 30/57 (52%), Gaps = 9/57 (15%)
Query: 124 LGDGSYSVCRRCVEKSTGQEYAVKIISRKIDCSE-------EINLLRACQGHPNICR 173
+G+G+Y V + + + G+ +A+K I + + EI++L+ + H NI +
Sbjct: 10 IGEGTYGVVYKA-QNNYGETFALKKIRLEKEDEGIPSTTIREISILKELK-HSNIVK 64
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Score = 39.9 bits (92), Expect = 0.001
Identities = 15/94 (15%), Positives = 31/94 (32%), Gaps = 14/94 (14%)
Query: 176 VEKSTGQEYAVKIISRKIDCSE-------EINLLRACQGHPNIVNLHCVFQDEVIDWDDF 228
+ + G+ +A+K I + + EI++L+ + H NIV L+ V
Sbjct: 21 AQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELK-HSNIVKLYDVI------HTKK 73
Query: 229 SRGIECVFFSSSLIIFFIILSFTLSFIHDYYHIQ 262
+ L + L + +
Sbjct: 74 RLVLVFEHLDQDLKKLLDVCEGGLESVTAKSFLL 107
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Score = 151 bits (383), Expect = 1e-41
Identities = 54/284 (19%), Positives = 98/284 (34%), Gaps = 45/284 (15%)
Query: 379 DLDKAGILGDGSYSVCRRCVEKSTGQEYAVKIISRKIDCSE----EINLLRACQGHPNIV 434
+L +G G + + + A+K I E E ++ HP +V
Sbjct: 6 ELTFVQEIGSGQFGLVHLGYWL-NKDKVAIKTIREGAMSEEDFIEEAEVMMKLS-HPKLV 63
Query: 435 NLHCVFQDEVHTYLVLELLKGGELLDRIRQKGRCGFTENEASRIMRQLVAAVHFMHSRGV 494
L+ V ++ LV E ++ G L D +R + R F + + + ++ V
Sbjct: 64 QLYGVCLEQAPICLVFEFMEHGCLSDYLRTQ-RGLFAAETLLGMCLDVCEGMAYLEEACV 122
Query: 495 VHRDLKPENLLFSDPAGDNIKVVDFGFACLKRESLHTP----CFTLQYAAPEVLRQDKSG 550
+HRDL N L + IKV DFG + +T F +++A+PEV +
Sbjct: 123 IHRDLAARNCLVGE--NQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFSFSR-- 178
Query: 551 YDENCDLWSLGVILVNVLRQDKSGYDENCDLWSLGVILYTMLCGRVPFHARSRDDSALSI 610
Y D+WS GV+++ + + + S +
Sbjct: 179 ------------------------YSSKSDVWSFGVLMWEVFSEGKIPY---ENRSNSEV 211
Query: 611 MARIKEGQFNFDAEAWSTVSSEAKELTKSLLTVNPAQRIRMMRV 654
+ I G + S+ ++ P R R+
Sbjct: 212 VEDISTGFRLYK---PRLASTHVYQIMNHCWKERPEDRPAFSRL 252
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Score = 55.5 bits (133), Expect = 8e-09
Identities = 18/72 (25%), Positives = 31/72 (43%), Gaps = 3/72 (4%)
Query: 894 HTYLVLELLKGGELLDRIRQKGRCGFTENEASRIMRQLVAAVHFMHSRGVVHRDLKPENL 953
LV E ++ G L D +R + R F + + + ++ V+HRDL N
Sbjct: 74 PICLVFEFMEHGCLSDYLRTQ-RGLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNC 132
Query: 954 LLSGISGNLIKI 965
L+ +IK+
Sbjct: 133 LVG--ENQVIKV 142
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Score = 44.7 bits (105), Expect = 2e-05
Identities = 34/257 (13%), Positives = 66/257 (25%), Gaps = 70/257 (27%)
Query: 117 DLDKAGILGDGSYSVCRRCVEKSTGQEYAVKIISRKIDCSEE----------------IN 160
+L +G G + + + A+K I E+ +
Sbjct: 6 ELTFVQEIGSGQFGLVHLGYWL-NKDKVAIKTIREGAMSEEDFIEEAEVMMKLSHPKLVQ 64
Query: 161 LLRACQGHPNICRRCVEKSTGQEYAVKIISRKIDCSEEINL---LRACQG---------- 207
L C IC E + + +++ + E L L C+G
Sbjct: 65 LYGVCLEQAPICL-VFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACVI 123
Query: 208 HPNIVNLHCVFQDE----VIDW-------DDFSRGIECVFFS------------------ 238
H ++ +C+ + V D+ DD F
Sbjct: 124 HRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFSFSRYSSKS 183
Query: 239 ---SSLIIFFIILSFTLSFIHDYYHIQYRRILKT--EPPIPEDLSPDVADFISRLLVKDP 293
S ++ + + S + + + + T P S V ++ + P
Sbjct: 184 DVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGFRLYKPRLASTHVYQIMNHCWKERP 243
Query: 294 RRRLGGGELDAEELKRH 310
R L R
Sbjct: 244 EDR-----PAFSRLLRQ 255
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 152 bits (385), Expect = 1e-41
Identities = 79/299 (26%), Positives = 109/299 (36%), Gaps = 68/299 (22%)
Query: 386 LGDGSYSVCRRCVEKSTGQEYAVKIISRKIDCSE-------EINLLRACQGHPNIVNLHC 438
+G+G+Y V + K TG+ A+K I + EI+LL+ HPNIV L
Sbjct: 10 IGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN-HPNIVKLLD 68
Query: 439 VFQDEVHTYLVLELLKGGELLDRIRQKGRCGFTENEASRIMRQLVAAVHFMHSRGVVHRD 498
V E YLV E L +L + G + QL+ + F HS V+HRD
Sbjct: 69 VIHTENKLYLVFEFL-HQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRD 127
Query: 499 LKPENLLFSDPAGDNIKVVDFGFACL---KRESLHTPCFTLQYAAPEVLRQDKSGYDENC 555
LKP+NLL + IK+ DFG A + TL Y APE+L K
Sbjct: 128 LKPQNLLINTE--GAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCK------- 178
Query: 556 DLWSLGVILVNVLRQDKSGYDENCDLWSLGVILYTMLCGRVPFHARSRDDSALSIMARIK 615
Y D+WSLG I M+ R F DS + + RI
Sbjct: 179 ------------------YYSTAVDIWSLGCIFAEMVTRRALFPG----DSEIDQLFRIF 216
Query: 616 EGQFNFDAEAW-------------------------STVSSEAKELTKSLLTVNPAQRI 649
D W + + + L +L +P +RI
Sbjct: 217 RTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRI 275
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 59.9 bits (144), Expect = 4e-10
Identities = 47/284 (16%), Positives = 78/284 (27%), Gaps = 99/284 (34%)
Query: 124 LGDGSYSVCRRCVEKSTGQEYAVKIISRKIDCSE-------EINLLRACQGHPNICR-RC 175
+G+G+Y V + K TG+ A+K I + EI+LL+ HPNI +
Sbjct: 10 IGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN-HPNIVKLLD 68
Query: 176 VEKSTGQEYAV-------------KIISRKIDCSEEINL----LRACQGHPNIVNLHCVF 218
V + + Y V I + L+ + LH
Sbjct: 69 VIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDL 128
Query: 219 QDEVIDWDDFSRGIECVFFSSSL------------------------------------- 241
+ + + + F +
Sbjct: 129 KPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCKYYSTAVDIWS 188
Query: 242 --IIFFIILSFTLSFIHDYYHIQYRRILKTEPPIPEDLSP-------------------- 279
IF +++ F D Q RI +T E + P
Sbjct: 189 LGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDF 248
Query: 280 ---------DVADFISRLLVKDPRRRLGGGELDAEELKRHPFFN 314
D +S++L DP +R+ A+ HPFF
Sbjct: 249 SKVVPPLDEDGRSLLSQMLHYDPNKRIS-----AKAALAHPFFQ 287
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 51.4 bits (122), Expect = 2e-07
Identities = 22/63 (34%), Positives = 31/63 (49%), Gaps = 1/63 (1%)
Query: 894 HTYLVLELLKGGELLDRIRQKGRCGFTENEASRIMRQLVAAVHFMHSRGVVHRDLKPENL 953
YLV E L +L + G + QL+ + F HS V+HRDLKP+NL
Sbjct: 75 KLYLVFEFL-HQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNL 133
Query: 954 LLS 956
L++
Sbjct: 134 LIN 136
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Score = 152 bits (384), Expect = 2e-41
Identities = 70/300 (23%), Positives = 107/300 (35%), Gaps = 61/300 (20%)
Query: 386 LGDGSYSVCRRCVE-KSTGQEYAVKIISRK-------IDCSEEINLLRACQG--HPNIVN 435
+G+G+Y + + K+ G+ A+K + + + E+ +LR + HPN+V
Sbjct: 15 IGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVR 74
Query: 436 LHCVFQD-----EVHTYLVLELLKGGELLDRIRQKGRCGFTENEASRIMRQLVAAVHFMH 490
L V E LV E + + + G +M QL+ + F+H
Sbjct: 75 LFDVCTVSRTDRETKLTLVFEHVDQDLT-TYLDKVPEPGVPTETIKDMMFQLLRGLDFLH 133
Query: 491 SRGVVHRDLKPENLLFSDPAGDNIKVVDFGFACLKRESLHTPCFTLQYAAPEVLRQDKSG 550
S VVHRDLKP+N+L + + + +L + TL Y APEVL Q
Sbjct: 134 SHRVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMALTSVVVTLWYRAPEVLLQ---- 189
Query: 551 YDENCDLWSLGVILVNVLRQDKSGYDENCDLWSLGVILYTMLCGRVPFHARSRDDSALSI 610
S Y DLWS+G I M + F S D I
Sbjct: 190 ----------------------SSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKI 227
Query: 611 MARI-------------------KEGQFNFDAEAWSTVSSEAKELTKSLLTVNPAQRIRM 651
+ I + + + K+L LT NPA+RI
Sbjct: 228 LDVIGLPGEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISA 287
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Score = 63.4 bits (153), Expect = 2e-11
Identities = 23/80 (28%), Positives = 37/80 (46%), Gaps = 1/80 (1%)
Query: 877 ITRARRRTFVNRSRYNVHTYLVLELLKGGELLDRIRQKGRCGFTENEASRIMRQLVAAVH 936
+ R V+R+ LV E + + + G +M QL+ +
Sbjct: 72 VVRLFDVCTVSRTDRETKLTLVFEHVDQDLT-TYLDKVPEPGVPTETIKDMMFQLLRGLD 130
Query: 937 FMHSRGVVHRDLKPENLLLS 956
F+HS VVHRDLKP+N+L++
Sbjct: 131 FLHSHRVVHRDLKPQNILVT 150
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Score = 49.5 bits (117), Expect = 9e-07
Identities = 9/59 (15%), Positives = 21/59 (35%), Gaps = 5/59 (8%)
Query: 260 HIQYRRILKTEPPIPEDLSPDVADFISRLLVKDPRRRLGGGELDAEELKRHPFFNVIDW 318
+ + + D+ D + + L +P +R + A HP+F ++
Sbjct: 248 QAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKR-----ISAYSALSHPYFQDLER 301
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Score = 40.2 bits (93), Expect = 9e-04
Identities = 14/60 (23%), Positives = 29/60 (48%), Gaps = 10/60 (16%)
Query: 124 LGDGSYSVCRRCVE-KSTGQEYAVKIISRK-------IDCSEEINLLRACQG--HPNICR 173
+G+G+Y + + K+ G+ A+K + + + E+ +LR + HPN+ R
Sbjct: 15 IGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVR 74
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Score = 39.5 bits (91), Expect = 0.001
Identities = 14/60 (23%), Positives = 25/60 (41%), Gaps = 9/60 (15%)
Query: 178 KSTGQEYAVKIISRK-------IDCSEEINLLRACQG--HPNIVNLHCVFQDEVIDWDDF 228
K+ G+ A+K + + + E+ +LR + HPN+V L V D +
Sbjct: 30 KNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDRETK 89
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Score = 151 bits (382), Expect = 2e-41
Identities = 68/299 (22%), Positives = 102/299 (34%), Gaps = 68/299 (22%)
Query: 386 LGDGSYSVCRRCVEKSTGQEYAVKIISRKIDCSE-------EINLLRACQGHPNIVNLHC 438
+G+G+Y + + T + A+K + D EI LL+ + H NIV LH
Sbjct: 10 IGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELK-HKNIVRLHD 68
Query: 439 VFQDEVHTYLVLELLKGGELLDRIRQKGRCGFTENEASRIMRQLVAAVHFMHSRGVVHRD 498
V + LV E G + QL+ + F HSR V+HRD
Sbjct: 69 VLHSDKKLTLVFEFCDQDLKKYFDSCNGDL--DPEIVKSFLFQLLKGLGFCHSRNVLHRD 126
Query: 499 LKPENLLFSDPAGDNIKVVDFGFACL---KRESLHTPCFTLQYAAPEVLRQDKSGYDENC 555
LKP+NLL + +K+ +FG A TL Y P+VL K
Sbjct: 127 LKPQNLLINR--NGELKLANFGLARAFGIPVRCYSAEVVTLWYRPPDVLFGAKL------ 178
Query: 556 DLWSLGVILVNVLRQDKSGYDENCDLWSLGVILYTMLCGRVPFHARSRDDSALSIMARIK 615
Y + D+WS G I + P + + RI
Sbjct: 179 -------------------YSTSIDMWSAGCIFAELANAGRPLFP---GNDVDDQLKRIF 216
Query: 616 EGQFNFDAEAWST-------------------------VSSEAKELTKSLLTVNPAQRI 649
E W + +++ ++L ++LL NP QRI
Sbjct: 217 RLLGTPTEEQWPSMTKLPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRI 275
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Score = 51.5 bits (122), Expect = 2e-07
Identities = 20/65 (30%), Positives = 28/65 (43%), Gaps = 2/65 (3%)
Query: 892 NVHTYLVLELLKGGELLDRIRQKGRCGFTENEASRIMRQLVAAVHFMHSRGVVHRDLKPE 951
+ LV E G + QL+ + F HSR V+HRDLKP+
Sbjct: 73 DKKLTLVFEFCDQDLKKYFDSCNGDL--DPEIVKSFLFQLLKGLGFCHSRNVLHRDLKPQ 130
Query: 952 NLLLS 956
NLL++
Sbjct: 131 NLLIN 135
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Score = 50.3 bits (119), Expect = 5e-07
Identities = 14/64 (21%), Positives = 28/64 (43%), Gaps = 5/64 (7%)
Query: 251 TLSFIHDYYHIQYRRILKTEPPIPEDLSPDVADFISRLLVKDPRRRLGGGELDAEELKRH 310
+++ + DY + + L+ D + LL +P +R+ AEE +H
Sbjct: 229 SMTKLPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRIS-----AEEALQH 283
Query: 311 PFFN 314
P+F+
Sbjct: 284 PYFS 287
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Score = 47.6 bits (112), Expect = 3e-06
Identities = 15/57 (26%), Positives = 25/57 (43%), Gaps = 8/57 (14%)
Query: 124 LGDGSYSVCRRCVEKSTGQEYAVKIISRKIDCSE-------EINLLRACQGHPNICR 173
+G+G+Y + + T + A+K + D EI LL+ + H NI R
Sbjct: 10 IGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELK-HKNIVR 65
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Score = 44.9 bits (105), Expect = 3e-05
Identities = 27/142 (19%), Positives = 44/142 (30%), Gaps = 19/142 (13%)
Query: 173 RRCVEKSTGQEYAVKIISRKIDCSE-------EINLLRACQGHPNIVNLHCVFQDEV--- 222
+ + T + A+K + D EI LL+ + H NIV LH V +
Sbjct: 19 FKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELK-HKNIVRLHDVLHSDKKLT 77
Query: 223 -------IDWDDFSRGIECVFFSSSLIIFFIILSFTLSFIHDYYHIQYRRILKTEPPIPE 275
D + + F L L F H ++ +R + I
Sbjct: 78 LVFEFCDQDLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCH-SRNVLHRDLKPQNLLINR 136
Query: 276 DLSPDVADFISRLLVKDPRRRL 297
+ +A+F P R
Sbjct: 137 NGELKLANFGLARAFGIPVRCY 158
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Score = 153 bits (387), Expect = 2e-41
Identities = 68/277 (24%), Positives = 124/277 (44%), Gaps = 22/277 (7%)
Query: 386 LGDGSYSVCRRCVEKSTGQEYAVKIISRKIDCSE-------EINLLRACQGHPNIVNLHC 438
+G G+Y V+ TG + A+K + R E+ LL+ + H N++ L
Sbjct: 26 VGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMR-HENVIGLLD 84
Query: 439 VFQDE------VHTYLVLELLKGGELLDRIRQKGRCGFTENEASRIMRQLVAAVHFMHSR 492
VF + YLV+ + G L ++ + + E+ ++ Q++ + ++H+
Sbjct: 85 VFTPDETLDDFTDFYLVMPFM--GTDLGKLMKHEK--LGEDRIQFLVYQMLKGLRYIHAA 140
Query: 493 GVVHRDLKPENLLFSDPAGDNIKVVDFGFACLKRESLHTPCFTLQYAAPEVLRQDKSGYD 552
G++HRDLKP NL ++ +K++DFG A + T Y APEV+ Y
Sbjct: 141 GIIHRDLKPGNLAVNE--DCELKILDFGLARQADSEMTGYVVTRWYRAPEVILNWM-RYT 197
Query: 553 ENCDLWSLGVILVNVLRQDKSGYDENCDLWSLGVILYTMLCGRVPFHARSRDDSALSIMA 612
+ D+WS+G I+ ++ K+ + + L L I+ F R + D A + M
Sbjct: 198 QTVDIWSVGCIMAEMITG-KTLFKGSDHLDQLKEIMKVTGTPPAEFVQRLQSDEAKNYMK 256
Query: 613 RIKEGQFNFDAEAWSTVSSEAKELTKSLLTVNPAQRI 649
+ E + A + S A L + +L ++ QR+
Sbjct: 257 GLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRV 293
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Score = 56.0 bits (134), Expect = 1e-08
Identities = 17/63 (26%), Positives = 36/63 (57%), Gaps = 4/63 (6%)
Query: 894 HTYLVLELLKGGELLDRIRQKGRCGFTENEASRIMRQLVAAVHFMHSRGVVHRDLKPENL 953
YLV+ + G L ++ + + E+ ++ Q++ + ++H+ G++HRDLKP NL
Sbjct: 97 DFYLVMPFM--GTDLGKLMKHEK--LGEDRIQFLVYQMLKGLRYIHAAGIIHRDLKPGNL 152
Query: 954 LLS 956
++
Sbjct: 153 AVN 155
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Score = 53.7 bits (128), Expect = 6e-08
Identities = 22/118 (18%), Positives = 44/118 (37%), Gaps = 20/118 (16%)
Query: 243 IFFIILSFTLSFIHDYYHIQYRRILKTEP--------PIPEDLSPDVADFISRLLVKDPR 294
I + + F+ + + +K P I + SP + + ++LV D
Sbjct: 231 IMKVTGTPPAEFVQRLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAE 290
Query: 295 RRLGGGELDAEELKRHPFFNVIDWDDLATKRIPAPFVPKISNELDVSNFS-DEFTKMI 351
+R + A E HP+F + + P V K + D + + DE+ ++
Sbjct: 291 QR-----VTAGEALAHPYFESLHDTE------DEPQVQKYDDSFDDVDRTLDEWKRVT 337
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Score = 48.3 bits (114), Expect = 3e-06
Identities = 14/57 (24%), Positives = 24/57 (42%), Gaps = 8/57 (14%)
Query: 124 LGDGSYSVCRRCVEKSTGQEYAVKIISRKIDCSE-------EINLLRACQGHPNICR 173
+G G+Y V+ TG + A+K + R E+ LL+ + H N+
Sbjct: 26 VGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMR-HENVIG 81
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Score = 46.4 bits (109), Expect = 1e-05
Identities = 14/55 (25%), Positives = 24/55 (43%), Gaps = 8/55 (14%)
Query: 174 RCVEKSTGQEYAVKIISRKIDCSE-------EINLLRACQGHPNIVNLHCVFQDE 221
V+ TG + A+K + R E+ LL+ + H N++ L VF +
Sbjct: 36 SAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMR-HENVIGLLDVFTPD 89
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Score = 151 bits (382), Expect = 3e-41
Identities = 51/302 (16%), Positives = 109/302 (36%), Gaps = 56/302 (18%)
Query: 372 FFEQYDMDLDKAG-ILGDGSYSVCRRCVEKSTGQEY---AVKIISRKIDCSE------EI 421
F ++ D+ K ++G G + K G+ A+K + + E
Sbjct: 19 FAKEIDISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEA 78
Query: 422 NLLRACQGHPNIVNLHCVFQDEVHTYLVLELLKGGELLDRIRQKGRCGFTENEASRIMRQ 481
+++ HPN+++L V ++ E ++ G L D ++ FT + ++R
Sbjct: 79 SIMGQFD-HPNVIHLEGVVTKSTPVMIITEFMENGSL-DSFLRQNDGQFTVIQLVGMLRG 136
Query: 482 LVAAVHFMHSRGVVHRDLKPENLLFSDPAGDNIKVVDFGFACLKRESLHTP--------C 533
+ A + ++ VHRDL N+L + KV DFG + + P
Sbjct: 137 IAAGMKYLADMNYVHRDLAARNILVNS--NLVCKVSDFGLSRFLEDDTSDPTYTSALGGK 194
Query: 534 FTLQYAAPEVLRQDKSGYDENCDLWSLGVILVNVLRQDKSGYDENCDLWSLGVILYTML- 592
+++ APE ++ K + D+WS G++++ ++
Sbjct: 195 IPIRWTAPEAIQYRK--------------------------FTSASDVWSYGIVMWEVMS 228
Query: 593 CGRVPFHARSRDDSALSIMARIKEGQFNFDAEAWSTVSSEAKELTKSLLTVNPAQRIRMM 652
G P+ + D ++ I++ + S +L + R +
Sbjct: 229 YGERPYWDMTNQD----VINAIEQD---YRLPPPMDCPSALHQLMLDCWQKDRNHRPKFG 281
Query: 653 RV 654
++
Sbjct: 282 QI 283
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Score = 60.9 bits (147), Expect = 2e-10
Identities = 17/72 (23%), Positives = 35/72 (48%), Gaps = 3/72 (4%)
Query: 894 HTYLVLELLKGGELLDRIRQKGRCGFTENEASRIMRQLVAAVHFMHSRGVVHRDLKPENL 953
++ E ++ G L D ++ FT + ++R + A + ++ VHRDL N+
Sbjct: 101 PVMIITEFMENGSL-DSFLRQNDGQFTVIQLVGMLRGIAAGMKYLADMNYVHRDLAARNI 159
Query: 954 LLSGISGNLIKI 965
L++ S + K+
Sbjct: 160 LVN--SNLVCKV 169
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Score = 44.0 bits (103), Expect = 5e-05
Identities = 30/199 (15%), Positives = 61/199 (30%), Gaps = 52/199 (26%)
Query: 110 FFEQYDMDLDKAG-ILGDGSYSVCRRCVEKSTGQEY---AVKIISRKIDCSEEINLLRAC 165
F ++ D+ K ++G G + K G+ A+K + + + L
Sbjct: 19 FAKEIDISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLS-- 76
Query: 166 QGHPNICRRCVEKSTGQEYAVKIISRKIDCSEEINLLRACQGHPNIVNLHCVFQDEVI-- 223
E +++ HPN+++L V
Sbjct: 77 --------------------------------EASIMGQFD-HPNVIHLEGVVTKSTPVM 103
Query: 224 ---------DWDDFSRGIECVFFSSSLIIFFIILSFTLSFIHDYYHIQYRRILKTEPPIP 274
D F R + F L+ ++ + ++ + +R + +
Sbjct: 104 IITEFMENGSLDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLA-DMNYVHRDLAARNILVN 162
Query: 275 EDLSPDVADF-ISRLLVKD 292
+L V+DF +SR L D
Sbjct: 163 SNLVCKVSDFGLSRFLEDD 181
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Score = 39.7 bits (92), Expect = 0.001
Identities = 11/78 (14%), Positives = 28/78 (35%), Gaps = 3/78 (3%)
Query: 237 FSSSLIIFFIILSFTLSFIHDYYHIQYRRILKTE-PPIPEDLSPDVADFISRLLVKDPRR 295
+S ++++ ++ + I + P P D + + KD
Sbjct: 217 WSYGIVMWEVMSYGERPYWDMTNQDVINAIEQDYRLPPPMDCPSALHQLMLDCWQKDRNH 276
Query: 296 RLGGGEL--DAEELKRHP 311
R G++ +++ R+P
Sbjct: 277 RPKFGQIVNTLDKMIRNP 294
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 149 bits (378), Expect = 5e-41
Identities = 61/295 (20%), Positives = 100/295 (33%), Gaps = 55/295 (18%)
Query: 379 DLDKAGILGDGSYSVCRRCVEKST---GQEYAVKIISRKIDCSE--------EINLLRAC 427
DL LGDGS+ V RR + AVK + + E+N + +
Sbjct: 9 DLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSL 68
Query: 428 QGHPNIVNLHCVFQDEVHTYLVLELLKGGELLDRIRQKGRCGFTENEASRIMRQLVAAVH 487
H N++ L+ V +V EL G LLDR+R+ F SR Q+ +
Sbjct: 69 D-HRNLIRLYGVVLTP-PMKMVTELAPLGSLLDRLRKHQG-HFLLGTLSRYAVQVAEGMG 125
Query: 488 FMHSRGVVHRDLKPENLLFSDPAGDNIKVVDFGFACLKRESLHTPCF------TLQYAAP 541
++ S+ +HRDL NLL + D +K+ DFG ++ + AP
Sbjct: 126 YLESKRFIHRDLAARNLLLATR--DLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAP 183
Query: 542 EVLRQDKSGYDENCDLWSLGVILVNVLRQDKSGYDENCDLWSLGVILYTMLC-GRVPFHA 600
E L+ + D W GV L+ M G+ P+
Sbjct: 184 ESLKTRT--------------------------FSHASDTWMFGVTLWEMFTYGQEPWIG 217
Query: 601 RSRDDSALSIMARIKEGQFNFDAEAWSTVSSEAKELTKSLLTVNPAQRIRMMRVK 655
+ I+ +I + + + P R + ++
Sbjct: 218 LNGSQ----ILHKIDKEGERL--PRPEDCPQDIYNVMVQCWAHKPEDRPTFVALR 266
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 62.1 bits (150), Expect = 5e-11
Identities = 22/63 (34%), Positives = 32/63 (50%), Gaps = 1/63 (1%)
Query: 894 HTYLVLELLKGGELLDRIRQKGRCGFTENEASRIMRQLVAAVHFMHSRGVVHRDLKPENL 953
+V EL G LLDR+R+ F SR Q+ + ++ S+ +HRDL NL
Sbjct: 84 PMKMVTELAPLGSLLDRLRKHQG-HFLLGTLSRYAVQVAEGMGYLESKRFIHRDLAARNL 142
Query: 954 LLS 956
LL+
Sbjct: 143 LLA 145
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 41.3 bits (96), Expect = 3e-04
Identities = 20/141 (14%), Positives = 43/141 (30%), Gaps = 23/141 (16%)
Query: 172 CRRCVEKSTGQEYAVKIISRKIDCSE--------EINLLRACQGHPNIVNLHCVFQDEVI 223
AVK + + E+N + + H N++ L+ V +
Sbjct: 27 GEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLD-HRNLIRLYGVVLTPPM 85
Query: 224 ----------DWDDFSRGIECVFFSSSLIIFFIILSFTLSFIHDYYHIQYRRILKTE-PP 272
D R + F +L + + ++ + ++ I R L
Sbjct: 86 KMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLESKRFIH--RDLAARNLL 143
Query: 273 IPEDLSPDVADF-ISRLLVKD 292
+ + DF + R L ++
Sbjct: 144 LATRDLVKIGDFGLMRALPQN 164
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 39.7 bits (92), Expect = 9e-04
Identities = 10/62 (16%), Positives = 21/62 (33%), Gaps = 2/62 (3%)
Query: 237 FSSSLIIFFIILSFTLSFIHDYYHIQYRRILKTE--PPIPEDLSPDVADFISRLLVKDPR 294
+ + ++ + +I +I K P PED D+ + + + P
Sbjct: 198 WMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKEGERLPRPEDCPQDIYNVMVQCWAHKPE 257
Query: 295 RR 296
R
Sbjct: 258 DR 259
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Score = 148 bits (375), Expect = 8e-40
Identities = 62/303 (20%), Positives = 114/303 (37%), Gaps = 74/303 (24%)
Query: 386 LGDGSYSVCRRCVEKSTGQEYAVKIISRKIDCSE-------EINLLRACQGHPNIVNLHC 438
+G G+Y + TG AVK +SR E+ LL+ + H N++ L
Sbjct: 26 VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMK-HENVIGLLD 84
Query: 439 VFQD-----EVHTYLVLELLKGGELLDRIRQKGRCGFTENEASRIMRQLVAAVHFMHSRG 493
VF E + ++ L G +L + ++ + T++ ++ Q++ + ++HS
Sbjct: 85 VFTPARSLEEFNDVYLVTHLMGADLNNIVKCQK---LTDDHVQFLIYQILRGLKYIHSAD 141
Query: 494 VVHRDLKPENLLFSDPAGDNIKVVDFGFACLKRESLHTPCFTLQYAAPEVLRQDKSGYDE 553
++HRDLKP NL ++ +K++DFG A + + T Y APE++
Sbjct: 142 IIHRDLKPSNLAVNED--CELKILDFGLARHTDDEMTGYVATRWYRAPEIMLNWM----- 194
Query: 554 NCDLWSLGVILVNVLRQDKSGYDENCDLWSLGVILYTMLCGRVPFHARSRDDSALSIMAR 613
Y++ D+WS+G I+ +L GR F + +
Sbjct: 195 --------------------HYNQTVDIWSVGCIMAELLTGRTLFPG----TDHIDQLKL 230
Query: 614 IKEGQFNFDAEAWST---------------------------VSSEAKELTKSLLTVNPA 646
I AE + A +L + +L ++
Sbjct: 231 ILRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSD 290
Query: 647 QRI 649
+RI
Sbjct: 291 KRI 293
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Score = 56.4 bits (135), Expect = 7e-09
Identities = 32/207 (15%), Positives = 64/207 (30%), Gaps = 15/207 (7%)
Query: 160 NLLRACQGHPNICRRCVEKSTGQEYAVKIISRKIDCSEEINLLRACQGHPNIVNLHCVFQ 219
NL I + + T E + +R E + +I ++ C+
Sbjct: 151 NLAVNEDCELKILDFGLARHTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMA 210
Query: 220 DEVIDWDDFSRGIECVFFSSSLIIFFIILSFTLSFIHDYYHIQYRRILKTEPPIP----- 274
+ + F L + + L I Y + L P +
Sbjct: 211 ELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFANVF 270
Query: 275 EDLSPDVADFISRLLVKDPRRRLGGGELDAEELKRHPFFNVIDWDDLATKRIPAPFVPKI 334
+P D + ++LV D +R + A + H +F + D + + P+
Sbjct: 271 IGANPLAVDLLEKMLVLDSDKR-----ITAAQALAHAYFA--QYHDPDDEPVADPYDQSF 323
Query: 335 SNELDVSNFSDEFTKMIPADSPAIVPP 361
+ DE+ + + + VPP
Sbjct: 324 ESR---DLLIDEWKSLTYDEVISFVPP 347
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Score = 48.7 bits (115), Expect = 2e-06
Identities = 15/61 (24%), Positives = 23/61 (37%), Gaps = 8/61 (13%)
Query: 174 RCVEKSTGQEYAVKIISRKIDCSE-------EINLLRACQGHPNIVNLHCVFQDEVIDWD 226
+ TG AVK +SR E+ LL+ + H N++ L VF +
Sbjct: 36 AAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMK-HENVIGLLDVFTPARSLEE 94
Query: 227 D 227
Sbjct: 95 F 95
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Score = 48.7 bits (115), Expect = 2e-06
Identities = 17/68 (25%), Positives = 36/68 (52%), Gaps = 3/68 (4%)
Query: 887 NRSRYNVHTYLVLELLKGGELLDRIRQKGRCGFTENEASRIMRQLVAAVHFMHSRGVVHR 946
RS + ++ L G +L + ++ + T++ ++ Q++ + ++HS ++HR
Sbjct: 89 ARSLEEFNDVYLVTHLMGADLNNIVKCQK---LTDDHVQFLIYQILRGLKYIHSADIIHR 145
Query: 947 DLKPENLL 954
DLKP NL
Sbjct: 146 DLKPSNLA 153
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 147 bits (371), Expect = 1e-39
Identities = 57/302 (18%), Positives = 101/302 (33%), Gaps = 65/302 (21%)
Query: 385 ILGDGSYSVCRRC-----VEKSTGQEYAVKIISRKIDCSE------EINLLRACQGHPNI 433
LG G++ ++ AVK++ +E E+ +L H NI
Sbjct: 30 TLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNI 89
Query: 434 VNLHCVFQDEVHTYLVLELLKGGELLDRIRQKG----------------RCGFTENEASR 477
VNL T ++ E G+LL+ +R+K +
Sbjct: 90 VNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLS 149
Query: 478 IMRQLVAAVHFMHSRGVVHRDLKPENLLFSDPAGDNIKVVDFGFACLKRESLHT-----P 532
Q+ + F+ S+ +HRDL N+L + G K+ DFG A + +
Sbjct: 150 FSYQVAKGMAFLASKNCIHRDLAARNILLTH--GRITKICDFGLARDIKNDSNYVVKGNA 207
Query: 533 CFTLQYAAPEVLRQDKSGYDENCDLWSLGVILVNVLRQDKSGYDENCDLWSLGVILYTML 592
+++ APE + Y D+WS G+ L+ +
Sbjct: 208 RLPVKWMAPESIFN--------------------------CVYTFESDVWSYGIFLWELF 241
Query: 593 CGRVPFHARSRDDSALSIMARIKEGQFNFDAEAWSTVSSEAKELTKSLLTVNPAQRIRMM 652
+ DS IKEG F + +E ++ K+ +P +R
Sbjct: 242 SLGSSPYPGMPVDSKF--YKMIKEG---FRMLSPEHAPAEMYDIMKTCWDADPLKRPTFK 296
Query: 653 RV 654
++
Sbjct: 297 QI 298
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 66.0 bits (160), Expect = 4e-12
Identities = 17/78 (21%), Positives = 30/78 (38%), Gaps = 16/78 (20%)
Query: 894 HTYLVLELLKGGELLDRIRQKG----------------RCGFTENEASRIMRQLVAAVHF 937
T ++ E G+LL+ +R+K + Q+ + F
Sbjct: 101 PTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAF 160
Query: 938 MHSRGVVHRDLKPENLLL 955
+ S+ +HRDL N+LL
Sbjct: 161 LASKNCIHRDLAARNILL 178
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 48.7 bits (115), Expect = 2e-06
Identities = 12/56 (21%), Positives = 19/56 (33%), Gaps = 6/56 (10%)
Query: 172 CRRCVEKSTGQEYAVKIISRKIDCSE------EINLLRACQGHPNIVNLHCVFQDE 221
++ AVK++ +E E+ +L H NIVNL
Sbjct: 44 AYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTIG 99
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 40.2 bits (93), Expect = 7e-04
Identities = 9/66 (13%), Positives = 25/66 (37%), Gaps = 2/66 (3%)
Query: 233 ECVFFSSSLIIFFIILSFTLSFIHDYYHIQYRRILK--TEPPIPEDLSPDVADFISRLLV 290
E +S + ++ + + + ++ +++K PE ++ D +
Sbjct: 227 ESDVWSYGIFLWELFSLGSSPYPGMPVDSKFYKMIKEGFRMLSPEHAPAEMYDIMKTCWD 286
Query: 291 KDPRRR 296
DP +R
Sbjct: 287 ADPLKR 292
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Score = 146 bits (368), Expect = 1e-39
Identities = 58/296 (19%), Positives = 104/296 (35%), Gaps = 52/296 (17%)
Query: 385 ILGDGSYSVCRRCVEKST---GQEYAVKIISRKIDCSE------EINLLRACQGHPNIVN 435
+G+G + + + S A+K S E +R HP+IV
Sbjct: 14 CIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFD-HPHIVK 72
Query: 436 LHCVFQDEVHTYLVLELLKGGELLDRIRQKGRCGFTENEASRIMRQLVAAVHFMHSRGVV 495
L V + ++++EL GEL Q + QL A+ ++ S+ V
Sbjct: 73 LIGVITEN-PVWIIMELCTLGELRS-FLQVRKYSLDLASLILYAYQLSTALAYLESKRFV 130
Query: 496 HRDLKPENLLFSDPAGDNIKVVDFGFACLKRESLH----TPCFTLQYAAPEVLRQDKSGY 551
HRD+ N+L S D +K+ DFG + +S + +++ APE + +
Sbjct: 131 HRDIAARNVLVSSN--DCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESINFRR--- 185
Query: 552 DENCDLWSLGVILVNVLRQDKSGYDENCDLWSLGVILYTMLC-GRVPFHARSRDDSALSI 610
+ D+W GV ++ +L G PF +D +
Sbjct: 186 -----------------------FTSASDVWMFGVCMWEILMHGVKPFQGVKNND----V 218
Query: 611 MARIKEGQFNFDAEAWSTVSSEAKELTKSLLTVNPAQRIRMMRVKLTFHAFHQAQK 666
+ RI+ G+ L +P++R R +K + +K
Sbjct: 219 IGRIENGE---RLPMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTILEEEK 271
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Score = 61.7 bits (149), Expect = 7e-11
Identities = 17/64 (26%), Positives = 29/64 (45%), Gaps = 1/64 (1%)
Query: 894 HTYLVLELLKGGELLDRIRQKGRCGFTENEASRIMRQLVAAVHFMHSRGVVHRDLKPENL 953
++++EL GEL Q + QL A+ ++ S+ VHRD+ N+
Sbjct: 81 PVWIIMELCTLGELRS-FLQVRKYSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNV 139
Query: 954 LLSG 957
L+S
Sbjct: 140 LVSS 143
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Score = 44.0 bits (103), Expect = 4e-05
Identities = 15/75 (20%), Positives = 28/75 (37%), Gaps = 6/75 (8%)
Query: 237 FSSSLIIFFIILSFTLSFIHDYYHIQYRRILKTE-PPIPEDLSPDVADFISRLLVKDPRR 295
+ + ++ I++ F + RI E P+P + P + +++ DP R
Sbjct: 193 WMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGERLPMPPNCPPTLYSLMTKCWAYDPSR 252
Query: 296 RLGGGELDAEELKRH 310
R ELK
Sbjct: 253 R-----PRFTELKAQ 262
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Score = 42.4 bits (99), Expect = 2e-04
Identities = 28/172 (16%), Positives = 55/172 (31%), Gaps = 24/172 (13%)
Query: 172 CRRCVEKSTGQEYAVKIISRKIDCSE------EINLLRACQGHPNIVNLHCVFQDEVI-- 223
++ A+K S E +R HP+IV L V + +
Sbjct: 26 GIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFD-HPHIVKLIGVITENPVWI 84
Query: 224 --------DWDDFSRGIECVFFSSSLIIFFIILSFTLSFIHDYYHIQYRRILKTEPPIPE 275
+ F + + +SLI++ LS L+++ +R I +
Sbjct: 85 IMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLES-KRFVHRDIAARNVLVSS 143
Query: 276 DLSPDVADF-ISRLLVKDPRRRLGGGE-----LDAEELKRHPFFNVIDWDDL 321
+ + DF +SR + + G+ + E + F + D
Sbjct: 144 NDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMF 195
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 145 bits (365), Expect = 5e-39
Identities = 51/303 (16%), Positives = 105/303 (34%), Gaps = 68/303 (22%)
Query: 385 ILGDGSYSVCRRCVEKST-------GQEYAVKIISRKIDCSE------EINLLRACQGHP 431
LG+G++ + AVK++ + E+ +++ H
Sbjct: 20 PLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHK 79
Query: 432 NIVNLHCVFQDEVHTYLVLELLKGGELLDRIRQKGRCG--------------FTENEASR 477
NI+NL + Y+++E G L + ++ + G + +
Sbjct: 80 NIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVS 139
Query: 478 IMRQLVAAVHFMHSRGVVHRDLKPENLLFSDPAGDNIKVVDFGFACLKRES-----LHTP 532
Q+ + ++ S+ +HRDL N+L ++ + +K+ DFG A
Sbjct: 140 CAYQVARGMEYLASKKCIHRDLAARNVLVTE--DNVMKIADFGLARDIHHIDYYKKTTNG 197
Query: 533 CFTLQYAAPEVLRQDKSGYDENCDLWSLGVILVNVLRQDKSGYDENCDLWSLGVILYTML 592
+++ APE L Y D+WS GV+L+ +
Sbjct: 198 RLPVKWMAPEALFDRI--------------------------YTHQSDVWSFGVLLWEIF 231
Query: 593 -CGRVPFHARSRDDSALSIMARIKEGQFNFDAEAWSTVSSEAKELTKSLLTVNPAQRIRM 651
G P+ ++ + +KEG + S ++E + + P+QR
Sbjct: 232 TLGGSPYPGVPVEE----LFKLLKEGHR---MDKPSNCTNELYMMMRDCWHAVPSQRPTF 284
Query: 652 MRV 654
++
Sbjct: 285 KQL 287
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 63.0 bits (152), Expect = 3e-11
Identities = 13/78 (16%), Positives = 31/78 (39%), Gaps = 14/78 (17%)
Query: 894 HTYLVLELLKGGELLDRIRQKGRCG--------------FTENEASRIMRQLVAAVHFMH 939
Y+++E G L + ++ + G + + Q+ + ++
Sbjct: 93 PLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLA 152
Query: 940 SRGVVHRDLKPENLLLSG 957
S+ +HRDL N+L++
Sbjct: 153 SKKCIHRDLAARNVLVTE 170
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 38.7 bits (89), Expect = 0.003
Identities = 10/75 (13%), Positives = 22/75 (29%), Gaps = 13/75 (17%)
Query: 123 ILGDGSYSVCRRCVEKST-------GQEYAVKIISRKIDCSE------EINLLRACQGHP 169
LG+G++ + AVK++ + E+ +++ H
Sbjct: 20 PLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHK 79
Query: 170 NICRRCVEKSTGQEY 184
NI +
Sbjct: 80 NIINLLGACTQDGPL 94
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 38.3 bits (88), Expect = 0.003
Identities = 9/74 (12%), Positives = 27/74 (36%), Gaps = 2/74 (2%)
Query: 237 FSSSLIIFFIILSFTLSFIHDYYHIQYRRILKTE-PPIPEDLSPDVADFISRLLVKDPRR 295
+S ++++ I + ++ + + P + + ++ + P +
Sbjct: 221 WSFGVLLWEIFTLGGSPYPGVPVEELFKLLKEGHRMDKPSNCTNELYMMMRDCWHAVPSQ 280
Query: 296 RLGGGELDAEELKR 309
R +L E+L R
Sbjct: 281 RPTFKQL-VEDLDR 293
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 145 bits (366), Expect = 7e-39
Identities = 44/289 (15%), Positives = 103/289 (35%), Gaps = 54/289 (18%)
Query: 379 DLDKAGILGDGSYSVCRRCVEKSTGQEYAVKIISRKIDCS----------EEINLLRACQ 428
+ K +LG G++ + + G++ + + +++ + +E ++ +
Sbjct: 10 EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVD 69
Query: 429 GHPNIVNLHCVFQDEVHTYLVLELLKGGELLDRIRQKGRCGFTENEASRIMRQLVAAVHF 488
+P++ L + L+ +L+ G LLD +R+ Q+ +++
Sbjct: 70 -NPHVCRLLGICLTS-TVQLITQLMPFGCLLDYVREHKDN-IGSQYLLNWCVQIAKGMNY 126
Query: 489 MHSRGVVHRDLKPENLLFSDPAGDNIKVVDFGFACL-----KRESLHTPCFTLQYAAPEV 543
+ R +VHRDL N+L ++K+ DFG A L K +++ A E
Sbjct: 127 LEDRRLVHRDLAARNVLVKT--PQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALES 184
Query: 544 LRQDKSGYDENCDLWSLGVILVNVLRQDKSGYDENCDLWSLGVILYTMLC-GRVPFHARS 602
+ Y D+WS GV ++ ++ G P+
Sbjct: 185 ILHRI--------------------------YTHQSDVWSYGVTVWELMTFGSKPYDGIP 218
Query: 603 RDDSALSIMARIKEGQFNFDAEAWSTVSSEAKELTKSLLTVNPAQRIRM 651
+ I + +++G+ + + + ++ R +
Sbjct: 219 ASE----ISSILEKGER---LPQPPICTIDVYMIMVKCWMIDADSRPKF 260
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 61.3 bits (148), Expect = 2e-10
Identities = 37/304 (12%), Positives = 87/304 (28%), Gaps = 75/304 (24%)
Query: 117 DLDKAGILGDGSYSVCRRCVEKSTGQEYAVKIISRKIDCS----------EEINLLRACQ 166
+ K +LG G++ + + G++ + + +++ + +E ++ +
Sbjct: 10 EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVD 69
Query: 167 GHPNICRRC-----------VEKSTGQEYAVKIISRKIDCSEEI---------------- 199
+P++CR + + K + +
Sbjct: 70 -NPHVCRLLGICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLE 128
Query: 200 ------------NLLRACQGHPNIVNLHCVFQDEVIDWDDFSRGI--------------- 232
N+L H I + + + + G
Sbjct: 129 DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHR 188
Query: 233 ---ECVFFSSSLIIFFIILSFTLSFIHDYYHIQYRRILK--TEPPIPEDLSPDVADFISR 287
S + + +++F + IL+ P P + DV + +
Sbjct: 189 IYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPICTIDVYMIMVK 248
Query: 288 LLVKDPRRRLGGGEL--DAEELKRHP-FFNVIDWDDLATKRIPA--PFVPKISNELDVSN 342
+ D R EL + ++ R P + VI D+ P F + +E D+ +
Sbjct: 249 CWMIDADSRPKFRELIIEFSKMARDPQRYLVIQGDERMHLPSPTDSNFYRALMDEEDMDD 308
Query: 343 FSDE 346
D
Sbjct: 309 VVDA 312
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 57.1 bits (137), Expect = 4e-09
Identities = 18/73 (24%), Positives = 33/73 (45%), Gaps = 3/73 (4%)
Query: 894 HTYLVLELLKGGELLDRIRQKGRCGFTENEASRIMRQLVAAVHFMHSRGVVHRDLKPENL 953
L+ +L+ G LLD +R+ Q+ ++++ R +VHRDL N+
Sbjct: 84 TVQLITQLMPFGCLLDYVREHKDN-IGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNV 142
Query: 954 LLSGISGNLIKIY 966
L+ + +KI
Sbjct: 143 LVK--TPQHVKIT 153
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Score = 141 bits (355), Expect = 2e-37
Identities = 54/287 (18%), Positives = 97/287 (33%), Gaps = 53/287 (18%)
Query: 385 ILGDGSYSVCRRCV---EKSTGQEYAVKIISRKIDCSE------EINLLRACQGHPNIVN 435
++G G + AVK ++R D E E +++ HPN+++
Sbjct: 34 VIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFS-HPNVLS 92
Query: 436 LH-CVFQDEVHTYLVLELLKGGELLDRIRQKGRCGFTENEASRIMRQLVAAVHFMHSRGV 494
L + E +VL +K G+L + IR + T + Q+ + F+ S+
Sbjct: 93 LLGICLRSEGSPLVVLPYMKHGDLRNFIRNETH-NPTVKDLIGFGLQVAKGMKFLASKKF 151
Query: 495 VHRDLKPENLLFSDPAGDNIKVVDFGFACLKRES-------LHTPCFTLQYAAPEVLRQD 547
VHRDL N + + +KV DFG A + +++ A E L+
Sbjct: 152 VHRDLAARNCMLDE--KFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESLQTQ 209
Query: 548 KSGYDENCDLWSLGVILVNVLRQDKSGYDENCDLWSLGVILYTMLCGRVPFHARSRDDSA 607
K + D+WS GV+L+ ++ P + D +
Sbjct: 210 K--------------------------FTTKSDVWSFGVLLWELMTRGAPPYP---DVNT 240
Query: 608 LSIMARIKEGQFNFDAEAWSTVSSEAKELTKSLLTVNPAQRIRMMRV 654
I + +G+ E E+ R +
Sbjct: 241 FDITVYLLQGRRLLQPE---YCPDPLYEVMLKCWHPKAEMRPSFSEL 284
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Score = 54.0 bits (129), Expect = 3e-08
Identities = 19/72 (26%), Positives = 32/72 (44%), Gaps = 3/72 (4%)
Query: 894 HTYLVLELLKGGELLDRIRQKGRCGFTENEASRIMRQLVAAVHFMHSRGVVHRDLKPENL 953
+VL +K G+L + IR + T + Q+ + F+ S+ VHRDL N
Sbjct: 103 SPLVVLPYMKHGDLRNFIRNETH-NPTVKDLIGFGLQVAKGMKFLASKKFVHRDLAARNC 161
Query: 954 LLSGISGNLIKI 965
+L +K+
Sbjct: 162 MLD--EKFTVKV 171
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Score = 39.0 bits (90), Expect = 0.002
Identities = 12/60 (20%), Positives = 21/60 (35%), Gaps = 10/60 (16%)
Query: 123 ILGDGSYSVCRRCV---EKSTGQEYAVKIISRKIDCSE------EINLLRACQGHPNICR 173
++G G + AVK ++R D E E +++ HPN+
Sbjct: 34 VIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFS-HPNVLS 92
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 140 bits (353), Expect = 3e-37
Identities = 51/308 (16%), Positives = 100/308 (32%), Gaps = 75/308 (24%)
Query: 386 LGDGSYSVCRRCVEKS-----TGQEYAVKIISRKIDCSE------EINLLRACQGHPNIV 434
+G+G++ + AVK++ + E L+ +PNIV
Sbjct: 21 IGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFD-NPNIV 79
Query: 435 NLHCVFQDEVHTYLVLELLKGGELLDRIRQKGRCG----------------------FTE 472
L V L+ E + G+L + +R +
Sbjct: 80 KLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSC 139
Query: 473 NEASRIMRQLVAAVHFMHSRGVVHRDLKPENLLFSDPAGDNIKVVDFGFACLKRES---- 528
E I RQ+ A + ++ R VHRDL N L + +K+ DFG + +
Sbjct: 140 AEQLCIARQVAAGMAYLSERKFVHRDLATRNCLVGE--NMVVKIADFGLSRNIYSADYYK 197
Query: 529 -LHTPCFTLQYAAPEVLRQDKSGYDENCDLWSLGVILVNVLRQDKSGYDENCDLWSLGVI 587
+++ PE + ++ Y D+W+ GV+
Sbjct: 198 ADGNDAIPIRWMPPESIFYNR--------------------------YTTESDVWAYGVV 231
Query: 588 LYTMLC-GRVPFHARSRDDSALSIMARIKEGQFNFDAEAWSTVSSEAKELTKSLLTVNPA 646
L+ + G P++ + ++ ++ +++G E L + + PA
Sbjct: 232 LWEIFSYGLQPYYGMAHEE----VIYYVRDGNIL---ACPENCPLELYNLMRLCWSKLPA 284
Query: 647 QRIRMMRV 654
R +
Sbjct: 285 DRPSFCSI 292
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 56.8 bits (136), Expect = 4e-09
Identities = 20/94 (21%), Positives = 33/94 (35%), Gaps = 24/94 (25%)
Query: 894 HTYLVLELLKGGELLDRIRQKGRCG----------------------FTENEASRIMRQL 931
L+ E + G+L + +R + E I RQ+
Sbjct: 90 PMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQV 149
Query: 932 VAAVHFMHSRGVVHRDLKPENLLLSGISGNLIKI 965
A + ++ R VHRDL N L+ ++KI
Sbjct: 150 AAGMAYLSERKFVHRDLATRNCLVG--ENMVVKI 181
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 39.8 bits (92), Expect = 0.001
Identities = 26/214 (12%), Positives = 61/214 (28%), Gaps = 28/214 (13%)
Query: 124 LGDGSYSVCRRCVEKS-----TGQEYAVKIISRKIDCSE------EINLLRACQGHPNIC 172
+G+G++ + AVK++ + E L+ +
Sbjct: 21 IGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVK 80
Query: 173 RRCVEKSTGQEYAVKIISRKIDCSEEINLLRACQGHPNIVNLHCVFQDEVIDWDDFSRGI 232
V + + +L + D S G
Sbjct: 81 LLGVCAVGKPMCLL------FEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGP 134
Query: 233 ECVFFSSSLIIFFIILSFTLSFIHDYYHIQYRRILKTE-PPIPEDLSPDVADF-ISRLLV 290
+ + L I + + ++++ + + R L T + E++ +ADF +SR +
Sbjct: 135 PPLSCAEQLCIARQVAA-GMAYLSERKFVH--RDLATRNCLVGENMVVKIADFGLSRNIY 191
Query: 291 KDPRRRLGG------GELDAEELKRHPFFNVIDW 318
+ G + E + + + D
Sbjct: 192 SADYYKADGNDAIPIRWMPPESIFYNRYTTESDV 225
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 138 bits (348), Expect = 6e-37
Identities = 49/286 (17%), Positives = 104/286 (36%), Gaps = 52/286 (18%)
Query: 385 ILGDGSYSVCRRCVEKSTGQE----YAVKIISR------KIDCSEEINLLRACQGHPNIV 434
++G G + + + K++ + A+K + ++D E ++ H NI+
Sbjct: 14 VIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFS-HHNII 72
Query: 435 NLHCVFQDEVHTYLVLELLKGGELLDRIRQKGRCGFTENEASRIMRQLVAAVHFMHSRGV 494
L V ++ E ++ G L +R+K F+ + ++R + A + ++ +
Sbjct: 73 RLEGVISKYKPMMIITEYMENGALDKFLREKDGE-FSVLQLVGMLRGIAAGMKYLANMNY 131
Query: 495 VHRDLKPENLLFSDPAGDNIKVVDFGFACL------KRESLHTPCFTLQYAAPEVLRQDK 548
VHRDL N+L + KV DFG + + + +++ APE + K
Sbjct: 132 VHRDLAARNILVNS--NLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWTAPEAISYRK 189
Query: 549 SGYDENCDLWSLGVILVNVLRQDKSGYDENCDLWSLGVILYTMLCGRVPFHARSRDDSAL 608
+ D+WS G++++ ++ + + S
Sbjct: 190 --------------------------FTSASDVWSFGIVMWEVMTYGERPY---WELSNH 220
Query: 609 SIMARIKEGQFNFDAEAWSTVSSEAKELTKSLLTVNPAQRIRMMRV 654
+M I +G F S +L A+R + +
Sbjct: 221 EVMKAINDG---FRLPTPMDCPSAIYQLMMQCWQQERARRPKFADI 263
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 54.5 bits (130), Expect = 2e-08
Identities = 17/72 (23%), Positives = 37/72 (51%), Gaps = 3/72 (4%)
Query: 894 HTYLVLELLKGGELLDRIRQKGRCGFTENEASRIMRQLVAAVHFMHSRGVVHRDLKPENL 953
++ E ++ G L +R+K F+ + ++R + A + ++ + VHRDL N+
Sbjct: 83 PMMIITEYMENGALDKFLREKDGE-FSVLQLVGMLRGIAAGMKYLANMNYVHRDLAARNI 141
Query: 954 LLSGISGNLIKI 965
L++ S + K+
Sbjct: 142 LVN--SNLVCKV 151
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 41.7 bits (97), Expect = 2e-04
Identities = 27/261 (10%), Positives = 73/261 (27%), Gaps = 72/261 (27%)
Query: 123 ILGDGSYSVCRRCVEKSTGQE----YAVKIISR------KIDCSEEINLLRACQGHPNIC 172
++G G + + + K++ + A+K + ++D E ++ H I
Sbjct: 14 VIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIR 73
Query: 173 RRCVEKSTGQEYAV----------KIISRKIDCSEEINLLRACQG--------------H 208
V + K + K + L+ +G H
Sbjct: 74 LEGVISKYKPMMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLANMNYVH 133
Query: 209 PNIVNLHCVFQDE----VIDWD------------------------------DFSRGIEC 234
++ + + V D+ + +
Sbjct: 134 RDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWTAPEAISYRKFTSA 193
Query: 235 VFFSSSLIIFFIILSFTLSFIHDYYHIQYRRILKT--EPPIPEDLSPDVADFISRLLVKD 292
S I+ + ++++ + + + + + P P D + + + ++
Sbjct: 194 SDVWSFGIVMWEVMTYGERPYWELSNHEVMKAINDGFRLPTPMDCPSAIYQLMMQCWQQE 253
Query: 293 PRRRLGGGEL--DAEELKRHP 311
RR ++ ++L R P
Sbjct: 254 RARRPKFADIVSILDKLIRAP 274
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Score = 135 bits (340), Expect = 1e-35
Identities = 60/323 (18%), Positives = 112/323 (34%), Gaps = 67/323 (20%)
Query: 386 LGDGSYSVCRRCVEKSTGQEYAVKIISRKIDCSE----EINLLRACQGHPNIVNLHCVFQ 441
+G G + R K G+E AVKI S + + S EI + H NI+
Sbjct: 11 IGKGRFGEVWRG--KWRGEEVAVKIFSSREERSWFREAEIYQTVMLR-HENILGFIAADN 67
Query: 442 DEVHT----YLVLELLKGGELLDRIRQKGRCGFTENEASRIMRQLVAAVHFMHS------ 491
+ T +LV + + G L D + + T ++ + + +H
Sbjct: 68 KDNGTWTQLWLVSDYHEHGSLFDYLNRYT---VTVEGMIKLALSTASGLAHLHMEIVGTQ 124
Query: 492 --RGVVHRDLKPENLLFSDPAGDNIKVVDFGFACLKRE-------SLHTPCFTLQYAAPE 542
+ HRDLK +N+L + D G A + + T +Y APE
Sbjct: 125 GKPAIAHRDLKSKNILVKK--NGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPE 182
Query: 543 VLRQDKSGYDENCDLWSLGVILVNVLRQDKSGYDENCDLWSLGVILYTMLCGR------- 595
VL + + D++++G++ + +
Sbjct: 183 VLDDS--------------------INMKHFESFKRADIYAMGLVFWEIARRCSIGGIHE 222
Query: 596 ---VPFHARSRDDSALSIMARIKEGQFNFDAEAWSTVSSEA----KELTKSLLTVNPAQR 648
+P++ D ++ M ++ Q S EA ++ + N A R
Sbjct: 223 DYQLPYYDLVPSDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAAR 282
Query: 649 IRMMRVKLTFHAFHQAQKEGFRL 671
+ +R+K T +Q+EG ++
Sbjct: 283 LTALRIKKTLSQL--SQQEGIKM 303
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Score = 57.5 bits (138), Expect = 2e-09
Identities = 14/81 (17%), Positives = 29/81 (35%), Gaps = 11/81 (13%)
Query: 885 FVNRSRYNVHTYLVLELLKGGELLDRIRQKGRCGFTENEASRIMRQLVAAVHFMHS---- 940
+ +LV + + G L D + + T ++ + + +H
Sbjct: 66 DNKDNGTWTQLWLVSDYHEHGSLFDYLNRYT---VTVEGMIKLALSTASGLAHLHMEIVG 122
Query: 941 ----RGVVHRDLKPENLLLSG 957
+ HRDLK +N+L+
Sbjct: 123 TQGKPAIAHRDLKSKNILVKK 143
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Score = 40.6 bits (94), Expect = 7e-04
Identities = 22/131 (16%), Positives = 41/131 (31%), Gaps = 25/131 (19%)
Query: 178 KSTGQEYAVKIISRKIDCSE----EINLLRACQGHPNIVNLHCVFQDEVIDWDDFSRGIE 233
K G+E AVKI S + + S EI + H NI+ + W +
Sbjct: 23 KWRGEEVAVKIFSSREERSWFREAEIYQTVMLR-HENILGFIAADNKDNGTWTQLWLVSD 81
Query: 234 CV-------------FFSSSLIIFFIILSFTLSFIHDYY-------HIQYRRILKTEPPI 273
+I + + L+ +H I +R + +
Sbjct: 82 YHEHGSLFDYLNRYTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILV 141
Query: 274 PEDLSPDVADF 284
++ + +AD
Sbjct: 142 KKNGTCCIADL 152
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Score = 39.1 bits (90), Expect = 0.002
Identities = 17/54 (31%), Positives = 23/54 (42%), Gaps = 7/54 (12%)
Query: 124 LGDGSYSVCRRCVEKSTGQEYAVKIISRKIDCSE----EINLLRACQGHPNICR 173
+G G + R K G+E AVKI S + + S EI + H NI
Sbjct: 11 IGKGRFGEVWRG--KWRGEEVAVKIFSSREERSWFREAEIYQTVMLR-HENILG 61
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Score = 132 bits (333), Expect = 3e-34
Identities = 68/314 (21%), Positives = 119/314 (37%), Gaps = 83/314 (26%)
Query: 385 ILGDGSYSVCRRCVEKSTGQEYAVKIISRKIDCSE-------EINLLRACQGHPNIVNLH 437
+G G+ + + + A+K +SR E+ L++ H NI++L
Sbjct: 24 PIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVN-HKNIISLL 82
Query: 438 CVFQDE------VHTYLVLELLKGGELLDRIRQKGRCGFTENEASRIMRQLVAAVHFMHS 491
VF + YLV+EL+ Q + S ++ Q++ + +HS
Sbjct: 83 NVFTPQKTLEEFQDVYLVMELMDANLC-----QVIQMELDHERMSYLLYQMLCGIKHLHS 137
Query: 492 RGVVHRDLKPENLLFSDPAGDNIKVVDFGFACLKRES--LHTPCFTLQYAAPEVLRQDKS 549
G++HRDLKP N++ +K++DFG A S + T Y APEV+
Sbjct: 138 AGIIHRDLKPSNIVVKS--DCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGM-- 193
Query: 550 GYDENCDLWSLGVILVNVLRQDKSGYDENCDLWSLGVILYTMLCGRVPFHARSRDDSALS 609
GY EN D+WS+G I+ M+ ++ F R D
Sbjct: 194 ------------------------GYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNK 229
Query: 610 IMARI----------------------------------KEGQFNFDAEAWSTVSSEAKE 635
++ ++ + F D+E +S+A++
Sbjct: 230 VIEQLGTPCPEFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARD 289
Query: 636 LTKSLLTVNPAQRI 649
L +L ++PA+RI
Sbjct: 290 LLSKMLVIDPAKRI 303
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Score = 55.0 bits (131), Expect = 2e-08
Identities = 27/185 (14%), Positives = 61/185 (32%), Gaps = 15/185 (8%)
Query: 167 GHPNICRRCVEKSTGQEYAVKIISRKIDCSEEINLLRACQGHPNIVNLHCVFQDEVIDWD 226
V G + V I S E + G I + V +
Sbjct: 180 VTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCP 239
Query: 227 DFSRGIECVFFSSSLIIFFIILSFTLSFIHDYYHIQYRRILKTEPPIPEDLSPDVADFIS 286
+F + ++ + + + + + + + + + D +S
Sbjct: 240 EFMKKLQP-------TVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLS 292
Query: 287 RLLVKDPRRRLGGGELDAEELKRHPFFNVIDWDDLATKRIPAPFVPKISNELDVSNFSDE 346
++LV DP +R + ++ +HP+ N W D A P P + + + + +E
Sbjct: 293 KMLVIDPAKR-----ISVDDALQHPYIN--VWYDPAEVEAPPPQIYDKQLD-EREHTIEE 344
Query: 347 FTKMI 351
+ ++I
Sbjct: 345 WKELI 349
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Score = 50.3 bits (119), Expect = 6e-07
Identities = 18/68 (26%), Positives = 32/68 (47%), Gaps = 5/68 (7%)
Query: 890 RYNVHTYLVLELLKGGELLDRIRQKGRCGFTENEASRIMRQLVAAVHFMHSRGVVHRDLK 949
YLV+EL+ Q + S ++ Q++ + +HS G++HRDLK
Sbjct: 92 EEFQDVYLVMELMDANLC-----QVIQMELDHERMSYLLYQMLCGIKHLHSAGIIHRDLK 146
Query: 950 PENLLLSG 957
P N+++
Sbjct: 147 PSNIVVKS 154
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Score = 46.1 bits (108), Expect = 1e-05
Identities = 26/217 (11%), Positives = 59/217 (27%), Gaps = 54/217 (24%)
Query: 123 ILGDGSYSVCRRCVEKSTGQEYAVKIISRKIDCSEEINLLRACQGHPNICRRCVEKSTGQ 182
+G G+ + + + A+K +SR
Sbjct: 24 PIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAY------------------- 64
Query: 183 EYAVKIISRKIDCSEEINLLRACQGHPNIVNLHCVFQD--------------EVIDWDDF 228
E+ L++ H NI++L VF E++D +
Sbjct: 65 --------------RELVLMKCVN-HKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLC 109
Query: 229 SRGIECVFFSSSLIIFFIILSFTLSFIHDYYHIQYRRILKTEPPIPEDLSPDVADF-ISR 287
+ + + +L + +H I +R + + + D + + DF ++R
Sbjct: 110 QVIQMELDHERMSYLLYQMLC-GIKHLHSAGII-HRDLKPSNIVVKSDCTLKILDFGLAR 167
Query: 288 LLVKDPRRRLGGG---ELDAEELKRHPFFNVIDWDDL 321
E + + +D +
Sbjct: 168 TAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSV 204
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 131 bits (330), Expect = 3e-34
Identities = 47/293 (16%), Positives = 101/293 (34%), Gaps = 59/293 (20%)
Query: 386 LGDGSYSVCRRCVEKS-----TGQEYAVKIISRKIDCSE------EINLLRACQGHPNIV 434
LG GS+ + V K A+K ++ E E ++++ ++V
Sbjct: 28 LGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFN-CHHVV 86
Query: 435 NLHCVFQDEVHTYLVLELLKGGELLDRIRQKGRCG--------FTENEASRIMRQLVAAV 486
L V T +++EL+ G+L +R + ++ ++ ++ +
Sbjct: 87 RLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGM 146
Query: 487 HFMHSRGVVHRDLKPENLLFSDPAGDNIKVVDFGFACLKRES-----LHTPCFTLQYAAP 541
++++ VHRDL N + ++ +K+ DFG E+ +++ +P
Sbjct: 147 AYLNANKFVHRDLAARNCMVAE--DFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSP 204
Query: 542 EVLRQDKSGYDENCDLWSLGVILVNVLRQDKSGYDENCDLWSLGVILYTMLCGRVPFHAR 601
E L+ + D+WS GV+L+ + +
Sbjct: 205 ESLKDGV--------------------------FTTYSDVWSFGVVLWEIATLAEQPY-- 236
Query: 602 SRDDSALSIMARIKEGQFNFDAEAWSTVSSEAKELTKSLLTVNPAQRIRMMRV 654
+ S ++ + EG + EL + NP R + +
Sbjct: 237 -QGLSNEQVLRFVMEGGLL---DKPDNCPDMLFELMRMCWQYNPKMRPSFLEI 285
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 54.5 bits (130), Expect = 2e-08
Identities = 14/80 (17%), Positives = 36/80 (45%), Gaps = 10/80 (12%)
Query: 894 HTYLVLELLKGGELLDRIRQKGRCG--------FTENEASRIMRQLVAAVHFMHSRGVVH 945
T +++EL+ G+L +R + ++ ++ ++ + ++++ VH
Sbjct: 97 PTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANKFVH 156
Query: 946 RDLKPENLLLSGISGNLIKI 965
RDL N +++ +KI
Sbjct: 157 RDLAARNCMVA--EDFTVKI 174
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 40.6 bits (94), Expect = 6e-04
Identities = 10/84 (11%), Positives = 28/84 (33%), Gaps = 4/84 (4%)
Query: 233 ECVFFSSSLIIFFIILSFTLSFIHDYYHIQYRRILKTE-PPIPEDLSPDVADFISRLLVK 291
+S ++++ I + R +++ P++ + + +
Sbjct: 215 YSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFVMEGGLLDKPDNCPDMLFELMRMCWQY 274
Query: 292 DPRRRLGGGELDAEELKR--HPFF 313
+P+ R E+ +K P F
Sbjct: 275 NPKMRPSFLEI-ISSIKEEMEPGF 297
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 126 bits (318), Expect = 9e-33
Identities = 60/301 (19%), Positives = 100/301 (33%), Gaps = 64/301 (21%)
Query: 385 ILGDGSYSVCRRCV-----EKSTGQEYAVKIISRKIDCSE------EINLLRACQGHPNI 433
LG G++ + +T + AVK++ SE E+ +L H N+
Sbjct: 20 PLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNV 79
Query: 434 VNLH-CVFQDEVHTYLVLELLKGGELLDRIRQKG--------------RCGFTENEASRI 478
VNL + +++E K G L +R K + T
Sbjct: 80 VNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICY 139
Query: 479 MRQLVAAVHFMHSRGVVHRDLKPENLLFSDPAGDNIKVVDFGFACLKRE-----SLHTPC 533
Q+ + F+ SR +HRDL N+L S+ + +K+ DFG A +
Sbjct: 140 SFQVAKGMEFLASRKCIHRDLAARNILLSE--KNVVKICDFGLARDIYKDPDYVRKGDAR 197
Query: 534 FTLQYAAPEVLRQDKSGYDENCDLWSLGVILVNVLRQDKSGYDENCDLWSLGVILYTMLC 593
L++ APE + Y D+WS GV+L+ +
Sbjct: 198 LPLKWMAPETIFDRV--------------------------YTIQSDVWSFGVLLWEIFS 231
Query: 594 GRVPFHARSRDDSALSIMARIKEGQFNFDAEAWSTVSSEAKELTKSLLTVNPAQRIRMMR 653
+ + D R+KEG A + E + P+QR
Sbjct: 232 LGASPYPGVKIDEE--FCRRLKEGT---RMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSE 286
Query: 654 V 654
+
Sbjct: 287 L 287
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 56.0 bits (134), Expect = 7e-09
Identities = 22/88 (25%), Positives = 34/88 (38%), Gaps = 16/88 (18%)
Query: 892 NVHTYLVLELLKGGELLDRIRQKG--------------RCGFTENEASRIMRQLVAAVHF 937
+++E K G L +R K + T Q+ + F
Sbjct: 90 GGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEF 149
Query: 938 MHSRGVVHRDLKPENLLLSGISGNLIKI 965
+ SR +HRDL N+LLS N++KI
Sbjct: 150 LASRKCIHRDLAARNILLS--EKNVVKI 175
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 43.7 bits (102), Expect = 7e-05
Identities = 14/82 (17%), Positives = 30/82 (36%), Gaps = 7/82 (8%)
Query: 231 GIECVFFSSSLIIFFIILSFTLSFIHDYYHIQYRRILK--TEPPIPEDLSPDVADFISRL 288
I+ +S ++++ I + ++ R LK T P+ +P++ +
Sbjct: 214 TIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTRMRAPDYTTPEMYQTMLDC 273
Query: 289 LVKDPRRRLGGGELDAEELKRH 310
+P +R EL H
Sbjct: 274 WHGEPSQR-----PTFSELVEH 290
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 120 bits (301), Expect = 6e-30
Identities = 60/302 (19%), Positives = 111/302 (36%), Gaps = 40/302 (13%)
Query: 386 LGDGSYSVCRRCVEKSTGQEYAVKIISR----KIDCSEEINLLRACQ----------GHP 431
LG G +S + A+KI+ +EI LL+ G
Sbjct: 21 LGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYTEAAEDEIKLLQRVNDADNTKEDSMGAN 80
Query: 432 NIVNLHCVFQDEVHTYLVLELLK---GGELLDRIRQKGRCGFTENEASRIMRQLVAAVHF 488
+I+ L F + + + ++ G LL I++ G +I +QL+ + +
Sbjct: 81 HILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGLDY 140
Query: 489 MH-SRGVVHRDLKPENLLFS----DPAGDNIKVVDFGFACLKRESLHTPCFTLQYAAPEV 543
MH G++H D+KPEN+L IK+ D G AC E T +Y +PEV
Sbjct: 141 MHRRCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEHYTNSIQTREYRSPEV 200
Query: 544 LRQDKSGYDENCDLWSLGVILVNVL-------RQDKSGYDENCDLWSLGV---------I 587
L + + D+WS ++ ++ + Y ++ D + + +
Sbjct: 201 LL--GAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHIAQIIELLGELPSYL 258
Query: 588 LYTMLCGRVPFHARSRDDSALSIMARIKEGQFNFDAEAWSTVSSEAKELTKSLLTVNPAQ 647
L R F++R + + E + + E + +L ++P +
Sbjct: 259 LRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRK 318
Query: 648 RI 649
R
Sbjct: 319 RA 320
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 69.3 bits (168), Expect = 6e-13
Identities = 23/95 (24%), Positives = 39/95 (41%), Gaps = 9/95 (9%)
Query: 252 LSFIHDYYHIQYRRILKTEPPIPEDLSPDVADFISRLLVKDPRRRLGGGELDAEELKRHP 311
L I +L + +D + +++DF+S +L DPR+R DA L HP
Sbjct: 275 LRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKR-----ADAGGLVNHP 329
Query: 312 FFNVIDWDDLATKRIPAPFVPKISNELDVSNFSDE 346
+ D L + I P + D+ + +E
Sbjct: 330 WLK----DTLGMEEIRVPDRELYGSGSDIPGWFEE 360
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 44.6 bits (104), Expect = 3e-05
Identities = 20/61 (32%), Positives = 33/61 (54%), Gaps = 3/61 (4%)
Query: 908 LDRIRQKGRCGFTENEASRIMRQLVAAVHFMH-SRGVVHRDLKPENLLLS--GISGNLIK 964
L I++ G +I +QL+ + +MH G++H D+KPEN+L+ NLI+
Sbjct: 111 LALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSPENLIQ 170
Query: 965 I 965
I
Sbjct: 171 I 171
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 43.9 bits (102), Expect = 7e-05
Identities = 26/148 (17%), Positives = 47/148 (31%), Gaps = 21/148 (14%)
Query: 124 LGDGSYSVCRRCVEKSTGQEYAVKIISR----KIDCSEEINLLRACQGHPNICRRCVEKS 179
LG G +S + A+KI+ +EI LL+ + + E S
Sbjct: 21 LGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYTEAAEDEIKLLQRVN-DADNTK---EDS 76
Query: 180 TGQEYAVKIISRKIDCSEEINLLRACQGHPNIVNLHCVFQDEVIDWDDFSRGIECVFFSS 239
G + +K++ PN V++ VF+ + + E
Sbjct: 77 MGANHILKLLDHFNHK------------GPNGVHVVMVFEVLGENLLALIKKYEHRGIPL 124
Query: 240 SLII-FFIILSFTLSFIHDYYHIQYRRI 266
+ L L ++H I + I
Sbjct: 125 IYVKQISKQLLLGLDYMHRRCGIIHTDI 152
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Score = 79.8 bits (196), Expect = 1e-17
Identities = 30/192 (15%), Positives = 55/192 (28%), Gaps = 27/192 (14%)
Query: 385 ILGDGSYSVCRRCVEKSTGQEYAVKIISRKIDCSEEINLLRAC--------------QGH 430
++G+G S C + E VK +++ R
Sbjct: 7 LMGEGKESAVFNCYSE-KFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEF 65
Query: 431 PNIVNLHCVFQDEVHTYLVLELLKGGELLDRIRQKGRCGFTENEASRIMRQLVAAVHFMH 490
+ L + V L++ I K ++ ++ V +
Sbjct: 66 RALQKLQGL-----AVPKVYAWEGNAVLMELIDAKELYRVRVENPDEVLDMILEEVAKFY 120
Query: 491 SRGVVHRDLKPENLLFSDPAGDNIKVVDFGFACLKRESLHTPCFTLQYAAPEVLRQD-KS 549
RG+VH DL N+L S+ I ++DF + E + +
Sbjct: 121 HRGIVHGDLSQYNVLVSEE---GIWIIDFPQS---VEVGEEGWREILERDVRNIITYFSR 174
Query: 550 GYDENCDLWSLG 561
Y D+ S
Sbjct: 175 TYRTEKDINSAI 186
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Score = 48.2 bits (114), Expect = 7e-07
Identities = 15/73 (20%), Positives = 27/73 (36%)
Query: 891 YNVHTYLVLELLKGGELLDRIRQKGRCGFTENEASRIMRQLVAAVHFMHSRGVVHRDLKP 950
+ V L++ I K ++ ++ V + RG+VH DL
Sbjct: 72 QGLAVPKVYAWEGNAVLMELIDAKELYRVRVENPDEVLDMILEEVAKFYHRGIVHGDLSQ 131
Query: 951 ENLLLSGISGNLI 963
N+L+S +I
Sbjct: 132 YNVLVSEEGIWII 144
|
Homologous Domains Detected by HHsearch
Original result of HHsearch against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 966 | |||
| d2j4za1 | 263 | Aurora-related kinase 1 (aurora-2) {Human (Homo sa | 100.0 | |
| d1nvra_ | 271 | Cell cycle checkpoint kinase chk1 {Human (Homo sap | 100.0 | |
| d1koba_ | 352 | Twitchin, kinase domain {California sea hare (Aply | 100.0 | |
| d1a06a_ | 307 | Calmodulin-dependent protein kinase {Rat (Rattus n | 100.0 | |
| d2ozaa1 | 335 | MAP kinase activated protein kinase 2, mapkap2 {Hu | 100.0 | |
| d1yhwa1 | 293 | pak1 {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1tkia_ | 321 | Titin, kinase domain {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1uu3a_ | 288 | 3-phosphoinositide dependent protein kinase-1 Pdk1 | 100.0 | |
| d1koaa2 | 350 | Twitchin, kinase domain {Caenorhabditis elegans, p | 100.0 | |
| d2jfla1 | 288 | STE20-like serine/threonine-protein kinase, SLK {H | 100.0 | |
| d1phka_ | 277 | gamma-subunit of glycogen phosphorylase kinase (Ph | 100.0 | |
| d1jksa_ | 293 | Death-associated protein kinase, Dap {Human (Homo | 100.0 | |
| d1s9ja_ | 322 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| d1u5ra_ | 309 | Serine/threonine protein kinase TAO2 {Rat (Rattus | 100.0 | |
| d1t4ha_ | 270 | Protein kinase wnk1 {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1o6la_ | 337 | Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9 | 100.0 | |
| d2java1 | 269 | Serine/threonine-protein kinase Nek2 {Human (Homo | 100.0 | |
| d1fota_ | 316 | cAMP-dependent PK, catalytic subunit {Baker's yeas | 100.0 | |
| d1rdqe_ | 350 | cAMP-dependent PK, catalytic subunit {Mouse (Mus m | 100.0 | |
| d1opja_ | 287 | Abelsone tyrosine kinase (abl) {Mouse (Mus musculu | 100.0 | |
| d1omwa3 | 364 | G-protein coupled receptor kinase 2 {Cow (Bos taur | 100.0 | |
| d1xjda_ | 320 | Protein kinase C, theta type {Human (Homo sapiens) | 100.0 | |
| d1rjba_ | 325 | Fl cytokine receptor {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1ua2a_ | 299 | Cell division protein kinase 7, CDK7 {Human (Homo | 100.0 | |
| d1o6ya_ | 277 | Mycobacterial protein kinase PknB, catalytic domai | 100.0 | |
| d1xwsa_ | 273 | Proto-oncogene serine/threonine-protein kinase Pim | 100.0 | |
| d1qpca_ | 272 | Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax | 100.0 | |
| d1uwha_ | 276 | B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1xbba_ | 277 | Tyrosine-protein kinase SYK {Human (Homo sapiens) | 100.0 | |
| d1gz8a_ | 298 | Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T | 100.0 | |
| d1sm2a_ | 263 | Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie | 100.0 | |
| d1jpaa_ | 299 | ephb2 receptor tyrosine kinase {Mouse (Mus musculu | 100.0 | |
| d1u59a_ | 285 | Tyrosine-protein kinase ZAP-70 {Human (Homo sapien | 100.0 | |
| d1blxa_ | 305 | Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T | 100.0 | |
| d1k2pa_ | 258 | Bruton's tyrosine kinase (Btk) {Human (Homo sapien | 100.0 | |
| d1q5ka_ | 350 | Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho | 100.0 | |
| d1mp8a_ | 273 | Focal adhesion kinase 1 (fak) {Human (Homo sapiens | 100.0 | |
| d1mqba_ | 283 | epha2 receptor tyrosine kinase {Human (Homo sapien | 100.0 | |
| d3bqca1 | 328 | Protein kinase CK2, alpha subunit {Rattus norvegic | 100.0 | |
| d1ywna1 | 299 | Vascular endothelial growth factor receptor 2 (kdr | 100.0 | |
| d1cm8a_ | 346 | MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1ob3a_ | 286 | Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) | 100.0 | |
| d1fmka3 | 285 | c-src tyrosine kinase {Human (Homo sapiens) [TaxId | 100.0 | |
| d1xkka_ | 317 | EGF receptor tyrosine kinase, Erbb-1 {Human (Homo | 100.0 | |
| d1byga_ | 262 | Carboxyl-terminal src kinase (csk) {Human (Homo sa | 100.0 | |
| d1vzoa_ | 322 | Ribosomal protein S6 kinase alpha 5, Msk1 {Human ( | 100.0 | |
| d1pmea_ | 345 | MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606 | 100.0 | |
| d1fvra_ | 309 | Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d3blha1 | 318 | Cell division protein kinase 9, CDK9 {Human (Homo | 100.0 | |
| d1ckia_ | 299 | Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1lufa_ | 301 | Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1u46a_ | 273 | Activated CDC42 kinase 1, ACK1 {Human (Homo sapien | 100.0 | |
| d1unla_ | 292 | Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T | 100.0 | |
| d1t46a_ | 311 | c-KIT receptor {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1fgka_ | 299 | Fibroblast growth factor receptor 1 {Human (Homo s | 100.0 | |
| d1csna_ | 293 | Casein kinase-1, CK1 {Fission yeast (Schizosacchar | 100.0 | |
| d2gfsa1 | 348 | MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d2b1pa1 | 355 | c-jun N-terminal kinase (jnk3s) {Human (Homo sapie | 100.0 | |
| d1r0pa_ | 311 | Hepatocyte growth factor receptor, c-MET {Human (H | 100.0 | |
| d1p4oa_ | 308 | Insulin-like growth factor 1 receptor {Human (Homo | 100.0 | |
| d1vjya_ | 303 | Type I TGF-beta receptor R4 {Human (Homo sapiens) | 100.0 | |
| d1q8ya_ | 362 | Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T | 100.0 | |
| d1o6la_ | 337 | Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9 | 100.0 | |
| d1fota_ | 316 | cAMP-dependent PK, catalytic subunit {Baker's yeas | 100.0 | |
| d1rdqe_ | 350 | cAMP-dependent PK, catalytic subunit {Mouse (Mus m | 100.0 | |
| d1xjda_ | 320 | Protein kinase C, theta type {Human (Homo sapiens) | 100.0 | |
| d1omwa3 | 364 | G-protein coupled receptor kinase 2 {Cow (Bos taur | 99.97 | |
| d1uu3a_ | 288 | 3-phosphoinositide dependent protein kinase-1 Pdk1 | 99.97 | |
| d1vzoa_ | 322 | Ribosomal protein S6 kinase alpha 5, Msk1 {Human ( | 99.96 | |
| d2j4za1 | 263 | Aurora-related kinase 1 (aurora-2) {Human (Homo sa | 99.94 | |
| d1jksa_ | 293 | Death-associated protein kinase, Dap {Human (Homo | 99.94 | |
| d1phka_ | 277 | gamma-subunit of glycogen phosphorylase kinase (Ph | 99.92 | |
| d1yhwa1 | 293 | pak1 {Human (Homo sapiens) [TaxId: 9606]} | 99.92 | |
| d1a06a_ | 307 | Calmodulin-dependent protein kinase {Rat (Rattus n | 99.92 | |
| d1koaa2 | 350 | Twitchin, kinase domain {Caenorhabditis elegans, p | 99.92 | |
| d1koba_ | 352 | Twitchin, kinase domain {California sea hare (Aply | 99.91 | |
| d1blxa_ | 305 | Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T | 99.91 | |
| d1nvra_ | 271 | Cell cycle checkpoint kinase chk1 {Human (Homo sap | 99.91 | |
| d2jfla1 | 288 | STE20-like serine/threonine-protein kinase, SLK {H | 99.91 | |
| d1tkia_ | 321 | Titin, kinase domain {Human (Homo sapiens) [TaxId: | 99.91 | |
| d2java1 | 269 | Serine/threonine-protein kinase Nek2 {Human (Homo | 99.9 | |
| d1xwsa_ | 273 | Proto-oncogene serine/threonine-protein kinase Pim | 99.9 | |
| d1s9ja_ | 322 | Dual specificity mitogen-activated protein kinase | 99.9 | |
| d2ozaa1 | 335 | MAP kinase activated protein kinase 2, mapkap2 {Hu | 99.89 | |
| d1gz8a_ | 298 | Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T | 99.89 | |
| d3bqca1 | 328 | Protein kinase CK2, alpha subunit {Rattus norvegic | 99.89 | |
| d1u5ra_ | 309 | Serine/threonine protein kinase TAO2 {Rat (Rattus | 99.89 | |
| d1ua2a_ | 299 | Cell division protein kinase 7, CDK7 {Human (Homo | 99.89 | |
| d1q5ka_ | 350 | Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho | 99.88 | |
| d1ob3a_ | 286 | Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) | 99.88 | |
| d2gfsa1 | 348 | MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606] | 99.87 | |
| d1unla_ | 292 | Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T | 99.87 | |
| d1cm8a_ | 346 | MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: | 99.87 | |
| d1zara2 | 191 | Rio2 serine protein kinase C-terminal domain {Arch | 99.87 | |
| d3blha1 | 318 | Cell division protein kinase 9, CDK9 {Human (Homo | 99.87 | |
| d1t4ha_ | 270 | Protein kinase wnk1 {Human (Homo sapiens) [TaxId: | 99.86 | |
| d2b1pa1 | 355 | c-jun N-terminal kinase (jnk3s) {Human (Homo sapie | 99.85 | |
| d1pmea_ | 345 | MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606 | 99.85 | |
| d1opja_ | 287 | Abelsone tyrosine kinase (abl) {Mouse (Mus musculu | 99.84 | |
| d1o6ya_ | 277 | Mycobacterial protein kinase PknB, catalytic domai | 99.83 | |
| d1q8ya_ | 362 | Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T | 99.81 | |
| d1rjba_ | 325 | Fl cytokine receptor {Human (Homo sapiens) [TaxId: | 99.81 | |
| d1qpca_ | 272 | Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax | 99.81 | |
| d1k2pa_ | 258 | Bruton's tyrosine kinase (Btk) {Human (Homo sapien | 99.8 | |
| d1fmka3 | 285 | c-src tyrosine kinase {Human (Homo sapiens) [TaxId | 99.79 | |
| d1xkka_ | 317 | EGF receptor tyrosine kinase, Erbb-1 {Human (Homo | 99.79 | |
| d1mp8a_ | 273 | Focal adhesion kinase 1 (fak) {Human (Homo sapiens | 99.78 | |
| d1sm2a_ | 263 | Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie | 99.77 | |
| d1xbba_ | 277 | Tyrosine-protein kinase SYK {Human (Homo sapiens) | 99.77 | |
| d1fvra_ | 309 | Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | 99.76 | |
| d1jpaa_ | 299 | ephb2 receptor tyrosine kinase {Mouse (Mus musculu | 99.75 | |
| d1u59a_ | 285 | Tyrosine-protein kinase ZAP-70 {Human (Homo sapien | 99.75 | |
| d1byga_ | 262 | Carboxyl-terminal src kinase (csk) {Human (Homo sa | 99.75 | |
| d1ywna1 | 299 | Vascular endothelial growth factor receptor 2 (kdr | 99.74 | |
| d1u46a_ | 273 | Activated CDC42 kinase 1, ACK1 {Human (Homo sapien | 99.74 | |
| d1fgka_ | 299 | Fibroblast growth factor receptor 1 {Human (Homo s | 99.73 | |
| d1lufa_ | 301 | Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax | 99.73 | |
| d1mqba_ | 283 | epha2 receptor tyrosine kinase {Human (Homo sapien | 99.71 | |
| d1uwha_ | 276 | B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | 99.71 | |
| d1t46a_ | 311 | c-KIT receptor {Human (Homo sapiens) [TaxId: 9606] | 99.71 | |
| d1p4oa_ | 308 | Insulin-like growth factor 1 receptor {Human (Homo | 99.7 | |
| d1ckia_ | 299 | Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax | 99.67 | |
| d1csna_ | 293 | Casein kinase-1, CK1 {Fission yeast (Schizosacchar | 99.63 | |
| d1r0pa_ | 311 | Hepatocyte growth factor receptor, c-MET {Human (H | 99.62 | |
| d1vjya_ | 303 | Type I TGF-beta receptor R4 {Human (Homo sapiens) | 99.34 | |
| d1zara2 | 191 | Rio2 serine protein kinase C-terminal domain {Arch | 99.03 | |
| d1j7la_ | 263 | Type IIIa 3',5"-aminoglycoside phosphotransferase | 98.05 | |
| d2pula1 | 392 | Methylthioribose kinase MtnK {Bacillus subtilis [T | 97.35 | |
| d1nd4a_ | 255 | Aminoglycoside 3'-phosphotransferase IIa (Kanamyci | 97.28 | |
| d1nw1a_ | 395 | Choline kinase {Caenorhabditis elegans [TaxId: 623 | 95.79 | |
| d1zyla1 | 325 | RdoA {Escherichia coli [TaxId: 562]} | 94.35 | |
| d2ppqa1 | 316 | Homoserine kinase ThrB {Agrobacterium tumefaciens | 92.09 | |
| d1j7la_ | 263 | Type IIIa 3',5"-aminoglycoside phosphotransferase | 90.15 |
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.5e-52 Score=447.12 Aligned_cols=243 Identities=32% Similarity=0.544 Sum_probs=210.3
Q ss_pred cccccccccccccEEEEEEEcCCCcEEEEEEecccc--------ChHHHHHHHHHhcCCCCceEEEEEEEeCCeEEEEEE
Q psy11767 380 LDKAGILGDGSYSVCRRCVEKSTGQEYAVKIISRKI--------DCSEEINLLRACQGHPNIVNLHCVFQDEVHTYLVLE 451 (966)
Q Consensus 380 ~~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~--------~~~~Ei~iL~~l~~HpnIV~l~~~~~~~~~~~lVmE 451 (966)
|+..+.||+|+||+||+|+++.+|+.||||++.+.. ...+|+++|+.+ +|||||+++++|.+++..|||||
T Consensus 8 y~i~~~iG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l-~hpnIv~~~~~~~~~~~~~ivmE 86 (263)
T d2j4za1 8 FEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL-RHPNILRLYGYFHDATRVYLILE 86 (263)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTC-CCTTBCCEEEEEECSSEEEEEEE
T ss_pred eEEEEEEecCCCcEEEEEEECCCCcEEEEEEEchHHccChHHHHHHHHHHHHHHhc-CCCCCCeEEEEEEECCEEEEEEe
Confidence 444789999999999999999999999999986421 245799999988 59999999999999999999999
Q ss_pred ccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCcEEEecCCCCCEEEEeecccccccC-CCc
Q psy11767 452 LLKGGELLDRIRQKGRCGFTENEASRIMRQLVAAVHFMHSRGVVHRDLKPENLLFSDPAGDNIKVVDFGFACLKRE-SLH 530 (966)
Q Consensus 452 y~~gg~L~~~l~~~~~~~l~e~~~~~i~~Qil~aL~yLHs~~IiHRDLKP~NILl~~~~~~~iKL~DFGla~~~~~-~~~ 530 (966)
||+||+|.+++.+.+ .+++.+++.|+.||+.||+|||++||+||||||+|||++. ++.+||+|||+|+.... ...
T Consensus 87 y~~~g~L~~~l~~~~--~l~e~~~~~i~~qi~~al~~lH~~~ivHrDiKp~Nill~~--~~~~kl~DFG~a~~~~~~~~~ 162 (263)
T d2j4za1 87 YAPLGTVYRELQKLS--KFDEQRTATYITELANALSYCHSKRVIHRDIKPENLLLGS--AGELKIADFGWSVHAPSSRRT 162 (263)
T ss_dssp CCTTCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECT--TSCEEECCCCSCSCCCCCCCE
T ss_pred ecCCCcHHHHHhhcC--CCCHHHHHHHHHHHHHHHHHHHHCCeeeeeeccccceecC--CCCEeecccceeeecCCCccc
Confidence 999999999998765 5999999999999999999999999999999999999975 56899999999976543 344
Q ss_pred cccccccccCchhhccCCCCCCCcccchhhhhhhhhhhhcCCCCCCCcCcchhHHHHHHHHhcCCCCCCCCCCchhHHHH
Q psy11767 531 TPCFTLQYAAPEVLRQDKSGYDENCDLWSLGVILVNVLRQDKSGYDENCDLWSLGVILYTMLCGRVPFHARSRDDSALSI 610 (966)
Q Consensus 531 ~~~gT~~Y~APEvl~~~~~~~~~~~Di~SlGvil~el~~~~~~~y~~~~DIWSlGvilyemltG~~Pf~~~~~~~~~~~~ 610 (966)
..+||+.|||||++.. ..|+.++|||||||++|+|++|++||.+.+. ..+
T Consensus 163 ~~~Gt~~Y~APE~~~~--------------------------~~~~~~~DiwSlGvilyell~G~~Pf~~~~~----~~~ 212 (263)
T d2j4za1 163 TLCGTLDYLPPEMIEG--------------------------RMHDEKVDLWSLGVLCYEFLVGKPPFEANTY----QET 212 (263)
T ss_dssp ETTEEGGGCCHHHHTT--------------------------CCCCTTHHHHHHHHHHHHHHHSSCTTCCSSH----HHH
T ss_pred ccCCCCcccCHHHHcC--------------------------CCCCchhhhhhHhHHHHHHhcCCCCCCCCCH----HHH
Confidence 5689999999999853 3478899999999999999999999987543 345
Q ss_pred HHHHHcCCCCCCchhhccCCHHHHHHHHHhcccCccccCChHHHHHHhhhhHH
Q psy11767 611 MARIKEGQFNFDAEAWSTVSSEAKELTKSLLTVNPAQRIRMMRVKLTFHAFHQ 663 (966)
Q Consensus 611 ~~~i~~~~~~~~~~~~~~is~e~~~Li~~~L~~dP~~R~t~~~v~~~~~~~~~ 663 (966)
+..+.++.+.++ ..+|+++++||.+||+.||++|||+.++ ..|+|+.
T Consensus 213 ~~~i~~~~~~~p----~~~s~~~~~li~~~L~~dp~~R~t~~ei--l~hp~~~ 259 (263)
T d2j4za1 213 YKRISRVEFTFP----DFVTEGARDLISRLLKHNPSQRPMLREV--LEHPWIT 259 (263)
T ss_dssp HHHHHTTCCCCC----TTSCHHHHHHHHHHTCSSGGGSCCHHHH--HTCHHHH
T ss_pred HHHHHcCCCCCC----ccCCHHHHHHHHHHccCCHhHCcCHHHH--HcCcCcC
Confidence 667777776544 3589999999999999999999999976 4577764
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.7e-52 Score=451.43 Aligned_cols=247 Identities=34% Similarity=0.567 Sum_probs=205.4
Q ss_pred cccccccccccccEEEEEEEcCCCcEEEEEEecccc------ChHHHHHHHHHhcCCCCceEEEEEEEeCCeEEEEEEcc
Q psy11767 380 LDKAGILGDGSYSVCRRCVEKSTGQEYAVKIISRKI------DCSEEINLLRACQGHPNIVNLHCVFQDEVHTYLVLELL 453 (966)
Q Consensus 380 ~~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~------~~~~Ei~iL~~l~~HpnIV~l~~~~~~~~~~~lVmEy~ 453 (966)
|+.++.||+|+||+||+|+++.+|+.||||++.... ...+|+++|+.+ +|||||++++++.+++..|||||||
T Consensus 7 y~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~~l~~l-~HpnIv~~~~~~~~~~~~~ivmEy~ 85 (271)
T d1nvra_ 7 WDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKML-NHENVVKFYGHRREGNIQYLFLEYC 85 (271)
T ss_dssp EEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHTC-CCTTBCCEEEEEEETTEEEEEEECC
T ss_pred eEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHhC-CCCCEeeEeeeeccCceeEEEEecc
Confidence 344789999999999999999999999999986532 356899999998 5999999999999999999999999
Q ss_pred CCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCcEEEecCCCCCEEEEeecccccccC-----C
Q psy11767 454 KGGELLDRIRQKGRCGFTENEASRIMRQLVAAVHFMHSRGVVHRDLKPENLLFSDPAGDNIKVVDFGFACLKRE-----S 528 (966)
Q Consensus 454 ~gg~L~~~l~~~~~~~l~e~~~~~i~~Qil~aL~yLHs~~IiHRDLKP~NILl~~~~~~~iKL~DFGla~~~~~-----~ 528 (966)
+||+|.+++.... .+++.+++.++.||+.||+|||++||+||||||+|||+++ ++.+||+|||+|+.... .
T Consensus 86 ~gg~L~~~l~~~~--~l~e~~~~~i~~qi~~al~ylH~~~IiHrDiKp~NILl~~--~~~~KL~DFG~a~~~~~~~~~~~ 161 (271)
T d1nvra_ 86 SGGELFDRIEPDI--GMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDE--RDNLKISDFGLATVFRYNNRERL 161 (271)
T ss_dssp TTEEGGGGSBTTT--BCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECT--TCCEEECCCTTCEECEETTEECC
T ss_pred CCCcHHHHHhcCC--CCCHHHHHHHHHHHHHHHHHHHHcCCccCcccHHHEEECC--CCCEEEccchhheeeccCCcccc
Confidence 9999999986544 6999999999999999999999999999999999999975 56899999999976432 2
Q ss_pred CccccccccccCchhhccCCCCCCCcccchhhhhhhhhhhhcCCCCCCCcCcchhHHHHHHHHhcCCCCCCCCCCchhHH
Q psy11767 529 LHTPCFTLQYAAPEVLRQDKSGYDENCDLWSLGVILVNVLRQDKSGYDENCDLWSLGVILYTMLCGRVPFHARSRDDSAL 608 (966)
Q Consensus 529 ~~~~~gT~~Y~APEvl~~~~~~~~~~~Di~SlGvil~el~~~~~~~y~~~~DIWSlGvilyemltG~~Pf~~~~~~~~~~ 608 (966)
..+.+||+.|||||++... ..++.++|||||||++|+|++|++||.........
T Consensus 162 ~~~~~GT~~Y~APE~~~~~-------------------------~~~~~~~DiwSlGvilyeml~G~~pf~~~~~~~~~- 215 (271)
T d1nvra_ 162 LNKMCGTLPYVAPELLKRR-------------------------EFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQE- 215 (271)
T ss_dssp BCCCCSCGGGSCTHHHHCS-------------------------SBCHHHHHHHHHHHHHHHHHHSSCSCSSSSTTSHH-
T ss_pred ccceeeCcCccCHhHhcCC-------------------------CCCCCceeeeHhHHHHHHHHhCCCCCCCCChHHHH-
Confidence 3456899999999998632 22467899999999999999999999876543322
Q ss_pred HHHHHHHcCCCCCCchhhccCCHHHHHHHHHhcccCccccCChHHHHHHhhhhHH
Q psy11767 609 SIMARIKEGQFNFDAEAWSTVSSEAKELTKSLLTVNPAQRIRMMRVKLTFHAFHQ 663 (966)
Q Consensus 609 ~~~~~i~~~~~~~~~~~~~~is~e~~~Li~~~L~~dP~~R~t~~~v~~~~~~~~~ 663 (966)
...+..... ....+..+|+++++||.+||+.||++|||+.++ ..|+|++
T Consensus 216 --~~~~~~~~~--~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~ei--l~hpwf~ 264 (271)
T d1nvra_ 216 --YSDWKEKKT--YLNPWKKIDSAPLALLHKILVENPSARITIPDI--KKDRWYN 264 (271)
T ss_dssp --HHHHHTTCT--TSTTGGGSCHHHHHHHHHHSCSSTTTSCCHHHH--TTCTTTT
T ss_pred --HHHHhcCCC--CCCccccCCHHHHHHHHHHcCCChhHCcCHHHH--hcCHhhC
Confidence 222233222 223456799999999999999999999999976 4577753
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Probab=100.00 E-value=1.2e-51 Score=464.67 Aligned_cols=254 Identities=33% Similarity=0.645 Sum_probs=219.7
Q ss_pred ecccccccccccccccccccEEEEEEEcCCCcEEEEEEecccc-----ChHHHHHHHHHhcCCCCceEEEEEEEeCCeEE
Q psy11767 373 FEQYDMDLDKAGILGDGSYSVCRRCVEKSTGQEYAVKIISRKI-----DCSEEINLLRACQGHPNIVNLHCVFQDEVHTY 447 (966)
Q Consensus 373 ~~~~~i~~~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~-----~~~~Ei~iL~~l~~HpnIV~l~~~~~~~~~~~ 447 (966)
++.|++ ++.||+|+||+||+|+++.+|+.||||++.... ...+|+.+|+.+ +|||||+++++|+++..+|
T Consensus 28 ~d~Y~i----~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~Ei~il~~l-~HpnIv~~~~~~~~~~~~~ 102 (352)
T d1koba_ 28 YDYYDI----LEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQL-HHPKLINLHDAFEDKYEMV 102 (352)
T ss_dssp GGTEEE----EEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTC-CSTTBCCEEEEEECSSEEE
T ss_pred ccceEE----EEEEecCCCeEEEEEEECCCCCEEEEEEECCcchhHHHHHHHHHHHHHhC-CCCCCCcEEEEEEECCEEE
Confidence 344554 689999999999999999999999999997543 245699999998 5999999999999999999
Q ss_pred EEEEccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCcEEEecCCCCCEEEEeecccccccC
Q psy11767 448 LVLELLKGGELLDRIRQKGRCGFTENEASRIMRQLVAAVHFMHSRGVVHRDLKPENLLFSDPAGDNIKVVDFGFACLKRE 527 (966)
Q Consensus 448 lVmEy~~gg~L~~~l~~~~~~~l~e~~~~~i~~Qil~aL~yLHs~~IiHRDLKP~NILl~~~~~~~iKL~DFGla~~~~~ 527 (966)
||||||+||+|.+++...+ ..|++.+++.|+.||+.||+|||++|||||||||+||||+....+.+||+|||+|+....
T Consensus 103 ivmE~~~gg~L~~~~~~~~-~~l~e~~~~~i~~qi~~aL~ylH~~~iiHRDiKp~NILl~~~~~~~vkL~DFGla~~~~~ 181 (352)
T d1koba_ 103 LILEFLSGGELFDRIAAED-YKMSEAEVINYMRQACEGLKHMHEHSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNP 181 (352)
T ss_dssp EEEECCCCCBHHHHTTCTT-CCBCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSTTCCCEEECCCTTCEECCT
T ss_pred EEEEcCCCChHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHCCeeecccccccccccccCCCeEEEeecccceecCC
Confidence 9999999999999886554 369999999999999999999999999999999999999755567999999999987543
Q ss_pred C--CccccccccccCchhhccCCCCCCCcccchhhhhhhhhhhhcCCCCCCCcCcchhHHHHHHHHhcCCCCCCCCCCch
Q psy11767 528 S--LHTPCFTLQYAAPEVLRQDKSGYDENCDLWSLGVILVNVLRQDKSGYDENCDLWSLGVILYTMLCGRVPFHARSRDD 605 (966)
Q Consensus 528 ~--~~~~~gT~~Y~APEvl~~~~~~~~~~~Di~SlGvil~el~~~~~~~y~~~~DIWSlGvilyemltG~~Pf~~~~~~~ 605 (966)
. ..+.+||+.|||||++.. ..|+.++|||||||++|+|++|++||.+.+.
T Consensus 182 ~~~~~~~~gt~~y~aPE~~~~--------------------------~~~~~~~DiwSlGvilyelltG~~Pf~~~~~-- 233 (352)
T d1koba_ 182 DEIVKVTTATAEFAAPEIVDR--------------------------EPVGFYTDMWAIGVLGYVLLSGLSPFAGEDD-- 233 (352)
T ss_dssp TSCEEEECSSGGGCCHHHHTT--------------------------CCBCHHHHHHHHHHHHHHHHHSCCSSCCSSH--
T ss_pred CCceeeccCcccccCHHHHcC--------------------------CCCCCccchHHHHHHHHHHHhCCCCCCCCCH--
Confidence 2 345678999999999852 3478899999999999999999999987543
Q ss_pred hHHHHHHHHHcCCCCCCchhhccCCHHHHHHHHHhcccCccccCChHHHHHHhhhhHHh
Q psy11767 606 SALSIMARIKEGQFNFDAEAWSTVSSEAKELTKSLLTVNPAQRIRMMRVKLTFHAFHQA 664 (966)
Q Consensus 606 ~~~~~~~~i~~~~~~~~~~~~~~is~e~~~Li~~~L~~dP~~R~t~~~v~~~~~~~~~~ 664 (966)
..++..|..+.+.++...+..+|+++++||.+||+.||.+|||+.++ ..|+|++.
T Consensus 234 --~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~ei--l~Hp~~~~ 288 (352)
T d1koba_ 234 --LETLQNVKRCDWEFDEDAFSSVSPEAKDFIKNLLQKEPRKRLTVHDA--LEHPWLKG 288 (352)
T ss_dssp --HHHHHHHHHCCCCCCSSTTTTSCHHHHHHHHTTSCSSGGGSCCHHHH--HTSTTTSS
T ss_pred --HHHHHHHHhCCCCCCcccccCCCHHHHHHHHHHccCChhHCcCHHHH--hcCHhhCC
Confidence 34567788888888887888999999999999999999999999976 45777653
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=1.3e-51 Score=455.94 Aligned_cols=248 Identities=38% Similarity=0.683 Sum_probs=203.7
Q ss_pred ccccccccccccEEEEEEEcCCCcEEEEEEecccc------ChHHHHHHHHHhcCCCCceEEEEEEEeCCeEEEEEEccC
Q psy11767 381 DKAGILGDGSYSVCRRCVEKSTGQEYAVKIISRKI------DCSEEINLLRACQGHPNIVNLHCVFQDEVHTYLVLELLK 454 (966)
Q Consensus 381 ~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~------~~~~Ei~iL~~l~~HpnIV~l~~~~~~~~~~~lVmEy~~ 454 (966)
+..+.||+|+||+||+|+++.+|+.||||++.+.. ...+|+++|+.+ +|||||+++++|++++.+|||||||+
T Consensus 12 ~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l-~HpnIv~l~~~~~~~~~~~lvmE~~~ 90 (307)
T d1a06a_ 12 DFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKI-KHPNIVALDDIYESGGHLYLIMQLVS 90 (307)
T ss_dssp EEEEESBSGGGGGEEEEEETTTCCEEEEEEEEC----------CHHHHHHHTC-CCTTBCCEEEEEECSSEEEEEECCCC
T ss_pred EEEEEEeeccCeEEEEEEECCCCCEEEEEEEchHHhhhHHHHHHHHHHHHHhC-CCCCCCcEEEEEEECCEEEEEEeccC
Confidence 33688999999999999999999999999997532 234799999998 59999999999999999999999999
Q ss_pred CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCcEEEec-CCCCCEEEEeecccccccC--CCcc
Q psy11767 455 GGELLDRIRQKGRCGFTENEASRIMRQLVAAVHFMHSRGVVHRDLKPENLLFSD-PAGDNIKVVDFGFACLKRE--SLHT 531 (966)
Q Consensus 455 gg~L~~~l~~~~~~~l~e~~~~~i~~Qil~aL~yLHs~~IiHRDLKP~NILl~~-~~~~~iKL~DFGla~~~~~--~~~~ 531 (966)
||+|.++|.+.+ .+++.+++.++.||+.||+|||++||+||||||+|||+.. ..++.+||+|||+|+.... ...+
T Consensus 91 gg~L~~~l~~~~--~l~e~~~~~~~~qi~~al~ylH~~~iiHrDiKp~Nil~~~~~~~~~vkl~DFG~a~~~~~~~~~~~ 168 (307)
T d1a06a_ 91 GGELFDRIVEKG--FYTERDASRLIFQVLDAVKYLHDLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGSVLST 168 (307)
T ss_dssp SCBHHHHHHTCS--CCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESSSSTTCCEEECCC--------------
T ss_pred CCcHHHhhhccc--CCCHHHHHHHHHHHHHHHHhhhhceeeeEEecccceeecccCCCceEEEeccceeEEccCCCeeee
Confidence 999999997754 6999999999999999999999999999999999999964 2356899999999976543 3456
Q ss_pred ccccccccCchhhccCCCCCCCcccchhhhhhhhhhhhcCCCCCCCcCcchhHHHHHHHHhcCCCCCCCCCCchhHHHHH
Q psy11767 532 PCFTLQYAAPEVLRQDKSGYDENCDLWSLGVILVNVLRQDKSGYDENCDLWSLGVILYTMLCGRVPFHARSRDDSALSIM 611 (966)
Q Consensus 532 ~~gT~~Y~APEvl~~~~~~~~~~~Di~SlGvil~el~~~~~~~y~~~~DIWSlGvilyemltG~~Pf~~~~~~~~~~~~~ 611 (966)
.+||+.|||||++.. ..|+.++|||||||++|+|++|++||.+... ..+.
T Consensus 169 ~~GT~~y~APE~~~~--------------------------~~~~~~~DiwSlGvilyell~g~~Pf~~~~~----~~~~ 218 (307)
T d1a06a_ 169 ACGTPGYVAPEVLAQ--------------------------KPYSKAVDCWSIGVIAYILLCGYPPFYDEND----AKLF 218 (307)
T ss_dssp ----CTTSCHHHHTT--------------------------CCCCTHHHHHHHHHHHHHHHHSSCSCCCSSH----HHHH
T ss_pred eeeCccccCcHHHcC--------------------------CCCCcHHHhhhhhHHHHHHHhCCCCCCCCCH----HHHH
Confidence 789999999999853 3478899999999999999999999987543 3456
Q ss_pred HHHHcCCCCCCchhhccCCHHHHHHHHHhcccCccccCChHHHHHHhhhhHH
Q psy11767 612 ARIKEGQFNFDAEAWSTVSSEAKELTKSLLTVNPAQRIRMMRVKLTFHAFHQ 663 (966)
Q Consensus 612 ~~i~~~~~~~~~~~~~~is~e~~~Li~~~L~~dP~~R~t~~~v~~~~~~~~~ 663 (966)
..+..+.+.++...++.+|+++++||.+||+.||++|||+.++ ..|+|..
T Consensus 219 ~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~ei--l~hp~~~ 268 (307)
T d1a06a_ 219 EQILKAEYEFDSPYWDDISDSAKDFIRHLMEKDPEKRFTCEQA--LQHPWIA 268 (307)
T ss_dssp HHHHTTCCCCCTTTTTTSCHHHHHHHHHHSCSSGGGSCCHHHH--HHSTTTT
T ss_pred HHHhccCCCCCCccccCCCHHHHHHHHHHccCCHhHCcCHHHH--hcCHhhC
Confidence 7788888888777788899999999999999999999999976 4477764
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.2e-52 Score=464.62 Aligned_cols=260 Identities=37% Similarity=0.676 Sum_probs=218.0
Q ss_pred eecccccccccc-cccccccccEEEEEEEcCCCcEEEEEEeccccChHHHHHHHHHhcCCCCceEEEEEEEe----CCeE
Q psy11767 372 FFEQYDMDLDKA-GILGDGSYSVCRRCVEKSTGQEYAVKIISRKIDCSEEINLLRACQGHPNIVNLHCVFQD----EVHT 446 (966)
Q Consensus 372 ~~~~~~i~~~~~-~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~~~~~Ei~iL~~l~~HpnIV~l~~~~~~----~~~~ 446 (966)
+.+.|++ + ++||+|+||+||+|++..+|+.||||++++.....+|+.++..+.+|||||+++++|++ +.++
T Consensus 9 i~~~y~i----~~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~E~~~~~~~~~hpnIv~l~~~~~~~~~~~~~~ 84 (335)
T d2ozaa1 9 IIDDYKV----TSQVLGLGINGKVLQIFNKRTQEKFALKMLQDCPKARREVELHWRASQCPHIVRIVDVYENLYAGRKCL 84 (335)
T ss_dssp GGGTEEE----EEEEEEECSSCEEEEEEETTTCCEEEEEEEECSHHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEE
T ss_pred cccCEEE----eeEEeeeccCeEEEEEEECCCCCEEEEEEECCcHHHHHHHHHHHHhcCCCCCCeEEEEEeecccCCCEE
Confidence 3455554 3 46999999999999999999999999998777788899998777689999999999986 4678
Q ss_pred EEEEEccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCcEEEecCC-CCCEEEEeecccccc
Q psy11767 447 YLVLELLKGGELLDRIRQKGRCGFTENEASRIMRQLVAAVHFMHSRGVVHRDLKPENLLFSDPA-GDNIKVVDFGFACLK 525 (966)
Q Consensus 447 ~lVmEy~~gg~L~~~l~~~~~~~l~e~~~~~i~~Qil~aL~yLHs~~IiHRDLKP~NILl~~~~-~~~iKL~DFGla~~~ 525 (966)
|||||||+||+|.++|.+++...|++.+++.|+.||+.||+|||++||+||||||+|||+++.. .+.+||+|||+|+..
T Consensus 85 ~ivmEy~~gg~L~~~i~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~iiHRDiKp~NIll~~~~~~~~~Kl~DFG~a~~~ 164 (335)
T d2ozaa1 85 LIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKET 164 (335)
T ss_dssp EEEEECCCSEEHHHHHHSCSCCCEEHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCSSTTCCEEECCCTTCEEC
T ss_pred EEEEECCCCCcHHHHHHhcCCCCcCHHHHHHHHHHHHHHHHHHHHcCCccccccccccccccccccccccccccceeeec
Confidence 9999999999999999877655799999999999999999999999999999999999997532 457999999999765
Q ss_pred cC--CCccccccccccCchhhccCCCCCCCcccchhhhhhhhhhhhcCCCCCCCcCcchhHHHHHHHHhcCCCCCCCCCC
Q psy11767 526 RE--SLHTPCFTLQYAAPEVLRQDKSGYDENCDLWSLGVILVNVLRQDKSGYDENCDLWSLGVILYTMLCGRVPFHARSR 603 (966)
Q Consensus 526 ~~--~~~~~~gT~~Y~APEvl~~~~~~~~~~~Di~SlGvil~el~~~~~~~y~~~~DIWSlGvilyemltG~~Pf~~~~~ 603 (966)
.. .....+||+.|||||++.. ..|+.++|||||||++|+|++|++||.+.+.
T Consensus 165 ~~~~~~~~~~gt~~y~aPE~~~~--------------------------~~y~~~~DiwSlGvily~lltg~~Pf~~~~~ 218 (335)
T d2ozaa1 165 TSHNSLTTPCYTPYYVAPEVLGP--------------------------EKYDKSCDMWSLGVIMYILLCGYPPFYSNHG 218 (335)
T ss_dssp CCCCCCCCCSCCCSSCCCCCCCG--------------------------GGGSHHHHHHHHHHHHHHHTTSSCSCEETTC
T ss_pred cCCCccccccCCcccCCcHHHcC--------------------------CCCCHHHHHHhhchhHHHHhhCCCCCCCCCH
Confidence 33 3456789999999999853 2378899999999999999999999987765
Q ss_pred chhHHHHHHHHHcCCCCCCchhhccCCHHHHHHHHHhcccCccccCChHHHHHHhhhhHH
Q psy11767 604 DDSALSIMARIKEGQFNFDAEAWSTVSSEAKELTKSLLTVNPAQRIRMMRVKLTFHAFHQ 663 (966)
Q Consensus 604 ~~~~~~~~~~i~~~~~~~~~~~~~~is~e~~~Li~~~L~~dP~~R~t~~~v~~~~~~~~~ 663 (966)
......+...+..+.+.++...+..+|+++++||++||+.||++|||+.++ ..|+|+.
T Consensus 219 ~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~ei--l~hp~~~ 276 (335)
T d2ozaa1 219 LAISPGMKTRIRMGQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEF--MNHPWIM 276 (335)
T ss_dssp C--------CCCSCSSSCCTTHHHHSCHHHHHHHHHHSCSSTTTSCCHHHH--HHSHHHH
T ss_pred HHHHHHHHHHHhcCCCCCCCcccccCCHHHHHHHHHHccCChhHCcCHHHH--HcCHHhh
Confidence 544444555667777777777788899999999999999999999999876 4567763
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.3e-51 Score=447.95 Aligned_cols=245 Identities=25% Similarity=0.426 Sum_probs=206.6
Q ss_pred ccccccccccccEEEEEEEcCCCcEEEEEEeccccC-----hHHHHHHHHHhcCCCCceEEEEEEEeCCeEEEEEEccCC
Q psy11767 381 DKAGILGDGSYSVCRRCVEKSTGQEYAVKIISRKID-----CSEEINLLRACQGHPNIVNLHCVFQDEVHTYLVLELLKG 455 (966)
Q Consensus 381 ~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~~-----~~~Ei~iL~~l~~HpnIV~l~~~~~~~~~~~lVmEy~~g 455 (966)
+.++.||+|+||+||+|+++.+|+.||||++..... ..+|+.+|+.+ +|||||+++++|.++++.|||||||+|
T Consensus 23 ~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~il~~l-~HpnIv~~~~~~~~~~~~~ivmEy~~g 101 (293)
T d1yhwa1 23 TRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMREN-KNPNIVNYLDSYLVGDELWVVMEYLAG 101 (293)
T ss_dssp CSCEECCCSSSCEEEEEEBTTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHHC-CCTTBCCEEEEEEETTEEEEEEECCTT
T ss_pred EEEEEEecCcCcEEEEEEECCCCCEEEEEEEecccChHHHHHHHHHHHHHhC-CCCCEeeEeEEEEECCEEEEEEEecCC
Confidence 346889999999999999999999999999865432 45799999998 599999999999999999999999999
Q ss_pred CCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCcEEEecCCCCCEEEEeecccccccC---CCccc
Q psy11767 456 GELLDRIRQKGRCGFTENEASRIMRQLVAAVHFMHSRGVVHRDLKPENLLFSDPAGDNIKVVDFGFACLKRE---SLHTP 532 (966)
Q Consensus 456 g~L~~~l~~~~~~~l~e~~~~~i~~Qil~aL~yLHs~~IiHRDLKP~NILl~~~~~~~iKL~DFGla~~~~~---~~~~~ 532 (966)
|+|.+++.+. .+++.+++.|+.||+.||+|||++|||||||||+|||++. ++.+||+|||+|+.... .....
T Consensus 102 g~L~~~~~~~---~l~~~~~~~i~~qi~~aL~yLH~~~iiHrDiKp~NILl~~--~~~vkl~DFG~a~~~~~~~~~~~~~ 176 (293)
T d1yhwa1 102 GSLTDVVTET---CMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGM--DGSVKLTDFGFCAQITPEQSKRSTM 176 (293)
T ss_dssp CBHHHHHHHS---CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECT--TCCEEECCCTTCEECCSTTCCBCCC
T ss_pred CcHHHHhhcc---CCCHHHHHHHHHHHHHHHHHHHHCCCcccCCcHHHeEECC--CCcEeeccchhheeecccccccccc
Confidence 9999987654 5999999999999999999999999999999999999975 56899999999976532 33466
Q ss_pred cccccccCchhhccCCCCCCCcccchhhhhhhhhhhhcCCCCCCCcCcchhHHHHHHHHhcCCCCCCCCCCchhHHHHHH
Q psy11767 533 CFTLQYAAPEVLRQDKSGYDENCDLWSLGVILVNVLRQDKSGYDENCDLWSLGVILYTMLCGRVPFHARSRDDSALSIMA 612 (966)
Q Consensus 533 ~gT~~Y~APEvl~~~~~~~~~~~Di~SlGvil~el~~~~~~~y~~~~DIWSlGvilyemltG~~Pf~~~~~~~~~~~~~~ 612 (966)
+||+.|||||++.. ..|+.++|||||||++|+|++|++||.+.+..+ .+..
T Consensus 177 ~gt~~Y~aPE~~~~--------------------------~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~---~~~~ 227 (293)
T d1yhwa1 177 VGTPYWMAPEVVTR--------------------------KAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLR---ALYL 227 (293)
T ss_dssp CSCGGGCCHHHHSS--------------------------SCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHH---HHHH
T ss_pred ccCCCccChhhhcC--------------------------CCCCchhceehHhHHHHHHhhCCCCCCCCCHHH---HHHH
Confidence 89999999999853 347889999999999999999999998755332 2222
Q ss_pred HHHcCCCCCCchhhccCCHHHHHHHHHhcccCccccCChHHHHHHhhhhHHh
Q psy11767 613 RIKEGQFNFDAEAWSTVSSEAKELTKSLLTVNPAQRIRMMRVKLTFHAFHQA 664 (966)
Q Consensus 613 ~i~~~~~~~~~~~~~~is~e~~~Li~~~L~~dP~~R~t~~~v~~~~~~~~~~ 664 (966)
.+..+.+.+ ..+..+|+++++||.+||+.||++|||+.++ ..|+|++.
T Consensus 228 ~~~~~~~~~--~~~~~~s~~~~~li~~~L~~dP~~R~s~~ei--l~Hp~~~~ 275 (293)
T d1yhwa1 228 IATNGTPEL--QNPEKLSAIFRDFLNRCLDMDVEKRGSAKEL--LQHQFLKI 275 (293)
T ss_dssp HHHHCSCCC--SSGGGSCHHHHHHHHHHTCSSTTTSCCHHHH--TTCGGGGG
T ss_pred HHhCCCCCC--CCcccCCHHHHHHHHHHccCChhHCcCHHHH--hcCHhhCC
Confidence 333333332 3346789999999999999999999999976 45788754
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.2e-51 Score=453.27 Aligned_cols=255 Identities=29% Similarity=0.546 Sum_probs=222.0
Q ss_pred eecccccccccccccccccccEEEEEEEcCCCcEEEEEEeccccC----hHHHHHHHHHhcCCCCceEEEEEEEeCCeEE
Q psy11767 372 FFEQYDMDLDKAGILGDGSYSVCRRCVEKSTGQEYAVKIISRKID----CSEEINLLRACQGHPNIVNLHCVFQDEVHTY 447 (966)
Q Consensus 372 ~~~~~~i~~~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~~----~~~Ei~iL~~l~~HpnIV~l~~~~~~~~~~~ 447 (966)
++++|.+ ++.||+|+||+||+|+++.+|+.||||+++.... ..+|+++|+.+ +|||||+++++|++++++|
T Consensus 3 ~~~rY~i----~~~lG~G~fg~Vy~~~~~~~~~~~AiK~i~~~~~~~~~~~~Ei~il~~l-~HpnIv~~~~~~~~~~~~~ 77 (321)
T d1tkia_ 3 LYEKYMI----AEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQVLVKKEISILNIA-RHRNILHLHESFESMEELV 77 (321)
T ss_dssp CTTTEEE----EEEEEECSSEEEEEEEETTTTEEEEEEEECCCTHHHHHHHHHHHHHHHS-CCTTBCCEEEEEEETTEEE
T ss_pred CccceEE----EEEEecCCCeEEEEEEECCCCcEEEEEEEcCCcccHHHHHHHHHHHHhC-CCCCCCeEEEEEEECCEEE
Confidence 4566665 6889999999999999999999999999976532 45799999988 5999999999999999999
Q ss_pred EEEEccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCcEEEecCCCCCEEEEeecccccccC
Q psy11767 448 LVLELLKGGELLDRIRQKGRCGFTENEASRIMRQLVAAVHFMHSRGVVHRDLKPENLLFSDPAGDNIKVVDFGFACLKRE 527 (966)
Q Consensus 448 lVmEy~~gg~L~~~l~~~~~~~l~e~~~~~i~~Qil~aL~yLHs~~IiHRDLKP~NILl~~~~~~~iKL~DFGla~~~~~ 527 (966)
||||||+||+|.++|.+.+. .+++.+++.|+.||+.||+|||++||+||||||+|||++......+||+|||+++....
T Consensus 78 lvmE~~~gg~L~~~i~~~~~-~l~e~~~~~i~~qi~~al~yLH~~~iiHrDlKp~NIll~~~~~~~ikl~DFG~~~~~~~ 156 (321)
T d1tkia_ 78 MIFEFISGLDIFERINTSAF-ELNEREIVSYVHQVCEALQFLHSHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKP 156 (321)
T ss_dssp EEECCCCCCBHHHHHTSSSC-CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSSCCCEEECCCTTCEECCT
T ss_pred EEEecCCCCcHHHHHHhcCC-CCCHHHHHHHHHHHHHHHHHHHHcCCCcccccccceeecCCCceEEEEcccchhhcccc
Confidence 99999999999999976542 59999999999999999999999999999999999999865566899999999976543
Q ss_pred C--CccccccccccCchhhccCCCCCCCcccchhhhhhhhhhhhcCCCCCCCcCcchhHHHHHHHHhcCCCCCCCCCCch
Q psy11767 528 S--LHTPCFTLQYAAPEVLRQDKSGYDENCDLWSLGVILVNVLRQDKSGYDENCDLWSLGVILYTMLCGRVPFHARSRDD 605 (966)
Q Consensus 528 ~--~~~~~gT~~Y~APEvl~~~~~~~~~~~Di~SlGvil~el~~~~~~~y~~~~DIWSlGvilyemltG~~Pf~~~~~~~ 605 (966)
. ..+.++|+.|+|||++.. ..|+.++|||||||++|+|++|++||.+.+.
T Consensus 157 ~~~~~~~~~t~~y~ape~~~~--------------------------~~~~~~~DiWSlGvily~ll~G~~Pf~~~~~-- 208 (321)
T d1tkia_ 157 GDNFRLLFTAPEYYAPEVHQH--------------------------DVVSTATDMWSLGTLVYVLLSGINPFLAETN-- 208 (321)
T ss_dssp TCEEEEEESCGGGSCHHHHTT--------------------------CEECHHHHHHHHHHHHHHHHHSSCTTCCSSH--
T ss_pred CCcccccccccccccchhccC--------------------------CCCCchhhcccHHHHHHHHHhCCCCCCCCCH--
Confidence 2 345678999999998852 3478899999999999999999999987543
Q ss_pred hHHHHHHHHHcCCCCCCchhhccCCHHHHHHHHHhcccCccccCChHHHHHHhhhhHHh
Q psy11767 606 SALSIMARIKEGQFNFDAEAWSTVSSEAKELTKSLLTVNPAQRIRMMRVKLTFHAFHQA 664 (966)
Q Consensus 606 ~~~~~~~~i~~~~~~~~~~~~~~is~e~~~Li~~~L~~dP~~R~t~~~v~~~~~~~~~~ 664 (966)
..++..|.++.+.++...|+.+|+++++||.+||..||++|||+.++ ..|+|++.
T Consensus 209 --~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~ei--l~hp~~~~ 263 (321)
T d1tkia_ 209 --QQIIENIMNAEYTFDEEAFKEISIEAMDFVDRLLVKERKSRMTASEA--LQHPWLKQ 263 (321)
T ss_dssp --HHHHHHHHHTCCCCCHHHHTTSCHHHHHHHHTTSCSSGGGSCCHHHH--HHSHHHHS
T ss_pred --HHHHHHHHhCCCCCChhhccCCCHHHHHHHHHHccCChhHCcCHHHH--hcCHhhcc
Confidence 35677788889988888888999999999999999999999999976 45777753
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.7e-51 Score=449.32 Aligned_cols=245 Identities=32% Similarity=0.582 Sum_probs=208.6
Q ss_pred cccccccccccccEEEEEEEcCCCcEEEEEEecccc--------ChHHHHHHHHHhcCCCCceEEEEEEEeCCeEEEEEE
Q psy11767 380 LDKAGILGDGSYSVCRRCVEKSTGQEYAVKIISRKI--------DCSEEINLLRACQGHPNIVNLHCVFQDEVHTYLVLE 451 (966)
Q Consensus 380 ~~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~--------~~~~Ei~iL~~l~~HpnIV~l~~~~~~~~~~~lVmE 451 (966)
|+..+.||+|+||+||+|+++.+|+.||||++.+.. ...+|+++|+.+ +|||||+++++|++++..|||||
T Consensus 10 y~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l-~HpnIv~l~~~~~~~~~~~ivmE 88 (288)
T d1uu3a_ 10 FKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRL-DHPFFVKLYFTFQDDEKLYFGLS 88 (288)
T ss_dssp EEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHC-CSTTBCCEEEEEECSSEEEEEEC
T ss_pred CEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccCHHHHHHHHHHHHHHHHc-CCCCeeEEEEEEEECCEEEEEEE
Confidence 444789999999999999999999999999986421 245799999998 59999999999999999999999
Q ss_pred ccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCcEEEecCCCCCEEEEeecccccccC----
Q psy11767 452 LLKGGELLDRIRQKGRCGFTENEASRIMRQLVAAVHFMHSRGVVHRDLKPENLLFSDPAGDNIKVVDFGFACLKRE---- 527 (966)
Q Consensus 452 y~~gg~L~~~l~~~~~~~l~e~~~~~i~~Qil~aL~yLHs~~IiHRDLKP~NILl~~~~~~~iKL~DFGla~~~~~---- 527 (966)
||+||+|.+++...+ .+++.+++.++.||+.||+|||++|||||||||+|||+++ ++.+||+|||+|+....
T Consensus 89 y~~gg~L~~~~~~~~--~l~e~~~~~~~~qi~~al~ylH~~~iiHrDiKp~NIll~~--~~~vkl~DFG~a~~~~~~~~~ 164 (288)
T d1uu3a_ 89 YAKNGELLKYIRKIG--SFDETCTRFYTAEIVSALEYLHGKGIIHRDLKPENILLNE--DMHIQITDFGTAKVLSPESKQ 164 (288)
T ss_dssp CCTTEEHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECT--TSCEEECCCTTCEECC-----
T ss_pred ccCCCCHHHhhhccC--CCCHHHHHHHHHHHHHHHHhhccccEEcCcCCccccccCC--CceEEecccccceecccCCcc
Confidence 999999999998776 5999999999999999999999999999999999999985 56899999999976532
Q ss_pred -CCccccccccccCchhhccCCCCCCCcccchhhhhhhhhhhhcCCCCCCCcCcchhHHHHHHHHhcCCCCCCCCCCchh
Q psy11767 528 -SLHTPCFTLQYAAPEVLRQDKSGYDENCDLWSLGVILVNVLRQDKSGYDENCDLWSLGVILYTMLCGRVPFHARSRDDS 606 (966)
Q Consensus 528 -~~~~~~gT~~Y~APEvl~~~~~~~~~~~Di~SlGvil~el~~~~~~~y~~~~DIWSlGvilyemltG~~Pf~~~~~~~~ 606 (966)
...+.+||+.|||||++.. ..|+.++|||||||++|+|++|++||.+.+.
T Consensus 165 ~~~~~~~GT~~Y~APE~~~~--------------------------~~~~~~~DiwSlGvilyell~g~~Pf~~~~~--- 215 (288)
T d1uu3a_ 165 ARANSFVGTAQYVSPELLTE--------------------------KSACKSSDLWALGCIIYQLVAGLPPFRAGNE--- 215 (288)
T ss_dssp -----CCCCGGGCCHHHHHT--------------------------CCCCHHHHHHHHHHHHHHHHHSSCSSCCSSH---
T ss_pred cccccccCCccccCceeecc--------------------------CCCCcccceehhhHHHHHHhhCCCCCCCcCH---
Confidence 2345689999999999863 3478899999999999999999999987543
Q ss_pred HHHHHHHHHcCCCCCCchhhccCCHHHHHHHHHhcccCccccCChHHH----HHHhhhhHH
Q psy11767 607 ALSIMARIKEGQFNFDAEAWSTVSSEAKELTKSLLTVNPAQRIRMMRV----KLTFHAFHQ 663 (966)
Q Consensus 607 ~~~~~~~i~~~~~~~~~~~~~~is~e~~~Li~~~L~~dP~~R~t~~~v----~~~~~~~~~ 663 (966)
..++.+|..+.+.++ ..+|+++++||.+||+.||++|||+.++ ....|+|++
T Consensus 216 -~~~~~~i~~~~~~~p----~~~s~~~~~li~~~L~~dP~~R~t~~e~~~~~~i~~Hpff~ 271 (288)
T d1uu3a_ 216 -YLIFQKIIKLEYDFP----EKFFPKARDLVEKLLVLDATKRLGCEEMEGYGPLKAHPFFE 271 (288)
T ss_dssp -HHHHHHHHTTCCCCC----TTCCHHHHHHHHTTSCSSGGGSTTSGGGTCHHHHHTSGGGT
T ss_pred -HHHHHHHHcCCCCCC----ccCCHHHHHHHHHHccCCHhHCcCHHHHcCCHHHHcCCccC
Confidence 345677777776654 3689999999999999999999999875 234566653
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Probab=100.00 E-value=4.3e-51 Score=459.67 Aligned_cols=253 Identities=30% Similarity=0.592 Sum_probs=219.2
Q ss_pred ecccccccccccccccccccEEEEEEEcCCCcEEEEEEeccccC-----hHHHHHHHHHhcCCCCceEEEEEEEeCCeEE
Q psy11767 373 FEQYDMDLDKAGILGDGSYSVCRRCVEKSTGQEYAVKIISRKID-----CSEEINLLRACQGHPNIVNLHCVFQDEVHTY 447 (966)
Q Consensus 373 ~~~~~i~~~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~~-----~~~Ei~iL~~l~~HpnIV~l~~~~~~~~~~~ 447 (966)
.++|++ .+.||+|+||+||+|+++.+|+.||||++..... ..+|+++|+.+ +|||||+++++|++++++|
T Consensus 25 l~~Y~i----~~~lG~G~fg~Vy~~~~~~~g~~vAvK~i~~~~~~~~~~~~~E~~il~~l-~HpnIv~~~~~~~~~~~~~ 99 (350)
T d1koaa2 25 LDHYDI----HEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVL-RHPTLVNLHDAFEDDNEMV 99 (350)
T ss_dssp GGTEEE----EEEEEEETTEEEEEEEETTTTEEEEEEEECCCSHHHHHHHHHHHHHHHHT-CCTTBCCEEEEEEETTEEE
T ss_pred ccCeEE----EEEEecCcCeEEEEEEECCCCCEEEEEEEcccchhhHHHHHHHHHHHHhC-CCCCCCcEEEEEEECCEEE
Confidence 355555 6889999999999999999999999999975432 35799999999 5999999999999999999
Q ss_pred EEEEccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCcEEEecCCCCCEEEEeecccccccC
Q psy11767 448 LVLELLKGGELLDRIRQKGRCGFTENEASRIMRQLVAAVHFMHSRGVVHRDLKPENLLFSDPAGDNIKVVDFGFACLKRE 527 (966)
Q Consensus 448 lVmEy~~gg~L~~~l~~~~~~~l~e~~~~~i~~Qil~aL~yLHs~~IiHRDLKP~NILl~~~~~~~iKL~DFGla~~~~~ 527 (966)
||||||+||+|.+++.+... .+++.+++.|+.||+.||+|||++|||||||||+|||++...++.+||+|||+|+....
T Consensus 100 ivmE~~~gg~L~~~l~~~~~-~l~e~~~~~i~~qi~~aL~ylH~~~iiHrDiKp~NIll~~~~~~~vkL~DFG~a~~~~~ 178 (350)
T d1koaa2 100 MIYEFMSGGELFEKVADEHN-KMSEDEAVEYMRQVCKGLCHMHENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDP 178 (350)
T ss_dssp EEECCCCSCBHHHHHTCTTS-CBCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSTTSCCEEECCCTTCEECCT
T ss_pred EEEEcCCCCCHHHHHHhhcC-CCCHHHHHHHHHHHHHHHHHHHhcCCeeeeechhHeeeccCCCCeEEEeecchheeccc
Confidence 99999999999999965432 59999999999999999999999999999999999999755567899999999987543
Q ss_pred C--CccccccccccCchhhccCCCCCCCcccchhhhhhhhhhhhcCCCCCCCcCcchhHHHHHHHHhcCCCCCCCCCCch
Q psy11767 528 S--LHTPCFTLQYAAPEVLRQDKSGYDENCDLWSLGVILVNVLRQDKSGYDENCDLWSLGVILYTMLCGRVPFHARSRDD 605 (966)
Q Consensus 528 ~--~~~~~gT~~Y~APEvl~~~~~~~~~~~Di~SlGvil~el~~~~~~~y~~~~DIWSlGvilyemltG~~Pf~~~~~~~ 605 (966)
. ..+.+||+.|||||++.. ..|+.++|||||||++|+|++|++||.+.+.
T Consensus 179 ~~~~~~~~gT~~Y~aPEv~~~--------------------------~~~~~~~DiwSlGvilyell~G~~Pf~~~~~-- 230 (350)
T d1koaa2 179 KQSVKVTTGTAEFAAPEVAEG--------------------------KPVGYYTDMWSVGVLSYILLSGLSPFGGEND-- 230 (350)
T ss_dssp TSCEEEECSCTTTCCHHHHHT--------------------------CCBCHHHHHHHHHHHHHHHHHSSCSSCCSSH--
T ss_pred ccccceecCcccccCHHHHcC--------------------------CCCChhHhhhhhhHHHHHHHhCCCCCCCCCH--
Confidence 2 335689999999999863 3478899999999999999999999987543
Q ss_pred hHHHHHHHHHcCCCCCCchhhccCCHHHHHHHHHhcccCccccCChHHHHHHhhhhHH
Q psy11767 606 SALSIMARIKEGQFNFDAEAWSTVSSEAKELTKSLLTVNPAQRIRMMRVKLTFHAFHQ 663 (966)
Q Consensus 606 ~~~~~~~~i~~~~~~~~~~~~~~is~e~~~Li~~~L~~dP~~R~t~~~v~~~~~~~~~ 663 (966)
..++..|..+.+.++...+..+|+++++||.+||..||++|||+.++ ..|+|..
T Consensus 231 --~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~ei--l~hp~~~ 284 (350)
T d1koaa2 231 --DETLRNVKSCDWNMDDSAFSGISEDGKDFIRKLLLADPNTRMTIHQA--LEHPWLT 284 (350)
T ss_dssp --HHHHHHHHHTCCCSCCGGGGGCCHHHHHHHHHHCCSSGGGSCCHHHH--HHSTTTS
T ss_pred --HHHHHHHHhCCCCCCcccccCCCHHHHHHHHHHccCChhHCcCHHHH--hcCcccC
Confidence 34567788888888888888999999999999999999999999976 4577764
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.6e-51 Score=445.32 Aligned_cols=251 Identities=29% Similarity=0.434 Sum_probs=210.6
Q ss_pred ccccccccccccEEEEEEEcCCCcEEEEEEecccc-----ChHHHHHHHHHhcCCCCceEEEEEEEeCCeEEEEEEccCC
Q psy11767 381 DKAGILGDGSYSVCRRCVEKSTGQEYAVKIISRKI-----DCSEEINLLRACQGHPNIVNLHCVFQDEVHTYLVLELLKG 455 (966)
Q Consensus 381 ~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~-----~~~~Ei~iL~~l~~HpnIV~l~~~~~~~~~~~lVmEy~~g 455 (966)
+.++.||+|+||+||+|+++.+|+.||||++.... ...+|+++|+.+ +|||||+++++|.+++..|||||||+|
T Consensus 15 ~i~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~E~~il~~l-~HpnIv~l~~~~~~~~~~~lvmEy~~~ 93 (288)
T d2jfla1 15 EIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASC-DHPNIVKLLDAFYYENNLWILIEFCAG 93 (288)
T ss_dssp EEEEEEEEETTEEEEEEEETTTCCEEEEEEEECSSSGGGGGTHHHHHHHHHC-CCTTBCCEEEEEEETTEEEEEEECCTT
T ss_pred EEeEEEeeCCCcEEEEEEECCCCeEEEEEEECcCCHHHHHHHHHHHHHHHhC-CCCCCCeEEEEEeeCCeEEEEEecCCC
Confidence 34688999999999999999999999999996542 356799999998 599999999999999999999999999
Q ss_pred CCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCcEEEecCCCCCEEEEeecccccccC---CCccc
Q psy11767 456 GELLDRIRQKGRCGFTENEASRIMRQLVAAVHFMHSRGVVHRDLKPENLLFSDPAGDNIKVVDFGFACLKRE---SLHTP 532 (966)
Q Consensus 456 g~L~~~l~~~~~~~l~e~~~~~i~~Qil~aL~yLHs~~IiHRDLKP~NILl~~~~~~~iKL~DFGla~~~~~---~~~~~ 532 (966)
|+|.+++.+... .+++.+++.++.||+.||+|||++||+||||||+|||++. ++.+||+|||+|+.... ...+.
T Consensus 94 g~L~~~~~~~~~-~l~e~~~~~i~~qi~~gL~ylH~~~ivHrDiKp~NIll~~--~~~~Kl~DFG~a~~~~~~~~~~~~~ 170 (288)
T d2jfla1 94 GAVDAVMLELER-PLTESQIQVVCKQTLDALNYLHDNKIIHRDLKAGNILFTL--DGDIKLADFGVSAKNTRTIQRRDSF 170 (288)
T ss_dssp EEHHHHHHHHTS-CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECT--TSCEEECCCTTCEECHHHHHHHTCC
T ss_pred CcHHHHHHhcCC-CCCHHHHHHHHHHHHHHHHHHHHCCEEEeecChhheeECC--CCCEEEEechhhhccCCCccccccc
Confidence 999999876543 6999999999999999999999999999999999999985 56899999999975432 23467
Q ss_pred cccccccCchhhccCCCCCCCcccchhhhhhhhhhhhcCCCCCCCcCcchhHHHHHHHHhcCCCCCCCCCCchhHHHHHH
Q psy11767 533 CFTLQYAAPEVLRQDKSGYDENCDLWSLGVILVNVLRQDKSGYDENCDLWSLGVILYTMLCGRVPFHARSRDDSALSIMA 612 (966)
Q Consensus 533 ~gT~~Y~APEvl~~~~~~~~~~~Di~SlGvil~el~~~~~~~y~~~~DIWSlGvilyemltG~~Pf~~~~~~~~~~~~~~ 612 (966)
+||+.|||||++.... .....|+.++|||||||++|+|++|++||.+.+..+ ++.
T Consensus 171 ~Gt~~y~APE~l~~~~---------------------~~~~~y~~k~DiwSlGvilyemltg~~Pf~~~~~~~----~~~ 225 (288)
T d2jfla1 171 IGTPYWMAPEVVMCET---------------------SKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPMR----VLL 225 (288)
T ss_dssp CSCCTTCCHHHHTTCS---------------------TTTSSTTTHHHHHHHHHHHHHHHHSSCTTTTSCGGG----HHH
T ss_pred ccccccCCHHHHhhcc---------------------cCCCCCChhhhHHHHHHHHHHHhhCCCCCCCCCHHH----HHH
Confidence 8999999999985322 123568999999999999999999999998876543 344
Q ss_pred HHHcCCCCCCchhhccCCHHHHHHHHHhcccCccccCChHHHHHHhhhhHH
Q psy11767 613 RIKEGQFNFDAEAWSTVSSEAKELTKSLLTVNPAQRIRMMRVKLTFHAFHQ 663 (966)
Q Consensus 613 ~i~~~~~~~~~~~~~~is~e~~~Li~~~L~~dP~~R~t~~~v~~~~~~~~~ 663 (966)
++..+.... ...+..+|+++++||.+||+.||++|||+.++ ..|+|..
T Consensus 226 ~i~~~~~~~-~~~~~~~s~~~~~li~~~L~~dp~~R~t~~el--l~hp~~~ 273 (288)
T d2jfla1 226 KIAKSEPPT-LAQPSRWSSNFKDFLKKCLEKNVDARWTTSQL--LQHPFVT 273 (288)
T ss_dssp HHHHSCCCC-CSSGGGSCHHHHHHHHHHSCSSTTTSCCHHHH--TTSGGGC
T ss_pred HHHcCCCCC-CCccccCCHHHHHHHHHHccCChhHCcCHHHH--hcCcccC
Confidence 555554322 22345789999999999999999999999976 4577764
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Probab=100.00 E-value=9.6e-51 Score=442.48 Aligned_cols=258 Identities=39% Similarity=0.733 Sum_probs=221.2
Q ss_pred eecccccccccccccccccccEEEEEEEcCCCcEEEEEEecccc--------------ChHHHHHHHHHhcCCCCceEEE
Q psy11767 372 FFEQYDMDLDKAGILGDGSYSVCRRCVEKSTGQEYAVKIISRKI--------------DCSEEINLLRACQGHPNIVNLH 437 (966)
Q Consensus 372 ~~~~~~i~~~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~--------------~~~~Ei~iL~~l~~HpnIV~l~ 437 (966)
|+++|++ .+.||+|+||+||+|+++.+|+.||||++.+.. ...+|+.+|+.+..|||||+++
T Consensus 1 f~~~y~~----~~~iG~G~~g~V~~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~ 76 (277)
T d1phka_ 1 FYENYEP----KEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLK 76 (277)
T ss_dssp CTTTEEE----EEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEE
T ss_pred CcccCEE----ceEEecCcCeEEEEEEECCCCCEEEEEEEecccccchhHHHHHHHHHHHHHHHHHHHHhcCCCCeEEEE
Confidence 4455555 789999999999999999999999999997542 1446999999997799999999
Q ss_pred EEEEeCCeEEEEEEccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCcEEEecCCCCCEEEE
Q psy11767 438 CVFQDEVHTYLVLELLKGGELLDRIRQKGRCGFTENEASRIMRQLVAAVHFMHSRGVVHRDLKPENLLFSDPAGDNIKVV 517 (966)
Q Consensus 438 ~~~~~~~~~~lVmEy~~gg~L~~~l~~~~~~~l~e~~~~~i~~Qil~aL~yLHs~~IiHRDLKP~NILl~~~~~~~iKL~ 517 (966)
++|+++++.|||||||+||+|.++|..++ .+++.+++.++.||+.||+|||++||+||||||+|||++. ++.+||+
T Consensus 77 ~~~~~~~~~~ivmE~~~~g~L~~~l~~~~--~l~e~~~~~~~~qi~~al~~lH~~~ivHrDlkp~Nill~~--~~~~kl~ 152 (277)
T d1phka_ 77 DTYETNTFFFLVFDLMKKGELFDYLTEKV--TLSEKETRKIMRALLEVICALHKLNIVHRDLKPENILLDD--DMNIKLT 152 (277)
T ss_dssp EEEECSSEEEEEEECCTTCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECT--TCCEEEC
T ss_pred eecccCcceEEEEEcCCCchHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHcCCcccccccceEEEcC--CCCeEEc
Confidence 99999999999999999999999998766 6999999999999999999999999999999999999974 5699999
Q ss_pred eecccccccC--CCccccccccccCchhhccCCCCCCCcccchhhhhhhhhhhhcCCCCCCCcCcchhHHHHHHHHhcCC
Q psy11767 518 DFGFACLKRE--SLHTPCFTLQYAAPEVLRQDKSGYDENCDLWSLGVILVNVLRQDKSGYDENCDLWSLGVILYTMLCGR 595 (966)
Q Consensus 518 DFGla~~~~~--~~~~~~gT~~Y~APEvl~~~~~~~~~~~Di~SlGvil~el~~~~~~~y~~~~DIWSlGvilyemltG~ 595 (966)
|||+|+.... .....+||+.|+|||++..... .....|+.++||||+||++|+|++|+
T Consensus 153 DFG~a~~~~~~~~~~~~~gt~~y~~PE~~~~~~~--------------------~~~~~~~~~~DiwslGvilyeml~g~ 212 (277)
T d1phka_ 153 DFGFSCQLDPGEKLREVCGTPSYLAPEIIECSMN--------------------DNHPGYGKEVDMWSTGVIMYTLLAGS 212 (277)
T ss_dssp CCTTCEECCTTCCBCCCCSCGGGCCHHHHHHHHC--------------------TTSCCBCTHHHHHHHHHHHHHHHHSS
T ss_pred cchheeEccCCCceeeeeccCCCCCHHHhhcccc--------------------ccCCCCCchheEcccchhhhhhccCC
Confidence 9999987543 2345678999999999863211 12456889999999999999999999
Q ss_pred CCCCCCCCchhHHHHHHHHHcCCCCCCchhhccCCHHHHHHHHHhcccCccccCChHHHHHHhhhhHH
Q psy11767 596 VPFHARSRDDSALSIMARIKEGQFNFDAEAWSTVSSEAKELTKSLLTVNPAQRIRMMRVKLTFHAFHQ 663 (966)
Q Consensus 596 ~Pf~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~is~e~~~Li~~~L~~dP~~R~t~~~v~~~~~~~~~ 663 (966)
.||.+.+. ......+..+.+.+....+..+|+++++||.+||+.||++|||+.++ ..|+|++
T Consensus 213 ~Pf~~~~~----~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~~p~~R~s~~ei--l~h~~~~ 274 (277)
T d1phka_ 213 PPFWHRKQ----MLMLRMIMSGNYQFGSPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEA--LAHPFFQ 274 (277)
T ss_dssp CSSCCSSH----HHHHHHHHHTCCCCCTTTGGGSCHHHHHHHHHHCCSSGGGSCCHHHH--TTSGGGC
T ss_pred CCCCCCCH----HHHHHHHHhCCCCCCCcccccCCHHHHHHHHHHccCChhHCcCHHHH--HcCHHHH
Confidence 99987653 24556677788777777778999999999999999999999999876 5566653
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.5e-50 Score=444.31 Aligned_cols=253 Identities=33% Similarity=0.627 Sum_probs=218.2
Q ss_pred eecccccccccccccccccccEEEEEEEcCCCcEEEEEEecccc-----------ChHHHHHHHHHhcCCCCceEEEEEE
Q psy11767 372 FFEQYDMDLDKAGILGDGSYSVCRRCVEKSTGQEYAVKIISRKI-----------DCSEEINLLRACQGHPNIVNLHCVF 440 (966)
Q Consensus 372 ~~~~~~i~~~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~-----------~~~~Ei~iL~~l~~HpnIV~l~~~~ 440 (966)
+.++|++ .+.||+|+||+||+|+++.+|+.||||++.+.. ...+|+.+|+.+ +|||||+++++|
T Consensus 8 i~d~Y~~----~~~lG~G~fg~Vy~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l-~HpnIv~~~~~~ 82 (293)
T d1jksa_ 8 VDDYYDT----GEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEI-QHPNVITLHEVY 82 (293)
T ss_dssp GGGTEEE----EEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHC-CCTTBCCEEEEE
T ss_pred cccCEEE----eEEEecCCCeEEEEEEECCCCCEEEEEEEEhhhcchhhhhHHHHHHHHHHHHHHhC-CCCCCCcEEEEE
Confidence 4455555 688999999999999999999999999986431 145799999998 599999999999
Q ss_pred EeCCeEEEEEEccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCcEEEecCC--CCCEEEEe
Q psy11767 441 QDEVHTYLVLELLKGGELLDRIRQKGRCGFTENEASRIMRQLVAAVHFMHSRGVVHRDLKPENLLFSDPA--GDNIKVVD 518 (966)
Q Consensus 441 ~~~~~~~lVmEy~~gg~L~~~l~~~~~~~l~e~~~~~i~~Qil~aL~yLHs~~IiHRDLKP~NILl~~~~--~~~iKL~D 518 (966)
+++.+.|||||||+||+|.+++.+.+ .+++.+++.++.||+.||+|||++||+||||||+|||++..+ ...+||+|
T Consensus 83 ~~~~~~~iv~E~~~gg~L~~~i~~~~--~l~~~~~~~~~~qi~~al~yLH~~~ivHrDiKp~Nill~~~~~~~~~vkl~D 160 (293)
T d1jksa_ 83 ENKTDVILILELVAGGELFDFLAEKE--SLTEEEATEFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIID 160 (293)
T ss_dssp ECSSEEEEEEECCCSCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCSSSSSCCEEECC
T ss_pred EECCEEEEEEEcCCCccccchhcccc--ccchhHHHHHHHHHHHHHHhhhhcceeecccccceEEEecCCCcccceEecc
Confidence 99999999999999999999998765 599999999999999999999999999999999999997532 23699999
Q ss_pred ecccccccC--CCccccccccccCchhhccCCCCCCCcccchhhhhhhhhhhhcCCCCCCCcCcchhHHHHHHHHhcCCC
Q psy11767 519 FGFACLKRE--SLHTPCFTLQYAAPEVLRQDKSGYDENCDLWSLGVILVNVLRQDKSGYDENCDLWSLGVILYTMLCGRV 596 (966)
Q Consensus 519 FGla~~~~~--~~~~~~gT~~Y~APEvl~~~~~~~~~~~Di~SlGvil~el~~~~~~~y~~~~DIWSlGvilyemltG~~ 596 (966)
||+|..... ...+.++|+.|+|||++.. ..|+.++||||+||++|+|++|+.
T Consensus 161 fG~a~~~~~~~~~~~~~~t~~y~APE~~~~--------------------------~~~~~~~DiwSlGvilyell~g~~ 214 (293)
T d1jksa_ 161 FGLAHKIDFGNEFKNIFGTPEFVAPEIVNY--------------------------EPLGLEADMWSIGVITYILLSGAS 214 (293)
T ss_dssp CTTCEECTTSCBCSCCCCCGGGCCHHHHTT--------------------------CCBCTHHHHHHHHHHHHHHHHSSC
T ss_pred hhhhhhcCCCccccccCCCCcccCHHHHcC--------------------------CCCCCcccchhhhHHHHHHHcCCC
Confidence 999976543 3445688999999999853 247889999999999999999999
Q ss_pred CCCCCCCchhHHHHHHHHHcCCCCCCchhhccCCHHHHHHHHHhcccCccccCChHHHHHHhhhhHH
Q psy11767 597 PFHARSRDDSALSIMARIKEGQFNFDAEAWSTVSSEAKELTKSLLTVNPAQRIRMMRVKLTFHAFHQ 663 (966)
Q Consensus 597 Pf~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~is~e~~~Li~~~L~~dP~~R~t~~~v~~~~~~~~~ 663 (966)
||.+.+. ...+..+..+.+.+....++.+|+++++||++||+.||++|||+.++ ..|+|++
T Consensus 215 Pf~~~~~----~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~ei--l~hp~~~ 275 (293)
T d1jksa_ 215 PFLGDTK----QETLANVSAVNYEFEDEYFSNTSALAKDFIRRLLVKDPKKRMTIQDS--LQHPWIK 275 (293)
T ss_dssp SSCCSSH----HHHHHHHHTTCCCCCHHHHTTSCHHHHHHHHTTSCSSGGGSCCHHHH--HHSTTTC
T ss_pred CCCCCCH----HHHHHHHHhcCCCCCchhcCCCCHHHHHHHHHHccCChhHCcCHHHH--hcCcccC
Confidence 9987543 34567788888888888888999999999999999999999999986 3477763
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.4e-50 Score=450.60 Aligned_cols=251 Identities=25% Similarity=0.436 Sum_probs=203.1
Q ss_pred ccccccccccccccEEEEEEEcCCCcEEEEEEeccccC------hHHHHHHHHHhcCCCCceEEEEEEEeCCeEEEEEEc
Q psy11767 379 DLDKAGILGDGSYSVCRRCVEKSTGQEYAVKIISRKID------CSEEINLLRACQGHPNIVNLHCVFQDEVHTYLVLEL 452 (966)
Q Consensus 379 ~~~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~~------~~~Ei~iL~~l~~HpnIV~l~~~~~~~~~~~lVmEy 452 (966)
+|+.++.||+|+||+||+|+++.+|+.||||+++.... ..+|+.+|+.+ +|||||+++++|.++.++||||||
T Consensus 7 ~y~~~~~iG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l-~HpnIv~l~~~~~~~~~~~iVmEy 85 (322)
T d1s9ja_ 7 DFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHEC-NSPYIVGFYGAFYSDGEISICMEH 85 (322)
T ss_dssp GEEEEEEEECCSSCCEEEEEETTTTEEEEEEEEECCCCTTHHHHHHHHGGGGGGC-CCTTBCCEEEEEECSSEEEEEEEC
T ss_pred CCEEEEEEecCCCeEEEEEEECCCCcEEEEEEEChhhCHHHHHHHHHHHHHHHhC-CCCCCCcEEEEEEECCEEEEEEEc
Confidence 45557899999999999999999999999999975422 45799999988 599999999999999999999999
Q ss_pred cCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhc-CceeccCCCCcEEEecCCCCCEEEEeecccccccC-CCc
Q psy11767 453 LKGGELLDRIRQKGRCGFTENEASRIMRQLVAAVHFMHSR-GVVHRDLKPENLLFSDPAGDNIKVVDFGFACLKRE-SLH 530 (966)
Q Consensus 453 ~~gg~L~~~l~~~~~~~l~e~~~~~i~~Qil~aL~yLHs~-~IiHRDLKP~NILl~~~~~~~iKL~DFGla~~~~~-~~~ 530 (966)
|+||+|.+++.+.+ .+++.+++.++.||+.||+|||++ ||+||||||+|||+++ .+.+||+|||+|+.... ...
T Consensus 86 ~~gg~L~~~l~~~~--~l~~~~~~~~~~qil~aL~yLH~~~~IiHRDiKP~NILl~~--~~~vkl~DFGla~~~~~~~~~ 161 (322)
T d1s9ja_ 86 MDGGSLDQVLKKAG--RIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNS--RGEIKLCDFGVSGQLIDSMAN 161 (322)
T ss_dssp CTTEEHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHHHHCCCCSCCSGGGEEECT--TCCEEECCCCCCHHHHHHTC-
T ss_pred CCCCcHHHHHhhcC--CCCHHHHHHHHHHHHHHHHHHHHhCCEEccccCHHHeeECC--CCCEEEeeCCCccccCCCccc
Confidence 99999999998775 599999999999999999999985 9999999999999975 56999999999976433 345
Q ss_pred cccccccccCchhhccCCCCCCCcccchhhhhhhhhhhhcCCCCCCCcCcchhHHHHHHHHhcCCCCCCCCCCchhHHHH
Q psy11767 531 TPCFTLQYAAPEVLRQDKSGYDENCDLWSLGVILVNVLRQDKSGYDENCDLWSLGVILYTMLCGRVPFHARSRDDSALSI 610 (966)
Q Consensus 531 ~~~gT~~Y~APEvl~~~~~~~~~~~Di~SlGvil~el~~~~~~~y~~~~DIWSlGvilyemltG~~Pf~~~~~~~~~~~~ 610 (966)
+.+||+.|||||++.. ..|+.++||||+||++|||++|+.||.+.+..+.....
T Consensus 162 ~~~GT~~Y~APEvl~~--------------------------~~y~~~~DiWSlGvil~ell~G~~Pf~~~~~~~~~~~~ 215 (322)
T d1s9ja_ 162 SFVGTRSYMSPERLQG--------------------------THYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMF 215 (322)
T ss_dssp --CCSSCCCCHHHHHC--------------------------SCCCTTHHHHHHHHHHHHHHHSSCCSSCCCTTHHHHHC
T ss_pred cccCCccccCchHHcC--------------------------CCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHH
Confidence 6789999999999863 34889999999999999999999999876543321111
Q ss_pred HHH--------------------------------------HHcCCCCCCchhhccCCHHHHHHHHHhcccCccccCChH
Q psy11767 611 MAR--------------------------------------IKEGQFNFDAEAWSTVSSEAKELTKSLLTVNPAQRIRMM 652 (966)
Q Consensus 611 ~~~--------------------------------------i~~~~~~~~~~~~~~is~e~~~Li~~~L~~dP~~R~t~~ 652 (966)
... +..... +......+|.++++||.+||+.||++|||+.
T Consensus 216 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~s~~~~dli~~~L~~dP~~R~ta~ 293 (322)
T d1s9ja_ 216 GCQVEGDAAETPPRPRTPGRPLSSYGMDSRPPMAIFELLDYIVNEPP--PKLPSGVFSLEFQDFVNKCLIKNPAERADLK 293 (322)
T ss_dssp ------------------------------CCCCHHHHHHHHHTSCC--CCCCBTTBCHHHHHHHHHHTCSSTTTSCCHH
T ss_pred HHHhcCCcccCCcccccccccccccccccccchhHHHHHhhhhccCC--ccCccccCCHHHHHHHHHHcCCChhHCcCHH
Confidence 000 000000 0001123689999999999999999999999
Q ss_pred HHHHHhhhhHHh
Q psy11767 653 RVKLTFHAFHQA 664 (966)
Q Consensus 653 ~v~~~~~~~~~~ 664 (966)
++ ..|+|.+.
T Consensus 294 e~--L~Hpf~~~ 303 (322)
T d1s9ja_ 294 QL--MVHAFIKR 303 (322)
T ss_dssp HH--HTSHHHHH
T ss_pred HH--hhCHhhCc
Confidence 76 45788754
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=4.5e-50 Score=443.88 Aligned_cols=248 Identities=23% Similarity=0.300 Sum_probs=207.6
Q ss_pred cccccccccccccEEEEEEEcCCCcEEEEEEecccc--------ChHHHHHHHHHhcCCCCceEEEEEEEeCCeEEEEEE
Q psy11767 380 LDKAGILGDGSYSVCRRCVEKSTGQEYAVKIISRKI--------DCSEEINLLRACQGHPNIVNLHCVFQDEVHTYLVLE 451 (966)
Q Consensus 380 ~~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~--------~~~~Ei~iL~~l~~HpnIV~l~~~~~~~~~~~lVmE 451 (966)
|+.++.||+|+||+||+|++..+|+.||||++.... ...+|+++|+.+ +|||||+++++|.++...|||||
T Consensus 17 y~~l~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l-~HpnIv~~~~~~~~~~~~~iv~E 95 (309)
T d1u5ra_ 17 FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKL-RHPNTIQYRGCYLREHTAWLVME 95 (309)
T ss_dssp EEEEEEEEECSSSEEEEEEETTTTEEEEEEEEECCSSCHHHHHHHHHHHHHHHTTC-CCTTBCCEEEEEEETTEEEEEEE
T ss_pred cEeeEEEecCCCeEEEEEEECCCCcEEEEEEEchhhccCHHHHHHHHHHHHHHHHC-CCCCEeeEEEEEEECCEEEEEEE
Confidence 455789999999999999999999999999997543 145699999998 59999999999999999999999
Q ss_pred ccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCcEEEecCCCCCEEEEeecccccccCCCcc
Q psy11767 452 LLKGGELLDRIRQKGRCGFTENEASRIMRQLVAAVHFMHSRGVVHRDLKPENLLFSDPAGDNIKVVDFGFACLKRESLHT 531 (966)
Q Consensus 452 y~~gg~L~~~l~~~~~~~l~e~~~~~i~~Qil~aL~yLHs~~IiHRDLKP~NILl~~~~~~~iKL~DFGla~~~~~~~~~ 531 (966)
||.||+|..++.... .+++.+++.|+.||+.||+|||++|||||||||+|||+++ ++.+||+|||+|+.... ...
T Consensus 96 ~~~~g~l~~~~~~~~--~l~e~~~~~i~~qi~~aL~yLH~~~iiHrDiKp~NILl~~--~~~~Kl~DFG~a~~~~~-~~~ 170 (309)
T d1u5ra_ 96 YCLGSASDLLEVHKK--PLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLSE--PGLVKLGDFGSASIMAP-ANS 170 (309)
T ss_dssp CCSEEHHHHHHHHTS--CCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEEET--TTEEEECCCTTCBSSSS-BCC
T ss_pred ecCCCchHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHhCCEeccCCCcceEEECC--CCCEEEeecccccccCC-CCc
Confidence 999999877665544 6999999999999999999999999999999999999985 56999999999976543 346
Q ss_pred ccccccccCchhhccCCCCCCCcccchhhhhhhhhhhhcCCCCCCCcCcchhHHHHHHHHhcCCCCCCCCCCchhHHHHH
Q psy11767 532 PCFTLQYAAPEVLRQDKSGYDENCDLWSLGVILVNVLRQDKSGYDENCDLWSLGVILYTMLCGRVPFHARSRDDSALSIM 611 (966)
Q Consensus 532 ~~gT~~Y~APEvl~~~~~~~~~~~Di~SlGvil~el~~~~~~~y~~~~DIWSlGvilyemltG~~Pf~~~~~~~~~~~~~ 611 (966)
.+||+.|||||++.... ...|+.++|||||||++|||++|+.||.+.+.. ..+
T Consensus 171 ~~GT~~Y~APE~~~~~~-----------------------~~~y~~~~DiwSlGvilyel~~g~~Pf~~~~~~----~~~ 223 (309)
T d1u5ra_ 171 FVGTPYWMAPEVILAMD-----------------------EGQYDGKVDVWSLGITCIELAERKPPLFNMNAM----SAL 223 (309)
T ss_dssp CCSCGGGCCHHHHTTTT-----------------------SCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHH----HHH
T ss_pred cccCccccCHHHHhccC-----------------------CCCcCchhhhhhHHHHHHHHHHCCCCCCCCCHH----HHH
Confidence 68999999999985321 235889999999999999999999999875432 334
Q ss_pred HHHHcCCCCCCchhhccCCHHHHHHHHHhcccCccccCChHHHHHHhhhhHHh
Q psy11767 612 ARIKEGQFNFDAEAWSTVSSEAKELTKSLLTVNPAQRIRMMRVKLTFHAFHQA 664 (966)
Q Consensus 612 ~~i~~~~~~~~~~~~~~is~e~~~Li~~~L~~dP~~R~t~~~v~~~~~~~~~~ 664 (966)
..+..+..... ....+|+++++||.+||+.||++|||+.++ ..|+|...
T Consensus 224 ~~i~~~~~~~~--~~~~~s~~~~~li~~~L~~dP~~Rpt~~el--l~Hp~~~~ 272 (309)
T d1u5ra_ 224 YHIAQNESPAL--QSGHWSEYFRNFVDSCLQKIPQDRPTSEVL--LKHRFVLR 272 (309)
T ss_dssp HHHHHSCCCCC--SCTTSCHHHHHHHHHHTCSSGGGSCCHHHH--TTCHHHHS
T ss_pred HHHHhCCCCCC--CCCCCCHHHHHHHHHHCcCChhHCcCHHHH--HhCHHhcC
Confidence 45554443322 124689999999999999999999999976 45777753
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.5e-50 Score=433.81 Aligned_cols=241 Identities=26% Similarity=0.409 Sum_probs=202.6
Q ss_pred cccccccccEEEEEEEcCCCcEEEEEEecccc-------ChHHHHHHHHHhcCCCCceEEEEEEEe----CCeEEEEEEc
Q psy11767 384 GILGDGSYSVCRRCVEKSTGQEYAVKIISRKI-------DCSEEINLLRACQGHPNIVNLHCVFQD----EVHTYLVLEL 452 (966)
Q Consensus 384 ~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~-------~~~~Ei~iL~~l~~HpnIV~l~~~~~~----~~~~~lVmEy 452 (966)
.+||+|+||+||+|++..+++.||+|++.... ...+|+++|+.+ +|||||+++++|++ +..+||||||
T Consensus 15 ~~iG~G~fg~Vy~~~~~~~~~~va~K~i~~~~~~~~~~~~~~~E~~il~~l-~HpnIv~~~~~~~~~~~~~~~~~ivmE~ 93 (270)
T d1t4ha_ 15 IEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGL-QHPNIVRFYDSWESTVKGKKCIVLVTEL 93 (270)
T ss_dssp EEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTC-CCTTBCCEEEEEEEESSSCEEEEEEEEC
T ss_pred eEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhC-CCCCeeeEEEEEeeccccCCEEEEEEeC
Confidence 46999999999999999999999999986543 145799999988 59999999999975 4568999999
Q ss_pred cCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcC--ceeccCCCCcEEEecCCCCCEEEEeecccccccCC-C
Q psy11767 453 LKGGELLDRIRQKGRCGFTENEASRIMRQLVAAVHFMHSRG--VVHRDLKPENLLFSDPAGDNIKVVDFGFACLKRES-L 529 (966)
Q Consensus 453 ~~gg~L~~~l~~~~~~~l~e~~~~~i~~Qil~aL~yLHs~~--IiHRDLKP~NILl~~~~~~~iKL~DFGla~~~~~~-~ 529 (966)
|+||+|.+++.+.. .+++.+++.++.||+.||+|||+++ |+||||||+|||+++ .++.+||+|||+|+..... .
T Consensus 94 ~~~g~L~~~l~~~~--~~~~~~~~~~~~qi~~gl~yLH~~~~~IiHrDiKp~NILl~~-~~~~~Kl~DFGla~~~~~~~~ 170 (270)
T d1t4ha_ 94 MTSGTLKTYLKRFK--VMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITG-PTGSVKIGDLGLATLKRASFA 170 (270)
T ss_dssp CCSCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHTSSSCCCCSCCCGGGEEESS-TTSCEEECCTTGGGGCCTTSB
T ss_pred CCCCcHHHHHhccc--cccHHHHHHHHHHHHHHHHHHHHCCCCEEeCCcChhhceeeC-CCCCEEEeecCcceeccCCcc
Confidence 99999999998765 5999999999999999999999998 999999999999964 2468999999999865433 3
Q ss_pred ccccccccccCchhhccCCCCCCCcccchhhhhhhhhhhhcCCCCCCCcCcchhHHHHHHHHhcCCCCCCCCCCchhHHH
Q psy11767 530 HTPCFTLQYAAPEVLRQDKSGYDENCDLWSLGVILVNVLRQDKSGYDENCDLWSLGVILYTMLCGRVPFHARSRDDSALS 609 (966)
Q Consensus 530 ~~~~gT~~Y~APEvl~~~~~~~~~~~Di~SlGvil~el~~~~~~~y~~~~DIWSlGvilyemltG~~Pf~~~~~~~~~~~ 609 (966)
.+.+||+.|||||++.. .|+.++|||||||++|+|++|++||.+.... ..
T Consensus 171 ~~~~GT~~Y~aPE~~~~---------------------------~~~~~~DIwSlGvilyel~~g~~Pf~~~~~~---~~ 220 (270)
T d1t4ha_ 171 KAVIGTPEFMAPEMYEE---------------------------KYDESVDVYAFGMCMLEMATSEYPYSECQNA---AQ 220 (270)
T ss_dssp EESCSSCCCCCGGGGGT---------------------------CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSH---HH
T ss_pred CCcccCccccCHHHhCC---------------------------CCCCcCchhhHHHHHHHHHHCCCCCCCcccH---HH
Confidence 46789999999998741 3788999999999999999999999765433 23
Q ss_pred HHHHHHcCCCCCCchhhccCCHHHHHHHHHhcccCccccCChHHHHHHhhhhH
Q psy11767 610 IMARIKEGQFNFDAEAWSTVSSEAKELTKSLLTVNPAQRIRMMRVKLTFHAFH 662 (966)
Q Consensus 610 ~~~~i~~~~~~~~~~~~~~is~e~~~Li~~~L~~dP~~R~t~~~v~~~~~~~~ 662 (966)
+...+..+.. +...+...++++++||.+||+.||++|||+.++ ..|+|+
T Consensus 221 ~~~~i~~~~~--~~~~~~~~~~~~~~li~~~l~~dp~~R~s~~el--l~Hp~f 269 (270)
T d1t4ha_ 221 IYRRVTSGVK--PASFDKVAIPEVKEIIEGCIRQNKDERYSIKDL--LNHAFF 269 (270)
T ss_dssp HHHHHTTTCC--CGGGGGCCCHHHHHHHHHHSCSSGGGSCCHHHH--HTSGGG
T ss_pred HHHHHHcCCC--CcccCccCCHHHHHHHHHHccCCHhHCcCHHHH--hCCccc
Confidence 4555655533 233445689999999999999999999999876 446765
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.1e-50 Score=447.86 Aligned_cols=243 Identities=35% Similarity=0.590 Sum_probs=209.8
Q ss_pred cccccccccccccEEEEEEEcCCCcEEEEEEecccc--------ChHHHHHHHHHhcCCCCceEEEEEEEeCCeEEEEEE
Q psy11767 380 LDKAGILGDGSYSVCRRCVEKSTGQEYAVKIISRKI--------DCSEEINLLRACQGHPNIVNLHCVFQDEVHTYLVLE 451 (966)
Q Consensus 380 ~~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~--------~~~~Ei~iL~~l~~HpnIV~l~~~~~~~~~~~lVmE 451 (966)
|+.+++||+|+||+||+|+++.+|+.||||++.+.. ...+|+.+|+.+ +|||||+++++|+++..+|+|||
T Consensus 7 y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l-~hp~Iv~l~~~~~~~~~~~iv~e 85 (337)
T d1o6la_ 7 FDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNT-RHPFLTALKYAFQTHDRLCFVME 85 (337)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSC-CCTTBCCEEEEEECSSEEEEEEE
T ss_pred cEEEEEEecCcCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhC-CCCCEEEEEeeecccccccccee
Confidence 455789999999999999999999999999997531 145799999988 59999999999999999999999
Q ss_pred ccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCcEEEecCCCCCEEEEeecccccccC---C
Q psy11767 452 LLKGGELLDRIRQKGRCGFTENEASRIMRQLVAAVHFMHSRGVVHRDLKPENLLFSDPAGDNIKVVDFGFACLKRE---S 528 (966)
Q Consensus 452 y~~gg~L~~~l~~~~~~~l~e~~~~~i~~Qil~aL~yLHs~~IiHRDLKP~NILl~~~~~~~iKL~DFGla~~~~~---~ 528 (966)
||+||+|.+++.+.+ .+++..++.++.||+.||+|||++|||||||||+|||++. ++.+||+|||+|+.... .
T Consensus 86 y~~gg~L~~~~~~~~--~~~e~~~~~~~~qil~al~ylH~~~iiHRDlKP~NILl~~--~g~vkl~DFG~a~~~~~~~~~ 161 (337)
T d1o6la_ 86 YANGGELFFHLSRER--VFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLDK--DGHIKITDFGLCKEGISDGAT 161 (337)
T ss_dssp CCTTCBHHHHHHHHS--CCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECT--TSCEEECCCTTCBCSCCTTCC
T ss_pred ccCCCchhhhhhccc--CCcHHHHHHHHHHHhhhhhhhhhcCccccccCHHHeEecC--CCCEEEeecccccccccCCcc
Confidence 999999999998876 5999999999999999999999999999999999999975 56999999999986432 3
Q ss_pred CccccccccccCchhhccCCCCCCCcccchhhhhhhhhhhhcCCCCCCCcCcchhHHHHHHHHhcCCCCCCCCCCchhHH
Q psy11767 529 LHTPCFTLQYAAPEVLRQDKSGYDENCDLWSLGVILVNVLRQDKSGYDENCDLWSLGVILYTMLCGRVPFHARSRDDSAL 608 (966)
Q Consensus 529 ~~~~~gT~~Y~APEvl~~~~~~~~~~~Di~SlGvil~el~~~~~~~y~~~~DIWSlGvilyemltG~~Pf~~~~~~~~~~ 608 (966)
..+.+||+.|||||++.. .+|+.++|||||||++|||++|++||.+.+. .
T Consensus 162 ~~~~~GT~~Y~aPE~~~~--------------------------~~y~~~~DiwSlGvilyeml~G~~pf~~~~~----~ 211 (337)
T d1o6la_ 162 MKTFCGTPEYLAPEVLED--------------------------NDYGRAVDWWGLGVVMYEMMCGRLPFYNQDH----E 211 (337)
T ss_dssp BCCCEECGGGCCGGGGSS--------------------------SCBCTTHHHHHHHHHHHHHHHSSCSSCCSSH----H
T ss_pred cccceeCHHHhhhhhccC--------------------------CCCChhhcccchhhHHHHHHHCCCCCCCcCH----H
Confidence 456789999999999853 3578999999999999999999999987654 3
Q ss_pred HHHHHHHcCCCCCCchhhccCCHHHHHHHHHhcccCccccCC-----hHHHHHHhhhhHH
Q psy11767 609 SIMARIKEGQFNFDAEAWSTVSSEAKELTKSLLTVNPAQRIR-----MMRVKLTFHAFHQ 663 (966)
Q Consensus 609 ~~~~~i~~~~~~~~~~~~~~is~e~~~Li~~~L~~dP~~R~t-----~~~v~~~~~~~~~ 663 (966)
.++..+..+.+.++ ..+|+++++||.+||++||++|++ +.++ ..|+|+.
T Consensus 212 ~~~~~i~~~~~~~p----~~~s~~~~dli~~~L~~dP~~R~~~~~~~~~ei--l~Hp~f~ 265 (337)
T d1o6la_ 212 RLFELILMEEIRFP----RTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEV--MEHRFFL 265 (337)
T ss_dssp HHHHHHHHCCCCCC----TTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHH--HTSGGGT
T ss_pred HHHHHHhcCCCCCC----ccCCHHHHHHHHhhccCCchhhcccccccHHHH--HcCcccc
Confidence 45667777776554 468999999999999999999996 4444 4577763
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.1e-50 Score=436.60 Aligned_cols=245 Identities=31% Similarity=0.469 Sum_probs=195.2
Q ss_pred ccccccccccccccEEEEEEEcCCCcEEEEEEeccccC-------hHHHHHHHHHhcCCCCceEEEEEEEe--CCeEEEE
Q psy11767 379 DLDKAGILGDGSYSVCRRCVEKSTGQEYAVKIISRKID-------CSEEINLLRACQGHPNIVNLHCVFQD--EVHTYLV 449 (966)
Q Consensus 379 ~~~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~~-------~~~Ei~iL~~l~~HpnIV~l~~~~~~--~~~~~lV 449 (966)
||+.++.||+|+||+||+|+++.+|+.||||++..... ..+|+++|+.+ +|||||++++++.+ +..+|||
T Consensus 5 dy~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l-~HpnIv~~~~~~~~~~~~~~~iv 83 (269)
T d2java1 5 DYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLREL-KHPNIVRYYDRIIDRTNTTLYIV 83 (269)
T ss_dssp GEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCTTSCHHHHHHHHHHHHHTTSC-CCTTBCCEEEEEEC----CEEEE
T ss_pred hCEEeEEEecCCCeEEEEEEECCCCCEEEEEEEChhhCCHHHHHHHHHHHHHHHHC-CCCCEeeEEEEEEeCCCCEEEEE
Confidence 34557899999999999999999999999999875432 34689999888 59999999999965 4568999
Q ss_pred EEccCCCCHHHHHHhc--CCCCCCHHHHHHHHHHHHHHHHHHHhcC-----ceeccCCCCcEEEecCCCCCEEEEeeccc
Q psy11767 450 LELLKGGELLDRIRQK--GRCGFTENEASRIMRQLVAAVHFMHSRG-----VVHRDLKPENLLFSDPAGDNIKVVDFGFA 522 (966)
Q Consensus 450 mEy~~gg~L~~~l~~~--~~~~l~e~~~~~i~~Qil~aL~yLHs~~-----IiHRDLKP~NILl~~~~~~~iKL~DFGla 522 (966)
||||+||+|.+++.+. ....+++.+++.++.||+.||+|||++| ||||||||+|||++. ++.+||+|||+|
T Consensus 84 mEy~~~g~L~~~i~~~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~~~~~~IiHrDiKp~NIll~~--~~~vkl~DFG~a 161 (269)
T d2java1 84 MEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDG--KQNVKLGDFGLA 161 (269)
T ss_dssp EECCTTEEHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHHCC---------CCGGGEEECT--TSCEEECCHHHH
T ss_pred EecCCCCcHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCCCEEeCcCchhhcCcCC--CCcEEEeeccce
Confidence 9999999999998642 2336999999999999999999999976 999999999999985 568999999999
Q ss_pred ccccC---CCccccccccccCchhhccCCCCCCCcccchhhhhhhhhhhhcCCCCCCCcCcchhHHHHHHHHhcCCCCCC
Q psy11767 523 CLKRE---SLHTPCFTLQYAAPEVLRQDKSGYDENCDLWSLGVILVNVLRQDKSGYDENCDLWSLGVILYTMLCGRVPFH 599 (966)
Q Consensus 523 ~~~~~---~~~~~~gT~~Y~APEvl~~~~~~~~~~~Di~SlGvil~el~~~~~~~y~~~~DIWSlGvilyemltG~~Pf~ 599 (966)
+.... ...+.+||+.|||||++.. ..|+.++|||||||++|||++|++||.
T Consensus 162 ~~~~~~~~~~~~~~gt~~Y~APE~l~~--------------------------~~~~~~~DIwSlGvilyel~tg~~Pf~ 215 (269)
T d2java1 162 RILNHDTSFAKAFVGTPYYMSPEQMNR--------------------------MSYNEKSDIWSLGCLLYELCALMPPFT 215 (269)
T ss_dssp HHC-----------CCCSCCCHHHHTT--------------------------CCCCHHHHHHHHHHHHHHHHHSSCSCC
T ss_pred eecccCCCccccCCCCcccCCHHHHcC--------------------------CCCChHHHHHhhCHHHHHHhhCCCCCC
Confidence 76543 2345689999999999852 347889999999999999999999998
Q ss_pred CCCCchhHHHHHHHHHcCCCCCCchhhccCCHHHHHHHHHhcccCccccCChHHHHHHhhhh
Q psy11767 600 ARSRDDSALSIMARIKEGQFNFDAEAWSTVSSEAKELTKSLLTVNPAQRIRMMRVKLTFHAF 661 (966)
Q Consensus 600 ~~~~~~~~~~~~~~i~~~~~~~~~~~~~~is~e~~~Li~~~L~~dP~~R~t~~~v~~~~~~~ 661 (966)
+.+. ..+..+|..+.+... +..+|+++++||.+||+.||++|||+.++ ..|||
T Consensus 216 ~~~~----~~~~~~i~~~~~~~~---~~~~s~~l~~li~~~L~~dp~~Rps~~el--l~hp~ 268 (269)
T d2java1 216 AFSQ----KELAGKIREGKFRRI---PYRYSDELNEIITRMLNLKDYHRPSVEEI--LENPL 268 (269)
T ss_dssp CSSH----HHHHHHHHHTCCCCC---CTTSCHHHHHHHHHHTCSSGGGSCCHHHH--HTSTT
T ss_pred CCCH----HHHHHHHHcCCCCCC---CcccCHHHHHHHHHHcCCChhHCcCHHHH--HhCCc
Confidence 7543 345566777765432 34689999999999999999999999976 34554
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=1.3e-49 Score=441.50 Aligned_cols=244 Identities=30% Similarity=0.575 Sum_probs=212.0
Q ss_pred ccccccccccccccEEEEEEEcCCCcEEEEEEecccc--------ChHHHHHHHHHhcCCCCceEEEEEEEeCCeEEEEE
Q psy11767 379 DLDKAGILGDGSYSVCRRCVEKSTGQEYAVKIISRKI--------DCSEEINLLRACQGHPNIVNLHCVFQDEVHTYLVL 450 (966)
Q Consensus 379 ~~~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~--------~~~~Ei~iL~~l~~HpnIV~l~~~~~~~~~~~lVm 450 (966)
+|+.++.||+|+||+||+|+++.+|+.||||++.+.. ...+|+.+|+.+ +|||||+++++|.++..+|+||
T Consensus 5 dy~i~~~lG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l-~HpnIv~~~~~~~~~~~~~ivm 83 (316)
T d1fota_ 5 DFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIV-THPFIIRMWGTFQDAQQIFMIM 83 (316)
T ss_dssp GEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSC-CBTTBCCEEEEEECSSEEEEEE
T ss_pred HeEEEEEEecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHhc-cCcChhheeeeEeeCCeeeeEe
Confidence 3555789999999999999999999999999996431 245799999988 5999999999999999999999
Q ss_pred EccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCcEEEecCCCCCEEEEeecccccccCCCc
Q psy11767 451 ELLKGGELLDRIRQKGRCGFTENEASRIMRQLVAAVHFMHSRGVVHRDLKPENLLFSDPAGDNIKVVDFGFACLKRESLH 530 (966)
Q Consensus 451 Ey~~gg~L~~~l~~~~~~~l~e~~~~~i~~Qil~aL~yLHs~~IiHRDLKP~NILl~~~~~~~iKL~DFGla~~~~~~~~ 530 (966)
|||+||+|.+++.... .+++..++.++.||+.||+|||++|||||||||+|||++. ++.+||+|||+|+.......
T Consensus 84 E~~~gg~l~~~~~~~~--~~~~~~~~~~~~qi~~al~~lH~~~iiHrDiKp~NILl~~--~g~vkL~DFG~a~~~~~~~~ 159 (316)
T d1fota_ 84 DYIEGGELFSLLRKSQ--RFPNPVAKFYAAEVCLALEYLHSKDIIYRDLKPENILLDK--NGHIKITDFGFAKYVPDVTY 159 (316)
T ss_dssp CCCCSCBHHHHHHHTS--SCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECT--TSCEEECCCSSCEECSSCBC
T ss_pred eecCCccccccccccc--cccccHHHHHHHHHHHhhhhhccCcEEccccCchheeEcC--CCCEEEecCccceEeccccc
Confidence 9999999999988765 5899999999999999999999999999999999999974 56999999999988777777
Q ss_pred cccccccccCchhhccCCCCCCCcccchhhhhhhhhhhhcCCCCCCCcCcchhHHHHHHHHhcCCCCCCCCCCchhHHHH
Q psy11767 531 TPCFTLQYAAPEVLRQDKSGYDENCDLWSLGVILVNVLRQDKSGYDENCDLWSLGVILYTMLCGRVPFHARSRDDSALSI 610 (966)
Q Consensus 531 ~~~gT~~Y~APEvl~~~~~~~~~~~Di~SlGvil~el~~~~~~~y~~~~DIWSlGvilyemltG~~Pf~~~~~~~~~~~~ 610 (966)
+.+||+.|||||++.. ..|+.++|||||||++|+|++|+.||.+.+. ..+
T Consensus 160 ~~~Gt~~Y~APE~l~~--------------------------~~y~~~~DiwSlGvilyemltG~~Pf~~~~~----~~~ 209 (316)
T d1fota_ 160 TLCGTPDYIAPEVVST--------------------------KPYNKSIDWWSFGILIYEMLAGYTPFYDSNT----MKT 209 (316)
T ss_dssp CCCSCTTTCCHHHHTT--------------------------CCBCTTHHHHHHHHHHHHHHHSSCTTCCSSH----HHH
T ss_pred cccCcccccCHHHHcC--------------------------CCCCchhhccccchhHHHHHhCCCCCCCcCH----HHH
Confidence 8899999999999853 3478899999999999999999999987543 345
Q ss_pred HHHHHcCCCCCCchhhccCCHHHHHHHHHhcccCccccC-----ChHHHHHHhhhhHH
Q psy11767 611 MARIKEGQFNFDAEAWSTVSSEAKELTKSLLTVNPAQRI-----RMMRVKLTFHAFHQ 663 (966)
Q Consensus 611 ~~~i~~~~~~~~~~~~~~is~e~~~Li~~~L~~dP~~R~-----t~~~v~~~~~~~~~ 663 (966)
+.++..+.+.++ +.+|++++++|.+||..||.+|+ |+.++ ..|||++
T Consensus 210 ~~~i~~~~~~~p----~~~s~~~~~li~~~L~~dp~~R~~~~r~t~~~i--l~Hp~f~ 261 (316)
T d1fota_ 210 YEKILNAELRFP----PFFNEDVKDLLSRLITRDLSQRLGNLQNGTEDV--KNHPWFK 261 (316)
T ss_dssp HHHHHHCCCCCC----TTSCHHHHHHHHHHTCSCTTTCTTSSTTTTHHH--HTSGGGS
T ss_pred HHHHHcCCCCCC----CCCCHHHHHHHHHHhhhCHHhccccchhhHHHH--HcCcccc
Confidence 667777766544 35899999999999999999997 66655 4677763
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=1.4e-48 Score=439.26 Aligned_cols=243 Identities=34% Similarity=0.608 Sum_probs=211.6
Q ss_pred cccccccccccccEEEEEEEcCCCcEEEEEEecccc--------ChHHHHHHHHHhcCCCCceEEEEEEEeCCeEEEEEE
Q psy11767 380 LDKAGILGDGSYSVCRRCVEKSTGQEYAVKIISRKI--------DCSEEINLLRACQGHPNIVNLHCVFQDEVHTYLVLE 451 (966)
Q Consensus 380 ~~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~--------~~~~Ei~iL~~l~~HpnIV~l~~~~~~~~~~~lVmE 451 (966)
|+.++.||+|+||+||+|+++.+|+.||||++.+.. ...+|+++|+.+ +|||||+++++|.+....|+|||
T Consensus 43 y~i~~~lG~G~fg~Vy~a~~~~~g~~~AvK~i~~~~~~~~~~~~~~~~E~~il~~l-~hpnIv~~~~~~~~~~~~~~v~e 121 (350)
T d1rdqe_ 43 FDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAV-NFPFLVKLEFSFKDNSNLYMVME 121 (350)
T ss_dssp EEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTC-CCTTBCCEEEEEECSSEEEEEEE
T ss_pred eEEEEEeecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHHc-CCCcEeecccccccccccccccc
Confidence 344789999999999999999999999999986421 145799999988 59999999999999999999999
Q ss_pred ccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCcEEEecCCCCCEEEEeecccccccCCCcc
Q psy11767 452 LLKGGELLDRIRQKGRCGFTENEASRIMRQLVAAVHFMHSRGVVHRDLKPENLLFSDPAGDNIKVVDFGFACLKRESLHT 531 (966)
Q Consensus 452 y~~gg~L~~~l~~~~~~~l~e~~~~~i~~Qil~aL~yLHs~~IiHRDLKP~NILl~~~~~~~iKL~DFGla~~~~~~~~~ 531 (966)
|+.||+|.+++.+.+ .+++.+++.|+.||+.||+|||++|||||||||+|||++. ++.+||+|||+|+.......+
T Consensus 122 ~~~~g~l~~~l~~~~--~l~e~~~~~i~~qi~~aL~yLH~~~iiHRDIKP~NILl~~--~g~ikL~DFG~a~~~~~~~~~ 197 (350)
T d1rdqe_ 122 YVAGGEMFSHLRRIG--RFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQ--QGYIQVTDFGFAKRVKGRTWT 197 (350)
T ss_dssp CCTTCBHHHHHHHHC--CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECT--TSCEEECCCTTCEECSSCBCC
T ss_pred cccccchhhhHhhcC--CCCHHHHHHHHHHHHHHHHHHHhCCEecCcCCHHHcccCC--CCCEEeeeceeeeeccccccc
Confidence 999999999998776 5999999999999999999999999999999999999975 569999999999887766677
Q ss_pred ccccccccCchhhccCCCCCCCcccchhhhhhhhhhhhcCCCCCCCcCcchhHHHHHHHHhcCCCCCCCCCCchhHHHHH
Q psy11767 532 PCFTLQYAAPEVLRQDKSGYDENCDLWSLGVILVNVLRQDKSGYDENCDLWSLGVILYTMLCGRVPFHARSRDDSALSIM 611 (966)
Q Consensus 532 ~~gT~~Y~APEvl~~~~~~~~~~~Di~SlGvil~el~~~~~~~y~~~~DIWSlGvilyemltG~~Pf~~~~~~~~~~~~~ 611 (966)
.+||+.|||||++.. ..|+.++|||||||++|+|++|++||.+.+. ..++
T Consensus 198 ~~Gt~~Y~APE~~~~--------------------------~~~~~~~DiwSlGvilyemltG~~Pf~~~~~----~~~~ 247 (350)
T d1rdqe_ 198 LCGTPEALAPEIILS--------------------------KGYNKAVDWWALGVLIYEMAAGYPPFFADQP----IQIY 247 (350)
T ss_dssp CEECGGGCCHHHHTT--------------------------CCBCTHHHHHHHHHHHHHHHHSSCSSCCSSH----HHHH
T ss_pred ccCccccCCHHHHcC--------------------------CCCCccccccchhHHHHHHHhCCCCCCCcCH----HHHH
Confidence 899999999999853 3478899999999999999999999987543 3456
Q ss_pred HHHHcCCCCCCchhhccCCHHHHHHHHHhcccCccccC-----ChHHHHHHhhhhHH
Q psy11767 612 ARIKEGQFNFDAEAWSTVSSEAKELTKSLLTVNPAQRI-----RMMRVKLTFHAFHQ 663 (966)
Q Consensus 612 ~~i~~~~~~~~~~~~~~is~e~~~Li~~~L~~dP~~R~-----t~~~v~~~~~~~~~ 663 (966)
.+|..+.+.++ ..+|+++.+||++||..||.+|+ |+.++ ..|+|++
T Consensus 248 ~~i~~~~~~~p----~~~s~~~~~li~~~L~~dP~kR~~~~r~t~~el--l~Hp~f~ 298 (350)
T d1rdqe_ 248 EKIVSGKVRFP----SHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDI--KNHKWFA 298 (350)
T ss_dssp HHHHHCCCCCC----TTCCHHHHHHHHHHSCSCTTTCTTSSTTTTHHH--HTSGGGT
T ss_pred HHHhcCCCCCC----ccCCHHHHHHHHHHhhhCHHhccccccccHHHH--HcCcccc
Confidence 67777766543 46899999999999999999995 77765 4577764
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=4.6e-49 Score=431.38 Aligned_cols=244 Identities=23% Similarity=0.364 Sum_probs=203.2
Q ss_pred ccccccccccccEEEEEEEcCCCcEEEEEEeccccC----hHHHHHHHHHhcCCCCceEEEEEEEeCCeEEEEEEccCCC
Q psy11767 381 DKAGILGDGSYSVCRRCVEKSTGQEYAVKIISRKID----CSEEINLLRACQGHPNIVNLHCVFQDEVHTYLVLELLKGG 456 (966)
Q Consensus 381 ~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~~----~~~Ei~iL~~l~~HpnIV~l~~~~~~~~~~~lVmEy~~gg 456 (966)
+..+.||+|+||+||+|+++.+|+.||||+++.... ..+|+++|+.+ +|||||+++++|.++...|||||||++|
T Consensus 20 ~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~E~~il~~l-~HpnIv~~~~~~~~~~~~~iv~E~~~~g 98 (287)
T d1opja_ 20 TMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEI-KHPNLVQLLGVCTREPPFYIITEFMTYG 98 (287)
T ss_dssp EEEEETTTTTTSSEEEEEEGGGTEEEEEEECCTTCSCHHHHHHHHHHHHHC-CCTTBCCEEEEECSSSSCEEEEECCTTC
T ss_pred EEeeEEeeCCCeEEEEEEECCCCeEEEEEEECCccchHHHHHHHHHHHHhC-CCCCEecCCccEeeCCeeEEEeecccCc
Confidence 346789999999999999999999999999975432 45799999998 5999999999999999999999999999
Q ss_pred CHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCcEEEecCCCCCEEEEeecccccccCCC----ccc
Q psy11767 457 ELLDRIRQKGRCGFTENEASRIMRQLVAAVHFMHSRGVVHRDLKPENLLFSDPAGDNIKVVDFGFACLKRESL----HTP 532 (966)
Q Consensus 457 ~L~~~l~~~~~~~l~e~~~~~i~~Qil~aL~yLHs~~IiHRDLKP~NILl~~~~~~~iKL~DFGla~~~~~~~----~~~ 532 (966)
+|.+++.+.....+++..++.++.||+.||+|||++||+||||||+|||++. ++.+||+|||+|+...... ...
T Consensus 99 ~l~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlKp~NILl~~--~~~~Kl~DFG~a~~~~~~~~~~~~~~ 176 (287)
T d1opja_ 99 NLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGE--NHLVKVADFGLSRLMTGDTYTAHAGA 176 (287)
T ss_dssp BHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECG--GGCEEECCCCCTTTCCSSSSEEETTE
T ss_pred chHHHhhhccccchHHHHHHHHHHHHHHHHHHHHHCCcccCccccCeEEECC--CCcEEEccccceeecCCCCceeeccc
Confidence 9999998766667999999999999999999999999999999999999985 5699999999998754322 223
Q ss_pred cccccccCchhhccCCCCCCCcccchhhhhhhhhhhhcCCCCCCCcCcchhHHHHHHHHhcCCCCCCCCCCchhHHHHHH
Q psy11767 533 CFTLQYAAPEVLRQDKSGYDENCDLWSLGVILVNVLRQDKSGYDENCDLWSLGVILYTMLCGRVPFHARSRDDSALSIMA 612 (966)
Q Consensus 533 ~gT~~Y~APEvl~~~~~~~~~~~Di~SlGvil~el~~~~~~~y~~~~DIWSlGvilyemltG~~Pf~~~~~~~~~~~~~~ 612 (966)
.||+.|+|||++.. ..|+.++|||||||++|||++|..||....... .+..
T Consensus 177 ~g~~~y~aPE~~~~--------------------------~~~~~k~DiwS~Gv~l~ell~~~~p~~~~~~~~---~~~~ 227 (287)
T d1opja_ 177 KFPIKWTAPESLAY--------------------------NKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLS---QVYE 227 (287)
T ss_dssp EECGGGCCHHHHHH--------------------------CCCSHHHHHHHHHHHHHHHHTTSCCSSTTCCHH---HHHH
T ss_pred cccccccChHHHcC--------------------------CCCCchhhhhhHHHHHHHHHhCCCCCCCcchHH---HHHH
Confidence 47899999999863 247889999999999999999777765443322 2334
Q ss_pred HHHcCCCCCCchhhccCCHHHHHHHHHhcccCccccCChHHHHHHhh
Q psy11767 613 RIKEGQFNFDAEAWSTVSSEAKELTKSLLTVNPAQRIRMMRVKLTFH 659 (966)
Q Consensus 613 ~i~~~~~~~~~~~~~~is~e~~~Li~~~L~~dP~~R~t~~~v~~~~~ 659 (966)
.+..+. . .+.+..+++++++||.+||+.||++|||+.++...+.
T Consensus 228 ~i~~~~-~--~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ei~~~L~ 271 (287)
T d1opja_ 228 LLEKDY-R--MERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFE 271 (287)
T ss_dssp HHHTTC-C--CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred HHhcCC-C--CCCCccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHH
Confidence 444432 2 2234568999999999999999999999998855444
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Probab=100.00 E-value=7.8e-49 Score=443.54 Aligned_cols=248 Identities=29% Similarity=0.471 Sum_probs=202.3
Q ss_pred cccccccccccccEEEEEEEcCCCcEEEEEEecccc--------ChHHHHHHHHHhc--CCCCceEEEEEEEeCCeEEEE
Q psy11767 380 LDKAGILGDGSYSVCRRCVEKSTGQEYAVKIISRKI--------DCSEEINLLRACQ--GHPNIVNLHCVFQDEVHTYLV 449 (966)
Q Consensus 380 ~~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~--------~~~~Ei~iL~~l~--~HpnIV~l~~~~~~~~~~~lV 449 (966)
|+..++||+|+||+||+|+++.+|+.||||++.+.. ...+|..+++.+. +|||||+++++|++++.+|||
T Consensus 6 y~i~~~lG~G~fg~Vy~~~~~~t~~~vAiK~i~~~~~~~~~~~~~~~~e~~~~~~l~~~~hpnIv~l~~~~~~~~~~~iv 85 (364)
T d1omwa3 6 FSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFI 85 (364)
T ss_dssp EEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSEEEEE
T ss_pred CeeeeEEecCCCeEEEEEEECCCCCEEEEEEEchHHcchhhHHHHHHHHHHHHHHHhcCCCCcEEEEEEEEEECCEEEEE
Confidence 444789999999999999999999999999986432 1234444343322 599999999999999999999
Q ss_pred EEccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCcEEEecCCCCCEEEEeecccccccC-C
Q psy11767 450 LELLKGGELLDRIRQKGRCGFTENEASRIMRQLVAAVHFMHSRGVVHRDLKPENLLFSDPAGDNIKVVDFGFACLKRE-S 528 (966)
Q Consensus 450 mEy~~gg~L~~~l~~~~~~~l~e~~~~~i~~Qil~aL~yLHs~~IiHRDLKP~NILl~~~~~~~iKL~DFGla~~~~~-~ 528 (966)
||||+||+|.++|.+.. .+++.+++.++.||+.||+|||++|||||||||+|||++. .+.+||+|||+|+.... .
T Consensus 86 mE~~~gg~L~~~l~~~~--~~~e~~~~~~~~qi~~aL~ylH~~~iiHrDlKP~NILl~~--~g~iKl~DFGla~~~~~~~ 161 (364)
T d1omwa3 86 LDLMNGGDLHYHLSQHG--VFSEADMRFYAAEIILGLEHMHNRFVVYRDLKPANILLDE--HGHVRISDLGLACDFSKKK 161 (364)
T ss_dssp ECCCCSCBHHHHHHHHC--SCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECS--SSCEEECCCTTCEECSSSC
T ss_pred EEecCCCcHHHHHHhcc--cccHHHHHHHHHHHHHHHHHHHHCCccceeeccceeEEcC--CCcEEEeeeceeeecCCCc
Confidence 99999999999998775 5899999999999999999999999999999999999974 56999999999986543 3
Q ss_pred CccccccccccCchhhccCCCCCCCcccchhhhhhhhhhhhcCCCCCCCcCcchhHHHHHHHHhcCCCCCCCCCCchhHH
Q psy11767 529 LHTPCFTLQYAAPEVLRQDKSGYDENCDLWSLGVILVNVLRQDKSGYDENCDLWSLGVILYTMLCGRVPFHARSRDDSAL 608 (966)
Q Consensus 529 ~~~~~gT~~Y~APEvl~~~~~~~~~~~Di~SlGvil~el~~~~~~~y~~~~DIWSlGvilyemltG~~Pf~~~~~~~~~~ 608 (966)
....+||+.|||||++.. ...|+.++|||||||++|+|++|+.||.+....+. .
T Consensus 162 ~~~~~GT~~y~APE~~~~-------------------------~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~-~ 215 (364)
T d1omwa3 162 PHASVGTHGYMAPEVLQK-------------------------GVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDK-H 215 (364)
T ss_dssp CCSCCSCGGGCCHHHHST-------------------------TCCCCTHHHHHHHHHHHHHHHHSSCSSCSSCSSCH-H
T ss_pred ccccccccccchhHHhhc-------------------------CCCCCcccchhHHHHHHHHHHhCCCCCCCCCHHHH-H
Confidence 456789999999999852 23578999999999999999999999987654432 2
Q ss_pred HHHHHHHcCCCCCCchhhccCCHHHHHHHHHhcccCccccCCh-----HHHHHHhhhhHH
Q psy11767 609 SIMARIKEGQFNFDAEAWSTVSSEAKELTKSLLTVNPAQRIRM-----MRVKLTFHAFHQ 663 (966)
Q Consensus 609 ~~~~~i~~~~~~~~~~~~~~is~e~~~Li~~~L~~dP~~R~t~-----~~v~~~~~~~~~ 663 (966)
.+...+... ....+..+|+++++||.+||+.||++|||+ .++ ..|+|++
T Consensus 216 ~~~~~~~~~----~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~~~~a~ei--l~Hp~f~ 269 (364)
T d1omwa3 216 EIDRMTLTM----AVELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEV--KESPFFR 269 (364)
T ss_dssp HHHHHSSSC----CCCCCSSSCHHHHHHHHHHTCSSTTTSTTTSSSTHHHH--HTSGGGT
T ss_pred HHHHhcccC----CCCCCCCCCHHHHHHHHHHcccCHHHhCCCcccCHHHH--HcCcccc
Confidence 223332222 233345789999999999999999999994 443 5677764
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-48 Score=434.93 Aligned_cols=244 Identities=30% Similarity=0.525 Sum_probs=206.8
Q ss_pred cccccccccccccEEEEEEEcCCCcEEEEEEecccc--------ChHHHHHHHHHhcCCCCceEEEEEEEeCCeEEEEEE
Q psy11767 380 LDKAGILGDGSYSVCRRCVEKSTGQEYAVKIISRKI--------DCSEEINLLRACQGHPNIVNLHCVFQDEVHTYLVLE 451 (966)
Q Consensus 380 ~~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~--------~~~~Ei~iL~~l~~HpnIV~l~~~~~~~~~~~lVmE 451 (966)
|+..+.||+|+||+||+|+++.+|+.||||++.+.. ....|+.+|....+|||||+++++|++++..|||||
T Consensus 4 y~i~~~iG~G~fg~Vy~~~~~~t~~~vAvK~i~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~~~~~~~~~~~~yivmE 83 (320)
T d1xjda_ 4 FILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLFFVME 83 (320)
T ss_dssp EEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEEEEE
T ss_pred eEEeeEEecCCCcEEEEEEECCCCCEEEEEEEchhhccChHHHHHHHHHHHHHHHhCCCCcEEEEEEEEccCCceeEEEe
Confidence 344689999999999999999999999999996421 134577777655579999999999999999999999
Q ss_pred ccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCcEEEecCCCCCEEEEeecccccccC---C
Q psy11767 452 LLKGGELLDRIRQKGRCGFTENEASRIMRQLVAAVHFMHSRGVVHRDLKPENLLFSDPAGDNIKVVDFGFACLKRE---S 528 (966)
Q Consensus 452 y~~gg~L~~~l~~~~~~~l~e~~~~~i~~Qil~aL~yLHs~~IiHRDLKP~NILl~~~~~~~iKL~DFGla~~~~~---~ 528 (966)
||+||+|.+++.... .+++.+++.++.||+.||+|||++||+||||||+|||++. .+.+||+|||+|+.... .
T Consensus 84 y~~~g~L~~~i~~~~--~~~e~~~~~~~~qi~~al~ylH~~~iiHrDikp~NiL~~~--~~~~kl~DFG~a~~~~~~~~~ 159 (320)
T d1xjda_ 84 YLNGGDLMYHIQSCH--KFDLSRATFYAAEIILGLQFLHSKGIVYRDLKLDNILLDK--DGHIKIADFGMCKENMLGDAK 159 (320)
T ss_dssp CCTTCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECT--TSCEEECCCTTCBCCCCTTCC
T ss_pred ecCCCcHHHHhhccC--CCCHHHHHHHHHHHHHHHHHHHhCCeeeccCcccceeecC--CCceeccccchhhhccccccc
Confidence 999999999998766 5899999999999999999999999999999999999985 56999999999975432 2
Q ss_pred CccccccccccCchhhccCCCCCCCcccchhhhhhhhhhhhcCCCCCCCcCcchhHHHHHHHHhcCCCCCCCCCCchhHH
Q psy11767 529 LHTPCFTLQYAAPEVLRQDKSGYDENCDLWSLGVILVNVLRQDKSGYDENCDLWSLGVILYTMLCGRVPFHARSRDDSAL 608 (966)
Q Consensus 529 ~~~~~gT~~Y~APEvl~~~~~~~~~~~Di~SlGvil~el~~~~~~~y~~~~DIWSlGvilyemltG~~Pf~~~~~~~~~~ 608 (966)
....+||+.|+|||++.. ..|+.++|||||||++|+|++|+.||.+.+. .
T Consensus 160 ~~~~~gt~~y~aPE~~~~--------------------------~~~~~~~DiwSlGvilyemltG~~PF~~~~~----~ 209 (320)
T d1xjda_ 160 TNTFCGTPDYIAPEILLG--------------------------QKYNHSVDWWSFGVLLYEMLIGQSPFHGQDE----E 209 (320)
T ss_dssp BCCCCSCGGGCCHHHHTT--------------------------CCBCTHHHHHHHHHHHHHHHHSSCSSCCSSH----H
T ss_pred ccccCCCCCcCCHHHHcC--------------------------CCCCchhhhhhhhHHHHHHHhCCCCCCCCCH----H
Confidence 345679999999999963 3478899999999999999999999987553 3
Q ss_pred HHHHHHHcCCCCCCchhhccCCHHHHHHHHHhcccCccccCChH-HHHHHhhhhHH
Q psy11767 609 SIMARIKEGQFNFDAEAWSTVSSEAKELTKSLLTVNPAQRIRMM-RVKLTFHAFHQ 663 (966)
Q Consensus 609 ~~~~~i~~~~~~~~~~~~~~is~e~~~Li~~~L~~dP~~R~t~~-~v~~~~~~~~~ 663 (966)
.++.++..+.+.++ ..+|+++++||.+||+.||++|||+. ++ ..|+|++
T Consensus 210 ~~~~~i~~~~~~~p----~~~s~~~~dli~~~L~~dP~~R~s~~~~l--~~hpff~ 259 (320)
T d1xjda_ 210 ELFHSIRMDNPFYP----RWLEKEAKDLLVKLFVREPEKRLGVRGDI--RQHPLFR 259 (320)
T ss_dssp HHHHHHHHCCCCCC----TTSCHHHHHHHHHHSCSSGGGSBTTBSCG--GGSGGGT
T ss_pred HHHHHHHcCCCCCC----ccCCHHHHHHHHHhcccCCCCCcCHHHHH--HhCchhc
Confidence 45667777766543 35899999999999999999999985 44 4477764
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.9e-48 Score=431.31 Aligned_cols=244 Identities=23% Similarity=0.377 Sum_probs=199.9
Q ss_pred cccccccccccccEEEEEEEcCCCc-----EEEEEEecccc------ChHHHHHHHHHhcCCCCceEEEEEEEeCCeEEE
Q psy11767 380 LDKAGILGDGSYSVCRRCVEKSTGQ-----EYAVKIISRKI------DCSEEINLLRACQGHPNIVNLHCVFQDEVHTYL 448 (966)
Q Consensus 380 ~~~~~~LG~G~fG~Vy~a~~~~tg~-----~vAvK~i~~~~------~~~~Ei~iL~~l~~HpnIV~l~~~~~~~~~~~l 448 (966)
|+..++||+|+||+||+|++..+++ .||||++.... ...+|+.+|..+.+|||||+++++|.+.+..||
T Consensus 39 ~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~l~~~~~~~~~~~l 118 (325)
T d1rjba_ 39 LEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTLSGPIYL 118 (325)
T ss_dssp EEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEE
T ss_pred eEEeeEEeeCCCeEEEEEEEcCCCcccceeEEEEEEeccccCHHHHHHHHHHHHHHHHhcCCCcEeEEEEEEeeCCeEEE
Confidence 3446899999999999999987654 79999986432 245799999998789999999999999999999
Q ss_pred EEEccCCCCHHHHHHhcCC---------------------CCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCcEEEe
Q psy11767 449 VLELLKGGELLDRIRQKGR---------------------CGFTENEASRIMRQLVAAVHFMHSRGVVHRDLKPENLLFS 507 (966)
Q Consensus 449 VmEy~~gg~L~~~l~~~~~---------------------~~l~e~~~~~i~~Qil~aL~yLHs~~IiHRDLKP~NILl~ 507 (966)
|||||+||+|.++|..+.. ..+++.+++.|+.||+.||+|||++|||||||||+|||++
T Consensus 119 v~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~yLH~~~IiHRDlKp~Nill~ 198 (325)
T d1rjba_ 119 IFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKSCVHRDLAARNVLVT 198 (325)
T ss_dssp EEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHTTEEETTCSGGGEEEE
T ss_pred EEEcCCCCcHHHHHHhccCCCcchhhhhccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCchhccccc
Confidence 9999999999999976532 2489999999999999999999999999999999999998
Q ss_pred cCCCCCEEEEeecccccccCCC-----ccccccccccCchhhccCCCCCCCcccchhhhhhhhhhhhcCCCCCCCcCcch
Q psy11767 508 DPAGDNIKVVDFGFACLKRESL-----HTPCFTLQYAAPEVLRQDKSGYDENCDLWSLGVILVNVLRQDKSGYDENCDLW 582 (966)
Q Consensus 508 ~~~~~~iKL~DFGla~~~~~~~-----~~~~gT~~Y~APEvl~~~~~~~~~~~Di~SlGvil~el~~~~~~~y~~~~DIW 582 (966)
. ++.+||+|||+|+...... .+.+||+.|||||++.. ..|+.++|||
T Consensus 199 ~--~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~--------------------------~~~~~~~Diw 250 (325)
T d1rjba_ 199 H--GKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFE--------------------------GIYTIKSDVW 250 (325)
T ss_dssp T--TTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHH--------------------------CCCCHHHHHH
T ss_pred c--CCeEEEeeccccccccCCCceeeeccccCCCccCChHHHcC--------------------------CCCCcceecc
Confidence 5 5699999999997654321 24567999999999863 2478899999
Q ss_pred hHHHHHHHHhc-CCCCCCCCCCchhHHHHHHHHHcCCCCCCchhhccCCHHHHHHHHHhcccCccccCChHHHHHH
Q psy11767 583 SLGVILYTMLC-GRVPFHARSRDDSALSIMARIKEGQFNFDAEAWSTVSSEAKELTKSLLTVNPAQRIRMMRVKLT 657 (966)
Q Consensus 583 SlGvilyemlt-G~~Pf~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~is~e~~~Li~~~L~~dP~~R~t~~~v~~~ 657 (966)
||||++|||++ |++||.+.+..+. +.++..+.+.++ .+..+|+++++||.+||+.||++|||+.++...
T Consensus 251 S~Gvil~emlt~g~~Pf~~~~~~~~----~~~~~~~~~~~~--~p~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~ 320 (325)
T d1rjba_ 251 SYGILLWEIFSLGVNPYPGIPVDAN----FYKLIQNGFKMD--QPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSF 320 (325)
T ss_dssp HHHHHHHHHTTTSCCSSTTCCCSHH----HHHHHHTTCCCC--CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred chhHHHHHHHhCCCCCCCCCCHHHH----HHHHHhcCCCCC--CCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence 99999999997 8999988665432 223333333322 334689999999999999999999999988543
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.4e-48 Score=429.53 Aligned_cols=250 Identities=25% Similarity=0.386 Sum_probs=199.4
Q ss_pred cccccccccccEEEEEEEcCCCcEEEEEEecccc----------ChHHHHHHHHHhcCCCCceEEEEEEEeCCeEEEEEE
Q psy11767 382 KAGILGDGSYSVCRRCVEKSTGQEYAVKIISRKI----------DCSEEINLLRACQGHPNIVNLHCVFQDEVHTYLVLE 451 (966)
Q Consensus 382 ~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~----------~~~~Ei~iL~~l~~HpnIV~l~~~~~~~~~~~lVmE 451 (966)
++++||+|+||+||+|+++.+|+.||||+++... ...+|+.+|+.+ +|||||+++++|.++++.|||||
T Consensus 2 ~l~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l-~hpnIv~~~~~~~~~~~~~ivmE 80 (299)
T d1ua2a_ 2 KLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQEL-SHPNIIGLLDAFGHKSNISLVFD 80 (299)
T ss_dssp EEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHC-CCTTBCCEEEEECCTTCCEEEEE
T ss_pred cceEeccCcCeEEEEEEECCCCcEEEEEEEehhhhhhhhHHHHHHHHHHHHHHHhC-CCCCEeEEEeeeccCCceeehhh
Confidence 4678999999999999999999999999986432 145799999998 59999999999999999999999
Q ss_pred ccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCcEEEecCCCCCEEEEeecccccccC---C
Q psy11767 452 LLKGGELLDRIRQKGRCGFTENEASRIMRQLVAAVHFMHSRGVVHRDLKPENLLFSDPAGDNIKVVDFGFACLKRE---S 528 (966)
Q Consensus 452 y~~gg~L~~~l~~~~~~~l~e~~~~~i~~Qil~aL~yLHs~~IiHRDLKP~NILl~~~~~~~iKL~DFGla~~~~~---~ 528 (966)
||.|+++...+... ..+++.+++.++.||+.||+|||++||+||||||+|||++. .+.+||+|||+|+.... .
T Consensus 81 ~~~~~~~~~~~~~~--~~l~~~~~~~~~~qil~aL~~lH~~~iiHrDiKp~NIli~~--~~~~KL~DFG~a~~~~~~~~~ 156 (299)
T d1ua2a_ 81 FMETDLEVIIKDNS--LVLTPSHIKAYMLMTLQGLEYLHQHWILHRDLKPNNLLLDE--NGVLKLADFGLAKSFGSPNRA 156 (299)
T ss_dssp CCSEEHHHHHTTCC--SSCCSSHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECT--TCCEEECCCGGGSTTTSCCCC
T ss_pred hhcchHHhhhhhcc--cCCCHHHHHHHHHHHHHHHHHhhccceecccCCcceEEecC--CCccccccCccccccCCCccc
Confidence 99887666554332 36999999999999999999999999999999999999974 56999999999976543 2
Q ss_pred CccccccccccCchhhccCCCCCCCcccchhhhhhhhhhhhcCCCCCCCcCcchhHHHHHHHHhcCCCCCCCCCCchhHH
Q psy11767 529 LHTPCFTLQYAAPEVLRQDKSGYDENCDLWSLGVILVNVLRQDKSGYDENCDLWSLGVILYTMLCGRVPFHARSRDDSAL 608 (966)
Q Consensus 529 ~~~~~gT~~Y~APEvl~~~~~~~~~~~Di~SlGvil~el~~~~~~~y~~~~DIWSlGvilyemltG~~Pf~~~~~~~~~~ 608 (966)
..+.+||+.|+|||++.. ...|+.++||||+||++|||++|.+||.+.+..+...
T Consensus 157 ~~~~~gt~~y~aPE~~~~-------------------------~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~l~ 211 (299)
T d1ua2a_ 157 YTHQVVTRWYRAPELLFG-------------------------ARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLT 211 (299)
T ss_dssp CCCSCCCCTTCCHHHHTT-------------------------CSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHH
T ss_pred ccceecChhhccHHHHcc-------------------------CCCCChhhhhhhcchHHHHHHhCcCCCCCCCHHHHHH
Confidence 345679999999999853 2347889999999999999999999998876544333
Q ss_pred HHHHHHHcCC---CC-------------CC----chhhccCCHHHHHHHHHhcccCccccCChHHHHHHhhhhHH
Q psy11767 609 SIMARIKEGQ---FN-------------FD----AEAWSTVSSEAKELTKSLLTVNPAQRIRMMRVKLTFHAFHQ 663 (966)
Q Consensus 609 ~~~~~i~~~~---~~-------------~~----~~~~~~is~e~~~Li~~~L~~dP~~R~t~~~v~~~~~~~~~ 663 (966)
.+...+.... +. .. ...++.+++++++||.+||+.||++|||+.++ ..|+|++
T Consensus 212 ~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~dP~~R~sa~e~--L~Hp~f~ 284 (299)
T d1ua2a_ 212 RIFETLGTPTEEQWPDMCSLPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQA--LKMKYFS 284 (299)
T ss_dssp HHHHHHCCCCTTTSSSTTSSTTCCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHH--HTSGGGT
T ss_pred HHHHhcCCCChhhccchhccchhhhhccCCCCChHHhcccCCHHHHHHHHHHccCChhhCcCHHHH--hCCHhhC
Confidence 3332221100 00 00 11234678999999999999999999999976 4577753
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Probab=100.00 E-value=7.1e-48 Score=419.32 Aligned_cols=243 Identities=27% Similarity=0.428 Sum_probs=197.3
Q ss_pred cccccccccccccccccccEEEEEEEcCCCcEEEEEEecccc--------ChHHHHHHHHHhcCCCCceEEEEEEEeCC-
Q psy11767 374 EQYDMDLDKAGILGDGSYSVCRRCVEKSTGQEYAVKIISRKI--------DCSEEINLLRACQGHPNIVNLHCVFQDEV- 444 (966)
Q Consensus 374 ~~~~i~~~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~--------~~~~Ei~iL~~l~~HpnIV~l~~~~~~~~- 444 (966)
++|++ .+.||+|+||+||+|++..+|+.||||+++... ...+|+++|+.+ +|||||++++++.++.
T Consensus 7 drY~i----~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~~l~~~-~hpniv~~~~~~~~~~~ 81 (277)
T d1o6ya_ 7 DRYEL----GEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAAL-NHPAIVAVYDTGEAETP 81 (277)
T ss_dssp TTEEE----EEEEEECSSEEEEEEEETTTTEEEEEEEECSTTTTCHHHHHHHHHHHHHHHTC-CCTTBCCEEEEEEEECS
T ss_pred ceeEE----eEEEeeCCCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhc-CCCCCCcccceeeeccC
Confidence 45555 688999999999999999999999999997542 135699999887 6999999999998654
Q ss_pred ---eEEEEEEccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCcEEEecCCCCCEEEEeecc
Q psy11767 445 ---HTYLVLELLKGGELLDRIRQKGRCGFTENEASRIMRQLVAAVHFMHSRGVVHRDLKPENLLFSDPAGDNIKVVDFGF 521 (966)
Q Consensus 445 ---~~~lVmEy~~gg~L~~~l~~~~~~~l~e~~~~~i~~Qil~aL~yLHs~~IiHRDLKP~NILl~~~~~~~iKL~DFGl 521 (966)
..|||||||+||+|.+++...+ .+++.+++.++.||+.||+|||++|||||||||+|||++. .+.++|+|||+
T Consensus 82 ~~~~~~lvmE~~~g~~L~~~~~~~~--~l~~~~~~~i~~qi~~al~~lH~~~iiHrDiKP~NIll~~--~~~~~l~d~~~ 157 (277)
T d1o6ya_ 82 AGPLPYIVMEYVDGVTLRDIVHTEG--PMTPKRAIEVIADACQALNFSHQNGIIHRDVKPANIMISA--TNAVKVMDFGI 157 (277)
T ss_dssp SSEEEEEEEECCCEEEHHHHHHHHC--SCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEET--TSCEEECCCTT
T ss_pred CCceEEEEEECCCCCEehhhhcccC--CCCHHHHHHHHHHHHHHHHHHHhCCccCccccCcccccCc--cccceeehhhh
Confidence 4899999999999999998775 5999999999999999999999999999999999999985 56899999999
Q ss_pred cccccC------CCccccccccccCchhhccCCCCCCCcccchhhhhhhhhhhhcCCCCCCCcCcchhHHHHHHHHhcCC
Q psy11767 522 ACLKRE------SLHTPCFTLQYAAPEVLRQDKSGYDENCDLWSLGVILVNVLRQDKSGYDENCDLWSLGVILYTMLCGR 595 (966)
Q Consensus 522 a~~~~~------~~~~~~gT~~Y~APEvl~~~~~~~~~~~Di~SlGvil~el~~~~~~~y~~~~DIWSlGvilyemltG~ 595 (966)
+..... .....+||+.|||||++.. ..|+.++|||||||++|+|++|+
T Consensus 158 ~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~--------------------------~~~~~~~DiwSlGvilyelltG~ 211 (277)
T d1o6ya_ 158 ARAIADSGNSVTQTAAVIGTAQYLSPEQARG--------------------------DSVDARSDVYSLGCVLYEVLTGE 211 (277)
T ss_dssp CEECC----------------TTCCHHHHTT--------------------------CCCCHHHHHHHHHHHHHHHHHSS
T ss_pred hhhhccccccccccccccCcccccCHHHHcC--------------------------CCCCcceecccchHHHHHHHhCC
Confidence 864322 2335679999999999852 34788999999999999999999
Q ss_pred CCCCCCCCchhHHHHHHHHHcCCCCCCchhhccCCHHHHHHHHHhcccCccccC-ChHHHH
Q psy11767 596 VPFHARSRDDSALSIMARIKEGQFNFDAEAWSTVSSEAKELTKSLLTVNPAQRI-RMMRVK 655 (966)
Q Consensus 596 ~Pf~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~is~e~~~Li~~~L~~dP~~R~-t~~~v~ 655 (966)
+||.+.+.. ..+.++..+...++...+..+|+++++||.+||+.||++|| |+.++.
T Consensus 212 ~Pf~~~~~~----~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dp~~R~~sa~~l~ 268 (277)
T d1o6ya_ 212 PPFTGDSPV----SVAYQHVREDPIPPSARHEGLSADLDAVVLKALAKNPENRYQTAAEMR 268 (277)
T ss_dssp CSCCCSSHH----HHHHHHHHCCCCCGGGTSSSCCHHHHHHHHHHTCSSGGGSCSSHHHHH
T ss_pred CCCCCcCHH----HHHHHHHhcCCCCCchhccCCCHHHHHHHHHHccCCHhHCHhHHHHHH
Confidence 999875432 33444445555555556678999999999999999999999 666653
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.7e-48 Score=419.50 Aligned_cols=242 Identities=29% Similarity=0.494 Sum_probs=203.2
Q ss_pred cccccccccccccccccccEEEEEEEcCCCcEEEEEEecccc-----------ChHHHHHHHHHhc-CCCCceEEEEEEE
Q psy11767 374 EQYDMDLDKAGILGDGSYSVCRRCVEKSTGQEYAVKIISRKI-----------DCSEEINLLRACQ-GHPNIVNLHCVFQ 441 (966)
Q Consensus 374 ~~~~i~~~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~-----------~~~~Ei~iL~~l~-~HpnIV~l~~~~~ 441 (966)
++|++ .++||+|+||+||+|++..+|+.||||++.+.. ...+|+.+|+.+. .|||||+++++|+
T Consensus 4 ~~Y~i----~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~~~h~nIv~~~~~~~ 79 (273)
T d1xwsa_ 4 SQYQV----GPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFE 79 (273)
T ss_dssp TTEEE----EEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEE
T ss_pred CeEEE----eEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccchhhhhHHHHHHHHHHHHHHhccCCCCccEEEEEEe
Confidence 45555 578999999999999999999999999986431 1457999999885 4999999999999
Q ss_pred eCCeEEEEEEccCC-CCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCcEEEecCCCCCEEEEeec
Q psy11767 442 DEVHTYLVLELLKG-GELLDRIRQKGRCGFTENEASRIMRQLVAAVHFMHSRGVVHRDLKPENLLFSDPAGDNIKVVDFG 520 (966)
Q Consensus 442 ~~~~~~lVmEy~~g-g~L~~~l~~~~~~~l~e~~~~~i~~Qil~aL~yLHs~~IiHRDLKP~NILl~~~~~~~iKL~DFG 520 (966)
+++..|+||||+.+ +++.+++.+.. .+++.+++.++.||+.||+|||++||+||||||+|||++. +.+.+||+|||
T Consensus 80 ~~~~~~lv~e~~~~~~~l~~~~~~~~--~l~e~~~~~~~~qi~~al~~lH~~~iiHrDiKp~NIll~~-~~~~vkl~DFG 156 (273)
T d1xwsa_ 80 RPDSFVLILERPEPVQDLFDFITERG--ALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDL-NRGELKLIDFG 156 (273)
T ss_dssp CSSEEEEEEECCSSEEEHHHHHHHHC--SCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEET-TTTEEEECCCT
T ss_pred eCCeEEEEEEeccCcchHHHHHhccC--CCCHHHHHHHHHHHHHHHHHHHHCCCccccCcccceEEec-CCCeEEECccc
Confidence 99999999999976 68888887765 5999999999999999999999999999999999999974 34689999999
Q ss_pred ccccccC-CCccccccccccCchhhccCCCCCCCcccchhhhhhhhhhhhcCCCCCCCcCcchhHHHHHHHHhcCCCCCC
Q psy11767 521 FACLKRE-SLHTPCFTLQYAAPEVLRQDKSGYDENCDLWSLGVILVNVLRQDKSGYDENCDLWSLGVILYTMLCGRVPFH 599 (966)
Q Consensus 521 la~~~~~-~~~~~~gT~~Y~APEvl~~~~~~~~~~~Di~SlGvil~el~~~~~~~y~~~~DIWSlGvilyemltG~~Pf~ 599 (966)
+|+.... ...+.+||+.|+|||++... ..|+.++|||||||++|+|++|+.||.
T Consensus 157 ~a~~~~~~~~~~~~GT~~y~aPE~~~~~-------------------------~~~~~~~DiwSlGvilyell~g~~Pf~ 211 (273)
T d1xwsa_ 157 SGALLKDTVYTDFDGTRVYSPPEWIRYH-------------------------RYHGRSAAVWSLGILLYDMVCGDIPFE 211 (273)
T ss_dssp TCEECCSSCBCCCCSCGGGSCHHHHHHS-------------------------CBCHHHHHHHHHHHHHHHHHHSSCSCC
T ss_pred cceecccccccccccCCCcCCHHHHcCC-------------------------CCCCcccccccceeeehhHhhCCCCCC
Confidence 9976544 34567899999999998632 224677999999999999999999997
Q ss_pred CCCCchhHHHHHHHHHcCCCCCCchhhccCCHHHHHHHHHhcccCccccCChHHHHHHhhhhHH
Q psy11767 600 ARSRDDSALSIMARIKEGQFNFDAEAWSTVSSEAKELTKSLLTVNPAQRIRMMRVKLTFHAFHQ 663 (966)
Q Consensus 600 ~~~~~~~~~~~~~~i~~~~~~~~~~~~~~is~e~~~Li~~~L~~dP~~R~t~~~v~~~~~~~~~ 663 (966)
+. ..+..+...++ ..+|+++++||.+||+.||++|||+.++ ..|+|.+
T Consensus 212 ~~----------~~i~~~~~~~~----~~~s~~~~~li~~~L~~dp~~R~s~~ei--l~hp~~~ 259 (273)
T d1xwsa_ 212 HD----------EEIIRGQVFFR----QRVSSECQHLIRWCLALRPSDRPTFEEI--QNHPWMQ 259 (273)
T ss_dssp SH----------HHHHHCCCCCS----SCCCHHHHHHHHHHTCSSGGGSCCHHHH--HTSGGGS
T ss_pred Cc----------hHHhhcccCCC----CCCCHHHHHHHHHHccCCHhHCcCHHHH--hcCHhhC
Confidence 52 12344544433 4689999999999999999999999976 4577763
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7e-48 Score=418.63 Aligned_cols=246 Identities=21% Similarity=0.344 Sum_probs=200.6
Q ss_pred ccccccccccccEEEEEEEcCCCcEEEEEEeccccC----hHHHHHHHHHhcCCCCceEEEEEEEeCCeEEEEEEccCCC
Q psy11767 381 DKAGILGDGSYSVCRRCVEKSTGQEYAVKIISRKID----CSEEINLLRACQGHPNIVNLHCVFQDEVHTYLVLELLKGG 456 (966)
Q Consensus 381 ~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~~----~~~Ei~iL~~l~~HpnIV~l~~~~~~~~~~~lVmEy~~gg 456 (966)
+..+.||+|+||+||+|+++ +++.||||++..... ..+|+++|+.+ +|||||++++++.+ +..|||||||++|
T Consensus 16 ~~~~~iG~G~fg~Vy~~~~~-~~~~vAvK~~~~~~~~~~~~~~E~~~l~~l-~HpnIv~~~g~~~~-~~~~iv~Ey~~~g 92 (272)
T d1qpca_ 16 KLVERLGAGQFGEVWMGYYN-GHTKVAVKSLKQGSMSPDAFLAEANLMKQL-QHQRLVRLYAVVTQ-EPIYIITEYMENG 92 (272)
T ss_dssp EEEEEEEEETTEEEEEEEET-TTEEEEEEEECTTSSCHHHHHHHHHHHHHC-CCTTBCCEEEEECS-SSCEEEEECCTTC
T ss_pred EEeEEEecCCCcEEEEEEEC-CCCEEEEEEEccCcCCHHHHHHHHHHHHhC-CCCCEeEEEeeecc-CCeEEEEEeCCCC
Confidence 34678999999999999986 578899999975432 56899999999 59999999998755 5679999999999
Q ss_pred CHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCcEEEecCCCCCEEEEeecccccccCC----Cccc
Q psy11767 457 ELLDRIRQKGRCGFTENEASRIMRQLVAAVHFMHSRGVVHRDLKPENLLFSDPAGDNIKVVDFGFACLKRES----LHTP 532 (966)
Q Consensus 457 ~L~~~l~~~~~~~l~e~~~~~i~~Qil~aL~yLHs~~IiHRDLKP~NILl~~~~~~~iKL~DFGla~~~~~~----~~~~ 532 (966)
+|.+++.......+++.++..|+.||+.||+|||++||+||||||+||||++ ++.+||+|||+|+..... ....
T Consensus 93 ~L~~~~~~~~~~~l~~~~~~~i~~qi~~gl~~lH~~~ivHrDiKp~NIll~~--~~~~Kl~DFGla~~~~~~~~~~~~~~ 170 (272)
T d1qpca_ 93 SLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHRDLRAANILVSD--TLSCKIADFGLARLIEDNEYTAREGA 170 (272)
T ss_dssp BHHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECT--TSCEEECCCTTCEECSSSCEECCTTC
T ss_pred cHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCccchhheeeec--ccceeeccccceEEccCCcccccccc
Confidence 9999886554446999999999999999999999999999999999999985 569999999999865432 2345
Q ss_pred cccccccCchhhccCCCCCCCcccchhhhhhhhhhhhcCCCCCCCcCcchhHHHHHHHHhcCCCCCCCCCCchhHHHHHH
Q psy11767 533 CFTLQYAAPEVLRQDKSGYDENCDLWSLGVILVNVLRQDKSGYDENCDLWSLGVILYTMLCGRVPFHARSRDDSALSIMA 612 (966)
Q Consensus 533 ~gT~~Y~APEvl~~~~~~~~~~~Di~SlGvil~el~~~~~~~y~~~~DIWSlGvilyemltG~~Pf~~~~~~~~~~~~~~ 612 (966)
.||+.|||||++... .|+.++|||||||++|||+||..||...... ..++.
T Consensus 171 ~gt~~y~APE~~~~~--------------------------~~~~~sDvwS~Gvvl~ellt~~~~~~~~~~~---~~~~~ 221 (272)
T d1qpca_ 171 KFPIKWTAPEAINYG--------------------------TFTIKSDVWSFGILLTEIVTHGRIPYPGMTN---PEVIQ 221 (272)
T ss_dssp CCCTTTSCHHHHHHC--------------------------EECHHHHHHHHHHHHHHHHTTTCCSSTTCCH---HHHHH
T ss_pred CCcccccChHHHhCC--------------------------CCCchhhhhhhHHHHHHHHhCCCCCCCCCCH---HHHHH
Confidence 689999999998632 3788999999999999999965554433322 23455
Q ss_pred HHHcCCCCCCchhhccCCHHHHHHHHHhcccCccccCChHHHHHHhhhhHH
Q psy11767 613 RIKEGQFNFDAEAWSTVSSEAKELTKSLLTVNPAQRIRMMRVKLTFHAFHQ 663 (966)
Q Consensus 613 ~i~~~~~~~~~~~~~~is~e~~~Li~~~L~~dP~~R~t~~~v~~~~~~~~~ 663 (966)
.+..+.... .+..+++++.+||.+||+.||++|||+.++...++.|+.
T Consensus 222 ~i~~~~~~~---~p~~~~~~l~~li~~cl~~~P~~Rpt~~ei~~~L~~~ft 269 (272)
T d1qpca_ 222 NLERGYRMV---RPDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDFFT 269 (272)
T ss_dssp HHHTTCCCC---CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred HHHhcCCCC---CcccChHHHHHHHHHHcCCCHhHCcCHHHHHHHhhhhhh
Confidence 666553322 234689999999999999999999999999887777764
|
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.4e-48 Score=418.97 Aligned_cols=244 Identities=22% Similarity=0.402 Sum_probs=194.9
Q ss_pred cccccccccccEEEEEEEcCCCcEEEEEEecccc-------ChHHHHHHHHHhcCCCCceEEEEEEEeCCeEEEEEEccC
Q psy11767 382 KAGILGDGSYSVCRRCVEKSTGQEYAVKIISRKI-------DCSEEINLLRACQGHPNIVNLHCVFQDEVHTYLVLELLK 454 (966)
Q Consensus 382 ~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~-------~~~~Ei~iL~~l~~HpnIV~l~~~~~~~~~~~lVmEy~~ 454 (966)
..+.||+|+||+||+|+.. ..||||+++... ...+|+.+|+.+ +|||||++++++. +...|||||||+
T Consensus 12 ~~~~lG~G~fg~Vy~~~~~---~~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l-~HpnIv~~~~~~~-~~~~~lv~Ey~~ 86 (276)
T d1uwha_ 12 VGQRIGSGSFGTVYKGKWH---GDVAVKMLNVTAPTPQQLQAFKNEVGVLRKT-RHVNILLFMGYST-APQLAIVTQWCE 86 (276)
T ss_dssp CCSEEEECSSCEEEEEESS---SEEEEEECCCSSCCTTHHHHHHHHHHHHTTC-CCTTBCCEEEEEC-SSSCEEEEECCC
T ss_pred EEEEEeeCCCcEEEEEEEC---CEEEEEEEEcccCCHHHHHHHHHHHHHHHhC-CCCCEeeeeEEEe-ccEEEEEEecCC
Confidence 3578999999999999753 369999986432 244699999998 5999999999875 456899999999
Q ss_pred CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCcEEEecCCCCCEEEEeecccccccC-----CC
Q psy11767 455 GGELLDRIRQKGRCGFTENEASRIMRQLVAAVHFMHSRGVVHRDLKPENLLFSDPAGDNIKVVDFGFACLKRE-----SL 529 (966)
Q Consensus 455 gg~L~~~l~~~~~~~l~e~~~~~i~~Qil~aL~yLHs~~IiHRDLKP~NILl~~~~~~~iKL~DFGla~~~~~-----~~ 529 (966)
||+|.+++..... .+++.++..|+.||+.||+|||++|||||||||+|||++. ++.+||+|||+|+.... ..
T Consensus 87 ~g~L~~~l~~~~~-~~~~~~~~~i~~qi~~gl~yLH~~~ivHrDlKp~NiLl~~--~~~~Kl~DFGla~~~~~~~~~~~~ 163 (276)
T d1uwha_ 87 GSSLYHHLHIIET-KFEMIKLIDIARQTAQGMDYLHAKSIIHRDLKSNNIFLHE--DLTVKIGDFGLATVKSRWSGSHQF 163 (276)
T ss_dssp EEEHHHHHHTSCC-CCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEET--TSSEEECCCCCSCC----------
T ss_pred CCCHHHHHhhccC-CCCHHHHHHHHHHHHHHHHHHhcCCEeccccCHHHEEEcC--CCCEEEccccceeeccccCCcccc
Confidence 9999999976543 6999999999999999999999999999999999999985 56999999999976432 22
Q ss_pred ccccccccccCchhhccCCCCCCCcccchhhhhhhhhhhhcCCCCCCCcCcchhHHHHHHHHhcCCCCCCCCCCchhHHH
Q psy11767 530 HTPCFTLQYAAPEVLRQDKSGYDENCDLWSLGVILVNVLRQDKSGYDENCDLWSLGVILYTMLCGRVPFHARSRDDSALS 609 (966)
Q Consensus 530 ~~~~gT~~Y~APEvl~~~~~~~~~~~Di~SlGvil~el~~~~~~~y~~~~DIWSlGvilyemltG~~Pf~~~~~~~~~~~ 609 (966)
.+.+||+.|||||++.... ...|+.++|||||||++|||+||+.||.+.+... .
T Consensus 164 ~~~~gt~~y~APE~l~~~~-----------------------~~~~~~~sDiwS~Gv~l~el~tg~~Pf~~~~~~~---~ 217 (276)
T d1uwha_ 164 EQLSGSILWMAPEVIRMQD-----------------------KNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRD---Q 217 (276)
T ss_dssp --CCCCGGGCCHHHHTTCS-----------------------SCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHH---H
T ss_pred cccccCcccCCHHHHhccc-----------------------CCCCCchhhhhhhHHHHHHHHHCCCCCCCCChHH---H
Confidence 3567899999999986321 2358889999999999999999999998765433 2
Q ss_pred HHHHHHcCCCCCC-chhhccCCHHHHHHHHHhcccCccccCChHHHHHHhh
Q psy11767 610 IMARIKEGQFNFD-AEAWSTVSSEAKELTKSLLTVNPAQRIRMMRVKLTFH 659 (966)
Q Consensus 610 ~~~~i~~~~~~~~-~~~~~~is~e~~~Li~~~L~~dP~~R~t~~~v~~~~~ 659 (966)
+...+..+..... ...+..+++++.+||.+||..||++|||+.++...+.
T Consensus 218 ~~~~~~~~~~~p~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~~il~~Le 268 (276)
T d1uwha_ 218 IIFMVGRGYLSPDLSKVRSNCPKAMKRLMAECLKKKRDERPLFPQILASIE 268 (276)
T ss_dssp HHHHHHHTSCCCCGGGSCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred HHHHHhcCCCCCcchhccccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHH
Confidence 3334444433322 2334568999999999999999999999998855443
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.2e-47 Score=417.98 Aligned_cols=248 Identities=21% Similarity=0.380 Sum_probs=198.9
Q ss_pred ecccccccccccccccccccEEEEEEEc--CCCcEEEEEEecccc-------ChHHHHHHHHHhcCCCCceEEEEEEEeC
Q psy11767 373 FEQYDMDLDKAGILGDGSYSVCRRCVEK--STGQEYAVKIISRKI-------DCSEEINLLRACQGHPNIVNLHCVFQDE 443 (966)
Q Consensus 373 ~~~~~i~~~~~~~LG~G~fG~Vy~a~~~--~tg~~vAvK~i~~~~-------~~~~Ei~iL~~l~~HpnIV~l~~~~~~~ 443 (966)
.+++.+..+ .++||+|+||+||+|.++ .+++.||||+++... ...+|+++|+.+ +|||||+++++++++
T Consensus 3 ld~~~~~le-~k~iG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l-~HpnIv~~~g~~~~~ 80 (277)
T d1xbba_ 3 LDRKLLTLE-DKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQL-DNPYIVRMIGICEAE 80 (277)
T ss_dssp CCGGGEEEE-EEEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTC-CCTTBCCEEEEEESS
T ss_pred echhhCeec-CCCcccCCCeEEEEEEEccCCcCeEEEEEEEChhhCCHHHHHHHHHHHHHHHhC-CCCCCceEEEEeccC
Confidence 344444333 257999999999999865 456789999996432 245799999998 599999999999765
Q ss_pred CeEEEEEEccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCcEEEecCCCCCEEEEeecccc
Q psy11767 444 VHTYLVLELLKGGELLDRIRQKGRCGFTENEASRIMRQLVAAVHFMHSRGVVHRDLKPENLLFSDPAGDNIKVVDFGFAC 523 (966)
Q Consensus 444 ~~~~lVmEy~~gg~L~~~l~~~~~~~l~e~~~~~i~~Qil~aL~yLHs~~IiHRDLKP~NILl~~~~~~~iKL~DFGla~ 523 (966)
..|||||||++|+|.+++.+.. .+++.++..|+.||+.||+|||++|||||||||+|||++. .+.+||+|||+|+
T Consensus 81 -~~~lvmE~~~~g~L~~~l~~~~--~l~~~~~~~i~~qi~~gl~ylH~~~iiHrDlKp~Nill~~--~~~~kl~DFGla~ 155 (277)
T d1xbba_ 81 -SWMLVMEMAELGPLNKYLQQNR--HVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVT--QHYAKISDFGLSK 155 (277)
T ss_dssp -SEEEEEECCTTEEHHHHHHHCT--TCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEE--TTEEEECCCTTCE
T ss_pred -CEEEEEEcCCCCcHHHHHhhcc--CCCHHHHHHHHHHHHHHHhhHHhCCcccCCCcchhhcccc--cCcccccchhhhh
Confidence 5789999999999999998765 5999999999999999999999999999999999999985 5699999999997
Q ss_pred cccCC------CccccccccccCchhhccCCCCCCCcccchhhhhhhhhhhhcCCCCCCCcCcchhHHHHHHHHhc-CCC
Q psy11767 524 LKRES------LHTPCFTLQYAAPEVLRQDKSGYDENCDLWSLGVILVNVLRQDKSGYDENCDLWSLGVILYTMLC-GRV 596 (966)
Q Consensus 524 ~~~~~------~~~~~gT~~Y~APEvl~~~~~~~~~~~Di~SlGvil~el~~~~~~~y~~~~DIWSlGvilyemlt-G~~ 596 (966)
..... .....||+.|||||++... .|+.++|||||||++|||++ |++
T Consensus 156 ~~~~~~~~~~~~~~~~gt~~y~APE~l~~~--------------------------~~~~~sDiwS~Gv~l~ellt~g~~ 209 (277)
T d1xbba_ 156 ALRADENYYKAQTHGKWPVKWYAPECINYY--------------------------KFSSKSDVWSFGVLMWEAFSYGQK 209 (277)
T ss_dssp ECCTTCSEEEC----CCCGGGCCHHHHHHC--------------------------EEEHHHHHHHHHHHHHHHHTTTCC
T ss_pred hccccccccccccccCCCceecCchhhcCC--------------------------CCCchhhhccchhhhhHHhhCCCC
Confidence 64321 1234689999999998632 36789999999999999997 899
Q ss_pred CCCCCCCchhHHHHHHHHHcCCCCCCchhhccCCHHHHHHHHHhcccCccccCChHHHHHHhhh
Q psy11767 597 PFHARSRDDSALSIMARIKEGQFNFDAEAWSTVSSEAKELTKSLLTVNPAQRIRMMRVKLTFHA 660 (966)
Q Consensus 597 Pf~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~is~e~~~Li~~~L~~dP~~R~t~~~v~~~~~~ 660 (966)
||.+.+.. .+...+..+... +.+..+++++.+||.+||+.||++|||+.++...++.
T Consensus 210 Pf~~~~~~----~~~~~i~~~~~~---~~p~~~~~~~~~li~~cl~~dp~~RPs~~~i~~~L~~ 266 (277)
T d1xbba_ 210 PYRGMKGS----EVTAMLEKGERM---GCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRN 266 (277)
T ss_dssp SSTTCCHH----HHHHHHHTTCCC---CCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHH
T ss_pred CCCCCCHH----HHHHHHHcCCCC---CCCcccCHHHHHHHHHHcCCCHhHCcCHHHHHHHhhC
Confidence 99876532 345566665432 2234689999999999999999999999998665544
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.7e-47 Score=419.16 Aligned_cols=254 Identities=31% Similarity=0.476 Sum_probs=201.8
Q ss_pred ccccccccccccccEEEEEEEcCCCcEEEEEEecccc-------ChHHHHHHHHHhcCCCCceEEEEEEEeCCeEEEEEE
Q psy11767 379 DLDKAGILGDGSYSVCRRCVEKSTGQEYAVKIISRKI-------DCSEEINLLRACQGHPNIVNLHCVFQDEVHTYLVLE 451 (966)
Q Consensus 379 ~~~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~-------~~~~Ei~iL~~l~~HpnIV~l~~~~~~~~~~~lVmE 451 (966)
+|+.++.||+|+||+||+|+++.+|+.||||++.... ...+|+++|+.+ +|||||+++++|+++.+.|+|||
T Consensus 3 ~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l-~Hp~Iv~~~~~~~~~~~~~iv~e 81 (298)
T d1gz8a_ 3 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKEL-NHPNIVKLLDVIHTENKLYLVFE 81 (298)
T ss_dssp TEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEC-------CCHHHHHHHHHHTTC-CCTTBCCEEEEEEETTEEEEEEE
T ss_pred CCEeccEEecCcCeEEEEEEECCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhC-CCCcEEEeccccccccceeEEEe
Confidence 3455789999999999999999999999999986432 245799999988 59999999999999999999999
Q ss_pred ccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCcEEEecCCCCCEEEEeecccccccC---C
Q psy11767 452 LLKGGELLDRIRQKGRCGFTENEASRIMRQLVAAVHFMHSRGVVHRDLKPENLLFSDPAGDNIKVVDFGFACLKRE---S 528 (966)
Q Consensus 452 y~~gg~L~~~l~~~~~~~l~e~~~~~i~~Qil~aL~yLHs~~IiHRDLKP~NILl~~~~~~~iKL~DFGla~~~~~---~ 528 (966)
||. |.+.+++......++++.+++.++.||+.||+|||++|||||||||+|||++. ++.+||+|||+|+.... .
T Consensus 82 ~~~-~~~~~~~~~~~~~~l~e~~~~~~~~qil~~L~yLH~~~IiHrDiKpeNIl~~~--~~~~kl~DFG~a~~~~~~~~~ 158 (298)
T d1gz8a_ 82 FLH-QDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINT--EGAIKLADFGLARAFGVPVRT 158 (298)
T ss_dssp CCS-EEHHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECT--TSCEEECSTTHHHHHCCCSBC
T ss_pred ecC-CchhhhhhhhcccCCCHHHHHHHHHHHHHHHHHhhcCCEEccccCchheeecc--cCcceeccCCcceeccCCccc
Confidence 996 45666665555557999999999999999999999999999999999999974 56899999999976543 2
Q ss_pred CccccccccccCchhhccCCCCCCCcccchhhhhhhhhhhhcCCCCCCCcCcchhHHHHHHHHhcCCCCCCCCCCchhHH
Q psy11767 529 LHTPCFTLQYAAPEVLRQDKSGYDENCDLWSLGVILVNVLRQDKSGYDENCDLWSLGVILYTMLCGRVPFHARSRDDSAL 608 (966)
Q Consensus 529 ~~~~~gT~~Y~APEvl~~~~~~~~~~~Di~SlGvil~el~~~~~~~y~~~~DIWSlGvilyemltG~~Pf~~~~~~~~~~ 608 (966)
....+||+.|+|||++... ..++.++||||+||++|+|++|++||.+.+..+...
T Consensus 159 ~~~~~gt~~y~apE~~~~~-------------------------~~~~~~~DiwSlGvily~m~~G~~Pf~~~~~~~~~~ 213 (298)
T d1gz8a_ 159 YTHEVVTLWYRAPEILLGC-------------------------KYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLF 213 (298)
T ss_dssp TTCCBCCCTTCCHHHHTTC-------------------------SSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHH
T ss_pred ceeecccceeeehhhhccc-------------------------cCCCccccccccchhhhHHhhCCCCCCCCCHHHHHH
Confidence 3445789999999988532 235789999999999999999999998765443333
Q ss_pred HHHHHHHcCCCC--------------CC-------chhhccCCHHHHHHHHHhcccCccccCChHHHHHHhhhhHH
Q psy11767 609 SIMARIKEGQFN--------------FD-------AEAWSTVSSEAKELTKSLLTVNPAQRIRMMRVKLTFHAFHQ 663 (966)
Q Consensus 609 ~~~~~i~~~~~~--------------~~-------~~~~~~is~e~~~Li~~~L~~dP~~R~t~~~v~~~~~~~~~ 663 (966)
.+.......... +. ....+.+|+++++||.+||..||++|||+.++ ..|+|++
T Consensus 214 ~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~t~~el--l~H~ff~ 287 (298)
T d1gz8a_ 214 RIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAA--LAHPFFQ 287 (298)
T ss_dssp HHHHHHCCCCTTTSTTGGGSTTCCTTSCCCCCCCHHHHSTTCCHHHHHHHHHHTCSSTTTSCCHHHH--HTSGGGT
T ss_pred HHHHhcCCCchhhccccccccccccccccccccchhhhccCCCHHHHHHHHHHccCChhHCcCHHHH--hCCHhhc
Confidence 222221110000 00 11234678999999999999999999999976 4577764
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.1e-47 Score=410.48 Aligned_cols=241 Identities=23% Similarity=0.395 Sum_probs=191.3
Q ss_pred cccccccccccccEEEEEEEcCCCcEEEEEEeccccC----hHHHHHHHHHhcCCCCceEEEEEEEeCCeEEEEEEccCC
Q psy11767 380 LDKAGILGDGSYSVCRRCVEKSTGQEYAVKIISRKID----CSEEINLLRACQGHPNIVNLHCVFQDEVHTYLVLELLKG 455 (966)
Q Consensus 380 ~~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~~----~~~Ei~iL~~l~~HpnIV~l~~~~~~~~~~~lVmEy~~g 455 (966)
|+..+.||+|+||+||+|++. +++.||||++..... ..+|+++|+.+ +|||||++++++.++...|+|||||++
T Consensus 7 ~~~~~~iG~G~fg~Vy~~~~~-~~~~vAvK~i~~~~~~~~~~~~E~~~l~~l-~HpnIv~~~g~~~~~~~~~lv~E~~~~ 84 (263)
T d1sm2a_ 7 LTFVQEIGSGQFGLVHLGYWL-NKDKVAIKTIREGAMSEEDFIEEAEVMMKL-SHPKLVQLYGVCLEQAPICLVFEFMEH 84 (263)
T ss_dssp EEEEEEEECCSSCCEEEEEET-TTEEEEEEECCSSSSCHHHHHHHHHHHHHC-CCTTBCCEEEEECSSSSCEEEEECCTT
T ss_pred cEEEEEEeeCCCeEEEEEEEC-CCCEEEEEEECCCcCcHHHHHHHHHHHHhc-CCCCcccccceeccCCceEEEEEecCC
Confidence 344678999999999999986 577899999975432 56799999998 599999999999999999999999999
Q ss_pred CCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCcEEEecCCCCCEEEEeecccccccCC----Ccc
Q psy11767 456 GELLDRIRQKGRCGFTENEASRIMRQLVAAVHFMHSRGVVHRDLKPENLLFSDPAGDNIKVVDFGFACLKRES----LHT 531 (966)
Q Consensus 456 g~L~~~l~~~~~~~l~e~~~~~i~~Qil~aL~yLHs~~IiHRDLKP~NILl~~~~~~~iKL~DFGla~~~~~~----~~~ 531 (966)
|+|.+++..... .+++..+..|+.||+.||+|||+++|+||||||+|||++. ++.+||+|||+|+..... ...
T Consensus 85 g~L~~~l~~~~~-~~~~~~~~~i~~qia~gl~~lH~~~iiHrDlKp~Nill~~--~~~~Kl~DFGla~~~~~~~~~~~~~ 161 (263)
T d1sm2a_ 85 GCLSDYLRTQRG-LFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLVGE--NQVIKVSDFGMTRFVLDDQYTSSTG 161 (263)
T ss_dssp CBHHHHHHTTTT-CCCHHHHHHHHHHHHHHHHHHHHTTCCCTTCSGGGEEECG--GGCEEECSCC---------------
T ss_pred CcHHHHhhcccc-CCCHHHHHHHHHHHHHHHHhhhccceeecccchhheeecC--CCCeEecccchheeccCCCceeecc
Confidence 999999876543 6899999999999999999999999999999999999985 568999999999765432 223
Q ss_pred ccccccccCchhhccCCCCCCCcccchhhhhhhhhhhhcCCCCCCCcCcchhHHHHHHHHhcC-CCCCCCCCCchhHHHH
Q psy11767 532 PCFTLQYAAPEVLRQDKSGYDENCDLWSLGVILVNVLRQDKSGYDENCDLWSLGVILYTMLCG-RVPFHARSRDDSALSI 610 (966)
Q Consensus 532 ~~gT~~Y~APEvl~~~~~~~~~~~Di~SlGvil~el~~~~~~~y~~~~DIWSlGvilyemltG-~~Pf~~~~~~~~~~~~ 610 (966)
..||+.|+|||++.. ..|+.++|||||||++|||++| .+||...+. ..+
T Consensus 162 ~~gt~~y~aPE~l~~--------------------------~~~~~k~DVwS~Gvil~el~t~~~~~~~~~~~----~~~ 211 (263)
T d1sm2a_ 162 TKFPVKWASPEVFSF--------------------------SRYSSKSDVWSFGVLMWEVFSEGKIPYENRSN----SEV 211 (263)
T ss_dssp ---CTTSCCHHHHTT--------------------------CCCCHHHHHHHHHHHHHHHHTTSCCTTCSCCH----HHH
T ss_pred eecCcccCChHHhcC--------------------------CCCCchhhhcchHHHHHHHHHCCCCCCCCCCH----HHH
Confidence 568999999999853 3478999999999999999995 666654332 234
Q ss_pred HHHHHcCCCCCCchhhccCCHHHHHHHHHhcccCccccCChHHHHHHh
Q psy11767 611 MARIKEGQFNFDAEAWSTVSSEAKELTKSLLTVNPAQRIRMMRVKLTF 658 (966)
Q Consensus 611 ~~~i~~~~~~~~~~~~~~is~e~~~Li~~~L~~dP~~R~t~~~v~~~~ 658 (966)
+..+..+..... +...++++.+||.+||+.||++|||+.++...+
T Consensus 212 ~~~i~~~~~~~~---p~~~~~~l~~li~~cl~~~p~~Rps~~~il~~L 256 (263)
T d1sm2a_ 212 VEDISTGFRLYK---PRLASTHVYQIMNHCWKERPEDRPAFSRLLRQL 256 (263)
T ss_dssp HHHHHHTCCCCC---CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred HHHHHhcCCCCC---ccccCHHHHHHHHHHccCCHhHCcCHHHHHHHH
Confidence 556666543322 235789999999999999999999999885443
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=3.7e-47 Score=418.62 Aligned_cols=242 Identities=19% Similarity=0.369 Sum_probs=191.2
Q ss_pred ccccccccccEEEEEEEcCCCc---EEEEEEeccccC------hHHHHHHHHHhcCCCCceEEEEEEEeCCeEEEEEEcc
Q psy11767 383 AGILGDGSYSVCRRCVEKSTGQ---EYAVKIISRKID------CSEEINLLRACQGHPNIVNLHCVFQDEVHTYLVLELL 453 (966)
Q Consensus 383 ~~~LG~G~fG~Vy~a~~~~tg~---~vAvK~i~~~~~------~~~Ei~iL~~l~~HpnIV~l~~~~~~~~~~~lVmEy~ 453 (966)
.++||+|+||+||+|+++.+|+ .||||.+..... +.+|+++|+.+ +|||||++++++.+++..|+|||||
T Consensus 31 ~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~HpnIv~l~g~~~~~~~~~iv~Ey~ 109 (299)
T d1jpaa_ 31 EQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQF-DHPNVIHLEGVVTKSTPVMIITEFM 109 (299)
T ss_dssp EEEEEECSSSEEEEEEECC---CCEEEEEEECCSSCCHHHHHHHHHHHHHHTTC-CCTTBCCEEEEECSSSSCEEEEECC
T ss_pred eeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhC-CCCCCccEEEEEeeCCEEEEEEEec
Confidence 5789999999999999987765 689998865432 45799999998 5999999999999999999999999
Q ss_pred CCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCcEEEecCCCCCEEEEeecccccccCCC----
Q psy11767 454 KGGELLDRIRQKGRCGFTENEASRIMRQLVAAVHFMHSRGVVHRDLKPENLLFSDPAGDNIKVVDFGFACLKRESL---- 529 (966)
Q Consensus 454 ~gg~L~~~l~~~~~~~l~e~~~~~i~~Qil~aL~yLHs~~IiHRDLKP~NILl~~~~~~~iKL~DFGla~~~~~~~---- 529 (966)
+||+|.+++..... .+++.++..++.||+.||+|||++|||||||||+||||+. ++.+||+|||+|+......
T Consensus 110 ~~g~L~~~~~~~~~-~l~~~~~~~i~~qia~gl~yLH~~~iiHrDlKp~NILl~~--~~~~Kl~DFGla~~~~~~~~~~~ 186 (299)
T d1jpaa_ 110 ENGSLDSFLRQNDG-QFTVIQLVGMLRGIAAGMKYLADMNYVHRDLAARNILVNS--NLVCKVSDFGLSRFLEDDTSDPT 186 (299)
T ss_dssp TTEEHHHHHHTTTT-CSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECT--TCCEEECCC--------------
T ss_pred CCCcceeeeccccC-CCCHHHHHHHHHHHHHHHHHHhhCCCccCccccceEEECC--CCcEEECCcccceEccCCCCcce
Confidence 99999998876543 5999999999999999999999999999999999999974 5699999999997653211
Q ss_pred ----ccccccccccCchhhccCCCCCCCcccchhhhhhhhhhhhcCCCCCCCcCcchhHHHHHHHHhc-CCCCCCCCCCc
Q psy11767 530 ----HTPCFTLQYAAPEVLRQDKSGYDENCDLWSLGVILVNVLRQDKSGYDENCDLWSLGVILYTMLC-GRVPFHARSRD 604 (966)
Q Consensus 530 ----~~~~gT~~Y~APEvl~~~~~~~~~~~Di~SlGvil~el~~~~~~~y~~~~DIWSlGvilyemlt-G~~Pf~~~~~~ 604 (966)
....+|+.|||||++.. ..|+.++|||||||++|||+| |++||.+.+..
T Consensus 187 ~~~~~~~~~t~~y~aPE~~~~--------------------------~~~~~~sDvwS~Gvvl~el~t~g~~Pf~~~~~~ 240 (299)
T d1jpaa_ 187 YTSALGGKIPIRWTAPEAIQY--------------------------RKFTSASDVWSYGIVMWEVMSYGERPYWDMTNQ 240 (299)
T ss_dssp ---------CGGGSCHHHHHS--------------------------CCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHH
T ss_pred eeecccccCCccccCHHHHhc--------------------------CCCCcccccccchHHHHHHHhCCCCCCCCCCHH
Confidence 12356899999999853 247889999999999999998 89999876532
Q ss_pred hhHHHHHHHHHcCCCCCCchhhccCCHHHHHHHHHhcccCccccCChHHHHHHhhhh
Q psy11767 605 DSALSIMARIKEGQFNFDAEAWSTVSSEAKELTKSLLTVNPAQRIRMMRVKLTFHAF 661 (966)
Q Consensus 605 ~~~~~~~~~i~~~~~~~~~~~~~~is~e~~~Li~~~L~~dP~~R~t~~~v~~~~~~~ 661 (966)
.++..+..+... +.+..+++++.+||.+||+.||++|||+.++...+..+
T Consensus 241 ----~~~~~i~~~~~~---~~~~~~~~~l~~li~~cl~~~P~~RPs~~ei~~~L~~~ 290 (299)
T d1jpaa_ 241 ----DVINAIEQDYRL---PPPMDCPSALHQLMLDCWQKDRNHRPKFGQIVNTLDKM 290 (299)
T ss_dssp ----HHHHHHHTTCCC---CCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHH
T ss_pred ----HHHHHHHcCCCC---CCCccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHH
Confidence 445566655322 12346899999999999999999999999986555443
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-46 Score=411.91 Aligned_cols=237 Identities=23% Similarity=0.396 Sum_probs=196.1
Q ss_pred ccccccccEEEEEEEcC--CCcEEEEEEeccccC------hHHHHHHHHHhcCCCCceEEEEEEEeCCeEEEEEEccCCC
Q psy11767 385 ILGDGSYSVCRRCVEKS--TGQEYAVKIISRKID------CSEEINLLRACQGHPNIVNLHCVFQDEVHTYLVLELLKGG 456 (966)
Q Consensus 385 ~LG~G~fG~Vy~a~~~~--tg~~vAvK~i~~~~~------~~~Ei~iL~~l~~HpnIV~l~~~~~~~~~~~lVmEy~~gg 456 (966)
+||+|+||+||+|.++. ++..||||+++.... +.+|+++|+.+ +|||||++++++.++ ..|||||||+||
T Consensus 16 ~iG~G~fg~Vy~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~E~~il~~l-~HpnIv~l~g~~~~~-~~~lvmE~~~~g 93 (285)
T d1u59a_ 16 ELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQL-DNPYIVRLIGVCQAE-ALMLVMEMAGGG 93 (285)
T ss_dssp EEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHC-CCTTBCCEEEEEESS-SEEEEEECCTTE
T ss_pred EEecccCeEEEEEEEecCCCcEEEEEEEEChhcCHHHHHHHHHHHHHHHhC-CCCCEeeEeeeeccC-eEEEEEEeCCCC
Confidence 49999999999998764 455899999975432 45699999998 599999999999764 589999999999
Q ss_pred CHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCcEEEecCCCCCEEEEeecccccccCC------Cc
Q psy11767 457 ELLDRIRQKGRCGFTENEASRIMRQLVAAVHFMHSRGVVHRDLKPENLLFSDPAGDNIKVVDFGFACLKRES------LH 530 (966)
Q Consensus 457 ~L~~~l~~~~~~~l~e~~~~~i~~Qil~aL~yLHs~~IiHRDLKP~NILl~~~~~~~iKL~DFGla~~~~~~------~~ 530 (966)
+|.+++..... .+++.++..++.||+.||+|||++||+||||||+|||++. ++.+||+|||+|+..... ..
T Consensus 94 ~L~~~l~~~~~-~l~~~~~~~i~~qi~~gL~ylH~~~iiHrDlKp~Nill~~--~~~~Kl~DFGla~~~~~~~~~~~~~~ 170 (285)
T d1u59a_ 94 PLHKFLVGKRE-EIPVSNVAELLHQVSMGMKYLEEKNFVHRDLAARNVLLVN--RHYAKISDFGLSKALGADDSYYTARS 170 (285)
T ss_dssp EHHHHHTTCTT-TSCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEEE--TTEEEECCCTTCEECTTCSCEECCCC
T ss_pred cHHHHhhcccc-CCCHHHHHHHHHHHHHHHHHHHhCCeecCcCchhheeecc--CCceeeccchhhhccccccccccccc
Confidence 99999865433 6999999999999999999999999999999999999985 569999999999765321 22
Q ss_pred cccccccccCchhhccCCCCCCCcccchhhhhhhhhhhhcCCCCCCCcCcchhHHHHHHHHhc-CCCCCCCCCCchhHHH
Q psy11767 531 TPCFTLQYAAPEVLRQDKSGYDENCDLWSLGVILVNVLRQDKSGYDENCDLWSLGVILYTMLC-GRVPFHARSRDDSALS 609 (966)
Q Consensus 531 ~~~gT~~Y~APEvl~~~~~~~~~~~Di~SlGvil~el~~~~~~~y~~~~DIWSlGvilyemlt-G~~Pf~~~~~~~~~~~ 609 (966)
..+||+.|||||++... .|+.++|||||||++|||+| |+.||.+.+.. .
T Consensus 171 ~~~gt~~y~aPE~~~~~--------------------------~~~~ksDVwS~Gv~l~E~lt~G~~Pf~~~~~~----~ 220 (285)
T d1u59a_ 171 AGKWPLKWYAPECINFR--------------------------KFSSRSDVWSYGVTMWEALSYGQKPYKKMKGP----E 220 (285)
T ss_dssp SSCCCGGGCCHHHHHHC--------------------------EECHHHHHHHHHHHHHHHHTTSCCTTTTCCTH----H
T ss_pred ccccCccccChHHHhCC--------------------------CCCccchhhcchHHHHHHHhCCCCCCCCCCHH----H
Confidence 45689999999998632 37889999999999999998 99999876543 3
Q ss_pred HHHHHHcCCCCCCchhhccCCHHHHHHHHHhcccCccccCChHHHHHHhh
Q psy11767 610 IMARIKEGQFNFDAEAWSTVSSEAKELTKSLLTVNPAQRIRMMRVKLTFH 659 (966)
Q Consensus 610 ~~~~i~~~~~~~~~~~~~~is~e~~~Li~~~L~~dP~~R~t~~~v~~~~~ 659 (966)
++..|..+... +.++.+++++.+||.+||..||++|||+.++...+.
T Consensus 221 ~~~~i~~~~~~---~~p~~~~~~l~~li~~cl~~~p~~RPs~~~i~~~L~ 267 (285)
T d1u59a_ 221 VMAFIEQGKRM---ECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMR 267 (285)
T ss_dssp HHHHHHTTCCC---CCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHH
T ss_pred HHHHHHcCCCC---CCCCcCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHH
Confidence 45566666532 223568999999999999999999999998855443
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.3e-46 Score=414.37 Aligned_cols=253 Identities=30% Similarity=0.426 Sum_probs=198.9
Q ss_pred cccccccccccccEEEEEEEcCC-CcEEEEEEeccc-------cChHHHHHHHHHhc--CCCCceEEEEEEEe-----CC
Q psy11767 380 LDKAGILGDGSYSVCRRCVEKST-GQEYAVKIISRK-------IDCSEEINLLRACQ--GHPNIVNLHCVFQD-----EV 444 (966)
Q Consensus 380 ~~~~~~LG~G~fG~Vy~a~~~~t-g~~vAvK~i~~~-------~~~~~Ei~iL~~l~--~HpnIV~l~~~~~~-----~~ 444 (966)
|+.++.||+|+||+||+|++..+ ++.||||++... ....+|+.+|+.+. +|||||+++++|.. ..
T Consensus 9 Y~i~~~LG~G~fg~V~~a~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~~l~~l~~~~HpnIv~~~~~~~~~~~~~~~ 88 (305)
T d1blxa_ 9 YECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDRET 88 (305)
T ss_dssp EEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEECSSEE
T ss_pred EEEEEEEecccCeEEEEEEEECCCCEEEEEEEEehhhccchHHHHHHHHHHHHHHHhhcCCCCcceeeeeecccccccCc
Confidence 34478999999999999999766 678999998642 13567999888764 69999999999863 35
Q ss_pred eEEEEEEccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCcEEEecCCCCCEEEEeeccccc
Q psy11767 445 HTYLVLELLKGGELLDRIRQKGRCGFTENEASRIMRQLVAAVHFMHSRGVVHRDLKPENLLFSDPAGDNIKVVDFGFACL 524 (966)
Q Consensus 445 ~~~lVmEy~~gg~L~~~l~~~~~~~l~e~~~~~i~~Qil~aL~yLHs~~IiHRDLKP~NILl~~~~~~~iKL~DFGla~~ 524 (966)
+.|++||||.++.+.... ......+++..++.++.||+.||+|||++|||||||||+|||+++ .+.+||+|||+++.
T Consensus 89 ~~~~~~e~~~~~~~~~~~-~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~ivHrDiKp~NILi~~--~~~~kl~dfg~~~~ 165 (305)
T d1blxa_ 89 KLTLVFEHVDQDLTTYLD-KVPEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTS--SGQIKLADFGLARI 165 (305)
T ss_dssp EEEEEEECCSCBHHHHHH-HSCTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECT--TCCEEECSCCSCCC
T ss_pred eEEEEEEeccCCchhhhh-hccCCCCCHHHHHHHHHHHHHHHHHHHhCCEEecCCCccEEEEcC--CCCeeecchhhhhh
Confidence 789999999877665443 334447999999999999999999999999999999999999975 56999999999876
Q ss_pred ccC--CCccccccccccCchhhccCCCCCCCcccchhhhhhhhhhhhcCCCCCCCcCcchhHHHHHHHHhcCCCCCCCCC
Q psy11767 525 KRE--SLHTPCFTLQYAAPEVLRQDKSGYDENCDLWSLGVILVNVLRQDKSGYDENCDLWSLGVILYTMLCGRVPFHARS 602 (966)
Q Consensus 525 ~~~--~~~~~~gT~~Y~APEvl~~~~~~~~~~~Di~SlGvil~el~~~~~~~y~~~~DIWSlGvilyemltG~~Pf~~~~ 602 (966)
... .....+||+.|||||++.. ..|+.++||||+||++|||++|++||.+.+
T Consensus 166 ~~~~~~~~~~~gT~~Y~APE~~~~--------------------------~~y~~~~DiwSlG~il~ell~g~~pf~~~~ 219 (305)
T d1blxa_ 166 YSFQMALTSVVVTLWYRAPEVLLQ--------------------------SSYATPVDLWSVGCIFAEMFRRKPLFRGSS 219 (305)
T ss_dssp CCGGGGGCCCCCCCTTCCHHHHTT--------------------------CCCCTHHHHHHHHHHHHHHHHSSCSCCCSS
T ss_pred hcccccCCCcccChhhcCcchhcC--------------------------CCCChhehhhchHHHHHHHHHCCCCCCCCC
Confidence 432 3456789999999999853 348899999999999999999999998876
Q ss_pred CchhHHHHHHHHHcC---CC----------------CCCchhhccCCHHHHHHHHHhcccCccccCChHHHHHHhhhhHH
Q psy11767 603 RDDSALSIMARIKEG---QF----------------NFDAEAWSTVSSEAKELTKSLLTVNPAQRIRMMRVKLTFHAFHQ 663 (966)
Q Consensus 603 ~~~~~~~~~~~i~~~---~~----------------~~~~~~~~~is~e~~~Li~~~L~~dP~~R~t~~~v~~~~~~~~~ 663 (966)
..+....++..+... .+ ......+..+|+++++||.+||+.||++|||+.++ ..|||++
T Consensus 220 ~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~sa~e~--L~Hpff~ 297 (305)
T d1blxa_ 220 DVDQLGKILDVIGLPGEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSA--LSHPYFQ 297 (305)
T ss_dssp HHHHHHHHHHHHCCCCGGGSCTTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHH--HTSGGGT
T ss_pred HHHHHHHHHHhhCCCchhcccccccchhhhhccccccchhhccccCCHHHHHHHHHHCcCChhHCcCHHHH--hcChhhc
Confidence 544333333222110 00 00112235689999999999999999999999876 5678864
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.9e-46 Score=401.84 Aligned_cols=238 Identities=21% Similarity=0.387 Sum_probs=200.9
Q ss_pred cccccccccccccEEEEEEEcCCCcEEEEEEecccc----ChHHHHHHHHHhcCCCCceEEEEEEEeCCeEEEEEEccCC
Q psy11767 380 LDKAGILGDGSYSVCRRCVEKSTGQEYAVKIISRKI----DCSEEINLLRACQGHPNIVNLHCVFQDEVHTYLVLELLKG 455 (966)
Q Consensus 380 ~~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~----~~~~Ei~iL~~l~~HpnIV~l~~~~~~~~~~~lVmEy~~g 455 (966)
|+..+.||+|+||+||+|+++ +++.||||++++.. +..+|+++|+.+ +|||||++++++.+++..|+||||+++
T Consensus 6 ~~~~~~iG~G~fg~Vy~~~~~-~~~~vAvK~l~~~~~~~~~~~~Ev~~~~~l-~HpnIv~~~g~~~~~~~~~iv~Ey~~~ 83 (258)
T d1k2pa_ 6 LTFLKELGTGQFGVVKYGKWR-GQYDVAIKMIKEGSMSEDEFIEEAKVMMNL-SHEKLVQLYGVCTKQRPIFIITEYMAN 83 (258)
T ss_dssp CCCCCCCCEETTEEEEEEEET-TTEEEEEEEEESSSSCHHHHHHHHHHHHTC-CCTTBCCEEEEECCSSSEEEEEECCTT
T ss_pred CEEeEEEecCCCeEEEEEEEC-CCCEEEEEEECcCcCCHHHHHHHHHHHHhc-CCCceeeEEEEEeeCCceEEEEEccCC
Confidence 344688999999999999985 78899999997643 256799999998 599999999999999999999999999
Q ss_pred CCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCcEEEecCCCCCEEEEeecccccccCC----Ccc
Q psy11767 456 GELLDRIRQKGRCGFTENEASRIMRQLVAAVHFMHSRGVVHRDLKPENLLFSDPAGDNIKVVDFGFACLKRES----LHT 531 (966)
Q Consensus 456 g~L~~~l~~~~~~~l~e~~~~~i~~Qil~aL~yLHs~~IiHRDLKP~NILl~~~~~~~iKL~DFGla~~~~~~----~~~ 531 (966)
|+|.+++..... .+++..+.+++.||+.||+|||++||+||||||+|||+++ ++.+||+|||+|+..... ...
T Consensus 84 g~l~~~~~~~~~-~~~~~~~~~i~~qi~~gl~~LH~~~iiH~dlk~~Nill~~--~~~~kl~DfG~a~~~~~~~~~~~~~ 160 (258)
T d1k2pa_ 84 GCLLNYLREMRH-RFQTQQLLEMCKDVCEAMEYLESKQFLHRDLAARNCLVND--QGVVKVSDFGLSRYVLDDEYTSSVG 160 (258)
T ss_dssp EEHHHHHHSGGG-CCCHHHHHHHHHHHHHHHHHHHHTTBCCSCCSGGGEEECT--TCCEEECCCSSCCBCSSSSCCCCCC
T ss_pred CcHHHhhhcccc-CCcHHHHHHHHHHHHHHHHHHhhcCcccccccceeEEEcC--CCcEEECcchhheeccCCCceeecc
Confidence 999999766543 5899999999999999999999999999999999999985 569999999999754322 224
Q ss_pred ccccccccCchhhccCCCCCCCcccchhhhhhhhhhhhcCCCCCCCcCcchhHHHHHHHHhc-CCCCCCCCCCchhHHHH
Q psy11767 532 PCFTLQYAAPEVLRQDKSGYDENCDLWSLGVILVNVLRQDKSGYDENCDLWSLGVILYTMLC-GRVPFHARSRDDSALSI 610 (966)
Q Consensus 532 ~~gT~~Y~APEvl~~~~~~~~~~~Di~SlGvil~el~~~~~~~y~~~~DIWSlGvilyemlt-G~~Pf~~~~~~~~~~~~ 610 (966)
..+|+.|+|||++... .|+.++|||||||++|||+| |+.||.+.+.. .+
T Consensus 161 ~~~t~~y~aPE~~~~~--------------------------~~~~ksDiwS~G~~l~el~t~g~~Pf~~~~~~----~~ 210 (258)
T d1k2pa_ 161 SKFPVRWSPPEVLMYS--------------------------KFSSKSDIWAFGVLMWEIYSLGKMPYERFTNS----ET 210 (258)
T ss_dssp SCCCGGGCCHHHHHHC--------------------------CCCHHHHHHHHHHHHHHHHTTSCCTTTTSCHH----HH
T ss_pred cCCCCCcCCcHHhcCC--------------------------CCCcceeecccchhhHhHHhcCCCCCCCCCHH----HH
Confidence 5689999999998632 37889999999999999998 89999876543 34
Q ss_pred HHHHHcCCCCCCchhhccCCHHHHHHHHHhcccCccccCChHHHH
Q psy11767 611 MARIKEGQFNFDAEAWSTVSSEAKELTKSLLTVNPAQRIRMMRVK 655 (966)
Q Consensus 611 ~~~i~~~~~~~~~~~~~~is~e~~~Li~~~L~~dP~~R~t~~~v~ 655 (966)
..++..+..... +...++++.+||.+||+.||++|||+.++.
T Consensus 211 ~~~i~~~~~~~~---p~~~~~~l~~li~~cl~~dP~~RPt~~eil 252 (258)
T d1k2pa_ 211 AEHIAQGLRLYR---PHLASEKVYTIMYSCWHEKADERPTFKILL 252 (258)
T ss_dssp HHHHHTTCCCCC---CTTCCHHHHHHHHHTTCSSGGGSCCHHHHH
T ss_pred HHHHHhCCCCCC---cccccHHHHHHHHHHccCCHhHCcCHHHHH
Confidence 556666543322 346789999999999999999999998874
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.6e-46 Score=419.46 Aligned_cols=255 Identities=27% Similarity=0.410 Sum_probs=199.9
Q ss_pred ccccccccccccccEEEEEEEcCCCcEEEEEEecccc-ChHHHHHHHHHhcCCCCceEEEEEEEe------CCeEEEEEE
Q psy11767 379 DLDKAGILGDGSYSVCRRCVEKSTGQEYAVKIISRKI-DCSEEINLLRACQGHPNIVNLHCVFQD------EVHTYLVLE 451 (966)
Q Consensus 379 ~~~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~-~~~~Ei~iL~~l~~HpnIV~l~~~~~~------~~~~~lVmE 451 (966)
+|+.+++||+|+||+||+|+++.+|+.||||++.+.. ...+|+++|+.+ +|||||+++++|.. ..++|||||
T Consensus 21 ~Y~~~k~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~Ei~il~~l-~h~niv~~~~~~~~~~~~~~~~~~~lv~E 99 (350)
T d1q5ka_ 21 SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNRELQIMRKL-DHCNIVRLRYFFYSSGEKKDEVYLNLVLD 99 (350)
T ss_dssp EEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSSSCCHHHHHHHHC-CCTTBCCEEEEEEEC--CCSCCEEEEEEE
T ss_pred CcEeeeEEeeCcCeEEEEEEECCCCCEEEEEEECccchHHHHHHHHHHhc-CCCCCCcEEEEEEecCccCCceEEEEEEe
Confidence 5566789999999999999999999999999997654 356899999998 59999999999854 346899999
Q ss_pred ccCCCCHHHHHHh--cCCCCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCcEEEecCCCCCEEEEeeccccccc--C
Q psy11767 452 LLKGGELLDRIRQ--KGRCGFTENEASRIMRQLVAAVHFMHSRGVVHRDLKPENLLFSDPAGDNIKVVDFGFACLKR--E 527 (966)
Q Consensus 452 y~~gg~L~~~l~~--~~~~~l~e~~~~~i~~Qil~aL~yLHs~~IiHRDLKP~NILl~~~~~~~iKL~DFGla~~~~--~ 527 (966)
||+++ +.+.+.. .....+++.+++.++.||+.||+|||++||+||||||+|||++. .+..+||+|||+|+... .
T Consensus 100 y~~~~-~~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~yLH~~~IiHrDiKp~NILl~~-~~~~~kl~DFG~a~~~~~~~ 177 (350)
T d1q5ka_ 100 YVPET-VYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDP-DTAVLKLCDFGSAKQLVRGE 177 (350)
T ss_dssp CCSEE-HHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECT-TTCCEEECCCTTCEECCTTS
T ss_pred ccCCc-cHHHHHhhhhccCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCcceEEEec-CCCceeEecccchhhccCCc
Confidence 99765 4333322 23346999999999999999999999999999999999999974 24589999999997653 2
Q ss_pred CCccccccccccCchhhccCCCCCCCcccchhhhhhhhhhhhcCCCCCCCcCcchhHHHHHHHHhcCCCCCCCCCCchhH
Q psy11767 528 SLHTPCFTLQYAAPEVLRQDKSGYDENCDLWSLGVILVNVLRQDKSGYDENCDLWSLGVILYTMLCGRVPFHARSRDDSA 607 (966)
Q Consensus 528 ~~~~~~gT~~Y~APEvl~~~~~~~~~~~Di~SlGvil~el~~~~~~~y~~~~DIWSlGvilyemltG~~Pf~~~~~~~~~ 607 (966)
...+.+||+.|+|||++.. ...|+.++||||+||++|||++|++||...+..+..
T Consensus 178 ~~~~~~gt~~y~aPE~~~~-------------------------~~~~~~~~DIwSlG~il~el~~g~~pf~~~~~~~~l 232 (350)
T d1q5ka_ 178 PNVSYICSRYYRAPELIFG-------------------------ATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQL 232 (350)
T ss_dssp CCCSCCSCTTSCCHHHHTT-------------------------CSSCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHH
T ss_pred ccccccccccccChHHhhc-------------------------ccCCCcceeecccceEEEehhhCCCCCCCCCHHHHH
Confidence 3456789999999998753 235789999999999999999999999876654433
Q ss_pred HHHHHHHHc-------------CCCCCC--------chhhccCCHHHHHHHHHhcccCccccCChHHHHHHhhhhHH
Q psy11767 608 LSIMARIKE-------------GQFNFD--------AEAWSTVSSEAKELTKSLLTVNPAQRIRMMRVKLTFHAFHQ 663 (966)
Q Consensus 608 ~~~~~~i~~-------------~~~~~~--------~~~~~~is~e~~~Li~~~L~~dP~~R~t~~~v~~~~~~~~~ 663 (966)
..++..+.. ....+. ....+.+++++.+||.+||++||++|||+.++ ..|+|++
T Consensus 233 ~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~--L~Hp~f~ 307 (350)
T d1q5ka_ 233 VEIIKVLGTPTREQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEA--CAHSFFD 307 (350)
T ss_dssp HHHHHHHCCCCHHHHHHHCC---CCCCCCCCCCCGGGTSCTTSCHHHHHHHHHHSCSSGGGSCCHHHH--HTSGGGG
T ss_pred HHHHHHhCCChHHhhhhhccchhhccccccccCchhhhcccCCCHHHHHHHHHHccCChhHCcCHHHH--hcCHhhc
Confidence 332221100 000000 11224579999999999999999999999976 4577764
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.8e-46 Score=403.42 Aligned_cols=242 Identities=23% Similarity=0.395 Sum_probs=190.7
Q ss_pred ccccccccccccEEEEEEEcCCC---cEEEEEEeccccC------hHHHHHHHHHhcCCCCceEEEEEEEeCCeEEEEEE
Q psy11767 381 DKAGILGDGSYSVCRRCVEKSTG---QEYAVKIISRKID------CSEEINLLRACQGHPNIVNLHCVFQDEVHTYLVLE 451 (966)
Q Consensus 381 ~~~~~LG~G~fG~Vy~a~~~~tg---~~vAvK~i~~~~~------~~~Ei~iL~~l~~HpnIV~l~~~~~~~~~~~lVmE 451 (966)
+..+.||+|+||+||+|++..++ ..||||.+..... ..+|+.+|+.+ +|||||++++++. ++..|+|||
T Consensus 10 ~l~~~iG~G~fg~Vy~a~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~E~~~l~~l-~HpnIv~l~~~~~-~~~~~iv~E 87 (273)
T d1mp8a_ 10 ELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQF-DHPHIVKLIGVIT-ENPVWIIME 87 (273)
T ss_dssp EEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTC-CCTTBCCEEEEEC-SSSCEEEEE
T ss_pred EEEEEEeeCCCcEEEEEEEecCCceeEEEEEEEeccccCHHHHHHHHHHHHHHHhC-CCCCEeeEEEEEe-cCeEEEEEE
Confidence 33678999999999999987653 5689998865332 45699999998 5999999999996 467899999
Q ss_pred ccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCcEEEecCCCCCEEEEeecccccccC----
Q psy11767 452 LLKGGELLDRIRQKGRCGFTENEASRIMRQLVAAVHFMHSRGVVHRDLKPENLLFSDPAGDNIKVVDFGFACLKRE---- 527 (966)
Q Consensus 452 y~~gg~L~~~l~~~~~~~l~e~~~~~i~~Qil~aL~yLHs~~IiHRDLKP~NILl~~~~~~~iKL~DFGla~~~~~---- 527 (966)
||++|+|.+++.... ..+++.+++.++.||+.||+|||++|||||||||+|||++. .+.+||+|||+|+....
T Consensus 88 ~~~~g~l~~~~~~~~-~~l~~~~~~~~~~qi~~gl~ylH~~~iiHrDlKp~NIll~~--~~~~Kl~DfG~a~~~~~~~~~ 164 (273)
T d1mp8a_ 88 LCTLGELRSFLQVRK-YSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSS--NDCVKLGDFGLSRYMEDSTYY 164 (273)
T ss_dssp CCTTEEHHHHHHHTT-TTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEE--TTEEEECC-------------
T ss_pred eccCCcHHhhhhccC-CCCCHHHHHHHHHHHHHHhhhhcccCeeccccchhheeecC--CCcEEEccchhheeccCCcce
Confidence 999999999887654 36999999999999999999999999999999999999985 56899999999976432
Q ss_pred CCccccccccccCchhhccCCCCCCCcccchhhhhhhhhhhhcCCCCCCCcCcchhHHHHHHHHhc-CCCCCCCCCCchh
Q psy11767 528 SLHTPCFTLQYAAPEVLRQDKSGYDENCDLWSLGVILVNVLRQDKSGYDENCDLWSLGVILYTMLC-GRVPFHARSRDDS 606 (966)
Q Consensus 528 ~~~~~~gT~~Y~APEvl~~~~~~~~~~~Di~SlGvil~el~~~~~~~y~~~~DIWSlGvilyemlt-G~~Pf~~~~~~~~ 606 (966)
.....+||+.|+|||++.. ..|+.++|||||||++|||++ |.+||.+.+..+
T Consensus 165 ~~~~~~gt~~y~apE~l~~--------------------------~~~~~~~DiwSlGvil~e~lt~g~~P~~~~~~~~- 217 (273)
T d1mp8a_ 165 KASKGKLPIKWMAPESINF--------------------------RRFTSASDVWMFGVCMWEILMHGVKPFQGVKNND- 217 (273)
T ss_dssp ------CCGGGCCHHHHHH--------------------------CCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGGG-
T ss_pred eccceecCcccchhhHhcc--------------------------CCCCCccccccchHHHHHHHhcCCCCCCCCCHHH-
Confidence 1234567999999999863 247889999999999999998 899998776543
Q ss_pred HHHHHHHHHcCCCCCCchhhccCCHHHHHHHHHhcccCccccCChHHHHHHhhh
Q psy11767 607 ALSIMARIKEGQFNFDAEAWSTVSSEAKELTKSLLTVNPAQRIRMMRVKLTFHA 660 (966)
Q Consensus 607 ~~~~~~~i~~~~~~~~~~~~~~is~e~~~Li~~~L~~dP~~R~t~~~v~~~~~~ 660 (966)
++.++..+... +.++.+|+++.+||.+||..||++|||+.++...+..
T Consensus 218 ---~~~~i~~~~~~---~~~~~~~~~~~~li~~cl~~dp~~Rps~~ei~~~L~~ 265 (273)
T d1mp8a_ 218 ---VIGRIENGERL---PMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLST 265 (273)
T ss_dssp ---HHHHHHTTCCC---CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred ---HHHHHHcCCCC---CCCCCCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHH
Confidence 44556665432 2345789999999999999999999999998654443
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-45 Score=403.61 Aligned_cols=245 Identities=18% Similarity=0.316 Sum_probs=193.8
Q ss_pred ccccccccccccEEEEEEEcCCC----cEEEEEEeccccC------hHHHHHHHHHhcCCCCceEEEEEEEeCCeEEEEE
Q psy11767 381 DKAGILGDGSYSVCRRCVEKSTG----QEYAVKIISRKID------CSEEINLLRACQGHPNIVNLHCVFQDEVHTYLVL 450 (966)
Q Consensus 381 ~~~~~LG~G~fG~Vy~a~~~~tg----~~vAvK~i~~~~~------~~~Ei~iL~~l~~HpnIV~l~~~~~~~~~~~lVm 450 (966)
+..++||+|+||+||+|.++.++ ..||||++..... +.+|+++|+.+ +|||||++++++.+....++||
T Consensus 10 ~~~~~iG~G~fG~Vy~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l-~H~nIv~~~g~~~~~~~~~~v~ 88 (283)
T d1mqba_ 10 TRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQF-SHHNIIRLEGVISKYKPMMIIT 88 (283)
T ss_dssp EEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTC-CCTTBCCEEEEECSSSSEEEEE
T ss_pred EeeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEEECcccChHHHHHHHHHHHHHHhc-CCCCEeeeeEEEecCCceEEEE
Confidence 34678999999999999988765 4799999865432 45799999998 5999999999999999999999
Q ss_pred EccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCcEEEecCCCCCEEEEeecccccccCC--
Q psy11767 451 ELLKGGELLDRIRQKGRCGFTENEASRIMRQLVAAVHFMHSRGVVHRDLKPENLLFSDPAGDNIKVVDFGFACLKRES-- 528 (966)
Q Consensus 451 Ey~~gg~L~~~l~~~~~~~l~e~~~~~i~~Qil~aL~yLHs~~IiHRDLKP~NILl~~~~~~~iKL~DFGla~~~~~~-- 528 (966)
|||.+|++.+.+..... .+++.++..++.||+.||+|||+++|+||||||+||||+. ++.+||+|||+|+.....
T Consensus 89 e~~~~~~l~~~~~~~~~-~~~~~~~~~i~~~i~~gl~~lH~~~iiHrDlKp~NILl~~--~~~~Kl~DFGla~~~~~~~~ 165 (283)
T d1mqba_ 89 EYMENGALDKFLREKDG-EFSVLQLVGMLRGIAAGMKYLANMNYVHRDLAARNILVNS--NLVCKVSDFGLSRVLEDDPE 165 (283)
T ss_dssp ECCTTEEHHHHHHHTTT-CSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECT--TCCEEECCCCC---------
T ss_pred EecccCcchhhhhcccc-cccHHHHHHHHHHHHHhhhhccccccccCccccceEEECC--CCeEEEcccchhhcccCCCc
Confidence 99999999998876543 6999999999999999999999999999999999999985 569999999999764321
Q ss_pred ----CccccccccccCchhhccCCCCCCCcccchhhhhhhhhhhhcCCCCCCCcCcchhHHHHHHHHhcCCCCCCCCCCc
Q psy11767 529 ----LHTPCFTLQYAAPEVLRQDKSGYDENCDLWSLGVILVNVLRQDKSGYDENCDLWSLGVILYTMLCGRVPFHARSRD 604 (966)
Q Consensus 529 ----~~~~~gT~~Y~APEvl~~~~~~~~~~~Di~SlGvil~el~~~~~~~y~~~~DIWSlGvilyemltG~~Pf~~~~~~ 604 (966)
.....||+.|||||++.. ..|+.++|||||||++|||++|..||......
T Consensus 166 ~~~~~~~~~gt~~Y~APE~l~~--------------------------~~~~~~sDI~S~Gvil~el~t~~~~~~~~~~~ 219 (283)
T d1mqba_ 166 ATYTTSGGKIPIRWTAPEAISY--------------------------RKFTSASDVWSFGIVMWEVMTYGERPYWELSN 219 (283)
T ss_dssp --------CCCGGGSCHHHHHS--------------------------CCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCH
T ss_pred cceEeccCCCCccccCHHHHcc--------------------------CCCCCcccccccHHHHHHHHhCCCCccccCCH
Confidence 123457999999999863 24788999999999999999976555443332
Q ss_pred hhHHHHHHHHHcCCCCCCchhhccCCHHHHHHHHHhcccCccccCChHHHHHHhhhh
Q psy11767 605 DSALSIMARIKEGQFNFDAEAWSTVSSEAKELTKSLLTVNPAQRIRMMRVKLTFHAF 661 (966)
Q Consensus 605 ~~~~~~~~~i~~~~~~~~~~~~~~is~e~~~Li~~~L~~dP~~R~t~~~v~~~~~~~ 661 (966)
..++..+..+... +.+..++.++.+||.+||..||++|||+.++...+..+
T Consensus 220 ---~~~~~~i~~~~~~---~~~~~~~~~l~~li~~cl~~~p~~RPt~~eil~~L~~l 270 (283)
T d1mqba_ 220 ---HEVMKAINDGFRL---PTPMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKL 270 (283)
T ss_dssp ---HHHHHHHHTTCCC---CCCTTCBHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHH
T ss_pred ---HHHHHHHhccCCC---CCchhhHHHHHHHHHHHCcCCHhHCcCHHHHHHHHHHH
Confidence 2445566655322 22346889999999999999999999999986555443
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Probab=100.00 E-value=1.3e-45 Score=410.73 Aligned_cols=251 Identities=24% Similarity=0.415 Sum_probs=201.9
Q ss_pred cccccccccccccEEEEEEEcCCCcEEEEEEecccc--ChHHHHHHHHHhcCCCCceEEEEEEEeC--CeEEEEEEccCC
Q psy11767 380 LDKAGILGDGSYSVCRRCVEKSTGQEYAVKIISRKI--DCSEEINLLRACQGHPNIVNLHCVFQDE--VHTYLVLELLKG 455 (966)
Q Consensus 380 ~~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~--~~~~Ei~iL~~l~~HpnIV~l~~~~~~~--~~~~lVmEy~~g 455 (966)
|+.+++||+|+||+||+|+++.+|+.||||+++... ...+|+.+|+.+.+||||++++++|... .+.|+|||||.+
T Consensus 37 y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~Ei~il~~l~~hpnIv~~~~~~~~~~~~~~~~v~e~~~~ 116 (328)
T d3bqca1 37 YQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVKKKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVFEHVNN 116 (328)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSSCHHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCSEEEEEECCCS
T ss_pred eEEEEEEecCcCeEEEEEEECCCCCEEEEEEECHHHHHHHHHHHHHHHhccCCCCCcEEEEEEEecCCCceeEEEeecCC
Confidence 445789999999999999999999999999997543 3557999999998899999999999854 569999999999
Q ss_pred CCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCcEEEecCCCCCEEEEeecccccccC--CCcccc
Q psy11767 456 GELLDRIRQKGRCGFTENEASRIMRQLVAAVHFMHSRGVVHRDLKPENLLFSDPAGDNIKVVDFGFACLKRE--SLHTPC 533 (966)
Q Consensus 456 g~L~~~l~~~~~~~l~e~~~~~i~~Qil~aL~yLHs~~IiHRDLKP~NILl~~~~~~~iKL~DFGla~~~~~--~~~~~~ 533 (966)
++|.... ..+++.+++.++.||+.||+|||++||+||||||+|||++. .++.+||+|||+|+.... .....+
T Consensus 117 ~~L~~~~-----~~l~e~~i~~i~~qil~aL~~LH~~gIvHrDiKp~NILi~~-~~~~vkl~DFG~a~~~~~~~~~~~~~ 190 (328)
T d3bqca1 117 TDFKQLY-----QTLTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDH-EHRKLRLIDWGLAEFYHPGQEYNVRV 190 (328)
T ss_dssp CBGGGTT-----TSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEET-TTTEEEECCGGGCEECCTTCCCCSCC
T ss_pred CcHHHHh-----cCCCHHHHHHHHHHHHHHHHHHhhcccccccccccceEEcC-CCCeeeecccccceeccCCCcccccc
Confidence 9987653 25999999999999999999999999999999999999974 344799999999976543 345667
Q ss_pred ccccccCchhhccCCCCCCCcccchhhhhhhhhhhhcCCCCCCCcCcchhHHHHHHHHhcCCCCCCCCCCchhHHHHHHH
Q psy11767 534 FTLQYAAPEVLRQDKSGYDENCDLWSLGVILVNVLRQDKSGYDENCDLWSLGVILYTMLCGRVPFHARSRDDSALSIMAR 613 (966)
Q Consensus 534 gT~~Y~APEvl~~~~~~~~~~~Di~SlGvil~el~~~~~~~y~~~~DIWSlGvilyemltG~~Pf~~~~~~~~~~~~~~~ 613 (966)
+|+.|+|||++.. ...|+.++||||+||++|+|++|+.||............+..
T Consensus 191 ~t~~y~aPE~~~~-------------------------~~~~~~~~DiwslG~~l~e~~~g~~pf~~~~~~~~~~~~i~~ 245 (328)
T d3bqca1 191 ASRYFKGPELLVD-------------------------YQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAK 245 (328)
T ss_dssp SCGGGCCHHHHTT-------------------------CCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHH
T ss_pred cCccccCcccccC-------------------------CCCCCcccchhhhhhhhHHhccCCCCCCCCchhHHHHHHHHH
Confidence 8999999998853 234788999999999999999999999876543322222211
Q ss_pred HH----------cCCCC--------------------CCchhhccCCHHHHHHHHHhcccCccccCChHHHHHHhhhhHH
Q psy11767 614 IK----------EGQFN--------------------FDAEAWSTVSSEAKELTKSLLTVNPAQRIRMMRVKLTFHAFHQ 663 (966)
Q Consensus 614 i~----------~~~~~--------------------~~~~~~~~is~e~~~Li~~~L~~dP~~R~t~~~v~~~~~~~~~ 663 (966)
+. ..... +....+..+|++++|||++||++||++|||+.++ ..|+|++
T Consensus 246 ~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~e~--L~Hp~F~ 323 (328)
T d3bqca1 246 VLGTEDLYDYIDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREA--MEHPYFY 323 (328)
T ss_dssp HHCHHHHHHHHHHTTCCCCGGGGGTCCCCCCCCGGGGCCTTTGGGCCHHHHHHHHHHSCSSGGGSCCHHHH--HTSGGGT
T ss_pred HHCCchhhhhhhhcccccCcccchhcccccccchhhcccccccccCCHHHHHHHHHHccCChhHCcCHHHH--hcCcccC
Confidence 11 00000 1112334689999999999999999999999986 4588875
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.7e-45 Score=404.78 Aligned_cols=246 Identities=24% Similarity=0.323 Sum_probs=189.6
Q ss_pred ccccccccccccEEEEEEEcC-----CCcEEEEEEeccccC------hHHHHHHHHHhcCCCCceEEEEEEEeC-CeEEE
Q psy11767 381 DKAGILGDGSYSVCRRCVEKS-----TGQEYAVKIISRKID------CSEEINLLRACQGHPNIVNLHCVFQDE-VHTYL 448 (966)
Q Consensus 381 ~~~~~LG~G~fG~Vy~a~~~~-----tg~~vAvK~i~~~~~------~~~Ei~iL~~l~~HpnIV~l~~~~~~~-~~~~l 448 (966)
+..+.||+|+||+||+|.+.. +++.||||++..... ..+|+.++.++.+|+|||.+++++..+ ...++
T Consensus 16 ~~~~~iG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~~~~i 95 (299)
T d1ywna1 16 KLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGPLMV 95 (299)
T ss_dssp EEEEEEEECSSCEEEEEEEESTTSSSCEEEEEEEEC----CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTTSCCEE
T ss_pred EEeeEEeecCCeEEEEEEEcCCCcccCCeEEEEEEEccccCcHHHHHHHHHHHHHHhhcCCCeEEEeeeeeccCCCeEEE
Confidence 346889999999999999764 457899999865432 345777888887899999999987654 56899
Q ss_pred EEEccCCCCHHHHHHhcC--------------CCCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCcEEEecCCCCCE
Q psy11767 449 VLELLKGGELLDRIRQKG--------------RCGFTENEASRIMRQLVAAVHFMHSRGVVHRDLKPENLLFSDPAGDNI 514 (966)
Q Consensus 449 VmEy~~gg~L~~~l~~~~--------------~~~l~e~~~~~i~~Qil~aL~yLHs~~IiHRDLKP~NILl~~~~~~~i 514 (966)
|||||++|+|.++|.... ...+++.+++.++.||+.||+|||++|||||||||+||||++ ++.+
T Consensus 96 v~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~ivHrDlKp~NILl~~--~~~~ 173 (299)
T d1ywna1 96 IVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSE--KNVV 173 (299)
T ss_dssp EEECCTTCBHHHHHHHTGGGBCC-----------CBCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECG--GGCE
T ss_pred EEEecCCCcHHHHHHhccccccccccchhhhhcccCCHHHHHHHHHHHHHHHHHHHhCCCcCCcCCccceeECC--CCcE
Confidence 999999999999997542 224899999999999999999999999999999999999985 5699
Q ss_pred EEEeecccccccCC-----CccccccccccCchhhccCCCCCCCcccchhhhhhhhhhhhcCCCCCCCcCcchhHHHHHH
Q psy11767 515 KVVDFGFACLKRES-----LHTPCFTLQYAAPEVLRQDKSGYDENCDLWSLGVILVNVLRQDKSGYDENCDLWSLGVILY 589 (966)
Q Consensus 515 KL~DFGla~~~~~~-----~~~~~gT~~Y~APEvl~~~~~~~~~~~Di~SlGvil~el~~~~~~~y~~~~DIWSlGvily 589 (966)
||+|||+|+..... ..+.+||+.|||||++... .|+.++|||||||++|
T Consensus 174 Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~--------------------------~~~~~sDiwS~Gvil~ 227 (299)
T d1ywna1 174 KICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDR--------------------------VYTIQSDVWSFGVLLW 227 (299)
T ss_dssp EECC------CCSCTTSCCTTSCCCGGGGCCHHHHHHC--------------------------CCCHHHHHHHHHHHHH
T ss_pred EEccCcchhhccccccccccCceeeCccccchhHhhcC--------------------------CCCcccceeehHHHHH
Confidence 99999999754321 2345789999999998632 4788999999999999
Q ss_pred HHhcC-CCCCCCCCCchhHHHHHHHHHcCCCCCCchhhccCCHHHHHHHHHhcccCccccCChHHHHHHhhh
Q psy11767 590 TMLCG-RVPFHARSRDDSALSIMARIKEGQFNFDAEAWSTVSSEAKELTKSLLTVNPAQRIRMMRVKLTFHA 660 (966)
Q Consensus 590 emltG-~~Pf~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~is~e~~~Li~~~L~~dP~~R~t~~~v~~~~~~ 660 (966)
||++| .+||.+....+. +...+..+... +.+..+++++++||.+||+.||++|||+.++...+..
T Consensus 228 ellt~~~~p~~~~~~~~~---~~~~~~~~~~~---~~~~~~~~~l~~li~~cl~~dP~~Rpt~~eil~~L~~ 293 (299)
T d1ywna1 228 EIFSLGASPYPGVKIDEE---FCRRLKEGTRM---RAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGN 293 (299)
T ss_dssp HHHTTSCCSSTTCCCSHH---HHHHHHHTCCC---CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred HHHhCCCCCCCCCCHHHH---HHHHHhcCCCC---CCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHH
Confidence 99986 568876655432 33344444322 2234689999999999999999999999988654443
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.7e-45 Score=412.95 Aligned_cols=249 Identities=27% Similarity=0.480 Sum_probs=195.3
Q ss_pred ccccccccccccEEEEEEEcCCCcEEEEEEeccccC-------hHHHHHHHHHhcCCCCceEEEEEEEeCC------eEE
Q psy11767 381 DKAGILGDGSYSVCRRCVEKSTGQEYAVKIISRKID-------CSEEINLLRACQGHPNIVNLHCVFQDEV------HTY 447 (966)
Q Consensus 381 ~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~~-------~~~Ei~iL~~l~~HpnIV~l~~~~~~~~------~~~ 447 (966)
+.++.||+|+||+||+|+++.+|+.||||++.+... ..+|+++|+.+ +|||||+++++|...+ ++|
T Consensus 21 ~~i~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l-~hpniv~l~~~~~~~~~~~~~~~~~ 99 (346)
T d1cm8a_ 21 RDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHM-RHENVIGLLDVFTPDETLDDFTDFY 99 (346)
T ss_dssp EEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHC-CBTTBCCCSEEECSCSSTTTCCCCE
T ss_pred EEEEEEecCCCeEEEEEEECCCCCEEEEEEEchhhcChHHHHHHHHHHHHHHhc-CCCCeeEEEEEeccCccccccceEE
Confidence 347899999999999999999999999999975422 45799999998 5999999999998664 579
Q ss_pred EEEEccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCcEEEecCCCCCEEEEeecccccccC
Q psy11767 448 LVLELLKGGELLDRIRQKGRCGFTENEASRIMRQLVAAVHFMHSRGVVHRDLKPENLLFSDPAGDNIKVVDFGFACLKRE 527 (966)
Q Consensus 448 lVmEy~~gg~L~~~l~~~~~~~l~e~~~~~i~~Qil~aL~yLHs~~IiHRDLKP~NILl~~~~~~~iKL~DFGla~~~~~ 527 (966)
|||||| +++|...+... .|++..++.++.||+.||+|||++||+||||||+|||++. ++.+||+|||+|+....
T Consensus 100 lv~e~~-~~~l~~~~~~~---~l~~~~~~~~~~qi~~aL~~LH~~~IiHrDiKp~NIL~~~--~~~~kl~Dfg~a~~~~~ 173 (346)
T d1cm8a_ 100 LVMPFM-GTDLGKLMKHE---KLGEDRIQFLVYQMLKGLRYIHAAGIIHRDLKPGNLAVNE--DCELKILDFGLARQADS 173 (346)
T ss_dssp EEEECC-SEEHHHHHHHC---CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECT--TCCEEECCCTTCEECCS
T ss_pred EEEecc-cccHHHHHHhc---cccHHHHHHHHHHHHHHHHHHHhCCCcccccCcchhhccc--ccccccccccceeccCC
Confidence 999999 66777766543 5999999999999999999999999999999999999985 56999999999988877
Q ss_pred CCccccccccccCchhhccCCCCCCCcccchhhhhhhhhhhhcCCCCCCCcCcchhHHHHHHHHhcCCCCCCCCCCchhH
Q psy11767 528 SLHTPCFTLQYAAPEVLRQDKSGYDENCDLWSLGVILVNVLRQDKSGYDENCDLWSLGVILYTMLCGRVPFHARSRDDSA 607 (966)
Q Consensus 528 ~~~~~~gT~~Y~APEvl~~~~~~~~~~~Di~SlGvil~el~~~~~~~y~~~~DIWSlGvilyemltG~~Pf~~~~~~~~~ 607 (966)
.....++|+.|+|||++.. ...++.++||||+||++|+|++|++||.+.+..+..
T Consensus 174 ~~~~~~~t~~y~aPE~~~~-------------------------~~~~~~~~DiwSlGvil~ell~g~~pf~~~~~~~~~ 228 (346)
T d1cm8a_ 174 EMTGYVVTRWYRAPEVILN-------------------------WMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQL 228 (346)
T ss_dssp SCCSSCSCGGGCCTHHHHT-------------------------TTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHH
T ss_pred ccccccccccccCHHHHcC-------------------------CCCCCccchhhcchHHHHHHHHCcCCCCCCChHHHH
Confidence 7777889999999999853 234688999999999999999999999876543322
Q ss_pred HHHHHHHH-------------------cCCCCCC----chhhccCCHHHHHHHHHhcccCccccCChHHHHHHhhhhHH
Q psy11767 608 LSIMARIK-------------------EGQFNFD----AEAWSTVSSEAKELTKSLLTVNPAQRIRMMRVKLTFHAFHQ 663 (966)
Q Consensus 608 ~~~~~~i~-------------------~~~~~~~----~~~~~~is~e~~~Li~~~L~~dP~~R~t~~~v~~~~~~~~~ 663 (966)
........ .+..... ......+++++++||.+||..||++|||+.++ ..|+|++
T Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~ei--L~Hp~f~ 305 (346)
T d1cm8a_ 229 KEIMKVTGTPPAEFVQRLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEA--LAHPYFE 305 (346)
T ss_dssp HHHHHHHCCCCHHHHHTCSCHHHHHHHHHSCCCCCCCGGGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHH--HHSGGGT
T ss_pred HHHHhccCCCcHHHHhhhcchhhhhhhccCCcccccchHHhccCCCHHHHHHHHHHCcCChhHCcCHHHH--hcChhhC
Confidence 11111100 0000011 11234679999999999999999999999976 4577764
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Probab=100.00 E-value=1e-45 Score=403.73 Aligned_cols=250 Identities=28% Similarity=0.407 Sum_probs=196.3
Q ss_pred ccccccccccccEEEEEEEcCCCcEEEEEEecccc-------ChHHHHHHHHHhcCCCCceEEEEEEEeCCeEEEEEEcc
Q psy11767 381 DKAGILGDGSYSVCRRCVEKSTGQEYAVKIISRKI-------DCSEEINLLRACQGHPNIVNLHCVFQDEVHTYLVLELL 453 (966)
Q Consensus 381 ~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~-------~~~~Ei~iL~~l~~HpnIV~l~~~~~~~~~~~lVmEy~ 453 (966)
+.+++||+|+||+||+|+++ +|+.||||++.... ...+|+.+|+.+ +|||||+++++|.+++..|+||||+
T Consensus 5 ~~~~~iG~G~fg~Vy~~~~~-~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l-~hpnIv~~~~~~~~~~~~~i~~e~~ 82 (286)
T d1ob3a_ 5 HGLEKIGEGTYGVVYKAQNN-YGETFALKKIRLEKEDEGIPSTTIREISILKEL-KHSNIVKLYDVIHTKKRLVLVFEHL 82 (286)
T ss_dssp EEEEEEEEETTEEEEEEEET-TSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGC-CCTTBCCEEEEEECSSCEEEEEECC
T ss_pred eeccEEecCCCcEEEEEEeC-CCCEEEEEEEehhhcChHHHHHHHHHHHHHHhC-CCCcEEeeeeecccCCceeEEEEee
Confidence 34789999999999999996 78999999996532 245799999998 5999999999999999999999999
Q ss_pred CCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCcEEEecCCCCCEEEEeecccccccCC---Cc
Q psy11767 454 KGGELLDRIRQKGRCGFTENEASRIMRQLVAAVHFMHSRGVVHRDLKPENLLFSDPAGDNIKVVDFGFACLKRES---LH 530 (966)
Q Consensus 454 ~gg~L~~~l~~~~~~~l~e~~~~~i~~Qil~aL~yLHs~~IiHRDLKP~NILl~~~~~~~iKL~DFGla~~~~~~---~~ 530 (966)
.++.+..+.... ..+++.+++.|+.||+.||+|||++|||||||||+|||++. ++.+||+|||+|...... ..
T Consensus 83 ~~~~~~~~~~~~--~~l~~~~~~~i~~qi~~~L~~LH~~~IvHrDiKp~NIll~~--~~~~kl~DfG~a~~~~~~~~~~~ 158 (286)
T d1ob3a_ 83 DQDLKKLLDVCE--GGLESVTAKSFLLQLLNGIAYCHDRRVLHRDLKPQNLLINR--EGELKIADFGLARAFGIPVRKYT 158 (286)
T ss_dssp SEEHHHHHHTST--TCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECT--TSCEEECCTTHHHHHCC------
T ss_pred hhhhHHHHHhhc--CCcchhhhHHHHHHHHHHHHHhccCcEEecCCCCceeeEcC--CCCEEecccccceecccCccccc
Confidence 776665554433 36999999999999999999999999999999999999975 569999999999765432 23
Q ss_pred cccccccccCchhhccCCCCCCCcccchhhhhhhhhhhhcCCCCCCCcCcchhHHHHHHHHhcCCCCCCCCCCchhHHHH
Q psy11767 531 TPCFTLQYAAPEVLRQDKSGYDENCDLWSLGVILVNVLRQDKSGYDENCDLWSLGVILYTMLCGRVPFHARSRDDSALSI 610 (966)
Q Consensus 531 ~~~gT~~Y~APEvl~~~~~~~~~~~Di~SlGvil~el~~~~~~~y~~~~DIWSlGvilyemltG~~Pf~~~~~~~~~~~~ 610 (966)
...+|+.|+|||++.. ...|+.++|||||||++|||++|++||.+.+..+....+
T Consensus 159 ~~~~~~~y~~pE~~~~-------------------------~~~~~~~~DiwslGv~l~el~~G~~pf~~~~~~~~~~~i 213 (286)
T d1ob3a_ 159 HEIVTLWYRAPDVLMG-------------------------SKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRI 213 (286)
T ss_dssp ---CCCTTCCHHHHTT-------------------------CCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHH
T ss_pred eecccchhhhHHHHhC-------------------------CCCCCcceeehhcCcHHHHHHHCCCCCCCCCHHHHHHHH
Confidence 4468999999999853 234788999999999999999999999876544333222
Q ss_pred HHHHHcCCC------------C---------CCchhhccCCHHHHHHHHHhcccCccccCChHHHHHHhhhhHH
Q psy11767 611 MARIKEGQF------------N---------FDAEAWSTVSSEAKELTKSLLTVNPAQRIRMMRVKLTFHAFHQ 663 (966)
Q Consensus 611 ~~~i~~~~~------------~---------~~~~~~~~is~e~~~Li~~~L~~dP~~R~t~~~v~~~~~~~~~ 663 (966)
......... . ........+|++++|||++||+.||++|||+.++ ..|+|++
T Consensus 214 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~s~~el--l~Hp~f~ 285 (286)
T d1ob3a_ 214 FRILGTPNSKNWPNVTELPKYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQA--LEHAYFK 285 (286)
T ss_dssp HHHHCCCCTTTSTTGGGSTTCCTTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHH--HTSGGGG
T ss_pred HHhhCCCChhhccchhhhhhcccccccccCcchhhhcccCCHHHHHHHHHHccCChhHCcCHHHH--hcCcccC
Confidence 221111000 0 0011234578999999999999999999999876 4577753
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.1e-46 Score=405.44 Aligned_cols=244 Identities=19% Similarity=0.297 Sum_probs=194.7
Q ss_pred cccccccccccEEEEEEEcCCCcEEEEEEeccccC----hHHHHHHHHHhcCCCCceEEEEEEEeCCeEEEEEEccCCCC
Q psy11767 382 KAGILGDGSYSVCRRCVEKSTGQEYAVKIISRKID----CSEEINLLRACQGHPNIVNLHCVFQDEVHTYLVLELLKGGE 457 (966)
Q Consensus 382 ~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~~----~~~Ei~iL~~l~~HpnIV~l~~~~~~~~~~~lVmEy~~gg~ 457 (966)
..+.||+|+||+||+|+++.+ +.||||++..... ..+|+.+|+.+ +|||||++++++.+ +..|+|||||++|+
T Consensus 21 i~~~iG~G~fg~Vy~~~~~~~-~~vAiK~l~~~~~~~~~~~~E~~~l~~l-~h~nIv~~~g~~~~-~~~~lv~Ey~~~g~ 97 (285)
T d1fmka3 21 LEVKLGQGCFGEVWMGTWNGT-TRVAIKTLKPGTMSPEAFLQEAQVMKKL-RHEKLVQLYAVVSE-EPIYIVTEYMSKGS 97 (285)
T ss_dssp EEEEEEECSSCEEEEEEETTT-EEEEEEECCTTSSCHHHHHHHHHHHHHC-CCTTBCCEEEEECS-SSCEEEECCCTTCB
T ss_pred EeeEEeeCCCeEEEEEEECCC-CEEEEEEECcccCCHHHHHHHHHHHHhc-ccCCEeEEEEEEec-CCeEEEEEecCCCc
Confidence 367899999999999999765 5799999975432 56799999998 59999999999855 56799999999999
Q ss_pred HHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCcEEEecCCCCCEEEEeecccccccCC----Ccccc
Q psy11767 458 LLDRIRQKGRCGFTENEASRIMRQLVAAVHFMHSRGVVHRDLKPENLLFSDPAGDNIKVVDFGFACLKRES----LHTPC 533 (966)
Q Consensus 458 L~~~l~~~~~~~l~e~~~~~i~~Qil~aL~yLHs~~IiHRDLKP~NILl~~~~~~~iKL~DFGla~~~~~~----~~~~~ 533 (966)
|..++.......+++.+++.|+.||+.||+|||++||+||||||+||||++ ++.+||+|||+|+..... .....
T Consensus 98 l~~~~~~~~~~~l~~~~~~~i~~~i~~gl~~LH~~~ivH~DlKp~NIll~~--~~~~kl~DfGla~~~~~~~~~~~~~~~ 175 (285)
T d1fmka3 98 LLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGE--NLVCKVADFGLARLIEDNEYTARQGAK 175 (285)
T ss_dssp HHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECG--GGCEEECCCCTTC--------------
T ss_pred hhhhhhhcccccchHHHHHHHHHHHHHHHHHHhhhheecccccceEEEECC--CCcEEEcccchhhhccCCCceeecccc
Confidence 999987654446999999999999999999999999999999999999985 568999999999765322 23456
Q ss_pred ccccccCchhhccCCCCCCCcccchhhhhhhhhhhhcCCCCCCCcCcchhHHHHHHHHhcCCCCCCCCCCchhHHHHHHH
Q psy11767 534 FTLQYAAPEVLRQDKSGYDENCDLWSLGVILVNVLRQDKSGYDENCDLWSLGVILYTMLCGRVPFHARSRDDSALSIMAR 613 (966)
Q Consensus 534 gT~~Y~APEvl~~~~~~~~~~~Di~SlGvil~el~~~~~~~y~~~~DIWSlGvilyemltG~~Pf~~~~~~~~~~~~~~~ 613 (966)
+|+.|+|||++... .|+.++|||||||++|||++|..||...... ..++..
T Consensus 176 gt~~y~aPE~~~~~--------------------------~~~~ksDI~S~Giil~el~t~~~p~~~~~~~---~~~~~~ 226 (285)
T d1fmka3 176 FPIKWTAPEAALYG--------------------------RFTIKSDVWSFGILLTELTTKGRVPYPGMVN---REVLDQ 226 (285)
T ss_dssp CCGGGSCHHHHHHC--------------------------CCCHHHHHHHHHHHHHHHHTTTCCSSTTCCH---HHHHHH
T ss_pred ccccccChHHHhCC--------------------------CCCcHHhhhcchHHHHHHHhCCCCCCCCCCH---HHHHHH
Confidence 89999999998632 3788999999999999999976555443332 234555
Q ss_pred HHcCCCCCCchhhccCCHHHHHHHHHhcccCccccCChHHHHHHhhhhH
Q psy11767 614 IKEGQFNFDAEAWSTVSSEAKELTKSLLTVNPAQRIRMMRVKLTFHAFH 662 (966)
Q Consensus 614 i~~~~~~~~~~~~~~is~e~~~Li~~~L~~dP~~R~t~~~v~~~~~~~~ 662 (966)
+..+... +.+..+++++++||.+||+.||++||++.++...++.++
T Consensus 227 i~~~~~~---~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~~~ 272 (285)
T d1fmka3 227 VERGYRM---PCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYF 272 (285)
T ss_dssp HHTTCCC---CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTTT
T ss_pred HHhcCCC---CCCcccCHHHHHHHHHHcccCHhHCcCHHHHHHHHhhhh
Confidence 6554322 234578999999999999999999999999876666554
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.8e-45 Score=405.68 Aligned_cols=241 Identities=19% Similarity=0.353 Sum_probs=194.3
Q ss_pred ccccccccccccccEEEEEEEcCCCc----EEEEEEecccc------ChHHHHHHHHHhcCCCCceEEEEEEEeCCeEEE
Q psy11767 379 DLDKAGILGDGSYSVCRRCVEKSTGQ----EYAVKIISRKI------DCSEEINLLRACQGHPNIVNLHCVFQDEVHTYL 448 (966)
Q Consensus 379 ~~~~~~~LG~G~fG~Vy~a~~~~tg~----~vAvK~i~~~~------~~~~Ei~iL~~l~~HpnIV~l~~~~~~~~~~~l 448 (966)
||+.+++||+|+||+||+|.+..+|+ .||+|.+.... ...+|+++|+.+ +|||||++++++.++ ..++
T Consensus 10 dy~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~HpnIv~l~g~~~~~-~~~~ 87 (317)
T d1xkka_ 10 EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV-DNPHVCRLLGICLTS-TVQL 87 (317)
T ss_dssp TEEEEEEEEECSSEEEEEEEECC----CCEEEEEEEECC----CTHHHHHHHHHHHHHC-CCTTBCCEEEEEESS-SEEE
T ss_pred HCEEeeEEecCCCeEEEEEEEcCCCCEEEEEEEEEEeccccCHHHHHHHHHHHHHHHhC-CCCCEeeEEEEEecC-CeeE
Confidence 46668999999999999999998887 57888875432 246799999998 599999999999875 5788
Q ss_pred EEEccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCcEEEecCCCCCEEEEeecccccccCC
Q psy11767 449 VLELLKGGELLDRIRQKGRCGFTENEASRIMRQLVAAVHFMHSRGVVHRDLKPENLLFSDPAGDNIKVVDFGFACLKRES 528 (966)
Q Consensus 449 VmEy~~gg~L~~~l~~~~~~~l~e~~~~~i~~Qil~aL~yLHs~~IiHRDLKP~NILl~~~~~~~iKL~DFGla~~~~~~ 528 (966)
+|||+.+|+|.+++..... .+++..++.|+.||+.||+|||++|||||||||+|||++. ++.+||+|||+|+.....
T Consensus 88 v~e~~~~~~l~~~~~~~~~-~~~~~~~~~i~~qi~~gl~yLH~~~iiHrDlKp~NIll~~--~~~~kl~DFGla~~~~~~ 164 (317)
T d1xkka_ 88 ITQLMPFGCLLDYVREHKD-NIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKT--PQHVKITDFGLAKLLGAE 164 (317)
T ss_dssp EEECCTTCBHHHHHHHTSS-SCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEE--TTEEEECCCSHHHHTTTT
T ss_pred EEEeccCCccccccccccc-CCCHHHHHHHHHHHHHHHHHHHHcCcccCcchhhcceeCC--CCCeEeeccccceecccc
Confidence 8999999999999877643 6999999999999999999999999999999999999985 569999999999765321
Q ss_pred -----CccccccccccCchhhccCCCCCCCcccchhhhhhhhhhhhcCCCCCCCcCcchhHHHHHHHHhc-CCCCCCCCC
Q psy11767 529 -----LHTPCFTLQYAAPEVLRQDKSGYDENCDLWSLGVILVNVLRQDKSGYDENCDLWSLGVILYTMLC-GRVPFHARS 602 (966)
Q Consensus 529 -----~~~~~gT~~Y~APEvl~~~~~~~~~~~Di~SlGvil~el~~~~~~~y~~~~DIWSlGvilyemlt-G~~Pf~~~~ 602 (966)
.....||+.|||||++..+ .|+.++|||||||++|||+| |.+||.+.+
T Consensus 165 ~~~~~~~~~~gt~~y~APE~l~~~--------------------------~~~~~sDvwS~Gvil~el~t~g~~p~~~~~ 218 (317)
T d1xkka_ 165 EKEYHAEGGKVPIKWMALESILHR--------------------------IYTHQSDVWSYGVTVWELMTFGSKPYDGIP 218 (317)
T ss_dssp CC--------CCTTTSCHHHHHHC--------------------------CCCHHHHHHHHHHHHHHHHTTSCCTTTTSC
T ss_pred cccccccccccCccccChHHHhcC--------------------------CCChhhhhhhHHHHHHHHHHCCCCCCCCCC
Confidence 2234579999999998632 37889999999999999998 899998765
Q ss_pred CchhHHHHHHHHHcCCCCCCchhhccCCHHHHHHHHHhcccCccccCChHHHHHH
Q psy11767 603 RDDSALSIMARIKEGQFNFDAEAWSTVSSEAKELTKSLLTVNPAQRIRMMRVKLT 657 (966)
Q Consensus 603 ~~~~~~~~~~~i~~~~~~~~~~~~~~is~e~~~Li~~~L~~dP~~R~t~~~v~~~ 657 (966)
..+ +...+..+.... .+..+++++.+||.+||..||++|||+.++...
T Consensus 219 ~~~----~~~~i~~~~~~~---~p~~~~~~~~~li~~cl~~dP~~RPs~~eil~~ 266 (317)
T d1xkka_ 219 ASE----ISSILEKGERLP---QPPICTIDVYMIMVKCWMIDADSRPKFRELIIE 266 (317)
T ss_dssp GGG----HHHHHHHTCCCC---CCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHH----HHHHHHcCCCCC---CCcccCHHHHHHHHHhCCCChhhCcCHHHHHHH
Confidence 443 344455554322 224689999999999999999999999987543
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.3e-45 Score=398.69 Aligned_cols=240 Identities=25% Similarity=0.444 Sum_probs=191.6
Q ss_pred ccccccccccccEEEEEEEcCCCcEEEEEEeccccC---hHHHHHHHHHhcCCCCceEEEEEEEe-CCeEEEEEEccCCC
Q psy11767 381 DKAGILGDGSYSVCRRCVEKSTGQEYAVKIISRKID---CSEEINLLRACQGHPNIVNLHCVFQD-EVHTYLVLELLKGG 456 (966)
Q Consensus 381 ~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~~---~~~Ei~iL~~l~~HpnIV~l~~~~~~-~~~~~lVmEy~~gg 456 (966)
+..+.||+|+||.||+|++. |..||||+++.... ..+|+++|+.+ +|||||++++++.+ ++.+|+||||+++|
T Consensus 10 ~~~~~lG~G~fg~Vy~~~~~--~~~vAvK~i~~~~~~~~~~~E~~~l~~l-~HpnIv~~~g~~~~~~~~~~lv~ey~~~g 86 (262)
T d1byga_ 10 KLLQTIGKGEFGDVMLGDYR--GNKVAVKCIKNDATAQAFLAEASVMTQL-RHSNLVQLLGVIVEEKGGLYIVTEYMAKG 86 (262)
T ss_dssp EEEEEEEECSSCEEEEEEET--TEEEEEEECCCCC--HHHHHTHHHHTTC-CCTTBCCEEEEECCC--CCEEEECCCTTE
T ss_pred EEeEEEecCCCeEEEEEEEC--CeEEEEEEECcHHHHHHHHHHHHHHHhC-CCCCEeeEEEEEEecCCcEEEEEeccCCC
Confidence 34678999999999999984 78999999976533 45799999998 59999999999854 46689999999999
Q ss_pred CHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCcEEEecCCCCCEEEEeecccccccCCCccccccc
Q psy11767 457 ELLDRIRQKGRCGFTENEASRIMRQLVAAVHFMHSRGVVHRDLKPENLLFSDPAGDNIKVVDFGFACLKRESLHTPCFTL 536 (966)
Q Consensus 457 ~L~~~l~~~~~~~l~e~~~~~i~~Qil~aL~yLHs~~IiHRDLKP~NILl~~~~~~~iKL~DFGla~~~~~~~~~~~gT~ 536 (966)
+|.++|.+.....+++..++.++.||+.||+|||+++|+||||||+|||++. ++.+||+|||+++..........+|+
T Consensus 87 ~L~~~l~~~~~~~l~~~~~~~i~~~i~~al~ylH~~~ivH~dlkp~Nil~~~--~~~~kl~dfg~s~~~~~~~~~~~~~~ 164 (262)
T d1byga_ 87 SLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVSE--DNVAKVSDFGLTKEASSTQDTGKLPV 164 (262)
T ss_dssp EHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECT--TSCEEECCCCC------------CCT
T ss_pred CHHHHHHhcCCCCCCHHHHHHHHHHHHhhccccccCceeccccchHhheecC--CCCEeecccccceecCCCCccccccc
Confidence 9999997765445899999999999999999999999999999999999985 56899999999987666666677899
Q ss_pred cccCchhhccCCCCCCCcccchhhhhhhhhhhhcCCCCCCCcCcchhHHHHHHHHhc-CCCCCCCCCCchhHHHHHHHHH
Q psy11767 537 QYAAPEVLRQDKSGYDENCDLWSLGVILVNVLRQDKSGYDENCDLWSLGVILYTMLC-GRVPFHARSRDDSALSIMARIK 615 (966)
Q Consensus 537 ~Y~APEvl~~~~~~~~~~~Di~SlGvil~el~~~~~~~y~~~~DIWSlGvilyemlt-G~~Pf~~~~~~~~~~~~~~~i~ 615 (966)
.|+|||++... .|+.++|||||||++|||++ |++||...+..+ +...+.
T Consensus 165 ~y~aPE~l~~~--------------------------~~t~~sDIwSfG~il~el~t~~~~p~~~~~~~~----~~~~i~ 214 (262)
T d1byga_ 165 KWTAPEALREK--------------------------KFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKD----VVPRVE 214 (262)
T ss_dssp TTSCHHHHHHC--------------------------CCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGGG----HHHHHT
T ss_pred cCCChHHHhCC--------------------------CCChHHHHHhHHHHHHHHHHCCCCCCCCCCHHH----HHHHHH
Confidence 99999998532 37889999999999999998 789988765443 344555
Q ss_pred cCCCCCCchhhccCCHHHHHHHHHhcccCccccCChHHHHHHh
Q psy11767 616 EGQFNFDAEAWSTVSSEAKELTKSLLTVNPAQRIRMMRVKLTF 658 (966)
Q Consensus 616 ~~~~~~~~~~~~~is~e~~~Li~~~L~~dP~~R~t~~~v~~~~ 658 (966)
.+.. ++....+++++.+||.+||..||++|||+.++...+
T Consensus 215 ~~~~---~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~L 254 (262)
T d1byga_ 215 KGYK---MDAPDGCPPAVYEVMKNCWHLDAAMRPSFLQLREQL 254 (262)
T ss_dssp TTCC---CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred cCCC---CCCCccCCHHHHHHHHHHcccCHhHCcCHHHHHHHH
Confidence 5432 223346889999999999999999999999885544
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.8e-45 Score=404.52 Aligned_cols=250 Identities=31% Similarity=0.542 Sum_probs=207.2
Q ss_pred cccccccccccccEEEEEEEc---CCCcEEEEEEecccc---------ChHHHHHHHHHhcCCCCceEEEEEEEeCCeEE
Q psy11767 380 LDKAGILGDGSYSVCRRCVEK---STGQEYAVKIISRKI---------DCSEEINLLRACQGHPNIVNLHCVFQDEVHTY 447 (966)
Q Consensus 380 ~~~~~~LG~G~fG~Vy~a~~~---~tg~~vAvK~i~~~~---------~~~~Ei~iL~~l~~HpnIV~l~~~~~~~~~~~ 447 (966)
|+.++.||+|+||+||+|++. .+|+.||||++++.. ...+|+++|+++.+||||+++++++++....|
T Consensus 26 y~~~~~IG~G~fg~Vy~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~~E~~il~~l~h~pnIv~~~~~~~~~~~~~ 105 (322)
T d1vzoa_ 26 FELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTETKLH 105 (322)
T ss_dssp EEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETTEEE
T ss_pred eEEEEEEecCCCeEEEEEEECccCCCCcEEEEEEEehHHhccchHHHHHHHHHHHHHHhccCCCeEEEeeeeeccCCcee
Confidence 444789999999999999984 479999999986431 24479999999986799999999999999999
Q ss_pred EEEEccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCcEEEecCCCCCEEEEeecccccccC
Q psy11767 448 LVLELLKGGELLDRIRQKGRCGFTENEASRIMRQLVAAVHFMHSRGVVHRDLKPENLLFSDPAGDNIKVVDFGFACLKRE 527 (966)
Q Consensus 448 lVmEy~~gg~L~~~l~~~~~~~l~e~~~~~i~~Qil~aL~yLHs~~IiHRDLKP~NILl~~~~~~~iKL~DFGla~~~~~ 527 (966)
+|||||.||+|.+++...+ .+++..++.++.||+.||+|||++||+||||||+|||++. .+.+||+|||+|+....
T Consensus 106 ~v~e~~~~~~L~~~i~~~~--~~~e~~~~~~~~Qi~~al~~lH~~~ivHrDiKp~Nill~~--~~~vkL~DFG~a~~~~~ 181 (322)
T d1vzoa_ 106 LILDYINGGELFTHLSQRE--RFTEHEVQIYVGEIVLALEHLHKLGIIYRDIKLENILLDS--NGHVVLTDFGLSKEFVA 181 (322)
T ss_dssp EEECCCCSCBHHHHHHHHS--CCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECT--TSCEEESCSSEEEECCG
T ss_pred eeeecccccHHHHHHHhcc--cccHHHHHHHHHHHHHHHHHhhcCCEEeccCCccceeecC--CCCEEEeeccchhhhcc
Confidence 9999999999999998876 5889999999999999999999999999999999999985 56999999999976432
Q ss_pred ----CCccccccccccCchhhccCCCCCCCcccchhhhhhhhhhhhcCCCCCCCcCcchhHHHHHHHHhcCCCCCCCCCC
Q psy11767 528 ----SLHTPCFTLQYAAPEVLRQDKSGYDENCDLWSLGVILVNVLRQDKSGYDENCDLWSLGVILYTMLCGRVPFHARSR 603 (966)
Q Consensus 528 ----~~~~~~gT~~Y~APEvl~~~~~~~~~~~Di~SlGvil~el~~~~~~~y~~~~DIWSlGvilyemltG~~Pf~~~~~ 603 (966)
...+..||+.|+|||.+... ...|+.++|||||||+||+|++|+.||.+.+.
T Consensus 182 ~~~~~~~~~~g~~~~~~pe~~~~~------------------------~~~~~~ksDIWSlG~iLyelltG~~PF~~~~~ 237 (322)
T d1vzoa_ 182 DETERAYDFCGTIEYMAPDIVRGG------------------------DSGHDKAVDWWSLGVLMYELLTGASPFTVDGE 237 (322)
T ss_dssp GGGGGGCGGGSCCTTCCHHHHTTC------------------------C---CTHHHHHHHHHHHHHHHHSSCTTSCTTS
T ss_pred cccccccccccccccchhHHhhcC------------------------CcCCCchhhhHHHHHHHHHHHhCCCCCCCCCH
Confidence 23456789999999998632 23467899999999999999999999998876
Q ss_pred chhHHHHHHHHHcCCCCCCchhhccCCHHHHHHHHHhcccCccccCC-----hHHHHHHhhhhHH
Q psy11767 604 DDSALSIMARIKEGQFNFDAEAWSTVSSEAKELTKSLLTVNPAQRIR-----MMRVKLTFHAFHQ 663 (966)
Q Consensus 604 ~~~~~~~~~~i~~~~~~~~~~~~~~is~e~~~Li~~~L~~dP~~R~t-----~~~v~~~~~~~~~ 663 (966)
.+....+..........+ +..+|+++.+||.+||.+||++||| +.++ ..|+|++
T Consensus 238 ~~~~~~i~~~~~~~~~~~----~~~~s~~~~~li~~~l~~dP~~R~s~~~~t~~ei--l~Hpff~ 296 (322)
T d1vzoa_ 238 KNSQAEISRRILKSEPPY----PQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEI--KEHLFFQ 296 (322)
T ss_dssp CCCHHHHHHHHHHCCCCC----CTTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHH--HTSGGGT
T ss_pred HHHHHHHHHhcccCCCCC----cccCCHHHHHHHHHHcccCHHHcCCCCcccHHHH--HcCHhhc
Confidence 665555555554544433 3468999999999999999999996 4444 5677763
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.2e-45 Score=409.92 Aligned_cols=249 Identities=27% Similarity=0.450 Sum_probs=194.0
Q ss_pred ccccccccccccEEEEEEEcCCCcEEEEEEeccccC------hHHHHHHHHHhcCCCCceEEEEEEEeCC-----eEEEE
Q psy11767 381 DKAGILGDGSYSVCRRCVEKSTGQEYAVKIISRKID------CSEEINLLRACQGHPNIVNLHCVFQDEV-----HTYLV 449 (966)
Q Consensus 381 ~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~~------~~~Ei~iL~~l~~HpnIV~l~~~~~~~~-----~~~lV 449 (966)
+.++.||+|+||+||+|++..+|+.||||++..... ..+|+.+|+.+ +|||||++++++..+. +.|++
T Consensus 11 ~~~~~LG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l-~hp~iv~~~~~~~~~~~~~~~~~~l~ 89 (345)
T d1pmea_ 11 TNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRF-RHENIIGINDIIRAPTIEQMKDVYLV 89 (345)
T ss_dssp EEEEECC---CCCEEEEEETTTCSEEEEEEECCTTCHHHHHHHHHHHHHHHHC-CCTTBCCCCEEECCSSTTTCCCEEEE
T ss_pred EEEEEEeeccCeEEEEEEECCCCcEEEEEEEehhcChHHHHHHHHHHHHHHHc-CCCCCCcEEEEEeeccccccceEEEE
Confidence 347899999999999999999999999999975432 35799999998 5999999999997653 34555
Q ss_pred EEccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCcEEEecCCCCCEEEEeecccccccC--
Q psy11767 450 LELLKGGELLDRIRQKGRCGFTENEASRIMRQLVAAVHFMHSRGVVHRDLKPENLLFSDPAGDNIKVVDFGFACLKRE-- 527 (966)
Q Consensus 450 mEy~~gg~L~~~l~~~~~~~l~e~~~~~i~~Qil~aL~yLHs~~IiHRDLKP~NILl~~~~~~~iKL~DFGla~~~~~-- 527 (966)
+|+.||+|.+++... .+++.+++.++.||+.||+|||++|||||||||+|||+++ .+.+||+|||+|+....
T Consensus 90 -~~~~~g~L~~~l~~~---~l~~~~i~~i~~qil~al~yLH~~~iiHRDIKp~NILl~~--~~~~kl~DfG~a~~~~~~~ 163 (345)
T d1pmea_ 90 -THLMGADLYKLLKTQ---HLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNT--TCDLKICDFGLARVADPDH 163 (345)
T ss_dssp -EECCCEEHHHHHHHC---CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECT--TCCEEECCCTTCEECCGGG
T ss_pred -EeecCCchhhhhhcC---CCCHHHHHHHHHHHHHHHHHHHHCCCcCCCCCcceEEECC--CCCEEEcccCceeeccCCC
Confidence 556699999999764 5999999999999999999999999999999999999985 56999999999975432
Q ss_pred ----CCccccccccccCchhhccCCCCCCCcccchhhhhhhhhhhhcCCCCCCCcCcchhHHHHHHHHhcCCCCCCCCCC
Q psy11767 528 ----SLHTPCFTLQYAAPEVLRQDKSGYDENCDLWSLGVILVNVLRQDKSGYDENCDLWSLGVILYTMLCGRVPFHARSR 603 (966)
Q Consensus 528 ----~~~~~~gT~~Y~APEvl~~~~~~~~~~~Di~SlGvil~el~~~~~~~y~~~~DIWSlGvilyemltG~~Pf~~~~~ 603 (966)
.....+||+.|+|||++.. ...|+.++||||+||++|+|++|+.||.+.+.
T Consensus 164 ~~~~~~~~~~gt~~y~aPE~l~~-------------------------~~~~~~~~DiwSlG~il~eml~g~~pf~~~~~ 218 (345)
T d1pmea_ 164 DHTGFLTEYVATRWYRAPEIMLN-------------------------SKGYTKSIDIWSVGCILAEMLSNRPIFPGKHY 218 (345)
T ss_dssp CBCCTTCCCCSCGGGCCGGGTTT-------------------------BCSCSTHHHHHHHHHHHHHHHHSSCSCCCSSH
T ss_pred ccceeeccccccceechHHHhhc-------------------------CCCCCchhhhhccCceehHHhhCCCCCCCCCH
Confidence 2345678999999999853 23478899999999999999999999987654
Q ss_pred chhHHHHHHHHHcC-----------------------CCCCCchhhccCCHHHHHHHHHhcccCccccCChHHHHHHhhh
Q psy11767 604 DDSALSIMARIKEG-----------------------QFNFDAEAWSTVSSEAKELTKSLLTVNPAQRIRMMRVKLTFHA 660 (966)
Q Consensus 604 ~~~~~~~~~~i~~~-----------------------~~~~~~~~~~~is~e~~~Li~~~L~~dP~~R~t~~~v~~~~~~ 660 (966)
.+............ ........++.+|+++++||.+||+.||++|||+.++ ..|+
T Consensus 219 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~ta~e~--L~hp 296 (345)
T d1pmea_ 219 LDQLNHILGILGSPSQEDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQA--LAHP 296 (345)
T ss_dssp HHHHHHHHHHHCSCCHHHHHTCCCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSTTTSCCHHHH--HTSG
T ss_pred HHHHHHHhhhccCCChhhhhhhhhhhhhcccccCCccCCCCHHHhCCCCCHHHHHHHHHHccCChhHCcCHHHH--hcCH
Confidence 33322221111000 0000112345789999999999999999999999977 4567
Q ss_pred hHH
Q psy11767 661 FHQ 663 (966)
Q Consensus 661 ~~~ 663 (966)
|.+
T Consensus 297 f~~ 299 (345)
T d1pmea_ 297 YLE 299 (345)
T ss_dssp GGT
T ss_pred hhc
Confidence 653
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.1e-45 Score=402.02 Aligned_cols=242 Identities=21% Similarity=0.379 Sum_probs=198.1
Q ss_pred cccccccccccEEEEEEEcCCCcE--EEEEEecccc------ChHHHHHHHHHhcCCCCceEEEEEEEeCCeEEEEEEcc
Q psy11767 382 KAGILGDGSYSVCRRCVEKSTGQE--YAVKIISRKI------DCSEEINLLRACQGHPNIVNLHCVFQDEVHTYLVLELL 453 (966)
Q Consensus 382 ~~~~LG~G~fG~Vy~a~~~~tg~~--vAvK~i~~~~------~~~~Ei~iL~~l~~HpnIV~l~~~~~~~~~~~lVmEy~ 453 (966)
..++||+|+||+||+|+++.+|.. ||||.+.... ...+|+++|..+.+|||||++++++.+++..|+|||||
T Consensus 14 ~~~~iG~G~fg~Vy~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~iV~ey~ 93 (309)
T d1fvra_ 14 FQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYA 93 (309)
T ss_dssp EEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEEEEEECCC
T ss_pred EEEEEeeCCCcEEEEEEECCCCeEEEEEEEEECcccChHHHHHHHHHHHHHHhccCCCCEeeEEEEEecCCeeEEEEEec
Confidence 357899999999999999998875 6777775322 25689999999867999999999999999999999999
Q ss_pred CCCCHHHHHHhcC--------------CCCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCcEEEecCCCCCEEEEee
Q psy11767 454 KGGELLDRIRQKG--------------RCGFTENEASRIMRQLVAAVHFMHSRGVVHRDLKPENLLFSDPAGDNIKVVDF 519 (966)
Q Consensus 454 ~gg~L~~~l~~~~--------------~~~l~e~~~~~i~~Qil~aL~yLHs~~IiHRDLKP~NILl~~~~~~~iKL~DF 519 (966)
+||+|.++|.... ...|++.++..++.||+.||.|||+++|+||||||+|||++. .+.+||+||
T Consensus 94 ~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~~lH~~~iiHrDlkp~NIL~~~--~~~~kl~Df 171 (309)
T d1fvra_ 94 PHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGE--NYVAKIADF 171 (309)
T ss_dssp TTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECG--GGCEEECCT
T ss_pred CCCcHHHHHhhccccccchhhhccccccCCCCHHHHHHHHHHHHHHHHhhhcCCccccccccceEEEcC--CCceEEccc
Confidence 9999999997541 246999999999999999999999999999999999999985 568999999
Q ss_pred cccccccCC--CccccccccccCchhhccCCCCCCCcccchhhhhhhhhhhhcCCCCCCCcCcchhHHHHHHHHhcCC-C
Q psy11767 520 GFACLKRES--LHTPCFTLQYAAPEVLRQDKSGYDENCDLWSLGVILVNVLRQDKSGYDENCDLWSLGVILYTMLCGR-V 596 (966)
Q Consensus 520 Gla~~~~~~--~~~~~gT~~Y~APEvl~~~~~~~~~~~Di~SlGvil~el~~~~~~~y~~~~DIWSlGvilyemltG~-~ 596 (966)
|+|+..... ....+||+.|+|||.+.. ..|+.++|||||||++|||++|. +
T Consensus 172 G~a~~~~~~~~~~~~~gt~~y~aPE~l~~--------------------------~~~~~~sDvwSfGvil~ell~~~~~ 225 (309)
T d1fvra_ 172 GLSRGQEVYVKKTMGRLPVRWMAIESLNY--------------------------SVYTTNSDVWSYGVLLWEIVSLGGT 225 (309)
T ss_dssp TCEESSCEECCC----CCTTTCCHHHHHH--------------------------CEECHHHHHHHHHHHHHHHHTTSCC
T ss_pred cccccccccccccceecCCcccchHHhcc--------------------------CCCCccceeehhHHHHHHHHhcCCC
Confidence 999765432 234568999999999863 23788999999999999999975 5
Q ss_pred CCCCCCCchhHHHHHHHHHcCCCCCCchhhccCCHHHHHHHHHhcccCccccCChHHHHHHh
Q psy11767 597 PFHARSRDDSALSIMARIKEGQFNFDAEAWSTVSSEAKELTKSLLTVNPAQRIRMMRVKLTF 658 (966)
Q Consensus 597 Pf~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~is~e~~~Li~~~L~~dP~~R~t~~~v~~~~ 658 (966)
||.+.+. ..++..+.++.. .+.+..+++++++||.+||..||++|||+.++...+
T Consensus 226 p~~~~~~----~~~~~~i~~~~~---~~~~~~~~~~~~~li~~cl~~dP~~RPs~~eil~~L 280 (309)
T d1fvra_ 226 PYCGMTC----AELYEKLPQGYR---LEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSL 280 (309)
T ss_dssp TTTTCCH----HHHHHHGGGTCC---CCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred CCCCCCH----HHHHHHHHhcCC---CCCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHHH
Confidence 6765543 244556665532 233457899999999999999999999999985443
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.3e-45 Score=402.83 Aligned_cols=246 Identities=26% Similarity=0.402 Sum_probs=191.8
Q ss_pred cccccccccccEEEEEEEcCCCcEEEEEEecccc-------ChHHHHHHHHHhcCCCCceEEEEEEEe--------CCeE
Q psy11767 382 KAGILGDGSYSVCRRCVEKSTGQEYAVKIISRKI-------DCSEEINLLRACQGHPNIVNLHCVFQD--------EVHT 446 (966)
Q Consensus 382 ~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~-------~~~~Ei~iL~~l~~HpnIV~l~~~~~~--------~~~~ 446 (966)
.++.||+|+||+||+|++..+|+.||||++.... ...+|+++|+.+ +||||+++++++.. +++.
T Consensus 14 i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l-~h~nii~~~~~~~~~~~~~~~~~~~~ 92 (318)
T d3blha1 14 KLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLL-KHENVVNLIEICRTKASPYNRCKGSI 92 (318)
T ss_dssp EEEEEEECSSSEEEEEEETTTCCEEEEEEC----CTTSSCHHHHHHHHHHHHC-CCTTBCCEEEEEEC----------CE
T ss_pred EEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHHh-cCCCccceEeeeecccccccccCceE
Confidence 3789999999999999999999999999985432 145899999998 59999999999865 4568
Q ss_pred EEEEEccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCcEEEecCCCCCEEEEeeccccccc
Q psy11767 447 YLVLELLKGGELLDRIRQKGRCGFTENEASRIMRQLVAAVHFMHSRGVVHRDLKPENLLFSDPAGDNIKVVDFGFACLKR 526 (966)
Q Consensus 447 ~lVmEy~~gg~L~~~l~~~~~~~l~e~~~~~i~~Qil~aL~yLHs~~IiHRDLKP~NILl~~~~~~~iKL~DFGla~~~~ 526 (966)
|+|||||.++.+.... .. ...+++..++.++.||+.||+|||++||+||||||+|||++. ++.+||+|||+|+...
T Consensus 93 ~iv~e~~~~~~~~~~~-~~-~~~~~~~~~~~i~~qil~~l~~lH~~~ivHrDlKp~NILl~~--~~~~kl~dfg~~~~~~ 168 (318)
T d3blha1 93 YLVFDFCEHDLAGLLS-NV-LVKFTLSEIKRVMQMLLNGLYYIHRNKILHRDMKAANVLITR--DGVLKLADFGLARAFS 168 (318)
T ss_dssp EEEEECCCEEHHHHHT-CT-TCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECT--TSCEEECCCTTCEECC
T ss_pred EEEEeccCCCccchhh-hc-ccccccHHHHHHHHHHHHHHHHhccCCEEecCcCchheeecC--CCcEEeeecceeeecc
Confidence 9999999776554433 32 336999999999999999999999999999999999999975 5689999999996543
Q ss_pred C-------CCccccccccccCchhhccCCCCCCCcccchhhhhhhhhhhhcCCCCCCCcCcchhHHHHHHHHhcCCCCCC
Q psy11767 527 E-------SLHTPCFTLQYAAPEVLRQDKSGYDENCDLWSLGVILVNVLRQDKSGYDENCDLWSLGVILYTMLCGRVPFH 599 (966)
Q Consensus 527 ~-------~~~~~~gT~~Y~APEvl~~~~~~~~~~~Di~SlGvil~el~~~~~~~y~~~~DIWSlGvilyemltG~~Pf~ 599 (966)
. ...+.+||+.|+|||++.. ...|+.++||||+||++|||++|++||.
T Consensus 169 ~~~~~~~~~~~~~~gT~~Y~aPE~~~~-------------------------~~~~~~k~DiwSlGvil~el~~g~~pf~ 223 (318)
T d3blha1 169 LAKNSQPNRYTNRVVTLWYRPPELLLG-------------------------ERDYGPPIDLWGAGCIMAEMWTRSPIMQ 223 (318)
T ss_dssp C-----CCCCCSCCSCGGGCCHHHHTT-------------------------CSSCCTHHHHHHHHHHHHHHHHSSCSCC
T ss_pred cccccccccccceecCHHHhhHHHHcC-------------------------CCCCCcHHHcccCCceeeeHhhCCCCCC
Confidence 2 2334679999999999853 2347899999999999999999999998
Q ss_pred CCCCchhHHHHHHHHHcCCCCCCchhh----------------------------ccCCHHHHHHHHHhcccCccccCCh
Q psy11767 600 ARSRDDSALSIMARIKEGQFNFDAEAW----------------------------STVSSEAKELTKSLLTVNPAQRIRM 651 (966)
Q Consensus 600 ~~~~~~~~~~~~~~i~~~~~~~~~~~~----------------------------~~is~e~~~Li~~~L~~dP~~R~t~ 651 (966)
+.+..+... .+.++.. .+ ..+.+ ...+++++|||.+||+.||++|||+
T Consensus 224 ~~~~~~~~~-~i~~~~~-~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~sa 299 (318)
T d3blha1 224 GNTEQHQLA-LISQLCG-SI--TPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDS 299 (318)
T ss_dssp CSSHHHHHH-HHHHHHC-CC--CTTTSTTCCCC-------CCSSCCBCHHHHHHHHHCCHHHHHHHHHHSCSSTTTSCCH
T ss_pred CCCHHHHHH-HHHHhcC-CC--ChhhccccchhhhhhhhcccccccccchhhhccccCCHHHHHHHHHHCcCChhHCcCH
Confidence 765433222 2222221 11 10000 1247889999999999999999999
Q ss_pred HHHHHHhhhhHH
Q psy11767 652 MRVKLTFHAFHQ 663 (966)
Q Consensus 652 ~~v~~~~~~~~~ 663 (966)
.++ ..|+|++
T Consensus 300 ~el--L~Hpff~ 309 (318)
T d3blha1 300 DDA--LNHDFFW 309 (318)
T ss_dssp HHH--HHSGGGS
T ss_pred HHH--HcChhhc
Confidence 976 4678864
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=3.8e-44 Score=393.74 Aligned_cols=249 Identities=22% Similarity=0.286 Sum_probs=196.3
Q ss_pred ccccccccccEEEEEEEcCCCcEEEEEEeccc---cChHHHHHHHHHhcCCCCceEEEEEEEeCCeEEEEEEccCCCCHH
Q psy11767 383 AGILGDGSYSVCRRCVEKSTGQEYAVKIISRK---IDCSEEINLLRACQGHPNIVNLHCVFQDEVHTYLVLELLKGGELL 459 (966)
Q Consensus 383 ~~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~---~~~~~Ei~iL~~l~~HpnIV~l~~~~~~~~~~~lVmEy~~gg~L~ 459 (966)
.+.||+|+||+||+|++..+|+.||||++... .....|+++|+.+.+|++|+.+.+++.++...++||||| +++|.
T Consensus 12 ~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~~~~~~E~~i~~~l~~~~~i~~~~~~~~~~~~~~ivme~~-~~~l~ 90 (299)
T d1ckia_ 12 GRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMELL-GPSLE 90 (299)
T ss_dssp EEEEEECSSSEEEEEEETTTTEEEEEEEEESCTTSCCHHHHHHHHHHSTTSTTCCCEEEEEEETTEEEEEEECC-CCBHH
T ss_pred eEEEeeCCCcEEEEEEECCCCCEEEEEEEchhccCHHHHHHHHHHHHccCCCcccEEEEEEecCCEEEEEEEEc-CCchh
Confidence 67899999999999999999999999998653 246679999999976677788888889999999999999 67777
Q ss_pred HHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCcEEEecC-CCCCEEEEeecccccccCC----------
Q psy11767 460 DRIRQKGRCGFTENEASRIMRQLVAAVHFMHSRGVVHRDLKPENLLFSDP-AGDNIKVVDFGFACLKRES---------- 528 (966)
Q Consensus 460 ~~l~~~~~~~l~e~~~~~i~~Qil~aL~yLHs~~IiHRDLKP~NILl~~~-~~~~iKL~DFGla~~~~~~---------- 528 (966)
+.+..... .+++.++..++.|++.||+|||++|||||||||+|||++.. .+..+||+|||+|+.....
T Consensus 91 ~~~~~~~~-~~~~~~~~~~~~qi~~~l~~lH~~~iiHrDiKp~NIl~~~~~~~~~vkl~DFG~a~~~~~~~~~~~~~~~~ 169 (299)
T d1ckia_ 91 DLFNFCSR-KFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRE 169 (299)
T ss_dssp HHHHHTTT-CCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECCGGGTTCEEECCCSSCEECBCTTTCCBCCCCB
T ss_pred hhhhhccC-CCcHHHHHHHHHHHHHHHHHHHHCCeeeccCCHhhccccccCCCceeeeeccCcceeccccccccceeccc
Confidence 77665443 69999999999999999999999999999999999998632 2457999999999765321
Q ss_pred CccccccccccCchhhccCCCCCCCcccchhhhhhhhhhhhcCCCCCCCcCcchhHHHHHHHHhcCCCCCCCCCCchhHH
Q psy11767 529 LHTPCFTLQYAAPEVLRQDKSGYDENCDLWSLGVILVNVLRQDKSGYDENCDLWSLGVILYTMLCGRVPFHARSRDDSAL 608 (966)
Q Consensus 529 ~~~~~gT~~Y~APEvl~~~~~~~~~~~Di~SlGvil~el~~~~~~~y~~~~DIWSlGvilyemltG~~Pf~~~~~~~~~~ 608 (966)
..+.+||+.|||||++.. ..|+.++|||||||++|||++|++||......+...
T Consensus 170 ~~~~~gt~~y~aPE~~~~--------------------------~~~~~~~DiwSlG~~l~el~tg~~P~~~~~~~~~~~ 223 (299)
T d1ckia_ 170 NKNLTGTARYASINTHLG--------------------------IEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQ 223 (299)
T ss_dssp CCSCCCCSSSCCHHHHTT--------------------------BCCCHHHHHHHHHHHHHHHHHSSCTTCCCC------
T ss_pred cCCcCCCccccCHHHHhC--------------------------CCCCChhhEEecCHHHHHHHhCCCcccccchHHHHH
Confidence 234579999999998852 347889999999999999999999998765433222
Q ss_pred HHHHHHHcCCCCCC-chhhccCCHHHHHHHHHhcccCccccCChHHHHHHhhh
Q psy11767 609 SIMARIKEGQFNFD-AEAWSTVSSEAKELTKSLLTVNPAQRIRMMRVKLTFHA 660 (966)
Q Consensus 609 ~~~~~i~~~~~~~~-~~~~~~is~e~~~Li~~~L~~dP~~R~t~~~v~~~~~~ 660 (966)
.. .+........+ ...+..+|+++.+||.+||..||++||++.++...+..
T Consensus 224 ~~-~~~~~~~~~~~~~~~~~~~p~~~~~li~~cl~~~p~~RP~~~~i~~~l~~ 275 (299)
T d1ckia_ 224 KY-ERISEKKMSTPIEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRN 275 (299)
T ss_dssp -H-HHHHHHHHHSCHHHHTTTSCHHHHHHHHHHHHSCTTCCCCHHHHHHHHHH
T ss_pred HH-HHhhcccCCCChhHhccCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHH
Confidence 21 12211111111 22345789999999999999999999999887554443
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=1.9e-44 Score=397.00 Aligned_cols=242 Identities=21% Similarity=0.337 Sum_probs=199.6
Q ss_pred cccccccccccccEEEEEEEc-----CCCcEEEEEEecccc------ChHHHHHHHHHhcCCCCceEEEEEEEeCCeEEE
Q psy11767 380 LDKAGILGDGSYSVCRRCVEK-----STGQEYAVKIISRKI------DCSEEINLLRACQGHPNIVNLHCVFQDEVHTYL 448 (966)
Q Consensus 380 ~~~~~~LG~G~fG~Vy~a~~~-----~tg~~vAvK~i~~~~------~~~~Ei~iL~~l~~HpnIV~l~~~~~~~~~~~l 448 (966)
|+.++.||+|+||+||+|+++ .+++.||||++.... ...+|+.+|+.+ +|||||++++++.+....++
T Consensus 15 ~~~~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~il~~l-~h~niv~~~~~~~~~~~~~~ 93 (301)
T d1lufa_ 15 IEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEF-DNPNIVKLLGVCAVGKPMCL 93 (301)
T ss_dssp CEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTC-CCTTBCCEEEEECSSSSCEE
T ss_pred cEEeEEEeeCCCeEEEEEEECCCccCCCCeEEEEEEEChhcChHHHHHHHHHHHHHHhc-CCCCcccceeeeccCCceEE
Confidence 344788999999999999976 356899999997543 245799999988 59999999999999999999
Q ss_pred EEEccCCCCHHHHHHhcC----------------------CCCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCcEEE
Q psy11767 449 VLELLKGGELLDRIRQKG----------------------RCGFTENEASRIMRQLVAAVHFMHSRGVVHRDLKPENLLF 506 (966)
Q Consensus 449 VmEy~~gg~L~~~l~~~~----------------------~~~l~e~~~~~i~~Qil~aL~yLHs~~IiHRDLKP~NILl 506 (966)
||||+++|+|.+++.... ...+++.++..|+.||+.||+|||+++||||||||+|||+
T Consensus 94 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~ylH~~~ivHrDlKp~NILl 173 (301)
T d1lufa_ 94 LFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERKFVHRDLATRNCLV 173 (301)
T ss_dssp EEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEE
T ss_pred EEEecCCCcHHHHHHhcCccccccccccccchhhhccccCCCCCCHHHHHHHHHHHHHHhhhcccCCeEeeEEcccceEE
Confidence 999999999999997532 1248999999999999999999999999999999999999
Q ss_pred ecCCCCCEEEEeecccccccC-----CCccccccccccCchhhccCCCCCCCcccchhhhhhhhhhhhcCCCCCCCcCcc
Q psy11767 507 SDPAGDNIKVVDFGFACLKRE-----SLHTPCFTLQYAAPEVLRQDKSGYDENCDLWSLGVILVNVLRQDKSGYDENCDL 581 (966)
Q Consensus 507 ~~~~~~~iKL~DFGla~~~~~-----~~~~~~gT~~Y~APEvl~~~~~~~~~~~Di~SlGvil~el~~~~~~~y~~~~DI 581 (966)
+. ++.+||+|||+|+.... ...+.++|+.|+|||++.. ..|+.++||
T Consensus 174 d~--~~~~Kl~DFGls~~~~~~~~~~~~~~~~~~~~y~aPE~~~~--------------------------~~~t~ksDV 225 (301)
T d1lufa_ 174 GE--NMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFY--------------------------NRYTTESDV 225 (301)
T ss_dssp CG--GGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHH--------------------------CCCCHHHHH
T ss_pred CC--CCcEEEccchhheeccCCccccccCCCCcCcCcCCHHHHcc--------------------------CCCChhhhh
Confidence 85 56899999999975422 2234678999999999863 348899999
Q ss_pred hhHHHHHHHHhcCC-CCCCCCCCchhHHHHHHHHHcCCCCCCchhhccCCHHHHHHHHHhcccCccccCChHHHHHH
Q psy11767 582 WSLGVILYTMLCGR-VPFHARSRDDSALSIMARIKEGQFNFDAEAWSTVSSEAKELTKSLLTVNPAQRIRMMRVKLT 657 (966)
Q Consensus 582 WSlGvilyemltG~-~Pf~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~is~e~~~Li~~~L~~dP~~R~t~~~v~~~ 657 (966)
|||||++|||++|. +||.+.+. .+++..+.++.... .+..+++++.+||.+||+.||++|||+.++...
T Consensus 226 wS~Gvvl~ell~~~~~p~~~~~~----~e~~~~v~~~~~~~---~p~~~~~~~~~li~~cl~~~P~~RPt~~ev~~~ 295 (301)
T d1lufa_ 226 WAYGVVLWEIFSYGLQPYYGMAH----EEVIYYVRDGNILA---CPENCPLELYNLMRLCWSKLPADRPSFCSIHRI 295 (301)
T ss_dssp HHHHHHHHHHHTTTCCTTTTSCH----HHHHHHHHTTCCCC---CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred ccchhhHHHHHccCCCCCCCCCH----HHHHHHHHcCCCCC---CCccchHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence 99999999999985 67776543 24556677776432 234689999999999999999999999988543
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.3e-44 Score=393.13 Aligned_cols=240 Identities=26% Similarity=0.412 Sum_probs=188.4
Q ss_pred cccccccccccccEEEEEEEcCC-C--cEEEEEEecccc--------ChHHHHHHHHHhcCCCCceEEEEEEEeCCeEEE
Q psy11767 380 LDKAGILGDGSYSVCRRCVEKST-G--QEYAVKIISRKI--------DCSEEINLLRACQGHPNIVNLHCVFQDEVHTYL 448 (966)
Q Consensus 380 ~~~~~~LG~G~fG~Vy~a~~~~t-g--~~vAvK~i~~~~--------~~~~Ei~iL~~l~~HpnIV~l~~~~~~~~~~~l 448 (966)
|+.++.||+|+||+||+|++..+ + ..||||++.+.. ...+|+++|+.+ +|||||++++++.++ ..++
T Consensus 10 ~~~~~~iG~G~fg~Vy~~~~~~~~~~~~~vAiK~l~~~~~~~~~~~~~~~~Ei~~l~~l-~H~nIv~~~g~~~~~-~~~l 87 (273)
T d1u46a_ 10 LRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSL-DHRNLIRLYGVVLTP-PMKM 87 (273)
T ss_dssp EEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHC-CCTTBCCEEEEECSS-SCEE
T ss_pred eEEEEEEecCCCeEEEEEEEECCCCcEEEEEEEEEChhhcCCHHHHHHHHHHHHHHHhC-CCCCEEEEEEEEeec-chhe
Confidence 44578899999999999987543 3 368999986431 245799999999 599999999999764 6789
Q ss_pred EEEccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCcEEEecCCCCCEEEEeecccccccCC
Q psy11767 449 VLELLKGGELLDRIRQKGRCGFTENEASRIMRQLVAAVHFMHSRGVVHRDLKPENLLFSDPAGDNIKVVDFGFACLKRES 528 (966)
Q Consensus 449 VmEy~~gg~L~~~l~~~~~~~l~e~~~~~i~~Qil~aL~yLHs~~IiHRDLKP~NILl~~~~~~~iKL~DFGla~~~~~~ 528 (966)
|||||++|+|.+++..+.. .+++..++.++.||+.||+|||++||+||||||+|||++. ++.+||+|||+++.....
T Consensus 88 v~e~~~~~~l~~~~~~~~~-~l~~~~~~~~~~qi~~gl~ylH~~~iiHrDikp~NIll~~--~~~vkl~DfGl~~~~~~~ 164 (273)
T d1u46a_ 88 VTELAPLGSLLDRLRKHQG-HFLLGTLSRYAVQVAEGMGYLESKRFIHRDLAARNLLLAT--RDLVKIGDFGLMRALPQN 164 (273)
T ss_dssp EEECCTTCBHHHHHHHHGG-GSCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEEEE--TTEEEECCCTTCEECCC-
T ss_pred eeeeecCcchhhhhhcccC-CCCHHHHHHHHHHHHHHHHHhhhCCEeeeeecHHHhcccc--ccceeeccchhhhhcccC
Confidence 9999999999998876543 5999999999999999999999999999999999999986 558999999999865332
Q ss_pred ------CccccccccccCchhhccCCCCCCCcccchhhhhhhhhhhhcCCCCCCCcCcchhHHHHHHHHhc-CCCCCCCC
Q psy11767 529 ------LHTPCFTLQYAAPEVLRQDKSGYDENCDLWSLGVILVNVLRQDKSGYDENCDLWSLGVILYTMLC-GRVPFHAR 601 (966)
Q Consensus 529 ------~~~~~gT~~Y~APEvl~~~~~~~~~~~Di~SlGvil~el~~~~~~~y~~~~DIWSlGvilyemlt-G~~Pf~~~ 601 (966)
.....+|+.|+|||++... .|+.++|||||||++|||++ |++||.+.
T Consensus 165 ~~~~~~~~~~~~~~~~~aPE~~~~~--------------------------~~~~~~Di~S~Gvil~emlt~G~~Pf~~~ 218 (273)
T d1u46a_ 165 DDHYVMQEHRKVPFAWCAPESLKTR--------------------------TFSHASDTWMFGVTLWEMFTYGQEPWIGL 218 (273)
T ss_dssp CCEEEC-----CCGGGCCHHHHHHC--------------------------EEEHHHHHHHHHHHHHHHHTTSCCTTTTC
T ss_pred CCcceecCccccCcccCCHHHHhCC--------------------------CCCcchhhhhhHHHHHHHHhCCCCCCCCc
Confidence 1234578899999998632 36788999999999999998 89999876
Q ss_pred CCchhHHHHHHHHHcCCCCCCchhhccCCHHHHHHHHHhcccCccccCChHHHHH
Q psy11767 602 SRDDSALSIMARIKEGQFNFDAEAWSTVSSEAKELTKSLLTVNPAQRIRMMRVKL 656 (966)
Q Consensus 602 ~~~~~~~~~~~~i~~~~~~~~~~~~~~is~e~~~Li~~~L~~dP~~R~t~~~v~~ 656 (966)
+.. .++..+.+....++ .+..+|+++.+||.+||..||++|||+.++..
T Consensus 219 ~~~----~~~~~i~~~~~~~~--~~~~~~~~l~~li~~cl~~dp~~RPt~~ei~~ 267 (273)
T d1u46a_ 219 NGS----QILHKIDKEGERLP--RPEDCPQDIYNVMVQCWAHKPEDRPTFVALRD 267 (273)
T ss_dssp CHH----HHHHHHHTSCCCCC--CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred CHH----HHHHHHHhCCCCCC--CcccccHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence 543 34455655544332 34578999999999999999999999998853
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.9e-44 Score=389.89 Aligned_cols=251 Identities=27% Similarity=0.390 Sum_probs=200.6
Q ss_pred ccccccccccccEEEEEEEcCCCcEEEEEEecccc-------ChHHHHHHHHHhcCCCCceEEEEEEEeCCeEEEEEEcc
Q psy11767 381 DKAGILGDGSYSVCRRCVEKSTGQEYAVKIISRKI-------DCSEEINLLRACQGHPNIVNLHCVFQDEVHTYLVLELL 453 (966)
Q Consensus 381 ~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~-------~~~~Ei~iL~~l~~HpnIV~l~~~~~~~~~~~lVmEy~ 453 (966)
+.++.||+|+||+||+|++..+|+.||||+++... ...+|+.+|+.+ +|||||+++++|.+....++|||++
T Consensus 5 ~~i~~LG~G~fg~V~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l-~h~niv~~~~~~~~~~~~~iv~~~~ 83 (292)
T d1unla_ 5 EKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKEL-KHKNIVRLHDVLHSDKKLTLVFEFC 83 (292)
T ss_dssp EEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTC-CCTTBCCEEEEEECSSEEEEEEECC
T ss_pred EeeeEEecCcCeEEEEEEECCCCcEEEEEEEehhhCChHHHHHHHHHHHHHHhc-CcCCEEeeccccccccceeEEeeec
Confidence 34789999999999999999999999999986432 135799999987 5999999999999999999999999
Q ss_pred CCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCcEEEecCCCCCEEEEeecccccccCC---Cc
Q psy11767 454 KGGELLDRIRQKGRCGFTENEASRIMRQLVAAVHFMHSRGVVHRDLKPENLLFSDPAGDNIKVVDFGFACLKRES---LH 530 (966)
Q Consensus 454 ~gg~L~~~l~~~~~~~l~e~~~~~i~~Qil~aL~yLHs~~IiHRDLKP~NILl~~~~~~~iKL~DFGla~~~~~~---~~ 530 (966)
.|++|..++...+ .+++..++.++.|++.||+|||++||+||||||+|||++. .+.+||+|||.|+..... ..
T Consensus 84 ~~~~l~~~~~~~~--~~~~~~~~~~~~q~~~aL~~lH~~~IvHrDiKP~NIli~~--~~~~kl~DFG~a~~~~~~~~~~~ 159 (292)
T d1unla_ 84 DQDLKKYFDSCNG--DLDPEIVKSFLFQLLKGLGFCHSRNVLHRDLKPQNLLINR--NGELKLANFGLARAFGIPVRCYS 159 (292)
T ss_dssp SEEHHHHHHHTTT--CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECT--TCCEEECCCTTCEECCSCCSCCC
T ss_pred ccccccccccccc--ccchhHHHHHHHHHHHHHHHhhcCCEeeecccCccccccc--CCceeeeecchhhcccCCCccce
Confidence 9988888776554 6899999999999999999999999999999999999975 568999999999865432 23
Q ss_pred cccccccccCchhhccCCCCCCCcccchhhhhhhhhhhhcCCCCCCCcCcchhHHHHHHHHhcCCCCCCCCCCchhHHHH
Q psy11767 531 TPCFTLQYAAPEVLRQDKSGYDENCDLWSLGVILVNVLRQDKSGYDENCDLWSLGVILYTMLCGRVPFHARSRDDSALSI 610 (966)
Q Consensus 531 ~~~gT~~Y~APEvl~~~~~~~~~~~Di~SlGvil~el~~~~~~~y~~~~DIWSlGvilyemltG~~Pf~~~~~~~~~~~~ 610 (966)
...+++.|+|||++... ..++.++||||+||++|||++|+.||............
T Consensus 160 ~~~~~~~~~~pe~~~~~-------------------------~~~~~~~DiwSlG~il~ell~g~~p~~~~~~~~~~~~~ 214 (292)
T d1unla_ 160 AEVVTLWYRPPDVLFGA-------------------------KLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKR 214 (292)
T ss_dssp SCCSCGGGCCHHHHTTC-------------------------SCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHHHHH
T ss_pred eeccccchhhhhHhccC-------------------------CCCCchhhccccchHHHHHhhCCCCCCCCCCHHHHHHH
Confidence 44578899999988532 23688999999999999999999997654443322222
Q ss_pred HHHHHcCCC----------------------CCCchhhccCCHHHHHHHHHhcccCccccCChHHHHHHhhhhHH
Q psy11767 611 MARIKEGQF----------------------NFDAEAWSTVSSEAKELTKSLLTVNPAQRIRMMRVKLTFHAFHQ 663 (966)
Q Consensus 611 ~~~i~~~~~----------------------~~~~~~~~~is~e~~~Li~~~L~~dP~~R~t~~~v~~~~~~~~~ 663 (966)
+........ .........+++++.+||.+||+.||.+|||+.++ ..|+|++
T Consensus 215 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~sa~e~--L~Hp~f~ 287 (292)
T d1unla_ 215 IFRLLGTPTEEQWPSMTKLPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEA--LQHPYFS 287 (292)
T ss_dssp HHHHHCCCCTTTCTTGGGSTTCCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHH--TTSGGGS
T ss_pred HHhhcCCCChhhhhhhhhcccccccccccccchhhhccccCCHHHHHHHHHHccCChhHCcCHHHH--hcChhhc
Confidence 222211100 00011234678999999999999999999999976 5677763
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.9e-44 Score=395.61 Aligned_cols=243 Identities=23% Similarity=0.366 Sum_probs=198.8
Q ss_pred ccccccccccEEEEEEEc-----CCCcEEEEEEeccccC------hHHHHHHHHHhcCCCCceEEEEEEEeCCeEEEEEE
Q psy11767 383 AGILGDGSYSVCRRCVEK-----STGQEYAVKIISRKID------CSEEINLLRACQGHPNIVNLHCVFQDEVHTYLVLE 451 (966)
Q Consensus 383 ~~~LG~G~fG~Vy~a~~~-----~tg~~vAvK~i~~~~~------~~~Ei~iL~~l~~HpnIV~l~~~~~~~~~~~lVmE 451 (966)
.+.||+|+||.||+|.+. .+++.||||++..... ..+|+.++..+.+|||||++++++.++...|||||
T Consensus 28 ~~~iG~G~fg~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~~~~~l~~HpnIv~~~g~~~~~~~~~lvmE 107 (311)
T d1t46a_ 28 GKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTIGGPTLVITE 107 (311)
T ss_dssp EEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEE
T ss_pred eeEEeecCCeEEEEEEEeccccCCCCeEEEEEEECcccCHHHHHHHHHHHHHHHhccCCCCEEEEEEEEeeCCEEEEEEE
Confidence 578999999999999864 4678999999975432 45688999998789999999999999999999999
Q ss_pred ccCCCCHHHHHHhcC----------------CCCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCcEEEecCCCCCEE
Q psy11767 452 LLKGGELLDRIRQKG----------------RCGFTENEASRIMRQLVAAVHFMHSRGVVHRDLKPENLLFSDPAGDNIK 515 (966)
Q Consensus 452 y~~gg~L~~~l~~~~----------------~~~l~e~~~~~i~~Qil~aL~yLHs~~IiHRDLKP~NILl~~~~~~~iK 515 (966)
||+||+|.+++.... ...+++.++..++.||+.||+|||++|||||||||+|||++. .+.+|
T Consensus 108 ~~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~~LH~~~ivHrDLKp~NIl~~~--~~~~k 185 (311)
T d1t46a_ 108 YCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNILLTH--GRITK 185 (311)
T ss_dssp CCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEET--TTEEE
T ss_pred cCCCCCHHHHHHhccccccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhCCeeecccccccccccc--cCccc
Confidence 999999999997643 225899999999999999999999999999999999999985 56999
Q ss_pred EEeecccccccCC-----CccccccccccCchhhccCCCCCCCcccchhhhhhhhhhhhcCCCCCCCcCcchhHHHHHHH
Q psy11767 516 VVDFGFACLKRES-----LHTPCFTLQYAAPEVLRQDKSGYDENCDLWSLGVILVNVLRQDKSGYDENCDLWSLGVILYT 590 (966)
Q Consensus 516 L~DFGla~~~~~~-----~~~~~gT~~Y~APEvl~~~~~~~~~~~Di~SlGvil~el~~~~~~~y~~~~DIWSlGvilye 590 (966)
|+|||+++..... ....+||+.|+|||++.. ..|+.++|||||||++||
T Consensus 186 i~DfG~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--------------------------~~~~~~~DIwS~G~~l~e 239 (311)
T d1t46a_ 186 ICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFN--------------------------CVYTFESDVWSYGIFLWE 239 (311)
T ss_dssp ECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHH--------------------------CCCCHHHHHHHHHHHHHH
T ss_pred ccccchheeccCCCcceEeeecccChHHcCHHHhcC--------------------------CCCCCcccccchHHHHHH
Confidence 9999999765432 123578999999999863 237889999999999999
Q ss_pred Hhc-CCCCCCCCCCchhHHHHHHHHHcCCCCCCchhhccCCHHHHHHHHHhcccCccccCChHHHHHHhh
Q psy11767 591 MLC-GRVPFHARSRDDSALSIMARIKEGQFNFDAEAWSTVSSEAKELTKSLLTVNPAQRIRMMRVKLTFH 659 (966)
Q Consensus 591 mlt-G~~Pf~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~is~e~~~Li~~~L~~dP~~R~t~~~v~~~~~ 659 (966)
|++ |.+||.+.+..+.. ...+..+.... ....+++++.+||.+||+.||++|||+.++...+.
T Consensus 240 llt~g~p~~~~~~~~~~~---~~~i~~~~~~~---~~~~~~~~l~~Li~~cl~~dP~~RPs~~~il~~L~ 303 (311)
T d1t46a_ 240 LFSLGSSPYPGMPVDSKF---YKMIKEGFRML---SPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIE 303 (311)
T ss_dssp HHTTTCCSSTTCCSSHHH---HHHHHHTCCCC---CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred HHhCCCCCCCCCCHHHHH---HHHHhcCCCCC---CcccccHHHHHHHHHHcCCChhHCcCHHHHHHHHH
Confidence 998 67777666554332 22333433222 22457899999999999999999999998865443
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.9e-44 Score=394.24 Aligned_cols=241 Identities=21% Similarity=0.384 Sum_probs=194.9
Q ss_pred ccccccccccEEEEEEEcCCC-------cEEEEEEeccccC------hHHHHHHHHHhcCCCCceEEEEEEEeCCeEEEE
Q psy11767 383 AGILGDGSYSVCRRCVEKSTG-------QEYAVKIISRKID------CSEEINLLRACQGHPNIVNLHCVFQDEVHTYLV 449 (966)
Q Consensus 383 ~~~LG~G~fG~Vy~a~~~~tg-------~~vAvK~i~~~~~------~~~Ei~iL~~l~~HpnIV~l~~~~~~~~~~~lV 449 (966)
.+.||+|+||.||+|++..++ ..||||++..... ..+|..++..+.+|||||+++++|.++...|+|
T Consensus 18 ~~~iG~G~fg~Vy~~~~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~e~~~l~~~~~HpnIv~~~~~~~~~~~~~~v 97 (299)
T d1fgka_ 18 GKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQDGPLYVI 97 (299)
T ss_dssp EEECC-----CEEEEEEECC----CCCEEEEEEECCCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEE
T ss_pred eeEEeecCCcEEEEEEEcCCCcccccCceEEEEEEECcccChHHHHHHHHHHHHHHHhcCCCeEEecccccccCCeEEEE
Confidence 678999999999999987654 4799999976543 345888888887899999999999999999999
Q ss_pred EEccCCCCHHHHHHhcCC--------------CCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCcEEEecCCCCCEE
Q psy11767 450 LELLKGGELLDRIRQKGR--------------CGFTENEASRIMRQLVAAVHFMHSRGVVHRDLKPENLLFSDPAGDNIK 515 (966)
Q Consensus 450 mEy~~gg~L~~~l~~~~~--------------~~l~e~~~~~i~~Qil~aL~yLHs~~IiHRDLKP~NILl~~~~~~~iK 515 (966)
||||++|+|.++|..+.. ..+++.+++.++.||+.||+|||+++||||||||+|||++. ++.+|
T Consensus 98 ~e~~~~g~l~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~ylH~~~ivHrDiKp~NiLl~~--~~~~k 175 (299)
T d1fgka_ 98 VEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTE--DNVMK 175 (299)
T ss_dssp ECCCTTCBHHHHHHTTSCC------------CCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECT--TCCEE
T ss_pred EEccCCCcHHHHHHhhcCCccccccccccCccccCCHHHHHHHHHHHHHHHHHhhhCCEEeeeecccceeecC--CCCeE
Confidence 999999999999976532 35899999999999999999999999999999999999985 56999
Q ss_pred EEeecccccccCC-----CccccccccccCchhhccCCCCCCCcccchhhhhhhhhhhhcCCCCCCCcCcchhHHHHHHH
Q psy11767 516 VVDFGFACLKRES-----LHTPCFTLQYAAPEVLRQDKSGYDENCDLWSLGVILVNVLRQDKSGYDENCDLWSLGVILYT 590 (966)
Q Consensus 516 L~DFGla~~~~~~-----~~~~~gT~~Y~APEvl~~~~~~~~~~~Di~SlGvil~el~~~~~~~y~~~~DIWSlGvilye 590 (966)
|+|||+++..... ....++|+.|+|||++.. ..|+.++|||||||++||
T Consensus 176 l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~l~~--------------------------~~y~~k~DiwS~Gvvl~e 229 (299)
T d1fgka_ 176 IADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFD--------------------------RIYTHQSDVWSFGVLLWE 229 (299)
T ss_dssp ECSTTCCCCGGGCCTTCCCTTSCCGGGGSCHHHHHH--------------------------CCCCHHHHHHHHHHHHHH
T ss_pred eccchhhccccccccccccccCCCChhhhhhhHhcC--------------------------CCCCchhhhHHhHHHHHH
Confidence 9999999765432 233568999999999863 248899999999999999
Q ss_pred Hhc-CCCCCCCCCCchhHHHHHHHHHcCCCCCCchhhccCCHHHHHHHHHhcccCccccCChHHHHHHh
Q psy11767 591 MLC-GRVPFHARSRDDSALSIMARIKEGQFNFDAEAWSTVSSEAKELTKSLLTVNPAQRIRMMRVKLTF 658 (966)
Q Consensus 591 mlt-G~~Pf~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~is~e~~~Li~~~L~~dP~~R~t~~~v~~~~ 658 (966)
|++ |.+||.+.+.. .+...+..+... +.+..+++++++||.+||+.||++|||+.++...+
T Consensus 230 ll~~g~~p~~~~~~~----~~~~~i~~~~~~---~~p~~~~~~l~~li~~cl~~dP~~Rps~~eil~~L 291 (299)
T d1fgka_ 230 IFTLGGSPYPGVPVE----ELFKLLKEGHRM---DKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDL 291 (299)
T ss_dssp HHTTSCCSSTTCCHH----HHHHHHHTTCCC---CCCSSCCHHHHHHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred hccCCCCCCCCCCHH----HHHHHHHcCCCC---CCCccchHHHHHHHHHHccCCHhHCcCHHHHHHHH
Confidence 998 78998765432 345556555322 23356899999999999999999999999985544
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Probab=100.00 E-value=8.8e-44 Score=390.26 Aligned_cols=253 Identities=23% Similarity=0.312 Sum_probs=205.1
Q ss_pred cccccccccccccccccccEEEEEEEcCCCcEEEEEEecccc---ChHHHHHHHHHhcCCCCceEEEEEEEeCCeEEEEE
Q psy11767 374 EQYDMDLDKAGILGDGSYSVCRRCVEKSTGQEYAVKIISRKI---DCSEEINLLRACQGHPNIVNLHCVFQDEVHTYLVL 450 (966)
Q Consensus 374 ~~~~i~~~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~---~~~~Ei~iL~~l~~HpnIV~l~~~~~~~~~~~lVm 450 (966)
++|++ .+.||+|+||+||+|++..+|+.||||++.... ...+|+++++.+.+|+||+.+++++.++...|+||
T Consensus 5 ~~Y~i----~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~~vm 80 (293)
T d1csna_ 5 VHYKV----GRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDAPQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLVI 80 (293)
T ss_dssp TTEEE----EEEEEECSSCEEEEEEETTTTEEEEEEEEECCTTSCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEEE
T ss_pred CceEE----EEEEecCCCeEEEEEEECCCCCEEEEEEEccccCcHHHHHHHHHHHHhcCCCCCCEEEEEeecCCccEEEE
Confidence 35555 678999999999999999999999999986543 35789999999987899999999999999999999
Q ss_pred EccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCcEEEecC---CCCCEEEEeecccccccC
Q psy11767 451 ELLKGGELLDRIRQKGRCGFTENEASRIMRQLVAAVHFMHSRGVVHRDLKPENLLFSDP---AGDNIKVVDFGFACLKRE 527 (966)
Q Consensus 451 Ey~~gg~L~~~l~~~~~~~l~e~~~~~i~~Qil~aL~yLHs~~IiHRDLKP~NILl~~~---~~~~iKL~DFGla~~~~~ 527 (966)
||| +++|.+++...+. .+++.++..++.|++.||+|||++|||||||||+|||++.. ..+.+||+|||+|+....
T Consensus 81 e~~-~~~l~~~~~~~~~-~~~~~~~~~i~~q~~~~l~~lH~~giiHrDiKp~Nili~~~~~~~~~~vkl~DFG~a~~~~~ 158 (293)
T d1csna_ 81 DLL-GPSLEDLLDLCGR-KFSVKTVAMAAKQMLARVQSIHEKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRD 158 (293)
T ss_dssp ECC-CCBHHHHHHHTTT-CCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECCSSSTTTTCEEECCCTTCEESBC
T ss_pred Eec-CCCHHHHHHhhcc-chhhHHHHHHHHHHHHHHHHHHHCCceeccCCccceeecCcccccCCceEEcccceeEEccc
Confidence 999 7899998876553 69999999999999999999999999999999999999742 246899999999976432
Q ss_pred ----------CCccccccccccCchhhccCCCCCCCcccchhhhhhhhhhhhcCCCCCCCcCcchhHHHHHHHHhcCCCC
Q psy11767 528 ----------SLHTPCFTLQYAAPEVLRQDKSGYDENCDLWSLGVILVNVLRQDKSGYDENCDLWSLGVILYTMLCGRVP 597 (966)
Q Consensus 528 ----------~~~~~~gT~~Y~APEvl~~~~~~~~~~~Di~SlGvil~el~~~~~~~y~~~~DIWSlGvilyemltG~~P 597 (966)
...+.+||+.|||||++.. ..|+.++|||||||++|||++|++|
T Consensus 159 ~~~~~~~~~~~~~~~~GT~~y~aPE~~~~--------------------------~~~~~~~DiwSlG~~l~elltg~~P 212 (293)
T d1csna_ 159 PVTKQHIPYREKKNLSGTARYMSINTHLG--------------------------REQSRRDDLEALGHVFMYFLRGSLP 212 (293)
T ss_dssp TTTCCBCCCCCCCCCCSCTTTCCHHHHTT--------------------------CCCCHHHHHHHHHHHHHHHHHSSCT
T ss_pred CccccceeecccCceEEchhhcCHHHhcC--------------------------CCCChHHHHHHhhHHHHHHHhCCCc
Confidence 1234579999999999852 3478899999999999999999999
Q ss_pred CCCCCCchhHHHHHHHHHcCCCC-CCchhhccCCHHHHHHHHHhcccCccccCChHHHHHHhh
Q psy11767 598 FHARSRDDSALSIMARIKEGQFN-FDAEAWSTVSSEAKELTKSLLTVNPAQRIRMMRVKLTFH 659 (966)
Q Consensus 598 f~~~~~~~~~~~~~~~i~~~~~~-~~~~~~~~is~e~~~Li~~~L~~dP~~R~t~~~v~~~~~ 659 (966)
|.+....... ....++...... ...+....+++++.+++..|+..+|++||+...+...+.
T Consensus 213 f~~~~~~~~~-~~~~~i~~~~~~~~~~~l~~~~p~~l~~ii~~~~~~~~~~rP~y~~l~~~l~ 274 (293)
T d1csna_ 213 WQGLKAATNK-QKYERIGEKKQSTPLRELCAGFPEEFYKYMHYARNLAFDATPDYDYLQGLFS 274 (293)
T ss_dssp TSSCCSCCHH-HHHHHHHHHHHHSCHHHHTTTSCHHHHHHHHHHHHCCTTCCCCHHHHHHHHH
T ss_pred CCCccchhHH-HHHHHHHhccCCCChHHhcCCCCHHHHHHHHHHhcCCcccCcCHHHHHHHHH
Confidence 9876543322 222233222111 122333568899999999999999999999877654443
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.5e-44 Score=405.23 Aligned_cols=253 Identities=26% Similarity=0.461 Sum_probs=199.0
Q ss_pred cccccccccccccccccccEEEEEEEcCCCcEEEEEEeccccC-------hHHHHHHHHHhcCCCCceEEEEEEEeC---
Q psy11767 374 EQYDMDLDKAGILGDGSYSVCRRCVEKSTGQEYAVKIISRKID-------CSEEINLLRACQGHPNIVNLHCVFQDE--- 443 (966)
Q Consensus 374 ~~~~i~~~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~~-------~~~Ei~iL~~l~~HpnIV~l~~~~~~~--- 443 (966)
++|++ ++.||+|+||+||+|++..+|+.||||++.+... ..+|+++|+.+ +|||||+++++|...
T Consensus 18 ~rY~i----~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l-~h~~iv~~~~~~~~~~~~ 92 (348)
T d2gfsa1 18 ERYQN----LSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHM-KHENVIGLLDVFTPARSL 92 (348)
T ss_dssp TTEEE----EEECGGGTTSSEEEEEETTTTEEEEEEECSCTTSSHHHHHHHHHHHHHHHHC-CCTTBCCCSEEECSCSST
T ss_pred CCeEE----EEEEecCCCeEEEEEEECCCCCEEEEEEECchhcChHHHHHHHHHHHHHHhc-CCCCeeeEEEEEeecccc
Confidence 45554 7899999999999999999999999999975432 35799999998 599999999999643
Q ss_pred --CeEEEEEEccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCcEEEecCCCCCEEEEeecc
Q psy11767 444 --VHTYLVLELLKGGELLDRIRQKGRCGFTENEASRIMRQLVAAVHFMHSRGVVHRDLKPENLLFSDPAGDNIKVVDFGF 521 (966)
Q Consensus 444 --~~~~lVmEy~~gg~L~~~l~~~~~~~l~e~~~~~i~~Qil~aL~yLHs~~IiHRDLKP~NILl~~~~~~~iKL~DFGl 521 (966)
...++||||+.||+|.+++... .+++.+++.++.||+.||+|||++||+||||||+|||++. ++.+|++|||+
T Consensus 93 ~~~~~~~i~~~~~gg~L~~~~~~~---~l~e~~~~~i~~qil~aL~~LH~~giiHrDiKp~NILi~~--~~~~kl~dfg~ 167 (348)
T d2gfsa1 93 EEFNDVYLVTHLMGADLNNIVKCQ---KLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNE--DCELKILDFGL 167 (348)
T ss_dssp TTCCCCEEEEECCSEEHHHHHTTC---CCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECT--TCCEEECCC--
T ss_pred ccCceEEEEEeecCCchhhhcccc---cccHHHHHHHHHHHHHHHHHHHhCCCcccccCCccccccc--cccccccccch
Confidence 3346667777899999998543 5999999999999999999999999999999999999975 56999999999
Q ss_pred cccccCCCccccccccccCchhhccCCCCCCCcccchhhhhhhhhhhhcCCCCCCCcCcchhHHHHHHHHhcCCCCCCCC
Q psy11767 522 ACLKRESLHTPCFTLQYAAPEVLRQDKSGYDENCDLWSLGVILVNVLRQDKSGYDENCDLWSLGVILYTMLCGRVPFHAR 601 (966)
Q Consensus 522 a~~~~~~~~~~~gT~~Y~APEvl~~~~~~~~~~~Di~SlGvil~el~~~~~~~y~~~~DIWSlGvilyemltG~~Pf~~~ 601 (966)
|........+.+||+.|+|||++.. ...++.++|||||||++|+|++|++||.+.
T Consensus 168 a~~~~~~~~~~~g~~~y~apE~~~~-------------------------~~~~~~~~DiwSlGv~l~~ll~g~~pF~~~ 222 (348)
T d2gfsa1 168 ARHTDDEMTGYVATRWYRAPEIMLN-------------------------WMHYNQTVDIWSVGCIMAELLTGRTLFPGT 222 (348)
T ss_dssp --CCTGGGSSSCHHHHTSCHHHHTT-------------------------CSCCCTTHHHHHHHHHHHHHHHSSCSCCCS
T ss_pred hcccCcccccccccccccCchhhcC-------------------------CccCCcccchhhhhHHHHHHHhCCCCCCCC
Confidence 9887766777889999999998753 234678999999999999999999999876
Q ss_pred CCchhHHHHHHHHHcCC-------------------CCCC----chhhccCCHHHHHHHHHhcccCccccCChHHHHHHh
Q psy11767 602 SRDDSALSIMARIKEGQ-------------------FNFD----AEAWSTVSSEAKELTKSLLTVNPAQRIRMMRVKLTF 658 (966)
Q Consensus 602 ~~~~~~~~~~~~i~~~~-------------------~~~~----~~~~~~is~e~~~Li~~~L~~dP~~R~t~~~v~~~~ 658 (966)
+.......++....... .... ...+..+|+++++||.+||+.||++|||+.++ ..
T Consensus 223 ~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~el--L~ 300 (348)
T d2gfsa1 223 DHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQA--LA 300 (348)
T ss_dssp SHHHHHHHHHHHHCCCCHHHHTTCCCHHHHHHHTTSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSGGGSCCHHHH--HT
T ss_pred CHHHHHHHHHHhcCCCChHHhhhccchhhhhhhhhcccCCCcchhhhcCCCCHHHHHHHHHHCcCChhhCcCHHHH--hc
Confidence 54433222222111000 0000 11234689999999999999999999999976 45
Q ss_pred hhhHH
Q psy11767 659 HAFHQ 663 (966)
Q Consensus 659 ~~~~~ 663 (966)
|+|++
T Consensus 301 Hp~f~ 305 (348)
T d2gfsa1 301 HAYFA 305 (348)
T ss_dssp SGGGT
T ss_pred CHhhC
Confidence 77763
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.5e-43 Score=397.02 Aligned_cols=251 Identities=28% Similarity=0.488 Sum_probs=189.2
Q ss_pred cccccccccccccccccccEEEEEEEcCCCcEEEEEEeccccC-------hHHHHHHHHHhcCCCCceEEEEEEEe----
Q psy11767 374 EQYDMDLDKAGILGDGSYSVCRRCVEKSTGQEYAVKIISRKID-------CSEEINLLRACQGHPNIVNLHCVFQD---- 442 (966)
Q Consensus 374 ~~~~i~~~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~~-------~~~Ei~iL~~l~~HpnIV~l~~~~~~---- 442 (966)
++|++ +++||+|+||+||+|+++.+|+.||||++.+... ..+|+.+|+.+ +|||||+++++|..
T Consensus 17 ~~Y~i----~~~LG~G~fg~V~~~~d~~t~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l-~hpnIv~~~~~f~~~~~~ 91 (355)
T d2b1pa1 17 KRYQN----LKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCV-NHKNIISLLNVFTPQKTL 91 (355)
T ss_dssp TTEEE----EEECSCC--CEEEEEEETTTTEEEEEEEEESTTSSHHHHHHHHHHHHHHHHC-CCTTBCCCSEEECSCCST
T ss_pred CCeEE----EEEeecCcCeEEEEEEECCCCCEEEEEEEChhhcCHHHHHHHHHHHHHHHhc-CCCCeeEEEEEEeccccc
Confidence 55555 7899999999999999999999999999975432 45799999998 59999999999964
Q ss_pred --CCeEEEEEEccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCcEEEecCCCCCEEEEeec
Q psy11767 443 --EVHTYLVLELLKGGELLDRIRQKGRCGFTENEASRIMRQLVAAVHFMHSRGVVHRDLKPENLLFSDPAGDNIKVVDFG 520 (966)
Q Consensus 443 --~~~~~lVmEy~~gg~L~~~l~~~~~~~l~e~~~~~i~~Qil~aL~yLHs~~IiHRDLKP~NILl~~~~~~~iKL~DFG 520 (966)
..++|+|||||.+ ++.+.+.. .+++..++.++.||+.||+|||++||+||||||+|||++. ++.+|++|||
T Consensus 92 ~~~~~~~iv~Ey~~~-~l~~~~~~----~~~~~~i~~~~~qil~gl~~LH~~giiHrDlKP~Nil~~~--~~~~kl~df~ 164 (355)
T d2b1pa1 92 EEFQDVYLVMELMDA-NLCQVIQM----ELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKS--DCTLKILDFG 164 (355)
T ss_dssp TTCCEEEEEEECCSE-EHHHHHTS----CCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECT--TCCEEECCCC
T ss_pred ccCceeEEEEeccch-HHHHhhhc----CCCHHHHHHHHHHHHHHHHHhhhcccccccCCcccccccc--ccceeeechh
Confidence 3689999999965 55555532 5899999999999999999999999999999999999985 5689999999
Q ss_pred ccccccC--CCccccccccccCchhhccCCCCCCCcccchhhhhhhhhhhhcCCCCCCCcCcchhHHHHHHHHhcCCCCC
Q psy11767 521 FACLKRE--SLHTPCFTLQYAAPEVLRQDKSGYDENCDLWSLGVILVNVLRQDKSGYDENCDLWSLGVILYTMLCGRVPF 598 (966)
Q Consensus 521 la~~~~~--~~~~~~gT~~Y~APEvl~~~~~~~~~~~Di~SlGvil~el~~~~~~~y~~~~DIWSlGvilyemltG~~Pf 598 (966)
+++.... .....++|+.|+|||++.+ ..|+.++||||+||++|+|++|++||
T Consensus 165 ~~~~~~~~~~~~~~~~t~~y~aPE~l~~--------------------------~~~~~~~DiwSlG~~l~ell~g~~pF 218 (355)
T d2b1pa1 165 LARTAGTSFMMTPYVVTRYYRAPEVILG--------------------------MGYKENVDIWSVGCIMGEMVRHKILF 218 (355)
T ss_dssp C---------------CCTTCCHHHHTT--------------------------CCCCTTHHHHHHHHHHHHHHHSSCSS
T ss_pred hhhccccccccccccccccccChhhhcC--------------------------CCCCCCcccccccchHHHHhhCCCCC
Confidence 9876543 2345578999999999853 34788999999999999999999999
Q ss_pred CCCCCchhHHHHHHHHH------------------cCCC----------------CCCchhhccCCHHHHHHHHHhcccC
Q psy11767 599 HARSRDDSALSIMARIK------------------EGQF----------------NFDAEAWSTVSSEAKELTKSLLTVN 644 (966)
Q Consensus 599 ~~~~~~~~~~~~~~~i~------------------~~~~----------------~~~~~~~~~is~e~~~Li~~~L~~d 644 (966)
.+.+.......++.... .+.. ..........|+++++||.+||..|
T Consensus 219 ~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~d 298 (355)
T d2b1pa1 219 PGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVID 298 (355)
T ss_dssp CCSSHHHHHHHHHHHHCCCCHHHHTTSCHHHHHHHHTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSS
T ss_pred CCCCHHHHHHHHHHhccCCCHHHHHHhhhhHHHHhhcCccccccccccccccccccccccccccCCHHHHHHHHHHCcCC
Confidence 87664433322222111 1100 0111112345788999999999999
Q ss_pred ccccCChHHHHHHhhhhHHh
Q psy11767 645 PAQRIRMMRVKLTFHAFHQA 664 (966)
Q Consensus 645 P~~R~t~~~v~~~~~~~~~~ 664 (966)
|++|||+.++ ..|||++.
T Consensus 299 P~~R~ta~el--L~Hpw~~~ 316 (355)
T d2b1pa1 299 PAKRISVDDA--LQHPYINV 316 (355)
T ss_dssp TTTSCCHHHH--HTSTTTGG
T ss_pred hhHCcCHHHH--hcCcccCC
Confidence 9999999976 56788753
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.2e-42 Score=384.54 Aligned_cols=241 Identities=21% Similarity=0.322 Sum_probs=192.8
Q ss_pred cccccccccEEEEEEEcCCC---cEEEEEEeccccC------hHHHHHHHHHhcCCCCceEEEEEEEe-CCeEEEEEEcc
Q psy11767 384 GILGDGSYSVCRRCVEKSTG---QEYAVKIISRKID------CSEEINLLRACQGHPNIVNLHCVFQD-EVHTYLVLELL 453 (966)
Q Consensus 384 ~~LG~G~fG~Vy~a~~~~tg---~~vAvK~i~~~~~------~~~Ei~iL~~l~~HpnIV~l~~~~~~-~~~~~lVmEy~ 453 (966)
++||+|+||+||+|++..++ ..||||++++... +.+|+++|.++ +|||||++++++.+ ++..++|||||
T Consensus 33 ~~iG~G~fg~Vyk~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l-~HpnIv~~~g~~~~~~~~~~lv~E~~ 111 (311)
T d1r0pa_ 33 EVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDF-SHPNVLSLLGICLRSEGSPLVVLPYM 111 (311)
T ss_dssp EEEEEETTEEEEEEEECC----CEEEEEEEECCCCCHHHHHHHHHHHHHHHTC-CCTTBCCCCEEEEETTTEEEEEEECC
T ss_pred eEEeecCCeEEEEEEEECCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhC-CCCCEeEEeEEEEecCCceEEEEEEe
Confidence 57999999999999987654 3699999865322 45799999998 59999999999765 56899999999
Q ss_pred CCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCcEEEecCCCCCEEEEeecccccccCC-----
Q psy11767 454 KGGELLDRIRQKGRCGFTENEASRIMRQLVAAVHFMHSRGVVHRDLKPENLLFSDPAGDNIKVVDFGFACLKRES----- 528 (966)
Q Consensus 454 ~gg~L~~~l~~~~~~~l~e~~~~~i~~Qil~aL~yLHs~~IiHRDLKP~NILl~~~~~~~iKL~DFGla~~~~~~----- 528 (966)
++|+|.+++..... .+++..+..++.|++.||.|||+.+|+||||||+|||+++ ++.+||+|||+++.....
T Consensus 112 ~~g~l~~~~~~~~~-~~~~~~~~~i~~qia~gL~~lH~~~iiHrDLK~~NILl~~--~~~~kL~DFG~~~~~~~~~~~~~ 188 (311)
T d1r0pa_ 112 KHGDLRNFIRNETH-NPTVKDLIGFGLQVAKGMKFLASKKFVHRDLAARNCMLDE--KFTVKVADFGLARDMYDKEFDSV 188 (311)
T ss_dssp TTCBHHHHHHCTTC-CCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECT--TCCEEECSSGGGCCTTTTTCCCT
T ss_pred ecCchhhhhccccc-cchHHHHHHHHHHHHHhhhhhcccCcccCCccHHhEeECC--CCCEEEecccchhhccccccccc
Confidence 99999999876543 5789999999999999999999999999999999999975 569999999999764321
Q ss_pred --CccccccccccCchhhccCCCCCCCcccchhhhhhhhhhhhcCCCCCCCcCcchhHHHHHHHHhcCCCCCCCCCCchh
Q psy11767 529 --LHTPCFTLQYAAPEVLRQDKSGYDENCDLWSLGVILVNVLRQDKSGYDENCDLWSLGVILYTMLCGRVPFHARSRDDS 606 (966)
Q Consensus 529 --~~~~~gT~~Y~APEvl~~~~~~~~~~~Di~SlGvil~el~~~~~~~y~~~~DIWSlGvilyemltG~~Pf~~~~~~~~ 606 (966)
.....||+.|+|||++... .|+.++|||||||++|||++|..||......
T Consensus 189 ~~~~~~~gt~~y~aPE~~~~~--------------------------~~~~ksDI~SfGivl~El~t~~~p~~~~~~~-- 240 (311)
T d1r0pa_ 189 HNKTGAKLPVKWMALESLQTQ--------------------------KFTTKSDVWSFGVLLWELMTRGAPPYPDVNT-- 240 (311)
T ss_dssp TCTTCSSCCGGGSCHHHHHHC--------------------------CCCHHHHHHHHHHHHHHHHTTSCCSCC------
T ss_pred eecccccccccccChHHHhcC--------------------------CCCChhHhhhhHHHHHHHHHCCCCCCCCCCH--
Confidence 1234579999999998632 3788999999999999999988887654322
Q ss_pred HHHHHHHHHcCCCCCCchhhccCCHHHHHHHHHhcccCccccCChHHHHHHhhh
Q psy11767 607 ALSIMARIKEGQFNFDAEAWSTVSSEAKELTKSLLTVNPAQRIRMMRVKLTFHA 660 (966)
Q Consensus 607 ~~~~~~~i~~~~~~~~~~~~~~is~e~~~Li~~~L~~dP~~R~t~~~v~~~~~~ 660 (966)
..+...+..|.....+ ..+++++.+||.+||..||++||++.++...+..
T Consensus 241 -~~~~~~i~~g~~~~~p---~~~~~~l~~li~~cl~~dP~~RPs~~ei~~~L~~ 290 (311)
T d1r0pa_ 241 -FDITVYLLQGRRLLQP---EYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISA 290 (311)
T ss_dssp ---CHHHHHTTCCCCCC---TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred -HHHHHHHHcCCCCCCc---ccCcHHHHHHHHHHcCCCHhHCcCHHHHHHHHHH
Confidence 2344556666543322 3578999999999999999999999998654433
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1e-42 Score=384.58 Aligned_cols=240 Identities=20% Similarity=0.330 Sum_probs=197.7
Q ss_pred ccccccccccccEEEEEEEcC-----CCcEEEEEEeccccC------hHHHHHHHHHhcCCCCceEEEEEEEeCCeEEEE
Q psy11767 381 DKAGILGDGSYSVCRRCVEKS-----TGQEYAVKIISRKID------CSEEINLLRACQGHPNIVNLHCVFQDEVHTYLV 449 (966)
Q Consensus 381 ~~~~~LG~G~fG~Vy~a~~~~-----tg~~vAvK~i~~~~~------~~~Ei~iL~~l~~HpnIV~l~~~~~~~~~~~lV 449 (966)
+..+.||+|+||.||+|.+.. +++.||||++..... ..+|+++|+.+ +|||||++++++..+...++|
T Consensus 23 ~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~VAvK~~~~~~~~~~~~~~~~E~~il~~l-~h~nIv~~~~~~~~~~~~~lv 101 (308)
T d1p4oa_ 23 TMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEF-NCHHVVRLLGVVSQGQPTLVI 101 (308)
T ss_dssp EEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGC-CCTTBCCEEEEECSSSSCEEE
T ss_pred EEeeEEeeCCCeEEEEEEECCcccCCCCcEEEEEEECcccChHHHHHHHHHHHHHHHc-CCCCEeeeeeEEecCCceeEE
Confidence 346789999999999998863 467899999975432 35799999888 599999999999999999999
Q ss_pred EEccCCCCHHHHHHhcC--------CCCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCcEEEecCCCCCEEEEeecc
Q psy11767 450 LELLKGGELLDRIRQKG--------RCGFTENEASRIMRQLVAAVHFMHSRGVVHRDLKPENLLFSDPAGDNIKVVDFGF 521 (966)
Q Consensus 450 mEy~~gg~L~~~l~~~~--------~~~l~e~~~~~i~~Qil~aL~yLHs~~IiHRDLKP~NILl~~~~~~~iKL~DFGl 521 (966)
||||++|+|.+++.... ...+++..+..++.|++.||+|||+++|+||||||+|||++. ++++||+|||+
T Consensus 102 ~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~gl~~LH~~~ivHrDlk~~NiLld~--~~~~Kl~DFGl 179 (308)
T d1p4oa_ 102 MELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAE--DFTVKIGDFGM 179 (308)
T ss_dssp EECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCSGGGEEECT--TCCEEECCTTC
T ss_pred EeecCCCCHHHHHHhcccccccccccCCCCHHHHHHHHHHHHHHHHHHhhCCeeeceEcCCceeecC--CceEEEeeccc
Confidence 99999999999986431 134789999999999999999999999999999999999984 56999999999
Q ss_pred cccccCC-----CccccccccccCchhhccCCCCCCCcccchhhhhhhhhhhhcCCCCCCCcCcchhHHHHHHHHhcC-C
Q psy11767 522 ACLKRES-----LHTPCFTLQYAAPEVLRQDKSGYDENCDLWSLGVILVNVLRQDKSGYDENCDLWSLGVILYTMLCG-R 595 (966)
Q Consensus 522 a~~~~~~-----~~~~~gT~~Y~APEvl~~~~~~~~~~~Di~SlGvil~el~~~~~~~y~~~~DIWSlGvilyemltG-~ 595 (966)
|+..... ....++|+.|+|||.+... .|+.++|||||||++|||++| .
T Consensus 180 a~~~~~~~~~~~~~~~~~t~~y~aPe~l~~~--------------------------~~~~~~Dv~S~G~il~El~t~~~ 233 (308)
T d1p4oa_ 180 TRDIYETDYYRKGGKGLLPVRWMSPESLKDG--------------------------VFTTYSDVWSFGVVLWEIATLAE 233 (308)
T ss_dssp CCGGGGGGCEEGGGSSEECGGGCCHHHHHHC--------------------------CCCHHHHHHHHHHHHHHHHHTSC
T ss_pred ceeccCCcceeeccceecccccCCHHHHccC--------------------------CCCcccccccHHHHHHHHHhCCC
Confidence 9755332 2334689999999998632 378899999999999999998 5
Q ss_pred CCCCCCCCchhHHHHHHHHHcCCCCCCchhhccCCHHHHHHHHHhcccCccccCChHHHHH
Q psy11767 596 VPFHARSRDDSALSIMARIKEGQFNFDAEAWSTVSSEAKELTKSLLTVNPAQRIRMMRVKL 656 (966)
Q Consensus 596 ~Pf~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~is~e~~~Li~~~L~~dP~~R~t~~~v~~ 656 (966)
+||.+.+. ..++..+..+.... ....+++++.+||.+||+.||++|||+.++..
T Consensus 234 ~p~~~~~~----~~~~~~i~~~~~~~---~p~~~~~~l~~li~~cl~~~P~~RPs~~~il~ 287 (308)
T d1p4oa_ 234 QPYQGLSN----EQVLRFVMEGGLLD---KPDNCPDMLFELMRMCWQYNPKMRPSFLEIIS 287 (308)
T ss_dssp CTTTTSCH----HHHHHHHHTTCCCC---CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred CCCCCCCH----HHHHHHHHhCCCCC---CcccchHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence 77876543 24455666665422 23468899999999999999999999998744
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3e-42 Score=379.92 Aligned_cols=251 Identities=20% Similarity=0.293 Sum_probs=186.3
Q ss_pred ccccccccccEEEEEEEcCCCcEEEEEEeccccC--hHHHHHHHH--HhcCCCCceEEEEEEEeCC----eEEEEEEccC
Q psy11767 383 AGILGDGSYSVCRRCVEKSTGQEYAVKIISRKID--CSEEINLLR--ACQGHPNIVNLHCVFQDEV----HTYLVLELLK 454 (966)
Q Consensus 383 ~~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~~--~~~Ei~iL~--~l~~HpnIV~l~~~~~~~~----~~~lVmEy~~ 454 (966)
.+.||+|+||.||+|++ +|+.||||++..... ..+|.+++. .+ +|||||++++++.++. .+|+|||||+
T Consensus 8 ~~~iG~G~fg~Vy~~~~--~g~~vAvK~~~~~~~~~~~~e~ei~~~~~~-~HpnIv~~~~~~~~~~~~~~~~~lv~Ey~~ 84 (303)
T d1vjya_ 8 QESIGKGRFGEVWRGKW--RGEEVAVKIFSSREERSWFREAEIYQTVML-RHENILGFIAADNKDNGTWTQLWLVSDYHE 84 (303)
T ss_dssp EEEEECCSSSEEEEEEE--TTEEEEEEEECGGGHHHHHHHHHHHTSTTC-CCTTBCCEEEEEEEECSSSEEEEEEEECCT
T ss_pred EEEEeeCCCeEEEEEEE--CCEEEEEEEECccchhHHHHHHHHHHHhhC-CCCcCcceEEEEEeCCCcceEEEEEEeccc
Confidence 46799999999999986 689999999965432 224544443 34 6999999999998654 6899999999
Q ss_pred CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHh--------cCceeccCCCCcEEEecCCCCCEEEEeeccccccc
Q psy11767 455 GGELLDRIRQKGRCGFTENEASRIMRQLVAAVHFMHS--------RGVVHRDLKPENLLFSDPAGDNIKVVDFGFACLKR 526 (966)
Q Consensus 455 gg~L~~~l~~~~~~~l~e~~~~~i~~Qil~aL~yLHs--------~~IiHRDLKP~NILl~~~~~~~iKL~DFGla~~~~ 526 (966)
+|+|.++|++. .+++.++..++.|++.||+|||+ +|||||||||+||||++ ++.+||+|||+++...
T Consensus 85 ~g~L~~~l~~~---~l~~~~~~~~~~~ia~gl~~lH~~~~~~~~~~~IvHrDlKp~NILl~~--~~~~Kl~DFGl~~~~~ 159 (303)
T d1vjya_ 85 HGSLFDYLNRY---TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKK--NGTCCIADLGLAVRHD 159 (303)
T ss_dssp TCBHHHHHHHC---CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCCGGGEEECT--TSCEEECCCTTCEEEE
T ss_pred CCCHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCeeccccCccceEEcC--CCCeEEEecCcccccc
Confidence 99999999875 48999999999999999999996 59999999999999975 5699999999997643
Q ss_pred C-------CCccccccccccCchhhccCCCCCCCcccchhhhhhhhhhhhcCCCCCCCcCcchhHHHHHHHHhcCCCCCC
Q psy11767 527 E-------SLHTPCFTLQYAAPEVLRQDKSGYDENCDLWSLGVILVNVLRQDKSGYDENCDLWSLGVILYTMLCGRVPFH 599 (966)
Q Consensus 527 ~-------~~~~~~gT~~Y~APEvl~~~~~~~~~~~Di~SlGvil~el~~~~~~~y~~~~DIWSlGvilyemltG~~Pf~ 599 (966)
. .....+||+.|||||++...... ....|+.++|||||||+||||++|.+||.
T Consensus 160 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~--------------------~~~~~~~k~Di~S~Gvvl~el~tg~~~~~ 219 (303)
T d1vjya_ 160 SATDTIDIAPNHRVGTKRYMAPEVLDDSINM--------------------KHFESFKRADIYAMGLVFWEIARRCSIGG 219 (303)
T ss_dssp TTTTEECC----CCSCGGGCCHHHHTTCSCT--------------------TCHHHHHHHHHHHHHHHHHHHHHTBCBTT
T ss_pred CCCcceeccccceecccCcCChhhccccccc--------------------cCCCcCcchhhhhhHHHHHHHhhCCCCCC
Confidence 2 12346789999999998642110 01125678999999999999999998874
Q ss_pred CCCCc-----------hhHHHHHHHHHcCCCCCC-chhh--ccCCHHHHHHHHHhcccCccccCChHHHHHHhhhh
Q psy11767 600 ARSRD-----------DSALSIMARIKEGQFNFD-AEAW--STVSSEAKELTKSLLTVNPAQRIRMMRVKLTFHAF 661 (966)
Q Consensus 600 ~~~~~-----------~~~~~~~~~i~~~~~~~~-~~~~--~~is~e~~~Li~~~L~~dP~~R~t~~~v~~~~~~~ 661 (966)
..... .....+...+..+..... +..+ .....++.+|+.+||+.||++|||+.++...+..+
T Consensus 220 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ei~~~L~~i 295 (303)
T d1vjya_ 220 IHEDYQLPYYDLVPSDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQL 295 (303)
T ss_dssp BCCCCCCTTTTTSCSSCCHHHHHHHHTTSCCCCCCCGGGGGCHHHHHHHHHHHTTCCSSGGGSCCHHHHHHHHHHH
T ss_pred cccccccchhhcccccchHHHHHHHHhccccCCCCCcccCChHHHHHHHHHHHHHcccCHhHCcCHHHHHHHHHHH
Confidence 32211 111122223333333211 1122 12335688999999999999999999986655544
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=8.5e-40 Score=367.68 Aligned_cols=266 Identities=24% Similarity=0.410 Sum_probs=197.1
Q ss_pred cccccceec-ccccccccccccccccccEEEEEEEcCCCcEEEEEEecccc----ChHHHHHHHHHhc----------CC
Q psy11767 366 IFKGSLFFE-QYDMDLDKAGILGDGSYSVCRRCVEKSTGQEYAVKIISRKI----DCSEEINLLRACQ----------GH 430 (966)
Q Consensus 366 if~G~~~~~-~~~i~~~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~----~~~~Ei~iL~~l~----------~H 430 (966)
+..|..|.+ +|.+ +++||+|+||+||+|+++.+|+.||||++++.. ...+|+++|+.+. +|
T Consensus 4 ~~~g~~~~~~rY~i----~~~LG~G~fg~Vy~~~~~~~g~~vAvKvi~~~~~~~~~~~~Ei~~l~~l~~~~~~~~~~~~~ 79 (362)
T d1q8ya_ 4 AFKGEPYKDARYIL----VRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYTEAAEDEIKLLQRVNDADNTKEDSMGA 79 (362)
T ss_dssp CCTTCEETTTTEEE----EEEEEECSSEEEEEEEETTTTEEEEEEEECSCHHHHHHHHHHHHHHHHHHHTCCSHHHHHHH
T ss_pred CCCCCCccCCcEEE----EEEEeeCCCeEEEEEEECCCCCEEEEEEEeccccchHHHHHHHHHHHHhcchhhhhhhhcCc
Confidence 455666654 5765 789999999999999999999999999997542 2456888888764 47
Q ss_pred CCceEEEEEEEe--CCeEEEEEEccCCCC-HHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHh-cCceeccCCCCcEEE
Q psy11767 431 PNIVNLHCVFQD--EVHTYLVLELLKGGE-LLDRIRQKGRCGFTENEASRIMRQLVAAVHFMHS-RGVVHRDLKPENLLF 506 (966)
Q Consensus 431 pnIV~l~~~~~~--~~~~~lVmEy~~gg~-L~~~l~~~~~~~l~e~~~~~i~~Qil~aL~yLHs-~~IiHRDLKP~NILl 506 (966)
+|||++++++.. ....++||+++..+. ............+++..++.++.||+.||+|||+ .||+||||||+|||+
T Consensus 80 ~~iv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qil~al~~lh~~~~IvHrDlKp~NIll 159 (362)
T d1q8ya_ 80 NHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRCGIIHTDIKPENVLM 159 (362)
T ss_dssp TTBCCCCEEEEEEETTEEEEEEEECCCCEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTCEECSCCSGGGEEE
T ss_pred CceEEEEEEeeeccccceeeeeeecccccccccccccccccCCcHHHHHHHHHHHHHHHHHHhhhcCcccccCChhHeee
Confidence 899999988864 456777787776554 3334444444579999999999999999999998 899999999999999
Q ss_pred ecCCC----CCEEEEeecccccccCCCccccccccccCchhhccCCCCCCCcccchhhhhhhhhhhhcCCCCCCCcCcch
Q psy11767 507 SDPAG----DNIKVVDFGFACLKRESLHTPCFTLQYAAPEVLRQDKSGYDENCDLWSLGVILVNVLRQDKSGYDENCDLW 582 (966)
Q Consensus 507 ~~~~~----~~iKL~DFGla~~~~~~~~~~~gT~~Y~APEvl~~~~~~~~~~~Di~SlGvil~el~~~~~~~y~~~~DIW 582 (966)
+.... ..+||+|||.|..........+||+.|+|||++.. ..|+.++|||
T Consensus 160 ~~~~~~~~~~~~kl~dfg~s~~~~~~~~~~~gt~~y~aPE~~~~--------------------------~~~~~~~Diw 213 (362)
T d1q8ya_ 160 EIVDSPENLIQIKIADLGNACWYDEHYTNSIQTREYRSPEVLLG--------------------------APWGCGADIW 213 (362)
T ss_dssp EEEETTTTEEEEEECCCTTCEETTBCCCSCCSCGGGCCHHHHHT--------------------------CCCCTHHHHH
T ss_pred eccCcccccceeeEeecccccccccccccccccccccChhhccc--------------------------cCCCcccccc
Confidence 74222 14899999999877766677889999999998863 2478899999
Q ss_pred hHHHHHHHHhcCCCCCCCCCCchh--HHHHHH---HHH---------cCCC------------CC--------------C
Q psy11767 583 SLGVILYTMLCGRVPFHARSRDDS--ALSIMA---RIK---------EGQF------------NF--------------D 622 (966)
Q Consensus 583 SlGvilyemltG~~Pf~~~~~~~~--~~~~~~---~i~---------~~~~------------~~--------------~ 622 (966)
|+||++++|++|+.||........ ....+. .+. .+.+ .. .
T Consensus 214 SlG~il~el~~g~~pF~~~~~~~~~~~~~~~~~~~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 293 (362)
T d1q8ya_ 214 STACLIFELITGDFLFEPDEGHSYTKDDDHIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEK 293 (362)
T ss_dssp HHHHHHHHHHHSSCCC---------CHHHHHHHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHT
T ss_pred chHHHHHHHHHCCCCCCCCccccccchhHHHHHHHHHhCCCCHHHhhcccccccccccchhhhccccccCCchhhhcccc
Confidence 999999999999999975432110 001111 110 0000 00 0
Q ss_pred chhhccCCHHHHHHHHHhcccCccccCChHHHHHHhhhhHH
Q psy11767 623 AEAWSTVSSEAKELTKSLLTVNPAQRIRMMRVKLTFHAFHQ 663 (966)
Q Consensus 623 ~~~~~~is~e~~~Li~~~L~~dP~~R~t~~~v~~~~~~~~~ 663 (966)
...+...+++++|||.+||++||.+|||+.++ ..|+|++
T Consensus 294 ~~~~~~~~~~~~dll~~mL~~dP~~Rpta~e~--L~Hp~f~ 332 (362)
T d1q8ya_ 294 YKFSKDEAKEISDFLSPMLQLDPRKRADAGGL--VNHPWLK 332 (362)
T ss_dssp TCCCHHHHHHHHHHHGGGGCSSTTTCBCHHHH--HTCGGGT
T ss_pred cccCcccCHHHHHHHHHHCCCChhHCcCHHHH--hcCcccC
Confidence 00112357889999999999999999999986 4588875
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.9e-38 Score=350.27 Aligned_cols=232 Identities=30% Similarity=0.532 Sum_probs=200.1
Q ss_pred CcceeeeecccccceEEEEEEcCCCCEEEEEeccccc--------hhhHHHHHHHHhhCCCcccccc-------------
Q psy11767 117 DLDKAGILGDGSYSVCRRCVEKSTGQEYAVKIISRKI--------DCSEEINLLRACQGHPNICRRC------------- 175 (966)
Q Consensus 117 df~~~~~LG~GsFGkV~La~~k~tg~~yAiKvl~K~~--------~~~~E~~il~~~~~~pfi~~~~------------- 175 (966)
||+++++||+|+||+|++|+++.||+.||||+++|.. ...+|.+||+++ +||||++.+
T Consensus 6 dy~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l-~hp~Iv~l~~~~~~~~~~~iv~ 84 (337)
T d1o6la_ 6 DFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNT-RHPFLTALKYAFQTHDRLCFVM 84 (337)
T ss_dssp GEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSC-CCTTBCCEEEEEECSSEEEEEE
T ss_pred hcEEEEEEecCcCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhC-CCCCEEEEEeeeccccccccce
Confidence 7999999999999999999999999999999998752 357899999988 599998732
Q ss_pred -----------------cccccchhHHHHHHHh----------hcccchhhhHhhhccCCceEEecCccc----------
Q psy11767 176 -----------------VEKSTGQEYAVKIISR----------KIDCSEEINLLRACQGHPNIVNLHCVF---------- 218 (966)
Q Consensus 176 -----------------~~~~~~~~~~~~~v~~----------~~~~~~e~nil~~~~gh~~iv~l~~~~---------- 218 (966)
+.+..+++++.+++.+ ..|++++ |||++.+|+++|+||+.+.
T Consensus 85 ey~~gg~L~~~~~~~~~~~e~~~~~~~~qil~al~ylH~~~iiHRDlKP~-NILl~~~g~vkl~DFG~a~~~~~~~~~~~ 163 (337)
T d1o6la_ 85 EYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSRDVVYRDIKLE-NLMLDKDGHIKITDFGLCKEGISDGATMK 163 (337)
T ss_dssp ECCTTCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGG-GEEECTTSCEEECCCTTCBCSCCTTCCBC
T ss_pred eccCCCchhhhhhcccCCcHHHHHHHHHHHhhhhhhhhhcCccccccCHH-HeEecCCCCEEEeecccccccccCCcccc
Confidence 2333334555555544 1256666 9999999999999998763
Q ss_pred ---------cccccccccCCCcceeeechhhHHHHHHHhhCCCCCCCCcHHHHHHHHHhCCCCCCCCCCHHHHHHHHhhc
Q psy11767 219 ---------QDEVIDWDDFSRGIECVFFSSSLIIFFIILSFTLSFIHDYYHIQYRRILKTEPPIPEDLSPDVADFISRLL 289 (966)
Q Consensus 219 ---------~~e~i~~~~y~~~~d~~~~~~~~il~~~m~~g~~pf~~~~~~~~~~~I~~~~~~~P~~~s~~a~dli~~LL 289 (966)
.+|++...+|+..+| ||+.||++|||++|.+||...+...++++|..+.+.||..+|++++|||++||
T Consensus 164 ~~~GT~~Y~aPE~~~~~~y~~~~D---iwSlGvilyeml~G~~pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~dli~~~L 240 (337)
T d1o6la_ 164 TFCGTPEYLAPEVLEDNDYGRAVD---WWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEIRFPRTLSPEAKSLLAGLL 240 (337)
T ss_dssp CCEECGGGCCGGGGSSSCBCTTHH---HHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCTTSCHHHHHHHHHHT
T ss_pred cceeCHHHhhhhhccCCCCChhhc---ccchhhHHHHHHHCCCCCCCcCHHHHHHHHhcCCCCCCccCCHHHHHHHHhhc
Confidence 257788888988777 66888999999999999999999999999999999999999999999999999
Q ss_pred ccCCCcccCCCCCCHHHHhcCCceeeeCccccccCCCCCCCCccccccccccccccccccCcCC
Q psy11767 290 VKDPRRRLGGGELDAEELKRHPFFNVIDWDDLATKRIPAPFVPKISNELDVSNFSDEFTKMIPA 353 (966)
Q Consensus 290 ~kdp~~RLG~~~~g~~~Ik~HpfF~~idW~~l~~k~~~pP~~P~i~~~~D~snFd~ef~~~~p~ 353 (966)
++||.+|+++...+++||++||||+++||+++..++++||++|.+.+..|++||+++|+.....
T Consensus 241 ~~dP~~R~~~~~~~~~eil~Hp~f~~i~~~~l~~~~~~~p~~P~~~~~~~~~~f~~~~~~~~~~ 304 (337)
T d1o6la_ 241 KKDPKQRLGGGPSDAKEVMEHRFFLSINWQDVVQKKLLPPFKPQVTSEVDTRYFDDEFTAQSIT 304 (337)
T ss_dssp CSSTTTSTTCSTTTHHHHHTSGGGTTCCHHHHHTTCSCCSCCCCCSSTTCCTTSCHHHHTSCCC
T ss_pred cCCchhhcccccccHHHHHcCcccccCCHHHHHhCCCCCCCCCCCCChhhhhhcCchhhhccCC
Confidence 9999999998766899999999999999999999999999999999999999999988765433
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=5.7e-35 Score=323.25 Aligned_cols=227 Identities=27% Similarity=0.465 Sum_probs=181.6
Q ss_pred ccC-CcceeeeecccccceEEEEEEcCCCCEEEEEeccccc--------hhhHHHHHHHHhhCCCcccccccccccc---
Q psy11767 114 YDM-DLDKAGILGDGSYSVCRRCVEKSTGQEYAVKIISRKI--------DCSEEINLLRACQGHPNICRRCVEKSTG--- 181 (966)
Q Consensus 114 ~~~-df~~~~~LG~GsFGkV~La~~k~tg~~yAiKvl~K~~--------~~~~E~~il~~~~~~pfi~~~~~~~~~~--- 181 (966)
|.| ||+++++||+|+||+|++|+++.||+.||||+++|.. ...+|..+|+++ +||+||+.+..+...
T Consensus 1 ~sl~dy~i~~~lG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l-~HpnIv~~~~~~~~~~~~ 79 (316)
T d1fota_ 1 YSLQDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIV-THPFIIRMWGTFQDAQQI 79 (316)
T ss_dssp CCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSC-CBTTBCCEEEEEECSSEE
T ss_pred CchhHeEEEEEEecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHhc-cCcChhheeeeEeeCCee
Confidence 445 8999999999999999999999999999999998752 357899999988 699998733222221
Q ss_pred ---------------------------hhHHHHHHHh----------hcccchhhhHhhhccCCceEEecCccc------
Q psy11767 182 ---------------------------QEYAVKIISR----------KIDCSEEINLLRACQGHPNIVNLHCVF------ 218 (966)
Q Consensus 182 ---------------------------~~~~~~~v~~----------~~~~~~e~nil~~~~gh~~iv~l~~~~------ 218 (966)
+.++.+++.+ ..|++++ |||++.+|+++|+||+.+.
T Consensus 80 ~ivmE~~~gg~l~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~iiHrDiKp~-NILl~~~g~vkL~DFG~a~~~~~~~ 158 (316)
T d1fota_ 80 FMIMDYIEGGELFSLLRKSQRFPNPVAKFYAAEVCLALEYLHSKDIIYRDLKPE-NILLDKNGHIKITDFGFAKYVPDVT 158 (316)
T ss_dssp EEEECCCCSCBHHHHHHHTSSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGG-GEEECTTSCEEECCCSSCEECSSCB
T ss_pred eeEeeecCCccccccccccccccccHHHHHHHHHHHhhhhhccCcEEccccCch-heeEcCCCCEEEecCccceEecccc
Confidence 2232333322 1255666 9999999999999998653
Q ss_pred ----------cccccccccCCCcceeeechhhHHHHHHHhhCCCCCCCCcHHHHHHHHHhCCCCCCCCCCHHHHHHHHhh
Q psy11767 219 ----------QDEVIDWDDFSRGIECVFFSSSLIIFFIILSFTLSFIHDYYHIQYRRILKTEPPIPEDLSPDVADFISRL 288 (966)
Q Consensus 219 ----------~~e~i~~~~y~~~~d~~~~~~~~il~~~m~~g~~pf~~~~~~~~~~~I~~~~~~~P~~~s~~a~dli~~L 288 (966)
.+|++....|+...| +|+.||++|+|++|.+||.+.+...++++|+++++.+|..+|++++|||++|
T Consensus 159 ~~~~Gt~~Y~APE~l~~~~y~~~~D---iwSlGvilyemltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li~~~ 235 (316)
T d1fota_ 159 YTLCGTPDYIAPEVVSTKPYNKSID---WWSFGILIYEMLAGYTPFYDSNTMKTYEKILNAELRFPPFFNEDVKDLLSRL 235 (316)
T ss_dssp CCCCSCTTTCCHHHHTTCCBCTTHH---HHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHCCCCCCTTSCHHHHHHHHHH
T ss_pred ccccCcccccCHHHHcCCCCCchhh---ccccchhHHHHHhCCCCCCCcCHHHHHHHHHcCCCCCCCCCCHHHHHHHHHH
Confidence 357777777877666 5578888899999999999999999999999999999999999999999999
Q ss_pred cccCCCcccCCCCCCHHHHhcCCceeeeCccccccCCCCCCCCcccc-cccccccccc
Q psy11767 289 LVKDPRRRLGGGELDAEELKRHPFFNVIDWDDLATKRIPAPFVPKIS-NELDVSNFSD 345 (966)
Q Consensus 289 L~kdp~~RLG~~~~g~~~Ik~HpfF~~idW~~l~~k~~~pP~~P~i~-~~~D~snFd~ 345 (966)
|++||.+|+++....+++|++||||++|+|+.|..++++|||+|.+. ...|+++||.
T Consensus 236 L~~dp~~R~~~~r~t~~~il~Hp~f~~i~~~~l~~~~~~~p~~p~~~~~~~d~~~f~~ 293 (316)
T d1fota_ 236 ITRDLSQRLGNLQNGTEDVKNHPWFKEVVWEKLLSRNIETPYEPPIQQGQGDTSQFDK 293 (316)
T ss_dssp TCSCTTTCTTSSTTTTHHHHTSGGGSSCCHHHHHTTCSCCSCCCCC------------
T ss_pred hhhCHHhccccchhhHHHHHcCcccccCCHHHHHhCCCCcCCCCCcCCCcchhhhcCC
Confidence 99999999988777899999999999999999999999999999864 4568899875
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=2.3e-34 Score=322.83 Aligned_cols=225 Identities=24% Similarity=0.416 Sum_probs=190.3
Q ss_pred CcceeeeecccccceEEEEEEcCCCCEEEEEeccccc--------hhhHHHHHHHHhhCCCccccccccc----------
Q psy11767 117 DLDKAGILGDGSYSVCRRCVEKSTGQEYAVKIISRKI--------DCSEEINLLRACQGHPNICRRCVEK---------- 178 (966)
Q Consensus 117 df~~~~~LG~GsFGkV~La~~k~tg~~yAiKvl~K~~--------~~~~E~~il~~~~~~pfi~~~~~~~---------- 178 (966)
||++++.||+|+||+|++|+++.||+.||||+++|.. ...+|.+||+++ +||+||+.+..+
T Consensus 42 ~y~i~~~lG~G~fg~Vy~a~~~~~g~~~AvK~i~~~~~~~~~~~~~~~~E~~il~~l-~hpnIv~~~~~~~~~~~~~~v~ 120 (350)
T d1rdqe_ 42 QFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAV-NFPFLVKLEFSFKDNSNLYMVM 120 (350)
T ss_dssp GEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTC-CCTTBCCEEEEEECSSEEEEEE
T ss_pred CeEEEEEeecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHHc-CCCcEeeccccccccccccccc
Confidence 6899999999999999999999999999999998742 357899999888 699998732222
Q ss_pred --------------------ccchhHHHHHHHh----------hcccchhhhHhhhccCCceEEecCccc----------
Q psy11767 179 --------------------STGQEYAVKIISR----------KIDCSEEINLLRACQGHPNIVNLHCVF---------- 218 (966)
Q Consensus 179 --------------------~~~~~~~~~~v~~----------~~~~~~e~nil~~~~gh~~iv~l~~~~---------- 218 (966)
...+.++.+++.+ ..|++++ |||++.+|+++|+||+.+.
T Consensus 121 e~~~~g~l~~~l~~~~~l~e~~~~~i~~qi~~aL~yLH~~~iiHRDIKP~-NILl~~~g~ikL~DFG~a~~~~~~~~~~~ 199 (350)
T d1rdqe_ 121 EYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPE-NLLIDQQGYIQVTDFGFAKRVKGRTWTLC 199 (350)
T ss_dssp ECCTTCBHHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGG-GEEECTTSCEEECCCTTCEECSSCBCCCE
T ss_pred ccccccchhhhHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCEecCcCCHH-HcccCCCCCEEeeeceeeeeccccccccc
Confidence 2222333333322 1255666 9999999999999999763
Q ss_pred ------cccccccccCCCcceeeechhhHHHHHHHhhCCCCCCCCcHHHHHHHHHhCCCCCCCCCCHHHHHHHHhhcccC
Q psy11767 219 ------QDEVIDWDDFSRGIECVFFSSSLIIFFIILSFTLSFIHDYYHIQYRRILKTEPPIPEDLSPDVADFISRLLVKD 292 (966)
Q Consensus 219 ------~~e~i~~~~y~~~~d~~~~~~~~il~~~m~~g~~pf~~~~~~~~~~~I~~~~~~~P~~~s~~a~dli~~LL~kd 292 (966)
.+|++....|+...| +|+.||++|+|++|.+||...+...++++|..+.+.+|..+|++++|||++||++|
T Consensus 200 Gt~~Y~APE~~~~~~~~~~~D---iwSlGvilyemltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li~~~L~~d 276 (350)
T d1rdqe_ 200 GTPEALAPEIILSKGYNKAVD---WWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHFSSDLKDLLRNLLQVD 276 (350)
T ss_dssp ECGGGCCHHHHTTCCBCTHHH---HHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCTTCCHHHHHHHHHHSCSC
T ss_pred CccccCCHHHHcCCCCCcccc---ccchhHHHHHHHhCCCCCCCcCHHHHHHHHhcCCCCCCccCCHHHHHHHHHHhhhC
Confidence 357777777877666 55788899999999999999999999999999999999999999999999999999
Q ss_pred CCcccCCCCCCHHHHhcCCceeeeCccccccCCCCCCCCccccccccccccccc
Q psy11767 293 PRRRLGGGELDAEELKRHPFFNVIDWDDLATKRIPAPFVPKISNELDVSNFSDE 346 (966)
Q Consensus 293 p~~RLG~~~~g~~~Ik~HpfF~~idW~~l~~k~~~pP~~P~i~~~~D~snFd~e 346 (966)
|.+|+++.+..+++|++||||+++||+.+..++++|||+|...+..|.+||++.
T Consensus 277 P~kR~~~~r~t~~ell~Hp~f~~~~~~~~~~~~~~~p~~p~~~~~~d~s~~~~~ 330 (350)
T d1rdqe_ 277 LTKRFGNLKNGVNDIKNHKWFATTDWIAIYQRKVEAPFIPKFKGPGDTSNFDDY 330 (350)
T ss_dssp TTTCTTSSTTTTHHHHTSGGGTTCCHHHHHTTCSCCSCCCCCCSTTCCTTSCCC
T ss_pred HHhccccccccHHHHHcCccccCCCHHHHHhcCCCcCccCCCCCcchhhhcCCC
Confidence 999998766689999999999999999999999999999999999999999863
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.4e-34 Score=320.72 Aligned_cols=230 Identities=26% Similarity=0.411 Sum_probs=168.1
Q ss_pred CcceeeeecccccceEEEEEEcCCCCEEEEEeccccc--------hhhHHHHHHHHhhCCCccccccccccc--------
Q psy11767 117 DLDKAGILGDGSYSVCRRCVEKSTGQEYAVKIISRKI--------DCSEEINLLRACQGHPNICRRCVEKST-------- 180 (966)
Q Consensus 117 df~~~~~LG~GsFGkV~La~~k~tg~~yAiKvl~K~~--------~~~~E~~il~~~~~~pfi~~~~~~~~~-------- 180 (966)
||+++++||+|+||+||+|+++.||+.||||+++|.. ....|..+|.+..+||+||+.+-.+..
T Consensus 3 dy~i~~~iG~G~fg~Vy~~~~~~t~~~vAvK~i~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~~~~~~~~~~~~yivm 82 (320)
T d1xjda_ 3 DFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLFFVM 82 (320)
T ss_dssp TEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEEEE
T ss_pred CeEEeeEEecCCCcEEEEEEECCCCCEEEEEEEchhhccChHHHHHHHHHHHHHHHhCCCCcEEEEEEEEccCCceeEEE
Confidence 7899999999999999999999999999999998742 346778888776789999872222221
Q ss_pred ----------------------chhHHHHHHHh----------hcccchhhhHhhhccCCceEEecCccc----------
Q psy11767 181 ----------------------GQEYAVKIISR----------KIDCSEEINLLRACQGHPNIVNLHCVF---------- 218 (966)
Q Consensus 181 ----------------------~~~~~~~~v~~----------~~~~~~e~nil~~~~gh~~iv~l~~~~---------- 218 (966)
...++.+++.+ ..|++++ |||.+.+|+.+|.||+.+.
T Consensus 83 Ey~~~g~L~~~i~~~~~~~e~~~~~~~~qi~~al~ylH~~~iiHrDikp~-NiL~~~~~~~kl~DFG~a~~~~~~~~~~~ 161 (320)
T d1xjda_ 83 EYLNGGDLMYHIQSCHKFDLSRATFYAAEIILGLQFLHSKGIVYRDLKLD-NILLDKDGHIKIADFGMCKENMLGDAKTN 161 (320)
T ss_dssp ECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGG-GEEECTTSCEEECCCTTCBCCCCTTCCBC
T ss_pred eecCCCcHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCccc-ceeecCCCceeccccchhhhccccccccc
Confidence 22333333332 1255555 9999999999999998653
Q ss_pred ---------cccccccccCCCcceeeechhhHHHHHHHhhCCCCCCCCcHHHHHHHHHhCCCCCCCCCCHHHHHHHHhhc
Q psy11767 219 ---------QDEVIDWDDFSRGIECVFFSSSLIIFFIILSFTLSFIHDYYHIQYRRILKTEPPIPEDLSPDVADFISRLL 289 (966)
Q Consensus 219 ---------~~e~i~~~~y~~~~d~~~~~~~~il~~~m~~g~~pf~~~~~~~~~~~I~~~~~~~P~~~s~~a~dli~~LL 289 (966)
.+|++....|+...| +|+.||++|+|++|.+||.+.+...++++|..+.+.+|..+|++++|||+++|
T Consensus 162 ~~~gt~~y~aPE~~~~~~~~~~~D---iwSlGvilyemltG~~PF~~~~~~~~~~~i~~~~~~~p~~~s~~~~dli~~~L 238 (320)
T d1xjda_ 162 TFCGTPDYIAPEILLGQKYNHSVD---WWSFGVLLYEMLIGQSPFHGQDEEELFHSIRMDNPFYPRWLEKEAKDLLVKLF 238 (320)
T ss_dssp CCCSCGGGCCHHHHTTCCBCTHHH---HHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCTTSCHHHHHHHHHHS
T ss_pred ccCCCCCcCCHHHHcCCCCCchhh---hhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCccCCHHHHHHHHHhc
Confidence 246677777877666 56788999999999999999999999999999999999999999999999999
Q ss_pred ccCCCcccCCCCCCHHHHhcCCceeeeCccccccCCCCCCCCccccccccccccccccccCcCCC
Q psy11767 290 VKDPRRRLGGGELDAEELKRHPFFNVIDWDDLATKRIPAPFVPKISNELDVSNFSDEFTKMIPAD 354 (966)
Q Consensus 290 ~kdp~~RLG~~~~g~~~Ik~HpfF~~idW~~l~~k~~~pP~~P~i~~~~D~snFd~ef~~~~p~d 354 (966)
++||.+|++. ..+|++||||++++|+.|..++++||+.|.+.+..|.+|||.++....+..
T Consensus 239 ~~dP~~R~s~----~~~l~~hpff~~~~~~~l~~~~~~pp~~p~~~~~~d~~~f~~~~~~~~~~~ 299 (320)
T d1xjda_ 239 VREPEKRLGV----RGDIRQHPLFREINWEELERKEIDPPFRPKVKSPFDCSNFDKEFLNEKPRL 299 (320)
T ss_dssp CSSGGGSBTT----BSCGGGSGGGTTCCHHHHHTTCSCC--------------------------
T ss_pred ccCCCCCcCH----HHHHHhCchhccCCHHHHHhcCCCCCCCCCCCCccchhhcChHhhhCCccC
Confidence 9999999963 247999999999999999999999999999999999999998886554443
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Probab=99.97 E-value=3.3e-32 Score=306.66 Aligned_cols=227 Identities=26% Similarity=0.394 Sum_probs=171.3
Q ss_pred CcceeeeecccccceEEEEEEcCCCCEEEEEeccccc--------hhhHHHHHHHHhh--CCCccccccccccc------
Q psy11767 117 DLDKAGILGDGSYSVCRRCVEKSTGQEYAVKIISRKI--------DCSEEINLLRACQ--GHPNICRRCVEKST------ 180 (966)
Q Consensus 117 df~~~~~LG~GsFGkV~La~~k~tg~~yAiKvl~K~~--------~~~~E~~il~~~~--~~pfi~~~~~~~~~------ 180 (966)
||+++++||+|+||+||+|+++.||+.||||+++|.. ...+|++++..++ +||+||+.+..+..
T Consensus 5 dy~i~~~lG~G~fg~Vy~~~~~~t~~~vAiK~i~~~~~~~~~~~~~~~~e~~~~~~l~~~~hpnIv~l~~~~~~~~~~~i 84 (364)
T d1omwa3 5 DFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSF 84 (364)
T ss_dssp TEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSEEEE
T ss_pred hCeeeeEEecCCCeEEEEEEECCCCCEEEEEEEchHHcchhhHHHHHHHHHHHHHHHhcCCCCcEEEEEEEEEECCEEEE
Confidence 8999999999999999999999999999999998752 2355666665543 69999873322222
Q ss_pred ------------------------chhHHHHHHHh----------hcccchhhhHhhhccCCceEEecCccc--------
Q psy11767 181 ------------------------GQEYAVKIISR----------KIDCSEEINLLRACQGHPNIVNLHCVF-------- 218 (966)
Q Consensus 181 ------------------------~~~~~~~~v~~----------~~~~~~e~nil~~~~gh~~iv~l~~~~-------- 218 (966)
...++.+++.+ ..|++++ |||++.+|+++|+||+.+.
T Consensus 85 vmE~~~gg~L~~~l~~~~~~~e~~~~~~~~qi~~aL~ylH~~~iiHrDlKP~-NILl~~~g~iKl~DFGla~~~~~~~~~ 163 (364)
T d1omwa3 85 ILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGLEHMHNRFVVYRDLKPA-NILLDEHGHVRISDLGLACDFSKKKPH 163 (364)
T ss_dssp EECCCCSCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGG-GEEECSSSCEEECCCTTCEECSSSCCC
T ss_pred EEEecCCCcHHHHHHhcccccHHHHHHHHHHHHHHHHHHHHCCccceeeccc-eeEEcCCCcEEEeeeceeeecCCCccc
Confidence 12222333322 1256666 9999999999999999663
Q ss_pred ---------cccccc-cccCCCcceeeechhhHHHHHHHhhCCCCCCCC---cHHHHHHHHHhCCCCCCCCCCHHHHHHH
Q psy11767 219 ---------QDEVID-WDDFSRGIECVFFSSSLIIFFIILSFTLSFIHD---YYHIQYRRILKTEPPIPEDLSPDVADFI 285 (966)
Q Consensus 219 ---------~~e~i~-~~~y~~~~d~~~~~~~~il~~~m~~g~~pf~~~---~~~~~~~~I~~~~~~~P~~~s~~a~dli 285 (966)
.+|++. ...|+..+| +|+.||++|+|++|.+||... +...+++.+....+.+|..+|++++|||
T Consensus 164 ~~~GT~~y~APE~~~~~~~~~~~~D---iwSlGvilyemltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li 240 (364)
T d1omwa3 164 ASVGTHGYMAPEVLQKGVAYDSSAD---WFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVELPDSFSPELRSLL 240 (364)
T ss_dssp SCCSCGGGCCHHHHSTTCCCCTHHH---HHHHHHHHHHHHHSSCSSCSSCSSCHHHHHHHSSSCCCCCCSSSCHHHHHHH
T ss_pred ccccccccchhHHhhcCCCCCcccc---hhHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcccCCCCCCCCCCHHHHHHH
Confidence 245664 345776666 557889999999999999753 4556778888899999999999999999
Q ss_pred HhhcccCCCcccCCCCCCHHHHhcCCceeeeCccccccCCCCCCCCccccccc-----ccccccccc
Q psy11767 286 SRLLVKDPRRRLGGGELDAEELKRHPFFNVIDWDDLATKRIPAPFVPKISNEL-----DVSNFSDEF 347 (966)
Q Consensus 286 ~~LL~kdp~~RLG~~~~g~~~Ik~HpfF~~idW~~l~~k~~~pP~~P~i~~~~-----D~snFd~ef 347 (966)
.++|++||.+|+++...+++||++||||+++||+.+..++++||++|...... |..+|++++
T Consensus 241 ~~~L~~dP~~R~t~~~~~a~eil~Hp~f~~i~~~~~~~~~~~~p~~p~~~~~~~~~~~d~~~~~~~~ 307 (364)
T d1omwa3 241 EGLLQRDVNRRLGCLGRGAQEVKESPFFRSLDWQMVFLQKYPPPLIPPRGEVNAADAFDIGSFDEED 307 (364)
T ss_dssp HHHTCSSTTTSTTTSSSTHHHHHTSGGGTTCCHHHHHTTCSCCSCCCCCC-----------------
T ss_pred HHHcccCHHHhCCCcccCHHHHHcCccccCCCHHHHhcCCCCcCcCCCCCCCCcCCccccccCChhh
Confidence 99999999999997666899999999999999999999999999999765444 344555443
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.97 E-value=6.7e-32 Score=294.61 Aligned_cols=209 Identities=25% Similarity=0.414 Sum_probs=167.2
Q ss_pred CcceeeeecccccceEEEEEEcCCCCEEEEEeccccc--------hhhHHHHHHHHhhCCCcccccccccccc-------
Q psy11767 117 DLDKAGILGDGSYSVCRRCVEKSTGQEYAVKIISRKI--------DCSEEINLLRACQGHPNICRRCVEKSTG------- 181 (966)
Q Consensus 117 df~~~~~LG~GsFGkV~La~~k~tg~~yAiKvl~K~~--------~~~~E~~il~~~~~~pfi~~~~~~~~~~------- 181 (966)
||+++++||+|+||+|++|+++.||+.||||+++|.. ...+|.+||+++ +||+||+.+..+...
T Consensus 9 dy~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l-~HpnIv~l~~~~~~~~~~~ivm 87 (288)
T d1uu3a_ 9 DFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRL-DHPFFVKLYFTFQDDEKLYFGL 87 (288)
T ss_dssp GEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHC-CSTTBCCEEEEEECSSEEEEEE
T ss_pred CCEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccCHHHHHHHHHHHHHHHHc-CCCCeeEEEEEEEECCEEEEEE
Confidence 7899999999999999999999999999999998742 357899999988 699999733222221
Q ss_pred -----------------------hhHHHHHHHh----------hcccchhhhHhhhccCCceEEecCccc----------
Q psy11767 182 -----------------------QEYAVKIISR----------KIDCSEEINLLRACQGHPNIVNLHCVF---------- 218 (966)
Q Consensus 182 -----------------------~~~~~~~v~~----------~~~~~~e~nil~~~~gh~~iv~l~~~~---------- 218 (966)
+.++.+++.+ ..|++++ |||.+.+|+++|+||+.+.
T Consensus 88 Ey~~gg~L~~~~~~~~~l~e~~~~~~~~qi~~al~ylH~~~iiHrDiKp~-NIll~~~~~vkl~DFG~a~~~~~~~~~~~ 166 (288)
T d1uu3a_ 88 SYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKGIIHRDLKPE-NILLNEDMHIQITDFGTAKVLSPESKQAR 166 (288)
T ss_dssp CCCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGG-GEEECTTSCEEECCCTTCEECC-------
T ss_pred EccCCCCHHHhhhccCCCCHHHHHHHHHHHHHHHHhhccccEEcCcCCcc-ccccCCCceEEecccccceecccCCcccc
Confidence 2222233322 1255666 9999999999999998662
Q ss_pred -----------cccccccccCCCcceeeechhhHHHHHHHhhCCCCCCCCcHHHHHHHHHhCCCCCCCCCCHHHHHHHHh
Q psy11767 219 -----------QDEVIDWDDFSRGIECVFFSSSLIIFFIILSFTLSFIHDYYHIQYRRILKTEPPIPEDLSPDVADFISR 287 (966)
Q Consensus 219 -----------~~e~i~~~~y~~~~d~~~~~~~~il~~~m~~g~~pf~~~~~~~~~~~I~~~~~~~P~~~s~~a~dli~~ 287 (966)
.+|++....|+...| +|+.||++|+|++|.+||...+...++++|+++++.||..+|++++|||++
T Consensus 167 ~~~~~GT~~Y~APE~~~~~~~~~~~D---iwSlGvilyell~g~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li~~ 243 (288)
T d1uu3a_ 167 ANSFVGTAQYVSPELLTEKSACKSSD---LWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDFPEKFFPKARDLVEK 243 (288)
T ss_dssp ---CCCCGGGCCHHHHHTCCCCHHHH---HHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHTTCCCCCTTCCHHHHHHHHT
T ss_pred cccccCCccccCceeeccCCCCcccc---eehhhHHHHHHhhCCCCCCCcCHHHHHHHHHcCCCCCCccCCHHHHHHHHH
Confidence 235666666765555 557778889999999999999999999999999999999999999999999
Q ss_pred hcccCCCcccCCCC-CCHHHHhcCCceeeeCccccccCCCCCCCCc
Q psy11767 288 LLVKDPRRRLGGGE-LDAEELKRHPFFNVIDWDDLATKRIPAPFVP 332 (966)
Q Consensus 288 LL~kdp~~RLG~~~-~g~~~Ik~HpfF~~idW~~l~~k~~~pP~~P 332 (966)
+|++||.+|+++.+ .+..+|++||||++|||+.|.++ .||.+|
T Consensus 244 ~L~~dP~~R~t~~e~~~~~~i~~Hpff~~i~w~~l~~~--~pP~l~ 287 (288)
T d1uu3a_ 244 LLVLDATKRLGCEEMEGYGPLKAHPFFESVTWENLHQQ--TPPKLT 287 (288)
T ss_dssp TSCSSGGGSTTSGGGTCHHHHHTSGGGTTCCCTTGGGS--CCCCCC
T ss_pred HccCCHhHCcCHHHHcCCHHHHcCCccCCCCHHHhhcC--CCCCCC
Confidence 99999999997643 25667999999999999999765 355444
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.96 E-value=2.8e-29 Score=277.98 Aligned_cols=219 Identities=32% Similarity=0.545 Sum_probs=168.1
Q ss_pred CcceeeeecccccceEEEEEE---cCCCCEEEEEeccccc---------hhhHHHHHHHHhhCCCcccccccccccc---
Q psy11767 117 DLDKAGILGDGSYSVCRRCVE---KSTGQEYAVKIISRKI---------DCSEEINLLRACQGHPNICRRCVEKSTG--- 181 (966)
Q Consensus 117 df~~~~~LG~GsFGkV~La~~---k~tg~~yAiKvl~K~~---------~~~~E~~il~~~~~~pfi~~~~~~~~~~--- 181 (966)
||++++.||+|+||+||+|++ +.||+.||||+++|.. ...+|.++|+++.+||+|++....+...
T Consensus 25 ~y~~~~~IG~G~fg~Vy~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~~E~~il~~l~h~pnIv~~~~~~~~~~~~ 104 (322)
T d1vzoa_ 25 NFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTETKL 104 (322)
T ss_dssp GEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETTEE
T ss_pred ceEEEEEEecCCCeEEEEEEECccCCCCcEEEEEEEehHHhccchHHHHHHHHHHHHHHhccCCCeEEEeeeeeccCCce
Confidence 799999999999999999997 5589999999998642 3568999999998889998722222111
Q ss_pred ---------------------------hhHHHHHHHh----------hcccchhhhHhhhccCCceEEecCcccc-----
Q psy11767 182 ---------------------------QEYAVKIISR----------KIDCSEEINLLRACQGHPNIVNLHCVFQ----- 219 (966)
Q Consensus 182 ---------------------------~~~~~~~v~~----------~~~~~~e~nil~~~~gh~~iv~l~~~~~----- 219 (966)
..++.+++.+ ..|++++ |+|++.+|..+|+||+.+..
T Consensus 105 ~~v~e~~~~~~L~~~i~~~~~~~e~~~~~~~~Qi~~al~~lH~~~ivHrDiKp~-Nill~~~~~vkL~DFG~a~~~~~~~ 183 (322)
T d1vzoa_ 105 HLILDYINGGELFTHLSQRERFTEHEVQIYVGEIVLALEHLHKLGIIYRDIKLE-NILLDSNGHVVLTDFGLSKEFVADE 183 (322)
T ss_dssp EEEECCCCSCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGG-GEEECTTSCEEESCSSEEEECCGGG
T ss_pred eeeeecccccHHHHHHHhcccccHHHHHHHHHHHHHHHHHhhcCCEEeccCCcc-ceeecCCCCEEEeeccchhhhcccc
Confidence 1111222222 1255555 99999999999999996621
Q ss_pred ---------------ccccccc--cCCCcceeeechhhHHHHHHHhhCCCCCCCC----cHHHHHHHHHhCCCCCCCCCC
Q psy11767 220 ---------------DEVIDWD--DFSRGIECVFFSSSLIIFFIILSFTLSFIHD----YYHIQYRRILKTEPPIPEDLS 278 (966)
Q Consensus 220 ---------------~e~i~~~--~y~~~~d~~~~~~~~il~~~m~~g~~pf~~~----~~~~~~~~I~~~~~~~P~~~s 278 (966)
+|.+... .|+...| .|+.|+++|+|++|.+||... ....+.+......+.+|..+|
T Consensus 184 ~~~~~~~~g~~~~~~pe~~~~~~~~~~~ksD---IWSlG~iLyelltG~~PF~~~~~~~~~~~i~~~~~~~~~~~~~~~s 260 (322)
T d1vzoa_ 184 TERAYDFCGTIEYMAPDIVRGGDSGHDKAVD---WWSLGVLMYELLTGASPFTVDGEKNSQAEISRRILKSEPPYPQEMS 260 (322)
T ss_dssp GGGGCGGGSCCTTCCHHHHTTCC---CTHHH---HHHHHHHHHHHHHSSCTTSCTTSCCCHHHHHHHHHHCCCCCCTTSC
T ss_pred cccccccccccccchhHHhhcCCcCCCchhh---hHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcccCCCCCcccCC
Confidence 1223222 2222333 457788888898999999764 344566677788999999999
Q ss_pred HHHHHHHHhhcccCCCcccCCCCCCHHHHhcCCceeeeCccccccCCCCCCCCcccccccc
Q psy11767 279 PDVADFISRLLVKDPRRRLGGGELDAEELKRHPFFNVIDWDDLATKRIPAPFVPKISNELD 339 (966)
Q Consensus 279 ~~a~dli~~LL~kdp~~RLG~~~~g~~~Ik~HpfF~~idW~~l~~k~~~pP~~P~i~~~~D 339 (966)
+++++||+++|++||.+|+++....++||++||||++|+|+.|..++++||++|.+.++.|
T Consensus 261 ~~~~~li~~~l~~dP~~R~s~~~~t~~eil~Hpff~~i~~~~l~~~~~~~p~~p~~~~~~~ 321 (322)
T d1vzoa_ 261 ALAKDLIQRLLMKDPKKRLGCGPRDADEIKEHLFFQKINWDDLAAKKVPAPFKPVIRDELD 321 (322)
T ss_dssp HHHHHHHHHHTCSSGGGSTTSSTTTHHHHHTSGGGTTCCHHHHHTTCSCCSCCCCCCC-CC
T ss_pred HHHHHHHHHHcccCHHHcCCCCcccHHHHHcCHhhcCCCHHHHHhCCCCcCCCCCCCCCCC
Confidence 9999999999999999999876557999999999999999999999999999999988766
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.94 E-value=9.5e-28 Score=258.11 Aligned_cols=192 Identities=23% Similarity=0.342 Sum_probs=156.8
Q ss_pred ccC-CcceeeeecccccceEEEEEEcCCCCEEEEEeccccc--------hhhHHHHHHHHhhCCCccccccccccc----
Q psy11767 114 YDM-DLDKAGILGDGSYSVCRRCVEKSTGQEYAVKIISRKI--------DCSEEINLLRACQGHPNICRRCVEKST---- 180 (966)
Q Consensus 114 ~~~-df~~~~~LG~GsFGkV~La~~k~tg~~yAiKvl~K~~--------~~~~E~~il~~~~~~pfi~~~~~~~~~---- 180 (966)
|.+ ||++++.||+|+||+|++|+++.||+.||||+++|.. ...+|.++|+++ +||+||+.+-.+..
T Consensus 3 ~~l~dy~i~~~iG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l-~hpnIv~~~~~~~~~~~~ 81 (263)
T d2j4za1 3 WALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL-RHPNILRLYGYFHDATRV 81 (263)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTC-CCTTBCCEEEEEECSSEE
T ss_pred cchhHeEEEEEEecCCCcEEEEEEECCCCcEEEEEEEchHHccChHHHHHHHHHHHHHHhc-CCCCCCeEEEEEEECCEE
Confidence 555 8999999999999999999999999999999998642 346799999988 69999872222111
Q ss_pred --------------------------chhHHHHHHHh----------hcccchhhhHhhhccCCceEEecCcccc-----
Q psy11767 181 --------------------------GQEYAVKIISR----------KIDCSEEINLLRACQGHPNIVNLHCVFQ----- 219 (966)
Q Consensus 181 --------------------------~~~~~~~~v~~----------~~~~~~e~nil~~~~gh~~iv~l~~~~~----- 219 (966)
...++.+++.+ ..|++++ |||++.+|+++|+||+.+..
T Consensus 82 ~ivmEy~~~g~L~~~l~~~~~l~e~~~~~i~~qi~~al~~lH~~~ivHrDiKp~-Nill~~~~~~kl~DFG~a~~~~~~~ 160 (263)
T d2j4za1 82 YLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKRVIHRDIKPE-NLLLGSAGELKIADFGWSVHAPSSR 160 (263)
T ss_dssp EEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGG-GEEECTTSCEEECCCCSCSCCCCCC
T ss_pred EEEEeecCCCcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeeeeeccc-cceecCCCCEeecccceeeecCCCc
Confidence 12222333322 1255666 99999999999999997642
Q ss_pred ------------ccccccccCCCcceeeechhhHHHHHHHhhCCCCCCCCcHHHHHHHHHhCCCCCCCCCCHHHHHHHHh
Q psy11767 220 ------------DEVIDWDDFSRGIECVFFSSSLIIFFIILSFTLSFIHDYYHIQYRRILKTEPPIPEDLSPDVADFISR 287 (966)
Q Consensus 220 ------------~e~i~~~~y~~~~d~~~~~~~~il~~~m~~g~~pf~~~~~~~~~~~I~~~~~~~P~~~s~~a~dli~~ 287 (966)
||++....|+...| +|+.|+++|+|++|.+||...+...++++|.+.++.+|..+|++++|||.+
T Consensus 161 ~~~~~Gt~~Y~APE~~~~~~~~~~~D---iwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li~~ 237 (263)
T d2j4za1 161 RTTLCGTLDYLPPEMIEGRMHDEKVD---LWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVTEGARDLISR 237 (263)
T ss_dssp CEETTEEGGGCCHHHHTTCCCCTTHH---HHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTTCCCCCTTSCHHHHHHHHH
T ss_pred ccccCCCCcccCHHHHcCCCCCchhh---hhhHhHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCCCccCCHHHHHHHHH
Confidence 46777777877666 457888889999999999999999999999999999999999999999999
Q ss_pred hcccCCCcccCCCCCCHHHHhcCCceee
Q psy11767 288 LLVKDPRRRLGGGELDAEELKRHPFFNV 315 (966)
Q Consensus 288 LL~kdp~~RLG~~~~g~~~Ik~HpfF~~ 315 (966)
+|++||.+|+. ++||.+||||.+
T Consensus 238 ~L~~dp~~R~t-----~~eil~hp~~~~ 260 (263)
T d2j4za1 238 LLKHNPSQRPM-----LREVLEHPWITA 260 (263)
T ss_dssp HTCSSGGGSCC-----HHHHHTCHHHHH
T ss_pred HccCCHhHCcC-----HHHHHcCcCcCC
Confidence 99999999983 899999999963
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.94 E-value=6e-27 Score=255.56 Aligned_cols=203 Identities=25% Similarity=0.428 Sum_probs=150.0
Q ss_pred CcceeeeecccccceEEEEEEcCCCCEEEEEeccccc-----------hhhHHHHHHHHhhCCCcccccccccccc----
Q psy11767 117 DLDKAGILGDGSYSVCRRCVEKSTGQEYAVKIISRKI-----------DCSEEINLLRACQGHPNICRRCVEKSTG---- 181 (966)
Q Consensus 117 df~~~~~LG~GsFGkV~La~~k~tg~~yAiKvl~K~~-----------~~~~E~~il~~~~~~pfi~~~~~~~~~~---- 181 (966)
.|+++++||+|+||+|++|+++.||+.||||+++|.. ...+|..+|+++ +||+||+.+-.+...
T Consensus 11 ~Y~~~~~lG~G~fg~Vy~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l-~HpnIv~~~~~~~~~~~~~ 89 (293)
T d1jksa_ 11 YYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEI-QHPNVITLHEVYENKTDVI 89 (293)
T ss_dssp TEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHC-CCTTBCCEEEEEECSSEEE
T ss_pred CEEEeEEEecCCCeEEEEEEECCCCCEEEEEEEEhhhcchhhhhHHHHHHHHHHHHHHhC-CCCCCCcEEEEEEECCEEE
Confidence 4699999999999999999999999999999998742 246799999998 699999732222221
Q ss_pred --------------------------hhHHHHHHHh----------hcccchhhhHhhhccC----CceEEecCccc---
Q psy11767 182 --------------------------QEYAVKIISR----------KIDCSEEINLLRACQG----HPNIVNLHCVF--- 218 (966)
Q Consensus 182 --------------------------~~~~~~~v~~----------~~~~~~e~nil~~~~g----h~~iv~l~~~~--- 218 (966)
..++.+++.+ ..|++++ |||.+.+| +.+|+|++.+.
T Consensus 90 iv~E~~~gg~L~~~i~~~~~l~~~~~~~~~~qi~~al~yLH~~~ivHrDiKp~-Nill~~~~~~~~~vkl~DfG~a~~~~ 168 (293)
T d1jksa_ 90 LILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLHSLQIAHFDLKPE-NIMLLDRNVPKPRIKIIDFGLAHKID 168 (293)
T ss_dssp EEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGG-GEEESCSSSSSCCEEECCCTTCEECT
T ss_pred EEEEcCCCccccchhccccccchhHHHHHHHHHHHHHHhhhhcceeecccccc-eEEEecCCCcccceEecchhhhhhcC
Confidence 1222222222 1245555 99987766 58999988653
Q ss_pred ---------------cccccccccCCCcceeeechhhHHHHHHHhhCCCCCCCCcHHHHHHHHHhCCCCCC----CCCCH
Q psy11767 219 ---------------QDEVIDWDDFSRGIECVFFSSSLIIFFIILSFTLSFIHDYYHIQYRRILKTEPPIP----EDLSP 279 (966)
Q Consensus 219 ---------------~~e~i~~~~y~~~~d~~~~~~~~il~~~m~~g~~pf~~~~~~~~~~~I~~~~~~~P----~~~s~ 279 (966)
.+|++....|+...| +|+.||++|+|++|.+||...+...++++|..+.+.+| ..+|+
T Consensus 169 ~~~~~~~~~~t~~y~APE~~~~~~~~~~~D---iwSlGvilyell~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~ 245 (293)
T d1jksa_ 169 FGNEFKNIFGTPEFVAPEIVNYEPLGLEAD---MWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDEYFSNTSA 245 (293)
T ss_dssp TSCBCSCCCCCGGGCCHHHHTTCCBCTHHH---HHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHTTCCCCCHHHHTTSCH
T ss_pred CCccccccCCCCcccCHHHHcCCCCCCccc---chhhhHHHHHHHcCCCCCCCCCHHHHHHHHHhcCCCCCchhcCCCCH
Confidence 245666666766665 45777889999999999999999999999999988876 57999
Q ss_pred HHHHHHHhhcccCCCcccCCCCCCHHHHhcCCceeeeCccccccCCCCCC
Q psy11767 280 DVADFISRLLVKDPRRRLGGGELDAEELKRHPFFNVIDWDDLATKRIPAP 329 (966)
Q Consensus 280 ~a~dli~~LL~kdp~~RLG~~~~g~~~Ik~HpfF~~idW~~l~~k~~~pP 329 (966)
+++|||+++|++||.+|++ ++||.+||||+.+||+....+...+|
T Consensus 246 ~~~~li~~~L~~dP~~R~s-----~~eil~hp~~~~~~~~~~l~~~~~~P 290 (293)
T d1jksa_ 246 LAKDFIRRLLVKDPKKRMT-----IQDSLQHPWIKPKDTQQALSSAWSHP 290 (293)
T ss_dssp HHHHHHHTTSCSSGGGSCC-----HHHHHHSTTTCC-------------C
T ss_pred HHHHHHHHHccCChhHCcC-----HHHHhcCcccCCCChhHhhccCCCCc
Confidence 9999999999999999984 89999999999999998877766655
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Probab=99.92 E-value=1e-25 Score=243.93 Aligned_cols=190 Identities=30% Similarity=0.469 Sum_probs=148.4
Q ss_pred CcceeeeecccccceEEEEEEcCCCCEEEEEeccccc--------------hhhHHHHHHHHhhCCCccccccc------
Q psy11767 117 DLDKAGILGDGSYSVCRRCVEKSTGQEYAVKIISRKI--------------DCSEEINLLRACQGHPNICRRCV------ 176 (966)
Q Consensus 117 df~~~~~LG~GsFGkV~La~~k~tg~~yAiKvl~K~~--------------~~~~E~~il~~~~~~pfi~~~~~------ 176 (966)
||++++.||+|+||+|++|+++.||+.||||+++|.. ...+|..+|+++..||+|++.+-
T Consensus 4 ~y~~~~~iG~G~~g~V~~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~~ 83 (277)
T d1phka_ 4 NYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYETNT 83 (277)
T ss_dssp TEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEECSS
T ss_pred cCEEceEEecCcCeEEEEEEECCCCCEEEEEEEecccccchhHHHHHHHHHHHHHHHHHHHHhcCCCCeEEEEeecccCc
Confidence 4589999999999999999999999999999998742 25679999999989999986222
Q ss_pred ------------------------ccccchhHHHHHHHh----------hcccchhhhHhhhccCCceEEecCcccc---
Q psy11767 177 ------------------------EKSTGQEYAVKIISR----------KIDCSEEINLLRACQGHPNIVNLHCVFQ--- 219 (966)
Q Consensus 177 ------------------------~~~~~~~~~~~~v~~----------~~~~~~e~nil~~~~gh~~iv~l~~~~~--- 219 (966)
.+..++.++.+++.+ ..|++++ |+|.+.+|+.+|+||+.+..
T Consensus 84 ~~~ivmE~~~~g~L~~~l~~~~~l~e~~~~~~~~qi~~al~~lH~~~ivHrDlkp~-Nill~~~~~~kl~DFG~a~~~~~ 162 (277)
T d1phka_ 84 FFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRALLEVICALHKLNIVHRDLKPE-NILLDDDMNIKLTDFGFSCQLDP 162 (277)
T ss_dssp EEEEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGG-GEEECTTCCEEECCCTTCEECCT
T ss_pred ceEEEEEcCCCchHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCcccccccc-eEEEcCCCCeEEccchheeEccC
Confidence 222223333344333 1255555 99999999999999987632
Q ss_pred ---------------ccccc------cccCCCcceeeechhhHHHHHHHhhCCCCCCCCcHHHHHHHHHhCCCCCCC---
Q psy11767 220 ---------------DEVID------WDDFSRGIECVFFSSSLIIFFIILSFTLSFIHDYYHIQYRRILKTEPPIPE--- 275 (966)
Q Consensus 220 ---------------~e~i~------~~~y~~~~d~~~~~~~~il~~~m~~g~~pf~~~~~~~~~~~I~~~~~~~P~--- 275 (966)
+|++. ...|+...| +|+.|+++|+|++|.+||.+.+...++++|+++...+|.
T Consensus 163 ~~~~~~~~gt~~y~~PE~~~~~~~~~~~~~~~~~D---iwslGvilyeml~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~ 239 (277)
T d1phka_ 163 GEKLREVCGTPSYLAPEIIECSMNDNHPGYGKEVD---MWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMSGNYQFGSPEW 239 (277)
T ss_dssp TCCBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHH---HHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCTTTG
T ss_pred CCceeeeeccCCCCCHHHhhccccccCCCCCchhe---EcccchhhhhhccCCCCCCCCCHHHHHHHHHhCCCCCCCccc
Confidence 12221 112333344 567888999999999999999999999999999887765
Q ss_pred -CCCHHHHHHHHhhcccCCCcccCCCCCCHHHHhcCCceee
Q psy11767 276 -DLSPDVADFISRLLVKDPRRRLGGGELDAEELKRHPFFNV 315 (966)
Q Consensus 276 -~~s~~a~dli~~LL~kdp~~RLG~~~~g~~~Ik~HpfF~~ 315 (966)
.+|++++|||+++|++||++|+. ++||++||||+.
T Consensus 240 ~~~s~~~~~li~~~L~~~p~~R~s-----~~eil~h~~~~~ 275 (277)
T d1phka_ 240 DDYSDTVKDLVSRFLVVQPQKRYT-----AEEALAHPFFQQ 275 (277)
T ss_dssp GGSCHHHHHHHHHHCCSSGGGSCC-----HHHHTTSGGGCT
T ss_pred ccCCHHHHHHHHHHccCChhHCcC-----HHHHHcCHHHHH
Confidence 79999999999999999999984 899999999974
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.92 E-value=1.1e-25 Score=245.53 Aligned_cols=188 Identities=20% Similarity=0.253 Sum_probs=146.7
Q ss_pred CcceeeeecccccceEEEEEEcCCCCEEEEEeccccc-----hhhHHHHHHHHhhCCCccccccccccc-----------
Q psy11767 117 DLDKAGILGDGSYSVCRRCVEKSTGQEYAVKIISRKI-----DCSEEINLLRACQGHPNICRRCVEKST----------- 180 (966)
Q Consensus 117 df~~~~~LG~GsFGkV~La~~k~tg~~yAiKvl~K~~-----~~~~E~~il~~~~~~pfi~~~~~~~~~----------- 180 (966)
+|++++.||+|+||+||+|+++.||+.||||++++.. ...+|..+|+++ +||+||+.+-.+..
T Consensus 21 ~Y~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~il~~l-~HpnIv~~~~~~~~~~~~~ivmEy~ 99 (293)
T d1yhwa1 21 KYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMREN-KNPNIVNYLDSYLVGDELWVVMEYL 99 (293)
T ss_dssp TBCSCEECCCSSSCEEEEEEBTTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHHC-CCTTBCCEEEEEEETTEEEEEEECC
T ss_pred ccEEEEEEecCcCcEEEEEEECCCCCEEEEEEEecccChHHHHHHHHHHHHHhC-CCCCEeeEeEEEEECCEEEEEEEec
Confidence 4689999999999999999999999999999998653 357899999988 69999872221111
Q ss_pred ------------------chhHHHHHHHh----------hcccchhhhHhhhccCCceEEecCccc--------------
Q psy11767 181 ------------------GQEYAVKIISR----------KIDCSEEINLLRACQGHPNIVNLHCVF-------------- 218 (966)
Q Consensus 181 ------------------~~~~~~~~v~~----------~~~~~~e~nil~~~~gh~~iv~l~~~~-------------- 218 (966)
.+.++.+++.+ ..|++++ |||.+.+|+++|+||+.+.
T Consensus 100 ~gg~L~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~iiHrDiKp~-NILl~~~~~vkl~DFG~a~~~~~~~~~~~~~~g 178 (293)
T d1yhwa1 100 AGGSLTDVVTETCMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSD-NILLGMDGSVKLTDFGFCAQITPEQSKRSTMVG 178 (293)
T ss_dssp TTCBHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGG-GEEECTTCCEEECCCTTCEECCSTTCCBCCCCS
T ss_pred CCCcHHHHhhccCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCcHH-HeEECCCCcEeeccchhheeecccccccccccc
Confidence 12222333322 1255666 9999999999999998653
Q ss_pred -----cccccccccCCCcceeeechhhHHHHHHHhhCCCCCCCCcHHHHHHHHHh-C--CCCCCCCCCHHHHHHHHhhcc
Q psy11767 219 -----QDEVIDWDDFSRGIECVFFSSSLIIFFIILSFTLSFIHDYYHIQYRRILK-T--EPPIPEDLSPDVADFISRLLV 290 (966)
Q Consensus 219 -----~~e~i~~~~y~~~~d~~~~~~~~il~~~m~~g~~pf~~~~~~~~~~~I~~-~--~~~~P~~~s~~a~dli~~LL~ 290 (966)
.+|++....|+...| +|+.||++|+|++|.+||...+...+..+|.. + .+.+|..+|++++|||+++|+
T Consensus 179 t~~Y~aPE~~~~~~~~~~~D---iwSlGvilyemltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~ 255 (293)
T d1yhwa1 179 TPYWMAPEVVTRKAYGPKVD---IWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPELQNPEKLSAIFRDFLNRCLD 255 (293)
T ss_dssp CGGGCCHHHHSSSCBCTHHH---HHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHHCSCCCSSGGGSCHHHHHHHHHHTC
T ss_pred CCCccChhhhcCCCCCchhc---eehHhHHHHHHhhCCCCCCCCCHHHHHHHHHhCCCCCCCCcccCCHHHHHHHHHHcc
Confidence 246676667776665 45778999999999999988777666666654 3 345678899999999999999
Q ss_pred cCCCcccCCCCCCHHHHhcCCcee
Q psy11767 291 KDPRRRLGGGELDAEELKRHPFFN 314 (966)
Q Consensus 291 kdp~~RLG~~~~g~~~Ik~HpfF~ 314 (966)
+||.+|+ .++||++||||+
T Consensus 256 ~dP~~R~-----s~~eil~Hp~~~ 274 (293)
T d1yhwa1 256 MDVEKRG-----SAKELLQHQFLK 274 (293)
T ss_dssp SSTTTSC-----CHHHHTTCGGGG
T ss_pred CChhHCc-----CHHHHhcCHhhC
Confidence 9999998 489999999996
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=99.92 E-value=1.4e-25 Score=246.41 Aligned_cols=189 Identities=26% Similarity=0.346 Sum_probs=145.7
Q ss_pred CcceeeeecccccceEEEEEEcCCCCEEEEEeccccc------hhhHHHHHHHHhhCCCcccccccccc-----------
Q psy11767 117 DLDKAGILGDGSYSVCRRCVEKSTGQEYAVKIISRKI------DCSEEINLLRACQGHPNICRRCVEKS----------- 179 (966)
Q Consensus 117 df~~~~~LG~GsFGkV~La~~k~tg~~yAiKvl~K~~------~~~~E~~il~~~~~~pfi~~~~~~~~----------- 179 (966)
.|+++++||+|+||+|++|+++.||+.||||+++|.. ...+|.++|+++ +||+||+.+-.+.
T Consensus 10 ~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l-~HpnIv~l~~~~~~~~~~~lvmE~ 88 (307)
T d1a06a_ 10 IYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKI-KHPNIVALDDIYESGGHLYLIMQL 88 (307)
T ss_dssp TEEEEEESBSGGGGGEEEEEETTTCCEEEEEEEEC----------CHHHHHHHTC-CCTTBCCEEEEEECSSEEEEEECC
T ss_pred ceEEEEEEeeccCeEEEEEEECCCCCEEEEEEEchHHhhhHHHHHHHHHHHHHhC-CCCCCCcEEEEEEECCEEEEEEec
Confidence 4799999999999999999999999999999998752 346899999998 6999987222211
Q ss_pred -------------------cchhHHHHHHHh----------hcccchhhhHhhh---ccCCceEEecCccc---------
Q psy11767 180 -------------------TGQEYAVKIISR----------KIDCSEEINLLRA---CQGHPNIVNLHCVF--------- 218 (966)
Q Consensus 180 -------------------~~~~~~~~~v~~----------~~~~~~e~nil~~---~~gh~~iv~l~~~~--------- 218 (966)
....++.+++.+ ..|++++ |||.. .+|+++|+||+.+.
T Consensus 89 ~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~al~ylH~~~iiHrDiKp~-Nil~~~~~~~~~vkl~DFG~a~~~~~~~~~~ 167 (307)
T d1a06a_ 89 VSGGELFDRIVEKGFYTERDASRLIFQVLDAVKYLHDLGIVHRDLKPE-NLLYYSLDEDSKIMISDFGLSKMEDPGSVLS 167 (307)
T ss_dssp CCSCBHHHHHHTCSCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGG-GEEESSSSTTCCEEECCC-------------
T ss_pred cCCCcHHHhhhcccCCCHHHHHHHHHHHHHHHHhhhhceeeeEEeccc-ceeecccCCCceEEEeccceeEEccCCCeee
Confidence 122233333322 1255555 98874 46899999998653
Q ss_pred ---------cccccccccCCCcceeeechhhHHHHHHHhhCCCCCCCCcHHHHHHHHHhCCCCCC----CCCCHHHHHHH
Q psy11767 219 ---------QDEVIDWDDFSRGIECVFFSSSLIIFFIILSFTLSFIHDYYHIQYRRILKTEPPIP----EDLSPDVADFI 285 (966)
Q Consensus 219 ---------~~e~i~~~~y~~~~d~~~~~~~~il~~~m~~g~~pf~~~~~~~~~~~I~~~~~~~P----~~~s~~a~dli 285 (966)
.||++....|+...| +|+.||++|+|++|.+||.+.+...++++|+.+.+.+| ..+|++++|||
T Consensus 168 ~~~GT~~y~APE~~~~~~~~~~~D---iwSlGvilyell~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li 244 (307)
T d1a06a_ 168 TACGTPGYVAPEVLAQKPYSKAVD---CWSIGVIAYILLCGYPPFYDENDAKLFEQILKAEYEFDSPYWDDISDSAKDFI 244 (307)
T ss_dssp -----CTTSCHHHHTTCCCCTHHH---HHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHTTCCCCCTTTTTTSCHHHHHHH
T ss_pred eeeeCccccCcHHHcCCCCCcHHH---hhhhhHHHHHHHhCCCCCCCCCHHHHHHHHhccCCCCCCccccCCCHHHHHHH
Confidence 356777777876655 45677788899999999999999999999999887765 57899999999
Q ss_pred HhhcccCCCcccCCCCCCHHHHhcCCceee
Q psy11767 286 SRLLVKDPRRRLGGGELDAEELKRHPFFNV 315 (966)
Q Consensus 286 ~~LL~kdp~~RLG~~~~g~~~Ik~HpfF~~ 315 (966)
+++|++||.+|++ ++||.+||||++
T Consensus 245 ~~~L~~dP~~R~s-----~~eil~hp~~~~ 269 (307)
T d1a06a_ 245 RHLMEKDPEKRFT-----CEQALQHPWIAG 269 (307)
T ss_dssp HHHSCSSGGGSCC-----HHHHHHSTTTTS
T ss_pred HHHccCCHhHCcC-----HHHHhcCHhhCC
Confidence 9999999999984 899999999975
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Probab=99.92 E-value=2.7e-25 Score=248.52 Aligned_cols=196 Identities=20% Similarity=0.313 Sum_probs=155.1
Q ss_pred CcceeeeecccccceEEEEEEcCCCCEEEEEeccccc-----hhhHHHHHHHHhhCCCcccccccc--------------
Q psy11767 117 DLDKAGILGDGSYSVCRRCVEKSTGQEYAVKIISRKI-----DCSEEINLLRACQGHPNICRRCVE-------------- 177 (966)
Q Consensus 117 df~~~~~LG~GsFGkV~La~~k~tg~~yAiKvl~K~~-----~~~~E~~il~~~~~~pfi~~~~~~-------------- 177 (966)
||+++++||+|+||+|++|+++.||+.||||++++.. ...+|.++|+++ +||+||+.+-.
T Consensus 27 ~Y~i~~~lG~G~fg~Vy~~~~~~~g~~vAvK~i~~~~~~~~~~~~~E~~il~~l-~HpnIv~~~~~~~~~~~~~ivmE~~ 105 (350)
T d1koaa2 27 HYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVL-RHPTLVNLHDAFEDDNEMVMIYEFM 105 (350)
T ss_dssp TEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECCCSHHHHHHHHHHHHHHHHT-CCTTBCCEEEEEEETTEEEEEECCC
T ss_pred CeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEcccchhhHHHHHHHHHHHHhC-CCCCCCcEEEEEEECCEEEEEEEcC
Confidence 6799999999999999999999999999999998753 357899999998 59999872211
Q ss_pred -----------------cccchhHHHHHHHh----------hcccchhhhHhhhc--cCCceEEecCccc----------
Q psy11767 178 -----------------KSTGQEYAVKIISR----------KIDCSEEINLLRAC--QGHPNIVNLHCVF---------- 218 (966)
Q Consensus 178 -----------------~~~~~~~~~~~v~~----------~~~~~~e~nil~~~--~gh~~iv~l~~~~---------- 218 (966)
+.....++.+++.+ ..|++++ |||++. +|+.+|+||+.+.
T Consensus 106 ~gg~L~~~l~~~~~~l~e~~~~~i~~qi~~aL~ylH~~~iiHrDiKp~-NIll~~~~~~~vkL~DFG~a~~~~~~~~~~~ 184 (350)
T d1koaa2 106 SGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHENNYVHLDLKPE-NIMFTTKRSNELKLIDFGLTAHLDPKQSVKV 184 (350)
T ss_dssp CSCBHHHHHTCTTSCBCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGG-GEEESSTTSCCEEECCCTTCEECCTTSCEEE
T ss_pred CCCCHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCeeeeechh-HeeeccCCCCeEEEeecchheecccccccce
Confidence 11122233333322 1255566 998854 5889999999763
Q ss_pred --------cccccccccCCCcceeeechhhHHHHHHHhhCCCCCCCCcHHHHHHHHHhCCCCCCC----CCCHHHHHHHH
Q psy11767 219 --------QDEVIDWDDFSRGIECVFFSSSLIIFFIILSFTLSFIHDYYHIQYRRILKTEPPIPE----DLSPDVADFIS 286 (966)
Q Consensus 219 --------~~e~i~~~~y~~~~d~~~~~~~~il~~~m~~g~~pf~~~~~~~~~~~I~~~~~~~P~----~~s~~a~dli~ 286 (966)
.+|++....|+...| .|+.|+++|+|++|.+||...+...++++|....+.+|. .+|++++|||+
T Consensus 185 ~~gT~~Y~aPEv~~~~~~~~~~D---iwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~ 261 (350)
T d1koaa2 185 TTGTAEFAAPEVAEGKPVGYYTD---MWSVGVLSYILLSGLSPFGGENDDETLRNVKSCDWNMDDSAFSGISEDGKDFIR 261 (350)
T ss_dssp ECSCTTTCCHHHHHTCCBCHHHH---HHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCSCCGGGGGCCHHHHHHHH
T ss_pred ecCcccccCHHHHcCCCCChhHh---hhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCcccccCCCHHHHHHHH
Confidence 246666667765555 457778889999999999999999999999999888774 58999999999
Q ss_pred hhcccCCCcccCCCCCCHHHHhcCCceeeeCccccc
Q psy11767 287 RLLVKDPRRRLGGGELDAEELKRHPFFNVIDWDDLA 322 (966)
Q Consensus 287 ~LL~kdp~~RLG~~~~g~~~Ik~HpfF~~idW~~l~ 322 (966)
++|++||.+|+. ++||.+||||+..+|....
T Consensus 262 ~~L~~dP~~R~t-----~~eil~hp~~~~~~~~~~~ 292 (350)
T d1koaa2 262 KLLLADPNTRMT-----IHQALEHPWLTPGNAPGRD 292 (350)
T ss_dssp HHCCSSGGGSCC-----HHHHHHSTTTSCTTCCSCC
T ss_pred HHccCChhHCcC-----HHHHhcCcccCCCCCCCch
Confidence 999999999984 8999999999999986543
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Probab=99.91 E-value=4.9e-25 Score=246.51 Aligned_cols=190 Identities=23% Similarity=0.362 Sum_probs=150.2
Q ss_pred CcceeeeecccccceEEEEEEcCCCCEEEEEeccccc-----hhhHHHHHHHHhhCCCccccccccccc-----------
Q psy11767 117 DLDKAGILGDGSYSVCRRCVEKSTGQEYAVKIISRKI-----DCSEEINLLRACQGHPNICRRCVEKST----------- 180 (966)
Q Consensus 117 df~~~~~LG~GsFGkV~La~~k~tg~~yAiKvl~K~~-----~~~~E~~il~~~~~~pfi~~~~~~~~~----------- 180 (966)
+|++++.||+|+||+|++|+++.||+.||||++++.. ...+|..+|+++ +||+||+.+-.+..
T Consensus 30 ~Y~i~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~Ei~il~~l-~HpnIv~~~~~~~~~~~~~ivmE~~ 108 (352)
T d1koba_ 30 YYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQL-HHPKLINLHDAFEDKYEMVLILEFL 108 (352)
T ss_dssp TEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTC-CSTTBCCEEEEEECSSEEEEEEECC
T ss_pred ceEEEEEEecCCCeEEEEEEECCCCCEEEEEEECCcchhHHHHHHHHHHHHHhC-CCCCCCcEEEEEEECCEEEEEEEcC
Confidence 4699999999999999999999999999999998753 346799999988 69999872222111
Q ss_pred --------------------chhHHHHHHHh----------hcccchhhhHhhh--ccCCceEEecCccc----------
Q psy11767 181 --------------------GQEYAVKIISR----------KIDCSEEINLLRA--CQGHPNIVNLHCVF---------- 218 (966)
Q Consensus 181 --------------------~~~~~~~~v~~----------~~~~~~e~nil~~--~~gh~~iv~l~~~~---------- 218 (966)
...++.+++.+ ..|++++ |||++ .+|+.+|+||+.+.
T Consensus 109 ~gg~L~~~~~~~~~~l~e~~~~~i~~qi~~aL~ylH~~~iiHRDiKp~-NILl~~~~~~~vkL~DFGla~~~~~~~~~~~ 187 (352)
T d1koba_ 109 SGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHEHSIVHLDIKPE-NIMCETKKASSVKIIDFGLATKLNPDEIVKV 187 (352)
T ss_dssp CCCBHHHHTTCTTCCBCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGG-GEEESSTTCCCEEECCCTTCEECCTTSCEEE
T ss_pred CCChHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecccccc-cccccccCCCeEEEeecccceecCCCCceee
Confidence 11222233222 1255566 99987 46899999999763
Q ss_pred --------cccccccccCCCcceeeechhhHHHHHHHhhCCCCCCCCcHHHHHHHHHhCCCCCCC----CCCHHHHHHHH
Q psy11767 219 --------QDEVIDWDDFSRGIECVFFSSSLIIFFIILSFTLSFIHDYYHIQYRRILKTEPPIPE----DLSPDVADFIS 286 (966)
Q Consensus 219 --------~~e~i~~~~y~~~~d~~~~~~~~il~~~m~~g~~pf~~~~~~~~~~~I~~~~~~~P~----~~s~~a~dli~ 286 (966)
.+|++....|+...| .|+.|+++|+|++|.+||.+.+...++++|..+.+.+|. .+|++++|||+
T Consensus 188 ~~gt~~y~aPE~~~~~~~~~~~D---iwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~ 264 (352)
T d1koba_ 188 TTATAEFAAPEIVDREPVGFYTD---MWAIGVLGYVLLSGLSPFAGEDDLETLQNVKRCDWEFDEDAFSSVSPEAKDFIK 264 (352)
T ss_dssp ECSSGGGCCHHHHTTCCBCHHHH---HHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHHCCCCCCSSTTTTSCHHHHHHHH
T ss_pred ccCcccccCHHHHcCCCCCCccc---hHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCcccccCCCHHHHHHHH
Confidence 246666667766655 446778899999999999999999999999999888774 68999999999
Q ss_pred hhcccCCCcccCCCCCCHHHHhcCCceeee
Q psy11767 287 RLLVKDPRRRLGGGELDAEELKRHPFFNVI 316 (966)
Q Consensus 287 ~LL~kdp~~RLG~~~~g~~~Ik~HpfF~~i 316 (966)
++|++||.+|+. ++||.+||||++.
T Consensus 265 ~~L~~dp~~R~s-----~~eil~Hp~~~~~ 289 (352)
T d1koba_ 265 NLLQKEPRKRLT-----VHDALEHPWLKGD 289 (352)
T ss_dssp TTSCSSGGGSCC-----HHHHHTSTTTSSC
T ss_pred HHccCChhHCcC-----HHHHhcCHhhCCC
Confidence 999999999984 8999999999874
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.91 E-value=7.3e-25 Score=239.67 Aligned_cols=195 Identities=18% Similarity=0.256 Sum_probs=148.9
Q ss_pred CCcceeeeecccccceEEEEEEcCC-CCEEEEEeccccc-------hhhHHHHHHHHhh--CCCccccccccccc-----
Q psy11767 116 MDLDKAGILGDGSYSVCRRCVEKST-GQEYAVKIISRKI-------DCSEEINLLRACQ--GHPNICRRCVEKST----- 180 (966)
Q Consensus 116 ~df~~~~~LG~GsFGkV~La~~k~t-g~~yAiKvl~K~~-------~~~~E~~il~~~~--~~pfi~~~~~~~~~----- 180 (966)
-+|++++.||+|+||+|++|+++.| +++||||++++.. ...+|.++|+.+. +||+|++.+-.+..
T Consensus 7 ~~Y~i~~~LG~G~fg~V~~a~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~~l~~l~~~~HpnIv~~~~~~~~~~~~~ 86 (305)
T d1blxa_ 7 QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDR 86 (305)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEECSS
T ss_pred CCEEEEEEEecccCeEEEEEEEECCCCEEEEEEEEehhhccchHHHHHHHHHHHHHHHhhcCCCCcceeeeeeccccccc
Confidence 3679999999999999999999765 6789999998642 3467889998764 79999873211110
Q ss_pred -------------------------------chhHHHHHHHh----------hcccchhhhHhhhccCCceEEecCccc-
Q psy11767 181 -------------------------------GQEYAVKIISR----------KIDCSEEINLLRACQGHPNIVNLHCVF- 218 (966)
Q Consensus 181 -------------------------------~~~~~~~~v~~----------~~~~~~e~nil~~~~gh~~iv~l~~~~- 218 (966)
.+.++.+++.+ ..|++++ |||.+..|+++|.||+.+.
T Consensus 87 ~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~ivHrDiKp~-NILi~~~~~~kl~dfg~~~~ 165 (305)
T d1blxa_ 87 ETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQ-NILVTSSGQIKLADFGLARI 165 (305)
T ss_dssp EEEEEEEEECCSCBHHHHHHHSCTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGG-GEEECTTCCEEECSCCSCCC
T ss_pred CceEEEEEEeccCCchhhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCEEecCCCcc-EEEEcCCCCeeecchhhhhh
Confidence 01111222222 1256666 9999999999999998653
Q ss_pred -----------------cccccccccCCCcceeeechhhHHHHHHHhhCCCCCCCCcHHHHHHHHHhC------------
Q psy11767 219 -----------------QDEVIDWDDFSRGIECVFFSSSLIIFFIILSFTLSFIHDYYHIQYRRILKT------------ 269 (966)
Q Consensus 219 -----------------~~e~i~~~~y~~~~d~~~~~~~~il~~~m~~g~~pf~~~~~~~~~~~I~~~------------ 269 (966)
.||++....|+..+| +|+.|+++|||++|.+||...+...++.+|+..
T Consensus 166 ~~~~~~~~~~~gT~~Y~APE~~~~~~y~~~~D---iwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 242 (305)
T d1blxa_ 166 YSFQMALTSVVVTLWYRAPEVLLQSSYATPVD---LWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPRD 242 (305)
T ss_dssp CCGGGGGCCCCCCCTTCCHHHHTTCCCCTHHH---HHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCGGGSCTT
T ss_pred hcccccCCCcccChhhcCcchhcCCCCChheh---hhchHHHHHHHHHCCCCCCCCCHHHHHHHHHHhhCCCchhccccc
Confidence 257777778877766 557778999999999999998888888887641
Q ss_pred ---------------CCCCCCCCCHHHHHHHHhhcccCCCcccCCCCCCHHHHhcCCceeeeCcc
Q psy11767 270 ---------------EPPIPEDLSPDVADFISRLLVKDPRRRLGGGELDAEELKRHPFFNVIDWD 319 (966)
Q Consensus 270 ---------------~~~~P~~~s~~a~dli~~LL~kdp~~RLG~~~~g~~~Ik~HpfF~~idW~ 319 (966)
...++..+|++++|||+++|++||.+|+. ++|+.+||||++|++.
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~s-----a~e~L~Hpff~~i~~~ 302 (305)
T d1blxa_ 243 VALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRIS-----AYSALSHPYFQDLERC 302 (305)
T ss_dssp CSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCC-----HHHHHTSGGGTTCCCC
T ss_pred ccchhhhhccccccchhhccccCCHHHHHHHHHHCcCChhHCcC-----HHHHhcChhhcCchhh
Confidence 01256678999999999999999999984 8999999999999863
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.91 E-value=5.2e-25 Score=237.54 Aligned_cols=188 Identities=20% Similarity=0.340 Sum_probs=139.6
Q ss_pred CcceeeeecccccceEEEEEEcCCCCEEEEEeccccc------hhhHHHHHHHHhhCCCcccccc---------------
Q psy11767 117 DLDKAGILGDGSYSVCRRCVEKSTGQEYAVKIISRKI------DCSEEINLLRACQGHPNICRRC--------------- 175 (966)
Q Consensus 117 df~~~~~LG~GsFGkV~La~~k~tg~~yAiKvl~K~~------~~~~E~~il~~~~~~pfi~~~~--------------- 175 (966)
||++++.||+|+||+|++|+++.||+.||||++++.. ...+|.++|+++ +||+||+.+
T Consensus 6 dy~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~~l~~l-~HpnIv~~~~~~~~~~~~~ivmEy 84 (271)
T d1nvra_ 6 DWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKML-NHENVVKFYGHRREGNIQYLFLEY 84 (271)
T ss_dssp EEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHTC-CCTTBCCEEEEEEETTEEEEEEEC
T ss_pred ceEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHhC-CCCCEeeEeeeeccCceeEEEEec
Confidence 5699999999999999999999999999999998642 357899999988 699998721
Q ss_pred ---------------cccccchhHHHHHHHh----------hcccchhhhHhhhccCCceEEecCccc------------
Q psy11767 176 ---------------VEKSTGQEYAVKIISR----------KIDCSEEINLLRACQGHPNIVNLHCVF------------ 218 (966)
Q Consensus 176 ---------------~~~~~~~~~~~~~v~~----------~~~~~~e~nil~~~~gh~~iv~l~~~~------------ 218 (966)
+.+.....++.+++.+ ..|++++ |||.+.+|+++|+||+.+.
T Consensus 85 ~~gg~L~~~l~~~~~l~e~~~~~i~~qi~~al~ylH~~~IiHrDiKp~-NILl~~~~~~KL~DFG~a~~~~~~~~~~~~~ 163 (271)
T d1nvra_ 85 CSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPE-NLLLDERDNLKISDFGLATVFRYNNRERLLN 163 (271)
T ss_dssp CTTEEGGGGSBTTTBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGG-GEEECTTCCEEECCCTTCEECEETTEECCBC
T ss_pred cCCCcHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCccCcccHH-HEEECCCCCEEEccchhheeeccCCcccccc
Confidence 1111122233333322 1256666 9999999999999998663
Q ss_pred ---------cccccccccC-CCcceeeechhhHHHHHHHhhCCCCCCCCcH-HHHHHHHHhCCCCCC--CCCCHHHHHHH
Q psy11767 219 ---------QDEVIDWDDF-SRGIECVFFSSSLIIFFIILSFTLSFIHDYY-HIQYRRILKTEPPIP--EDLSPDVADFI 285 (966)
Q Consensus 219 ---------~~e~i~~~~y-~~~~d~~~~~~~~il~~~m~~g~~pf~~~~~-~~~~~~I~~~~~~~P--~~~s~~a~dli 285 (966)
.+|++....| +...| +|+.|+++|+|++|.+||..... ...+..+.......+ ..+|++++|||
T Consensus 164 ~~~GT~~Y~APE~~~~~~~~~~~~D---iwSlGvilyeml~G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li 240 (271)
T d1nvra_ 164 KMCGTLPYVAPELLKRREFHAEPVD---VWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPLALL 240 (271)
T ss_dssp CCCSCGGGSCTHHHHCSSBCHHHHH---HHHHHHHHHHHHHSSCSCSSSSTTSHHHHHHHTTCTTSTTGGGSCHHHHHHH
T ss_pred ceeeCcCccCHhHhcCCCCCCCcee---eeHhHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCccccCCHHHHHHH
Confidence 2355555444 33444 55788888899999999976443 344555555444333 47899999999
Q ss_pred HhhcccCCCcccCCCCCCHHHHhcCCcee
Q psy11767 286 SRLLVKDPRRRLGGGELDAEELKRHPFFN 314 (966)
Q Consensus 286 ~~LL~kdp~~RLG~~~~g~~~Ik~HpfF~ 314 (966)
+++|++||.+|+. ++||.+||||+
T Consensus 241 ~~~L~~dP~~R~t-----~~eil~hpwf~ 264 (271)
T d1nvra_ 241 HKILVENPSARIT-----IPDIKKDRWYN 264 (271)
T ss_dssp HHHSCSSTTTSCC-----HHHHTTCTTTT
T ss_pred HHHcCCChhHCcC-----HHHHhcCHhhC
Confidence 9999999999984 89999999995
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.91 E-value=1.1e-24 Score=236.91 Aligned_cols=188 Identities=24% Similarity=0.308 Sum_probs=146.2
Q ss_pred CcceeeeecccccceEEEEEEcCCCCEEEEEecccc-----chhhHHHHHHHHhhCCCcccccc----------------
Q psy11767 117 DLDKAGILGDGSYSVCRRCVEKSTGQEYAVKIISRK-----IDCSEEINLLRACQGHPNICRRC---------------- 175 (966)
Q Consensus 117 df~~~~~LG~GsFGkV~La~~k~tg~~yAiKvl~K~-----~~~~~E~~il~~~~~~pfi~~~~---------------- 175 (966)
+|++++.||+|+||+|++|+++.||+.||||++++. ....+|.++|+++ +||+||+.+
T Consensus 13 ~Y~i~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~E~~il~~l-~HpnIv~l~~~~~~~~~~~lvmEy~ 91 (288)
T d2jfla1 13 FWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASC-DHPNIVKLLDAFYYENNLWILIEFC 91 (288)
T ss_dssp TEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECSSSGGGGGTHHHHHHHHHC-CCTTBCCEEEEEEETTEEEEEEECC
T ss_pred CeEEeEEEeeCCCcEEEEEEECCCCeEEEEEEECcCCHHHHHHHHHHHHHHHhC-CCCCCCeEEEEEeeCCeEEEEEecC
Confidence 479999999999999999999999999999999864 2457899999998 599998722
Q ss_pred ---------------cccccchhHHHHHHHh----------hcccchhhhHhhhccCCceEEecCccc------------
Q psy11767 176 ---------------VEKSTGQEYAVKIISR----------KIDCSEEINLLRACQGHPNIVNLHCVF------------ 218 (966)
Q Consensus 176 ---------------~~~~~~~~~~~~~v~~----------~~~~~~e~nil~~~~gh~~iv~l~~~~------------ 218 (966)
+.+...+.++.+++.+ ..|++++ |||.+.+|.++|+||+.+.
T Consensus 92 ~~g~L~~~~~~~~~~l~e~~~~~i~~qi~~gL~ylH~~~ivHrDiKp~-NIll~~~~~~Kl~DFG~a~~~~~~~~~~~~~ 170 (288)
T d2jfla1 92 AGGAVDAVMLELERPLTESQIQVVCKQTLDALNYLHDNKIIHRDLKAG-NILFTLDGDIKLADFGVSAKNTRTIQRRDSF 170 (288)
T ss_dssp TTEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGG-GEEECTTSCEEECCCTTCEECHHHHHHHTCC
T ss_pred CCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEEEeecChh-heeECCCCCEEEEechhhhccCCCccccccc
Confidence 1111122222333322 1255555 9999999999999999763
Q ss_pred -------cccccc-----cccCCCcceeeechhhHHHHHHHhhCCCCCCCCcHHHHHHHHHhCCC---CCCCCCCHHHHH
Q psy11767 219 -------QDEVID-----WDDFSRGIECVFFSSSLIIFFIILSFTLSFIHDYYHIQYRRILKTEP---PIPEDLSPDVAD 283 (966)
Q Consensus 219 -------~~e~i~-----~~~y~~~~d~~~~~~~~il~~~m~~g~~pf~~~~~~~~~~~I~~~~~---~~P~~~s~~a~d 283 (966)
.+|++. ...|+...| .|+.||++|+|++|.+||...+...++.+|+.+.+ ..|..+|++++|
T Consensus 171 ~Gt~~y~APE~l~~~~~~~~~y~~k~D---iwSlGvilyemltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~s~~~~~ 247 (288)
T d2jfla1 171 IGTPYWMAPEVVMCETSKDRPYDYKAD---VWSLGITLIEMAEIEPPHHELNPMRVLLKIAKSEPPTLAQPSRWSSNFKD 247 (288)
T ss_dssp CSCCTTCCHHHHTTCSTTTSSTTTHHH---HHHHHHHHHHHHHSSCTTTTSCGGGHHHHHHHSCCCCCSSGGGSCHHHHH
T ss_pred ccccccCCHHHHhhcccCCCCCChhhh---HHHHHHHHHHHhhCCCCCCCCCHHHHHHHHHcCCCCCCCccccCCHHHHH
Confidence 235553 334555555 44677888999999999998888888899998753 456789999999
Q ss_pred HHHhhcccCCCcccCCCCCCHHHHhcCCcee
Q psy11767 284 FISRLLVKDPRRRLGGGELDAEELKRHPFFN 314 (966)
Q Consensus 284 li~~LL~kdp~~RLG~~~~g~~~Ik~HpfF~ 314 (966)
||+++|++||.+|+. ++||.+||||+
T Consensus 248 li~~~L~~dp~~R~t-----~~ell~hp~~~ 273 (288)
T d2jfla1 248 FLKKCLEKNVDARWT-----TSQLLQHPFVT 273 (288)
T ss_dssp HHHHHSCSSTTTSCC-----HHHHTTSGGGC
T ss_pred HHHHHccCChhHCcC-----HHHHhcCcccC
Confidence 999999999999984 89999999996
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.91 E-value=8.5e-25 Score=241.60 Aligned_cols=187 Identities=26% Similarity=0.372 Sum_probs=145.0
Q ss_pred cceeeeecccccceEEEEEEcCCCCEEEEEeccccc----hhhHHHHHHHHhhCCCccccccccccc-------------
Q psy11767 118 LDKAGILGDGSYSVCRRCVEKSTGQEYAVKIISRKI----DCSEEINLLRACQGHPNICRRCVEKST------------- 180 (966)
Q Consensus 118 f~~~~~LG~GsFGkV~La~~k~tg~~yAiKvl~K~~----~~~~E~~il~~~~~~pfi~~~~~~~~~------------- 180 (966)
|.++++||+|+||+|++|+++.||+.||||++++.. ...+|.++|+++ +||+||+.+-.+..
T Consensus 7 Y~i~~~lG~G~fg~Vy~~~~~~~~~~~AiK~i~~~~~~~~~~~~Ei~il~~l-~HpnIv~~~~~~~~~~~~~lvmE~~~g 85 (321)
T d1tkia_ 7 YMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQVLVKKEISILNIA-RHRNILHLHESFESMEELVMIFEFISG 85 (321)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCTHHHHHHHHHHHHHHHS-CCTTBCCEEEEEEETTEEEEEECCCCC
T ss_pred eEEEEEEecCCCeEEEEEEECCCCcEEEEEEEcCCcccHHHHHHHHHHHHhC-CCCCCCeEEEEEEECCEEEEEEecCCC
Confidence 489999999999999999999999999999999753 357899999988 59999872221111
Q ss_pred ------------------chhHHHHHHHh----------hcccchhhhHhhhccC--CceEEecCcccc-----------
Q psy11767 181 ------------------GQEYAVKIISR----------KIDCSEEINLLRACQG--HPNIVNLHCVFQ----------- 219 (966)
Q Consensus 181 ------------------~~~~~~~~v~~----------~~~~~~e~nil~~~~g--h~~iv~l~~~~~----------- 219 (966)
...++.+++.+ ..|++++ |||.+.++ .++|.||+.+..
T Consensus 86 g~L~~~i~~~~~~l~e~~~~~i~~qi~~al~yLH~~~iiHrDlKp~-NIll~~~~~~~ikl~DFG~~~~~~~~~~~~~~~ 164 (321)
T d1tkia_ 86 LDIFERINTSAFELNEREIVSYVHQVCEALQFLHSHNIGHFDIRPE-NIIYQTRRSSTIKIIEFGQARQLKPGDNFRLLF 164 (321)
T ss_dssp CBHHHHHTSSSCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGG-GEEESSSSCCCEEECCCTTCEECCTTCEEEEEE
T ss_pred CcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCCccccccc-ceeecCCCceEEEEcccchhhccccCCcccccc
Confidence 12222233322 1255666 99987554 678899886632
Q ss_pred -------ccccccccCCCcceeeechhhHHHHHHHhhCCCCCCCCcHHHHHHHHHhCCCCCCC----CCCHHHHHHHHhh
Q psy11767 220 -------DEVIDWDDFSRGIECVFFSSSLIIFFIILSFTLSFIHDYYHIQYRRILKTEPPIPE----DLSPDVADFISRL 288 (966)
Q Consensus 220 -------~e~i~~~~y~~~~d~~~~~~~~il~~~m~~g~~pf~~~~~~~~~~~I~~~~~~~P~----~~s~~a~dli~~L 288 (966)
+|++....|+...| .|+.|+++|+|++|.+||...+...++++|+++.+.+|. .+|++++|||+++
T Consensus 165 ~t~~y~ape~~~~~~~~~~~D---iWSlGvily~ll~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~ 241 (321)
T d1tkia_ 165 TAPEYYAPEVHQHDVVSTATD---MWSLGTLVYVLLSGINPFLAETNQQIIENIMNAEYTFDEEAFKEISIEAMDFVDRL 241 (321)
T ss_dssp SCGGGSCHHHHTTCEECHHHH---HHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCCCCCHHHHTTSCHHHHHHHHTT
T ss_pred cccccccchhccCCCCCchhh---cccHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCChhhccCCCHHHHHHHHHH
Confidence 23444445554444 446777788999999999999999999999999999885 7999999999999
Q ss_pred cccCCCcccCCCCCCHHHHhcCCcee
Q psy11767 289 LVKDPRRRLGGGELDAEELKRHPFFN 314 (966)
Q Consensus 289 L~kdp~~RLG~~~~g~~~Ik~HpfF~ 314 (966)
|++||.+|++ ++||.+||||+
T Consensus 242 L~~dp~~R~s-----~~eil~hp~~~ 262 (321)
T d1tkia_ 242 LVKERKSRMT-----ASEALQHPWLK 262 (321)
T ss_dssp SCSSGGGSCC-----HHHHHHSHHHH
T ss_pred ccCChhHCcC-----HHHHhcCHhhc
Confidence 9999999984 89999999996
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.90 E-value=1.4e-24 Score=233.84 Aligned_cols=187 Identities=20% Similarity=0.238 Sum_probs=145.4
Q ss_pred CcceeeeecccccceEEEEEEcCCCCEEEEEeccccc-------hhhHHHHHHHHhhCCCccccccccc--cc-------
Q psy11767 117 DLDKAGILGDGSYSVCRRCVEKSTGQEYAVKIISRKI-------DCSEEINLLRACQGHPNICRRCVEK--ST------- 180 (966)
Q Consensus 117 df~~~~~LG~GsFGkV~La~~k~tg~~yAiKvl~K~~-------~~~~E~~il~~~~~~pfi~~~~~~~--~~------- 180 (966)
||++++.||+|+||+|++|+++.||+.||||++++.. ...+|.++|+++ +||+||+.+-.. ..
T Consensus 5 dy~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l-~HpnIv~~~~~~~~~~~~~~~iv 83 (269)
T d2java1 5 DYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLREL-KHPNIVRYYDRIIDRTNTTLYIV 83 (269)
T ss_dssp GEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCTTSCHHHHHHHHHHHHHTTSC-CCTTBCCEEEEEEC----CEEEE
T ss_pred hCEEeEEEecCCCeEEEEEEECCCCCEEEEEEEChhhCCHHHHHHHHHHHHHHHHC-CCCCEeeEEEEEEeCCCCEEEEE
Confidence 7899999999999999999999999999999998752 246789999888 699998732111 11
Q ss_pred ---------------------------chhHHHHHHHh---------------hcccchhhhHhhhccCCceEEecCccc
Q psy11767 181 ---------------------------GQEYAVKIISR---------------KIDCSEEINLLRACQGHPNIVNLHCVF 218 (966)
Q Consensus 181 ---------------------------~~~~~~~~v~~---------------~~~~~~e~nil~~~~gh~~iv~l~~~~ 218 (966)
...++.+++.+ ..|++++ |||.+.+|+++|.||+.+.
T Consensus 84 mEy~~~g~L~~~i~~~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~~~~~~IiHrDiKp~-NIll~~~~~vkl~DFG~a~ 162 (269)
T d2java1 84 MEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPA-NVFLDGKQNVKLGDFGLAR 162 (269)
T ss_dssp EECCTTEEHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHHCC---------CCGG-GEEECTTSCEEECCHHHHH
T ss_pred EecCCCCcHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCCCEEeCcCchh-hcCcCCCCcEEEeecccee
Confidence 01111111111 1134445 9999999999999988542
Q ss_pred -------------------cccccccccCCCcceeeechhhHHHHHHHhhCCCCCCCCcHHHHHHHHHhCCC-CCCCCCC
Q psy11767 219 -------------------QDEVIDWDDFSRGIECVFFSSSLIIFFIILSFTLSFIHDYYHIQYRRILKTEP-PIPEDLS 278 (966)
Q Consensus 219 -------------------~~e~i~~~~y~~~~d~~~~~~~~il~~~m~~g~~pf~~~~~~~~~~~I~~~~~-~~P~~~s 278 (966)
.+|++....|+...| .|+.|+++|||++|.+||...+...++++|.++.+ .+|..+|
T Consensus 163 ~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~D---IwSlGvilyel~tg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~s 239 (269)
T d2java1 163 ILNHDTSFAKAFVGTPYYMSPEQMNRMSYNEKSD---IWSLGCLLYELCALMPPFTAFSQKELAGKIREGKFRRIPYRYS 239 (269)
T ss_dssp HC-----------CCCSCCCHHHHTTCCCCHHHH---HHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHTCCCCCCTTSC
T ss_pred ecccCCCccccCCCCcccCCHHHHcCCCCChHHH---HHhhCHHHHHHhhCCCCCCCCCHHHHHHHHHcCCCCCCCcccC
Confidence 246666667766555 44677899999999999999999999999998876 5788999
Q ss_pred HHHHHHHHhhcccCCCcccCCCCCCHHHHhcCCce
Q psy11767 279 PDVADFISRLLVKDPRRRLGGGELDAEELKRHPFF 313 (966)
Q Consensus 279 ~~a~dli~~LL~kdp~~RLG~~~~g~~~Ik~HpfF 313 (966)
+++++||+++|++||.+|. .++||.+|||-
T Consensus 240 ~~l~~li~~~L~~dp~~Rp-----s~~ell~hp~i 269 (269)
T d2java1 240 DELNEIITRMLNLKDYHRP-----SVEEILENPLI 269 (269)
T ss_dssp HHHHHHHHHHTCSSGGGSC-----CHHHHHTSTTC
T ss_pred HHHHHHHHHHcCCChhHCc-----CHHHHHhCCcC
Confidence 9999999999999999997 48999999983
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.90 E-value=2.8e-24 Score=231.88 Aligned_cols=190 Identities=19% Similarity=0.304 Sum_probs=142.7
Q ss_pred ccchhccCCcceeeeecccccceEEEEEEcCCCCEEEEEeccccc-----------hhhHHHHHHHHhh-CCCccccccc
Q psy11767 109 LFFEQYDMDLDKAGILGDGSYSVCRRCVEKSTGQEYAVKIISRKI-----------DCSEEINLLRACQ-GHPNICRRCV 176 (966)
Q Consensus 109 ~~~~~~~~df~~~~~LG~GsFGkV~La~~k~tg~~yAiKvl~K~~-----------~~~~E~~il~~~~-~~pfi~~~~~ 176 (966)
||..+| ++.++||+|+||+|++|+++.||+.||||+++|.. ...+|..+|+++. .||+||+.+-
T Consensus 1 pl~~~Y----~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~~~h~nIv~~~~ 76 (273)
T d1xwsa_ 1 PLESQY----QVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLD 76 (273)
T ss_dssp CCTTTE----EEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEE
T ss_pred CCCCeE----EEeEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccchhhhhHHHHHHHHHHHHHHhccCCCCccEEEE
Confidence 455555 89999999999999999999999999999998742 2468999999986 4999987221
Q ss_pred cccc-------------------------------chhHHHHHHHh----------hcccchhhhHhhhcc-CCceEEec
Q psy11767 177 EKST-------------------------------GQEYAVKIISR----------KIDCSEEINLLRACQ-GHPNIVNL 214 (966)
Q Consensus 177 ~~~~-------------------------------~~~~~~~~v~~----------~~~~~~e~nil~~~~-gh~~iv~l 214 (966)
.+.. ...++.+++.+ ..|++++ |||.+.+ |..+|+||
T Consensus 77 ~~~~~~~~~lv~e~~~~~~~l~~~~~~~~~l~e~~~~~~~~qi~~al~~lH~~~iiHrDiKp~-NIll~~~~~~vkl~DF 155 (273)
T d1xwsa_ 77 WFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDE-NILIDLNRGELKLIDF 155 (273)
T ss_dssp EEECSSEEEEEEECCSSEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGG-GEEEETTTTEEEECCC
T ss_pred EEeeCCeEEEEEEeccCcchHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCccccCccc-ceEEecCCCeEEECcc
Confidence 1111 12222233322 1255556 9999854 78999999
Q ss_pred Ccccc-----------------ccccccccC-CCcceeeechhhHHHHHHHhhCCCCCCCCcHHHHHHHHHhCCCCCCCC
Q psy11767 215 HCVFQ-----------------DEVIDWDDF-SRGIECVFFSSSLIIFFIILSFTLSFIHDYYHIQYRRILKTEPPIPED 276 (966)
Q Consensus 215 ~~~~~-----------------~e~i~~~~y-~~~~d~~~~~~~~il~~~m~~g~~pf~~~~~~~~~~~I~~~~~~~P~~ 276 (966)
+.+.. +|++....| +...| .|+.|+++|+|++|.+||..+ +.|+.+.+.+|..
T Consensus 156 G~a~~~~~~~~~~~~GT~~y~aPE~~~~~~~~~~~~D---iwSlGvilyell~g~~Pf~~~------~~i~~~~~~~~~~ 226 (273)
T d1xwsa_ 156 GSGALLKDTVYTDFDGTRVYSPPEWIRYHRYHGRSAA---VWSLGILLYDMVCGDIPFEHD------EEIIRGQVFFRQR 226 (273)
T ss_dssp TTCEECCSSCBCCCCSCGGGSCHHHHHHSCBCHHHHH---HHHHHHHHHHHHHSSCSCCSH------HHHHHCCCCCSSC
T ss_pred ccceecccccccccccCCCcCCHHHHcCCCCCCcccc---cccceeeehhHhhCCCCCCCc------hHHhhcccCCCCC
Confidence 97632 344443333 23334 457788889999999999864 4688899999999
Q ss_pred CCHHHHHHHHhhcccCCCcccCCCCCCHHHHhcCCceeeeC
Q psy11767 277 LSPDVADFISRLLVKDPRRRLGGGELDAEELKRHPFFNVID 317 (966)
Q Consensus 277 ~s~~a~dli~~LL~kdp~~RLG~~~~g~~~Ik~HpfF~~id 317 (966)
+|++++|||+++|++||.+|.. ++||.+||||+++-
T Consensus 227 ~s~~~~~li~~~L~~dp~~R~s-----~~eil~hp~~~~~~ 262 (273)
T d1xwsa_ 227 VSSECQHLIRWCLALRPSDRPT-----FEEIQNHPWMQDVL 262 (273)
T ss_dssp CCHHHHHHHHHHTCSSGGGSCC-----HHHHHTSGGGSSCC
T ss_pred CCHHHHHHHHHHccCCHhHCcC-----HHHHhcCHhhCCCC
Confidence 9999999999999999999984 89999999998653
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.90 E-value=2.5e-24 Score=237.88 Aligned_cols=196 Identities=20% Similarity=0.281 Sum_probs=146.2
Q ss_pred CCcceeeeecccccceEEEEEEcCCCCEEEEEeccccc------hhhHHHHHHHHhhCCCccccccccccc---------
Q psy11767 116 MDLDKAGILGDGSYSVCRRCVEKSTGQEYAVKIISRKI------DCSEEINLLRACQGHPNICRRCVEKST--------- 180 (966)
Q Consensus 116 ~df~~~~~LG~GsFGkV~La~~k~tg~~yAiKvl~K~~------~~~~E~~il~~~~~~pfi~~~~~~~~~--------- 180 (966)
-||++++.||+|+||+|++|+++.||+.||||++++.. ...+|..+|+++ +||+||+.+-.+..
T Consensus 6 d~y~~~~~iG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l-~HpnIv~l~~~~~~~~~~~iVmE 84 (322)
T d1s9ja_ 6 DDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHEC-NSPYIVGFYGAFYSDGEISICME 84 (322)
T ss_dssp GGEEEEEEEECCSSCCEEEEEETTTTEEEEEEEEECCCCTTHHHHHHHHGGGGGGC-CCTTBCCEEEEEECSSEEEEEEE
T ss_pred cCCEEEEEEecCCCeEEEEEEECCCCcEEEEEEEChhhCHHHHHHHHHHHHHHHhC-CCCCCCcEEEEEEECCEEEEEEE
Confidence 47899999999999999999999999999999998642 357899999888 69999872221111
Q ss_pred ---------------------chhHHHHH------HH-hh----cccchhhhHhhhccCCceEEecCccc----------
Q psy11767 181 ---------------------GQEYAVKI------IS-RK----IDCSEEINLLRACQGHPNIVNLHCVF---------- 218 (966)
Q Consensus 181 ---------------------~~~~~~~~------v~-~~----~~~~~e~nil~~~~gh~~iv~l~~~~---------- 218 (966)
.+.++.++ +. +. .|++++ |||.+.+|+.+|+||+.+.
T Consensus 85 y~~gg~L~~~l~~~~~l~~~~~~~~~~qil~aL~yLH~~~~IiHRDiKP~-NILl~~~~~vkl~DFGla~~~~~~~~~~~ 163 (322)
T d1s9ja_ 85 HMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPS-NILVNSRGEIKLCDFGVSGQLIDSMANSF 163 (322)
T ss_dssp CCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHHHCCCCSCCSGG-GEEECTTCCEEECCCCCCHHHHHHTC---
T ss_pred cCCCCcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHhCCEEccccCHH-HeeECCCCCEEEeeCCCccccCCCccccc
Confidence 12222222 22 21 266666 9999999999999999763
Q ss_pred -------cccccccccCCCcceeeechhhHHHHHHHhhCCCCCCCCcHHH------------------------------
Q psy11767 219 -------QDEVIDWDDFSRGIECVFFSSSLIIFFIILSFTLSFIHDYYHI------------------------------ 261 (966)
Q Consensus 219 -------~~e~i~~~~y~~~~d~~~~~~~~il~~~m~~g~~pf~~~~~~~------------------------------ 261 (966)
.+|++....|+...| .|+.|+++|||++|.+||...+...
T Consensus 164 ~GT~~Y~APEvl~~~~y~~~~D---iWSlGvil~ell~G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (322)
T d1s9ja_ 164 VGTRSYMSPERLQGTHYSVQSD---IWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRPLSSY 240 (322)
T ss_dssp CCSSCCCCHHHHHCSCCCTTHH---HHHHHHHHHHHHHSSCCSSCCCTTHHHHHC-------------------------
T ss_pred cCCccccCchHHcCCCCCcHHH---HHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhcCCcccCCccccccccccccc
Confidence 357777778887776 4578888999999999997643221
Q ss_pred ------------HHHHHHhC-CCCCCC-CCCHHHHHHHHhhcccCCCcccCCCCCCHHHHhcCCceeeeCcccc
Q psy11767 262 ------------QYRRILKT-EPPIPE-DLSPDVADFISRLLVKDPRRRLGGGELDAEELKRHPFFNVIDWDDL 321 (966)
Q Consensus 262 ------------~~~~I~~~-~~~~P~-~~s~~a~dli~~LL~kdp~~RLG~~~~g~~~Ik~HpfF~~idW~~l 321 (966)
+.+.+... .+..|. .+|++++|||+++|+.||.+|. .++|+.+||||+..+|+.+
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~-----ta~e~L~Hpf~~~~~~~~~ 309 (322)
T d1s9ja_ 241 GMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERA-----DLKQLMVHAFIKRSDAEEV 309 (322)
T ss_dssp -----CCCCHHHHHHHHHTSCCCCCCBTTBCHHHHHHHHHHTCSSTTTSC-----CHHHHHTSHHHHHHHHSCC
T ss_pred ccccccchhHHHHHhhhhccCCccCccccCCHHHHHHHHHHcCCChhHCc-----CHHHHhhCHhhCcCCcccc
Confidence 11222222 233343 4689999999999999999998 4899999999999998765
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.89 E-value=2.9e-24 Score=238.64 Aligned_cols=189 Identities=21% Similarity=0.278 Sum_probs=143.6
Q ss_pred Cccee-eeecccccceEEEEEEcCCCCEEEEEeccccchhhHHHHHHHHhhCCCcccccccccc----------------
Q psy11767 117 DLDKA-GILGDGSYSVCRRCVEKSTGQEYAVKIISRKIDCSEEINLLRACQGHPNICRRCVEKS---------------- 179 (966)
Q Consensus 117 df~~~-~~LG~GsFGkV~La~~k~tg~~yAiKvl~K~~~~~~E~~il~~~~~~pfi~~~~~~~~---------------- 179 (966)
||+++ ++||+|+||+|++|+++.||+.||||++++.....+|..+|.+..+||+||+.+-.+.
T Consensus 12 ~y~i~~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~E~~~~~~~~~hpnIv~l~~~~~~~~~~~~~~~ivmEy~ 91 (335)
T d2ozaa1 12 DYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDCPKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECL 91 (335)
T ss_dssp TEEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECSHHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEEEEEECC
T ss_pred CEEEeeEEeeeccCeEEEEEEECCCCCEEEEEEECCcHHHHHHHHHHHHhcCCCCCCeEEEEEeecccCCCEEEEEEECC
Confidence 66776 5899999999999999999999999999988788899999988889999987322211
Q ss_pred --------------------cchhHHHHHHHh----------hcccchhhhHhhhc---cCCceEEecCccc--------
Q psy11767 180 --------------------TGQEYAVKIISR----------KIDCSEEINLLRAC---QGHPNIVNLHCVF-------- 218 (966)
Q Consensus 180 --------------------~~~~~~~~~v~~----------~~~~~~e~nil~~~---~gh~~iv~l~~~~-------- 218 (966)
..+.++.+++.+ ..|++++ |||++. .|+++|+||+.+.
T Consensus 92 ~gg~L~~~i~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~iiHRDiKp~-NIll~~~~~~~~~Kl~DFG~a~~~~~~~~~ 170 (335)
T d2ozaa1 92 DGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPE-NLLYTSKRPNAILKLTDFGFAKETTSHNSL 170 (335)
T ss_dssp CSEEHHHHHHSCSCCCEEHHHHHHHHHHHHHHHHHHHHTTEECCCCSGG-GEEESCSSTTCCEEECCCTTCEECCCCCCC
T ss_pred CCCcHHHHHHhcCCCCcCHHHHHHHHHHHHHHHHHHHHcCCcccccccc-ccccccccccccccccccceeeeccCCCcc
Confidence 112222233222 1255566 999875 4789999998663
Q ss_pred ----------cccccccccCCCcceeeechhhHHHHHHHhhCCCCCCCCcH----HHHHHHHHhCCCCCCC----CCCHH
Q psy11767 219 ----------QDEVIDWDDFSRGIECVFFSSSLIIFFIILSFTLSFIHDYY----HIQYRRILKTEPPIPE----DLSPD 280 (966)
Q Consensus 219 ----------~~e~i~~~~y~~~~d~~~~~~~~il~~~m~~g~~pf~~~~~----~~~~~~I~~~~~~~P~----~~s~~ 280 (966)
.+|++....|+..+| .|+.|+++|+|++|.+||...+. ..++.+|..+.+.+|. .+|++
T Consensus 171 ~~~~gt~~y~aPE~~~~~~y~~~~D---iwSlGvily~lltg~~Pf~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~ 247 (335)
T d2ozaa1 171 TTPCYTPYYVAPEVLGPEKYDKSCD---MWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWSEVSEE 247 (335)
T ss_dssp CCCSCCCSSCCCCCCCGGGGSHHHH---HHHHHHHHHHHTTSSCSCEETTCC--------CCCSCSSSCCTTHHHHSCHH
T ss_pred ccccCCcccCCcHHHcCCCCCHHHH---HHhhchhHHHHhhCCCCCCCCCHHHHHHHHHHHHhcCCCCCCCcccccCCHH
Confidence 256676667766655 45777889999999999986543 3456677778888885 58999
Q ss_pred HHHHHHhhcccCCCcccCCCCCCHHHHhcCCcee
Q psy11767 281 VADFISRLLVKDPRRRLGGGELDAEELKRHPFFN 314 (966)
Q Consensus 281 a~dli~~LL~kdp~~RLG~~~~g~~~Ik~HpfF~ 314 (966)
++|||+++|++||.+|+. +.+|.+||||.
T Consensus 248 ~~~li~~~L~~dP~~R~s-----~~eil~hp~~~ 276 (335)
T d2ozaa1 248 VKMLIRNLLKTEPTQRMT-----ITEFMNHPWIM 276 (335)
T ss_dssp HHHHHHHHSCSSTTTSCC-----HHHHHHSHHHH
T ss_pred HHHHHHHHccCChhHCcC-----HHHHHcCHHhh
Confidence 999999999999999984 89999999995
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.89 E-value=6.4e-24 Score=231.81 Aligned_cols=190 Identities=27% Similarity=0.400 Sum_probs=138.6
Q ss_pred CcceeeeecccccceEEEEEEcCCCCEEEEEeccccc-------hhhHHHHHHHHhhCCCccccccccccc---------
Q psy11767 117 DLDKAGILGDGSYSVCRRCVEKSTGQEYAVKIISRKI-------DCSEEINLLRACQGHPNICRRCVEKST--------- 180 (966)
Q Consensus 117 df~~~~~LG~GsFGkV~La~~k~tg~~yAiKvl~K~~-------~~~~E~~il~~~~~~pfi~~~~~~~~~--------- 180 (966)
||++++.||+|+||+|++|+++.||+.||||++++.. ...+|.+||+++ +||+|++.+..+..
T Consensus 3 ~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l-~Hp~Iv~~~~~~~~~~~~~iv~e 81 (298)
T d1gz8a_ 3 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKEL-NHPNIVKLLDVIHTENKLYLVFE 81 (298)
T ss_dssp TEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEC-------CCHHHHHHHHHHTTC-CCTTBCCEEEEEEETTEEEEEEE
T ss_pred CCEeccEEecCcCeEEEEEEECCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhC-CCCcEEEeccccccccceeEEEe
Confidence 8999999999999999999999999999999997642 357899999987 69999872222211
Q ss_pred ----------------------chhHHHHHHHh----------hcccchhhhHhhhccCCceEEecCcccc---------
Q psy11767 181 ----------------------GQEYAVKIISR----------KIDCSEEINLLRACQGHPNIVNLHCVFQ--------- 219 (966)
Q Consensus 181 ----------------------~~~~~~~~v~~----------~~~~~~e~nil~~~~gh~~iv~l~~~~~--------- 219 (966)
.+.++.+++.+ ..|+++| |||.+.+++.+|+||+.+..
T Consensus 82 ~~~~~~~~~~~~~~~~~l~e~~~~~~~~qil~~L~yLH~~~IiHrDiKpe-NIl~~~~~~~kl~DFG~a~~~~~~~~~~~ 160 (298)
T d1gz8a_ 82 FLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQ-NLLINTEGAIKLADFGLARAFGVPVRTYT 160 (298)
T ss_dssp CCSEEHHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGG-GEEECTTSCEEECSTTHHHHHCCCSBCTT
T ss_pred ecCCchhhhhhhhcccCCCHHHHHHHHHHHHHHHHHhhcCCEEccccCch-heeecccCcceeccCCcceeccCCcccce
Confidence 22233333322 1256666 99999999999999986631
Q ss_pred ----------ccccccccC-CCcceeeechhhHHHHHHHhhCCCCCCCCcHHHHHHHHHhC------------------C
Q psy11767 220 ----------DEVIDWDDF-SRGIECVFFSSSLIIFFIILSFTLSFIHDYYHIQYRRILKT------------------E 270 (966)
Q Consensus 220 ----------~e~i~~~~y-~~~~d~~~~~~~~il~~~m~~g~~pf~~~~~~~~~~~I~~~------------------~ 270 (966)
+|++....| +...| .| +.||++|+|++|.+||...+......+|.+. .
T Consensus 161 ~~~gt~~y~apE~~~~~~~~~~~~D--iw-SlGvily~m~~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~ 237 (298)
T d1gz8a_ 161 HEVVTLWYRAPEILLGCKYYSTAVD--IW-SLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYK 237 (298)
T ss_dssp CCBCCCTTCCHHHHTTCSSCCTHHH--HH-HHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGSTTCC
T ss_pred eecccceeeehhhhccccCCCcccc--cc-ccchhhhHHhhCCCCCCCCCHHHHHHHHHHhcCCCchhhccccccccccc
Confidence 244444443 33444 34 5677888999999999988776666666531 1
Q ss_pred CCCC-----------CCCCHHHHHHHHhhcccCCCcccCCCCCCHHHHhcCCceeee
Q psy11767 271 PPIP-----------EDLSPDVADFISRLLVKDPRRRLGGGELDAEELKRHPFFNVI 316 (966)
Q Consensus 271 ~~~P-----------~~~s~~a~dli~~LL~kdp~~RLG~~~~g~~~Ik~HpfF~~i 316 (966)
..+| ..+|++++|||+++|++||.+|. .++||.+||||+++
T Consensus 238 ~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~-----t~~ell~H~ff~~~ 289 (298)
T d1gz8a_ 238 PSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRI-----SAKAALAHPFFQDV 289 (298)
T ss_dssp TTSCCCCCCCHHHHSTTCCHHHHHHHHHHTCSSTTTSC-----CHHHHHTSGGGTTC
T ss_pred cccccccccchhhhccCCCHHHHHHHHHHccCChhHCc-----CHHHHhCCHhhccC
Confidence 1111 25789999999999999999998 48999999999755
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Probab=99.89 E-value=1.1e-23 Score=232.88 Aligned_cols=194 Identities=22% Similarity=0.274 Sum_probs=138.1
Q ss_pred CcceeeeecccccceEEEEEEcCCCCEEEEEecccc--chhhHHHHHHHHhhCCCccccccccc----------------
Q psy11767 117 DLDKAGILGDGSYSVCRRCVEKSTGQEYAVKIISRK--IDCSEEINLLRACQGHPNICRRCVEK---------------- 178 (966)
Q Consensus 117 df~~~~~LG~GsFGkV~La~~k~tg~~yAiKvl~K~--~~~~~E~~il~~~~~~pfi~~~~~~~---------------- 178 (966)
||++++.||+|+||+||+|+++.||+.||||++++. ....+|..+|+++++||+|++.+..+
T Consensus 36 ~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~Ei~il~~l~~hpnIv~~~~~~~~~~~~~~~~v~e~~~ 115 (328)
T d3bqca1 36 DYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVKKKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVFEHVN 115 (328)
T ss_dssp GEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSSCHHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCSEEEEEECCC
T ss_pred CeEEEEEEecCcCeEEEEEEECCCCCEEEEEEECHHHHHHHHHHHHHHHhccCCCCCcEEEEEEEecCCCceeEEEeecC
Confidence 789999999999999999999999999999999975 35678999999999999998722211
Q ss_pred -------------ccchhHHHHHHHh----------hcccchhhhHhhhccCC-ceEEecCcccc---------------
Q psy11767 179 -------------STGQEYAVKIISR----------KIDCSEEINLLRACQGH-PNIVNLHCVFQ--------------- 219 (966)
Q Consensus 179 -------------~~~~~~~~~~v~~----------~~~~~~e~nil~~~~gh-~~iv~l~~~~~--------------- 219 (966)
...+.++.+++.+ ..|++++ |||.+.+|+ ++|.||+.+..
T Consensus 116 ~~~L~~~~~~l~e~~i~~i~~qil~aL~~LH~~gIvHrDiKp~-NILi~~~~~~vkl~DFG~a~~~~~~~~~~~~~~t~~ 194 (328)
T d3bqca1 116 NTDFKQLYQTLTDYDIRFYMYEILKALDYCHSMGIMHRDVKPH-NVMIDHEHRKLRLIDWGLAEFYHPGQEYNVRVASRY 194 (328)
T ss_dssp SCBGGGTTTSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGG-GEEEETTTTEEEECCGGGCEECCTTCCCCSCCSCGG
T ss_pred CCcHHHHhcCCCHHHHHHHHHHHHHHHHHHhhccccccccccc-ceEEcCCCCeeeecccccceeccCCCcccccccCcc
Confidence 1112333344333 1255666 999987664 89999997631
Q ss_pred ---cccccc-ccCCCcceeeechhhHHHHHHHhhCCCCCCCC-cHHHHHHHHHh-------------CCC----------
Q psy11767 220 ---DEVIDW-DDFSRGIECVFFSSSLIIFFIILSFTLSFIHD-YYHIQYRRILK-------------TEP---------- 271 (966)
Q Consensus 220 ---~e~i~~-~~y~~~~d~~~~~~~~il~~~m~~g~~pf~~~-~~~~~~~~I~~-------------~~~---------- 271 (966)
+|++.. ..|+...| .| +.|+++|+|++|.+||... +.......|.. ...
T Consensus 195 y~aPE~~~~~~~~~~~~D--iw-slG~~l~e~~~g~~pf~~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~ 271 (328)
T d3bqca1 195 FKGPELLVDYQMYDYSLD--MW-SLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIELDPRFNDIL 271 (328)
T ss_dssp GCCHHHHTTCCCCCTHHH--HH-HHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHHHHHHHTTCCCCGGGGGTC
T ss_pred ccCcccccCCCCCCcccc--hh-hhhhhhHHhccCCCCCCCCchhHHHHHHHHHHHCCchhhhhhhhcccccCcccchhc
Confidence 233332 34555555 34 5667788888888888643 22222222211 000
Q ss_pred --------------CCCCCCCHHHHHHHHhhcccCCCcccCCCCCCHHHHhcCCceeeeCcc
Q psy11767 272 --------------PIPEDLSPDVADFISRLLVKDPRRRLGGGELDAEELKRHPFFNVIDWD 319 (966)
Q Consensus 272 --------------~~P~~~s~~a~dli~~LL~kdp~~RLG~~~~g~~~Ik~HpfF~~idW~ 319 (966)
..+..+|++++|||+++|+.||.+|++ ++|+.+||||++|.||
T Consensus 272 ~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~t-----a~e~L~Hp~F~~v~~~ 328 (328)
T d3bqca1 272 GRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLT-----AREAMEHPYFYTVVKD 328 (328)
T ss_dssp CCCCCCCGGGGCCTTTGGGCCHHHHHHHHHHSCSSGGGSCC-----HHHHHTSGGGTTSCCC
T ss_pred ccccccchhhcccccccccCCHHHHHHHHHHccCChhHCcC-----HHHHhcCcccCCCCCC
Confidence 011347899999999999999999994 8999999999999997
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=99.89 E-value=1.5e-23 Score=230.35 Aligned_cols=187 Identities=18% Similarity=0.165 Sum_probs=143.8
Q ss_pred cceeeeecccccceEEEEEEcCCCCEEEEEeccccc--------hhhHHHHHHHHhhCCCccccccccccc---------
Q psy11767 118 LDKAGILGDGSYSVCRRCVEKSTGQEYAVKIISRKI--------DCSEEINLLRACQGHPNICRRCVEKST--------- 180 (966)
Q Consensus 118 f~~~~~LG~GsFGkV~La~~k~tg~~yAiKvl~K~~--------~~~~E~~il~~~~~~pfi~~~~~~~~~--------- 180 (966)
|+.++.||+|+||+|++|+++.||+.||||++++.. ...+|.++|+++ +||+||+.+-.+..
T Consensus 17 y~~l~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l-~HpnIv~~~~~~~~~~~~~iv~E 95 (309)
T d1u5ra_ 17 FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKL-RHPNTIQYRGCYLREHTAWLVME 95 (309)
T ss_dssp EEEEEEEEECSSSEEEEEEETTTTEEEEEEEEECCSSCHHHHHHHHHHHHHHHTTC-CCTTBCCEEEEEEETTEEEEEEE
T ss_pred cEeeEEEecCCCeEEEEEEECCCCcEEEEEEEchhhccCHHHHHHHHHHHHHHHHC-CCCCEeeEEEEEEECCEEEEEEE
Confidence 789999999999999999999999999999998642 356799999998 59999872221111
Q ss_pred ---------------------chhHHHHHHHh----------hcccchhhhHhhhccCCceEEecCccc-----------
Q psy11767 181 ---------------------GQEYAVKIISR----------KIDCSEEINLLRACQGHPNIVNLHCVF----------- 218 (966)
Q Consensus 181 ---------------------~~~~~~~~v~~----------~~~~~~e~nil~~~~gh~~iv~l~~~~----------- 218 (966)
...++.+++.+ ..|++++ |||++.+|+.+|+||+.+.
T Consensus 96 ~~~~g~l~~~~~~~~~l~e~~~~~i~~qi~~aL~yLH~~~iiHrDiKp~-NILl~~~~~~Kl~DFG~a~~~~~~~~~~GT 174 (309)
T d1u5ra_ 96 YCLGSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAG-NILLSEPGLVKLGDFGSASIMAPANSFVGT 174 (309)
T ss_dssp CCSEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGG-GEEEETTTEEEECCCTTCBSSSSBCCCCSC
T ss_pred ecCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCEeccCCCcc-eEEECCCCCEEEeecccccccCCCCccccC
Confidence 12222233222 1255555 9999999999999999764
Q ss_pred ----ccccccc---ccCCCcceeeechhhHHHHHHHhhCCCCCCCCcHHHHHHHHHhCCCC--CCCCCCHHHHHHHHhhc
Q psy11767 219 ----QDEVIDW---DDFSRGIECVFFSSSLIIFFIILSFTLSFIHDYYHIQYRRILKTEPP--IPEDLSPDVADFISRLL 289 (966)
Q Consensus 219 ----~~e~i~~---~~y~~~~d~~~~~~~~il~~~m~~g~~pf~~~~~~~~~~~I~~~~~~--~P~~~s~~a~dli~~LL 289 (966)
.+|++.. ..|+...| .|+.||++|||++|.+||.+.+....+.+|+.+... .+..+|++++|||.++|
T Consensus 175 ~~Y~APE~~~~~~~~~y~~~~D---iwSlGvilyel~~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~s~~~~~li~~~L 251 (309)
T d1u5ra_ 175 PYWMAPEVILAMDEGQYDGKVD---VWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPALQSGHWSEYFRNFVDSCL 251 (309)
T ss_dssp GGGCCHHHHTTTTSCCBCTHHH---HHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCCCSCTTSCHHHHHHHHHHT
T ss_pred ccccCHHHHhccCCCCcCchhh---hhhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCCCCCCCCCCCHHHHHHHHHHC
Confidence 3466643 24655555 446778888999999999988887778888876543 34568999999999999
Q ss_pred ccCCCcccCCCCCCHHHHhcCCcee
Q psy11767 290 VKDPRRRLGGGELDAEELKRHPFFN 314 (966)
Q Consensus 290 ~kdp~~RLG~~~~g~~~Ik~HpfF~ 314 (966)
++||.+|+. +++|.+||||.
T Consensus 252 ~~dP~~Rpt-----~~ell~Hp~~~ 271 (309)
T d1u5ra_ 252 QKIPQDRPT-----SEVLLKHRFVL 271 (309)
T ss_dssp CSSGGGSCC-----HHHHTTCHHHH
T ss_pred cCChhHCcC-----HHHHHhCHHhc
Confidence 999999984 89999999995
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.89 E-value=2.8e-23 Score=226.66 Aligned_cols=188 Identities=23% Similarity=0.278 Sum_probs=137.1
Q ss_pred ceeeeecccccceEEEEEEcCCCCEEEEEeccccc----------hhhHHHHHHHHhhCCCcccccc-------------
Q psy11767 119 DKAGILGDGSYSVCRRCVEKSTGQEYAVKIISRKI----------DCSEEINLLRACQGHPNICRRC------------- 175 (966)
Q Consensus 119 ~~~~~LG~GsFGkV~La~~k~tg~~yAiKvl~K~~----------~~~~E~~il~~~~~~pfi~~~~------------- 175 (966)
+.+++||+|+||+|++|+++.||+.||||++++.. ...+|.++|+++ +||+||+.+
T Consensus 1 E~l~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l-~hpnIv~~~~~~~~~~~~~ivm 79 (299)
T d1ua2a_ 1 EKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQEL-SHPNIIGLLDAFGHKSNISLVF 79 (299)
T ss_dssp CEEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHC-CCTTBCCEEEEECCTTCCEEEE
T ss_pred CcceEeccCcCeEEEEEEECCCCcEEEEEEEehhhhhhhhHHHHHHHHHHHHHHHhC-CCCCEeEEEeeeccCCceeehh
Confidence 36789999999999999999999999999998642 246799999998 599998722
Q ss_pred -----------------cccccchhHHHHHHHh----------hcccchhhhHhhhccCCceEEecCcccc---------
Q psy11767 176 -----------------VEKSTGQEYAVKIISR----------KIDCSEEINLLRACQGHPNIVNLHCVFQ--------- 219 (966)
Q Consensus 176 -----------------~~~~~~~~~~~~~v~~----------~~~~~~e~nil~~~~gh~~iv~l~~~~~--------- 219 (966)
+.+...+.+..+++.+ ..|++++ |||.+.+|..+|+||+.+..
T Consensus 80 E~~~~~~~~~~~~~~~~l~~~~~~~~~~qil~aL~~lH~~~iiHrDiKp~-NIli~~~~~~KL~DFG~a~~~~~~~~~~~ 158 (299)
T d1ua2a_ 80 DFMETDLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQHWILHRDLKPN-NLLLDENGVLKLADFGLAKSFGSPNRAYT 158 (299)
T ss_dssp ECCSEEHHHHHTTCCSSCCSSHHHHHHHHHHHHHHHHHHTTCCCCCCCGG-GEEECTTCCEEECCCGGGSTTTSCCCCCC
T ss_pred hhhcchHHhhhhhcccCCCHHHHHHHHHHHHHHHHHhhccceecccCCcc-eEEecCCCccccccCccccccCCCccccc
Confidence 1222223333344333 1366666 99999999999999997632
Q ss_pred ----------cccccc-ccCCCcceeeechhhHHHHHHHhhCCCCCCCCcHHHHHHHHHhC--CC---------------
Q psy11767 220 ----------DEVIDW-DDFSRGIECVFFSSSLIIFFIILSFTLSFIHDYYHIQYRRILKT--EP--------------- 271 (966)
Q Consensus 220 ----------~e~i~~-~~y~~~~d~~~~~~~~il~~~m~~g~~pf~~~~~~~~~~~I~~~--~~--------------- 271 (966)
+|++.. ..|+...| .|+.|+++|||++|.+||...+...+..+|.+. .+
T Consensus 159 ~~~gt~~y~aPE~~~~~~~~~~~~D---iwSlGvil~el~~g~~pf~~~~~~~~l~~i~~~~~~~~~~~~~~~~~~~~~~ 235 (299)
T d1ua2a_ 159 HQVVTRWYRAPELLFGARMYGVGVD---MWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSLPDYV 235 (299)
T ss_dssp CSCCCCTTCCHHHHTTCSCCCHHHH---HHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTTTSSSTTSSTTCC
T ss_pred ceecChhhccHHHHccCCCCChhhh---hhhcchHHHHHHhCcCCCCCCCHHHHHHHHHHhcCCCChhhccchhccchhh
Confidence 234432 24554444 346677888899999999998888888887642 11
Q ss_pred ---CC--------CCCCCHHHHHHHHhhcccCCCcccCCCCCCHHHHhcCCceeee
Q psy11767 272 ---PI--------PEDLSPDVADFISRLLVKDPRRRLGGGELDAEELKRHPFFNVI 316 (966)
Q Consensus 272 ---~~--------P~~~s~~a~dli~~LL~kdp~~RLG~~~~g~~~Ik~HpfF~~i 316 (966)
.+ ...+|++++|||+++|+.||++|+. ++|+.+||||++.
T Consensus 236 ~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~dP~~R~s-----a~e~L~Hp~f~~~ 286 (299)
T d1ua2a_ 236 TFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARIT-----ATQALKMKYFSNR 286 (299)
T ss_dssp CCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCC-----HHHHHTSGGGTSS
T ss_pred hhccCCCCChHHhcccCCHHHHHHHHHHccCChhhCcC-----HHHHhCCHhhCCC
Confidence 01 1357899999999999999999984 8999999999754
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.88 E-value=2.2e-23 Score=232.76 Aligned_cols=193 Identities=23% Similarity=0.249 Sum_probs=142.0
Q ss_pred cCCcceeeeecccccceEEEEEEcCCCCEEEEEeccccc-hhhHHHHHHHHhhCCCccccccccc---------------
Q psy11767 115 DMDLDKAGILGDGSYSVCRRCVEKSTGQEYAVKIISRKI-DCSEEINLLRACQGHPNICRRCVEK--------------- 178 (966)
Q Consensus 115 ~~df~~~~~LG~GsFGkV~La~~k~tg~~yAiKvl~K~~-~~~~E~~il~~~~~~pfi~~~~~~~--------------- 178 (966)
+.+|+.+++||+|+||+||+|+++.||+.||||++++.. ...+|..||+++ +||+|++....+
T Consensus 19 ~~~Y~~~k~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~Ei~il~~l-~h~niv~~~~~~~~~~~~~~~~~~~lv 97 (350)
T d1q5ka_ 19 EVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNRELQIMRKL-DHCNIVRLRYFFYSSGEKKDEVYLNLV 97 (350)
T ss_dssp EEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSSSCCHHHHHHHHC-CCTTBCCEEEEEEEC--CCSCCEEEEE
T ss_pred cCCcEeeeEEeeCcCeEEEEEEECCCCCEEEEEEECccchHHHHHHHHHHhc-CCCCCCcEEEEEEecCccCCceEEEEE
Confidence 447899999999999999999999999999999998753 457899999998 699998732111
Q ss_pred -cc-----------------------chhHHHHHHHh----------hcccchhhhHhhhccC-CceEEecCcccc----
Q psy11767 179 -ST-----------------------GQEYAVKIISR----------KIDCSEEINLLRACQG-HPNIVNLHCVFQ---- 219 (966)
Q Consensus 179 -~~-----------------------~~~~~~~~v~~----------~~~~~~e~nil~~~~g-h~~iv~l~~~~~---- 219 (966)
.. .+.++.+++.+ ..|++++ |||++.+| +++|+||+.+..
T Consensus 98 ~Ey~~~~~~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~yLH~~~IiHrDiKp~-NILl~~~~~~~kl~DFG~a~~~~~~ 176 (350)
T d1q5ka_ 98 LDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQ-NLLLDPDTAVLKLCDFGSAKQLVRG 176 (350)
T ss_dssp EECCSEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGG-GEEECTTTCCEEECCCTTCEECCTT
T ss_pred EeccCCccHHHHHhhhhccCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCcc-eEEEecCCCceeEecccchhhccCC
Confidence 00 01111222222 1255556 99998875 789999997632
Q ss_pred --------------ccccc-cccCCCcceeeechhhHHHHHHHhhCCCCCCCCcHHHHHHHHHh----------------
Q psy11767 220 --------------DEVID-WDDFSRGIECVFFSSSLIIFFIILSFTLSFIHDYYHIQYRRILK---------------- 268 (966)
Q Consensus 220 --------------~e~i~-~~~y~~~~d~~~~~~~~il~~~m~~g~~pf~~~~~~~~~~~I~~---------------- 268 (966)
+|++. ...|+...| +|+.|+++|||++|.+||...+...++.+|+.
T Consensus 177 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~D---IwSlG~il~el~~g~~pf~~~~~~~~l~~i~~~~g~~~~~~~~~~~~~ 253 (350)
T d1q5ka_ 177 EPNVSYICSRYYRAPELIFGATDYTSSID---VWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMNPN 253 (350)
T ss_dssp SCCCSCCSCTTSCCHHHHTTCSSCCTHHH---HHHHHHHHHHHHHTSCSSCCSSHHHHHHHHHHHHCCCCHHHHHHHCC-
T ss_pred cccccccccccccChHHhhcccCCCccee---ecccceEEEehhhCCCCCCCCCHHHHHHHHHHHhCCChHHhhhhhccc
Confidence 23333 345666555 44677888999999999998887777777753
Q ss_pred -CCCCC------------CCCCCHHHHHHHHhhcccCCCcccCCCCCCHHHHhcCCceeeeC
Q psy11767 269 -TEPPI------------PEDLSPDVADFISRLLVKDPRRRLGGGELDAEELKRHPFFNVID 317 (966)
Q Consensus 269 -~~~~~------------P~~~s~~a~dli~~LL~kdp~~RLG~~~~g~~~Ik~HpfF~~id 317 (966)
....+ ...+|++++|||+++|++||.+|+. +.|+.+||||+.+.
T Consensus 254 ~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~t-----a~e~L~Hp~f~~~~ 310 (350)
T d1q5ka_ 254 YTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLT-----PLEACAHSFFDELR 310 (350)
T ss_dssp --CCCCCCCCCCCGGGTSCTTSCHHHHHHHHHHSCSSGGGSCC-----HHHHHTSGGGGGGG
T ss_pred hhhccccccccCchhhhcccCCCHHHHHHHHHHccCChhHCcC-----HHHHhcCHhhcccc
Confidence 11222 2457999999999999999999984 89999999997653
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Probab=99.88 E-value=2.1e-23 Score=226.05 Aligned_cols=187 Identities=23% Similarity=0.334 Sum_probs=139.2
Q ss_pred CcceeeeecccccceEEEEEEcCCCCEEEEEeccccc-------hhhHHHHHHHHhhCCCccccccc-------------
Q psy11767 117 DLDKAGILGDGSYSVCRRCVEKSTGQEYAVKIISRKI-------DCSEEINLLRACQGHPNICRRCV------------- 176 (966)
Q Consensus 117 df~~~~~LG~GsFGkV~La~~k~tg~~yAiKvl~K~~-------~~~~E~~il~~~~~~pfi~~~~~------------- 176 (966)
+|++++.||+|+||+|++|+++ +|+.||||++++.. ...+|.++|+++ +||+|++.+-
T Consensus 3 ~Y~~~~~iG~G~fg~Vy~~~~~-~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l-~hpnIv~~~~~~~~~~~~~i~~e 80 (286)
T d1ob3a_ 3 KYHGLEKIGEGTYGVVYKAQNN-YGETFALKKIRLEKEDEGIPSTTIREISILKEL-KHSNIVKLYDVIHTKKRLVLVFE 80 (286)
T ss_dssp SEEEEEEEEEETTEEEEEEEET-TSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGC-CCTTBCCEEEEEECSSCEEEEEE
T ss_pred CceeccEEecCCCcEEEEEEeC-CCCEEEEEEEehhhcChHHHHHHHHHHHHHHhC-CCCcEEeeeeecccCCceeEEEE
Confidence 6799999999999999999996 88999999997642 357899999988 5999987221
Q ss_pred -----------------ccccchhHHHHHHHh----------hcccchhhhHhhhccCCceEEecCcccc----------
Q psy11767 177 -----------------EKSTGQEYAVKIISR----------KIDCSEEINLLRACQGHPNIVNLHCVFQ---------- 219 (966)
Q Consensus 177 -----------------~~~~~~~~~~~~v~~----------~~~~~~e~nil~~~~gh~~iv~l~~~~~---------- 219 (966)
.+...+.++.+++.+ ..|++++ |||.+.+|+.+|+||+.+..
T Consensus 81 ~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~IvHrDiKp~-NIll~~~~~~kl~DfG~a~~~~~~~~~~~~ 159 (286)
T d1ob3a_ 81 HLDQDLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHDRRVLHRDLKPQ-NLLINREGELKIADFGLARAFGIPVRKYTH 159 (286)
T ss_dssp CCSEEHHHHHHTSTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGG-GEEECTTSCEEECCTTHHHHHCC-------
T ss_pred eehhhhHHHHHhhcCCcchhhhHHHHHHHHHHHHHhccCcEEecCCCCc-eeeEcCCCCEEecccccceecccCccccce
Confidence 111122233333322 1256666 99999999999999986532
Q ss_pred ---------cccccc-ccCCCcceeeechhhHHHHHHHhhCCCCCCCCcHHHHHHHHHh--CC-----------------
Q psy11767 220 ---------DEVIDW-DDFSRGIECVFFSSSLIIFFIILSFTLSFIHDYYHIQYRRILK--TE----------------- 270 (966)
Q Consensus 220 ---------~e~i~~-~~y~~~~d~~~~~~~~il~~~m~~g~~pf~~~~~~~~~~~I~~--~~----------------- 270 (966)
+|++.. ..|+...| .|+.|+++|||++|.+||...+...++.+|.. +.
T Consensus 160 ~~~~~~y~~pE~~~~~~~~~~~~D---iwslGv~l~el~~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~ 236 (286)
T d1ob3a_ 160 EIVTLWYRAPDVLMGSKKYSTTID---IWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKYDP 236 (286)
T ss_dssp --CCCTTCCHHHHTTCCSCCTHHH---HHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGSTTCCT
T ss_pred ecccchhhhHHHHhCCCCCCccee---ehhcCcHHHHHHHCCCCCCCCCHHHHHHHHHHhhCCCChhhccchhhhhhccc
Confidence 233332 23455555 44678889999999999998887777777653 11
Q ss_pred ----------CCCCCCCCHHHHHHHHhhcccCCCcccCCCCCCHHHHhcCCcee
Q psy11767 271 ----------PPIPEDLSPDVADFISRLLVKDPRRRLGGGELDAEELKRHPFFN 314 (966)
Q Consensus 271 ----------~~~P~~~s~~a~dli~~LL~kdp~~RLG~~~~g~~~Ik~HpfF~ 314 (966)
..+++.+|++++|||+++|++||++|+. ++||.+||||+
T Consensus 237 ~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~s-----~~ell~Hp~f~ 285 (286)
T d1ob3a_ 237 NFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRIT-----AKQALEHAYFK 285 (286)
T ss_dssp TCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCC-----HHHHHTSGGGG
T ss_pred ccccccCcchhhhcccCCHHHHHHHHHHccCChhHCcC-----HHHHhcCcccC
Confidence 1245678999999999999999999984 89999999997
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.87 E-value=1.9e-22 Score=224.36 Aligned_cols=190 Identities=20% Similarity=0.199 Sum_probs=138.7
Q ss_pred CcceeeeecccccceEEEEEEcCCCCEEEEEeccccc-------hhhHHHHHHHHhhCCCcccccccccc----------
Q psy11767 117 DLDKAGILGDGSYSVCRRCVEKSTGQEYAVKIISRKI-------DCSEEINLLRACQGHPNICRRCVEKS---------- 179 (966)
Q Consensus 117 df~~~~~LG~GsFGkV~La~~k~tg~~yAiKvl~K~~-------~~~~E~~il~~~~~~pfi~~~~~~~~---------- 179 (966)
.|++++.||+|+||+|++|+++.||+.||||+++|.. ...+|.+||+++ +||+||+.+..+.
T Consensus 19 rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l-~h~~iv~~~~~~~~~~~~~~~~~ 97 (348)
T d2gfsa1 19 RYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHM-KHENVIGLLDVFTPARSLEEFND 97 (348)
T ss_dssp TEEEEEECGGGTTSSEEEEEETTTTEEEEEEECSCTTSSHHHHHHHHHHHHHHHHC-CCTTBCCCSEEECSCSSTTTCCC
T ss_pred CeEEEEEEecCCCeEEEEEEECCCCCEEEEEEECchhcChHHHHHHHHHHHHHHhc-CCCCeeeEEEEEeeccccccCce
Confidence 3589999999999999999999999999999998752 357899999998 6999986332211
Q ss_pred ------------------------cchhHHHHHHHh----------hcccchhhhHhhhccCCceEEecCcccc------
Q psy11767 180 ------------------------TGQEYAVKIISR----------KIDCSEEINLLRACQGHPNIVNLHCVFQ------ 219 (966)
Q Consensus 180 ------------------------~~~~~~~~~v~~----------~~~~~~e~nil~~~~gh~~iv~l~~~~~------ 219 (966)
..+.++.+++.+ ..|++++ |||.+.+|+.++.+++.+..
T Consensus 98 ~~i~~~~~gg~L~~~~~~~~l~e~~~~~i~~qil~aL~~LH~~giiHrDiKp~-NILi~~~~~~kl~dfg~a~~~~~~~~ 176 (348)
T d2gfsa1 98 VYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPS-NLAVNEDCELKILDFGLARHTDDEMT 176 (348)
T ss_dssp CEEEEECCSEEHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGG-GEEECTTCCEEECCC----CCTGGGS
T ss_pred EEEEEeecCCchhhhcccccccHHHHHHHHHHHHHHHHHHHhCCCcccccCCc-cccccccccccccccchhcccCcccc
Confidence 112222233322 1256666 99999999999999987643
Q ss_pred ----------ccccccc-cCCCcceeeechhhHHHHHHHhhCCCCCCCCcHHHHHHHHHhCCCCC---------------
Q psy11767 220 ----------DEVIDWD-DFSRGIECVFFSSSLIIFFIILSFTLSFIHDYYHIQYRRILKTEPPI--------------- 273 (966)
Q Consensus 220 ----------~e~i~~~-~y~~~~d~~~~~~~~il~~~m~~g~~pf~~~~~~~~~~~I~~~~~~~--------------- 273 (966)
+|++... .++..+| .|+.|+++|+|++|.+||...+...+++.|+......
T Consensus 177 ~~~g~~~y~apE~~~~~~~~~~~~D---iwSlGv~l~~ll~g~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~ 253 (348)
T d2gfsa1 177 GYVATRWYRAPEIMLNWMHYNQTVD---IWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARN 253 (348)
T ss_dssp SSCHHHHTSCHHHHTTCSCCCTTHH---HHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCHHHHTTCCCHHHHH
T ss_pred cccccccccCchhhcCCccCCcccc---hhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCChHHhhhccchhhhh
Confidence 2333332 3445555 3456788899999999999988887777776432221
Q ss_pred ----------------CCCCCHHHHHHHHhhcccCCCcccCCCCCCHHHHhcCCceeee
Q psy11767 274 ----------------PEDLSPDVADFISRLLVKDPRRRLGGGELDAEELKRHPFFNVI 316 (966)
Q Consensus 274 ----------------P~~~s~~a~dli~~LL~kdp~~RLG~~~~g~~~Ik~HpfF~~i 316 (966)
...+|++++|||++||+.||.+|+. ++||.+||||+.+
T Consensus 254 ~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~t-----a~elL~Hp~f~~~ 307 (348)
T d2gfsa1 254 YIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRIT-----AAQALAHAYFAQY 307 (348)
T ss_dssp HHTTSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSGGGSCC-----HHHHHTSGGGTTT
T ss_pred hhhhcccCCCcchhhhcCCCCHHHHHHHHHHCcCChhhCcC-----HHHHhcCHhhCCC
Confidence 1357999999999999999999984 8999999999854
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.87 E-value=1.5e-22 Score=219.35 Aligned_cols=189 Identities=23% Similarity=0.298 Sum_probs=135.3
Q ss_pred CcceeeeecccccceEEEEEEcCCCCEEEEEeccccc-------hhhHHHHHHHHhhCCCcccccccccc----------
Q psy11767 117 DLDKAGILGDGSYSVCRRCVEKSTGQEYAVKIISRKI-------DCSEEINLLRACQGHPNICRRCVEKS---------- 179 (966)
Q Consensus 117 df~~~~~LG~GsFGkV~La~~k~tg~~yAiKvl~K~~-------~~~~E~~il~~~~~~pfi~~~~~~~~---------- 179 (966)
+|++++.||+|+||+|++|+++.||+.||||++++.. ...+|..+|+++ +||+|++.+..+.
T Consensus 3 ry~~i~~LG~G~fg~V~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l-~h~niv~~~~~~~~~~~~~iv~~ 81 (292)
T d1unla_ 3 KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKEL-KHKNIVRLHDVLHSDKKLTLVFE 81 (292)
T ss_dssp SEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTC-CCTTBCCEEEEEECSSEEEEEEE
T ss_pred CCEeeeEEecCcCeEEEEEEECCCCcEEEEEEEehhhCChHHHHHHHHHHHHHHhc-CcCCEEeeccccccccceeEEee
Confidence 5799999999999999999999999999999997642 347899999886 6999986221111
Q ss_pred --------------------cchhHHHHHHHh----------hcccchhhhHhhhccCCceEEecCccccc---------
Q psy11767 180 --------------------TGQEYAVKIISR----------KIDCSEEINLLRACQGHPNIVNLHCVFQD--------- 220 (966)
Q Consensus 180 --------------------~~~~~~~~~v~~----------~~~~~~e~nil~~~~gh~~iv~l~~~~~~--------- 220 (966)
..+.+..+++.+ ..|++++ |||.+.+++++|+||+.+...
T Consensus 82 ~~~~~~l~~~~~~~~~~~~~~~~~~~~q~~~aL~~lH~~~IvHrDiKP~-NIli~~~~~~kl~DFG~a~~~~~~~~~~~~ 160 (292)
T d1unla_ 82 FCDQDLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHSRNVLHRDLKPQ-NLLINRNGELKLANFGLARAFGIPVRCYSA 160 (292)
T ss_dssp CCSEEHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGG-GEEECTTCCEEECCCTTCEECCSCCSCCCS
T ss_pred eccccccccccccccccchhHHHHHHHHHHHHHHHhhcCCEeeecccCc-ccccccCCceeeeecchhhcccCCCcccee
Confidence 112233333332 1255666 999999999999999876421
Q ss_pred ----------cccccc-cCCCcceeeechhhHHHHHHHhhCC-CCCCCCcHHHHHHHHHh--------------------
Q psy11767 221 ----------EVIDWD-DFSRGIECVFFSSSLIIFFIILSFT-LSFIHDYYHIQYRRILK-------------------- 268 (966)
Q Consensus 221 ----------e~i~~~-~y~~~~d~~~~~~~~il~~~m~~g~-~pf~~~~~~~~~~~I~~-------------------- 268 (966)
|++... .|+...| .| +.|+++|+|++|. |+|...+....+++|..
T Consensus 161 ~~~~~~~~~pe~~~~~~~~~~~~D--iw-SlG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (292)
T d1unla_ 161 EVVTLWYRPPDVLFGAKLYSTSID--MW-SAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLPDYK 237 (292)
T ss_dssp CCSCGGGCCHHHHTTCSCCCTHHH--HH-HHHHHHHHHTTTSCCSCCCSSHHHHHHHHHHHHCCCCTTTCTTGGGSTTCC
T ss_pred eccccchhhhhHhccCCCCCchhh--cc-ccchHHHHHhhCCCCCCCCCCHHHHHHHHHhhcCCCChhhhhhhhhccccc
Confidence 223222 2444444 44 4556666666655 55677777777777653
Q ss_pred ---------CCCCCCCCCCHHHHHHHHhhcccCCCcccCCCCCCHHHHhcCCceee
Q psy11767 269 ---------TEPPIPEDLSPDVADFISRLLVKDPRRRLGGGELDAEELKRHPFFNV 315 (966)
Q Consensus 269 ---------~~~~~P~~~s~~a~dli~~LL~kdp~~RLG~~~~g~~~Ik~HpfF~~ 315 (966)
.....+..+|++++|||+++|+.||.+|++ ++||.+||||++
T Consensus 238 ~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~s-----a~e~L~Hp~f~~ 288 (292)
T d1unla_ 238 PYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRIS-----AEEALQHPYFSD 288 (292)
T ss_dssp CCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCC-----HHHHTTSGGGSS
T ss_pred ccccccccchhhhccccCCHHHHHHHHHHccCChhHCcC-----HHHHhcChhhcC
Confidence 112244567999999999999999999984 899999999974
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.87 E-value=1.4e-22 Score=225.64 Aligned_cols=192 Identities=21% Similarity=0.239 Sum_probs=135.5
Q ss_pred CcceeeeecccccceEEEEEEcCCCCEEEEEeccccc-------hhhHHHHHHHHhhCCCccccccccccc---------
Q psy11767 117 DLDKAGILGDGSYSVCRRCVEKSTGQEYAVKIISRKI-------DCSEEINLLRACQGHPNICRRCVEKST--------- 180 (966)
Q Consensus 117 df~~~~~LG~GsFGkV~La~~k~tg~~yAiKvl~K~~-------~~~~E~~il~~~~~~pfi~~~~~~~~~--------- 180 (966)
.|++++.||+|+||+|++|+++.||+.||||++++.. ...+|..+|+++ +||+||+.+-.+..
T Consensus 19 ~Y~~i~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l-~hpniv~l~~~~~~~~~~~~~~~ 97 (346)
T d1cm8a_ 19 VYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHM-RHENVIGLLDVFTPDETLDDFTD 97 (346)
T ss_dssp SEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHC-CBTTBCCCSEEECSCSSTTTCCC
T ss_pred cEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEchhhcChHHHHHHHHHHHHHHhc-CCCCeeEEEEEeccCccccccce
Confidence 5699999999999999999999999999999998642 357899999998 69999873322111
Q ss_pred -------------------------chhHHHHHHHh----------hcccchhhhHhhhccCCceEEecCcccc------
Q psy11767 181 -------------------------GQEYAVKIISR----------KIDCSEEINLLRACQGHPNIVNLHCVFQ------ 219 (966)
Q Consensus 181 -------------------------~~~~~~~~v~~----------~~~~~~e~nil~~~~gh~~iv~l~~~~~------ 219 (966)
.+.++.+++.+ ..|++++ |||.+.+|+.++.||+.+..
T Consensus 98 ~~lv~e~~~~~l~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~IiHrDiKp~-NIL~~~~~~~kl~Dfg~a~~~~~~~~ 176 (346)
T d1cm8a_ 98 FYLVMPFMGTDLGKLMKHEKLGEDRIQFLVYQMLKGLRYIHAAGIIHRDLKPG-NLAVNEDCELKILDFGLARQADSEMT 176 (346)
T ss_dssp CEEEEECCSEEHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGG-GEEECTTCCEEECCCTTCEECCSSCC
T ss_pred EEEEEecccccHHHHHHhccccHHHHHHHHHHHHHHHHHHHhCCCcccccCcc-hhhcccccccccccccceeccCCccc
Confidence 11112222222 1255555 99999999999999987643
Q ss_pred ----------cccccc-ccCCCcceeeechhhHHHHHHHhhCCCCCCCCcHHHHHHHHHhCCC-----------------
Q psy11767 220 ----------DEVIDW-DDFSRGIECVFFSSSLIIFFIILSFTLSFIHDYYHIQYRRILKTEP----------------- 271 (966)
Q Consensus 220 ----------~e~i~~-~~y~~~~d~~~~~~~~il~~~m~~g~~pf~~~~~~~~~~~I~~~~~----------------- 271 (966)
+|++.. ..++...| .|+.|+++|+|++|.+||.+.+......++.....
T Consensus 177 ~~~~t~~y~aPE~~~~~~~~~~~~D---iwSlGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 253 (346)
T d1cm8a_ 177 GYVVTRWYRAPEVILNWMRYTQTVD---IWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQRLQSDEAKN 253 (346)
T ss_dssp SSCSCGGGCCTHHHHTTTCCCTTHH---HHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHTCSCHHHHH
T ss_pred cccccccccCHHHHcCCCCCCccch---hhcchHHHHHHHHCcCCCCCCChHHHHHHHHhccCCCcHHHHhhhcchhhhh
Confidence 344443 34555555 44677888899999999988776655544432111
Q ss_pred --------------CCCCCCCHHHHHHHHhhcccCCCcccCCCCCCHHHHhcCCceeeeCc
Q psy11767 272 --------------PIPEDLSPDVADFISRLLVKDPRRRLGGGELDAEELKRHPFFNVIDW 318 (966)
Q Consensus 272 --------------~~P~~~s~~a~dli~~LL~kdp~~RLG~~~~g~~~Ik~HpfF~~idW 318 (966)
..+..+|++++|||+++|+.||.+|+. ++||.+||||+.+.+
T Consensus 254 ~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~t-----a~eiL~Hp~f~~~~~ 309 (346)
T d1cm8a_ 254 YMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVT-----AGEALAHPYFESLHD 309 (346)
T ss_dssp HHHHSCCCCCCCGGGTCTTCCHHHHHHHHHHSCSSTTTSCC-----HHHHHHSGGGTTTC-
T ss_pred hhccCCcccccchHHhccCCCHHHHHHHHHHCcCChhHCcC-----HHHHhcChhhCcCCC
Confidence 123568999999999999999999984 899999999998765
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Probab=99.87 E-value=8.4e-23 Score=208.18 Aligned_cols=125 Identities=21% Similarity=0.303 Sum_probs=100.3
Q ss_pred ccccccccccEEEEEEEcCCCcEEEEEEecccc-----------------------ChHHHHHHHHHhcCCCCceEEEEE
Q psy11767 383 AGILGDGSYSVCRRCVEKSTGQEYAVKIISRKI-----------------------DCSEEINLLRACQGHPNIVNLHCV 439 (966)
Q Consensus 383 ~~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~-----------------------~~~~Ei~iL~~l~~HpnIV~l~~~ 439 (966)
.+.||+|+||+||+|++. +|+.||||++.... ....|...|..+ .|+|++..+++
T Consensus 5 g~~IG~G~~g~Vy~a~~~-~g~~vAvKi~r~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l-~~~~v~~~~~~ 82 (191)
T d1zara2 5 GKLMGEGKESAVFNCYSE-KFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKL-QGLAVPKVYAW 82 (191)
T ss_dssp EEEEEECSSEEEEEEEET-TTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHT-TTSSSCCEEEE
T ss_pred CCEeeeCcceEEEEEECC-CCCEEEEEEEecccchhhhhhhhhhhccHHHHHHHHHHHHHHHHHHHHc-cCCCcceEEEe
Confidence 468999999999999985 69999999874210 012467777777 49999998865
Q ss_pred EEeCCeEEEEEEccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCcEEEecCCCCCEEEEee
Q psy11767 440 FQDEVHTYLVLELLKGGELLDRIRQKGRCGFTENEASRIMRQLVAAVHFMHSRGVVHRDLKPENLLFSDPAGDNIKVVDF 519 (966)
Q Consensus 440 ~~~~~~~~lVmEy~~gg~L~~~l~~~~~~~l~e~~~~~i~~Qil~aL~yLHs~~IiHRDLKP~NILl~~~~~~~iKL~DF 519 (966)
.. .++||||++++.+. .+++..+..++.|++.||+|||++||+||||||+|||+++ +.++|+||
T Consensus 83 ~~----~~lvme~~~~~~~~---------~l~~~~~~~i~~ql~~~l~~lH~~giiHrDiKP~NILv~~---~~~~liDF 146 (191)
T d1zara2 83 EG----NAVLMELIDAKELY---------RVRVENPDEVLDMILEEVAKFYHRGIVHGDLSQYNVLVSE---EGIWIIDF 146 (191)
T ss_dssp ET----TEEEEECCCCEEGG---------GCCCSCHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEEET---TEEEECCC
T ss_pred cC----CEEEEEeecccccc---------chhhHHHHHHHHHHHHHHHHHhhCCEEEccCChhheeeeC---CCEEEEEC
Confidence 32 27999999876542 2556677889999999999999999999999999999974 36999999
Q ss_pred cccccc
Q psy11767 520 GFACLK 525 (966)
Q Consensus 520 Gla~~~ 525 (966)
|+|...
T Consensus 147 G~a~~~ 152 (191)
T d1zara2 147 PQSVEV 152 (191)
T ss_dssp TTCEET
T ss_pred CCcccC
Confidence 998654
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.87 E-value=2.5e-22 Score=220.79 Aligned_cols=188 Identities=20% Similarity=0.248 Sum_probs=135.5
Q ss_pred CcceeeeecccccceEEEEEEcCCCCEEEEEeccccc-------hhhHHHHHHHHhhCCCccccccccccc---------
Q psy11767 117 DLDKAGILGDGSYSVCRRCVEKSTGQEYAVKIISRKI-------DCSEEINLLRACQGHPNICRRCVEKST--------- 180 (966)
Q Consensus 117 df~~~~~LG~GsFGkV~La~~k~tg~~yAiKvl~K~~-------~~~~E~~il~~~~~~pfi~~~~~~~~~--------- 180 (966)
+|++++.||+|+||+||+|+++.+|+.||||++++.. ...+|.++|+++ +||+|++.+-.+..
T Consensus 11 rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l-~h~nii~~~~~~~~~~~~~~~~~ 89 (318)
T d3blha1 11 KYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLL-KHENVVNLIEICRTKASPYNRCK 89 (318)
T ss_dssp GEEEEEEEEECSSSEEEEEEETTTCCEEEEEEC----CTTSSCHHHHHHHHHHHHC-CCTTBCCEEEEEEC---------
T ss_pred CEEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHHh-cCCCccceEeeeecccccccccC
Confidence 6799999999999999999999999999999997642 357899999998 59999762211100
Q ss_pred -----------------------------chhHHHHHHHh----------hcccchhhhHhhhccCCceEEecCcccc--
Q psy11767 181 -----------------------------GQEYAVKIISR----------KIDCSEEINLLRACQGHPNIVNLHCVFQ-- 219 (966)
Q Consensus 181 -----------------------------~~~~~~~~v~~----------~~~~~~e~nil~~~~gh~~iv~l~~~~~-- 219 (966)
.+.++.+++.+ ..|++++ |||.+.+|.++|.|++.+..
T Consensus 90 ~~~~iv~e~~~~~~~~~~~~~~~~~~~~~~~~i~~qil~~l~~lH~~~ivHrDlKp~-NILl~~~~~~kl~dfg~~~~~~ 168 (318)
T d3blha1 90 GSIYLVFDFCEHDLAGLLSNVLVKFTLSEIKRVMQMLLNGLYYIHRNKILHRDMKAA-NVLITRDGVLKLADFGLARAFS 168 (318)
T ss_dssp -CEEEEEECCCEEHHHHHTCTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGG-GEEECTTSCEEECCCTTCEECC
T ss_pred ceEEEEEeccCCCccchhhhcccccccHHHHHHHHHHHHHHHHhccCCEEecCcCch-heeecCCCcEEeeecceeeecc
Confidence 01111222222 1255566 99999999999999987621
Q ss_pred ---------------------cccccc-ccCCCcceeeechhhHHHHHHHhhCCCCCCCCcHHHHHHHHHhCCCCCCCC-
Q psy11767 220 ---------------------DEVIDW-DDFSRGIECVFFSSSLIIFFIILSFTLSFIHDYYHIQYRRILKTEPPIPED- 276 (966)
Q Consensus 220 ---------------------~e~i~~-~~y~~~~d~~~~~~~~il~~~m~~g~~pf~~~~~~~~~~~I~~~~~~~P~~- 276 (966)
+|++.. ..|+..+| .|+.|+++|||++|.+||...+.....+.|......++..
T Consensus 169 ~~~~~~~~~~~~~~gT~~Y~aPE~~~~~~~~~~k~D---iwSlGvil~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~ 245 (318)
T d3blha1 169 LAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPID---LWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITPEV 245 (318)
T ss_dssp C-----CCCCCSCCSCGGGCCHHHHTTCSSCCTHHH---HHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTT
T ss_pred cccccccccccceecCHHHhhHHHHcCCCCCCcHHH---cccCCceeeeHhhCCCCCCCCCHHHHHHHHHHhcCCCChhh
Confidence 233332 25655555 5578888899999999999887777666665422222211
Q ss_pred -------------------------------CCHHHHHHHHhhcccCCCcccCCCCCCHHHHhcCCcee
Q psy11767 277 -------------------------------LSPDVADFISRLLVKDPRRRLGGGELDAEELKRHPFFN 314 (966)
Q Consensus 277 -------------------------------~s~~a~dli~~LL~kdp~~RLG~~~~g~~~Ik~HpfF~ 314 (966)
.+++++|||.++|+.||++|++ ++||..||||+
T Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~s-----a~elL~Hpff~ 309 (318)
T d3blha1 246 WPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRID-----SDDALNHDFFW 309 (318)
T ss_dssp STTCCCC-------CCSSCCBCHHHHHHHHHCCHHHHHHHHHHSCSSTTTSCC-----HHHHHHSGGGS
T ss_pred ccccchhhhhhhhcccccccccchhhhccccCCHHHHHHHHHHCcCChhHCcC-----HHHHHcChhhc
Confidence 3789999999999999999984 89999999995
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.86 E-value=3.3e-22 Score=215.27 Aligned_cols=185 Identities=17% Similarity=0.252 Sum_probs=139.1
Q ss_pred ceeeeecccccceEEEEEEcCCCCEEEEEeccccc-------hhhHHHHHHHHhhCCCccccccccccc-----------
Q psy11767 119 DKAGILGDGSYSVCRRCVEKSTGQEYAVKIISRKI-------DCSEEINLLRACQGHPNICRRCVEKST----------- 180 (966)
Q Consensus 119 ~~~~~LG~GsFGkV~La~~k~tg~~yAiKvl~K~~-------~~~~E~~il~~~~~~pfi~~~~~~~~~----------- 180 (966)
.+.+.||+|+||+||+|+++.||+.||+|++++.. ...+|.++|+++ +||+||+.+-.+..
T Consensus 12 ~~~~~iG~G~fg~Vy~~~~~~~~~~va~K~i~~~~~~~~~~~~~~~E~~il~~l-~HpnIv~~~~~~~~~~~~~~~~~iv 90 (270)
T d1t4ha_ 12 KFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGL-QHPNIVRFYDSWESTVKGKKCIVLV 90 (270)
T ss_dssp EEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTC-CCTTBCCEEEEEEEESSSCEEEEEE
T ss_pred EeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhC-CCCCeeeEEEEEeeccccCCEEEEE
Confidence 56678999999999999999999999999998642 346899999988 59999973321110
Q ss_pred -----------------------chhHHHHHHHh-------h-----cccchhhhHhhh-ccCCceEEecCccc------
Q psy11767 181 -----------------------GQEYAVKIISR-------K-----IDCSEEINLLRA-CQGHPNIVNLHCVF------ 218 (966)
Q Consensus 181 -----------------------~~~~~~~~v~~-------~-----~~~~~e~nil~~-~~gh~~iv~l~~~~------ 218 (966)
...++.+++.+ . .|++++ |||++ .+|+++|+||+.+.
T Consensus 91 mE~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~gl~yLH~~~~~IiHrDiKp~-NILl~~~~~~~Kl~DFGla~~~~~~~ 169 (270)
T d1t4ha_ 91 TELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCD-NIFITGPTGSVKIGDLGLATLKRASF 169 (270)
T ss_dssp EECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTSSSCCCCSCCCGG-GEEESSTTSCEEECCTTGGGGCCTTS
T ss_pred EeCCCCCcHHHHHhccccccHHHHHHHHHHHHHHHHHHHHCCCCEEeCCcChh-hceeeCCCCCEEEeecCcceeccCCc
Confidence 01111122211 1 245555 99996 47999999998763
Q ss_pred -----------cccccccccCCCcceeeechhhHHHHHHHhhCCCCCCC-CcHHHHHHHHHhCCC--CCCCCCCHHHHHH
Q psy11767 219 -----------QDEVIDWDDFSRGIECVFFSSSLIIFFIILSFTLSFIH-DYYHIQYRRILKTEP--PIPEDLSPDVADF 284 (966)
Q Consensus 219 -----------~~e~i~~~~y~~~~d~~~~~~~~il~~~m~~g~~pf~~-~~~~~~~~~I~~~~~--~~P~~~s~~a~dl 284 (966)
.+|++.. .|+...| .|+.|+++|+|++|.+||.. .+...++++|..+.. .+|...+++++||
T Consensus 170 ~~~~~GT~~Y~aPE~~~~-~~~~~~D---IwSlGvilyel~~g~~Pf~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~l 245 (270)
T d1t4ha_ 170 AKAVIGTPEFMAPEMYEE-KYDESVD---VYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVKPASFDKVAIPEVKEI 245 (270)
T ss_dssp BEESCSSCCCCCGGGGGT-CCCTHHH---HHHHHHHHHHHHHSSCTTTTCSSHHHHHHHHTTTCCCGGGGGCCCHHHHHH
T ss_pred cCCcccCccccCHHHhCC-CCCCcCc---hhhHHHHHHHHHHCCCCCCCcccHHHHHHHHHcCCCCcccCccCCHHHHHH
Confidence 2465543 5766655 45677888999999999964 566778899987643 4677899999999
Q ss_pred HHhhcccCCCcccCCCCCCHHHHhcCCcee
Q psy11767 285 ISRLLVKDPRRRLGGGELDAEELKRHPFFN 314 (966)
Q Consensus 285 i~~LL~kdp~~RLG~~~~g~~~Ik~HpfF~ 314 (966)
|+++|++||.+|. .++||.+||||+
T Consensus 246 i~~~l~~dp~~R~-----s~~ell~Hp~fk 270 (270)
T d1t4ha_ 246 IEGCIRQNKDERY-----SIKDLLNHAFFQ 270 (270)
T ss_dssp HHHHSCSSGGGSC-----CHHHHHTSGGGC
T ss_pred HHHHccCCHhHCc-----CHHHHhCCcccC
Confidence 9999999999998 489999999995
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.85 E-value=3.7e-22 Score=223.19 Aligned_cols=190 Identities=18% Similarity=0.275 Sum_probs=139.0
Q ss_pred CcceeeeecccccceEEEEEEcCCCCEEEEEeccccc-------hhhHHHHHHHHhhCCCccccccccccc---------
Q psy11767 117 DLDKAGILGDGSYSVCRRCVEKSTGQEYAVKIISRKI-------DCSEEINLLRACQGHPNICRRCVEKST--------- 180 (966)
Q Consensus 117 df~~~~~LG~GsFGkV~La~~k~tg~~yAiKvl~K~~-------~~~~E~~il~~~~~~pfi~~~~~~~~~--------- 180 (966)
+|+++++||+|+||+||+|+++.||+.||||++++.. ...+|..+|+++ +||+||..+-.+..
T Consensus 18 ~Y~i~~~LG~G~fg~V~~~~d~~t~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l-~hpnIv~~~~~f~~~~~~~~~~~ 96 (355)
T d2b1pa1 18 RYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCV-NHKNIISLLNVFTPQKTLEEFQD 96 (355)
T ss_dssp TEEEEEECSCC--CEEEEEEETTTTEEEEEEEEESTTSSHHHHHHHHHHHHHHHHC-CCTTBCCCSEEECSCCSTTTCCE
T ss_pred CeEEEEEeecCcCeEEEEEEECCCCCEEEEEEEChhhcCHHHHHHHHHHHHHHHhc-CCCCeeEEEEEEecccccccCce
Confidence 3699999999999999999999999999999998642 356899999988 69999873332211
Q ss_pred ------------------------chhHHHHHHHh----------hcccchhhhHhhhccCCceEEecCccc--------
Q psy11767 181 ------------------------GQEYAVKIISR----------KIDCSEEINLLRACQGHPNIVNLHCVF-------- 218 (966)
Q Consensus 181 ------------------------~~~~~~~~v~~----------~~~~~~e~nil~~~~gh~~iv~l~~~~-------- 218 (966)
.+.++.+++.+ ..|++++ |||.+.+++.++++++.+.
T Consensus 97 ~~iv~Ey~~~~l~~~~~~~~~~~~i~~~~~qil~gl~~LH~~giiHrDlKP~-Nil~~~~~~~kl~df~~~~~~~~~~~~ 175 (355)
T d2b1pa1 97 VYLVMELMDANLCQVIQMELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPS-NIVVKSDCTLKILDFGLARTAGTSFMM 175 (355)
T ss_dssp EEEEEECCSEEHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGG-GEEECTTCCEEECCCCC----------
T ss_pred eEEEEeccchHHHHhhhcCCCHHHHHHHHHHHHHHHHHhhhcccccccCCcc-ccccccccceeeechhhhhcccccccc
Confidence 12222233322 1255555 9999999999999987542
Q ss_pred ----------cccccccccCCCcceeeechhhHHHHHHHhhCCCCCCCCcHHHHHHHHHh--------------------
Q psy11767 219 ----------QDEVIDWDDFSRGIECVFFSSSLIIFFIILSFTLSFIHDYYHIQYRRILK-------------------- 268 (966)
Q Consensus 219 ----------~~e~i~~~~y~~~~d~~~~~~~~il~~~m~~g~~pf~~~~~~~~~~~I~~-------------------- 268 (966)
.+|++....|+...| -|+.|+++|+|++|.+||...+...+..+|+.
T Consensus 176 ~~~~~t~~y~aPE~l~~~~~~~~~D---iwSlG~~l~ell~g~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~ 252 (355)
T d2b1pa1 176 TPYVVTRYYRAPEVILGMGYKENVD---IWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRNY 252 (355)
T ss_dssp -----CCTTCCHHHHTTCCCCTTHH---HHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHTTSCHHHHHH
T ss_pred ccccccccccChhhhcCCCCCCCcc---cccccchHHHHhhCCCCCCCCCHHHHHHHHHHhccCCCHHHHHHhhhhHHHH
Confidence 346777777777766 34677889999999999988777666665542
Q ss_pred --CCCCCC--------------------CCCCHHHHHHHHhhcccCCCcccCCCCCCHHHHhcCCceeee
Q psy11767 269 --TEPPIP--------------------EDLSPDVADFISRLLVKDPRRRLGGGELDAEELKRHPFFNVI 316 (966)
Q Consensus 269 --~~~~~P--------------------~~~s~~a~dli~~LL~kdp~~RLG~~~~g~~~Ik~HpfF~~i 316 (966)
+.+.+. ..+|++++|||+++|+.||++|+ .++||.+||||+..
T Consensus 253 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~-----ta~elL~Hpw~~~~ 317 (355)
T d2b1pa1 253 VENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRI-----SVDDALQHPYINVW 317 (355)
T ss_dssp HHTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSC-----CHHHHHTSTTTGGG
T ss_pred hhcCccccccccccccccccccccccccccCCHHHHHHHHHHCcCChhHCc-----CHHHHhcCcccCCC
Confidence 221111 12478899999999999999998 48999999999864
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.85 E-value=1.3e-21 Score=217.82 Aligned_cols=189 Identities=20% Similarity=0.248 Sum_probs=134.3
Q ss_pred CcceeeeecccccceEEEEEEcCCCCEEEEEeccccc------hhhHHHHHHHHhhCCCccccccccccc----------
Q psy11767 117 DLDKAGILGDGSYSVCRRCVEKSTGQEYAVKIISRKI------DCSEEINLLRACQGHPNICRRCVEKST---------- 180 (966)
Q Consensus 117 df~~~~~LG~GsFGkV~La~~k~tg~~yAiKvl~K~~------~~~~E~~il~~~~~~pfi~~~~~~~~~---------- 180 (966)
.|++++.||+|+||+|++|+++.||+.||||+++|.. ...+|..||+++ +||+|++.+.....
T Consensus 9 rY~~~~~LG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l-~hp~iv~~~~~~~~~~~~~~~~~~ 87 (345)
T d1pmea_ 9 RYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRF-RHENIIGINDIIRAPTIEQMKDVY 87 (345)
T ss_dssp TEEEEEECC---CCCEEEEEETTTCSEEEEEEECCTTCHHHHHHHHHHHHHHHHC-CCTTBCCCCEEECCSSTTTCCCEE
T ss_pred CeEEEEEEeeccCeEEEEEEECCCCcEEEEEEEehhcChHHHHHHHHHHHHHHHc-CCCCCCcEEEEEeeccccccceEE
Confidence 4689999999999999999999999999999998642 457899999998 69999862211111
Q ss_pred -----------------------chhHHHHHHHh----------hcccchhhhHhhhccCCceEEecCccc---------
Q psy11767 181 -----------------------GQEYAVKIISR----------KIDCSEEINLLRACQGHPNIVNLHCVF--------- 218 (966)
Q Consensus 181 -----------------------~~~~~~~~v~~----------~~~~~~e~nil~~~~gh~~iv~l~~~~--------- 218 (966)
.+.++.+++.+ ..|++++ |||++.+|+++|+||+.+.
T Consensus 88 l~~~~~~g~L~~~l~~~~l~~~~i~~i~~qil~al~yLH~~~iiHRDIKp~-NILl~~~~~~kl~DfG~a~~~~~~~~~~ 166 (345)
T d1pmea_ 88 LVTHLMGADLYKLLKTQHLSNDHICYFLYQILRGLKYIHSANVLHRDLKPS-NLLLNTTCDLKICDFGLARVADPDHDHT 166 (345)
T ss_dssp EEEECCCEEHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGG-GEEECTTCCEEECCCTTCEECCGGGCBC
T ss_pred EEEeecCCchhhhhhcCCCCHHHHHHHHHHHHHHHHHHHHCCCcCCCCCcc-eEEECCCCCEEEcccCceeeccCCCccc
Confidence 01111222222 1255666 9999999999999998652
Q ss_pred -------------ccccccc-ccCCCcceeeechhhHHHHHHHhhCCCCCCCCcHHHHHHHHHhC--CC-----------
Q psy11767 219 -------------QDEVIDW-DDFSRGIECVFFSSSLIIFFIILSFTLSFIHDYYHIQYRRILKT--EP----------- 271 (966)
Q Consensus 219 -------------~~e~i~~-~~y~~~~d~~~~~~~~il~~~m~~g~~pf~~~~~~~~~~~I~~~--~~----------- 271 (966)
.+|++.. ..|+..+| .|+.|+++|+|++|.+||...+...++..++.. .+
T Consensus 167 ~~~~~~~gt~~y~aPE~l~~~~~~~~~~D---iwSlG~il~eml~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 243 (345)
T d1pmea_ 167 GFLTEYVATRWYRAPEIMLNSKGYTKSID---IWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINL 243 (345)
T ss_dssp CTTCCCCSCGGGCCGGGTTTBCSCSTHHH---HHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHTCCCH
T ss_pred eeeccccccceechHHHhhcCCCCCchhh---hhccCceehHHhhCCCCCCCCCHHHHHHHHhhhccCCChhhhhhhhhh
Confidence 1344433 34555555 446778888899999999887766555444320 00
Q ss_pred ------------------CCCCCCCHHHHHHHHhhcccCCCcccCCCCCCHHHHhcCCceee
Q psy11767 272 ------------------PIPEDLSPDVADFISRLLVKDPRRRLGGGELDAEELKRHPFFNV 315 (966)
Q Consensus 272 ------------------~~P~~~s~~a~dli~~LL~kdp~~RLG~~~~g~~~Ik~HpfF~~ 315 (966)
.....+|++++|||.++|++||.+|+. ++|+.+||||+.
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t-----a~e~L~hpf~~~ 300 (345)
T d1pmea_ 244 KARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIE-----VEQALAHPYLEQ 300 (345)
T ss_dssp HHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSTTTSCC-----HHHHHTSGGGTT
T ss_pred hhhcccccCCccCCCCHHHhCCCCCHHHHHHHHHHccCChhHCcC-----HHHHhcCHhhcc
Confidence 113468999999999999999999984 899999999963
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Probab=99.84 E-value=2.1e-21 Score=210.75 Aligned_cols=193 Identities=18% Similarity=0.207 Sum_probs=144.2
Q ss_pred CCccchhccC---CcceeeeecccccceEEEEEEcCCCCEEEEEeccccc----hhhHHHHHHHHhhCCCcccccccccc
Q psy11767 107 GSLFFEQYDM---DLDKAGILGDGSYSVCRRCVEKSTGQEYAVKIISRKI----DCSEEINLLRACQGHPNICRRCVEKS 179 (966)
Q Consensus 107 ~~~~~~~~~~---df~~~~~LG~GsFGkV~La~~k~tg~~yAiKvl~K~~----~~~~E~~il~~~~~~pfi~~~~~~~~ 179 (966)
++|.++.||+ ||++.+.||+|+||+||+|+++.||+.||||++++.. ...+|..+|+++ +||+||+.+-...
T Consensus 5 ~~p~~~~wei~~~~~~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~E~~il~~l-~HpnIv~~~~~~~ 83 (287)
T d1opja_ 5 SSPNYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEI-KHPNLVQLLGVCT 83 (287)
T ss_dssp TSTTCCTTBCCGGGEEEEEETTTTTTSSEEEEEEGGGTEEEEEEECCTTCSCHHHHHHHHHHHHHC-CCTTBCCEEEEEC
T ss_pred CCCCCcccEecHHHeEEeeEEeeCCCeEEEEEEECCCCeEEEEEEECCccchHHHHHHHHHHHHhC-CCCCEecCCccEe
Confidence 4567788887 7899999999999999999999999999999998652 457899999998 6999987222111
Q ss_pred cc--------------------------------hhHHHHHHHh----------hcccchhhhHhhhccCCceEEecCcc
Q psy11767 180 TG--------------------------------QEYAVKIISR----------KIDCSEEINLLRACQGHPNIVNLHCV 217 (966)
Q Consensus 180 ~~--------------------------------~~~~~~~v~~----------~~~~~~e~nil~~~~gh~~iv~l~~~ 217 (966)
.. ..++.+++.+ ..|++++ |||++.+|+++|+||+.+
T Consensus 84 ~~~~~~iv~E~~~~g~l~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlKp~-NILl~~~~~~Kl~DFG~a 162 (287)
T d1opja_ 84 REPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRDLAAR-NCLVGENHLVKVADFGLS 162 (287)
T ss_dssp SSSSCEEEEECCTTCBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGG-GEEECGGGCEEECCCCCT
T ss_pred eCCeeEEEeecccCcchHHHhhhccccchHHHHHHHHHHHHHHHHHHHHHCCcccCccccC-eEEECCCCcEEEccccce
Confidence 11 1111222222 1255555 999999999999999976
Q ss_pred c--------------------cccccccccCCCcceeeechhhHHHHHHHhh-CCCCCCCCcHHHHHHHHHhC-CCCCCC
Q psy11767 218 F--------------------QDEVIDWDDFSRGIECVFFSSSLIIFFIILS-FTLSFIHDYYHIQYRRILKT-EPPIPE 275 (966)
Q Consensus 218 ~--------------------~~e~i~~~~y~~~~d~~~~~~~~il~~~m~~-g~~pf~~~~~~~~~~~I~~~-~~~~P~ 275 (966)
. .+|++....|+...| .|+ .|+++|||++ |.|||...+...+++.|..+ .+.+|.
T Consensus 163 ~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~k~D--iwS-~Gv~l~ell~~~~p~~~~~~~~~~~~~i~~~~~~~~~~ 239 (287)
T d1opja_ 163 RLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSD--VWA-FGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMERPE 239 (287)
T ss_dssp TTCCSSSSEEETTEEECGGGCCHHHHHHCCCSHHHH--HHH-HHHHHHHHHTTSCCSSTTCCHHHHHHHHHTTCCCCCCT
T ss_pred eecCCCCceeeccccccccccChHHHcCCCCCchhh--hhh-HHHHHHHHHhCCCCCCCcchHHHHHHHHhcCCCCCCCc
Confidence 3 235555566765554 344 5566666665 67778788888888877765 578899
Q ss_pred CCCHHHHHHHHhhcccCCCcccCCCCCCHHHHhc
Q psy11767 276 DLSPDVADFISRLLVKDPRRRLGGGELDAEELKR 309 (966)
Q Consensus 276 ~~s~~a~dli~~LL~kdp~~RLG~~~~g~~~Ik~ 309 (966)
.+++++++||.++|++||.+|.. +++|..
T Consensus 240 ~~~~~l~~li~~cl~~dP~~Rps-----~~ei~~ 268 (287)
T d1opja_ 240 GCPEKVYELMRACWQWNPSDRPS-----FAEIHQ 268 (287)
T ss_dssp TCCHHHHHHHHHHTCSSGGGSCC-----HHHHHH
T ss_pred cchHHHHHHHHHHcCCCHhHCcC-----HHHHHH
Confidence 99999999999999999999984 788843
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Probab=99.83 E-value=5.8e-21 Score=205.86 Aligned_cols=186 Identities=18% Similarity=0.219 Sum_probs=140.7
Q ss_pred CcceeeeecccccceEEEEEEcCCCCEEEEEeccccc--------hhhHHHHHHHHhhCCCccccccccccc--------
Q psy11767 117 DLDKAGILGDGSYSVCRRCVEKSTGQEYAVKIISRKI--------DCSEEINLLRACQGHPNICRRCVEKST-------- 180 (966)
Q Consensus 117 df~~~~~LG~GsFGkV~La~~k~tg~~yAiKvl~K~~--------~~~~E~~il~~~~~~pfi~~~~~~~~~-------- 180 (966)
+|+++++||+|+||+||+|+++.||+.||||++++.. ...+|..+|+++ +||+||+.+..+..
T Consensus 8 rY~i~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~~l~~~-~hpniv~~~~~~~~~~~~~~~~ 86 (277)
T d1o6ya_ 8 RYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAAL-NHPAIVAVYDTGEAETPAGPLP 86 (277)
T ss_dssp TEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTTTCHHHHHHHHHHHHHHHTC-CCTTBCCEEEEEEEECSSSEEE
T ss_pred eeEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhc-CCCCCCcccceeeeccCCCceE
Confidence 4689999999999999999999999999999998742 346799999876 79999872221111
Q ss_pred --------------------------chhHHHHHHHh----------hcccchhhhHhhhccCCceEEecCccc------
Q psy11767 181 --------------------------GQEYAVKIISR----------KIDCSEEINLLRACQGHPNIVNLHCVF------ 218 (966)
Q Consensus 181 --------------------------~~~~~~~~v~~----------~~~~~~e~nil~~~~gh~~iv~l~~~~------ 218 (966)
...++.+++.+ ..|++++ |||++.++..+|.+++...
T Consensus 87 ~lvmE~~~g~~L~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~iiHrDiKP~-NIll~~~~~~~l~d~~~~~~~~~~~ 165 (277)
T d1o6ya_ 87 YIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQALNFSHQNGIIHRDVKPA-NIMISATNAVKVMDFGIARAIADSG 165 (277)
T ss_dssp EEEEECCCEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGG-GEEEETTSCEEECCCTTCEECC---
T ss_pred EEEEECCCCCEehhhhcccCCCCHHHHHHHHHHHHHHHHHHHhCCccCccccCc-ccccCccccceeehhhhhhhhcccc
Confidence 01111222222 1256666 9999999999999987542
Q ss_pred ----------------cccccccccCCCcceeeechhhHHHHHHHhhCCCCCCCCcHHHHHHHHHhCCCCCC----CCCC
Q psy11767 219 ----------------QDEVIDWDDFSRGIECVFFSSSLIIFFIILSFTLSFIHDYYHIQYRRILKTEPPIP----EDLS 278 (966)
Q Consensus 219 ----------------~~e~i~~~~y~~~~d~~~~~~~~il~~~m~~g~~pf~~~~~~~~~~~I~~~~~~~P----~~~s 278 (966)
.+|++....|+...| .|+.|+++|+|++|.+||...+...++.+++.+.+.+| ..+|
T Consensus 166 ~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~D---iwSlGvilyelltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~s 242 (277)
T d1o6ya_ 166 NSVTQTAAVIGTAQYLSPEQARGDSVDARSD---VYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVREDPIPPSARHEGLS 242 (277)
T ss_dssp -------------TTCCHHHHTTCCCCHHHH---HHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHCCCCCGGGTSSSCC
T ss_pred ccccccccccCcccccCHHHHcCCCCCccee---cccchHHHHHHHhCCCCCCCcCHHHHHHHHHhcCCCCCchhccCCC
Confidence 246666666765555 45788899999999999999999888999998877655 5789
Q ss_pred HHHHHHHHhhcccCCCcccCCCCCCHHHHhcCCc
Q psy11767 279 PDVADFISRLLVKDPRRRLGGGELDAEELKRHPF 312 (966)
Q Consensus 279 ~~a~dli~~LL~kdp~~RLG~~~~g~~~Ik~Hpf 312 (966)
+++++||+++|++||.+|.. .+++++ |+|
T Consensus 243 ~~l~~li~~~L~~dp~~R~~----sa~~l~-~~l 271 (277)
T d1o6ya_ 243 ADLDAVVLKALAKNPENRYQ----TAAEMR-ADL 271 (277)
T ss_dssp HHHHHHHHHHTCSSGGGSCS----SHHHHH-HHH
T ss_pred HHHHHHHHHHccCCHhHCHh----HHHHHH-HHH
Confidence 99999999999999999985 366664 443
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=99.81 E-value=9.8e-21 Score=211.18 Aligned_cols=210 Identities=21% Similarity=0.272 Sum_probs=140.3
Q ss_pred cceeeeecccccceEEEEEEcCCCCEEEEEeccccc----hhhHHHHHHHHhh----------CCCccccccccccc---
Q psy11767 118 LDKAGILGDGSYSVCRRCVEKSTGQEYAVKIISRKI----DCSEEINLLRACQ----------GHPNICRRCVEKST--- 180 (966)
Q Consensus 118 f~~~~~LG~GsFGkV~La~~k~tg~~yAiKvl~K~~----~~~~E~~il~~~~----------~~pfi~~~~~~~~~--- 180 (966)
|.++++||+|+||+|++|+++.||+.||||+++|.. ...+|..+|+.+. .||+|++....+..
T Consensus 15 Y~i~~~LG~G~fg~Vy~~~~~~~g~~vAvKvi~~~~~~~~~~~~Ei~~l~~l~~~~~~~~~~~~~~~iv~~~~~~~~~~~ 94 (362)
T d1q8ya_ 15 YILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFNHKGP 94 (362)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCHHHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEEEEET
T ss_pred EEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeccccchHHHHHHHHHHHHhcchhhhhhhhcCcCceEEEEEEeeeccc
Confidence 489999999999999999999999999999999863 3467888888764 35777653211111
Q ss_pred --------------------------------chhHHHHHH------Hh-h----cccchhhhHhhhccCC------ceE
Q psy11767 181 --------------------------------GQEYAVKII------SR-K----IDCSEEINLLRACQGH------PNI 211 (966)
Q Consensus 181 --------------------------------~~~~~~~~v------~~-~----~~~~~e~nil~~~~gh------~~i 211 (966)
...++.+++ .. . .|++++ |||++.+|. .++
T Consensus 95 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qil~al~~lh~~~~IvHrDlKp~-NIll~~~~~~~~~~~~kl 173 (362)
T d1q8ya_ 95 NGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRCGIIHTDIKPE-NVLMEIVDSPENLIQIKI 173 (362)
T ss_dssp TEEEEEEEECCCCEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTCEECSCCSGG-GEEEEEEETTTTEEEEEE
T ss_pred cceeeeeeecccccccccccccccccCCcHHHHHHHHHHHHHHHHHHhhhcCcccccCChh-HeeeeccCcccccceeeE
Confidence 011112222 11 1 255666 999987665 577
Q ss_pred EecCccc----------------cccccccccCCCcceeeechhhHHHHHHHhhCCCCCCCCcHH-------HH------
Q psy11767 212 VNLHCVF----------------QDEVIDWDDFSRGIECVFFSSSLIIFFIILSFTLSFIHDYYH-------IQ------ 262 (966)
Q Consensus 212 v~l~~~~----------------~~e~i~~~~y~~~~d~~~~~~~~il~~~m~~g~~pf~~~~~~-------~~------ 262 (966)
.|++.+. .+|++....|+...| .|+.|+++++|++|.+||..++.. .+
T Consensus 174 ~dfg~s~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~D---iwSlG~il~el~~g~~pF~~~~~~~~~~~~~~~~~~~~~ 250 (362)
T d1q8ya_ 174 ADLGNACWYDEHYTNSIQTREYRSPEVLLGAPWGCGAD---IWSTACLIFELITGDFLFEPDEGHSYTKDDDHIAQIIEL 250 (362)
T ss_dssp CCCTTCEETTBCCCSCCSCGGGCCHHHHHTCCCCTHHH---HHHHHHHHHHHHHSSCCC---------CHHHHHHHHHHH
T ss_pred eecccccccccccccccccccccChhhccccCCCcccc---ccchHHHHHHHHHCCCCCCCCccccccchhHHHHHHHHH
Confidence 7777653 245666666766555 345667778888999999743221 11
Q ss_pred -----------------------------------HHHHHhCCCCCCCCCCHHHHHHHHhhcccCCCcccCCCCCCHHHH
Q psy11767 263 -----------------------------------YRRILKTEPPIPEDLSPDVADFISRLLVKDPRRRLGGGELDAEEL 307 (966)
Q Consensus 263 -----------------------------------~~~I~~~~~~~P~~~s~~a~dli~~LL~kdp~~RLG~~~~g~~~I 307 (966)
...++.....++...+++++|||.++|+.||.+|+. ++|+
T Consensus 251 lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~Rpt-----a~e~ 325 (362)
T d1q8ya_ 251 LGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRAD-----AGGL 325 (362)
T ss_dssp HCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTTCBC-----HHHH
T ss_pred hCCCCHHHhhcccccccccccchhhhccccccCCchhhhcccccccCcccCHHHHHHHHHHCCCChhHCcC-----HHHH
Confidence 111222344455667899999999999999999984 8999
Q ss_pred hcCCceeeeCccccccCCCCCCCCccccccccc
Q psy11767 308 KRHPFFNVIDWDDLATKRIPAPFVPKISNELDV 340 (966)
Q Consensus 308 k~HpfF~~idW~~l~~k~~~pP~~P~i~~~~D~ 340 (966)
.+||||+++. ...+++.|..+...+..|.
T Consensus 326 L~Hp~f~~~~----~~~~~~~p~~~~~~~~~~~ 354 (362)
T d1q8ya_ 326 VNHPWLKDTL----GMEEIRVPDRELYGSGSDI 354 (362)
T ss_dssp HTCGGGTTCT----TCTTCCCTTSCTTCBSTTS
T ss_pred hcCcccCCCC----CcccCCCCCcccCCCCCCC
Confidence 9999999444 4456777777776555554
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.81 E-value=2.2e-20 Score=206.09 Aligned_cols=195 Identities=14% Similarity=0.151 Sum_probs=141.6
Q ss_pred CCccchhccC---CcceeeeecccccceEEEEEEcCCCC-----EEEEEeccccc------hhhHHHHHHHHhhCCCccc
Q psy11767 107 GSLFFEQYDM---DLDKAGILGDGSYSVCRRCVEKSTGQ-----EYAVKIISRKI------DCSEEINLLRACQGHPNIC 172 (966)
Q Consensus 107 ~~~~~~~~~~---df~~~~~LG~GsFGkV~La~~k~tg~-----~yAiKvl~K~~------~~~~E~~il~~~~~~pfi~ 172 (966)
...|..++|+ ||+++++||+|+||+|++|+++.+++ .||+|++.+.. ...+|..+|+++.+||+||
T Consensus 25 ~~~~~~kwei~~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv 104 (325)
T d1rjba_ 25 EYEYDLKWEFPRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIV 104 (325)
T ss_dssp GSCCCGGGBCCGGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBC
T ss_pred hcCCCccccCCHHHeEEeeEEeeCCCeEEEEEEEcCCCcccceeEEEEEEeccccCHHHHHHHHHHHHHHHHhcCCCcEe
Confidence 3455556676 78999999999999999999987765 69999987541 3578999999998999998
Q ss_pred cccccccc-----------------------------------------------------chhHHHHHHHh--------
Q psy11767 173 RRCVEKST-----------------------------------------------------GQEYAVKIISR-------- 191 (966)
Q Consensus 173 ~~~~~~~~-----------------------------------------------------~~~~~~~~v~~-------- 191 (966)
+.+-.... ...++.+++.+
T Consensus 105 ~l~~~~~~~~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~yLH~~~ 184 (325)
T d1rjba_ 105 NLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKS 184 (325)
T ss_dssp CEEEEECSSSSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHTT
T ss_pred EEEEEEeeCCeEEEEEEcCCCCcHHHHHHhccCCCcchhhhhccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCC
Confidence 72211111 11122233222
Q ss_pred --hcccchhhhHhhhccCCceEEecCcccc---------------------ccccccccCCCcceeeechhhHHHHHHHh
Q psy11767 192 --KIDCSEEINLLRACQGHPNIVNLHCVFQ---------------------DEVIDWDDFSRGIECVFFSSSLIIFFIIL 248 (966)
Q Consensus 192 --~~~~~~e~nil~~~~gh~~iv~l~~~~~---------------------~e~i~~~~y~~~~d~~~~~~~~il~~~m~ 248 (966)
..|++++ |||.+.+|+++|.||+.+.. +|++....|+...| +|+.||++|||+
T Consensus 185 IiHRDlKp~-Nill~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~D---iwS~Gvil~eml 260 (325)
T d1rjba_ 185 CVHRDLAAR-NVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSD---VWSYGILLWEIF 260 (325)
T ss_dssp EEETTCSGG-GEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHH---HHHHHHHHHHHT
T ss_pred eeeccCchh-ccccccCCeEEEeeccccccccCCCceeeeccccCCCccCChHHHcCCCCCccee---ccchhHHHHHHH
Confidence 1255666 99999999999999997632 34555555655444 446778888887
Q ss_pred h-CCCCCCCCcHHHHHHHHHhC--CCCCCCCCCHHHHHHHHhhcccCCCcccCCCCCCHHHHhcC
Q psy11767 249 S-FTLSFIHDYYHIQYRRILKT--EPPIPEDLSPDVADFISRLLVKDPRRRLGGGELDAEELKRH 310 (966)
Q Consensus 249 ~-g~~pf~~~~~~~~~~~I~~~--~~~~P~~~s~~a~dli~~LL~kdp~~RLG~~~~g~~~Ik~H 310 (966)
+ |.+||.+.+....+.+|+.+ .+.+|..+|+++++||.++|++||.+|. .++||.+|
T Consensus 261 t~g~~Pf~~~~~~~~~~~~~~~~~~~~~p~~~~~~l~~li~~cl~~dP~~RP-----t~~ei~~~ 320 (325)
T d1rjba_ 261 SLGVNPYPGIPVDANFYKLIQNGFKMDQPFYATEEIYIIMQSCWAFDSRKRP-----SFPNLTSF 320 (325)
T ss_dssp TTSCCSSTTCCCSHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSC-----CHHHHHHH
T ss_pred hCCCCCCCCCCHHHHHHHHHhcCCCCCCCCcCCHHHHHHHHHHcCCChhHCc-----CHHHHHHH
Confidence 5 89999876555555666655 5667889999999999999999999997 47888765
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.81 E-value=2.6e-20 Score=200.44 Aligned_cols=195 Identities=15% Similarity=0.191 Sum_probs=142.6
Q ss_pred cchhccC---CcceeeeecccccceEEEEEEcCCCCEEEEEeccccc----hhhHHHHHHHHhhCCCcccccccccccc-
Q psy11767 110 FFEQYDM---DLDKAGILGDGSYSVCRRCVEKSTGQEYAVKIISRKI----DCSEEINLLRACQGHPNICRRCVEKSTG- 181 (966)
Q Consensus 110 ~~~~~~~---df~~~~~LG~GsFGkV~La~~k~tg~~yAiKvl~K~~----~~~~E~~il~~~~~~pfi~~~~~~~~~~- 181 (966)
|.+.+|. +|++++.||+|+||+|++|+++ +++.||||++++.. ...+|..+|+++ +||+||+.+-.....
T Consensus 4 ~~~~wei~~~~~~~~~~iG~G~fg~Vy~~~~~-~~~~vAvK~~~~~~~~~~~~~~E~~~l~~l-~HpnIv~~~g~~~~~~ 81 (272)
T d1qpca_ 4 WEDEWEVPRETLKLVERLGAGQFGEVWMGYYN-GHTKVAVKSLKQGSMSPDAFLAEANLMKQL-QHQRLVRLYAVVTQEP 81 (272)
T ss_dssp TTCTTBCCGGGEEEEEEEEEETTEEEEEEEET-TTEEEEEEEECTTSSCHHHHHHHHHHHHHC-CCTTBCCEEEEECSSS
T ss_pred CCCCeecCHHHeEEeEEEecCCCcEEEEEEEC-CCCEEEEEEEccCcCCHHHHHHHHHHHHhC-CCCCEeEEEeeeccCC
Confidence 5566777 7889999999999999999986 67889999998742 457899999998 699998722111100
Q ss_pred ------------------------------hhHHHHHHHh----------hcccchhhhHhhhccCCceEEecCcccc--
Q psy11767 182 ------------------------------QEYAVKIISR----------KIDCSEEINLLRACQGHPNIVNLHCVFQ-- 219 (966)
Q Consensus 182 ------------------------------~~~~~~~v~~----------~~~~~~e~nil~~~~gh~~iv~l~~~~~-- 219 (966)
..++.++..+ ..|++++ |||++.+|+++|+||+.+..
T Consensus 82 ~~iv~Ey~~~g~L~~~~~~~~~~~l~~~~~~~i~~qi~~gl~~lH~~~ivHrDiKp~-NIll~~~~~~Kl~DFGla~~~~ 160 (272)
T d1qpca_ 82 IYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHRDLRAA-NILVSDTLSCKIADFGLARLIE 160 (272)
T ss_dssp CEEEEECCTTCBHHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGG-GEEECTTSCEEECCCTTCEECS
T ss_pred eEEEEEeCCCCcHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCccchh-heeeecccceeeccccceEEcc
Confidence 1111222211 1255555 99999999999999997631
Q ss_pred ------------------ccccccccCCCcceeeechhhHHHHHHHh-hCCCCCCCCcHHHHHHHHHhC-CCCCCCCCCH
Q psy11767 220 ------------------DEVIDWDDFSRGIECVFFSSSLIIFFIIL-SFTLSFIHDYYHIQYRRILKT-EPPIPEDLSP 279 (966)
Q Consensus 220 ------------------~e~i~~~~y~~~~d~~~~~~~~il~~~m~-~g~~pf~~~~~~~~~~~I~~~-~~~~P~~~s~ 279 (966)
+|++....|+...| .|+ .|+++|||+ +|.|||...+...+++.|..+ .+..|..+++
T Consensus 161 ~~~~~~~~~~~gt~~y~APE~~~~~~~~~~sD--vwS-~Gvvl~ellt~~~~~~~~~~~~~~~~~i~~~~~~~~p~~~~~ 237 (272)
T d1qpca_ 161 DNEYTAREGAKFPIKWTAPEAINYGTFTIKSD--VWS-FGILLTEIVTHGRIPYPGMTNPEVIQNLERGYRMVRPDNCPE 237 (272)
T ss_dssp SSCEECCTTCCCCTTTSCHHHHHHCEECHHHH--HHH-HHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCCCCCCTTCCH
T ss_pred CCccccccccCCcccccChHHHhCCCCCchhh--hhh-hHHHHHHHHhCCCCCCCCCCHHHHHHHHHhcCCCCCcccChH
Confidence 23444444543333 454 555556655 578888888888889999875 5778999999
Q ss_pred HHHHHHHhhcccCCCcccCCCCCCHHHHhc--CCceee
Q psy11767 280 DVADFISRLLVKDPRRRLGGGELDAEELKR--HPFFNV 315 (966)
Q Consensus 280 ~a~dli~~LL~kdp~~RLG~~~~g~~~Ik~--HpfF~~ 315 (966)
++++||+++|..||.+|. .+++|.+ |+||..
T Consensus 238 ~l~~li~~cl~~~P~~Rp-----t~~ei~~~L~~~fts 270 (272)
T d1qpca_ 238 ELYQLMRLCWKERPEDRP-----TFDYLRSVLEDFFTA 270 (272)
T ss_dssp HHHHHHHHHTCSSGGGSC-----CHHHHHHHHHHHHHH
T ss_pred HHHHHHHHHcCCCHhHCc-----CHHHHHHHhhhhhhc
Confidence 999999999999999997 3889977 888853
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.80 E-value=7.6e-20 Score=195.29 Aligned_cols=183 Identities=16% Similarity=0.144 Sum_probs=136.9
Q ss_pred CcceeeeecccccceEEEEEEcCCCCEEEEEeccccc----hhhHHHHHHHHhhCCCcccccccccccc-----------
Q psy11767 117 DLDKAGILGDGSYSVCRRCVEKSTGQEYAVKIISRKI----DCSEEINLLRACQGHPNICRRCVEKSTG----------- 181 (966)
Q Consensus 117 df~~~~~LG~GsFGkV~La~~k~tg~~yAiKvl~K~~----~~~~E~~il~~~~~~pfi~~~~~~~~~~----------- 181 (966)
||++++.||+|+||+|++|+++ +++.||||+++|.. ...+|.++|.++ +||+|++.+-.....
T Consensus 5 ~~~~~~~iG~G~fg~Vy~~~~~-~~~~vAvK~l~~~~~~~~~~~~Ev~~~~~l-~HpnIv~~~g~~~~~~~~~iv~Ey~~ 82 (258)
T d1k2pa_ 5 DLTFLKELGTGQFGVVKYGKWR-GQYDVAIKMIKEGSMSEDEFIEEAKVMMNL-SHEKLVQLYGVCTKQRPIFIITEYMA 82 (258)
T ss_dssp CCCCCCCCCEETTEEEEEEEET-TTEEEEEEEEESSSSCHHHHHHHHHHHHTC-CCTTBCCEEEEECCSSSEEEEEECCT
T ss_pred HCEEeEEEecCCCeEEEEEEEC-CCCEEEEEEECcCcCCHHHHHHHHHHHHhc-CCCceeeEEEEEeeCCceEEEEEccC
Confidence 8999999999999999999996 78899999999753 457899999998 699998722211111
Q ss_pred --------------------hhHHHHHHHh----------hcccchhhhHhhhccCCceEEecCccc-------------
Q psy11767 182 --------------------QEYAVKIISR----------KIDCSEEINLLRACQGHPNIVNLHCVF------------- 218 (966)
Q Consensus 182 --------------------~~~~~~~v~~----------~~~~~~e~nil~~~~gh~~iv~l~~~~------------- 218 (966)
..++.++..+ ..|++++ |+|.+.+++++|.|++.+.
T Consensus 83 ~g~l~~~~~~~~~~~~~~~~~~i~~qi~~gl~~LH~~~iiH~dlk~~-Nill~~~~~~kl~DfG~a~~~~~~~~~~~~~~ 161 (258)
T d1k2pa_ 83 NGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQFLHRDLAAR-NCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGS 161 (258)
T ss_dssp TEEHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHTTBCCSCCSGG-GEEECTTCCEEECCCSSCCBCSSSSCCCCCCS
T ss_pred CCcHHHhhhccccCCcHHHHHHHHHHHHHHHHHHhhcCcccccccce-eEEEcCCCcEEECcchhheeccCCCceeeccc
Confidence 0011122111 0133444 9999999999999998763
Q ss_pred -------cccccccccCCCcceeeechhhHHHHHHHhh-CCCCCCCCcHHHHHHHHHhC-CCCCCCCCCHHHHHHHHhhc
Q psy11767 219 -------QDEVIDWDDFSRGIECVFFSSSLIIFFIILS-FTLSFIHDYYHIQYRRILKT-EPPIPEDLSPDVADFISRLL 289 (966)
Q Consensus 219 -------~~e~i~~~~y~~~~d~~~~~~~~il~~~m~~-g~~pf~~~~~~~~~~~I~~~-~~~~P~~~s~~a~dli~~LL 289 (966)
.+|++....|+...| .| +.|+++|||++ |.+||...+..+++++|.++ .+..|...++++++||+++|
T Consensus 162 ~~t~~y~aPE~~~~~~~~~ksD--iw-S~G~~l~el~t~g~~Pf~~~~~~~~~~~i~~~~~~~~p~~~~~~l~~li~~cl 238 (258)
T d1k2pa_ 162 KFPVRWSPPEVLMYSKFSSKSD--IW-AFGVLMWEIYSLGKMPYERFTNSETAEHIAQGLRLYRPHLASEKVYTIMYSCW 238 (258)
T ss_dssp CCCGGGCCHHHHHHCCCCHHHH--HH-HHHHHHHHHHTTSCCTTTTSCHHHHHHHHHTTCCCCCCTTCCHHHHHHHHHTT
T ss_pred CCCCCcCCcHHhcCCCCCccee--ec-ccchhhHhHHhcCCCCCCCCCHHHHHHHHHhCCCCCCcccccHHHHHHHHHHc
Confidence 134455555654444 34 55566667765 89999998888999999986 56788899999999999999
Q ss_pred ccCCCcccCCCCCCHHHHhcC
Q psy11767 290 VKDPRRRLGGGELDAEELKRH 310 (966)
Q Consensus 290 ~kdp~~RLG~~~~g~~~Ik~H 310 (966)
+.||.+|.. +++|.+|
T Consensus 239 ~~dP~~RPt-----~~eil~~ 254 (258)
T d1k2pa_ 239 HEKADERPT-----FKILLSN 254 (258)
T ss_dssp CSSGGGSCC-----HHHHHHH
T ss_pred cCCHhHCcC-----HHHHHHH
Confidence 999999983 8888876
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.79 E-value=1.1e-19 Score=196.73 Aligned_cols=189 Identities=15% Similarity=0.171 Sum_probs=137.5
Q ss_pred CcceeeeecccccceEEEEEEcCCCCEEEEEeccccc----hhhHHHHHHHHhhCCCcccccccccccc-----------
Q psy11767 117 DLDKAGILGDGSYSVCRRCVEKSTGQEYAVKIISRKI----DCSEEINLLRACQGHPNICRRCVEKSTG----------- 181 (966)
Q Consensus 117 df~~~~~LG~GsFGkV~La~~k~tg~~yAiKvl~K~~----~~~~E~~il~~~~~~pfi~~~~~~~~~~----------- 181 (966)
||.+.+.||+|+||+|++|+++.| +.||||+|++.. ...+|..+|+++ +||+||+.+-.....
T Consensus 18 ~~~i~~~iG~G~fg~Vy~~~~~~~-~~vAiK~l~~~~~~~~~~~~E~~~l~~l-~h~nIv~~~g~~~~~~~~lv~Ey~~~ 95 (285)
T d1fmka3 18 SLRLEVKLGQGCFGEVWMGTWNGT-TRVAIKTLKPGTMSPEAFLQEAQVMKKL-RHEKLVQLYAVVSEEPIYIVTEYMSK 95 (285)
T ss_dssp GEEEEEEEEECSSCEEEEEEETTT-EEEEEEECCTTSSCHHHHHHHHHHHHHC-CCTTBCCEEEEECSSSCEEEECCCTT
T ss_pred HEEEeeEEeeCCCeEEEEEEECCC-CEEEEEEECcccCCHHHHHHHHHHHHhc-ccCCEeEEEEEEecCCeEEEEEecCC
Confidence 788999999999999999999877 459999998653 457899999998 699998722111111
Q ss_pred --------------------hhHHHHHHHh----------hcccchhhhHhhhccCCceEEecCccc-------------
Q psy11767 182 --------------------QEYAVKIISR----------KIDCSEEINLLRACQGHPNIVNLHCVF------------- 218 (966)
Q Consensus 182 --------------------~~~~~~~v~~----------~~~~~~e~nil~~~~gh~~iv~l~~~~------------- 218 (966)
..++.+++.+ ..|++++ |||.+.+|.++|.||+.+.
T Consensus 96 g~l~~~~~~~~~~~l~~~~~~~i~~~i~~gl~~LH~~~ivH~DlKp~-NIll~~~~~~kl~DfGla~~~~~~~~~~~~~~ 174 (285)
T d1fmka3 96 GSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAA-NILVGENLVCKVADFGLARLIEDNEYTARQGA 174 (285)
T ss_dssp CBHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGG-GEEECGGGCEEECCCCTTC-------------
T ss_pred CchhhhhhhcccccchHHHHHHHHHHHHHHHHHHhhhheecccccce-EEEECCCCcEEEcccchhhhccCCCceeeccc
Confidence 1111222222 1244445 9999999999999999763
Q ss_pred -------cccccccccCCCcceeeechhhHHHHHHHhhCCCCCCCCcHHHHHHHHHhC-CCCCCCCCCHHHHHHHHhhcc
Q psy11767 219 -------QDEVIDWDDFSRGIECVFFSSSLIIFFIILSFTLSFIHDYYHIQYRRILKT-EPPIPEDLSPDVADFISRLLV 290 (966)
Q Consensus 219 -------~~e~i~~~~y~~~~d~~~~~~~~il~~~m~~g~~pf~~~~~~~~~~~I~~~-~~~~P~~~s~~a~dli~~LL~ 290 (966)
.+|++....|+... |.|++|+++++++.+|.|||.......+++.|..+ .+.+|..+++++++||.++|+
T Consensus 175 ~gt~~y~aPE~~~~~~~~~ks--DI~S~Giil~el~t~~~p~~~~~~~~~~~~~i~~~~~~~~~~~~~~~l~~li~~cl~ 252 (285)
T d1fmka3 175 KFPIKWTAPEAALYGRFTIKS--DVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPPECPESLHDLMCQCWR 252 (285)
T ss_dssp -CCGGGSCHHHHHHCCCCHHH--HHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCCCCCCTTSCHHHHHHHHHHTC
T ss_pred cccccccChHHHhCCCCCcHH--hhhcchHHHHHHHhCCCCCCCCCCHHHHHHHHHhcCCCCCCcccCHHHHHHHHHHcc
Confidence 12444444554433 34555444444445578888888888888888865 567899999999999999999
Q ss_pred cCCCcccCCCCCCHHHHhc--CCceee
Q psy11767 291 KDPRRRLGGGELDAEELKR--HPFFNV 315 (966)
Q Consensus 291 kdp~~RLG~~~~g~~~Ik~--HpfF~~ 315 (966)
.||++|. .+++|.. |+||..
T Consensus 253 ~dP~~Rp-----s~~~i~~~L~~~~~~ 274 (285)
T d1fmka3 253 KEPEERP-----TFEYLQAFLEDYFTS 274 (285)
T ss_dssp SSGGGSC-----CHHHHHHHHHTTTSC
T ss_pred cCHhHCc-----CHHHHHHHHhhhhcC
Confidence 9999997 4889977 888853
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.79 E-value=7.8e-20 Score=200.94 Aligned_cols=185 Identities=17% Similarity=0.176 Sum_probs=133.3
Q ss_pred CcceeeeecccccceEEEEEEcCCCCE----EEEEecccc------chhhHHHHHHHHhhCCCcccccccccccc-----
Q psy11767 117 DLDKAGILGDGSYSVCRRCVEKSTGQE----YAVKIISRK------IDCSEEINLLRACQGHPNICRRCVEKSTG----- 181 (966)
Q Consensus 117 df~~~~~LG~GsFGkV~La~~k~tg~~----yAiKvl~K~------~~~~~E~~il~~~~~~pfi~~~~~~~~~~----- 181 (966)
||+++++||+|+||+||+|+++.+|+. ||+|.+++. ....+|..+|+++ +||+||+.+-.....
T Consensus 10 dy~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~HpnIv~l~g~~~~~~~~~v 88 (317)
T d1xkka_ 10 EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV-DNPHVCRLLGICLTSTVQLI 88 (317)
T ss_dssp TEEEEEEEEECSSEEEEEEEECC----CCEEEEEEEECC----CTHHHHHHHHHHHHHC-CCTTBCCEEEEEESSSEEEE
T ss_pred HCEEeeEEecCCCeEEEEEEEcCCCCEEEEEEEEEEeccccCHHHHHHHHHHHHHHHhC-CCCCEeeEEEEEecCCeeEE
Confidence 799999999999999999999999985 666766543 1457899999998 699998722111111
Q ss_pred -------------------------hhHHHHHHHh----------hcccchhhhHhhhccCCceEEecCccc--------
Q psy11767 182 -------------------------QEYAVKIISR----------KIDCSEEINLLRACQGHPNIVNLHCVF-------- 218 (966)
Q Consensus 182 -------------------------~~~~~~~v~~----------~~~~~~e~nil~~~~gh~~iv~l~~~~-------- 218 (966)
..++.+++.+ ..|++++ |||++.+|+++|.||+.+.
T Consensus 89 ~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~gl~yLH~~~iiHrDlKp~-NIll~~~~~~kl~DFGla~~~~~~~~~ 167 (317)
T d1xkka_ 89 TQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAAR-NVLVKTPQHVKITDFGLAKLLGAEEKE 167 (317)
T ss_dssp EECCTTCBHHHHHHHTSSSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGG-GEEEEETTEEEECCCSHHHHTTTTCC-
T ss_pred EEeccCCcccccccccccCCCHHHHHHHHHHHHHHHHHHHHcCcccCcchhh-cceeCCCCCeEeeccccceeccccccc
Confidence 1122233222 1255555 9999999999999998653
Q ss_pred -------------cccccccccCCCcceeeechhhHHHHHHHhh-CCCCCCCCcHHHHHHHHHhCC-CCCCCCCCHHHHH
Q psy11767 219 -------------QDEVIDWDDFSRGIECVFFSSSLIIFFIILS-FTLSFIHDYYHIQYRRILKTE-PPIPEDLSPDVAD 283 (966)
Q Consensus 219 -------------~~e~i~~~~y~~~~d~~~~~~~~il~~~m~~-g~~pf~~~~~~~~~~~I~~~~-~~~P~~~s~~a~d 283 (966)
.+|++....|+...| .|+.|+++|||++ |.+||...+...++..|..+. +..|+.+++++.+
T Consensus 168 ~~~~~~~gt~~y~APE~l~~~~~~~~sD---vwS~Gvil~el~t~g~~p~~~~~~~~~~~~i~~~~~~~~p~~~~~~~~~ 244 (317)
T d1xkka_ 168 YHAEGGKVPIKWMALESILHRIYTHQSD---VWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPICTIDVYM 244 (317)
T ss_dssp -------CCTTTSCHHHHHHCCCCHHHH---HHHHHHHHHHHHTTSCCTTTTSCGGGHHHHHHHTCCCCCCTTBCHHHHH
T ss_pred ccccccccCccccChHHHhcCCCChhhh---hhhHHHHHHHHHHCCCCCCCCCCHHHHHHHHHcCCCCCCCcccCHHHHH
Confidence 134555555654444 3456666676765 899999888888888888754 7889999999999
Q ss_pred HHHhhcccCCCcccCCCCCCHHHHhcCC
Q psy11767 284 FISRLLVKDPRRRLGGGELDAEELKRHP 311 (966)
Q Consensus 284 li~~LL~kdp~~RLG~~~~g~~~Ik~Hp 311 (966)
||.++|..||.+|. .+.+|..|-
T Consensus 245 li~~cl~~dP~~RP-----s~~eil~~l 267 (317)
T d1xkka_ 245 IMVKCWMIDADSRP-----KFRELIIEF 267 (317)
T ss_dssp HHHHHTCSSGGGSC-----CHHHHHHHH
T ss_pred HHHHhCCCChhhCc-----CHHHHHHHH
Confidence 99999999999997 488998884
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.78 E-value=1.4e-19 Score=194.51 Aligned_cols=184 Identities=18% Similarity=0.242 Sum_probs=131.0
Q ss_pred CcceeeeecccccceEEEEEEcCCC---CEEEEEeccccc------hhhHHHHHHHHhhCCCcccccccccccc------
Q psy11767 117 DLDKAGILGDGSYSVCRRCVEKSTG---QEYAVKIISRKI------DCSEEINLLRACQGHPNICRRCVEKSTG------ 181 (966)
Q Consensus 117 df~~~~~LG~GsFGkV~La~~k~tg---~~yAiKvl~K~~------~~~~E~~il~~~~~~pfi~~~~~~~~~~------ 181 (966)
+|+++++||+|+||+||+|+++.++ ..+|||++++.. ...+|..+|+++ +||+|++.+-.....
T Consensus 8 ~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~E~~~l~~l-~HpnIv~l~~~~~~~~~~iv~ 86 (273)
T d1mp8a_ 8 RIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQF-DHPHIVKLIGVITENPVWIIM 86 (273)
T ss_dssp GEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTC-CCTTBCCEEEEECSSSCEEEE
T ss_pred HeEEEEEEeeCCCcEEEEEEEecCCceeEEEEEEEeccccCHHHHHHHHHHHHHHHhC-CCCCEeeEEEEEecCeEEEEE
Confidence 6789999999999999999987654 468999987532 357899999998 699998722211111
Q ss_pred ------------------------hhHHHHHHHh----------hcccchhhhHhhhccCCceEEecCcccc--------
Q psy11767 182 ------------------------QEYAVKIISR----------KIDCSEEINLLRACQGHPNIVNLHCVFQ-------- 219 (966)
Q Consensus 182 ------------------------~~~~~~~v~~----------~~~~~~e~nil~~~~gh~~iv~l~~~~~-------- 219 (966)
..++.+++.+ ..|++++ |||.+.+|.++|+||+.+..
T Consensus 87 E~~~~g~l~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~iiHrDlKp~-NIll~~~~~~Kl~DfG~a~~~~~~~~~~ 165 (273)
T d1mp8a_ 87 ELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLESKRFVHRDIAAR-NVLVSSNDCVKLGDFGLSRYMEDSTYYK 165 (273)
T ss_dssp ECCTTEEHHHHHHHTTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGG-GEEEEETTEEEECC--------------
T ss_pred EeccCCcHHhhhhccCCCCCHHHHHHHHHHHHHHhhhhcccCeeccccchh-heeecCCCcEEEccchhheeccCCccee
Confidence 1111222211 1244455 99999999999999986532
Q ss_pred ------------ccccccccCCCcceeeechhhHHHHHHHh-hCCCCCCCCcHHHHHHHHHhCC-CCCCCCCCHHHHHHH
Q psy11767 220 ------------DEVIDWDDFSRGIECVFFSSSLIIFFIIL-SFTLSFIHDYYHIQYRRILKTE-PPIPEDLSPDVADFI 285 (966)
Q Consensus 220 ------------~e~i~~~~y~~~~d~~~~~~~~il~~~m~-~g~~pf~~~~~~~~~~~I~~~~-~~~P~~~s~~a~dli 285 (966)
+|++....|+...| .| +.||++|||+ .|.+||...+...++++|.++. +.+|..+++++++||
T Consensus 166 ~~~~~gt~~y~apE~l~~~~~~~~~D--iw-SlGvil~e~lt~g~~P~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~li 242 (273)
T d1mp8a_ 166 ASKGKLPIKWMAPESINFRRFTSASD--VW-MFGVCMWEILMHGVKPFQGVKNNDVIGRIENGERLPMPPNCPPTLYSLM 242 (273)
T ss_dssp -----CCGGGCCHHHHHHCCCSHHHH--HH-HHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTTCCCCCCTTCCHHHHHHH
T ss_pred ccceecCcccchhhHhccCCCCCccc--cc-cchHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCHHHHHHH
Confidence 24454555655444 34 4555555555 5999999988888999999875 679999999999999
Q ss_pred HhhcccCCCcccCCCCCCHHHHhcC
Q psy11767 286 SRLLVKDPRRRLGGGELDAEELKRH 310 (966)
Q Consensus 286 ~~LL~kdp~~RLG~~~~g~~~Ik~H 310 (966)
.++|..||.+|.. +++|..|
T Consensus 243 ~~cl~~dp~~Rps-----~~ei~~~ 262 (273)
T d1mp8a_ 243 TKCWAYDPSRRPR-----FTELKAQ 262 (273)
T ss_dssp HHHTCSSGGGSCC-----HHHHHHH
T ss_pred HHHcCCCHhHCcC-----HHHHHHH
Confidence 9999999999973 7888766
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.77 E-value=4.2e-19 Score=189.85 Aligned_cols=183 Identities=15% Similarity=0.154 Sum_probs=134.3
Q ss_pred CcceeeeecccccceEEEEEEcCCCCEEEEEeccccc----hhhHHHHHHHHhhCCCccccccccccc------------
Q psy11767 117 DLDKAGILGDGSYSVCRRCVEKSTGQEYAVKIISRKI----DCSEEINLLRACQGHPNICRRCVEKST------------ 180 (966)
Q Consensus 117 df~~~~~LG~GsFGkV~La~~k~tg~~yAiKvl~K~~----~~~~E~~il~~~~~~pfi~~~~~~~~~------------ 180 (966)
||++++.||+|+||+|++|+++ +++.||||++++.. ...+|.++|+++ +||+||+.+-....
T Consensus 6 ~~~~~~~iG~G~fg~Vy~~~~~-~~~~vAvK~i~~~~~~~~~~~~E~~~l~~l-~HpnIv~~~g~~~~~~~~~lv~E~~~ 83 (263)
T d1sm2a_ 6 ELTFVQEIGSGQFGLVHLGYWL-NKDKVAIKTIREGAMSEEDFIEEAEVMMKL-SHPKLVQLYGVCLEQAPICLVFEFME 83 (263)
T ss_dssp CEEEEEEEECCSSCCEEEEEET-TTEEEEEEECCSSSSCHHHHHHHHHHHHHC-CCTTBCCEEEEECSSSSCEEEEECCT
T ss_pred HcEEEEEEeeCCCeEEEEEEEC-CCCEEEEEEECCCcCcHHHHHHHHHHHHhc-CCCCcccccceeccCCceEEEEEecC
Confidence 6899999999999999999987 56789999998742 467899999998 59999872211110
Q ss_pred -------------------chhHHHHHHHh----------hcccchhhhHhhhccCCceEEecCccc-------------
Q psy11767 181 -------------------GQEYAVKIISR----------KIDCSEEINLLRACQGHPNIVNLHCVF------------- 218 (966)
Q Consensus 181 -------------------~~~~~~~~v~~----------~~~~~~e~nil~~~~gh~~iv~l~~~~------------- 218 (966)
...++.+++.+ ..|++++ |||.+.+|.++|.||+.+.
T Consensus 84 ~g~L~~~l~~~~~~~~~~~~~~i~~qia~gl~~lH~~~iiHrDlKp~-Nill~~~~~~Kl~DFGla~~~~~~~~~~~~~~ 162 (263)
T d1sm2a_ 84 HGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAAR-NCLVGENQVIKVSDFGMTRFVLDDQYTSSTGT 162 (263)
T ss_dssp TCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCTTCSGG-GEEECGGGCEEECSCC----------------
T ss_pred CCcHHHHhhccccCCCHHHHHHHHHHHHHHHHhhhccceeecccchh-heeecCCCCeEecccchheeccCCCceeecce
Confidence 01111222222 1245555 9999999999999998652
Q ss_pred -------cccccccccCCCcceeeechhhHHHHHHHhh-CCCCCCCCcHHHHHHHHHhC-CCCCCCCCCHHHHHHHHhhc
Q psy11767 219 -------QDEVIDWDDFSRGIECVFFSSSLIIFFIILS-FTLSFIHDYYHIQYRRILKT-EPPIPEDLSPDVADFISRLL 289 (966)
Q Consensus 219 -------~~e~i~~~~y~~~~d~~~~~~~~il~~~m~~-g~~pf~~~~~~~~~~~I~~~-~~~~P~~~s~~a~dli~~LL 289 (966)
.+|++....|+...| .| +.|+++|||++ |.|||...+...+++.|..+ .+..|...++++.+||.++|
T Consensus 163 ~gt~~y~aPE~l~~~~~~~k~D--Vw-S~Gvil~el~t~~~~~~~~~~~~~~~~~i~~~~~~~~p~~~~~~l~~li~~cl 239 (263)
T d1sm2a_ 163 KFPVKWASPEVFSFSRYSSKSD--VW-SFGVLMWEVFSEGKIPYENRSNSEVVEDISTGFRLYKPRLASTHVYQIMNHCW 239 (263)
T ss_dssp --CTTSCCHHHHTTCCCCHHHH--HH-HHHHHHHHHHTTSCCTTCSCCHHHHHHHHHHTCCCCCCTTSCHHHHHHHHHHT
T ss_pred ecCcccCChHHhcCCCCCchhh--hc-chHHHHHHHHHCCCCCCCCCCHHHHHHHHHhcCCCCCccccCHHHHHHHHHHc
Confidence 245566566665444 34 45566666655 78899888888889999876 56778899999999999999
Q ss_pred ccCCCcccCCCCCCHHHHhcC
Q psy11767 290 VKDPRRRLGGGELDAEELKRH 310 (966)
Q Consensus 290 ~kdp~~RLG~~~~g~~~Ik~H 310 (966)
++||.+|. .+++|.+|
T Consensus 240 ~~~p~~Rp-----s~~~il~~ 255 (263)
T d1sm2a_ 240 KERPEDRP-----AFSRLLRQ 255 (263)
T ss_dssp CSSGGGSC-----CHHHHHHH
T ss_pred cCCHhHCc-----CHHHHHHH
Confidence 99999997 37888765
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.77 E-value=1.6e-19 Score=194.77 Aligned_cols=187 Identities=17% Similarity=0.189 Sum_probs=133.1
Q ss_pred eeecccccceEEEEEEc--CCCCEEEEEeccccc-------hhhHHHHHHHHhhCCCcccccccccccc-----------
Q psy11767 122 GILGDGSYSVCRRCVEK--STGQEYAVKIISRKI-------DCSEEINLLRACQGHPNICRRCVEKSTG----------- 181 (966)
Q Consensus 122 ~~LG~GsFGkV~La~~k--~tg~~yAiKvl~K~~-------~~~~E~~il~~~~~~pfi~~~~~~~~~~----------- 181 (966)
|.||+|+||+|++|.++ .+++.||||++++.. ...+|..+|+++ +||+||+.+-.....
T Consensus 13 k~iG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l-~HpnIv~~~g~~~~~~~~lvmE~~~~ 91 (277)
T d1xbba_ 13 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQL-DNPYIVRMIGICEAESWMLVMEMAEL 91 (277)
T ss_dssp EEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTC-CCTTBCCEEEEEESSSEEEEEECCTT
T ss_pred CCcccCCCeEEEEEEEccCCcCeEEEEEEEChhhCCHHHHHHHHHHHHHHHhC-CCCCCceEEEEeccCCEEEEEEcCCC
Confidence 57999999999999865 466899999997642 357899999998 699998733222111
Q ss_pred ------------------hhHHHHHHHh----------hcccchhhhHhhhccCCceEEecCcccc--------------
Q psy11767 182 ------------------QEYAVKIISR----------KIDCSEEINLLRACQGHPNIVNLHCVFQ-------------- 219 (966)
Q Consensus 182 ------------------~~~~~~~v~~----------~~~~~~e~nil~~~~gh~~iv~l~~~~~-------------- 219 (966)
..++.++..+ ..|++++ |||++.+|+++|+||+.+..
T Consensus 92 g~L~~~l~~~~~l~~~~~~~i~~qi~~gl~ylH~~~iiHrDlKp~-Nill~~~~~~kl~DFGla~~~~~~~~~~~~~~~~ 170 (277)
T d1xbba_ 92 GPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAAR-NVLLVTQHYAKISDFGLSKALRADENYYKAQTHG 170 (277)
T ss_dssp EEHHHHHHHCTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGG-GEEEEETTEEEECCCTTCEECCTTCSEEEC----
T ss_pred CcHHHHHhhccCCCHHHHHHHHHHHHHHHhhHHhCCcccCCCcch-hhcccccCcccccchhhhhhcccccccccccccc
Confidence 1111122211 1245555 99999999999999997632
Q ss_pred --------ccccccccCCCcceeeechhhHHHHHHHhh-CCCCCCCCcHHHHHHHHHhC-CCCCCCCCCHHHHHHHHhhc
Q psy11767 220 --------DEVIDWDDFSRGIECVFFSSSLIIFFIILS-FTLSFIHDYYHIQYRRILKT-EPPIPEDLSPDVADFISRLL 289 (966)
Q Consensus 220 --------~e~i~~~~y~~~~d~~~~~~~~il~~~m~~-g~~pf~~~~~~~~~~~I~~~-~~~~P~~~s~~a~dli~~LL 289 (966)
+|++....|+...| .| +.|+++|||++ |.+||...+...+++.|.++ .+.+|..+++++++||.++|
T Consensus 171 ~gt~~y~APE~l~~~~~~~~sD--iw-S~Gv~l~ellt~g~~Pf~~~~~~~~~~~i~~~~~~~~p~~~~~~~~~li~~cl 247 (277)
T d1xbba_ 171 KWPVKWYAPECINYYKFSSKSD--VW-SFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGERMGCPAGCPREMYDLMNLCW 247 (277)
T ss_dssp CCCGGGCCHHHHHHCEEEHHHH--HH-HHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHT
T ss_pred CCCceecCchhhcCCCCCchhh--hc-cchhhhhHHhhCCCCCCCCCCHHHHHHHHHcCCCCCCCcccCHHHHHHHHHHc
Confidence 23333334433333 34 56666777665 89999988888888999875 57899999999999999999
Q ss_pred ccCCCcccCCCCCCHHHH---hcCCceeeeCc
Q psy11767 290 VKDPRRRLGGGELDAEEL---KRHPFFNVIDW 318 (966)
Q Consensus 290 ~kdp~~RLG~~~~g~~~I---k~HpfF~~idW 318 (966)
.+||.+|.. +.+| .+|+||..+|+
T Consensus 248 ~~dp~~RPs-----~~~i~~~L~~~~~~~~~e 274 (277)
T d1xbba_ 248 TYDVENRPG-----FAAVELRLRNYYYDVVNE 274 (277)
T ss_dssp CSSTTTSCC-----HHHHHHHHHHHHHHHHHH
T ss_pred CCCHhHCcC-----HHHHHHHhhCHHhhcCCC
Confidence 999999974 6676 46777765553
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.76 E-value=3.6e-19 Score=194.88 Aligned_cols=185 Identities=15% Similarity=0.198 Sum_probs=135.9
Q ss_pred CcceeeeecccccceEEEEEEcCCCCE--EEEEecccc------chhhHHHHHHHHhhCCCccccccccccc--------
Q psy11767 117 DLDKAGILGDGSYSVCRRCVEKSTGQE--YAVKIISRK------IDCSEEINLLRACQGHPNICRRCVEKST-------- 180 (966)
Q Consensus 117 df~~~~~LG~GsFGkV~La~~k~tg~~--yAiKvl~K~------~~~~~E~~il~~~~~~pfi~~~~~~~~~-------- 180 (966)
||++.++||+|+||+||+|+++.||.. +|||.+++. ....+|.++|.++.+||+||+.+-....
T Consensus 11 ~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~iV~ 90 (309)
T d1fvra_ 11 DIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAI 90 (309)
T ss_dssp GCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEEEEEE
T ss_pred HcEEEEEEeeCCCcEEEEEEECCCCeEEEEEEEEECcccChHHHHHHHHHHHHHHhccCCCCEeeEEEEEecCCeeEEEE
Confidence 789999999999999999999999986 566766543 2457899999998889999872211111
Q ss_pred --------------------------------------chhHHHHHHHhh----------cccchhhhHhhhccCCceEE
Q psy11767 181 --------------------------------------GQEYAVKIISRK----------IDCSEEINLLRACQGHPNIV 212 (966)
Q Consensus 181 --------------------------------------~~~~~~~~v~~~----------~~~~~e~nil~~~~gh~~iv 212 (966)
...++.+++.+. .|++++ |||.+.++.++|.
T Consensus 91 ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~~lH~~~iiHrDlkp~-NIL~~~~~~~kl~ 169 (309)
T d1fvra_ 91 EYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAAR-NILVGENYVAKIA 169 (309)
T ss_dssp CCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGG-GEEECGGGCEEEC
T ss_pred EecCCCcHHHHHhhccccccchhhhccccccCCCCHHHHHHHHHHHHHHHHhhhcCCccccccccc-eEEEcCCCceEEc
Confidence 011222332221 244444 9999999999999
Q ss_pred ecCcccc------------------ccccccccCCCcceeeechhhHHHHHHHh-hCCCCCCCCcHHHHHHHHHhC-CCC
Q psy11767 213 NLHCVFQ------------------DEVIDWDDFSRGIECVFFSSSLIIFFIIL-SFTLSFIHDYYHIQYRRILKT-EPP 272 (966)
Q Consensus 213 ~l~~~~~------------------~e~i~~~~y~~~~d~~~~~~~~il~~~m~-~g~~pf~~~~~~~~~~~I~~~-~~~ 272 (966)
||+.+.. +|.+....|+...| .|+ .|+++|||+ ++.+||...+...++++|.++ .+.
T Consensus 170 DfG~a~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sD--vwS-fGvil~ell~~~~~p~~~~~~~~~~~~i~~~~~~~ 246 (309)
T d1fvra_ 170 DFGLSRGQEVYVKKTMGRLPVRWMAIESLNYSVYTTNSD--VWS-YGVLLWEIVSLGGTPYCGMTCAELYEKLPQGYRLE 246 (309)
T ss_dssp CTTCEESSCEECCC----CCTTTCCHHHHHHCEECHHHH--HHH-HHHHHHHHHTTSCCTTTTCCHHHHHHHGGGTCCCC
T ss_pred cccccccccccccccceecCCcccchHHhccCCCCccce--eeh-hHHHHHHHHhcCCCCCCCCCHHHHHHHHHhcCCCC
Confidence 9987632 34454555544433 455 455555555 467899999999999999875 788
Q ss_pred CCCCCCHHHHHHHHhhcccCCCcccCCCCCCHHHHhcC
Q psy11767 273 IPEDLSPDVADFISRLLVKDPRRRLGGGELDAEELKRH 310 (966)
Q Consensus 273 ~P~~~s~~a~dli~~LL~kdp~~RLG~~~~g~~~Ik~H 310 (966)
+|..+++++++||.++|.+||++|. .+++|.+|
T Consensus 247 ~~~~~~~~~~~li~~cl~~dP~~RP-----s~~eil~~ 279 (309)
T d1fvra_ 247 KPLNCDDEVYDLMRQCWREKPYERP-----SFAQILVS 279 (309)
T ss_dssp CCTTBCHHHHHHHHHHTCSSGGGSC-----CHHHHHHH
T ss_pred CCccCCHHHHHHHHHHcCCChhHCc-----CHHHHHHH
Confidence 8999999999999999999999997 48899887
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Probab=99.75 E-value=1.2e-18 Score=189.80 Aligned_cols=183 Identities=15% Similarity=0.149 Sum_probs=128.3
Q ss_pred CcceeeeecccccceEEEEEEcCCCC---EEEEEecccc------chhhHHHHHHHHhhCCCccccccccccc-------
Q psy11767 117 DLDKAGILGDGSYSVCRRCVEKSTGQ---EYAVKIISRK------IDCSEEINLLRACQGHPNICRRCVEKST------- 180 (966)
Q Consensus 117 df~~~~~LG~GsFGkV~La~~k~tg~---~yAiKvl~K~------~~~~~E~~il~~~~~~pfi~~~~~~~~~------- 180 (966)
+|++.++||+|+||+||+|+++.+|+ .+|||.+++. ....+|..+|+++ +||+||+.+-....
T Consensus 27 ~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~HpnIv~l~g~~~~~~~~~iv 105 (299)
T d1jpaa_ 27 CVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQF-DHPNVIHLEGVVTKSTPVMII 105 (299)
T ss_dssp GEEEEEEEEECSSSEEEEEEECC---CCEEEEEEECCSSCCHHHHHHHHHHHHHHTTC-CCTTBCCEEEEECSSSSCEEE
T ss_pred hcEEeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhC-CCCCCccEEEEEeeCCEEEEE
Confidence 67899999999999999999998876 5899988754 1357899999998 69999872211111
Q ss_pred ------------------------chhHHHHHHHh----------hcccchhhhHhhhccCCceEEecCcccc-------
Q psy11767 181 ------------------------GQEYAVKIISR----------KIDCSEEINLLRACQGHPNIVNLHCVFQ------- 219 (966)
Q Consensus 181 ------------------------~~~~~~~~v~~----------~~~~~~e~nil~~~~gh~~iv~l~~~~~------- 219 (966)
...++.++..+ ..|++++ |||++.+|+++|.||+.+..
T Consensus 106 ~Ey~~~g~L~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHrDlKp~-NILl~~~~~~Kl~DFGla~~~~~~~~~ 184 (299)
T d1jpaa_ 106 TEFMENGSLDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLADMNYVHRDLAAR-NILVNSNLVCKVSDFGLSRFLEDDTSD 184 (299)
T ss_dssp EECCTTEEHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGG-GEEECTTCCEEECCC------------
T ss_pred EEecCCCcceeeeccccCCCCHHHHHHHHHHHHHHHHHHhhCCCccCccccc-eEEECCCCcEEECCcccceEccCCCCc
Confidence 11111222221 1255555 99999999999999996531
Q ss_pred -----------------ccccccccCCCcceeeechhhHHHHHHHhh-CCCCCCCCcHHHHHHHHHhC-CCCCCCCCCHH
Q psy11767 220 -----------------DEVIDWDDFSRGIECVFFSSSLIIFFIILS-FTLSFIHDYYHIQYRRILKT-EPPIPEDLSPD 280 (966)
Q Consensus 220 -----------------~e~i~~~~y~~~~d~~~~~~~~il~~~m~~-g~~pf~~~~~~~~~~~I~~~-~~~~P~~~s~~ 280 (966)
+|++....|+...| .| +.|+++|||++ |.+||.+.....+.+.|..+ .+..|..++++
T Consensus 185 ~~~~~~~~~~~t~~y~aPE~~~~~~~~~~sD--vw-S~Gvvl~el~t~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 261 (299)
T d1jpaa_ 185 PTYTSALGGKIPIRWTAPEAIQYRKFTSASD--VW-SYGIVMWEVMSYGERPYWDMTNQDVINAIEQDYRLPPPMDCPSA 261 (299)
T ss_dssp -----------CGGGSCHHHHHSCCCCHHHH--HH-HHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTTCCCCCCTTCCHH
T ss_pred ceeeecccccCCccccCHHHHhcCCCCcccc--cc-cchHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCccchHH
Confidence 23344445544444 34 55666677765 89999998888888888875 57788999999
Q ss_pred HHHHHHhhcccCCCcccCCCCCCHHHHhc
Q psy11767 281 VADFISRLLVKDPRRRLGGGELDAEELKR 309 (966)
Q Consensus 281 a~dli~~LL~kdp~~RLG~~~~g~~~Ik~ 309 (966)
+.+||.++|.+||.+|.. +.+|.+
T Consensus 262 l~~li~~cl~~~P~~RPs-----~~ei~~ 285 (299)
T d1jpaa_ 262 LHQLMLDCWQKDRNHRPK-----FGQIVN 285 (299)
T ss_dssp HHHHHHHHTCSSTTTSCC-----HHHHHH
T ss_pred HHHHHHHHcCCCHhHCcC-----HHHHHH
Confidence 999999999999999974 566654
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.75 E-value=7.6e-19 Score=190.19 Aligned_cols=188 Identities=17% Similarity=0.186 Sum_probs=132.5
Q ss_pred Ccceeee-ecccccceEEEEEEcCC--CCEEEEEeccccc------hhhHHHHHHHHhhCCCcccccccccccc------
Q psy11767 117 DLDKAGI-LGDGSYSVCRRCVEKST--GQEYAVKIISRKI------DCSEEINLLRACQGHPNICRRCVEKSTG------ 181 (966)
Q Consensus 117 df~~~~~-LG~GsFGkV~La~~k~t--g~~yAiKvl~K~~------~~~~E~~il~~~~~~pfi~~~~~~~~~~------ 181 (966)
+|.+..+ ||+|+||+||+|.++.+ +..||||++++.. ...+|..+|+++ +||+||+.+-.....
T Consensus 9 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~E~~il~~l-~HpnIv~l~g~~~~~~~~lvm 87 (285)
T d1u59a_ 9 NLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQL-DNPYIVRLIGVCQAEALMLVM 87 (285)
T ss_dssp GEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHC-CCTTBCCEEEEEESSSEEEEE
T ss_pred CeEECCcEEecccCeEEEEEEEecCCCcEEEEEEEEChhcCHHHHHHHHHHHHHHHhC-CCCCEeeEeeeeccCeEEEEE
Confidence 5667775 99999999999987654 4589999998642 357799999998 699998722111111
Q ss_pred ------------------------hhHHHHHHHh----------hcccchhhhHhhhccCCceEEecCcccc--------
Q psy11767 182 ------------------------QEYAVKIISR----------KIDCSEEINLLRACQGHPNIVNLHCVFQ-------- 219 (966)
Q Consensus 182 ------------------------~~~~~~~v~~----------~~~~~~e~nil~~~~gh~~iv~l~~~~~-------- 219 (966)
..++.++..+ ..|++++ |||++.+|+++|+||+.+..
T Consensus 88 E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~gL~ylH~~~iiHrDlKp~-Nill~~~~~~Kl~DFGla~~~~~~~~~~ 166 (285)
T d1u59a_ 88 EMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNFVHRDLAAR-NVLLVNRHYAKISDFGLSKALGADDSYY 166 (285)
T ss_dssp ECCTTEEHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGG-GEEEEETTEEEECCCTTCEECTTCSCEE
T ss_pred EeCCCCcHHHHhhccccCCCHHHHHHHHHHHHHHHHHHHhCCeecCcCchh-heeeccCCceeeccchhhhccccccccc
Confidence 1111222211 1245555 99999999999999987632
Q ss_pred --------------ccccccccCCCcceeeechhhHHHHHHHhh-CCCCCCCCcHHHHHHHHHhC-CCCCCCCCCHHHHH
Q psy11767 220 --------------DEVIDWDDFSRGIECVFFSSSLIIFFIILS-FTLSFIHDYYHIQYRRILKT-EPPIPEDLSPDVAD 283 (966)
Q Consensus 220 --------------~e~i~~~~y~~~~d~~~~~~~~il~~~m~~-g~~pf~~~~~~~~~~~I~~~-~~~~P~~~s~~a~d 283 (966)
+|++....|+...| .| +.|+++|||++ |.+||...+...++..|.++ .+.+|+.+++++.+
T Consensus 167 ~~~~~~~gt~~y~aPE~~~~~~~~~ksD--Vw-S~Gv~l~E~lt~G~~Pf~~~~~~~~~~~i~~~~~~~~p~~~~~~l~~ 243 (285)
T d1u59a_ 167 TARSAGKWPLKWYAPECINFRKFSSRSD--VW-SYGVTMWEALSYGQKPYKKMKGPEVMAFIEQGKRMECPPECPPELYA 243 (285)
T ss_dssp CCCCSSCCCGGGCCHHHHHHCEECHHHH--HH-HHHHHHHHHHTTSCCTTTTCCTHHHHHHHHTTCCCCCCTTCCHHHHH
T ss_pred ccccccccCccccChHHHhCCCCCccch--hh-cchHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCCcCCHHHHH
Confidence 23333334443333 34 55566676665 99999987777888999876 57899999999999
Q ss_pred HHHhhcccCCCcccCCCCCCHHHH---hcCCcee
Q psy11767 284 FISRLLVKDPRRRLGGGELDAEEL---KRHPFFN 314 (966)
Q Consensus 284 li~~LL~kdp~~RLG~~~~g~~~I---k~HpfF~ 314 (966)
||.++|.+||.+|.. +.+| .+|+||.
T Consensus 244 li~~cl~~~p~~RPs-----~~~i~~~L~~~~~~ 272 (285)
T d1u59a_ 244 LMSDCWIYKWEDRPD-----FLTVEQRMRACYYS 272 (285)
T ss_dssp HHHHTTCSSGGGSCC-----HHHHHHHHHHHHHH
T ss_pred HHHHHcCCCHhHCcC-----HHHHHHHHHHHHHH
Confidence 999999999999963 5555 5677764
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.75 E-value=8.1e-19 Score=187.63 Aligned_cols=181 Identities=17% Similarity=0.193 Sum_probs=132.9
Q ss_pred CcceeeeecccccceEEEEEEcCCCCEEEEEeccccc---hhhHHHHHHHHhhCCCccccccccc--ccchh--------
Q psy11767 117 DLDKAGILGDGSYSVCRRCVEKSTGQEYAVKIISRKI---DCSEEINLLRACQGHPNICRRCVEK--STGQE-------- 183 (966)
Q Consensus 117 df~~~~~LG~GsFGkV~La~~k~tg~~yAiKvl~K~~---~~~~E~~il~~~~~~pfi~~~~~~~--~~~~~-------- 183 (966)
||+++++||+|+||.|++|+++ |+.||||++++.. ...+|.++|+++ +||+||+.+-.. .....
T Consensus 8 ~~~~~~~lG~G~fg~Vy~~~~~--~~~vAvK~i~~~~~~~~~~~E~~~l~~l-~HpnIv~~~g~~~~~~~~~~lv~ey~~ 84 (262)
T d1byga_ 8 ELKLLQTIGKGEFGDVMLGDYR--GNKVAVKCIKNDATAQAFLAEASVMTQL-RHSNLVQLLGVIVEEKGGLYIVTEYMA 84 (262)
T ss_dssp GEEEEEEEEECSSCEEEEEEET--TEEEEEEECCCCC--HHHHHTHHHHTTC-CCTTBCCEEEEECCC--CCEEEECCCT
T ss_pred HeEEeEEEecCCCeEEEEEEEC--CeEEEEEEECcHHHHHHHHHHHHHHHhC-CCCCEeeEEEEEEecCCcEEEEEeccC
Confidence 7899999999999999999985 7789999998753 467899999998 699999833211 11100
Q ss_pred -----------------------HHHHHHHh-------h---cccchhhhHhhhccCCceEEecCcccc-----------
Q psy11767 184 -----------------------YAVKIISR-------K---IDCSEEINLLRACQGHPNIVNLHCVFQ----------- 219 (966)
Q Consensus 184 -----------------------~~~~~v~~-------~---~~~~~e~nil~~~~gh~~iv~l~~~~~----------- 219 (966)
.+.++..+ . .|++++ |+|.+.+|+++|.|++.+..
T Consensus 85 ~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~al~ylH~~~ivH~dlkp~-Nil~~~~~~~kl~dfg~s~~~~~~~~~~~~~ 163 (262)
T d1byga_ 85 KGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAAR-NVLVSEDNVAKVSDFGLTKEASSTQDTGKLP 163 (262)
T ss_dssp TEEHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGG-GEEECTTSCEEECCCCC------------CC
T ss_pred CCCHHHHHHhcCCCCCCHHHHHHHHHHHHhhccccccCceeccccchH-hheecCCCCEeecccccceecCCCCcccccc
Confidence 11111111 0 133333 99999999999999986642
Q ss_pred -----ccccccccCCCcceeeechhhHHHHHHHhh-CCCCCCCCcHHHHHHHHHh-CCCCCCCCCCHHHHHHHHhhcccC
Q psy11767 220 -----DEVIDWDDFSRGIECVFFSSSLIIFFIILS-FTLSFIHDYYHIQYRRILK-TEPPIPEDLSPDVADFISRLLVKD 292 (966)
Q Consensus 220 -----~e~i~~~~y~~~~d~~~~~~~~il~~~m~~-g~~pf~~~~~~~~~~~I~~-~~~~~P~~~s~~a~dli~~LL~kd 292 (966)
+|++....|+...| .| +.|+++|||++ |.+||...+...++.+|.+ ..+.+|..+++++++||+++|..|
T Consensus 164 ~~y~aPE~l~~~~~t~~sD--Iw-SfG~il~el~t~~~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~li~~cl~~d 240 (262)
T d1byga_ 164 VKWTAPEALREKKFSTKSD--VW-SFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGYKMDAPDGCPPAVYEVMKNCWHLD 240 (262)
T ss_dssp TTTSCHHHHHHCCCCHHHH--HH-HHHHHHHHHHTTSCCSCTTSCGGGHHHHHTTTCCCCCCTTCCHHHHHHHHHHTCSS
T ss_pred ccCCChHHHhCCCCChHHH--HH-hHHHHHHHHHHCCCCCCCCCCHHHHHHHHHcCCCCCCCccCCHHHHHHHHHHcccC
Confidence 45565556654444 34 56677777765 8999998888888999987 478899999999999999999999
Q ss_pred CCcccCCCCCCHHHHhc
Q psy11767 293 PRRRLGGGELDAEELKR 309 (966)
Q Consensus 293 p~~RLG~~~~g~~~Ik~ 309 (966)
|.+|.. +.+|.+
T Consensus 241 P~~Rps-----~~~l~~ 252 (262)
T d1byga_ 241 AAMRPS-----FLQLRE 252 (262)
T ss_dssp GGGSCC-----HHHHHH
T ss_pred HhHCcC-----HHHHHH
Confidence 999984 556544
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.74 E-value=1.7e-18 Score=188.29 Aligned_cols=185 Identities=17% Similarity=0.166 Sum_probs=122.6
Q ss_pred CcceeeeecccccceEEEEEEcC-----CCCEEEEEeccccc------hhhHHHHHHHHhhCCCccccccccc-------
Q psy11767 117 DLDKAGILGDGSYSVCRRCVEKS-----TGQEYAVKIISRKI------DCSEEINLLRACQGHPNICRRCVEK------- 178 (966)
Q Consensus 117 df~~~~~LG~GsFGkV~La~~k~-----tg~~yAiKvl~K~~------~~~~E~~il~~~~~~pfi~~~~~~~------- 178 (966)
+|++++.||+|+||+|++|+++. +++.||||++++.. ....|..+|.++.+||.|+......
T Consensus 14 ~y~~~~~iG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~~~ 93 (299)
T d1ywna1 14 RLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGPL 93 (299)
T ss_dssp GEEEEEEEEECSSCEEEEEEEESTTSSSCEEEEEEEEC----CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTTSCC
T ss_pred HEEEeeEEeecCCeEEEEEEEcCCCcccCCeEEEEEEEccccCcHHHHHHHHHHHHHHhhcCCCeEEEeeeeeccCCCeE
Confidence 78999999999999999999765 45789999998642 3466778888888899997511110
Q ss_pred ----------------------------------------ccchhHHHHHHHh----------hcccchhhhHhhhccCC
Q psy11767 179 ----------------------------------------STGQEYAVKIISR----------KIDCSEEINLLRACQGH 208 (966)
Q Consensus 179 ----------------------------------------~~~~~~~~~~v~~----------~~~~~~e~nil~~~~gh 208 (966)
.....++.+++.+ ..|++++ |||++.+|+
T Consensus 94 ~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~ivHrDlKp~-NILl~~~~~ 172 (299)
T d1ywna1 94 MVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAAR-NILLSEKNV 172 (299)
T ss_dssp EEEEECCTTCBHHHHHHHTGGGBCC-----------CBCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGG-GEEECGGGC
T ss_pred EEEEEecCCCcHHHHHHhccccccccccchhhhhcccCCHHHHHHHHHHHHHHHHHHHhCCCcCCcCCcc-ceeECCCCc
Confidence 0011122222222 1255556 999999999
Q ss_pred ceEEecCcccc---------------------ccccccccCCCcceeeechhhHHHHHHHhh-CCCCCCCCcHHHHHHH-
Q psy11767 209 PNIVNLHCVFQ---------------------DEVIDWDDFSRGIECVFFSSSLIIFFIILS-FTLSFIHDYYHIQYRR- 265 (966)
Q Consensus 209 ~~iv~l~~~~~---------------------~e~i~~~~y~~~~d~~~~~~~~il~~~m~~-g~~pf~~~~~~~~~~~- 265 (966)
++|.||+.+.. +|++....|+...| .| +.|+++|||++ +.+||...+....+.+
T Consensus 173 ~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sD--iw-S~Gvil~ellt~~~~p~~~~~~~~~~~~~ 249 (299)
T d1ywna1 173 VKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSD--VW-SFGVLLWEIFSLGASPYPGVKIDEEFCRR 249 (299)
T ss_dssp EEECC------CCSCTTSCCTTSCCCGGGGCCHHHHHHCCCCHHHH--HH-HHHHHHHHHHTTSCCSSTTCCCSHHHHHH
T ss_pred EEEccCcchhhccccccccccCceeeCccccchhHhhcCCCCcccc--ee-ehHHHHHHHHhCCCCCCCCCCHHHHHHHH
Confidence 99999997631 23444444544444 44 45566666664 5788876544333444
Q ss_pred HHh-CCCCCCCCCCHHHHHHHHhhcccCCCcccCCCCCCHHHHhcC
Q psy11767 266 ILK-TEPPIPEDLSPDVADFISRLLVKDPRRRLGGGELDAEELKRH 310 (966)
Q Consensus 266 I~~-~~~~~P~~~s~~a~dli~~LL~kdp~~RLG~~~~g~~~Ik~H 310 (966)
+.. ..+.+|..+++++++||.++|++||.+|.. +++|.+|
T Consensus 250 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt-----~~eil~~ 290 (299)
T d1ywna1 250 LKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPT-----FSELVEH 290 (299)
T ss_dssp HHHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCC-----HHHHHHH
T ss_pred HhcCCCCCCCccCCHHHHHHHHHHcCCChhHCcC-----HHHHHHH
Confidence 444 367889999999999999999999999974 7888876
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.74 E-value=2.1e-18 Score=185.46 Aligned_cols=182 Identities=24% Similarity=0.282 Sum_probs=123.3
Q ss_pred CcceeeeecccccceEEEEEEcC-CCC--EEEEEeccccc--------hhhHHHHHHHHhhCCCcccccccccccc----
Q psy11767 117 DLDKAGILGDGSYSVCRRCVEKS-TGQ--EYAVKIISRKI--------DCSEEINLLRACQGHPNICRRCVEKSTG---- 181 (966)
Q Consensus 117 df~~~~~LG~GsFGkV~La~~k~-tg~--~yAiKvl~K~~--------~~~~E~~il~~~~~~pfi~~~~~~~~~~---- 181 (966)
||++++.||+|+||+||+|+++. +++ .||||+++|.. ...+|.++|+++ +||+|++.+-.....
T Consensus 9 d~~~~~~iG~G~fg~Vy~~~~~~~~~~~~~vAiK~l~~~~~~~~~~~~~~~~Ei~~l~~l-~H~nIv~~~g~~~~~~~~l 87 (273)
T d1u46a_ 9 DLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSL-DHRNLIRLYGVVLTPPMKM 87 (273)
T ss_dssp GEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHC-CCTTBCCEEEEECSSSCEE
T ss_pred HeEEEEEEecCCCeEEEEEEEECCCCcEEEEEEEEEChhhcCCHHHHHHHHHHHHHHHhC-CCCCEEEEEEEEeecchhe
Confidence 78999999999999999999754 333 68999998742 347899999998 799998722211111
Q ss_pred --------------------------hhHHHHHHHh-------h---cccchhhhHhhhccCCceEEecCcccc------
Q psy11767 182 --------------------------QEYAVKIISR-------K---IDCSEEINLLRACQGHPNIVNLHCVFQ------ 219 (966)
Q Consensus 182 --------------------------~~~~~~~v~~-------~---~~~~~e~nil~~~~gh~~iv~l~~~~~------ 219 (966)
..++.++..+ . .|++++ |||++.++.++|.||+.+..
T Consensus 88 v~e~~~~~~l~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~iiHrDikp~-NIll~~~~~vkl~DfGl~~~~~~~~~ 166 (273)
T d1u46a_ 88 VTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLESKRFIHRDLAAR-NLLLATRDLVKIGDFGLMRALPQNDD 166 (273)
T ss_dssp EEECCTTCBHHHHHHHHGGGSCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGG-GEEEEETTEEEECCCTTCEECCC-CC
T ss_pred eeeeecCcchhhhhhcccCCCCHHHHHHHHHHHHHHHHHhhhCCEeeeeecHH-HhccccccceeeccchhhhhcccCCC
Confidence 1111122211 1 244444 99999999999999986542
Q ss_pred ----------------ccccccccCCCcceeeechhhHHHHHHHhh-CCCCCCCCcHHHHHHHHHhCC--CCCCCCCCHH
Q psy11767 220 ----------------DEVIDWDDFSRGIECVFFSSSLIIFFIILS-FTLSFIHDYYHIQYRRILKTE--PPIPEDLSPD 280 (966)
Q Consensus 220 ----------------~e~i~~~~y~~~~d~~~~~~~~il~~~m~~-g~~pf~~~~~~~~~~~I~~~~--~~~P~~~s~~ 280 (966)
+|++....|+...| .|+.|+++|||++ |.+||...+...++++|.... +..|..++++
T Consensus 167 ~~~~~~~~~~~~~~~aPE~~~~~~~~~~~D---i~S~Gvil~emlt~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 243 (273)
T d1u46a_ 167 HYVMQEHRKVPFAWCAPESLKTRTFSHASD---TWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKEGERLPRPEDCPQD 243 (273)
T ss_dssp EEEC-----CCGGGCCHHHHHHCEEEHHHH---HHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTSCCCCCCCTTCCHH
T ss_pred cceecCccccCcccCCHHHHhCCCCCcchh---hhhhHHHHHHHHhCCCCCCCCcCHHHHHHHHHhCCCCCCCcccccHH
Confidence 22333333333333 3456677777765 899999999999999998774 4567889999
Q ss_pred HHHHHHhhcccCCCcccCCCCCCHHHHh
Q psy11767 281 VADFISRLLVKDPRRRLGGGELDAEELK 308 (966)
Q Consensus 281 a~dli~~LL~kdp~~RLG~~~~g~~~Ik 308 (966)
+++||.++|..||++|. .+.+|.
T Consensus 244 l~~li~~cl~~dp~~RP-----t~~ei~ 266 (273)
T d1u46a_ 244 IYNVMVQCWAHKPEDRP-----TFVALR 266 (273)
T ss_dssp HHHHHHHHTCSSGGGSC-----CHHHHH
T ss_pred HHHHHHHHcCCChhHCc-----CHHHHH
Confidence 99999999999999997 377774
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.73 E-value=5.2e-18 Score=184.69 Aligned_cols=184 Identities=13% Similarity=0.117 Sum_probs=128.2
Q ss_pred CcceeeeecccccceEEEEEEcCCCC-------EEEEEeccccc------hhhHHHHHHHHhhCCCcccccccccc----
Q psy11767 117 DLDKAGILGDGSYSVCRRCVEKSTGQ-------EYAVKIISRKI------DCSEEINLLRACQGHPNICRRCVEKS---- 179 (966)
Q Consensus 117 df~~~~~LG~GsFGkV~La~~k~tg~-------~yAiKvl~K~~------~~~~E~~il~~~~~~pfi~~~~~~~~---- 179 (966)
+|.+++.||+|+||.|++|+++.+++ .||||++++.. ...+|..+|.++.+||+||+.+-...
T Consensus 14 ~~~l~~~iG~G~fg~Vy~~~~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~e~~~l~~~~~HpnIv~~~~~~~~~~~ 93 (299)
T d1fgka_ 14 RLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQDGP 93 (299)
T ss_dssp GEEEEEECC-----CEEEEEEECC----CCCEEEEEEECCCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSS
T ss_pred HeEEeeEEeecCCcEEEEEEEcCCCcccccCceEEEEEEECcccChHHHHHHHHHHHHHHHhcCCCeEEecccccccCCe
Confidence 77899999999999999999887764 79999998752 35678888888889999987211110
Q ss_pred ------------------------------------------cchhHHHHHHHh----------hcccchhhhHhhhccC
Q psy11767 180 ------------------------------------------TGQEYAVKIISR----------KIDCSEEINLLRACQG 207 (966)
Q Consensus 180 ------------------------------------------~~~~~~~~~v~~----------~~~~~~e~nil~~~~g 207 (966)
....++.+++.+ ..|++++ |||.+.+|
T Consensus 94 ~~~v~e~~~~g~l~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~ylH~~~ivHrDiKp~-NiLl~~~~ 172 (299)
T d1fgka_ 94 LYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAAR-NVLVTEDN 172 (299)
T ss_dssp CEEEECCCTTCBHHHHHHTTSCC------------CCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGG-GEEECTTC
T ss_pred EEEEEEccCCCcHHHHHHhhcCCccccccccccCccccCCHHHHHHHHHHHHHHHHHhhhCCEEeeeeccc-ceeecCCC
Confidence 011122222222 1245555 99999999
Q ss_pred CceEEecCcccc---------------------ccccccccCCCcceeeechhhHHHHHHHh-hCCCCCCCCcHHHHHHH
Q psy11767 208 HPNIVNLHCVFQ---------------------DEVIDWDDFSRGIECVFFSSSLIIFFIIL-SFTLSFIHDYYHIQYRR 265 (966)
Q Consensus 208 h~~iv~l~~~~~---------------------~e~i~~~~y~~~~d~~~~~~~~il~~~m~-~g~~pf~~~~~~~~~~~ 265 (966)
..+|+|++.+.. +|++....|+..+| .|+ .|+++|||+ .|.+||...+...+++.
T Consensus 173 ~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~y~~k~D--iwS-~Gvvl~ell~~g~~p~~~~~~~~~~~~ 249 (299)
T d1fgka_ 173 VMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSD--VWS-FGVLLWEIFTLGGSPYPGVPVEELFKL 249 (299)
T ss_dssp CEEECSTTCCCCGGGCCTTCCCTTSCCGGGGSCHHHHHHCCCCHHHH--HHH-HHHHHHHHHTTSCCSSTTCCHHHHHHH
T ss_pred CeEeccchhhccccccccccccccCCCChhhhhhhHhcCCCCCchhh--hHH-hHHHHHHhccCCCCCCCCCCHHHHHHH
Confidence 999999986642 23344445554444 344 555556555 58999999999999999
Q ss_pred HHhC-CCCCCCCCCHHHHHHHHhhcccCCCcccCCCCCCHHHHhc
Q psy11767 266 ILKT-EPPIPEDLSPDVADFISRLLVKDPRRRLGGGELDAEELKR 309 (966)
Q Consensus 266 I~~~-~~~~P~~~s~~a~dli~~LL~kdp~~RLG~~~~g~~~Ik~ 309 (966)
|.++ .+.+|.++++++++||.++|.+||.+|.. +.||.+
T Consensus 250 i~~~~~~~~p~~~~~~l~~li~~cl~~dP~~Rps-----~~eil~ 289 (299)
T d1fgka_ 250 LKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPT-----FKQLVE 289 (299)
T ss_dssp HHTTCCCCCCSSCCHHHHHHHHHHTCSSGGGSCC-----HHHHHH
T ss_pred HHcCCCCCCCccchHHHHHHHHHHccCCHhHCcC-----HHHHHH
Confidence 8875 67889999999999999999999999974 667643
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=99.73 E-value=4.9e-18 Score=185.00 Aligned_cols=182 Identities=14% Similarity=0.139 Sum_probs=132.6
Q ss_pred CcceeeeecccccceEEEEEEcC-----CCCEEEEEeccccc------hhhHHHHHHHHhhCCCccccccccccc-----
Q psy11767 117 DLDKAGILGDGSYSVCRRCVEKS-----TGQEYAVKIISRKI------DCSEEINLLRACQGHPNICRRCVEKST----- 180 (966)
Q Consensus 117 df~~~~~LG~GsFGkV~La~~k~-----tg~~yAiKvl~K~~------~~~~E~~il~~~~~~pfi~~~~~~~~~----- 180 (966)
||++++.||+|+||+||+|+.+. +++.||||++++.. ...+|..+|+++ +||+|+..+.....
T Consensus 14 ~~~~~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~il~~l-~h~niv~~~~~~~~~~~~~ 92 (301)
T d1lufa_ 14 NIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEF-DNPNIVKLLGVCAVGKPMC 92 (301)
T ss_dssp GCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTC-CCTTBCCEEEEECSSSSCE
T ss_pred HcEEeEEEeeCCCeEEEEEEECCCccCCCCeEEEEEEEChhcChHHHHHHHHHHHHHHhc-CCCCcccceeeeccCCceE
Confidence 78999999999999999999864 66899999998642 457899999988 69999862211111
Q ss_pred -------------------------------------------------chhHHHHHHHh----------hcccchhhhH
Q psy11767 181 -------------------------------------------------GQEYAVKIISR----------KIDCSEEINL 201 (966)
Q Consensus 181 -------------------------------------------------~~~~~~~~v~~----------~~~~~~e~ni 201 (966)
...++.++..+ ..|++++ ||
T Consensus 93 ~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~ylH~~~ivHrDlKp~-NI 171 (301)
T d1lufa_ 93 LLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERKFVHRDLATR-NC 171 (301)
T ss_dssp EEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGG-GE
T ss_pred EEEEecCCCcHHHHHHhcCccccccccccccchhhhccccCCCCCCHHHHHHHHHHHHHHhhhcccCCeEeeEEccc-ce
Confidence 01111122111 1255555 99
Q ss_pred hhhccCCceEEecCccc---------------------cccccccccCCCcceeeechhhHHHHHHHhh-CCCCCCCCcH
Q psy11767 202 LRACQGHPNIVNLHCVF---------------------QDEVIDWDDFSRGIECVFFSSSLIIFFIILS-FTLSFIHDYY 259 (966)
Q Consensus 202 l~~~~gh~~iv~l~~~~---------------------~~e~i~~~~y~~~~d~~~~~~~~il~~~m~~-g~~pf~~~~~ 259 (966)
|.+.+++++|.||+.+. .+|.+....|+...| .|+ .||++|||++ +.+||...+.
T Consensus 172 Lld~~~~~Kl~DFGls~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~t~ksD--VwS-~Gvvl~ell~~~~~p~~~~~~ 248 (301)
T d1lufa_ 172 LVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESD--VWA-YGVVLWEIFSYGLQPYYGMAH 248 (301)
T ss_dssp EECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHH--HHH-HHHHHHHHHTTTCCTTTTSCH
T ss_pred EECCCCcEEEccchhheeccCCccccccCCCCcCcCcCCHHHHccCCCChhhh--hcc-chhhHHHHHccCCCCCCCCCH
Confidence 99999999999999763 123444445554444 344 5555565554 5789999999
Q ss_pred HHHHHHHHhCC-CCCCCCCCHHHHHHHHhhcccCCCcccCCCCCCHHHHh
Q psy11767 260 HIQYRRILKTE-PPIPEDLSPDVADFISRLLVKDPRRRLGGGELDAEELK 308 (966)
Q Consensus 260 ~~~~~~I~~~~-~~~P~~~s~~a~dli~~LL~kdp~~RLG~~~~g~~~Ik 308 (966)
.++.++|..+. +..|..+++++.+||.++|+.||.+|.. +.+|.
T Consensus 249 ~e~~~~v~~~~~~~~p~~~~~~~~~li~~cl~~~P~~RPt-----~~ev~ 293 (301)
T d1lufa_ 249 EEVIYYVRDGNILACPENCPLELYNLMRLCWSKLPADRPS-----FCSIH 293 (301)
T ss_dssp HHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCC-----HHHHH
T ss_pred HHHHHHHHcCCCCCCCccchHHHHHHHHHHcCCChhHCcC-----HHHHH
Confidence 99999999875 4578899999999999999999999973 77773
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.71 E-value=1.3e-17 Score=180.14 Aligned_cols=183 Identities=15% Similarity=0.176 Sum_probs=129.4
Q ss_pred CcceeeeecccccceEEEEEEcCCC----CEEEEEeccccc------hhhHHHHHHHHhhCCCcccccccccccc-----
Q psy11767 117 DLDKAGILGDGSYSVCRRCVEKSTG----QEYAVKIISRKI------DCSEEINLLRACQGHPNICRRCVEKSTG----- 181 (966)
Q Consensus 117 df~~~~~LG~GsFGkV~La~~k~tg----~~yAiKvl~K~~------~~~~E~~il~~~~~~pfi~~~~~~~~~~----- 181 (966)
+|++.++||+|+||+||+|+++.++ ..||||++++.. ...+|.++|+++ +||+||+.+-.....
T Consensus 8 ~~~~~~~iG~G~fG~Vy~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l-~H~nIv~~~g~~~~~~~~~~ 86 (283)
T d1mqba_ 8 CVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQF-SHHNIIRLEGVISKYKPMMI 86 (283)
T ss_dssp TEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTC-CCTTBCCEEEEECSSSSEEE
T ss_pred HeEeeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEEECcccChHHHHHHHHHHHHHHhc-CCCCEeeeeEEEecCCceEE
Confidence 5789999999999999999998776 379999997542 356899999998 699998722111110
Q ss_pred --------------------------hhHHHHHHHh----------hcccchhhhHhhhccCCceEEecCccc-------
Q psy11767 182 --------------------------QEYAVKIISR----------KIDCSEEINLLRACQGHPNIVNLHCVF------- 218 (966)
Q Consensus 182 --------------------------~~~~~~~v~~----------~~~~~~e~nil~~~~gh~~iv~l~~~~------- 218 (966)
..++.++..+ ..|++++ |||++.+|+++|.||+.+.
T Consensus 87 v~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~~i~~gl~~lH~~~iiHrDlKp~-NILl~~~~~~Kl~DFGla~~~~~~~~ 165 (283)
T d1mqba_ 87 ITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLANMNYVHRDLAAR-NILVNSNLVCKVSDFGLSRVLEDDPE 165 (283)
T ss_dssp EEECCTTEEHHHHHHHTTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGG-GEEECTTCCEEECCCCC---------
T ss_pred EEEecccCcchhhhhcccccccHHHHHHHHHHHHHhhhhccccccccCccccc-eEEECCCCeEEEcccchhhcccCCCc
Confidence 0111122111 1255555 9999999999999998763
Q ss_pred ---------------cccccccccCCCcceeeechhhHHHHHHHh-hCCCCCCCCcHHHHHHHHHhC-CCCCCCCCCHHH
Q psy11767 219 ---------------QDEVIDWDDFSRGIECVFFSSSLIIFFIIL-SFTLSFIHDYYHIQYRRILKT-EPPIPEDLSPDV 281 (966)
Q Consensus 219 ---------------~~e~i~~~~y~~~~d~~~~~~~~il~~~m~-~g~~pf~~~~~~~~~~~I~~~-~~~~P~~~s~~a 281 (966)
.+|++....|+...| .|+ .|+++|||+ +|.|||...+...+++.|..+ .+.+|..+++++
T Consensus 166 ~~~~~~~~~gt~~Y~APE~l~~~~~~~~sD--I~S-~Gvil~el~t~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~l 242 (283)
T d1mqba_ 166 ATYTTSGGKIPIRWTAPEAISYRKFTSASD--VWS-FGIVMWEVMTYGERPYWELSNHEVMKAINDGFRLPTPMDCPSAI 242 (283)
T ss_dssp --------CCCGGGSCHHHHHSCCCCHHHH--HHH-HHHHHHHHHTTSCCTTTTCCHHHHHHHHHTTCCCCCCTTCBHHH
T ss_pred cceEeccCCCCccccCHHHHccCCCCCccc--ccc-cHHHHHHHHhCCCCccccCCHHHHHHHHhccCCCCCchhhHHHH
Confidence 234455555554444 454 555566665 578888888888888888875 678899999999
Q ss_pred HHHHHhhcccCCCcccCCCCCCHHHHhc
Q psy11767 282 ADFISRLLVKDPRRRLGGGELDAEELKR 309 (966)
Q Consensus 282 ~dli~~LL~kdp~~RLG~~~~g~~~Ik~ 309 (966)
++||.++|..||.+|.. +.+|..
T Consensus 243 ~~li~~cl~~~p~~RPt-----~~eil~ 265 (283)
T d1mqba_ 243 YQLMMQCWQQERARRPK-----FADIVS 265 (283)
T ss_dssp HHHHHHHTCSSTTTSCC-----HHHHHH
T ss_pred HHHHHHHCcCCHhHCcC-----HHHHHH
Confidence 99999999999999974 667754
|
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.71 E-value=5.4e-18 Score=182.54 Aligned_cols=181 Identities=14% Similarity=0.109 Sum_probs=126.6
Q ss_pred CcceeeeecccccceEEEEEEcCCCCEEEEEeccccc-------hhhHHHHHHHHhhCCCccccccccccc---------
Q psy11767 117 DLDKAGILGDGSYSVCRRCVEKSTGQEYAVKIISRKI-------DCSEEINLLRACQGHPNICRRCVEKST--------- 180 (966)
Q Consensus 117 df~~~~~LG~GsFGkV~La~~k~tg~~yAiKvl~K~~-------~~~~E~~il~~~~~~pfi~~~~~~~~~--------- 180 (966)
+|.+++.||+|+||+||+|+++. .||||++++.. ...+|..+|.++ +||+||+.+-....
T Consensus 9 ~~~~~~~lG~G~fg~Vy~~~~~~---~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l-~HpnIv~~~~~~~~~~~~lv~Ey 84 (276)
T d1uwha_ 9 QITVGQRIGSGSFGTVYKGKWHG---DVAVKMLNVTAPTPQQLQAFKNEVGVLRKT-RHVNILLFMGYSTAPQLAIVTQW 84 (276)
T ss_dssp CCCCCSEEEECSSCEEEEEESSS---EEEEEECCCSSCCTTHHHHHHHHHHHHTTC-CCTTBCCEEEEECSSSCEEEEEC
T ss_pred cEEEEEEEeeCCCcEEEEEEECC---EEEEEEEEcccCCHHHHHHHHHHHHHHHhC-CCCCEeeeeEEEeccEEEEEEec
Confidence 67899999999999999998753 49999998541 346799999998 69999872111100
Q ss_pred ---------------------chhHHHHHHHh----------hcccchhhhHhhhccCCceEEecCcccc----------
Q psy11767 181 ---------------------GQEYAVKIISR----------KIDCSEEINLLRACQGHPNIVNLHCVFQ---------- 219 (966)
Q Consensus 181 ---------------------~~~~~~~~v~~----------~~~~~~e~nil~~~~gh~~iv~l~~~~~---------- 219 (966)
...++.++..+ ..|++++ |||++.+|+++|+||+.+..
T Consensus 85 ~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~gl~yLH~~~ivHrDlKp~-NiLl~~~~~~Kl~DFGla~~~~~~~~~~~~ 163 (276)
T d1uwha_ 85 CEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHAKSIIHRDLKSN-NIFLHEDLTVKIGDFGLATVKSRWSGSHQF 163 (276)
T ss_dssp CCEEEHHHHHHTSCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGG-GEEEETTSSEEECCCCCSCC----------
T ss_pred CCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHhcCCEeccccCHH-HEEEcCCCCEEEccccceeeccccCCcccc
Confidence 01111222221 1255556 99999999999999997631
Q ss_pred -----------ccccccc---cCCCcceeeechhhHHHHHHHhhCCCCCCCCc-HHHHHHHHHhCCC-----CCCCCCCH
Q psy11767 220 -----------DEVIDWD---DFSRGIECVFFSSSLIIFFIILSFTLSFIHDY-YHIQYRRILKTEP-----PIPEDLSP 279 (966)
Q Consensus 220 -----------~e~i~~~---~y~~~~d~~~~~~~~il~~~m~~g~~pf~~~~-~~~~~~~I~~~~~-----~~P~~~s~ 279 (966)
+|++... .|+...| .|+.||++|||++|.+||.+.+ ...+...+..+.. .+|..+++
T Consensus 164 ~~~~gt~~y~APE~l~~~~~~~~~~~sD---iwS~Gv~l~el~tg~~Pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~ 240 (276)
T d1uwha_ 164 EQLSGSILWMAPEVIRMQDKNPYSFQSD---VYAFGIVLYELMTGQLPYSNINNRDQIIFMVGRGYLSPDLSKVRSNCPK 240 (276)
T ss_dssp --CCCCGGGCCHHHHTTCSSCCCCHHHH---HHHHHHHHHHHHHSSCTTTTCCCHHHHHHHHHHTSCCCCGGGSCTTCCH
T ss_pred cccccCcccCCHHHHhcccCCCCCchhh---hhhhHHHHHHHHHCCCCCCCCChHHHHHHHHhcCCCCCcchhccccchH
Confidence 3444322 2443344 4467788889999999998644 4455555555432 35678899
Q ss_pred HHHHHHHhhcccCCCcccCCCCCCHHHHhcC
Q psy11767 280 DVADFISRLLVKDPRRRLGGGELDAEELKRH 310 (966)
Q Consensus 280 ~a~dli~~LL~kdp~~RLG~~~~g~~~Ik~H 310 (966)
++++||.++|..||.+|. .+.+|..|
T Consensus 241 ~l~~li~~cl~~dp~~RP-----t~~~il~~ 266 (276)
T d1uwha_ 241 AMKRLMAECLKKKRDERP-----LFPQILAS 266 (276)
T ss_dssp HHHHHHHHHTCSSGGGSC-----CHHHHHHH
T ss_pred HHHHHHHHHcCCCHhHCc-----CHHHHHHH
Confidence 999999999999999997 37888766
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.71 E-value=1.1e-17 Score=183.14 Aligned_cols=184 Identities=15% Similarity=0.163 Sum_probs=130.4
Q ss_pred CcceeeeecccccceEEEEEEc-----CCCCEEEEEeccccc------hhhHHHHHHHHhhCCCccccccccccc-----
Q psy11767 117 DLDKAGILGDGSYSVCRRCVEK-----STGQEYAVKIISRKI------DCSEEINLLRACQGHPNICRRCVEKST----- 180 (966)
Q Consensus 117 df~~~~~LG~GsFGkV~La~~k-----~tg~~yAiKvl~K~~------~~~~E~~il~~~~~~pfi~~~~~~~~~----- 180 (966)
||++.++||+|+||+|++|+++ .+++.||||++++.. ...+|..+|.++.+||+||+.+-....
T Consensus 24 ~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~~~~~l~~HpnIv~~~g~~~~~~~~~ 103 (311)
T d1t46a_ 24 RLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTIGGPTL 103 (311)
T ss_dssp GEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCE
T ss_pred HeEEeeEEeecCCeEEEEEEEeccccCCCCeEEEEEEECcccCHHHHHHHHHHHHHHHhccCCCCEEEEEEEEeeCCEEE
Confidence 7789999999999999999974 577899999998742 357899999999899999862211111
Q ss_pred -------------------------------------------chhHHHHHHHh----------hcccchhhhHhhhccC
Q psy11767 181 -------------------------------------------GQEYAVKIISR----------KIDCSEEINLLRACQG 207 (966)
Q Consensus 181 -------------------------------------------~~~~~~~~v~~----------~~~~~~e~nil~~~~g 207 (966)
...++.+++.+ ..|++++ |||.+.+|
T Consensus 104 lvmE~~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~~LH~~~ivHrDLKp~-NIl~~~~~ 182 (311)
T d1t46a_ 104 VITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAAR-NILLTHGR 182 (311)
T ss_dssp EEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGG-GEEEETTT
T ss_pred EEEEcCCCCCHHHHHHhccccccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhCCeeecccccc-cccccccC
Confidence 11222333322 1255555 99999999
Q ss_pred CceEEecCcccc---------------------ccccccccCCCcceeeechhhHHHHHHHhh-CCCCCCCCcHHHHHHH
Q psy11767 208 HPNIVNLHCVFQ---------------------DEVIDWDDFSRGIECVFFSSSLIIFFIILS-FTLSFIHDYYHIQYRR 265 (966)
Q Consensus 208 h~~iv~l~~~~~---------------------~e~i~~~~y~~~~d~~~~~~~~il~~~m~~-g~~pf~~~~~~~~~~~ 265 (966)
+++|.||+.+.. +|++....|+...| .| +.|+++|||++ |.|||...+....+.+
T Consensus 183 ~~ki~DfG~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~D--Iw-S~G~~l~ellt~g~p~~~~~~~~~~~~~ 259 (311)
T d1t46a_ 183 ITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESD--VW-SYGIFLWELFSLGSSPYPGMPVDSKFYK 259 (311)
T ss_dssp EEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHH--HH-HHHHHHHHHHTTTCCSSTTCCSSHHHHH
T ss_pred cccccccchheeccCCCcceEeeecccChHHcCHHHhcCCCCCCccc--cc-chHHHHHHHHhCCCCCCCCCCHHHHHHH
Confidence 999999986642 23344444544444 34 55566666664 8888877665555556
Q ss_pred HHh--CCCCCCCCCCHHHHHHHHhhcccCCCcccCCCCCCHHHHhc
Q psy11767 266 ILK--TEPPIPEDLSPDVADFISRLLVKDPRRRLGGGELDAEELKR 309 (966)
Q Consensus 266 I~~--~~~~~P~~~s~~a~dli~~LL~kdp~~RLG~~~~g~~~Ik~ 309 (966)
++. ..+..|..+++++++||.++|..||.+|.. +++|..
T Consensus 260 ~i~~~~~~~~~~~~~~~l~~Li~~cl~~dP~~RPs-----~~~il~ 300 (311)
T d1t46a_ 260 MIKEGFRMLSPEHAPAEMYDIMKTCWDADPLKRPT-----FKQIVQ 300 (311)
T ss_dssp HHHHTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCC-----HHHHHH
T ss_pred HHhcCCCCCCcccccHHHHHHHHHHcCCChhHCcC-----HHHHHH
Confidence 654 356788899999999999999999999984 676653
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.70 E-value=1e-17 Score=183.13 Aligned_cols=191 Identities=15% Similarity=0.153 Sum_probs=134.6
Q ss_pred CcceeeeecccccceEEEEEEcC-----CCCEEEEEeccccc------hhhHHHHHHHHhhCCCccccccccccc-----
Q psy11767 117 DLDKAGILGDGSYSVCRRCVEKS-----TGQEYAVKIISRKI------DCSEEINLLRACQGHPNICRRCVEKST----- 180 (966)
Q Consensus 117 df~~~~~LG~GsFGkV~La~~k~-----tg~~yAiKvl~K~~------~~~~E~~il~~~~~~pfi~~~~~~~~~----- 180 (966)
||++++.||+|+||+|++|+++. +++.||||++++.. ...+|.++|+++ +||+||+.+-....
T Consensus 21 ~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~VAvK~~~~~~~~~~~~~~~~E~~il~~l-~h~nIv~~~~~~~~~~~~~ 99 (308)
T d1p4oa_ 21 KITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEF-NCHHVVRLLGVVSQGQPTL 99 (308)
T ss_dssp GEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGC-CCTTBCCEEEEECSSSSCE
T ss_pred HeEEeeEEeeCCCeEEEEEEECCcccCCCCcEEEEEEECcccChHHHHHHHHHHHHHHHc-CCCCEeeeeeEEecCCcee
Confidence 78999999999999999999864 45789999998742 347899999998 59999872111110
Q ss_pred -----------------------------------chhHHHHHHHh-------h---cccchhhhHhhhccCCceEEecC
Q psy11767 181 -----------------------------------GQEYAVKIISR-------K---IDCSEEINLLRACQGHPNIVNLH 215 (966)
Q Consensus 181 -----------------------------------~~~~~~~~v~~-------~---~~~~~e~nil~~~~gh~~iv~l~ 215 (966)
...++.++..+ . .|++.+ |||.+.+++++|.||+
T Consensus 100 lv~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~gl~~LH~~~ivHrDlk~~-NiLld~~~~~Kl~DFG 178 (308)
T d1p4oa_ 100 VIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANKFVHRDLAAR-NCMVAEDFTVKIGDFG 178 (308)
T ss_dssp EEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCSGG-GEEECTTCCEEECCTT
T ss_pred EEEeecCCCCHHHHHHhcccccccccccCCCCHHHHHHHHHHHHHHHHHHhhCCeeeceEcCC-ceeecCCceEEEeecc
Confidence 01122222222 1 144444 9999999999999999
Q ss_pred cccc---------------------ccccccccCCCcceeeechhhHHHHHHHhh-CCCCCCCCcHHHHHHHHHhCC-CC
Q psy11767 216 CVFQ---------------------DEVIDWDDFSRGIECVFFSSSLIIFFIILS-FTLSFIHDYYHIQYRRILKTE-PP 272 (966)
Q Consensus 216 ~~~~---------------------~e~i~~~~y~~~~d~~~~~~~~il~~~m~~-g~~pf~~~~~~~~~~~I~~~~-~~ 272 (966)
.+.. +|.+....|+...| .|+ .|+++|||++ +.+||...+...+++.|.++. +.
T Consensus 179 la~~~~~~~~~~~~~~~~~t~~y~aPe~l~~~~~~~~~D--v~S-~G~il~El~t~~~~p~~~~~~~~~~~~i~~~~~~~ 255 (308)
T d1p4oa_ 179 MTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSD--VWS-FGVVLWEIATLAEQPYQGLSNEQVLRFVMEGGLLD 255 (308)
T ss_dssp CCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHH--HHH-HHHHHHHHHHTSCCTTTTSCHHHHHHHHHTTCCCC
T ss_pred cceeccCCcceeeccceecccccCCHHHHccCCCCcccc--ccc-HHHHHHHHHhCCCCCCCCCCHHHHHHHHHhCCCCC
Confidence 7632 12233333433333 455 4455555554 579999999999999998754 56
Q ss_pred CCCCCCHHHHHHHHhhcccCCCcccCCCCCCHHHHhc------CCceeeeC
Q psy11767 273 IPEDLSPDVADFISRLLVKDPRRRLGGGELDAEELKR------HPFFNVID 317 (966)
Q Consensus 273 ~P~~~s~~a~dli~~LL~kdp~~RLG~~~~g~~~Ik~------HpfF~~id 317 (966)
.|..+++++++||.++|+.||.+|.. +++|.+ +|+|+.++
T Consensus 256 ~p~~~~~~l~~li~~cl~~~P~~RPs-----~~~il~~L~~~~~~~~~~~~ 301 (308)
T d1p4oa_ 256 KPDNCPDMLFELMRMCWQYNPKMRPS-----FLEIISSIKEEMEPGFREVS 301 (308)
T ss_dssp CCTTCCHHHHHHHHHHTCSSGGGSCC-----HHHHHHHHGGGSCTTHHHHC
T ss_pred CcccchHHHHHHHHHHcCCChhHCcC-----HHHHHHHHHHhcCCCCcCCC
Confidence 78899999999999999999999974 777765 66665444
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=99.67 E-value=9.3e-18 Score=182.31 Aligned_cols=199 Identities=18% Similarity=0.142 Sum_probs=128.1
Q ss_pred cceeeeecccccceEEEEEEcCCCCEEEEEecccc---chhhHHHHHHHHhhCCCcccccc-------------------
Q psy11767 118 LDKAGILGDGSYSVCRRCVEKSTGQEYAVKIISRK---IDCSEEINLLRACQGHPNICRRC------------------- 175 (966)
Q Consensus 118 f~~~~~LG~GsFGkV~La~~k~tg~~yAiKvl~K~---~~~~~E~~il~~~~~~pfi~~~~------------------- 175 (966)
|++++.||+|+||+||+|+++.||+.||||++++. .....|.++|++++.|+.|+...
T Consensus 9 Y~l~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~~~~~~E~~i~~~l~~~~~i~~~~~~~~~~~~~~ivme~~~~~ 88 (299)
T d1ckia_ 9 YRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMELLGPS 88 (299)
T ss_dssp EEEEEEEEECSSSEEEEEEETTTTEEEEEEEEESCTTSCCHHHHHHHHHHSTTSTTCCCEEEEEEETTEEEEEEECCCCB
T ss_pred EEEeEEEeeCCCcEEEEEEECCCCCEEEEEEEchhccCHHHHHHHHHHHHccCCCcccEEEEEEecCCEEEEEEEEcCCc
Confidence 68999999999999999999999999999998864 35678999999998777775311
Q ss_pred -----------cccccchhHHHHHHHh----------hcccchhhhHhhh---ccCCceEEecCcccc------------
Q psy11767 176 -----------VEKSTGQEYAVKIISR----------KIDCSEEINLLRA---CQGHPNIVNLHCVFQ------------ 219 (966)
Q Consensus 176 -----------~~~~~~~~~~~~~v~~----------~~~~~~e~nil~~---~~gh~~iv~l~~~~~------------ 219 (966)
+.......++.+++.+ ..|++++ |||.+ .++..+|+||+.+..
T Consensus 89 l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~iiHrDiKp~-NIl~~~~~~~~~vkl~DFG~a~~~~~~~~~~~~~~ 167 (299)
T d1ckia_ 89 LEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPD-NFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPY 167 (299)
T ss_dssp HHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGG-GEEECCGGGTTCEEECCCSSCEECBCTTTCCBCCC
T ss_pred hhhhhhhccCCCcHHHHHHHHHHHHHHHHHHHHCCeeeccCCHh-hccccccCCCceeeeeccCcceeccccccccceec
Confidence 1111111222223222 1255555 99754 445689999987632
Q ss_pred --------------ccccccccCCCcceeeechhhHHHHHHHhhCCCCCCCCcHHHH---HHHHHhCC-----CCCCCCC
Q psy11767 220 --------------DEVIDWDDFSRGIECVFFSSSLIIFFIILSFTLSFIHDYYHIQ---YRRILKTE-----PPIPEDL 277 (966)
Q Consensus 220 --------------~e~i~~~~y~~~~d~~~~~~~~il~~~m~~g~~pf~~~~~~~~---~~~I~~~~-----~~~P~~~ 277 (966)
+|++...+|+...| .|+.|+++|||++|.+||........ +.++.... ...+..+
T Consensus 168 ~~~~~~~gt~~y~aPE~~~~~~~~~~~D---iwSlG~~l~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 244 (299)
T d1ckia_ 168 RENKNLTGTARYASINTHLGIEQSRRDD---LESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIEVLCKGY 244 (299)
T ss_dssp CBCCSCCCCSSSCCHHHHTTBCCCHHHH---HHHHHHHHHHHHHSSCTTCCCC-------HHHHHHHHHHSCHHHHTTTS
T ss_pred cccCCcCCCccccCHHHHhCCCCCChhh---EEecCHHHHHHHhCCCcccccchHHHHHHHHHhhcccCCCChhHhccCC
Confidence 23344445544444 33556778899999999976544332 22222221 1235678
Q ss_pred CHHHHHHHHhhcccCCCcccCCCCCCHHHHhcCCcee-------eeCccccc
Q psy11767 278 SPDVADFISRLLVKDPRRRLGGGELDAEELKRHPFFN-------VIDWDDLA 322 (966)
Q Consensus 278 s~~a~dli~~LL~kdp~~RLG~~~~g~~~Ik~HpfF~-------~idW~~l~ 322 (966)
++++.+||.++|.+||.+|.... -..++.+|+|.+ .+||+.+.
T Consensus 245 p~~~~~li~~cl~~~p~~RP~~~--~i~~~l~~~~~~~~~~~~~~~Dw~~~~ 294 (299)
T d1ckia_ 245 PSEFATYLNFCRSLRFDDKPDYS--YLRQLFRNLFHRQGFSYDYVFDWNMLK 294 (299)
T ss_dssp CHHHHHHHHHHHHSCTTCCCCHH--HHHHHHHHHHHHHTCCCSCCCHHHHGG
T ss_pred CHHHHHHHHHHccCChhHCcCHH--HHHHHHHHHHHHcCCCCCCCcCchhhc
Confidence 99999999999999999996310 123445676653 25666554
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Probab=99.63 E-value=3.8e-16 Score=169.26 Aligned_cols=176 Identities=15% Similarity=0.110 Sum_probs=123.1
Q ss_pred cceeeeecccccceEEEEEEcCCCCEEEEEeccccc---hhhHHHHHHHHhhCCCccccccccccc--------------
Q psy11767 118 LDKAGILGDGSYSVCRRCVEKSTGQEYAVKIISRKI---DCSEEINLLRACQGHPNICRRCVEKST-------------- 180 (966)
Q Consensus 118 f~~~~~LG~GsFGkV~La~~k~tg~~yAiKvl~K~~---~~~~E~~il~~~~~~pfi~~~~~~~~~-------------- 180 (966)
|++++.||+|+||+||+|+++.||+.||||++++.. ...+|.++|.++++||.++........
T Consensus 7 Y~i~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~~vme~~~~~ 86 (293)
T d1csna_ 7 YKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDAPQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLVIDLLGPS 86 (293)
T ss_dssp EEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCTTSCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEEEECCCCB
T ss_pred eEEEEEEecCCCeEEEEEEECCCCCEEEEEEEccccCcHHHHHHHHHHHHhcCCCCCCEEEEEeecCCccEEEEEecCCC
Confidence 589999999999999999999999999999997643 457899999999888988651111111
Q ss_pred ----------------chhHHHHHHHh----------hcccchhhhHhhhc-----cCCceEEecCcccc----------
Q psy11767 181 ----------------GQEYAVKIISR----------KIDCSEEINLLRAC-----QGHPNIVNLHCVFQ---------- 219 (966)
Q Consensus 181 ----------------~~~~~~~~v~~----------~~~~~~e~nil~~~-----~gh~~iv~l~~~~~---------- 219 (966)
...++.+++.. -.|++++ |||.+. +|+.+|+||+.+..
T Consensus 87 l~~~~~~~~~~~~~~~~~~i~~q~~~~l~~lH~~giiHrDiKp~-Nili~~~~~~~~~~vkl~DFG~a~~~~~~~~~~~~ 165 (293)
T d1csna_ 87 LEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHEKSLVYRDIKPD-NFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHI 165 (293)
T ss_dssp HHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGG-GEEECCSSSTTTTCEEECCCTTCEESBCTTTCCBC
T ss_pred HHHHHHhhccchhhHHHHHHHHHHHHHHHHHHHCCceeccCCcc-ceeecCcccccCCceEEcccceeEEcccCccccce
Confidence 11111122211 1255555 999853 57889999997631
Q ss_pred ----------------ccccccccCCCcceeeechhhHHHHHHHhhCCCCCCC---CcHHHHHHHHHhCCCC-----CCC
Q psy11767 220 ----------------DEVIDWDDFSRGIECVFFSSSLIIFFIILSFTLSFIH---DYYHIQYRRILKTEPP-----IPE 275 (966)
Q Consensus 220 ----------------~e~i~~~~y~~~~d~~~~~~~~il~~~m~~g~~pf~~---~~~~~~~~~I~~~~~~-----~P~ 275 (966)
+|++....|+...| .|+.|+++|+|++|.+||.. .+....+++|...+.. .+.
T Consensus 166 ~~~~~~~~~GT~~y~aPE~~~~~~~~~~~D---iwSlG~~l~elltg~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~~ 242 (293)
T d1csna_ 166 PYREKKNLSGTARYMSINTHLGREQSRRDD---LEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQSTPLRELCA 242 (293)
T ss_dssp CCCCCCCCCSCTTTCCHHHHTTCCCCHHHH---HHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHHHHHHHHSCHHHHTT
T ss_pred eecccCceEEchhhcCHHHhcCCCCChHHH---HHHhhHHHHHHHhCCCcCCCccchhHHHHHHHHHhccCCCChHHhcC
Confidence 24444445554444 45778888999999999974 3344456666543322 335
Q ss_pred CCCHHHHHHHHhhcccCCCccc
Q psy11767 276 DLSPDVADFISRLLVKDPRRRL 297 (966)
Q Consensus 276 ~~s~~a~dli~~LL~kdp~~RL 297 (966)
.++++..+|+..++..+|.+|.
T Consensus 243 ~~p~~l~~ii~~~~~~~~~~rP 264 (293)
T d1csna_ 243 GFPEEFYKYMHYARNLAFDATP 264 (293)
T ss_dssp TSCHHHHHHHHHHHHCCTTCCC
T ss_pred CCCHHHHHHHHHHhcCCcccCc
Confidence 7889999999999999999995
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.62 E-value=3.3e-16 Score=171.29 Aligned_cols=184 Identities=13% Similarity=0.114 Sum_probs=119.9
Q ss_pred CcceeeeecccccceEEEEEEcCCCC---EEEEEecccc------chhhHHHHHHHHhhCCCcccccccc--cccc----
Q psy11767 117 DLDKAGILGDGSYSVCRRCVEKSTGQ---EYAVKIISRK------IDCSEEINLLRACQGHPNICRRCVE--KSTG---- 181 (966)
Q Consensus 117 df~~~~~LG~GsFGkV~La~~k~tg~---~yAiKvl~K~------~~~~~E~~il~~~~~~pfi~~~~~~--~~~~---- 181 (966)
..++-++||+|+||+||+|++..++. .||||.+++. ....+|.++|.++ +||+|++.+-. ....
T Consensus 28 ~~~~~~~iG~G~fg~Vyk~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l-~HpnIv~~~g~~~~~~~~~~l 106 (311)
T d1r0pa_ 28 IVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDF-SHPNVLSLLGICLRSEGSPLV 106 (311)
T ss_dssp EEEEEEEEEEETTEEEEEEEECC----CEEEEEEEECCCCCHHHHHHHHHHHHHHHTC-CCTTBCCCCEEEEETTTEEEE
T ss_pred eeccceEEeecCCeEEEEEEEECCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhC-CCCCEeEEeEEEEecCCceEE
Confidence 34456899999999999999876543 6999999863 2458899999998 59999873211 0000
Q ss_pred --------------------------hhHHHHHHHh----------hcccchhhhHhhhccCCceEEecCcccc------
Q psy11767 182 --------------------------QEYAVKIISR----------KIDCSEEINLLRACQGHPNIVNLHCVFQ------ 219 (966)
Q Consensus 182 --------------------------~~~~~~~v~~----------~~~~~~e~nil~~~~gh~~iv~l~~~~~------ 219 (966)
..++.++..+ ..|+++. |||++..++++|.||+.+..
T Consensus 107 v~E~~~~g~l~~~~~~~~~~~~~~~~~~i~~qia~gL~~lH~~~iiHrDLK~~-NILl~~~~~~kL~DFG~~~~~~~~~~ 185 (311)
T d1r0pa_ 107 VLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASKKFVHRDLAAR-NCMLDEKFTVKVADFGLARDMYDKEF 185 (311)
T ss_dssp EEECCTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGG-GEEECTTCCEEECSSGGGCCTTTTTC
T ss_pred EEEEeecCchhhhhccccccchHHHHHHHHHHHHHhhhhhcccCcccCCccHH-hEeECCCCCEEEecccchhhcccccc
Confidence 0011112111 1144444 99999999999999986642
Q ss_pred -----------------ccccccccCCCcceeeechhhHHHHHHHhh-CCCCCCCCcHHHHHHHHHhC-CCCCCCCCCHH
Q psy11767 220 -----------------DEVIDWDDFSRGIECVFFSSSLIIFFIILS-FTLSFIHDYYHIQYRRILKT-EPPIPEDLSPD 280 (966)
Q Consensus 220 -----------------~e~i~~~~y~~~~d~~~~~~~~il~~~m~~-g~~pf~~~~~~~~~~~I~~~-~~~~P~~~s~~ 280 (966)
+|++....|+... |-|++ |+++|||++ +.||+...+...+...|..+ .+..|..++++
T Consensus 186 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~ks--DI~Sf-Givl~El~t~~~p~~~~~~~~~~~~~i~~g~~~~~p~~~~~~ 262 (311)
T d1r0pa_ 186 DSVHNKTGAKLPVKWMALESLQTQKFTTKS--DVWSF-GVLLWELMTRGAPPYPDVNTFDITVYLLQGRRLLQPEYCPDP 262 (311)
T ss_dssp CCTTCTTCSSCCGGGSCHHHHHHCCCCHHH--HHHHH-HHHHHHHHTTSCCSCC------CHHHHHTTCCCCCCTTCCHH
T ss_pred ccceecccccccccccChHHHhcCCCCChh--Hhhhh-HHHHHHHHHCCCCCCCCCCHHHHHHHHHcCCCCCCcccCcHH
Confidence 1223333343333 34554 455555554 66666555555667777765 56788999999
Q ss_pred HHHHHHhhcccCCCcccCCCCCCHHHHhcC
Q psy11767 281 VADFISRLLVKDPRRRLGGGELDAEELKRH 310 (966)
Q Consensus 281 a~dli~~LL~kdp~~RLG~~~~g~~~Ik~H 310 (966)
+.+||.++|.+||.+|. .+.||.+|
T Consensus 263 l~~li~~cl~~dP~~RP-----s~~ei~~~ 287 (311)
T d1r0pa_ 263 LYEVMLKCWHPKAEMRP-----SFSELVSR 287 (311)
T ss_dssp HHHHHHHHTCSSGGGSC-----CHHHHHHH
T ss_pred HHHHHHHHcCCCHhHCc-----CHHHHHHH
Confidence 99999999999999997 48899887
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.34 E-value=3.6e-13 Score=146.15 Aligned_cols=92 Identities=20% Similarity=0.270 Sum_probs=77.4
Q ss_pred hHHHHhCCcCCCcceeeeeccccC----ceEEEEEeccCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHh----
Q psy11767 869 FEEQLLGPITRARRRTFVNRSRYN----VHTYLVLELLKGGELLDRIRQKGRCGFTENEASRIMRQLVAAVHFMHS---- 940 (966)
Q Consensus 869 ~e~~il~~l~~~~i~~~~~~~~~~----~~~yLVmEy~~gg~L~~~i~~~~~~~~~~~~~~~~~~qi~~al~ylH~---- 940 (966)
.|...+..++||||+++++..... ..+|||||||++|+|.+++.+. .++..+...++.|++.|+.|+|.
T Consensus 46 ~ei~~~~~~~HpnIv~~~~~~~~~~~~~~~~~lv~Ey~~~g~L~~~l~~~---~l~~~~~~~~~~~ia~gl~~lH~~~~~ 122 (303)
T d1vjya_ 46 AEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYLNRY---TVTVEGMIKLALSTASGLAHLHMEIVG 122 (303)
T ss_dssp HHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEEEECCTTCBHHHHHHHC---CBCHHHHHHHHHHHHHHHHHHHCCBCS
T ss_pred HHHHHHhhCCCCcCcceEEEEEeCCCcceEEEEEEecccCCCHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHhhhh
Confidence 355566789999999999876543 3689999999999999999765 38999999999999999999996
Q ss_pred ----CCCcccCCCCCCeEeecCCCCeeee
Q psy11767 941 ----RGVVHRDLKPENLLLSGISGNLIKI 965 (966)
Q Consensus 941 ----~gIiHRDlKPeNILl~~~~~~~iki 965 (966)
+|||||||||+||||+.+ + .+||
T Consensus 123 ~~~~~~IvHrDlKp~NILl~~~-~-~~Kl 149 (303)
T d1vjya_ 123 TQGKPAIAHRDLKSKNILVKKN-G-TCCI 149 (303)
T ss_dssp TTCBCEEECSCCCGGGEEECTT-S-CEEE
T ss_pred hccCCCeeccccCccceEEcCC-C-CeEE
Confidence 699999999999999753 3 3454
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Probab=99.03 E-value=3.3e-11 Score=121.21 Aligned_cols=77 Identities=21% Similarity=0.275 Sum_probs=62.4
Q ss_pred hhHHHHhCCcCCCcceeeeeccccCceEEEEEeccCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccC
Q psy11767 868 LFEEQLLGPITRARRRTFVNRSRYNVHTYLVLELLKGGELLDRIRQKGRCGFTENEASRIMRQLVAAVHFMHSRGVVHRD 947 (966)
Q Consensus 868 l~e~~il~~l~~~~i~~~~~~~~~~~~~yLVmEy~~gg~L~~~i~~~~~~~~~~~~~~~~~~qi~~al~ylH~~gIiHRD 947 (966)
..|...+.++.+.+++..++... .+|||||+.+..+.+ ++...+..++.|++.++.|||++||+|||
T Consensus 62 ~~e~~~l~~l~~~~v~~~~~~~~----~~lvme~~~~~~~~~---------l~~~~~~~i~~ql~~~l~~lH~~giiHrD 128 (191)
T d1zara2 62 RNEFRALQKLQGLAVPKVYAWEG----NAVLMELIDAKELYR---------VRVENPDEVLDMILEEVAKFYHRGIVHGD 128 (191)
T ss_dssp HHHHHHHHHTTTSSSCCEEEEET----TEEEEECCCCEEGGG---------CCCSCHHHHHHHHHHHHHHHHHTTEECSC
T ss_pred HHHHHHHHHccCCCcceEEEecC----CEEEEEeeccccccc---------hhhHHHHHHHHHHHHHHHHHhhCCEEEcc
Confidence 45777888899988887765432 279999998864321 45566778999999999999999999999
Q ss_pred CCCCCeEeec
Q psy11767 948 LKPENLLLSG 957 (966)
Q Consensus 948 lKPeNILl~~ 957 (966)
|||+|||++.
T Consensus 129 iKP~NILv~~ 138 (191)
T d1zara2 129 LSQYNVLVSE 138 (191)
T ss_dssp CSTTSEEEET
T ss_pred CChhheeeeC
Confidence 9999999985
|
| >d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Type IIIa 3',5"-aminoglycoside phosphotransferase species: Enterococcus faecalis [TaxId: 1351]
Probab=98.05 E-value=1.3e-05 Score=82.65 Aligned_cols=74 Identities=11% Similarity=0.101 Sum_probs=56.3
Q ss_pred cccccccEEEEEEEcCCCcEEEEEEecccc-----ChHHHHHHHHHhcCCCCceEEEEEEEeCCeEEEEEEccCCCCHHH
Q psy11767 386 LGDGSYSVCRRCVEKSTGQEYAVKIISRKI-----DCSEEINLLRACQGHPNIVNLHCVFQDEVHTYLVLELLKGGELLD 460 (966)
Q Consensus 386 LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~-----~~~~Ei~iL~~l~~HpnIV~l~~~~~~~~~~~lVmEy~~gg~L~~ 460 (966)
.+.|+.+.||+.. ..++.+.||+..... ...+|...|+.+.++--+.+++.++.+++..|+||++++|..+.+
T Consensus 22 ~~G~s~~~v~rv~--~~~~~~vlk~~~~~~~~~~~~~~~E~~~l~~l~~~vpvP~vl~~~~~~~~~~lv~~~l~G~~~~~ 99 (263)
T d1j7la_ 22 TEGMSPAKVYKLV--GENENLYLKMTDSRYKGTTYDVEREKDMMLWLEGKLPVPKVLHFERHDGWSNLLMSEADGVLCSE 99 (263)
T ss_dssp SCCCSSSEEEEEE--CSSCEEEEEEECGGGTTSTTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEECCSSEEHHH
T ss_pred CCCCCCCcEEEEE--eCCCeEEEEEcCCCcccchhhHHHHHHHHHHHhccCCCCcEEEEEecCCceEEEEEecccccccc
Confidence 3345557899875 456678889876432 356899999888767667889999999999999999999877754
Q ss_pred H
Q psy11767 461 R 461 (966)
Q Consensus 461 ~ 461 (966)
.
T Consensus 100 ~ 100 (263)
T d1j7la_ 100 E 100 (263)
T ss_dssp H
T ss_pred c
Confidence 3
|
| >d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Methylthioribose kinase MtnK species: Bacillus subtilis [TaxId: 1423]
Probab=97.35 E-value=0.00018 Score=79.27 Aligned_cols=73 Identities=15% Similarity=0.132 Sum_probs=48.3
Q ss_pred ccccccccccEEEEEEEcCCCcEEEEEEecc------c---cC---hHHHHHHHHHhcCC--CCceEEEEEEEeCCeEEE
Q psy11767 383 AGILGDGSYSVCRRCVEKSTGQEYAVKIISR------K---ID---CSEEINLLRACQGH--PNIVNLHCVFQDEVHTYL 448 (966)
Q Consensus 383 ~~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~------~---~~---~~~Ei~iL~~l~~H--pnIV~l~~~~~~~~~~~l 448 (966)
.+.||.|....||++.+..+++.|.||.-.. . .. ...|.+.|+.+..+ ..+++++.+ ++...++
T Consensus 31 ~~eig~G~~N~vfrV~~~~~~~svivKqa~p~~r~~g~~~~~~~~R~~~E~~~L~~~~~~~p~~vP~v~~~--d~~~~~l 108 (392)
T d2pula1 31 CQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--DTEMAVT 108 (392)
T ss_dssp EEECCSSSSEEEEEEEC----CEEEEEEECCGGGC--CCCCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--ETTTTEE
T ss_pred EEEeCCCceEeEEEEEeCCCCeEEEEecCCchhcccCCCCCCCHHHHHHHHHHHHHhhhhCCCCcceEEEE--cCCCCEE
Confidence 3468999999999999888888999996431 0 01 34588888876544 346666654 4445689
Q ss_pred EEEccCCCC
Q psy11767 449 VLELLKGGE 457 (966)
Q Consensus 449 VmEy~~gg~ 457 (966)
|||++.+..
T Consensus 109 vmE~L~~~~ 117 (392)
T d2pula1 109 VMEDLSHLK 117 (392)
T ss_dssp EECCCTTSE
T ss_pred EEeccCCcc
Confidence 999997654
|
| >d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]
Probab=97.28 E-value=0.00042 Score=70.49 Aligned_cols=72 Identities=15% Similarity=0.052 Sum_probs=51.7
Q ss_pred ccccc-ccEEEEEEEcCCCcEEEEEEecccc--ChHHHHHHHHHhcCC-CCceEEEEEEEeCCeEEEEEEccCCCCH
Q psy11767 386 LGDGS-YSVCRRCVEKSTGQEYAVKIISRKI--DCSEEINLLRACQGH-PNIVNLHCVFQDEVHTYLVLELLKGGEL 458 (966)
Q Consensus 386 LG~G~-fG~Vy~a~~~~tg~~vAvK~i~~~~--~~~~Ei~iL~~l~~H-pnIV~l~~~~~~~~~~~lVmEy~~gg~L 458 (966)
+..|. -+.||+... ..+..+.+|+-.... ....|...|+.+..+ -.+.+++.+..+++..++|||+++|.++
T Consensus 18 ~~~G~s~~~v~r~~~-~~~~~~vlK~~~~~~~~~l~~E~~~l~~L~~~gvpvP~v~~~~~~~~~~~~v~~~i~G~~~ 93 (255)
T d1nd4a_ 18 QTIGCSDAAVFRLSA-QGRPVLFVKTDLSGALNELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGEVPGQDL 93 (255)
T ss_dssp CSCTTSSCEEEEEEC-TTSCCEEEEEECSCTTSCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEECCSSEET
T ss_pred cCCcccCCeEEEEEe-CCCCEEEEEeCCccCHhHHHHHHHHHHHHHhcCCCCCceeeecccccceEEEEEeeecccc
Confidence 34444 367898764 456678889875432 466799988877543 3367888888888899999999987554
|
| >d1nw1a_ d.144.1.8 (A:) Choline kinase {Caenorhabditis elegans [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Choline kinase domain: Choline kinase species: Caenorhabditis elegans [TaxId: 6239]
Probab=95.79 E-value=0.0085 Score=65.23 Aligned_cols=71 Identities=8% Similarity=0.009 Sum_probs=49.4
Q ss_pred ccccccccccEEEEEEEcC-------CCcEEEEEEecccc---ChHHHHHHHHHhcCCCCceEEEEEEEeCCeEEEEEEc
Q psy11767 383 AGILGDGSYSVCRRCVEKS-------TGQEYAVKIISRKI---DCSEEINLLRACQGHPNIVNLHCVFQDEVHTYLVLEL 452 (966)
Q Consensus 383 ~~~LG~G~fG~Vy~a~~~~-------tg~~vAvK~i~~~~---~~~~Ei~iL~~l~~HpnIV~l~~~~~~~~~~~lVmEy 452 (966)
++.|+.|--=.+|++.... ..+.|.+++..... +..+|..+++.+..+.-..+++++|.+ .+||||
T Consensus 47 v~~l~GGltN~~y~v~~~~~~~~~~~~~~~vllRi~g~~~~~idr~~E~~i~~~ls~~gl~Pkll~~~~~----g~I~ef 122 (395)
T d1nw1a_ 47 ISRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNPETESHLVAESVIFTLLSERHLGPKLYGIFSG----GRLEEY 122 (395)
T ss_dssp EEEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSCCCHHHHHHHHHHHHHHHHTTSSSCEEEEETT----EEEECC
T ss_pred EEEcCCccccceEEEEeCCCCccccCCCCcEEEEecCCcchhhHHHHHHHHHHHHHhCCCCCeEEEEcCC----ceEEEE
Confidence 4567777777899987653 34567777765322 244688899888766555688888753 689999
Q ss_pred cCCCC
Q psy11767 453 LKGGE 457 (966)
Q Consensus 453 ~~gg~ 457 (966)
++|..
T Consensus 123 i~g~~ 127 (395)
T d1nw1a_ 123 IPSRP 127 (395)
T ss_dssp CCEEE
T ss_pred ecccc
Confidence 98743
|
| >d1zyla1 d.144.1.6 (A:4-328) RdoA {Escherichia coli [TaxId: 562]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: RdoA species: Escherichia coli [TaxId: 562]
Probab=94.35 E-value=0.038 Score=58.10 Aligned_cols=63 Identities=11% Similarity=0.150 Sum_probs=40.1
Q ss_pred cEEEEEEEcCCCcEEEEEEecccc----ChHHHHHHHHHhcCC----CCceEE--EEEEEeCCeEEEEEEccCC
Q psy11767 392 SVCRRCVEKSTGQEYAVKIISRKI----DCSEEINLLRACQGH----PNIVNL--HCVFQDEVHTYLVLELLKG 455 (966)
Q Consensus 392 G~Vy~a~~~~tg~~vAvK~i~~~~----~~~~Ei~iL~~l~~H----pnIV~l--~~~~~~~~~~~lVmEy~~g 455 (966)
-.||++.. .+|+.|++|+..... ....|...|..|..+ +..+.. -..+..++..+.+++++.|
T Consensus 36 N~vy~v~~-~dg~~~VlK~~rp~~~s~~~i~~E~~~l~~L~~~gipv~~p~~~~g~~~~~~~~~~~~l~~~~~G 108 (325)
T d1zyla1 36 NRVYQFQD-EDRRRFVVKFYRPERWTADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPSVGG 108 (325)
T ss_dssp SEEEEECC-TTCCCEEEEEECTTTSCHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEECCCC
T ss_pred ceeEEEEc-CCCCEEEEEEeCCCCCCHHHHHHHHHHHHHHHhcCCCCCCceecCCCeeeeeeeEEEEEEeecCC
Confidence 47998765 468889999975432 245688888776522 111111 1223556778999999976
|
| >d2ppqa1 d.144.1.6 (A:5-320) Homoserine kinase ThrB {Agrobacterium tumefaciens [TaxId: 358]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Homoserine kinase ThrB species: Agrobacterium tumefaciens [TaxId: 358]
Probab=92.09 E-value=0.14 Score=53.03 Aligned_cols=31 Identities=39% Similarity=0.708 Sum_probs=25.0
Q ss_pred cCceeccCCCCcEEEecCCCCCEEEEeeccccc
Q psy11767 492 RGVVHRDLKPENLLFSDPAGDNIKVVDFGFACL 524 (966)
Q Consensus 492 ~~IiHRDLKP~NILl~~~~~~~iKL~DFGla~~ 524 (966)
.|+||.|+.++|||+++ +...-|+||+.++.
T Consensus 183 ~giIHgDl~~dNvl~~~--~~v~gvIDF~~~~~ 213 (316)
T d2ppqa1 183 AGVIHADLFQDNVFFLG--DELSGLIDFYFACN 213 (316)
T ss_dssp EEEECSCCCGGGEEEET--TEEEEECCCTTCEE
T ss_pred cccccCCcchhhhhccc--ccceeEeccccccc
Confidence 47999999999999974 33457999998743
|
| >d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Type IIIa 3',5"-aminoglycoside phosphotransferase species: Enterococcus faecalis [TaxId: 1351]
Probab=90.15 E-value=0.11 Score=52.01 Aligned_cols=28 Identities=11% Similarity=0.065 Sum_probs=19.8
Q ss_pred eeeeeccccCceEEEEEeccCCCCHHHH
Q psy11767 883 RTFVNRSRYNVHTYLVLELLKGGELLDR 910 (966)
Q Consensus 883 ~~~~~~~~~~~~~yLVmEy~~gg~L~~~ 910 (966)
++++.....+...|+|||+++|.++.+.
T Consensus 73 P~vl~~~~~~~~~~lv~~~l~G~~~~~~ 100 (263)
T d1j7la_ 73 PKVLHFERHDGWSNLLMSEADGVLCSEE 100 (263)
T ss_dssp CCEEEEEEETTEEEEEEECCSSEEHHHH
T ss_pred CcEEEEEecCCceEEEEEeccccccccc
Confidence 4444444556788999999999776543
|